id|nct_id|organization|name|phone|email|extension
21251468|NCT00903760|The University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Professor, Leukemia|713-745-3428|ggarciam@mdanderson.org|
21251469|NCT01177956|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21297203|NCT01835223|Roswell Park Cancer Institute|Katy Wang, Statistician, M.A.|716-845-1300|katy.wang@roswellpark.org|6269
21297204|NCT00787189|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
21297205|NCT01458418|Children's Mercy Hospital|Corey Schurman|8162343000|crschurman@cmh.edu|
21297206|NCT02718716|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21297207|NCT02942485|University of Helsinki|Dr. Svetlana Vakkilainen|+358407693375|svetlanakostjukovitch@gmail.com|
21297208|NCT02638168|Penn State Health Milton S Hershey Medical Center|Raman Baweja, MD, MS|7175318134|rbaweja@pennstatehealth.psu.edu|
21297209|NCT01991522|St. Michael's|Dr. Samir C. Grover|416-864-5628|samir.grover@utoronto.ca|
21297210|NCT04302545|King Edward Medical University, Lahore, Pakistan|Shazia Saaqib|+92-3214708583|shaziasaaqib@gmail.com|
21236261|NCT04745169|Baylor College of Medicine|Elizabeth Lorenz, MD|713-798-2694|elizabeth.lorenz@bcm.edu|
21236262|NCT00639717|University of Michigan Comprehensive Cancer Center|Dr. Gregory Yanik|734-764-3243|jelevine@umich.edu|
21236263|NCT00746954|Louis Stokes DVA Medical Center|Kingman P. Strohl MD|216-7913800|kingman.strohl@va.gov|
21236264|NCT04396834|UNC-Chapel Hill|Christian Hendershot|(919) 962-5565|christian_hendershot@med.unc.edu|
21236265|NCT02053350|UVirginia|Dr. Cirle Warren|(434) 924-5242|CA6T@hscmail.mcc.virginia.edu|
21236266|NCT03521635|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21236267|NCT00896168|Xian-Janssen Pharmaceutical Ltd|Director of Medical Affairs|(8610) 5821 8359||
21236268|NCT03832010|Cutaneous Translational Research Program|Ruizhi Wang|4105027546|rwang@jhmi.edu|
21236269|NCT01227889|GlaxoSmithKline|GSK Response Center|866-435-7343||
21236270|NCT01148810|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21236271|NCT02165722|University of Pittsburgh|Richard K. Zimmerman, MD, MPH, MA|412-383-2354|zimmer@pitt.edu|
21236272|NCT02880852|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21236273|NCT01235910|University of Colorado|Christina Aquilante, Pharm.D.|303-724-6126|christina.aquilante@ucdenver.edu|
21236274|NCT05423509|University of New Mexico Health System|Selina Silva, MD|505-272-4107|ssilva@salud.unm.edu|
21236275|NCT06390098|Asceneuron SA|Asceneuron Clinical Research|+ 41 21 353 8245|clinicaltrials.gov@asceneuron.com|
21236276|NCT02417246|UF|Dr. Larisa H Cavallari|352-273-8245|lcavallari@cop.ufl.edu|
21236277|NCT03535649|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
21236278|NCT00317239|Luitpold Pharmaceuticals, Inc.|Mark Falone|610-650-4200|mfalone@luitpold.com|
21236279|NCT04408469|Yale University School of Public Health|Dr. Danielle Chiaramonte|646-429-9407|danielle.chiaramonte@yale.edu|
21236280|NCT04321460|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21236281|NCT02824913|Parion Sciences|Jose Boyer|919-313-1182|jboyer@parion.com|
21236282|NCT02553330|Incyte Organization|Study Director|855-463-3463|medinfo@incyte.com|
21251470|NCT01639742|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21251471|NCT02330276|Va San Diego Healthcare System|Robert R. Henry, MD|8585528585|rrhenry@outlook.com|3648
21251472|NCT01256671|Endoceutics|Director of Data Analysis|418-653-0033|celine.martel@endoceutics.com|215
21251473|NCT01266018|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21251474|NCT03167151|Oxford University Hospitals NHS Foundation Trust|Dr Andrew S Protheroe|01865 253275|andrew.protheroe@oncology.ox.ac.uk|
21251475|NCT01458522|Duke University|Aatif M. Husain, M.D.|919-668-8700|aatif.husain@duke.edu|
21251476|NCT00516139|GlaxoSmithKline|GSK Response Center|866-435-7343||
21251477|NCT00416598|The Ohio State University|William Blum, M.D.||William.Blum@osumc.edu|
21281966|NCT03548779|University of North Carolina at Chapel Hill|Jonathan Berg, MD, PhD|919-966-7043|jonathan_berg@med.unc.edu|
21297211|NCT04003987|Indiana University School of Medicine|Yar Yeap|(317) 274-0275|yyeap@iupui.edu|
21297212|NCT00084656|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
21297213|NCT00651625|University of New Mexico|Wilmer L. Sibbitt, MD, Principal Investigator|505 272-4761|wsibbitt@salud.unm.edu|
21297214|NCT03550404|Pacific Institute for Research and Evaluation|Cathleen Willging|505-765-2328|cwillging@pire.org|
21297215|NCT00908466|University of Nebraska|Quan Dong Nguyen, MD, MSc|4025591855|quan.nguyen@unmc.edu|
21297216|NCT00666965|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
21297217|NCT03624127|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
21297218|NCT03036189|Montana State University|Suzanne Held|4069946321|suzanne@montana.edu|
21297219|NCT01860950|Medical University of South Carolina|Dr. Jeffrey J. Borckardt|8437923295|borckard@musc.edu|
21297220|NCT01204216|Research Service, Cincinnati VA Medical Center|Robert M Cohen, MD, Physician,|5136748676|robert.cohen@uc.edu|
21297221|NCT04775264|AtriAN Medical Ltd|Barry O'Brien|+353872934292|barry.obrien@atrianmedical.com|
21297222|NCT03665688|UTMB Galveston|Antonio Saad Director of Clinical Research Division|409 772 0982|afsaad@utmb.edu|
21297223|NCT03238924|Medical University of South Carolina|Dr. Julianne Flanagan|843-792-5569|Hellmuth@musc.edu|
21236283|NCT01205685|Vanderbilt-Ingram Cancer Center|Dr. Ingrid Mayer|615-936-2033|ingrid.mayer@vanderbilt.edu|
21236284|NCT01666002|Stanford University|Jean Tang MD PhD, assistant professor|650-723-6316|tangy@stanford.edu|
21281967|NCT01481766|Hospital for Sick Children, Toronto, Canada|Dr. Patricia Parkin|416-81307654|patricia.parkin@sickkids.ca|
21297224|NCT03576716|University of Washington|Dr. Ian de Boer|206-616-5403|IDeBoer@Nephrology.washington.edu|
21297225|NCT00559988|Biotronik, Inc|Crystal Miller|503-451-8051|crystal.miller@biotronik.com|
21236285|NCT05053087|Mayo Clinic|Benjamin K. Wilke, M.D.|904-953-2405|Wilke.Benjamin@mayo.edu|
21251478|NCT01226732|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21266637|NCT04284787|Yale School of Medicine|Amer Zeidan, MBBS Professor of Internal Medicine (Hematology)|(203) 200-4363|amer.zeidan@yale.edu|
21281968|NCT00347958|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21297226|NCT02891382|Universidad Peruana Cayetano Heredia|Dr. J Jaime Miranda|+511 241 69 78|Jaime.Miranda@upch.pe|
21297227|NCT01455194|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21297228|NCT02249182|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21297229|NCT02516228|Philips|Sr. Clinical Operations Manager|3034753417|pat.olsen@philips.com|
21297230|NCT03916484|University of North Carolina at Chapel Hill|Kate Muessig, PhD|850-644-3299|kmuessig@fsu.edu|
21297231|NCT05090852|UPenn|Natasha Mirza, MD|215 662 2979|natasha.mirza@pennmedicine.upenn.edu|
21297232|NCT01196416|Memorial Sloan Kettering Cancer Center|Dr. Mark Dickson|646-888-4164|DicksonM@mskcc.org|
21297233|NCT00504894|Weill Cornell Medicine|Kane Pryor|(212) 746-2953|kap9009@med.cornell.edu|
21297234|NCT00148941|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21297235|NCT03050320|McMaster University/University of Waterloo|Dr. Monica Maly|519-888-4567|mrmaly@uwaterloo.ca|37916
21236286|NCT04171700|University of Pennsylvania|Kim Reiss Binder|1 215 360 0735|Kim.ReissBinder@uphs.upenn.edu|
21236287|NCT01169467|Duke University Medical Center|Dr. Keith Dombrowski|(919)|keith.dombrowski@dm.duke.edu|
21236288|NCT03058679|University of Pennsylvania|Dr. James D. Lewis|215-573-5137|lewisjd@pennmedicine.upenn.edu|
21236289|NCT01098006|GlaxoSmithKline|GSK Response Center|866-435-7343||
21236290|NCT04137380|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21236291|NCT04634604|Jaeb Center for Health Research|Ray Kraker|8139758690|rkraker@jaeb.org|
21236292|NCT00346034|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21236293|NCT03660683|George Washington University Medical Faculty Associates|Dr. Sabyasachi Sen|301-461-6676|ssen1@email.gwu.edu|
21236294|NCT00941603|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21236295|NCT02079805|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21236296|NCT00383435|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21236297|NCT00583557|GlaxoSmithKline|GSK Response Center|866-435-7343||
21236298|NCT02347761|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
21236299|NCT03950739|United Therapeutics Corp.|United Therapeutics Global Medical Information|919-485-8350|clinicaltrials@unither.com|
21236300|NCT03625570|Louisiana State University Health Sciences Center - New Orleans|Dr. Noelle G. Moreau|504-568-4291|nmorea@lsuhsc.edu|
21236301|NCT03646513|Smith+Nephew, Inc.|Andrew Copey|+61.490.503.157|andrew.copley@smith-nephew.com|
21236302|NCT01732835|Biostable Science and Engineering, Inc.|John Wheeler|512-386-1996|John.wheeler@biostable-s-e.com|
21236303|NCT02334748|Novartis Pharma AG|Study Director|+1 (862) 778-8300|Novartis.email@novartis.com|
21236304|NCT01046643|The University of Michigan|Dr. Yolanda Smith|(734) 936-7401|ysmith@med.umich.edu|
21236305|NCT02388321|Maimonides Medical Center|Sergey Motov, MD (Prinicipal Investigator)|718-283-8693|smotov@maimonidesmed.org|
21236306|NCT01776645|Stanford University|Dr. Sean Mackey|650-724-2795|smackey@pain.stanford.edu|
21297236|NCT01092663|KineMed, Inc.|Carine Beysen, PhD|510-655-6525|cbeysen@kinemed.com|123
21297237|NCT00788710|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21236307|NCT00817089|UPENN|David Oslin|215 823 5894|oslin@upenn.edu|
21236308|NCT00283504|CHILDREN'S HOSPITAL OF THE KING'S DAUGHTERS|MARIPAZ MORALES MD|7576688255|MARIPAZ.MORALES@CHKD.ORG|
21236309|NCT00823082|GrifolsTherapeutics Inc.|Michael Ken Woodward, BSc, M.Sc|+1 919-316-6675|michael.woodward@grifols.com|
21236310|NCT03452917|University of Washington|Francis Kim|206-897-5264|fkim@u.washington.edu|
21236311|NCT03198000|Johnson & Johnson Consumer Inc.|Amisha Parikh-Das, PhD, MPH|(973) 255-8701|AParikh1@its.jnj.com|
21236312|NCT02937545|Duke University School of Medicine|Susanne B Haga|919-684-0325|susanne.haga@duke.edu|
21236313|NCT01767116|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
21236314|NCT00659633|University of Alabama at Birmigham|Dr. Michael Froelich|205-975-3328|mfroelich@uabmc.edu|
21236315|NCT00968669|MedImmune|Joe Parker, MD|301-398-0000|parkerJ@medimmune.com|
21236316|NCT02255175|UNC School of Medicine|Crystal Edler Schiller, PhD|919-966-4810|crystal_schiller@med.unc.edu|
21236317|NCT03836287|Botanix Pharmaceuticals|Anthony Robinson MS CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
21236318|NCT00986999|University of Hawaii|Cecilia M. Shikuma M.D.|808 692-1328|shikuma@hawaii.edu|
21236319|NCT05799495|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21236320|NCT02100072|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
21236321|NCT04644328|Massachusetts Institute of Technology|Esther Duflo|617-258-7013|eduflo@mit.edu|
21236322|NCT04102501|Retrotope|Mark G. Midei, MD, VP Medical Affairs|4103715357|mark@retrotope.com|
21236323|NCT03329352|Fisher & Paykel Healthcare|Hanie Yee|+64 9 574 0123|Hanie.Yee@fphcare.co.nz|7909
21297238|NCT01008904|Virginia Commonwealth University|Thomas J. Smith, MD|410-955-2091|tsmit136@jhmi.edu|
21236324|NCT02338362|Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada|Dr. Graham Trope|1-416-603-5117|graham.trope@uhn.ca|
21236325|NCT04798586|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21251479|NCT02166476|The Medicines Company|Global Health Science Center|888-977-6326|medical.information@themedco.com|
21251480|NCT05155566|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21251481|NCT03752177|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21281969|NCT04033237|University of Vermont|Sarah H. Heil, PhD|802-656-8712|Sarah.Heil@uvm.edu|
21297239|NCT00365274|The University of Texas (UT) MD Anderson Cancer Center|Michelle Fanale, MD / Associate Professor||CR_Study_Registration@mdanderson.org|
21297240|NCT04534881|Saint Louis University|Sandeep Dhindsa|13149774911|sandeep.dhindsa@health.slu.edu|
21297241|NCT01008449|UAB|Principal Investigator|205-934-3411|dana_figueroa_marzilli@hotmail.com|
21251482|NCT04367480|University of Rochester NCORP Research Base|Jennifer Gewandter, PhD|585-275-2141|Jennifer_Gewandter@urmc.rochester.edu|
21251483|NCT03382561|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21251484|NCT01076244|Center for Pain Relief|Timothy Deer|(304) 347-6144|Diana.tolentino@stfh.net|
21251485|NCT03427060|Akari Therapeutics|Chief Scientific Officer|+44 208 004 0261|miles.nunn@akaritx.com|
21251486|NCT00781937|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21251487|NCT00013611|University of Minnesota|Gary Collins, M.S.|612-626-9006|gary-c@ccbr.umn.edu|
21251488|NCT01150045|Alliance for Clinical Trials in Oncology|Jeffrey A. Meyerhardt, MD, MPH|617-632-6855|jmeyerhardt@partners.org|
21281970|NCT02159053|Novartis Pharmaceuticals|Study Director|8627788300||
21251489|NCT01432626|University of Pittsburgh|Dr. Prem Soman|412 647 3435|somanp@upmc.edu|
21251490|NCT01642147|Huashan Hospital Fudan University|Xiao-Yu Yang|086-021-52889999|xiaoyuyangfudan@gmail.com|7693
21251491|NCT01657799|AbbVie|Global Medical Services|800-633-9110||
21251492|NCT00174447|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21251493|NCT02367430|Columbia University|Dr. Carolyn Rodriguez|650-723-6158|cr2163@stanford.edu|
21251494|NCT00568698|Stanford University|Principal Investigator||clinicaltrials-gov@lists.stanford.edu|
21251495|NCT03021551|Masimo Corporation|Cristina Johnson|949-297-7000|ClinicalResearchDept@masimo.com|
21251496|NCT02229578|University of Florida|Brenda Fahy, MD|859-402-4360|bfahy@anest.ufl.edu|
21251497|NCT01777126|Pharmacy Department, University Hospitals Leuven & Department of Pharmaceutical and Pharmacological Sciences, KULeuven, Belgium|Peter Declercq|003216342340|peter.declercq@uzleuven.be|
21251498|NCT00412880|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21251499|NCT00565266|Penn State Hershey College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu|
21251500|NCT02232399|University of Gothenburg|Prof. Albert Gyllencreutz Castellheim|+46708979820|albert.castellheim@gu.se|
21251501|NCT03017937|Cincinnati Chidren's Hospital|Kim Foss|5136365971|kim.foss@cchmc.org|
21251502|NCT02706951|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21251503|NCT02489734|Children's Hospital of Fudan University|Dr. Xuan Wang|021-18017591058|13818318679@139.com|
21251504|NCT04883060|University of Iowa|Matthew Howard III|(319) 356-8468|matthew-howard@uiowa.edu|
21251505|NCT03603639|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
21251506|NCT02440334|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. John Eisenbrey|(215) 503-5188|john.eisenbrey@jefferson.edu|
21251507|NCT04585737|Orlando Immunology Center|Wendy Wert, Clinical Research manager|4076473960|wwert@oicorlando.com|
21251508|NCT02720211|Axon Optics|Director of Clinical Trials|8012304851|bradley.katz@hsc.utah.edu|
21251509|NCT00551135|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21251510|NCT04599855|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21251511|NCT04294667|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21251512|NCT02165397|Pharmacyclics LLC, An AbbVie Company|Lori Styles|(408) 215-3770|lstyles@pcyc.com|
21251513|NCT04799418|Scion NeuroStim, Inc|Robert Black|919-260-5528|bacllc@earthlink.net|
21281971|NCT01262287|University of Connecticut School of Medicine|Dr. Jonathan Covault|860-679-7560|jocovault@uchc.edu|
21251514|NCT03297398|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
21251515|NCT00424554|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21266638|NCT01874353|AstraZeneca|Global Clinical Program Lead|1-877-240-9479|information.center@astrazeneca.com|
21266639|NCT03728881|Division of Cancer Epidemiology and Genetics, NCI|Aimée R. Kreimer, PhD|240.276.7102|kreimera@mail.nih.gov|
21266640|NCT05379686|Steno Diabetes Center Copenhagen|Dr|+45 39 68 08 00|SDC-FP-Stenoinfo@regionh.dk|
21297242|NCT01220180|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21297243|NCT00771056|Northwell Health (formerly North Shore LIJ Health System)|Kanti R Rai, MD|(718)470-4050|krai@nshs.edu|
21297244|NCT02262754|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21297245|NCT00223704|Vanderbilt University|Mias Pretorius, Associate Professor of Anesthesiology and Clinical Pharmacology|615-8757402|mias.pretorius@vanderbilt.edu|
21297246|NCT01299116|FHI 360|Dr. David Hubacher|919 544 7040|dhubacher@fhi360.org|11223
21297247|NCT01338857|New York University Langone Medical Center|Matthias A. Karajannis, MD|212-263-9630|matthias.karajannis@nyumc.org|
21297248|NCT04079114|Zimmer Biomet|Emilie Rohmer, Clinical Operations Manager|+41 58 85 48210|Emilie.Rohmer@zimmerbiomet.com|
21297249|NCT01727414|Cincinnati Children's Hospital|Tanya Froehlich|5136361154|tanya.froehlich@cchmc.org|
21297250|NCT04016844|University of Iowa|Dr.Thorsten Rudroff|17205323701|thorsten-rudroff@uiowa.edu|
21266641|NCT04517253|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21297251|NCT01364389|Novartis Pharmaceuticals|Study Director|862-778-8300||
21297252|NCT01534195|Ora|Keith Lane|9786896500|klane@oraclinical.com|
21297253|NCT01227005|University of Texas Health Science Center-Houston|Bryan A. Cotton, MD, MPH|713-500-7354|bryan.a.cotton@uth.tmc.edu|
21297254|NCT00629798|Memorial Sloan Kettering Cancer Center|Dr. Roni Tamari, MD|646-608-3738|tamarir@mskcc.org|
21251516|NCT04611347|University of Virginia|Brent DeGeorge, MD|434.982.4263|BD6U@uvahealth.org|
21297255|NCT02554981|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21251517|NCT00611715|Vanderbilt-Ingram Cancer Center|Ingrid Mayer, MD|615-936-2033|ingrid.mayer@vanderbilt.edu|
21251518|NCT00107978|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
21251519|NCT02669407|Duke University|Marat Fudim, M.D.|919-684-8111|marat.fudim@duke.edu|
21297256|NCT00492336|Maryland Psychiatric Research Center|Dr. Robert Buchanan, M.D.|410-402-7876|rbuchanan@som.umaryland.edu|
21236326|NCT01669343|Princess Margaret Hospital|Dr. David Cescon|416-946-2000|dave.cescon@uhn.on.ca|
21236327|NCT00968617|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21251520|NCT01841697|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21251521|NCT00727415|GIMEMA|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it|
21251522|NCT01624298|Johns Hopkins University|Stephanie Skavenski|+260966674841|sskavenski@yahoo.com|
21251523|NCT00345800|Cares|UCB|+1 844 599|UCBCares@ucb.com|2273
21251524|NCT01973062|Case Comprehensive Cancer Center|Manmeet Ahluwalia, MD|216-444-6145|ahluwam@ccf.org|
21251525|NCT03634839|Yale University|Dr. Suchitra Krishnan-Sarin|(203)974-7595|suchitra.krishnan-sarin@yale.edu|
21251526|NCT00350298|MassBiologics|Director of Clinical Affairs|617-474-3000|MBLClinicalDirector@umassmed.edu|
21251527|NCT04198948|University of Sarajevo|Associate Professor Tanja Dujic, PhD|+38733586194|tanja.dujic@ffsa.unsa.ba|
21251528|NCT00233389|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21251529|NCT01127321|MedImmune, LLC.|David Close, Director, Clinical Development|301-398-0000|closeda@medimmune.com|
21251530|NCT00719043|GlaxoSmithKline|GSK Response Center|866-435-7343||
21251531|NCT02113410|Florida Atlantic University|Dr. Juyoung Park|561-297-4537|jpark14@fau.edu|
21251532|NCT01588366|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21251533|NCT00302159|National Cancer Institute, national Institutes of Health|Kevin Camphausen, M.D.|301-496-5457|camphauk@mail.nih.gov|
21251534|NCT01809899|Georgetown University Medical Center|Mary Ann Dutton|2026871997|mad27@georgetown.edu|
21251535|NCT04962698|Georgia Institute of Technology|Prof. Minoru Shinohara|404-894-1030|shinohara@gatech.edu|
21251536|NCT00853229|Cleveland Clinic|Lynn Borzi (Research Administrator)|216-445-3158|BORZIL@ccf.org|
21251537|NCT02208037|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
21251538|NCT00585975|ISTA Pharmaceuticals, Inc.|Tim McNamara, PharmD|949-788-6000|tmcnamara@istavision.com|
21251539|NCT03082612|Emory University|Dr. Jill Hamilton|404-727-8749|jill.b.hamilton@emory.edu|
21251540|NCT00736125|Duke University Medical Center|Dr. Terri Monk|919-286-6938|terri.monk@duke.edu|
21266642|NCT06048367|West China Hospital of Sichuan University|Professor. Yongsheng Wang|18980602258|wangys@wchscu.cn|
21251541|NCT02632812|Galeno Desenvolvimento de Pesquisas Ltda.|Gilberto De Nucci, PhD, principal investigator|55.19.32516928|denucci@gilbertodenucci.com|
21251542|NCT00952848|Virginia Commonwealth University|Thomas J. Smith, MD, FACP|410-955-2091|tsmit136@jhmi.edu|
21251543|NCT02413593|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21251544|NCT03845075|Saniona A/S|Janus Schreiber Larsen|7070 5225|janus.larsen@saniona.com|+45
21251545|NCT02564718|Bayer|Therapeutic Area Head|+1-888-84-22937|clinical-trials-contact@bayer.com|
21251546|NCT00104637|Columbia University|David J. Lederer, MD|212-305-7771|dl427@columbia.edu|
21251547|NCT00857233|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
21251548|NCT01130168|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21251549|NCT02725528|McMaster University|Dr. Achilles Thoma|905-523-0019|athoma@mcmaster.ca|
21251550|NCT02058836|Wake Forest University Health Sciences|Dr. Ryan Terlecki|336-716-2011|rterlecki@wakehealth.edu|
21251551|NCT00835185|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21251552|NCT04522206|NYU LAngone Health - Long Island|Muhammad B. Tariq, M.D|602-363-1134|Muhammad.Tariq2@nyulangone.org|
21251553|NCT02176837|Hope Pharmaceuticals|Craig Sherman, MD|4806071970|sherman@hopepharm.com|
21251554|NCT00566345|Ology Bioservices|Sr. Manager, Clinical & Regulatory Operations|386-418-8751|angie.kimbler@ologybio.com|
21251555|NCT03151551|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21251556|NCT03526679|National Taiwan University Hospital|Dr. Tom Wei-Wu Chen|+886-2-23123456|tomwchen@ntuh.gov.tw|66002
21251557|NCT00966264|Helsinki University|Ritva Hurskainen|+23845872267|ritva.hurskainen@hus.fi|
21266643|NCT04088331|Boston Scientific|Winnie Chen|952-930-6000|Winnie.Chen@bsci.com|
21266644|NCT05505734|Avillion Life Sciences|Chief Medical Officer|+44 (0)203 764 9530|contact@avillionls.com|
21266645|NCT03598140|UTexas Southwestern|Dr. Joshua Gaston|817-637-8043|drgaston@outlook.com|
21266646|NCT05674838|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
21266647|NCT03137888|Emory University|Dr. Hui-Kuo Shu|4047781900|hgshu@emory.edu|
21266648|NCT01266876|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com|
21266649|NCT04870099|Indiana University|Prof. Lorenzo Lorenzo-Luaces, Assistant Professor|8123456193|lolorenz@indiana.edu|
21266650|NCT05016037|Vanderbilt University Medical Center|Dr. Stephen Camarata|(615) 579-5608|stephen.camarata@vumc.org|
21266651|NCT03575351|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
21266652|NCT03715205|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21266653|NCT02623699|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21266654|NCT00557323|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21266655|NCT00592072|Yale School of Medicine|Dr Robert Sherwin|203-785-6222|robert.sherwin@yale.edu|
21236328|NCT00298233|Oxford University Clinical Research Unit|Dr. Jeremy Farrar|+84 839237954|info@oucru.org|
21251558|NCT01473745|ChangGungMH|Dr. Yi Hsuan Chen|+886227135211|acantehr@gmail.com|3533
21251559|NCT02366143|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21266656|NCT03369704|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21236329|NCT02371369|Contact for Clinical Trial Information|Daiichi Sankyo|1-908-992-6400|CTRinfo@dsi.com|
21297257|NCT00241904|Johns Hopkins University|Dr. Jerilyn Allen|410-614-4882|jallen1@jhu.edu|
21236330|NCT01024387|Dana-Farber Cancer Institute|Matthew H. Kulke, MD|617.632.5136|Matthew_Kulke@dfci.harvard.edu|
21266657|NCT04732780|Imperial College London|Dr Vicky McKechnie|02083830689|vicky.mckechnie@nhs.net|
21266658|NCT01863901|Pacira Bioscience, Inc.|Medical Information|1-855-793-9729|MedInfo@Pacira.com|
21266659|NCT01611662|Fox Chase Cancer Center|Elizabeth Plimack, MD|215-728-3889|Elizabath.Plimack@fccc.edu|
21266660|NCT02010567|UNC Lineberger|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
21266661|NCT00118040|University of Wisconsin|Howard H. Bailey, M.D.|608-263-8624|hhbailey@wisc.edu|
21266662|NCT03733249|Bellicum Pharmaceuticals|Rivogenlecleucel Study Team|(832) 384-1100|clinicaltrials@bellicum.com|
21297258|NCT02413047|Indiana University|Dr. Matthew Bohm, DO (Principal Investigator)|3179485136|mbohm@iu.edu|
21297259|NCT03043651|United Therapeutics|Louis Holdstock|919-425-8866|lholdstock@unither.com|
21266663|NCT02213081|Northwestern University|Dr. Serdar Bulun|312-472-3980|Serdar.Bulun@nm.org|
21266664|NCT00772889|GlaxoSmithKline|GSK Response Center|866-435-7343||
21266665|NCT03323086|The Miriam Hospital|Dr. Michael Carey|401 793 8218|michael_carey@brown.edu|
21266666|NCT00355615|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
21266667|NCT00085644|Abbott|Global Medical Services|800-633-9110||
21266668|NCT03676465|University of Virginia|Dr. Mark DeBoer|(434) 924-5956|deboer@virginia.edu|
21266669|NCT04259346|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
21266670|NCT03330106|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21266671|NCT01004874|Duke University Medical Center|Dr. Annick Desjardins, MD, FRCPC|9196846173|annick.desjardins@duke.edu|
21266672|NCT00486889|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21266673|NCT02618512|Alexion|Alexion Medical Monitor|617-613-1071|Bert.Yao@alexion.com|
21266674|NCT01738594|Northwestern University|Barbara Pro, MD|312-695-6832|barbara.pro@nm.org|
21266675|NCT01836029|VentiRx|Kristi Manjarrez|206 689 2256|kmanjarrez@ventirx.com|
21266676|NCT00376675|Mayo Clinic|Dr. Amit Sood|507-284-1623|sood.amit@mayo.edu|
21266677|NCT01833026|University of Illinois at Chicago|Min Joo|3129968039||
21251560|NCT00575042|University of Miami|Dr. Cynthia Levy|305-243-2330|clevy@med.miami.edu|
21251561|NCT00158197|Friends Research Institute|Joy Chudzynski|323-333-8122|joychud@ucla.edu|
21251562|NCT00589303|Mayo Clinic|Dr. Win K. Shen|480-342-0348|wshen@mayo.edu|
21251563|NCT04836559|Janssen Research & Development, LLC|Executive Medical Director Neuro|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21251564|NCT00730015|Ironwood Pharmaceuticals|Doug Levine, MD|617.374.3906|dlevine@ironwoodpharma.com|
21251565|NCT04978350|UNC Lineberger Comprehensive Cancer Center|Angelo Navas|919-445-1128|angelo_navas@med.unc.edu|
21266678|NCT00942422|Barbara Ann Karmanos Cancer Institute|Jeffrey Zonder, M.D.|313-576-8732|zonderj@karmanos.org|
21251566|NCT02370251|University of Oklahoma|Kimberly Ernst, MD|405-271-5215|kimberly-ernst@ouhsc.edu|42039
21266679|NCT01332851|Family and Child Nursing, University of Washington|Dr. Monica Oxford|206-685-6107|mloxford@uw.edu|
21251567|NCT04469465|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
21297260|NCT01630889|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|059study@fibrogen.com|
21297261|NCT02974842|nVision Medical|Surbhi Sarna|408 655 3577|surbhi@nvisionmedical.com|
21297262|NCT02980133|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21236331|NCT03855189|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21266680|NCT01947894|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21281972|NCT02492984|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21297263|NCT01854281|University Hospital Motol|Jakub Honek, MD|+42022443|jakub.honek@gmail.com|4901
21297264|NCT03968848|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21251568|NCT04120376|Children's Hospital of Philadelphia|Dr. Cynthia Mollen|2153701217|mollenc@chop.edu|
21297265|NCT01000324|GlaxoSmithKline|GSK Response Center|866-435-7343||
21297266|NCT00360724|NY State Psychiatric Institute|David Hellerstein MD|6467748000|hellers@nyspi.columbia.edu|
21251569|NCT02053610|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21251570|NCT01165177|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21251571|NCT00126659|UT MD Anderson Cancer Center|Eric Jonasch, MD / Associate Professor||caperez@mdanderson.org|
21251572|NCT01667406|Imperial College London|Professor Waljit Dhillo|442083833242|w.dhillo@imperial.ac.uk|
21251573|NCT00490945|Vanda Pharmaceuticals Inc.|Marlene Dressman, Ph.D.|202-734-3462|marelene.dressman@vandapharma.com|
21251574|NCT00567840|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|212-227-7540|Dan.Everitt@tballiance.org|
21251575|NCT02309346|Hospital de Clínicas de Porto Alegre|Ricardo Francalacci Savaris|+55 51 33596042|rsavaris@hcpa.edu.br|
21251576|NCT03634306|Mercy Hospital St. Louis|David Levine, MD|314-251-7650|David.Levine@Mercy.net|
21266681|NCT03796195|Northwestern University|David Walega, MD|3126952500|d-walega@northwestern.edu|
21266682|NCT04445051|Coloplast A/S|Vice President, Medical Affairs|+4549111111|clinical-studies@coloplast.com|
21236332|NCT02854540|Stanford School of Medicine|Dr. Marlyanne Pol-Rodriguez|650-721-7144|mpr@stanford.edu|
21266683|NCT02201472|Cincinnati Children's Hospital|Dr. Stephanie Merhar|513-803-5180|stephanie.merhar@cchmc.org|
21266684|NCT01300767|Alcon Research|Director of Clinical Trials|1-800-241-7629||
21266685|NCT03256136|Massachusetts General Hospital|Dr. Jessica Lin|617-724-1134|jjlin1@partners.org|
21266686|NCT01188811|Oregon Health & Science University|Rebecca Spain, MD, MSPH|503-494-5759|spainr@ohsu.edu|
21251577|NCT02312206|Prothena Biosciences|Wendy Curlin|(650) 837-8550|clinicaltrials@prothena.com|
21251578|NCT04915131|Bloom Technologies NV|Managing Director|+14156038067|julien@bloomlife.com|
21251579|NCT01006616|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21251580|NCT03414047|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21251581|NCT04593823|scPharmaceuticals|Dr. John Mohr, PharmD; Sr VP Clinical Development and Medical Affairs|7813017220|jmohr@scpharma.com|
21251582|NCT04068051|Axsome Therapeutics, Inc.|Caroline Streicher, Vice President, Clinical Operations|212-332-5061|cstreicher@axsome.com|
21251583|NCT04974723|Radius Health, Inc.|Clinical Operations|617-551-4000|info@radiuspharm.com|
21251584|NCT02877732|Stanford Concussion and Brain Performance Center/ Stanford Emergency Medicine|Dr. Jamshid Ghajar|(650) 725-5562|jghajar@stanford.edu|
21251585|NCT00992992|GlaxoSmithKline|GSK Response Center|866-435-7343||
21251586|NCT03197025|National Cancer Institute|Scott Norberg, DO|301-275-9668|scott.norberg@mail.nih.gov|
21251587|NCT00217022|Mayo Clinic, Rochester MN|Dr. Darrell Pardi|507-538-1231|pardi.darrell@mayo.edu|
21251588|NCT00458393|University of California, San Francisco|David Glidden|415-514-8009|david.glidden@ucsf.edu|
21251589|NCT02725567|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21251590|NCT02625571|Penn State College of Medicine|Dr. Brian Allen|717-531-4100|ballen1@pennstatehealth.psu.edu|323492
21266687|NCT01602744|Tel Aviv University|Dvora Frankenthal|0097235326835|shai_f@zahav.net.il|
21266688|NCT02858713|Department of Dermatology, Odense University Hospital|M.D. Mathias Tiedemann Svendsen|+45 61265827|m_tiedemann@hotmail.dk|
21266689|NCT01316380|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21266690|NCT00108277|VA Palo Alto Health Care System / Stanford University School of Medicine|Walton T. Roth, M.D.|650-493-5000|wtroth@stanford.edu|65243
21266691|NCT00609167|Mayo Clinic|Dr. A. Keith Stewart||stewart.keith@mayo.edu|
21281973|NCT02453334|American Regent, Inc|Mark A. Falone, MD MPH|631-772-3544|mfalone@americanregent.com|61844
21266692|NCT00712270|Kettering Health Network|Manager, Research Operations and Regulatory Compliance|937-395-8367|innovationcenter@ketteringhealth.org|
21297267|NCT01068158|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com|
21297268|NCT01959243|Bausch & Lomb Incorporated|Director, Medical Affairs||Heleen.DeCory@bausch.com|
21266693|NCT02574520|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
21266694|NCT00886691|NRG Oncology|Linda Gedeon for Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org|
21266695|NCT01251315|Charles R Drew University of Medicine and Science|Dr .Naureen Tareen|323-568-3359|aaant@aol.com|
21266696|NCT03935594|Vanderbilt university medical center|Dr. Salam AlKassis|(615)322-2350|salam.al.kassis@vumc.org|
21266697|NCT01435122|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jonathan R. Strosberg|813-745-3636|jonathan.strosberg@moffitt.org|
21266698|NCT04412668|aTyR Pharma|Study Director|858 731 8389|clinicaltrials@atyrpharma.com|
21266699|NCT00985140|Stanford University Cancer Center|Richard T. Hoppe, MD Henry S. Kaplan Harry Lebeson Professor of Cancer Biology|(650) 723-5510|hoppe@stanford.edu|
21266700|NCT03864627|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
21266701|NCT00802880|Washington University School of Medicine|Brian Van Tine, M.D., Ph.D.|314-362-5817|bvantine@dom.wustl.edu|
21266702|NCT01388491|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21266703|NCT04035473|Athenex|Regional Project Manager|+886-277039399|lmeiying@athenex.com|
21266704|NCT00112840|University of Miami - Sylvester Comprehensive Cancer Center|Jaime Merchan, M.D.||jmerchan2@med.miami.edu|
21266705|NCT04511338|Fresenius Medical Care North America|Senior Director of Statistics and Data Management|1-781-249-8216|chianghong.ho@fmc-na.com|
21266706|NCT02497287|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266707|NCT03782376|Janssen-Cilag Ltd.|Senior Director GI Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266708|NCT02659098|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266709|NCT04363944|University at Buffalo|Dr. Jeanne Langan|17168292905|jlangan@buffalo.edu|
21266710|NCT03517722|Janssen Research & Development, LLC|DIRECTOR CLINICAL RESEARCH GI.|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266711|NCT00360672|UT MD Anderson Cancer Center|Gautam Borthakur, M.D./Associate Professor|713-563-1586|eharriso@mdanderson.org|
21266712|NCT03573804|Dartmouth-Hitchcock|Timothy B Rooney, MD, PI|603-650-5000|timothy.b.rooney@hitchcock.org|
21281974|NCT02362672|Nektar Therapeutics|Medical Affairs||StudyInquiry@nektar.com|
21281975|NCT03611777|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21281976|NCT01369030|Pamlab, Inc.|Lori W Barrentine, MS, PA-C, Director of Clinical Affairs|985-867-5788|lbarrentine@pamlab.com|
21297269|NCT02596945|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21297270|NCT01368081|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21281977|NCT06152224|UW School of Medicine and Public Health|Ushma Patel, MD|(608) 287-5898|upatel@uwhealth.org|
21281978|NCT06028438|Janssen Research & Development|Medical Director Rheumatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21281979|NCT05625802|University of Michigan|Christopher Fung|734-763-4091|chfung@med.umich.edu|
21281980|NCT00383760|Princess Margaret Cancer Centre|Dr. Malcolm Moore|416-945-2263|malcolm.moore@uhn.ca|
21297271|NCT00238238|Meyer Cancer Center, Weill Cornell Medical College|John P Leonard, M.D.||jpleonar@med.cornell.edu|
21297272|NCT04978818|Johns Hopkins School of Public Health|Dr. Laura Hammit|4436510000|lhammitt@jhu.edu|
21251591|NCT02777242|Antares Pharma, Inc.|Jonathan Jaffe, MD|609-359-3020|jjaffe@antarespharma.com|
21251592|NCT05178979|Boston College|Katelyn Sileo|617-552-3205|sileoka@bc.edu|
21297273|NCT04517643|Johns Hopkins Medicine|Robert Hobbs|410-502-1229|rhobbs3@jhmi.edu|
21266713|NCT00952419|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21266714|NCT01592773|Forest Research Institute|Joel Trugman, MD|201-427-8681|Joel.Trugman@frx.com|
21266715|NCT04418427|Adverum Biotechnologies|Study Medical Director|650-656-9323|clinicaltrials@adverum.com|
21266716|NCT00121485|Thoratec Corporation|Poornima Sood, MD, MBA, Sr. Director, Clinical Affairs|781 852 8334|psood@thoratec.com|
21266717|NCT01654224|University of Pittsburgh|David Nace, MD, MPH|412 692-2366|naceda@upmc.edu|
21266718|NCT02306928|Aarhus University Hospital, Department of infectious diseases|Dr. Kristina Öbrink-Hansen|+45 7845 2845|krisoebr@rm.dk|
21236333|NCT00586105|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21236334|NCT02679690|University of Pittsburgh|Sheryl Ondrejko, DNP||sherylannmarieo@gmail.com|
21266719|NCT03763942|Emory University|Dr. Jeb Jones|404-712-2275|jeb.jones@emory.edu|
21266720|NCT00166504|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21266721|NCT02200510|CincinnatiChildrens|Lori Crosby|5136365380|lori.crosby@cchmc.org|
21266722|NCT03057106|Canadian Cancer Trials Group|Dr. Keyue Ding|1-613-533-6430|kding@ctg.queensu.ca|77705
21266723|NCT03691649|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
21266724|NCT04423718|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21266725|NCT00911183|Institut Bergonié|Pr Pierre Soubeyran|33(0)556333333|p.soubeyran@bordeaux.unicancer.fr|
21266726|NCT03825536|University of California, San Francisco|Sulggi A. Lee|415-735-5127|sulggi.lee@ucsf.edu|
21281981|NCT02829320|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21281982|NCT00628212|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21281983|NCT02490371|QEHHongKong|Dr. Helen LUK|852-9208 5366|clkyz02@ha.org.hk|
21281984|NCT01605552|Indiana University-Purdue University Indianapolis (IUPUI)|Jesse C. Stewart, Ph.D.|(317) 274-6761|jstew@iupui.edu|
21266727|NCT05298774|Yale University|Dr. Ira Leeds|(203)785-2616|ira.leeds@yale.edu|
21266728|NCT04992507|The Ohio State University Comprehensive Cancer Center|Dr. Aslam Ejaz|614-293-7171|aejaz@uic.edu|
21266729|NCT04574570|IRCCS Istituto Ortopedico Rizzoli|Dr Stefano Zaffagnini|+3905163665706366111|stefano.zaffagnini@unibo.it|
21266730|NCT04651777|Western Universtiy|Dr. Grace E Parraga|519-931-5365|gparraga@robarts.ca|
21266731|NCT00576147|Baylor College of Medicine|Claudia Robertson|(713) 798-8932|claudiar@bcm.edu|
21266732|NCT03070119|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21266733|NCT01023516|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21266734|NCT02060903|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
21266735|NCT01058395|Wayne State University|Dr. Jay Meythaler|(313) 375-7226|jmeythal@med.wayne.edu|
21266736|NCT01996865|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21266737|NCT05304611|National Institute of Allergy and Infectious Diseases (NIAID)|Dr. Peter Crompton|301-761-5042|pcrompton@niaid.nih.gov|
21266738|NCT02354690|National Center for Cancer Immune Therapy|Inge Marie Svane|0045386889339|inge.marie.svane@regionh.dk|
21266739|NCT00515099|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21266740|NCT03342404|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21266741|NCT05333289|ModernaTX, Inc|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
21266742|NCT03148899|Medical Faculty Associates at The George Washington University|Dr. Vivek Jain|202-741-2676|vjain@mfa.gwu.edu|
21266743|NCT00372489|Affymax|VP, Clinical Development|650-812-8700|info@affymax.com|
21266744|NCT01866306|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21266745|NCT04430036|University of Texas Health Science Center at San Antonio|Robert Svatek, MD|210-567-5643|svatek@uthscsa.edu|
21266746|NCT05559203|University of Stirling|Prof Anna C. Whittaker|0178646|a.c.whittaker@stir.ac.uk|7816
21266747|NCT01249157|Memorial Sloan Kettering|Dr. Maxine Jochelson|646-888-4507|JochelsM@mskcc.org|
21266748|NCT02392468|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21266749|NCT03630016|Owlet Baby Care, Inc.|Madison Kenley, CCRP, BS|801-552-8383|mkenley@owletcare.com|
21266750|NCT05083949|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21266751|NCT01562678|Beth Israel Deaconess Medical Center|Dr. Christos Mantzoros|617-667- 8630|cmantzor@bidmc.harvard.edu|
21266752|NCT01678560|Yale University|Meir Kryger, MD|203-815-0914|meir.kryger@yale.edu|
21266753|NCT00959699|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21281985|NCT01073605|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21266754|NCT04228445|Provepharm, Inc.|Senior Director of Clinical Operations|6106018605|todd.koch@provepharm.com|
21266755|NCT02583360|The Research Institute at Nationwide Children's Hospital|Sudarshan Jadcherla MD|614-355-6433|sudarshan.jadcherla@nationwidechildrens.org|
21266756|NCT00606294|Memorial Sloan Kettering Cancer Center|Dr. Nancy Lee, MD|212-639-3341|leen2@mskcc.org|
21266757|NCT03924427|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
21266758|NCT03028467|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21266759|NCT01895634|Johnson & Johnson K.K. Medical Company|Depertment Chief, Clinical Operation|+81-3-4411-6789|yikeda5@its.jnj.com|
21266760|NCT00471315|Medical University of South Carolina|Peter Cotton, MD|(843) 792-6999|CottonP@MUSC.edu|
21266761|NCT01365091|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
21297274|NCT01007838|UWalesBangor|Danielle Kirkman|00 44 1248 388254|pepa03@bangor.ac.uk|
21266762|NCT03398824|Boston Children's Hospital|Akiko Shimamura|617-919-6946|akiko.shimamura@childrens.harvard.edu|
21266763|NCT05307523|University of Washington|Reham A. Abuatiq, Research coordinator and a PhD candidate|6198309638|rabuat@uw.edu|
21266764|NCT05116683|Columbia University|Benjamin Izar, MD|212-304-5871|bi2175@cumc.columbia.edu|
21266765|NCT00392951|Children's Hospital of Philadelphia|David T. Teachey, MD|267-426-5802|teacheyd@email.chop.edu|
21266766|NCT03298048|UTexas_Houston|Dr. Herbert DuPont|713-500-9366|herbert.l.dupont@uth.tmc.edu|
21266767|NCT02875366|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21266768|NCT00683774|Virginia Commonwealth University|Dr. John Nestler|804-828-3389|jnestler@mcvh-vcu.edu|
21266769|NCT03595176|Shockwave Medical|Randee Randoll|408.577.7856|rrandoll@shockwavemedical.com|
21266770|NCT00514592|Umeå University|Dr Elias Johansson|+46907850000|elias.johansson@neuro.umu.se|
21266771|NCT02735044|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21266772|NCT01682759|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21266773|NCT02308709|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
21266774|NCT00864123|University of South Florida|Eric Storch, Ph.D.|727-767-8230|estorch@health.usf.edu|
21266775|NCT01201967|Massachusetts General Hospital|Jeff C. Huffman, MD|6177242910|jhuffman@partners.org|
21266776|NCT02058251|Medical University of South Carolina|Dr. Sudie Back|843-792-5915|backs@musc.edu|
21266777|NCT02116361|Allergan, Inc|Arlene Lum, PMP|714-246-5548|lum_arlene@allergan.com|
21266778|NCT01425307|The University of Texas School of Public Health|Barry Robert Davis|713-500-9515|barry.r.davis@uth.tmc.edu|
21266779|NCT04076579|University of Michigan Rogel Cancer Center|Clinical Trials Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
21266780|NCT01712776|Cleveland Clinic|Dr. Sharon E. Mace, Director of Research, ESI|(216) 445-4598|maces@ccf.org|
21266781|NCT01997892|Amgen Inc.|Study Director|866-572-6436||
21266782|NCT02531633|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21297275|NCT02277119|Topcon|Charles Reisman|201-599-5283|CREISMAN@topcon.com|
21297276|NCT01345669|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21266783|NCT04097925|Hospital de Bellvitge|Clinical Project Manager|+34675335888|anavarroa@bellvitgehospital.cat|
21266784|NCT02608099|Baim Institute for Clinical Research|Director of Trial Design and Development|617-307-5200|TrialDesignandDevelopmentStaff@baiminstitute.org|
21266785|NCT01952041|University of Washington School of Medicine|Dror Ben-Zeev, PhD|(206) 685-9655|dbenzeev@uw.edu|
21266786|NCT01736176|AbbVie|Global Medical Services|800-633-9110||
21297277|NCT00516165|Massachusetts General Hospital|Dr.Andrew X. Zhu|617-724-4000|azhu@mgh.harvard.edu|
21266787|NCT00186121|Stanford University Medical Center|Melinda Telli, MD|650-724-9533|mtelli@stanford.edu|
21266788|NCT03650387|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|Aesthetic.Trials@merz.com|
21266789|NCT00417248|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
21266790|NCT01569568|Children's National Medical Center|Dr. Andrea Gropman|202-476-2120|agropman@childrensnational.org|
21266791|NCT05815758|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
21266792|NCT03661983|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21266793|NCT02903966|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21266794|NCT00934791|Mayo Clinic|Dr. Patrick G. Dean|507-266-6953|dean.patrick2@mayo.edu|
21266795|NCT02353806|University of Texas Southwestern Medical Center|Jamie Morgan, MD|214-645-3838|jamie.morgan@utsouthwestern.edu|2147665011
21266796|NCT01320033|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
21266797|NCT02425891|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21281986|NCT03491462|Zevra Denmark A/S|Medical Affairs|+1-888-289-5607|medicalaffairs@zevra.com|
21281987|NCT03018080|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
21281988|NCT00740792|Meda Pharmaceuticals|David Ginsberg,D.O.|7325642364|david.ginsberg@meda.us|
21281989|NCT01921322|Medtronic Diabetes|John Shin, PhD|818-576-4019|john.shin@medtronic.com|
21281990|NCT03612596|The University of Texas Medical Branch|Eloisa Martinez|409-266-9643|esmartin@utmb.edu|
21281991|NCT01050582|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|Clinical Leader|609-730-6581||
21281992|NCT01019694|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21281993|NCT00795002|The Sidney Kimmel Comprehensive Cancer Center|Judith Karp, MD|410-502-7726|jkarp2@jhmi.edu|
21281994|NCT00026494|Memorial Sloan Kettering Cancer Center|Dr. Lisa Deangelis|212-639-7997|deangell@mskcc.org|
21281995|NCT00441129|Medtronic Minimed|Suiying Huang, Statistician|8184763319|suiying.huang@medtronic.com|
21281996|NCT01455597|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21266798|NCT00963469|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21281997|NCT04632069|Medical University of South Carolina|Dr Dorothea Jenkins|843-792-2112|jenkd@musc.edu|
21281998|NCT02573181|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21266799|NCT00585104|University of Utah Health Sciences Center|Andrew D. Michaels, MD|(801) 585-5971|Andrew.Michaels@hsc.utah.edu|
21266800|NCT00782756|Memorial Sloan Kettering Cancer Center|Dr. Philip Gutin|212-639-8556|gutinp@mskcc.org|
21266801|NCT04124952|SightTrust Eye Institute|Andrew Shatz, MD|877.878.7890|ashatz@sighttrust.com|
21281999|NCT01737710|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21282000|NCT04042623|Aravive|Dr. Reshma Rangwala, Chief Medical Officer|936-355-1910|rrangwala@aravive.com|
21297278|NCT02478255|Duke University|Bastiaan Driehuys, PhD (Professor of Radiology)|919 684-7786|bastiaan.driehuys@duke.edu|
21297279|NCT03068767|Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation|Chief of internal medicine department|+886-2-6628-9779|uld888@yahoo.com.tw|2317
21266802|NCT02943577|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
21266803|NCT01355224|Boston University School of Public Health|Dr. Catharine Wang|617-638-5187|clwang@bu.edu|
21266804|NCT00808028|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21266805|NCT01222767|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|0034 91846 60 00|clinicaltrials@pharmamar.com|
21266806|NCT04228276|Palo Alto VA|Dr. Jong Yoon|6504935000|jong.yoon@va.gov|
21266807|NCT06085443|YSLAB|Mélody DUTOT|33 (0)2.98.53.30.03|melody.dutot@yslab.fr|
21266808|NCT00081263|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|lgedeon@gogstats.org|
21266809|NCT01852591|H. Lee Moffitt Cancer Center and Research Institute|Frederick Locke, M.D.|813-745-3509|frederick.locke@moffitt.org|
21266810|NCT05706623|VectivBio AG|Clinical Trial Information Desk|617.621.7722|ClinicalTrialEnquiries@ironwoodpharma.com|
21282001|NCT03412734|TriHealth Inc.|Catrina Crisp, MD MSc|513-463-4300|Catrina_Crisp@trihealth.com|
21282002|NCT00423332|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
21282003|NCT03935425|Flint Rehab|Daniel Zondervan|9493137322|dzondervan@flintrehab.com|
21282004|NCT02035202|UCSD|Colin Depp|858 822 4251|cdepp@ucsd.edu|
21282005|NCT03777436|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21282006|NCT00885664|University of Cincinnati|Dr. Carl J. Fichtenbaum|513-584-6361|carl.fichtenbaum@uc.edu|
21297280|NCT02566317|Arizona State University|Matthew Buman, PhD|602-827-2289|mbuman@asu.edu|
21297281|NCT02611817|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21297282|NCT03077919|RTI International|Kristine L. Rae Olmsted, MSPH|919-541-8035|krolmsted@rti.org|
21297283|NCT03738618|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
21297284|NCT00826618|University of Miami|Thomas A. Albini, MD|3054825006|talbini@med.miami.edu|
21297285|NCT02175979|Catharina Hospital|dr Misha Luyer|+31402399111|misha.luyer@catharinaziekenhuis.nl|
21297286|NCT01332253|Senior Manager, Clinical Operations|Byron Kaelin|615-255-0068|bkaelin@cumberlandpharma.com|250
21297287|NCT01487265|Sarah Cannon Research Institute|Charles H. Davis|615-524-4341|charles.davis2@scri-innovations.com|
21297288|NCT03499314|NYU Langone Health|Leigh Charvet, PhD|(929) 455-5141|Leigh.Charvet@nyulangone.org|
21297289|NCT01618695|Eisai Co., Ltd.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
21297290|NCT00952081|UMDNJ|Alex Bekker, MD, PhD|973-972-5007|bekkeray@umdnj.edu|
21297291|NCT00439296|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
21297292|NCT02291419|Cleveland Clinic|Dr. Venu Menon|216-445-5390|menonv@ccf.org|
21297293|NCT00931606|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21297294|NCT00871338|GlaxoSmithKline|GSK Response Center|866-435-7343||
21297295|NCT02391363|Baylor College of Medicine|Melinda A. Stanley, PhD|713-794-8841|mstanley@bcm.edu|
21297296|NCT01016600|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
21297297|NCT00872599|Vanderbilt University|Nancy J. Brown, M.D.|615-343-8701|nancy.j.brown@vanderbilt.edu|
21297298|NCT01937260|Valeant Pharmaceuticals|Director of Clinical Trials|908|binu.alexander@valeant.com|
21297299|NCT03826186|University of Iowa Hospitals and Clinics|Vice Chair for Research|319-335-9595|donna-hammond@uiowa.edu|
21297300|NCT03032263|Wake Forest University Health Sciences|Dr. Thomas Templeton|336-716-4285|ttemplet@wakehealth.edu|
21297301|NCT02737475|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21297302|NCT05148806|NHS Blood and Transplant|Gillian Powter Trial Manager|44 7590 353091|gillian.powter@nhsbt.nhs.uk|
21297303|NCT04042324|Rockwell Medical, Inc|Raymond Pratt, MD|248 960 9009|rpratt@rockwellmed.com|405
21297304|NCT02950480|University of California, San Francisco|Dr. Pamela Munster|(415) 885-7810|pamela.munster@ucsf.edu|
21297305|NCT03251937|Boston Scientific|Director of Clinical Sciences|661 949 4350|roshini.jain@bsci.com|
21297306|NCT01363661|ECSOR|Jacques Bruhwyler, Project Manager|3267444093|Jacques.Bruhwyler@ecsor.com|
21297307|NCT00385138|The Medicines Company|Meredith Todd|973.290.6088|meredith.todd@themedco.com|
21297308|NCT02219334|Baylor College of Medicine|Shabana Yusuf/Associate Professor of Pediatrics|832-824-5388|syusuf@bcm.edu|
21297309|NCT00607867|Minneapolis VA Health Care System, Metabolic Research Labortory|Mary C. Gannon, Ph.D.|6124672895|ganno004@umn.edu|
21297310|NCT00921843|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
21297311|NCT00711971|University of Michigan|Ellen Mozurkewich, Adjunct Assistant Professor|(734) 546-2772|emozurkewich@salud.unm.edu|
21297312|NCT01177189|Salt Lake City VAMC|Van Reese|801 582 1565|van.reese@hsc.utah.edu|
21297313|NCT03606187|SGX Medical|VP of Clinical Affairs|6613108409|wpark@sgxmedical.com|
21297314|NCT03704688|Memorial Sloan Kettering Cancer Center|Dr. Kathryn Arbour|646-608-3792|arbourk@mskcc.org|
21297315|NCT01566500|Columbia University|Marie Chesaniuk|212-854-0127|mc3333@columbia.edu|
21297316|NCT04774926|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21297317|NCT01393639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21297318|NCT03626545|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
21297319|NCT04274556|Demiroglu Bilim University|Nurten OZEN|+90 212 213 64 86|ozenurten@yahoo.com.tr|
21297320|NCT00793325|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21297321|NCT00413036|Celgene|Associate Director, Clinical Trial Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21266811|NCT01267955|Institut Bergonie|Pr Italiano Antoine, Department of Medical Oncology|0524071947|a.italiano@bordeaux.unicancer.fr|
21266812|NCT00729560|Virginia Commonwealth University|Dr. John Nestler|804-828-3389|jnestler@mcvh-vcu.edu|
21282007|NCT01998932|Imperial College London|Miss Sarah Onida|: +44 (0) 20 3311 7335|s.onida@imperial.ac.uk|
21282008|NCT00685399|Novartis Pharmaceuticals|Study Director|862-778-8300||
21266813|NCT03233308|Aerie Pharmaceuticals, Inc|Theresa GH Heah, MD, MBA|908-947-3844|theah@aeriepharma.com|
21297322|NCT00972530|Department of Research and Development County Council of Gavleborg/Uppsala University|Dr Tomas Weitoft|+46 26 154388|tomas.weitoft@lg.se|
21266814|NCT03662789|Oslo University Hospital|Dr. Lars Gullestad|0047 97644772|lars.gullestad@medisin.uio.no|
21266815|NCT02136134|Janssen R&D US|Director, Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266816|NCT02974621|Massachusetts General Hospital|Isabel Arillaga-Romany, MD PhD|877-442-3324|iarrillaga@mgh.harvard.edu|
21266817|NCT00732472|GlaxoSmithKline|GSK Response Center|866-435-7343||
21266818|NCT02159768|National University Hospital|Senior Consultant|+65 67724200|eugene_liu_hc@nuhs.edu.sg|
21266819|NCT02432690|Sumitomo Pharma Oncology|Tegan Nguyen|617-674-8745|tegan.nguyen@oncology.sumitomo-pharma.com|
21266820|NCT02559115|Memorial Sloan Kettering Cancer Center|Dr. Hebert A. Vargas Alvarez , MD|646-888-5410|vargasah@mskcc.org|
21282009|NCT00758485|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21297323|NCT03397342|Montefiore Medical Center|Dr. Madhur Garg|718-920-4140|mgarg@montefiore.org|
21297324|NCT05979922|Photozig, Inc.|Bruno Kajiyama|6506947595|info@photozig.com|
21297325|NCT03400163|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21297326|NCT02524158|VA San Diego|Dr. Erik J. Groessl|858-552-8585|erik.groessl@va.gov|6347
21297327|NCT03100058|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21297328|NCT03671304|UT Southwestern Medical Center|Dr. Muhammad Beg|214-648-4180|muhammad.beg@utsouthwestern.edu|
21297329|NCT03041896|MCRA|Glenn Stiegman|2025525800|gstiegman@mcra.com|
21297330|NCT00596830|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21297331|NCT00887926|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21297332|NCT02097030|CooperVision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|jvega@coopervision.com|
21297333|NCT04869358|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21297334|NCT01192828|University of Colorado Denver|Dr. Johan Van Hove, Primary Investigator|303-724-2338|johan.vanhove@childrenscolorado.org|
21297335|NCT01336023|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
21297336|NCT04373746|Nationwide Children's Hospital|Dr. Joseph D. Tobias|614-722-4200|joseph.tobias@nationwidechildrens.org|
21297337|NCT01894022|GlaxoSmithKline|GSK Response Center|866-435-7343||
21297338|NCT03001778|Klein Buendel|Valerie Myers, PhD|3035654343|vmyers@kleinbuendel.com|
21297339|NCT00235716|Dept. of Veterans Affairs Cooperative Stduies Program|Peter Guarino, PhD, Director WH-CSPCC|203-932-5711|peter.guarino@va.gov|3780
21297340|NCT01545050|CSL behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
21297341|NCT03235089|CooperVision, Inc|Lee Hall, BSc, PhD, MCOptom, FBCLA|925 251 6684|lhall@coopervision.com|
21297342|NCT02673684|Defense and Veterans Center for Integrative Pain Management|Mary McDuffie|301-400-4242|mmcduffie@dvcipm.org|
21297343|NCT02355210|University of Nebraska-Lincoln|Heather Rasmussen, Assistant Professor|402-472-1373|hrasmussen2@unl.edu|
21297344|NCT04699461|ADC Therapeutics|Contact ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
21297345|NCT00767767|Weill Cornell Medicine|Kane Pryor|(212) 746-2969|kap9009@med.cornell.edu|
21236335|NCT00754845|Canadian Cancer Trials Group|Senior Biostatistician|6135336430|dtu@ctg.queensu.ca|
21236336|NCT01286259|University of California, San Francisco|Steven G. Deeks|(415) 476-4082|Steven.Deeks@ucsf.edu|
21236337|NCT01027793|Brazilian Center for Studies in Dermatology|Dr. Doris Hexsel|+55 51 30262633|cientifico@cbed.org.br|
21236338|NCT00927927|Novo Nordisk A/S|Public Access to Clinical Trials||RA-RNDUS-ClinTriDisc@ITS.JNJ.com|
21236339|NCT01344460|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21236340|NCT00558285|Novartis Pharmaceuticals|Study Director|862-778-8300||
21236341|NCT01538745|SAUSHEC|Josh Miller|210-916-7111|joshmillersr@gmail.com|
21282010|NCT00656292|Mayo Clinic|Michael J. Brown, M.D.|507-284-6317|Brown.Michael3@mayo.edu|
21282011|NCT00921557|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
21282012|NCT03259425|Huntsman Cancer Institute|Data Manager, Research Compliance Office|8015850601|compliance@hci.utah.edu|
21282013|NCT03451591|University of Edinburgh|Prof Joanna Wardlaw|0131 465 9599|joanna.wardlaw@ed.ac.uk|
21282014|NCT00214786|Baylor University Medical Center|Dr. Marlon Levy|214-820-2050|Marlon.Levy@baylorhealth.edu|
21282015|NCT00812981|GlaxoSmithKline|GSK Response Center|866-435-7343||
21236342|NCT01429259|Hartford Hospital|Joseph L. Kuti, Pharm.D.|860-972-3612|joseph.kuti@hhchealth.org|
21282016|NCT00999609|Spark Therapeutics|Clinical Director||clinicaltrials@sparktx.com|
21282017|NCT04666259|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21282018|NCT04178122|VA Boston Healthcare System|Morgan Danowski|617-595-5385|morgan.danowski@va.gov|
21282019|NCT02684097|Icahn School of Medicine at Mount Sinai|Dr. Emma Guttman|212-241-9728|emma.guttman@mountsinai.org|
21282020|NCT00462709|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21282021|NCT00425750|Vanderbilt-Ingram Cancer Center|Barbara Murphy, M.D.|615-343-4677||
21282022|NCT04339062|Dana-Farber Cancer Institute|Dr. Glenn Hanna|617-632-3090|glenn_hanna@dfci.harvard.edu|
21282023|NCT01197534|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
21297346|NCT01549925|Huntsman Cancer Institute|Mark Wade|801-213-5746|mark.wade@hci.utah.edu|
21297347|NCT00061633|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
21297348|NCT01431963|GlaxoSmithKline|GSK Response Center|866-435-7343||
21236343|NCT01682460|CCLR|Research Manager|519-888-4742|cclr2@sciborg.uwaterloo.ca|
21266821|NCT04571684|University of Kansas Medical Center|Principal Investigator|913-945-7709|skessler2@kumc.edu|
21297349|NCT00554372|SillaJen Biotherapeutics, Inc.|Manager, IP, Contracts, Translational Research|415 281 8886|tchiaverotti@sillajen.com|
21297350|NCT03253328|Washington University School of Medicine|Mohamed A Zayed|314-362-5648|zayedm@wustl.edu|
21297351|NCT02301624|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
21297352|NCT00547521|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21297353|NCT04254666|University of Massachusetts Chan Medical School|Carol Curtin|774-455-6527|carol.curtin@umassmed.edu|
21297354|NCT02798978|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21297355|NCT02475278|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21297356|NCT04794270|Johnson & Johnson VIsion Care, Inc.|Benjamin Straker - Principal Research Optometrist|1-904-312-0604|bstraker@its.jnj.com|
21236344|NCT00724282|University of Chicago|Andrea Eiring|773-702-3657|aeiring@bsd.uchicago.edu|
21297357|NCT01271725|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21236345|NCT03811912|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
21297358|NCT00704938|National Cancer Institute, National Institues of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
21297359|NCT00801229|Massachusetts General Hospital|Joseph Biderman, MD|617-726-1746||
21297360|NCT02300259|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21297361|NCT02510001|University of Oxford Clinical Trials and Research Governance (CTRG)|Heather House|01865 572245|heather.house@admin.ox.ac.uk|
21297362|NCT06831513|UT Southwestern Medical Center - School of Health Professions|Dara Spivey, CPO, LPO|(214) 645-8250|dara.spivey@utsouthwestern.edu|
21297363|NCT00724984|Pharmacyclics|Dr. Thorsten Graef|855-427-8846|pharmacyclics@medcomsol.com|
21236346|NCT01615731|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
21297364|NCT01504841|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
21236347|NCT03586648|Johnson & Johnson Vision Care Inc.|Thomas Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|904-443-3402|TKarkkai@its.jnj.com|
21236348|NCT00377234|Hoffmann-LaRoche|Medical Communications|800-821-8590||
21297365|NCT01468350|Acorda Therapeutics, Inc.|Vice President - Clinical Development & Medical Affairs|914-347-4300|hhenney@acorda.com|
21236349|NCT01024569|University of Illinois at Chicago|Judith A Cook|312-355-3921|jcook@uic.edu|
21266822|NCT03993119|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21236350|NCT00492349|University of Maryland|L. Elliot Hong, M.D.|410-402-6828|ehong@mprc.umaryland.edu|
21266823|NCT00963820|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21266824|NCT00557362|University of California San Francisco Proctor Foundation|Tom M/ Lietman|4155022662|tom.lietman@ucsf.edu|
21266825|NCT04556175|Northern Arizona University|Dr Julie Baldwin|928-523-6566|Julie.Baldwin@nau.edu|
21266826|NCT05549505|Arvinas Estrogen Receptor, Inc|Arvinas Estrogen Receptor, Inc.|475-345-3366|clinicaltrialsARV-471@arvinas.com|
21266827|NCT06408818|innovation Research and Training|Dr. Tracy Scull|9194937700|tscull@irtinc.us|
21266828|NCT02756845|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21266829|NCT01878175|Durham VA Medical Center|Kelli Allen|919-286-0411|kelli.allen@va.gov|7090
21282024|NCT02683928|Ichnos Sciences SA|Study Director|2013314000|clinicaltrialsdisclosuredesk@ichnossciences.com|
21282025|NCT01276756|Cairo University|Dr. Hany Shehab|00201111111071|h.shehab@drshehab.com|
21282026|NCT00580151|University of Texas-Galveston|Walter Meyer, M.D.|409-770-6718|wmeyer@utmb.edu|
21282027|NCT01786161|Massachusetts General Hospital|Hsin Lin|6177241314|hlin13@mgh.harvard.edu|
21282028|NCT02630251|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|1
21282029|NCT01453088|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
21282030|NCT04586244|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21282031|NCT02670525|Dana-Farber Cancer Institute|Dr. Yana Pikman|6176324754|yana_pikman@dfci.harvard.edu|
21282032|NCT02505217|University of Vermont|David J Schneider, MD|802-656-8955|david.schneider@uvm.edu|
21236351|NCT00626522|AstraZeneca|Esther Garcia||ClinicalTrialTransparency@astrazeneca.com|
21236352|NCT01928719|Penn State College of Medicine|Nicolle Krebs|717-531-5673|nkrebs@pennstatehealth.psu.edu|
21236353|NCT00414700|TiGenix n.v.|Nel Van Lommel, MSc, Manager Clinical Operations Europe, TiGenix n.v.|+3216396060|nel.vanlommel@tigenix.com|
21236354|NCT02367911|Therapeutics, Inc.|Clinical Research Director|858-571-1800|projectmanager@therapeuticsinc.com|
21236355|NCT00263666|GlaxoSmithKline|GSK Response Center|866-435-7343||
21236356|NCT00902304|Novartis Pharmaceuticals|Study Director|862-778-8300||
21236357|NCT00838110|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21236358|NCT01003899|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21266830|NCT01842334|Beth Israel Deaconess Medical Center|Dr. Kevin P Hill, Director of the Division of Addiction Psychiatry|617-667-1504|khill1@bidmc.harvard.edu|
21282033|NCT01334229|Laval University|Dr. Patrick Couture MD, PhD, FRCP|418-654-2106|patrick.couture@crchul.ulaval.ca|
21282034|NCT00634036|University of Pittsburgh|Dr. Fernando Holguin|412-692-2817|holguinf@upmc.edu|
21282035|NCT03517540|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
21282036|NCT03896022|Columbia University|Carolyn Westhoff, MD|212-305-4805|clw3@cumc.columbia.edu|
21297366|NCT03149055|Memorial Sloan Kettering Cancer Center|Genovefa Papanicolaou MD|212-639-8361|papanicg@mskcc.org|
21266831|NCT03299166|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
21282037|NCT04573322|Diffusion Pharmaceuticals|Chris Galloway, MD (Chief Medical Officer)|(434) 220-0718|cgalloway@diffusionpharma.com|
21236359|NCT00352365|SWOG|Study Statistician|206-667-4623||
21236360|NCT02811861|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
21266832|NCT01937624|Steadman Hawkins Clinic of the Carolinas/Greenville Health System|Dr. Kyle Cassas|864-454-7422|kcassas@ghs.org|
21297367|NCT04440813|Vanderbilt University Medical Center|Dr. Carolyn Audet|615-343-2418|carolyn.m.audet@vumc.org|
21297368|NCT02255461|St. Jude Children's Research Hospital|Jie Huang|9015955750|jie.huang@stjude.org|
21297369|NCT04120402|Eupraxia Pharmaceuticals Ltd.|Chief Scientific Officer|250-590-3968|amalone@eupraxiapharma.com|
21297370|NCT04648683|Vanderbilt University Medical Center|Carrie Brintz|615-875-9885|carrie.brintz@vumc.org|
21297371|NCT00291018|DePuy Synthes Spine|Erin Prifogle|508-977-6451|eprifog1@its.jnj.com|
21297372|NCT00630344|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-8313|mary_taplin@dfci.harvard.edu|
21297373|NCT01357551|Durham VA Medical Center|Dr. Corrine Voils|9192860411|corrine.voils@va.gov|5196
21297374|NCT01626092|Masonic Cancer Center, University of Minnesota|Weston P Miller, MD|612-626-2778|mill4991@umn.edu|
21297375|NCT01015781|VA RR&D, NCRAR|James A. Henry, Ph.D., Principal Investigator|5032208262|james.henry@va.gov|57466
21282038|NCT00615550|Columbia Laboratories|George W Creasy MD|973-486-8797|Gcreasy@columbialabs.com|
21297376|NCT02967510|ITF Research Pharma SLU|Javier Suárez Almarza|+34 916572323|jsuarez@itfsp.com|
21236361|NCT04743908|The University of Chicago|Dr. John Schneider|(773) 702-2453|jschnei1@uchicago.edu|
21236362|NCT03822533|Region Västra Götaland, Närhälsan|Chan-Mei Ho-Henriksson, PhD-student, RPT|+46709892821|chan-mei.ho@vgregion.se|
21236363|NCT01512225|Sunnybrook Research Institute|Dr. Elizabeth Asztalos|416-480-6100,|elizabeth.asztalos@sunnybrook.ca|87791
21282039|NCT06868654|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21282040|NCT01777282|GlaxoSmithKline|GSK Response Center|866-435-7343||
21282041|NCT04015518|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21282042|NCT00550745|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21282043|NCT00764660|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21236364|NCT04969783|Masonic Cancer Center|Dr. Dorothy Hatsukami|612-626-2121|hatsu001@umn.edu|
21236365|NCT02489500|Boston Medical Center|Vaishali Sanchorawala, MD|6176388261|sfenness@bu.edu|
21236366|NCT00512135|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
21236367|NCT03422250|IRCCS Centro San Giovanni di Dio Fatebenefratelli|Michela Pievani|+39 030 35011|mpievani@fatebenefratelli.eu|
21236368|NCT03812146|VA Center for Integrated Healthcare|Dr. Kyle Possemato|315-425-4400|Kyle.Possemato@va.gov|53551
21236369|NCT00377819|Amgen Inc.|Study Director|866-572-6436||
21282044|NCT02186873|Johnson&Johnson|Senior Director Clinical Development, Immunology General||ClinicalTrialDisclosure@its.jnj.com|
21236370|NCT01917526|Mahidol University|Department of Anesthesiology, Siriraj Hospital|66-2-41979889|manee95@hotmail.com|501
21236371|NCT02099838|Huazhong University of Science and Technology|Dr. Yu|027-83662883|xfyu188@163.com|
21297377|NCT01336413|VHA Durham|Christine E. Marx, MD MA|9192860411|christine.marx@va.gov|3626
21297378|NCT01440816|OncoSec Medical Incorporated|Sharron E Gargosky, Chief Clinical Regulatory Officer|+1 858-255-4729|ClinicalTrialsInfo@OncoSec.com|
21297379|NCT01832155|University of Minnesota|Corjena Cheung, Assistant Professor|612-624-5198|corjena@umn.edu|
21297380|NCT00847886|Lexicon Pharmaceuticals, Inc.|Joel P. Freiman, MD, MPH - Medical Director, Drug Safety|281-863-3000||
21297381|NCT02462720|BTG International Inc.|Lynn Allen|425-410-3152|lynn.allen@btgplc.com|
21297382|NCT03250182|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|1-877-240-9479|information.center@astrazeneca.com|
21297383|NCT04240574|Rosalind Franklin University|Jacque Ortiz|847-578-8423|jacquelyn.ortiz@rosalindfranklin.edu|
21297384|NCT03668613|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21236372|NCT02066857|Emory University|Claude Jarrett, M.D.|404-778-8099|CJarrett@wilmingtonhealth.com|
21236373|NCT01175382|University of Alabama at Birmingham|Dr. Kathryn Burgio|205-558-7064|kburgio@uabmc.edu|
21236374|NCT00774787|Rigel Dermatology|Darrell Rigel|212-684-5964|dsrigel@prodigy.net|
21236375|NCT04535037|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21236376|NCT02031276|Boehringer Ingelheim|Boehringer Ingelheim Call Center|+1 800 243 0127|clintriage.rdg@boehringer-ingelheim.com|
21297385|NCT02106494|Heron Therapeutics|Robert Geller, M.D.|650-366-2626|rgeller@herontx.com|
21297386|NCT01858740|Fred Hutchinson Cancer Center|Marie Bleakley, MD|206-667-6572|mbleakle@fredhutch.org|
21236377|NCT02731131|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21236378|NCT02509624|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21236379|NCT02043782|Coloplast A/S|Medical Director|+45 4911 1395|dkbir@coloplast.com|
21236380|NCT00874029|Halt Medical, Inc|Laura Kemp, Sr. VP Clinical Affairs|408-375-1465|lkemp@haltmedical.com|
21236381|NCT01953926|Puma Biotechnology, Inc.|Sr Director, Clinical Operations|4242486500|clinicaltrials@pumabiotechnology.com|
21236382|NCT01276587|Columbia University|Margaret Lee, MD|212-305-6290|ml653@cumc.columbia.edu|
21236383|NCT01949480|University of Pittsburgh|Dr. Anna Uskova, Principal Investigator|412) 623-2167|UskoAA@anes.upmc.edu|
21282045|NCT03694002|SWOG Statistics and Data Management Center|Study Statistician|2066672894|mhsieh@fredhutch.org|
21282046|NCT00596687|Emory Univ SOM|Guillermo Umpierrez|4047781665|geumpie@emory.edu|
21297387|NCT03386487|Yale University|Dr. Deepak Cyril D'Souza, M.D.|203-932-5711|deepak.dsouza@yale.edu|2594
21297388|NCT01068769|Dana-Farber Cancer Institute|Dr. Suzanne George|617-632-5204|sgeorge2@partners.org|
21297389|NCT00734968|University of Missouri|Daniel Jackson MD|573 499 6041|jacksondl@health.missouri.edu|
21297390|NCT04776317|Saint Louis University|Daniel F. Hoft, MD, PhD|314-977-5500|daniel.hoft@health.slu.edu|
21297391|NCT00896025|University of Texas Southwestern Medical Center|William M. Lee, MD|214-645-6111|william.lee@utsouthwestern.edu|
21236384|NCT00144339|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21266833|NCT00423592|Gilead Sciences, Inc.|Annemarie Vance|650-524-3829|Annemarie.Vance@gilead.com|
21266834|NCT00062647|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
21266835|NCT03296280|South Texas Veterans Health Care System / UT Health San Antonio|Nilam Soni|210-949-9454|sonin@uthscsa.edu|
21266836|NCT02005510|University of Washington|Dr. Rachel Winer|2066165081|rlw@uw.edu|
21266837|NCT00255008|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21266838|NCT02470429|Alcon, A Novartis Division|WW Medical Affairs Director, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com|
21266839|NCT00322387|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
21266840|NCT02092168|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21266841|NCT00707486|HemCon Medical Technologies|Staci McAdams|(503)245-0459|staci@hemcon.com|103
21266842|NCT01976624|Allergan, Inc|Vice President GSE,|714-246-4500|clinicaltrials@allergan.com|
21266843|NCT03144089|University of Iowa Hospitals and Clinics|Ron Abrons, MD|(319) 353-8061|ron-abrons@uiowa.edu|
21266844|NCT02299206|Northwestern University|Dermatology CTU|312-503-5944|NUdermatologyCTU@northwestern.edu|
21266845|NCT00691054|University of Miami Sylvester Comprehensive Cancer Center|Caio Max Rocha Lima MD|305-243-7770|crocha@med.miami.edu|
21266846|NCT04673630|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21266847|NCT03374891|"University of Colorado Denver | Anschutz"|Daniel Matlock, MD|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
21266848|NCT03219476|Medical College of Wisconsin|Lubna Chaudhary|414-805-4600|lchaudhary@mcw.edu|
21266849|NCT01226472|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
21266850|NCT03128307|Zyppah|Jonathan Greenburg, DDS|(818) 414- 4817|jgreenburg@outlook.com|
21282047|NCT06098339|CooperVision Inc.|José A. Vega, O.D., MSc., PhD, FAAO|925-621-3761|JVega2@coopervision.com|
21282048|NCT00300885|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21282049|NCT01637922|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21297392|NCT01067144|Stanford University|Dr. Ian Carroll|(650) 723-6411|ic38@stanford.edu|
21282050|NCT01515865|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21297393|NCT01317901|Aptevo Therapeutics|Scott C. Stromatt|206-859-6675|sstromatt@apvo.com|
21282051|NCT03981900|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21282052|NCT00184717|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21236385|NCT00305058|Montefiore Medical Center|Andrew Chang, MD|718-920-6626|achang3@yahoo.com|
21297394|NCT01843062|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
21297395|NCT01059994|University of Texas Medical Branch|Melinda Sheffield-Moore|4097728126|melmoore@utmb.edu|
21282053|NCT03126630|Mayo Clinic|Dr. Aaron Mansfield|(507) 284-2511|mansfield.aaron@mayo.edu|
21282054|NCT04181606|The Pennsylvania State University|Dr. David Proctor|(814)863-0724|dnp3@psu.edu|
21282055|NCT00302848|Berlin Center for Epidemiology and Health Research, Germany|Juergen Dinger, MD, PhD, Principal Investigator|+49 30 94510145|dinger@zeg-berlin.de|
21297396|NCT00066963|Professor, S/D- PREV/REST|Stuart Gansky|415-502-8094|stuart.gansky@ucsf.edu|
21297397|NCT03194646|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
21297398|NCT01578577|Northwestern University|Dr. Stephen Persell|312-503-6464|spersell@nm.org|
21297399|NCT04406649|Satsuma Pharmaceuticals, Inc.|Vice President of Regulatory Affairs and Quality|650-837-0799|clin.inquiries@satsumarx.com|
21297400|NCT03068754|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
21297401|NCT03037983|Palo Alto VA|Jong Yoon|510-220-7086|jhyoon1@stanford.edu|
21297402|NCT02697188|Clarus Therapeutics|Theodore Danoff, MD, PhD|847-562-4300|tdanoff@clarustherapeutics.com|212
21297403|NCT01361178|University of Pittsburgh|Andrej Petrov, MD|412-648-6215|petrovaa@upmc.edu|
21297404|NCT01399866|Massachusetts General Hospital - Harvard Medical School|A. Eden Evins, MD, MPH. Director of the MGH-Harvard Center for Addiction Medicine|6176434679|a_eden_evins@hms.harvard.edu|
21297405|NCT00881647|University of California, San Francisco|Thomas C. Neylan, MD|415-750-6961|thomas.neylan@ucsf.edu|
21297406|NCT02726022|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21297407|NCT03274518|University of São Paulo|Dr. Bruno Caldin da Silva|+5511997620521|bruno.caldin@hc.fm.usp.br|
21297408|NCT02518191|Shanghai 6th People's Hospital Affiliated to Shanghai Jiao Tong University|Dr. ZONG|86 (21) 24058549|tigerzong@msn.com|
21297409|NCT00781859|ThromboGenics|Petra Kozma-Wiebe|+32 16751310|petra.kozma@thrombogenics.com|
21236386|NCT03330834|Sun Yat-sen University Cancer Center|Dr.Yuxiang Ma|86 020 87343894|mayx@sysucc.org.cn|
21297410|NCT01339897|N30 Pharmaceuticals Inc.|Janice M Troha|720-945-7714|janice.troha@n30pharma.com|
21297411|NCT01990859|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21266851|NCT01747447|Brigham and Women's Hospital|Meryl S LeBoff, M.D.|1-800-388-3963|vitalstudy@partners.org|
21282056|NCT01450306|Hartford Hospital|Dr David Tolin|860-545-7685|david.tolin@hhchealth.org|
21282057|NCT04687137|Shire|Study Director|: +1 866 842 5335|ClinicalTransparency@shire.com|
21297412|NCT00761202|Allergan, Inc.|Vice President Medical Affairs - Europe|(714)246-4500|clinicaltrials@allergan.com|
21297413|NCT00622388|GlaxoSmithKline|GSK Response Center|866-435-7343||
21297414|NCT00348309|GlaxoSmithKline|GSK Response Center|866-435-7343||
21297415|NCT01743040|UCLA Biomed|Joseph Thomas, MD|310-222-2544|jthomas@labiomed.org|
21266852|NCT00740116|Department of Obstetrics and Gynaecology, and Department of Clinical and Experimental Medicine, Linköpings universitet (LIU), Sweden|Professor Dr. Preben Kjölhede|+4638231188|preben.kjolhede@liu.se|
21282058|NCT02510664|Baylor College of Medicine|Marisa Hilliard PhD, Principal Investigator|832-824-7209|marisa.hilliard@bcm.edu|
21282059|NCT04090060|Medical college of Wisconsin|Alan Nyitray, PhD|414-955-7701|anyitray@mcw.edu|
21236387|NCT02388633|OregonHSU|Jonathan Lindner, MD|5034949191|lindnerj@ohsu.edu|
21236388|NCT00288587|Cleveland Clinic Foundation|Leighann Cesar, RN|216-445-6551|cesar1@ccf.org|
21236389|NCT02944877|University of California, Irvine|Dr. Sean Young|714-413-2347|syoung5@hs.uci.edu|
21236390|NCT01136291|Department of Obstetrics and Gynecology - University of Campinas|Fernanda Garanhani de Castro Surita|+551935219304|surita@unicamp.br|
21236391|NCT00127673|Case Western Reserve University|Dr. Norah C Feeny|2163682695|ncf2@case.edu|
21236392|NCT03238001|Digital Cognition Technologies|SVP, Clinical Affairs|6174331777|aholway@digitalcogtech.com|
21236393|NCT04964089|Kodiak Sciences Inc|Pablo Velazquez-Martin|1 (650) 281-0850|ClinOps@kodiak.com|
21236394|NCT04369469|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
21236395|NCT03135522|The Johns Hopkins University School of Medicine|Dr. Robert A. Wise, M.D.|410-905-5688|rwise@jhmi.edu|
21236396|NCT03483623|David Grant Medical Center, Clinical Investigation Facility, Travis AFB, CA|Lt Col Laurie Migliore|707-423-7280|laurie.a.migliore.mil@mail.mil|
21236397|NCT01165281|Janssen Pharm KK Japan|Medical Director|＋81-3-5509||
21236398|NCT02863991|Chimerix, Inc.|Chief Medical Officer|919-806-1074|clinicaltrials@chimerix.com|101
21236399|NCT01154634|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|
21236400|NCT00364858|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
21236401|NCT00363766|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21236402|NCT03151434|Indiana University Department of Anesthesiology|Dr. Yar Luan Yeap|3172740275|yyeap@iupui.edu|
21236403|NCT02345512|National Health Service Greater Glasgow & Clyde|Ms Jennifer Crockett|0141 276 4900|jennifer.crockett@ggc.scot.nhs.uk|4912
21282060|NCT02176655|Clinvest/A Division of Banyan Group Inc.|Heather Manley|417-841-3664|hmanley@clinvest.com|
21236404|NCT02121847|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21236405|NCT01660906|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21236406|NCT02142049|Pharmacyclics, LLC|Director of Clinical Operations|408-774-0330|Clinical_Directors@pcyc.com|
21236407|NCT03478891|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD|301-451-8715|martin.gaudinski@nih.gov|
21266853|NCT02499172|Johns Hopkins Bloomberg School of Public Health|Dr. Mohammad Ali|410-502-3154|mali25@jhu.edu|
21236408|NCT02099006|University of Rochester|Adrienne Bonham MD|(585) 273-3314|adrienne_bonham@urmc.rochester.edu|
21236409|NCT05932290|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21236410|NCT03864614|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
21236411|NCT01850004|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21236412|NCT00910481|King's College London|Professor Divaka Perera|02071887188|divaka.perera@kcl.ac.uk|
21236413|NCT01489579|Kaiser Permanente|Alicia Cymbala|303-972-5384|Alicia.A.Cymbala@kp.org|
21266854|NCT01293123|University of California, San Diego|Scott Letendre, Principal Investigator|6195438080|sletendre@ucsd.edu|
21236414|NCT04827576|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21236415|NCT04295564|OHSU|Dr. Cindy McEvoy|503-494-0223|mcevoyc@ohsu.edu|
21236416|NCT04537923|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21236417|NCT01261611|Ipsen Innovation|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21236418|NCT02527798|Duke University|Leigh Gosnell|919-668-1280|leigh.gosnell@duke.edu|
21236419|NCT04690855|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 921-2050|fsharmin@hoosiercancer.org|
21236420|NCT01808690|University of Colorado Denver/Children's Hospital Colorado|Dr. Kristen J Nadeau|720-777-2855|Kristen.Nadeau@childrenscolorado.org|
21266855|NCT01111331|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21266856|NCT04495673|University of Minnesota|Kelvin Lim|(612) 626-6772|kolim@umn.edu|
21236421|NCT02395120|Case Western Reserve University|Dr. Suchitra Nelson|216-368-3469|sxn15@case.edu|
21236422|NCT01275625|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21236423|NCT00381966|Johns Hopkins University|Daniel Song|401-502-5875|dsong2@jhmi.edu|
21236424|NCT05732454|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21266857|NCT02386605|Greater Los Angeles VA Healthcare System|Dr. Felice Reddy|3104783711|felice.reddy@gmail.com|
21282061|NCT02053766|The University of Texas Health Science Center at Houston|Maria Matuszczak|713 -500-5075|maria.matuszczak@uth.tmc.edu|
21282062|NCT00435708|Queen's University Belfast|Professor Michelle McKinley|02890978936|m.mckinley@qub.ac.uk|
21297416|NCT01894243|AstraZeneca|Anitra Fielding - Senior Research Physician||ClinicalTrialTransparency@astrazeneca.com|
21236425|NCT01153633|B. Braun Medical AG|Medical Scientific Affairs Manager|+41 58 258 55 47||
21297417|NCT01067469|UT MD Anderson Cancer Center|Dr. John F de Groot/Chair Ad Interim, Neuro-Oncology|713- 745-3072|jdegroot@mdanderson.org|
21297418|NCT04006392|Erchonia Corporation|Clinical Affiairs|888.242.0571|tsammons@erchonia.com|501
21236426|NCT03846024|University of Vermont|Ethan Jones|802-656-9437|ethan.d.jones@med.uvm.edu|
21251593|NCT04626271|Healthy.io|Dr. Danielle Jeddah (Director of Clinical Development) OR Jennifer Kachel Acobas (Director of RA)|0543111050, 0528345562|danielle.jeddah@healthy.io, jennifer.acobas@healthy.io|
21297419|NCT01853605|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
21297420|NCT01424033|University of Michigan|Jan Stevens|7349365566|janstev@med.umich.edu|
21297421|NCT01946152|UT MD Anderson Cancer Center|Michael Wang,MD/ Professor, Lymphoma-Myeloma|(713) 792-2860|miwang@mdanderson.org|
21266858|NCT01842282|University of Michigan|Elif Oral|734-615-7271|eliforal@med.umich.edu|
21282063|NCT03915587|University of Colorado|Sarkis Chris Derderian|720-777-6163|sarkis.derderian@childrenscolorado.org|
21251594|NCT00817336|Nathan Kline Institute|Joshua Kantrowitz|646-774-6738|jk3380@cumc.columbia.edu|
21282064|NCT01718535|Mount Sinai Services Inc.|Azar Azad|416-856-8545|aazad@mtsinai.on.ca|
21282065|NCT04747886|Cedars-Sinai Medical Center|Dr. Sarah-Jeanne Salvy|310-423-6423|sarah.salvy@cshs.org|
21282066|NCT03431831|University of Nebraska Medical Center|Trina Aguirre|308-632-0410|taguirre@unmc.edu|0412
21282067|NCT00179660|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21282068|NCT04478695|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21282069|NCT00644917|Smith & Nephew Biotherapeutics|Jaime E Dickerson, Jr, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
21282070|NCT00402688|Ortho-McNeil Janssen Scientific Affairs, LLC|Therapeutic Area Lead, Anti-Infective Franchise|908-927-5220||
21297422|NCT00894361|PI/study coordinator retired due to personal family health matters and study sponsor then withdrew funding. Study terminated and no data was collected or analyzed from any participant.|Terence J. Gioe, M.D.||tjgioe@gmail.com|
21297423|NCT00286494|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21297424|NCT04207060|Mayo Clinic|Dr. Santhi Swaroop Vege|(507) 266-6931|vege.santhi@mayo.edu|
21297425|NCT00465088|Abbott|Global Medical Services|800-633-9110||
21297426|NCT01871441|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Neal Flomenberg|215 955-0182|dolores.gross@jefferson.edu|
21236427|NCT03725982|Institute of Occupational and Social Medicine and Health Services Research|Tessy Luger|004970712984364|Tessy.Luger@med.uni-tuebingen.de|
21236428|NCT03319277|Cleveland Clinic|Emily RW Davidson, M.D.|812-272-2380|dr.emily.rose@gmail.com|
21236429|NCT01262651|GW Pharmaceuticals Ltd.|Medical Enquiries||medinfo.USA@gwpharm.com|
21236430|NCT03388619|National Cancer Institute|Dr. Deborah E. Citrin|301-496-5457|citrind@mail.nih.gov|
21236431|NCT02239679|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Anna Houlihan|9147608796|Anna.Houlihan@sunpharma.com|
21236432|NCT01517802|Janssen Research & Development, LLC|DIRECTOR CLINICAL RESEARCH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21236433|NCT01206738|University of Aberdeen|Prof Shaun Treweek||streweek@mac.com|
21236434|NCT02605954|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21236435|NCT00093145|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21236436|NCT01310036|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21236437|NCT01175668|Baystate Medical Center|Rachana Singh, MD|413-794-2400|rachana.singhmd@bhs.org|
21236438|NCT00709722|Nippon Kayaku Co., Ltd.|Pharmaceuticals Group|+81-3-6731-5200||
21236439|NCT03359096|University of Pennsylvania|Raj C. Dedhia, MD, MSCR|215-349-5009|Raj.Dedhia@pennmedicine.upenn.edu|
21236440|NCT04433767|Vanderbilt University Medical Cdenter|Warren Taylor, MD, Director of the DIvision of Geriatric Psychiatry|615-322-1073|warren.d.taylor@vumc.org|
21236441|NCT00819182|Indiana University|Janet S Carpenter, PhD, RN, FAAN|317-278-6093|carpentj@iupui.edu|
21236442|NCT00167544|Nationwide Children's Hospital Clinical Research Institute|Dr. Nehal Parikh|614-355-6657|nehal.parikh@nationwidechildrens.org|
21236443|NCT03538626|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
21236444|NCT01156701|GlaxoSmithKline|GSK Response Center|866-435-7343||
21236445|NCT01434602|National Cancer Institute|Dr. Mark R. Gilbert|240-760-6023|mark.gilbert@nih.gov|
21236446|NCT01835626|University of California, San Francisco|Dr. Sue Yom|(415) 353-9893|Sue.Yom@ucsf.edu|
21236447|NCT02232893|Tsumura USA Inc|Yu Tanaka|609-799-2083|Yu Tanaka <tanaka_yuu@mail.tsumura.co.jp>|
21236448|NCT01108081|VA Boston Healthcare System|Dr. David Sparrow|857-364-6400|david.sparrow@va.gov|
21236449|NCT01764945|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21266859|NCT03738878|Yale University|Nancy J. Brown|2037854672|nancy.j.brown@yale.edu|
21282071|NCT01566539|Emory University|Dr. James Rilling|404-727-3062|jrillin@emory.edu|
21282072|NCT02049905|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
21282073|NCT02892110|MUSC|Amanda Wagner, Program Manager|843-792-0484|wagne@musc.edu|
21282074|NCT02653144|Montefiore Medical Center|Dr. Amaresh Vydyanathan|7189204316|avydyana@montefiore.org|
21282075|NCT04724538|P. Hertsen Moscow Oncology Research Institute|Mariia Sedova, MD|+79253093463|mariya.sedova58@gmail.com|
21282076|NCT00945035|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21282077|NCT00835224|James J Peters VAMC|Dr. Jill M. Wecht|718 584-9000|jm.wecht@va.gov|3122
21282078|NCT02097238|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21282079|NCT03728348|Exact Sciences|Alexandra Massoud, Sr. Director of Clinical Affairs|608.284.5700|clinicaltrials@exactsciences.com|
21282080|NCT01282372|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
21282081|NCT02993250|Janssen Pharmaceutical K.K., Japan|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21282082|NCT02560922|University of North Carolina at Chapel Hill|Kelli D. Allen, PhD|919-966-0558|kdallen@email.unc.edu|
21282083|NCT00356148|Marmara University School of Medicine|Prof. Bahadir M Gulluoglu|902164256565|bmgulluoglu@marmara.edu.tr|4012
21282084|NCT02730403|NYU Grossman School of Medicine|John Rotrosen|646-754-4763|john.rotrosen@nyulangone.org|
21282085|NCT02737930|University of Rochester|Bogachan Sahin|(585) 275-2530|bogachan_sahin@urmc.rochester.edu|
21282086|NCT04481789|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please e-mail|cti-inq-ml@ml.mt-pharma.co.jp|
21282087|NCT01413750|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
21282088|NCT03124407|Vizuri Health Sciences|Vice President Clinical Operations|919-397-4782|twarneke@vizuriusa.com|
21282089|NCT00648115|VA North Texas Health Care System|James LePage|210-857-0240|james.lepage@va.gov|
21266860|NCT01888965|Georgetown Lombardi Comprehensive Cancer Center|John L Marshall|202 444 7064|marshalj@georgetown.edu|
21266861|NCT03793010|Flexion Therapeutics, Inc.|David Golod, Vice President, Clinical Operations|(781) 305-7572|dgolod@flexiontherapeutics.com|
21282090|NCT02105987|GlaxoSmithKline|GSK Response Center|866-435-7343||
21236450|NCT01308918|Institut universitaire de cardiologie et de pneumologie de Quebec|Nathalie Gagne|418 656-8711|nathalie.gagne@criucpq.ulaval.ca|2645
21282091|NCT03004638|MedImmune LLC|Richard George|+1-301-398-5681|information.center@astrazenea.com|
21236451|NCT00648908|Acorda Therapeutics, Inc.|Andrew Blight, PhD Chief Scientific Officer|914-347-4300|ablight@acorda.com|4102
21236452|NCT05077267|Bavarian Nordic A/S|Bavarian Nordic Call Center|+1-844-422-8274|medical.information_us@bavarian-nordic.com|
21236453|NCT02911948|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21282092|NCT02705365|Massachusetts General Hospital|Sanja Percac-Lima, MD, PhD|617-643-6980|spercaclima@partners.org|
21282093|NCT05653479|Upstream Bio|Sumathi Sivapalasingam, Vice President of Clinical Development|1 917-499-0789|sumathi.sivapalasingam@upstreambio.com|
21236454|NCT04747977|Ocular Therapeutix|Clinical Project Manager|781-357-4000|clinicalaffairs@ocutx.com|
21236455|NCT00690521|University of New Mexico Health Sciences|Joe Anderson|505-272-3664|janderson@salud.unm.edu|
21236456|NCT01573702|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
21236457|NCT00358735|Medical Compression Systems|Clifford W Colwell, M.D Scripps Clinic|972-4-6266630|Jbarak@mcsmed.com|412
21236458|NCT03864900|National Taipei University of Nursing and Health Sciences|Director of Nursing Department|886-2-28712121|tsaejyy@ntunhs.edu.tw|3100
21236459|NCT03165045|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21236460|NCT02308033|Curatek Pharmaceuticals|Vice President|847-806-7680|info@curatek.com|
21236461|NCT00759109|Merck Sharp and Dohme Corp.|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21236462|NCT01827904|Insightec|Nadir Alikacem, SVP Global Regulated Clinical Affairs|214-360-9900|nadira@insightec.com|
21236463|NCT04773015|GE Healthcare|Paul Sherwin, MD, PhD|609 510 3686|PaulSherwin@ge.com|
21236464|NCT00780962|Beth Israel Deaconess Medical Center|Nathan I. Shapiro, MD, MPH|617-754-2323|nshapiro@bidmc.harvard.edu|
21236465|NCT02908269|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21236466|NCT00142909|Yale University School of Medicine|Rajita Sinha, Ph.D|203-737-5805|rajita.sinha@yale.edu|
21236467|NCT03971643|InflaRx|Prof. Dr. Niels C. Riedemann|+49-(0) 3641-508 180|niels.riedemann@inflarx.de|
21236468|NCT01660763|AcelRx Pharmaceuticals, Inc|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
21236469|NCT00345397|Medical College of Wisconsin and Zablocki VAMC Milwaukee, WI|Mary F. Otterson, MD; Professor of Surgery|414-384-2000|Motterso@mcw.edu|4-1619
21236470|NCT01870843|Xian-Janssen Pharmaceutical Ltd|Associate TA Manager||ClinicalTrialDisclosure@its.jnj.com|
21236471|NCT01910519|Emory University|Nadine Rouphael MD|404-712-1435|nroupha@emory.edu|
21236472|NCT04266028|Desentum Oy|Head of Clinical Operations|+358400224892|Info@desentum.fi|
21236473|NCT03325712|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21236474|NCT00952653|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21236475|NCT02265237|AbbVie|Global Medical Information|800-633-9110||
21236476|NCT00650546|Department of Gastroenterology, San Antonio Uniformed Services Health Consortium|Patrick R Kenney, DO||pat.kenney@us.army.mil|
21236477|NCT01178853|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@KowaUS.com|
21236478|NCT03550313|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21236479|NCT00839072|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
21236480|NCT00380068|Gilead Sciences Inc|Martine Allard, PhD; Senior Clinical Research Scientist|650-524-3898|martine.allard@gilead.com|
21236481|NCT01297062|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21251595|NCT01253447|The University of Texas (UT) MD Anderson Cancer Center|Marina Konopleva, MD, PHD / Professor||CR_Study_Registration@mdanderson.org|
21251596|NCT02299427|University of Alabama at Birmingham|David Schwebel|205-934-8745|schwebel@uab.edu|
21251597|NCT02108652|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21251598|NCT03035318|Cleveland Clinic Foundation|Joseph P. Iannotti, MD, PhD|216-287-1149|IANNOTJ@ccf.org|
21251599|NCT03311269|Vascular Inisights, LLC|Ms. Lorraine Hanley, MBA|617-519-1109|lorraine.hanley@merit.com|
21251600|NCT01182181|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21251601|NCT01586975|Northwestern University|Northwestern University|312.503.4394|r-bernstein@northwestern.edu|
21251602|NCT04706793|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21251603|NCT04438382|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21251604|NCT00823836|GlaxoSmithKline|GSK Response Center|866-435-7343||
21251605|NCT02446613|GlaxoSmithKline|GSK Response Center|866-435-7343||
21251606|NCT00745498|Seoul National University Bundang Hospital Department of Ophthalmology|Dr. Se Joon Woo|+82-31-787-7377|sejoon1@hanmail.net|
21251607|NCT02706847|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21282094|NCT00984542|Vanderbilt-Ingram Cancer Center|Leora Horn, MD|615-936-2033|leora.horn@vanderbilt.edu|
21282095|NCT03187730|NYU Langone|Elizabeth Vargas|310-486-9775|elizabeth.varagas@nyulangone.org|
21282096|NCT00504712|Barnsley Hospital NHS Foundation Trust|Professor TH Jones|01226 431684||
21282097|NCT02097745|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21282098|NCT02064816|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21251608|NCT01062971|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
21266862|NCT00908050|Baylor College of Medicine/Houston Methodist|William Ondo, MD|713-363-8390|wondo@houstonmethodist.org|
21282099|NCT01435304|Maine Medical Center|Dr. Robert S Kramer|207-662-1486|Kramer@mmc.com|
21297427|NCT01835158|Harvard|Toni K. Choueiri, MD|(617) 632-5456|toni_choueiri@dfci.harvard.edu|
21236482|NCT02279641|Study Information Center AstraZeneca|Jesse Hall, MD|+1 877-240-9479|information.center@astrazeneca.com|
21251609|NCT01324700|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD, Professor of Psychiatry|214-645-6950|sherwood.brown@utsouthwestern.edu|
21251610|NCT05479747|Faculty of Dentistry, Ain Shams University|Dr|+11112228724|AlaaMahmoud@dent.asu.edu.eg|
21251611|NCT01795859|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21251612|NCT00904722|The University of Texas (UT) MD Anderson Cancer Center|Sattva S. Neelapu, MD/Associate Professor, Lymphoma/Myeloma||CR_Study_Registration@mdanderson.org|
21251613|NCT00661713|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
21236483|NCT01682837|UT Southwestern Medical Center at Dallas|John Poindexter|2146486857|john.poindexter@utsouthwestern.edu|
21251614|NCT01801982|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21282100|NCT01757184|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
21282101|NCT01959464|Carolinas Healthcare System|Bradley Hurst, M.D., Director of Assisted Reproduction|704-355-3149|bhurst@carolinas.org|
21282102|NCT04468347|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
21282103|NCT03515811|Medtronic|Andrea DiScipio, Senior Clinical Research Specialist|781-491-5350|andrea.l.discipio@medtronic.com|
21282104|NCT00237458|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
21282105|NCT03218826|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
21236484|NCT01494051|Oregon Health & Science University|Dr. Melanie Gillingham|503-494-1682|gillingm@ohsu.edu|
21251615|NCT01966978|UT Southwestern Medical Center|Dr. Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
21251616|NCT00727506|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21236485|NCT03021187|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21251617|NCT01214421|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
21251618|NCT03783689|SPR Therapeutics, Inc|Clinical Affairs|216-378-9106|support@sprtherapeutics.com|
21251619|NCT01351337|Huashan Hospital|Dr Jinsong Wu|862152888771|wjsongc@126.com|
21251620|NCT04887506|Tavanta Therapeutics|Head, Clinical Development|+1 833776 8963|info@tavanta.com|
21251621|NCT00589836|Cleveland Clinic|Zoran Popovic MD|216 444-9242|popoviz@ccf.org|
21251622|NCT03780010|TRACON Pharmaceuticals Inc|Medical Monitor|8585500780|clinicaltrials@traconpharma.com|
21282106|NCT05868577|Atrium Health Wake Forest Baptist|Michael Jones, DPM|704-355-2000|michael.jones4@advocatehealth.org|
21282107|NCT03564119|Sol-Gel Technologies, Ltd.|Sol-Gel|972-8-9313433|info@sol-gel.com|
21282108|NCT01115244|Vanderbilt University Medical Center|Mary Beth Cole|(615) 322-6485||
21282109|NCT02644668|Cytokinetics, Inc.|MD Cytokinetics|650-624-2929|medicalaffairs@cytokinetics.com|
21282110|NCT00961350|POZEN|John Fort, MD / Chief Medical Officer|919-913-1030|jfort@pozen.com|
21282111|NCT02915705|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
21282112|NCT01500382|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21282113|NCT01131455|ColumbiaOG|Vicki L Jones, Research Coordinator|573-443-2402|v.jones@columbiaorthogroup.com|4391
21282114|NCT04818034|University of California, San Francisco|Marshall Stoller|415-514-0918|victoria.hogue@ucsf.edu|
21282115|NCT01760655|Tevogen Bio|Dolores Grosso|848-256-5751|dolores.grosso@tevogen.com|
21282116|NCT03100968|University of Alabama at Birmingham|Adam Sturdivant|205-934-4042|Adamsturdivant@uabmc.edu|
21282117|NCT03960008|Lahey Hospital & Medical Center|Julia Roache, Manger, Research Programs|7817443055|julia.roache@lahey.org|
21282118|NCT03056638|Memorial Sloan Kettering Cancer Center|Dr. Michael Zelefsky, MD|212-639-6802|zelefskm@mskcc.org|
21282119|NCT02530125|Northwestern University|Winter, Jane MD|312 695 4033|Jwinter@nm.org|
21282120|NCT00468481|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21282121|NCT03187418|Centre Hospitalier de l'Universite de Montreal (CHUM)|Dr. Michael Marchand, MD|514-890-8000|michael.marchand-gareau@umontreal.ca|
21282122|NCT00728468|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21282123|NCT01568034|BIAL - Portela & Cª S.A.|Head of Clinical Research|+351-229866100|clinical.trials@bial.com|
21282124|NCT03831113|University of Pittsburgh|Dr Steve Caritis|412 641 4874|scaritis@mail.magee.edu|
21282125|NCT04134429|insel Gruppe AG|Dr. med. Christa König|+41 31 632 21 11|christa.koenig@insel.ch|
21236486|NCT01664078|Cordis US Corp|Jennifer Lee|+1-669-699-6851|jennifer.lee02@cordis.com|
21236487|NCT04782323|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
21236488|NCT03351049|University of Pittsburgh|David Brienza|412.624.6383|dbrienza@pitt.edu|
21236489|NCT02877485|Stanford Facial Plastic and Reconstructive Surgery|Sam P. Most MD|650-736-3223|smost@stanford.edu|
21236490|NCT01700816|Massachusetts General Hospital|Carlos Fernandez Robles MD|6176432410|cfernandez-robles@mgh.harvard.edu|
21236491|NCT03832192|care.coach|Principal Investigator|8554374569|pi@care.coach|2
21236492|NCT01915563|Althaia Xarxa Assistencial Universitaria de Manresa|Dr Rafael Fernandez|34.8732550|rfernandezf@althaia.cat|3730
21236493|NCT02259608|Radboud UMC|Rob Arts|0031 24|rob.jw.arts@radboudumc.nl|36 67206
21236494|NCT02596451|Glenmark Pharmaceuticals Ltd|Cathy Tyrrell|91 2267720000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
21236495|NCT02730819|Mayo Clinic|Dr. Jason Sluzevich|904-953-9453|Sluzevich.Jason@mayo.edu|
21236496|NCT00156065|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21236497|NCT02891187|UNewMexico|Dr. Jennifer Thompson|16366790301|jthompson626@gmail.com|
21251623|NCT01190449|Weill Cornell Medicine Cornell University|Cara Rosenbaum, MD|(646) 962-6500|car9156@med.cornell.edu|
21236498|NCT03581305|NIH/CC|Dima Hammoud, Senior investigator|3014023041|hammoudd@cc.nih.gov|
21282126|NCT04392375|The Ohio State University|Kara Rood, MD|440-321-0264|Kara.Rood@osumc.edu|
21282127|NCT02498444|Stanford University|Jeffrey Feinstein, MD|6507252297|jeff.feinstein@stanford.edu|
21282128|NCT03656692|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
21282129|NCT02693106|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
21282130|NCT02669901|Univesity of New Mexico School of Medicine|Dr. Joanna Katzman, Principal Investigator|(505) 272-2321|JKatzman@salud.unm.edu|
21251624|NCT00487825|Novartis Pharmaceuticals|Study Director|862-778-8300||
21251625|NCT01986114|Sumitomo Dainippon Pharmaceutical|Clinical Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
21282131|NCT00742963|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com|
21282132|NCT00735969|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|High Dose Ribavirin in Combination With Peginterferon for Patients With Chronic Hepatitis C Genotype|(301) 402-5115|mg228m@nih.gov|
21282133|NCT01164579|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21282134|NCT02215200|Benaroya Research Institute|Carla Greenbaum, MD|1-800-425-8361|cjgreen@benaroyaresearch.org|
21282135|NCT02464163|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
21282136|NCT02476578|CLALIT HEALTH SERVICES|Dr. Nir Tsabar|+97246049512|NIR.TSABAR@CLALIT.ORG.IL|
21251626|NCT01190644|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21282137|NCT00927862|Intermountain Healthcare|Dr. Jeffrey L. Anderson, Director of CV Research and Professor of Medicine|801-507-4704|jeffrey.anderson@imail.org|
21282138|NCT04157296|University of Michigan|Yanni Liu|734-936-9275|yanniliu@med.umich.edu|
21282139|NCT03980145|Indiana University|Peter Altenburger|3172780703|paltenbu@iu.edu|
21236499|NCT01798927|UT Southwestern Medical Center|Karen McCain, PT, DPT, NCS|214-648-1559|karen.mccain@utsouthwestern.edu|
21282140|NCT02088905|University of Pittsburgh|Benjamin L. Handen, PhD|412-235-5445|handenbl@upmc.edu|
21236500|NCT01159691|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
21236501|NCT02250612|Sylentis|Clinical Trials Department||info@sylentis.com|
21282141|NCT01562782|The Rogosin Institute|Lisa Hudgins, M.D.|646-317-0805|lih2013@nyp.org|
21282142|NCT02308540|PATH|Dr. Steve Lamola|1-206-285-3500|slamola@path.org|
21297428|NCT00296140|Roudebush VA Medical Center|Dr. Linda Williams|317-988-2715|Linda.Williams6@va.gov|
21282143|NCT01091662|Sunovion Phamaceuticals Inc.|Eslicarbazepine acetate Medical Director|866-503-7813|clinicaltrialsdisclosure@sunovion.com|
21297429|NCT02932748|University of Kansas Medical Center|Anna M. Gorczyca, PhD|913-588-9077|agorczyca@kumc.edu|
21282144|NCT04109391|Tanvex|Study Director|19494838507|jennifer.lai@tanvex.com|
21236502|NCT01490632|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21236503|NCT02332720|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21236504|NCT00384085|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi-aventis.com|
21236505|NCT02346383|CCAMP|J Kelby Hutcheson MD|8642956399|khutchesonmd@carolinapain.com|
21236506|NCT00467870|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
21236507|NCT03489304|Perelman School of Medicine|Dr. Matthew Kayser|215 898 8298|kayser@pennmedicine.upenn.edu|
21236508|NCT02261363|University of Nevada, Reno|Jennifer Pearson|7756825005|jennipearson@unr.edu|
21236509|NCT02301143|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
21251627|NCT04411186|Medical University of South Carolina|Dr. David Gutman, M.D., MBA, Associate Professor of Anesthesiology|843-792-5454|gutman@musc.edu|
21236510|NCT03774186|Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus|Dr. Sarit Polsky|303-724-8575|sarit.polsky@cuanschutz.edu|
21251628|NCT02172911|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
21282145|NCT01371110|Baylor College of Medicine (previously Icahn School of Medicine at Mount Sinai)|Wayne Goodman|713-798-4945|wayne.goodman@bcm.edu|
21282146|NCT00443079|UCSDMED|Dr. Heather Patton|619-543-2470|hpatton@ucsd.edu|
21282147|NCT02649439|National Cancer Institute|Dr. Ravi Madan|301-480-7168|rm480i@nih.gov|
21282148|NCT00911612|Mayo Clinic|Dr. Michael Camilleri|507-266-2306|camilleri.michael@mayo.edu|
21282149|NCT01106911|University of Pittsburgh|Dr. Jules H. Sumkin|412-641-1976|jsumkin@upmc.edu|
21282150|NCT05393869|The Ohio State University College of Public Health|Dr. Joanne G. Patterson|614-247-1780|patterson.1191@osu.edu|
21282151|NCT01814696|Partners Healthcare Connected Health Innovation|Kamal Jethwani, MD, MPH|617-724-3410|kjethwani@partners.org|
21282152|NCT00776295|H. Lee Moffitt Cancer Center|Mohamed Kharfan Dabaja, MD|961-1350000|MK143@aub.edu.lb|5350
21282153|NCT00713258|Nycomed|Clinical Trial Operations|+45 4677 1111|clinicaltrials@nycomed.com|
21282154|NCT02307279|Gelesis|Harry Leider, MD, MBA|(443)934-4906|hleider@gelesis.com|
21282155|NCT02484456|National Institute of Mental Health|Zarate, Carlos|+1 301 451 0861|zaratec@mail.nih.gov|
21251629|NCT01589926|Children's Hospital at Montefiore|Kerry Morrone, MD, Asst Prof of Pediatrics|718-741-2342|kmorrone@montefiore.org|
21251630|NCT00566813|University of Illinois at Chicago|Jose Oberholzer, MD|312-996-6771|jober@uic.edu|
21251631|NCT04795336|NYU Langone Health|Joshua C Rozell, MD|212-598-6000|Joshua.rozell@nyulangone.org|
21251632|NCT01638390|Carl Zeiss Meditec, Inc.|Todd Otani, Senior Clinical Research Scientist|925-557-4513|todd.otani@zeiss.com|
21251633|NCT04012619|West China Hospital, Sichuan University|Prof. You Lu|13398179653|radyoulu@hotmail.com|
21251634|NCT04596995|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21251635|NCT05499130|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
21251636|NCT05382039|Loma Linda University|Eric Johnson|9095584632|ejohnson@llu.edu|47471
21282156|NCT00708214|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21297430|NCT00475904|EpiCept Corporation|Chief Medical Officer|914-606-3500|sallard@epicept.com|
21282157|NCT02199795|MetroHealth Medical Center|Dr. Jayme Knutson|2169573557|jsk12@case.edu|
21282158|NCT04922255|University of Pittsburgh|Megan Bradley, MD|2487701681|megsbrad2010@gmail.com|
21251637|NCT04464421|University of Tennessee Health Science Center|Karen Derefinko, PhD|9014482526|kderefin@uthsc.edu|
21251638|NCT02577003|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Dvelopment|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21251639|NCT02786004|GE Healthcare|Beth Heckel|262-312-7269|beth.heckel@med.ge.com|
21251640|NCT01234883|Baxter Healthcare|Drew Jones, M.D.|224-270-2659|Drew_Jones@baxter.com|
21251641|NCT03210519|Department of Nutrition, Chung Shan Medical University|Dr. Nae-Cherng Yang|886-0936810214|naeman@csmu.edu.tw|
21251642|NCT00476242|NYS Psychiatric Institute|Adam Bisaga|646-774-6155|amb107@columbia.edu|
21251643|NCT03865953|Lateral Pharma Pty Ltd|Mr David Kenley|+61 (0)400 151 490|dk@lateral-pharma.com|
21251644|NCT01181492|Huazhong University of Science&Technology|Zhang Xianwei|027 83662853|ourpain@163.com|
21251645|NCT00485953|University of Pittsburgh|Dr. Susan Greenspan|412-692-2476|greenspn@pitt.edu|
21282159|NCT02073448|Galderma K.K|Clinical Project Manager|+81 3 5937 3850|GaldermaKK.ClinDev@galderma.com|
21282160|NCT03522714|Northwestern University|Peter Ullrich, Clinical Research Coordinator|3129267037|peter.ullrich@nm.org|
21251646|NCT01216072|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21251647|NCT04070768|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
21251648|NCT01704547|UMGCCC|Elizabeth M. Nichols, MD|410-328-2324|enichols1@umm.edu|
21282161|NCT02677922|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
21251649|NCT01560871|Texas Woman's University|Dr. Suh-Jen Lin|214-689-7718|slin@twu.edu|
21251650|NCT00409409|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
21251651|NCT01278615|University of Chicago|Dr. Sonali M. Smith|773-834-2895|smsmith@medicine.bsd.uchicago.edu|
21251652|NCT02138253|Conatus Pharmaceuticals, Inc.|Steven Mento, Ph.D., CEO|858-376-2622|smento@conatuspharma.com|
21251653|NCT01918371|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21251654|NCT01006889|University of Florida|Dr. Kenneth Cusi|352-273-8661|kcusi@ufl.edu|
21282162|NCT03761030|New York State Psychiatric Institute|Dr. Bret Rutherford|646 774 8660|bret.rutherford@nyspi.columbia.edu|
21251655|NCT00243022|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Glen Stevens||steveng@ccf.org|
21251656|NCT02085473|MedImmune, LLC|Meena Jain|+44 (0) 1223 895966|jainm@medimmune.com|
21251657|NCT01390441|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21251658|NCT03802617|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email olly|rinsyousiken@pharm.kissei.co.jp|
21251659|NCT00621192|Eunice Kennedy Shriver National Institute of Child Health and Human Development|David Siegel, MD|301-595-8670|siegelda@mail.nih.gov|
21282163|NCT05708976|University of California San Francisco|Ashley E. Mason, PhD|4155146820|ashley.mason@ucsf.edu|
21282164|NCT01303172|Immodulon Therapeutics Ltd|Chief Medical Officer|+44 (0) 20 3137 6346|info@immodulon.com|
21282165|NCT00514215|Barbara Ann Karmanos Cancer Institute|Peter Littrup, M.D.|313-576-8758|littrupp@karmanos.org|
21282166|NCT03635515|University of Minnesota|Ronald Ordinola Zapata DDS, MS, PhD|(612) 624-9900|rordinol@umn.edu|
21251660|NCT01099579|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21251661|NCT02569957|Sidney Kimmel Cancer Center at Thomas Jefferson University|Russell Schilder|215-503-3057|russell.schilder@jefferson.edu|
21282167|NCT03278223|Visioncare Research Ltd.|Mr Thomas Boyes, Clinical Project Manager|+441252 718719|t.boyes@visioncare.co.uk|223
21282168|NCT02099110|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21282169|NCT02293512|VA Portland Healthcare System|Erin Martz, PhD|503.220.8262|erin.martz@va.gov|56006
21251662|NCT02635386|Woman's Hospital|Dr Karen Elkind-Hirsch|2252315278|karen.elkind-hirsch@womans.org|
21282170|NCT03627546|Weill Cornell Medicine|Kristen Marks|212-746-4177|markskr@med.cornell.edu|
21282171|NCT01992172|Physicians Institute|Sharon Keene, MD|(520) 290-5555|monican@appliedbiology.com|
21282172|NCT01537042|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493||
21282173|NCT02741076|Janssen Pharmaceuticals, Inc.|John Han, Associate Director, Statistics|484-354-3547|jhan9@its.jnj.com|
21282174|NCT01779440|Dartmouth-Hitchcock|Mary F. Brunette, MD|603-229-5419|Mary.F.Brunette@hitchcock.org|
21282175|NCT01329380|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21251663|NCT03174782|University of California, San Francisco- Fresno|Kamell Eckroth-Bernard|559-431-6226|kamell.eckroth-bernard@ucsf.edu|
21251664|NCT03178045|Memorial Sloan Kettering Cancer Center|Robert Allen Jr., MD|646-608-8041|allenr1@mskcc.org|
21251665|NCT01078922|Oncology Specialists, SC|Research Manager|847-410-0658|ktolzien@oncmed.net|
21251666|NCT00980590|Cleveland Clinic|Dr. Daniel Sessler|216-445-6500|sessled@ccf.org|
21251667|NCT03850275|Clarkson University|Ali Boolani|3152681663|aboolani@clarkson.edu|
21251668|NCT00725543|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21251669|NCT02168478|Medimetriks|Noah L. Rosenberg, MD, Chief Medical Officer|2019194083|Noahrosie@yahoo.com|
21251670|NCT01157377|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21251671|NCT05523219|SERF|Sponsor|+33 4.72.05.60.10|clinical@serf.fr|
21251672|NCT01087814|University of Minnesota|Ann Seguin|612-625-7472|segu0017@umn.edu|
21251673|NCT02918292|The Emmes Company|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
21251674|NCT02650466|Alfred E. Mann Insitute at the University of Southern California|Cesar E. Blanco,PhD; Sr Director R&D|2138211619|cblanco@usc.edu|2138211619
21251675|NCT03545412|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
21251676|NCT02392104|William S. Middleton Memorial Veterans Hospital|Andrea Porter, PharmD|608-890-0742|andrea.porter@wisc.edu|
21251677|NCT01963169|University of Maryland, Baltimore|Eun-Shim Nahm|410-706-4913|enahm@son.umaryland.edu|
21266863|NCT01562379|Johns Hopkins Bloomberg School of Public Health|Parul Christian|1-410-955-1188|pchrist1@jhu.edu|
21282176|NCT02965573|argenx BVBA|Regulatory Manager|+32 93103400|regulatory@argenx.com|
21282177|NCT00086619|Massachusetts General Hospital|Robert Neer, MD|617-726-6723|rneer@partners.org|
21251678|NCT02636608|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21282178|NCT01209520|University of Miami|Ikechukwu Akunyili MD|305-243-6626|IAkunyili@med.miami.edu|
21282179|NCT02508077|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
21282180|NCT03291431|Stanford University School of Medicine, Department of Psychiatry and Behavioral Sciences|Dr. Timothy C. Durazzo/Project PI|650-493-5000|tdurazzo@stanford.edu|62982
21282181|NCT05908526|University of Maryland, Baltimore|Emerson Wickwire, PhD|410-706-4771|ewickwire@som.umaryland.edu|
21251679|NCT03912532|NGM Biopharmaceuticals, Inc|VP, Clinical Operations|650-243-5555|ngm282@ngmbio.com|
21282182|NCT02448537|Massachusetts General Hospital|Gregory Cote, M.D., Ph.D|617-724-4000|gcote@partners.org|
21251680|NCT04913948|Ottawa Hospital Research Institute|Dr. Darine El-Chaar|(613) 737-8899|delchaar@toh.ca|78797
21282183|NCT04725812|Cedars-Sinai Medical Center|Professor of Medicine, Cedars-Sinai Medical Center|310-423-7608|sananth.karumanchi@csmc.edu|
21251681|NCT03947918|University of California, San Francisco|Suzanna Martinez|415-476-2300|suzanna.martinez@ucsf.edu|
21282184|NCT05778851|PAVmed Inc., Lucid Diagnostics Inc.|Victoria T. Lee, MD CMO, SVM Clinical Affairs|425.218.6535|VTL@PAVmed.com|
21282185|NCT00839800|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21282186|NCT02801617|Laboratorios Sophia|Dr. Oscar Olvera|(33) 3001 4200|oscar.olvera@sophia.com.mx|1074
21282187|NCT02417142|UMass Medical School|Xiaoduo Fan, MD, MPH|(508) 856 -3881|xiaoduo.fan@umassmed.edu|
21282188|NCT04511520|National medical research center for therapy and preventive medicine|Dr. Maria Makhinova|+79104803524|longtimeaftertomorrow@gmail.com|
21282189|NCT03421210|Duke University|Anthony DeVito, MD|919-684-1377|anthony.devito@duke.edu|
21282190|NCT00912743|Astra Zeneca LLP|Angela Sawyer, Clinical Delivery Director|+44 1625 512397|angele.sawyer@astrazeneca.com|
21282191|NCT01136356|Johns Hopkins University, School of Medicine|Eric C. Strain, MD|410-550-1191|estrain1@jhmi.edu|
21282192|NCT00178685|University of Rochester|Dr. Geoffrey Williams|585-530-2050|geoffrey_williams@urmc.rochester.edu|
21282193|NCT00820248|Canadian Cancer Trials Group|Wendy Parulekar|613-533-6430|wparulekar@ctg.queensu.ca|
21282194|NCT02237196|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21282195|NCT01057810|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21282196|NCT00267969|Centocor Research & Development, Inc.|Dir. Clinical Research|1-800-457-6399||
21282197|NCT00862823|University of Alabama at Birmingham|Jennifer King|205-934-2696|jenking@uab.edu|
21297431|NCT00880191|Mayo Clinic|Debra L. Barton RN, PhD, AOCN|507/284-1623|barton.debra@mayo.edu|
21297432|NCT01635881|Boston Scientific|Andrey Nersesov, Clinical Trial Manager|1-508-683-4988|Andrey.Nersesov@bsci.com|
21297433|NCT00939562|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21297434|NCT00774800|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|(858) 794-8889||
21297435|NCT01919801|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21297436|NCT01677858|Amgen Inc.|Study Director|866-572-6436||
21297437|NCT01331109|Forest Research Institute|Robert Palmer, MD|1-201-427-8200|robert.palmer@frx.com|8218
21297438|NCT00988091|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21297439|NCT00773747|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21297440|NCT04260347|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21297441|NCT00994422|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com|
21297442|NCT02669212|National Institutes of Health|Dr. Brian Walitt|202-549-7669|brian.walitt@nih.gov|
21236511|NCT03214367|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21236512|NCT03740490|Stephenson Cancer Center, University of Oklahoma Health Sciences|Michael Businelle|405-271-8001|michael-businelle@ouhsc.edu|50460
21236513|NCT03268811|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
21236514|NCT00511862|BTG International Canada Inc.|Director of Clinical Operations|613-801-1880|TheraSphereClinical@btgplc.com|
21236515|NCT04726709|University of Idaho|Dr. Rajal Cohen|2088856324|rcohen@uidaho.edu|
21236516|NCT01286779|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21236517|NCT04827212|Northeastern University|Dr. Dinesh John|(801) 230-6320|d.john@northeastern.edu|
21251682|NCT03783871|Ethicon|Erin Meyers|937-681-0322|eprifog1@its.jnj.com|
21236518|NCT00574080|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|PettyNathanM@uams.edu|2461
21236519|NCT00599326|UT Southwestern Medical Center at Dallas|Amit Pandya, M.D.|214-645-8300|amit.pandya@utsouthwestern.edu|
21236520|NCT00784810|Napp Pharmaceuticals Ltd|Director of Medical Affairs|01223 424444||
21251683|NCT06638840|Oticon medical|Director of Clinical Affairs|+46 31 748 61 00|studyinfor@oticonmedical.com|
21251684|NCT05990387|Indiana University|Dr. Blair Johnson|8128558699|bj33@iu.edu|
21251685|NCT00815919|Dana-Farber Cancer Institute|John Koreth, MBBS, DPhil|617-632-2949|John_Koreth@dfci.harvard.edu|
21251686|NCT03522389|Mahidol University|Sunee Bovonsunthonchai|66855926144|sunee.bov@mahidol.ac.th|
21251687|NCT04680637|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21251688|NCT00604188|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21266864|NCT01030757|University of New Mexico|Ben Liem, MD|505-272-0086|bliem@salud.unm.edu|
21251689|NCT01939301|Indiana University|Jeffrey A. Kline, MD|317-880-3900|jefkline@iu.edu|
21251690|NCT02242643|GlaxoSmithKline|GSK Response Center|866-435-7343||
21266865|NCT03350724|The University of Texas Health Science Center at Houston|Jennifer James, DMD, MS|713-486-4383|Jennifer.D.James@uth.tmc.edu|
21297443|NCT03549104|University of Illinois at Chicago|Pamela Martyn-Nemeth|312-996-7903|pmartyn@uic.edu|
21266866|NCT02134912|SWOG|Melanoma Statistician|2066674623|jmoon@fredhutch.org|
21297444|NCT01806675|Stanford University|Sanjiv Sam Gambhir, Professor for Clinical Investigation in Cancer Research and Professor|650-725-6175|sgambhir@stanford.edu|
21297445|NCT03078855|University of Rochester|Michael Brady, PhD|585-275-5830|michael_brady@urmc.rochester.edu|
21297446|NCT00391027|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21297447|NCT03422536|University of Arizona Cancer Center|Rachel Jarrett|5206260375|rjarrett@email.arizona.edu|
21297448|NCT00532298|GlaxoSmithKline|GSK Response Center|866-435-7343||
21297449|NCT00479856|GlaxoSmithKline|GSK Response Center|866-435-7343||
21297450|NCT01973998|Lewis Katz School of Medicine Temple University|Michael R. Jacobs - Director of Research Development|2157072242|michael.jacobs@tuhs.temple.edu|
21297451|NCT04164732|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21297452|NCT02141360|GE Healthcare|Chief Medical Officer - Head Health Initiative|262-544-3633|Victor.Miranda@ge.com|
21297453|NCT04493203|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MSCCR, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
21297454|NCT00773773|Memorial Sloan Kettering Cancer Center|Dr. Paul Tempst, PhD|212-639-8923|liljah@mskcc.org|
21297455|NCT03937960|University of Alabama at Birmingham|Dr. Bhuvana Sunil|2056389107|dr.bhuvana.s@gmail.com|
21297456|NCT00129467|Portland Veterans Affairs Medical Center|Dr. Linda Ganzini|(503) 220-8262|linda.ganzini@va.gov|56492
21297457|NCT01009086|Janssen Research & Development, LLC|Director, Clinical Research|1-800-526-7736||
21297458|NCT01424228|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21297459|NCT00881465|University of South Florida|Eric Storch, Ph.D.|7277678230|estorch@health.usf.edu|
21297460|NCT00932165|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21297461|NCT01846741|Cyberonics, Inc.|Bita Najimipour, Clinical Study Manager|(281) 228-7370|bita.najimipour@cyberonics.com|
21297462|NCT00767819|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21297463|NCT01623739|UTHSCSA Periodontics|Guy Huynh-Ba|2105673569|huynhba@uthscsa.edu|
21297464|NCT01323140|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com|
21297465|NCT05392803|University of California San Diego|Brian Ilfeld, MD, MS|(858) 220-5714|baabdullah@health.ucsd.edu|
21297466|NCT04294147|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21297467|NCT00604045|San Diego State University/University of California Joint Doctoral Program in Clinical Psychology|Dr. Nader Amir|6192293740|namir@mail.sdsu.edu|
21297468|NCT03029091|Cincinnati Children's Hospital Medical Center|Marc E. Rothenberg, MD, PhD|513 636-7177|marc.rothenberg@cchmc.org|
21297469|NCT03916081|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
21297470|NCT03929640|Milton S. Hershey Medical Center|Serdar Ural|717-531-6209|sural@pennstatehealth.psu.edu|
21297471|NCT01240135|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
21297472|NCT04146935|Yale School of Medicine|Dr. Karl Insogna|203-785-3272|karl.insogna@yale.edu|
21297473|NCT04118595|University of North Carolina at Chapel Hill|Michelle Meyer, PhD|919-966-6539|mlmeyer@unc.edu|
21266867|NCT01935622|Virginia Commonwealth University|Antonio Abbate|8048280513|aabbate@vcu.edu|
21251691|NCT04243512|University of Maryland Baltimore|Amber Kleckner|410-706-5961|amber.kleckner@umaryland.edu|
21251692|NCT01103232|Vakif Gureba Training and Research Hospital|ILHAN KARACAN|+ 90 212 4531700|ilhankaracan@hotmail.com|
21297474|NCT00699335|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
21297475|NCT01371305|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
21297476|NCT04038567|Duke University|Christopher Cox|919-681-7232|christopher.cox@duke.edu|
21297477|NCT01817959|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
21297478|NCT01124955|Federal University of São Paulo|Tatiana Molinas Hasegawa|55 115576 4239|tatianamolinas@hotmail.com|
21297479|NCT00692419|VA Pittsburgh Healthcare System, Center for Health Equity Research and Promotion|Steven D. Weisbord MD|412-360-3911|steven.weisbord@va.gov|
21297480|NCT04450329|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
21297481|NCT02841241|Intermountain Medical Center|Office of Research|8015077000|officeofresearch@imail.org|
21297482|NCT03244826|Dana-Farber Cancer Institute|Dr. Gregory Abel (Principal Investigator)|617-632-1906|gregory_abel@dfci.harvard.edu|
21251693|NCT03500835|Children's Hospital Los Angeles|Alaina Vidmar|323-361-4606|avidmar@chla.usc.edu|
21251694|NCT00443599|Boston Children's Hospital|Dr. Michael Agus|617-355-5849|michael.agus@childrens.harvard.edu|
21251695|NCT05093504|CytoSorbents|Weihong Fan|1 732-329-888|wfan@cytosorbents.com|
21251696|NCT02272244|Thomas Jefferson Universiy|Ronald Myers(Priniciple Investigator)|215-5034085|ronald.myers@jefferson.edu|
21251697|NCT00212992|Ottawa Hospital Research Institute|Dr. Ian G. Stiell, Senior Scientist|613-798-5555|istiell@ohri.ca|18683
21251698|NCT05347485|Janssen Scientific Affairs, LLC|Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21251699|NCT01536587|GlaxoSmithKline|GSK Response Center|866-435-7343||
21251700|NCT02666664|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
21251701|NCT03616964|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
21251702|NCT03445793|National Jewish Health|Jennifer Taylor-Cousar, Principal Investigator|3032702764|taylorcousarj@njhealth.org|
21251703|NCT04986566|City of Hope Medical Center|Dr, Laleh Melstrom|626-359-8111|lmelstrom@coh.org|
21251704|NCT04090528|University of Wisconsin - Madison|Douglas G. McNeel, MD PhD|(608) 263-4198|dm3@medicine.wisc.edu|
21266868|NCT02636049|Rockwell Medical, Inc|Clinical Project Manager|248-960-9009|sgrimberg@rockwellmed.com|
21297483|NCT02387008|University of North Carolina at Chapel Hill|Gidgetta Kang|919-537-3968|gidget_jenkins@unc.edu|
21266869|NCT03702439|Imperial Prostate|David Eldred-Evans|020 7594 7773|d.eldred-evans@imperial.ac.uk|
21266870|NCT04806165|Washington University in St. Louis School of Medicine|Ellen E. Fitzsimmons-Craft|314-286-2074|fitzsimmonse@wustl.edu|
21297484|NCT04356352|Wake Forest University Health Sciences|Michael Norton, MD|336-716-8791|mnorton@wakehealth.edu|
21297485|NCT01515046|The University of Iowa|Joseph J. Cullen, MD, FACS|319-353-8297|joseph-cullen@uiowa.edu|
21297486|NCT00416455|NRG Oncology Statistics and Data Management Center|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
21297487|NCT02456857|MD Anderson Cancer Center|Dr. Clinton Yam|(832) 589-8343|cyam@mdanderson.org|
21297488|NCT01983774|Columbia University|Emily DiMango, MD|212-305-0631|ead3@cumc.columbia.edu|
21297489|NCT01138501|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21297490|NCT03696589|Teachers College, Columbia University|Lori Quinn|212-678-3424|lq2165@tc.columbia.edu|
21297491|NCT00847197|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21297492|NCT00828750|GlaxoSmithKline|GSK Response Center|866-435-7343||
21297493|NCT04378114|Medtronic Diabetes|Robin Mottackel|8185764886|robin.e.mottackel@medtronic.com|
21297494|NCT00830180|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21297495|NCT01832532|Cincinnati Children's Hospital Medical Center|Raouf Amin, MD|(513) 636-7945|Raouf.Amin@cchmc.org|
21297496|NCT01366885|OHSU|Dr. Gene Stubbs|503-939-7351|stubbsgene@comcast.net|
21297497|NCT01730586|The University of Texas (UT) MD Anderson Cancer Center|Dr. Michael Overman, Associate Professor, GI Medical Oncology|713-792-7734|MOverman@mdanderson.org|
21297498|NCT02964767|SinghRK|Dr. Ranjan K Singh|91+9431263911|dr_ranjankumarsingh@yahoo.com|
21297499|NCT03712787|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21297500|NCT01865448|Unidad de Apoyo a la Investigacion. Hospital Rio Hortega|Dr. Daniel de Luis|983420400|dadluis@yahoo.es|83523
21297501|NCT04255862|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21297502|NCT05111249|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21297503|NCT05128578|University of Pittsburgh|Shari Rogal|412-360-6177|rogalss@upmc.edu|
21297504|NCT00799266|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21297505|NCT00954993|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21297506|NCT00265317|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com|
21297507|NCT00725049|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
21297508|NCT00732875|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21297509|NCT04756804|Zurex Pharma, Inc.|VP, Reg Affairs|608.203.9090|customercare@zurexpharma.com|
21236521|NCT04969250|University of Minnesota|Melissa Skeans, Statistician/Protocol Manager|612-626-9011|tico@insight-trials.org|
21236522|NCT00563784|UT MD Anderson Cancer Center|Dr. Steven H. Lin/Radiation Oncology|713-563-8490|shlin@mdanderson.org|
21236523|NCT02119416|SUNYBuffalo|Jennifer Temple|716-829-5593|jltemple@buffalo.edu|
21236524|NCT04004611|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21236525|NCT03434119|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21236526|NCT04360824|University of Iowa Hospitals & Clinics|Dr. Usha Perepu|1-319-356-2195|usha-perepu@uiowa.edu|
21236527|NCT00304070|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21236528|NCT00320216|Centocor Research & Development, Inc.|Senior Director Clinical Research|1-800-457-6399||
21236529|NCT03421197|Dr Reddy's Laboratories|Srinivas Sidgiddi, Sr Director, Clinical Development|609-375-9910|srinivassidgiddi@drreddys.com|
21236530|NCT04118348|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
21236531|NCT00779246|Christiana Care Health System|Marci Drees, MD, MS|302-733-5602|mdrees@christianacare.org|
21236532|NCT04153409|Lateral Pharma Pty Ltd|Mr David Kenley|+61400151490|dk@lateral-pharma.com|
21236533|NCT03579459|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21236534|NCT00148343|Case Western Reserve University/MetroHealth Medcial Center|Lynne Sheffler, MD|216-957-3570|lsheffler@metrohealth.org|73556
21236535|NCT04844281|The Ohio State University College of Optometry|Jennifer Fogt, OD MS|16142928858|OPTEyeStudies@osu.edu|
21297510|NCT00660179|Actelion Pharmaceuticals Ltd|Parisa Danaietash||parisa.danaietash@actelion.com|
21297511|NCT01362894|Alcon Research, Ltd.|Stacie Cummings, O.D.|1-800-241-7629||
21297512|NCT05362058|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21297513|NCT06292130|Pro-Change Behavior Systems, Inc.|Sara Johnson, PhD|401.360.2980|sjohnson@prochange.com|
21297514|NCT00398567|Puma Biotechnology, Inc|Senior Director, Clinical Operations|+1 424 248 6500|clinicaltrials@pumabiotechnology.com|
21297515|NCT02551822|University of New Mexico Health Sciences Center, Department of Obstetrics & Gynecology, Division of Urogynecology|Dr. Yuko Komesu, MD|505-272-6382|YKomesu@salud.unm.edu|
21297516|NCT04273893|University of Virginia|UVA Radiation Oncology Clinical Research Coordinator|434-243-0008|UVARADONCClinicalTrials@uvahealth.org|
21297517|NCT05613257|Cedars Sinai Medical Center|Joel Arnold|310-423-9839|joel.arnold@cshs.org|
21236536|NCT00353275|UT Health Science Center at Houston|Dr. Lillian S. Kao|713-566-5095|Lillian.S.Kao@uth.tmc.edu|
21297518|NCT00694018|VA Ann Arbor Center for Clinical Management Research|Sarah L. Krein, PhD, RN|734-845-3621|sarah.krein@va.gov|
21236537|NCT02844946|Baylor College of Medicine|Dr. Lilian Dindo|713-440-4637|lilian.dindo@bcm.edu|
21236538|NCT01617421|Clinical Center|Middleton, Kimberly|+1 301 496 9083|middletonk@mail.nih.gov|
21236539|NCT01754714|Abbott|Associate Director Clinical Services|+31 29-44-79-196|taco.baardman@abbott.com|
21236540|NCT02528214|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21251705|NCT02056626|University of Rochester|John Bisognano|585-341-7800|john_bisognano @ urmc.rochester.edu|
21251706|NCT01780454|Massachusetts General Hospital|Dr. David Sachs|617-726-4065|David.Sachs@tbrc.mgh.harvard.edu|
21251707|NCT03415243|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21251708|NCT04916002|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21251709|NCT05923112|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21251710|NCT04351269|Aziyo Biologics, Inc.|Associate Director of Clinical Operations|470-514-4085|clinical@aziyo.com|
21297519|NCT01036321|H. Lee Moffitt Cancer Center and Research Institute|Nagi Kumar, Ph.D.|813-745-6885|nagi.kumar@moffitt.org|
21297520|NCT02920749|Department of Anaesthesiology and Intensive Therapy, University of Pecs|Dr. Timea Bocskai|36 72 507374|bocskai.timea@pte.hu|
21251711|NCT04486313|Romark|Sr. Director, Research Operations|8132828544|jessica.fulgencio@romark.com|
21297521|NCT05438576|Mayo Clinic|Demilade Adedinsewo, M.B, Ch.B.|904-953-0859|adedinsewo.demilade@mayo.edu|
21251712|NCT02768597|Mayo Clinic|Dr. Mark E. Morrey|507-284-2511|morrey.mark@mayo.edu|
21251713|NCT03064152|Brigham and Women's Hospital|Dr. Michaela K. Farber|6177591609|mfarber@bwh.harvard.edu|
21251714|NCT06533527|Cleveland Clinic Florida (Weston Hospital)|Dr. Tilak Shah|954-659-5646|shaht3@ccf.org|
21251715|NCT01162135|Thomas Jefferson University|Jianqing Lin, MD|215-955-8874|Jianqing.Lin@jefferson.edu|
21251716|NCT01777334|GlaxoSmithKline|GSK Response Center|866-435-7343||
21251717|NCT01951768|Geneva University Hospitals, Balgrist University Hospital|Dr. med. Ilker Uçkay|+41 44 386 11 11|ilker.uckay@balgrist.ch|
21251718|NCT06576674|University of North Carolina at Chapel Hill|Michael Bremmer, PhD|301-827-0566|mbremmer@unc.edu|
21266871|NCT03770689|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21266872|NCT03040479|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
21297522|NCT02881762|University of Maryland, Baltimore|Dr Lydia Tang|14107066567|lydiatang@ihv.umaryland.edu|
21297523|NCT00626444|Thomas Jefferson University|Daniel Monti, MD|215-955-4410|Daniel.Monti@jefferson.edu|
21297524|NCT04054375|Northwestern University School of Medicine|Dr. Senda Ajroud-Driss|(312) 944-0063|s-ajroud@northwestern.edu|
21297525|NCT01856582|Cincinnati Children's Hospital Medical Center|Rebecca Marsh, MD/Associate Professor of Pediatrics|513-803-9063|Rebecca.Marsh@cchmc.org|
21297526|NCT01763606|Memorial Sloan Kettering Cancer Center|Dr. Lisa DeAngelis, MD|212-639-8000|deangell@mskcc.org|
21297527|NCT00646399|Biosynexus|Irwin Scher, MD|301-330-5800|irwinscher@biosynexus.com|
21297528|NCT04865237|Imperial College London|Professor Christopher Chiu|02083832301|c.chiu@imperial.ac.uk|
21297529|NCT02160145|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Devlopment|609 524 6788|clinicaltransparency@otsuka-us.com|
21297530|NCT00395850|University of Arkansas for Medical Sciences|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu|
21297531|NCT02540993|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
21297532|NCT00844558|University of Iowa|Neil Segal|3193560737|segal-research@uiowa.edu|
21297533|NCT00588094|Memorial Sloan Kettering Cancer Center|Dr. Craig Moskowitz|212-639-7992|moskowic@mskcc.org|
21297534|NCT01868334|University of Pittsburgh|Richard K. Zimmerman, MD, MPH, MA|412-383-2354|zimmer@pitt.edu|
21297535|NCT03777319|The Abigal Wexner Research Institute at Nationwide Children's Hospital|Dr. Kevin Flanigan|614-722-5615|kevin.flanigan@nationwidechildrens.org|
21297536|NCT02951429|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21297537|NCT04569357|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
21297538|NCT02202538|Parker Hannifin Corporation|Ryan Farris|(216) 896-3335|ryan.farris@parker.com|
21297539|NCT01457846|Astrazeneca|Donal Landers|+44 1625 231890|Donal.Landers@astrazeneca.com|
21297540|NCT01853878|GlaxoSmithKline|GSK Response Center|866-435-7343||
21297541|NCT03368235|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21297542|NCT02828020|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21297543|NCT03688620|GlaxoSmithKline|Enhanced safety surveillance of GSK's quadrivalent seasonal influenza vaccines|877-379-3718|GSKClinicalSupportHD@gsk.com|
21297544|NCT01183065|Memorial Sloan Kettering Cancer Center|Ho, Alan, MD, PhD (Assistant Attending)|+1646-888-4235|HoA@mskcc.org|
21297545|NCT05546229|Cari Health Inc.|Chief Medical Officer|619 2343725|drcarr@carihealth.com|
21297546|NCT03657095|Lung Biotechnology PBC Study Director|Lung Biotechnology PBC|301-608-9292|info@lungbiotechnology.com|
21297547|NCT02713659|The Children's Hospital of Philadelphia|Dr. James Guevara|215-590-1130|guevara@email.chop.edu|
21297548|NCT00392990|Northwestern University|Leo Gordon, MD||l-gordon@northwestern.edu|
21297549|NCT04331002|University of Kentucky|Dr. Austin Stone|859-218-3131|austin.stone@uky.edu|
21297550|NCT03845738|Dentsply IH AB d.b.a Dentsply Sirona Implants|Director Center of Clinical Research, AnnaKarin Lundgren|+46 31 376 30 00|annakarin.lundgren@dentsplysirona.com|
21297551|NCT00825812|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21297552|NCT01078844|Johns Hopkins University School of Medicine|Eric Samstad, MD|410-550-0171|esamsta1@jhmi.edu|
21297553|NCT00991406|Cleveland VAMC|Elizabeth Hardin|216-791-3800|Elizabeth.HardinvandenBogert@va.gov|4698
21297554|NCT03597061|University of Cincinnati|Cathleen Stough, Ph.D.|513-556-5589|odarcc@ucmail.uc.edu|
21297555|NCT02006979|University of Alberta|Dr. Amy Kirkham, Postdoctoral Research Fellow|7804926874|amy.kirkham@ualberta.ca|
21297556|NCT02038075|University of Utah|Dr. Craig Bryan|8015877978|craig.bryan@utah.edu|
21297557|NCT03477838|Virginia Commonwealth University|Evan Sisson, PharmD|804-828-8076|emsisson@vcu.edu|
21297558|NCT01931163|The Methodist Hospital Research Institute|Dr. Jenny Chang|713 441-0680|jcchang@houstonmethodist.org|
21297559|NCT02519595|Children's Hospital of Michigan|Nirupama Kannikeswaran|313-745-5260|nkannike@dmc.org|
21251719|NCT00720369|McLean Hospital|Cara McCabe, BA|617-855-2410|cfmccabe@partners.org|
21266873|NCT02145429|University of Pittsburgh|Charles F. Reynolds, MD|(412) 246-6414|reynoldscf@upmc.edu|
21266874|NCT03139435|Wake Forest Baptist Comprehensive Cancer Center|Roy Strowd|336-713-5440|rstrowd@wakehealth.edu|
21266875|NCT01944462|Thomas Jefferson University|Laura T. Pizzi, PharmD, MPH; Principal Investigator|215-955-1159|laura.pizzi@rutgers.edu|
21266876|NCT04465240|University of Southern California|Daniel A. Hackman, Ph.D.|(213) 821-3112|dhackman@usc.edu|
21266877|NCT02274311|Hospital das Clinicas da Faculdade de Medicina da USP|Dr. Felipe Henning Gaia Duarte|+5511987550990|drfelipegaia@outlook.com|
21266878|NCT00508001|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21266879|NCT04437511|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21266880|NCT05032755|Duke University Medical Center|Maggie Sweitzer|919-668-0094|maggie.sweitzer@duke.edu|
21236541|NCT00407537|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21236542|NCT02384759|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
21236543|NCT01605617|Mayo Clinic|Dr. Jeffrey L. Cornella|480-342-2867|cornella.jeffrey@mayo.edu|
21266881|NCT02498600|NRG Oncology|Linda Gedeon for Michael Sill, PhD.|716-845-1169|linda.gedeon@roswellpark.org|
21266882|NCT03093350|Baylor College of Medicine|Shaun Bulsara|713-798-8014|sbulsara@bcm.edu|
21266883|NCT05085275|USRC Kidney Research|Stephanie Brillhart, Senior Director Regulatory Compliance|303-881-9451|stephanie.brillhart@usrenalcare.com|
21266884|NCT01319045|UCLA|Jamil Aboulhosn|310-825-5950|jaboulhosn@mednet.ucla.edu|
21236544|NCT00347308|The New York Eye & Ear Infirmary|Anthony P. Sclafani, MD|212-979-4200|asclafani@nyee.edu|
21266885|NCT02912572|Dana-Farber Cancer Institute|Dr. Panagiotis Konstantinopoulos|617-632-5269|Panagiotis_Konstantinopoulos@dfci.harvard.edu|
21266886|NCT05064007|Johns Hopkins University|Dr. Junxin Li|4105022608|junxin.li@jhu.edu|
21236545|NCT00121238|University of Michigan Comprehensive Cancer Center|Maha Hussain, M.D.|(734)936-8906|mahahuss@med.umich.edu|
21266887|NCT04430894|Dana-Farber Cancer Institute|Elizabeth K. O'Donnell, MD|617-632-3000|Elizabeth_ODonnell@DFCI.HARVARD.EDU|
21266888|NCT01602822|Fenway Health|Dr. Kenneth Mayer|617-927-6400|kmayer@fenwayhealth.org|
21236546|NCT01380327|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21236547|NCT00325468|Amgen Inc.|Study Director|866-572-6436||
21266889|NCT00854061|Bausch Health|Study Director||susan.harris@bauschhealth.com|
21236548|NCT03593655|Stellenbosch University, Centre for Medical Ethics and Law|Gonasagrie Nair|27-21-938-7050|gnair@sun.ac.za|
21266890|NCT00853112|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21266891|NCT02782364|University Hospital of South Manchester|Karen Telford|01612916654|karen.telford@uhsm.nhs.uk|
21266892|NCT04209634|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21236549|NCT05046795|Viatris|Dik WH Ng, PhD|+44 (0)1304 626895|dik.ng@viatris.com|
21236550|NCT01127178|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21236551|NCT04174521|Vanderbilt University Medical Center|Bryan Shepherd|615-343-3496|bryan.shepherd@vumc.org|
21236552|NCT03009110|Indiana University School of Medicine|Graham Hogg|317-962-0415|gahogg@iu.edu|
21236553|NCT02365467|Medtronic|Alexa Glandon, Medtronic Clinical Study Manager|12624087021|alexa.a.glandon@medtronic.com|
21236554|NCT04667117|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21236555|NCT03447782|Boston Children's Hospital|Dr. Alyssa Lebel|7812161960|alyssa.lebel@childrens.harvard.edu|
21236556|NCT02666950|Mayo Clinic|Lisa Sproat, M.D.|480/301-8000|Sproat.Lisa@mayo.edu|
21236557|NCT03819660|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|3054203200|gingenito@catalystpharma.com|
21236558|NCT03965052|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
21236559|NCT00884585|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21236560|NCT02545907|Leeds Institute of Clinical Trials Research|Alexandra Pitchford|0113 343 9077|medcatal@leeds.ac.uk|
21236561|NCT03970109|National Institutes of Health|Dr. Daniel Falk|301-443-0788|falkde@mail.nih.gov|
21236562|NCT04323436|Novartis|Study Director|862-778-8300|Novartis.email@novartis.com|
21236563|NCT02720484|Northwestern University|Devalingam Mahalingam|312.472.0564|mahalingam@northwestern.edu;|
21236564|NCT05039268|Macquarie University|Richard Gan|+61 2 9812 3739|richard.gan@mq.edu.au|
21236565|NCT01253343|Cincinnati Children's Hospital Medical Center|Dr. Drew Barzman|513-636-4788|drew.barzman@cchmc.org|
21236566|NCT01617629|PrimaBioMed, Ltd.|Marc Voigt|49 173 6771602|marc.voigt@primabiomed.com.au|
21236567|NCT01663636|Center for Global Health, University of Colorado|Dr. Edwin J. Asturias|3037246282|edwin.asturias@ucdenver.edu|
21236568|NCT02715765|University of Minnesota|Kelvin Lim|612-273-9803|kolim@umn.edu|
21236569|NCT02060890|University of California, San Francisco|Nicholas Butowski MD Professor of Neuro-Oncology|414-353-2966|Thelma.Munoz@ucsf.edu|
21236570|NCT02838017|NorthShore University HealthSystem|Lena Braginsky|2245952705|lena.braginsky.mfm@gmail.com|
21236571|NCT01692197|UT MD Anderson Cancer Center|Borthakur,Gautam MD|713-563-1586|CR_Study_Registration@mdanderson.org|
21236572|NCT02120924|Teva Pharmaceuticals USA, Inc.|Director, CE Studies|1-888-483-8279|USMedinfo@tevapharm.com|
21236573|NCT01884350|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21236574|NCT03510481|NIAID/LMIV|Dr. Patrick Duffy|301-761-5089|patrick.duffy@nih.gov|
21236575|NCT02756624|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
21236576|NCT03588572|Guangzhou General Hospital of Guangzhou Military Command|Dr.Yan Liu|0086-02088654756|yanliu@139.com|0086
21236577|NCT02267382|Mycovia Pharmaceuticals|Sr Vice President, Clinical Development|(919) 467-8539|info@mycovia.com|
21236578|NCT01308580|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21236579|NCT03823651|Duke University Medical Center|Dr. Anthony Sung|919-668-1000|anthony.sung@duke.edu|
21266893|NCT00608491|Duke University|Jenny Ibarra|9192363291|jenny.ibarra@duke.edu|
21266894|NCT02750501|Alcresta Therapeutics, Inc.|"Madhumalli (Molly) Sarkar, MD, PhD, Head of Clinical Development"|617 431 8866|msarkar@alcresta.com|
21251720|NCT06136897|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21266895|NCT03797144|Medtronic|Clinical Research Specialist|+39 3450225929|francesca.molineris@medtronic.com|
21251721|NCT00756457|Ithaca College|Jeff Houck, PhD|585-340-9619|jhouck@ithaca.edu|
21251722|NCT02947100|Nemours/AI duPont Hospital|Dr Robin Miller|302-651-5500|rmiller@nemours.org|
21266896|NCT00403390|Children's Hospital Boston|Jeremi Carswell, MD|617-355-7476|Jeremi.Carswell@childrens.harvard.edu|
21251723|NCT00822770|The University of Texas (UT) MD Anderson Cancer Center|Marina Konopleva, MD, PhD / Associate Professor|713-794-1628|mkonople@mdanderson.org|
21266897|NCT01796106|DMG Dental Material Gesellschaft mbH|Manager Clinical Research|04084006|clinicalresearch@mtcompanies.com|232
21266898|NCT04107935|University of Pittsburgh|Dr. Linda Siminerio|412-559-0359|similx@upmc.edu|
21251724|NCT02402322|Universitat Autonoma de Barcelona|Dr. Pablo Oromendia|+34 665175467|p.oromendia@gmail.com|
21266899|NCT02268942|Medtronic Cardiac Rhythm and Heart Failure|Mary Jacoski|+15087390909|mary.v.jacoski@medtronic.com|
21251725|NCT02818998|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21251726|NCT00926380|Massachusetts General Hospital|Natalie David||ndavid2@mgh.harvard.edu|
21266900|NCT00995215|MetroHealth Medical Center|Dr. Anthony Dimarco|216-778-3906|adimarco@metrohealth.org|
21251727|NCT04919070|University of Rochester|Dr. Sally Norton|5852759814|sally_norton@urmc.rochester.edu|
21251728|NCT00632021|Vanderbilt University Medical Center|Research Coordinator|6159364819|Kathryn.m.goggins@vanderbilt.edu|
21251729|NCT01296555|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21266901|NCT05393570|UTSW - O'Donnell School of Public Health|Sarah E. Messiah|(972) 546-2919|Sarah.Messiah@UTSouthwestern.edu|
21251730|NCT02250534|University of Vermont|Stephen T. Higgins, PhD, Professor, Department of Psychiatry|802-735-6267|stephen.higgins@uvm.edu|
21266902|NCT00002981|Memorial Sloan Kettering Cancer Center|Dr. Steven Larson, MD|212-639-7373|LarsonS@MSKCC.ORG|
21251731|NCT01101061|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21251732|NCT01587118|Tuscaloosa Research and Education Advancement Corp|Sandra Creel|205-554-2000|sandra.creel@va.gov|1-2840
21266903|NCT01300949|Wills Eye Hospital|George L. Spaeth, MD|215-928-3123|gspaeth@willseye.org|
21251733|NCT00537329|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21251734|NCT03599622|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21251735|NCT00778921|Novartis Pharmaceuticals|Study Director|862-778-8300||
21266904|NCT01833806|Insightec|Nadir Alikacem, VP Global Regulated Clinical Affairs & CRO|(214) 630-2000|nadira@insightec.com|
21266905|NCT00056550|GTC Biotherapeutics|Denise Tilton, RN, MHA, Director Clinical Development|508-370-5257|denise.tilton@gtc-bio.com|
21266906|NCT00195624|National Heart Lung and Blood Institute|Young, Neal|+1 301 496 5093|youngns@mail.nih.gov|
21236580|NCT05350449|University of Nevada Las Vegas|Dr. Nirmala Lekhak|702-895-5983|nirmala.lekhak@unlv.edu|
21251736|NCT00572533|University of Louisville|Adam E Gaweda|502-852-0766|adam.gaweda@louisville.edu|
21251737|NCT00267098|Medtronic CRDM Clinical|BLOCK HF Clinical Trial Leader|763-526-2729|medtroniccrmtrials@medtronic.com|
21236581|NCT02498483|Columbia University|Jennifer Woo Baidal|212-342-2962|jw3286@cumc.columbia.edu|
21236582|NCT01625897|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21251738|NCT00798304|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21236583|NCT01432366|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21236584|NCT01997398|Barrow Neurlogical Institute / St. Joseph's Hosptial & Medical Center|Francisco A. Ponce, MD|602-406-3242||
21251739|NCT02031536|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21251740|NCT04211389|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
21251741|NCT04069585|TEOXANE SA|Clinical Project Manager|+41(0) 22 344 96 36|clinical@teoxane.com|
21251742|NCT00547534|University of Rochester Medical Center|Dr. Jonathan Friedberg|585-275-4911|Jonathan_Friedberg@urmc.rochester.edu|
21251743|NCT04206085|Viveve|Vice President, Clinical & Medical Affairs|720-696-8100|clinicalaffairs@viveve.com|
21251744|NCT03200444|Coloplast A/S|Director of Pre-Clinical Research|49111111|dklfn@coloplast.com|+45
21251745|NCT00087555|Jazz Pharmaceuticals, Inc.|Grace Wang, MD Director of Clinical Development & Medical Monitor|650-496-3777||
21236585|NCT04546581|University of Minnesota|James Neaton|612-626-9040|neato001@umn.edu|
21236586|NCT02526693|Wills Eye Hospital|George L. Spaeth, MD|215-928-3123|gspaeth@willseye.org|
21236587|NCT03009045|Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center|Loren G. Miller|310-222-5623|lgmiller@ucla.edu|
21236588|NCT01585103|Mayo Clinic|Dr. Jeffrey Alexander|507-284-1825|Alexander.Jeffrey14@mayo.edu|
21236589|NCT01349569|Johns Hopkins University|Ivan Borrello, MD|4109554967|iborrell@jhmi.edu|
21236590|NCT01944631|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21251746|NCT01530087|Hollister Incorporated|Director, Global Clinical Affairs|847.918.3467|Stacy.Haddad@hollister.com|
21251747|NCT02760485|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21236591|NCT04389762|Professor Lu Neurological Clinic|Professor Lu|+886-3-396-0388|lucs.clinic@gmail.com|
21236592|NCT02692248|MFAR|Responsable person designated by the sponsor|+34934344412|investigacion@mfar.net|
21236593|NCT00328510|Thomas Jefferson University|Maria Werner-Wasik, MD|215-955-7679|Maria.Werner-Wasik@jeffersonhospital.org|
21236594|NCT01412944|Novartis|Study Director|862-778-8300||
21251748|NCT03845023|Apnimed, Inc|Clinical Trials|6015008880|clinicaltrials@apnimed.com|
21251749|NCT01182207|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21251750|NCT01427738|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21266907|NCT03296072|GlaxoSmithKline|GSK Response Center|866-435-7343 Ext:|GSKClinicalSupportHD@gsk.com|
21266908|NCT02421146|Psychiatry Research, The Zucker Hillside Hospital|Andrea Joanlanne|7184708898|ajoanlanne@northwell.edu|
21266909|NCT03887286|University of Miami|Mary Sokoloski|305 585-6683|msokoloski@med.miami.edu|
21266910|NCT01885104|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21251751|NCT02353871|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21251752|NCT05314374|Mayo Clinic|Andres Acosta|507-266-6931|acosta.andres@mayo.edu|
21251753|NCT01743976|Wake Forest School of Medicine|James C. Eisenach|336-716-4182|jimeisenach@gmail.com|
21251754|NCT02658175|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
21251755|NCT02072421|Harvard Clinical Research Institute|Priscilla Driscoll-Shemp|617-307-5200|priscilla.driscoll-shempp@hcri.harvard.edu|
21251756|NCT00762645|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21251757|NCT04996940|University of Kansas Medical Center|Leah Lambart Graduate Research Assistant|9139457862|llambart@kumc.edu|
21251758|NCT05238103|Johns Hopkins University|Lena Mathews, MD MHS|410-502-0469|lmathew6@jhmi.edu|
21266911|NCT00126425|GE Healthcare|Jose M Zubeldia, M.D.|011-44-1494-543137|jose.zubeldia@ge.com|
21266912|NCT01894776|Ottawa Hospital Research Institute|Dr. Bill Cameron|613-737-8899|bcameron@toh.ca|78923
21266913|NCT02415595|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21266914|NCT02614261|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21266915|NCT00926263|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21266916|NCT02460172|ZipLine Medical|Wendy Winters, Clinical Project Manager|408-506-1866|wwinters0@gmail.com|
21266917|NCT04350372|Abbott Structural Heart|Karine Miquel|+32 479 600 107|karine.miquel@abbott.com|
21266918|NCT03512275|Janssen Research & Development, LLC|Director Clinical Research Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266919|NCT00113555|Uromedica|Timothy Plouffe|763-999-7048|tplouffe@uromedica-inc.com|
21266920|NCT03858686|Foresee Pharmaceuticals|Yisheng Lee, MD, Chief Medical Officer|4088234807|yisheng.lee@foreseepharma.com|
21266921|NCT00102804|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21266922|NCT02094664|UCLA Mattel Children's Hospital|Dr. Diana Chen|3108255930|dychen@mednet.ucla.edu|
21266923|NCT00758576|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21266924|NCT01855919|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21266925|NCT03455530|University of Arizona|Dr. Paloma Beamer|520-626-0006|pbeamer@arizona.edu|
21266926|NCT01183728|Instituto de Biología y Genética Molecular (IBGM)|Dr. Javier García-Sancho|+34 98 318 48 27|jgsancho@ibgm.uva.es|
21266927|NCT03037489|Medivir AB|Linda Basse, Cheif Medical Officer|+46 8 546 831 00|linda.basse@medivir.com|
21266928|NCT04167514|CSL Behring|Clinical Study Disclosure Manager|1- 610-878-4697|clinicaltrials@cslbehring.com|
21266929|NCT00939055|EndoGastric Solutions|Senior Director Clinical Affairs|650-823-9093|gsahyun@endogastricsolutions.com|
21266930|NCT00584987|The University of Chicago|Dr. Robert M. Naclerio, MD|(773) 702-1865|rnacleri@surgery.bsd.uchicago.edu|
21266931|NCT03502941|University of Arkansas for Medical Sciences|David D.Church, Ph.D.|5015265709|dchurch@uams.edu|
21266932|NCT03595982|Icahn School of Medicine at Mount Sinai|Dr. Melissa Chu Lam|520-360-8807|melissachu.md@gmail.com|
21266933|NCT01866839|National Heart Lung and Blood Institute|Aue, Georg|+1 301 451 7141|aueg@nhlbi.nih.gov|
21266934|NCT02773849|Ferring Pharmaceuticals|Global Clinical Compliance|+1 862-286-5200|Disclosure@ferring.com|
21266935|NCT00723489|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21266936|NCT01599585|National Center for Telehealth and Technology|Larry D. Pruitt, PhD|253-968-2946|larry.d.pruitt21.civ@mail.mil|
21266937|NCT03657576|The University of Alabama at Birmingham|James Markert, MD|2059347171|jmarkert@uabmc.edu|
21266938|NCT04632589|University of Iowa|Anna Stanhewicz, PhD|3194671732|anna-stanhewicz@uiowa.edu|
21266939|NCT01263470|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
21266940|NCT00610714|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21266941|NCT01327573|Yale University|Dr. Sanjay Kulkarni|203-785-6501|sanjay.kulkarni@yale.edu|
21266942|NCT01108263|Georgetown University|Dr. John Steinberg, Principal Investigator|202-444-0793|zr40@georgetown.edu|
21266943|NCT00638989|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com|
21266944|NCT05245071|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
21266945|NCT03288311|Vanderbilt University Medical Center|Jonathan Casey, Assistant Professor of Medicine|6158754681|Jonathan.d.Casey@vumc.org|
21266946|NCT01553591|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21266947|NCT02477800|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
21266948|NCT02871791|Dana-Farber Cancer Institute|Sara Tolaney, MD MPH|617-632-5743|Sara_Tolaney@dfci.harvard.edu|
21266949|NCT01426009|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
21266950|NCT02283333|Ralph H. Johnson VA Medical Center|Dr. Ron Acierno, PI|843-364-1667|ron.acierno@va.gov|
21266951|NCT01856855|University of Alabama at Birmingham (UAB)|John Fiveash, MD|(205) 975-0224|jfiveash@uabmc.edu|
21266952|NCT04099836|Duke University Medical Center|Dr. Thomas Stinchcombe|919-681-9509|Thomas.stinchcombe@duke.edu|
21266953|NCT01550315|Vanderbilt Universtiy|Alfredo Gamboa|6158751003|alfredo.gamboa@vumc.org|
21266954|NCT02005211|AstraZeneca|Vice President, Neuroscience iMed||ClinicalTrialTransparency@astrazeneca.com|
21266955|NCT01917136|University of Pennsylvania|Dr. Yuchi Han|215-662-2855|yuchi.han@uphs.upenn.edu|
21266956|NCT04589832|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 921-2050|fsharmin@hoosiercancer.org|
21266957|NCT00397631|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21266958|NCT02202161|GlaxoSmithKline|GSK Response Center|866-435-7343||
21266959|NCT00952133|NYU Langone Medical Center|Jeanna Blitz, MD|212-263|jeanna.viola@nyumc.org|0667
21266960|NCT03685643|University of Hong Kong|Dr Wong Chi Wai William|(852) 2518-5650|wongwcw@hku.hk|
21266961|NCT02661256|NYU-Winthrop Hospital|Nazeeh Hanna, MD|6314211424|nazeehhanna@gmail.com|
21266962|NCT02943668|Fred Hutch Cancer Research Center|Dr. Bart Scott|206.667.1990|bscott@fredhutch.org|
21266963|NCT01930487|Ocular Vascular Research Center, Indiana University School of Medicine|Brent Siesky, PhD, Assistant Director|317-278-0177|bsiesky@indiana.edu|
21266964|NCT01563406|Rush University Medical Center|Mary Hayden, MD|3129428727|mhayden@rush.edu|
21266965|NCT00533351|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21266966|NCT01828567|Durham VA Center of Innovation in Primary Care|Eugene Z Oddone, MD, MPSc|919-286-0411|eugene.oddone@va.gov|
21266967|NCT01099761|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21266968|NCT02332876|University of San Diego, California|Dr. Sheri Hartman|8585349235|sjhartman@ucsd.edu|
21266969|NCT02402881|The Johns Hopkins University|Elliott R Haut, MD PhD|410-502-3122|ehaut1@jhmi.edu|
21266970|NCT03325010|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
21266971|NCT03580525|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-932-5711|mehmet.sofuoglu@yale.edu|4809
21266972|NCT01637090|Boston Medical Center|Adam Lerner, MD|617-638-8265|adam.lerner@bmc.org|
21266973|NCT04474366|University of California, San Francisco|Esther Kim|415-353-9392|Esther.kim@ucsf.edu|
21266974|NCT04063865|Indiana University|Chandrashekhar Kubal|317-312-2601|sakubal@iupui.edu|
21266975|NCT00320190|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21266976|NCT01700140|SymBio Pharmaceuticals|Nobuyuki Koseki|+81-3-5472-1127||
21266977|NCT01060124|Medical affairs, Janssen Korea, Ltd.|CRA|82220944835||
21266978|NCT01183481|Sunnybrook Health Sciences Centre|Dr. Edward Chow|416-480-4998|edward.chow@sunnybrook.ca|
21266979|NCT04330989|University of North Carolina at Chapel Hill|Benjamin Chi|9194454147|bchi@med.unc.edu|
21266980|NCT00518336|GlaxoSmithKline|GSK Response Center|866-435-7343||
21266981|NCT03074318|Northwestern University|Seth Pollack, MD, Director of Sarcoma Program|312-503-5320|seth.pollack@northwestern.edu|
21266982|NCT03399786|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21266983|NCT00511706|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21266984|NCT03109418|University of Alabama at Birmingham|Adam Sturdivant|205-934-4042|Adamsturdivant@uabmc.edu|
21266985|NCT02043704|TriHealth|Clinical Research Specialist|513-862-2341|ganga_devaiah@trihealth.com|
21266986|NCT02972658|AstraZeneca|AstraZeneca Information Center|877-240-9479|information.center@astrazeneca.com|
21266987|NCT01054339|Applied Genetic Technologies Corp.|Ellery D. Mangas|386-462-7106|emangas@agtc.com|
21266988|NCT03958149|Imperial College Healthcare NHS Trust|Key investigator|02033121077|annabellelee@nhs.net|
21266989|NCT02785588|GE Healthcare|Yvonne Celestial|+33 130709133|MarieYvonne.CELESTIAL@ge.com|
21266990|NCT00461851|Yale University Yale Cancer Center|Dr Michael Hurwitz|2037371600|Hari.deshpande@yale.edu|
21266991|NCT00621764|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21266992|NCT01493024|ZS Pharma, Inc|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21266993|NCT00724243|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21266994|NCT03031327|Dompé Farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
21266995|NCT00669240|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21266996|NCT00686699|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21266997|NCT00908895|Département d'orthopédie, CHA-Pavillon Enfant-Jésus Québec|Dr Stéphane Pelet, MD, PhD|418-649-0252|stephane.pelet.ortho@gmail.com|3165
21266998|NCT00364611|Sanofi-aventis|Trial Transparency Team||Contact-us@sanofi.com|
21266999|NCT02059174|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21267000|NCT00087594|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21251422|NCT01519778|Cubist Pharmaceuticals|Carisa De Anda, Phd, Vice President Clinical Research|8583522639|carisa.deanda@cubist.com|
21267001|NCT00768040|Novartis Pharmaceuticals|Study Director|862-778-8300||
21267002|NCT01646151|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21267003|NCT00416572|Carnegie Mellon University|Michael F. Scheier, PhD|412-268-3791|scheier@cmu.edu|
21267004|NCT02094612|Kaiser Permanente Division of Research|Monique Does, Project manager|510-891-3612|monique.does@kp.org|
21267005|NCT00290355|GlaxoSmithKline|GSK Response Center|866-435-7343||
21267006|NCT03345849|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21267007|NCT03991936|Weill Cornell Medicine|Dr. Shari Lipner|6469623376|shl9032@med.cornell.edu|
21267008|NCT03577028|Harpoon Therapeutics|Medical Director|1-650-452-728|HPN4241001@harpoontx.com|
21267009|NCT00777036|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21267010|NCT05564039|Eli Lilly and Company|Chief Medical Officer|08004595979|ClinicalTrials.gov@lilly.com|
21282198|NCT00887315|Department of Health Studies, University of Chicago|Dr. Sang Mee Lee|773-834-6765|slee@health.bsd.uchicago.edu|
21282199|NCT00291876|GlaxoSmithKline|GSK Response Center|866-435-7343||
21282200|NCT01309360|Helios-Kliniken Schwerin|Dr.med.Ronald Seidel|0049 (0)385 520-4251|ronald.seidel@helios-kliniken.de|
21282201|NCT00619892|UCSF Fresno|Andrew Goddard, M.D.|559-499-6580|agoddard@fresno.ucsf.edu|
21282202|NCT02901067|Denver Health Medical Center|Study Coordinator, James Chandler|303-602-3798|james.chandler@dhha.org|
21267011|NCT01685372|University of Colorado School of Medicine|Donna Curtis, MD, MPH|720-777-6981|donna.curtis@childrenscolorado.org|
21267012|NCT02055872|McMaster University|Simon Oczkowski|905 521 2100|oczkowsj@mcmaster.ca|42442
21267013|NCT00829010|GlaxoSmithKline|GSK Response Center|866-435-7343||
21267014|NCT01029691|University of Michigan|Louise O'Brien|734 647-9064|louiseo@med.umich.edu|
21267015|NCT00369564|Nemours Children's Clinic|Scott Bradfield, MD|904-697-3793|sbradfie@nemours.org|
21267016|NCT00137267|Bedford VA Medical Center|Dr. David Smelson|781-687-2845|david.smelson@va.gov|
21267017|NCT03501979|University of Alabama at Birmingham|Dr. Erica Stringer-Reasor|205-975-2914|esreasor@uabmc.edu|
21267018|NCT05492877|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
21267019|NCT00129376|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
21267020|NCT03369340|Philip Morris Products S.A.|Christelle Haziza, Director Health Science and Biostatistics|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
21267021|NCT02599441|University at Buffalo|Research coordinator|7162043209|mk67@buffalo.edu|
21267022|NCT00513370|Abbott|Medical Information Specialist|1-800-633-9110||
21267023|NCT00528840|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
21267024|NCT01603628|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21267025|NCT01969565|Emory University|Jonathan Kaufman, MD|404-778-1900|jlkaufm@emory.edu|
21267026|NCT00832091|RegeneRx Biopharmaceuticals, Inc.|Nabila Turjman, PhD, Executive Director, Regulatory Affairs|301-208-9191|nturjman@regenerx.com|108
21267027|NCT00952588|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21267028|NCT00398086|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21267029|NCT04084210|University of Wisconsin- Madison|Megan Piper, PhD, Director of Research Professor|608-265-5472|mep@ctri.wisc.edu|
21267030|NCT02087241|SCRI Development Innovations|Charles H. Davis|+615-524-4341|charles.davis2@scri-innovations.com|
21267031|NCT01955005|Iowa City VA Health Care System|Carolyn L Turvey|319 338 0581|Carolyn.Turvey@VA.Gov|7714
21267032|NCT02201251|Janssen Research & Development, LLC|Director - Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21267033|NCT03531918|Fred Hutchinson Cancer Center|Roland Walter, Member of Clinical Research Division|206-667-3599|rwalter@fredhutch.org|
21267034|NCT00778310|University of Texas Health Science Center at San Antonio|Steven R. Pliszka MD|210-567-5475|pliszka@uthscsa.edu|
21267035|NCT00572728|ACRIN|Ben Herman|401.863.9188|bherman@stat.brown.edu|
21267036|NCT00679380|Santarus, Inc.|Michael Huang, M.D., Senior Medical Director|858-314-5700|contact@santarus.com|
21267037|NCT02724111|Korea University Guro Hospital|Dr Byung Gun Lim|82-2-2626-1437|bglim9205@korea.ac.kr|
21267038|NCT00928304|Piramal Imaging|Dr. Juergen Hirschfeld|49 30 461 1246 15|juergen.hirschfeld@piramal.com|
21267039|NCT04337203|Wake Forest Baptist Comprehensive Cancer Center|Carol Kittel|336-399-3832|c.kittel@wakehealth.edu|
21267040|NCT02141854|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21267041|NCT03258762|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21267042|NCT01868594|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical Research and Medical Information Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
21267043|NCT00356434|Johns Hopkins Univ|Abimbola Aina|410-955-8496|aaina1@jhmi.edu|
21267044|NCT01190020|University of Iowa|Robert Summers, MD|319-356-2130|robert-summers@uiowa.edu|
21267045|NCT06853210|Adichunchanagiri Institute of Medical Sciences|Dr Naveen N|+91-9980023372|naveen_uno1@yahoo.co.in|
21267046|NCT02422186|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21267047|NCT00703729|CU Sports Medicine|Dr. Eric McCarty|303-441-2118|cyndi.long@ucdenver.edu|
21267048|NCT03053180|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21267049|NCT01928186|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
21267050|NCT04540627|mAbxience Research SL|Director of Clinical Trials|+34917711500|susana.millan@mabxience.com|
21267051|NCT01465958|Grifols Therapeutics Inc|Henry Li, PhD|800-20-2807|henry.li@grifols.com|
21267052|NCT06115681|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21267053|NCT00211536|Sr. Clinical Research Manager|John Shin|818-576-4019|john.shin@medtronic.com|
21267054|NCT02583399|Cumberland Pharmaceuticals Inc.|Sr. Manager, Clinical Operations|615-255-0068|bkaelin@cumberlandpharma.com|
21267055|NCT02759939|Dartmouth College|Rachel Thompson|6036530860|rachel.thompson@dartmouth.edu|
21267056|NCT04397757|University of Pennsylvania|Regulatory Lead|512-662-4484|psom-ind-ide@pobox.upenn.edu|
21267057|NCT02306148|University of Sao Paulo - School of Medicine|Dr Isabel Sacco|0055 11 996431511|icnsacco@usp.br|
21267058|NCT01901809|Johns Hopkins University School of Medicine|Kavita Sharma, MD|410-955-7670|ksharma8@jhmi.edu|
21267059|NCT02776904|University of Arkansas for Medical Sciences|Dr. Charlotte Yates|501-450-5542|cyates@uca.edu|
21267060|NCT02646891|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
21267061|NCT01542632|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21267062|NCT00033514|Medical University of South Carolina|Carolyn Britten|843-792-4271|britten@musc.edu|
21267063|NCT03225833|Wave Life Sciences|Medical Director|855-215-4687|clinicaltrials@wavelifesci.com|
21267064|NCT01228084|Oregon Health & Science University, Knight Cancer Institute|Joshi Alumkal, MD|503-494-1091||
21267065|NCT05306964|University of Pittsburgh|Raghavan Murugan, MD, MS, FRCP, Principal Investigator|412-647-8499|muruganr@ccm.upmc.edu|
21267066|NCT04564027|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|Information.center@astrazeneca.com|
21267067|NCT05827978|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
21282203|NCT00942890|University of Tennessee Health Science Center|Dr. Laura Talbot|901-448-3630|ltalbot@uthsc.edu|
21282204|NCT00821964|University of Washington|Principal Investigator||TrialTVG@medicine.washington.edu|
21282205|NCT02156908|Nathan Kline Institute|Joshua Kantrowitz|646-774-6738|josh.kantrowitz@nki.rfmh.org|
21282206|NCT02049814|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21282207|NCT04594070|University of Texas Medical Branch Galveston|Dr. Melody Safarzadeh|9082854962|mesafarz@utmb.edu|
21282208|NCT03852264|University of Arizona|Dr. Evan MacLean|520-621-0386|evanmaclean@arizona.edu|
21282209|NCT03660189|The MetroHealth System|Dr. Chloe Castro|2167784527|ccastro@metrohealth.org|
21282210|NCT04513080|Talkspace|Aarthi Padmanabhan|240-273-6191|aarthi.padmanabhan@talkspace.com|
21282211|NCT02477826|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21282212|NCT05753904|University of Missouri|Vicki Jones|573-882-7583|jonesvicki@health.missouri.edu|
21282213|NCT00183885|USC/Norris Comprehensive Cancer Center|Victoria Soto|(323) 865-0451|victoria.soto@med.usc.edu|
21282214|NCT04972110|Repare Therapeutics Inc|Repare Therapeutics Medical Monitor|1 (857) 340-5402|clininfo@reparerx.com|
21282215|NCT03620643|The Royal Marsden NHS Foundation Trust|Clinical Trial Manager|02078082887|rolo.trial@rmh.nhs.uk|
21282216|NCT05310071|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21282217|NCT02418949|Shirley Ryan AbilityLab|Alexander Barry|3122381435|abarry@sralab.org|
21282218|NCT00014495|Memorial Sloan Kettering Cancer Center|Dr. Martin Tallman|212-639-3842|tallmanm@mskcc.org|
21282219|NCT00828568|Taro Pharmaceuticals USA|Medical Director|(914) 345-9001|medical.affairs@taro.com|6427
21282220|NCT01045187|Xoft, Inc.|Kelly W Elliott RN, MS|408-419-2428|Kelliott@xoftinc.com|
21282221|NCT01342523|University of Wisconsin|Stevens Smith, PhD|608-262-7563|sss@ctri.wisc.edu|
21282222|NCT00556946|University of California, Irvine|Kristen M. Kelly, M.D.|949-824-7103|kmkelly@uci.edu|
21282223|NCT00403481|Daiichi Sankyo|John J. Raia, R.Ph, Pharm. D.|1-877-437-7763|druginfo@dsus.com|
21282224|NCT00396656|Novartis Pharmaceuticals|Study Director|862 778-8300||
21282225|NCT02091089|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
21282226|NCT02755467|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
21282227|NCT02929589|MOMMC|Amanda Crawford|702-653-3583|amanda.j.crawford.ctr@health.mil|
21282228|NCT01537926|UTHealth Science Center at Houston|Dr. Ali J. Marian|713-500-2310|Ali.J.marian@uth.tmc.edu|
21297560|NCT00387036|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
21297561|NCT00850538|New England Baptist Hospital|Carl Talmo|617-724-5474|ctalmo@nebh.org|
21297562|NCT03188510|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
21297563|NCT05261009|Wake Forest School of Medicine|Daryl Henshaw, MD|336-716-4498|dhenshaw@wakehealth.edu|
21297564|NCT01736618|Boston Scientific - Rhythm Management|Clinical Trial Manager or Director of Clinical Trials (Cardiology Rhythm Management)|1-800-227-3422|jill.leigh@bsci.com|
21297565|NCT04167137|Synlogic|Aoife Brennan, MB, BCh, BAO, MMSc|(857) 999-0767|aoife@synlogictx.com|
21297566|NCT02634827|Mayo Clinic|Aref Al-Kali, MD|507-538-0871|AlKali.Aref@mayo.edu|
21297567|NCT02762331|Virginia Commonwealth University|Donald Brophy, PharmD|(804) 827-1455|dbrophy@vcu.edu|
21297568|NCT01849419|University of Chicago|Dr. Harriet de Wit|(773) 702-3560|hdew@uchicago.edu|
21297569|NCT02714283|Oregon Health & Science University|Emily Henkle, PhD, MPH|503-494-6226|henkle@ohsu.edu|
21297570|NCT02461745|Southern California Permanente Medical Group|Division of Clinical Trials Research|(626) 564-5667|clinical.trials@kp.org|
21297571|NCT02921087|SUNY College of Optometry Clinical Vision Research Center|Danielle Iacono, OD|212-938-5936|diacono@sunyopt.edu|
21297572|NCT00211887|Icahn School of Medicine at Mount Sinai|Dr. Fred D. Lublin|212-241-6854|fred.lublin@mssm.edu|
21297573|NCT00571974|Roswell Park Cancer Institute|Gal Shafirstein, D.Sc.|716-845-4025|Gal.Shafirstein@RoswellPark.org|
21297574|NCT02813889|Penn Medicine Center for Physical Medicine and Rehabilitation|Dr. Michelle J. Johnson|4148130128|johnmic@pennmedicine.upenn.edu|
21297575|NCT05589610|Equillium, Inc.|Clinical Trial Manager|8582401200|clinicaltrials@equilliumbio.com|
21297576|NCT00555880|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21297577|NCT02346461|National Human Genome Research Institute|Carrillo, Nuria|+1 301 402 2324|nuria.carrillo@nih.gov|
21297578|NCT00941915|Assistant Research Practice Manager|Joan Cahill, BSN RN OCN CCRP|(919) 668-5211|joan.cahill@duke.edu|
21297579|NCT01702025|Department of Health and Exercise Science|Christopher Bell, Ph.D.|(970) 491-7522|christopher.bell@colostate.edu|
21297580|NCT01336140|Rush University Medical center|Rami Doukky|312-942-4655|rami_doukky@rush.edu|
21297581|NCT03928717|Providence College|Dr. Nick Tarantino|4018651612|ntaranti@providence.edu|
21297582|NCT02363621|Sierra Eye Associates|Dr. Arshad Khanani|775-329-0286|Arshad.Khanani@gmail.com|
21297583|NCT00581581|University of Rochester|Ronnie Guillet, MD, PhD|585-275-6209|ronnie_guille@urmc.rochester.edu|
21297584|NCT01504412|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|+81 362251111 (M-F 9-5 JST)|dsclinicaltrial@daiichisankyo.co.jp|
21297585|NCT05224453|Prince Sattam bin Abdulaziz University|Dr. Gopal Nambi|0501878382|physio_gopal@rediffmail.com|
21297586|NCT02837029|Northwestern University, Feinberg School of Medicine|Aparna Kalyan, MBBS, FRACP|312 926 4291|Aparna.kalyan@northwestern.edu|
21297587|NCT03370042|Kamineni Institute of dental sciences|Dr. Raga Bindu|09849441800|ragha.j16@gmail.com|
21297588|NCT03437577|University of Minnesota|Susan Marino|612-624-2964|marin007@umn.edu|
21297589|NCT01013194|ISMETT-UPMC|Dr Giada Pietrosi|+390912192111|gpietrosi@ismett.edu|
21297590|NCT05380505|NYU Langone Health|Marie Bragg, PhD|646-501-2717|Marie.Bragg@nyulangone.org|
21297591|NCT00381693|Mayo Clinic|Dr. Ruben A. Mesa|507-284-3533|mesa.ruben@mayo.edu|4-3533
21282229|NCT02343939|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21282230|NCT04668248|Brigham and Women's Hospital|Julie Lauffenburger, PharmD, PhD|617-525-8865|jlauffenburger@bwh.harvard.edu|
21282231|NCT00460811|Ironwood Pharmaceuticals|Doug Levine, MD|617.374.3906|dlevine@ironwoodpharma.com|
21282232|NCT02821754|Principal Investigator|Dr. Tim F. Greten|240-760-6114|tim.greten@nih.gov|
21282233|NCT03480542|Hackensack Meriden Health|Cole McCoy|551-204-5529|cole.mccoy@hmhn.org|
21236595|NCT01990950|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|alan.saunders@cookmedical.com|321204
21251759|NCT05739994|Indiana University Bloomington|Dr. Hannah Block|8128555390|hjblock@iu.edu|
21236596|NCT02863926|Indiana University School of Medicine|Kristen Wanczyk / Certified Clinical Research Nurse Coordinator|317-7988-9548|keevans@iu.edu|
21236597|NCT05356221|Oticon Medical|Dr. Nicole Amichetti|+1 609-366-0424|nitc@oticonmedical.com|
21251760|NCT02647645|Nova Southeastern University|Raymond L Ownby, MD, PhD|9542621481|ro71@nova.edu|
21236598|NCT02061384|University of Washington School of Medicine|Dr. John Amory|2066161727|jamory@uw.edu|
21236599|NCT02716974|Johns Hopkins University School of Medicine|Kenneth Pienta|410-502-3137|kpienta1@jh.edu|
21282234|NCT00799474|The University of North Carolina at Chapel Hill, Gillings School of Global Public Health|Dr. Noel Brewer, PhD|919-966-3282|ntb1@unc.edu|
21236600|NCT02473952|Grifols Therapeutics, LLC|Rhonda Griffin, BSN|919-316-6693|Rhonda.Griffin@Grifols.com|
21236601|NCT02312739|Division of Family Planning, University of New Mexico|Sunderjeet Kaur|Email|HSC-familyplanningresearch@salud.unm.edu|
21236602|NCT00455195|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
21236603|NCT00823719|GlaxoSmithKline|GSK Response Center|866-435-7343||
21236604|NCT02117570|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021||
21236605|NCT02148250|University of Minnesota|Elizabth Seaquist, MD|612-624-9176|seaqu001@umn.edu|
21236606|NCT00958919|Dartmouth-Hitchcock|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org|
21236607|NCT02357836|UT Southwestern Medical Center|Dr. David Gerber|214-648-4180|David.Gerber@UTSouthwestern.edu|
21236608|NCT02508480|Boston University|Dr. Zlatka Russinova|617-353-3549|zlatka@bu.edu|
21236609|NCT02806986|Grifols Therapeutics LLC|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
21236610|NCT03043664|Duke University Medical Center|Michael Morse, MD|919-668-1861|michael.morse@duke.edu|
21236611|NCT01540851|Brigham and Women's Hospital|Elena Losina, PhD|617-732-6928|elosina@partners.org|
21236612|NCT03732209|Fralin Biomedical Research Institute at VTC|Jeffrey Stein|540-526-2124|jstein1@vtc.vt.edu|
21236613|NCT04139317|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21236614|NCT05857163|TenNor Therapeutics (Suzhou) Limited.|Guozhu Geng|0512-86861990|guozhu.geng@tennorx.com|
21236615|NCT03621696|Washington University School of Medicine|Douglas Adkins, M.D.|314-747-8475|dadkins@wustl.edu|
21236616|NCT00413413|Novartis Pharmaceuticals|Study Director|862 778-8300||
21236617|NCT05348681|Aristea Therapeutics|Aristea Therapeutics|858-465-6142|info@aristeatx.com|
21236618|NCT00782340|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
21236619|NCT01866410|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
21236620|NCT00553267|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21282235|NCT00994461|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21282236|NCT02977572|INTENSIVE CARE UNIT. HOSPITAL GENERAL UNIVERSITARI CASTELLO|Dr. Alberto Belenguer Muncharaz|0034-964-725000|belengueralberto8@gmail.com|
21282237|NCT04571645|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
21282238|NCT01166438|RTI International|Dr. Marie Gantz|919-597-5110|mgantz@rti.org|
21282239|NCT04321356|University of Tennessee|Michael LaCour|865-974-9376|mlacour@utk.edu|
21282240|NCT02060838|Nationwide Children's Hospital|Aymen Naguib, MD|(614) 722-0596|Aymen.Naguib@nationwidechildrens.org|
21282241|NCT00454363|UT MD Anderson Cancer Center|Dr. James Yao, MD/Professor, GI Medical Oncology, Study Principal Investigator|713-792-2828|jyao@mdanderson.org|
21282242|NCT02811965|Lincoln Memorial University|Jennifer Savage, DNP, APN, FNP-BC||jennifer.savage@lmunet.edu|
21282243|NCT01863667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21236621|NCT04389840|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
21236622|NCT02078284|Pugent Sound Blood Center|Sherrill Slichter|206-292-6541|sjslichter@psbc.org|
21236623|NCT00096135|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21236624|NCT01306162|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21236625|NCT01947946|AZ-PPD|Steven Fox|441480716682|steven.fox@ppdi.com|
21236626|NCT00833989|GlaxoSmithKline|GSK Response Center|866-435-7343||
21236627|NCT01458574|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21236628|NCT02125786|St. Jude Children's Research Hospital|Thomas E. Merchant, DO, PhD|8662785833|referralinfo@stjude.org|
21236629|NCT01365494|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21282244|NCT01731119|UNC-Chapel Hill|Dr. Linmarie Sikich||linmarie_sikich@med.unc.edu|
21282245|NCT02837731|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
21282246|NCT00315458|Purdue Pharma L.P.|Clinical Leader, Executive Medical Director|800-733-1333||
21282247|NCT01294241|Amryt Pharma|Head of Clinical Development|+353 1 669 4606|medinfo@amrytpharma.com|
21282248|NCT00523848|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21282249|NCT01669863|Hannover Medical School|Dr Marius Hoeper|00495115323530|hoeper.marius@mh-hannover.de|
21282250|NCT00489918|Zosano Pharma Inc.|Don Kellerman, VP of Clinical Development and Medical Affairs|(510) 745-4004|dkellerman@zosanopharma.com|
21282251|NCT02748213|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21282252|NCT00913263|Dept. of Surgery, Tampere University Hospital, Tampere, Finland|Teuvo Tammela, Professor|+358-3-31164621|teuvo.tammela@uta.fi|
21282253|NCT00068393|ECOG Statistical Office|Study Statistician|617-632-3012||
21282254|NCT01941745|"Tufts Medical Center | Division of Newborn Medicine"|Jonathan M. Davis, MD|(617) 636-5322|jdavis@tuftsmedicalcenter.org|
21282255|NCT01190410|Cares|UCB|+1844599|UCBCares@ucb.com|2273
21282256|NCT01399047|University of Rochester Medical Center|Erika Augustine, MD, MS|585-275-2808|erika_augustine@urmc.rochester.edu|
21282257|NCT00836888|Ono Pharmaceutical Co. Ltd|Ohyama Yukiya||y.ohyama@ono.co.jp|
21282258|NCT02046005|Brigham and Women's Hospital|Dr. Elizabeth Karlson|617-732-5078|ekarlson@bwh.harvard.edu|
21282259|NCT00893997|UT MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Associate Professor|713-792-7305|eharriso@mdanderson.org|
21282260|NCT04556084|Medical College of Wisconsin|Michael Burke|4149554198|mmburke@mcw.edu|
21282261|NCT04797611|Scion NeuroStim, Inc|Robert Black|919-260-5528|bacllc@earthlink.net|
21282262|NCT03867409|Mayo Clinic of Jacksonville|Dr. Janice Krieger|904-953-6160|krieger.janice@mayo.edu|
21282263|NCT05864612|Wake Forest University Health Sciences|Heidi Munger-Clary, MD, MPH, FACNS, FAES|336-716-7110|heidi.mungerclary@advocatehealth.org|
21282264|NCT03300505|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
21282265|NCT05119595|B.Braun Aesculap|Diana Kupferschmid, Study Manager of B. Braun|0049746195|studies@aesculap.de|0
21282266|NCT01806961|Sipirig AG|Dr. Francine Santoro|+41 62 387 87 87|francine.santoro@galderma.com|87 20
21282267|NCT04532619|University of Oregon|Camille C. Cioffi|541-525-4886|ccioffi@uoregon.edu|
21282268|NCT01108341|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21282269|NCT01976650|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21282270|NCT04973176|University Hospitals Coventry and Warwickshire NHS Trust|Dr Cyprian Mendonnca|02476964000|cyprian.mendonca@uhcw.nhs.uk|25784
21282271|NCT02986282|Warsaw Medical University|Dr Jacek Lewandowski|5992828|jlewandowski@wum.edu.pl|+48 22
21282272|NCT03467217|Johns Hopkins Bloomberg School of Public Health|Laura Wilson|410-955-0719|lwilson9@jhu.edu|
21282273|NCT00769067|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21282274|NCT01270464|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21282275|NCT03528369|Vizuri Health Sciences|Vice President Clinical Operations|919-397-4782|twarneke@vizuriusa.com|
21282276|NCT05656534|The Ohio State University|Dr. Stephanie Gorka|614-366-1027|stephanie.gorka@osumc.edu|
21282277|NCT00302328|Glostrup Hospital|Ulrik Christensen|+4538634825|bisan@regionh.dk|
21282278|NCT01288937|Columbia University|Thomas H. Brannagan, MD|(212) 305-0405|tb2325@cumc.columbia.edu|
21282279|NCT01517763|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0100|CPAPtrial@fphcare.co.nz|
21282280|NCT01750697|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21282281|NCT00288366|Northwestern University|Herbert Y Meltzer|1 312 503 0309|h-meltzer@northwestern.edu|
21282282|NCT00857896|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21282283|NCT02907918|Washington University School of Medicine|Foluso O. Ademuyiwa, M.D., MPH|314-454-8313|bisiademuyiwa@wustl.edu|
21282284|NCT01431716|Actelion Pharmaceuticals Ltd|Thomas Pfister, PhD, Senior Clinical Scientist|+41 61 565 5932|thomas.pfister@actelion.com|
21282285|NCT02016105|Sandoz|Global Program Medical Director|+49 8024 476|biopharma.clinicaltrials@sandoz.com|0
21282286|NCT01214083|VA Connecticut Healthcare System|Gihyun Yoon, MD|203-932-5711|gihyun.yoon@va.gov|7421
21282287|NCT01908829|Astellas Pharma Europe Ltd|Clinical Trial Disclosure|+44 (0)20 3379 8000|Astellas.resultsdisclosure@astellas.com|
21282288|NCT02865499|Univ TX Health Science Center San Antonio|Dean L. Kellogg, Jr, MD, PhD|2106175197|kelloggd@uthscsa.edu|
21282289|NCT02792192|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21282290|NCT02320058|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
21282291|NCT01339923|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21282292|NCT01430403|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21282293|NCT00608777|DermResearch, PLLC|Leon Kircik, M.D.|502-5451-9000|wedoderm@yahoo.com|
21282294|NCT02743936|Brooke Army Medical Center|Dr. Michael D. April|210-916-0808|Michael.D.April@post.harvard.edu|
21282295|NCT01075256|GlaxoSmithKline|GSK Response Center|866-435-7343||
21282296|NCT03502070|Director Global Clinical Operations, General Medicine|Keri L Vaughan|+1 267.980.5015|keri.vaughan@mylan.com|
21282297|NCT02115581|Children's Medical Center|Giv Heidari-Bateni MD/MPH|3142991984|givhb@yahoo.com|
21282298|NCT03723850|University of Chicago|Dr. David Gallo|773-702-8829|dgallo@uchicago.edu|
21282299|NCT03147690|Boston Children's Hospital|Dr. David Mooney, MD MPH|617-355-7800|david.mooney@childrens.harvard.edu|
21282300|NCT00591565|SUNY Upstate|Thomas Schwartz|3154643166|schwartt@upstate.edu|
21282301|NCT02835625|Cancer Registry of Norway|Prof. Solveig Hofvind|+47 22928828|solveig.hofvind@kreftregisteret.no|
21282302|NCT03850483|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21282303|NCT03232931|Emory University|Dr. Nathalie Maitre|404-712-8920|nathalie.linda.maitre@emory.edu|
21282304|NCT04925557|State University of New York at Buffalo|Dr. Robert Zivadinov|716-248-2140|rzivadinov@bnac.net|
21282305|NCT05488470|Division of Cardiology at the Rhode Island and Miriam Hospital, Warren Alpert School of Medicine, Brown University|Antony Chu, M.D., FACC, FAHA, FHRS, FACP, Director of Complex Ablation - Arrhythmia Services Section|401-444-8689|antony_chu@brown.edu|
21282306|NCT01283334|Emory University|Nabil F. Saba, MD|404-778-1900|nfsaba@emory.edu|
21282307|NCT05127330|Butler Hospital|Brandon Gaudiano, Ph.D.|401-455-6457|bgaudiano@butler.org|
21282308|NCT04981470|neuroloop|Clinical Affairs|+497611543390|study@neuroloop.de|
21282309|NCT04402138|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|SCRI.InnovationsMedical@scri.com|
21236630|NCT02663128|Eli Lilly and Company|Chief Medical Officer|800-545-5079||
21236631|NCT01812044|Duke University Medical Center|Laura Enyedi, M.D.|919-684-2038|laura.enyedi@dm.duke.edu|
21236632|NCT05070897|Hôpital Européen Georges Pompidou|Pr Elena Paillaud|0156093310|elena.paillaud@aphp.fr|
21251761|NCT01688310|Catholic University of Mozambique Medical School|Dr. Peter Millard|2078663503|pmillard@mac.com|
21236633|NCT03832946|Galecto Biotech aps|Hans Schambye - Chief Executive Officer|+4526373726|info@galecto.com|
21236634|NCT03394924|Enanta Pharmaceuticals, Inc.|Nathalie Adda|+1 6176070705|nadda@enanta.com|
21236635|NCT01842789|Acessa Health, Inc.|Laura Kemp, Clinical Affairs Consultant|4083751465|lkemp@acessahealth.com|
21236636|NCT00450424|Fox Chase Cancer Center|Kristen Sorice|215-214-1433|Kristen.Sorice@fccc.edu|
21236637|NCT01311102|Harbor-UCLA Medical Center|Dr. Anita Nelson|310-222-3871|anitanelsonwhc@earthlink.net|
21236638|NCT03277313|Takeda|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
21251762|NCT04599907|Candesant Biomedical|Erin Tims, VP of Clinical Affairs|19255776863|etims@candesant.com|
21251763|NCT01466790|Janssen Research & Development, LLC|Medical Leader||ClinicalTrialDisclosure@its.jnj.com|
21251764|NCT00356811|GlaxoSmithKline|GSK Response Center|866-435-7343||
21251765|NCT03668223|Dana Farber Cancer Institute|Dr. Abby Rosenberg|617-632-5286|abbyr_rosenberg@dfci.harvard.edu|
21251766|NCT05502783|National Heart, Lung, and Blood Institute (NHLBI) at National Institutes of Health (NIH)|Dr. Georg Aue|301.547.9490|aueg@nhlbi.nih.gov|
21251767|NCT01641653|Rutgers-New Jersey Medical School|Vasanti Tilak, MD|973 972-7477|tilakva@njms.rutgers.edu|
21251768|NCT00129935|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
21251769|NCT02783573|AstraZeneca|AstraZeneca Information Center|1-877-240-9479|information.center@astrazeneca.com|
21251770|NCT00656201|Brigham and Women's Hospital|Elena Yanushpolsky, MD|617-732-4648|lgreenberg@partners.org|
21251771|NCT01434680|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21251772|NCT04991766|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21251773|NCT05781750|Kezar Life Sciences, Inc.|Regulatory Affairs|650-822-5600|clinicaltrials@kezarbio.com|
21251774|NCT05621252|Pliant Therapeutics|Pliant Therapeutics Medical Monitor|650-481-6770|clintrials@pliantrx.com|
21251775|NCT02078726|University of California, San Francisco|John Cello, MD|628-206-4767|John.Cello@ucsf.edu|
21251777|NCT05765435|Cionic|Rebecca Webster|888-481-3724|rebecca@cionic.com|
21251778|NCT01952847|UT MD Anderson Cancer Center|Aung Naing, MD-Professor, Invest. Cancer Therapeutics|(713) 563-3885|anaing@mdanderson.org|
21251779|NCT01585441|National Eye Institute|Emily Chew, MD|301-496-6583|emily.chew@nih.gov|
21251780|NCT03182998|Mayo Clinic|Dr. Jon C. Tilburt, MD, MPH|480-301-3401|tilburt.jon@mayo.edu|
21251781|NCT01013961|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
21251782|NCT02643225|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
21251783|NCT01271504|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21251784|NCT00940875|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21251785|NCT00943787|University of Virginia|Mary Oliveri|434-982-0602|mc7m@virginia.edu|
21251786|NCT01850589|Staten Island University Hospital|Dr. Jonathan Deitch, PI, Director of Vascular Surgery|718-226-9000|jonathan_deitch@siuh.edu|1278
21251787|NCT03721705|Renew Research|Billy Tally, CEO|949-545-8466|bill2@stage2innovations.com|
21251788|NCT01843777|National Center for Rehabilitative Auditory Research|M. Samantha Lewis, PhD|503-220-8262|Michele.Lewis3@va.gov|51996
21251789|NCT01449149|Department of Radiation Oncology, PENN MEDICINE|Michelle Alonso-Basanta, MD PhD|215 615 3782|michelleab@uphs.upenn.edu|
21251790|NCT05147350|Repare Therapeutics INC|Repare Therapeutics Medical Monitor|857-340-5402|clininfo@reparerx.com|
21251791|NCT01080326|Mayo Clinic|Juliane Bingener-Casey, M.D.|507-538-9007|BingenerCasey.Juliane@mayo.edu|
21251792|NCT03563313|University of Virginia|Sue Brown, MD|434-962-0602|sab2f@virginia.edu|
21251793|NCT02025855|Frederick Health|Thomas Smoot|2405663250|tlsmoot@frederick.health|
21251794|NCT01628692|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21251795|NCT02437071|Memorial Sloan Kettering Cancer Center|Dr. Neil Segal, MD, PhD|646-888-4187|segaln@mskcc.org|
21251796|NCT01200498|The University of Texas MD Anderson Cancer Center|Alfonso Quintas-Cardama, MD/Assistant Professor|713-745-4009|eharriso@mdanderson.org|
21251797|NCT01640171|Retina Vitreous Associates of Florida|Steven Cohen|7274459110|scohen@health.usf.edu|
21251798|NCT03513068|ResMed|Maureen Crocker, Sr. Manager Market Access|+65 9815 2195|maureen.crocker@resmed.com|
21251799|NCT04788511|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21251800|NCT03636373|Rutgers, The State University of New Jersey|Naomi Schlesinger, MD|732 235 6117|Naomi.Schlesinger@hsc.utah.edu|
21251801|NCT02353468|University of Colorado|Choon-kee Lee, MD|7208489252||
21251802|NCT00003477|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
21251803|NCT00153985|Dana-Farber Cancer Institute|Catherine Wu, MD|617-632-5943|cwu@partners.org|
21251804|NCT01236352|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21251805|NCT01575873|Amgen Inc.|Study Director|866-572-6436||
21251806|NCT00672451|Wake Forest University Health Sciences|Dr. John Burkart|33671662958|jburkart@wakehealth.edu|
21251807|NCT01031498|UT MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-745-5783|eharrison@mdanderson.org|
21251808|NCT02688530|Hospital for Special Surgery|Meghan Kirksey, MD, PhD|212-606-1206|Kirkseym@hss.edu|
21251809|NCT01658020|Asan Midical Center|Principal Investigator|+82-2-3010-3136|ymoh55@amc.seoul.kr|
21251810|NCT02526186|MOMH|Amanda Crawford|7025633583|amanda.j.crawford.ctr@health.mil|
21236639|NCT02005471|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21236640|NCT00801827|Vanderbilt_University|Julia Dunn, MD|615-343-8389|julia.dunn@va.gov|
21282310|NCT00784238|Clinical Research Team, Medical Affairs Korea|Senior Clinical research Associate|82-2-2094-4804||
21282311|NCT04325568|New York University|Dr. Lawrence Yang|(212) 992-6334|lawrence.yang@nyu.edu|
21282312|NCT04390503|Columbia University|Jessica Justman, MD|212-342-0537|jj2158@cumc.columbia.edu|
21282313|NCT00078767|Allegheny Singer Research Institute|Judith Cohen, MD||judith.cohen@ahn.org|
21282314|NCT03508726|University of Iowa, Holden Comprehensive Cancer Center|Varun Monga, MD|319-384-9497|varun-monga@uiowa.edu|
21282315|NCT01068730|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
21282316|NCT02919423|University of Arkansas for Medical Sciences|Merideth Addicott, Assistant Professor|501-526-8436|maddicott@uams.edu|
21282317|NCT01113385|Children's National|Asha Moudgil MD, Professor of Pediatrics|202-476-5058|amoudgil@childrensnational.org|
21282318|NCT02989246|Children's Hospital Los Angeles|Dr Robinder Khemani, Associate Director of Research ACCM|323-361-2376|rkhemani@chla.usc.edu|
21282319|NCT02497040|uludag university|Dr.Banu Otlar Can|+905323827044|botlar@hotmail.com|
21282320|NCT03233529|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21282321|NCT03260244|Abbott|Associate Director, Clinical Research, Electrophysiology|651-756-3813|anne.sarver@abbott.com|
21282322|NCT01177293|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21282323|NCT02207803|Virginia Commonwealth University|Dr. Paul Perrin|8048273894|pperrin@vcu.edu|
21282324|NCT00594100|W. L. Gore & Associates|Andrew Garcia|(800) 437-8181|AGarcia@WLGore.com|
21282325|NCT04286581|University of Minnesota|Dr. Jacob Hutchins, MD|612-624-9990|hutc0079@umn.edu|
21282326|NCT02973503|CHU Clermont-Ferrand|Armand Abergel|+33473750523|aabergel@chu-clermontferrand.fr|
21282327|NCT01620190|University of Washington|Research Manager|206-606-7445|smasters@seattlecca.org|
21282328|NCT02875613|UC San Diego - Moores Cancer Center|Dr. Assuntina Sacco|858-822-5210|agsacco@ucsd.edu|
21282329|NCT02347774|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
21282330|NCT04306965|Tufts Medical Center|Study Coordinator|617-636-1579|courtney.donovan@tuftsmedicine.org|
21282331|NCT04112043|University of Florida|Dr. Robert Mankowski|352-294-5055|r.mankowski@ufl.edu|
21282332|NCT00181285|University of Illinois at Chicago|Jerry A. Krishnan|312-413-0637|jakris@uic.edu|
21282333|NCT02285166|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21282334|NCT03219840|The University of Texas Health Science Center at Houston|Flavia S. Lakschevitz, DDS, PhD, MSc|604-822-3863|flavia.lakschevitz@dentistry.ubc.ca|
21282335|NCT00832572|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21282336|NCT00384839|Texas Oncology, P.A|Dr. Guru Sonpavde|(281) 332-7505|Guru.Sonpavde@USOncology.com|
21282337|NCT00863343|Meso Scale Diagnostics, LLC.|Dennis Mertz, Director Regulatory and Clinical Affairs|240 631-2522|dmertz@mesoscale.com|2809
21282338|NCT01421225|Boston Children's Hospital|Garry Steil (Assistant Prof. of Pediatrics)|617-355-7504|garry.steil@childrens.harvard.edu|
21282339|NCT02714595|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
21282340|NCT01322490|Bavarian Nordic A/S|Program Lead, Clinical Operations|+ 45 3326|info@bavarian-nordic.com|8383
21282341|NCT02257489|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21282342|NCT01896128|Burke Rehabilitation Hospital|Pasquale Fonzetti MD|(914) 597-2502|pfonzett@burke.org|
21282343|NCT00863356|HemCon Medical Technologies|V.P., Clinical Affairs|971.223.4904|jody.oyama@hemcon.com|
21282344|NCT02023411|PGIMER|Dr Ashu Rastogi|9781001046|ashuendo@gmail.com|
21282345|NCT01996254|SPR Therapeutics, Inc.|Clinical Affairs|216-378-9108|support@SPRTherapeutics.com|
21282346|NCT05478135|Prova Health|Dr Jack Halligan|07742161980|jack.halligan@provahealth.com|
21282347|NCT00693238|University of Florida|Randal Henderson, MD, MBA|904-588-1800|rhenderson@floridaproton.org|
21282348|NCT02411396|Johns Hopkins University School of Medicine|Sophie Lanzkron, MD, MHS, Associate Professor of Medicine and Oncology|410-502-8642|slanzkr@jhmi.edu|
21282349|NCT00436475|Tufts Medical Center|Dr. Anastassios G. Pittas|617-636-5689|apittas@tuftsmedicalcenter.org|
21282350|NCT02071706|GE Healthcare|Yvonne Celestial|+33625023857|MarieYvonne.CELESTIAL@ge.com|
21282351|NCT00179777|University of Helsinki|Professor Mikael Knip|+3582941 25222|mikael.knip@helsinki.fi|
21282352|NCT02247440|Institut de Recherche pour le Developpement|Gonzague Jourdain|+66818830065|Gonzague.Jourdain@ird.fr|
21282353|NCT00661609|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21282354|NCT00637000|Reckitt Benckiser Pharmaceuticals, Inc.|Rolley E. Johnson, PharmD, Vice President, Clinical, Scientific and Regulatory Affairs|804-379-1090|ed.johnson@reckittbenckiser.com|7089
21282355|NCT00839527|GlaxoSmithKline|GSK Response Center|866-435-7343||
21282356|NCT00562302|Angiotech|Thomas Doyle|352.338.0440|tdoyle@angio.com|
21282357|NCT01855243|Cairo University|Eman Said Sayed|01001186079|gaviota_3011@hotmail.com|002
21282358|NCT03615144|Memorial Sloan Kettering Cancer Center|Maria Cancio, MD|212-639-7196|canciom@mskcc.org|
21282359|NCT00943150|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
21282360|NCT01860040|Western Regional Medical Center|Director of Clinical Research|6232073000|jessica.coats@ctca-hope.com|
21282361|NCT01931995|Massachusetts General Hospital|Dr. Mark Eldaief|6177261728|MELDAIEF@PARTNERS.ORG|
21282362|NCT00679289|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21282363|NCT00937040|Ortho-McNeil Janssen Scientific Affairs, LLC|VP Medical Affairs, CNS|609-730-2136||
21282364|NCT02324504|Boston Children's Hospital|Dr. Michael Agus|617 355-5849|michael.agus@childrens.harvard.edu|
21282365|NCT04002115|Penn State Health|Dr. Seema Naik|7175310003|snaik@pennstatehealth.psu.edu|289626
21282366|NCT00554515|Beth Israel Deaconess Medical Center|David F. McDermott, MD||dmcdermo@bidmc.harvard.edu|
21282367|NCT00461773|The Christ Hospital|Gina G. Chung, MD|(513) 564-7771|gina.chung@thechristhospital.com|
21282368|NCT02477332|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
21282369|NCT04657198|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21282370|NCT03793842|Michigan Medicine|Robert Hyzy, MD|734-936-5201|rhyzy@med.umich.edu|
21282371|NCT02549287|Georgia State University|Dr. Daniel Whitaker|404-413-1282|dwhitaker@gsu.edu|
21282372|NCT03340454|NYU Langone Health|Yi-Ling Tan|646-501-3489|yi-ling.tan@nyulangone.org|
21282373|NCT02171234|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|francisco.rocha@bial.com|
21282374|NCT02568189|Icahn School of Medicine at Mount Sinai|James W Tsung MD, MPH|212 241 6272|james.tsung@mountsinai.org|
21282375|NCT01052480|Leidos Biomedical Research, Inc. is support to the National Institute of Allergy and Infectious Diseases (NIAID)|John Beigel, M.D.|301-451-9881|jbeigel@niaid.nih.gov|
21282376|NCT01094574|Stanford School of Medicine|Martin Angst, MD, Professor, Dept. of Anesthesia, Stanford SOM|650-498-5109|ang@stanford.edu|
21282377|NCT01385137|SWOG Statistical Center|Study Statistician|206-667-4623||
21282378|NCT02461433|Johns Hopkins University|Mahmoud Malas|410-550-4546|bmalas1@jhmi.edu|
21282379|NCT01030289|Medical University of South Carolina|Jeffrey Borckardt, Ph.D|843-792-3295|borckard@musc.edu|
21282380|NCT02260869|Lumbrera LLC|David Cedeno|3098266974|dclumbrera@gmail.com|
21282381|NCT04019613|Mayo Clinic|Dr. Brandon M. Wiley|507-255-1051|Wiley.Brandon@mayo.edu|
21282382|NCT03806933|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|Aesthetic.Trials@merz.com|
21282383|NCT02028767|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21282384|NCT03325816|Georgetown University|Chul Kim, MD|202-444-2223|Chul.Kim@gunet.georgetown.edu|
21282385|NCT04606394|PRISM|Gary T Ferguson, M.D.|248-514-6063|garytferguson@msn.com|
21282386|NCT00954941|The University of Texas MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-794-5783|eharriso@mdanderson.org|
21282387|NCT01053663|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21282388|NCT02920008|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
21282389|NCT01862250|University of Toronto|Estelle B. Gauda|416-813-4908|estelle.gauda@sickkids.ca|
21282390|NCT01631149|Leiden University Medical center|Dr. Albert Dahan|3171 526 2301|a.dahan@lumc.nl|
21282391|NCT00090493|University of Arkansas for Medical Sciences - MIRT|Frits van Rhee, MD, PhD|(501) 686-8230|vanrheefrits@uams.edu|
21282392|NCT01316211|Paradigm Spine|Fran Magee, DVM|212-367-7274|fran.magee@paradigmspine.com|
21282393|NCT01769508|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21282394|NCT02751450|GlaxoSmithKline|GSK Response Center|866-435-7343||
21282395|NCT02587598|Call Center|Incyte Corporation|1-855-463-3463|medinfo@incyte.com|
21282396|NCT01704651|Mayo Clinic|Dr. Jamie N. Bakkum-Gamez|507-266-8661|Bakkum.Jamie@mayo.edu|
21282397|NCT00791661|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21282398|NCT01131169|Memorial Sloan Kettering Cancer Center|Sergio Giralt, MD|646-608-3731|GiraltS@mskcc.org|
21282399|NCT00634803|Yale University|Richard S. Schottenfeld, M.D.|203-974-7349|richard.schottenfeld@yale.edu|
21251811|NCT05903183|Icosavax Inc.|Icosavax Clinical Operations|206-737-0085|clinops@icosavax.com|
21282400|NCT00638222|The University of Toledo, HSC|Christopher Cooper, MD|419.383.6030|christopher.cooper@utoledo.edu|
21282401|NCT00427921|Abbott Laboratories|Medical Information Specialist|Phone: (800) 633-9110||
21282402|NCT00900159|Brigham and Women's Hospital; Harvard Medical School|Dr. Orfeu M. Buxton|617-507-9177|Orfeu_Buxton@HMS.Harvard.edu|
21282403|NCT00520533|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21282404|NCT01877642|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7777|ClinicalTrialsInfo@alexza.com|
21282405|NCT02593097|Mayo Clinic|Amaal J. Starling, M.D.|480-301-6574|Starling.Amaal@mayo.edu|
21282406|NCT02858583|University of Alberta|Georg Schmölzer|780-735-4647|schmolze@ualberta.ca|
21282407|NCT03759587|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21282408|NCT00853645|Boston Scientific|Gena Kantor, MPH|1-800-227-3422|gena.kantor@bsci.com|
21282409|NCT00006178|National Institutes of Health|Dr. Allan D. Kirk||allank@intra.niddk.nih.gov|
21282410|NCT01218087|Boston Children's Hospital|Michele DeGrazia|617-919-1222|michele.degrazia@childrens.harvard.edu|
21282411|NCT03170362|Department of Veteran Affairs|David Oslin|215-823-5894|dave.oslin@va.gov|
21282412|NCT04615403|Glaukos|Study Manager|949-481-8076|ldoan@glaukos.com|
21282413|NCT00552396|Innate Pharma|Dr Renaud Buffet Senior Director, Clinical Development and Translational Research|+33430303032|renaud.buffet@innate-pharma.fr|
21282414|NCT00665431|Pozen|Sr VP Clinical Research|919 913 1030|eorlemans@pozen.com|
21282415|NCT00529373|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development,|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21282416|NCT01074268|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21282417|NCT01578239|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21282418|NCT03000010|University of Michigan|G. Ying Li|734-936-5715|yingyuli@med.umich.edu|
21282419|NCT02347813|University of Rochester|Alice Pentland, MD|585-275-1998|alice_pentland@urmc.rochester.edu|
21282420|NCT01017536|Aeras|Bernard Landry|301-547-2900|blandry@aeras.org|
21282421|NCT01119859|Hoffmann-La Roche|Medical Communications|800 821-8590||
21282422|NCT00603473|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21282423|NCT00691444|Oregon Health and Science University|OHSU Integrity Department|1-877-733-8313|irb@ohsu.edu|
21282424|NCT01134939|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21282425|NCT00733421|Foot & Ankle Surgical Centre|Jan Jakobsson PI, MD, PhD, Professor|46702500960|jan.jakobsson@ki.se|
21282426|NCT03817229|Cincinnati Children's Hospital Medical Center|Avani Modi, Ph.D.|5136364864|avani.modi@cchmc.org|
21282427|NCT04185220|National Cancer Institute|Dr. Kevin Conlon|240-858-3570|conlonkc@mail.nih.gov|
21282428|NCT01031680|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
21282429|NCT04471194|Pennsylvania State University College of Medicine|Jennifer L. Moss, PhD|717-531-0003|jmoss1@pennstatehealth.psu.edu|323429
21282430|NCT01029782|Interior Health|Dawn Dalen|250-862-4449|dawn.dalen@interiorhealth.ca|
21282431|NCT03649932|University of Texas Medical Branch|Dr. Sunil Jain|4097722815|amnahqasim@gmail.com|
21282432|NCT02703467|Imperial College London|Professor Fan Chung|00442075947954|f.chung@imperial.ac.uk|
21282433|NCT00757042|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21282434|NCT03319732|RVL Pharmaceuticals, Inc.|Vice President Regulatory Affairs and Quality|908-809-1300|regulatory@rvlpharma.com|
21282435|NCT00150488|Queen Unviersity|J. Curtis Nickel|613 548 2497|jcn@queensu.ca|
21282436|NCT00481351|Universidade de São Paulo|Otavio Celeste Mangili, MD|+554499928818|otaviomangili@yahoo.com.br|
21282437|NCT00389532|Sanofi pasteur Inc|Medical Director||RegistryContactUS@sanofipasteur.com|
21282438|NCT02729051|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21282439|NCT02702388|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21282440|NCT04892706|Bausch Health Americas, Inc|Study Director|908-541-8664|alison.magnotti-nagel@bauschhealth.com|
21282441|NCT03652636|Indiana University|Jordan Swensson, MD|317-944-1837|jswensso@iu.edu|
21282442|NCT00251303|National Institute of Mental Health, Pediatrics and Developmental Neuroscience Branch|Dr. Susan E. Swedo|301-496-5323|swedos@mail.nih.gov|
21282443|NCT01736397|Keryx Biopharmaceuticals|Keryx Medical Information|1-844-44-KERYX (844-445-3799)|medicalinfo@keryx.com|
21282444|NCT05088603|Atrium Health Wake Forest Baptist Health Department of Neurosurgery|Dr. Kyle Fargen|336-716-6702|kfargen@wakehealth.edu|
21282445|NCT01868438|Medicines for Malaria Venture|Stephan Duparc|+41 22 799 4070|duparcs@mmv.org|351
21282446|NCT01828983|Memphis VA Medical Center|Dr. Linda Nichols|901 523-8990|linda.nichols@va.gov|5082
21282447|NCT03555565|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21282448|NCT03138252|University Hospitals Cleveland Medical Center|Dr. Alison Bauer|216-844-3787|alison.bauer@uhhospitals.org|
21282449|NCT00076752|National Cancer Institute, National Institutes of Health|Dr. Steven Pavletic|301-402-4899|pavletis@mail.nih.gov|
21282450|NCT00394836|GlaxoSmithKline|GSK Response Center|866-435-7343||
21282451|NCT01560234|AstraZeneca R&D|Ajay Aggarwal||ClinicalTrialTransparency@astrazeneca.com|
21282452|NCT01284348|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21282453|NCT00892151|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
21282454|NCT02799667|Tufts Medical Center|Ashley T. Peterson, MD, Study Coordinator|617-636-5000|apeterson@tuftsmedicalcenter.org|2382
21282455|NCT04075682|University of South Carolina|Dr. James F. Thrasher|803.777.4862|thrasher@sc.edu|
21282456|NCT00744965|UT Southwestern Medical Center|Kenneth J. Leveno, MD|214-648-2316|kenneth.leveno@utsouthwestern.edu|
21282457|NCT01222520|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21282458|NCT04081610|Laboratorios Sophia|Dr. Alejandra Sanchez-Rios|+52 (33) 3001 4200|alejandra.sanchez@sophia.com.mx|1190
21282459|NCT00497289|B.Braun Melsungen AG|Study manager|+49 5661 71|studies@bbraun.com|0
21282460|NCT03423173|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21282461|NCT03348930|University of Chicago|Dr. Jon Grant|7738341325|jgrant4@bsd.uchicago.edu|
21282462|NCT03533114|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
21282463|NCT01062113|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21282464|NCT01663285|University of Michigan Comprehensive Cancer Center|Dr. Ajjai Alva|734-647-8921|ajjai@umich.edu|
21282465|NCT02261948|Centro Cardiologoco Monzino|Piergiuseppe Agostoni|02 5800|piergiuseppe.agostoni@ccfm.it|2772
21282466|NCT01080118|Northwestern University Feinberg School of Medicine|Dr. Gildasio DeOliveira|312-472-3573|g-jr@northwestern.edu|
21282467|NCT03457116|NYU Langone Health|Judy Lee, MD|(646) 501-7906|Judy.Lee@nyulangone.org|
21282468|NCT02196688|Hutchison Medipharma Ltd|Dr. Songhua Fan|+86 21 2067 3058|songhuaf@hmplglobal.com|5058
21282469|NCT02295020|LSUHSC-NO -Orthopaedic Department|Dr. Vinod Dasa|(504) 412-1700|vdasa@lsuhsc.edu|
21282470|NCT01290679|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
21282471|NCT04791319|Janssen Research & Development, LLC|Director Clinical Research Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21282472|NCT04709692|University of Kentucky|R. Kiplin Guy|859-257-5290|kip.guy@uky.edu|
21282473|NCT04431908|Yale School of Medicine|Dr. R. Peter Manes|(203) 785-5430|rpeter.manes@yale.edu|
21282474|NCT02209519|University of Alabama at Birmingham|Jane Schwebke, MD|205-975-5665|jschwebk@uabmc.edu|
21282475|NCT00766636|University of Texas MD Anderson Cancer Center|Jason B. Fleming, MD / Surgical Oncology|713-563-2300|CR_Study_Registration@mdanderson.org|
21282476|NCT03139578|Johnson & Johnson Vision|Anna Sulley BSc MCOptom FAAO|+44 1344864043|asulley1@its.jnj.com|
21282477|NCT04087720|Horizon Therapeutics USA, Inc.|Supra Verma, MD|866-479-6742|clinicaltrials@horizontherapeutics.com|
21282478|NCT02880475|Mundipharma (China) Pharmaceutical Co. , Ltd|Junjiao Ma|01065636711|Junjiao.Ma@mundipharma.com.cn|
21282479|NCT00478777|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21282480|NCT00305084|Clinical Operations|MolMed S.p.A.|0039 02212771|clinical.operations@molmed.com|
21282481|NCT01377922|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|305-420-3200|gingenito@catalystpharma.com|
21282482|NCT02145260|Brigham and Women's Hospital|Finnian Mc Causland|6177326432|fmccausland@bwh.harvard.edu|
21282483|NCT02553499|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21282484|NCT01582178|Vitkovice Hospital|Premysl Falt, MD|+420595633|faltprem@centrum.cz|205
21282485|NCT00842023|Western University of Health Sciences|Dr. Sheryl L. Chow|9094695379|schow@westernu.edu|
21282486|NCT01726270|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21251812|NCT03371823|University of Delaware|Dr. Megan Wenner|302-831-7343|mwenner@udel.edu|
21251813|NCT04870957|University of Michigan|Afton Hassett, PsyD|734-763-5226|afton@med.umich.edu|
21251814|NCT05970640|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21251815|NCT04340843|Washington University in St. Louis School of Medicine|Dr. Mia Weiss|3147473096|m.c.weiss@wustl.edu|
21251816|NCT06862154|Marmara University School of Medicine|Dr. Emre Kudu|+902166254545|dr.emre.kudu@gmail.com|
21251817|NCT02911805|Atlanta VA|Jeffrey H. Boatright, PhD|404-321-6111|jeffrey.boatright@va.gov|
21251818|NCT03733899|Johnson & Johnson Vision Care, Inc.|Thomas Karkkainen, OD, MS, FAAO Sr. Principal Research Optometrist|904-443-3402|TKarkkai@its.jnj.com|
21282487|NCT01323387|Synthes Spine|Clinical Research Associate|610-719-5942|knappk@synthes.com|
21282488|NCT02948751|Columbia University|Kevin Kalinsky, MD|212-305-0170|kk2693@columbia.edu|
21282489|NCT01464164|Feinstein Institutes for Medical Research|Adrianna Vlachos, MD|516-562-1506|avlachos@northwell.edu|
21282490|NCT01972438|National Institutes of Health|Manuel B. Datiles, III, MD, Principal Investigator, NEI|301-594-7052|DatilesM@nei.nih.gov|
21282491|NCT02887183|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21282492|NCT02434146|University of Wisconsin Carbone Cancer Center|Margo L Hoover-Regan|608-263-6200|mhooverregan@pediatrics.wisc.edu|
21282493|NCT00687544|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21282494|NCT01186692|Medtronic|Susan Patterson|763.526.1544|susan.patterson@medtronic.com|
21282495|NCT02195869|Pharmacyclics LLC, An AbbVie Company|Manuela Juretic, Associate Director, Clinical Operations|(408) 215.3628|mjuretic@pcyc.com|
21282496|NCT02654977|University of Michigan|Dr. Elif Oral|734-615-7271|eliforal@umich.edu|
21282497|NCT02934698|MUSC|Patrick Flume|843-792-3167|flumepa@musc.edu|
21282498|NCT01921101|University of Illinois at Chicago|Dr. Carol Braunschweig, Professor|3129962575|braunsch@uic.edu|
21282499|NCT01266291|University of Pennsylvania|John Pollard, MD|215-873-5909|john.pollard@uphs.upenn.edu|
21282500|NCT03456804|Karmanos Cancer Institute|Elisabeth Heath, M.D.|313-576-8717|heathe@karmanos.org|
21282501|NCT03225105|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21282502|NCT01729338|Duke University Medical Center|Gwynn Long|919-668-0838|gwynn.long@duke.edu|
21282503|NCT00679029|University of Nebraska|Elizabeth Reed|(402) 559-5388|ereed@unmc.edu|
21282504|NCT03396315|Columbia University|Mariana Bucovsky|12123057225|mb3523@cumc.columbia.edu|
21282505|NCT00160706|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
21282506|NCT02162719|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21282507|NCT03214380|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21282508|NCT02230696|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
21282509|NCT01905553|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21282510|NCT01070095|St. Michael's Hospital|Dr. Samir Gupta|(416) 864-6060|guptas@smh.ca|2252
21282511|NCT00655707|ImperialC|Professor Nagy Habib|+442033138574|nagy.habib@imperial.ac.uk|
21282512|NCT03692325|Dana-Farber Cancer Institute|Glenn Hanna, MD|617-632-3090|gjhanna@partners.org|
21282513|NCT02817516|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21282514|NCT00527644|University of Missouri Health Care|Bruce Ramshaw, M.D.|5738841925|kadysj@health.missouri.edu|
21282515|NCT01920958|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21282516|NCT00610155|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21282517|NCT05406479|Insitute of Tropical Medicine|Carolien Hoof|+32470102562|choof@itg.be|
21282518|NCT00140244|BIDMC|Dr. Christos Mantzoros|617-667-8630|cmantzor@bidmc.harvard.edu|
21282519|NCT00379080|Adult Brain Tumor Consortium|Stuart A Grossman, MD Director of ABTC|410-955-8837|grossman@jhmi.edu|
21282520|NCT01089608|Laboratoires Thea|Dr Pascale POULIQUEN|0473981436|p.pouliquen@laboratoires-thea.fr|
21282521|NCT04292912|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21282522|NCT00955955|Massachusetts General Hospital- Depression Clinical and Research Program|Dr. George Papakostas- Director of Treatment Resistant Depression Studies|617-726-6697|gpapakostas@partners.org|
21282523|NCT03575793|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
21282524|NCT01250873|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21282525|NCT01665950|Massachusetts General Hospital, Center for Quantitative Health|Dr. Roy Perlis|617-643-6310|rperlis@partners.org|
21282526|NCT01127451|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21282527|NCT03055897|Alcon Research, LLC|Senior CDMA Project Lead, CDMA Ocular Health|1-888-451-3937|alcon.medinfo@alcon.com|
21282528|NCT02429778|VA Palo Alto Health Care System|Christine Gould, PhD|650-493-5000|Christine.Gould@va.gov|68899
21282529|NCT03521115|PIRE|Dr. Brenda A. Miller|5105205889|BMiller@prev.org|
21282530|NCT03063086|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21282531|NCT01598090|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
21282532|NCT03628339|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21282533|NCT02726906|UC San Diego|Judy Pa, PhD|858-246-1333|jpa@ucsd.edu|
21282534|NCT00355147|VA Stroke QUERI Center, Roudebush VAMC|Teresa Damush, Ph.D.|317-988-4277|Teresa.Damush@va.gov|
21282535|NCT02793674|Presbyterian Hospital|Thomas Weiler, MD|505-724-7044|tweiler@gmail.com|
21282536|NCT01146379|Washington University School of Medicine|Dr. Catherine Lang|314-286-1945|langc@wustl.edu|
21282537|NCT03557931|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
21282538|NCT02394340|Bausch Health Americas, Inc.|Director of Clinical Operations||aloncaric@bauschhealth.com|
21282539|NCT00737204|New York State Psychiatric Institute|Judith G. Rabkin, Ph.D., M.P.H.|(646) 774-8075|jgr1@columbia.edu|
21282540|NCT03605862|Romark Laboratories, L.C.|Jessica Fulgencio|813-282-8544|jessica.fulgencio@romark.com|
21282541|NCT00364923|Allos Therapeutics, Inc|Michael Saunders, M.D.|303-426-6262|msaunders@allos.com|
21282542|NCT01721096|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
21282543|NCT02401048|Pharmacyclics|Emily Liu|(669) 224-1899|aliu@pcyc.com|
21282544|NCT01826513|University of Western Australia|Prof. David Hillman & Prof. Peter Eastwood|+61 8 9346 1706|peter.eastwood@health.wa.gov.au|
21282545|NCT01355575|Imperial College London|Dr Jeremy Cobbold|+44 1865228756|jeremy.cobbold@ndm.ox.ac.uk|
21282546|NCT02685358|VA Palo Alto Health Care System|Eric Kuhn, PhD|650-493-5000|eric.kuhn@va.gov|23160
21282547|NCT00765336|Medicis Global Services Corporation|Director of Clinical Trials||ClinicalTrials@Medicis.com|
21282548|NCT00511914|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21282549|NCT00570063|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21282550|NCT00697463|Columbia University|Elizabeth Shane, MD|212-305-7225|es54@cumc.columbia.edu|
21282551|NCT03307252|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21282552|NCT01554527|University of Michigan|Dr. Ronald Chervin|734-647-9064|chervin@med.umich.edu|
21282553|NCT02157376|AstraZeneca|Barry Traxler||barry.traxler@astrazeneca.com|
21282554|NCT00966992|Washington University School of Medicine|Perry Grigsby, M.D.|314-362-8502|pgrigsby@radonc.wustl.edu|
21282555|NCT04200651|New York Eye Surgery Center; University of Colorado|Dr. Nicholas Tan|3476175971|tannicholas97@gmail.com|
21282556|NCT01523782|ERYTECH Pharma|Denise Tilton, Global Head Clinical Operations & Program Management|+1 857-706-1587|dtilton@erytech.com|
21282557|NCT02547220|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
21282558|NCT03771560|UCSF|Dr. Robert Hendren|415-502-3500|STAR@ucsf.edu|
21282559|NCT04201574|Allysta Pharmaceuticals, Inc.|Clinical Trial Admin|(510) 560-6592|clinicaltrial.admin@allysta.com|
21282560|NCT02428309|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21282561|NCT02981082|University of Pittsburgh|Dr. Robert Lafyatis|412-648-7040|lafyatis@pitt.edu|
21282562|NCT00596817|H. Lundbeck A/S|H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
21282563|NCT04138953|Emory University|Michael Borich, DPT, PhD|404-712-0612|michael.borich@emory.edu|
21282564|NCT00869622|VA Boston Healthcare System|Antonio A. Lazzari, M.D., Ph.D|(857) 364-6381|Antonio.Lazzari@va.gov|
21282565|NCT03063437|Microbiome Health Research Institute|Majdi Osman, MD, MPH|6175752201|majdi@openbiome.org|
21282566|NCT00602836|Mayo Clinic|Dr. Tait Shanafelt||shanafelt.tait@mayo.edu|
21282567|NCT04250350|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
21282568|NCT02195622|IU Health Physicians Urology|James Lingeman, MD|317-962-3700||
21282569|NCT03190668|University of Florida|Christoph Seubert, MD|352-273-8960|cseubert@anest.ufl.edu|
21282570|NCT00378508|Yale University|Kevan Herold, MD|203-785-6507|kevan.herold@yale.edu|
21282571|NCT04082572|M.D. Anderson Cancer Center|Michael J. Overman, MD|(713) 792-2828|moverman@mdanderson.org|
21282572|NCT00730730|Medtronic Aortic and Peripheral Vascular|Arslan Malik - Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com|
21282573|NCT00956592|Oregon Health & Science University|Michael Aziz|503-494-5581|azizm@ohsu.edu|
21282574|NCT03192306|Benu BioPharma, Inc.|Dr. Eric Morrel, VP Clinical Research|5082085634|emorrel@benubio.com|
21282575|NCT04932655|Cassava Sciences, Inc.|Nadav Friedmann, PhD, MD|512-501-2444|eschoen@cassavasciences.com|
21282576|NCT00638716|ConjuChem Biotechnologies Inc.|Associate Director of Regulatory Affairs|310-405-7549|Aleece.Nolasco@nantbio.com|
21282577|NCT00083759|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21282578|NCT03567005|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21282579|NCT00280397|Eisai Co., Ltd.|Akihiko Tsuruoka|+81-3-3817-5252||5252
21282580|NCT06175026|Stanford University|Dr. Anna H. Grummon, PhD|(650) 644-7366|agrummon@stanford.edu|
21282581|NCT04347564|Augenheilkunde Lindenthal|Daniela Claessens|017229227962|daniela.claessens@gmx.de|
21282582|NCT02225860|Tufts Medical Center|Ronald D. Perrone|6176362372|rperrone@tuftsmedicalcenter.org|
21282583|NCT01028014|University of Alabama at Birmingham|Dr. William Jerod Greer|205-934-7874|wjgreer@uab.edu|
21282584|NCT05338502|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21282585|NCT00555464|Medical College of Wisconsin|Beth Drolet, MD|414-955-2817|sjoachim@mcw.edu|
21282586|NCT02669836|Washington University|David D. Limbrick MD|314-454-3212|T.Meehan@wustl.edu|
21282587|NCT04826965|Duke University|Suhail Mithani, MD|919-681-8390|suhail.mithani@duke.edu|
21282588|NCT00832871|University of New Mexico Comprehensive Cancer Center|Dr. Fa-chyi Lee|505-925-0405|FLee@salud.unm.edu|
21282589|NCT00729157|Memorial Sloan Kettering Cancer Center|Dr. David Pfister|646-888-4237|pfisterd@mskcc.org|
21282590|NCT01683266|Sanofi|Trial Transparency Team||Contact--US@sanofi.com|
21282591|NCT03766165|Johns Hopkins University; Indiana University|Dr. Larissa Jennings Mayo-Wilson|1-812-856-0902|ljmayowi@iu.edu|
21282592|NCT02217410|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21282593|NCT04903496|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21282594|NCT00756236|Department of Anesthesia. OUHSC|Dr. Mehmet Ozcan, MD|405-271-4351|mehmet-ozcan@ouhsc.edu|
21282595|NCT01940887|Ophthotech Corp.|Keith Westby|212-845-8200|Keith.Westby@ophthotech.com|
21282596|NCT00090220|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21282597|NCT02475265|Massachusetts General Hospital|Dr. Pouneh Fazeli|617-726-3870|pkfazeli@partners.org|
21282598|NCT03499899|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
21282599|NCT04501640|Astellas Pharma China, Inc.|Clinical Trial Disclosure|+86-(0)10-85216666|astellas.resultsdisclosure@astellas.com|
21282600|NCT03655470|Brown University|Anthony Spirito, PI|4014441929|anthony_spirito@brown.edu|
21282601|NCT04590586|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21282602|NCT01893281|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21282603|NCT03879525|Wake Forest School of Medicine|Heidi Munger Clary, MD, MPH|336-716-7110|hmungerc@wakehealth.edu|
21282604|NCT05481125|Alcon Research, LLC|Director, Clinical Projects, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21282605|NCT02244463|Dana-Farber Cancer Institute|Kartik Sehgal, MD|(617) 632-3090|Kartik_Sehgal@dfci.harvard.edu|
21282606|NCT03834766|Tris Pharma, Inc.|Antonio Pardo|19175149058|apardo@trispharma.com|
21282607|NCT03702010|Hospital Universitario de Salamanca|Dr. Francisco José Sánchez Montero|923291100|fjsmontero@saludcastillayleon.es|
21282608|NCT00910208|Albert Einstein College of Medicine|Polly Bijur, PhD|718-430-4217|polly.bijur@einstein.yu.edu|
21282609|NCT00778869|Merck, Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21282610|NCT02449798|Bard Access Systems, Inc.|Gina Gilbert, BSN, RN|407-489-0935|Gina.Gilbert@crbard.com|
21282611|NCT01985932|University of Pennsylvania|Curtiland Deville, MD|215-662-2428|deville@uphs.upenn.edu|
21282612|NCT03474731|University of Kentucky|Dr. Nancy Schoenberg|(859) 323-8175|nesch@uky.edu|
21282613|NCT01707108|Rambam Health Care Campus|Director of Trial|+97247772983|j_horwitz@rambam.health.gov.il|
21282614|NCT00675428|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
21282615|NCT02805179|University of Michigan|Michelle Kim, MD|734-936-4300|michekim@med.umich.edu|
21282616|NCT00886743|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21282617|NCT04105218|University of Colorado Anschutz Medical Campus|Clinical Research Support Center|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
21282618|NCT03831360|Butler Hospital|Dr. Lisa Uebelacker|401-455-6381|LUebelacker@butler.org|
21282619|NCT03388645|National Institute of Allergy and Infectious Diseases|Lesia Dropulic|+1 301 496 7675|dropulicl@niaid.nih.gov|
21282620|NCT00482677|Canadian Cancer Trials Group|Keyue Ding|613-5336430|kding@ctg.queensu.ca|
21282621|NCT00582608|Memorial Sloan Kettering Cancer Center|Dr. Shakeel Modak|212-639-7623|modaks@mskcc.org|
21282622|NCT02819973|Duke Clinical Research Institute|Kevin Thomas, MD|919-668-8700|kevin.thomas@duke.edu|
21282623|NCT00550043|Incyte Corporation|Study Director|1-855-463-3463||
21282624|NCT00789698|Sunovion Pharmaceuticals|Medical Director, CNS|1-866-503-6351||
21282625|NCT01870973|The Ohio State University|Dr. Melissa Drum|6142923596|drum.13@osu.edu|
21282626|NCT01314872|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21282627|NCT00199797|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21282628|NCT00504725|Duke University Medical Center|Andrew Shaw MD|9192866938|andrew.shaw@duke.edu|
21282629|NCT01435018|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21282630|NCT03205761|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
21282631|NCT00636194|Bausch & Lomb|Robert Steffen OD|(585) 338-6399|robert.steffen@bausch.com|
21282632|NCT03470012|cyberDERM|Danielle Fendrick|610-325-0881|dfendrick@cyberderm-inc.com|
21282633|NCT00972816|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com|
21282634|NCT02163226|UT MD Anderson Cancer Center|Dr. Quynh-Nhu Nguyen, MD,Associate Professor, Radiation Oncology Department|(713) 563-2450|qnnguyen@mdanderson.org|
21282635|NCT01770366|Baystate Medical Center|Sofija Zagarins|413-794-2876|sofija.zagarins@baystatehealth.org|
21297592|NCT02598297|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21297593|NCT00345865|Masonic Cancer Center, University of Minnesota|Dr.Veronika Bachanova|612-625-5469|bach0173@umn.edu|
21297594|NCT05651867|Quantum Surgical|Marion Chassouant|0033781425198|m.chassouant@quantumsurgical.com|
21297595|NCT02553395|CooperVision Inc.|Paul Chamberlain|925 730-6754|PChamberlain@coopervision.com|
21297596|NCT02159976|Department of Internal Medicine, Seoul National University Bundang Hospital|Nayoung Kim, M.D., Ph.D.|+ 82-31-787-7008|nayoungkim49@empas.com|
21297597|NCT02206035|Froedtert and the Medical college of Wisconsin|William Drobyski, MD|414-456-4941|wdrobysk@mcw.edu|
21297598|NCT00887549|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21297599|NCT05173012|Sage Therapeutics|Carrie Vaudreuil|(857) 259-4766|carrie.vaudreuil@sagerx.com|
21236641|NCT00627705|Stanford University School of Medicine|Antonio Hardan, MD|650-736-1235|hardanay@stanford.edu|
21236642|NCT02663817|University of Miami|Dr. Ivaylo Mihaylov|305-243-8223|i.mihaylov@med.miami.edu|
21297600|NCT00100789|SWOG Statistical Center|Study Statistician|206-667-4623||
21297601|NCT02936843|The University of Michigan|Rodica Pop-Busui, MD, PhD|Phone 734-647-9809|rpbusui@med.umich.edu|
21297602|NCT03472950|University of Kansas Medical Center|Jeffrey Statland, MD|913-945-9933|Jstatland@kumc.edu|
21297603|NCT01393821|Mayo Clinic|Aminah Jatoi, M.D.|(507) 284-7202|Jatoi.Aminah@mayo.edu|
21236643|NCT03431168|UAB|Dr. Jodie Dionne|2059756530|jdionne@uabmc.edu|
21297604|NCT05419232|Nationwide Children's Hospital|Jason Newland|6147223416|jason.newland@nationwidechildrens.org|
21236644|NCT01410448|Novartis Pharmaceuticals|Study Director|862-778-8300||
21236645|NCT02535065|Cook Research Incorporated|Manager, Biostatistics|7654637537|Alan.Saunders@CookMedical.com|321204
21236646|NCT03712917|Ataturk University|Mustafa Ceylan|+905062773216|drmuson16@hotmail.com|
21236647|NCT03843788|Rutgers, The State University of New Jersey|Dr. Adrienne Simonds|8565667190|simondad@shp.rutgers.edu|
21236648|NCT00932893|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21236649|NCT00443547|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com|
21236650|NCT00791765|Amgen Inc.|Study Director|866-572-6436||
21236651|NCT04575896|Johns Hopkins University|Niraj Desai, MD|410-614-8297|ndesai13@jhmi.edu|
21236652|NCT00924287|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg|301-496-4164|sar@mail.nih.gov|
21251819|NCT00307047|Abbott Vascular|Ellen Travis|408-845-1512|ellen.travis@av.abbott.com|
21251820|NCT00379769|GlaxoSmithKline|GSK Response Center|866-435-7343||
21251821|NCT02825251|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21251822|NCT00349466|Can-Fite Biopharma|Pnina Fishman, PhD|011972 3 924 1114|pnina@canfite.co.il|
21297605|NCT02608463|University of Arkansas for Medical Sciences|Dr. Shona Ray-Griffith|501-526-8428|slray@uams.edu|
21251823|NCT02852356|Ovation Fertility|Director|5126107474|tex@ovationfertility.com|
21251824|NCT01689363|Amphastar Pharmaceuticals, Inc.|Gisela Sharp|(909) 980-9484|GiselaS@amphastar.com|2016
21282636|NCT00593684|Baylor Health Care System|Furgan Moin, MD|214-820-7604|Furgan.Moin@baylorhealth.edu|
21282637|NCT03625466|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21282638|NCT05318092|AngioDynamics, Inc.|Elizabeth Manning|339-237-2765|liz.manning@angiodynamics.com|
21282639|NCT01694069|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
21282640|NCT00664859|Veloxis Pharmaceuticals, Inc.|Director, Regulatory Affairs|919-591-3090|bbu@veloxis.com|
21282641|NCT00748189|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
21297606|NCT01318408|Drexel University College of Medicine|Carol Lippa, MD|215-762-7090|clippa@drexelmed.edu|
21282642|NCT02062710|Montefiore Medcial Center|Peter Dicpinigaitis, MD|718-904-2676|pdicpini@montefiore.org|
21297607|NCT00377858|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21297608|NCT03534141|University of California, San Francisco|Dr. Michael P. Bokoch, Principal Investigator|415-476-8389|Michael.Bokoch@ucsf.edu|
21297609|NCT00517361|The University of Chicago|Dr. Rita Nanda|773-834-2756|rnanda@medicine.bsd.uchicago.edu|
21297610|NCT00972725|GlaxoSmithKline|GSK Response Center|866-435-7343||
21297611|NCT01511068|Cincinnati Children's Hospital Medical Center|Dr. Bruce Trapnell|513636-6361|Bruce.Trapnell@cchmc.org|
21297612|NCT01824355|Ascensia Healthcare|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
21282643|NCT04481191|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21297613|NCT04124705|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21297614|NCT00661622|Thomas Jefferson University|Takami Sato, MD|215-955-8874|Takami.Sato@jefferson.edu|
21282644|NCT02593526|UNewMexico|Mark Unruh|5052728800|MLUnruh@salud.unm.edu|
21282645|NCT00546117|Washington University|Judith Lieu, MD|314-454-6162|lieuj@wustl.edu|
21282646|NCT01323153|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
21282647|NCT02579343|Counseling and Psychological Services|Adam McCabe|239-590-7950|amccabe@fgcu.edu|
21282648|NCT00977704|Medicis R&D Clinical Research Department|Head of Clinical Trials||ClinicalTrialsQuery@Medicis.com|
21282649|NCT04984278|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
21297615|NCT04016259|The University of Texas Health Science Center at Houston|"Hyochol Brian Ahn, PhD, RN, MSN, Associate Professor"|713-500-2179|Hyochol.Ahn@uth.tmc.edu|
21297616|NCT04067609|Yale School of Medicine|Dr Audrey Merriam|203-785-7813|audrey.merriam@yale.edu|
21297617|NCT04765202|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
21297618|NCT04929249|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21297619|NCT05758402|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
21297620|NCT02332291|Vanderbilt University Medical Center|Warren D. Taylor, MD, MHSc|615-322-1073|warren.d.taylor@vumc.org|
21297621|NCT04867733|University of Iowa|Nicole Brogden|319-335-8752|nicole-brogden@uiowa.edu|
21297622|NCT01716455|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21297623|NCT00820872|Mayo Clinic|Alvaro Moreno-Aspitia, M.D.|(904) 953-7291|morenoaspitia.alvaro@mayo.edu|
21297624|NCT03197922|Emory University|Nathan Call, PhD|404-785-9428|ncall@emory.edu|
21297625|NCT01987583|Ministry of Health|Dr. Nouran Aleyeidi|00966504304577|dr.nouran@live.com|
21297626|NCT01620762|Circassia Ltd|VP Clinical Operations|+44 1865 405560||
21297627|NCT03521479|Squarex LLC|Hugh McTavish|6512078270|hmctavish@squarex-pharma.com|
21297628|NCT00095173|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21297629|NCT01620528|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
21297630|NCT01436266|Boston Medical Center|Sarita Sonalkar, MD|617 414 7304|sarita.sonalka@bmc.org|
21297631|NCT03514433|Boston Medical Center|Tracy A Battaglia, MD, MPH|617 638 7428|Tracy.Battaglia@bmc.org|
21297632|NCT01122849|GlaxoSmithKline|GSK Response Center|866-435-7343||
21297633|NCT03256253|New York State Psychiatric Institute|John Mariani MD|6467748181|john.mariani@nyspi.columbia.edu|
21297634|NCT03997825|Relievant Medsystems|Diane Sahr, VP of Clinical Research|(650) 368-1000|dsahr@relievant.com|
21297635|NCT01153698|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21297636|NCT00465647|Purdue Pharma L.P.|Executive Medical Director|800-733-1333||
21297637|NCT02220712|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21297638|NCT00760838|Ghent University Hospital|dr. Brusselle Guy|003293322604|guy.brusselle@uzgent.be|
21297639|NCT01628965|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
21297640|NCT02561221|Pennington Biomedical Research Center|Dr. Peter T. Katzmarzyk, Associate Executive Director of Population and Public Health Sciences|225-763-2536|doctors@pbrc.edu|
21297641|NCT00330681|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21297642|NCT02578186|Procter & Gamble|Andrew L. Carr, PhD|513-622-0928|carr.an@pg.com|
21297643|NCT03824587|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
21297644|NCT01300572|Fred Hutchinson Cancer Research Center|Brenda Sandmaier, MD|(206) 667-4961|bsandmai@fredhtuch.org|
21297645|NCT00986362|ThromboGenics NV|Dr. Petra Kozma-Wiebe|+32 16751310|petra.kozma@thrombogenics.com|
21297646|NCT03621657|University of Wisconsin-Madison|Dr. Nasia Safdar|608-263-1545|ns2@medicine.wisc.edu|
21297647|NCT03058692|Baylor College of Medicine|Robert L. Atmar, M.D.|713-798-6849|ratmar@bcm.edu|
21297648|NCT03777059|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21297649|NCT03004911|School of Medicine at the University of Sao Paulo|Amélia Pasqual Marques|+55 11 3091 7451|pasqual@usp.br|
21297650|NCT02679755|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21297651|NCT01061359|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21297652|NCT02610777|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21297653|NCT02324283|Juntendo University|Dr. Izumi Kawagoe|+81338133111|ikawago@juntendo.ac.jp|
21297654|NCT00411671|University of Texas (UT) MD Anderson Cancer Center|George Blumenschein, MD / Professor, Thoracic/Head & Neck Med Oncology||CR_Study_Registration@mdanderson.org|
21297655|NCT04737278|BDL Biochemistry, consultant for Mitosynergy|Dr Barbara Leinweber, PhD|(520)334-5444|barb@bdlbiochem.com|
21236653|NCT04704375|LECOM|Dr. Santiago Lorenzo|941-782-5974|slorenzo@lecom.edu|
21297656|NCT03671213|Moximed, Inc.|Rose Weinstein, Director of Clinical Affairs|415-312-0255|rsweinstein@moximed.com|
21297657|NCT00889512|University Reproductive Associates|Dr. Peter G. McGovern|201-288-6330|mcgovepg@uranj.com|
21297658|NCT00546000|Fougera Pharmaceuticals Inc.|Angela C. Kaplan|631-659-2256|angela.kaplan@sandoz.com|
21297659|NCT03223337|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21297660|NCT03688074|AstraZeneca|Globall Clinical Head|+1 877-240-9479|information.center@astrazeneca.com|
21297661|NCT00726414|Mutual Phrmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21297662|NCT01362608|Novartis|Clinical Disclosure Office|862-778-8300||
21297663|NCT00889824|WashingtonU|Joel Goebel, MD|(314) 362-7344|goebelj@ent.wustl.edu|
21297664|NCT03056339|The University of Texas MD Anderson Cancer Center|Dr. Loretta Nastoupil, M.D. / Stem Cell Transplantation and Cellular Therapy Department|713-792-2860|lnastoupil@mdanderson.org|
21297665|NCT01048658|Oregon Health & Science University|Dr. Rosenne Botha|503-494-3666|whru@ohsu.edu|
21297666|NCT00939536|Accutest Research Laboratories Pvt. Ltd.|Kedar Joshi|+91 22 27780718||
21297667|NCT05690555|Cleveland Clinic|Cecile Ferrando, M.D.|216-444-0642|ferranc2@ccf.org|
21297668|NCT04171219|M.D. Anderson Cancer Center|Aung Naing, MD|713-563-3885|anaing@mdanderson.org|
21297669|NCT04784143|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
21297670|NCT04809285|Medtronic|Binh Ngo (Clinical Research Director)|9492027218|binh.ngo@medtronic.com|
21297671|NCT02974257|BIDMC|Dr. Katherine Berg|617-754-2281|kberg@bidmc.harvard.edu|
21297672|NCT03526146|San Francisco Veterans Affairs Health Care System, San Francisco, CA|Linda L. Chao|415-221-4810|linda.chao@ucsf.edu|24386
21297673|NCT02644343|Cochlear|Cochlear Clinical Studies|(303) 790-9010|clinicalstudies@cochlear.com|
21251825|NCT00321685|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
21251826|NCT00624910|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
21251827|NCT05064488|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21251828|NCT03023722|Yale University|Stacey Stein, MD|203 737-1600|stacey.stein@yale.edu|
21251829|NCT00590564|Memorial Sloan Kettering Cancer Center|Dr. Gary Deng|646-888-0841|dengg@mskcc.org|
21251830|NCT01012245|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21251831|NCT02684123|Icahn School of Medicine at Mount Sinai|Dr. Emma Guttman-Yassky|(212) 241-9728|Emma.Guttman@mountsinai.org|
21251832|NCT02120001|Massachusetts General Hospital|Robert Kacmarek, Director Respiratory Care|(617) 726-2000|rkacmarek@mgh.harvard.edu|
21251833|NCT02037477|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
21251834|NCT01245140|GlaxoSmithKline|GSK Response Center|866-435-7343||
21251835|NCT02635360|University of Virginia|Dr. Linda R. Duska|434-944-9135|LRD5D@uvahealth.org|
21251836|NCT04082429|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21251837|NCT00334542|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|4432876489|vstearn1@jhmi.edu|
21251838|NCT03118050|University of Texas Medical Branch|Elena Volpi, MD, PhD|210-562-6139|volpi@uthscsa.edu|
21251839|NCT02833805|Johns Hopkins University|Dr. Amy DeZern|410-502-7208|adezerb1@jhmi.edu|
21251840|NCT00980642|Cleveland Clinic|Dr. Andrea Kurz|216 445-9924|KURZA@ccf.org|
21251841|NCT02125279|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
21251842|NCT01607879|Froedtert and the Medical college of Wisconsin|Kathryn Bylow, MD|414-805-4600|kbylow@mcw.edu|
21251843|NCT03845140|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21251844|NCT05020145|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21251845|NCT01592045|United Therapeutics Corporation|Allison Lim|919-425-8799|alim@unither.com|
21251846|NCT05034939|VentureMed Group, Inc.|Vice President, Clinical, Regulatory & Quality|763-296-2021|jschweiger@venturemedgroup.com|
21251847|NCT02472145|Janssen Research & Development, LLC|Senior Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21251848|NCT03101033|Xijing Hospital, the Fourth Military Medical University|Dr yan lu|029-84775337|yanlu001@fmmu.edu.cn|029-847753
21251849|NCT02049515|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
21282650|NCT04696055|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
21282651|NCT03969901|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21282652|NCT00348595|Johns Hopkins University School of Medicine|Mario Eisenberger|(410) 614-3511|eisenma@jhmi.edu|
21282653|NCT00382590|UT MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Associate Professor|713-745-3428|eharriso@mdanderson.org|
21282654|NCT02589626|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21282655|NCT03645395|Molecular Templates, Inc.|Study Director|862-204-7184|trials@mtem.com|
21251850|NCT01653210|Univerisity of Virginia|Sue Brown, MD||sab2f@virginia.edu|
21251851|NCT03042299|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21282656|NCT02564900|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|1-908-992-6400|CTRinfo@dsi.com|
21251852|NCT00521976|Stavanger University Hospital|Dennis W.T. Nilsen MD PhD FESC FAHA|+4705151|nide@sus.no|9455
21282657|NCT02317276|UCSF Dermatology|Sarah Arron, MD, PhD|415-353-9684|Sarah.Arron@ucsf.edu|
21251853|NCT01280604|Mercer University/ Kaiser Permanente|Kendra Manigault, PharmD, BCPS, BCACP, CDE|678-547-6216|manigault_kr@mercer.edu|
21282658|NCT01289639|VA Puget Sound Health Care System|Kristina Utzschneider|206-277-3568|kutzschn@u.washington.edu|6-3568
21282659|NCT02780713|AstraZeneca AB|AZD9496 Global clinical leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
21282660|NCT01931475|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21282661|NCT02821338|US Food and Drug Administration|Office of Generic Drugs, Center for Drug Evaluation and Research|240-402-7920|genericdrugs@fda.hhs.gov|
21282662|NCT02423343|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21282663|NCT02111577|SOTIO a.s.|Prof. Radek Spisek, M.D., Ph.D.|+420 2241 75101|spisek@sotio.com|
21282664|NCT04967885|Dartmouth College|Elizabeth Saunders|6036467006|elizabeth.c.saunders@dartmouth.edu|
21282665|NCT00654875|Novartis Pharmaceuticals|Study Director|862-778-8300||
21282666|NCT01011465|Harvard School of Public Health|Dr. Laura Kubzansky|617-432-3589|lkubzans@hsph.harvard.edu|
21282667|NCT03921840|Johns Hopkins University|Junxin Li|4105022608|jli248@jhu.edu|
21282668|NCT02042950|UT MD Anderson Cancer Center|Dr. Hun Ju Lee/ Assistant Professor, Lymphoma/Myeloma|(713) 794-1829|hunlee@mdanderson.org|
21282669|NCT00723008|U.S. Army Institute of Surgical Research|LTC. Elizabeth Mann-Salinas, PhD, RN,CCRN,CCNS|210-916-3527|Elizabeth.Mann@us.army.mil|
21282670|NCT02935179|Taipei Medical University|Dr. Sing-Chung Li|886-2-27361661|sinchung@tmu.edu.tw|6560
21282671|NCT00882778|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21282672|NCT01014988|GlaxoSmithKline|GSK Response Center|866-435-7343||
21282673|NCT01254318|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21251854|NCT00133575|Brigham and Women's Hospital|Lindsey R. Baden, M.D.|617-732-6801|LBaden@partners.org|
21251855|NCT00513747|The Arthur James Comprehensive Cancer Center|John Byrd, MD|614-293-9869|john.byrd@osumc.edu|
21251856|NCT00825305|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com|
21251857|NCT03617289|Henry Ford Health System|Dr. Jason Muir|517-861-6451|jmuir1@hfhs.org|
21282674|NCT03933618|Albany Medical Center|Dr. Charles Welliver|518-262-3341|wellivr@amc.edu|
21282675|NCT01137110|Washington University|Dr Theresa Human|314-747-8799|theresa.human@bjc.org|
21282676|NCT00422695|Rutgers School of Dental Medicine|Eli Eliav|973 972 7210|eliavel@sdm.rutgers.edu|
21282677|NCT01088672|Stryker NV|Amelia Saliba, AIS Clinical Program Manager|510-413-2500|aisstudies@stryker.com|
21282678|NCT00153543|CDC/Arctic Investigations Program|Karen Miernyk|9077293453|kmiernyk@cdc.gov|
21282679|NCT04678232|Case Western Reserve University|Norah Feeny, PhD|(216) 368-2695|ncf2@case.edu|
21282680|NCT03482453|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
21282681|NCT00251238|Radboud University Nijmegen, The Netherlands|Dr. SJH Bredie, MD, PhD|0031 24 3618819|bas.bredie@radboudumc.nl|
21282682|NCT03478644|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21282683|NCT00767455|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
21282684|NCT03687684|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
21282685|NCT03634033|Grand Valley State University|Dr. Sandra Spoelstra|616-331-5905|spoelsts@gvsu.edu|
21282686|NCT01351480|AARDS Research, Inc.|Norman B Gaylis, MD|305-652-6676|drnbg@rheum-care.com|
21282687|NCT01106677|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1 800 526 7736||
21282688|NCT03937908|Oregon Health & Science University|Dr. Amala Soumyanath|503-494-6878|soumyana@ohsu.edu|
21282689|NCT03875092|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21251858|NCT01715883|University of Pittsburgh|Matthew Morrell, MD|412-647-8477|morrellmr@upmc.edu|
21251859|NCT01850030|Abbott|Erik van Leeuwen MSc, PMP|+31294479241|erik.vanleeuwen@abbott.com|
21282690|NCT04114357|Indiana University|Heba M Ismail|317-278-8326|heismail@iu.edu|
21251860|NCT00246090|Eisai Call Center|Eisai Inc.|888-422-4743||
21251861|NCT03053453|NYU Langone Health|Dr. Arthur Hertling|2125986085|Arthur.Hertling@nyulangone.org|
21251862|NCT02554383|University of Pittsburgh|Nader Shaikh|412-692-8111|nader.shaikh@chp.edu|
21251863|NCT01536197|University of Illinois at Urbana Champaign|M. Yanina Pepino|217-300-2374|ypepino@illinois.edu|
21251864|NCT00715117|Pennsylvania State University|Jill P Smith, MD Professor Emeritus of medicine|717-531-3694|jsmith2@psu.edu|
21251865|NCT01545557|Galderma|Clinical project manager|817-961-5655|aestheticclinicaltrials@galderma.com|
21251866|NCT03180008|University of Illinois at Chicago|Andrew DeMott, MPH|312-355-3174|ademot1@uic.edu|
21251867|NCT02581059|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
21251868|NCT01999777|Proximagen, LLC|David Sequeira,|952-658-7437|dsequeira@proximagen.com|
21251869|NCT00873327|Duke University Medical Center|Brian Smith, MD. MPH|919-668-8951|brian.smith@duke.edu|
21251870|NCT04590404|Vanderbilt University Medical Center|Dr. Hilary Tindle|(615) 875-9726|hilary.tindle@vumc.org|
21251871|NCT02394665|University of Miami|Fazilat Ishkanian MD, PhD|305-243-4200|f.ishkanian@med.miami.edu|
21251872|NCT00569127|SWOG|SWOG Statistician|206-667-4408||
21251873|NCT05147272|Repare Therapeutics|Repare Therapeutics Medical Monitor|857-340-5402|clininfo@reparerx.com|
21251874|NCT03149029|Massachusetts General Hospital Cancer Center|Ryan J. Sullivan, MD|617-643-3614|RSULLIVAN7@mgh.harvard.edu|
21251875|NCT03172975|George Washington University|David J. Diemert, MD|202-994-2909|ddiemert@gwu.edu|
21251876|NCT03735121|Hoffman-La-Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21251877|NCT04750577|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21251878|NCT04980378|Globus Medical|Jessica Fulwider, Lead Clinical Project Manager|703-772-1455|jfulwider@globusmedical.com|
21251879|NCT02473042|The University of Texas MD Anderson Cancer Center|Alicia Kowalski, MD|(713) 563-5614|amkowalsk@mdanderson.org|
21251880|NCT00796627|Johns Hopkins University|Dr. John Harmon|410-550-0405|jharmon@jhmi.edu|
21251881|NCT02037256|Barbara Ann Karmanos Cancer Institute|Dr. Divaya Bhutani|501-680-9229|db3203@cumc.columbia.edu|
21251882|NCT03007732|University of California, San Francisco|Dr. David Oh, MD, PhD|(415) 476-1000|David.Oh@ucsf.edu|
21251883|NCT00311246|UIC|Nadera J Sweiss|312-996-5723|nsweiss@uic.edu|
21251884|NCT02386839|Shire (Note: This product was divested to Oak Hill Bio in 2022)|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
21251885|NCT02101983|University of Rochester|Deborah Mulford|585-275-5823|deborah_mulford@urmc.rochester.edu|
21251886|NCT02634814|University of North Carolina at Chapel Hill|Brian Pietrosimone, PhD|919-962-3617|brian@unc.edu|
21251887|NCT03725605|Lytix Biopharma AS|Director Scientific Research Baldur Sweinbjornsson|+47 413 44 682|Baldur.Sveinbjornsson@lytixbiopharma.com|
21251888|NCT01503086|Children's Oncology Group|Results Reporting Coordinator|6262411500|resultsreportingcoordinator@childrensoncologygroup.org|
21251889|NCT04021043|MD Anderson Cancer Center|Joe Chang, MD|(713) 563-2337|jychang@mdanderson.org|
21251890|NCT00826228|Northwestern University Feinberg School of Medicine|Thomas J Schnitzer|3125032315|tjs@northwestern.edu|
21251891|NCT01246999|University of Rochester|John Treanor MD, Professor of Medicine|585-275-5871|John_Treanor@urmc.rochester.edu|
21251892|NCT01867047|Duke University Medical Center|Michael Bolognesi, MD||michael.bolognesi@duke.edu|
21251893|NCT04650698|NYU Langone|Arthur Hertling, MD|212-598-6085|Arthur.Hertling@nyulangone.org|
21251894|NCT01090011|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21251895|NCT03778294|Mayo Clinic|Dr Sujay Vora|480-342-1262|Vora.Sujay@mayo.edu|
21251896|NCT01197612|University of Michigan|Garrett Griffin, MD||ggriffin@mw-fp.com|
21251897|NCT02859064|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
21251898|NCT04403542|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21251899|NCT03325790|Sound Pharmaceuticals, Inc.|Dr. Jonathan Kil|206-634-2559|info@soundpharma.com|
21251900|NCT01730950|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21282691|NCT01585324|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21282692|NCT00653133|I-Flow Corporation|Alan Dine Director of Clinical Research|513-253-8033|alan.dine@kcc.com|
21282693|NCT03693612|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21282694|NCT01058993|University of Washington|David D. Dale, MD|206-543-7215|dcdale@u.washington.edu|
21282695|NCT00809471|Vivus, Inc|Wesley W Day PhD|650-934-5200||
21282696|NCT03448575|Kaiser Permanente Washington Health Research Institute|Robert Penfold, PhD|206-316-7544|robert.b.penfold@kp.org|
21282697|NCT00287872|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Ivan Borrello|(410) 955-4967|iborrell@jhmi.edu|
21282698|NCT04364802|University of Kentucky|Alexandra Kejner|859-323-6741|aeke234@uky.edu|
21282699|NCT01669174|Novartis Pharmaceuticals|Study Director|862-778-8300||
21282700|NCT03788434|Vedanta Biosciences|Jeffrey Silber|(857) 706-1427|ConsortiumIO-ctinquiries@vedantabio.com|
21282701|NCT01953601|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21282702|NCT01246349|The Hospital for Sick Children|Beverly Walpole|416. 813 7654|bwalpole@uoguelph.ca|328363
21282703|NCT02991729|UNC School of Medicine Maternal Fetal Medicine|Laura Carlson, MD|8643503140|lauramosbycarlson@gmail.com|
21282704|NCT05537441|Yale University|Daniella Meeker|(213)926-2658|daniella.meeker@yale.edu|
21282705|NCT04310397|The University of Texas MD Anderson Cancer Center|Rodabe Amaria, MD|(713) 792-2921|rnamaria@mdanderson.org|
21282706|NCT05225298|Stanford University|Shuchi Anand, MD, MS|650-725-2207|sanand2@stanford.edu|
21282707|NCT00723255|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
21282708|NCT00614523|Amgen Inc.|Study Director|866-572-6436||
21282709|NCT01450826|Duke University Medical Center|Mary Lou Affronti, DNP, RN, MHSc, ANP|9196845301|mary.affronti@duke.edu|
21282710|NCT03962790|Johnson & Johnson Vision Care|Brian Pall, Director Clinical Science, Vision Care|1-800-843-2020|bpall@its.jnj.com|
21282711|NCT02877095|Duke Clinical Research Institute|Rachel Olson, Project Leader|919-309-5544|rachel.e.olson@duke.edu|
21282712|NCT02223650|Jaeb Center for Health Research|Ray Kraker, M.S.P.H., Director of PEDIG Coordinating Center|(813) 975-8690|rkraker@jaeb.org|
21282713|NCT05167370|Cincinnati Children's Hospital Medical Center|Dr. Sonata Jodele|(513) 636-5917|Sonata.Jodele@cchmc.org|
21282714|NCT01934517|U of Montreal|Vincent Peloquin|514-343-6056|vincent-claude.peloquin@umontreal.ca|
21282715|NCT03966924|Recros Medica|Head of Clinical Development|925-223-8581|clinical@recrosmedica.com|
21282716|NCT02153671|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
21282717|NCT03854370|Wright State University|Dr. Geoffrey Towers|937-208-2850|geoffrey.towers@wright.edu|
21282718|NCT02796352|University of Pittsburgh Cancer Institute|Barbara Stadterman, Regulatory Supervisor|(412) 647-5554|stadtermanbm@upmc.edu|
21282719|NCT01767506|Johns Hopkins University|Sheila K West|410 955 2606|shwest@jhmi.edu|
21282720|NCT00452673|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21282721|NCT02656290|Edwards Lifesciences, LLC|Aya Westbrook, PhD, Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Aya_Westbrook@edwards.com|
21282722|NCT04638881|Stanford University School of Medicine|Dr. Richard K. Kim|3475869661|rkwkim@stanford.edu|
21282723|NCT01608087|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21282724|NCT00722566|Johnson & Johnson Pharmaceutical Research & Development|Helgi Van de Velde, M.D., Ph.D.||HVDVELDE@ITS.JNJ.COM|
21282725|NCT00401544|Amgen Inc.|Study Director|866-572-6436||
21282726|NCT04411810|NYU Langone Health|David Polsky, MD, PhD|212-263-9087|David.Polsky@nyulangone.org|
21282727|NCT03461952|Canadian Cancer Trials Group|Janet Dancey|613-533-6430|jdancey@ctg.queensu.ca|
21282728|NCT03991299|Vanderbilt University Medical Center|Dr Cyndya Shibao|6159364584|cyndya.shibao@vumc.org|
21282729|NCT04304235|The University of British Columbia|J Mark Ansermino|1 604 875 2711|anserminos@yahoo.ca|
21282730|NCT02278939|University of California San Francisco, School of Nursing|Dr. Melinda Sarmiento Bender and Dr. Yoshimi Fukuoka|(415) 514-3151|melinda.bender@ucsf.edu; yoshimi.fukuoka@ucsf.edu|
21282731|NCT00930774|National Center for Rehabilitative Auditory Research, Portland VA Medical Center|Dr. Gabrielle H Saunders|503-220-8262|gabrielle.saunders@va.gov|56210
21282732|NCT03200704|Novadaq Technologies ULC, now a part of Stryker|Colleen Roden, Director of Clinical Sciences and Operations|931-267-2041|colleen.roden@stryker.com|
21282733|NCT00425061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21282734|NCT03436693|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp|
21282735|NCT00187681|UCSF|Kathy Giacomini, Ph.D|4154761936|Kathy.Giacomini@ucsf.edu|
21282736|NCT00626821|Coloplast|Helle Aaes Senior Scientific Manager|+45 49112949|dkheaa@coloplast.com|
21282737|NCT01471340|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21282738|NCT01981954|Astellas Pharma Europe B.V.|Medical Director|+31 (0) 715455050|astellas.resultsdisclosure@astellas.com|
21282739|NCT02274870|Northwell Health|Director of Research, Anesthesiology|718-470-7630|odowling@northwell.edu|
21282740|NCT00887783|Dept. Oncology, Odense University Hospital|Dr. Olfred Hansen, Professor, Ph.D.|+4524241588|olfred.hansen@rsyd.dk|
21282741|NCT01975571|University of Iowa|Dr. Camille Dunn|3193538776|camille-dunn@uiowa.edu|
21282742|NCT00489086|Children's Hospital of Oakland Research Institute, Oakland|Ervin H Epstein Jr., MD|510-450-5688|eepstein@chori.org|
21282743|NCT01609543|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21282744|NCT03341143|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
21282745|NCT02294396|Astellas Pharma Inc.|Medical Director|+81-3-3244-0512|astellas.resultsdisclosure@astellas.com|
21282746|NCT02120833|Johnson & Johnson Consumer and Personal Products Worldwide|Chirstopher Nunez, PhD/Study Director|973-385-7984 USA EST|cnunez1@its.jnj.com|
21282747|NCT02438826|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
21282748|NCT02784613|San Diego Sexual Medicine|Irwin Goldstein|619-265-8865|dr.irwingoldstein@gmail.com|
21297674|NCT02034877|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21297675|NCT00536471|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21297676|NCT01703507|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Wenyin Shi|215-955-6702|Wenyin.Shi@jefferson.edu|
21297677|NCT02461927|VA CT Healthcare System, Yale University|Dr. Gihyun Yoon|(203) 932-5711|gihyun.yoon@yale.edu|7421
21297678|NCT04878211|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21297679|NCT00328614|Thomas Jefferson University|Edouard Trabulsi, MD|215-955-1000|Edouard.Trabulsi@jefferson.edu|
21297680|NCT03574779|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21297681|NCT02783599|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
21297682|NCT01898429|Dartmouth Hitchcock Medical Center|Paul E. Holtzheimer, MD|603-650-4914|Paul.E.Holtzheimer@hitchcock.org|
21297683|NCT00783614|Minneapolis Medical Foundation|Dr. Jason Baker|612-873-2705|baker459@umn.edu|
21297684|NCT00856544|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21297685|NCT01564732|Duke University Medical Center|Dana Portenier, M.D.|919-470-7031|dana.portenier@duke.edu|
21297686|NCT01159015|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
21297687|NCT01687101|Thomas Jefferson University, Jefferson Headache Center|Stephen D Silberstein, MD|215-955-2243|bruce.smith@jefferson.edu|
21297688|NCT01401517|TheraVasc Inc.|Tony Giordano|318-349-3851|tgiordano@theravasc.com|
21297689|NCT05274269|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21297690|NCT01685697|Univeristy of Alberta|Georg Schmolzer|7807354660|georg.schmoelzer@me.com|
21297691|NCT01854034|Massachusetts General Hospital|Lecia Van Dam Sequist, M.D.|617-724-4000|lvsequist@partners.org|
21297692|NCT01948063|BIDMC|Michael W Donnino|617-754-2341|mdonnino@bidmc.harvard.edu|
21297693|NCT01077401|University of Nebraska|Quan Dong Nguyen, MD, MSc|4025591855|quan.nguyen@unmc.edu|
21297694|NCT05234957|Benha University|Dr. Mohamed Farid|00201003354636|mohamed.farid@fmed.bu.edu.eg|
21297695|NCT01340053|Ardelyx|Chief Development Officer|510 745 1752|drosenbaum@ardelyx.com|
21297696|NCT04427072|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
21297697|NCT05232864|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
21297698|NCT01636986|Alcon Research, Ltd.|Jami Kern, PhD|1-888-452-3937|alcon.medinfo@alcon.com|
21297699|NCT00705146|VIHA|Helia Sillem MScOT|2507557611|helia.sillem@viha.ca|
21297700|NCT01623869|Memorial Sloan-Kettering Cancer Center|Sandra Pierina D'Angelo, M.D.||dangelos@mskcc.org|
21297701|NCT03664765|JOHN D DINGELL VA MEDICAL CENTER|Dr. Abdulghani Sankari Principal Investigator|13135761000|abdulghani.sankari@va.gov|63105
21297702|NCT00383162|GlaxoSmithKline|GSK Response Center|866-435-7343||
21297703|NCT03533244|Allgenesis Biotherapeutics|Tan Nguyen|+886-2-8787-1232|tan.nguyen@allgenesis.com|
21297704|NCT01496846|University of Michigan|Dr Tatiana Botero, Director of Postgraduate Program in Endodontics|734-936-2526|tbotero@umich.edu|
21297705|NCT01772576|Boston Scientific|Ursula Appl|003224167213|ursula.appl@bsci.com|
21297706|NCT00923845|National Cancer Institute|Dr. Daniel Fowler|301-435-8641|fowlerda@mail.nih.gov|
21297707|NCT00961714|Alphatec Spine, Inc.|Glen Seidner, Clinical Affairs|760-494-6789|gseidner@alphatecspine.com|
21297708|NCT02019875|University of Washington|Kenneth Thummel|206-543-0819|thummel@u.washington|
21297709|NCT00177255|University of Pittsburgh|Nathan Bahary, MD|412-864-7764|baharyn@upmc.edu|
21297710|NCT02873338|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
21297711|NCT01620944|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21297712|NCT03170193|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21297713|NCT00375518|Memorial Sloan Kettering Cancer Center|Dr. David Amar|212-639-6798|amard@mskcc.org|
21297714|NCT06037408|Emphycorp, Inc.|Dr. Alain Martin|(908) 237-1561|al.martin.hq@emphycorp.com|
21297715|NCT01211340|University of Missouri|Debra Parker Oliver|573-884-5301|oliverdr@missouri.health.edu|
21297716|NCT03052816|UH Hospitals Cleveland Medical Center/MetroHealth Medical Center at time of study protocol|Andrey Petrikovets MD|323 243 9091|andrepetrikovets@yahoo.com|
21297717|NCT03755661|Boston University|LaNeia Thomas|617-358-6346|laneia@bu.edu|
21297718|NCT04000581|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kris.Attwood@roswellpark.org|
21297719|NCT00895453|Vienna Medical School|Armin Witt MD|+43140400|armin.witt@meduniwien.ac.at|2821
21297720|NCT02110264|UCLA|David Farabee|3109630009|dfarabee@mednet.ucla.edu|
21297721|NCT01748825|National Cancer Institute|Dr. Naoko Takebe|240-781-3320|takeben@nih.gov|
21297722|NCT00965419|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21297723|NCT00997594|Mie University|Dr. Koichiro Yamakado|+81-59-231-5029|yama@clin.medic.mie-u.ac.jp|5630
21297724|NCT01128244|University of Florida|Dr. Jesse F. Gregory|(352) 392-1991|jfgy@ufl.edu|225
21297725|NCT02380443|Mirror Biologics, Inc|Dr. Michael Har-Noy|7602167494|harnoy@mirrorbio.com|
21297726|NCT03571555|Royal Holloway University of London|Dr. Michael Evangeli|00447801543681|michael.evangeli@rhul.ac.uk|
21297727|NCT02214290|Texas Tech University|Dr. Arturo Figueroa|8068345587|arturo.figueroa@ttu.edu|
21297728|NCT00699608|GlaxoSmithKline|GSK Response Center|866-435-7343||
21297729|NCT04220554|University of Southern Denmark|Consultant, MD, PhD Mathias Tiedemann Svendsen|0045 61265827|mtsvendsen@health.sdu.dk|
21297730|NCT01363908|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21297731|NCT05258149|Johnson & Johnson Vision Care, Inc.|Thomas R. Karkkainen, OD, MS, FAAO|1-800-843-2020|TKarkkai@its.jnj.com|
21297732|NCT01442714|Stanford University|Dr. Bruno Medeiros|650-723-5007|brunom@stanford.edu|
21297733|NCT04808141|Sword Health Inc|Fernando Dias Correia|+1 (646) 379-6751|fcorreia@swordhealth.com|
21297734|NCT00394706|University of Washington|Siobhan Brown, PhD-Biostatistician|206-685-1302|spes@uw.edu|
21297735|NCT04846322|Yale University|Ula Hwang, MD|+1 (203) 7371774|ula.hwang@yale.edu|
21251901|NCT02737826|Medical University of South Carolina|Dr. Kelly Barth|843-792-0686|stephen@musc.edu|
21251902|NCT00667459|Medtronic Spinal|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
21251903|NCT02568397|Eli Lilly and Company|Chief Medical Officer|800-545-5079||
21282749|NCT01551264|Washington University School of Medicine|Matthew Dobbs MD|561-844-5255|mdobbs@paleyinstitute.org|
21251904|NCT00078377|Cephalon, Inc.|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
21251905|NCT02354651|University of Florida|Dr. Barbara Smith|3522945315|bksmith@ufl.edu|
21251906|NCT00581893|University of Iowa|Erik St. Louis|507-266-7456|StLouis.Erik@mayo.edu|
21251907|NCT02550938|Align Technology, Inc.|Allison Mossing, Sr. Clinical Research Associate|4084701046|amossing@aligntech.com|
21251908|NCT01367847|University of North Carolina at Chapel Hill|Deborah Jones, PhD|919-962-3995|djjones@email.unc.edu|
21251909|NCT01454739|Bioverativ Therapeutics Inc.|Bioverativ Study Medical Director|781-6631801|clinicaltrials@bioverativ.com|
21251910|NCT00535938|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21251911|NCT01375751|Amgen Inc.|Study Director|866-572-6436||
21282750|NCT01965366|Emory University|Dr. Barbara Rothbaum|404-712-8866|brothba@emory.edu|
21282751|NCT04152837|Centessa Pharmaceuticals|Milena Kanova|+44 7780 430583|milena.kanova@centessa.com|
21282752|NCT00586820|Mayo Clinic|Dr. Amir Lerman|507-255-6670|lerman.amir@mayo.edu|
21282753|NCT02073929|Center of Endocrinology and Metabolism, Dept. of Internal Medicine, Herlev Gentofte Hospital, Denmark|Professor Jens Faber|+4538689016|jens.faber@regionh.dk|
21282754|NCT01483027|Boston Scientific|Chantal Laframboise|+1 613 882 0876|chantal.laframboise@bsci.com|
21282755|NCT03763929|Diffusion Pharmaceuticals Inc|Clinical Operations|434-220-0718|clinicaltrials@diffusionpharma.com|
21282756|NCT02504827|University of Southern California|Paul Beringer|323-442-1402|beringer@usc.edu|
21282757|NCT00686829|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21282758|NCT00725361|StanfordU|Lorinda Chung|650-736-0727|shauwei@stanford.edu|
21282759|NCT01732640|Johns Hopkins University|Hao Wang|410-614-3426|hwang76@jhmi.edu|
21282760|NCT04574908|Wake Forest University Health Sciences|Portable Hemodynamic Monitoring on Hosp Units|336.716.4498|akhanna@wakehealth.edu|
21282761|NCT03070002|Northwestern University|MASSIMO CRISTOFANILLI, MD|312-503-1114|massimo.cristofanilli@nm.org|
21282762|NCT02754427|University of British Columbia|Dr. Kristin Campbell|604-827-4704|kristin.campbell@ubc.ca|
21282763|NCT00712543|Cumberland Pharmaceuticals Inc.|Bryan Voss, Ph.D.|615-255-0068|bvoss@cumberlandpharma.com|
21282764|NCT06366087|BARDA|Michael D. Schwartz, MD MPH/Division of CBRN Countermeasures|(202)-260-0849|Michael.Schwartz@hhs.gov|
21282765|NCT03717051|University of Hong Kong|Dr. Derek Cheung|39176652|derekcheung@hku.hk|
21282766|NCT01397786|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21282767|NCT04432090|AdventHealth, Orlando|Richard Pratley|407-303-2519|richard.pratley.md@adventhealth.com|
21282768|NCT00743730|Medical College of Wisconsin|Keri R. Hainsworth, PhD, Research Director|414-266-6306|khainswo@mcw.edu|
21282769|NCT02836236|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21282770|NCT00831311|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21282771|NCT01322594|MedImmune, Limited|Ed Piper|+44 (0) 1223 471 471|pipered@medimmune.com|
21282772|NCT01300338|Mayo Clinic|Dr. Frederick North|507-284-5164|North.Frederick@mayo.edu|
21282773|NCT01470651|New York State Psychiatric Institute-Research Foundation for Mental Hygene|Judith Rabkin|646-774-8075|jgr1@cumc.columbia.edu|
21282774|NCT00908791|Norris Cotton Cancer Center|Burton Eisenberg, MD, Deputy Director, Norris Cotton Cancer Center|603-653-3613|Burton.L.Eisenberg@Dartmouth.edu|
21282775|NCT02461524|Medtronic|Kristel Wittebols Sr. Clinical Research Director|31 (0)43-3566566|kristel.wittebols@medtronic.com|
21282776|NCT00880581|Stanford University|Ronald Levy|6507256452|levy@stanford.edu|
21282777|NCT01943851|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21282778|NCT00981669|Instituto Butantan|Alexander Roberto Precioso|+5511-2627-9372|alexrp@butantan.gov.br|9372
21282779|NCT00101036|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
21282780|NCT00381238|GlaxoSmithKline|GSK Response Center|866-435-7343||
21282781|NCT00061373|NIH/NINDS and University of Texas Southwestern, Clinical Research Institute of Austin|Steven Warach, MD, PhD; Principal Investigator|512-324-8383|swarach@seton.org|
21282782|NCT02806544|Vanderbilt University|Laila Agrawal|615-322-4967|laila.saied@vanderbilt.edu|
21282783|NCT00843037|University Health Network|Dr. Jennifer Knox, PI|(416) 946-2000|jennifer.knox@uhn.ca|5131
21282784|NCT03535194|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
21282785|NCT01665157|National Taiwan University Hospital|Han-Mo Chiu, M.D., Ph.D.||hanmochiu@ntu.edu.tw|
21282786|NCT01916681|University of Pennsylvania|Dr. Lisa Levine|2156626913|lisa.levine@uphs.upenn.edu|
21282787|NCT00860535|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21282788|NCT04429555|Medicinova Inc|Malath Makhay|8582468680|makhay@medicinova.com|
21282789|NCT02703272|Janssen Research & Development, LLC|Clinical Scientist|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21282790|NCT00384748|University of Georgia|Neale Chumbler, PhD|706-369-5975|chumbler@uga.edu|
21282791|NCT04470544|Mayo Clinic|Alan Haruo Bryce, M.D.|(480)301-8335|Bryce.Alan@mayo.edu|
21282792|NCT01680861|Miami Transplant Institute|Jeffrey Gaynor, Ph.D. biostatistician||jgaynor@med.miami.edu|
21282793|NCT02173522|University of Miami|Shivank Bhatia|305-243-7500|sbhatia1@med.miami.edu|
21282794|NCT05835011|Taiho Oncology, Inc.|Taiho Central|844-878-2446|medicalinformation@taihooncology.com|
21282795|NCT04720911|UMass Chan Medical School|Dr. Celine Larkin|5084211436|celine.larkin@umassmed.edu|
21251912|NCT02980523|Laboratorios Sophia|Clinical pharmacologist|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
21282796|NCT04807205|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
21297736|NCT03369249|New York State Psychiatric Institute|Katherine Elkington|16467746965|ke2143@cumc.columbia.edu|
21297737|NCT02546492|University of MAryland sSchool of Medicine|A Haririan|410-328-5720|ahariria@som.umaryland.edu|
21297738|NCT02003534|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21297739|NCT03920254|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
21297740|NCT03040674|Lung Health Institute|Melissa Rubio, PhD, APRN|2145042117|pidallas@thelunghealthinstitute.com|
21297741|NCT01934010|Auris Medical Inc.|Thomas Meyer, CEO|+1 312 396 4150|hear@aurismedical.com|
21297742|NCT04112303|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21297743|NCT02506192|Minneapolis VA Health Care System|Ronald R Bach, PhD, Principal Investigator|(612)467-6315|ronald.bach@va.gov|
21297744|NCT00709618|GlaxoSmithKline|GSK Response Center|866-435-7343||
21297745|NCT02703324|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21297746|NCT02096549|Department of Anesthesiology and Pain medicine, Yeungnam University School of Medicine, Daegu, Republic of Korea|Sung Mee Jung, M.D|+82-53-620-3368|applejsm@gmail.com|
21297747|NCT04042909|Brown University|Kate B. Carey|4018636558|kate_carey@brown.edu|
21297748|NCT04303572|University of Pittsburgh|Dr. Margaret Ragni, Principal Investigator|412-209-7288|ragni@pitt.edu|
21297749|NCT06312592|Washington University in St. Louis|Dr. Lindsay Stark|314-935-4747|lindsaystark@wustl.edu|
21297750|NCT04428619|UCLA|Lin Chang|310-206-0192|linchang@mednet.ucla.edu|
21297751|NCT03785405|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21297752|NCT03705559|University of Kentucky|Shanna Babalonis, Ph. D.|859-257-1881|babalonis@uky.edu|
21297753|NCT01858766|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21297754|NCT03517228|Memorial Sloan Kettering Cancer Center|Dr. Mario Leitao, MD|212-639-3987|leitaom@mskcc.org|
21297755|NCT01543074|Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston TX|Rod Dashwood|7136777806|rdashwood@ibt.tamhsc.edu|
21297756|NCT00945256|University of Texas Medical Branch|Dr Melinda Sheffield-Moore, Professor of Medicine|409-772-8707|melmoore@utmb.edu|
21297757|NCT01979952|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21297758|NCT03781414|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21297759|NCT00156390|University of Pittsburgh|Dr. Samir Saba|412-802-3372|sabas@upmc.edu|
21297760|NCT00245037|Oregon Health and Science University|Richard T. Maziarz, MD|503-494-6345|maziarzr@ohsu.edu|
21297761|NCT01439594|Massachusetts General Hospital|Dr. Gary Tearney, PI|617-724-2979|GTEARNEY@PARTNERS.ORG|
21297762|NCT01053988|GlaxoSmithKline|GSK Response Center|866-435-7343||
21297763|NCT01922271|Novartis Pharmaceuticals|Study Director|862-778-8300||
21297764|NCT00719355|University of Illinois at Chicago|Eileen G. Collins PhD, RN|312-413-5621|ecollins@uic.edu|
21297765|NCT03724890|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21297766|NCT04210622|Medtronic, Inc|Clinical Research Specialist|800-328-2518|medtroniccastrials@medtronic.com|
21297767|NCT02093962|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com|
21297768|NCT01844778|Novartis|Study Director|862-778-8300||
21297769|NCT03605914|The University of Texas Health Science Center at Houston|Martin J. Citardi, MD, Professor and Chair, Department of Otorhinolaryngology|(713) 500-5410|Martin.J.Citardi@uth.tmc.edu|
21297770|NCT02161757|AstraZeneca|Global Clinical Lead|+1 301-398-0582|ClinicalTrialTransparency@astrazeneca.com|
21297771|NCT00391625|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21297772|NCT00328861|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
21297773|NCT02275156|Amgen Inc.|Study Director|866-572-6436||
21297774|NCT01130896|Johns Hopkins University|Henry Halperin, MD|410-955-2412|nsaju1@jhmi.edu|
21297775|NCT02106403|GlaxoSmithKline|GSK Response Center|866-435-7343||
21297776|NCT02024724|Northwestern University, Feinberg School of Medicine|Antoun Nader, M.D.|312-695-4814|a-nader2@northwestern.edu|
21297777|NCT00639626|Nationwide Children's Hospital|Julie Rice, RN|6143553142|julie.rice@nationwidechildrens.org|
21297778|NCT00379912|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
21297779|NCT04405076|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
21297780|NCT04310566|Johnson & Johnson Vision Care|Thomas Karkkainen - Sr.Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
21297781|NCT03301298|Promentis Pharmaceuticals|Dean Brostowin|617-300-6172|dbrostowin@promentispharma.com|
21297782|NCT02560012|The University of Texas Health Science Center, Houston|Research Manager|713-500-6919|Marka.Lyons@uth.tmc.edu|
21297783|NCT02218008|Alkermes, Inc.|Eva Stroynowski|781-609-7000|eva.stroynowski@alkermes.com|
21297784|NCT00408434|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21297785|NCT03139344|University of Iowa Department of Physical Therapy and Rehabilitation Science|Dr. Richard K. Shields|319-335-9791|richard-shields@uiowa.edu|
21297786|NCT01088399|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21297787|NCT00928694|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21297788|NCT00118430|Indiana University|Kurt Kroenke|3172749046|kkroenke@regenstrief.org|
21297789|NCT02147288|Yale University|Dr. Marc Walker||marc.walker@yale.edu|
21297790|NCT02069392|University of Maryland School of Medicine|Britta Hahn, Ph.D.|4104026112|bhahn@som.umaryland.edu|
21297791|NCT00269633|Thomas Jefferson University|Roseann Talarico|215 503 4743|roseann.talarico@jefferson.edu|
21297792|NCT04412707|Oncopeptides AB|VP Chief Operating Officer|+46 8 615 20 40|trials@oncopeptides.com|
21297793|NCT02222610|Retina Consultants of Texas|Dr. Amy C. Schefler|(713) 524-3434|acsmd@retinaconsultantstexas.com|
21297794|NCT00615017|AstraZeneca|Justin Lindemann||ClinicalTrialTransparency@astrazeneca.com|
21297795|NCT02232022|Northwell Health|Jeffrey M. Katz|516-562-3062|jkatz2@northwell.edu|
21297796|NCT04775953|Duke University|Thomas L. Holland, MD|919-613-4268|thomas.holland@duke.edu|
21297797|NCT01698814|Alcon Research, Ltd.|Terri Pasquine, Sr. Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21297798|NCT00855959|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21297799|NCT02607618|Motif BioSciences|Stephanie Noviello|908-432-7802|stephanie.noviello@motifbio.com|
21297800|NCT00368641|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
21297801|NCT04014062|Lambda Therapeutic Research Ltd.|Dr. Anshul Attrey, M.D. Principal Investigator|+91-79-40202020|anshulattrey@lambda-cro.com|
21297802|NCT02477124|Duke University|Jennifer Gallagher|9199701551|jennifer.gallagher@duke.edu|
21297803|NCT03038126|University of Maryland Baltimore|Jeffrey C. Fink, MD MS; Principal Investigator|410-328-4822|jfink@som.umaryland.edu|
21297804|NCT01724866|Spectrum Pharmaceuticals, Inc, Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|(949) 788-6700|shanta.chawla@sppirx.com|
21297805|NCT01340586|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21297806|NCT01424501|GlaxoSmithKline|GSK Response Center|866-435-7343||
21297807|NCT01173601|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21297808|NCT01980095|RedHill Biopharma|Dr. Ira Kalfus|1-917-817-7517|ira@redhillbio.com|
21297809|NCT00721188|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
21297810|NCT03974945|Rocky Mountain Regional Department of Veterans Affairs|Dr. Alena Grabowski|303-492-5208|alena.grabowski@va.gov|
21297811|NCT04506502|Zeltiq Aesthetics|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
21297812|NCT01449006|St Vincent's Hospital, Sydney, Australia|Prof. Bruce Brew|61 2 8382 1111|bruce.brew@svha.org.au|4100
21251913|NCT00633945|University of Pennsylvania|Dr. Victoria Werth|215-898-0168|werth@mail.med.upenn.edu|
21297813|NCT03350815|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
21297814|NCT02517541|Scientific and Regulatory affairs|Zenia M Størling|+45 49111869|dkzenst@coloplast.com|
21297815|NCT02828436|University of Minnesota|Manda Keller-Ross|612-625-3175|kell0529@umn.edu|
21297816|NCT00566462|Eisai Call Center|Eisai Inc.|888-422-4743||
21297817|NCT03782701|Bascom Palmer Eye Institute|Dr. Wendy Lee|(305) 243-2020|wlee@med.miami.edu|
21297818|NCT00526591|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@case.edu|
21297819|NCT06068426|Cincinnati Children's|Dr. David Vitale|(513) 517-7040|David.Vitale@cchmc.org|
21297820|NCT04720417|Thomas Jefferson University|Rino Seedor, MD|215-955-8874|Rino.Seedor@Jefferson.edu|
21297821|NCT03329092|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21297822|NCT03314987|University of Louisville|Dr. Timothy O'Toole Associate Professor|15024190808|tim.otoole@louisville.edu|
21297823|NCT03829449|Akari Therapeutics Plc|Dr Wynne Weston-Davies|0208 004 6106|wynne.weston-davies@akaritx.com|
21297824|NCT00887510|University of Florida|Rhonda M Cooper-DeHoff|352 273-6184|dehoff@cop.ufl.edu|
21297825|NCT00203424|Translational Oncology Research International|Dr. Fairooz F. Kabbinavar, Chief Medical Officer|310-824-1934|FKabbina@mednet.ucla.edu|
21297826|NCT04759157|University of Utah|Dr. Kelly Baron|801-585-7588|kelly.baron@utah.edu|
21297827|NCT01415401|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader|1-888-451-3937|alcon.medinfo@alcon.com|
21251914|NCT00882115|UCLA Department of Medicine/Center for Human Nutrition|Zhaoping Li|310-206-1987|zli@mednet.ucla.edu|
21251915|NCT02552147|Vanderbilt University Medical Center|Alan Lewis, MD, PhD|(615) 936-4997|alan.s.lewis@vumc.org|
21251916|NCT01547598|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21251917|NCT01573949|University of California Los Angeles|Tamara Horwich, MD, MS|310-825-8816|thorwich@mednet.ucla.edu|
21251918|NCT00777634|McLean Hospital|Study Coordinator|617-855-2984|eryan@mclean.harvard.edu|
21251919|NCT00872001|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21251920|NCT04071301|Essity Hygiene and Health|Fredrik Agholme, Clinical Trials Manager, Clinical Affairs|+46 73 0323634|Fredrik.AGHOLME@essity.com|
21251921|NCT00121667|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
21251922|NCT05186311|Becton, Dickinson and Company|Clinical Program Manager|9292850651|Pierre.Asselin@bd.com|
21251923|NCT02879383|Fractyl Laboratories, Inc.|Sarah Hackett, Director of Clinical Operations|(781) 902-8840|shackett@fractyl.com|
21251924|NCT03178344|Department of Psychiatry, UNC Chapel Hill|Jhana Parikh|919-966-9929|jhana_parikh@med.unc.edu|
21251925|NCT02018653|University of Texas (UT) MD Anderson Cancer Center|Sai-Ching J. Yeung, MD||CR_Study_Registration@mdanderson.org|
21251926|NCT02677870|UHCMC|Dr. Lori-Anne Schillaci|216-844-3936|lori-anne.schillaci@uhhospitals.org|
21251927|NCT03714659|New Jersey Regenerative Institute|Dr. Gerard Malanga|9739988301|gmalangamd@hotmail.com|
21251928|NCT04468230|Virginia Commonwealth University|Renato Martins, MD|804-828-1965|MasseyCPC@vcu.edu|
21251929|NCT04560374|Marmara University Faculty of Health Sciences Department of Pediatric Nursing|Dr. Çağrı Çövener Özçelik|009-0216-777-57-00|ccovener@gmail.com|5773
21251930|NCT02239744|Department of Environmental Health, School of Public Health, Fudan University|Dr. Haidong Kan|86-21-54237908|kanh@fudan.edu.cn|
21251931|NCT00983853|Vertex Pharmaceuticals Incorporated|Medical Monitor|1-617-444-6777|medicalinfo@vrtx.com|
21251932|NCT02599688|Peregrine Ophthalmic Pte Ltd|Chief Operating Officer|65 97914382|jchua@peregrineop.com|
21251933|NCT00996502|Columbia University|CU PRS Administrator|212-342-1643|ClinicalTrialsGov@cumc.columbia.edu|
21251934|NCT05400837|Johns Hopkins University|Nino Isakadze|443-997-0270|nisakad1@jh.edu|
21251935|NCT01318876|Laval University|Gaston De Serres|418-666-7000|gaston.deserres@ssss.gouv.qc.ca|274
21251936|NCT00443209|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21297828|NCT00836186|Johns Hopkins University|Jean Wright, MD PI|410-614-3950|jwrigh71@jhmi.edu|
21297829|NCT04079816|Masimo Corporation|Ahmed Alghazi|949-297-7000|aalghazi@masimo.com|
21297830|NCT01128946|GlaxoSmithKline|GSK Response Center|866-435-7343||
21297831|NCT00621140|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21297832|NCT00145574|Daiichi Sankyo|Howard Kessler|732-590-5032|hmkessler@dsi.com|
21297833|NCT00527904|POZEN|Senior Vice President, Clinical Research|919-913-1030|eorlemans@pozen.com|
21297834|NCT03323801|University of Washington School of Medicine|Dr. John Amory|2066161727|jamory@uw.edu|
21297835|NCT00766051|University of Utah at the time of the study|Lynne La Corte, PhD, OTR/L, OTD|970 4330981|lflacorte@independence.net|
21297836|NCT02669121|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21297837|NCT02708355|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21297838|NCT03216746|UFParaná|Dr Luciana Reichert Assunção Zanon|554133604025|lurassuncao@yahoo.com.br|
21297839|NCT01320202|Rockwell Medical|Senior Director, Clinical Research & Operations|248-960-9009|rd@rockwellmed.com|
21297840|NCT00635882|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21297841|NCT00835341|Peking University School of Oncology|Department of Etiology|+8610-88196752|dengdajun@bjmu.edu.cn|
21297842|NCT02513472|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21297843|NCT01957410|Janssen Research & Development, LLC|Director||ClinicalTrialDisclosure@its.jnj.com|
21297844|NCT03747640|Florida State University|Hyochol Ahn, PhD, MSN, MS-ECE, MS-CTS, APRN, ANP-BC, FAAN|850-644-2647|hahn@fsu.edu|
21297845|NCT01711645|Vanderbilt Medical Center|Kathryn M. Edwards, MD|615-322-3078|Kathryn.edwards@vanderbilt.edu|
21297846|NCT01041521|Tufts University|Christine Wanke, Principal Investigator||christine.wanke@tufts.edu|
21297847|NCT03691662|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
21297848|NCT01746173|Dana-Farber Cancer Institute|Philippe Armand MD, PhD|617.632.2305|Philippe_Armand@dfci.harvard.edu|
21297849|NCT00714311|Medical University of Vienna|Stephan Doering|+43140400|stephan.doering@meduniwien.ac.at|25190
21297850|NCT01278797|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21297851|NCT00588354|Mayo Clinic|Dr. Marc A. Huntoon|(507) 284-2511|huntoon.marc@mayo.edu|
21297852|NCT04182672|The University of Texas Health Science Center at Houston|Pritish Bawa, MD|713-500-7702|Pritish.Bawa@uth.tmc.edu|
21297853|NCT04522141|Lucerne University of Applied Sciences and Arts|Dr. Mirjam Stieger|0041798852810|mirjam.stieger@hslu.ch|
21297854|NCT03052049|Northwestern Medical Group|Jennifer Karp RN|312-926-5289|jkarp@nm.org|
21297855|NCT02328027|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21297856|NCT03304873|NYU Grossman School of Medicine|Jennifer Lighter, MD|212-263-5454|Jennifer.Lighter@nyulangone.org|
21297857|NCT03319212|Johnson & Johnson Vision Care, Inc.|Elizabeth Dow, OD, FAAO - Principal Research Optometrist|904-443-1061|edow1@its.jnj.com|
21297858|NCT03637517|Medicines for Malaria Venture|Stephan Chalon, MD|+41 22 555 0369|chalons@mmv.org|
21297859|NCT00400569|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-2158|alberto.chiappori@moffitt.org|
21297860|NCT00620113|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21297861|NCT00852241|Loyola Medicine|Rebecca Tung, MD|(708) 216-4962|rtung@loyolamedicine.org|
21297862|NCT03848949|Rush University Medical Center|Dr. Daniel D. Bohl|414.640.7245|danielbohl@gmail.com|
21297863|NCT02524418|University of Florida|Dr. Peter V. Draganov MD|352-273-9472|peter.draganov@medicine.ufl.edu|
21297864|NCT03850535|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21297865|NCT04230213|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21297866|NCT00524472|Cleveland Clinic|Andra Duncan, MD|216 445-2372|DUNCANA@ccf.org|
21297867|NCT00486824|Stanford University|Dr. Deirdre Lyell|6507255720|dlyell@stanford.edu|
21297868|NCT02748070|Stanford University|Michael Chang|(650) 725-6500|michael.t.chang@stanford.edu|
21297869|NCT00240500|GlaxoSmithKline|GSK Response Center|866-435-7343||
21297870|NCT00619307|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21297871|NCT00801398|Endo Pharmaceuticals|Saji Vijayan|(800) 462-3636|ClinicalTrials@Endo.com|
21297872|NCT00534976|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21297873|NCT00861471|New York University Cancer Institute|Anna Ferrari, MD|212-731-5389|anna.ferrari@nyumc.org|
21297874|NCT00669383|OHSU|Cindy McEvoy, MD|503-494-0223|mcevoyc@ohsu.edu|
21297875|NCT02476006|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21297876|NCT01704404|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
21297877|NCT00806988|Icahn School of Medicine at Mount Sinai|Alan Moskowitz, MD|212-659-9568|alan.moskowitz@mountsinai.org|
21297878|NCT04306510|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
21297879|NCT03106636|University of Oregon|Dr. Philip Fisher|541-346-4968|philf@uoregon.edu|
21297880|NCT01915173|Massachusetts General Hospital|Michelle L. Dossett, MD, PhD, MPH|617-643-6034|mdossett@mgh.harvard.edu|
21297881|NCT03755882|Johnson & Johnson Vision Care Inc.|Brian Pall, OD, MS, FAAO- Director of clinical Sciences|904 443-1290|BPALL@its.jnj.com|
21297882|NCT01073449|Dept. of Arrhythmology - Cliniche Humanitas Gavazzeni|Dr. Giosue Mascioli|+39 035 4204159|giosuemascioli@mac.com|
21297883|NCT01746368|Tuscaloosa VA Medical Center (Retired)|Ann Mahaney-Price, DNP|205-409-8301|amparnp@yahoo.com|
21297884|NCT05636852|GE HealthCare|Paul Sherwin, MD, PhD|+1 (609) 510-3686|PaulSherwin@gehealthcare.com|
21297885|NCT01664182|Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee, CA 96161|Thomas J Semrad, MD, MAS|+1 530 582 6450|tsemrad@tfhd.com|
21297886|NCT02221674|Grünenthal GmbH|Director of Clinical Trials|+49 241 569|Clinical-Trials@grunenthal.com|3223
21267068|NCT04785144|Kaiser Permanente Washington|Lisa Jackson|206-442-5216|lisa.a.jackson@kp.org|
21297887|NCT02557542|Imperial College London|Mr Roshan Bootun|+442033117335|r.bootun@imperial.ac.uk|
21297888|NCT04390880|VA Greater Los Angeles Healthcare System|Gholam Berenji, M.D.|310-268-3547|Gholam.Berenji@va.gov|
21297889|NCT00195091|Memorial Sloan Kettering Cancer Center|Dr. Tiffany Traina MD|646-888-4558|trainat@MSKCC.ORG|
21297890|NCT01028846|Albert Einstein College of Medicine|Dr. Meredith Hawkins|718-839-7975|meredith.hawkins@einsteinmed.edu|
21236654|NCT02241967|Ralph H. Johnson VA Medical Center|Jeffrey Borckardt, Ph.D|843-792-3295|Jeffrey.Borckardt@va.gov|
21236655|NCT03929029|Dana Farber Cancer Institute|Dr. Patrick A. Ott|6175829030|patrick_ott@dfci.harvard.edu|
21236656|NCT04579757|HUTCHMED Limited|Nicky Murray|+44 7738 881999|nicolam@hutch-med.com|
21236657|NCT01843192|Ethicon, part of Johnson & Johnson|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
21236658|NCT00803647|NSABP Foundation|Diana Gosik, Director Department of Site and Study Management|412-339-5333|diana.gosik@nsabp.org|
21236659|NCT00856856|Abbott Vascular International BVBA|Susan Veldhof|31653428610|susan.veldhof@av.abbott.com|
21236660|NCT00728819|Penn Medicine|Associate Professor of Radiology|2156627892|ITKINMAX@GMAIL.COM|
21236661|NCT00434057|Electro-Optical Sciences, Inc.|Joanna Adrian / Director, Clinical Operations and Medical Affairs|(914)591-3783|adrian@eosciences.com|732
21282797|NCT00941863|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21282798|NCT00823043|Vistakon|Arthur Shedden MD|904-443-1557||
21282799|NCT02655510|Mayo Clinic|Vijay Shah, M.D.|507-284-3917|Shah.Vijay@mayo.edu|
21282800|NCT02048826|University of California at Irvine|Prof. David Reinkensmeyer|949-824-5218|dreinken@uci.edu|
21282801|NCT05875025|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
21282802|NCT04259424|Medical University of South Caroina|Ryan Ross|843-792-3477|rossre@musc.edu|
21282803|NCT01913535|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|mfava@mgh.harvard.edu|
21236662|NCT00085410|Fox Chase Cancer Center|Assistant Professor, Medical Oncology|215-214-1676|crystal.denlinger@fccc.edu|
21282804|NCT01098500|GlaxoSmithKline|GSK Response Center|866-435-7343||
21282805|NCT02218736|Duke Clnical Research Institute|Kathy Hijek, Associate Director of Clinical Operations|919-668-8700|kathy.hijek@duke.edu|
21297891|NCT00795236|Oregon Health & Science University|Alfred Lewy|(503) 494-7746|lewy@ohsu.edu|
21297892|NCT01821859|Oregon Health and Science University|Tanja Pejovic|503-494-5125|pejovict@ohsu.edu|
21297893|NCT00475709|St Jude Medical|Kelly Erickson|16517566580|kaerickson@sjm.com|
21297894|NCT04752358|Adaptimmune|Clinical Trials Management|+1 (215) 825-9260|clinicaltrials@adaptimmune.com|
21297895|NCT00684775|"Johns Hopkins School of Medicine: Department of Psychiatry"|Dr. Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
21297896|NCT00555672|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21297897|NCT06041919|Thirty Respiratory Ltd|Inva Hoti|+44 (0) 1235 431200|Inva.Hoti@30.technology|
21297898|NCT04211441|Medtronic, Inc|Director of Clinical Research|800-328-2518|medttroniccastrials@medtronic.com|
21297899|NCT02465372|Wake Forest University Health Sciences|Dr. Justin Moore|336-716-3702|jusmoore@wakehealth.edu|
21297900|NCT01147055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21297901|NCT02186665|Galderma|Michael Graeber|(817)961-5000|michael.graeber@galderma.com|
21297902|NCT01151371|Vistakon|Kathy Lorenz-Osborn, OD|+1 904 443-1032|kosborn@its.jnj.com|
21297903|NCT02023996|Memorial Sloan Kettering Cancer Center|Dr. Neeta Pandit-Taskar, MD|212-639-3046|pandit-n@MSKCC.ORG|
21297904|NCT03400176|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21297905|NCT01561053|Grifols|AMBAR clinical manager|+34 935712200|AMBARclinical@grifols.com|
21297906|NCT02211456|Oxford University Hospitals NHS FT|Dr James Gamble|00441865221012|james.gamble@ouh.nhs.uk|
21297907|NCT01090063|Tufts Medical Center|Dr. Alice Gottlieb|617-636-7462|Agottlieb@tuftsmedicalcenter.org|
21297908|NCT00874848|Biothera|Jamie Lowe, Vice President, Clinical Development|651-256-4653|jlowe@biothera.com|
21297909|NCT02326233|Samsung Bioepis Co., Ltd.|Director of Clinical Trials||sbregistry@samsung.com|
21297910|NCT03202134|AZSintJanAV|Jan Mulier|003250452490|jan.mulier@azsintjan.be|
21297911|NCT00966550|Illinois Institute of Technology|Dr. Britt Burton-Freeman|312-567-5307|bburton@iit.edu|
21297912|NCT04698993|Draegerwerk AG & Co. KGaA|Dr Rainer Polzius|+498824514429|rainer.polzius@draeger.com|
21297913|NCT01371734|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21297914|NCT00206440|Baylor College of Medicine|Mothaffar Rimawi|713 798 1999|rimawi@bcm.tmc.edu|
21297915|NCT00958165|CardioFocus, Inc|Burke T. Barrett|508 658-7200|bbarrett@cardiofocus.com|
21297916|NCT01298765|BIODELIVERY|Vice President, Operations|919-582-0294|twarneke@bdsi.com|
21297917|NCT03565237|Takeda|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
21297918|NCT02467842|SK bioscience|Hayoung Lee|+82-2-2008-2552|haylee@sk.com|
21297919|NCT01140061|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21251937|NCT00224029|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
21297920|NCT00952393|University of Colorado|Dr. Robert Freedman|3037244940|Robert.Freedman@ucdenver.edu|
21297921|NCT00428389|Novartis Pharmaceuticals|Study Director|862-778-8300||
21297922|NCT04090242|Becton Dickinson|Edward Mahoney|978-901-7248|Edward.Mahoney@bd.com|
21297923|NCT02687581|State University of New York College of Optometry|Dr. Jingyun Wang|212-938-5759|jwang@sunyopt.edu|
21297924|NCT01340573|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21297925|NCT01019369|Baylor College of Medicine|Anitra Beasley, MD, MPH|832-826-7318|anitra.beasley@bcm.edu|
21297926|NCT01098305|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@mail.med.upenn.edu|
21297927|NCT00172042|Novartis Pharmaceuticals|Study Director|862-778-8300||
21297928|NCT01979133|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD|2146466948|sherwood.brown@utsouthwestern.edu|
21297929|NCT02859441|National Institutes of Health|Henry E Wiley, M.D., Principal Investigator, NEI|301-496-6583|wileyhe@nei.nih.gov|
21297930|NCT04338971|Neurolutions|Director of Clinical Affairs|831-316-5466|lsouders@neurolutions.com|
21297931|NCT04371666|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG3019-093DMDStudy@fibrogen.com|
21297932|NCT02092025|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21297933|NCT02927938|Levine Cancer Institute|Dr. James Symanowski; Chair, Department of Cancer Biostatistics|9804422371|james.symanowski@atriumhealth.org|
21297934|NCT00264537|Centocor Research & Development, Inc.|Director Clinical Research|1-800-457-6399||
21297935|NCT02834247|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21297936|NCT00811174|Octapharma|Michael Eppolito|201-604-1155|michael.eppolito@octapharma.com|
21297937|NCT01938040|Rutgers/State University of New Jersey (NJMS)|Alex Bekker, MD, PhD|973 972-5007|bekkeray@njms.rutgers.edu|
21297938|NCT00108862|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21297939|NCT01137032|Fougera Pharmaceuticals Inc.|Angela C. Kaplan, Associate Director Clinical Development|631-659-2256|angela.kaplan@sandoz.com|
21297940|NCT01076036|Corindus, Inc|Michail M. Pankratov, MD, PhD, Vice President of Clinical & Regulatory Affairs|508-653-3335|Michail.Pankratov@Corindus.com|206
21297941|NCT01345188|Midwest Cardiovascular Research Foundation|Dr Nicolas W Shammas|5633242828|shammas@mchsi.com|
21297942|NCT04526145|Ohio State University|Dr. Kathy Wright|614-292-0309|wright.2104@osu.edu|
21297943|NCT04477759|Medical College of Wisconsin|Musaddiq Awan, MD|414-805-4497|mawan@mcw.edu|
21297944|NCT03364738|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
21297945|NCT03245398|Swiss Tropical and Public Health Institute|Dr Jennifer Keiser|+41 61 284 8218|jennifer.keiser@swisstph.ch|
21297946|NCT02576795|BioMarin (UK) Ltd|Konstantia-Maria Chavele, PhD, Director, Clinical Sciences|+44 207-4203351|KonstantiaMaria.Chavele@bmrn.com|
21297947|NCT01702246|UCSF Benioff Children's Hospital Oakland|Dr. Carolyn Hoppe|(510)428-3193|choppe@mail.cho.org|
21297948|NCT01518374|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
21297949|NCT02123823|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21297950|NCT01870505|Memorial Sloan Kettering Cancer Center|Dr. Sarat Chandarlapaty, MD, PhD|646-888-4311|ChandarS@MSKCC.ORG|
21297951|NCT00465452|The University of Toledo|Julia Spears|419-383-6728|julia.spears@utoledo.edu|
21297952|NCT02687139|Johns Hopkins University|Mohamad Allaf, MD|410-502-7710|mallaf@jhmi.edu|
21297953|NCT03254940|Duke University|Dr. Gary G. Bennett (PI/Dean of Trinity College of Arts & Sciences)|(919) 808-7821|gary.bennett@duke.edu|
21297954|NCT01635855|Merz Pharmaceuticals North America|Merz Pharmaceuticals North America|800-334-0514|clinicaltrials@merzusa.com|
21297955|NCT03190460|University of Washington School of Nursing|Dr. Hilaire Thompson|2066165641|hilairet@uw.edu|
21297956|NCT01350245|Thomas Jefferson University|Dolores Grosso, CRNP, DNP|215-955-8874|Dolores.Grosso@jefferson.edu|
21297957|NCT03828019|JHSPH Center for Clinical Trials|Elizabeth E. Sugar|410-614-7837|esugar2@jhu.edu|
21297958|NCT05715242|Stanford University School of Medicine|Michele L. Patel, PhD|650-549-7047|michele.patel@stanford.edu|
21297959|NCT02652468|University of Madison Carbone Cancer Center|Vaishalee Kenkre|(608) 263-1699|vpkenkre@medicine.wisc.edu|
21297960|NCT02910102|Axovant Sciences, Inc.|Director, Clinical Development|1-833-296-8268|clinicaltrials@axovant.com|
21297961|NCT02021955|VA Puget Sound Health Care Sysem|Margaret Collins|206.764.2085|margaret.collins@va.gov|
21297962|NCT04384523|Wuhan Healthgen Biotechnology Corp.|Daichang Yang|18602708398|dyang@oryzogen.com|
21297963|NCT04565951|Center to Improve Veteran Involvement in Care (CIVIC), HSR&D Center of Innovation, VA Portland Health Care System|Dr. Alan Teo|503-220-8262|alan.teo@va.gov|52461
21297964|NCT02748928|Syneron Medical|Director of Clinical Affairs|+972-73-2442347|shlomitm@syneron-candela.com|
21297965|NCT04677504|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21297966|NCT03182907|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21297967|NCT02109809|Wake Forest University Health Sciences|Dr. Gordon Phillips|336-716-0659|gophilli@wakehealth.edu|
21297968|NCT03771274|Carolina Eyecare Physicians, LLC|Director of Research|8438813937|helga.sandoval@carolinaeyecare.com|
21297969|NCT02815644|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21297970|NCT00384332|University of Alabama at Birmingham|Candace Cromer|2059753442|clreed@uab.edu|
21297971|NCT01771250|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21297972|NCT02058563|GlaxoSmithKline|GSK Response Center|866-435-7343||
21297973|NCT00483938|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21251938|NCT00020722|Barbara Ann Karmanos Cancer Institute|Lawrence G. Lum, M.D., D.Sc|(313) 576-8326|luml@karmanos.org|
21297974|NCT01718444|UIC|Albert Asante, MD MPH|3123552634|akdasante@yahoo.com|
21297975|NCT04039217|Emory University|Dr. Colleen Kelley|404-712-1823|colleen.kelley@emory.edu|
21236663|NCT03073603|University of Colorado School of Medicine|John R. Corboy, MD|13037242187|john.corboy@cuanschutz.edu|
21236664|NCT03701555|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21236665|NCT04757649|San Diego State University|Dr. Aaron Blashill|619-594-2245|ajblashill@sdsu.edu|
21236666|NCT03750487|Partnership to End Addiction|Sarah Dauber, Vice President|212-841-5270|sdauber@toendaddiction.org|
21236667|NCT00344682|UMass Medical School|Dr. Kristina Deligiannidis|508-856-5928|kristina.deligiannidis@umassmemorial.org|
21236668|NCT02508311|James J Peters VA Medical Center|Gregory Schilero|7185849000|gregory.schilero@va.gov|6701
21236669|NCT04955639|Pivot Health Technologies Inc.|Craig Fujii, Sr. Director of Clinical Affairs and Data Science|650-906-4255|craig@pivot.co|
21236670|NCT04447404|DURECT Corporation|Executive Director, Regulatory Affairs|408-777-1417|jill.burns@durect.com|
21236671|NCT00413153|Massachusetts General Hospital|Steven K. Grinspoon, MD|617-724-9109|sgrinspoon@partners.org|
21236672|NCT02962687|Durham VA HSR&D|Susan N Hastings|919-286-6986|susan.hastings@va.gov|
21236673|NCT00454051|Novartis Pharmaceuticals|Study Director|862-778-8300||
21236674|NCT02097472|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
21236675|NCT00924885|Vitrolife|Director of clinical investigations|0046708228063|thardarson@vitrolife.com|
21236676|NCT02862106|Institute of Immunology，PLA|Dr.Wu|02368752230|wuyuzhang@yahoo.com|86
21236677|NCT03966157|Saint Louis University|Dr. Samuel J. Burton|3147500811|s.burton.1818@gmail.com|
21236678|NCT02995967|UAB|Joseph Malek|2059965466|jmalek@uabmc.edu|
21236679|NCT01221597|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
21236680|NCT03305016|Ascendis Pharma, Inc.|Aimee D Shu, MD|+1 650 352 8389|ADS@ascendispharma.com|
21236681|NCT02504073|Kantonsspital Baselland Standort Bruderholz|Alexandra Bellwald|0041797429755|alexandra.bellwald@ksbl.ch|
21236682|NCT04420689|Alume Biosciences|Chief Medical Officer|858-922-3966|brett.berman@alumebiosciences.com|
21236683|NCT04323852|Shahid Beheshti Medical School|Dr. ََAfshin Zarghi|021-22439781|Mpajouhesh@sbmu.ac.ir|
21236684|NCT04022668|Yeditepe University|Emre Aslanger|0216578000|mr_aslanger@hotmail.com|4240
21236685|NCT02278328|Children's Hospital of Philadelphia|Timothy Roberts, Professor|267 426 0307|robertstim@email.chop.edu|
21236686|NCT00377676|VeroScience|Richard Scranton|401 816-0525|richard_scranton@veroscience.com|
21236687|NCT03834779|UT Southwestern Medical Center|Dr. Ank Nijhawan|214-648-2777|ank.nijhawan@utsouthwestern.edu|
21236688|NCT00574587|Montefiore Medical Center|Markenya Mirander|718-862-8840|MMIRANDE@montefiore.org|
21236689|NCT02040116|Wake Forest Baptist Medical Center|LeAnne Kennedy|336-713-3400|lakenned@wakehealth.edu|
21236690|NCT01519206|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
21236691|NCT02014116|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21236692|NCT01470027|Weill Cornell Medicine|Dr. Dikoma C. Shungu, Professor of Physics in Radiology|2127462481|dcs7001@med.cornell.edu|
21236693|NCT01040130|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21236694|NCT01972061|University of Pittsburgh|Dr. Christopher Chermansky|412-6418385|chermanskycj2@upmc.edu|
21236695|NCT00412087|Medical University of South Carolina|Dr. Carol Wagner|18437922112|wagnercl@musc.edu|
21236696|NCT01618864|Iluminage|Director of Clinical Affairs|+972 547 800 260|doranr@iluminagebeauty.com|
21236697|NCT01109992|Brigham and Women's Hospital|Sharmila Dorbala|617-732-6215|sdorbala@partners.org|
21236698|NCT01805297|Dean McGee Eye Institute|Robert E. Leonard, II, MD|405-271-6060|sonny-icks@dmei.org|
21236699|NCT00690755|James A. Haley VA Research Department|Robert Farese, MD|813-972-2000|Robert.Farese@va.gov|
21236700|NCT04287920|Mayo Clinic|Douglas (Doug) A. Simonetto, M.D.|507-284-4824|Simonetto.Douglas@mayo.edu|
21236701|NCT00958035|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21236702|NCT02952924|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21236703|NCT03085563|Children's Hospital Colorado|Paul Szefler, MD, FAAP|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
21236704|NCT01435577|Grünenthal GmbH|Director of Clinical Trials|+241 569 3223||
21236705|NCT03585244|Foundation for Prader-Willi Research|Theresa Strong, PhD - Director of Research Programs|888-322-5487|theresa.strong@fpwr.org|702
21236706|NCT02830594|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
21236707|NCT01934218|Seikagaku Corporation|Clinical Development Dept.|(81)3-5220-8948|yuko.shibata@seikagaku.co.jp|
21236708|NCT04575428|Duke University|Marat Fudim, MD, MHS|919-684-1284|marat.fudim@duke.edu|
21236709|NCT02955511|Cedars Sinai Medical Center|Dr. Ofelia Loani Elvir Lazo, Research Project Advisor|3104231682|ofelia.elvir-lazo@cshs.org|
21236710|NCT03273946|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21236711|NCT01220557|Forschungsinstitut der Diabetes Akademie Mergentheim|Norbert Hermanns, PhD|+49 7931 594|hermanns@diabetes-zentrum.de|553
21236712|NCT00430768|UMASS Medical School|Dr. Terry Flotte|(508) 856-2107|Terry.Flotte@umassmed.edu|
21251939|NCT04016272|Florida State University|Dr. Hyochol Ahn|850-644-2647|hahn@fsu.edu|
21282806|NCT03452488|Biophytis S.A.|Cendrine Tourette|+331 44 27 33 00|cendrine.tourette@biophytis.com|
21282807|NCT00565643|Lehigh Valley Health Network|Daniel Kiefer|484-664-7521|daniel_g.kiefer@lvhn.org|
21282808|NCT04016779|Supernus|Joseph Hull, Ph.D., Director Clinical research|240-403-5324|jhull@supernus.com|
21282809|NCT00623935|University of Michigan Comprehensive Cancer Center|Dr. Gregory Yanik, M.D.|734-936-8785|gyanik@umich.edu|
21282810|NCT00747474|Taiwan Liposome Company, Ltd.|Shu Chi Hsu|650-872-8816|shuchi@tlcbio.com|102
21282811|NCT01590121|Imperial College London|Dr. Claire Shovlin, Principal Investigator|+44 208 383 1178|c.shovlin@imperial.ac.uk|
21282812|NCT02829723|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21282813|NCT03514485|Children's Hospital of Philadelphia|Tyra Bryant-Stephens, MD|215-590-5261|stephenst@chop.edu|
21236713|NCT00762320|Phoenix Children's Hospital|Laura Clarke-Steffen, PhD, RN|602-933-0234|lclarke@choenixchildrens.com|
21282814|NCT03075891|Galderma|Rajeev Chavda|0033492382928|rajeev.chavda@galderma.com|
21236714|NCT02199028|Stanford University|Dr Bruce Buckingham|(408) 356-0911|buckingham@stanford.edu|
21236715|NCT00867217|University of Kansas Medical Center|Dr. Bruce Kimler|(913) 588-4523|bkimler@kumc.edu|
21236716|NCT01881126|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21236717|NCT01760239|HealthPartners Institute|Elyse Kharbanda, MD MPH|952-967-5038|Elyse.O.Kharbanda@healthpartners.com|
21236718|NCT01983293|Abbott|Clay Cohorn|1 972 309 8087|clay.cohorn@abbott.com|
21236719|NCT03147248|Celltrion. Inc.|SungHyun Kim|+82 32 850 5778|SungHyun.Kim@celltrion.com|
21236720|NCT03750552|Theravance Biopharma Inc|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
21236721|NCT02062632|Mayo Clinic|Terence T. Sio, MD, MS|507/284-2511|sio.terence@mayo.edu|
21236722|NCT02156674|Masonic Cancer Center, University of Minnesota|Elizabeth Braunlin MD, PhD|612 626 2755|braun002@umn.edu|
21236723|NCT00773968|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21236724|NCT01562756|Palmer College of Chiropractic|Ting Xia, PhD (Principal Investigator)|563-884-5161|Ting.Xia@palmer.edu|
21236725|NCT04517396|University of Pennsylvania|Katherine Greene|215-662-7580|katherine.greene@pennmedicine.upenn.edu|
21236726|NCT02008890|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21236727|NCT02207816|GlaxoSmithKline|GSK Response Center|866-435-7343|cc781166@gsk.com|
21236728|NCT05912400|University of Arkansas for Medical Sciences|I-Shin Wen|5016868274|IWen@uams.edu|24024
21236729|NCT02522494|Jesse Brown VA Medical Center|Howard S. Gordon, MD|(312) 569-7331|howard.gordon2@va.gov|
21236730|NCT03240588|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
21236731|NCT01449305|isRed Pharma & Biotech Research Corporation|Mirror Hsieh|886-8-7628188|mingrong@bioisred.com|
21236732|NCT01259713|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21236733|NCT02091726|University of New England|Peter S. Millard, MD, PhD|2072992131|pmillard@mac.com|
21236734|NCT06111742|Boston Children's Hospital, Harvard Medical School|Harrison Pravder|516-426-8166|hpravder@meei.harvard.edu|
21236735|NCT03461003|The University of Texas Health Science Center at Houston|Joyce P Samuel, MD, MS|713-500-6708|joyce.samuel@uth.tmc.edu|
21236736|NCT01914926|Maimonides Medical Center|Christian Fromm, MD; Director of Research|718-283-6391|cfromm@maimonidesmed.org|
21236737|NCT01227681|Buddhist Tzu Chi General Hospital Hualien|Dr. Chen Shin-Yuan|+886-3-8561825|william.sychen@msa.hinet.net|2151
21236738|NCT02047045|Guang'anmen Hospital, China Academy Chinese Medical Sciences|Zhishun Liu|+86 010 88002331|liuzhishun@aliyun.com|
21236739|NCT03508843|University of Alabama at Birmingham|Dr David Schwebel|1-205-934-8745|schwebel@uab.edu|
21236740|NCT03555396|Columbia University|Dr. Alissa Davis|212-851-2224|ad3324@columbia.edu|
21236741|NCT02536508|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|1-877-240-9479|information.center@astrazeneca.com|
21236742|NCT01889420|University of New Mexico|Dulcinea Quintana, MD|505-272-4661|dcandelaria@salud.unm.edu|
21236743|NCT04829344|American Genomics, LLC|Michelle Widmann|919-600-1819|mwidmann@calclinicalsolutions.com|
21236744|NCT03814889|Stanford University|Allison Okamura|(650) 723-3148|aokamura@stanford.edu|
21236745|NCT00922428|Pascoe pharmazeutische Präparate GmbH|Anja Braschoss|0049 641 7960100|KlinischeForschung@pascoe.de|
21236746|NCT03403725|Menarini Ricerche SPA|Corporate Director of Clinical Sciences|+39 055 56809933|acapriati@menarini-ricerche.it|
21236747|NCT00546728|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
21236748|NCT00373334|Braintree Laboratories, Inc.|Clinical Operations Manager|781-843-2202|jmcgowan@braintreelabs.com|
21236749|NCT04862143|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
21236750|NCT02103439|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28|linkova@biocad.ru|930
21236751|NCT02370602|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21236752|NCT02606838|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
21236753|NCT02898974|Colorado State University|Manager of Research Operations|9704912242|Laurie.Biela@colostate.edu|
21236754|NCT02864082|Timber Pharmaceuticals|Alan Mendelsohn, MD|2673004249|amendelsohn@timberpharma.com|
21236755|NCT05725005|Asceneuron SA|Asceneuron Clinical Research|+ 41 21 353 8245|clinicaltrials.gov@asceneuron.com|
21282815|NCT01813214|Lombardi Comprehensive Cancer Center|Dr Michael Atkins|202-687-2795|mba41@georgetown.edu|
21236756|NCT02310750|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21236757|NCT01226745|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21236758|NCT01298128|Mount Sinai Hospital|Dr. Kimberly Liu|416-586-5367|kliu@mtsinai.on.ca|
21236759|NCT01090453|GlaxoSmithKline|GSK Response Center|866-435-7343||
21236760|NCT00522275|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
21236761|NCT05045625|Albany Medical College|Clinical Research Coordinator|518-262-2367|khazeno@amc.edu|
21282816|NCT05229952|University of Alabama at Birmingham|Dr Sonia Fargue|2059756932|sfargue@uab.edu|
21236762|NCT03867734|University of Washington|Lindley A. Barbee, MD, MPH|206-744-2595|lbarbee@uw.edu|
21282817|NCT00179673|Celgene Corporation|Senior Manager, Clinical Trials Disclosure|888-260-1599|clinicaltrialdisclosure@celgene.com|
21236763|NCT00718718|Janssen Research & Development, LLC|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
21236764|NCT02467777|Fox Valley Orthopaedic Institute|Vishal Mehta|6305841400|vmehta@fvortho.com|
21236765|NCT02276482|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21236766|NCT00253864|Ottawa Hospital Research Institute|Clinical Research Coordinator|613-737-8899|kmcilquham@ohri.ca|79839
21236767|NCT04697758|AsclepiX Therapeutics|Dr A Shojaei|8005723545|ashojaei@asclepix.com|
21236768|NCT00360529|Sprout Pharmaceuticals|Sprout Pharmaceuticals|1-919-882-0850|clinicaltrials@sproutpharma.com|
21251423|NCT02270671|University College Dublin|Dr Amanda Fitzgerald|+35317168541|amanda.fitzgerald@ucd.ie|
21282818|NCT00492648|GlaxoSmithKline|GSK Response Center|866-435-7343||
21282819|NCT00282113|University of California Davis|Mark A. Underwood MD|916-734-5061|mark.underwood@ucdmc.ucdavis.edu|
21236769|NCT01629329|EINSTEIN MEDICAL CENTER|Kamran Mohiuddin, Director Clinical Research Emergency Department|2154562313|MOHIUDDK@EINSTEIN.EDU|
21236770|NCT01592643|Stanford University School of Medcine|Edward E. Manche|6507255765|edward.manche@stanford.edu|
21236771|NCT00110617|Novartis Pharmaceuticals|Study Director|862-778-8300||
21236772|NCT04764396|University of Michigan|Eileen Carpenter|734-615-3948|eicarpen@med.umich.edu|
21236773|NCT03708198|UVA Health|William Manson, MD|4349242283|wcm6m@virginia.edu|
21236774|NCT01781572|Pfizer|Study Director|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21236775|NCT01218438|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21236776|NCT03230916|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21282820|NCT02387957|Ophthotech Corp.|Denise Teuber|646-753-8461|denise.teuber@ophthotech.com|
21236777|NCT00383448|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|612-626-2313|orcha001@umn.edu|
21236778|NCT00045110|Adult Brain Tumor Consortium|Lauren E Abrey, MD|410-955-8837|jfisher@jhmi.edu|
21236779|NCT01932164|Hospital Sirio Libanes|Dra Daniela Franco Bueno|+5511997900159|dbuenousp@gmail.com|
21236780|NCT02587351|University of Minnesota|John Connett|612-626-9010|john-c@umn.edu|
21236781|NCT01438541|Molnlycke Health Care AB|Tina Kjellén|+46317223098|tina.kjellen@molnlycke.com|
21236782|NCT02091167|Federal University of Espírito Santo|Dr. Ester Miyuki Nakamura-Palacios, Coordinator of Clinical Trials|+55 27 3335-7337|emnpalacios@gmail.com|
21236783|NCT01218646|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21236784|NCT00722761|MGH Curtis|Alexa B. Kimball|617-726-5066|harvardskinstudies@partners.org|
21236785|NCT04198662|University of California, San Diego|Brian M. Ilfeld, MD, MS|(858) 822-0776|bilfeld@health.ucsd.edu|
21236786|NCT02693665|Children's National Medical Center|Dr. Maureen E. Lyon, PhD, Professor of Pediatrics, Principal Investigator|703-346-2873|mlyon@childrensnational.org|
21236787|NCT03096782|University of Texas MD Anderson Cancer Center|Amanda Olson, MD / Stem Cell Transplantation|713-745-1505|alolson@mdanderson.org|
21236788|NCT03662750|Imperial College London|Prof Roland Veltkamp|020 3311 7296|r.veltkamp@imperial.ac.uk|
21236789|NCT03156023|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21236790|NCT01496352|Dr. Reddy's Laboratories, Inc.|Kent Allenby, MD, VP, Drug Development|609-375-9855|kallenby@drreddys.com|
21236791|NCT05872035|Apple|Rajiv Kumar, MD|8669055303|htclinicalquestions@apple.com|
21236792|NCT05819749|Hennepin Healthcare Research Institute|Katherine Diaz Vickery|612-873-6852|katherine.vickery@hcmed.org|
21236793|NCT04560166|Y-mAbs Therapeutics|Chief Operating Officer|+4570261414|clinicaltrials@ymabs.com|
21236794|NCT00976599|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21236795|NCT00844857|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21236796|NCT00570674|Dana-Farber Cancer Institute|Roy B. Tishler, MD|617.632.5734|RTISHLER@LROC.HARVARD.EDU|
21236797|NCT03069482|Duke University Psychiatry & Behavioral Sciences|Dr. Roger Vilardaga|9196813441|roger.vilardaga@duke.edu|
21236798|NCT01641978|Hospital Universitario de Getafe|Susana Arias Rivera|+34916839360|susana.arias@salud.madrid.org|2459
21236799|NCT02358603|Department of Cardiology, Ruijin Hospital Luwan Branch, Shanghai Jiao Tong University School of Medicine|Dr. Zhao, Jianrong||drzjr@126.com|
21236800|NCT03576547|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani, MD./Professor|713-745-0394|fravandi@mdanderson.org|
21236801|NCT01461668|University of California Irvine|Raveena Singh|949-824-9285|ravsingh@uci.edu|
21236802|NCT01912612|University of Michigan Rogel Cancer Center|Lynn Henry, MD, PhD|734-936-9868|norahh@med.umich.edu|
21236803|NCT01009931|Rutgers Cancer Institute of New Jersey|Tatiana Zelinskaya|(732) 235-9837|zelinsta@cinj.rutgers.edu|
21236804|NCT00581230|UT Medical School at Houston|Carin A. Hagberg|713-500-6222|carin.a.hagberg@uth.tmc.edu|
21236805|NCT03165526|Abbott Medical Device|Courtney Weiler|224 430 4918|ClinicalTrials.gov_SH_Inquiries@abbott.com|
21236806|NCT02349295|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21236807|NCT03248739|Wake Forest University School of Medicine|Kyle Fargen|336-716-8641|kfargen@wakehealth.edu|
21236808|NCT01780922|Washington State Unviversity|Boon P. Chew|5093351427|boonchew@wsu.edu|
21236809|NCT00620750|New York University School of Medicine|Marc Gourevitch, MD, MPH|212-263-8553|marc.gourevitch@nyumc.org|
21236810|NCT00852631|AstraZeneca|Gerard Lynch||clinicaltrialtransparency@astrazeneca.com|
21236811|NCT04717596|Abigail Wexner Research Institute|Dr. Elise Berlan|6147222458|elise.berlan@nationwidechildrens.org|
21236812|NCT00765843|Rosalind Franklin University of Medicine and Science|Ryan Crews|847-578-8437|ryan.crews@rosalindfranklin.edu|
21236813|NCT04066114|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21236814|NCT02564523|Janssen Vaccines & Prevention B.V|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21236815|NCT00448539|Eisai Inc.|Eisai Medical Information|1 8882472378|esi_medinfo@eisai.com|
21236816|NCT03349710|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21236817|NCT00695903|Cubist Pharmaceuticals|Medical Director||ellie.hershberger@cubist.com|
21236818|NCT02696317|Alcon, A Novartis Division|Sr. Brand Lead, Global Medical Affairs, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21236819|NCT01343368|Masonic Cancer Center, University of Minnesota|Dr. Angela Smith|612-626-8094|smith719@umn.edu|
21236820|NCT04256733|University of Montana|Dr. Laurie Slovarp|406-243-2107|laurie.slovarp@umontana.edu|
21236821|NCT04542343|CHARLES R. DREW UNIVERSITY OF MEDICINE AND SCIENCE|DR. MOHSEN BAZARGAN|323-357-3655|mohsenbazargan@cdrewu.edu|
21236822|NCT00237744|Malcom Randall VA Medical Center, Gainesville Florida|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center|(352) 376-1611|jjd17@case.edu|6603
21236823|NCT02539342|Medical College of Wisconsin|Michael J Burke, MD|414-955-4170|mmburke@mcw.edu|
21282821|NCT02887248|Sarah Cannon Development Innovations, LLC|Sarah Cannon|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
21251940|NCT00884897|Maryland Psychiatric Research Center|Deanna L. Kelly Pharm.D., BCPP|410-402-96860|dkelly@mprc.umaryland.edu|
21251941|NCT03306420|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21251942|NCT00763451|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21251943|NCT01827046|Johns Hopkins University Division of Brain Injury Outcomes|Dr. Daniel F. Hanley|4106146996|dhanley@jhmi.edu|
21251944|NCT00763490|University of Michigan Comprehensive Cancer Center|Dr. Daniel Couriel, M.D.|734-936-8785|dcouriel@umich.edu|
21251945|NCT01473992|University of South Florida|M. Jason Highsmith|8139743806|mhighsmi@health.usf.edu|
21251946|NCT02357264|Maimonides Medical Center|Eitan Dickman, MD|718-283-6057|edickman@maimonidesmed.org|
21251947|NCT03623373|Washington University School of Medicine|Brad S. Kahl, M.D.|314-273-3591|bkahl@wustl.edu|
21251948|NCT02282917|Mass General Brigham|Matthew E Stenerson, MSc, Clinical Research Project Manager|7155721100|matthew_stenerson@meei.harvard.edu|
21251949|NCT00115336|Cincinnati Children's Hospital Medical Center|Dr. Charles Quinn|5138033086|charles.quinn@cchmc.org|
21251950|NCT02482610|The Ohio State University|Richard Bruno, PhD, RD|6142925522|bruno.27@osu.edu|
21251951|NCT03272711|Washington University School of Medicine|Dr. Eric Lenze|314-362-1671|lenzee@wustl.edu|
21251952|NCT02165826|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21251953|NCT03698019|SWOG Statistics and Data Management Center|Melanoma Committee Statistician|2066674623|jmoon@fredhutch.org|
21251954|NCT03569891|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
21251955|NCT02176863|Instituto Grifols, S.A.|Sandra Camprubi, PhD/Senior Director, Clinical Operations|+34 67 0923160|sandra.camprubi@grifols.com|
21251956|NCT01527162|Seattle Children's Research Institute|Kristie Bjornson, PhD, PT|206 884-2066|kristie.bjornson@seattlechildrens.org|
21251957|NCT03987295|Alector|Alector Medical Information|650-826-2454|medinfo@alector.com|
21251958|NCT02419417|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21251959|NCT01240551|National Cancer Institute|Dr. Karen Kurdziel|301-443-0622|kurdziek@mail.nih.gov|
21251960|NCT00159263|Imperial College London|Peter Barnes|+44 (0)20 7594 7959|p.j.barnes@imperial.ac.uk|
21251961|NCT03945773|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
21251962|NCT00725712|GlaxoSmithKline|GSK Response Center|866-435-7343||
21251963|NCT01515943|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
21251964|NCT03941600|Washington University School of Medicine|Dr. Kerri Morgan|314-286-1659|morgank@wustl.edu|
21251965|NCT04024462|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21251966|NCT00580489|Metrohealth Medical Center|Charles Emerman|2167783577|cemerman@metrohealth.org|
21251967|NCT01673022|Indiana University School of Medicine|Research Coordinator|317-944-2654|jmvinter@iupui.edu|
21251968|NCT05687032|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21251969|NCT02134717|University of Pittsburgh|Kevin Gibson MD|412-624-7095|gibsonkf@upmc.edu|
21251970|NCT02330094|Mayo Clinic|Dr. William D. Freeman|904-953-7103|freeman.william1@mayo.edu|
21282822|NCT02397122|Kirikkale University|Dr. H. Gencay Keceli|+905326714377|monsieur_gencay@yahoo.com|
21282823|NCT01500187|University of Health Science Center|Franklin Garcia-Godoy DDDS, MS PhD||fgarciagodoy@gmail.com|
21282824|NCT02521051|Massachusetts General Hospital|Justin Gainor, MD|617-724-4000|jgainor@partners.org|
21282825|NCT05819086|University of Wisconsin School of Medicine and Public Health Center for Tobacco Research and Intervention|Regulatory Manager|608-262-7568|mark.zehner@ctri.wisc.edu|
21282826|NCT00926848|University of Nebraska Medical Center|Bernice Yates|402-861-1713|bcyates@unmc.edu|
21282827|NCT04192071|University of Florida|Melissa Vilaro, Assistant Professor|352-2733525|mgraveley@ufl.edu|
21282828|NCT00604591|Columbia University|Edward D. Huey, MD|212-305-1134|edh2126@cumc.columbia.edu|
21282829|NCT04740827|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21282830|NCT02147158|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21282831|NCT00940823|Prism Eye Institute|Dr. Iqbal Ike K. Ahmed|905-456-3937|ike.ahmed@utoronto.ca|
21282832|NCT02863445|Oregon Health and Science University|Dr. Alison Edelman|503-494-3666|edelmana@ohsu.edu|
21282833|NCT04520997|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
21282834|NCT03689374|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21282835|NCT00860249|Northwestern University, Department of General Internal Medicine|Kenzie A. Cameron, PhD, MPH|312-503-3910|K-Cameron@northwestern.edu|
21282836|NCT00743288|Oncotherapeutics|Director, Clinical Operations|323-623-1200|lthulin@oncotherapeutics.com|
21282837|NCT00519428|NYSPInstitute|Jonathan W. Stewart, M.D.|212-543-5745|jws6@columbia.edu|
21282838|NCT00688701|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21282839|NCT00029536|Beth Israel Deaconess Medical Center|Dr. Andrew G. Herzog|781-431-0277|aherzog@bidmc.harvard.edu|
21282840|NCT01953874|ResMed|Adam Benjafield|(858)836-6782|adam.benjafield@resmed.com|
21282841|NCT00811317|Massachusetts General Hospital|Steven Russell|6177261848|sjrussell@mgh.harvard.edu|
21282842|NCT01168908|Kennedy Krieger Institute|Kathryn Wagner, MD, PhD|443-923-9525|wagnerk@kennedykrieger.org|
21282843|NCT01275755|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
21282844|NCT03653351|Washington University in Saint Louis|Eric Lenze MD|314-362-5154|lenzee@wustl.edu|
21251971|NCT00708851|Psoriasis Treatment Center of Central New Jersey|Jerry Bagel, MD|609-443-4501|dreamacres1@aol.com|
21251972|NCT02866669|University of Alabama at Birmingham|Dr. Andrea Cherrington|205-996-2885|acherrington@uabmc.edu|
21251973|NCT01437423|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21282845|NCT04420585|Montefiore Medical Center|Dr. Kerry Morrone|718-741-2342|kmorrone@montefiore.org|
21282846|NCT02715700|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21282847|NCT00477750|Mayo Clinic|Dr. Vivek Roy||roy.vivek@mayo.edu|
21251974|NCT03792347|Ruijin Hospital, Shanghai JiaoTong University School of Medicine|Prof. Hecheng Li, Chair of Thoracic Surgery|(86)13917113402|lihecheng2000@hotmail.com|
21251975|NCT02743897|Perelman School of Medicine|Dr. Peter Reese|215-900-3782|amussell@upenn.edu|
21251976|NCT01392703|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21251977|NCT03912662|Medtronic|Marion Blanc|+33 4 74 08 90 00|marion.blanc@medtronic.com|
21251978|NCT01236378|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21251979|NCT03724253|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21251980|NCT03343093|University of Minnesota|Gudrun Kilian|612-626-9568|kilian@umn.edu|
21251981|NCT01790295|Icahn School of Medicine at Mount Sinai|Dr. John Mascarenhas|212-241-3417|john.mascarenhas@mssm.edu|
21251982|NCT02224469|University Medical Center Utrecht|Dr E.J. Aarnoutse|+31887555123|e.j.aarnoutse@umcutrecht.nl|
21251983|NCT01821105|The Ohio State University|Edward Martin, MD|614-293-8843|Edward.Martin@osumc.edu|
21251984|NCT03080142|UC Davis Medical Center, Department of Anesthesiology|Jon Zhou MD|9167035028|jonzhou@ucdavis.edu|
21251985|NCT00325598|Washington University School of Medicine|Imran Zoberi, M.D.|314-362-8525|izoberi@radonc.wustl.edu|
21251986|NCT00607672|Vanderbilt University School of Medicine|Dr. Mias Pretorius|16153430665|mias.pretorius@vanderbilt.edu|
21251987|NCT03218566|Penumbra, Inc.|Erin Archard, Sr. Clinical Study Manager|+1 510 995 9801|earchard@penumbrainc.com|
21251988|NCT04937920|DermBiont, Inc|Emma Taylor, MD (Chief Medical Officer)|510-607-8155|emma@dermbiont.com|
21251989|NCT02872012|University of Michigan Kellogg Eye Center|Dr. Anjali Shah|734-763-8122|arshah@med.umich.edu|
21251990|NCT03000348|NovaBiotics Ltd|Dr Deborah O'Neil, CEO|01224 711 377|deborah@novabiotics.co.uk|
21251991|NCT00723125|BrUOG|William Sikov, MD|4018633000|Roxanne_Wood@brown.edu|
21251992|NCT01807182|Fred Hutchinson Cancer Center|Dr. Sylvia Lee|206-606-2274|smlee@fredhutch.org|
21251993|NCT00813982|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
21251994|NCT00478205|Eisai Call Center|Eisai Inc.|888-422-4743||
21251995|NCT01012947|Ajou University|Dr. Kang Soo Lee|821087812077|kpsimon@hanmail.net, antiaging@ajou.ac.kr|
21251996|NCT02127125|San Antonio Geriatric Research, Education, and Clinical Center|Dr. Nicolas Musi|(210) 562-6140|musi@uthscsa.edu|
21251997|NCT00855413|The University of North Carolina|Dr. Cynthia Gay|9198432726|cynthia_gay@med.unc.edu|
21251998|NCT00675584|Penn State Hershey College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu|
21251999|NCT03332784|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21252000|NCT01018732|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21252001|NCT00978562|OHSU KCI|Edward Neuwelt, MD|503-494-5626|huddlesa@ohsu.edu|
21252002|NCT03299959|Smith+Nephew, Inc|Senior Manager Clinical Compliance|07811407089|datasharing.gcs@smith-nephew.com|
21252003|NCT01310699|San Francisco VA Medical Center|Dr. Tonya Kaltenbach|415-221-4810|tonya.kaltenbach@va.gov|94121
21252004|NCT00926575|Soligenix, Inc.|Dhara Patel, Clinical Coordinator|609-538-8200|dpatel@soligenix.com|
21252005|NCT00490698|The University of Texas (UT) MD Anderson Cancer Center|Shi-Ming Tu, MD / Professor||CR_Study_Registration@mdanderson.org|
21252006|NCT00668785|West Coast Retina Medical Group, Inc.|J. Michael Jumper, MD|415-972-4600|jmjumper@westcoastretina.com|
21252007|NCT00469859|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21252008|NCT04124471|Children's Hospital of Philadelphia|Ignacio Tapia, MD|(267) 426-5842|tapia@chop.edu|
21252009|NCT06017050|Center for Innovative Public Health Research|Michele Ybarra|8773026858|michele@innovativepublichealth.org|801
21252010|NCT02394925|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, OD, MS, FAAO Sr. Principal Research Optometrist|904 443-3402|TKarkkai@its.jnj.com|
21252011|NCT03670277|Johnson & Johnson Vision Care|Xu Cheng, MD, PhD, FAAO - Sr. Principal Clinical Scientist|1-800-843-2020|xcheng6@its.jnj.com|
21252012|NCT02660112|Mayo Clinic|Ralitza H. Gavrilova, M.D.|507-293-1283|Gavrilova.Ralitza@mayo.edu|
21252013|NCT03459846|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21252014|NCT00001481|National Institute of Mental Health (NIMH)|Dr. Peter Schmidt|+1 301 496 6120|peterschmidt@mail.nih.gov|
21252015|NCT00310180|ECOG-ACRIN Cancer Research Group|ECOG-ACRIN statistician|617-632-3000|eatrials@jimmy.harvard.edu|
21252016|NCT02035696|Seqirus|Clinical Trial Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
21252017|NCT01882413|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21252018|NCT02358668|The Chinese University of Hong Kong|Dr Andrea Luk|852-26324276|andrealuk@cuhk.edu.hk|
21252019|NCT02104505|Center for Environmental Medicine, Asthma and Lung Biology; University of North Carolina, Chapel Hill|Allison Burbank, MD|919-843-2714|allison_burbank@med.unc.edu|
21252020|NCT01845805|Sidney Kimmel Cancer Center at Johns Hopkins|Nilofer Azad, MD|410-614-9169|nazad2@jhmi.edu|
21252021|NCT01317875|Incyte Corporation|Incyte Corporation Call Center, Study Director|1-855-463-3463|medinfo@incyte.com|
21252022|NCT01381575|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21252023|NCT01377389|UT MD Anderson Cancer Center|Aparicio,Ana,M.D. / Genitourinary Medical Oncology|713-792-7734|AAPARICIO@MDANDERSON.ORG|
21252024|NCT04546217|University of Alabama at Birmingham|Dr. Sarah dos Anjos|2059347323|smanjos@uab.edu|
21252025|NCT03020069|NYU Langone Health|Jeniece Ilkowitz RN, MA, CDE|212-263-9910|Jeniece.ilkowitz@nyulangone.org|
21252026|NCT05224843|Yale University|Fuad Abujarad|+1 (203) 737-5088|fuad.abujarad@yale.edu|
21252027|NCT03305887|Johnson & Johnson Medical Shanghai Ltd.|Xiaolei, Wang|+86 21 33378749|xwang183@its.jnj.com|
21252028|NCT01439867|Amgen Inc.|Study Director|866-572-6436||
21282848|NCT00601172|GlaxoSmithKline|GSK Response Center|866-435-7343||
21282849|NCT04434469|Genetech|Medical Communications|800-821-8590|genentech@druginfo.com|
21282850|NCT01579045|Vistakon/Johnson & Johnson Vision Care|Katherine Osborn Lorenz, OD MS|904-443-3123|kosborn@its.jnj.com|
21252029|NCT00863512|Duke University Medical Center|David Harpole, M.D.||david.harpole@duke.edu|
21252030|NCT03121820|GEROPHARM|GEROPHARM Clinical Leader|+7(812) 703-79-75|inform@geropharm.ru|
21252031|NCT01920932|St. Jude Children's Research Hospital|Matt Ehrhardt, MD|(901) 595-5913|matt.ehrhardt@stjude.org|
21297976|NCT00106353|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21252032|NCT02906020|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21252033|NCT01124097|BIAL - Portela & Cª S.A.|Director R&D|+351-229866100|clinical.trials@bial.com|
21252034|NCT00425607|Dana-Farber Cancer Institute|Dr. Mark Kieran|617-632-4907|mark_kieran@dfci.harvard.edu|
21252035|NCT00193479|Sarah Cannon Research Institute|John D. Hainsworth, MD|615-329-7274|jhainsworth@tnonc.com|
21297977|NCT01371552|Alcon Research, Ltd.|Joachim Nick, Dipl. Ing.|+49 6022 240 520|joachim.nick@cibavision.com|
21282851|NCT04184362|SFVA|Joannalyn Delacruz, Ph.D.|415-375-5748|Joannalyn.Delacruz@va.gov|
21297978|NCT03364309|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21297979|NCT00167310|UPittsburgh|Dr. Jeffrey K. Yao, Research Professor|412-360-6781|jkyao@pitt.edu|
21282852|NCT01949844|Cedars-Sinai Medical Center|Dr. Behzad Sharif, Assistant Professor|310-423-7758||
21282853|NCT00712881|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21297980|NCT00615992|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21282854|NCT00537316|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21282855|NCT02651155|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21282856|NCT01867710|Janssen Pharmaceutica N.V|Medical Affairs Director||ClinicalTrialDisclosure@its.jnj.com|
21282857|NCT00526669|GlaxoSmithKline|GSK Response Center|866-435-7343||
21282858|NCT00784303|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21236824|NCT01369342|Janssen Research & Development, LLC|Vice President||ClinicalTrialDisclosure@its.jnj.com|
21282859|NCT03315286|Weill Cornell Medicine|Dr. George Varghese, Principal Investigator|646-962-3376|giv9006@med.cornell.edu|
21282860|NCT02828124|Bristol Myers-Squibb|Phase 1/2 Study of BMS-986183 in Subjects with Advanced Hepatocellular Carcinoma|Please email|Clinical.Trials@bms.com|
21282861|NCT02989649|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21282862|NCT00330343|JHU|Myron Yaster|9552393|myaster1@jhmi.edu|
21236825|NCT01816594|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21282863|NCT00256854|GlaxoSmithKline|GSK Response Center|866-435-7343||
21236826|NCT04723576|RAND|Lisa S. Meredith|310.393.0411|seidel@rand.org|7365
21236827|NCT02727894|Institution for Clinical and Experimental Medicine|Jan Král|+420605273008|jan.kral@centrum.cz|
21282864|NCT06586788|Indiana School of Medicine|Dr. Rebecca McNally Keehn|(317) 274-2121|mcnallyr@iu.edu|
21236828|NCT04320069|Insulet Corporation|Dr. Trang Ly|9786007628|tly@insulet.com|
21236829|NCT03204279|Helsinn Healthcare SA|Edwin de Wit - Head of Clinical Development|+41 91 985 2121|info-HHC@helsinn.com|
21236830|NCT01064739|Vanderbilt University|Dr. Emily Garland|615 936 1748|emily.garland@vanderbilt.edu|
21236831|NCT01571362|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21236832|NCT04258020|OhioHealth|Dr. Kiran Devulapally|614-566-9143|kiran.devulapally@ohiohealth.com|
21236833|NCT03117738|Nature Cell co., ltd|Project Manager|02-545-4137|tin50@stemcellbio.com|
21236834|NCT01669629|Vistakon|Kathy Osborn, OD, MS, FAAO, FBCLA Senior Principal Research Optometrist|904 443-1032|kosborn@its.jnj.com|
21236835|NCT01347333|Mercy Research|Michelle McFarland, MPH, CHRC|314-251-8827|michelle.mcfarland@mercy.net|
21236836|NCT02366338|Mugla Sitki Kocman University|Ozcan Basaran|+902522120724|basaran_ozcan@yahoo.com|
21236837|NCT00130533|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
21236838|NCT03927950|Department of Psychiatry, University of Tartu|Eduard Maron|+3727318812|eduard.maron@kliinikum.ee|
21236839|NCT01491854|Novartis Pharma AG|Study Director|862-778-8300|novartis.email@novartis.com|
21236840|NCT01026974|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21236841|NCT01631630|National Institute on Alcohol Abuse and Alcoholism|Diazgranados, Nancy|+1 301 435 9386|nancy.diazgranados@nih.gov|
21236842|NCT02162420|Masonic Cancer Center|Christen Ebens, MD, MPH|612-624-4511|ebens012@umn.edu|
21236843|NCT03638141|Sidney Kimmel Comprehensive Center|Ana De Jesus-Acosta|4432870411|adejesu1@jh.edu|
21236844|NCT03579563|The University of Iowa|Dr. Yu-Hsiang Wu|319-3359758|yu-hsiang-wu@uiowa.edu|
21282865|NCT03990571|The University of Texas M D Anderson Cancer Center|Dr. Renata Ferrarotto|(713) 745-6774|rferrarotto@mdanderson.org|
21282866|NCT02798289|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21282867|NCT02410798|Synapse Biomedical|Anthony Ignagni|440-774-2488|aignagni@synapsebiomedical.com|110
21282868|NCT03047720|Indiana University|Dr Benjamin Whittam|317.944.8896|bwhittam@iupui.edu|
21282869|NCT01475851|GlaxoSmithKline|GSK Response Center|866-435-7343||
21282870|NCT04603482|Case Western Reserve University|Jaclene Zauszniewski, PhD|216.368.3612|jaz@case.edu|
21282871|NCT00732758|Children's Hospital of Pittsburgh|Kumaravel Rajakumar|412-692-5822|rajakumark@upmc.edu|
21282872|NCT00373958|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21282873|NCT01777568|Cleveland Clinic|Kurz, M.D., Andrea|(216) 445-9924|KURZA@ccf.org|
21282874|NCT03382834|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|3016283313|ACTGCT.Gov@s-3.com|
21282875|NCT02949843|Wake Forest Baptist Comprehensive Cancer Center|William Petty|3367163313|wpetty@wakehealth.edu|
21282876|NCT03613649|DynPort Vaccine Company LLC, a GDIT Company|George A. Saviolakis, MD, PhD, Medical Director|1-240-651-8116|George.Saviolakis@gdit.com|
21282877|NCT02693171|United Therapeutics Corp.|Odette Jordan, MD, PMP|919-425-5606|ojordan@unither.com|
21297981|NCT01895959|University of California, San Francisco|Xiaojuan Li, PhD|415-353-4909|Xiaojuan.li@ucsf.edu|
21297982|NCT01868477|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21297983|NCT00349778|Stanford University|Dr. Sally Arai|650-723-0822|sarai1@stanford.edu|
21297984|NCT01811186|Asan Medical Center|Hoseong Lee|82-2-3010-3521|hosng@amc.seoul.kr|
21297985|NCT02465203|Novartis|Study Director|+41613241111||
21297986|NCT02973516|Guerbet|Jing Hao, MD, Head of Global Medical Affairs and Clinical Development|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
21297987|NCT00042991|Operations and Biostatistics Center for Pediatric Brain Tumor Consortium (PBTC)|Mehmet Kocak|9015952947|mehmet.kocak@stjude.org|
21297988|NCT02387554|Bundang Seoul National University Hospital|Principal Investigator||mekka@snu.ac.kr|
21297989|NCT02268994|Keryx Biopharmaceuticals, Inc.|Keryx Medical Information|1-844-44-KERYX (844-445-3799)|medicalinfo@keryx.com|
21297990|NCT03193736|iSTAR Medical|Zubair Hussain, VP Clinical and Regulatory Affairs|+3210771658|zubair@istarmed.com|
21297991|NCT02022436|University of Pittsburgh Medical Center|Rabih Chaer|4128023025|chaerra@upmc.edu|
21297992|NCT03369236|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|1 855-752-2356|clinicaltrials@alexion.com|
21297993|NCT00423449|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21297994|NCT03334812|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21297995|NCT01153724|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21297996|NCT02697435|VAPHS|Debra Kaye Weiner, M.D.|412-360-2920|Debra.Weiner@va.gov|
21297997|NCT00870545|Memphis VAMC|Dr. Linda Nichols|901 523-8990|linda.nichols@va.gov|5082
21297998|NCT02178696|University of Michigan|Jon-Kar Zubieta||JONKAR.ZUBIETA@hsc.utah.edu|
21297999|NCT02508428|Anderson Orthopaedic Research Institute|C. Anderson Engh, Jr., MD|703-619-4411|research@aori.org|
21298000|NCT01574651|Novartis Pharnaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21298001|NCT00445770|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21298002|NCT00947115|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21298003|NCT03274856|GLWL Research Inc|Caroline Fortier|1.514.708.4417|caroline.fortier@glwlresearch.com|
21298004|NCT03228212|Johnson & Johnson Vision Care Inc.|John Buch -SENIOR PRINCIPAL RESEARCH OPTOMETRIST|904 443-1707|JBUCH@its.jnj.com|
21298005|NCT00934128|The University of Texas (UT) MD Anderson Cancer Center|David Hui, MD, MSc, FRCPC||HMoreno@mdanderson.org|
21252036|NCT00079339|Pediatric Brain Tumor Consortium|Pediatric Brain Tumor Consortium (James M. Boyett, Ph.D)|901-595-4986|james.boyett@stjude.org|
21252037|NCT00559377|UWMC Dept of Radiology|Joseph G Rajendran|206-221-4421|rajan@u.washington.edu|
21252038|NCT04312256|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|Renew.J@mayo.edu|
21298006|NCT01807299|Universidade Federal de São Paulo|PhD José Carlos F. Galduróz||galduroz@unifesp.br|
21252039|NCT02563548|Halozyme Therapeutics|VP, Clinical Development|858-794-8889|medinfo@halozyme.com|
21252040|NCT00590226|EUSOM|Guillermo Umpierrez, MD|4047781665|geumpie@emory.edu|
21252041|NCT00371176|Boston VA Healthcare System|Dr. Brett Litz|857 364 4131|brett.litz@va.gov|
21252042|NCT00203047|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21252043|NCT01580904|Universidade Estadual da Paraíba|Impacto da Atenção Farmacêutica em pacientes diabéticos (IPCD)|558387010977|patriciatrindad@yahoo.com.br|
21252044|NCT01453023|GlaxoSmithKline|GSK Response Center|866-435-7343||
21252045|NCT03721172|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21252046|NCT00420784|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com|
21252047|NCT00148668|Dana-Farber Cancer Institute|Dr Eric Winer|617-632-2335|eric_winer@dfci.harvard.edu|
21252048|NCT03934099|LG Chem|Younghwan Jang|02-6987-4154|younghj@lgchem.com|
21252049|NCT02417441|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21252050|NCT05628285|Oticon Medical AB|Director of Clinical Affairs|0046-31-7486100|studyinfo@oticonmedical.com|
21252051|NCT02339506|Brigham and Women's Hospital|Dr. Gail Kurr Adler|(617) 732-8742|gadler@bwh.harvard.edu|
21252052|NCT02869867|Centre Hospitalier Départemental Vendée|Dr Yves-Marie PLUCHON|251446248|yves-marie.pluchon@chd-vendee.fr|+33
21252053|NCT06476834|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21252054|NCT05288829|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
21252055|NCT05555615|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|844-422-2342|medicalinformation@acadia-pharm.com|
21252056|NCT03016598|Portland VA|Delaney.McKechnie@va.gov|360-696-4061|Delaney.McKechnie@va.gov|32017
21252057|NCT00820664|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
21252058|NCT01728623|Eisai Inc.|Inquiry Service||eisai-chiken_hotline@hhc.eisai.co.jp|
21252059|NCT01667549|Monell Chemical Senses Center|Julia A. Mennella, PhD; Study Principal Investigator|267-519-4880|mennella@monell.org|
21252060|NCT01407276|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21252061|NCT04947514|Montefiore Medical Center|Dr. Amy Yao|7189204800|amyao@montefiore.org|123
21252062|NCT04092452|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21252063|NCT00696488|Wake Forest University Health Sciences|Steve Feldman, MD|336-716-3775|sfeldman@wakehealth.edu|
21252064|NCT01367444|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21252065|NCT01791413|Mahidol University|Dr. Weena Krutsawad|66812070264|vna_fe2@hotmail.com|
21252066|NCT03382769|Cochlear Limited|PRS Specialist, Clinical Affairs|+612 9428 6555|cltd-prs-admin@cochlear.com|
21298007|NCT01392547|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21298008|NCT04404556|Cincinnati Children's Hospital Medical Center|Avani Modi, Ph.D.|513-636-4864|avani.modi@cchmc.org|
21252067|NCT05594589|Eisai Korea Inc. Medical department|Serena SoYoun Kwon|+82-2-3451-5533|s-kwon@eisaikorea.com|
21252068|NCT01536171|University of Florida|Dr. Heather K. Vincent, PhD|352-273-7410|vincehk@ortho.ufl.edu|
21252069|NCT01262092|University of Arkansas for Medical Sciences|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu|
21252070|NCT03784820|University of North Carolina at Chapel Hill|Hunna Watson, PhD|984-974-5217|hunna_watson@med.unc.edu|
21252071|NCT02336425|Novartis Pharmaceuticals|Study Director|862-778-8300||
21252072|NCT01191008|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21252073|NCT03786744|Samara Medical Center Dinasty|Volchkov Stanislav|+78469564455|quality@cordbank.ru|
21252074|NCT02145169|Albert Einstein Medical Center|Kamran Mohiuddin. Director Clinical Research Emergency Department|2154562313|MOHIUDDK@EISNTEIN.EDU|
21252075|NCT02201901|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21252076|NCT03766373|Novus Therapeutics|Clinical Director|949-679-1110|study004@novustherapeutics.com|
21252077|NCT04441905|Pharmaceutical Product Development (PPD), part of Thermo Fisher Scientific|Kristie Miller, MD|512-747-1504|kristie.miller@ppd.com|
21252078|NCT00127842|Amgen Inc.|Study Director|866-572-6436||
21252079|NCT01385748|Onxeo|Berangere Vasseur, MD|+33 (0)1 45 58 76 00|b.vasseur@onxeo.com|
21252080|NCT01443403|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
21252081|NCT02562235|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
21252082|NCT01200342|UT MD Anderson Cancer Center|Sapna P. Patel, MD / Assistant Professor||CR_Study_Registration@mdanderson.org|
21252083|NCT02748889|Georgetown University Medical Center - Lombardi Comprehensive Cancer Center|Dr Giuseppe Giaccone|202-687-7072|gg496@georgetown.edu|
21252084|NCT03595124|Children's Oncology Group|Results Reporting Coordinator|6262411500|resultsreportingcoordinator@childrensoncologygroup.org|
21252085|NCT04075903|University of Alabama at Birmingham Division of Clinical Immunology and Rheumatology|Lesley Jackson, MD, MSPH|205-934-1779|lejackson@uabmc.edu|
21252086|NCT03607422|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21252087|NCT03258723|Yale School of Medicine|Marcella Nunez-Smith, MD, MHS|(203) 785-6454|marcella.nunez-smith@yale.edu|
21252088|NCT04832971|Arrowhead Pharmaceuticals, Inc.|Patrick O'Brien, Chief Operating Officer|626-304-3400|PObrien@arrowheadpharma.com|
21252089|NCT01107899|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21252090|NCT03584152|Stanford University|Sam P. Most, MD, MBA|(650) 724-8019|smost@stanford.edu|
21252091|NCT01351805|Brigham and Women's Hospital/ Harvard Medical School|Karen Costenbader|16177326088|kcostenbader@bwh.harvard.edu|
21252092|NCT05274750|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21252093|NCT00983749|Department of Emergency Medicine, University of California San Diego Health System|Kama Guluma, M.D.|619-543-6463|kguluma@ucsd.edu|
21252094|NCT04292470|University of California Davis|Dr. Michelle Dossett|916-734-5367|mdossett@ucdavis.edu|
21252095|NCT00283283|Walter Reed National Vaccine Healthcare Center Network|COL Renata J. M. Engler, MD|202-782-9461|renata.engler@na.amedd.army.mil|8819
21252096|NCT00867100|Valeant Pharmaceuticals|Director of Clinical Trials|908|binu.alexander@valeant.com|
21252097|NCT02701062|AtriCure|Nfii Ndikintum, VP Clinical Affairs and Biometrics|(513) 644-8192|nndikintum@atricure.com|
21252098|NCT01597843|Clement J Zablocki VA Medical Center|Jeff Whittle, MD, MPH|414-384-2000|jeffrey.whittle@va.gov|46444
21252099|NCT01375673|WJB Dorn VAMC (VHA)|Andrea M. Boyd, PhD, Asscoaite Nurse Executive, Research/Education|803.776.4000|andrea.boyd@va.gov|5654
21252100|NCT06193967|University of Tennessee, Knoxville|Dr. Hollie Raynor|865-974-9126|hraynor@utk.edu|1
21252101|NCT04340947|University of Oklahoma Health Sciences|Professor of Pediatrics|405-271-1903|heal-lab@ouhsc.edu|
21252102|NCT04698915|Galera Therapeutics|Judy Schnyder, Sr. Vice President Clinical Operations and Data Management|484-870-9625|jschnyder@galeratx.com|
21252103|NCT02312557|Oregon Health & Science University|Rachel Slottke|503-494-6117|slottker@ohsu.edu|
21252104|NCT00979953|Cubist Pharmaceuticals|VP of Clinical Research|(781) 860-8660||
21252105|NCT00399841|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
21252106|NCT04829747|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21252107|NCT01535001|Aalborg University Hospital|Dr. Søren T. Skou|+4523708640|sots@rn.dk|
21252108|NCT02367352|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21252109|NCT05878873|Colorado State University|Dr. Brett Fling|(970) 491-3451|brett.fling@colostate.edu|
21252110|NCT04982588|Medtronic, Inc.|Fairy Liu|+86-02120325765|rs.evolutprochinaclinicalstudy@medtronic.com|
21282878|NCT02388815|Abbott Diabetes Care|Jolyon Bugler, Snr Director Clinical Development & Regulatory Affairs|01993863164|joe.bugler@abbott.com|
21282879|NCT00319592|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21282880|NCT03429244|Indianan University School of Medicine|Jennifer Lehman|3179489575|jgeck@iu.edu|
21282881|NCT00474201|National Institutes of Health|Scott Penzak|301-496-2997|sp286u@nih.gov|
21282882|NCT02380261|Alcon, a Novartis company|Dir Clinical Operations - LACAR, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
21282883|NCT00750139|Merz Pharmaceuticals, LLC|Associate Medical Director- Dermatology|800-334-0514||
21282884|NCT00658775|Eisai Call Center|Eisai Inc.|888-422-4743||
21282885|NCT02258373|Jaeb Center for Health Research|Katrina Ruedy|8139758690|kruedy@jaeb.org|
21282886|NCT01992653|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21282887|NCT01435460|Bausch & Lomb, Incorporated|Tuyen Ong|(973) 360-6389|tuyen.ong@bausch.com|
21282888|NCT01706939|Icahn School of Medicine at Mount Sinai|Dr. Marshall R Posner|(212) 659-5461|marshall.posner@mssm.edu|
21282889|NCT01046903|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21282890|NCT01303406|National Hospital for Neurology and Neurosurgery|Dr Paola Giunti|020 3448 3141|violet.le-fevre@uclh.nhs.uk|
21282891|NCT05476250|Masimo Coporation|Ahmed Alghazi|949-297-7000|studies@masimo.com|
21298009|NCT02451917|Endocrinology Division, University of São Paulo Medical School,|Marcia Silva Queiroz, MD, PhD|+ 5511 26616293|marcia.queiroz@hc.fm.usp.br|
21298010|NCT02871635|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21298011|NCT00502671|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21298012|NCT03796637|PTC Therapeutics, Inc.|Medical Information|1-866-562-4620|medinfo@ptcbio.com|
21298013|NCT00853151|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21298014|NCT01510158|Ardea Biosciences, MD|Nihar Bhakta, MD|1-858-652-6671|nbhakta@ardeabio.com|
21298015|NCT03078556|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21252111|NCT01383447|Johns Hopkins Sidney Kimmel Cancer Center|Dr. Patrick Brown|410-614-4915|pbrown2@jhmi.edu|
21252112|NCT00577135|Duke University|Jeff Sharp|919.668.7086|jeff.sharp@dm.duke.edu|
21252113|NCT02375347|University of Florida|Volker Mai, PhD, MPH|3522739398|vmai@epi.ufl.edu|
21252114|NCT02229227|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21252115|NCT00340704|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21252116|NCT01908751|McMaster University|Dr. Mohit Bhandari|9055274322|bhandam@mcmaster.ca|
21252117|NCT03880019|Columbia University Medical Center|Matthew Ingham, MD|646-317-7141|mi2337@cumc.columbia.edu|
21252118|NCT05218499|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
21252119|NCT00894504|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21252120|NCT06733103|University of East Anglia|Sophie Livsey|07947272186|sophie.livsey1@nhs.net|
21252121|NCT04620369|Mayo Clinic|Dr. Charles L. Loprinzi|507-284-2511|cloprinzi@mayo.edu|
21252122|NCT03635086|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21252123|NCT02196077|Pearl Therapeutics Inc.|Paul Dorinsky, MD, FCCP|650-305-2600|pdorinsky@pearltherapeutics.com|
21252124|NCT03316807|Shanxi Medical University|Suping Wang, PhD|#86-351-4135103|spwang88@163.com|
21252125|NCT02046512|Washington University in St. Louis School of Medicine|Kimberly Reske, Research Coordinator|3147474041|kreske@wustl.edu|
21252126|NCT03482752|Savara Inc|Raymond D Pratt, Chief Medical Officer|+1 512 784 8757|ray.pratt@savarapharma.com|
21252127|NCT03566979|Johnson & Johnson Worldwide|Steven Sacavage, Associate Director Clinical Research|215-273-8568|SSacavag@its.jnj.com|
21252128|NCT00658606|Astellas Pharma Canada, Inc.|Director, Scientific Affairs||ClinicalTrials@us.astellas.com|
21252129|NCT01056263|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21252130|NCT04556305|University of Illinois Chicago|Dr. Shannon Halloway|(312) 996-7800|sthallow@uic.edu|
21252131|NCT01358331|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure||ClinicalTrialsDisclosure@merck.com|
21252132|NCT06314438|University of Washington|Principal Investigator|206-221-3595|stonew@uw.edu|
21252133|NCT05190770|Memorial Sloan Kettering Cancer Center|Dr. Alina Markova, MD|646-608-2342|markovaa@mskcc.org|
21252134|NCT02923193|Shockwave Medical|Birgit Greschner|650-575-6199|bgreschner@shockwavemedical.com|
21252135|NCT01907269|University of Alabama at Birmingham|Dr. Elizabeth J. Rahn|2059966552|rahneli@uab.edu|
21252136|NCT01431950|GlaxoSmithKline|GSK Response Center|866-435-7343||
21252137|NCT00738283|Baylor College of Medicine|Steven A. Abrams, MD|713-798-7164|sabrams@bcm.edu|
21252138|NCT01210651|UCSF|Sudha Prathikanti, MD|415-516-3867|sudha.prathikanti@gmail.com|
21252139|NCT02559310|Nabriva Therapeutics US, Inc.|Jennifer Schranz, MD, Chief Medical Officer|610-981-2842|jennifer.schranz@nabriva.com|
21252140|NCT03595878|University of North Carolina Lineberger Comprehensive Cancer Center|Colette Shen|+1 984-974-0400|cjshen@email.unc.edu|
21252141|NCT03494985|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21252142|NCT03036124|AstraZeneca|AstraZeneca Clinical Study Information Center|+1-877-240-9479|information.center@astrazeneca.com|
21252143|NCT02282059|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21252144|NCT02774668|University of Missouri|Elizabeth Parks, Professor of Nutrition and Exercise Physiology|573-882-5864|parksej@missouri.edu|
21252145|NCT04886518|Harmony Biosciences|Sharon Wolfe-Schwartz, Executive Director, Medical and Regulatory Writing|267-965-0270|swolfe-schwartz@harmonybiosciences.com|
21252146|NCT00433511|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21252147|NCT04328623|Centre Hospitalier Départemental Vendée|Adeline TROJET-BOSSARD|251446572|adeline.trojet-bossard@ght85.fr|+33
21252148|NCT03023553|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
21252149|NCT00742326|NIAID|Colleen Hadigan MD MPH|301-594-5754|hadiganc@niaid.nih.gov|
21252150|NCT00150618|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21252151|NCT04458818|Combined Military Hospital Kharian, Punjab Pakistan|Dr Muhammad Noman Karim|+923313358884|f9noman@gmail.com|
21252152|NCT02493946|Ipsen|Medical Director, Neurology||clinical.trials@ipsen.com|
21282892|NCT04013672|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|David Peereboom, MD|1-866-223-8100|TaussigResearch@ccf.org|
21282893|NCT03887442|TTCC Grupo Español de Tratamiento de Tumores de Cabeza y Cuello|Carmen Montalbán, Manager|+34676154172|ttccmanager@yahoo.com|
21282894|NCT00556933|Wright State University, Dayton, Ohio|R. Brian Stevens, MD, PhD|937-545-4817|rbstevens1@icloud.com|
21282895|NCT00688662|Medical University of South Carolina|Dr Peter Cotton|8438767217|cottonp@musc.edu|
21282896|NCT03010800|Oklahoma University Health Science Center|Dr. Robert Hurst|405-271-3930|Robert-Hurst@ouhsc.edu|
21282897|NCT04463251|R-Pharm|Sergey Grishin, Director, Dep. of Clinical Development and Medical Expertise in Autoimmune Diseases|0074959567937|sa.grishin@rpharm.ru|1506
21282898|NCT03318497|UT Southwestern Medical Center|Kelli Key, PhD|214-648-8152|Kelli.Key@UTSouthwestern.edu|
21298016|NCT00832416|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
21298017|NCT02114606|University of North Carolina at Chapel Hill|Evan Dellon, MD|919-966-2511|evan_dellon@med.unc.edu|
21252153|NCT00965497|University of South Carolina School of Medicine|Meera Narasimhan, MD|803-434-1100|shardeman@uscmed.sc.edu|
21252154|NCT02878603|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21252155|NCT02689453|National Cancer Institute|Dr. Kevin Conlon|240-858-3570|conlonkc@mail.nih.gov|
21252156|NCT01162486|Johns Hopkins University School of Medicine|Dr. Kelly E. Dooley|410-955-3100|kdooley1@jhmi.edu|
21252157|NCT00794924|Kaplan-Harzfeld Geriatric Medical Center|Hilla Zaharoni|97288595350|hilla_z@clalit.org.il|
21252158|NCT00953615|Mayo Clinic|Keith D. Lindor, M.D.|507-284-2969|lindor.keith@mayo.edu|
21252159|NCT03274895|SIFI SpA|Dr. Jelle Kleijn|+31615643708|jelle.kleijn@sifigroup.com|
21252160|NCT01055704|Mayo Clinic|Dr Michael Camilleri|5072662305|camilleri.michael@mayo.edu|
21252161|NCT01969851|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21252162|NCT01294436|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
21252163|NCT02389764|UT MD Anderson Cancer Center|Ueno,Naoto,M.D., PH.D. / Breast Medical Oncology|713-792-2817|nueno@mdanderson.org|
21252164|NCT03037203|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2159707145|ClinicalTrialDisclosure@JazzPharma.com|
21252165|NCT03434028|Massachusetts General Hospital|PETAL Clinical Coordinating Center PI|617-872-2882|tthompson1@mgh.harvard.edu|
21252166|NCT02037776|Osaka Medical College|Kazunari Tominaga, M.D., Ph. D.|+81-72-683-1221|in2139@osaka-med.ac.jp|8096
21252167|NCT02498236|University of California, Los Angeles|Dr. Stephen R. Marder|3104783711|SMarder@mednet.ucla.edu|83647
21252168|NCT02296892|PAION UK Ltd|Trial Information|+49 2414453101|reg_paion@paion.com|
21252169|NCT00585078|Beth Israel Deaconess Medical Center Beth Israel Deaconess|Rebecca Miksad MD MPH|617.667.2100|rmiksad@bidmc.harvard.edu|
21252170|NCT03928392|Loma Linda University|Dr. Dragana Krpalek|9095584328|dkrpalek@llu.edu|41340
21252171|NCT04198571|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21252172|NCT01814072|Northwestern University Feinberg School of Medicine|Bonnie Spring, PhD, ABPP|312-908-2293|bspring@northwestern.edu|
21252173|NCT04253119|MSD Pharmaceuticals LLC|Vladimir Achikyan, Medical Affairs Manager|79161981264|vladimir.achikyan@merck.com|
21252174|NCT02562898|University of California, San Francisco|Dr. Margaret Tempero|415-353-7528|Margaret.Tempero@ucsf.edu|
21252175|NCT01936467|Johns Hopkins Hospital|Dr. Mouen Khashab|443-287-1960|mkhasha1@jhmi.edu|
21252176|NCT01011868|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21252177|NCT01255761|UCB Clinical Trial Call Center|(UCB) Study Director|+1 887 822 9493||
21252178|NCT04147858|Aptinyx|Aptinyx Clinical Development|847-871-0377|clinicalstudies@aptinyx.com|1
21252179|NCT00794170|University of Pennsylvania|Karen Glanz|215-898-0613|kglanz@upenn.edu|
21252180|NCT02615938|LMU/ Haunersches Kinderspital|Prof. Matthias Griese|+498944000|matthias.griese@med.uni-muenchen.de|57870
21252181|NCT06173687|Cochlear Limited|PRS Specialist|+612 9428 6555|cltd-prs-admin@cochlear.com|
21252182|NCT04905849|UC San Francisco|Dr. Joaquin A. Anguera, Associate Professor|415 502 7322|joaquin.anguera@ucsf.edu|
21252183|NCT04121897|University of North Carolina at Chapel Hill|Dana McCarty, PT, DPT|919-843-8792|dana_mccarty@med.unc.edu|
21252184|NCT05010850|SafeHeal|Heather Cronin, VP Clinical Affairs|5184289593|hcronin@safeheal.com|
21252185|NCT03981939|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21252186|NCT02037620|University of Louisville|Dr. Susan Harkema|502-581-8675|susan.harkema@louisville.edu|
21252187|NCT02810873|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Mathew Thakur|215-503-7874|mathew.thakur@jefferson.edu|
21252188|NCT00838929|Thomas Jefferson University|Wenyin Shi, MD, PhD|215-955-4111|Wenyin.Shi.@jefferson.edu|
21252189|NCT03771638|Bridge HIV, San Francisco Department of Public Health|Dr. Susan Buchbinder|628.217.7479|susan.buchbinder@sfdph.org|
21252190|NCT04101565|Johns Hopkins Dept of Pediatrics / Division of Adolescent/Young Adult Medicine|Dr. Arik Marcell|4432878946|amarcell@jhu.edu|
21252191|NCT04461158|Medical University of South Carolina|Dr. Jim C. Oates, MD, Rheumatology Division Director|843-792-1991|oatesjc@musc.edu|
21252192|NCT03375320|Dana-Farber Cancer Institute|Jennifer A. Chan, MD, MPH|617-632-6315|jang@partners.org|
21252193|NCT03348631|NRG Oncology|Christopher Purdy on behalf of Mike Sill, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
21252194|NCT01068210|Memorial Sloan Kettering Cancer Center|Dr. Lee Jones, PhD|646-888-8103|jonesl3@mskcc.org|
21252195|NCT00699842|Thomas Jefferson University|Emmanuel Besa, MD|215-955-8874|Emmanuel.Besa@jefferson.edu|
21252196|NCT03170518|Janssen Research & Development, LLC|Director Clinical Leader Internal Medicine|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21252197|NCT03342196|University Hospitals, Case Comprehensive Cancer Center|Principle Investigator|216-844-0139|Leland.Metheny@uhhospitals.org|
21252198|NCT00546078|GlaxoSmithKline|GSK Response Center|866-435-7343||
21252199|NCT02325830|Cardiac Dimensions|Vice President of Clinica Affairs|425-605-5922|aswenson@cardiacdimensions.com|
21252200|NCT03512197|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21252201|NCT01806389|Johns Hopkins University School of Medicine|Dr. Lauren Jansson|410-550-5438|ljansson@jhmi.edu|
21252202|NCT03842436|Brigham and Women's Hospital|Peter R. Chai, MD, MMS|617-732-5640|pchai@bwh.harvard.edu|
21252203|NCT01948076|Brigham and Women's Hospital|Maria Yialamas|617-732-5500|myialamas@partners.org|
21252204|NCT02121912|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0123|CPAPtrial@fphcare.co.nz|
21252205|NCT01151423|Ablynx|Medical Monitor|+32 (9) 262 00 00|clinicaltrials@ablynx.com|
21252206|NCT03995225|Yale School of Medicine|Kathleen A Garrison|415-260-8618|kathleen.garrison@yale.edu|
21252207|NCT01263054|Halyard Health, Inc.|Mark Lavigne|508-837-1427|mark.lavigne@hyh.com|
21252208|NCT03358238|University of Wisconsin-Madison|Amy Cochran|608-262-0772|cochran4@wisc.edu|
21252209|NCT00869947|Eastern Colorado Healthcare System|Dr. Alena Grabowski|303-492-5208|alena.grabowski@va.gov|
21252210|NCT02314689|University of Mississippi Medical Center|Suvankar Majumdar MD|6019845220|smajumdar@umc.edu|
21267069|NCT04453722|Cleveland Clinic|Daniel I. Sessler, Professor & Chair|216-445-6500|DS@CCF.org|
21252211|NCT04596540|Swedish Orphan Biovitrum AB (publ)|Blank Clinical Study Physician, MD|+46 8 697 20 00|medical.info@sobi.com|
21252212|NCT02633397|Dean, University of Maryland School of Medicine, Vice President for Medical Affairs, University of Maryland, Baltimore|Mark Gladwin|410-706-7410|mgladwin@som.umaryland.edu|
21252213|NCT02950259|Earle A. Chiles Research Institute, Providence Cancer Institute|Dr. David B. Page|503-215-6588|david.page2@providence.org|
21252214|NCT02520310|Abbott Structural Heart|Sripad Bellary|650-353-1726|sripad.bellary@abbott.com|
21252215|NCT01340014|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
21252216|NCT05101993|AtriCure|Randall Lee, VP Medical Affairs, Clinical Affairs|650-347-0419|RLee@atricure.com|
21252217|NCT04577573|James J. Peters VA Medical Center|Noam Y. Harel, MD, PhD|718-584-9000|noam.harel@va.gov|1742
21252218|NCT01124838|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21252219|NCT04526665|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
21252220|NCT05752474|Hebrew Rehabilitation Center, Hebrew SeniorLife|Dae Hyun Kim|6179715362|daehyunkim@hsl.harvard.edu|
21252221|NCT02065882|Biotest AG|Dr. Christina Erb|00496103801|christina.erb@biotest.com|0
21252222|NCT01784523|Hospital for Special Surgery|Doruk Erkan, MD|212 774-2291|erkand@hss.edu|
21252223|NCT01907906|Terumo BCT Biotechnologies, LLC|Ray Goodrich, PhD|(303) 231-4832||
21252224|NCT04052425|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21252225|NCT04334278|University of Kentucky|Caitlin Conley|8592571939|caitlin.conley2@uky.edu|
21252226|NCT01189110|VAMC St. Louis MO|Deborah Fritz FNP PhD|314-652-4100|deborah.fritz@va.gov|53692
21252227|NCT01732549|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21252228|NCT01150461|Massachusetts General Hospital|Michael A. Fifer, MD|617 726-1832|mfifer@partners.org|
21252229|NCT01681992|GlaxoSmithKline|GSK Response Center|866-435-7343||
21252230|NCT01415934|University of Colorado|Carrie Brill|303 808 9708|CARRIE.BRILL@UCDENVER.EDU|
21252231|NCT03377361|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21252232|NCT03698994|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21252233|NCT04042077|Menarini Ricerche S.p.A.|Corporate Director of Clinical Sciences|0555680|acapriati@menarini-ricerche.it|9990
21252234|NCT01080300|Depomed|Head of R&D|510-744-8000|msweeney@depomed.com|
21252235|NCT02844777|Vidac Pharma|Max Herzberg|0544257381|maxherzberg@gmail.com|
21252236|NCT01776008|Washington University School of Medicine|Cynthia Ma, M.D., Ph.D.||cma@dom.wustl.edu|
21252237|NCT01163474|Houston VA HSR&D|Donna Smith/Project Coordinator|(713)440-4423|Donna.Smithd19d7@va.gov|
21252238|NCT00383123|GlaxoSmithKline|GSK Response Center|866-435-7343||
21252239|NCT02781311|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21252240|NCT04115189|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21252241|NCT04547023|Stanford University|Yair Blumenfeld, MD|650-498-4069|yairb@stanford.edu|
21252242|NCT00250432|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21252243|NCT01637077|Mayo Clinic|Charles L. Loprinzi, M.D.|507/284-1623|loprinzi.charles@mayo.edu|
21252244|NCT02638103|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21252245|NCT04683510|University of Tennessee Health Science Center|Principle investigator|(901)448-2383|mmart126@uthsc.edu|
21252246|NCT02353312|Providence VA Medical Center|Wen-Chih Wu, MD|4012737100|wen-chih.wu@va.gov|16237
21252247|NCT04199052|University of California San Diego|Dr. Jamila K. Stockman, Professor|(858) 822-4652|jstockman@health.ucsd.edu|
21252248|NCT04907357|Medical University of South Carolina|Kathleen Brady, MD, PhD|843-792-5205|bradyk@musc.edu|
21252249|NCT00365547|Masonic Cancer Center, University of Minnesota|Arkadiusz Dudek, M.D.|612-624-0123|dudek002@umn.edu|
21252250|NCT03692052|Agios Pharmaceuticals, Inc.|Medical Affairs|833-228-8474|medinfo@agios.com|
21252251|NCT02257918|Louisiana State University Health Sciences Center|Stephanie N. Taylor, MD|(504) 658-2622|staylo2@lsuhsc.edu|
21252252|NCT00936598|University of Pittsburgh|Professor|412-623-5965|bovbjergdh@upmc.edu|
21252253|NCT01654068|University of Kentucky|Ronal McGarry|859-323-6486|rcmcga2@email.uky.edu|
21252254|NCT00691600|Baylor College of Medicine|Andrea T. Cruz, MD, MPH|832-824-5582|acruz@bcm.edu|
21252255|NCT00486252|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21252256|NCT01261247|Mayo Clinic Cancer Center|Patrick Johnston, MD, PhD|507-284-2511|johnston.patrick@mayo.edu|
21252257|NCT01740154|Case Comprehensive Cancer Center|Dr. Brian Rini|216-444-9567|rinib2@ccf.org|
21252258|NCT05723263|University of North Carolina at Chapel Hill|Joseph Tucker, MD, PhD|919-966-2536|jdtucker@med.unc.edu|
21252259|NCT03358472|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
21252260|NCT03811002|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21252261|NCT04013971|Emory University|Trisha Kesar, PT, PhD|404-712-5803|tkesar@emory.edu|
21252262|NCT05853900|Click Therapeutics|Clinical Development|347-460-8607|click_ct_contact@clicktherapeutics.com|
21252263|NCT05564637|Mayo Clinic|Yogesh Reddy, M.B.B.S.|507-284-2904|reddy.yogesh@mayo.edu|
21252264|NCT02706249|Beth Israel Deaconess Medical Center, Harvard Medical School|Jeffrey Zwicker, Division of Thrombosis and Haemostasis, Division of Hematology and Oncology|617.667.9299|jzwicker@bidmc.harvard.edu|
21252265|NCT04704219|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21252266|NCT00217737|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21252267|NCT04978129|University of Texas at Arlington|Melissa Lewis|817-272-9833|Melissa.Lewis@uta.edu|
21298018|NCT01999400|University of Michigan|Dr. Duxin Sun|734-763-9783|pharmacy.research@umich.edu|
21298019|NCT04421482|NYU Langone Health|Nazeeh Hanna, MD|516-663-3853|Nazeeh.hanna@nyulangone.org|
21252268|NCT00551746|Intermountain Healthcare|Benjamin D Horne, PhD, MPH|801-507-4708|Benjamin.Horne@imail.org|
21252269|NCT05454813|Medline Industries, L:P|Julie Miller|630-418-6891|jamiller@medline.com|
21252270|NCT04949802|ViaLase Inc.|Melvin Sarayba, MD|9494662856|melvin.sarayba@vialase.com|
21252271|NCT00233480|Ahmanson-UCLA Cardiomyopathy Center|Tamara B Horwich, MD|310-825-8676|thorwich@mednet.ucla.edu|
21252272|NCT00474526|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21252273|NCT00953147|Sunovion|Respiratory Medical Director|1-866-503-6351||
21252274|NCT01484431|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21252275|NCT02224404|Universitair Ziekenhuis Gent|Dr. Hilde Beele|09/332 22 87|Hilde.Beele@uzgent.be|
21252276|NCT01251770|Hospital General de Niños Pedro de Elizalde|Dr Facundo Jorro Barón|00541143632100|jorrobox@yahoo.com.ar|2035
21252277|NCT02763215|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
21252278|NCT00725270|Stanford University|Alan Schatzberg|650-723-8331|afschatz@stanford.edu|
21252279|NCT00769600|MSKCCC|Charles Rudin, MD|646-888-4336|rudinc@mskcc.edu|
21252280|NCT01020877|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21252281|NCT00953771|Mount Sinai Beth Israel|Dr. Ilan Shapira|212-844-8948|Ilan.Shapira@mountsinai.org|
21252282|NCT00974259|University of Pennsylvania|Ramon Diaz-Arrastia|215-662-9732|Ramon.Diaz-Arrastia@uphs.upenn.edu|
21252283|NCT00944229|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
21252284|NCT02963090|Duke Cancer Institute|Thomas Stinchcombe, MD|(919) 668-6688|thomas.stinchcombe@duke.edu|
21252285|NCT05330988|Department of Veterans Affairs|Dr. John H. Kindred|8437924328|john.kindred1@va.gov|
21252286|NCT00015847|OHSU Knight Cancer Institute|Dr. Brian Druker|503-494-7999|trials@ohsu.edu|
21252287|NCT00709228|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21252288|NCT01007110|University of Kansas Medical Center|Kathleen Gustafson, Ph.D.|(913) 588-0065|kgustafson@kumc.edu|
21252289|NCT02179177|Duke University|Nirmish Shah, MD|919-668-5178|nirmish.shah@duke.edu|
21252290|NCT00022659|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
21298020|NCT01466127|Massachusetts General Hospital|Elizabeth Hoge, M.D.|617-724-0859|ehoge@mgh.harvard.edu|
21298021|NCT03010319|Integra LifeSciences|Andrew Tummon Director, Global Clinical Affairs|609-936-5490|andrew.tummon@integralife.com|
21252291|NCT02349152|University of Pittsburgh|Dr. Kathirvel Subramaniam, MD, MPH|412-647-5635|subramaniamk@upmc.edu|
21252292|NCT00884650|Children's Hospital Colorado|Dr. Frank Chang|720-777-6900|Chang.Frank@tchden.org|
21298022|NCT02128724|University of Oxford|Stasya Ng|+441865 617083|octo-BKM120@oncology.ox.ac.uk|
21298023|NCT01023711|University of Rochester|John Treanor, M.D.|585-275-5871|john_treanor@urmc.rochester.edu|
21298024|NCT02751580|Sidney Kimmel Cancer Center at Thomas Jefferson University|Nicole Simone, MD|215-955-6702|nicole.simone@jefferson.edu|
21298025|NCT02588261|Astellas Pharma Global Development, Inc.|Senior Medical Director|1800 888-7704|astellas.resultsdisclosure@astellas.com|
21298026|NCT04829916|Guard Therapeutics|Head of Clinical Operations|+46733319438|trials@guardtherapeutics.com|
21298027|NCT02287467|NIAID|Dr. Richard Davey|301-496-8029|rdavey@niaid.nih.gov|
21298028|NCT04343755|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
21298029|NCT02292446|Novaratis Pharmaceuticals|Study Director|888-669-6682|novartis.email@novartis.com|
21298030|NCT00412243|The University of Texas M. D. Anderson Cancer Center|Stefan Fader, M.D./Associate Professor|713/745-4613|eharriso@mdanderson.org|
21298031|NCT05292131|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21298032|NCT04491539|Florida State University|Henna Budhwani|(850) 644-3296|hbudhwani@fsu.edu|
21298033|NCT02735343|MOMH|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
21298034|NCT03054649|Alcon Research, LLC|Sr. Clinical Trial Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21298035|NCT01804881|North York Family Health Team|Principal Investigator|4164943003|dsouthgate@nyfht.com|130
21298036|NCT01625000|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21298037|NCT00566852|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21298038|NCT00132808|Novartis Pharmaceuticals|Study Director|862-778-8300||
21298039|NCT01938833|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Maysa Abu-Khalaf|215 503-4685|maysa.abu-khalaf@jefferson.edu|
21298040|NCT00577824|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21298041|NCT04531241|Johnson & Johnson Vision Care, Inc.|Meredith Bishop, OD, MS, FAAO|1-800-843-2020|mbishop4@its.jnj.com|
21298042|NCT02362464|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|maengh@mail.nih.gov|
21298043|NCT05870865|TrialSpark|TrialSpark|Please Email|soothe.info@trialspark.com|
21298044|NCT03427749|University of Ottawa Heart Institute|Dr. Terrence Ruddy|613-696-7267|truddy@ottawaheart.ca|
21298045|NCT02104947|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21298046|NCT00548145|Osaka University Hospital|Hiroaki Kazui,Ph.D.|81-6-6879-3051|kazui@psy.med.osaka-u.ac.jp|
21298047|NCT03089541|Yale School of Medicine|Dr. Deepa Camenga, Principal Investigator|12037378310|deepa.camenga@yale.edu|
21298048|NCT02324816|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
21298049|NCT02863328|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21298050|NCT02484222|the Children's Hospital of Fudan University|Dr.Wang Xuan|18017591058|18017591058@163.com|
21252293|NCT00880022|vanderbilt university|sheila h ridner|615-322-0831|Sheila.Ridner@Vanderbilt.edu|
21298051|NCT03301350|University of Wisconsin Carbone Cancer Center|Kari Wisinski, MD|608-262-2876|kbwisinski@medicine.wisc.edu|
21252294|NCT01634269|Medttronic|Hiroko Ookubo|81367760811|hiroko.ookubo@medtronic.com|
21298052|NCT00858637|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21252295|NCT02154906|UT Health Science Center San Antonio|Brian L. Mealey|210-567-3567|mealey@uthscsa.edu|
21252296|NCT04646369|University of Pittsburgh|Oliver Lindhiem|4122465909|lindhiemoj@upmc.edu|
21252297|NCT01516749|University of California, San Francisco|Kieron S. Leslie, MD|415-206-4777|lesliek@derm.ucsf.edu|
21252298|NCT00566540|The Ohio State University Comprehensive Cancer Center|Enzer Ozer, MD|614-293-8074|enver.ozer@osumc.edu|
21252299|NCT03994731|Horizon Therapeutics USA, Inc.|Medical Monitor|866-479-6742|clinicaltrials@horizontherapeutics.com|
21252300|NCT01100606|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
21252301|NCT00732992|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21252302|NCT00405938|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21252303|NCT04530604|University of Michigan|Principal Investigator, Dr. Greg Yanik|734 232-9335|gyanik@med.umich.edu|
21252304|NCT00762476|University of Virginia|Dr. Ronald Turner|(434) 243-9864|RBT2N@hscmail.mcc.virginia.edu|
21252305|NCT02838134|Radboud University Medical Center|Dr M.C. Warlé|+31-24362415333|Michiel.Warlé@radboudumc.nl|
21252306|NCT02694445|Department of Neurology, Xuan Wu Hospital,Beijing,China|Jianping Jia|010-63150669|jiajp@vip.126.com|
21252307|NCT01584518|Creighton University|Dr Anjan Talukdar|402-280-3586|talukdar.anjan@gmail.com|
21252308|NCT01774045|Taipei Veterans General Hospital|Dr. Cheng-Ta Li|886-2-2871-2121|on5083@msn.com|7027
21252309|NCT02332902|The University of Texas Health Science Center at Houston|Dr. Mary Kay Koenig||Mary.K.Koenig@uth.tmc.edu|
21252310|NCT01267240|Princess Margaret Cancer Centre|Dr.Eric Chen, Principal Investigator|416-946-4501|eric.chen@uhn.ca|2263
21252311|NCT04674189|CureVac SE|Clinical Trial Information|0049 6976805870|clinicaltrials@curevac.com|
21252312|NCT02266342|W.L. Gore & Associates|Charee Robe, Biostatistician|928-864-4048|crobe@wlgore.com|
21252313|NCT03023423|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21252314|NCT00681668|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21252315|NCT04277507|Aerin Medical|Director of Clinical Operations|650-518-9624|alaborde@aerinmedical.com|
21252316|NCT00583947|Sepracor Inc|Respiratory Medical Director|866-503-6351||
21252317|NCT05226130|VA San Diego Healthcare System, San Diego, CA|Ruth Klaming, PhD|858-552-8585|rklaming@health.ucsd.edu|
21252318|NCT03974022|Dizal Pharmaceuticals|Li Zheng|862161097899|clinicaltrials@dizalpharma.com|
21252319|NCT02884492|Columbia University Medical Center (Taub Institute)|William C. Kreisl, MD|212-305-9194|wck2107@cumc.columbia.edu|
21252320|NCT06719986|Purdue Pharma|Clinical Leader|1-888-726-7535|Purduemedinfo@pharma.com|
21252321|NCT04581343|PanCAN|Samantha Pedersen, Sr. Director Clinical Operations|310.706.3726|spedersen@pancan.org|
21298053|NCT02305238|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21251424|NCT02693704|EPFL|Gilles Courtois|0041216932631|gilles.courtois@epfl.ch|
21251425|NCT02007200|University of Michigan Comprehensive Cancer Center|Gregory T. Wolf, M.D.|800-865-1125|gregwolf@umich.edu|
21251426|NCT03598699|AxeroVision, Inc.|Dr. Achim Krauss|+1 (484) 238-6255|achim.h.krauss@gmail.com|
21251427|NCT02330562|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21251428|NCT01547117|Vanderbilt University Medical Center|Alfredo Gamboa, MD|6158751003|alfredo.gamboa@vumc.org|
21251429|NCT00258362|Masonic Cancer Center, University of Minnesota|Melissa Geller, M.D.|612-626-3111|gelle005@umn.edu|
21251430|NCT03927690|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21251431|NCT04026399|Medical University of South Carolina|Na Jin Seo|8437920084|seon@musc.edu|
21251432|NCT03248141|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21251433|NCT00675792|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21251434|NCT04182113|Indiana University|Clinical Research Manager|3178808495|iupdp@iupui.edu|
21251435|NCT01496365|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21251436|NCT01015677|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21251437|NCT01660256|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21251438|NCT01184885|Thomas Jefferson University|Margaret Kasner, MD|215-955-8874|Margaret.Kasner@jefferson.edu|
21251439|NCT01646385|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21251440|NCT03491215|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novatis.email@novartis.com|
21251441|NCT03539068|Department of Veterans Affairs- Office of Research and Development|Anne G. Sadler, Ph.D., R.N.|319-338-0581|anne.sadler@va.gov|7992
21251442|NCT00541671|Christiana Care Health System|Deb Marco|302-733-4130|DMarco@christianacare.org|
21251443|NCT04205955|SWOG Statistics and Data Management Center|Palliative and End of Life Care Committee Statistician|2066677685|karnold@fredhutch.org|
21251444|NCT00548847|Emory University|Martha Arellano, MD|404-778-1900|marella@emory.edu|
21251445|NCT02988349|Sichuan University|Dr. Xin Xu|86-28-85503494|xin.xu@scu.edu.cn|
21251446|NCT00751634|Northwestern University|Dr. Andrew Naidech|312-503-3335|a-naidech@northwestern.edu|
21251447|NCT00511797|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21251448|NCT03269695|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21251449|NCT05043883|CathVision|Mads Matthiesen|+4531470730|mem@cathvision.com|
21251450|NCT02420041|Naval Medical Center San Diego|LCDR Ian M Fowler, MD|619-532-8954|ian.m.fowler.mil@mail.mil|
21251451|NCT01818427|University of Pittsburgh|Dr. Jason Sperry|412 6922850|sperryjl@upmc.edu|
21251452|NCT00905359|Medtronic Spinal and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
21252322|NCT03213704|Children's Oncology Group|Results Reporting Coordinator|(626) 241-1500|resultsreportingcoordinator@childrensoncologygroup.org|
21252323|NCT03660826|NRG Oncology|Helen Huang on behalf of Danielle Enserro, PhD.|(716) 845-1300|huangh@nrgoncology.org|2318
21252324|NCT03931746|Northwell Health Department of Dermatology|Sr. Clinical Data Analyst|516-321-8508|astrunk1@northwell.edu|
21252325|NCT01183390|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21252326|NCT03267810|University of Miami|Elizabeth Felix|305-243-4497|efelix@med.miami.edu|
21252327|NCT05609604|UBuffalo|Paresh Dandona|17168818924|ghanim@buffalo.edu|
21282899|NCT01628198|Icahn School of Medicine at Mount Sinai|Dr. Vivek Y Reddy|212-241-7114|vivek.reddy@mountsinai.org|
21252328|NCT03222505|Rehabilitation Institute of Chicago|Arun Jayaraman, PT, PhD; Director of Max Nader Lab for Rehabilitation Technologies and Outcomes|3122386875|ajayaraman@ricres.org|
21282900|NCT01743560|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21282901|NCT02965729|Pennington Biomedical Research Center|Dr. Amanda Staiano|225-763-2729|amanda.staiano@pbrc.edu|
21252329|NCT02113124|The Transitional Learning Center at Galveston|Dr. Brent Masel|409-762-6661|bmasel@tlcgalveston.org|411
21252330|NCT02514239|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21252331|NCT03299049|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21252332|NCT02980042|University of Colorado Anschutz, Neurology Department|Dr. Timothy Vollmer|3037242187|timothy.vollmer@ucdenver.edu|
21252333|NCT03466047|Imperial College London|Carel le Roux|7970719453|c.leroux@imperial.ac.uk|
21252334|NCT02277054|Filatov Institite of Eye Diseases and Tissue Therapy of the NAMS of Ukraine|Dr. Oleksiy Buznyk|+380487181548|a_buznik@bk.ru|
21252335|NCT02460575|Tulane University|Dr. Richard Oberhelman|504-988-2511|oberhel@tulane.edu|
21252336|NCT02521363|Memorial Sloan Kettering Cancer Center|Dr. Tiffany Traina, MD|646-888-4558|trainat@MSKCC.ORG|
21252337|NCT02356705|Bassett Healthcare|Dr. David Ullman|585-750-7510|doccfi@hotmail.com|
21282902|NCT02842580|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
21282903|NCT01827267|Puma Biotechnology|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
21282904|NCT05367973|Dare Bioscience, Inc.|Jessica Hatheway, VP Clinical Operations|858-926-7655|jhatheway@darebioscience.com|
21282905|NCT04999163|Procyrion, Inc.|Sr. Director, Clinical Affairs|650-208-1118|tami@procyrion.com|
21282906|NCT00840307|UT Southwestern Medical Center|Dr. Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
21282907|NCT01346189|University of Pennsylvania and Department of Veteran Affairs|Dr. Kevin G. Volpp||volpp70@wharton.upenn.edu|
21282908|NCT00900757|Duke University Medical Center|Mary Lou Affronti|919-684-6239|mary.affronti@dm.duke.edu|
21282909|NCT03834974|University of Connecticut|Dr. Sherry Pagoto|860-486-8979|sherry.pagoto@uconn.edu|
21282910|NCT05113979|OnPointVision|Lynne Archer|949-749-4170|larcher@onpoint-vision.com|
21282911|NCT00976820|GlaxoSmithKline|GSK Response Center|866-435-7343||
21282912|NCT00968981|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21282913|NCT01489254|Synthon BV|VP Clinical Development|+3124727700|clinicaltrials@synthon.com|
21282914|NCT00281632|GlaxoSmithKline|GSK Response Center|866-435-7343||
21282915|NCT03613909|Cochlear Ltd|Marian Jones, Principal Investigator|+61498008181|mjones@cochlear.com|
21282916|NCT02233101|Rush University Medical Center|Craig J. Della Valle, MD|312-432-2350|craigdellavalle@rushortho.com|
21282917|NCT04748458|IRCCS Istituto Ortopedico Rizzoli|Dr Francesco Castagnini|+390516366418|francescocastagnini@hotmail.it|
21282918|NCT02050919|OHSU Knight Cancer Institute|Christopher Ryan, MD|503-494-8487|ryanc@ohsu.edu|
21282919|NCT02691936|Cleveland Clinic Foundation|Dr. Marie Fidela Paraiso|216-444-3428|PARAISM@ccf.org|
21282920|NCT01878084|Alexandria University|Prof. Mona K. Marei|002-03-4858353|mona.marei@gmail.com|
21252338|NCT00592293|Massachusetts General, Hospital|Torunn Yock, MD|6177262000|tyock@mgh.harvard.edu|
21252339|NCT01933243|Nationwide Children's Hospital|Andrea Bonny|614-722-2458|andrea.bonny@nationwidechildrens.org|
21252340|NCT01606319|Penn State University Dept of Public Health Sciences|David Mauger, PhD|717.573.0336|dmauger@psu.edu|
21252341|NCT01270828|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21252342|NCT01810939|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
21252343|NCT02870972|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
21252344|NCT04497389|University of Utah|Joseph Tonna, MD|801-587-6271|joseph.tonna@hsc.utah.edu|
21252345|NCT04400487|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21282921|NCT00749684|Merck Sharp and Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
21282922|NCT03696108|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21282923|NCT02643849|SRS Medical|Director of Clinical Trials|800-345-5642|info@srsmedical.com|
21282924|NCT03891862|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
21282925|NCT01053962|Synergy Pharmaceuticals Inc|Dr. Laura Barrow/Senior Vice President Clinical Development|212-297-0020|lbarrow@synergypharma.com|
21282926|NCT04143594|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21282927|NCT03089697|Institute of iNtRON Biotechnology|Jun SooYoun, Ph.D. / Executive Director/ Principal researcher|+82-31-739-5332|jsy@intron.co.kr|
21282928|NCT00638443|University of Rochester|John Markman, MD|585-340-8926|maria_frazer@urmc.rochester.edu|
21282929|NCT01044290|HSRD, Durham VAMC|Karen Steinhauser, PhD|919 668-2148|karen.steinhauser@duke.edu|
21252346|NCT01821937|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21252347|NCT01677299|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com|
21252348|NCT03445533|Idera Pharmaceuticals, Inc.|Head of Clinical Operations|484-348-1605|lcolfer@iderapharma.com|
21252349|NCT02615509|Philips AB|Daniel Stenströmer|+46 708 303 767|daniel.stenstromer@philips.com|
21252350|NCT03274453|New York University School of Medicine|Kirsten Boenigk|212 598 6085|Kirsten.Boenigk@nyumc.org|
21252351|NCT00945672|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21252352|NCT00447590|Apollo Endosurgery|Laura Eaton, R.N., BSN, CCRN-R|949-468-9301|laura.eaton@apolloendo.com|
21298054|NCT00195663|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21252353|NCT00609947|Medtronic CardioVascular|Lynda Chaplin - Study Manager|(707) 543-5459|lynda.chaplin@medtronic.com|
21252354|NCT00504075|Bio Products Laboratory Limited|Tim Aldwinckle, MD|+44 2089572565|Tim.Aldwinckle@bpl.co.uk|
21252355|NCT01186705|Memorial Sloan Kettering Cancer Center|Dr. Leonard Saltz|646-888-4286|saltzl@mskcc.org|
21282930|NCT01878812|GlaxoSmithKline|GSK Response Center|866-435-7343||
21282931|NCT01646021|Janssen-Cilag International NV|Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
21298055|NCT01380834|Children's Hospital of UPMC|Dr. Mihaela Visoiu|412-692-5260|visoium@upmc.edu|
21282932|NCT00438100|The University of Tokyo|Tempei Miyaji|+81-3-5800-9086|tmiyaji@m.u-tokyo.ac.jp|
21282933|NCT01967706|Philip Morris Products S.A.|Christelle HAZIZA|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
21282934|NCT01021761|Bucci Laser Vision|Frank A. Bucci, Jr., MD|570-825-5949|Buccivision@aol.com|
21282935|NCT00614120|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21282936|NCT02737631|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
21282937|NCT05129137|Unither Pharmaceuticals|Non-Clinical and Clinical Project Manager|+33 (0)1 44 63 51 78|clinicaltrials@unither-pharma.com|
21282938|NCT05093530|Pneumagen Ltd|CEO|+44 7748357352|douglas.thomson@pneumagen.com|
21282939|NCT01552915|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21298056|NCT03214406|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
21298057|NCT00604695|Brigham & Women's Hospital|C. Michael Gibson, MS, MD|617-632-7753|mgibson@perfuse.org|
21298058|NCT01898013|Durham VA Medical Center|Jennifer C. Naylor, PhD|9192860411|jennifer.naylor2@va.gov|
21298059|NCT04560075|University of Pittsburgh|Dr. Tina Goldstein|(412) 246-5604|goldtr@upmc.edu|
21298060|NCT04551950|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21298061|NCT01100775|University of Maryland Baltimore|Ms. Dawn Detamore|410 402 6820|DDetamore@som.umaryland.edu|
21298062|NCT00429169|Columbia University/NYSPI|Michael F. Grunebaum, MD|212-543-5842|mfg14@columbia.edu|
21298063|NCT01180296|Fetal Medicine Foundation?USA|David McKenna|937-208-4005|dsmckenna@mvh.org|
21282940|NCT00979420|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21282941|NCT01054196|Weill Cornell Medicine|Roger Pearse, M.D. PhD|646-962-6500|rnp2001@med.cornell.edu|
21282942|NCT02223546|Medical University of Graz|Gerald Seidel, MD|+43 316 385 12394|gerald.seidel@medunigraz.at|
21282943|NCT05831644|Vicore Pharma AB|Director Clincial Operations|+46 (0) 31 788 05 60|info@vicorepharma.com|
21282944|NCT04676451|Penn State Hershey Medical Center|Amy Longenecker|717-531-1513|alongenecker@pennstatehealth.psu.edu|
21282945|NCT01512446|Ruhr-Universität Bochum|Johannes Pfeilschifter, MD||Johannes.Pfeilschifter@rub.de|
21282946|NCT03421145|3M Health Care Business Group|Manager of Biostatistics|6518152737|swalters@mmm.com|
21282947|NCT01820572|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21282948|NCT00595517|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21282949|NCT01167881|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21282950|NCT02107859|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
21282951|NCT00977314|Sonitus Medical, Inc.|Clinical Trials Manager|8668162076|lily@sonitusmedical.com|
21282952|NCT01343277|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
21282953|NCT02344251|MUSC|Dr. Aimee McRae-Clark||mcraeal@musc.edu|
21282954|NCT01894100|University of North Carolina at Chapel Hill|Yvonne M. Golightly, PT, PhD|919-966-0566|golight@email.unc.edu|
21282955|NCT00288600|Fundação Oswaldo Cruz|Maria Elisabeth Moreira|552125541911|bebeth@iff.fiocruz.br|
21282956|NCT00135512|GlaxoSmithKline|GSK Response Center|866-435-7343||
21282957|NCT01094301|SPRTherapeutics|Clinical Affairs|216-378-9108|support@SPRTherapeutics.com|
21282958|NCT03600194|Philips|Jeff Jasko|412-542-3836|jeff.jasko@philips.com|
21282959|NCT04439214|ECOG-ACRIN Cancer Research Group|Study Statistician|16176323012|eatrials@jimmy.harvard.edu|
21282960|NCT02235077|Duke Clinical Research Institute|Adrian Hernandez, MD|919 668 7515|adrian.hernandez@duke.edu|
21282961|NCT03852628|RTI International|PASA Core Leadership|919-541-6002|shirsch@rti.org|
21282962|NCT02964208|Abbott|Ryan Gage|+1 612 805 6398|ryan.gage@abbott.com|
21282963|NCT03767153|Venus Concept|Clinical Research Manager|888-907-0115|rmays@venusconcept.com|
21282964|NCT00430573|BostonUCRC|Michael W. Otto, Ph.D.|(617)353-9610|mwotto@bu.edu|
21282965|NCT06343467|TRIA Orthopedic Center|Megan Reams; Director of Orthopaedic Research|(952) 806-5329|megan.reams@tria.com|
21282966|NCT00684320|San Diego State University/University of California Joint Doctoral Program in Clinical Psychology|Dr. Nader Amir|(619) 229-3740|namir@mail.sdsu.edu|
21282967|NCT01668173|Memorial Sloan Kettering Cancer Center|Dr. Raajit Rampal|212-639-2194|RampalR@mskcc.org|
21298064|NCT00166439|Mayo Clinic|Patrick B. Johnston, M.D., Ph.D.|507/284-5362|johnston.patrick@mayo.edu|
21282968|NCT05020665|Kronos Bio, Inc.|VP, Corporate Affairs|+16507815200|media@kronosbio.com|
21282969|NCT00101166|H. Lee Moffitt Cancer Center and Research Institute|Dr. Sophie Dessureault|813-745-1965|sophie.dessureault@moffitt.org|
21282970|NCT01868022|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21282971|NCT00746564|St. Jude Medical|Director, Clinical Studies|1-800-733-3455|tshipman@sjm.com|
21282972|NCT03297645|Virginia Commonwealth University|Robin S. Everhart, PhD|(804) 828-7249|reverhart@vcu.edu|
21282973|NCT03386994|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21282974|NCT00877487|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21282975|NCT04679311|Washington University School of Medicine|Steven Weintraub MD|314-652-4100|weintraub@wustl.edu|55298
21282976|NCT02118727|University of Missouri Health Care|Richard Barohn, MD|573-882-3693|rbarohn@health.missouri.edu|
21282977|NCT03033602|VA Boston Healthcare System & Boston University School of Medicine|Dr. Denise Sloan, Professor of Psychiatry|857-364-6333|dsloan@bu.edu|
21282978|NCT03425396|Paratek Pharmaceuticals, Inc.|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
21282979|NCT01441765|Beth Israel Deaconess Medical Center|Dr. David Avigan, Principal Investigator|617-667-9920|davigan@bidmc.harvard.edu|
21282980|NCT01758731|University of Colorado, Denver|Dr. David Raben|303-724-3027|david.raben@ucdenver.edu|
21282981|NCT04445714|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21282982|NCT04223635|Daiichi Sanyko, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21282983|NCT04965311|OHSU Knight Cancer Institute|Dr. Brett Sheppard|503-494-9169|sheppard@ohsu.edu|
21282984|NCT02551770|GWD Consult|Dr. Manfred Klasser|+49 6108 825 65 20|manfred.klasser@gwd-consult.de|
21282985|NCT02122887|Bar Ilan University|Moran Influs|972-35317943|moran.influs@gmail.com|
21282986|NCT01082211|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21282987|NCT03725761|Wisconsin Institutes for Medical Research|Joshua M Lang, MD, MS|(608) 265-8131|jmlang@medicine.wisc.edu|
21282988|NCT03527264|Brown Oncology Research Group|Don S. Dizon, MD|4018633000|BrUOG@Brown.edu|
21282989|NCT05129293|Trinity Health Of New England|Mandell Center Research Team|860-714-3005|MSResearch@TrinityHealthOfNE.org|
21282990|NCT00784550|GlaxoSmithKline|GSK Response Center|866-435-7343||
21282991|NCT05903924|Vanda Pharmaceuticals|Vanda Pharmaceuticals|2027343400|clinicaltrials@vandapharma.com|
21282992|NCT00174967|Takeda Global Research & Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21282993|NCT03558152|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21282994|NCT04166591|New York University|Dr. Sudha Arunachalam|212-998-4139|sudha@nyu.edu|
21282995|NCT03960021|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Pr Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
21282996|NCT02219581|Emory University|Thomas L. Bradbury, MD|404-759-3912|tombradburymd@gmail.com|
21282997|NCT01936181|Samsung Bioepis|Director, Clinical Development|+82 31 8061 4534||
21282998|NCT00697541|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
21282999|NCT02086448|University of Pittsburgh|Dr. Francesca Facco|412-641-1220|Faccof@upmc.edu|
21283000|NCT01302444|Rhode Island Hospital|James R Klinger, MD||jklinger@lifespan.org|
21283001|NCT00205868|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
21283002|NCT01730534|AstraZeneca|Global Study Leader|+49 4103 708 3792|Sandra.ranft@astrazeneca.com|
21283003|NCT02980341|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21283004|NCT02004886|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21283005|NCT01369108|3M Oral Care Solutions Division|Rolf Halvorson|651-733-3384|rhhalvorson@mmm.com|
21283006|NCT01895608|James H Quillen VAMC|Dr. Courtney Hall|423-926-1171|courtney.hall@va.gov|7518
21283007|NCT01876784|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21283008|NCT03505593|ENvizion Medical|Clinical Director|+972-72-2288240|anath@envizionmed.com|
21283009|NCT01194531|Natera (formerly Gene Security Network)|Nina Wemmer, MS,CGC, Study Coordinator|650-249-9090|nwemmer@natera.com|
21283010|NCT02822573|Wake Forest NCORP Research Base|Lead Biostatistician (Emily Dressler, PhD)|336-716-0891|NCORP@wakehealth.edu|
21283011|NCT05239494|University of Alabama at Birmingham|Andrew Pucker, OD, PhD|920-579-2900|andrewpucker@hotmail.com|
21283012|NCT04798989|Tisento Therapeutics|Clinical Research|1-857-259-5371|hello@tisentotx.com|
21283013|NCT02892422|H. Lundbeck A/S|Email contact via|+45 36301311|LundbeckClinicalTrials@Lundbeck.com|
21283014|NCT00405522|The Hospital for Sick Children, Toronto, Ontario, Canada|Dr. Jason Hayes|416-813-7654|jason.hayes@sickkids.ca|208963
21283015|NCT02855359|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
21283016|NCT01023256|MorphoSys|Roman Korolkiewicz|+498989927|Roman.Korolkiewicz@morphosys.com|208
21283017|NCT02581475|Shandong University Qilu Hospital|Dr. Yanqing Li|+86-531-82169236|liyanqing@sdu.edu.cn|
21283018|NCT00725608|RB Pharmaceuticals|Global Medical Director|+1 (804) 379 1090|Tim.Baxter@reckittbenckiser.com|
21283019|NCT01154088|GlaxoSmithKline|GSK Response Center|866-435-7343||
21283020|NCT01084668|Abbott|Global Medical Services|800-633-9110||
21283021|NCT02447497|3M|Nancy Klinger|651 491 9433|nmklinger@mmm.com|
21283022|NCT00985959|Janssen Pharm KK Japan|Director|+81-3-4411-5801||
21283023|NCT01570634|Salient Pharmaceuticals Incorporated|Richard scruggs|7135899859|rscruggs@salientpharmaceuticals.com|
21283024|NCT00671528|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21283025|NCT04257032|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21283026|NCT00602459|Ohio State University|John Byrd, M.D.||john.byrd@osumc.edu|
21283027|NCT01295827|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21283028|NCT00022698|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21283029|NCT02439814|Medical University of South Carolina|Dr. McRae-Clark|843-792-5216|mcraeal@musc.edu|
21283030|NCT02119455|University of Connecticut- Division of Orthodontics|Dr. Flavio Uribe|8606792550|furibe@uchc.edu|
21283031|NCT01217476|Olympus France S.A.S|Mr. Akira Kondo, Manager, Clinical R&D|+33-1-4560-6849|akira.kondo@olympus.fr|
21283032|NCT03129945|University of California, Irvine|Judith Chung|714-456-8695|judithc@hs.uci.edu|
21283033|NCT00813813|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com|
21283034|NCT00986921|Boston University Department of Obstetrics and Gynecology|Director of Clinical Research|617-414-5175|rstudy@bmc.org|
21283035|NCT03699280|Imperial College London|Ms Nandita Deo|07939360357|nandita.deo@gmail.com|
21283036|NCT02396420|South Florida Medical Imaging|Cynthia Toot ARNP|954-267-6626|cynthia.toot@holy-cross.com|
21283037|NCT06137131|Ghent University|Dr. Iris Meerschman|+32499294636|iris.meerschman@ugent.be|
21283038|NCT00569673|NRG Oncology, Statistics and Data Management Center, Buffalo Office|Jessalyn Reboy|716-845-7738|ReboyJ@nrgoncology.org|
21283039|NCT01273623|Boston Scientific|Susanna Kennedy|763.494.2601|susanna.kennedy@bsci.com|
21283040|NCT01493284|St Jude Medical|Sr Clinical Scientist|4159179696|alicia.kimber@abbott.com|
21283041|NCT01640379|Johns Hopkins University|Dr. Maria Trent|4109552910|mtrent2@jhmi.edu|
21283042|NCT00325156|GlaxoSmithKline|GSK Response Center|866-435-7343||
21283043|NCT03489707|Medical College of Wisconsin|Alan Nyitray, PhD|414-955-7701|anyitray@mcw.edu|
21283044|NCT02060058|Kaohsiung Medical University Hospital|Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine|+886-7-3121101|hsmonyan@gmail.com|6770
21283045|NCT06229132|Columbia University|Corina Lelutiu-Weinberger, PhD|(212) 342-1502|cl4265@cumc.columbia.edu|
21283046|NCT03030989|University of Chicago|Randee Estes, Study Coordinator|773-702-1209|restes@medicine.bsd.uchicago.edu|
21283047|NCT02730377|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21283048|NCT03917472|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21283049|NCT02706886|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
21283050|NCT01154296|Department of Sociomedical Sciences/Mailman School of Public Health/Columbia University|Lisa Metsch, PhD, Stephen Smith Professor and Chair of Sociomedical Sciences|212-305-3577|lm2892@columbia.edu|
21283051|NCT02203851|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21283052|NCT04934189|Hunter College of the City University of New York|Danielle S. Berke, Ph.D.|212-772-5550|db2800@hunter.cuny.edu|
21283053|NCT00765895|Johns Hopkins Data Coordinating Centers|Mark Van Natta|410-614-1362|mvannat1@jhu.edu|
21283054|NCT03320850|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
21283055|NCT02893553|James J Peters VAMC|Dr. Jill Wecht|718-584-9000|jm.wecht@va.gov|3122
21283056|NCT01968356|3M Health Care|Joan E. Paulson|651-736-6583|jepaulson@mmm.com|
21283057|NCT01871402|Therapeutics, Inc.|Clinical Research, Therapeutics, Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com|
21283058|NCT04594941|GE HealthCare|Francois Tranquart, M.D., Ph.D|447775543206|francois.tranquart@ge.com|
21283059|NCT00231114|Asthmatx, Inc.|Narinder S Shargill, PhD|408-419-0100||
21283060|NCT00823069|Medicis|Mary Sanstead|480-291-5926|msanstead@medicis.com|
21283061|NCT02031640|Teva Branded Pharmaceutical Products, R&D, Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21283062|NCT02161484|University of Pittsburgh|Dr. Rita Merman, P.I.|41256322137|MermanRB@upmc.edu|
21283063|NCT02005692|Leaf Healthcare, Inc.|Barrett Larson, MD, Chief Medical Officer|650-701-3652|barrett.larson@leafhealthcare.com|
21283064|NCT01194999|Barrie Urology Associates - The Male/Female Health and Research Centre|Joseph A Zadra, MD CM FRCSC|705-727-0551|joezadra@rogers.com|
21283065|NCT01895270|University of Arkansas for Medical Sciences|Alison Oliveto, PhD|501-526-8441|olivetoalison@uams.edu|
21283066|NCT00635453|Universidade Federal de Ciências da Saúde de Porto Alegre|Dr. Marcia Vitolo|+555133038798|marciavitolo@hotmail.com|
21283067|NCT02091375|GW Research Ltd.|Medical Enquires||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
21283068|NCT00068367|SWOG Statistical Center|Study Statistician|206-667-4623|sarcoma@crab.org|
21283069|NCT02682823|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21283070|NCT05896527|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21283071|NCT02879617|UPMC Hillman Cancer Center|Barbara Stadterman, Regulatory Specialist Supervisor|412-647-5554|stadtermanbm@upmc.edu|
21283072|NCT01279070|Parc Sanitari Sant Joan de Déu|Dr. Aida Farreny|+34 936406350|afarreny@pssjd.org|2373
21283073|NCT03781583|University of Michigan Medical School|James Weiland|734-764-9793|weiland@umich.edu|
21283074|NCT02222545|Omeros Corporation|Clinical Trial Manager|(206) 676-5000|ctinfo@omeros.com|
21283075|NCT01938430|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21283076|NCT04533412|Icahn School of Medicine at Mount Sinai|Alex D. Federman, MD, MPH|(212) 824-7565|alex.federman@mountsinai.org|
21283077|NCT02233296|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21283078|NCT03261674|VA Palo Alto|Dr Ansgar Furst; Rayma Williams|(650) 339-4015|ansgar.furst@va.gov; rayma.williams@va.gov|
21283079|NCT01883817|University of Cincinnati|Director Clinical Research Management|513-558-8621|gayathri.kavikondala@uc.edu|
21283080|NCT02353442|São Carlos Fedetal University|Dayana Rosa|+55 16 33066695|dad_rosa@hotmail.com|
21283081|NCT00979875|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|(858) 794-8889||
21283082|NCT01945970|Unilever R&D Research Vlaardingen|Dr Theo Mulder|+31 10 460 8315|theo.mulder@gmail.com|
21283083|NCT00782184|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21283084|NCT00890084|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21283085|NCT02738879|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21283086|NCT01438294|Universidade Nove de Julho|Evelim Leal de Freitas Dantas Gomes, PhD PT|5511976333349|evelimfreitas@hotmail.com|
21298065|NCT01511081|UT MD Anderson Cancer Center|Joe Chang, MD/Professor, Radiation Oncology Department|713-792-7734|CR_Study_Registration@mdanderson.org|
21298066|NCT04072887|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21283087|NCT03330262|Barron Associates|Principal Research Scientist|434-973-1215|barron@barronassociates.com|125
21283088|NCT01075646|Department of Anesthesia, Reanimation Bellvitge University Hospital|Noelia Fustran|932607323|nfustran@bellvitgehospital.cat|
21283089|NCT01520558|Coronado Biosciences|Vice President, Clinical Operations|7816524516|nsilver@coronadobio.com|
21283090|NCT01647516|Celgene Corporation|Anne McClain, Senior Manager|908-673-9100|ClinicalTrialDisclosure@Celgene.com|
21283091|NCT01323595|Weill Cornell Medical College|Chairman, Department of Urology|212 746-5491|pnschleg@med.cornell.edu|
21283092|NCT04964544|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21283093|NCT03875274|BPKIHS|Dr. Pankaj Baral|9856037077|pankajbaral7@gmail.com|
21283094|NCT01613222|GEHealthcare|Jeffrey Conner|414-477-8374|Jeffrey.Conner@ge.com|
21283095|NCT03829618|Penn State Hershey Medical Center|Zoulfira Nisnevitch-Savarese, M.D.|717-531-6597|znisnevitchsavarese@pennstatehealth.psu.edu|
21283096|NCT02319174|Rice 360: Institute for Global Health|Dr. Rebecca Richards-Kortum|713-348-3823|rkortum@rice.edu|
21283097|NCT03155178|3M|Joan E. Paulson|651-736-6583|jepaulson@mmm.com|
21283098|NCT02833844|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21283099|NCT00308087|Genzyme Corporation|Genzyme MedInfo||medinfo@genzyme.com|
21283100|NCT04323306|MMV|Benoit Bestgen|+41 79 765 18 68|bestgenb@mmv.org|
21283101|NCT02809859|Fisher & Paykel Healthcare|Clinical Research Scientist|+64 9 574 0123|CPAP.TRIAL@fphcare.co.nz|7044
21283102|NCT00089778|National Cancer Institute (NCI), National Institutes of Health (NIH)|James Yang, M.D.|301-496-1574|jamesyang@mail.nih.gov|
21283103|NCT04712019|3M|Biostatistics Manager|651-382-2876|swalters@mmm.com|
21283104|NCT04525079|Celltrion Inc|JiWoong Lim|82-32-850-5806|jiwoong.lim@celltrion.com|
21283105|NCT05010512|Alcon Research, LLC|Associate Director, Clinical Projects - CDMA Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21283106|NCT01118624|Spectrum Pharmaceuticals|Pankaj Sharma, MD|949-743-9264|pankaj.sharma@sppirx.com|
21283107|NCT01023841|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21283108|NCT04240457|ChicagoArbor Eye Care|David Lubeck, MD|708-798-6633|david.lubeck@chicagoarboreye.com|
21283109|NCT02858180|Duke University|Andrew Muir, MD|919-684-2052|muir0002@duke.edu|
21283110|NCT00844480|Northwestern University|Thomas Schnitzer|312-503-2315|tjs@northwestern.edu|
21283111|NCT00537576|University of California, San Francisco|Anke Hemmerling, Project Director|415-597-4963|ahemmerling@globalhealth.ucsf.edu|
21283112|NCT01516008|Janssen Research & Development, L.L.C.|Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
21283113|NCT02805660|Mirati Therapeutics|Tavette Neskorik, Senior Director, Clinical Science|858-332-3552|neskorikt@mirati.com|
21283114|NCT01923298|The University of Arizona Cancer Center|Dr. Pavani Chalasani|520-626-0191|pchalasani@uacc.arizona.edu|
21283115|NCT02572076|Motus GI Medical Technologies Ltd.|Ravit Peled -Director of Clinical Trial|0733243823|ravit@motusgi.com|203
21283116|NCT04064411|Radius Health, Inc.|Clinical Operations|617-551-4000|info@radiuspharm.com|
21283117|NCT00170625|Charite Campus Vichow Klinikum|Prof. Dr. Jalid Sehouli|+49 30-450564052|jalid.sehouli@charite.de|
21283118|NCT03512210|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|301-628-3348|ACTGCT.gov@fstrf.org|
21283119|NCT03309657|University of Queensland Center for Clinical Research|Prof. Jason Roberts|+61 7 334 65032|j.roberts2@uq.edu.au|
21283120|NCT01470781|McLean Hospital/Harvard Medical School|Dr. Kathryn Lewandowski|617-855-2886|klewandowski@mclean.harvard.edu|
21283121|NCT03192995|University of California at San Francisco|Dr. Glenn-Milo Santos, Associate Professor|415-867-1151|glenn-milo.santos@ucsf.edu|
21283122|NCT01286168|Mayo Clinic|Dr. Amy C. Degnim|507-284-6357|Degnim.Amy@mayo.edu|
21283123|NCT01424514|GlaxoSmithKline|GSK Response Center|866-435-7343||
21283124|NCT06207149|Vanderbilt University|Meghan Burke|6153431014|meghan.burke@vanderbilt.edu|
21283125|NCT02653170|Michigan State University|Dr. Mathew Reeves|517-353-8623|reevesm@msu.edu|
21283126|NCT02002533|University of Rochester|Gary Morrow|585-275-9961|gary_morrow@urmc.rochester.edu|
21283127|NCT02147522|USC Suzanne Dworak-Peck School of Social Work|Kathleen Ell, DSW, Principle Investigator|760-399-0263|ell@usc.edu|
21283128|NCT01482065|Johns Hopkins University|Dr. Seva Polotsky, M.D., PhD|410-550-6386|vpolots1@jhmi.edu|
21283129|NCT01942486|University of Utah|Bradley Katz|8015871079|bradley.katz@hsc.utah.edu|
21283130|NCT03728426|Brigham and Women's Hospital/Dana-Farber Cancer Institute|Dr. Amy Sherman|6175253575|acsherman@bwh.harvard.edu|
21283131|NCT02064270|University of Missouri, Department of Orthopaedic Surgery|Stacee Clawson, Research Manager|5738849017|clawsons@health.missouri.edu|
21283132|NCT02424630|Chuncheon Sacred Heart Hospital|Dr Jung-Taek Hwang|82 33 240 5197|drakehjt@hanmail.net|
21283133|NCT01741792|Amgen, Inc.|Study Director|866-572-6436||
21283134|NCT05139303|University of Kentucky College of Dentistry Division of Orofacial Pain|Dr. Isabel Moreno Hay|8593233440|imo226@uky.edu|
21283135|NCT00949403|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
21283136|NCT01676896|UTexasAustin|Sharon Horner|512-471-7951|shorner@mail.nur.utexas.edu|
21283137|NCT03614078|PRCL Research Inc|Caroline Fortier|1-514-708-4417|caroline.fortier@prclresearch.com|
21283138|NCT03886519|University of North Carolina at Chapel Hill|Emily Gower, PhD|919-966-1420|egower@unc.edu|
21283139|NCT04789291|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21283140|NCT03729570|Emory University|Aaron Siegler, PhD|404-712-9733|asiegle@emory.edu|
21283141|NCT00805870|Western Michigan University|Dr. Christopher C. Cheatham|269-387-2542|chris.cheatham@wmich.edu|
21283142|NCT01576276|Massachusetts General Hospital|Dr. Jian Kong|617-726-7893|jkong2@mgh.harvard.edu|
21283143|NCT01867294|Mayo Clinic|Aminah Jatoi, M.D.|507.284.1623|jatoi.aminah@mayo.edu|
21283144|NCT00631410|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21283145|NCT03998163|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
21283146|NCT01322035|University of South Alabama, Department of Surgery|Dr. William O. Richards|251-471-7993|brichards@health.southalabama.edu|
21283147|NCT00727844|Tuberculosis Research Section, LCID, NIAID, NIH|Dr. Clifton Barry|301-451-9554|cbarry@niaid.nih.gov|
21283148|NCT04569968|Bolu Abant İzzet Baysal University|Tamer ÇANKAYA|5335519171|tamercankaya@hotmail.com|+90
21283149|NCT06191393|Aptitude Medical Systems, Inc|Brad Killingsworth|2814674855|brad.killingsworth@aptitudemedical.com|
21283150|NCT03912818|Stanford University|Sandy Srinivas|650-725-2078|sandysri@stanford.edu|
21283151|NCT03861871|NYU Langone Health|Latoya King|646 558 083|latoya.king@nyulangone.org|
21283152|NCT00570349|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
21283153|NCT05600270|Lahey Hospital and Medical Center|Neev Mehta|781-744-1933|neev.n.mehta@lahey.org|
21283154|NCT02458768|LG Life Sciences|Jonghee Jin|82-2-6924-3122|jonghee@lgls.com|
21283155|NCT02773212|University of Illinois at Chicago|Dr. Margaret Wardle|(312)413-5564|mwardle@uic.edu|
21283156|NCT03843632|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21283157|NCT03085238|MTrap|Vice President, RA/QA/CA|3013258537|cmitchell@m-trap.com|
21283158|NCT01892709|Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-7476|achang@montefiore.org|
21283159|NCT05356533|University of Washington|Jennifer Cadigan|206-543-5689|cadiganj@uw.edu|
21283160|NCT01931956|Abbott Vascular|Jeffrey T Ellis||jeffrey.ellis@av.abbott.com|
21283161|NCT02847494|Montefiore Health|Benjamin W. Friedman, MD|17189206626|befriedm@montefiore.org|
21252356|NCT01689857|Seoul National University Bundang Hospital|Dr. Chanyeong Heo|82317877222|lionheo@snu.ac.kr|
21283162|NCT02294175|James A. Haley Veterans Hospital and Clinics|Dr. Linda Cowan|813-558-3932|linda.cowan@va.gov|
21283163|NCT01901653|AbbVie Stemcentrx|Senior Director, Clinical Operations|(650) 827-4879|isobel.lakatos@abbvie.com|
21283164|NCT02548351|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
21283165|NCT00792688|Glycotex, Inc.|Dr. Reinhard Koenig, CEO|301-670-2825|Reinhard.Koenig@glycotexinc.com|
21283166|NCT00322231|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21283167|NCT03226769|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21283168|NCT02640677|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21283169|NCT04553471|Washington University School of Medicine|Pamela Samson, M.D.|314-747-1786|psamson@wustl.edu|
21283170|NCT02036840|Nationwide Children's Hospital|Ralph Beltran, MD|614-722-4200|Ralph.Beltran@nationwidechildrens.org|
21283171|NCT02778074|Linkoping University|Dr Peter Johansson|0460700896548|peter.b.johansson@liu.se|
21283172|NCT02255305|NorthShore UH|Jennifer Grant|847-570-2420|jgrant@northshore.org|
21283173|NCT01684943|Massachusetts General Hospital|Courtney A Balliro|617-726-1242|cballiro@partners.org|
21283174|NCT05685264|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21283175|NCT03395184|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21283176|NCT01290978|cyberDERM Clinical Studies|Dr. Gary Grove|610-325-0112||
21283177|NCT02342197|Kasr El-Aini Hospital|Nawara Mohamed|0223654060|nawaram@kasrelaini.edu.eg|002
21283178|NCT01746420|Wright Medical|Justin Moss|615-236-4984|justin.moss@wright.com|
21283179|NCT01817582|Bausch & Lomb Incorporated|Director of Clinical Operations||Jon.Williams@bauschhealth.com|
21283180|NCT03053063|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21283181|NCT02600845|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21283182|NCT02341495|Loyola University Medical Center|Dr. Elizabeth Henry|708-327-3153|ehenry@lumc.edu|
21283183|NCT01188876|Massachusetts General Hospital|Marcela del Carmen, MD, MPH|617-724-4800|MDELCARMEN@mgh.harvard.edu|
21283184|NCT00356135|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21283185|NCT03963232|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
21252357|NCT04148989|Intermountain Health|Director, Office of Research|(801) 408-1991|officeofresearch@imail.org|
21252358|NCT02362503|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21252359|NCT02643628|Suneva Medical|Director of Clinical Affairs|858-324-6268|alehman@sunevamedical.com|
21252360|NCT02977286|Tufts Medical Center|Erik Garpestad, M.D.|617-636-5388|egarpestad@tuftsmedicalcenter.org|
21252361|NCT03329300|University of Alabama at Birmingham Department of Pediatrics|Marissa Gowey, PhD|2056386618|marissa.gowey.phd@gmail.com|
21252362|NCT00786643|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
21252363|NCT02526498|Cancer Institute of New Jersey|Bruce Haffty|732-235-5203|hafftybg@cinj.rutgers.edu|
21252364|NCT05000047|Sonova USCS|Principal Investigator, Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
21252365|NCT04148651|Candela Corporation|Medical Director|+1 949.599.7657|konikap@candelamedical.com|
21252366|NCT00594022|R.P. Chiacchierini & Associates|R.P. Chiacchierini & Associates|(240) 683-3738|rpc@rpcaconsulting.com|
21252367|NCT04591171|The University of Texas Health Science Center at Houston|Joyce P Samuel, MD, MS|713-500-6708|joyce.samuel@uth.tmc.edu|
21252368|NCT03392168|Arcutis|Study Inquiry|650-847-4115|studyinquiry@arcutis.com|5
21252369|NCT01093469|Wake Forest|Dr Alan Fleischer|336-716-3775|adclark@wakehalth.edu|
21283186|NCT03617770|University of Illinois at Chicago|Dr. Pamela Martyn-Nemeth|3129967903|pmartyn@uic.edu|
21283187|NCT01672710|Institute for Health and the Environment, University at Albany|David O. Carpenter MD|518-525-2660|dcarpenter@albany.edu|
21283188|NCT00321698|Portland VAMC|Dr. Mark Garzotto|541-728-0665|garzotto@ohsu.edu|
21298067|NCT00856297|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21252370|NCT01245374|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21283189|NCT05033262|The University of Pennsylvania School of Nursing|Emily Summerhayes|6099233786|esummer@nursing.upenn.edu|
21283190|NCT05270395|University of Kentucky|Dr. McLouth|859-562-2526|laurie.mclouth@uky.edu|
21283191|NCT03055494|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
21283192|NCT03197467|AIO-Studien-gGmbH|AIO-Studien-gGmbH Help Desk|0049-30-8145344|info@aio-studien-ggmbh.de|31
21283193|NCT03666533|Department of Veterans Affairs Northeast Ohio Healthcare system|Dr. Svetlana Pundik|216-791-3800|svetlana.pundik@va.gov|63732
21283194|NCT02017717|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
21283195|NCT01515462|Fondazione Telethon ETS|Sean Russell|+39 02 2022 17210|srussell@telethon.it|
21283196|NCT04488419|Athira Pharma|Dr. Javier San Martin, CMO|1-866-725-0930|clinicaltrials@athira.com|
21283197|NCT01089933|OHRI|Dr Michelle Chiu|613-798-5555|mchiu@toh.ca|14169
21283198|NCT01296542|Bucci Laser Vision|Frank A. Bucci Jr., MD|570-825-5949|buccivision@aol.com|
21283199|NCT04743804|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
21283200|NCT04338269|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21283201|NCT00970632|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21283202|NCT05210101|Brigham and Women's Hospital|Sophia Koo, MD|6175258418|skoo@bwh.harvard.edu|
21283203|NCT03506568|Devers Eye Institute|Dr. Robert Kinast|503-413-8202|robertkinast@gmail.com|
21283204|NCT02487771|University of Kansas Medical Center|Susan Carlson, PhD|(913) 588-5359|SCARLSON@kumc.edu|
21283205|NCT03796442|Seoul National University Hospital|Prof. Ho Young Hwang|00-82-2-2072-3020|scalpel@snu.ac.kr|
21283206|NCT01429064|Orion Pharma, Development, R&D|Head of Oncology|+358 10 4261|mika.mustonen@orionpharma.com|
21283207|NCT03408444|Johnson & Johnson Vision Care, Inc.|Xu Cheng - Sr. Principal Clinical Scientist|1-800-843-2020|xcheng6@its.jnj.com|
21283208|NCT03875482|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21283209|NCT02355821|RGNKC|Ekaterina Dudinskaya, head of age-related metabolic and endocrine disorders laboratory|+79031914690|katharina.gin@gmail.com|
21283210|NCT00507819|The Children's Hospital of Philadelphia|David J. Goldberg, MD|267-426-8143|goldbergda@email.chop.edu|
21283211|NCT01187771|University of Pittsburgh|Sanjay Patel|412-692-2035|patelsr2@upmc.edu|
21283212|NCT03961061|Wake Forest Health Sciences|Justin B. Moore, PhD|336-716-3702|jusmoore@wakehealth.edu|
21283213|NCT04507256|AstraZeneca|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
21283214|NCT02360631|University of Kansas Medical Center|Lisa Sanderson Cox|913-588-2643|lcox@kumc.edu|
21283215|NCT02256982|Massachusetts General Hospital|Ted Hong, MD|617-726-6050|tshong1@partners.org|
21283216|NCT02777970|Menarini Ricerche|Dr. Angela Capriati (Clinical Sciences Director)|+39 055 5680|acapriati@menarini-ricerche.it|9933
21283217|NCT02347891|Northwell Health|Principal Investigator|5167082550|gmarder@northwell.edu|
21283218|NCT02319967|University of Illinois at Chicago|Jerry A. Krishnan, MD, PhD|312-413-3291|chicagotrial@uic.edu|
21283219|NCT02195310|KCI Europe Holding B.V.|Daniela Weichert, PhD|+353 (0) 860436155|daniela.weichert@acelity.com|
21283220|NCT02541669|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21283221|NCT04739722|Geneoscopy Inc.|Chief Medical and Science Officer|314-887-7777|contact@geneoscopy.com|
21283222|NCT00834639|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21283223|NCT01869699|University of California, San Francisco|Dr. Hildy Schell-Chaple|415-353-1039|hildegarde.schell-chaple@ucsf.edu|
21283224|NCT01083186|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21283225|NCT05028075|Center for Digital Health|Director of Research|2674280125|digitalhealth@uphs.upenn.edu|
21283226|NCT03783130|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD|301-451-8715|martin.gaudinski@nih.gov|
21283227|NCT03419598|University of Bath|Professor Richie Gill|01225 383627|r.gill@bath.ac.uk|
21283228|NCT00380081|Purdue Pharma LP|Clinical Leader|800-733-1333||
21283229|NCT00459706|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21283230|NCT00189306|Graceway Pharmaceuticals|Medical Director|267-984-0400|jim.lee@gracewaypharma.com|
21283231|NCT02017912|Brainstorm Cell Therapeutics|Chief Medical Officer|+1-201-488-0460|ClinicalTrial@brainstorm-cell.com|
21283232|NCT03640481|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
21283233|NCT00535847|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com|
21283234|NCT04889157|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21283235|NCT02747849|UPittsburgh|Rajeev Chaudhry, MD|412-692-7932|rajeev.chaudhry@chp.edu|
21283236|NCT04756128|Methodist Hospital|Daniel Delaney, PharmD|952-993-5442|daniel.delaney@parknicollet.com|
21283237|NCT03197870|EyePoint Pharmaceuticals, Inc|David Bauer|8573410747|dbauer@eyepointpharma.com|
21283238|NCT01618019|Hanyang University|Dr. Yongsoon Park|82-2-2220-1205|yongsoon@hanyang.ac.kr|
21283239|NCT03845491|Stryker Neurovascular|Sr. Clinical Project Manger|510-413-2500|lisa.park@stryker.com|
21283240|NCT01508130|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21283241|NCT01680159|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21283242|NCT02200536|Damascus University|Assistant Professor Easter Joury|00963955650456|easterjoury@icloud.com|
21283243|NCT02783729|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
21283244|NCT00901017|Institut Straumann AG|Marc Quirynen, Professor|+4161965|michael.hotze@straumann.com|1235
21283245|NCT02288091|Massachusetts General Hospital|Sabrina Paganoni, MD, PhD|617-724-3914|spaganoni@mgh.harvard.edu|
21283246|NCT03403751|Atox Bio, Ltd.|Wayne M Dankner, MD, Chief Medical Officer|1-919-219-6377|wayned@atoxbio.com|
21252371|NCT04529005|University of Illinois Chicago College of Pharmacy|Scott Benken|3123554107|benken@uic.edu|
21283247|NCT02105246|San Francisco VA Healthcare System|Dr. Mary Whooley|415-221-4810|mary.whooley@va.gov|
21283248|NCT01623037|Zeltiq Aesthetics|Kerrie Jiang, Executive Director Regulaory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
21283249|NCT00387010|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21283250|NCT02071810|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21283251|NCT00520481|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21283252|NCT04586634|Coloplast|Director of Clinical Strategy|+4549111111|clinical-studies@coloplast.com|
21283253|NCT00789256|Dartmouth-Hitchcock Medical Center|Marc Gautier, MD - Principal Investigator|603-650-5529|marc.gautier@hitchcock.org|
21283254|NCT00471718|Vanderbilt-Ingram Cancer Center|Jeff Sosman, MD|615-936-3048|jeff.sosman@vanderbilt.edu|
21283255|NCT02841280|Indiana University|Dr. Rajiv Agarwal|3179882241|ragarwal@iu.edu|
21283256|NCT00957268|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21283257|NCT05152966|FARAPULSE|Christopher (Kit) Schneider|6176867661|christopher.schneider@bsci.com|
21283258|NCT01340027|Astellas Pharma Europe, B.V.|Medical Director||Astellas.resultsdisclosure@astellas.com|
21283259|NCT00833482|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21283260|NCT02496091|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
21283261|NCT03518619|Butler Hospital|Ana M. Abrantes, Ph.D.|401-455-6440|Ana_Abrantes@Brown.edu|
21283262|NCT02663102|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21283263|NCT02234596|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian,|646-888-4186|janjigiy@mskcc.org|
21283264|NCT04089904|University of Chicago|Theodore Karrison (Research Professor)|7737029326|tkarrison@health.bsd.uchicago.edu|
21283265|NCT03681990|3M|Joan E. Paulson|651-736-6583|jepaulson@mmm.com|
21283266|NCT02759055|HealthPartners Institute|Patrick J O'Connor|952-967-5034|Patrick.J.OConnor@HealthPartners.Com|
21283267|NCT02515994|Johnson & Johnson Vision Care Inc.|Kristy Canavan, O.D., F.A.A.O. Principle Research Optometrist|904-443-1474|KCANAVA2@its.jnj.com|
21283268|NCT00326781|University of Pennsylvania|Caryn Lerman, Ph.D.|215-746-7141|clerman@mail.med.upenn.edu|
21283269|NCT04045132|The Children's Hospital of Philadelphia|Dr. James Guevara|2155901130|guevara@chop.edu|
21283270|NCT04598451|Argenx|Regulatory Manager|Please email:|regulatory@argenx.com|
21283271|NCT04630249|The Medical University of South Carolina|Constance Guille|843-792-6489|guille@musc.edu|
21283272|NCT01632150|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21283273|NCT01131884|University of Rochester|K.Rao Poduri, M.D., Chair of Physical Medicine & Rehab|585-275-6978|kr_poduri@urmc.rochester.edu|
21283274|NCT01473394|Forest Research Institute, Inc.|Carl Gommoll|201 427-8000||
21283275|NCT03391232|Treos Bio|Chef Scientific Officer|+3615500826|eniko.toke@treosbio.com|
21283276|NCT02091960|Astellas Global Development, Inc. (APGD)|Clinical Transparency|800-888-7704|astellas.resultsdisclosure@astellas.com|
21283277|NCT04178824|Icahn School of Medicine at Mount Sinai|Allan Geliebter PhD|212-523-4574|Allan.Geliebter@mountsinai.org|
21283278|NCT01579084|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21283279|NCT02637895|University of Miami Miller School of Medicine|Dr. Philip Harvey|305 243 4094|pharvey@med.miami.edu|
21283280|NCT04810247|The Miriam Hospital|Dr. KayLoni Olson|401-793-8971|kayloni.olson@lifespan.org|
21283281|NCT03794661|Abbott Medical Devices Neuromodulation|Binith Cheeran|+15122864262|binith.cheeran@abbott.com|
21283282|NCT01995175|GlaxoSmithKline|GSK Response Center|866-435-7343|lr24921@gsk.com|
21283283|NCT00984061|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21283284|NCT00761280|Isarna Therapeutics GmbH, formerly Antisense Pharma GmbH|Medical Officer|+49-89-890831|info@isarna-therapeutics.com|0
21283285|NCT00535782|Hoffman-LaRoche|Medical Communications|800-821-8590||
21283286|NCT04777201|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21283287|NCT02045862|Astellas Pharma Europe B.V.|Clinical Trial Disclosure|+44 (0) 20 3379 8000|astellas.resultsdisclosure@astellas.com|
21283288|NCT02697890|TuftsUSDM|Y. Natalie Jeong|6176366531|natalie.jeong@tufts.edu|
21283289|NCT02691013|University of California San Diego|Dr. Robert Owens|858-657-5258|rowens@ucsd.edu|
21283290|NCT06017752|Boise State University|Dr. Aida Midgett|2084261219|aidamidgett@boisestate.edu|
21283291|NCT02111785|Department of Neurosurgery, University of Virginia Health System|Dr. Daniel Raper|4349823244|raper@virginia.edu|
21283292|NCT02275780|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21283293|NCT03960866|Ocuphire Pharma, Inc.|Mina Sooch|248-681-9815|msooch@ocuphire.com|
21283294|NCT05129475|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21283295|NCT01899742|GlaxoSmithKline|GSK Response Center|866-435-7343||
21283296|NCT02662764|AcelRx Pharmaceuticals, Inc|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
21283297|NCT04874233|Prism Clinical Research|Amy Eastenson, MD|1-651-641-2900|aeastenson@prismresearchinc.com|
21283298|NCT00759785|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21283299|NCT00177307|University of Pittsburgh|Nathan Bahary, MD|412-864-7764|baharyn@upmc.edu|
21283300|NCT02677038|M D Anderson Cancer Center|Dr. Milind Javle|713-792-5434|mjavle@mdanderson.org|
21283301|NCT02523924|Johns Hopkins University|Steven Rowe, MD|4105028052|srowe8@jhmi.edu|
21283302|NCT02609100|Washington University School of Medicine in St. Louis|Dr. Vladimir M. Kushnir|314-362-3685|vkushnir@wustl.edu|
21283303|NCT01460654|Massachusetts General Hospital|Dr. Benjamin Leder|6177266723|bzleder@partners.org|
21283304|NCT01917812|Johns Hopkins University School of Medicine|Dr. Seth S Martin|410-955-7376|smart100@jhmi.edu|
21283305|NCT05178641|Procter & Gamble Co.|Dr. Susanna Brink, Clinical Scientist|+49 6196 89 4474|brink.s@pg.com|
21283306|NCT01783639|Gardia Medical|Dr. Vardit Segal|+972-4-6277166|Vardit@Gardiamedical.com|106
21283307|NCT00343785|Fred Hutchinson Cancer Research Center|Dr. Rainer Storb, Director Transplantation Biology|2066676839|rstrob@fredhutch.org|
21283308|NCT01013844|Northwestern University Department of Dermatology|June Robinson, MD|312-695-6624|june-robinson@northwestern.edu|
21283309|NCT00278148|Case Comprehensive Cancer Center|Dr. Nathan Pennell|21684459281|penneln@ccf.org|
21283310|NCT01223469|St. Jude Medical/Endosense|Hendrik Lambert PhD, VP of Clinical and Regulatory Affairs||Hendrik.Lambert@endosense.com|
21283311|NCT01546168|Icahn School of Medicine at Mount Sinai|Dr. Vivek Y Reddy|212-241-7114|vivek.reddy@mountsinai.org|
21283312|NCT01902758|University of Montana|Director of the Montana Center for Work Physiology and Exercise Metabolism|406-243-2117|brent.ruby@mso.umt.edu|
21283313|NCT02850016|The Rockefeller University|Marina Caskey|212-327-7396|mcaskey@rockefeller.edu|
21283314|NCT00070018|SWOG Statistical Center|Study Statistician|206-667-4623||
21283315|NCT00669552|Columbia University|Jose' Dizon, MD|212-305-8559|jmd11@columbia.edu|
21283316|NCT00271011|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski|734-615-3969|zalupski@umich.edu|
21283317|NCT04442269|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21283318|NCT03802565|Neurana Pharmaceuticals, Inc.|Randall Kaye, MD - Chief Medical Officer|858-732-0708|rkaye@neuranapharma.com|
21283319|NCT03559868|Yale University, Yale School of Medicine|Mehal Wajahat MD, DPhil|877.925.3637|wajahat.mehal@yale.edu|
21283320|NCT00430352|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21283321|NCT03099694|Children's Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders, Key Laboratory of Pediatrics in Chongqing|Prof. Shi Yuan|13508300283|15084335697@163.com|
21283322|NCT04326439|Emory University|Dr. Himalee Sabnis|404-727-3285|hsabnis@emory.edu|
21283323|NCT01446237|GlaxoSmithKline|GSK Response Center|866-435-7343||
21283324|NCT03492398|Seoul National University Hospital|Inseung Jeon|82-2-2072-1920|isjeon0127@snu.ac.kr|
21283325|NCT03951064|University of North Carolina at Chapel Hill|Jackson Pettee|984-215-6872|jackson_pettee@med.unc.edu|
21283326|NCT01565369|Avid Radiopharmaceuticals|Chief Medical Officer|215-798-0700|clinicaloperations@avidrp.com|
21283327|NCT02468154|Istituto Ortopedico Rizzoli|Luisa Veronesi|0516366694|cristiana.forni@ior.it|0039
21283328|NCT01744184|University Hospitals Dorset NHS Foundation Trust|Dr Simon McLaughlin|01202303626|Simon.McLaughlin@uhd.nhs.uk|
21283329|NCT00072280|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21283330|NCT00197002|GlaxoSmithKline|GSK Response Center|866-435-7343||
21283331|NCT02345265|Dana-Farber Cancer Institute|Dr. Joyce Liu|617-632-5269|Joyce_Liu@dfci.harvard.edu|
21283332|NCT05072106|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar's Oncology, Business Unit,|0034918466000|AEincoming@pharmamar.com|
21283333|NCT03839459|University of Rochester Medical Center|Brea Lipe, MD|(585) 275-4099|Brea_Lipe@URMC.Rochester.edu|
21283334|NCT04240886|Basilea Pharmaceutica International Ltd, Allschwil|Study Director|+41 79 701 0551|marc.engelhardt@basilea.com|
21283335|NCT00771264|Uroplasty, Inc.|Susan Holman, Cheif Operating Officer|952-426-6143|susan.holman@uroplasty.com|
21283336|NCT04769466|LifeBio|Lisbeth Sanders|937-303-4574|beth@lifebio.com|
21283337|NCT04161079|Medtentia International Ltd Oy|Olli Keränen / Chief Executive Officer|+358 50 3567090|ok@medtentia.com|
21283338|NCT05027048|Stanford|Dr. Jessica Ansari|650-723-5349|jansari@stanford.edu|
21283339|NCT04327661|Vanda Pharmaceuticals Inc.|Vanda Pharmaceuticals Inc.|2027343400|clinicaltrials@vandapharma.com|
21283340|NCT02357706|Charite Department of Sleepmedizin|Prof Dr med Ingo Fietze|+49 30 450 513 122|ingo.fietze@charite.de|
21283341|NCT03369067|University of Virginia Center for Diabetes Technology|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
21283342|NCT00981045|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
21283343|NCT01054300|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21283344|NCT00135798|University Colorado, Denver|Gregory T. Everson, M.D., Director of Hepatology|720-848-2245|greg.everson@UCDenver.edu|
21283345|NCT00738881|Roswell Park Cancer Institute|Alex A. Adjei, M.D., Ph.D|507/538-1760|alex.adjei@roswellpark.org|
21283346|NCT00387751|University of Texas Health Science Center at San Antonio|Dr. John Sarantopoulos|210-450-1000|sarantopoulo@uthscsa.edu|
21283347|NCT02416193|Loyola University Chicago|Mary Byrn, R.N., Ph.D.|(773) 508-8973|mbyrn@luc.edu|
21283348|NCT03671564|Daiichi Sankyo, Inc.|Clinical Director|908-992-6400|CTRinfo@dsi.com|
21283349|NCT01282164|Cleveland Clinic|Dr. Amir H. Hamrahian|216-445-8555|hamraha@ccf.org|
21283350|NCT04521621|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21283351|NCT01663779|Yale School of Medicine|Kevin M. Schuster|203-785-2572|kevin.schuster@yale.edu|
21283352|NCT05845567|Italfarmaco SpA|Maurizio Caserini, MD|+ 39 02 64431|m.caserini@italfarmacogroup.com|
21283353|NCT00742872|American University of Beirut Medical Center|Dr. Ala Sharara|+961-3-350000|as08@aub.edu.lb|
21283354|NCT01968707|3M|Joan Paulson|651-736-6583|jepaulson@mmm.com|
21283355|NCT02946073|Braeburn|Susan Franks, SVP, Head of Regulatory Affaires|6104678719|sfranks@braeburnrx.com|
21283356|NCT01104246|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com|
21283357|NCT05803096|Beth Israel Medical Center|Dr. Heidi Rayala|16176673739|hrayala@bidmc.harvard.edu|
21283358|NCT01588457|UT Health San Antonio|Charles Bowden, MD|2105675393|bowdenc@uthscsa.edu|
21283359|NCT02062944|Northwestern University|Josh Levitsky|312 695 4413|josh.levitsky@nm.org|
21298068|NCT02248636|Puget Sound VA|William Banks, Associate Chief of Staff for Research|206 764-2701|william.banks4@va.gov|
21298069|NCT03887221|Zambon S.p.A.|Valentina Zanin|+39 02 665241|valentina.zanin@zambongroup.com|
21252372|NCT01782690|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21252373|NCT04946942|Weill Medical College of Cornell University|Catherine Riffin, PhD|(203) 303-4904|acr2213@med.cornell.edu|
21252374|NCT01227616|AMAG Pharmaceuticals|Medical Information||CTInterest@covispharma.com|
21252375|NCT00920647|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21252376|NCT00569192|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
21252377|NCT05032066|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21252378|NCT04297618|Centre for Ocular Research and Education|Jill Woods|(519) 888-4567|jwoods@uwaterloo.ca|36743
21252379|NCT02600897|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21252380|NCT05304117|Western Carolina University|Dr. R Turner Goins|828.227.3515|rtgoins@wcu.edu|
21252381|NCT02614183|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21252382|NCT02259621|Johns Hopkins SKCCC Clinical Research Office Coordinating Center|Jasmine Brooks|6673068335|jbrook54@jhmi.edu|
21252383|NCT05992922|Iacta Pharmaceuticals|Chief Operating Officer|714-330-8532|sj@iactapharma.com|
21252384|NCT04680533|University of Rochester|Jennifer Gewandter|(585) 276-5661|jennifer_gewandter@urmc.rochester.edu|
21252385|NCT04991753|Janssen Research & Development|Medical Director Rheumatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21252386|NCT02797522|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
21252387|NCT00132678|Johnson & Johnson Pharmaceutical Research and Development|Director of Clinical Research|609 730-4576||
21252388|NCT01901419|Department of Anesthesiology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan|Dr. Tso-Chou Lin|+886-2-87927128|tclin@mail.ndmctsgh.edu.tw|
21252389|NCT01888874|Galapagos N.V.|Clinical Trial Information Desk|+32 (0)15 342 900|rd@glpg.com|
21283360|NCT02035748|Alcon, a Novartis company|EMEA Medical Affairs Lead, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
21283361|NCT02083185|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21283362|NCT01740128|James J. Peters VAMC|Noam Y. Harel, MD, PhD|718-584-9000|noam.harel@va.gov|1742
21283363|NCT02474589|SIGA Technologies|Dennis E Hruby, PhD, Chief Scientific Officer|541-753-2000|dhruby@siga.com|
21283364|NCT02231879|LMI/NIAID/NIH|Dr. David H. McDermott|301-761-6647|dmcdermott@niaid.nih.gov|
21283365|NCT05007041|Duke University|Dr. Kenneth Schmader|919-660-7572|kenneth.schmader@duke.edu|
21283366|NCT00705718|Medtronic|Karla Betz, Principal Clinical Research Specialist|763-526-2737|karla.h.betz@medtronic.com|
21283367|NCT00711828|Mayo Clinic|Craig B. Reeder, M.D.||Reeder.Craig@mayo.edu|
21283368|NCT00423189|Retina Consultants of Houston|David M. Brown|713-524-3434|dmbmd@houstonretina.com|
21283369|NCT01890226|Emory University|Dr. Benjamin Druss|404-712-9602|bdruss@emory.edu|
21283370|NCT01844206|Columbia University|Dr. Allison Lee|305-582-6077|al3196@cumc.columbia.edu|
21283371|NCT05028413|University of Pennsylvania|Associate Professor Mucio C. Delgado, MD, MS|215-74-826|mucio.delgado@pennmedicine.upenn.edu|
21283372|NCT01459718|Novartis Pharmaceuticals|Study Director|862-778-1873||
21283373|NCT00715728|Vienna General Hospital/University of Vienna|Olga Plattner, Medical Doctor|43-1-40-400-4103|olga.plattner@meduniwien.ac.at|
21283374|NCT02939716|University of Nottingham|Robin Spiller|01158231090|robin.spiller@nottingham.ac.uk|
21283375|NCT00976209|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21283376|NCT00574249|Abbott|Medical Information Specialist|1-800-633-9110||
21283377|NCT03488849|InnoVital Systems|Chief Medical Officer|2022862328|amit@innovitalsystems.com|
21283378|NCT01542034|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
21283379|NCT01546571|Polynoma|Clinical Program Director|5418405451|karihatten@polynoma.com|
21283380|NCT01421186|MorphoSys AG|Dr Winrich Rauschning, Clinical Project Lead (external)|+4989 89927|winrich.rauschning@external.morphosys.com|0
21283381|NCT01880086|Weill Cornell Medical College|Dr. Peter N. Schlegel|2127465491|pnschleg@med.cornell.edu|
21283382|NCT04360174|Ocular Therapeutix|Chief Medical Officer|7813574000|clinicalaffairs@ocutx.com|
21283383|NCT04021121|University of California, San Francisco|Dr. Felicia Chow|(628) 206-4449|felicia.chow@ucsf.edu|
21283384|NCT00978250|National Cancer Institute|Dr. James Doroshow|240-781-3320|jim_doroshow@nih.gov|
21283385|NCT03826628|AFT Pharmaceuticals Ltd.|Ioana Stanescu|+64 9 488 0232|ioana.stanescu@aftpharm.com|712
21283386|NCT01330394|Federal University of Espírito Santo|Dr. Ester Miyuki Nakamura-Palacios|+55 27 7775-7337|emnpalacios@gmail.com|
21283387|NCT02029989|UMN, College of Pharmacy|Dr. Mark E. Schneiderhan|8452540458|meschnei@d.umn.edu|
21283388|NCT05036668|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
21283389|NCT04601103|3M Health Care Business Group|Brenda Coalwell, Clinical Affairs Manager|16517362456|bccoalwell1@mmm.com|
21283390|NCT05168878|University of Colorado|Dr. Maya Haasz|7204789231|maya.haasz@childrenscolorado.org|
21283391|NCT00381043|University of North Carolina at Chapel Hill|Dr. J.C. Garbutt|919-966-4652|jc_garbutt@med.unc.edu|
21283392|NCT02880865|PATH|Jorge Flores, MD|(202) 822-0033|jeflores@path.org|
21283393|NCT02224820|Dept of Transplant Surgery, Uppsala University Hospital|Dr. Tomas Lorant|+46 70 677 29 01|tomas.lorant@surgsci.uu.se|
21283394|NCT03724877|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21283395|NCT00125242|VA Salt Lake City Health Care System|Dr. Julie Wambaugh|801-582-1565|julie.wambaugh@health.utah.edu|1363
21283396|NCT01664949|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21283397|NCT04654754|Rush University|Dr. Jie Li|3125634643|jie_li@rush.edu|
21283398|NCT02727777|UT MD Anderson Cancer Center|Dr. Jason R. Westin/Lymphoma/Myeloma|713-792-3750|jwestin@mdanderson.org|
21283399|NCT01738503|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
21252390|NCT05302440|University of Hong Kong|Dr. Derek Yee Tak CHEUNG|3917 6652|derekcheung@hku.hk|
21283400|NCT04687072|Argenx|Regulatory manager|Please email|regulatory@argenx.com|
21252391|NCT00475644|Eli Lilly and Company|Cheif Medical Officer|800-545-5979||
21283401|NCT02272842|Innlandet Hospital Trust|Tor Strand|+4790971086|tors@me.com|
21283402|NCT01187498|Birmingham VA Medical Center|Kathryn L. Burgio, PhD|205-558-7064|kburgio@uabmc.edu|
21283403|NCT05376241|University of Colorado|Laura Scherer|303-724-5749|laura.scherer@cuanschutz.edu|
21283404|NCT03036098|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21283405|NCT05773781|University of Liverpool|Mr Jason Fleming|0151 529 5259|Jason.Fleming@liverpool.ac.uk|
21283406|NCT01632904|Incyte Corporation|Study Director|855 463-3463||
21283407|NCT01944670|Skeletal Dynamics, LLC|Ana Escagedo|305-596-7585|AEscagedo@SkeletalDynamics.com|
21283408|NCT06474078|Chang Gung Memorial Hospital|Dr. Chun Bing Chen|03-3281200|chunbing.chen@gmail.com|8494
21283409|NCT03339726|JNJWorldwide|Steven Sacavage, PharmD, Associate Director, Global Pain & Allergy Clinical Research|215 273-8568|ssacavag@its.jnj.com|8568
21283410|NCT02210247|Pacira Pharmaceuticals Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
21283411|NCT04542499|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21283412|NCT02142361|Optometry Research Group (GIO)|Robert Montés-Mico O.D., MPhil, PhD Optometry|34-9635-44764|robert.montes@uv.es|
21283413|NCT04281784|University of Washington|Janaki Torrence, Research Coordinator|206-402-7357|jtorrenc@uw.edu|
21283414|NCT04035434|CRISPR Therapeutics AG|Annie Weaver, PhD: Study Director|+1 617-315-4600|info@crisprtx.com|
21283415|NCT02210286|Stanford University|Alison Myoraku|6507244559|myoraku@stanford.edu|
21283416|NCT02879994|Jonsson Comprehensieve Cancer Center|Dr. Edward Garon|(310)586-2098|egaron@mednet.ucla.edu|
21283417|NCT02143791|Abbott|Devyani Nanduri|+1 510 561 4328|devyani.nanduri@abbott.com|
21283418|NCT04112160|UT Southwestern Dept of Urology|Dr. Brett Johnson|214-645-3526|brett.johnson@utsouthwestern.edu|
21283419|NCT03051516|Fred Hutchinson Cancer Center|Margaret M. Madeleine, PhD|206-667-4630|mmadelei@fredhutch.org|
21283420|NCT01272141|Emory University School of Medicine|William Read, MD|1-888-946-7447|william.l.read@emory.edu|
21283421|NCT04984681|University of Alabama at Birmingham|Crystal Chapman Lambert|205-934-3481|cclamber@uab.edu|
21283422|NCT01214252|Covidien|Annie Choi|781-839-1756|annie.choi@covidien.com|
21283423|NCT02817698|Yale University|Marc Grasso|2037377074|marc.grasso@yale.edu|
21283424|NCT00552032|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21283425|NCT02327403|Massachusetts General Hospital|Dr. Leonardo V Riella, MD, PhD|6176436266|LRIELLA@MGH.HARVARD.EDU|
21283426|NCT00880230|Medtronic Aortic and Peripheral Vascular|Arslan Malik - Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com|
21283427|NCT01258075|Daiichi Sankyo|Contact of Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21283428|NCT02612610|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21283429|NCT01260272|L-MARC Research center|Kathy Schmitz, Site Manager|502 214 3990|kschmitz@lmarc.com|
21283430|NCT04060199|NS Pharma, Inc.|Medical Affairs|+1(201) 986-3860|trialinfo@nspharma.com|
21283431|NCT00478699|Fundación GECP|Eva Pereira|+34 934302006|epereira@gecp.org|
21283432|NCT01629290|University of Michigan School of Dentistry|Danika Downey, DDS|330-877-8783|danika.downey@gmail.com|
21283433|NCT01252563|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21283434|NCT01866657|University Hospitals Cleveland Medical Center|Dr. Edwin Avery|440-391-0690|Edwin.avery@uhhospitals.org|
21283435|NCT00214149|UW Hospital and Clinics|Diana Trask, research coordinator for study|608-263-9528|trask@humonc.wisc.edu|
21283436|NCT05174949|University of Oklahoma Health Sciences Center|Dr. Yuan Yang (Principal Investigator) C/o Dr. Shirley James (Project Biostatistician)|4052712131|shirley-james@ouhsc.edu|46812
21283437|NCT02951533|Janssen-Cilag GmbH|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21283438|NCT04351373|Mayo Clinic|Dr. Matthew Carlson|507-284-8532|Carlson.Matthew@mayo.edu|
21283439|NCT04537910|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21283440|NCT00896181|Stanford University|Dr. A. Dimitrios Colevas, Professor of Medicine (Oncology)|650-724-9707|colevas@stanford.edu|
21283441|NCT01123941|Novartis Vaccines Institute for Global Health|Dr. Audino Podda, MD|+39 0577 243496|audino.podda@novartis.com|
21283442|NCT03338803|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21283443|NCT05083923|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21283444|NCT01203826|Alexion Pharmaceuticals, Inc.|Director of Clinical Trials|475-230-2596|ClinicalTrials@alexion.com|
21283445|NCT02751879|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21283446|NCT01537068|NYSPI|David Hellerstein MD|646-774-8000|desdesk@nyspi.columbia.edu|
21283447|NCT06011161|VISN 2 Center of Excellence for Suicide Prevention|Dev Crasta|585-364-8119|Dev.Crasta@va.gov|
21283448|NCT05805085|CooperVision Inc.|José A. Vega OD, MSc, PhD, FAAO|+19256213761|jvega2@coopervision.com|
21283449|NCT02291601|Bioscience Labs|C Beausoleil|460-782-5498|cbeausoleil@biosciencelabs.com|
21283450|NCT00756561|University of Washington, Dept. of Medicine|Mara Roth, MD|(206) 221-0519|mylang@u.washington.edu|
21283451|NCT01597375|Brigham and Women's Hospital|Tanya Laidlaw|617-525-1034|tlaidlaw@bwh.harvard.edu|
21283452|NCT00624195|UCSD|Dr. Ron Ellis|619-543-5079|roellis@ucsd.edu|
21283453|NCT01190267|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21283454|NCT04017832|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21283455|NCT00796705|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21283456|NCT03376256|University of Miami|Dr. Ralf Gebhard|3055858365|rgebhard@med.miami.edu|
21283457|NCT02251106|University of Alberta|Dr. Greg Kawchuk|780-492-6891|greg.kawchuk@ualberta.ca|
21283458|NCT02375555|Dana Farber Cancer Institute|Ajantha Nithi|857-215-2829|ajantha_nithi@dfci.harvard.edu|
21283459|NCT02091986|AstraZeneca|Global Clinical Lead Göran Eckerwall||ClinicalTrialTransparency@astrazeneca.com|
21283460|NCT00606554|Boston University School of Medicine|Allan Walkey, MD, MSc|617-638-4860|alwalkey@bu.edu|
21298070|NCT02487030|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21298071|NCT02123576|The Pennsylvania State University Division of Gastroenterology and Hepatology Milton S. Herhsey Medical Center|Dr. Jonathan G. Stine|717-531-0003|jstine@pennstatehealth.psu.edu|28-9478
21298072|NCT02395614|Vanderbilt university medical center|Dr. Kent K. Higdon|615-936-0160|kent.hidgon@vumc.org|
21298073|NCT01985425|Population Health Research Institute|Dr. Philip Devereaux|905-527-4322|philipj@mcmaster.ca|40654
21298074|NCT04649177|BostonSight|Daniel Brocks, MD|(781)726-7337|ecrowley@bostonsight.org|
21298075|NCT00999544|University of Kentucky|Dr. Sharon Walsh|859-257-6485|sharon.walsh@uky.edu|
21298076|NCT04683835|Neurosteer|Nathan Intrator, Prof.|+1 (401) 837-0351|nathan@neurosteer.com|
21298077|NCT02936635|Cytokinetics, Inc.|MD Cytokinetics|650-624-2929|medicalaffairs@cytokinetics.com|
21298078|NCT02407223|Janssen Research & Development, LLC|Scientific Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21298079|NCT00447226|GlaxoSmithKline|GSK Response Center|866-435-7343||
21298080|NCT02309944|Masonic Cancer Center, University of Minnesota|Deanna GK Teoh|612-626-3111|dkteoh@umn.edu|
21298081|NCT03049917|University of Washington|Dr.|206-422-5564|jsyker@uw.edu|
21298082|NCT01860287|University of Chicago|Dr. Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
21298083|NCT01478971|Takeda|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
21298084|NCT00988013|University of Illinois at Chicago|Dr. Damiano Rondelli|312-996-6179|drond@uic.edu|
21298085|NCT01402817|Indiana University School of Medicine - Pediatrics|Chie-Schin Shih, MD|317-948-8568|shih2@iu.edu|
21298086|NCT00681629|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21298087|NCT00412893|Astellas Pharma Global Development, Inc.|Medical Head Immunology, Transplant and Infectious Disease Therapeutic Area||resultsdisclosure@astellas.com|
21298088|NCT01751984|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
21298089|NCT00587158|Mayo Clinic|Hatem Amer, MD, FASN; Assistant Professor of Medicine; Division of Nephrology and Hypertension|507-256-1963|amer.hatem@mayo.edu|
21298090|NCT01136408|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21298091|NCT02274792|Amgen Inc.|Study Director|866-572-6436||
21298092|NCT00476827|Duke University|Kimberly Blackwell, MD|919-668-1748|kimberly.blackwell@duke.edu|
21298093|NCT00981461|Lexington International, LLC|David Michaels|5614170200|dm@hairmax.com|
21298094|NCT00571038|Clement J. Zablocki VA Medical Center|Jeff Whittle, MD, MPH|414-384-2000|jeffrey.whittle@va.gov|46444
21298095|NCT05786508|University of Minnesota|Brent Leininger|6126266477|lein0122@umn.edu|
21298096|NCT01761019|Department of Dermatology, University of Pittsburgh School of Medicine|Laura K. Ferris, MD, PhD|412-647-2013|ferrlk@upmc.edu|
21298097|NCT03781778|Fred Hutchinson Cancer Research Center|Marian L. Neuhouser, PhD|2066674797|mneuhous@fredhutch.org|
21298098|NCT00225498|Feinstein Institute for Medical Research, Zucker Hillside Hospital|Anil K. Malhotra, MD|718-470-8012|malhotra@lij.edu|
21298099|NCT01456169|Takeda GlobalResearch and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21298100|NCT00935311|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21298101|NCT02652156|Midwestern Regional Medical Center|Director of Clinical Trials|847-731-1648|Bruce.Steinert@CTCA-Hope.com|
21298102|NCT01822457|Imperial Vascular Unit|Mr Pasha Normahani|+44 (0) 20 759 48904|pnormahani@gmail.com|
21298103|NCT02223338|Loma Linda University|Dr. David Sierpina|9095582154|dsierpina@llu.edu|
21298104|NCT00496080|Ethicon|Piet Hinoul MD|908-218-2585|phinoul@its.jnj.com|
21298105|NCT04098809|Benaroya Research Institute at Virginia Mason|Dr. Andrew Stamm|206-223-6772|Andrew.Stamm@virginiamason.org|
21298106|NCT03101254|Dana-Farber Cancer Institute|Dr. Elizabeth Buchbinder|6176325055|elizabeth_buchbinder@dfci.harvard.edu|
21298107|NCT00570310|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21298108|NCT00759161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21298109|NCT03329846|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21298110|NCT02741596|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21298111|NCT00479336|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
21298112|NCT03066193|Yale University|Dr. Michael H. Bloch|2037374539|michael.bloch@yale.edu|
21298113|NCT00900666|Mary Free Bed Rehabilitation Hospital|Krisanne B. Chapin, PhD|616-493-9831|krisanne.chapin@maryfreebed.com|
21298114|NCT02947646|Actuated Medical|Director Quality Assurance & Regulatory Affairs|814-355-0003|medical.affairs@actuatedmedical.com|
21298115|NCT04854551|University of Colorado Anschutz Medical Campus|Joshua Gowin|3037243769|joshua.gowin@cuanschutz.edu|
21298116|NCT01165541|Geisel School of Medicine At Dartmouth|Mary Brunette, MD|603-271-7642|mary.brunette@dartmouth.edu|
21298117|NCT02859246|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana|617-573-4331|Reza_Dana@meei.harvard.edu|
21298118|NCT05280717|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
21298119|NCT00080301|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21298120|NCT01521507|TearScience, Inc.|Study Director|919-467-4007|cstevens@tearscience.com|
21298121|NCT04034004|UC San Diego|Dr. Fadel Zeidan|858-246-8342|zeidanlaboratory@ucsd.edu|
21298122|NCT04317040|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21298123|NCT02518971|Michigan Medicine|Andrew Urquhart|734-936-6636|andrewu@med.umich.edu|
21298124|NCT00757237|Gilead Sciences, Inc.|Mark Bresnik, MD, Director, Clinical Research|(650) 522-5934|mark.bresnik@gilead.com|
21298125|NCT00947271|The Miriam Hospital|Dr. Michael Carey|401-793-8218|michael_carey@brown.edu|
21298126|NCT05150990|University of California Santa Barbara|Dr. Nancy Collins|805-568-0042|ncollins@ucsb.edu|
21298127|NCT01022138|Karmanos Cancer Institute|Dr. Abhinav Deol|313-576-8093|deola@karmanos.org|
21252392|NCT04486625|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21252393|NCT01411241|Sanofi Pasteur|Director||Contact-US@sanofi.com|
21252394|NCT02301377|University of Michigan|Dr. Aarti Shakkottai|734-764-4123|aartik@med.umich.edu|
21283461|NCT00915876|University of Michigan|Amy Pai|7346470005|amypai@med.umich.edu|
21283462|NCT01662791|Mayo Clinic|Dr. John K. DiBaise|480-301-6990|DiBaise.John@mayo.edu|
21283463|NCT03626363|Michigan Technological University|Kelly Kallio, Assistant Vice President of Sponsored Programs|9064872226|kmkallio@mtu.edu|
21283464|NCT01970475|Amgen Inc.|Study Director|866-572-6436||
21283465|NCT00960986|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21283466|NCT01984892|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu|
21283467|NCT04464720|University of California San Francisco|Dr. Stephanie M Holm|415-514-0878|stephanie.holm@ucsf.edu|
21283468|NCT00342563|Yale University School of Medicine|Dr. Elizabeth Ralevski|+1 203-932-5711|elizabeth.ralevski@yale.edu|x4282
21283469|NCT02156895|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21283470|NCT03955081|OLYMPUS EUROPA SE & CO. KG|Peter Teichmann, PhD|+49 40 23773|peter.teichmann@olympus.com|7835
21283471|NCT03495154|Medtronic|Alyssa Sutch, Senior Clinical Research Specialist|612-214-9756|alyssa.m.sutch@medtronic.com|
21283472|NCT05013788|The University of Texas Health Science Center at Houston|Monica Kodakandla, MD|713-500-5666|RMonica.Kodakandla@uth.tmc.edu|
21283473|NCT04383938|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
21283474|NCT03728985|W.L. Gore and Associates|Rizwan Afzal|1-623-234-5408|rafzal@wlgore.com|
21283475|NCT00688935|Oregon Health and Science University|OHSU Integrity Department|1-877-733-8313|irb@ohsu.edu|
21283476|NCT01294696|Merck Sharp & Dohme Corp|Vice President, Late Stage Group Development Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21283477|NCT05633992|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21297046|NCT02170870|Mayo Clinic|Dr. Adil E. Bharucha, Principal Investigator|507-284-2687|bharucha.adil@mayo.edu|
21297047|NCT01450098|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21297048|NCT01128192|Veterans Medical Research Foundation|Principal Investigator|858-552-8585|rrhenry@ucsd.edu|
21297049|NCT05443256|University of New Mexico|Dr. James F. Cavanagh|5052773890|jcavanagh@unm.edu|
21297050|NCT00125957|McLean Hospital|Dr. Beth Murphy|617-855-2000|bmurphy5@partners.org|2297
21297051|NCT00482625|Weill Cornell College of Medicine|Dr. Steven Lipkin|212-774-7160|stl2012@med.cornell.edu|
21297052|NCT01078363|Stanford University|William F. Fearon, M.D.|650 725-2621|wfearon@stanford.edu|
21297053|NCT03828617|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21297054|NCT03354273|GE HealthCare|Francois Tranquart, M.D., Ph.D|447775543206|francois.tranquart@ge.com|
21297055|NCT03121365|The Children's Hospital of Phiadelphia|Dr. James Guevara|215-590-1130|Guevara@email.chop.edu|
21297056|NCT03229109|Maale Carmel Mental Health Center|Anatoly Kreinin|(+972) -4-8559315|kranata@gmail.com|
21297057|NCT03653988|University of Iowa Hospitals and Clinics|Melinda Seering, M.D.|(319) 384-8466|melinda-seering@uiowa.edu|
21297058|NCT04207749|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21297059|NCT00655629|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21297060|NCT03416127|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
21297061|NCT00244101|Vermont Oxford Network|Roger F. Soll, MD|802 865 4814|roger.soll@uvmhealth.org|212
21297062|NCT03387020|St. Jude Children's Research Hospital|Dr. Arzu Onar-Thomas|901-595-5499|arzu.onar@stjude.org|
21297063|NCT01452919|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21297064|NCT02421588|Pharma Mar S.A.|Pharma Mar S.A.|0034918466000|clinicaltrials@pharmamar.com|
21297065|NCT01359943|Novartis Pharmaceuticals|Study Director|862-778-8300||
21297066|NCT02516592|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21297067|NCT01110382|Janssen R&D US|Therapeutic Areas Director||ClinicalTrialDisclosure@its.jnj.com|
21297068|NCT02004977|University of Minnesota|Dr. Susie Nanney|612-626-6794|msnanney@umn.edu|
21297069|NCT00098306|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21297070|NCT00470418|James J Peters VA Medical Center|Dr. Hillel Grossman|718-584-9000|hillel.grossman2@va.gov|5752
21297071|NCT01946126|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21297072|NCT03688100|Cedars-Sinai Medical Center|Dr. Waguih IsHak|310-423-3515|Waguih.IsHak@cshs.org|
21297073|NCT04783077|University of Minnesota|Susan Telke|6125902697|telke001@umn.edu|
21297074|NCT01331291|Massachusetts General Hospital|Tracy T. Batchelor, MD|617-643-1938|tbatchelor@mgh.harvard.edu|
21297075|NCT01026220|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21297076|NCT04684992|Cairn Diagnostics|Chief Scientist and Compliance Officer|615-376-5464|cwilliams@cairndx.com|
21297077|NCT00409344|Massachusetts General Hospital|Ulrich Schmidt, MD PhD|617-724-6490|uschmidt@partners.org|
21297078|NCT03776461|Venus Concept|Director of Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
21252395|NCT03211234|Santen Inc|R&D Quality Manager|+1 415 268 9199|clinicaltrials@santen.com|
21252396|NCT02412735|Mesoblast, Inc.|Christopher James, VP Head of Clinical Operations|212-880-2060|Christopher.James@Mesoblast.com|7925
21252397|NCT01006980|Hoffman-LaRoche|Medical Communications|800-821-8590||
21252398|NCT01483144|Cancer Prevention Pharmaceuticals|Michelle Boytim|520-908-7774|mboytim@canprevent.com|
21252399|NCT02124811|Emory University|Robert Cotes, MD|(404) 616-4752|robert.o.cotes@emory.edu|
21267070|NCT00712712|Institute Bergonie|Dr. Jean Palussière|05 56 33 37 50|j.palussiere@bordeaux.unicancer.fr|
21297079|NCT02163421|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21297080|NCT01389323|BristolMyers Squibb|BristolMyers Squibb Study Director||Clinical.Trials@bms.com|
21252400|NCT03412916|Center for Health Outcomes and Interdisciplinary Research, Department of Psychiatry, Massachusetts General Hospital|Ana-Maria Vranceanu|(617) 724-3953|avranceanu@mgh.harvard.edu|
21283478|NCT02276053|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21283479|NCT02956447|Massachusetts General Hospital|Dr. Stephanie Seminara|617-724-5390|MGHKisspeptinResearch@partners.org|
21283480|NCT01004406|VA North Texas Health Care System, Dallas, TX and University of Texas Southwestern Medical Center|Dr. Subhash Banerjee|214-857-1608|Subhash.Banerjee@va.gov, Subhash.Banerjee@UTSouthwestern.edu|
21283481|NCT00929474|St. Jude Medical|Manager of Clinical Studies|818-493-2522|klee3@sjm.com|
21283482|NCT02907593|Oregon Health & Science University|Dr. Cindy McEvoy|5034945598|mcevoyc@ohsu.edu|
21283483|NCT03050541|University of Chicago|Office of Clinical Research|(773) 834-1238|tkyeo@bsd.uchicago.edu|
21283484|NCT01196936|University of Alabama at Birmingham|Dr. Smita Bhatia|(205) 638-2120|sbhatia@peds.uab.edu|
21283485|NCT04488497|Weill Cornell Medicine|Dr. Iris Navarro Millan|646-962-7875|vam4007@med.cornell.edu|
21283486|NCT04322539|HUTCHMED International|William Schelman, MD, PhD|+1-973-306-4490|williams@hutch-med.com|
21283487|NCT02111746|The University of Texas Health Science Center at Houston|Dr. Kristofer M Charlton-Ouw|(713) 486-5100|Kristofer.CharltonOuw@uth.tmc.edu|
21283488|NCT01849068|Laval University|Dr. Patrick Couture MD, PhD, FRCP|418-654-2106|patrick.couture@crchul.ulaval.ca|
21283489|NCT04063657|University of California, Davis|Dr. Christopher Kreulen|(916) 734-6805|ckreulen@ucdavis.edu|
21283490|NCT03409107|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21283491|NCT01185509|Dana-Farber Cancer Institute|Ian Krop, MD, PhD|617.632.6973|Ian_Krop@dfci.harvard.edu|
21283492|NCT00916344|BIOTRONIK SE & Co.KG|Dr. Evelyn Diessel|+49 (0) 30 68905|evelyn.diessel@biotronik.com|1231
21283493|NCT03991013|University of Cape Town|Prof Graeme Meintjes|+27 (0) 21 4066075|Graeme.Meintjes@uct.ac.za|
21283494|NCT00828074|City of Hope|Paul Frankel, Ph.D.|626-359-8111|pfrankel@coh.org|65265
21283495|NCT00258349|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
21283496|NCT01088243|National Jewish Health|Dr. Lisa A. Maier|303-398-1983|MaierL@NJHealth.org|
21283497|NCT02122770|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21283498|NCT01041976|Edith Nourse Rogers Memorial VA|Lisa Mueller|781-687-3192|Lisa.Mueller@va.gov|
21283499|NCT02658734|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21283500|NCT02262000|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
21283501|NCT01007136|University of Texas Southwestern|Timea Hodics, M.D.||Timea.Hodics@UTSouthwestern.edu|
21283502|NCT01128218|SIU Medicine|Barbara Lokaitis, BA, CCRP / Senior Clinical Research Coordinator|217.545.9737|blokaitis@siumed.edu|
21283503|NCT01230424|Tufts Medical Center|Dr. Timothy McAlindon|6176365610|tmcalindon@tuftsmedicalcenter.org|
21283504|NCT02370667|McMaster University|Dr. Monica Maly|905-525-9140|mmaly@mcmaster.ca|27823
21283505|NCT03536949|RVL Pharmaceuticals, Inc.|Senior Director of Clinical Operations|908-809-1423|mvelasco@osmotica.com|
21283506|NCT02901275|Johns Hopkins University School of Medicine|Dr. Kelly Dunn|410-550-2254|kdunn9@jhmi.edu|
21283507|NCT02954653|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21283508|NCT03054064|Parker Hannifin Corporation|Ryan J. Farris, Ph.D., P.E.|2168963335|ryan.farris@parker.com|
21283509|NCT04329091|UNIVERSITY OF CHICAGO|Al McAuley, Clinical Research Manager|7738343274|amcauley1@bsd.uchicago.edu|
21283510|NCT04106089|Rutgers University Camden|Dr. Lauren Daniel|856-225-6535|lauren.daniel@rutgers.edu|
21283511|NCT03787303|Aultman Hospital|Shruti Trehan MD|3303634162|trehanshruti4@gmail.com|
21283512|NCT02938949|Virginia Commonwealth University|Cory Trankle, MD|804-213-2679|cory.trankle@vcuhealth.org|
21283513|NCT00371644|VA North Texas Health Care System|Dr. Alina Suris|2148572312|alina.suris@va.gov|
21283514|NCT00785213|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21283515|NCT01500213|Tesaro|Martin Huber, M.D., Senior Vice President and Chief Medical Officer|862.228.2483|mhuber@tesarobio.com|
21283516|NCT02386345|Abbott|Clinical Program Director|6517566717|kristin.ruffner@abbott.com|
21283517|NCT01005888|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21283518|NCT01043705|Medtronic plc|Lynn Landborg, Clinical Research Manager|763 526 2877|lynn.landborg@medtronic.com|
21283519|NCT00669019|University of Chicago|Dr. Thomas F. Gajewski|773-702-4601|tgajewsk@medicine.bsd.uchicago.edu|
21283520|NCT02003963|Pennington Biomedical Research Center|Dr. Amanda Staiano|2257632729|amanda.staiano@pbrc.edu|
21283521|NCT00581542|University of Rochester, Strong Mem orial Hospital|Franci Gigilotti|585 275-0588|francis_gigilotti@urmc.rochester.edu|
21283522|NCT01801280|Charité University Hospital - Department of Nephrology|Olesja Rissling|+49 30 450 514 153|olesja.rissling@charite.de|
21283523|NCT00176644|Cancer Institute of New Jersey|Dr. Mark Stein|732-235-8675|steinmn@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
21283524|NCT05020366|University of Pittsburgh|Dr. Angela Caldwell|412-383-7231|arl78@pitt.edu|
21283525|NCT00392496|Sunnybrook Health Sciences Centre|Dr. Rena Buckstein|416-480-5847|rena.buckstein@sunnybrook.ca|
21283526|NCT04150705|Washington University School of Medicine|Tyler Fraum, M.D.|314-362-2928|tylerjfraum@wustl.edu|
21283527|NCT01065714|DermResearch, PLLC|Leon Kircik, M.D.|502-451-9000|wedoderm@yahoo.com|
21283528|NCT05870956|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21283529|NCT04065451|Indiana University|Clinical Research Specialist|317-948-0724|rlahr@iu.edu|
21283530|NCT03045276|Children's Hospital of Philadelphia|Dr. Sandra Amaral|2678443097|amarals@chop.edu|
21283531|NCT02267772|The University of Texas Health Science Center at Houston|Jerrie S. Refuerzo, MD, Associate Professor|713-500-6416|jerrie.s.refuerzo@uth.tmc.edu|
21283532|NCT02046395|Tulane University|Vechi Batuman|(504)988-5346|vbatuma@tulane.edu|
21283533|NCT04616573|Sight Sciences, Inc.|Kavita Dhamdhere, MD, PhD|877-266-1144|kdhamdhere@sightsciences.com|
21283534|NCT03641326|National Cancer Institute|Dr. Mark Gilbert|240-760-6023|mark.gilbert@nih.gov|
21283535|NCT03003494|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21283536|NCT00794040|Mood, Brain and Development Unit, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health|Dr Argyris Stringaris|(301) 443-8019|argyris.stringaris@nih.gov|
21283537|NCT04696354|Philips|Danielle Op den Kamp, Sr Manager Clinical Operations|+31 (0)627218737|Danielle.op.den.kamp@philips.com|
21283538|NCT03005327|X4 Pharmaceuticals|Chief Medical Officer|(857) 529-8300|patientinfo@x4pharma.com|
21283539|NCT03040804|Montefiore Medical Center|Steven R. Cohen, MD, MPH|7189208352|srcohen@montefiore.org|
21283540|NCT01263782|UT MD Anderson Cancer Center|Dr. George Simon, Thoracic/Head & Neck Med Onc|713-794-4740|GSIMON@MDANDERSON.ORG|
21283541|NCT01490073|University of Washington|Elizabeth Micks|206-616-4939|emicks@uw.edu|
21283542|NCT02782065|Boston Children's Hospital|Leah Abecassis|6173552299|leah.abecassis@childrens.harvard.edu|
21283543|NCT04545567|University of Virginia|Mark DeBoer|1 434 924 0123|mdd5z@virginia.edu|
21283544|NCT03979807|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21283545|NCT02000882|US Oncology Research|Taqi Mohammad|7138702175|taqi.mohammad@mckesson.com|
21283546|NCT00538512|University of Michigan School of Public Health|Arnold S. Monto, MD|734-764-5453|asmonto@umich.edu|
21283547|NCT02417961|AstraZeneca|Mitchell Goldman, Global Clinical Lead Benralizumab|+1 301 398 0323|Mitchell.Goldman@astrazeneca.com|
21283548|NCT01390428|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21283549|NCT05079750|University of Oxford|Dr. Paola Cicconi|01865 611425|paola.cicconi@ndm.ox.ac.uk|
21283550|NCT00642603|Genentech, Inc.|Medical Communications|800-821-8590||
21283551|NCT05091346|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
21283552|NCT05897827|University of Pittsburgh|Robert W. S. Coulter|412-624-0647|robert.ws.coulter@pitt.edu|
21283553|NCT03569293|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21283554|NCT04843761|University of Minnesota|Shweta Sharma Mistry|612-626-9021|shwetas@ccbr.umn.edu|
21283555|NCT00715104|Dendreon Corporation|Lynn Ngo|206-274-6763|lngo@dendreon.com|
21283556|NCT02059434|AstraZeneca|AstraZeneca Clinical Study Information Center||ClinicalTrialTransparency@astrazeneca.com|
21283557|NCT02928770|Stanford University|Clete A. Kushida, M.D., Ph.D.|6507217560|clete@stanford.edu|
21283558|NCT03201874|Seattle Children's Hospital|Tonya Palermo, Professor, Anesthesiology and Pain Medicine, Seattle Children's Hospital|206-884-4208|tonya.palermo@seattlechildrens.org|
21283559|NCT00962949|Vanderbilt University Medical Center|Hossam Mustafa|615-343-6499|adcresearch@vanderbilt.edu|
21283560|NCT05103176|University of Michigan|Dr. Michael Vesia, Assistant Professor|734 763-3905|mvesia@umich.edu|
21283561|NCT05409131|Insulet Corporation|Dr. Trang Ly|9786007628|tly@insulet.com|
21283562|NCT04644185|Sinocelltech Ltd.|Dr.|13522038372|yuanxin_chen@sinocelltech.com|
21283563|NCT05128773|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21283564|NCT04250714|Boston Scientific|Nele Cielen - Clinical Trial Manager|0032470991143|nele.cielen@bsci.com|
21283565|NCT04697056|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
21283566|NCT03617861|Mayo Clinic|Michael Camilleri, MD|507-266-2305|camilleri.michael@mayo.edu|
21283567|NCT00345878|GlaxoSmithKline|GSK Response Center|866-435-7343||
21283568|NCT00308750|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21283569|NCT01358578|Novartis|Study Director|862-778-8300||
21283570|NCT01643798|Medical University of South Carolina|Joseph Taylor|8437295729|taylorjj@musc.edu|
21283571|NCT03605849|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21283572|NCT02102100|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-932-5711|mehemt.sofuoglu@yale.edu|4809
21283573|NCT03870529|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-716-4760|jkettler@wakehealth.edu|
21283574|NCT02045732|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21283575|NCT05014815|BeiGene|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
21283576|NCT04516343|Biomotum|Chief Science Officer|(800) 566-2531|zach@biomotum.com|
21283577|NCT03833804|UW School of Medicine and Public Health|Majid Afshar, MD|608-263-1792|mafshar@medicine.wisc.edu|
21283578|NCT05185622|Santhera|Dr Shabir Hasham|+41 61 906 89 50|Shabir.Hasham@santhera.com|
21283579|NCT06303167|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21283580|NCT01877551|Washington University School of Medicine|Dr. Dominic Reeds|3143628430|dreeds@wustl.edu|
21283581|NCT02659514|Spectrum Pharmaceuticals, Inc, Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|9497886700|shanta.chawla@sppirx.com|
21283582|NCT00348790|Northwestern University|Jeffrey Raizer, MD|312-503-4724|jraizer@nmff.org|
21283583|NCT03719287|3M|Helen Han|651-737-9234|mhan3@mmm.com|
21283584|NCT03687372|Aclaris Therapeutics, Inc.|Aclaris Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
21283585|NCT02614222|The Cooper Health System|Dr. Ronak Desai|856-342-2000|desai-ronak@cooperhealth.edu|
21283586|NCT03602391|University of Texas at Arlington|JEREMY A FORSBERG|8172722105|ogcs@uta.edu|
21283587|NCT00984139|GlaxoSmithKline|GSK Response Center|866-435-7343||
21283588|NCT00108485|Diabetes Research Institute|Dr. Ronald Goldberg|305-243-6574|RGoldber@med.miami.edu|
21283589|NCT02725580|Amicus Therapeutics|Amicus Therapeutics Patient Advocacy|+1 609-662-2000|clinicaltrials@amicusrx.com|
21283590|NCT00878969|Vanderbilt University|T. Alp Ikizler, MD|615-343-6104|alp.ikizler@vanderbilt.edu|
21283591|NCT00655733|Hutchison MediPharma|Hua Mu,Senior Vice President of Clinical Research and Development|861 3564487805|huam@hmplglobal.com|
21283592|NCT01608815|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21283593|NCT01152359|VA Medical Center|William S. Yancy, Jr.|919-286-0411|william.yancy2@va.gov|7770
21298128|NCT01397461|Ferrer Internacional, S.A.|Clinical Research Manager|+34 93 509 32 75|nalbareda@ferrer.com|
21298129|NCT01588444|UT Health Sci Ctr San Antonio|Dr. Brian Mealey|210-567-3567|mealey@uthscsa.edu|
21298130|NCT01514201|St. Jude Children's Research Hospital|Catherine Billups|901-595-3709|catherine.billups@stjude.org|
21298131|NCT00590863|Univeristy of Texas Southwestern Medical Center, Dallas|Madhukar H. Trivedi, M.D.|214-648-0188|Madhukar.Trivedi@UTSouthwestern.edu|
21298132|NCT03124836|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
21298133|NCT00637416|University of Kansas Medical Center|Director, ENT Clinical Research|(913) 588-7154|ksykes@kumc.edu|
21298134|NCT03318016|University of Colorado Hospital|Daniel Pollyea, MD Associate Professor|720-848-8084|daniel.pollyea@cuanschutz.edu|
21298135|NCT01070173|Tripler Army Medical Center|Dr. Jordan Pinsker|808-433-6338|jordan.pinsker@us.army.mil|
21298136|NCT02403999|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21298137|NCT02715609|Washington University School of Medicine|Dr. Jiayi Huang|314-362-8516|jiayi.huang@wustl.edu|
21298138|NCT00310817|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21298139|NCT00799435|Baylor|David Aguilar, MD|713-798-0280|daguilar@bcm.edu|
21298140|NCT03319134|UT Dallas|Clinical Trial Manager|9723337277|Sarah.McLeod@utdallas.edu|
21298141|NCT04300309|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21298142|NCT05725746|Washington University in St. Louis|Cindy Schwarz|314-935-3063|cschwarz@wustl.edu|
21298143|NCT04607837|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
21298144|NCT00367835|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21298145|NCT04346654|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
21298146|NCT03375489|Massachusetts General Hospital|Jennifer Temel, MD|617-724-4000|jtemel@mgh.harvard.edu|
21298147|NCT04030520|University of California San Francisco|Dr Rachel King|+256785304516|rachel.king@ucsf.edu|
21298148|NCT04209205|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21298149|NCT00597402|Duke University Medical Center|Annick Desjardins, MD, FRCPC|9196846173|annick.desjardins@duke.edu|
21298150|NCT04864639|Duke University|Leonor Corsino, MD, MHS|919-684-4005|leonor.corsinonunez@duke.edu|
21298151|NCT03449758|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21298152|NCT02848222|University of Alabama at Birmingham|Dr Jason Nichols|205-975-3497|jjn@uab.edu|
21298153|NCT01606709|UConnHealth|Lawrence Engmann|8605258283|lengmann@uchc.edu|
21298154|NCT00584012|Holden Comprehensive Cancer Center|Cena Jones-Bitterman|319-353-4596|cena-jones@uiowa.edu|
21298155|NCT05561582|University of Central Florida|Abigail Wilson|407-823-1026|Abigail.Wilson@ucf.edu|
21298156|NCT02451943|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21298157|NCT03937713|VA ORD|Associate Chief of Staff for Research|716-862-6528|ali.el-solh@va.gov|
21298158|NCT03652181|University of Chicago, Medicine and Biological Sciences Division|Agnieszka Stadnik|(773) 702-8996|astadnik@bsd.uchicago.edu|
21298159|NCT02029911|Minerva Surgical, Inc.|Dr. Eugene Skalnyi, VP Medical Affairs|(1) 650-284-3500|eugenes@minervasurgical.com|
21298160|NCT00763386|Zimmer|Kacy Arnold, Associate Director, Clinical Affairs|574-371-8336|kacy.arnold@zimmer.com|
21298161|NCT01217944|Novartis Pharmaceuticals|Study Director|862-778-8300||
21298162|NCT00950846|Baylor College of Medicine/Texas Children's Hospital|Dr. Caridad A. Martinez|832-824-4692|camartin@texaschildrens.org|4670
21298163|NCT01717872|Women and Children's Hospital of buffalo|Dr. Jerrold Lerman|716 878 7701|jerrold.lerman@gmail.com|
21298164|NCT00483405|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
21298165|NCT04426318|Center for Healthy Minds|Matthew Hirshberg|608-262-0035|hirshberg@wisc.edu|
21298166|NCT04587050|Imperial College london|Dr Tamara Elliott|02075946230|te04@ic.ac.uk|
21298167|NCT02152761|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
21298168|NCT01957202|GlaxoSmithKline|GSK Response Center|866-435-7343||
21298169|NCT01290757|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21298170|NCT00352001|CCCC|Dr. Mikkael Sekeres|216-445-9353|sekerem@ccf.org|
21298171|NCT02021643|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21298172|NCT02631551|Glenmark Pharmaceuticals Ltd.|Study Director|(201) 684-8000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
21298173|NCT01284517|Sunovion|Medical Director, CNS|1-866-503-6351||
21298174|NCT03393494|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
21298175|NCT04390243|Cedar Sinai Medical Center|Andrew Hendifar, M.D.|310-423-2217|Andrew.Hendifar@cshs.org|
21298176|NCT01314001|University of Pennsylvania|Paul M. Sanborn, M.S.|215-746-7150|sanborn@mail.med.upenn.edu|
21298177|NCT01196026|GlaxoSmithKline|GSK Response Center|866-435-7343||
21298178|NCT01843023|Friends Research Institute|Dr. Shannon Gwin Mitchell|410-837-3977|smitchell@friendsresearch.org|238
21298179|NCT05139927|NYU|Marya Gwadz, PhD|917-863-2125|mg2890@nyu.edu|
21298180|NCT04980612|University of California San Francisco|Wolf Mehling, MD|415|wolf.mehling@ucsf.edu|9021331
21298181|NCT01502228|IndianaU|Dr. Theodore Logan|(317) 948-7449|tlogan@iu.edu|
21298182|NCT05730387|Institute for Global Health at BC Children's Hospital and BC Women's Hospital + Health Centre|Matthew O. Wiens|6048292562|matthew.wiens@bcchr.ca|
21298183|NCT02728089|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21298184|NCT04669301|University of Rochester|Dr. Allison Magnuson|585-602-5085|allison_magnuson@urmc.rochester.edu|
21298185|NCT00632619|Florida International University|James G Waxmonsky|305 348 3258|jwaxmons@fiu.edu|
21298186|NCT01221350|Centro Universitario de Ciencias de la Salud, Mexico|Fernando R Siller Lopez, Ph.D.|523310585200|fsiller@cucs.udg.mx|33723
21298187|NCT02352844|Washington University School of Medicine|Saiama Waqar, M.D.|314-362-5737|saiamawaqar@wustl.edu|
21283594|NCT02174913|Mahidol University|Department of Anesthesiology, Siriraj Hospital|66-2-41979889|manee95@hotmail.com|501
21283595|NCT04495816|Icahn School of Medicine at Mount Sinai|Dr. David Lerner|212-241-9410|david.lerner2@mountsinai.org|
21283596|NCT03141983|University of Pennsylvania|Natalie Kuzla|2672524208|nkuzla@pennmedicine.upenn.edu|
21283597|NCT01695330|Oncotherapeutics|Dr. James Berenson|310-420-9649|jberenson@berensonocology.com|
21283598|NCT01826370|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21283599|NCT04489381|Romark, L.C.|Jessica Fulgencio|8132828544|jessica.fulgencio@romark.com|
21283600|NCT02865590|Department MESVA - University of L'Aquila|Enrico Marchetti DDS, PhD|+39862433304|enrico.marchetti@univaq.it|
21283601|NCT03199612|Montefiore Einstein|Omar Saeed|718-920-2626|osaeed@montefiore.org|
21283602|NCT05127304|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21283603|NCT01323010|University of Sao Paulo|Dr Fabio Pereira Muchão|+5511 983835563|fabiomuchao@gmail.com|
21283604|NCT03973918|ABTC Consortium|Director of ABTC Consortium|410-955-8837|jfisher@jhmi.edu|
21283605|NCT00351741|USAISR|Principal Investigator|210-916-3054|kevin.chung@us.army.mil|
21283606|NCT04050124|NYU Langone Health|Scott Gorenstein, MD|5166638498|Scott.Gorenstein@nyulangone.org|
21283607|NCT04281901|Department of Otorhinolaryngology and Cervicofacial Surgery, University Medical Centre Ljubljana, Ljubljana, Slovenia. Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.|Domen Vozel, M.D., Saba Battelino, M.D., PhD.|+386 (0)1 522 83 07|domen.vozel@kclj.si|
21283608|NCT03584464|Medtronic, plc|Alissa Anderson, Clinical Study Manager|7075912434|alissa.anderson@medtronic.com|
21283609|NCT03336268|Chestnut Health Systems|Dr. Dennis Watson|312-274-5316|dpwatson@chestnut.org|
21283610|NCT04424966|Ivy Brain Tumor Center|Dr. Nader Sanai|602-406-8605|research@ivybraintumorcenter.org|
21283611|NCT00347919|GlaxoSmithKline|GSK Response Center|866-435-7343||
21283612|NCT01419080|Saint Luke's Hospital of Kansas City|John Spertus|816-932-8270|jspertus@saint-lukes.org|
21283613|NCT04009668|University of Michigan|Dr. Zubin Modi|(734) 232-6798|modiz@med.umich.edu|
21283614|NCT02419612|AstraZeneca|Global Clinical Lead|+1 877-240-9479|information.center@astrazeneca.com|
21283615|NCT00533702|Eli Lilly and company|Chief Medical Officer|800-545-5979||
21283616|NCT01095978|Abbott|Global Medical Services|1-800-633-9110||
21283617|NCT02266472|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
21283618|NCT00965341|The University of Texas (UT) MD Anderson Cancer Center|Rony Dev, DO / Assistant Professor|713-745-4192|HMoreno@mdanderson.org|
21283619|NCT02807506|Penn Medicine Center for Physical Medicine and Rehabilitation|Dr. Michelle J. Johnson|4148130128|johnmic@pennmedicine.upenn.edu|
21283620|NCT01077739|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21283621|NCT00877071|University of Pittsburgh Medical Center|Dr. David Geller|412-692-2001|gellerda@upmc.edu|
21283622|NCT04413552|Indivior, Inc.|Global Director, Clinical Development|804-594-4488|TrialDisclosure@Indivior.com|
21283623|NCT05723328|Hackensack Meridian Carrier Clinic|Zachary D. Fischer PhD, MT-BC|908-281-1324|Zachary.Fischer@hmhn.org|
21283624|NCT03476174|Hoosier Cancer Research Network|Jeff Smith|317-634-5842|jsmith@hoosiercancer.org|41
21283625|NCT01794793|RECORDATIGROUP|Mario Maldonado, MD / Head of Clinical Development Global Endocrinology|+41798030344|maldonado.m@recordati.com|
21283626|NCT04852679|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
21283627|NCT01752634|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21283628|NCT05562934|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
21283629|NCT04216784|Rush University Medical Center|Lance Lineberger|312-942-5126|Lance_Lineberger@rush.edu|
21283630|NCT01702532|GlaxoSmithKline|GSK Response Center|866-435-7343||
21283631|NCT00623597|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21283632|NCT01451164|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials||CL_OPCJ_RDA_Team@otsuka.jp|
21283633|NCT01846221|Columbia University|Allison Lee, MD - Assistant Professor of Anesthesiology|212-342-2028|al3196@cumc.columbia.edu|
21283634|NCT04599933|Orasis Pharmaceuticals, Ltd.|Head of Regulatory Affairs|+972-9-8877745|iris.meisner@orasis-pharma.com|
21283635|NCT05098067|Women and Infants Hospital|Dr. Lauren Murphy|2107222589|lmmurphy@wihri.org|
21283636|NCT02872857|The University of Texas Health Science Center at Houston|HuiMahn Alex Choi, Associate Professor|713-500-5638|Huimahn.A.Choi@uth.tmc.edu|
21283637|NCT02663752|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21283638|NCT02963558|Wake Forest University School of Medicine|D Clark Files, MD|336-716-8898|dfiles@wakehealth.edu|
21283639|NCT00842075|UColorado|Dr. H. Peter Chase|303-724-2323|peter.chase@ucdenver.edu|
21283640|NCT00850096|CPEX Pharmaceuticals, Inc.|Chief Medical Officer|603-658-6100||503
21283641|NCT03226678|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
21283642|NCT01371877|University of Nebraska Medical Center|Dr. Jill Poole|402-559-4087|japoole@unmc.edu|
21283643|NCT03427268|Pharmamar, S.A.|Clinical Developtment, Department of PharmaMar´s Oncology, Business Unit.|0034 91846 60 00|clinicaltrials@pharmamar.com|
21283644|NCT00546455|UCSD|MARIO CHOJKIER|858-552-8585|mchojkier@gmail.com|7283
21283645|NCT01813734|Massachusetts General Hospital|Dr. Alice Shaw|617-724-4000|ASHAW1@mgh.harvard.edu|
21283646|NCT04946552|Yale School of Medicine|Renata Belfort De Aguiar, MD, PhD|(203) 785-5331|renata.aguiar@yale.edu|
21283647|NCT05283135|Oregon Medical Research Center, PC|Benjamin Ehst, MD, PhD|5032451525|behst@oregonmedicalresearch.com|
21283648|NCT04186806|3M Health Care|Elaine Egging/Project Manger|651-737-0263|eegging@mmm.com|
21283649|NCT01701193|University of Saskatchewan|Roger Pierson, PhD|306-884-1059|roger.pierson@usask.ca|
21283650|NCT02720744|Flamel Ireland Limited|Jennifer Gudeman|+1 (314) 750-2751|jgudeman@avadel.com|
21283651|NCT01482962|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21283652|NCT02407457|Endologix, Inc.|Sharone Trifskin|949-599-8860|strifskin@endologix.com|
21298188|NCT05888181|UZ Leuven|Patrick Verschueren|003216342541|patrick.verschueren@uzleuven.be|
21298189|NCT03165916|GI Clinical Research Enterprise|Tina Higginbotham|615-322-4643|tina.higginbotham@vumc.org|
21298190|NCT04137731|Joint Replacement Center of Montefiore Medical Center|Clinical Research Director|9292466352|sereffer@montefiore.org|
21298191|NCT03830359|Laboratoires Thea|ESTRADE|0635156453|marielle.estrade@theapharma.com|
21298192|NCT00362648|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21298193|NCT02204072|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
21298194|NCT03983304|Zeltiq Aesthetics|Lori Brandt, Director, Clinical Trial Management|925 621-7460|lori.brandt@abbvie.com|
21298195|NCT01587040|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21298196|NCT00432341|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
21252401|NCT03991741|University of California, San Diego|Gregory Daniels, MD, PhD|(858) 822-5354|CancerCTO@health.ucsd.edu|
21298197|NCT03035331|Mayo Clinic|Yi Lin|507-293-5189|Lin.Yi@mayo.edu|
21298198|NCT02314221|VA RR&D National Center for the Medical Consequences of Spinal Cord Injury|Ann M. Spungen, EdD|718-584-9000|ann.spungen@va.gov|5814
21298199|NCT03453489|Barbara Ann Karmanos Cancer Institute|Anthony F. Shields, MD, PhD|313-576-8735|shieldsa@karmanos.org|
21298200|NCT03838978|Moximed, Inc.|Alexandra Kraenzlin, Director of Clinical Affairs|+41 44 515 62 06|akraenzlin@moximed.com|
21298201|NCT05236257|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21298202|NCT05747027|Endeavor Health|Urogynecology Research Coordinator|847-570-4729|JLee5@northshore.org|
21298203|NCT03071393|University of Florida|Emily Fox, Principal Investigator|904-742-2500|ejfox@phhp.ufl.edu|
21298204|NCT00048347|NIAID|Peter Mannon, MD|205-934-4726|pmannon@uab.edu|
21298205|NCT02343406|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21298206|NCT05169424|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
21298207|NCT01746225|International Breast Cancer Study Group (IBCSG)|Heidi Roschitzki-Voser|+41 31 511 94 18|heidi.roschitzki@ibcsg.org|
21298208|NCT00595478|Dartmouth College|Catherine Stanger, Ph.D.|603-646-7023|catherine.stanger@dartmouth.edu|
21298209|NCT03401671|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21298210|NCT02713828|ECOG Stats Center|Dr Zhuoxin Sun|617-632-3012|zhuoxin@jimmy.harvard.edu|
21298211|NCT02451514|GlaxoSmithKline|GSK Response Center|866-435-7343||
21298212|NCT03302247|Fox Chase Cancer Center|Martin Edelman|215-728-5682|Martin.Edelman@fccc.edu|
21298213|NCT03197376|PATH|Dr. Steve Lamola|+ 1 206.302.6067|slamola@path.org|
21298214|NCT01092910|Envoy Medical Corp.|Elizabeth Anderson, PhD|651-361-8080|landerson@envoymedical.com|
21298215|NCT00147316|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21298216|NCT03508609|Caladrius Biosciences, Inc.|William Sietsema|9495352391|bsietsema@caladrius.com|
21298217|NCT00999518|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21298218|NCT00122369|Beth Israel Deaconess Medical Center (at time of study); now Hypnalgesics, LLC|Elvira V. Lang, MD|978 404 9724|elang@bidmc.harvard.edu|
21298219|NCT03294850|AdventHealth Translational Research Institute|Dr. Karen Corbin|(407) 303-7100|Karen.Corbin@AdventHealth.com|
21298220|NCT01445080|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21298221|NCT03857542|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21298222|NCT01594931|Medicines for Malaria Venture (MMV)|Stephan Duparc, MD, Chief Medical Officer|+41 22 555 0300|duparcs@mmv.org|351
21298223|NCT03868254|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21298224|NCT01525615|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21298225|NCT04050618|CooperVision, Inc.|Jose A. Vega, O.D., MSc, FAAO|925-621-3761|javega@coopervision.com|
21298226|NCT00948753|University of Pennsylvania Abramson Cancer Center|David Porter|215-662-2862|david.porter@pennmedicine.upenn.edu|
21298227|NCT00655538|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
21298228|NCT01101035|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21298229|NCT00922623|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4000|clinicaltrials@merzaesthetics.com|
21298230|NCT02420379|Sarepta Therapeutics, Inc.|Medical Director|+1-888-727-3782|clinicaltrials@sarepta.com|
21298231|NCT03633344|Omnifarma Kyiv LLC|Oleg Kurchenko|+380503319653|Kurchenko@omnifarma.kiev.ua|
21298232|NCT03795116|SUNY Downstate Health Sciences University|Jared Jagdeo MD, MS|347-466-9263|jared.jagdeo@downstate.edu|
21252402|NCT06024278|Weill Cornell Medicine|Dr. Veerawat Phongtankuel|212-746-7000|vep9012@med.cornell.edu|
21252403|NCT04896008|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@MSD.com|
21252404|NCT03430583|Mezzion Pharmaceuticals|Dr. Scott Oglesby|919-260-5782|Oglesby@granzer.biz|
21283653|NCT06137703|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21283654|NCT02160847|Georgia State University|Dr. Jenelle Shanley Chatham|404-413-1340|jshanley@gsu.edu|
21283655|NCT01801358|Array BioPharma, Inc.|Study Director|303-381-6604|clinicaltrials@arraybiopharma.com|
21283656|NCT00108342|Department of Veterans Affairs - VAGLA|Nina G. Schneider, Ph.D., Principle Investigator|310-268-3059|ngs@ucla.edu|
21283657|NCT01210495|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21283658|NCT03502018|Maimonides Medical Center|Dr. Kevin Kang|718-283-8805|kkang@maimonidesmed.org|
21283659|NCT01384019|Seoul national university Bundang hospital|Dr. Chang-Hwan Yoon|+82-31-787-7052|changhwanyoon@snubh.org|
21298233|NCT00977171|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
21298234|NCT01764711|Vanderbilt Universtiy|Alfredo Gamboa|6158751003|alfredo.gamboa@vumc.org|
21298235|NCT01410890|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21298236|NCT00217425|ECOG Statistical Office|Study Statistician|617-632-3012||
21298237|NCT03951077|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21298238|NCT00681889|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana|617-573-3313|Cornea_Research@meei.harvard.edu|
21298239|NCT00086047|Cincinnati Children's Hospital Medical Center|Susmita Kashikar-Zuck, PhD|513 636 6337|Susmita.Kashikar-Zuck@cchmc.org|
21298240|NCT01395901|Helsinn Healthcare SA|Salvatore Chessari|+41 91 985 21 21|salvatore.chessari@helsinn.com|
21298241|NCT03923790|The University of Texas Health Science Center at Houston|Anjail Sharrief, MD, MPH, Associate Professor|713-500-6538|anjail.z.sharrief@uth.tmc.edu|
21298242|NCT01798966|Hamilton Glaucoma center|Anjali Parekh|+1858 822-1553|anjalism@gmail.com|
21298243|NCT01165983|Beth Israel Deaconess Medical Center|Aristidis Veves, Research Director|617-632-7075|aveves@bidmc.harvard.edu|
21298244|NCT03579940|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21298245|NCT00671034|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21298246|NCT03726489|University of Pennsylvania|Brooke Bishop|215-615-0523|brooke.bishop@pennmedicine.upenn.edu|
21298247|NCT02279667|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21298248|NCT00713544|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
21298249|NCT00797277|National Taiwan University Hospital|Dr. Tzung-Jeng Hwang|+886-2-23123456|tjhwang@ntu.edu.tw|66792
21298250|NCT00786799|University of California, San Francisco|Robert L. Hendren, D.O.|415-476-7198|robert.hendren@ucsf.edu|
21298251|NCT02544503|Emory University|Cathrin Buetefisch, MD, PhD|404-712-5507|cathrin.buetefisch@emory.edu|
21298252|NCT02380287|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
21298253|NCT04473963|Ablacon, Inc|Eliza Lawrence|+16507049907|elawrence@cortexep.com|
21298254|NCT04640311|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21298255|NCT01641601|UCSF|Kirsten Salmeen|628-213-5314|kesalmeen@gmail.com|
21298256|NCT02123849|University of Arizona|Dr. Sherry Chow|5206263358|schow@azcc.arizona.edu|
21298257|NCT01799226|UMichigan|Janet Kinney|734-615-5452|kinneyj@umich.edu|
21298258|NCT02178995|Stanford University|Jesse Adams, MD|2069144771|jadamsuw@stanford.edu|
21298259|NCT01388907|Sofradim Production COVIDIEN|Patrice BECKER, Global Director, Clinical Affairs|+33 4 74 08 92 38|patrice.becker@covidien.com|
21298260|NCT03361293|University of Minnesota|Jeffrey Wozniak, PhD, LP|612-273-9741|jwozniak@umn.edu|
21298261|NCT01910402|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21298262|NCT01797263|VA Center for Health Information and Communication|Dr. Matthew J. Bair|317-988-2058|mbair@iupui.edu; matthew.bair@va.gov|
21298263|NCT02342223|VA Northern California Health Care System|Jared Jagdeo, MD, MS|917-837-9796|jrjagdeo@gmail.com|
21298264|NCT01200368|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21298265|NCT00535002|Medical University of South Carolina|Dr. McRae-Clark|843-792-5216|mcraeal@musc.edu|
21298266|NCT03071887|Massachusetts General Hospital|Dr. Christina Psaros|617.726.7458|cpsaros@mgh.harvard.edu|
21298267|NCT00181766|Massachusetts General Hospital|Joseph Biederman, MD|617-726-1743|jbiederman@partners.org|
21298268|NCT01526213|UNC-Chapel Hill|Mary F. Paine, RPh, PhD|919-966-9984|mpaine@unc.edu|
21298269|NCT00061893|Children's Oncology Group|Results Reporting Coordinator||resultsreportingcoordinator@childrensoncologygroup.org|
21298270|NCT00687804|Novartis Pharmaceuticals|Study Director|862 778-8300||
21298271|NCT03573323|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21298272|NCT03188432|Wake Forest Baptist Comprehensive Cancer Center|Principal investigator|3367135440|Michael.G.Kelly@advocatehealth.org|
21298273|NCT03869008|UTMC|Bashar Kahaleh, MD|4193834271|bashar.kahaleh@utoledo.edu|
21298274|NCT04498143|University of Denver|Dr. Kathryn Fox|3015202715|Kathryn.Fox@du.edu|
21298275|NCT06260670|Ablacon, Inc|Eliza Lawrence|+16507049907|elawrence@cortexep.com|
21298276|NCT00413218|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|5473
21298277|NCT00206336|Baylor College of Medicine|Dr. Joseph Jankovic|713-798-6556|josephj@bcm.edu|
21298278|NCT04912583|The University of Texas Health Science Center at Houston|Radha Korupolu, MD|713-797-5233|Radha.korupolu@uth.tmc.edu|
21298279|NCT02486016|University of Maryland, Baltimore School of Pharmacy|Dr. Audra Stinchomb (PI)|410-706-2646|astinchc@rx.umaryland.edu|
21298280|NCT03672292|Scynexis|David Angulo|201-884-5471|David.Angulo@scynexis.com|
21298281|NCT00799903|GlaxoSmithKline|GSK Response Center|866-435-7343||
21298282|NCT03088917|Radboudumc|Prof. dr. J.P.H. Drenth|0031243613999|joost.drenth@radboudumc.nl|
21298283|NCT01695135|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21298284|NCT02753946|Nabriva Therapeutics plc|Chief Medical Officer|(610) 816-6640|officeUS@nabriva.com|
21298285|NCT00490269|Uniformed Services University for the Health Sciences|Dr. Lou Cantelina|301-295-3240|louis.cantelina@usuhs.edu|
21298286|NCT01633541|University of Michigan Rogel Cancer Center|Dr. Paul Swiecicki|734-647-1017|pswiecic@med.umich.edu|
21298287|NCT05919888|SSMHealth SLUCare Physician Group|Dr. Randall Otto|314-614-2970|randall.otto@slucare.ssmhealth.com|
21298288|NCT03559933|Stimdia Medical, Inc.|Tim Miller|612.940.3454|tmiller@stimdia.com|
21298289|NCT00286429|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21298290|NCT03245775|University of Virginia|Dr. Jamie Zoellner, Professor of Public Health Sciences|4349624488|jz9q@virginia.edu|
21298291|NCT00112125|Impulse Dynamics (USA) Inc|Angela Stagg, Sr. Director, Clinical and Data Operations|8453592389|angelas@impulse-dynamics.com|
21298292|NCT02709330|Duke University|Richard Bedlack, MD, PhD|919-668-2839|richard.bedlack@duke.edu|
21298293|NCT02660853|Imperial College London|Professor Fan Chung|00442075947954|f.chung@imperial.ac.uk|
21298294|NCT01550757|US Department of Veterans Affairs|Thomas O'Toole, MD|(401) 273-7100|thomas.otoole@va.gov|6359
21298295|NCT01426958|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21298296|NCT02968368|Shield Therapeutics|Jackie Mitchell MA DPhil|+44 (0) 191 511 8515|jmitchell@shieldtx.com|
21298297|NCT00040443|RespireRx Pharmaceuticals|Richard Purcell|732-492-1797|rpurcell@respirerx.com|
21298298|NCT03315572|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21298299|NCT00991939|New England Research Institutes, Inc.|Susan F. Assmann, PhD|617-923-7747|sassmann@neriscience.com|548
21298300|NCT00740584|Starpharma Pty Ltd|Clinical Development Manger|+61 3 9532 2700|clare.price@starpharma.com|
21298301|NCT01461707|University of California, San Francisco|JiWon Choi|415-514-2534|jiwon.choi@ucsf.edu|
21298302|NCT01337336|GlaxoSmithKline|GSK Response Center|866-435-7343||
21298303|NCT00855816|VA Palo Alto Health Care System / Stanford University School of Medicine|Walton T. Roth, M.D.|650-493-5000|wtroth@stanford.edu|65243
21298304|NCT04502290|University of Pittsburgh|Amit Sethi|4123836619|asethi@pitt.edu|
21298305|NCT00837213|GlaxoSmithKline|GSK Response Center|866-435-7343||
21298306|NCT01290614|University of Minnesota|Paul Drawz, MD|6126255423|draw0003@umn.edu|
21298307|NCT00452868|Wake Forest Baptist Health|Dr. Janet Tooze|336-716-0286|jtooze@wakehealth.edu|
21298308|NCT02524171|Center for Innovation to Implementation, VA Palo Alto|Daniel M. Blonigen, PhD|650-493-5000|daniel.blonigen@va.gov|27828
21298309|NCT01379183|Mayo Clinic|Dr. Jeff L. Fidler|507-284-5010|fidler.jeff@mayo.edu|
21298310|NCT02507388|Alcon, A Novartis Division|Global Program Clinical Head, Ophthalmology|1-888-451-3937|alcon.medinfo@alcon.com|
21298311|NCT04400058|CRMG|Patrick Murphy|4138210022|p.murphy@crmg-usa.com|
21298312|NCT02868554|University of North Carolina at Chapel Hill|Ching-Chang Ko, DDS, PhD|919-537-3763|ching-chang_ko@unc.edu|
21298313|NCT00216671|Janssen Cilag Spain|EMEA Medical Affairs Director Psychiatry|+34 91 7228043||
21298314|NCT02714569|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21298315|NCT01684202|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21298316|NCT00191308|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21298317|NCT00466921|Northwestern University|Clinical Trials Office|312-695-1301||
21298318|NCT00779025|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
21298319|NCT03710642|Alzheimer's Disease Cooperative Study (ADCS)|Clinical Operations|858-246-1333|alzinfo@ucsd.edu|
21298320|NCT00587678|University of Virginia|Dr Christopher Kramer|434-243-0736||
21298321|NCT00226811|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21298322|NCT05282927|Durham VA Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT)|Dr. Kelli Allen|919-286-0411|Kelli.Allen@va.gov|177090
21298323|NCT02741635|Fisher & Paykel Healthcare Ltd.|Christine Lambert|+64 9 574 0123|christine.lambert@fphcare.co.nz|7172
21298324|NCT02727907|BIOCAD|Linkova Yuliya|+7(495)9926628|linkova@biocad.ru|930
21298325|NCT01427933|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21298326|NCT01643382|University of California, San Francisco|Justin Parekh, MD, MAS|415-595-3707|justin.parekh@ucsfmedctr.org|
21298327|NCT01010971|Sunovion|Respiratory Medical Director|1-866-503-6351||
21298328|NCT05447663|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
21298329|NCT01128426|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21298330|NCT01100320|Purdue Pharma L.P.|Stephen Harris, MD|203-588-7592|Stephen.Harris@Pharma.com|
21298331|NCT05729568|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21298332|NCT04181762|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
21298333|NCT01717001|University of Tennessee|Rebecca Robertson|865-974-2093|rrober28@utk.edu|
21298334|NCT02534909|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
21298335|NCT05049850|Hansa Biopharma AB|Study Director|+46 46 16 56 70|clinicalstudyinfo@hansabiopharma.com|
21298336|NCT04752332|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21298337|NCT01895946|AstraZeneca UK Limited|Dr Justin P. O. Lindemann, MBChB MBA, Medical Science Director, AZD5363|(0)7920 250301|Justin.Lindemann@astrazeneca.com|+44
21298338|NCT02915978|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
21298339|NCT00924443|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21298340|NCT03657849|Regions Hospital|Meghan O'Brien / Study Coordinator|612-437-1141|meghan.e.obrien@healthpartners.com|
21298341|NCT03402035|University of Pittsburgh|Jason Sperry|4128028270|sperryjl@upmc.edu|
21298342|NCT02451124|Case Comprehensive Cancer Center|Amitabh Chak|2168443217|axc22@cwru.edu|
21298343|NCT01248949|MedImmune, LLC|Mohammed Dar, MD|301-398-0000|information.center@astrazeneca.com|
21298344|NCT01973413|Univeristy of VIrginia|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
21298345|NCT00942825|CanBas Co., Ltd.|Takumi Kawabe, MD, PhD|81559543666|takumi@canbas.co.jp|
21298346|NCT00186901|St. Jude Children's Research Hospital|Sue Kaste, DO|866-278-5833|referralinfo@stjude.org|
21298347|NCT01546688|Eisai Call Center|Eisai Inc.|888-422-4743||
21298348|NCT00667849|Bioventus LLC|Peter Heeckt, MD (CMO)|1-800-396-4325|peter.heeckt@bioventusglobal.com|
21298349|NCT02921490|Mayo Clinic|Vance Lehman|1-507-284-2511|lehman.vance@mayo.edu|
21251453|NCT02669615|Medical College of Wisconsin|Parameswaran Hari|4148054600|phari@mcw.edu|
21251454|NCT02271230|Brigham and Women's Hospital|Dr. Luc Djousse|617-525-7591|ldjousse@rics.bwh.harvard.edu|
21251455|NCT01283022|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21251456|NCT04354168|Boston University Chobanian & Avedisian School of Medicine, Family Medicine|Brian Jack, MD|617-414-6207|brian.jack@bmc.org|
21251457|NCT02287233|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21298350|NCT00782483|University of Arkansas for Medical Sciences/Arkansas Children's Hospital|Dr. Gal Shafirstein|501-364-7546|jboswell@uams.edu|
21298351|NCT03543137|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21252405|NCT04201288|Brown University|Ethan Moitra, Associate Professor of Psychiatry and Human Behavior|401-444-1949|ethan_moitra@brown.edu|
21298352|NCT01052077|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21298353|NCT01802710|Hospital Galdakao-Usansolo|Dra Miren Orive|0034 944007105|miren.orivecalzada@osakidetza.net|
21298354|NCT02528786|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21298355|NCT01099397|University of Florida|Mariellen Moore|352-273-6381|marielm@ufl.edu|
21298356|NCT02363959|Duke University|Scott Shofer MD, PhD|919-668-2402|scott.shofer@duke.edu|
21298357|NCT02696759|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|bscanlan@uams.edu|
21298358|NCT00003199|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
21298359|NCT00940498|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21298360|NCT00983385|Grünenthal GmbH|Director of Clinical Trials|+49 241 569|Clinical-Trials@grunenthal.com|3223
21298361|NCT00930930|Vanderbilt-Ingram Cancer Center|Dr. Ingrid Mayer|615-936-2033|ingrid.mayer@vanderbilt.edu|
21252406|NCT06456385|Medical University of South Carolina|Dr. Xiaolong Peng|8437928642|pengxi@musc.edu|
21298362|NCT00900029|Smith & Nephew, Inc.|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
21298363|NCT03152591|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21298364|NCT02587819|Biosceptre UK|Dr Shaun McNulty|01223496092|shaun.mcnulty@biosceptre.com|
21298365|NCT00859547|ZymoGenetics|John Pribble, Vice President, Medical Affairs; Scot Maxon, Scientific Information|(206) 428-2756; (206) 434-3365|John.Pribble@bms.com; Scot.Maxon@bms.com|
21298366|NCT01473732|Montefiore Medical Center|Dr. Enver Akalin, Medical Director Kidney Transplant|718-920-4815|eakalin@montefiore.org|
21298367|NCT03271424|University of North Carolina Chapel Hill|Dr. Audrey Pettifor|919-966-7439|apettif@email.unc.edu|
21298368|NCT00997035|University of California, San Francisco|Kathryn Ray|415-514-3227|kathryn.ray@ucsf.edu|
21298369|NCT00269919|Janssen Korea Ltd., Korea|Medical CRA|+82-2-2094-4804||
21298370|NCT02471014|University of Florida|Mathew Sebastian, PhD|8644901978|mathewsebastian@ufl.edu|
21298371|NCT04685798|Washington University School of Medicine|Gloria J. Guzman Pérez-Carrillo, M.D.|314-362-5950|guzman.gloria@wustl.edu|
21298372|NCT01908530|Imperial College London|Prof Nick Oliver|07957163617|nick.oliver@imperial.ac.uk|
21298373|NCT03187119|West Virginia University|Dr. Christina Duncan|304-293-1289|Christina.Duncan@mail.wvu.edu|
21298374|NCT00824473|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us|
21298375|NCT01965704|Stanford University|David Drover|650-725-0364|ddrover@stanford.edu|
21298376|NCT00337207|Northwestern University|Clinical Research Office Administrator|312-695-1301|cancertrials@northwestern.edu|
21298377|NCT01479868|Janssen Research & Development|Director & Study Responsible Scientist||ClinicalTrialDisclosure@its.jnj.com|
21298378|NCT01177007|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
21298379|NCT00195039|Weill Cornell Medicine|Scott Tagawa, MD||guonc@med.cornell.edu|
21298380|NCT02109640|University of Edinburgh|Hugh M Paterson|44 131 537 1000|hugh.paterson@ed.ac.uk|
21298381|NCT01155336|University of Rochester|Dr. Robert Block|585 275-3356|robert_block@urmc.rochester.edu|
21298382|NCT02336230|Mesoblast, Inc.|Christopher James, VP Head of Clinical Operations|212-880-2060|Christopher.James@Mesoblast.com|7925
21298383|NCT02526277|The Ohio State University|Ariane Park, MD|614.293.4969|Ariane.Park@osumc.edu|
21298384|NCT05065905|Saint-Petersburg State Medical Academy n.a. I.I.Mechnikov of Ministry of Health, Saint-Petersburg, Russia, 195067|Dr. med. Sc., Prof. Tamara Sologub|+78125439609|mechnik@mail.ru|
21298385|NCT03305770|Alcon, A Novartis Division|Sr Director Project Leadership|1-888-451-3937|alcon.medinfo@alcon.com|
21298386|NCT03539601|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21298387|NCT01970306|Memorial Sloan Kettering Cancer Center|Dr. Vivian Strong, MD|212-639-5056|strongv@mskcc.org|
21298388|NCT03472326|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21298389|NCT03386721|Hoffmann-La Roche|Medical Communications|08008218590|genentech@druginfo.com|
21298390|NCT00700713|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21298391|NCT01592071|University of Miami|Dr. John Lewis|(305) 243-6227|jelewis@miami.edu|
21298392|NCT00666406|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21298393|NCT01369784|Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea (GELTAMO)|Dr. Carlos Panizo|+ 34 948 25 54 00|cpanizo@unav.es|
21298394|NCT04871425|University of Washington|Complex Family Planning Division|206.221.9074|uwfp@uw.edu|
21298395|NCT00596752|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
21298396|NCT02538042|Duke University|Dr. F. Joseph McClernon|9196682963|joseph.mcclernon@duke.edu|
21298397|NCT04797780|Syros Pharmaceuticals|Tiffany Crowell|617-674-9069|info@syros.com|
21298398|NCT02586727|Murray Ocular Oncology & Retina|Dr. Timothy Murray|3054877470|tmurray@murraymd.com|
21298399|NCT05167825|Janssen Pharmaceutical K.K.|Executive Medical Director CP|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21298400|NCT02440685|Libertas BioSciences|Niranjan Rao|908-872-1133|niranjan@libertasbiosciences.com|
21298401|NCT05431478|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21298402|NCT02326597|Emory University|Lakshmanan Krishnamurti, MD|4047270710|lkrishn@emory.edu|
21298403|NCT02119663|Incyte Corporation|Study Director|855 463-3463||
21298404|NCT01870726|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21298405|NCT01773187|CTI BioPharma Corp.|Beth Ziemba|206-272-4347|bziemba@ctibiopharma.com|
21298406|NCT02978833|Hospital for Special Surgery|Jennifer Cheng|6467146870|chengj@hss.edu|
21298407|NCT01123395|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21298408|NCT03691571|The Hospital of the University of Pennsylvania|Dr. Cory M. Tschabrunn|215-614-0482|coryt@pennmedicine.upenn.edu|
21298409|NCT04186871|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21298410|NCT00746694|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21298411|NCT00250276|GlaxoSmithKline|GSK Response Center|866-435-7343||
21298412|NCT00555217|VA Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh, PA|Linda Fried, MD, MPH|412-360-3930|Linda.Fried@va.gov|
21298413|NCT01135095|Department of Medicine, Cardiology Division, Columbia University Medical Center and New York Presbyterian Hospital, New York|Dr. Andrew J. Einstein|+1 212 305-4275|Andrew.einstein@columbia.edu|
21298414|NCT03421106|University of Connecticut|Caitlin Caspi|(860) 486-2834|caitlin.caspi@uconn.edu|
21298415|NCT00950248|National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr. Bibiana Bielekova|(240) 669-2724|bibi.bielekova@nih.gov|
21298416|NCT02919072|Sintetica SA|Anna Guaita|+41 (0)91640 42 50|aguaita@sintetica.com|
21298417|NCT02578199|YALE|Dr. Rachel Barnes|203-785-6395|rachel.barnes@yale.edu|
21298418|NCT01657292|Birken AG|Head of pharmaceutical development|+49 7233 97490|t.zahn@birken.eu|
21298419|NCT02424175|Brigham and Women's Hospital|Dr. Jessica Allegretti|6177325500|jallegretti@bwh.harvard.edu|
21298420|NCT00650845|Guerbet|Pierre Desché, MD - VP Development, Medical and Regulatory Affairs.|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
21298421|NCT01900652|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21298422|NCT03761810|Sol-Gel Technologies, Ltd.|Sol-Gel|972-8-9313433|info@sol-gel.com|
21298423|NCT00869518|University of California, San Francisco|Brian S. Schwartz, MD|415-476-5767|brian.schwartz@ucsf.edu|
21298424|NCT04178720|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21298425|NCT03922620|Geisinger Medical Center|Dr. Gerard Cush|5702716700|MSKIresearch@geisinger.edu|
21298426|NCT03566082|Smith + Nephew|Fleur Derdeyn, Principal Clinical Study Manager|0032 497 60 20 32|fleur.derdeyn@smith-nephew.com|
21298427|NCT02663622|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21298428|NCT00662545|UCSF SFGH|Anne Luetkemeyer|415 476 4082|aluetkemeyer@php.ucsf.edu|130
21298429|NCT04618744|Oramed, Ltd.|Chief Scientific Officer|+97225660001|miriam@oramed.com|
21298430|NCT00511238|Onyx Pharmaceuticals|Onyx Medical Information|1-877-ONYX-121|medinfo@onyx.com|
21298431|NCT00163020|Obstetrix Medical Group, Inc|Kimberly Maurel|714-593-9171|kimberly_maurel@pediatrix.com|
21298432|NCT02744092|Dana-Farber Cancer Institute|Dr. Jean Connors|(617) 632-3000|jconnors@bwh.harvard.edu|
21298433|NCT01929226|Elusys Therapeutics, Inc.|Senior Director of Regulatory|973-808-0222|cdillon@elusys.com|
21298434|NCT01026012|University of Maryland Cardiology|Dr. Scott Jerome|410-876-0086|sjerome@medicine.umaryland.edu|
21298435|NCT04367831|Columbia University|Sahil A. Parikh, MD|212-305-3617|sap2196@cumc.columbia.edu|
21298436|NCT01227980|National Institute on Alcohol Abuse and Alcoholism|Melanie Schwandt|301-451-6960|melanies@mail.nih.gov|
21298437|NCT00330759|Amgen Inc.|Study Director|866-572-6436||
21298438|NCT03110471|swansea university|sue jordan|+44 (0) 1792 518541|s.e.jordan@swansea.ac.uk|
21298439|NCT00972335|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21298440|NCT01072188|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
21298441|NCT06083987|University of Pittsburgh|Dr. Ana Radovic|4126927227|anr94@pitt.edu|
21298442|NCT00984308|Department of Veterans Affairs|Dawn M. Bravata, MD|317-988-2676|dawn.bravata2@va.gov|
21298443|NCT00287222|University of Arkansas for Medical Sciences|Sandy Annis|5016868274|amannis@uams.edu|
21298444|NCT00592904|Eisai Call Center|Eisai Inc.|888-422-4743||
21298445|NCT03456076|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21298446|NCT03906071|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
21298447|NCT01359904|MUHC|Sameena Iqbal|5149341934|sameena.iqbal@mcgill.ca|44034
21298448|NCT03594773|University of Pittsburgh School of Medicine|Holly Swartz, MD|4122465588|SwartzHA@upmc.edu|
21298449|NCT03191630|The Ohio State University|Dr. Tara O'Brien|6142928045|obrien.782@osu.edu|
21298450|NCT02707146|Division of Research, Kaiser Permanente Northern California|Dr. Richard Grant|510-891-5993|Richard.W.Grant@kp.org|
21298451|NCT02640547|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21298452|NCT02459119|Dana Farber Cancer Institute|Dr. Guru Sonpavde, MD|617-632-2429|gsonpavde@gmail.com|
21298453|NCT00193206|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
21298454|NCT03018691|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21298455|NCT03618420|University of Colorado School of Medicine|Petter Bjornstad, M.D., Assistant Professor of Pediatrics and Medicine|7207774659|petter.bjornstad@childrenscolorado.org|
21298456|NCT01433016|Exalenz Bioscience|Clinical Trials Manager|+972-8-9737513|avrahamh@exalenz.com|
21298457|NCT03369418|UCLA|Kirsten Tillisch|1 310 208-5400|ktillisch@mednet.ucla.edu|
21298458|NCT01485094|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|Clinical-Trials@grunenthal.com|
21298459|NCT02148523|University of Pennsylvania|Dr. Peter P. Reese|215-898-6086|peter.reese@uphs.upenn.edu|
21298460|NCT03315039|Moleculin Biotech Inc|Chief Scientific Officer|862-273-1432|DPicker@moleculin.com|
21298461|NCT01450761|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21298462|NCT01582139|University of Virginia|Marc D Breton, Ph.D.|434-982-6484|mb6nt@virginia.edu|
21298463|NCT01220739|University of California, San Diego|Dr. Thomas Hemmen|858-657-7190|themmen@ucsd.edu|
21298464|NCT03801174|University of Wisconsin - Madison|Corrine Voils, PhD|608-262-9636|voils@surgery.wisc.edu|
21298465|NCT03081156|Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center|William Stringer, MD|424-571-7626|stringer@ucla.edu|
21298466|NCT03767257|Memorial Sloan Kettering Cancer Center|Dr. Malin Hultcrantz, MD, PhD|646-608-3714|hultcram@mskcc.org|
21298467|NCT04435366|Astellas Pharma Global Development, Inc|Clinical Transparency|800-888-7704|astellas.resultsdisclosure@astellas.com|
21298468|NCT04112810|Medical College of Wisconsin|William R Drobyski, MD, FACP, FASTCT|414-456-4941|wdrobysk@mcw.edu|
21298469|NCT01687296|GlaxoSmithKline|GSK Response Center|866-435-7343||
21298470|NCT01618669|Astellas Pharma Global Development, Inc. (APGD)|Senior Medical Director, Medical Affairs||Astellas.resultsdisclosure@astellas.com|
21298471|NCT01680666|Stanford University|Matias Bruzoni, MD|650-723-6439|mbruzoni@stanford.edu|
21298472|NCT03259087|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21298473|NCT02396212|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21298474|NCT04950465|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
21298475|NCT04308941|BostonSight|Dr. Daniel Brocks|(781) 726-7506|ecrowley@bostonsight.org|
21298476|NCT03740659|NTC srl|Alessandro Colombo|+390243850490|alessandro.colombo@ntcpharma.com|
21298477|NCT03507036|UT Southwestern|Jennifer Barillas|214-645-8907|jennifer.barillas@utsouthwestern.edu|
21298478|NCT00940901|Johns Hopkins University, School of Medicine|Dr. Arthur L. Burnett, Director of Sexual Medicine Fellowship Program|410-614-3986|aburnett@jhmi.edu|
21298479|NCT00740207|Bracco Diagnostics Inc.|Usha Halemane|609-514-2578|usha.halemane@diag.bracco.com|
21298480|NCT00580723|University of California, Irvine|Brian Swasdibutra, Clinical Research Coordinator|9498247103|bswasdib@uci.edu|
21298481|NCT00684996|SWOG Statistical Center|Study Statistician|206-667-4623||
21298482|NCT03676972|Peking University Third Hospital|Dr. Lulin Ma|13701010872|malulin@medmail.com.cn|+86
21298483|NCT00550953|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21298484|NCT03797586|Guang'anmen Hospital, China Academy Chinese Medical Sciences|Dr.Zhishun Liu|+86 010 88002331|liuzhishun@aliyun.com|
21298485|NCT01219985|Centre Hospital-Universitaire d'Amiens|Pr. Marc-Etienne Meyer|+33 3 22 45 59 64|meyer.marc-etienne@chu-amiens.fr|
21298486|NCT02680665|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21252407|NCT01877148|Universidade Federal de Pernambuco|Kátia Monte-Silva|+ 55 (81) 2126-7579|monte.silvakk@gmail.com|
21298487|NCT02292719|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21298488|NCT02940496|MD Anderson Cancer Center|Ahmed Kaseb, MD|(713) 792-2828|akaseb@mdanderson.org|
21298489|NCT04289311|Medical University of South Carolina|Shannon Phillips, PhD, RN, Associate Professor|843-792-9379|phillipss@musc.edu|
21298490|NCT02286921|SKCCC at JHU|Dr. Samual Denmeade|410-955-8875|denmesa@jhmi.edu|
21298491|NCT04089761|Theranica Bio-Electronics Ltd|Dr Dagan Harris. VP Clinical and Regulatory Affairs|+972723909755|daganh@theranica.com|
21298492|NCT00770601|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|Novartis.email@novartis.com|
21298493|NCT04739436|Duke University Medical Center|Sherri L. Smith, PhD, AuD, CCC-A|(919) 684-2426|sherri.smith@duke.edu|
21298494|NCT00676013|University of Texas Medical Branch|David Herndon, MD|409-770-6731|dherndon@utmb.edu|
21298495|NCT00428948|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affairs|800 562-3974||
21298496|NCT02506634|FirstSunYetSen|Dr. Niandi Tan|+86 15989117039|tanniandi@126.com|
21298497|NCT03622814|Medical University of South Carolina|Teresa Kelechi|843-810-3157|kelechtj@musc.edu|
21298498|NCT04417361|UCSF|Jeffrey D. Sharon|4153532757|jeffrey.sharon@ucsf.edu|
21298499|NCT00892775|GlaxoSmithKline|GSK Response Center|866-435-7343||
21298500|NCT00699660|Veterans Affairs at TVHS|Theodore Speroff PhD|615-636-9476|ted.speroff@va.gov|
21298501|NCT02937558|Xeris Pharmaceuticals, Inc.|Khaled Junaidi|312-517-1461|xerisclintrials@xerispharma.com|
21298502|NCT01971385|Massachusetts General Hospital|Dr. Maria Alora-Palli|6177265066|mpalli@mgh.harvard.edu|
21298503|NCT04408040|Northside Hospital|H. Kent Holland, MD|404-255-1930|kholland@bmtga.com|
21298504|NCT03678311|Cleveland Clinic|Dr. Reena Mehra|216-444-2165|mehrar@ccf.org|
21298505|NCT01633788|Allergan plc|Ronald Bradford|1-714-846-5486|Bradford_Ron@allergan.com|
21298506|NCT02986711|Penn State University College of Medicine|Jessica Yingst|7175310003|jmy5048@psu.edu|289511
21298507|NCT01848158|Seattle Children's Hospital|Jane Di Gennaro, MD MS|206-987-6988|jane.digennaro@seattlechildrens.org|
21298508|NCT01389882|Seoul National University Hospital|Dr. Juyoung Lee|lamb4122@snu.ac.kr|lamb4122@snu.ac.kr|
21298509|NCT03790111|TerSera Therapeutics Inc.|Janine North, Executive Director-Clinical Development|888 600 8116|jnorth@tersera.com|
21298510|NCT03074409|University of Electronic Science and Technology of China|Dr. Shuxia Yao|+8618111297596|yaoshuxia@uestc.edu.cn|
21298511|NCT03811340|TriHealth Inc.|Rachel Pauls, MD|513-463-4300|Rachel_Pauls@trihealth.com|
21298512|NCT00280917|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il|
21298513|NCT03529110|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21298514|NCT05104450|Veterans Health Administration|Dr. Lucas Donovan|206-277-6783|Lucas.Donovan@va.gov|
21298515|NCT00769886|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
21298516|NCT01172535|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
21298517|NCT05413668|Quotient Sciences|Jeffrey Levy|+44 (0)115 974 9000|jeffrey.levy@quotientsciences.com|
21298518|NCT01631994|NYU Winthrop Hospital, Dep't of Gastroenterology|David Friedel, MD|(516) 663-2528|DFriedel@nyuwinthrop.org|
21298519|NCT00714415|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21298520|NCT01588561|McLean Hospital|Scott Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu|
21298521|NCT01818596|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21252408|NCT05646719|Opus Genetics|Sarah Callahan|984-884-6030|Scallahan@opusgtx.com|
21267071|NCT02591511|Taipei medical university|Dr. Chia-Yun Lin|+886919986391|windoct@hotmail.com|
21298522|NCT01327677|Johns Hopkins University School of Medicine|Athir Morad, M.D.|4109552611|morada@jhmi.edu|
21298523|NCT02794766|Universidade de Passo Fundo|Prof. Fernando Fornari|+555433168395|fernandofornari@gmail.com|
21298524|NCT00123123|University at Buffalo|Frank A. Scannapieco|716-829-3373|fas1@buffalo.edu|
21298525|NCT03461146|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608 Japanese only|cti-inq-ml@ml.mt-pharma.co.jp|
21298526|NCT02073682|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|1-908-992-6400|CTRinfo@DSI.com|
21298527|NCT01740414|New York State Psychiatric Institute|Dr. Sandra Comer|646-774-6146|comersd@nyspi.columbia.edu|
21298528|NCT02293798|Mark Mofid, M.D.|Dr. Mark Mofid|8589099000|drmofid@drmofid.com|
21298529|NCT04152772|Butler Hospital|Mascha van 't Wout-Frank|401-680-4198|Mascha_vant_Wout@brown.edu|
21298530|NCT02501590|Head of The Pediatric Neurology and Developmental Unit|Aviva Mimouni-Bloch|97297709048|abloch@clalit.org.il|
21298531|NCT02545608|Q-Med AB|Head of Development|+ 46 (0) 18 474 90 00|reception.seupp@galderma.com|
21298532|NCT03782233|The First Affiliated Hospital of Nanjing Medical University|Dr. He Huang|13852476684|hh19871117@126.com|
21298533|NCT04524858|Aclaris Therapeutics, Inc.|Ajay Aggarwal|484-540-6296|Clintrials@aclaristx.com|
21298534|NCT01623115|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21298535|NCT05202418|Emory University|Dr. Bonney Reed|404-727-8312|ebreed@emory.edu|
21298536|NCT02562716|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|smcdonou@fredhutch.org|
21298537|NCT00556998|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21298538|NCT02519439|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
21298539|NCT01775371|Albert Einstein College of Medicine|Dr. Polly Bijur|718-430-4217|polly.bijur@einsteinmed.edu|
21298540|NCT04961541|Novavax Inc.|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
21298541|NCT00851279|Stereotaxis Inc.|Dr Qun Sha, MD, Director of Clinical Trials|314 678 6143|qun.sha@stereotaxis.com|
21298542|NCT02330055|Beth Israel Deaconess Medical Center|Dr. Matthias Eikermann|6176673364|meikerma@bidmc.harvard.edu|
21298543|NCT02959437|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21298544|NCT02905266|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21298545|NCT05973006|Novavax Inc.|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
21298546|NCT02481297|The University of Texas MD Anderson Cancer Center|Dr. Nitin Jain/Associate Professor|713-745-6080|njain@mdanderson.org|
21298547|NCT03967054|Colorado State University|Brian D. Foy, PhD.|970-491-3470|Brian.Foy@colostate.edu|
21298548|NCT03884790|GreenBone Ortho SpA|Senior Clinical Affairs Manager|+393479747691|sonia.granados@greenbone.it|
21298549|NCT01862536|VA Boston Healthcare System|Dr. Ronald Goldstein|857-203-6578|Ronald.Goldstein@va.gov|
21298550|NCT03201419|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
21298551|NCT03868943|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-716-7548|rstrowd@wakehealth.edu|
21298552|NCT02777827|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
21298553|NCT04551066|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21298554|NCT00369577|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
21298555|NCT00398320|Stanford University School of Medicine|Pamela L Kunz, MD|650-725-8738|pkunz@stanford.edu|
21298556|NCT00064792|NICHD, NIH|Dr. Forbes Porter, Clinical Director, NICHD|301-435-4432|fdporter@mail.nih.gov|
21298557|NCT03137225|Virginia Commonwealth University|Henry J. Rozycki, MD|8048289602|henry.rozycki@vcuhealth.org|
21298558|NCT03915470|Destiny Pharma|Clinical Project Manager|+44 (0)1273-704440|info@destinypharma.com|
21298559|NCT03160898|Cytokinetics, Inc.|MD Cytokinetics|650-624-2929|medicalaffairs@cytokinetics.com|
21298560|NCT02601833|University of Michigan School of Dentistry|Emily Yanca Project and Data Manager|734-763-3988|emthorpe@umich.edu|
21298561|NCT00434109|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-7257|jonathan.strosberg@moffitt.org|
21298562|NCT00103740|Novartis Pharmaceuticals|Study Director|862-778-8300||
21298563|NCT01463306|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21298564|NCT02771197|The Blood and Marrow Transplant Group of Georgia/Northside Hospital|Dr. Scott Solomon|404-255-1930|ssolomon@bmtga.com|
21298565|NCT02155920|University of Texas Southwestern Medical School|Daniel C. Bowers, MD|214-648-3896|Daniel.Bowers@utsouthwestern.edu|
21298566|NCT02781610|Seattle Children's|Michelle Skalland (Biostatistician)|206-884-7519|michelle.skalland@seattlechildrens.org|
21298567|NCT00291486|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21298568|NCT01045694|University of Missouri-Columbia|Stephen Colbert|573-882-2275|colberts@health.missouri.edu|
21298569|NCT04725500|Philips|Chuck Cain|412-657-1814|chuck.cain@philips.com|
21298570|NCT00857857|GlaxoSmithKline|GSK Response Center|866-435-7343||
21298571|NCT03310723|BC Women's Hospital, Department of Anesthesia|Research Assistant|604-875-2424|james.taylor1@phsa.ca|6076
21298572|NCT02098746|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21298573|NCT02372877|Fresenius Kabi|Jason Friedmann|847-550-2365|jason.friedmann@fresenius-kabi.com|
21298574|NCT02362321|CHU de Québec|Principal Investigator|418-649-0252|michel.prudhomme.chuq@gmail.com|
21298575|NCT03273673|Virginia Tech|Dr. Robin Queen|(540) 231-3134|rmqueen@vt.edu|
21298576|NCT01982123|University of Washington Medical Center|Dr. Jing Zeng|2065984110|jzeng13@uw.edu|
21298577|NCT01822197|Nationwide Childrens Hospital|Dr Ben Kopp|6147224766|benjamin.kopp@nationwidechildrens.org|
21298578|NCT01132807|Alliance for Clinical Trials in Oncology|David J. Straus, MD|212-639-8365|strausd@mskcc.org|
21236845|NCT03526250|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21298579|NCT00742183|Mölnlycke Health Care|Viktoria Ahlenius Körner|+46-31-722 32 46|viktoria.ahleniuskorner@molnlycke.com|
21236846|NCT04420221|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21236847|NCT01715805|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21236848|NCT01391962|National Cancer Institute|Dr. Alice P. Chen|240-781-3320|chenali@mail.nih.gov|
21236849|NCT02105948|GlaxoSmithKline|GSK Response Center|866-435-7343||
21236850|NCT01140191|Walter Reed National Military Medical Center (WRNMMC)|COL Glenn W. Wortman|301-295-6400|glenn.wortmann@amedd.army.mil|
21236851|NCT02558010|Medical College of Wisconsin|Keri R. Hainsworth, PhD|414-266-6306|khainswo@mcw.edu|
21236852|NCT04072159|Arizona State University, College of Health Solutions|Dr. Alexis Koskan (Assistant Professor)|602-827-2792|alexis.koskan@asu.edu|
21236853|NCT03980470|University Hospital Zurich|Dr Ronny R. Buechel|+41442551059|ronny.buechel@usz.ch|
21236854|NCT01196975|GlaxoSmithKline|GSK Response Center|866-435-7343||
21236855|NCT00105027|The EMMES Corporation|Paul C. VanVeldhuisen, Ph.D.|301-251-1161|score@emmes.com|
21236856|NCT04558346|University of Kansas Medical Center|Dr. Michael Rippee|913-945-7486|mrippee@kumc.edu|
21236857|NCT00724971|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21252409|NCT05890027|Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida|Dr. Sara T. Wester|(305)-243-2020|swester2@med.miami.edu|
21252410|NCT01594827|Johns Hopkins Unviversity School of Medicine|Dr. Mark Jennings|410-502-7044|mjenni15@jhmi.edu|
21283660|NCT04416737|Stanford University|Dr. Rayhan Lal|650-725-2908|inforay@stanford.edu|
21283661|NCT03332628|University of Iowa|Nicole Brogden, Associate Professor|(319) 335-8752|nicole-brogden@uiowa.ed|
21283662|NCT00640653|University of Pennsylvania|Dr. John B. Jemmott III|215-573-9366|jjemmott@asc.upenn.edu|
21298580|NCT04057807|Yale School of Medicine|Adam Mecca|203.764.8100|adam.mecca@yale.edu|
21298581|NCT03477396|City of Hope|Dr. MIna Sedrak|626-359-8111|msedrak@coh.org|
21298582|NCT00068341|Jonsson Comprehensive Cancer Center|Helena Chang, M.D., Ph.D., Revlon/UCLA Breast Center|310-794-5640|hchang@mednet.ucla.edu|
21298583|NCT01080807|Cephalon, Inc.|Vice President, Medical Affairs|610-727-6353||
21298584|NCT02271698|Duke University Health System|Dr. Stuart Alan Grant|919-681-6437|stuart.grant@duke.edu|
21298585|NCT02430090|Ankara Numune Training and Research Hospital|Dr. Müge Çakırca|+905054433177|mugeturkoglu81@hotmail.com|
21298586|NCT00494585|The University of Texas M. D. Anderson Cancer Center|Srdan Verstovsek M.D./Associate Professor|713-792-7305|eharriso@mdanderson.org|
21298587|NCT01507688|VA HSRD PRIS-M QUERI and CHIC HSRD Centers|Teresa Damush Ph.D.|317-988-4277|Teresa.Damush@va.gov|
21298588|NCT00936702|Mayo Clinic|Matthew P. Goetz, M.D.|507 284-2511|goetz.matthew@mayo.edu|
21298589|NCT02532465|Nationwide Children's Hospital|Senthil Krishna, MD|614-722-4200|Senthil.Krishna@nationwidechildrens.org|
21298590|NCT00790192|Sunovion|Josephine Cucchiaro, PhD, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
21298591|NCT00354679|Memorial Sloan Kettering Cancer Center|Dr. David Ilson|646-888-4183|ilsond@mskcc.org|
21298592|NCT00466440|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21298593|NCT02493036|Synthetic Biologics Inc|Michael Kaleko|(240) 238-3862|mkaleko@syntheticbiologics.com|
21298594|NCT01844388|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21298595|NCT03187132|CedarsSinaiMC|R. Brennan Spiegel|310-423-6784|Brennan.Spiegel@cshs.org|
21298596|NCT02045095|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21298597|NCT02525588|Stryker|Britta von den Brincken, Clinical Study Manager|+491638999202|britta.vondenbrincken@stryker.com|
21298598|NCT01837277|Federal University of Bahia|Professor Carlos Brites|+5555992329552|crbrites@hotmail.com|
21298599|NCT01556451|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21298600|NCT04497116|Repare Therapeutics Inc|Repare Therapeutics Medical Monitor|1 (857) 340-5402|clininfo@reparerx.com|
21298601|NCT05963022|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21298602|NCT02698826|Cooper University Health Care|Brian Roberts, MD/ REOX Study Director|856-342-2352|roberts-brian-w@cooperhealth.edu|
21298603|NCT00945282|ViiV Healthcare|GSK Response Center|866-435-7343||
21298604|NCT02915263|Beth Israel Deaconess Medical Center|Christopher Gibbons MD|617-632-8454|cgibbons@bidmc.harvard.edu|
21298605|NCT02478463|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21298606|NCT01879683|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21298607|NCT01508169|Hospital de Clinicas da Universidade Estadual de Campinas (Unicamp)|Cecilia de Morais Barbosa|+55-19-35217113|cecimbarbosa@gmail.com|
21298608|NCT01825187|New Hanover Regional medical Center|Dr. William Hope|(910)667-9233|william.hope@nhrmc.org|667
21298609|NCT01698502|University of Copenhagen|Michael Lund|+45 3532 7519|michaeltl@sund.ku.dk|
21298610|NCT00004092|City of Hope National Medical Center|Paul Frankel, Ph.D.|(626) 256-4673|pfrankel@coh.org|65265
21298611|NCT01961271|Mundipharma Pte Ltd|Valerie Anne Leck|+65 6511 1165|info.rma@mundipharma.com.sg|
21283663|NCT01472757|Vectura Limited|Gary Burgess, MD|+44(0)1249 667700|clinical.enquiries@vectura.com|
21283664|NCT02619396|John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust|Dr Milena Leo|0186522055|milena.leo@ouh.nhs.uk|
21283665|NCT01549041|DukeUMC|Joseph P McEvoy, MD|9198199295|JPMCEVOY@DUKE.EDU|
21298612|NCT03600740|Mayo Clinic|Erik H. Middlebrooks, M.D.|904-953-6696|Middlebrooks.Erik@mayo.edu|
21298613|NCT01702558|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21298614|NCT02230566|Ultragenyx Pharmaceutical Inc|Kim Mooney, Associate Director, Patient Advocacy Medical Services|408-981-3526|kmooney@ultragenyx.com|
21298615|NCT06309953|Bausch & Lomb|Jason Vittitow, PhD|908-541-3060|jason.vittitow@bausch.com|
21298616|NCT01788566|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21283666|NCT02543892|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
21298617|NCT01338818|Novartis Pharmaceuticals|Study Director|8627788300||
21298618|NCT01620086|University of Arkansas for Medical Sciences|Erik Messias, MD|501-526-8142|emessias@uams.edu|
21298619|NCT00895284|Mayo Clinic|Dr. Rosanne Kho|408-301-5811|kho.rosanne@mayo.edu|
21298620|NCT03030417|National Cancer Institute|Dr. Alice P. Chen|240-781-3320|chenali@mail.nih.gov|
21298621|NCT01539759|University of North Carolina|Erika Levi, MD and Gretchen Stuart, MD|(919) 843-5633|Erika.Levi@gmail.com|
21298622|NCT01078441|ECOG Statistical Office|Study Statistician|617-632-3012||
21298623|NCT01425801|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
21298624|NCT02175017|Ono Pharmaceutical Co., Ltd.|Medical Information Center||clinical_trial@ono-pharma.com|
21298625|NCT04915729|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21298626|NCT03575403|University of Kentucky|Dr. Craig R. Rush, Ph.D.|8592575388|crush2@uky.edu|
21298627|NCT03066596|Montefiore Medical Center|Marina Reznik, MD, MS|718-741-2494|mreznik@montefiore.org|
21298628|NCT00773513|Hoffmann-La Roche|Medical Communications|(+41) 616878333|global.trial_information@roche.com|
21298629|NCT02864901|Office of Regulated Activities|Emily Badraslioglu, Senior Regulatory Advisor & FDA Sponsor Representative|(301) 619-6828|emily.d.badraslioglu.civ@health.mil|
21298630|NCT02946034|Massachusetts General Hospital|Dr. Raymond Chung|617-726-5925|Chung.Raymond@mgh.harvard.edu|
21298631|NCT04544358|University of Illinois at Chicago|Dr. David X Marquez|312.996.1209|marquezd@uic.edu|
21298632|NCT01951651|Baylor|Mandeep Bajaj|713-798-1712|bajaj@bcm.edu|
21298633|NCT00782717|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937 and 817.568.6725|medinfo@alconlabs.com|
21298634|NCT03359174|Yale Univeristy|Clinical Research Coordinator|203 737 6839|laura.cusack@yale.edu|
21298635|NCT02446717|AbbVie|Global Medical Services|800-633-9110||
21298636|NCT03149172|Tufts University|Dr. Yong Hur|6176366531|Yong.Hur@tufts.edu|
21298637|NCT00239733|Weill Cornell|Kristen Marks|212-746-4177|markskr@med.cornell.edu|
21298638|NCT03715803|Universidad de Buenos Aires|Dr. Agustín Sampietro|+5491158336327|asampietro@live.com.ar|
21298639|NCT01332994|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21298640|NCT01807598|Stanford University|Jason R. Gotlib|650-736-1253|jason.gotlib@stanford.edu|
21298641|NCT04170543|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21298642|NCT04378270|University of Pittsburgh|Jeffrey Gusenoff, MD|(412) 641-3960|gusenoffja@upmc.edu|
21298643|NCT01156714|VAORD|Fred Ivey|410-605-7000|Frederick.Ivey@va.gov|6582
21298644|NCT01236521|VA Center for Health Information and Communication|Dr. Matthew J. Bair|317-988-2058|mbair@iupui.edu; Matthew.Bair@va.gov|
21298645|NCT03946748|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21298646|NCT02784171|Canadian Cancer Trials Group|Dr. Lesley Seymour|613533600|lseymour@ctg.queensu.ca|75544
21298647|NCT04661150|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21298648|NCT04965688|Inova Health System|Adam Cohen, MD|7035767279|adam.cohen@inova.org|
21298649|NCT05907395|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21298650|NCT02701283|Medtronic Structural Heart & Aortic Clinical Research & Medical Science|Kristin Smith, Clinical Research Manager|763-526-3095|kristin.m.smith@medtronic.com|
21298651|NCT04544956|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21298652|NCT04266795|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21298653|NCT03043872|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21298654|NCT00543387|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21298655|NCT02267538|Peking University First Hospital|Dr. Dong-Xin Wang,PHD,the director of department of Anesthesiology and Critical Care Medicine|+8613910731903|wangdongxin@hotmail.com|
21298656|NCT03932760|University of Utah|Gwen Latendresse|801-587-9636|Gwen.Latendresse@nurs.utah.edu|
21236858|NCT01462344|GlaxoSmithKline|GSK Response Center|866-435-7343||
21236859|NCT05244525|The University of Texas Health Science Center at Houston|James M. Gregory, MD|(713) 486-7500|James.M.Gregory@uth.tmc.edu|
21236860|NCT03086447|Johnson & Johnson Vision|Kristy Canavan- SENIOR PRINCIPAL RESEARCH OPTOMETRIST|904 443-1474|KCANAVA2@its.jnj.com|
21236861|NCT00581529|University of Michigan Comprehensive Cancer Center|Dr. Lori Pierce, M.D.|734-764-9922|ljpierce@umich.edu|
21236862|NCT02657226|The University of Pittsburgh|Dr. John Kellum|4123834202|kas287@pitt.edu|
21236863|NCT01128413|Washington University School of Medicine|Dr. Chris Holthaus|314-747-5994|holthauscv@wustl.edu|
21236864|NCT03680755|Temple University Kornberg School of Dentistry|Associate Dean for Research & Chair Department of Oral Health Sciences|215-707-1773|marisol.tellez.merchan@temple.edu|
21236865|NCT02075593|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21236866|NCT00726752|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21236867|NCT01588184|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21236868|NCT01096992|The University of Texas MD Anderson Cancer Center|William Wierda, MD./Professor|713-745-0428|CR_Study_Registration@mdanderson.org|
21236869|NCT00907153|Penn State Hershey Medical Center|Dr. Nazia Raja-Khan|717-531-8395|nrajakhan@psu.edu|
21236870|NCT04098939|Aarhus University Hospital|Søren Helbo Skaarup|+4528911869|soeska@rm.dk|
21236871|NCT00778648|Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie , Charité - Universitätsmedizin Berlin, Germany|Dr. Stephanie Roll|+49 30 450 529023|stephanie.roll@charite.de|
21236872|NCT01911403|Hospital de Sao Joao, E.P.E.|Dr. Paulo Morgado|+351 22 551 2100|vilaresmorgado@iol.pt|
21236873|NCT01773070|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
21298657|NCT02774148|Spectrum Health|Andrea Mantel|616-486-2051|andrea.mantel@spectrumhealth.org|
21298658|NCT02137096|University of Florida|John Fort, MD|352-273-9120|john.fort@ufl.edu|
21298659|NCT01223183|University of Pittsburgh|Tim Corcoran|412-624-8918|corcorante@upmc.edu|
21298660|NCT03772665|Acucela, dba Kubota Vision|Dr. Jeff Gregory|2068058310|clinicaltrials@acucela.com|
21252411|NCT03334253|Jaeb Center for Health Research|Raymond Kraker, PEDIG Coordinating Center Director|8139758690|rkraker@jaeb.org|
21252412|NCT00968526|GlaxoSmithKline|GSK Response Center|866-435-7343||
21252413|NCT00584077|University of Texas-Galveston|Alexander Duarte, MD|409-772-2436|aduarte@utmb.edu|
21252414|NCT02106962|California Insitute of Renal Research, Inc.|Mark M. Boiskin, M.D.|858-637-4600|mboiskin@bnmg.org|
21252415|NCT02030002|University of Minnesota|Thorsten Gruenheid|612-625-3903|tgruenhe@umn.edu|
21252416|NCT01327612|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21252417|NCT01294397|Amgen Inc.|Study Director|866-572-6436||
21252418|NCT05569421|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21252419|NCT02406248|AstraZeneca R&D|Brilinta Global Clinical Lead|+46 31 776 10 00|kontakt@astrazeneca.com|
21252420|NCT04079634|Northwestern University|Nishant Verma, MD|3129262148|nishant.verma@nm.org|
21252421|NCT03812029|ENYO Pharma SA|Pietro Scalfaro|+33437700219|ps@enyopharma.com|
21252422|NCT00479882|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21252423|NCT03106753|Icahn School of Medicine at Mount Sinai|Dr. Natalie Porat|973-919-6166|poratnat@gmail.com|
21252424|NCT02874014|Mayo Clinic|Dr. C. Richard Choo|507-284-3261|Choo.C@mayo.edu|
21252425|NCT03149042|University at Buffalo|Dr. Ciprian Ionita|7164004283|cnionita@buffalo.edu|
21252426|NCT01643044|Wayne State University|Steven Ondersma, PhD|313-444-9797|sondersm@med.wayne.edu|
21252427|NCT01434745|Washington State University|Dr. jean-Baptiste Roullet|5093587666|j.roullet@wsu.edu|
21252428|NCT03836859|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 513831|clinical.trials@dompe.com|
21252429|NCT02470780|University of Cincinnati/UC Health|Hilary Perez PhD|5135582577|perezhe@ucmail.uc.edu|
21252430|NCT01023958|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21252431|NCT04646291|Mosie Baby (Consultant)|Karina Loyo, Ph.D., MBA, CCDM|512-563-1393|karina@drkarina.com|
21252432|NCT00790205|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21252433|NCT03933462|Philips|Sara Garbin|724-787-8550|sara.garbin@philips.com|
21252434|NCT00980746|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
21252435|NCT04805073|University of Florida Health Gainesville|Adam Wendling, MD, Division Chief Obstetric Anesthesiology|3528707461|Awendling@anest.ufl.edu|
21252436|NCT03937141|Chinook Therapeutics, Inc.|Chinook Therapeutics, Inc. (formerly Aduro Biotech, Inc.)|206-485-7051|clinicaltrials@chinooktx.com|
21252437|NCT02975102|Bausch + Lomb|Associate Director, Global Clinical Operations|+49 30 330 93|natasa.orlic-pleyer@bausch.com|318
21252438|NCT02609672|McMaster University/University of Waterloo|Dr. Monica Maly|519-888-4567|mrmaly@uwaterloo.ca|37916
21252439|NCT01441635|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21252440|NCT01912404|Conatus Pharmaceuticals Inc.|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
21252441|NCT01661764|Vanderbilt University Medical Center|Harvey J Murff|615 936 8319|harvey.j.murff@vanderbilt.edu|
21252442|NCT02269423|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21252443|NCT01430468|Cleveland Clinic Foundation|Joseph P. Iannotti, MD, PhD|216-445-5151|iannotj@ccf.org|
21252444|NCT01281839|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
21252445|NCT01305239|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21252446|NCT04176731|Insulet Corporation|Dr. Trang Ly|9786007628|tly@insulet.com|
21252447|NCT03518567|Brown University|Elizabeth Aston, PhD|401-863-6668|elizabeth_aston@brown.edu|
21252448|NCT01754753|The University of Sheffield|Daniel Hind - Assistant Director Sheffield Clinical Trials Research Unit|441142220707|d.hind@sheffield.ac.uk|
21252449|NCT03229486|Pusan National University Yangsan Hospital|Professor|0553602756|anesktk@pusan.ac.kr|
21252450|NCT00856245|University of Kansas Cancer Center|Siddhartha Ganguly, MD|(913) 588-6030|sganguly@kumc.edu|
21252451|NCT01443923|NIAID/NIH|Dr. Shyam Kottilil|301-435-0936|skottilil@niaid.nih.gov|
21252452|NCT01426230|Depomed|Head of R&D|510-744-8000|msweeney@depomed.com|
21252453|NCT01292304|University of Florida|Giuseppe (Joseph) Morelli, MD|352-273-9508|giuseppe.morelli@medicine.ufl.edu|
21252454|NCT00243074|SWOG Statistical Center|Lung Committee Statistician|206-667-4623|jmoon@fredhutch.org|
21252455|NCT00344032|GlaxoSmithKline|GSK Response Center|866-435-7343||
21252456|NCT01754987|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Daniel Monti|215 955-2221|daniel.monti@jefferson.edu|
21252457|NCT05131477|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|contact-us@saonofi.com|6
21252458|NCT02194829|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21252459|NCT06915285|VisionQuest Biomedical Inc|Vinayak Joshi|3054845674|vjoshi@visionquest-bio.com|
21252460|NCT03939689|Lantheus|June Li, Vice President, Biometrics and Data Sciences|978-671-8107|lij@lantheus.com|
21252461|NCT04427280|The Royal Marsden NHS Foundation Trust|Senior Trial Manager (for the CARDS study)|020 8642 6011|gi.trials@rmh.nhs.uk|3807
21283667|NCT01199822|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21283668|NCT04027075|Oregon Research Behavioral Intervention Strategies, Inc.|Dana Smith|541-484-2123|dana.smith@influentsin.com|
21283669|NCT00526331|UT MD Anderson Cancer Center|Gabriel Mena, MD / Professor||CR_Study_Registration@mdanderson.org|
21252462|NCT04057573|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21252463|NCT04944290|Padagis LLC|Jonathan Schwartz|929-502-7291|jonathan.schwartz@padagis.com|
21252464|NCT03388268|Washington University in St. Louis|Kimberly Reske, MPH, Research Coordinator|314-747-4041|kreske@wustl.edu|
21252465|NCT01475305|Medimmune, LLC|Hasan Jafri, Medical Director|301-398-4431|jafrih@medimmune.com|
21252466|NCT00790400|Novartis Pharmaceuticals|Novartis Pharmaceuticals|862-778-8300||
21283670|NCT02335749|Zeltiq Aesthetics|Kerrie Jiang, Director Clinical Affairs|925-621-7462|kerrie.jiang@allergan.com|
21252467|NCT00699153|Bausch & Lomb, Inc.|Laura Trusso, MS.|(585) 338-5561|laura.trusso@bausch.com|
21252468|NCT03054051|Emory University|Kate Winskell Enger PhD|404-727-5286|swinske@emory.edu|
21252469|NCT01997905|Methodist Hospital Houston|Basel Ramlawi, MD|713-441-5200|basel.ramlawi@gmail.com|
21252470|NCT00078338|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21252471|NCT04043143|"University of Colorado Denver | Anschutz"|Karsten Bartels, MD, PhD, MBA|303-724-1111|karsten.bartels@cuanschutz.edu|
21252472|NCT04307940|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21252473|NCT02734498|Wake Forest School of Medicine|James Kimball, MD|336-716-9702|jkimball@wakehealth.edu|
21252474|NCT04624243|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21252475|NCT04996004|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21252476|NCT05543174|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21252477|NCT03104075|The Jackson Laboratory|Dr. Jacques Banchereau|860-837-2443|jacques.banchereau@jax.org|
21252478|NCT00789360|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
21252479|NCT03559062|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21252480|NCT01757197|Weill Cornell Medicine|Usama Gergis, MD|(212) 746-2119|usg2001@med.cornell.edu|
21298661|NCT04437485|Indiana University-Purdue University Indianapolis (IUPUI)|Jesse C. Stewart, PhD., Principal Investigator|317-274-6761|jstew@iupui.edu|
21298662|NCT03553758|Massachusetts General Hospital DACCPM|Dr. Oluwaseun Johnson-Akeju|617-724-7200|oluwaseun.akeju@mgh.harvard.edu|
21298663|NCT01454791|MS Center at Evergreenhealth Care|Theodore R, Brown, MD Principle Investigator|425-899-5350|trbrown@evergreenhealth.com|
21298664|NCT01467505|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21298665|NCT02719171|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21298666|NCT02807623|Defense Health Agency Immunization Healthcare Division South Atlantic Region Vaccine Safety hub|Laurie Housel|910-432-4015|laurie.a.housel.civ@mail.mil|
21298667|NCT02614729|Purdue University|Dr. Heather Leidy|765-496-0184|hleidy@purdue.edu|
21298668|NCT01083849|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21298669|NCT04456634|Medicines for Malaria Venture (MMV)|Jacques Herve|+41 79 370 40 63|hervej@mmv.org|
21298670|NCT01875159|Uniformed Services University|Carl E. Hunt, M.D.|240-694-2676|carl.hunt@usuhs.edu|
21298671|NCT01412164|Shanghai Microport Medical (Group) Co.,Ltd.|Kefei Li|+86-21-38954600×6700|kfli@microport.com|
21298672|NCT02752880|Chang Gung Memorial Hospital|Dr. YH Huang|+886975360240|igighuang@gmail.com|
21298673|NCT01045967|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21298674|NCT03493945|National Cancer Institute|Dr. James L. Gulley|301-480-7164|gulleyj@mail.nih.gov|
21298675|NCT03689582|University of Michigan Rogel Cancer Center|Morand Piert, MD|734-936-5388|mpiert@med.umich.edu|
21298676|NCT04662359|University of Pennsylvania|Dr. Michael George|215-662-2454|michael.george@pennmedicine.upenn.edu|
21298677|NCT01364584|University of Colorado School of Medicine|Judith G Regensteiner, PhD|303-724-2247|judy.regensteiner@ucdenver.edu|
21298678|NCT01121146|AORI|C. Anderson Engh, Jr., MD|703-619-4411|research@aori.org|
21298679|NCT04363879|AtriumHealth|Dr. Brad Hurst, Director of Assisted Reproduction Program|7043553153|Brad.Hurst@atriumhealth.org|
21298680|NCT03922581|Emory University|Abigail Lott, PhD|404-712-0159|abigail.lott@emoryhealthcare.org|
21298681|NCT04472611|Yale University School of Medicine|Dr. Alexandra Lansky|203 737 2142|alexandra.lansky@yale.edu|
21298682|NCT00764699|Nationwide Children's Hospital|Julie Rice, RN|6143553142|julie.rice@nationwidechildrens.org|
21298683|NCT05098028|Bausch Health Americas, Inc|Varsha Bhatt|7072301712|varsha.bhatt@bauschhealth.com|
21298684|NCT01508312|Memorial Sloan Kettering Cancer Center|Dr. Alison Moskowitz|212-639-4839|moskowia@mskcc.org|
21298685|NCT02223715|Otsuka Pharmaceutical Co., LTD.|Study Director, Yoshitaka Kotobuki, Mr|+81-3-6361-7366||
21298686|NCT02222558|TesoRx Pharma, LLC|Michael Oefelein, MD, Chief Medical Officer|909-595-0500|karl@tesorx.com|104
21298687|NCT01745367|Aveo Pharmaceuticals, Inc.|Chief Medical Officer|857-400-0101|Clinical@aveooncology.com|
21298688|NCT00896298|UT Southwestern Medical Center|Dr. Abhimanyu Garg|214-648-2895|abhimanyu.garg@utsouthwestern.edu|
21298689|NCT02322281|Clovis Oncology|Vi Nguyen|+1 415 915 9982|vnguyen@clovisoncology.com|
21298690|NCT01020786|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21298691|NCT01358825|GlaxoSmithKline|GSK Response Center|866-435-7343||
21236874|NCT01559844|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21236875|NCT02181803|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21236876|NCT00951041|GlaxoSmithKline|GSK Response Center|866-435-7343||
21236877|NCT00780208|Medical University of South Carolina|Aimee McRae-Clark, Professor|843-792-5216|mcraeal@musc.edu|
21236878|NCT05645354|The University of Texas Health Science Center at Houston|Irene Tami-Maury, DMD,MSc,DrPH-NHSN|713-500-9234|Irene.M.Tami-Maury@uth.tmc.edu|
21236879|NCT01578993|Semprus BioSciences|Ulla Wallin, Director of Clinical Research|1-617-577-2205|ulla.wallin@semprusbio.com|
21236880|NCT01795833|Imperial College London|Nick Oliver|02033111093|nick.oliver@imperial.ac.uk|
21236881|NCT04477187|UT Southwestern|Research Coordinator|214-645-8907|jennifer.barillas@utsouthwestern.edu|
21236882|NCT02460991|Boston Scientific|Kristi Winterfeldt|763-494-1165|kristi.winterfeldt@bsci.com|
21236883|NCT01296568|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21236884|NCT00321854|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21252481|NCT03322540|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21298692|NCT03571204|National Institute of Allergy and Infectious Diseases|Sneller, Michael|+1 301 496 0491|msneller@niaid.nih.gov|
21283671|NCT00033657|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
21283672|NCT01259375|Huntsman Cancer Institute|Dr. Sunil Sharma|801-587-5559|sunil.sharma@hci.utah.edu|
21252482|NCT02153905|National Cancer Institute|Dr. Steven Rosenberg|240-858-3080|sr78a@nih.gov|
21252483|NCT00520845|Vanderbilt-Ingram Cancer Center|Dr. Leora Horn|615-322-4967|leora.horn@vanderbilt.edu|
21252484|NCT00351377|Novartis Pharmaceuticals|Study Director|862-778-8300||
21252485|NCT00703339|Lung Rx|Rosa Negro-Vilar|240-821-1881|rnegrovilar@lungrx.com|
21252486|NCT02493062|St. Louis Fetal Care Institute|Dr. Laura Vricella|3146784488|fetalcare@ssmhealth.com|
21252487|NCT01762904|Universidad de Guanajuato|Alejandro E. Macías|+52 477 7 14 58 59|aaeemmhh@yahoo.com|4644
21252488|NCT01967069|Promius Pharma|Director of Clinical Operations|609-282-1476|kgulbronson@promiuspharma.com|
21252489|NCT01528319|Johnson & Johnson K.K. Medical Company|Department Chief, Clinical Development & PMS|+81-3-4411-6789|yikeda5@its.jnj.com|
21252490|NCT02132832|The University of Texas Health Science Center at Houston|Scott D. Lane, PhD|(713) 486-2535|Scott.D.Lane@uth.tmc.edu|
21252491|NCT00581477|Vanderbilt University Medical Center|Alfredo Gamboa MD|6158751003|alfredo.gamboa@vumc.org|
21252492|NCT06381986|Sunhawk Vision Biotech|President|+886-72222660|hjuo@shvbiotech.com|
21252493|NCT03443414|Verona Pharma|Brian Maurer, Senior Clinical Operations Director|(914) 767-5037|brian.maurer@veronapharma.com|
21252494|NCT02097303|Carolina Research Professionals, LLC|Dr. Neal D. Shore, MD, FACS, CPI|843-449-1010|nshore@carolinaresearchprofessionals.com|243
21252495|NCT03017742|Masimo Corporation|Cristina Johnson|(949) 297-7000|clinicalresearchdept@masimo.com|
21252496|NCT00780455|Bayer Healthcare AG|Medical Affiars Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21252497|NCT05262751|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21252498|NCT03690427|University of California, Los Angeles|Mary Rezk-Hanna, PhD|3102068654|mrhanna@mednet.ucla.edu|
21252499|NCT00727740|Yale University School of Medicine|Priya Jamidar, MD|203-785-6228|priya.jamidar@yale.edu|
21252500|NCT03519204|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21252501|NCT02956837|GlaxoSmithKline|GSK Response Center|866-435-7343|shm60684@gsk.com|
21252502|NCT01824589|Advanced Circulatory|Sr. Clinical Research Associate|651.403.5600|nburkhart@advancedcirculatory.com|
21252503|NCT02597712|Trio Medicines Ltd|Dr Malcolm Boyce|+44 20 8961 4130|mboyce@triomedicines.com|
21252504|NCT02614690|Connecticut Children's Medical Center|Dr, Mark Lee|860-837-7421|Mlee01@connecticutchildrens.org|
21252505|NCT01727505|University of Miami School of Medicine, Dept. of Pediatrics - Div. of Neonatology|Nelson Claure, MSc, PhD, Director Neonatal Pulmonary Research Lab|305 585 6408|nclaure@miami.edu|
21252506|NCT02627118|UConn Health|Andre Kaplan, MD||kaplan@uchc.edu|
21252507|NCT02637323|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
21252508|NCT01154140|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21252509|NCT00358644|Eisai Inc.|Eisai Call Center|888-422-4743||
21252510|NCT00513708|SUNY Buffalo|Schieder, Jeffrey|716-645-2977|jss10@buffalo.edu|
21252511|NCT00368875|Montefiore Medical Center - New York|NYCC Regulatory Coordinator|718-379-6862|sforde@montefiore.org|
21252512|NCT03327831|UC Irvine|Christopher Zachary|949-824-5515|czachary@uci.edu|
21252513|NCT01564277|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21252514|NCT02595372|IndianaU|Dr. Kathy Miller|(317) 948-3855|kathmill@iu.edu|
21252515|NCT02588872|Rush University Medical Center|Mukesh Ahuja|312-432-2380|cole.research@rushortho.com|
21252516|NCT01594970|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21252517|NCT00401258|McLean Hospital|Brian Brennan, M.D.|617-855-2911|bbrennan@partners.org|
21252518|NCT02378038|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21252519|NCT03697122|Duke University|Negmeldeen Mamoun, M.D.|919-681-3551|negmeldeen.mamoun@duke.edu|
21252520|NCT02079025|Exact Imaging|Manager, Clinical Research|905-415-0030|bwodlinger@exactimaging.com|204
21252521|NCT04276051|Emory University|Alexandra Migdal, MD|404-778-3280|alexandra.love.migdal@emory.edu|
21252522|NCT01299480|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21252523|NCT01374568|UAB|Dr. Amy Warriner|2059964004|awarriner@uabmc.edu|
21252524|NCT00617929|Masonic Cancer Center, University of Minnesota|Jakub Tolar, MD|612-624-7180|tolar003@umn.edu|
21252525|NCT04160988|Acer Healthcare Inc.|Regulator Manager|886-6-26963131|Johnny.Lu@acer.com|5789
21252526|NCT00844597|Sarepta Therapeutics|Edward M. Kaye, MD, Interim CEO, SVP & Chief Medical Officer|617-274-4003|EKaye@Sarepta.com|
21252527|NCT01250509|University of California, San Francisco|Jennifer Daubenmier, PhD|415-514-8601|jennifer.daubenmier@ucsf.edu|
21252528|NCT02506933|City of Hope Medical Center|Dr. Ryotaro Nakamura, MD|6263598111|RNakamura@coh.org|
21252529|NCT06840769|Helsinn Healthcare SA|Tulla Spinelli|+41.91.985.21.21|Tulla.Spinelli@helsinn.com|
21252530|NCT02726945|GID Bio|Director of Clinical Operations|3039524901|s.samudre@gidbio.com|105
21252531|NCT02473965|Grifols Therapeutics LLC|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
21252532|NCT03816761|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21252533|NCT02560753|T3DTherapeutics|John Didsbury, PhD|9199490517|didsj919@t3dtherapeutics.com|
21252534|NCT03085836|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21252535|NCT02296502|University of Pittsburgh|Benjamin L Handen, PhD|412-235-5445|handenbl@upmc.edu|
21252536|NCT01667926|Massachusetts General Hospital|Dr. Cristina Cusin|6177263855|ccusin@mgh.harvard.edu|
21252537|NCT01976273|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
21252538|NCT00603525|GlaxoSmithKline|GSK Response Center|866-435-7343||
21252539|NCT06476548|Moffitt Cancer Center|Dr. Christine Vinci|813-745-5421|Christine.Vinci@moffitt.org|
21298693|NCT02721875|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21298694|NCT02888106|Hepatera LLC|Yana Deloveri|+7 495 762 52 53|deloveri@hepatera.ru|42-14
21298695|NCT00857285|Daiichi Sankyo, Inc.|Senior Director, Regulatory Operations|732-590-5000|hmkessler@dsus.com|
21298696|NCT00837200|Milton S Hershey Medical Center|Joseph J Drabick, MD|717-531-5911|jdrabick@hmc.psu.edu|
21298697|NCT03435185|University of Health Sciences Dr. Lütfi Kırdar Kartal Training and Research Hospital|Dr. Cem Bölük|+902164413900|cem.boluk@sbu.edu.tr|
21298698|NCT04142034|University of Arkansas for Medical Sciences|Jeannette Lee|5015266712|jylee@uams.edu|
21298699|NCT01076959|Abbott|Global Medical Services|800-633-9110||
21298700|NCT02491983|MedSIR|Alicia Garcia|+34 611261467|alicia.garcia@medsir.org|
21298701|NCT01887132|National Institute of Mental Health (NIMH)|Ashura W Buckley|(301) 496-5190|shu.buckley@nih.gov|
21298702|NCT04445662|Massachusetts General Hospital|Travis P Baggett MD MPH|617-643-9314|tbaggett@mgh.harvard.edu|
21298703|NCT00279916|Mayo Clinic|Dr. Laura Orvidas|507-284-3410|orvidas.laura@mayo.edu|
21298704|NCT00731679|Salix|David Sorscher|919-862-1827|david.sorscher@salix.com|
21298705|NCT02488005|Icahn School of Medicine at Mount Sinai|Becky Phan|212-824-7785|becky.phan@mssm.edu|
21298706|NCT03384940|Daiichi Sanyko, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21298707|NCT03087513|Toronto Western Hospital/University Health Network|Study Coordinator|416-603-5800|emad.alazazi@uhnresearch.ca|6237
21298708|NCT04628780|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21298709|NCT05315479|Baudax Bio|Development|484-395-2440|info@baudaxbio.com|
21298710|NCT03269994|Memorial Sloan Kettering Cancer Center|Dr. Michael D'Angelica, MD|212-639-3226|dangelim@mskcc.org|
21298711|NCT04303559|University of Pittsburgh|Dr. Margaret Ragni, Principal Investigator|412-209-7288|ragni@pitt.edu|
21298712|NCT00592488|Vanderbilt University|Todd Rice, MD|615 322-3412|todd.rice@vanderbilt.edu|
21298713|NCT01987102|Isofol Medical AB|Chief Medical Officer|+46 (0)702433750|karin.ganlov@isofolmedical.com|
21298714|NCT01288989|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21298715|NCT01327599|Alcon Research, Ltd.|Doug Hubatsch, Therapeutic Unit Head, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
21298716|NCT01132313|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21298717|NCT03890588|HealthPartners Institute|JoAnn Sperl-Hillen, MD, Senior Clinical Investigator|952-967-5009|joann.m.sperlhillen@healthpartners.com|
21298718|NCT00165672|Eisai Co.,Ltd. Eisai Product Creation Systems|Nobuyuki Sugisaki, Study Director|+81-3-3817-3908|n-sugisaki@hhc.eisai.co.jp|
21298719|NCT02052752|GlaxoSmithKline|GSK Response Center|866-435-7343||
21298720|NCT04854694|FaceView Mask, LLC|Jeanne Hahne, MSN, RN|4155188574|jeannehahne@gmail.com|
21298721|NCT05864586|OhioSUCCC|Dr. Theodore L. Wagener|614-366-4265|Theodore.Wagener@osumc.edu|
21298722|NCT03635424|Medtronic Coronary and Structural Heart Clinical|Hatice Bilgic Lim, PhD; Principal Clinical Research Specialist|763-526-1018|hatice.bilgic.lim@medtronic.com|
21298723|NCT05017701|Masimo Corporation|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
21298724|NCT04896593|Anxiety Disorders Center|David Tolin, Ph.D.|860-545-7685|david.tolin@hhchealth.org|
21298725|NCT03405818|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21298726|NCT04441255|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21298727|NCT00121186|SWOG Statistical Center|Study Statistician|206-667-4623||
21298728|NCT02679170|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21298729|NCT00992459|Hyperion Therapeutics|Bruce Scharschmidt, MD, SVP, Chief MedicaL & Development Officer|650-745-7851|bruce.scharschmidt@hyperiontx.com|
21298730|NCT01023724|Bucci Laser Visiosn|Frank A. Bucci, Jr., MD|570-825-5949|Buccivision@aol.com|
21298731|NCT01025830|University of California Berkeley|Jayne Byakika Tusiime|1 510 219 7567|tusiimej@berkeley.edu|
21298732|NCT00549445|University of Alabama at Birmingham|J. Edwin Blalock, PhD|205-934-6439|blalock@uab.edu|
21298733|NCT00513435|Memorial Sloan-Kettering Cancer Center|Matthew Fury, MD|646-888-4233|furym@mskcc.org|
21252540|NCT03374488|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
21236885|NCT03905655|Romark Laboratories, L.C.|Jessica Fulgencio|813-282-8544|jessica.fulgencio@romark.com|
21252541|NCT04595682|University of Kentucky|Dr. Mark Fillmore|8592574728|fillmore@uky.edu|
21298734|NCT02302365|Terumo BCT|Isobelle Galeon, MD, MPH, MSCS, Medical Monitor Clinical Safety|+1 303 542-5166|Isobelle.Galeon@Terumobct.com|
21298735|NCT00227721|Barbara Ann Karmanos Cancer Institute|Robert Morris, M.D.|313-576-9436|rmorris@med.wayne.edu|
21298736|NCT05298202|University of Montana|Dustin Slivka|(406) 243-2389|dustin.slivka@umontana.edu|
21298737|NCT02539797|University of California, Los Angeles|Dr. Yuri Rassovsky|3104783711|yurir@ucla.edu|
21298738|NCT01432405|Baylor College of Medicine|Mandeep Bajaj|713-798-1712|bajaj@bcm.edu|
21298739|NCT02467179|University of California San Diego|Dr. Gregory Feld|(858) 246-2972|gfeld@ucsd.edu|
21298740|NCT01139814|Catheter Robotics, Inc.|Vice President, Clinical and Regulatory Affairs|973-426-0300|research@catheterrobotics.com|
21298741|NCT02796677|AstraZeneca AB|Global Clinical Leader|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
21298742|NCT00942903|The Netherlands Cancer Institute|Prof. Dr. F.J.M. Hilgers|+31-20-5122550|f.hilgers@nki.nl|
21298743|NCT04002960|Masimo|Chelsea Frank|949-297-7000|studies@masimo.com|
21298744|NCT00961181|University Medical Center, Freiburg i.Br., Germany|Prof. Dr. Christoph Hehrlein|+49 761 270|christoph.hehrlein@uniklinik-freiburg.de|6095
21298745|NCT01609348|Johns Hopkins University|Paul Rosenberg, MD|410-550-9883|prosenb9@jhmi.edu|
21298746|NCT01777308|GlaxoSmithKline|GSK Response Center|866-435-7343||
21298747|NCT03410628|electroCore Inc.|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
21298748|NCT03212326|Weill Cornell Medical College|Dr. Christopher Liu|212-746-2655|chl7001@med.cornell.edu|
21298749|NCT03430791|Miami Cancer Institute at Baptist Health, Inc.|Yazmin Odia|786-596-2000|YazminO@baptisthealth.net|
21298750|NCT00383786|Baylor College of Medicine|Sanjay Mathew, MD/PI|7137985439|sjmathew@bcm.edu|
21298751|NCT00985673|GlaxoSmithKline|GSK Response Center|866-435-7343||
21298752|NCT02252146|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
21298753|NCT00531284|Amgen, Inc.|Study Director|866-572-6436||
21298754|NCT00291135|University of Kansas Medical Center Research Institute|Carol J. Fabian, M.D.|913-588-7791|cfabian@kumc.edu|
21298755|NCT02219464|Vanderbilt University Medical Center|Cindy Pastern, RN BSN CCRP|615-343-0259|cindy.pastern@vanderbilt.edu|
21298756|NCT03057496|Schepens Eye Research Institute of Massachusetts Eye and Ear|Alex Bowers|617 912 2512|alex_bowers@meei.harvard.edu|
21298757|NCT02040623|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
21298758|NCT02981368|Lantheus Medical Imaging / Progenics Pharmaceuticals|David Myl|914-582-1120|david.myl@lantheus.com|
21298759|NCT02544321|University of Colorado Denver|Irene Schauer, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
21298760|NCT01517750|HELIOS-Klinik Ambrock|Dr Georg Nilius|+492331-9742005|klinik-ambrock.pneumo@t-online.de|
21298761|NCT01584232|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21298762|NCT01307319|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21298763|NCT02735239|Ludwig Institute for Cancer Research|Jonathan Skipper|212-450-1539|jskipper@lcr.org|
21298764|NCT02152631|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21298765|NCT05904470|Atea Pharmaceuticals, Inc.|Atea Clinical Trials|1-857-284-8891|ateaclinicaltrials@ateapharma.com|
21298766|NCT03776747|University of Iowa|Dr. Eric Hoffman|(319) 356-1381|eric-hoffman@uiowa.edu|
21298767|NCT00381004|The University of Texas (UT) MD Anderson Cancer Center|Alessandra Ferrajoli, MD/Professor, Leukemia||CR_Study_Registration@mdanderson.org|
21298768|NCT01560286|BioMarin Pharmaceutical Inc|Sr. Medical Director, Clinical Science|415-475-5854|Ari.Gershman@bmrn.com|
21298769|NCT02785185|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
21298770|NCT00666666|Rutgers Cancer Institute of New Jersey|Robert DiPaola, MD|732-235-8675|zelinsta@cinj.rutgers.edu, dipaolrs@cinj.rutgers.edu, rizzoji@cinj.rutgers.edu|
21298771|NCT00763412|Washington University in St Louis|Ana Maria Arbelaez|314-286-1138|arbelaez_a@kids.wustl.edu|
21298772|NCT01380769|Cerulean Pharma Inc.|Adrian Senderowicz|617 551 9600|asenderowicz@ceruleanrx.com|
21298773|NCT00178477|University of Rochester Medical Center|Walter O'Dell, Ph.D.|585-275-9996|walter_odell@urmc.rochester.edu|
21298774|NCT05030350|Vistagen Therapeutics, Inc.|Ester Salman, MPH|650-577-3693|clinicalstudies@vistagen.com|
21298775|NCT03654690|Brown University|Dr. Tyler Wray|4018636659|tyler_wray@brown.edu|
21298776|NCT02711137|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21298777|NCT00203229|Thomas Jefferson University|M. Alan Stiles|215-955-6215|Alan.Stiles@Jefferson.edu|
21298778|NCT01544920|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21298779|NCT00965081|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21298780|NCT02541812|University of Manitoba|Dr. Mandana Modirrousta|2042372303|mmodirrousta@sbgh.mb.ca|
21298781|NCT01367834|UNC Chapel Hill|Rebecca Knickmeyer Santelli|9199662216|rebecca_knickmeyer@med.unc.edu|
21298782|NCT00631358|Alcon Labs|Alcon Clinical|1-888-451-3937; 1-817-568-6725|medinfo@alconlabs.com|
21298783|NCT04140396|Stanford University|Chi-Ho Ban Tsui|(650) 200-9107|bantsui@stanford.edu|
21298784|NCT01569841|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21298785|NCT01859923|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21298786|NCT05350163|Miami Cancer Institute at Baptist Health, Inc.|Director, Research Concept & Protocol Development|(786) 527-9546|MCIResearchConceptAndProtocolDev@baptisthealth.net|
21236886|NCT02277106|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
21236887|NCT01292928|Boston Scientific Corporation|Philip Ghizoni, Clinical Trial Manager|763-255-0036|Philip.Ghizoni@bsci.com|
21252542|NCT06490302|CooperVision, Inc.|Jose A. Vega,OD,MSc, PhD|9256213761|javega@coopervision.com|
21298787|NCT01191723|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
21236888|NCT01059565|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21298788|NCT03101566|University of Michigan Rogel Cancer Center|Vaibhav Sahai, MBBS, MS|734-936-4991|vsahai@med.umich.edu|
21298789|NCT00113841|UT MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor|713-792-9660|xzhou@mdanderson.org|
21298790|NCT00488488|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21298791|NCT01126723|Institute for Aging Research, Hebrew SeniorLife|Dr. Lewis Lipsitz|617-971-5318|lipsitz@hsl.harvard.edu|
21298792|NCT03901144|Perrigo/ACO Hud Nordic|Dr Tina Holm|+46732744113|tina.holm@perrigo.com|
21298793|NCT02021565|Atlanta VA Medical Center|Patricia C. Griffiths|404-321-6111|Patricia.Griffiths@va.gov|7138
21298794|NCT02451995|Imperial College Healthcare|Dr Vishal Luther|07828913612|v.luther14@imperial.ac.uk|
21298795|NCT05114473|University of Valencia|Dr. Borja Perez-Dominguez|697464680|f.borja.perez@uv.es|34
21298796|NCT04936061|CoolTech|Clinical Trial Manager|570-228-8140|jholland@cooltechcorp.com|
21298797|NCT01451385|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
21298798|NCT01598922|McLean Hospital|Dr.Isabelle Rosso|6178552607|irosso@partners.org|
21298799|NCT04184297|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21298800|NCT02412098|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21298801|NCT03089580|University of Michigan / Kellogg Eye Center|Sarah Wood|734-615-2479|skwood@med.umich.edu|
21298802|NCT04491136|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21298803|NCT02452424|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
21298804|NCT03790917|National Medical Research Center for Preventive Medicine|professor Sergey Yu. Martsevich|89161643690|sergeymartsevich@mail.ru|
21236889|NCT03263429|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
21298805|NCT00386243|Center on Implementing Evidence Based Practice|Matthew J. Bair, MD MS|317-988-2058|mbair@iupui.edu|
21298806|NCT00176462|Rutgers Cancer Institute of New Jersey|Richard Drachtman, MD|732-235-8675|drachtri@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu|
21298807|NCT03274063|University of Edinburgh|Dr Philip Riches|07944625313|priches@staffmail.ed.ac.uk|
21298808|NCT01840345|Virginia Commonwealth University|Dr. Dace Svikis|(804) 827-1184|dssvikis@vcu.edu|
21298809|NCT01150097|Novartis Pharmaceuticals|Study Director|862-778-8300||
21298810|NCT01301833|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21298811|NCT02373774|Columbia University Medical Center|Raquel Schrager|(212) 305-4687|rs3823@cumc.columbia.edu|
21298812|NCT02918617|University of Texas Health San Antonio|Bennett Amaechi, DDS|210-567-3185|amaechi@uthscsa.edu|
21298813|NCT05736874|Duke University|Susanna Naggie, MD, MHS, FIDSA|919-684-2584|susanna.naggie@duke.edu|
21298814|NCT00984256|US Army Medical Materiel Development Activity (USAMMDA)|Michelle Mathers|301-619-8061|Michelle.mathers@us.army.mil|
21298815|NCT03270943|University of North Carolina at Chapel Hill|Christine Lathren, MD, MPH|919-966-8586|lathren@email.unc.edu|
21298816|NCT00246519|University of Florida|Julie A. Johnson|352-273-6007|johnson@cop.ufl.edu|
21298817|NCT01131507|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
21298818|NCT01790594|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21298819|NCT02038153|Montefiore|Dr. Ira Braunschweig|718 920-4826|ibraunsc@montefiore.org|
21298820|NCT02647281|GlaxoSmithKline|GSK Response Center|866-435-7343||
21298821|NCT00527735|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21298822|NCT01855412|Cardiovascular Systems, Inc.|Clinical Trials Manager|651.259.2500|clinicaltrials_csi@csi360.com|
21298823|NCT00404651|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21298824|NCT01302483|Department of Periodontics & Endodontics, School of Dental Medicine, University of Buffalo, SUNY|Dr. Sebastian Ciancio|(716) 829-3848|ciancio@buffalo.edu|
21298825|NCT03347123|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21298826|NCT00181363|Maastro Radiation Oncology|J. Buijsen,|+31 (0)88-44-55-666|jeroen.buijsen@maastro.nl|
21298827|NCT02960516|Vanderbilt university medical center|Dr. Wesley Thayer|+1 (615)936-3759|wesley.thayer@vumc.org|
21298828|NCT00669214|Genentech, Inc.|Medical Communications|800-821-8590||
21298829|NCT00754377|Louis Stokes VA Medical Center|Dr. David Aron|(216) 791-2300|david.aron@va.gov|5836
21298830|NCT03431441|Johnson & Johnson Vision Care|Meredith Bishop OD, MS, FAAO|904-443-1396|mbishop4@its.jnj.com|
21298831|NCT01276639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21298832|NCT03999515|Fred Hutchinson Cancer Center|Dr. Michael Schweizer|2066066252|mtschwei@fredhutch.org|
21298833|NCT03985761|Rutgers The State University of NJ|Dr. Gerard G Fluet DPT, PhD|(973) 972-8529|fluetge@shp.rutgers.edu|
21298834|NCT01285401|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21298835|NCT02163824|Kala Pharmaceuticals, Inc|VP, Clinical Development||Results001@kalarx.com|
21298836|NCT02107703|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21298837|NCT02366312|NYU College of Dentistry|Dr. Brian Schmidt|212-998-8900|brianl.schmidt@nyu.edu|
21298838|NCT05200143|Providence Portland Medical Center|Dr. Matthew Taylor|503-215-1979|canrsrchstudies@providence.org|
21298839|NCT03719131|Emory University|Kavita Dhodapkar, MD|404-785-1112|kavita.dhodapkar@emory.edu|
21298840|NCT02420093|University of Michigan Health System|Patricia Connors, PT, DScPT, OMPT|734-763-6464|pattyconnors219@gmail.com|
21298841|NCT03170661|LUMC|Drs. Maarten Honing|0715264038|g.h.m.honing@lumc.nl|
21298842|NCT03244917|Hebrew SeniorLife|Susan Mitchell MD, MPH|6172813669|smitchell@hsl.harvard.edu|
21236890|NCT04530448|West Virginia University|Ankit Sakhuja, MD|304.598.6092|ankit.sakhuja@hsc.wvu.edu|
21298843|NCT00964496|Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine|Zhizheng Ge, MD. Ph.D. Director of the Clinical Trials|86-21-68383015|zhizhengge@yahoo.com.cn|
21236891|NCT00303966|University of Chicago|Dr. Wendy Stock|773-834-8982|wstock@medicine.bsd.uchicago.edu|
21252543|NCT03065075|University of Massachusetts|Dr. Tania Sierra|508-334-9840|tania.sierra@umassmemorial.org|
21252544|NCT02484664|Brigham and Women's Hospital|Dr. David Kwiatkowski|8573070781|dk@rics.bwh.harvard.edu|
21252545|NCT00583466|Johns Hopkins University|Johns Hopkins ClinicalTrials.gov Program|410-550-6484|registerclinicaltrials@jhmi.edu|
21252546|NCT03926195|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
21252547|NCT03054337|Akebia Therapeutics|Akebia Therapeutics|(617) 844-6128|trials@akebia.com|
21252548|NCT02838979|University of Washington|Ernest Ayers|206-685-1423|ayerse@uw.edu|
21252549|NCT01661205|AtriCure, Inc.|Vice President, Clinical Operations|513-755-4562|SZink@AtriCure.com|
21252550|NCT00346905|Boston Scientific|Director, Endoscopy Clinical Affairs|1-508-333-1015||
21252551|NCT00874731|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21252552|NCT05105087|Thomas Jefferson University|Ji-Bin Liu, MD|215-955-4862|jxl120@jefferson.edu|
21252553|NCT01736540|Novartis|Study Director|862-778-8300||
21252554|NCT03470740|Chang Gung University of Science and Technology|Su-Hui Chen|886-3-2118999|sophee@mail.cgust.edu.tw|3216
21283673|NCT00628095|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21283674|NCT02635542|University of Chicago|Rebecca M Gerlach, MD|773-702-6700|rgerlach@dacc.uchicago.edu|
21283675|NCT03932331|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21283676|NCT03379753|TriHealth Inc.|Rachel Pauls, MD|513-463-4300|Rachel_Pauls@trihealth.com|
21283677|NCT02738255|Brigham and Women's Hospital|Andrew Wellman|6174078483|awellman@rics.bwh.harvard.edu|
21283678|NCT04535531|Novan|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
21283679|NCT01508052|Gachon University|Dr.Kwak|82324603400|hyun615@gilhospital.com|
21283680|NCT02225366|UT MD Anderson Cancer Center|Dr. Rodabe Amaria,MD, Associate Professor, Melanoma Medical Oncology|(713) 792-2921|rnamaria@mdanderson.org|
21283681|NCT00742508|GlaxoSmithKline|GSK Response Center|866-435-7343||
21298844|NCT01272232|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21298845|NCT02159066|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-102|ClinicalTrials.gov_Inquiries@pfizer.com|
21283682|NCT02767492|Hawkins Foundation|Kyle Adams|864 454-7458|kyle.adams@hawkinsfoundation.com|
21283683|NCT03619902|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
21283684|NCT04450407|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
21283685|NCT02251548|Dana-Farber Cancer Institute|Matthew Davids, MD|617-632-6331|matthew_davids@dfci.harvard.edu|
21283686|NCT02537431|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|Medinfo@ultragenyx.com|
21283687|NCT04542421|u of colorado|Dr Anna Maw|720-848-4289|anna.maw@cuanschutz.edu|
21283688|NCT02336360|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
21283689|NCT02754674|Samsung Medical Center|Wang, JoonHo|82-2-3410-3507|mdwang88@gmail.com|
21283690|NCT05523011|Paracrine Therapeutics Private Limited|Lai Ruenn Chai|+6593375977|ruennchai.lai@paracrinetherapeutics.com|
21283691|NCT00287989|MSKCC|Charles M. Rudin, MD, PhD.|646-888-4527|rudinc@mskcc.org|
21283692|NCT03197324|Theracos Sub, LLC|Albert Collinson, Ph.D.|508-688-4221|acollinson@theracos.com|
21283693|NCT00102531|Insmed|Margaret Galluzzi|(908) 977-9900|Margaret.Galluzzi@Insmed.com|
21283694|NCT00288067|University of Washington|Dr. Ajay Gopal|206-288-2035|agopal@uw.edu|
21283695|NCT02776644|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21283696|NCT00710684|GlaxoSmithKline|GSK Response Center|866-435-7343||
21283697|NCT04778059|US Biotest, Inc.|Dr. Gere diZerega|8055951300|gere.dizerega@usbiotest.com|
21283698|NCT02832375|GlaxoSmithKline|GSK Response Center|866-435-7343||
21283699|NCT00514904|GlaxoSmithKline|GSK Response Center|866-435-7343||
21283700|NCT00084318|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21283701|NCT04676412|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21283702|NCT05741346|BioCryst Pharmaceuticals Inc.|Study Director|+001 919859 1302|clinicaltrials@biocryst.com|
21283703|NCT03711058|Sidney Kimmel Cancer Center at Johns Hopkins|Nilofer Azad, MD|610-614-9169|nazad2@jhmi.edu|
21283704|NCT04439357|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21283705|NCT05573672|Canadian College of Naturopathic Medicine|Monique Aucoin|416 498 1255|maucoin@ccnm.edu|223
21283706|NCT05906836|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21283707|NCT05711381|Hanmi Pharmaceutical Co., Ltd.|Moon Hee Lee, MD|+82 2 410 9062|mhlee7@hanmi.co.kr|
21283708|NCT02407132|University of Arkansas for Medical Sciences|Dr. Pearl McElfish|479-713-8680|pamcelfish@uams.edu|
21298846|NCT00255190|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21298847|NCT02513121|University of California, San Diego|Dr. Jeffrey Schwimmer|858-966-8907|jschwimmer@ucsd.edu|
21298848|NCT02609308|Universidad Autónoma de Nuevo León|Carlos Acosta-Olivo, PhD|+52 81 8347-3056|dr.carlosacosta@gmail.com|
21298849|NCT04537793|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21298850|NCT01303939|Wills Eye Hospital, Glaucoma Research Center|George L. Spaeth, MD|215-928-3123|gspaeth@willseye.org|
21298851|NCT02254473|TRIA Orthopaedic Center|Megan Reams|952-806-5329|megan.reams@tria.com|
21298852|NCT00256724|Advanced Circulatory|Nathan Burkhart|651.403.5600|nburkhart@advancedcirculatory.com|
21252555|NCT01735175|Sandoz|Strategic Planning, Biopharmaceutical Clinical Development|+49 (0) 8024 476 - 0|biopharma.clinicaltrials@sandoz.com|
21252556|NCT02676843|Columbia University|William Kreisl, MD|212-342-2380|wck2107@cumc.columbia.edu|
21283709|NCT02672332|Novan, Inc.|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
21283710|NCT03790618|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
21283711|NCT01458951|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21283712|NCT03384784|University of Pennsylvania|Rebecca Ashare|215.746.7143|rlashare@pennmedicine.upenn.edu|
21283713|NCT00585013|Baylor College of Medicine|Paul Checchia MD|832-826-5011|checchia@bcm.edu|
21283714|NCT01668966|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21283715|NCT04392167|Duke University|Dr. Adam Wax|919-660-5143|a.wax@duke.edu|
21283716|NCT01779167|Weill Cornell Medicine|Peter Martin, MD|646.962.2064|amr2017@med.cornell.edu|
21283717|NCT01573767|GlaxoSmithKline|GSK Response Center|866-435-7343||
21283718|NCT02339155|GlaxoSmithKline|GSK Response Center|866-435-7343||
21283719|NCT02176083|University of California, San Diego|Irene Su, MD MSCE|8588225986|hisu@ucsd.edu|
21283720|NCT01279564|Rambam Health Care Campus|Dr. Michal Barak|972 4 8542487|m_barak@rambam.health.gov.il|
21283721|NCT05932225|Alcon Research, LLC|Clinical Trial Lead, CDMA Trial Management Operations|1-888-451-3937|alcon.medinfo@alcon.com|
21283722|NCT01911780|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21283723|NCT04247880|University of Washington|Dr. Marissa Baker|206 616 4709|bakermg@uw.edu|
21283724|NCT03506945|University of California San Diego|Brent Mausbach|8588227529|bmausbach@ucsd.edu|
21283725|NCT04076059|Astellas Pharma China, Inc|Clinical Transparency|+86-(0)10-85216666|astellas.resultsdisclosure@astellas.com|China only
21283726|NCT02677896|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-0512|astellas.resultsdisclosure@astellas.com|
21283727|NCT03902522|CytoDyn|Joseph Meidling|13609808524|jmeidling@cytodyn.com|
21283728|NCT02729038|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21283729|NCT05363072|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21283730|NCT00741091|Boston Scientific Corporation|Todd Kornmann, Specialist, Prin Reg Affairs|763-494-1348|Todd.Kornmann@bsci.com|
21283731|NCT01527487|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21283732|NCT00767039|Boston Medical Center|Alan Fujii MD (PI)|617-4414-3735|Alan.Fujii@bmc.org|
21283733|NCT01575275|Cleveland Clinic|Dr. Michael Vogelbaum|2164448564|vogelbm@ccf.org|
21283734|NCT02833935|McGill University|Shane Sweet|514-398-4184|shane.sweet@mcgill.ca|09903
21283735|NCT02505334|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21283736|NCT00597506|Duke University Medical Center|Herbert Hurwitz, MD|919-668-1861|herbert.hurwitz@duke.edu|
21283737|NCT02961062|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21283738|NCT00667186|University of Cincinnati College of Medicine|Michael S. Lyons|513-558-0890|lyonsme@ucmail.uc.edu|
21283739|NCT00081731|University of Toledo|Christopher Cooper, MD|419-383-6297|christopher.cooper@utoledo.edu|
21283740|NCT01629823|ALA-ACRC|Janet T Holbrook, PhD, MPH|443-287-3170|jholbro1@jhu.edu|
21283741|NCT03258008|UT MD Anderson Cancer Center|Dr. John Heymach, PHD-Chair, Thoracic-Head & Neck Med Onc|(713) 792-6363|jheymach@mdanderson.org|
21283742|NCT00525902|Oregon Health & Science University|Eric B. Suhler|503-494-5023|suhlere@ohsu.edu|
21283743|NCT00455520|Johnson & Johnson Pharmaceutical Research & Development|Senior Director, Clinical Leader|609-730-4537||
21283744|NCT00109876|Rhode Island Hospital/Alpert Medical School|Damian E. Dupuy, MD|401 - 444 - 5184|ddupuy@lifespan.org|
21283745|NCT01683422|Loma Linda University Health|Gary Yang|909 558 4000|gyang@llu.edu|88056
21283746|NCT03448939|Sol-Gel Technologies, Ltd.|Sol-Gel|972-8-9313433|info@sol-gel.com|
21283747|NCT00986986|University of Hawaii at Manoa|Dominic Chow|(808)737-2751|dominicc@hawaii.edu|
21283748|NCT03124121|Guy's & St Thomas' Hospital|Dr Mark Samaan|07740637713|mark.samaan@gstt.nhs.uk|
21283749|NCT03235115|CooperVision|Jose Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com|
21283750|NCT00656851|Washington Univ Med Sch|Kevin Yarasheski, PhD|3143628173|key@wustl.edu|
21283751|NCT02560324|University of Pennsylvania|Principal Investigator|215-746-5789|rlashare@pennmedicine.upenn.edu|
21283752|NCT00654992|Seoul National University Bundang Hospital|Effect of erythropoietin in kidney after cardiac surgery|82-31-787-7014|kyna@snubh.org|
21283753|NCT03782298|Smtih + Nephew, Inc|Judith Horner|+44 1482 673251|Judith.horner@smith-nephew.com|
21283754|NCT02431806|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21283755|NCT02484651|Universidade Aberta, Mathematics Section|Prof. Catarina S Nunes|+351 300 001 705|cnunes@bio-mathematics.org|
21283756|NCT05238025|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
21283757|NCT01638312|Kaohsiung Medical University Chung-Ho Memorial Hospital|JihJin Tsai, MD|886-7-3121101|jijits@cc.kmu.edu.tw|6358
21283758|NCT02278120|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
21283759|NCT01317797|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
21283760|NCT01378377|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21283761|NCT03026530|Region Ostergotland|Dr. Kihlstedt Pasquier|0046101041000|ebba.kihlstedt.pasquier@regionostergotland.se|
21283762|NCT05537792|Georgia Institute of Technology|Dr. Aaron Young|404.385.5306|aaron.young@me.gatech.edu|
21283763|NCT00954512|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21283764|NCT04814368|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
21283765|NCT04530591|Hospital of the University of Pennsylvania|Jacob Brenner, Assistant Professor of Medicine|215-662-2222|Jacob.Brenner@pennmedicine.upenn.edu|
21283766|NCT04216589|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
21283767|NCT03721835|Smith+Nephew, Inc.|Karlie Morgan|+1.512.496.7507|Karlie.Morgan@smith-nephew.com|
21283768|NCT04198584|University of North Carolina at Chapel Hill|Donna Evon, PhD|919-966-6732|donna_evon@med.unc.edu|
21283769|NCT05250102|Medline Industries, LP|Julie J. Finley|(800) 633-5463|jjfinley@medline.com|
21283770|NCT02100670|GlaxoSmithKline|GSK Response Center|866-435-7343||
21283771|NCT02634268|VA Puget Sound Health Care System|Margaret Collins|206.764.2085|margaret.collins@va.gov|
21283772|NCT01892085|University of Florida|Leslie Parker|352 215 9360|Parkela@ufl.edu|
21283773|NCT01797159|The SKCCC at Johns Hopkins|The SKCCC at Johns Hopkins|4109556980|kjansen3@jhmi.edu|
21283774|NCT00503997|Vanderbilt-Ingram Cancer Center|Jill Gilbert, M.D.|615-343-4677|jill.gilbert@vanderbilt.edu|
21283775|NCT01195844|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21252557|NCT00759642|University of Kansas Cancer Center|Priyanka Sharma, MD|913-945-5059|PSHARMA2@kumc.edu|
21283776|NCT00087126|NRG Oncology|Angela Kuras on behalf of James Kauderer|716-845-5702|kurasa@nrgoncology.org|
21283777|NCT01839799|University of Pennsylvania|Jennifer Louie, Program Manager|215-220-9668|Jennifer.Louie2@pennmedicine.upenn.edu|
21283778|NCT02787057|Peking University First Hospital|Dr. Jie Dong|+86 010 66551708|jie.dong@bjmu.edu.cn|
21283779|NCT00435487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21283780|NCT00492817|The University of Texas MD Anderson Cancer Center|Amol J. Ghia, MD|(832) 628-7357|ajghia@mdanderson.org|
21283781|NCT00835679|Vanderbilt-Ingram Cancer Center|Emily Chan, MD|615-343-4677|emily.chan@vanderbilt.edu|
21283782|NCT02978859|Columbia University|Benjamin Izar|212 304 5871|bi2175@cumc.columbia.edu|
21283783|NCT02719938|University of North Carolina at Chapel Hill|Laura C. Hanson, MD, MPH|919-843-4096|lhanson@med.unc.edu|
21283784|NCT00955968|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
21283785|NCT01455181|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21283786|NCT05020899|Boston Medical Center|Lisa Quintiliani, PhD|617-638-2777|lisa.quintiliani@bmc.org|
21283787|NCT00565669|Carolina Eye|Helga Sandoval||hps@cepmd.com|
21283788|NCT01068626|University of Gothenburg|Kristjan Karason|+46 31 342 7554|kristjan.karason@gu.se|
21283789|NCT01785849|Amgen Inc.|Study Director|866-572-6436||
21283790|NCT01032239|Medtronic Clinical Neuromodulation|Alessandra Calabrese, PhD||alessandra.calabrese@medtronic.com|
21283791|NCT00204477|University of Texas Medical Branch Galveston|Leejane W. Lu|(409)772-1011|llu@utmb.edu|
21283792|NCT01940900|Ophthotech Corp.|Denise Teuber||denise.teuber@ophthotech.com|
21283793|NCT03098498|Department of Periodontology, University Hospital Wuerzburg|Dr. Yvonne Jockel-Schneider|49-931-201-72620|jockel_y@ukw.de|
21283794|NCT04713592|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21283795|NCT01056198|Healthpoint Biotherapeutics|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|817-302-3914|jaime.dickerson@healthpoint.com|
21283796|NCT01382225|Alcon Research, Ltd.|Michela Montecchi-Palmer, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21283797|NCT02426749|University of Manitoba|Dr Zahra Moussavi|204 474 7023|Zahra.Moussavi@umanitoba.ca|
21283798|NCT01797081|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21283799|NCT00359736|Miami VAHS|Dr. Robert M Jackson, ACOS/R|305-575-3548|robert.jackson4@va.gov|
21283800|NCT01852201|Medical University of SC|Jonathan Lena, MD|843-792-9226|lena@musc.edu|
21283801|NCT02513498|H. Lee Moffitt Cancer Center|Dr. Joseph Pidala|813-745-2556|joseph.pidala@moffitt.org|
21283802|NCT02057419|The Miriam Hospital|Dr Kate Guthrie, Principal Investigator, Project WISH Lead Investigator|401-793-8180|kate.guthrie@brownhealth.org|
21283803|NCT05513703|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21283804|NCT01177709|Nathan Kline insistute for Psychiatric Research|Robert C smith MD|845-298-6531|rsmith@nki.rfmh.org|
21283805|NCT01793688|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21283806|NCT03596723|Kala Pharmaceuticals, Inc|VP Clinical Development|781-996-5252|Results010@kalarx.com|
21283807|NCT01698879|CETLAM|Dr. Jordi Sierra|+34 93 434 44 12|jsierra@santpau.cat|
21283808|NCT00150800|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21283809|NCT04972968|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21283810|NCT03649178|Vanderbilt University Medical Center|C. Michael Stein MD|615-936-3420|michael.stein@vumc.org|
21283811|NCT04120584|Inmode|Maria Shusterman|9057076787|Maria.Shusterman@inmodemd.com|
21283812|NCT01996410|OhioHealth|John Elliott|614-566-3643|John.Elliott@ohiohealth.com|
21283813|NCT03660475|Penn State Hershey Medical Center|Joseph Sassani, MD, MHA|717 531 8783|jsassani@pennstatehealth.psu.edu|
21283814|NCT03814720|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Alicia T Widge, M.D.|301-451-8715|alicia.widge@nih.gov|
21283815|NCT03083561|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21283816|NCT02135107|Eisai Co., Ltd. and EA Pharma Co., Ltd.|Public Relations Group (EA Pharma Co., Ltd.)|+81-(0)3-6280-9600|contact_ea@eapharma.co.jp|
21283817|NCT00474045|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21283818|NCT02009397|University of Louisville, James Graham Brown Cancer Center|Dr. Jason Chesney|502-562-3429|jason.chesney@louisville.edu|
21283819|NCT00581347|University of Rochester Medical Center|Peter Szilagyi|585-275-5798|peter_szilagyi@urmc.rochester.edu|
21283820|NCT02987374|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
21283821|NCT00191282|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21283822|NCT04756154|3M|Linda Olson|651-736-3586|lkolson2@mmm.com|
21283823|NCT00655473|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
21283824|NCT01312233|Spine Institute for Quality|Christine M Goertz, DC, PhD (Study Principal Investigator)|301-335-0071|cgoertz@spineiq.org|
21283825|NCT03430895|Memorial Sloan Kettering Cancer Center|Dr. Samuel Funt, MD|646-888-4770|funts@mskcc.org|
21283826|NCT01550705|University of Utah|John D. Phillips, Ph.D.|801-581-6650|john.phillips@hsc.utah.edu|
21283827|NCT00138073|Massachusetts General Hospital|Jaime Chang|617-726-9069|jchang4@partners.org|
21283828|NCT03301740|University of North Carolina at Chapel Hill|Jennifer E. Flythe, MD, MPH|(919) 445-2656|jflythe@med.unc.edu|
21252558|NCT00755417|Depomed|Head of Research & Development|650-462-5900|msweeney@depomed.com|108
21252559|NCT05143138|WL Gore|Cinzia Santin, Clinical Study Mgt, Gore Medical Products|+393463645539|csantin@wlgore.com|
21252560|NCT01993849|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
21252561|NCT01895036|NYSPI|Linda Sherman|6467747158|lsherma@nyspi.columbia.edu|
21252562|NCT02103114|Duke University|Dr. Edmund Jooste|919-681-4877|edmund.jooste@duke.edu|
21252563|NCT01266161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21252564|NCT02335905|Baylor College of Medicine|Sheldon L. Kaplan|832-824-4330|skaplan@bcm.edu|
21252565|NCT01436305|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21252566|NCT03563066|McMaster University|Gail Gauvreau|9055259140|gauvreau@mcmaster.ca|22791
21252567|NCT04692467|Weill Cornell Medicine|Dr. Margaret McNairy|646-962-8140|mam9365@med.cornell.edu|
21252568|NCT01160237|GlaxoSmithKline|GSK Response Center|866-435-7343||
21252569|NCT01485120|GE Healthcare|Jeff Conner|414-721-2423||
21252570|NCT00422734|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21252571|NCT02344342|University of Michgan Health Systems|Todd Koelling, MD|734-936-5265|tkoellin@med.umich.edu|
21252572|NCT00848484|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21252573|NCT03355209|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21252574|NCT01081886|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
21252575|NCT02567708|GlaxoSmithKline|GSK Response Center|866-435-7343||
21252576|NCT00706654|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affairs|800 562-3974||
21252577|NCT01261000|Cedars-Sinai Medical Center|Vivian Hwe|424-315-4489|hwev@cshs.org|
21252578|NCT01151215|Astrazeneca|Dr Serban Ghiorghiu||ClinicalTrialTransparency@astrazeneca.com|
21252579|NCT01427725|Medical affairs|Medical affairs manager|+81-3-5656-0516||
21252580|NCT00760747|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21252581|NCT01447576|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
21252582|NCT03128671|University of Miami|Cindy Munro|305-284-2107|cmunro@miami.edu|
21252583|NCT01976572|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21252584|NCT04463680|University of Colorado Anschutz Medical Campus|Aaron Lazorwitz|3037242019|aaron.lazorwitz@cuanschutz.edu|
21252585|NCT00388804|UT MD Anderson Cancer|Andrew Lee, MD / Professor||lhamblin@mdanderson.org|
21283829|NCT02584998|CMC VAMC|Emily Carter Paulson, MD MSCA|215-823-5880|emily.paulson@va.gov|
21283830|NCT01173055|University of Michigan|Daniel Clauw, MD|734-998-6901|dclauw@med.umich.edu|
21283831|NCT00456508|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21283832|NCT04253782|Yale School of Medicine|Daniel Joseph, MD|(203) 785-4404|daniel.joseph@yale.edu|
21283833|NCT01690910|St. Joseph Mercy Hospital|Amy Burghardt|734-712-2027|amy.burghardt@stjoeshealth.org|
21283834|NCT01254851|Loyola University Medical Center|Linda Brubaker|708-216-4033|lbrubaker@lumc.edu|
21283835|NCT01306045|National Cancer Institute|Dr. Arun Rajan|240-760-6236|rajana@nih.gov|
21283836|NCT05685732|Corium, LLC|Ronald Tashjian|6172337474|rtashjian@corium.com|
21283837|NCT02640404|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21283838|NCT04908202|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21283839|NCT05397171|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21283840|NCT01842906|Stanford Department of Emergency Medicine|Dr. Grant Lipman|415-290-9286|gslipman@stanford.edu|
21283841|NCT04765722|McMaster University|Dr. Imran Satia|905 5212100|satiai@mcmaster.ca|76228
21283842|NCT05175131|Abbott|Suntje Sander-Struckmeier, PhD|+49 (0) 511 6750 3254|suntje.sander@abbott.com|
21283843|NCT03117881|University of Alabama at Birmingham|Dr. Tapan Mehta|205) 975-9171|tapan@uab.edu|
21283844|NCT01027897|Grady Health System|Prasad Abraham|404-616-3246|pabraham@gmh.edu|
21283845|NCT01661933|The Prince Charles Hospital|Dr John Croese. The Chief Investigator|+61733716164|jcroese@bigpond.com|
21283846|NCT03385304|University of Maryland, Baltimore|Research Administrator|410-706-6823|ahowe@som.umaryland.edu|
21283847|NCT01097421|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21283848|NCT01120249|SWOG|Melissa Plets|206.667.2707|mplets@fredhutch.org|
21283849|NCT02052596|GlaxoSmithKline|GSK Response Center|866-435-7343||
21283850|NCT00558896|Mayo Clinic|Dr. Martha Lacy||lacy.martha@mayo.edu|
21283851|NCT00182728|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
21283852|NCT02063178|University of Tennessee Health Science Center|Rebecca Krukowski|9014482426|rkrukows@uthsc.edu|
21283853|NCT00250458|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21283854|NCT00230022|Wayne State University|Steven J. Ondersma|313-577-6680|s.ondersma@wayne.edu|
21283855|NCT00723190|Shionogi USA|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
21283856|NCT00001656|National Institute of Mental Health|Judith L. Rapoport, M.D.|301-496-6080|rapoporj@mail.nih.gov|
21283857|NCT00201240|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
21283858|NCT01135069|Spear Pharma|K.L. Spear M.D.|239-433-3442|spear@spearpharma.com|
21283859|NCT00480493|University of Massachusetts, Worcester|Susan Sullivan-Bolyai|508-856-4185|susan.sullivan-bolyai@umassmed.edu|
21283860|NCT03747302|Norris Cotton Cancer Center|Dr. Ardis Olson|603-643-2385|Ardis.Olson@dartmouth.edu|
21283861|NCT03769675|Mayo Clinic|Narayan R. Kissoon, M.D.|507-284-4961|Kissoon.Narayan@mayo.edu|
21252586|NCT02592707|Ipsen Pharma|Medical Director|see email|clinical.trials@ipsen.com|
21252587|NCT02998476|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21283862|NCT00583375|Wright Medical|Stephen Roach|615-656-7466|Stephen.Roach@wright.com|
21298853|NCT01217463|Olympus France S.A.S|Mr. Akira Kondo, Manager, Clinical R&D|+33-1-4560-6849|akira.kondo@olympus.fr|
21298854|NCT02197702|StJustineH|Dr Francine Ducharme|5143454931|Francine.m.ducharme@umontreal.ca|4398
21298855|NCT00706446|Brigham and Women's Hospital|Dr. Elliot Israel|6177328201|eisrael@partners.org|
21298856|NCT03148613|Carrot Inc.|Director Clinical Affairs|650-906-4255|craig@carrot.co|
21298857|NCT02485561|Washington University in St. Louis|Amy McQueen|3142862016|amcqueen@wustl.edu|
21298858|NCT02878317|University of Nottingham|Professor Maarten Taal|01332 224618|m.taal@nottingham.ac.uk|
21298859|NCT00057863|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
21298860|NCT02462148|Wake Forest Baptist Health|Dr. Jimmy Turner|3368064498|jturner@wakehealth.edu|
21298861|NCT01308736|Rutgers Robert Wood Johnson Medical School|Dr. Marc Steinberg|7322354341|marc.steinberg@rutgers.edu|
21298862|NCT03609177|Dana Farber Cancer Institute|James Tulsky, MD, Chair of Suppportive Oncology Department|617-582-9201|JamesA_Tulsky@dfci.harvard.edu|
21298863|NCT03246789|Weill Cornell Institute of Geriatric Psychiatry|Dr. Patricia Marino|(914) 997-8691|pam2029@med.cornell.edu|
21298864|NCT03948334|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21298865|NCT02927392|University of Colorado Anschutz Medical Campus|Edward L. Melanson, PhD|303-724-0935|ed.melanson@cuanschutz.edu|
21298866|NCT03095248|Cincinnati Children's Hospital Medical Center|Senior Regulatory Specialist|15135350640|andrea.bidwell@cchmc.org|
21298867|NCT03775486|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21298868|NCT05477485|Virginia Commonwealth University|Dr. April D. Kimmel|(804) 628-6273|adkimmel@vcu.edu|
21298869|NCT05081219|Atrium Health Wake Forest Baptist|Suzanne Craft, PhD|336.713.8846|Suzanne.Craft@advocatehealth.org|
21298870|NCT05274958|Carilion Clinic|Director Psychiatry Clinical Research|540-527-4900|askablinger@carilionclinic.org|
21298871|NCT06235905|Navitorpharma|Senior Director Clinical Development|3018382521|gceresoliborroni@supernus.com|
21298872|NCT00866814|C.R. Bard: Davol, Inc.|Dawn Heimer/Director, Clinical Affairs|401-825-8681|dawn.heimer@crbard.com|
21298873|NCT05551611|Kocaeli University|Dr. Suzi ÖZDEMİR|05548488674|suzi.ozdemir@gmail.com|
21298874|NCT00319254|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21298875|NCT00848783|NYU Cancer Institute|Franco Muggia, MD|212-263-6485|franco.muggia@nyumc.org|
21298876|NCT01712204|TWi Biotechnology, Inc.|Medical Director|+886-2-26573350|Carl.Brown@twipharma.com|368
21298877|NCT02315534|Sumitomo Dainippon Pharma Oncology|Connor Marshall|843-364-8039|cmarshall@bostonbiomedical.com|
21298878|NCT01059318|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21298879|NCT04266925|University of Alabama at Birmingham|Dr David Schwebel,|205-934-4068|schwebel@uab.edu|
21298880|NCT02110095|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
21298881|NCT02679287|University of Virginia|Sue Brown, MD|434-982-0602|sab2f@virginia.edu|
21298882|NCT01408459|University of Illinois at Chicago|Dr. Phyllis E. Bowen|708-524-0586|pbowen@uic.edu|
21298883|NCT01511016|Baylor College of Medicine|Leanne Scott, PhD, Director of Sponsored Programs|713-798-6978|lbscott@bcm.edu|
21298884|NCT02831764|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21298885|NCT03400852|Mallinckrodt|Medical Information Call Center|1-800-844-2830|MedInfo@mnk.com|
21298886|NCT02341235|The University of Texas Medical Branch|Eloisa Martinez|409-266-9643|esmartin@utmb.edu|
21298887|NCT04115384|HealthPartners Institute|Manager Research Operations|651-495-6363|ClinicalTrials@HealthPartners.com|
21298888|NCT00411749|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21298889|NCT01495286|University of Arkansas|Anita Mitchell PhD, coinvestigator|501-686-7021|AMitchell@uams.edu|
21298890|NCT03001557|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
21298891|NCT01794000|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21298892|NCT00796666|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21298893|NCT02531217|aTyr Pharma|Study Director|858 731 8389|clinicaltrials@atyrpharma.com|
21298894|NCT01135134|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21298895|NCT02576639|Novartis Pharmaceuticals|Study Director|862-778-8300||
21298896|NCT00628030|Virginia Commonwealth University|Suzanne E Mazzeo, Professor of Psychology|804-827-9211|semazzeo@vcu.edu|
21298897|NCT03392935|University of Utah Dermatology|Dr. Karen Stolman, Assistant Professor, Dermatology|8015816465|ks@checkmateproductions.com|
21298898|NCT01156480|NorthShore University HealthSystem|Dr. Brandy Frost|847-570-2033|bfrost@northshore.org|
21298899|NCT01255423|Novartis Consumer Health|Clinical Project Leader|0041223635528||
21298900|NCT00988598|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21298901|NCT01176058|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21298902|NCT01858363|Spectranetics|Nicolas Aguirre|+1-312-297-6655|nicolas.aguirre@philips.com|
21298903|NCT00429949|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
21298904|NCT00764361|Nanotherapeutics, Inc.|John Abernethy, MD - Medical Director|386-462-9663|jabernethy@nanotherapeutics.com|326
21298905|NCT02090426|Massachusetts Institute of Technology|Amy Finkelstein, PhD|6173246995|jgubb@mit.edu|
21298906|NCT02079038|Vertiflex|Steve Reitzler|442-325-5934|Stephen.reitzler2@bsci.com|
21298907|NCT01141712|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
21298908|NCT03480152|National Cancer Institute|Dr. Steven Rosenberg|240-858.3080|steven-rosenberg@nih.gov|
21298909|NCT03634085|Venn Life Sciences|Simone van Broekhoven / Clinical Trial Manager|+310765480625|simone.vanbroekhoven@vennlife.com|
21298910|NCT04276233|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21298911|NCT00876200|Hospices Civils de Lyon|Dr Behrouz KASSAI-KOUPAI|472116911|behrouz.kassai-koupai@chu-lyon.fr|+33
21283863|NCT02844907|Durham VAMC|David D'Alessio, MD|919-684-5778|david.dalessio2@va.gov|
21283864|NCT02772276|MediBeacon|Richard B Dorshow, PhD|314-735-0967|rbdorshow@medibeacon.com|
21283865|NCT00738062|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
21283866|NCT00550862|Intercept Pharmaceuticals|Dr. David Shapiro|858-652-6800|dshapiro@interceptpharma.com|
21283867|NCT03207074|Imperial College London|Dr Diana Marcus|07525133957|d.marcus16@imperial.ac.uk|
21283868|NCT01099774|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21283869|NCT02248974|Baylor College of Medicine|Dr. Jennifer Blumenthal-Barby|(713) 798-3785|jennifer.blumenthal-barby@bcm.edu|
21283870|NCT03488225|The University of Texas MD Anderson Cancer Center|Elias Joseph Jabbour, MD./ Professor|713-792-4764|ejabbour@mdanderson.org|
21283871|NCT04093492|Medical College of Wisconsin|Dr. Mir A Basir|414-266-6820|mbasir@mcw.edu|
21283872|NCT02303990|University of Pennsylvania|Dr. Amit Maity|215) 662-3759|maity@uphs.upenn.edu|
21283873|NCT01576003|Cincinnati Children's Hospital Medical Center|Conrad R. Cole, MD|513-636-6155|conrad.cole@cchmc.org|
21283874|NCT01928797|Brigham and Women's Hospital|Dr. Bhavani Kodali|617-732-8220|BKODALI@BWH.HARVARD.EDU|
21283875|NCT02945254|Brigham and women's Hospital|Andrew Wellman|6174078483|awellman@rics.bwh.harvard.edu|
21283876|NCT01711619|Medtronic|Global Clinical Study Manager||medtronicneurotrials@medtronic.com|
21283877|NCT00783224|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21283878|NCT04631107|Apnimed, Inc.|Clinical Trials|617-500-8880|clinicaltrials@apnimed.com|
21283879|NCT02525536|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21283880|NCT01432275|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993863164|joe.bugler@abbott.com|
21283881|NCT00475878|Butler Hospital|Dr. Michael Stein|401-455-6646|michael_stein@brown.edu|
21283882|NCT00096993|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
21283883|NCT03280225|Central Arkansas Veterans Healthcare System|Dr. Sara J. Landes|501-257-3385|sara.landes@va.gov|
21283884|NCT01828216|Chinese University of Hong Kong|David SC Hui|852 2632 2211|dschui@cuhk.edu.hk|
21283885|NCT01440569|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21283886|NCT02203162|Montefiore Medical Center|Peter Dicpinigaitis, MD|718-904-2676|pdicpini@montefiore.org|
21283887|NCT01438814|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21283888|NCT02584959|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21283889|NCT03526055|Ohio Pain Clinic|Dr. Amol Soin|937-434-2226|drsoin@ohiopainclinic.com|
21283890|NCT00195494|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21283891|NCT00513357|University of Texas MD Anderson Cancer Center|Dr. Egidio Del Fabbro|713-563-4157|ammarin@mdanderson.org|
21283892|NCT01162122|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21283893|NCT02020512|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21283894|NCT01001806|Bucci Laser Vision|Frank A. Bucci, Jr., MD|570-825-5949|Buccivision@aol.com|
21283895|NCT00878605|VA Greater Los Angeles Healthcare System|Dr. Zhaoping Li, Section Chief|310-268-3528|zhaoping.li@va.gov|
21283896|NCT03442699|Hartford Hospital/Institute of Living|David Tolin, Ph.D.|860-545-7685|david.tolin@hhchealth.org|
21283897|NCT01966068|Children's Hospital of Philadelphia|Alexander Fiks, MD, MSCE|267-426-2304|fiks@email.chop.edu|
21283898|NCT00808639|Dana-Farber Cancer Institute|Toni Choueiri, MD|617-632-5456|toni_choueiri@dfci.harvard.edu|
21283899|NCT01717482|Mayo Clinic|Dennis Wigle, M.D., Ph.D.|507-284-8462|Wigle.Dennis@mayo.edu|
21283900|NCT02345460|Case Comprehensive Cancer Center|Dr. Davendra Sohal|216-444-8258|sohald@ccf.org|
21283901|NCT01790828|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21283902|NCT00129727|Massachusetts General Hospital|Richard T Penson MD MRCP|617-726-5867|rpenson@partners.org|
21283903|NCT03589976|NYU Langone Health|Jose-Alberto Palma, MD, PhD|212-263-7225|JoseAlberto.PalmaCarazo@nyulangone.org|
21283904|NCT02089334|Rexahn Pharmaceuticals Inc.|Doug Swirsky/ Chief Executive Officer|240-268-5300|swirskyd@rexahn.com|
21283905|NCT06350461|Seattle Children's|Margaret Kloster|206-884-7862|margaret.kloster@seattlechildrens.org|
21283906|NCT00754208|University of Nebrasa Medical Center|Joan Daughton|402-552-6006|jdaughton@childrensomaha.org|
21283907|NCT03597009|University of North Carolina Lineberger Comprehensive Cancer Center|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
21283908|NCT00754520|Zimmer Biomet|Clinical Project Lead|+31 62 395 6378|lisette.smid@zimmerbiomet.com|
21283909|NCT01645891|EO2 Concepts|Dr. Mark Q Niederauer|2103387703|m.niederauer@eo2.com|
21283910|NCT01239212|Cincinnati Children's Hospital Medical Center|Dr. Stephanie Merhar|513-636-4200|stephanie.merhar@cchmc.org|
21283911|NCT02294461|Astellas Pharma Inc|Clinical Trial Disclosure|8008887704|astellas.resultsdisclosure@astellas.com|
21283912|NCT00549601|Novartis Pharmaceuticals|Study Director|862-778-8300||
21283913|NCT02389374|Menzies School of Health Research|Benedikt Ley|889468643|benedikt.ley@menzies.edu.au|
21283914|NCT00908596|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21283915|NCT00224406|Dompé farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
21283916|NCT01556997|Symplmed Pharmaceuticals LLC|Jeff Feldstein, Sr. Vice President and CMO|888-552-9769|feldstein@symplmed.com|
21283917|NCT01010009|Northumbria university|Emma Wightman|+44 (0) 191 2437253|emma.l.wightman@unn.ac.uk|
21283918|NCT01361113|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
21283919|NCT01250171|Novartis Pharmaceuticals|Study Director|862 778-8300||
21283920|NCT04550832|LigaChem Bioscience, Inc.|Seonghye Cheon|+82)02-6952-0689|scheon@ligachembio.com|
21283921|NCT04823130|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21283922|NCT03312595|Acera Surgical, Inc.|Chief Science Officer|844-879-2237|information@acera-surgical.com|
21283923|NCT03315455|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21283924|NCT03596671|BlueWind Medical|Medical Affairs|612-203-5739|peter.rodine@bluewindmedical.com|
21298912|NCT01946139|Emmes Company, LLC|Kimberly Mosby-Griffin|301 251-1161|kmosby@emmes.com|10158
21236892|NCT02297308|Terumo Medical Corporation|Robert Gash, Director of Clinical Affairs|732-302-4931|robert.gash@terumomedical.com|
21236893|NCT01981564|Johns Hopkins University School of Medicine, Department of Pediatrics|Dr. Arlene Butz|410-614-5963|abutz@jhmi.edu|
21298913|NCT00296816|Sanofi|Trial Trans[parency Team||Contact_us@sanofi.com|
21298914|NCT01012258|Merck Serono (Beijing) Pharmaceutical R&D Co., Ltd.|Medical Responsible|+49-6151-72-5200|service@merckgroup.com|
21298915|NCT03742973|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21236894|NCT04936230|Weill Cornell Medicine|Himanshu Nagar, MD|212-746-3704|hnagar@med.cornell.edu|
21236895|NCT02219932|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21236896|NCT00511004|NIAID|Thomas B. Nutman|301-496-5398|tnutman@niaid.nih.gov|
21236897|NCT00990652|Northwestern University|Jeffrey Raizer, MD|312-503-4724|jraizer@nmff.org|
21236898|NCT05177770|Coherus BioSciences|Allison Intondi, Vice President, Clinical Operations|800-794-5434|ClinicalTrials@Coherus.com|
21236899|NCT00233493|University Hospitals Cleveland Medical Center Center for Medical Mycology|Dr. Mahmoud Ghannoum|216-844-8580|Mahmoud.Ghannoum@case.edu|
21236900|NCT04618718|Protembis GmbH|Karl von Mangoldt|+49 241 9903 3621|kvm@protembis.com|
21236901|NCT02388386|Scripps Clinic Medical Group|Sanjeev Bhavanni MD|6196601842|bhavnani.sanjeev@scrippshealth.org|
21236902|NCT01672801|Boston IVF|Alan Penzias|781-434-6500|apenzias@bostonivf.com|
21236903|NCT01673802|University of Alabama at Bimringham|John V. Thomas, MD; Principal Investigator|205-996-4132|jvthomas@uabmc.edu|
21236904|NCT03726346|Fisher & Paykel Healthcare Ltd.|Bhavi Ogra|+64 9 574 0123|bhavi.ogra@fphcare.co.nz|7675
21283925|NCT03327948|Axonics, Inc.|Gita Ghadimi|9497516412|gita.ghadimi@axonics.com|
21283926|NCT02304380|University of North Carolina at Chapel Hill|Renée Ferrari, PhD|(919) 843-1341|rferrari@unc.edu|
21283927|NCT00328094|Beth Israel Deaconess Medical Center, Boston, MA|Dr. Balachundhar Subramaniam, MD MPH|6177542675|bsubrama@bidmc.harvard.edu|
21283928|NCT00473824|ADMA Biologics, Inc.|Rebecca Avila|561-989-5853|reavila@admabio.com|
21283929|NCT01349322|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21283930|NCT04527003|MSHersheyMC|Dr. Kristin Riley|7175316647|kriley1@pennstatehealth.psu.edu|
21283931|NCT00985426|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-665-0414|rjanssen@dynavax.com|
21298916|NCT01814527|East Carolina University|Joseph Armen DO|252-744-3212|armenj@ecu.edu|
21298917|NCT00687401|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21298918|NCT02366195|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21236905|NCT04159688|Yale University|Dr. Ansel Hillmer|203-737-6400|ansel.hillmer@yale.edu|
21236906|NCT00054353|Fred Hutch|Marco Mielcarek, MD||mmielcar@fredhutch.org|
21236907|NCT01988246|Cole Eye Institute - Cleveland Clinic|Rishi Singh, MD|216-445-9497|singhr@ccf.org|
21236908|NCT02384954|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
21236909|NCT01692340|The Ohio State University|Steven K. Clinton, MD PhD|614-293-2886|steven.clinton@osumc.edu|
21298919|NCT02520726|University of Utah|Brent Kious, MD|801-585-1418|brent.kious@hsc.utah.edu|
21298920|NCT02119871|Department of Cardiothoracic Surgery, Lund University|Maya Landenhed Smith|+4646173639|maya.landenhed_smith@med.lu.se|
21298921|NCT00721396|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21298922|NCT00148759|Emory University|Ighovwerha Ofotokun, MD, MSc|404-616-0659|iofotok@emory.edu|
21298923|NCT00434226|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
21298924|NCT02052544|DSM Nutritional Products Ltd Branch Pentapharm|Anne Brisset|41 61 706 4837|Anne.Brisset@pentapharm.com|
21298925|NCT00430716|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21298926|NCT03865446|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21298927|NCT00675909|Seattle Children's Hospital|Eileen Klein, MD, MPH|206-987-2599|eileen.klein@seattlechildrens.org|
21298928|NCT01329978|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21298929|NCT02952365|Stanford University School of Medicine|Edward E. Manche|6507255765|edward.manche@stanford.edu|
21298930|NCT03324802|Mayo Clinic|Carlos E. Vargas, M.D.|4803421262|Vargas.Carlos@mayo.edu|
21298931|NCT01188772|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21298932|NCT00287716|InterMune, Inc.|Bill Bradford, MD, PhD|(415) 466-2200|bbradford@intermune.com|
21298933|NCT03081884|Emory University|David M. Schuster, MD|404-712-4859|dschust@emory.edu|
21298934|NCT02294058|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|AMcClain@celgene.com|
21298935|NCT05006261|Spaulding Rehabilitation Hospital|Paolo Bonato, PhD|617-952-6319|pbonato@mgh.harvard.edu|
21298936|NCT00512876|U.S. Army Warfighter Refractive Surgery Research Center|Principal Investigator|571-231-1600|rose.sia@us.army.mil|
21298937|NCT04532034|Temple University|Elizabeth THomas|215-204-1699|tug66715@temple.edu|
21298938|NCT01887184|The University of Hong Kong|Professor Chi Wai Cheung|22553303|cheucw@hku.hk|
21298939|NCT01550809|Departamento de Endocrinología y Nutrición, Hospital Clínico Universitario de Valencia, Universitat de València, Valencia, Spain|Francisco Javier Ampudia Blasco|+34 96 3862665|Francisco.J.Ampudia@uv.es|
21298940|NCT00154297|Novartis Pharmaceuticals|Study Director|862-778-8300||
21236910|NCT02372396|Veterans Medical Research Foundation|Dr. Ariel Lang|858-552-8585|ajlang@ucsd.edu|5359
21252588|NCT04855734|Children's National Hospital|Dr. Maureen E. Lyon, Clinical Health Psychologist, Professor of Pediatrics|703-346-2873|mlyon@childrensnational.org|
21298941|NCT00650767|Array BioPharma, Inc.|Study Director|303-381-6604|clinicaltrials@arraybiopharma.com|
21298942|NCT01125800|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
21283932|NCT04829331|Acera Surgical|Matthew MacEwan|440-477-1890|macewan@acera-surgical.com|
21298943|NCT00801216|IRCCS Ospedale San Raffaele|Dr. Andrés José Maria Ferreri|022643 7649|ferreri.clinicaltrials@hsr.it|
21298944|NCT05481359|Cortex, Inc|Eliza Lawrence|+16507049907|elawrence@cortexep.com|
21298945|NCT03741088|HistoSonics, Inc.|Clinical Affairs Manager|651.398.7586|christine.sullivan@histosonics.com|
21298946|NCT04894669|Masimo|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
21298947|NCT00348673|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21298948|NCT02756572|University of Washington/Seattle Cancer Care Alliance|Mary-Elizabeth Percival, MD, MS|206-606-1320|mperciva@seattlecca.org|
21298949|NCT01505374|Hospital for Special Surgery|Stavros G. Memtsoudis, MD, PhD|212-606-1206|memtsoudiss@hss.edu|
21298950|NCT02682992|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, Regulatory Specialist Supervisor|412-647-5554|stadtermanbm@upmc.edu|
21298951|NCT00320515|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21298952|NCT01114828|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
21298953|NCT03628976|Georgia Institute of Technology|Dr. Minoru Shinohara|404-894-1030|shinohara@gatech.edu|
21298954|NCT00851786|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21298955|NCT03145259|University of Maryland, Baltimore School of Pharmacy|Dr. Audra Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
21298956|NCT04177212|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
21298957|NCT01792115|NIDDK|Dr. Yaron Rotman|301-451-6553|rotmanyaron@mail.nih.gov|
21298958|NCT01279681|Mayo Clinic|Joleen M. Hubbard, M.D.|507 284-3121|hubbard.joleen@mayo.edu|
21298959|NCT01943591|Centre hospitalier de l'Université de Montréal Research Centre|Dr. Jean Raymond|514-890-8000|jraymond.nri@gmail.com|27235
21298960|NCT01253642|OHSU Knight Cancer Institute|Kristi Eilers|503-494-2897|eilersk@ohsu.edu|
21298961|NCT03798717|University of Portsmouth|Dr. Ant Shepherd|02392845289|ant.shepherd@port.ac.uk|
21298962|NCT04104256|University of California Los Angeles, Division of General Internal Medicine and Health Services Research|Project Manager|310-825-8253|cvillaflores@mednet.ucla.edu|
21298963|NCT04388111|Houston Methodist Hospital|Research Coordinator|346 238 1603|tsullivan@houstonmethodist.org|
21298964|NCT00387881|GlaxoSmithKline|GSK Response Center|866-435-7343||
21298965|NCT02719535|The Hong Kong Polytechnic University|Dr. Andrew Lam|85227666109|andrew.kc.lam@polyu.edu.hk|
21298966|NCT05473026|University of Florida|Lakeshia Cousin, PhD, APRN, AGPCNP-BC|352-273-6318|lakeshiacousin@ufl.edu|
21298967|NCT01050634|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21298968|NCT00496015|GlaxoSmithKline|GSK Response Center|866-435-7343||
21298969|NCT01116401|Brigham & Women's Hospital|Hadine Joffe|617-732-4906|hjoffe@partners.org|
21298970|NCT01590979|Staten Island University Hospital, Northwell Health|Soad Bekheit, MD|718-226-6629|msills@northwell.edu|
21298971|NCT02730728|University of Pennsylvania|Dr Nabil Elkassabany|2156628000|nabil.elkassabany@uphs.upenn.edu|
21298972|NCT01293825|University Hospitals of Cleveland|Martha Sajatovic, Professor of Psychiatry|(216) 844-2808|martha.sajatovic@uhhospitals.org|
21298973|NCT00346216|Pfizer, Inc|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21298974|NCT00914186|Taisho Pharmaceutical R&D Inc.|Fred Henry MS, MPH,|973-898-6200|F-Henry@taihso-rd.com|
21298975|NCT03788057|The Regional Public Hospital in Lesko, Poland|Dr. Janusz Ciółkowski|+48 134698071|ciolkowski.janusz@gmail.com|
21298976|NCT03956550|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21298977|NCT04244253|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21298978|NCT02525653|Memorial Sloan Kettering Cancer Center|Dr. Paul Paik, MD|646-608-3759|paikp@mskcc.org|
21298979|NCT01147666|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441||
21283933|NCT01967641|New York State Psychiatric Institute|Dr. Maria A. Sullivan, M.D., Ph.D|646-774-6152|mas23@columbia.edu|
21283934|NCT03181503|Galderma|Clinical Operations|(0) 4 93 95 70 70|Clinical.Studies@galderma.com|+33
21283935|NCT01573325|Northwestern Memorial Hospital|Rebecca Duke DNP, MSN, NP-BC Transplant Surgery Nurse Practitioner|3126951686|rduke@nmh.org|
21283936|NCT02718248|Ottawa Hospital Research Institute|Sarah MacLean|6137378899|samaclean@ohri.ca|73011
21283937|NCT01313494|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21283938|NCT01404208|MGH|Dr. Daniel Geller|617 724 5141|dan.geller@mgh.harvard.edu|
21283939|NCT02570139|3M Critical and Chronic Care Solutions Division|Anne Swearingen, Manager, Clinical Operations|651 736 7826|aswearingen@mmm.com|
21283940|NCT02258542|AstraZeneca|Ubaldo Martin, Global Clinical Lead Benralizumab|+1 301 398 0163|Ubaldo.Martin@astrazeneca.com|
21283941|NCT01032070|Astellas Pharma Global Development, Inc|Senior Medical Director, Medical Oncology||ClinicalTrials.Disclosure@us.astellas.com|
21283942|NCT02554318|Medical Faculty Wijaya Kusuma Surabaya|Dr. Budhi Setiawan|+6287751644522|nehesa@gmail.com|
21283943|NCT02332239|Department of Emergency Medicine, Alpert Medical School, Brown University|Megan L. Ranney, MD, MPH, FACEP|401-444-2557|megan_ranney@brown.edu|
21283944|NCT01541839|University of Alberta|Dr. Erin Wright|780-407-7656|erin.wright@me.com|
21283945|NCT00894790|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21283946|NCT01472965|St. Jude Children's Research Hospital|Joshua Wolf, MBBS, BA|901-595-1475|joshua.wolf@stjude.org|
21283947|NCT01393132|Wayne State Univeristy, Detroit, MI|Gabriel Sosne, MD|248-594-6702|gsosne@med.wayne.edu|
21283948|NCT00334802|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21283949|NCT03422159|Community Medical Center Department of Critical Care, Department of Nephrology|Jose Iglesias, DO|732-557-8070|jiglesias23@gmail.com|
21283950|NCT03436199|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com|
21283951|NCT00085098|Children's Oncology Group|Results Coordinator|(626) 447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21283952|NCT01886781|University of Stellenbosch, South Africa|Cheryl Stevenson|0827514411|cheryl@retaildc.co.za|
21283953|NCT04812795|University of Pennsylvania|Dr. Andy Tan|2157466546|andy.tan@asc.upenn.edu|
21283954|NCT01935700|Kaohsiung Medical University Hospital|Dr. Zu-Yau Lin|88677317123|linzuyau@yahoo.com.tw|
21283955|NCT01935128|University of Toledo Medical Center|Michael A. Rees, MD, PhD|419 383-3961|michael.rees2@utoledo.edu|
21283956|NCT00231283|Cordis|Sidney Cohen, MD PhD, Vice President|650 614-2726|scohen7@its.jnj.com|
21283957|NCT00772005|Cephalon, Inc.|Vice President, Clinical Research, CNS/Pain|1-800-896-5855||
21297081|NCT01183468|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21236911|NCT02890381|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
21236912|NCT01390246|University of Texas Medical Branch|Dr. Tatiana Nanovskaya, PhD|409-772-3908|tnnanovs@utmb.edu|
21236913|NCT00214136|University of Wisconsin Carbone Cancer Center|Dr. Mark A. Ritter|608-263-8500|ritter@humonc.wisc.edu|
21236914|NCT01272934|Novartis Consumer Health|Clinical Project Leader|0041223635228||
21236915|NCT04313634|Mayo Clinic|Sundeep Khosla, M.D.|507-255-6663|khosla.sundeep@mayo.edu|
21236916|NCT05219877|Department of Urology, Faculty of Medicine University of Indonesia - Cipto Mangunkusumo General Hospital|Prof. dr. Harrina Erlianti|+62 816-825-226|harrinaerlianti@gmail.com|
21236917|NCT00680316|Genentech, Inc.|Medical Communications|800-821-8590||
21236918|NCT01762046|Massachusetts General Hospital|Jose C. Florez, MD, PhD|6176433308|jcflorez@partners.org|
21236919|NCT03595904|Icahn School of Medicine at Mount Sinai|Dr. Sarah Miller|212-824-7783|Sarah.Miller@mssm.edu|
21236920|NCT01581281|Cincinnati Children's Hospital Medical Center|Scott Powers, PhD|513-636-8106|scott.powers@cchmc.org|
21236921|NCT04458948|UNM HSC|Cristina Beato|505-272-1734|CBeato@salud.unm.edu|
21236922|NCT02087163|Align Technology|Allison Mossing|4084701056|amossing@aligntech.com|
21236923|NCT02187991|Sarah Cannon Development Innovations, LLC|Taqi Mohammad|713-870-2175|taqi.mohammad@scri.com|
21236924|NCT01548690|University of Texas Southwestern Medical Center|William M. Lee, MD|(214) 645-6110|William.Lee@UTSouthwestern.edu|
21236925|NCT03006328|NYU Langone Health|Sandra Wittleder, PhD|212-263-4149|sandra.wittleder@nyulangone.org|
21236926|NCT01117311|Mayo Clinic|Dr. Adrian Vella|507-284-3289|vella.adrian@mayo.edu|
21236927|NCT01358526|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
21236928|NCT01778465|Western University|Clinical Trials Program Coordinator|+15196466100|taciano.rocha@sjhc.london.on.ca|61125
21236929|NCT01003249|Wake Forest University Health Sciences|Dr. Gopal Badlani|3367165928|gbadlani@wakehealth.edu|
21236930|NCT02194621|RBHS-Rutgers School of Dental Medicine, Oral Biology Department|Daniel Fine, DMD|973-972-3728|finedh@sdm.rutgers.edu|
21236931|NCT04631666|Institute of Virology|Prof. Florian Klein|49221478|florian.klein@uk-koeln.de|85800
21236932|NCT00714168|University of Pittsburgh|John M. Jakicic, PhD|412-383-4001|jjakicic@pitt.edu|
21236933|NCT02037347|Yale University|Brett King MD|203-785-4092|brett.king@yale.edu|
21236934|NCT04988308|Janssen Research & Development, LLC|Director Clinical Research Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21236935|NCT03143218|London School of Hygiene and Tropical Medicine|Professor Brian Greenwood|+442072994707|brian.greenwood@lshtm.ac.uk|
21236936|NCT00809757|Sunovion|Respiratory Medical Director|1-866-503-6351||
21236937|NCT00659334|OHSU Knight Cancer Institute|Dr. Edward Neuwelt|503-494-5626|neuwelte@ohsu.edu|
21236938|NCT03034577|The University of Melbourne|Prof Colin Royse|+61408467548|Colin.Royse@unimelb.edu.au|
21236939|NCT01174342|Meir Medical Center|Amit Meshi|+972523580222|amitmeshi@gmail.com|
21236940|NCT02625623|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21236941|NCT03910413|The University of Alabama at Birmingham|Andrew Smith|205-934-4080|andrewdennissmith@uabmc.edu|
21236942|NCT00240487|The Children's Hospital of Philadelphia|Richard Lin|2155905505|linr@email.chop.edu|
21236943|NCT02345031|Autifony Therapeutics Ltd|Clinical Project Manager|+44 1438 906860|info@autifony.com|
21236944|NCT02434692|Implandata Ophthalmic Products|Clinical Study Manager|+49 (0) 511 - 2204 2580|clinical@implandata.com|
21236945|NCT02062359|National Cancer Institute|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
21236946|NCT02338154|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
21236947|NCT01092338|Children's Hospital of Philadephia|Virginia Stallings|215-590-1664|stallingsv@email.chop.edu|
21236948|NCT03393000|Diffusion Pharmaceuticals Inc|Vice President of Clinical Operations|434-220-0718|clinicaltrials@diffusionpharma.com|
21236949|NCT02388724|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21236950|NCT01217073|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21236951|NCT01552213|Stanford University, School of Medicine|Anna Girsen, Research Operations Manager|(650) 725-5720|agirsen@stanford.edu|
21236952|NCT03317002|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21236953|NCT01592435|Carestream Health, Inc.|Susan Pate, MS, RN, RAC, Senior Manager, Clinical Affairs|585-627-6557|susan.pate@carestream.com|
21236954|NCT02212574|Johns Hopkins University|Dr. Kenneth Cohen|(410) 614-5055|kcohen@jhmi.edu|
21236955|NCT02703350|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21236956|NCT02015676|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21236957|NCT01426191|xiangbei welman pharmacuticol CO.,LTD|Directer of clinical trials|020-38868707|gap@welman.com.cn|
21236958|NCT00476476|Dana-Farber Cancer Institute|Neil Horowitz MD|617.732.8843|NHOROWITZ@mgh.harvard.edu|
21236959|NCT00971048|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
21236960|NCT01189279|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21236961|NCT03321396|Department of Internal Medicine, National Cheng Kung University|Dr. Xi-Zhang Lin|886-6-2353535|linxz@mail.ncku.edu.tw|6202
21252589|NCT03277352|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21298980|NCT05470387|Palisade Bio|Mitchell Jones, CMO|858-704-4900|mitchell.jones@palisadebio.com|
21298981|NCT03367858|University of Rhode Island|Dr. Sarah Feldstein Ewing|401-874-4251|feldsteinewing@uri.edu|
21298982|NCT04177706|Medical University of South Carolina|Prinicipal Investigator|8438761199|JONJEN@musc.edu|
21298983|NCT03831477|Venus Concept|Director of Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
21298984|NCT03004365|Armata Pharmaceuticals, Inc.|Clinical Operations|3106652928|info@armatapharma.com|
21298985|NCT01619839|Nektar Therapeutics|Study Director|415-482-5300|medicalaffairs@nektar.com|
21298986|NCT03822897|Canadian Cancer Trials Group|Dr. Wendy Ranjana Parulekar|613 533 6430|wparulekar@ctg.queensu.ca|
21298987|NCT03174366|Western University of Health Sciences|David Shofler|9097063898|dshofler@westernu.edu|
21298988|NCT00101686|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21298989|NCT00985465|GlaxoSmithKline|GSK Response Center|866-435-7343||
21298990|NCT01054456|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
21298991|NCT04701333|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
21298992|NCT01292187|Tarsa Therapeutics, Inc.|Dr. David Krause, Chief Medical Officer|1-267-273-7940|dkrause@tarsatherapeutics.com|
21298993|NCT03880058|Scarless Labs Inc.|Dr. Elisabeth Leeflang|213-788-2128|Clin_Info@scarlesslabs.com|
21298994|NCT02354534|Johns Hopkins University|Cornelia L. Trimble, MD|410-502-0512|CervixDoctor@jhmi.edu|
21298995|NCT03957551|University of Iowa|John Rieth, MD|(319) 356-1616|john-rieth@uiowa.edu|
21298996|NCT02021669|Washington University School of Medicine|Robert M. Carney, Ph.D|314-286-1305|carneyr@wustl.edu|
21298997|NCT00700440|Cancer Center, Sun Yat-sen University|Dr. Lu Tai-xiang|86-20-87343372|lutx@mail.sysu.edu.cn|
21298998|NCT02717494|Westat|Lauren Laimon, Senior Study Director|240-453-2987|LaurenLaimon@westat.com|
21298999|NCT01168726|University of Missouri|Dr. Matthew P. Martens, Professor; Division Executive Director|573-882-3382|martensmp@missouri.edu|
21252590|NCT01769430|University of Maryland, College Park|Professor & Director PHAB Lab|424-246-8358|phablab@umd.edu|
21299000|NCT02093793|Boston Scientific|Director of Clinical Sciences|6619494350|roshini.jain@bsci.com|
21236962|NCT03280121|Daniel and Daniel Consulting, LLC|Cynthia Harris, Director of Clinical Trials|775-392-2975|cindy@clinregconsult.com|
21236963|NCT01043432|Rocky Mountain MIRECC|Lisa A. Brenner|303-399-8020|lisa.brenner@va.gov|2571
21236964|NCT02633137|Memorial Sloan Kettering Cancer Center|Dr. Anita Kumar, MD|646-608-3780|kumara2@mskcc.org|
21236965|NCT04738643|University of Pennsylvania|Robert Schnoll, PhD|215-746-7143|schnoll@pennmedicine.upenn.edu|
21236966|NCT03996473|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21236967|NCT03759873|University of Texas Medical Branch, Division of Cardiovascular Medicine|Dr. Diann Gaalema|409-772-1533|digaalem@utmb.edu|
21236968|NCT04597190|University of Washington|John Fortney|2066856955|fortneyj@uw.edu|
21236969|NCT04349553|Prokarium|Kristen Albright|+44 (0) 7375 124 275|kristen.albright@prokarium.com|
21236970|NCT03256162|Trinity College Dublin|Dr Bronagh Gallagher|01 249|bgallag@tcd.ie|3200
21236971|NCT01869491|Reckitt Benckiser|Clinical Data Controller||clinicaldatacontroller@reckitt.com|
21236972|NCT02935062|Federal University of Santa Maria|Márcia Keske-Soares|55 55 999726370|marcia-keske.soares@ufsm.br|
21236973|NCT01546194|NorthShore University HealthSystem|Glenn Murphy|847-570-2760|dgmurphy2@yahoo.com|
21236974|NCT00836641|Goethe University Childrens Hospital|Prof Markus Rose|0049-696301|Markus.Rose@kgu.de|5754
21236975|NCT01910129|electroCore Inc.|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
21236976|NCT03543826|University of Washington|Adrienne James|206-744-4634|ajames1@uw.edu|
21236977|NCT03449030|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21236978|NCT00965523|Eisai|Tatsuo Watanabe, Study Director|+81-3-3817-5252||
21236979|NCT02415400|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
21236980|NCT03825380|Laboratoires Théa|Corentin LE CAMUS|0473981414|Corentin.LECAMUS@theapharma.com|
21236981|NCT00601926|The Ohio State University Comprehensive Cancer Center|Paul Monk, MD|614-293-2886|Paul.Monk@osumc.edu|
21236982|NCT01968213|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
21236983|NCT00388414|Stanford University|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu|
21236984|NCT01392560|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21236985|NCT02081846|Cincinnati Children's Hospital Medical Center|Dr. Heidi Sucharew (Biostatistician)|513-803-1920|heidi.sucharew@cchmc.org|
21236986|NCT01939028|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Chad Michener|216-444-6601|michenc@ccf.org|
21236987|NCT01404572|Bristol-Myers Squibb (BMS)|BMS Study Director||Clinical.Trials@bms.com|
21236988|NCT00295750|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
21236989|NCT00322348|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21252591|NCT03746509|University of Minnesota|Juergen Konczak|612-624-4370|jkonczak@umn.edu|
21252592|NCT00554996|Barbara Trautner, MD, PhD|Barbara Trautner, MD, PhD|713-440-4438|barbara.trautner@va.gov|
21283958|NCT01225289|Tehran University of Medical Sciences|The Study of the Effects of Vitamin A Supplementation on Immune System and Th1/Th2 Balance in Patien|+98 912 2182815|sjafarirad@gmail.com|
21283959|NCT01044758|Johns Hopkins University School of Medicine|Gregory Krauss, M.D.|(410) 955-2822|gkrauss@jhmi.edu|
21283960|NCT03887117|Philip Morris Products S.A.|Christelle Haziza, Global Head Clinical Research and Execution|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
21283961|NCT03301844|NTC srl|Alessandro Colombo|+39 02 4385 0490|alessandro.colombo@ntcpharma.com|
21283962|NCT05087966|San Diego State University|Dr. Aaron Blashill|619-594-2245|ajblashill@sdsu.edu|
21299001|NCT01808196|Cincinnati Children's Hospital Medical Center|Pablo Abonia, MD|513-636-|pablo.abonia@cchmc.org|
21299002|NCT03370718|M.D. Anderson Cancer Center|Mouhammed A. Habra, MD|713-792-2841|mahabra@mdanderson.org|
21236990|NCT01650259|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21236991|NCT01289912|Boston Children's Hospital|Dr. Mustafa Sahin|617-355-8994|Mustafa.Sahin@childrens.harvard.edu|
21236992|NCT00626431|Abbott|Global Medical Services|800-633-9110||
21236993|NCT00802854|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21236994|NCT01683864|University Clinic of Tübingen|Prof. Alfred Königsrainer|0049 7071 2983290|silvia.wagner@med.uni-tuebingen.de|
21236995|NCT01177904|IVI Madrid|Dr. Graciela Kohls|91 180 29 00|graciela.kohls@ivi.es|
21236996|NCT02293044|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
21236997|NCT00989287|GlaxoSmithKline|GSK Response Center|866-435-7343||
21236998|NCT00695669|GlaxoSmithKline|GSK Response Center|866-435-7343||
21236999|NCT02512575|AstraZeneca AB|Global Clinical Leader|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
21237000|NCT03421691|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
21237001|NCT01047839|Valneva Austria GmbH|Senior Scientist Clinical Research|+43 1 206 20|katrin.dubischar-kastner@valneva.com|1175
21299003|NCT00479713|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21299004|NCT00214539|Boston Scientific Corporation|G Mark Grubb, RN, CCRA|412-716-0717|Mark.Grubb@bsci.com|
21299005|NCT04106609|Maple Tree Cancer Alliance|Dr. Karen Wonders|937-477-8213|karen.wonders@mapletreecanceralliance.org|
21299006|NCT00141102|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21299007|NCT03061201|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21299008|NCT01572480|National Cancer Institute|Dr. Elizabeth Hill|240-760-6183|Elizabeth.Hill@nih.gov|
21299009|NCT03116685|OxThera|Chief Operating Officer|0046 86600223|elisabeth.lindner@oxthera.com|
21299010|NCT04194944|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
21299011|NCT03100149|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21299012|NCT03400475|University of Iowa|Dr. Ahmed Mahrous|3193336517|ahmedmohamed-mahrous@uiowa.edu|
21299013|NCT05214768|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21299014|NCT03066063|Barron Associates, Inc.|Richard Adams|434-973-1215|adams@bainet.com|
21237002|NCT02726451|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
21237003|NCT02522715|Oregon Health & Science University|Rachel Slottke, Program Manager|503-494-6117|slottker@ohsu.edu|
21237004|NCT01808313|GlaxoSmithKline|GSK Response Center|866-435-7343||
21237005|NCT00477191|Department of Dermatology, Mass General Hospital|Alexa Boer Kimball, MD MPH|617-726-0149|akimball@partners.org|
21237006|NCT01289067|Icahn School of Medicine at Mount Sinai|Dr. Bobby Liaw|(212) 604-6010|bobby.liaw@mountsinai.org|
21237007|NCT04656847|Sevier|Medical manager - Yuriy Burtsev|8-495-93707-00|Yuriy.Burtsev@servier.com|
21237008|NCT03301051|Medicago|Medical Director|+1 418-658-9393|clinicaltrialinquiries@medicago.com|
21237009|NCT00047879|National Cancer Institute, National Institutes of Health|Howard A. Fine, M.D.|301-402-6383|hfine@mail.nih.gov|
21237010|NCT02073331|Aziyo Biologics, Inc.|Clinical Director|510-730-7973|clinical@aziyo.com|
21237011|NCT00572234|University of Nebraska Medical Center|Kathleen Grant|402-995-4347|kathleen.grant2@va.gov|
21237012|NCT03858803|Portland State University|Dr. Janet S. St. Lawrence|971-978-7801|janetsstlawrence@gmail.com|
21237013|NCT01359735|Smith & Nephew|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
21237014|NCT03736434|The Ohio State University College of Nursing|Dr. Kathy Wright|614-292-0309|wright.2104@osu.edu|
21237015|NCT03738150|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21237016|NCT03762135|University of Michigan|Dr. Susan Woolford|734-615-8214|swoolfor@med.umich.edu|
21237017|NCT01962974|Janssen Pharmaceuticals|STRATEGIC LEAD||ClinicalTrialDisclosure@its.jnj.com|
21237018|NCT00147966|UCSD|Arthur Kavanaugh|858-657-7040|akavanaugh@ucsd.edu|
21237019|NCT04598152|The Ohio State University College of Medicine|Jay Fournier, PhD|614-293-9600|jay.fournier@osumc.edu|
21237020|NCT00955877|Washington University in St. Louis School of Medicine|Diego Morales|3144544688|d.morales@wustl.edu|
21237021|NCT00746603|Weill Cornell Medicine|Jennifer Levine, MD|212-305-9770|jel9022@med.cornell.edu|
21237022|NCT01965834|University of Miami|Denise Pereira MD|305-243-4909|dpereira2@med.miami.edu|
21252593|NCT05310201|Medical University of South Carolina|Angela Moreland, PhD|8437928209|moreland@musc.edu|
21252594|NCT01920477|Novartis Pharmaceuticals|Study Director|1-888-669-6682|Novartis.email@novartis.com|
21252595|NCT01681277|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21252596|NCT03838731|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21252597|NCT04227145|Children's Mercy Kansas City|Emily Hurley|(816) 731-7093|eahurley@cmh.edu|
21252598|NCT02271984|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21252599|NCT01088984|Teva Pharmaceuticals USA|Manager|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21252600|NCT01228318|Emory University|Igho Ofotokun, MD, MSc|404-616-0659|iofotok@emory.edu|
21237023|NCT00158743|BTG International Inc|Suzanne Ward Pharm D|610-278-1660|suzanne.ward@btgplc.com|
21252601|NCT03011567|NYU Langone Health|Christina Penfield, MD, MPH|646-754-2700|christina.penfield@gmail.com|
21237024|NCT03674177|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21237025|NCT03387852|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21237026|NCT02493127|Massachusetts General Hospital|Taylor Pong, Research Coordinator|617-726-1569|tpong1@partners.org|
21237027|NCT00670774|Mayo Clinic|Dr. Mark D. Stegall|507-284-6275|Stegall.Mark@mayo.edu|
21237028|NCT01913600|Medtronic, Coronary & Structural Heart Clinical|Lisa Bousquette, Clinical Research Director|707-591-2967|rs.medtroniccardiovascularclinicaltrials@medtronic.com|
21237029|NCT02010060|University of Virginia|Damon Swift|(434) 924-1436|dls3s@virginia.edu|
21237030|NCT04414696|Kaiser Permanente|Lyndsay Avalos|5108210300|lyndsay.a.avalos@kp.org|
21237031|NCT06660823|Ain Shams University|Dr.Mohammed Abd Al Jawad,Professor of cardiac surgery|+201111219461|mohammed_abdaljawad@med.asu.edu.eg|
21237032|NCT02979639|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21237033|NCT01429532|SunYat-senU|Prof. Yizhi Liu|+86-20-87330341|Reviewborad_SYsU@163.com|
21237034|NCT01877408|University of New England|Dr. Peter Millard|2078663503|pmillard@mac.com|
21237035|NCT02621931|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21237036|NCT01292603|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21237037|NCT03282981|VA Northern California Health Care System|Dr. Sara Dahle and Dr. Rosyln Rivkah Isseroff|916-843-7151|sara.dahle@va.gov|
21237038|NCT03870763|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21237039|NCT02985866|University of Virginia Center for Diabetes Technology|Boris Kovatchev, PhD|434-982-0602|mc7m@virginia.edu|
21237040|NCT01949311|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|1-844-734-6643|clinicaltrials@regeneron.com|
21237041|NCT03272633|Cancer Institute of New Jersey Rutgers|Roger K. Strair, MD|732-235-4523|strairrk@cinj.rutgers.edu|
21237042|NCT04279314|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261|medicalinformation@acadia-pharm.com|2897
21237043|NCT02120027|MENARINI Group|Angela Capriati, MD PhD - Corporate Director Clinical Research|+39 055 5680|acapriati@menarini-ricerche.it|9990
21237044|NCT01002872|Northshore University Healthsystem|Dr Stuart Sprague|847-570-1761|ssprague@northshore.org|
21237045|NCT00692094|Oregon Health and Science University|OHSU Integrity Department|1-877-733-8313|irb@ohsu.edu|
21237046|NCT01471054|Oncology Service, Wills Eye Hospital|Arman Mashayekhi, MD|215-928-3105|arman_mash@yahoo.com|
21237047|NCT03166618|Allergan Sales LLC|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
21237048|NCT00798720|University of Wisconsin|Abigail Mapes, Thoracic Oncology Research Program Manager|(608) 262-8158|acmapes@medicine.wisc.edu|
21237049|NCT03137303|University of Illinois at Chicago|Min J. Joo, MD MPH|312-996-8039|joo@uic.edu|
21237050|NCT03561090|Ironwood Pharmaceuticals, Inc.|Ironwood Study Chair|(617) 621-7722|Info@ironwoodpharma.com|
21237051|NCT03663231|University of Rochester|Ralph Saunders|585-275-1141|ralph_saunders@urmc.rochester.edu|
21237052|NCT02566031|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
21237053|NCT03031938|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21237054|NCT05762835|University of California at Davis|Dr. Jennifer Rosenthal|9167344719|rosenthal@ucdavis.edu|
21237055|NCT02007291|Federal University of Minas Gerais|Luís Felipe José Ravic de Miranda|55-31-3225-2337|ravicmiranda@gmail.com|
21237056|NCT02479412|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
21237057|NCT04386096|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
21237058|NCT05457608|CooperVision|Jose A. Vega,OD,MSc,FAAO|9256213761|jvega2@coopervision.com|
21237059|NCT04402866|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
21237060|NCT03667053|Zealand Pharma A/S|Dr Kim Mark Knudsen|+4550603780|KMKnudsen@zealandpharma.com|
21237061|NCT01877538|Department of Nuclear Medicine & PET Center, Aarhus University Hospital|Dr. Per Borghammer|+0045 23818581|perborgh@rm.dk|
21237062|NCT00515502|GlaxoSmithKline|GSK Response Center|866-435-7343||
21237063|NCT02732938|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21237064|NCT03647501|The Ohio State University|Shelby Miracle|614-366-1648|shelby.miracle@osumc.edu|
21237065|NCT01613248|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21237066|NCT01636882|Viralytics Ltd|Mark Grose|1 647 821 7673|mark.grose@viralytics.com|
21237067|NCT02964416|Aga Khan University|Dr Asma Abdus Salam|+92-21-34864715|asma.salam.azhar@gmail.com|4639
21237068|NCT04307004|University of Alabama at Birmingham|Emily B. Levitan, Professor and Vice Chair|(205) 975-7680|elevitan@uab.edu|
21237069|NCT05545072|Emory University|Thomas S Edwards, MD Assistant Professor, Rhinology and Skull Base Surgery Division|4045017710|thomas.edwards@emory.edu|
21237070|NCT02395042|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21237071|NCT02647359|PTC Therapeutics, Inc.|Medical Information|1-866-562-4620|medinfo@ptcbio.com|
21237072|NCT04642638|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
21237073|NCT06476366|Department of Dermatology, Emirates Military Hospital|Dr Ahsan Tameez-ud-din|051-9293480|ahsantameezuddinmalik@gmail.com|312
21237074|NCT04313881|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21237075|NCT00727272|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21237076|NCT00651664|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21237077|NCT04053764|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
21237078|NCT04732286|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21237079|NCT01733056|Emory University|Dr. Robert Swerlick|404-727-3669|rswerli@emory.edu|
21237080|NCT00319098|GlaxoSmithKline|GSK Response Center|866-435-7343||
21237081|NCT01201629|OKC VA Medical Center|Dr. Meheroz H. Rabadi|405-456-5298|meheroz.rabadi@va.gov|
21237082|NCT00875836|MUSC|Dr. Aimee McRae-Clark|843.792.5216|mcraeal@musc.edu|
21237083|NCT00936858|Dana-Farber Cancer Institute|Dr. Glenn Hanna|6176323090|glenn_hanna@dfci.harvard.edu|
21237084|NCT00584727|Vistakon|Kurt Moody, OD, FAAO|904-443-3088||
21237085|NCT00092131|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21237086|NCT02341417|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21237087|NCT01857531|Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@duke.edu|
21237088|NCT02576067|Icahn School of Medicine at Mount Sinai|Zahi Fayad, PhD|212-824-8471|zahi.fayad@mssm.edu|
21237089|NCT04773587|Arcutis|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
21237090|NCT00435370|Baylor College of Medicine|Dr. Thomas R. Kosten|(713) 794-7032|kosten@bcm.edu|
21237091|NCT02132611|Cardiovascular Systems, Inc.|Clinical Project Manager|651-259-1600|clinicaltrials_csi@csi360.com|
21237092|NCT03943095|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21237093|NCT02298192|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21237094|NCT02352948|AstraZeneca|Medical Science Director|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
21237095|NCT01995123|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health; William S Middleton Memorial Veterans Hospital|Jessica Cook, PhD|608-265-9775|jwcook@ctri.wisc.edu|
21237096|NCT01428765|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21237097|NCT00596440|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@mail.med.upenn.edu|
21237098|NCT02096900|Loma Linda University|Amgad H. Hanna, MD|909-558-4475|ahanna@llu.edu|
21237099|NCT02763384|Washington University School of Medicine|Geoffrey L. Uy, M.D.|314-747-8439|guy@wustl.edu|
21237100|NCT04657211|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21237101|NCT05054816|Sonova Canada|Jinyu Qian, PhD; VP Sonova Innovation Centre Toronto|647-262-4826|jinyu.qian@sonova.com|
21237102|NCT05672628|The University of Texas Health Science Center at Houston|Seema S Aggarwal, PhD, APRN, AGNP-C|713-500-9946|Seema.S.Aggarwal@uth.tmc.edu|
21237103|NCT06273774|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21237104|NCT00660010|Abbott Laboratories|Global Medical Services|800-633-9110||
21237105|NCT01177098|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21237106|NCT06167031|Tzu Chi University|Associate professer Mei-Lin Hsieh|886933513291|shaer@gms.tcu.edu.tw|
21237107|NCT00360308|Eisai Call Center|Eisai Inc.|888-422-4743||
21237108|NCT04786444|Valneva Austria GmbH|Clinical Strategy Manager|+43 1 206 20|office@valneva.com|0
21237109|NCT00373399|New York State Psychiatric Institute|Margaret Haney|646-774-6153|mh235@cumc.columbia.edu|
21237110|NCT00324870|Johns Hopkins University|Michael Carducci, MD|410-614-6337|carducci@jhmi.edu|
21237111|NCT00725452|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21237112|NCT00713648|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21237113|NCT01733732|Alcon Research, Ltd.|Abayomi Ogundele, Pharm.D, Global Brand Medical Affairs Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21237114|NCT00464815|GlaxoSmithKline|GSK Response Center|866-435-7343||
21237115|NCT01402141|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Baek-Hwan Cho, MD|82-63-250-1579|chobh@jbnu.ac.kr|
21237116|NCT00845663|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
21237117|NCT03806270|Yeditepe U|Dr. Ferda F. Kartufan|+902165784000|ferdasozer@gmail.com|4754
21237118|NCT01324271|Acclarent, Inc.|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
21237119|NCT02807558|Syros Pharmaceuticals|Tiffany Crowell|617-674-9069|tcrowell@syros.com|
21237120|NCT06116591|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21237121|NCT05585307|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21237122|NCT01972841|Astellas Pharma Europe B.V.|Medical Director|+31 (0) 71 5455 050|astellas.resultsdisclosure@astellas.com|
21237123|NCT01360606|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
21237124|NCT02734212|VISN 5 MIRECC|Dr. Amy Drapalski|410-637-1855|amy.drapalski@va.gov|
21237125|NCT00688636|Univerisity of Pittsburgh|Research Coordinator|412-648-9173|goldbyreffnerka@upmc.edu|
21237126|NCT01572727|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21237127|NCT02195986|Mylan Inc.|Abhijit Barve, Head of Global Clinical Research||abhijit.barve@mylan.com|
21237128|NCT02571218|IRCCS Policlinico San Donato|Giuseppe Ciconte|+39 02 52 77 42 60|g.ciconte@gmail.com|
21237129|NCT02834780|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21237130|NCT03150056|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21237131|NCT03335033|Mayo Clinic|Matthew W. Urban|507-284-3703|Urban.Matthew@mayo.edu|
21237132|NCT00395876|Genentech, Inc.|Medical Communications|800-821-8590||
21283963|NCT01914159|Dept of Ophthalmology, University of Bonn, Bonn, Germany|Tim U. Krohne, MD, FEBO|+49 228 287|krohne@uni-bonn.de|15505
21283964|NCT01037127|GlaxoSmithKline|GSK Response Center|866-435-7343||
21283965|NCT00334633|University of Alabama at Birmingham|jane R Schwebke, MD|205-975-5665|schwebke@uab.edu|
21283966|NCT00656487|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
21283967|NCT00078949|NCIC|Seninor Biostatistician for LY12|613-533-6000|bechen@ctg.queensu.ca|77703
21283968|NCT02667626|University of California, San Diego|Irene Su, MD MSCE|8588225986|hisu@ucsd.edu|
21283969|NCT02309723|Tufts Medical Center|Dr.Yue Zhong, Project Director of Center for the Evaluation of Value and Risk in Health|6176361424|yzhong@tuftsmedicalcenter.org|
21283970|NCT02560623|Mayo Clinic|Dr. Prasad G. Iyer|507-293-7911|iyer.Prasad@mayo.edu|
21283971|NCT01125813|Octapharma AG|Dr Sigurd Knaub|41 55 451 21 41|sigurd.knaub@octapharma.ch|
21283972|NCT05216991|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|renew.j@mayo.edu|
21283973|NCT01143064|Besins Healthcare Ireland Ltd|Global Chief Medical Officer|+353 87 1039215|clinicaldevelopment@besins-healthcare.com|
21283974|NCT02453282|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
21283975|NCT00323037|CTI Clinical Trial and Consulting Services|Sandy Stagge, RN, BSN|513-619-1837|sstagge@ctifacts.com|
21283976|NCT02327013|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
21299015|NCT06019728|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
21252602|NCT00770029|Merz Pharmaceuticals GmbH|Dr. Matthias Zerm|0049-69-1503|matthias.zerm@merz.de|865
21252603|NCT03480932|Johns Hopkins Bloomberg School of Public Health|Dr. Shruti Mehta|4432873837|smehta@jhu.edu|
21252604|NCT03057847|University of Pittsburgh|Dr. Elizabeth Krans|412-641-3532|kransee@upmc.edu|
21252605|NCT00168389|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21252606|NCT02138786|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
21252607|NCT02088957|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
21252608|NCT01028677|UNC_ChapelHill|Dr. Cort Pedersen|919 966-4447|cort_pedersen@med.unc.edu|
21252609|NCT00775411|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21252610|NCT00426127|University of Iowa|Daniel Berg, MD|319-353-7800|daniel-j-berg@uiowa.edu|
21252611|NCT04191421|Emory University|Dr. Olatunji Alese, MD|404-778-6639|olatunji.alese@emory.edu|
21252612|NCT03111095|University of Wisconsin School of Medicine and Public Health|Kara Hoppe, DO|(206) 371-4014|khoppe2@wisc.edu|
21252613|NCT02413645|Hospital Clinic-HIVACAT|Dr. Felipe Garcia|932275400|fgarcia@clinic.cat|2844
21252614|NCT00387244|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
21252615|NCT00955708|Boston Scientific|Director of Clinical Trial Management - cRM franchise|1-800-227-3422|elaine.larson@bsci.com|
21252616|NCT01016262|Forest Laboratories|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
21252617|NCT01128270|University of Florida|Peter W. Stacpoole,MD|(352) 273-9023|pws@ufl.edu|
21252618|NCT03738475|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21252619|NCT00677534|University of Kansas Medical Center|Dr. Jason Stubbs|913-588-3867|jstubbs@kumc.edu|
21252620|NCT05214378|Cleveland Department of Veterans Affairs|Dennis Bourbeau|216-791-3800|dennis.bourbeau@va.gov|
21252621|NCT04638660|Ocuphire Pharma, Inc.|Drey Coleman|8134041993|dcoleman@ocuphire.com|
21252622|NCT04028921|Children's Mercy Kansas City|Dr. Robin Shook, PhD|(816) 234-9443|rpshook@cmh.edu|
21252623|NCT02451176|Cleveland Clinic Foundation|Dr. Michael Rosen|12164453441|rosenm@ccf.org|
21252624|NCT00863681|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21252625|NCT05138289|HeartFlow|Saba Mirza|650-241-1221|smirza@heartflow.com|
21252626|NCT00659880|RTI Surgical|Robin Waite, RN|386-418-8888|rwaite@rtix.com|
21252627|NCT01853475|Medicines for Malaria Ventire (MMV)|Dr Thomas Rueckle|+41 22 799 4567|ruecklet@mmv.org|
21252628|NCT03199469|Astellas Pharma Global Development, Inc. (APGD)|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
21252629|NCT01031628|SARC|Research Project Manager|(734) 930-7600|sarc@sarctrials.org|
21252630|NCT01304498|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21252631|NCT03080493|University of California, Davis|Mitchell Creinin, MD|916-734-6670|mdcreinin@ucdavis.edu|
21252632|NCT02803593|Emory University|Dr. Eun Ok Im|404-712-9805|eun.ok.im@emory.edu|
21252633|NCT03632083|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
21252634|NCT04245345|Medtronic|Rachel Vasseur, Sr. Clinical Research Specialist|6123550360|rachel.s.vasseur@medtronic.com|
21252635|NCT01834586|EvergreenHealth Multiple Sclerosis Center|Theodore Brown|425-8995350|trbrown@evergreenhealth.com|
21252636|NCT01512797|Columbia University Medical Center|Dr. Blandine Laferrere|212-851-5562|bbl14@columbia.edu|
21252637|NCT03325777|The University of Texas at Austin|Dr. Jasper Smits|512-475-8095|smits@utexas.edu|
21252638|NCT03004404|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21252639|NCT01937975|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21252640|NCT02522728|Stryker Orthopaedics|Eric Garling, PhD Snr. Director Medical & Scientific Affairs Europe|+31 6 467 135 18|Eric.Garling@stryker.com|
21252641|NCT02028325|Indiana University|Aaron Cohen-Gadol, MD, MSc|317-362-8760|acohen@goodmancampbell.com|
21252642|NCT04210843|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
21252643|NCT01099917|Memorial Sloan Kettering Cancer Center|Dr. Barrie Cassileth|646-888-0801|Cassileth@mskcc.org|
21252644|NCT02990468|BioMimetix JV LLC|Director of Clinical Operations|303-862-7268|contact@bmxpharma.com|
21252645|NCT01059305|The University of Texas (UT) MD Anderson Cancer Center|Bonnie Glisson, MD/Professor, Thoracic/Head & Neck Med Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
21252646|NCT01001390|St. Jude Children's Research Hospital|Kirsten K. Ness, PT, PhD|866-966-5934|info@stjude.org|
21252647|NCT02251236|University of California, San Diego|Scott Letendre, Principal Investigator|6195438080|sletendre@ucsd.edu|
21252648|NCT01721954|Sirtex Medical|Janet Bell, M.B.A.|+ 888-474-7839|jbell@sirtex.com|710
21252649|NCT01825577|Saint Louis University|Dr. Ahsan Khan|314-977-4826|khanay@slu.edu|
21252650|NCT01016847|Duke Asthma Allergy and Airway Center|Monica Kraft, M.D.|9194790719|denise.beaver@dm.duke.edu|
21252651|NCT04230122|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21252652|NCT01621776|University of Florida|Janet Silverstein, MD|352-334-1390|silvejh@peds.ufl.edu|
21252653|NCT01495572|National Cancer Institute|Udai Kammula M.D.|301-435-8606|kammulau@mail.nih.gov|
21252654|NCT04379011|University of Minnesota|Dr. Ricardo Battaglino|612-625-2661|rbattagal@umn.edu|
21252655|NCT02078492|Maimonides Medical Center|Dr. Sergey Motov|718-283-8693|smotov@maimonidesmed.org|
21252656|NCT05672771|University of Illinois|Dr. Elizabeth A L Stine-Morrow|217-244-2167|eals@illinois.edu|
21252657|NCT02080546|Duke University Medical Center|Dr Paula S Lee|919-684-3765|paula.s.lee@duke.edu|
21299016|NCT02647723|University of Chicago|Dr. Kate Keenan|773-702-4449|kekeenan@uchicago.edu|
21252658|NCT03321253|Necip Fazil City Hospital|Dr. Bunyamin Kutluksaman|903442282800|bkutluksaman@gmail.com|
21252659|NCT00108745|NRG Oncology|Christopher Purdy on behalf of Austin Miller PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
21252660|NCT01228175|University of Colorado Boulder|Dr. Kent Hutchison|303-492-8163|kent.hutchison@colorado.edu|
21252661|NCT00402051|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21252662|NCT00277095|Uromedica|Sabitha R Shriram|763-694-9880|sshriram@uromedica-inc.com|216
21252663|NCT01956097|Ewha Brain Institute, Ewha W. University|Soonhyun Ban, RN, MS|+82-2-3277-6550|soonhyun.s.ban@gmail.com|6554
21252664|NCT05415748|UCSF|Dr. Scott Bauer|650-515-2879|scott.bauer@ucsf.edu|
21252665|NCT03075527|Dana-Farber Cancer Institute|Mark Awad, MD, PhD|6176323468|mark_awad@dfci.harvard.edu|
21252666|NCT05472740|Duke University|Amelia Scott, Research Program Leader|(919) 613-4584|amelia.lorenzo@duke.edu|
21252667|NCT03832595|University of Pittsburgh|Dr. Manisha Jhamb|4126477062|jhambm@upmc.edu|
21252668|NCT03790306|Genesee Orthopedic & Hand Surgery Associates, P.C.|Andrew Wickline, MD|315-735-4496|awickline23@gmail.com|
21267072|NCT01104922|UPMC Hillman Cancer Center|Barbara Stadterman, Regulatory Supervisor; ClinicalTrials.gov Admin|412-647-5554|stadtermanbm@upmc.edu|
21267073|NCT02329860|clinical operation|Zexiang.huang/ project manager|13811725417|zexiang.huang@hengrui.com|
21267074|NCT02289833|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21267075|NCT00809055|Brigham and Women's Hospital|Dr. Terrie Inder|617-525-6650|tinder@partners.org|
21267076|NCT00779116|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21283977|NCT02380859|Dartmouth-Hitchcock Medical Center|Stephen L. Lee, MD PhD|603-650-5104|stephen.l.lee@hitchcock.org|
21283978|NCT01565668|Contact for Clinical Trial Information|Daiichi Sankyo|1-908-992-6400|CTRinfo@dsi.com|
21283979|NCT04258254|University of Delaware|Anjana Bhat, Study PI|4435238680|abhat@udel.edu|
21267077|NCT01714336|Mayo Clinic|Dr. Mark Pagnano|507-284-2511|pagnano.mark@mayo.edu|
21267078|NCT04995666|Phonak Audiology Research Center|Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
21267079|NCT03667573|Malcom Randall VA Medical Center|Dr. David Clark|352-376-1611|davidclark@ufl.edu|105244
21267080|NCT01756833|University of Maryland School of Medicine|Michael L. Terrin, MDCM, MPH, Contact Principal Investigator|410-706-6139|mterrin@som.umaryland.edu|
21267081|NCT04554394|Pulse Biosciences, Inc.|William A. Knape|(919) 757-2033|bill.knape@pulsebiosciences.com|
21267082|NCT01766401|Forest Research Institute, Inc|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
21267083|NCT00886587|Johnson & Johnson Consumer Inc|Amisha Parikh-Das, PhD/Study Director|973 385-2863 USA EST|AParikh1@its.jnj.com|
21267084|NCT01523613|University of Michigan|Dr. Mathilde Peters||mcpete@umich.edu|
21267085|NCT00808132|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21267086|NCT02795182|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21267087|NCT01108068|University of Maryland School of Medicine|Elizabeth Streeten, MD|410-328-3335|estreete@som.umaryland.edu|
21267088|NCT01021553|GlaxoSmithKline|GSK Response Center|866-435-7343||
21267089|NCT00696774|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21267090|NCT01950364|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21267091|NCT00033293|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21267092|NCT00935701|Kennedy Krieger Institute|Lana Warren|4439239312|WarrenL@kennedykrieger.org|
21267093|NCT00836953|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21267094|NCT01200758|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
21267095|NCT02711553|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21267096|NCT05259800|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
21267097|NCT04048876|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21267098|NCT01197794|AstraZeneca|Alison Holt||ClinicalTrialTransparency@astrazeneca.com|
21267099|NCT04055844|University of Minnesota, Masonic Cancer Center|Mark Juckett , MD|612-676-4200|juck0001@umn.edu|
21267100|NCT04716010|University of North Carolina at Chapel Hill|Lindsey Smith Taillie, PhD|(919) 445-8313|taillie@unc.edu|
21267101|NCT01529450|Stanford University|Anne Chang, MD|(650) 721 7151|alschang@stanford.edu|
21267102|NCT03457636|Skin Sciences, PLLC|M. McAllister|5024519000|mmdermresearch@yahoo.com|
21267103|NCT02996500|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21267104|NCT02187224|Yale University School of Medicine, Department of Psychiatry|Elizabeth Ralevski|203-932-5711|elizabeth.ralevski@yale.edu|4282
21267105|NCT00835276|Manager, Biopharmaceutics|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21267106|NCT01347840|Ethicon Endo-Surgery, Inc.|Amy Mahanes|513-337-8366|amahanes@its.jnj.com|
21267107|NCT01010776|Jan-Cil Brazil|Medical Group Manager|55 11 3030-2770||
21267108|NCT01229410|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21267109|NCT01736930|Jaeb Center for Health Resesarch|Roy W. Beck, MD, PhD|813-975-8690|jdrfapp2@jaeb.org|
21267110|NCT01359111|PATH|Courtney Jarrahian|206-285-3500|cjarrahian@path.org|
21267111|NCT00678249|Bard Peripheral Vascular, Inc.|John Reviere, Director, Clinical Affairs|480-303-2644|john.reviere@crbard.com|
21267112|NCT01045551|Columbia University Medical Center|Julian Mackay-Wiggan, MD, MS|212-305-6953|jc299@cumc.columbia.edu|
21267113|NCT01744340|BrUOG-Brown University Oncology Research Group|Howard Safran, MD|4018633000|kristen_mitchell@brown.edu|
21267114|NCT01579162|HepQuant, LLC|Elyse Handley|303-923-2109|elyse.handley@hepquant.com|
21267115|NCT02545049|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
21283980|NCT02255552|Sarepta Therapeutics, Inc.|Medical Director|+1-800-690-2003|clinicaltrials@sarepta.com|
21267116|NCT01586962|Novartis|Clinical Project Leader|+41223633111||
21267117|NCT05954065|Erchonia|Clinical Affairs Manager|8882420571|tsammons@erchonia.com|
21267118|NCT02369211|Brigham and Women's Hospital|James Webber|(617) 732-6877|jwebber1@partners.org|
21267119|NCT04223778|Merck Sharp and Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21267120|NCT05325333|Purdue University|Dr. Patricia Deevy, Research Associate|765-496-1821|deevy@purdue.edu|
21299017|NCT05524220|The University of Texas Health Science Center at Houston|Erikka Washington, MD|713-500-6202|Erikka.L.Washington@uth.tmc.edu|
21299018|NCT05579977|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21299019|NCT01406990|Creighton University|Dr. Katie Packard, PharmD|402-280-4566|kathleenpackard@creighton.edu|
21299020|NCT01611194|Intermountain Healthcare|Lindell Weaver, MD, FACP, UHM|801-408-3623|lindell.weaver@imail.org|
21299021|NCT00452790|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21299022|NCT02918357|University of California, San Francisco|Dr. Thomas Hope|(415) 221-4810|thomas.hope@ucsf.edu|2264
21299023|NCT01604291|Hoffmann-La Roche|Medical Communications|800-821-8590|Genentech@druginfo.com|
21299024|NCT01871519|Medtronic Spinal|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
21299025|NCT00794950|University of Michigan|Alon Z. Weizer, MD, MS|734-615-6662|aweizer@umich.edu|
21299026|NCT02485704|ParaPRO, LLC|Kerry W. Mettert, MBA, MT(ASCP)|317-810-6205|kerrym@parapro.com|
21299027|NCT00932321|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
21299028|NCT01147042|NIH CC|Dr. John Gallin|301-827-5428|jgallin@cc.nih.gov|
21299029|NCT00915954|Cedars-Sinai Medical Center|Dr. Odelia Cooper|310-423-2830|coopero@cshs.org|
21299030|NCT02777021|Children's Hospital of Philadelphia|Dr. Richard Aplenc|267-426-7252|aplenc@email.chop.edu|
21299031|NCT00599872|Greer Laboratories|Bob Esch, VP Research & Development|828.759.7845|esch@greerlabs.com|
21299032|NCT01474317|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
21299033|NCT00453154|Duke University Medical Center|Dr. Neal Ready||ready001@mc.duke.edu|
21299034|NCT03052101|University of Cincinnati|Elizabeth Kopras|513-558-4831|koprasej@uc.edu|
21299035|NCT03714178|Farapulse|Kit Schneider|617-686-7661|kschnieder@farapulse.com|
21299036|NCT01169103|Massachusetts General Hospital|Madhusmita Misra|617-724-5602|mmisra@partners.org|
21299037|NCT02843165|University of California, San Diego|Andrew Sharabi|(858) 822-5354|CancerCTO@health.ucsd.edu|
21299038|NCT00248495|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21299039|NCT05552027|Children's Hospital of Philadelphia|Morgan O'Donald|267-499-4114|ODONALDM@chop.edu|
21299040|NCT03518294|The Penn State College of Medicine|Dr. Jonathan Stine|7175311017|jstine@pennstatehealth.psu.edu|
21299041|NCT03360682|Hospital Clínic/IDIBAPS, University of Barcelona|Jose M. Miro Meda (PI), MD, PhD, Consultant, Infectious Diseases Service|93 227 54 30|JMMIRO@clinic.cat|
21299042|NCT01441843|Erasmus University Medical Centre|Dr. M. Klimek|+31107033713|m.klimek@erasmusmc.nl|
21299043|NCT01363700|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
21299044|NCT03827655|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21299045|NCT03649217|Moterum Technologies, Inc.|Brianne Darcy|(864) 659-3180|brie@moterumtechnologies.com|
21299046|NCT02643459|Herlev Hospital, Department of Cardiology|Dr. Martin Schultz|004538683868|martin.schultz@regionh.dk|
21299047|NCT02552966|Northwestern University|Dr. John Pandolfino, Principal Investigator|3126950182|j-pandolfino@northwestern.edu|
21299048|NCT00961311|Medtronic Cardiovascular|K. Bogdanovich||rs.medtroniccardiovascularclinicaltrials@medtronic.com|
21299049|NCT00230126|The Ohio State University|Miguel Villalona|614-366-5068|miguel.villalona@osumc.edu|
21299050|NCT02365649|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21299051|NCT03483896|University of Southern California|Prof. Kyle Konis, Ph.D|(213) 740-2723|kkonis@usc.edu|
21299052|NCT04875806|NextCure, Inc|Senior VP, Clinical and Translational Development|240-399-4900|NCClin@nextcure.com|
21299053|NCT01433172|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jhanelle Gray|813-745-3050|jhanelle.gray@moffitt.org|
21299054|NCT00431626|Northwestern U|Borko D. Jovanovic, MS, PhD|312 503 2008|borko@northwestern.edu|
21299055|NCT03084796|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
21299056|NCT01708317|Washington University School of Medicine|Dr. Fahd A Ahmad|314-286-0298|ahmad_f@kids.wustl.edu|
21299057|NCT02741245|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21237133|NCT02270450|SWOG Statistics and Data Management Center|Palliative and End of Life Care Committee Statistician|2066674623|karnold@fredhutch.org|
21237134|NCT02363738|University Health Network|Dr. Roger McIntyre|416-603-5279|roger.mcintyre@uhn.ca|
21237135|NCT03282227|Zosano Pharma Corporation|Donald Kellerman, PharmD, Sr. VP, Clin Dev and Med Affairs|(510) 745-4004|dkellerman@zosanopharma.com|
21237136|NCT03282890|UConn|Dr. Michael Copenhaver|860-208-3632|michael.copenhaver@uconn.edu|
21283981|NCT01447446|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21283982|NCT02657577|Pennington Biomedical Research Center|Leanne Redman, Principal Investigator|2257630947|Leanne.Redman@pbrc.edu|
21283983|NCT05323994|Sevier|Denis Morozov|8-495-93707-00|denis.morozov@servier.com|
21283984|NCT00595114|Brigham and Women's Hospital|Dr. Bruce D. Levy|617-525-5407|blevy@partners.org|
21283985|NCT00454818|Celladon Corporation|Jeffrey J. Rudy, Vice President|1 858-366-4288|jrudy@celladon.net|
21283986|NCT03180515|Stanford School of Medicine|Bronte-Stewart Lab|6507236709|hbsmovlab@gmail.com|
21283987|NCT03435224|Masimo|Chelsea Frank|(949) 297-7000|studies@masimo.com|
21283988|NCT02523235|University California San Diego|Brian Ilfeld, MD, MS|858-822-0776|bilfeld@ucsd.edu|
21283989|NCT04472026|University Of Florida|Naykky Singh Ospina|352) 273-8656|naykky.singhospina@medicine.ufl.edu|
21283990|NCT03077659|NanOlogy, LLC|Gere S. diZerega, MD|805-595-1300|gere.dizerega@usbiotest.com|
21283991|NCT02570321|UCSF, Proctor Foundation|Sarah Abedelrahman, Research Data Analyst|2135093817|sarah.abdelrahman@ucsf.edu|
21283992|NCT01985958|University of Pennsylvania|Edgar Ben-Josef, M.D.|215-662-3932|Edgar.Ben-Josef@uphs.upenn.edu|
21283993|NCT01836809|Virginia Commonwealth University|Keyur Shah, MD|804-828-4571|kshah@mcvh-vcu.edu|
21283994|NCT01273155|National Cancer Institute|Naoko Takebe, M.D., Ph.D.|240-781-3398|Takeben@mail.nih.gov|
21237137|NCT02937168|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21237138|NCT00700401|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21237139|NCT02491671|Hospital Universitario de Salamanca|Dr. Marcelo Jiménez|923291100|mfjl@usal.es|
21237140|NCT00682734|Montefiore Medical Center|Benjamin Friedman|718 920 6626|befriedm@montefiore.org|
21237141|NCT02251990|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21237142|NCT03265600|Cambridge Health Alliance|Dr. Zev Schuman-Olivier|617-591-6132|zschuman@cha.harvard.edu|
21237143|NCT00535730|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21237144|NCT05525494|UCLA|Principal Investigator|310-206-6328|pszilagyi@mednet.ucla.edu|
21237145|NCT02464449|Ann Arbor VA Healthcare System|Dr. John Piette, PhD|734-845-3626|jpiette@umich.edu|
21237146|NCT00729833|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21237147|NCT00355082|GlaxoSmithKline|GSK Response Center|866-435-7343||
21237148|NCT03570619|University of Michigan Rogel Cancer Center|University of Michigan Cancer Center Admin|7349369499|ClinicalTrialsgov_CCAdmin@umich.edu|
21237149|NCT05893992|Sonova|Dr. Jonathan Vaisberg|9057456785|jonathan.vaisberg@sonova.com|
21237150|NCT01954017|Leadiant Biosciences, Inc.|Scott Rodgers, MS, CCRA, ACRP-PM / Sr Director of Clinical Operations|301-670-1565|scott.rodgers@leadiant.com|
21237151|NCT03346759|University of Michigan|Jason Bell, MD|7342323897|jasonbel@med.umich.edu|
21237152|NCT03341910|Dr. Reddy's Laboratories, Inc|Dr. Srinivas Sidgiddi, Sr. Director, Clinical Development|609-375-9910|srinivassidgiddi@drreddys.com|
21237153|NCT02474927|University of Pittsburgh|John McDyer|(412) 624-8915|mcdyerjf@upmc.edu|
21237154|NCT02599194|Stanford University|Andrei H. Iagaru|(650) 725-4711|aiagaru@stanford.edu|
21237155|NCT03919422|Department of Anesthesiology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital|Dr. Junfen Zhang, director of the clinical trial|+8618930173689|zhangjunfeng@sjtu.edu.cn|
21237156|NCT04177758|Rush University Medical Center|Anne DeBenedetti, MSc|312-432-2468|anne.debenedetti@rushortho.com|
21237157|NCT00374842|GlaxoSmithKline|GSK Response Center|866-435-7343||
21237158|NCT00744653|Copenhagen University Hospital Herlev|MD Louise Wichmann Matthiessen|+ 45 38 68 98 58|louise.wichmann.matthiessen@gmail.com|
21237159|NCT03826667|Smith+Nephew, Inc.|Judith Horner|+44 1482 673251|Judith.horner@smith-nephew.com|
21237160|NCT00808808|MedImmune, LLC|Seth Toback, MD|301-398-0000|tobacks@medimmune.com|
21237161|NCT01681589|NYU Langone Health|Prin Amorapanth, MD, PhD|212-263-6037|Prin.Amoropanth@nyulangone.org|
21237162|NCT00679939|GlaxoSmithKline|GSK Response Center|866-435-7343||
21237163|NCT01680328|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21237164|NCT00074035|The Ohio State University Medical Center|Sherif S. Farag, M.D., Ph.D.||farag-1@medctr.osu.edu|
21237165|NCT01453595|Memorial Sloan Kettering Cancer Center|Dr. Martin Voss|646-422-4631|vossm@mskcc.org|
21237166|NCT03166761|Vanderbilt University Medical Center|Byron Schneider|(615)936-7708|byron.j.schneider@vumc.org|
21237167|NCT02653482|Saint Luke's Hospital of Kansas City|Program Manager, Cardiometabolic Research|8166957561|DEFINE-HF@saint-lukes.org|
21237168|NCT03969654|Zimmer Biomet, Inc.|Director of Clinical Operations|8006136131|Clinicaloperations@zimmerbiomet.com|
21237169|NCT01864564|University of Texas at Austin|Lorie M. Harper, MD, MSCI|512-324-7036|lorie.harper@austin.utexas.edu|
21237170|NCT03077724|Vanderbilt University Medical Center|Harvey J Murff|615 936 8319|harvey.j.murff@vanderbilt.edu|
21237171|NCT02269670|Emory University|Dr. Suchita Pakkala|404-686-3496|suchita.pakkala@emoryhealthcare.org|
21237172|NCT00234065|Department of Clinical Research and Development, Otsuka Pharmaceutical Co., Ltd.|Masahiko Abe, Director Cardiovascular Projects|+81-6-6943-7722|abems@otsuka.jp|2545
21237173|NCT00003508|Burzynski Research Institute, Inc|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
21237174|NCT02160314|Procter & Gamble Company Global Clinical Sciences|Mylissa Trowbridge||trowbridge.mm@pg.com|
21237175|NCT00593567|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
21237176|NCT02993445|Temple University Hospital|Dr. Jeffrey Henderer|267-418-9126|Jeffrey.Henderer@tuhs.temple.edu|
21237177|NCT01946542|Duke University Medical Center|William Kraus|919-684-2063|william.kraus@duke.edu|
21237178|NCT00871689|Masonic Cancer Center, University of Minnesota|Michael Verneris, M.D.|612-626-2961|verneris@umn.edu|
21237179|NCT03576768|Medical University of South Carolina|Colleen Hanlon, PhD|843-792-9888|hanlon@musc.edu|
21237180|NCT00590902|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris|646-888-4205|krism@mskcc.org|
21237181|NCT00785291|UCSF Comprehensive Cancer Center|Hope Rugo, M.D.||hrugo@medicine.ucsf.edu|
21237182|NCT02119260|GlaxoSmithKline|GSK Response Center|866-435-7343||
21237183|NCT05183022|University of Alabama at Birmingham|Andrew D. Pucker, OD, PhD|1-920-579-2900|apucker@uab.edu|
21237184|NCT02057874|Vanderbilt University Medical Center|Professor of Surgery and Cancer Biology|615-936-2956|lee.gorden@vanderbilt.edu|
21237185|NCT00799292|Mt Sinai School of Medicine, Department of Obstetrics and Gynecology|Charles Ascher-Walsh MD, MPH|212-241-2827|charles.ascher-walsh@mssm.edu|
21237186|NCT01738984|University of Hawaii, School of Nursing and Dental Hygiene|Cheryl Albright|8089569716|cherylal@hawaii.edu|
21237187|NCT00610116|Department of Cardiology and Rhythmology, Augusta Hospital, Duesseldorf, Germany.|Joachim Winter, MD|+49 (0) 2118|joachim.winter@uniklinik-duesseldorf.de|1173
21237188|NCT01760889|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21237189|NCT00920426|ViiV Healthcare|GSK Response Center|866-435-7343||
21299058|NCT01787461|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21299059|NCT03259555|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21299060|NCT02800863|Abbott Vascular|Nicole Harbert|(972) 526-4841|Nicole.harbert@abbott.com|
21252669|NCT00954187|Loma Linda University|Julio Narvaez, MD|9095589408|thamilton@llu.edu|
21252670|NCT05504954|Department of Medicine, Center for Dissemination and Implementation Science, University of Illinois Chicago|Dr. Geri Donenberg|312-996-8602|gerid@uic.edu|
21283995|NCT04908475|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21252671|NCT03412773|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
21283996|NCT01739764|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21252672|NCT03317990|University College London|Professor Greg Shaw|+44 (0)20 7679 2000|ncita.neurosafe@ucl.ac.uk|
21252673|NCT02643303|Ludwig Institute for Cancer Research|Jonathan Skipper|12124501539|jskipper@lcr.org|
21252674|NCT00974818|Memorial Slaon Kettering Cancer Center|Dr. Guido Dalbagni|646-422-4394|Dalbagng@mskcc.org|
21252675|NCT01174446|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21252676|NCT00847626|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21252677|NCT00737477|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21252678|NCT01132820|NRG Oncology /GOG|Linda Gedeon for Michael Sill, PhD|716 845-1169|lgedeon@gogstats.org|
21252679|NCT01370655|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21252680|NCT01730378|GlaxoSmithKline|GSK Response Center|866-435-7343||
21252681|NCT02687035|Edwards Lifesciences|Edwards THV Clinical Affairs|949-250-2500|THV_CT.gov@edwards.com|
21252682|NCT01102764|Medical University of South Carolina|Ron Acierno, PhD|843-792-2949|acierno@musc.edu|
21252683|NCT01048697|Texas Tech UHSC|Ronald Hall|214-654-9404|ronald.hall@ttuhsc.edu|
21283997|NCT00404924|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21283998|NCT03887429|Promentis Pharmaceuticals|Chad Beyer|(414) 238 2992|cbeyer@promentispharma.com|
21283999|NCT00926536|Stanford University|Dr Nishita Kothary|6504986020|kothary@stanford.edu|
21284000|NCT01267201|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21284001|NCT00483704|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21284002|NCT00819780|Amgen Inc.|Study Director|866-572-6436||
21284003|NCT03912428|National Institute of Mental Health|Dr. Robert Innis|+1 301 594 1368|robert.innis@nih.gov|
21284004|NCT01553240|New York State Psychiatric Institute|Linda Sherman|(646) 774-7158|lsherma@nyspi.columbia.edu|
21284005|NCT02637713|Montefiore Medical Center|Dr. Erin Moran-Atkin|718-920-4800|emoran2@montefiore.org|
21252684|NCT00667394|National Cancer Institute, National Institutes of Health|Dr. Katherine Warren|301-435-4683|warrenk@box-w.nih.gov|
21252685|NCT03165747|Emory University|Roberto Pacifici, MD|404-712-8420|roberto.pacifici@emory.edu|
21252686|NCT02160730|Cedars-Sinai Medical Center|Dr. Ning-Ai Liu|310-423-7382|ning-ai.liu@cshs.org|
21252687|NCT05000216|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21252688|NCT04076943|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG4592-092Study@fibrogen.com|
21252689|NCT03119233|Endologix|Tammy Stiver, Manager, Clinical Affairs|5136731452|tstiver@endologix.com|
21284006|NCT02847182|Duke University|Jesse D. Troy, PhD, MPH|919-668-1102|cordbloodtherapyinfo@dm.duke.edu|
21284007|NCT02345889|Indiana University|Rachel Lahr|3179480724|rlahr@iu.edu|
21284008|NCT04325698|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21284009|NCT00962091|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21284010|NCT00003910|ECOG Statistical Office|Study Statistician|617-632-3012||
21284011|NCT01768845|West Virginia Universtiy|Michael Craig, MD|304-293-4980|craigm@wvumedicine.org|
21284012|NCT02086682|Mayo Clinic|Dr. Marie Hogan|507-266 -1963|Hogan.Marie@mayo.edu|
21284013|NCT02044874|Arena Pharmaceuticals, Inc|Head of Document Operations|858-453-7200|ct.gov@arenapharm.com|
21284014|NCT02889835|UAB School of Dentistry|Nathaniel Lawson DMD PhD|205-975-8302|nlawson@uab.edu|
21284015|NCT05072964|FARAPULSE|Allison Anderson|651-582-5077|Allison.Anderson@bsci.com|
21284016|NCT02342548|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21284017|NCT02987972|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21284018|NCT01726036|TriHealth|Rachel G. Sinkey MD - PI|513-862-6918|pam_plummer@trihealth.com|
21284019|NCT01047332|Brigham and Women's Hospital|Dr. David L. Carr-Locke, MD, FRCP||dcarrlocke@chpnet.org|
21284020|NCT00291161|Houston HSRD Center of Excellence|Mark Kunik, MD, MPH|713-794-8639|kunik.marke@va.gov|
21284021|NCT04231396|BioSpeech|K. Lindaas, Principal Investigator|(503) 522-6276|kirstylindaas@biospeech.com|
21284022|NCT00787917|Novartis Pharmaceuticals|Study Director|862 778-8300||
21284023|NCT03521817|Pennington Biomedical Research Center|John W Apolzan|225-763-2827|john.apolzan@pbrc.edu|
21284024|NCT03153982|University of California, San Francisco|WIlliam Ryan, MD|(415) 502-1877|William.Ryan@ucsf.edu|
21284025|NCT05530980|University of South Carolina College of Nursing|Dr. Demetrius Abshire|803-576-6262|abshired@mailbox.sc.edu|
21284026|NCT02172040|Kitov Pharmaceuticals, Ltd.|J. Paul Waymack, M.D., Chief Medical Officer|(202) 965-2215|paul@kitovpharma.com|
21284027|NCT01463267|Kent State University|Joel Hughes|3306727721|jhughes1@kent.edu|
21252690|NCT00509249|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
21252691|NCT02224703|GW Research Ltd|Medical Enquiries|+44 01223 238170; +18778862810|medinfo@gwpharm.com; medinfo@greenwichbiosciences.com|
21252692|NCT00332462|Novartis Pharmaceuticals|Study Director|862-778-8300||
21252693|NCT01476449|Retina Vitreous Associates of Florida|David Eichenbaum, MD|727-323-0077|deichenbaum@retinavitreous.com|
21284028|NCT00778102|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21284029|NCT01328548|McMaster University|Dr. Mark Loeb|905 515 9140|loebm@mcmaster.ca|26679
21284030|NCT03200847|University of Colorado Hospital|Dr. Martin McCarter|13037242725|martin.mccarter@cuanschutz.edu|
21284031|NCT02824562|UAB|Jessica Merlin|2059967894|jmerlin@uabmc.edu|
21252694|NCT02922023|University of Florida Colleges of Pharmacy and Medicine|Katherine Vogel Anderson, Pharm.D., BCACP, FCCP|352-273-6240|kvanderson@cop.ufl.edu|
21252695|NCT02159040|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
21252696|NCT03151746|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.edu|
21252697|NCT01602510|GlaxoSmithKline|GSK Response Center|866-435-7343||
21252698|NCT01195623|Uppsala UH|Lena Blomgren MD PhD|+46851774173|lena.blomgren@karolinska.se|
21299061|NCT00607087|sanofi-aventis|Medical Affairs Study Director||publicregistryGMA@sanofi-aventis.com|
21299062|NCT06098937|Bausch & Lomb|Jeffery Schafer, OD, MS Director, Clinical Research|585-338-5664|jeffery.schafer@bausch.com|
21299063|NCT01774799|Hebrew SeniorLife|Dr. Susan Mitchell|617-971-5326|smitchell@hsl.harvard.edu|
21299064|NCT03649074|Akili Interactive|Clinical Operations and Research Manager|8572543399|dfarlow@akiliinteractive.com|
21299065|NCT04487106|The University of Texas MD Anderson Cancer Center|Nichols Short MD/Associate Professor|713-563-4485|NShort@mdanderson.org|
21299066|NCT04332107|University of California, San Francisco FI Proctor Foundation|Dr. Thomas Lietman, Director of the UCSF FI Proctor Foundation|415-476-1442|tom.lietman@ucsf.edu|
21299067|NCT00717249|Johnson & Johnson Vision Care Inc.|Brian Pall, O.D., M.S. Principal Research Optometrist|904-443-3500|BPALL@its.jnj.com|1290
21299068|NCT01670721|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21299069|NCT06172348|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21299070|NCT03799341|VA Pittsburgh Healthcare System|Sarah Forster, PhD|412-209-9208|sarah.forster2@va.gov|
21299071|NCT04037891|Akari|Wynne H Weston-Davies|+44(0)7801 281283|wynne.weston-davies@akaritx.com|
21299072|NCT03446313|University of California, San Francisco|Linda Park, Principle Investigator|415-502-6616|linda.park@ucsf.edu|
21299073|NCT03213834|University of Florida|Erin Silverman, Research Coordinator|352-273-5870|erin.silverman@medicine.ufl.edu|
21299074|NCT00543777|UT MD Anderson Cancer Center|Haesun Choi, MD/Professor, Abdominal Imaging Department|(713) 745-4693|hchoi@mdanderson.org|
21299075|NCT02360228|University of North Carolina at Chapel Hill|Dr. Flavio Frohlich|(919) 966-4584|flavio_frohlich@med.unc.edu|
21299076|NCT01137370|Department of Medicine and Lung Institute, Seoul National University College of Medicine|Jae-Joon Yim|+82-2-2072-2059|yimjj@snu.ac.kr|
21299077|NCT00350844|Ann and Robert H. Lurie Children's Hospital of Chicago|Dr. Robert I. Liem|312-227-4842|Rliem@luriechildrens.org|
21299078|NCT01232868|Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
21299079|NCT04481243|Mayo Clinic|Ana L. Creo, M.D.|507-284-3300|Creo.Ana@mayo.edu|
21299080|NCT04564846|Oramed, Ltd.|Chief Scientific Officer|+97225660001|miriam@oramed.com|
21299081|NCT00865345|Medtronic|Scott Lee M.D.|818-576-4204|scott.w.lee@medtronic.com|
21299082|NCT03737123|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
21237190|NCT01466985|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21237191|NCT03100617|UCaliforniaDavis|Dr. Ladson Hinton|9167343485|lwhinton@ucdavis.edu|
21252699|NCT02278484|Entellus Medical|Ellen O'Malley|763-463-1598|eomalley@entellusmedical.com|952
21252700|NCT00534495|Children's Hospital at Montefiore|Dr.Norman T.Ilowite|718-696-2602|NILOWITE@montefiore.org|
21284032|NCT03334422|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21284033|NCT01313221|Amgen Inc.|Study Director|866-572-6436||
21299083|NCT01519323|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21299084|NCT00445549|National Cancer Institute, National Institutes of Health|Elise C. Kohn, M.D.|301-496-4916|kohne@mail.nih.gov|
21299085|NCT04290039|BARDA|Brenda Wolling, Regulatory SME|(202) 692-4763|Brenda.Wolling@hhs.gov|
21299086|NCT03439280|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21299087|NCT01914003|QOL Medical, LLC|Heather Smith, Director of One Patient Services|919-832-4949|hsmith@onepatientservices.com|
21299088|NCT03629886|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21299090|NCT03683173|Washington University School of Medicine|Diana Parra Perez, Ph.D.|314-286-1426|parrad@wustl.edu|
21299091|NCT01535807|Inova Heart and Vascular Institute|Lisa Fornaresio, PhD|703-776-7071|lisa.fornaresio@inova.org|
21299092|NCT01378988|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com|
21299093|NCT01521026|UCSD|Elizabeth Twamley, PhD|6195436684|etwamley@ucsd.edu|
21252701|NCT02920970|CooperVision Inc.|Sr. Manager Global Medical Scientific Affairs|925-621-3761|javega@coopervision.com|
21284034|NCT00401401|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
21284035|NCT05459558|HALEON|Haleon Response Center|+447880182593|ww.clinical-trial-register@haleon.com|
21284036|NCT01887288|CTCA|Jessica L. Coats|6232073899|jessica.coats@ctca-hope.com|
21284037|NCT01092637|National Perinatal Epidemiology Unit, University of Oxford|Clinical Trials Unit|+44 1865 289700|ctu@npeu.ox.ac.uk|
21284038|NCT02921750|Mölnlycke Health Care|Maria Åberg Håkansson|+46 31722 3000|maria.aberghakansson@molnlycke.com|
21284039|NCT04703270|St George's, University of London|Dr Sarah Sturrock|020 8672 9944|ssturroc@sgul.ac.uk|
21284040|NCT03309696|University of Arkansas for Medical Sciences|Dr Mark Mennemeier|205 410 2413|msmennemeier@uams.edu|
21284041|NCT04643964|The Ohio State University|Dr. Daniel Strunk|6146884891|strunk.20@osu.edu|
21284042|NCT02638129|Orexigen Therapeutics, Inc.|Global Head of Development|858-875-8600|MedInfo@Orexigen.com|
21284043|NCT02949908|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21284044|NCT05070468|Alborz University of Medical Sciences|Dr. Masoumeh Farahani|09123783823|drfarahani73@yahoo.com|
21284045|NCT01048905|Emory University School of Medicine|Claudia R. Morris MD, FAAP|404-727-5500|claudia.r.morris@emory.edu|
21267121|NCT01004861|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
21284046|NCT02607280|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21252702|NCT01711853|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21252703|NCT04191616|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21252704|NCT04910139|Sound Health Systems|Paramesh Gopi|408-316-3631|pgopi@soundhealth.life|
21252705|NCT03285555|Cleveland Clinic|Viktor Krebs|216-444-2600|krebsv@ccf.org|
21252706|NCT00604708|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|1175
21252707|NCT02221557|Sunstar Americas, Inc.|Akane Takemura, R&D Senior Manager|847-794-4276|akane.takemura@us.sunstar.com|
21252708|NCT01277887|Yale University School of Medicine|Lisa Fucito, PhD|203 974-5759|lisa.fucito@yale.edu|
21252709|NCT00415051|US Army Medical Research Institute of infectious Diseases (USAMRIID)|COL Phillip R. Pittman, MD, MPH|301-619-4994|phillip.pitman@amedd.army.mil|
21252710|NCT04916730|University of California, San Diego|Michael J. Wilkinson, MD|(858)246-2510|mjwilkinson@health.ucsd.edu|
21252711|NCT02670122|Ramon y Cajal University Hospital. Vascular and Interventional Radiology Service|Jose Urbano Garcia, MD, PhD, EBIR, FCIRSE|+ 34 606 31 84 30|jurbano34@gmail.com ; jurbano@salud.madrid.org|
21252712|NCT02781649|Johns Hopkins University|Christine Durand, MD|410-955-5684|cdurand2@jhmi.edu|
21252713|NCT02762903|Columbia University|William N. Levine, MD|212-305-0998|wnl1@cumc.columbia.edu|
21252714|NCT00723749|RB Pharmaceuticals|Global Medical Director|+1 (804) 379 1090|Tim.Baxter@reckittbenckiser.com|
21252715|NCT00996606|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21252716|NCT00305344|University of Florida|Dr Michael Haller|352.273.9264|hallemj@peds.ufl.edu|
21252717|NCT05985538|University of North Carolina at Chapel Hill|Dr. Seth M. Noar|9192607269|noar@unc.edu|
21252718|NCT04363957|University of California, San Diego|Dr. Jyoti Mayadev|(858) 822-5354|CancerCTO@health.ucsd.edu|
21252719|NCT06534671|Vanderbilt University Medical Center|Prince J. Kannankeril, MD, MSCI|(615) 322-7447|prince.kannankeril@vumc.org|
21252720|NCT00281320|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21252721|NCT00921947|VaxInnate|Dr. David N.Taylor|609-860-2260|david.taylor@vaxinnate.com|
21252722|NCT00475228|University o Pittsburgh|Heather Hohmann, MD|412-641-1441|hhohmann@mail.magee.edu|
21252723|NCT00338988|University Texas MD Anderson Cancer Center|Melanie Thomas, MD/Assistant Professor|713-794-4869|mjlim@mdanderson.org|
21252724|NCT02209181|McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.|Joseph Aquilina, MD, Senior Director, Clinical Research|(215) 273-8025|JAquilin@its.jnj.com|
21252725|NCT02579772|Queen's University|Dr. J. Alberto Neder|613-548-2255|nederalb@gmail.com|
21284047|NCT02368210|Therapeutics, Inc.|Clinical Research Director|858-571-1800|projectmanager@therapeuticsinc.com|
21284048|NCT00577005|University of Massachusetts Medical School|Gerardo Gonzalez, MD|508 856 6480|gerardo.gonzalez@umassmed.edu|
21284049|NCT01004432|Janssen Scientific Affairs, LLC|Study Director|215-325-4209|rdehorat@its.jnj.com|
21284050|NCT00590538|The Children's Hospital of Philadelphia|Ronald Rubenstein, MD, PhD|1-215-590-1281|rubensteinr@email.chop.edu|
21284051|NCT02539134|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21284052|NCT04566133|National Cancer Institute|Dr. Tim F. Greten|2407606114|gretentf@mail.nih.gov|
21284053|NCT02604550|Emory University|John Xerogeanes, MD|404-778-7202|jxeroge@emory.edu|
21284054|NCT00908076|Baylor College of Medicine|Christine Hunter|713-798-6556|chunter@bcm.edu|
21284055|NCT02382796|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21284056|NCT02609724|UZ Leuven|Prof. Nele Devoogdt|0032 16 34 25 15|nele.devoogdt@uzleuven.be|
21284057|NCT04007107|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21284058|NCT04526574|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21284059|NCT04068688|Duke University|Lauren Franz MBChB, MPH|919-681-0023|lauren.franz@duke.edu|
21284060|NCT04679051|Texas Tech University|Joaquin U Gonzales|806 834 5944|joaquin.gonzales@ttu.edu|
21284061|NCT00006305|University of Pittsburgh|Dr. Maria Brooks|4126241618|brooks@edc.pitt.edu|
21284062|NCT00662558|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21284063|NCT00329641|SWOG Statistical Office|SWOG Melanoma Statistician|206-667-4408||
21284064|NCT01075399|Certus International, Inc.|Edward M. Aten, MD, President|603.627.1212|eaten@certusintl.com|
21284065|NCT00396877|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi-aventis.com|
21284066|NCT05765253|Argon Medical Devices|Danyel Carr|469-731-1421|Danyel.Carr@argonmedical.com|
21284067|NCT02348359|Brace Pharma Capital|Vice President, Clinical and Regulatory|240-403-7153|info@Tyrogenex.com|
21284068|NCT01881087|Fundación Valle del Lili|Dr. Fredy Ariza, MD., MSc., PhD(a).|+57 3319090|fredyariza@hotmail.com|4122
21297082|NCT03927404|University of Pittsburgh|Dr. Sashwati Roy|412-648-8297|sar453@pitt.edu|
21297083|NCT02641067|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21297084|NCT02851823|Izmir Katip Celebi University, Dentistry Faculty|Assoc.Prof.Dr. Mehmet Sağlam|+90 530 324 99 48|dtmehmetsaglam@gmail.com|
21297085|NCT01300260|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21297086|NCT02128074|Keryx Biopharmaceuticals, Inc|Keryx Medical Information|1-844-44-KERYX (844-445-3799)|medicalinfo@keryx.com|
21297087|NCT04033068|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21297088|NCT01069705|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21297089|NCT02607228|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21297090|NCT04407234|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21297091|NCT00727558|Vistakon|Kurt Moody OD, FAAO/ Director|904-443-3088|kmoody1@its.jnj.com|
21297092|NCT02280317|Valirx plc|Dr Suzanne Dilly|+44 2476796496|suzanne.dilly@valirx.com|
21299094|NCT01329263|University of Pennsylvania|Dr. Andrew Strasser|2157465788|strasse3@mail.med.upenn.edu|
21299095|NCT00934635|Janssen Cilag|Medical Development Manager; Medical and Scientific Affairs|0049-2137-955-1240||
21284069|NCT02631070|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21284070|NCT02669914|Washington University School of Medicine|Ramaswamy Govindan, M.D.|314-362-5737|rgovindan@wustl.edu|
21299096|NCT01702844|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
21299097|NCT02995980|University of Alabama at Birmingahm|Rachael Lancaster, MD|205-934-4080|mvetrano@uabmc.edu|
21299098|NCT03232346|NYS Psychiatric Institute|Dr. Adam Bisaga|646-774-6155|adam.bisaga@nyspi.columbia.edu|
21252726|NCT04072445|Mayo Clinic|Dr. Amit Mahipal|507-293-0487|Mahipal.Amit@mayo.edu|
21252727|NCT04641962|Astellas Pharma Global Development, Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
21252728|NCT02281500|Instituto Grifols S.A.|Jordi Navarro Puerto|+34 935712200|jordi.navarro@grifols.com|
21252729|NCT02171247|Duke University Medical Center|Daniel T Boll, MD|919-684-2711|daniel.boll@duke.edu|
21252730|NCT05239598|Penn Dental Medicine|Dr. Pat Corby|215-898-1162|patcorby@upenn.edu|
21252731|NCT02222870|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21252732|NCT04535544|Janssen Research & Development, LLC|Senior Director Medical Lead|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21252733|NCT03429166|VA HSR&D|Amanda Borsky, PhD|2024435739|amanda.borsky@va.gov|
21252734|NCT02354820|Indiana University School of Medicine|William E. Bennett, Jr. Principal Investigator|3172786928|webjr@iu.edu|
21252735|NCT03312023|Institute of Human Virology, University of Maryland Baltimore|Dr. Joel V. Chua|1-410-706-5704|jchua@ihv.umaryland.edu|
21252736|NCT02706405|Fred Hutchinson Cancer Center|Dr. Jordan Gauthier|2066672713|jgauthier@fredhutch.org|
21252737|NCT01182441|Boston Scientific|WATCHMAN Trial Manager|1-800-227-3422||
21252738|NCT02304705|University of Kentucky|Dr. Maya Guglin|859-323-4738|maya.guglin@uky.edu|
21252739|NCT03140280|Medical College of Wisconsin|Ehab Atallah, MD|414-805-4600|eatallah@mcw.edu|
21252740|NCT02981108|Jiangsu Hansoh Pharmaceutical Group Co., Ltd.|Alison Li|86-21-51211850|Alison.li@hspharm.com|
21252741|NCT00663702|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
21252742|NCT03056300|Ethicon|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
21252743|NCT03733990|Faron Pharmaceuticals Ltd|Chief Medical Officer|+35824695151|info@faron.com|
21252744|NCT04079868|Durham VA Geriatric Research Education and Clinical Center|Dr. Cathleen Colon-Emeric|9192860411|cathleen.colon-emeric@va.gov|6932
21252745|NCT05262517|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21252746|NCT05620108|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|renew.j@mayo.edu|
21252747|NCT05602727|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21252748|NCT00465998|Stavanger University Hospital|Professor Torbjørn Moe Eggebø|+4792699433|tme@lyse.net|
21252749|NCT02038842|Service d'immunologie clinique - Hôpital Henri Mondor|Pr. Jean-Daniel Lelièvre|+33 1 49 81 24 55|jean-daniel.lelievre@hmn.aphp.fr|
21252750|NCT05241314|University of Minnesota|Sarah Hoffman|612-625-0606|hoff0742@umn.edu|
21252751|NCT04414202|INSTITUT REGIONAL DU CANCER DE MONTPELLIER Cancer de Montpellier|Mme Aurore Moussion, Director of Direction of Clinical Research and Innovation|0467613102|drci-icm105@icm.unicancer.fr|+33
21252752|NCT01656252|ECOG-ACRIN Biostatistics Center|PrECOG Statistician|617-632-3633|jmanola@jimmy.harvard.edu|
21252753|NCT00626197|F. Hoffmann-La Roche Ltd/Genentech Inc.|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21252754|NCT05332912|University of Alabama, Tuscaloosa|Professor Emeritus|2052002183|emerrill@ua.edu|
21252755|NCT00929253|Virginia Tech|Dr. Warren K. Bickel|540-526-2015|wkbickel@vt.edu|
21252756|NCT02769442|University of Maryland School of Medicine, Department of Emergency Medicine|Siamak Moayedi Md|4103288025|smoayedi@em.umaryland.edu|
21252757|NCT00384189|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21252758|NCT04517669|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
21252759|NCT03338296|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
21252760|NCT05048238|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21284071|NCT04742309|University of California San Diego|Brian Ilfeld, MD, MS|(858) 822-0776|bilfeld@health.ucsd.edu|
21299099|NCT02920892|Rush University Medical Center|Elizabeth Berry-Kravis, MD PhD|312-942-4036|Elizabeth_Berry-Kravis@rush.edu|
21299100|NCT01092728|The University of Texas (UT) MD Anderson Cancer Center|Kevin Kim, MD/Melanoma Medical Oncology|1-877-MDA-6789|CR_Study_Registration@mdanderson.org|
21299101|NCT02336607|Astrazeneca|BP of Astrazeneca|+86 21 60302288|aztrial_results_posting@astrazeneca.com|
21299102|NCT01721161|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21299103|NCT02851303|Brown Family Medicine|Dr. Mary Beth Sutter|401-921-7981|marybeth_sutter@brown.edu|
21299104|NCT01454596|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|sar@nci.nih.gov|
21252761|NCT00186017|Stanford University School of Medicine|Dr. Terence A. Ketter, MD.|6507232507|tketter@stanford.edu|
21284072|NCT00980018|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21284073|NCT01118988|Pediatric Pain and Palliative Care Program; University of California, Los Angeles|Dr. Lonnie K. Zeltzer, MD|310-825-0731|LZeltzer@mednet.ucla.edu|
21284074|NCT00551161|North Shore-LIJ Health System|Marc L. Gordon,MD|516-562-3492|MLGordon@nshs.edu|
21284075|NCT00934856|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
21284076|NCT01256385|University of Chicago|Dr. Tanguy Seiwert|(773) 702-2452|tseiwert@medicine.bsd.uchicago.edu|
21284077|NCT00336323|Jaeb Center for Health Research, Diabetic Retinopathy Clinical Research Network|Name/Official Title: Adam Glassman, M.S., Director|(813) 975-8690|drcrnet@jaeb.org|
21284078|NCT01666210|Ocular Therapeutix, Inc.|Eric Ankerud|781-357-4013|eankerud@ocutx.com|
21284079|NCT02326298|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21252762|NCT04481373|Baylor College of Medicine|Thomas Giordano|7137988918|tpg@bcm.edu|
21252763|NCT02057575|Aerie Pharmaceuticals, Inc|Theresa GH Heah, MD, MBA|908-947-3844|theah@aeriepharma.com|
21252764|NCT01254552|Guerbet|Corinne Dubourdieu, Head of Clinical Projects and Medical Writing|+33(0)1 45 91 50 00|corinne.dubourdieu@guerbet.com|
21252765|NCT02979249|Icahn School of Medicine at Mount Sinai|Dr. Hetanshi Naik|212-659-8512|hetanshi.naik@mssm.edu|
21252766|NCT01125046|Northwestern University|Priya Kumthekar, MD||Priya.Kumthekar@nm.org|
21252767|NCT01012362|Masonic Cancer Center, University of Minnesota|Dr. Arkadiusz Dudek|651-254-3321|Arkadiusz.Z.Dudek@HealthPartners.com|
21252768|NCT01146600|Emory University School of Medicine|Lynn Marie Trotti, MD, MSc|404-728-4752|lbecke2@emory.edu|
21252769|NCT04076787|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21252770|NCT02766777|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
21252771|NCT01886287|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-7257|jonathan.strosberg@moffitt.org|
21252772|NCT03842228|The University of Texas MD Anderson Cancer Center|Dr. Timothy Yap|(713) 839-5458|tyap@mdanderson.org|
21252773|NCT01346072|University of North Carolina Chapel Hill|Kirkwood F. Adams, Jr., MD|919-966-2877|kfa@med.unc.edu|
21252774|NCT01361594|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
21252775|NCT03697551|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
21252776|NCT03651700|Clinical Research Coordinator|Daniela Sacchetti, MS|215-573-4336|danielas@pennmedicine.upenn.edu|
21252777|NCT03874754|Johns Hopkins School of Nursing|Nada Lukkahatai|2407509867|nada.lukkahatai@jhu.edu|
21252778|NCT01262547|Massachusetts General Hospital|Dr. Alexandra Kimball|617-726-5066|harvardskinstudies@partners.org|
21252779|NCT01889069|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21252780|NCT03168542|Johnson & Johnson Vision Care, Inc.|Tom Karkkainen, OD MS, FAAO - Sr. Principal Research Optometrist|904 443-3402|TKarkkai@its.jnj.com|
21252781|NCT01426347|Johns Hopkins University|Uzma Jalal Haque|410-550-0578|uhaque@jhmi.edu|
21252782|NCT00455741|Massachusetts General Hospital|Dr. Janet E. Hall|617-877-1112|hall.janet@mgh.harvard.edu|
21252783|NCT01715207|SamsungMC|Prof Duk-Kyung Kim|01099333413|dukkyung.kim@samsung.com|
21252784|NCT03041792|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21252785|NCT04978090|University of Kentucky|Dr. Andrew Bernard|859-257-3253|andrew.bernard@uky.edu|
21252786|NCT03745898|Brigham and Women's Hospital|Dr. Susan Redline|(617) 732-5500|sredline@bwh.harvard.edu|
21252787|NCT04263987|Vanderbilt University Medical Center|Nicholas kavoussi|615-322-7401|nicholas.l.kavoussi@vumc.org|
21252788|NCT02227992|Ethicon, Inc.|Senior Franchise Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21252789|NCT00561145|Wageningen University|Dr Lisette de Groot|+31-317482220|lisette.degroot@wur.nl|
21252790|NCT01509547|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
21252791|NCT00935532|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21252792|NCT01691950|Imperial College London|Mr Richard M Kwasnicki PhD MRCS|+44 (0) 20 759 48904|rmk107@ic.ac.uk|
21252793|NCT01371708|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021||
21252794|NCT02514551|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21252795|NCT02142153|F2G|Dr Anthony Kennedy|0044 161 785 1273|TKennedy@f2g.com|
21252796|NCT01399918|Memorial Sloan Kettering Cancer Center|Dr. Darren Feldman|646-888-4740|Feldmand@MSKCC.ORG|
21252797|NCT03197766|BioMarin Pharmaceutical Inc.|Alice Huntsman Labed|+44 207 4203392|alice.huntsmanlabed@bmrn.com|
21252798|NCT01791972|Director, Clinical Research|Teva Branded Pharmaceutical Products, R&D Inc.|1-215-591-3000|ustevatrials@tevapharm.com|
21252799|NCT00632502|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21252800|NCT00570908|Baylor Coolege of Medicine|Dr. Mothaffar Rimawi|7137981811|rimawi@bcm.edu|
21252801|NCT01213524|Brown University|Jennifer Tidey, Ph.D.|401-863-6418|Jennifer_Tidey@brown.edu|
21252802|NCT00630734|University of Colorado Denver|Christina Aquilante, Pharm.D.|303-724-6126|christina.aquilante@ucdenver.edu|
21252803|NCT06411613|VA Puget Sound Health Care System|Dawn Bates|206-277-3012|dawn.bates@va.gov|
21252804|NCT02519348|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21252805|NCT01110408|Janssen R&D US|Therapeutic Areas Director||ClinicalTrialDisclosure@its.jnj.com|
21252806|NCT00669877|The University of Texas (UT) MD Anderson Cancer Center|Naval Daver, Assistant Professor, Leukemia|1-877-632-6789|CR_Study_Registration@mdanderson.org|
21252807|NCT04103892|Clexio Biosciences Ltd|Regulatory Affairs Lead|972-733318704|myriam.belahcen@clexio.com|
21252808|NCT03008005|Wayne State University|Dr. Christine Rabinak, Principal Investigator|(313) 577-9875|rabinak@wayne.edu|
21252809|NCT00975676|International Breast Cancer Study Group (IBCSG)|Head Trial Activities and Deputy Director Dr. Heidi Roschitzki-Voser Organization|+41 31 511 94 00|heidi.roschitzki@ibcsg.org|
21252810|NCT02548078|GlaxoSmithKline|GSK Response Center|866-435-7343|aal77632@gsk.com|
21252811|NCT00862836|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21252812|NCT05855967|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21284080|NCT01834716|Mayo Clinic|Neill Graff-Radford|9049537103|graffradford.neill@mayo.edu|
21284081|NCT00073983|SARC|SARC Chief Operating Officer|734-930-7600|sarc@sarctrials.org|
21284082|NCT04010747|Boston Medical Center & BU Chobanian & Avedisian School of Medicine|Emily R Kline, PhD|401-206-0586|emily.kline@bmc.org|
21284083|NCT03976323|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21252813|NCT04147195|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21252814|NCT03554629|Clinical Research Program Manager|Kathleen H. Niebel RN BSN BSME|978-549-9325|kathleen.h.niebel@gmail.com|
21252815|NCT05817383|Hebrew Rehabilitation Center|Dr. Courtney Millar|6179715531|courtneymillar@hsl.harvard.edu|
21252816|NCT01195948|National Institutes of Health|Robert Nussenblatt, MD, MPH|301-496-3123|robert.nussenblatt@nih.gov|
21252817|NCT05577715|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21252818|NCT04339959|University of New Mexico|Dr. Cindy Blair|15059257907|CiBlair@salud.unm.edu|
21252819|NCT05282121|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21252820|NCT00561431|University of Alabama at Birmingham|Ashita Tolwani, M.D.|2059752021|atolwani@uab.edu|
21252821|NCT03301155|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
21252822|NCT00448201|UNC Lineberger Comprehensive Cancer Center|Dr. Thomas Shea|919-966-7746|tom_shea@med.unc.edu|
21284084|NCT03800836|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21284085|NCT05670314|University of Nottingham|Dr Afroditi Kouraki|0115 8231676|afroditi.kouraki1@nottingham.ac.uk|+44
21252823|NCT03510455|National Institute of Dental and Craniofacial Research|Rachel I. Gafni|301-594-9924|gafnir@mail.nih.gov|
21252824|NCT02190903|University of Pennsylvania School of Medicine|Mark D Neuman|2157467468|neumanm@mail.med.upenn.edu|
21252825|NCT04958642|Mandos, LLC|Executive Vice President, Regulatory Affairs|619-905-0489|jspinella@mandoshealth.com|
21252826|NCT02942004|Sage Therapeutics|Medical Monitor|617-299-8380|info@sagerx.com|
21252827|NCT05627258|Vaccine Research Center Clinical Trials Program, NIAID|Lesia K. Dropulic, M.D./Principal Investigator; Laura Novik, R.N., M.A./Study Coordinator|301-451-8717|lesia.dropulic@nih.gov; laura.novik@nih.gov|
21252828|NCT01541384|University of Pennsylvania|Dr. Peter Reese|215-898-6086|peter.reese@uphs.upenn.edu|
21252829|NCT01923662|VAORD|Ronald J Triolo|216-791-3800|Ronald.Triolo@va.gov|64138
21252830|NCT01199068|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21252831|NCT01250925|Massachusetts Eye and Ear Infirmary|Dr. Pedram Hamrah|617-573-3313|cornea_research@meei.harvard.edu|
21252832|NCT00678301|GlaxoSmithKline|GSK Response Center|866-435-7343||
21252833|NCT01939353|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21252834|NCT03573947|Duke Cancer Institute|Dr. Jeffrey Clarke|9196819509|jeffrey.clarke@duke.edu|
21252835|NCT00335140|Johns Hopkins Cancer Center|Lode Swinnen, MD|(410) 955-8603|lswinne1@jhmi.edu|
21252836|NCT03296800|Theracos Sub, LLC|Albert Collinson|(508) 688-4221|acollinson@theracos.com|
21252837|NCT03882177|Johns Hopkins University School of Medicine|Petros C. Karakousis, MD|410-502-8233|petros@jhmi.edu|
21252838|NCT01685229|Acclarent Inc.|Clinical Manager|949-453-6408|PChen126@ITS.JNJ.com|
21252839|NCT00558844|Insmed Incorporated|Kevin Mange (Senior VP, Clinical Development and Medical Affairs)|908-947-2651|kevin.mange@insmed.com|
21252840|NCT03596762|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
21252841|NCT03085225|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
21252842|NCT01193010|Massachusetts General Hospital|Rachel Gottlieb, Clinical Research Coordinator|617.724.4985|rgottlieb3@mgh.harvard.edu|
21252843|NCT01371825|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
21252844|NCT00895895|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21252845|NCT03019640|Yago Nieto, PhD / Stem Cell Transplantation Department|UT MD Anderson Cancer Center|713-792-8750|ynieto@mdanderson.org|
21252846|NCT00504777|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21252847|NCT01572740|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21252848|NCT00441259|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21252849|NCT00478192|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
21252850|NCT01818531|Wake Forest University Health Sciences|Dr. Daryl Henshaw|3367166344|dhenshaw@wakehealth.edu|
21252851|NCT00214019|UW Madison|Gina Crisafi|6082654554|gmc@medicine.wisc.edu|
21252852|NCT00137969|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21252853|NCT00477490|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21252854|NCT01465763|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21252855|NCT01646177|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21252856|NCT00668265|Beth Israel Medical Center|Igor Galynker, MD|212 420 4535|igalynke@chpnet.org|
21252857|NCT00820170|Memorial Sloan Kettering Cancer Center|Dr. Monica Fornier|646-888-4563|fornierm@mskcc.org|
21252858|NCT03995316|Oregon Research Behavior Intervention Strategies, Inc. dba Influents Innovations|David Smith|541-484-2123|david.smith@influetnsin.com|
21252859|NCT05479734|University of Oklahoma Health Sciences|David Bard, Director of EmBRACER Center|4052718001|David-Bard@ouhsc.edu|
21252860|NCT02138097|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21252861|NCT00664534|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21284086|NCT01709864|Novartis Pharmaceuticals|Study Director|862-778-8300||
21284087|NCT01066793|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21284088|NCT01520519|The University of Texas MD Anderson Cancer Center|Jan Burger MD./Professor|713-563-1487|jaburger@mdanderson.org|
21284089|NCT00994214|Ipsen|Medical Director, Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21284090|NCT03246061|Relievant Medsystems|Chris Hilker, Sr. Director Clinical Affairs|(650) 368-1000|chilker@relievant.com|
21284091|NCT02864316|Sidney Kimmel Comprehensive Cancer Center|Patrick Forde, MBBCh|410-955-3974|pforde1@jhmi.edu|
21284092|NCT04710368|Mount Sinai Hospital|Annapoorna S Kini, M.D.|(212) 241-4181|annapoorna.kini@mountsinai.org|
21237192|NCT00955357|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
21237193|NCT02481310|Northwestern University|Barbara Pro, MD|312-695-6832|barbara.pro@northwestern.edu|
21252862|NCT00600613|Memorial Sloan Kettering Cancer Center|Dr. Yoshiya Yamada|212-639-2950|yamadaj@mskcc.org|
21252863|NCT02623998|McMaster University|Dr. Natalia McInnes|19055212100|natalia.mcinnes@mcmaster.ca|73794
21252864|NCT00167206|Masonic Cancer Center, University of Minnesota|Margaret MacMillan, M.D.|612-626-2778|macmi002@umn.edu|
21252865|NCT01436253|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21252866|NCT01495598|National Cancer Institute|Dr. Robert Yarchoan|240-760-6075|robert.yarchoan@nih.gov|
21252867|NCT04844879|Medacta International SA|Medical Affairs Department|+41 91 696 60 60|myclinicaldata@medacta.ch|
21252868|NCT05576662|Stanford University|Linda N. Geng, MD, PhD|650-723-4000|geng@stanford.edu|
21252869|NCT01647945|Stanford University|Dr. Edda Spiekerkoetter|650-724-1493|eddas@stanford.edu|
21252870|NCT05217641|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
21252871|NCT05292586|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
21252872|NCT02755129|Medtronic|Ilaria Marcotullio|+39 06 32814218|ilaria.marcotullio@medtronic.com|
21252873|NCT01744704|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
21252874|NCT01040169|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
21252875|NCT00350727|GlaxoSmithKline|GSK Response Center|866-435-7343||
21252876|NCT03564353|UT Dallas|Clinical Trial Manager|972-883-7277|Sarah.McLeod@utdallas.edu|
21252877|NCT02645123|University of Ioannina School of Medicine|Dr. Georgios Krekoukias|00306934609400|gkrekos@gmail.com|
21252878|NCT03633799|Sebela Women's Health|Elizabeth Gray, Manager, Clinical Operations|760-593-8383|Elizabeth.gray@sebelapharma.com|
21252879|NCT07025837|Citruslabs|Patrick Renner|4242450285|hello@citruslabs.com|
21252880|NCT01435772|BioMarin Pharmaceutical Inc.|Debra Lounsbury, Principal Scientist, Clinical Sciences|415-506-6348|DLounsbury@bmrn.com|
21252881|NCT03238963|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21252882|NCT05823012|Xeris Pharmaceuticals, Inc.|Valentina Conoscenti, MD|1-877-XERIS-37|Clinicaltrials@xerispharma.com|
21252883|NCT01424813|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21252884|NCT05899413|University of California, San Francisco|Dr. Yoobin Park|6289461325|yoobin.park@ucsf.edu|
21252885|NCT01555489|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Daniel Monti|215 955-2221|daniel.monti@jefferson.edu|
21252886|NCT07149155|Dell Medical School, The University of Texas at Austin|Project Coordinator|NA|SFA@austin.utexas.edu|
21252887|NCT06149104|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
21252888|NCT00918879|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21252889|NCT04707664|Partner Therapeutics, Inc.|Medical Information|1-888-479-5385|PartnerTx@medcomminc.com|
21252890|NCT00357110|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21252891|NCT03789175|NHLBI, NIH|Dr. Paul Hwang|3014353068|hwangp@mail.nih.gov|
21252892|NCT00225017|Northwestern University|Robert Murphy|312-503-9000|r-murphy@northwestern.edu|
21252893|NCT01977677|Stanford University School of Medicine|Lawrence Recht, MD, Professor of Neurology|650-725-8630|lrecht@stanford.edu|
21252894|NCT01498887|Novartis Pharmaceuticals|Study Director|862-778-8300||
21252895|NCT04335591|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
21252896|NCT05530577|University of Southern California|Christian Hendershot, PhD|323-442-1082|christian.hendershot@usc.edu|
21252897|NCT05467293|Yuyu Pharma, Inc.|Robert Wonsang Yu|+82 2 6972 9062|wsyu@yuyu.co.kr|
21252898|NCT06264128|SleepRes|Bernie Hete|+1 615-921-2406|bhete@sleepres.com|
21252899|NCT01077128|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21252900|NCT01706705|UT MD Anderson Cancer Center|Dr. Ann Klopp / Associate Professor, Radiation Oncology|713-563-6930|aklopp@mdanderson.org|
21252901|NCT02863289|NHS Tayside|Mr Benedict Clift|01382 660111|ben.clift@nhs.net|35160
21252902|NCT00458952|Progenics Pharmaceuticals, Inc.|Senior Director, Clinical Science Communications|914 784-1825|vdipippo@progenics.com|
21252903|NCT02476175|CHU de Quebec-Universite Laval|Dr Stephane Bolduc||Stephane.Bolduc@fmed.ulaval.ca|
21252904|NCT03237377|Johns Hopkins SKCCC CRO Coordinating Center|Jasmine Brooks, Senior Research Program Coordinator|667-306-8335|jbrook54@jhmi.edu|
21252905|NCT04421950|University of Arkansas for Medical Sciences and Arkansas Children's Nutrition Ce|Eva C. Diaz, Principal Investigator|5013643056|ecdiazfuentes@uams.edu|
21252906|NCT01252355|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21252907|NCT03289351|Phoenix Children's|Dr. Justin Lee|6029330016|jlee8@phoenixchildrens.com|
21252908|NCT02175641|Washington Universtiy in St. Louis|Leopoldo J. Cabassa, Associate Professor|314-935-2829|ljcabassa@wustl.edu|
21252909|NCT04546425|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21252910|NCT02579135|North Carolina State University|Dr. Laura Widman|919-513-2546|lmwidman@ncsu.edu|
21252911|NCT02964325|Terumo Blood and Cell Technologies|Robert Cortes, Jr. MD|+1.303.231.4353|Robert.Cortes@terumobct.com|
21252912|NCT03079284|Maine Medical Center|Dr. Alexa Craig|207-396-7337|craiga@mmc.org|
21252913|NCT02195479|Janssen Research and Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21252914|NCT01263509|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
21252915|NCT00967005|Yale University|Dr. Marc N. Potenza, M.D., Ph.D.|203-737-3553|marc.potenza@yale.edu|
21252916|NCT02593123|Virginia Commonwealth University Massey Cancer Center|Dr. Amir Toor, Principal Investigator|804 828 5116|amir.toor@vcuhealth.org|
21252917|NCT05071053|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
21252918|NCT03993210|DFCI|Clare Tempany|617-732-7858|ctempany@bwh.harvard.edu|
21252919|NCT01445327|National Cancer Institute|Dr. Deborah E. Citrin|301-496-5457|citrind@mail.nih.gov|
21252920|NCT03514277|Reconstructive Orthopedics|Robert Greenleaf|609-267-9400|bob.greenleaf1@gmail.com|
21299105|NCT01775774|University of California San Francisco|Michael A. Matthay, MD|415-353-1206|michael.matthay@ucsf.edu|
21299106|NCT00271375|Atlanta VAMC|Patricia Griffiths|404-321-6111|Patricia.Griffiths@va.gov|7138
21299107|NCT00614380|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21299108|NCT02314936|KGK Synergize Inc.|Dr. Tetyana Pelipyagina|5194389374|drtetyana@kgksynergize.com|
21299109|NCT01506271|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21299110|NCT03476135|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21299111|NCT00973752|Massachusetts General Hospital|Dr. Amir Fathi|617-724-1124|afathi@partners.org|
21299112|NCT00104650|Amgen Inc.|Study Director|866-572-6436||
21299113|NCT01391663|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21252921|NCT04868539|Brigham and Women's Hospital|Dr. Charles Czeisler, Ph.D., M.D.|617-732-4013|cacadmin@partners.org|
21299114|NCT01894607|University of Texas (UT) MD Anderson Cancer Center|Ott Le, MD/Associate Professor, Diagnostic Radiation Body Imaging||CR_Study_Registration@mdanderson.org|
21299115|NCT04388254|Cassava Sciences|Sr. Associate Director|5125013180|bmurray@cassavasciences.com|
21299116|NCT02870283|Universidade Federal do Rio Grande do Sul|Dra. Ana Flávia Silva Lima|+5551999185180|afbslima@gmail.com|
21299117|NCT02401347|Stanford Medicine at Stanford University|Melinda L Telli, MD|(650) 724-9533|mtelli@stanford.edu|
21299118|NCT01685567|Silk Road Medical, Inc.|Linda Ruedy. Sr. Director, Clinical and Regulatory Affairs|(408) 585-2113|lruedy@silkroadmed.com|
21299119|NCT02586623|H. Lundbeck A/S|Email contact via|+45 36301311|LundbeckClinicalTrials@lundbeck.com|
21299120|NCT02910466|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21299121|NCT04037865|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21299122|NCT00965250|National Cancer Institute, National Institutes of Health|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov|
21299123|NCT02537717|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
21299124|NCT05051579|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21299125|NCT02221869|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-970-7145|ClinicalTrialDisclosure@JazzPharma.com|
21299126|NCT00066677|Fox Chase Cancer Center|Steven J. Cohen|215-728-2450|s_cohen@fccc.edu|
21299127|NCT00271102|Geisinger|Office of Research Compliance|570-214-9628|orc@geisinger.edu|
21299128|NCT01116648|Dana-Farber Cancer Institute|Dr. Joyce Liu|617-632-5269|joyce_liu@dfci.harvard.edu|
21299129|NCT04539938|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21299130|NCT02511379|Alcon, A Novartis Division|Study Director Med Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
21299131|NCT01857297|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
21299132|NCT03492125|MingSight Pharmaceuticals|Kai Zhang|8582055958|kzhang@mingsight.com|
21299133|NCT01420926|Weill Medical College of Cornell University|Gail Roboz, M.D||gar2001@med.cornell.edu|
21299134|NCT01572207|Case Western Reserve University|Matthew Plow|216-368-8969|map208@case.edu|
21299135|NCT01459588|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21299136|NCT03858049|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21299137|NCT02079740|Massachusetts General Hospital|Ryan Corcoran, MD PhD|617-724-4000|rbcorcoran@mgb.org|
21299138|NCT04617782|Corium, Inc.|Ronald Tashjian, Sr. Director of Clinical Operations|6172337474|rtashjian@coriumintl.com|
21299139|NCT01650298|ABBOTT|Grant Kim|818-493-3147|gkim@sjm.com|
21299140|NCT02849418|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21299141|NCT01405768|Washington University School of Medicine|L. Stewart Massad, M.D.|314-362-3181|massadl@wudosis.wustl.edu|
21299142|NCT03692208|The University of Chicago|Dr. Elbert Huang|(773) 834-9143|ehuang@medicine.bsd.uchicago.edu|
21299143|NCT02682381|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21299144|NCT05482308|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21299145|NCT03016312|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21299146|NCT01366872|Orthopaedic Associates of Michigan, PC|Dr. John G. Anderson|616-459-7101|John.Anderson@oamichigan.com|797
21299147|NCT01631435|Given Imaging- Covidien|Ravit Peled , Clinical trials manager|+972 (4) 909-7894|Ravit.peled@covidien.com|7894
21299148|NCT01421017|NYU Langone Health|Sylvia Adams|212-731-5795|sylvia.adams@nyumc.org|
21299149|NCT02313766|CaenUH|Pr Jean-Luc Hanouz|33 2 31 06 47 36|hanouz-jl@chu-caen.fr|
21299150|NCT04233008|Brigham and Women's Hospital|Sarah Little|617-732-5452|selittle@bwh.harvard.edu|
21299151|NCT00416624|Mayo Clinic|Charles L. Loprinzi, M.D.|507-266-6247|loprinzi.charles@mayo.edu|
21299152|NCT01005251|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
21299153|NCT02193776|TB Alliance|Almari Conradie, Director, Clinical Operations|+27 12 991 6328|almari.conradie@tballiance.org|
21299154|NCT02754570|University of Colorado|Rachel Gerle|720-848-5096|rachel.gerle@ucdenver.edu|
21299155|NCT01755234|Northwestern University|Gildasio De Oliveira|312-695-4858|g-jr@northwestern.edu|
21299156|NCT03812380|UT Southwestern Medical Center|Khashayar Sakhaee, MD|214-648-0324|Khashayar.Sakhaee@UTSouthwestern.edu|
21299157|NCT00558246|Ethicon|Phyllis Britnell|1 908 218-3060|pbritnel@its.jnj.com|
21299158|NCT00303823|The University of Arizona|H-H. Sherry Chow, Ph.D.|520-626-3358|schow@azcc.arizona.edu|
21299159|NCT00981149|ECU SODM|Sharon Gordon, DDS|2527377125|gordons@ecu.edu|
21299160|NCT01220167|Par Pharmaceutical|Medical Affairs|800-828-9393|DrugInfo@strativapharma.com|
21237194|NCT04953390|Sonova USCS|Principal Investigator|630-821-5000|phonakaudiologyresearch@gmail.com|
21299161|NCT00622505|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21252922|NCT01401153|Research Institute of Child Nutrition|Prof. Dr. Mathilde Kersting|+49-231-792210-18|kersting@fke-do.de|
21252923|NCT05486728|Sunhawk Vision Biotech|President|+886-7-2222660|hjuo@shvbiotech.com|
21252924|NCT02204657|University Malaya Medical Centre|Dr Sharmila SP|60379492299|sharmsp13@gmail.com|
21252925|NCT01038427|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21252926|NCT02180243|War Related Illness and Injury Study Center|Matthew Reinhard, PsyD|202-745-8000|matthew.reinhard@va.gov|55785
21252927|NCT01137578|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21252928|NCT01461005|MCRA|Justin Eggleton, Senior Director, Spine Regulatory Affairs|2025525804|jeggleston@mcra.com|
21252929|NCT04954326|Institut de Recherches Internationales Servier|Therapeutic Area in Oncology|+33155724366|clinicaltrials@servier.com|
21252930|NCT01460225|Dartmouth-Hitchcock Medical Center|Dr. Brian Lacy|603-650-5215|brian.e.lacy@hitchcock.org|
21252931|NCT03083665|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21252932|NCT03635099|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21252933|NCT01289210|VentiRx Pharmaceuticals Inc.|Kristi Manjarrez, Vice President, Clinical Affairs|206-689-2259|kmanjarrez@ventirx.com|
21252934|NCT06285240|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21252935|NCT05380362|UBNS|Dr. Ellen Carl|716-218-1000|ecarl@ubns.com|7260
21252936|NCT05140915|University of Massachusetts Chan Medical School|Dr. Rajani Sadasivam|(508) 856-8923|rajani.sadasivam@umassmed.edu|
21252937|NCT04520659|Johns Hopkins University Bloomberg School of Public Health|Suzanne Woods, CRNP-P, CCRP, Manager, RSVPeds Team|(443) 813-0697|swoods12@jhu.edu|
21252938|NCT04430439|University of California, Irvine|Karen Lindsay|949-824-0148|kllindsa@hs.uci.edu|
21252939|NCT04485611|Durham VA Health Care System|Dr. Atilio Barbeito, Chief, Anesthesiology Service|(919) 286-6938|atilio.barbeito@va.gov|177150
21252940|NCT04879849|Takeda|Medical Director|+1-877-825-3327|Trialdisclosures@takeda.com|
21252941|NCT03361865|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
21252942|NCT03603002|Johns Hopkins University, Department of Radiation Oncology|Dr. K. Ranh Voong|410-550-6597|kvoong1@jhmi.edu|
21252943|NCT02819024|Barbara Ann Karmanos Cancer Institute|Anthony F. Shields, MD, PhD|3135768735|shieldsa@karmanos.org|
21252944|NCT05371665|Montana State University|Brandon Scott|(406) 994-5218|brandon.scott2@montana.edu|
21252945|NCT00777764|Genentech, Inc.|Medical Communications|800-821-8590||
21252946|NCT03551691|Children's Hospital of Philadelphia|Dr. Virginia Stallings|267-425-1633|stallingsv@chop.edu|
21252947|NCT02367040|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21252948|NCT02477618|Sage Therapeutics|Helen Colquhoun, MD - Vice President, Medical Science|(617) 229-5234|Helen@sagerx.com|
21252949|NCT02446821|Sebela Women's Health Inc.|Elizabeth Gray, Manager, Clinical Operations|760-593-8383|elizabeth.gray@sebelapharma.com|
21252950|NCT03007420|Boston Children's Hospital|Pradeep Dinakar, MD|857-218-3556|Pradeep.Dinakar@childrens.harvard.edu|
21252951|NCT01655251|Connecticut Children's Medical Center|Dr. Sharon R. Smith|860-545-9000|srsmith@connecticutchildrens.org|
21252952|NCT02638883|Cochlear Limited|PRS Specialist, Clinical Affairs|+612 9428 6555|cltd-prs-admin@cochlear.com|
21252953|NCT02284009|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21252954|NCT03841526|Xeris Pharmaceuticals|Dawn Harper, VP Clinical Devlopment|1-877-XERIS-37|clinicaltrials@xerispharma.com|
21252955|NCT04193826|Conformal Medical, Inc|Aly Dechert / Manager of Clinical Operations|(603) 718-8742|adechert@conformalmedical.com|
21252956|NCT01876082|Department of Medical Oncology, Institut bergonié|Pr Antoine Italiano, coordinating investigator|05.47.30.60.88|a.italiano@bordeaux.unicancer.fr|
21252957|NCT04854850|University of Pittsburgh|Robyn T. Domsic|412-383-8000|rtd4@pitt.edu|
21252958|NCT04092530|University of Illinois at Chicago|Kristin Rankin|708-710-8411|krankin@uic.edu|
21252959|NCT04683627|Noven Pharmaceutical|Robert Kirshoff|5512332668|clinicaltrials@noven.com|
21252960|NCT03829501|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21252961|NCT02964013|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21252962|NCT01123070|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8270|USMedInfo@tevapharm.com|
21252963|NCT04942366|Ziauddin University|Mubarra Rao|03343088915|mubarrar@gmail.com|
21252964|NCT00282672|University of north Carolina|Nicholas Shaheen|(919) 966-7047|nshaheen@med.unc.edu|
21252965|NCT02525718|Northwestern Memorial Hospital|Dr. Mohammed Alghoul||malghoul@nm.org|
21252966|NCT00747227|Abbott medical Optics, Inc.|Nicholas Taranatino, O.D., Head, Global Clinical Research & Devlopment|866-427-8477|nicholas.tarantino@amo.abbott.com|8613
21252967|NCT03284229|Spectranetics Corporation|Spectranetics Corporation|719-447-2211|Ami.Sood@philips.com|
21252968|NCT00384774|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21252969|NCT00814177|McMaster University|Sam Schulman, MD|1-905-5270271|schulms@mcmaster.ca|44479
21252970|NCT02952534|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
21252971|NCT01151852|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
21252972|NCT04325282|Stanford University|Fiona Baumer, MD, MS|(650) 723-0993|fbaumer@stanford.edu|
21252973|NCT04087811|Boston Scientific|Roshini Jain, Sr. Director Clinical Sciences|16619494350|roshini.jain@bsci.com|
21284093|NCT03278847|Imperial College London|Dr Chris Gale, Reader in Neonatal Medicine|+44 203 3153519|christopher.gale@imperial.ac.uk|
21284094|NCT02020837|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|BScanlan@uams.edu|
21284095|NCT01777139|GlaxoSmithKline|GSK Response Center|866-435-7343||
21284096|NCT04987931|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21284097|NCT01253668|Merck|Dr. Stephen Keefe|215-220-9693|stephen.keefe@merck.com|
21284098|NCT00616603|Loma Linda University Department of Anesthesiology|Patricia Moore, CCRP|909-558-8493|pamoore@llu.edu|
21252974|NCT04833127|NYS Psychiatric Institute and Columbia University|Dr. Susie Hoffman|718 744 7686|sh51@cumc.columbia.edu|
21252975|NCT04440839|UNIVERSITY OF CALIFORNIA DAVIS|Misty Humphries|9167342028|mdhumphries@health.ucdavis.edu|
21252976|NCT04210427|Saint Louis University|Purnima Modi|3149772029|purnima.modi.1@slu.edu|
21252977|NCT03512964|Johns Hopkins University School of Medicine, Division of Infectious Diseases|Joyce Jones, MD|443-287-8530|jjone154@jhmi.edu|
21252978|NCT01499303|AstraZeneca|Bernadette Weidman|800-456-3669|ClinicalTrialTransparency@astrazeneca.com|
21252979|NCT00461981|MedImmune, LLC|Christopher Ambrose, MD|301-398-0000|ambrosec@medimmune.com|
21252980|NCT02242097|Northwestern University, Feinberg School of Medicine|Dr. Reem Karmali|(312) 695-0990|reem.karmali@northwestern.edu|
21252981|NCT01562041|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21252982|NCT03031496|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21252983|NCT02339545|Cardiovascular Systems, Inc.|Clinical Trials Manager|651.259.2500|clinicaltrials_csi@csi360.com|
21252984|NCT03868787|Northwestern University Feinberg School of Medicine|Ashley Turner, MD Assistant Professor of Obstetrics and Gynecology|2316200549|ashley.turner1@nm.org|
21252985|NCT01399697|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21252986|NCT03435692|Seattle Children's Hospital|David E. Liston, MD, MPH|206-987-3996|david.liston@seattlechildrens.org|
21252987|NCT04313608|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21252988|NCT02510040|Jaeb Center for Health Research|Raymond Kraker, PEDIG Coordinating Center Director|813-975-8690|rkraker@jaeb.org|
21252989|NCT01712061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21252990|NCT01238536|University of Washington|Janna Friedly M.D.|206-744-3664|friedlyj@uw.edu|
21252991|NCT00758342|Alcon Research, Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21252992|NCT04606901|Temple University Hospital|Dr. Ellen Hauck|2674438719|ellen.hauck@tuhs.temple.edu|
21252993|NCT01677767|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21252994|NCT00842244|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21252995|NCT02807272|Kura Oncology Inc.|Clinical Operations|+1 617 588-3755|KO-TIP-004@kuraoncology.com|
21252996|NCT00858689|FRAXA Research Foundation|Michael R. Tranfaglia MD|978-462-1990|info@fraxa.org|
21252997|NCT01162863|University of Michigan|Dr. Richard J Saad|734-936-4780|rsaad@umich.edu|
21252998|NCT02992691|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21252999|NCT00588692|Mayo Clinic|Dr. Barry A. Borlaug|507-284-4442|borlaug.barry@mayo.edu|
21253000|NCT05071586|University of Wisconsin - Madison|Bernadette Gillick|608-381-2699|bgillick@wisc.edu|
21253001|NCT00392925|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21253002|NCT03538938|University of Wisconsin School of Medicine and Public Health|Danielle McCarthy|6082655949|demccarthy@ctri.wisc.edu|
21253003|NCT00755105|USDA Grand Forks Human Nutrition Research Center|Janet Hunt, PhD|701-795-8353|janetrhunt@gmail.com|
21253004|NCT02202785|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21253005|NCT02985840|OhioHealth Research Institutute|Chelsea Blessing, PhD|(513) 461-1772|chelsea.blessing@ohiohealth.com|
21253006|NCT03398902|Rory Meyers College of Nursing, New York University|Dr. Susan Malone|212-992-7047|sm7760@nyu.edu|
21253007|NCT01229878|VA Providence Healthcare System|Kel Morin|347-346-0380|kel.morin@va.gov|
21253008|NCT02775071|Temple University|David Sarwer|215-707-8632|dsarwer@temple.edu|
21253009|NCT03945825|University of Iowa Carver College of Medicine|Patricia Winokur, MD|319-384-1735|patricia-winokur@uiowa.edu|
21253010|NCT00203268|Thomas Jefferson University|Stephen D. Silberstein, MD|215-955-2243|Stephen.Silberstein@Jefferson.edu|
21253011|NCT04041037|Integra LifeSciences|Allison Matthews|443-766-3869|allison.matthews@integralife.com|
21253012|NCT04958200|Boston University|Tibor Palfai, PhD|6173539345|palfai@bu.edu|
21253013|NCT01310231|Mount Sinai Hospital|Pamela Goodwin/PI|416 586-8211|Pamela.goodwin@sinaihealth.ca|
21253014|NCT03852719|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21253015|NCT05619575|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
21253016|NCT01647542|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21253017|NCT02397447|Institute of Experimental and Clinical Therapeutics|Dra. Esperanza Martínez Abundis|+52-33-10-58-52-00|esperanzamartnezabundi@yahoo.com|34211
21253018|NCT04897841|University of Wisconsin - Madison|Sharon Blohowiak|608-417-6957|sblohowiak@wisc.edu|
21253019|NCT02994069|University of Kentucky|Dr. Susanne Arnold|859-323-6522|susanne.arnold@uky.edu|
21253020|NCT02603328|University of Chicago, Medicine and Biological Sciences Division|Agnieszka Stadnik|773-702-8996|astadnik@bsd.uchicago.edu|
21253021|NCT06926673|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21253022|NCT06532357|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21253023|NCT03345576|Richmond VAMC|Ashraf S. Gorgey|8046755000|ashraf.gorgey@va.ogv|3386
21253024|NCT01255631|CUMC Plastic Surgery|Christine Rohde|212-342-3707|chr2111@cumc.columbia.edu|
21253025|NCT00515671|IUPUI|Michelle Salyers|317-274-2904|mpsalyer@iupui.edu|
21253026|NCT00264303|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
21253027|NCT02311673|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
21253028|NCT02566044|Novartis Pharmaceutical|Study Director|862-778-8300|novartis.email@novartis.com|
21253029|NCT02683772|ResMed|Maureen Crocker, Manager Medical Affairs|8588366653|maureen.crocker@resmed.com|
21253030|NCT04165031|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21284099|NCT04108988|Yale School of Medicine|Dr. Kimberly Hieftje|(203) 737-3301|kimberly.hieftje@yale.edu|
21284100|NCT04395391|Exact Sciences|Alexandra Massoud, Vice President of Clinical Affairs|608-284-5700|clinicaltrials@exactsciences.com|
21237195|NCT00643916|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21237196|NCT03035292|Cambridge University Hospitals NHS Trust|Dr Stephen Kelleher, Director of R&D|01223 217418|r&denquiries@addenbrookes.nhs.uk|
21237197|NCT01698684|Vivus, Inc.|Wesley W Day, PhD|650-934-5200||
21237198|NCT02925455|Case Western Reserve University and MetroHealth System|Michael Fu|215-368-0355|mjf24@case.edu|
21299162|NCT00619515|Case Comprehensive Cancer Center|Dr. Lee Ponsky|216-844-4831|lee.ponsky@uhhospitals.org|
21299163|NCT01839058|Western University|Keith McIntosh|519-646-6100|keith.mcintosh@sjhc.london.on.ca|61312
21299164|NCT01453140|Hackensack University Medical Center|Dr. Michele Donato, MD|551-996-2000|MDonato@hackensackumc.org|3524
21299165|NCT02634333|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|mhuggins@jaeb.org|
21299166|NCT03936608|The University of Kansas|Amit Noheria|9135889757|amit.noheria@gmail.com|
21299167|NCT01332123|university of pittsburgh|Goeran Fiedler|4126246475|gfiedler@pitt.edu|
21237199|NCT01808950|Galderma Spirig|Dr. Francine Santoro|+41623878720|francine.santoro@galderma.com|
21237200|NCT01907191|Saint Francis Hospital and Medical Center|Sanjay Sinha, MD|860-714-6654|ssinha3300@gmail.com|
21237201|NCT00686166|SWOG Statistical Center|SWOG Statistician|206-667-4408||
21237202|NCT01514448|Novartis Pharmaceuticals|Study Director|862-778-8300||
21237203|NCT00985725|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21237204|NCT00993655|Canadian Cancer Trials Group|Senior Biostatistician|6135336430||
21237205|NCT03912259|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21237206|NCT01549613|University of Cincinnati, Dept. of Emergency Medicine|George J. Shaw, MD, PhD|513-558-8098|shawge@ucmail.uc.edu|
21237207|NCT02131272|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21237208|NCT01925950|Soligenix, Inc.|Dr. Richard Straube|609-538-8200||
21237209|NCT00381940|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
21237210|NCT03162224|Global Clinical Lead|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21237211|NCT04162769|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
21237212|NCT00000392|NIMH|Benedetto Vitiello, MD - Supervisory Medical Officer|301-443-3357|bvitiell@mail.nih.gov|
21237213|NCT00485485|UT MD Anderson Cancer Center|Anne Tsao, M.D. / Associate Professor|713-792-6363|mejprice@mdanderson.org|
21237214|NCT03430674|Indiana University|Jamie Renbarger, MD|317-944-8784|jarenbar@iu.edu|
21237215|NCT02071173|Boston Scientific|Kelly Aspinwall|1-800-CARDIAC|kelly.aspinwall@bsci.com|
21237216|NCT00386880|Doylestown Hospital|Abraham A. Ashkenazi, MD-Principal Investigator|215-625-2894|aashkenazi2001@yahoo.com|
21237217|NCT02436265|Indiana University|Aali shah MD|317-944-9981|ashah9@iuhealth.org|
21237218|NCT04052204|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials_gov_Inquiries@pfizer.com|
21237219|NCT01433354|Novartis Pharmaceuticals|Study Director|862--778--8300||
21237220|NCT04794803|Dompé Farmaceutici|Dr Maria De Pizzol, BSc|+39 02 583831|clinops@pec.dompe.it|
21237221|NCT04149405|OndokusMU|Feyza Otan Özden|+905322535106|feyza_otan@yahoo.com|
21237222|NCT01507220|The Ohio State University|Sergio Bergese, MD|(614) 293-9027|bergese.1@osu.edu|
21237223|NCT00937924|University of California, Irvine|Dr. Kenneth Chang|714-456-6187|kchang@uci.edu|
21237224|NCT04650555|Humanetics Corporation|Michael D Kaytor, PhD|952-400-0405|mkaytor@humaneticscorp.com|
21237225|NCT03152526|Miltenyi Biotec|Clinical Project Manager|617-218-0055|lorenb@miltenyibiotec.com|
21237226|NCT04818346|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21237227|NCT05553808|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21237228|NCT02273141|Norgine Ltd|Lucy Clayton|+44-1895-826669|LClayton@norgine.com|
21237229|NCT00492284|QLT Inc.|Medical Information Department|1-800-663-5486|medaff@qltinc.com|
21299168|NCT02748863|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
21299169|NCT00231777|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21299170|NCT00657046|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
21299171|NCT04678115|VA Central Western Massachusetts|Kevin Houston|781-588-7674|kevin.houston2@va.gov|
21299172|NCT00890825|AstraZeneca|Tracy Cunningham|1-877-400-4656|clinicaltrialtransparency@astrazeneca.com|
21299173|NCT00844376|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21299174|NCT00920855|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21299175|NCT02303093|Octapharma Pharmazeutika Produktionsgesm.b.H.,|Dr. Bernhard Rohrbacher|+431610324182|bernhard.rohrbacher@octapharma.com|
21299176|NCT02021942|Klinik und Poliklinik für Neurologie der Universitaet Regensburg|Prof. Dr. Berthold Schalke|+49 941 941|berthold.schalke@medbo.de|3010
21299177|NCT00510835|UPittsburgh|Derek C. Angus, MD, MPH, FRCP|(412) 647-6965|angusdc@ccm.upmc.edu|
21299178|NCT02997501|Astrazeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21299179|NCT00152503|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21299180|NCT03253679|M D Anderson Cancer Center|Dr. Siqing Fu|713-792-4318|siqingfu@mdanderson.org|
21299181|NCT04816214|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
21299182|NCT04393493|hospital civil de guadalajara|Dr Jonathan Chavez Iñiguez|3313299609|jonarchi_10@hotmail.com|
21299183|NCT03863509|University of Wisconsin-Madison|Dr James H. Stein|608-262-2075|jhs@medicine.wisc.edu|
21237230|NCT02154763|The Ottawa Hospital|Dr.Joseph Mamazza|613-798-5555|jmamazza@toh.on.ca|
21237231|NCT02293538|Alcon Research, Ltd.|Global Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21237232|NCT02439710|Institute for Policy Advancement Ltd|Mark W Skinner|+1-202-253-8342|mskinnerdc@gmail.com|
21237233|NCT01410773|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
21237234|NCT03152552|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21253031|NCT00818168|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21253032|NCT03079297|University of Texas Southwestern|Maria Monastirsky|214-648-0174|Maria.Monastirsky@utsouthwestern.edu|
21253033|NCT00667225|University of North Carolina, Chapel Hill|Dean Morrell|919-843-5539|morrell@med.unc.edu|
21253034|NCT02993406|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
21253035|NCT03563157|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
21253036|NCT02248818|AstraZeneca LP|Joel Posner MD||ClinicalTrialTransparency@astrazeneca.com|
21253037|NCT02942277|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Patrick E. Duffy|301.761.5089|patrick.duffy@nih.gov|
21253038|NCT02187159|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|1-908-992-6400|CTRinfo@DSI.com|
21253039|NCT05520775|University of North Carolina at Chapel Hill|Christian Hendershot|(213) 821-0769|christian.hendershot@usc.edu|
21253040|NCT01283152|Baylor University Medical Center|Robert S. Rahimi, M.D., M.S.C.R. Assistant Professor, Department of Medicine|214-820-8500|Robert.Rahimi@Baylorhealth.edu|
21253041|NCT02441985|University of Florida|Aparna Wagle Shukla|3522945400|aparna.shukla@neurology.ufl.edu|
21253042|NCT04020185|ImmuneSensor Therapeutics Inc.|Vice President of Clinical Operations and Project Management|210-380-5164|tmooneyham@immunesensor.com|
21253043|NCT00527787|POZEN Inc|Senior Vice President, Clinical Research|919-913-1030|eorlemans@pozen.com|
21253044|NCT03330405|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21253045|NCT02783027|University of Pittsburgh|Dr. Daniel Patterson|412-864-3830|pdp3@pitt.edu|
21253046|NCT01736189|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21253047|NCT03809039|Mitsubishi Tanabe Pharma Europe Ltd|Clinical Trials, Information Desk|Please e-mail|regulatory@mt-pharma-eu.com|
21253048|NCT00702962|MSHERSHEY MC|Dr. C. Belani|717-531-1078|cbelani@psu.edu|
21253049|NCT05435482|University of California, San Francisco|Ji Won Choi|415.340.1434|jiwon.choi@ucsf.edu|
21253050|NCT01923467|University of Michigan|Larry An, MD|734-763-6099|lcan@med.umich.edu|
21253051|NCT01876901|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
21253052|NCT01145898|Indiana University|Alon Harris|317-278-00177|alharris@indiana.edu|
21253053|NCT00879775|Department of Family Medicine, Dongguk University Ilsan Hospital, Republic of Korea|Sang-Yeon Suh, M.D.,Ph.D|0082-031-961-7490|fmmodel@gmail.com|
21253054|NCT01068665|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21253055|NCT01373580|ReVision Optics|Tracy Shwaery, Global Clinical Research Manager|9497072740|tshwaery@revisionoptics.com|157
21253056|NCT03552523|MGH Diabetes Research Center|Courtney Balliro|617-726-1242|cballiro@partners.org|
21253057|NCT00694109|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21253058|NCT02523690|Johns Hopkins University|Dr. Dale Needham|410-287-3343|dale.needham@jhmi.edu|
21253059|NCT00846807|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21253060|NCT00245960|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21253061|NCT00737698|Imperial College London|Dr Samantha Amanda Sathyapala|+442073518029|s.sathyapala@imperial.ac.uk|
21253062|NCT01067846|Brain Imaging Research Center|Clint Kilts, PhD|526-8163|CDKilts@uams.edu|
21253063|NCT02817906|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinicalTrials@itci-inc.com|
21253064|NCT00672737|Stanford University|Anthony Doufas, MD, PhD|(650) 498-7699|agdoufas@stanford.edu|
21253065|NCT01675453|Academician EN Meshalkin State Budget Research Institute of Circulation Pathology|Dr. Evgeny Fominskiy|+79139538754|evfominskiy@gmail.com|
21253066|NCT02193490|University of Illinois Chicago|Dr. Sandeep Jain|312-996-4476|jains@uic.edu|
21253067|NCT00201877|The Ohio State University Comprehensive Cancer Center|Kristie Blum, MD|614-293-4519|Kristie.Blum@osumc.edu|
21253068|NCT02299414|University of Alabama at Birmingham|Dr. Alan Tita|(205) 934-9616|atita@uabmc.edu|
21253069|NCT03686423|NYU Langone Health|Ryan Brown, PhD|2122633396|Ryan.Brown@nyulangone.org|
21253070|NCT02833077|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
21253071|NCT04662060|Stanford University|Manesha Desai, PhD|(650) 725-1946|manisha.desai@stanford.edu|
21253072|NCT00316017|Clinical Trial Center, University of Washington, Seattle, WA|Susanne May, PhD|206-685-1302|sjmay@uw.edu|
21253073|NCT04157400|MUSC|Nathan Rowland|843-792-6590|rowlandn@musc.edu|
21253074|NCT01809834|School of Optometry, University of Waterloo|Lyndon Jones, PhD, FCO|519-888-4742|ljones@uwaterloo.ca|
21253075|NCT04201262|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
21253076|NCT02902770|Maimonides Medical Center|Antonios Likourezos|7182836896|alikourezos@maimonidesmed.org|
21253077|NCT05718466|Henry Ford Health System|Marissa Gilbert|313-556-8422|mgilber6@hfhs.org|
21253078|NCT01253135|Smith & Nephew|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
21253079|NCT01802151|Department of Food Science and Human Nutrition, University of Florida|Dr. Wendy Dahl|352-392-1991|wdahl@ufl.edu|224
21253080|NCT00685139|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21253081|NCT00833261|UT Southwestern Medical Center|Dr. Lucien Nedzi|214-645-7653|lucien.nedzi@utsouthwestern.edu|
21253082|NCT03149809|Atlanta VA Health Care System|E. Camille Vaughan, MD, MS|404 315 4100|elizabeth.vaughan2@va.gov|373100
21253083|NCT01692951|Cleveland Clinic Foundation|Daniel Sessler, MD|216-444-4900|sessled@ccf.org|
21253084|NCT01174576|Harokopio University|Dr. Mary Yannakoulia|00302109549175|myianna@hua.gr|
21253085|NCT03425097|Stanford University|Thomas A Zikos, MD|(408) 426-5599|zikosta@stanford.edu|
21253086|NCT03339245|The Rockefeller University|Dr. Peter R Holt|212-327-7706|holtp@rockefeller.edu|
21253087|NCT02420951|Brigham and Women's Hospital|Dr. Wolfgang Fitz|6177329501|wfitz@partners.org|
21253088|NCT00288639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21253089|NCT02815579|University of California, San Francisco|Dr. Sheri Weiser|(628) 206-2427|Sheri.Weiser@ucsf.edu|
21253090|NCT02389452|Sanofi|Trial Transparency Team||Contact --US@Sanofi.com|
21253091|NCT02385240|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
21253092|NCT01006252|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21253093|NCT01014208|GlaxoSmithKline|GSK Response Center|866-435-7343||
21253094|NCT00769652|Rutgers Cancer Institute of New Jersey|Dr. Elizabeth Poplin, MD (sub-investigator)|732-235-8675|poplinea@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
21253095|NCT00414908|Abbott Products|Sven Voet - Global Communication|+41 61 487 08 56|sven.voet@abbott.com|
21253096|NCT01076153|Abbott|Global Medical Services|1-800-633-9110||
21253097|NCT02988050|Menoufia University|Professor Ezzeldin Ibrahim, Professor of Anaesthesia|00201006303178|ezzeldin7@yahoo.com|
21253098|NCT04143945|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21253099|NCT04045964|The University of Texas Health Science Center at Houston|Angela Stotts, PhD|(713) 500-7590|Angela.L.Stotts@uth.tmc.edu|
21253100|NCT00567567|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|Resultsreportingcoordinator@childrensoncologygroup.org|
21253101|NCT03433677|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
21253102|NCT02658877|NYU Langone Health|Joan Reibman|212 263 6479|Joan.Reibman@nyulangone.org|
21253103|NCT00608868|Medical, Astrazeneca Korea|Hui Jung Sin||huijung.sin@astrazeneca.com|
21253104|NCT00626626|Penn State Hershey Medical Center|Dr David Claxton|717-531-8401|dclaxton@hmc.psu.edu|
21253105|NCT03417544|Dana-Farber Cancer Institute|Nancy Lin, MD|617-632-3800|Nancy_Lin@dfci.harvard.edu|
21253106|NCT02931253|The Donald Guthrie Foundation for Education and Research|Pramod Deshmukh, MD|570 887 2284|Pramod.Deshmukh@guthrie.org|
21253107|NCT02440425|Moffitt Cancer Center|Robert M. Wenham, MD, MS, FACOG, FACS|813-745-5739|Robert.Wenham@moffitt.org|
21253108|NCT01701102|Hospital for Special Surgery|Jennifer Cheng|212-774-7377|chengj@hss.edu|
21253109|NCT04145700|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21253110|NCT03750786|Isofol|Karin Gedda|+46 (0) 729 9453 37|karin.gedda@isofolmedical.com|
21253111|NCT00780559|University of Maryland School of Medicine|Clinical Research Coordinator|(410) 328-6583|inmed@som.umaryland.edu|
21253112|NCT01333813|GlaxoSmithKline|GSK Response Center|866-435-7343||
21253113|NCT01766713|UCSD|Rohit Loomba|858-534-2624|roloomba@ucsd.edu|
21253114|NCT00847522|Huntsman Cancer Institute|Mark Wade|8012135746|mark.wade@hci.utah.edu|
21253115|NCT01840410|Novartis|Study Director|862-778-8300||
21253116|NCT00839956|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
21253117|NCT00972322|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21253118|NCT00671177|San Francisco VA Medical Center|Dr. Tonya Kaltenbach|415-221-4810|tonya.kaltenbach@va.gov|24103
21253119|NCT03682185|University of Pennsylvania|Dr. Nancy A. Hodgson|215-573-7387|hodgsonn@nursing.upenn.edu|
21253120|NCT00462605|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|B. Douglas Smith|410-614-5068|smithdo@jhmi.edu|
21253121|NCT03548220|Agios Pharmaceuticals, Inc.|Medical Affairs|833-228-8474|medinfo@agios.com|
21253122|NCT03853551|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|8772409479
21253123|NCT01734239|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21253124|NCT01075958|Northumbria University|Dr Philippa Jackson|+44 191 204 8818|philippa.jackson@northumbria.ac.uk|
21253125|NCT01021618|Hartford Hospital|Gary V Heller, MD, PhD|860-545-5527|aahlber@harthosp.org|
21253126|NCT01240915|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21253127|NCT04297631|Washington University|Venessa Riegler|3143621721|rieglerv@wustl.edu|
21253128|NCT01720277|Brown University and Providence VA Medical Center|Dr. Stefan Gravenstein|401-863-3172|Stefan_gravenstein@brown.edu|
21253129|NCT02574845|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21253130|NCT03151993|Federal Center for Brain and Neurotechnology|Dr. Eugene I. Gusev, President of the Federal Center for Brain and Neurotechnology|495-280-01-74|egusev2339@gmail.com|+7
21253131|NCT01867333|National Cancer Institute|Ravi A. Madan|301-480-7168|rm480i@nih.gov|
21253132|NCT03101462|Saint Louis University|Daniel F. Hoft, MD, PhD|314-977-5500|daniel.hoft@health.slu.edu|
21253133|NCT02119442|UCLA|Soraya Sadeghi|3108255950|smsadeghi@mednet.ucla.edu|
21253134|NCT01249027|Abbott Vascular|Leong Roy|8133 7475|roy.leong@abbott.com|+65
21253135|NCT03878277|University of Colorado School of Medicine|Petter Bjornstad, M.D., Assistant Professor of Pediatrics and Medicine|7207774659|petter.bjornstad@childrenscolorado.org|
21253136|NCT00968071|The University of Texas M. D. Anderson Cancer Center|Gautam Borthakur M.D./Associate Proffesor|713-563-1586|eharriso@mdanderson.org|
21253137|NCT01696045|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
21253138|NCT01559129|Celgene Corporation|Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
21253139|NCT03525392|Ipsen Pharma SAS|Medical Director|see email|clinical.trials@ipsen.com|
21253140|NCT03262662|University at Buffalo|Larry Hawk, PhD|716-829-2323|lhawk@buffalo.edu|
21253141|NCT00831129|University of Chicago|Dr. George Bakris|773-702-7936|bbrisky@medicine.bsd.uchicago.edu|
21253142|NCT01669577|University of São Paulo|Luiz Guilherme Villares da Costa, MD|5511985584737|lgvc76@yahoo.com.br|
21253143|NCT02917603|UMissouri|Debra Parker Oliver; PI|573-356-6719|oliverdr@missouri.edu|
21253144|NCT04462289|Minneapolis VA Health Care System|Dr. Anne Melzer|6124674413|anne.melzer2@va.gov|
21253145|NCT00818779|Texas Tech University Health Sciences Center School of Medicine|Gary Meyerrose|806-743-3150|gary.meyerrose@ttuhsc.edu|
21253146|NCT01518153|University of Texas (UT) MD Anderson Cancer Center|Richard E. Champlin, MD/Chair, Stem Cell Transplantation|713-792-8750|CR_Study_Registration@mdanderson.org|
21267122|NCT03276494|Ohio State University|Thomas Lawson|614-366-7312|thomas.lawson@osumc.edu|
21253147|NCT00132873|Jazz Pharmaceuticals, Inc.|Mortimer Mamelak, MD|650 496 3777|roman.skowronski@jazzpharma.com|
21253148|NCT04276415|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21284101|NCT00367484|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|Bettina Stubinski/Senior Medical Director|+49 6151 72 5200|service@merckgroup.com|
21284102|NCT02470403|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21284103|NCT00987402|University Hospital, Geneva|Stephan Harbarth MD|+41-22-372.3357|stephan.harbarth@hcuge.ch|
21284104|NCT01362517|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
21284105|NCT03878875|Imperial|Hemna Santilale|020|hemna.santilale@nhs.net|
21284106|NCT02273908|Medical Affairs, Pfizer Japan Inc.|Study Director : Koichi Fujii, MD|81-3-5309-9370|koichi.fujii@pfizer.com|
21284107|NCT00369161|Novartis Pharmaceuticals|Study Director|862-778-8300||
21284108|NCT01440387|GlaxoSmithKline|GSK Response Center|866-435-7343||
21284109|NCT03303391|University of Texas Southwestern Medical Center|Peter Van Buren|214-645-8293|peter.vanburen@utsouthwestern.edu|
21284110|NCT03008278|Yale School of Medicine|Michael Cecchini, MD|(203) 200-4422|michael.cecchini@yale.edu|
21284111|NCT00422422|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493||
21284112|NCT01389258|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
21284113|NCT03313310|UNC Chapel Hill, ATN Coordinating Center|Betty Rupp|919-962-6603|brupp@email.unc.edu|
21284114|NCT03019003|Massachusetts General Hospital Cancer Center|Dr. Sara Pai, MD, PhD|6178779118|sara.pai@mgh.harvard.edu|
21284115|NCT01593254|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
21284116|NCT02292186|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
21284117|NCT01443494|Intensive Care Unit, Zhongda Hospital, Southeast University|Jingyuan Xu|86-025-83262550|xujingyuanmail@163.com|
21284118|NCT00501059|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21284119|NCT00719914|Brigham and Women's Hospital|C. Michael Gibson, MS, MD|617-632-7753|mgibson@perfuse.org|
21284120|NCT02124759|UTHSC San Antonio|Dr. Nicolas Musi|630-5001|musi@uthscsa.edu|210
21284121|NCT03653091|Fractyl Health, Inc.|Sarah Hackett, Sr. Director of Clinical Operations|(781) 902-8840|shackett@fractyl.com|
21284122|NCT04249622|Mayo Clinic|Saranya Chumsri, MD|904-953-2000|Chumsri.Saranya@mayo.edu|
21284123|NCT04250298|Medical University Graz|Dr. Camilla Drexler-Helmberg|0043316385|camilla.drexler@uniklinikum.kages.at|83066
21284124|NCT03604705|Basilea Pharmaceutica International Ltd, Allschwil|Study Director|+41 79 701 0551|marc.engelhardt@basilea.com|
21284125|NCT03689543|National Institute of Mental Health|Dr. Peter Schmidt|+1 301 496 6120|peterschmidt@mail.nih.gov|
21284126|NCT00932451|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21284127|NCT01294371|Abbvie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21284128|NCT05619536|Cidara Therapeutics, Inc.|Chief Medical Officer|858-888-7868|clinicaltrialinfo@cidara.com|
21284129|NCT04272606|University of Iowa|Catherine Olinger|319-384-5892|catherine-olinger@uiowa.edu|
21284130|NCT00725101|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21284131|NCT05727306|University of Sheffield|Andrew G. Messenger|+44 114 222 2000|a.g.messenger@sheffield.ac.uk|
21284132|NCT02814227|University of Michigan|J. Todd Arnedt, PhD|734-615-8666|tarnedt@med.umich.edu|
21284133|NCT00157248|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21284134|NCT03191864|Ellodi Pharmaceuticals (Formerly Adare Pharmaceuticals)|Senior Director Clinical Operations and Medical Affairs|(609) 450-1312|karol.knoop@ellodipharma.com|
21284135|NCT00415597|King Pharmaceuticals Research and Development, Inc.|Vice President, Clinical Development|919-653-7001||
21284136|NCT01447927|University Hospitals of Cleveland, Case Medical Center|Dr. Amitabh Chak|216-844-5385|Amitabh.chak@case.edu|
21284137|NCT04102865|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
21284138|NCT04149574|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
21284139|NCT04506905|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21284140|NCT02093390|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21284141|NCT02168777|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21284142|NCT00441363|VeroScience|Donna Cowan|401 816-0525|donna_cowan@veroscience.com|
21284143|NCT03529799|University of Miami|Michael Hoffer|305 243-1484|michael.hoffer@miami.edu|
21284144|NCT03315962|UCSF|Gabe Chamie|(415) 476-4082|gabriel.chamie@ucsf.edu|
21284145|NCT01911793|Cedars Sinai Medical Center|Phillip Fleshner, MD|310-289-9224|pfleshner@aol.com|
21284146|NCT03774394|University of Florida|Francesco Franchi, MD|+1-904-244-2060|francesco.franchi@jax.ufl.edu|
21284147|NCT02697916|Duke University; Duke Clinical Research Institute|W. Schuyler Jones, MD|919-668-8917|schuyler.jones@duke.edu|
21284148|NCT00290693|University of Miami Sylvester Comprehensive Cancer Center|Caio Max Rocha Lima MD|305-243-7770|crocha@med.miami.edu|
21237235|NCT00567242|University of Florida|Bruce Crosson, PhD / Professor|352-273-6617|nossorc1@phhp.ufl.edu|
21237236|NCT02372409|Washington University School of Medicine|Andrew Cluster, M.D.|314-454-6018|acluster@wustl.edu|
21237237|NCT04084314|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21237238|NCT00622167|Massachusetts General Hospital|Iris McNulty, RN|617 726 2612|imcnulty@partners.org|
21237239|NCT03336619|Romark|Sr. Director, Research Operations|8132828544|jessica.fulgencio@romark.com|
21253149|NCT03309813|Insightec|Nadir Alikacem, VP Global Regulated Clinical Affairs|214-630-9900|NadirA@Insightec.com|
21284149|NCT05625477|Zhuhai Trinomab Pharmaceutical Co., Ltd.|Wenxi Xiang|18083065921|xiangwenxi@trinomab.com|
21237240|NCT01300546|Clinvest/A Division of Banyan Group Inc.|Jeanne Tarrasch|417-841-3673|jtarrasch@clinvest.com|
21237241|NCT02820623|Northwestern University|Rinad Beidas, PhD|312-503-0546|rinad.beidas@northwestern.edu|
21237242|NCT02271386|The Children's Hospital of Philadelphia|Alexander Fiks, MD, MSCE|2674262304|fiks@email.chop.edu|
21237243|NCT00866840|Rutgers Cancer Institute of New Jersey|James Goydos, MD|(732) 235-7593|goydosjs@cinj.rutgers.edu|
21237244|NCT00765193|Department of Dermatology, Medical University of Graz-Austria|Iris Zalaudek, MD|+436763328269|iris.zalaudek@medunigraz.at|
21237245|NCT00126438|GE Healthcare|Jose Zubeldia, M.D.|011-44-1494-543137|jose.zubeldia@ge.com|
21237246|NCT02313428|University of Pittsburgh|Sashwati Roy|412-648-8297|sar543@pitt.edu|
21237247|NCT05374421|Erchonia Corporation|Clinical Affairs Manager|864-531-0064|tsammons@erchonia.com|501
21237248|NCT05023304|Vance Thompson Vision|Director of Clinical Trials|1-605-371-7075|keeley.boever@vancethompsonvision.com|
21237249|NCT05132699|University of Texas Health Science Center at San Antonio|Casey Straud|210-562-6742|straud@uthscsa.edu|
21237250|NCT04370054|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21237251|NCT02314624|Evidence Based Practice Institute|Linda Dimeff, PhD|206-384-7371|linda.dimeff@jasprhealth.com|
21237252|NCT03595579|Axsome Therapeutics, Inc.|Amanda Jones, PharmD, Senior Vice President of Clinical Development|212-332-3223|ajones@axsome.com|
21237253|NCT03151005|Department of Endocrinology, Xinqiao Hospital, Army Military Medical University|Min Long, MD|023-68763255|longmin_casper@163.com|
21237254|NCT01718028|Alcon Research, Ltd.|Abayomi Ogundele, Pharm.D.|1-888-451-3937|alcon.medinfo@alcon.com|
21237255|NCT02216123|GlaxoSmithKline|GSK Response Center|866-435-7343||
21237256|NCT05159622|George Washington University|Uriyoan Colon-Ramos|202994 1899|uriyoan@gwu.edu|
21253150|NCT01327846|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21253151|NCT02205034|CHU Toulouse|Pr Maithe Tauber|+33534558551|tauber.mt@chu-toulouse.fr|
21237257|NCT02163733|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
21253152|NCT04343976|Massachusetts General Hospital|Sponsor-Investigator|617-724-3836|chung.raymond@mgh.harvard.edu|
21253153|NCT02807883|University of Texas MD Anderson Cancer Center|Partow Kebriaei, MD / Stem Cell Transplantation Department|713-745-0663|pkebriae@mdanderson.org|
21253154|NCT00594880|the Wistar Institute|Luis Montaner|215 898 3934|montaner@mail.wistar.org|
21253155|NCT02206061|University of Rochester|Jill Halterman, MD|5852755798|jill_halterman@urmc.rochester.edu|
21253156|NCT04608773|University of Pittsburgh|Anne Fisher|4126479665|amf91@pitt.edu|
21253157|NCT01868425|University of Wisconsin - Madison|John Shepler|608-263-8100|jashepler@wisc.edu|
21253158|NCT01077518|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21253159|NCT00422812|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
21253160|NCT00623805|Hoffmann-La Roche|Medical Communications|800 821-8590||
21253161|NCT03599687|Yorkshire Ambulance Service NHS Trust|Richard Pilbery|+447463734823|r.pilbery@nhs.net|
21253162|NCT00635128|GlaxoSmithKline|GSK Response Center|866-435-7343||
21253163|NCT01803282|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21253164|NCT01949389|VA Connecticut Healthcare system|Eric Hermes|203 932 5711|eric.hermes@va.gov|7422
21253165|NCT02671500|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21253166|NCT01807000|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21253167|NCT03746392|University of Washington|Program Coordinator (Elizabeth Nielsen)|206-744-9516|eniels9@uw.edu|
21253168|NCT03086655|University of California San Francisco|Dr. Maria Ekstrand|+1 (415) 502-1000|Maria.Ekstrand@ucsf.edu|17142
21253169|NCT00798434|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21253170|NCT04522921|Department of Clinical Medicine, Aarhus University / Steno Diabetes Center Aarhus, Aarhus University Hospital|Dorthe Dalstrup Pauls|+45 28256406|dorthedalstrup@clin.au.dk|
21253171|NCT01217437|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21253172|NCT00871286|Northwestern|Rakesh Chandra|312-695-8182|rchandra@nmff.org|
21253173|NCT00558792|Bracco Diagnostics Inc|Usha Halemane, Executive Director of Medical Biometrics and Medical Writing|609-514-2578|usha.halemane@diag.bracco.com|
21253174|NCT01736943|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
21253175|NCT00387426|UT MD Anderson Cancer Center|Srdan Verstovsek, MD / Associate Professor||eharriso@mdanderson.org|
21253176|NCT00890695|KEMRI/Wellcome Trust Research Programme|Dr James Berkley|+254 41 522535|jberkley@kilifi.kemri-wellcome.org|
21253177|NCT04420949|University of Wisconsin - Madison|Dr. Kreg Gruben|608 262 2711|kreg.gruben@wisc.edu|
21253178|NCT02314780|Medical University of Vienna|Dr. Martin Andreas|+ 43 1 40400|martin.andreas@meduniwien.ac.at|69660
21253179|NCT00129480|Portland VA Medical Center|Steven K. Dobscha MD|503-220-8262|steven.dobscha@va.gov|52207
21253180|NCT03986944|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
21253181|NCT03002220|MedSIR|Alicia Garcia|+34 611261467|alicia.garcia@medsir.org|
21253182|NCT01015560|SWOG Statistical Center|Study Statistician|206-667-4623||
21253183|NCT00837694|University at Buffalo|Jennifer L. Temple|716-829-5593|jltemple@buffalo.edu|
21253184|NCT01008410|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
21253185|NCT00297427|University of Pittsburgh|Dr. Sandra Engberg|412-624-6616|sje1@pitt.edu|
21253186|NCT01127893|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21253187|NCT01262677|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21253188|NCT02055781|CTI BioPharma Corp.|Beth Ziemba||bziemba@ctibiopharma.com|
21253189|NCT02787044|Brigham and Women's Hospital|Dr. Scott Solomon|857-307-1960|ssolomon@bwh.harvard.edu|
21253190|NCT01638429|Cedars-Sinai Medical Center|Dr Ruchi Mathur|310-423-4774|Ruchi.Mathur@cshs.org|
21253191|NCT02324608|Cancer Institute of New Jersey Rutgers|Dr. Adam Berger|732-235-8675|ab2047@cinj.rutger|
21253192|NCT03889704|University of Pittsburgh|Dr. Edward Burton|4126924670|eab25@pitt.edu|
21253193|NCT03482466|Baylor College of Medicine; Michael E. DeBakey VA Medical Center; Menninger Clinic|Ramiro Salas|7137983502|rsalas@bcm.edu|
21253194|NCT04552899|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21253195|NCT00673959|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21253196|NCT02383940|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21253197|NCT02308787|Terumo BCT|Raymond P. Goodrich, PhD, VP, Scientific and Clinical Affairs; Chief Science Officer-BBT|(303) 231-4357|Ray.Goodrich@terumobct.com|
21253198|NCT00565773|Duke University|Allan D. Kirk, MD, PhD|919-681-1400|allan.kirk@duke.edu|
21253199|NCT01598662|University Louisville|Nancy Alsip|502-852-2905|nancy.alsip@louisville.edu|
21253200|NCT02530970|Aziyo Biologics, Inc.|Clinical Director|470-514-4085|clinical@aziyo.com|
21253201|NCT02770612|Brigham and Women's Hospital|Brian T Bateman|617-278-0930|bbateman@partners.org|
21253202|NCT02636725|University of Miami|Jonathan Trent MD|305-243-2581|JTrent@med.miami.edu|
21253203|NCT03478904|National Cancer Institute|William D. Figg, Pharm.D.|240-760-6179|figgw@mail.nih.gov|
21253204|NCT00886795|Johns Hopkins University|Clifton O. Bingham III, M.D.|410-550-0578|cbingha2@jhmi.edu|
21253205|NCT01283516|Novartis Pharmaceuticals|Study Director|862-778-8300||
21253206|NCT01098318|University of Pennsylvania|Dr. Jun Mao, Associate Professor|215-746-2481|jun.mao@uphs.upenn.edu|
21253207|NCT00860847|Los Angeles Biomedical Research Inst.|Dr Matthew Budoff|310-222-4107|mbudoff@labiomed.org|
21253208|NCT00444275|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
21253209|NCT03030859|University of Pennsylvania School of Nursing|Jie Deng, PhD, PI|215-573-2393|jiedeng@nursing.upenn.edu|
21253210|NCT00743431|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21253211|NCT03291288|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21253212|NCT04978493|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21253213|NCT01896726|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21253214|NCT01128114|AstraZeneca|Gerard Lynch||clinicaltrialtransparency@astrazeneca.com|
21253215|NCT00208325|DePuy International|Kimberly Dwyer, Ph.D, CCRA||kdwyer2@its.jnj.com|
21253216|NCT04662931|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
21253217|NCT01254747|Alcon Research|Director of Alcon Clinical, Atlanta|1-800-241-7629||
21253218|NCT04187326|UMass Chan School of Medicine|Dr. Elliot Edmiston, Associate Professor of Psychiatry & Behavioral Sciences|5088566480|kale.edmiston@umassmed.edu|
21253219|NCT02406677|AstraZeneca Pharmaceuticals LP|Naeem Khan, MD, VP, CVMD TA|302-886-5526|Naeem.Khan@astrazeneca.com|
21253220|NCT02654652|Universidade Federal de Minas Gerais|Dr. Maria Isabel Correia|+55 31 34098033|isabel_correia@uol.com.br|
21253221|NCT02387970|Columbia University|Panos N. Papapanou, DDS, PhD|(212) 342-3008|pp192@cumc.columbia.edu|
21253222|NCT01533753|University of Wisconsin Carbone Cancer Center|Dr. Justine Bruce|608-263-7107|jybruce@medicine.wisc.edu|
21253223|NCT04531098|VBI Vaccines|Dr. Francisco Diaz-Mitoma|1 613 297 3304|fdiazmitoma@vbivaccines.com|
21253224|NCT02145468|GlaxoSmithKline|GSK Response Center|866-435-7343||
21253225|NCT00586612|GlaxoSmithKline|GSK Response Center|866-435-7343||
21253226|NCT05235269|Attralus|Scott Stephens, Senior Director Clinical Operations|321-228-7400|sstephens@attralus.com|
21253227|NCT03810235|School of Medicine and Public Health University of Wisconsin-Madison|Kathleen M. Antony, M.D, M.S.C.I|608-417-6099|kantony@wisc.edu|
21253228|NCT04777864|Seattle Children's Research Institute|Dr. Emily Kroshus|206-884-5326|Emily.Kroshus@seattlechildrens.org|
21253229|NCT01198067|M.D. Anderson Cancer Center|Sheeba K. Thomas, MD|713-792-2860|sthomas@mdanderson.org|
21253230|NCT04908631|Duke University|Howard W. Francis, MD|919-681-8069|howard.francis@duke.edu|
21253231|NCT06655558|Topmed|Edith Martin|418 683-2104|emartin@topmed.ca|1302
21253232|NCT04839185|UW School of Medicine and Public Health|Dinesh Shah, MD|608-417-6099|dmshah@wisc.edu|
21253233|NCT03468478|Hospital do Rim - Fundação Oswaldo Ramos|Dr. Helio Tedesco Silva Junior|55 11 50878113|heliotedesco@medfarm.com.br|
21253234|NCT03524092|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21253235|NCT04303780|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21253236|NCT03826030|Duke University|Wayne Feng, MD|919-681-1700|wayne.feng@duke.edu|
21253237|NCT06122870|Johns Hopkins University|Dr. Kawsar Talaat|410-336-9164|ktalaat@jhu.edu|
21284150|NCT01692002|Imperial College London|Prof Gary Frost Head of Section for Nutrition Research|07872850308|g.frost9296@gmail.com|
21253238|NCT04893460|Oregon Research Behavioral Intervention Strategies Inc.|Dr. Dana Smith|541-484-2123|danas@ori.org|
21253239|NCT04746846|Virginia Commonwealth University|Ingrid Pretzer-Aboff, Ph.D., RN , FGSA, FAAN|804-828-3340|iaboff@vcu.edu|
21253240|NCT04500769|University of Kentucky|Douglas Long|859-323-5438|delong2@uky.edu|
21253241|NCT01967147|Alcon Research, Ltd.|Global Brand Med Affairs Lead, GCRA, GMA Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
21253242|NCT03843554|University of Pittsburgh|Associate Vice Chancelor, Clinical Trials Operations|412-383-2561|pat.corby@pitt.edu|
21253243|NCT02896075|University of Texas at Austin|Stephanie Lapierre|512-471-8594|stephlap1116@gmail.com|
21284151|NCT04849416|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21253244|NCT02218606|Memorial Sloan Kettering Cancer Center|Dr. Susan Slovin, MD, PhD|646-422-4472|slovins@MSKCC.ORG|
21253245|NCT03203473|Dana Farber Cancer Institute|Toni K Choueiri, MD|(617) 632-5456|toni_choueiri@dfci.harvard.edu|
21253246|NCT01882543|Department of Urology, Queens University, Ontario|J. Curtis Nickel|613-548-2497|jcn@queensu.ca|
21253247|NCT01325311|University of Wisconsin|Howard H. Bailey|608-263-8624|hhbailey@wisc.edu|
21253248|NCT01901432|ITALFARMACO S.p.A.|Medical Expert|+39 026443 258|p.bettica@italfarmaco.com|
21253249|NCT00379288|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21253250|NCT00979550|University of Kentucky Healthcare|Henry C. Vasconez, MD|8593236328|betsy.fink@uky.edu|
21253251|NCT04396366|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
21253252|NCT00926497|Children's Hospital of Lucerne|Martin Stocker, MD|0041412051288|martin.stocker@ksl.ch|
21253253|NCT03439254|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
21253254|NCT03795753|Emory University|Dr. Nancy Collop|404-712-7533|nancy.collop@emory.edu|
21253255|NCT00128102|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21253256|NCT01531673|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21253257|NCT00568178|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21284153|NCT02598778|MMC - Dentistry|Kakanantadilok, Nuntiya|(888) 700-6623|nkakanan@montefiore.org|
21284154|NCT03749499|University of Chicago Illinois|Heather M. Prendergast MD, MS, MPH, Professor, Department of Emergency Medicine|3124131214|hprender@uic.edu|
21284155|NCT00791037|University of Washington|Dr. Mary L. Disis|206-543-8557|ndisis@u.washington.edu|
21284156|NCT00998205|University of Missouri-Columbia|Anand Chockalingam|573-882-2296|chockalingama@missouri.edu|
21284157|NCT02635009|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
21284158|NCT00981058|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21284159|NCT05916131|University of Michigan|Yu Kuei Lin, MD|734-232-1573|yuklin@med.umich.edu|
21284160|NCT02667587|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21284161|NCT02542293|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21284162|NCT03030118|Penn State Hershey College of Medicine|Nancy J Olsen MD, Professor of Medicine|717-531-4921|nolsen@pennstatehealth.psu.edu|
21284163|NCT04529850|Galera Therapeutics|Judy Schnyder|484-870-9625|jschnyder@galeratx.com|
21284164|NCT00310466|ALK-Abelló A/S|Kim Simonsen, Senior Director|+4545747576||
21284165|NCT02278367|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
21284166|NCT00810017|MedStar Health Research Institute|Scientific Center Administrator, Oncology Research|(301) 560-7300|Research@MedStar.net|
21284167|NCT02397291|"University of Colorado Denver | Anschutz"|Henry Galan|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
21284168|NCT01472939|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21284169|NCT00114738|National Cancer Institute|Dr. Wyndham Wilson|301-435-2415|wyndham_wilson@nih.gov|
21284170|NCT00316914|Mayo Clinic|Dr. Axel Grothey|507-184-2779|grothey.axel@mayo.edu|
21284171|NCT01675154|UT Southwestern Medical Center|Dr. Abhimanyu Garg|214-648-8295|abhimanyu.garg@utsouthwestern.edu|
21284172|NCT02971800|CHU de Québec|Dr Philippe Laberge|+1(418)525-4444|philippe.laberge@fmed.ulaval.ca|
21284173|NCT00766467|Dana-Farber Cancer Insitute|Eudocia Quant Lee, MD|617-632-2166|eqlee@partners.org|
21284174|NCT02223819|Columbia University|Shaheer A. Khan, DO|212-342-5162|sk4488@cumc.columbia.edu|
21284175|NCT04339179|INA-RESPOND|Publication Division|+62214208693|inapublikasi@ina-respond.net|
21284176|NCT00259285|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21284177|NCT01917344|Boston Children's Hospital|Susan Waisbren, P.h.D|617-355-7346|susan.waisbren@childrens.harvard.edu|
21284178|NCT00943670|Hoffman-LaRoche|Medical Communications|800-821-8590||
21284179|NCT01777295|GlaxoSmithKline|GSK Response Center|866-435-7343||
21284180|NCT00624559|University of Delaware|Dr. William Farquhar|302-831-6178|wbf@udel.edu|
21284181|NCT00426660|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21284182|NCT00980174|Amgen Inc.|Study Director|866-572-6436||
21284183|NCT01546038|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21284184|NCT01398410|Eisai Co., Ltd.|Nobuyuki Sugisaki|+81-3-3817-3908||3908
21284185|NCT04245202|Ege University Medical Faculty Hospital|Dr. Aykut Eşki|05303009760|aykuteski1984@gmail.com|
21284186|NCT00717275|University of Florida|Dr. Erin M. Dunbar|352-273-9000|edunbar@neurosurgery.ufl.edu|
21284187|NCT03329248|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
21284188|NCT01522235|Beth Israel Deaconess Medical Center|Dr. Roy Freeman|6176328454|rfreeman@bidmc.harvard.edu|
21284189|NCT03769194|Valneva Austria GmbH|Director Clinical Strategy|+43120620|office@valneva.com|0
21284190|NCT03000530|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21284191|NCT01996657|Wuhan Asia Heart Hospital|Dr.Litao Zhang|+862765796888|zhengleetau@qq.com|8204
21253258|NCT01332630|UT MD Anderson Cancer Center|Ibrahim,Nuhad K.,M.D. / Breast Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
21284192|NCT01523704|Fujita Health University School of Medicine|Eiichi Watanabe, MD, PhD|+81-562-93-2312|enwatan@fujita-hu.ac.jp|
21284193|NCT01430624|Medical University of South Carolina|Heidi Resnick, Ph.D.|843-792-2945|resnickh@musc.edu|
21284194|NCT01133288|Kennedy Krieger Institute|Eric Levey, M.D.|443-923-9148|levey@kennedykrieger.org|
21284195|NCT00798018|Department of Anesthesiology, West China Second Hospital|Han Huang|80-028-8550-3753|huanghan1981@hotmail.com|
21284196|NCT02565706|William Paterson University|Jennifer Di Noia|973.720.3714|dinoiaj@wpunj.edu|
21284197|NCT00416793|UT MD Anderson Cancer Center|Gauri Varadhachary, MD Associate Professor|713-792-2828|mjlim@mdanderson.org|
21284198|NCT01672294|VA HSRD Durham VA Medical Center|Karen Steinhauser, PhD|9196682148|karen.steinhauser@va.gov|
21284199|NCT03379792|AdventHealth Translational Research Institute|Richard E. Pratley|407-303-2519|richard.pratley.md@adventhealth.com|
21284200|NCT01285492|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21284201|NCT01121536|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21253259|NCT01318018|Dept. of Anesthesiology and Intensive Care Medicine|Prof. Dr.Martin Soehle|++49-228-287-|martin.soehle@ukb.uni-bonn.de|11378
21253260|NCT04476251|National Cancer Institute|Scott M. Norberg D.O.|301-275-9668|scott.norberg@nih.gov|
21284202|NCT03646149|VA Greater Los Angeles|Sonya Gabrielian, MD, Investigator|310-478-3711|sonya.gabrielian@va.gov|49853
21284203|NCT00401960|Weill Medical College|K Rhee|6469626224|kyr9001@med.cornell.edu|
21253261|NCT02334982|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21253262|NCT01008553|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387||
21253263|NCT00921687|Louis Stokes Cleveland VA Medical Center|Paul Drawz, MD, MHS, MS|6126255423|draw0003@umn.edu|
21253264|NCT02124603|Casa di Cura Di Stefano|Dr.Marcello Santocono|+393356070002|santocono.m@alice.it|
21253265|NCT01663922|St Stephens AIDS Trust|Dr Akil Jackson|0203 315 6503|akil.jackson@chelwest.nhs.uk|
21253266|NCT01507987|Abbott|Grant Kim, Program Director - Traditional Cardiac Rhythm Management|818-493-3147|grant.kim1@abbott.com|
21253267|NCT01534143|Barbara Ann Karmanos Cancer Institute|Zaid Al-Kahdimi, M.D.|(313) 576-8022|zalkadh@emory.edu|
21253268|NCT04512703|ZOLL Medical Corporation|Mike Osz|4129683333|mosz@zoll.com|14104
21253269|NCT00597246|Memorial Sloan Kettering Cancer Center|Ronald Blasberg, MD|646-888-2211|blasberr@mskcc.org|
21253270|NCT03283254|Columbia University|Elizabeth Werner, Ph.D.|646-774-8945|ew150@cumc.columbia.edu|
21253271|NCT04786964|Checkpoint Therapeutics|James Oliviero|212-574-2830|jfo@checkpointtx.com|
21253272|NCT02591953|Rush|Dr. Jeremy Alland|3124322434|jeremy.alland@rushortho.com|
21253273|NCT02060370|University of Texas MD Anderson Cancer Center|Dr. Eric Jonasch, MD/Professor, Genitourinary Medical Oncology|713-792-2830|ejonasch@mdanderson.org|
21253274|NCT01896557|Heart Institute of University of Sao Paulo Medical School|Remo Holanda de Mendonca Furtado|+5511 26615058|remo_holanda@hotmail.com|
21253275|NCT00731133|UAMS|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu|
21253276|NCT03098563|Johns Hopkins University|Claudia Campbell|4105507989|ccampb41@jhmi.edu|
21253277|NCT01517295|International Clinical Research Institute|Srinivas Nalamachu|913.317.5300|nalamachu@yahoo.com|
21253278|NCT02672852|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21253279|NCT02182947|Children's Mercy Hospital|Nadia Hijaz|3139204958|nmhijaz@cmh.edu|
21253280|NCT03248882|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21253281|NCT04308590|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
21253282|NCT02734576|North Shore University Hospital Northwell Health|Dr. Athos Patsalides|516-562-2244|apatsalides@northwell.edu|
21253283|NCT01156376|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
21253284|NCT01493427|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
21253285|NCT00827099|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD|404-255-1930|ssolomon@bmtga.com|
21253286|NCT03846453|Hanall Biopharma|Project Manager|82-222041763|parksm@hanall.co.kr|
21253287|NCT01681121|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-970-7145|ClinicalTrialDisclosure@JazzPharma.com|
21253288|NCT02628028|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21253289|NCT02839889|Four Seasons Compassion for Life|Janet Bull, MD|8286926178|jbull@fourseasonscfl.org|302
21253290|NCT02738853|Medtronic|Phuong-Uyen Le|763-526-0989|phuong-uyen.n.le@medtronic.com|
21253291|NCT01390870|GlaxoSmithKline|GSK Response Center|866-435-7343||
21253292|NCT01012297|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Administration and Operations|(716) 845-5702|kurasa@nrgoncology.org|
21253293|NCT00515723|Washington University School of Medicine and Florida Atlantic University|John Newcomer, M.D.|561-297-0252|jnewcomer@fau.edu|
21253294|NCT00653523|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21253295|NCT02870049|UC San Diego|Samir Gupta, MD|07/09/2018|s1gupta@health.ucsd.edu|
21253296|NCT05686122|Duke University School of Medicine|Sarah Kelleher, PhD|919-416-3405|sarah.kelleher@duke.edu|
21253297|NCT05543707|Pardes Biosciences|Vice President, Quality|4042815163|jenna.tagliaferri@pardesbio.com|
21253298|NCT00186888|St. Jude Children's Research Hospital|Ibrahim Qaddoumi MD|1-866-278-5833|info@stjude.org|
21253299|NCT05511038|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
21253300|NCT02108964|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21253301|NCT03006848|St Jude Children's Research Hospital|Dr. Michael Bishop|866-278-5833|referralinfo@stjude.org|
21253302|NCT05543187|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21253303|NCT00384397|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21253304|NCT02336451|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21253305|NCT03520712|BioMarin Pharmaceutical (UK) Ltd.|Konstantia-Maria Chavele, PhD, Director, Clinical Sciences|+44207|KonstantiaMaria.Chavele@bmrn.com|4203351
21253306|NCT05570630|University of Rochester|Cynthia Rand, PI|5852759316|cynthia_rand@urmc.rochester.edu|
21253307|NCT04531982|Acadia Pharmaceuticals Inc.|Senior Director, Medical Information|8444222342|medicalinformation@acadia-pharm.com|
21253308|NCT04998812|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21253309|NCT03446001|TauRx Therapeutics Management Ltd.|Sotereos Gates, PhD|+44 (0) 7771 570707|s.gates@taurx.com|
21253310|NCT06748729|Össur Iceland ehf.|Laurine Roussillon|+3548221812|lroussillon@ossur.com|
21253311|NCT03578887|University of Washington|Ellen Schur, MD, MS|206-543-8433|ellschur@uw.edu|
21253312|NCT01099215|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21253313|NCT02083107|AinShams University|Dr. Mohamed S. Sweed, Dr.Mourad M.El-Said, Dr.Amgad E. Abou-Gamrah, Dr.Mohamed M. Abd-El-Hamid|01001222047|drmsweed@gmail.com|+2
21284204|NCT02649426|ReCor Medical Inc.|Chief Clinical Officer|+1-650-420-8048|hreeve-stoffer@recormedical.com|
21253314|NCT03333876|Philips Respironics|Noah Papas|4122776436|Noah.Papas@philips.com|
21253315|NCT00336700|UPMC CancerCenter|Herbert Zeh, MD|412-692-2852|zehxhx@upmc.edu|
21253316|NCT00095498|Amgen Inc.|Study Director|866-572-6436||
21253317|NCT00550589|Statistical Center of AIDS Malignancy Consortium|Jeannette Lee|(501) 526-6712|jylee@uams.edu|
21253318|NCT05020327|University Hospitals Cleveland Medical Center|Dr. Ankita Desai|216-844-3645|Ankita.Desai@UHhospitals.org|
21253319|NCT00166712|Comprehensive Transplant Center, Northwestern University|Joseph Leventhal, MD, PhD, Associate Professor|(312) 695-1703|jleventh@nmh.org|
21253320|NCT01302080|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21253321|NCT04370548|Dare Bioscience, Inc.|VP, Clinical Operations|858-926-7655|nzack@darebioscience.com|109
21253322|NCT00503139|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21253323|NCT01827475|Emergency Medicine, Stony Brook U|Dr. Adam Singer|631 444 7856|adam.singer@stonybrook.edu|
21253324|NCT00833833|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21253325|NCT02040259|Stryker Neurovascular|Minyi Ji, Biostatistician, Clinical Evidence|+1 (510) 980-5689|minyi.ji@stryker.com|
21253326|NCT00316602|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
21253327|NCT01142232|IndianaU|Dr. Attaya Suvannasankha|(317) 278-9306|asuvanna@iu.edu|
21253328|NCT00626990|EORTC|Dr. Thierry Gorlia|027741652|thierry.gorlia@eortc.org|
21253329|NCT04138576|ServierRussia|Medical Manager-Olga Linnik|8-495-93707-00|olga.linnik@servier.com|1316
21253330|NCT01994837|AbbVie|Global Medical Services|800-633-9110||
21253331|NCT00574873|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21253332|NCT00581555|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21253333|NCT05816330|National Institute of Allergy and Infectious Diseases (NIAID)|Dr. Peter D Crompton|301-761-5042|pcrompton@niaid.nih.gov|
21253334|NCT00201643|Obstetrix Medical Group, Inc.|Kimberly A. Maurel, MSN, CNS|714-593-9171|kimberly_maurel@pediatrix.com|
21253335|NCT03446781|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|ClinicalTrials@Endo.com|
21253336|NCT02060539|CooperVision|Cheryl McKinnon|925-251-2034|cmckinnon@coopervision.com|
21253337|NCT02093949|Saint joseph hospital|Dr Julien Seitz|+330491807044|jseitz@hopital-saint-joseph.fr|
21253338|NCT02796300|UCLA Medical Center|Principal Investigator|310-267-8771|EdwardLee@mednet.ucla.edu|
21253339|NCT05141500|Stryker Sustainability Solutions|Monique Ketcher|602-354-0917|monique.ketcher@stryker.com|
21284205|NCT01606202|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
21253340|NCT01940939|Dr.LIU|ShanghaiMHC|862134773775|erliu110@126.com|
21253341|NCT01470001|University at Buffalo|Dr Tova Ablove|716-878-7138|tablove@buffalo.edu|
21253342|NCT03268603|Mayo Clinic|Nathan Staff, M.D., Ph.D.|507-293-1283|Staff.Nathan@mayo.edu|
21253343|NCT01725126|GlaxoSmithKline|GSK Response Center|866-435-7343||
21253344|NCT03733314|EA Pharma Co., Ltd|Corporate Communication Dept.|+81-(0)3-6280-9600|contact_ea@eapharma.co.jp|
21253345|NCT03214640|Wake Forest Health Science|Peter Pan, MD|336-716-1228|ppan@wakehealth.edu|
21253346|NCT04246021|King Hussein Cancer Center|Dr. Hikmat Abdel-Razeq|0096265300460|habdelrazeq@khcc.jo|1403
21253347|NCT01693900|Beaumont Health|Randy Fayne, DO|248-898-1905|rfyane@beaumont.org|
21253348|NCT02075073|Samsung Bioepis|Director, Clinical Development|+82 31 8061 4534||
21253349|NCT03894618|Shattuck Labs|VP, Clinical Operations|919-864-2700|clinicaltrials@shattucklabs.com|
21253350|NCT04481568|Northwell Health|Dr. Liron Sinvani, Principal Investigator|646-766-7169|ldanay@northwell.edu|
21253351|NCT02683785|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21253352|NCT01305408|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21253353|NCT00795275|University of Colorado Anschutz Medical Campus|Leigh Perreault, MD|303-249-7732|leigh.perreault@ucdenver.edu|
21253354|NCT02233803|GlaxoSmithKline|GSK Response Center|866-435-7343||
21253355|NCT00468143|NYU School of Medicine|Dr. Lenard Adler|(212) 263-3580|lenard.adler@nyumc.org|
21253356|NCT01353118|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
21253357|NCT02297100|Wake Forest University Health Sciences|Dr. Robert Evans|336-713-0320|revans@wakehealth.edu|
21253358|NCT01204710|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21253359|NCT04561778|Geisinger Health System|Dr Pugazhendhi Vijayaraman|5708086020|pvijayaraman1@geisinger.edu|5444
21253360|NCT04531904|CERENOVUS|Cerenovus Clinical Research Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21253361|NCT01743989|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
21253362|NCT04655027|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-94 79|information.center@astrazeneca.com|
21253363|NCT03519997|University Texas Southwestern Medical Center|David Hsieh|214/648-4180|David.Hsieh@UTSouthwestern.edu|
21253364|NCT03361605|University of Michigan|Amy McKinney|734-647-8129|adrongo@med.umich.edu|
21253365|NCT02906007|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
21253366|NCT01800890|Coloplast A/S|Marian Sinvani|+45 4911 2356|dkmards@coloplast.com|
21253367|NCT04372121|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
21253368|NCT00542542|University of Texas MD Anderson Cancer Center|Dr. Farzin Goravanchi, Professor, Anesthesiology & Perioperative Medicine|713-563-5613|CR_Study_Registration@mdanderson.org|
21253369|NCT06988800|Muvik|Dr. Chelsea Gordon|9063990332|chelsea@muviklabs.io|
21284206|NCT00306787|Novartis Pharmaceuticals|Study Director|862-778-8300||
21284207|NCT01870297|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979||
21284208|NCT00337779|Teva Pharmaceutical Industries, Ltd.|Chen Duksin, MD|972-9-863-4642|chen.duksin@teva.co.il|
21237258|NCT02723864|National Cancer Institute|Dr. Alice Chen|240-781-3274|chenali@mail.nih.gov|
21299184|NCT01673828|Department of Neurology, School of Medicine, University of California, Davis|Dr. Michael Rogawski|916-734-6285|rogawski@ucdavis.edu|
21237259|NCT00082173|Johns Hopkins University|Dr. Richard Chaisson|410-955-1755|rchaiss@jhmi.edu|
21237260|NCT00746590|BTG International Ltd.|Claire Daugherty|+1 801 556 8882|claire.daugherty@btgplc.com|
21237261|NCT01738750|University of Utah|Dr. Eric Scaife|801-662-2950|eric.scaife@imail2.org|
21237262|NCT02526654|Wills Eye Hospital, Glaucoma Research Center|Dr. L. Jay Katz|215-928-3123|ljkatz@willseye.org|
21237263|NCT02633800|Daiichi Sankyo, Inc.|Global Clinical Leader|9089926400|CTRinfo@DSI.com|
21299185|NCT00990106|VA Puget Sound Health Care System|Murray Raskind, MD|206-277-3797|Murray.Raskind@va.gov|
21299186|NCT02926638|SWOG|Lung Committee Statistician|2066677733|kmini@fredhutch.org|
21299187|NCT01663012|Stanford University School of Medicine650-|Lawrence Recht, MD, Professor of Neurology|650-725-8630|lrecht@stanford.edu|
21299188|NCT00791908|Northwestern University|Murad Alam, MD|312-695-6785|m-alam@northwestern.edu|
21299189|NCT02464410|Veterans Health Administration|Amy Bohnert|734-845-3638|amybohne@med.umich.edu|
21299190|NCT00882440|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
21299191|NCT04319198|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21299192|NCT00905450|Bausch Health|Study Director||susan.harris@bauschhealth.com|
21299193|NCT00467077|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
21299194|NCT02123134|Allergan, Inc|Beta Bowen|714-246-4446|Bowen_Beta@allergan.com|
21299195|NCT00962208|The Hong Kong Polytechnic University|Prof Pauline Cho|(852) 2766-6100|sopaulin@polyu.edu.hk|
21299196|NCT00904813|Karolinska Institutet|Anna Martling|+46851770000|anna.martling@ki.se|
21237264|NCT01030861|Benaroya Research Institute|Carla Greenbaum, MD|206-342-6933|cjgreen@benaroyaresearch.org|
21237265|NCT02836418|aTyr Pharma|Study Director|858 731 8389|clinicaltrials@atyrpharma.com|
21237266|NCT02261493|Allergan, Inc|Tanya Brandstetter|714-246-2567|brandstetter_tanya@Allergan.com|
21237267|NCT03643952|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21237268|NCT01358968|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21237269|NCT01597050|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
21237270|NCT01992380|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
21237271|NCT02065336|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
21237272|NCT00209417|GE Healthcare|Paul Gordon, PhD|011-47-2318-5822|Paul.Gordon@ge.com|
21237273|NCT00363675|Shrines Hospitals for Children - Boston|Mary Jo Baryza, Diredtor of Therapeutic Services|617-371-4749|mbaryza@shrinenet.org|
21237274|NCT01803074|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21237275|NCT05098054|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21237276|NCT01016769|Memorial Sloan Kettering Cancer Center|Dr. David Pfister, MD|646-888-4237|pfisterd@mskcc.org|
21237277|NCT01618162|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
21237278|NCT01654549|Tehran University of Medical Sciences|Dr Raika Jamali|982163120000|jamalira@tums.ac.ir|411
21237279|NCT01763931|SKCCC at Johns Hopkins|Vered Stearns, MD|410-614-1361|HopkinsBreastTrials@jhmi.edu|
21237280|NCT04460742|University of Rochester|Adam Simning|585-474-9534|adam_simning@urmc.rochester.edu|
21237281|NCT04391023|University of Iowa|Dr. Alexandra Courtney Fietsam|N/A|alexandra-fietsam@uiowa.edu|
21237282|NCT01270347|Horizon Pharma USA, Inc|Medical Monitor|1-866-479-6742|medicalinformation@horizontherapeutics.com|
21299197|NCT01173016|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|612-626-2313|orcha001@umn.edu|
21299198|NCT00657540|Rocky Mountain Poison and Drug Center|Victoria Anderson - Research Projects Manager|303-389-1236|victoria.anderson@rmpdc.org|
21299199|NCT01731912|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
21299200|NCT00141453|Daiichi Sankyo, Inc|Howard Kessler|732-590-5032|hmkessler@dsi.com|
21299201|NCT02043938|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
21299202|NCT03010527|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21299203|NCT01458639|Cyclomedica Australia Pty Ltd|Gary Somerville, Quality and Regulatory Manager|+61 (0)2 9541 0411|gsomerville@cyclomedica.com.au|
21299204|NCT04245111|Dartmouth Health Orthopaedics|Dr. Ida Leah Gitajn|(603) 650-5133|Ida.Leah.Gitajn@hitchcock.org|
21299205|NCT06039579|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21299206|NCT02349633|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21299207|NCT00667628|Taiho Oncology, Inc.|Taiho Central|+1 844-878-2446|medicalinformation@taihooncology.com|
21299208|NCT04663321|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
21299209|NCT04862065|Abbott Laboratories|Tuan Bui (Manager Clinical Research)|224-668-4702|tuan.l.bui@abbott.com|
21299210|NCT02611479|Surgical Outcomes Research Center - SORCE|Dr. Amy Cizik - Research Assistant Professor, Ph.D., M.P.H.,|206-744-4631|amorgan2@uw.edu|
21299211|NCT00743249|Alcon Research, Ltd.|Theresa A. Landry, Ph.D.|1-888-451-3937|alcon.medinfo@alcon.com|
21299212|NCT01960140|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21299213|NCT02269124|Massachusetts Eye and Ear|Dr. Michael S. Cohen, MD|6175733190|Michael_Cohen@MEEI.HARVARD.EDU|
21299214|NCT03776864|University of Washington|Dr. Ryan Lynch|206-606-1739|rclynch@uw.edu|
21237283|NCT02085408|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21299215|NCT03452540|Afimmune|Study Director|+353 1 2946380|regulatory.afimmune@afimmune.com|
21237284|NCT02189798|Advanced Bionics|Michelle Caulfield, Senior VP, Global Quality Assurance and Regulatory Affairs|6613621400|clinicalresearch@advancedbionics.com|
21299216|NCT00716963|McMaster University|Dr. Gail Gauvreau|905-525-9140|gauvreau@mcmaster.ca|22791
21299217|NCT01009060|GlaxoSmithKline|GSK Response Center|866-435-7343||
21253370|NCT02344290|REPRIEVE Clinical Coordinating Center|REPRIEVE Project Manager|617-724-9109|mghreprievetrial@mgb.org|
21253371|NCT03898778|Minnesota Medical Technologies Corporation|VP of Regulatory Affairs|507-533-0366|rmanglin@mnmedicaltechnologies.com|
21284209|NCT01074255|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21284210|NCT00314132|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21284211|NCT01451632|Merrimack Pharmaceuticals, Inc.|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
21284212|NCT00585715|University of California, Irvine|Kristen M. Kelly, M.D.|949-824-7103|kmkelly@uci.edu|
21284213|NCT04891406|Imperial Tobacco Ltd|Simon McDermott|+44 (0)117 332 0225|simon.mcdermott@uk.imptob.co|
21284214|NCT03627416|Jagiellonian University Medical College|Dr. Jakub Antczak|+48 795 421 153|jantczak@uj.edu.pl|
21284215|NCT02968433|Stanford University|Dr. Helen Bronte-Stewart|650-723-6709|hbsmovlab@gmail.com|
21284216|NCT00875433|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21284217|NCT00637806|Endo Pharmaceuticals Inc.|M. Todd Kirby, PhD|(484) 216-6491|kirby.todd@endo.com|
21284218|NCT00885742|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
21284219|NCT01319851|Emory University|Dr. John Horan|404-785-1272|jthoran@emory.edu|
21284220|NCT00622336|Celgene Corporation|Senior Manager, Clinical Trial Disclosure|1-888-260-1599|ClinicalTrialDisclosure@celgene.com|
21284221|NCT04612777|New York State Psychiatric Institute|Dr. Michael Compton|4043759231|mtc2176@cumc.columbia.edu|
21284222|NCT05497960|IMPACTIV (Vivo)|Eric Levitan|770-331-3208|eric@teamvivo.com|
21284223|NCT04148287|Basilea Pharmaceutica International Ltd, Allschwil|Study Director|+41 79 701 0551|marc.engelhardt@basilea.com|
21299218|NCT02726620|Vanderbilt University Medical Center|Jonathan Wanderer|615-536-5194|jon.wanderer@vanderbilt.edu|
21284224|NCT01131065|Instituto Grifols, S.A.|Michael Woodward, BSc, M.Sc|+34 935712200|michael.woodward@grifols.com|
21284225|NCT02923245|Brown University|Almaz Dessie, MD||almaz@brown.edu|
21284226|NCT00824382|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21284227|NCT02680834|TactileMedical|Clinical Research Director|612-540-5267|astone@tactilemedical.com|
21284228|NCT02520427|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21284229|NCT00793624|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21284230|NCT02227368|AstraZeneca Pharmaceuticals LP|Naeem Khan, MD|+1 302-885-8976|Naeem.Khan@astrazeneca.com|
21284231|NCT01043094|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@KowaUS.com|
21284232|NCT02437188|Baylor College of Medicine|Dr. Lilian Dindo, Assistant Professor|713-440-4637|lilian.dindo@bcm.edu|
21284233|NCT01663857|Eli Lilly and Company|Chief Medical Officer|800-575-5979|Clinicaltrials.gov@lilly.com|
21284234|NCT02517021|Helsinn Healthcare SA|Dr. Ruben Giorgino|+41 91 985 2121|ruben.giorgino@helsinn.com|
21284235|NCT01172808|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21284236|NCT00499343|U.T. M.D. Anderson Cancer Center|Chitra M. Hosing, MD / Associate Professor|713-792-8750||
21284237|NCT03959488|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21284238|NCT01716520|GlaxoSmithKline|GSK Response Center|866-435-7343||
21284239|NCT02370056|Cleveland Clinic|Dr. Emre Gorgun|216 444-1244|GORGUNE@ccf.org|
21253372|NCT05430815|Emory University|Anne Dunlop, MD, MPH|404-712-8520|amlang@emory.edu|
21253373|NCT04047862|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21253374|NCT05014568|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
21284240|NCT00593606|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
21284241|NCT00869557|Gilead Sciences, Inc|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21253376|NCT06118957|University of Utah Obgyn|Elizabeth Turner, MPH, Senior Regulatory Coordinator|8012018929|elizabeth.e.turner@hsc.utah.edu|
21253377|NCT01732822|AstraZeneca R&D|Brilinta Global Clinical Lead|+46 31 776 10 00|kontakt@astrazeneca.com|
21253378|NCT01077271|Abbott|Global Medical Services|1-800-633-9110||
21253379|NCT00215137|Duke University Medical Center Dept of Psychiatry|Wei Zhang MD|919 684 5645|wei.zhang@duke.edu|
21253380|NCT04684394|Gemini Therapeutics, Inc.|Gemini Therapeutics, Inc.|617-401-4401|clinicaltrials@geminitherapeutics.com|
21253381|NCT02548845|Otsuka Pharmaceutical Europe Ltd.|Medical Department|+44(0)2037475000||
21253382|NCT00482690|University of Nebraska Medical Center|Stephen Rennard|402-559-7313|srennard@unmc.edu|
21253383|NCT00591370|Memorial Sloan-Kettering Cancer Center|Dr. Paul Chapman|212-639-7357|chapmanp@mskcc.org|
21253384|NCT00640133|Butler Hospital|Dr. Benjamin Greenberg|(401) 455-6602|be3ngreenb@gmail.com|26602
21253385|NCT01183260|Cleveland Clinic|Alison Klika, Research Program Manager|216-444-4954|klikaa@ccf.org|
21253386|NCT02225132|National Heart Lung and Blood Institute|Fitzhugh, Courtney|+1 301 402 6496|courtney.fitzhugh@nih.gov|
21253387|NCT01202903|Novartis Pharmaceuticals|Study Director|862-778-8300||
21253388|NCT00095056|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
21253389|NCT00306670|Georgetown University|Craig M Kessler, MD|202-444-8676|kesslerc@georgetown.edu|
21253390|NCT04019990|Hacetepe University|Ceyda Sofuoğlu M.Sc.|+905338557742|ceyda_sofuoglu@hotmail.com|
21253391|NCT02654691|Aarhus University|Nanna Finnerup|0045 78463382|finnerup@clin.au.dk|
21253392|NCT02735577|New York State Psychiatric Institute|Nasir Naqvi, MD|6467748181|nasir.naqvi@nyspi.columbia.edu|
21253393|NCT01951352|UCSD Dermatology Clinical Trials|UCSD Dermatology Clinical Trials Manager|(858)657-8390|dermstudies@ucsd.edu|
21284242|NCT02305446|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21284243|NCT05940077|Tufts University|Dr. Evan Papa|617-636-4056|evan.papa@tufts.edu|
21253394|NCT04142359|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
21253395|NCT02898077|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21253396|NCT00794144|Alcon Research Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21253397|NCT02885324|Indiana University|Dr. Scott Coven|317-944-8784|scoven@iu.edu|
21253398|NCT01066520|Biologische Heilmittel Heel GmbH|Dr. Istvan Zatik|+4972215013192|istvan.zatik@heel.com|
21253399|NCT03896152|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21253400|NCT04939701|Astellas Pharma Global Development Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
21253401|NCT03199118|Cairo University|Sarah Elbanna, assistant lecturer at the Oral Medicine and Periodontology department|+201000760002|srhelbanna@gmail.com|
21253402|NCT01353859|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21253403|NCT01656200|University of Liverpool|Dr Lance Turtle|+44 151 795 9626|lance.turtle@liverpool.ac.uk|
21253404|NCT02236988|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21253405|NCT01652495|Istituto Ortopedico Rizzoli|Milva Battaglia, Director of Clinical Trials|0516366026|milva.battaglia@ior.it|0039
21253406|NCT05775991|University of Rochester|Dr. Allison Magnuson|585-602-5085|allison_magnuson@urmc.rochester.edu|
21253407|NCT00919191|Valeant Pharmaceuticals International, Inc|David Lineberry, Associate Director, Clinical Operations|949-973-1153|David.Lineberry@valeant.com|
21253408|NCT00821951|Yale University|Dr. Roy H Decker, MD PhD|203 737-2758|roy.decker@yale.edu|
21253409|NCT01461811|Alcon Research, Ltd.|Mary Fahmy, OD, Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21253410|NCT01072630|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21253411|NCT03046121|Penn State University|Marie Boltz PhD|215-962-9712|mpb40@psu.edu|
21253412|NCT04155047|Sunovion Respiratory Development Inc.|Respiratory Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
21253413|NCT04514510|National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH)|Arun Shet, MD, PhD|301.827.6808|arun.shet@nih.gov|
21253414|NCT02781090|Montefiore Medical Center|Dr. Jonathan Shuter|718-920-7845|jshuter@montefiore.org|
21253415|NCT00643617|Accuray, Inc.|Director of Clinical Affairs|608-824-3421|sgodbold@accuray.com|
21253416|NCT01208103|UT MD Anderson Cancer Center|Dr. Michael Overman/Gastrointestinal Medical Oncology|713-745-4317|MOverman@mdanderson.org|
21253417|NCT02551653|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21253418|NCT00416195|Eisai Call Center|Eisai Inc.|888-422-4743||
21299219|NCT04864249|University of Pittsburgh Medical Center, Magee-Womens Hospital|Dr. Alisse Hauspurg|412-641-1381|janickia@upmc.edu|
21253419|NCT01882764|Hutchison MediPharma Ltd|Dr. Rongjun Liu|+86 21 2067 3203|rongjunl@hmplglobal.com|
21253420|NCT00414167|Yale University School of Medicine|Dr. Marney A. White|203-785-4349|marney.white@yale.edu|
21253421|NCT00472849|The University of Texas MD Anderson Cancer Center|William G. Wierda, MD, PhD, BS / Associate Professor|713-745-0428|eharriso@mdanderson.org|
21253422|NCT01606670|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
21253423|NCT05254080|Medical University of South Carolina|Dr. Christopher W. Austelle|843-792-2872|austelle@musc.edu|
21253424|NCT03653208|ImmuneMed Inc.|Byoungok Ahn|+82-2-527-8391|ahnbo@immunemed.co.kr|
21253425|NCT00368927|National Jewish Health|James R. Jett, M.D.|303-270-2601|JettJ@NJHealth.org|
21253426|NCT01877239|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21253427|NCT04368364|The University of Texas Health Science Center at Houston|Sudipta Sen, MD, Assistant Professor|713-500-6200|Sudipta.Sen@uth.tmc.edu|
21253428|NCT01989169|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21253429|NCT01114880|Abbott|Global Medical Services|1-800-633-9110||
21253430|NCT02539459|Fox Chase Cancer Center|Robert Uzzo, M.D.|215-728-3096|robert.uzzo@fccc.edu|
21299220|NCT03192826|Patras Medical School|OPHTHALMOLOGY PATRAS|6975801961|cgeorg@upatras.gr|
21299221|NCT00739401|Endologix|Elisa Hebb, VP Clinical Affairs|949-598-4628|ehebb@endologix.com|
21299222|NCT01239381|Massachusetts General Hospital|Theodore S Hong, MD, physician radiation oncology|617-726-6050|TSHONG1@mgh.harvard.edu|
21299223|NCT00988884|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21299224|NCT02738008|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
21299225|NCT04621448|University of California, San Francisco|Dr. Deborah Barnes|415-502-2943|deborah.barnes@ucsf.edu|
21299226|NCT03022396|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
21299227|NCT04590014|Vapotherm Inc|Katherine Gerich|5854696753|kgerich@vtherm.com|
21299228|NCT00468299|University of Rochester|Dr. Sarah Betstadt|585-276-5368|sarah_betstadt@urmc.rochester.edu|
21299229|NCT01216202|Karolinska Institutet|Anna Martling|+46851770000|anna.martling@ki.se|
21299230|NCT03546621|Hepatera LLC|Dr.Alexander Alexandrov|+7 (495) 726-52-53|alexandrov@myr-pharma.com|42-03
21299231|NCT00646646|University of Alabama at Birmingham|Dr. Michael Froelich|205-934-4711|froelich@uab.edu|
21253431|NCT00283244|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
21299232|NCT00226590|Karmanos Cancer Institute (formerly at Moffitt Cancer Center)|Gerald Bepler, M.D., Ph.D., c/o Moffitt Cancer Center|813-745-4398|beplerg@karmanos.org|
21299233|NCT00377520|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21299234|NCT00660192|Yale School of Medicine|Baman,Jabbari M.D. Porfessor of Neurology|203-737-2464|bahman.jabbari@yale.edu|
21299235|NCT02111447|GLA|Research Coordinator|7163236570|tgensler@greatlakesanes.com|
21299236|NCT01091675|Unidad de Reumatología, Hospital Parc Tauli de Sabadell. Institut Universitari UAB|Dr. Jordi Gratacós Masmitjá|937.23.10.10|jgratacosmas@gmail.com|
21299237|NCT02794207|Children's Hospital of Philadelphia|Dr. Richard Aplenc|267-426-7252|aplenc@email.chop.edu|
21299238|NCT04908397|Vanderbilt University Medical Center|Anna R. Hemnes|615-343-8227|anna.r.hemnes@vumc.org|
21253432|NCT01585155|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21253433|NCT02235311|University of Missouri - Columbia|Ashley McCormick, PharmD, BCPS|573-771-7798|ausmusash@health.missouri.edu|
21284244|NCT00388297|The George Washington University Biostatistics Center|Elizabeth Thom, Ph.D.|301-881-9260|e_thom@bsc.gwu.edu|
21284245|NCT01492101|Nektar|Alison Hannah, MD||AHannah@nektar.com|
21284246|NCT03933020|The University of Texas Health Science Center at Houston|Rohini D. Samudralwar, MD|(832) 325-7077|Rohini.D.Samudralwar@uth.tmc.edu|
21284247|NCT01463358|Casa di Cura san Pio XI|Massimo Santini MD FESC FACC|+390666494491|m.santini@rmnet.it|
21284248|NCT01004718|University of Pennsylvania|Ellen Napier, CRNP|215.279.1972|ellen.napier@pennmedicine.upenn.edu|
21284249|NCT04105010|Dizal Pharmaceuticals|Rika Chen|862161095875|clinicaltrials@dizalpharma.com|
21284250|NCT01211483|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21284251|NCT03724084|The Ohio State University Comprehensive Cancer Center|Dr. James Blachly|614-293-7484|James.Blachly@osumc.edu|
21284252|NCT01149421|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21284253|NCT03570554|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
21284254|NCT03738800|Mayne Pharma|Mayne Pharma|1 252 752 3800|us.medicalinformation@maynepharma.com|
21284255|NCT00355706|Pain Management Center of Paducah|Laxmaiah Manchikanti, MD|2705548373|drm@asipp.org|100
21284256|NCT02719353|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
21284257|NCT02777944|Bournemouth University|Prof. Katherine Appleton|+441202965985|k.appleton@bournemouth.ac.uk|
21284258|NCT00231309|Emory University|Kuang-Yueh Chiang, MD|404-785-1441|kuang-yueh.chiang@choa.org|
21284259|NCT01153620|B. Braun Medical, Centre of Excellence|Medical Affairs Manager|+41 58 258 55 47||
21284260|NCT03515629|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21284261|NCT00424021|Gilead Sciences, Inc.|Karen L Miller, PhD|650-524-3892|KarenL.Miller@gilead.com|
21284262|NCT01254721|SM&M Korea|Hui Jung Sin / Clinical Project Leader|82-2-2188-2165|ClinicalTrialTransparency@astrazeneca.com|
21284263|NCT02477709|Afferent Pharmaceuticals, Inc.|Chief Medical Officer|650-286-1276|info@afferentpharma.com|
21284264|NCT03170609|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21284265|NCT05708703|University of Minnesota, Masonic Cancer Center|Dr. Rachel Vogel|612-624-6928|isak0023@umn.edu|
21284266|NCT02315872|Providence Health & Services|Lynette Currie|503-216-1034|lynette.currie@providence.org|
21284267|NCT01592292|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21284268|NCT00335959|SWOG Statistical Center|Study Statistician|206-667-4623||
21284269|NCT02028169|AbbVie|Global Medical Services|800-633-9110||
21284270|NCT03482167|University of Delaware|Christopher R. Martens, Ph.D.|302-831-7270|cmartens@udel.edu|
21284271|NCT00737893|Johns Hopkins Brady Urological Institute|Dr. Hiten Patel|410-502-7710|hiten.patel@lumc.edu|
21284272|NCT01001598|Boston Children's Hospital|Colin A. Sieff|617 919-4241|colin.sieff@childrens.harvard.edu|
21284273|NCT02722837|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21284274|NCT02167815|Nemocnice Podlesí|MuDr Jan Stryja|+420 558 304 111|Jan.stryja@atlas.cz|
21284275|NCT01343667|W. L. Gore & Associates|Bryan Randall, Clinical Biostatistician|928-864-4832|BRandall@WLGore.com|
21284276|NCT00810446|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21284277|NCT02240069|University of Montana|Curtis Noonan|406-243-4957|curtis.noonan@umontana.edu|
21284278|NCT00106639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21284279|NCT01096589|Centre for Reasearch and Implementation of Clinical Practice (CRICP)|Prof. Christine Moffatt, Principal Investigator|+44 20 73 51 14 11|christine.moffatt@cricp.org.uk|
21299239|NCT03318549|University of Miami|Vice Chair of Research|305-326-6373|fmedeiros@med.miami.edu|
21299240|NCT00462306|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu|
21253434|NCT00658788|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5000|elizabeth.nieman@galderma.com|
21253435|NCT03898167|The University of Texas MD Anderson Cancer Center|Dr. Jane Montealegre|713-792-0919|jrmontealegre@mdanderson.org|
21253436|NCT01937026|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21253437|NCT00994175|National Heart Lung and Blood Institute|Levine, Stewart|+1 301 402 1448|levines@nhlbi.nih.gov|
21253438|NCT02745353|UCSD|Eric Roeland, MD|(858) 534-7079|eroeland@ucsd.edu|
21253439|NCT04015869|Yale University School of Medicine, Department of Psychiatry|Elizabeth Ralevski|203-932-5711|Elizabeth.Ralevski@yale.edu|1-4282
21253440|NCT03232580|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21284280|NCT00948506|University of Pennsylvania|Joy Wan|2157466364|joy.wan@uphs.upenn.edu|
21284281|NCT01294007|ATEC Spine|Saba Pasha, Director Clinical Research & Data Science|760-356-6639|spasha@atecspine.com|
21299241|NCT03515824|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21299242|NCT00539994|GlaxoSmithKline|GSK Response Center|866-435-7343||
21299243|NCT02673918|University of British Columbia|Bolette Rafn|604-827-1914|bolette.rafn@ubc.ca|
21299244|NCT05470985|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21299245|NCT01917747|UK Dept. of Otolaryngology Head and Neck Surgery|Dr. Matthew L. Bush|859-218-2168|matthew.bush@uky.edu|
21284282|NCT03233204|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21299246|NCT06451965|University of East Anglia|Ercan Hassan (Trainee Clinical Psychologist)|07496337806|nue22cyu@uea.ac.uk|
21237285|NCT03842995|Hudson Alpha Institute for Biotechnology|Greg Cooper, PhD|2563279490|gcooper@hudsonalpha.org|
21284283|NCT01043562|Vanderbilt University (current institution)|Dr. Andrew E. Radbill|615-322-7447|andrew.radbill@vanderbilt.edu|
21237286|NCT01362140|Amgen Inc.|Study Director|866-572-6436||
21299247|NCT04879628|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
21299248|NCT00055692|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
21299249|NCT02348593|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-970-7145|ClinicalTrialDisclosure@JazzPharma.com|
21299250|NCT00360412|Eisai Call Center|Eisai Inc.|888-422-4743||
21299251|NCT03861273|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21299252|NCT00191334|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21299253|NCT03064490|Duke University Health System (DUHS)|Linda Kaltenbach/Regulatory Coordinator|(919) 668-3726|linda.kaltenbach@duke.edu|
21299254|NCT01855360|Brigham and WQomen's Hospital|Rodney H Falk|6175257053|rfalk@bwh.harvard.edu|
21299255|NCT01063153|Massachusetts General Hospital|Chief, Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD|(617)-724-0006|jbiederman@partners.org|
21299256|NCT01777776|Array BioPharma, Inc.|Study Director|303-381-6604|info@arraybiopharma.com|
21299257|NCT02722564|St. Luke's University Health Network|Holly Stankewicz, D.O.|484-526-4000|holly.stankewicz@gmail.com|
21299258|NCT01273766|Comprehensive Cancer Center of Wake Forest University|Dr. Mary Ann Knovich|336-716-7973|mknovich@wakehealth.edu|
21299259|NCT01782898|Northwestern University|Gildasio De Oliveira, M.D.|312-695-4858|gjr@northwestern.edu|
21299260|NCT02426580|The Nephrology Department, the Chengdu Second Affiliated Hospital of Chongqing Medical University, the Third Peoples's Hospital of Chengdu|Dr. Gong Rong, Dr. Han Tianzhao, Dr. Leonard Stern|+86 028-61318708|gongr2006@sina.com|
21299261|NCT00383552|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21299262|NCT03096834|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21299263|NCT00966654|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
21253441|NCT00091169|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
21299264|NCT00575185|University of Minnesota|Hank Balfour MD|(612) 626-5670|balfo001@umn.edu|
21299265|NCT04046328|Pharmascience Inc.|Clinical Study Manager|514-340-9800|researchsupport@pharmascience.com|
21299266|NCT01195701|TriHealth Hatton Research Institute|Academic Clinical Research Supervisor|513-862-2330|Angie_Fellner@trihealth.com|
21299267|NCT01600326|University of Michigan|Jon Jacobson|734 936-4365|jjacobsn@umich.edu|
21299268|NCT04456504|University of Wisconsin School of Pharmacy|Mary Hayney, PharmD, MPH, FCCP, BCPS|608-265-4666|mary.hayney@wisc.edu|
21299269|NCT00762359|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21299270|NCT01342913|GlaxoSmithKline|GSK Response Center|866-435-7343||
21299271|NCT05295849|University of Connecticut|Sherry Pagoto, PhD|860-486-5917|sherry.pagoto@uconn.edu|
21253442|NCT04410523|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21253443|NCT00490490|Stanford University Medical Center|Susan J. Knox, MD, Associate Professor of Radiation Oncology|(650) 725-2720|sknox@stanford.edu|
21253444|NCT03207451|Inova Health System|Director of Clinical Trials|443-244-1497|kevin.bliden@inova.org|
21253445|NCT02040584|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21284284|NCT02908074|Mereo BioPharma Group|Jackie Parkin|+44 (0) 333 023 7300|enquiries@mereobiopharma.com|
21284285|NCT02073565|OrbusNeich|Debbie Morrell, Clinical Research Manager|954-730-0711|DMorrell@OrbusNeich.com|
21284286|NCT01764997|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21284287|NCT01650545|University of Maryland|Aldo Tullio Iacono|410 328 4351|aiacono@umm.edu|
21284288|NCT00082017|National Cancer Institute, National Institues of Health|Wyndham Wilson, M.D.|301-435-2415|wilsonw@mail.nih.gov|
21284289|NCT00684749|University of Minnesota|Umar Choudry/Bruce Cunningham|6126250697|choud008@umn.edu|
21284290|NCT02539654|Alcon, A Novartis Division|Clinical Scientific Director, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
21284291|NCT03046056|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21284292|NCT00525876|UT MD Anderson Cancer Center|Issa F. Khouri, MD/ Professor||celsaenz@mdanderson.org|
21284293|NCT02217800|Strongbridge Biopharma|Fredric Cohen, MD|610-254-9200|f.cohen@strongbridgebio.com|
21284294|NCT03282591|Menlo Therapeutics Inc.|Anna Gururajan|(650) 486-1416|agururajan@menlotx.com|
21284295|NCT02290925|Faculty of Medicine & Allied Sciences, Rajarata University of Sri Lanka|Professor Sisira Siribaddana|+94777326940|sisira.siribaddana@gmail.com|
21284296|NCT05869864|American University|Caroline Kuo, DPhil, MPhil|2028857385|ckuo@american.edu|
21284297|NCT01973335|Ziekenhuis Oost-Limburg|Dr. Frederik Verbrugge, researcher|0473924199|frederik.verbrugge@zol.be|+32
21284298|NCT00506714|Arthritis Foundation|Meika A. Fang, MD|310-478-3711|meika.fang@va.gov|84503
21284299|NCT02289105|Fostering Improvement in End-of-Life Decision Science Program|Dr. Scott Halpern|215-5739461|shalpern@exchange.upenn.edu|
21284300|NCT00176436|Maryland Psychiatric Research Center|M. Patricia Ball, R.N., C.,M.S.|410-402-7663|pball@mprc.umaryland.edu|
21284301|NCT00676572|Imperial College London|Professor Kian Fan Chung|00442075947954|f.chung@imperial.ac.uk|
21284302|NCT01966419|Mallinckrodt|Medical Information Call Center|800-844-2830|MedInfo@mnk.com|
21284303|NCT02956057|Tomas Bata Hospital|Kojecky Vladimir|+420577552512|kojecky@bnzlin.cz|
21284304|NCT00565916|Washington University School of Medicine|Dr. Robert Gropler MD|314-747-3878|groplerr@mir.wustl.edu|
21284305|NCT00985517|Sangamo Therapeutics|Medical Monitor|510-970-6000|clinicaltrials@sangamo.com|
21284306|NCT01420679|Spectrum Pharmaceuticals, Inc|Gajanan Bhat|949-743-9219|gajanan.Bhat@sppirx.com|
21284307|NCT00412217|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21284308|NCT01069419|UCB Clinical Trial Call Center|UCB (Study Director)|+1887 822 9493||
21284309|NCT01678885|Pennington Biomedical Research Center|Corby Martin, Ph.D.|225-763-2585|corby.martin@pbrc.edu|
21284310|NCT00956631|Vertos Medical|VP of Clinical, Regulatory and Quality|9493490008|cmyers@vertosmed.com|216
21299272|NCT04375150|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21299273|NCT02656017|University of Pittsburgh|Dr. Kyongtae Bae|412-647-3500|baek@upmc.edu|
21299274|NCT02039115|Center for Interventional Endoscopy|Robin (Barron-Nelson) Kangas|407.303.5503|Robin.Barron@flhosp.org|
21299275|NCT04755816|University of Michigan College of Pharmacy|Dr. MICHAEL DORSCH|734/647-1452|mdorsch@umich.edu|
21299276|NCT02792231|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21299277|NCT02469623|Acutus Medical, Inc.|Steve McQuillan, Sr. Vice President Regulatory, Clinical, & Quality Assurance|442232608-|steven.mcquillan@acutus.com|
21299278|NCT04073186|Johnson & Johnson Vision Care|Thomas Karkkainen- Sr. Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
21299279|NCT03309878|Johns Hopkins University|Grants Administrative Manager|443-927-3568|JHCCCRO@jhmi.edu|
21299280|NCT01884077|Washington University School of Medicine - Dept of Orthopaedic Surgery|Dr. Aaron Chamberlain|314-362-9283|chamberlaina@wudosis.wustl.edu|
21299281|NCT00473434|Jan-Cil Australia|Regional Medical Affairs Therapeutic Lead Immunol|61 2 88753219||
21299282|NCT02836652|Abbott|Poornima Sood|7818528334|poornima.sood@abbott.com|
21299283|NCT03679975|Aquestive Therapeutics|Gary Slatko, Chief Medical Officer|908-941-7050|clinicaltrials@aquestive.com|
21299284|NCT00659802|Hutchison Medipharma|Dr. Rongjun Liu|+86 21 2067 3203|rongjunl@hmplglobal.com|
21299285|NCT05757648|University Hospitals Cleveland Medical Center|Dr. Ying An|(216)368-3277|Ying.An@UHhospitals.org|
21299286|NCT01008943|Cook Medical|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|765-463-7537|ssnyder@medinst.com|
21299287|NCT00861705|Warren Alpert Medical School of Brown University, Department of Medicine|William M. Sikov, M.D.|401-793-7151|wsikov@lifespan.org|
21299288|NCT05789745|Nucleus Network|Trisha Shamp, Ph.D|651-641-2925|t.shamp@nucleusnetwork.com|
21299289|NCT03294590|Boston University Henry M. Goldman School of Dental Medicine|Belinda Borrelli, PhD|617-358-3358|belindab@bu.edu|
21253446|NCT00996476|Janssen Pharmaceutical K.K., Japan|DIrector|81 3 44115639||
21253447|NCT01802567|Penn State Health Children's Hospital|Giselle Sholler, MD|7175310003|gsaulniersholler@pennstatehealth.psu.edu|
21253448|NCT01895101|Amphia Hospital|Dr. Thierry V Scohy|0031765955570|tscohy@amphia.nl|
21299290|NCT01962441|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21299291|NCT02055898|Imperial College London|Keith Boland||k.boland@imperial.ac.uk|
21299292|NCT01500772|Debiopharm International S.A.|Vice President, Clinical Research and Development|4121 321 01 11|info-international@debiopharm.com|
21299293|NCT00718510|Department of Psychiatry, University of Alberta|Dr. Serdar Dursun|(780) 492-7319|dursun@ualberta.ca|
21299294|NCT02201524|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21299295|NCT00423657|Cerexa, Inc.|Vice President, Clinical Sciences|(510) 285-9200|clinicaltrials@cerexa.com|
21299296|NCT00474955|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21299297|NCT02855203|Peter MacCallum Cancer Centre|Office of Cancer Research|+61 3 85597364|OCR@petermac.org|
21299298|NCT03650088|University of North Carolina at Chapel Hill|Deborah F. Tate, PhD|919-966-5851|dtate@unc.edu|
21299299|NCT01620060|Sunovion|Medical Director, CNS|1-866-503-6351||
21299300|NCT00499681|Vanderbilt-Ingram Cancer Center|Ingrid Mayer, MD, Principal Investigator|615-936-2033|ingrid.mayer@vanderbilt.edu|
21299301|NCT04575155|Northwestern University|Dr. Michael Wolf|(312) 503-5592|mswolf@northwestern.edu|
21299302|NCT03808090|University of Alabama at Birmingham|Dr Kyle Wood|205-996-2295|kylewood@uabmc.edu|
21299303|NCT06237049|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
21299304|NCT03748823|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
21299305|NCT03275740|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21299306|NCT02972931|AIDS Research Institute IrsiCaixa|Dr. Judith Dalmau|934656374|jdalmau@irsicaixa.es|161
21299307|NCT02519023|University of Minnesota|Dr. Jacob Hutchins|6122505535|hutc0079@umn.edu|
21299308|NCT04486235|Corporal Michael J. Crescenz VA Medical Center|Jocelyn Remmert, PhD|215-823-5800|jocelyn.remmert@va.gov|
21299309|NCT03935126|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21299310|NCT00982735|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21299311|NCT00756106|Massachusetts General Hospital|Dr. Elizabeth Gerstner||EGERSTNER@mgh.harvard.edu|
21299312|NCT02898454|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21299313|NCT00689390|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21299314|NCT02343263|Indiana University|Bruce H. Matt, MD, MSc|3172781215|bmatt@iupui.edu|
21299315|NCT02570503|Virginia Commonwealth University|Teresa Potter|804-828-6749|teresa.potter@vcuhealth.org|
21299316|NCT03040141|Visterra Inc.|Head of Regulatory Affairs|+1 617-498-1070|info@visterrainc.com|
21299317|NCT04731636|LifeTechScientific|Clinical manager|15695219339|Xuwei@lifetechmed.com|
21299318|NCT01623479|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21299319|NCT01384734|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21299320|NCT02922725|University of Utah|Brent M. Kious|801-585-1418|brent.kious@hsc.utah.edu|
21299321|NCT01300234|GlaxoSmithKline|GSK Response Center|866-435-7343||
21299322|NCT05675046|Sonex Health, Inc.|Amy Stegner, Vice President Clinical Affairs|(888) 518-8780|astegner@sonexhealth.com|
21253449|NCT00436852|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21253450|NCT00370682|Phramongkutklao Hospital, Bangkok, Thailand|Verrachai Watanaveeradej, MD|662-644-8971|veerachaiw@yahoo.com|
21299323|NCT04612725|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21237287|NCT01518868|Bausch Health|Study Director||robert.steffen@bausch.com|
21253451|NCT03167359|Emory University|Dr. Mylin Torres|404-778-3473|matorre@emory.edu|
21253452|NCT03339583|I.M. Sechenov First Moscow State Medical University|Polina Pchelina|+79036701725|polbox@mail.ru|
21253453|NCT00943852|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21253454|NCT02141620|University of Kentucky|William W. Stoops|859-257-5388|william.stoops@uky.edu|
21253455|NCT00772330|InnFocus, Inc.|Sharon Herbert, Associate Director of Clinical Operations|(415) 268-9059|sharon.herbert@santen.com|
21253456|NCT00734591|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21253457|NCT00730275|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21253458|NCT00356408|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
21253459|NCT05487586|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21253460|NCT03921723|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21253461|NCT03015129|Memorial Sloan Kettering Cancer Center|Dr. Vicky Makker, MD|646-888-4224|makkerv@mskcc.org|
21253462|NCT05187364|Medical University of South Carolina|Dr. Amber Jarnecke|843-876-3115|jarnecka@musc.edu|
21253463|NCT02757872|NYU Langone|Dr. Michal Melamed|212-263-0705|michal.melamed@nyulangone.org|
21253464|NCT00939822|University of Wisconsin School of Medicine and Public Health|Dr. Cynthia M. Carlsson|608-256-1901|cmc@medicine.wisc.edu|11691
21253465|NCT05032872|Brandeis University|Xin Yao Lin|6462583562|xylin@brandeis.edu|
21253466|NCT01143870|University of Pennsylvania|Anjali Gopalan|575-640-3893|agopalan@upenn.edu|
21253467|NCT04091061|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21253468|NCT00406692|Boston University|Clifford Knapp, PhD|617-414-1990|cknapp@bu.edu|
21253469|NCT00821587|University of Florida|Roberto J. Firpi-Morell, MD|352-273-9500|firpirj@medicine.ufl.edu|9466
21253470|NCT04488770|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
21253471|NCT03547739|University of Alabama at Birmingham|Janet M. Turan, PhD, MPH|2059757770|jmturan@uab.edu|
21253472|NCT05731999|Kontigo Care AB|Markku Hämälainen, CSO|+46 (0)76 947 3132|markku.hamalainen@kontigocare.com|
21253473|NCT01744392|Health Services Research & Development, Durham VAMC|Hayden B. Bosworth, PhD|919-286-0411|hayden.bosworth@va.gov|7107
21253474|NCT02369068|Beaumont Hospital, Royal Oak|Deborah Hasenau RN, Director, Urology Research|248-551-0804|Deborah.Hasenau@Beaumont.org|
21253475|NCT04664075|Imperial College London|Senior Clinical Research Nurse|02083833231|flu-rsv-study@imperial.ac.uk|
21253476|NCT01696955|University of Chicago|Theodore Karrison|773-702-9326|tkarrison@health.bsd.uchicago.edu|
21253477|NCT00799981|Wellspect Health Care|Head of Medical Affairs|+46313763000|mace@wellspect.com|
21253478|NCT00798590|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
21253479|NCT02741323|University of California, San Francisco|Clinical Research Manager|415-595-1226|Rodney.Rogers@ucsf.edu|
21253480|NCT01152814|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21253481|NCT01280357|Monica Healthcare Ltd|Ian How|+44 (0)115912|ianhow@monicahealthcare.com|4540
21253482|NCT03284203|University of Chicago|Mary Akel|773-834-4489|makel@medicine.bsd.uchicago.edu|
21253483|NCT00992225|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21253484|NCT03466073|BioAegis Therapeutics Inc.|Mark DiNubile MD|609-706-5866|mdinubile@bioaegistx.com|
21253485|NCT00744757|Medical Affairs, Janssen Taiwan|Medical Director|+886-2-23761255||
21253486|NCT00532493|VA Puget Sound Health Care System|Dr. Murray Rasknd|(206) 764-2702|Murray.Raskind@va.gov|
21253487|NCT05833100|i-SENS, Inc.|Moon Hwan Kim|+82 (0)2 910 0521|mhkim@i-sens.com|
21253488|NCT02045875|Asthma Management Systems|Andrew G Weinstein MD|302 893 5455|agwmd@aol.com|
21253489|NCT00841555|The Ohio State University Comprehensive Cancer Center|Mario Ammirati, MD|614-293-1970|Mario.Ammirati@osumc.edu|
21253490|NCT04348435|Hope Biosciences Stem Cell Research Foundation|Ridhima Vij, PhD|346-900-0340|ridhima@hopebio.org|102
21253491|NCT00905515|East Carolina University|Director of Clinical Trials|252-744-0671|bryantw@ecu.edu|
21253492|NCT00775463|United Therapeutics Corporation|Oral Treprostinil Program Head|919-485-8350|klaliberte@unither.com|
21253493|NCT02980731|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21253494|NCT03918499|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
21253495|NCT01789567|Medtronic Bakken Research Center|Kitty Schapira|+31433566802|kitty.schapira@medtronic.com|
21253496|NCT00682851|Magee-Womens Research Institute|Lorna Rabe|412-641-6042|lrabe@mwri.magee.edu|
21253497|NCT02731690|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
21253498|NCT00872989|SWOG Statisticial Center|Lung Committee Statistician|206-667-4623||
21253499|NCT00660543|Oregon Health and Science University|Dr. Edward Neuwelt|503-494-5626|neuwelte@ohsu.edu|
21253500|NCT00661479|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21253501|NCT03900416|Lawrence University|Dr. Lori Hilt|920-832-7050|lori.m.hilt@lawrence.edu|
21253502|NCT00307684|Janssen-Cilag G.m.b.H.|European Medical Affairs Director Neurology|+49 2137 955258|bschaeu2@its.jnj.com|
21253503|NCT00224887|Stanford University|Dr. Donna Matheson|650-723-5895|donna.matheson@stanford.edu|
21253504|NCT00338962|Yale University|Elizabeth Ralevski|203-932-5711|elizabeth.ralevski@yale.edu|4282
21253505|NCT00910039|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|David Peereboom, MD|216-445-6068|peerebd@ccf.org|
21253506|NCT02147899|Symbiomix Therapeutics|VP Clinical Operations|609-722-7250|nadetoro@symbiomix.com|112
21299324|NCT01928927|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21253507|NCT01911390|Department of Environmental and Radiological Health Sciences|Dr Elizabeth Ryan|970-491-1536|E.P.Ryan@colostate.du|
21253508|NCT04850794|University of North Carolina at Chapel Hill|Kelsey Thompson, MS|919-966-1007|kelsey_thompson@med.unc.edu|
21299325|NCT02775916|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
21299326|NCT00948064|University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor, Leukemia Department|713-745-3428|CR_Study_Registration@mdanderson.org|
21299327|NCT00179621|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21299328|NCT02973100|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21299329|NCT01364896|University of Pittsburgh|Ross Cranston|412-383-1675|rdc27@pitt.edu|
21299330|NCT01393158|Oregon Health & Science University|Dr. Eric Simpson,|503-494-2121|simpsone@ohsu.edu|
21299331|NCT02413918|University of Texas HEalth Science Center San Antonio|Charles Bowden, MD|210-567-5405|BowdenC@uthscsa.edu|
21299332|NCT04233801|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21299333|NCT01419795|Fred Hutchinson Cancer Research Center|Dr. Mohamed Sorror|206-667-6298|msorror@fredhutch.org|
21299334|NCT01391364|Bausch Health|Study Director||robert.steffen@bausch.com|
21299335|NCT01690052|Indiana University School of Dentistry|Juan F. Yepes DDS, MD, MPH, MS, DrPH, Associate Professor|317-944-9601|jfyepes@iupui.edu|
21299336|NCT01453049|GlaxoSmithKline|GSK Response Center|866-435-7343||
21299337|NCT02421172|Novartis Pharmaceuticals|Study Director|8627788300||
21299338|NCT00928486|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-888-260-1599|ClinicalTrialDisclosure@celgene.com|
21299339|NCT01841281|UC Davis|Dr. Nicholas Kenyon|916-734-3564|njkenyon@ucdavis.edu|
21299340|NCT00683878|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
21299341|NCT03112681|Zydus Therapeutics Inc.|Dr Deven Parmar|7324050886|dparmar@zydustherapeutics.com|
21299342|NCT02869633|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
21299343|NCT04024891|Ocuphire Pharma, Inc.|Drey Coleman|8134041993|dcoleman@ocuphire.com|
21299344|NCT03397264|Opthea|Director of Clinical Research|+61 3 9826 0399|info@opthea.com|
21299345|NCT03287791|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
21299346|NCT03441477|NIDEK Co., LTD.|Tadakazu Ichimura|+81-533-67-8904|tadakazu_ichimura@nidek.co.jp|
21299347|NCT03095651|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21299348|NCT01381016|University of Colorado Denver|Associate Professor|(303) 724-2037|alex.polotsky@ucdenver.edu|
21299349|NCT01048879|University of Michigan|Bruce A. Mueller|7346154578|muellerb@umich.edu|
21299350|NCT02891174|University of Michigan|Dr. Elizabeth Langen|734-764-3406|elangen@med.umich.edu|
21299351|NCT04494841|MMJ Labs|Dr. Amy Baxter|1 877 805 2899|abaxter@mmjlabs.com|
21299352|NCT03893396|Groupe Hospitalier de la Rochelle Ré Aunis|Caroline Allix-Béguec, clinical research manager|+33516494246|caroline.allix-beguec@ght-atlantique17.fr|
21299353|NCT04607668|G1 Therapeutics, Inc|Clinical Trial Info|+1 9192139835|clinicalinfo@g1therapeutics.com|
21299354|NCT02250326|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21299355|NCT01693029|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|004980244760|biopharma.clinicaltrials@sandoz.com|
21299356|NCT05801991|Southern California College of Optometry|Erin Rueff, OD, PhD (Principal Investigator)|714-463-7586|erueff@ketchum.edu|
21299357|NCT01451723|Louisiana Health Sciences Center-New Orleans|Jesus Lovera MD|50-903 9302|jlover@lsuhsc.edu|
21299358|NCT00833040|AcelRx Pharmaceuticals, Inc.|Dr. Pamela Palmer|650-216-3504|ppalmer@acelrx.com|
21299359|NCT01893801|Cancer Research and Biostatistics|Adam Rosenthal|(206) 839-1797|adamr@crab.org|
21299360|NCT03489863|University of Florida College of Medicine Jacksonville|Dominick J. Angiolillo|9042443378|dominick.angiolillo@jax.ufl.edu|
21299361|NCT05196828|Noctrix Health, Inc.|Jonathan Charlesworth, PhD|804-683-4279|jcharlesworth@noctrixhealth.com|
21299362|NCT01096316|Dept Psychiatry & Behavioral Sciences University of Washington|Jurgen Unutzer MD MPH MA, Professor and Chair|206-543-3752|unutzer@uw.edu|
21253509|NCT01227382|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu|
21253510|NCT04678505|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21253511|NCT02946853|University of Rochester|Dr. Jonathan Steinberg|9734364155|jsteinberg@summithealth.com|
21253512|NCT00635661|New York University,. Rusk Institute|Dr. Irene Ward|212-263-6073|Irene.ward@nyumc.org|
21267123|NCT04610827|Mayo Clinic|Julie M. Baughn, M.D.|507-293-1031|Baughn.Julie@mayo.edu|
21299363|NCT02763644|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
21299364|NCT02648204|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21253513|NCT02033083|Planned Parenthood of New York City|Director of Clinical Training and Research|212-274-7340|ctri@ppnyc.org|
21253514|NCT00403767|Johnson & Johnson Pharmaceutical Research & Development L.L.C.|Head of Development, CV & UROL|1 908-927-7767||
21253515|NCT03192475|University of Pittsburgh|Elizabeth Mary Venditti PhD, Associate Professor of Psychiatry and Epidemiology|(412) 647-1027|vendittiem@upmc.edu|
21253516|NCT01641159|University of Cincinnati College of Medicine; Department of Psychiatry|Dr. Theresa Winhusen|513-585-8227|winhust@ucmail.uc.edu|
21253517|NCT03980808|Georgia Institute of Technology|Salimah LaForce, M.S.|404-385-4614|salimah@cacp.gatech.edu|
21237288|NCT00529399|Benaroya Research Institute|Carla Greenbaum||cjgreen@benaroyaresearch.org|
21253518|NCT00632489|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21253519|NCT01404429|PGIMER, India|Varun Dhir, Assistant Professor, Internal Medicine|+91-8872229998|varundhir@gmail.com|
21253520|NCT05330676|University of Pennsylvania|John C. Greenwood, MD, MS|856-816-7172|john.greenwood@pennmedicine.upenn.edu|
21253521|NCT00436605|Yale University School of Medicine|Harriet Kluger|203-737-2572|Harriet.Kluger@yale.edu|
21253522|NCT02755818|University of California, Davis|George Kaysen MD - Principal Investigator|916-734-3774|gakaysen@ucdavis.edu|
21253523|NCT03014011|Bispebjerg Hospital|MD Malin Nilsson|50595861|mnil0028@regionh.dk|0045
21253524|NCT03417570|Washington University School of Medicine|Vladimir M. Kushnir, M.D.|314-454-5960|vkushnir@wustl.edu|
21253525|NCT00573859|University of California, Irvine|Jean Gehricke, Ph.D.|949-824-1834|jgehrick@uci.edu|
21253526|NCT02416453|Janssen Research & Development, LLC|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21253527|NCT01143181|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
21253528|NCT03223662|National Cancer Institute|Caryn Steakley|240-858-3749|steaklec@nih.gov|
21253529|NCT02229851|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21253530|NCT03541200|Mitsubishi Tanabe Pharma Development America|Clinical Trials, Information Desk|Please email|information@mt-pharma-us.com|
21253531|NCT03459443|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|1.855.752.2356|clinicaltrials@alexion.com|
21253532|NCT01276379|GEMCAD|Joan Maurel Santasusana|+ 34 93 434 44 12|JMAUREL@clinic.cat|
21253533|NCT01111240|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21253534|NCT00749957|Applied Genetic Technologies Corporation|Chief Medical Officer|386-462-2204|jchulay@agtc.com|7205
21253535|NCT01170390|Oregon Health & Science University|Dr. Alison Edelman|503.418.2585|edelmana@ohsu.edu|
21253536|NCT00680992|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21253537|NCT02245022|University of Liverpool|Catriona Waitt|0778288217|cwaitt@liverpool.ac.uk|
21253538|NCT02425904|Dana-Farber Cancer Institute/Boston Children's Hospital|Barbara Degar, MD|617-632-5186|Barbara_Degar@dfci.harvard.edu|
21253539|NCT05384938|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21253540|NCT02626455|Bayer AG|Therapeutic Area Head|30 300139003|clinical-trials-contact@bayer.com|
21253541|NCT05148962|Gritstone bio, Inc.|Elizabeth Martin, Vice President, Clinical Development Infectious Disease|+1 (877) 520-2233|clinicalstudies@gritstone.com|
21253542|NCT06665919|Tbilisi State Medical University|Konstantine Liluashvili , MD., PH.D.|+995599908899|k.liluashvili@tsmu.edu|
21253543|NCT01144377|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21253544|NCT01525238|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
21253545|NCT01214642|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21253546|NCT04696653|Johns Hopkins University School of Medicine|Gail Daumit, MD, MHS|410-614-6460|gdaumit@jhmi.edu|
21253547|NCT02954198|Medical University of South Carolina|Dr. David Taber|843-792-4003|taberd@musc.edu|
21253548|NCT05820295|Weill Cornell Medicine|Lisa Kern, MD, MPH|646-962-5889|lmk2003@med.cornell.edu|
21253549|NCT00848588|Ottawa Hospital Research Institute|Manya Charette|613-798-5555|mancharette@ohri.ca|17758
21253550|NCT02075476|Hospital Gregorio Marañón|Dr. Carlos Álvarez|0034915868000|calvargon@gmail.com|
21253551|NCT02081443|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu|
21253552|NCT02914275|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
21253553|NCT04343287|BRIM Biotechnology, Inc.|Erin Chang, Vice President of Portfolio Management Department|0226598779|erin.chang@brimbiotech.com|119
21253554|NCT03527550|McLean Hospital|Dr. Andrew Peckham|617-855-2946|adpeckham@mclean.harvard.edu|
21253555|NCT01659853|Galerma Laboratories|Dr. Warren Winkelman|817-961-5494|warren.winkelman@galderma.com|
21253556|NCT01085968|VA Overton Brooks|Elizabeth Disbrow|318-6757184|edisbr@lsuhsc.edu|
21253557|NCT03053518|NYU Langone Health|Mary Sevick, MD|646-501-2621|Mary.Sevick@nyulangone.org|
21253558|NCT02683876|MEBO Research|Maria De la Torre|7862286880|maria.delatorre@meboresearch.org|
21253559|NCT06612255|Melinta Therapeutics, LLC|Medical Information|1-844-633-6568|medinfo@melinta.com|
21253560|NCT00488475|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21253561|NCT01141647|James A. Haley Veterans' Hospital|Lisa Ottomanelli, PhD|813-558-3917|lisa.ottomanelli-slone@va.gov|
21253562|NCT00267085|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/794-5783|eharriso@mdanderson.org|
21299365|NCT06418152|Cleveland Clinic|Jay Alberts, PhD|216-445-3222|albertj@ccf.org|
21237289|NCT03695172|Duke University Medical Center|Amanda Kumar, MD|919-681-4607|amanda.kumar@duke.edu|
21253563|NCT04073446|Boston Scientific|Roshini Jain, Sr. Director Clinical Sciences|16619494350|roshini.jain@bsci.com|
21299366|NCT05108246|SUNY at Buffalo|Nikhil Satchidanand|7168162884|ns1@buffalo.edu|
21237290|NCT02672111|Braeburn|Sonnie Kim|1 610 467 8717|sonnie@braeburnrx.com|
21237291|NCT02486328|Ufuk University Faculty of Medicine|Dr Perihan Ekmekçi|+903122044000|erdogduperi@gmail.com|
21237292|NCT06242444|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
21237293|NCT03317977|Wayne State University|Deborah Ellis, Ph.D.|313-577-1055|dellis@med.wayne.edu|
21237294|NCT02076152|Massachusetts General Hospital|Elizabeth Gerstner, MD|617-724-2887|EGERSTNER@PARTNERS.ORG|
21237295|NCT02635880|Cutera|Ginger Pocock|4156575702|gpocock@cutera.com|
21237296|NCT02046980|Daegu Kyungbook Dizziness society|Dr. Hyun Ah Kim|+82-53-250-7475|kha0206@dsmc.or.kr|
21237297|NCT01474681|Novartis Pharmaceuticals|Study Director|862-778-8300||
21237298|NCT01972516|Dana-Farber Cancer Institute|Susana Campos, MD|617-632-5269|susana_campos@dfci.harvard.edu|
21253564|NCT02797080|Horizon Pharma Ireland, Ltd, Dublin, Ireland|Julie Ball, MS, Executive Director, Clinical Development & Operations|(224) 383-3000|clinicaltrials@horizonpharma.com|
21253565|NCT02638597|University of Texas Southwestern Medical Center|Principal Investigator|2146480188|madhukar.trivedi@UTSouthwestern.edu|
21253566|NCT04035499|University of Rochester Medical Center|Dr. Kah Poh Loh|585-276-4353|kahpoh_loh@urmc.rochester.edu|
21253567|NCT00951015|ViiV Healthcare|GSK Response Center|866-435-7343||
21253568|NCT01167452|Texas Tech University Health Sciences Center|Ronald Hall, PharmD, MSCS|214-358-9009|ronald.hall@ttuhsc.edu|
21253569|NCT03819634|Stanford|Bruce Buckingham|6508040476|buckingham@stanford.edu|
21253570|NCT00299494|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21253571|NCT01538966|Cedars-Sinai Medical Center|Vivian Hwe|424-315-4489|hwev@cshs.org|
21253572|NCT01417104|The Ohio State University|Sanjay Rajagopalan, MD|614-247-7760|sanjay.rajagopalan@osumc.edu|
21253573|NCT01416389|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21253574|NCT01365481|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
21253575|NCT00757627|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21253576|NCT00047697|University of Pittsburgh|Benjamin L. Handen, PhD|412-235-5445|handenbl@upmc.edu|
21253577|NCT00958841|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21253578|NCT00858364|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21253579|NCT02818244|Cleveland Clinic|Marc Gillinov MD|216 445-8841|GILLINOM@ccf.org|
21253580|NCT00688870|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21253581|NCT01140295|The Children's Hospital of Philadelphia|Petar Mamula|215-590-9146|mamula@email.chop.edu|
21253582|NCT03682302|Pacira Pharmaceuticals|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
21253583|NCT01390077|University of California, San Diego|William Leo Nyhan, M.D., Ph.D.|(619)543-5337|wnyhan@ucsd.edu|
21253584|NCT01489891|Hospital Universitario Infanta Cristina|Dr. Felipe de la Morena|0034659716030|felipe_de_la_morena@hotmail.com|
21253585|NCT00707759|FONDECYT|Maria Angela Delucchi|56-2-25755972|madelucchi@gmail.com|
21253586|NCT00948766|Novartis Pharmaceuticals|Study Director|862 778-8300||
21253587|NCT01769326|University of California Irvine|Steven Cramer, M.D.|(949) 824-8748|scramer@uci.edu|
21253588|NCT01036438|Molnlycke Health Care AB|Ann Larkö|+46 722 3338|ann.larko@molnlycke.com|
21253589|NCT00888927|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
21253590|NCT02153073|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21253591|NCT03189745|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21253592|NCT03702231|National Institutes of Health (NIH) / The National Heart, Lung, and Blood Institute (NHLBI)|Christopher Pleyer, M.D. Principal Investigator, NIH, NHLBI|510.709.6649|christopher.pleyer@nih.gov|
21253593|NCT00421954|New York State Psychiatric Institute|Linda Sherman|(646) 774-7158|lsherma@nyspi.columbia.edu|
21253594|NCT02729831|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.harvard.edu|
21253595|NCT00864253|Celgene Corporation|Anne McClain|888-260-1599|clinicaltrialdisclosure@celgene.com|
21253596|NCT05745701|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21253597|NCT01747551|Dana-Farber Cancer Institute|Peter Enzinger|617-632-3029||
21253598|NCT01607476|Mayo Clinic|Dr. Val Lowe|507-255-3616|vlowe@mayo.edu|
21253599|NCT04445987|Arcutis Biotherapeutics|Arcutis Medical Information|+1 844 692-6729|medinfo@arcutis.com|
21253600|NCT01609062|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|800-983-4587|medinfo@bmrn.com|
21253601|NCT03772587|Momenta Pharmaceuticals, Inc.|DIRECTOR CLINICAL RESEARCH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21253602|NCT05907707|University of North Carolina at Chapel Hill|Andrea Seiler, MD|+41 316322111|andrea.seiler@insel.ch|
21253603|NCT05260021|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21253604|NCT03842358|Washington University School of Medicine|Debbie Bennett, M.D.|314-454-7696|debbie.bennett@wustl.edu|
21253605|NCT01200290|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21253606|NCT01187381|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21253607|NCT00607724|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21253608|NCT00151281|Weill Cornell Medical College|Dr. Jia Ruan|646-962-2068|jruan@med.cornell.edu|
21253609|NCT04349631|Hope Biosciences Research Foundation|Ridhima Vij, PhD|346-900-0340|ridhima@hopebio.org|102
21253610|NCT03037931|American Regent, Inc.|Elizabeth Ernst, Global Executive Director of Regulatory Affairs|631-605-5753|eernst@americanregent.com|3551
21253611|NCT02407990|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21253612|NCT01238900|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu|
21253613|NCT01198756|GlaxoSmithKline|GSK Response Center|866-435-7343||
21237299|NCT01483924|ApoPharma Inc.|Fernando Tricta, MD|Phone: 416-401-7332|ftricta@apopharma.com|
21237300|NCT00003298|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
21253614|NCT02915302|Sanofi Pasteur Inc.|Medical Director|800-633-1610|RegistryContactUs@sanofipasteur.com|1#
21253615|NCT02062593|Imperial College London|Rasha Al-Lamee|+447976276923|r.al-lamee13@imperial.ac.uk|
21253616|NCT04343872|University of Alabama at Birmingham|Dr. Andrea L. Cherrington|205-996-2885|acherrington@uabmc.edu|
21253617|NCT02134977|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21253618|NCT03828747|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21253619|NCT03646656|Department of Veterans Administration|Dr. Karen Goldstein|919.826.0411|karen.goldstein@va.gov|1707764
21253620|NCT05263388|Ferring Pharmaceuticals|Global Clinical Compliance|+1 862-286-5200|Disclosure@ferring.com|
21253621|NCT03651622|University of North Carolina at Chapel Hill|Elizabeth Mayer-Davis, PhD|919-966-7218|mayerdav@email.unc.edu|
21253622|NCT01519089|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21253623|NCT00127205|SWOG Statistics & Data Management Center|SWOG statistician|2066674263|jmiao@fredhutch.org|
21253624|NCT03377699|Novo Nordisk A/S|Clinical Transparency Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21253625|NCT02580305|Suven Life Sciences|Ramakrishna Nirogi, PhD|+9140 2319 3956|nvsrk@suven.com|
21253626|NCT03582943|Washington University School of Medicine|Dr. Catherine Lang|314-286-1945|langc@wustl.edu|
21253627|NCT01181323|Cincinnati Children's Hospital Medical Center|Mark Steinhoff, MD|513-636-2791|Mark.steinhoff@cchmc.org|
21253628|NCT01177800|Beijing, China R&D|Senior Therapeutic Area Physician|+86 010 58218358||
21253629|NCT02071290|St. Michael's Hospital|Dr. Ori Rotstein|416-864-6060|rotsteino@smh.ca|5304
21253630|NCT03535506|Georgetown University|Nicole Swanson|2026879194|ns1209@georgetown.edu|
21253631|NCT05126563|Hope Biosciences Research Foundation|Ridhima Vij, PhD|346-900-0340|ridhima@hopebio.org|102
21253632|NCT05560243|University of Alabama at Birmingham|Isabel Scarinci, Principal Investigator|2059757177|scarinci@uab.edu|
21253633|NCT01232738|UKansasMCRI|Yunxia Wang|913-588-6970|ywang@kumc.edu|
21253634|NCT02503852|Kerastem|Eric Daniels, M.D., Chief Medical Officer|858.348.8050|edaniels@puregraft.com|
21253635|NCT03231800|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
21253636|NCT00859222|Dana-Farber Cancer Institute|Patrick Y. Wen, MD|617-632-2166|Patrick_Wen@dfci.harvard.edu|
21253637|NCT00942305|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
21253638|NCT00400725|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
21253639|NCT01941719|TUSPM|Dr. Jinsup Song|2157775872|jsong@temple.edu|
21253640|NCT01480219|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21253641|NCT02535091|SK Life Science, Inc.|Medical Director|402-835-5977|smisra@sklsi.com|
21253642|NCT05319912|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
21253643|NCT00359983|GlaxoSmithKline|GSK Response Center|866-435-7343||
21253644|NCT01259089|Northwestern University|Clinical Trials Office|312-695-1301||
21299367|NCT05256901|Emory University|Viola Vaccarino, MD, PhD, Principal Investigator|404-727-8710|lvaccar@emory.edu|
21299368|NCT02314052|Dicerna Pharmaceuticals|Ralf Rosskamp|617-621-8097|rrosskamp@dicerna.com|
21299369|NCT02422498|Memorial Sloan Kettering Cancer Center|Dr. Simon Powell, MD|212-639-3639|powells@mskcc.org|
21299370|NCT02653326|Universidad de Valparaiso|Carla Taramasco|2508306|carla.taramasco@uv.cl|+56 32
21299371|NCT01752426|The University of Texas MD Anderson Cancer Center|Jan Burger MD./Professor|713-563-1487|jaburger@mdanderson.org|
21299372|NCT05075746|Bausch & Lomb|Johnson Varughese|9089271162|johnson.varughese@bausch.com|
21299373|NCT01045460|Johns Hopkins University|Ivan Borrello, MD|4109554967|iborrell@jhmi.edu|
21299374|NCT00097500|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21299375|NCT00189098|Wilhelmina Children's Hospital, University Medical Center Utrecht|Prof. A. Schilder|0031 302504580|A.Schilder@umcutrecht.nl|
21299376|NCT00524485|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21299377|NCT01889667|Oramed|Chief Scientific Officer|+972-2-566-0001|aviva@oramed.com|
21299378|NCT00642356|Novartis Pharmaceuticals|Study Director|862 778-8300||
21299379|NCT02767271|Bausch Health Americas, Inc|Director of Clinical Operations||aloncaric@bauschhealth.com|
21299380|NCT00005906|TMB/NHLBI|Joel Moss|301-496-1597|mossj@nhlbi.nih.gov|
21299381|NCT04551989|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21299382|NCT04201431|University of Oxford|Dr. Angela Minassian|01865611425|angela.minassian@ndm.ox.ac.uk|
21299383|NCT04055675|Kendall Regional Medical Center|Dr. Tony Zitek|305-480-6602|zitek10@gmail.com|
21299384|NCT02694744|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
21299385|NCT00966186|Seoul National University Bundang Hospital|Jung-Won Hwang|82-31-787-7499|jungwon@snubh.org|
21299386|NCT00686777|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21299387|NCT00667888|UT MD Anderson Cancer Center|Karen Huffman, MD/ Associate Professor, Radiation Oncology Department|(713) 563-2339|khoffman1@mdanderson.org|
21299388|NCT01945021|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21299389|NCT00883779|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21299390|NCT00983346|Huntsman Cancer Institute|Mark Wade|801-213-5746|mark.wade@hci.utah.edu|
21237301|NCT03369444|University College London|Pratima Chowdary|+44(0)20 7472 6835|p.chowdary@ucl.ac.uk|
21299391|NCT00099372|RTI International|Dr. Marie Gantz|919-597-5110|mgantz@rti.org|
21299392|NCT00003468|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
21299393|NCT05748275|Multack Eye Care|Dr Sam Multack|815-889-3333|smultack@mecvision.com|
21253645|NCT00548262|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21253646|NCT01712659|National Cancer Institute|Kevin C. Conlon|240-858-3570|conlonkc@mail.nih.gov|
21253647|NCT04535310|The Ohio State University College of Optometry|Jennifer Fogt|16142928858|OPT-EyeStudies@osu.edu|
21253648|NCT00924118|Johns Hopkins Hospital|Steven P. Schulman, MD|4109557378|sschulma@jhmi.edu|410
21253649|NCT01278173|Lundbeck|H||LundbeckClinicalTrials@Lundbeck.com|
21253650|NCT03358251|Prudentix Ltd.|Head of QA/RA|+972-72-394-22-24|tsipi@prudentix.com|
21253651|NCT02091206|GW Research Ltd.|Medical Enquires||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
21253652|NCT00293059|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21253653|NCT03568643|UCSF FI Proctor Foundation|Dr Catherine Oldenburg|(415) 502-8843|catherine.oldenburg@ucsf.edu|
21253654|NCT02297139|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21253655|NCT03367429|Weill Cornell Medicine|Michael O'Dell, M.D.|19175495179|mio2005@med.cornell.edu|
21253656|NCT01821352|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com|
21253657|NCT05051462|University of Toronto|Barna Konkoly-Thege|+1 (705) 549 3181|konkoly.thege.barna@gmail.com|2614
21253658|NCT05597787|University of Delaware|Valerie Earnshaw|(302) 831-6500|earnshaw@udel.edu|
21253659|NCT01241604|Philips Respironics|Jeremy Powers|412-542-3669|jeremy.powers@philips.com|
21253660|NCT01593787|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300||
21253661|NCT01717742|Hospital for Sick Children|Dr. Eyal cohen|416-813-7654|eyal.cohen@sickkids.ca|
21253662|NCT01133418|Cincinnati Children's Hospital Medical Center|Dr. Jeff Epstein|5136368296|jeff.epstein@cchmc.org|
21253663|NCT00452023|The University of Texas MD Anderson Cancer Center|Lucia Masarova MD/Assistant Professor|832-750-4211|LMasarova@mdanderson.org|
21253664|NCT04150068|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21253665|NCT05316701|Orca Biosystems, Inc.|Chief Medical Officer|530-414-9743|info@orcabio.com|
21253666|NCT01946529|St. Jude Children's Research Hospital|Sara Federico, MD|901-595-2220|sara.federico@stjude.org|
21253667|NCT04679935|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21253668|NCT04362189|Hope Biosciences Stem Cell Research Foundation|Ridhima Vij, PhD|346-900-0340|ridhima@hopebio.org|102
21253669|NCT02111681|Memorial Sloan Kettering Cancer Center|Dr. Daphna Gelblum, MD|914-367-7273|gelblumd@mskcc.org|
21253670|NCT05116540|Hope Biosciences Research Foundation|Maureen Gerwin|(346) 900-0340|maureen@hopebio.org|
21253671|NCT00923260|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|Dr. Miguel F Herrera|(+52) 55 54870208|miguelfherrera@gmail.com|
21253672|NCT03241927|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu|
21253673|NCT01850446|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
21253674|NCT00591721|University of Illinois at Chicago|Marcia Finlayson, PhD|312-996-4603|marciaf@uic.edu|
21253675|NCT03507777|Abbott Vascular|Jana Buccola, Director Clinical Programs|+1-408-845-1049|jana.buccola@abbott.com|
21253676|NCT01879722|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21253677|NCT00697697|MAP Pharmaceuticals, Inc. a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
21253678|NCT03784001|University of California, Los Angeles|Tanera van Diggelen|4086231219|tvandiggelen@gmail.com|
21253679|NCT02440659|Arbor Research Collaborative for Health|Francesca Tentori|734-665-4108|christina.pustulka@arborresearch.org|
21253680|NCT00774930|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21253681|NCT01153321|AstraZeneca|Anna Malmgren||ClinicalTrialTransparency@astrazeneca.com|
21253682|NCT04032613|University of North Carolina at Chapel Hill|Jennifer E. Flythe, MD, MPH|919-445-2656|jflythe@med.unc.edu|
21253683|NCT00424385|Oncology Specialists, SC|Sigrun Hallmeyer, MD Director of Research; Chadi Nabhan, MD FACP (PI)|847-268-8200|shallmeyer@oncmed.net|
21253684|NCT00355199|Ospedale Papa Giovanni XXIII, Bergamo|Alessandro Rambaldi|0352673684|arambaldi@asst-pg23.it|+39
21253685|NCT04245228|Mayo Clinic|Dr. Cassie Kennedy, PI|1-507-284-2511|kennedy.cassie@mayo.edu|
21253686|NCT00964886|VA San Diego Healthcare System|Joseph H. Atkinson MD|858 552 8585|joseph.atkinson@va.gov|2568
21253687|NCT04587752|Yale University|Dr. Janet Lydecker|2037374299|janet.lydecker@yale.edu|
21253688|NCT05870228|University of Strathclyde|Stephanie McCrory|07538376660|stephanie.mccrory@strath.ac.uk|
21253689|NCT01244529|Johnson & Johnson Vision Care|Kathy Osborn, OD|1-904-443-1032|kosborn@its.jnj.com|
21253690|NCT04075994|University of Pittsburgh|Dr. Jared Magnani|(412)383-0611|magnanij@pitt.edu|
21253691|NCT01247285|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21253692|NCT04928287|Hope Biosciences Research Foundation|Ridhima Vij, PhD|346-900-0340|ridhima@hopebio.org|102
21253693|NCT00252577|VA San Diego Healthcare System|John Kelsoe|858-552-8585|john.kelsoe@va.gov|5704
21253694|NCT02402153|UNEEG medical A/S|Clinical Manager|+45 41414244|lybl@UNEEG.com|
21253695|NCT01125514|Novartis Pharmaceuticals|Study Director|862-778-8300||
21253696|NCT01655693|ONXEO|Olivier De Beaumont; Chief Medical Officer|+33 (0) 1 45 58 95 33|o.debeaumont@onxeo.com|
21253697|NCT00357331|Weill Medical College|Assistant Professor of Medicine|212-746-1670|sinhana@med.cornell.edu|
21253698|NCT00929110|Novartis Pharmaceuticals|Study Director|862 778-8300||
21253699|NCT03794700|University of Colorado Anschutz Medical Campus|Channing Tate, PHD Assistant Professor|3037248985|channing.tate@cuanschutz.edu|
21253700|NCT02120287|UPMC Hillman Cancer Center|Barbara Stadterman|412-647-5554|stadtermanbm@upmc.edu|
21237302|NCT04330638|UZ Gent|Anja Delporte|+3293320228|anja.delporte@uzgent.be|
21253701|NCT01163292|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21253702|NCT02643472|Children's National Health System|Dr. Karen Fratantoni|202-476-4793|kfratant@childrensnational.org|
21253703|NCT01258595|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21253704|NCT01215188|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21253705|NCT01012414|Thomas Jefferson University|David Whellan MD|215 955 5050|david.whellan@jefferson.edu|
21253706|NCT02601300|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
21253707|NCT02310100|Abbott|Lori Rusch, Ph.D.|1-651-756-2668|lori.rusch@abbott.com|
21253708|NCT00673400|Cantonal Hospital St. Gallen, Department of Surgery|Ulrich Beutner PhD|+41 71 494 1111|ulrich.beutner@kssg.ch|
21253709|NCT01680640|University of Southampton|Christopher D Byrne|44 (0)23 8120 8818|cdtb@soton.ac.uk|
21253710|NCT01127763|Mt Sinai School of Medicine|Amy Tiersten, MD|212-249-3300|amy.tiersten@mssm.edu|
21253711|NCT00528931|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
21253712|NCT00477659|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
21253713|NCT02571153|Pontificia UCSP|Eduardo Toshiyuki Moro||eduardo_moro@terra.com.br|
21253714|NCT03122223|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
21253715|NCT03835351|Cleveland Clinic Foundation|Dr. Michael Rosen|12164453441|rosenm@ccf.org|
21253716|NCT01151410|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
21253717|NCT01253018|VA Maryland Health Care System|Dr. Christopher T. Bever, Jr. MD, MBA|(410) 605-7000|christopher.bever@va.gov|7130
21253718|NCT02935660|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
21253719|NCT00291642|UCB S.A.|UCB|+1844 599|UCBCares@ucb.com|2273
21253720|NCT01820585|Bial - Portela & Cª, S.A.|Head of Clinical Research Section|+ 351 22 986 61 00|clinical.trials@bial.com|
21253721|NCT02285153|Medical University of Vienna|Bernd Jilma|+434040029180|bernd.jilma@meduniwien.ac.at|
21253722|NCT00939159|UT MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Associate Professor|713-792-7305|eharriso@mdanderson.org|
21253723|NCT01472549|Washington University|Methodius Tuuli|6785582874|methodiustuuli@yahoo.com|
21253724|NCT02327351|National Research Center for Pediatric Hematology , Moscow, Russian Federation|Balashov Dmitriy, head of HSCT department|84956647078|Dmitriy.Balashov@fccho-moscow.ru|6534
21253725|NCT03590366|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
21253726|NCT01630694|University of Rochester|Jacek Wojtczak|585-273-2972|jacek_wojtczak@urmc.rochester.edu|
21253727|NCT01118013|Blood and Marrow Transplant Group of Georgia|Asad Bashey, MD, PhD||abashey@bmtga.com|
21253728|NCT01413503|University of California, San Francisco|Paul A. Fitzgerald, MD|415-665-1136|Paul.Fitzgerald2@ucsf.edu|
21299394|NCT03915717|Sonavex|Katy Feeny|443-862-2024|kfeeny@sonavex.com|
21299395|NCT03550378|MedImmune, LLC|Lars Hansen|+1 301 398 4563|information.center@astrazeneca.com|
21299396|NCT00626275|Cubist Pharmaceuticals|Vice President, Clinical Research|1.781.860.8660||
21299397|NCT01362348|GlaxoSmithKline|GSK Response Center|866-435-7343||
21299398|NCT00399516|Boston Scientific|Brad Hershey, MS|(661) 949-4828|Brad.Hershey@bsci.com|
21299399|NCT00837902|Vanderbilt University Medical Center|Dr. C. Michael Stein|615-936-3420|mike.stein@vumc.org|
21299400|NCT05550779|University of Colorado Colorado Springs|Dr. Lori James|7192554172|ljames@uccs.edu|
21299401|NCT03349723|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21299402|NCT03409796|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21299403|NCT05622734|University of Washington School of Nursing|Oleg Zaslavsky|2068493301|ozasl@uw.edu|
21299404|NCT01908426|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
21299405|NCT00960622|St Luke's Roosevelt Hospital New York|Dr. Donald Phillip Kotler|212 523 3670|dkotler@chpnet.org|
21299406|NCT03270436|University of Arkansas for Medical Sciences|Dr. Pearl A. McElfish|479-713-8680|pamcelfish@uams.edu|
21299407|NCT01419236|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21299408|NCT02173769|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21299409|NCT01977547|Washington University School of Medicine|Dr. Philip C. Spinella|3142860858|pspinella@wustl.edu|
21299410|NCT02041325|BVARI|Dr. Nikhil C. Munshi|857-203-6172|nikhil_munshi@va.gov|
21299411|NCT00851357|UCSD|Principal Investigator|858-300-1056|szhu@ucsd.edu|
21299412|NCT01314313|Edwards Lifesciences|Tenley Koepnick||Tenley_Koepnick@edwards.com|
21299413|NCT04346745|Columbia University|Associate Professor|2128512246|jl4658@columbia.edu|
21299414|NCT01838694|Invion, Inc.|Mitchell Glass, M.D., EVP of R&D|+61 7 3295 0500|mitchell.glass@inviongroup.com|
21299415|NCT00945958|SPARC|Dr Shravanti Bhowmik||shravanti.bhowmik@sparcmail.com|
21299416|NCT02356159|National Cancer Institute|Dr. Najla El Jurdi|240-992-4033|najla.eljurdi@nih.gov|
21299417|NCT02529852|M D Anderson Cancer Center|Jason Westin|(713) 792-3750|jwestin@mdanderson.org|
21299418|NCT03206216|Stanford University Medical Center|Seema Nagpal, MD|650-725-8630|snagpal@stanford.edu|
21299419|NCT01582061|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21299420|NCT04664153|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21299421|NCT03388346|UIHC|Dr. Michael Graham|319-356-4302|michael-graham@uiowa.edu|
21299422|NCT00474123|Heart Institute (InCor) Hospital of the Faculty of Medicine, University of São Paulo (HCFMUSP)|Comparison of Antiplatelet and Anti-inflammatory Effects of High Dose Statin Monotherapy Versus Mode|55-11-30695058|eduardopesaro@hotmail.com|
21299423|NCT01600885|Yale University|John Krystal, MD|203-785-6396|john.krystal@yale.edu|
21299424|NCT00702468|GW Pharma Ltd|Richard Potts Clinical Operations Director|+44 1353 616600|rp@gwpharm.com|
21299425|NCT00088530|CTIBioPharma Corp.|Simran Bedi Singh|(206) 272-4000|ssingh@ctibiopharma.com|
21299426|NCT00300755|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21299427|NCT04571944|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21299428|NCT02163902|Allergan, Inc|Beta Bowen|714-246-4446|Bowen_Beta@allergan.com|
21284311|NCT05873335|Gabi SmartCare|Edouard Carton|472537844|edouard.carton@gabismartcare.com|
21284312|NCT00365209|University of California, Irvine|Dr. Frank L. Meyskens, Jr.|714-456-6310|flmeyske@uci.edu|
21284313|NCT03114657|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21284314|NCT00115037|UPENN|David Oslin, MD|215-823-5894|oslin@upenn.edu|
21284315|NCT01179737|Novartis Pharnaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21284316|NCT02600767|CDC|Alexandre Macedo de Oliveira|404 718 4751|acq7@cdc.gov|
21284317|NCT03597022|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
21284318|NCT00312572|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
21284319|NCT05385224|EnteraSense Ltd.|David Collins, Director of Technical Operations|091 750 246|david@enterasense.com|
21284320|NCT01688141|University of Leicester|Professor Nigel Brunskill|+44 116 258 8043|njb18@le.ac.uk|
21284321|NCT04521114|CytoDyn Inc.|Joseph Meidling, Senior Director - Clinical Operations|(360) 980-8524|jmeidling@cytodyn.com|
21284322|NCT00553358|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@Novartis.com|
21284323|NCT02614131|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21284324|NCT03209518|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21284325|NCT01832818|RTI Surgical|Robin Waite|386-418-8888|rwaite@rtix.com|
21284326|NCT00236899|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21284327|NCT02854605|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21284328|NCT00568334|GlaxoSmithKline|GSK Response Center|866-435-7343||
21284329|NCT01897571|Epizyme, Inc.|Medical Lead or Designee|(855) 500-1011|clinicaltrials@epizyme.com|
21284330|NCT03217968|CEFALY Technology|Clinical Trial Department director|+3243676722|info@cefaly.com|
21284331|NCT00625404|FHI 360|Jennifer Deese, Principal Investigator|919-544-7040|jdeese@fhi360.org|11292
21284332|NCT05268016|Meiji Pharma USA Inc.|Meiji Pharma USA Inc. Study Lead|+1 201-777-7133|mpu.contact@meiji.com|
21284333|NCT02943785|Daiichi Sankyo|Contact for Clinical Trial Information|+ 1 908-992-6400|CTRinfo@dsi.com|
21284334|NCT00032630|VA Medical Center, Denver, Colorado|Frederick Grover, MD|303-393-2863|Frederick.Grover@ucdenver.edu|
21237303|NCT00856050|Dana-Farber Cancer Institute|Dr. Suzanne George|617-632-5204|sgeorge2@partners.org|
21253729|NCT03970538|LimFlow|Director, Clinical Affairs|559-970-1012|kmccaffrey@limflow.com|
21253730|NCT02001064|UCSD HIV Neurobehavioral Research Program (HNRP)|Dr. David J Moore, Professor of Psychiatry|619-543-5093|djmoore@ucsd.edu|
21253731|NCT03960047|University Of Guelph|Professor Barbara A. Morrongiello|5195461637|bmorrong@uoguelph.ca|
21253732|NCT01982448|Dana-Farber Cancer Institute|Clinical Trials Office|617-632-5313|ctopm@dfci.harvard.edu|
21253733|NCT02158052|Massachusetts General Hospital|Thomas Spitzer, MD|6177241124|tspitzer@mgh.harvard.edu|
21253734|NCT00969709|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
21253735|NCT03695237|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21253736|NCT00055601|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21253737|NCT04461483|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21284335|NCT01281956|National Institutes of Health|Dr. William Theodore|301-496-1505|theodorw@ninds.nih.gov|
21284336|NCT01897792|UAB Department of Anesthesiology|Jean-Francois Pittet, MD|205-996-4755|jpittet@uabmc.edu|
21284337|NCT00456261|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21284338|NCT04482036|Eskenazi Health|Jessica Broughton|317-903-6276|jessica.broughton@eskenazihealth.edu|
21284339|NCT03083769|Southern Medical University|Dr. Liang Li|86 20 61648510|liliang@smu.edu.cn|
21284340|NCT01904903|MedStar|Allison Moses|301-256-2728|Allison.E.Moses@medstar.net|
21284341|NCT03578146|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
21284342|NCT05972941|The Ohio State University College of Public Health|Dr. Joanne G. Patterson|614-247-1780|patterson.1191@osu.edu|
21284343|NCT02624388|UVA Health|William Petersen|434-924-8499|wcp3g@uvahealth.org|
21284344|NCT01634659|Alcon Research, Ltd.|Jami Kern, MBA, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
21284345|NCT00586508|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21284346|NCT02079636|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21284347|NCT02918552|University of Pittsburgh|Tara Sheila Stakich|412-864-2082|tss54@pitt.edu|
21284348|NCT04395274|Ohio State University Comprehensive Cancer Center|Dr. Alayna Tackett|614-558-2679|alayna.tackett@osumc.edu|
21284349|NCT03325894|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21284350|NCT01876979|OMFS & HD|Department Chair|302-320-6458|dmeara@christianacare.org|
21284351|NCT02202044|University of Colorado|Tracey MacDermott|303-724-2757|Tracey.MacDermott@ucdenver.edu|
21284352|NCT01362244|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21253738|NCT02217332|Knopp Biosciences|Head of Regulatory|4124881776|greg@knoppbio.com|
21284353|NCT01712334|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21284354|NCT02681757|Children's Hospital Colorado|Choi Young Mee MD|7207770859|youngmeeyoungmee@gmail.com|
21284355|NCT02919267|Institut universitaire de cardiologie de de pneumologie de Québec|Dr Jean Bussières|418-656-8711|jbuss@criucpq.ulaval.ca|2944
21284356|NCT03467763|Memorial Sloan Kettering Cancer Center|Dr. James Flory|6468883790|floryj@mskcc.org|
21284357|NCT02407054|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21284358|NCT01863498|Children's Mercy Kansas City|Dr. Shawn St. Peter|816-234-3575|sspeter@cmh.edu|
21253739|NCT00834626|Kirloskar Hospital|Dr. Neeraj Gupta|+91-40-23296241|drugale@kirloskarhospital.com|
21253740|NCT04004936|Atlanta VAHCS|Dr. Elizabeth Camille Vaughan/ Atlanta Site Section Chief Birmingham/Atlanta GRECC|404 315 4100|elizabeth.vaughan2@va.gov|373118
21253741|NCT03725085|Reckitt Benckiser Inc.|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
21253742|NCT02704754|Howard University|Thomas A Mellman|12022575961|TMellman@Howard.edu|
21253743|NCT02699086|BioLite, Inc.|Hsien-Ming Wu|+886-6579631|sonnywu@bioliteinc.com|
21253744|NCT04464954|Mike O'Callaghan Military Medical Center|Amanda Crawford|7026532067|amanda.j.crawford.ctr@health.mil|
21253745|NCT03809429|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
21253746|NCT00538915|DallasAllergyImmunology|Richard L. Wasserman, M.D., Ph.D.|(972) 566-7788|drrichwasserman@gmail.com|
21299429|NCT03119259|Indiana University|Dr. Richard Holden|812-586-1965|rjholden@iu.edu|
21299430|NCT02525471|Massachusetts General Hospital|Sabrina Paganoni, MD, PhD|617-724-3914|spaganoni@mgh.harvard.edu|
21253747|NCT02716818|Diurnal Limited|Information Line|+44 (0) 2920 682069|info@diurnal.co.uk|
21299431|NCT02527681|Basilea Pharmaceutica International Ltd.|Project Physician|+41 79 701 0551|marc.engelhardt@basilea.com|
21253748|NCT02245737|AstraZeneca|AstraZeneca Information Center|1-877-240-9479|information.center@astrazeneca.com|
21253749|NCT03866798|Clinical Research Management Group|Patrick Murphy|4138210022|p.murphy@crmg-usa.com|
21253750|NCT03786042|Dartmouth college|Research Scientist|603-646-5408|john.brand@dartmouth.edu|
21253751|NCT00836745|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21253752|NCT02551718|University Of Washington|Dr. Percival|206-606-1320|mperciva@seattlecca.org|
21253753|NCT02366468|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21253754|NCT00446043|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
21253755|NCT00359216|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21253756|NCT05540717|Allergy Therapeutics (UK) Ltd.|Pieter-Jan De Kam, Clinical Director|+44 (0) 1903 844 700|pieter-jan.dekam@allergytherapeutics.com|
21253757|NCT00037830|Thomas Jefferson University|Dr. Jay Schneider|215-503-0370|jay.schneider@jefferson.edu|
21253758|NCT01327495|University of Washington|Stephanie Page, MD, PhD|206-616-0483|page@uw.edu|
21253759|NCT03385343|Mayo Clinic|Kevin Buller Clinical Research Coordinator|507-255-4803|Buller.Kevin@mayo.edu|
21253760|NCT01841931|Maimonides Medical Center|Director of Research, Department of Psychiatry|718-283-7162|tjacob@maimonidesmed.org|
21253761|NCT03398213|Bnai Zion Medical Center|Prof. Elad Schiff|972-506267243|elad.schiff@b-zion.org.il|
21253762|NCT00700427|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21253763|NCT01767701|Queen Mary University of London|Professor Gavin Giovannoni||g.giovannoni@qmul.ac.uk|
21253764|NCT02796625|University of Maryland Baltimore|Dr. David Seminowicz|14107063476|dseminowicz@umaryland.edu|
21253765|NCT02057523|Loyola University Medical Center|Sanjeev Akkina|7082166389|sanjeev.akkina@lumc.edu|
21253766|NCT02758847|University of Pittsburgh|Dr Rabih Chaer|4128023333|chaerra@upmc.edu|
21253767|NCT00941070|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Charles Kunos|330-375-4485|kunosc@summahealth.org|
21253768|NCT03174431|The Ohio State University|Silpa Nekkanti|614-293-4643|silpa.nekkanti@osumc.edu|
21253769|NCT03500159|Aquinox Pharmaceuticals (Canada) Inc.|Clinical|604-629-9223|clinical@aqxpharma.com|
21299432|NCT00867165|Merck Sharp & Dohme.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21299433|NCT00539981|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21299434|NCT03360903|University of Chicago|Aaron Fox|(773) 702-0021|aaronfox@uchicago.edu|
21299435|NCT01759420|Carl R Darnall Army Medical Center|Peter Moffett MD|254-288-8302|peter.m.moffett.mil@mail.mil|
21299436|NCT01422161|New York University School of Medicine|Preeti Raghavan, MD|212 598 6206|raghap01@nyumc.org|
21299437|NCT01129622|Mount Sinai Hospital|Robert F Casper|416-972-0777|casper@lunenfeld.ca|
21299438|NCT02051764|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
21299439|NCT00591006|The University of Texas Southwestern Medical Center|E. Sherwood Brown|214 645 6950|sherwood.brown@utsouthwestern.edu|
21299440|NCT03071263|Vifor Pharma Inc.|Clinical Support & Regulatory Intelligence, Regulatory Affairs Director|+1 250 708 4296|Clive.Burge@viforpharma.com|
21299441|NCT00732212|CURE Digestive Diseases Research Center|Dennis M. Jensen, M.D.|310-268-3569|djensen@mednet.ucla.edu|
21299442|NCT01991808|University of Pennsylvania|Lilie Lin, MD|215-622-6515|lin@uphs.upenn.edu|
21299443|NCT03289208|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please Email|cti-inq-ml@ml.mt-pharma.co.jp|
21299444|NCT00662207|Hines VA Hospital, Research Service|James S. Walter, Ph.D.|708-202-5805|James.Walter@va.gov|
21299445|NCT00647296|Knopp Biosciences|Head of Regulatory|4124881776|greg@knoppbio.com|
21299446|NCT00871871|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21299447|NCT02354235|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21299448|NCT03069352|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21299449|NCT02621424|VA Palo Alto|Jauhtai Cheng, MD, Staff Neurologist|650-493-5000|jauhtai.cheng2@va.gov|63617
21237304|NCT01953081|Theravance Biopharma US, Inc.|Dr. Brett Haumann, SVP, Clinical Development|650-808-6000|BHaumann@theravance.com|
21253770|NCT02111187|Associate professor of oncology and urology|Emmanuel Antonarakis|443-287-0553|eantona1@jhmi.edu|
21253771|NCT00560066|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21253772|NCT00506441|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21253773|NCT00735475|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
21299450|NCT05626673|Pray.com|Breanne Laird|9095574002|breanne.laird@pray.com|
21253774|NCT00684723|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21253775|NCT02544451|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21253776|NCT02338973|National Institutes of Health|Wadih Zein, MD, Principal Investigator, NEI|301-496-8118|zeinw@nei.nih.gov|
21299451|NCT05148234|National Cancer Institute|Dr. Najla El Jurdi|240-992-4033|najla.eljurdi@nih.gov|
21299452|NCT02099864|Oregon Health & Science University|Dr. Alexandra Sokolova, M.D.|(503) 494-4396|sokolova@ohsu.edu|
21299453|NCT04750642|Cochlear|Aaron Parkinson|13039414951|aparkinson@cochlear.com|
21299454|NCT01697397|G-Tech Medical|Steve Axelrod, PhD, CEO|650-269-1479|steve.axelrod@gtechhealth.com|
21299455|NCT01650194|Astellas Pharma Global Development, Inc. (APGD)|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
21299456|NCT06319898|Atrium Health Wake Forest Baptist|Dr. Erin Franks|7043041160|erin.franks@atriumhealth.org|
21299457|NCT04158583|Hoffman-La-Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21299458|NCT03043885|UCSF|Daniel Clark|415.476.1101|daniel.clark@ucsf.edu|
21299459|NCT02649556|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|christelle.haziza@pmi.com|
21299460|NCT01414634|Neuroimmunology and MS Research, Department of Neurology, University Hospital Zürich, 8091 Zürich, Switzerland|Roland Martin|044 255 11 25|roland.martin@usz.ch|
21299461|NCT03224130|Cincinnati Children's Hospital Medical Center|Dr. Heidi Sucharew (Biostatistician)|513-803-1920|heidi.sucharew@cchmc.org|
21299462|NCT00414635|Community Research Initiative of New England (CRINE)|Calvin Cohen, MD|617 502 1700|ccohen@crine.org|
21299463|NCT02714400|UCSD|Dillon Gilbertson|8582452155|dcgilbertson@health.ucsd.edu|62155
21299464|NCT04124939|Urology Department, Wake Forest University|Sachin N. Vyas, Research Manager|336-713-4098|svyas@wakehealth.edu|
21299465|NCT02210000|GlaxoSmithKline|GSK Response Center|866-435-7343||
21299466|NCT00308139|AstraZeneca|ClinicalTrialTransparency@astrazeneca.com||ClinicalTrialTransparency@astrazeneca.com|
21299467|NCT02152826|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
21299468|NCT02780401|University of Washington Medical Center|Jennifer S. Childs|2066162305|childj@u.washington.edu|
21299469|NCT02542046|UCaliforniaSF|Dr. Benjamin Yeh|4155149318|ben.yeh@ucsf.edu|
21299470|NCT01751061|Duke University|Dr. Christopher Cox|9196817232|Christopher.cox@duke.edu|
21299471|NCT02660788|BC Cancer|Dr. Alan Nichol|604-877-6046|anichol@bccancer.bc.ca|
21299472|NCT00322777|Canadian Institute of Natural and Integrative Medicine|Dr. Badri Rickhi|403-220-0022|b.ricki@cinim.org|0
21299473|NCT00768989|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21299474|NCT02153086|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21299475|NCT00791388|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com|
21299476|NCT01194830|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21299477|NCT03115359|Pennsylvania State University|Aleksandra E. Zgierska, MD, PhD|717-531-8187|azgierska@pennstatehealth.psu.edu|
21299478|NCT01317472|Indiana University|Terese Stevens, Dept administrator|317-278-3187|tstevens@iupui.edu|
21299479|NCT01815918|Hospital for Special Surgery|Kethy Jules-Elysee, MD|212-606-1206|JulesElyseeK@HSS.EDU|
21299480|NCT04682197|Atrium Wake Forest Baptist Health|Dr. Charles H. Tegeler|336-716-9447|BBRP@wakehealth.edu|
21299481|NCT02690181|GlaxoSmithKline|GSK Response Center|866-435-7343||
21299482|NCT04673214|MEXICAN SOCIAL SECURITY INSTITUTE|Dr. GILBERTO CRUZ ARTEAGA|55 87 44 22|gilberto.cruz@imss.gob.mx|15320
21299483|NCT03285724|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
21299484|NCT02412306|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21299485|NCT03480048|Michigan State University|Jean Kerver, PhD, MSc, RD, Assistant Professor|231-392-8227|jkerver@epi.msu.edu|
21299486|NCT03804840|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
21299487|NCT00443040|Tioga Pharmaceuticals|Dr. Allen Mangel, Chief Medical Officer|919-485-5668|mangel@tiogapharma.com|
21299488|NCT00866177|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646-888-4162|chapmanp@mskcc.org|
21299489|NCT04951115|Weill Cornell Medicine|Ashish Saxena|646-962-2066|ahs9018@med.cornell.edu|
21299490|NCT00435409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21299491|NCT05120713|University of Southern California|Dr. Andy Kim|213-740-5156|andyk@usc.edu|
21299492|NCT03631940|Sharp Healthcare|Dr. Anup Katheria|8589394170|Anup.Katheria@sharp.com|
21299493|NCT00117637|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21299494|NCT03255902|William Beaumont Hospitals|Donna Marvicsin, Nurse Practitioner, Pediatric Endocrinology|248-568-6932|donna.marvicsin@beaumont.org|
21299495|NCT03324607|Duke University Medical Center|Yuh-Chin T. Huang, MD, MHS|9196843069|huang002@mc.duke.edu|
21299496|NCT02646826|Wellesley Pharmaceuticals, LLC|David Dill|2154930168|ddill@wellesleypharma.com|
21299497|NCT02914639|OcuTerra Therapeutics, Inc.|Chief Medical Officer|(617) 701-7382|info@ocuterratx.com|
21253777|NCT00844532|Abbott Vascular|David R Rutledge|408-845-3820|david.rutledge@av.abbott.com|
21253778|NCT05086276|Frequency Therapeutics|Director of Clinical Trials|781-315-4600|clinicaltrialsinformation@frequencytx.com|
21253779|NCT03592745|Feinstein Institutes for Medical Research at Northwell Health|Senior Research Coordinator|5165623646|jchang14@northwell.edu|
21253780|NCT02270515|University of Illinois, Chicago|Dr. Denise M. Hynes, Professor, College of Medicine|312-355-0083|dhynes@uic.edu|
21253781|NCT00738894|W. L. Gore & Associates|Bryan Randall|928-864-4832|BRandall@WLGore.com|
21299498|NCT01814774|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21299499|NCT00189540|AnGes|Director of Clinical Operations|240-780-9031|information@anges-mg.com|
21299500|NCT00062439|SWOG Statistical Center|Lung Committee Statistician|206-667-4623||
21299501|NCT01924845|BioMarin Pharmaceuticals|Debra Lounsbury, Principal Scientist, Clinical Sciences|415-506-6348|DLounsbury@bmrn.com|
21299502|NCT01903356|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21299503|NCT00286442|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21299504|NCT02140047|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608|cti-inq-ml@ml.mt-pharma.co.jp|
21299505|NCT02174731|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
21299506|NCT00079040|ECOG Statistical Office|Study Statistician|617-632-3012||
21299507|NCT00325897|Denver Health Medical Center|Dr. Richard Albert|303-436-6900|ralbert@dhha.org|
21299508|NCT04079296|Astellas Pharma Global Development Inc|Clinical Trial Disclosure|8008887704|astellas.resultsdisclosure@astellas.com|
21299509|NCT00467740|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21237305|NCT01041638|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21237306|NCT05207813|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
21237307|NCT01316926|GlaxoSmithKline|GSK Response Center|866-435-7343||
21237308|NCT02649868|Clinical Center|Wood, Bradford|+1 301 496 7739|bwood@mail.cc.nih.gov|
21237309|NCT03762473|University of Alabama at Birmingham|Graham Towns, MD|(205)934-1801|gtowns@uabmc.edu|
21237310|NCT03373604|Columbia University|Patrick Lao, PhD|212-342-1399|pjl2133@cumc.columbia.edu|
21237311|NCT00710424|GW Pharm Ltd|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
21251339|NCT00543062|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
21251340|NCT00464945|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21251341|NCT03831854|Cleveland Clinic|Dr Kamal Maheshwari|216-318-7235|maheshk@ccf.org|
21251342|NCT02438371|The University of Texas Health Science Center at Houston|Jerrie S. Refuerzo, MD|(713) 500-6416|Jerrie.S.Refuerzo@uth.tmc.edu|
21251343|NCT01161446|University of Washington|Dr. David Katz|206-744-5877|dkatz7@u.washington.edu|
21251344|NCT02536742|International Breast Cancer Study Group|Head Trial Activities and Deputy Director: Dr. Heidi Roschitzki-Voser|+41 31 511 94 00|heidi.roschitzki@ibcsg.org|
21251345|NCT01844726|Northwestern University|Dr. James Reilly|312-503-4809|james.reilly@northwestern.edu|
21251346|NCT03898960|CERENOVUS|Senior Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21251347|NCT03481556|Oncopeptides AB|VP Chief Operating Officer|+46 8 615 20 40|trials@oncopeptides.com|
21251348|NCT01101997|Zeltiq Aesthetics|Kerrie Jiang, Executive Director Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
21251349|NCT01316887|GlaxoSmithKline|GSK Response Center|866-435-7343||
21251350|NCT00469456|Forest Research Institute, a subsidiary of Forest Laboratories Inc.|Stephen Graham, PhD|201-427-8156|stephen.graham@frx.com|
21251351|NCT00364377|Mayo Clinic|Adrian Vella|507-284-3754|vella.adrian@mayo.edu|
21251352|NCT00336817|Upittsburgh|Dr. Roberto Lopez-Solis|412-647-5173|lopezrc@upmc.edu|
21253782|NCT05017103|M D Anderson Cancer Center|Neeta Somaiah, MD|713-792-3626|nsomaiah@mdanderson.org|
21253783|NCT02656329|GE Healthcare|Francois Tranquart, M.D., Ph.D.|0-44-1494-543037|francois.tranquart@ge.com|
21253784|NCT03699826|University of Iowa|Aaron Boes|319-353-8587|aaron-boes@uiowa.edu|
21253785|NCT01081665|Abbott|Global Medical Services|1-800-633-9110||
21284359|NCT00932698|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21284360|NCT02436031|Brigham and Women's Hospital|Andrew Wellman, MD, PhD||awellman@rics.bwh.harvard.edu|
21251353|NCT03672175|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21284361|NCT04438499|Laborie Medical Technologies|Adele Campbell|16032558251|ACampbell@laborie.com|
21284362|NCT00602290|University of California, Los Angeles|Dr. Helen Lavretsky|310-794-4619|hlavretsky@mednet.ucla.edu|
21284363|NCT03850691|Masonic Cancer Center, University of Minnesota|Evidio Domingo-Musibay, MD|612-625-9604|musib024@umn.edu|
21284364|NCT03765229|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat G. Canter MD MS, Clinical Trial Analyst|(919) 962-0000|Melahat_Canter@med.unc.edu|
21284365|NCT02913105|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21284366|NCT05243563|USA Health|Catera Duhon|251-415-1598|cduhon@health.southalabama.edu|
21284367|NCT00703326|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21284368|NCT03364036|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21284369|NCT02661061|Trinity College Dublin|Dr Martha Finnegan|0863638264|mfinneg@tcd.ie|
21284370|NCT02578940|Blue Earth Diagnostics, Ltd.|Peter Gardiner MB ChB, MRCP, FFPM|1-781-552-3403|P.Gardiner@blueearthDx.com|
21253786|NCT03796962|Xenon Pharmaceuticals Inc.|Medical Affairs|+1-604-484-3300|medicalaffairs@xenon-pharma.com|
21284371|NCT00693485|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21284372|NCT00888290|Albert Einstein College of Medicine|Michal Melamed|718-430-2496|michal.melamed@einsteinmed.org|
21284373|NCT03341936|Dana Farber Cancer Institute|Glenn J. Hanna, MD|6176326799|GJHANNA@partners.org|
21284374|NCT06046209|CooperVision, Inc.|Lee Hall|+19252516684|lhall@coopervision.com|
21284375|NCT04525131|University of Kansas Medical Center|Dr. John A Taylor|9135888170|jtaylor27@kumc.edu|
21284376|NCT00858468|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21284377|NCT02131636|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21253787|NCT00719329|Johns Hopkins Bloomberg School of Public Health|Dr. Luke Mullany|410-502-2626|lmullany@jhsph.edu|
21253788|NCT03211117|Mayo Clinic|Ashish V. Chintakuntlawar, MBBS, Ph.D.|(855) 776-0015|Chintakuntlawar.Ashish@mayo.edu|
21253789|NCT03916458|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21253790|NCT02546921|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
21253791|NCT01373151|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
21253792|NCT02186600|University of Nebraska Medical Center|Laura Bilek|402-559-6923|lbilek@unmc.edu|
21253793|NCT03026075|Motus GI Medical Technologies Ltd.|Ravit Peled -Director of Clinical Trial|0733243823|ravit@motusgi.com|203
21253794|NCT03381339|Marquette Univeristy|Associate Dean|4142885944|andrew.dentino@marquette.edu|
21253795|NCT01468181|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21253796|NCT00513305|Cephalon, Inc.|Sponsor's Medical Expert, Clinical Research|1-800-896-5855||
21253797|NCT00636805|Duke University Medical Center|Mary Lou Affronti|919-6846239|mary.affronti@dm.duke.edu|
21253798|NCT03491891|First Hospital of Jilin University|Xiang Wang|+86-13504321434|jdwxiang123@126.com|
21253799|NCT03776539|Eloxx Pharmaceuticals|Executive Director Clinical Trials|1-781-577-5300|CTI@eloxxpharma.com|
21253800|NCT02101385|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
21253801|NCT03621787|co-PI|Kathleen Sienko|734647249|sienko@umich.edu|
21253802|NCT02199743|UT Southwestern Medical Center|Debra Bushong, MS, LPC|214-648-4653|debra.bushong@utsouthwestern.edu|
21253803|NCT02516332|Duke University|Patrick Smith, Ph.D.|919-681-3006|patrick.j.smith@duke.edu|
21253804|NCT01546636|NorthShore University HealthSystem|Glenn Murphy, MD, Director of Clinical Research|847-570-2760|gmurphy@northshore.org|
21253805|NCT03573583|University of Florida|Todd Manini|(352) 273-5914|tmanini@ufl.edu|
21253806|NCT01597141|Maine Medical Center Research Institute|William R. McFarlane, M.D.|207-662-4348|mcfarw@mmc.org|
21253807|NCT01658150|Icahn School of Medicine at Mount Sinia|Dr. Katherine Burdick|212-659-8841|katherine.burdick@mssm.edu|
21253808|NCT04187989|University of Michigan|Dr. Erin Bonar|7347647936|erinbona@med.umich.edu|
21267124|NCT01693562|MedImmune, LLC|Ashok Gupta|+13013981287|information.center@astrazeneca.com|
21253810|NCT01144052|Ospedale Civico|Claudio Globbi, Dr. med.|+41 91 811 6921|claudio.gobbi@eoc.ch|
21253811|NCT00105001|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
21253812|NCT03836716|Zevra Denmark A/S|Medical Affairs|+1-888-289-5607|medicalaffairs@zevra.com|
21284378|NCT02173379|Abbott Vascular|Kelly A. Stockelman, PhD|720-951-8649|Kelly.Stockelman@abbott.com|
21299510|NCT02903160|Icahn School of Medicine at Mount Sinai|Dr. Bobby Liaw|212-604-6010|bobby.liaw@mountsinai.org|
21299511|NCT01838317|University of Texas Southwestern Medical Center|Dr. Muhammad Shaalan Beg|214-648-4180|muhammad.beg@utsouthwestern.edu|
21299512|NCT01664910|The University of Texas MD Anderson Cancer Center|Dr. Issa Khouri, MD/Stem Cell Transplantation and Cellular Therapy Department|713-745-0049|ikhouri@mdanderson.org|
21299513|NCT02240485|Université du Québec à Trois-Rivières|Dr. Joël Tremblay|4186592170|joel.tremblay@uqtr.ca|2820
21299514|NCT02374164|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
21299515|NCT01919229|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21299516|NCT01632020|University of Arkansas for Medical Sciences|Daisy Wade|5016868274|dewade@uams.edu|
21299517|NCT04368260|University of Virginia|Dr. Amy Mathers|434-924-9678|ajm5b@virginia.edu|
21299518|NCT00549640|Mayo Clinic|Dr. Richard D. Hurt|507-266-1944|nicotineresearch@mayo.edu|
21299519|NCT00803283|Janssen Taiwan|Medical Advisor|886-2-23762158||
21299520|NCT01983228|Minneapolis Veterans Affairs Health Care System|Dr. Diana Burgess, Principal Investigator|612-467-1591|diana.burgess@va.gov|
21299521|NCT04999839|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21299522|NCT02734693|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
21299523|NCT03261336|Inova Schar Cancer Institute|Stephanie Van Bebber, Sr. Director Clinical Trials|5714720213|Stephanie.VanBebber@inova.org|
21299524|NCT03174353|University of Washington|Dr. Venu Pillarisetty|206-616-4924|vgp@uw.edu|
21299525|NCT00292942|Uniformed Services University of the Health Sciences|Louis Cantilena, Jr., MD, PhD|301-295-0016|lcantilina@usuhs.mil|
21299526|NCT00644358|Allergan, Inc.|Therapeutic Area Head|1-877-277-8566|IR-CTRegistration@allergan.com|
21299527|NCT03180385|Children's Hospitals and Clinics of Minnesota|Mark Lo Galbo, MPH, CCRP|(612)-813-7828|mark.logalbo@childrensmn.org|
21299528|NCT02732600|VISN 5 Mental Illness Research, Education, and Clinical Center|Richard Goldberg|410-637-1851|Richard.Goldberg@va.gov|
21299529|NCT03111875|Cleveland Clinic|Daniel I. Sessler, MD|216-444-4900|sessled@ccf.org|
21253813|NCT01983254|Duke University|Christopher Cox, PI|9196817232|christopher.cox@duke.edu|
21267125|NCT04735432|argenx BV|Regulatory Manager|+32 9 310 34 00|regulatory@argenx.com|
21253814|NCT01954966|University of Pennsylvania|Claudia Iannelli|6104424426|Claudia.iannelli@pennmedicine.upenn.edu|
21284379|NCT00674479|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani, MD/Professor|713-745-0394|fravandi@mdanderson.org|
21284380|NCT06226649|National Cheng Kung University|Mr. Chun-Yi Ho|886-6-2353535|eggman0011@gmail.com|5852
21284381|NCT01450072|UBNS|Dr. Ellen Carl|716-218-1000|ecarl@ubns.com|7260
21284382|NCT01056913|St John of God Hospital Vienna|Bernhard Dauser (MD)|+43121121|bernhard.dauser@gmail.com|5098
21284383|NCT02553798|Dermira, Inc.|Eugene A. Bauer, MD, Chief Medical Officer|650-421-7202|eugene.bauer@dermira.com|
21284384|NCT00894244|Northwestern University|Dr. Murad Alam|(312) 695-6785|m-alam@northwestern.edu|
21284385|NCT01636947|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21284386|NCT02696434|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
21284387|NCT01586871|University of Minnesota|Aaron Kelly PhD|612-626-3492|kelly105@umn.edu|
21284388|NCT00445744|FHCRC|H. Joachim Deeg MD|206 667 4409|jdeeg@fhcrc.org|
21284389|NCT01522131|The University of Texas Health Science Center at Houston|Rosemary Thomas, DMD, MS|713-486-4074|rosemary.thomas@uth.tmc.edu|
21284390|NCT01810705|Erytech Pharma|Anne-Sophie Clermont|+33 4 78 78 15 70|anne-sophie.clermont@erytech.com|
21284391|NCT00427999|Novartis Pharmaceuticals|Study Director|862-778-8300||
21237312|NCT01986881|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21253815|NCT00831753|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21253816|NCT01467882|Debiopharm International, S.A.|Eija Lundström|:+41 21 3210111|eija.lundstrom@debiopharm.com|
21253817|NCT01631227|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
21253818|NCT00766363|EnVivo Pharmaceuticals, Inc.|Maria Gawryl, Ph.D., Vice President, Regulatory Affairs & Drug Development|617-225-4264|mgawryl@envivopharma.com|
21253819|NCT03020576|Columbia University Medical Center/ Dept. of Rehabilitation & Regenerative Medicine|Lauri Bishop, PT, DPT Research Physical Therapist|212-305-6095|LB2413@cumc.columbia.edu|
21253820|NCT03292432|University of North Carolina at Chapel Hill|Rachel Goolsby - Research Manager|9198430685|rwgoolsby@unc.edu|
21253821|NCT01498679|GlaxoSmithKline|GSK Response Center|866-435-7343||
21253822|NCT02483000|Fred Hutchinson Cancer Research Center|Dr. Ajay Gopal|206-606-2037|agopal@uw.edu|
21253823|NCT01871805|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21253824|NCT02006251|Cleveland Clinic|Wael Barsoum|2164444954|barsouw@ccf.org|
21253825|NCT03307005|Johns Hopkins University|Rashmi Nisha Aurora, MD, MHS|443-513-6535|rnaurora@jhmi.edu|
21253826|NCT03535597|Memorial Healthcare Systerm|Dr. Jianli Niu|954-265-6653|jniu@mhs.net|
21253827|NCT03484273|University of Calgary|Dr. Satish R. Raj|403-210-6152|satish.raj@ucalgary.ca|
21253828|NCT03097484|University of Kentucky|John Bauer, MD|859-218-2927|john.bauer@uky.edu|
21253829|NCT01426867|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21253830|NCT00468104|Midwest Pulmonary and critical care|George Thommi|402 206 7372|tommi4@cox.et|
21253831|NCT01263665|W.L. Gore & Associates|Keli Sapp|9288643964|kesapp@wlgore.com|
21253832|NCT00461513|Veterans Health Administration|Dr. Meg Plomondon|303-370-75770|Meg.Plomondon@va.gov|
21253833|NCT00294515|Hoffmann-La Roche|Medical Communications|800-821-8590||
21253834|NCT02706899|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
21253835|NCT00324675|"University Hospital Carl Gustav Carus, Dresden"|Dr. Frank Pistrosch|0049 351 4400580|frank.pistrosch@uniklinikum-dresden.de|
21253836|NCT00381615|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21253837|NCT01670760|3M|Terri White|651-733-0228|twhite3@mmm.com|
21253838|NCT02335710|University of Tennessee|Richard D. Komistek, Ph. D.|8659742093|rkomiste@utk.edu|
21253839|NCT04771611|Mayo Clinic|James L. Kirkland, M.D., Ph.D.|507-538-3817|Kirkland.James@mayo.edu|
21253840|NCT03992131|pharmaand GmbH|Medical Information Department|+43/1/3560006|medinfo@pharmaand.com|
21253841|NCT04811131|Arcutis|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
21253842|NCT04718779|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21253843|NCT02601976|Getz Pharma|Mr. Jaffer Bin Baqar|111111511|jaffer.baqar@getzpharma.com|2710
21253844|NCT03181789|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
21253845|NCT01131182|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21253846|NCT03001076|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
21253847|NCT04602221|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
21253848|NCT02576587|Cleveland Clinic|Dr. Reena Mehra|216-444-4946|mehrar@ccf.org|
21253849|NCT01080716|Vaccine Trial Treatment Center, Mahidol University|Punnee Pitisutithum, MBBS, DTM&H, FRCPT|66-2-643-5599|tmppt@mahidol.ac.th|
21253850|NCT01056718|Mercy Hospital East Communities|Denise Janosik, MD|314-251-3920|Denise.Janosik@mercy.net|
21253851|NCT00777088|Medtronic|Darren LaCour|949-680-1274|darren.j.lacour@medtronic.com|
21253852|NCT01139580|GlaxoSmithKline|GSK Response Center|866-435-7343||
21253853|NCT01546675|Department of Veterans Affairs|Linda Resnik, PT, PhD|401-273-7100|linda.resnik@va.gov|2368
21253854|NCT02387268|M.C.Carmel|Dr.Kobie Dickstein|048250055|kobiedi@clalit.org.il|
21253855|NCT03230877|Fisher & Paykel Healthcare Ltd.|Sarah Gunson|+64 9 574 0123|sarah.gunson@fphcare.co.nz|7675
21253856|NCT03117998|REMD Biotherapeutics, Inc|"Dung Zung Thai, MD, PhD"|415-225-9338|zungthai@remdbio.com|
21253857|NCT01253070|Washington University School of Medicine|Geoffrey Uy, MD||guy@dom.wustl.edu|
21284392|NCT02284568|Teva Pharmaceutical Industries Ltd|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21253858|NCT00878826|Stanford University|Dr. Deirdre Lyell|650-736-1191|dlyell@stanford.edu|
21253859|NCT00545753|ParaPRO LLC|Director of Quality and Regulatory|317-810-6205|kerrym@parapro.com|
21253860|NCT00710905|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21253861|NCT01011153|MELA Sciences, Inc.|Joanna Adrian, Director of Clinical Operatons and Medical Affairs|914-591-3783|adrian@melasciences.com|732
21253862|NCT03014479|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21253863|NCT00531453|Johnson & Johnson Pharmaceutical Research & Development|Dr. Helgi van de Velde||HVDVELDE@ITS.JNJ.COM|
21253864|NCT01081132|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21253865|NCT05061472|University of Colorado Anschutz Medical Campus|Adnin Zaman, MD|5852761001|adnin.zaman@cuanschutz.edu|
21253866|NCT02489968|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21253867|NCT03738423|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21253868|NCT02299089|Camurus AB|Clinical Trial Manager|+46 46 2876 530|Info@Camurus.com|
21253869|NCT01728337|CBED|Dr Doris Hexsel|30262633|cbed@cbed.com.br|
21253870|NCT03981861|ChildrensMHC|Tania Burgert|203 676 4545|tsburgert@cmh.edu|
21253871|NCT03973931|University of Colorado|Dr. Michael Ho|303-590-5969|michael.ho@cuanschutz.edu; p.michael.x-ho@kp.org|
21253872|NCT01022112|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21253873|NCT03541174|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 58844 1977|idorsiaclinicaltrials@idorsia.com|
21253874|NCT00275262|Abbott|Global Medical Services|800-633-9110||
21253875|NCT02002650|Xijing hospital of digestive diseases|Hui Luo|862984771536|fmmulh@163.com|
21253876|NCT02594163|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
21253877|NCT01342341|Ernest Gallo Clinic and Research Center|Dr. Jennifer Mitchell, Clinical Project Director|510-985-3921|jmitchell@gallo.ucsf.edu|
21253878|NCT00715962|Birmingham VAMC|Cynthia J. Brown, MD, MSPH|205-933-8101|cynthia.brownd44b2@va.gov|7300
21253879|NCT02738203|Stanford University, Department of OB/GYN|Research Manager|6507211562|familyplanningresearch@stanford.edu|
21253880|NCT05087979|Virginia Commonwealth University|Vishal Yajnik, MD, MS|804-663-3519|vishal.yajnik@vcuhealth.org|
21253881|NCT01135537|Sickkids|Dr Tal Schechter-Finkelstein|4168136906|tal.schechter-finkelstein@sickkids.ca|
21253882|NCT02295553|The Hospital for Sick Children, Toronto, Ontario, Canada|Dr. Jason Hayes|416-813-7654|jason.hayes@sickkids.ca|208963
21253883|NCT02680002|BARDA|Silvija Tresnjak-Smith|202-557-1993|Silvija.Tresnjak-Smith@hhs.gov|
21253884|NCT00705679|University of Washington|Jeanne Marrazzo, MD, MPH, FACP, FIDSA|206-744-3679|jmm2@uw.edu|
21253885|NCT03527173|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21253886|NCT02856828|Duke University Health Systems|Dr. Rachel Reilly|919-668-0291|rachel.reilly@duke.edu|
21253887|NCT00423943|University of California, Los Angeles|Michael Minzenberg|310-825-7642|MMinzenberg@mednet.ucla.edu|
21253888|NCT03730480|Ascensia Diabetes Care|Pragathi Shelat|1 (862) 229-6679|pragathi.shelat@ascensia.com|
21253889|NCT01248780|Janssen Research & Development|Associate Director, Clinical Research|610-500-3369||
21253890|NCT04097301|AGC Biologics|Anna Stornaiuolo|0221277440|astornaiuolo@agcbio.com|
21253891|NCT01227577|Novartis|Study Director|862-778-8300||
21253892|NCT00901186|Novartis Pharmaceuticals|Study Director|1-862-778-8300||
21253893|NCT00107120|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Daniel Ventura, PhD|201-427-8252|daniel.ventura@frx.com|
21253894|NCT01119105|Nabriva Therapeutics|Jennifer Schranz, M.D., Chief Medical Officer|610-981-2842|jennifer.schranz@nabriva.com|
21253895|NCT01639495|Biosense Webster, Inc.|Robert Stagg, PhD, Manager, Clinical Franchise|(949) 450-7779|rstagg@its.jnj.com|
21253896|NCT02383056|University of Miami|Dr. Keyvan Nouri|305-243-3380|Knouri@med.miami.edu|
21253897|NCT04214600|Cairo University|Dr. Nadine Mansour|(+2)01001482455- 01001465719|lotfynadine@gmail.com|
21253898|NCT02935452|University of Southampton|Ms Lindsay Welch|07881205106|lw13e14@soton.ac.uk|
21253899|NCT00210470|University of Michigan Hospital|Gregory T. Wolf||gregwolf@umich.edu|
21253900|NCT01635920|Alcon Research, Ltd.|Sharon Holden Thomas, O.D., Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com|
21253901|NCT01813929|University of Colorado Denver|Irene Schauer, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
21253902|NCT01587027|Medical Center of the Rockies|Gary Luckasen, M.D.|(970)624-1686|gary.luckasen@uchealth.org|
21253903|NCT01164644|University of Wisconsin School of Medicine and Public Health|Dr. Scott R. Chaiet|(608) 263-1092|scottchaiet@yahoo.com|
21253904|NCT01239043|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21253905|NCT02929329|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21284393|NCT02454075|Trio Medicines|Dr Malcolm Boyce|020 8961 4130|mboyce@hmrlondon.com|
21284394|NCT01642485|Richmond Pharmacology Ltd|Dr Jorg Taubel|+44(0)2086645200|j.taubel@richmondpharmacology.com|
21284395|NCT02651415|BC Cancer|Dr. Barbara Melosky|604-877-6000|bmelosky@bccancer.bc.ca|
21284396|NCT03956615|Vrije Universiteit Brussel|Dr. Matthias D'Huyvetter|+3224776013|afspraak_nucleaire@uzbrussel.be|
21284397|NCT01955109|DBV Technologies|Chief Medical Officer|33-1-55-42-78-78|clinicaltrials@dbv-technologies.com|
21284398|NCT02798120|Novan|Cathy White, Vice President, Drug Development Operations|9194858080|clinical@novan.com|
21253906|NCT02121301|Ciurem Pharma Inc|Gosse B. Bruinsma|613-866-9609|gbb@CIUREM.COM|
21253907|NCT00692276|Vertiflex|Steve Reitzler|442-325-5934|sreitzler@vertiflex.com|
21284399|NCT01361867|Spaulding Rehabilitation Hospital|Paolo Bonato|617-952-6319|pbonato@partners.org|
21284400|NCT05656885|CooperVision Inc.|Dr. Jose A Vega OD, MSc, FAAO|+19256213761|javega@coopervision.com|
21253908|NCT01033422|Can-Fite BioPharma Ltd|Zivit Harpaz|972-3-9241114|zivit@canfite.co.il|
21253909|NCT00353522|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
21253910|NCT00434213|Noven Pharmaceuticals, Inc.|Amaury Sanchez, Sr. Manager, Regulatory Affairs||asanchez@noven.com|
21253911|NCT04988867|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261|medicalinformation@acadia-pharm.com|2897
21253912|NCT01699503|Indiana University|Dr. Nicole Fowler|317-274-9021|fowlern@iupui.edu|
21253913|NCT01639560|Mayo Clinic|Jon O. Ebbert, MD|507-266-1944|nicotineresearch@mayo.edu|
21253914|NCT00911937|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21253915|NCT04560010|NYU Langone|Arthur Hertling, MD|212-263-5072|Arthur.hertling@nyulangone.org|
21253916|NCT00633880|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
21253917|NCT00700778|Fox Chase Cancer Center|Dr. Jose Russo|215-728-4782|Jose.Russo@fccc.edu|
21284401|NCT02366403|War Related Illness and Injury Study Center, VA Palo Alto Healthcare System|Peter Bayley, PhD|650 493-5000|peter.bayley@va.gov|68653
21284402|NCT03013985|Emory University|Dr. Guillermo Umpierrez|404-778-1665|GEUMPIE@emory.edu|
21284403|NCT01887678|Biologische Heilmittel Heel GmbH|Christine Frank, PhD, Global Clinical Project Manager|+49 7221 501 3188|christine.frank@heel.com|
21284404|NCT03411902|Wake Forest School of Medicine|Kristen Beavers|336-758-5855|beaverkm@wfu.edu|
21284405|NCT01044589|Cleveland Clinic|Dr. Massarat Zutshi|(216) 444-3540|zutshim@ccf.org|
21284406|NCT00791492|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21284407|NCT02322333|Clinvest Research|Jim Sly MS|4178413673|jsly@clinvest.com|
21284408|NCT00076999|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21284409|NCT04964986|VectivBio AG|Clinical Trial Information Desk|617.621.7722|ClinicalTrialEnquiries@ironwoodpharma.com|
21253918|NCT01504477|Georgetown University|Michael Pishvaian|202-444-2223|pishvaim@georgetown.edu|
21284410|NCT01217385|American College of Radiology|Donna Hartfeil, Director Protocol Management|215-717-2765|dhartfeil@acr.org|
21237313|NCT01258608|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21237314|NCT04205630|Byondis B.V.|Clinical Development|0031246795101|clinicaltrials@byondis.com|
21253919|NCT04927247|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21237315|NCT00676182|James A. Haley Veterans' Hospital|Dr. Kris Siddharthan|813-558-3950|Krishnaswami.Siddharthan@va.gov|
21253920|NCT00350103|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21253921|NCT02842151|Alcon, A Novartis Division|Senior Global Brand Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21253922|NCT02559895|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
21253923|NCT00320528|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21253924|NCT04828837|NTUNHS|Wang Szu-Yi|886-97140315|jachiex@gmail.com|
21253925|NCT01397422|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com|
21253926|NCT00760474|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21253927|NCT04664400|Dartmouth College|Tor D Wager, PhD|(603)-646-2196|Tor.D.Wager@Dartmouth.edu|
21253928|NCT01262027|The University of Texas (UT) MD Anderson Cancer Center|Vicente Valero, MD/Professor, Breast Medical Oncology|713-792-7734|vvalero@mdanderson.org|
21253929|NCT00610740|Masonic Cancer Center, University of Minnesota|Levi Downs, Jr., M.D.|612-626-6628|downs008@umn.edu|
21253930|NCT02688218|Oregon Health and Science University|Joseph El Youssef|503-418-5128|elyoussj@ohsu.edu|
21253931|NCT02577822|Northwestern University|David Manning, MD|312-695-6800|david.manning@nm.org|
21253932|NCT03748992|Medical University of South Carolina|Patrick Flume, MD|843-792-3167|flumepa@musc.edu|
21253933|NCT03691909|Hope Biosciences Stem Cell Research Foundation|Linette Rehkopf RPh|346-900-0340|linette@hopebio.org|102
21253934|NCT05452278|Imperial Brands PLC|Libby Clarke|+44 (0117) 3320221|libby.clarke@impbrands.com|
21253935|NCT03663257|Philips Medical Systems Nederland B.V.|Joris de Groot|+31621949619|joris.ah.de.groot@philips.com|
21253936|NCT04512430|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
21253937|NCT01905150|Hirschfeld Oncology|Dr. Azriel Hirschfeld|718-732-4050|ah@honcology.com|
21253938|NCT03670004|Jesse Brown VA Medical Center|Dr. Matthew Major|312-503-5731|matthew.major2@va.gov|
21253939|NCT00383110|Ralph H. Johnson VAMC|Leonard Egede, MD, MS|843-789-6670|leonard.egede@va.gov|
21253940|NCT00835900|Roswell Park Cancer Institute|Dr. Martin Mahoney|7168452300|martin.mahoney@roswellpark.org|
21237316|NCT04250727|Yale School of Medicine|Lisa Fucito, PhD: Associate Professor of Psychiatry; Director, Tobacco Treatment Service, Psychiatry|(203) 688-1878|lisa.fucito@yale.edu|
21253941|NCT01758900|Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine|Zhizheng Ge, MD. Ph.D. Director of the Clinical Trials|86-21-68383015|zhizhengge@yahoo.com.cn|
21253942|NCT03122691|Johns Hopkins University School of Medicine|Dr. Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
21253943|NCT03762200|ETHICON, Inc|Patricia Schleckser|01 908 218 2244|PSchleck@its.jnj.com|
21253944|NCT04577001|Mayo Clinic|Dr. Hilary DuBrock|(507) 284-2957|DuBrock.Hilary@mayo.edu|
21253945|NCT00588900|UNC Lineberger Comprehensive Cancer Center|Bert O'Neil, M.D.||bert_oneil@med.unc.edu|
21253946|NCT04949243|Duke University|Saira Siddiqui, MPH|919-688-8464|saira.siddiqui@duke.edu|
21253947|NCT01865747|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
21253948|NCT01464775|MercyMC|Dr. Fermin Barrueto|410-321-8452|fbarrueto@mdmercy.com|
21253949|NCT00611975|Yale School of Medicine|Margaret Altemus|646-209-6277|margaret.altemus@yale.edu|
21253950|NCT04625413|University of Rochester Medical Center|Dr. Kah Poh Loh|585-276-4353|kahpoh_loh@urmc.rochester.edu|
21253951|NCT05618912|Indiana University School of Medicine|Dr. Syril Keena T. Que|317-944-7744|ques@iu.edu|
21253952|NCT00432666|Merz Pharmaceuticals GmbH|Angelika Hanschmann|++49-69-1503|angelika.hanschmann@merz.de|538
21253953|NCT00978627|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21253954|NCT01506453|St. Jude Children's Research Hospital|Doralina Anghelescu, MD|(901) 595-4034|doralina.anghelescu@stjude.org|
21253955|NCT00452426|Ethicon Endo-Surgery|James Martin, PhD|513 337-7000||
21253956|NCT00605215|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21253957|NCT04058366|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21253958|NCT04497142|Brigham and Women's Hospital|Steven Tobochnik, MD|617-732-7432|stobochnik@bwh.harvard.edu|
21253959|NCT01302067|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21253960|NCT01076192|AbbVie|Global Medical Information|800-633-9110||
21253961|NCT01034176|Brigham and Women's Hospital|Dr. Anil Chandraker|617-525-8203|achandraker@partners.org|
21253962|NCT00266227|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
21253963|NCT00670631|University of Iowa|Guido Tricot, MD, PhD||guido-tricot@uiowa.edu|
21253964|NCT01290315|Luitpold Pharmaceuticals, Inc.|Angelia Butcher|610-650-4200|abutcher@luitpold.com|811
21253965|NCT03296033|Wake Forest School of Medicine|Daryl Henshaw, MD|336-716-6344|dhenshaw@wakehealth.edu|
21253966|NCT03076333|Joint UNC/NC State Department of Biomedical Engineering|David S Lalush|919-513-7671|dslalush@ncsu.edu|
21253967|NCT00896051|Tibotec|Senior Director|+32 (0) 14 641 265||
21253968|NCT00194987|Weill MC|Dr James Bussel|917-291-5091|jbussel@med.cornell.edu|
21253969|NCT01664598|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21253970|NCT02342743|CEFALY Technology|Clinical Trials Department director|+3243676722|info@cefaly.com|
21253971|NCT03602066|University of Arizona Cancer Center|Jared Robbins, MD|520-626-6724|jrobbins@arizona.edu|
21253972|NCT00092495|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21253973|NCT02778932|University Hospital Schleswig-Holstein, Campus Kiel|Priv.-Doz. Dr. med. Axel Fudickar|0049500|axel.fudickar@uksh.de|20801
21253974|NCT00936741|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
21253975|NCT03356626|Seoul National University Hospital, Seoul National University College of Medicine|Seong-Ho Kong|+82-2-2072-4199|seongho.kong@snu.ac.kr|
21253976|NCT01008319|University of Oklahoma|LaTasha Craig, MD|405-271-8787|latasha-craig@ouhsc.edu|
21253977|NCT00704379|Baylor College of Medicine|Dr. Ricardo Jorge|713-794-7010|Ricardo.Jorge@bcm.edu|
21253978|NCT04513652|American Genomics, LLC|Martin Uram, MD|848-444-0665|martin@amgenomics.net|
21253979|NCT03212989|University of North Carolina at Chapel Hill|Cynthia Gay, MD, MPH|919-966-6712|cynthia_gay@med.unc.edu|
21253980|NCT00795366|University of Miami|Kenneth Proctor, PhD, Professor of Surgery|305-585-1178|kproctor@med.miami.edu|
21253981|NCT01236534|University of Rochester|Andrew Goodman, MD|585-275-7854|andrew_goodman@urmc.rochester.edu|
21253982|NCT04955444|The Methodist Hospital Research Institute|Elsie Rizk|7134412557|erizk@houstonmethodist.org|
21253983|NCT01844687|Columbia University Medical Center|Margaret Haney, PhD., Professor|(646) 774-6153|mh235@columbia.edu|
21253984|NCT02235831|Alcon Research, Ltd.|Sr. Global Brand Lead, GCRA, Vision Care|1-888-451-3937||
21253985|NCT01963923|Complejo Hospitalario Universitario A Coruña|Esther Gimenez Moolhuyzen|679336288|raquel.sebio@udc.es|
21253986|NCT04638920|University Hospital Zurich|Prof. Malcolm Kohler, Sponsor-Investigator|+41442551111|malcolm.kohler@usz.ch|
21253987|NCT03775434|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
21253988|NCT01435616|Eli Lilly and Company|Chief Medical Officer|800 545 5979||
21253989|NCT00371683|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21253990|NCT00453193|The University of Texas M D Anderson Cancer Center|Farhad Ravandi-Kashani MD/Associate Professor|713-745-0394|eharriso@mdanderson.org|
21253991|NCT00438672|Massachusetts General Hospital|Dr. David Ring|617-724-3953|dring@partners.org|
21299530|NCT04264442|Fulcrum Therapeutics|Call Center|617-651-8853|clinicaltrials@fulcrumtx.com|
21299531|NCT01290523|University of California San Francisco Department of Radiology|Dr Nicholas Fidelman|(415) 353-1300|Nicholas.Fidelman@ucsf.edu|
21299532|NCT00399308|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21299533|NCT00740220|Wake Forest University|Arjun Chatterjee, MD, MS, FCCP|336.716.4649|achatter@wfubmc.edu|
21299534|NCT00633477|Takeda|Takeda Study Registration Call Center|800-778-2860|medicalinformation@tpna.com|
21253992|NCT01030406|Acura Pharma|Dr. Ron Spivey|847-705-7709|rspivey@acurapharm.com|
21253993|NCT04540887|Wake Forest Institute for Regenerative Medicine|Dr. Stephen Walker|33-713-7272|swalker@wakehealth.edu|
21299535|NCT02539823|Icahn School of Medicine at Mount Sinai|Yasmin Hurd, PhD|212 824 9314|yasmin.hurd@mssm.edu|
21299536|NCT00770653|Takeda Pharma GmbH, Aachen (Germany)|Medical Director|+49 800 8253325|clinicaltrialregistry@tpna.com|
21253994|NCT04887064|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21253995|NCT03419832|Wake Forest School of Medicine|Joseph E. Andrews, Jr., PhD, CIP, CCRP|336-716-7658|jandrews@wakehealth.edu|
21253996|NCT01394978|Davol, Inc.|Dawn Heimer, PhD|+1-401-825-8681|Dawn.Heimer@CRBard.com|
21253997|NCT03562975|University Of South Florida|Clinical Research Manager|18139749423|amjackson@usf.edu|
21253998|NCT00552929|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21253999|NCT01147536|Agenus Inc.|Agenus, Inc. Clinical Trial Information|781-674-4265|clinicaltrialinfo@Agenusbio.com|
21254000|NCT01846494|Duke Clinical Research Institute|Allison DeLong|919-668-6855|allison.delong@duke.edu|
21254001|NCT02592876|Seattle Genetics, Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
21254002|NCT01305200|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreporingcoordinator@childrensoncologygroup.org|
21254003|NCT00925353|St. Luke's Mountain States Tumor and Medical Research Institute|Colleen K. Lambertz, MBA, MSN, FNP|208 463 6018|lambertc@slhs.org|
21254004|NCT03647488|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21254005|NCT00812331|Janssen Research & Development United States|Global Clinical DVLP Manager||ClinicalTrialDisclosure@its.jnj.com|
21254007|NCT03694275|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21254008|NCT02502799|Florida International University|Dr. William E. Pelham Jr.|305-348-3002|wpelham@fiu.edu|
21254009|NCT00153062|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21254010|NCT00690040|Hemek Medical center|Dr. Raed Salim|97246494031|salim_ra@clalit.org.il|
21254011|NCT01304238|GlaxoSmithKline|GSK Response Cente|866-435-7343||
21254012|NCT01589237|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21254013|NCT00117845|National Cancer Institute, National Institutes of Health|Thomas Waldmann, M.D.|301-496-6656|tawald@mail.nih.gov|
21254014|NCT01022268|Imperial College London|Dr Jethro Herberg|+44 - 0207 594 3990|j.herberg@imperial.ac.uk|
21254015|NCT00734097|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
21254016|NCT05130047|Mayo Clinic|Michael Camilleri, M.D., D.Sc.|507-284-2687|camilleri.michael@mayo.edu|
21254017|NCT02233543|Novartis Pharmaceuticals|Study Director|862-778-8300||
21254018|NCT00603304|University of Alabama at Birmingham|Dr. Alan Cantor|(205) 934-6887|acantor@uab.edu|
21254019|NCT01775475|AIDS Malignancy Consortium Statistical and Data Analysis Center|Study Statistician|(212) 659-9558|amcpm@emmes.com|
21254020|NCT00435591|Astellas Pharma Global Development|Senior Medial Director, Medical Affairs||clinicaltrials@us.astellas.com|
21254021|NCT02618915|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|Medinfo@ultragenyx.com|
21254022|NCT00007345|National Cancer Institute|Dr. Kieron Dunleavy|301-435-1007|DunleavK@mail.nih.gov|
21254023|NCT04433585|Nektar Therapeutics|Study Director|8554828676|StudyInquiry@nektar.com|
21254024|NCT02074553|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21254025|NCT00686725|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21254026|NCT04875676|Vaxart|Vice President Regulatory|(650) 747-6028|mdrayton@vaxart.com|
21254027|NCT02454179|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
21254028|NCT03182725|University of California - San Diego Health|Dr. Pam Taub|858-246-2342|ptaub@health.ucsd.edu|
21254029|NCT03103763|Penobscot Bay Medical Center|Caroline Knight, RN, Clinical Research Manager|207-301-8959|cknight@pbmc.org|
21254030|NCT00938470|Mayo Clinic|Steven R Alberts MD MPH|507-284-4918|alberts.steven@mayo.edu|
21254031|NCT03245151|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21254032|NCT01970345|Icahn School of Medicine at Mount Sinai|Dr. Alexander Kolevzon|(212) 659-8762|alexander.kolevzon@mssm.edu|
21254033|NCT01346475|University of Washington|Dr. Christine Johnston|206-520-4340|cjohnsto@u.washington.edu|
21254034|NCT01552603|Legacy Health System|Kenneth Ward|971-570-2632|kenward503@msn.com|
21254035|NCT00618618|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
21254036|NCT01488877|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21254037|NCT00621777|Massachusetts General Hospital|A. Eden Evins, MD, MPH|6176434679|a_eden_evins@hms.harvard.edu|
21254038|NCT00955253|Imperial College London|Dr Paresh Malhotra|0208 846 1234|p.malhotra@imperial.ac.uk|
21254039|NCT04797650|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
21254040|NCT03250234|USARIEM|Dr. Lee Margolis|508-206-2335|lee.m.margolis.civ@mail.mil|
21254041|NCT00309959|NRG Oncology|Angela Kuras on behalf of James Kauderer|716-845-5702|kurasa@nrgoncology.org|
21254042|NCT02663518|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21254043|NCT02470910|DFCI/BWH|Anthony D'Amico|8572151489|adamico@bwh.harvard.edu|
21254044|NCT00006011|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
21254045|NCT03178643|DCRI|Dr. Steve Taylor|9198245232|steve.taylor@duke.edu|
21254046|NCT02015455|University of Washington|Dr. Sandra K Johnston, PhD, RN Executive Administrative Director- CLEAR Center|206-221-7444|stonesk@uw.edu|
21254047|NCT01097707|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21254048|NCT02029872|Johns Hopkins University School of Nursing|Dr. Jason Farley|4105027563|jfarley1@jhu.edu|
21254049|NCT03699085|University of Washington|Lauren Whiteside, Primary Investigator|206-744-8464|laurenkw@uw.edu|
21254050|NCT03568331|Vanda Pharmaceuticals Inc.|Vanda Pharmaceuticals Inc.|202-734-3400|clinicaltrials@vandapharma.com|
21254051|NCT00158860|GlaxoSmithKline|GSK Response Center|866-435-7343||
21254052|NCT03047395|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21254053|NCT01145209|National Heart Lung and Blood Institute|Wiestner, Adrian MD, PhD|+1.301.594.6855|wiestnea@nhlbi.nih.gov|
21299537|NCT00289653|Centre for Addiction and Mental Health|Dr. Peter Selby|416-535-8501|peter.selby@camh.ca|36859
21299538|NCT01962792|Pharmacyclics LLC|Thorsten Graef, Head of Clinical Development|+1 (408) 215-3127|tgraef@pcyc.com|
21299539|NCT04906499|University of North Carolina at Chapel Hill|Caroline Lisee, PhD|919-962-2025|liseecar@email.unc.edu|
21254054|NCT00580645|Yale School of Medicine|Sherry McKee PhD|203-737-3529|sherry.mckee@yale.edu|
21254055|NCT01157676|University of Miami|Dipen Parekh, MD|305 243 6591|parekhd@miami.med.edu|
21254056|NCT00682890|Virginia Commonwealth University|Dr. John Nestler|804-828-3389|jnestler@mcvh-vcu.edu|
21254057|NCT03028220|Imperial College London|Prof Nick Oliver|02075942460|nick.oliver@imperial.ac.uk|
21254058|NCT02595073|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
21254059|NCT02261597|Beth Israel Deaconess Medical Center, Harvard Medical School|Dr. Monika Haack|617-667-5234|mhaack@bidmc.harvard.edu|
21299540|NCT00837252|National Eye Institute|Catherine M. Meyerle, MD|301-435-7821|meyerlec@nei.nih.gov|
21299541|NCT00644423|Durham VA Medical Center|Christine Marx, MD MA|919-286-0411|marx0001@mc.duke.edu|3626
21299542|NCT03525444|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21299543|NCT03240601|Shepherd Center|Dr. Edelle Field-Fote|4046034274|edelle.field-fote@shepherd.org|
21299544|NCT00262860|University of Rochester|Jonathan W. Friedberg|585-273-4150|jonathan_friedberg@urmc.rochester.edu|
21299545|NCT00878501|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21299546|NCT04416204|University of Alabama at Birmingham|Dr. Rita Basu|2059341200|rbasu@uabmc.edu|
21299547|NCT01183689|Wake Forest University School of Medicine|Mark Espeland|336-716-2826|mespelan@wakehealth.edu|
21299548|NCT01959503|C.R. Bard|Dawn Heimer|401-825-8681|Dawn.Heimer@crbard.com|
21299549|NCT00281463|Human Engineering Research Laboratories|Rory Cooper, PhD|412-822-3700|rcooper@pitt.edu|
21299550|NCT02985827|Ora|Senior Director of Research and Development|9786858900|klane@oraclinical.com|
21299551|NCT03598036|Aurinia Pharmaceuticals Inc.|Clinical Trial Support|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
21299552|NCT04231669|Washington University in St. Louis|Dr. Ozge Sensoy Bahar|314-935-9403|ozge.sensoybahar@wustl.edu|
21299553|NCT05626738|ENDOSTART SRL|Alessandro Tozzi|0571843033|a.tozzi@endostart.com|0039
21299554|NCT02681809|ThromboGenics|Global Clinical Development|+3216751310|info@oxurion.com|
21299555|NCT03585660|Department of Radiology, University of Chicago|Dr. Aytekin Oto, MD, MBA|1-773-702-8553|aoto@bsd.uchicago.edu|
21299556|NCT05635461|Cerevance|Michelle Charles, Executive Director Regulatory Affairs|(408) 220-5722|michelle.charles@cerevance.com|
21254060|NCT04860297|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
21254061|NCT00396019|AstraZeneca|Dr. Regina Jakacki||regina.jakacki@astrazeneca.com|
21254062|NCT00741390|Becton Dickinson|Kenneth Kassler-Taub, VP Medical Affairs|201-847-7009|kenneth_kassler_taub@bd.com|
21254063|NCT00003453|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
21254064|NCT00620282|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21254065|NCT02217475|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21254066|NCT02615002|Neurim Pharmaceuticals|Tali Nir, DVM, VP Clinical and Regulatory Affairs|+972-3-7684902|talin@neurim.com|
21254067|NCT04738292|Froedtert / Medical College of Wisconsin|Sailaja Kamaraju, MD, MS|414-805-4600|skamaraju@mcw.edu|
21254068|NCT02971761|Department of Medical Oncology, City of Hope|Yuan Yuan, MD, PhD.|626-256-4673|yuyuan@coh.org|89200
21254069|NCT02442336|Fox Chase Cancer Center|Carolyn Fang|215-728-4062|carolyn.fang@fccc.edu|
21254070|NCT02478710|Premier Health|Director of Clinical Research|19374747850|jllader@premierhealth.com|
21254071|NCT01237587|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21254072|NCT01011387|Mölnlycke Health Care AB|Jenny Thorell|0046 31 7223000|jenny.thorell@molnlycke.com|
21254073|NCT01285609|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21254074|NCT01142115|Clinical Regulatory Development, Global R&D|Trine Møller Kruse|+4549112174|dktrm@coloplast.com|
21254075|NCT03208036|Minneapolis VA Health Care System|Tasha Nienow|612-467-1004|tasha.nienow@va.gov|
21254076|NCT01879553|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21254077|NCT02019667|National Institutes of Health|Dr. William Theodore|301-496-1505|theodorw@ninds.nih.gov|
21254078|NCT02432196|Edwards Lifesciences, LLC|Sabrina Hundt, Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Sabrina_Hundt@edwards.com|
21254079|NCT03924765|Georgia Institute of Technology|Dr. Aaron Young|404-385-5306|aaron.young@me.gatech.edu|
21254080|NCT05038163|NBER|Sarah Holmes Berk|617-588-1445|sholmes@nber.org|
21254081|NCT05453201|James J. Peters Veterans Affairs Medical Center|Dr. Marianne Goodman|6462457071|mggoodman2001@yahoo.com|
21254082|NCT01934790|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21254083|NCT00935818|Mayo Clinic|Dr. Jon Ebbert|507-284-4736|ebbert.jon@mayo.edu|
21254084|NCT00867308|Johns Hopkins University|Amy DeZern, MD|4105027208|adezern1@jhmi.edu|
21254085|NCT00604825|GlaxoSmithKline|GSK Response Center|866-435-7343||
21254086|NCT03465904|CEFALY Technology|Clinical Trials Department director|+32 4 367 67 22|ClinicalTrial@cefaly.com|
21254087|NCT00616902|Abbott|Global Medical Services|800-633-9110||
21299557|NCT03661723|Dana-Farber Cancer Institute|David A. Reardon, MD (Clinical Director, Center for Neuro-Oncology)|617-632-2166|david_reardon@dfci.harvard.edu|
21254088|NCT03207009|bluebird bio, Inc|Study Medical Director|+1-833-999-6378|clinicaltrials@bluebirdbio.com|
21254089|NCT02924428|Venus Concept Ltd.|Director, Clinical Affairs|416-222-6144|mgronski@venusconcept.com|517
21254090|NCT01877837|Hackensack Meridian Health|Elana Smilow|5519965673|Elana.Smilow@hmhn.org|
21254091|NCT00645801|retired|Director of Gastrointestinal Research||anngimd@icloud.com|
21299558|NCT00910104|Boston Children's Hospital|Mark Puder MD PhD|617-355-1838|mark.puder@childrens.harvard.edu|
21254092|NCT00759915|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com|
21254093|NCT04259645|UPMC Department of Anesthesiology and Perioperative Medicine|Anna Uskova, MD|412-623-2167|uskoaa@upmc.edu|
21254094|NCT00932113|Tufts Medical Center|Nicole Dumont|617 636 7462|ndonovan1@tuftsmedicalcenter.org|
21254095|NCT00504660|UT MD Anderson Cancer Center|Charles A. Conrad, MD / Professor|713-745-1896|skang@mdanderson.org|
21254096|NCT01773291|Kaohsiung Chang Gung Memorial Hospital|Wen-Long Hu, Deputy Director, Department of Chinese Medicine|+886-7-7317123|oolonghu@gmail.com|2334
21254097|NCT02480153|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21254098|NCT01403610|UT Health San Antonio|Andrew Brenner|210-450-1000|regulatoryaffairs@uthscsa.edu|
21299559|NCT04364386|InPress Technologies Inc|Jan Segnitz, MD|(408) 238-9279|jsegnitz@gmail.com|
21254099|NCT00203476|TuscaloosaREAC|Raela Williford, PharmD|(205) 554-2000|Raela.Williford@va.gov|2433
21299560|NCT04019379|University of Minnesota|Kathleen M. Hill Gallant, PhD|612-625-5285|hillkm@umn.edu|
21254100|NCT01190514|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21254101|NCT02080312|UCSD|Julie Bykowski|619-543-6766|jbykowski@ucsd.edu|
21254102|NCT00512317|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
21299561|NCT04750824|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21299562|NCT00807911|Asan Medical Center|Dr. Tae Won Kim|+82-2-3010-3910|twkimmd@amc.seoul.kr|
21254103|NCT01491672|Novartis|Study Director|862-778-8300||
21254104|NCT04390022|Barcelona Institute for Global Health|Carlos Chaccour|0034666293112|carlos.chaccour@isglobal.org|
21254105|NCT03241225|Weill Cornell Medicine|Dr. Jo Anne Sirey|914-997-4333|jsirey@med.cornell.edu|
21299563|NCT03859024|University of Alabama at Birmingham|Dr. Adam Baumgarten|205-996-6769|abaumgarten@uabmc.edu|
21254106|NCT00852540|GlaxoSmithKline|GSK Response Center|866-435-7343||
21254107|NCT02550470|Rutgers - New Jersey Medical School|Dr. Eloy, PI|973 972 5007|eloyje@njms.rutgers.edu|
21254108|NCT03064035|Methodist Hospital|Zachary Stoecker, PharmD|952-977-5520|Zachary.Stoecker@parknicollet.com|
21254109|NCT00560560|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21299564|NCT04175730|University of Illinois at Chicago|Dr. Michael Abern|312-996-9330|mabern1@uic.edu|
21254110|NCT01253304|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21254111|NCT01534689|Regulatory Insight, Inc.|Clinical Consultant|6157129743|elvira@reginsight.com|
21254112|NCT01004848|Icahn School of Medicine at Mount Sinai|Carol R. Horowitz, MD, MPH|212-659-9567|carol.horowitz@mountsinai.org|
21254113|NCT01160289|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21254114|NCT03909529|CMP Pharma|Paul Sudhakar|816-507-8249|pauls@ptspharma.com|
21254115|NCT01090479|Northwestern University|Michael Murray, MD|312-926-4444|m.murray8278@gmail.com|
21299565|NCT03192176|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
21254116|NCT01156792|GlaxoSmithKline|GSK Response Center|866-435-7343||
21254117|NCT00768079|MedImmune, LLC|Joseph M. Parker, Director, Clinical Development|+1 301-398-4095|information.center@astrazeneca.com|
21254118|NCT02876159|Emory University|Dr. Mark J. Mulligan, M.D., F.I.D.S.A|404-712-1370|mmulli2@emory.edu|
21299566|NCT05796557|Yale|Oliver Karam|203-785-4651|oliver.karam@yale.edu|
21254119|NCT00564889|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
21254120|NCT01721460|University od Wisconsin - Madison|Dr. Aeyal Raz|608-263-8100|raz@wisc.edu|
21254121|NCT00141219|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21254122|NCT00297596|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSarah@scresearch.net|
21254123|NCT01577745|MedImmune, LLC|Mohammed Dar|301-398-1008|information.center@astrazeneca.com|
21299567|NCT03562195|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21299568|NCT00836589|BIOTRONIK, INC|Kelly Mohr|800-547-0394|kelly.mohr@biotronik.com|
21254124|NCT01580423|Dartmouth-Hitchcock Medical Center|Donald A. Mahler|603 650-5533|Donald.a.mahler@hitchcock.org|
21299569|NCT00614575|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21254125|NCT01324440|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21254126|NCT02884908|University of Maryland School of Medicine|Dr. Melanie Bennett|4107060892|mbennett@som.umaryland.edu|
21299570|NCT01018030|GlaxoSmithKline|GSK Response Center|866-435-7343||
21299571|NCT01890343|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
21254127|NCT02450799|Alcon, A Novartis Division|Phase IV, Clinical and Regulatory Affairs, Alcon Japan|1-888-451-3937|alcon.medinfo@alcon.com|
21254128|NCT01801735|Iroko Pharmaceuticals, LLC|Alexis Gomez, Director of Clinical Operations|267-546-1426|agomez@iroko.com|
21254129|NCT04080908|NYU Langone Health|Stuart Katz|2122633946|Stuart.Katz@nyulangone.org|
21254130|NCT01293487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21254131|NCT01975974|University of Iowa Hospitals and Clinics|Dr. Kenichi Ueda|319-356-2633|kenichi-ueda@uiowa.edu|
21254132|NCT02703259|Christiana Care Health Systems|Dr. Terri Huynh|302-623-4410|terri.huynh@christianacare.org|
21254133|NCT00287690|Imperial College London|Dr Carolyn Webb|+44 3301288121|c.webb@imperial.ac.uk|
21254134|NCT01146782|ApniCure, Inc.|Andrea Brown, Director, Clinical Affairs|650-361-9000|abrown@apnicure.com|122
21254135|NCT02414932|Trinity College Dublin|Dr Martha Finnegan|0035312493385|mfinneg@tcd.ie|
21254136|NCT00470366|Memorial Sloan Kettering Cancer Center|Dr. Darren Feldman, MD|646-422-4491|feldmand@mskcc.org|
21267126|NCT04657003|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21299572|NCT00436332|SWOG Statistical Center|Lung Committee Statistician|206-667-6197|jmoon@fhcrc.org|
21237317|NCT01393782|George Washington University Medical Faculty Associates|Clinical Trials Unit, Department of Anesthesiology and Critical Care Medicine|202-715-4750|mseneff@mfa.gwu.edu|
21237318|NCT02943408|Veterans Affairs Rocky Mountain (VISN 19) Mental Illness Research Education and Clinical Center (MIRECC)|Dr. Samantha Hack|720-234-2017|samantha.hack@va.gov|
21237319|NCT01106833|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
21237320|NCT01621126|Massachusetts General Hospital|Dr. Jon J.P. Warner, Chief of Shoulder Service MGH, Harvard Professor of Orthopaedics.|617-724-3140|jwarner@mgh.harvard.edu|
21237321|NCT00886340|Yale School of Nursing|Robin Whittemore, PhD|203-737-2351|robin.whittemore@yale.edu|
21237322|NCT03224182|Spectrum Pharmaceuticals, Inc, Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|(949) 788-6700|shanta.chawla@sppirx.com|
21237323|NCT02606279|Wake Forest University Health Sciences|Katherine Schafer, Assistant Professor Internal Medicine|13367166342|kschafer@wakehealth.edu|336
21237324|NCT00746122|Imperial College London|Professor Janet Powell|44-2033117312|j.powell@imperial.ac.uk|
21237325|NCT02184611|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21237326|NCT00160680|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21237327|NCT04493216|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21254137|NCT01021215|University of Texas (UT) MD Anderson Cancer|Dr. Powel H. Brown, MD Anderson Phase I/II Prevention Consortium|(713) 745-3672|CR_Study_Registration@mdanderson.org|
21254138|NCT01688830|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21254139|NCT04822597|University of Wisconsin School of Medicine and Public Health|Heather B Neuman, MD, MS, FACS|(608) 263-7064|neuman@surgery.wisc.edu|
21254140|NCT00591851|Memorial Sloan-Kettering Cancer Center|Dr. Chau Dang|914-367-7181|dangc@mskcc.org|
21254141|NCT01099475|Maastricht University Medical Centre|Dr. MAJ van den Broek, MD|31 43 3884502|m.vandenbroek@maastrichtuniversity.nl|
21254142|NCT01781078|Boston Scientific|Kelly Aspinwall|651-582-4560|Kelly.Aspinwall@bsci.com|
21254143|NCT02217501|UT Southwestern Medical Center|Subhash Banerjee, MD|214-857-1608|Subhash.Banerjee@utsouthwestern.edu|
21254144|NCT03417895|Jiangsu Hengrui Pharmaceuticals Co., Ltd.|Yuanchao Wang; SPM|86-18036618707|yuanchao.wang@hengrui.com|
21254145|NCT01942785|Email contact via H. Lundbeck A/S|Study director||LundbeckClinicalTrials@lundbeck.com|
21254146|NCT05121246|mAbxience Research S.L.U.|Dr. Susana Millán|+34 682821346|susana.millan@mabxience.com|
21254147|NCT04688320|"LLC SuperGene"|Dr. Sergey Markin|(495) 287-98-07|info@supergene.ru|+7
21254148|NCT01783847|Iran university of Medical Sciences|Mohsen Bahmani Kashkouli|00989121777003|mkashkouli2@gmail.com|
21254149|NCT01007643|University of Manitoba|Dr Erika Persson|780-492-4752|epersson@ualberta.ca|
21254150|NCT03706313|Duke University|Jeff Gadsden|919-681-6437|jeff.gadsden@duke.edu|
21254151|NCT01710332|Mid Atlantic Retina|Allen C. Ho, MD|215-459-0477|mformoso@midatlanticretina.com|
21254152|NCT02359877|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
21254153|NCT02110147|Wellstat Therapeutics Corporation|Wellstat Medical Information|800.914.0071|medinfo@wellstat.com|
21254154|NCT02340767|National Dental PBRN|Dr. Sonia Makhija|2059965298|smakhija@uab.edu|
21254155|NCT01621737|UCSD|David Feifel|(858) 412-4130|dfeifel@kadimanp.com|
21254156|NCT03029351|State University of NY at Buffalo|Paresh Dandona|7165351852|dandona@buffalo.edu|
21254157|NCT00910689|Ohio University|Kenneth Holroyd|(740) 593-1085|holroyd@ohio.edu|
21254158|NCT01290029|Amgen Inc.|Study Director|866-572-6436||
21254159|NCT00189488|Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com|
21254160|NCT01764685|University of Pennsylvania Perelman School of Medicine|Henry R. Kranzler, M.D.|215-386-6662|kranzler@mail.med.upenn.edu|
21254161|NCT02349425|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21254162|NCT01143038|Amgen Inc.|Study Director|866-572-6436||
21254163|NCT02336178|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21254164|NCT03310268|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21254165|NCT03346161|Washington University School of Medicine|Mary C. Politi, Ph.D.|314-747-1967|mpoliti@wustl.edu|
21254166|NCT01236365|Nemours Children's Clinic|Nelly Mauras, MD|904-697-3674|nmauras@nemours.org|
21254167|NCT00558259|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21254168|NCT00703937|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
21254169|NCT01183234|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21254170|NCT03840915|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21254171|NCT00822172|CPC Clinical Research|William Hiatt, MD, President|3038609900|william.hiatt@cpcmed.org|
21254172|NCT00700258|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21254173|NCT02349646|St. Jude Medical|Jennifer Duggan|+32(0)27746827|jduggan@sjm.com|
21254174|NCT04772898|Creighton University|Anastasia Kyvelidou|4022805749|aky61380@creighton.edu|
21254175|NCT00473265|Columbia University Medical Center|John P. Bilezikian MD|212-305-2663|jpb2@columbia.edu|
21254176|NCT00832637|University of New Mexico|Yehuda Patt, MD|5059250405|yzpatt@salud.unm.edu|
21254177|NCT00370331|GlaxoSmithKline|GSK Response Center|866-435-7343||
21254178|NCT02947087|MUSouthCarolina|Hongjun Wang, PhD|8437921800|wangho@musc.edu|
21254179|NCT00545051|Hoffmannb-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21254180|NCT01854138|ProMedica|Karl J. Beer, MD|419-578-4260|karl.beer@promedica.org|
21254181|NCT01888900|National Institute of Diabetes and Digestive and Kidney Diseases|Dr. Marc Ghany|301-402-5515|marcg@mail.nih.gov|
21254182|NCT03271021|Foamix Pharmaceuticals|Senior Director, Clinical Operations|9089630117|kendra.gulbronson@foamix.com|
21254183|NCT03215810|Moffitt Cancer Center|Ben Creelan, MD|813-745-4541|ben.creelan@moffitt.org|
21254184|NCT02313233|Kaohsiung Municipal TA- TUNG Hospital|Dr. Ching- Chia Li|886-7-291-1101||
21299573|NCT00472108|Galderma R&D SNC|CTA Coordinator|+33 493 95 70 85|cta.coordinator@galderma.com|
21299574|NCT03582215|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.strauss@fda.hhs.gov|
21299575|NCT01791244|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21299576|NCT01856270|University of Washington|Dr. Jeanne Hoffman|206-221-6511|jeanneh@uw.edu|
21299577|NCT00703014|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21299578|NCT04949191|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21299579|NCT05121766|Hackensack Meridian Health|Arunima Sarkar, MD|5519961140|arunima.sarkar@hmhn.org|
21299580|NCT00730158|UPMC Hillman Cancer Center|Edward Chu, MD|(412) 648-6589|chue2@upmc.edu|
21299581|NCT03535974|Fundatia Bio-Forum|Dr. Felician Stancioiu|+40727500402|felicians11@gmail.com|
21254185|NCT03139669|University of Virginia|Dr. Emma Mitchell Associate Professor|4342433962|emm6z@virginia.edu|
21254186|NCT01859988|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com|
21254187|NCT02930226|University of Cincinnati|Jose A. Cancelas, M.D., Ph.D.|513-558-1324|Jose.Cancelas@cchmc.org|
21254188|NCT00635427|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21254189|NCT04595318|Montefiore Health System|Dr. Shadi Nahvi|718 920 5379|snahvi@montefiore.org|
21254190|NCT01506609|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21254191|NCT01096823|Pediatric Pain and Palliative Care Program; University of California, Los Angeles|Dr. Lonnie K. Zeltzer, MD|(310) 825-0731|LZeltzer@mednet.ucla.edu|
21254192|NCT01710891|MinneapolisMRF|Brian Driver|6128739528|Brian.Driver@hcmed.org|
21254193|NCT00577473|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
21254194|NCT01990560|Ichan School of Medicine at Mount Sinai|Dr. Alice C. Levine|212-241-1500|alice.levine@mountsinai.org|
21254195|NCT00732225|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21254196|NCT02084056|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21254197|NCT00938860|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21254198|NCT01605019|Houston Methodist Research Institute|Raquel R Bunge|713-441-3912|rrbunge2@houstonmethodist.org|
21254199|NCT01464840|University of Alabama at Birmingham|Amelia Sutton, M.D., Ph.D.|205-934-5612|alsutton@uab.edu|
21254200|NCT00468559|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
21254201|NCT00862719|IndianaU|Dr. Sherif Farag|317-944-0920|ssfarag@iu.edu|
21254202|NCT00324116|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21254203|NCT01153958|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21254204|NCT01856868|UC Davis Health|Dr. Craig McDonald, Professor and Chair|(916) 734-4293|cmmcdonald@ucdavis.edu|
21254205|NCT02624791|UVa Center for Behavioral Medicine Research|Project Coordinator|434-924-8656|tab2v@hscmail.mcc.virginia.edu|
21254206|NCT00998790|American Medical Systems|Laura Olson, Clinical Project Manager|952-930-6428|laura.olson2@bsci.com|
21254207|NCT01605916|Biometrics Department, Science Affairs Division, R&D, Astrazeneca Japan|Masahiro Nii||Masahiro.Nii@astrazeneca.com|
21254208|NCT02632526|AstraZeneca AB|A study to assess the safety, tolerability, pharmacokinetics & dynamics of AZD5718 in healthy male||ClinicalTrialTransparency@astrazeneca.com|
21254209|NCT01103362|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
21254210|NCT00669682|Columbia University|Jose' Dizon, MD|212-305-8559|jmd11@columbia.edu|
21254211|NCT00412061|Novartis Pharmaceuticals|Study Director|862-778-8300||
21254212|NCT00060424|Fred Hutch|David G Maloney, MD PhD||dmaloney@fredhutch.org|
21254213|NCT03406078|AstraZeneca|Global Clinical Head|+1 302 885 1180|information.center@astrazeneca.com|
21254214|NCT03661762|Norfolk and Norwich University Hospitals NHS Foundation Trust|Mr John Phillips|: +44 1603 593054|john.phillips@mac.com|
21254215|NCT03616977|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
21254216|NCT02859324|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
21254217|NCT03798691|UW School of Medicine and Public Health|Freddy Caldera, DO|608-628-8201|fcaldera@medicine.wisc.edu|
21254218|NCT02186223|Bio2 Medical, Inc.|Chief Medical Officer|720-833-5675|langel@bio2medical.com|
21254219|NCT00252733|AstraZeneca|Niklas Berglind, GPS Atacand|+46 31 7766310|ClinicalTrialTransparency@astrazeneca.com|
21254220|NCT00618982|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21254221|NCT01197833|BTG International Inc|David Wright MB FRCS|610-278-1660|david.wright@btgplc.com|
21254222|NCT00706433|Dusa Pharmaceuticals, Inc.|Anna Houlihan||houlihana@dusapharma.com|
21254223|NCT01035073|University of Pennsylvania|Tyrone Quarterman|215-349-5537|tyroneq@upenn.edu|
21254224|NCT04101318|Coloplast|Vice President, Medical Affairs|+45 4911 1111|clinical-studies@coloplast.com|
21254225|NCT00888628|Massachusetts General Hospital|James F. Markmann, M.D. Ph.D - Chief, Division of Transplant Surgery|617-643-4087|kcrisalli@mgh.harvard.edu|
21254226|NCT04601870|University of Wisconsin-Madison School of Medicine and Public Health Center for Tobacco Research and Intervention|Mark Zehner|16082627568|mark.zehner@ctri.wisc.edu|
21254227|NCT01879059|University of Kansas Medical Center|John P. Thyfault, PhD|913-588-1790|jthyfault@kumc.edu|
21254228|NCT00993668|UCB, Inc|UCB Clinical Trial Call Center|+1 877 822 9493||
21254229|NCT02207569|Medtronic|Kristin Smith|763-526-3095|kristin.m.smith@medtronic.com|
21254230|NCT02585232|Tuscaloosa VA Medical Center|Dr. Michelle Hilgeman|205-554-2000|Michelle.Hilgeman@va.gov|3278
21254231|NCT00297232|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21254232|NCT02350777|Memorial Sloan Kettering Cancer Center|Dr. Roni Tamari, MD|212-639-5987|tamarir@mskcc.org|
21254233|NCT03038438|Medtronic|Stephanie Cihlar|763.258.9524|stephanie.a.cihlar@medtronic.com|
21254234|NCT03406260|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21254235|NCT03098420|University of Alabama at Birmingham|Dr. Joel Feinstein|205-934-4696|jfeinstein@uabmc.edu|
21254236|NCT01029652|Novartis Pharmaceuticals|Study Director|862 778-8300||
21254237|NCT02318992|University of Texas School of Public Health|Dr. Herbert DuPont|713 500 9366|herbert.l.dupont@uth.tmc.edu|
21254238|NCT02095951|Wayne State University School of Medicine - Children's Hosp. of Michigan|Eric McGrath, MD|313-745-5862|emcgrath@med.wayne.edu|
21254239|NCT05383508|Philip Morris Products S.A.|Christelle Haziza, Global Head Clinical Research and Execution|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
21254240|NCT01621568|National Cancer Institute|Dr. Arun Rajan|240-760-6236|rajana@mail.nih.gov|
21254241|NCT02399254|Saint Francis Hospital and Medical Center|Richard ZuWallack, MD|860-714-4055|RZuWalla@TrinityHealthOfNE.org|
21254242|NCT02065687|NRG Oncology|Christopher Purdy on behalf of Michael Sill, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
21254243|NCT00662818|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21254244|NCT01642251|ECOG-ACRIN Cancer Research Group|Study Statistician||eatrials@jimmy.harvard.edu|
21254245|NCT01302860|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
21254246|NCT01993927|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21254247|NCT00895154|Washington University|Dr. Allison King|314-454-4291|king_a@wustl.edu|
21254248|NCT03988920|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
21254249|NCT00540046|Basic Health International|Miriam Cremer MD MPH|(646) 593-8694|miriam.cremer@gmail.com|
21254250|NCT01588431|UT Health San Antonio|Anand Karnad, MD|210-450-1267|karnad@uthscsa.edu|
21254251|NCT03954392|Vanderbilt University|Judy Garber, Ph.D., Professor of Psychology and Human Development|16153305605|judy.garber@vanderbilt.edu; jgarber.vanderbilt@gmail.com|
21254252|NCT02533531|LifeWatch Services, Inc.|Paul Hanneman|1 847 720 2231|Phanneman@gobio.com|
21254253|NCT03814187|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21254254|NCT02047903|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21254255|NCT01014533|University of Michigan|Kirk Brower||kbrower@med.umich.edu|
21254256|NCT02689518|University of California San Diego|Professor Michael Goldbaum|858 534 3516|mgoldbaum@ucsd.edu|
21254257|NCT01942590|Duke University Health System|Dwight Koeberl, M.D., Ph.D.|919-684-2036|dwight.koeberl@duke.edu|
21254258|NCT00312923|Rush University Medical Center|Barbara Swanson|312-942-8977|barbara_a_swanson@rush.edu|
21254259|NCT01226095|Abbott|Global Medical Services|800-633-9110||
21254260|NCT03283072|University of Florida|Mark Bishop|3522736112|bish@ufl.edu|
21254261|NCT02552368|Washington University School of Medicine - Department of Neurology|Dr. Thy Huskey|314-362-4503|huskeyt@wustl.edu|
21254262|NCT00911768|Kyung Hee East-West Neo Medical Center|Jae-Woo Park, KMD, PhD|+082-02-440-6219|pjw2907@khu.ac.kr|
21254263|NCT02734953|Allegheny Health Network|Dr Raymond Benza|412-359-3131|raymond.benza@ahn.org|
21254264|NCT00467350|Children's Mercy Hospitals and Clinics|Melissa Miller MD|8162343000|mmiller@cmh.edu|
21254265|NCT00515853|University of Southampton|Sophie A. Pilkington|+44 (0)23 8059 5058|rgioinfo@soton.ac.uk|
21284411|NCT01432561|University of California San Diego|Dr. Ranjan Dohil, P.I.|619-471-9554|rdohil@ucsd.edu|
21254266|NCT03965351|Cincinnati Children's Hospital Medical Center|Mary Banks|513-636-2147|mary.banks@cchmc.org|
21254267|NCT04041453|Universidad Nacional de Salta|Alejandro J Krolewiecki|+54 911 3183-8673|alekrol@hotmail.com|
21254268|NCT00943111|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21254269|NCT02819557|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
21254270|NCT02665338|Medical University of South Carolina|Dr. Xingbao Li|843 7925729|lixi@musc.edu|
21254271|NCT00998335|University of Florida|Dr. Kenneth Cusi|352-273-7236|KCusi@ufl.edu|
21254272|NCT04548544|University of California, San Francisco|Olga Tymofiyeva|415-514-4870|Olga.Tymofiyeva@ucsf.edu|
21254273|NCT00728910|University of Pennsylvania|Richard Dunbar MD|215-662-9024|richard.dunbar@uphs.upenn.edu|
21284412|NCT00796744|US Biotest|Dr. Shelagh Verco|805-595-1300|shelagh.verco@usbiotest.com|
21284413|NCT01534208|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
21284414|NCT02046772|Hospital Universitario Príncipe de Asturias|Antonio Rodríguez Miguel|+34 91 887 81 00|antonio.hupa@gmail.com|2610
21284415|NCT00672841|University of Utah|Kimberly E. Hanson, MD, MHS|801.585.2867|kim.hanson@hsc.utah.edu|
21284416|NCT02638259|Sandoz|Sandoz Biopharma Clinical Development - Strategic Planning|0049(0)80244760|biopharma.clinicaltrials@sandoz.com|
21284417|NCT02569086|Aarhus University Hospital, Department of infectious diseases|Dr. Kristina Öbrink-Hansen|+45|krisoebr@rm.dk|78452845
21284418|NCT04299048|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21284419|NCT00634049|Astellas Pharma Global Development, Inc.|Vice President, Medical Head ID/IM/TX|(224) 205-8800|Astellas.resultsdisclosure@astellas.com|
21284420|NCT01717391|The University of Iowa|John M. Buatti, MD|319-356-2699|john-buatti@uiowa.edu|
21284421|NCT03677934|Hoffmann-La Roche|Medical Communications|800 821-8590|global-roche-genentech-trials@gene.com|
21284422|NCT02952872|Wayne State University|Dr. Emily Grekin|313-577-2820|grekine@wayne.edu|
21284423|NCT04769739|Evergreen General Hospital|Chi-Liang Cheng|0919768058|chiliang.cheng@gmail.com|
21284424|NCT01260584|Daiichi Sankyo|Brian Baker|973-944-2712|bbaker@dsi.com|
21284425|NCT00045734|Adult Brain Tumor Consortium (ABTC)|Patrick Wen, MD|410-955-8837|jfisher@jhmi.edu|
21284426|NCT02069093|Novartis Pharmaceuticals|Study Director|862-778-8300||
21284427|NCT03290547|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
21284428|NCT03434249|SOFAR S.p.A|LAURA PATRUCCO|+390202 909 362291|laura.patrucco@sofarfarm.it|
21284429|NCT00561470|sanofi-aventis|International Clinical Development Study Director||contact-us@sanofi.com|
21284430|NCT01889355|AgaMatrix, Inc|Senior Clinical Research Technician|603-328-6035|krocha@agamatrix.com|
21284431|NCT00232596|GlaxoSmithKline|GSK Response Center|866-435-7343||
21284432|NCT01253174|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21284433|NCT01160380|Oncotherapeutics|Director of Clinical Operations|310-623-1200|lthulin@oncotherapeutics.com|
21284434|NCT02510820|CooperVision|Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
21284435|NCT03089853|University of Alabama at Birmingham|Surya P Bhatt|205-934-5555|sbhatt@uabmc.edu|
21284436|NCT01317004|Novartis Pharmaceuticals|Study Director|862-778-8300||
21284437|NCT04542278|University of Wisconsin - Madison School of Medicine and Public Health|Dawn Elfenbein, MD, MPH, FACS|(608) 263-1387|elfenbein@surgery.wisc.edu|
21284438|NCT01080976|BIDMC|Charles Safran|617-278-8170|csafran@bidmc.harvard.edu|
21284439|NCT04114656|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21284440|NCT01393106|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21254274|NCT04155203|Padagis|Jonathan Schwartz|929-502-7291|jonathan.schwartz@padagis.com|
21254275|NCT02368457|Oral and Maxillofacial Surgeon|Dr. Miriam Martos|+34932746179|miryam.martos@gmail.com|
21254276|NCT00669279|University of Florida|Dr. Benjamin J Epstein|3523590945|epstein@cop.ufl.edu|
21284441|NCT03052920|Washington University in St. Luis|Jill B Firszt, PI|314-362-4760|FirsztJ@wustl.edu|
21267127|NCT00935766|Denver Health Medical Center|Carlin Long, MD|303-602-3899|carlin.long@dhha.org|
21299582|NCT04059549|UW Madison|Olivia Vjorn|6084772614|ocody@wisc.edu|
21299583|NCT02639494|Mayo Clinic|Dr. Rajiv Gulati|507-538-6325|Gulati.Rajiv@mayo.edu|
21299584|NCT02678351|Stanford Medicine at Stanford University|Andrea Otte|650-736-4183|anotte@stanford.edu|
21299585|NCT01011673|Montefiore Medical Center, Albert Einstein College of Medicine|Benjamin Friedman, MD|718-920-6626|BEFRIEDM@montefiore.org|
21299586|NCT00651924|VA Connecticut Healthcare System|Robert Kerns, Ph.D.|203-932-5711|robert.kerns@va.gov|3841
21299587|NCT00960063|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21299588|NCT03273426|Seoul National University Hospital|Dr. Wonshik Han|+82-2-2072-1958|hanw@snu.ac.kr|
21299589|NCT05083351|Masimo|Director, Clinical Lab Operations|(949) 297-7000|studies@masimo.com|
21299590|NCT01611792|University of Vermont Medical Center, Burlington, VT|Dr. Sharon M. Henry|802 847-6733|Sharon.Henry@uvm.edu|
21299591|NCT04097431|Mount St Mary's University|Dr. Griffin Rooker|(301) 447-5143|g.w.rooker@msmary.edu|
21299592|NCT00582361|UAB|Research Nurse Coordinator|205-996-6781|Talyor.vlack@ortho.uab.edu|
21299593|NCT00584415|University of Oklahoma Health Sciences Center|Sunny Po, MD., Study Principal Investigator|405-271-9696|sunny-po@ouhsc.edu|
21299594|NCT00556894|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il|
21299595|NCT03883581|NOVA Southeastern University|Lauren Tabor Gray|954-914-5447|Lauren.taborgray@nova.edu|
21299596|NCT03332459|Janssen Research & Development, LLC|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21299597|NCT05190120|University of California San Francisco|Dr. Pedram Aleshi|(415) 271-1627|pedram.aleshi@ucsf.edu|
21299598|NCT03062358|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21299599|NCT05893862|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21299600|NCT01400698|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merck.de|
21299601|NCT01602224|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21299602|NCT03346434|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21299603|NCT01941485|Alcon Research, Ltd.|Global Brand Med Affairs Lead, Refractive, VGR|1-888-451-3937|alcon.medinfo@alcon.com|
21299604|NCT02741128|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21299605|NCT02081677|Johnson & Johnson Vision Care Inc.|Tawnya Wilson, Principal Research Optometrist|904-443-1834|TWilson@ITS.JNJ.com|
21299606|NCT01419769|Boston Scientific Corp.|Lina Ginnetti|508-683-4512|Lina.Ginnetti@bsci.com|
21299607|NCT03406377|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
21299608|NCT00812708|University of California Los Angeles|Kevin M. Miller, MD|(310) 206-9951|millerpatients@jsei.ucla.edu|
21299609|NCT03965130|Yale|Dr. Kitt Falk Petersen|203 737 1942|kitt.petersen@yale.edu|
21299610|NCT02764385|Oregon Health & Science University|Sue Flocke|5034946697|flocke@ohsu.edu|
21299611|NCT04235140|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21299612|NCT02587520|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21299613|NCT00672555|Department of surgery, Cantonal hospital of St. Gallen|Lukas Marti; principal investigator|0041794120153|lukas.marti@kssg.ch|
21299614|NCT00350025|Fox Chase Cancer Center|Dr. Yu-Ning Wong|215-728-3889|yu-ning.wong@fccc.edu|
21299615|NCT04516746|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21299616|NCT00503750|Emory University|Dr. Ruth O'Regan|404-778-8808|roregan@emory.edu|
21299617|NCT00446849|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21299618|NCT04861597|Montefiore Medical Center|Ruby Greywoode M.D. M.S., Assistant Professor of Medicine|347-671-8205|rgreywoode@montefiore.org|
21299619|NCT04992312|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21299620|NCT05546476|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21299621|NCT03793751|Tata Main Hospital, Tata Steel|Dr.Deb Sanjay Nag|+91-9431166582|debsanjay@gmail.com|
21299622|NCT03316196|VA San Diego Healthcare System|Dr. Jessica Bomyea|8585528585|jessica.bomyea@va.gov|1416
21299623|NCT03137654|UFlorida|Ben Lewis, Assistant Professor, UF Department of Psychiatry|3522948724|benlewis@ufl.edu|
21299624|NCT03583099|Weill Cornell Medicine|Fernando J. Martinez, MD, MS|646-962-2370|fjm2003@med.cornell.edu|
21299625|NCT04890652|Department of Psychiatry, Yale University School of Medicine|Dongju Seo, Associate Professor|475-441-3457|dongju.seo@yale.edu|
21299626|NCT04709068|Current Health|Clinical Research Lead|617-208-4239|study.team@currenthealth.com|
21299627|NCT01706458|UWCCC|Mary Jane Staab - Program Manager|608-262-4304|mjs@medicine.wisc.edu|
21299628|NCT04854135|Washington University in St. Louis|Paulina Cruz Bravo, MD|314-922-8620|pcruz@wustl.edu|
21299629|NCT02766023|University of California San Francisco|Craig Cohen, MD, MPH|(415) 476-5874|Craig.Cohen@ucsf.edu|
21299630|NCT05875532|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21237328|NCT02172755|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|francisco.rocha@bial.com|
21237329|NCT03318523|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21237330|NCT02858050|Saint Michael's Medical Center|Jihad Slim, MD|9738772663|jsmdsmmc@gmail.com|
21237331|NCT03148470|University of Fribourg|Prof. Dr. Jean-Marie Annoni|++4126 306 3802|jean-marie.annoni@unifr.ch|
21237332|NCT01615328|Seoul National University Bundang Hospital|Jin-Sup Yeom|82-31-787-7190|highcervical@gmail.com|
21237333|NCT00254982|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21237334|NCT00483184|Nobel Ilac San ve Tic. A.S.|Hasan Zeytin MD., Ph.D.|+90 216 6336012|hasan.zeytin@nobel.com.tr|6012
21299631|NCT00072462|Queen Mary University of London|Professor Jack Cuzick|+442078823504|j.cuzick@qmul.ac.uk|
21254277|NCT03387137|Johns Hopkins University Bloomberg School of Public Health|Suzanne Woods, CRNP-P, CCRP, Manager, RSVPeds Team|(410) 614-1880|swoods12@jhu.edu|
21254278|NCT05593445|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21254279|NCT05559476|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21284442|NCT01698268|Beaumont Health|Kaveh Aslani, MD|248-898-81905|kaslani@beaumont.org|
21284443|NCT02263729|University of Pittsburgh|James J. Irrgang|412-383-9865|jirrgang@pitt.edu|
21254280|NCT05110690|Washington University School of Medicine|Michael Avidan, MBBCh, FCASA|314-273-4136|avidanm@wustl.edu|
21254281|NCT04289051|Sunstar Americas, Inc.|Akane Takemura|18477944276|akane.takemura@us.sunstar.com|
21254282|NCT00717067|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21284444|NCT04591015|Scripps Health|Athena Philis-Tsimikas, MD, Co-Principal Investigator|858-678-7045|philis-tsimikas.athena@scrippshealth.org|
21284445|NCT02509078|Mass General Hospital (PETAL Clinical Coordinating Center)|Katie Oldmixon|617-726-4777|coldmixon@mgh.harvard.edu|
21284446|NCT03594955|Sanofi-Aventis Research & Development|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21284447|NCT01829997|RTI Surgical|Kristina Shine|386-418-8888|kshine@rtix.com|4404
21284448|NCT03539484|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21284449|NCT04997265|Vanderbilt University Medical Center|Whitney Gannon|6109095789|whitney.gannon@vumc.org|
21284450|NCT00631163|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21284451|NCT04103034|Band Therapeutics|Tia DeFeo-Fraulini|7819186561|tia.defeo-fraulini@bandtherapeutics.com|
21284452|NCT00460265|Amgen Inc.|Study Director|866-572-6436||
21284453|NCT00904839|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21284454|NCT04344535|Stony Brook University|Elliott Bennett-Guerrero|6314446026|elliott.bennett-guerrero@stonybrookmedicine.edu|
21284455|NCT01069315|McMaster University|Paula McKay, Manager|9055274322|mckayp@mcmaster.ca|44131
21284456|NCT01853696|Cornea Research Foundation of America|Marianne Price, PhD|317-814-2990|mprice@cornea.org|
21284457|NCT01797094|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21284458|NCT02147067|Emory University|Habib Samady, MD|(404) 778-1237|hsamady@emory.edu|
21284459|NCT00821015|Icahn School of Medicine at Mount Sinai|Dr. Vivek Y Reddy|212-241-7114|vivek.reddy@mountsinai.org|
21284460|NCT04103515|University of Tennessee|Dr. Michael LaCour|8659742093|mlacour@utk.edu|
21284461|NCT02410213|Luitpold Pharmaceuticals, Inc.|Angelia Butcher|610-650-4200|abutcher@lpicrd.com|811
21284462|NCT05821296|Dermosciences France|Sara Bayo Rodriguez|638966321|clinicaltrials@dermaceutic.com|0033
21284463|NCT00090987|AMC|Jeannette Y. Lee, Director of Statistical Center|(501) 526-6712|jylee@uams.edu|
21284464|NCT00713661|Nycomed|Clinical Trial Operations|+45 4677 1111|clinicaltrials@nycomed.com|
21284465|NCT00990665|St. Jude Medical|Clay Cohorn: Director, Clinical Study Management|972 309 8087|ccohorn@sjm.com|
21284466|NCT02603562|aTyr Pharma|Study Director|858 731 8389|clinicaltrials@atyrpharma.com|
21284467|NCT00270231|University of Pennsylvania|Caryn Lerman, Ph.D.|215-746-7141|clerman@mail.med.upenn.edu|
21284468|NCT05749068|Silicon Valley Gastroenterolgy|Dr. George Triadafilopoulos|(650) 988-7530|info@siliconvalleygi.com|
21284469|NCT04208321|ICON Early Phase Services, LLC|Dr. Cassandra Key, Senior Medical Director|210-283-4120|Cassandra.key@iconplc.com|
21284470|NCT00574795|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21284471|NCT01712308|The University of Texas MD Anderson Cancer|Prithviraj Bose MD/Associate Professor|713-792-7747|PBose@mdanderson.org|
21284472|NCT00957905|Memorial Sloan Kettering Cancer Center|Dr. Darren Feldman|646-422-4491|feldmand@mskcc.org|
21284473|NCT04292639|Vital USA Inc.|Mark H Khachaturian, PhD|+1(561)282-6074|mark.khachaturian@vvvital.com|
21284474|NCT02450552|Massachusetts General Hospital - Neurological Clinical Research Institute|Protocol Investigator|617-726-2000|Brian.Wainger@MGH.HARVARD.EDU|
21284475|NCT04877535|Washington University School of Medicine|Christopher King|(314) 362-8649|christopherking@wustl.edu|
21284476|NCT00925652|Dana-Farber Cancer Institute|Erica Mayer MD MPH|617-632-2335|emayer@partners.org|
21284477|NCT01969084|Beth Israel deaconess Medical Center|Aristidis Veves|617 632 7075||
21284478|NCT05079230|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21284479|NCT01524783|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21284480|NCT00100841|Montefiore Medical Center|Lisa Escobar-Peralta|718-379-6866|lescobar@montefiore.org|
21284481|NCT02920177|University of Michigan|Jordyn Sessel|734-615-0934|jsessel@med.umich.edu|
21284482|NCT03164265|University of Pittsburgh|Dr. Angus Thomson|(412) 624-6392|thomsonaw@upmc.edu|
21284483|NCT04907227|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21284484|NCT03723070|Boston Scientific|Clinical Trial Manager|+32 470 991143|nele.cielen@bsci.com|
21284485|NCT00824434|Boston Scientific|Ruth Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com|
21284486|NCT00721279|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21284487|NCT03673345|University of Rochester|Jennifer Nayak, MD, PI|5852750526|Jennifer_nayak@urmc.rochester.edu|
21284488|NCT05153148|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21284489|NCT02267135|Novartis Pharmaceuticals|Study Director|+1 (800) 778-8300|trialandresults.registries@novartis.com|
21284490|NCT00900731|Novartis Pharmaceuticals|Study Director|862 778-8300||
21284491|NCT00131365|InSightec|Nadir Alikacem|214.630.2000|nadira@insightec.com|
21284492|NCT04608344|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21284493|NCT05249127|Clarity Pharmaceuticals|Dr Othon Gervasio, Chief Medical Officer|+61 2 9209 4037|info@claritypharmaceuticals.com|
21284494|NCT03053427|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-0512|astellas.resultsdisclosure@astellas.com|
21284495|NCT03816644|Albert Einstein College of Medicine|Dr. Joe Verghese|7184303808|joe.verghese@einsteinmed.edu|
21284496|NCT01801241|Cleveland Clinic Foundation|Joseph P. Iannotti, MD, PhD|216-287-1149|IANNOTJ@ccf.org|
21284497|NCT02607306|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21254283|NCT02090959|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
21254284|NCT03480217|Center for Behavioral Cardiovascular Health, Columbia University Irving Medical Center|Ian Kronish|212-342-1335|ik2293@columbia.edu|
21254285|NCT00522873|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21254286|NCT00657020|GlaxoSmithKline|GSK Response Center|866-435-7343||
21254287|NCT02190045|CAVHS/ UAMS|Kalpana Padala, MD|501-257-1000|kppadala@uams.edu|
21254288|NCT02029846|Johns Hopkins University|Dr. Hsin-Chieh Yeh|410-614-4316|hyeh1@jhmi.edu|
21254289|NCT02561754|University of Kansas Medical Center|Dr. Joseph Donnelly|785-864-3880|jdonnelly@ku.edu|
21254290|NCT02966301|MEDSENIC|RIEGER François - CEO - Scientific Director|+33671733159|fr@medsenic.org|
21254291|NCT02367820|Nektar Therapeutics|Medical Affairs|855-482-8676|StudyInquiry@nektar.com|
21254292|NCT01336803|Stanford University|Heike Daldrup-Link|650-723-8996|heiked@stanford.edu|
21254293|NCT02937454|Vifor (International) AG.|FER-CARS-06 Clinical Study Team|+41 588 518 000|FER-CARS-06.study@viforpharma.com|
21254294|NCT01375114|UT MD Anderson Cancer Center|Dr. Sriram Yennu, MD-Professor, Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
21284498|NCT03240406|Albert Einstein College of Medicine|Dr. Yasmin Mossavar-Rahmani|718-430-2136|yasmin.mossavar-rahmani@einsteinmed.edu|
21284499|NCT00756600|Boston Children's Hospital Anesthesia Foundation|Dr Mary Ellen McCann|6173557737|mary.mccann@childrens.harvard.edu|
21284500|NCT02360475|GlaxoSmithKline|GSK Response Center|866-435-7343||
21284501|NCT00316862|Memorial Sloan-Kettering Cancer Center|David H. Ilson, M.D., Ph.D.||ilsond@mskcc.org|
21284502|NCT00642954|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21284503|NCT01344759|Cincinnati Children's Hosptial Medical Center|Dr. Mohamed Mahmoud|513-636-4408|Mohamed.Mahmoud@cchmc.org|
21284504|NCT01890759|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21284505|NCT02732015|UT MD Anderson Cancer Center|Saroj Vadhan,MD-Clinical Professor, Cytokine & Supportive Oncology|713-792-7966|svadhanr@mdanderson.org|
21284506|NCT01980628|Pharmacyclics, LLC|Isaiah Dimery, MD, Senior Medical Director|408-215-3579|idimery@pcyc.com|
21284507|NCT01084148|Orfagen|Clinical Project Manager|0033 5 34 50 64 62|caroline.miklaszewski@orfagen.com|
21284508|NCT05437640|University of Alabama at Birmingham|Dr. Christine Ferguson|205-934-7773|cfergus2@uab.edu|
21284509|NCT02474355|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21284510|NCT02287688|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21284511|NCT03015194|National Heart Lung and Blood Institute (NHLBI)|Robert Lederman, M.D. Principal Investigator, NIH, NHLBI|301.402.6769|ledermar@nhlbi.nih.gov|
21284512|NCT05251064|University of Virginia|Dr. Mark Miller|(434) 243-7778|mdm3p@uvahealth.org|
21284513|NCT01937715|Pfizer Inc.|Pfizer ClincialTrials.gov Call Center|+18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21284514|NCT00632632|Weill Cornell Medical College|JoAn Difede, PhD|212 746 3079|jdifede@med.cornell.edu|
21284515|NCT00433017|Novartis Pharmaceuticals|Study Director|862 778-8300||
21284516|NCT00153816|Geisel School of Medicine at Dartmouth|Leila A. Mott, Statistical Analyst|603-650-3447|Leila.A.Mott@Dartmouth.EDU|
21284517|NCT01760447|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21284518|NCT02030886|Yale School of Medicine|Dr James Liu|+1 203 785 2020|liu.ji@yale.edu|
21284519|NCT02485418|University of Texas Southwestern|Deryk Walsh, MD|2144566393|deryk.walsh@utsouthwestern.edu|
21284520|NCT01937884|University of Arizona|Dr. Katri Typpo|5206265485|ktyppo@email.arizona.edu|
21284521|NCT02826577|University of Chicago|Compliance Specialist|773-702-6505|czwieg@bsd.uchicago.edu|
21284522|NCT03943823|The University of Texas Health Science Center at Houston|Sunbola Ashimi, PhD|713-500-6410|Sunbola.S.Ashimi@uth.tmc.edu|
21284523|NCT01167634|University of Pennsylvania School of Medicine|Laurie Norton|2155738799|lanorton@mail.med.upenn.edu|215
21284524|NCT01656187|UT Southwestern Medical Center|E. Sherwood Brown, MD, PhD|214-645-6950|sherwood.brown@utsouthwestern.edu|
21284525|NCT03292471|VA Pittsburgh/California State University, East Bay|Dr. Michelle Gravier|510 885-3215|michelle.gravier@csueastbay.edu|
21284526|NCT03924505|RTI International|Dr. Barrot H Lambdin|628-200-6707|blambdin@rti.org|
21284527|NCT00939471|Acclarent, Inc.|Laura England, Manager-Clinical|650-687-4466|lenglan1@its.jnj.com|
21284528|NCT00310076|Comprehensive Cancer Center of Wake Forest University|Greg Russell, MS|336-716-5449|grussell@wakehealth.edu|
21284529|NCT03003000|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21284530|NCT02447575|Baylor College of Medicine|Dr. Nicola Hanania|(713) 873-3454|hanania@bcm.edu|
21284531|NCT04933617|National Cancer Institute|Dr. Mark Roschewski|240-760-6183|mark.roschewski@nih.gov|
21284532|NCT00466206|UCSF-Benioff Children's Hospital|Michael Harrison, MD|415 476-2538|pedsurg@ucsfmedctr.org|
21284533|NCT02191046|Thammasat university|Dr.Araya Satdhabudha|0813414900|araya221@gmail.com|662
21284534|NCT01964716|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21284535|NCT00089635|Amgen Inc.|Study Director|866-572-6436||
21254295|NCT01474434|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21237335|NCT03901326|People's Liberation Army General Hospital|Dr Junjie Yang|13581662680|fearlessyang@126.com|86
21237336|NCT02794285|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21237337|NCT03252587|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21237338|NCT03945188|Arena Pharmaceuticals, a wholly owned subsidiary of Pfizer|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
21237339|NCT00789438|Institut für Anästhesiologie und Operative Intensivmedizin, Universitätsklinukum Schleswig-Holstein, Campus Kiel|Christoph Ilies M.D.|+49-431-597|christoph.ilies@anaesthesie.uni-kiel.de|2991
21237340|NCT02167074|Erasmusm MC University Medical Center Rotterdam|Dr. P. van Riet|0031648237608|p.vanriet@erasmusmc.nl|
21237341|NCT04969198|University of Wisconsin-Madison|Jesse Kaye|608-262-8885|jtkaye@ctri.wisc.edu|
21237342|NCT03074630|AmsterdamUMC|Erik van Bommel|+31 20 4444444|e.vanbommel@amsterdamumc.nl|
21237343|NCT04009291|Ascendis Pharma, Inc.|Aimee D. Shu, MD|+1 650 352 8389|ADS@ascendispharma.com|
21237344|NCT03998618|Indiana University|Dr. Catherine Mosher|317-274-6769|cemosher@iu.edu|
21237345|NCT01386528|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
21237346|NCT00335322|Kirby Institute|Sean Emery|9385 0900|semery@kirby.unsw.edu.au|
21237347|NCT02576678|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
21237348|NCT04434560|Duke University|Sarah Sammons, MD|919-684-4563|sarah.sammons@duke.edu|
21237349|NCT01988779|UR Medicine Otolaryngology|Research Program Manager|5852751186|paul_allen@urmc.rochester.edu|
21237350|NCT02275065|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21237351|NCT01284426|Division of Allergy and Immunology, Department of Pediatrics, Siriraj Hospital, Mahidol University|Professor Orathai Jirapongsananuruk, Director of Clinical Trials|024197000|siojr@mahidol.ac.th|
21254296|NCT02192879|Duke University Medical Center|Elizabeth Malinzak, MD|919-681-9660|elizabeth.malinzak@duke.edu|
21254297|NCT01833845|BioLineRx LTD|Dr. Arnon Aharon|972-2-548-9100|arnona@biolinerx.com|104
21254298|NCT03606668|NYU Langone Health|Leigh Charvet, PhD|(929) 455-5141|Leigh.Charvet@nyulangone.org|
21254299|NCT01014143|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
21254300|NCT01847469|Yale University School of Medicine, VA Connecticut Healthcare System|Dr. Ismene Petrakis|(203) 932-5711|ismene.petrakis@yale.edu|
21254301|NCT00952120|University of Chicago|Lawrence Gottlieb|(773) 702-6302|lgottlie@surgery.bsd.uchicago.edu|
21254302|NCT01878214|Washington University School of Medicine in St. Louis|Jaime Strickland, MA|314-454-7337|jstrickl@dom.wustl.edu|
21254303|NCT00495586|CAMFIC|Carl Llor|+34 3011777|carles.llor@urv.cat|
21254304|NCT00992433|Baylor College of Medicine|Hana El Sahly, MD|713-798-2058|hanae@bcm.edu|
21254305|NCT02038543|Mayo Clinic|Dr. John C. Lieske|507-284-2064|Lieske.John@mayo.edu|
21254306|NCT02647866|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
21254307|NCT03618823|UPMC Children's Hospital of Pittsbugh|Senior Research Associate|1412-692-9879|nelsonjl2@upmc.edu|
21254308|NCT00944073|Center for Vaccine Development, University of Maryland|Karen Kotloff, MD|401-706-5328|kkotloff@medicine.umaryland.edu|
21254309|NCT02334423|Evolus, Inc|Rui L. Avelar, MD|(805)689-8668|rui@evolusinc.com|
21254310|NCT02765802|Eiger BioPharmaceuticals, Inc|SVP, Clinical Development|1-650-618-1621|info@eigerbio.com|
21254311|NCT00920075|Medical University of South Carolina|Deborah A Bowlby, Asst.Professor, Pediatric Endocrinology|843-792-6807|bowlbyd@musc.edu|
21254312|NCT02224690|GW Research Ltd.|Medical Enquires||medinfo.USA@gwpharm.com, medinfo@greenwichbiosciences.com|
21254313|NCT02962960|AstraZeneca AB|Global Clinical Lead|301-398-5799|ClinicalTrialTransparency@astrazeneca.com|
21254314|NCT02354443|Fate Therapeutics, Inc.|Chris Storgard, Chief Medical Officer|866-875-1833|chris.storgard@fatetherapeutics.com|
21254315|NCT00528645|Mayo Clinic|Julian R. Molina, M.D., Ph.D.|507-284-8318|molina.julian@mayo.edu|
21254316|NCT01154010|Massachusetts Eye and Ear Infirmary|Director of the Ocular Immunology and Uveitis Service|617-573-5549|George_Papaliodis@meei.harvard.edu|
21254317|NCT00439231|NHLBI/NIH|Georg Aue|301.451.7141|AueG@nhlbi.nih.gov|
21254318|NCT03294148|Weill Cornell Medicine|Dr. Yoni Ashar|(646) 962-2820|joa9188@med.cornell.edu|
21254319|NCT02073747|University Medical Center of Southern Nevada|Emergency Department Research Coordinator|702-224-7124|wesley.forred@umcsn.com|
21254320|NCT02413333|Alcon Research, Ltd.|Global Medical Affairs Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21254321|NCT01465347|Diffusion Pharmaceuticals Inc|Chief Executive Officer|(434) 220-0718|DKalergis@diffusionpharma.com|
21254322|NCT02996474|National Heart Lung and Blood Institute|Christopher Hourigan|+1 301 451 0257|christopher.hourigan@nih.gov|
21254323|NCT04493502|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
21254324|NCT02891837|Asklepion Pharmaceuticals, LLC|Gurdyal Kalsi, MD, MFPM (Hon)|+1 410.736.3750|gurdyal.kalsi@asklepionpharm.com|
21254325|NCT00709852|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21237352|NCT00417079|sanofi-aventis|International Clinical Development Study Director||GV-Contact-us@sanofi-aventis.com|
21237353|NCT00694603|Massachusetts General Hospital|Dr. Lecia Sequist|617-724-4000|lvsequist@partners.org|
21237354|NCT01687257|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21237355|NCT01922076|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21237356|NCT01181050|Novo Nordisk A/S|Public Access to Clinical Trials||RA-RNDUS-ClinTriDisc@ITS.JNJ.com|
21237357|NCT01201057|Starpharma|Dr Jeremy Paull||jeremy.paull@starpharma.com|
21237358|NCT04259086|Revance Therapeutics, Inc.|Todd Gross, PhD, VP, Clinical Development & Data Science|510-742-3400|tgross@revance.com|
21267128|NCT01823991|H. Lee Moffitt Cancer Center and Research Institute|Dr. Nagi Kumar|813-745-6885|nagi.kumar@moffitt.org|
21284536|NCT02603107|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21284537|NCT02572856|University of Washington Medical Center|David Flum, MD|206 616-5440|daveflum@uw.edu|
21254326|NCT00185965|School of Medicine, Stanford University|Ronald Levy, MD / Robert K and Helen K Summy Professor of Medicine|650-725-6452|levy@stanford.edu|
21254327|NCT01048671|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21237359|NCT04899349|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
21254328|NCT03901482|Satsuma Pharmaceuticals, Inc.|Vice President of Regulatory Affairs and Quality|650-837-0799|clin.inquiries@satsumarx.com|
21299632|NCT02384551|VA ORD|Heidi J Silver|615-875-9355|heidi.j.silver@vumc.org|
21237360|NCT01018394|Mayo Clinic|Dr. Jon Ebbert|507-266-1944|nicotineresearch@mayo.edu|
21237361|NCT03792126|University Hospitals Dorset NHS Foundation Trust|Louise Johnson|0300 019 4473|Louise.Johnson@uhd.nhs.uk|
21237362|NCT03240692|Stanford University|Dr. Nolan Williams|650-800-6920|nolanw@stanford.edu|
21237363|NCT00683644|University of Iowa|richard tyler|319 356 2471|rich-tyler@uiowa.edu|
21237364|NCT01027000|Dana Farber Cancer Institute|Edwin P. Alyea, MD||edwin_alyea@dfci.harvard.edu|
21237365|NCT03591068|Optinose|Jennifer Carothers|908-432-3061|jennifer.carothers@optinose.com|
21237366|NCT00617344|Sanofi Pasteur Inc.|Medical Director||Contact-US@sanofi.com|
21237367|NCT01178086|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
21237368|NCT04184791|Feinstein Institute for Medical Research at Northwell|Dr. Ritesh Ramdhani|516-325-7000|rramdhani@northwell.edu|
21237369|NCT00983073|Grünenthal GmbH|Clinical Trial Helpdesk|+49 241 569|clinical-trials@grunenthal.com|3223
21237370|NCT01400503|Janssen Research & Development, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21237371|NCT01417026|Children's Hospital of Philadelphia|Robert Schultz, PhD|267-426-7540|schultzrt@email.chop.edu|
21237372|NCT01669122|GlaxoSmithKline|GSK Response Center|866-435-7343||
21237373|NCT02959996|Massachussetts General Hospital|Malavika Prabhu|6177249028|mprabhu@mgh.harvard.edu|
21237374|NCT02962908|PepTcell Ltd (trading as SEEK)|Dr Olga Pleguezuelos, Chief Scientific Officer|+44 020 7153 6601|olga.pleguezuelos@seekacure.com|
21237375|NCT01261338|University of Cincinnati|Ronald J. Jandacek, PhD, Principal Investigator|513-558-5492|ronald.jandacek@uc.edu|
21237376|NCT05557942|Aerovate Therapeutics|Toll Free Number|(888) 373-8110|clinicaltrials@aerovatetx.com|
21237377|NCT01962493|GlaxoSmithKline|GSK Response Center|866-435-7343||
21237378|NCT02258477|University of Colorado, Anschutz Health and Wellness Center|Dr. James Hill|303-724-9974|james.hill@ucdenver.edu|
21237379|NCT01839734|The Ruth M. Rothstein CORE Center|Dr. Gregory Huhn|312-572-4575|ghuhn@cookcountyhhs.org|
21237380|NCT01329029|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21237381|NCT06854601|Pharmasoft|Y.E. Meshcherskiy, Medical Director|+ 7 (495) 626-47- 55|meshcherskiy_y@pharmasoft.ru|140
21237382|NCT01751126|Santen Inc|R&D Quality Manager|4152689199|evelyn.chikere@santen.com|
21237383|NCT01253525|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21237384|NCT01332227|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21237385|NCT03751631|Eyenovia, Inc.|VP, Development|714-269-8838|gclasby@eyenoviabio.com|
21237386|NCT02822222|RMJ Holdings LLC d/b/a RMJH Rx|Russell Jaffe, M.D., Chief Executive Officer|(703) 840-4440|rjaffe@rmjholdings.com|
21237387|NCT01143688|National Jewish Health|Michael E. Wechsler M.D.|617-285-4987|wechslerm@NJHealth.org|
21237388|NCT00428090|GlaxoSmithKline|GSK Response Center|866-435-7343||
21237389|NCT03078270|George Washington University|Daniel Lieberman, M.D.|202-741-2899|dlieberman@mfa.gwu.edu|
21237390|NCT00440531|Merck Sharp & Dohme Corp|Senior Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
21237391|NCT00447057|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21237392|NCT00385580|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21237393|NCT00677833|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21254329|NCT00296400|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21254330|NCT00513604|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
21254331|NCT01853774|Arizona State University|Professor, College of Nursing and Health Innovation|6024960740|linda.larkey@asu.edu|
21254332|NCT05332145|HealthPartners Institute|Stephanie Hooker, PhD, MPH|952-967-5056|stephanie.a.hooker@healthpartners.com|
21254333|NCT04555031|Bausch & Lomb|Study Director|5853386399|robert.steffen@bausch.com|
21254334|NCT02433340|AbbVie|Global Medical Services|800-633-9110||
21254335|NCT01178385|University of South Florida|Dr. Eric Storch|727-767-8230|estorch@health.usf.edu|
21254336|NCT03032393|Youngstown State University|Associate Professor|330941-2702|wge@ysu.edu|
21254337|NCT00857272|Braintree Laboratories, Inc.|John McGowan, Associate Director, Clinical Research|781-843-2202|jmcgowan@braintreelabs.com|
21254338|NCT00985946|University of Wisconsin Carbone Cancer Center|Noelle LoConte|608-265-5883|ns3@medicine.wisc.edu|
21254339|NCT03797677|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
21254340|NCT02679508|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21254341|NCT03538301|Nitto Denko Corporation|Nitto Denko Corporation Study Director|858-255-3010|clinicaltrialinfo005@nitto.com|
21254342|NCT05652647|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21254343|NCT05326815|The Cleveland Clinic Foundation|Kim Jenkins|216-445-4791|jenkink@ccf.org|
21254344|NCT02631577|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21254345|NCT03136445|NHS Blood and Transplant|A/Prof Lise Estcourt|44 1865 387789|Lise.Estcourt@nhsbt.nhs.uk|
21299633|NCT04349891|Mayo Clinic Arizona|Dr. Jay Pasricha|(480)301-4279|pasricha.jay@mayo.edu|
21254346|NCT00979134|AstraZeneca|Donal Landers|+44 1625 231890|Donal.Landers@astrazeneca.com|
21237394|NCT00184548|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21237395|NCT02583425|Dr. Reddy's|Director, Clinical Development|609-375-9900||
21254347|NCT05172050|Dompé Farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
21254348|NCT05917470|Oncternal Therapeutics|Mary Breitmeyer|760-703-2802|mbreitmeyer@oncternal.com|
21254349|NCT01533597|Soonchunhyang Bucheon Hospital|Dr. Kwang-Woo Lee|+82 32 621 5465|urolkw@schmc.ac.kr|
21254350|NCT04807582|Imperial College London|Professor Eric Aboagye|0203 313 3720|eric.aboagye@imperial.ac.uk|
21254351|NCT01586910|Medtronic, Inc.|Peggy Yunker|763-514-4000|surtavi@medtronic.com|
21254352|NCT00953407|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
21254353|NCT02502097|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21254354|NCT01111474|Federal University of São Paulo|Dr. Olga Dumont Flecha - PHD student|38 35326082|olgaflecha@gmail.com|
21254355|NCT02564354|ProQR Therapeutics|Medical Monitor|+31 6 20 183 437|clinical@proqr.com|
21254356|NCT04193436|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21254357|NCT02234687|New York University School of Medicine|Charles Marmar, MD|646 754 4855|Charles.Marmar@nyumc.org|
21254358|NCT02518490|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
21254359|NCT00346632|Kyowa Kirin Pharmaceutical Development, Inc.|Project Leader|6099191100|clinical.info@kyowakirin.com|
21254360|NCT02469389|VISN 5 MIRECC|Dr. Melanie Bennett|(410) 637-1850|Melanie.Bennett@va.gov|
21254361|NCT02354508|Novartis Pharmaceuticals|Study Director|826-778-8300|novartis.email@novartis.com|
21254362|NCT03587974|UCaliforniaDavis|Dr. Ladson Hinton|9167343485|lwhinton@ucdavis.edu|
21254363|NCT04447846|Kenndey Krieger Institute|Dr. Anne Comi|443-923-9127|comi@kennedykrieger.org|
21254364|NCT00946101|MedImmune, LLC an affiliate of AstraZeneca AB|Elissa Malkin, D.O.|301-398-0000|malkine@medimmune.com|
21254365|NCT00093808|Mayo Clinic|Winston Tan, MD|904-953-7290|Tan.Winston@mayo.edu|
21254366|NCT00871780|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
21254367|NCT03575754|London Health Sciences Centre|Dr. Derek Cool|519-685-8500|derek.cool@lhsc.on.ca|54965
21254368|NCT00523640|University of Chicago|Theodore Karrison, PhD|773-702-9326|tkarrison@health.bsd.uchicago.edu|
21254369|NCT06377488|Johnson & Johnson Vision Care|Johnson & Johnson Vision Care Study Contact|1-800-843-2020|RFrankl1@its.jnj.com|
21254370|NCT03476707|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
21254371|NCT00652327|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21254372|NCT01076647|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21254373|NCT02926898|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21254374|NCT03814031|Henry Ford Hospital|Yoshihisa Morita|3059784358|YOSHIHISA.MORITA@JEFFERSON.EDU|
21254375|NCT02292927|Imperial Colege London|Colin Bicknell|02033126072|alison.deslandes@imperial.nhs.uk|
21254376|NCT00568802|Stanford University|Principal Investigator||clinicaltrials-gov@lists.stanford.edu|
21254377|NCT01039792|UCSF|Dr. Robert Hendren|415-502-3500|STAR@ucsf.edu|
21254378|NCT01656733|University of Connecticut School of Medicine|Cheryl Oncken, MD, MPH|860-679-3425|oncken@uchc.edu|
21254379|NCT03625895|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21254380|NCT02081417|Department of Psychiatry and Behavioral Sciences, University of New Mexico|Annette Crisanti, PhD|505-850-7430|acrisanti@salud.unm.edu|
21254381|NCT01288521|University of Iowa|Sony Tuteja, Pharmd|215-573-7834|sony.tuteja@gmail.com|
21254382|NCT01415531|Forest Research Institute|Tatjana Lukic, MD, MSc|(201) 427-8649|tanya.lukic@frx.com|
21254383|NCT05753670|Endeavor Health|Dr. Ghazaleh Rostami Nia|847-570-4729|GRostamiNia@northshore.org|
21254384|NCT00122460|Merck Serono|Inmaculada Ollero/Clinical Trial Manager|+34935655433|iollero@merck.es|
21254385|NCT01236339|W.L. Gore and Associates, Inc.|Arthur Scott / Clinical Study Manager|623.234.5263|artscott@wlgore.com|
21284538|NCT01693185|Konkuk University Medical Center|Dr. Tae-Yop Kim, Professor of Anesthesiology|82-2-2030-5445|taeyop@gmail.com|
21284539|NCT00419159|Novartis Pharmaceuticals|Study Director|862-778-8300||
21284540|NCT01017601|Mayo Clinic|Julian Molina, M.D, Ph.D.|507-284-1328|Molina.julian@mayo.edu|
21284541|NCT01857102|Johnson and Johnson Vision Care Inc.|Kathrine E. Osborn, OD, MS, FAAO- DIRECTOR GLOBAL STRATEGIC CLAIMS|904-443-1032|KOSBORN@its.jnj.com|
21284542|NCT01115556|Vitreous Retina Macula Consultants of New York|K. Bailey Freund, MD (or Galyna Ganieva, Research Manager)|212-861-9797|gganieva@vrmny.com|6929
21284543|NCT02648477|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
21284544|NCT05604794|University of Toronto|Dr Chris Lo|65 6709 3003|chris.lo@utoronto.ca|203
21284545|NCT00497770|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21284546|NCT00438802|Mayo Clinic|Thomas E. Witzig, M.D.||witzig.thomas@mayo.edu|
21284547|NCT02117713|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
21284548|NCT01094782|Massachusetts General Hospital|Dr. Lucy Chen|6177246102|mghpainresearch@partners.org|
21284549|NCT02503254|Philip Morris Products S.A.|Cam Tuan Tran|+41 (58) 242 2620|CamTuan.Tran@pmi.com|
21284550|NCT02073656|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21284551|NCT02638051|Clifford Hospital|Prof. Clifford LK Pang, President of Clifford Hospital|(8620) 34710038|cpang@cliffordgroup.com|
21284552|NCT02054910|University of Alabama at Birmingham|Jaypal Ramesh|205-975-9564|jramesh@uab.edu|
21284553|NCT01625689|PATH|Senior Clinical Research Scientist|206-285-3500|klewis@path.org|
21284554|NCT00889187|Brigham and Women's Hospital / Dana Farber Cancer Institute|Harvey Mamon, MD, PhD|617-732-8564|HMAMON@LROC.HARVARD.EDU|
21284555|NCT02770768|University of Chicago|Compliance Specialist|773-702-6505|czwieg@bsd.uchicago.edu|
21284556|NCT02208050|St. Vincent's University Hospital|Professor Christopher McGuigan|+35312214209|C.McGuigan@svhg.ie|
21284557|NCT03806231|Intermountain Healthcare|Molly Adams, Clinical Research Project Coordinator|(801)507-7030|molly.adams@imail.org|
21284558|NCT00467961|NIH NHLBI|Minocher Battiwalla, MD|301-827-0939|minoo.battiwalla@mail.nih.gov|
21254386|NCT02054741|University of Rochester, Medical Center|Dr. Supriya Mohile, Professor of Medicine|585-275-0394|URCC_GAP70@urmc.rochester.edu|
21254387|NCT02325557|Advaxis, Inc.|Sumitra Sheeri|609-423-2528|sheeri@advaxis.com|
21254388|NCT01502631|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21254389|NCT01488487|Div. of Hematology and Oncology, Univ. of North Carolina at Chapel Hill|Dr. Hanna Sanoff|919-966-4431|hanna_sanoff@med.unc.edu|
21254390|NCT02534038|Avanir Pharmaceuticals, Inc.|Sanjay Dubé, M.D.|949-389-6700|sdube@avanir.com|
21254391|NCT00395460|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21254392|NCT02943226|The University of Texas Health Science Center at Houston|Joseph P. Hasapes, M.D.|(713) 566-5440|Joseph.P.Hasapes@uth.tmc.edu|
21254393|NCT00250926|Dana Farber Cancer Institute|Steven P. Treon MD PhD|617 632 2681|steven_treon@dfci.harvard.edu|
21254394|NCT00298090|UTHSCSA|Jane Youngers|210-567-2340|youngers@uthscsa.edu|
21254395|NCT01708213|TauTona Group|Ann Thomas|650-331-2461|athomas@tautonagroup.com|
21254396|NCT02319525|UAB|Dr. Jasvinder Singh, Principal Investigator|2059343235|jasvinder.md@gmail.com|
21254397|NCT02489123|University of Washington|Ajay K. Gopal, MD|206-606-2037|agopal@uw.edu|
21254398|NCT04299438|University of Pennsylvania|Dr. Jennifer McCoy|215 662 4000|jennifer.mccoy@pennmedicine.upenn.edu|
21254399|NCT04223830|Boston Scientific|Victoria Lazzari|508-382-9132|victoria.lazzari@bsci.com|
21254400|NCT01806623|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21254401|NCT01737827|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21254402|NCT01451827|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21254403|NCT01964924|The Ohio State University Comprehensive Cancer Center|Bhuvaneswari Ramaswamy|614-293-8858|Bhuvaneswari.Ramaswamy@osumc.edu|
21284559|NCT00326170|UT MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Associate Professor|713-792-7305|eharriso@mdanderson.org|
21284560|NCT02429310|Imperial College London|Professor Alun Davies|02033117320|a.h.davies@imperial.ac.uk|
21284561|NCT00394433|Dana-Farber Cancer Institute|Peter C. Enzinger, MD|617-632-6855|Peter_Enzinger@dfci.harvard.edu|
21254404|NCT01528345|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21284562|NCT03646305|York University|Keisha C. Gobin, MA|416-736-2100|kgobin@yorku.ca|33153
21284563|NCT01554176|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21254405|NCT01034163|Novartis|Study Director|862-778-8300||
21254406|NCT02424734|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21284564|NCT02678000|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21284565|NCT03759366|Alexion Pharmaceuticals Inc.|Alexion Europe SAS European Clinical Trial Information|7 87148158|clinicaltrials.eu@alexion.com|
21284566|NCT00539032|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21284567|NCT01653327|Dartmouth-Hitchcock Medical Center|Dr. Thomas Davis|1-603-650-8626|Thomas.H.Davis@hitchcock.org|
21284568|NCT01859949|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21284569|NCT03041467|Medtronic|Phally Roffe, Clinical Study Manager|763.526.0350|phally.s.roffe@medtronic.com|
21284570|NCT01238341|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu|
21284571|NCT05206734|Royal Hospital for Children and Young People, Edinburgh|Richard K Russell|0131 312 0431|richard.russell@nhs.scot|
21284572|NCT04228965|Medical University of South Carolina|Erin A. McClure, Principal Investigator|843-792-7192|mccluree@musc.edu|
21284573|NCT02330172|Seoul national university Bundang Hospital|Eunsu Choi|821032990658|potterydoll@hanmail.net|
21284574|NCT00734656|University of Connecticut Health Center|Jonathan Covault|860-679-7560|jocovault@uchc.edu|
21284575|NCT03214679|University School of Medicine, New York|Ben Eckhardt|212-562-1000|benjamin.eckhardt@nyumc.org|
21284576|NCT01601067|VA San Diego|Sonya Norman, PhD|858-552-8585|sonya.norman@va.gov|
21284577|NCT04513899|University of California, Irvine, Sue & Bill Gross School of Nursing|Dr Adeline Nyamathi|(949) 824-8932|anyamath@hs.uci.edu|
21284578|NCT02707172|Kaohsiung Medical University|Dr. Ming-Tsang Wu|+886-7-3121101|e_encourage@yahoo.com|2315
21284579|NCT00298363|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21284580|NCT00135356|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21284581|NCT01306214|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21284582|NCT02686814|Medtronic|Jessica Halverson, Clinical Research Director|(800) 633-8766|rs.perigonjapantrial@medtronic.com|
21284583|NCT01026818|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21284584|NCT01908582|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21284585|NCT01110967|Medtronic Spinal & Biologics|Cristina Faria|+41 (0)21 802 70 00|cristina.faria@medtronic.com|
21284586|NCT01090050|Clinvest/A Division of Banyan Group Inc.|Jeanne Tarrasch|417-841-3673|jtarrasch@clinvest.com|
21284587|NCT02232061|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
21284588|NCT06439095|Van Yuzuncu Yil University Faculty of Dentistry|Dr. Burçin Avcı, Assistant Professor|+90 5359558140|burcinavci@yyu.edu.tr|
21284589|NCT02368886|Mayo Clinic Arizona|Tanios Bekaii-Saab, M.D.|507/266-0800|Bekaii-Saab.Tanios@mayo.edu|
21284590|NCT02339974|Henry Ford Health|Dr. Brian O'Neill|313-970-6483|boneil3@hfhs.org|
21284591|NCT03484403|Dallas VA Medical Center|Dr Thiru Annaswamy|214-857-0273|thiru.annaswamy@va.gov|
21284592|NCT04278924|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21284593|NCT04767529|Akero Therapeutics, Inc.|Kitty Yale|(650) 487-6488|harmonystudies@akerotx.com|
21284594|NCT00253370|ECOG Statistical Office|Study Statistician|617-632-3012||
21254407|NCT01445301|GlaxoSmithKline|GSK Response Center|866-435-7343||
21284595|NCT00983541|Huntsman Cancer Institute|Christopher Anker, MD|801-213-4241|candace.larson@hci.utah.edu|
21254408|NCT00752557|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21254409|NCT02141451|Masonic Cancer Center, University of Minnesota|Dr. Veronika Bachanova|612-625-5469|bach0173@umn.edu|
21254410|NCT02150343|Circassia Ltd|VP Clinical Operations|+44 1865 405560|kirsten.evans@circassia.com|
21254411|NCT00190749|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21254412|NCT02729753|C2 Therapeutics|Marcia Wachna, Director of Clinical Research||marcia@c2therapeutics.com|
21254413|NCT01090427|Janssen Research & Development, LLC|VICE PRESIDENT IMMUNOLOGY||ClinicalTrialDisclosure@its.jnj.com|
21254414|NCT01043393|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914-345-9001|natalie.yantovskiy@taro.com|
21254415|NCT03002753|Christoph-Dornier-Stiftung Münster|Christian Rupp, M. Sc.|00492514183440|rupp@cds-muenster.de|
21254416|NCT03103490|Professor of Radiology (Nuclear Medicine)|Andrei Iagaru|(650) 725-4711|aiagaru@stanford.edu|
21254417|NCT03456427|GE Healthcare|Beth Heckel|1-262-312-7269|beth.heckel@med.ge.com|
21254418|NCT00928018|Dana Farber Cancer Institute|Philippe Armand, MD, PhD|617-632-2305|parmand@partners.org|
21254419|NCT02008877|SARC|SARC|(734) 930-7600|sarc@sarctrials.org|
21254420|NCT02909764|Monell Chemical Senses Center|Julie A. Mennella|2675194880|mennella@monell.org|
21254421|NCT04227704|Washington University School of Medicine|Dr. David Monks|314-323-1845|dmonks@wustl.edu|
21254422|NCT02317432|Disparities Research Unit, MGH|Margarita Alegria, PI|617-724-1237|malegria@mgh.harvard.edu|
21254423|NCT00715754|University of Utah|Laurie Moyer-Mileur|801/587-7488|Laurie.Moyer-Mileur@hsc.utah.edu|
21254424|NCT04609306|University of Orthopaedics|Jonathan Wright, MD|(352) 273-7001|wrightjo@ortho.ufl.edu|
21254425|NCT00156819|Johns Hopkins Center for Clinical Trials|Razan Yasin|443-287-5796|ryasin1@jhu.edu|
21254426|NCT02808143|Northwestern University Feinberg School of Medicine|Joshua Meeks, MD, PhD|312-363-8959|Joshua.meeks@northwestern.edu|
21254427|NCT03718533|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
21254428|NCT02370810|Anglia Ruskin Univeristy|Eldre Beukes|1223698847|eldre.beukes@anglia.ac.uk|2847
21254429|NCT01248065|Penn State University Dept. of Public Health Sciences|Tonya S. King, PhD|717-531-7178|tking@psu.edu|
21254430|NCT00893984|Minneapolis Heart Institute Foundation|Chief Medical Officer|612-863-3900|scott.sharkey@allina.com|
21254431|NCT01762501|Sogo Rinsho Medefi Co., Ltd|Naoyuki Takano|+81-3-6901-6079|takano.naoyuki@sogo-medefi.jp|
21254432|NCT02781844|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21254433|NCT02725801|University of Kentucky Division of Plastic Surgery|Lesley Wong|859-323-7505|lesley.wong@uky.edu|
21254434|NCT04256629|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21254435|NCT00321373|GlaxoSmithKline|GSK Response Center|866-435-7343||
21254436|NCT01774487|Baylor College of Medicine and Texas Children's Hospital|Sanjiv Harpavat|832-824-2099|harpavat@bcm.edu|2144
21254437|NCT01383499|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21254438|NCT00477334|Novartis Pharmaceuticals|Study Director|862-778-8300||
21254439|NCT02572882|University of Pennsylvania|Natalie Kuzla|215-573-2935|nkuzla@pennmedicine.upenn.edu|
21254440|NCT04275089|Reia, LLC|Kaitlin Maier|2032742886|kaitlin@reiahealth.com|
21254441|NCT02418676|State University of Maringá - Paraná - Brazil|Dra. Graciette Matioli|55 44 3011-3868|gmatioli@uem.br|
21254442|NCT01079663|Dexcel Pharma|Clinical Trial Department Manager|972-4-6364000|sigalit.melcer@dexcel.com|467
21254443|NCT01028937|NTK Enterprises, Inc.|Nancy Lockerman|831-869-1384|nlockerman@opti-k.com|
21254444|NCT00760006|Chilsren's Hospital of Pittsburgh of UPMC|Dr. Joseph E. Losee|412-692-6203|joseph.losee@chp.edu|
21254445|NCT00461032|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21254446|NCT00180323|Rigshospitalet, Copenhagen Unviversity Hospital, Denmark|Dr. Jesper Hastrup Svendsen||jesper.hastrup.svendsen@rh.regionh.dk|
21254447|NCT03486457|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21254448|NCT02257567|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21254449|NCT03536143|Krystal Biotech|Dr. Hubert Chen, MD, Senior Vice President of Clinical Development|(412) 586-5830|inquiries@krystalbio.com|
21254450|NCT01174160|Cardiome Pharma|Jonathan Mather, Director, Head of Regulatory Affairs|+44 (0)7581148916|jmather@cardiome.com|
21254451|NCT01590017|AMC Statistical Center|Jeannette Lee, PhD.|501-526-6712|jylee@uams.edu|
21254452|NCT02527343|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
21254453|NCT05767021|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21254454|NCT04055090|Helixmith Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
21254455|NCT04426851|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21254456|NCT01944371|University of California, San Francisco|Steven G. Deeks|4156064082|Steven.Deeks@ucsf.edu|404
21254457|NCT03256851|Wayne State University|Dr. Nora Fritz|(313) 577-1096|nora.fritz@wayne.edu|
21254458|NCT01065844|The University of Iowa|John M. Buatti, M.D., Chair, Department of Radiation Oncology|319-356-2699|john-buatti@uiowa.edu|
21254459|NCT00552240|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21254460|NCT00801931|Columbia University|Prakash Satwani, MD|212-305-0223|ps2087@cumc.columbia.edu|
21284596|NCT00004088|City of Hope|Brenda Williams, Senior Director, Clinical Trials Office|626-218-2702|bwilliams@coh.org|
21284597|NCT03706469|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
21284598|NCT02636699|DBV Technologies|Chief Medical Officer|33-1-55-42-78-78|clinicaltrials@dbv-technologies.com|
21284599|NCT00624832|Novartis Pharmaceuticals|Study Director|862-778-8300||
21284600|NCT01939223|Bayer|Therapeutic Area Head|+49 30 300139003|clinical-trials-contact@bayer.com|
21254461|NCT02679573|Melinta Therapeutics, Inc.|Sue Cammarata|312-724-9401|scammarata@melinta.com|
21254462|NCT00116337|MetroHealth Medical Center|Dr. Anthony Dimarco|216-778-3906|adimarco@metrohealth.org|
21254463|NCT03545503|New Hanover Regional Medical Center|William F. Powers, IV, MD, FACS|910-667-9232|william.powers@nhrmc.org|
21254464|NCT02128542|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21254465|NCT02483585|Amgen Inc.|Study Director|866-572-6436||
21254466|NCT01485055|Nationwide Childrens Hospital|Rajinder Bajwa|6147222000|rajinder.bajwa@nationwidechildrens.org|
21254467|NCT01935180|VA Medical Center|Dr. Heiko Pohl|8022959362|heiko.pohl@dartmouth.edu|5595
21254468|NCT00825916|Capstone Therapeutics|Denise Lamon, Director of Regulatory Affairs|800-937-5520|dlamon@capstonethx.com|5206
21254469|NCT00912301|Mayo Clinic|Michael L. Camilleri, MD|507-266-2306|camilleri.michael@mayo.edu|
21254470|NCT01098097|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21254471|NCT04196101|Enanta Pharmaceuticals, Inc|Guy De La Rosa, MD Senior Director, Infectious Diseases|(617) 607-0800|gdelarosa@enanta.com|
21254472|NCT00394082|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21254473|NCT02684851|CarolinasHS|Rachel Seymour, PhD|704-355-6969|Rachel.Seymour@carolinashealthcare.org|
21254474|NCT03430531|Penn State Hershey Medical Center|Dr. Verghese Cherian|7175318521|vcherian@pennstatehealth.psu.edu|
21254475|NCT01768117|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21254476|NCT01945060|University of Virginia|Marc D Breton|14349826484|mb6nt@virginia.edu|
21254477|NCT02939170|Alcon, A Novartis Division|Clinical Project Lead, Clinical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
21254478|NCT01000636|Galderma|Farzaneh SIDOU Clinical Project Manager|00 33 4 93 95 70 70|farzaneh.sidou@galderma.com|
21254479|NCT00138671|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21254480|NCT01808326|GlaxoSmithKline|GSK Response Center|866-435-7343||
21254481|NCT00906945|Washington University School of Medicine|Geoffrey Uy, M.D.|314-454-8304|guy@wustl.edu|
21254482|NCT01853644|Northwestern University|Daniela Matei|312.472.4684|daniela.matei@northwestern.edu|
21254483|NCT00705523|UPenn|Dr. Jennifer Plebani|215-222-3200|jplebani@mail.med.upenn.edu|152
21254484|NCT02673515|Medical University of Graz|Assoc.-Prof.Dr. Harald Sourij|+43 316 385|norbert.tripolt@medunigraz.at|78038
21254485|NCT01323972|GlaxoSmithKline|GSK Response Center|866-435-7343||
21254486|NCT00994682|University of Florida|Dr. Kenneth Cusi|352-273-8662|kcusi@ufl.edu|
21254487|NCT01049217|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21254488|NCT00589121|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21254489|NCT02412371|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21254490|NCT00847808|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21254491|NCT01116102|Baxter Healthcare Corporation|George Harb, MD, MPH||george_harb@baxter.com|
21254492|NCT05000931|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
21254493|NCT00925132|University of Iowa|Mohammed Milhem|319-356-2324||
21254494|NCT02545933|University of Florida|Dr. Dominick Angiolillo|9042443378|dominick.angiolillo@jax.ufl.edu|
21254495|NCT03149549|CytomX Therapeutics|Monika Vainorius|(650) 515-3185|clinicaltrials@cytomx.com|
21254496|NCT01892540|University Hospitals|Philipp Frank Graner|+1 216-844-8275|philipp.graner@uhhospitals.org|
21254497|NCT01370590|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21254498|NCT01134952|LondonHSC|Dr Vivian McAlister|5196632920|vmcalist@uwo.ca|
21254499|NCT06298669|Rutgers|Maya Guglin|9085968459|maya.guglin@rutgers.edu|
21254500|NCT04617275|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21254501|NCT02437253|Los Angeles Biomedical Research Institute at Harbor-UCLA|Dr. Lynda Polgreen (PI)|310-222-1961|lpolgreen@labiomed.org|
21254502|NCT00133809|Emory University|Nicole Turgeon MD|404-727-3257|nturgeo@emory.edu|
21254503|NCT00729378|University of Arizona|Dr. Scott Going, Ph.D.|520-626-3432|going@u.arizona.edu|
21254504|NCT00690443|Aegerion Pharmaceuticals|Chief Medical Officer|617-500-7867||
21254505|NCT02874924|Univ TX Health Science Center San Antonio|Dean L. Kellogg, Jr, MD, PhD|2106175197|kelloggd@uthscsa.edu|
21254506|NCT01689337|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21254507|NCT01874431|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21254508|NCT03834051|Vancouver Island Health Authority|Dr. Christine Lee|250 519 1898|christine.lee@viha.ca|
21254509|NCT00642772|Center for Health Services Research in Primary Care, Durham VA Medical Center|Dr. Kelli Allen|919-286-0411|kelli.allen@va.gov|7090
21254510|NCT05877508|University of California San Francisco|Michael Peluso|(415) 502-2449|michael.peluso@ucsf.edu|
21254511|NCT01147601|Oregon Health & Science University|Dr. Alfons Krol|503-494-9993|krola@ohsu.edu|
21284601|NCT04379700|NYU Langone Health|Bedros Taslakian, MD|212-263-5898|bedros.taslakian@nyulangone.org|
21284602|NCT00935064|University of Delaware/Christiana Care Health System|Dr. Raelene E. Maser|302-831-8400|rmaser@udel.edu|
21284603|NCT03004924|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21284604|NCT00911586|Clarus Therapeutics, Inc.|Robert E. Dudley, PhD, CEO and President|847-562-4300|rdudley@clarustherapeutics.com|
21284605|NCT02555930|Imperial College London|Dr Harriet Kemp|+44 20 3315 8816|h.kemp@imperial.ac.uk|
21284606|NCT01010399|Franco Felizarta, MD|Franco Felizarta, MD|661-324-3128|felizarta@pol.net|
21284607|NCT03611101|Exalenz Bioscience|Clinical Trial Manager|+972-8-9737513|avrahamh@exalenz.com|
21254512|NCT04800432|University of South Florida|Tatyana Harris|(813) 974-7454|trharris1@usf.edu|
21254513|NCT00549783|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
21284608|NCT01370616|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21237396|NCT03232983|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
21237397|NCT02548455|Abbott|Clay Cohorn, Clinical Program Director|972-309-8087|clay.cohorn@abbott.com|
21237398|NCT00530855|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
21237399|NCT00815295|Duke University Medical Center|Neal Ready, MD|919-668-6688|neal.ready@duke.edu|
21237400|NCT01137474|Clinical Trial Transparency|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com|
21237401|NCT01515410|Depomed|Head of R&D|510-744-8000|msweeney@depomed.com|
21237402|NCT04124926|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-PHAT (7428)|medicalinformation@phathompharma.com|
21237403|NCT01250977|Center for Interdisciplinary Research on Nicotine Addiction|Benjamin Albelda (Project Manager)|215-746-7173|albeldab@pennmedicine.upenn.edu|
21237404|NCT02578238|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21237405|NCT03644186|ETOP IBCSG Partners Foundation|Dr. Heidi Roschitzki|+41 31 511 94 00|TOUCH-monitoring@etop.ibcsg.org|
21237406|NCT03712891|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
21237407|NCT02701985|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21237408|NCT04235036|The Blood and Marrow Transplant Group of Georgia|Dr. Scott Solomon|404-255-1930|ssolomon@bmtga.com|
21237409|NCT01640808|Pharmaceutical Division, Clinical Administration Dept.|Administrator of clinical trial information||ctrdinfo@kowa.co.jp|
21237410|NCT02477111|Cordis, A Cardinal Health Company|Jennifer Lee, Clinical Project Manager|669-699-6851|jennifer.lee02@cordis.com|
21237411|NCT00989768|Brazilian Center for Studies in Dermatology|Juliana de Souza|+55 51 3026 2633|pesquisa@cebd.org.br|
21237412|NCT02192502|Cleveland Clinic|Dr. Andra Duncan|216-538-6944|duncana@ccf.org|
21237413|NCT01381692|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21237414|NCT01328574|National Cancer Institute|Dr. Andrea Apolo|301-451-1984|apoloab@mail.nih.gov|
21237415|NCT03206203|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
21237416|NCT03160027|University of California, San Francisco & San Francisco VA Medical Center|Dr. Linda Chao|14152214810|linda.chao@ucsf.edu|24386
21237417|NCT01798550|Emory University|Christine Kempton MD, MSc|404-778-1900|ckempto@emory.edu|
21237418|NCT02308748|U.S. Food and Drug Administration|David G Strauss, MD, PhD|301-796-6323|david.strauss@fda.hhs.gov|
21237419|NCT01152580|Duquesne University|Dr. Paula Witt-Enderby, Professor of Pharmacology and Toxicology|412-396-4346|wittp@duq.edu|
21237420|NCT01570829|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
21237421|NCT01994954|University of Massachusetts Medical School|Dr. Lawrence Rhein|508-334-6206|Lawrence.Rhein@umassmemorial.org|
21237422|NCT00449176|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
21237423|NCT02472964|Mylan Inc|Clinical Program Manager|412-651-9530|gail.tribble@mylan.com|
21237424|NCT01454583|Foundation Stiftung Institut fuer Herzinfarktforschung Ludwigshafen, Germany|Professor Dr. Uwe Zeymer|+49 621 503 2813|Uwe.Zeymer@t-online.de|
21237425|NCT01749982|Columbia University|Megan N Hall|212-305-3161|mh2825@columbia.edu|
21237426|NCT02654808|Columbia University|Dr. Timothy Ryntz|212-305-4973|ter2111@cumc.columbia.edu|
21237427|NCT00113568|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21237428|NCT01625221|Torax Medical, Inc.|VP of Clinical Affairs|651-361-8900|aderosier@toraxmedical.com|
21237429|NCT01680848|Dental PBRN Japan|Director of the Dental PBRN Japan|+81-93-285-3022|info@dentalpbrn.jp|
21237430|NCT00377403|Washington University in St Louis|Jane Garbut,MD|314-454-8613|jgarbutt@dom.wustl.edu|
21237431|NCT02186210|Seoul National University Hospital Dept of Anesthesiology|Dr Yunseok Jeon|82-2-2072-2465|jeonyunseok@gmail.com|
21237432|NCT01826812|The Wilmer Eye Institute, Johns Hopkins|Dr. Esen K. Akpek|410-955-5214|esakpek@jhmi.edu|
21237433|NCT01684748|Virginia Polytechnic Institute & State University|Elaina Marinik, Ph.D.|5402318299|emarinik@vt.edu|
21237434|NCT01921296|University of Michigan Hospital|Dr. Norah Lynn Henry, Associate Professor of Internal Medicine|734-936-4991|norahh@umich.edu|
21237435|NCT01207102|Duke University Medical Center|Dr Kimberly Blackwell|919-6681748|black034@mc.duke.edu|
21237436|NCT00452387|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
21237437|NCT00969501|Georgia Institute for Clinical Research, LLC|Arnold Weil, MD|770-421-2030|research@lowbackpain.com|
21237438|NCT00736645|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
21254514|NCT05398237|University of Arizona Cancer Center|Clara Curiel-Lewandrowski, MD|(520) 626-5351|ccuriel@arizona.edu|
21254515|NCT01529203|Galderma|Clinical Project Manager|(33) 4 92 38 67 33|may.ma@galderma.com|
21254516|NCT01312857|Memorial Sloan Kettering Cancer Center|Dr. Nancy Kemeny, MD|646-888-4180|kemenyn@MSKCC.ORG|
21254517|NCT01749904|Bausch + Lomb, a division of Valeant Pharmaceuticals|H. DeCory, Director Medical Affairs|585 732-3284|heleen_H_decory@bausch.com|
21254518|NCT01382706|USC/Norris Comprehensive Cancer Center|Tali Homsey|(323) 865-0451|tali.homsey@med.usc.edu|
21254519|NCT04745026|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
21254520|NCT01984671|Duke University School of Medicine|Tamara Somers, PhD|919-416-3408|tamara.somers@duke.edu|
21254521|NCT02344004|Insmed Inc|Kevin Mange (Senior Vice President, Clinical Development & Medical Affairs, ALIS)|908-947-2651|kevin.mange@insmed.com|
21254522|NCT00509587|Princess Margaret Cancer Centre|Dr. Natasha Leighl|416-946-2399|natasha.leighl@uhn.ca|
21254523|NCT00577577|Insmed|Insmed Medical Information|1-844-446-7633|medicalinformation@insmed.com|
21254524|NCT00232544|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
21254525|NCT00116753|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
21299634|NCT05164120|MedStar Health Georgetown Transplant Institute|Alexander Kroemer, MD; Khalid Kahn, MD|202-444-3700|Alexander.Kroemer@gunet.georgetown.edu; Khalid.M.Khan@gunet.georgetown.edu|
21254526|NCT01200589|Novartis Pharmaceuticals|Study Director|862-778-8300||
21254527|NCT00986973|The Children's Hospital of Philadelphia|Dr. Can Ficicioglu|2155905876|ficicioglu@email.chop.edu|
21254528|NCT00598273|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
21254529|NCT01590082|The University of Texas (UT) MD Anderson Cancer Center|Sapna P. Patel, Associate Professor, Melanoma Medical Oncology|(713) 792-2921|sppatel@mdanderson.org|
21254530|NCT02434497|AstraZeneca Plc|Robin Mukherjee|+46317761000|robin.mukherjee@astrazeneca.com|
21254531|NCT01210664|University of California San Francisco Diabetes Center|Jeffrey Bluestone, PhD|415-502-5677|jeff.bluestone@ucsf.edu|
21254532|NCT02891408|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21254533|NCT02549196|Allergan, Inc|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
21254534|NCT01442779|Texas Tech University Health Sciences Center|Lorenz Lutherer, MD, PhD|806-743-2532|Lorenz.Lutherer@ttuhsc.edu|
21254535|NCT05249829|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
21254536|NCT00578461|Baylor College of Medicine|Robert Krance, MD|832-824-4661|rakrance@txch.org|
21254537|NCT00196976|GlaxoSmithKline|GSK Response Center|866-435-7343||
21254538|NCT01535560|Alcon Research, Ltd.|Sally Schieb, Sr. Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21254539|NCT02009761|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21254540|NCT02740374|The Ohio State University Wexner Medical Center - Department of Anesthesiology|Alberto Uribe|6142933559|alberto.uribe@osumc.edu|
21254541|NCT02842827|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21254542|NCT00825825|Steward St. Elizabeth's Medical Center|Tara Lauriat, Ph.D.|617-789-2404|tara.lauriat@steward.org|
21254543|NCT01815138|UConn Helth|Lawrence Engmann|8605258283|lengmann@uchc.edu|
21254544|NCT00882687|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21254545|NCT00577356|Virginia Mason Medical Center|Jacqueline Vuky, MD|(206) 223-6193|Jacqueline.Vuky@vmmc.org|32246
21254546|NCT02649946|BD/Bard|Heather Lam, Associate Project Manager, Clinical Affairs|(763) 390-8616|heather.lam@bd.com|
21254547|NCT00950950|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21254548|NCT01809002|Axogen|Stacy Arnold, VP of Clinical Research|770-833-2570|sarnold@axogeninc.com|
21254549|NCT01047293|Huntsman Cancer Institute|Sunil Sharma|801-587-5559|sunil.sharma@hci.utah.edu|
21254550|NCT00491829|Sprout Pharmaceuticals|Scientific Program Director|9198820850|clinicaltrials@sproutpharma.com|
21254551|NCT01920854|Rockwell Medical|Senior Director, Clinical Research & Operations|248-960-9009|rd@rockwellmed.com|
21254552|NCT00757783|Johnson & Johnson Pharmaceutical Research & Development|Vice President, Tibotec Therapeutics Clinical Affairs|877-732-2488||
21254553|NCT02372136|Gerber Foundation, UT Southwestern Med Ctr, Children's Medical Center|National Grant Gerber Foundation) (LPB); George L. MacGregor Professorship (CRR); National Children'|214-648-3903|luc.brion@utsouthwestern.edu|
21254554|NCT03265938|Icahn School of Medicine at Mount Sinai|Dr. Samuel DeMaria|(212) 241-1518|samuel.demaria@mountsinai.org|
21254555|NCT01588496|Amgen Inc.|Study Director|866-572-6436||
21254556|NCT03143166|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21254557|NCT05924945|Masimo Corporation|Chelsea Frank|9492977000|clinicalresearchdept@masimo.com|
21254558|NCT02471833|Emory University|Whitney Wharton, PhD|404-712-7359|w.wharton@emory.edu|
21254559|NCT04619251|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21254560|NCT01986075|New York State Psychiatric Institute|Kenneth Carpenter, PhD|646-774-8181|kenneth.carpenter@nyspi.columbia.edu|
21254561|NCT03683823|The University of Texas at Austin|Dr. Michael Telch|512-560-4100|telch@austin.utexas.edu|
21254562|NCT02677428|VA Connecticut Healthcare System|Marc Rosen|203-932-5711|marc.rosen@va.go|2112
21254563|NCT01946438|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21254564|NCT05195489|NYU Langone Health|Kimberly Hoagwood, PhD|240-401-4289|Kimberly.Hoagwood@nyulangone.org|
21254565|NCT03224351|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21254566|NCT01328717|Ascensia Diabetes Care|Dr. Daniel Brown|574-256-7754|daniel.brown@ascensia.com|
21254567|NCT00346268|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21254568|NCT00031551|NINR/NIH|Suzanne Wingate|301-827-0982|suzanne.wingate@nih.gov|
21254569|NCT02164383|University of Wisconsin Center for Tobacco Research and Intervention|Tanya Schlam, PhD|608-262-4149|trschlam@ctri.wisc.edu|
21254570|NCT01036763|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21254571|NCT01672723|University of California, Los Angeles|Dr. Naomi Eisenberger|310-267-5196|neisenbe@ucla.edu|
21254572|NCT00743275|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21254573|NCT01966380|Sahlgrenska university hospital|Prof. Jan Faergemann|031-3421000|jan.faergemann@derm.gu.se|
21284609|NCT00462449|Department of Physical Medicine and Rehabilitation University of Pittsburgh|Dr. Michael C. Munin|412-648-6848|muninm@upmc.edu|
21284610|NCT00187278|St Jude Medical|Pascale Ducloux, Clinical Manager|+3227746709|pducloux@sjm.com|
21284611|NCT02735096|Innervo Technology|Dr. Hui Tang|5732896776|htang@innervotech.com|
21284612|NCT01080391|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21284613|NCT00678470|University of California at San Francisco|John Koo MD|4154764701|john.koo@ucsfmedctr.org|
21284614|NCT02083653|Symphogen A/S|Chief Scientific Officer|+45 8838 2600|info@symphogen.com|
21284615|NCT01938989|Alcon Research, Ltd.|Melvin Sarayba, Franchise Head Cataract, GMA|1-888-451-3937|alcon.medinfo@alcon.com|
21284616|NCT00428922|The Ohio State University Comprehensive Cancer Center|Bhuvaneswari Ramaswamy, MD|614-293-0066|Bhuvaneswari.Ramaswamy@osumc.edu|
21284617|NCT03423147|Icahn School of Medicine at Mount Sinai|Nicola Tavella|212-241-3888|nicola.tavella@mssm.edu|
21284618|NCT01048099|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21254574|NCT00575029|University of Arkansas|Dr. Donald Bodenner|501-526-5710|bodennerdonald@uams.edu|
21254575|NCT01980654|Pharmacyclics|Dr. Jutta Neuenburg|408-215-3735|jneuenburg@pcyc.com|
21284619|NCT01987232|Amgen Inc.|Study Director|866-572-6436||
21284620|NCT01605032|Albert Einstein College of Medicine/Montefiore Medical Center|Ira Braunschweig, MD|718-920-4057|IBRAUNSC@montefiore.org|
21284621|NCT01731470|Beaumont Hospital, Royal Oak|Kenneth Peters MD|248-551-0387|Kenneth.Peters@Beaumont.edu|
21284622|NCT00564395|Children's Hospital at Montefiore|Dr. Rubina Heptulla|718-920-7004|rheptull@montefiore.org|
21284623|NCT01324570|Purdue Pharma L.P.|Clinical Leader|800-733-1333|stacy.baldridge@pharma.com|
21284624|NCT00207727|Centocor Research & Development, Inc.|Sr. Dir. Clinical Research|1-800-457-6399||
21284625|NCT05362695|Ironwood Pharmaceuticals, Inc|Ironwood Study Chair|617-621-7722|info@ironwoodpharma.com|
21284626|NCT01093651|Washington Univ Med Sch|Kevin Yarasheski, PhD|3143628173|key@wustl.edu|
21284627|NCT03611582|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21284628|NCT01783821|Mayo Clinic|Dr. Emir Festic|904-953-9758|Festic.Emir@mayo.edu|
21284629|NCT02333383|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21284630|NCT00986947|Johns Hopkins University School of Medicine|Andrew Singer, MD|410-550-6484|registerclinicaltrials@jhmi.edu|
21284631|NCT00463840|New York University Cancer Institute|Theresa Ryan, MD|212-731-5430|theresa.ryan@nyumc.org|
21284632|NCT02978885|Columbia University|Gebhard Wagener, MD|212-305-6494|gw72@cumc.columbia.edu|
21284633|NCT01669785|Salus Research, Inc.|Jeffery L. Milleman, DDS, MPA|260-755-1099||
21284634|NCT00866333|Syndax Pharmaceuticals, Inc.|Michael L. Meyers, MD, PhD, Chief Medical Officer|+1-646-690-7620|mmeyers@syndax.com|
21284635|NCT02669082|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21284636|NCT04284930|Cleveland Clinic|Risal Djohan|216 312-6146|djohanr@ccf.org|
21284637|NCT04918355|University of Colorado|Heather Tolle|303-724-9924|heather.tolle@cuanschutz.edu|
21284638|NCT04683939|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
21284639|NCT04852276|National Institute of Allergy and Infectious Diseases (NIAID)|Emily Ricotta, PhD|240-550-3474|emily.ricotta@nih.gov|
21284640|NCT01687283|GlaxoSmithKline|GSK Response Center|866-435-7343||
21284641|NCT02092649|University of Guelph|Sebastian Jannas-Vela MSc|(519)-824-4129|sjannas@uoguelph.ca|53907
21284642|NCT01533948|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21284643|NCT01153009|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21284644|NCT00410072|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21284645|NCT02242019|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com|
21284646|NCT04316260|Medical University of South Carolina|Noelle Natale|843-876-2426|natalen@musc.edu|
21284647|NCT03307837|Concentric Analgesics|Dr. John Donovan, President and Founder|415-676-8940|JOHN@CONCENTRICANALGESICS.COM|
21284648|NCT01744483|Oregon Health Science & Science University|Dr Miriam Treggiari|(503) 494-8311|treggiar@ohsu.edu|
21284649|NCT03915626|University of Maryland, Baltimore School of Pharmacy|Dr. Audra L. Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
21284650|NCT03083353|The University of Texas at Austin|Sara Reedy|512-232-4319|Sarah.Fella@austin.utexas.edu|
21284651|NCT01754766|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21284652|NCT04757805|Nationwide Children's Hospital|Giorgio Veneziano, MD|614-722-4200|Giorgio.Veneziano@nationwidechildrens.org|
21284653|NCT02469168|Walter Reed National Military Medical Center|Jody Richardson, MSN, RN|301-295-7798|jody.richardson.ctr@usuhs.edu|
21284654|NCT01533688|UOklahoma|Dr. Mohammad Madhoun|405-456-326-|mohammad-madhoun@ouhsc.edu|
21284655|NCT04046263|"University of Colorado Denver | Anschutz"|Jessica Kendrick, MD|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
21284656|NCT01888653|Columbia University Medical Center/New York State Psychiatric Institute|Yuval Neria|6467748092|yuval.neria@nyspi.columbia.edu|
21284657|NCT02081014|Xeris Pharmaceuticals, Inc.|Martin J. Cummins, VP Drug Development|512-498-2675|mjcummins@xerispharma.com|
21284658|NCT03678675|Tufts Medical Center|Jean Hostage|617-636-4549|jeanhostage@gmail.com|
21284659|NCT02335346|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21284660|NCT03300050|PATH|Jorge Flores, MD|(202) 822-0033|jeflores@path.org|
21284661|NCT01214668|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21284662|NCT02907619|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21284663|NCT03326518|Lument AB|Dr Thomas Fork|+46 705336996|thomas.fork@lumentab.com|
21284664|NCT01375374|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
21284665|NCT02065518|University of Tennessee Health Science Center|Dr. Laura Talbot|901-448-3630|ltalbot@uthsc.edu|
21284666|NCT01066663|Dana-Farber Cancer Institute|Jennifer R Brown MD PhD|l 617-632-4894|Jennifer_Brown@dfci.harvard.edu|
21284667|NCT00571103|University of Iowa Carver College of Medicine|Dr. Donald W Black|319-3534431|donald-black@uiowa.edu|
21284668|NCT03735407|CheckCap|Clinical Director|972-4-8303401|daniella.bleistein@check-cap.com|
21284669|NCT03108066|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21284670|NCT00564278|Columbia Univ Med Center and New York State Psychiatric Institute|Roberto Lewis-Fernandez, MD, Professor of Psychiatry CUMC - NYSPI|646-774-8102|rlewis@nyspi.columbia.edu|
21284671|NCT00560703|Organization: Galderma R&D, Inc|Michael Graeber|609-409-7701|clinicaltrials@galderma.com|
21284672|NCT04847232|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21284673|NCT03798327|Icahn School of Medicine at Mount Sinai|Dr. Nathan Goldstein|212-844-1712|Nathan.goldstein@mssm.edu|
21284674|NCT02476916|Agios Pharmaceuticals, Inc.|Medical Affairs|833-228-8474|medinfo@agios.com|
21284675|NCT04400656|Imperial College London|Ms Puja Jadav|0203 311 5473|p.jadav@imperial.ac.uk|
21284676|NCT06010732|Indiana University School of Dentistry|Domenick T. Zero|3179877507|dzero@iu.edu|
21254576|NCT02831387|Parion Sciences|Jose Boyer|919-313-1182|jboyer@parion.com|
21254577|NCT00192647|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21254578|NCT00876928|Charles R. Drew University|Mayer B. Davidson, MD|323 357-3439|mayerdavidson@cdrewu.edu|
21254579|NCT00118755|Hoffmann-La Roche|Medical Communications|800-821-8590||
21254580|NCT02204176|Wayne State University and Michigan State University|Dr. Phuong Vo|616-634-0566|votrucph@msu.edu|
21254581|NCT00292162|NHS|Michael MacDonald|01412112000|michael.macdonald@nhs.net|
21254582|NCT01016977|GlaxoSmithKline|GSK Response Center|866-435-7343||
21254583|NCT02080221|Brown University Oncology Research Group|Howard Safran, MD|4018633000|BrUOG@BROWN.EDU|
21254584|NCT02394951|Washington University in Saint Louis|Dr. Simon Haroutounian|3143622628|sharout@wustl.edu|
21254585|NCT04005053|University of Minnesota|Kathryn Cullen|612-273-9732|rega0026@umn.edu|
21254586|NCT03184870|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
21254587|NCT05081388|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
21254588|NCT03786783|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21254589|NCT01776541|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21254590|NCT01285843|Medacta International|Ing. Elisa Bonacina, Clinical Data Manager|+41 91 696 60 60|bonacina@medacta.ch|
21254591|NCT04279392|University of Nebraska Medical Center|Laura Bilek|402-690-3524|lbilek@unmc.edu|
21254592|NCT01171807|Quince Therapeutics (former Erydel SpA)|Irene Maccabruni, M.Sc.|+39 02 36504470|imaccabruni@quincetx.com|
21254593|NCT01901341|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
21254594|NCT04964388|UNIVERSITY OF MISSISSIPPI MEDICAL CENTER|Amy Wigglesworth|6018153164|ajwigglesworth@umc.edu|
21254595|NCT00757588|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
21254596|NCT05478499|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21254597|NCT02476279|Division of Gastroenterology & Hepatology, Medical University of South Carolina|Dr. B. Joseph Elmunzer|8437926982|elmunzer@musc.edu|
21254598|NCT02208999|CEMKA|Stéphane Bouée, Medical director|331.41.87.95.25|stephane.bouee@cemka.fr|
21254599|NCT00319839|University of California, Irvine|Chao Family Comprehensive Cancer Center|(877) 827-8839|UCstudy@uci.edu|
21254600|NCT04494256|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21254601|NCT00262951|University of Minnesota, Masonic Cancer Center|Edward Greeno, M.D.|612-626-6418|green049@umn.edu|
21254602|NCT01778023|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21254603|NCT00903630|University of Minnesota, Dept. of OBGYN|Dr. Levi Downs, Jr|612-626-3111|downs008@umn.edu|
21254604|NCT03086213|Shenzhen Third People,s Hospital|Thoracic surgical department|13823135410|daoren_000113@126.com|
21254605|NCT01616056|FHCRC|Stephanie J. Lee MD MPH|206-667-6190|sjlee@fhcrc.org|
21254606|NCT01249274|Yale University|Kimberly A. Yonkers, M.D.|203-764-6621|kimberly.yonkers@yale.edu|
21254607|NCT03451162|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21254608|NCT03658668|NYU Langone Health|Mathew Lustberg, MA|929 445 5090|Matthew.Lustberg@nyulangone.org|
21254609|NCT04634825|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
21254610|NCT02777385|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
21254611|NCT00402597|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|VP FRANCHISE MED LDR|1 908 927 7767||
21254612|NCT01100034|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21254613|NCT01831856|Institut de Recherche Pierre Fabre|Karim KEDDAD, MD, PhD Head of Medical Unit|+33 5 34 50 61 69|Karim.keddad@pierre-fabre.com|
21254614|NCT04756960|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
21254615|NCT00836095|Penn State Milton S. Hershey Medical Center|Sonia Vaida MD, Professor of Anesthesiology|7175318433|svaida@hmc.psu.edu|
21254616|NCT03609853|Johns Hopkins School of Medicine|Dr. Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
21254617|NCT01602562|GlaxoSmithKline|GSK Response Center|866-435-7343||
21254618|NCT02411357|University of Vermont|Sarah H. Heil, PhD|802-656-8712|sarah.heil@uvm.edu|
21254619|NCT02003573|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21254620|NCT00803751|UT Medical School, Houston|Maria Matuszczak|713-498-2768|maria.matuszczak@uth.tmc.edu|
21254621|NCT03102645|Department of Clinical Pharmacology, University Hospital Bispebjerg and Frederiksberg|Jonatan Kornholt|+4538635604|jonatan.kornholt@regionh.dk|
21254622|NCT01413087|Anchiano Therapeutics Israel Ltd.|Dr. David Kerstein|857-259-4626|david.kerstein@anchiano.com|
21254623|NCT05026710|University of Michigan|Khurshid Ghani, MD|734-763-2797|kghani@med.umich.edu|
21254624|NCT03539887|The University of Texas Health Science Center at Houston|Rodrigo Machado-Vieira, MD, PhD, MSc|(713) 741-5000|Rodrigo.MachadoVieira@uth.tmc.edu|
21254625|NCT00126503|Vanderbilt-Ingram Cancer Center|Jeffrey Sosman, MD|615-936-3048|jeff.sosman@vanderbilt.edu|
21254626|NCT02523599|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
21254627|NCT03519971|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21254628|NCT03141905|University of Maryland, Baltimore|Jeffrey C. Fink MD, MS (Principal Investigator)|410-328-4822|jfink@som.umaryland.edu|
21254629|NCT05180500|University of Pittsburgh|Dr. Sharon Hillier, PhD|412-641-6435|hillsl@mwri.magee.edu|
21254630|NCT02760277|ReveraGen Biopharma Inc.|Dr. Eric P. Hoffman|240-672-0295|ericphoffman@gmail.com|
21254631|NCT04134845|Vanderbilt University Medical Center|Dr. William Stevenson|615-322-2318|William.g.stevenson@vumc.org|
21254632|NCT04927884|CSSIFM|Chaitali Nangia, MD Oncologist|855-797-9277|Chaitali.nangia@cssifm.org|
21254633|NCT01775124|Novartis|Study Director|862-778-8300||
21284677|NCT03141034|Washington University School of Medicine|Kian-Huat Lim, M.D., Ph.D.|314-362-6157|kian-huat.lim@wustl.edu|
21254634|NCT00727311|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclsoure@merck.com|
21254635|NCT03992846|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
21254636|NCT01845220|Johns Hopkins University|Jed W. Fahey, Sc.D.|4106142607|jfahey@jhmi.edu|
21254637|NCT04487834|Calisia University, Kalisz, Poland|Jacek Piatek|+48883389788|drpiatek@interia.eu|
21254638|NCT01177722|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21254639|NCT00850603|Sanofi Pasteur Inc|Medical Director||RegistryContactUs@sanofipasteur.com|
21254640|NCT00484289|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21254641|NCT01828073|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
21254642|NCT01592500|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
21254643|NCT02049151|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Centre|496151725200|service@merckgroup.com|
21254644|NCT03572478|University of Chicago|Walter STadler|773-702-4150|wstadler@medicine.bsd.uchicago.edu|
21254645|NCT03057977|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21254646|NCT01201317|AstraZeneca|Heather Bryson||clinicaltrialtransparency@astrazeneca.com|
21254647|NCT01350336|Boston Scientific Corp.|G Mark Grubb|(412) 716-0717|grubbm@bsci.com|
21254648|NCT04234425|Montana State University|Dr. Lauren Davis|8287736328|lauren.davis6@montana.edu|
21254649|NCT02795429|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21254650|NCT02079610|University of Pittsburgh School of Medicine|Kymberly Young, PhD|412-648-6179|youngk@pitt.edu|
21254651|NCT05220254|Stanford University|Judith Prochaska|(650) 724-3608|jpro@stanford.edu|
21254652|NCT03794908|University of Michigan|Helen Burgess|734-615-8303|bhelen@umich.edu|
21254653|NCT00861263|University of FLorida|Dr. Peter Draganov MD|352-273-9472|peter.draganov@medicine.ufl.edu|
21254654|NCT00250679|Sepracor Inc.|Respiratory Medical Director|1-866-503-6351||
21254655|NCT01093521|University of Washington|Christopher H. Goss, MD MSc|206-543-3166|goss@u.washington.edu|
21254656|NCT00448279|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21254657|NCT03907410|Children's Hospital of Philadelphia|Chen Kenyon|2674266339|kenyonc@chop.edu|
21254658|NCT01981473|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21254659|NCT04776148|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21254660|NCT00738582|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21254661|NCT02563522|Helixmith Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
21254662|NCT01052103|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21254663|NCT00799513|San Raffaele Hospital IRCCS|Principal Investigator|0226437649|ferreri.andres@hsr.it|
21254664|NCT00624923|Joslin Diabetes Center|Dr. Allison Goldfine|617-309-2400|allison.goldfine@joslin.harvard.edu|
21254665|NCT02440451|University of Coimbra|Prof. Dr. Miguel Castelo-Branco|+351239790000|mcbranco@fmed.uc.pt|
21284678|NCT00715520|Emory University|Dr. Cathrin Buetefisch|4047121894|cathrin.buetefisch@emory.edu|
21284679|NCT00178646|UTHealth|Gerard E. Francisco|7137975246|Gerard.E.Francisco@uth.tmc.edu|
21284680|NCT04942210|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext: 6#|Contact-US@sanofi.com|
21284681|NCT03688802|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
21284682|NCT04122625|Debiopharm International S.A.|Head Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
21284683|NCT04348500|Cedars Sinai Medical Center|Dr. Stanley C. Jordan, MD|310-423-2641|sjordan@cshs.org|
21284684|NCT02776670|Alcon, A Novartis Division|Head, CDMA Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21284685|NCT03699540|University of Kentucky|Shanna Babalonis, Ph.D.|859-257-1881|babalonis@uky.edu|
21284686|NCT02066727|Tianjin Medical University General Hospital|Dr Yuechun LU|15902233666|luyuechun@sina.com|
21284687|NCT05460078|Atrium Health|Dr. Jason Roberge|7043550268|jason.roberge@atriumhealth.org|
21284688|NCT02697591|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
21284689|NCT02722746|University of Florida, College of Medicine|Dr. Terrie Vasilopoulos|3522738910|tvasilopoulos@anest.ufl.edu|
21284690|NCT04595279|Johns Hopkins University|Matthew Johnson|410-550-0056|mwj@jhu.edu|
21284691|NCT03624569|The Ohio State University|Richard Bruno, Principal Investigator|6142925522|bruno.27@osu.edu|
21284692|NCT01294748|Micell Technologies|Jeffrey Mifek, VP Clinical Affairs|919-313-2102|jmifek@micell.com|
21284693|NCT01618916|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21284694|NCT03292614|Dietrich-Bonhoeffer-Klinikum|Ulrike Holland|+49 395 775 3427|aug-st2@dbknb.de|
21284695|NCT01084538|Abbott|Global Medical Services|1-800-633-9110||
21284696|NCT00803205|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
21284697|NCT00090584|New England Research Institutes|Anne Stoddard, ScD|617-972-3331|astoddard@neriscience.com|
21284698|NCT04493151|Center for Anti-Infective Research and Development, Hartford Hospital|Dr. Joseph L. Kuti, PharmD, FIDP, FCCP|(860) 972-3612|Joseph.Kuti@hhchealth.org|
21284699|NCT02536781|Khon Kaen University|Faculty of Pharmaceutical Science|+66-43-362092|lsucharat@gmail.com|
21254666|NCT01749605|University of Iowa|Brett Faine, PI|319-310-8067|brett-faine@uiowa.edu|
21254667|NCT00666679|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21254668|NCT00903006|University of Texas MD Anderson Cancer Center|Ana Gonzalez-Angulo, MD / Associate Professor, Breast Medical Oncology|713-792-2817|CR_Study_Registration@mdanderson.org|
21284700|NCT00508157|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21284701|NCT04164004|Stanford University|Alexander Sandhu|9097671214|ats114@stanford.edu|
21254669|NCT03405792|University of Florida|Ashley Ghiaseddin, MD|352-273-9000|ashley.ghiaseddin@neurosurgery.ufl.edu|
21284702|NCT02258334|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21254670|NCT00918580|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21254671|NCT04882995|UMass Chan Medical School|Dr. Deepali Maheshwari|4137948764|deepali.mahesh@gmail.com|
21254672|NCT04371198|Duke University Health System|Joan Cahill BNS OCN CCRP|(919) 668-5211|Joan.Cahill@duke.edu|
21254673|NCT00372229|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21254674|NCT01347762|Beth Israel Deaconess Medical Center|Kevin P. Hill, M.D., M.H.S., Principal Investigator|617 667 1597|khill1@bidmc.harvard.edu|
21254675|NCT00701220|The Ohio State University|Philip F. Binkley, MD, MPH|(614) 293-3956|binkley.2@osu.edu|
21254676|NCT03235284|Federal University of Bahia - FUBA|Dr.Pietro Araújo|71992520519|pietro.araujo@ufba.br|
21254677|NCT00690820|Solvay Pharmaceuticals|Sven Voet - Global Communication|+32(0)2 509 69 77|sven.voet@solvay.com|
21254678|NCT05208866|Centessa Pharmaceuticals|Milena Kanova|+44 7780 430583|milena.kanova@centessa.com|
21254679|NCT02996565|HealthPartners Institute|Karen Margolis, MD MPH|952-967-7301|Karen.L.Margolis@HealthPartners.com|
21254680|NCT04964414|UPMC Children's Hospital of Pittsburgh|Dr. Amber Shaffer|412-692-6874|shafferad@upmc.edu|
21254681|NCT03881553|University of Pittsburgh School of Medicnie|Elisabeth Salisbury, PhD|412-246-5378|salisburye2@upmc.edu|
21254682|NCT03572387|Icahn School of Medicine at Mount Sinai|Vaibhav Patel, MD|212-659-5511|vaibhav.patel@mountsinai.org|
21254683|NCT02951767|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21254684|NCT03426605|OrphAI Therapeutics|Esther Nkrumah|2675121750|enkrumah@orphai-therapeutics.com|
21254685|NCT00609765|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-2069|jonathan.strosberg@moffitt.org|
21254686|NCT02054520|NewLink Genetics Corporation|Manager, Clinical Operations|515-598-5020|csmith@linkp.com|2624
21254687|NCT01272804|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21254688|NCT02232243|University of Kentucky|Peng Wang|(859) 257-4488|p.wang@uky.edu|
21254689|NCT00490724|Clinical Science Initiative Dept. Janssen Pharmaceutical K.K./ Tokyo Japan|Manager|+81.3.4411.5653||
21254690|NCT03218397|Duke University|Vance Fowler, MD, MHS|919-613-5678|vance.fowler@duke.edu|
21254691|NCT01796548|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-792-7200||5888
21254692|NCT02457559|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21254693|NCT00974376|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
21254694|NCT00462332|GIMEMA Foundation Data Center|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it|
21254695|NCT03866473|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|drcrnet@jaeb.org|
21254696|NCT02495792|Brooke Army Medical Center|MAJ Jamie Morris|210-221-3700|jamie.b.morris.mil@mail.mil|
21254697|NCT05590884|Guerbet|Frantz Hebert, Global Head of Clinical Development|+33 680249334|frantz.hebert@guerbet.com|
21254698|NCT02112838|Rigel Pharmaceuticals|Sandra Tong|1-650-624-1207|stong@rigel.com|
21254699|NCT04308395|Sol-Gel Technologies, Ltd.|VP Clinical & Regulatory Affairs|+972-73-3729453|Ofra.Levy-Hacham@sol-gel.com|
21254700|NCT04443153|UVA Center for Diabetes Technology|Marc Breton, PhD|434-982-6484|marc.breton@virginia.edu|
21254701|NCT02549014|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21254702|NCT04763421|Ethicon Endo-Surgery|Senior Director of Clinical Affairs|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21254703|NCT03110224|Zimmer Biomet|Annette Tieu|971-482-9622|annette.tieu@zimmerbiomet.com|
21254704|NCT05328167|Thomas Jefferson University|Dr. John Eisenbrey, Associate Professor|215-503-5188|john.eisenbrey@jefferson.edu|
21254705|NCT05406752|Unither-Pharmaceuticals|Non-Clinical & Clinical Project Manager|+33 (0)1 44 63 51 78|clinicaltrials@unither-pharma.com|
21254706|NCT00409773|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21254707|NCT01919814|Pennington Biomedical Research Center|Frank Greenway, MD|2257632578|frank.greenway@pbrc.edu|
21254708|NCT01440374|Novartis Pharmaceuticals|Study Director|862-778-8300||
21254709|NCT00619762|LifeCell|Director of Clinical Operations|908.809.7856|djacobs@lifecell.com|
21254710|NCT04812548|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
21254711|NCT02673151|Stanford University|Andrei Iagaru, Professor of Radiology (Nuclear Medicine)|(650) 725-4711|aiagaru@stanford.edu|
21254712|NCT02141984|AbbVie|Global Medical Services|800-633-9110||
21254713|NCT02482870|Recep Tayyip Erdogan University School of Medicine|Dr. Başar Erdivanlı|+904642130491|berdivanli@gmail.com|2128
21254714|NCT01765192|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21254715|NCT04187053|University of Texas Health Science Center at Houston|Srinivas Ayilavarapu, BDS, DSc, MDS|713-486-4390|srinivas.ayilavarapu@uth.tmc.edu|
21254716|NCT04874415|University of Pittsburgh|Dr. Mary Ellen Vajravelu|412-692-6533|MaryEllen.Vajravelu@pitt.edu|
21254717|NCT00691327|Allergan, Inc.|Medical Monitor|714-246-4500|clinicaltrials@allergan.com|
21254718|NCT05062759|AstraZeneca Clinical Study Information Center|Global Clinical Head|+187724094 79|information.center@astrazeneca.com|
21254719|NCT04981366|University of São Paulo|Prof. Hamilton Roschel|+55 11 30618789|hars@usp.br|
21254720|NCT03214094|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21254721|NCT00310037|University of California, San Francisco|Lawrence D. Kaplan, MD||lkaplan@medicine.ucsf.edu|
21254722|NCT02136420|Massachusetts Eye and Ear Infirmary|Faisal Karmali|617-573-5593|faisal_karmali@meei.harvard.edu|
21254723|NCT00440999|Medicines for Malaria Venture|Stephan Duparc, MD|+41 22 555 0300|duparcs@mmv.org|
21254724|NCT02700945|Medtronic|Carola Alfaro Vives|763-526-1539|carola.alfaro.vives@medtronic.com|
21254725|NCT05559099|National Institute of Allergy and Infectious Diseases|Lori Dodd|2406695247|doddl@niaid.nih.gov|
21254726|NCT04018092|University of Florida - Norman Fixel Brain Institute|Dr. Dawn Bowers|3522220100|dawnbowers@phhp.ufl.edu|
21254727|NCT06469242|Alcon Research, LLC|Sr. Principal, Clinical Project Management, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21237439|NCT04403698|Study Principal Investigator Ghent Universitary Hospital|Prof. dr. Ruth Wittoek|+329 332 25 20|Ruth.Wittoek@Ugent.be|
21237440|NCT00977665|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21237441|NCT00833638|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21237442|NCT00490646|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21237443|NCT02137369|Emory University|Dr. Dunlop|404-727-8969|bdunlop@emory.edu|
21237444|NCT03543254|St. Olavs Hospital HF|Knut Hagen|+4795401579|knut.hagen@ntnu.no|
21237445|NCT02077166|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21237446|NCT03519854|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21237447|NCT01420848|University of São Paulo|Leonice Fumiko Sato Kurebayashi|(5511 991126023)|fumie_ibez@yahoo.com.br|
21237448|NCT02899728|Dana- Farber Cancer Institute|Jacob Sands, MD|617-632-6049|Jacob_Sands@DFCI.HARVARD.EDU|
21237449|NCT03776136|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21237450|NCT03754803|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21237451|NCT04951336|Krupp Center for Integrative Research, University of California San Diego|Gordon Saxe, M.D./Ph.D.|6195435765|gsaxe@health.ucsd.edu|
21237452|NCT04348604|Case Western Reserve University|Joy Yala, Data Manager|216-368-0783|jxy790@case.edu|
21237453|NCT02097108|AGMT|Public contact Daniela Wolkersdorfer|00436626404411|d.wolkersdorfer@agmt.at|
21237454|NCT06675500|Ain Shams University|Dr.Sarah Elghareeb,lecturer of Anesthesia and ICU|+201012434690|Sarahhamdy@med.asu.edu.eg|
21237455|NCT00127608|GlaxoSmithKline|GSK Response Center|866-435-7343||
21237456|NCT05245864|UAMS|Arny A. Ferrando|501-526-5711|AFerrando@uams.edu|
21237457|NCT05520138|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21237458|NCT01475136|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21237459|NCT01323530|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
21237460|NCT01194570|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21237461|NCT04171102|University of Cagliari|Prof. Dr. Giuseppe Amato|337963197|amatomed@gmail.com|
21237462|NCT04918784|Acera Surgical, Inc.|Matthew MacEwan|440-477-1890|macewan@acera-surgical.com|
21237463|NCT01712009|Amgen Inc.|Study Director|866-572-6436||
21237464|NCT01111123|Mount Siani School of Medicine Department of Dermatology|Jason Emer, MD|2122413288|jason.emer@mssm.edu|43288
21237465|NCT04333420|InflaRx GmbH|Prof. Niels C. Riedemann|+49 3641-508-180|niels.Riedemann@inflarx.de|
21237466|NCT00265980|Professor of Pediatrics and Medicine at the Columbia University|Michael Rosenbaum, MD|212-305-9949|mr475@cumc.columbia.edu|
21237467|NCT01203930|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21237468|NCT01835262|Maimonides Medical Center|Antonios Likourezos|718-283-6896|alikourezos@maimonidesmed.org|
21237469|NCT04050865|Ocular Therapeutix|Clinical Project Manager|781-357-4000|clinicalaffairs@ocutx.com|
21237470|NCT01266850|Vanderbilt University Medical Center|Kathryn M. Edwards, MD|615-322-3078|kathryn.edwards@vanderbilt.edu|
21237471|NCT01437124|Wirral NHS Trust|Hussain Kazi|0151 678 6111|hussainkazi@nhs.net|
21237472|NCT02035332|Minerva Surgical, Inc.|Dr. Eugene Skalnyi, VP Medical Affairs|(1) 650-284-3500|eugenes@minervasurgical.com|
21237473|NCT00857207|Malcom Randall VAMC|Julia Kay Waid-Ebbs, Health Science Specialist|352-871-0282|Julia.Waid-Ebbs@va.gov|
21237474|NCT01100255|Stanford University|Dr. Carolyn Rodriguez, Assistant Professor|6507236158|carolynrodriguez@stanford.edu|
21254728|NCT05041101|The University of Texas MD Anderson Cancer Center|Sadia Saleem, MD|(281) 566-1900|ssaleem@mdanderson.org|
21254729|NCT00211185|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21254730|NCT00249002|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21254731|NCT00069108|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21254732|NCT00986674|ECOG Statistical Office|Study Statistician|617-632-3012||
21254733|NCT00842985|Yale University|Mehmet Sofuoglu, M.D., Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
21254734|NCT01037244|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
21254735|NCT01411215|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21254736|NCT04025580|National Institutes of Health|Rachel Sparks|240-292-4642|rachel.sparks@nih.gov|
21254737|NCT02832154|Wake Forest University Health Sciences|Study coordinator|336-713-5061|drlittle@wakehealth.edu|
21254738|NCT03305731|University of Illinois at Chicago|Dr. Emily Kringle|312-996-9665|kringle@uic.edu|
21254739|NCT01952054|UT MD Anderson Cancer Center|Ueno,Naoto,M.D., PH.D. / Breast Medical Oncology|713-792-2817|nueno@mdanderson.org|
21254740|NCT04578574|University of Miami|Eva Widerstrom-Noga, PhD; Roberta Vastano, PhD|305243-7125; 305243-8847|ewiderstrom-noga@med.miami.edu; Rxv331@med.miami.edu|
21254741|NCT01718353|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21254742|NCT01959516|Novartis Pharmaceuticals|Study Director|862-778-8300||
21254743|NCT00455325|Washington University School of Medicine|Janet McGill, MD|(314) 362-8688|jmcgill@wustl.edu|
21254744|NCT01366495|Friends Research Institute|Dr. Michael S. Gordon, Senior Research Scientist|410-837-3977|mgordon@friendsresearch.org|251
21254745|NCT01765465|DongGuk University Ilsan Hospital|Dr. In Woong Han||cardioman76@gmail.com|
21254746|NCT02745392|Zosano Pharma Corporation|Dr. Donald Kellerman|(510) 745-4004|dkellerman@zosanopharma.com|
21254747|NCT00968227|Washington University|Michael Diringer PI|314-362-2999|diringerm@wustl.edu|
21254748|NCT02004353|Cochlear|Jasmin Kaur|+41612058238|jakaur@cochlear.com|
21284703|NCT05822648|Stanford University|Dr. Eric Stice|650-723-7885|estice@stanford.edu|
21237475|NCT03073148|Tangible Science|Director of Research and Development|650-241-1045|kelly@tangiblescience.com|108
21237476|NCT00414817|Kaiser Permanente, Center for Health Research|Dr. William Vollmer, Senior Investigator|503-335-6755||
21254749|NCT01691768|CAPRISA|Nonhlanhla Yende-Zuma|+27 31 260 4392|nonhlanhla.yende@caprisa.org|
21254750|NCT01759368|VTT Technical Research Centre of Finland|Anna-Leena Orsama|+358408485966|anna-leena.orsama@vtt.fi|
21254751|NCT01651442|National Jewish Health|Bryan Simmons|303-398-1850|simmonsb@njhealth.org|
21254752|NCT00336895|UPittsburgh|Dr. Roberto Lopez-Solis|412-647-5173|lopezrc@upmc.edu|
21254753|NCT01959334|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21254754|NCT03362879|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21254755|NCT01768637|University of Arkansas for Medical Sciences|Nishank Jain, MD|5016865295|njain2@uams.edu|
21254756|NCT01007448|Bausch Health Americas, Inc.|Director of Clinical Operations||aloncaric@bauschhealth.com|
21254757|NCT01054170|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21254758|NCT02751320|GlaxoSmithKline|GSK Response Center|866-435-7343||
21254759|NCT02666846|Futura Medical Developments Limited|Director of Clinical Development|01483685683|tim.holland@futuramedical.com|
21254760|NCT01337115|Centro Hospitalar do Porto|Dr Raul Carvalho|+351226176114|raul@meo.pt|
21254761|NCT03386110|Hunter College|Tyrel J. Starks|212-206-7919|tstarks@hunter.cuny.edu|
21254762|NCT02684253|Memorial Sloan Kettering Cancer Center|Dr. Sean McBride, MD, MPH|646-608-2450|mcbrides@mskcc.org|
21254763|NCT02697292|Mayo Clinic|Sean J. Pittock, M.D.|507-2084-4741|Pittock.Sean@mayo.edu|
21254764|NCT03426267|Sun Pharma Advanced Research Company Limited|Head-Clinical Development|912266455645|clinical.trials@sparcmail.com|
21254765|NCT01981772|The Ohio State University College of Dentistry|Sara Fowler|6142923596|fowler.276@osu.edu|
21254766|NCT02094755|University of Southern California|Dr. Leonardo Clavijo|3234426130|lclavijo@usc.edu|
21254767|NCT01001559|Red Oak Psychiatry Associates|Dr. Lawrence Ginsberg|281-893-4111|larrydg@earthlink.net|151
21254768|NCT03801915|National Cancer Institute|Dr. Jonathan Hernandez|240-760-6072|jonathan.hernandez@nih.gov|
21254769|NCT02308020|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|ClinicalTrials.gov@lilly.com|
21254770|NCT01211288|University of Alabama at Birmingham|Dr. Toni Tien Neumeier|205-934-5459|neumeier@uab.edu|
21254771|NCT01270971|Anacor Pharmaceuticals, Inc.|Sheryl Baldwin, RN/Associate Director|650-223-8597|clinicaltrials@anacor.com|
21254772|NCT00001984|NIDDK, NIH|Dr. Alan Kirk||allank@intra.niddk.nih.gov|
21254773|NCT03333837|Wake Forest University School of Medicine|Christina Hugenschmidt, PhD|336-713-8116|chugensc@wakehealth.edu|
21254774|NCT01551212|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21254775|NCT04217590|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astazeneca.com|
21254776|NCT01013285|UCLA Neuro-Oncology Program|Albert Lai|310-825-5321|albertlai@mednet.ucla.edu|
21254777|NCT00704405|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21254778|NCT01395888|GlaxoSmithKline|GSK Response Center|866-435-7343||
21254779|NCT02641496|Veterans Affairs Palo Alto Health Care System|Lisa Kinoshita, Ph.D. (Principal Investigator)|650-493-5000|Lisa.Kinoshita@va.gov|65633
21254780|NCT03035201|Wake Forest University School of Medicine|Mark Espeland, PhD; Multiple Principal Investigator|336-716-2826|mespelan@wakehealth.edu|
21254781|NCT02390050|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
21254782|NCT01522469|Arog Pharmaceuticals|Edward McDonald|214-593-0500|emcdonald@arogpharma.com|
21254783|NCT03727438|Department of Veteran Affairs ADAPT|Jennifer Zervakis|919 286-0411|jennifer.zervakis@va.gov|17 6174
21254784|NCT06729606|University of Minnesota|Shweta Sharma Mistry|612-626-9021|shwetas@ccbr.umn.edu|
21254785|NCT04849507|Medical University of South Carolina|Dr Dorothea Jenkins|843-792-2112|jenkd@musc.edu|
21254786|NCT00235547|University of Washington|Dr. Sarah Prager|415-206-8715|pragers@uw.edu|
21254787|NCT01201343|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21254788|NCT01716117|Stryker Neurovascular|Scott Courts, Clinical Program Manager|5104132170|scott.courts@stryker.com|
21254789|NCT01557283|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21254790|NCT03645057|University of Rochester|Julie Ryan|(585) 276-3862|Julie_Ryan@URMC.Rochester.edu|
21254791|NCT01873495|Emory University|Martha Arellano, MD|404-778-1900|marella@emory.edu|
21254792|NCT02978144|Columbia University|Gebhard Wagener, MD|(212) 305-6494|gw72@cumc.columbia.edu|
21284704|NCT03564795|KeraNetics|Luke Burnett|336.725.0621|lburnett@keranetics.com|
21284705|NCT00770133|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
21284706|NCT00432276|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21284707|NCT00594386|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
21284708|NCT03557684|UCLA|Joshua H. Cho, MD, PhD|3104286218|hjcho@mednet.ucla.edu|
21284709|NCT04459598|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21284710|NCT00422292|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21284711|NCT02243046|Global Research Consultants|Dr. Franklin Garcia-Godoy|954-888-9102|fgarciagodoy@gmail.com|
21284712|NCT02301039|Sarcoma Alliance for Research Through Collaboration|Research Manager|734-930-7600|sarc@sarctrials.org|
21284713|NCT00810498|Philips|Jeff Jasko|412-542-3651|jeff.jasko@philips.com|
21284714|NCT04494425|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21284715|NCT01291264|University of California, San Francisco|Dr. Julius Schachter, Professor of Laboratory Medicine|415 824 5115|julius.schachter@ucsf.edu|
21284716|NCT01270321|Emory University|Dr. Taofeek Owonikoko|404-778-5575|TOWONIK@emory.edu|
21284717|NCT03151083|VA Connecticut Healthcare System|Dr. Eric Hermes|203 932 5711|eric.hermes@va.gov|7422
21254793|NCT04363801|Leap Therapeutics, Inc.|Douglas Onsi / President and CEO|617-218-1116|donsi@leaptx.com|
21254794|NCT03864146|Minneapolis VAHCS|Eric Dieperink, MD|612-467-4010|eric.dieperink@va.gov|
21284718|NCT04003623|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21254795|NCT01112306|Actelion Pharmaceuticals Ltd|Scientific Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21254796|NCT00881608|Repros Therapeutics|Jennifer Wike|2817193402|jwike@reprosrx.com|
21254797|NCT00427336|UT MD Anderson Cancer Center|Paolo Anderlini, MD / Professor||mvpacheco@mdanderson.org|
21254798|NCT02579174|Northwestern University|Melissa Shauver, MPH|312-472-6024|melissa.shauver1@nm.org|
21254799|NCT00655486|UCB, Inc|UCB Clinical Trial Call Center|+1 877 822 9493||
21254800|NCT04218084|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21237477|NCT00361140|Moffitt Cancer Center|Dr. Teresa Field|(813) 745-7202|Teresa.Field@moffitt.org|
21254801|NCT01205152|Alexion Pharmaceuticals, Inc.|Director of Clinical Trials|475-230-2596|ClinicalTrials@alexion.com|
21254802|NCT02783768|CUIMC|Elizabeth C. Oelsner, MD, MPH|212-305-9056|eco7@cumc.columbia.edu|
21254803|NCT01853137|Osama AlAli|Dr.|00963992262582|osama-alali@hotmail.com|
21254804|NCT03401229|AstraZeneca|Maria Jison, MD Global Clinical Head, FASENRA, Late-stage R&I|+13013980340|Maria.Jison@astrazeneca.com|
21254805|NCT05333224|Istanbul Medeniyet University|Ayca Evkaya Acar|+905544263263|ayca.evkaya@gmail.com|
21254806|NCT00585377|Huntsman Cancer Institute|Mark Wade|801-213-5746|mark.wade@hci.utah.edu|
21254807|NCT00848926|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
21254808|NCT04316182|APICES|Juan Luis Sanz (MW)|+34 918166804|juanluis.sanz@apices.es|103
21254809|NCT00966277|University of Texas (UT) MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor, Sarcoma Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
21254810|NCT03339570|Hospital Gregorio Maranon|Dr. Mikel Aburto|34915868000|mikelaburto@hotmail.com|7007
21254811|NCT01127139|Abbott|Global Medical Services|1-800-633-9110||
21254812|NCT01136772|Columbia University|T. Scott Stroup|646-774-8435|stroups@nyspi.columbia.edu|
21254813|NCT01498653|GlaxoSmithKline|GSK Response Center|866-435-7343||
21254814|NCT02388646|OrthoIndy|Dr. Frank Kolisek|3178845160|fkolisek@orthoindy.com|
21254815|NCT03421431|Enanta Pharmaceuticals|Kristin Sanderson|617-607-0775|ksanderson@enanta.com|
21254816|NCT00972205|National Cancer Institute (NCI), National Institutes of Health (NIH)|Susan S. Bates, M.D.|301-402-0984|Batess@mail.nih.gov|
21254817|NCT02216357|Cumberland Pharmaceuticals Inc.|Senior Manger, Clinical Operations|615-255-0068|bkaelin@cumberlandpharma.com|250
21254818|NCT00828841|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
21254819|NCT00141726|University of Michgan Comprehensive Cancer Center|Gregory Yanik, M.D.|734-936-8785|gyanik@umich.edu|
21254820|NCT04147650|Aurinia Pharmaceuticals|Clinical Trial Support|(250) 744-2487|clinicaltrials@auriniapharma.com|
21254821|NCT00235326|McMaster University|John Marshall|9055212100|marshllj@mcmaster.ca|76782
21254822|NCT04409886|Maimonides Medical Center|Gene Sobol|718-283-6000|gsobol@maimonidesmed.org|
21254823|NCT01849822|California Institute of Technology|Dr. Richard Andersen|16263958336|andersen@vis.caltech.edu|
21254824|NCT01477333|United Therapeutics Corp.|Kevin LaLiberte, PharmD|919-425-8176|KLaliberte@unither.com|
21254825|NCT01178671|Research Foundation for Mental Hygiene|Franklin Schneier MD|6467748041|fschneier@nyspi.columbia.edu|
21254826|NCT02435966|Physios & Universidad Europea de Madrid|Gracia M. Gallego, M.Sc.|+34 609036607|gracia.maria.gallego@gmail.com|
21254827|NCT04620811|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
21254828|NCT02501538|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
21254829|NCT01078675|AstraZeneca, R&D, B&I|Niklas Berglind, GPS|+46317766310|niklas.berglind@astrazeneca.com|
21254830|NCT02316366|Nationwide Children's Hospital|Dr. Renee Quarrie, fellow|2037136871|reneepetagae@gmail.com|
21254831|NCT00928746|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21254832|NCT03311334|Sumitomo Pharma America|Mimi M. Lee, MSW, CCRP|617-674-6800|mimi.lee@oncology.sumitomo-pharma.com|
21254833|NCT01804062|Medtronic|Michael Luna-Victoria|303 305 2463|michael.luna-victoria@medtronic.com|
21254834|NCT02513303|Vascular Therapies, Inc.|Rakesh Raghubanshi|9176204369|rakesh@vasculartx.com|
21254835|NCT04129216|Johns Hopkins University|Dr. Mehran Habibi|4105505522|mhabibi2@jhmi.edu|
21254836|NCT02581631|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21254837|NCT04023110|University of Pennsylvania|Bonnie Ky, MD, MSCE|215-573-6606|bonnie.ky@pennmedicine.upenn.edu|
21254838|NCT01191268|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21254839|NCT01313689|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
21254840|NCT02481947|Braintree Laboratories, Inc.|Vice President, Clinical Affairs|781-843-2202|john.mcgowan@sebelapharma.com|
21254841|NCT00551460|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|2066674623|amoseley@fredhutch.org|
21254842|NCT00419666|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
21254843|NCT02027623|Washington University|Linda van Dillen, PT, PhD, FAPTA; Research Division Director|314-286-1427|vandillenl@wustl.edu|
21254844|NCT05007808|Buzzz Pharmaceuticals Limited|Deirdre O'Keefe, PhD, Head of IP and Portfolio Management|+447733104786|deirdre@hotmail.co.uk|
21299635|NCT04851691|University of California Los Angeles, Division of General Internal Medicine and Health Services Research|Project Manager|310-825-8253|cvillaflores@mednet.ucla.edu|
21254845|NCT01886378|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
21254846|NCT01736865|Tufts Medical Center|Dr. Anastassios Pittas|617-636-5694|apittas@tuftsmedicalcenter.org|
21299636|NCT03532542|Sarepta Therapeutics, Inc.|Medical Director|1-888-727-3782|SareptAlly@sarepta.com|
21299637|NCT02795117|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
21299638|NCT02595983|Alnylam Pharmaceuticals Inc|Chief Medical Office|866.330.0326|Clinicaltrials@alnylam.com|
21299639|NCT03550118|University of Washington|Daniel Ballesteros|206-221-5873|danieb25@uw.edu|
21299640|NCT01187017|NIHNHLBI|Bhavisha Patel, MD|301.402.3477|bhavisha.patel@nih.gov|
21254847|NCT02292654|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21254848|NCT01740323|Emory University|Andrew Miller, MD|404-727-8260|amill02@emory.edu|
21254849|NCT02858349|University of Cincinnati|Pierce Boyne|5135587499|Pierce.Boyne@uc.edu|
21254850|NCT02464033|Linkoeping University|Johnny Ludvigsson, MD, PhD, Prof Linkoeping University|+46 13 28 68 54|Johnny.Ludvigsson@liu.se|
21254851|NCT06172881|The Ohio State University College of Optometry|Dr. Jennifer Fogt, OD, MS|614-292-0882|fogt.78@osu.edu|
21254852|NCT03324451|College of Nursing,Kaohsiung Medical University|Ruey-Hsia Wang|886-3-3121101|wrhsia@kmu.edu.tw|2641
21254853|NCT02112708|Institut Català de la Salut|Principal Investigator: Carme Rovira Aler|+34686838979|crovira.bcn.ics@gencat.cat|
21254854|NCT02374671|Refocus Group, Inc.|Director of Regulatory & Quality|214-368-0200|lstewart@refocus-group.com|431
21254855|NCT00903682|Janssen-Cilag EMEA|EMEA Medical Affairs Director Virology|+31 6 542 454 37||
21254856|NCT03169101|University of Pennsylvania|Rebecca Ashare, PhD|7168296273|rlashare@pennmedicine.upenn.edu|
21254857|NCT02250092|University of Minnesota|Bernadette Gillick|612-626-6415|gillick@umn.edu|
21254858|NCT00600886|Novartis Pharmaceuticals|Study Director|862-778-8300||
21254859|NCT01028027|Bausch & Lomb Incorporated|Tuyen Ong, MD|(973) 360-6389|tuyen.ong@bausch.com|
21254860|NCT01321151|UT Southwestern Medical Center|Megan Marks, Ph.D.|214-648-0882|megan.marks@utsouthwestern.edu|
21254861|NCT03801473|Sultan Abdulhamid Han Training and Research Hospital|Tugba Ozsoy|+902165422020|tugbaozsoyy@gmail.com|3876
21254862|NCT00286078|Boston Scientific|Clinical Research Information|855-213-9890|BSNClinicalTrials@bsci.com|
21254863|NCT02572843|Swiss Cancer Institute|Regulatory Affairs|+41 31 389 91 91|regulatory@swisscancerinstitute.ch|
21254864|NCT01078454|ECOG Statistical Office|Study Statistician|617-632-3012||
21254865|NCT05929339|Wake Forest University School of Medicine|James C. Eisenach, MD|336716-4182|jimeisenach@gmail.com|
21254866|NCT03440320|Colorado State University|Dr Arlene Schmid|970-491-7562|arlene.schmid@colostate.edu|
21254867|NCT01912456|CSL Behring GmbH|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
21254868|NCT00185679|Stanford Cancer Institute|Ginna G Laport, MD|650-723-8222|ginna.laport@stanford.edu|13911
21254869|NCT01422226|University of Colorado Denver|Christina Gavito|303-724-5559|christina.gavito@ucdenver.edu|
21254870|NCT00709696|University of Minnesota|Dr. Marc Mooney|612-991-6875|moon0078@umn.edu|
21254871|NCT00001962|NIH National Heart, Lung and Blood Institute|Neal Young MD|301-496-5093|youngns@nhlbi.nih.gov|
21254872|NCT00171704|Novartis Pharmaceuticals|Novartis Pharmaceuticals|862-778-8300||
21254873|NCT00231153|Cadence Pharmaceuticals, Inc.|Catherine Hardalo, MD Vice President Anti-Infectives, Clinical Development|858-436-1439|chardalo@cadencepharm.com|
21254874|NCT00320541|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21254875|NCT03719170|VA Ann Arbor Healthcare System|Dr. Sameer Saini|734-845-3504|sameer.saini@va.gov|
21254876|NCT04281004|University of Utah|Mark Mifflin, MD|801-583-4152|mark.mifflin@hsc.utah.edu|
21254877|NCT00701779|Deaconess Clinic, Inc.|Paul F. Siami, MD CPI|812-426-9576|research.paul.siami@deaconess.com|
21254878|NCT02245672|Mylan Pharma UK Ltd|Dik Ng, PhD|+44-7467-941703|dik.ng@mylan.co.uk|
21254879|NCT01640054|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
21254880|NCT00029172|Roudebush VAMC Center of Excellence|Dr. Linda Williams|317-988-3337|linda.williams6@va.gov|
21254881|NCT01620255|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21254882|NCT01322048|Vanderbilt University Medical Center|Mayur B. Patel|6153225000|mayur.b.patel@vanderbilt.edu|
21254883|NCT01146054|Stanford University Comprehensive Cancer Center|Albert C. Koong, M.D., Ph.D., Sue and Bob McCollum Professor, Associate Chair of Radiation Onocology|650-498-7703|akoong@stanford.edu|
21254884|NCT01155375|AMAG Pharmaceuticals, Inc.|Medical Information|+1-877-411-2510|amag@druginfo.com|
21254885|NCT04335812|Lamar University|Dr. Vinaya Manchaiah, Jo Mayo Endowed Professor|(409) 812 9443|vmanchaiah@lamar.edu|
21254886|NCT02901041|Boston University|Dr. Todd Farchione|(617) 353-9610|tfarchio@bu.edu|
21254887|NCT03890419|Duke University|Padma Gulur|919-681-4660|padma.gulur@duke.edu|
21254888|NCT00975507|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21254889|NCT03818204|VA Central Western Massachusetts|Kevin Houston|781-588-7674|kevin.houston2@va.gov|
21254890|NCT00887250|Merck & Co., Inc.|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
21254891|NCT05754333|Astellas Pharma Global Development, Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
21254892|NCT00605644|Bausch Health|Study Director||susan.harris@bauschhealth.com|
21254893|NCT02959450|INCMNSZ|Dr. Aurora Serralde|+52-55-54870900|aurora.serraldez@incmnsz.mx|2193
21254894|NCT02070588|GE Healthcare|Chief Medical Officer - Head Health Initiative|262-544-3633|Victor.Miranda@ge.com|
21254895|NCT00819390|ACTG Network Coordinating Center, Social and Scientific Systems|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21254896|NCT01209780|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21254897|NCT02709096|BioPharmX, Inc.|AnnaMarie Daniels|310-701-2080|amdaniels@biopharmx.com|
21254898|NCT00818649|Masonic Cancer Center, University of Minnesota|Erica Warlick, M.D.|612-625-5467|ewarlick@umn.edu|
21254899|NCT00505284|Eisai Call Center|Eisai Inc.|888-422-4743||
21254900|NCT03513588|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21254901|NCT01275131|Halozyme Therapeutics, Inc|Vice President, Endocrinology Clinical Development|(858)794-8889||
21254902|NCT01911065|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
21254903|NCT00953745|Washington University School of Medicine|Dr. Charles R. Conway, MD|314-362-7566|conwayc@psychiatry.wustl.edu|
21254904|NCT03063125|University of Kansas Medical Center|Katie Glavin|913-588-8721|kglavin@kumc.edu|
21254905|NCT03075410|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21254906|NCT02053792|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
21254907|NCT01427751|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
21254908|NCT02775695|Froedtert and the Medical College of Wisconsin|Susan Tsai, MD|414-805-9720|stsai@mcw.edu|
21254909|NCT04546789|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21254910|NCT03430206|Stanford University|Thomas Caruso, MD, MEd|(626) 275-0341|tjcaruso@stanford.edu|
21254911|NCT00368992|SWOG|Lung Committee Statistician|206-667-4623||
21254912|NCT00790751|Vivus, Inc|Wesley W Day PhD|650-934-5200||
21254913|NCT02427464|Helixmith Co., Ltd.|Jinsub Lee, PhD|+82-10-8256-0439|jinsub.lee@helixmith.com|
21254914|NCT04016558|University of California, San Francisco|Danielle Hessler|415-476-6196|danielle.hessler@ucsf.edu|
21254915|NCT05330312|Vicore Pharma|Director Clinical Operations|+46317880560|info@vicorepharma.com|
21254916|NCT04118374|Vanderbilt University Medical Center|Justin M Gregory, MD, MSCI|(615) 322- 7427|metabolism@vumc.org|
21254917|NCT00557947|Ethicon Inc|John Lombard|908-218-2877|Jlombar8@its.jnj.com|
21254918|NCT05227703|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21254919|NCT05849103|Vanderbilt University Medical Center|Sarah Osmundson, MD, MS|6158752231|sarah.osmundson@vumc.org|
21254920|NCT03756129|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21254921|NCT03373201|Vanda Pharmaceuticals|Medical Director|202-734-3400|clinicaltrials@vandapharma.com|
21254922|NCT03464097|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21254923|NCT05572021|Atrium Health|Greg Scarola, MS, MBA|704-355-5766|Gregory.Scarola@advocatehealth.org|
21254924|NCT03432260|DURECT Corporation|Director of Regulatory Affairs|408-777-1418|jill.burns@durect.com|
21254925|NCT02186847|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21254926|NCT03319849|Neurotech Pharmaceuticals, LLC|CMO|401-333-3880|neurotech@neurotechusa.com|
21254927|NCT00112047|Gilead Sciences|Dara Wambach MA, Associate Director, Regulatory Affairs|650-522-5163|dara.wambach@gilead.com|
21254928|NCT01307579|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21254929|NCT05370521|Spruce Biosciences|Chief Medical Officer|415-655-4169|clinicaltrials@sprucebio.com|
21254930|NCT03170349|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
21254931|NCT02491632|UT MD Anderson Cancer Center|Sriram Yennu,MD- Professor, Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
21254932|NCT03938545|Immunovant, Inc|Central Study Contact|1-800-797-0414|clinicaltrials@immunovant.com|
21254933|NCT01060540|Durham VA Medical Center|Corrine Voils, PhD|919-286-0411|corrine.voils@va.gov|5196
21254934|NCT04262947|Lahey Hospital and Medical Center|Thomas Schnelldorfer|781-744-5100|thomas.schnelldorfer@lahey.org|
21254935|NCT01222507|Washington University|Dr. Jay Piccirillo|314-362-7508|piccirilloj@ent.wustl.edu|
21254936|NCT02647320|Daiichi Sankyo|Daiichi Sankyo Contact for Clinical Trial Information|+81-3-6225-1111(M-F 9-5 JST)|dsclinicaltrial@daiichisankyo.co.jp|
21254937|NCT00596427|Kinemed, Inc|Carine Beysen, PhD|5106556525|cbeysen@kinemed.com|123
21254938|NCT01605292|Long Beach VA Medical Center|Arnold Seto, MD, MPA|(562) 826-8000|arnold.seto@va.gov|5486
21254939|NCT03836989|Oregon Health and Science University|Dr. Myriam Loyo|503-494-8510|loyo@ohsu.edu|
21254940|NCT02401867|Fenway Community Health|Sari Reisner, ScD|617-927-6017|sari.reisner@childrens.harvard.edu|
21254941|NCT01650246|Ardea Biosciences, Inc.|Maple Fung, MD|1-858-652-6721|mfung@ardeabio.com|
21254942|NCT00081770|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21254943|NCT02268474|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
21254944|NCT03435497|RAND Corporation|Laura Bogart, PhD|3103930411|lbogart@rand.org|7281
21254945|NCT02315352|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21254946|NCT01614197|Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL)|Roy Leong|323-361-5132|rleong@chla.usc.edu|
21254947|NCT01824160|Johns Hopkins University|RICHARD RINGEL|410-714-6745|rringel@jhmi.edu|
21254948|NCT03628898|Masimo Corporation|Chelsea Frank|949-297-7000|studies@masimo.com|
21254949|NCT03442985|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
21254950|NCT00362453|Tufts Medical Center|Chenchen Wang, MD, MSc, Associate Professor|617-636-3251|cwang2@tuftsmedicalcenter.org|
21254951|NCT01217957|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
21254952|NCT00971932|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21254953|NCT03077360|"University of Colorado Denver | Anschutz"|Bryan Bergman|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
21254954|NCT01206777|The Ohio State University Comprehensive Cancer Center|Jeffrey Jones, MD|614-688-7942|Jeffrey.Jones@osumc.edu|
21254955|NCT04344600|Johns Hopkins School of Medicine|Mark Sulkowski|410-955-7538|msulkowski@jhmi.edu|
21254956|NCT01535014|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical Research and Medical Information Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
21254957|NCT05398016|University of Nevada Las Vegas|Dr. Brenna Renn, PI|7028950569|brenna.renn@unlv.edu|
21284719|NCT02918097|Universidade Federal do Rio Grande do Sul|D.r. Ana Flávia Barros da Silva Lima|5551999185180|afbslima@gmail.com.br|
21284720|NCT04640038|Children's Hospital of Philadelphia|Misun Hwang|267-425-7129|hwangm@chop.edu|
21284721|NCT01190189|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21284722|NCT00904917|Children's Hospital of Philadelphia|Rhonda C. Boyd, Ph.D.|215-590-3945|boydr@email.chop.edu|
21284723|NCT02442206|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21284724|NCT01471444|University of Texas MD Anderson Cancer Center|Richard Champlin, MD / Stem Cell Transplantation|713-792-3618|rchampli@mdanderson.org|
21284725|NCT01225926|Alcon Research, Ltd.|Manoj Venkiteshwar, Brand Lead, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
21284726|NCT03972501|Azura Ophthalmics|Charles Bosworth|17145598435|charles.bosworth@azuraophthalmics.com|
21284727|NCT01709409|OHRI|Dr. Brigitte Lemyre|613-737-8899|blemyre@toh.on.ca|71882
21284728|NCT02412878|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21284729|NCT02190721|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|USMedInfo@tevapharm.com|
21284730|NCT05025332|Neuren Pharmaceuticals|Chief Medical Officer|+61 (3) 9092 0480|MedicalInformation@neurenpharma.com|
21284731|NCT04676152|Masimo Corporation|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
21284732|NCT01928199|Washington University in St. Louis|Rowena Delos Santos|314-362-8351|delossantos@wustl.edu|
21284733|NCT00755261|SKCCC, Johns Hopkins University|Christian Meyer, M.D., Ph.D.|4105025940|cmeyer13@jhmi.edu|
21284734|NCT02107313|Prana Biotechnology|Dr Caroline Herd|+61393494906|info@pranabio.com|
21237478|NCT01791725|Transition Therapeutics Ireland Limited|Aleksandra Pastrak,MD, PhD, VP of Clinical Development and Medical Officer|+1 416 263 1227|apastrak@transitiontherapeutics.com|
21254958|NCT00824161|The University of Texas M.D. Anderson Cancer Center|Scott Kopetz, MD|713-792-2828||
21254959|NCT04754477|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
21254960|NCT00655863|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21254961|NCT05093699|Mayo Clinic|Dr Robert Anderson|507-284-4341|anderson.robert2@mayo.edu|
21254962|NCT01990209|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
21254963|NCT02203695|Johns Hopkins University, School of Medicine|Dr. Daniel Song|410-502-5875|dsong2@jh.edu|
21254964|NCT01122862|GlaxoSmithKline|GSK Response Center|866-435-7343||
21254965|NCT00846391|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21254966|NCT04040400|University of Louisville Brown Cancer Center|Shiao Woo, MD Principal Investigator|502-562-4360|shiao.woo@louisville.edu|
21254967|NCT01790126|Janssen Research & Development, LLC|EXECUTIVE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21254968|NCT02955147|Mass General Hospital|Dr. Sebastian Unizony|(617) 726-7938|sunizony@mgh.harvard.edu|
21254969|NCT00527592|Alcon Research, Ltd.|Director of Medical Affairs|1-800-862-5266|medinfo@alconlabs.com|
21254970|NCT01636960|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21254971|NCT01580969|Huntsman Cancer Institute|Josiah Hawks|801-585-0601|Josiah.Hawks@hci.utah.edu|
21254972|NCT01745848|University of Pittsburgh|Dr. Jessica Bon Field|412-648-6494|bonjm@upmc.edu|
21254973|NCT03463161|University of Chicago|Theodore Karrison, PhD|(773) 702-9326|tkarrison@health.bsd.uchicago.edu|
21254974|NCT01105754|University of Rochester|Dr. Jill Halterman|585-275-5798|jill_halterman@urmc.rochester.edu|
21254975|NCT06338462|Yale School of Public Health|Dr. J. Lucian Davis|203-785-3665|lucian.davis@yale.edu|
21254976|NCT00390182|University of Maryland Baltimore|Nancy Kennedy|410-328-2513|nkennedy@umm.edu|
21254977|NCT02791945|University of California, San Francisco/San Francisco VA Healthcare System|Dr. Steven L. Batki, MD|415-221-4810|steven.batki@ucsf.edu|23671
21254978|NCT01001832|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21254979|NCT02453360|University of Wisconsin School of Medicine|Kristopher Schroeder|608-263-8100|kmschro1@wisc.edu|
21254980|NCT02594826|Fox Chase Cancer Center|Dr. Carolyn Fang|1-888-369-2427|carolyn.fang@fccc.edu|
21254981|NCT03527238|University of Florida|Ali Zarrinpar|352-265-0606|ali.zarrinpar@surgery.ufl.edu|
21254982|NCT01427595|University of Virginia Center for Research in Reproduction|Dr. Christine Burt Solorzano|4342436911|pcos@virginia.edu|
21254983|NCT03581825|Johnson & Johnson Vision Care|Thomas R. Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|904-443-3402|TKarkkai@its.jnj.com|
21254984|NCT00979810|Memorial Sloan Kettering Cancer Center|Michelle Bradbury, MD, PhD|646-888-3373|bradburm@mskcc.org|
21254985|NCT03110185|Washington University School of Medicine Department of Anesthesiology|Dr. Ben Palanca|314-273-9076|palancab@wustl.edu|
21254986|NCT04877730|University of Virginia|Sue Brown|434-982-0602|sab2f@virginia.edu|
21254987|NCT03804502|Sight Sciences, Inc.|VP, Medical and Clinical Affairs|1-877-266-1144|jdickerson@sightsciences.com|
21254988|NCT04737187|Taiho Oncology, Inc.|Taiho|+1-844-878-2446|medicalinformation@taihooncology.com|
21254989|NCT00345293|Rockefeller University|Mayu Frank, MS, ANP, Clinical Research Nurse Practitioner|212-327-7443|frankm@rockefeller.edu|
21254990|NCT02871258|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
21254991|NCT04873232|Helixmith, Co., LTD|Jinsub Lee, PhD|+82-10-8256-0439|jinsub.lee@helixmith.com|
21254992|NCT01340196|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21254993|NCT03660553|The Lundquist Research Institute|Rajesh Garg|310-222-1968|rajesh.garg@lundquist.org|
21254994|NCT01709747|CTI Clinical Trial and Consulting Services|Heather Kapushoc, Sr. Biostatistician|571-315-2574|hkapushoc@ctifacts.com|
21254995|NCT04109196|Rush University Medical Center|Dr. Philip Held|312-942-1423|philip_held@rush.edu|
21254996|NCT00604279|Xian-Janssen Pharmaceutical Ltd|Local Trial Manager|86-10-5821 8213||
21254997|NCT00355056|St. Jude Medical|Director, Global Clinical Affairs|818-493-3648|aoza@sjm.com|
21299641|NCT00772538|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21254998|NCT00816400|MedImmune|A Dose-escalation Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-575|1-877-240-9479|information.center@astrazeneca.com|
21299642|NCT00001832|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
21254999|NCT02884427|Universidad Andrés Bello|Professor Hernán Andrés de la Barra O., DC,PT,Mg|56226618402|quiropraxiayequilibrio@gmail.com|
21255000|NCT01072877|BTG International Inc|David Wright MB FRCS|610-278-1660|david.wright@btgplc.com|
21299643|NCT00713609|GlaxoSmithKline|GSK Response Center|866-435-7343||
21255001|NCT00601419|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21299644|NCT04529083|VA North Texas Health Care System|Dr. James Le Page|214-857-1437|james.lepage@va.gov|
21299645|NCT00060528|National Cancer Instititute (NCI), National Institutes of Health (NIH)|James L. Gulley, M.D.|301-435-2956|gulleyj@mail.nih.gov|
21299646|NCT04196686|Lucile Packard Children's Hospital Stanford|Samuel Rodriguez, MD|(650)723-6412|sr1@stanford.edu|
21255002|NCT01786174|Massachusetts General Hospital|James D. Berry, MD, MPH|617-726-5097|jdberry@mgh.harvard.edu|
21255003|NCT00995020|Affiliation: Oswaldo Cruz Foundation|Investigator: MJCamargo [Camargo Maria José] Official Title: PHD|00552199777009|mariaj.camargo@hotmail.com|
21255004|NCT04878731|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21255005|NCT01097785|University of Missouri|Paul Fadel|1-573-884-5220|fadelp@health.missouri.edu|
21299647|NCT03780452|UAB Department of Orthopaedic Surgery|Dr. Ashish Shah|(205) 930-8339|ashishshah@uabmc.edu|
21255006|NCT02730988|Wake Forest University|Kristen Beavers|3367585855|beaverkm@wfu.edu|
21255007|NCT00876694|Novartis Pharmaceuticals|Study Director|862-778-8300||
21255008|NCT00288509|Ipsen|Senior Director, Medical Development, Neurology||clinical.trials@ipsen.com|
21255009|NCT02382016|Actelion Pharmaceuticals Ltd.|Clinical Trial Disclosure Desk|+41 61 565 6565|clinical-trials-disclosure@its.jnj.com|
21255010|NCT00084266|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21255011|NCT00730171|Ironwood Pharmaceuticals, Inc.|Michael Hall, MD|(617) 621-7722||
21255012|NCT01215422|UNIVERSITY OF ALBERTA|DR. JOAN ROBINSON|780-248-5540|jr3@ualberta.ca|
21255013|NCT01729156|Department of Nuclear Medicine & PET Centre, Aarhus University Hospital|Lars C. Gormsen, Consultant|004578456260|lars.christian.gormsen@clin.au.dk|
21255014|NCT03607539|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+8613382419112|jessica.yi@innoventbio.com|
21255015|NCT02047643|Stanford University|Bruce Buckingham, M.D.|408-356-0911|buckingham@stanford.edu|
21255016|NCT01386788|EKoch|Ernst Koch|++49 6257 1788|Ernst.MW.Koch@t-online.de|
21255017|NCT04256603|MetroHealth|c. kim|216 778 7800|ckim3@metrohealth.com|
21255018|NCT00462865|BrUOG|Bachir Sakr, MD|4018633000|kayla_rosati@brown.edu|
21299648|NCT04701814|Pharos university in Alexandria|P.T Moataz Abdelaal|1060081213|moataz.abd.student@pua.edu.eg|+20
21255019|NCT02120625|Nimbus Concepts, LLC|J. Scott Bainbridge, MD (PI)|303-522-5219|jscottbainbridge@gmail.com|
21255020|NCT00120406|Cook|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|765-463-7537|ssnyder@medinst.com|
21255021|NCT06336603|Regulatory Affairs|Head|9122 66455645|Clinical.Trial@sunpharma.com|
21255022|NCT02113241|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
21255023|NCT00388453|Vanderbilt University|Michael Vaezi, MD, PhD|615.322.3739|michael.vaezi@vanderbilt.edu|
21255024|NCT00762970|Vistakon USA|XU CHENG, PRINCIPAL CLINICAL SCIENTIST|1 904 443-1245|xcheng6@its.jnj.com|
21255025|NCT01295034|Icahn School of Medicine at Mount Sinai|Andrea D. Branch PhD|212 659 8371|andrea.branch@mssm.edu|
21255026|NCT00879762|Saint Louis University Medical Center|Sharon E. Frey, M.D.|315-977-5500|sharon.frey@health.slu.edu|
21255027|NCT03008707|University of Pusa|Dario Tartaglia|+393334491229|dario261184@gmail.com|
21255028|NCT01115660|Wake Forest School of Medicine|Dr. Cheryl Bushnell|(336) 716-2357|cbushnel@wakehealth.edu|
21255029|NCT01313637|GlaxoSmithKline|GSK Response Center|866-435-7343||
21255030|NCT01274585|Massachusetts General Hospital|Does Percutaneous Tibial Nerve Stimulation (PTNS) Improve Outcomes in Patients|617-643-0541|lsavitt@partners.org|
21255031|NCT00676065|Center for Epidemiology and Health Research Germany|Juergen Dinger, MD, PhD|+49 30 945 101 20|dinger@zeg-berlin.de|
21255032|NCT00795951|Rady Children's Hospital, San Diego, CA|SE Jacob, MD and L Eichenfield, MD|858-576-1700|leichenfield@rchsd.org|4825
21255033|NCT04572841|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21255034|NCT05103228|Dunamenti REK IVF Center (former Kaali Institute)|Dr Peter Kovacs|+3612022802|peterkovacs1970@hotmail.com|
21255035|NCT01323647|GlaxoSmithKline|GSK Response Center|866-435-7343||
21255036|NCT00712673|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21255037|NCT01774110|University of Texas Southwestern Medical Center|Karen McCain, PT, DPT, NCS, Principal Investigator|214-648-1559|karen.mccain@utsouthwestern.edu|
21255038|NCT00640016|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com|
21255039|NCT01222273|Children's Hospital of Pittsburgh of UPMC|Joseph M. Pilewski, MD|(412) 692-2164|pilewskijm@upmc.edu|
21255040|NCT02924064|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please e-mail|cti-inq-ml@ml.mt-pharma.co.jp|
21255041|NCT02699983|Rutgers Robert Wood Johnson Medical School|Jeanne Ferrante|848-932-5252|jeanne.ferrante@rutgers.edu|
21255042|NCT03575143|University of California San Diego|Robert L. Owens, MD|8586575258|rowens@health.ucsd.edu|
21255043|NCT02566265|Yale University School of Medicine|Andrew Branagan, MD|617-459-5234|andrew.branagan@yale.edu|
21255044|NCT00261846|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21255045|NCT02294227|Novartis Pharmaceuticals|Clinical Disclosure Office|+1 (862) 778-8300|Novartis.email@novartis.com|
21255046|NCT02145247|UCSDMED|R. Jeffrey Chang|858-534-8930|rjchang@ucsd.edu|
21255047|NCT00887432|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kris.Attwood@roswellpark.org|
21255048|NCT00899548|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Antonio C. Wolff, M.D.|410-614-4192|awolff@jhmi.edu|
21255049|NCT02269332|Mike O'Callaghan Military Medical Center|Senior Research Associate/Research Manager|7026533583|amanda.j.crawford.ctr@health.mil|
21255050|NCT00610467|University of California Irvine|Professor|949-824-6001|msu@uci.edu|
21255051|NCT04781387|Crestone, Inc.|Vice President, Clinical Development|(609) 900-5733|lboccumini@crestonepharma.com|
21255052|NCT00679627|Johnson & Johnson Pharmaceutical Research & Development|Director, Clinical Research|1 609-730-7674||
21255053|NCT00448123|William Beaumont Hospital|Robert Swor, DO|248-89-81970|raswor@beaumont.edu|
21255054|NCT02318797|University of Pittsburgh Department of Psychiatry|Charles Reynolds, MD|412-246-6414|reynoldscf@upmc.edu|
21255055|NCT00645047|University of California San Diego|Zia Agha|858-552-8585|zagha@ucsd.edu|
21255056|NCT02656160|Brigham and women's Hospital|Andrew Wellman, MD, PhD||awellman@rics.bwh.harvard.edu|
21284735|NCT02830074|John D. Dingell VA Medical Center|Dr. M.Safwan Badr, MD, Ph.D.|3135763548|m.badr@va.gov|
21299649|NCT01292486|Terumo BCT|Jerome R Bill, M.D.|303-231-4729|jerry.bill@terumobct.com|
21299650|NCT00087152|SWOG|Lead Statistician - Breast Cancer Committee|(206) 839-1761|williamb@crab.org|
21299651|NCT04369404|Massachusetts General Hospital|Karen Sepucha, PhD|617-724-3350|ksepucha@mgh.harvard.edu|
21299652|NCT03130738|Hill Dermaceuticals, Inc.|Rosario G Ramirez, MD|407-323-1887|nini.ramirez@hillderm.com|
21299653|NCT01995708|Memorial Sloan Kettering Cancer Center|Dr. David Chung, MD, PhD|646-608-3770|ChungD1@MSKCC.ORG|
21299654|NCT00265564|Office of Mental Health Operation, Veterans Health Administration|Jodie Trafton, Director Program Evaluation and Resource Center|650-493-5000|Jodie.Trafton@va.gov|22474
21299655|NCT03043534|WakeForest|Dr Amy McMichael|336-716-3775|amcmicha@wakehealth.edu|
21299656|NCT00119847|Stony Brook University|Dr. Eric J. Rashba|631-444-3575|eric.rashba@stonybrookmedicine.edu|
21299657|NCT01553084|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|6082627563|sss@ctri.wisc.edu|
21299658|NCT04698343|Noctrix Health, Inc.|Jonathan Charlesworth, PhD|804-683-4279|jcharlesworth@noctrixhealth.com|
21299659|NCT05139680|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21299660|NCT03581279|MDC Associates, Inc.|Manager, Regulatory and Clinical Affairs|9787055012|t2@mdcassoc.com|
21299661|NCT02756338|BIOTRONIK, Inc.|Crystal Miller|800-547-0394|crystal.miller@biotronik.com|
21299662|NCT04309110|Firstkind Ltd|Dr Kieron Day|+44 (0) 1494 572040|kieron.day@firstkindmedical.com|
21299663|NCT01339689|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
21299664|NCT01046565|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
21299665|NCT03740048|Wake Health|Dr Zhidong Lin|3367138720|zlin@wakehealth.edu|
21299666|NCT01069484|Norwegian School of Sport Sciences, Department of Sports Medicine, Oslo, Norway|Dr. Gunvor Hilde|+47 41366045|gunvor.hilde@gmail.com|
21284736|NCT01031004|Vistakon|John Buch/Principal Research Optometrist|904-443-1707||
21284737|NCT01641471|Cleveland Clinic - Section of Adult Reconstrution|Research Program Manager|216-444-4954|klikaa@ccf.org|
21284738|NCT04575584|Merck Sharp & Dohme, LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21284739|NCT02634801|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21284740|NCT00940576|University of Jena, Institute of Nutrition, Department of Nutritional Physiology Jena, Thuringia, Germany|Gerhard Jahreis, Prof. Dr.|+(49)3641/949610|gerhard.jahreis@uni-jena.de|
21284741|NCT04392219|Ridgeback Biotherapeutics|Dr. Wendy Painter|786-687-2495|EIDD2801@ridgebackbio.com|
21284742|NCT01548768|Columbia University Irving Medical Center|Dr. Joan Bathon, MD|212-305-6327|jmb2311@cumc.columbia.edu|
21284743|NCT02784288|University of Michigan|Paul Swiecicki|734-647-1017|pswiecic@med.umich.edu|
21284744|NCT02757625|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21284745|NCT00645671|Bausch & Lomb|Dr. Tuyen Ong|(973) 360-6389|Tuyen.Ong@bausch.com|
21284746|NCT05600036|Alumis Inc.|SVP, Development Operations|(650) 231-6625|clinicaltrials@alumis.com|
21284747|NCT04401202|King Abdulaziz University|Dr. Abdulrahman Koshak|0543292333|aekoshak@kau.edu.sa|
21284748|NCT03491397|University of California Los Angeles|Siddharth A. Padia, MD|310-825-2992|SPadia@mednet.ucla.edu|
21284749|NCT02714036|MEDICINOVA, INC|Director, Research and Development|858-373-1500|clinicaltrialinfo@medicinova.com|
21284750|NCT01006590|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21284751|NCT03332095|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
21284752|NCT05697627|University of Michigan|Hannah Becker|(734) 764-2580|hcbecker@umich.edu|
21284753|NCT00895934|Fred Hutchinson Cancer Research Center|Roland B. Walter, MD, PhD|206-667-3599|rwalter@fhcrc.org|
21284754|NCT02343380|University of Turin|Dr Simona Bo|0039116335543|simona.bo@unito.it|5541
21284755|NCT02700698|University of Arkansas for Medical Sciences; Arkansas Children's Research Institute|Elisabet Borsheim, PhD|501-364-3053|EBorsheim@uams.edu|
21284756|NCT00703118|Tibotec|Medical Leader|1 609 730-3174||
21284757|NCT02867202|the 1st affiliated hospital of Wenzhou Medical University.|the 1st affiliated hospital of Wenzhou Medical University.|0886-0577-88069525|zfy983023@hotmail.com|
21284758|NCT03743402|University of Washington|Dr. Mark Sullivan|2066853184|sullimar@uw.edu|
21284759|NCT02540161|Duke University Medical Center|Principal Investigator|9196845301|dukebrain1@duke.edu|
21284760|NCT04527978|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21284761|NCT00055497|Abbott|Global Medical Services|800-633-9110||
21284762|NCT00048165|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21284763|NCT00731731|Mayo Clinic|Evanthia Galanis, M.D.||galanis.evanthia@mayo.edu|
21284764|NCT03780972|ONL Therapeutics|Director of Clinical Operations|(734) 412-8787|info@onltherapeutics.com|
21284765|NCT03973697|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
21284766|NCT01490697|Massachusetts General Hospital|Roger K. Pitman, MD|617-726-5333|roger_pitman@hms.harvard.edu|
21284767|NCT00379808|University of Florida|Dr Julie Johnson, PI|352-273-6007|johnson@cop.ufl.edu|
21284768|NCT04779606|Sintetica SA|Dr.Elisabetta Donati, Corporate Director Scientific Affairs|+41.91.640.42.50|edonati@sintetica.com|
21284769|NCT03725033|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
21284770|NCT03742258|Northwestern University|Dr. Reem Karmali, MD|(312) 695-0711|reem.karmali@northwestern.edu|
21284771|NCT01380691|Eli Lilly Company|Chief Medical Officer|800-545-5979||
21284772|NCT01952080|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21284773|NCT01782352|Brigham and Women's Hospital; 900 Commonwealth Ave, 3rd fl.; Boston, MA 02215|VITAL Study Director|1-800-388-3963|vitalstudy@partners.org|
21284774|NCT01333956|Hospital for Special Surgery|Dr. Jacques YaDeau|212-606-1206|yadeauj@hss.edu|
21284775|NCT02134353|Pharmaxis|Dr Brett Charlton|+61 2 9454 7200|Brett.Charlton@pharmaxis.com.au|210
21284776|NCT00477607|VA RR&D National Center for Rehbilitative Auditory Research|Dawn Konrad-Martin|503-220-8262|dawn.martin@va.gov|52962
21284777|NCT01732471|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21284778|NCT01953432|Michael E. DeBakey VA Medical Center|Daryl Shorter, MD|713-798-4870|shorter@bcm.edu|
21284779|NCT00474786|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21284780|NCT02892513|Medical College of Wisconsin|Carrie Y. Peterson, MD, MS|414-955-5783|cypeterson@mcw.edu|
21284781|NCT03426436|North Shore University Hospital|Director of Clinical Research for Emergency Medicine|(516) 562-1513|TLi2@northwell.edu|
21284782|NCT04776018|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21284783|NCT03260426|Cedars Sinai Medical Center|Phillip Fleshner, MD|310-289-9224|pfleshner@aol.com|
21284784|NCT00386425|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21284785|NCT02440854|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21284786|NCT03525808|Boston Scientific|Ornela Gjata|(508)-683-4155|Ornela.Gjata@bsci.com|
21284787|NCT01108237|DePuy Orthopaedics, Inc.|Sam Himden|574-372-7231|SHimden@its.jnj.com|
21284788|NCT01681095|William Beaumont Hospital|Marc P. Sakwa, M.D.|248/898-0123|marc.sakwa@beaumont.org|
21284789|NCT02178358|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
21284790|NCT03297021|Icahn School of Medicine at Mount Sinai|Dr. Daniel Katz|212-241-7475|Daniel.Katz@mountsinai.org|
21284791|NCT02734862|Cidara Therapeutics, Inc.|Taylor Sandison, M.D., MPH|858-888-7868|clinicaltrialinfo@cidara.com|
21284792|NCT02095197|Northwestern University, Feinberg School of Medicine|David Walega, MD|312-695-2500|d-walega@northwestern.edu|
21284793|NCT00493311|Mallinckrodt Pharmaceuticals|Lawrence Hill|(908) 238-6370|lawrence.hill@mallinckrodt.com|
21284794|NCT02779075|Mayo Clinic|Adrian Vella|507-202-8490|vella.adrian@mayo.edu|
21284795|NCT00790556|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21284796|NCT03247322|Medical University of South Carolina|David Taber, PharmD, MS|843-792-3368|taberd@musc.edu|
21284797|NCT01005901|Novartis Pharmaceuticals|Study Director|862-778-8300||
21284798|NCT00957424|Roswell Park Cancer Institute|Richard O'Connor|716-845-4517|richard.oconnor@roswellpark.org|
21284799|NCT01038752|Optimum Therapeutics|Dr. M. Guillaume Wientjes||gwientjes@optimumtx.com|
21284800|NCT02053259|Arizona State University|Dr. Marc Adams|602-827-2470|marc.adams@asu.edu|
21284801|NCT00591019|University of Arkansas for Medical Sciences (UAMS)|Dr John Dornhoffer|501 686-5140|dornhofferjohnl@uams.edu|
21284802|NCT04165135|Hoffmann-La Roche|Medical Communications|800 821 8590|genentech@druginfo.com|
21284803|NCT03714776|Ionis Pharmaceuticals, Inc|Ionis Pharmaceuticals, Inc|800-679-4747|patients@ionisph.com|
21284804|NCT00915603|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21284805|NCT00423358|University of Wisconsin|Karen E Hansen, MD, MS|608-263-3457|keh@medicine.wisc.edu|
21284806|NCT05053035|Alector|Alector Medical Information|650-826-2454|medinfo@alector.com|
21284807|NCT00438256|Massachusetts General Hospital|Theodore Hong, MD|617-724-1159|TSHONG1@mgh.harvard.edu|
21284808|NCT02005627|Imperial College London|Stephen R Durham|+44207-351-8024|s.durham@imperial.ac.uk|
21284809|NCT04000360|The Cleveland Clinic Foundation|Dr. Jay L. Alberts|440-708-3735|albertj@ccf.org|
21284810|NCT02865811|Dana-Farber Cancer Institute|Dr. Ursula Matulonis|617-632-2334|ursula_matulonis@dfci.harvard.edu|
21284811|NCT03014622|Revance Therapeutics, Inc.|Todd Gross, PhD, VP Data Science, Interim Head of Clinical Development|510-742-3400|tgross@revance.com|
21284812|NCT00938587|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21284813|NCT00849290|Dendreon Corporation|Director, Clinical Operations|206-455-2476|clinical@dendreon.com|
21284814|NCT01178814|Columbia University Irving Medical Center|Mark Heaney, MD|646-317-5199|mlh2192@cumc.columbia.edu|
21284815|NCT01687387|Innate Pharma|Director Clinical Operations|+33043030|info@innate-pharma.fr|30
21255057|NCT00815685|H. Lee Moffitt Cancer Center and Research Institute|Nagi Kumar, Ph.D., via Moffitt Cancer Center|813-745-6885|nagi.kumar@moffitt.org|
21255058|NCT01079741|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu|
21284816|NCT03838510|San Francisco Department of Public Health, University fo California San Francisco|Phillip Coffin, MD, MIA|628-217-6282|phillip.coffin@sfdph.org|
21255059|NCT00511472|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21255060|NCT00446992|University of Nevada School of Medicine|Dr. Brian Kirkpatrick|775-682-8459|bkirkpatrick@medicine.nevada.edu|
21255061|NCT00406653|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21255062|NCT00940108|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
21255063|NCT01668667|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
21255064|NCT04576455|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21255065|NCT03143816|Barbara Davis Center for Diabetes, University of Colorado|Satish Garg MD|3037246713|satish.garg@ucdenver.edu|
21255066|NCT03045068|The University of Texas Health Science Center at Houston|Nischal K Gautam, MD|713-500-6200|Nischal.K.Gautam@uth.tmc.edu|
21255067|NCT01122160|USDA|Beverly Clevidence|301-504-8367|beverly.clevidence@ars.usda.gov|
21255068|NCT05779397|Masimo Corporation|Ahmed Alghazi|949-297-7000|aalghazi@masimo.com|
21255069|NCT01256658|Novartis|Study Director|41 61 324 1111||
21255070|NCT03330457|Portola Pharmaceuticals|Head of Clinical Development|650-246-7000|ClinicalTrials@Portola.com|
21255071|NCT00719563|University of Michigan School of Nursing|Debra L. Barton, RN, PhD, AOCN, FAAN|734-763-3868|debbartn@umich.edu|
21255072|NCT03290196|Andrews Research and Education Foundation|Jessica Truett|8509168570|jessica.truett@andrewsref.org|
21255073|NCT02986334|Northwestern University|Apkar Vania Apkarian|312-503-0404|a-apkarian@northwestern.edu|
21255074|NCT04142450|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21255075|NCT01480674|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21255076|NCT03249714|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21255077|NCT01996813|Loyola University Medical Center|Douglas Evans, M.D.|708-216-2523|devans@lumc.edu|
21255078|NCT00816348|NSLIJ Health System|Cindy Haller MD|516-472-3650|challer@lij.edu|
21299667|NCT00758771|UCSF|John V. Fahy, MD, MSc|4154769940|john.fahy@ucsf.edu|
21255079|NCT01138007|GlaxoSmithKline|GSK Response Center|866-435-7343||
21255080|NCT03548987|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21255081|NCT04661878|Duke University School of Nursing|Dr. Marta Mulawa|(919) 684-9555|marta.mulawa@duke.edu|
21255082|NCT05580588|Shanghai Pharma Biotherapeutics USA Inc.|CSO|8587755354|kenneth@sphbio.com|
21255083|NCT03867175|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|3367130031|mfarris@wakehealth.edu|
21255084|NCT03603028|UAB|David A. Brown|205-975-2788|dbrownpt@uab.edu|
21255085|NCT01468831|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov|
21255086|NCT02768870|Edwards Lifesciences, LLC|Sabrina Hundt, Director, Clinical Affairs, Surgical Structural Heart|949-250-2500|Sabrina_Hundt@edwards.com|
21255087|NCT02963610|Fox Chase Cancer Center|Hossein Borghaei, DO, MS|215-214-4297|Hossein.Borghaei@fccc.edu|
21255088|NCT00063154|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
21255089|NCT01287065|GlaxoSmithKline|GSK Response Center|866-435-7343||
21255090|NCT02875977|Loyola University Medical Center|Cynthia Brincat, M.D., Ph.D.|708-216-2180|cbrincat@lumc.edu|
21255091|NCT01259726|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21255092|NCT00490009|Stanford University Medical Center|Susan J Knox, MD, Associate Professor of Radiation Oncology|650-725-2720|sknox@stanford.edu|
21255093|NCT01211197|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21255094|NCT00959166|Imperial College London|Prof Alan Winston|+44 (0)20 3312 1603|a.winston@imperial.ac.uk|
21255095|NCT01776424|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21255096|NCT00700973|VA Palo Alto Health Care System|Christine Timko|650-617-2746|Christine.Timko@va.gov|
21255097|NCT02019927|Will Eye Hopsital|Ann Murchison MD|267-733-9617|Visionresearch@willseye.org|
21255098|NCT02618031|Cleveland Clinic Akron General|John Elias|330-344-6176|eliasj@ccf.org|
21255099|NCT02169453|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21255100|NCT01426763|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21255101|NCT00928447|Halozyme Therapeutics|Chief Medical Officer|855-495-3639|halozyme@EVERSANA.com|
21255102|NCT01259284|UT MD Anderson Cancer Center|Ara Vaporciyan, MD, BS / Professor||CR_Study_Registration@mdanderson.org|
21255103|NCT00069238|National Cancer Institute|Dr. Wyndham WIlson|301-435-2415|wilsonw@mail.nih.gov|
21255104|NCT02271425|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21255105|NCT00926211|Restoration Robotics|Miguel Canales, M.D.|650-965-3612|miguel@restorationrobotics.com|206
21255106|NCT01032382|US Army Medical Materiel Development Activity (USAMMDA)|Director, Division of Regulated Activites and Compliance|301-619-0197|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil|
21255107|NCT04508023|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21255108|NCT02988622|Univeristy of Iowa, Hospitals and Clinics|Dr. Marta VanBeek|(319) 384-6012|marta-vanbeek@uiowa.edu|
21255109|NCT03261700|National Center for PTSD, located at the VA Boston Healthcare System|Dr. Katherine Iverson, PI|857-364-2066|katherine.iverson@va.gov|
21255110|NCT00983931|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21255111|NCT04009850|Yale School of Medicine|Dr. Krysten Bold|203-974-7603|krysten.bold@yale.edu|
21299668|NCT00528957|Gilead Sciences|Clinical Trial Disclosures & Transparency||GileadClinicalTrials@gilead.com|
21255112|NCT01281969|NIMH|Dr. David I. Driver|301.496.1683|david.driver@nih.gov|
21255113|NCT03525431|University of California, San Francisco|Mary Norton|(415) 476 4080|mary.norton@ucsf.edu|
21255114|NCT01723254|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21255115|NCT01564628|Acarix A/S|Claus Christensen|+45 29724411|dkcbc@acarix.com|
21255116|NCT04640077|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21255117|NCT01257425|Ipsen|Director, Uro-oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21255118|NCT01822301|University of Pittsburgh|J. Peter Rubin|412-624-9703|rubipj@upmc.edu|
21299669|NCT01323582|University of Florida|Baharak Moshiree MD|305-243-2515|bmoshiree@med.miami.edu|
21299670|NCT04326920|UZ Gent|Cedric Bosteels|+3293325909|cedric.bosteels@ugent.be|
21299671|NCT02970799|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21299672|NCT00083889|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21299673|NCT00960375|V Maryland Healthcare System|Dr. Melanie Bennett, Research Health Scientist|410-637-1859|Melanie.Bennett@va.gov|
21299674|NCT03473236|GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.|R. Aranda M.D. / Senior Vice President of Clinical Development|(858) 684-1300|raranda@gossamerbio.com|
21299675|NCT03138369|Neurovalens Ltd|Paul McGeoch, MD|858-232-3312|paul.mcgeoch@neurovalens.com|+1
21299676|NCT02228681|GOG Foundation|Linda Gedeon for Virginia Filiaci, PhD|716-845-1169|lgedeon@gogstats.org|
21299677|NCT01784991|Albert Einstein Medical Center|Kamran Mohiuddin, Director Clinical Research Emergency Department|2154562313|MOHIUDDK@EINSTEIN.EDU|
21299678|NCT02588599|Arizona Institute of Footcare Physicians|Kerry Zang DPM|480-834-8804|kerryzang@aol.com|
21299679|NCT03353675|Transgene|Director of Medical Affairs|+ 33 (0)3 88 27 91 00|clinical.trials@transgene.fr|
21299680|NCT00402168|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21299681|NCT00550407|GlaxoSmithKline|GSK Response Center|866-435-7343||
21299682|NCT02370420|Universidad Autonoma de Nuevo Leon|Felix Vilchez Cavazos|811 049 80 70|vilchez.doctor@hotmail.com|
21299683|NCT02856412|San Francisco Veterans Health Care System|Thomas Neylan, MD|415-750-6961|Thomas.Neylan@va.gov|
21299684|NCT05790460|Abramson Cancer Center at the University of Pennsylvania|Charu Aggarwal, MD, MPH|215-662-6318|charu.aggarwal@pennmedicine.upenn.edu|
21237479|NCT02690974|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21255119|NCT02409368|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21255120|NCT04262817|Yale School of Medicine|Asti Jackson, Ph.D.|475-241-4904|asti.jackson@yale.edu|
21255121|NCT02240693|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21255122|NCT03343301|Amgen|Study Director|866-572-6436|medinfo@amgen.com|
21255123|NCT02668185|Imperial College London|Professor Wajit Dhillo|+44 (0)20 7594 2489|w.dhillo@imperial.ac.uk|
21255124|NCT01013597|University of Wisconsin Carbone Cancer Center|Abigail Mapes, Thoracic Oncology Research Program Manager|608-262-8158|acmapes@medicine.wisc.edu|
21255125|NCT00427895|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21255126|NCT02953860|University of Colorado|Professor Anthony Elias|720-848-0347|anthony.elias@cuanschutz.edu|
21255127|NCT00585195|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21255128|NCT00770341|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@Merck.com|
21255129|NCT00603720|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
21255130|NCT02796560|University of Sherbrooke|Dr Marjorie Carbonneau|819-346-1110|Marjorie.Carbonneau@USherbrooke.ca|22180
21255131|NCT03995667|Oregon Health & Science University|Dr. Timur Mitin, MD, PhD|503-494-8756|mitin@ohsu.edu|
21255132|NCT02533570|Seattle Genetics, Inc|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
21255133|NCT00529958|University of Calgary Sport Medicine Centre|ACL RCT Research Coordinator|403-220-8944|aclstudy@ucalgary.ca|
21255134|NCT03816332|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
21255135|NCT04947527|Advantage Silver Dental Arrest, LLC|Dr. Peter Milgrom|2062516831|drmilgrom@silverarrest.com|
21255136|NCT03534284|University of Washington|Dr. Raj Mehrotra|206-221-7138|rmehrotr@uw.edu|
21255137|NCT03316300|Neurotech Pharmaceuticals, LLC|CMO|401-333-3880|neurotech@neurotechusa.com|
21255138|NCT03164564|HPTN Statistical & Data Management Center|HPTN Statistical Manager|206-667-4004|HPTN-Data-Access@scharp.org|
21255139|NCT03081052|Duke University|Kamrouz Ghadimi, M.D., M.H.Sc.|919-681-6532|kamrouz.ghadimi@duke.edu|
21255140|NCT00294554|Johns Hopkins University School of Medicine|Laura Marsh, MD|713-794-8907|laura.marsh2@va.gov|
21255141|NCT02544217|Khondrion B.V.|Edwin Spaans, PharmD.|+31654997700|spaans@khondrion.com|
21255142|NCT00887679|Duke University Medical Center|Dr. Ashwin A Patkar Associate Professor|919-668-3626|ashwin.patkar@duke.edu|
21255143|NCT02683941|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
21255144|NCT03136328|Montefiore Medical Center|Charito Love, MD|718-406-8462|clove@montefiore.org|
21255145|NCT02075541|GlaxoSmithKline|GSK Response Center|866-435-7343|lp542096@gsk.com|
21255146|NCT02434939|Makerere University ,College of Health Sciences, Department of Anesthesia and Critical care|Dr.Lubega Felix Anthony|+256777756571|falubega@chs.mak.ac.ug|
21255147|NCT03181451|Shield Therapeutics|Jackie Mitchell MA DPhil|+44 (0) 191 511 8515|jmitchell@shieldtx.com|
21255148|NCT01326533|University of Pittsburgh|Frederico Toledo|412-692-2848|.toledofs@upmc.edu|
21255149|NCT04079803|Cassava Sciences, Inc.|Nadav Friedmann, PhD, MD, Chief Medical Officer|512-501-1900|nfriedmann@cassavasciences.com|
21255150|NCT00759330|Teikoku Pharma USA, Inc.|Director of Clinical Trials|408-501-1821||
21255151|NCT01519466|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993 863164|joe.bugler@abbott.com|
21255152|NCT01134016|Golden Biotechnology Corp.|Dr. Howard Cheng, Director of clinical trials|886-2808-6006|howard@goldenbiotech.com.tw|
21255153|NCT00807235|Discovery Laboratories, Inc.|Robert Segal, MD|215-488-9300|rsegal@discoverylabs.com|
21255154|NCT01210079|School of Nursing, University of California, Los Angeles|Margaret (Peggy) Compton, RN PhD|(310) 206-2825|pcompton@sonnet.ucla.edu|
21255155|NCT01242800|ECOG-ACRIN Cancer Research Group|Study Statistician|16176323012|eatrials@jimmy.harvard.edu|
21255156|NCT00982995|University of Michgan Comprehensive Cancer Center|Susan Urba|734-615-4762|surba@umich.edu|
21255157|NCT02341859|Coopervision Japan|Taku Muraoka, OD, Director Professional Services Organization|81-3-5449-6619|taku.muraoka@jp.coopervision.com|
21255158|NCT04845633|Damascus University|Dr. Line Droubi|00963966896989|droubiline@gmail.com|
21255159|NCT03598088|Dare Bioscience, Inc.|Jessica Hatheway VP, Clinical Operations|858-926-7655|jhatheway@darebioscience.com|
21255160|NCT00511901|University of Medicine and Dentistry of New Jersey|Jeffrey L Carson, MD|732-235-7122|carson@umdnj.edu|
21255161|NCT02447172|Innocoll|Charlene A. Tucker MS, Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
21255162|NCT06020118|Duke University|Dr. Emmanuel Walter|919 620 5346|chip.walter@duke.edu|
21255163|NCT01204398|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21255164|NCT03562247|Vanderbilt University Medical Center|Lisa Lancaster, MD|615-322-2386|lisa.lancaster@vumc.org|
21255165|NCT01296347|ImperialNHSTrust|Dr Gillian Chumbley|+44 203 311 1000|gillian.chumbley@imperial.nhs.uk|Bleep 5865
21255166|NCT04633551|University of South Carolina|Abbi Lane-Cordova|8037777568|lanecord@mailbox.sc.edu|
21255167|NCT01163916|Abbott|Global Medical Services|800-633-9110||
21255168|NCT00423930|Memorial Sloan Kettering Cancer Center|David Pfister, MD|646-888-4232|pfisterd@mskcc.org|
21255169|NCT04002401|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
21255170|NCT02337751|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21255171|NCT01910181|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21255172|NCT02656823|DENTSPLY IH AB,|Ulrika Bonander|31 376 30 68|ulrika.bonander@dentsplysirona.com|+46
21255173|NCT00822523|Loma Linda University|Gordon Perterson, MD|909-558-4000|gpeterson@llu.edu|
21255174|NCT01340651|Incyte Corporation|Study Director|855 463-3463||
21255175|NCT01315353|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21255176|NCT03567434|Baylor University|Dr. Jason Carter|254-710-4499|jason_carter1@baylor.edu|
21255177|NCT01009580|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21255178|NCT02880540|Children's National Hospital|Janelle Vaughns MD|202-476-2025|jvaughns@childrensnational.org|4165
21255179|NCT04469270|Helixmith Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
21255180|NCT01607112|GlaxoSmithKline|GSK Response Center|866-435-7343||
21255181|NCT04485858|CorNeat Vision|Clinical Research Associate|0586753739|talia@corneat.com|
21255182|NCT03413735|The Ohio State University|Dr. Richard Bruno|614-292-5522|bruno.27@osu.edu|
21255183|NCT05269355|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
21255184|NCT03705832|Columbia University|Emily DiMango, MD|212-305-0631|ead3@columbia.edu|
21255185|NCT01050790|Virginia Commonwealth University/Massey Cancer Center|Amir A. Toor, MD, Associate Professor of Medicine|804-828-4360|atoor@mcvh-vcu.edu|
21255186|NCT01880528|Mayo Clinic|Terence T Sio, MD, MS|480/301-7050|Sio.Terence@mayo.edu|
21255187|NCT00081497|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
21255188|NCT01439360|GlaxoSmithKline|GSK Response Center|866-435-7343||
21255189|NCT06609135|UMASS Chan Medical School|Dr. Lawrence Rhein, Chair of Pediatrics at UMASS Chan Medical School|5083346581|lawrence.rhein@umassmemorial.org|
21255190|NCT02390245|Wills Eye Hospital|Dr. L. Jay Katz|215-825-4713|jmolineaux@willseye.org|
21255191|NCT06729593|University of Minnesota|Shweta Sharma Mistry|612-626-9021|shwetas@ccbr.umn.edu|
21255192|NCT05437510|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21255193|NCT03573401|Biofrontera Bioscience GmbH|Research and Development|+49 214 876 32|regulatory@biofrontera.com|66
21255194|NCT05677893|Oneness Biotech Co., Ltd.|Director of Clinical Research|+886-2-2703-1098|Jessica.Ho@onenessbio.com.tw|
21255195|NCT03217266|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21255196|NCT02101034|Washington University School of Medicine|Douglas R. Adkins, M.D.|314-362-4471|dadkins@wustl.edu|
21284817|NCT03913104|University of California, San Francisco|Natalie Morris|(415) 353-4724|natalie.morris@ucsf.edu|
21284818|NCT01243294|Coloplast A/S|Pia Nordmand, Clinical Trial Manager|+4549113250|dkpialn@coloplast.com|
21284819|NCT00048997|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||seiferheldw@nrgoncology.org|
21284820|NCT02819440|Vanderbilt University Medical Center|Evan Brittain|6153224382|evan.brittain@vumc.org|
21284821|NCT03763058|Centre d'Evaluation et Traitement de la Douleur|Dr Guilhem Parlongue|00262262912037|guilhem_parlongue@hotmail.com|
21284822|NCT02759835|National Cancer Institute|Azam Ghafoor|240-858-3289|azam.ghafoor@nih.gov|
21284823|NCT00602446|Masonic Cancer Center, University of Minnesota|Linda J. Burns, MD|612-624-8144|burns019@umn.edu|
21284824|NCT00002525|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
21284825|NCT03304184|University of Michigan|Elizabeth Van Tubergen|2487045640|evantub@umich.edu|
21284826|NCT01267422|Department of Ophthalmology, Tongji Hospital Tongji Medical College, Huazhong University of Science and Technology|Bin Li|+86-13638673626|libin-12@163.com|
21284827|NCT03420222|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21284828|NCT00284154|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21284829|NCT02104167|Zimmer Biomet|Clinical Affairs|303-501-8571|tammy.stinson2@zimmerbiomet.com|
21284830|NCT02112877|Boston Scientific|Nancy O'Connell, Sr. Clinical Research Manager|763-494-2706|nancy.oconnell@bsci.com|
21284831|NCT00212264|University of Alabama at Birmingham|Patricia S Goode, MD|2055587064|pgoode@uabmc.edu|
21284832|NCT02051335|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21284833|NCT03409120|University of Alabama at Birmingham|Christopher Gonzalez|2059753732|clg17@uab.edu|
21284834|NCT00595101|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
21299685|NCT02919761|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
21237480|NCT05276830|BioXcel Therapeutics|Vice President Head of Clinical Operations|(475) 355 5177|cgommoll@bioxceltherapeutics.com|
21255197|NCT01390181|Grand Traverse Heart Associates|Anna Booher|231 935-5800|annabooher3@gmail.com|
21255198|NCT01101477|Chang Gung Memorial Hospital|Dr. Ting-Yu Lin|886 3 3281200|yuebaoyuebao@yahoo.com.tw|5108
21255199|NCT00720941|Novartis Pharmaceuticals|Study Director|862 778 8300|Novartis.email@Novartis.com|
21255200|NCT01708122|Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center - Urology|Richard Reznichek|3102222724|RReznichek@dhs.lacounty.gov|
21299686|NCT00410956|Memorial Sloan Kettering Cancer Center|Dr. William Jarnagin, MD|212-639-7601|jarnagiw@mskcc.org|
21299687|NCT03760029|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21299688|NCT00524511|UMass Memorial Medical Center|Dawn Tasillo, MD|5083346255|tasillod@ummhc.org|
21299689|NCT03305666|Denver Health and Hospital Authority|Dr. Fredric Pieracci|(303) 436-4029|Fredric.Pieracci@dhha.org|
21299690|NCT01001221|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi.com|
21299691|NCT02388269|electroCore LLC|Clinical Affairs Department electroCore LLC|+1 973 355 6683|clinical@electrocorellc.com|
21299692|NCT03882021|Abbott|Laura Zitella Verbick|+1-612-961-7336|laura.zitellaverbick@abbott.com|
21299693|NCT03098641|Groupe Hospitalier de la Rochelle Ré Aunis|Dr Philippe Ferry|+33 5 46 45 50 50|philippe.ferry@ch-larochelle.fr|
21299694|NCT02542865|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21299695|NCT01469221|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
21299696|NCT00659061|Aga Khan University|Professor Zulfiqar Ahmed Bhutta|4930051|zulfiqar.bhutta@aku.edu|4782
21299697|NCT01210716|Fenwal, Inc|Sr. Mgr. Clinical Affairs|847-550-5620|carrie.pineda@fenwalinc.com|
21299698|NCT00790803|Wake Forest Baptist Health Eye Center|Dr. Shree Kurup|336-716-4091|skk@retinacenterspc.com|
21299699|NCT04657679|Georgetown University|Sandra Swain, MD,|(202) 687-8487|sandra.swain@georgetown.edu|
21299700|NCT01490151|Stanford University|Dr. Bruce Buckingham, MD|408-356-0911|buckingham@stanford.edu|
21299701|NCT03853473|Medical College of Wisconsin|Matthew J. Durand, Ph.D., Principal Investigator|414-955-5619|mdurand@mcw.edu|
21299702|NCT00475670|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21299703|NCT02004236|BrainMech Foundation|Moises Domingo president of Brainmech Foundation|+441615312645|moises@bigdata4brain.co.uk|
21255201|NCT00420017|Purdue University|James E Tisdale PharmD|317-613-2315|hwroblew@iupui.edu|306
21255202|NCT01717989|Amgen Inc.|Study Director|866-572-6436||
21255203|NCT03224325|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|+1
21255204|NCT02598557|UT MD Anderson Cancer Center|Parijatham S. Thomas, MD., Associate Professor, Clinical Cancer Prevention|(713) 745-1075|psthomas@mdanderson.org|
21255205|NCT02864381|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21255206|NCT00667355|Abbott|Global Medical Services|1-800-633-9110||
21255207|NCT01917513|Helios Dr. Horst Schmidt Kliniken, Wiesbaden, Germany|Prof. Ralf Kiesslich||ralf.kiesslich@hsk-wiesbaden.de|
21255208|NCT00687973|Novartis Pharmaceuticals|Study Director|862 778-8300||
21255209|NCT04465760|OREGON HEALTH & SCIENCE UNIVERSITY|Joseph Shatzel MD MCR|5034948311|shatzel@ohsu.edu|
21255210|NCT00731120|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21255211|NCT00604812|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21255212|NCT02120716|University of Michigan|Golfo Tzilos, PhD|7349987120|gtzilos@med.umich.edu|
21255213|NCT01012713|University of California San Francisco|Dr. John Koo|4154764701|john.koo@ucsfmedctr.org|
21255214|NCT00985153|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21255215|NCT03370471|Atlanta VA Health Care System|Amy D Rodriguez, PhD|404-321-6111|amy.rodridguez@va.gov|204201
21255216|NCT04176848|Canadian Cancer Trials Group|Dr. Lesley Seymour|6135336430|lseymour@ctg.queensu.ca|
21255217|NCT00561951|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21255218|NCT01765179|Clarus Therapeutics|Sr. VP Clinical and Medical Affairs|847-562-4300|tdanoff@clarustherapeutics.com|
21255219|NCT02640157|AbbVie|Global Medical Services|800-633-9110||
21255220|NCT01596621|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21255221|NCT00710021|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21255222|NCT01679405|University Medical Center Mainz|Prof. Dr. Markus Moehler|0049613117|Markus.Moehler@unimedizin-mainz.de|7275
21255223|NCT04677179|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
21255224|NCT01536015|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
21255225|NCT04819776|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
21255226|NCT01201265|Hoffmann-La Roche|Medical Communications|800-821-8590||
21255227|NCT02041520|Instituto Mexicano del Seguro Social, UMAE HE No. 1 Bajio|Dr. Norma Amador|+524777174800|norma.amador@imss.gob.mx|31315
21255228|NCT00413972|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21255229|NCT01992393|Case Western Reserve University|Joy Yala, Data & Regulatory Coordinator II|216-368-0783|jxy790@case.edu|
21255230|NCT01898923|Oneness Biotech Co., Ltd.|Henry Chang, Associate Director of Clinical Research|+886 2 2703 1098|henry.chang@onenessbio.com.tw|366
21284835|NCT01578499|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21284836|NCT01606748|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21284837|NCT04100590|New York State Psychiatric Institute|Caroline A Arout, PhD|646-774-6167|caroline.arout@nyspi.columbia.edu|
21284838|NCT02910726|Memorial Sloan Kettering Cancer Center|Neeta Pandit-Taskar, MD|1-833-MSK-KIDS|pandit-n@mskcc.org|
21284839|NCT01313351|Rapid Pathogen Screening, Inc|Robert Sambursky, MD|9415581853|rob.sambursky@lumosdiagnostics.com|
21284840|NCT00862459|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21284841|NCT00358956|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21284842|NCT00655681|University of New Mexico Carrie Tingley Hospital|Elizabeth A. Szalay MD|505 272-5214|eszalay@salud.unm.edu|
21284843|NCT05011890|University of North Carolina Lineberger Comprehensive Cancer Center|Gita Mody|+1 919-966-3382|gita_mody@med.unc.edu|
21299704|NCT01168349|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21299705|NCT02970981|NYU Langone Health - Perlmutter Cancer Center|Jeffrey S. Weber, MD, PhD|212 731 6262|Jeffrey.Weber@nyulangone.org|
21299706|NCT03259230|Swedish Orphan Biovitrum|Medical Director|+4686972000|clinical@sobi.com|
21299707|NCT01033240|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21299708|NCT02913482|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21299709|NCT05468814|Hospital Universitario Reina Sofía|Ms. Irene Calzado Álvarez de Lara|+34618093419|ircaalla@gmail.com|
21299710|NCT02955589|Huya Japan G.K.|Huya Japan clinical development||japanclinical@huyabio.com|
21299711|NCT04716426|ELJ Consultancy|Ernesto Cesar Pinto Leal Junior|+55 11 975222856|ceo@eljconsultancy.com|
21299712|NCT04797585|Cleveland Clinic Foundation|Cecile Ferrando, M.D.|216-444-0642|ferranc2@ccf.org|
21299713|NCT02987231|Institute of Science and Technology of São José dos Campos (Unesp)|Dr. Mauro P. Santamaria|+55 (16) 981937777|mauro.santamaria@unesp.br|
21299714|NCT01650558|University of Maryland School of Medicine|Miriam K. Laufer, M.D., M.P.H.|410-706-5333|mlaufer@som.umaryland.edu|
21299715|NCT02960217|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
21299716|NCT00918385|Duke University|Dr. Daniel George|(919) 668 4615|daniel.george@duke.edu|
21299717|NCT03207126|Imperial College London|Diana Marcus|07525133957|diana.marcus@nhs.net|
21299718|NCT01476722|alcon Blobal Medical Affairs|Jami Kern, Ph.D.|1-888-451-3937||
21299719|NCT00079326|Dana-Farber Cancer Institute|Craig Bunnell|617-632-3800|cbunnell@partners.org|
21299720|NCT02005016|VA Pittsburgh Healthcare System|Dr. Michael Dickey|412-360-6467|michael.dickey@va.gov|
21299721|NCT03324776|MODEL Clinical Research LLC|Philip Levin, MD|4102413438|pal3420@yahoo.com|
21255231|NCT03087019|Dana-Farber Cancer Institute|Jonathan Schoenfeld, MD, MPH|617-632-3591|jonathan_schoenfeld@dfci.harvard.edu|
21255232|NCT02678247|Northwestern University|Dr. Stefania Fatone, Principle Investigator|3125035717|s-fatone@northwestern.edu|
21255233|NCT01907360|Ironshore Pharmaceuticals and Development, Inc.|Chief Scientific Officer|13457498174|bev@ironshorepharma.com|
21255234|NCT00723021|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21255235|NCT00282282|Dana-Farber Cancer Institute|Vincent T. Ho, MD Associate Professor of Medicine, Harvard Medical School|(617) 632-5938|vincent_ho@dfci.harvard.edu|
21255236|NCT02739360|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21255237|NCT00637923|Romark Laboratories, L.C.|Marc Ayers|813-282-8544|Marc.Ayers@romark.com|
21255238|NCT00026208|Stanford Univeristy Medical Center|Jessica C Lam, BS|650-723-0437|jclam11@stanford.edu|
21255239|NCT05462886|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
21255240|NCT02618642|Rzeszow University|Jolanta Zwolińska PhD|48 505095199|jolantazwolinska@op.pl|
21255241|NCT01000285|Washington University School of Medicine|Lee Ratner, M.D., Ph.D.|314-362-8836|lratner@dom.wustl.edu|
21255242|NCT02181387|Wake Forest School of Medicine|Peter H. Pan, MD, MSEE|336-718-8278|ppan@wakehealth.edu|
21255243|NCT02881957|University of Utah|Dr. Michael Karsy|801-581-6908|michael.karsy@hsc.utah.edu|
21255244|NCT02254278|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@gmail.com|
21255245|NCT05203068|"Federal State Budgetary Institution National Medical Research Center of Phthisiopulmonology and Infectious Diseases of the Ministry of Health of the Russian Federation"|Dr. Kazakov Aleksey Vladimirovich, principal investigator|+79254666638|alexeykazakov1982@yandex.ru|
21299722|NCT00625131|VA Medical Center, Durham, NC|Angela Kirby, MS; Regulatory Coordinator|9192860411|angela.kirby@va.gov|5526
21299723|NCT01003301|Johns Hopkins University|Sarbjit S. Saini|410-550-2129|ssaini@jhmi.edu|
21299724|NCT00918281|GE Healthcare|Matthew Miller|011-44-1494-543981|matthew.miller@ge.com|
21299725|NCT01636765|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21299726|NCT02978417|Duke University|Michele Easter, Ph.D.|919-385-0862|michele.easter@duke.edu|
21299727|NCT03485924|Johns Hopkins Medical Institute|Dr. Eun Ji Shin|4106140950|eshin3@jhmi.edu|
21299728|NCT02675907|Recro Pharma, Inc.|Randall Mack|484-395-2470|rmack@recropharma.com|2406
21299729|NCT05288816|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
21299730|NCT03416868|Massachusetts General Hospital; Harvard Medical School|Jarrad Van Stan, PhD, CCC-SLP|617-643-8410|jvanstan@mgh.harvard.edu|
21299731|NCT00564681|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21299732|NCT00988832|Merck Sharp and Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21299733|NCT03174184|Vanderbilt University Medical Center|Kelly Dooley, MD, PhD|6153228972|kelly.e.dooley@vumc.org|
21299734|NCT00004563|University of Texas Health Science Center at Houston|Maureen Mayes, MD|+1 (713) 500-6900|Maureen.D.Mayes@uth.tmc.edu|
21299735|NCT00995761|Gyeongsang National University Hospital|Gyeong-Won Lee M.D.Ph.D.|82-55-750-8066|brightree@lycos.co.kr|
21299736|NCT00409539|Sunovion|Medical Director, Urology|1-866-503-6351||
21299737|NCT04258423|Indiana University|Dr. Chandrashekhar Kubal|317-312-2601|sakubal@iupui.edu|
21299738|NCT04388683|Tufts Medical Center|Dr. Marvin Konstam|617-636-6293|mkonstam@tuftsmedicalcenter.org|
21299739|NCT01352117|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21299740|NCT01766050|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21299741|NCT03577275|NorthSea Therapeutics BV|Dr Patrick Round|+44(0)7979502770|patrick.round@northseatherapeutics.com|
21299742|NCT00385671|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21299743|NCT00717574|Department of Anesthesia. OUHSC|Dr. Mehmet Ozcan, MD|405-271-4351|mehmet-ozcan@ouhsc.edu|
21237481|NCT05090709|Edinburgh Napier University|Dr Rebecca Hamilton|0131455|rebeccaisabel.hamilton@napier.ac.uk|2350
21299744|NCT00558142|University of Edinburgh|Prof M Eddleston|01312426776|m.eddleston@ed.ac.uk|
21299745|NCT00278343|Juarvinski Cancer Centre|Dr. Hal Hirte|905-387-9495|hirteh@hhsc.ca|
21284844|NCT00093847|Massachusetts General Hospital|Dr George Papakostas, M.D.|6177266697|gpapakstas@partners.org|
21284845|NCT03417024|GE Healthcare|Sr. Clinical Affairs Project Manager|2624095722|kevin.r.siewert@ge.com|
21284846|NCT03168919|St. Jude Children's Reaserch Hospital|Asim K. Bag, MD Bag|9015953347|asim.bag@stjude.org|
21284847|NCT01085136|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21284848|NCT02195427|Teoxane|Clinical Project Manager|+41 (0) 22 344 96 36|m.chenet@teoxane.com|
21284849|NCT00083720|ImClone, LLC|Chief Medical Officer||ClinicalTrials@imclone.com|
21284850|NCT01210144|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21284851|NCT02655419|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21284852|NCT02604173|Stanford University|Dr. Grant Lipman|415-290-9286|gslipman@stanford.edu|
21284853|NCT04226495|University of Nebraska Medical Center|Jeffrey Songster|308-520-2847|jeffrey.songster@unmc.edu|
21284854|NCT02232477|Lundquist Institute|Dr. Agnes Chen|424-306-7635|ahchen@lundquist.org|
21299746|NCT01021020|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlmutual.com|
21299747|NCT00755183|Andover Eye|Dr. Mark Abelson|9784750705||
21299748|NCT00904943|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21299749|NCT02498925|McLean Hospital|Christian Webb, PhD|6178554429|cwebb@mclean.harvard.edu|
21299750|NCT03547518|William Beaumont Hosptial|Jennifer Giordano, RN BSN Clinical Research Manager|248-551-3517|jennifer.giordano@corewellhealth.org|
21299751|NCT00907426|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21299752|NCT04742556|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21299753|NCT04247347|Case Western Reserve University|Jaclene Zauszniewski, PhD|216.368.3612|jaz@case.edu|
21299754|NCT03035032|Astellas Pharma Sinagpore Pte Ltd|Clinical Trial Disclosure|+65 6500 9330|astellas.resultsdisclosure@astellas.com|
21299755|NCT03789669|Johnson & Johnson Surgical Vision|Brian Pall, Dr.|+1 904 6292289|bpall@its.jnj.com|
21299756|NCT02923726|Boston Scientific|Jacqueline Beaulieu, Sr. Clinical Trial Manager|1-800-227-3422|jacqueline.beaulieu@bsci.com|
21299757|NCT04386291|NYS Psychiatric Institute|Dr. Brian A Fallon|646-774-8052|baf1@cumc.columbia.edu|
21299758|NCT02399215|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-1300|Chong.Wang@Roswellpark.org|
21299759|NCT01089504|University of Rochester|Ronnie Guillet|585-275-6209|ronnie_guillet@urmc.rochester.edu|
21299760|NCT01048593|Eyepoint Pharmaceuticals, Inc.|Regulatory Affairs Specialist|6179726318|dbauer@eyepointpharma.com|
21299761|NCT00914849|Washington University School of Medicine|John DiPersio, M.D., Ph.D.|314-454-8304|jdipersi@dom.wustl.edu|
21299762|NCT05106959|University of New Mexico South West Clinical Trials Network|Cade Arnink|505-918-0341|clarnink@salud.unm.edu|
21299763|NCT03448406|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21299764|NCT02689427|The University of Texas MD Anderson Cancer Center|Clinton Yam, MD|(832) 589-8343|cyam@mdanderson.org|
21299765|NCT04602390|Anokion US|Medical Director|+1 857.320.6607|clinicaltrials@anokion.com|
21299766|NCT01546857|Rutgers-New Jersey Medical School|Jean Daniel Eloy|9739721470|eloyje@njms.rutgers.edu|973
21299767|NCT01176032|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21299768|NCT00375999|Gangnam Severance Hospital, Yonsei University College of Medicine|Dr. Jae Yong Cho|82-2-2019-4363|chojy@yuhs.ac|
21299769|NCT05005260|Mayo Clinic|Johar Paul|5072556804|Paul.Johar@mayo.edu|
21299770|NCT03164668|University of Minnesota|Michael Kotlyar|612-625-1160|kotly001@umn.edu|
21299771|NCT01277744|UT MD Anderson Cancer Center|Andrea Hayes-Jordan M.D. / Surgical Oncology|713-794-4616|AHJORDAN@MDANDERSON.ORG|
21299772|NCT04205240|The Ohio State University Comprehensive Cancer Center|Dr. Srinivas Devarakonda|614-293-3196|Srinivas.Devarakonda@osumc.edu|
21299773|NCT02358473|Kyowa Kirin Pharmaceutical Development, Inc.|Regional_Program Lead|1-609-919-1000|clinical.info@kyowa-kirin-pharma.com|
21299774|NCT06047210|Swedish Orphan Biovitrum|Medical Director|+4686972000|clinical@sobi.com|
21299775|NCT06133816|University of Pennslyvania|Katharine Rendle, PI|215-349-5442|katharine.rendle@pennmedicine.upenn.edu|
21299776|NCT00590187|Cyclacel Pharmaceuticals|Julius, Huang, PhD.|760-877-2708|jhuang@cyclacel.com|
21299777|NCT04038359|Secura Bio, Inc.|Ohad Bentur, MD, MHA, MSc|1-702-254-0011|obentur@securabio.com|
21284855|NCT01268189|USAISR|Leopoldo C. Cancio, COL, MC|210-916-3301|leopoldo.c.cancio.mil@mail.mil|
21284856|NCT00762034|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21284857|NCT00497146|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21284858|NCT01741350|University of Connecticut|Dr. Michael M. Copenhaver, Ph.D.|860 208-3632|michael.copenhaver@uconn.edu|
21284859|NCT04571385|Acesion Pharma|Birgitte Vestbjerg|+45 20772575|bve@acesionpharma.com|
21284860|NCT02499263|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21299778|NCT00526292|Memorial Sloan Kettering Cancer Center|Dr. Katherine Hsu|646-888-2667|hsuk@mskcc.org|
21299779|NCT02296164|Helsinn Therapeutics (U.S.), Inc.|Bill Bailey|+1 732 603 2848|bill.bailey@helsinn.com|
21299780|NCT02654782|Mayo Clinic|Dr. William C. Oliver, Jr.|507-255-4240|oliver.william@mayo.edu|
21299781|NCT03624881|Biosense Webster, Inc.|Senior Safety Officer CSS|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21299782|NCT00168844|Boehringer Ingelheim|Boehringer Ingelheim|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21299783|NCT01260649|MGH|Dr. Cristina Cusin|617 726 64221|ccusin@mgh.harvard.edu|
21299784|NCT03557970|Oregon Health and Science University|Elie Traer, MD PhD|5034943553|traere@ohsu.edu|
21299785|NCT00112736|Adult Brain Tumor Consortium (ABTC)|Dr. Patrick Y Wen||pwen@partners.org|
21284861|NCT00424593|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21299786|NCT02138890|Zimmer Biomet|Mr. Cahit Akbas|+31622981737|Cahit.Akbas@zimmerbiomet.com|
21299787|NCT03019406|Genzyme, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21255246|NCT00955487|University of Colorado School of Medicine/Children's Hospital Colorado|Dr. John Kinsella|(303) 724-2853|john.kinsella@ucdenver.edu|
21255247|NCT00826111|Steward St. Elizabeth's Medical Center of Boston, Inc.|Tara Lauriat, Ph.D.|617-789-2404|tara.lauriat@steward.org|
21255248|NCT02805725|Institut Bergonie|Pr Antoine Italiano|+ 33 5 47 30 60 88|a.italiano@bordeaux.unicancer.fr|
21255249|NCT01195545|University of Washington|Brant Oelschlager, MD|206-543-3518|brant@uw.edu|
21255250|NCT01837069|NYU Langone Health|Jeffrey Berger|212 263 4004|Jeffrey.Berger@nyulangone.org|
21255251|NCT04968197|Mayo Clinic|Gaurav N. Pradhan, Ph.D.|(480) 301-5351|Pradhan.Gaurav@mayo.edu|
21255252|NCT03511053|Dallas VA Medical Center|Dr. Thiru M. Annaswamy, Staff Physician, PM&R Service|2148570273|thiru.annaswamy@va.gov|
21255253|NCT02425644|Actelion Pharmaceuticals Ltd (a Janssen Pharmaceutical Company of Johnson & Johnson)|Senior Director Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21255254|NCT02720536|Novartis Pharmaceuticals|Study Director|888-778-8300|Novartis.email@novartis.com|
21255255|NCT01028222|Study Director|Novartis|862-778-8300||
21255256|NCT00146328|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21255257|NCT00300781|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
21255258|NCT00792805|Novartis Pharmaceuticals|Study Director|862 778-8300||
21255259|NCT01213589|Medtronic|Richard Jonkers, PhD|800-217-1617|richard.jonkers@medtronic.com|3727
21255260|NCT02072434|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|1-908-992-6400|CTRinfo@dsi.com|
21255261|NCT03599557|University of California, Los Angeles|Principal Investigator|(310) 206-6328|pszilagyi@mednet.ucla.edu|
21255262|NCT02525861|Baxalta|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
21255263|NCT00888433|Baker IDI Heart and Diabetes Institute|Murray Esler, Principal Investigator||murray.esler@bakeridi.edu.au|
21255264|NCT01810692|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21255265|NCT00402363|GlaxoSmithKline|GSK Response Center|866-435-7343||
21255266|NCT02090374|Imperial College London|Professor Trevor Hansel|+44 (0)20 3312 5733|t.hansel@imperial.ac.uk|
21255267|NCT00819260|Dartmouth-Hitchcock|Carolyn L. Kerrigan MD|603-650-5148|carolyn.kerrigan@hitchcock.org|
21255268|NCT00937833|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@CookBiotech.com|
21255269|NCT01707225|Virginia Commonwealth University|Rajiv Malhotra, DO|804-828-9071|rajiv.malhotra@vcuhealth.org|
21255270|NCT03278106|Mayo Clinic|Amit Mahipal MBBS|+1 (507) 293-0487|Mahipal.amit@mayo.edu|
21255271|NCT02175004|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
21255272|NCT01607554|University of New Mexico Comprehensive Cancer Center|Valerie Parks, RN|505-925-0390|vparks@salud.unm.edu|
21255273|NCT00162032|Lantheus Medical Imaging|Cesare Orlandi, MD, Chief Medical Officer|978-671-8686|Cesare.Orlandi@lantheus.com|
21255274|NCT03952806|Biohaven Pharmaceuticals, Inc|Chief Medical Officer|+1 203-404-0410|clinicaltrials@biohavenpharma.com|
21255275|NCT01137955|Celiac Disease Center at Columbia University|Dr. Peter Green|(212) 305-5590|mtm2111@columbia.edu|
21255276|NCT02027701|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
21255277|NCT00756470|University of Texas (UT) MD Anderson Cancer Center|Ricardo Alvarez, MD/Breast Medical Oncology|713-792-2817|CR_Study_Registration@mdanderson.org|
21255278|NCT00820027|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21255279|NCT02604433|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21255280|NCT03285178|Cyclerion Therapeutics, Inc.|Senior Medical Director|1-857-327-8778|info@cyclerion.com|
21255281|NCT01128738|GlaxoSmithKline|GSK Response Center|866-435-7343||
21255282|NCT02673203|Yale University School of Medicine|Renata Belfort De Aguiar, MD, PhD; Assistant Professor of Medicine (Endocrinology)|(877) 925-3637|renata.aguiar@yale.edu|
21255283|NCT00325039|New England Research Institutes, Inc.|Heather Litman, PhD|617 972 3297|hlitman@neriscience.com|
21255284|NCT02287376|Depomed|Clinical Operations|510-744-8000|clinicaltrials@depomed.com|
21255285|NCT01009203|University of Pittsburgh Medical Center|Julie E. Bauman, MD|4126486507|baumanje@upmc.edu|
21255286|NCT02796001|University of Virginia School of Medicine|Ronald Turner, MD|4349819964|rbt2n@virginia.edu|
21255287|NCT00892723|Capstone Therapeutics|Denise Lamon|800-937-5520|dlamon@capstonethx.com|5206
21255288|NCT02974088|Medical Entomology Centre|Ian Burgess|+44 1223 810070|ian@insectresearch.com|
21255289|NCT00426153|Mayo Clinic|Marie Hogan, MD, PhD, Assistant Prof of Medicine, College of Medicine|507-266-9364|hogan.marie@mayo.edu|
21255290|NCT00150969|University Health Network|Dr. Angela M Cheung|416-340-4841|jscher@uhnresearch.ca|
21255291|NCT00615836|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21255292|NCT01630434|TransMedics, Inc.|VP, Clinical Affairs|978.552.0900|ldamme@transmedics.com|
21255293|NCT03554954|National University of Singapore|Dr. Kim Jung Eun|65161136|fstkje@nus.edu.sg|+65
21255294|NCT02121834|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21255295|NCT02578862|Ochsner Medical Center|Edward D McCoul, MD, MPH|504-842-4080|edward.mccoul@ochsner.org|
21255296|NCT01110876|University of Texas (UT) MD Anderson Cancer Center|John de Groot, MD/Associate Professor, NEURO-ONCOLOGY|(713) 745-3072|jdegroot@mdanderson.org|
21255297|NCT03128008|Duke University Health System|Linda Kaltenbach, PhD|(919) 681-6804|Linda.Kaltenbach@duke.edu|
21255298|NCT01768520|Hanlim Pharm|Clinical Trial Unit|82234896297|yrsong@hanlim.com|2234896297
21255299|NCT00343252|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21255300|NCT03975595|University of Virginia|Dr. Patrick Finan|(720) 244-1702|tpx4xe@virginia.edu|
21299788|NCT01446159|MedImmune, LLC|Shahram Rahimian|+1-800-236-9933|information.center@astrazeneca.com|
21299789|NCT01969708|The Emmes Corporation|Principal Investigator of the SCORE2 Data Coordinating Center|301-251-1161|score2@emmes.com|
21299790|NCT03668873|Cleveland Clinic Foundation|Cynthia R. Johnson, PhD|216 448-6440|johnsoc@ccf.org|
21255301|NCT00394953|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21255302|NCT01610011|McLean Hospital|Marc J. Kaufman, Ph.D., Principal Investigator|617-855-3469|kaufman@mclean.harvard.edu|
21255303|NCT02335125|University of Washington Harborview Medical Center|Douglas Zatzick, MD|(206) 744-6701|dzatzick@uw.edu|
21255304|NCT00710996|Alcon Research, Ltd.|Rick Potvin|817-551-4815|Rick.Potvin@alconlabs.com|
21255305|NCT03021954|Dr Cipto Mangunkusumo Hospital|dr. Fernandi Moegni|+62-82298111778|fernandi71@ui.ac.id|
21255306|NCT02917278|Purdue University|Kathleen Hill Gallant|765-494-0101|hillgallant@purdue.edu|
21255307|NCT02196714|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
21255308|NCT00690833|Wake Forest University Health Sciences|Dr Steve feldman|336-716-3775|sfeldman@wakehealth.edu|
21255309|NCT01592864|GlaxoSmithKline|GSK Response Center|866-435-7343||
21255310|NCT00256451|University of Pennsylvania|David Oslin, MD|2158235894|oslin@upenn.edu|
21255311|NCT03353350|Hanmi Pharmaceutical Co., Ltd.|Sujin Jung|+82-2-410-0473|sujin.jung@hanmi.co.kr|
21255312|NCT03037619|University of South Carolina|Christine Pellegrini|803-777-0911|cpellegrini@sc.edu|
21255313|NCT04318951|Medical School Berlin|Prof. Dr. Benjamin Stahl|+49 30 7668 375 708|benjamin.stahl@medicalschool-berlin.de|
21255314|NCT01294683|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21255315|NCT01881750|Stanford University School of Medicine|Antonio Hardan, MD|650-736-1235|hardanay@stanford.edu|
21255316|NCT00307125|DAIT/NIAID|Director, Clinical Research Operations Program (CROP)|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21255317|NCT00051363|Stanford University|Deborah A. Nichols|208-908-7364|dnichols@cableone.net|
21255318|NCT01290601|WRAIR|Shirley Lee-Lecher|301-251-5000|usarmy.detrick.medcom-wrair.mbx.ocid@mail.mil|
21255319|NCT02571049|Dr. Reddy's|Director of Clinical Development|609-375-9900|cfritz@drreddys.com|
21255320|NCT00865969|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
21255321|NCT01942720|Medtronic|Clinical Trials Manager|+972-4-9097952|michal.kedar-datel@medtronic.com|
21255322|NCT05195814|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21255323|NCT04823221|Boao Yiling Life Care Center|Dr. Ming Liu|139 1103 6970|liuming9876@yeah.net|+86
21255324|NCT00973362|Hologic, Inc.|Vice President Clinical Affairs|858-410-8000|rainer.ziermann@hologic.com|
21255325|NCT05116046|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21255326|NCT00146757|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
21255327|NCT00759291|UT Southwestern|Dr. Joshua Beckman|214-648-3100|joshua.beckman@utsouthwestern.edu|
21255328|NCT04388774|Icahn School of Medicine at Mount Sinai|Dr. Alexander Kolevzon|(212) 659-8762|alexander.kolevzon@mssm.edu|
21255329|NCT02076178|GlaxoSmithKline|GSK Response Center|866-435-7343||
21255330|NCT01026454|University of Washington|Connie Celum, MD, MPH|206-520-3800|ccelum@uw.edu|
21255331|NCT02893930|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21255332|NCT01142596|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21255333|NCT02349360|University of Florida|Wendy Dahl Associate Professor|3522943707|wdahl@ufl.edu|
21255334|NCT01054846|Parkview Health|Thein Zhu|260-266-1279|thein.zhu@parkview.com|
21255335|NCT03586687|Penn State Hershey Medical Center|Cayce Onks, DO|7175317127|conks@pennstatehealth.psu.edu|
21255336|NCT04250987|Coloplast|Vice President, Medical Affairs|+45 4911 1111|clinical-studies@coloplast.com|
21255337|NCT01614743|DeNova Research|Steven H Dayan, MD|312-335-2070|sdayan@drdayan.com|
21284862|NCT02496039|Avanir Pharmaceuticals|Nadine Knowles; Executive Director, Research & Development Operations|1-949-268-8972|nknowles@avanir.com|
21284863|NCT00255840|CIPRA-SA|Dr Ian Sanne|+27 11 276 8800|isanne@witshealth.co.za|
21284864|NCT00530790|GlaxoSmithKline|GSK Response Center|866-435-7343||
21284865|NCT01464619|The Children's Hospital of Philadelphia|James Guevara, MD, MPH|215-590-1130|guevara@email.chop.edu|
21284866|NCT02612688|Brown University|Jessica A. Ogarek, Senior Biostatistician|401-863-9356|jessica_ogarek@brown.edu|
21284867|NCT04006509|University of Florida|Leslie A. Parker|352 273 6384|parkela@ufl.edu|
21284868|NCT00080483|University of Pennsylvania|Peter J. Snyder M.D.|215-898-0208|pjs@mail.med.upenn.edu|
21284869|NCT01660802|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21284870|NCT01119846|GlaxoSmithKline|GSK Response Center|866-435-7343||
21255338|NCT02919657|Medfit Rx|David Michael|9196109893|dmichael@medfitrx.net|
21255339|NCT02446886|Weill Cornell Medicine|Research Coordinator|6469625736|liz4005@med.cornell.edu|
21255340|NCT03478163|Cedars Sinai|Melissa Wong, MD MHDS|310-423-0895|wongmsx@cshs.org|
21255341|NCT01971203|Icahn School of Medicine at Mount Sinai|Cindy J. Aaronson, MSW, PhD|212-241-3169|cindy.aaronson@mssm.edu|
21255342|NCT03318809|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21255343|NCT01862133|Regenstrief Institute|William M. Tierney, MD|(317) 274-9094|wtierney@regenstrief.org|
21255344|NCT04668586|Haukeland University Hospital|Øyvind Ulvik|+47 97 50 00|doc.ulvik@online.no|
21255345|NCT00775450|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21255346|NCT04071795|NYU Langone Health|Erin Rogers|6465012544|Erin.Rogers@nyulangone.org|
21255347|NCT03057808|University of Virginia|Dr. Rebecca Krukowski|4349245303|wae4mq@virginia.edu|
21255348|NCT03552822|University of Alabama at Birmingham|Dr. Mark Powell|2059346007|mfpowell@uabmc.edu|
21255349|NCT01055262|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com|
21255350|NCT00752622|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21255351|NCT04329832|Intermountain Healthcare|Naresh Kumar|8013827483|naresh.kumar@imail.org|
21255352|NCT00392327|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21255353|NCT00178126|University of PIttsburgh|David Brienza|(412) 624-6383|DBrienza@pitt.edu|
21255354|NCT00421707|GlaxoSmithKline|GSK Response Center|866-435-7343||
21255355|NCT05056987|Alcon Research, LLC|Senior Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21255356|NCT01575028|Nationwide Children's Hospital|Tarun Bhalla|(614) 722-4200|Tarun.Bhalla@NationwideChildrens.org|
21255357|NCT01182194|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21255358|NCT01948908|Columbia University College of Physicians and Surgeons|Daniel S. Tsze|212-305-9825|dst2141@columbia.edu|
21255359|NCT01585987|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21255360|NCT03291587|Wake Forest NCORP Research Base|Lead Biostatistician|3367160891|NCORP@wakehealth.edu|
21255361|NCT02197767|Mayo Clinic|Dr. Stephen B. Erickson|507-284-4083|Erickson.Stephen@mayo.edu|
21255362|NCT00796120|PharmaMar SA Av de los Reyes 1, Poligono Industrial La Mina 28770 Colmenar Viejo, Madrid, Spain|Medical Specialist, Clinical Oncology|+34 91 646-6087||
21255363|NCT01280110|Departamento de Oftalmologia - Universidade Estadual de Campinas - Campinas - Brazil|Vital Paulino Costa|55-19-35217396|vp.costa@uol.com.br|
21255364|NCT02520284|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21255365|NCT03737474|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21255366|NCT02279394|Dana-Farber Cancer Institute|Dr. Irene Ghobrial|617-632-4198|Irene_Ghobrial@dfci.harvard.edu|
21255367|NCT01139658|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21255368|NCT00971243|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21255369|NCT00803270|New England Resesarch Institutes|Anne M. Stoddard|617-972-3331|astoddard@neriscience.com|
21255370|NCT02737917|Lincoln Medical Center|Dr. Nicholas Caputo|718-579-6010|ncaputo.md@gmail.com|
21255371|NCT02903368|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-7221|mtaplin@partners.org|
21255372|NCT06515483|Loops, LLC|Steven Kayser, President|360-366-3009|stevenkayser@flossloops.com|
21255373|NCT03454828|Yale University School of Medicine: Pediatrics Endocrinology|Nicola Santoro|2037376356|nicola.santoro@yale.edu|
21255374|NCT03722407|Moffitt Cancer Center|Eric Padron, MD|813-745-2864|eric.padron@moffitt.org|
21255375|NCT02788903|Penn State College of Medicine|Jennifer Kraschnewski|717-531-8161|jkraschnewski@pennstatehealth.psu.edu|
21255376|NCT00147823|SUNY Upstate Medical University|Timothy A. Damron, MD|315-464-8604|damront@upstate.edu|
21255377|NCT03769181|Sanofi Aventis Recherche & Développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21255378|NCT01485354|Spaulding Rehabilitation Hospital|Paolo Bonato|617-952-6319|pbonato@partners.org|
21255379|NCT03566810|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21255380|NCT00509665|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
21255381|NCT03338192|Washington University Pain Center in St. Louis|Burel Goodin|3142736403|burel@wustl.edu|
21255382|NCT00733993|Virginia Commonwealth University|F. Gerard Moeller|804-828-4134|fgmoeller@vcu.edu|
21255383|NCT00985166|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21255384|NCT00567268|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21255385|NCT01117454|Vanderbilt University Medical Center|Dr. Prince J. Kannankeril, MD, MSCI|615 322-7447|prince.kannankeril@vanderbilt.edu|
21255386|NCT00389857|Sanofi Pasteur Inc|Medical Director||RegistryContactUs@sanofipasteur.com|
21284871|NCT01404949|Memorial Sloan Kettering Cancer Center|Dr. Jae Park, MD|646-608-3743|parkj6@mskcc.org|
21255387|NCT02276872|United Therapeutics|Derek Solum, PhD|919-425-8122|dsolum@unither.com|
21255388|NCT04175808|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21255389|NCT03312348|Sheffield Children's NHS Trust|Dr Shammi Ramlakhan - Chief Investigator|+44 1142262331|shammi.ramlakhan@sch.nhs.uk|
21255390|NCT00818389|Massachusetts General Hospital|Elizabeth Simpson|617-726-3430|esimpson1@partners.org|
21255391|NCT04263909|BWH Anesthesia|Linda S. Aglio, MD MS|6177328480|laglio@bwh.harvard.edu|33328
21284872|NCT01505179|UCSD MED CLINICAL TRIALS|Denise Barnard, MD|858 246-2996|dbarnard@ucsd.edu|
21255392|NCT00068588|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
21255393|NCT03840486|Emory University|Steven Lindsey, MD|913-706-0232|steven.m.lindsey@emory.edu|
21284873|NCT02334384|Eastern Virginia Medical School|Kenji Cunnion|7574465125|cunniokm@evms.edu|
21251354|NCT01196819|Shanghai Microport Medical (Group) Co.,Ltd.|Kefei Li|+86-21-38954600×6700|kfli@microport.com|
21251355|NCT01129115|University of Kansas Medical Center|Dr. Jeffrey Burns|913-588-0555|kuamp@kumc.edu|
21251356|NCT01747837|Icahn School of Medicine at Mount Sinai|Sam Commack|212-824-8931|sam.cammack@mountsinai.org|
21251357|NCT00935259|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21251358|NCT01246050|VA Medical Center Nashville|Henry Ooi|615-8736373|henry.ooi@va.gov|
21251359|NCT03856047|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21251360|NCT03410108|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21255394|NCT01978262|Johns Hopkins University|Kawsar Talaat|410-502-9627|ktalaat@jhu.edu|
21255395|NCT02982187|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21255396|NCT01128894|GlaxoSmithKline|GSK Response Center|866-435-7343||
21237482|NCT01644734|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21237483|NCT01922115|UNC Chapel Hill|Dr. Elizabeth Geller|919-966-4717|elizabeth_geller@med.unc.edu|
21237484|NCT04977050|University of New Mexico|Dr. Akshay Sood|505-272-4751|ASood@salud.unm.edu|
21237485|NCT02157779|Providence VA Medical Center|M. Tracie Shea, PhD|401-273-7100|MaryTracie.Shea@va.gov|6248
21237486|NCT03610464|Tris Pharma, Inc.|Antonio Pardo MD|16107502210|apardo@trispharma.com|
21237487|NCT00487162|UMDNJ-NJMS|J. Jeffrey Freda, MD, MBA|973 972-5007|jjfreda@umdnj.edu|
21237488|NCT01292876|University of Pittsburgh|Maria Alexander, Office Manager|412-624-5308|alexanderm3@upmc.edu|
21237489|NCT01627327|GlaxoSmithKline|GSK Response Center|866-435-7343||
21237490|NCT01175850|Medtronic - CardioVascular|Clinical Research Director|+31433566580|kristel.wittebols@medtronic.com|
21237491|NCT04294966|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
21237492|NCT02525874|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21237493|NCT01692782|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
21237494|NCT02161133|Veterans Affairs New Jersey Healthcare System|Lisa McAndrew|862-400-3317|lisa.mcandrew@va.gov|
21237495|NCT04341116|I-Mab Biopharma US Ltd|Claire Xu|3177558242|Claire.Xu@i-mabbiopharma.com|
21237496|NCT02081573|University of Pittsburgh School of Nursing|Judith A. Callan|412-383-5321|callanja@pitt.edu|
21237497|NCT04109703|Soovu Labs|Charles Chabal, MD|206-579-4910|Chuck@Soovu.com|
21237498|NCT00338884|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21237499|NCT00423176|Merck, Sharp & Dohme Corp.|Senior Vice Presdient, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21237500|NCT02013622|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21237501|NCT00224874|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
21237502|NCT02355002|Massachusetts General Hospital|Drs. Joan Camprodon and Sabine Wilhelm|6177265340|jcamprodon@mgh.harvard.edu|
21237503|NCT05554237|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21237504|NCT04224155|Bausch & Lomb|Johnson Varughese|9089271162|johnson.varughese@bausch.com|
21237505|NCT05130970|CSL Behring LLC|Trial Registration Coordinator|610 878 4000|clinicaltrials@cslbehring.com|+1
21237506|NCT02921997|Vanderbilt Vaccine Research Program|C. Buddy Creech, MD, MPH|615-343-0332|buddy.creech@vanderbilt.edu|
21237507|NCT01904448|University of North Carolina at Chapel Hill|Craig A. Buchman, MD, FACS|314-362-7395|buchmanc@wustl.edu|
21237508|NCT03896035|VANTHCS|Una Makris, MD (PI)|2148570240|una.makris2@va.gov|
21237509|NCT01556438|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21237510|NCT03819491|Consult Med Iasi|Dr. Delia Reurean-Pintilei|+40232233387|drdeliapintilei@gmail.com|
21237511|NCT01506193|GlaxoSmithKline|GSK Response Center|866-435-7343||
21237512|NCT01839110|University of Pennsylvania|Dr. Yuchi Han|215-662-2855|yuchi.han@uphs.upenn.edu|
21237513|NCT01388816|Proprietary Products, Dr. Reddy's Laboratories, Inc.|Kent Allenby, MD|609-375-9855|kallenby@drreddys.com|
21237514|NCT04575467|Caliway Biopharmaceuticals Pty Ltd|Candra Chou|886226971355|candra.chou@caliway.com|1317
21237515|NCT00743366|New York State Psychiatric Institute|Dr. Ziva Cooper|646-774-6129|reslabsurc@gmail.com|
21237516|NCT00675766|West Los Angeles Veterans Association|Dr. Charles Hinkin|310-478-3711|chinkin@ucla.edu|44214
21237517|NCT01967732|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
21237518|NCT03028974|Stanford University|Cornelia Dekker, MD|650-724-4437|cdekker@stanford.edu|
21237519|NCT01955954|Palo Alto Health Sciences, Inc|Debra Reisenthel|9255948404|debra@pahealthsciences.com|
21237520|NCT01569438|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21237521|NCT01330433|Loma Linda University, Dept of Cardiovascular and Thoracic Surgery|Research Coordinator|909-558-4355|vayermiller@llu.edu|
21237522|NCT03084666|University of Alabama at Birmingham|Brant Wagener, MD, PhD|12059346007|bwagener@uabmc.edu|
21237523|NCT02300220|Imperial College London|Professor Jadwiga Wedzicha|02075947947|j.wedzicha@imperial.ac.uk|
21237524|NCT04322682|Montreal Heart Institute|Dr. Jean-Claude Tardif (Principle Investigator)|514 376-3330|jean-claude.tardif@icm-mhi.org|3612
21237525|NCT02238379|Yale University|Dr. Helena Rutherford|203-737-3408|helena.rutherford@yale.edu|
21237526|NCT04123067|Penn State Hershey Medical Center|Dr. Kerstin Bettermann|717-531-1803|kbettermann@pennstatehealth.psu.edu|
21237527|NCT00441090|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
21237528|NCT01441102|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov|
21237529|NCT03085485|University of Alabama at Birmingham|Bo Liu|(205) 975-7868|boliu@uabmc.edu|
21237530|NCT01022762|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21237531|NCT00605280|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21255397|NCT03437278|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21255398|NCT02202551|Adamas Pharmaceuticals, Inc.|Reed Johnson|510-450-3500|rjohnson@adamaspharma.com|
21255399|NCT02349451|AbbVie|Global Medical Services|800-633-9110||
21255400|NCT02168842|University of Rochester Medical Center, Department of Biostatistics and Computational Biology|David Oakes, PhD|5852752405|david_oakes@urmc.rochester.edu|
21255401|NCT02147353|Icahn School of Medicine at Mount Sinai|Dr. Shelbi C. Jim On|212-241-6500|shelbi.jimon@mountsinai.org|
21255402|NCT00592761|UAMS Medical Center|Gary McCullough|501-852-7886|mcculloughgaryh@uams.edu|
21255403|NCT02019888|NCRAR|M. Patrick Feeney|503-273-5306|Patrick.Feeney@va.gov|
21255404|NCT02311998|The University of Texas MD Anderson Cancer Center|Nitin Jain MD/Associate Professor|713-745-6080|njain@mdanderson.org|
21255405|NCT00550368|Stanford University|Dr. Julie Parsonnet|(650) 725-4561|parsonnt@stanford.edu|
21255406|NCT00186069|Stanford University|Anna Girsen, Manager of Research Operations|(650) 725-5720|agirsen@stanford.edu|
21255407|NCT01762722|Duke University Medical Center|Dr David MacLeod|919-812-3201|david.macleod@duke.edu|
21255408|NCT01794923|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21255409|NCT01749540|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21255410|NCT01581541|Stanford University School of Medicine|Dr. Shivaani Kummar|650-724-9084|skummar@stanford.edu|
21255411|NCT00576836|Duke University Medical Center|M. Louise Markert, MD, PhD Professor of Pediatrics and Immunology|919-684-6263|marke001@mc.duke.edu|
21255412|NCT00894686|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21255413|NCT03267940|Halozyme Therapeutics|VP, Medical, Regulatory and Drug Safety|858-794-8889|medinfo@halozyme.com|
21255414|NCT01074216|Memorial Sloan Kettering Cancer Center|Dr. Barrie Cassileth|646-888-0801|Cassileth@mskcc.org|
21255415|NCT01323634|GlaxoSmithKline|GSK Response Center|866-435-7343||
21255416|NCT01759407|Nationwide Children's Hospital|Nicole Elsey, MD|614-722-4200|Nicole.Elsey@nationwidechildrens.org|
21255417|NCT00742053|C.R. Bard|Christopher DiMatteo/Clinical Scineces Manager|801-522-5487|chris.dimatteo@crbard.com|
21255418|NCT02265367|University of Minnesota|Michael Kotlyar|612-625-1160|kotly001@umn.edu|
21255419|NCT03349892|University of California, Los Angeles|Robert K. Chin, MD, PhD , Assistant Clinical Professor|(310) 825-9771|rkchin@mednet.ucla.edu|
21255420|NCT02092220|Massachusetts General Hospital|Dr Steven J Russell|617-726-1848|sjrussell@partners.org|
21255421|NCT00960531|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21255422|NCT00593957|Kennedy Krieger Institute|Dr Sakkubai Naidu Professor of Neurology and Pediatrics|443-923-2778|naidu@kennedykrieger.org|
21255423|NCT02411578|Jaeb Center for Health Research|Stephanie DuBose|813-975-8690|t1dstats2@jaeb.org|
21255424|NCT00494481|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21255425|NCT00332189|BioMarin Pharmaceutical, Inc.|Medical Information Services|1-800-983-4587|medinfo@bmrn.com|
21255426|NCT02370043|Kaneq Bioscience Limited|Dr. Gosse Bruinsma|1-613-800-0955|gosse.bruinsma@kaneqbioscience.ca|
21255427|NCT01231516|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21255428|NCT02460666|University of California, Los Angeles|Helen Lavretsky, MD|(310) 794-4619|HLavretsky@mednet.ucla.edu|
21255429|NCT05266586|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
21255430|NCT02225353|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|clinical-trials@grunenthal.com|
21255431|NCT03707925|UT MD Anderson Cancer Center|Roberto Casal, MD/ Associate Professor, Pulmonary Medicine|713-745-2645|rfcasal@mdanderson.org|
21255432|NCT02876835|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21255433|NCT01117857|Massachusetts General Hospital|Dr. Marlene Freeman, MD|617-643-6403|mfreeman@partners.org|
21237532|NCT01302119|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@Pfizer.com|
21237533|NCT01662882|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
21237534|NCT01775904|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21237535|NCT00518115|GlaxoSmithKline|GSK Response Center|866-435-7343||
21237536|NCT04891419|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21237537|NCT01055769|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21237538|NCT04133831|Carnegie Mellon University|Gretchen Chapman|412-268-3665|gchapman@andrew.cmu.edu|
21255434|NCT04683731|Trustees of Indiana University|Dr. Peter H. Schwartz, MD, PhD|317-278-4037|phschwar@iu.edu|
21255435|NCT01411839|University of California, San Francisco|Dr. John A. Sauceda|415-460-6045|john.sauceda@ucsf.edu|
21237539|NCT00680407|Meda Pharmaceuticals, Inc.|Associate Director, Clinical Research and Operations||michael.purzycki@meda.us|
21237540|NCT01377480|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21255436|NCT03282240|Sanofi Pasteur Inc.|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21255437|NCT01675479|Abbott Medical Optics|Head of Clinical Science|714-247-8613|khileman@its.jnj.com|
21255438|NCT02910739|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21255439|NCT01572922|St. Jude Children's Research Hospital|Jane Hankins, MD|866-278-5833|Jane.Hankins@stjude.org|
21255440|NCT05312151|Compass Pathways|Chief Medical Officer|07443136539|info@compasspathways.com|
21255441|NCT00959647|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
21255442|NCT03824639|VA Boston Healthcare System|Dr. David Sparrow|857-364-6400|david.sparrow@va.gov|
21255443|NCT05959629|University of Pennsylvania School of Dental Medicine|Dr. Bekir Karabucak|215-898-4927|bekirk@upenn.edu|
21255444|NCT03620890|The University of Texas Health Science Center at Houston|Michal Fishel Bartal, MD, Assistant Professor|713-500-6421|Michal.F.Bartal@uth.tmc.edu|
21255445|NCT04596384|City of Hope|Virginia Sun, Professor|+16269888652|VSun@coh.org|
21255446|NCT04751656|University of Florida|Megan McVay|352-294-1638|megan.mcvay@ufl.edu|
21255447|NCT03253926|New York State Psychiatric Institute|Margaret Haney|646-774-6153|mh235@cumc.columbia.edu|
21255448|NCT01103245|Vanderbilt University Medical Center|James M. Luther|(615) 936-3420|james.luther@vanderbilt.edu|
21237541|NCT00915031|University of California, Irvine|Linda Huynh|7144567354|lindamh@uci.edu|
21299791|NCT04267380|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21237542|NCT00876915|University of Rochester|Charles Francis, MD|(585) 275-5823|charles_francis@urmc.rochester.edu|
21237543|NCT02673398|City of Hope|Dr. Yuan Yuan|626-359-8111|Yuyuan@coh.org|
21237544|NCT04128293|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21237545|NCT04177680|Matinas BioPharma|Dr. James J Ferguson, MD|(908) 505-0964|jferguson@matinasbiopharma.com|
21237546|NCT04924283|Medical University of South Carolina|Christine Hahn|843-518-2875|hahnc@musc.edu|
21299792|NCT00593346|Washington University School of Medicine|Imran Zoberi, M.D.|314-362-8525|izoberi@radonc.wustl.edu|
21237547|NCT00365391|Wayne State University|Philip A. Philip, M.D., Ph.D., F.R.C.P.||philipp@karmanos.org|
21237548|NCT03014674|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21237549|NCT03764449|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21237550|NCT05745142|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21237551|NCT00499031|NRG Oncology Statisics and Data Management Center, Buffalo Office|Melissa Leventhal|716-845-4030|mleventhal@gmail.com|
21237552|NCT00911534|Eisai Call Center|Eisai Inc.|888-422-4743||
21299793|NCT03155724|BIOTRONIK|Clinical Studies Engineer Manager|800-547-0394|crystal.miller@biotronik.com|
21255449|NCT05640466|Sohag University|Hussien Sedik Mohamed, Orthopedic Surgery Resident, Sohag University|+20-1065840049|hussien_sediek_post@med.sohag.edu.eg|
21255450|NCT01444651|Massachusetts General Hospital|Dr. Jennifer Ho|617-726-6411|jho1@partners.org|
21299794|NCT00849940|Duke University Medical Center|David MacLeod, M.B.|919-681-3551|david.macleod@dm.duke.edu|
21255451|NCT01929980|Cincinnati Children's Hospital Medical Center|Pooja Khandelwal, MD|513-803-9063|Pooja.Khandelwal@cchmc.org|
21255452|NCT03236246|Keryx|Keryx Medical Information|1-844-44-KERYX (844-445-3799)|medicalinfo@keryx.com|
21255453|NCT01570036|Cancer Insight|Program Director, Karen Arrington, RN, BSN|210-243-5711|karrington@cancerinsight.com|
21255454|NCT00969878|Baylor|Thomas Kosten|7137947032|kosten@bcm.edu|
21255455|NCT01676909|Department of Veterans Affairs, VAMHCS MIRECC|Mary Brighid Walsh|410-637-1860|marybrighid.walsh@va.gov|
21255456|NCT04615247|Principal Investigator|Alison Huang, MD|415-353-7900|alison.huang@ucsf.edu|
21255457|NCT00247377|UCI|Ninh Nguyen|714-456-8598|ninhn@uci.edu|
21255458|NCT00823901|MGH CURTIS|Alexandra B. Kimball, MD|617-726-5066|harvardskinstudies@partners.org|
21255459|NCT01369511|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21255460|NCT05057923|DreamTec Research Limited|Keith Kwong|+85237052355|keithkwong@dreamtec.hk|
21255461|NCT01376349|Alliance for Clinical Trials in Oncology|Debra Barton, R.N., Ph.D.||debbartn@med.umich.edu|
21255462|NCT00718640|Janssen Inc., Canada|Director, Medical Affairs Oncology|416-382-5078||
21255463|NCT00819286|Biomet Microfixation|Brian Hatcher|904-741-4400|brian.hatcher@biomet.com|
21255464|NCT05193500|New York University|Dr. Sudha Arunachalam|212-998-4139|sudha@nyu.edu|
21255465|NCT02064855|Stryker Spine|Marissa Conrad, Senior Director of Clinical and Medical Affairs|201-749-8162|marissa.conrad@stryker.com|
21299795|NCT01239511|Sinphar Pharmaceutical Co., Ltd.|Melanie Huang|886-2-27603688|wthuang@sinphar.com.tw|2190
21299796|NCT03309020|National Institutes of Health|Teresa Magone, MD, Principal Investigator, NEI|301-435-4562|teresa.magonedequadroscosta@nih.gov|
21299797|NCT01128049|University of Rochester Medical Center, Flaum Eye Institute|James Aquavella, MD|585-275-8944|James_Aquavella@URMC.Rochester.Edu|
21299798|NCT00601835|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21299799|NCT00880620|Impax Laboratories, LLC|Kaihong Jiang, Senior Director, Head of Biometrics|908-307-2234|kaihong.jiang@amneal.com|
21299800|NCT02787564|University of Hohenheim|Prof. Dr. Nanette Ströbele-Benschop|+49711 459 24260|N.Stroebele@uni-hohenheim.de|24260
21299801|NCT00880698|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
21299802|NCT05086705|The Ohio State University Comprehensive Cancer Center|Dr. Sagar Sardesai|614-293-6401|sagar.sardesai@osumc.edu|
21299803|NCT04972162|WSAUDAS|Dr. Veronika Littmann|+4991313080|veronika.littmann@wsa.com|
21299804|NCT02994108|Florida State University College of Medicine|Mary Gerend|8506451541|mary.gerend@med.fsu.edu|
21299805|NCT00089297|ECOG Statistical Office|Study Statistician|617-632-3012||
21299806|NCT00904969|American Medical System|Laura Olson, Clinical Project Manager|952-930-6000|laura.olson2@bsci.com|
21299807|NCT01097668|Apitope Technology (Bristol) Ltd|Chief Executive Officer|+44(0)117 3707720|keith.martin@apitope.com|
21299808|NCT04396756|Pliant Therapeutics, Inc.|Gregory P. Cosgrove, MD, Vice President, Clinical Development|1-650-481-6770|GCosgrove@pliantrx.com|
21299809|NCT00603408|Washington University School of Medicine|Rebecca Aft, M.D., Ph.D.|314-747-0063|aftr@wudosis.wustl.edu|
21299810|NCT01295814|IC Study, LLC|Philip C. Bosch, MD|760-743-3135|pboschmd@gmail.com|
21299811|NCT00574197|Cedars-Sinai Medical Center|Ernst Schwarz, MD, PhD|(310) 840-7089|Ernst.Schwarz@cshs.org|
21299812|NCT04515771|Richard L. Roudebush VA Medical Center|Dr. Johanne Eliacin|317-988-5000|Johanne.Eliacin@va.gov|
21299813|NCT02535481|UCL|EPIGRAAFT Trial team|020 7679 2000|epigraaft@gmail.com|
21299814|NCT00948246|Allergan Medical|Medical Monitor|(805) 961-5000|devicetrials@allergan.com|
21299815|NCT00148317|Weill Cornell Medical College|Jennifer Hess|6469629440|jmh2004@med.cornell.edu|
21299816|NCT02670811|Centro de Investigación en Alimentación y Desarrollo, A.C.|Dr. Belinda Vallejo Galland|526622892400|vallejo@ciad.mx|365
21299817|NCT04199351|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21299818|NCT00874510|Center for Health Incentives and Behavioral Economics|Kevin Volpp, MD, PhD|215.573-0270|volpp70@exchange.upenn.edu|
21237553|NCT02133534|Duke University Medical Center|Research Practice Manager|919 681 6819|bixby001@duke.edu|
21237554|NCT04322604|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
21255466|NCT01176773|Allergan Medical|Medical Monitor|(805) 961-5000|devicetrials@allergan.com|
21255467|NCT00927160|Icahn School of Medicine at Mount Sinai|Dr. William Hung|718-584-9000|william.hung@mssm.edu|
21255468|NCT04384848|Northwestern University|David Cella|312-503-1725|d-cella@northwestern.edu|
21255469|NCT01285050|Johns Hopkins University|David Thomas|410-502-6043|dthomas@jhmi.edu|
21255470|NCT01498289|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|mduong@fredhutch.org|
21255471|NCT01423253|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
21255472|NCT00078754|The University of Chicago|Dr. Emil F. Coccaro, MD|773-834-4083|ecoccaro@yoda.bsd.uchicago.edu|
21255473|NCT02804178|Millendo Therapeutics|Clinical Trial Information|+1 734-845-9000|millendo@millendo.com|
21255474|NCT01401907|MGH|Jennifer Temel MD|617-724-4000|jtemel@partners.org|
21255475|NCT01477320|University of Louisville|Dr. Mohamed Saad|5028525841|mohamed.saad@louisville.edu|
21255476|NCT02513745|Carolina Eyecare Physicians, LLC|Helga P. Sandoval, MD, MSCR. Director of Research|8438813937|helga.sandoval@carolinaeyecare.com|
21255477|NCT01116882|Harvard Clinical Research Institute|Priscilla Driscoll-Shemp|617-307-5200|priscilla.driscoll-shempp@hcri.harvard.edu|
21255478|NCT00547365|University of Tennessee Graduate School of Medicine|Alan Solomon, MD|865-305-9167|asolomon@utmck.edu|
21255479|NCT03933774|St. Vincent's Hospital|Dr. Jung Min Bae|82-31-881-8982|jminbae@gmail.com|
21255480|NCT00504881|UCB Clinical Trial Call Center|UCB (Study Director)|+1 877 822 9493||
21255481|NCT01777269|GlaxoSmithKline|GSK Response Center|866-435-7343||
21284874|NCT02651688|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21284875|NCT00625183|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21237555|NCT00420992|King Pharmaceuticals Research and Development, Inc.|Vice President, Clinical Development|919-653-7001||
21237556|NCT02003352|Brain Synergy Institute|Frederick R Carrick|321-868-6464|drfrcarrick@post.harvard.edu|
21237557|NCT00930293|University of Pittsburgh|Jill M. Cyranowski, PhD|412-246-5588|cyranowskijm@upmc.edu|
21237558|NCT00850473|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
21284876|NCT01863732|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
21237559|NCT02045238|Hospital Universitario - Sao Paulo University|Dr. Mateus Deckers Leme|X551130919200|mateusdl@gmail.com|9451
21237560|NCT02677116|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21284877|NCT03084315|University of Minnesota|Anne Joseph, MD, MPH|612-625-3789|lagre010@umn.edu|
21237561|NCT03342638|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
21237562|NCT00554970|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
21284878|NCT04424914|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21237563|NCT01292239|Janssen Pharmaceutical K.K., Japan|Director|81 3 44115639||
21237564|NCT03213158|University of Wisconsin - Madison|Fahid Aziz, MD|(608) 262-5420|faziz@wisc.edu|
21237565|NCT03649230|Purdue Pharma (Canada)|Graeme Donnelly|905.837-6498|graeme.donnelly@purdue.ca|
21237566|NCT00579280|University of South Florida College of Medicine|David V. Sheehan, MD, MBA|813-974-4544|dsheehan@health.usf.edu|
21237567|NCT01693068|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21284879|NCT00460746|Tibotec Therapeutics Clinical Affairs, Division of Centocor Ortho Biotech Services, LLC|Vice President, Tibotec Therapeutics Clinical Affairs|877-732-2488|rfalcon@its.jnj.com|
21237568|NCT04126408|northwell health|northwell health|5165620100|trebeiz@northwell.edu|
21237569|NCT00295022|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21284880|NCT00789685|Faron Pharmaceuticals Limited|Dr Ilse Piippo, MD|+358 2469 5151|ilse.piippo@faronpharmaceuticals.com|
21237570|NCT01551199|Michael E. DeBakey VA Medical Center|Dr. Ellen Teng|(713) 791-1414|ellen.teng@va.gov|25513
21237571|NCT00734630|Forest Laboratories, Inc.|Noah Rosenberg , MD, Exec. Dir, Clin Dev, Cardiovascular and Metabolism|2014278000|noah.rosenberg@frx.com|2133
21237572|NCT01239030|Rhodes Pharmaceuticals|Akwete Adjei, PhD|401-202-9408|Akwete.Adjei@pharma.com|
21237573|NCT02235493|Alexion Pharmaceuticals|Senior Medical Director, Clinical Development|203-272-2596|clinicaltrials@alxn.com|
21237574|NCT00827918|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21237575|NCT00802074|Garden State Infectious Disease Associates|David Condoluci|856-566-3190|dcondoluci@gsida.org|
21237576|NCT02979262|Yale University Child Study Center|Dr. Carla Stover|2037853486|carla.stover@yale.edu|
21237577|NCT02291614|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21237578|NCT00127101|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
21237579|NCT00843167|Oregon Health & Science University|Dr. Jackilen Shannon|541-706-6861|shannoja@ohsu.edu|
21237580|NCT03743038|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
21237581|NCT01159054|Brigham and Women's Hospital|Kambiz Zandi-Nejad|617-732-6660|kzandinejad@partners.org|34769 page
21237582|NCT01662310|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
21237583|NCT03088826|Maimonides Medical Center|Sergey Motov|718283600|smotov@maimonidesmed.org|
21237584|NCT03156660|University of Virginia|Dr. Rebecca Krukowski|4349245303|wae4mq@virginia.edu|
21237585|NCT02432105|Alcon, A Novartis Division|Clinical Scientific Director, GCRA - Global Clinical Development|1-888-451-3937|alcon.medinfo@alcon.com|
21255482|NCT00352911|VGX Pharmaceuticals, LLC|Mary Giffear, Sr. Clinical Scientist|267 440 4220|mgiffear@inovio.com|
21255483|NCT01783041|Children's Hospital at Montefiore, Albert Einstein College of Medicine|Mamta Fuloria|718-904-4105|mfuloria@montefiore.org|
21255484|NCT03717129|Johns Hopkins University|Dr. Craig Hendrix|4109559707|chendrix@jhmi.edu|
21255485|NCT03796260|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21255486|NCT00753272|GlaxoSmithKline|GSK Response Center|866-435-7343||
21255487|NCT01193920|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21255488|NCT03099005|UCSD|Brook Henry|(619) 543-4737|blhenry@ucsd.edu|
21255489|NCT04195958|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21255490|NCT02791737|The Ohio State University Comprehensive Cancer Center|Dr. Ashley Rosko|614-293-3196|Ashley.Rosko@osumc.edu|
21255491|NCT00883051|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21255492|NCT02513719|Abbott Vascular|Kusano Hajime|408-645-1626|hajime.kusano@av.abbott.com|
21255493|NCT02577601|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|503-494-0757|mccrimmo@ohsu.edu|
21255494|NCT01335009|Eisai Inc.|Eisai Medical Information|18882742378|esi_medinfo@eisai.com|
21255495|NCT04824521|University of Montana|Dr. Sarah Reese|7313940288|Sarah.reese@mso.umt.edu|
21255496|NCT01598311|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21255497|NCT00688103|School of Medicine, Toho University|Dr. Hideto Kameda|+81-3-3468-1251|hideto.kameda@med.toho-u.ac.jp|2326
21255498|NCT03144804|Massachusetts General Hospital|Aparna Parikh, MD|617-339-8452|aparna.parikh@mgh.harvard.edu|
21255499|NCT04223856|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
21255500|NCT04417127|Brown University School of Public Health|Omar Galarraga, PhD (Study Contact PI)|+1 (401) 863-2331|omar_galarraga@brown.edu|
21255501|NCT06060717|Fisher & Paykel Healthcare Ltd|Kelly Tay|+64 9-282-9734|kelly.tay@fphcare.co.nz|5634
21255502|NCT06018844|Children's Mercy Research Institute|Priscilla Connell|8166014543|Endocrine-RisingT1deAlliance@cmh.edu|
21255503|NCT05591274|University of Miami, Miller School of Medicine|Russell Saltzman|3052431152|R.Saltzman@med.miami.edu|
21255504|NCT02087748|Lotus Clinical Research, LLC|Anne Arriaga, VP of Clinical Operations|626-397-3412|anne@lotuscr.com|
21267129|NCT05158244|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21255505|NCT03219320|Aptinyx|Aptinyx Clinical Development|847-871-0377|clinicalstudies@aptinyx.com|1
21255506|NCT03078907|Actelion Pharmaceuticals Ltd|Clinical Registry group|844-434-4210|clinical-trials-disclosure@its.jnj.com|
21255507|NCT01955122|UMC Utrecht|Prof. Peter Siersema|+31 88 7559338|P.D.Siersema@umcutrecht.nl|
21255508|NCT01672788|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21255509|NCT02445196|Stanford University|Dr. C. Barr Taylor|415-987-1810|btaylor@stanford.edu|
21255510|NCT03874325|Moffit Cancer Center|Hung Khong, MD|813-745-3828|hung.khong@moffitt.org|
21255511|NCT03329196|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608 Japanese only|cti-inq-ml@ml.mt-pharma.co.jp|
21255512|NCT02464228|Kura Oncology, Inc.|Clinical Operations|+1 617-588-3755|KO-TIP-002@kuraoncology.com|
21255513|NCT00619190|UNC Chapel Hill|Linmarie Sikich, MD|919-972-7499|lsikich@med.unc.edu|
21255514|NCT02952001|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
21255515|NCT01774851|Merrimack Pharmaceuticals|MM-111 Medical Director|617-441-1000||
21255516|NCT00148954|Boston Scientific|Greg Voss, Clinical Director|651-581-3068|gregory.voss@bsci.com|
21255517|NCT01794520|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21255518|NCT00281021|James Graham Brown Cancer Center, University of Louisville|Dr. Goetz Kloecker|502-562-4358|ghkloe01@exchange.louisville.edu|
21255519|NCT04796896|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
21255520|NCT02021292|Actelion Pharmaceuticals Ltd.|Clinical Trial Disclosure Desk||clinical-trials-disclosure@actelion.com|
21255521|NCT06078579|Cairo university|Dr. Bahaa Mahmoud Fawzy|+201033559646|bahaamust66@gmail.com|
21255522|NCT05972733|HilleVax, Inc.|Astrid Borkowski, Chief Medical Officer|+1 (617) 213-6562|aborkowski@hillevax.com|
21255523|NCT01177787|Gachon University of Medicine and Science|Dr. Kyu Rae LeeMD.PhD.|8232-770-1215|baria07@daum.net|
21255524|NCT01637623|University of Wisconsin School of Pharmacy|John M. Dopp|608-265-9352|john.dopp@wisc.edu|
21255525|NCT02824263|Johns Hopkins University School of Medicine|Jonathan Jun|410-550-0115|jjun2@jhmi.edu|
21255526|NCT00568321|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21255527|NCT00980681|Guerbet|Pierre Desche, MD, Head of Clinical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
21255528|NCT01859078|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21255529|NCT01180998|Johnson & Johnson Vision Care|Kathy Osborn, OD|1-904-443-1032|KOsborn@its.jnj.com|
21255530|NCT01176968|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21255531|NCT04658186|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
21255532|NCT04098068|Sidney Kimmel Comprehensive Center at Johns Hopkins University|Dung Le, MD|443-287-0002|dle@jhmi.edu|
21255533|NCT03871829|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21255534|NCT02993523|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21255535|NCT03694418|Montana State University|Dr. Elizabeth Rink|4066000297|elizabeth.rink@montana.edu|
21255536|NCT04231539|Roswell Park Comprehensive Cancer Center|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
21255537|NCT01806129|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21255538|NCT04288778|Janssen Research & Development, LLC|Medical Advisor|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21255539|NCT04485104|Jazz Pharmaceuticals, Inc.|Director Clinical Trial Disclosure & Transparency|+1 215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
21255540|NCT04442737|Janssen Scientific Affairs, LLC|Vice President Medical Affairs Infectious Disease and Vaccines (IDV)|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21255541|NCT00744523|Medtronic Aortic and Peripheral Vascular|Arslan Malik, Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com|
21255542|NCT01139021|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21255543|NCT04092101|University of Vermont|Stacey C. Sigmon, PhD|802-656-9987|stacey.sigmon@uvm.edu|
21255544|NCT05057247|Dana-Farber Cancer Institute|Glenn J. Hanna, M.D.|617-632-309|glenn_hanna@dfci.harvard.edu|
21255545|NCT01720173|NRG Oncology|Angela Kuras on behalf of Wei Deng, PhD|716-845-5702|kurasa@nrgoncology.org|
21255546|NCT00784693|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21255547|NCT05458479|Massachusetts General Hospital Lurie Center for Autism|Dr. Robyn Thom|7818601700|rthom@mgh.harvard.edu|
21255548|NCT03673865|Emory University|Dina Amin|404-251-8895|dina.amin@emory.edu|
21255549|NCT03588728|University of Pittsburgh|Cynthia Conklin, Ph.D.|4125869840|conkca@upmc.edu|
21255550|NCT01388790|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21255551|NCT00908232|Janssen-Cilag Germany|EMEA Medical Affairs Director Oncology|+49 2137 955-492||
21255552|NCT03153137|Actelion Pharmaceuticals Ltd|Senior Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21255553|NCT01821378|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
21255554|NCT00195507|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21255555|NCT00528866|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21284881|NCT02791438|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21284882|NCT01603394|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21255556|NCT02888665|Northwestern University|Seth Pollack, MD, Director of Sarcoma Program|312-503-5320|seth.pollack@northwestern.edu|
21255557|NCT00993915|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21255558|NCT01386658|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21255559|NCT02267356|Mycovia Pharmaceuticals|Sr Vice President, Clinical Development|(919) 467-8539|info@viamet.com|
21255560|NCT02465463|Emory|Dr. Tanvi Dhere|404-686-1000|tdhere@emory.edu|
21255561|NCT01368809|Department of Anesthesiology at Cedars-Sinai Medical Center in Los Angeles|Paul F White|214-7703775|paul.white@cshs.org|
21255562|NCT01067326|Mayo Clinic|Dr. Amir Lerman|507-255-4152|lerman.amir@mayo.edu|
21255563|NCT00696761|the Department of Urology, Asan Medical Center, University of Ulsan College|Kanghyon Song, Myung-Soo Choo, Kyu-Sung Lee, Ji-Yeon Han, Young-Suk Lee,|82-2-3010-3735|mschoo@amc.seoul.kr|
21255564|NCT01230788|Emory University|Dr. Todd Cooper|404-785-3000|tmcoope@emory.edu|
21255565|NCT00323297|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21255566|NCT00564018|UT Southwestern Medical Center|Soumya Adhikari, MD|214 456 5959|soumya.adhikari@utsouthwestern.edu|
21255567|NCT00986440|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21255568|NCT01869075|Sunnybrook HSC|Artemis Diamantouros|416-480-6100|artemis.diamantouros@sunnybrook.ca|3654
21255569|NCT01721603|University of California, San Francisco|Alain Algazi, MD|(415) 353-7552|Alain.Algazi@ucsf.edu|
21255570|NCT00954421|University of Florida|Dr. Kelly Foote|352-273-5550|foote@neurosurgery.ufl.edu|
21255571|NCT02979925|VA San Diego Healthcare System|Albert Leung, MD|858-552-8585|albert.leung@va.gov|3866
21255572|NCT03231943|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21255573|NCT00658684|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21255574|NCT06605391|Emory University|Fayron Epps, PhD, RN|678-723-8188|fepps@emory.edu|
21255575|NCT01078220|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21255576|NCT03226275|Merck KGaA Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21255577|NCT03442114|Cincinnati Children's Medical Center|Dr. Lori Crosby|5136365380|Lori.Crosby@cchmc.org|
21255578|NCT01128361|University of Kansas Medical Center|Dr. Jeffrey Burns|913-588-0555|jburns2@kumc.edu|
21255579|NCT00530868|UAB|Lisle Nabell|205 934-3061|Lnabell@uabmc.edu|
21255580|NCT01681628|Thought field Therapy Foundation UK Ltd.|Dr R H Robson|+44 (0)1952550688|r.robson2@btinternet.com|
21255581|NCT00257686|Kowa Research Institute|Bill Arana|9194331600|barana@kowaus.com|
21255582|NCT00846651|Penn State Milton S. Hershey Medical Center|Sonia Vaida|7175318433|svaida@hmc.psu.edu|
21255583|NCT01566682|ProLung|Michael Garff, Chief Operating Officer|8012049625|mag@prolunginc.com|
21255584|NCT04229472|Oxford University Hospitals NHS Foundation Trust|Timothy R Betts|+44 (0)1865 220256|timothy.betts@cardiov.ox.ac.uk|
21255585|NCT04356183|Duke University|Kim Huffman, MD, PhD|919-613-7797|kim.huffman@duke.edu|
21255586|NCT05736211|Wake Forest University School of Medicine|Dr. Parissa Ballard|704-355-2000|parissa.ballard@advocatehealth.org|
21255587|NCT02158520|Mayo Clinic|Svetomir N. Markovic MD, PhD|507/266-0800|markovic.svetomir@mayo.edu|
21255588|NCT02634346|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
21255589|NCT00992511|GlaxoSmithKline|GSK Response Center|866-435-7343||
21255590|NCT02743377|National Institute of Mental Health|Dr Robert Innis|+1 301 693 2979|innisr@mail.nih.gov|
21255591|NCT02076113|Lahey Hospital & Medical Center|Zoher Ghogawala, MD|781-744-8984|zoher.ghogawala@lahey.org|
21255592|NCT03260595|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21255593|NCT05664763|Yale University|Stephen R Baldassarri, M.D.|203-785-3627|stephen.baldassarri@yale.edu|
21255594|NCT01087931|Vanderbilt University|Kevin O'Neill|615-936-5677||
21255595|NCT00769860|University of Kansas Medical Center|Dr. Richard Barohn|(913) 588-6094|RBAROHN@kumc.edu|
21255596|NCT01633814|University of Missouri|Principal Investigator|573-884-5220|fadelp@health.missouri.edu|
21255597|NCT00934141|University of Wisconsin - Madison|Dr. David H Gustafson|608-890-1436|dhgustaf@wisc.edu|
21255598|NCT00412971|Fredriksberg hospital|Gregers G. Hermann|(+45) 38163536|gregershermann@hotmail.com|
21255599|NCT01106404|Neuromodulation Emerging Therapy Clinical Research, Medtronic, Inc|Mark Sun, Senior Clinical Research Manager|763-526-8098|mark.sun@medtronic.com|
21255600|NCT01629784|Northwestern University|Hae Bae, CRCC|312-695-6829|j-bae@northwestern.edu|
21255601|NCT02430051|University of Southern California|Dr. Leah Stein Duker|(323)442-0371|lstein@chan.usc.edu|
21255602|NCT03681886|Alcon, LLC|Sr. Clinical Trial Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21255603|NCT02198430|Real Fundación Victoria Eugenia|Dr. Rubén Cuesta-Barriuso|+34913146508|ruben.cuestab@gmail.com|
21255604|NCT03272763|Fisher & Paykel Healthcare Ltd.|Rebecca Thomson|+64 9 574 0123|Rebecca.Thomson@fphcare.co.nz|7675
21255605|NCT01050907|Fast-Track Drugs and Biologics, LLC|Jonathan D. Berman|301-922-2097|jberman@fasttrackresearch.com|
21255606|NCT02030405|Stanford University Medical Center|Bruno Carneiro de Medeiros, MD|650-498-6000|bruno.medeiros@stanford.edu|
21255607|NCT00132496|Eisai Medical Research Inc.|Yufang Lu, MD, PhD, Study Director|201-403-2500||
21255608|NCT00287339|UNC_ChapelHill|Dr Nicholas Shaheen|919 9667047|nshaheen@med.unc.edu|
21255609|NCT00388154|University of Texas (UT) MD Anderson Cancer Center|Jubilee Brown, MD/Associate Professor, Gynecology Oncology & Reproductive Medicine|713-745-8837|CR_Study_Registration@mdanderson.org|
21255610|NCT03482583|University of Florida|Dr. Ramzi Salloum, Assistant Professor|352-294-4997|rsalloum@ufl.edu|3522944994
21255611|NCT04526197|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
21255612|NCT01209143|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
21255613|NCT00267631|Maimonides Medical Center|Dr. Estevan Garcia, MD; Principal Investigator|718-283-6352|EsGarcia@maimonidesmed.org|
21255614|NCT00381303|Tibotec Therapeutics Clinical Affairs (TTCA), Division of Centocor Ortho Biotech Services, LLC|Vice President, Tibotec Therapeutics Clinical Affairs|877-732-2488||
21255615|NCT01136811|University of Chicago|Shirley Rodriguez|773-834-4337|srodrigu@surgery.bsd.uchicago.edu|
21255616|NCT01211522|Vanderbilt University Medical Center|E Wesley Ely|‭(615) 936-3395‬|wes.ely@vumc.org|
21255617|NCT02441062|University of Iowa, Holden Comprehensive Cancer Center|M.Sue O'Dorisio|(319) 335-7234|sue-odorisio@uiowa.edu|
21255618|NCT01145755|AstraZeneca|Gerard Lynch|645895|aztrial_results_posting@astrazeneca.com|+44 1509
21255619|NCT02740972|NS Pharma, Inc.|Medical Affairs|(201) 986-3860|trialinfo@nspharma.com|
21255620|NCT00372385|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com|
21255621|NCT01966471|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21255622|NCT01222260|Columbia University Medical Center|Suzanne Lentzsch, M.D., PhD.|212-304-5485|sl3440@cumc.columbia.edu|
21255623|NCT05062083|National Institute of Mental Health (NIMH)|Dr. Robert Innis|301-594-1368|robert.innis@nih.gov|
21255624|NCT03481023|Riverside Medical Center|Dr. Brad Suprenant|(815) 939-9400|blsuprenant@comcast.net|
21255625|NCT01030198|Cynosure, Inc.|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
21255626|NCT02279862|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21255627|NCT03431857|Zimmer Biomet|Emilie Rohmer, Clinical Ops manager|+41588548210|emilie.rohmer@zimmerbiomet.com|
21255628|NCT01323621|GlaxoSmithKline|GSK Response Center|866-435-7343||
21255629|NCT01119001|University of Michigan|Jane Huggins|734-936-7177|janeh@umich.edu|
21255630|NCT04343248|Romark, L.C.|Sr. Director, Research Operations|8132828544|jessica.fulgencio@romark.com|
21255631|NCT05629962|Atea Pharmaceuticals, Inc.|Atea Clinical Trials|1-857-284-8891|ateaclinicaltrials@ateapharma.com|
21255632|NCT05245097|ActiveProtective|Dr Rebecca J Tarbert|267-242-6125|Rebecca@activeprotective.com|
21255633|NCT04770493|Brown University|Dr. Robert Miranda Jr.|401-863-6658|Robert_Miranda_Jr@brown.edu|
21255634|NCT00692978|Imperial College London|Dr Omar Usmani|02073158051|o.usmani@imperial.ac.uk|
21255635|NCT03604523|UMass Medical School|Dr. David Cave|508-856-8399|david.cave@umassmemorial.org|
21255636|NCT00458341|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
21255637|NCT05461794|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
21255638|NCT02083705|University of Alberta|Georg Schmölzer|7807354647|georg.schmoelzer@me.com|
21255639|NCT01162317|Atlanta VAMC|Wei Huang (PI)|404-321-6111|wei.huang@va.gov|6517
21255640|NCT05090995|Yale University School of Medicine|Lisa Fucito, PhD|203-200-1470|Lisa.fucito@yale.edu|
21255641|NCT02730598|University of Kansas Medical Center|Neil Segal|(913) 945-8985|segal-research@kumc.edu|
21255642|NCT00810394|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu|
21255643|NCT03254485|Akebia Therapeutics|Akebia Therapeutics|6178446128|trials@akebia.com|
21255644|NCT00467285|Samuel Stratton VAMC|Dr. Subhashini Yaturu|518-626-5642|Subhashini.Yaturu@va.gov|
21255645|NCT03891524|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21255646|NCT01104116|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
21255647|NCT02958267|OhioHealth|Joseph J Ruane, DO|614-566-3810|joseph.ruane@ohiohealth.com|
21255648|NCT00475033|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21255649|NCT00047320|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|Resultsreportingcoordinator@childrensoncologygroup.org|
21284883|NCT05811026|Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwan|Dr. Chang-Ming Huang|+886-2-23123456|daniel510791@gmail.com|262141
21255650|NCT04821869|Pulmonary Research Institute of Southeast MIchigan|Gary T Ferguson, MD, Director|248-478-6908|garytferguson@msn.com|
21255651|NCT04044183|Center for Health Outcomes and Interdisciplinary Research, Department of Psychiatry, Massachusetts General Hospital|Ana-Maria Vranceanu|(617) 724-3953|avranceanu@mgh.harvard.edu|
21255652|NCT04614662|The Hospital for Sick Children|Lillian Sung|4168135287|lillian.sung@sickkids.ca|
21284884|NCT00394771|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21299819|NCT03623243|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
21299820|NCT00979901|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21299821|NCT03924622|University of Washington|Becky Ostrem CIP Compliance Administrator, Regulatory Affairs|2066858138|bostrem@uw.edu|
21255653|NCT01603082|AstraZeneca|Tomas LG Andersson, MD, PhD|1-800-236-9393|ClinicalTrialTransparency@astrazeneca.com|
21299822|NCT00248625|University of Pittsburgh|Robert H. Squires, Jr.|412-692-8648|squiresr@upmc.edu|
21255654|NCT04086433|Regulatory Mark|Alison Sathe|5133047971|alison@regulatorymark.com|
21255655|NCT00852592|UPittsburgh|Assistant Professor of Psychiatry|412-246-5248|sitdk@upmc.edu|
21255656|NCT05467774|MetroHealth Hospital/Case Western Reserve University|Dr. James Sulzer|5125419036|jss280@case.edu|
21255657|NCT01452854|UCSF|Dr. Mitchell Rosen|415-353-7394|thomas.remble@ucsfmedctr.org|
21299823|NCT02464540|Federal University of Pelotas|Dr Noéli Boscato|5553999530000|noeliboscato@gmail.com|
21299824|NCT03284710|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
21299825|NCT02994238|Northwestern University|Kathy Boon- Clinical Research Associate|312-503-4687|kathy.boon@northwestern.edu|
21255658|NCT00846885|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21299826|NCT05941702|University of Manchester|Krishna Panchmatia|07857543272|krishna.panchmatia@postgrad.manchester.ac.uk|
21299827|NCT02814916|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21299828|NCT02047032|Gunang'anmen Hospital|Zhishun Liu|86 88002331|liuzhishun@aliyun.com|
21299829|NCT03359629|Maale Carmel Mental Health Center|Anatoly Kreinin|(+972) -4-8559315|kranata@gmail.com|
21299830|NCT00286468|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21299831|NCT02953652|Huya Japan G.K.|Huya Japan Clinical Development||japanclinical@huyabio.com|
21299832|NCT03679247|Brigham and Women's Hospital|Lipika Samal|6177327063|lsamal@bwh.harvard.edu|
21299833|NCT02887820|University of Pittsburgh|Amy Monroe|412-623-6382|monroeal@upmc.edu|
21299834|NCT00671658|The University of Texas (UT) MD Anderson Cancer Center|Hagop Kantarjian, MD./ Chair|713-792-7026|eharriso@mdanderson.org|
21299835|NCT00442169|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21299836|NCT01809938|GuysThomasNHSTrust / Rockingham General Hospital|Dr. Sam Hillyard|+61424055820|sghillyard@yahoo.co.uk|
21255659|NCT01862640|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|DT-inquiry@otsuka.jp|
21255660|NCT05085665|Washington University in St. Louis|Dr. Philip Budge|314-747-5532|pbudge@wustl.edu|
21255661|NCT01774084|Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset, Stockholm, Sweden;|Thomas Nyström MD, PhD|+4686163211|thomas.nystrom@ki.se|
21255662|NCT03026127|Weill Cornell Medicine|Dr. Dimitris Kiosses|914-997-4381|dkiosses@med.cornell.edu|
21255663|NCT03027557|Aalborg University Hospital|Professor Peter Vestergaard|+45 97 66 36 00|p.vestergaard@rn.dk|
21255664|NCT03270332|University of Miami|Dr. Adam Wanner|3053010563|awanner@miami.edu|
21255665|NCT01699789|RAND Corporation|Kenneth B. Wells|310-794-3728|kwells@mednet.ucla.edu|
21255666|NCT00822588|Astra Tech AB|Head of Clinical Research Area Health Care|+46317763000||
21267130|NCT00551200|Hyperion Therapeutics|Sr. Vice President and Chief Medical Officer, Bruce F. Scharschmidt|(650) 745-7851|bruce.scharschmidt@hyperiontx.com|
21267131|NCT02408016|FHCRC|Dr. Aude Chapuis|2066674369|achapuis@fredhutch.org|
21267132|NCT00805194|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21267133|NCT04334876|Indiana University|Courtney Rowan|317-944-7065|coujohns@iu.edu|
21267134|NCT02184520|Globus Medical|Jacqueline Myer|610-930-1800|jmyer@globusmedical.com|
21267135|NCT02185040|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|866-260-1599|ClinicalTrialDisclosure@Celgene.com|
21267136|NCT02530281|Dermira, Inc.|Eugene A. Bauer, MD, Chief Medical Officer|650-421-7202|eugene.bauer@dermira.com|
21284885|NCT03884985|University of Rochester|Martina Poletti|(585) 275-4801|martina_poletti@urmc.rochester.edu|
21284886|NCT02906033|Helsinki University Hospital|MNSc Maria Pulkkinen|+358 50 427 2678|maria.pulkkinen@hus.fi|
21284887|NCT00687882|Johns Hopkins All Children's Hospital|Dr. Neil A Goldenberg, Associate Dean of Research|727-767-3674|neil@jhmi.edu|
21284888|NCT01236326|Weill Cornell Medical College|Meredith J. Aull, Pharm.D.|(212) 746-0727|mea9008@med.cornell.edu|
21284889|NCT03092934|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
21284890|NCT02664922|University of California, Los Angeles|Jennifer Scovotti|310.206.4484|jscovotti@mednet.ucla.edu|
21284891|NCT00624650|OHSU|Samantha Ruimy|5034940724|ruimy@ohsu.edu|
21284892|NCT03782974|USANA Health Sciences|Dr. Jeremy Tian|01-801-954-7658|jeremy.tian@usanainc.com|
21284893|NCT00714753|Mayo Clinic|Thomas M. Pisansky, M.D.||Pisansky.Thomas@mayo.edu|
21299837|NCT03617172|Vanderbilt University Medical Center|Sr. Clinical Trials Operations Manager|6159360815|stephanie.anne.smith@vumc.org|
21299838|NCT02051452|Harvard Medical School|Dr. Ken Solt, MD, Associate Professor of Anaesthesia|6177264359|ksolt@mgh.harvard.edu|
21299839|NCT01166139|Hospital For Special Surgery|Annel Fernandez|212 774 2123|fernandeza@hss.edu|
21299840|NCT02587221|Seqirus|Seqirus Clinical Trial Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
21299841|NCT02546609|Nusirt Biopharma Inc.|Barbara Cannon|615-656-7898|BCannon@nusirt.com|
21299842|NCT02212015|Universität Heidelberg/Universitätsmedizin Mannheim|Prof. Dr. med. Peter Hohenberger|+49 0621 383 2609|peter.hohenberger@umm.de|
21299843|NCT03988400|Ralph H. Johnson VA|Jesse Dean|8437929566|deaje@musc.edu|
21299844|NCT04913610|Drugs for Neglected Diseases initiative|Clinical Trial Data|41 22 906 9230|ctdata@dndi.org|
21299845|NCT03186209|AstraZeneca|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
21237586|NCT00683826|Columbia University Medical Center|Henry N. Ginsberg MD, Gissette Reyes Soffer MD|2123059298|gr2104@columbia.edu|
21237587|NCT01302847|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|MPAACT.ctgov@fstrf.org|
21237588|NCT01565707|Astellas Pharma Europe B.V.|Medical Director, Medical Science - Urology||Astellas.resultsdisclosure@astellas.com|
21267137|NCT03557801|Vanderbilt University Medical Center|Dr. Lucy Spalluto|615 343 1187|lucy.b.spalluto@vumc.org|
21237589|NCT04365660|Stanford University|Dr. Kristen Ganjoo, MD|650-498-6000|kganjoo@stanford.edu|
21237590|NCT04302350|The First Affiliated Hospital of Nanjing Medical University|Dr.cunming Liu|13951890866|cunmingliu@njmu.edu.cn|
21255667|NCT04226833|Genentech, Inc|Medical Communications|800 821-8590|genentech@druginfo.com|
21255668|NCT02088788|Geisinger|Melissa Troup|570-214-5433|matroup@geisinger.edu|
21255669|NCT00364156|University of Pennsylvania|Dr. Caryn Lerman|215-746-7141|clerman@mail.med.upenn.edu|
21255670|NCT01050205|University of Pittsburgh|Dr. Andrea Kriska|412-383-1286|aky@pitt.edu|
21255671|NCT00324701|Ralph H. Johnson VAMC|Leonard E. Egede, MD, MS|843-789-6670|Leonard.Egede@va.gov|
21255672|NCT00403754|Novartis Pharmaceuticals|Study Director|862 778-8300||
21255673|NCT02075411|Children's Hospital of Philadelphia|Harshad Gurnaney, MBBS, MPH|215-590-1858|gurnaney@email.chop.edu|
21255674|NCT01891721|VA Greater Los Angeles Healthcare System|Dr. Carol Jahchan|310-478-3711|carol.jahchan@va.gov|42953
21255675|NCT00633061|Univesity of Oklahoma College of Medicine|Janna Journeycake, MD||janna-journeycake@ouhsc.edu|
21255676|NCT02000427|Amgen Inc.|Study Director|866-572-6436||
21255677|NCT02708095|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21255678|NCT05125679|Janssen-Cilag Limited|Senior EMEA Medical Advisor Immunology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21255679|NCT05640648|Yale School of Public Health|Dr. J. Lucian Davis|203-785-3665|lucian.davis@yale.edu|
21255680|NCT03829319|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21255681|NCT01005459|Wake Forest School of Medicine-Anesthesiology|Peter H. Pan MD, MSEE|336-718-8278|ppan@wakehealth.edu|
21255682|NCT02271477|Ente Ospedaliero Cantonale|Dr. med. Andrea Saporito, Vice-Director of Anaesthesiology|091/811.89.78|andrea.saporito@eoc.ch|
21237591|NCT01311674|Emergent Biosolutions|Christine Hall, Sr. Director Clinical Research||chall@ebsi.com|
21237592|NCT01371851|University of Arkansas for Medical Sciences|Alison Oliveto, PhD|501-526-8441|olivetoalison@uams.edu|
21237593|NCT02012491|University of Pennsylvania|Dr. Courtney Schreiber|215-615-5234|Courtney.Schreiber@uphs.upenn.edu|
21237594|NCT00450411|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21237595|NCT02430194|Eiger BioPharmaceuticals, Inc.|Senior VP, Clinical Development|1-650-618-1621|info@eigerbio.com|
21237596|NCT03969719|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21237597|NCT05608629|Icahn School of Medicine at Mount Sinai|Dr. Benjamin H Natelson|(212) 844-6665|Benjamin.Natelson@mountsinai.org|
21237598|NCT02130193|GlaxoSmithKline|GSK Response Center|866-435-7343||
21237599|NCT01212770|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21237600|NCT02243943|LUMC|Prof Dr A. Dahan|+31 71 526 2301|a.dahan@lumc.nl|
21237601|NCT00829387|VA Connecticut Healthcare System|Rebecca Czlapinski|203-932-5711|rebecca.czlapinski@va.gov|3357
21237602|NCT03036163|Nearmedic Plus|Viсtoria Shcherbakova|+7 (495) 741 49 89|Viktoriya.Shcherbakova@nearmedic.ru|3869
21237603|NCT00707031|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21237604|NCT02747238|Icahn School of Medicine at Mount Sinai|Dr. Barbara Orlando|917-496-7490|barbara.orlando@mountsinai.org|
21237605|NCT03195010|FHCRC|Dr Bethany Samuelson Bannow|5034949925|samuelsb@ohsu.edu|
21237606|NCT02680054|Oxford University Hospitals NHS Trust|Dr Rachel Besser|01865 741741|rachel.besser@ouh.nhs.uk|
21237607|NCT01951625|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21237608|NCT03962894|University of Florida|Jennifer Fishe|904-244-4046|Jennifer.Fishe@jax.ufl.edu|
21237609|NCT03854461|Queen's University Belfast|Prof. Jayne Woodside|+44 (0)28 9097 8942|j.woodside@qub.ac.uk|8942
21237610|NCT05616962|Primus Pharmaceuticals, Inc.|Director of Clinical Trials|480-483-1410|info@primusrx.com|
21237611|NCT02030015|University of Minnesota|Jeanine Jarnes, PharmD|612-626-5131|utzx0002@umn.edu|
21237612|NCT00514943|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21237613|NCT00833560|Jan-Cil Germany|Therapeutic Areas Director|+49 2137 955-492||
21237614|NCT00477230|CardioFocus, Inc.|Burke T. Barrett, Study Director|508 658-7200|bbarrett@cardiofocus.com|
21237615|NCT03382782|Illinois Institute of Technology|Dr. Lindsay Sheehan, Co-Investigator|312-567-7983|lsheehan@iit.edu|
21237616|NCT01316510|UC Davis|Mark Underwood|916-734-8672|munderwood@ucdavis.edu|
21255683|NCT01210118|Hellenic Anticancer Society|Professor Panagiotis Behrakis|00302106470056|pbehraki@hsph.harvard.edu|
21255684|NCT00777946|Novartis Pharmaceuticals|Study Director|862-778-8300||
21255685|NCT01079130|Novartis Pharmaceuticals|Study Director|862-778-8300||
21255686|NCT03221192|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21255687|NCT03019796|University of Castilla-La Mancha|Proffessor|925268800|ricardo.mora@uclm.es|
21255688|NCT01491893|Istari Oncology|Garrett Nichols, MD|(919) 245.7662|gnichols@istarioncology.com|
21255689|NCT00763867|Duke University|Jenny Ibarra|919.236.3291|jenny.ibarra@duke.edu|
21255690|NCT01389765|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21255691|NCT02069353|University of Pittsburgh|Jonathan Elmer|412-647-9489|elmerjp@upmc.edu|
21255692|NCT03645954|Lithuanian Univrsity of Health Sciences|Principal Investigator Inna Jaremko|+37064857386|inna.jaremko@kaunoklinikos.lt|
21255693|NCT01696942|Milton S. Hershey Medical Center|Dr. David Stewart|717-531-0003|dstewart@pennstatehealth.psu.edu|
21255694|NCT01422850|CytoVac A/S|Christer Lundell-Ek, Project Manager - Clinical Development||cle@cytovac.dk|
21255695|NCT04484831|University of Florida|Dr. Michelle Cardel, Adjunct Professor|352-273-8811|mcardel@ufl.edu|
21255696|NCT00508352|Ottawa Hospital Research Institute|Dr. Jean-Michel Caudrelier|613-737-8899|jcaudrelier@toh.ca|70216
21255697|NCT02244996|Hong Kong Polytechnic University|Dr. Henry Chan|85227667937|henryhl.chan@polyu.edu.hk|
21255698|NCT00174265|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21255699|NCT01473160|Alcon Research, Ltd.|Joachim Nick, Dipl. Ing.|+49 6022 240 520|joachim.nick@cibavision.com|
21255700|NCT03471871|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
21255701|NCT03040622|Inova Heart and Vascular Institute|Kevin Bliden|443-244-1497|kevin.bliden@inova.org|
21237617|NCT01785680|Washington University School of Medicine in St. Louis|Mark Manary|3144542178|manary@kids.wustl.edu|
21237618|NCT03409666|Zimmer Biomet|Lisette Smid|+31 62 395 6378|lisette.smid@zimmerbiomet.com|
21255702|NCT02818920|Duke University|Neal Ready, MD, PhD|919-681-6932|neal.ready@duke.edu|
21255703|NCT00445068|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21237619|NCT01866943|Hospital for Special Surgery|Research Fellow|917-843-6655|berlinerz@hss.edu|
21237620|NCT01666951|Veloxis Pharmaceuticals|Christina Sylvest|+4520553877|csy@veloxis.com|
21255704|NCT02673619|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21255705|NCT03444324|Biotest AG|Dr. Christina Erb|00496103801|christina.erb@biotest.com|0
21255706|NCT03834038|Vancouver Island Health Authority|Dr. Christine Lee|250-519-1898|christine.lee@islandhealth.ca|
21255707|NCT00724308|VA NY Harbor Healthcare System|Dr. Scott Sherman|212-686-7500|scott.sherman@va.gov|7386
21255708|NCT06071754|Masimo Corporation|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
21255709|NCT00234494|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
21255710|NCT04533451|Mayo Clinic|Dr. Aminah Jatoi|507-266-9160|Jatoi.Aminah@mayo.edu|
21255711|NCT00293722|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21255712|NCT00538304|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21255713|NCT05344092|Department of Veterans Affairs|Dr. Erin Reilly|781-687-2000|Erin.Reilly@va.gov|4191
21255714|NCT04498169|Aerie Pharmaceuticals Inc.|Michelle Senchyna, PhD. VP, Clinical Development and Medical Affairs.|+1 908-947-3551|msenchyna@aeriepharma.com|
21255715|NCT06069778|BioNTech SE|BioNTech clinical trials patient information|+49 61319084|patients@biontech.de|0
21255716|NCT03801902|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21255717|NCT02260882|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21255718|NCT02119325|GlaxoSmithKline|GSK Response Center|866-435-7343||
21255719|NCT01063829|AiCuris Anti-infective Cures GmbH|Chief Medical Officer|004920231763|info@aicuris.com|0
21284894|NCT02993354|Montefiore Medical Center|Dr. Peter Bernstein|718-904-2767|pbernste@montefiore.org|
21284895|NCT00505661|UT MD Anderson Cancer Center|John Kavanagh, MD / Professor|713-792-2933||
21284896|NCT02061683|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21284897|NCT01907217|St Patrick's University Hospital|Prof Declan McLoughlin|+353 1 2493343|d.mcloughlin@tcd.ie|
21284898|NCT03704948|University of Iowa|Lisa S. Segre|13193357079|lisa-segre@uiowa.edu|
21284899|NCT01726621|Medtronic MiniMed, Inc|Clinical Research Manager|8185765171|julie.sekella@medtronic.com|
21284900|NCT01764659|UMMC MSGCC|Howard Zhang, PhD|(410)706-6510|hzhang@umm.edu|
21284901|NCT04504175|Washington University in St. Louis|Dr. Eric Lenze|314-362-5154|lenzee@wustl.edu|
21284902|NCT01210352|Endo Pharmaceuticals|Saji Vijayan|(800) 462-3636|ClinicalTrials@Endo.com|
21284903|NCT03338569|University of Minnesota|Ronald Reilkoff, MD|612-624-0999|rreilkof@umn.edu|
21284904|NCT04607980|Amgen Inc.|Study Director|8665726436|medinfo@amgen.com|
21284905|NCT02379273|Cochlear Americas|Aaron J Parkinson, PhD, Principal Clinical Project Manager|3035242563|aparkinson@cochlear.com|
21284906|NCT00448812|Boston Scientific Corp.|G Mark Grubb, RN, CCRA|+1 (412) 716-0717|grubbm@bsci.com|
21284907|NCT01051440|Steward St. Elizabeth's Medical Center|Tara Lauriat|617-789-2404|tara.lauriat@steward.org|
21284908|NCT01854879|Cochlear Americas|Lori O'Neill Director of Research|(303) 790-9010|loneill@cochlear.com|
21284909|NCT02012959|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
21284910|NCT01212159|Temple University School of Medicine|Alfred A. Bove|215-707-9259|alfred.bove@tuhs.temple.edu|
21284911|NCT02135016|First Hospital of CMU|Dr. Jun Wang|8602483283100|wjun2000@hotmail.com|
21284912|NCT02788188|National Institute of Allergy and Infectious Diseases|Davey, Richard|+1 301 496 8029|rdavey@niaid.nih.gov|
21284913|NCT00582426|Novartis|Study Director|1-800-778-8300||
21284914|NCT00199849|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21284915|NCT00662311|Departments of Radiation Oncology and Global Health University of Washington Medical Center|Shilpen Patel|206-598-4100|shilpenp@uw.edu|
21284916|NCT02164318|Duke University Medical Center|Dr. Jeffrey Lawson|919-681-2533|lawso006@mc.duke.edu|
21284917|NCT04727528|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21284918|NCT04656301|NY State Psychiatric Institute|Dr. Franklin Schneier|6467748041|franklin.schneier@nyspi.columbia.edu|
21284919|NCT02508103|University of North Carolina at Chapel Hill|Dr. Susan Girdler|919-966-2179|susan_girdler@med.unc.edu|
21284920|NCT01467271|Guerbet|Corinne Dubourdieu, Head of Clinical Projects and Medical Writing|+33(0)1 45 91 50 00|corinne.dubourdieu@guerbet.com|
21284921|NCT03738163|Mölnlycke Health Care|Sabrina Chowdhury|+44 (0)7769 907654|sabrina.chowdhury@molnlycke.com|
21284922|NCT01964989|Seqirus|Clinical Study Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
21284923|NCT02815267|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
21284924|NCT02769312|Providence VA Medical Center, Center for Neurorestoration and Neurotechnology|Dr. Noah S. Philip|401-273-7100|noah.philip@va.gov|6235
21284925|NCT01579669|Portland State University|Christina Nicolaidis, MD, MPH|5037259603|nicol22@pdx.edu|
21284926|NCT04126317|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21284927|NCT00660595|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21284928|NCT01148459|GlaxoSmithKline|GSK Response Center|866-435-7343||
21284929|NCT00948922|H. Lee Moffitt Cancer Center and Research Institute|Dr. Melissa Alsina|813-745-7202|melissa.alsina@moffitt.org|
21284930|NCT04854057|Spaulding Rehabilitation|Dr. Randy Trumbower|6179526822|randy.trumbower@mgh.harvard.edu|
21284931|NCT02131233|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21284932|NCT05114564|CooperVision|José A. Vega, O.D., MSc., FAAO|925-621-3761|JVega2@coopervision.com|
21284933|NCT01679028|Tasly Pharmaceuticals, Inc.|Dr. Henry SUN|240-744-6225|henrysunusa@gmail.com|
21284934|NCT00177866|University of Pittseburgh|George Arnold, MD|412 621-2334|Arnoldgl@upmc.edu|
21284935|NCT00339833|National Institutes of Health|Jonathan Krakoff, M.D./National Institute of Diabetes and Digestive and Kidney Diseases|6022005217|jkrakoff@mail.nih.gov|
21284936|NCT00217581|Barbara Ann Karmanos Institute|Philip A. Philip, M.D., Ph.D., F.R.C.P|(313) 576-8746|philipp@karmanos.org|
21255720|NCT05073679|Penn State College of Medicine|Dr. Rosemary Claire Roden|717-531-1383|rroden@pennstatehealth.psu.edu|
21255721|NCT00533468|Children's Hospital of Philadelphia|Dr James Reingold|6027516093|reingoldj@email.chop.edu|
21255722|NCT00954174|NRG Oncology|Linda Gedeon on behalf of Virginia Filiaci, PhD.|716-845-1169|Linda.Gedeon@roswellpark.org|
21255723|NCT02234323|Bioverativ, a Sanofi company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6
21255724|NCT00559585|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21255725|NCT04209621|National Institutes of Health (NIH) / The National Heart, Lung, and Blood Institute (NHLBI)|Sun, Clare, M.D. Principal Investigator, NIH, NHLBI|301.402.1806|clare.sun@nih.gov|
21255726|NCT02249767|Spear Pharmaceuticals|Dr. Spear|239-560-2411|spear@spearpharm.com|
21255727|NCT01372410|GlaxoSmithKline|GSK Response Center|866-435-7343||
21255728|NCT02644941|Humacyte Global Inc|Shamik Parikh, Chief Medical Officer|919-313-9633|sparikh@humacyte.com|130
21255729|NCT04585646|CooperVision, Inc|Lee Hall, PhD|(925) 251 6684|lhall@coopervision.com|
21255730|NCT01145495|Weill Cornell Medical College|Peter Martin, M.D.||pem9019@med.cornell.edu|
21255731|NCT00706550|Michael E. DeBakey Veterans Affairs Medical Center|Dr. Maria C. Rodriguez-Barradas|713-794-7384|Maria.Rodriguez-Barradas2@va.gov|
21255732|NCT01886313|Winston Pharmaceuticals|Dr. Scott B. Phillips|8473628200|scott@winstonlabs.com|
21255733|NCT01207726|SKCCC|Charlie Rudin, MD|646.888.4527|rudinc@mskcc.org|
21255734|NCT04325308|University of Alabama at Birmingham|Ariel Salas|2059344680|asalas@uab.edu|
21255735|NCT04884763|Indiana University School of Dentistry|Dr. Domenick Zero|3179877507|dzero@iu.edu|
21255736|NCT03294109|university of Californiia|Siamak Rahman, MD|310 2678839|sirahman@mednet.ucla.edu|
21255737|NCT03030235|Saint Luke's Hospital of Kansas City|PRESERVED-HF Study Manager|816-932-9858|PRESERVED-HF@saint-lukes.org|
21255738|NCT01717768|TesoRx Pharma LLC|Michael Oefelein, MD, Chief Medical Officer|909-595-0500|karl@tesorx.com|104
21255739|NCT00448435|GlaxoSmithKline|GSK Response Center|866-435-7343||
21255740|NCT00809523|Yale University|Paul Desan, MD, PhD|203 785 2618|paul.desan@yale.edu|
21255741|NCT04195581|CooperVision, Inc|Jose Vega, OD, MSc, FAAO|925-621-3761|JVega2@coopervision.com|
21255742|NCT00821431|ConvaTec|Kim Peters, Director of Clinical Affairs|07889841338|kim.peters@convatec.com|
21255743|NCT01387230|GlaxoSmithKline|GSK Response Center|866-435-7343||
21255744|NCT03712189|Children's Hospital Los Angeles|Dr Todd P Chang|13233612109|tochang@chla.usc.edu|
21255745|NCT04561765|Yale University|Ondrej Blaha|203.737.4468|ondrej.blaha@yale.edu|
21255746|NCT01182766|University of Virginia School of Medicine|Dr. Nassima Ait-Daoud Tiouririne|(434) 243-0570|NAT7B@uvahealth.org|
21255747|NCT00717054|Drexel University College of Medicine|Michael Green, DO|215-762-7798|michael.green@drexelmed.edu|
21255748|NCT01009554|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
21255749|NCT01605253|Rush University Medical Center|Mark Pollack, MD|3129425372|mark_pollack@rush.edu|
21255750|NCT02554903|Actelion Pharmaceuticals US, Inc|Medical Affairs Associate Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21255751|NCT02973048|Centre Hospitalier Universitaire Saint Pierre|Panayota Kapessidou|+32.2.535|pkapessi@ulb.ac.be|3750
21255752|NCT01405937|Merck Sharp & Dohme Corp|Vice President, Late Stage Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21255753|NCT02340091|LG Chem|Study Leader|82-2-6987-4148|sodam@lgchem.com|
21255754|NCT04427501|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21255755|NCT03170154|Alcon Research, LLC|Sr. Clinical Trial Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21255756|NCT01906346|University of Kentucky|Joshua A. Lile, Ph.D.|859-420-0503|jalile2@uky.edu|
21255757|NCT04974515|University of Miami, Miller School of Medicine|Naresh M. Punjabi, MD, PhD|305-243-6388|npunjabi@miami.edu|
21255758|NCT04936841|University of Wisconsin School of Medicine and Public Health|Zachary Morris, MD, PhD|(608) 263-2603|zmorris@humonc.wisc.edu|
21255759|NCT00639223|U. of Pennsylvania Health System|Steven Halbert MD, MSCE|215 510 2221|shalbert@mail.med.upenn.edu|
21255760|NCT01244451|GIMEMA|Alfonso Piciocchi|+39 06 70390528|a.piciocchi@gimema.it|
21255761|NCT01163721|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21255762|NCT01786239|Northwell Health|Delbert Robinson MD|7184708195|drobinso@northwell.edu|
21255763|NCT00680823|Children's Hospital of Pittsburgh|Dr. Robert Hickey|412 692 7692|robert.hickey@chp.edu|
21255764|NCT02208297|Bausch Health|Study Director||susan.harris@bauschhealth.com|
21255765|NCT04484259|University of Florida College of Medicine Jacksonville|Francesco Franchi, MD|904-244-5515|francesco.franchi@jax.ufl.edu|
21255766|NCT03951220|University of Oxford|Gaurav Agarwal|07826636655|gaurav.agarwal@medsci.ox.ac.uk|
21255767|NCT04498832|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21255768|NCT04931836|University of Minnesota|Mark Pereira, PhD|612-624-4173|map@umn.edu|
21255769|NCT06389838|Kranus Health GmbH|Director of Clinical Trials|+491756939818|medical@kranushealth.com|
21255770|NCT06268288|Mayo Clinic|Lytitia Shea, M.D.|507-422-9847|shea.lytitia@mayo.edu|
21255771|NCT04893577|University of Utah MidValley Dermatology|Christopher Hull, MD|801-213-0375|adrianne.evans@hsc.utah.edu|
21255772|NCT02146326|Indiana University|Michelle Salyers, PhD / Professor, Department of Psychology|317-274-2904|mpsalyer@iupui.edu|
21255773|NCT03153111|Actelion|Clinical Scientific Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21255774|NCT05066724|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21284937|NCT02829047|Vibrant Gastro|Clinical trials manager|046663322|service@vibrantgastro.com|
21284938|NCT02020135|Progenics Pharmaceuticals, Inc.|Dr. Vincent A. DiPippo|(646) 975-2502|vdipippo@progenics.com|
21284939|NCT03077607|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21284940|NCT01597492|GlaxoSmithKline|GSK Response Center|866-435-7343||
21284941|NCT02570750|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21267138|NCT00535236|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21299846|NCT01026844|Massachusetts General Hospital|Lecia Sequist, MD|617-724-4000|lvsequist@partners.org|
21267139|NCT02390323|Hospital for Special Surgery|Semih Gungor|212-606-1206|gungors@hss.edu|
21267140|NCT00141297|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21267141|NCT01671176|Oticon Medical LLC|Ravi Sockalingam|9082023524|rsoc@oticomedical.com|
21267142|NCT02987205|Prollenium Medical Technologies, Inc.|Ario Khoshbin, President|866-353-3015||
21267143|NCT03558503|UroGen Pharma|Elyse Seltzer, MD|1-646-492-8518|elyse.seltzer@urogen.com|
21267144|NCT02481986|University of Illinois Chicago|Molly A Martin, MD|312-996-2363|mollyma@uic.edu|
21267145|NCT00848172|NINDS|Mark Hallett|301-496-9526|hallettm@ninds.nih.gov|
21267146|NCT04566445|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21267147|NCT02061540|Mirum|Study Physician|1 650-667-4085|medinfo@mirumpharma.com|
21267148|NCT01076270|Fred Hutchinson Cancer Research Center|Dr. William Bensinger|206-667-4730|wbensing@fredhutch.org|
21267149|NCT01948518|Cleveland Clinic|Umur Hatipoğlu, MD|216-636-5344|HATIPOU@ccf.org|
21267150|NCT04005755|AFT Pharmaceuticals|Jennifer Zhang -Project Leader|+ 64 9 488 0232|jenniferz@aftpharm.com|710
21267151|NCT04509024|Carnegie Mellon University|Dr. Seth Wiener, Associate Professor|412-268-5669|sethw1@cmu.edu|
21267152|NCT02561273|University of Nebraska Medical Center|Matthew Lunning|402-559-7164|mlunning@unmc.edu|
21267153|NCT02723019|Scripps Health|Athena Philis-Tsimikas, MD, Co-Principal Investigator|858-678-7045|philis-tsimikas.athena@scrippshealth.org|
21267154|NCT03597789|University of North Carolina at Chapel Hill|Deborah Jones, PhD|919-962-5082|djjones@email.unc.edu|
21267155|NCT00958191|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@stryker.com|
21267156|NCT00611767|Yale University School of Medicine|Dr. Ismene L. Petrakis, Professor of Psychiatry|203-932-5711|Ismene.petrakis@yale.edu|2244
21267157|NCT01642004|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21267158|NCT02718625|Smith & Nephew, Inc.|Natasha Schappell, Clinical Study Manager|817-302-3949|Natasha.Schappell@smith-nephew.com|
21267159|NCT00598806|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
21267160|NCT01818765|Oxford university hospitals NHS Foundation Trust|Dr James Gamble|+441865221012|drjgamble1@jhpg.net|
21267161|NCT01562327|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21267162|NCT01947127|Faculty of Medicine, Chulalongkorn University|Khrongwong Musikatavorn, M.D.|+6622564553|kmusikatavorn@yahoo.com|
21267163|NCT00170846|Novartis Pharmaceuticals|Study director|862-778-8300||
21267164|NCT00706264|Hospital Vall d'Hebron|Maria M Goya|934893085|maria.goya@vhir.org|4652
21267165|NCT02079311|Universitätsklinikum Gießen und Marburg GmbH|Prof Alexander Torossian|(+49) 06421 - 286 9864|alexander.torossian@med.uni-marburg.de|
21267166|NCT00887913|Syneron Medical Ltd|Hanit Brenner-Lavie|972-73-244-2200|hanitb@syneron.com|581
21267167|NCT03341728|University of North Caroilina at Chapel Hill|Jason R Franz, PhD|919-966-6119|jrfranz@email.unc.edu|
21267168|NCT01708915|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21267169|NCT01369069|University of Virginia|Karen C. Johnston, MD|434 924-5323|kj4v@virginia.edu|
21267170|NCT00721357|Ralph H Johnson VAMC|Chris Gregory|(843)792-1078|Christopher.Gregory@va.gov|
21267171|NCT02573012|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21267172|NCT01846208|Icahn School of Medicine at Mount Sinai|Dr. Hugh A. Sampson|212-659-9426|hugh.sampson@mssm.edu|
21267173|NCT01424306|Fred Hutchinson Cancer Research Center|Mario Kratz|206-667-7362|mkratz@fredhutch.org|
21267174|NCT03231228|B. Braun Medical Inc.|Diana Valencia MD|610-596-2875|diana.valencia@bbraunusa.com|
21267175|NCT00369928|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com|
21267176|NCT01875874|Vital Therapies, Inc.|Robert Ashley|858-673-6840|rashley@vitaltherapies.com|
21267177|NCT00407420|University of Bristol|Julian Hamilton-Shield|00441173420183|j.p.h.shield@bristol.ac.uk|
21267178|NCT02096471|The Univ of Alabama at Birmingham|Gary Cutter, PhD|205.975-5048|cutterg@uab.edu|
21267179|NCT00374127|New York State Psychiatric Institute at Columbia University Medical Center|Dr. Meg Haney, Professor of Neurobiology|6467746153|meg.haney@nyspi.columbia.edu|
21267180|NCT03344562|University of Texas Southwestern Medical Center|Dr. Amy Mathews - ASSISTANT PROFESSOR|214/645-1719|Amy.Mathews@UTSouthwestern.edu|
21267181|NCT01635244|University of Michigan|David Bach, MD|734-615-4907|dbach@med.umich.edu|
21267182|NCT01401101|RAND Corporation|Lisa S. Meredith, PhD|310.393.0411|seidel@rand.org|7365
21267183|NCT02463331|Clinic Hospital of University of Sao Paulo|Lydia Teófilo de Moraes Falcão|55-81-996486935|lydiatmf@yahoo.com.br|81
21267184|NCT02382276|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21267185|NCT01222416|Vanderbilt-Ingram Cancer Center|A Bapsi Chakravarthy, MD Program Director, Radiation Oncology|615-322-2555|babsi.chak@vanderbilt.edu|
21267186|NCT04840849|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21284942|NCT01410240|Baxter BioScience|Maurice Bagot D'Arc, MD, Sr Medical Director Medical Affairs , BioSurgery||maurice_bagot_d'arc@baxter.com|
21284943|NCT00496587|The University of Texas MD Anderson Cancer Center|Dr. Nazir Tannir/|713-792-7734|CR_Study_Registration@mdanderson.org|
21284944|NCT00482170|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21284945|NCT01557517|National Cancer Institute|Dr. Najla El Jurdi|240-992-4033|najla.eljurdi@nih.gov|
21284946|NCT00162097|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21284947|NCT01204918|Yale University|Gerard Sanacora, PhD, MD: Professor of Psychiatry; Director, Yale Depression Research Program|(203) 974-7535|gerard.sanacora@yale.edu|
21284948|NCT00004500|Discovery Laboratories, Inc.|Dr. Robert Segal|215-488-9300|rsegal@discoverylabs.com|
21299847|NCT05435339|Genmab|CLINICAL TRIAL INFORMATION|+45 7020 2728|clinicaltrials@genmab.com|
21267187|NCT00281528|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21267188|NCT02313506|Arthritis Research Canada|Dr. Linda Li|604-207-4020|lli@arthritisresearch.ca|
21267189|NCT00945594|University of Oklahoma Health Sciences Center|Lieschen Quiroz, MD|405-271-8787|lieschen-quiroz@ouhsc.edu|
21267190|NCT02746991|EyePoint Pharmaceutical|Flavio Leonin Jr., MD|617-972-6024|fleonin@eyepointpharma.com|
21267191|NCT03049852|Cloudbreak Therapeutics, LLC|Dr, Jinsong Ni|9496789752|Ni-Jinsong@cloudbreaktherapeutics.com|
21267192|NCT02709889|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21267193|NCT00656799|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21267194|NCT05281094|HilleVax, Inc.|Astrid Borkowski, Chief Medical Officer|+1 (617) 213-6562|aborkowski@hillevax.com|
21267195|NCT03347279|AstraZeneca|Global Clinical Head|+1 302 885 1180|information.center@astrazeneca.com|
21267196|NCT02385292|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21267197|NCT01792024|University of Chicago|Dr. Aytekin Oto|773-834-7424|aoto@radiology.bsd.uchicago.edu|
21267198|NCT03818399|Virginia Commonwealth University|Roy Sabo, PhD|804-828-3047|roy.sabo@vcuhealth.org|
21267199|NCT00718887|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21267200|NCT00775138|Insmed|Dr. Kevin Mange, Sr. Vice President, Clinical Development|908-947-2651|Kevin.Mange@Insmed.com|
21267201|NCT00103207|ECOG Statistical Office|Study Statistician|617-632-3012||
21267202|NCT00811395|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi-aventis.com|
21267203|NCT02417129|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21267204|NCT01228149|Dept. of Ophthalmology, University Medical Center Mainz|Dr. Dr. Katrin Lorenz|00496131174069|lorenz@augen.klinik.uni-mainz.de|
21267205|NCT03442933|Universidad Europea de Madrid|Gerson Garrosa Martín|+34 663 294 774|g.garrosa@gmail.com|0034
21267206|NCT00890201|Hospital de La Serena|Marcelo A. Beltran, M.D. - Department of Surgery - Hospital de La Sererna|56 51 485923|beltran_01@yahoo.com|
21267207|NCT02181504|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21267208|NCT01671605|Vanderbilt University Medical Center|Valentina Kon|6153224883|valentina.kon@vanderbilt.edu|
21267209|NCT01469637|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21267210|NCT01371721|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21267211|NCT01795716|Shanghai Jiaotong University School of Medicine Ruijin Hospital|Dr. Zhou Li|13816510379|lizhou999_999@yahoo.com|
21267212|NCT02877134|Janssen Research & Development, LLC|DIRECTOR CLINICAL RESEARCH GI|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21267213|NCT01055457|Johson & Johnson Vision Care Inc.|Kristy Canavan, O.D.- PRINCIPAL RESEARCH OPTOMETRIST, Clin Ops|904-443-3500|KCANAVA2@its.jnj.com|
21267214|NCT04922710|AdventHealth Research Institute|Kirk Erickson, Director of Translational Neuroscience|412-576-3724|kirk.erickson@adventhealth.com|
21267215|NCT02031627|Tactile Medical|Susy Peters, Clinical Trial Manager|612-540-7175|speters@tactilemedical.com|
21267216|NCT00384449|Oregon Health & Science University|Dr. Christina J. Flaxel|(503) 418-3352|flaxelc@ohsu.edu|
21267217|NCT01100762|University of Maryland, Baltimore|Gad Alon, PhD, PT|410-706-7733|galon@som.umaryland.edu|
21267218|NCT03116841|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21267219|NCT03267576|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21267220|NCT00882362|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
21267221|NCT01268514|Medtronic|Andrea DiScipio, Clinical Research Associate|781-491-5350|andrea.l.discipio@medtronic.com|
21267222|NCT01432938|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21267223|NCT01601873|The University of Texas Health Science Center at Houston|Kristofer Charlton-Ouw, MD|(713) 486-5117|Kristofer.CharltonOuw@uth.tmc.edu|
21267224|NCT01555541|University of California, San Francisco|Charalambos Andreadis, MD, MSCE, Associate Professor of Clinical Medicine|877-827-3222|cancertrials@ucsf.edu|
21267225|NCT02736474|Shanghai Mental Health Center|Chief Physician Dr Du. Jiang Du|86-21-64387250|dujiangdou@163.com|
21267226|NCT03147495|PLA Institute of Orthopaedics, Xijing Hospital, Fourth Military Medical University, No.17, Changle West Road, Xincheng District, Xi'an, Shanxi Province, China|Dr. Cheng Huang|0086-57427754027|jfj113hc@163.com, jfj906hc@163.com|
21267227|NCT01024946|Memorial Sloan Kettering Cancer Center|Dr. Lee Krug|646-888-4201|krugl@mskcc.org|
21267228|NCT02483611|University of Sao Paulo|Dra Waynice Neiva de Paula Garcia|551636021000|waynicegarcia@gmail.com|2211
21267229|NCT02608892|Children's Hospital of Eastern Ontario|Dr Denise Harrison|613-737-7600|dharrison@cheo.on.ca|4140
21267230|NCT00877890|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21267231|NCT00984009|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21267232|NCT02871570|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21267233|NCT00928499|University of California, Irvine|Karen Noblett, MD|714-456-8564|knoblett@uci.edu|
21267234|NCT04396106|Atea Pharmaceuticals, Inc.|Atea Clinical Trials|1-857-284-8891|ateaclinicaltrials@ateapharma.com|
21267235|NCT01628718|Massachusetts Veterans Epidemiological Research and Information Center|Brett T. Litz, PhD|617-584-9314|litzb@bu.edu|
21267236|NCT00703781|ISTA Pharmaceuticals, Inc.|Tim McNamara, PharmD|949-788-6000|tmcnamara@istavision.com|
21267237|NCT03714256|Permobil|Vice President of Research and Innovation|+46703836763|karin.leire@permobil.com|
21267238|NCT01225211|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21267239|NCT01987609|UCSD Medicine|Director of Clinical Trials Unit|858-657-8322|dermstudies@Ucsd.edu|
21267240|NCT01134328|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
21267241|NCT00537810|Yale University School of Medicine|Dr. Carlos Grilo|2037852792|carlos.grilo@yale.edu|
21284949|NCT01963091|MUSC|Dr. Moran-Santa Maria|843-792-8187|moranm@musc.edu|
21267242|NCT01066546|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21267243|NCT03860181|Medical University of South Carolina|Josef Eichinger, MD|843-876-0111|eichinge@musc.edu|
21267244|NCT03452397|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
21267245|NCT00125268|Mayo Clinic|Dr. Matthew A. Butters|480-301-7745|butters.matthew@mayo.edu|
21267246|NCT00925522|St. Jude Medical|Nancy Ouch, Project Manager|949.769.5041|nouch@sjm.com|
21267247|NCT02253173|TherapeuticsMD|Sebastian Mirkin, MD, Chief Medical Officer|561-961-1900|sebastian.mirkin@therapeuticsmd.com|1952
21267248|NCT02561572|Sheffield Teaching Hospitals NHS Foundation Trust|Dr Matthew Wiles|00441142712381|matthew.wiles@sth.nhs.uk|
21267249|NCT02691468|Department of Anesthesiology and Pain medicine, Yeungnam University School of Medicine, Daegu, Republic of Korea|Sung Mee Jung, M.D|+82-53-620-3368|applejsm@gmail.com|
21267250|NCT05439876|School of Nursing, College of Medicine, National Taiwan University, Taipei, Taiwan|Shao-Yu Tsai|(02)23123456#288904|stsai@ntu.edu.tw|
21267251|NCT01436357|University of New Mexico and Johns Hopkins University|Kimberly Page, Ph.D., M.P.H. and Andrea Cox, M.D., Ph.D.|505-272-2520, 410-502-2715|pagek@salud.unm.edu, acox@jhmi.edu|
21267252|NCT03300557|University of Minnesota/Masonic Cancer Center|Britt Erickson|612-626-6283|bkeric@umn.edu|
21267253|NCT04960397|University of Maryland|Dr. James D. Campbell|410-706-5328|jcampbel@som.umaryland.edu|
21267254|NCT01394211|University of Arizona Cancer Center|Program Coordinator|5206260301|aselegue@email.arizona.edu|
21267255|NCT04191096|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21299848|NCT01283139|MedImmune, LLC|Gabor Illei, MD, Senior Director, Clinical Development|301-398-0000|IlleiG@Medimmune.com|
21299849|NCT03218384|NYU Langone Health|Stuart Katz, MD|2122633946|Stuart.Katz@nyulangone.org|
21299850|NCT02025179|Northwestern University|Dr. Thomas Schnitzer|312-503-2315|tjs@northwestern.edu|
21299851|NCT02362724|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
21299852|NCT01854359|National Institutes of Allergy and Infectious Diseases|Dr. Peter Kosa (Staff Scientist)|(301) 731-6444|peter.kosa@nih.gov|
21299853|NCT01927497|Academic medical center|prof. dr. P.J. Tanis|0031205669111|g.d.musters@amc.nl|
21299854|NCT00395746|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21299855|NCT04528641|Reithera|Medical Director|06 99775|roberto.camerini@reithera.com|352
21299856|NCT00517296|Vanderbilt University Medical Center|David A. Schwartz, MD|615-322-4643|david.a.schwartz@vanderbilt.edu|
21299857|NCT04764162|Virginia Tech|Dr. Kevin Davy|(540)231-3487|kdavy@vt.edu|
21299858|NCT03361137|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21299859|NCT05358366|University of North Carolina at Chapel Hill|Natalia Villegas Rodriguez, PhD|919-966-4260|navilleg@email.unc.edu|
21299860|NCT03009058|Immodulon Therapeutics Ltd|Chief Medical Odfficer|+44 (0)20 3137 6346|info@immodulon.com|
21299861|NCT05556265|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21299862|NCT02103309|Alcon Japan, Ltd.|Director of Clinical Trials|1-888-451-3937|alcon.medinfo@alcon.com|
21299863|NCT03077542|National Heart, Lung, and Blood Institute at National Institutes of Health|Courtney Fitzhugh, M.D.|301.402.6496|fitzhughc@nhlbi.nih.gov|
21267256|NCT03285061|Brigham & Women's Hospital|Dr. Christopher Chiodo|617-983-7363|cchiodo@bwh.harvard.edu|
21267257|NCT02683668|Imperial College London|Dr Omar Usmani|02073158051|o.usmani@imperial.ac.uk|
21267258|NCT00631969|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21267259|NCT03893630|University of Kentucky|Dr. John M. O'Brien|8592575158|john.obrien2@uky.edu|
21267260|NCT02390167|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
21267261|NCT00027027|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21267262|NCT00290329|GlaxoSmithKline|GSK Response Center|866-435-7343||
21267263|NCT02442765|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21267264|NCT00003389|ECOG-ACRIN Statistical Office|Study statistician|617-632-6012||
21267265|NCT01662752|St Mark's Hospital|Professor Robin Kennedy|+44(0)2082354046|robin.kennedy@nhs.net|
21267266|NCT05466240|Atea Pharmaceuticals, Inc.|Atea Clinical Trials|1-857-284-8891|ateaclinicaltrials@ateapharma.com|
21267267|NCT04880642|Vicore Pharma|CEO Carl-Johan Dalsgaard|+46 (0) 317880560|info@vicorepharma.com|
21267268|NCT00561795|GlaxoSmithKline|GSK Response Center|866-435-7343||
21267269|NCT02807376|Ethicon|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
21267270|NCT02009501|Mount Sinai St. Luke's|Dr. John C. Lantis II||JLantis@chpnet.org|
21267271|NCT00948389|Bristol-Myers Squibb|BMS Study Director||clinical.trials@bms.com|
21267272|NCT03574987|University of Bath|Professor Javier Gonzalez|0122538|j.t.gonzalez@bath.ac.uk|5518
21267273|NCT04586127|Wake Forest University School of Medicine|Dr. Emily Haines|(336) 716-5170|ehaines@wakehealth.edu|
21267274|NCT00932399|Seattle Epidemiologic Research and Information Center|Alyson Littman|206-277-4182|alyson.littman@va.gov|
21267275|NCT01072500|Wake Forest School of Medicine|Michael Miller|336-716-6837|mmiller@wakehealth.edu|
21267276|NCT01611558|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21267277|NCT01520727|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21267278|NCT03798366|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
21267279|NCT01245972|ucsdmed|S. Brian Jiang|8586571663|s2jiang@ucsd.edu|
21267280|NCT04005885|CooperVision. Inc|Jose A. Vega, O.D., MSc., FAAO|925 621 3761|javega@coopervision.com|
21267281|NCT00366106|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
21299864|NCT00795704|University of Mississippi Medical Center|Daniel Riche|601-984-2640|driche@umc.edu|
21299865|NCT03980730|vTv Therapeutics LLC|VP Clinical Operations|3368410300|jfreeman@vtvtherapeutics.com|
21267282|NCT01412333|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21267283|NCT02089191|Alcon Research, Ltd.|Global Medical Affairs Brand Lead - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21267284|NCT00750867|University of Massachusetts Medical School|Dr.Peter Novak|508-334-4973|novakp@ummhc.org|
21267285|NCT00394654|MedImmune|Don Raible, MD|301-398-0000|raibleD@medimmune.com|
21267286|NCT00474539|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21267287|NCT03442595|MedStar Health|Dr Michelle F Magee, Director MedStar Diabetes Institute|202-877-2383|michelle.f.magee@medstar.net|
21267288|NCT04050540|University of Washington, Department of Global Health|Jenell Stewart|206 520 3866|jenells@uw.edu|
21267289|NCT03018340|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
21267290|NCT01836549|University of Tennessee Health Science Center|Dr. Mehmet Kocak|9014482937|mkocak1@uthsc.edu|901
21267291|NCT04652102|CureVac AG|Clinical Trial Information|0049 6976805870|clinicaltrials@curevac.com|
21267292|NCT02192190|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21267293|NCT01657253|Laboratorios Sophia S.A. de C.V.|Leopoldo M Baiza-Duran MD, Director of Clinical Trials|52+ 33 30014200|leopoldo.baiza@sophia.com.mx|
21267294|NCT00381706|Dana Farber Cancer Institute|Peter Enzinger, M.D.||peter_enzinger@dfci.harvard.edu|
21267295|NCT02364999|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21267296|NCT00550615|University of Nebraska Medical Center|Julie M Vose|402-559-348|jmvose@unmc.edu|
21267297|NCT00598585|Charles R. Drew University|Theodore C. Friedman MD PhD|3106685197|theodorefriedman@cdrewu.edu|
21267298|NCT00545584|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21267299|NCT03514394|University of Washington|Morgan Johnson|17154161493|mjohn23@uw.edu|
21267300|NCT00461552|UT Southwestern Medical Center|Dr. Abhimanyu Garg|214-648-2895|abhimanyu.garg@utsouthwestern.edu|
21267301|NCT00523744|Novartis Pharmaceuticals|Study Director|862-778-8300||
21267302|NCT01289028|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
21299866|NCT01300728|Sutter Neurology Medical Group|Shawn Kile, MD|(916) 454-6850|KileS@sutterhealth.org|
21255775|NCT01313117|Northwestern University|Jeffrey Allen M.D.|312-695-8636|jallen1@nmff.org|
21255776|NCT01786187|Michigan State University|Amy Hoffman, RN, PhD|517 355 8348|amy.hoffman@ht.msu.edu|
21255777|NCT01350453|University of Southampton|Jane Burridge|+44(0)2380 598 885|jhb1@soton.ac.uk|
21255778|NCT03602261|OPKO Health|Akhtar Ashfaq|305-575-423|AAshfaq@opko.com|
21255779|NCT03706417|MaineHealth|Principal Investigator|207-396-6920|alexa.craig@mainehealth.org|
21255780|NCT05938998|University of Kansas Medical Center|Dr. Amy Bodde|913-588-7983|abodde@kumc.edu|
21255781|NCT01306890|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@Dendreon.com|
21255782|NCT02217436|Rady Children's Hospital San Diego|Dr. Amy Williams Bryl|8589668036|abryl@rchsd.org|
21255783|NCT02656420|JHSPH|Dr. Thomas W. Kensler|410-955-1292|tkensle1@jhu.edu|
21255784|NCT04612036|University of Tennessee|Michael LaCour|865-974-9376|mlacour@utk.edu|
21255785|NCT01088464|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21255786|NCT01611948|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
21255787|NCT01974089|Centre for Clinical Research, North Denmark Regional Hospital, Hjoerring, Denmark|Dorte Melgaard|+4526281086|dmk@rn.dk|
21255788|NCT04641299|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21255789|NCT03018587|Cutera, Inc.|Margot Doucette|(415) 657-5518|mdoucette@cutera.com|
21255790|NCT03662139|Department of PM&R, Marmara University School of Medicine|Naime Evrim Karadag-Saygi, Prof. Dr.|00902166570606|evrimkaradag4@hotmail.com|1628
21255791|NCT01890148|AstraZeneca|Larsson, Bengt|+46 (0) 317064277|ClinicalTrialTransparency@astrazeneca.com|
21255792|NCT01215175|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21255793|NCT01920594|GlaxoSmithKline|GSK Response Center|866-435-7343||
21255794|NCT00929656|Malcom Randall VAMC|Dr. Dorian Rose, Research Health Scientist|352-376-1611|Dorian.Rose@va.gov|5238
21255795|NCT01990534|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21255796|NCT01831544|Medtronic|Methee Schreuder|+31611597388|methee.schreuder@medtronic.com|
21255797|NCT03422172|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21255798|NCT04147234|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|001
21255799|NCT02496897|Altimmune|Stephanie Holland, Clinical Project Manager|240-654-1450|SHolland@Altimmune.com|40
21255800|NCT00140231|BIDMC|Christos Mantzoros|6176678633|cmantzor@bidmc.harvard.edu|
21255801|NCT01426516|Genomind|Dr. Rachel Scott|267-989-3435|rscott@genomind.com|
21255802|NCT05104476|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
21255803|NCT03865940|Vanderbilt University Medical Center|Shelby Meier, PhD - Senior Scientific Project Manager|6159369228|shelby.meier@vumc.org|
21255804|NCT02170389|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
21255805|NCT01621230|UTexasSouthwestern|Margaret Craig, MD|2142638919|maggieanes@gmail.com|
21255806|NCT02596620|Chang Gung Memorial Hospital, Taiwan|Dr. Wei-Chen Tai|886-975056026|luketai1019@gmail.com|
21255807|NCT01054144|Moffitt Cancer Center|Rachid Baz, MD|813-745-3163|Rachid.Baz@moffitt.org|
21255808|NCT03952585|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21255809|NCT02310672|Actelion Pharmaceuticals Ltd|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21267303|NCT04623255|University College London|Prof Marie Scully|+ 44 (0)20 3447 9884|m.scully@ucl.ac.uk|
21255810|NCT03258554|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
21255811|NCT04704336|NYU Langone Health|Olugbenga Ogedegbe, MD|646-501-3435|Olugbenga.Ogedegbe@nyulangone.org|
21255812|NCT03118674|Wake Forest School of Medicine|Herbert L. Bonkovsky, MD|3367137341|hbonkovs@wakehealth.edu|
21267304|NCT00998985|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21299867|NCT04076540|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21299868|NCT03474588|Yale University Department of Psychiatry|Dr. Brian Kiluk, Ph.D.|203-737-1544|brian.kiluk@yale.edu|
21299869|NCT03902418|University of CApe Town|Landon Myer|0829430578|landon.myer@uct.ac.za|
21299870|NCT04570930|University of Michigan|Dr. Noelle E Carlozzi|734-764-0644|PMR-CODAlab@med.umich.edu|
21255813|NCT00867113|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21255814|NCT01236105|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21255815|NCT02178553|Mayo Clinic Rochester|Dr. James D. Hannon|507-284-7289|hannon.james@mayo.edu|
21255816|NCT00695253|Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center|Rodney A. White, M. D.|310 963-5230|rawhite@ucla.edu|
21255817|NCT01641809|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21255818|NCT02097641|University of California San Francisco|Michael A. Matthay, MD|415-502-7434|michael.matthay@ucsf.edu|
21255819|NCT01444209|University of Texas Southwestern Medical Center|Dr. Robert Timmerman|214/645-7637|robert.timmerman@utsouthwestern.edu|
21255820|NCT04145544|Nurami Medical Ltd|Dr. Amir Bahar (COO & Clinical Director)|+972-747408888|Amir@nurami-medical.com|
21255821|NCT00651157|Mayo Clinic Cancer Center|Evanthia Galanis, M.D.||galanis.evanthia@mayo.edu|
21255822|NCT03510988|Weill Cornell Medicine|Katerina Dodelzon, MD|646 962 9650|kad9090@med.cornell.edu|
21255823|NCT00688181|Boston Scientific Corporation|Director, Clinical Operations|(952) 930-6300|Teresa.Takle-Flach@bsci.com|
21255824|NCT00408603|Sunesis Pharmaceuticals, Inc.|Dr. Linda Neuman, Vice President, Clinical Development|(650) 266-3760|lneuman@sunesis.com|
21255825|NCT01472380|Mutual Pharmaceutical Company, Inc.|VP, Clinical Development and Medical Affairs|215-697-1743|clinicaltrials@urlmutual.com|
21255826|NCT02511678|Galil Medical, a wholly owned indirect subsidiary of Boston Scientific|Sr. Clinical Trial Specialist|651-287-5000|GalilClinical@bsci.com|
21267305|NCT02152540|DVBIC, VA Palo Alto/Stanford School of Medicine|Dr. Maheen M. Adamson|6502136307|madamson@stanford.edu|
21267306|NCT00415623|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21267307|NCT01855867|The Fenway Institute|Dr. Kenneth Mayer, Medical Research Director|6179276374|kmayer@fenwayhealth.org|
21267308|NCT00193128|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21267309|NCT03516227|National Defense Medical Center, Taiwan|Dr. Yu-Ju Chen|886-287923100|judychen37@gmail.com|18762
21267310|NCT02520141|M D Anderson Cancer Center|Milind Javle|(713) 792-5434|mjavle@mdanderson.org|
21267311|NCT02036476|Dana-Farber Cancer Institute|Dr. Robert Haddad|617.632.3090|ROBERT_HADDAD@DFCI.HARVARD.EDU|
21267312|NCT02168816|Loyola University Medical Center|Michael Pinzur, M.D.|708-216-4993|mpinzu1@lumc.edu|
21267313|NCT01893879|Stanford University|Leslie Roche, RN|650-723-1396|lesroche@stanford.edu|
21267314|NCT00410514|Astellas Pharma Global Development, Inc. (APGD)|Associate Medical Director, Medical Sciences||ClinicalTrials.Disclosure@us.astellas.com|
21267315|NCT00060333|Mayo Clinic|Barbara A. Pockaj, MD|507/284-3559|pockaj.barbara@mayo.edu|
21267316|NCT00671515|University Hospitals Cleveland Medical Center|Dr. Joseph Calabrese|216-844-2865|Joseph.Calabrese@UHhospitals.org|
21267317|NCT02985684|W. L. Gore & Associates|Bryan Randall|928-864-4832|BRandall@WLGore.com|
21267318|NCT02020304|Wake Forest School of Medicine|Vernon H Ross MD|336-718-8278|vhross@wakehealth.edu|
21267319|NCT02469597|Northwell Health- Cohen Children's Medical Center|Dr. Kristy Williamson|718-470-7640|kwilliam12@nshs.edu|
21267320|NCT02308839|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com|
21267321|NCT01265719|Pfizer, Inc|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21267322|NCT00387829|Intergra LifeSciences|Director of Medical Affairs|609-275-0500|clinicalaffairs-neuro@integralife.com|
21267323|NCT01451203|Astellas Pharma Inc|Vice President, Japan/Asia Clinical Development||Astellas.resultsdisclosure@astellas.com|
21267324|NCT02554721|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21267325|NCT02049385|National Institute of Mental Health|Zarate, Carlos|+1 301 451 0861|zaratec@mail.nih.gov|
21267326|NCT04607291|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kris.Attwood@roswellpark.org|
21267327|NCT01749930|Bausch + Lomb, a division of Valeant Pharmaceuticals|H. DeCory, Director Medical Affairs|585 732-3284|heleen_H_decory@bausch.com|
21267328|NCT00945945|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21267329|NCT00626327|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21267330|NCT01619176|CNR IAC|DR. Christine Nardini|+393386947833|christine.nardini.rsrc@gmail.com|
21267331|NCT02967562|King's College London|Professor Anne Greenough|02032999000|anne.greenough@kcl.ac.uk|
21267332|NCT01800162|University of Pennsylvania|Dr. Kurt Barnhart|215-662-2974|KBarnhart@uphs.upenn.edu|
21267333|NCT00286156|Cleveland Clinic|Dr William Braun Consultant Staff Nephrology, Cleveland Clinic|216/444/6995|braunw@ccf.org|
21267334|NCT01173874|New York State Psychiatric Institute|Dr. Joshua Kantrowitz|646-774-8436|mcarlson@nyspi.columbia.edu|
21267335|NCT00676806|Tufts Medical Center|Andreas Klein, MD|617-636-8884|aklein2@tuftsmedicalcenter.org|
21267336|NCT02447952|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21299871|NCT00945009|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21299872|NCT03863795|National Cancer Institute|Annette Kaufman|301-467-8521|kaufmana@mail.nih.gov|
21299873|NCT03414983|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
21299874|NCT02608684|Cedars-Sinai Medical Center|Bobbie J. Rimel, MD|310-423-1126|Bobbie.Rimel@cshs.org|
21299875|NCT01910298|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21299876|NCT01775501|Massachusetts General Hospital|Dr. Lipika Goyal|617-724-4000|LGOYAL@PARTNERS.ORG|
21299877|NCT03037385|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21299878|NCT04273737|Columbia University Irving Medical Center|Dr. Heakyung Kim|212-305-9416|hk2641@cumc.columbia.edu|
21299879|NCT03937570|Division of Cardiac Surgery, Department of Surgery - University of Verona|Marzia Lilliu, MD, PhD|+39 3281383539|marzialilliu@gmail.com|
21299880|NCT03007966|Wake Forest University Health Sciences|Christopher Edwards|336-716-4498|chedward@wakehealth.edu|
21299881|NCT03365102|Brown University|Richard Jones|401-444-1943|rich_jones@brown.edu|
21299882|NCT00474487|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@Novartis.com|
21299883|NCT00419393|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
21255827|NCT01295281|Wellspect HealthCare|Dikran Shamoun|+46313764275|dikran.shamoun@wellspect.com|
21255828|NCT00292461|Eisai Co., Ltd.|Takao Ishii, Asia regulatory affaires|81-3-3817-3914||
21255829|NCT05101707|Medical University of South Carolina|Dr Dorothea Jenkins|(843)792-2112|jenkd@musc.edu|
21255830|NCT03049735|Myovant Sciences GmbH|Clinical Trials at Myovant|+1 650 238 0250|clinicaltrials@myovant.com|
21255831|NCT04225221|University of North Carolina at Chapel Hill|Jessica Baker, PhD|984-235-0858|jhbaker@med.unc.edu|
21255832|NCT02684357|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21255833|NCT01853982|Cubist Pharmaceuticals, Inc.|Vice President, Clinical Research|1.781.860.8660||
21255834|NCT00390910|GlaxoSmithKline|GSK Response Center|866-435-7343||
21255835|NCT01839487|Halozyme Therapeutics|VP, Clinical Development|858-794-8889|medinfo@halozyme.com|
21255836|NCT04585776|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21255837|NCT03877432|Taipei Medical University|Dr. Chih-Wei Peng|886-2-27361661|cwpeng@tmu.edu.tw|3070
21255838|NCT05772156|NewYork-Presbyterian Hospital, Columbia University Irving Medical Center|Intramuscular Methylergonovine to Decrease Blood Loss During Cesarean Delivery for Twins: A Triple-B|877-843-2229|hbg2115@cumc.columbia.edu|
21255839|NCT03872453|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
21255840|NCT00352885|Emory University|Bobbi Woolwine|404-712-9620|bwoolwi@emory.edu|
21255841|NCT01678209|Icahn School of Medicine at Mount Sinai|Beth Krone, PhD|212-241-8014|beth.krone@mssm.edu|
21255842|NCT02960113|Rutgers Robert Wood Johnson Medical School|Shaul Cohen, MD|732-235-8717|chohensh@rwjms.rutgers.edu|
21255843|NCT03756350|Venus Concept|Dr. Matthew Gronski|(888) 907-0115|mgronski@venusconcept.com|
21255844|NCT04283981|The University of Texas Health Science Center at Houston|Simon Young|(713) 486-2568|simon.young@uth.tmc.edu|
21255845|NCT03157232|Masimo|Tala Harake||studies@masimo.com|
21255846|NCT00928564|UC Irvine|Dr. Felicia Lane|17144566155|kbacca@uci.edu|
21255847|NCT04697264|University of Surrey|Miss Irene Ray|07490749704|i.ray@surrey.ac.uk|
21255848|NCT03434353|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21255849|NCT03739762|Kaiser Permanente|Dori Rosenberg, Principal Investigator|206-287-2532|dori.e.rosenberg@kp.org|
21255850|NCT00390611|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21255851|NCT01521897|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21255852|NCT00385203|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
21255853|NCT03308942|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21237621|NCT02366910|Coopervision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|jvega@coopervision.com|
21299884|NCT02220920|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21299885|NCT04392739|SIGA Technologies|Emily Blum, Assoc. Director of Clinical Research|541-224-1305|eblum@siga.com|
21299886|NCT05719311|Entero Therapeutics|VP, Regulatory, QA & Compliance|9194491484|AChandler@Enterothera.com|
21299887|NCT05176314|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21299888|NCT05753449|Allegheny Health Network|Megan Hendricks, regulatory Specialist|412-330-6206|megan.hendricks@ahn.org|
21299889|NCT05543265|Massachusetts General Hospital|Mark Clapp, MD|617-724-2000|mark.clapp@mgh.harvard.edu|
21299890|NCT05316597|University of Washington|Dr. Gregory Bratman|2065437591|bratman@uw.edu|
21299891|NCT02118584|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21299892|NCT04204447|University at Buffalo|Andrew Talal|7168884737|ahtalal@buffalo.edu|
21299893|NCT03557294|Arizona State University|Scott Leischow, PhD|602-496-3300|scott.leischow@asu.edu|
21299894|NCT02939287|Rush University Medical Center|Danielle Murphy, PharmD, BCOP, BCPS|3129472401|danielle_murphy@rush.edu|
21267337|NCT00579527|Duke University Medical Center|M. Louise Markert, MD, PhD Professor of Pediatrics and Immunology|919-684-6263|marke001@mc.duke.edu|
21267338|NCT00203294|Thomas Jefferson University|Kathleen Bradley|215-955-2025|Kathleen.Bradley@Jefferson.edu|
21267339|NCT02541994|Ochsner Health Services|Dr. Andrew Lawton|504-842-3995|andrew.lawton@ochsner.org|
21267340|NCT02405091|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
21267341|NCT01009333|Medtronic Neuromodulation|Maureen McGuire, Sr. Program Manager|763-526-8425|maureen.mcguire@medtronic.com|
21267342|NCT01948791|Novartis Pharmaceuticals|Study Director|862-778-8300||
21267343|NCT01056601|Masonic Cancer Center, University of Minnesota|Arkaduisz Dudek, M.D.|612-624-0123|dudek002@umn.edu|
21267344|NCT02815982|University of South Florida|Dr. Marilyn Stern|8139740966|mstern1@usf.edu|
21267345|NCT00135694|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21267346|NCT02584660|Janssen Scientific Affairs, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21267347|NCT00660816|CCCC|Dr. Afshin Dowlati|216-844-1228|afshin.dowlati@uhhospitals.org|
21267348|NCT00374452|VA Palo Alto Health Care System|Mary K. Goldstein, MD|650-493-5000|mary.goldstein@va.gov|1,1,62105
21267349|NCT01003067|Hirslanden Bern|Prof. Christoph A. Maurer|+41 31 335 33 33|christoph.maurer@hin.ch|
21267350|NCT01012037|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21267351|NCT02583711|Imperial College London|Ms Aliza Abeles|07834987667|aliza.abeles@gmail.com|
21267352|NCT02237898|Yale School of Medicine|Dr. Megan Smith|(203) 764-8655|megan.smith@yale.edu|
21267353|NCT02282930|Mayo Clinic|Dr. Fernando Fervenza|507-266-1045|fervenza.fernando@mayo.edu|
21267354|NCT06022224|ImmunityBio|Lennie Sender, Chief Operating Officer|855-797-9277|lennie.sender@immunitybio.com|
21267355|NCT00542425|Radius Health, Inc.|Program Director|(617) 551-4700|info@radiuspharm.com|
21267356|NCT00472043|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
21267357|NCT03726749|MGH|Dr Sebastian Unizony|617-726-7938|sunizony@mgh.harvard.edu|
21267358|NCT04957745|Schepens Eye Research Institute of Massachusetts Eye and Ear|Dr. Jaehyun Jung|6179122525|jaehyun_jung@meei.harvard.edu|
21267359|NCT03032523|Yale University|Laura Nally, MD, Instructor in Pediatrici Endocrinology|9728324734|laura.nally@yale.edu|
21267360|NCT02590406|Institut universitaire Cardiologie et Pneumologie de Québec|Dr Jean S Bussières|418-656-8711|jbuss@criucpq.ulaval.ca|2944
21267361|NCT05375838|ModernaTX, Inc|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
21267362|NCT00957723|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@Stryker.com|
21299895|NCT02927301|Genentech|Medical Communications|800-821-8590|genentech@druginfo.com|
21267363|NCT02178592|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21267364|NCT02975206|Menlo Therapeutics Inc.|Anna Gururajan|(650) 486-1416|agururajan@menlotx.com|
21267365|NCT00807989|Yonsei University Severance Hospital|Dr. Yoon||BILEE@yuhs.ac|
21267366|NCT01984294|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21267367|NCT03675685|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|ClinicalTrials@Endo.com|
21267368|NCT00392210|University of Rochester|Michael K. Flynn, MD|585-273-3232||
21267369|NCT02067104|University of Arizona|Amy Selegue|520-626-0301|aselegue@email.arizona.edu|
21267370|NCT02610231|Kyowa Kirin|Development Devision - Project Management Department|609-919-1100|kkd.clintrial.82@kyowakirin.com|
21267371|NCT01431794|Johns Hopkins University School of Medicine|Dr. Ana De Jesus-Acosta|443-287-0411|adejesu1@jhmi.edu|
21299896|NCT02218372|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
21299897|NCT02753283|University of Pittsburgh|Dr. Susan Greenspan|+14126922477|greenspn@pitt.edu|
21299898|NCT03406780|Capricor, Inc.|Mark Awadalla|858-727-1755|clinicaltrialsgov@capricor.com|
21299899|NCT04090203|Cleveland Clinic|Dr. Jaclyn Bjelac|216 445-1449|bjelacj2@ccf.org|
21299900|NCT01488045|St. Joseph Mercy Hospital|Robert K. Cleary, MD|734.712.8150|Robert.Cleary@trinity-health.org|
21299901|NCT05043363|Imperial College London|Mr James Kinross|02033121947|j.kinross@imperial.ac.uk|
21299902|NCT00333775|Hoffmann-La Roche|Medical Communications|800 821-8590||
21299903|NCT02476617|AbbVie|Global Medical Services|800-633-9110||
21299904|NCT01383928|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21267372|NCT01901679|The Rockefeller University|Dr. Peter R Holt|212-327-7706|holtp@rockefeller.edu|
21267373|NCT01279954|Oregon Health & Science University|Eric Suler, MD|503-494-5023|suhlere@ohsu.edu|
21267374|NCT02140762|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21267375|NCT02067806|Sintetica SA|Dr.Elisabetta Donati, Corporate Director Scientific Affairs|+41.91.640.42.50|edonati@sintetica.com|
21267376|NCT01711359|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21267377|NCT01066637|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
21267378|NCT01385098|Houston Methodist Hosptial|Sherman Vadim|713-441-5514|vsherman@tmhs.org|
21267379|NCT02698176|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21267380|NCT02449915|TriHealth Inc.|Jennifer Yeung, DO|513-463-4300|Jennifer_Yeung@trihealth.com|
21267381|NCT01497665|Angiochem Inc.|Betty Lawrence, Vice President, Development|514-788-7800|blawrence@angiochem.com|205
21267382|NCT01021293|GlaxoSmithKline|GSK Response Center|866-435-7343||
21299905|NCT02491684|AstraZeneca|Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21267383|NCT03502265|University of Southern California|Beth Smith|323-361-4670|beth.smith@usc.edu|
21299906|NCT01149096|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21299907|NCT01350947|Huntsman Cancer Institute|Mark Wade|801-213-5746|mark.wade@hci.utah.edu|
21255854|NCT01131351|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21255855|NCT02194062|Yale School of Medicine|Paul Neubauer|2037855430|paul.neubauer@yale.edu|
21255856|NCT01281007|EMS|Manager of Clinical Trials|+5501938874176|pesquisa.clinica@ems.com.br|
21255857|NCT05787782|Masimo|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
21255858|NCT01008696|Medical Affairs, Seoul, Korea|Clinical Research Associate|82-2-2094-4835||
21255859|NCT04964960|University of Kentucky|Dr. John Villano|859-323-0405|jlvillano@uky.edu|
21255860|NCT02960854|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email|Clinical.Trials@bms.com|
21255861|NCT00221195|Tulane University|Cindy Leissinger|504-988-5433|cleissi@tulane.edu|
21255862|NCT01247571|NRG Oncology|Linda Gedeon for William Brady, PhD.|716-845-1169|lgedeon@gogstats.org|
21255863|NCT00833911|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
21255864|NCT01383161|University of California, Los Angeles|Gary Small, MD|310-825-0291|gsmall@mednet.ucla.edu|
21255865|NCT02431650|Medicines for Malaria Venture|Dr. Jörg J. Möhrle|+41 22 555 0369|moehrlej@mmv.org|
21255866|NCT01736085|UCSD|Principal Investigator|8583001056|szhu@ucsd.edu|
21255867|NCT01423812|The Ruth M. Rothstein CORE Center|Gregory Huhn, MD|312-572-4575|ghuhn@cookcountyhhs.org|
21255868|NCT03942406|ILiAD Biotechnologies|Chief Medical Officer|800-603-3525|contact@iliadbiotech.com|
21255869|NCT01207596|International Clinical Research Institute|Srinivas Nalamachu|913-317-5300|nalamachu@yahoo.com|
21255870|NCT00216203|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
21255871|NCT01627002|ProtAffin Biotechnologie AG|ProtAffin Biotechnologie AG||office@protaffin.com|
21255872|NCT03155373|Imperial College Healthcare NHS Trust|Jonathan Afoke|02033132026|j.afoke@nhs.net|
21255873|NCT02616614|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
21255874|NCT02748018|Medtronic Diabetes|Colleen Haberman, Sr. Clinical Research Manager|6127503275|colleen.p.haberman@medtronic.com|
21255875|NCT02856893|EORTC|Yassin Pretzenbacher|+32 2 774 1365|yassin.pretzenbacher@eortc.org|
21255876|NCT01662115|Cleveland Clinic Florida|Chief Academic Office|9546595278|weisse@ccf.org|
21255877|NCT02691260|University of Wisconsin-Madison|Corrine Voils|608-262-9636|voils@surgery.wisc.edu|
21255878|NCT01324323|Celgene Corporation|Senior Manager, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21255879|NCT00537485|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6131-7366||
21255880|NCT01158651|UAB|Karen Cole-Plourde|205-934-5140|kplourde@uab.edu|
21255881|NCT01191541|Department of pediatrics, Institute of Hematology and Blood Diseases Hospital.|xiaofan Zhu|+86 22 23909001|xfzhu@ihcams.ac.cn|
21255882|NCT01601847|Case Western Reserve University|Dr. Anna Maria Hibbs|216-844-3387|annamaria.hibbs@cwru.edu|
21255883|NCT00631189|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21255884|NCT04464265|University of Michigan Medical School|Zirui Huang, PhD|734-615-2875|huangzu@med.umich.edu|
21255885|NCT01284062|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21255886|NCT00974090|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21255887|NCT05361668|Crinetics Pharmaceuticals, Inc.|Study Director|(858) 450-6464|medinfo@crinetics.com|
21255888|NCT00642382|Cartiva, Inc|Director Clinical Operations|770-754-3805|rtownsend@cartiva.net|
21255889|NCT01026142|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21255890|NCT00634010|The University of Texas (UT) MD Anderson Cancer Center|Eduardo Bruera, MD, Chair, Palliative Care Medicine||CR_Study_Registration@mdanderson.org|
21255891|NCT01019317|University of Texas (UT) MD Anderson Cancer Center|Elias Joseph Jabbour MD/Assistant Professor|713-792-4764|eharriso@mdanderson.org|
21255892|NCT01012739|Novartis Pharmaceuticals|Study Director|862 778-8300||
21255893|NCT04540133|UCSF|Dr. Alessandro Villa|415-476-2045|Alessandro.Villa@ucsf.edu|
21255894|NCT04029480|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21255895|NCT04786119|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
21255896|NCT06132763|Virginia Commonwealth University|Sarah Farthing|804-527-4756|sarah.malone@vcuhealth.org|
21255897|NCT03857321|Atrium Health Wake Forest|Suzanne Craft, PhD|336-713-8846|suzcraft@wakehealth.edu|
21255898|NCT03714425|Brigham and Women's Hospital|Robert Jamison|617-732-9046|rjamison@bwh.harvard.edu|
21255899|NCT03622619|Eye Research Group, SOVS, UNSW Sydney|Dr Jacqueline Tan|02 9385 6551|jacqueline.tan@unsw.edu.au|
21255900|NCT01658826|AiCuris Anti-infective Cures GmbH|Information Desk|+4920231763|info@aicuris.com|0
21255901|NCT00617188|Masonic Cancer Center, University of Minnesota|Peter Argenta, M.D.|612-626-6037|argenta@umn.edu|
21255902|NCT01377753|National Cancer Institute|Dr. Peter Pinto|240-760-6249|pintop@mail.nih.gov|
21255903|NCT03196232|Stanford University|George A Fisher, Colleen Haas Chair in the School of Medicine|650) 725-9057|georgeaf@stanford.edu|
21255904|NCT00866697|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
21255905|NCT00447382|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21255906|NCT02408861|Icahn School of Medicine at Mount Sinai|Dr Himanshu Joshi MBBS MPH PhD|2126599635|Himanshu.Joshi@mountsinai.org|
21255907|NCT04567615|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
21255908|NCT05028517|Mt. Hope Family Center, University of Rochester|Christie L. M. Petrenko, Ph.D.|5852752991|christie_petrenko@urmc.rochester.edu|241
21255909|NCT04890054|Oregon Rural Practice Research Network|Robert Durr, M.P.H.|503-418-3592|durrr@ohsu.edu|
21255910|NCT03022318|Robert W Snyder, MD, PhD, PC|Dr. Robert W. Snyder|5206616516|rsnyder781@gmail.com|
21255911|NCT00523718|Yale University|Christopher Pittenger|(203) 974-7675|christopher.pittenger@yale.edu|
21255912|NCT01436071|GlaxoSmithKline|GSK Response Center|866-435-7343||
21255913|NCT01194453|Sun Yat-sen University Cancer Center|Dr. Li Zhang|87342288|zhangli6@mail.sysu.edu.cn|
21255914|NCT03808688|Aerie Pharmaceuticals|VP, Medical Affairs|949-246-8731|jmwilliams@aeriepharma.com|
21255915|NCT01940354|Hospital of the University of Pennsylvania|Scott Trerotola, MD|215-662-6983|scott.trerotola@uphs.upenn.edu|
21255916|NCT01096342|Mayo Clinic Cancer Center|Shaji Kumar, M.D.||kumar.shaji@mayo.edu|
21255917|NCT00909792|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
21255918|NCT02393677|Govt. Medical College, Haldwani.|Dr. Bikramjit Das|(05946)-228393|bikramjit_81@rediff.com|
21255919|NCT00813319|Emory University Rollins School of Public Health|Dr. Ralph DiClemente, Principal Investigator|404-727-0237|rdiclem@emory.edu|
21255920|NCT01448213|Cornea Research Foundation of America|Marianne O. Price, PhD|317-814-2990|mprice@cornea.org|
21255921|NCT00454532|Bionovo|Mary Tagliaferri, MD|5106012000|clinicaltrials@bionovo.com|
21255922|NCT04906616|University of California, San Francisco|Dr. Amy Conroy|415-476-6021|Amy.Conroy@ucsf.edu|
21255923|NCT00607880|Mayo Clinic|Albert G. Hakaim, M.D.||Hakaim.Albert@mayo.edu|
21255924|NCT02267603|Cancer Immunotherapy Trials Network|Administrative Director|206-667-6609|citn.core.reg@hvtn.org|
21255925|NCT04606771|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21255926|NCT01346488|AbbVie|Global Medical Information|800-633-9110||
21255927|NCT01754857|University of Wisconsin Carbone Cancer Center|Julie Chang, MD|800-622-9822|clinicaltrials@cancer.wisc.edu|
21255928|NCT04682977|University of Illinois Chicago|Dr. Mansha Mirza|312-355-5427|mmirza2@uic.edu|
21255929|NCT03083847|National Institute of Allergy and Infectious Diseases|Patrick Duffy|(301) 761-5089|Patrick.Duffy@nih.gov|
21255930|NCT01214187|Brigham and Women's Hospital|Ivan Rosas, MD|617-278-0434|irosas@rics.bwh.harvard.edu|
21255931|NCT01233869|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21255932|NCT02967354|Uppsala University Hospital|Dr Per-Ola Carlsson|+46184714425|per-ola.carlsson@mcb.uu.se|
21255933|NCT03189862|University of Michigan|Leah E. Robinson|(734) 647-7645|lerobin@umich.edu|
21255934|NCT02545322|Department of Therapeutic Radiology and Oncology, Medical University of Graz|Peter Winkler, PhD (Head of Medical Physics)|+43 316 385|peter.winkler@medunigraz.at|83193
21255935|NCT03690141|Effector Therapeutics|Mark Densel, Vice President Development Operations|8589258215|mdensel@effector.com|
21255936|NCT00041067|SWOG|Study statistician|206-667-4623||
21255937|NCT00778622|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21255938|NCT04744285|Roswell Park Comprehensive Cancer Center|Kris Attwood|877-275-7724|askroswell@roswellpark.org|
21255939|NCT01822522|AMC Operations and Data Management Cener|Kim Mosby-Griffin|301-251-1161|kmosby@emmes.com|10158
21255940|NCT01807923|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21255941|NCT02403622|Microbiome Health Research Institute|Majdi Osman, MD, MPH|6175752201|mosman@openbiome.org|
21255942|NCT04721821|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21255943|NCT03836807|Dompé farmaceutici S.p.A.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
21255944|NCT00685685|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21255945|NCT04029116|SCYNEXIS|Dr. David Angulo|(201) 884-5471|david.angulo@scynexis.com|
21255946|NCT03531788|University of Pittsburgh|Roxanna M. Bendixen, Principal Investigator|4123836603|bendixen@pitt.edu|
21255947|NCT02469896|Barrow Neurological Institute|Shafeeq Ladha, MD|602-406-8989|Shafeeq.Ladha@Barrowneuro.org|
21255948|NCT02510560|Elgan Pharma Ltd.|Miki Olshansky, Chief Executive Officer|972-4-6098626|Miki@elganpharma.com|
21255949|NCT00882310|Columbia University|Paul Oberstein, MD|212-305-0592|po2178@cumc.columbia.edu|
21255950|NCT04722250|Medtronic Cardiovascular|Myra Fan Director|763 514 4000|rs.smarttrial@medtronic.com|
21255951|NCT01464229|MGH|Esther Howe|617-726-8895|ehowe3@partners.org|
21255952|NCT04233164|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Franco, Luis|+1 240 220 4366|luis.franco@nih.gov|
21255953|NCT02014740|University of Miami|Prof Gianluca Iacobellis|3052433636|giacobellis@med.miami.edu|
21255954|NCT03684642|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21255955|NCT04556396|Loyola University Medical Center|Kristin Baldea|708-216-9000|kbaldea@lumc.edu|
21255956|NCT01843218|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
21255957|NCT01431534|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21255958|NCT01643525|Johns Hopkins University|Dr. Paul Nyquist||pnyquis1@jhmi.edu|
21255959|NCT01959048|Hadassah-Hebrew University|Jacob Strahilevitz|972508946353|jstrahilevitz@hadassah.org.il|
21255960|NCT04201821|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
21255961|NCT01395316|University of Chicago|Dr. Adil Javed||ajaved@neurology.bsd.uchicago.edu|
21255962|NCT02540538|MaastrichtUMC|Astrid ML Oude Lashof, MD, PHD|0031433876644|a.oudelashof@mumc.nl|
21255963|NCT02846532|Janssen Research & Development, LLC|SR DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21255964|NCT05103280|University of Nebraska at Omaha|Sara A. Myers, PhD - Professor|(402) 554-3246|samyers@nebraska.edu; ffallahtafti@unomaha.edu|
21255965|NCT04908189|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
21255966|NCT05649657|New Taipei Municipal Tucheng Hospital, Chang Gung Memorial Hospital|Dr. Shu-Chun Huang|0952818169|h0711@ms13.hinet.net|
21255967|NCT04598477|Argenx|Regulatory Manager|Please email:|regulatory@argenx.com|
21255968|NCT05359003|Wake Forest University School of Medicine|Halley Alexander, MD, MS, FACNS|336-716-6898|halley.alexander@advocatehealth.org|
21255969|NCT05183360|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21255970|NCT05579990|University of Alabama at Birmingham|Dr. Camille Worthington|205-975-7274|cschneid@uab.edu|
21255971|NCT00607022|University of Iowa|Clark Stanford|319-335-7381|CStanford@uiowa.edu|
21255972|NCT01313650|GlaxoSmithKline|GSK Response Center|866-435-7343||
21255973|NCT04313153|Akebia Therapeutics, Inc.|Akebia Therapeutics, Inc.|6178446128|trials@akebia.com|
21255974|NCT05586269|Boston Children's Hospital|Dr. Allison Wu|6173556058|allison.wu@childrens.harvard.edu|
21255975|NCT04752475|Associate Professor of Prenatal Pediatrics at CUIMC|Russell Miller, MD|212-305-3151|rsm20@cumc.columbia.edu|
21255976|NCT04532372|City of Hope Medical Center|Dr. Sanjeet Dadwal|626-359-8111|sdadjeet@coh.org|
21255977|NCT03435003|Stony Brook University|Dr. Konstantinos Spaniolas|631-444-8330|konstantinos.spaniolas@stonybrookmedicine.edu|
21255978|NCT03998176|University of Nebraska Medical Center|Josh Havens|402-559-2674|jhavens@unmc.edu|
21255979|NCT00749879|Repros Therapeutics Inc, an Allergan Affiliate|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
21255980|NCT02348775|Baylor College of Medicine|R. V. Sekhar M.D.|713-798-3908|rsekhar@bcm.edu|
21255981|NCT03335163|University of Colorado Anschutz Medical Campus|Dr. Aaron Lazorwitz|3037242019|aaron.lazorwitz@cuanschutz.edu|
21255982|NCT04650282|University of Michigan|Michael Popovich|(734) 936-1808|mipopovi@med.umich.edu|
21255983|NCT02137512|Jaeb Center for Health Research|John Lum, Artificial Pancreas Project Director|8139758690|jlum@jaeb.org|
21255984|NCT02020863|University of California, Irvine Health|Maxime Cannesson, PhD|714- 456-5059|mcanness@uci.edu|
21255985|NCT01016964|Lexington International, LLC|David Michaels|5614170200|las@hairmax.com|
21255986|NCT00863109|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21255987|NCT00702845|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21255988|NCT00440700|University of Minnesota|Dr. Linda Chlan|612-624-6658|chlan001@umn.edu|
21255989|NCT02645760|Khonkaen University|Rungthip Chalermsan|+66 835603675|chalermsanrungthip@gmail.com|
21255990|NCT01524133|Atlanta VAMC|Sheila Rauch|404-321-6111|sheila.rauch@va.gov|3122
21255991|NCT00786825|University of Minnesota|Elizabeth Seaquist, MD|612-624-9176|seaqu001@umn.edu|
21255992|NCT04344860|University Of Pittsburgh|Nicoletta Machin|(412) 209-7280|machinnc2@upmc.edu|
21255993|NCT00467389|Substance Abuse Research Laboratory, Kansas City VA Medical Center|Kenneth Grasing|(816) 922-2756|kenneth.grasing@va.gov|
21255994|NCT03352011|VA Center for Integrated Heathcare|Dr. Kyle Possemato|315-425-4400|kyle.possemato@va.gov|53551
21255995|NCT00056862|National Institute of Diabetes and Digestive and Kidney Diseases|Jay H. Hoofnagle, M.D.|3014961333|hoofnaglej@extra.niddk.nih.gov|
21255996|NCT05341700|Virginia Tech|Dr. Enette Larson-Meyer|5402311025|enette@vt.edu|
21255997|NCT03574441|Augusta University|Efrain Riveros Perez|7067217361|eriverosperez@augusta.edu|
21255998|NCT03974334|University of Massachusetts Medical School|Dr. Paula Gardiner|7744416716|paula.gardiner@umassmed.edu|
21255999|NCT03326895|Ethicon Endo-Surgery|Jason Waggoner, PhD|+1 513.337.8310|jwaggon1@its.jnj.com|
21256000|NCT00931944|Knopp Biosciences|Head of Regulatory|4124881776|greg@knoppbio.com|
21256001|NCT01109173|Alcon Research|Dana Sager, Clinical Manager Group Leader|1-817-551-8603|dana.sager@alconlabs.com|
21256002|NCT03610399|Acre Health State Secretariat|Suiane Negreiros|55 68 9983 1266|omsvalle@hotmail.com|
21256003|NCT02340728|Memorial Sloan Kettering Cancer Center|Mark Schattner, MD|212-639-3148|schattnm@mskcc.org|
21256004|NCT04178967|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
21256005|NCT05211739|Alcon Research, LLC|Clinical Project Lead, CRD Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21256006|NCT00628251|AstraZeneca|Paula del Rosario|+44 7884 735492|ClinicalTrialTransparency@astrazeneca.com|
21256007|NCT00728481|Mayo Clinic|Dr. Amy Foxx-Orenstein, D.O., Associate Prof. of Medicine, College of Medicine|480-301-8806|foxx-orenstein.amy@mayo.edu|
21256008|NCT02354781|Nationwide Children's Hospital|Dr. Jerry Mendell|1-614-722-4877|Jerry.Mendell@nationwidechildrens.org|
21256009|NCT00626210|VAPAHCS|Dr. Jamie Zeitzer|6504935000|jzeitzer@stanford.edu|62410
21256010|NCT01463384|Huntington Medical Research Institutes|Principal Investigator|6263975840|mrs@hmri.org|
21256011|NCT01251120|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21256012|NCT01968070|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21256013|NCT03078595|Johann Wolfgang Goethe-University Frankfurt|Prof. Dr. med. dent. Peter Eickholz|+4915112433230|eickholz@med.uni-frankfurt.de|
21256014|NCT00890929|Stanford University Medical Center|Bruno C Medeiros, MD|650-498-6000|bruno.medeiros@stanford.edu|
21256015|NCT00108069|National Cancer Institute|Kathy Warren, M.D.|301-435-4683|warrenk@box-w.nih.gov|
21256016|NCT03367715|NYU Langone Health - Perlmutter Cancer Center|Sylvia Kurz, MD, PhD|212-731-6267|Sylvia.Kurz@nyulangone.org|
21256017|NCT01237340|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21256018|NCT01272947|Novartis Consumer Health S.A.|Clinical Project Leader|+41 22 3635528||
21256019|NCT02019420|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21256020|NCT02401412|Hollister Incorporated|Stacy Haddad, Global Clinical Affairs Director|847-680-2837|stacy.haddad@hollister.com|
21256021|NCT02374398|Eastern Maine Medical Center|Dr. Alexandru Seviciu|207-973-5918|aseviciu@emhs.org|
21256022|NCT02756351|CytaCoat AB|Dr Jacob Odeberg|+46 (0) 70 2087571|jacob.odeberg@scilifelab.se|
21256023|NCT06154213|University of Connecticut|Sherry Pagoto, PhD|(860) 486-5917|sherry.pagoto@uconn.edu|
21256024|NCT02742766|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21237622|NCT02623322|Hoffmann-La Roche|Medical Communications|(+41) 616878333|global.trial_information@roche.com|
21267384|NCT01273207|National Heart Lung and Blood Institute|Dr Richard Childs|+301-451-7128|childsr@nhlbi.nih.gov|
21267385|NCT01672827|GE Healthcare|Paul Sherwin, M.D.|1-609-514-6820|paulsherwin@ge.com|
21267386|NCT04235959|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21267387|NCT00125138|H. Lundbeck A/S|H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
21267388|NCT00041119|Dana-Farber Cancer Institute|Lawrence N. Shulman, M.D.|(617)-632-2277|Lawrence_Shulman@dfci.harvard.edu|
21267389|NCT03228836|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+8613382419112|jessica.yi@innoventbio.com|
21267390|NCT01722552|Boston University School of Public Health|Dr Lora Sabin|617-414-1272|lsabin@bu.edu|617
21267391|NCT00405756|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21267392|NCT02404792|University of Colorado|Kristine Erlandson (PI)|303-724-4941|kristine.erlandson@ucdenver.edu|
21267393|NCT02870348|Instituto Grifols SA|Sandra Camprubi|+34935710049|sandra.camprubi@grifols.com|
21267394|NCT01051856|Mayo Clinic|Florencia G. Que, MD|507-284-6178|que.florencia@mayo.edu|
21267395|NCT00672139|Salix Pharmaceuticals|David Sorscher|919-862-1827|david.sorscher@salix.com|
21267396|NCT02381795|Clinvest Research|Clinical Data Manager|417-883-7889|jsly@clinvest.com|
21267397|NCT02176226|Northwestern University|David C. Mohr, PhD|312-503-1403|d-mohr@northwestern.edu|
21267398|NCT03894501|Rutgers Robert Wood Johnson Medical School|Nina Cooperman|732-235-8569|cooperna@rwjms.rutgers.edu|
21267399|NCT01488994|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21267400|NCT02908841|Western Connecticut Health Network|Joann Petrini|203-739-6882|Joann.Petrini@wchn.org|
21267401|NCT02465957|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
21267402|NCT01117428|Symphogen A/S|Chief Scientific Officer|+45 8838 2600|info@symphogen.com|
21267403|NCT00602043|University of Pennsylvania|Dr. David Mankoff|(2015) 615-3687|david.mankoff@uphs.upenn.edu|
21267404|NCT01038635|The University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
21267405|NCT01227252|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21267406|NCT04912297|Finnish Institute for Health and Welfare|Dr. Merit Melin, Research manager||merit.melin@thl.fi|
21267407|NCT04542525|Alcon Research, LLC|Director of Clinical Projects, Surgical|+1-817-909-6199|jessie.hull@alcon.com|
21267408|NCT01034709|QIAGEN|Kevin Modarress, PhD Senior Manager Regulatory Affairs Operations NA, Regulatory Affairs|301-944-7103|kevin.modarress@qiagen.com|
21267409|NCT01060150|Medical Affairs / Janssen-Cil Korea|Clinical Research Director|82-2-2094-4518||
21267410|NCT01970540|Pharma Mar S.A.|Pharma Mar S.A.|0034918466000|clinicaltrials@pharmamar.com|
21267411|NCT02736149|Eiger BioPharmaceuticals, Inc.|Senior VP, Clinical Development|1-650-272-6138|info@eigerbio.com|
21267412|NCT00242710|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21267413|NCT01683058|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21267414|NCT01057394|CardioFocus, Inc.|Burke Barrett, VP, Regulatory & Clinical Affairs|508 658-7200|bbarrett@cardiofocus.com|
21267415|NCT01195636|Xenon Pharmaceuticals Inc.|Dr. Paul Goldberg, VP Clinical Development|604-484-3300|pgoldberg@xenon-pharma.com|
21267416|NCT03727802|Toray Industries, Inc|Clinical Trials Information Desk|+81-3-3245-8576|clinical-trials.toray.mb@mail.toray|
21299908|NCT04739982|Stanford University|Kaiti Dunlap, Clinical Research Coordinator|650-497-9214|kdunlap2@stanford.edu|
21299909|NCT03651765|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
21299910|NCT03267277|National Institute of Environmental Health Sciences|Dr. Adam Schiffenbauer|+1 301 451 6270|adam.schiffenbauer@nih.gov|
21299911|NCT00953667|UPenn|Muredach Reilly|215-573-1214|muredach@mail.med.upenn.edu|
21299912|NCT03521570|Emory University|Nabil F. Saba MD, FACP|404-778-0278|nfsaba@emory.edu|
21299913|NCT04076696|University of North Carolina at Chapel Hill|Director, Clinical Research, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
21299914|NCT00322881|Dana-Farber Cancer Institute|Ursula A. Matulonis, MD|617-632-2334|umatulonis@partners.org|
21299915|NCT03496844|University of Arizona|Phillip Kuo, MD PhD|5206268318|pkuo@arizona.edu|
21299916|NCT02151487|UT Southwestern Medical Center|Dawood Nasir|214-590-5352|Dawood.Nasir@UTSouthwestern.edu|
21299917|NCT00537394|ACTG Network Coordinating Center, Social & Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301)628-3313|ACTGCT.Gov@s-3.com|
21299918|NCT02183675|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21299919|NCT01521117|Oregon Health & Science University|Amie Hiller, MD|503 721 1091|peterami@ohsu.edu|
21299920|NCT01056822|Pharmaceuticals|Novartis|+1 (862) 778-8300||
21299921|NCT03896438|University of Minnesota|Melanie Stimac|612-301-2449|stima011@umn.edu|
21299922|NCT03025282|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
21299923|NCT00392392|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net|
21299924|NCT01377584|University of Pittsburgh|Faith Luyster, PhD|412-624-7910|fsl3@pitt.edu|
21299925|NCT01336933|University of Nebraska Medical Center|Julie M Vose|402-559-3848|jmvose@unmc.edu|
21299926|NCT04875013|DR. EYTAN A. DAVID, MD, Otolaryngologist|Dr. Eytan David|(604) 988-0598|dr.david@shaw.ca|
21256025|NCT01868139|University of Maryland School of Medicine|Dr. Bruce Greenwald|4103288731|bgreenwa@medicine.umaryland.edu|
21256026|NCT03140423|Division of Infectious Diseases, University of California Irvine School of Medicine|Dr. Susan S. Huang, MD, MPH|(714) 456-5047|sshuang@hs.uci.edu|
21256027|NCT05118204|Albert Einstein College of Medicine|Aaron Fox|718-920-7173|adfox@montefiore.org|
21256028|NCT06263582|UNC Lineberger Comprehensive Cancer Center|Sorgi Kate|919-966-5280|kasorgi@email.unc.edu|
21256029|NCT03454308|Medical University of South Carolina|Dr. Jessica Chandler|843-792-1928|chandlje@musc.edu|
21256030|NCT05393037|MSD|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21299927|NCT05135871|Shanghai LianBio Development Co., Ltd|Brianna Sun|+862123081188|brianna.sun@lianbio.com|
21299928|NCT00525512|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21256031|NCT02593786|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21256032|NCT01554488|William S. Middleton Memorial VA Hospital|Mihaela Teodorescu, MD-Principle Investigator|(608)2561901|mt3@medicine.wisc.edu|11080
21256033|NCT01474863|Vanderbilt University Medical Center|Todd Rice, MD|6153223412|todd.rice@vanderbilt.edu|
21256034|NCT00012298|Mayo Clinic|Thomas E. Witzig, M.D.||witzig.thomas@mayo.edu|
21256035|NCT00708175|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21256036|NCT02038920|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
21256037|NCT02383589|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21256038|NCT01829399|Anesthesiology Department, University of NC at Chapel Hill|Randall F. Coombs, M.D.|919-966-5136|rcoombs@aims.unc.edu|
21256039|NCT02906787|Perelman School of Medicine, University of Pennsylvania|Janet Audrain-McGovern, Ph.D. Director, Addictions, Department of Psychiatry|(215) 746-7145|audrain@pennmedicine.upenn.edu|
21256040|NCT01703663|University of Michigan|Devin L. Brown, MD, MS|734-936-9075|devinb@umich.edu|
21256041|NCT03823768|Medical University of South Carolina|Professor|8437922724|taberd@musc.edu|
21256042|NCT03901053|The University of Iowa|Jason M. Wilken, PT, PhD|319-335-6857|jason-wilken@uiowa.edu|
21256043|NCT02113579|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
21256044|NCT00726622|Mayo Clinic|Tonia M. Young-Fadok, M.D.||youngfadok.tonia@mayo.edu|
21256045|NCT02462928|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
21256046|NCT00395863|Bracco Diagnostics Inc.|Gianpaolo Pirovano, MD, Executive Director, Head Corporate Medical Development|609-514-2226|gianpaolo.pirovano@diag.bracco.com|
21256047|NCT03873493|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21256048|NCT04085341|Graybug Vision|Director, Global Clinical Development Operations|5622098872|bpatel@graybug.vision|
21256049|NCT00682565|Cytokinetics, Inc.|Medical Director|650-624-3053||
21256050|NCT01244243|University of California, Irvine|Steve Cramer|7144566876|scramer@uci.edu|
21256051|NCT02973425|UMass Chan Medical School|Rajani Sadasivam|15088568923|Rajani.Sadasivam@umassmed.edu|
21256052|NCT03503513|University of Michigan|Dr. Denise Tate|(734) 647-5195|dgtate@umich.edu|
21256053|NCT01170039|Emory University|Jennifer Christie|404-778-4594|jchris6@emory.edu|
21256054|NCT04621734|University of Texas Health Science Center at San Antonio|Dr. Veronica Armijo-Garcia|210-274-8969|mirelesv@uthscsa.edu|
21256055|NCT02366728|Duke University|Mustafa Khasraw, M.D.|919-668-6688|mustafa.khasraw@duke.edu|
21256056|NCT03632109|University of Washington|Dr. Lindley Barbee, Principal Investigator|206.744.2595|lbarbee@u.washington.edu|
21256057|NCT00966823|Rhode Island Hospital|Francois I. Luks, MD, PhD|401-228-0556|Francois_Luks@brown.edu|
21256058|NCT00059839|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21256059|NCT01187550|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21256060|NCT00733304|GlaxoSmithKline|GSK Response Center|866-435-7343||
21256061|NCT05178134|Scandinavian Biopharma Holding AB|Head of Clinical Development|+4684705600|info@scandinavianbiopharma.se|
21256062|NCT01330914|San Francisco Veterans Affairs Medical Center|Dr. Anne Schafer|(415) 221-4810|anne.schafer@va.gov|24895
21256063|NCT04504357|Boston University School of Public Health, Departments of Global Health and Epidemiology|Jacob Bor, ScD SM|(617) 358-2176|jbor@bu.edu|
21256064|NCT05352048|University of Kentucky|Dr. Francis Farhadi|859-323-5661|francis.farhadi@uky.edu|
21256065|NCT01660607|Stanford University|Dr. Everett Meyer|650-725-5816|evmeyer@stanford.edu|
21256066|NCT00998426|Johns Hopkins Medicine|Kirti Shetty, MD|202 660 5555|kshetty1@jhmi.edu|
21256067|NCT02308007|Curatek Pharmaceuticals|Vice President|847-806-7680|info@curatek.com|
21256068|NCT00528567|Hoffman-LaRoche|Medical Communications|800-821-8590||
21284950|NCT03517449|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21284951|NCT03319810|Sutter Institute for Medical Research|Carol Parise, PhD, Research Scientist|(916) 887-4744|PariseC@sutterhealth.org|
21284952|NCT01918072|VA Greater Los Angeles Healthcare System, West Los Angeles, CA|Donna L. Washington, MD, MPH|310-478-3711|donna.washington@va.gov|49479
21284953|NCT02893423|Maimonides Medical Center|Kalpana Tyagaraj|718-283-1753|KTyagaraj@maimonidesmed.org|
21284954|NCT04677387|University of North Carollina at Chapel Hill|Delesha Carpenter, PhD, MSPH|828-250-3916|dmcarpenter@unc.edu|
21284955|NCT00269477|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21284956|NCT00431067|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21284957|NCT01912352|Seoul National University|Dr. Jae-Won Kim|822-2072-3648|adore412@paran.com|
21284958|NCT03760458|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
21284959|NCT00750919|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21284960|NCT01701505|Big Grins Pediatric Dentistry|Dr. Gregory D. Evans, DDS|970-407-1020|greg@biggrinswithdrgreg.com|
21284961|NCT02445859|The Universit yof Leeds|Andrew Kirby|0044 113 3923989|a.kirby@leeds.ac.uk|
21284962|NCT00459368|Henry Ford Health System|L. Keoki Williams, MD, MPH|313-874-5454||
21284963|NCT02603926|UC Davis MIND Institute|Dr. Randi Hagerman|916-703-0247|rjhagerman@ucdavis.edu|
21284964|NCT02670382|Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University|Dr. Stefania Lamon-Fava, Scientist I|617-556-3105|stefania.lamon-fava@tufts.edu|
21284965|NCT03244618|Unilever|Dr Jane Matheson|+44 (0)1516413633|jane.matheson@unilever.com|
21256069|NCT03085758|Adrenomed AG|Jens Zimmermann|+49 (0) 3302 20 77 810|jzimmermann@adrenomed.com|
21267417|NCT01566981|Department of family medicine, Medical Faculty in Ljubljana|Dr. Rade Iljaž|'386 31 300- 381|radeiljaz@gmail.com|
21267418|NCT02177942|GlaxoSmithKline|GSK Response Center|866-435-7343||
21267419|NCT03427528|Northwestern University, CCH|Dr. Darius Tandon|+1 312 503 3398|dtandon@northwestern.edu|
21267420|NCT03062605|UCLA|Dr. Vladimir W. Spolsky|310-794-0700|vspolsky@dentistry.ucla.edu|
21267421|NCT04180475|University of Virginia|John Stankovic|434-982-2275|jas9f@virginia.edu|
21267422|NCT01234337|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21267423|NCT02139176|UNC Chapel Hill/UNC Project Lilongwe|Nora Rosenberg, PhD|+265 (0)99 109 0676|Nora_Rosenberg@unc.edu|
21267424|NCT01309646|GlaxoSmithKline|GSK Response Center|866-435-7343||
21267425|NCT02246309|Center for Human Reproduction|Dr. David Barad, Director of Clinical Research|2129944400|dbarad@theCHR.com|212
21267426|NCT00247962|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21267427|NCT02555722|CooperVision Inc.|Senior Manager, Clinical Research|925-730-6754|PChamberlain@coopervision.com|
21267428|NCT00702949|Mayo Clinic|Charles Loprinzi, M.D.|507/284-1623|cloprinzi@mayo.edu|
21267429|NCT01365195|Cedars Sinai Medical Center|Research project Advisor|310-423-1682|Ofelia.Elvir-Lazo@cshs.org|
21267430|NCT00824746|Chonnam National University Hwasun Hospital|Young-Chul Kim, MD, PhD|82-61-379-7614|kyc0923@jnu.ac.kr|
21267431|NCT03525613|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
21267432|NCT03480360|Dartmouth-Hitchcock Medical Center|Kenneth Meehan, MD|(603) 650-4628|Kenneth.R.Meehan@hitchcock.org|
21267433|NCT02365961|Hawkins Foundation|Hawkins Foundation Research Coordinator|864 454 7458|info@hawkinsfoundation.com|
21267434|NCT01315873|New York University School of Medicine|Michael Grossbard, MD|646 501 9305|Michael.Grossbard@nyumc.org|
21267435|NCT01756391|Boston Children's Hospital|Wanda Phipatanakul|617-355-6117|wanda.phipatanakul@childrens.harvard.edu|
21267436|NCT02120469|City of Hope|Dr. Yuan Yuan|626-359-8111|yuyuan@coh.org|
21267437|NCT01040728|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21267438|NCT02076243|Icahn School of Medicine at Mount Sinai|Dr. Philip Friedlander|212-824-8584|philip.friedlander@mssm.edu|
21267439|NCT00590031|Memorial Sloan Kettering Cancer Center|Dr. David Ilson, Attending|+1646-888-4183|ilsond@mskcc.org|
21267440|NCT01809327|Janssen Research & Development, LLC|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
21299929|NCT01601535|New Approaches to Neuroblastoma Therapy|NANT Medical Director|323-361-5687|nantops@chla.usc.edu|
21299930|NCT00534365|Cleveland Clinic|Lynn Borzi (Research Administrator)|216-445-3158|BORZIL@ccf.org|
21299931|NCT04576988|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21299932|NCT01938079|Columbia University|Amy L. Dzierba, Pharm.D., BCPS, BCCCP, FCCM|212-305-5852|ald9012@nyp.org|
21299933|NCT03371836|KennedyKrieger|Project Director|443-923-7600|Salpekar@kennedykrieger.org|
21299934|NCT04897711|Utah State University|Stephanie Borrie|435-797-1388|stephanie.borrie@usu.edu|
21299935|NCT04886154|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21299936|NCT05305443|University of Illinois Urbana Champaign|Dr. Liliane Windsor|217-300-1782|lwindsor@illinois.edu|
21299937|NCT03919773|UT Southwestern Medical Center|Dr. Steven Vernino|214-648-8816|steven.vernino@utsouthwestern.edu|
21299938|NCT02977403|Eunice Kennedy Shriver National Institute of Health, NIH|Dr. Jack Yanovski|301-496-0858|jy15i@nih.gov|
21299939|NCT04659044|Perlmutter Cancer Center at NYU Langone Health|Catherine Diefenbach M.D.|(212) 731-5670|Catherine.diefenbach@nyulangone.org|
21299940|NCT02891447|University of M D Anderson Cancer Center|Dr. Brian Badgwell|713-745-7351|bbadgwell@mdanderson.org|
21299941|NCT04966013|EmitBio Inc|Chief Medical Officer|919.321.1734|info@emitbio.com|
21299942|NCT03724942|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81363617366|CL_OPCJ_RDA_Team@otsuka.jp|
21299943|NCT04875975|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21299944|NCT02429830|Torax Medical, Inc|Senior Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21299945|NCT03960541|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21299946|NCT01395797|New York State Psychiatric Institute|Sandra Comer PhD|646 774-6146|sdc10@columbia.edu|
21299947|NCT02958917|National Jewish Health|Dr. Evans Fernández|303-388-4461|fernandezevans@njheallth.org|
21299948|NCT03714672|Grünenthal GmbH|Clinical Trial Helpdesk|+49 241 569|clinical-trials@grunenthal.com|3223
21299949|NCT03629535|NYU Langone Health|Greta Piper, MD|212-263-4778|Greta.Piper@nyulangone.org|
21299950|NCT02364700|New York University|Grace Kim PhD, OTR/L|121-998-5846|gjk207@nyu.edu|
21299951|NCT03904017|University of Colorado|Layne Dylla|303-724-1716|layne.dylla@cuanschutz.edu|
21299952|NCT00681044|Boston Medical Center|Dr. Vaishali Sanchorawala, Director of Stem Cell Transplant Program|617-637-7017|vaishali.sanchorawala@bmc.org|
21299953|NCT03649646|Boryung Pharm. CO., LTD|Myung Sook Hong|82-2-708-8238|mshong@boryung.co.kr|
21299954|NCT01074502|UNC Chapel Hill|Aida Lugo-Somolinos MD-PI|919-843-9447|alugosom@med.unc.edu|
21299955|NCT01691534|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|212-227-7540|Dan.Everitt@tballiance.org|
21299956|NCT00674817|GlaxoSmithKline|GSK Response Center|866-435-7343||
21299957|NCT00726063|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
21299958|NCT01231984|Becton Dickinson|Laurence Hirsch, MD|201-847-6513|Laurence_Hirsch@bd.com|
21267441|NCT03196973|Laboratorios Salvat, S.A.|Medical Director|933946400|ejimenez@svt.com|
21267442|NCT01610414|GlaxoSmithKline|GSK Response Center|866-435-7343||
21267443|NCT02176005|Da Volterra|Dr. Annie Ducher, Chief Medical Officer|+33 1 58 39 32 20|annie.ducher@davolterra.com|
21267444|NCT00826540|Mayo Clinic|Dr. Axel Grothey, M.D.|(507) 284-4430|grothey.axel@mayo.edu|
21267445|NCT01166386|Carolinas Healthcare System, Carolinas Medical Center|Dr. Janet Niemeier|704 355 2046|janet.niemeier@carolinashealthcare.org|
21299959|NCT02182895|Brigham and Women's Hospital|Dr. Rajesh Garg, MD|617-732-5584|rgarg@partners.org|
21256070|NCT01122576|Bausch & Lomb Incorporated|Quintus Ngumah, OD, PhD|(973) 360-6450|Quintus.Ngumah@bausch.com|
21256071|NCT05696236|University of Michigan|Charles Schuler|734-232-2154|schulerc@med.umich.edu|
21256072|NCT01829360|University of Kansas|Holly Storkel|7858640099|hstorkel@ku.edu|
21256073|NCT02024165|Winnie Palmer Hospital for Women and Babies|John Busowski, MD|407-435-1485|john.busowski@orlandohealth.com|
21256074|NCT00024167|University of Texas (UT) MD Anderson Cancer Center|Shi-Ming Tu, MD/Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org|
21256075|NCT01132612|Novartis Pharmaceuticals|Study Director|862-778-8300||
21256076|NCT00729781|Medtronic Xomed, Inc.|David Hodge, Project Manager|(+1-904) 281-2774|david.l.hodge@medtronic.com|
21256077|NCT02252536|NIAAA|Megan Ryan|3014434225|mryan1@mail.nih.gov|
21256078|NCT01438151|Mount Sinai|Dr. Shradha Agarwal|212-659-9261|shradha.agarwal@mssm.edu|
21256079|NCT00859950|Weill Cornell Medical College|Dr. Ana Krieger|646-962-7378|ack2003@med.cornell.edu|
21256080|NCT01836042|Glaukos|Jeff Wells, PharmD, MBA, RAC|949-367-9600|jwells@glaukos.com|227
21256081|NCT02822950|Michigan State University|Gary Stein|517-353-5126|steing@msu.edu|
21256082|NCT00006392|SWOG Statistical Center|Study Statistician|2066674623||
21256083|NCT00072358|Memorial Sloan Kettering Cancer Center|Dr. Brian Kushner, MD|1-833-MSK KIDS|kushnerb@MSKCC.ORG|
21256084|NCT02459769|University of Rochester|Charles Kamen, PhD|585-275-9958|charles_Kamen@urmc.rochester.edu|
21256085|NCT01186796|Mayo Clinic|Johannes. D. Veldhuis, M.D.|507-255-0902|Veldhuis.Johannes@mayo.edu|
21256086|NCT03838198|University of Michigan|Ewa Czyz|734-764-9466|ewac@umich.edu|
21256087|NCT01049243|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-1877|sfeldman@wfubmc.edu|
21256088|NCT01936909|Virginia Commonwealth University|Benjamin Van Tassell|8048284583|bvantassell@vcu.edu|
21256089|NCT02378220|Harding University College of Pharmacy / Unity Health - White County Medical Center, Searcy, Arkansas, USA|Lindsay Elliott|5012794800|lselliott@harding.edu|
21256090|NCT00578786|Gilead Sciences, Inc.|Hunter Gillies, MD, DSEM|650-522-1214|hunter.gillies@gilead.com|
21256091|NCT00312221|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
21256092|NCT02060721|Actelion Pharmaceuticals Ltd.|Clinical Scientific Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21256093|NCT05105789|UW School of Medicine and Public Health|Ellen Wald, MD|(608) 263-8558|erwald@pediatrics.wisc.edu|
21256094|NCT00038727|George Washington University|Marinella Temprosa, PI of Coordinating Center|3018819260|ella@bsc.gwu.edu|
21256095|NCT02558231|Actelion Pharmaceuticals Ltd.|Principal Clinical Scientist|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21256096|NCT02257957|Universidad Nacional de Colombia|Dr Marcel Y Avila|+5713165000|myavilac@unal.edu.co|15119
21256097|NCT02066051|Mayo Clinic|Dr. Joanne F. Shen|480-301-8377|shen.joanne@mayo.edu|
21256098|NCT01294150|NeoTract|Emily Hergenreter Director of Clinical Affairs|650-739-5570|ehergenreter@neotract.com|
21256099|NCT01093625|Vistakon|Katherine E. Osborn||clinicalstudies@its.jnj.com|
21256100|NCT02608879|NYU Langone Medical Center|Patricia Corby, Principal Investigator|646-501-2615|patricia.corby@nyumc.org|
21256101|NCT01840605|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21256102|NCT03739437|The University of Oklahoma Health Sciences Center|Dr. Darla Kendzor|(405) 271-8001|Darla-Kendzor@ouhsc.edu|50478
21256103|NCT03359590|Profil Institut für Stoffwechselforschung GmbH|Dr. Christoph Kapitza|+49 2131 4018|christoph.kapitza@profil.com|157
21256104|NCT01557348|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21256105|NCT06132425|University of California, Los Angeles|Nora Barnes-Horowitz|(310) 825-2961|nbarneshorowitz@ucla.edu|
21256106|NCT04014361|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21256107|NCT06308666|Centre for Ocular Research and Education|Jill Woods|(519) 888-4567|jwoods@uwaterloo.ca|36743
21256108|NCT05225103|Duke University|David Goldston|919-681-1100|david.goldston@duke.edu|
21256109|NCT01130051|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21256110|NCT02767128|Rockwell Medical, Inc|Clinical Project Manager|248-960-9009|sgrimberg@rockwellmed.com|
21256111|NCT04252287|Janssen Scientific Affairs, LLC|Director CVM Health Equity|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21256112|NCT01544023|University of Rostock, Klinikum Südstadt der Hansestadt Rostock, Frauenklinik|Dr. Max Dieterich|+4938144016145|max.dieterich@uni-rostock.de|
21256113|NCT00835120|University Hospitals Case Medical Center|Carla Conroy|216-844-2871|carla.conroy@Uhhospitals.org|
21256114|NCT02499770|G1 Therapeutics|Chandra Lovejoy|001 9192991250|clovejoy@g1therapeutics.com|
21256115|NCT02564926|Astrazeneca, Korea|EunYoung Kim / Local Study Specialist|82 2 2188 0946|EunYoung.Kim@astrazeneca.com|0946
21256116|NCT01019980|Novartis Pharmaceuticals|Study Director|862-778-8300||
21256117|NCT03610165|Cleveland Clinic Foundation|Dr. Kamal Maheshwari|216-4454311|maheshk@ccf.org|
21256118|NCT01351753|University of Iowa|Gary Pierce, PhD|13193359487|gary-pierce@uiowa.edu|
21256119|NCT04600336|Mayo Clinic|Bradley J. Stish, MD|507-538-6120|stish.bradley@mayo.edu|
21256120|NCT01310803|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
21256121|NCT03746951|Nationwide Children's Hospital|Dr. Senthil Krishna|614-722-4200|Senthil.Krishna@nationwidechildrens.org|
21256122|NCT03047551|Columbia University|Carolyn Westhoff, MD|212-305-4805|clw3@cumc.columbia.edu|
21256123|NCT01999569|Carolinas Healthcare System|Bradley Hurst, M.D., Director of Assisted Reproduction|704-355-3149|bhurst@carolinas.org|
21267446|NCT02802735|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21237623|NCT03563716|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21256124|NCT01493557|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21256125|NCT01355484|GTx Inc.|Senior Director, Clinical Operations|1-901-261-3795|mdesordi@gtxinc.com|
21256126|NCT02012296|University of Chicago|Theodore Karrison|773-702-9326|tkarrison@health.bsd.uchicago.edu|
21256127|NCT04321980|Orpheris, Inc.|Jeffrey L Cleland, PhD, Executive Chair|650-505-5048|cleland@orpheris.com|
21256128|NCT00727649|Birmingham VA Medical Center|Dr. Alayne Markland, PI of this clinical trial|205-933-8101|alayne.markland@va.gov|6365
21256129|NCT01681810|University of Pittsburgh|Dr. Kara Hughan|4126925173|kara.hughan@chp.edu|
21256130|NCT01826851|URochester|Peter A. Knight, MD|(585) 275-6340|Peter_Knight@URMC.Rochester.edu|
21256131|NCT00434421|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21256132|NCT01087957|Innovative Neurotronics|Helen Rogers PT, PhD|512-721-1922|hrogers@ininc.us|
21256133|NCT03842163|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21256134|NCT01636414|OrthoCarolina Research Institute|Senior Research Scientist|704-323-2265|susan.odum@orthocarolina.com|
21256135|NCT03829241|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
21256136|NCT00698451|Janssen Services, LLC|Senior Director|1 215 325-5329|tmcgowan@its.jnj.com|
21256137|NCT01292447|Women and Infants Hospital|Rebecca Allen|4012741122|rhallen@wihri.org|
21256138|NCT02224599|Kiromic|CMO and Head of Clinical Operations|(832) 968-4888|sdahlbeck@kiromic.com|
21256139|NCT04216251|Massachusetts General Hspital|Andrew T. Chan, MD, MPH|617-726-3212|achan@partners.org|
21256140|NCT00129623|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21256141|NCT00596934|University of Michigan|Dr. Elif A. Oral|734-615-7271|eliforal@med.umich.edu|
21256142|NCT02315898|University of Michigan|Dr. Kathleen Stringer|734-647-4775|stringek@med.umich.edu|
21256143|NCT02445755|Stanford University School of Medicine|Vinod K. Bhutani, MD|(650) 723-5711|bhutani@stanford.edu|
21256144|NCT04214301|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
21256145|NCT01296035|Women & Infants Hospital|Director of Clinical Trials|401-274-1122|jmari@wihri.org|
21267447|NCT01564485|University of California, Irvine|Ashwini Erande, Clinical Coordinator|714 456 7025|aerande@uci.edu|
21267448|NCT00852761|GlaxoSmithKline|GSK Response Center|866-435-7343||
21267449|NCT03922711|Prilenia|Prilenia|+972 775558|info@prilenia.com|482
21256146|NCT01674712|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
21256147|NCT00866723|Dana-Farber Cancer Institute|Panagiotis Konstantinopoulos|(617) 632-5269|panagiotisa_konstantinopoulos@dfci.harvard.edu|
21256148|NCT02797067|Changhai Hospital|Yangyang Qian|13818040017|919835863@qq.com|
21267450|NCT02390362|The Research Institute at Nationwide Children's Hospital|William E. Smoyer, MD.|6147222683|william.smoyer@nationwidechildrens.org|
21256149|NCT01271803|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21256150|NCT02616523|University Clinical Center Ljubljana|dr. Lea Andjelković|0038615223810|lea.andjelkovic@gmail.com|
21256151|NCT01975428|Scripps Translational Science Institute|Eric J. Topol, M.D.|858-554-5708|etopol@scripps.edu|
21256152|NCT00995007|National Cancer Institute|Dr. Katherine E. Warren|301-435-4683|warrenk@box-w.nih.gov|
21256153|NCT03933397|Duke Clinical Research Institute - Duke University Medical Center|Huiman Barnhardt, PhD|919-668-7313|huiman.barnhart@duke.edu|
21256154|NCT01078207|Covidien|Fran Haury, RRT Research Coordinator, Clinical Affairs|303 305-2314|fran.haury@covidien.com|
21267451|NCT04009824|University of Maryland School of Medicine - Center for Vaccine Development|Dr. Matthew Laurens|410-706-5328|mlaurens@som.umaryland.edu|
21267452|NCT01512849|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21267453|NCT00554840|Maryland Psychiatric Research Center|Elaine Weiner, M.D.|410-402-7694|eweiner@mprc.umaryland.edu|
21267454|NCT04728815|Duke University|Scott Compton, Ph.D.|919-668-0063|compt004@duke.edu|
21267455|NCT01084096|NICHDGlobal|Dr. Elizabeth McClure, Data Coordinating Center PI|919-316-3773|mcclure@rti.org|
21256155|NCT01610687|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
21256156|NCT03675776|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
21267456|NCT02033369|NYSPI|Franklin Schneier, MD|646-774-8041|fschneier@nyspi.columbia.edu|
21267457|NCT00711009|Abbott|Global Medical Services|800-633-9110||
21267458|NCT04335929|Lamar University|Dr. Vinaya Manchaiah, Jo Mayo Endowed Professor|(409) 812 9443|vmanchaiah@lamar.edu|
21267459|NCT03999203|Queen's University Belfast|Professor Liam Heaney|02890976376|l.heaney@qub.ac.uk|
21267460|NCT01319539|Columbia University Medical Center|Kevin Kalinsky, MD|212-305-1945|kk2693@cumc.columbia.edu|
21267461|NCT02534324|Faculty of Medicine, Chulalongkorn University|Dr. Khrongwong Musikatavorn|+66818390511|Khrongwong.m@chulahospital.org|
21267462|NCT01138995|Bioness|Keith McBride, CTO|661-362-4866|Keith.McBride@bioness.com|
21267463|NCT05604781|Center For Sight|Director of Clinical Research|8438813937|hsandoval@cepmd.com|
21267464|NCT00303602|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21267465|NCT02885506|Medicines for Malaria Venture|Dr Cristina Donini|0041 22 555 0312|doninic@mmv.org|
21267466|NCT02889861|Immunocore, LLC|Chris Holland, Executive Director Head of Biometrics|1-267-589-9204|chris.holland2@immunocore.com|
21267467|NCT00620126|University of Maryland. Baltimore|PI|410-706-3387|rcross@medicine.umaryland.edu|
21267468|NCT00784225|SWOG Statistical Center|SELECT/S0000B Statistician|2066674623|adarke@fredhutch.org|
21284966|NCT00006110|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
21256157|NCT00999713|Penn State College of Medicine|Neal J. Thomas, M.D.|717-531-5337|nthomas@psu.edu|
21256158|NCT01130974|Bausch & Lomb Inc.|Robert Steffen|(585) 338-6399|robert.steffens@bausch.com|
21267469|NCT02551874|AstraZeneca|Global Clinical Lead|+46 (0)31 7761000|ClinicalTrialTransparency@astrazeneca.com|
21267470|NCT00313716|Baylor College of Medicine|Claudia Robertson, MD|713-873-2792|claudiar@bcm.edu|
21267471|NCT02491463|GlaxoSmithKline|GSK Response Center|866-435-7343||
21267472|NCT01491802|Queen's University|Kathy Webb|613-549-6666|kw2@queensu.ca|4950
21284967|NCT03469999|Columbia University Irving Medical Center|Dr. Heakyung Kim|212-305-9416|hk2641@cumc.columbia.edu|
21284968|NCT00094536|Cooper Surgical|Chief Medical Officer|203-601-5200|Robert.Auerbach@coopersurgical.com|
21284969|NCT01900431|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21284970|NCT00435019|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21284971|NCT00385827|Janssen Research & Development|Director||ClinicalTrialDisclosure@its.jnj.com|
21284972|NCT01421147|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21284973|NCT00136214|BIDMC|Nezam Afdhal|617632118|nafdhal@bidmc.harvard.edu|
21284974|NCT00171158|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21284975|NCT03630705|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
21284976|NCT02757352|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21284977|NCT03536663|Fresenius Medical Care North America|Senior Director of Statistics and Data Management|781-699-4203|ChiangHong.Ho@fmc-na.com|
21284978|NCT04750278|Foresee Pharma|Chief Medical Officer|408-823-4807|yisheng.lee@foreseepharma.com|
21284979|NCT05725824|University of Arizona|Dr. Bryan Wong|5206268549|bryanwong@arizona.edu|
21284980|NCT01616758|Oncternal Therapeutics|Mary Bretimeyer|8582092082|mbreitmeyer@oncternal.com|208
21284981|NCT03231397|Washington University School of Medicine|Dr. Sean J. English|(314) 362-5707|sjenglish@wustl.edu|
21284982|NCT01054222|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21284983|NCT03782571|Johnson & Johnson Vision Care, Inc.|Thomas R. Karkkainen, OD, MS, FAAO|904 443-3402|TKarkkai@its.jnj.com|2126
21256159|NCT02966223|Indiana University|Mark Tann, MD|317- 948-8782|matann@iupui.edu|
21267473|NCT03993314|University of Alabama at Birmingham|Dr. Mark Powell|205-934-6007|mfpowell@uabmc.edu|
21256160|NCT02876302|Dana-Farber Cancer Institute|Dr. Filipa Lynce, MD, Principal Investigator|617-632-3800|Filipa_Lynce@dfci.harvard.edu|
21256161|NCT04409353|Cedars-Sinai Medical Center|Samuel Eberlein|310-423-6721|samuel.eberlein@cshs.org|
21256162|NCT05315947|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21256163|NCT01080677|Stanford University School of Medicine|Professor of Neurology|650-723-5184|chos@stanford.edu|
21256164|NCT00671554|Greenville Hospital System|Joe Stephenson, MD|864-455-3600|joe.stephenson@usoncology.com|
21256165|NCT01578967|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
21256166|NCT02204566|Massachusetts General Hospital|Dr. Gary Tearney, PI|617-724-2979|GTEARNEY@PARTNERS.ORG|
21256167|NCT03747419|Dana-Farber Cancer Institute|Kent Mouw|6176325734|kent_mouw@dfci.harvard.edu|
21256168|NCT04275297|Osher Center for Integrative Health|A. Gracie Kelly, MS, Research Assistant|6153431554|gracie.kelly@vumc.org|
21256169|NCT05564299|Massachusetts General Hospital|Ingrid V Bassett|617-724-3341|ibassett@mgh.harvard.edu|
21256170|NCT01093326|Actelion Pharmaceuticals Ltd|Director Clinical Leader Neuroscience|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21256171|NCT04435782|Actelion Pharmaceuticals Ltd|Study Responsible Scientist|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21256172|NCT03672461|University of California, San Francisco|Alison Huang, MD|415-353-7900|Alison.Huang@ucsf.edu|
21256173|NCT04225806|InterVene, Inc|Clinical Affairs|6509957137|ClinSupport@intervene-med.com|
21256174|NCT00315939|University of Virginia|Boris Kovatchev, PhD|434-924-5592|bpk2u@virginia.edu|
21256175|NCT00977574|NRG Oncology|Linda Gedeon for Virginia Filiaci, PhD|716-845-1169|lgedeon@gogstats.org|
21256176|NCT04223791|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21256177|NCT04667247|Krupp Center for Integrative Research, University of California San Diego|Gordon Saxe, M.D./Ph.D.|6195435765|gsaxe@health.ucsd.edu|
21256178|NCT05460273|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21256179|NCT04124614|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21256180|NCT05749952|University of Pittsburgh|Sashwati Roy|412 624 0422|sasr453@pitt.edu|
21256181|NCT00332839|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300||
21256182|NCT00789867|Imperial College|Samia Soussi|0207 594 7980|s.soussi@imperial.ac.uk|
21256183|NCT00594516|Johnson & Johnson Pharmaceutical Research & Development|Mila Etropolski, MD Clinical Leader|609-730-4537|metropol@its.jnj.com|
21256184|NCT00521924|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21256185|NCT01876251|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21256186|NCT00982865|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21256187|NCT02460497|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
21256188|NCT03876171|University of Miami|Louis Herns Marcelin, Ph.D.|3052848493|lmarcel2@miami.edu|
21256189|NCT02953639|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21256190|NCT01830855|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21256191|NCT01667081|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21256192|NCT03034460|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
21256193|NCT00699803|Bausch Health|Study Director||susan.harris@bauschhealth.com|
21237624|NCT03775200|Compass Pathways|Medical Director|07443136539|info@compasspathways.com|
21237625|NCT01786512|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21237626|NCT00361374|Massachusetts General Hospital|Dr David Mischoulon, Director of Research, Depression Clinical and Research Program|617-724-5198|dmischoulon@partners.org|
21237627|NCT02450331|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21237628|NCT02080871|W.L. Gore & Associates|Hector R Novoa|928-864-3867|hnovoa@wlgore.com|
21237629|NCT00234052|Northwestern University|Clinical Trials Office|312-695-1301||
21237630|NCT01410474|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21237631|NCT02428296|Children's National Medical Center|Dr. Kim Keppler-Noreuil|2024766287|kkepplerno@childrensnational.org|
21237632|NCT03384173|University of Wisconsin, Madison|Matthew Harer|608-417-6236|mwharer@wisc.edu|
21237633|NCT00828984|Northwestern University|Dr. Seema Khan|312-503-4236|s-khan2@northwestern.edu|
21237634|NCT03509974|Cochlear|George Cire|+13038855440|gcire@cochlear.com|
21237635|NCT02258139|Bausch Health|Study Director|585-338-6399|robert.steffen@bausch.com|
21237636|NCT00464646|NSABP Foundation, Inc.|Director, Department of Site and Study Management|1-800-270-3165|industrytrials@nsabp.org|
21237637|NCT04493931|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21237638|NCT00863655|Novartis Pharmaceuticals|Study Director|862-778-8300||
21237639|NCT01040858|Portland VA Healthcare System|Dr. Daniel Storzbach|503-220-8262|Daniel.Storzbach@va.gov|56497
21237640|NCT01291498|Oxford University Hospitals NHS Trust|Mr Radu Mihai||radu.mihai@ouh.nhs.uk|
21237641|NCT03294330|Penn State College of Medicine|Colette Pameijer|717-531-5272|cpameijer@pennstatehealth.psu.edu|
21237642|NCT04139564|AppliedVR|Vice President of Research|13108901584|tmaddox@appliedvr.io|
21237643|NCT00002558|Memorial Sloan Kettering Cancer Center|Dr. Robert Motzer|646-422-4312|motzerr@mskcc.org|
21237644|NCT00558428|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21237645|NCT04528069|Alcon Research, LLC|Director of Clinical Projects, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21237646|NCT01814371|Washington University School of Medicine|Stephanie Fritz, MD, MSCI|3144544115|fritz.s@wustl.edu|
21256194|NCT00295633|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
21256195|NCT01798992|University of Colorado, Denver|Dr. Michael Bristow, MD PhD|303-724-5453|Michael.Bristow@ucdenver.edu|
21256196|NCT02294682|GlaxoSmithKline|GSK Response Center|866-435-7343||
21256197|NCT01516970|Janssen-Cilag GmbH|Medical Leader, Medical Department||ClinicalTrialDisclosure@its.jnj.com|
21256198|NCT01205438|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21267474|NCT01864746|German Breast Group (GBG) Forschungs GmbH|Prof. Dr. Sibylle Loibl|+49 6102 7480|penelope@gbg.de|0
21237647|NCT01016938|Universtity of Maryland School of Medicine|Warren D'Souza, PhD, MBA|410-328-7159|wdsouza@umm.edu|
21284984|NCT03504189|Nuvo Group|VP Clinical|+972-3-6242266|adar.shani@nuvocares.com|1630
21237648|NCT04158050|Helsinki University Hospital|Dr Paula Kauppi|+358504286802|paula.kauppi@hus.fi|
21256199|NCT03823404|Quince Therapeutics, Inc.|Dr. Karen Smith|650 722 9813|ksmith@quincetx.com|
21267475|NCT00663208|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21267476|NCT01005966|GlaxoSmithKline|GSK Response Center|866-435-7343||
21267477|NCT03500302|Johns Hopkins University|Allison Hays|443-287-6827|ahays2@jhmi.edu|
21267478|NCT02399345|AbbVie|Global Medical Information|800-633-9110||
21267479|NCT00039377|Roswell Park Cancer Institute|Meir Wetzler, M.D.||meir.wetzler@roswellpark.org|
21299960|NCT03103542|Swedish Orphan Biovitrum AB|Medical Information|+468 6972000|medical.info@sobi.com|
21299961|NCT03566511|Albert Einstein College of Medicine|Dr. Meredith Hawkins|718-839-7975|meredith.hawkins@einsteinmed.edu|
21299962|NCT02903771|Kazia Therapeutics Ltd|Jeremy Simpson|+61 400410974|Jeremy.simpson@kaziatherapeutics.com|
21299963|NCT03299556|Purdue Pharma L.P.|Thomas Alfieri, PhD - Director, Medical Affairs Strategic Research|(475) 299-6085|thomas.alfieri@pharma.com|
21267480|NCT02873598|University of Colorado Cancer Center|Dr. Sana Karam|7208480141|sana.karam@cuanschutz.edu|
21267481|NCT04067310|Instituto Nacional do Câncer|Director of Clinical Trials|+552132076549|cecilia.silva@inca.gov.br|
21267482|NCT01041027|Montefiore Medical Center|Dr. Dennis Yi-Shin Kuo|718-405-8086|dykuo@montefiore.org|
21267483|NCT01347931|Clinical Reseach Consulting|Richard J. Morishige, MS, RRT|510-606-0375|rjmorishige@gmail.com|
21267484|NCT01249404|Ipsen|Medical Director, Neurology||clinical.trials@ipsen.com|
21267485|NCT03890731|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21267486|NCT04144140|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
21267487|NCT01640353|SI-BONE, Inc.|Daniel Cher, MD, Vice President of Clinical Affairs|650-269-5763|dcher@si-bone.com|
21267488|NCT03479203|University of Pennsylvania|Felix W.Wehrli, PhD|215-662-7951|felix.wehrli@pennmedicine.upenn.edu|
21267489|NCT02679222|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
21267490|NCT04354870|NYU Langone Health - Bellevue Hospital|H. Michael Belmont, MD|646-501-7400|Michael.Belmont@nyulangone.org|
21267491|NCT04450394|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
21267492|NCT01066819|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21267493|NCT03891199|West Virginia University|Brock A. Lindsey, MD|304-293-1317|blindsey@hsc.wvu.edu|
21267494|NCT00303719|Masonic Cancer Center, University of Minnesota|Erica Warlick, MD|612-625-8942|ewarlick@umn.edu|
21267495|NCT01641952|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21267496|NCT04853368|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21267497|NCT02990325|Abivax|Sophie Biguenet|+33 (0) 1 53 83 08 41|sophie.biguenet@abivax.com|
21267498|NCT01822886|"Policlinico S.Orsola-Malpighi - Institute of Hematology L. e A. Seràgnoli, University of Bologna, Via Massarenti, 9-40138 Bologna, Italy"|Zinzani Pier Luigi/Argnani Lisa|+39 0516364042|pierluigi.zinzani@unibo.it/lisa.argnani@unibo.it|
21267499|NCT03633461|Oyster Point Pharma, Inc.|Jeffery Nau|609-382-9035|jnau@oysterpointrx.com|
21267500|NCT01880320|Galderma R&D|Galderma CPM|00 33 4 93 95 70 70|clinicaltrials@galderma.com|
21267501|NCT04495166|Medical School of the University of Sao Paulo|Daniel Fatori|5511 96162-6183|daniel.fatori@gmail.com|
21267502|NCT02176031|Dana-Farber Cancer Institute|Dr. Corey Cutler|617-632-3470|CSCUTLER@PARTNERS.ORG|
21267503|NCT02516605|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21267504|NCT02643420|Spectrum Pharmaceuticals, Inc, Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|(949) 788-6700|shanta.chawla@sppirx.com|
21267505|NCT01710709|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development||DT-inquiry@otsuka.jp|
21267506|NCT04446039|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21267507|NCT00667381|University of California, Irvine|Arnold Seto|714-456-6699|aseto@uci.edu|
21267508|NCT01716585|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
21267509|NCT02275052|GlaxoSmithKline|GSK Response Center|866-435-7343||
21267510|NCT05102734|Perelman School of Medicine at the University of Pennsylvania|Dr. John C. Greenwood|18568167172|john.greenwood@pennmedicine.upenn.edu|
21267511|NCT00275834|Duke University Medical Center|Kishore Gadde|919-668-0208|kishore.gadde@duke.edu|
21267512|NCT01143116|Wellspect Health Care|Head of Medical Affairs|+46313763000|mace@wellspect.com|
21267513|NCT03055806|Ixchelsis Limited|Chief Medical Officer|44 (0) 1227-832760|ian.osterloh@ixchelsis.com|
21267514|NCT04601194|Indiana University|Michelle Salyers|317-274-2904|mpsalyer@iu.edu|
21267515|NCT02630459|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21267516|NCT00846027|Hoffmann-La Roche|Medical Communications|800 821-8590||
21267517|NCT01694667|University of California, San Francisco|Stephen Bent|415-221-4810|Stephen.Bent@ucsf.edu|3457
21267518|NCT04905563|Le Bonheur Children's Hospital|Lindsey Locke, MSN|(901) 287-8931|lindsey.locke@lebonheur.org|
21267519|NCT01797302|University of Pittsburgh School of Medicine|Kumaravel Rajakumar|412-692-5822|kumaravel.rajakumar@chp.edu|
21267520|NCT02911324|Columbia University/New York State Psychiatric Institute|Reilly Kayser, MD|646-774-8118|reilly.kayser@nyspi.columbia.edu|
21267521|NCT00689611|Divisions of Cardiology and Clinical Epidemiology, Jewish General Hospital/McGill University|Dr. Mark J. Eisenberg|514.340.8222|mark.eisenberg@mcgill.ca|3564
21267522|NCT00568399|Washington University School of Medicine|James Delmez, MD|314 362 7207|jdelmez@dom.wustl.edu|
21267523|NCT00106626|Merck & Co., Inc.|Senior Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
21267524|NCT02519777|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
21267525|NCT00266799|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21267526|NCT02607865|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21267527|NCT00994890|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21256200|NCT01446016|Houston Methodist|Dr. Jenny Chang|713-441-0681|jcchang@houstonmethodist.org|
21256201|NCT02525055|hVIVO Services Limeted|Dr Nicolas Noulin|+442077561365|n.noulin@hvivo.com|
21256202|NCT00404066|Stanford University Medical Center|George Albert Fisher, MD, PhD|650-725-9057|georgeaf@stanford.edu|
21256203|NCT01002456|Dept. of Veterans Affairs|Dr. Madeline McCarren|708 786 7987|madeline.mccarren@va.gov|
21256204|NCT01399190|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21267528|NCT04111185|Duke University|Marat Fudim, MD, MHS|919-684-1284|marat.fudim@duke.edu|
21267529|NCT01899729|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
21267530|NCT03474172|Guangdong Provincial Hospital of Chinese Medicine|Director of department of Clinical Epidemiology|+862081887233|darongwu@163.com|35842
21267531|NCT00795717|Tufts University School of Medicine|Christine A. Wanke, MD|617-636-3811|christine.wanke@tufts.edu|
21267532|NCT00211692|VA San Diego Healthcare System|Samuel B. Ho, MD, Chief GI Section|858-552-8585|samuel.ho2@va.gov|2631
21267533|NCT01021423|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21267534|NCT00122317|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alexion.com|
21267535|NCT03756285|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21267536|NCT00957034|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
21267537|NCT05315297|Stanford University School of Medicine|Dr. Raymond Chou, MD|650-723-5256|raymond.chou@stanford.edu|
21267538|NCT00027846|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21267539|NCT01503229|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
21267540|NCT01354964|Albert Einstein College of Medicine|Dr. Meredith Hawkins|7184302903|meredith.hawkins@einsteinmed.org|2903
21267541|NCT01062230|Huntsman Cancer Institute at the University of Utah Medical Center|Maurizio Zangari, MD Principal Investigator|801-585-3229||
21267542|NCT01459016|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21267543|NCT04259749|RAND|William G. Shadel|412-683-2300|shadel@rand.org|4489
21267544|NCT03922945|VIVUS|Sr. Director, Clinical Research|650-934-5200|clinical@vivus.com|
21267545|NCT02493712|Holy Stone Healthcare Co., Ltd|YUCHIH, Chen|886287975966|ivychen@hshc.com.tw|272
21267546|NCT02528643|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|5473
21267547|NCT02058940|The University of North Carolina at Chapel Hill|Nicole R. Pinelli|919-962-1641|nickipinelli@unc.edu|
21267548|NCT02377674|Xeltis|Eliane Schutte, CEO|+31 40 751 7614|clinical@xeltis.com|
21267549|NCT03521089|Mayo Clinic|Dr. Yonas Geda|480-301-6934|geda.yonas@mayo.edu|
21267550|NCT01494753|Laboratoires Théa|Dr Pascale Pouliquen - Medical Director|33 473 981 436|p.pouliquen@laboratoires-thea.fr|
21267551|NCT02039687|Araim Pharmaceuticals, Inc.|Chief Medical Officer|914-762-7586|info@araimpharma.com|
21267552|NCT02132169|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
21267553|NCT00053482|Emergent BioSolutions|Eddie Darton, Medical Director|240-631-3688|dartone@ebsi.com|
21267554|NCT05064449|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21267555|NCT01432236|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21267556|NCT04492514|University of Cincinnati|Clinical Research Director|513-584-0156|mcmahasn@ucmail.uc.edu|
21267557|NCT01524900|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21267558|NCT03758612|TB Alliance|Majda Benhayoun|347-601-8225|majda.benhayoun@tballiance.org|
21267559|NCT00959192|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21267560|NCT00532441|Hoosier Cancer Research Network, Inc.|Dr. EG Chiorean, MS|317-921-2050|jsmith@hoosiercancer.org|
21267561|NCT01967134|IAVI|Dr. Dereck Tait|27214424991|dtait@iavi.org|
21267562|NCT00443534|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21267563|NCT01603615|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21267564|NCT00305773|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Steven Gore, MD||gorest@jhmi.edu|
21267565|NCT03419741|Medical University of SouthCarolina|Dr. Xingbao Li|843 7925729|lixi@musc.edu|
21267566|NCT00303329|Novartis Pharmaceuticals|Study Director|862-778-8300||
21267567|NCT00570089|Cedars-Sinai Medical Center|C. Noel Bairey Merz, MD|310-423-9680|merz@cshs.org|
21267568|NCT03384316|National Cancer Institute|Dr. Julius Y. Strauss|240-858-3999|straussjy@nci.nih.gov|
21267569|NCT00413231|Medtronic Vascular, Inc.|PJ Belmont, Clinical Research Specialist|707-480-3025|PJ.Belmont@Medtronic.com|
21267570|NCT03474380|HSRD ADAPT|Courtney Van Houtven|919-286-6936|courtney.vanhoutven@va.gov|
21267571|NCT00836342|Clinical Unit for Research Trials in Skin, Massachusetts General Hospital|Kristen Corey|617-726-1302|kcorey1@partners.org|
21267572|NCT01539720|Planned Parenthood of the St. Louis Region and Southwest Missouri|Director of Research|314-531-7526|research@ppslr.org|384
21267573|NCT00298766|Johnson & Johnson Pharmaceutical Research & Development|Dr. Helgi van de Velde||HVDVELDE@ITS.JNJ.COM|
21267574|NCT01192139|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
21267575|NCT03812224|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21267576|NCT01731951|Geron Corp.|Study Director|650-473-7700|myf2001-info@geron.com|
21267577|NCT00348686|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21284985|NCT00950729|Centre hospitalier universitaire de Sherbrooke (CHUS)|François Cabana|1-819-346-1110|francois.cabana@usherbrooke.ca|14233
21284986|NCT01240902|Medtronic, Inc.|Hatice Bilgic Lim||rs.medtroniccardiovascularclinicaltrials@medtronic.com|
21284987|NCT02665741|University of California, Davis|Dr. Sooraj Tejaswi|916-734-7215|stejaswi@ucdavis.edu|
21284988|NCT03543176|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21284989|NCT01267929|Postgraduate Studied Program, faculty of medicine, Thammasat University|Miss Namfon Mahasup|+66 867733596|namfon_pt@yahoo.com|
21284990|NCT01602679|University of Virginia Center for Research in Reproduction|Dr. Christopher R. McCartney|4342430329|cm2hq@virginia.edu|
21267578|NCT01258738|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21267579|NCT02418000|Spirita Oncology, LLC|Chief Development Officer|+1 (713) 898-8965|linda.paradiso@spiritaoncology.com|
21256205|NCT05395104|Shionogi|Shionogi Clinical Trials Administrator Clinical Support Help Line|1-800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
21256206|NCT00381563|New England Baptist Hospital|Director of Clinical Trials|(617)754-6602|pmccree@caregroup.harvard.edu|
21256207|NCT01287364|Sunovion|Respiratory Medical Director|1-866-503-6351||
21256208|NCT00744211|University of South Carolina SOM|Francis G. Spinale|803-777-3964|cvctrc@uscmed.sc.edu|
21256209|NCT00000125|Washington University School of Medicine|Michael Kass MD|314-362-5713|kass@vision.wustl.edu|
21256210|NCT01761279|Portsmouth Hospitals NHS Trust|Dr Pete Basford, Endoscopy Research Fellow|+447890990445|petebasford@hotmail.com|
21256211|NCT05372653|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81363617366|CL_OPCJ_RDA_Team@otsuka.jp|
21256212|NCT00117507|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21256213|NCT03740997|GE HealthCare|David Thompson, MD, PhD|+44 7775 543206|david.thompson1@gehealthcare.com|
21256214|NCT01003990|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21256215|NCT01750931|GlaxoSmithKline|GSK Response Center|866-435-7343||
21256216|NCT00928174|The Queen's Medical Center|Sandi Kwee, Principal Investigator|808-691-5466|skwee@queens.org|
21256217|NCT01343485|Planned Parenthood Federation of America|Zoe Unger, Research Program Coordinator|212-261-4702|zoe.unger@ppfa.org|
21256218|NCT01829425|University of New Mexico|Dr. Yuko Komesu|5052490726|ykomesu@salud.unm.edu|
21256219|NCT03681951|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21256220|NCT02187809|H. Lundbeck A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com|
21256221|NCT01020448|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21256222|NCT01230554|Bausch Health Americas, Inc|Robert Steffen||Robert.Steffen@bausch.com|
21256223|NCT01505010|University of Leuven|Dr. Jan A. Staessen|+32 16 34 7104|jan.staessen@med.kuleuven.be|
21256224|NCT03837379|Medical University of South Carolina|Dr. Jennifer Dahne|843-876-2280|dahne@musc.edu|
21256225|NCT04553068|Evofem|Catherine Maher|8585501900|cmaher@evofem.com|
21256226|NCT02080455|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|617-242-5142|alison.long@aegerion.com|
21256227|NCT02218190|Washington University School of Medicine|Michael P. Kelly, MD, MSc|314-747-2511|kellymi@wustl.edu|
21256228|NCT00698932|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21256229|NCT00601705|Cleveland Clinic|Dr. David Adelstein|216 444-9310|ADELSTD@ccf.org|
21256230|NCT04513665|Memorial Sloan Kettering Cancer Center|Dr. Vicky Makker, MD|646-888-4224|makkerv@mskcc.org|
21256231|NCT01653964|Mayo Clinic|Dr. Carrie Hruska|5072663991|hruska.carrie@mayo.edu|
21256232|NCT02232282|Loyola University Chicago|Larissa Bresler, MD|7086433827|lbresler@lumc.edu|
21256233|NCT02146599|Abbott Medical Optics|Anne Buteyn; Manager, Clinical Research|949-505-2029|anne.buteyn@abbott.com|
21237649|NCT00617981|Celsion Corporation|Nicholas Borys, M.D. Senior Vice President and Chief Medical Officer|609-896-9100|nborys@celsion.com|
21256234|NCT04246801|Laboratorios Salvat, S.A|Medical Director|+34933946400|ejimenez@svt.com|
21256235|NCT02743351|Fate Therapeutics|Executive Director, Clinical Operations|858.875.1800|info@fatetherapeutics.com|
21256236|NCT01368042|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21256237|NCT01621542|Sunovion Pharmaceuticals Inc.|WT2725 Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
21299964|NCT05365217|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21299965|NCT02918370|UT Southwestern|E. Sherwood Brown MD PhD MBA|214-645-6950|sherwood.brown@utsouthwestern.edu|
21299966|NCT00322855|University of New Mexico|Christine M. Gan, Ph.D|5059250387|cgan@salud.unm.edu|
21299967|NCT01680341|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21299968|NCT01440959|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
21299969|NCT03796728|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21299970|NCT04914364|Duke University|Ashley Poole|919-538-6272|ashley.poole@duke.edu|
21299971|NCT01263769|UT MD Anderson Cancer Center|Dr. Jose Karam, MD, Associate Professor, Urology|(713) 745-0374|jakaram@mdanderson.org|
21299972|NCT01346358|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21299973|NCT02839096|University of Missouri School of Medicine|Research Success Core|(573) 817-3386|obgynresearchsuccesscore@health.missouri.edu|
21299974|NCT05058365|The University of Hong Kong|Professor Lam Shui-fong|85239172388|lamsf@hku.hk|
21299975|NCT05444855|Children's Mercy Hospitals and Clinics|Melissa Miller MD|816234300|mmiller@cmh.edu|
21237650|NCT02123108|University of California Los Angeles|Dr. Fady M. Kaldas|310-825-8138|FKaldas@mednet.ucla.edu|
21256238|NCT03694613|Fundacion Santa Fe, Bogotá, Colombia|Dr. Sergio Lerma|+57 3017752726|serlerma@gmail.com|
21256239|NCT04207801|Aurigene Discovery Technologies Limited|Divyesh Mandavia|9427181182|divyesh_m@aurigene.com|
21256240|NCT00544648|Vanderbilt-Ingram Cancer Center|Vicki Keedy, MD|615-936-3524|vicki.keedy@vanderbilt.edu|
21267580|NCT00724594|Medical University of South Carolina|Dr. Dorothea Jenkins|843-792-4341|jenkd@musc.edu|
21267581|NCT00490815|Alimera Sciences, Inc|Kathleen Billman, Senior Director of Scientific Affairs|678-527-1302|kathleen.billman@alimerasciences.com|
21267582|NCT04335552|Duke University|Jason Stout, MD, MHS|919-668-0826|jason.stout@dm.duke.edu|
21267583|NCT02195531|Philips Research|Senior Scientist|+31628041122|Joyca.lacroix@philips.com|
21267584|NCT01284127|Johns Hopkins University|Michael Levy|443-287-4612|mlevy@jhmi.edu|
21267585|NCT02516306|Encore Vision, Inc|Jerry M. Stein, Ph.D.|817-292-6963|summercreekc@gmail.com|
21267586|NCT03243981|Stanford University|Anne Lynn Chang, MD|650-723-6316|alschang@stanford.edu|
21267587|NCT03227692|Zimmer Biomet G.K.|Senior Manager of Clinical Affairs|+81-3-6402-6610|takahito.nakai@zimmerbiomet.com|
21267588|NCT01783223|Hennepin Healthcare Department of Emergency Medicine|Director of Research|6128733000|james.miner@hmced.org|
21267589|NCT00256204|Teva Branded Pharmaceutical Products R&D|Dennis Ahern, MS, Director|215-293-6339|dennis.ahern@tevausa.com|
21267590|NCT01351415|Hoffmann-La Roche|Medical Communications|888-6821-8590|genentech@druginfo.com|
21267591|NCT02169466|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|clinical.trials@bial.com|
21267592|NCT01694966|Cosmo Technologies Ltd|R&D Manager|111111111|rjones@cosmopharma.com|11111
21267593|NCT00699582|Eisai Call Center|Eisai Inc.|888-422-4743||
21267594|NCT00389805|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
21267595|NCT03117309|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
21267596|NCT01402375|Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-6626|achang3@yahoo.com|
21267597|NCT00641745|Sunovion|Josephine Cucchiaro, PhD; Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
21267598|NCT01646346|Yale University|Dr. Suzanne Evans, MD, MPH|(203) 785-5175|suzanne.evans@yale.edu|
21267599|NCT02130635|GlaxoSmithKline|GSK Response Center|866-435-7343||
21299976|NCT00702702|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com|
21299977|NCT01500733|National Heart Lung and Blood Institute|Ahn, Inhye|+1 301 827 1203|inhye.ahn@nih.gov|
21299978|NCT01667900|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21299979|NCT01283555|PATH|Jessica Cohen|206-285-3500|jcohen@path.org|
21299980|NCT00468169|University of Chicago|Everett E Vokes, MD|(773) 702-9306|evokes@medicine.bsd.uchicago.edu|
21299981|NCT00784563|Veterans Affairs Medical Center of Iowa City|Ergun Y. Uc, MD|319-356-8753|ergun-uc@uiowa.edu|
21299982|NCT00321789|Veterans Affairs Medical Center|Corrine I. Voils|919-286-0411|corrine.voils@va.gov|5196
21299983|NCT01576341|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com|
21299984|NCT00617734|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21299985|NCT00556075|Repros Therapeutics Inc.|Jennifer L. Wike|2817193402|jwike@reprosrx.com|
21299986|NCT02485691|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21299987|NCT02747186|University of North Carolina at Chapel Hill|Raymond P. White Jr., DDS, PhD|919-537-3944|ray_white@unc.edu|
21299988|NCT01897025|National University Hospital|Dr Effie Chew|65-67726198|effie_chew@nuhs.edu.sg|
21299989|NCT00310765|retired|Dr. Ann Silverman||anngimd@icloud.com|
21299990|NCT03542812|University of Utah|Candice Fike|801-587-7804|candice.fike@hsc.utah.edu|
21299991|NCT01420861|Oncternal Therapeutics|Mary Breitmeyer|8582092082|mbreitmeyer@oncternal.com|208
21299992|NCT00791934|Acclarent, Inc.|Clinical Director|650-687-5888|lenglan1@its.jnj.com|
21299993|NCT00829738|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
21299994|NCT03413891|University Hospitals Leuven|Mrs. Barbara Debaveye|003216 341463|barbara.debaveye@uzleuven.be|
21299995|NCT04905134|Duke University|Walter T. Lee, MD, MHS|919-613-6407|walter.lee@duke.edu|
21237651|NCT01982240|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020||
21237652|NCT00716092|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21256241|NCT02663271|University of Florida|David Tran, MD, PhD|352-273-9000|david.tran@neurosurgery.ufl.edu|
21256242|NCT00460551|Genmab A/S|Eva Järlid Westerberg PhD|+45 7020 2728|E.Westerberg@genmab.com|
21256243|NCT01351623|Memorial Sloan Kettering|Nikoletta Lendvai, MD|(212) 639-3368|lendvain@mskcc.org|
21256244|NCT00690235|University of Texas Southwestern Medical Center|Carol A. Tamminga, MD|214-645-2789|carol.tamminga@utsouthwestern.edu|
21256245|NCT04399122|Joint Warfighter Refractive Surgery Center, Wilford Hall Ambulatory Surgical Center|Dr. Jose E. Capo-Aponte|(210) 292-2554|Jose.E.CapoAponte.ctr@mail.mil|
21256246|NCT02322229|Alcon, A Novartis Division|Worldwide Medical Affairs Director, GMA Retina Lucentis|1-888-451-3937|alcon.medinfo@alcon.com|
21256247|NCT00705432|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21256248|NCT00521053|Provectus Biopharmaceuticals, Inc.|Eric Wachter, Chief Technology Officer|1-865-769-4011|wachter@pvct.com|23
21299996|NCT03137992|Lupin Research Inc|Dr. Mark Lepore|(443) 740-9323|marklepore@lupin.com|
21256249|NCT05390580|Washington University School of Medicine - Neurology Department|Dr. Osvaldo J. Laurido-Soto, PI|314-362-7382|ojlaurido-soto@wustl.edu|
21256250|NCT04448756|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21256251|NCT02129205|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21256252|NCT02877927|Paratek Pharmaceuticals, Inc.|Dr. Paul McGovern; Vice President, Clinical Affairs|484-751-4935|Paul.Mcgovern@paratekpharma.com|
21256253|NCT00601250|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21256254|NCT04376060|Saint Joseph University|Dr Sarah Khalil|0096170322739|sarahfkhalil2@gmail.com|
21256255|NCT01791803|North Shore Medical Center|Dr. Faysal M. Hasan|978-741-1200|fhasan@partners.org|4901
21256256|NCT00972777|Bausch & Lomb Incorporated|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
21256257|NCT00805038|Case Western Reserve University|Ash Sehgal|216-778-7728|axs81@cwru.edu|
21256258|NCT04946825|University of Vermont|Elias Klemperer, PhD|802-656-1641|elias.klemperer@med.uvm.edu|
21256259|NCT03426787|Washington University in St. Louis School of Medicine|Dr. Mary C Politi|3147471967|mpoliti@wustl.edu|
21256260|NCT02592551|Baylor College of Medicine|Bryan Burt, MD|713-798-6376|burt@bcm.edu|
21256261|NCT00483561|University of Nebraska Medical Center|Ralph Hauke, MD|402-354-8124|rhauke@nebraskacancer.com|
21256262|NCT01653288|Children's Hospital of Philadelphia|Dr. Nancy Kassam-Adams|2155903118|adamsn@email.chop.edu|
21256263|NCT00908583|University of Cincinnati|E. Steve Woodle|513-558-6001|woodlees@ucmail.uc.edu|
21256264|NCT00993954|University of Alberta|Dr Andrew Dixon|780-492-3553|andrew.dixon@albertahealthservices.ca|
21256265|NCT00860951|University of Michigan|Jane Huggins|734-936-7177|janeh@umich.edu|
21256266|NCT01950247|American Regent, Inc.|Mark Falone, MD.|631.772.3544|mfalone@americanregent.com|
21256267|NCT01831921|Wake Forest School of Medicine|Mara Z. Vitolins, DrPH, MPH, RDN|(336) 716-2886|mvitolin@wakehealth.edu|
21256268|NCT01069120|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
21256269|NCT00763971|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21256270|NCT02334787|Otsuka Pharmaceutical Co., LTD.|Study Director, Department of Clinical Management|+81-3-6361-7366||
21256271|NCT02022085|Radboud University Medical Centre, Nijmegen, The Netherlands|Professor Emmanuel Mylanus|+31 24 361 1111|Emmanuel.Mylanus@radboudumc.nl|
21256272|NCT00931242|Tufts Medical Center|Alice B Gottlieb, MD, PhD|617 636 4802|agottlieb@tuftsmedicalcenter.org|
21256273|NCT02713542|Arthrex|Clinical Affairs Manager|2395984302|INC_ClinicalResearch@arthrex.com|
21256274|NCT03631667|Oregon State University|David E. Williams, PhD|541-737-3277|david.williams@oregonstate.edu|
21256275|NCT03383289|Columbia University in the City of New York|Jeanne Teresi, EdD, PhD|212-305-9379|jat61@cumc.columbia.edu|
21256276|NCT00884325|DermResearch, PLLC|Leon H. Kircik, M.D.|502-451-9000|wedoderm@yahoo.com|
21267600|NCT01142791|InSightec|Nadir Alikacem|214-630-2000|nadira@insightec.com|
21267601|NCT05592145|Atrium Health Wake Forest Baptist|Renea Jennings RN,BSN,CCRP|336-716-4417|rjenning@wakehealth.edu|
21267602|NCT01981096|Cincinnati Children's Hospital Medical Center|Susmita Kashikar-Zuck, PhD|513 636 6337|susmita.kashikar-zuck@cchmc.org|
21267603|NCT01454531|ALK-ABELLÓ|ALICIA MARIN|+34 913276127|amaes@alk.net|
21267604|NCT01277666|GlaxoSmithKline|GSK Response Center|866-435-7343||
21267605|NCT02886338|TMU|Fat-Moon, Suk|29307930|fmsuk@tmu.edu.tw|7923
21267606|NCT00807456|DENTSPLY Implants|Manager Global Clinical Affairs|+46313763500|ClinicalResearchMolndal@dentsplysirona.com|
21267607|NCT06334055|Masimo Corporation|Ahmed Alghazi, M.B.Ch.B|949-297-7000|studies@masimo.com|
21267608|NCT00498706|Northwestern University|Dr. David C. Mohr|312-503-1403|d-mohr@northwestern.edu|
21267609|NCT03308799|MC2 Therapeutics|Birgitte Vestbjerg|+45 2077 2575|bve@mc2therapeutics.com|
21267610|NCT02146274|Duke University School of Medicine|Vice Dean of Clinical Research|919-684-4979|awindham@duke.edu|
21267611|NCT01349491|University of Oklahoma Health Sciences Center|Stavros Stavrakis|405-271-9696|stavros-stavrakis@ouhsc.edu|37539
21267612|NCT00750360|GlaxoSmithKline|GSK Response Center|866-435-7343||
21267613|NCT00001151|NIH|Stephen J. Marx, M.D./National Institute of Diabetes and Digestive and Kidney Diseases|3014965051|marxs@mail.nih.gov|
21267614|NCT03927703|Novan|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
21267615|NCT02600715|University of Kansas School of Medicine-Wichita|Jennifer Duong, MPH, Research Associate|316-962-3126|jduong@kumc.edu|
21267616|NCT00656136|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21267617|NCT02500901|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-643-5842|jsmith@hoosiercancer.org|41
21267618|NCT00612573|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
21267619|NCT05386368|Atrium Health Wake Forest Baptist|Joseph Molnar MD|336-716-4171|jmolnar@wakehealth.edu|
21267620|NCT00821886|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21267621|NCT03938857|Duke University|Mara L. Becker, MD, MSCE|919-613-1942|mara.becker@duke.edu|
21267622|NCT02127970|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21267623|NCT01398176|UFlorida|Dr. Susan S. Percival|352-392-1991|percival@ufl.edu|201
21267624|NCT00542321|University of Texas Health Science Center at Houston|Sandra K. Hanneman, PhD, RN, FAAN|713-500-2030|Sandra.K.Hanneman@uth.tmc.edu|
21267625|NCT01639599|Seoul St.Mary's Hospital,|Young Eun Moon|822-2258-6163|0910momo@naver.com|
21267626|NCT01871870|Legacy Health System|Dr. Ken Ward|971-570-2632|kenward503@msn.com|
21267627|NCT04138758|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21267628|NCT00923481|National Cancer Institute, National Institutes of Health|Dr. Shivaani Kummar|301-435-5402|kummars@mail.nih.gov|
21267629|NCT00519090|Novartis Pharmaceuticals|Study Director|862-778-8300||
21267630|NCT02988115|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
21267631|NCT00253747|University of CIncinnati|Dr. Theresa Winhusen|513-487-7800|winhusen@carc.uc.edu|
21267632|NCT00816062|Medtronic|Rianna Rapson|7635262170|rianna.k.rapson@medtronic.com|
21267633|NCT00104299|DAIT/NIAID|Associate Director, Clinical Research Program|(301) 594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21267634|NCT02452034|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21267635|NCT04646668|University of Kansas Medical Center|Leah Lambart Graduate Research Assistant|9139457862|llambart@kumc.edu|
21267636|NCT00431132|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21267637|NCT03672006|Medical College of Wisconsin|Dr. Shelia Hanson|414-266-3728|shanson@mcw.edu|
21267638|NCT03288987|Aryogen|Dr. Nasim Anjidani (Director of Medical- Clinical Trials)|009809125477964|anjidani.n@orchidpharmed.com|
21267639|NCT01508221|University of Cincinnati|Alison Kastl|513-584-0436|Kastla@ucmail.uc.edu|
21267640|NCT02764229|Lycera Corp.|H. Jeffrey Wilkins MD, Chief Medical Officer|484-243-6222|wilkins@lycera.com|
21267641|NCT01904760|Department of Anesthesiology, Peking University School and Hospital of Stomatology, Beijing, China|Xudong Yang|8610-82195287|kqyangxudong@163.com|
21267642|NCT00783263|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21267643|NCT00721136|Johns Hopkins Medical Institutions|Charles Henrikson, MD|503 494 7400|chenriks@jhmi.edu|
21267644|NCT00732199|John D. Dingell VA Medical Center|Susmita Chowdhuri|313 576 1000|susmita.chowdhuri@va.gov|3685
21267645|NCT01747928|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21267646|NCT02242305|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21267647|NCT03547960|Imperial College London|Gary Frost|2075940959|g.frost@imperial.ac.uk|
21267648|NCT00107536|The Ohio State University Comprehensive Cancer Center|Tanio Bekaii-Saab, MD|614-293-9863|Tanios.Bekaii-Saab@osumc.edu|
21299997|NCT04359810|Columbia University Irving Medical Center|Max O'Donnell, MD|212-305-5794|mo2130@columbia.edu|
21299998|NCT03221556|Boston Medical Center|Caroline Kistin, MD MSc|(617) 414-3638|caroline_kistin@brown.edu|
21299999|NCT04760782|University of Vermont|Dr. David Lunardini|(802) 847-2663|david.lunardini@uvmhealth.org|
21300000|NCT01486966|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21300001|NCT02392806|Saint Louis University|Noah Hillman|3145779292|noah.hillman@health.slu.edu|
21300002|NCT03125226|University of Washington School of Medicine|Dr. Jing Zeng|2065985998|jzeng13@uw.edu|
21267649|NCT00611351|University of Nebraska Medical Center|Lori Maness-Harris|402-559-3848|lmaness@unmc.edu|
21300003|NCT00506350|GlaxoSmithKline|GSK Response Center|866-435-7343||
21300004|NCT01607957|Taiho Oncology, Inc.|Taiho|+1 844-878-2446|medicalinformation@taihooncology.com|
21267650|NCT03018028|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21300005|NCT01691794|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
21300006|NCT04972786|University of New Mexico|Dr. Jeremy Hogeveen|773-941-2182|jhogeveen@unm.edu|
21300007|NCT00844844|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals Inc.||clinicaltrials@alxn.com|
21300008|NCT03905096|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21300009|NCT01943344|Vivasure Medical|Dr Chris Martin|+353 9 395 440|chris.martin@vsuremed.com|
21300010|NCT02016781|The Emmes Company|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
21300011|NCT05460754|Montana State University|Dr. Mary P Miles|406 994-6678|mmiles@montana.edu|
21300012|NCT00781768|Loyola University Medical Center|Patrick Stiff, M.D.|708-327-3148|pstiff@lumc.edu|
21300013|NCT04567628|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21300014|NCT02458313|University of Colorado School of Medicine|Dr. Kristina Legget|3037245809|kristian.legget@cuanschutz.edu|
21300015|NCT00199381|Kyowa Hakko Kirin Pharma, Inc.|Director of Clinical Trials|609-919-1100|mcantillon@kyowa-kirin-pharma.com|
21300016|NCT02892344|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21300017|NCT00751296|University Health Network - Princess Margaret Cancer Centre|Dr. Christine Chen|416-946-2827|Christine.Chen@uhn.ca|
21300018|NCT00181168|Johns Hopkins Univ|Paul W. Ladenson, MD, Professor and PI|4109553663|ladenson@jhmi.edu|
21256277|NCT01641237|GlaxoSmithKline|GSK Response Center|866-435-7343||
21256278|NCT01540825|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21256279|NCT00832117|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21256280|NCT01301456|Pfizer, Inc.|Pfizer ClinicalTrials.gov|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21256281|NCT03239483|"Fundacio Lluita Contra la Sida, Hospital Universitari Germans Trias | Pujol"|Dr. Ross D. Cranston|34-934-657-897|rdcranston@outlook.com|
21256282|NCT03678103|Masimo Corporation|Chelsea Frank|949-297-7000|studies@masimo.com|
21256283|NCT00201838|The Ohio State Unversity Comprehensive Cancer Center|Miguel Villalona-Calero, MD|614-293-5484|Miguel.Villalona@osumc.edu|
21256284|NCT04422990|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21256285|NCT00713479|University of California, Los Angeles|Dr Edythe London|(310) 825-0606|elondon@mednet.ucla.edu|
21256286|NCT00113230|UT MD Anderson Cancer Center|Christopher H. Crane, MD / Associate Professor|713-792-2933||
21256287|NCT00770770|Alimera Sciences, Inc.|Kathleen Billman, Senior Director, Scientific Affairs|678-527-1302|kathleen.billman@alimerasciences.com|
21256288|NCT02486653|University of Wisconsin - Madison|Dr. Evie Carchman, MD|608-263-2521|carchman@surgery.wisc.edu|
21256289|NCT01006265|Actelion Pharmaceuticals Ltd.|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21256290|NCT01245387|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21256291|NCT02101021|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21256292|NCT02221349|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
21256293|NCT02632721|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21256294|NCT01572675|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21256295|NCT00223678|Vanderbilt Medical Center|Dr. Anthony Langone|615-936-1179|anthony.langone@vanderbilt.edu|
21256296|NCT03346057|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21256297|NCT02921269|Johns Hopkins University|ETCTN Grants Administrative Manager|443-927-3568|jmurra33@jhmi.edu|
21256298|NCT01326728|National Cancer Institute|Dr. Ronald Gress|301-496-1791|gressr@mail.nih.gov|
21256299|NCT01184053|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
21256300|NCT02939989|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21256301|NCT03620019|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat Canter|(919) 962-0000|Melahat_Canter@med.unc.edu|
21256302|NCT02536755|Genzyme, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21256303|NCT02301936|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21300019|NCT02318706|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|1-908-992-6400|CTRinfo@dsi.com|
21300020|NCT04328077|Terns, Inc.|Study Director|+1 650-525-5535|clinicaltrials@ternspharma.com|101
21300021|NCT01702311|Emory University|Guillermo Umpierrez, MD|404-778-1663|geumpie@emory.edu|
21256304|NCT03065023|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21256305|NCT01102803|Southern Methodist University|Dr. Jasper Smits|214-768-4125|jsmits@smu.edu|
21256306|NCT01667107|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21256307|NCT03427125|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
21300022|NCT03081117|Johns Hopkins University|Dr. Leah Rubin, Associate Professor of Neurology, Psychiatry, and Epidemiology|410-955-7311|lrubin@jhu.edu|
21300023|NCT00809185|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Anjali Advani|216-445-9354|advania@ccf.org|
21300024|NCT00804908|AbbVie|Global Medical Information|800-633-9110||
21300025|NCT01428258|University of Wisconsin-Madison|Dr. Denise M Ney|608-262-4386|ney@nutrisci.wisc.edu|
21300026|NCT01968447|LUMC|Albert Dahan|+31 71 52 62301|a.dahan@lumc.nl|
21300027|NCT00981656|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21300028|NCT00687596|Taiho Oncology, Inc.|Taiho Central|+1 844-878-2446|medicalinformation@taihooncology.com|
21300029|NCT03402217|Ci3 at the University of Chicago|Ellen McCammon|773-834-8462|emccammon@bsd.uchicago.edu|
21300030|NCT02005549|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21300031|NCT00499486|The Sidney Kimmel Comprehensive Cancer Centre at Johns Hopkins|Dr. Hidalgo||mhidalgo@cnio.es|
21300032|NCT03288103|Cincinnati Childrens Hospital Medical Center|Dr. Philippe Backeljauw, MD|15136368444|Philippe.backlejauw@cchmc.org|
21256308|NCT02281357|AstraZeneca|Global Clinical Lead|+1 301-398-0582|ClinicalTrialTransparency@astrazeneca.com|
21256309|NCT01162239|University of California, San Francisco|Dr. Gary Humfleet, PhD|(415) 476-7674|Gary.Humfleet@ucsf.edu|
21256310|NCT05180279|Medical University of South Carolina|Dr Garth Swanson|843-876-2152|swansong@musc.edu|
21256311|NCT02733185|Mount Sinai Medical Center of Florida|Dr. Gervasio Lamas|305-674-2162|Gervasio.Lamas@msmc.com|
21256312|NCT01810016|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
21256313|NCT04572854|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
21256314|NCT04115878|University of Arizona|Daniel Combs, MD|520-626-7780|combs89@arizona.edu|
21256315|NCT07052682|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21256316|NCT06950879|Ghent University|Ruth Van der Looven|003293324237|ruth.Vanderlooven@uzgent.be|
21256317|NCT01330134|University of Chicago|John P. Kress, MD|773-702-1000|jkress@medicine.bsd.uchicago.edu|
21256318|NCT00683163|UNIVERSITY OF CALIFORNIA, SAN FRANCISCO|Dr. Dennis Black|415-514-8159|dblack@psg.ucsf.edu|
21256319|NCT02246582|Medtronic Diabtes|Smita Barua, Clinical Trial Manager|818.576.5534|smita.barua@medtronic.com|
21256320|NCT02229539|Mayo Clinic|Robert C. Miller, MD, MS|904-953-1003|miller.robert@mayo.edu|
21256321|NCT02899078|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
21256322|NCT03441334|Texas Woman's University|Hui-Ting Goh, Assistant Professor|2146897723|HGoh1@twu.edu|
21256323|NCT00088907|ECOG Statistical Office|Study Statistician|617-632-3012||
21256324|NCT01932242|Elusys Therapeutics, Inc.|Senior Director of Regulatory|973-808-0222|cdillon@elusys.com|
21256325|NCT01944293|Columbia University Medical Center - NY State Psychiatric Institute|Michael Grunebaum, MD|646-774-7573|michael.grunebaum@nyspi.columbia.edu|
21256326|NCT00316355|Hartford Hospital|David Tolin|860-545-7685|david.tolin@hhchealth.org|
21256327|NCT00682448|Rush University Medical Center|Stephanie Cavanaugh, MD||Stephanie_Cavanaugh@rush.edu|
21256328|NCT00311376|Allergan, Inc.|Therapeutic area Head|714-246-4500|clinicaltrials@allergan.com|
21256329|NCT00257166|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21256330|NCT00525044|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21256331|NCT02553265|NYU Langone Health|Horacio C Kaufmann, MD|212-263-7225|Horacio.Kaufmann@nyulangone.org|
21256332|NCT02039726|Contact for Clinical Trial Information|Daiichi Sankyo|1-908-992-6400|CTRinfo@dsi.com|
21256333|NCT00713817|GW Pharma Ltd|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
21256334|NCT01817907|Brigham and women's Hospital|D. Andrew Wellman|617-732-8483|awellman@rics.bwh.harvard.edu|
21256335|NCT04415658|Washington University in St. Louis School of Medicine|Dr. Rajat Dhar|3143622999|dharr@wustl.edu|
21256336|NCT01025492|University of Utah|Scott Low|801-585-1380|scott.low@hsc.utah.edu|
21256337|NCT01650285|BrUOG|Dr. Anthony Mega|4018633000|kayla_rosati@brown.edu|
21256338|NCT00659529|National Jewish Health|Jennifer L. Taylor-Cousar, MD|(303) 270-2764|Taylor-CousarJ@NJHealth.org|
21256339|NCT00916539|Massachusetts General Hospital|Taylor Pong, Research Coordinator|617-726-1569|tpong1@partners.org|
21256340|NCT02053909|Boca Raton Regional Hospital|Dr. Alexander Kulik|561-955-6300|alex_kulik@yahoo.com|
21256341|NCT03627767|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21256342|NCT00621751|Atrium Health; Currently at Indiana University School of Medicine|Flora Hammond, MD|317-292-6781|flora.hammond@rhin.com|
21256343|NCT02528370|Hospital Galdakao-Usansolo|Dr Cristobal Esteban|0034 94 400 7000|cristobal.estebangonzalez@osakidetza.eus|7002
21256344|NCT03498131|Providence Health & Services|Director of PBSI /WC Clinical Research Program|(503) 216-1012|Chiayi.Chen@providence.org|
21256345|NCT04439071|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
21256346|NCT00892177|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-7733|galanis.evanthia@mayo.edu|
21256347|NCT05097716|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21256348|NCT01949155|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
21256349|NCT00418951|The University of Texas MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-745-5783|eharrison@mdanderson.org|
21256350|NCT02224313|Eastern Virginia Medical School|Dr.David Archer|7574467444|archerdf@evms.edu|
21256351|NCT03568045|Yale School of Medicine|Dr. Melissa Knauert|203-785-4162|melissa.knauert@yale.edu|
21256352|NCT00800436|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21256353|NCT04808622|Diffusion Pharmaceuticals|Chris Galloway, MD (Chief Medical Officer)|(434) 220-0718|cgalloway@diffusionpharma.com|
21256354|NCT00711529|Stanford Hospital|Shannon MacLaughlan, MD|650-724-0456|smaclaug@stanford.edu|
21256355|NCT05417607|Duke University|Lauren Franz MBChB, MPH|919-681-0023|lauren.franz@duke.edu|
21256356|NCT01673568|Hvidovre Hospital University of Copenhagen|Mette W. Christoffersen|38625826|mette.willaume@gmail.com|
21256357|NCT01177384|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21256358|NCT03606980|Children's Hospital of the King's Daughters|Dana Reesman, PT, DPT|757-668-4894|dana.reesman@chkd.org|
21256359|NCT01849497|Amgen Inc.|Study Director|866-572-6436||
21256360|NCT03044886|Department of Stomatology, Beijing Chao-yang Hospital, Capital Medical University|Dr. Wang Zuomin|+86-010-85231492|wzuomin@sina.cn|
21256361|NCT01083628|University of California, Berkeley|Dr. Adrian Aguilera|510-642-8564|aguila@berkeley.edu|
21256362|NCT01174238|University of California, San Francisco|Adil Daud, MD|415-353-7392|adaud@medicine.ucsf.edu|
21256363|NCT01416987|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21284991|NCT02693717|UT MD Anderson Cancer Center|Jianjun Gao, MD PHD, Associate Professor, Genitourinary Medical Oncology|(713) 563-4195|jgao1@mdanderson.org|
21284992|NCT03610334|Inflectis Bioscience|Dr Anne Visbecq (Chief Medical Officer)|0630632020|annevisbecq@inflectisbioscience.com|33
21284993|NCT01134263|Sanofi Pasteur|Trial Transparency Team||Contact-US@sanofi.com|
21300033|NCT01867671|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21300034|NCT02967991|University Hospitals Case Western Reserve|Shaffer Mok|4404065500|Shaffer.Mok@UHHospitals.org|
21300035|NCT02968134|The University of Queensland|Prof. Jason Roberts|+61 7 3646 4108|j.roberts2@uq.edu.au|
21300036|NCT01349543|Imperial College London|Prof Peter JM Openshaw|07973820801|p.openshaw@imperial.ac.uk|
21300037|NCT05467007|The George Washington University|Dr. Andrew C. Meltzer|202-741-2952|Ameltzer@mfa.gwu.edu|
21300038|NCT04819945|GATT Technologies B.V.|Dr Stuart Head, MD, PhD, Chief Medical Officer|+31645306042|s.head@gatt-tech.com|
21300039|NCT00551759|ECOG Statistical Office|Study Statistician|617-632-3012||
21300040|NCT04531176|The Cleveland Clinic Foundation|Kim Jenkins|216-445-4791|jenkink@ccf.org|
21300041|NCT00214045|University of Wisconsin School of Medicine and Public Health|Dr. Stephen Nakada|(608)263-1359|nakada@urology.wisc.edu|
21300042|NCT00561652|Minneapolis VA Medical Center|Dr. Howard Fink|612-467-3304|howard.fink@va.gov|
21300043|NCT04643808|Medical Univesristy of South Carolina|Dr Dorothea Jenkins|843-792-2112|jenkd@musc.edu|
21300044|NCT04484961|Houston Methodist Hospital|Bradley Lambert, PhD|8326872483|bslambert@houstonmethodist.org|
21300045|NCT00388349|Stanford University|Dr. Sally Arai|650-723-0822|sarai1@stanford.edu|
21300046|NCT01063049|Gastroenterology Services|Dr. David Gerard|630 969 1167|davidpgerard@comcast.net|
21300047|NCT03656939|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21300048|NCT01345240|GlaxoSmithKline|GSK Response Center|866-435-7343||
21300049|NCT01259063|Memorial Sloan Kettering Cancer Center|Dr. Guido Dalbagni|646-422-4394|dalbagng@mskcc.org|
21300050|NCT00774046|University of Chicago|Dr. Lucy A. Godley|773-702-4140|lgodley@medicine.bsd.uchicago.edu|
21300051|NCT04372017|Sanford Health|Dr. Susan Hoover|605-328-8120|Susan.Hoover@sanfordhealth.org|
21300052|NCT00762164|Bronx VA Medical Center|Dr. Lawrence Baruch|718-584-9000|lawrence.baruch@va.gov|6776
21300053|NCT00568022|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21300054|NCT02946580|Massachusetts General Hospital|Dr. Kyle Staller|617-724-7556|kstaller@mgh.harvard.edu|
21300055|NCT00685165|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21300056|NCT03050801|National Institutes of Health|Dr. Eric Wassermann|301-496-0151|wassermanne@ninds.nih.gov|
21300057|NCT03600909|Memorial Sloan Kettering Cancer Center|Dr. Farid Boulad, MD|1-833-MSK-KIDS|bouladf@MSKCC.ORG|
21300058|NCT01844765|NovartisPharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21300059|NCT04292535|Michigan State University|Matthew B. Pontifex|517-432-5105|pontifex@msu.edu|
21300060|NCT03914417|Icahn School of Medicine at Mount Sinai|Dr. Sharon Rose|212-241-3288|sharone.rose@gmail.com|
21300061|NCT03836625|Vanderbilt University|Kate Clouse|(615) 343-5351|kate.clouse@vanderbilt.edu|
21300062|NCT04609319|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21300063|NCT01247324|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21300064|NCT00301808|Barbara Ann Karmanos Cancer Institute|Shrish Gadgeel, M.D.|(313) 556-8820|sgadgee1@hfhs.org|
21300065|NCT02234843|Therapeutic Area Head|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21300066|NCT01319981|The University of Texas MD Anderson Cancer Center|Elias Joseph Jabbour, MD./ Professor|713-792-4764|ejabbour@mdanderson.org|
21300067|NCT01001975|Merck Sharpe & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21300068|NCT05010707|Washington University in St. Louis, School of Medicine|Thomas Baranski, MD, PhD|314-747-3997|baranski@wustl.edu|
21300069|NCT03518086|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21300070|NCT01740713|Consorzio per Valutazioni Biologiche e Farmacologiche|Clinical Research Coordinator|0039 0382 25075|mariagraziafelisi@cvbf.net|
21300071|NCT02336282|St. Jude Children's Research Hospital|Kevin Krull, PhD|(901) 595-5891|kevin.krull@stjude.org|
21300072|NCT04084171|University of Virginia Center for Diabetes Technology|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
21300073|NCT03563209|İzmir Katip Çelebi University, Faculty of Medicine|ilker şengül|05337333698|ilkrsngl@gmail.com|
21300074|NCT01404039|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526156|felipe.fregni@ppcr.hms.harvard.edu|
21300075|NCT00668148|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21300076|NCT02702492|Karyopharm Therapeutics Inc|Karyopharm Medical Information|(888) 209-9326|clinicaltrials@karyopharm.com|
21300077|NCT05472090|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 799-8599|greg.sullivan@tonixpharma.com|
21267651|NCT02532998|AstraZeneca AB|AZD9977 Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
21284994|NCT03585712|HRA Pharma|Agnes Hemon|0140337092|a.hemon@hra-pharma.com|
21284995|NCT05835063|University of Michigan|Melissa Cousino|(734) 936-4220|melcousi@med.umich.edu|
21284996|NCT01280682|Department of Endocrinology, First Affiliated Hospital of Nanjing Medical University|Yang Tao|+86-13851498409|dryangtao@sina.com|
21284997|NCT00548249|Rockwell Medical|Richard C. Yocum, MD|858-229-8585|ryocum@rockwellmed.com|
21284998|NCT02007278|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21284999|NCT01557868|American Orthopaedic Society for Sports Medicine|Dr. Barton Mann|847-292-4900|bart@aossm.org|
21285000|NCT04475718|Orange Square Designs|Lisa Marceau|4014284197|lisa@orangesquare.com|
21285001|NCT02886884|University of Miami|Dr. Joshua M. Hare, MD|305-243-5579|jhare@med.miami.edu|
21300078|NCT01456039|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
21237653|NCT02219048|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21285002|NCT01429441|ThromboGenics N.V.|Dr. Petra Kozma-Wiebe|+32 16 751 497|petra.kozma@thrombogenics.com|
21237654|NCT02436330|University of Illinois College of Medicine at Peoria|Dr. Amy L. Christison|309-624-9188|alc@uic.edu|
21237655|NCT00868439|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
21237656|NCT01132326|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
21237657|NCT04535947|SilkTech Biopharmaceuticals|Brian Lawrence|6172720691|brianlawrence@silk-tech.com|
21237658|NCT02396745|Allegheny Singer Research Institute|Mara Yerk, Administrative Director|412-389-3059|mara.yerk@ahn.org|
21237659|NCT04111757|Bausch & Lomb|Johnson Varughese|9089271162|johnson.varughese@bausch.com|
21237660|NCT04867369|NYU Langone Health|Arthur Hertling, MD|212-598-6085|arthur.hertling@nyulangone.org|
21237661|NCT04212091|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
21237662|NCT03492281|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
21237663|NCT00587964|Memorial Sloan Kettering Cancer Center|Dr. Kathryn Beal|212-639-5159|bealk@mskcc.org|
21237664|NCT05725317|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21237665|NCT02813070|GE Healthcare|Paul Sherwin, M.D., PhD|+1-774-843-3888|PaulSherwin@ge.com|
21237666|NCT00818753|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21237667|NCT01389973|Janssen, R&D, LLC, Spring House, PA|Senior Director, Clinical Development, Immunology||ClinicalTrialDisclosure@its.jnj.com|
21237668|NCT02693743|University of Arkansas for Medical Sciences|Favrin Smith|1 (501) 526-8488|SmithFavrinM@uams.edu|
21237669|NCT02626780|The GID Group|Director of Clinical Affairs|3039524901|GIDAA-01@thegidgroup.com|
21237670|NCT04304833|University of Arkansas for Medical Sciences|Judith Weber|5012961982|weberjudithl@uams.edu|
21237671|NCT02858895|Medicenna Therapeutics Inc|Rosemina Merchant - Chief Development Officer|604-340-3081|nmerchant@medicenna.com|
21237672|NCT03163758|Peking Union Medical College Hospital|Dr. Weihong Zhang|01069159581|ZhangWeiHong@pumch.cn|
21237673|NCT04907942|Click Therapeutics|Shaheen Lakhan, MDPhD, FAAN Study Chair|Not applicable|Science@clicktherapeutics.com|
21285003|NCT02279745|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
21256364|NCT04411953|Cycle Pharmaceuticals|Head of Global Regulatory Affairs and Clinical Development|+441223803635|claudia.percivalle@cyclepharma.com|
21256365|NCT00732251|Cedars Sinai Medical Center|Felicia Mayes|310-423-0825|mayesf@cshs.org|
21256366|NCT00824824|Massachusetts Eye and Ear Infirmary|Louis R. Pasquale, MD|617-573-4270|Louis_Pasquale@meei.harvard.edu|
21256367|NCT02684279|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
21256368|NCT00228566|Cephalon, Inc.|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
21256369|NCT05975840|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21256370|NCT00232141|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21256371|NCT00782288|Johns Hopkins University|Pamela L. Zeitlin, M.D., Ph.D., Professor and Director of SOM Pediatric Pulmonary|443-287-8981|pzeitlin@jhmi.edu|
21256372|NCT00823303|Washington University School of Medicine|Dr. Daniel W. Coyne|3143627211|dcoyne@dom.wustl.edu|
21256373|NCT04263896|University of Chicago|Dr. Sandra Laveaux|773-702-6118|slaveaux@bsd.uchicago.edu|
21256374|NCT06291831|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21256375|NCT05868811|Children's Mercy Hospital|Dr. Kai Ling Kong|5157712880|kkong@cmh.edu|
21256376|NCT02060383|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21256377|NCT00829049|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
21256378|NCT04050670|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21256379|NCT00761306|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
21256380|NCT00268437|Mayo Clinic|Aminah Jatoi, M.D.|507/284-4918|jatoi.aminah@mayo.edu|
21256381|NCT05162027|University of Maryland, School of Dentistry|Dr. Marcela Romero Reyes|4107067168|mromero@umaryland.edu|
21256382|NCT02982239|Sleep and Health Research Program - University of Arizona|Dr. Michael Grandner|5206260105|grandner@psychiatry.arizona.edu|
21256383|NCT00907257|Valeant Pharmaceuticals International, Inc|David Lineberry|949-973-1153|David.Lineberry@valeant.com|
21256384|NCT00880555|Department of Veterans Affairs|Dr. David Glenn Clark|843-792-7446|clarkda@musc.edu|
21256385|NCT04163900|NuCana plc|Medical and Scientific Affairs Department|+44 131 357 1111|info@nucana.com|
21256386|NCT01651104|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21256387|NCT04296877|The Ohio State University College of Optometry|Jennifer Fogt|16142928858|OPT-EyeStudies@osu.edu|
21256388|NCT00283049|sanofi-aventis|Medical Affairs study director||publicregistryUSMA@sanofi-aventis.com|
21256389|NCT01873417|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
21256390|NCT00785044|GE Healthcare|Jose M Zubeldia, M.D.|011-44-1494-543137|jose.zubeldia@ge.com|
21256391|NCT01628107|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21256392|NCT01086410|GlaxoSmithKline|GSK Response Center|866-435-7343||
21256393|NCT04196803|Vanderbilt University Medical Center|Dr. Qi Dai|615)936-0707|qi.dai@vanderbilt.edu|
21256394|NCT01022996|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registry@novartis.com|
21256395|NCT03523728|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21256396|NCT02230254|Second Affiliated Hospital of Zhejiang University|Dr. Wang Jian'an|010-85216440|Yuwei.Zhang@bsci.com|
21256397|NCT02023242|Ivantis, Inc.|Richard Hope|949-333-1310|rhope@ivantisinc.com|
21256398|NCT01667536|Progenics Pharmaceuticals, Inc.|Senior Director, Clinical Science Communications|914 784-1825|vdipippo@progenics.com|
21256399|NCT00419120|Tengion, Inc.|Sunita Sheth, MD - Chief Medical Officer|267-960-4805|sunita.sheth@tengion.com|
21256400|NCT01655329|Georgetown University Medical Center|Matthew T. Freedman|4105429680|MTFreedman@verizon.net|
21256401|NCT00710879|Bausch & Lomb Incorporated|Joseph Barr, OD, MS|(585) 338-6439|joseph.t.barr@bausch.com|
21256402|NCT01809132|UTexas Southwestern Medical Center|Dr. Mack C. Mitchell|2146485036|mack.mitchell@utsouthwestern.edu|
21256403|NCT04854434|Karyopharm Therapeutics Inc|Karyopharm Medical Information|(888) 209-9326|clinicaltrials@karyopharm.com|
21256404|NCT03349775|Beth Israel Deaconness Medical Center|Dr. Jennifer Ho|617-735-4102|jho@bidmc.harvard.edu|
21256405|NCT00760019|Brigham and Women's Hospital|Dr. Joshua Beckman|617-732-6186|jbeckman@partners.org|
21256406|NCT01274715|Michael DeBakey VAMC|Aanand Naik, MD|713-794-8541|anaik@bcm.edu|
21256407|NCT03583450|University of California, San Francisco|Dr. Jina Sinskey|857-998-0137|jina.sinskey@ucsf.edu|
21256408|NCT01186939|Celgene Corporation|CL Beach||CLBeach@celgene.com|
21256409|NCT01817855|AstraZeneca|Naimish Patel|+1 781 839 4061|Naimish.Patel@astrazeneca.com|
21256410|NCT03945591|NYU Langone Health|Ahmad Al-Homsi|6465017621|Samer.Al-Homsi@nyulangone.org|
21256411|NCT00698204|University of Connecticut Health Center|Dr. Rajesh V. Lalla|860-679-8007|lalla@uchc.edu|
21256412|NCT01179672|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21256413|NCT00210184|Institut Bergonie|Pr Marianne Fonck|+33556333333||
21256414|NCT02316340|UT Health San Antonio|Dr. Sukeshi Arora|2104502872|ARORAS@UTHSCSA.EDU|
21256415|NCT01835015|Alcon Research, Ltd.|Director, Translational Medicine Expert, Ophthalmology|1-888-451-3937|alcon.medinfo@alcon.com|
21256416|NCT01690897|University of British Columbia|Dr. Lori Brotto|604 875 4111|Lori.Brotto@vch.ca|68901
21256417|NCT03781323|University of Rochester|Richard Dunne|585-275-5823|Richard_Dunne@urmc.rochester.edu|
21256418|NCT01178333|New England Research Institutes|Dr. Susan Assmann, Principal Research Scientist|617-972-3048|sassmann@neriscience.com|
21256419|NCT00975715|Novartis|Study Director|41 61 324 1111||
21256420|NCT01241552|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21256421|NCT04004429|SynAct Pharma|Thomas Jonassen, Chief Scientific Officer|+45 4015 6669|tj@SynActpharma.com|
21256422|NCT02606461|Karyopharm Therapeutics Inc|Karyopharm Medical Information|(888) 209-9326|clinicaltrials@karyopharm.com|
21285004|NCT02033200|Vivus Inc|VP of Development|650-934-5200||
21267652|NCT02543801|Kootenai Health|Director of Research Programs|2086254223|salbritton@kh.org|
21267653|NCT01756846|University Medical Center Utrectht|Dr. Judith Poldervaart|008875 55105|j.poldervaart@umcutrecht.nl|
21267654|NCT01521260|University Medical Center Groningen - Center for dentistry and oral hygiene|Y.C.M. de Waal|+31 50-3639051|y.c.m.de.waal@umcg.nl|
21267655|NCT02065479|University of Florida|Dr. Dominick Angiolillo|904-244-3378|dominic.angiolillo@jax.ufl.edu|
21267656|NCT02625610|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21267657|NCT02074436|Emory University|Dr. Ana Antun|404-778-1900|ana.antun@emoryhealthcare.org|
21267658|NCT03490734|University of North Carolina at Chapel Hill|Kyle Burger, PhD, RD, MPH|9198439933|kyle_burger@unc.edu|
21267659|NCT00792922|Johns Hopkins University|Sheila K West|410 955 2606|shwest@jhmi.edu|
21267660|NCT02505269|Massachusetts General Hospital|Dr. Jeremy Abramson|617-724-4000|JABRAMSON@mgh.harvard.edu|
21267661|NCT02692560|Kaiser Permanente Washington Health Research Institute|Dori Rosenberg, PhD, MPH|206-287-2532|rosenberg.d@ghc.org|
21267662|NCT01529827|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21267663|NCT03810053|University of Arkansas for Medical Sciences|Matthew Henry|5016868274|mhenry3@uams.edu|
21267664|NCT00715949|The Children's Hospital of Philadelphia|Michael L. Nance|215-590-5932|nance@email.chop.edu|
21300079|NCT04936945|Soahg University|Dr. Magdy Mohamed Amien|0934602963|portal@med.sohag.edu.eg|
21300080|NCT02170376|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21300081|NCT00578539|Baylor College of Medicine|Robert Krance, MD|832-824-4661|rakrance@txch.org|
21300082|NCT04106557|Ovid Therapeutics|Todd F. Baumgartner, M.D., MPH|802-752-5168|tbaumgartner@ovidrx.com|
21300083|NCT02326155|Celltrion Inc|JiWoong Lim|82-32-850-5702|jiwoong.lim@celltrion.com|
21300084|NCT00939393|Acclarent, Inc.|Clinical Director|650-687-5888|lenglan1@its.jnj.com|
21300085|NCT00313014|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
21300086|NCT01280903|University of Pittsburgh|Elizabeth A. Schlenk|412-624-4103|els100@pitt.edu|
21300087|NCT03453164|Fukushima medical university of medicine|Prof. Koji Kono|+81245471259|kojikono@fmu.ac.jp|
21300088|NCT03829228|USANA Health Science|Dr. Junqiang Tian|8019547462|jeremy.tian@usanainc.com|
21300089|NCT02177695|SWOG Statistics and Data Management Center|Genitourinary Committee Statistician|2066674623|mplets@fredhutch.org|
21300090|NCT02844569|University of North Carolina at Chapel Hill|Dr. Thiago Morelli|919-537-3727|thiago_morelli@unc.edu|
21300091|NCT03085095|Myovant Sciences GmbH|Clinical Trials at Myovant|650-278-8743|ClinicalTrials@Myovant.com|
21300092|NCT02770014|Dana-Farber Cancer Institute|Geoffrey Oxnard, MD|617-632-6049|geoffrey_oxnard@dfci.harvard.edu|
21300093|NCT03459079|University of Florida|Kenneth Cusi|352-505-9060|kcusi@ufl.edu|
21300094|NCT00242502|University of Texas MD Anderson Cancer Center|Ahmed Kaseb, MD/ Professor||MJLim@mdanderson.org|
21300095|NCT05101122|Apnimed|Clinical Trials|6015008880|clinicaltrials@apnimed.com|
21300096|NCT00976183|Gynecologic Oncology Associates|John P. Micha, M.D.|949-642-5165|Research@gynoncology.com|
21300097|NCT00834977|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21300098|NCT04945733|Janssen Pharmaceutical K.K.|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21300099|NCT02007096|Division of General Surgery, Department of Surgery, The Mount Sinai Medical Center|Dr. Celia M Divino|212-241-5499|Celia.Divino@mountsinai.org|
21300100|NCT05660577|Bausch & Lomb|Study Director|5102595284|aloncaric@bausch.com|
21300101|NCT04723056|Stanford University|Linda Nguyen|650-736-0431|nguyenlb@stanford.edu|
21300102|NCT05106894|Children's Hospital Los Angeles|Dr. Beth A. Smith|3233614670|bsmith@chla.usc.edu|
21300103|NCT04441138|Rush University Medical Center|Dr. Gaurav Marwaha|3129424399|Gaurav_Marwaha@Rush.edu|
21300104|NCT03363841|Scynexis|David Angulo|201-884-5471|David.Angulo@scynexis.com|
21300105|NCT00821795|Lexington VAMC|Dennis G Karounos, MD Principal investigator|859 233-4511|dennis.karounos@va.gov|4430
21300106|NCT02156076|Bristol-Myers Squibb|Study Director||Clinical.Trials@bms.com|
21300107|NCT03431285|King Fahd University Hospital- Imam Abdulrahman Bin Faisal University|Dr. Muhammed Alshahrani|+966138966666|msshahrani@iau.edu.sa|2002
21300108|NCT04026113|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21300109|NCT00989911|Ahamanson/UCLA ACHDC|Dr. Jamil Aboulhosn|3108255950|jaboulhosn@mednet.ucla.edu|
21300110|NCT01527149|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
21300111|NCT02992288|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
21300112|NCT00656513|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21300113|NCT00771277|VA Medical Center Memphis|Dr. Linda O. Nichols|901 523-8990|linda.nichols@va.gov|5082
21300114|NCT02392637|UT MD Anderson Cancer Center|Dr. Milind Javle, Professor, GI Medical Oncology|(713) 792-5434|mjavle@mdanderson.org|
21300115|NCT03913455|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
21300116|NCT03962491|Virginia Commonwealth University|Kathryn Polak, PhD|(804) 827-1184|polakkm@vcu.edu|
21300117|NCT00106704|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21300118|NCT03165617|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
21300119|NCT05236270|University of Oklahoma Health Sciences|Dr. Amanda Janitz|405-271-2229|amanda-janitz@ouhsc.edu|48081
21300120|NCT03486912|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
21300121|NCT01499940|West Virginia Universtiy|Gerald Higa, PharmD|(304) 293-1461|ghiga@hsc.wvu.edu|
21300122|NCT01184898|Thomas Jefferson University|Margaret Kasner, MD|215-955-8874|Margaret.Kasner@jefferson.edu|
21300123|NCT02893293|Stanford University|Heike Daldrup-Link, MD|(650) 725-2548|mairead@stanford.edu|
21267665|NCT00420212|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
21267666|NCT01326910|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, Sr. Specialist Clinical Quality Systems and Process|928-277-0715|jhauze@its.jnj.com|
21267667|NCT03701061|Emory University|Nadine Rouphael|404-712-1435|nroupha@emory.edu|
21300124|NCT01339832|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21300125|NCT05328102|Xencor, Inc|Michael Chiarella|858-945-2415|mchiarella@xencor.com|
21300126|NCT01569191|Aston University|Prof James Wolffsohn|+44(0)1212044140|j.s.w.wolffsohn@aston.ac.uk|
21300127|NCT01614249|University of Nairobi|Mrs. Rose Okoyo Opiyo|+254 020 2726300|roseopiyo@uonbi.ac.ke|43481
21300128|NCT02954536|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian,MD|646-888-4186|janjigiy@mskcc.org|
21300129|NCT05498649|Scripps Optometric Group|Dr Keith Wan|858-530-2800|keithmwan@gmail.com|
21300130|NCT02731469|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28|linkova@biocad.ru|930
21237674|NCT05338333|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21267668|NCT02274766|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com|
21267669|NCT00869375|OUHSC|J. Emilio Exaire MD|405 271 4742|jose-exaire@ouhsc.edu|44744
21267670|NCT02394028|Hoffmann La-Roche|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy|800 821-8590|genentech@druginfo.com|
21267671|NCT04733664|Richard L. Roudebush VA Medical Center|Dr. Arjun D. Sinha|---|adsinha@iu.edu|
21267672|NCT00866606|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21267673|NCT01205646|Barbara Ann Karmanos Cancer Institute|Ulka Vaishampayan, M.D.|(313) 576-8718|vaishamu@karmanos.org|
21267674|NCT04129242|The Medical University of SC|Dr. Bashar Badran|843-792-6076|badran@musc.edu|
21267675|NCT02582151|Lawson Health Research|Blayne Welk|5196466000|lawson@lawsonresearch.ca|
21267676|NCT03198884|SIHF Healthcare|John Verna|618-337-8153|jverna@sihf.org|
21267677|NCT00806494|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21267678|NCT01914510|University Health Network - Princess Margaret Cancer Centre|Dr. Amit Oza|416-946-2818|amit.oza@uhn.ca|
21267679|NCT01158885|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
21267680|NCT02504424|AirXpanders|Director of Clinical Affairs|650-390-9000|kkelley@airxpanders.com|
21267681|NCT00426842|James J Peters VAMC|Dr. Jill M. Wecht|718-584-9000|jm.wecht@va.gov|3122
21267682|NCT01230827|Johnson & Johnson Pharmaceutical Research & Development|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
21267683|NCT00805142|Janssen R&D, 1125 Trenton-Harbourton Road, Titusville, PA 18902, USA|Senior Director, Clinical Leader|609-730-6777||
21267684|NCT00424463|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21267685|NCT01801189|Legacy Weight and Diabetes Institute|Dr. Valerie Halpin|503-413-7557|vhalpin@lhs.org|
21267686|NCT02927990|Philips Medical Systems B.V.|Pim van Lochem|+31 (0)634322891|pim.vanlochem@philips.com|
21267687|NCT00960323|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21267688|NCT03414372|University of North Carolina at Chapel Hill|Bryce Stamp, MPH|919-966-7430|bstamp@ad.unc.edu|
21267689|NCT00772031|The EMMES Corporation|Anne S Lindblad, PhD|301 251 1161|alindblad@emmes.com|105
21267690|NCT03428230|Sintetica SA|Dr.Elisabetta Donati, Corporate Director Scientific Affairs|+41.91.640.42.50|edonati@sintetica.com|
21267691|NCT02194699|AstraZeneca|Global Clinical Lead|+1 301-398-0582|ClinicalTrialTransparency@astrazeneca.com|
21267692|NCT02719028|Golden Biotechnology Corp|Howard Cheng|+886-2-28086006|howard@goldenbiotech.com|
21267693|NCT03287960|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
21267694|NCT01191190|University of California, San Diego|Januario E Castro, MD|(858) 822-6600|jecastro@ucsd.edu|
21267695|NCT01753765|Pacira Bioscience, Inc.|Medical Information|1-855-793-9729|MedInfo@Pacira.com|
21267696|NCT01667731|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21267697|NCT00561912|UT MD Anderson Cancer Center|Ana M. Aparicio, MD / Assistant Professor||CR_Study_Registration@mdanderson.org|
21267698|NCT01977651|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
21267699|NCT01111058|University of Chicago|Everett Vokes, MD|(773) 702-9306|evokes@medicine.bsd.uchicago.edu|
21267700|NCT02790476|University of Southern California|Jason Doctor|213.821.8142|jdoctor@usc.edu|
21267701|NCT03287089|Atrium Health|Dina Bastawros, MD|336-718-1970|dina.bastawros@gmail.com|
21267702|NCT01729559|Scripps Mercy Hospital|Steven R. Shackford, MD|619-299-2600|shackford.steven@scrippshealth.org|
21267703|NCT01028131|Wayne State University|Steven J. Ondersma|313-577-6680|s.ondersma@wayne.edu|
21267704|NCT03520842|Stanford University|Heather Wakelee|(650) 498-6000|ccto-website@stanford.edu|
21267705|NCT04383665|Keck School of Medicine of University of Southern California|Dr Darrin Lee|(323) 442-5720|darrinjl@usc.edu|
21267706|NCT04056325|Swiss Tropical and Public Health Institute|Prof Dr Jennifer Keiser|+41 61 284 82 18|jennifer.keiser@swisstph.ch|
21267707|NCT04249076|Laboratorios Salvat, S.A|Medical Director|+34933946400|ejimenez@svt.com|
21267708|NCT00147082|Imperial College London|Professor Louise Donnelly|+442075947895|l.donnelly@imperial.ac.uk|
21267709|NCT00265382|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21267710|NCT02996981|TriHealth Inc.|Dr. Rachel Pauls|513-463-4300|Rachel_Pauls@trihealth.com|
21267711|NCT00362440|BIDMC|Dr. Christos Mantzoros|617-667-8630|cmantzor@bidmc.harvard.edu|
21267712|NCT01396486|Massachusetts General Hospital|Dr. Janet Wozniak|617-724-5600|jwozniak@partners.org|
21267713|NCT00082628|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21300131|NCT03094416|IBSA|Claudia Scarsi|+41583601000|claudia.scarsi@ibsa.ch|
21300132|NCT00979940|Indiana University School of Medicine|Dr. Rolf Kreutz|3179620500|rkreutz@iu.edu|
21256423|NCT02764164|Cincinnati Childrens Hospital Medical Center|Dr. Ernest Pedapati|5137361901|ernest.pedapati@cchmc.org|
21256424|NCT00851682|Washington University|Robert Grubb, III|314 454-7185|grubbr@wudosis.wustl.edu|
21256425|NCT01534013|Imperial College London|Prof Nick Oliver|02075942433|nick.oliver@imperial.ac.uk|
21256426|NCT03633526|Vertex Pharmaceuticals Incorporated|Medical Monitor|+1 617 341 6777|medicalinfo@vrtx.com|
21256427|NCT00789750|Daiichi Sankyo, Inc.|Global Clinical Leader|9089926400||
21256428|NCT01379573|NYU Langone Health|Jill Buyon|+1 212 263 0746|Jill.Buyon@nyulangone.org|
21256429|NCT04234672|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
21256430|NCT02871778|Parion Sciences|Karl Donn|919 313 1185|kdonn@parion.com|
21256431|NCT02653300|Oramed Pharmaceuticals|Miriam Kidron, Ph.D.|+972-2-566-0100|miriam@oramed.com|
21256432|NCT03530917|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21256433|NCT02289352|Teva Pharmaceuticals USA, Inc.|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
21256434|NCT01390272|Durham VA Medical Center, Durham, NC|Dr. George Lee Jackson, PhD MHA|919-286-0411|George.Jackson3@va.gov|7091
21256435|NCT00307333|University of Virginia|Joseph R. Moorman, MD|434-982-3367|rm3h@virginia.edu|
21256436|NCT04166383|National Cancer Institute|Dr. Tim F. Greten|240-760-6114|gretentf@mail.nih.gov|
21256437|NCT00387764|GlaxoSmithKline|GSK Response Center|866-435-7343||
21256438|NCT02499081|University of Arkansas for Medical Sciences|Maurizio Zangari, MD|501-686-8274|MZangari@uams.edu|
21256439|NCT00375219|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21256440|NCT02767323|Duke University|Dr. Lysianne Beynel|9193386273|lysianne.beynel@gmail.com|
21256441|NCT01847430|GlaxoSmithKline|GSK Response Center|866-435-7343||
21256442|NCT02251379|Johns Hopkins University|Corinne Keet|410-955-5883|ckeet1@jhmi.edu|
21256443|NCT02667275|Aclaris Therapeutics|Judy Schnyder, Sr. Director Clinical Operations|484-329-2144|jschnyder@aclaristx.com|
21256444|NCT01756040|University of Maryland Baltimore|Rose Marie Viscardi, M.D.|410-328-6003|rviscard@som.umaryland.edu|
21256445|NCT04479436|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|9089926400|CTRinfo@dsi.com|
21256446|NCT04872348|Sight Sciences, Inc.|VP, Medical and Clinical Affairs|1-877-266-1144|jdickerson@sightsciences.com|
21256447|NCT03938038|The University of Texas Health Science Center at Houston|Gabrielle Hatton, MD|713-500-7211|gabrielle.e.hatton@uth.tmc.edu|
21256448|NCT00791258|Daiichi Sankyo, Inc|John Raia|(973) 944-2683|jraia@dsi.com|
21256449|NCT00436618|Mayo Clinic|Thomas E. Witzig M.D.|(507) 284-0527|witzig.thomas@mayo.edu|
21256450|NCT01994382|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
21256451|NCT00314249|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Robert Palmer, MD|1-201-427-8218|robert.palmer@frx.com|
21256452|NCT04667377|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21256453|NCT02066311|The Feinstein Institute for Medical Research|Dr. Meggan Mackay|516-562-3838|mmackay@northwell.edu|
21256454|NCT00359021|Tibotec|SENIOR DIRECTOR R&D|1 609 730-7548||
21256455|NCT03861936|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21256456|NCT00006151|University of Pennsylvania|Peter Gariti||gar1iti@mail.med.upenn.edu|
21256457|NCT05418673|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21256458|NCT03923556|University of Colorado School of Medicine|Dr. Ana Fernandez-Bustamante|720-848-6744|ana.fernandez-bustamante@cuanschutz.edu|
21256459|NCT01986920|Aclaris Therapeutics|Christopher Powala, Chief Operating Officer|484-324-7933|cpowala@aclaristx.com|
21256460|NCT01338415|Actelion Pharmaceuticals Ltd|Principal Clinical Scientist||ClinicalTrialDisclosure@its.jnj.com|
21256461|NCT01118325|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21256462|NCT03334409|Mayo Clinic, Rochester|Lance Pagliaro, M.D.|(507)293-0566|Pagliaro.lance@mayo.edu|
21256463|NCT02563093|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21256464|NCT02150499|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351|clinicaltrialsdisclousre@sunovion.com|
21256465|NCT03000088|Ajou University School of Medicine|Dr. Jiyoung Lee|82-31-219-5689|leejiyoung0616@gmail.com|667
21256466|NCT01526551|University of Kentucky College of Public Health|Dr. Robin Vanderpool|859-218-2102|robin@kcr.uky.edu|
21256467|NCT00874770|Bristol-Myers Squibb International Corporation|BristolMyers Squibb Study Director||clinical.trials@bms.com|
21256468|NCT05215262|Mount Sinai Adolescent Health Center|Sarah Wood, MD, MSHP|(332) 227-4355|Sarah.Wood@mountsinai.org|
21267714|NCT01612494|Washington University School of Medicine|Dr. Angela Lumba-Brown|314-362-4325|lumba_a@kids.wustl.edu|
21267715|NCT03459794|University of Georgia|Dr Adrian Wolstenholme|706 542 2404|adrianw@uga.edu|
21267716|NCT03481634|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21267717|NCT02358876|Great Lakes NeuroTechnologies Inc|Biomedical Research Manager|2163615410|dheldman@glneurotech.com|
21267718|NCT02350660|University of Virginia|Department of Medicine and Pediatrics|434.924.0000|spc7w@virginia.edu|
21267719|NCT04422951|Stanford University|Thomas N. Robinson, MD, MPH|(650) 723-5331|tom.robinson@stanford.edu|
21267720|NCT01849289|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21267721|NCT00352027|St. Jude Children's Research Hospital|Jamie Flerlage, MD|901-595-0392|jamie.flerlage@stjude.org|
21267722|NCT04491591|Washington University School of Medicine|Mary Politi, Ph.D.|314-747-1967|mpoliti@wustl.edu|
21267723|NCT03099304|Incyte|Incyte Corporation Call Center (US)|1.855.463.3463|medinfo@incyte.com|
21267724|NCT02142712|University of New Mexico - Neurology Department|Dr. Vishnumurthy Shushrutha Hedna|505-272-3342|Drshushrutha@gmail.com|
21267725|NCT02239562|University of Miami|Christopher O'Brien|305-243-2329|CObrien@med.miami.edu|
21267726|NCT02599324|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21267727|NCT01058356|Pharmbio Korea Co., Ltd.|Korea Association for the Study of Intestinal Disease (KASID)|82-2-587-2551|pharmbio@hotmail.com|
21267728|NCT02993783|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21267729|NCT00606021|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21267730|NCT01309581|Mount Sinai School of Medicine|James Murrough|212 241 7574|James.Murrough@mssm.edu|
21267731|NCT03480841|University of North Carolina at Chapel Hill|Dr. Linda Beeber|(919) 966-8148|beeber@email.unc.edu|
21267732|NCT01362049|University of Vermont Medical Center, Burlington, VT|Dr. Sharon M. Henry|(802) 847-7633|Sharon.Henry@uvm.edu|
21267733|NCT01202643|Center for Human Reproduction|Dr. David Barad|212 994-4400|dbarad@theCHR.com|
21267734|NCT02417935|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21267735|NCT00852124|UMARYLAND|Alessio Fasano|617-726-1450|afasano@partners.org|
21267736|NCT02850276|Icahn School of Medicine at Mount Sinai|Dr. Jessica Robinson-Papp|212-241-8390|jessica.robinson-papp@mssm.edu|
21267737|NCT02910492|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
21267738|NCT00989664|GlaxoSmithKline|GSK Response Center|866-435-7343||
21267739|NCT02994043|University of Colorado Denver|Jamie Laurin|303-724-3183|JAIME.LAURIN@CUANSCHUTZ.EDU|
21267740|NCT00095836|Massachusetts General Hospital|John Clark, MD|617-724-4000|jrclark@partners.org|
21267741|NCT00962780|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21267742|NCT01813149|Cleveland Clinic Foundation|Michael Stanton Hicks, MD|216-445-3497|stantom@ccf.org|
21267743|NCT04098172|First Affiliated Hospital of Xi 'an Jiaotong University|Dr. Ning Guo|13991229101|drnguo@gmail.com|+86
21267744|NCT00982111|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21285005|NCT02820181|The First Hospital of Shanxi Medical University|Dr.Jun Tian|+8618612270351|zguotian@126.com|
21267745|NCT00620815|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21267746|NCT00983827|University of Utah|Dr. Steven Edgley|801-581-4695|carma.hyde@hsc.utah.edu|
21267747|NCT04227119|Emory University|Anand Shah, MD|404-712-4063|anand.d.shah@emory.edu|
21267748|NCT00422942|Hoffmann-LaRoche|Medical Communications Organization|800-821-8590|genentech@druginfo.com|
21267749|NCT00149227|Department of Cardiology, Kyoto Prefectural University of Medicine|Prof. Hiroaki Matsubara|+81-75-251-5511|matsubah@koto.kpu-m.ac.jp|
21267750|NCT02828982|University of Michigan|Dr. Deanna Gates|(734) 647-2698|gatesd@umich.edu|
21267751|NCT02312934|Vanderbilt University Medical Center|Dr. Paul A. Newhouse|(615) 327-7009|paul.newhouse@vumc.org|
21267752|NCT03395704|La Jolla Pharmaceutical Company|Stew Kroll, MA|650-576-9679|skroll@ljpc.com|
21267753|NCT01156012|Laboratoires Théa|Dr Pascale Pouliquen - Medical Director|33 473 981 436|p.pouliquen@laboratoires-thea.fr|
21267754|NCT03458234|University of Alabama at Birmingham (UAB)|Andrew McDonald, MD; Principal Investigator|(205) 934-5670|ammcdonald@uabmc.edu|
21267755|NCT07072962|Baylor College of Medicine|Bijan Najafi|424-467-7127|najafi.bijan@gmail.com|
21237675|NCT00251745|Takeda Global Research & Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
21237676|NCT00512148|Tengion declared bankruptcy in 2014|Tengion declared bankruptcy and there is no results contact|There is no Tengion phone||
21237677|NCT01355588|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|828
21237678|NCT03284788|University of Florida|Dr. Michelle Cardel, Adjunct Professor|352-273-8811|mcardel@ufl.edu|
21237679|NCT04605978|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33 1 55 72 60 00|scientificinformation@servier.com|
21237680|NCT03813238|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
21237681|NCT03104699|Agenus, Inc.|Clinical Trial Information|1-781-674-4265|clinicaltrialinfo@Agenusbio.com|
21237682|NCT01690130|Medical University of South Carolina|TMS in Nicotine Craving|8437925729|lixi@musc.edu|
21237683|NCT00605293|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21237684|NCT03581981|Atlanta VAHCS|Sheila Rauch|404-321-6111|sheila.rauch@va.gov|203122
21237685|NCT02606903|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21237686|NCT00420199|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21237687|NCT05095272|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr. Patrick E. Duffy; Lab Chief|240.381.1317|patrick.duffy@nih.gov|
21237688|NCT01826227|Memorial Sloan Kettering Cancer Center|Dennis Chi, MD|212-639-5016|chid@mskcc.org|
21237689|NCT02249819|Northwell Health|Johanna Chang, Senior Research Coordinator|(516)562-3646|jchang14@northwell.edu|
21237690|NCT01260350|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21237691|NCT03046212|Hospital de Clínicas de Porto Alegre|Graciele Sbruzzi|55 51 9423-9420|graciele.sbruzzi@ufrgs.br|
21237692|NCT02570126|GlaxoSmithKline|GSK Response Center|866-435-7343||
21237693|NCT00626028|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
21237694|NCT05224050|Rutgers, The State University of New Jersey|Dr. Teresa Leyro|848-445-2090|tml124@psych.rutgers.edu|
21237695|NCT01335204|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
21237696|NCT00917579|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21237697|NCT00754338|Centre for Contact Lens Research|Craig A Woods, Research Manager|1 519 888 4567|cawoods@sciborg.uwaterloo.ca|36547
21237698|NCT04208516|UPMC|Jeremy Kearns, MD|412-623-5296|kearnsjt@upmc.edu|
21237699|NCT00831779|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
21256469|NCT00588536|Memorial Sloan Kettering Cancer Center|Dr. Tanya Trippett|212-639-8267|trippet1@mskcc.org|
21256470|NCT00718549|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21256471|NCT01576172|University of Chicago|Theodore Karrison, PhD|(773) 702-9326|tkarrison@health.bsd.uchicago.edu|
21256472|NCT03496324|Reckitt Benckiser Healthcare (UK) Ltd|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
21256473|NCT02092350|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
21256474|NCT00239226|Medtronic BRC - Medtronic Italia SpA|Giorgio Corbucci - Sr Principal Scientist|+39 02 241371|giovanna.zucchi@medtronic.com|
21256475|NCT00646906|University of Pennsylvania|Tilo Grosser, MD|215-573-7600|tilo@pennmedicine.upenn.edu|
21256476|NCT01303965|IndianaU|Dr. Sherif Farag|(317) 278-0460|ssfarag@iu.edu|
21256477|NCT00956657|NHS Greater Glasgow & Clyde|Gavin H. Taylor, Clinical Psychologist|0141 211 2134|gavin.taylor@ggc.scot.nhs.uk|
21256478|NCT00729482|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
21256479|NCT02448225|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
21256480|NCT04060563|MOMH|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
21256481|NCT01892306|Massachusetts General Hospital|Kristen Ellard, PhD|617-726-6422|kellard@partners.org|
21267756|NCT00577382|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu|
21256482|NCT00806676|Johns Hopkins University School of Medicine|Dr. Jeffrey Fadrowski|410-955-2467|jfadrow1@jhmi.edu|
21256483|NCT02137122|University of Florida|Adam Woods|352-294-5842|ajwoods@phhp.ufl.edu|
21267757|NCT01345162|IRCCS Policlinico S Matteo|Dr Massimo Allegri|00390382502627|massimo.allegri@unipv.it|
21267758|NCT02049476|Wilmer Eye Institute, Johns Hopkins University School of Medicine|Jennifer E. Thorne, MD, PhD; Professor of Ophthalmology & Epidemiology,Director of Ocular Immunology|410-955-2966|jthorne@jhmi.edu|
21267759|NCT03007472|Cochlear|Cochlear Clinical Studies|(303) 790-9010|clinicalstudies@cochlear.com|
21267760|NCT00649220|Merz Pharmaceuticals GmbH|Manager Public Disclosure|+49 69 1503 865|matthias.zerm@merz.de|
21267761|NCT00525499|AndroScience Corp|Charles CY Shih, PhD|(858) 638-7230|cyshih@androscience.com|
21267762|NCT01856920|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Office|855-797-9277|Bobby.Reddy@immunitybio.com|
21285006|NCT03383692|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21285007|NCT03816007|VA San Diego Healthcare System|Dr. Erik Groessl|858-642-6347|erik.groessl@va.gov|
21285008|NCT01218971|Alkermes, Inc.|Bernard L. Silverman, MD|781-609-6000|bernard.silverman@alkermes.com|
21285009|NCT01428115|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21285010|NCT02179749|The Scripps Research Institute|Barbara J. Mason, Ph.D.|858-784-7328|mason@scripps.edu|
21285011|NCT01897766|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21285012|NCT01810783|H. Lundbeck A/S|Email contact via||LundbeckClinicalTrials@Lundbeck.com|
21285013|NCT00793546|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21285014|NCT02620384|Aultman Hospital|Director of Research Programs|330-363-7274|mary.amos@aultman.com|
21285015|NCT02071082|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21285016|NCT02101359|Laboratoires Thea|Medical director|33-4-73-98-14-36|p.pouliquen@laboratoires-thea.fr|
21285017|NCT00494221|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
21285018|NCT00732680|Mayo Clinic|Rizwan Siwani, MBBS|507-284-9155|siwani.rizwan@mayo.edu|
21285019|NCT03040427|Cleveland Clinic Foundation|Dr. Wael A. Jaber|216.444.8305|jaberw@ccf.org|
21285020|NCT01841567|Klinik und Poliklinik für Orthopädie und Unfallchirurgie der Uniklinik Köln|Dr Kourosh Zarghooni|+49 2247887294|kourosh.zarghooni@uk-koeln.de|
21285021|NCT00630747|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21285022|NCT03858894|Santen Inc|R&D Quality Manager|415 268 9199|evelyn.chikere@santen.com|
21285023|NCT02732327|Allergan|David Melnick, MD|201-427-8554|Melnick_David@Allergan.com|
21285024|NCT04503668|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
21285025|NCT02306694|Oregon Health & Science University|Dr. Jayson Taylor|503-494-8716|taylojas@ohsu.edu|
21285026|NCT00603382|GlaxoSmithKline|GSK Response Center|866-435-7343||
21285027|NCT00395642|BIOTRONIK, Inc.|Katerina de Metz (Director, Clinical Studies)|800-547-0394|katerina.demetz@biotronik.com|
21285028|NCT02183909|University of California, San Francisco|Janet Myers, PhD, MPH, MA|415-502-1000|janet.myers@ucsf.edu|14626
21285029|NCT01327313|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21285030|NCT01573754|University of Texas Medical Branch Galveston|Dr. Karl Anderson|409-772-4661|kanderso@utmb.edu|
21285031|NCT01665677|Medical College of Wisconsin|Dr. Medhi Hamadani|414-805-6800|mhamadani@mcw.edu|
21285032|NCT01078298|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21285033|NCT03489941|Bausch & Lomb|Heleen DeCory|(585) 338-8161|heleen.decory@bausch.com|
21285034|NCT00659776|Oregon Health and Science University|Amy Huddleston|503-494-2910|huddlesa@ohsu.edu|
21285035|NCT00742027|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21285036|NCT01180049|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21285037|NCT00628927|University of Cincinnati|Dr. Theresa Winhusen|513-487-7800|winhusen@carc.uc.edu|
21285038|NCT02798354|Children's Hospital at Montefiore and Albert Einstein College of Medicine|Dr. Michael Rinke|718-741-2597|mrinke@montefiore.org|
21285039|NCT01298141|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21285040|NCT02109445|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21285041|NCT00958412|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21285042|NCT02552888|Tulane School of Medicine|Dr. Jing Chen|5049886110|jchen@tulane.edu|
21285043|NCT01833936|Orthopedic Foot and Ankle Center|Dr. Christopher Hyer|6148958747|ofacresearch@orthofootankle.com|
21285044|NCT02371668|National Institute of Allergy and Infectious Diseases|Memoli, Matthew|+1 301 443 5971|mm982v@nih.gov|
21285045|NCT04227405|University of Maryland|Dr. Mariana Falconier, Associate Professor|301-405-4004|marianak@umd.edu|
21285046|NCT03396822|University of Maryland School of Medicine|Daniel Harrison|410-328-5605|dharrison@som.umaryland.edu|
21285047|NCT04985942|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646 440-9333|ITCIClinicalTrials@itci-inc.com|
21285048|NCT01305772|Duke University Medical Center|Neal Ready,MD|919-681-6932|neal.ready@dm.duke.edu|
21285049|NCT03372382|McGovern Medical School, University of Texas, Health Science Center at Houston|Dr Jenifer Dinis, MD|713 500 6421|jenifer.dinis@uth.tmc.edu|
21285050|NCT01128400|Washington University School of Medicine|M. Yanina Pepino|3143628113|ypepino@dom.wustl.edu|
21285051|NCT03488563|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
21285052|NCT01088711|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21285053|NCT00576524|Children's Hospital of Philadelphia|Marsha Wallace|(215) 590-0119|wallacem@email.chop.edu|
21285054|NCT01411319|University of Miami|Alan Pollack, MD, PhD|305-243-4916|apollack@med.miami.edu|
21300133|NCT02158442|Osprey Medical|Michele Shepard|952.955.8236|mshepard@ospreymed.com|
21300134|NCT01668784|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21300135|NCT02761330|Washington Universtiy School of Medicine|Alyssa Labonte|314-273-7338|alabonte@wustl.edu|
21267763|NCT00731094|VA Pittsburgh Healthcare System|Kelly Hyman Burkitt, PhD|412-360-2202|Kelly.Burkitt@va.gov|
21267764|NCT02515890|University of Pittsburgh|Keith M. Vogt, MD., PhD.|412-999-8570|vogtkm@upmc.edu|
21267765|NCT02906644|Duke University|Clinical Research Coordinator|(919) 668-5055|al.salley@duke.edu|
21267766|NCT00608426|Center for Chronic Disease Outcomes Research|Steven Fu, Director|612-467-1979|steven.fu@va.gov|
21267767|NCT00761891|Department of Pharmacology, School of Medicine, Vanderbilt University|Olivier Boutaud, PhD|615-343-7398|olivier.boutaud@vanderbilt.edu|
21267768|NCT00777790|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21267769|NCT01453439|Massachusetts General Hospital|Dr. Sabine Wilhelm, Ph.D.|+1(617)724-6146|swilhelm@mgh.harvard.edu|
21267770|NCT01014442|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21267771|NCT02074059|Windtree Therapeutics, Inc.|Executive Director, Biostatistics & Data Management|215-488-9300|psimmons@windtreetx.com|9477
21267772|NCT02512094|Faculty of Medicine Siriraj Hospital, Mahidol University|Panai Laohaprasitiporn||panailao@gmail.com|
21267773|NCT00014560|Dartmouth Hitchcock|Dr. Pamela Ely|603-653-9071||
21267774|NCT02195895|Northwestern University|Dr. Thomas Schnitzer|312-503-2315|tjs@northwestern.edu|
21267775|NCT00672490|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21267776|NCT00804596|Ascensia Diabetes Care|Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
21267777|NCT03128372|Medtronic|Julia Katilius|1 303-305-2278|julia.z.katilius@medtronic.com|
21267778|NCT02030067|Processa Pharmaceuticals|Director Drug Development and Regulatory Affairs|443-631-6614|pfranks@processapharmaceuticals.com|
21267779|NCT02735382|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health|Mark Zehner, MS|6082627568|mark.zehner@ctri.wisc.edu|
21267780|NCT03570476|University of Washington|Dr. Bruce Montgomery, PI|206-598-0860|rbmontgo@uw.edu|
21267781|NCT00545740|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21267782|NCT02117024|Clinical Development|Lori McDermott|919-794-8950|lmcdermott@heatbio.com|
21267783|NCT00565721|GE Healthcare|Paul Gordon, PhD|011-47-2318-5822|paul.gordon@ge.com|
21267784|NCT01483378|NYU Langone Medical Center|Dr. Elisabeth J. Cohen|212-263-3262|elisabeth.cohen@nyumc.org|
21267785|NCT04062240|Mayo Clinic|Dr. Matthew Ritter|507-255-5123|Ritter.Matthew@mayo.edu|
21267786|NCT02026193|Rambam health Care campus|Dr Shahar Kol , Director IVF Unit|97247773232|skol@rambam.health.gov.il|
21267787|NCT03986671|Powell Mansfield Inc.|Chris Studer|6198101000|cstuder@powellmansfield.com|
21267788|NCT03323385|Baudax Bio Inc.|Development|484-395-2440|info@baudaxbio.com|
21267789|NCT01455064|Abbott Diabetes Care|Shridhara A. Karinka, Ph.D., Director of Clinical Affairs|510-749-6393|SHRIDHARA.ALVA@ABBOTT.COM|
21267790|NCT04118127|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21267791|NCT03845504|Stanford University|Director, Research Development, Integrity and Strategy|(650) 736-4559|aimnoe@stanford.edu|
21267792|NCT05223478|Ocuphire|Drey Coleman VP of Clinical Operations|8134041993|dcoleman@ocuphire.com|
21267793|NCT01072656|Cleveland Clinic|Dr Andre Machado|216-444-4270|machada@ccf.org|
21267794|NCT01681836|University of Pittsburgh|Dr. Kara Hughan|412-692-5170|kara.hughan@chp.edu|
21267795|NCT02109939|Assurex Health|Lindsey Burns|5137015068|lindsey.burns@myriad.com|
21267796|NCT04815291|Merit Medical Systems Inc.|Casey Holland|6178420251|casey.holland@merit.com|
21267797|NCT02646332|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|williamhsup@yahoo.com.tw|78233
21267798|NCT00527722|UT MD Anderson Cancer Center|Sanjay Gupta, MD|713-563-7341|srao@mdanderson.org|
21267799|NCT02363322|NIAID/LIR|Dr. Richard T. Davey, Jr.|301-496-8029|rdavey@niaid.nih.gov|
21267800|NCT02269709|University of Michigan|Frank W. DiPaola, MD|734-763-9650|dipaolaf@med.umich.edu|
21267801|NCT02909504|University Hospitals Cleveland Medical Center|Dr. Keming Gao, MD, PhD|2168442865|keming.gao@UHhospitals.org|
21267802|NCT02055976|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21267803|NCT00751335|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0100|CPAP.trial@fphcare.co.nz|7044
21267804|NCT00090844|Division of Hematology & Oncology, University of California, San Francisco|Pamela Munster, MD|415-476-1000|Pmunster@medicine.ucsf.edu|
21267805|NCT03769753|Memorial Sloan Kettering Cancer Center|T. Peter Kingham, MD|212-639-5260|kinghamp@mskcc.org|
21267806|NCT01070381|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
21267807|NCT01869686|Amgen Inc.|Study Director|866-572-6436||
21267808|NCT01657903|GlaxoSmithKline|GSK Response Center|866-435-7343||
21267809|NCT01032265|Umeå University, Umeå, Sweden|Dr. Eva Samuelsson|+46706966440|eva.samuelsson@jll.se|
21300136|NCT05386329|Massachusetts General Hospital, Department of Psychiatry|Director, Center for OCD and Related Disorders|617-724-6146|swilhelm@mgh.harvard.edu|
21300137|NCT03638453|Dana Farber Cancer Institute/Boston Children's Hospital|Dr. Kira Bona, MD, MPH|617-632-4688|kira.bona@childrens.harvard.edu|
21300138|NCT03183869|Lawson Health Research Institute|Chantelle Graf, RN|519-685-8500|chantelle.graf@sjhc.london.on.ca|35352
21300139|NCT02657889|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21300140|NCT00464698|Massachusetts General Hospital|Darin D. Dougherty, MD|617-724-6300|ddougherty@partners.org|
21300141|NCT02855281|Hospital Bethanien Solingen, Clinic of Pneumology and Allergology, Center for Sleep Medicine and Respiratory Care, Solingen, Germany|Dr. Lars Hagmeyer|0212636004|institut@klinik-bethanien.de|
21267810|NCT01888367|Promius Pharma, LLC, Dr. Reddy's Laboratories|VP, Drug Development|609-375-9855|kallenby@drreddys.com|
21267811|NCT01854918|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21267812|NCT00673075|Forest Laboratories|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|1-201-427-8259|John.Whalen@frx.com|
21267813|NCT00574340|University of Maryland, Baltimore|Dr. Stephen N. Davis|410-328-2488|sdavis@medicine.umaryland.edu|
21267814|NCT00198042|Hospital for Special Surgery|Scott Rodeo, MD|212-606-1000|rodeos@hss.edu|
21267815|NCT02146352|Boston Scientific Corp.|Lina Ginnetti|508-683-4512|Lina.Ginnetti@bsci.com|
21267816|NCT02918006|Vaxart, Inc.|Sean Tucker, PhD, Chief Scientific Officer|650-550-3502|stucker@vaxart.com|
21267817|NCT02936206|Icahn School of Medicine at Mount Sinai|Dr. Amy Tiersten|212-241-3300|amy.tiersten@mssm.edu|
21267818|NCT02510885|Duke Eye Center|Dr. Priyatham Mettu|919-684-9010|priyatham.mettu@duke.edu|
21267819|NCT03091920|Cyclerion Therapeutics, Inc.|Senior Medical Director|1-857-327-8778|info@cyclerion.com|
21267820|NCT00453349|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21267821|NCT03373006|HALO Diagnostics|Chief Research Officer|760-766-2047|bernadette@halodx.com|
21267822|NCT00381810|Genentech, Inc.|Medical Communications Specialist|800 821-8590|genentech@druginfo.com|
21267823|NCT00367380|Malaria Vaccine and Drug Development|Sócrates Herrera MD, principal investigator|(572) 5216232 - 5574929|sherrera@inmuno.org|
21267824|NCT01513460|Novartis Pharmaceuticals|Study Director|862-778-8300||
21267825|NCT00489216|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
21267826|NCT00396266|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
21267827|NCT02475564|Hospital de Clínicas de Porto Alegre, RS|Dr. Ricardo Francalacci Savaris|+55 51 33598653|rsavaris@hcpa.edu.br|
21267828|NCT02705755|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
21267829|NCT01906489|Akebia Therapeutics|Akebia Therapeutics|617-844-6128|trials@akebia.com|
21267830|NCT04524663|Stanford University|Dr. Julie Parsonnet, MD|(650) 725-4561|parsonnt@stanford.edu|
21267831|NCT03359811|UT MD Anderson Cancer Center|Dr. Juan Cata, MD, Associate Professor, Anesthesiology & PeriOper Med|(713) 792-7452|jcata@mdanderson.org|
21267832|NCT01233076|CIBA VISION|Joe Rappon, OD, MS, FAAO / Head, Clinical Trial Management|1-678-415-3343|Joseph.Rappon@cibavision.com|
21267833|NCT04308668|University of Minnesota|David Boulware, MD, MPH|6125552020|covid19@umn.edu|
21267834|NCT01266967|GlaxoSmithKline|GSK Response Center|866-435-7343||
21267835|NCT01519700|Sandoz|Dr. Roumen Nakov, Global Programme Medical Director|+49 8024 4764704|roumen.nakov@sandoz.com|
21267836|NCT05111548|University of Michigan|Dr. Cynthia Burton|734-615-9821|czburton@med.umich.edu|
21267837|NCT00103376|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
21267838|NCT00386152|Centocor Ortho Biotech Services, LLC|Nephrology Therapeutic Area, Medical Lead|215-325-4176||
21267839|NCT01101321|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
21267840|NCT02083406|Medicines for Malaria Venture (MMV)|Fiona Macintyre, PhD|+41 22 555 0319|macintyref@mmv.org|
21267841|NCT02577107|Novartis Pharmaceuticals|Study Director|862-778-8300||
21267842|NCT01182480|Denver Health and Hospital Authority|Andrew W. Steele, MD, MPH, MSc|303-602-9773|andy.steele@dhha.org|
21285055|NCT04948827|Camino Pharma|Gonul Velicelebi|858-201-2901|gonul@caminopharma.com|
21285056|NCT03441685|Vanderbilt University Medical Center|Dr. C. Melanie Schuele|615-936-5256|melanie.schuele@vanderbilt.edu|
21300142|NCT03341299|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
21285057|NCT00527124|Barbara Ann Karmanos Cancer Institute|Elisabeth I. Heath|313-576-8715|heathe@karmanos.org|
21285058|NCT04096001|Stanford Prevention Research Center, School of Medicine, Stanford University|Judith J Prochaska, PhD|650-724-3608|jpro@stanford.edu|
21285059|NCT00460239|Johns Hopkins University School of Medicine|Eric C. Strain, M.D.|410-550-1191|ecsgss@aol.com|
21285060|NCT02455453|Washington University School of Medicine|Farrokh Dehdashti, M.D.|314-747-1604|dehdashtif@wustl.edu|
21285061|NCT02094326|Hospital Virgen de la Macarena|Dr. Federico Navarro Sarabia|+34 955 00 80 00|federico.navarro.sarabia@gmail.com|
21285062|NCT01535443|Laboratorios Sophia, SA de CV|Baiza-Duran Leopoldo, Medial Director|+52 (33)30014200|lbaiza@sophia.com.mx|
21285063|NCT02620683|University of North Carolina Chapel Hill|Dr Raymond P. White Jr|919-537-3944|ray_white@unc.edu|
21285064|NCT00893074|Johns Hopkins University|Ryan Vandrey, PhD|410-550-4036|rvandrey@jhmi.edu|
21285065|NCT00760487|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21285066|NCT04957212|Cinnagen Co.|Dr.Nasim Anjidani|0989125477964|anjidani.n@orchidpharmed.com|
21285067|NCT02813473|ECRI|Ron van Amsterdam|+31102062802|RvAmsterdam@cardialysis.nl|
21285068|NCT02260817|Decatur Memorial Hospital, Decatur, IL|Thomas H. Tarter, M.D., Ph.D - Director, Urologic Oncology, Cancer Care Specialists of Illinois|(217) 876-6600|ttarter@ccsci.net|
21285069|NCT03299101|Pittsburgh VA Healthcare System, CHERP|Dr. Daniel E Hall|4123602016|daniel.hall2@va.gov|
21285070|NCT06363292|Laboratorios Sophia|Alejandra Sanchez Rios|+ 52 33 3001 4200|alejandra.sanchez@sophia.com.mx|1190
21300143|NCT01243190|The university of Texas MD Anderson Cancer Center|William Wierda MD./Professor|713-745-0428|wwierda@mdanderson.org|
21300144|NCT04295720|University of Arizona|Phillip H. Kuo, MD, PhD|520-626-1957|pkuo@arizona.edu|
21300145|NCT00335777|Jefferson Headache Center|Stephen D. Silberstein, MD|215-955-2243|stephen.silberstein@jefferson.edu|
21300146|NCT03821402|Revance Therapeutics, Inc.|Todd Gross, PhD, VP, Clinical Development & Data Science|510-742-3400|tgross@revance.com|
21300147|NCT02166346|Johns Hopkins University|Michael Levy, Principal Investigator|443-287-4412|mlevy@jhmi.edu|
21300148|NCT05024032|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21267843|NCT01980056|Weill Cornell Medicine|Clinical Trials Administrator|212-746-0284|ray2013@med.cornell.edu|
21267844|NCT03010358|OHSU Knight Cancer Institute|Bria Thurlow|503-494-4292|thurlow@ohsu.edu|
21267845|NCT01973205|Novartis|Clinical Project Leader|9735038000||
21300149|NCT01209689|Hoffmann-La Roche|Medical Communications|800 821-8590||
21267846|NCT02135848|GlaxoSmithKline|GSK Response Center|866-435-7343||
21267847|NCT00083616|Amgen Inc.|Study Director|866-572-6436||
21267848|NCT01474993|UMass Medical School|Andrew Zimmerman, M.D.|508-856-3279|Andrew.Zimmerman@umassmemorial.org|
21267849|NCT03258710|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21267850|NCT03451630|UPMC Center for High-Value Health Care|Kelly Williams, PhD, MPH|412-454-1198|williamsk17@upmc.edu|
21267851|NCT02041533|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21267852|NCT02813681|University of Texas Medical Branch|Denise Wilkes|409-772-1221|dwilkes@utmb.edu|
21267853|NCT01077310|Yale School of Medicine|Principle Investigator|203-737-2883|sandra.springer@yale.edu|
21267854|NCT01957111|University of Pennsylvania|Philip Gehrman|215-746-3578|gehrman@exchange.upenn.edu|
21285071|NCT00519584|Cleveland Clinic|K. C. Cummings III, MD|216-444-1016|cummink2@ccf.org|
21285072|NCT05259917|KalVista Pharmaceuticals Ltd.|Vice President Clinical|1 (857) 999-0075|clinical@kalvista.com|
21256484|NCT00962390|Ausio Pharmaceuticals, LLC|Rick Schwen, PhD, DABT, RAC / Vice President of Regulatory Affairs|513-731-0222|rick@ausiopharma.com|
21256485|NCT02613884|Kate Farms|Vanessa Millovich|3522634409|vannanole@gmail.com|
21256486|NCT03331861|Columbia University Irving Medical Center|Barry Fine, MD|212-305-5755|bmf2002@cumc.columbia.edu|
21256487|NCT00528580|University of Chicago|Millie Maleckar|773-702-1472|mmalecka@bsd.uchicago.edu|
21256488|NCT02518997|Stanford University|Melissa Scala|650-723-5711|mscala@stanford.edu|
21256489|NCT00131469|OHSU|Eric Orwoll|15034940225|orwoll@ohsu.edu|
21256490|NCT02945150|Massachusetts General Hospital|Dr. Raymond Chung|617-724-7562|Chung.Raymond@mgh.harvard.edu|
21256491|NCT01910116|Seoul National University Hospital|Prof. Eun Bong Lee|822-2072-3944|leb7616@snu.ac.kr|
21256492|NCT01727765|University of Portsmouth|Dr Mitch Lomax|02392845297|mitch.lomax@port.ac.uk|
21285073|NCT00592592|Massachusetts General, Hospital|Torunn Yock, MD|6177262000|tyock@mgh.harvard.edu|
21285074|NCT01090141|Unknown|Tawanda Gumbo||Unknown@utsouthwestern.edu|
21285075|NCT00795769|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
21285076|NCT00435188|Durham VA Research and Development|Miriam C. Morey, Ph.D.|919-286-0411|miriam.morey@va.gov|6776
21285077|NCT01915771|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|617-500-5142|alison.long@aegerion.com|
21285078|NCT00497055|San Francisco Department of Public Health|Phillip O. Coffin, Director of Substance Use Research|415-437-6282|phillip.coffin@sfdph.org|
21285079|NCT00575510|Mayo Clinic|Dr. Carmen Radecki Breitkopf|507-266-0969|radeckibreitkopf.carmen@mayo.edu|
21285080|NCT02697734|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21285081|NCT02324699|Icahn School of Medicine at Mount Sinai|Dr. Bruce Sands|212-241-8100|bruce.sands@mssm.edu|
21285082|NCT03970200|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
21285083|NCT01098162|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
21285084|NCT01605825|Acorda Therapeutics, Inc.|Study Director|914-347-4300||
21285085|NCT02740335|Clinical Research Management Group|Patrick Murphy|413-821-0022|p.murphy@crmg-usa.com|
21285086|NCT00380718|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21285087|NCT01349933|Mayo Clinic|Brigette Buig-Yue Ma, MBBS, FRACP||brigette@clo.cuhk.edu.hk|
21285088|NCT01706575|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21285089|NCT02230540|Rigshospitalet, Department of Urology|Per Bagi, MD|+45 3545 8310|Per.bagi@regionh.dk|
21285090|NCT04333225|Baylor Scott & White Research Institute|Peter A. McCullough, MD, MPH|2148412000|peteramccullough@gmail.com|
21285091|NCT00621517|East Tennessee State University|Max Bayard MD|802-524-8805|mmbayard3@gmail.com|
21285092|NCT02949141|Patan Academy of Health Science|Darlene R House, MD|+977 9810339799|dhouse@iupui.edu|
21285093|NCT03439462|Aadi Bioscience, Inc.|Aadi Medical Information|1-888-246-2234|MedInfo@aadibio.com|
21285094|NCT02155322|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21285095|NCT00523809|UT MD Anderson Cancer Center|Naoto Ueno, MD / Professor||CR_Study_Registration@mdanderson.org|
21285096|NCT02356107|University of Utah|Brent Kious, MD, PhD|(801) 581-4888|Brent.Kious@hsc.utah.edu|
21285097|NCT00822328|Cheng Hsin Rehabilitation Medical Center|Dr.Yi-Hsien Lin|+886-2-28264400|d49311001@ym.edu.tw|5750
21285098|NCT02787681|Loma Linda University|H. Bryant Nguyen, MD|909-558-4000|hbnguyen@llu.edu|
21285099|NCT03260790|Mayo Clinic|Avni Y. Joshi, M.D., M.S.|507-284-3165|Joshi.Avni@mayo.edu|
21285100|NCT01215435|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21285101|NCT00840034|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21285102|NCT02870205|Glenmark Pharmaceuticals Ltd|Study Director|(201) 684-8000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
21285103|NCT01945294|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21285104|NCT02839876|Duke University Medical Center|Dr. Jeff Gadsden|919-681-6437|jeff.gadsden@duke.edu|
21285105|NCT00636961|Novartis Pharmaceuticals|Study Director|862-778-8300||
21285106|NCT02721017|University of California San Francisco Department of Surgery|Dr. Benjamin Padilla|415-476-3642|Benjamin.Padilla@ucsf.edu|
21285107|NCT01156051|Children's Specialized Hospital|Thomas A Rugino MD|732-797-3826|trugino@childrens-specialized.org|
21285108|NCT01738191|Medical University of South Carolina|Dr. Vanessa Hinson|843-792-9115|hinsonvk@musc.edu|
21256493|NCT01196533|Morristowm Memorial Hospital|Dr. Frank Smart|973-214-2601|frank.smart@atlantichealth.org|
21267855|NCT03961529|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21285109|NCT02483572|University of Nebraska Medical Center|Wayne Fisher|4025598863|wfisher@unmc.edu|
21300150|NCT03780244|QMedAB|Clinical Project Manager|817-961-5000|aestheticclinicaltrials@galderma.com|
21300151|NCT02345070|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21300152|NCT01054885|GlaxoSmithKline|GSK Response Center|866-435-7343||
21300153|NCT02443688|Celtaxsys, Inc.|Director, Clincal Operations|4702060153|sbirnbaum@celtaxsys.com|123
21256494|NCT00911625|Rush University Medical Center|David Baldwin, MD|312-942-2813|david_baldwin@rush.edu|
21256495|NCT00590044|Emory University SOM|Guillermo Umpierrez|4047781663|geumpie@emory.edu|
21256496|NCT00888381|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
21256497|NCT02729740|Penumbra, Inc.|Director of Clinical Affairs|+1 510 995 2183|blawson@penumbrainc.com|
21256498|NCT00757003|Stanford University|Dr. Daniel Sze, Principal Investigator|650-723-0728|dansze@stanford.edu|
21256499|NCT04267770|Imperial College London|Nick Oliver|+44 20 7594 1796|nick.oliver@imperial.ac.uk|
21256500|NCT03044249|Mediti Pharma Inc.|Chief Executive Officer|1-514-993-7207|ivan.shaw@meditipharma.com|
21256501|NCT01560923|Masonic Cancer Center, University of Minnesota|Dr.Gautam Jha|612-624-5373|jhaxx014@umn.edu|
21256502|NCT01995578|Memorial Sloan Kettering Cancer Center|Dr. Roni Tamari MD|646-608-3738|tamarir@mskcc.org|
21256503|NCT00703053|Saint Louis University|Robert Belshe, MD|314-977-9030|belsherb@slu.edu|
21256504|NCT03785678|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21256505|NCT02374021|Brigham and Women's Hospital|Dr. Daniel Solomon|617-732-5356|dsolomon@bwh.harvard.edu|
21256506|NCT03007979|Washington University School of Medicine|Cynthia X. Ma, M.D., Ph.D.|314-362-9383|cynthiaxma@wustl.edu|
21256507|NCT01624259|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21256508|NCT01298518|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21237700|NCT04020341|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21256509|NCT02273726|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|064study@fibrogen.com|
21237701|NCT05763628|CooperVision Inc.|José A. Vega OD, PhD, MSc, FAAO|+19256213761|jvega2@coopervision.com|
21237702|NCT02872701|On Target Laboratories|Tim Biro|216-533-3082|tbiro@ontargetlabs.com|
21237703|NCT00187226|St. Jude Children's Research Hospital|Thomas E. Merchant, DO, PhD|901-595-3604|thomas.merchant@stjude.org|
21237704|NCT04683926|Syntrix Pharmaceuticals|Aaron Schuler|253-833-8009|aschuler@syntrixbio.com|21
21237705|NCT00941993|Acclarent|Clinical Director|650-687-5888|lenglan1@its.jnj.com|
21237706|NCT04385368|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21237707|NCT00319748|Masonic Cancer Center, University of Minnesota|Melissa Geller, M.D.|612-626-3111|gelle005@umn.edu|
21237708|NCT02054806|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21237709|NCT04721925|University of Michigan|Erin Bonar|7347647936|erinbona@med.umich.edu|
21237710|NCT00677235|Bard Peripheral Vascular|John Van Vleet|1-800-321-4254|John.VanVleet@CRBard.com|
21237711|NCT00995501|Cleveland clinic|Daniel Sessler, MD|216-445-4900|sesseld@ccf.org|
21237712|NCT03871595|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21256510|NCT01979835|principal investigator|Ellen Wiebe|6047095611|ellenwiebe@gmail.com|
21256511|NCT01479829|Loyola University Medical Center|Dr. Angelos Halaris|708-216-3272|ahalaris@luc.edu|
21256512|NCT00591825|Laureate Institute for Brain Research (LIBR)|Robin Aupperle, PhD|(913) 588-9078|raupperle@laureateinstitute.org|
21256513|NCT01444456|Amgen Inc.|Study Director|866-572-6436||
21267856|NCT03644173|Hackensack meridian Health|Manager, Investigator Initiated Research Program|5519961244|Elli.GournaPaleoudis@hmhn.org|
21267857|NCT03500419|Mayo Clinic|Matthew (Matt) J. Ziegelmann, M.D.|507-266-3982|Ziegelmann.Matthew@mayo.edu|
21267858|NCT01497899|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21267859|NCT04269629|Department of Dermatology and Venerology|Assoz.-Prof. Dr. Gunter Sturm|+4331638580318|gunter.sturm@medunigraz.at|
21285110|NCT00350779|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclsoure@merck.com|
21285111|NCT00528372|AstraZeneca Pharmaceuticals|Boaz Hirshberg||ClinicalTrialTransparency@astrazeneca.com|
21267860|NCT00412425|UT MD Anderson Cancer Center|Agop Bedikian, MD Professor||asreckew@mdanderson.org|
21267861|NCT01874288|Alopexx Oncology, LLC|Chief Medical Officer||daniel.vlock@alopexx.com|
21285112|NCT02006056|Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto|Dr. Edward Chow|416-480-4974|edward.chow@sunnybrook.ca|
21285113|NCT02432144|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
21285114|NCT00262002|Novartis Vaccine and Diagnostics S.r.l|Posting Director||RegistryContactVaccineUS@novartis.com|
21285115|NCT03951753|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21285116|NCT04633291|Coloplast A/S|Vice President, Medical Affairs|+4549111111|clinical-studies@coloplast.com|
21285117|NCT01037816|Hisamitsu Pharmaceutical Co., Inc.|Yoshinobu Higashi, Section Manager, International Regulatory Affairs|+81-3-5293-1712|Yoshinobu_Higashi@hisamitsu.co.jp|
21285118|NCT00727090|Northwestern University|Andrew M Naidech|312-503-3592|a-naidech@northwestern.edu|
21285119|NCT00966355|Korea University College of Medicine|Prof. Soon Ho Um|+82-2-920-5019|umsh@korea.ac.kr|
21285120|NCT01299896|Vanderbilt University|Dr. Hilary A. Tindle|615-875-9726|hilary.tindle@vanderbilt.edu|
21285121|NCT04474054|FARAPULSE|Christopher (Kit) Schneider|617-686-7661|christopher.schneider@bsci.com|
21285122|NCT01523834|Azienda Sanitaria Universitaria Integrata di Udine (A.S.U.I. Udine) - SOC Clinica Ematologica|Dr. Francesco Zaja, Co-Investigator of the Study|+39 0432559604|francesco.zaja@asuiud.sanita.fvg.it|
21285123|NCT01502956|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
21237713|NCT04321239|University of Michigan|Mary Janevic|734 647 3194|mjanevic@umich.edu|
21285124|NCT04076319|USC Suzanne Dworak-Peck School of Social Work|Dr. Benjamin Henwood|+1 (213) 821-0496|bhenwood@usc.edu|
21285125|NCT01441245|Department of Internal Medicine, University of Siena, Le Scotte hospital, Siena, Italy|Alberto Palazzuoli MD, Cardiology Unit|+39577585363|palazzuoli2@unisi.it|
21285126|NCT02626000|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21285127|NCT01662856|Grifols Therapeutics Inc|Henry Li, PhD|+1 919 316 6042|henry.li@grifols.com|
21285128|NCT01944644|Weill Cornell Medical College|Marc Dubin, M.D.|(212) 746-5817|mrd9035@med.cornell.edu|
21285129|NCT03457818|Columbia University|Dr. Mishaela Rubin|2019528237|mrr6@cumc.columbia.edu|
21285130|NCT01393522|Mercy Health Research|Timothy R. Smith, MD|314-251-8895|Timothy.Smith@mercy.net|
21285131|NCT03746405|Duke University|Dr Lysianne Beynel|919-681-1157|lysianne.beynel@duke.edu|
21285132|NCT03479008|Unversity of Michigan|Dr. Benjamin Bassin|734 763-2134|bsbassin@med.umich.edu|
21285133|NCT00412932|Daiichi Sankyo|John Raia|973-630-2683|jraia@dsus.com|
21285134|NCT01515566|University of Texas MD Anderson Cancer Center|David Hui, MD, MSc, FRCPC / Asst. Professor, Palliative Care and Rehabilitation Medicine|713-792-6085|CR_Study_Registration@mdanderson.org|
21285135|NCT02085070|Yale Cancer Center|Director, Clinical Trials Office|12037372572|Joyce.Tull@yale.edu|
21285136|NCT01796301|Amgen Inc.|Study Director|866-572-6436||
21285137|NCT00667563|AMC|Jeannette Y. Lee|5015266712|jylee@uams.edu|
21285138|NCT01041274|NYU Langone Medical Center|Principal Investigator|646-754-4843|donald.goff@nyumc.org|
21285139|NCT02028780|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21285140|NCT02872909|University of Dundee|Professor Sally Ibbotson|01382 383499|s.h.ibbotson@dundee.ac.uk|
21285141|NCT02187029|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21285142|NCT02985021|VA Puget Sound HCS|Dr. Bruce Montgomery, PI|2062776878|rbmontgo@uw.edu|
21285143|NCT01491841|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
21285144|NCT00741598|Mood and Anxiety Disorders Program, Icahn School of Medicine at Mount Sinai|Dr. Dan V. Iosifescu|212-241-4480|dan.iosifescu@mssm.edu|
21285145|NCT04105842|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
21285146|NCT01951573|Alcon Research, Ltd.|Mary Fahmy, Head, Clinical Development, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21285147|NCT04399889|Duke University|Emily Poehlein, MB|919-668-8473|emily.poehlein@duke.edu|
21285148|NCT01537835|Denver Health and Hospital Authority|Marisha Burden, MD|303-602-5011|Marisha.Burden@dhha.org|
21285149|NCT00707980|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21285150|NCT01152996|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21285151|NCT02163681|University of Missouri|Talissa Altes, MD|573-882-1026|altest@health.missouri.edu|
21285152|NCT01648920|Aerocrine, Inc.|Nancy Herje, BSN, RN, MBA. Director, Clinical Development and Medical Affairs|919-449-8873|nancy.herje@aerocrine.com|
21285153|NCT02937636|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21285154|NCT00770913|Eisai Co.,Ltd. Eisai Product Creation Systems|Tomoki Kubota, Study Director|+81-3-3817-3908|t2-kubota@hhc.eisai.co.jp|
21285155|NCT02347072|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|650-350-2600|creisner@pearltherapeutics.com|
21285156|NCT02259699|University of California, Irvine|Dr. Lari Wenzel|949-824-3926|lwenzel@uci.edu|
21285157|NCT00777062|University of Pennsylvania|Dr. Kyle Kampman|215-222-3200|kampman@mail.med.upenn.edu|109
21285158|NCT01134393|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21285159|NCT03658642|Yale School of Medicine|Ted Melnick, MD, MHS Associate Professor of Emergency Medicine and of Biostatistics (Health Informat|(203) 785-5174|edward.melnick@yale.edu|
21285160|NCT00098670|The Ohio State University|Dr. Thomas Lin||thomas.lin@osumc.edu|
21285161|NCT03230838|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21285162|NCT00521885|Lehigh Valley Health Network|Leslie Baga, Director of Research|610 402 1285|Leslie.Baga@lvhn.org|
21285163|NCT01607346|GlaxoSmithKline|GSK Response Center|866-435-7343||
21285164|NCT02912455|Cleveland Clinic|Dr. Sangeeta Kashyap|(216) 445-2679|kashyas@ccf.org|
21285165|NCT01124370|Respicardia|Linda Nelson, VP Clinical Affairs|952-540-4479|lnelson@respicardia.com|
21285166|NCT00073008|GlaxoSmithKline|GSK Response Center|866-435-7343||
21285167|NCT02036541|Allergan plc|Rupali Nangia|714-246-6020|rupali.nangia@allergan.com|
21285168|NCT01836185|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21285169|NCT00808470|University of Texas at Dallas|Dr. Colleen Le Prell|214-905-3018|colleen.leprell@utdallas.edu|
21285170|NCT01778751|Durham Veterans Affairs Medical Center|Dr Matthew J Crowley|919-286-6936|matthew.crowley@va.gov|
21300154|NCT02379728|Global Innovations for Reproductive Health & Life|Dr. Allan Kember, Director of Programs|+1-902-580-8385|allan.kember@mail.utoronto.ca|
21300155|NCT01112917|BRIGHT Research Partners|Andrea Fenton Abbs - Study Director|612-298-7460|andrea@brightresearchpartners.com|
21300156|NCT04135417|Humacyte Inc.|Shamik Parikh, Chief Medical Officer|919-313-9633|sparikh@humacyte.com|130
21300157|NCT01827137|Sellas Life Sciences|Dragan Cicic|646-200-5278|info@sellaslife.com|
21300158|NCT04538989|Rezolute|Chief Medical Officer (Dr. Brian Roberts)|650-206-4507|brian@rezolutebio.com|
21300159|NCT02878343|UPenn|Dr. Karen Glanz||kglanz@pennmedicine.upenn.edu|
21300160|NCT04196777|Iowa City VA Health Care System|Daniel Livorsi|319-688-3871|daniel.livorsi@va.gov|
21300161|NCT00837434|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21285171|NCT02669667|MedImmune|Rene van der Merwe|+44 (0)1223 898263|information.center@astrazeneca.com|
21300162|NCT01709721|CTI Clinical Trial and Consulting Services|Heather Kapushoc, Sr. Biostatistician|571-315-2574|hkapushoc@ctifacts.com|
21300163|NCT02230410|Mayo Clinic|Dr. Kenneth K. Wang|507-293-7911|wang.kenneth@mayo.edu|
21256514|NCT02142738|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21256515|NCT03042780|H Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, MD|813-745-7257|Jonathan.Strosberg@moffitt.org|
21256516|NCT01168973|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21256517|NCT00930722|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21300164|NCT02135861|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21300165|NCT04614363|Houston Methodist|Dr. Brian Miles|713-441-8113|bjmiles@houstonmethodist.org|
21300166|NCT02558894|AstraZeneca|Global Clinical Lead|+1 301-398-0000|ClinicalTrialTransparency@astrazeneca.com|
21300167|NCT04558125|Cedars-Sinai Medical Center|Victor Tapson, MD|919-971-6441|Victor.Tapson@cshs.org|
21300168|NCT01748292|Retina Consultants of Houston|Charles C. Wykoff, MD, PhD|713-524-3434|ccwmd@houstonretina.com|
21300169|NCT03199976|Helsinki University Central Hospital|Dr Anne Kotaniemi-Syrjänen|+35894711|anne.kotaniemi-syrjanen@hus.fi|
21300170|NCT01761877|Stony Brook University|Dr. Alison T Stopeck|5206476982|Alison.Stopeck@stonybrookmedicine.edu|
21300171|NCT00003475|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
21300172|NCT03020667|Uwatoko Clinic|Kunihiko Uwatoko, MD|+81-52-991-4602|uwatoko.clinic@gmail.com|
21300173|NCT03697252|Karuna Therapeutics, Inc.|Stephen Brannan|857-449-2234|sbrannan@karunatx.com|
21300174|NCT01780506|Gilead Sciences|Gilead Clinical Study Information Center||GileadClinicalTrials@gilead.com|
21300175|NCT01096875|Ankara University Medical Faculty, Department of Cardiovascular Surgery|Prof. A. Ruchan Akar MD., FRCS(CTh).|+90 533 646 06 84|akarruchan@gmail.com|
21300176|NCT03926208|Rush University Medical Center|Dr. Daniel D. Bohl|414.640.7245|danielbohl@gmail.com|
21300177|NCT00412984|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21300178|NCT02199184|The University of Texas MD Andeerson Cancer Center|Elias Joseph Jabbour|713-792-4764|ejabbout@mdanderson.org|
21300179|NCT04097678|Twin Cities Spine Center|Clinical Research Director|612-775-6222|jmdawson@tcspine.com|
21300180|NCT03694678|Massachusetts General Hospital|Ana-Maria Vranceanu|6178931664|avranceanu@mgh.harvard.edu|
21300181|NCT02435212|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|novartis.email@novartis.com|
21300182|NCT04852302|National Cancer Institute|Dr. Kevin Camphausen|240-760-6205|camphauk@mail.nih.gov|
21300183|NCT04711850|Hansa Biopharma AB|Vice President Research and Development|+4646165670|info@hansabiopharma.com|
21300184|NCT05249582|Palo Alto University|Erick Kim|(510) 457-1584|ekim@paloaltou.edu|
21300185|NCT04393935|Emory University|Natalie Crawford, PhD|404-712-9445|ndcrawford@emory.edu|
21300186|NCT03844997|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|Sudipto Mukherjee, MD, PhD|866-223-8100|TaussigResearch@ccf.org|
21300187|NCT00135226|Nuffield Department of Population Health|Prof Jane Armitage|+44 (0)1865 743743|ascend@ndph.ox.ac.uk|
21300188|NCT04689139|Petrovsky NRCS|Dr. Artem Gubko|+79684241490|gubko@artvig.ru|
21300189|NCT00965354|Imperial College|Openshaw, Peter J M|07973 820 801|p.openshaw@imperial.ac.uk|
21300190|NCT02380573|University of Texas Health Science Center at San Antonio|Dr. Peter Fox|210-567-8150|fox@uthscsa.edu|
21300191|NCT03279081|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21300192|NCT05379179|University of Arizona|Jessica Winters|520-780-1882|jwinters1@arizona.edu|
21300193|NCT00771914|University of Rochester Division of Epidemiology, Department of Community and Preventive Medicine|Robert Block, MD, MPH, FACP|585-275-3356|robert_block@urmc.rochester.edu|
21300194|NCT04842747|Veru|Gary Barnette PhD CSO|800-606-9382|veruclinicaltrials@verupharma.com|
21300195|NCT01743469|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21300196|NCT00317473|USAMRU-K|Mark A. Withers, MD PhD|+254-722-449-357|aodika@wrp-ksm.org|
21300197|NCT02285855|UT MD Anderson Cancer Center|Stephen Chun/Assistant Professor, Radiation Oncology|713- 563-9600|sgchun@mdanderson.org|
21300198|NCT02516696|Weill Cornell Medicine|Multiple Myeloma Program Manager|646.962.9376|hyk4001@med.cornell.edu|
21300199|NCT01260493|Vårdalinstitute, University of Gothenburg|Professor Synneve Dahlin-Ivanoff ( Research leader)|+46 31 7865733|synneve.dahlin-ivanoff@gu.se|
21300200|NCT01451606|University of Maryland, Baltimore|Dr. Joel Greenspan|4107067090|jgreenspan@umaryland.edu|
21300201|NCT02718898|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21300202|NCT02989493|University of Wisconsin|John Curtin|608-262-0387|jjcurtin@wisc.edu|
21300203|NCT02163538|University Louisville|Dr. Resad Pasic|502-561-7465|resad.pasic@louisville.edu|
21300204|NCT04011540|University of Pennsylvania|Lauren Southwick|267-428-0125|lauren.southwick@pennmedicine.upenn.edu|
21300205|NCT01468558|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
21300206|NCT01126749|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
21300207|NCT00599014|Emory University|Dr. Javed Butler|404-778-5136|jbutle4@emory.edu|
21300208|NCT00976274|Department of Family Medicine, Yonsei University College of Medicine|Dr. Jae-Yong Shim|(+82) 2-2019-3480|hope@yuhs.ac|
21300209|NCT00627393|New England Research Institutes, Inc.|Susan Assmann, PhD|617-972-3048|sassmann@neriscience.com|
21300210|NCT05194124|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
21300211|NCT05494385|Indiana University School of Medicine|Dr. Anna Guanzon|2197651884|amguanzon89@gmail.com|
21300212|NCT03694353|BioMarin Pharmaceutical Inc|Debra Lounsbury/Sr. Director, Clinical Sciences|415-506-6348|Dlounsbury@bmrn.com|
21300213|NCT03804528|University of Miami|Joyce Gomes-Osman|305-284-2632|j.gomes@miami.edu|
21300214|NCT00584948|University of California, Davis Medical Center|Randi J Hagerman, MD|916-703-0247|randi.hagerman@ucdmc.ucdavis.edu|
21300215|NCT05138653|Cerevel Therapeutics|Cerevel Central Contact|8572500977|info@cerevel.com|
21256518|NCT00415506|Oregon Health & Science University|Dr. Eric B. Suhler|503-494-5023|suhlere@ohsu.edu|
21300216|NCT04607005|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21285172|NCT01819844|Massachusetts General Hospital|Steven J. Russell|617-726-8722|sjrussell@partners.org|
21285173|NCT03557476|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
21256519|NCT00388505|Novartis Pharmaceuticals|Study Director|862-778-8300||
21256520|NCT02650999|University of Pennsylvania, Clinical Research Unit|Ellen Napier, Nurse Pracitioner|215.279.1972|ellen.napier@pennmedicine.upenn.edu|
21256521|NCT04311697|Applied Pharma Rersearch|Paola Prina|4847169881|paola.prina@apr.ch|
21256522|NCT02285920|University of Pennsylvania|Laura M. Dember, MD|215-573-5264|ldember@pennmedicine.upenn.edu|
21256523|NCT00986544|"Department of Surgery, Hospital P. Colombo, Via Orti Ginnetti 7, 00049 Velletri (Rome), Italy"|Marcello Picchio|+39696102228|marcellopicchio@libero.it|
21256524|NCT01871220|University of Iowa College of Dentistry|Dr. Christopher Barwacz|3193843002|chris-barwacz@uiowa.edu|
21256525|NCT01383096|Nucleus Network|Peter Hodsman|+ 613 9076 8900|businessdevelopment@nucleusnetwork.com.au|
21256526|NCT04013789|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21267862|NCT04212221|Zai Lab (Shanghai) Co.,Ltd.|Medical Director|+86 4008201022|medinfo@zailaboratory.com|
21237714|NCT05072080|Bavarian Nordic|Medical Information|1-844-422-8274|medical.information_na@bavarian-nordic.com|
21237715|NCT00053989|Roswell Park Comprehensive Cancer Center|Theresa Hahn, PhD|716084505819|theresa.hahn@roswellpark.org|
21237716|NCT03205371|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21237717|NCT01851174|CTCA|Jessica L. Coats|6232073899|jessica.coats@ctca-hope.com|
21237718|NCT03786952|Ohio Northern University|Phillip Zoladz|419-772-2142|p-zoladz@onu.edu|
21237719|NCT04918147|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21237720|NCT03565887|RVL Pharmaceuticals, Inc.|Senior Director of Clinical Operations|908-809-1423|mvelasco@osmotica.com|
21237721|NCT02975973|Baylor College of Medicine|Raymond Cho|713-798-7781|Raymond.Cho@bcm.edu|
21237722|NCT03804710|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21237723|NCT00526123|Tufts Medical Center|Dr. Klemens B. Meyer|617-636-9421|kmeyer@tuftsmedicalcenter.org|
21237724|NCT03182868|University of Miami|Michael Hoffer|305 243-1484|michael.hoffer@miami.edu|
21237725|NCT02958969|BWH|Gregory Piazza|6177326984|gpiazza@bwh.harvard.edu|
21237726|NCT02191267|Brigham and Women's Hospital|Dr. Martha Shenton|617-699-6152|shenton@bwh.harvard.edu|
21237727|NCT00668902|Indiana University School of Medicine|Zeruesenay Desta|+1 (317) 274-2823|zdesta@iu.edu|
21237728|NCT03030222|Saint Luke's Hospital of Kansas City|Study Manager|816-932-9858|EMBRACE-HF@saint-lukes.org|
21237729|NCT01830127|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21237730|NCT02732366|University of Pittsburgh, Department of Physical Therapy|Christine M. McDonough, Assistant Professor of Physical Therapy|4123834603|cmm295@pitt.edu|
21237731|NCT02339831|Brigham and Women's Hospital|Wolfgang Fitz MD|617-732-9500|wfitz@partners.org|
21237732|NCT00941330|Emory University|Jane Meisel, MD|404-778-1900|jane.l.meisel@emory.edu|
21237733|NCT00951275|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21237734|NCT03260868|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21237735|NCT00541450|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||clinicaltrialsdisclosure@spcorp.com|
21237736|NCT01112579|Medtronic Cardiac Rhythm and Heart Failure|DEFEAT-HF Clinical Team|1-800-328-2518|MedtronicCRMtrials@medtronic.com|
21237737|NCT03645759|Michael E. Debakey VA Medical Center|Dr. Gina Evans|832-269-3048|gina.evans@va.gov|
21237738|NCT00902694|Johns Hopkins University School of Medicine|Gail Daumit, MD, MHS|410-614-6460|gdaumit@jhmi.edu|
21237739|NCT00725296|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21237740|NCT03360942|Dartmouth-Hitchcock Medical Center|Cristina Ferrazzano Yaussy, MPH, CCRP, Research Regulatory Affairs Specialist|603-650-5333|Cristina.Ferrazzano.Yaussy@hitchcock.org|
21237741|NCT03456700|Mayo Clinic|Aminah Jatoi MD|507/284-2511|Jatoi.Aminah@mayo.edu|
21237742|NCT01116934|JWGUniversity|Prof. Dr. Peter Eickholz|+49-69-6301|eickholz@med.uni-frankfurt.de|5642
21237743|NCT00613951|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21237744|NCT01437449|Stanford University|Dr. A. Dimitrios Colevas, Professor of Medicine (Oncology)|650-724-9707|colevas@stanford.edu|
21256527|NCT01172197|NHS Tayside|Dr G McLeod|+44 1382 7974440848|g.a.mcleod@dundee.ac.uk|
21256528|NCT00616434|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
21256529|NCT00467779|Hoffmann-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21256530|NCT01509079|HealthPartnersInstitute|Dr. Alice Shapiro|952-993-1704|shapia@parknicollet.com|
21256531|NCT04912245|Wake Forest University Health Sciences|Tele Voice|336.716.8028|jgabbard@wakehealth.edu|
21256532|NCT01205230|GlaxoSmithKline|GSK Response Center|866-435-7343||
21256533|NCT00041080|Gynecologic Oncology Group (GOG) Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
21256534|NCT00058552|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21267863|NCT00636506|American Medical Systems|Men's Health Clinical Affairs|952-930-6328|Karen.Seybold@ammd.com|
21256535|NCT02428855|Massachusetts General Hospital|Dr. Bruce Giantonio|617-724-4000|BGIANTONIO@mgh.harvard.edu|
21267864|NCT01624974|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21267865|NCT02607735|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21267866|NCT01376908|BioMarin Pharmaceutical Inc.|Medical Information Services|+1-800-983-4587|medinfo@bmrn.com|
21267867|NCT01646255|UCB|Study Director|+1877 822||9493
21267868|NCT02430389|Northwester University|Laura B. Hemmer, M.D.|312-695-0061|l-hemmer@northwestern.edu|
21267869|NCT00742391|LEO Pharma|Dr. Torsten Skov|+4520736294|torsten.skov@leo-pharma.com|
21267870|NCT00205374|University of Wisconsin-Madison|J. Scott McMurray, MD|608-262-7181|mcmurray@surgery.wisc.edu|
21267871|NCT01241318|"Ariadne Labs|BWH & HSPH"|Katherine Semrau (Epidemiologist, co-PI)|6177805311|ksemrau@ariadnelabs.org|
21300217|NCT02331134|University of Colorado Hospital|Antonio Jimeno, MD, PhD|3037242478|antonio.jimeno@cuanschutz.edu|
21300218|NCT04825574|Blueprint Medicines|Blueprint Medicines Medical Information|1-888-258-7768|medinfo@blueprintmedicines.com|
21300219|NCT05967260|Oregon Health & Science University|Clara Mosquera-Lopez|503--418-4129|mosquera@ohsu.edu|
21300220|NCT05565742|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21300221|NCT04163341|University of Alabama at Birmingham|Dr. Michael Mugavero|202-966-5822|mmugavero@uab.edu|
21300222|NCT03735875|The University of Texas MD Anderson Cancer Center|Naval Daver, MD./Professor|713-794-4392|NDaver@mdanderson.org|
21300223|NCT02711891|Rush University Medical Center|Kathleen C. Heneghan, RN, PhD|3123395943|kheneghan@facs.org|
21300224|NCT00079417|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
21300225|NCT01615939|Northwestern University, Feinberg School of Medicine|Antoun Nader|312-695-3045|a-nader2@northwestern.edu|
21300226|NCT04671017|Valneva Austria GmbH|Clinical Strategy Manager|+43 1 206 20|office@valneva.com|0
21300227|NCT01586364|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
21300228|NCT02121535|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
21300229|NCT04944992|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21300230|NCT00091949|Yale School of Medicine|Walter N. Kernan|203-764-7000|walter.kernan@yale.edu|
21300231|NCT00303069|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com|
21300232|NCT01520506|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
21300233|NCT00758667|Vanderbilt University|R. Bruce Shack, MD|615-936-0160|bruce.shack@vanderbilt.edu|
21300234|NCT03531112|University of North Carolina at Chapel Hill|Rachel Goode, PhD|919-962-6429|rwgoode@email.unc.edu|
21300235|NCT01256788|Steadman Hawkins Clinic of the Carolinas/Greenville Health System|Dr. Douglas Wyland|864-454-7422|dwyland@ghs.org|
21300236|NCT01972217|AstraZeneca|Medical Director|+13028851180|ClinicalTrialTransparency@astrazeneca.com|
21300237|NCT05366738|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-7428|medicalinformation@phathompharma.com|
21300238|NCT02798627|University of Pennsylvania Perelman School of Medicine|Kyle Kampman, MD|2157462764|kampman@pennemdicine.upenn.edu|
21300239|NCT04639245|Fred Hutchinson Cancer Center|Dr. Damian Green|(855) 557-0555|dgreen@fredhutch.org|
21300240|NCT00535496|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21300241|NCT01074814|Translational Drug Development|Linda Vocila, Executive Director Clinical Strategy|6023588311|lvocila@td2inc.com|
21300242|NCT03175367|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
21300243|NCT02851615|Cincinnati Children's Hospital Medical Center|Dr. Lori Crosby|513-636-5380|Lori.Crosby@cchmc.org|
21300244|NCT01843621|Dept of Pediatrics, Pharmongkutklao Hospital, Bankok, Thailand|Sriluck Simasathien, MD|66-2-644-8971|ssriluck@yahoo.com|
21300245|NCT00371150|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21300246|NCT03337477|AstraZeneca Clinical|Study Information Center|+1 877 240 9479|information.center@astrazeneca.com|
21300247|NCT03304626|University of Cincinnati|Khurram Bari|513-558-2898|khurram.bari@uc.edu|
21300248|NCT00744497|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21300249|NCT03182374|Zimmer Biomet|Clinical Project Lead|+41791522905|miguelcorreatapia@zimmerbiomet.com|
21300250|NCT03651479|Eastern Mediterranean University|Asst. Prof. Dr. Gozde Iyigun|+903926303011|gozde.iyigun@emu.edu.tr|
21300251|NCT02437344|NYSPI|Linda Sherman|6467747158|lsherma@nyspi.columbia.edu|
21300252|NCT06271993|Covalon Technologies Inc.|Director of Regulatory Affairs|888-236-4944|customerservice@covalon.com|
21300253|NCT04613362|Richard L. Roudebush VA Medical Center|Dr. Teresa Damush|317-988-4277|teresa.damush@va.gov|
21300254|NCT05172128|Duke University Medical Center|Dr. P. Murali Doraiswamy|9196845933|murali.doraiswamy@duke.edu|
21300255|NCT03331315|University of Tennessee - West Cancer Center|Michael Ulm|404-281-9480|mulm@westclinic.com|
21300256|NCT00481832|Stanford University School of Med|Wen-Kai Weng, MD; Associate Professor of Medicine|650-723-7689|wkweng@stanford.edu|
21300257|NCT03416985|University of California Los Angeles|Joan Pi Anfruns, DMD|310-825-0834|jpianfruns@dentistry.ucla.edu|
21300258|NCT00581308|W. L. Gore & Associates|Jay Donosky|(800) 437-8181|jdonosky@wlgore.com|
21300259|NCT00456846|Celgene Corporation|Anne McClain|888-260-1599|clinicaltrialdisclosure@celgene.com|
21300260|NCT03137381|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
21300261|NCT01980017|University of Ottawa Heart Institute|Dr. Robert Reid|6136967393|breid@ottawaheart.ca|
21300262|NCT03848325|University of Pittsburgh|Sanjay R. Patel MD, MS|412-383-0607|patelsr2@upmc.edu|
21267872|NCT02355665|JNJWorldwide|Andrew Myers, MD, Director, Clinical Research|(215) 273-8421 USA EST|AMyers3@its.jnj.com|
21267873|NCT02380703|Baylor College of Medicine|Mark Kunik, MD, MPH, Primary Investigator|713-794-8639|mkunik@bcm.edu|
21267874|NCT03607994|Wake Forest Baptist Health|Catherine Tegeler - Project Manager|336-716-9341|categele@wakehealth.edu|
21285174|NCT00868751|Tufts Medical Center|Research Administration||mcoughlin@tuftsmedicalcenter.org|
21285175|NCT03628716|Bavarian Nordic A/S|Bavarian Nordic Call Center|1-844-422-8274|medical.information_us@bavarian-nordic.com|
21285176|NCT00856843|Braintree Laboratories, Inc.|John McGowan|781-843-2202|jmcgowan@braintreelabs.com|
21285177|NCT03755518|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
21285178|NCT03172364|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21285179|NCT01714609|Yale University|Dr. Garcia-Tsao|(203) 737-6063|guadalupe.garcia-tsao@yale.edu|
21285180|NCT03403621|Mayo Clinic|Dr. Alexander Meves|507-284-3668|Meves.Alexander@mayo.edu|
21285181|NCT00583102|University of Iowa|Raymond Hohl, MD|319-356-8110|rhohl@pennstatehealth.psu.edu|
21285182|NCT00182000|Massachusetts General Hospital|Sabine Wilhelm, PhD|6177246146|swilhelm@partners.org|
21285183|NCT01905592|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21285184|NCT01483599|Janssen Research & Development, LLC|Senior Director, Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
21285185|NCT00401193|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21285186|NCT02526160|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
21285187|NCT00398216|Daiichi Sankyo, Inc.|William Maxwell, Assoc. Director|732-590-5000|wmaxwell@dsi.com|
21285188|NCT00570960|University of Virginia|Patrick G. Northup, M.D.|434-924-0000|northup@virginia.edu|
21285189|NCT01142947|Center for Individualized and Genomic Medicine Research, Henry Ford Health System|L. Keoki Williams, MD, MPH|313-874-5454|kwillia5@hfhs.org|
21285190|NCT04378569|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
21285191|NCT01048944|Southern Illinois University Carbondale|David G. Gilbert, Ph.D.|618-45303558|dgilbert@siu.edu|
21285192|NCT01844817|Sarah Cannon Development Innovations|Charles Davis, RAC||Charles.Davis2@scri-innovations.com|
21285193|NCT01133704|Dendreon Corporation|Kathleen Picha|206-265-4545|kpicha@dendreon.com|
21285194|NCT02207400|GlaxoSmithKline|GSK Response Center|866-435-7343||
21285195|NCT02362425|National Institute of Nursing|Katherine Meileur Chief, Neuromuscular Symptoms Unit|301-435-1503|meilleurk@mail.nih.gov|
21285196|NCT00596453|Johns Hopkins Medical Institutions|Misop Han, M.D.|410-502-7454|mhan1@jhmi.edu|
21285197|NCT03417752|VA Center of Excellence for Suicide Prevention|Elizabeth Karras, PhD|585-393-7285|elizabeth.karras-pilato@va.gov|
21285198|NCT02771860|University Gent|Prof. dr. Ruth Wittoek|+3293322522|anuschka.vandenbogaert@uzgent.be|
21285199|NCT04304508|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21285200|NCT00699400|EMD Serono, Inc.|Mary C. Mahony, PhD, HCLD (AAB)|781.681.2438|mary.mahony@emdserono.com|
21285201|NCT02688764|Vifor Fresenius Medical Care Renal Pharma France|Milica Enoiu / Clinical Research Manager|+41588518264|milica.enoiu@viforpharma.com|
21285202|NCT02113007|Sarah Cannon Development Innovations|Charles H. Davis, RAC|615-524-4341|charles.davis2@scri-innovations.com|
21285203|NCT00885378|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
21300263|NCT03044106|University of North Carolina at Chapel Hill|Nicholas Wise, DC|(864) 494-1001|nicholas_wise@med.unc.edu|
21300264|NCT02057250|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21300265|NCT03379818|University of Birmingham|Dr Andrea Krott|+44 (0)121 414 4903|a.krott@bham.ac.uk|
21267875|NCT01228435|Massachusetts General Hospital|Lecia Sequist|617-726-7812|lvsequist@partners.org|
21267876|NCT00498927|Memorial Sloan Kettering Cancer Center|Dr. Antonio Omuro|212 639 7523|omuroa@mskcc.org|
21267877|NCT00780676|University of Texas (UT) MD Anderson Cancer Center|Stacy Moulder, MD/Associate Professor, Breast Medical Oncology|713-792-2360|CR_Study_Registration@mdanderson.org|
21267878|NCT01882439|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021||
21267879|NCT01775995|University of Wisconsin Madison|Aleksandra Zgierska, MD PhD|(608) 263-7882|aleksandra.zgierska@fammed.wisc.edu|
21267880|NCT01997333|Celldex Therapeutics|Head of Regulatory Affairs|844-723-9363|info@celldex.com|
21267881|NCT03691831|Aclaris Therapeutics, Inc.|Aclaris Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
21267882|NCT02198040|Universidad de Murcia|Rubén Cuesta-Barriuso, PhD|+34 913146508|ruben.cuestab@gmail.com|
21267883|NCT00337935|Centocor Ortho-Biotech LLC.|Vice President, Medical Affairs|800.457.6399||
21267884|NCT00329433|Washington University School of Medicine|Michael S. Avidan, MBBCh|314-747-4155|avidanm@wustl.edu|
21267885|NCT01080794|Beth Israel Deaconess Medical Center|Dr. Alvaro Pascual-Leone|(617) 667-0203|apleone@bidmc.harvard.edu|
21267886|NCT01189201|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21267887|NCT01682876|GlaxoSmithKline|GSK Response Center|877-379-3718|GSKClinicalSupportHD@gsk.com|
21267888|NCT00578331|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21267889|NCT03852901|National Institute on Aging|Josephine M. Egan, MD, Clinical Director|410-558-8414|eganj@mail.nih.gov|
21285204|NCT01775787|UConn Health|Dr. Cheryl Oncken|860-679-3425|oncken@uchc.edu|
21285205|NCT03026283|Northwell Health|Pamela Noack|212 434 4926|pnoack@northwell.edu|
21285206|NCT00824655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21285207|NCT03252145|University of California, San Francisco|Betty Smoot, DPTSc, PT|(707) 494-8262|Betty.Smoot@ucsf.edu|
21285208|NCT03091738|Virginia Commonwealth University|Jasmohan Bajaj, MD|804-828-4060|jasmohan.bajaj@vcuhealth.org|
21285209|NCT01466075|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
21285210|NCT01763827|Amgen Inc.|Study Director|866-572-6436||
21285211|NCT01826981|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21285212|NCT00168428|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
21285213|NCT00777335|University of California Los Angeles (UCLA) / Cancer International Research Group (CIRG) (Translational Research in Oncology TRIO) Inc.|Dr. Richard Finn|+ 1 310 586 2091|RFinn@mednet.ucla.edu|
21285214|NCT02384538|AbbVie|Global Medical Services|800-633-9110||
21285215|NCT05886907|Alcon Research, LLC|Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21285216|NCT01763203|Icahn School of Medicine at Mount Sinai|Dr. Barbara Vickrey; Chair of Neurology|2122415698|barbara.vickrey@mssm.edu|
21285217|NCT02187861|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21285218|NCT02756819|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21285219|NCT03083808|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 634-5842|fsharmin@hoosiercancer.org|75
21285220|NCT01027468|Medical University of Vienna|Assoc.Prof.PD.Dr.Stefan Sacu|+43404001|stefan.sacu@meduniwien.ac.at|7937
21285221|NCT00988000|Imperial College|Professor Martyn Partridge|+44 (0)20 7594 7959|m.partridge@imperial.ac.uk|
21237745|NCT00655980|University of Chicago Medicine|Principal Investigator|7737022544||
21285222|NCT04217317|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-713-5878|dfunes@wakehealth.edu|
21285223|NCT02087943|CelgeneCorp|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-888-260-1599|amcclain@celgene.com|
21285224|NCT01690299|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|clinicaltrialdisclosure@celgene.com|
21285225|NCT04313400|Amarex Clinical Research, LLC|Dr. Ahmad Bayat, Sr Director II, Regulatory Affairs|301-956-2523|ahmadb@amarexcro.com|
21285226|NCT00329745|GlaxoSmithKline|GSK Response Center|866-435-7343||
21285227|NCT03146741|University of Pennsylvania|Dr. Peter Reese|215-900-3782|peter.reese@uphs.upenn.edu|
21285228|NCT03224624|VA San Diego Healthcare System|Dena Rifkin|8585528585|dena.rifkin@va.gov|2784
21285229|NCT02589847|Rebiotix, Inc.|Clinical Development|651-705-8778|US8-StudyInfo@ferring.com|
21285230|NCT01884545|NYU Rory Meyers College of Nursing|Allison A. Vorderstrasse, DNSc, APRN, FAAN|212-998-5786|allisonvorderstrasse@nyu.edu|
21285231|NCT01424241|Columbia University Medical Center|Pamela Freda, MD|212-305-2254|puf1@columbia.edu|
21285232|NCT00551525|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21285233|NCT05050448|Medical Pain Consultants|Dr. Ralph Ortiz|607-844-9979|rodoc@cnymail.com|
21285234|NCT05391555|University of California San Francisco|Rachel Eshima McKay|415-476-9035|rachel.eshima@ucsf.edu|
21285235|NCT00303472|Amgen Inc.|Study Director|866-572-6436||
21285236|NCT02488018|Addis Ababa University [Office telephone +251011-655-1927]|Abera Belay (PhD Candidate)|Mobile +251911840655|ab.berabelay@gmail.com|
21285237|NCT03571607|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21285238|NCT05537428|Yale University|Philip Corlett|2039747866|philip.corlett@yale.edu|
21285239|NCT00123682|VA New York Harbor Healthcare System|Dr. Scott Sherman, PI|212-686-7500|scott.sherman@va.gov|7386
21285240|NCT00596102|Valneva Austria GmbH|Katrin Dubischar-Kastner|+43 1 20620|info@valneva.com|0
21285241|NCT00359294|PharmaMar USA Inc|Responsible medical officer|1 212 201 6770|ccoronado@pharmamar.com|
21285242|NCT00583011|University of Oklahoma Health Science Center|Andrew Elimian, MD|9142317323|aelimian@aol.com|
21285243|NCT04208412|KalVista Pharmaceuticals Ltd.|Vice President Clinical|1 (857) 999-0075|clinical@kalvista.com|
21285244|NCT01608672|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21285245|NCT01808222|Emory University|David Schuster MD|404-712-4859|dschust@emory.edu|
21285246|NCT01096680|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21285247|NCT00830518|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21285248|NCT04318132|Nidek.co., ltd.|Tadakazu Ichimura|+81-533-67-8904|tadakazu_ichimura@nidek.co.jp|
21285249|NCT01420016|HealthPartners Institute|Dr. Patrick O'Connor|952-967-5034|patrick.j.oconnor@healthpartners.com|
21285250|NCT01454414|University of North Carolina at Chapel Hill|Dr. Meagan Vaughn|9196986208|meagan.vaughn@unc.edu|
21285251|NCT00586898|Memorial Sloan Kettering Cancer Center|Dr. Howard Scher|646-422-4323|Scherh@mskcc.org|
21285252|NCT02320227|Church & Dwight Co., Inc.|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
21285253|NCT01994902|Coloplast A/S|Medical Director|+45 49111395|dkbir@coloplast.com|
21285254|NCT01085084|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21285255|NCT01962948|Fox Chase Cancer Center|Protocol Development Coordinator|215-728-4097|ryan.romasko@fccc.edu|
21285256|NCT00376532|Thomas Jefferson University|David J. Whellan MD|215 955 2636|david.whellan@jefferson.edu|
21285257|NCT02849704|Children's Hospital of Philadelphia|Virginia Stallings, MD|267.425.1633|stallingsv@email.chop.edu|
21285258|NCT01290952|Azienda Ospedaliera Luigi Sacco|Dr. Massimo Lemma|0039 0239042876|lemma.massimo@hsacco.it|
21285259|NCT00707967|GlaxoSmithKline|GSK Response Center|866-435-7343||
21285260|NCT00314808|Duke University|Deborah H. Allen, MSN, RN, CNS, FNP-BC, AOCNP|(919) 681-4719|allen079@mc.duke.edu|
21256536|NCT01312038|Middle Ear Physiology Laboratory|Ellen Mandel, MD|412-692-6214|mandele@pitt.edu|
21285261|NCT02579382|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21300266|NCT03367793|Ohio State University College of Optometry|Dr. Heather Anderson, Study PI|614-247-5825|anderson.3881@osu.edu|
21300267|NCT00260533|University of California San Diego|Murray B. Stein MD, MPH|858-534-6400|mstein@ucsd.edu|
21300268|NCT01310777|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21300269|NCT00643864|CarolinasHS|Dr. Mark Hirsch, Senior Scientist|704 355 7673|mark.hirsch@carolinashealthcare.org|
21300270|NCT04218240|University of Pennsylvania|Kyle M. Kampman, MD|2157462764|kampman@pennmedicine.upenn.edu|
21300271|NCT03292926|Hospital for Special Surgery, Anesthesiology|Dr. Jonathan Beathe|2126061036|beatheJ@hss.edu|
21285262|NCT04560868|Kaiser Permanente Washington Health Research Institute|Director, Investigative Science|206-287-2737|jennifer.b.mcclure@kp.org|
21285263|NCT03084302|University of Pittsburgh|Bethany Barone Gibbs, Associate Professor, University of Pittsburgh|412-383-4002|bbarone@pitt.edu|
21285264|NCT01301079|Federal University of Sao Paulo|Plínio da Cunha Leal|55-98-8852-2021|pliniocunhaleal@hotmail.com|
21300272|NCT02453737|Mayo Clinic|Dr. Robert W. Mutter|507-284-3191|Mutter.Robert@mayo.edu|
21267890|NCT00911508|Mayo Clinic|Dr. Douglas L. Packer|507-255-6263|CABANA@mayo.edu|
21267891|NCT03374982|University of Nebraska Medical Center|Zachary Houser|402-980-9633|zach.houser@unmc.edu|
21267892|NCT00240331|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21267893|NCT01409382|Hospital Federal dos Servidores do Estado|Dr. Silvia Hoirisch-Clapauch|55-21-999737500|sclapauch@gmail.com|
21267894|NCT04563845|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21267895|NCT01020812|Stanford University|Daniel T Chang|650-723-6171|dtchang@stanford.edu|
21267896|NCT00187655|UCSF|Richard Castro, MD|4155144363|Rich.Castro@ucsf.edu|
21267897|NCT01115166|Department of Anaestesilogy and Intensive Care|Joachim Zdolsek|+46101030000|joachim.zdolsek@lio.se|
21267898|NCT02138227|Temple University|Dr. Laura Siminoff|(215) 204-8726|lasiminoff@temple.edu|
21267899|NCT00346476|Desmond Tutu HIV Centre|Prof LG Bekker|+27216506966|Linda-Gail.Bekker@hiv-research.org.za|
21267900|NCT04156802|Wake Forest University School of Medicine|Merideth Addicott, PhD|336-716-7792|maddicot@wakehealth.edu|
21267901|NCT00692198|Johns Hopkins Bloomberg School of Public Health|James Tonascia, PhD|410-955-8175|jtonasc1@jhu.edu|
21267902|NCT00218439|University of Minnesota College of Pharmacy|Dr. Michael Kotlyar|612-625-1160|kotly001@umn.edu|
21267903|NCT02615158|University of Maryland School of Medicine|Dr. Maureen Black|410-706-2136|mblack@som.umaryland.edu|
21267904|NCT00883896|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21267905|NCT02546193|Mayo Clinic|VanessaTorbenson, M.D.|507-266-9873|torbenson.vanessa@mayo.edu|
21267906|NCT00991458|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21267907|NCT03306589|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|1
21267908|NCT03339999|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21267909|NCT03028324|University of Miami|Joyce Rios Gomes-Osman|305-284-2632|j.gomes@miami.edu|
21267910|NCT03380091|University of California, San Francisco|Heather Huddleston|(415) 353-3040|Heather.Huddleston@ucsf.edu|
21267911|NCT03802331|Boehringer Ingelheim|Boehringer Ingelheim|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21267912|NCT01196793|Imperial College London NHS Trust|Dr Hermione Lyall|02033126965|hermione.lyall@nhs.net|
21267913|NCT00368069|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
21267914|NCT03432819|RAND Corporation|Laura Bogart, PhD|(310) 393-0411|lbogart@rand.org|7281
21267915|NCT00760994|VA Puget Sound Health Care System|Tracy Simpson, Ph.D.|206-277-3337|tracy.simpson@va.gov|
21267916|NCT03138798|Icahn School of Medicine at Mount Sinai|Dr. Eric Bergh|908-625-8148|eric.bergh@mssm.edu|
21267917|NCT00529152|ApoPharma|Dian Shaw, Manager Clinical Research|416-401-7283|dshaw@apotex.com|
21267918|NCT02500706|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21267919|NCT01878786|MedStar Georgetown Transplant Institute|Dr. Matthew Cooper|202-444-0753|Matthew.Cooper@gunet.georgetown.edu|
21267920|NCT00078715|Experimental Therapeutics and Pathophysiology Branch, DIRP, NIMH|Dr. Carlos A. Zarate, Jr.|301-451-0861|zaratec@mail.nih.gov|
21267921|NCT02347124|Kaiser Permanente Washington Health Research Institute|Dr. Jennifer McClure|206-287-2737|mcclure.j@ghc.org|
21267922|NCT01000311|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21267923|NCT02183792|University of Southern California School of Pharmacy|Tien Ng, Pharm.D.|3234421840|tienng@usc.edu|
21267924|NCT01408862|Institute of Medical Research (UBA-CONICET)|Dr. Carlos Jose Pirola|541145148701|cpirola@ciudad.com.ar|167
21267925|NCT04411472|AM-Pharma|AM-Pharma Office|+31 (0)30 22 89 222|office@am-pharma.com|
21267926|NCT05060003|Washington University School of Medicine|George Ansstas, M.D.|314-362-5677|gansstas@wustl.edu|
21267927|NCT01558791|National Center for PTSD|Dr. Jessica Hamblen, PI|802-296-5132|Jessica.Hamblen@va.gov|5389
21267928|NCT01747655|AbbVie|Global Medical Information|1-800-633-9110||
21267929|NCT02275559|UMass Chan Medical School|Dr James Carmody|5088561205|james.carmody@umassmed.edu|
21267930|NCT01373294|H. Lee Moffitt Cancer Center and Research Institute|Dr. Mayer Fishman|813-745-8311|mayer.fishman@moffitt.org|
21267931|NCT00684073|Schering-Plough|Head, Clinical Trials Registry and Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
21267932|NCT02699632|Pennington Biomedical Research Center|Leanne Redman, Principal Investigator|2257630947|Leanne.Redman@pbrc.edu|
21267933|NCT01259388|Birmingham VA Medical Center|Dr. John Rinker|205-934-2402|John.Rinker@va.gov|
21267934|NCT00758420|BTG International Inc.|David Wright MBBS|610-943-3538|david.wright@btgplc.com|
21267935|NCT05414422|Perception Neuroscience|Clinical Trials Group|+49 (0) 89 2153 9035|clinicaltrials@perceptionneuroscience.com|
21267936|NCT02728804|SWOG Statistics and Data Management Center|Cancer Care Delivery Committee Statistician|2066674623|adarke@fredhutch.org|
21267937|NCT00591786|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21267938|NCT01835964|University of Virginia|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
21267939|NCT01920061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21267940|NCT00554229|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21267941|NCT03969589|VISN 5 MIRECC|Amy Drapalski|443-421-6273|amy.drapalski@va.gov|
21267942|NCT03143855|Virginia Commonwealth University|Dr. F. Gerard Moeller|804-828-4134|fgmoeller@vcu.edu|
21267943|NCT02514889|UCLA Fielding School of Public Health, 650 Charles Young Drive, Los Angeles, CA 90095|William J. McCarthy, Ph.D., Professor|310-794-7587|wmccarth@ucla.edu|
21267944|NCT02978339|Mayo Clinic|John E. Eaton, M.D.|507-284-3917|Eaton.John@mayo.edu|
21267945|NCT01665040|Boston Scientific|Roshini Jain, Director of Clinical Sciences|6619494350|rjain@bsci.com|
21267946|NCT05453006|University of Minnesota|Christina Bliss Barsness|612-625-7179|blis0015@umn.edu|
21267947|NCT00195702|Abbott|Global Medical Services|800-633-9110||
21267948|NCT03721549|WCCT Global|Erin Flynn, Associate Director of Regulatory Affairs|7207713080|erin.flynn@wcct.com|
21267949|NCT00508469|Alcon France|Severine Durier, PharmD|+33 1 47 10 48 43||
21256537|NCT01372150|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21256538|NCT03198520|Solvay® Dental 360|Tim Shary Compliance and Product Specialist|770-772-8665|Tim.shary@solvay.com|
21256539|NCT01670539|West Virginia University|Georgia L Narsavage|304-293-6729|gnarsavage@hsc.wvu.edu|
21256540|NCT04353596|Medizinische Universität Innsbruck/ Medical University Innsbruck|Prof. Dr. Axel Bauer|0043 512 504 25621|Axel.Bauer@i-med.ac.at|
21256541|NCT02665052|Baltimore VA Medical Center VA Maryland Health Care System|Dr. Susan S. Conroy|(410) 637-3213|susan.conroy@va.gov|
21256542|NCT02234284|University of California San Francisco|Dr. David Thom|415-206-2278|David.Thom@UCSF.edu|
21256543|NCT03023059|Robert W Snyder, MD, PhD, PC|Dr. Robert W. Snyder|5206616516|rsnyder781@gmail.com|
21256544|NCT00536809|GlaxoSmithKline|GSK Response Center|866-435-7343||
21256545|NCT00233363|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21256546|NCT01495858|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21256547|NCT04880447|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21256548|NCT01364623|Acerus Pharmaceuticals Corporation|Dr. Nathan Bryson, Vice President, Scientific Affairs|1-416-679-0776|nbryson@aceruspharma.com|
21256549|NCT01353508|Novartis|Study Director|862-778-1873||
21256550|NCT01033552|University of Minnesota, Masonic Cancer Center|Dr. Jakub Tolar|(612) 626-5654|tolar003@umn.edu|
21256551|NCT01958788|Concordia University|Elizabeth Hebert|1-514-848-2424|el_heber@live.concordia.ca|2199
21256552|NCT00433914|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21256553|NCT02844920|Gynesonics|Taraneh G. Farazi, Ph.D. (Vice President, Clinical Affairs)|650-216-3878|tfarazi@gynesonics.com|
21256554|NCT04534491|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
21256555|NCT00240981|Brigham & Women's Hospital|Dr. Shalender Bhasin|617-525-9150|sbhasin@partners.org|
21256556|NCT00766090|GlaxoSmithKline|GSK Response Center|866-435-7343||
21256557|NCT03024970|CooperVision, Inc.|Myhanh Nguyen, OD, FAAO|925-730-6716|mnguyen@coopervision.com|
21256558|NCT00574288|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
21256559|NCT01106027|Mayo Clinic|Dr. Mark Stegall|507-284-6275|Stegall.Mark@mayo.edu|
21256560|NCT00356889|University of Wisconsin Cancer Center|William Schelman, M.D.||wrs@medicine.wisc.edu|
21256561|NCT02678416|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
21256562|NCT01170546|Department of Physical Medicine and Rehabilitation, Chang Gung Memorial Hospital|Shih-Wei Chou, MD, PhD|88633281200|h0711@ms13.hinet.net|3846
21256563|NCT00736034|Sourazky Tel-Aviv Medical Center|Dr. V. Vakhapova|972-3-6973698|vedanicek@gmail.com|
21256564|NCT04458103|Massachusetts General Hospital|David D'Alessandro|617-726-8841|DADALESSANDRO@mgh.harvard.edu|
21256565|NCT01983839|Aarhus University Hospital, Department of infectious diseases|Dr Kristina Öbrink-Hansen|+4578452845|krisoebr@rm.dk|
21256566|NCT01514136|Coloplast A/S|Birte Petersen Jakobsen, MD|+45 4911 1990|dkbir@coloplast.com|
21256567|NCT03945357|Prisma Health|Aimee Hanvey|864-760-7350|aimee.hanvey@prismahealth.org|
21256568|NCT01561495|AbramsonCC Radiation Oncolocy|Susan Prendergast, RN|215-662-4267|susan.prendergast@pennmedicine.upenn.edu|
21256569|NCT04666350|PATH|Chris F Ockenhouse, MD, PhD|+1 (202) 716-5849|cockenhouse@path.org|
21256570|NCT00531882|University Hospitals Case Medical Center|Michael W Konstan, MD|2168445267|michael.konstan@uhhospitals.org|
21256571|NCT02431897|University of Texas Southwestern Medical Center Dallas|Dr. David D. Rahn|12146486430|david.rahn@utsouthwestern.edu|
21256572|NCT00955279|Johnson & Johnson Pharmaceutical Research & Development|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
21256573|NCT01159912|GlaxoSmithKline|GSK Response Center|866-435-7343||
21256574|NCT05426759|AtriAN Medical Ltd|Barry O'Brien PhD|+353872934292|barry.obrien@atrianmedical.com|
21256575|NCT00822354|Northwestern University|Clinical Trials Coordinator|312-695-6829|j-bae@northwestern.edu|
21256576|NCT02347488|UCLA Department of Anesthesiology|Nir Nahum Hoftman, MD|310-267-8679|nhoftman@mednet.ucla.edu|
21256577|NCT05314712|Center for American Indian and Rural Health Equity|Vernon Grant|406-531-9310|vernon.grant@montana.edu|
21256578|NCT03734016|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21256579|NCT02715466|B. Braun Melsungen AG|Study Manager|00495661/71|studies@bbraun.com|0
21256580|NCT00846547|Seaside Therapeutics|Dr. Paul Wang, Vice President of Clinical and Medical Affairs|617-374-9009|pwang@seasidetherapeutics.com|1015
21256581|NCT01744353|Brown Oncology Research Group|Helena Lau|4018633000|helena_lau@brown.edu|
21256582|NCT00121836|Hoffmann-LaRoche|Medical Communications|800-821-8590||
21256583|NCT02737852|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annhita.ghassemi@churchdwight.com|
21256584|NCT03688880|Grünenthal GmbH|Grünenthal Clinical-Trials Helpdesk|+49 241 569|clinical-trials@grunenthal.com|3223
21256585|NCT05745675|UCSF Hypoxia Research Laboratory|Dr. Philip Bickler|1-415-476-1411|philip.bickler@ucsf.edu|
21256586|NCT01704287|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21256587|NCT04042740|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
21256588|NCT03713034|Yale University|Tyra Pendergrass Boomer|(203) 737-6101|tyra.pendergrass@yale.edu|
21256589|NCT02615470|Auburn University|Salisa Westrick|3348448314|westrsc@auburn.edu|
21256590|NCT02000596|University of Maryland Greenebaum Comprehensive Cancer Center|Kate Tkaczuk|410-328-7394|ktkaczuk@umm.edu|
21256591|NCT01717287|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21256592|NCT04024228|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21256593|NCT02982590|HOSPITAL UNIVERSITI SAINS MALAYSIA|DR W YUS HANIFF W ISA|09-767 3000|wyhaniff@usm.my|
21256594|NCT00886704|Ludwig Maximilians-University Munich|Clemens von Schacky, Head, Preventive Cardiology, University of Munich|+498951600|clemens.vonschacky@med.uni-muenchen.de|2165
21267950|NCT04823494|GN|Todd Fortune|763-772-5566|tfortune@gnresound.com|
21267951|NCT01884675|GlaxoSmithKline|GSK Response Center|866-435-7343||
21267952|NCT01277757|University of Texas (UT) MD Anderson Cancer Center|Funda Meric-Bernstam, MD/Chair, Investigational Cancer Therapeutics|713-563-4347|fmeric@mdanderson.org|
21267953|NCT04120116|Frequency Therapeutics|Director of Clinical Trials|781-315-4600|clinicaltrialsinformation@frequencytx.com|
21267954|NCT00965458|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21267955|NCT01846039|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21267956|NCT03330275|Johnson & Johnson Vision Care, Inc.|John Buch- SENIOR PRINCIPAL RESEARCH OPTOMETRIST|904 443-1707|JBUCH@its.jnj.com|
21267957|NCT02528331|Duke University|Richard Weiner, MD, PhD|919-681-8742|weine002@duke.edu|
21267958|NCT01522963|University of Minnesota|Michael Kotlyar|6126251160|kotly001@umn.edu|
21267959|NCT01091116|Menarini-Ricerche|Clinical Research Director|+39-055-56809990||
21267960|NCT03824704|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
21267961|NCT01160458|National Cancer Institute, National Institutes of Health|Dr. Raffit Hassan, M.D.|301-451-8742|hassanr@mail.nih.gov|
21267962|NCT00182793|City of Hope|Paul Frankel, Ph.D.|626-359-8111|pfrankel@coh.org|65265
21267963|NCT02155660|AstraZeneca|Ulbaldo Martin|1.301.398.0163|ulbaldo.martin@astrazeneca.com|
21267964|NCT03730987|University of Miami|Dr. Victoria Behar-Zusman|305-2849139|vbehar-zusman@miami.edu|
21267965|NCT02505945|Torax Medical|Adam Ahlstrom|651-361-8900|aahlstro@its.jnj.com|
21267966|NCT02406586|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
21285265|NCT00649792|Acorda Therapeutics, Inc.|Andrew Blight, PhD Chief Scientific Officer|914-347-4300|ablight@acorda.com|4102
21267967|NCT01072175|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21267968|NCT02839330|Seqirus|Seqirus Clinical Trial Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
21267969|NCT00438815|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21267970|NCT01733758|GlaxoSmithKline|GSK Response Center|866-435-7343||
21267971|NCT02357394|University of Kansas Health System, Dept of OBGYN|Dr. Gene Lee|9135886201|glee@kumc.edu|
21267972|NCT01811004|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
21267973|NCT02545270|Department of Anesthesiology, Herlev and Gentofte Hospital, University of Copenhagen, Herlev Denmark|MD. G. G. Nervil||gustavnervil@gmail.com|
21267974|NCT00661362|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21267975|NCT02206776|Stanford University|Dr. Carolyn Rodriguez, Assistant Professor|650-723-4095|ocdresearch@stanford.edu|
21267976|NCT00535262|Depression Evaluation Service, New York State Psychiatric Institute|Deborah A. Deliyannides, M.D. Research Psychiatrist|(212) 543-5734|deliiyan@nyspi.columbia.edu|
21267977|NCT01707667|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21267978|NCT02675933|Dell Children's Medical Center of Central Texas|Dr. Catherine Yee|5123240000|ceyee@ascension.org|86878
21285266|NCT00368459|Stanford University|Victor Henderson|650-723-5456|vhenderson@stanford.edu|
21267979|NCT04382066|PharmaMar, S.A.|Clinical Development Virology Business Unit PharmaMar|+34 91 846 60 00|clinicaltrials@pharmamar.com|
21267980|NCT01430559|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21267981|NCT00859495|Columbia University|Robert Taub, MD||rntaubipod@gmail.com|
21267982|NCT01220024|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
21267983|NCT02467504|Peking university People's Hospital|Prof. Zhanguo Li|+86-13810001444|13810001444@163.com|
21267984|NCT00174460|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21267985|NCT04225026|Galera Therapeutics|Judy Schnyder, Sr. Vice President, Clinical Operations|484-870-9625|jschnyder@galeratx.com|
21267986|NCT00579059|Biomet, LLC|Megan Lawson, Clinical Research Specialist|1-800-348-9500|megan.lawson@biomet.com|1183
21267987|NCT03698370|Stanford University|Dr. Andrei Iagaru, MD|650-728-4711|aiagaru@stanford.edu|
21267988|NCT04738123|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21267989|NCT00779506|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21267990|NCT03982069|University of Pittsburgh|Dr. Katherine Williams|412-383-1979|kvw3@pitt.edu|
21267991|NCT03137433|University of Minnesota|Aaron Kelly, PhD|612-626-3492|kelly105@umn.edu|
21267992|NCT00914940|Fred Hutchinson Cancer Research Center|Marie Bleakley, MD|206-667-6572|mbleakle@fredhutch.org|
21267993|NCT01853397|Solta Medical|Director of Clinical Programs|510-259-5284|aloncaric@solta.com|
21267994|NCT01724021|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21285267|NCT01457417|Healthcare Pharmaceuticals, Inc|Cynthia Sirard, MD|617-714-0357|CSirard@hcven.com|
21285268|NCT00715299|VAHSRD and Medical University of South Carolina|Steve Kautz, PhD, Principal Investigator|843-792-3867|kautz@musc.edu|
21285269|NCT02020889|GlaxoSmithKline|GSK Response Center|866-435-7343||
21285270|NCT01540981|UNMC|Joyce Black|(402) 559-6573|jblack@unmc.edu|
21285271|NCT00809094|Stanford University|Dr. Carol Conrad|650-723-8325|cconrad@stanford.edu|
21285272|NCT02457195|The Pennsylvania State University College of Medicine|Dr. Piotr Janicki|7175315680|pjanicki@pennstatehealth.psu.edu|
21285273|NCT05347966|UBC|Dr. Haakon Nygaard|604-827-0600|haakon.nygaard@ubc.ca|
21285274|NCT02768792|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
21300273|NCT04552301|Icahn School of Medicine at Mount Sinai|Dr. Juan Wisnivesky|(212) 241-2125|juan.wisnivesky@mountsinai.org|
21300274|NCT00074165|OHSU Knight Cancer Institute|Dr. Edward Neuwelt|503-494-5626|neuwelte@ohsu.edu|
21300275|NCT02673372|Maimonides Medical Center|Sergey Motov, Director of Research|718-283-8693|smotov@maimonidesmed.org|
21300276|NCT01069003|Medtronic|Sidney Cohen, Sr. Clinical Medical Advisor|707-591-7277|sidney.a.cohen@medtonic.com|
21300277|NCT00347022|GUERBET|Corinne DUBOURDIEU|+33.1.45.91.50.00|corinne.dubourdieu@guerbet-group.com|
21300278|NCT03593902|Northwestern University|Kathleen Quigley|312-695-8192|kathleen.quigley@nm.org|
21300279|NCT00888134|Massachusetts General Hospital|Donald P. Lawrence|617-643-3614|dplawrence@mgh.harvard.edu|
21300280|NCT03043313|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
21300281|NCT00795535|University of Miami|Kenneth Proctor, PhD, Professor of Surgery|305-355-4960|kproctor@med.miami.edu|
21300282|NCT00286728|VAHSRD|Christine Timko|650-617-2746|Christine.Timko@va.gov|
21300283|NCT02651675|Regenxbio Inc.|Clinical Development Lead|240-552-8968|srastogi@regenxbio.com|
21300284|NCT00374140|University of Pittsburgh|Ahmad Tarhini, MD, PhD|(412) 648-6578|tarhiniaa@upmc.edu|
21300285|NCT02246530|University of Alabama at Birmingham|Dr. Breanna Willeford, DO|205-934-4131|breannawilleford@uabmc.edu|
21300286|NCT03816696|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21285275|NCT04819438|Zambon S.p.A.|Dr. Mathias Knecht, Chief Medical Officer|+41.91.960.4187|mathias.knecht@zambongroup.com|
21285276|NCT02716506|Kanta-Häme Central Hospital|Dr Nina Mattsson|+358407338307|nina.mattsson@fimnet.fi|
21285277|NCT05359952|Fox Chase Cancer Center|Dr. Jennifer Reese, Associate Professor|215-214-3223|Jennifer.Reese@fccc.edu|
21285278|NCT03836209|PrECOG|Li Chen, MS; Statistician|857-284-3670|Li Chen <lic@ds.dfci.harvard.edu>|
21285279|NCT05980013|Zynex Monitoring Solutions|ZMS Clinical|888-386-4185|clinical@zynex.com|
21285280|NCT03739710|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21285281|NCT01753115|Emergent BioSolutions|Robert Hopkins, MD, MPH & TM, FACP, FIDSA, Medical Monitor|301-944-0136|HopkinsR@ebsi.com|
21285282|NCT03642067|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dung Le, MD|443-287-0002|dle@jhmi.edu|
21285283|NCT03124160|FHI 360|David Hubacher|+1-919-321-3459|dhubacher@fhi360.org|
21285284|NCT01263717|Massachusetts General Hospital|Steven K. Grinspoon, MD|617-724-9109|sgrinspoon@partners.org|
21285285|NCT05753735|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Nikola Anusic, Protocol Study Coordinator|216-421-5986|a.nikolau@icloud.com|
21285286|NCT01461473|Stanford University|Clete A. Kushida, M.D., Ph.D.|650-721-7560|clete@stanford.edu|
21285287|NCT01882803|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
21285288|NCT02869893|Cincinnati Children's Hospital Medical Center|Dr. Andrew Trout|513-803-3004|andrew.trout@cchmc.org|
21285289|NCT01563913|VA Portland Health Care System|Kathryn Chung, MD|5037211091|Kathryn.Chung@va.gov|
21285290|NCT03066778|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21285291|NCT01784926|Oslo University Hospital|Dr. Olav Kristianslund|+4723015168|olav.kristianslund@medisin.uio.no|
21285292|NCT02091414|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21256595|NCT04968041|Florida State University|Julia Sheffler|850-644-4199|julia.sheffler@med.fsu.edu|
21285293|NCT00551174|Hoffmann-La Roche|Medical Communications|800-821-8590||
21285294|NCT01534416|Icahn School of Medicine at Mount Sinai|Dr. Rachel L. Barr Grzesh|212-241-2995|rachel.barr@mssm.edu|
21256596|NCT02163187|Memorial Sloan Kettering Cancer Center|Dr. Martin Weister, MD|212-639-6698|weiser1@mskcc.org|
21285295|NCT04676724|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21285296|NCT00287729|InterMune, Inc.|Bill Bradford, MD, PhD|(415) 466-2200|bbradford@intermune.com|
21285297|NCT02782377|University Hospital of South Manchester|Nick Heywood|+447739002473|nheywood@doctors.org.uk|
21285298|NCT01515696|Medical University of Vienna|Nadja Haiden M.D.|+431404003232|nadja.haiden@meduniwien.ac.at|
21285299|NCT00657657|GlaxoSmithKline|GSK Response Center|866-435-7343||
21285300|NCT02521792|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
21285301|NCT00398047|Wake Forest University Health Sciences|Ralph D'Agostino Jr., Ph.D.|113-716-3483|rdagosti@wfubmc.edu|
21285302|NCT01188668|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21285303|NCT00902746|Nobelpharma|Department director of clinical development department 1|+81-3-5651-1177|murakami@nobelpharma.co.jp|
21285304|NCT03360214|Columbia University|Sherene Ishtihar|212-342-3681|si2271@cumc.columbia.edu|
21285305|NCT02946021|Tactile Medical|Jill Christensen|(612) 355-5123|jchristensen@tactilemedical.com|
21285306|NCT02588092|ADC Therapeutics|ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
21285307|NCT01348100|Novartis Pharmaceuticals|Study Director|862 778-8300||
21237746|NCT01367262|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21237747|NCT05540522|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21256597|NCT02709694|Hospital for Special Surgery|Dr. Lisa Mandl|(212) 774-2960|mandll@hss.edu|
21256598|NCT03281668|University of North Carolina at Chapel Hill/Thurston Arthritis Research Center|Yvonne Golightly, PhD|919-966-0566|golight@email.unc.edu|
21256599|NCT01901575|NYU Langone Medical Center|Avrimin M. Kogan, MD|(212) 263-5072|Avrimin.Kogan@nyumc.org|
21256600|NCT02234479|University of Maryland|Elizabeth Nichols, MD|410-328-2324|enichols1@umm.edu|
21256601|NCT03947983|The University of Texas Austin|Kavita Radhakrishnan|5124717936|kradhakrishnan@mail.nur.utexas.edu|
21256602|NCT00677820|MedImmune LLC, an affiliate of AstraZeneca|Raburn Mallory, MD/ Sr Dir Clinical Development|301-398-0000|malloryr@medimmune.com|
21256603|NCT04746833|VA Connecticut Healthcare System|Dr. Brent A. Moore|2034352243|brent.moore@yale.edu|
21256604|NCT02247765|Medtronic|Michael Luna-Victoria|3034068955|michael.luna-victoria@medtronic.com|
21256605|NCT02357134|UT MD Anderson Cancer Center|David Hui, MD/ Associate Professor, Palliative Care Medicine|(713) 792-6258|dhui@mdanderson.org|
21256606|NCT02716675|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
21256607|NCT00623974|UT MD Anderson Cancer Center|Mimi Hu, MD / Professor||CR_Study_Registration@mdanderson.org|
21256608|NCT00290290|Baylor College of Medicine|Rabih Darouiche, M.D.|713-794-8858|rabihd@bcm.edu|
21267995|NCT01005875|University of Alabama at Birmingham|Dr. Kimberly Keene|2-5-934-5670|kkeene@uab.edu|
21267996|NCT00606931|Naviscan Inc|Judith E Kalinyak, MD, PhD, Medical Director|858-587-3641|jkalinyak@naviscan.com|108
21237748|NCT00254202|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
21267997|NCT00286234|Sanford School of Medicine, University of South Dakota|Dr. William Harris|16052716917|bill@omegaquant.com|2
21267998|NCT02499380|PneumRx|Jörg Rennecke|+49 211 5422750|medical.services@btgplc.com|
21237749|NCT02459574|Imperial College London|Prof. Prapa Kanagaratnam|02033123783|p.kanagaratnam@imperial.ac.uk|
21237750|NCT04427202|University of Chicago Medicine|Mai T. Pho, MD MPH|773-834-3689|mpho@bsd.uchicago.edu|
21237751|NCT05501860|American Genomics, LLC|Michelle Widmann|919-600-1819|mwidmann@calclinicalsolutions.com|
21237752|NCT00636649|Duke University Medical Center|Kishore Gadde|919-668-0208|kishore.gadde@duke.edu|
21237753|NCT04508699|San Diego State University|AVP for Research Support Services|619-594-5938|rss@sdsu.edu|
21237754|NCT04866017|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
21237755|NCT00506493|Medtronic, Inc.|Kristin Lawman|763-514-9809|kristin.j.lawman@medtronic.com|
21237756|NCT01266642|UT MD Anderson Cancer Center|Dr. Benjamin Smith, Professor, Radiation Oncology Department|(713) 563-2380|bsmith3@mdanderson.org|
21237757|NCT01735201|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21267999|NCT04241627|University of Southern California Keck School of Medicine Department of Pediatrics|Caitlin Sayegh|13233617748|cssayegh@chla.usc.edu|
21237758|NCT02063230|AstraZeneca|Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com|
21268000|NCT03681808|Bausch & Lomb|Study Director|585-338-6399|Robert.Steffen@bausch.com|
21237759|NCT02238925|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency||tom.chmielewski@jazzpharma.com|
21268001|NCT03123549|NuVasive, Inc.|Jessica Fulwider|7037721455|jfulwider@nuvasive.com|
21237760|NCT02178059|AstraZeneca R&D|Göran Eckerwall, Medical Science Director|1-800-236-9933|Goran.Eckerwall@astrazeneca.com|
21268002|NCT03742271|Johnson & Johnson Vision Care Inc.|John Buch OD F.A.A.O- Sr. Principal Research Optometrist|+1 904 443-1707|JBUCH@its.jnj.com|
21237761|NCT00289887|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21237762|NCT00175825|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21237763|NCT04098406|Clene Nanomedicine|Jeremy Evan, PA-C|5419086335|jeremy@clene.com|
21268003|NCT01468844|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov|
21237764|NCT02001194|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh Patel||mpatel@upenn.edu|
21268004|NCT03194256|Brown University|Suzanne Colby|4028636621|suzanne_colby@brown.edu|
21268005|NCT00266695|Chromaderm|info@chroma-derm.com|info@chroma-derm.com||
21237765|NCT03040713|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
21268006|NCT02853318|Roswell Park Comprehensive Cancer Institute|Katy Wang, Statistician, M.A.|7168451300|katy.wang@roswellpark.org|6269
21237766|NCT01490502|The Johns Hopkins University School of Medicine|Sandra D. Cassard, ScD|443-287-4353|scassar1@jhmi.edu|
21268007|NCT04490499|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21237767|NCT02281448|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21237768|NCT03338894|Atlantic Children's Health/Atlantic Health Outpatient|Dr. Alycia Leiby|973--971-5676|alycia.leiby@atlantichealth.org|
21268008|NCT00245635|Montefiore Medical Center, Albert Einstein College of Medicine|Eric Hollander, MD|7189204287|eholland@montefiore.org|
21237769|NCT04452292|University of Kentucky|Dr. Charles Kunos|859-323-2354|charles.kunos@uky.edu|
21237770|NCT01782443|DFCI|Dr. Jennifer Chan|617-632-6315|jang@partners.org|
21237771|NCT01624948|UCSF|Allison Webber MD|415 353 8382|allison.webber2@ucsf.edu|
21237772|NCT03039595|Oxford Univeristy Hospitals NHS Foundation Trust|Dr Helen Jones|01865 235657|helen.jones3@ouh.nhs.uk|
21237773|NCT00952367|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21256609|NCT03374995|Wake Forest University Health Sciences|Principal investigator|336-716-5440|kwinkfie@wakehealth.edu|
21268009|NCT03125902|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21237774|NCT01040260|University of California, San Francisco|Dr. Timothy Carmody|(415) 221-4810|Timothy.Carmody@ucsf.edu|26344
21268010|NCT01843933|Yale University|Melissa Langhan|2037377413|melissa.langhan@yale.edu|
21285308|NCT01129804|UConn Health|Mark D. Litt, PhD; Principal Investigator|860-679-4680|litt@uchc.edu|
21256610|NCT00393796|University of Michigan Comprehensive Cancer Center|Dr. Maha Hussain, M.D.|1-800-865-1125|mahahuss@umich.edu|
21256611|NCT01211535|Alcon Global Medical Affairs|Jami Kern, Ph.D.|1-888-451-3937||
21285309|NCT03882957|Geisel School of Medicine (Dartmouth College)|Diane Gilbert-Diamond|603-646-5403|diane.gilbert-diamond@dartmouth.edu|
21256612|NCT03319407|Mayo Clinic|Robert L. McClain, M.D.|904-956-1728|Mcclain.Robert@mayo.edu|
21285310|NCT03762681|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21285311|NCT03290391|Boston Medical Center and BU Chobanian & Avedisian School of Medicine|Jeffrey Samet, MD MA MPH|(617) 414-7288|jsamet@bu.edu|
21256613|NCT00119041|Louis Stokes VA Medical Center|David C. Aron, MD, MS|(216) 791-2300|david.aron@va.gov|5702
21285312|NCT02548949|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21256614|NCT05686928|Galderma|Thu Q. Nguyen, PhD|8179615495|thu.nguyen@galderma.com|
21285313|NCT03148067|University of Sao Paulo|Physician|551126616900|priscila.rosalba@hc.fm.usp.br|
21285314|NCT01396551|Varian Medical Systems|Julie Allen|206-330-2605|julie.allen@varian.com|
21285315|NCT03337048|Coloplast A/S|Vice President, Medical Affairs|+45 49111111|clinical-studies@coloplast.com|
21285316|NCT03796676|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21285317|NCT00535392|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
21285318|NCT02772809|University of Pennsylvania|Michelle J Johnson|215 893-2665|johnmic@pennmedicine.upenn.edu|
21285319|NCT02828137|Inha University Hospital|Dr. Sung Woo Kwon|821031133363|kwonswdr@gmail.com|
21285320|NCT02860507|Merck Pharmaceuticals|Chadwick Neal / Medical Affairs Director|2056010605|chadwick.neal@merck.com|
21285321|NCT00534105|Baystate Medical Center|Glenn Markenson MD|413-794-8073|glenn.markenson@bhs.org|
21285322|NCT00723697|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||ClinicalTrialsDisclosure@merck.com|
21285323|NCT01289574|AndroScience Corp|Charles CY Shih, PhD|(858) 638-7230|cyshih@androscience.com|
21285324|NCT02770846|Folktandvården Skåne AB|Björn Gjelvold|+46709467870|bjorn.gjelvold@gmail.com|
21285325|NCT03402230|University of Arizona|Sherry Chow, PhD|5206263358|schow@azcc.arizona.edu|
21285326|NCT00978341|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21285327|NCT02452554|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21285328|NCT02749799|Dr. Reddys Laboratories Inc|Dr. Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
21285329|NCT02070978|Merck KGaA Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21285330|NCT02946489|New York State Psychiatric Institute|Elias Dakwar, MD|6467748728|elias.dakwar@nyspi.columbia.edu|
21285331|NCT00520767|Barbara Ann Karmanos Cancer Institute|Jeffrey Zonder, M.D.|313-576-8732|zonderj@karmanos.org|
21285332|NCT05346237|University hospital Osijek|Željka Laksar Klarić|+38598666494|zeljka.l.klaric@gmail.com|
21285333|NCT02957357|The University of North Carolina at Chapel Hill|Dr. Ronald Chen|984-974-0400|ronald_chen@med.unc.edu|
21285334|NCT01220726|Weill Cornell Medical College|Dr. Alexis Te|646-962-4811|aet2005@med.cornell.edu|
21285335|NCT03304106|Cochlear Limited|Laura Chenier, Clinical Project Manager|422-325-4171|lchenier@cochlear.com|
21285336|NCT03188523|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21285337|NCT01649362|Centre Hospitalier de Luxembourg|Dr Manon Bache|+352 4411 3157|manon.bache@hotmail.com|
21285338|NCT02753816|Spectrum Health|Dr. Betsy Steensma|(616) 391-5701|elizabeth.steensma@spectrumhealth.org|
21285339|NCT02259400|"AOU G. Martino Universitary Hospital of Messina"|Dr. Vincenzo Salvo|+39 0902212132|salvovincenzo@virgilio.it|
21256615|NCT01701999|California Department of Public Health|Dr. Jessica Khouri|510-231-7600|Jessica.Khouri@cdph.ca.gov|
21256616|NCT05111041|Duke University|Devon Noonan, Ph.D.|919-684-3786|devon.noonan@duke.edu|
21256617|NCT01011439|CLIOSS S.r.l.|Dr. Cristina Davite|+39 0031 58|regulatory@clioss.com|1482
21256618|NCT00702364|Craig Hospital|Cynthia Harrison-Felix, PhD|303-789-8565|charrison-felix@craighospital.org|
21285340|NCT00112918|Hoffman-LaRoche|Medical Communications|800-821-8590||
21285341|NCT02372383|UColorado|Dr. Stacey Martiniano|7207776181|stacey.martiniano@childrenscolorado.org|
21256619|NCT00866749|The University of Texas MD Anderson Cancer Center|Michael Andreeff MD./Professor|713-792-7261|mandreeff@mdanderson.org|
21237775|NCT00885092|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
21256620|NCT01365585|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21256621|NCT02361944|Vanderbilt University|Frederic T. BIllings IV|6159368487|frederic.t.billings@vumc.org|
21256622|NCT03123250|PROCEPT BioRobotics Corporation|Angela Lee|650-232-7215|a.lee@procept-biorobotics.com|
21256623|NCT01772004|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21256624|NCT03591354|University of Virginia|Sue Brown, MD|434-982-0602|sab2f@virginia.edu|
21256625|NCT00773136|University of Miami|Dr. Sara Wester|305-326-6132|swester2@med.miami.edu|
21256626|NCT01688856|The MetroHealth System|Dr. Jayme Knutson|216-957-3557|jsk12@case.edu|
21256627|NCT01210170|University of Miami|Adam Wanner, MD|(305) 243-2568|awanner@med.miami.edu|
21256628|NCT02032550|University of Pennsylvania|Ravishankar Jayadevappa|215-898-3798|jravi@pennmedicine.upenn.edu|
21256629|NCT02463071|AstraZeneca|Torbjorn Lundstrom, MD, PhD|+46 31 706 4100|torbjorn.lundstrom@astrazeneca.com|
21256630|NCT05144113|Spaulding Rehabilitation Hospital|Dr. J.Andrew Taylor|616-758-5503|jandrew_taylor@hms.harvard.edu|
21256631|NCT03422679|Cellestia Biotech AG|Maria Bobadilla, Chief Development Officer|+41616332957|maria.bobadilla@cellestia.com|
21256632|NCT00175877|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
21256633|NCT02705807|GlaxoSmithKline|GSK Response Center|866-435-7343||
21256634|NCT00995475|University of Dundee|Professor Brian J Lipworth|+44 1382 383188|b.j.lipworth@dundee.ac.uk|
21256635|NCT03061175|Rutgers Cancer Institute of New Jersey|Dr. Sharon Manne, Associate Director, Population Science|732-235-6759|mannesl@cinj.rutgers.edu|
21256636|NCT00760669|Clinical Research Team, Medical Affairs, Medical Dept. Janssen Korea|Clinical Research Associate|+82-2-2094-4879||
21256637|NCT02003014|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21256638|NCT01883986|VA Puget Sound Health Care System|Lynn F. Reinke, PhD, ARNP|206-277-4186|lynn.reinke1@va.gov|
21256639|NCT02456662|University of Rochester|Sarah Betstadt, MD, MPH|585-276-5367|sarah_betstadt@urmc.rochester.edu|
21256640|NCT00982007|Luitpold Pharmaceuticals, Inc.|Mark A. Falone|610-650-4200|mfalone@luitpold.com|
21256641|NCT00504153|The University of Chicago|Dr. Hedy Kindler|(773) 702-0360|hkindler@medicine.bsd.uchicago.edu|
21256642|NCT00074581|Fred Hutchinson Cancer Research Center|Dr. Deborah Donnell|2066675661|deborah@scharp.org|
21256643|NCT00617604|Astellas Pharma Europe B.V|Senior Director Medical Science||Astellas.resultsdisclosure@astellas.com|
21256644|NCT01708291|University of Rochester|Sandra Jee|585-273-4657|sandra_jee@urmc.rochester.edu|
21256645|NCT03142438|Fisher & Paykel Healthcare|Hanie Yee|+64 9 574 0123|Hanie.Yee@fphcare.co.nz|7909
21256646|NCT00805025|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21256647|NCT04029961|Medical College of Wisconsin|John LaDisa|414-288-6739|jladisa@mcw.edu|
21256648|NCT00688155|Wake Forest School of Medicine|Mark Espeland, PhD|336-761-2826|mespelan@wakehealth.edu|336
21256649|NCT01499953|University Hospital Dresden, Centre for Vascular Medicine|PD Dr. med. Jan Beyer-Westendorf|+49-351-4582899|Jan.Beyer@uniklinikum-dresden.de|
21256650|NCT00382720|sanofi-aventis|International Clinical Development Clinical Study Director||contact-us@sanofi-aventis.com|
21256651|NCT02414399|University of Washington|Dr. Patricia Pavlinac|206 616-8326|ppav@uw.edu|
21256652|NCT01858532|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21256653|NCT00514514|Novartis|Study Director|862-778-8300||
21237776|NCT05120115|MetroHealth Hospital|James Sulzer|5125419036|jss280@case.edu|
21237777|NCT01113502|Abramson Cancer Center of the University of Pennsylvania|Dr. Noelle Frey||noelle.frey@pennmedicine.upenn.edu|
21237778|NCT01144026|Thymon LLC|Dr. Gideon Goldstein|(973) 467-9558|gidgold@gmail.com|
21237779|NCT00781391|Daiichi Sankyo, Inc.|James Hanyok, Sr. Director|732-590-5000|jhanyok@dsi.com|
21237780|NCT03616184|University of Nebraska Medical Center|Vijaya Bhatt|402-559-8008|vijaya.bhatt@unmc.edu|
21237781|NCT00708916|New York University School of Medicine|Andrew Franks, MD, Principal Investigator|212-263-5244|andrew.franks@nyumc.org|
21237782|NCT04270292|Demiroglu Bilim University|Nurten OZEN|+90 (212) 275 75 82|ozenurten@yahoo.com.tr|
21237783|NCT01984684|Melinta Therapeutics, Inc.|Sue Cammarata (Chief Medical Officer)|1-844-MELINTA (1-844-635-4682)|clinicaltrials@melinta.com|
21237784|NCT00850889|Allergan, Inc.|Steven P. James, MD, VP, Global Medical Affairs|714-246-4500|james_steven@allergan.com|
21237785|NCT02681614|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Bryan Traughber|+1 216-884-2516|bryan.traughber@uhhospitals.org|
21237786|NCT02835339|Oregon Health and Science University|Kathleen Brookfield, MD, PhD, MPH|503-494-2101|brookfie@ohsu.edu|
21237787|NCT01077544|Novartis Pharmaceuticals|Study Director|82-778-8300|trialandresults.registries@novartis.com|
21237788|NCT04273139|Dana-Farber Cancer Institute|Jorge J. Castillo, Md|617-632-2681|jorgej_castillo@dfci.harvard.edu|
21237789|NCT04575051|University of Pittsburgh|Dr. Catherine Palmer|412-383-6565|cvp@pitt.edu|
21237790|NCT03624504|Medtronic (Shanghai) Management Co., Ltd.|Weifan Sun, Clinical Study Manager|021-20325267|weifan.sun@medtronic.com|86
21237791|NCT02862457|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21237792|NCT00951483|Loyola University Chicago|Angelos Halaris, MD, PhD|708-216-3275|ahalaris@lumc.edu|
21237793|NCT03364751|Philip Morris Products S.A.|Christelle Haziza, Director Clinical Science & Biostatistics|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
21237794|NCT04542018|University of Michigan|Prashant Singh, MBBS|734-647-1191|singhpr@med.umich.edu|
21237795|NCT00689221|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21237796|NCT01029054|University of Michigan Hospital|Dr. Mark Kaminski, M.D.|734-936-5310|mkaminsk@umich.edu|
21237797|NCT02671032|Cochlear|Bernadette Pickering|+61296115909|bpickering@cochlear.com|
21256654|NCT02829307|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21256655|NCT01021956|STEBA Biotech|Bertrand Gaillac International Project Leader|+33 9 74 19 79 05|b.gaillac@stebabiotech.com|
21268011|NCT00890396|New England Research Institutes, Inc.|Susan Assmann, PhD|617-972-3048|sassmann@neriscience.com|
21268012|NCT00440232|Jefferson Headache Center/Thomas Jefferson University|Stephen D. Silberstein, M.D.|215-955-2243|stephen.silberstein@jefferson.edu|
21268013|NCT00819052|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21268014|NCT00362297|University of Washington|Dr. Christine Johnston|206-520-4340|cjohnsto@u.washington.edu|
21268015|NCT03512028|Washington University School of Medicine|Catherine Lang|314-286-1945|langc@wustl.edu|
21268016|NCT03529162|Saint Louis University|Sarah Dawson, Research Nurse|314-977-4106|sarah.dawson@health.slu.edu|
21268017|NCT01522391|Pergamum AB|Margit Mahlapuu PhD, Assoc. Prof. in Molecular Medicine|+46 70 631 01 09|margit.mahlapuu@pergamum.com|
21285342|NCT01255904|Baylor College of Medicine|Jason Reynolds|(210) 704-2680|jmreynol@bcm.edu|
21285343|NCT03258645|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21285344|NCT02061813|Dr. Reddy's Laboratories Inc.|Dr Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
21285345|NCT01705080|Abbott|Steven Madej|651-756-2230|smadej@sjm.com|
21285346|NCT01999985|H. Lee Moffitt Cancer Center and Research Institute|Thoracic CRO, attn: Dr. Ben Creelan|813-745-3050|ben.creelan@moffitt.org; thoraciccro@moffitt.org|
21285347|NCT01704755|AbbVie (prior sponsor, Abbott)|Global Medical Information|800 633-9110||
21285348|NCT00828061|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21285349|NCT01400906|GlaxoSmithKline|GSK Response Center|866-435-7343||
21285350|NCT02075008|Novartis Pharmaceuticals|Study Director|862-778-8300||
21285351|NCT03130959|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
21285352|NCT04446429|Applied Biology|Director of Clinical Trials|+1-949-387-4526|monican@appliedbiology.com|
21285353|NCT05205005|Harry S. Truman Memorial Veterans' Hospital|Harry S. Truman Memorial Veterans' Hospital Research Service|573- 814-6000|Camila.Manrique-Acevedo@va.gov|56550
21285354|NCT02821416|AstraZeneca|Maria Jison|001-202-577-6213|Maria.Jison@astrazeneca.com|
21285355|NCT01247675|Ascendis Pharma A/S|Michael Beckert, MD|(+49) 172-155-2596|mb@ascendispharma.com|
21285356|NCT03042910|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21285357|NCT02256917|Octapharma|Sylvia Werner|415 260-9577|sylvia.werner@octapharma.com|
21285358|NCT02933528|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
21285359|NCT02700425|The University of Chicago|Dr. Gaurav A. Upadhyay, MD|773-702-5988|gupadhyay@medicine.bsd.uchicago.edu|
21285360|NCT00313586|ECOG Statistical Office|Study Statistician|617-632-3012||
21300287|NCT01506596|Vector Oncology LLC|Dr. Mark Walker, VP of Scientific Affairs|901-435-5570|mwalker@vectoroncology.com|
21300288|NCT01488890|Sanofi Pasteur|Medical Director||Contact-US@sanofi.com|
21300289|NCT05712460|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21300290|NCT05560425|University of North Carolina at Chapel Hill|Elena Vidrascu, PhD, MSc|919-843-9193|elena91@live.unc.edu|
21300291|NCT05082857|Wake Forest University School of Medicine|Anna Miller-Fitzwater, MD, MPH|336-713-0630|amillerf@wakehealth.edu|
21300292|NCT04363320|University of Wisconsin - Madison|Todd Molfenter, PhD|608-262-1685|tdmolfenter@wisc.edu|
21300293|NCT03475004|University of Colorado|Dr. Christopher Lieu|303-724-6390|christopher.lieu@cuanschutz.edu|
21300294|NCT00604565|Rockwell Medical|Ajay Gupta, MD|248-960-9009|rd@rockwellmed.com|
21300295|NCT03645122|VA Pittsburgh Healthcare System|Assistant Director for Clinical and Regulatory Affairs|412-822-3669|Nikitha.Deepak@va.gov|
21300296|NCT04756427|Washington University|Darla Shores|314-454-6173|shores@wustl.edu|
21300297|NCT02260934|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21300298|NCT01436526|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21300299|NCT03605667|Biohaven Pharmaceuticals, Inc|Chief Medical Officer|+1 203-404-0410|clinicaltrials@biohavenpharma.com|
21300300|NCT05632211|Alvotech Swiss AG|Clinical Development and Medical Lead|+41 78 659 89 89|alvotech.clinical@alvotech.com|
21300301|NCT04366349|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21300302|NCT01235897|University of California, San Francisco|Jo Chien, MD|415-885-7577|crss@ucsf.edu|
21300303|NCT05421624|Boston University|Franchino Porciuncula, EdD, PT, DScPT|(617) 353-7525|fporciun@bu.edu|
21300304|NCT03755206|Johns Hopkins Center for Indigenous Health|Dr. Emily E. Haroz, Associate Professor|4109556931|eharoz1@jhu.edu|
21300305|NCT03642873|Reckitt Benckiser, Inc|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
21300306|NCT05737069|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
21300307|NCT05178173|University of North Carolina at Chapel Hill|Laura Jacox, DMD, PhD|919-966-9731|ljacox@live.unc.edu|
21300308|NCT03472885|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
21300309|NCT00092417|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21300310|NCT00425269|University of Oslo|Victoria Telle Hjellset|0047 22 85 06 12|t.v.t.hjellset@medisin.uio.no|
21300311|NCT01084655|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21300312|NCT00906204|Wright State University Boonshoft School of Medicine, Dayton, Ohio, USA|Dr. R. Brian Stevens, MD, PhD, FACS|937-545-4817|rbstevens1@icloud.com|
21300313|NCT00696072|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21300314|NCT01597596|Sanofi|Trial Transparency Team||Contact -US@sanofi.com|
21300315|NCT01601236|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
21300316|NCT00992108|UCLA Neurology|Marisa Chang, MD|310-794-1870|marisachang@mednet.ucla.edu|
21300317|NCT02189317|Emory University|John W Xerogeanes, MD|404-778-7202|jxeroge@emory.edu|
21268018|NCT00517634|GlaxoSmithKline|GSK Response Center|866-435-7343||
21268019|NCT00701064|VA|Shawn Youngstedt|803-767-3208|shawn.youngstedt@asu.edu|
21268020|NCT02098733|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21268021|NCT00939094|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21285361|NCT01639703|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical Writing|+33 (0) 1 45 91 50 00|corinne.dubourdieu@guerbet-group.com|
21285362|NCT02087670|Universidad de Antioquia|Jesus Alberto Plata Contreras|5742196478|rehabilitacionsalud@siu.udea.edu.co|
21285363|NCT00479115|Cincinnati Children's Hospital Medical Center|Stella Davies, MBBS, PhD, MRCP|513-636-1371|Stella.Davies@cchmc.org|
21285364|NCT00264290|University of California, San Francisco|Peter W. Hunt, M.D.|415-476-4082|phunt@php.ucsf.edu|345
21285365|NCT04472494|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
21285366|NCT03519919|CooperVision.Inc|Jose A. Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com|
21285367|NCT03076996|FHI 360|Dr. Lisa Dulli|919-544-7040|ldulli@fhi360.org|11396
21285368|NCT00587795|Mayo Clinic|Dr. David Dennison|507-284-7405|Dennison.David@mayo.edu|
21285369|NCT02144077|Biofrontera Bioscience GmbH|Clinical Trial Department|+49 214 876 32 66|ameluz@biofrontera.com|
21285370|NCT00943592|University of Chicago|Dr. Andrew Artz|773-834-8980|aartz@medicine.bsd.uchicago.edu|
21285371|NCT01909973|Northwestern University|David C. Mohr, PhD|312-503-1403|d-mohr@northwestern.edu|
21285372|NCT01462305|Philips|Sr. Clinical Development Scientisit|+41 79 460 0622|fatima.sertkuniyoshi@philips.com|
21285373|NCT00169104|Dartmouth-Hitchcock Medical Center / Norris Cotton Cancer Center|Gary N. Schwartz MD|(603) 653-6181|gary.n.schwartz@hitchcock.org|
21285374|NCT00232557|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
21285375|NCT03476642|Penn State MS Hershey College of Medicine-PennState Health|Dr. Sanjib Adhikary|717-531-6140|sadhikary@pennstatehealth.psu.edu|
21285376|NCT02438280|University of Washington|Dr. Greg Huang, Professor and Chair of Orthodontics|(206) 616-6996|ghuang@uw.edu|
21285377|NCT02826161|Sumitomo Dainippon Pharma Oncology|Matthew Hitron, MD|617-674-6800|mhitron@bostonbiomedical.com|
21285378|NCT04435808|The University of New Mexico School of Medicine|Walter Dehority|5052725535|wdehority@salud.unm.edu|
21285379|NCT00351936|Massachusetts General Hospital Schizophrenia Research Program|Dr. David Henderson|(617) 912-7800|dchenderson@partners.org|
21285380|NCT02081001|Xeris Pharmaceuticals, Inc.|Martin J. Cummins, VP for Drug Development|512-498-2675|mcummins@xerispharma.com|
21285381|NCT00524680|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21285382|NCT01146561|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21285383|NCT02801370|Otonomy|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
21285384|NCT00893971|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|605-305-2600|creisner@pearltherapeutics.com|
21285385|NCT00492232|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21285386|NCT01416155|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21285387|NCT03078127|University of North Carolina at Chapel Hill|Scott Donaldson, MD|984-974-9198|scott_donaldson@med.unc.edu|
21285388|NCT00829829|Regeneron Pharmaceuticals, Inc. Phone:|Clinical Trial Management||clinicaltrials@regeneron.com|
21285389|NCT02685072|Yale School of Public Health|Kimberly Yonkers, MD|(203) 764-6621|kimberly.yonkers@yale.edu|
21285390|NCT00477204|University of Colorado Denver|David Maahs, MD, PhD|303-724-2323|david.maahs@ucdenver.edu|
21285391|NCT00382109|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21285392|NCT01249833|Trial Management Group Inc.|Joanne Morris, Clinical Research Quality Manager|4169297717|joanne@tmginvestigators.com|
21285393|NCT01900899|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21285394|NCT02774005|Santhera Pharmaceuticals (Switzerland) Ltd|Head of Regulatory Affairs EU|+41 6190689|julien.gaudias@santhera.com|50
21285395|NCT03035916|China-Japan Unit Hospital of Jilin University|Dr. Guoqing Zhao|0435-84995117|zhaogq65@126.com|
21285396|NCT03885999|The Chinese University of Hong Kong, Department of Surgery, Prince of Wales Hospital|Dr. Kaori Futaba|0085264630121|kfutaba@surgery.cuhk.edu.hk|
21285397|NCT01451554|Mayo Clinic|Jon O. Ebbert, MD|507-255-3965|ebbert.jon@mayo.edu|
21285398|NCT01790516|Inova Health Care System|Dr John Deeken, PI|703 776 8161|john.deeken@inova.org|
21285399|NCT01402986|MedImmune, LLC|Meena Jain, MB BChir, Director, Clinical Development,|301-398-0000|JainM@medimmune.com|
21285400|NCT03749109|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
21285401|NCT03178851|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21285402|NCT02226120|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21285403|NCT00076258|UT Southwestern Medical Center|Madhukar H Trivedi|214-648-0188|madhukar.trivedi@utsouthwestern.edu|
21285404|NCT03034135|Cantex Pharmaceuticals|Stephen Marcus MD|9543153660|smarcus@cantex.com|
21285405|NCT02669043|Massachusetts General Hospital|Dr.Cristina Cusin|617-726-6421|ccusin@partners.org|
21285406|NCT03634813|Yale School of Medicine|Robert B. Schonberger, Director of Clinical Scientist Track Program|203-785-3941|robert.schonberger@yale.edu|
21285407|NCT03884270|Loyola University Chicago|Dr. Sarah Kinsinger|708-216-0464|sarah.kinsinger@lumc.edu|
21285408|NCT00661453|University of Utah|Dr. Kathryn Swoboda|801-585-9717|swoboda@genetics.utah.edu|
21285409|NCT03638466|Supernus Pharmaceuticals|Gianpiera Ceresoli-Borroni Director Clinical Research|3018382521|gceresoliborroni@supernus.com|
21285410|NCT02576977|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21285411|NCT03251482|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21285412|NCT04508647|University of Colorado Hospital|Manali Kamdar, MD|720-848-6400|manali.kamdar@cuanschutz.edu|
21237798|NCT01939548|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21285413|NCT02447328|AstraZeneca Korea|Karin Otter, MD, PhD|+82 2 2188 0968|Karin.Otter@astrazeneca.com|
21300318|NCT02419001|Synthetic Biologics Inc.|Michael Kaleko|(240) 238-3862|mkaleko@syntheticbiologics.com|
21300319|NCT02231086|Amsterdam UMC|Prof. dr. P.J. Tanis|+31-20-4444444|p.j.tanis@amsterdamumc.nl|
21300320|NCT00732030|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21300321|NCT02151058|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
21300322|NCT03027609|Aridis Pharmaceutical Inc|Lynne Deans|001-925200|deansl@aridispharma.com|3089
21300323|NCT02006472|Prilenia|Prilenia|+972 775558|info@prilenia.com|482
21300324|NCT00886379|Brigham and Women's Hospital|Dr. Janet Rich-Edwards|617-525-7929|jr33@partners.org|
21300325|NCT01684917|Imperial College London|Professor Gary Frost|+44 (0)20 7594 0959|g.frost@imperial.ac.uk|
21300326|NCT00459316|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
21300327|NCT01614886|Novartis Pharmaceuticals|Study Director|862-778-8300||
21300328|NCT01207414|Novartis Pharmaceuticals|Study Director|862-778-8300||
21300329|NCT03520998|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
21300330|NCT01435382|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21300331|NCT00910650|University of California at Los Angeles, Jonsson Comprehensive Cancer Center|Ignacio Baselga|310 206-2090|ibaselga@mednet.ucla.edu|
21300332|NCT00423579|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21300333|NCT03542877|University of Colorado|Dr. Wells Messersmith|303-724-0747|wells.messersmith@cuanschutz.edu|
21300334|NCT04004988|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21300335|NCT03873116|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
21300336|NCT04682366|Wake Forest|Majid Mirzazadeh|336-716-4131|mmirzaza@wakehealth.edu|
21300337|NCT02383576|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21300338|NCT02738801|Galapagos NV|Evelyn Fox|003215342900|evelyn.fox@glpg.com|3215342900
21300339|NCT01590264|Washington University in Saint Louis|Dr. Jay F. Piccirillo|314-362-8641|piccirilloj@ent.wustl.edu|
21300340|NCT00231816|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21300341|NCT01075243|GlaxoSmithKline|GSK Response Center|866-435-7343||
21300342|NCT00551642|Mallinckrodt|Medical Information Call Center|800-556-3314|medinfo@mnk.com|
21300343|NCT03337308|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
21300344|NCT01292135|Pharmacyclics|Thorsten Graef, MD|855.427.8846|medinfo@pcyc.com|
21300345|NCT05810740|Pierre Fabre Médicament|Ana Catarina Pinto, Responsible Medical Officer|5 3450 6059|ana.catarina.pinto@pierre-fabre.com|
21300346|NCT03529669|Oxford University Hospitals NHS Trust|Dr Somnath Mukherjee|01865 617018|Somnath.Mukherjee@ouh.nhs.uk|
21300347|NCT05135767|Brown University|Hayley Treloar Padovano, PhD|4018636623|hayley_treloar@brown.edu|
21300348|NCT02694185|Rocky Mountain Regional VA Medical Center|Elizabeth Cheng|720-857-5101|elizabeth.cheng@va.gov|
21300349|NCT02532517|Cerenovus|Christopher Hendricks|415-656-6565|CHendric@its.jnj.com|
21300350|NCT03312231|Kaiser Permanente Washington Health Research Institute|Lisa A. Jackson, MD, MPH|206-442-5216|lisa.a.jackson@kp.org|
21300351|NCT03157830|Providence Health & Services|Director of PBSI /WC Clinical Research Program|(503) 216-1012|Chiayi.Chen@providence.org|
21300352|NCT05417438|UMass Chan Medical School|Reem Najjar|7742750890|Reem.najjar@umassmed.edu|
21300353|NCT02845297|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Ivana Gojo|410-502-8775|igojo1@jhmi.edu|
21300354|NCT01664975|Zhengzhou University|Mingzhi Zhang|0371-66295564|mingzhi_zhang@126.com|
21300355|NCT04272242|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
21300356|NCT04053036|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
21300357|NCT02681523|Imperial College London|Laura Kenny|+44 (0)20 7594 2806|l.kenny@imperial.ac.uk|
21300358|NCT05856422|Clinimark|Associate Researcher|833 373 0998|Carolyn.Cohen@element.com|1
21300359|NCT02677493|IL-YANG PHARM.|Clinical Research Manager|+82-70-7165-7316|hlpark@ilyang.co.kr|7316
21285414|NCT02672176|University of California, Davis|Heather M. Young, Principal Investigator|916-734-4745|hmyoung@ucdavis.edu|
21285415|NCT02823470|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21285416|NCT02155309|Henry Jackson Military Foundation for Naval Medical Research Unit - Dayton|Daniel Geyer, MPH|(937) 938-3922|daniel.geyer.1.ctr@us.af.mil|
21285417|NCT01073163|Teva Pharmaceuticals USA|Manager|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21285418|NCT00703677|Westat|René Gonin, PhD (Math. Stats.)|301-251-1500|renegonin@westat.com|
21285419|NCT01677182|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21285420|NCT02501161|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21285421|NCT00762762|Colgate Palmolive Co.|William DeVizio, DMD|732-878-7901|william_devizio@colpal.com|
21285422|NCT02748057|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21285423|NCT01990573|Washington University School of Medicine|Dr. Anshuman Sharma|314-457-3147|sharma.a@wustl.edu|
21285424|NCT02511132|Gradalis, Inc.|Clinical and Regulatory Operations|214-442-8100|info@gradalisinc.com|
21285425|NCT01983826|University of Iowa|Dr. Darren P. Casey||darren-casey@uiowa.edu|
21285426|NCT04541329|University of California, San Francisco|Raymond Cho, MD, PhD|415 353 7800|rashes@ucsf.edu|
21285427|NCT02906579|Cyclerion Therapeutics, Inc.|Senior Medical Director|1-857-327-8778|info@cyclerion.com|
21285428|NCT02030119|Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh S. Patel|215-898-3367|mpatel@upenn.edu|
21268022|NCT01078389|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21268023|NCT02361307|Mahidol University|Piyapat Dajpratham|6624197508|piyapat.daj@mahidol.ac.th|
21268024|NCT00421928|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
21268025|NCT02582216|Hôpital Erasme|Dominique Mouraux|+32/2.555.38.48|dmouraux@ulb.ac.be|
21268026|NCT01545375|GlaxoSmithKline|GSK Response Center|866-435-7343||
21268027|NCT02223637|GlaxoSmithKline|GSK Response Center|866-435-7343|geetha.x.kamath@gsk.com|
21268028|NCT04177862|University of Minnesota|Dr. Jonah Pearson|218-280-8348|pears731@umn.edu|1
21268029|NCT05637515|Biocon Biologics Limited|Sarika S Deodhar|0802808|Sarika.Deodhar@biocon.com|5302
21268030|NCT03233009|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21268031|NCT00564876|Duke University Medical Center|Neal Ready, MD|919-668-6688|neal.ready@duke.edu|
21268032|NCT04516291|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21268033|NCT03039686|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21268034|NCT02158949|University of Southern California|Elizabeth Burner|3234096667|eburner@usc.edu|
21268035|NCT01855607|Columbia University Irving Medical Center|Dawn L. Hershman, MD, MS, FASCO|212 305-1945|dlh23@columbia.edu|
21268036|NCT02181634|ECOG-ACRIN Biostatistics Center|PrECOG Statistician|617-632-3633|pcata@jimmy.harvard.edu|
21268037|NCT04250558|Dartmouth Hitchcock Medical Center|Dr. Ida Leah Gitajn|(603) 650-5133|ida.leah.gitajn@hitchcock.org|
21268038|NCT04812678|FasciaFrance|Dr Bertrand|+33682308609|isa.bertrand.cerap@gmail.com|
21285429|NCT00759655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21285430|NCT02179047|taipei city hospital|chen yueh-chung|88627093600|chenyuehchung.tw@yahoo.com.tw|3741
21285431|NCT03331263|Medline Industries, Inc.|Senior Regulatory Affairs Specialist|8476433515|aminarcik@medline.com|
21285432|NCT01703169|Huntsman Cancer Institute|Kimberlee Taylor|8012135673|Kimberlee.Taylor@hci.utah.edu|
21256656|NCT00762892|UT Health Science Center Houston|Tanvir Bell, MD|713-500-6759|Tanvir.K.Bell@uth.tmc.edu|
21237799|NCT03311373|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|1-877-240-9479|information.center@astrazeneca.com|
21237800|NCT01188109|Emory University|Shishir K. Maithel, MD|404-778-1900|smaithe@emory.edu|
21237801|NCT00205348|University of Wisconsin-Madison|Dr. Herbert Chen|608-263-1387|chen@surgery.wisc.edu|
21237802|NCT01297959|Excited States/Exoxemis, Inc|Jackson T Stephens, Jr|(402) 884-2316|sstephens@exoxemis.com|
21237803|NCT00344461|University of Maryland, Institute Of Human Virology|Charles E. Davis, Jr., MD|410-706-4608|cdavis@ihv.umaryland.edu|
21237804|NCT01667432|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21237805|NCT00182754|Mayo Clinic|Aminah Jatoi, M.D|507-284-4918|jatoi.aminah@mayo.edu|
21256657|NCT00338039|UT MD Anderson Cancer Center|Christopher H. Crane, MD / Professor||CR_Study_Registration@mdanderson.org|
21256658|NCT05506956|Johns Hopkins University|Kristen Murray, Program Manager|410-614-6707|kmeckel2@jhmi.edu|
21256659|NCT01848288|Alcon Research, Ltd.|Doug Fanney, Director, Global Medical Affairs, Cataract Instrumentation|1-888-451-3937|alcon.medinfo@alcon.com|
21256660|NCT02091778|Podiatry and Foot health, Stott Lane Salford ,UK|Paul Chadwick|0161 206 4710|paul.chadwick@salford.nhs.uk|
21256661|NCT01841749|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
21237806|NCT00553696|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21237807|NCT01054768|Children's Hospital & Research Center at Oakland|Ashutosh Lal, MD|5104283172|ashutosh.lal@ucsf.edu|
21237808|NCT00686881|Merck Sharp & Dohme Corp..|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21237809|NCT02471651|California Retina Consultants|Dr. Gabriel Gordon|8059631648|gabe@californiaretina.com|3034
21237810|NCT02085252|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21237811|NCT00671931|Cincinnati Children's Hospital|Mohamed Mahmoud, MD Principal Investigator|513 636-7426|mohamed.mahmoud@cchmc.org|
21256662|NCT04774250|Washington University in St. Louis|Dr. Craig Buchman, Lindburg Professor & Chair, Department of Otolaryngology-Head & Neck Surgery|314-362-2914|buchmanc@wustl.edu|
21256663|NCT01825057|Yale School of Medicine|Steve Martino|203-932-5711|steve.martino@yale.edu|7418
21256664|NCT01688596|Penn State Milton S. Hershey Medical Center|Dr. Matthew F. Davies, M.D.|7175310003|mdavies@hmc.psu.edu|283519
21256665|NCT01480284|GlaxoSmithKline|GSK Response Center|866-435-7343||
21256666|NCT00066742|SWOG Statistical Center|Lung Committee Statistician|206-652-2267||
21256667|NCT02015442|Imperial College London|Prof Gary Frost|020 7594 0959|g.frost@imperial.ac.uk|
21256668|NCT01488279|Frist Clinic Endocrinology|Dr. Annis Marney|615-403-8398|annis.marney@hcahealthcare.com|
21256669|NCT03593850|Universidad del Rosario|Dr. Juan Sebastian Martin Saavedra|2672200532|juans.martin@urosario.edu.co|
21256670|NCT00003895|Providence Cancer Center, Earle A. Chiles Research Institute, Robert W. Franz Cancer Center|Walter J. Urba, MD, PhD; Physician Director of Research|503-215-5696|Walter.Urba@providence.org|
21256671|NCT01380730|Amgen Inc.|Study Director|866-572-6436||
21256672|NCT02490475|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21256673|NCT04130633|Johns Hopkins University School of Medicine|C. Austin Zamarripa, PhD|410-550-6969|czamarr2@jh.edu|
21256674|NCT01195090|Department of Internal Medicine, Mackay Memorial Hospital|Dr. Sung-Chen Liu|886-2-2543-3535|pine3.tw@yahoo.com.tw|2174
21256675|NCT04784897|Innovation Pharmaceuticals Inc.|Senior Vice President, Clinical Sciences|978-921-4125|info@ipharminc.com|
21256676|NCT01236573|National Cancer Institute|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
21256677|NCT02783443|University Hospital Hradec Kralove|Dr. David Astapenko|+420608177374|astapenko.d@seznam.cz|
21256678|NCT00823823|Children's Hospital Boston|Dr. Donald Bae|617-355-6808|donald.bae@childrens.harvard.edu|
21256679|NCT04754802|Vistagen Therapeutics, Inc.|Ester Salman, MPH|650-577-3693|clinicalstudies@vistagen.com|
21237812|NCT01460940|The Ohio State University Comprehensive Cancer Center|Dr. Kristie Blum|614-293-4590|Kristie.Blum@osumc.edu|
21237813|NCT02925676|UNEEG medical|Clinical Research Associate|+45 25657550|clinical@uneeg.com|
21237814|NCT02291679|Ironwood Pharmaceuticals, Inc.|Michael Hall, MD|(617) 621-7722||
21237815|NCT02048072|Cantonal Hospital of St. Gallen|Jochen Vehoff|0041714941111|jochen.vehoff@kssg.ch|
21237816|NCT01648270|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
21237817|NCT04969263|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|extension
21237818|NCT04154787|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21256681|NCT01614821|Dana-Farber Cancer Institute|Dr. Steven Treon|617-632-2681|steven_treon@dfci.harvard.edu|
21256682|NCT00324753|Center for Health Equity Research and Promotion (VAPHS)|Maria K. Mor|(412) 360-2240|maria.mor@va.gov|
21256683|NCT02902081|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
21256684|NCT00303979|Medtronic Cardiac Rhythm Disease Management|IMPROVE HF, Clinical Research Specialist||medtronicCRMtrials@medtronic.com|
21256685|NCT04366050|UCSD|Rohit Loomba, MD, MHSc|858-246-2201|roloomba@ucsd.edu|
21256686|NCT00619970|CHLA|Brynie Slome Collins MD|323 361 2181|bcollins@chla.usc.edu|
21256687|NCT04792567|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
21256688|NCT02201420|Navidea Biopharmaceuticals, Inc.|Dr. Frederick O. Cope, Chief Scientific Officer|614-793-7500|fcope@navidea.com|140
21256689|NCT01490814|Medtronic|Ralf Meyer|+49215981490|ralf.meyer@medtronic.com|
21256690|NCT00496730|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
21256691|NCT01314963|Stanford Univeristy Medical Center|Craig Levin, PhD; Professor of Radiology (Molecular Imaging Program at Stanford/Nuclear Medicine)|650-736-0449|cslevin@stanford.edu|
21256692|NCT00889226|CMC|Dr. Hoyoung Sohn|82-2-222-2222|abc@snu.ac.kr|3333
21256693|NCT02170779|VA Research and Development|Cinda Hugos, Physical Therapist|503-220-8262|hugosc@ohsu.edu|52338
21256694|NCT00369785|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
21256695|NCT00800683|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21256696|NCT02247960|University of Rochester|Jean Joseph|585-341-7795|jean_joseph@urmc.rochester.edu|
21256697|NCT02367066|AstraZeneca|Dr. Stanko Skrtic, MD, PhD||ClinicalTrialTransparency@astrazeneca.com|
21256698|NCT01848353|University of Oklahoma Health Sciences Center|Kevin Short, PhD, Associate Professor|(405) 271-8001|kevin-short@ouhsc.edu|43094
21256699|NCT00953719|DePuy Orthopaedics, Inc.|Sam Himden|574-372-7231|shimden@its.jnj.com|
21256700|NCT00935272|Medicis Global Services|Heather M Corey|480-291-5981|hcorey@medicis.com|
21256701|NCT02017379|Texas Tech University Health Sciences Center at El Paso|Research Compliance Officer|915-215-4814|jackie.roberts@ttuhsc.edu|
21256702|NCT03492554|Apple|Health Technology Clinical Operations|1-866-905-5303|htclinicalquestions@apple.com|
21256703|NCT01591317|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21256704|NCT04340557|Sharp HealthCare|Matthew Geriak, PharmD|858-939-3717|matthew.geriak@sharp.com|
21256705|NCT00529451|Novartis Pharmaceuticals|Study Director|862-778-8300||
21256706|NCT04305275|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
21256707|NCT00199836|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21237819|NCT03053050|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21256708|NCT01235793|Cedars-Sinai Medical Center|Yuliya Linhares, MD|310-423-4646|Yuliya.Linhares@cshs.org|
21268039|NCT01793610|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
21268040|NCT02392078|Monteris Medical|Christa Seligman|(952) 463-7747|cseligman@monteris.com|
21268041|NCT02079077|University of Manitoba|Keith Fowke|204-789-3296|keith.fowke@umanitoba.ca|
21268042|NCT02087085|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21268043|NCT00635804|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21256709|NCT01692691|Western Regional Medical Center|Jessica L. Coats|623-207-3899|jessica.coats@ctca-hope.com|
21256710|NCT00407654|Princess Margaret Cancer Centre|Dr. Malcolm Moore|416-945-2263|malcolm.moore@uhn.ca|
21256711|NCT02303704|Ch. Pervaiz Elahi Institute of Cardiology, Multan, Pakistan.|Dr. Muhammad Sher-i-Murtaza|0333-6107570|sherm.cpeic@gmail.com|
21256712|NCT04411628|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21256713|NCT01034540|Biofortis Clinical Research (formerly Provident)|John Marshall, General Manager|630-748-5339|john.marshall@mxns.com|
21256714|NCT02232126|University of Southern California|Dr. Susan Enguidanos|213-740-9822|enguidan@usc.edu|
21256715|NCT01353079|GREER Laboratories, Inc.|Terrance Coyne, M.D., Executive Vice President of Research & Development; Chief Medical Officer|(828) 759-7495|tcoynemd@greerlabs.com|
21256716|NCT02336763|UCLA|Mitchell Kamrava, MD|310-825-9775|mkamrava@mednet.ucla.edu|
21256717|NCT05293743|The Hospital for Sick Children|Dr. Maryse Bouchard|4168137654|maryse.bouchard@sickkids.ca|224522
21256718|NCT01292798|California Retina Consultants|Director of Research|8059631648|gabe@californiaretina.com|3034
21256719|NCT01200238|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu|
21256720|NCT00482703|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21256721|NCT03548285|University of Texas Southwestern Medical Center|David Sher, MD|214-645-8525|david.sher@utsouthwestern.edu|
21256722|NCT00314353|NSABP Foundation, Inc.|Diana Gosik|412-330-4692|diana.gosik@nsabp.org|
21268044|NCT02680158|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21268045|NCT03734601|Stanford University|Robert Lowsky, Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)|650-723-0822|rlowsky@stanford.edu|
21268046|NCT01425268|AirXpanders|Director of Clinical Affairs|650-390-9000|kkelley@airxpanders.com|9003
21268047|NCT00719706|McLean Hospital|Dr. Brian Brennan|617-855-2911|bbrennan@partners.org|
21268048|NCT02681094|AstraZeneca|Global Clinical Leader|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
21268049|NCT00134563|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi-aventis.com|
21268050|NCT03382639|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
21268051|NCT00987558|Bial - Portela & Cª, S.A.|Head of Clinical Research||jose.rocha@bial.com|
21268052|NCT00682539|Department of Ophthalmology, Medical University Vienna|Dr. Katharina Kriechbaum|00431 40400 79480|katharina.kriechbaum@meduniwien.ac.at|
21268053|NCT02257970|Stanford University, School of Medicine|Dr. Stanley Rockson|650-725-7571|rockson@stanford.edu|
21268054|NCT02477215|Medical College of Wisconsin|Parameswaran Hari|414-805-4600|phari@mcw.edu|
21285433|NCT00905567|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21256723|NCT01428661|Vanda Pharmaceuticals Inc.|Curt Wolfgang, Ph.D.|202-734-3400|curt.wolfgang@vandapharma.com|
21256724|NCT05907213|University of Pittsburgh, UPMC Department of Anesthesiology & Perioperative Medicine|Dr. Katherine Grace Lim, Chief of the Division of OB & Women's Anesthesiology|412-641-1778|limkg2@upmc.edu|
21256725|NCT02322125|University of Alberta|Dr. Jaynie Yang|780-492-2894|jaynie.yang@ualberta.ca|
21256726|NCT01183143|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21256727|NCT04096274|Boise State University|Dr. Nathaniel Williams|2084263145|natewilliams@boisestate.edu|
21256728|NCT04490395|Duke University|Jennifer Plumb Vilardaga, PhD|919-668-6123|jennifer.plumb.vilardaga@duke.edu|
21256729|NCT01861028|Conformis|Director of Clinical and Technical Research|781-345-9103|sumesh.zingde@conformis.com|
21256730|NCT05092919|Perelman School of Medicine, University of Pennsylvania|Janet Audrain-McGovern, Ph.D. Director, Addictions, Department of Psychiatry|(215) 746-7145|audrain@pennmedicine.upenn.edu|
21256731|NCT01490684|King Abdulaziz Medical City|Dr Hasan Al-Dorzi|966535888632|aldorzih@yahoo.com|
21256732|NCT00618436|University of Pittsburgh|Dr. Lori Shutter|1-412-647-8410|shutterla@upmc.edu|
21256733|NCT01942148|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Trials|+81-3-6361-7366||
21256734|NCT02248259|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21256735|NCT00625989|McMaster University|Dr. Gail Gauvreau|905-525-9140|gauvreau@mcmaster.ca|22791
21256736|NCT01180478|CROES|J. de la Rosette, chairman CROES|+31 20 5666030|info@croesoffice.org|
21256737|NCT02807480|Laureate Institute for Brain Research|Robin Aupperle|918-502-5744|raupperle@laureateinstitute.org|
21256738|NCT02369848|Shockwave Medical, Inc.|Gheda Sahyun, Director of Clinical Affairs|510-624-9073|gsahyun@shockwavemedical.com|
21256739|NCT01979159|VA Salt Lake City Health Care System|Dr. Julie Wambaugh|801-582-1565|julie.wambaugh@va.gov|1363
21256740|NCT02114164|OhioHealth|Dr. Oscar Martinez|(614) 544-8104|oscar.martinez@ohiohealth.com|
21256741|NCT00096785|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21285434|NCT01473940|Northwestern University|Mary Mulcahy, MD|312-695-0990|Mary.Mulcahy@nm.org|
21285435|NCT00534248|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||ClinicalTrialsDisclosure@merck.com|
21285436|NCT02532257|The University of Texas MD Anderson Cancer Center|Loretta Nastoupil, MD|(713) 792-2860|lnastoupil@mdanderson.org|
21285437|NCT02849171|Memorial Sloan Kettering Cancer Center|Ronald Blasberg, MD|646-888-2211|blasberr@mskcc.org|
21285438|NCT00459810|Oregon Health & Science University Knight Cancer Institute|Study Coordinator|(503) 494-2897|eilersk@ohsu.edu|
21285439|NCT03132415|University of Pennsylvania|Jose Bauermeiser|215-898-9993|bjose@upenn.edu|
21300360|NCT03253393|University of New South Wales|Dr Jacqueline Tan|+612 9385 6551|jacqueline.tan@unsw.edu.au|
21256742|NCT01838616|Grünenthal GmbH|Study Director|+49 241 569|Clinical-Trials@grunenthal.com|3223
21256743|NCT00257725|New York State Psychiatric Institute|Laurence Greenhill, MD|212-543-5340|GREENHIL@nyspi.columbia.edu|
21256744|NCT02573870|GlaxoSmithKline|GSK Response Center|866-435-7343||
21256745|NCT01408992|Khon Kaen University|Dr. Kwanchanok Yimtae|66-43348396|kwayim@kku.ac.th|
21256746|NCT02081534|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
21256747|NCT01007032|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21256748|NCT00709111|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21256749|NCT00915772|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21256750|NCT02809131|Vanderbilt University Medical Center|Christopher R. Ellis, MD, FACC, FHRS|(615)-936-2523|Christopher.ellis@vumc.org|
21285440|NCT00315614|University of Miami|Dr. Rodolfo Alejandro|3052435324|ralejand@med.miami.edu|
21256751|NCT00791336|The University of Iowa|John M. Buatti, M.D., Chair, Department of Radiation Oncology|319-356-2699|john-buatti@uiowa.edu|
21256752|NCT00549939|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21256753|NCT01735279|Department of Psychobiology, Universidade Federal de São Paulo (UNIFESP), Rua Napoleão de Barros, São Paulo , Brazil|Md PhD José Carlos F. Galduróz|+55 11 2149 0000|galduroz@unifesp.br|
21256754|NCT00806195|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21256755|NCT02319668|GlaxoSmithKline|GSK Response Center|866-435-7343||
21256756|NCT01161043|Medtronic Diabetes|Suiying Huang|8185763319|suiying.huang@medtronic.com|
21256757|NCT02164929|Duke University Medical Center|Timothy Miller, MD||timothy.miller2@duke.edu|
21256758|NCT03496220|Angulus|Dr. Perry Dubin|‪(917) 426-5911‬|perry@angulus.us|
21256759|NCT00365456|Nycomed|Clinical Trial Operations|+45 4677 1111|clinicaltrials@nycomed.com|
21256760|NCT01846728|University of Colorado Anschutz Medical Campus|Edward Melanson, PhD|303-724-0935|ed.melanson@cuanschutz.edu|
21256761|NCT00550654|National Cancer Institute, National Institutes of Health|Deborah Citrin, M.D.|301-496-5457|citrind@mail.nih.gov|
21256762|NCT00701090|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21256763|NCT00873366|Mayo Clinic|Dr. Matthew P. Goetz|507-284-2511|goetz.matthew@mayo.edu|
21256764|NCT01537198|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
21256765|NCT01127659|University of Buffalo|Paresh Dandona|716) 961-9900|pdandona@kaleidahealth.org|
21256766|NCT01299376|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21256767|NCT03769246|Columbia University Medical Center|Dr. Anna-Christina Bevelaqua|(212) 342-0085|ab3302@cumc.columbia.edu|
21256768|NCT00113074|University of Iowa|Mark Vander Weg|319-338-0581|mark-vanderweg@uiowa.edu|7717
21256769|NCT03680911|University of Miami|Roy R. Casiano, MD|305-243-5290|rcasiano@med.miami.edu|
21256770|NCT03962738|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21256771|NCT01478360|Novartis Pharmaceuticals|Study Director|862-778-8300||
21256772|NCT01221727|Amgen Inc.|Study Director|866-572-6436||
21256773|NCT02566577|Emory University|Arshed A. Quyyumi|404-727-3655|aquyyum@emory.edu|
21256774|NCT01289821|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21256775|NCT02941926|Novartis Pharmaceuticals|Study director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21256776|NCT00097773|Seattle Childrens Hospital|Bonnie Ramsey, MD|206-987-5725|bonnie.ramsey@seattlechildrens.org|
21256777|NCT01009034|Maple Leaf Research|Tony Antoniou|4164657936|tantoniou@smh.toronto.on.ca|
21256778|NCT00474708|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21256779|NCT03700320|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
21256780|NCT03770091|UPMC|John Fowler|412-605-3245|fowlerjr@upmc.edu|
21256781|NCT02243865|Chordate|Dr Jan-Åke Åkesson|+46 8 40015586|info@chordate.com|
21256782|NCT02179671|AstraZeneca|Phillip Dennis|1 + 301-398-5549|Phillip.Dennis@astrazeneca.com|
21256783|NCT02054325|UPECLIN|Dr. Matheus Bertanha|+55 14 38116305|matheus.fameca@ig.com.br|
21256784|NCT05093322|HUTCHMED Limited|Nick Lawn|+44 7826 422448|nickl@hutch-med.com|
21256785|NCT00898443|UAB|Marsha Wakefield, M.D.|205-934-4696|mwakefield@uab.edu|
21256786|NCT03613662|Scilex Pharmaceuticals, Inc.|Associate Director Clinical Operations|6503866709|cambrose@scilexpharma.com|
21256787|NCT01843972|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21256788|NCT00615472|Columbia University|Eric J Heyer|212-305-9072|ejh3@cumc.columbia.edu|
21256789|NCT00932425|University of California San Francisco|Wade Smith, MD, PhD|415-353-8897|smithw@neurology.ucsf.edu|
21256790|NCT03086265|Stanford University|Vladimir Nekhendzy, M.D., FASA|650-498-4055|nek@stanford.edu|
21256791|NCT00916279|Lutonix Inc. a subsidiary of C.R. Bard|Chris Barry|763-445-2352|LutonixResearch@crbard.com|
21256792|NCT00310804|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21256793|NCT04310085|Medicines for Malaria Venture|Dr Stephan Chalon|+41 22 555 0379|chalons@mmv.org|
21256794|NCT02717754|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21256795|NCT00667823|Actelion Pharmaceuticals Ltd|Senior Clinical Leader PH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21256796|NCT03828292|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21256797|NCT04376827|Janssen Research & Development, LLC|Senior Director Clinical Research MD|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21256798|NCT03697720|NorthShore University HealthSystem|Kevin Hellman, Research Associate Professor|847-570-2622|khellman@northshore.org|
21256799|NCT03496012|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21256800|NCT05745662|UCSF Hypoxia Research Laboratory|Dr. Philip Bickler|1-415-476-1411|philip.bickler@ucsf.edu|
21256801|NCT05030454|Washington University School of Medicine|Pamela Samson, M.D., MPHS|314-747-1786|psamson@wustl.edu|
21256802|NCT02053168|BD Interventional - Surgery|Dawn Heimer|401-825-8681|Dawn.Heimer@crbard.com|
21268055|NCT00285857|Stanford University|James M. Ford|(650) 498-6689|jmf@stanford.edu|
21268056|NCT00508872|UT MD Anderson Cancer Center|Eddie Abdalla, MD/Assistant Professor|713-792-6940||
21268057|NCT03927209|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21268058|NCT03558230|Medical University of South Carolina|Dr. Na Jin Seo|843-792-0084|seon@musc.edu|
21268059|NCT02210559|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG3019-069Study@fibrogen.com|
21268060|NCT00310440|Nor Consult, LLC|Lead Clinical Research Associate|2066076861|p15@nor-consult.com|
21268061|NCT00792467|Italfarmaco SpA|Maurizio Caserini, MD|+39 0264431|m.caserini@italfarmaco.com|
21268062|NCT01256424|Photocure|Vice President Research and Development|+47 22062210|ifh@photocure.no|
21268063|NCT01287403|Clinical Development Unit / Metabolic Unit|Dr Maurice Beaumont, MD, PhD|+41217858054|maurice.beaumont@rdls.nestle.com|
21268064|NCT01098266|Molmed S.p.A|Clinical Operations|003902212771|clinical.operations@molmed.com|
21268065|NCT04871451|AEON Biopharma, Inc.|Dana Testa, PharmD|949-354-6499|dt@aeonbiopharma.com|
21268066|NCT00727246|University of Pittsburgh|Patricia M Arenth PhD|412-648-6666|arenpm@upmc.edu|
21268067|NCT04594213|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
21268068|NCT01636102|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21268069|NCT01654666|XuanWu Hospital, Capital Medical University|Xunming Ji, M.D.,Ph.D|8683198127|jixunming@vip.163.com|
21268070|NCT04805892|Quality Research and Invention LLC|Zanetta Malanowska-Stega|6464001204|jstega@optonline.net|
21268071|NCT01616173|Northwestern University, Feinberg School of Medicine|Rohit Rahangdale MD|312-695-3045|ryrahangdale@hotmail.com|
21268072|NCT04680273|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
21268073|NCT04168775|University of North Carolina at Chapel Hill|Michael B. Drummond, MD|919-966-7054|brad_drummond@med.unc.edu|
21268074|NCT00504595|Novartis Pharmaceuticals|Study Director|862-778-8300||
21268075|NCT00958282|University of Minnesota|Dr. Marc Mooney|6129916875|moon0078@umn.edu|
21268076|NCT04462731|University of Pennsylvania|Ya-Hsin Yu|215-898-4927|yayu@upenn.edu|
21268077|NCT01218477|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21268078|NCT00787527|University of Texas MD Anderson Cancer Center|Yasuhiro Oki, MD/ Associate Professor|713-792-2860|yoki@mdanderson.org|
21268079|NCT03970330|MSHersheyMC|Dr. Kristin Riley|717-531-6447|kriley1@pennstatehealth.psu.edu|
21268080|NCT04051320|University of North Carolina at Chapel Hill|Crystal Schiller, PhD|919-966-5243|crystal_schiller@med.unc.edu|
21268081|NCT00733096|Johns Hopkins School of Medicine|Steven P. Cohen|410-955-1822|scohen40@jhmi.edu|
21268082|NCT03485976|Oregon Health & Science University, Department of Dermatology|Teri Greiling, MD, PhD|503-494-8452|PRPStudy@ohsu.edu|
21268083|NCT01199952|University of California, San Francisco|Director for Research Operations|415-206-2476|abby.sokoloff@ucsf.edu|
21268084|NCT02132312|Omeros Corporation|Omeros Clinical Trial Information|ctinfo@omeros.com|ctinfo@omeros.com|
21268085|NCT00089505|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21268086|NCT02543918|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979||
21268087|NCT03503617|Flint Rehabilitation Devices|Daniel Zondervan|9493137322|dzondervan@flintrehab.com|
21268088|NCT00486720|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21268089|NCT02780869|Biom'up|Rachel Hoffman, Vice President Clinical Operations North America|404-702-9253|r.hoffman@biomup.com|
21268090|NCT04745065|Pro-Change Behavior Systems, Inc.|Kerry E. Evers|401-360-2980|kevers@prochange.com|
21268091|NCT00252499|VA Puget Sound Health Care System|Kristina Utzschneider, MD|206-277-3568|kristina.utzschneider@va.gov|
21268092|NCT03137173|Basilea Pharmaceutica International Ltd.|Project Physician|+41 79 701 0551|marc.engelhardt@basilea.com|
21256803|NCT03785925|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
21256804|NCT01575106|Massachusetts General Hospital|Jian Kong|617-726-7893|JKONG2@mgh.harvard.edu|
21256805|NCT01206062|Wake Forest University Health Sciences|David Reboussin|336-716-6844|drebouss@wakehealth.edu|
21256806|NCT00957528|The University of Texas Medical Branch at Galveston|Randall Urban, M.D., Professor of Medicine|409- 772-1176|rurban@utmb.edu|
21256807|NCT01673919|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21256808|NCT01101438|Canadian Cancer Trials Group|Professor Bingshu Chen|+16135336000|bechen@ctg.queensu.ca|77703
21256809|NCT05335356|Biocon Biologics Limited|Dr Sarika D|080 2808|Sarika.Deodhar@biocon.com|5302
21256810|NCT04747834|Regulatory Pathways Group, Inc.|Gretchen Neumann|19494667124|gneumann@regulatorypathways.com|
21256811|NCT05368961|Cleveland Clinic|Michelle Levay, Nurse Research Manager|216-445-4749|levaym@ccf.org|54749
21285441|NCT02224612|Medline Industries, Inc.|Ed Drower|847-643-3874|edrower@medline.com|
21268093|NCT00423267|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21268094|NCT03702166|UT Health San Antonio|John Moring, PhD|(210) 562-6716|moringj@uthscsa.edu|
21268095|NCT01333865|Massachusetts General Hospital|Gagan Joshi, MD|617-724-2344|joshi.gagan@mgh.harvard.edu|
21268096|NCT00807768|NRG Oncology|Linda Gedeon for Virginia Filiaci, PhD|716-845-1169|lgedeon@gogstats.org|
21268097|NCT04126187|Gainesville Eye Associates|Clayton Blehm, MD|17705324444|claytonblehm@gmail.com|
21268098|NCT00784836|Biogen Idec Inc.|Biogen Idec Medical Director||clinicaltrials@biogenidec.com|
21268099|NCT02720627|Cassiopea, SpA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
21268100|NCT03417999|Children's Hospital of Philadelphia|Dr. Kelly Grogan|410-279-6994|grogank@chop.edu|
21268101|NCT02613910|GlaxoSmithKline|GSK Response Center|866-435-7343||
21268102|NCT00695318|Alimera Sciences, Inc.|Kathleen Billman, Senior Director, Scientific Affairs|678-527-1302|kathleen.billman@alimerasciences.com|
21268103|NCT00490477|University of Turin, Italy|V. M. Ranieri, MD|00390116334001|marco.ranieri@unito.it|
21268104|NCT03726320|NYU Langone Health|Danil Makarov|212-263-4961|Danil.Makarov@nyulangone.org|
21268105|NCT02679560|UC Davis|Dr. Ian Brown|(916)734-1279|iebrown@ucdavis.edu|
21268106|NCT02028182|Allerderm(dba) SmartPractice|Kathryn Shannon|6022250595|kshannon@smarthealth.com|
21268107|NCT01519648|National Hematological Society|Professor Galina A Klyasova|+7(495)6125181|klyasova.g@blood.ru|
21268108|NCT01684930|Victoria University|Jason D. Allen, PhD|61 3 9919 4264|jason.allen@vu.edu.au|
21268109|NCT01336647|Hatchtech Pty Ltd|Clinical Manager|+61 3 9092 0490|tahveninen@hatchtech.com.au|
21268110|NCT03808298|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21268111|NCT01004822|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21268112|NCT01858701|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21268113|NCT01674010|Transition Therapeutics Ireland Limited|Aleksandra Pastrak,MD, PhD, VP of Clinical Development and Medical Officer|+1 416 263 1227|apastrak@transitiontherapeutics.com|
21268114|NCT05040295|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21268115|NCT00953849|Ralph H. Johnson VA Medical Center, Charleston, SC|M. Rita I. Young, Ph.D.|843-792-9953|rita.young@va.gov|
21268116|NCT01801475|Stanford University|Dr. David R Drover|6507250364|ddrover@stanford.edu|
21268117|NCT01559649|Michael E. DeBakey VA Medical Center|Stephanie Daniels|713-743-2570|skdaniels@uh.edu|
21268118|NCT01786707|University of Miami School of Medicine|Dr. Rodolfo Alejandro|3052435324|ralejand@med.miami.edu|
21268119|NCT00444028|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
21268120|NCT00346775|GlaxoSmithKline|GSK Response Center|866-435-7343||
21268121|NCT02946515|University of Minnesota - Division of Epidemiology and Community Health|Dr. Nancy E. Sherwood, Associate Professor|612-625-4567|sherw005@umn.edu|
21268122|NCT01881867|Cancer Immunotherapy Trials Network|CITN Director|206-667-4141|mcheever@fredhutch.org|
21268123|NCT01054209|Brighton and Sussex University Hospitals Trust|Dr Mark Harper|01273696955|mark.harper@bsuh.nhs.uk|4307
21268124|NCT03044691|Unversity of Florida|Assistant Professor|(352) 294-4997|rsalloum@ufl.edu|
21268125|NCT01096017|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
21268126|NCT02600559|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
21268127|NCT02818582|National Institute of Allergy and Infectious Diseases|Higgs, Elizabeth|+1 301 768 3947|ehiggs@niaid.nih.gov|
21268128|NCT02196025|University of Florida|Robyn Nelson|3522945563|r.nelson@ufl.edu|
21268129|NCT00594958|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|0
21268130|NCT01513538|Medtronic|Céline This|33 6 89 71 90 67|celine.this@medtronic.com|
21268131|NCT02843282|University of Texas at Dallas, Center for BrainHealth|Erin Venza, Research Clinician|972-883-3208|erin.venza@utdallas.edu|
21268132|NCT05981443|University of Kentucky|Dr. Cody Blanchard|859-323-5867|cody.blanchard@uky.edu|
21268133|NCT00224952|The Children's Mercy Hospital|J. Steven Leeder Pharm D, PhD|816-234-3059|sleeder@cmh.edu|
21268134|NCT00408408|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org|
21268135|NCT00917553|University of Michigan|Dr. Thomas W. Gardner|734 232-8404|tomwgard@med.umich.edu|
21268136|NCT01905241|Cleveland Clinic Foundation|Joseph P. Iannotti, MD, PhD|216-287-1149|IANNOTJ@ccf.org|
21268137|NCT03172026|University of California Los Angeles|Dr. Bruce H. Dobkin|310-206-6500|BDobkin@mednet.ucla.edu|
21268138|NCT01177943|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21268139|NCT02109731|University of Rochester|Dr. Suzanne Karan|5852751384|suzanne_karan@urmc.rochester.edu|
21268140|NCT00779142|Wake Forest Baptist Health Eye Center|Dr. Shree Kurup|336-716-4091|skurup@wakehealth.edu|
21268141|NCT02816255|Weill Cornell Medicine|Matthew R. Ebben, Ph.D.|646-962-9313|mae2001@med.cornell.edu|
21268142|NCT00026559|National Institute of Mental Health|Pao, Maryland|+1 301 435 5770|paom@mail.nih.gov|
21268143|NCT01303159|Weill Cornell Medical College|Michel Kahaleh|646-962-4797|mik9071@med.cornell.edu|
21251458|NCT03004586|UT MD Anderson Cancer Center|George Eapen,MD/ Professor, Pulmonary Medicine|(713) 563-4256|geapen@mdanderson.org|
21268144|NCT00496782|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21237820|NCT01077830|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21237821|NCT01865708|Children's Healthcare of Atlanta|Dr. Jana Stockwell|404-785-1868|jana.stockwell@choa.org|
21256812|NCT05714982|UNC|Principal Investigator|(919) 966-3282|ntb@unc.edu|
21256813|NCT03677596|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21256814|NCT00415857|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/792-7305|eharrison@mdanderson.org|
21256815|NCT02210065|U.T. MD Anderson Cancer Center|Dr. Betul Oran / Associate Professor, Stem Cell Transplantation|713-745-2820|BOran@mdanderson.org|
21256816|NCT03634397|Penn State College of Medicine|Dr Candice Maenza|7175310003|cmaenza@pennstatehealth.psu.edu|283146
21256817|NCT04748653|University of California San Francisco|Alison El Ayadi, Associate Professor|415-476-5877|alison.elayadi@ucsf.edu|
21256818|NCT00922480|Boryung Pharmaceuticals|Manager of Clinical Research|+82-2-708-8069|rainbowleo@boryung.co.kr|
21256819|NCT02446314|The University of Reading|Prof Claire Williams|0118 378 7540|claire.williams@reading.ac.uk|
21256820|NCT00112671|Princess Margaret Phase II Consortium|Dr. Srikala Sridhar|416-946-4501|srikala.sridhar@uhn.ca|2662
21256821|NCT03716050|Wake Forest Baptist Health|Ivo Pestana|336-716-4171|ipestana@wakehealth.edu|
21256822|NCT02901574|Johns Hopkins University School of Medicine|Rajani Sebastian, PhD|410-502-5012|rsebast3@jhmi.edu|
21256823|NCT01010633|Bausch & Lomb Incorporated|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
21256824|NCT00073528|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21256825|NCT03086057|Brown University|Dr. Katie Biello|401-863-3082|katie_biello@brown.edu|
21256826|NCT02937194|The University of Hong Kong|Prof Wong, May Chun Mei|852-28590422|mcmwong@hku.hk|
21256827|NCT02887404|Cleveland Clinic Foundation|Dr. Kamal Maheshwari|216-4454311|maheshk@ccf.org|
21256828|NCT01494350|Institut Pasteur of Tunis|Afif Ben Salah, MD, PhD|011-216-71-792-429|afif.bensalah@pasteur.rns.tn|
21256829|NCT01786603|University of Kansas Medical Center|Dr. Richard Barohn|913-945-9944|rbarohn@kumc.edu|
21256830|NCT02132884|Fox Chase Cancer Center|Dr. Hossein Borghaei|215-2141515|Hossein.Borghaei@fccc.edu|
21256831|NCT01978535|Mayo Clinic|Dr. Amie Jones|507-284-6063|Jones.Amie@mayo.edu|
21256832|NCT01937598|Div. Diabetology, Med. Dep. I, St. Josef-Hospital (Ruhr-Univeristy Bochum), change of address 01.01.20015|Prof. Dr. M. A. Nauck, Principle Investigator|+49-234-509|michael.nauck@rub.de|6332
21256833|NCT00749476|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21256834|NCT01022242|Uppsala University Hospital|Monica Wiig||monica.wiig@akademiska.se|
21256835|NCT03654976|ALK-Abelló A/S|Senior Director Global Clinical Development|0045 45747576|clinicaltrials@alk.net|
21256836|NCT03098836|Duke University Medical Center|Daniel George, MD|(919) 668-8108|daniel.george@duke.edu|
21256837|NCT03986866|University of Arkansas for Medical Sciences|Johnathan Goree, MD|(501) 686-8818|JHGoree@uams.edu|
21256838|NCT01500525|Capital Institute of Pediatrics|Ling Cao，MD,Pulmonologist, Professor|86-13910610319|caoling9919@163.com|
21268145|NCT01288911|Astellas Pharma Global Development, Inc. (APGD)|Executive Medical Director||Astellas.resultsdisclosure@astellas.com|
21268146|NCT01632345|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21268147|NCT02431559|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
21268148|NCT05489146|University of Pittsburgh|Amit Sethi, Associate Professor, Department of Occupational Therapy,|4123836619|asethi@pitt.edu|
21285442|NCT03498313|University of Illinois at Chicago|Dr. Tory Eisenlohr-Moul, Assistant Professor of Psychiatry|859-317-0503|temo@uic.edu|
21285443|NCT04026750|High Point Clinical Trials Center|Melanie Fein, MD|1-336-841-0700|mfein@highpointctc.com|2530
21285444|NCT02630563|Roche Trial Information Hotline|F. Hoffmann-La Roche AG|+41 61 6878333|global.trial_information@roche.com|
21285445|NCT04812184|Indiana University School of Medicine|Nicholas Pettit|18653688599|nrpettit@iu.edu|
21285446|NCT00929994|Toronto Rehab|Dr.|4169781739|dina.brooks@utoronto.ca|
21285447|NCT00621257|children's Hospital Boston|Helen Pappa, MD, MPH, Principal Investigator|617-355-6058|helen.pappa@childrens.harvard.edu|
21285448|NCT00184002|USC Norris Comprehensive Cancer Center|Victoria Soto - Project Specialist|(323) 865-0454|Victoria.Soto@med.usc.edu|
21285449|NCT00581061|University of California, Irvine|Doug Skarecky|714-456-6744|dwskarec@uci.edu|
21285450|NCT00694356|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21285451|NCT01042392|Novartis Pharmaceuticals|Study Director|862-778-8300||
21285452|NCT03117361|Pharma Mar, S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|+34 918466000|clinicaltrials@pharmamar.com|
21285453|NCT00540644|IndianaU|Dr. Attaya Suvannasankha|317-944-0920|asuvanna@iu.edu|
21285454|NCT01869777|Wake Forest University Health Sciences|Principal investigator|336-716-5440|tpardee@wakehealth.edu|
21285455|NCT00878800|Topotarget A/S|PRS Administrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com|
21285456|NCT02072941|University of California San Francisco|Dr. Rebecca Sudore|(415) 221-4810|rebecca.sudore@ucsf.edu|23475
21285457|NCT01247350|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21285458|NCT02982863|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21285459|NCT03549598|Mayo Clinic|John P. Bois, M.D.|507-284-3545|Bois.John@mayo.edu|
21285460|NCT04167189|PhenoSolve|Lynn Feldman|617-879-1670|lynn@phenosolve.com|
21268149|NCT02452892|Tal Medical|Dr. Atul Pande, MD, Chief Medical Officer||apande@talmedical.com|
21268150|NCT03820388|University of California Davis|Dr. Hong Liu|916-734-5031|hualiu@ucdavis.edu|
21268151|NCT00469391|GI Dynamics, Inc.|Clinical Affairs Manager|781.357.3261|pkeating@gidynamics.com|
21268152|NCT05047601|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21268153|NCT01294319|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|Dr. Lynnette Nieman|301-496-4000|niemanl@mail.nih.gov|
21268154|NCT00596622|Indiana University School of Medicine|Amit Anand|3172747422|aanand@iupui.edu|
21268155|NCT03279731|Perelman School of Medicine at the University of Pennsylvania|Kelly C. Allison, PhD|2158982823|kca@pennmedicine.upenn.edu|
21268156|NCT01205399|C. R. Bard: Davol, Inc.|Dawn Heimer/Director, Clinical Affairs|401-825-8681|dawn.heimer@crbard.com|
21285461|NCT02328937|Johnson & Johnson Vision Care Inc.|Tawnya Wilson - PRINCIPAL RESEARCH OPTOMETRIST|+1 904 443-1834|TWilson@ITS.JNJ.com|
21285462|NCT00435461|GlaxoSmithKline|GSK Response Center|866-435-7343||
21285463|NCT01768559|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21285464|NCT02681458|Islamic Azad University of Mashhad|Dr. Hassan Yazdanfar|00985136631004|hasanyazdanfar@yahoo.com|
21285465|NCT00237692|Center for Primary Care, HSRD COIN|Hayden B. Bosworth, PhD|919-286-0411|hayden.bosworth@va.gov|7107
21256839|NCT00545064|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21256840|NCT01775735|Boston Scientific|Director, Clinical Sciences and Scientific Communication||Roshini.Jain@bsci.com|
21256841|NCT01660451|Bayer|Therapeutic Area Head|+1-888-8422937|clinical-trials-contact@bayer.com|
21256842|NCT04688775|H. Lundbeck A/S|Email contact via H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@Lundbeck.com|
21256843|NCT03880032|Johns Hopkins Bloomberg School of Public Health|Pamela Surkan|4105027396|psurkan@jhu.edu|
21256844|NCT01770912|University of Florida|Charles G. Widmer, Associate Professor|352-273-5696|widmer@dental.ufl.edu|
21256845|NCT03250832|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21256846|NCT01380639|Schön Klinik Berchtesgadener Land|Dr. Klaus Kenn|+49 8652 931541|kkenn@schoen-kliniken.de|
21256847|NCT01536951|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21256848|NCT03982342|Nationwide Children's Hospital|Carl Backes, MD|1-614-355-6729|Carl.Backes@nationwidechildrens.org|
21256849|NCT00545402|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21256850|NCT01721876|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21256851|NCT01252810|GE Healthcare|Ruben Sheng, M.D.|609-514-6899|Rubin.Sheng@ge.com|
21268157|NCT00302731|University of Kansas Medical Center|Jeanne A Drisko, MD, CNS, FACN|913-588-6208|jdrisko@kumc.edu|
21285466|NCT01737879|Amgen Inc.|Study Director|866-572-6436||
21285467|NCT04274075|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
21268158|NCT01535638|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21285468|NCT01386944|UCB|UCB Clinical Trial Call Center|++1 877 822 9493||
21285469|NCT03883477|Cedars-Sinai Medical Center, Department of Orthopedic Surgery|Clinical Trial RN|3104235900|rodriquezsv@csmns.org|
21256852|NCT03805750|University of California San Diego|F.B. Nahab MD|858-822-6683|fnahab@health.ucsd.edu|
21256853|NCT01984164|Emory University|Dr. Hajjar|404-712-2036|ihabhajjar@emory.edu|
21256854|NCT02811549|Advanced Bionics|Ankur Kaushal, VP of Global Regulatory Affairs|661 362 1400|clinicalresearch@advancedbionics.com|
21256855|NCT05082376|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
21256856|NCT00493220|Baxter Healthcare Corporation|George Harb, MD, MPH||george_harb@baxter.com|
21256857|NCT01771055|University of Louisville|Dr. Jason Smith|502-852-5675|josmit19@louisville.edu|
21256858|NCT04391036|University of Pittsburgh Medical School|Dr. Leslie Meyn|412-641-4233|meynla@mwri.magee.edu|
21285470|NCT04186221|TransMedics, Inc.|Laura Damme, VP Clinical Affairs|978-552-0900|ldamme@transmedics.com|
21285471|NCT00531947|Mylan Specialty L.P.|Kim Portland, Ph.D.|908.542.2636|kimberly.portland@mylan.com|
21285472|NCT02432209|Yale School of Public Health|Fangbai Sun|2037855185|fangbai.sun@yale.edu|
21285473|NCT00305565|Cyberonics Inc.|Mark Bunker Sr. Director, Global Medical Affairs|281-228-7223|Mark.Bunker@cyberonics.com|
21285474|NCT04485637|University of Southern California|Wandi Bruine de Bruin|4126385875|wandibdb@usc.edu|
21285475|NCT02348008|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-921-2050|jsmith@hoosiercancer.org|
21285476|NCT04399538|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21285477|NCT03852498|bluebird bio, Inc|Study Medical Director|+1-833-999-6378|clinicaltrials@bluebirdbio.com|
21285478|NCT01588405|United Therapeutics|Nicole Leedom|919-425-5870|nleedom@unither.com|
21285479|NCT03268005|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21285480|NCT01181947|St. Antonius Ziekenhuis|Dr. Robin Heijmen|0031306092047|r.heijmen@antoniusziekenhuis.nl|
21268159|NCT03524664|Mt. Hope Family Center, University of Rochester|Dr. Christie Petrenko|(585) 275-2991|christie_petrenko@urmc.rochester.edu|241
21268160|NCT00515021|Vanderbilt University Medical Center|James Muldowney|615-936-1720|james.muldowney@vanderbilt.edu|
21268161|NCT02185729|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
21268162|NCT03077646|Children's Hospital at Montefiore|Alyssa Silver, MD|718-741-2304|alysilve@montefiore.org|
21268163|NCT00434876|Philadelphia VAMC|Subhajit Chakravorty|215-823-5800|Subhajit.Chakravorty@va.gov|3405
21268164|NCT03159455|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21268165|NCT02022566|Lunds university|Physical therapist Therese Jönsson|0046703360721|therese.jonsson@med.lu.se|
21268166|NCT02713490|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
21268167|NCT01714726|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21268168|NCT00501969|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
21268169|NCT02965027|VA Puget Sound Health Care System|Hollie Holmes|206-277-6207|Hollie.Holmes@va.gov|
21268170|NCT00665366|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21268171|NCT03628781|Cincinnati Children's Hospital Medical Center|Dr. Jeff Epstein|15136368296|jeff.epstein@cchmc.org|
21268172|NCT00994123|Merrimack Pharmaceuticals|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
21285481|NCT01926197|Stanford Medicine at Stanford University|Samantha Wong|650-498-8495|swong8@stanford.edu|
21285482|NCT00410059|UT MD Anderson Cancer Center|Vice President Clinical Research/Clinical Research Operations|713-792-7734|CR_Study_Registration@mdanderson.org|
21285483|NCT02756364|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21285484|NCT02223364|Mayo Clinic|Dr. Sandra L. Kopp|507-284-6637|Kopp.Sandra@mayo.edu|
21285485|NCT02984267|Arizona Anesthesia Consultants|Dr. Thomas Vernon|480-570-7082|tvernon@azanesthesia.net|
21285486|NCT01342172|Icahn School of Medicine at Mount Sinai|Dr. Matthew Galsky|212-241-8816|matthew.galsky@mssme.edu|
21285487|NCT04811664|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
21285488|NCT02717442|Otonomy, Inc.|Otonomy Medical Information Center|1-844-686-4636|medinfo@otonomy.com|
21285489|NCT02724410|Atrium Health|Dr. B. Todd Heniford|704-355-3168|Todd.Heniford@atriumhealth.org|
21285490|NCT02919007|Home Skinovations|Dr Liora Levi|+97249097470|LioraL@silkn.com|
21285491|NCT03117634|Singapore National Eye Center|Gemmy Cheung, Principal Investigator|+65 6322 8335|gemmy.cheung.c.m@singhealth.com.sg|
21285492|NCT00802672|Perrigo Company|Jonathan Schwartz|718-960-0119|jonathan.schwartz@perrigo.com|
21285493|NCT00006244|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
21285494|NCT04441788|Ionis Pharmaceuticals, Inc|Ionis Pharmaceuticals, Inc|800-679-4747|patients@ionisph.com|
21285495|NCT00753298|Astra Tech AB|Head of Therapeutic Area Health Care|+46317763000||
21285496|NCT03859648|MED-EL Corporation|MED-EL Corporation|919-314-1437|research.us@medel.com|
21285497|NCT02315664|Arthritis Research Canada|Dr. Linda Li, Professor, University of British Columbia|604-207-4020|lli@arthritisresearch.ca|
21285498|NCT03159299|Yale School of Nursing|Robin Whittemore, PhD|203-737-2351|robin.whittemore@yale.edu|
21285499|NCT00995722|University Of Miami|Dr. Benatar|305-243-6480|MBenatar@med.miami.edu|
21285500|NCT00667992|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21285501|NCT04336475|Cukurova University|Dr Nihan Cuzdan, MD, principal investigator|05052706846|nihancuzdan@hotmail.com|
21285502|NCT01952418|Massachusetts General Hospital|Norman Nishioka, MD|6177264422|NNISHIOKA@PARTNERS.ORG|
21285503|NCT02489448|Yale School of Medicine|Lajos Pusztai, MD, DPhil Professor of Medicine (Medical Oncology)|(203) 737-8309|lajos.pusztai@yale.edu|
21285504|NCT03834025|University of North Carolina at Chapel Hill|Marisa Domino, PhD|919-966-3891|domino@unc.edu|
21285505|NCT02793947|University of Iowa Hospitals and Clinics|Dr. Michael Willey|319-384-8452|michael-willey@uiowa.edu|
21285506|NCT02096276|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21285507|NCT02090777|Duke Eye Center|Jullia Rosdahl MD PhD|919-684-8850|jullia.rosdahl@duke.edu|
21285508|NCT02213380|The second affiliated hospital and Yuying children's hospital of Wenzhou medical university|Ting Li|008613587876896|liting1021@aliyun.com|
21285509|NCT03063619|M D Anderson Cancer Center|Dr. Banu Arun|(713) 792-2817|barun@mdanderson.org|
21285510|NCT01563198|Hypnalgesics, LLC d/b/a Comfort Talk|Elvira V. Lang, MD (PI of SBIR grant)|617 734 9087|drevlang@gmail.com|
21285511|NCT01310127|Discover Vision Centers|Melissa Toyos, MD|816-478-1230|mtoyos@discovervision.com|
21285512|NCT01490840|Novartis|Study Director|862-778-8300||
21285513|NCT03639857|University of Central Florida College of Medicine|Dr. David Weinstein|407-266-4900|david.weinstein@ucf.edu|
21268173|NCT02687815|University of Pittsburgh|Dr. Juan Celedón|(412) 692-8429|juan.celedon@chp.edu|
21237822|NCT01857882|University Health Network|Dr. Toni Zhong|416-340-3858|toni.zhong@uhn.ca|
21237823|NCT00455975|Sarah Cannon Research Institute|John Hainsworth MD|1-877-691-7274|asksarah@scresearch.net|
21237824|NCT01610427|GlaxoSmithKline|GSK Response Center|866-435-7343||
21256859|NCT00068575|UT MD Anderson Cancer Center|Peter Pisters, MD / Professor||asanmigu@mdanderson.org|
21256860|NCT03184077|Virginia Commonwealth University|Lindsay Morrell, MD|410-823-1120|lmorrellmcv@gmail.com|
21256861|NCT01590550|Loma Linda University|Rita Sheth, MD|909-558-8242|rsheth@llu.edu|
21256862|NCT01889238|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21256863|NCT04136184|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
21256864|NCT04887155|UCLA Semel Institute|Marc Weintraub|3108251300|mjweintraub@mednet.ucla.edu|
21256865|NCT03318978|Oregon State University|David E. Williams, PhD|541-737-3277|david.williams@oregonstate.edu|
21256866|NCT02844816|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|ctangen@fredhutch.org|
21256867|NCT05834348|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21256868|NCT04633174|Dartmouth-Hitchcock Medical Center|Dr. Nicholas Daniel, Staff Physician, Emergency Services|(603) 650-7254|Nicholas.Daniel@hitchcock.org|
21256869|NCT02592018|UCSF Department of Dermatology|Dr. Wilson Liao|415-476-4701|wilson.liao@ucsf.edu|
21256870|NCT00891319|MetroHealth Medical Center|Dr. Jayme Knutson|2169573557|jsk12@case.edu|216
21256871|NCT06156215|University of California San Francisco|Dr Melanie Molina|512.294.4366|melanie.molina@ucsf.edu|
21256872|NCT04631796|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21256873|NCT04456764|University of Pittsburgh|P. Daniel Patterson|412-647-3078|pdp3@pitt.edu|
21256874|NCT04360551|University of Hawaii at Manoa John A Burns School of Medicine|Cecilia M. Shikuma MD|808 692-1328|shikuma@hawaii.edu|
21256875|NCT05338515|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
21256876|NCT04701138|University of North Carolina at Chapel Hill|Saame Shaikh, PhD|919-843-4348|shaikhsa@email.unc.edu|
21256877|NCT03138538|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21256878|NCT01798589|Dermatology Specialists|Joseph Fowler, MD|502-583-7546|fowlerjoe@msn.com|
21256879|NCT01524198|King Saud University|Dr. Abdullah Alangari|966506287276|alangari100@gmail.com|
21256880|NCT02232802|Chemi SpA (Part of Italfarmaco Group)|Paolo Bettica, MD|+39 02 64431|p.bettica@italfarmaco.com|
21256881|NCT00634634|Cancer Institute of New Jersey|Dr. Deborah Toppmeyer|732-235-5203|toppmede@cinj.rutgers.edu|
21256882|NCT00885703|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21256883|NCT01490450|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
21256884|NCT00404820|Novartis Pharmaceuticals|Study Director|862 778-8300||
21256885|NCT00938717|Ironwood Pharmaceuticals|Doug Levine, MD|617.374.3906|dlevine@ironwoodpharma.com|
21256886|NCT00998049|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
21256887|NCT01462435|Iroko Pharmaceuticals, LLC|Daniel Solorio|267-546-3150|dsolorio@iroko.com|
21256888|NCT03600142|University of Utah|Dr. Melissa Watt|8015817201|melissa.watt@hsc.utah.edu|
21256889|NCT01543152|Sangamo Therapeutics|Medical Monitor|510-970-6000|clinicaltrials@sangamo.com|
21256890|NCT04639973|Baylor College of Medicine|Cara Buskmiller, MD|832-824-1000|cara.buskmiller@bcm.edu|
21256891|NCT00636675|University of North Carolina Chapel HIll|Ruth A. Anderson|919-966-8785|rutha@email.unc.edu|
21256892|NCT00857532|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
21256893|NCT02687542|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21256894|NCT01227187|George Washington University|Lakhmir Chawla|202-715-4752|lchawla@mfa.gwu.edu|
21256895|NCT03901105|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
21256896|NCT00914927|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
21256897|NCT01519934|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
21256898|NCT03442036|University of California San Diego|John J. Finneran IV, MD|4083073004|jfinneran@ucsd.edu|
21256899|NCT02475070|Lund University|Dr Bo Ahrén|+46462220758|Bo.Ahren@med.lu.se|
21300361|NCT03204188|National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI)|Adrian Wiestner, M.D., Ph.D., Principal Investigator|301-594-6855|wiestnea@nhlbi.nih.gov|
21300362|NCT03641937|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
21300363|NCT01350999|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21300364|NCT03593044|The Ohio State University College of Optometry|Dr. Jeffrey Walline|(614) 247-6840|walline.1@osu.edu|
21300365|NCT02208310|University of Michigan|Peter Higgins|7346472964|phiggins@umich.edu|
21300366|NCT03298035|The University of Texas Health Science Center at Houston|Catherine C. Beaullieu, MD|(713) 500-6044|Catherine.C.Beaullieu@uth.tmc.edu|
21300367|NCT01698333|Therapeutics Inc.|Clinical Research|858-571-1800|clinicalresearch@therapeuticsinc.com|
21300368|NCT01462370|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21300369|NCT02092610|Radboud University Hospital Nijmegen Medical Centre|Dr. Myrthe Hol|(024) 36 14934|Myrthe.Hol@radboudumc.nl|
21300370|NCT03198715|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21300371|NCT00473564|University of Alabama at Birmingham|William Carroll, MD|205-934-9767|wcarroll@uabmc.edu|
21300372|NCT00914316|William Beaumont Hospital|Barbara Higgins, RN|248 551-1535|Barbara.Higgins@beaumont.org|
21300373|NCT03131219|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
21268174|NCT00379639|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21256900|NCT04109222|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21268175|NCT02558634|Vancouver Coastal Health Research Association|Amanda Chisholm, Manager, Internal Awards|6048754111|amanda.chisholm@vch.ca|21696
21268176|NCT01238861|MedImmune, LLC|Rene van der Merwe, MBChB, MFPM, Medical Officer|301-398-0000|vandermerwer@medimmune.com|
21268177|NCT03868410|Cleveland Clinic|Dr. Ela Plow|216-445-6728|plowe2@ccf.org|
21268178|NCT01827462|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
21268179|NCT02452320|Weill Cornell Medicine|Farrell Cooke, Senior Research Assistant|212-746-2774|fac2010@med.cornell.edu|
21268180|NCT03737812|AbbVie|Global Medical Services|800-699-9110|abbvieclinicaltrials@abbvie.com|
21268181|NCT02624713|Tel-Hai College|Prof. Moria Golan|972547240330|moria.golan@mail.huji.ac.il|
21268182|NCT06104423|A.MENARINI I.F.R SrL|Simone Baldini Global Clinical Operations Manager|055 56801|sbaldini@menarini.it|
21268183|NCT03814499|Fondazione Telethon|Head of Clinical Development and Operations|+3902202217224|szancan@telethon.it|
21300374|NCT01635504|University of British Columbia|Dr. Shannon Humphrey|(604) 714-0222|shannon@carruthers-humphrey.com|
21268184|NCT00822185|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21268185|NCT00462501|Memorial Sloan Kettering Cancer Center|Dr. Leonard Saltz|646-888-4286|saltzl@mskcc.org|
21268186|NCT03740152|Massachusetts General Hospital|Dr. Paolo Cassano, M.D.|617-643-9622|pcassano@mgh.harvard.edu|
21268187|NCT03764813|Fondazione Policlinico Gemelli IRCCS|luciana teofilili medical director of the UNICATT cord blood bank|39 06 30154180|luciana.teofili@unicatt.it|
21268188|NCT05600101|Dana-Farber Cancer Institute|Dr. Gregory Abel|(877) 442-3324|Gregory_Abel@dfci.harvard.edu|
21268189|NCT03947333|Vanderbilt University Medical Center|William Martinez, MD|(615) 936-1010|william.martinez@vumc.org|
21268190|NCT02898662|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
21268191|NCT00399542|Sucampo Pharmaceuticals, Inc.|Raymond Panas, PhD|301-961-3400|info@sucampo.com|
21256901|NCT02577406|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21268192|NCT04652245|Meda Pharma GmbH & Co. KG (A Viatris Company)|Christine Kolb|+496172888|christine.kolb@viatris.com|2511
21268193|NCT02071823|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21268194|NCT00967473|Alcon Research, Ltd.|Director of Alcon Clinical|888-451-3937; 817-568-6725|medinfo@alconlabs.com|
21268195|NCT00556140|Massachusetts General Hospital|Dr. John Matthews|617-724-0847|jmatthews@partners.org|
21268196|NCT00851721|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21268197|NCT04047472|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21268198|NCT01333501|Novartis Pharmaceuticals|Study Director|862-778-8300||
21256902|NCT02138617|UNC Lineberger Comprehensive Cancer Center|Melahat Canter|(919) 962-0000|Melahat_Canter@med.unc.edu|
21268199|NCT01016912|Bristol-Myers Squibb International Corporation|BristolMyers Squibb Study Director||clinical.trials@bms.com|
21268200|NCT00955682|GlaxoSmithKline|GSK Response Center|866-435-7343||
21268201|NCT01680835|Medtronic|Jennifer Seamans, M.S., Clinical Research Program Manager|763-398-7455|jennifer.l.seamans@medtronic.com|
21300375|NCT00616759|Loma Linda University|Ronald L. Warnell, M.D.|909-558-9551|rwarnell@llu.edu|
21300376|NCT01528332|Philips Consumer Lifestyle|Dr. Elke Naujokat|+31 (0) 631974213|elke.naujokat@philips.com|
21300377|NCT02399163|GlaxoSmithKline|GSK Response Center|866-435-7343||
21300378|NCT00600080|Johnson & Johnson Vision Care|Kurt Moody, OD|+1 904 443-3088|kmoody1@its.jnj.com|
21256903|NCT00125762|BIDMC|Nezam Afdhal|6176321118|nafdhal@bidmc.harvard.edu|
21256904|NCT01970488|Amgen Inc.|Study Director|866-572-6436||
21256905|NCT01816061|DCVAMC|Dr.Joel Scholten|2027458000|joel.scholten@va.gov|55099
21268202|NCT04834375|Northwell Health|Dr. Stella Hahn|516-465-5400|sthahn@northwell.edu|
21268203|NCT03026556|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21300379|NCT04163952|Cancer Institute of New Jersey Rutgers|Dr. Adam Berger|732-235-8675|ab2047@cinj.rutger.edu|
21300380|NCT04225897|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21300381|NCT00074711|Creighton University|Robert P Heaney, MD|402 280 4029|rpheaney@creighton.edu|
21256906|NCT01671111|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21256907|NCT01231659|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21256908|NCT00509067|Department of Psychiatry Georgetown University Medical School|Dr. Stephen I. Deutsch|757.446.5888|DeutscSI@EVMS.EDU|
21256909|NCT01286454|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21256910|NCT01898689|UC San Diego|Dr. Brian Ilfeld|(858) 444-5949|bilfeld@ucsd.edu|
21256911|NCT00702325|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21256912|NCT00814671|Johns Hopkins University|Susan Dorman|410-955-1755|dsusan1@jhmi.edu|
21256913|NCT04556136|Madigan Army Medical Center|Dr. Mary McCarthy|253-968-3695|mary.s.mccarthy1.civ@health.mil|
21256914|NCT01507779|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
21256915|NCT01022502|Chang Gung Memorial Hospital|Yin-Ku Lin, MD. PhD.|886-2-24313131|lin1266@adm.cgmh.org.tw|2127
21268204|NCT02924129|Saluda Medical|Angela Leitner|651-208-4223|angela.leitner@saludamedical.com|
21300382|NCT03466658|Penn State Health|Dr. Hyunmin Kim|717-531-4826|hkim2@pennstatehealth.psu.edu|
21300383|NCT01537666|Savara Inc.|Taneli Jouhikainen, MD, MBA; Chief Operating Officer|(888) 302-4876|info@savarapharma.com|
21256916|NCT00861913|Karmanos Cancer Institute, Wayne State University|Amy M. Weise, D. O.|313-576-8952||
21256917|NCT02101515|George Washington University School of Medicine and Health Sciences|Alexis Gimovsky, MD|2027412603|agimovsk@mfa.gwu.edu|
21285514|NCT01025284|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21237825|NCT00999466|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21256918|NCT01751399|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21256919|NCT03199040|Washington University School of Medicine|Williams Gillanders, M.D.|314-747-0072|gillandersw@wustl.edu|
21256920|NCT01226459|Johnson & Johnson Healthcare Products Division of MCNEIL-PPC, Inc.|Study Director|(973) 385-3203||
21256921|NCT01092143|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21256922|NCT00117598|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21256923|NCT00382018|SWOG|Breast Committee Statistician|2066675712|jmiao@fredhutch.org|
21256924|NCT01020591|CDHA|Wendy Jardine|902 429 6218|wendymjardine@gmail.com|
21256925|NCT02219321|University of Texas Southwestern Medical Center|Enas Kandil|214-648|Enas.Kandil@UTSouthwestern.edu|9374
21256926|NCT04743921|University of Alabama at Birmingham Department of Orthopaedic Surgery|Dr. Amit Momaya|205-975-2663|amomaya@uabmc.edu|
21256927|NCT00427349|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
21256928|NCT03057613|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Shlomo Koyfman|1-866-223-8100|TaussigResearch@ccf.org|
21256929|NCT01660321|ParaPro|Director, Quality and Regulatory|317-810-6205|kerrym@parapro.com|
21256930|NCT02426476|Columbia VA Health Care System, Virginia Commonwealth University, University of South Carolina|James Burch, MS, PhD, Professor|803-404-1552|burch@mailbox.sc.edu|
21256931|NCT02064920|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21256932|NCT02109562|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
21256933|NCT03023930|Yale University|Dr. Gail D'Onofrio|(203) 785-7059|gail.donofrio@yale.edu|
21256934|NCT03598647|The Miriam Hospital|Jessica Unick, PD (Principal Investigator)|401-793-8966|junick@lifespan.org|
21256935|NCT00445224|University of Kentucky|Dr. Tim L. Uhl Principal Investigator|859-323-1100|tluhl2@uky.edu|80858
21256936|NCT03372928|US Army Research Institute of Environmental Medicine|Jess Gwin|508-206-2300|jessica.a.gwin.ctr@mail.mil|
21256937|NCT01463670|Memorial Sloan Kettering Cancer Center|Dr. Hani Hassoun MD|646-608-3718|hassounh@mskcc.org|
21256938|NCT03029715|Menoufia Univeristy|Dr Ezzeldin Ibrahim|0021006303178|ezzeldin7@yahoo.com|
21256939|NCT00520884|University of Pennsylvania, Department of Medicine, Division of Endocrinology, Diabetes and Metabolism|Anne Cappola, M.D., Sc.M.|215-573-5359|ACappola@mail.med.upen.edu|
21256940|NCT03650842|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-5817|Joseph.Tobias@nationwidechildrens.org|
21256941|NCT01973777|University of British Columbia|Dr Ellen Wiebe|6047095611|ellenwiebe@gmail.com|
21256942|NCT03887533|National Institute of Child Health and Human Development (NICHD)|Dr. Forbes Porter|301-435-4432|fdporter@mail.nih.gov|
21256943|NCT00176605|Rutgers Cancer Institute of New Jersey|Dr. Mark Stein|732-235-8675|steinmn@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
21237826|NCT01357616|Alcon Research, Ltd.|Mandy Ye, Head, Clinical Trial Management, Asia|1-888-451-3739|alcon.medinfo@alcon.com|
21256944|NCT02877693|Abbott|Grant Kim, Director Clinical Programs|818-493-3147|grant.kim1@abbott.com|
21256945|NCT01566773|Pearl Therapeutics Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
21256946|NCT01033734|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21256947|NCT04814342|UCSF Hypoxia Research Laboratory|Dr. Philip Bickler|1-415-476-1411|philip.bickler@ucsf.edu|
21256948|NCT01489670|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21256949|NCT00139776|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21256950|NCT00187096|St. Jude Children's Research Hospital|Jeffrey Rubnitz, MD|1-866-278-5833|info@stjude.org|
21256951|NCT00674583|GlaxoSmithKline|GSK Response Center|866-435-7343||
21256952|NCT04223843|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21256953|NCT00111800|GlaxoSmithKline|GSK Response Center|866-435-7343||
21256954|NCT02752035|Astellas Pharma Global Development, Inc.|Clinical Transparency|800-888-7704|astellas.resultsdisclosure@astellas.com|
21256955|NCT00357214|Tufts University|Bess Dawson-Hughes|617 556 3066|bess.dawson-hughes@tufts.edu|6175100519
21256956|NCT01687179|Brigham and Women's Hospital|Elizabeth P. Henske, MD|857-307-0782|ehenske@bwh.harvard.edu|
21256957|NCT00330876|Kowa Research Institute|Bill Arana|919 433 1600|barana@kowaus.com|
21256958|NCT03329911|Bio-Thera Solutions Ltd.|Yufeng Zhang|+86 2038251386|yfzhang@bio-thera.com|
21256959|NCT00971178|Department of Anaesthesiology, the University of Hong Kong|Clinical Assistant Professor|852-22553303|cheucw@hku.hk|
21300384|NCT00360230|GlaxoSmithKline|GSK Response Center|866-435-7343||
21300385|NCT02703597|University of Florida|Assistant Professor|3526279467|gkhalil@ufl.edu|
21300386|NCT03219723|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21300387|NCT02461758|University of Wisconsin School of Medicine and Public Health|FREDDY CALDERA, ASST PROFESSOR , GASTROENTEROLOGY|(608) 263-1995|fcaldera@medicine.wisc.edu|
21300388|NCT00929695|Fred Hutchinson Cancer Research Center|Marco Mielcarek|206-667-2827|mmielcar@fhcrc.org|
21300389|NCT01352715|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21300390|NCT02000440|GlaxoSmithKline|GSK Response Center|866-435-7343||
21300391|NCT02416206|The Blood and Marrow Transplant Group of Georgia|Dr. Scott Solomon|404-255-1930|ssolomon@bmtga.com|
21300392|NCT05179785|University of Pittsburgh|Mary Phillips|4123838206|fmristudies@upmc.edu|
21300393|NCT05966142|Duke University|Hrishikesh Chakraborty, PhD|919-668-1238|hrishikesh.chakraborty@duke.edu|
21300394|NCT04849364|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
21300395|NCT01643668|Massachusetts General Hospital|Yi-Bin Chen, MD|617-726-0187|YCHEN6@PARTNERS.ORG|
21300396|NCT00573508|Astellas Pharma Global Development|Astellas Medical Monitor||clinicaltrials@us.astellas.com|
21300397|NCT03253796|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21300398|NCT00528112|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21300399|NCT02559622|Novartis Pharmaceuticals|Study Director|862--778--8300||
21300400|NCT00894803|University of Cincinnati|Dr Arthur Pancioli|513-558-8087|arthur.pancioli@uc.edu|
21300401|NCT00449696|Seikagaku Corporation|Clinical Development Dept.|81-3-5220-8950|hiroyuki.hosokawa@seikagaku.co.jp|
21300402|NCT01808755|Divisione Urologia IRCCS Policlinico San Matteo Pavia, Italy|D. Porru|39-0382-503868/503872|danieleporru@tin.it|
21300403|NCT01033019|Novartis|Study Director|862-778-8300||
21300404|NCT03710187|University of Tennessee Medical Center|Pharm D, Pharmacist Specialist, Critical Care|865-305-9134|swinters@utmck.edu|
21300405|NCT01052493|Imperial College London|Dr Tricia Tan|020 83838038|t.tan@imperial.ac.uk|
21300406|NCT02105740|Universidade de Brasília|Gil Montenegro|556181487323|prof.gilmontenegro@gmail.com|
21256960|NCT02161575|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21256961|NCT00326209|Bausch Health Americas, Inc.|Director of Clinical Operations||lindsey.mathew@bauschhealth.com|
21256962|NCT00714285|GlaxoSmithKline|GSK Response Center|866-435-7343||
21256963|NCT01621633|Novartis Pharmaceuticals|Study Director|862-778-8300||
21256964|NCT01131676|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
21256965|NCT01111851|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21256966|NCT01961349|CO RI&A TA, R&D|Hideo Negi|+81 6 4803 3533|H.Negi@astrazeneca.com|4716
21256967|NCT00731055|New York State Psychiatric Institute|Dr. Adam Bisaga|646-774-6155|amb107@columbia.edu|
21256968|NCT05525689|Northwestern University|Dr. David Mohr|312-503-1403|d-mohr@northwestern.edu|
21256969|NCT01353196|VA Medical Center VA Maryland Health Care System, Baltimore, MD|Brajesh K. Lal, MD|410-605-7000|blal@som.umaryland.edu|
21256970|NCT01085786|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|886-7-3462121|pihsu@isca.vghks.gov.tw|8233
21256971|NCT00258011|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
21256972|NCT01921751|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21256973|NCT01075412|The University of Iowa|Sarah McGuire, PhD|214-645-7613|Sarah.McGuire@utsouthwestern.edu|
21256974|NCT00053703|UNC Chapel Hill|Linmarie Sikich, MD|919-972-9744|lsikich@med.unc.edu|
21256975|NCT03407651|Catalyst Biosciences|Howard Levy, Chief Medical Officer|+1.650.266.6871|hlevy@catbio.com|
21256976|NCT00351416|Massachusetts General Hospital|Janet Hall|617-877-1112|jehall@partners.org|
21256977|NCT01854645|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
21256978|NCT02774616|Biotronik SE & Co.KG|Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
21256979|NCT04261504|Arizona State University|Yi-Yuan Tang|4807903577|yiyuan@asu.edu|
21256980|NCT01817751|Virginia Commonwealth University Massey Cancer Center|Massey Cancer Center CTO Operations Managers|877-4627739|ctoclinops@vcu.edu|
21256981|NCT00555477|University of Michigan Comprehensive Cancer Center|Dr. Norah Lynn Henry|734-936-4991|norahh@umich.edu|
21256982|NCT00397033|Ortho McNeil Janssen Scientific Affairs, LLC|Vice President, Medical Affairs, CNS|609-730-2136||
21256983|NCT03519867|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21256984|NCT01846624|Stanford University Medical Center|David Joseph Iberri, MD; Clinical Assistant Professor (Hematology)|650-498-6000|diberri@stanford.edu|
21256985|NCT01721057|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21256986|NCT01202279|Reckitt Benckiser|Kim Clark|855.966.5483|ClinicalRequests@rb.com|
21256987|NCT03574753|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
21256988|NCT01177683|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
21256989|NCT00580372|University of Arkansas for Medical Science|Dr. Bart Barlogie|501-526-2873||
21256990|NCT00617539|University of California San Francisco|Michelle Melisko, MD|415-353-7070|Michelle.Melisko@ucsf.edu|
21256991|NCT02546765|Beth Israel Deaconess Medical Center|Dr. Balachundhar Subramaniam|6176320706|bsubrama@bidmc.harvard.edu|6176320706
21256992|NCT01977820|BioMarin Pharmaceutical Inc.|Medical Information Services|+1-800-983-4587|medinfo@bmrn.com|
21256993|NCT00698997|University California Davis|Dr. Sally Rogers|916-703-0264|sjrogers@ucdavis.edu|
21268205|NCT01135368|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21300407|NCT03431259|Massachusetts General Hospital|Marilyn Heng, Principal Investigator|6176430149|mheng@mgh.harvard.edu|
21256994|NCT00475722|University of Michigan|Dr. Zora Djuric|734-615-6210|zoralong@umich.edu|
21256995|NCT02568475|Florida Atlantic University|Ruth M. Tappen, Principal Investigator|561-297-2613|rtappen@health.fau.edu|
21300408|NCT03931941|Clinical Development|Clinical Development|651-705-8778|US8-Studyinfo@ferring.com|
21300409|NCT01318577|Bausch Health|Study Director|585-338-6399|robert.steffen@bausch.com|
21300410|NCT03944577|University of Nebraska Medical Center|Douglas Stoller|402-559-0815|douglas.stoller@unmc.edu|
21300411|NCT02968758|GenePOC|Dr Keith Chiasson, PhD|418-650-3535|keith.chiasson@genepoc.ca|322
21300412|NCT03011099|UT health PM&R|Chang, Shuo-Hsiu, PT, PhD|713-799-7016|Shuo-Hsiu.Chang@uth.tmc.edu|
21300413|NCT00129246|Associate Professor of Psychiatry and Program Director, Smoking Cessation Service at Smilow Cancer Hospital at Yale-New Haven|Benjamin A. Toll, PhD|(203) 974 5767|benjamin.toll@yale.edu|
21300414|NCT00283296|Human Engineering Research Laboratories|Rory Cooper, PhD|412-822-3700|rcooper@pitt.edu|
21300415|NCT03558737|University of Utah|Bradley Yoder|801-581-7052|bradley.yoder@hsc.utah.edu|
21300416|NCT01294553|GlaxoSmithKline|GSK Response Center|866-435-7343||
21300417|NCT01217229|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
21300418|NCT01032538|Martina Hansens Hospital|Tor Kjetil Nerhus|+47 93409934|kjnerhus@gmail.com|
21300419|NCT00453206|Wake Forest University Health Sciences|David Hurd, MD|336-716-2843|dhurd@wakehealth.edu|
21300420|NCT03058146|University of California, San Diego|Dr. Zvinka Zlatar|858-822-7737|zzlatar@health.ucsd.edu|
21300421|NCT00632229|University of South Florida|Dr. Eric Storch|727-767-8230|estorch@health.usf.edu|
21300422|NCT00577889|Mayo Clinic Cancer Center|Robert McWilliams, M.D.||McWilliams.robert@mayo.edu|
21300423|NCT03094325|NYU Langone Health|Daniel Swistel, MD|646-754-7217|Daniel.Swistel@nyulangone.org|
21300424|NCT03041181|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-643-5842|jsmith@hoosiercancer.org|41
21300425|NCT03536572|VA San Diego Healthcare System|Carl J. Stepnowky, Deputy ACOS R&D|858-642-3269|carl.stepnowsky@va.gov|
21300426|NCT01903460|Mirum|Study Physician|+1 650-667-4085|medinfo@mirumpharma.com|
21300427|NCT03104868|Northwestern University|Dr. Michael Wolf|312-503-5592|mswolf@northwestern.edu|
21300428|NCT00005780|National Cancer Institute|Dr. Christopher J. Melani|240-760-6057|christopher.melani@nih.gov|
21300429|NCT04973449|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
21300430|NCT00521079|EnteroMedics Inc|Senior Vice President of Clinical|651-634-3209|ktweden@enteromedics.com|
21300431|NCT00888173|NRG Oncology|Linda Gedeon For Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org|
21300432|NCT03542487|Office of Evaluation Sciences, General Services Administration|Mattie Toma|859-621-0517|mattie.toma@gsa.gov|
21300433|NCT01539824|Immodulon Therapeutics Ltd|Chief Medical Officer|+44 (0)20 3137 6346|info@immodulon.com|
21300434|NCT04408989|mabxience Research SL|Susana Millan|+3491771500|susana.millan@mabxience.com|
21300435|NCT02628873|Wright State University|Steven Lindheim|858-740-1083|doclalalindheim@gmail.com|
21300436|NCT04672239|Recovery Research Institute, Department of Psychiatry, Massachusetts General Hospital|Bettina B. Hoeppner, Ph.D., MS|617-643-1988|bhoeppner@mgh.harvard.edu|
21300437|NCT02560038|The University of Texas Health Science Center at Houston|Marka Lyons, Research Manager|713-500-6919|Marka.Lyons@uth.tmc.edu|
21300438|NCT03597347|Savara Inc|Raymond D Pratt, Chief Medical Officer|+1 512 784 8757|ray.pratt@savarapharma.com|
21300439|NCT04606134|University of Rochester Medical Center|Mara Weinstein MD|(585) 275-7546|Mara_Weinsteinvelez@URMC.Rochester.edu|
21300440|NCT00107653|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21300441|NCT00541658|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
21300442|NCT01099267|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21300443|NCT04986904|University of Virginia|Dr. Kelly Shaffer|434-982-1022|kshaffer@virginia.edu|
21300444|NCT04080505|Columbia University|Jennifer Kuo, MD|212-305-6969|jhk2029@cumc.columbia.edu|
21300445|NCT03108131|The University of Texas MD Anderson Cancer Center|Dr. Kanwal Raghav|(917) 733-0356|kpraghav@mdanderson.org|
21300446|NCT02920632|Amsterdam UMC, Vrije Universiteit|Dr. Chris Vriend|+31625694912|c.vriend@amsterdamumc.nl|
21300447|NCT00498940|Columbia University Medical Center|Santos Cabreriza/ Associate Scientist|212-305-9515|sc45@cumc.columbia.edu|
21300448|NCT02023086|Université de Montréal|Langis Michaud|5149166312|langis.michaud@umontreal.ca|
21300449|NCT04760613|NYU Langone health|Stephen Ross, MD|212-263-6289|Stephen.ross@nyulangone.org|
21300450|NCT01083771|Brown University Oncology Research Group (BrUOG)|Anthony Mega, MD|4018633000|kayla_rosati@brown.edu|
21300451|NCT04082819|SE Health|SE Research Centre|N/A|research@sehc.com|
21300452|NCT01181349|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21300453|NCT01533207|NRG Oncology|Linda Gedeon on behalf of Danielle Enserro, PhD|716-845-1169|linda.gedeon@roswellpark.org|
21300454|NCT00124943|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21300455|NCT00321620|Amgen Inc.|Study Director|866-572-6436||
21300456|NCT03181932|Savara Inc|Raymond D Pratt, Chief Medical Officer|+1 512 784 8757|ray.pratt@savarapharma.com|
21300457|NCT01887327|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|ClinicalTrials@mnk.com|5
21300458|NCT00874094|NY Eye & Ear Infirmary|Anthony P Sclafani, MD|212-979-4200|asclafani@nyee.edu|
21300459|NCT00408317|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
21300460|NCT01747876|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21300461|NCT00853307|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21256996|NCT02625233|Johson & Johnson Vision Care Inc.|Kristy Canavan, O.D., FAAO Principal Research Optometrist|904 443-1474|KCANAVA2@its.jnj.com|
21256997|NCT04425720|Montefiore Medical Center|Dr. Jonathan Leff|7189204316|jleff@montefiore.org|
21256998|NCT00290186|Dayton Children's Hospital|Daniel J. Lacey, MD, PhD|937-641-3080|LaceyD@childrensdayton.org|
21256999|NCT01675635|Mundipharma (China) pharmaceutical Co, LTD.|Ms. Dan Zhu, Clinical operation and quality lead of the study|0086-10-65636800|medical.mcpc@mundipharma.com.cn|
21257000|NCT00262522|Abbott|Global Medical Services|800-633-9110||
21257001|NCT04272892|University of Oxford|Dr Melanie Fleming|+441865611461|melanie.fleming@ndcn.ox.ac.uk|
21257002|NCT06557122|Encoll Corp|Dr. Subramanian Gunasekaran, PhD|+1 (510) 396-8581|guna@encoll.com|
21257003|NCT02454140|University of California, San Diego|Dr. James D. Murphy|(858) 822-6040|j2murphy@health.ucsd.edu|
21257004|NCT05359679|Kaiser Permanente Washington|Lorella Palazzo PhD|206-287-2900|lorella.g.palazzo@kp.org|
21257005|NCT05314517|Kinevant|Study Director|(+1) 646-494-6491|kinevant.resolve-lung@kinevant.com|
21257006|NCT04714073|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21257007|NCT01777412|Johns Hopkins University|Michael Levy|443-287-4412|mlevy@jhmi.edu|
21257008|NCT02710136|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21257009|NCT02269787|Department of Veterans Affairs|Dr. Christine Timko, Research Career Scientist|6504935000|Christine.Timko@va.gov|23336
21257010|NCT00798135|IndianaU|Kathy Miller, MD||kathmill@iupui.edu|
21257011|NCT03337542|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
21257012|NCT01401842|University of South Florida|John M. Mayer, DC, PhD / Study Director|813-974-3818|jmayer2@health.usf.edu|
21257013|NCT00282295|GlaxoSmithKline|GSK Response Center|866-435-7343||
21257014|NCT00430482|Boston University Charles River Campus|Michael W. Otto, Ph.D.|(617)353-9610|mwotto@bu.edu|
21257015|NCT03996980|Universidad de Sevilla|Dr. Manuel Pabón-Carrasco|954 350 997|mpabon2@us.es|+34
21257016|NCT04890314|Weill Cornell Medicine|Dr. Jim C. Hu|(646) 962-6363|jch9011@med.cornell.edu|
21257017|NCT03116997|Memorial Sloan Kettering Cancer Center|Dr. German Echeverry, MD|212-639-8865|echeverg@mskcc.org|
21257018|NCT00574145|Vanderbilt-Ingram Cancer Center|Nancy Wells, DNSc., R.N|615-322-6184|nancy.wells@vanderbilt.edu|
21257019|NCT03227471|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21257020|NCT03427047|Medacta USA|Rena Mandino, Director, Clinical Research|352-359-3581|rmandino@medacta.us.com|
21257021|NCT00766038|University of Pennsylvania|Ramon Diaz-Arrastia|215-662-9732|Ramon.Diaz-Arrastia@uphs.upenn.edu|
21257022|NCT00449670|GlaxoSmithKline|GSK Response Center|866-435-7343||
21257023|NCT03743311|AO Servier|Olga Linnik|+7 495 9370700|olga.linnik@servier.com|
21257024|NCT00847145|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21257025|NCT02833974|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21257026|NCT04467424|University Hospital of Split|Dr. Ana Nevescanin Biliskov, pediatric anesthesiologist|00385912508001|anevescanin@gmail.com|
21257027|NCT01114503|GlaxoSmithKline|GSK Response Center|866-435-7343||
21257028|NCT00833053|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||clinicaltrialsdisclosure@merck.com|
21257029|NCT02187471|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|1-908-992-6400|CTRinfo@DSI.com|
21257030|NCT02318667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21257031|NCT02289742|Alcon Research, Ltd.|Global Medical Affairs, Brand Lead - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21257032|NCT02865018|Icahn School of Medicine at Mount Sinai, Corrine Goldsmith Dickinson Center for MS|Ilana Katz Sand|212-241-6854|ilana.katzsand@mssm.edu|
21257033|NCT01365039|Bausch & Lomb Incorporated|Robert Steffen, OD, MS|(585) 338-6399|robert.steffen@bausch.com|
21257034|NCT00867789|Children's Mercy Hospital|Dr. Joan Giovanni|8162343430|gegiovanni@cmh.edu|
21257035|NCT00294060|Medtronic CRDM|P3 Study Team|800-328-2518|medtroniccrmtrials@medtronic.com|
21257036|NCT01360554|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21257037|NCT03668600|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
21257038|NCT01925573|University of Maryland Medical Center|Caitlin Eggleston|4103287586|caitlineggleston@umm.edu|
21257039|NCT00424749|Mayo Clinic|Dr. Fernando C. Fervenza||fervenza.fernando@mayo.edu|
21300462|NCT02135432|University of Alabama at Birmingham|Steven M. Rowe|205-975-6385|smrowe@uab.edu|
21300463|NCT03163303|University of California, San Francisco|Dr. Derek Satre|(415) 476-7382|derek.satre@ucsf.edu|
21300464|NCT02177123|InnFocus, Inc.|Sharon Herbert, Associate Director of Clinical Operations|(415) 268-9059|sharon.herbert@santen.com|
21300465|NCT01391546|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21300466|NCT03961672|City of Hope Medical Center|Dr. Alexey Danilov, MD|626-359-8111|adanilov@coh.org|
21300467|NCT02988466|University of Minnesota, Masonic Cancer Center|Mark Juckett, MD|(612) 626-5654|juck0001@umn.edu|
21300468|NCT01921205|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21300469|NCT02584686|Department of Andrlolgy, Sexology & STDs, Cairo University|Prof. Dr. Hussein Ghanem, Chairman of Andrology Department|00201001176111|hmhghanem@gmail.com|
21300470|NCT01122238|UWisconsin|Stevens Smith|608-262-7563|sss@ctri.medicine.wisc.edu|
21300471|NCT02121158|VA Cooperative Studies Program Coordinating Center, West Haven, CT|Michael T. Wininger, Ph.D., Study Biostatistician|203-932-5711|michael.wininger@va.gov|3262
21300472|NCT04843007|NanoAlvand|Dr. Hamidreza kafi|9129232594|Kafi.h@orchidpharmed.com|+98
21300473|NCT03125395|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21300474|NCT02531802|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
21300475|NCT01028820|The University of North Carolina at Chapel Hill|Linmarie Sikich, M.D.|(919) 972-7499|lsikich@med.unc.edu|
21300476|NCT04030143|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21300477|NCT00871975|LABORIE|Clinical Research Administrator|905 612 1170|acampbell@laborie.com|2274
21300478|NCT05131308|Kansas City Heart Rhythm Institute|Dhanunjaya Lakkireddy|913-449-1297|dhanunjaya.lakkireddy@hcahealthcare.com|
21300479|NCT01436149|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21300480|NCT01690143|University of Alabama at Birmingham|Luciano J Costa, Principal Investigator|205-209-6038|ljcosta@uabmc.edu|
21268206|NCT01348828|Endologix|Sripad Bellary, Director Clinical Affairs|9257011628|sbellary@endologix.com|
21268207|NCT02442284|AbbVie|Global Medical Services|800-633-9110||
21268208|NCT01610752|Pennington Biomedical Research Center|Dr. Leanne M. Redman|2257630947|leanne.redman@pbrc.edu|
21268209|NCT00283062|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
21268210|NCT01482598|Abbott|Alessandra Denaro, Sr. Director Clinical Site Management||alessandra.denaro@abbott.com|
21268211|NCT02694562|Boston Scientific|Angela Schutt|763-494-2166|angela.schutt@bsci.com|
21268212|NCT00827112|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21268213|NCT03088345|Medical College of Wisconsin/Children's Hospital of Wisconsin|Dr. Amee Bigelow|5136364200|amee.bigelow@cchmc.org|
21268214|NCT01521494|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
21268215|NCT00877929|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21268216|NCT01140646|Mayo Clinic|Dr. Amit Sood|507-284-1623|sood.amit@mayo.edu|
21268217|NCT03006276|BioDelivery Sciences|Todd Kunkel, PharmD Director, Scientific Communications|913-940-1789|tkunkel@bdsi.com|
21268218|NCT00689728|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21268219|NCT03245372|Hospital Universitario Virgen del Rocío, Servicio Andaluz de Salud|Dr. Alejandro Domínguez-Blanco|0034660762856|aledguez@gmail.com|
21268220|NCT02155725|LFB Biomédicaments|Medical Director France|33 169827229|zitounis@lfb.fr|
21268221|NCT00842829|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21268222|NCT04047342|Geisinger Clinic|Amir Goren|5702144395|agoren@geisinger.edu|
21268223|NCT01861587|Medical University of South Carolina|Jeffrey Borckardt, Ph.D|843-792-3295|borckard@musc.edu|
21268224|NCT03815006|Manchester University NHS Foundation Trust|Dr Lala Leelarathna|01612766706|lalantha.leelarathna@manchester.ac.uk|
21268225|NCT02612194|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
21268226|NCT02539160|University of Florida College of Medicine Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3378|dominick.angiolillo@jax.ufl.edu|
21268227|NCT01681004|SI-BONE, Inc.|Daniel Cher, Vice President of Clinical Affairs|408-207-0700|dcher@si-bone.com|
21268228|NCT00372905|Northwestern University|Jane Winter, MD|312 695 4033|Jwinter@nm.org|
21268229|NCT01728454|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21268230|NCT00387621|Mayo Clinic|Dr Horng Chen|507-284-4343|chen.horng@mayo.edu|
21268231|NCT00689299|Greer Laboratories, Inc. for Antigen Laboratories, Inc.|Mark Hites|828-759-7548|mhites@greerlabs.com|
21268232|NCT01190839|Janssen Pharmaceuticals|Strategic Lead Gastroenterology||ClinicalTrialDisclosure@its.jnj.com|
21268233|NCT02218424|Ann & Robert H. Lurie Children's Hospital of Chicago|Hubert Benzon, MD; Primary Investigator|312-227-5122|hbenzon@luriechildrens.org|
21268234|NCT02980211|University of Iowa College of Dentistry|Dr. Gustavo Avila-Ortiz, Professor and Chair, Department of Periodontics|3193357241|gustavo-avila@uiowa.edu|
21268235|NCT01832753|The Children's Hospital of Philadelphia|Andrea Kelly, MD MSCE|215-590-3174|kellya@email.chop.edu|43174
21268236|NCT00765726|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21268237|NCT02058966|Veterans Affairs Portland Healthcare System|Dr. William Hoffman|503-220-8262|hoffmanw@ohsu.edu|56491
21268238|NCT02993731|Sumitomo Dainippon Pharma Oncology|Cindy Oh|617-674-8628|coh@bostonbiomedical.com|
21268239|NCT01265511|Scynexis|Katyna Borroto-Esoda|9192374431|katyna.borroto-esoda@scynexis.com|
21268240|NCT01362062|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21268241|NCT01272245|UT MD Anderson Cancer Center|Kantarjian,Hagop M|713-792-7026|CR_Study_Registration@mdanderson.org|
21268242|NCT02545504|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21268243|NCT01148836|Cleveland Clinic|Jacqueline Sharp, CNP|216-636-0000|pylej@ccf.org|
21268244|NCT00758394|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
21268245|NCT01197495|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
21268246|NCT01922336|Samsung Bioepis Co., Ltd.|Director of Clinical Trials|+82 31 8061 4534|sbregistry@samsung.com|
21268247|NCT00950755|GlaxoSmithKline|GSK Response Center|866-435-7343||
21268248|NCT00508820|Amgen Inc.|Study Director|866-572-6436||
21268249|NCT03539900|Yale University|Dr Carlos Grilo|203 785 7210|carlos.grilo@yale.edu|
21268250|NCT01002573|Cumberland Pharmaceuticals Inc.|Senior Manager, Clinical Operations|615-255-0068|bkaelin@cumberlandpharma.com|
21268251|NCT00690612|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21268252|NCT02926833|Kite, A Gilead Company|Medical Information|844-454-5483(1-844-454-KITE)|medinfo@kitepharma.com|
21268253|NCT01945866|Jaeb Center for Health Research|Adam Glassman|8139758690|drcrnet@jaeb.org|
21268254|NCT01716221|University of Colorado|Dr. Olga Klepitskaya|303-724-8984|olga.klepitskaya@ucdenver.edu|
21268255|NCT00957827|University of Pennsylvania|Eric Granquist|215 880-7568|eric.granquist@uphs.upenn.edu|
21268256|NCT02930889|University of Minnesota|Jafar Golzarian, MD|612-626-5566|jafar@umn.edu|
21268257|NCT04398030|Capillary BioMedical, Inc.|Alayne Lehman Director of Clinical Affairs|949-317-1711|alayne.lehman@capillarybio.com|
21268258|NCT01206296|MedStar Health Research Institute|Director of Clinical Trials|301-560-7300|Research@MedStar.Net|
21300481|NCT04757766|Servier|olga linnik|8-495-93707-00|olga.linnik@servier.com|
21268259|NCT01520038|University of Pennsylvania|John Christodouleas, MD|215-662-6568|christojo@uphs.upenn.edu|
21300482|NCT04771455|Northwestern University|Dr. Andrea Graham|312-503-5266|andrea.graham@northwestern.edu|
21300483|NCT04006288|University of Florida|Dr. Dominick J Angiolillo. Professor of med University of Florida College of Medicine-Jacksonville|904-244-3378|dominick.angiolillo@jax.ufl.edu|
21300484|NCT01710345|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
21300485|NCT01766440|Galderma|Michael Graeber|(817)961-5000|michael.graeber@galderma.com|
21285515|NCT01465230|Yale University|Dr. Terri Parker|203-737-5312|terri.parker@yale.edu|
21285516|NCT02014519|GlaxoSmithKline|GSK Response Center|866-435-7343||
21285517|NCT02542397|Atrium Health/Levine Cancer Institute, Department of Cancer Biostatistics|Danielle M Boselli|12017903385|Danielle.Boselli@AtriumHealth.org|
21285518|NCT00389467|Georgetown University|Chelsea S. Kidwell, MD|202-687-7302|ck256@georgetown.edu|
21285519|NCT01738919|Aarhus University Hospital|Janni Kjaergaard Thillemann|+45 28137303|teamjanni@gmail.com|
21285520|NCT00547248|GlaxoSmithKline|GSK Response Center|866-435-7343||
21285521|NCT02020369|LFB USA Inc.|Jeffry Lawrence, MD, Vice President, Clinical Development|+1.508.370.5113|jeffry.lawrence@lfb-usa.com|
21285522|NCT02090283|Amicus Therapeutics, Inc.|Patient Advocacy|+1-609-662-2000|clinicaltrials@amicusrx.com|
21285523|NCT04727736|UPMC Hillman Cancer Center|Barbara M Stadterman, Clinical Research Manager - Regulatory|412-647-5554|stadtermanbm@upmc.edu|
21285524|NCT00697593|Merck Serono S.A., a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21285525|NCT00685360|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21285526|NCT01504672|Umeå University|Dr. Maria Gustafsson|0046703978717|maria.gustafsson@umu.se|
21285527|NCT01408901|Northwestern University|Mary McDermott MD|312-503-6419|mdm608@northwestern.edu|
21285528|NCT00074815|Duke University School of Medicine|Jeffrey Sapyta, PhD|919-668-0069|jeffrey.sapyta@duke.edu|
21285529|NCT01309451|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com|
21285530|NCT00889915|Duke Clinical Research Institute - Duke University School of Medicine|John S. March, MD, MPH|919-668-7818|john.march@duke.edu|
21285531|NCT00547157|Amgen Inc.|Study Director|866-572-6436||
21285532|NCT00090870|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
21285533|NCT03021317|University of Chicago|Sr. Compliance Specialist|773-702-6505|czwieg@bsd.uchicago.edu|
21285534|NCT01151345|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21285535|NCT01765569|Organization: Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21285536|NCT01030718|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21285537|NCT00423813|Jazz Pharmaceuticals, Inc.|Grace Wang, MD, Medical Monitor & Director of Clinical Development|650-496-3777||
21285538|NCT01904032|Loyola University Chicago|Sue Penckofer, Ph.D., F.A.A.N.|773-508-8949|spencko@luc.edu|
21285539|NCT01961167|W. L. Gore & Associates|Melissa Zambeck|928-856-4900|mzambeck@wlgore.com|
21285540|NCT02383355|Radboudumc|Wouter van der Heijden|0031 24 3616980|wouter.vanderheijden@radboudumc.nl|
21285541|NCT02446847|The Rockefeller University|Dr. Marina Caskey, Associate Professor of Clinical Investigation|212-327-7396|mcaskey@rockefeller.edu|
21285542|NCT02984644|University of Texas Health Science Center at San Antonio|Dr. Eugenio Cersosimo|210-358-7200|cersosimo@uthscsa.edu|
21285543|NCT03790865|Millendo Therapeutics|Clinical Trial Information|+1 734-845-9000|millendo@millendo.com|
21285544|NCT00502853|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21285545|NCT02308371|University of North Carolina|Dr. Melissa Hines|901-652-6138|mhinesthomas@gmail.com|
21285546|NCT01446250|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
21285547|NCT00980655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21285548|NCT04162795|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
21285549|NCT03939533|CRMG|Patrick Murphy|413-821-0022|p.murphy@crmg-usa.com|
21285550|NCT02029274|Novartis Pharmaceuticals|Study Director|862-778-8300||
21285551|NCT00357890|Nemours Children's Health|Larry A Fox, MD|9046973600|larry.fox@nemours.org|
21285552|NCT00845676|San Francisco General Hospital/UCSF|Brad Hare, MD|415-476-4082|chare@php.ucsf.edu|556
21285553|NCT03597139|Aurinia Pharmaceuticals|Mary Palmen|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
21285554|NCT05052697|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21285555|NCT03275389|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21285556|NCT02427802|Innocoll|Lesley Russell, MBChB, MRCP, Chief Medical Officer|484-406-5206|lrussell@innocoll.com|
21285557|NCT02634983|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21285558|NCT00467558|University of Minnesota|Jon E. Grant, MD|612-273-9736|grant045@umn.edu|
21237827|NCT01478009|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Chang-Seop Lee|82-63-276-8284|lcsmd@jbnu.ac.kr|
21237828|NCT02298361|OCHIN, Inc.|Jennifer E. DeVoe, MD, DPhil|503-943-2618|devoej@ohsu.edu|
21237829|NCT01798394|University of Minnesota|Nicole Tosun|612-624-5439|tosun004@umn.edu|
21285559|NCT04679948|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21268260|NCT02641691|Washington University School of Medicine|Hyun Kim, M.D.|314-362-8502|kim.hyun@wustl.edu|
21268261|NCT03503565|KYUNG HEE UNIVERSITY HOSPITAL AT GANGDONG|Dr Hyungseok Seo|+821029306885|seohyungseok@gmail.com|
21268262|NCT03799198|Novo Nordisk A/S|Clinical Transparency and Medical Writing Office (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21268263|NCT03427931|University of Virginia|Sue Brown, MD|4349820602|sab2f@virginia.edu|
21268264|NCT02501642|James A. Haley VA|Tracy Kretzmer, Ph.D.|813-972-2000|tracy.kretzmer@va.gov|5729
21268265|NCT03724305|Henry Ford Health|Chaewon Sagong|2483442409|csagong1@hfhs.org|
21268266|NCT05959564|University of Maryland, College Park|Xiaoli Nan|301-405-0640|nan@umd.edu|
21268267|NCT00548340|Vanda Pharmaceuticals Inc.|Marlene Dressman, Ph.D.|202-734-3462|marlene.dressman@vandapharma.com|
21268268|NCT03410693|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21268269|NCT01789476|Cara Therapeutics, Inc.|Frédérique Menzaghi, PhD, Vice President Research & Development|(203) 567-1502|fmenzaghi@caratherapeutics.com|
21268270|NCT00953576|Beth Israel Deaconess Medical Center|Glenn Bubley, MD||gbubley@bidmc.harvard.edu|
21285560|NCT05188729|Verrica Pharmaceuticals|Susan Cutler, VP Medical Affairs|484-773-089|scutler@verrica.com|
21285561|NCT03646487|University of Illinois Chicago|Mary Dawn Koenig, PhD, RN, FACNM|312-996-7982|marydh@uic.edu|
21285562|NCT01732445|Mayo Clinic|Ruben A. Mesa, M.D.|480/301-8335|mesa.ruben@mayo.edu|
21268271|NCT03778021|University of Washington, Department of Epidemiology|Shirley A.A. Beresford, Principal Investigator|206 543 9512|beresfrd@uw.edu|
21268272|NCT00679042|CellTrans Inc.|Jennifer Cook|312-413-7727|jenny@celltransinc.com|
21268273|NCT03053102|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
21268274|NCT01798056|GlaxoSmithKline|GSK Response Center|866-435-7343||
21268275|NCT01269346|Eisai Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
21268276|NCT02145949|University of Oregon|Dr. Hans Dreyer|541-346-3902|hcdreyer@uoregon.edu|
21268277|NCT00460421|Swedish Orphan Biovitrum|Medical Program Director|+46 8 697 20 00|clinical@sobi.com|
21268278|NCT04542304|Stanford University|Tammy Lisa Sirich, MD|650-849-1907|tsirich@stanford.edu|
21268279|NCT04963231|Rhythm Clinical Trials|Rhythm Pharmaceuticals, Inc.|857-264-4280|clinicaltrials@rhythmtx.com|
21268280|NCT02928900|University of Washington|Pamela Kohler|206.221.5746|pkohler2@uw.edu|
21268281|NCT01059175|Medtronic|Latifa Foudali|+33 631992144|latifa.foudali@medtronic.com|
21268282|NCT02957149|Mayo Clinic|Matthew Gettman, MD|507-284-3249|Gettman.Matthew@mayo.edu|
21268283|NCT06045026|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
21268284|NCT00148109|University of Michigan Comprehensive Cancer Center|Dr. Rashmi Chugh|(734) 936-5710|rashmim@umich.edu|
21268285|NCT02547064|Keimyung university|Hyun-Chang Kim|+821028862876|onidori1979@gmail.com|
21268286|NCT02557308|Celltrion Inc|JiWoong Lim|82-32-850-5702|jiwoong.lim@celltrion.com|
21268287|NCT03911401|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21268288|NCT00538434|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000||
21268289|NCT04337827|Cleveland Clinic Foundation, Case Comprehensive Cancer Center|Dr. Deepa Jagadeesh|1-866-223-8100|TaussigResearch@ccf.org|
21268290|NCT00351611|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21268291|NCT03417245|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21268292|NCT01589185|Aridis Pharmaceuticals, Inc.|Lynne Deans, M.T.|408-385-1742|deansl@aridispharma.com|
21268293|NCT02046993|Kwong Wah Hospital|Dr Lorna Ng|(852) 23322311|ngl@ha.org.hk|
21268294|NCT04491955|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|hoyoung.maeng@nih.gov|
21268295|NCT00886626|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
21268296|NCT02708524|Johnson & Johnson Vision Care Inc.|Kristy Canavan, O.D. PRINCIPAL RESEARCH OPTOMETRIST|904-443-1474|KCANAVA2@its.jnj.com|
21285563|NCT02362191|University of North Carolina at Chapel Hill|David Rubinow, MD|919-445-0220|drubinow@med.unc.edu|
21268297|NCT00457951|Chimerix|Zahra Masoud|763-300-0559|zmasoud@chimerix.com|
21268298|NCT03781167|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21268299|NCT00638820|Masonic Cancer Center, University of Minnesota|Paul Orchard, M.D.|612-626-2313|orcha001@umn.edu|
21268300|NCT04435431|Integrative Research Laboratories Sweden AB|Joakim Tedroff, Chief Medical Officer|+46707601691|joakim.tedroff@irlab.se|
21268301|NCT00679354|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21268302|NCT00267202|Novartis Pharmaceuticals|Clinical Director|862-778-1768|maria.figliomeni@novartis.com|
21268303|NCT03831282|Masimo|Vikram Ramakanth|949-297-7416|clinicalresearchdept@masimo.com|
21268304|NCT00334893|Memorial Sloan-Kettering Cancer Center|Dr. Martee L. Hensley|646-888-4222|hensleym@mskcc.org|
21268305|NCT00920582|Provention Bio, Inc.|Sharon Rowland|443-987-0797|SRowland@proventionbio.com|
21268306|NCT03360695|Massachusetts General Hospital|Kelly Irwin, MD, MPH|617-643-4453|kirwin1@partners.org|
21268307|NCT01552408|Retina Consultants of Houston|David M. Brown, MD|713-524-3434|dmbmd@houstonretina.com|
21268308|NCT02208466|Spaulding Rehabilitation Hospital|Dr. Felipe Fregni|6179526158|fregni.felipe@mgh.harvard.edu|
21268309|NCT01365468|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21268310|NCT01526343|Washington University School of Medicine|Jennifer Bell, Manager of Clinical Trials|314-747-6969|jennifer.bell@wustl.edu|
21268311|NCT00617994|Incyte|Incyte Corporation Call Center (US)|1.855.463.3463|medinfo@incyte.com|
21268312|NCT01018680|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21268313|NCT05056311|Indiana University|Elaine Cuevas|317-278-7495|elinder@iu.edu|
21268314|NCT00960869|POZEN|John Fort, MD / Chief Medical Officer|919-913-1030|jfort@pozen.com|
21268315|NCT01358266|Santen Inc.|Clinical Operations|+1-415-268-9100|clinicaltrials@santen.com|
21268316|NCT01710007|Orient Europharma Co., Ltd.|Vivian Lu|+886-2-2755-4881|Vivian.Lu@oppharma.com|2958
21268317|NCT01153971|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21268318|NCT03814824|Northwell Health|Dr. Arvind Trindade|516-387-3990|atrindade@northwell.edu|
21268319|NCT00835861|Maternal-Fetal Medicine and Obstetrics at UT Southwestern|M. Ashley Hickman Zink|469-303-3591|m.ashley.hickman@gmail.com|
21268320|NCT01700907|Sapporo Medical University School of Medicine|Michiaki Yamakage|+81116112111|yamakage@sapmed.ac.jp|3568
21268321|NCT01778296|The Second Hospital of Tangshan|Dr. Chao Chen|86-13700350471|ts_chenchao@163.com|
21268322|NCT03472586|Thomas Jefferson University|Marlana Orloff, MD|215-955-9974|marlana.orloff@jefferson.edu|
21268323|NCT01342445|University of Rhode Island|Dr. Lisa Weyandt|(401)874-2087|lisaweyandt@uri.edu|
21268324|NCT02652793|Hospital Clinic of Barcelona|Dr. José Luis Blanco|+34 932275400|jlblanco@clinic.cat|
21268325|NCT04511533|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21300486|NCT01502293|OncoSec Medical Incorporated|Kellie Malloy, Chief Clinical Development Officer|858-375-9989|kmalloy@oncosec.com|
21300487|NCT00307801|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21300488|NCT02596867|TTUHSC-EP|Zeina Nahleh|9152155195|zeina.nahleh@ttuhsc.edu|
21300489|NCT00391586|Dana Farber Cancer Institute|Dennie Jones, MD|617-632-6478|DennieV_Jones@DFCI.HARVARD.EDU|
21300490|NCT00198822|Center for Human Nutrition, Department of International Health, Johns Hopkins Bloomberg School of Public Health|Prof. Keith P West, Jr., Principal Investigator|410-955-2061|kwest@jhsph.edu|
21300491|NCT01409707|University of Mississippi Medical Center|Dr. Scott Coffey|601-815-5588|scoffey@umc.edu|
21300492|NCT02784548|VA San Diego Healthcare System|Dr. Thomas Rutledge|8585528585|thomas.rutledge@va.gov|7273
21300493|NCT02323217|Imperial College London|Dr Robin J Tyacke|(0)20 7594 7096|r.tyacke@imperial.ac.uk|+44
21300494|NCT03224819|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21300495|NCT02059278|Point Guard Partners LLC|Jeremy Brace|727-458-2823|jbrace@pointguardllc.com|
21300496|NCT00737672|W.L. Gore and Associates, Inc.|Clinical Project Manager|928-864-3771|cavery@wlgore.com|
21300497|NCT02735863|ABIVAX|Sharon Skare|+33153830961|sharon.skare@abivax.com|
21300498|NCT00829426|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21300499|NCT03955146|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|zephyrus@fibrogen.com|
21300500|NCT04798183|Pusan National University Yangsan Hospital|Sungchul huh, M.D., Ph.D.||dr.huhsc@gmail.com|0553604250
21300501|NCT00311766|RegeneRx Biopharmaceuticals, Inc.|Study Director, David R. Crockford|617-285-5588|dcrockford@regenerx.com|
21300502|NCT02002598|Columbia University|Suzanne Lentzsch, MD|646-317-4840|sl3440@cumc.columbia.edu|
21300503|NCT00537134|Centre Hospitalier de l'Université de Montréal (CHUM)|Ruby Klink|(514) 890-8000|ruby.klink.chum@ssss.gouv.qc.ca|27235
21300504|NCT02961894|Rex Medical|Colin Valentis|610-629-6051|cvalentis@rexmedical.com|
21300505|NCT03373240|Yale University|Dr. Arielle Baskin-Sommers|203-432-9257|arielle.baskin-sommers@yale.edu|
21300506|NCT02867436|Motol University Hospital|Zdeněk Šumník, PI|+420702000087|zdenek.sumnik@lfmotol.cuni.cz|
21300507|NCT01551186|Washington University School of Medicine, St. Louis, Missouri|Dr. Erik Dubberke, MD, MSPH|314-454-8354|edubberk@wustl.edu|
21300508|NCT04123470|Lokon Pharma|Angelica Loskog CEO|+46 18-50 74 44|angelica.loskog@lokonpharma.com|
21300509|NCT04029883|Cedars-Sinai Medical Center|Dr. Joseph Ebinger|424-315-2284|cda-research@cshs.org|
21300510|NCT02018562|Johns Hopkins University|Vinciya Pandian PhD, MSN, RN, ACNP-BC, FAAN|4436553482|vpandia1@jhu.edu|
21300511|NCT04876521|All India Institute of Medical Sciences|Dr. Biswa Ranjan Mishra|09438884220|psych_biswa@aiimsbhubaneswar.edu.in|
21300512|NCT05408429|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21268326|NCT01928758|Penn State College of Medicine|Jonathan Foulds|717-531-3504|jfoulds@psu.edu|
21300513|NCT03435211|Masimo|Chelsea Frank|(949) 297-7000|studies@masimo.com|
21300514|NCT01253291|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21268327|NCT02718131|University of Alabama at Birmingham|Karen Cole-Plourde|205-934-5140|kplourde@uab.edu|
21268328|NCT03198559|University of Melbourne|Professor Sharon Lewin|+61 (0)3 8344 3309|sharon.lewin@unimelb.edu.au|
21268329|NCT03693846|University of Pennsylvania|Thomas Karasic, MD|215-614-1858|thomas.karasic@pennmedicine.upenn.edu|
21268330|NCT01100931|National Cancer Institute, National Institutes of Health|Dr. Giuseppe Giaccone|301-496-4916|giacconeg@mail.nih.gov|
21268331|NCT01474291|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21268332|NCT03471507|Duke University Medical Center|Lance Roy, M.D.|919-684-8111|lance.roy@duke.edu|
21268333|NCT02103608|Tennesse clinical research center|Dr. Michael Gold|615-383-2400|drgold@goldskincare.com|
21268334|NCT01388946|Aretaieo Hospital University of Athens|Argyro Fassoulaki|+30 6936701333|fassoula@aretaieio.uoa.gr|
21268335|NCT00598442|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
21268336|NCT05375942|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21268337|NCT04620356|kimberlyClark|Clinical Science Manager|+55 11 45034500|debora.rodrigues@kcc.com|
21268338|NCT02951143|University of Kentucky|Mikhail Koffarnus|8593236402|koffarnus@uky.edu|
21268339|NCT01590628|Gamida Cell|Kelly Myers, CRA|026595631|kelly@gamida-cell.com|
21268340|NCT00475657|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21268341|NCT00731640|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21268342|NCT04899362|the First Hospital of Jilin University|Dr Yi Yang|0431|doctoryangyi@163.com|88782378
21268343|NCT03554798|FIDEC Corporation|Ricardo Rüttimann, PhD|+5491161188536|rruttimann@fidec-online.org|
21268344|NCT03866811|Columbia University|Dr. Lauren Chernick|2123056628|lc2243@columbia.edu|
21285564|NCT00947310|University of Rochester, Heart Research Follow-up Program|Dr. Arthur J. Moss|585-275-5391|arthur.moss@heart.rochester.edu|
21285565|NCT02171429|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21285566|NCT00320242|Beth Israel Deaconess Medical Center and Harvard Medical School|Dr. David K. Simon, Associate Professor of Neurology|617-735-3251|dsimon1@bidmc.harvard.edu|
21285567|NCT00558012|University of Pittsburgh|Dr. Susan Greenspan|412-692-2477|greenspn@pitt.edu|
21285568|NCT01724177|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
21285569|NCT00472732|Children's Research Institute|Andrea Gropman, M.D.|202-476-2120|agropman@childrensnational.org|
21285570|NCT00305227|University of Washington|Ann Stapleton, MD|206-616-4121|stapl@uw.edu|
21285571|NCT00632125|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com|
21285572|NCT05133323|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
21285573|NCT02697214|The Cleveland Clinic|Marc Gillinov, MD|216 445-8841|GILLINOM@ccf.org|
21285574|NCT02459197|Tools4Patient|Chief Scientific Officer|+32 71 91|alvaro.pereira@tools4patient.com|94 00
21285575|NCT00577772|Mayo Clinic|Dr. John K. DiBaise|480-301-6990|dibaise.john@mayo.edu|
21285576|NCT00572455|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21285577|NCT00909220|Northwestern University|Jackie Gollan, Ph.D. Associate Professor of Psychiatry and Behavioral Sciences|312-695-6121|j-gollan@northwestern.edu|
21285578|NCT01449864|University of Pennsylvania|John Plastaras, MD, PhD|267-972-3539|plastaras@uphs.upenn.edu|
21285579|NCT02082769|Department of Endocrinology, Xijing Hospital, Fourth Military Medical University|Qiuhe Ji|+86-29-84775213|qiuheji@hotmail.com|
21285580|NCT04152083|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
21285581|NCT01308463|Zimmer Biomet|Kelly Francher|574-371-9783|kelly.francher@zimmerbiomet.com|
21285582|NCT01354197|Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand|Kaweesak Chittawatanarat|053-935533|kchittaw@gmail.com|
21285583|NCT00105989|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21285584|NCT03280056|Brainstorm Cell Therapeutics|Chief Medical Officer|+1-201-488-0460|ClinicalTrial@brainstorm-cell.com|
21285585|NCT01101750|MedStar Health Research Institute|Veronica Gomez-Lobo, MD|202-877-4099|veronica.gomez-lobo@medstar.net|
21285586|NCT01029262|Celgene Corporation|Anne McClain, Senior Study Manager|888-260-1588|clinicaltrialdisclosure@celgene.com|
21285587|NCT01753713|Case Comprehensive Cancer Center|Manmeet Ahluwalia, MD|216-844-5060|ahluwam@ccf.org|
21285588|NCT00807612|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
21285589|NCT04607135|Duke University|Kathy Nightingale, Ph.D.|919-660-5175|kathy.nightingale@duke.edu|
21285590|NCT03465709|Apellis Pharmaceuticals. Inc.|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
21285591|NCT00705341|Johns Hopkins University|Anne Capser|410-955-8183|ashankli@jhsph.edu|
21285592|NCT02237989|Eskisehir Osmangazi University|Dr. Fulya Bakılan|+905057737335|fulyabakilan@gmail.com|
21285593|NCT03665077|George Washington Cancer Center|Dr. Pavani Chalasani|(202)-741-2277|pavani.chalasani@email.gwu.edu|
21285594|NCT01472822|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Jeong-Hwan Seo, MD|82-63-276-8284|vivaseo@jbnu.ac.kr|
21285595|NCT00205660|Washington University|Michael Yingling|5735791412|yinglinm@wustl.edu|
21285596|NCT02959918|Selecta Biosciences, Inc.|Dr. Peter Traber|713-540-9776|ptraber@selectabiosciences.com|
21285597|NCT00837967|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21285598|NCT02504320|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
21285599|NCT00941304|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
21285600|NCT03293394|Spedali Civili di Brescia|Prof. Barbara Borroni|+39 0303995631|bborroni@inwind.it|
21285601|NCT04978337|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21268345|NCT04629534|Medical University of South Carolina|Carol Wagner|843-792-5179|wagnercl@musc.edu|
21268346|NCT00808665|Vanderbilt University Medical Center|James Blair DO|615-343-6082|james.l.blair@vanderbilt.edu|
21268347|NCT01258803|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21268348|NCT00678652|Clinical Trials Center, WRAIR|Paul B. Keiser, M.D.||noinformation@available.com|
21268349|NCT05146999|Galderma Research & Development, LLC|Felipe Weinberg, MD, MPH|817-961-5000|aestheticclinicaltrials@galderma.com|
21268350|NCT03319160|Zoll|Mike Osz|412-968-3333|mosz@zoll.com|
21268351|NCT03223649|National Institutes of Health|Jack A. Yanovski, MD, PhD|3014960858|jy15i@nih.gov|
21268352|NCT04533204|VA Ann Arbor Healthcare System; University of Michigan|Dr. Benjamin Hampstead|734-763-9259|bhampste@med.umich.edu|
21268353|NCT00383292|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21268354|NCT00697255|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21268355|NCT02347345|Aaron Diamond AIDS Research Center|Martin Markowitz MD|212-448-5020|mmarkowitz@adarc.org|
21268356|NCT04034225|Sensei Bio|Alice Drumheller|2404548027|adrumheller@senseibio.com|
21268357|NCT03523390|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21268358|NCT02260791|Fujifilm Kyowa Kirin Biologics Co., Ltd., EU Branch|Clinical Trial Information|+44 1896 668 173|Clinical-Trials@fk-b.com|
21268359|NCT02172820|The University of Vermont|Diann Gaalema, Ph.D., PI|802-656-9874|Diann.Gaalema@med.uvm.edu|
21268360|NCT04246996|Dell Medical School at The University of Texas at Austin|Mary Rieger, MD, MAS|512-324-7036|mary.rieger@austin.utexas.edu|
21268361|NCT01230021|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21268362|NCT00545974|UCSF Memory and Aging Center|Dr. Adam L. Boxer|4154760668|aboxer@memory.ucsf.edu|
21268363|NCT00736840|Exalenz Bioscience|Clinical Trial Manager|972-8-9737500|avrahamh@exalenz.com|513
21268364|NCT02815670|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21268365|NCT01411917|University of Wisconsin School of Medicine, Department of Anesthesiology|Kristopher Schroeder|608-232-1542|kmschro1@wisc.edu|
21268366|NCT02791906|University of Pennsylvania|Associate Professor|2152007779|julio.chirinos@uphs.upenn.edu|
21268367|NCT01815099|Hartford Hospital|Gretchen Diefenbach|860-545-7685|gretchen.diefenbach@hhchealth.org|
21268368|NCT01475214|Jean Mayer Human Nutrition Research Center on Aging at Tufts University|Dr. Bess Dawson-Hughes|617-556-3066|bess.dawson-hughes@tufts.edu|
21268369|NCT03289676|UNIVERSITY OF MASSACHUSETTS BOSTON|Dr. Sun Kim|6172875372|sun.kim@umb.edu|6172875372
21268370|NCT02354599|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21268371|NCT00280059|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21268372|NCT02984228|Hospital for Special Surgery|Jennifer Cheng|6467146870|chengj@hss.edu|
21268373|NCT00495794|VA Center for Clinical Management Research; University of Michigan|Dr. Michele Heisler|734-845-3504|mheisler@umich.edu|
21300515|NCT01838395|BioLineRx Ltd.|VP Clinical & Medical Affairs|+972-8-642-9100|clinicaltrials@biolinerx.com|
21268374|NCT02127931|CogCubed|Monika Roots, MD|6122509737|monika.d.heller@gmail.com|
21268375|NCT01636076|Novartis Pharmaceuticals|Study Director|862-778-8300||
21268376|NCT01159665|ThromboGenics|Dr. Petra Kozma-Wiebe|+32 16751310|Petra.kozma@thrombogenics.com|
21268377|NCT01130831|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21268378|NCT00951912|the First Affiliated Hospital of Sun Yat-sen University|Dr. Yan-bin Ye|8620-87755766|yanbinye72@163.com|8179
21268379|NCT01212627|Brown University Oncology Research Group (BrUOG)|Angela Taber, MD|4018633000|kayla_rosati@brown.edu|
21268380|NCT02173158|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|857-242-5142|alison.long@aegerion.com|
21268381|NCT01377194|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
21268382|NCT00323479|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
21300516|NCT05972993|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21300517|NCT03866577|Momenta Pharmaceuticals, Inc.|Senior Director Clinical Development Head Rheumatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21268383|NCT03014700|Stanford university School of Medicine|Glyn David Williams|650-723-5728|jumbo@stanford.edu|
21268384|NCT04927858|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0217|clinicaltriage.rdg@boehringer-ingelheim.com|
21268385|NCT00967343|Kiadis Pharma Netherlands B.V.|Andrew Sandler, MD / Chief Medical Officer|+1 206 779 9213|a.sandler@Kiadis.com|
21268386|NCT03461705|Columbia University|Ajay Kirtane, MD, SM|212-305-7060|akirtane@columbia.edu|
21268387|NCT02549040|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21268388|NCT02195349|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21268389|NCT02777554|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21268390|NCT01541644|University of Maryland Baltimore Greenebaum Cancer Center|Emily Parks|410-328-7340|eparks@umm.edu|
21268391|NCT01458535|AbbVie|Global Medical Services|800-633-9110||
21268392|NCT01008059|Washington University|Evan D. Kharasch, MD PhD|314-362-8796|kharasch@wustl.edu|
21268393|NCT02706327|Eastern Mediterranean University|Yasin YURT|+905338724271|fzt.yasinyurt@gmail.com|
21268394|NCT05450198|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@msd.com|
21268395|NCT04550234|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21268396|NCT01224171|Millennium Pharmaceuticals Inc.|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
21268397|NCT01097057|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
21268398|NCT01270139|Ural Institute of Cardiology|Dr. Alexander Kharlamov|0031627849118|drskharlamov@gmail.com|
21268399|NCT01512758|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21268400|NCT02702115|Sangamo Therapeutics, Inc.|Medical Monitor|(510) 307-7266|clinicaltrials@sangamo.com|
21300518|NCT00453895|University of Würzburg|Prof. Dr. Martin Fassnacht|+49-931-201-39201|fassnacht_m@medizin.uni-wuerzburg.de|
21257040|NCT01263483|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
21257041|NCT05143489|Maimonides Medical Center|Director of Research Administraton|7182836896|alikourezos@maimo.org|
21257042|NCT04630171|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.edu|
21257043|NCT05500274|The University of Chicago|Dr. John Schneider|(773) 702-2453|jschnei1@uchicago.edu|
21257044|NCT04252859|Huntsman Cancer Institute, Center for Quantitative Cancer Imaging|Sam Mitchell|801-213-6110|sam.mitchell@hci.utah.edu|
21257045|NCT05807464|UCSF Hypoxia Research Laboratory|Dr. Philip Bickler|1-415-476-1411|philip.bickler@ucsf.edu|
21257046|NCT01555151|Novartis Pharmaceuticals|Clinical Disclosure Office|+1(862)778-8300||
21257047|NCT03596866|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21257048|NCT00702754|Solstice Neurosciences, Inc|Regulatory Affairs Specialist||regulatoryaffairs@usworldmeds.com|
21257049|NCT02343159|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21257050|NCT00635479|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu|
21257051|NCT02114268|MedImmune, LLC|M. Pamela Griffin, MD, Senior Director|301-398-0000|information.center@astrazeneca.com|
21257052|NCT03269435|Montefiore|Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
21257053|NCT03959332|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21257054|NCT01431274|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21257055|NCT00003702|NRG Oncology|Angela M. Kuras on behalf of Virginia Filiaci|7168455702|kurasa@nrgoncology.org|
21257056|NCT02790138|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21257057|NCT04037748|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21257058|NCT04702737|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21257059|NCT02047253|University of Alabama at Birmingham|Pam Dixon, RN, BSN, OCN|205-975-9875|pamdixon@uab.edu|
21257060|NCT00832520|UNM Comprehensive Cancer Center|Valerie Parks, RN|505-925-0390|vparks@salud.unm.edu|
21257061|NCT03472924|Oregon State University|Marc Norcross, PhD, ATC|541-737-6788|marc.norcross@oregonstate.edu|
21257062|NCT01908972|Seoul National University College of Medicine|Prof. Tae Hyun Choi|82-10-5595-5829|psthchoi@snu.ac.kr|
21257063|NCT03491007|Durham VA Healthcare Center|Susan O'Loughlin|919-286-0411|susan.o'loughlin@va.gov|
21257064|NCT02504554|Arizona State University|James Adams|480 965 3316|jim.adams@asu.edu|
21257065|NCT05318937|Sage Therapeutics|Amy Bullock|617-949-5151|amy.bullock@sagerx.com|
21257066|NCT01877915|Janssen Research & Development, LLC|SENIOR DIRECTOR, CLINICAL LEADER CV|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21257067|NCT01045798|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21257068|NCT01449461|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21257069|NCT02072928|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21257070|NCT02228720|Intersect ENT|James Stambaugh|6506412103|jstambaugh@intersectent.com|
21257071|NCT00290199|UAB|Dr. Alan Tita|205-934-9616|atita@uab.edu|
21257072|NCT00232583|UT Southwestern Medical Center|Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
21257073|NCT04702451|Volta Medical|Paola Milpied|+33768025499|paola.milpied@volta-medical.com|
21257074|NCT00583024|University of Iowa/Holden Comprehensive Cancer Center|David Lubaroff, PhD|(319) 335-8423|david-lubaroff@uiowa.edu|
21257075|NCT04347226|Columbia University|Mark N. Stein, MD|917-658-2771|mns2146@cumc.columbia.edu|
21257076|NCT04198623|UCSF Fresno/Community Cancer Institute|Mohammed Sani Bukari MD, Associate clinical professor|3473019055|Mohammed.Bukari@ucsf.edu|
21257077|NCT01054742|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21257078|NCT03366298|Imperial College London|Dr Paul Turner|+44 20 3312 7754|p.turner@imperial.ac.uk|
21257079|NCT02481921|Providence VA Medical Center|Dr. Wen-Chih Wu|401-273-7100|wen-chih.wu@va.gov|16237
21257080|NCT05050318|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21257081|NCT04259411|Abbott Structural Heart|Janani Aiyer/ Clinical Scientist II|+1(669)287-4507|Janani.aiyer@abbott.com|
21257082|NCT00736255|DukeUMC|Scott Kollins, PhD|9196810014|kolli001@mc.duke.edu|
21257083|NCT00095875|Dana Farber Cancer Institute|Robert I Haddad, MD|617-632-3090|rihaddad@partners.org|
21257084|NCT04183790|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21257085|NCT01251653|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21257086|NCT00675922|University of Texas Medical Branch|Tina Mack-Moshay, ClinicalTrials.gov Administrator|409-266-6917|tlmackmo@utmb.edu|
21257087|NCT01502709|University of North Carolina|Dr Asma Khan|919 537 3389|asma_khan@dentistry.unc.edu|
21257088|NCT02722863|Korea Otsuka Pharmaceutical Co.,Ltd.|Huiyeong,Shim/Associate CTM for LPS & ISS|02-3287-9220|hyshim@otsuka.co.kr|
21257089|NCT00346073|GlaxoSmithKline|GSK Response Center|866-435-7343||
21257090|NCT01140360|Indiana University|Dr. Kent Robertson|317-944-4969|krobert@iu.edu|
21257091|NCT00457015|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21257092|NCT03670953|Impax Laboratories, LLC|Pamela Fitzpatrick, Senior Director, Specialty Regulatory Affairs|631-633-2104|pfitzpatrick@amneal.com|
21257093|NCT04179734|Imperial College London|Professor Waljit S. Dhillo, Principal Investigator|00442075943487|w.dhillo@imperial.ac.uk|
21257094|NCT00290615|Duke University Medical Center|Brant Hamel|919-68-1861|brant.hamel@duke.edu|
21257095|NCT00937937|SWOG Statistical Center|Melanoma Committee Statistician|2066674623|jmoon@fredhutch.org|
21300519|NCT05530252|BeijingSHCMU|Dr.Nannan Han|15701545851|qhddenver@126.com|
21257096|NCT00984490|Vanderbilt-Ingram Cancer Center|Ingrid Mayer, MD|615-936-2033|ingrid.mayer@vanderbilt.edu|
21257097|NCT03197493|Robert W Snyder, MD, PhD, PC|Dr. Robert W. Snyder|5206616516|rsnyder781@gmail.com|
21300520|NCT02195518|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21268401|NCT06304064|Capricor Inc.|Study Director|858-727-1755|mawadalla@capricor.com|
21268402|NCT04140942|University of Michigan|Brittany Ross|(734) 764-2368|rossbrit@umich.edu|
21268403|NCT01161173|Hoffman-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
21268404|NCT01911546|Former: Cedars-Sinai Medical Center, Comprehensive Transplant Center|Dr. Joseph Kahwaji, MD, MPH|310-423-2641|joseph.m.kahwaji@kp.org|
21268405|NCT01407068|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
21268406|NCT02213666|Beth Israel Deaconess Medical Center|Elad Anter, MD|617-632-9209|eanter@bidmc.harvard.edu|
21268407|NCT01319422|Yale University|Madhav Dhodapkar, M.D.|203-785-4144|madhav.dhodapkar@yale.edu|
21268408|NCT01399619|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21268409|NCT02918968|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
21268410|NCT05602818|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21268411|NCT00750061|China Spinal Cord Injury Network|Dr. Wendy Cheng|+852 28660829|wendycheng@chinasci.net|
21268412|NCT03661346|University of Texas Medical Branch - Galveston|Dr. Mohamad Chaaban|281-338-0829|mrchaaba@UTMB.EDU|
21268413|NCT00892710|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21268414|NCT00229931|Dean McGee Eye Institute|Robert E. Leonard, II, MD|405-271-6307|sonny-icks@dmei.org|
21268415|NCT02992743|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21268416|NCT00761735|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21300521|NCT04825678|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21300522|NCT00723736|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21300523|NCT03818256|Corcept Therapeutics Incorporated|Medical Director|650-327-3270|info@corcept.com|
21300524|NCT01723384|San Francisco Department of Public Healt|Dr. Glenn-Milo Santos|415-437-6231|glenn-milo.santos@ucsf.edu|
21300525|NCT04370873|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21300526|NCT00400179|Taiho Pharma USA, Inc.|Taiho|+1 844-878-2446|medicalinformation@taihooncology.com|
21257098|NCT00054704|NIMH, DIRP, Experimental Therapeutics and Pathophysiology Branch|Dr. Carlos Zarate|3014510861|zaratec@mail.nih.gov|
21257099|NCT02329964|Korea University Anam Hospital|Seolju Park|+82-10-6314-6013|gursla2@naver.com|
21257100|NCT00362414|University of California Irvine|Dr. Steven Cramer|(714) 456-6876|scramer@uci.edu|
21257101|NCT02603120|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21257102|NCT01469182|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21257103|NCT00366275|Division of Hematology, Fondazione IRCCS Policlinico San Matteo, University of Pavia|Luca Arcaini MD|+390382501308|luca.arcaini@unipv.it|
21257104|NCT02236520|Vanderbilt University Medical Center|Alp Ikizler|(615) 343-7592|alp.ikizler@vumc.org|
21257105|NCT01785160|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21257106|NCT03807349|Zimmer Biomet|Ryan Boylan, Clinical Affairs Manager|574-371-9784|ryan.boylan@zimmerbiomet.com|
21257107|NCT00094770|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21257108|NCT00253643|Oregon Health & Science University|Dr. Jackilen Shannon|503-220-8262|shannoja@ohsu.edu|54868
21257109|NCT00825500|Alexza Pharmaceuticals, Inc|Chief Scientific Officer|650.944.7777|jcassella@alexza.com|
21257110|NCT01368536|Novartis Pharmaceuticals|Study Director|862-778-8300||
21257111|NCT01035099|Weill Cornell Medicine|Rodriq Stubbs|646-962-3276|res2011@med.cornell.edu|
21257112|NCT02636582|UT MD Anderson Cancer Center|Dr. Isabelle Bedrosian, MD, Professor, Breast Surgical Oncology|(713) 563-1872|ibedrosian@mdanderson.org|
21257113|NCT04451161|University of Washington|Dr. Aaron Lyon|(206) 221-8604|lyona@uw.edu|
21257114|NCT00454857|Amgen Inc.|Study Director|866-572-6436||
21257115|NCT00596947|Hospital of the University of Pennsylvania|Jennifer Trofe-Clark, Clinical Transplant Research Pharmacist|215-614-4274|jennifer.trofe-clark@uphs.upenn.edu|
21257116|NCT00829179|Duke University Medical Center|John S. Sundy M.D. PhD|(919) 668-2169|john.sundy@duke.edu|
21257117|NCT03000179|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
21257118|NCT02512809|Nationwide Children's Hospital|Joseph D. Tobias, MD|6147224200|joseph.tobias@nationwidechildrens.org|
21257119|NCT00827606|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21257120|NCT01748942|Oregon Health and Science University|Daniel Clayburgh, MD PhD|503-494-8510|clayburg@ohsu.edu|
21257121|NCT03437564|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21257122|NCT00243386|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21257123|NCT04995055|Johnson & Johnson Vision Care, Inc. (JJVC)|Thomas R. Karkkainen, OD, MS, FAAO|1-800-843-2020|TKarkkai@its.jnj.com|
21257124|NCT01017003|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21257125|NCT01358760|Endoceutics|Director of Data Analysis|418-653-0033|celine.martel@endoceutics.com|215
21257126|NCT04695392|UPENN|Martha A.Q. Curley, RN, PhD|2155739449|curley@nursing.upenn.edu|
21257127|NCT01506960|Massachusetts General Hospital|Iris McNulty|617 726 2612|imcnulty@partners.org|
21257128|NCT01034592|Stanford University Medical Center|Jason R Gotlib, MD, Professor of Medicine (Hematology)|650-867-2823|jason.gotlib@stanford.edu|
21257129|NCT01987960|A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com|
21257130|NCT01379469|Washington University School of Medicine|David Rudnick MD, PhD- Associate Professor|314-286-2832|rudnick_d@wustl.edu|
21257131|NCT00807742|Brown University|Damaris Rohsenow, Ph.D.|401-863-6648|damaris_rohsenow@brown.edu|
21268417|NCT00381680|Childrens's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21268418|NCT00398476|GlaxoSmithKline|GSK Response Center|866-435-7343||
21257132|NCT00912002|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21257133|NCT04814823|UCSF Hypoxia Research Laboratory|Dr. Philip Bickler|1-415-476-1411|philip.bickler@ucsf.edu|
21257134|NCT02247245|University of Leeds|Dr Haqeel Jamil|0113 343 3241|haqeel.jamil@nhs.net|
21257135|NCT05678257|NuCana plc|Medical and Scientific Affairs Department|+44 131 357 1111|info@nucana.com|
21257136|NCT03520959|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21257137|NCT01357577|VA National Center for PTSD|Jessica L. Hamblen, PhD|8022965132|jessica.hamblen@va.gov|
21257138|NCT04419610|Imperial College|Dr David Owen|07575089144|d.owen@imperial.ac.uk|
21257139|NCT01439282|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21257140|NCT00751777|Valneva Austria GmbH|Head Clinical Development|0043120620|info@valneva.com|0
21257141|NCT00307151|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
21257142|NCT02204150|Mass General Hospital|Gary Tearney|617-724-2979|gtearney@partners.org|
21257143|NCT00980200|GlaxoSmithKline|GSK Response Center|866-435-7343||
21257144|NCT01617460|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
21257145|NCT02013180|Catalca Ilyas Cokay State Hospital|Dr. Mustafa Zafer Temiz|+90 212 787 19 12|dr_mustafazafertemiz@hotmail.com|1178
21257146|NCT01535573|The University of Texas Health Science Center at Houston|Joy M. Schmitz, PhD, Professor and Director of Center For Neurobehavioral Research On Addictions||Joy.M.Schmitz@uth.tmc.edu|
21257147|NCT02966509|Stanford University and VA Palo Alto Health Care System|Dr. Manali Patel|650-723-4000|manalip@stanford.edu|
21257148|NCT03332498|Moffitt Cancer Center|Richard D. Kim, MD|813-745-1277|Richard.Kim@moffitt.org|
21300527|NCT03589859|VA Northeast Ohio Healthcare System|Dr. Mark Walker|216-791-3800|mark.walker5@va.gov|65229
21300528|NCT04671901|Memorial Sloan Kettering Cancer Center|Dr. Michael Ortiz MD|212-639-6057|ortizm2@mskcc.org|
21300529|NCT00626106|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
21300530|NCT02201953|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21300531|NCT03591406|Vifor (International) Inc.|VIT-IRON-2011-004 Clinical Study Team|+41 58 851 80 00|VIT-IRON-2011-004.study@viforpharma.com|
21300532|NCT02144610|AnGes USA, Inc.|Dr. Susan Pitman Lowenthal|240-780-9025|spitmanlowenthal@anges-usa.com|
21300533|NCT02505919|PROCEPT BioRobotics Corporation|Angela Lee|6502327215|a.lee@procept-biorobotics.com|
21300534|NCT04743778|University of Michigan, School of Social Work|Dr. Jaclynn Hawkins|(734) 615-2817|jachawk@umich.edu|
21300535|NCT02796170|Tulane University|Dragana Lovre|(504)988-9928|dlovre@tulane.edu|
21300536|NCT01527370|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21300537|NCT02191111|University of Mississippi|Dr. Meagen Rosenthal|662-915-2475|mmrosent@olemiss.edu|
21300538|NCT03415685|Lutronic|Alexander Denis, Global Manager of Clinical Research|9788959206|adenis@lutronic.com|
21300539|NCT01834911|New York Medical College|Dr. Robert Fekete|9143451313|robert_fekete@nymc.edu|
21300540|NCT00482053|Stanford University Medical Center|Wen-Kai Weng, Assistant Professor of Medicine|650-723-7689|wkweng@stanford.edu|
21300541|NCT03611829|McGill University|Mallory Frayn, PhD (c)|514-398-1399|mallory.frayn@mail.mcgill.ca|
21300542|NCT02224560|GW Research Ltd|Medical Enquiries||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
21300543|NCT00728689|Siga Technologies, Inc.|Annie Frimm, Vice President, Regulatory Affairs|951-303-8797|afrimm@siga.com|
21300544|NCT01523366|AstraZeneca|Tomas LG Andersson, MD, PhD|1-800-236-9933|ClinicalTrialTransparency@astrazeneca.com|
21300545|NCT04454918|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21300546|NCT04543279|Washington University School of Medicine|Dr. Amy Zhou|314-362-8814|a.zhou@wustl.edu|
21300547|NCT02871934|VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA|Dr. Jason Vassy|857-364-2561|jvassy@partners.org|
21300548|NCT03216226|Zealand Pharma A/S|Kim Mark Knudsen|+45 50603780|KMKnudsen@zealandpharma.com|
21300549|NCT00425802|Memorial Sloan Kettering Cancer Center|Hugo Castro-Malaspina, MD|212-639-8197|castro-h@mskcc.org|
21300550|NCT00887809|Memorial Sloan Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org|
21300551|NCT03131570|ROCKEFELLER UNIVERSITY|Dr. James G. Krueger|2123277409|KRUEGEJ@MAIL.ROCKEFELLER.EDU|
21300552|NCT04596267|Boston Medical Center|Dr. Eric Devine|617-418-7888|eric.devine@bmc.org|
21300553|NCT00071058|National Cancer Institute, National Institutes of Health|Antonio Fojo, M.D.|301-496-2631|FojoT@mail.nih.gov|
21300554|NCT00765206|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21300555|NCT05261386|ADS Therapeutics LLC|Dr. Rong Yang|9496798408|rong_yang@cloudbreaktherapeutics.com|
21300556|NCT03995368|VA Greater Los Angeles Healthcare System|Dr. Jonathan K. Wynn|3104783711|Jonathan.Wynn@va.gov|44957
21300557|NCT03755934|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
21300558|NCT01498068|Janssen Belgium|Compound Development Team Leader|32 14 64 13 70||
21300559|NCT00361296|Johns Hopkins University|Doug Smith, MD|4102872935|smithdo@jhmi.edu|
21300560|NCT00940771|Bill Holt Clinic, Phoenix Children's Hospital|Janice Piatt, MD, Medical Director|602-933-0955|jpiatt@phoenixchildrens.com|
21300561|NCT02252666|University of Wisconsin - Madison|Dr. Mitchell Tyler|(608) 262-5112|metyler1@wisc.edu|
21300562|NCT01353898|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21300563|NCT02072668|University of Tennessee Center for the Heath Sciences|Dr. Kenneth Ataga|901.448.3181|kataga@uthsc.edu|
21300564|NCT02668653|Daiichi Sankyo Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21300565|NCT03678493|University of Minnesota, Masonic Cancer Center|Armin Rashidi, MD, PhD|(612) 273-8383|arashidi@umn.edu|
21257149|NCT00916357|Halozyme|Vice President, Endocrinology Clinical Development|858-794-8889||
21300566|NCT02431637|Medicines for Malaria Venture|Dr. Jörg J. Möhrle|+41 22 555 0369|moehrlej@mmv.org|
21268419|NCT00998166|Columbia University|Mark Stoopler, MD|212-305-8230|mbs5@cumc.columbia.edu|
21268420|NCT03045926|Ipsen Pharma SAS|Medical Director|+33 (0)158335000|clinical.trials@ipsen.com|
21300567|NCT01352793|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21300568|NCT00656448|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/794-5783|eharriso@mdanderson.org|
21300569|NCT04322526|University of Pittsburgh|Dr. Marta Pecina|734-945-2473|pecinam@upmc.edu|
21300570|NCT03146585|University Hospital Hradec Kralove|Dr. David Astapenko|+420608177374|astapenko.d@seznam.cz|
21300571|NCT01716234|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21300572|NCT02667119|UConn Health|Kristyn Zajac, PhD|860-679-8572|zajac@uchc.edu|
21300573|NCT01523756|Coloplast A7S|Marianne Raff|+45 4911 2562|dkmr@oloplast.com|
21300574|NCT00993967|Santhera Pharmaceuticals|Thomas Meier, PhD|+41 61 906 89 50|thomas.meier@santhera.com <Thomas.Meier@santhera.com>|
21300575|NCT03994081|University of North Carolina at Chapel Hill|Tobias Schwippel, MD|919-966-9929|tobias_schwippel@unc.edu|
21300576|NCT03783078|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21300577|NCT02758210|Emory University|Mikhael El Chami, MD|404-686-2504|melcham@emory.edu|
21300578|NCT01467960|Villa Melitta|Sarah Dassati|+39 0471 471|sarahdassati@yahoo.it|471
21300579|NCT02620774|Center for Anti-infective Research and Development|David Nicolau|860-972-3941|david.nicolau@hhchealth.org|
21300580|NCT00474812|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Charles Nock MD|216-844-3862|charles.nock@uhhospitals.org|
21300581|NCT02180100|Peking University Shenzhen Hospital|Prof. Shangrong Fan|86755-83923333|fanshangrong@163.com|5502
21300582|NCT05452486|University of Arkansas for Medical Sciences|Dr. Caitlin Price|(501) 686-8125|CEPrice@uams.edu|
21300583|NCT03175679|BeijingYouanH|Dr. LJUN|861366138148|lujun98@ccmu.edu.cn|
21300584|NCT04792645|University of Chicago|Dr. Jon Grant|773-834-3778|jongrant@uchicago.edu|
21300585|NCT04309396|Mayo Clinic Arizona|Dr. Jay Pasricha|(480)301-4279|pasricha.jay@mayo.edu|
21300586|NCT00651742|Taiho Oncology, Inc|Taiho|+1 844-878-2446|medicalinformation@taihooncology.com|
21300587|NCT05378672|Zealand Pharma A/S|Clinical Operations|+45 88 77 36 00|clinicaltrials@zealandpharma.com|
21300588|NCT05720897|Indiana University|Stuart Schrader|3172781409|sschrade@iu.edu|
21300589|NCT04780061|Patterson Institute for Integrative Oncology Research|Clinical Trial Coordinator|6137921222|mlegacy@thechi.ca|1
21300590|NCT02344108|Mass General Brigham|Matthew E Stenerson, MS, Clinical Research Project Manager|7155721100|matthew_stenerson@meei.harvard.edu|
21300591|NCT04050553|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21300592|NCT01535040|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
21300593|NCT02086175|Dana-Farber Cancer Institute|Caron A. Jacobson, MD|617-632-6404|cajacobson@partners.org|
21300594|NCT01074970|Hoosier Cancer Research Network|Director of Clinical Data Management|317-634-5842|jsmith@hoosiercancer.org|41
21300595|NCT00734149|Duke University Medical Center|Cristina Gasparetto, MD|919-668-1017|gaspa001@mc.duke.edu|
21300596|NCT05430854|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21300597|NCT04314284|Washington University School of Medicine|Mary Politi, Ph.D.|314-747-1967|mpoliti@wustl.edu|
21300598|NCT03353688|University of Alabama at Birmingham|Program Manger|(205) 934-0683|clg17@uab.edu|
21300599|NCT00938704|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
21300600|NCT01652235|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
21300601|NCT03205709|Columbia University Medical Center|D.P. Devanand, M.D.|774-8658|dpd3@cumc.columbia.edu|646
21300602|NCT03111121|West Virginia University|Pavithra Ranganathan Ellison, MD|3045984122|pavithra.ellison@hsc.wvu.edu|
21300603|NCT03043794|Johns Hopkins University, Department of Radiation Oncology|Dana Baker Kaplin, MPH|410-614-3950|dkaplin1@jhmi.edu|
21300604|NCT05291520|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21300605|NCT01347112|Mayo Clinic|Dr. Richard Hurt|507-284-7313|rhurt@mayo.edu|
21300606|NCT05462756|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21300607|NCT02079246|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
21300608|NCT03666663|UCSF|Dr.Nina Riggins|7028064831|Nina.Riggins7@gmail.com|
21300609|NCT02393378|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21300610|NCT00354978|UT MD Anderson Cancer Center|Scott Kopetz, MD Associate Professor|713-792-2828|mjlim@mdanderson.org|
21300611|NCT05764785|University of Massachusetts Boston|Dr. Jean Rhodes|(617) 620-9147‬|jean.rhodes@umb.edu|
21300612|NCT02536976|Struthers Parkinson's Center|Dr. Sotirios Parashos|001-952-993-5495|sotirios.parashos@parknicolet.com|
21300613|NCT00071890|INSERM U897 Bordeaux FRANCE|Pr G. Chene|557571392|genevieve.chene@isped.u-bordeaux2.fr|+33
21300614|NCT01671319|University of Wisconsin Carbone Cancer Center|Dr. Amyé Tevaarwerk|608-262-2837|at4@medicine.wisc.edu|
21300615|NCT01389596|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21300616|NCT01709084|Janssen R&D US|Director, R&D, Medical Departement||ClinicalTrialDisclosure@its.jnj.com|
21300617|NCT00214201|UW Madison|Director of Clinical Trials|608-263-2565||
21300618|NCT01354899|Molnlycke Health Care AB|Tina Kjellen|+46317223098|tina.kjellen@molnlycke.com|
21300619|NCT00463567|Novartis Pharmaceuticals|Study Director|862-778-8300||
21300620|NCT03881852|Axsome Therapeutics, Inc.|Caroline Streicher, Executive Director, Clinical Operations|212-332-5061|cstreicher@axsome.com|
21300621|NCT00641667|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387||
21300622|NCT01124006|DePuy Synthes Spine|Mark Lotito|508-880-8045|Mlotito@its.jnj.com|
21300623|NCT05887388|University of North Carolina at Chapel Hill|Mark Toles, PhD|919-966-5684|mtoles@email.unc.edu|
21285602|NCT02497404|Weill Cornell Medical College|Sebastian Mayer, MD|646-962-7950|sam2033@med.cornell.edu|
21285603|NCT01436227|M.D. Anderson Cancer Center|Eric Jonasch, MD|713-792-2830|ejonasch@mdanderson.org|
21285604|NCT04865419|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21285605|NCT03853291|Weill Cornell Medicine|Dr. Catherine Riffin, Assistant Professor of Psychology in Medicine|646.962.7160|acr2213@med.cornell.edu|
21285606|NCT02974803|Canadian Cancer Trials Group|Lesely Seymour|6135336430|lseymour@ctg.queensu.ca|
21285607|NCT01654263|Group Health Research Institute|Lisa A. Jackson, MD, MPH|206-442-5216|Jackson.L@ghc.org|
21285608|NCT01658904|National Cancer Institute|Dr. Ronald Gress|301-496-1791|gressr@dc10a.nci.nih.gov|
21285609|NCT02611765|Baylor College of Medicine|Jose Serpa-Alvarez|713 798-7910|jaserpaa@bcm.edu|
21285610|NCT02934555|Beth Israel Deaconess Medical Center|Dr. Michael Donnino|6177542882|mdonnino@bidmc.harvard.edu|
21285611|NCT04074330|Takeda|Medical Director|1-877-825-3327|TrialDisclosures@takeda.com|
21285612|NCT00972283|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21285613|NCT03338244|UC San Francisco - Proctor Foundation|Thomas Lietman|(415) 476-1442|tom.lietman@ucsf.edu|
21285614|NCT04229771|William Beaumont Hospital|Dr. Dianne Schlachter, Staff Physician|248-551-2020|dianne.schlachter@beaumont.org|
21285615|NCT02903420|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@edwards.com|
21285616|NCT03162328|Philips|Gary Garcia|6085129475|gary.garcia@philips.com|
21285617|NCT03092791|Takeda|Senior Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
21285618|NCT02182830|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21285619|NCT00913770|Yale University|Gail D'Onofrio, MD, MS|203-785-4404|gail.donofrio@yale.edu|
21285620|NCT01990768|University of Washington, Resuscitation Outcomes Consortium|Dr. Susanne May|206-685-1302|rochelp@uwctc.org|
21285621|NCT00334295|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21285622|NCT00681265|Eyeon Therapeutics, Inc.|David M. Kleinman||dave@eyeontherapeutics.com|
21285623|NCT00248833|WRAIR|Paul B. Keiser|866-856-3259|clinical1@na.amedd.army.mil|
21285624|NCT01243177|UCB Cares|UCB (Study Director)|+1 887 822 9493||
21285625|NCT02636439|Wake Forest School of Medicine|Dalane W. Kitzman, MD|336-716-3274|dkitzman@wakehealth.edu|
21285626|NCT02494401|University of New Mexico|Janet Poole|(505) 272-1753|JPoole@salud.unm.edu|
21285627|NCT03031340|Montefiore Medical Center|Dr.Singh Nair|7189205932|sinair@montefiore.org|
21285628|NCT04530838|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21285629|NCT00803712|Amgen Inc.|Study Director|866-572-6436||
21300624|NCT00842335|Jubilant Clinsys Inc.|Jane Fisher, Senior Manager, Regulatory Affairs|+1 (919) 518-8786|jfisher@clinsys.com|
21300625|NCT00836693|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21300626|NCT01213472|GlaxoSmithKline|GSK Clinical Trials|877-379-3718|GSKClinicalSupportHD@gsk.com|
21300627|NCT00129402|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21300628|NCT02131259|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21300629|NCT01472289|TotipotentSC|Dr. Venkatesh Ponemone|+91-124-4976860|venkatesh.ponemone@totipotentsc.com|
21300630|NCT00907335|Valeant Pharmaceuticals International, Inc|David Lineberry, Associate Director, Clinical Operations|949-973-1153|David.Lineberry@valeant.com|
21300631|NCT03879772|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21300632|NCT02989597|Montefiore Medical Center|Dr. Andrew J. Kobets|718-920-7400|akobets@montefiore.org|
21300633|NCT02698215|University of California Los Angeles|Lara Ray, PhD|310-794-5383|lararay@psych.ucla.edu|
21300634|NCT01210313|ABCSG (Austrian Breast & Colorectal Cancer Study Group)|Trial Office Director|+43 1 4089230|info@abcsg.at|
21300635|NCT03982355|IMperial COllege London|Dr SImon Dryden|+447828464949|simon.dryden@imperial.ac.uk|
21300636|NCT02226367|VA Puget Sound Health Care System|Murray Raskind, MD|(206) 277-3797|Murray.Raskind@va.gov|
21300637|NCT03773978|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
21300638|NCT03113487|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
21300639|NCT03777982|Dana Farber/Mass General Brigham Cancer Care|Anthony D'Amico|857-215-1489|adamico@bwh.harvard.edu|
21300640|NCT02958995|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21300641|NCT04189952|University of Miami|Craig Moskowitz, MD|305-243-9009|chm78@med.miami.edu|
21300642|NCT00870740|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21300643|NCT04916587|University of Colorado, Denver|Dr. Monica Perez Jolles|303-724-0829|monica.jolles@cuanschutz.edu|
21300644|NCT04475081|Louisiana State University Health - New Orleans|Associate Dean for Research|9858693445|pfidel@lsuhsc.edu|
21300645|NCT04298697|Emory University|Colleen Kelley, MD, MPH|404-712-1823|colleen.kelley@emory.edu|
21300646|NCT03592186|Brown University School of Public Health|Sara Becker, Ph.D, Principal Investigator|4018636604|sara_becker@brown.edu|
21300647|NCT04266717|University of Delaware|Michele A. Lobo|302-831-8526|malobo@udel.edu|
21300648|NCT00963859|The University of Texas (UT) MD Anderson Cancer Center|John W. Davis, MD / Assistant Professor||CR_Study_Registration@mdanderson.org|
21300649|NCT01342211|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21300650|NCT04223479|The University of Jordan|Lana M. Agraib|+962|lanamg2007@yahoo.com|00000
21300651|NCT03205423|New York State Psychiatric Institute|Jermaine Jones|7577533212|jermaine.jones@NYSPI.Columbia.edu|
21300652|NCT02749422|NYU Langone Health|Anli Liu|929-455-2340|Anli.Liu@nyulangone.org|
21300653|NCT00911170|Amgen Inc.|Study Director|866-572-6436||
21300654|NCT02594124|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21300655|NCT01824836|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21300656|NCT05523089|Cidara Therapeutics, Inc.|Chief Medical Officer|858-888-7868|clinicaltrialinfo@cidara.com|
21300657|NCT01582477|St. Elizabeth's Medical Center|Andrew Sternlicht, MD|617-789-2777|andrew.sternlicht@steward.org|
21300658|NCT02786394|The University Of British Columbia|Associate Professor MC Ashe|604-675-2574|maureen.ashe@ubc.ca|
21300659|NCT02083354|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21300660|NCT03312634|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
21300661|NCT04828343|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21300662|NCT01148979|McLean Hospital|J. Alexander Bodkin, MD|617-855-3186|abodkin@mclean.harvard.edu|
21300663|NCT00777153|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
21300664|NCT01833247|Stanford University Department of Neurology|Robert S. Fisher, MD, PhD|650-7215289|robert.fisher@stanford.edu|
21300665|NCT02230995|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21300666|NCT00554216|Vivus, Inc.|Wesley W. Day PhD|650-934-5200|day@vivus.com|
21300667|NCT01679314|electroCore LLC|Annelie Andersson|+46 721 803076|annelie.andersson@electrocorellc.com|
21300668|NCT01615120|Oncternal|Mary Breitmeyer|858-434-1113|MBreitmeyer@oncternal.com|
21300669|NCT02937116|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+8613382419112|jessica.yi@innoventbio.com|
21300670|NCT00565084|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21300671|NCT01712399|MedImmune, LLC.|Marius Albulescu, MD|301-398-0000|clinicaltrialenquiries@medimmune.com|
21300672|NCT01357850|GlaxoSmithKline|GSK Response Center|866-435-7343||
21300673|NCT04610281|Ullo World|Dr. Brigitte Laurent|+33782096875|brigitte@ullo.fr|
21300674|NCT02648919|University of Hawaii Cancer Center|Stacy Mercado, IIT/ Education Manager|8084404561|smercado@cc.hawaii.edu|
21300675|NCT01803607|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21300676|NCT03252431|Generon/Evive Biotech|Christina Tay|1-908-540-0816|christina.tay@evivebiotech.com|
21300677|NCT02812342|Yale Dermatology - Middlebury|Brett King, MD, PhD, BA, Associate Professor of Dermatology|(203) 737-4825|brett.king@yale.edu|
21300678|NCT03824769|University of Connecticut|Zeely Denmat|860-455-3842|zeely.denmat@uconn.edu|
21300679|NCT02266888|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21300680|NCT00632814|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21300681|NCT02351856|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21300682|NCT01550224|Stanford University Medical Center|Steven Edward Coutre, MD; Professor of Medicine (Hematology)|650-725-4040|coutre@stanford.edu|
21300683|NCT01424215|Maimonides|Danny Sherwinter|7182837952|dsherwinter@maimonidesmed.org|
21300684|NCT04939714|Emory University|Carolyn Clevenger, DMP, APRN|404-712-2394|carolyn.clevenger@emory.edu|
21300685|NCT01458392|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21300686|NCT03762993|Purdue University|Preeti Sivasankar|765-494-3788|preeti@purdue.edu|
21300687|NCT02993107|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
21300688|NCT01281124|The Ohio State University Comprehensive Cancer Center|Greg Otterson|614-293-2887|Greg.Otterson@osumc.edu|
21300689|NCT03038100|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21300690|NCT01198795|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|58124
21300691|NCT00918255|Abbott|Global Medical Services|800-633-9110||
21300692|NCT01116986|UWisconsin|Stevens Smith|608-262-7563|sss@ctri.medicine.wisc.edu|
21300693|NCT02038933|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21300694|NCT03250273|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Nilofer Azad, MD|410-614-9169|nazad2@jhmi.edu|
21300695|NCT04154904|Oregon Health and Science University|Jessica Castle|1503-494-7072|castleje@ohsu.edu|
21300696|NCT00706238|GlaxoSmithKline|GSK Response Center|866-435-7343||
21300697|NCT00936715|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21300698|NCT04441892|Mayo Clinic|Dr. Michael J. Ackerman|507-284-8900|ackerman.michael@mayo.edu|
21300699|NCT03877510|Impax Laboratories, LLC|Pamela Fitzpatrick, Senior Director, Specialty Regulatory Affairs|631-633-2104|pfitzpatrick@amneal.com|
21300700|NCT01337960|VA Maryland Health Care System|Larry Forrester, PhD|410-637-3241|Larry.Forrester@va.gov|
21300701|NCT00267059|The University of Texas M. D. Anderson Cancer Center|Alessandra Ferrajoli, MD, BS / Associate Professor|713-792-2063|eharriso@mdanderson.org|
21300702|NCT03763877|Poxel|Director, Medical Operations|+33 (0)4 37 37 20 10|carole.thang@poxelpharma.com|
21300703|NCT01213316|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21300704|NCT03040336|Pittsburgh VA Healthcare System, CHERP|Dr. Daniel E Hall|4123602016|daniel.hall2@va.gov|
21300705|NCT02282605|Destiny Pharma|Director of Projects|+44 (0) 1273 704440|medinfo@destinypharma.com|
21300706|NCT03938259|Baylor College of Medicine7|Dr. Adam Adler|832-824-5801|Adam.adler@bcm.edu|
21300707|NCT00763035|Wake Forest University Health Sciences|Gregory Hundley|+1 (336) 716-0607|ghundley@wakehealth.edu|336
21300708|NCT00089752|University of Pennsylvania School of Nursing|Terri E. Weaver, PhD, RN, FAAN|215-898-2992|tew@nursing.upenn.edu|
21300709|NCT01271946|Arstasis|Debra Cogan, Director of Quality, Regulatory and Clinical|650-261-8073|dcogan@arstasis.com|
21300710|NCT02435992|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21300711|NCT00930046|Boston Children's Hospital|Dr. Navil Sethna|781-216-1650|navil.sethna@childrens.harvard.edu|
21300712|NCT01598532|Spaulding Rehabilitation Hospital|Ross D. Zafonte, DO|617-952-5227|rzafonte@partners.org|
21300713|NCT00912808|Oregon Health & Science University|Kathryn Chung, MD|503 220 8262|chungka@ohsu.edu|51091
21300714|NCT00702221|BTG International Inc.|SVP, Clinical Development|610-278-1660|thomas.king@btgplc.com|
21300715|NCT03856788|Icahn School of Medicine at Mount Sinai|Christina Jeng, MD, FASA|212) 241-6426|christina.jeng@mountsinai.org|
21300716|NCT00767364|Wayne State University School of Medicine, Children's Hospital of Michigan|Eric McGrath, MD|313-745-5863|emcgrath@med.wayne.edu|
21300717|NCT03345784|University Health Network, Princess Margaret Cancer Centre|Dr. Stephanie Lheureux, PI|416-946-2818|stephanie.lheureux@uhnresearch.ca|
21300718|NCT01249261|Warner Chilcott|Grexan J. Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
21300719|NCT03114683|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+8613382419112|jessica.yi@innoventbio.com|
21300720|NCT03941288|Mayo Clinic|Michael Camilleri, MD|507-266-2305|camilleri.michael@mayo.edu|
21300721|NCT02415608|Stanford University Medical Center|Jason Robert Gotlib, MD; Professor of Medicine (Hematology)|650-498-6000|C.Langford@stanford.edu|
21300722|NCT01055197|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21300723|NCT00389610|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Daniel Laheru, MD|410-955-8974|laherda@jhmi.edu|
21300724|NCT00538902|Abbott|Global Medical Services|800-633-9110||
21300725|NCT01615484|University of North Carolina at Chapel Hill|Thomas Egan, MD, MSc, FACS|919-966-3381|thomas_egan@med.unc.edu|
21300726|NCT00497081|San Francisco Department of Public Health|Glenn-Milo Santos, MPH|415.437.6231|glenn-milo.santos@sfdph.org|
21300727|NCT01967940|Gilead Sciences|Gilead Clinical Study Information Center||GileadClinicalTrials@gilead.com|
21300728|NCT04109547|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21300729|NCT01550003|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21300730|NCT05567783|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
21300731|NCT05005182|Mayo Clinic|Abhishek Mangaonkar|507-538-0173|Mangaonkar.Abhishek@mayo.edu|
21300732|NCT03675126|Sarepta Therapeutics, Inc.|Medical Director|1-888-727-3782|SareptAlly@sarepta.com|
21300733|NCT00001959|NIDDK, NIH|Jeffrey B Kopp, MD|3015943403|jbkopp@nih.gov|
21300734|NCT03712358|Istari Oncology|Lisa Franklin|919-245-7662|lfranklin@istarioncology.com|
21300735|NCT02638220|Travere Therapeutics, Inc.|Cheryl Wong Po Foo/Director, Clinical Development|8889697879|cheryl.wongpofoo@travere.com|
21300736|NCT01350258|Thomas Jefferson University|Dolores Grosso, CRNP, DNP|215-955-8874|Dolores.Grosso@jefferson.edu|
21300737|NCT04323124|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21300738|NCT06904586|Duzce University|Assistant Professor|+905059313588|gizem123demir@hotmail.com|
21300739|NCT03841604|Zambon SpA|Elena Tiberio, BSc|+39 02665241|clinicaltrials@zambongroup.com|
21300740|NCT01193244|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21300741|NCT04591353|University of Alabama at Birmingham|Promil Kukreja|205-934-4042|Pkukreja@uab.edu|
21300742|NCT03906448|University of Florida|David Tran, MD, PhD|352-273-9000|david.tran@neurosurgery.ufl.edu|
21300743|NCT01647217|Tissuetech Inc|Hosam El Sheha, MD, PhD|305-274-1299|hsheha@tissuetechinc.com|
21300744|NCT01774721|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21300745|NCT01936870|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21300746|NCT01047358|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21300747|NCT04790916|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21300748|NCT00248040|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
21300749|NCT00779155|Pico-Tesla Magnetic Therapies, LLC|Allen S. Braswell CEO|303-795-3222|abraswell@pico-tesla.com|
21300750|NCT00832299|Beth Israel Medical Center|Peter Kozuch, MD||pkozuch@chpnet.org|
21300751|NCT02930824|University of Florida|Dr. Larisa Cavallari|(352) 273-8245|LCavallari@cop.ufl.edu|
21300752|NCT00628108|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
21300753|NCT03848832|GW Research Ltd|Medical Enquiries|1-833-424-6724|medinfo@gbio.com|
21300754|NCT02494323|Bet-Loewenstein|Dr.Yaron Sacher|97297709918|ysacher@clalit.org.il|
21300755|NCT01760733|Telemark Hospital Trust|MD, PhD Kristian Heldal|+4790018417|hkri@ous-hf.no|
21300756|NCT00815659|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21300757|NCT00719472|Genentech, Inc.|Medical Communications|800-821-8590||
21300758|NCT02395471|Medtronic MITG Gastrointestinal & Hepatology|Dr.Jaime Kean|303-882-6759|Jaime.M.Kean@medtronic.com|
21300759|NCT03847896|Avillion LLP|Chief Medical Officer|+44 (0)203 764 9530|avillion@avillionllp.com|
21300760|NCT00118417|Massachusetts General Hospital|Naomi M. Simon, MD|617-726-7913|nsimon@partners.org|
21300761|NCT02978781|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21300762|NCT00785785|Novartis Pharmaceuticals|Study Director|862-778-8300||
21300763|NCT02453321|University of Pittsburgh Medical Center|Kevin King, DO - Clinical Asst. Professor|412 748-5589|kingkk@upmc.edu|
21300764|NCT01244893|Johnson & Johnson Vision Care|Brian Pall, O.D., M.S., F.A.A.O. Senior Research Optometrist|(904) 443-1290|BPALL@its.jnj.com|
21300765|NCT00357552|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21300766|NCT00976404|Northwestern University|Baiba Berzins, MPH|312-695-5012|baiba@northwestern.edu|
21300767|NCT02301416|Wake Forest School of Medicine|Jamy Ard|336-716-9837|jard@wakehealth.edu|
21300768|NCT02086500|University of Pittsburgh|Dr. Jason Sperry MD, MPH|4128028270|sperryjl@upmc.edu|
21300769|NCT00711191|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21300770|NCT03926611|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
21300771|NCT00084136|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21300772|NCT01524796|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21300773|NCT03543878|Georgia Institute of Technology|Annabelle C. Singer, PhD|510-501-9659|asinger@gatech.edu|
21300774|NCT00080535|National Cancer Institute, National Institutes of Health|Robert J. Kreitman, M.D.|301-496-6947|kreitmar@mail.nih.gov|
21268421|NCT03648073|University of Alabama at Birmingham|Samuel Galgano, Principal Investigator|2059341449|samuelgalgano@uabmc.edu|
21268422|NCT00450814|Mayo Clinic|Angela Dispenzieri, M.D., Morie A. Gertz, M.D.|(507) 284-2511|Dispenzieri.Angela@mayo.edu, Gertz.Morie@mayo.edu|
21268423|NCT03724552|Massachusetts General Hospital|T. Atilla Ceranoglu, MD|617-726-1291|aceranoglu@mgh.harvard.edu|
21268424|NCT03602976|University of Pennsylvania|Dr. Ethan Weinberg|215-349-8222|ethan.weinberg@pennmedicine.upenn.edu|
21268425|NCT04837807|The University of Alabama at Birmingham|Dr. Andrew Pucker|920-579-2900|apucker@uab.edu|
21268426|NCT03732534|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
21268427|NCT03735849|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
21268428|NCT05113277|Florida State University|Danielle M. Morabito|850) 645-1766|morabito@psy.fsu.edu|
21268429|NCT03125382|IMP|Drª. Milene Fernandes|00351965751328|milenefernandes@hotmail.com|
21268430|NCT00612456|GlaxoSmithKline|GSK Response Center|866-435-7343||
21268431|NCT03907072|WAVE Life Sciences|Medical Director|855-215-4687|clinicaltrials@wavelifesci.com|
21268432|NCT02463097|Medtronic Minimed|Thomas Thoub|8185763142|thomas.troub@medtronic.com|
21268433|NCT03326323|Inova Heart and Vascular Institute|Eric L. Sarin MD|703-776-4138|eric.sarin@inova.org|
21268434|NCT03260699|Department of Orthopaedic Surgery, Cleveland Clinic|Alison Klika, Research Manager|216 444-4954|klikaa@ccf.org|
21268435|NCT05227404|University of Minnesota|Eileen Denning|612-626-8049|edenning@umn.edu|
21268436|NCT02078557|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21268437|NCT02787655|Atl VA|Joe Nocera|404 321 6111|joe.nocera2@va.gov|206354
21268438|NCT03556202|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21268439|NCT00665002|H. Lee Moffitt Cancer Center and Research Institute|Jeffrey E. Lancet, M.D.|813-745-6841|jeffrey.lancet@moffitt.org|
21268440|NCT01005355|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21268441|NCT01315158|Washington University School of Medicine|Faris Murad, M.D.||fmurad@northshore.org|
21268442|NCT01591044|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
21268443|NCT00643851|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
21268444|NCT01353976|AmDerma Pharmaceuticals|Candis Edwards|631-974-7949|cedwards@amderma.com|
21268445|NCT04806334|Cedars-Sinai Medical Center|Charles J Rosser, MD|310-423-3723|Charles.rosser@cshs.org|
21268446|NCT00660829|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us|
21268447|NCT03747497|MicuRx Pharmaceuticals, Inc.|Study Director|510-782-2022|info@micrux.com|
21268448|NCT01977573|GlaxoSmithKline|GSK Response Center|866-435-7343||
21268449|NCT03044730|Northwestern University, Feinberg School of Medicine|William John Gradishar, MD, FACP, FASCO|(312) 695-4541|w-gradishar@northwestern.edu|
21268450|NCT00934661|Anesthesiology|Dr. Pamela Nagle Assistant Professor|336-716-7180||
21268451|NCT00990782|Cleveland Clinic|Dr. John Vargo|(216) 445-5012|vargoj@ccf.org|
21268452|NCT01846442|Endoceutics|Director of Data Analysis|418-653-0033|celine.martel@endoceutics.com|215
21268453|NCT01685320|Campus Bio-medico University|Prof. Massimiliano Carassiti|+39-06-225411952|m.carassiti@unicampus.it|
21268454|NCT02477319|Seattle Children's Hospital|Umer Khan (Principal Biostatistician)|206-884-7516|umer.khan@seattlechildrens.org|
21268455|NCT01013207|ResMed Ltd|Alison Wimms|+61 8884 2583|alison.wimms@resmed.com.au|
21268456|NCT00151775|Daiichi Sankyo|Howard Kessler, Senior Director Regulatory Operations|732-590-5032|hmkessler@dsi.com|
21268457|NCT00247416|University of Kentucky Markey Cancer Center|Suzane Arnold, MD|859 323 8043|smarno0@uky.edu|
21268458|NCT02660489|Imperial College London|Professor Sebastian Johnston|+44 (0)20 7594 3764|s.johnston@imperial.ac.uk|
21268459|NCT00474994|Memorial Sloan Kettering Cancer Center|Dr. Mary Keohan|646-888-4160|KeohanM@mskcc.org|
21268460|NCT00278473|Icahn School of Medicine at Mount Sinai|Dr. Mary V. Solanto|212-241-5420|Mary.Solanto@mssm.edu|
21268461|NCT02322866|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21268462|NCT03735680|OncoNano Medicine, Inc.|Vice President, Clinical Operations|682-285-1411|clinicaltrials@onconanomed.com|
21268463|NCT03930524|University of Michigan|Dr. Megan Patrick|734-763-5043|meganpat@umich.edu|
21268464|NCT00761761|Univeristy Of Pittsburgh Medical Center|K.N. Roy Chengappa, MD|412-246-5006|chengappakn@upmc.edu|
21268465|NCT04602078|Spanish Oncology GenitoUrinary Group (SOGUG)|A responsible person designated by the Sponsor|0034934344412|investigacion@mfar.net|
21268466|NCT03757585|Massachusetts General Hospital|Janet Wozniak|6176436617|jwozniak@partners.org|
21268467|NCT03342911|Thomas Jefferson University|Jennifer Johnson|215-955-8874|jxj021@jefferson.edu|
21268468|NCT05064436|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
21268469|NCT01711736|GlaxoSmithKline|GSK Response Center|866-435-7343||
21268470|NCT04579666|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
21285630|NCT03565874|Department of Child and Adolescent Psychiatry, University Hospital of Lausanne|Dr. Sébastien Urben|+41 21 314 7492|sebastien.urben@chuv.ch|
21285631|NCT01196377|Vanderbilt University School of Medicine|Dr. Donald H Arnold|6155790516|don.arnold@vanderbilt.edu|
21285632|NCT02588586|The Rockefeller University|Dr. Marina Caskey, Professor of Clinical Investigation|2123277396|mcaskey@rockefeller.edu|
21285633|NCT03335813|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. John Greskovich|1-866-223-8100|taussigresearch@ccf.org|
21268471|NCT03290131|RVL Pharmaceuticals, Inc.|Vice President, Regulatory Affairs and Quality|908-809-1300|Regulatory@RVLpharma.com|
21268472|NCT03099096|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21268473|NCT00361504|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
21268474|NCT01374516|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21268475|NCT00401414|Brigham and Women's Hospital|Mark A. Creager|617-732-5267|mcreager@partners.org|
21300775|NCT01374438|Metabolic Solutions Development Company|Dr. Jerry Colca|269.343.8732|jcolca@msdrx.com|
21300776|NCT02612779|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21300777|NCT02004041|Vanda Pharmaceuticals Inc.|Vanda Pharmaceuticals Inc.|202-734-3400|clinicaltrials@vandapharma.com|
21300778|NCT02633306|University of Minenesota|Stephen Haines, MD|612 624-6666|shaines@umn.edu|
21300779|NCT01744977|Durham Veterans Affairs Medical Center|Hayden Bosworth, PhD|919-286-6936|hayden.bosworth@va.gov|
21237830|NCT03255824|Montefiore Medical Center|Dr. Patrick Nolan|718-405-8195|pnolan@montefiore.org|
21237831|NCT05072457|Hearts for Hearing|Lead Investigator|405-548-4335|phonakaudiologyresearch@gmail.com|
21237832|NCT03247790|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21300780|NCT01101867|The Ohio State University|Dr. Kathleen Dungan|614-685-3333|kathleen.dungan@osumc.edu|
21300781|NCT03774576|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21300782|NCT03041038|Northwestern University|Dr. Amy Paller|3126953721|NUderm-research@northwestern.edu|
21300783|NCT00803569|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21300784|NCT02900378|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21300785|NCT03769519|Duke|Isaretta L. Riley, MD, MPH|919-286-0411|isaretta.riley@duke.edu|
21300786|NCT01134055|GlaxoSmithKline|GSK Response Center|866-435-7343||
21300787|NCT03429270|Laborie|Stephanie Gallone, Clinical Research Manager|9056121170|sgallone@laborie.com|1755
21300788|NCT04798196|UW-Madison|Gina Landucci|(608) 890-1440|gina.landucci@wisc.edu|
21300789|NCT00571493|University of Nebraska Medical Center|Julie M Vose|402-559-3848|jmvose@unmc.edu|
21300790|NCT02512783|Children's Hospitals and Clinics of Minnesota|Angela Doucette|6128137144|angela.doucette@childrensmn.org|
21300791|NCT00734539|Duke Univiersity Medical Center|Daniel K. Benjamin Jr|919-668-7081|danny.benjamin@dm.duke.edu|
21300792|NCT02148874|The Ohio State University Wexner Medical Center|Lisa Christian, PhD|614-293-0936|lisa.christian@osumc.edu|
21300793|NCT00705016|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21300794|NCT02233517|VAORD|Elizabeth Van Voorhees|(919) 286-0411|elizabeth.vanvoorhees@va.gov|6435
21300795|NCT00942604|LEO Pharma|Dr. Torsten Skov|+4520736294|torsten.skov@leo-pharma.com|
21300796|NCT01656408|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21300797|NCT04008745|University of Sao Paulo|Isabel de Camargo Neves Sacco|+551130918426|icnsacco@usp.br|
21300798|NCT00817843|UMC Utrecht|Professor F.L.J. Visseren, MD PhD|0031-88-7555555|f.l.j.visseren@umcutrecht.nl|
21300799|NCT04351334|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21300800|NCT00904982|University of Pennsylvania Perelman School of Medicine|Stephen E. Kimmel, MD, MSCE/Director, Clinical Epidemiology|(215) 898-1740|stevek@mail.med.upenn.edu|
21300801|NCT02593006|Hackensack University Medical Center|Yukiko Kimura MD|551-996-5306|yukiko.kimura@hackensackmeridian.org|
21300802|NCT04119414|University of Miami|Stephen Weiss|7862108684|sweiss2@med.miami.edu|
21300803|NCT02054689|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MSCCR, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
21300804|NCT01929317|GlaxoSmithKline|GSK Response Center|866-435-7343||
21300805|NCT02514083|National Heart Lung and Blood Institute (NHLBI)|Inhye Ahn, M.D.|301-827-1203|inhye.ahn@nih.gov|
21300806|NCT01899040|Scion NeuroStim, Inc|Robert Black|919-260-5528|bacllc@earthlink.net|
21300807|NCT04051996|Yale University|Dr. Amer Zeidan|(203) 200-4363|amer.zeidan@yale.edu|
21300808|NCT02153632|Osmotica Pharmaceuticals|George Wagner, VP of Regulatory Affairs|9088091357|gwagner@osmotica.ccom|
21300809|NCT00595088|Bnai Zion Medical Center|Dr. Sarel Halachmi|+97248359542|sarel.halachmi@b-zion.org.il|
21300810|NCT00735436|Duke University Medical Center|Annick Desjardins, MD, FRCPC||annick.desjardins@dm.duke.edu|
21300811|NCT04586205|University of Pennsylvania|Yvette Sheline|215-573-0082|sheline@pennmedicine.upenn.edu|
21300812|NCT03894124|Chelsea and Westminster NHS Foundation Trust|Research Operations Manager|+442033156825|chelwest.research@nhs.net|
21300813|NCT04684836|Vanderrbilt University|Jessica Ancker, MS, PhD|(615) 322-5000|jessica.s.ancker@vumc.org|
21300814|NCT04040933|Johnson & Johnson Consumer Inc. (J&JCI)|Robin Mathew|908-904-5034|rmathew1@its.jnj.com|
21300815|NCT02066181|Memorial Sloan-Kettering Cancer Center|Mrinal Murugesan Gounder M.D.|646-888-4167|gounderm@mskcc.org|
21300816|NCT00775190|Beaumont Health System|Evie Russell, RN|248-898-5388|Evie.Russell@beaumont.org|
21300817|NCT02141295|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21300818|NCT01710501|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21300819|NCT02169427|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21300820|NCT02409277|University of Utah|Flory Nkoy|801-662-3660|flory.nkoy@hsc.utah.edu|
21300821|NCT00420771|NYSPI|John J. Mariani, MD|212-543-5987|jm2330@columbia.edu|
21300822|NCT01432730|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21300823|NCT01235741|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21300824|NCT01421719|Stanford University|Rodney U. Anderson, MD|6504984240|rua@stanford.edu|
21300825|NCT00959985|Massachusetts General Hospital|Dr. Alphonse G Taghian, MD PhD|617-726-6050|ataghian@partners.org|24369
21300826|NCT02696967|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21300827|NCT01942837|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-7221|mtaplin@partners.org|
21300828|NCT01298648|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21237833|NCT01091155|novoGI|Eran Choman, VP Clinical Affairs & Statistics|+972 9 8603000|eran.choman@novogi.com|
21300829|NCT02392624|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21300830|NCT03819114|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
21300831|NCT01635439|NWAFH|Ahmed Abdelaziz|0096644411088|webmaster@nwafh.med.sa|
21300832|NCT02492763|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21300833|NCT01772316|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21300834|NCT02085161|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21300835|NCT01394003|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21300836|NCT03537404|R-Pharm|Emiliya Krasavina, Medical Adviser|0074959567937|krasavina@rpharm.ru|
21300837|NCT00068692|ECOG-ACRIN statistical office|Statistician||eatrials@jimmy.harvard.edu|
21300838|NCT01222689|university of california san francisco|Dr. Andrew Ko, MD|415-353-7286|Andrew.Ko@ucsf.edu|
21300839|NCT01600716|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21300840|NCT03481595|Cleveland Clinic Florida|Carlos Higuera|9546595430|higuerc@ccf.org|
21300841|NCT03557034|Cleveland Clinic|Khaldoun Tarakji, MD, MPH|216-445-9225|TARAKJK@ccf.org|
21300842|NCT02540629|Seoul National University Hospital|Dr. Jeong Ho Park|+821035426282|timthe@gmail.com|
21300843|NCT01759446|Acura Pharma|Dr. Al Brzeczko|847-705-7709|abrzeczko@acurapharm.com|
21300844|NCT00882557|Cubist Pharmaceuticals, Inc.|Ed Campanaro/Vice President, Clinical Operations|781-860-8318|ed.campanaro@cubist.com|
21300845|NCT01383356|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21300846|NCT02035267|Allergan, Inc|Beta Bowen|1-714-246-4446|Bowen_Beta@allergan.com|
21300847|NCT04803396|Dompé farmaceutici SpA|dr. Mauro P. Ferrari|+39 02 583831|clinops@pec.dompe.it|
21300848|NCT04827680|Venus Concept|Director of Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
21300849|NCT03038880|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21300850|NCT03134703|Johns Hopkins All Children's Hospital|Sandra Brooks, MD|727-767-4313|sbrook36@jhmi.edu|
21300851|NCT00956007|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
21300852|NCT01746901|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21300853|NCT01208207|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21300854|NCT02177032|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
21300855|NCT01526577|LG Life Sciences|Dong Yeop Shin|82 2 6924 3114|dongyeopshin@lgls.com|
21300856|NCT01605799|San Francisco VA Medical Center|Dr. Shira Maguen|415-221-4810|shira.maguen@va.gov|22511
21300857|NCT00686712|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu|
21300858|NCT01151189|Aeras|Product Director; Bernard Landry|301-547-2919|blandry@aeras.org|
21300859|NCT01318915|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21300860|NCT00926237|University of Arkansas for Medical Sciences|Dr Mark Mennemeier|205 410 2413|msmennemeier@uams.edu|
21300861|NCT00999102|NY Presbyterian Hospital - Weill Cornell Medical Center|Dr. Samuel Mann, PI|212-746-2200|sjmann@med.cornell.edu|
21300862|NCT01808456|Inova Fairfax Hospital|Dr. Ravinder Wali|7037764001|ravinder.wali@inova.org|
21300863|NCT03714880|University of Pittsburgh|Suji Uhm, MD, MPH|412-641-4590|uhms@upmc.edu|
21300864|NCT03352609|MUSC|Dr Friedrich|843-792-9888|friedric@musc.edu|
21300865|NCT03507569|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21300866|NCT03815929|Principle Investigator|Dr. Ekta Kapoor|507 538-7103|kapoor.ekta@mayo.edu|
21300867|NCT03313037|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21300868|NCT02760498|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21300869|NCT02205736|Levine Cancer Institute at Carolinas Healthcare System|Dr. James Symanowski|9804422371|james.symanowski@carolinashealthcare.org|
21300870|NCT02529072|Duke University Medical Center|Principal Investigator|9196845301|dukebrain1@duke.edu|
21300871|NCT01624350|Medtronic|Medtronic (Sponsor)|508.452.4095|michelle.v.disalvo@medtronic.com|
21300872|NCT02546388|University of Pennslyvania|Paco Bravo, MD|1-215-220-9494|Paco.Bravo@pennmedicine.upenn.edu|
21300873|NCT01198977|Rehabilitation Care Services; MS Center of Excellence (MSCOE), VA Puget Sound Health Care System|Aaron Turner, PhD, Director, Rehabilitation Psychology; Asst Director Research, MSCOE|206-277-6134|Aaron.Turner@med.va.gov|
21237834|NCT03432364|Sangamo Therapeutics, Inc.|Medical Monitor|(510) 307-7266|clinicaltrials@sangamo.com|
21257150|NCT05102344|University of California, Irvine|Sabrina E.B. Schuck, Ph.D.|9495335465|sabrina@uci.edu|
21257151|NCT06098248|VPIX Medical, Inc|Min-Jae Jeong|82425350676|clinical@vpixmedical.com|
21257152|NCT05611671|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21257153|NCT01911442|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
21257154|NCT01648790|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21300874|NCT04410367|Blue Earth Diagnostics, Ltd.|Chief Medical Officer|+44 (0)1865 784 186|contact@blueearthDx.com|
21300875|NCT01899521|Atlanta VA Medical Center|Dr. Ashish Mehta|404-321-6111|Ashish.Mehta@va.gov|207133
21237835|NCT00522301|Memorial Sloan Kettering Cancer Center|Dr. William Tew|646-888-4220|teww@mskcc.org|
21268476|NCT00683852|Massachusetts General Hospital, CTNI|Martina Flynn, Director, Clinical Trial Operations|617-643-6028|mflynn2@partners.org|
21268477|NCT02190604|Novartis|Study Director|862-778-8300||
21268478|NCT02797951|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21268479|NCT00814502|Massachusetts General Hospital|Kaloyan Tanev, M.D.|617-726-7511|ktanev@partners.org|
21268480|NCT01901393|Cumberland Pharmaceutical Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
21268481|NCT03709342|CalciMedica|Sudarshan Hebbar, MD|816-838-7105|sudarshan@calcimedica.com|
21268482|NCT06016556|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21268483|NCT00370994|Pain Management Center of Paducah|Dr. Laxmaiah Manchikanti|270-554-8373|drlm@thepainmd.com|101
21268484|NCT00591305|Boston Medical Center|Zhi Wang, MD|617-414-1590|zwang@bu.edu|
21268485|NCT00265109|Weill Cornell Medicine|Katharine A. Phillips MD|646-962-2820|kap9161@med.cornell.edu|
21268486|NCT01757821|University of Minnesota|James Carey|612-626-2746|carey007@umn.edu|
21268487|NCT02185131|University of Pittsburgh|Jack R. Cornelius, M.D., M.P.H.|412-246-5149|corneliusjr@upmc.edu|
21268488|NCT00499694|Barbara Ann Karmanos Cancer Institute|Ulka Vaishampayan, M.D.|(313) 576-8718|vaishamu@karmanos.org|
21268489|NCT00620191|Columbia University Medical Center|Jose Luchsinger|212-3054730|jal94@cumc.columbia.edu|
21268490|NCT01830621|The Ottawa Hospital Regional Cancer Centre|Dr. Derek Jonker|613-737-7700|djonker@ottawahospital.on.ca|70170
21268491|NCT03604159|NYU Langone|Dr. Joshua Lee|646-501-3552|Joshua.Lee@nyulangone.org|
21268492|NCT03570658|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21268493|NCT03301272|University of North Carolina at Chapel Hill|Daniel Roque, MD|919-966-8178|droque@neurology.unc.edu|
21268494|NCT02243306|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21268495|NCT01598831|Asahi Kasei Pharma America Corp.|Director of Clinical Operations|(781) 419-1919|pallton@akpamerica.com|
21268496|NCT02384096|Boston Scientific Neuromodulation|Director, Clinical Sciences and Scientific Communication||Roshini.Jain@bsci.com|
21268497|NCT04768881|Karyopharm Therapeutics Inc|Karyopharm Medical Information|(888) 209-9326|clinicaltrials@karyopharm.com|
21268498|NCT02903121|Oregon Health and Science University|Alison Edelman, MD, MPH|5034943666|edelmana@ohsu.edu|
21268499|NCT04236986|Yale University|Dr. Kelly Cosgrove Principal Investigator|2037376969|kelly.cosgrove@yale.edu|
21268500|NCT02249377|New York Langone Health|Eric Strauss, MD|646 501 7223|Eric.Strauss@nyumc.org|
21268501|NCT00307736|Massachusetts General Hospital|Lawrence Blaszkowsky|6177244637|lblaszkowsky@partners.org|
21268502|NCT01475513|Virginia Commonwealth University|Kai Cheang|8049863269|kicheang@vcu.edu|
21285634|NCT02861664|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21285635|NCT00905632|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21285636|NCT01520207|Brigham and Women's Hosptial|Dr. Finnian Mc Causland|6177326432|fmccausland@partners.org|
21285637|NCT02964338|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21285638|NCT02239640|Medtronic|Oscar Bolanos|949-527-0822|Oscar.bolanos@medtronic.com|
21285639|NCT01867515|VA Portland HCS, RR&D National Center for Auditory Rehabilitative Research|Michelle R. Molis, PhD|503-220-8262|michelle.molis@va.gov|55574
21285640|NCT05076604|Washington University School of Medicine|Matthew Schill|3147470707|schillm@wustl.edu|
21285641|NCT03397121|The Medicines Company|Vice President - Regulatory Operations|973-985-0597|frank.bosley@novartis.com|
21285642|NCT00327340|OncoGenex Pharmaceuticals|Monica S. Krieger, PhD|425-686-1558|mkrieger@oncogenex.com|
21285643|NCT00856791|Onconova Therapeutics, Inc.|Francois E. Wilhelm, MD, PhD|609 281-7086|fwilhelm@onconova.us|
21285644|NCT04846270|Essity Hygiene and Health AB|Fredrik Agholme|+4670323634|fredrik.agholme@essity.com|
21285645|NCT00700375|Osaka General Medical Center|Prevention on Conrast-Induced Nephropathy With Bolus Injection of Sodium Bicarbonate|81-6-6692-1201|u_hiromichi@yahoo.co.jp|
21285646|NCT00206427|Baylor Breast Cancer|Dr. Mothaffar Rimawi|713-798-1311|rimawi@bcm.tmc.edu|
21285647|NCT04085601|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
21285648|NCT03492437|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21285649|NCT03872843|Wake Forest|Dr. Jorge Gutierrez|336-716-2011|jgutierrez@wakehealth.edu|
21285650|NCT00281697|Genentech, Inc.|Medical Communications|800 821-8590||
21285651|NCT01761643|UC San Diego|Mike Duszynski|6195438080|mduszynski@health.ucsd.edu|
21285652|NCT00856999|Oregon Health & Sciences University|Roger Dailey, MD, FACS|503-494-3020|daileyr@ohsu.edu|
21285653|NCT02465437|Corbus Pharmaceuticals, Inc.|John Skutnik, MS|781-562-9853|jskutnik@corbuspharma.com|
21285654|NCT00003483|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
21285655|NCT02609386|Eterna Therapeutics|VP of Quality|212-582-1199|info@eternatx.com|
21285656|NCT00103662|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
21285657|NCT00610168|GlaxoSmithKline|GSK Response Center|866-435-7343||
21285658|NCT01135524|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
21285659|NCT03318003|University of Michigan|Louise O'Brien|734 647-9064|louiseo@med.umich.edu|
21285660|NCT00397189|Neurim Pharmaceuticals|VP clinical and regulatory affairs|+972-3-6499340|Talin@neurim.com|
21285661|NCT00411450|Amgen Inc.|Study Director|866-572-6436||
21285662|NCT01716663|Biosense Webster|Ellen Harris, Project Manager, Clinical Operations|909-839-7376|eharris8@its.jnj.com|
21285663|NCT01059773|Janssen-Cilag France|EMEA THERAPEUTIC AREA LEADER|+33 6 15167408||
21285664|NCT02258217|OhioHealth Research Institute|Anand Gupta|614-788-3868|anand.gupta@ohiohealth.com|
21285665|NCT00235573|University of Florida|Gail Kauwell|352-392-1991|gkauwell@ufl.edu|227
21285666|NCT02762071|Johns Hopkins University|Uma Srikumaran|443-546-1550|us@jhmi.edu|
21285667|NCT00141518|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21285668|NCT01806168|Vancouver Coastal Health / Vancouver General Hospital|Kawai Leong, MD, MSc, FRCPC|604-875-8289|kawai.leong@vch.ca|
21285669|NCT02693262|University of California, San Diego|Jonathan Hsu, MD, MAS|858-246-2972|jonathan.hsu@ucsd.edu|
21285670|NCT00614874|Creighton University School of Medicine|Dr. Tammy Wichman|402-449-4486|wichman@creighton.edu|
21285671|NCT03904420|Cochlear Limited|Laura Chenier|+14423254171|lchenier@cochlear.com|
21285672|NCT01468454|Children's Hospital of Philadelphia - Department of Radiology|Lisa J. States, MD|267-245-7146|states@chop.edu|
21285673|NCT02620787|Center for Anti Infective Research and Development|Dr. David P. Nicolau|(860) 972-3941|david.nicolau@hhchealth.org|
21285674|NCT01100723|University of Colorado|Dr. David M. Spiegel|303-724-7797|david.spiegel@ucdenver.edu|
21285675|NCT04892446|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21285676|NCT01549340|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21285677|NCT03173456|Department of Emergency Medicine Albert Einstein Coll of Med|Dr. Polly Bijur|914-661-4707|polly.bijur@einsteinmed.org|
21285678|NCT01733121|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
21285679|NCT04736069|Ufuk University|Nihan Cüzdan|5052706846|nihancuzdan@hotmail.com|
21285680|NCT03061188|Northwestern University, Feinberg School of Medicine|Young Kwang Chae, MD, MPH, MBA|312-926-4248|YCHAE@nm.org|
21285681|NCT05446142|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21285682|NCT01509612|Medical University of Vienna|Michael Frass, MD|+436645453040|office@ordination-frass.at|
21285683|NCT04633226|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21285684|NCT01183416|Memorial Sloan Kettering Cancer Center|Dr. Brian Kushner, MD|212-639-6793|kushnerb@mskcc.org|
21285685|NCT03620383|Oregon Health & Science University|Ramsey Al-Hakim, MD|503-494-7660|alhakim@ohsu.edu|
21285686|NCT00184093|USC Norris Comprehensive Cancer Center|Victoria Soto - Project Specialist|(323) 865-0454|Victoria.Soto@med.usc.edu|
21237836|NCT04186780|Universidade de Sorocaba|Dr. Luciane Cruz Lopes|+ 55 15 2101-7104|luciane.lopes@prof.uniso.br|
21268503|NCT01365182|Case Western Reserve University|Amy Zhang PhD|2163680968|amy.zhang@case.edu|
21237837|NCT01699022|SPARC|Dr. Shravanti Bhowmik|02266455645|shravanti.bhowmik@sparcmail.com|5626
21237838|NCT04539821|VA Connecticut Healthcare System|Dr. Brent Moore|203-435-2243|brent.moore@va.gov|
21237839|NCT04635579|University of Washington|Dr Scott Telfer|2062292022|telfers@uw.edu|
21237840|NCT02066402|Bayer|Therapeutic Area Head|+49 30 300139003|clinical-trials-contact@bayer.com|
21237841|NCT00152464|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21237842|NCT02462876|W. L. Gore & Associates|Eric Novak|314-440-2119|enovak@wlgore.com|
21237843|NCT02565914|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21237844|NCT04465357|Clinvest Research|Jim Sly|4178413673|jsly@clinvest.com|
21237845|NCT00378352|National Institute on Aging, NIH|Edward Lakatta, M.D.|410-558-8218|lakattae@grc.nia.nih.gov|
21237846|NCT00266825|University of Kansas Medical Center|Dr. Susan Carlson|913-588-5359|SCARLSON@kumc.edu|
21237847|NCT00430248|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
21237848|NCT01754467|Northwestern University|Christine Pellegrini, PhD|312-503-1395|c-pellegrini@northwestern.edu|
21237849|NCT01970462|Ohio State University|Kathleen Dungan|614-685-3333|kathleen.dungan@osumc.edu|
21237850|NCT02230956|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21237851|NCT01970982|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
21237852|NCT01146496|University of Edinburgh|Michael Eddleston|01312426776|m.eddleston@ed.ac.uk|
21237853|NCT01133158|GELTAMO|Francisco Javier Peñalver|91 621 98 24|fjpenalver@fhalcorcon.es|
21237854|NCT04886479|CooperVision Inc.|Director Global Clinical Affairs|+19256213761|jvega2@coopervision.com|
21237855|NCT04555096|Galera Therapeutics|Judy Schnyder, SVP Clinical Operations and Data Management|2155937119|jschnyder@galeratx.com|
21237856|NCT00382824|Lahey Hospital & Medical Center|Jordan Jara|7817442958|jordan.jara@lahey.org|2958
21237857|NCT03923959|LancasterGH|Halle Becker|7175441401|halle.becker@pennmedicine.upenn.edu|
21237858|NCT05711641|Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo|Dr. Tatiane Vacaro Campos|+551126617585|tati_vacaro@hotmail.com|
21237859|NCT03574597|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21237860|NCT04040751|Emory University|Sarah Blanton, PT, DPT|404-712-2222|sblanto@emory.edu|
21237861|NCT02355743|BloodCenter of Wisconsin, Medical College of Wisconsin|Lynn Malec|414-257-2424|lynn.malec@bcw.edu|
21237862|NCT02413580|Grifols Therapeutics LLC|Rhonda Griffin|9193166693|Rhonda.Griffin@grifols.com|
21237863|NCT03583554|Baylor College of Medicine and Michael E. DeBakey VA Medical Center|Dr. Marijn Lijffijt, Assistant Professorq|713-798-5642|marijn.lijffijt@bcm.edu|
21237864|NCT01215292|University of Washington|Mara Roth, MD|206-221-0519|mylang@uw.edu|
21237865|NCT00036569|National Cancer Institute|Kathy Warren, M.D.|301-435-4683|warrenk@mail.nih.gov|
21237866|NCT01596582|Boston Medical Center|Paul C. Schroy III, MD, MPH|671-638-8335|paul.schroy@bmc.org|
21237867|NCT01428076|BTG International Inc.|David Wright MB FRCS|610-278-1660|david.wright@btgplc.com|
21237868|NCT00262821|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
21237869|NCT00765388|Coloplast A/S|Seema Suchdev Wrisberg|+4549113519|dkssw@coloplast.com|
21237870|NCT01846182|Central Texas Veterans Health Care System|Charles J. Foulks, M.D., ACOS/R|254 743 2643|Charles.Foulks@va.gov|
21237871|NCT03923933|Head of Nephrology Hospital General de México|Rafael Vadez-Ortiz M.D. PhD|+52 2789-2000|rafavaldez@gmail.com|1253
21237872|NCT02454101|AinShamsU|ahmed kotb|0100868199|ahmedmkotp@hotmail.com|+2
21237873|NCT02342886|TB Alliance|Leandra Lombard, Director, Clinical Operations|+27 87 700 3900|Leandra.Lombard@tballiance.org|
21237874|NCT00387673|Miami VA Healthcare System|Kristina Beekhuizen|305-575-7000|Kristina.Beekhuizen@va.gov|
21268504|NCT03164629|University of Miami|Shivank Bhatia, MD|305-585-7500|SBhatia1@miami.edu|
21237875|NCT00765674|Novartis Pharmaceuticals|Study Director|862 778-8300||
21237876|NCT03138096|Radboud University Medical Center|Dr. M.B.B. McCall|+31642166480|Matthew.McCall@radboudumc.nl|
21237877|NCT01813474|AstraZeneca|Medical Director||ClinicalTrialTransparency@astrazeneca.com|
21237878|NCT03015402|University of Pittsburgh|Dr. Michael Risbano, Director of Advanced Cardiopulmonary Exercise Testing Program|412-692-2210|risbanomg@upmc.edu|
21268505|NCT00735839|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21268506|NCT01990339|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21268507|NCT01728194|Well Cornell Medicine|Faith M. Gunning, PhD, Vice Chair for Research, Dept of Psychiatry|212-746-5832|fgd2002@med.cornell.edu|
21268508|NCT03241485|University of Chicago Medicine|Richa Dhawan|773-702-1000|rdhawan@dacc.uchicago.edu|
21300876|NCT01588522|BPGbio Inc.|Bing Nie|617-588-1002|bing.nie@bpgbio.com|
21300877|NCT04504253|University of Utah|Brent Kious, MD|8015851418|brent.kious@hsc.utah.edu|
21300878|NCT02855125|Taiho Oncology, Inc.|Taiho Central|+1 844-878-2446|medicalinformation@taihooncology.com|
21300879|NCT04467905|Milestone Pharmaceuticals Inc.|Leonid Kokovin-Sher|1 450-912-6783|lkokovin-sher@milestonepharma.com|
21300880|NCT05370495|Seinda|Jing-Feng Huang, Ph.D.|1.858.254.9188|jfhuang@SeindaPharm.com|
21300881|NCT01590888|Prana Biotechnology|Dr Caroline Herd|+61393494906|info@pranabio.com|
21300882|NCT02118441|Department of Anesthesia, St. Paul's Hospital|S. K. W. Schwarz, MD, PhD|604-806-8337|stephan.schwarz@ubc.ca|
21237879|NCT00316082|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
21268509|NCT02309372|Indiana University School of Medicine|Samir K. Gupta, MD, MS|3172747926|sgupta1@iu.edu|
21237880|NCT01011829|University of California, Los Angeles|Steve Shoptaw PhD|310 794 0619|sshoptaw@mednet.ucla.edu|225
21300883|NCT04375085|Elixir Medical Corp|Candace Elek, EVP Clinical Research|4086362000|celek@elixirmedical.com|
21300884|NCT03124342|VANDERBILT UNIVERSITY MEDICAL CENTER|Matthew W. Semler, MD, MSc|(615) 322-3412|matthew.w.semler@vumc.org|
21285687|NCT01903993|Hoffmann-La Roche|Medical Communications|800 821|genentech@druginfo.com|8590
21300885|NCT00847509|Certus International, Inc.|Edward M. Aten, M.D.|603.627.1212|eaten@certusintl.com|
21257155|NCT01486927|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
21300886|NCT02653417|Radius Pharmaceuticals, Inc.|Clinical Operations|617-551-4000|clinopsinfo@radiuspharm.com|
21300887|NCT01705509|Cardiovascular Institute of the South|Agostino Ingraldi, MD, FACC|337-988-1585|Agostino.Ingraldi@cardio.com|
21300888|NCT00904033|University of Rochester|Luke J Peppone, PhD, MPH|585-275-7827|Luke_Peppone@urmc.rochester.edu|
21300889|NCT02736890|Icahn School of Medicine at Mount Sinai|Dr. Thomas Bryce|212-241-6321|thomas.bryce@mountsinai.org|
21300890|NCT02201394|Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai|Dr. Juan J. Badimon||Juan.Badimon@mssm.edu|
21300891|NCT03077412|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21300892|NCT02904954|Weill Cornell Medicine|Cathy Spinelli, RN BSN|212-746-3328|caf2007@med.cornell.edu|
21300893|NCT00753506|Sheppard Pratt|Dr. Faith Dickerson|410-938-4359|fdickerson@sheppardpratt.org|
21300894|NCT04226742|University of California, Irvine|Stephen Schueller|949-824-3850|s.schueller@uci.edu|
21300895|NCT05097963|Mayo Clinic|Vinay Chandrasekhara, M.D.|507-284-2687|Chandrasekhara.Vinay@mayo.edu|
21300896|NCT00214890|UCSD|Sheldon Morris|6195438080|shmorris@ucsd.edu|
21300897|NCT01417377|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21300898|NCT00384670|Department of Pediatrics, Pharamongkutklao Hospital|Sriluck Simasathien ; Infectious Disease Consultant|66-2-644-8971||
21300899|NCT02113982|Stemline Therapeutics, Inc.|Ira Gupta, MD|877-332-7967|clinicaltrials@menarinistemline.com|
21300900|NCT03349034|Icahn School of Medicine at Mount Sinai|Dr. Brett Miles|(212) 241-9410|brett.miles@mountsinai.org|
21300901|NCT00865566|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
21300902|NCT03403283|University of Alabama at Birmingham|maria grant|13528714314|mariagrant@uabmc.edu|
21257156|NCT02159729|Allergan, Inc|Beta Bowen|714-246-4446|Bowen_Beta@allergan.com|
21257157|NCT00573430|AstraZeneca|Gerard Lynch|+44 7780 956181|aztrial_results_posting@astrazeneca.com|5895
21257158|NCT02445651|Thomas Jefferson University|Andrew Newberg, M.D.|215-503-3423|Andrew.Newberg@jefferson.edu|
21257159|NCT02953340|Spectrum Pharmaceuticals Inc. Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|(949) 788-6700|shanta.chawla@sppirx.com|
21257160|NCT04232553|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21257161|NCT02969915|Johns Hopkins University|Gregory M. Lucas|410 614 0560|glucas@jhmi.edu|
21257162|NCT04580446|UT Southwestern Medical Center|Dr. Dominic Moon|214-645-8525|Dominic.Moon@UTSouthwestern.edu|
21257163|NCT01378858|Albert Einstein College of Medicine|Shadi Nahvi, MD, MS|718 920 5379|snahvi@montefiore.org|
21257164|NCT02664272|Smith & Nephew, Inc.|Vice President of Medical Affairs|+41 41 7662222|luca.orlandini@smith-nephew.com|
21257165|NCT03073980|Massachusetts General Hospital|John C. Petrozza, M.D.|617-726-8868|jpetrozza@mgh.harvard.edu|
21257166|NCT04810689|USCalifornia|Darcy Spicer|3238653904|DSPICER@USC.EDU|
21257167|NCT01412554|Oslo University Hospital Ullevål, Norway|MD PhD Tonje Amb Aksnes|+22119101|tonjeaksnes@hotmail.com|47
21257168|NCT00450723|UM/Sylvester Comprehensive Cancer Center|Eli Avisar MD|305-243-4902|eavisar@med.miami.edu|
21257169|NCT01806857|Center for Neurological Study|Richard Smith, MD|858-455-5463|cnsonline@ymail.com|
21257170|NCT00789880|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21257171|NCT06347731|Varian Medical Systems|Sophia Shao|+86-21-23156400|sophia.shao@varian.com|
21257172|NCT00609986|Medical University of South Carolina|Dr. Kathie Hermayer|843-792-2529|hermayer@musc.edu|
21257173|NCT03159091|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
21257174|NCT02667418|Hines VA|Dr. Stuart Johnson|708--202-8387|Stuart.Johnson2@va.gov|257772
21257175|NCT02044133|Centre hospitalier départemental Vendée|Dr Yves BLEHER|0251446572|yves.bleher@ght85.fr|
21257176|NCT04722042|University of North Carolina at Chapel Hill|Margaret Dillon, AuD, PhD|919-966-5251|mdillon@med.unc.edu|
21257177|NCT02046096|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
21257178|NCT00487396|Given Imaging|Director, Clinical Affairs|+972-4-9097777|Hila.Debby@givenimaging.com|
21257179|NCT04969276|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21257180|NCT03834519|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|Clinicaltrialsdisclosure@msd.com|
21257181|NCT04551677|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21268510|NCT00242658|Penn State Milton S. Hershey Medical Center|Chris Sciamanna, MD, MPH|717-531-8161|cns10@psu.edu|
21268511|NCT02054572|Amgen Inc.|Study Director|866-572-6436||
21285688|NCT05095311|Indiana University|Curtis Goss, Student Investigator|8178080085|csgoss13@gmail.com|
21285689|NCT03124537|Brandeis University|Alycia Bisson|781 736 3284|lifespanlab@brandeis.edu|
21285690|NCT03681184|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
21285691|NCT02787083|Philadelphia Urosurgical Associates, PC|Kristene E Whitmore MD|215-704-1457|bladder1@aol.com|
21285692|NCT00282152|Vanderbilt University Medical Center|David Charles, MD||david.charles@Vanderbilt.Edu|
21285693|NCT03301831|Case Western Reserve University|Valerie Boebel Toly, PhD, RN, CPNP|(216) 368-3082|vab@case.edu|
21285694|NCT01440634|UT Southwestern Medical Center|Dr. Carlos H Timaran|2146450533|timaran1@msn.com|
21285695|NCT03373461|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21285696|NCT03020550|University of California, Davis|Michelle Dossett, MD, PhD|916-734-5367|mdossett@ucdavis.edu|
21257182|NCT04655144|University of Miami|Prasoon Mohan, MD|7736563386|prasoonpm@gmail.com|
21257183|NCT05166226|Pennington Biomedical Research Center|Dr. Corby Martin|+1 (225) 763-2585|corby.martin@pbrc.edu|
21257184|NCT00943579|Children's Health Council|Glen R. Elliott, Ph.D., MD|650.688.3649|gelliott@chconline.org|
21268512|NCT00928642|Madigan Army Medical Center|COL David E. McCune, MD, MC|253-968-1155|david.e.mccune.mil@mail.mil|
21268513|NCT02205177|Mayo Clinic|Stephen P Whiteside, PhD, LP|507-284-2933|Whiteside.Stephen@mayo.edu|
21268514|NCT02576652|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21268515|NCT01811693|Keck School of Medicine of USC|Nerses Sanossian, MD|323-442-7793|nsanossi@usc.edu|
21268516|NCT00553319|Columbia University|Frances R. Levin, M.D.|646-774-6137|frl2@columbia.edu|
21300903|NCT01039376|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
21300904|NCT03252925|The First Affiliated Hospital of Soochow University|Yue Han|13901551669|hanyue@suda.edu.cn|
21300905|NCT00123422|Edward Hines Jr. ,VA Hospital|Eileen Collins|708-202-3525|eileen.collins@va.gov|
21300906|NCT00521404|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21300907|NCT04555616|University of Kentucky|Elizabeth Rhodus|859-257-5567|elizabeth.rhodus@uky.edu|
21300908|NCT03089281|Boston Scientific|Clinical Trial Manager|1-800-227-3422|Sara.Veraghtert@bsci.com|
21300909|NCT01750229|Medtronic Neuromodulation|Neuro Clinical Trials||medtronicneurotrials@medtronic.com|
21300910|NCT02683577|Ipsen Pharma|Medical Director||clinical.trials@ipsen.com|
21300911|NCT03594110|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21300912|NCT05571605|University of North Texas|Dr. Justin Sprick|940-565-2226|justin.sprick@unt.edu|
21300913|NCT02085460|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21300914|NCT02351817|Coloplast A/S|Medical Director|+45 4911 1395|dkbir@coloplast.com|
21257185|NCT05097144|CooperVision Inc.|José A. Vega OD, MSc, FAAO|9256213761|JVega2@coopervision.com|
21257186|NCT00418665|Amgen Inc.|Study Director|866-572-6436||
21257187|NCT00853749|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21257188|NCT00450242|University of North Carolina, Dept. of Obstetrics and Gynecology|Denniz Zolnoun, MD, MPH|919-966-7764|denniz_zolnoun@med.unc.edu|
21257189|NCT00841204|The University of Arizona|H-H. Sherry Chow, Ph.D.|520-626-3358|schow@azcc.arizona.edu|
21257190|NCT01129921|Napa Pain Institute|Eric Grigsby, MD|707-252-9660|egrig@aol.com|
21257191|NCT00687440|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21257192|NCT02786134|Brigham and Women's Hospital|Dr. Marcelo Di Carli|617-732-6290|mdicarli@bwh.harvard.edu|
21257193|NCT05470465|U.S. Food and Drug Administration|Jeffry Florian|301-796-4847|Jeffry.Florian@fda.hhs.gov|
21257194|NCT05937165|Hebrew SeniorLife, Marcus Institute of Aging, Harvard Medical School|Courtney Millar|6179715531|courtneymillar@hsl.harvard.edu|
21257195|NCT01538628|Boston Scientific Corporation|Director, Clinical Operations|952-930-6000|teresa.takle-flach@bsci.com|
21257196|NCT02701868|Pennington Biomedical Research Center|Abby Altazan|2257632801|Abby.Altazan@pbrc.edu|
21257197|NCT00586261|Mayo Clinic|Dr. Patricia Best|507-284-4441|best.patricia@mayo.edu|
21257198|NCT03703882|Astria Therapeutics, Inc|Andrew Nichols, PhD - Chief Scientific Officer|617-349-1971|anichols@astriatx.com|
21257199|NCT01321710|University of California, San Francisco|Kathryn Lee, RN, PhD|415-476-4442|kathryn.lee@nursing.ucsf.edu|
21257200|NCT03370536|Icahn School of Medicine at Mount Sinai|Dr. Vivek Reddy|(212) 241-7114|vivek.reddy@mountsinai.org|
21257201|NCT01761292|Italfarmaco SpA|Paolo Bettica, MD|+39 02 64431|p.bettica@italfarmaco.com|
21257202|NCT00840086|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21257203|NCT03577730|University of Michigan|Phillip Vlisides|734-936-4280|pvliside@umich.edu|
21257204|NCT03810781|Syracuse VA Medical Center|Dr. Richard Servatius|315-744-3370|richard.servatius@va.gov|
21257205|NCT02181816|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21257206|NCT00909181|Antares Pharma|Kaushik Dave|609 359 3020|kdave@antarespharma.com|
21257207|NCT05152927|University of California, San Francisco|Dr. Quan-Yang Duh, MD|(415) 221-4810|quan-yang.duh@ucsf.edu|
21257208|NCT02349048|Janssen R&D BE|Associate Director, Medical Department||ClinicalTrialDisclosure@its.jnj.com|
21257209|NCT02219282|DorkuzEU|Semih Kucukguclu|902324125707|semih.kucukguclu@gmail.com|
21257210|NCT00309465|Beaumont Health System|Tamra Dukatz, CRNA, MSN|248 992-4741 (pager)|tdukatz@beaumont.edu|
21257211|NCT00383084|Johns Hopkins University|Kevin Fontaine, PhD|443-449-4314|kfontai1@jhmi.edu|
21257212|NCT02113436|GlaxoSmithKline|GSK Response Center|866-435-7343||
21257213|NCT04075721|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21257214|NCT05895552|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21257215|NCT03810911|Richard L. Roudebush Veterans Affairs Medical Center|Dr. Rajiv Agarwal MD MS|(317) 988-2241|ragarwal@iu.edu|
21257216|NCT04770532|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21257217|NCT02703090|Boston Children's Hospital|Dr. Barry Kussman|617-355-6225|barry.kussman@childrens.harvard.edu|
21257218|NCT04707157|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
21257219|NCT00585611|UW-Madison at time of study|Nancy Sweitzer||nancysweitzer@shc.arizona.edu|
21300915|NCT03216512|Duke University|Dr Scott Kollins|919-681-0014|scott.kollins@duke.edu|
21300916|NCT01011894|Memorial Sloan Kettering Cancer Center|Dr. Renier Brentjens|212-639-7053|brentjer@mskcc.org|
21268517|NCT04369742|NYU Langone Health|Mark Mulligan, MD|(212) 263-5182|Mark.mulligan@nyulangone.org|
21300917|NCT03418714|Johns Hopkins University|Frederick Barrett|4105509777|fbarret2@jhmi.edu|
21257220|NCT00133991|Johns Hopkins University|Yvette Kasamon, MD||ykasamon@jhmi.edu|
21300918|NCT00417417|NHLBI/NIH|Richard O. Cannon III, MD|301-496-9895|cannonr@nih.gov|
21268518|NCT03575975|Georgia Institute of Technology|Dr. Young-Hui Chang|404-894-9993|yh.chang@ap.gatech.edu|
21268519|NCT00465894|University of Alabama at Birmingham|Dr. Holly E. Richter|205-934-1704|hrichter@uabmc.edu|
21268520|NCT01349816|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
21268521|NCT01207427|Cubist Pharmaceuticals|Vice President Clinical Research|(781) 860-8660||
21268522|NCT01230489|University of Missouri-Columbia|Harold Moore|5738824433|mooreh@health.missouri.edu|
21268523|NCT02451137|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21268524|NCT01441882|Oregon Health & Science University|Stephen Spurgeon|503-494-4606|spurgeos@ohsu.edu|
21268525|NCT01302366|Perlmutter Cancer Center at NYU Langone|Amitabha Mazumder, MD|212-731-5757|amitabha.mazumder@nyumc.org|
21268526|NCT00847002|Tactile Systems Technology, Inc|Sunday Hoy, Director of Clinical Research|612.355.5100||
21268527|NCT00198107|Indiana University|Christopher J. McDougle, MD|781-860-1783|cmcdougle@partners.org|
21268528|NCT02513732|Abbott|Hajime Kusano, Senior Adviser Clinical|+1 4088451626|hajime.kusano@abbott.com|
21268529|NCT00467051|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21268530|NCT03377803|Verrica Pharmaceuticals|Susan Cutler, VP, Medical Affairs|484-773-0898|scutler@verrica.com|
21268531|NCT02147132|UC COM Psychiatry Dept. -- Addiction Sciences Division|Jeff Theobald|5135858281|theobajy@ucmail.uc.edu|
21268532|NCT00808769|The Procter & Gamble Company|John Mcrorie, PhD, FACG, AGAF|513-622-1423|mcrorie.jw@pg.com|
21268533|NCT04070157|USWM, LLC|Medical Affairs|1-888-900-8796|medinfo@usworldmeds.com|
21268534|NCT01966458|Medtronic|Thomas Vassiliades|+15085321942|thomas.a.vassiliades@medtronic.com|
21268535|NCT02842736|Channel Medsystems|Clinical and Regulatory Affairs|510-338-9301|clinreg@channelmedsystems.com|
21268536|NCT00453336|University of Miami Sylvester Comprehensive Cancer Center|Francisco Civantos MD|305-243-5276|fcivanto@med.miami.edu|
21268537|NCT00940446|OrthoIndy|Dr David A Fisher|(317) 802-2000|dafisher@orthoindy.com|
21268538|NCT03323034|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21268539|NCT01002118|University of Iowa|Jennifer Robinson|319-384-1563|jennifer-g-robinson@uiowa.edu|
21268540|NCT02646566|Acacia Pharma|Dr Gabriel Fox|01223875919764|GabrielFox@acaciapharma.com|
21268541|NCT02806700|Center for Digital Health|Director of Research|2674280125|digitalhealth@uphs.upenn.edu|
21268542|NCT01255865|3M|Terri White|651-733-0228|twhite3@mmm.com|
21268543|NCT04887922|Washington University School of Medicine|Chet Hammill, M.D., MCR|314-273-1809|hamillc@wustl.edu|
21268544|NCT00953017|Fort Belvoir Community Hospital|Dr. Michael Hjelkrem|531-231-2015|mhjelkrem@yahoo.com|
21268545|NCT01711424|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21268546|NCT01300741|Alcon Research|Director of Clinical Trials|1-800-241-7629||
21268547|NCT04854421|Pennington Biomedical Research Center|Dr. Steven Heymsfield|(225) 763-2541|steven.heymsfield@pbrc.edu|
21268548|NCT00721513|Wake Forest University Health Sciences|Dr. Mercedes Porosnicu|336-716-8664|mporosni@wakehealth.edu|
21268549|NCT00718809|IndianaU|Dr. Patrick Loehrer|317-944-0920|ploehrer@iu.edu|
21268550|NCT00463385|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21268551|NCT00798161|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21268552|NCT00344968|Alimera Sciences, Inc.|Kathleen Billman, Senior Director of Scientific Affairs|678-572-1302|kathleen.billman@alimerasciences.com|
21268553|NCT01905631|Center for Clinical and Cosmetic Research|Dr. Mark Nestor|3059336716|nestormd@admcorp.com|
21268554|NCT01141569|BC Cancer Agency Vancouver Cancer Centre|Dr. Christian Kollmannsberger|604-877-6000|ckollmannsberger@bccancer.bc.ca|
21268555|NCT04001790|Virginia Commonwealth University|Carol Schall|8048286979|cmschall@vcu.edu|
21268556|NCT00465101|American Medical Systems|Mara M. LaRock, Senior Manager, Clinical Franchise Lead|952-930-6000|mara.larock@bsci.com|
21268557|NCT04548349|Beth Israel Deaconess Medical Center|Jean S. McGee, MD, PhD|(617) 667-5834|jmcgee2@bidmc.harvard.edu|
21268558|NCT03948646|Botanix Pharmaceuticals|Anthony Robinson MS CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
21268559|NCT04585906|Johns Hopkins Center for Indigenous Health|Emily E. Haroz, PhD, Co-Director of Research|410-960-9503|eharoz1@jhu.edu|
21268560|NCT04626947|University of Pittsburgh|David G. Binion|412-647-4194|binion@pitt.edu|
21268561|NCT01766466|The Medicines Company|Jayne Prats, PhD - VP, Global Knowledge Management|888.779.MDCO|jayne.prats@themedco.com|1510
21268562|NCT00629343|Columbia University|Robert Taub, MD, PhD|(212) 305-4076|rnt1@columbia.edu|
21268563|NCT04246593|State University of New York at Buffalo|Dr. Lucia Leone|(716) 829-6040|lucialeo@buffalo.edu|
21285697|NCT02014051|SymBio Pharmaceuticals|Director of Clinical Trials|+81-3-5472-1127|kgoto.34@symbiopharma.com|
21285698|NCT01972464|Yale School of Medicine|Ariadna Forray|2037648620|ariadna.forray@yale.edu|
21285699|NCT04254081|University of California, San Diego|UCSD Family Planning Research|(858) 329-4464|familyplanningresearch@health.ucsd.edu|
21285700|NCT02820870|VA Center for Clinical Management Research|Jeremy Sussman, MD, MS - Principal Investigator|(734) 845-5200|jeremysu@med.umich.edu|
21285701|NCT01369745|Zalicus|Margaret Lee,PhD|617-301-7142|mlee@zalicus.com|
21285702|NCT02754518|University of Chicago|Sara Kalantari, MD|773-834-6853|skalantari@medicine.bsd.uchicago.edu|
21285703|NCT00613821|Oregon Health & Science University|Dr. Alison Edelman|503-494-3666|whru@ohsu.edu|
21285704|NCT02051790|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
21285705|NCT01266824|Children's Hospital of Philadelphia|Dr. Amy Cohen|215-590-1000|cohenam@email.chop.edu|
21285706|NCT02302846|The University of Texas MD Anderson Cancer Center|Courtney DiNardo, MD/Assistant Professor|713-794-1141|CR_Study_Registration@mdanderson.org|
21285707|NCT02104427|TaiGen Biotechnology Co., Ltd.|Li-Wen Chang|+886-2-8177-7072|lwchang@taigenbiotech.com|1227
21268564|NCT04278846|Cleveland Clinic|Raymond Isakov, MD|216 445-3765|ISAKOVR@ccf.org|
21268565|NCT01012765|Novartis Pharmaceuticals|Study Director|862-778-8300||
21268566|NCT01326312|Oncternal|Mary Breitmeyer|858-434-1113|mbreitmeyer@oncternal.com|
21268567|NCT00903357|Department of Pediatrics, Soonchunhyang University Hospital|Bok Yang Pyun, M.D.|+82-2-709-9339|bypyun@hanmail.net|
21268568|NCT01211405|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
21268569|NCT01463631|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21268570|NCT00740129|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21268571|NCT04081727|ZSX Medical, LLC|Director of Clinical Affairs|617-631-8865|info@zsxmedical.com|
21268572|NCT05664672|Altria|Functional Director Clinical Research|8043352366|Jeffery.S.Edmiston@altria.com|
21268573|NCT02394457|Naval Medical Center San Diego|Steven Hanling, MD|619-532-8954|steven.r.hanling@mail.mil|
21268574|NCT00863265|Washington University School of Medicine|Richard E. Ostlund MD|314-362-3516|rostlund@wustl.edu|
21268575|NCT02370173|University of Arizona|"Dr. William D. Scott Killgore"|(520) 621-0605|killgore@arizona.edu|
21268576|NCT01326481|TRACON Pharmaceuticals Inc|Charles Theuer, Medical Monitor|8585500780|ctheuer@traconpharma.com|
21268577|NCT04553497|Ege University Faculty of Medicine, Physical Medicine and Rehabilitation|Dr. Emine Duran|+905372103145|docemineduran@gmail.com|
21268578|NCT01038609|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21268579|NCT04604015|NovaSignal|Manja Lenkin|8776387251|manja.lenkin@novasignal.com|
21268580|NCT02811640|Ottawa Hospital Research Institute|Dr. Deborah Zimmerman|613-738-8400|dzimmerman@toh.ca|81620
21268581|NCT00954356|Xenon Pharmaceuticals Inc.|Vice President Clinical|6044843300|pgoldberg@xenon-pharma.com|
21268582|NCT02939326|Bonti|Wajdie Ahmad|9493796569|wajdie@bonti.com|
21268583|NCT01668017|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21268584|NCT01087944|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21268585|NCT03590613|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21268586|NCT01979003|University of Arkansas for Medical Sciences|Alexander Burnett|5016868274|aburnett@uams.edu|
21268587|NCT00976521|Atrium Medical Corporation|Leah Hollins, Director of Clinical Affairs|603-880-1433|lhollins@atriummed.com|5365
21268588|NCT01731600|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21268589|NCT00544674|Proacta, Inc.|Director of Clinical Development|858-642-0386|clinicalops@proacta.com|
21268590|NCT00129220|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21268591|NCT00540228|GlaxoSmithKline|GSK Response Center|866-435-7343||
21268592|NCT01883362|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21268593|NCT01383317|Wake Forest University Health Sciences|Dr. Scott Miller|3367167437|scmiller@wakehealth.edu|
21268594|NCT01766024|BIOCAD|Director of Clinical Trials|7 (812) 380 49 33|biryulin@biocad.ru|925
21268595|NCT02569996|Roche Trial Information Hotline|F. Hoffmann-La Roche AG|+41 61 6878333|global.trial_information@roche.com|
21268596|NCT03740724|Castle Creek Biosciences|Castle Creek Biosciences Clinical Trial Director|484-713-6000|clinicalresearch@castlecreekbio.com|
21268597|NCT02279082|Dr. Reddy's Laboratories|Clinical Operations Director|609-282-1476|kgulbronson@promiuspharma.com|
21268598|NCT02032433|NYU School of Medicine|John Rotrosen|646-754-4763|john.rotrosen@nyumc.org|
21268599|NCT03996694|BioDelivery Sciences|Todd Kunkel, PharmD Director, Scientific Communications|913-940-1789|tkunkel@bdsi.com|
21268600|NCT01171794|Stanford University School of Medicine|Grant S Lipman ( PI)|4152909286|lipmangrant@gmail.com|
21268601|NCT00661037|Ospedali del Tigullio, Lavagna, Italy|Dr Michele Brignole|0185 329567329|aritmo@asl4.liguria.it|0039
21268602|NCT01055184|University of Rochester|Dr. John J. Treanor|585-275-5871|john_treanor@urmc.rochester.edu|
21268603|NCT02526017|Five Prime Therapeutics|Helen Collins, Chief Medical Officer|650-745-9633|helen.collins@fiveprime.com|
21268604|NCT03078504|Saint Louis University|Dr.Zafar Jamkhana|314-577-8856|zafar.jamkhana@health.slu.edu|
21268605|NCT00238108|Brigham and Women's Hospital|Dr. Frank Scheer|617-732-7014|fscheer@rics.bwh.harvard.edu|
21268606|NCT01548573|University of Iowa|Guido Tricot, MD, PhD|319-356-3425|guido-tricot@uiowa.edu|
21268607|NCT03541356|Impel NeuroPharma|Karen Craig, PhD (Medical Writer)|206-568-1466|kcraig@impelnp.com|
21268608|NCT00447265|DAIT/NIAID|Associate Director for Clinical Research|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21268609|NCT00503035|UT MD Anderson Cancer Center|Dr. Imad Shureiqi, MD|713-745-4929|ishureiqi@mdanderson.org|
21268610|NCT03533829|Duke Vaccine and Trials Unit|Kristen Gunnell|9196848891|kristen.gunnell@duke.edu|
21268611|NCT05028816|UT Southwestern Department of Plastic Surgery Research|Jennifer Barillas, Research Coordinator|214-645-8907|jennifer.bqarillas@utsouthwestern.edu|
21268612|NCT04552769|Stanford University|Saad A. Khan, MD|650-498-6000|saad.a.khan@stanford.edu|
21268613|NCT00070070|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21268614|NCT04576702|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
21268615|NCT04389294|Hospital for Special Surgery|Dr. Ellen M. Soffin|(212) 606-1206|SoffinE@HSS.edu|
21268616|NCT01982539|Depomed|Clinical Operations||clinicaltrials@depomed.com|
21268617|NCT02985996|Emory University|Dr. Colleen Kelley|404-712-1823|colleen.kelley@emory.edu|
21268618|NCT00401726|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21268619|NCT02067728|University of Illinois College of Medicine at Peoria|Dr. Amy L. Christison|309-655-3613|alc@uicomp.uic.edu|
21268620|NCT01015170|Centre for Addiction and Mental Health|Dr. Peter Selby; Dr. Laurie Zawertailo Principal Investigator|416-535-8501|laurie.zawertailo@camh.ca|77422
21268621|NCT00933543|Photocure|Project director Per Fuglerud|+47 22 06 16 54|pf@photocure.no|
21268622|NCT00694070|Ascensia Diabetes Care|Clinical Research Scientist|574-257-3063||
21268623|NCT04988035|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
21268624|NCT03532048|Baylor College of Medicine|Teresia O'Connor|7137986782|teresiao@bcm.edu|
21257221|NCT04311216|University of Liverpool|Dr Fraser Philp|01517942000|f.philp@liverpool.ac.uk|
21257222|NCT05998148|Lundquist Institute for Biomedical Innovation|Jonathan Wu|6268227769|wu.jonathan.g@gmail.com|
21300919|NCT00891904|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21257223|NCT04085523|Ascendis Pharma, Inc.|Aimee D. Shu, MD|+1 650 352 8389|ads@ascendispharma.com|
21257224|NCT03473652|Centre François Baclesse|Alexandra LECONTE|0231455002|a.leconte@baclesse.unicancer.fr|
21257225|NCT05599672|University of Utah|Gerald (Jerry) Cochran, PhD|801-213-0654|jerry.cochran@hsc.utah.edu|
21257226|NCT01181076|Oslo University Hospital|Kristin Skaarud|4723070000|kskaarud@ous-hf.no|
21257227|NCT03912376|Memorial Sloan Kettering Cancer Center|Dr. Michelle Bradbury, MD, PhD|917-294-4585|bradburm@MSKCC.ORG|
21257228|NCT04338516|UT Health San Antonio (UTHSA), San Antonio, Texas|Angela Palaiologou-Gallis , DDS., MS|210-450 8736|PalaiologouA@uthscsa.edu|
21257229|NCT03977974|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21300920|NCT01046396|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
21257230|NCT06689527|Santhera Pharmaceuticals LTD|Shabir Hasham MD, Chief Medical Officer|+41 79 520 95 18|shabir.hasham@santhera.com|
21257231|NCT04526899|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
21257232|NCT02580409|Spaulding Rehabilitation Hospital|Dr. Jonathan Bean|617 952 6813|jfbean@mgh.harvard.edu|
21257233|NCT00516048|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21257234|NCT02263079|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21257235|NCT02628236|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Anna Houlihan|8452681943|Anna.Houlihan@sunpharma.com|
21257236|NCT01584479|University of Michigan|William Giannobile, Principal Investigator|734-764-1562|wgiannob@umich.edu|
21257237|NCT02554019|Biotest AG|Dr. Peter Röttgen|+496103801|peter.roettgen@biotest.com|803
21257238|NCT02463409|Vanderbilt University Medical Center|Dr. Ashley Shoemaker|615-343-8816|ashley.h.shoemaker@vanderbilt.edu|615
21257239|NCT02538016|Boston Children's Hospital|Alyssia Venna|617-919-6352|Alyssia.Venna@childrens.harvard.edu|
21257240|NCT00003535|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
21300921|NCT03122509|Memorial Sloan Kettering Cancer Center|Dr. Neil Segal, MD, PhD|646-888-4187|segaln@mskcc.org|
21257241|NCT01875783|Joslin Diabetes Center|Dr. Jennifer Sun|617-209-2554|jennifer.sun@joslin.harvard.edu|
21300922|NCT04041414|University of Southern California|Jeremy Goldbach, PhD, LMSW|(213) 821-6460|goldbach@usc.edu|
21300923|NCT00665652|Dartmouth Hitchcock Medical Center|Elijah Stommel|603-650-5104|elijah.w.stommel@hitchcock.org|
21300924|NCT02161016|RTI Surgical|Robin Waite|386-418-8888|rwaite@rtix.com|
21257242|NCT05400213|University of Texas Health Science Center at San Antonio|Brian Mealeey, DDS, MS|210-450-8736|mealey@uthscsa.edu|
21257243|NCT01278745|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21257244|NCT01148537|Purdue Pharma L.P.|Executive Medical Director|800-733-1333||
21257245|NCT05630001|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21257246|NCT02860676|University of California, San Diego|Michael Choi, MD|858-534-1765|mychoi@ucsd.edu|
21257247|NCT05374525|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21257248|NCT04738474|University of Washington|Jill Steiner|2062218240|jills8@uw.edu|
21257249|NCT01349101|Thomas Jefferson University|Dr. John Wagner|215-955-8874|JLW102@jefferson.edu|
21257250|NCT00632099|New York State Psychiatric Institute|Dr. Suzette Evans|646-774-6136|se18@columbia.edu|
21257251|NCT00754832|Oregon Health & Science University|Dr. Michelle Cameron|503-418-1971|cameromi@ohsu.edu|
21257252|NCT01517893|University of Massachusetts Medical School|John E. Harris, MD, PhD|508-856-1982|john.harris@umassmed.edu|
21257253|NCT05032612|The University of Texas Health Science Center at Houston|Timothy Kirkpatrick, DDS|713-486-4227|timothy.c.kirkpatrick@uth.tmc.edu|
21300925|NCT01749215|University of California, San Francisco/San Francisco VA Healthcare System|Dr. Steven L. Batki|415-221-4810|steven.batki@ucsf.edu|23671
21300926|NCT02382705|University of British Columbia|Dr. Robert Enns|604 688 6332|cgalorport@gmail.com|
21300927|NCT01807624|Jean Brown Research Center|Dr. Derek Muse|(801) 261-2000|participate@jeanbrownresearch.com|
21257254|NCT01409213|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21257255|NCT00865904|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21257256|NCT01651351|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21257257|NCT02225080|Integra LifeSciences Corporation|Director, Global Clinical Affairs|609-936-5490|andrew.tummon@integralife.com|
21300928|NCT03060096|Wake Forest NCORP Research Base|Dr. Emily Dressler|336-716-0891|NCORP@wakehealth.edu|
21300929|NCT01441076|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Grayson, Peter|+1 301 827 9187|peter.grayson@nih.gov|
21300930|NCT00380367|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21300931|NCT01559857|Stanford University|Dr. Natalie Rasgon|6507249694|natalie.rasgon@stanford.edu|
21300932|NCT00847210|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21257258|NCT00843518|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21257259|NCT00589420|Abramson Cancer Center|Ravi Amaravadi|2156622222|ravi.amaravadi@pennmedicine.upenn.edu|
21257260|NCT01953575|Mayo Clinic|David A. Katzka|507-284-4824|Katzka.David@mayo.edu|
21257261|NCT03113656|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
21257262|NCT01131520|Friends Research Institute|Robert Schwartz|410-837-3977|rschwartz@friendsresearch.org|
21257263|NCT04118270|University of Massachusetts Medical School|Alok Kapoor|917-856-4538|alok.kapoor@umassmed.edu|
21257264|NCT04857996|Unity Biotechnology, Inc.|Study Director|650-513-0096|UBX1325_medicalmonitor@unitybiotechnology.com|
21268625|NCT03557775|Medical University of South Carolina|Dr. Heather Shaw Bonilha|843-792-2527|bonilhah@musc.edu|
21268626|NCT02626910|University of Pennsylvania|Dr. Hillary R. Bogner|215-746-4181|Hillary.Bogner@uphs.upenn.edu|
21268627|NCT00308555|UCSF/San Francisco General Hospital|Dr. Donald I. Abrams|415-476-4082|dabrams@hemeonc.ucsf.edu|444
21268628|NCT02694393|University of Pittsburgh|Dr. Joseph Pilewski|(412) 692-2210‬|pilewskijm@upmc.edu|
21268629|NCT01225029|Icahn School of Medicine at Mount Sinai|Dr. Annemarie Stroustrup|212-241-6186|annemarie.stroustrup@mssm.edu|
21268630|NCT04113746|Icahn School of Medicine at Mount Sinai|Juan P. Wisnivesky, MD, DrPH|212-824-7567|juan.wisnivesky@mountsinai.org|
21268631|NCT00830310|University Hospitals Case Medical Center|Christopher Bialko|216-286-4362|Christopher.Bialko@UHhospitals.org|
21268632|NCT01050998|MedImmune, LLC|Marius Albulescu, Associate Medical Director|301-398-0000|albulescum@medimmune.com|
21268633|NCT01533974|Fred Hutchinson Cancer Research Center|Jonathan B. Bricker, Ph.D.|206-667-5074|jbricker@fredhutch.org|
21268634|NCT01428882|Hospital San Pedro de Alcantara, Caceres|Dr. Javier Molina-Infante|0034927621543|xavi_molina@hotmail.com|
21268635|NCT01678586|Massachusetts General Hospital|Dr. Lucy Chen|617-724-6102|mghpainresearch@partners.org|
21268636|NCT02967393|Vanderbilt University Medical Center|Kathryn M. Edwards MD|615-322-8792|kathryn.edwards@vanderbilt.edu|
21268637|NCT00429026|U.T. M.D. Anderson Cancer Center|Naoto Ueno, MD, PhD / Associate Professor|713-792-8754|CR_Study_Registration@mdanderson.org|
21268638|NCT01694849|GENFIT|Carol Addy, MD MMSc|+01 6179536469||
21268639|NCT00895817|Walter Reed Army Medical Center|Dr. Fouad J Moawad|(301) 295-4600|fouad.moawad@us.army.mil|
21268640|NCT02223520|Johns Hopkins Medical Institutions|Aaron M. Milstone, M.D., M.H.S.|410-614-3917|amilsto1@jhmi.edu|
21268641|NCT00570492|GlaxoSmithKline|GSK Response Center|866-435-7343||
21268642|NCT00976989|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21268643|NCT04930562|BioNova Pharmaceutical Limited Company|Medical Director|+86(21)50901280|yu.wang@bionovapharma.com|
21268644|NCT00889928|Ethicon Endo Surgery, Inc|Sheryl Helsinger|513-337-3079|SHelsing@its.jnj.com|
21268645|NCT00752206|SARC|SARC|(734) 930-7600|sarc@sarctrials.org|
21268646|NCT01484691|University of California, San Francisco|PI: Prescott G. Woodruff, MD, MPH|415-514-2061|prescott.woodruff@ucsf.edu|
21268647|NCT04717466|University of Miami|Dr. Hideki Mochizuki|305-234-4472|hxm414@med.miami.edu|
21268648|NCT05705544|Vanderbilt University Medical Center|Dr. Fabian Maldonado|(615) 322-5000|fabien.maldonado@vumc.org|
21268649|NCT04668157|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21268650|NCT03958045|University of Kentucky|Dr. Zhonglin Hao|859-218-6704|zhonglin.hao@uky.edu|
21268651|NCT03550989|Philip Morris Products S.A.|Christelle Haziza, Director Health Science and Biostatistics|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
21268652|NCT05437211|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21268653|NCT00674440|Children's Hospital of Philadelphia/Perelman School of Medicine, University of Pennsylvania|Lisa J. States, MD|267-425-7146|states@chop.edu|
21268654|NCT02221882|Eli Lilly and Company|Chief Medical Officer|800+545-5979|ClinicalTrials.gov@lilly.com|
21268655|NCT00796367|Vivus, Inc|Wesley W Day, PhD|650.934.5200|day@vivus.com|
21268656|NCT04828993|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21268657|NCT00617942|Brown University Oncology Research Group (BrUOG)|William Sikov, MD|4018633000|BrUOG@brown.edu|
21268658|NCT03679117|Lifespan Hospital|Margaret Bublitz|401-323-3356|mbublitz@lifespan.org|
21268659|NCT04095039|Duke University School of Medicine|Hrishikesh Chakraborty, DrPH|919-668-1238|hrishikesh.chakraborty@duke.edu|
21268660|NCT04794491|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@jazzpharma.com|
21268661|NCT02023515|UKentucky|Kelly Webber, PhD, RD, LD|859-257-4351|kelly.webber@uky.edu|859
21268662|NCT01314261|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21268663|NCT02129192|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21268664|NCT01231620|GlaxoSmithKline|GSK Response Center|866-435-7343||
21268665|NCT01466972|University of California, San Francisco|Dr. Hope Rugo, MD|(415) 353-7070|Hope.Rugo@ucsf.edu|
21268666|NCT01143818|Abbott|Global Medical Services|800-633-9110||
21268667|NCT01756209|Pugliese Hospital of Catanzaro|Dr Francesco Peltrone, Responsible of clinical trial|+.39 0961 7123222|gallelli@unicz.it|
21268668|NCT01633398|National University Health System, Singapore|Carolyn Lam|(65)67048965|carolyn.lam@duke-nus.edu.sg|
21268669|NCT03216499|Adult Brain Tumor Consortium (ABTC)|Roy Strowd, MD|410-955-8837|jfisher@jhmi.edu|
21268670|NCT04557189|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21268671|NCT01479777|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.|Dr. Cristina Sadowsky|443-923-9210|sadowsky@kennedykrieger.org|
21268672|NCT04717323|Altec Inc.|Dr. Paola Contessa|5085458236|pcontessa@altecresearch.com|
21268673|NCT01553708|Faculty of Pharmaceutical Sciences, Chulalongkorn University|Associate Prof. Pornanong Aramwit, Pharm.D., Ph.D.|+66-02-218-8409|paramwit@gmail.com|
21268674|NCT05461742|Brown University|Dr. Tayla von Ash|401-863-6192|tayla_ash@brown.edu|
21268675|NCT00869362|Massachusetts General Hospital Diabetes Center|Deborah J. Wexler MD|617-726-8722|dwexler@partners.org|
21268676|NCT01241591|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21268677|NCT00478218|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
21268678|NCT02335229|St. Jude Medical|Jennifer Duggan|+32(0)27746827|jduggan@sjm.com|
21268679|NCT02389621|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
21285708|NCT01464190|Vifor Pharma|Medical Information|41 58 851 8222|medinfo@viforpharma.com|
21285709|NCT01896193|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21285710|NCT03407417|University of Florida|Dr. Benjamin Lok|352-214-9829|lok@ufl.edu|
21268680|NCT04158466|Bausch Health|Study Director|(585) 338-6399|robert.steffen@bausch.com|
21300933|NCT02504151|Yale|Dr. Mohini Ranganathan|(203)932-5711|mohini.ranganathan@yale.edu|2546
21300934|NCT05038982|Johns Hopkins University|Shawn Kwatra|410-502-7546|skwatra1@jhmi.edu|
21300935|NCT00472576|Experimental Therapeutics and Pathophysiology Branch, DIRP, NIMH|Dr. Carlos Zarate|301-451-0861|zaratec@mail.nih.gov|
21300936|NCT04170608|FARAPULSE|Christopher Schneider|617-686-7661|kschneider@farapulse.com|
21300937|NCT01454102|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21300938|NCT04355143|University of California Los Angeles|Reza Ardehali, MD, PhD|310-825-5280|rardehali@mednet.ucla.edu|
21300939|NCT03739203|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21300940|NCT01782378|VA Boston Healthcare System, Jamaica Plain Campus, Boston, MA|Margaret Naeser, PhD|857-364-4030|Margaret.Naeser@va.gov; mnaeser@bu.edu|
21300941|NCT00830440|GI Dynamics, Inc.|Manager of Clinical Affairs|781.357.3263|kwoessner@gidynamics.com|
21300942|NCT02592798|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21300943|NCT01188343|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21300944|NCT01143246|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
21257265|NCT02988661|Emory University|Cristina Drenkard, MD, PhD|404-251-8901|cdrenka@emory.edu|
21257266|NCT01392677|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
21257267|NCT01380379|Stanford University|Dr. Jennifer Keller|650-724-0070|jkeller@stanford.edu|
21257268|NCT02324075|Stanford University|Prof. Stephen P. Luby, MD|+1-650-723-4129|sluby@stanford.edu|
21257269|NCT05493280|UT Southwestern|Lead Coordinator|214-645-8907|jennifer.barillas@utsouthwestern.edu|
21257270|NCT06608368|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
21257271|NCT01258504|University of Heidelberg|Prof. Dr. med. Gerd Mikus|4962215639197|gerd.mikus@med.uni-heidelberg.de|
21257272|NCT02530528|MicroBioTest|Dr. MH Bashir|7039250100|muhammad.bashir@microbac.com|
21257273|NCT02611154|Sports Medicine Research & Testing Laboratory|Dr. Geoffry Miller|801-994-9519|gmiller@smrtl.org|
21257274|NCT02982954|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21257275|NCT02634151|NeuroBo Pharmaceuticals|Vice President Clinical Operations|+1 (857) 702-9600|info@neurobopharma.com|
21257276|NCT02347098|VA North Texas Health Care System, Dallas, TX and University of Texas Southwestern Medical Center|Dr. Subhash Banerjee|214-857-1608|Subhash.Banerjee@va.gov, Subhash.Banerjee@UTSouthwestern.edu|
21257277|NCT01444742|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor|713-745-3428|CR_Study_Registration@mdanderson.org|
21257278|NCT02830880|Emory University|David Schuster, MD|(404) 712-4859|dschust@emory.edu|
21257279|NCT00871845|Allegheny Singer Research Institute|Hossam Kandil||Hossam.KANDIL@ahn.org|
21257280|NCT00896779|Stanford University|Steven Sanislo, MD|650-723-6995|ssanislo@stanford.edu|
21257281|NCT01843842|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Head of department of clinical trials|+74952761575|PutilovskiyMA@materiamedica.ru|302
21257282|NCT01376778|The George Washington University Biostatistics Center|Dr. Rebecca Clifton, MFMU Principal Investigator|301-881-9260|rclifton@bsc.gwu.edu|
21257283|NCT03462576|Exalenz Bioscience|Avrahm Hershkowitz/ Clinical Trial Manager|972-8-9737513|avrahamh@exalenz.com|
21257284|NCT00271596|University of Iowa; Elks Rehab Hospital|Leigh Beglinger, PhD|319-353-4489|leigh-beglinger@elksrehab.org|
21257285|NCT01063075|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21257286|NCT01329679|DavidGrant|Sachin Shah|707-423-3277|sshah@pacific.edu|
21257287|NCT04206605|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21257288|NCT05879107|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21257289|NCT00685880|Mayo Clinic|Dr. Jeffrey S. Brault|507-284-1643|brault.jeffrey@mayo.edu|
21257290|NCT02662036|Washington University School of Medicine|Terence Myckatyn, M.D.|314-996-8800|myckatyn@wustl.edu|
21257291|NCT03418129|Duke University|Eric Elbogen, Ph.D.|919-684-9983|eric.elbogen@duke.edu|
21257292|NCT02087956|University of Rochester|Dr. Ellen Poleshuck|585-275-3138|ellen_poleshuck@urmc.rochester.edu|
21257293|NCT00942175|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21257294|NCT01940471|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21257295|NCT02973087|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21257296|NCT03710486|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21257297|NCT00445705|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21257298|NCT01279850|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21257299|NCT01147744|GlaxoSmithKline|GSK Response Center|866-435-7343||
21257300|NCT01555567|University of Michigan|Riann Palmieri-Smith|7346153154|riannp@umich.edu|
21257301|NCT01342484|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21257302|NCT01840579|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21257303|NCT01058070|Torax Medical, Inc.|VP of Clinical Affairs|651-361-8900|aderosier@toraxmedical.com|
21257304|NCT03302975|Univeristy of British Columbia|Chris Napier|604-721-1310|chris.napier@ubc.ca|
21257305|NCT01436084|University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Professor, Leukemia|1-877-MDA-6789|CR_Study_Registration@mdanderson.org|
21257306|NCT03067571|The University of Texas MD Anderson Cancer Center|Gautam Borthakur MD/Professor|713-563-1586|gborthak@mdanderson.org|
21257307|NCT03497806|Finch Therapeutics|Dr. Shrish Budree|(857) 322-4646|sbudree@finchtherapeutics.com|646
21300945|NCT01663103|University of Colorado Anschutz Medical Campus|Dr. Kristen Nowak|303-724-4842|Kristen.Nowak@ucdenver.edu|
21300946|NCT00363480|GlaxoSmithKline|GSK Response Center|866-435-7343||
21268681|NCT02815540|Gillette Children's Specialty Healthcare|Director of Research|651-229-1745|Research@gillettechildrens.com|
21257308|NCT02090413|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21257309|NCT05419128|CHESS - University of Wisconsin--Madison|Kasey Thompson|608-590-7821|kfwagner@wisc.edu|
21257310|NCT05248295|MGH IHP|Lauryn Zipse|6176433245|lzipse@mghihp.edu|
21257311|NCT04066491|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21257312|NCT04506086|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21257313|NCT04490018|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21257314|NCT01839396|Boston Scientific|Roshini Jain, Director of Clinical Sciences|6619494355|roshini.jain@bsci.com|
21257315|NCT02321930|UCLA|Veena K. Ranganath|310-825-4321|vranganath@mednet.ucla.edu|
21257316|NCT01484977|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493||
21257317|NCT01133379|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
21257318|NCT00591214|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21257319|NCT02726971|Department of Hysteroscopic Center, Fuxing Hospital, Capital Medical University, Beijing, China|Dr. YH Liu|8618301474064|emmagj@126.com|
21257320|NCT00597753|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
21257321|NCT03080883|Mayo Clinic|Dr. Robert McBane|(507)266-3964|mcbane.robert@mayo.edu|
21268682|NCT00726882|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21268683|NCT00594568|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21268684|NCT01249625|University of Texas Southwestern|Dr. Trish Perl|214-648-9022|Trish.Perl@UTSouthwestern.edu|
21268685|NCT00290511|UT MD Anderson Cancer Center|Dr. Felipe Samaniego, MD-Professor, Lymphoma-Myeloma|(713) 745-6824|fsamaniego@mdanderson.org|
21268686|NCT02204449|UHN Toronto|Dr. Sherry Grace|416.736.2100|sgrace@yorku.ca|22364
21268687|NCT04645342|UCSF|Dr. Thomas Dewland|415-476-5706|thomas.dewland@ucsf.edu|
21268688|NCT01976663|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
21268689|NCT04780776|Boston University School of Medicine|Dr. Michael F. Holick|(617) 358-6139|mfholick@bu.edu|
21268690|NCT05888740|Vibrato Medical|Vice President of Clinical Affairs|2139215088|bisrat@vibratomedical.com|
21268691|NCT03113760|AB2 Bio Ltd.|Eduardo Schiffrin|+41 21 694 00 40|eduardo.schiffrin@ab2bio.com|
21268692|NCT01982942|Medicinova Inc|Director, Medical Writing|8582468680|makhay@medicinova.com|
21268693|NCT04384120|Henry Ford Health|Dr. Joseph Tramer|2165362904|jtramer1@hfhs.org|
21268694|NCT01151085|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21268695|NCT03246152|Cairo University|Dr. Ayman Elnahry|00201224927604|ayman_elnahri@hotmail.com|
21268696|NCT01243762|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21268697|NCT00003526|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
21268698|NCT02059265|NRG Oncology|Christopher Purdy on behalf of Austin Miller|(716)845-1300|purdyc@nrgoncology.org|2296
21268699|NCT01499498|Imperial College London|Dr Borja Mora Peris|020 3312 6789|b.mora-peris@imperial.ac.uk|
21268700|NCT03303144|Rockwell Medical|Dr Ray Pratt|248 960-9009|rpratt@rockwellmed.com|405
21268701|NCT03358407|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21268702|NCT00483574|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21268703|NCT03605758|Albert Einstein College of Medicine|Dr. Christina Coyle|718-430-3525|christina.coyle@einsteinmed.edu|
21268704|NCT04804579|Boston University School of Public Health|Theresa W. Kim MD|(617) 414-6932|therkim@bu.edu|
21268705|NCT00489411|University of Michigan School of Nursing|Ellen Lavoie Smith, PhD, APRN, AOCN, FAAN|734-936-1267|Ellenls@med.umich.edu|
21268706|NCT04436497|Healey Center for ALS at Massachusetts General Hospital|Healey Center for ALS Project Management|833-425-8257 (HALT ALS)|healeyalsplatform@mgh.harvard.edu|
21268707|NCT01748162|University of Michigan|Dr. David J. Brown||davidjb@med.umich.edu|
21268708|NCT03219372|Cedars Sinai Medical Center|Shehnaz K. Hussain, PhD, ScM|310-429-9859|Shehnaz.Hussain@cshs.org|
21268709|NCT03841331|Menlo Therapeutics, Inc.|Iain Stuart|1-800-775-7936|Iain.Stuart@foamix.com|
21268710|NCT04145531|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
21268711|NCT04640168|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
21268712|NCT00779857|AtriCure, Inc.|Jim Lucky|1-513-755-4101|jlucky@atricure.com|
21268713|NCT00635362|University of Chicago|Amy Whitaker, MD|773-834-4129|awhitaker@babies.bsd.uchicago.edu|
21285711|NCT00844090|Omaha VA Medical Center|Cyrus Desouza MD|402-995-5506|cyrus.desouza@va.gov|
21268714|NCT04338685|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21237881|NCT02216773|Imperial College London|Professor Long Jiao|+44 2033133937|l.jiao@imperial.ac.uk|
21237882|NCT00528775|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21237883|NCT01995461|Marshfield Clinic Research Foundation|Dr. Rachel Stankowski|715-389-3442|stankowski.rachel@mcrf.mfldclin.edu|
21237884|NCT00540124|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21237885|NCT01163097|Swedish Orphan Biovitrum|Medical Program Director|+46 8 697 20 00|clinical@sobi.com|
21237886|NCT04540874|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21268715|NCT00234533|Ipsen|Medical Director, Pediatric Endocrinology||clinical.trials@ipsen.com|
21268716|NCT02967055|University of Colorado Anschutz Medical Campus|Aaron Lazorwitz|3037242019|aaron.lazorwitz@cuanschutz.edu|
21257352|NCT00388973|AstraZeneca|Medical Science Director, Seroquel||AZTrial_Results_Posting@astrazeneca.com|
21257353|NCT01652885|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21268717|NCT00908375|Northwestern University|K Malik|3129262280|kmalikmd@yahoo.com|
21268718|NCT02279888|Vanderbilt University Medical Center|Dr. Lynne Stevenson|6159368187|lynne.w.stevenson@vanderbilt.edu|
21237887|NCT00796302|Ohio State University|Michael Aman|614-688-4196|Aman.1@osu.edu|
21300947|NCT05465317|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
21268719|NCT03449342|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21285712|NCT01460732|Hypertension Center, Third University Department of Medicine|George S. Stergiou|0030 210 7763117|gstergi@med.uoa.gr|
21285713|NCT01048541|Coloplast|Kristine Gjødsbøl, PhD|+4549113557|dkkg@coloplast.com|
21285714|NCT01300247|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21285715|NCT00922116|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21285716|NCT05612217|Servier|olga linnik|8-495-93707-00|olga.linnik@servier.com|
21285717|NCT03060291|University of Oregon Prevention Science Institute|Dr. Allison Caruthers|503-412-3770|ascaru@uoregon.edu|
21285718|NCT00718094|University Louisville|Gerald Dryden, MD|502-852-0156|gwdryd01@louisville.edu|
21285719|NCT00618826|University of Cincinnati|Alison Kastl|513-584-0436|kastla@ucmail.uc.edu|
21285720|NCT03193047|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
21285721|NCT05171270|University of Oxford|Professor Laura Coates|07870257823|laura.coates@ndorms.ox.ac.uk|
21285722|NCT01509664|New York Obesity Nutrition Research Center|Dr Allan Geliebter|212-523-4184|ag58@columbia.edu|
21285723|NCT00613379|Cytodyn, Inc.|Dr. Nader Pourhassan|360-980-8524|npourhassan@cytodyn.com|
21285724|NCT02404610|Hennepin Healthcare|Audrey Hendrickson|6128739528|audrey.hendrickson@hcmed.org|
21285725|NCT02306850|Saint Louis University|John Richart, MD|314-577-8854|john.richart@health.slu.edu|
21285726|NCT02420262|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
21285727|NCT01210222|NRG Oncology|Linda Gedeon for Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org|
21285728|NCT05593770|Research Organization (KC) Ltd|Clinical Project Manager|+44 (0) 7494 795 982|nectar@rokcservices.com|
21285729|NCT02098395|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21285730|NCT01310582|Clinical Research Group|Kirtanaa Voralu, Associate Director Research Management|215-255-7878|kirtanaa.voralu@drexelmed.edu|7878
21285731|NCT01861002|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Roy Leong, BA, CCRP|323-361-5132|rleong@chla.usc.edu|
21285732|NCT04060797|Zhongda Hospital Affiliated to Southeast University|Dr. Gaojun Teng|13805175100|gjteng@vip.sina.com|
21285733|NCT00110357|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21285734|NCT04004260|Lamar University|Vinaya Manchaiah, Jo Mayo Endowed Professor|(409) 821 9443|vmanchaiah@lamar.edu|
21285735|NCT03774888|University of Alabama at Birmingham|Hussein Basma, DDS, MS|2059344506|basma86@uab.edu|
21285736|NCT02360280|Minneapolis VA Medical Center|Paulo R. Shiroma|612-467-2264|paulo.shiroma@va.gov|
21285737|NCT02536105|Massachusetts General Hospital|Dr. Thomas Spencer|617-724-5600|spencer@helix.mgh.harvard.edu|
21285738|NCT04585243|Pennsylvania State University College of Medicine|Jennifer L. Moss, PhD|717-531-0003|jmoss1@pennstatehealth.psu.edu|323429
21300948|NCT04634253|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21300949|NCT04355169|Shionogi Inc.|Shionogi Clinical Trials Administrator Clinical Support Help Line|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
21300950|NCT02048670|Mayo Clinic|Dr. Devin L. McCaslin|507-284-3410|mccaslin.devin@mayo.edu|
21300951|NCT01457703|University of Colorado Denver|Clinical Research Regulatory Manager|303-724-6501|Chanel.mansfield@ucdenver.edu|
21300952|NCT01658436|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|trialandresults.registries@novartis.com|
21237888|NCT01777854|UH|Carissa Wentland DO|320-392-4737|carissa.wentland@gmail.com|
21285739|NCT06329687|Oyster Point Pharma Inc|Marian Macsai, MD|3122592477|marian.macsai@viatris.com|
21285740|NCT02733341|The Royal Wolverhampton NHS Trust|Professor James Cotton|01902307999|jamescotton@nhs.net|
21285741|NCT04156906|The Children's Hospital of Philadelphia|Stella Chou, MD|215-590-0947|chous@chop.edu|
21285742|NCT05415462|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
21285743|NCT00290654|Masonic Cancer Center, University of Minnesota|Todd Tuttle, M.D.|612-625-2991|tuttl005@umn.edu|
21285744|NCT01408719|Agriculture and Agri-food Canada|Dr. Nancy Ames|204-474-7187|nancy.ames@agr.gc.ca|
21285745|NCT00544908|City of Hope|Paul Frankel, Ph.D.|626-256-4673|pfrankel@coh.org|65265
21285746|NCT02998996|Eurocine Vaccines AB|Anna-Karin Maltais|+46 76 233 81 62|annakarin.maltais@eurocine-vaccines.com|
21285747|NCT02022735|University of Miami|Corneliu Luca, MD, PhD|305-243-6732|cluca@med.miami.edu|
21285748|NCT01087203|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21285749|NCT00537290|Hospital for Special Surgery|Doruk Erkan, MD|212 774-2291|erkand@hss.edu|
21285750|NCT04388176|Vicore Pharma AB|Carl-Johan Dalsgaard|+46 70 975 98 63|carl-johan.dalsgaard@vicorepharma.com|
21285751|NCT00360009|University of Florida Department of Neurology|Michael Okun, M.D.|352-273-5550|okun@neurology.ufl.edu|
21285752|NCT01616160|Massachusetts General Hospital|Daniel L. Hamilos, M.D.|617-726-5090|dhamilos@partners.org|
21285753|NCT01540513|University of Wisconsin Carbone Cancer Center|Dr. Lance Hall|608-263-5585|lhall@uwhealth.org|
21285754|NCT02273362|Mayo Clinic|Kenneth K. Tanabe, M.D.|507-284-2511|ktanabe@partners.org|
21285755|NCT03283930|National Institute of Mental Health (NIMH)|Dr. Daniel Pine|+1 301 594 1318|daniel.pine@nih.gov|
21285756|NCT00805129|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin, MD|646-888-4700|bajorind@mskcc.org|
21285757|NCT02600611|Motif BioSciences|David Huang|936-577-5770|david.huang@motifbio.com|
21285758|NCT00571662|University of Nebraska Medical Center|R Gregory Bociek|402-559-5388|rgbociek@unmc.edu|
21285759|NCT02588664|Wake Forest University Health Sciences|Dr. Pamela W. Duncan|(336) 716-5068|pduncan@wakehealth.edu|
21285760|NCT03167255|NS Pharma, Inc.|Medical Affairs|+1(201) 986-3860|trialinfo@nspharma.com|
21285761|NCT01429298|Department of Emergency Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-7464|achang@montefiore.org|
21285762|NCT03866278|Massachusetts General Hospital|Principal investigator|6176709739|patrick.purdon@MGH.HARVARD.EDU|
21257354|NCT00075400|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
21257355|NCT01183559|Igor Astsaturov, MD, PhD, Assistant Professor, Medical Oncology|Igor Astsaturov, MD, PhD, Assistant Professor, Medical Oncology|215 728-3135|Igor.Astsaturov@fccc.edu|
21257356|NCT03723707|NYU Langone Health|Mauricio Arcila-Mesa|646-501-4660|Mauricio.arcila-mesa@nyulangone.org|
21257357|NCT00075023|NINR/NIH|Suzanne Wingate|301-827-0982|suzanne.wingate@nih.gov|
21257358|NCT04342871|UNC Lineberger|Eliza Park|919-966-3494|leeza_park@med.unc.edu|
21257359|NCT03382665|Zimmer Biomet|Fabrizio Lucchini, Clinical Jr.Project Lead|0041798575924|Fabrizio.Lucchini@zimmerbiomet.com|
21257360|NCT00666458|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21257361|NCT01429584|University of Utah Department of Anesthesiology|Dr. Elizabeth Thackeray|(801) 581-6393|elizabeth.thackeray@hsc.utah.edu|
21257362|NCT04002037|UMissourri|Vicki L Jones|573-882-7583|jonesvicki@health.missouri.edu|
21257363|NCT00750698|Syndax Pharmaceuticals|Syndax Pharmaceuticals|781-419-1400|clinicaltrials@syndax.com|
21257364|NCT00402649|University of Maryland Center for Vaccine Development|Ina Stephens, MD|410-706-1123|istephen@medicine.umaryland.edu|
21257365|NCT01999465|University of Michigan|Dr. Lynda Yang|7349365017|bpclinic@umich.edu|
21257366|NCT02325219|Janssen Pharmaceutical K.K., Japan|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21257367|NCT02187172|University of Pennsylvania|Dr. Joel Gelfand|215-662-3514|joel.gelfand@pennmedicine.upenn.edu|
21257368|NCT01523496|University Hospitals Cleveland Medical Center|Dr Grace McComsey|216-844-2739|Grace.McComsey@UHhospitals.org|
21257369|NCT02933034|Stanford University|Phillip C. Yang|(650) 498-8008|phillip@stanford.edu|
21257370|NCT01549275|Kaohsiung Medical University Hospital|Dr. Zu-Yau LIn|886-7-323-4553|linzuyau@yahoo.com.tw|
21257371|NCT06243198|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21257372|NCT03179891|Aquestive Therapeutics|Director of Clinical Operations|908-941-1900|clinicaltrials@aquestive.com|
21257373|NCT02605187|Stanford University School of Medicine|Dr. Brendan Carvalho|650-861-8607|bcarvalho@stanford.edu|
21257374|NCT02969187|Cleveland Clinic|Dr. Philip R. Schauer|216-444-4794|schauep@ccf.org|
21257375|NCT01761084|University of Waterloo|Dr. Lora Giangregorio|5198884567|lmgiangr@uwaterloo.ca|36357
21257376|NCT00940589|Neurim Pharmaceuticals (1991) LTD|Amnon Katz|972-3-768-4906|amnonk@neurim.com|
21257377|NCT03719690|Kura Oncology, Inc.|Clinical Operations|617-588-3755|KO-TIP-007@kuraoncology.com|
21257378|NCT02006342|The University of Texas Health Science Center at Houston|Dr. Pratik B. Doshi|713-608-6537|Pratik.B.Doshi@uth.tmc.edu|
21257379|NCT00530270|Rho Federal Systems Division|Karen Kesler, PhD|919-408-8000|karen_kesler@rhoworld.com|244
21257380|NCT01517529|University of Cincinnati|Dr. Mohamed Tarek M Shata|(513) 558-6110|mohamed.shata@uc.edu|
21257381|NCT03374189|St. Vincent's Hospital|Dr. Hee Youn Kim|82-31-249-7473|khyoun10589@gmail.com|
21257382|NCT02375724|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
21257383|NCT00330382|University of California, Irvine|Dr. Frank Meyskens, Jr.|714-456-6310|flmeyske@uci.edu|
21257384|NCT04712110|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21257385|NCT01197521|AstraZeneca|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
21257386|NCT02018822|University of Rochester|Hans Malmstrom|585-275-5087|hans_malmstrom@urmc.rochester.edu|
21257387|NCT02285777|GlaxoSmithKline|GSK Response Center|866-435-7343||
21257388|NCT03201458|Johns Hopkins University|Grants Administrative Manager|4439273568|JHCCCRO@jhmi.edu|
21257389|NCT01785459|Carolinas Medical Center|Dr. Sean Fox|704-355-3181|Sean.Fox@atriumhealth.org|
21285763|NCT00227019|Stanford University|Heather Wakelee, MD|650-736-7221|hwakelee@stanford.edu|
21285764|NCT02500719|University of Arkansas for Medical Sciences|Dr. Keith A. Bush|501.526.8347|kabush@uams.edu|
21285765|NCT00181883|Massachusetts General Hospital|Janet Wozniak, MD|617-503-1038|jwozniak@partners.org|
21285766|NCT05305989|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
21285767|NCT00585325|University of Wisconsin-Madison|Cindy Schmitz, RN, MS, NP|608-262-2664|CSchmitz@uwhealth.org|
21285768|NCT00154375|Novartis Pharmaceuticals|Study Director|862-778-8300||
21285769|NCT03538691|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21285770|NCT01909141|Cairo University|Dr. Ghada Abdel Fattah|00201006513305|ghadaabdelfatah2007@yahoo.com|
21285771|NCT04672044|Birmingham VA Medical Center|Research Integrity Officer|2059338101|latanya.higginbottom@va.gov|337436
21285772|NCT00792116|Baylor|Craig Johnston|713-798-2068|caj@bcm.edu|
21285773|NCT02453256|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21285774|NCT03479944|Alcon Japan Ltd.|Group Manager, Surgical, Alcon Japan|03-6899-5061|alcon.medinfo@alcon.com|
21285775|NCT00729300|Baylor College of Medicine|Christopher Verrico|713-791-1313|verrico@bcm.edu|26020
21285776|NCT01066871|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21285777|NCT01680653|Stanford University|Dr. Bruce Buckingham|650-725-6549|bbendo@stanford.edu|
21285778|NCT01941537|Rockefeller University|James Krueger|2123277730|kruegej@rockefeller.edu|
21285779|NCT05259163|Evolution Optiks|Raul Mihali|2039815480|raul.mihali@evolutionoptiks.com|
21285780|NCT05251233|Washington University School of Medicine|Natasha Leigh-Matijakovich, M.D.|314-362-7147|leigh@wustl.edu|
21285781|NCT00913081|University of Pennsylvania|Richard L. Dunbar, MD, PI|609 413-1067|richard.dunbar@uphs.upenn.edu|
21285782|NCT00452439|University of Texas (UT) MD Anderson Cancer Center|Maria Cabanillas, Associate Professor, Endocrine Neoplasia and HD|(713) 563-0764|mcabani@mdanderson.org|
21285783|NCT01550510|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Daniel Monti|215 955-2221|daniel.monti@jefferson.edu|
21285784|NCT03440619|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
21285785|NCT00463801|Novartis Pharmaceuticals|Study Director|862-778-8300||
21285786|NCT00669318|Mayo Clinic Cancer Center|Timothy G. Call MD||call.timothy@mayo.edu|
21285787|NCT01431313|University of Pittsburgh|Marc A. Simon, MD|4128023131|SIMONMA@UPMC.EDU|
21285788|NCT02484092|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21285789|NCT00215644|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
21285790|NCT05554640|Johnson & Johnson Vision Care (JJVC)|John R. Buch, O.D., M.S.|1-800-843-2020|jbuch@its.jnj.com|
21285791|NCT03512353|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21285792|NCT03569098|Ipsen Pharma|Medical Director|see email|clinical.trials@ipsen.com|
21285793|NCT03939923|West Virginia University|Director of Research in Department of Anesthesiology|304-598-4122|david.scalzo@hsc.wvu.edu|
21285794|NCT02581488|Smith and Nephew|SR. Clinical Study Manager, US Global Clinical Operations|+1 817-302-3959|Darrell.Lange@smith-nephew.com|
21300953|NCT03987503|University of California, San Francisco|Dr. Meghan D. Morris, Associate Professor|415-574-0651|meghan.morris@ucsf.edu|
21300954|NCT00702299|University of Arizona|Dr. Setsuko Chambers|520/626.0950|schambers@azcc.arizona.edu|
21300955|NCT02708186|Axovant Sciences GMBH|Senior Director of Clinical Research|1-833-296-8268|clinicaltrials@axovant.com|
21300956|NCT00888940|Cubist Pharmaceuticals, Inc.|Alistair Wheeler, MD MFPM, Senior Director Clinical Research|781-860-8660|awheeler@cubist.com|
21300957|NCT03801408|University of Arkansas for Medical Sciences|Sara Jones, Principal Investigator|501-526-7846|sljones@uams.edu|
21300958|NCT01662765|Bahcesehir University, School of Medicine|Dr. Mehmet Kaplan|+905056268899|dr.kaplan27@gmail.com|
21300959|NCT04377659|Memorial Sloan Kettering Cancer Center|Dr. Boglarka Gyurkocza, MD|646-608-3768|gyurkocb@mskcc.org|
21300960|NCT00664443|Ottawa Hospital Research Institute|Manya Charette|613-798-5555|mancharette@ohri.ca|17758
21300961|NCT02202759|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21300962|NCT01987453|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21300963|NCT04953728|University of Michigan|Jiande Chen|734-764-3880|cjiande@med.umich.edu|
21300964|NCT01646125|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21300965|NCT02105662|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21300966|NCT02331277|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21300967|NCT02042274|University of Guelph|Dr. David Mutch, Associate Professor|519-824-4120|dmutch@uoguelph.ca|53322
21300968|NCT01376804|Hoffman-LaRoche|Medical Communications|800-821-8590||
21300969|NCT01071798|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21300970|NCT00842296|Medtronic|Stephanie Brucato, Principal Clinical Research Specialist|508-261-8000|stephanie.m.brucato@medtronic.com|
21300971|NCT04816552|Johns Hopkins School of Public Health|Dr. Christine Marie George|(202) 657-5798|cmgeorge@jhu.edu|
21300972|NCT01528969|Kuwait University, Faculty of Dentistry|Prof. Eino Honkala|+965 65638938|eino.honkala@hsc.edu.kw|
21300973|NCT01908062|Oregon Health & Science University|Todd Korthuis|503-494-8044|korthuis@ohsu.edu|
21300974|NCT03584789|HealthPartners Institute|D. Brad Rindal, DDS, Associate Dental Director Research|952-967-5026|donald.b.rindal@healthpartners.com|
21300975|NCT01357525|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS|412-647-5554|stadtermanbm@upmc.edu|
21300976|NCT04646044|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
21285795|NCT01639144|Center for Research & Grants, Baptist Health South Florida|Gary M. Kiebzak, Ph.D., Co-investigator and Clinical Research Administrator|786-268-6224|garyk@baptisthealth.net|
21257390|NCT00715026|Zimmer|Director, Clinical Affairs|574-371-8019|erin.osborn@zimmer.com|
21285796|NCT00983645|Loma Linda University Medical Center Transplantation Institute|Dr. Pedro Baron|909-558-3636|pbaron@llu.edu|36792
21285797|NCT02418234|Hangzhou first people's hospital|Prof. Shenglin Ma|086057156007664|mashenglin@medmail.com.cn|
21257391|NCT04490863|Masimo Corporation|Vikram Ramakanth|949-297-7000|ClinicalResearchDept@masimo.com|
21285798|NCT02121795|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230|ClinicalTrialDisclosures@gilead.com|
21285799|NCT01588158|Massachusetts General Hospital|Neal Chen, MD||nchen1@partners.org|
21285800|NCT01001910|Montefiore Medical Center|Clinical Supervisor|718-405-8395|bkhaksari@montefiore.org|
21285801|NCT03200548|University of Michigan|Suzanna Zick|734-998-9553|szick@med.umich.edu|
21285802|NCT00059228|National Institute of Mental Health|Schmidt, Peter|+1 301 496 6120|peterschmidt@mail.nih.gov|
21285803|NCT00511810|University of Cincinnati|Robert McNamara, PhD|513-558-5601|robert.mcnamara@uc.edu|
21285804|NCT02896569|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
21285805|NCT01462630|Fox Chase Cancer Center|Protocol Development Coordinator|215-728-4097|ryan.romasko@fccc.edu|
21285806|NCT02592447|H Lee Moffitt Cancer Center and Research Institute|Heather Jim, PhD|813-745-6369|Heather.Jim@moffitt.org|
21285807|NCT03428100|Eli Lilly and Company|Chief Medical Officer|800-459-5979|ClinicalTrials.gov@lilly.com|
21285808|NCT03628378|Columbia University Irving Medical Center|Jeffrey A. Geller, MD|212-305-1120|jg2520@cumc.columbia.edu|
21285809|NCT02105285|Otsuka Pharmaceutical Co., Ltd.|Deputy General Manager, Headquarters of Clinical Development|+81-3-6361-7366||
21257392|NCT00761007|Menarini Group- Clinical Research|Angela Capriati MD PhD, Clinical Research Director|+39 055 5680|acapriati@menarini-ricerche.it|9933
21257393|NCT01496131|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21285810|NCT02364388|Seno Medical Instruments, Inc|Shaan Schaeffer, VP Clinical Operations|2106156501|sschaeffer@senomedical.com|
21285811|NCT03231306|UAB|Coretta Thomas, Scientist & Data Manager for NF Consortium|2059758629|coretta@uab.edu|
21285812|NCT02585713|Mayo Clinic|Robert D. McBane, M.D.|507/284-4565|Mcbane.robert@mayo.edu|
21285813|NCT02264210|Sun Yat-sen University Cancer Center|Dr. Si-Yu Wang|86-20-87343439|wangsy@sysucc.org.cn|
21285814|NCT01150903|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21257394|NCT00750737|University of Texas (UT) MD Anderson Cancer Center|Issam Raad, MD / Chair, Infectious Diseases|713-792-7943|CR_Study_Registration@mdanderson.org|
21285815|NCT00573872|University of Alabama at Birmingham|John Fiveash, MD|205-975-0224|jfiveash@uabmc.edu|
21257395|NCT03625687|Massachusetts General Hospital|Raymond Chung, MD|6177247562|Chung.Raymond@mgh.harvard.edu|
21285816|NCT02609984|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21300977|NCT00602472|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21257396|NCT01543828|Novartis Pharmaceuticals|Study Director|862-778-8300||
21257397|NCT00941668|Colgate Palmolive|Willliam DeVizio-DMD|732-878-7901|William_DeVizio@colpal.com|
21257398|NCT01069172|AMO Development, LLC|Luis Atiles, Manager, Clinical Research|214 537-6784|luis.atiles@amo.abbott.com|
21257399|NCT01396226|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21300978|NCT01938716|UT MD Anderson Cancer Center|Dr. Gauri R Varadhachary,Professor, GI Medical Oncology|713-792-2828|gvaradha@mdanderson.org|
21300979|NCT02803580|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21300980|NCT02885025|VA Greater Los Angeles Healthcare System|Joseph Yusin Chief division Allergy Immunology|3104783711|joseph.yusin2@va.gov|40230
21300981|NCT02054104|National Cancer Institute|Dr. David Schrump|240-858-7000|schrumpd@mail.nih.gov|
21300982|NCT01908803|Alcon Research, Ltd.|Sr Clinical Project Lead, GCRA, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
21300983|NCT02404025|Novartis Pharmaceuticals|Study Director|1-888-669-6682|novartis.email@novartis.com|
21300984|NCT00823615|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
21300985|NCT00098813|Memorial Sloan-Kettering Cancer Center|Dr. David Pfister|646-888-4237|pfisterd@mskcc.org|
21300986|NCT00955916|H. Lee Moffitt Cancer Center and Research Institute|Rami Komrokji, M.D.|813-745-4291|rami.komrokji@moffitt.org|
21300987|NCT02230670|Conatus Pharmaceuticals|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
21300988|NCT01943903|HeartFlow|VP, Clinical|408-314-2335|smullen@heartflow.com|
21300989|NCT01907854|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21300990|NCT02215252|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21268720|NCT02283411|Abbott Diabetes Care|Shridhara A Karinka, PhD|510-749-6393|shridhara.alva@abbott.com|
21300991|NCT02118961|Mitsubishi Tanabe Pharma Corporation / The Research Foundation for Microbial Diseases of Osaka University|Clinical Trials, Information Desk / Clinical Development counter||cti-inq-ml@ml.mt-pharma.co.jp/clinicaldevelopment@mail.biken.or.jp|
21300992|NCT05488535|Advanced Bionics|Emily Cardenas, Au.D.|16616785405|Emily.Cardenas@advancedbionics.com|
21268721|NCT01683565|Nationwide Children's Hospital|Dr. Sarah Keim|614-722-3177|Sarah.Keim@nationwidechildrens.org|
21268722|NCT01738672|University of Pittsburgh|Ya'aqov Abrams, MD||abramsym@upmc.edu|
21268723|NCT00945815|SWOG Statistical Center|SWOG Leukemia Statistician|206-667-4408||
21268724|NCT02400281|Arog Pharmaceuticals|Edward McDonald|214-593-0500|emcdonald@arogpharma.com|
21257400|NCT00711425|DENTSPLY Implants|Manager Global Clinical Operations|+46313763500||
21257401|NCT03901079|BSC|Chenchen FAN|+861085216427|chenchen.fan@bsci.com|
21268725|NCT04524507|University of North Carolina at Chapel Hill|Luther Bartelt, MD|919-966-2537|barteltl@ad.unc.edu|
21268726|NCT01066624|South Texas Veterans Health Care System|Juan J Toro|210-617-5300|juan.toro2@va.gov|16777
21285817|NCT01456143|Mt Sinai|Brett Miles||Brett.Miles@mountsinai.org|
21257402|NCT00916149|VA New York Harbor Healthcare System, NYU|Beth Leeman-Markowski, MD|212-686-7500|beth.leeman-markowski@nyumc.org|
21285818|NCT01843803|Department of Veterans Affairs|Frances M Weaver|708-202-5866|frances.weaver@va.gov|
21257403|NCT02997735|Children's Hospital of Philadelphia|Brian Jenssen, MD MSHP|215-554-4390|JenssenB@email.chop.edu|
21285819|NCT01850394|Faculty of Medicine, Ramathibodi Hospital, Mahidol University|Dr. Paphon Sa-ngasoongsong|66-2-2011589|chan3s@hotmail.com|
21285820|NCT00086450|Icahn School of Medicine at Mount Sinai|Dr. Valentin Fuster, M.D., Ph.D.|212-860-1056|valentin.fuster@mssm.edu|
21285821|NCT00784719|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21285822|NCT03509181|McLean Hospital|Courtney Beard|617-855-3557|cbeard@mclean.harvard.edu|
21285823|NCT05285787|Epizon Pharma|John Rudy|2127551000|jrudey@epizonpharma.com|
21285824|NCT03382418|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
21285825|NCT02472886|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21285826|NCT01051817|Novartis Pharmaceuticals|Study Director|862-778-8300||
21285827|NCT00438204|Barbara Ann Karmanos Cancer Institute|Antionette J. Wozniak, M.D., F.A.C.P.|(313)576-8752|wozniakt@karmanos.org|
21285828|NCT00320788|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator||clinicaltrials@regeneron.com|
21285829|NCT03576924|University of British Columbia|Dr. Mary Jung|1-250-807-9670|mary.jung@ubc.ca|
21285830|NCT04533438|Aerin Medical|Sr. Manager of Clinical Operations|312-888-0441|tdang@aerinmedical.com|
21285831|NCT02651337|Alcyone LifeSciences|Director of Clinical Operations|9787091946|jmcguire@alcyonels.com|
21285832|NCT02137226|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21257404|NCT00912028|University of Campinas, Brazil|Carlos E Leite Arieta MD, PhD||ra-visus-clnclstds@its.jnj.com|
21257405|NCT00841568|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
21257406|NCT03002155|University of Washington (affiliation)|Sara Morgan, PhD|651-229-1719|sjmorgan@uw.edu|
21257407|NCT00978029|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21257408|NCT00545298|Nitric BioTherapeutics Inc|Frank J. McCaney, CEO Sponsor|215-788-6200|fmccaney@nbtherapeutics.com|
21257409|NCT01793142|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21257410|NCT01820364|Array BioPharma, Inc.|Study Director|303-381-6604|clinicaltrials@arraybiopharma.com|
21257411|NCT01087775|San Francisco VA Medical Center|Dr. Karen Seal|4152214810|Karen.Seal@va.gov|24852
21257412|NCT00974675|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com|
21257413|NCT00825162|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
21257414|NCT03803059|Crown Laboratories, Inc|Thomas Hitchcock, PhD.|8883723982|THitchcock@crownlaboratories.com|
21257415|NCT02904915|The University of Texas Health Science Center at Houston|Pamela D. Berens, MD|713-500-6471|Pamela.D.Berens@uth.tmc.edu|
21257416|NCT01293968|Qazvin University of Medical Sciences|Dr.Katayun Borhanmojabi|09127841440|ka.mojabi@yahoo.com|
21257417|NCT00255970|RTI Biologics|Clinical Projects, Director|386-418-8888|rparkhurst@rtix.com|
21257418|NCT03996876|University of California, San Francisco|Aoife O'Donovan, Associate Professor of Psychiatry|4152214810|aoife.odonovan@ucsf.edu|x24959
21257419|NCT00121108|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21257420|NCT02971631|University of Cambridge|Mr Geoffrey Roberts|01223767176|geoffroberts@cantab.net|
21257421|NCT04090580|"Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Vasco de Quiroga 15, Belisario Domínguez Secc 16, Tlalpan, 14080, CDMX, Mexico. Department of endocrinology and lipid metabolism"|Miguel Ángel Gómez Sámano|+52 1 55 59939816|miguel.gomezs@incmnsz.mx|
21257422|NCT02562924|University of Vermont Medical Center|Dr. Daniel Gerges|8028474535|daniel.gerges@uvmhealth.org|
21257423|NCT00747643|H. Lee Moffitt Cancer Center and Research Institute|Thomas H. Brandon, Ph.D.|813-745-1750|thomas.brandon@moffitt.org|
21257424|NCT01423162|Food and Nutrition Research Institute|Trinidad P. Trinidad|6328372071|trinidadtp@yahoo.com.ph|2281
21257425|NCT00390546|University of British Columbia|Dr. Shubhayan Sanatani|604-875-2345|ssanatani@cw.bc.ca|7955
21257426|NCT01308008|VA GRECC|Neil Alexander MD|734-845-3048|nalexand@umich.edu|
21257427|NCT01417195|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21257428|NCT01239342|The University of Texas (UT) MD Anderson Cancer Center|Eric Jonasch, MD/Professor, Genitourinary Medical Oncology|713-792-7734|EJonasch@mdanderson.org|
21257429|NCT02918864|Rush University Medical Center|Dr. Latha Valluripalli Soorya|(312) 942-6238|latha_soorya@rush.edu|
21257430|NCT03303950|HCI Research Compliance Office|Data Manager|8015850601|compliance@hci.utah.edu|
21257431|NCT03289650|Northwestern University|Lorenzo Gallon|312 695 4457|l-gallon@northwestern.edu|
21300993|NCT00892099|Massachusetts General Hospital|Dr. Ishir Bhan|617-726-3934|ibhan@mgh.harvard.edu|
21300994|NCT01657019|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21300995|NCT03910244|Cleveland Clinic|Keith McCrae, MD|216-445-7809|mccraek@ccf.org|
21300996|NCT01106690|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
21300997|NCT02346721|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21300998|NCT04455815|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
21300999|NCT02106390|GlaxoSmithKline|GSK Response Center|866-435-7343||
21301000|NCT03219528|University of Michigan|Allen Lee|734-936-4785|allenlee@med.umich.edu|
21301001|NCT00790842|PrECOG|PrECOG Statistician|978-835-3516|jbmanola@gmail.com|
21301002|NCT02968004|OPKO Health, Inc.|OPKO Health, Inc.|3055754100|contact@opko.com|
21301003|NCT05029362|The University of Texas Health Science Center at Houston|Irene Tami-Maury, DMD, MSc, DrPH|(713) 500-9234|Irene.M.Tami-Maury@uth.tmc.edu|
21301004|NCT03734692|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
21257432|NCT01733472|Region Skane|Andreas Harsten|46708870567|andreas.harsten@skane.se|
21257433|NCT02257372|GlaxoSmithKline|GSK Response Center|866-435-7343||
21257434|NCT04325542|Medical Mission Institute|Dr Christa Kasang||christa.kasang@medmissio.de|
21257435|NCT04203745|Candela Medical|Dr. Konika Patel Schallen|508-358-0357|konikap@candelamedical.com|
21257436|NCT00880399|GlaxoSmithKline|GSK Response Center|866-435-7343||
21257437|NCT04353284|Yale School of Medicine|Geoffrey Chupp, MD Professor of Medicine (Pulmonary); Director, Yale Center for Asthma and Airways D|(203) 785-3627|geoffrey.chupp@yale.edu|
21257438|NCT03045861|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21257439|NCT03448068|Mayo Clinic|Dr. Andrew W. Gorlin|480-342-2446|Gorlin.Andrew@mayo.edu|
21257440|NCT04773106|Implandata Ophthalmic Products GmbH|Clinical Study Manager|+49 (0) 511 - 2204 2580|clinical@implandata.com|
21268727|NCT01594424|Cedars-Sinai Medical Center, Comprehensive Transplant Center|Jua Choi, PharmD|310-248-8186|jua.choi@cshs.org|
21301005|NCT00419952|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21268728|NCT00508118|Duke University Medical Center|Andrew Shaw MD|919 286 6938|andrew.shaw@duke.edu|
21268729|NCT02441517|Astellas Pharma Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|5473
21268730|NCT03039699|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
21268731|NCT02911285|Medical University of South Carolina|Stacey Sellers, Program Manager|843-792-5807|sellersst@musc.edu|
21268732|NCT00422227|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21268733|NCT01941472|Peking Union Medical College Hospital|Bin Du|8610-69155036|dubin98@gmail.com|
21268734|NCT00686894|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21268735|NCT00963040|MedVadis Research Corporation|Egilius L.H. Spierings, M.D., Ph.D.|781-588-5430|Spierings@MedVadis.com|
21268736|NCT01790633|Service des maladies infectieuses et tropicales - Hôpital Saint-Antoine|Dr. Julie Bottero|+33 1 49 28 04 24|julie.bottero@aphp.fr|
21268737|NCT02010359|Children's Hospital of Philadelphia|Dr. Rachana Shah|215-590-3390|shahr@email.chop.edu|
21268738|NCT00761462|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21268739|NCT02047929|Carolinas HealthCare System|Dr. Thomas Ludden|704-608-2390|tom.ludden@carolinashealthcare.org|
21268740|NCT02985541|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
21268741|NCT02848781|College of Medicine - Phoenix|Rodrick Tung, MD|602-521-3090|rodricktung@arizona.edu|
21268742|NCT02163759|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21268743|NCT02883400|Atrium Health|Dr. Mark Russo,|704-355-6649|mark.russo@atriumhealth.org|
21268744|NCT00333437|University of California San Francisco|Jeffrey A. Golden, MD|415-353-2935|Jeff.Golden@ucsf.edu|
21268745|NCT02696980|University of Vermont|Anne Dixon, MD|802 847 2700|anne.dixon@uvm.edu|
21268746|NCT03022526|University of Pittsburgh|Dr. Grace Lim|412-641-2179|limkg2@upmc.edu|
21268747|NCT02748096|University of Oxford|Professor Anrew Price|+44 1865 223421|andrew.price@ndorms.ox.ac.uk|
21268748|NCT01756586|University of Chicago|TARIQ MALIK|773-834 3643|tmalik@dacc.uchicago.edu|
21268749|NCT00451191|George Washington University Biostatistics Center|Kathryn Hirst, PhD, Research Professor, PI of coordinating center|301-881-9260|khirst@bsc.gwu.edu|8025
21268750|NCT01972282|St. Antonius Ziekenhuis, Nieuwegein, Netherlands|Dr. Lucas V.A. Boersma||l.boersma@antoniusziekenhuis.nl|
21268751|NCT00846573|UMass Medical School|Dr. Mitchell Albert|(617) 875-2141|albertmi@tbh.net|
21268752|NCT05732610|Medical Group Care|Tomaz Lovse|239 631 1907|tomaz.lovse@mgc.us|
21268753|NCT00656669|IndianaU|Dr. Kathy Miller|317-944-0920||
21268754|NCT03575806|Tsinghua University|Statistician of Clinical Trials||majunfan2@sina.com|
21268755|NCT00219349|New York State Psychiatric Institute|Franklin Schneier MD|2125435368|fschneier@nyspi.columbia.edu|
21268756|NCT03446846|Minerva Neurosciences, Inc.|Head of Research & Development|617.600.7375|jsaoud@minervaneurosciences.com|
21268757|NCT01945034|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21268758|NCT00470301|Montefiore Medical Center|NYCC Coordinating Center|718-405-8404|jsparano@montefiore.org|
21268759|NCT02191033|Yale University|Deepa Camenga, MD|203-737-8310|deepa.camenga@yale.edu|
21268760|NCT02222246|Duke University|Dr. Paula Tanabe|919-613-6038|paula.tanabe@duke.edu|
21268761|NCT02544607|Massachusetts General Hospital|Dr. Cristina Cusin|617-726-6421|ccusin@mgh.harvard.edu|
21268762|NCT00560573|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21268763|NCT01339273|Oxford University Hospitals NHS Trust|Dr Nicholas Crabtree|01865 221590|nicholas.crabtree@ouh.nhs.uk|
21268764|NCT03988049|University of Utah Dermatology|Dr. David Smart, Assistant Professor, Dermatology|8015816465|david.smart@hsc.utah.edu|
21268765|NCT04969653|Momentum Data Ltd|Dr Andrew McGovern|07531221970|andy.mcgovern@momentumdata.co.uk|
21268766|NCT03986216|Northwestern University|Dr. Jun Yao|3129089060|j-yao4@northwestern.edu|
21268767|NCT03413618|Pirogov Russian National Research Medical University|Dr. Kirill Lobastov|+7-985-211-63-31|lobastov_kv@hotmail.com|
21268768|NCT00423137|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21268769|NCT04446182|Huntsman Cancer Institute/University of Utah|Clinicaltrials.gov/CTRP Specialist|8012136215|IITDataManagement@hci.utah.edu|
21268770|NCT04196023|Vanderbilt University Medical Center|Dr. Qi Dai|(615)936-0707|qi.dai@vanderbilt.edu|
21268771|NCT01005810|Medical University of South Carolina|Dr. Kevin M. Gray, Associate Professor|843-792-6330|graykm@musc.edu|
21268772|NCT04359758|Georgetown Lombardi Comprehensive Cancer center|Marc D. Schwartz, PhD|2026870185|schwartm@georgetown.edu|
21268773|NCT01797458|Preventive and Paediatric Dentistry Department of Greifswald University, Germany|Prof. Dr. Christian Splieth|+ 49 3834 867101|splieth@uni-greifswald.de|
21301006|NCT03126591|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21301007|NCT02115048|Translational Research In Oncology (TRIO)|Director, Project Management|+33 1 58 10 09 09|TRIO020.contact@trioncology.org|
21301008|NCT03722238|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21301009|NCT01285323|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21301010|NCT02606643|Saint Louis University|Gary Furhman|314-977-2090|jathompson@slu.edu|
21301011|NCT00217399|Georgetown University|Dr. Claudine Isaacs|202-444-3677|isaacsc@georgetown.edu|
21268774|NCT04753606|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
21268775|NCT02866721|University Hospitals, Rainbow Babies and Children's Hospital|Erica Roesch, MD|(216) 844-3267|Erica.Roesch@UHHospitals.org|
21301012|NCT00093041|Genmab A/S|VP Clinical Operations Eva Järlid Westerberg|+45 7020 2728|E.Westerberg@genmab.com|
21268776|NCT00442572|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21268777|NCT04366258|NYU Langone Health|Dan Iosifescu, MD|646-754-5156|Dan.Iosifescu@nyulangone.org|
21268778|NCT00276458|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21268779|NCT04259905|The University of Texas Medical Branch|Eloisa Martinez|409-266-9643|esmartin@utmb.edu|
21268780|NCT01042288|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21268781|NCT03205046|Acerta Pharma B.V.|Acerta Clinical Trials|1-888-292-9613|acertamc@dlss.com|
21268782|NCT01023815|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21268783|NCT01383759|Memorial Sloan Kettering Cancer Center|Dr. Hani Hassoun|212-639-3228|hassounh@mskcc.org|
21268784|NCT02556112|711 Human Performance Wing, U.S. Air Force|Col Nicole Armitage|937-255-3784|nicole.armitage@us.af.mil|
21268785|NCT01977625|University of Pennsylvania|C. Neill Epperson, M.D|215-573-8871|cepp@mail.med.upenn.edu|
21268786|NCT01717521|UWMC|Dr. Laurent Bollag|2063277328|bollag@uw.edu|
21268787|NCT03455556|Mayo Clinic|Alex A Adjei, MD, PhD|(507) 284-2511|Adjei.Alex@mayo.edu|
21268788|NCT00634933|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21268789|NCT02304484|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21268790|NCT04419558|FibroGen, Inc.|Clinical Trial Information Desk|(415) 978-1427|zephyrus@fibrogen.com|
21268791|NCT03522506|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
21268792|NCT03480243|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21268793|NCT03158532|ISCS|Roberto Léo da Silva|55 48 999099790|robertoleo@hotmail.com|
21268794|NCT06241768|Wake Forest University School of Medicine|Dr. Anna Snavely|336-716-2011|asnavely@wakehealth.edu|
21268795|NCT04957979|HealthPartners Institute|Steven P. Dehmer, PhD|952-967-5216|steven.p.dehmer@healthpartners.com|
21268796|NCT02566304|Thomas Jefferson University|Usama Gergis, MD|215-955-8874|usama.gergis@jefferson.edu|
21268797|NCT04410991|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21268798|NCT03282123|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
21268799|NCT00764465|GSIDA|David Condoluci|856-566-3190|dcondoluci@gsida.org|
21268800|NCT01195662|ClinicalTrialTransparency|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com|
21268801|NCT03457701|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21268802|NCT03329404|Terumo Blood and Cell Technologies|Robert Cortes, Jr. MD|+1.303.231.4353|Robert.Cortes@terumobct.com|
21268803|NCT01250418|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu|
21268804|NCT00104858|Fred Hutchinson Cancer Research Center|Dr. Mohamed Sorror|206-667-6298|msorror@fredhutch.org|
21268805|NCT06288607|The First Affiliated Hospital with Nanjing Medical University|Dr. Yang Xu|+8613851856794|yangxu@njmu.edu.cn|
21268806|NCT01298323|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21268807|NCT01761565|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
21268808|NCT02161380|Bascom Palmer Eye Institute.|Dr. Byron Lam.|305 326 6021|blam@med.miami.edu|
21268809|NCT05510297|University of Southern California|Dr. Stacey Schepens Niemiec|323-442-2069|schepens@usc.edu|
21268810|NCT04409262|Hoffmann - La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21268811|NCT03572153|Baylor University|Gary Elkins, PhD|254-296-0824|gary_elkins@baylor.edu|
21268812|NCT00948896|University of California, San Francisco|Dr. Grant Dorsey|415-206-4680|grant.dorsey@ucsf.edu|
21268813|NCT01590810|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21268814|NCT02229513|Baylor University Medical Center|Dr. Janice Mitchell, PI|713-705-6240|janicemitchellmd@gmail.com|
21268815|NCT01791543|Vanderbilt University Medical Center|William G Stevenson, MD|1-615-322-2318|william.g.stevenson@vumc.org|
21268816|NCT05981508|Morehouse School of Medicine|Candice L. Alick, PhD|404-752-1009|calick@msm.edu|
21268817|NCT01740297|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21268818|NCT02263118|Ecole Polytechnique|Dr. Jose Tomas Prieto|+50252800643|jose-tomas.prieto@polytechnique.edu|
21268819|NCT00563706|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21268820|NCT04074109|VA Palo Alto Health Care System|Peter Bayley, PhD|650-493-5000|peter.bayley@va.gov|68653
21268821|NCT02383966|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21268822|NCT00887562|Columbia University|Michio Hirano, MD|12123051048|mh29@cumc.columbia.edu|
21268823|NCT00270205|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21268824|NCT00066573|NCIC Clinical Trials Group|Dr. Wendy Parulekar|1-613-533-6430|wparulekar@ctg.queensu.ca|
21268825|NCT03965754|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
21268826|NCT00437294|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21268827|NCT02277665|Dartmouth-Hitchcock|Dr. Alan J. Budney|603-646-7088|alan.j.budney@dartmouth.edu|
21268828|NCT02064231|Coloplast A/S|Birte Petersen Jakobsen, MD|+45 4911 1395|dkbir@coloplast.com|
21268829|NCT05292248|Case Western Reserve University|Kylie Meyer, Principal Investigator|216-368-1928|knm77@case.edu|
21268830|NCT01198327|Wilmer Eye Institute|Peter Campocahiro|410-955-5106|pcampo@jhmi.edu|
21268831|NCT01422876|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21268832|NCT00921934|Department for Complementary and Alternative Medicine|Dr. med. Martin Schencking|+0049-2602-684-614||
21268833|NCT00536991|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21268834|NCT01600755|Cook MyoSite Incorporated|Ron Jankowski, PhD|412-963-7380|Ron.Jankowski@CookMyosite.com|
21268835|NCT00938392|GlaxoSmithKline|GSK Response Center|866-435-7343||
21268836|NCT01366846|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21268837|NCT00122954|Oregon Health & Science University|Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu|
21268838|NCT00626574|University of South Florida|Enrico M Camporesi MD|813-844-7170|ecampore@health.usf.edu|
21268839|NCT01683331|University of Michigan|Akinlolu Ojo|734 936-4890|aojo@umich.edu|
21257441|NCT04172714|Emory University|Nima Kokabi, MD|(404) 778-4747|nima.kokabi@emory.edu|
21268840|NCT00558831|Northwestern University|Amy Paller, MD|312-695-6829|apaller@nmff.org|
21257442|NCT02833922|Institute for Reproductive Health|Dr. Victoria Jennings|2026871392|Victoria.Jennings@georgetown.edu|
21257443|NCT00530894|Edwards Lifesciences|Tenley Koepnick|949-250-6504|tenley_koepnick@edwards.com|
21257444|NCT01349465|Janssen Research & Development, LLC|Study Responsible Scientist||ClinicalTrialDisclosure@its.jnj.com|
21257445|NCT01230242|MaineHealth|Clinicaltrials.gov Administrator|207.396.8228|llemire@mmc.org|
21257446|NCT05433571|Johnson & Johnson Vision Care (JJVC)|Ross Franklin|1-800-843-2020|RFRANKL1@its.jnj.com|
21257447|NCT04329702|Duke University|Christopher Cox|9196817232|christopher.cox@duke.edu|
21257448|NCT00766532|University of Wisconsin|Dr. Karen Hansen|608-263-0517|keh@medicine.wisc.edu|
21257449|NCT01438489|MedImmune, LLC|Gabor Illei, MD, Senior Director|301-398-0000|illeig@Medimmune.com|
21257450|NCT03451786|Carl Zeiss|Michael Bonilla|+1 925-557-4100|michael.bonilla@zeiss.com|
21257451|NCT01372384|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21257452|NCT03129321|Mylan Inc.|Abhijit Barve, Head of Global Clinical Research||abhijit.barve@mylan.com|
21257453|NCT00067028|The University of Texas M. D. Anderson Cancer Center|Hagop M Kantarjian,MD/Chair, Leukemia|(713) 792-7026|hkantarjian@mdanderson.org|
21257454|NCT02576444|Yale School of Medicine: Medical Oncology|Joseph Paul Eder, MD|(203) 737-6980|joseph.eder@yale.edu|
21257455|NCT00988143|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21257456|NCT00842231|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21257457|NCT03503877|University of California, San Francisco|Mitchell Rosen|415-353-7475|Mitchell.Rosen@ucsf.edu|
21257458|NCT03370120|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
21257459|NCT03672370|Zimmer Biomet|Clinical Project Lead, Sandra Rosser|+41 (0)58 854 84 09|sandra.rosser@zimmerbiomet.com|
21257460|NCT01977599|UCL|Dr Robert Kerrison, Senior Research Fellow|02076798268|Robert.kerrison.13@ucl.ac.uk|
21257461|NCT02700412|University of Alabama at Birmingham|Dr. Jerzy Szaflarski, MD, PhD|205-934-3866|jszaflarski@uabmc.edu|
21257462|NCT00928889|Novartis Pharmaceuticals|Study Director|862 778-8300||
21257463|NCT02310776|Northwestern Medicine|Ellen B. Mendelson, MD, FACR, Lee F. Rogers Professor of Medical Education in Radiology, Profess|3124720436|emendels@nm.org|
21257464|NCT02888093|University of Iowa Hospitals and Clinics|Dr. Joseph Kowalski|3193561616|joseph-kowalski@uiowa.edu|
21257465|NCT04416555|Cleveland Clinic|Dr. Sabry Ayad|216.476.7052|Saayad@ccf.org|
21257466|NCT01118273|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21257467|NCT03782402|CUIMC|Diana Martinez|646-774-6160|dm437@cumc.columbia.edu|
21257468|NCT01923285|Abbott|Robyn Capobianco|512-286-4274|robyn.capobianco@abbott.com|
21257469|NCT01356407|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21257470|NCT01309659|Duke University Medical Center|Harvey J Cohen, MD|919-660-7502|harvey.cohen@dm.duke.edu|
21257471|NCT01441037|National Heart Lung and Blood Institute|Young, Neal|+1 301 496 5093|youngns@mail.nih.gov|
21268841|NCT04341727|Washington University School of Medicine|Jane O'Halloran|314 454 0058|janeohalloran@wustl.edu|
21268842|NCT02856282|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21268843|NCT00057330|GlaxoSmithKline|GSK Response Center|866-435-7343||
21268844|NCT02406937|Sprim (Shanghai) Consulting Co., Ltd.|Dr. Charlie Zhang|+86 (21) 51097272|charlie.zhang@sprim.cn|
21268845|NCT04311411|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21268846|NCT02354352|Ohio State University|Dr. Subha Raman|614-293-8963|raman.1@osu.edu|
21268847|NCT04961645|Emory University|Daniel Dilks, PhD|404-727-2980|dilks@emory.edu|
21268848|NCT05059366|University of Miami|Alecia Sabartinelli Stein, MD|305 585 8380|asabartinelli@med.miami.edu|
21268849|NCT01828164|SmileSonica Inc.|John Simon, Regulatory Affairs Manager|780-975-0095|john@johnsimon.ca|
21301013|NCT02158546|Alkermes|Eva Stroynowski|781-609-7000|eva.stroynowski@alkermes.com|
21301014|NCT02376998|University Magna Graecia of Catanzaro|Prof. Raffaele Serra|+3909613647380|rserra@unicz.it|
21301015|NCT01194856|Cleveland Clinic|Marisa Tungsiripat|2164442037|tungsim@ccf.org|
21301016|NCT02488915|Neuravi Ltd|Mairsíl Claffey|0035391394123|mclaffey@neuravi.com|
21301017|NCT03408392|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21301018|NCT00885170|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21301019|NCT03771664|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21268850|NCT03546270|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
21268851|NCT00750373|Asan Medical Center|Dr. Duk-Hyun Kang|82-2-3010-3149|dhkang@amc.seoul.kr|
21257472|NCT02184195|AstraZeneca AB|Global Clinical Leader|1-877-240-9479|information.center@astrazeneca.com|
21257473|NCT02242578|The University of Texas at Austin|Robert J Buchanan, MD|512-324-7991|robertbuchanan@utexas.edu|
21268852|NCT02940392|Boston Scientific|Director, Clinical Operations|9529306000|teresa.takle-flach@bsci.com|
21301020|NCT02120898|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
21268853|NCT00978120|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21268854|NCT03253809|Cleveland Clinic|Dr. Mark Neibauer|216-444-3160|niebaum@ccf.org|
21268855|NCT03992456|Duke Cancer Institute|John Strickler, MD|(507) 284-2511|john.strickler@duke.edu|
21257474|NCT02716987|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
21268856|NCT03176953|National Center for PTSD|Sonya Norman, PhD|858-518-8266|sonya.norman@va.gov|
21268857|NCT00762073|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21268858|NCT01068418|Brigham and Women's Hospital, Harvard Medical School|Jonathan S. Williams|6177325666|jwilliams5@partners.org|
21268859|NCT00910000|Dana-Farber Cancer Institute|Ursula Matulonis, MD|617-632-2334|umatulonis@partners.org|
21268860|NCT04637815|RAND|David P. Kennedy|3104673904|davidk@rand.org|6133
21268861|NCT02594384|OrphAI Therapeutics|Esther Nkrumah|267 512-1750|enkrumah@orphai-therapeutics.com|
21268862|NCT02427568|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
21268863|NCT01049360|AstraZeneca|Esther Garcia||ClinicalTrialTransparency@astrazeneca.com|
21268864|NCT02058849|University of Kentucky|Dr. Travis Thomas, Associate Professor|859-218-0863|dth225@uky.edu|
21268865|NCT02276274|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21268866|NCT05147311|Brigham and Women's Hospital|Dr. Hermioni Amonoo, Director of Well-Being and Cancer Research Program|‭(617) 525-7472‬|hermioni_amonoo@dfci.harvard.edu|
21268867|NCT02504099|AbbVie|Global Medical Services|800-633-9110||
21268868|NCT00145795|The University of Chicago Department of Health Studies, Section of Infectious Diseases and Global Health|Dr. David Pitrak|(773) 702-2710|dpitrak@medicine.bsd.uchicago.edu|
21268869|NCT05240313|Boston College|Christopher Salas-Wright|617-552-1295|christopher.salas-wright@bc.edu|
21268870|NCT02648646|University of North Carolina|Yvonne Golightly PT, PhD, Assistant Professor of Epidemiology|919-966-0566|golight@email.unc.edu|
21268871|NCT01539512|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21268872|NCT01522755|Medtronic|Foudali Latifa|+33 631992144|latifa.foudali@medtronic.com|
21268873|NCT03414658|Dana-Farber Cancer Institute|Adrienne G. Waks, MD|617-632-3800|Adrienne_Waks@dfci.harvard.edu|
21268874|NCT02388906|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21268875|NCT04365387|Galderma Research & Development, LLC|Sponsor|817 961 5000|aestheticclinicaltrials@galderma.com|
21268876|NCT05934591|University of Illinois Urbana Champaign|Dr. Liliane Windsor|2173001782|lwindsor@illinois.edu|
21301021|NCT00561925|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21301022|NCT00684021|UT-Houston School of Public Health|Lemuel Moye, MD, PhD|713-500-9518|Lemmoye@msn.com|
21301023|NCT02556177|GE Healthcare|John Strohmeyer|609-865-7423|john.strohmeyer@ge.com|
21301024|NCT04320316|University of Alabama at Birmingham|M.D|12056389107|hdabdullatif@uabmc.edu|
21301025|NCT03818321|TriHealth|Dr. Rachel Pauls|513-463-4300|Rachel_Pauls@trihealth.com|
21257475|NCT02829138|University of Guelph|Dr. David M Mutch|+1-519-824-4120|dmutch@uoguelph.ca|53322
21301026|NCT05069948|The University of Edinburgh and NHS Lothian|Aimun Jamjoom|0131 536 1000|v1ajamjo@ed.ac.uk|
21301027|NCT01285557|Taiho Oncology, Inc.|Taiho|+1 844-878-2446|medicalinformation@taihooncology.com|
21301028|NCT05353777|Levita Magnetics|Vivian Soto|+56958360507|VSoto@Levita.com|
21301029|NCT05786651|Lehigh University|Nancy Carlisle|610-758-5122|nbc415@lehigh.edu|
21301030|NCT03207763|Emory University|Evan Anderson, MD|404-727-1746|evanderson@emory.edu|
21257476|NCT02588976|Triemli City Hospital|Director Clinical Trial|+41 44 416 25 52|christoph.hofer@triemli.stzh.ch|
21257477|NCT04744207|Gesynta Pharma AB|Study Director|+46 73 386 4246|ctg@gesynta.se|
21257478|NCT00974246|Valley Medical Research|Meenakshi Patel, MD|937-208-8298|mpatelmd@ymail.com|
21257479|NCT03096730|Tianjin Medical University General Hospita|Dr. Guolin Wang|13002211205|1464322162@qq.com|
21257480|NCT00808236|BeneChill, Inc.|Becky Inderbitzen, Vice President of Clincial Affairs|858-695-8118|binderbitzen@benechill.com|
21257481|NCT00961220|Case Comprehensive Cancer Center|Dr. Kevin Cooper|216-844-3111|kevin.cooper@uhhospitals.org|
21257482|NCT02651584|Braeburn Pharmaceuticals|Sonnie Kim|1 610 467 8717|sonnie@braeburnrx.com|
21257483|NCT04041284|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
21301031|NCT00990704|Abbott|Global Medical Services|800-633-9110||
21301032|NCT00194532|University Of Washington|Ann Stapleton, MD|206-616-4121|stapl@uw.edu|
21301033|NCT01002339|Hospital Universitario de Canarias. Universidad de La Laguna. Spain|Dr. Armando Torres Ramírez|+34630989515|atorres@ull.es|
21301034|NCT02350296|Dompé farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
21301035|NCT05050227|VA Greater Los Angeles Healthcare System, UCLA David Geffen School of Medicine|Lucinda B. Leung, MD, PhD, MPH|310-478-3711|lleung@mednet.ucla.edu|
21301036|NCT01187355|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
21301037|NCT01519921|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21301038|NCT00385216|Columbia University|Pamela Flood, MD|212-305-2008|pdf3@columbia.edu|
21301039|NCT01721044|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21301040|NCT03102437|Impulse Dynamics|Angela Stagg|18453592389|astagg@impulsedynamics.com|
21301041|NCT01499355|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21301042|NCT00722072|OHSU Knight Cancer Institute|Dr. Stephen Chui|503-494-8534|chuis@ohsu.edu|
21301043|NCT02420821|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21301044|NCT03129568|Okayama University Hospital|Dr. Hidemasa Oh|086-235-6506|hidemasa@okayama-u.ac.jp|6506
21301045|NCT02911844|University of Pennsylvania|Dr. Steven Kawut|215-573-0258|kawut@upenn.edu|
21301046|NCT01356277|McGill University Health Centre|Dr. Bethany Foster|514-412-4461|bethany.foster@mcgill.ca|
21257484|NCT01784770|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21257485|NCT03455491|PHARMENTERPRISES LLC|CEO Vladimir Nebolsin|+7 (985) 728-75-72|ph@pharmenterprises.ru|
21257486|NCT01391286|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21257487|NCT00258674|Baylor Research Institute|Baylor Research Institute|214-820-9991|Elizabeth.Cothran@baylorhealth.edu|
21268877|NCT05770401|University of Montana|Jane Reynolds Salois|406-243-2138|jane.salois@umontana.edu|
21257488|NCT01252745|Acerus Pharmaceuticals Corporation|Vice President|(416) 679-0776|nbryson@aceruspharma.com|
21257489|NCT01439672|University of Virginia|Sue Brown, MD||sab2f@virginia.edu|
21257490|NCT00432042|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21257491|NCT03497585|Pennine Acute NHS Trust|Dr Deborah Antcliff|0161 7242168|Deborah.Antcliff@pat.nhs.uk|
21257492|NCT01744665|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
21257493|NCT00492752|BAYER|Therapeutic Area Head|<not disclosed>|clinical-trials-contact@bayerhealthcare.com|
21257494|NCT02222207|BAYER|Therapeutic Area Head||Clinical-Trial-Disclosure@bayer.com|
21257495|NCT04682405|Washington University School of Medicine|Keith Stockerl-Goldstein, M.D.|314-747-7859|ksgoldstein@wustl.edu|
21257496|NCT03557281|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21257497|NCT01199042|Bethesda North Hospital|Dr. Shahrokh Javaheri|513-793-7378|shahrokhjavaheri@icloud.com|
21257498|NCT05030012|Vapotherm|Katherine Gerich|5854696753|kgerich@vtherm.com|
21257499|NCT03357731|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
21257500|NCT01773109|University of Pennsylvania (Abramson Cancer Center)|Dr. Charu Aggarwal|2156624000|charu.aggarwal@pennmedicine.upenn.edu|
21257501|NCT03118232|University of California, Irvine|Dr. Susan Huang|714-456-5047|sshuang@hs.uci.edu|
21257502|NCT04036708|Michigan State University|Michael J Boivin|1-517-884-0281|boivin@msu.edu|
21257503|NCT04766021|Indiana University|Dr. Blair Johnson|8128558699|bj33@indiana.edu|
21257504|NCT01656031|Comprehensive Cancer Center of Wake Forest University|Dr. Bayard Powell|336-716-7970|bpowell@wakehealth.edu|
21257505|NCT01849874|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21257506|NCT02104583|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21257507|NCT04640272|Ribomic, Inc.|Dr. Yoshikazu Nakamura|81-3-3440-3303|yoshi@ribomic.com|
21257508|NCT04673292|Johns Hopkins School of Medicine; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University School of Nursing|Jacky Jennings,PhD, MPH; Shruti Mehta, PhD, MPH; Jason Farley, PhD, MPH, ANP-BC, FAAN|410-550-4132|jennings@jhmi.edu; smehta@jhu.edu; jfarley1@jhu.edu|
21257509|NCT02535715|University of Texas Health San Antonio|Curtis Triplitt, PharmD|210-358-7228|triplitt@uthscsa.edu|
21257510|NCT03709654|Naked Biome|Emma Taylor, MD CEO|626-260-1230|emma.t@nakedbiome.com|
21257511|NCT01902966|UT MD Anderson Cancer Center|Lois M. Ramondetta, MD, Professor, Gynecologic Oncology & Reproductive Medicine|713-745-0307|lramonde@mdanderson.org|
21257512|NCT01040351|Cairo university|Usama M.Fouda, M.D, PhD|+20123595106|umfrfouda@yahoo.com|
21257513|NCT01230307|University of Michigan|Barry Bleske|734-763-3232|bbleske@umich.edu|
21257514|NCT01422356|Melbourne Sexual Health Centre, Alfred Health|Associate Professor Marcus Chen|+61 3 9341 6260|mchen@mshc.org.au|
21257515|NCT02256540|University of Colorado Anschutz Medical Campus|Dr. Kerrie Moreau|303-724-1914|kerrie.moreau@cuanschutz.edu|
21257516|NCT03923426|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrialsgov_Inquiries@Pfizer.com|
21257517|NCT00429403|UT MD Anderson Cancer Center|Naoto Ueno, MD / Professor||CR_Study_Registration@mdanderson.org|
21257518|NCT00751400|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21257519|NCT00676676|Massachusetts General Hospita|Dr. Karen K. Miller|617-726-3870|kkmiller@partners.org|
21257520|NCT01918007|National and Kapodistrian University of Athens School of Medicine and Aghia Sophia Children's Hospital, Athens, Greece|Dr. Athanasios Kaditis, Head, Division of Pediatric Pulmonology, First Department of Pediatrics|+302132013000|akaditis@med.uoa.gr|
21257521|NCT01261507|Georgetown University Medical Center|Matthew T. Freedman, MD|4105429680|freedmmt@georgetown.edu|
21268878|NCT00402298|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
21268879|NCT00480077|Medtronic Bakken Research Center|Director CRDM|31-43-3566813||
21268880|NCT05966129|Duke University|Hrishikesh Chakraborty, PhD|919-668-1238|hrishikesh.chakraborty@duke.edu|
21268881|NCT05182840|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21268882|NCT00938457|Mayo Clinic|Dr. Robert C. Miller|507-284-2669|miller.robert@mayo.edu|
21268883|NCT02478281|American Regent Inc.|Hal Rathfon, RPh|631-772-3555|HRathfon@americanregent.com|
21268884|NCT00412360|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
21268885|NCT02486263|Nationwide Children's Hospital|Dr. Sudarshan Jadcherla|614-355-6643|sudarshan.jadcherla@nationwidechildrens.org|
21268886|NCT01078974|Dana-Farber Cancer Institute|Steven P. Treon|617-632-2681|steven_treon@dfci.harvard.edu|
21268887|NCT01393444|University of Pittsburgh|Jennifer Collinger|412-383-1274|collingr@pitt.edu|
21268888|NCT00113321|The University of Texas M. D. Anderson Cancer Center|Hagop Kantarjian, M.D., Professor|713/792-7026|eharriso@mdanderson.org|
21268889|NCT02730234|Midwest Cardiovascular Research Foundation|Nicolas W Shammas|5633242828|shammasg@mcrfmd.com|102
21268890|NCT01397409|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21268891|NCT03418727|Ocugen|Vijay Tammara, VP, Strategic Regulatory Operations|484-328-4751|Vijay.tammara@ocugen.com|
21268892|NCT03145207|University of Maryland, Baltimore School of Pharmacy|Dr. Audra Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
21268893|NCT05436067|CFD Research Corporation|Dr. Paulien Roos|256 715 6817|paulien.roos@cfd-research.com|
21268894|NCT01396434|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21268895|NCT05689554|University of Washington|Dr. Elizabeth Phelan|(206) 744-9112|phelane@uw.edu|
21268896|NCT01678794|Mayo Clinic|Horng H. Chen, M.D.|507-284-8896|chen.horng@mayo.edu|
21268897|NCT00509223|Baker IDI Heart and Diabetes Institute|Jonathan Shaw, MD, FRACP, FRCP|+61 (0) 3 8532 1821|jonathan.shaw@bakeridi.edu.au|
21268898|NCT03315780|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
21268899|NCT01001195|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21268900|NCT03839693|Clinical Research Management Group|Patrick Murphy|4138210022|p.murphy@crmg-usa.com|
21268901|NCT04524351|Annovis Bio|Maria Maccecchini, PhD, CEO|(610) 727-3710|maccecchini@annovisbio.com|
21268902|NCT00700115|Emory University School of Medicine|Dr. Igho Ofotokun|404-616-0659|iofotok@emory.edu|
21268903|NCT02983305|University of Michigan|Sara|734-936-7567|weisssar@umich.edu|
21268904|NCT00706901|Charleston VAMC|Elizabeth Santa Ana, Ph.D.|(843) 789-7168|elizabeth.santaana2@va.gov|
21268905|NCT00822237|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21268906|NCT03433482|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21268907|NCT02464176|Wake Forest Baptist Medical Center|Dr. James D. Turner|3367164998|jturner@wakehealth.edu|
21268908|NCT01646268|UCB Clinical Trial Call Center|Study Director|+1 844-599-2279||
21268909|NCT00906776|Rotschild hospital|Prof Philippe Bouchard|+33614656947|phbouch@noos.fr|
21268910|NCT00461591|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
21268911|NCT01473602|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21268912|NCT00449761|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21268913|NCT01969201|IBSA Insitut Biochimique|Project Leader|+41 58 360 10 00|rd@ibsa.ch|
21268914|NCT00518531|Amgen Inc.|Study Director|866-572-6436||
21268915|NCT00054639|UT MD Anderson Cancer Center|Anas Younes, MD / Professor||CR_Study_Registration@mdanderson.org|
21268916|NCT03464110|Duke University|Dr. Kathryn Pollak|919-681-4757|kathryn.pollak@duke.edu|
21268917|NCT04621227|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21268918|NCT02916056|vTv Therapeutics|Ann Gooch PhD, VP Clinical Development & Regulatory Operations|336-841-0300|agooch@vtvtherapeutics.com|80544
21268919|NCT00124709|Novartis Pharmaceuticals|Study Director|862-778-8300||
21268920|NCT03491800|University of North Carolina at Chapel Hill|Crystal Wiley Cené, MD, MPH, FAHA|919-445-6783|crystal_cene@med.unc.edu|
21268921|NCT02303977|Abramson Cancer Center, Penn Presbyterian Medical Center|Dr. Christine Ciunci|215-662-9801|christine.ciunci@pennmedicine.upenn.edu|
21268922|NCT03724422|University of Louisville|Salwa Rashid|5028526964|salwa.rashid@louisville.edu|
21268923|NCT01491737|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21268924|NCT04058990|Boston Scientific Japan K.K.|Sachiyo Sato/Clinical Project Manager|+81-3-6853-7500|Sachiyo.Sato@bsci.com|
21268925|NCT01363999|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
21268926|NCT02506101|Johns Hopkins Medicine|Dr. Ginette Okoye|410-502-7546|CTReP@jhmi.edu|
21268927|NCT01308476|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21268928|NCT00812968|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21268929|NCT02696382|University of Colorado Denver|Dr. Jennifer Stevens-Lapsley|303.724.9170|jennifer.stevens-lapsley@cuanschutz.edu|
21268930|NCT00494234|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
21268931|NCT03478982|Cares|UCB|+1 844 599|UCBCares@ucb.com|2273
21268932|NCT00556907|USC/Norris Comprehensive Cancer Center|Tali Homsey|(323) 865-0451|tali.homsey@med.usc.edu|
21268933|NCT00505765|Semel Institute at UCLA|Stephen R. Marder|310-268-3647|marder@ucla.edu|
21268934|NCT02743117|MedImmune, LLC|Raburn Mallory, MD|301-398-000|information.center@astrazeneca.com|
21268935|NCT03864406|Clinical Center|Hadigan, Colleen|+1 301 594 5754|hadiganc@niaid.nih.gov|
21257522|NCT01471015|University of Utah|Dr. Mariana Baserga|801-581-7052|mariana.baserga@hsc.utah.edu|
21257523|NCT04206020|Mitotech S.A.|Chief Operating Officer|+352621692785|info@mitotechpharma.com|
21257524|NCT04962022|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21257525|NCT02684604|Ain Shams Maternity hospital|amr ahmed mahmoud riad|01005347179|amr.riad@med.asu.edu.eg|+2
21257526|NCT03962101|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21257527|NCT00552175|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21257528|NCT05112536|G1 Therapeutics, Inc.|Clinical Trial Info.|919-213-9835|clinicalinfo@g1therapeutics.com|
21257529|NCT03972969|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
21257530|NCT02919436|Maine Medical Center|Dr. Anand Rughani|207-885-0011|arughani@mmc.org|
21257531|NCT00283595|Massachusetts General Hospital|Anne Klibanski, MD|617-726-3870|aklibanski@partners.org|
21257532|NCT02409290|MRC CTU at UCL, University College London, London UK|Dr Ruth Goodall|+44 2076704728|r.goodall@ucl.ac.uk|
21257533|NCT04607148|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21257534|NCT00804570|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21257535|NCT00290342|GlaxoSmithKline|GSK Response Center|866-435-7343||
21257536|NCT03341975|Children's Mercy Hospitals and Clinics|Melissa Miller MD|8162343430|mmiller@cmh.edu|
21257537|NCT01056510|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21257538|NCT02285998|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
21257539|NCT02830776|Formerly - Tulane University Department of Dermatology. Currently - Suzanne Bruce and Associates, PA|Megan Couvillion, MD, FAAD|504-473-2915|megan.couvillion@gmail.com|
21257540|NCT03029143|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21257541|NCT02445625|University of Coimbra|Prof. Dr. Miguel Castelo-Branco|+351239790000|mcbranco@fmed.uc.pt|
21257542|NCT01394627|Brigham and Women's Hospital|Gail Adler|617-732-5661|gadler@partners.org|
21257543|NCT01617070|USC/Keck School of Medicine|Shoji Yano|323-226-3816|syano@usc.edu|
21257544|NCT00573989|Wake Forest University Health Sciences|Dr. Mercedes Porosnicu|336-716-8664|mporosni@wakehealth.edu|
21257545|NCT03223428|TerSera Therapeutics LLC|Noran Osman, PharmD, MHS, Associate Director, External Research and Medical|+1-224-754-4605|nosman@tersera.com|
21257546|NCT02777268|Simbec Research Limited|Dr Girish Sharma|+44 1443 690977||
21257547|NCT02230384|University of Pittsburgh|K.N. Roy Chengappa, MD / Principal Investigator|412-246-5006|chengappakn@upmc.edu|412
21257548|NCT00777101|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
21257549|NCT05376215|Phonak Audiology Research Center|Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
21257550|NCT02031770|University of Colorado Denver|Dr. Jessica Kendrick|3037244837|Jessica.Kendrick@ucdenver.edu|
21257551|NCT00282334|Dept. of Medical Research, Holstebro Hospital|Line Bille Madsen|+45 99125421|linemads@rm.dk|
21257552|NCT00471705|Universidad de Antioquia - Colombia|Iván Darío Vélez Bernal|574 + 219 6501 - 02|idvelez@pecet-colombia.org|
21257553|NCT01301950|DePuy Synthes|Sam Himden, Clinical Portfolio Leader|574-372-7231|shimden@its.jnj.com|
21257554|NCT01066585|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com|
21257555|NCT01071538|University of Pittsburgh|Jordan F. Karp, MD|412-246-6048|karpjf@upmc.edu|
21257556|NCT00455689|Brigham & Women's Hospital|Hadine Joffe, MD MSc|617-732-4906|hjoffe@bwh.harvard.edu|
21257557|NCT02424253|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21257558|NCT00884273|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
21257559|NCT00353834|Joslin Diabetes Center|Edward S. Horton, MD|6173091995|edward.horton@joslin.harvard.edu|
21257560|NCT04018794|University of California, San Francisco|Dr. Melissa Dvorsky|4154767167|melissa.dvorsky@ucsf.edu|
21257561|NCT01031550|UMDNJ|Yuriy Gubenko, MD|973 972-5007|yuriygubenko@yahoo.com|
21257562|NCT01671423|Einstein Medical Center|Scott Goldstein|2154561836|goldstes@einstein.edu|
21257563|NCT03021499|Aurinia Pharmaceuticals|Rashieda Gluck|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
21285833|NCT00882661|Globus Medical|Jacqueline Myer|610-930-1800|jmyer@globusmedical.com|
21285834|NCT04270695|China Medical University|Ms Weng|0975127007|chuyu0608@gmail.com|
21257564|NCT04093843|West Virginia University|Amelia Adcock, MD|304-598-6127|akadcock@hsc.wvu.edu|
21257565|NCT02122198|University of Colorado Denver|Kerry Hildreth, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
21257566|NCT02581202|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21257567|NCT04050982|Stanford University|Linda Ottoboni|(650) 498-5914|LOttoboni@stanfordhealthcare.org|
21257568|NCT00609791|City of Hope|Dr. Mina Sedrak|6263598111|msedrak@coh.org|
21257569|NCT04218201|NYU Langone Health|Rebecca Stone|646-754-5322|Rebecca.Stone@nyulangone.org|
21257570|NCT04649255|Sirtex Medical|Janet Bell|+ 888-474-7839|jbell@sirtex.com|
21257571|NCT02387359|Synergy Pharmaceuticals Inc.|VP Regulatory Affairs & Clinical QA|646-675-7283|ejaeger@synergypharma.com|
21257572|NCT00291447|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21257573|NCT00122681|GlaxoSmithKline|GSK Response Center|866-435-7343||
21257574|NCT02819635|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21257575|NCT01476475|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21257576|NCT00441974|GlaxoSmithKline|GSK Response Center|866-435-7343||
21257577|NCT03070470|U.S. Food and Drug Administration|Jose Vicente, PhD|301-796-8442|Jose.VicenteRuiz@fda.hhs.gov|
21257578|NCT01757678|HeartFlow|VP Clinical, Quality & Regulatory Affairs|650-241-1221|clinicalresearch@heartflow.com|
21257579|NCT01146873|Columbia University|Louise Kuhn, PhD|212-305-2398|lk24@cumc.columbia.edu|
21257580|NCT04512040|VA Palo Alto Health Care System|Peter Bayley, PhD|650-493-5000|peter.bayley@va.gov|68653
21257581|NCT02055820|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21257582|NCT05074251|UCLA|Dr. Dvora Joseph Davey|310-701-1526|dvoradavey@ucla.edu|
21257583|NCT00631020|UCLA Center for Health Promotion and Disease Prevention|Dr. Steven Shoptaw|310-794-0619|sshoptaw@mednet.ucla.edu|225
21257584|NCT01468584|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21257585|NCT02614859|Fox Chase Cancer Center|Dr. Daniel Geynisman|215-728-3889|Daniel.Geynisman@fccc.edu|
21257586|NCT03548935|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21257587|NCT04677959|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
21257588|NCT01074190|Northwerstern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.edu|
21257589|NCT00397813|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fredhutch.org|
21257590|NCT00732303|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
21257591|NCT01399788|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21257592|NCT02459795|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
21257593|NCT03699007|Stanford University Medical School|Dr. Laura Simons|(650) 736-0838|lesimons@stanford.edu|
21257594|NCT04718974|Infectious Diseases Institute, College of Health Sciences, Makerere University|Dr. Agnes Bwanika Naggirinya|+256752521570|anaggirinya@idi.co.ug|
21257595|NCT00845728|Novartis Pharmaceuticals|Study Director|862-778-8300||
21257596|NCT01389752|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21257597|NCT03259074|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
21257598|NCT01594515|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21257599|NCT00053417|Acorda Therapeutics|Andrew Blight, PhD|914-347-4300|ablight@acorda.com|102
21257600|NCT01713621|Medicines for Malaria Venture|Dr. Jörg J. Möhrle|+41 22 555 03 00|moehrlej@mmv.org|
21257601|NCT02327052|Hospital São Rafael|Dr. Milena Botelho Pereira Soares|+557132816455|milenabpsoares@gmail.com|
21257602|NCT00445484|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Ivan Borrello|(410) 955-4967|iborrell@jhmi.edu|
21257603|NCT04251910|BioXcel Therapeutics|Vice President Head of Clinical Operations|(475) 355 5177|cgommoll@bioxceltherapeutics.com|
21257604|NCT01722604|Bausch & Lomb|Daniel Donatello|(585) 338-5306|Daniel.Donatello@bausch.com|
21257605|NCT03451084|ASLAN Pharmaceuticals|Study Director|+65 6222 4235|contact@aslanpharma.com|
21257606|NCT03339206|University of North Carolina at Chapel Hill|Adam O. Goldstein|984-974-0210|adam_goldstein@med.unc.edu|
21257607|NCT02668874|University of Iowa College of Dentistry|Director of Clinical Research|319-467-1398|dentistry-research@uiowa.edu|
21257608|NCT00619255|University of Washington|Doug Zatzick, MD|(206) 744-6701|dzatzick@uw.edu|
21257609|NCT02121262|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21257610|NCT03300674|Montefiore|Benjamin W. Friedman|718-920-6626|befriedm@montefiore.org|
21257611|NCT01553188|National Cancer Institute|Dr. Ravi Madan|301-480-7168|madanr@mail.nih.gov|
21257612|NCT05289570|Duke University|Ian Welsby, MD|919-681-6752|ian.welsby@duke.edu|
21257613|NCT04544475|NYU Langone Health|Lila Nachtigall|2122636361|Lila.Nachtigall@nyulangone.org|
21285835|NCT01398358|University of Michigan|Julie Lumeng, MD|jlumeng@umich.edu|jlumeng@umich.edu|
21285836|NCT00003896|SWOG Statistical Center|Gynecologic Committee Statistician|206-667-4623||
21285837|NCT02373137|Kaiser Permanente / University of California, San Francisco|Dr. Jennifer Rose-Nussbaumer|650-299-2111|Jennifer.Rose-Nussbaumer@kp.org|
21285838|NCT00985686|Canadian Institute of Natural and Integrative Medicine|Dr. John Toews|4032200022|j.toews@cinim.org|111
21285839|NCT03134911|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21257614|NCT01947816|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21257615|NCT01024010|Mayo Clinic|Tait D. Shanafelt, M.D.||shanafelt.tait@mayo.edu|
21285840|NCT02559570|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21285841|NCT02364076|Georgetown University Medical Center -Lomabardi Comprehensive Cancer Center|Dr Giuseppe Giaccone|202-687-7072|gg496@georgetown.edu|
21268936|NCT01207219|The Department of Psychiatry,HKU|Dr.Lin Jingxia|+85222553064|jingxia.lin@gmail.com|
21268937|NCT01012609|Memorial Sloan Kettering Cancer Center|Dr. Ira Dunkel, MD|212-639-2153|dunkeli@mskcc.org|
21268938|NCT00924820|The University of Texas (UT) MD Anderson Cancer Center|John F de Groot, Professor, Neuro-Oncology|(713) 745-3072|jdegroot@mdanderson.org|
21268939|NCT01725217|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21268940|NCT00585468|University of Utah|Fuad Shihab, MD|801-585-3823|fuad.shihab@hsc.utah.edu|
21268941|NCT03919669|University of WI Alzheimer's Disease Research Center|Dr. Sterling Johnson|608-262-9549|scj@medicine.wisc.edu|
21268942|NCT01265875|Dartmouth-Hitchcock Medical Center|Timothy Gardner, MD|603-650-6472|timothy.b.gardner@hitchcock.org|
21268943|NCT01958593|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
21268944|NCT02369874|AstraZeneca|Nassim Morsli|+44 7384 520046|nassim.morsli@astrazeneca.com|
21268945|NCT02331680|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366||
21268946|NCT04505592|Icahn School of Medicine at Mount Sinai|Dr. Hooman Poor|(212) 241-5656|hooman.poor@mountsinai.org|
21268947|NCT00761085|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
21268948|NCT04784455|Akari Therapeutics|Chief Scientific Officer|+44 208 004 0261|miles.nunn@akaritx.com|
21268949|NCT04298229|Vanderbilt University Medical Center|Zachary Cox|615-966-7107|zachary.l.cox@vumc.org|
21268950|NCT00262119|Medtronic|Senior Clinical Research Manager|0039-0632814225|andrea.grammatico@medtronic.com|
21268951|NCT00859313|AcelRx Pharmaceuticals, Inc.|Dr. Pamela Palmer|650-216-3504|ppalmer@acelrx.com|
21268952|NCT03142919|LIBR|Jonathan Savitz|9185025104|jsavitz@laureateinstitute.org|
21268953|NCT05939388|Wake Forest University Health Sciences|Michelle Olshan-Perlmutter|704-358-2800|michell.olshanperlmutter@atriumhealth.org|
21268954|NCT03901274|University of South Carolina|Dr. Mark Weist|803-777-8438|weist@mailbox.sc.edu|
21285842|NCT02497937|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21285843|NCT00396383|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
21285844|NCT01839916|University of Chicago|Dr. Hongtao Liu|773-834-1736|hliu2@medicine.bsd.uchicago.edu|
21285845|NCT03471832|CooperVision|Jose A.Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com|
21268955|NCT05570604|Ohio State University|Dr. Diane Von Ah|614-688-0722|vonah.1@osu.edu|
21285846|NCT02385110|The University of Texas MD Anderson Cancer Center|Naval Daver, MD./Professor|713-794-4392|NDaver@mdanderson.org|
21285847|NCT00534638|GlaxoSmithKline|GSK Response Center|866-435-7343||
21285848|NCT00990509|University of Arizona|Chelsea Kidwell, MD|(520) 626-7159|ckidwell@neurology.arizona.edu|
21285849|NCT02710084|Icahn School of Medicine at Mount Sinai|Alexander Kolevzon, MD|212-659-9134|alexander.kolevzon@mssm.edu|
21285850|NCT01124292|Georgia Institute of Technology|Dr. Maysam Ghovanloo|404-385-7048|mgh@gatech.edu|
21285851|NCT00481767|GlaxoSmithKline|GSK Response Center|866-435-7343||
21285852|NCT01366638|Janssen Pharmaceutical K.K., Japan|Director|81 3 44115639||
21285853|NCT00636636|Depomed|Head of R&D|650-462-5900|msweeney@depomed.com|108
21285854|NCT00524173|NIDDK|Marc Ghany, MD|301-402-5115|marcg@intra.niddk.nih.gov|
21285855|NCT01554163|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21285856|NCT00857961|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21285857|NCT01381926|UAB|Dr. Amy Warriner|205-996-4004|awarriner@uabmc.edu|
21285858|NCT02271217|Acorda Therapeutics|Holly Roberts, Executive Medical Director|914-326-5000|hroberts@acorda.com|
21285859|NCT03974802|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
21285860|NCT02624947|Novavax Inc|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
21285861|NCT03107182|University of Chicago|Ari Rosenberg|773-702-8222|arirosenberg@bsd.uchicago.edu|
21285862|NCT05787860|Icahn School of Medicine at Mount Sinai|Giselle Singer|212-241-3288|giselle.singer@mssm.edu|
21285863|NCT06785090|College of Medicine, University of Baghdad|Enas Sabeeh|09647704294077|inas.abd2206m@comed.uobaghdad.edu.iq|
21285864|NCT01065558|Psyadon Pharmaceuticals|Dr. Richard Chipkin|301-919-2020|rchipkin@psyadonrx.com|
21285865|NCT03654729|Egetis Therapeutics AB|Kristina Sjoblom Nygren|+46732344698|kristina.sjoblom@egetis.com|
21285866|NCT01449734|CSCC Germany, Jena University Hospital|Christiane Hartog, MD|+49 3641 9323171|christiane.hartog@med.uni-jena.de|
21285867|NCT04780815|ImperialBrands PLC|Simon McDermott|+44 (0)117 332 0225|simon.mcdermott@uk.imptob.com|
21285868|NCT00652145|University of Pennsylvania|James D. Lewis, MD, MSCE|215-573-5137|lewisjd@mail.med.upenn.edu|
21285869|NCT04611542|Oregon Research Behavioral Intervention Strategies, Inc. dba Behavioral Influents Innovations|Dr. Jeremy Jones|541-484-2123|jeremy.jones@influentsin.com|
21285870|NCT00493012|Heart and Diabetes Center North Rhine-Westfalia|Dr. Armin Zittermann|+49 5731 97|azittermann@hdz-nrw.de|1912
21285871|NCT02915159|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21285872|NCT04534517|Johnson & Johnson Vision Care Inc.|Thomas Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
21285873|NCT00872521|Jan-Cil Australia|Regional Medical Affairs Director Asia Pacific|61 427564369||
21285874|NCT00433550|Mayo Clinic|Robert R. McWilliams, M.D.||mcwilliams.robert@mayo.edu|
21285875|NCT05225558|LigaChem Biosciences, Inc.|Seonghye Cheon|+82)2-6952-0689|scheon@ligachembio.com|
21285876|NCT01089127|Novartis Pharmaceuticals|Study Director|862 778-8300||
21285877|NCT03929263|Oklahoma State University|Kara Kerr|9186971478|kara.kerr@okstate.edu|
21285878|NCT02134795|Scion NeuroStim|Dr. Robert Black|(919) 260-5528|rblack@scionneurostim.com|
21301047|NCT00454324|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
21301048|NCT03000608|Santalis Pharmaceuticals|Dr. Paul Castella|2103992316|paulc@santalispharmaceuticals.com|101
21285879|NCT02258659|University of Chicago|Dr. Everett Vokes|773-702-9306|evokes@medicine.bsd.uchicago.edu|
21285880|NCT03990051|Glia, LLC|Wei-wei Chang, PhD; President|(617) 794-8922|chang@gliacell.com|
21268956|NCT04527380|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21268957|NCT04479358|University of Chicago|Pankti Reid, MD|7737021220|pankti.reid@bsd.uchicago.edu|
21268958|NCT03655951|innovation Research & Training|Dr. Tracy Scull|919-493--7700|tscull@irtinc.us|118
21268959|NCT04678557|Vertex|Medical Information|617-341-6777|medicalinfo@vrtx.com|
21268960|NCT00121251|Weill Cornell Medical College|Cooperative Group Program Manager|646-962-9377|has7003@med.cornell.edu|
21268961|NCT06212310|UT Southwestern Medical Center|Sayoni Lahiri|214-645-2563|sayoni.lahiri@utsouthwestern.edu|
21268962|NCT01140815|AORI|Knee Research Director|7036194423|nancylparks@gmail.com|
21268963|NCT03280628|Vanderbilt University Medical Center|Dr. Holly Hanson|615-936-7317|holly.r.hanson@vumc.org|
21268964|NCT01361308|Noven Therapeutics, LLC|Sailaja Bhaskar, Executive Director, Clinical Research|(212) 287-0798|sbhaskar@noven.com|
21268965|NCT02503215|Nephrology Division, University of São Paulo|Dr Bruno Caldin da Silva|5511997620521|brunocaldin@hotmail.com|
21268966|NCT04478994|Horizon Pharma USA, Inc.|Medical Monitor|1-866-479-6742|medicalinformation@horizontherapeutics.com|
21268967|NCT02192307|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
21268968|NCT01728376|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21268969|NCT01064830|University of North carolina-Chapel Hill|Aida Lugo-Somolinos MD|919-843-9447|alugosom@med.unc.edu|
21268970|NCT05299359|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21268971|NCT03110107|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21268972|NCT05471921|Columbia University|Jeremy Kane|212-305-2862|jk4397@cumc.columbia.edu|
21268973|NCT03927989|Medical University of South Carolina|Dr. Alana Rojewski (PI)|843-876-1593|rojewski@musc.edu|
21268974|NCT02593175|MD Anderson Cancer Center|Clinton Yam|832-589-8343|cyam@mdanderson.org|
21268975|NCT04199312|Zeltiq Aesthetics|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
21268976|NCT03772574|BC Women's Hospital|Dr. Anthony Chau|604-875-2158|anton.chau@ubc.ca|
21268977|NCT00617175|MEDTRONIC Clinical Research Institute|Laura Manotta|+39022413.1|laura.manotta@medtronic.com|
21268978|NCT03586427|Gate Neurosciences, Inc|Chief Medical Officer|2032473895|ron.burch@gateneuro.com|
21268979|NCT03193996|Mayo Clinic|Tyson Scrabeck|507-538-1016|scrabeck.tyson@mayo.edu|
21268980|NCT05125224|Brigham and Women's Hospital|Rishi J Desai, PhD|617-278-0932|rdesai@bwh.harvard.edu|
21268981|NCT00593385|Getinge|Elizabeth Bulger, Director of Clinical Affairs|1-603-864-5368|elizabeth.bulger@getinge.com|
21268982|NCT01471197|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21268983|NCT02352831|Washington University School of Medicine|Andrea Wang-Gillam, M.D., Ph.D.|314-362-5740|awang-gillam@wustl.edu|
21268984|NCT00924313|National Cancer Institute, National Institutes of Health|Dr. Peter L. Choyke|301-402-8409|pchoyke@mail.nih.gov|
21268985|NCT00302068|DukeUMC|Dr. James Blumenthal|919-684-3969|blume003@mc.duke.edu|
21268986|NCT01298362|Hellenic Society of Breast Surgeons|Christos J Markopoulos, MD, MPhil Professor of Surgery-Athens University Medical School|+30 210 6862527|cmarkop@hol.gr|
21268987|NCT02980666|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21268988|NCT01335620|Imperial College London|Alan Winston|+442033121603|a.winston@imperial.ac.uk|21603
21268989|NCT01453296|GlaxoSmithKline|GSK Response Center|866-435-7343||
21268990|NCT00620776|University of Pennsylvania|Dr. Paul Crits-Christoph|(215) 662-7993|crits@mail.med.upenn.edu|
21268991|NCT04983589|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21268992|NCT00761969|Department of Vascular Diseases, University of Ljubljana Med Ctr|Ales Blinc, MD, DSc|+386 1 522 80 32|ales.blinc@kclj.si|
21268993|NCT01279265|University of Texas Health Science Center at Houston|Dr. J. Marc Rhoads, Director, Pediatric Gastroenterology|713-500-7642|j.marc.rhoads@uth.tmc.edu|
21268994|NCT03155269|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21268995|NCT03056456|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21268996|NCT00455923|GlaxoSmithKline|GSK Response Center|866-435-7343||
21268997|NCT02686749|Cleveland Clinic|Oussama Wazni, MD|216-444-2131|waznio@ccf.org|
21268998|NCT04762771|baptist health south florida|Raul Herrera, MD (Director Miami Cardiac & Vascular Institute)|786-596-7609|RaulH@BaptistHealth.net|
21268999|NCT02319642|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21269000|NCT00483119|NYU School of Medicine|Elise Kelman, Associate Director of Research Administration|2122639073|elise.kelman@nyumc.org|
21269001|NCT04409509|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
21269002|NCT04668066|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269003|NCT02219477|AbbVie|Global Medical Services|800-633-9110||
21269004|NCT00596466|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269005|NCT01891669|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269006|NCT01015118|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21269007|NCT00147290|Medtronic|Elisabetta Santi|003906328141|elisabetta.santi@medtronic.com|
21269008|NCT00071006|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269009|NCT05261126|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21269010|NCT05074303|University of Florida|Dr. Wendy Dahl|3522943707|wdahl@ufl.edu|
21269011|NCT03671746|Massachusetts General Hospital|Dr. Arun Aneja, MD, PhD|617-726-6546|aaneja@mgh.harvard.edu|
21269012|NCT05116241|ILiAD Biotechnologies|Chief Medical Officer|800-603-3525|contact@iliadbiotech.com|
21269013|NCT03810417|University of Maryland|Stephen Gottlieb, MD|410-328-7877|sgottlie@som.umaryland.edu|
21269014|NCT03668379|University of California, San Francisco|John Sauceda, PhD, Associate Professor|415-502-1000|john.sauceda@ucsf.edu|17172
21269015|NCT00953173|Apollo Endosurgery Inc|Director of Clinical Affairs|512-279-5157|jose.naveira@apolloendo.com|
21269016|NCT00938366|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21269017|NCT02396849|Indiana University|Christina Tiller|317-044-4522|ctiller@iu.edu|
21269018|NCT03328325|University of Rochester|Angela Branche, MD, Site Principal Investigator|585-275-5871|angela_branche@urmc.rochester.edu|
21269019|NCT00931515|Pioneer Surgical Technology|Director of Regulatory and Clinical Affairs|906-225-5602|emilydowns@pioneersurgical.com|
21269020|NCT01054443|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
21269021|NCT00985114|GI Dynamics, Inc.|Clinical Affairs Manager|781.357.3263|kwoessner@gidynamics.com|
21269022|NCT02950831|St. Jude Medical|Filippo Agnesi|14694184987|filippo.agnesi@abbott.com|
21269023|NCT04487886|Emory University|Edmund Waller, MD, PhD|404-727-4995|ewaller@emory.edu|
21269024|NCT01869959|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21257616|NCT00841789|Seattle Childrens hospital|Michael A Portman|2069871014|michael.portman@seattlechildrens.org|
21257617|NCT00964743|H. Lee Moffitt Cancer Center and Research Institute|Edward Pan, M.D.|813-745-3871|edward.pan@moffitt.org|
21285881|NCT01411852|Resuscitation Outcomes Consortium|Susanne May, PhD, Principal Investigator|206-685-1302|sjmay@uw.edu|
21285882|NCT00272844|Boston Children's Hospital|Dr. Mira Irons|617-355-2449|mira.irons@childrens.harvard.edu|
21285883|NCT02855567|Icahn School of Medicine at Mount Sinai|Dr. Charles Ascher-Walsh|212-241-2827|Charles.ascher-walsh@mssm.edu|
21285884|NCT03743025|Emory University|Dr. Francisco J. Pasquel|404-778-1695|fpasque@emory.edu|
21285885|NCT00791700|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21285886|NCT03672344|BioStream Technologies, LLC|Michael Farber|856-222-1122|farberm@biostreamtech.com|
21285887|NCT00996034|Yale University|Irina Esterlis, Ph.D.|203-932-5711|irina.esterlis@yale.edu|3109
21285888|NCT01720524|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21257618|NCT03317795|Mayo Clinic|Dr. Shannon K. Laughlin-Tommaso|507-538-5783|LaughlinTommaso.Shannon@mayo.edu|
21285889|NCT02493452|Synergy Pharmaceuticals Inc.|VP Regulatory Affairs & Clinical QA|646-675-7283|ejaeger@synergypharma.com|
21285890|NCT00527826|GlaxoSmithKline|GSK Response Center|866-435-7343||
21301049|NCT03133793|Sponsored Programs Adminstration (SPA)|Dr. Mario Medina, Director of Sponsored Programs Administration|913-588-5724|mmedina3@kumc.edu|
21301050|NCT03486834|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21257619|NCT00886600|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
21257620|NCT00501007|Rutgers, The State University of New Jersey|Marc L. Steinberg, Ph.D.|732-235-4341|marc.steinberg@rutgers.edu|
21257621|NCT00047060|National Heart Lung and Blood Institute|Aue, Georg|+1 301 451 7141|aueg@nhlbi.nih.gov|
21257622|NCT03917823|University of California San Diego|Brian Ilfeld, MD, MS|858-822-0776|bilfeld@health.ucsd.edu|
21257623|NCT00135668|Duke University Medical Center|Scott Schulman, MD|919-681-4877|schul003@mc.duke.edu|
21257624|NCT02016820|Columbia University|Daniel E. Freedberg, MD, MS||def2004@cumc.columbia.edu|
21269025|NCT01965600|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269026|NCT01375491|University of California, San Diego|Dr. Karen Louise Herbst|858-552-8585|kaherbst@gmail.com|7384
21269027|NCT00157157|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21269028|NCT02260804|CELLTRION, Inc.|Dr. Sung Hyun Kim|+82-32-850-5000|contact@celltrion.com|
21301051|NCT02535806|Children's Mercy Hospital|Dr. Keith August|816-302-6808|kjaugust@cmh.edu|
21301052|NCT02745119|Hoffmann-La Roche|Medical Communications|616878333|global.trial_information@roche.com|+41
21301053|NCT00960999|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
21301054|NCT00432172|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
21301055|NCT02536963|Rebiscan|CEO|857-600-0982|jgshaka@rebiscan.com|
21301056|NCT02668393|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21301057|NCT02141204|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21301058|NCT02139007|UAB|Jeff Foster|205-996-6086|pjfoster@uabmc.edu|
21301059|NCT00515619|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
21301060|NCT02379091|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21301061|NCT02053376|UPMC Hillman Cancer Center|Barbara Stadterman, Regulatory Supervisor|412-647-5554|stadtermanbm@upmc.edu|
21269029|NCT00457249|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21269030|NCT00514709|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21269031|NCT02411110|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21269032|NCT04888377|RTI International|Elizabeth McClure|919-316-3773|mcclure@rti.org|
21269033|NCT00526162|Medtronic CRDM|CRDM Core Clinical Organization|800-328-2518|jamie.l.reynolds@medtronic.com|
21269034|NCT01169259|Brigham and Women's Hospital; 900 Commonwealth Ave, 3rd fl.; Boston, MA 02215|VITAL Study Director|1-800-388-3963|vitalstudy@partners.org|
21269035|NCT04242446|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21269036|NCT03587116|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
21269037|NCT04293341|Department of Veterans Affairs|Daniel Gros, PhD|843-789-7311|daniel.gros@va.gov|
21269038|NCT06390085|University of Virginia, Systems and Information Engineering|Gregory Gerling|4349240533|gg7h@virginia.edu|
21269039|NCT05993299|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21269040|NCT05644756|Brown University|Dr. Ruben Martinez|4014441915|ruben_martinez@brown.edu|
21269041|NCT03093480|Bioverativ, a Sanofi company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6
21269042|NCT03526549|Endo Pharmaceuticals|Clinical Operations|1-800-462-3636|ClinicalTrials@Endo.com|
21269043|NCT00478933|Medtronic BRC|Margriet Kruijshoop, Clinical Research Manager|+31623910708|margriet.kruijshoop@medtronic.com|
21269044|NCT00643006|Gothenburg University|Dr. K Mannerkorpi|046-31-24220|kaisa.mannerkorpi@rheuma.gu.se|
21269045|NCT02203305|University of North Carolina at Chapel Hill|Dr. Margaret Dillon|9199665251|mdillon@med.unc.edu|
21269046|NCT02384200|UCSD Medical Center|Paul Zupkas, Ph.D.|6195432628|pzupkas@ucsd.edu|
21269047|NCT01283009|Memphis VA Medical Center|Dr. Gianfranco U. Meduri|(901) 577-7520|Gianfranco.Meduri@va.gov|
21237889|NCT02510144|University of Maryland Baltimore|Dr. Mohit Gilotra|(301) 502-4102|mgilotra@som.umaryland.edu|
21237890|NCT02124265|Johns Hopkins University School of Medicine|Carisa Cooney|443-287-4629|ccooney3@jhmi.edu|
21237891|NCT02115633|RxFunction, Inc.|Lars Oddsson, PhD|8572340382|loddsson@rxfunction.com|
21237892|NCT01786967|University of North Carolina at Chapel Hill|Jennifer Wu, MD, MPH|919-966-0014|jennifer_wu@med.unc.edu|
21237893|NCT00981084|University of Missouri - Kansas City|Dr. Jared Bruce|401-499-4043|brucejm@umkc.edu|
21237894|NCT01602536|University of California, Irvine|Cornelia Pechmann|310-892-0619|cpechman@uci.edu|
21237895|NCT02543658|First affilitated hospital of Nanchang university|Wenhua He|+8613879182642|hewenhua@ncu.edu.cn|
21237896|NCT00789815|Chung Gung Memorial Hospital|Ting-Yu Lin|886 3 3281200|yuebaoyuebao@yahoo.com.tw|5108
21237897|NCT01321554|Eisai, Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21237898|NCT02355067|Children's Hospital of Philadelphia|Dr. James Guevara|215-590-1130|guevara@email.chop.edu|
21237899|NCT01553318|Wake Forest Baptist|dennis ang|336-716-4209|dang@wakehealth.edu|
21237900|NCT02018445|SeaSpine|Sara Tish Mikoczi|760-216-5652|tish.mikoczi@seaspine.com|
21237901|NCT01787097|Imperial College|Dr Omar S Usmani|+44 (0)20 7351 8051|o.usmani@imperial.ac.uk|
21237902|NCT01139190|PLx Pharma LLC|Ronald Zimmerman, CEO & President|713-842-1249|ron.zimmerman@plxpharma.com|205
21237903|NCT01023568|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
21237904|NCT01341977|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21237905|NCT03896009|Axsome Therapeutics, Inc.|Caroline Streicher, Executive Director, Clinical Operations|212-332-5061|cstreicher@axsome.com|
21237906|NCT00437645|Novartis Pharmaceuticals|Study Director|862 778-8300||
21237907|NCT00662857|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
21237908|NCT03966053|Feinstein Institutes for Medical Research|Adrianna Vlachos, MD|5165623757|avlachos@northwell.edu|
21237909|NCT02832622|Abbott|Kwangdeok Lee, PhD|1-972-526-9673|kwangdeok.lee@abbott.com|
21237910|NCT02472652|Thomas D Gazda MD PC|Thomas D Gazda MD|480 518 6299|goodgazda@yahoo.com|
21237911|NCT02713711|UC de Maule|Professor Gabriel Nasri Marzuca Nassr|56 71 203463|gmarzuca@gmail.com|
21237912|NCT04586569|Boston Children's Hospital|Dr. Linda Bulich|617-355-7737|linda.bulich@childrens.harvard.edu|
21237913|NCT00998400|University of Bologna|Professor Chiara Rafanelli|0039 051 2091847|chiara.rafanelli@unibo.it|
21237914|NCT03704584|Emory University|Dr. Charles Daly|404-919-6168|charles.a.daly@emory.edu|
21237915|NCT03185832|Boston Scientific|Caroline Beaudoint|+32479904163|Caroline.Beaudoint@bsci.com|
21237916|NCT03675451|Weill Cornell Medicine|Junaid Niaz|212.746.5793|mjn3001@med.cornell.edu|
21237917|NCT01777321|GlaxoSmithKline|GSK Response Center|866-435-7343||
21237918|NCT02127372|Duke University Medical Center|Gordana Vlahovic, MD|919-681-4047|Gordana.vlahovic@dm.duke.edu|
21237919|NCT02173548|Virginia Commonwealth University|Antonio Abbate, MD, PhD|(804) 828-0513|antonio.abbate@vcuhealth.org|
21237920|NCT03597568|University of I|Dr. Diana Jalal|319-338-0581|diana-jalal@uiowa.edu|
21237921|NCT04141774|UW School of Medicine and Public Health|Dr. Vivek Prabhakaran, MD, PhD|(608) 265-5269|vprabhakaran@uwhealth.org|
21237922|NCT03822117|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21237923|NCT04280653|Mati Therapeutics Inc.|Deepank Utkhede|778-991-3301|dutkhede@matitherapeutics.com|
21269048|NCT00615927|Duke University Medical Center|Annick Desjardins, MD, FRCPC|919-668-|annick.desjardins@dm.duke.edu|
21269049|NCT00183170|Boston University School of Public Health|Dr. Jonathan Howland, Professor||jhowl@bu.edu|
21285891|NCT00158262|Massachusetts General Hospital|Roger K. Pitman, M.D.|617-726-5333|roger_pitman@hms.harvard.edu|
21237924|NCT05443659|Theranica|Dr Dagan Harris, VP Clinical and Regulatory Affairs|+972542220121|daganh@theranica.com|
21237925|NCT05131165|RAND Corporation|Sebastian Linnemayr|310-393-0411|slinnema@rand.org|6734
21237926|NCT01267292|The University of Texas Health Science Center at Houston|Scott Lane, PhD|713-486-2535|Scott.D.Lane@uth.tmc.edu|
21237927|NCT01127646|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21269050|NCT03707145|Aberystwyth University|Dr Marco Arkesteijn|+44(0)1970628559|maa36@aber.ac.uk|
21237928|NCT03466086|Johnson & Johnson Vision|Meredith Bishop, OD, MS, FAAO|904-443-1396|MBishop4@its.jnj.com|
21237929|NCT01291784|Icahn School of Medicine at Mount Sinai|Dr. John O. Mascarenhas|212-241-6756|john.mascarenhas@mssm.edu|
21237930|NCT03002610|University of Split School of Medicine|Ivan Buljan|+385989027209|ibuljan@mefst.hr|
21237931|NCT03802123|ImaginAb|Director, Regulatory Affairs|: +1.310.730.5869|ethomas@imaginab.com|
21237932|NCT01822587|MUSC|Michael Saladin|843-792-5306|saladinm@musc.edu|
21237933|NCT01274182|Sandoz|Global Program Medical Director|+49 8024 476|biopharma.clinicaltrials@sandoz.com|0
21237934|NCT01701414|Dept of Emergency Medicine, Rhode Island Hospital|Francesca Beaudoin MD, MS|401-444-2577|fbeaudoin@lifespan.org|
21237935|NCT00117676|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21237936|NCT00952822|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21237937|NCT01362439|Janssen-Cilag SpA, Cologno Monzese, Milan - Italy|Therapeutic Area Medical Manager|+39 0225101||
21237938|NCT04475549|Cyclerion Therapeutics, Inc.|Cyclerion Clinical Development|1-857-327-8778|info@cyclerion.com|
21257625|NCT01732809|Brazilian Center for Studies in Dermatology|Scientific Coordinator|+55 51 30262633|cientifico@cbed.org.br|
21257626|NCT00473343|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
21257627|NCT02290873|PAION UK Ltd|Trial Information|+49 2414453101|reg_paion@paion.com|
21237939|NCT04852055|Brown University|Project Director|(401) 863-7345|ellen_mccreedy@brown.edu|
21237940|NCT03575325|Moffitt Cancer Center|Bijal D. Shah, MD, MS|813-745-4294|Bijal.Shah@moffitt.org|
21237941|NCT03905330|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
21257628|NCT03715153|Institut de Recherches Internationales Servier (I.R.I.S.)|Dr. Pierre-François PENELAUD|+ 33 1 55 72 68 58|pierre-francois.penelaud@servier.com|
21257629|NCT00075088|University of California, San Francisco|Barbara J Drew, PhD|415-476-4302|barbara.drew@nursing.ucsf.edu|
21237942|NCT02712905|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21237943|NCT04496219|University of Washington|Dr. Sarah Psutka, MD, MS|206-598-4294|spsutka@uw.edu|
21237944|NCT03178266|ZipLine Medical|Wendy Winters, Clinical Project Manager|4085061866|wwinters0@gmail.com|
21237945|NCT01812655|Arkansas Children's Hospital|Debra Jeffs, PhD, RN, Principal Investigator|501-364-3239|jeffsda@archildrens.org|
21301062|NCT03326713|Rutgers Cancer Institute|Anita Y. Kinney, PhD|(732) 865-3375|anita.kinney@rutgers.edu|
21237946|NCT02363946|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|6263043400||
21237947|NCT04435665|NFlection|Director of Clinical Operations|7078532199|comara@nflectionrx.com|
21237948|NCT00419263|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|(919) 859-1302||
21237949|NCT00862134|Proacta, Inc.|Director of Clinical Development|858-642-0386|clinicalops@proacta.com|
21237950|NCT02652481|Boston Scientific|Clinical Trial Manager|+32479983495|anneleen.viville@bsci.com|
21237951|NCT01494584|GlaxoSmithKline|GSK Response Center|866-435-7343||
21237952|NCT06030414|Lumen Bioscience|Senior Medical Director|206-899-1904|trials@lumen.bio|
21237953|NCT00374322|GlaxoSmithKline|GSK Response Center|866-435-7343||
21237954|NCT01522417|Medicure|Kyle Brown|204-594-3411|kbrown@medicure.com|
21237955|NCT01352598|Mercy|Jaymeson Stroud, MD|314-251-6844|Jaymeson.Stroud@mercy.net|
21237956|NCT00506064|UT MD Anderson Cancer Center|Una Srejic, MD / Professor|713-792-6914|CR_Study_Registration@mdanderson.org|
21301063|NCT00771758|Ortho-McNeil Janssen Scientific Affair, LLC.|Senior Director of Clinical Development, Pain|(908)927-5465||
21301064|NCT03067077|Stanford University School of Medcine|Edward E. Manche|6507255765|edward.manche@stanford.edu|
21301065|NCT00935584|VA san Diego Healthcare System|Dr. Zia Agha|8586421295|zia.agha@va.gov|
21301066|NCT00687193|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21301067|NCT02129699|European Thoracic Oncology Platform|European Thoracic Oncology Platform|+41 31389 93 91|SPLENDOUR@etop-eu.org|
21301068|NCT01394016|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21301069|NCT03534804|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
21301070|NCT02530515|UT MD Anderson Cancer Center|Dr. Chitra Hosing / Stem Cell Transplantation|(713) 745-3219|cmhosing@mdanderson.org|
21301071|NCT00174187|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21301072|NCT04161157|University of Kentucky|Dr. Laurie McLouth|859-562-2526|laurie.mclouth@uky.edu|
21301073|NCT03752567|Farmacia La Regina|Dr. Raffaele La Regina|+393389066138|raffaele.laregina@gmail.com|
21301074|NCT03529695|USC Center for Economic and Social Research|Kayla De La Haye, PhD, Research Scientist|323-442-8228|delahaye@usc.edu|
21301075|NCT06482125|Universitas Pelita Harapan|Dr. Corry Quando Yahya|2181383190900|corry.yahya@lecturer.uph.edu|
21301076|NCT02833233|Memorial Sloan Kettering Cancer Center|Dr. Elizabeth Comen|646-888-4525|comene@mskcc.org|
21301077|NCT02991768|University of Kansas Medical Center|Clinical Research Coordinator|913-588-3520|edelaney2@kumc.edu|
21301078|NCT04701762|Cleveland Clinic|Kurt Ruetzler|216 407-4108|ruetzlk@ccf.org|
21301079|NCT05030129|Rush University Medical Center|Elizabeth Berry-Kravis, MD PhD|312-942-4036|Elizabeth_Berry-Kravis@rush.edu|
21301080|NCT04922216|University of North Carolina at Chapel Hill|Brooke Nezami, PhD|919-966-5852|bnezami@unc.edu|
21301081|NCT03278249|University of Cincinnati Cancer Center|Rekha Chaudhary, MD, Adjunct-Associate Professor of Medicine|513-558-2119|Rekha.chaudhary@uc.edu|
21301082|NCT02017405|Entera Health, Inc.|Audrey L. Shaw, Ph.D.|919 971 8000|audrey.shaw@enterahealth.com|
21301083|NCT01399372|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21301084|NCT01732718|University of North Carolina at Chapel Hill|Kenneth Ataga, MD|901-448-2813|kataga@uthsc.edu|
21237957|NCT02460692|University of California, San Diego|Thomas D. Marcotte, PhD|619-543-5044|tmarcotte@health.ucsd.edu|
21237958|NCT01298999|Columbia University Medical Center|Julian A Abrams, MD|2123059541|ja660@cumc.columbia.edu|
21257630|NCT01519765|Stanford University|Dr. Linh Tran|925-642-2241|lltran20@gmail.com|
21285892|NCT01421641|Oregon Health & Science University|Paula Bednarek|(503) 418-4500|bednarek@ohsu.edu|
21285893|NCT00883415|University of Maryland Baltimore|Jeffrey C. Fink MD, MS; Principal Investigator|410-328-4822|jfink@som.umaryland.edu|
21285894|NCT02420119|HaEmek Medical Center|Dr.Frieda Wolf|97246495476|friedawolf@hotmail.com|
21285895|NCT01808261|GlaxoSmithKline|GSK Response Center|866-435-7343||
21285896|NCT03956030|Penn State Health, Milton S. Hershey Medical Center|Dr. Christina DeAngelis|717-531-5994|cdeangelis2@pennstatehealth.psu.edu|3763
21285897|NCT04501952|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21285898|NCT02080364|vTv Therapeutics LLC|Ann Gooch PhD,RAC,CCRP; Vice President Clinical Development & Regulatory Operations|336-841-0300|agooch@vtvtherapeutics.com|80544
21285899|NCT02256839|QIAGEN Sciences|Clinical Study Coordinator|301-944-7094|andrew.schumacher@qiagen.com|
21285900|NCT00436826|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21301085|NCT00921895|Rapid Pathogen Screening, Inc.|Robert Sambusky, MD|941-556-1853|sambursky@rpsdetectors.com|
21301086|NCT01177397|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
21301087|NCT01358721|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21301088|NCT01765972|Johnson & Johnson Vision Care Inc.|Katherine Osborn Lorenz, OD, MS|614 459-9477|KOSBORN@its.jnj.com|
21301089|NCT02446899|AstraZeneca AB|Global Clinical Lead|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
21301090|NCT01554241|University of California, San Francisco|Janice B.Schwartz, M.D., Professor of Medicine|(415) 406-1573|janice.schwartz@ucsf.edu|
21257631|NCT04126083|Mayo Clinic|W. Michael Hooten, M.D.|507-266-9672|Hooten.William@mayo.edu|
21257632|NCT02941705|Cedar Sinai|Russell Haber|(310) 967-8322|Russell.Haber@CSHS.org|
21257633|NCT04402970|University of Missouri|Dr. Zach Holliday|5738829072|hollidayz@health.missouri.edu|
21257634|NCT03499509|The University of Alabama at Birmingham|Barbara Gower, PhD|205-934-4087|bgower@uab.edu|
21257635|NCT02437864|University of New Mexico Health Sciences Center (HSC)|Dr. Codruta Soneru|5052722610|csoneru@salud.unm.edu|
21257636|NCT02822885|Benha university|dr khalid M Salama|01225861026|dr.khalid_sleem@yahoo.com|
21257637|NCT00645593|University of Michigan Comprehensive Cancer Center|Dr. Maha Hussain, M.D.|(734) 647-8903|mahahuss@umich.edu|
21257638|NCT01585272|Novartis Pharmaceutical|Study Director|862-778-8300||
21257639|NCT02577146|Washington University School of Medicine|Alana Desai, M.D.|(314) 362-7581|desaia@wustl.edu|
21301091|NCT00742235|Massachusetts General Hospital|Principal Investigator|617-726-3934|ibhan@partners.org|
21301092|NCT00433004|University of Pennsylvania|Arden McAllister|215-662-3532|arden.mcallister@uphs.upenn.edu|267
21301093|NCT01051518|Medtronic|M. Hollander|+31620534428|maarten.hollander@medtronic.com|
21301094|NCT05661409|Emory University|Dr. Matthew K. Whalin|404-616-5014|mwhalin@emory.edu|
21301095|NCT04287036|Johnson & Johnson Vision Care|Meredith Bishop OD, MS, FAAO|1-800-843-2020|mbishop4@its.jnj.com|
21301096|NCT04730271|DePuy Synthes|Ian Leslie|N/A|ileslie1@its.jnj.com|
21301097|NCT00998296|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21301098|NCT04396639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21257640|NCT00891982|GlaxoSmithKline|GSK Response Center|866-435-7343||
21257641|NCT00781911|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21257642|NCT01357655|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21257643|NCT05003622|Pierre Fabre Medicament|Jean Claude Vedovato|+33 609828746|jean.claude.vedovato@pierre-fabre.com|
21257644|NCT03924752|Georgia Institute of Technology|Dr. Aaron Young|404-385-5306|aaron.young@me.gatech.edu|
21257645|NCT02258451|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21257646|NCT04138017|University of Virginia|Eric McVey, Clinical Research Coordinator|434.243.5382|eric.mcvey@uvahealth.org|
21257647|NCT01682135|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21257648|NCT00129766|MedImmune|M. Pamela Griffin, Sr. Director, Clinical Development|301-398-0000|clinicaltrialenquiries@medimmune.com|
21257649|NCT01081912|Zogenix|Kevin Romanko|(510) 550-8323|kromanko@zogenix.com|
21257650|NCT02037295|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Jonathan Krakoff, M.D.|(602) 200-5217|jkrakoff@mail.nih.gov|
21257651|NCT01140451|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
21257652|NCT00556452|University of Michigan Cancer Center|Dr. John Magenau|734/936-8785|johnmage@umich.edu|
21257653|NCT02152085|University of Colorado Boulder|Roger Enoka|3034927232|enoka@colorado.edu|
21257654|NCT00661531|Georgetown University|Dr. Claudine Isaacs|2024443677|isaacsc@georgetown.edu|
21269051|NCT04221477|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21269052|NCT05445466|BIDMC|Dr. Paulo Lizano|201-776-6708|lizanopl@gmail.com|
21269053|NCT01714921|Medtronic GmbH|ProSA clinical research contact|004921598149|rs.dusclinicalcooperation@medtronic.com|0
21269054|NCT02265874|The Ohio State University Wexner Medical Center|Dr. Elliott Crouser|16142934925|elliott.crouser@osumc.edu|
21269055|NCT01215968|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21269056|NCT01085331|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21269057|NCT05643573|Bayer AG|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
21269058|NCT04678440|University of California Davis|Simon Cherry|(530) 754-9419|srcherry@ucdavis.edu|
21269059|NCT04563039|Avvio Medical, Inc.|VP of RA / QA / CA|4158872037|clinicalaffairs@avviomed.com|
21269060|NCT04242498|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21269061|NCT00056472|Weill Cornell Medical College|Barnett S. Meyers, MD|914-997-5721|bmeyers@med.cornell.edu|
21269062|NCT02500732|University of Calgary|Dr. Satish R Raj|403-210-6152|satish.raj@ucalgary.ca|
21269063|NCT03205605|University of Maryland, Baltimore School of Pharmacy|Dr. Audra Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
21269064|NCT01958619|Medicines for Malaria Venture (MMV)|Dr Thomas Rueckle PhD|+41 22 799 4567|ruecklet@mmv.org|
21269065|NCT03677440|Kessler Foundation|Brian Sandroff, PhD|973-965-6649|bsandroff@kesslerfoundation.org|
21269066|NCT01710839|Retina Consultants of Houston|Charles C Wykoff, PhD, MD|713-524-3434|ccwmd@houstonretina.com|
21269067|NCT03759340|Aclaris Therapeutics, Inc.|Marco Cardillo, Clinical Trial Manager|484-540-6299|mcardillo@aclaristx.com|
21269068|NCT03795233|Boston Medical Center|Tamar Barlam, MD MSC|617 414 5190|tamar.barlam@bmc.org|
21269069|NCT02756182|Laborie|Clinical Research Manager|9056121170|sgallone@laborie.com|1755
21269070|NCT00409565|University of Pittsburgh Cancer Institute|Michael Gibson, MD|412-692-2600|gibsonmk@upmc.edu|
21269071|NCT01003691|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269072|NCT03225313|Theodor Bilharz Research Institute|Dr Muhammed Hussein|00201001434459|muhamed.hussein@gmail.com|
21269073|NCT03832907|Emory University|Dr. Umpierrez|404-778-1665|geumpie@emory.edu|
21269074|NCT00828009|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21269075|NCT03826771|Medical University of South Carolina|Chris Gregory|843-792-1078|gregoryc@musc.edu|
21269076|NCT01676818|USC/Norris Comprehensive Cancer Center|Tali Homsey|(323) 865-0451|tali.homsey@med.usc.edu|
21269077|NCT06768658|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21269078|NCT03548454|Stanford University|Dr. Vafi Salmasi|650-725-0246|vsalmasi@stanford.edu|
21269079|NCT01600677|UPittsburgh|Steven M. Handler, MD, PhD|412-864-1878|handler@pitt.edu|
21269080|NCT02899884|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21269081|NCT01100073|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21269082|NCT03099265|Yale School of Medicine|Kimberly L. Johung, MD, PhD Associate Professor of Therapeutic Radiology|(203) 200-2008|kimberly.johung@yale.edu|
21269083|NCT02284880|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21269084|NCT01656850|Taipei Medical University|Liu, Jen-Fang|+886-3-2118999|liujenfa@mail.cgust.edu.tw|5487
21269085|NCT02074982|Novartis Pharmaceuticals|Study Director|862-778-8300||
21269086|NCT03305159|Northwestern University Feinberg School of Medicine|Supriya Rastogi|supriya.rastogi@northwestern.e|supriya.rastogi@northwestern.edu|
21269087|NCT02094573|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21269088|NCT02875340|ValiSeek Limited|Suzanne Dilly|+442030084416|suzanne.dilly@valirx.com|
21269089|NCT03681769|Medical University of South Carolina|Dr. Jeff Borckardt|843-792-3295|borckard@musc.edu|
21269090|NCT01160770|Lundbeck LLC|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
21269091|NCT05279807|A. Menarini Industrie Farmaceutiche Riunite SrL|Clinical Operation Director|+39 055 5680459|pfabrizzi@menarini.it|
21269092|NCT03985982|Croma Pharma|Clinical Development - Head of Clinical Operations|+432262684680|clinical.studies@croma.at|
21269093|NCT05981365|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269094|NCT02989623|Thomas Jefferson University|Mathew Thakur|215-503-7874|Mathew.Thakur@Jefferson.edu|
21269095|NCT05984784|Inmagene LLC|Clinical Trials Lead|(858) 345-6927|ClinicalTrials@imagenebio.com|
21269096|NCT00005803|Fred Hutch|David G Maloney, MD PhD||dmaloney@fredhutch.org|
21269097|NCT00766727|Neodyne|VP, R&D/OPS|5104564128|jzepeda@neodynebio.com|128
21269098|NCT05102162|University of Florida College of Pharmacy|Nicole Maranchick|352-273-6803|n.maranchick@cop.ufl.edu|
21269099|NCT01353586|Biosense Webster, Inc|Kendra McInnis, Manager, Clinical Operations|909-839-7284|kmcinnis@its.jnj.com|
21269100|NCT05027958|Division of Intramural Research, NHLBI|Kevin P. Fennelly, M.D., MPH, ATSF|301-385-0807|kevin.fennelly@nih.gov|
21269101|NCT02871921|MGH|Dr. Hiroko Dodge, Director of Research Analytics|724-494-3605|hdodge@mgh.harvard.edu|
21269102|NCT00595946|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
21269103|NCT04369885|University of North Carolina at Chapel Hill|Michael B Drummond, MD|919-966-7054|brad_drummond@med.unc.edu|
21269104|NCT02511587|Medical University of Vienna|Univ.-Prof. Dr. Ursula Wiedermann|0043 1 40160 38291|ursula.wiedermann@meduniwien.ac.at|
21269105|NCT00890409|Children's Hospital, Fudan University|Prof. Xiaomei Shao|86-21-64931913|zhou_wenhao@yahoo.com.cn|
21269106|NCT02353572|University of Colorado|Choon-kee Lee, MD|7208489252||
21301099|NCT01544335|Massachusetts General Hospital|Associate Director, Lymphedema Research Program|6177240127|cbrunelle@mgh.harvard.edu|
21269107|NCT03099655|Medtronic|Erika Pouliot|+17635261270|erika.pouliot@medtronic.com|
21269108|NCT03715335|Cincinnati Children's Hospital Medical Center|Dr. Jennifer Reed|(513) 636-7966|jennifer.reed@cchmc.org|
21269109|NCT02234427|Johns Hopkins School of Medicine|Rehan Qayyum|410-955-7781|rqayyum@jhmi.edu|
21257655|NCT03134599|CooperVision|Jose Vega, O.D., MSc., FAAO|9252516213761|javega@coopervision.com|
21257656|NCT03078075|UT Southwestern Medical Center|Dr. Madhukar Trivedi|214/648-0188|Madhukar.Trivedi@UTSouthwestern.edu|
21257657|NCT02841397|Masimo Corporation|Cristina Johnson|(949) 297-7000|clinicalresearchdept@masimo.com|
21257658|NCT04331795|University of Chicago, Department of Medicine Section of Rheumatology|Dr. Pankti Reid|773-702-6119|pankti.reid@uchospitals.edu|
21257659|NCT01224626|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21257660|NCT04784182|Auburn University|Drew Frugé|3348448433|adf0003@auburn.edu|
21257661|NCT00705783|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affairs|800 562-3974||
21257662|NCT01707043|Wake Forest|Steve Feldman, MD|336-716-3775|sfeldman@wakehalth.edu|
21257663|NCT02086786|Rovi S.A. Laboratorios Farmacéuticos|Jordi Llaudó Garín ( Clinical Development Manager)|+34913756230|jllaudo@rovi.es|
21257664|NCT00713427|Boston Scientific Corporation|Joyce Peetermans, PhD - Vice President, Global Clinical Programs|508-683-4211|Joyce.Peetermans@bsci.com|
21257665|NCT01298752|Bausch Health|Study Director||susan.harris@bauschhealth.com|
21257666|NCT01923129|Cedars Sinai Medical Center|Dr. Phillip Fleshner|(310) 289-9224|Phillip.Fleshner@cshs.org|
21257667|NCT01549002|ColumbiaU|Dr. Daniel Fenster|212-305-9825|dbf2114@columbia.edu|
21257668|NCT01251367|Ipsen|Medical Director, Neurology,||clinical.trials@ipsen.com|
21257669|NCT02189213|RFMH|Amir Levine|646 481 2566|amir.levine@nyspi.columbia.edu|
21257670|NCT03998046|Northwestern University|Ronald Ackermann, MD, MPH|(312)-503-3232|r.ackermann@northwestern.edu|
21257671|NCT02370615|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21257672|NCT02512224|The University of Tokyo Hospital|Dr. Sumito Ogawa|+81-3-5800-8830|suogawa-tky@umin.ac.jp|
21257673|NCT00506883|AR Scientific, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21257674|NCT00078325|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
21257675|NCT00578136|The Children's Hospital of Philadelphia|Harshad Gurnaney, MBBS, MPH|267-426-5850|gurnaney@email.chop.edu|
21257676|NCT01699542|Boston Scientific Corporation|Joyce Peetermans, PhD - Vice President, Global Clinical Programs|508-683-4211|Joyce.Peetermans@bsci.com|
21257677|NCT00730964|GE Healthcare|Rubin Sheng, MD|1-609-514-6899|Rubin.Sheng@ge.com|
21257678|NCT00754793|University of Washington|Dr. Greg E. Davis, MD MPH|206-543-5230|gedavis@uw.edu|
21257679|NCT00932360|University of Iowa|Dana Dailey|319-335-7149|dana-dailey@uiowa.edu|
21257680|NCT03471975|Ajou University School of Medicine|Jihoon Hwang|+821093103304|kironojh@gmail.com|
21257681|NCT01892163|Moorfields Eye Hospital NHS Foundation Trust|Professor Sobha Sivaprasad|02072533411|sobha.sivaprasad@moorfields.nhs.uk|
21257682|NCT02012621|University of Colorado-AMC|Dr. Jose Castillo-Mancilla|303-724-4934|jose.castillo-mancilla@cuanschutz.edu|
21257683|NCT01445821|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
21257684|NCT01624662|OptiNose|Vice President Global Clinical Operations & Outsourcing|267-364-3508|jennifer.carothers@optinose.com|
21257685|NCT00361270|Michael E DeBakey VAMC|Wright Williams, Ph.D., ABPP|713-794-7629|wright.williams@va.gov|
21257686|NCT00533442|University of Miami|Dr. George W. Burke, III|305-355-5111|gburke@med.miami.edu|
21257687|NCT02351505|The Ohio State University Comprehensive Cancer Center|Erin Bertino, MD|614-293-8054|Erin.Bertino@osumc.edu|
21257688|NCT04013529|Corporal Michael J. Crescenz VA Medical Center|Manik Chhabra|(215) 823-5800|manik.chhabra@va.gov|
21257689|NCT05815719|Instituto Bernabeu|Juan Carlos Castillo|+34965154000|jcastillo@institutobernabeu.com|
21257690|NCT04473690|KBio Inc|Katrina Whelan|2706893345|katrinaw@KBio.com|
21257691|NCT00517751|Medtronic Spinal and biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
21257692|NCT02958007|VA Maryland Healthcare System|Anjana Muralidharan|443-421-6275|anjana.muralidharan2@va.gov|
21257693|NCT00495820|Central Arkansas Veterans Healthcare System|Prasad Padala, MD, MS, Associate Director for Clinical Programs, GRECC|5012572537|prasad.padala@va.gov|
21257694|NCT00820950|Incyte|Incyte Corporation Call Center (US)|1.855.463.3463|medinfo@incyte.com|
21257695|NCT01878526|Khon Kaen University|Dr.Chingching Foocharoen|6643363746|fching@kku.ac.th|
21257696|NCT01246583|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21257697|NCT05264740|McMaster University|Dr. Laura Anderson|N/a|ln.anderson@mcmaster.ca|
21257698|NCT02901925|Dartmouth-Hitchcock|Dr. David Roberts|603-650-|David.W.Roberts@dartmouth.edu|
21257699|NCT05885737|CSL Behring|Clinical Study Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
21257700|NCT01292642|McLean Hospital|Kevin P Hill, MD, MHS|617-855-4501|khill@mclean.harvard.edu|
21301100|NCT02223858|Veterans Affairs Pittsburgh Healthcare System|Dr. Leslie R.M. Hausmann|412-360-2112|leslie.hausmann@va.gov|
21301101|NCT04211909|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21301102|NCT03198507|Redhill Biopharma Inc.|June Almenoff, Chief Scientific Officer|(984) 444 7010|jalmenoff@redhillus.com|
21301103|NCT00124514|cincinnatichildrens|Hermine Brunner|5136367982|hermine.brunner@cchmc.org|
21301104|NCT03977818|Institut Bergonié|Pr Antoine Italiano|33 5 56 33 33 33|a.italiano@bordeaux.unicancer.fr|
21301105|NCT00241839|University of Florida|Mark S. Segal, MD, PhD; Assistant Professor and Chief, Division of Nephrology|352-273-8821|Mark.Segal@medicine.ufl.edu|
21257701|NCT02484911|First Affiliated Hospital of Harbin Medical University|Dr.Zhang|85555068|daxinmay@126.com|
21257702|NCT04129528|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
21257703|NCT00218491|Medical University of SC|Robert Malcolm, MD|843-792-1901|malcomr@musc.edu|
21269110|NCT01870921|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
21269111|NCT00941681|Cytokinetics, Inc.|Project Manager|650-624-2918||
21269112|NCT02060188|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21269113|NCT03107442|FIBAO|Dr José Antonio Vargas-Hitos|625943933|joseantoniovh@hotmail.com|+34
21269114|NCT02242942|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21269115|NCT04882085|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269116|NCT05014672|Calliditas Therapeutics AB|Head of Clinical Operations|+4684113005|info@calliditas.com|
21269117|NCT04455620|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
21269118|NCT03792633|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
21269119|NCT00145119|Medtronic Bakken Research Center|Director CRDM|+31 43 3566||566
21269120|NCT05681715|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21269121|NCT05455684|Janssen Research and Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21269122|NCT05204563|Evopoint Biosciences USA, Inc.|Evopoint Biosciences|646-750-2661|info@evopointbio.com|
21269123|NCT04411641|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
21269124|NCT02268214|AstraZenenca|Anna Maria Langkilde|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
21269125|NCT02951130|UC Davis School of Medicine|Satyan Lakshminrusimha|916 734 5178|slakshmi@health.ucdavis.edu|
21269126|NCT01119118|University of Wisconsin Carbone Cancer Center|Dr. Glenn Liu|608-265-8689|gxl@medicine.wisc.edu|
21269127|NCT01652040|Hunter Holmes McGuire VA Medical Center|Ashraf S. Gorgey|8046755000|ashraf.gorgey@va.gov|3386
21269128|NCT05267652|Vanderbilt University Medical Center|Jonathan D Casey, MD, MSc|615-875-4681|Jonathan.d.Casey@vumc.org|
21269129|NCT07002632|University of Health Sciences, Gaziosmanpasa Training and Research Hospital|Ethem ilhan, MD|+90 505 591 86 50|ethem.ilhan@sbu.edu.tr|
21269130|NCT02711306|Taipei Medical University|Dr. Sing-Chung Li|886-2-27361661|sinchung@tmu.edu.tw|6560
21269131|NCT01519635|Service of Nephrology, Centre Hospitalier Universitaire Vaudois, Lausanne|Prof Michel Burnier|+41 21 314 11 54|michel.burnier@chuv.ch|
21257704|NCT00605423|Johns Hopkins University|Peter Campochiaro, M.D.||pcampo@jhmi.edu|
21257705|NCT00490568|GlaxoSmithKline|GSK Response Center|866-435-7343||
21257706|NCT01066364|UCSD|Rohit Loomba, MD|858-246-2201|roloomba@ucsd.edu|
21257707|NCT02289222|University of Maryland Greenebaum Comprehensive Cancer Center|Ashraf Badros M.B.Ch.B|410-328-1230|Abadros@umm.edu|
21257708|NCT01351389|Brown University, Center for Alcohol and Addiction Studies|Dr. Peter Monti|(401) 863-6661|peter_monti@brown.edu|
21257709|NCT02868242|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21257710|NCT03776175|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21257711|NCT03077347|University of CA Davis Health|Tiffany T . Norris|916-703-9193|ttnorris@ucdavis.edu|
21257712|NCT01981590|Medtronic Bakken Research Center|Lilian Kornet, Prin.Scientist|+31433566710|lilian.kornet@medtronic.com|
21257713|NCT02770547|Purdue University|Bruno Roseguini, Assistant Professor|(765) 496-2612|brosegui@purdue.edu|
21257714|NCT01324232|Avanir Pharmaceuticals|Avanir Medical Information|855-572-2722|medinfo@avanir.com|
21257715|NCT00393887|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@cookbiotech.com|
21257716|NCT01265615|Ural Institute of Cardiology, Ural State Medical Academy|Dr. Alexander Kharlamov|+79638547663|drskharlamov@gmail.com|
21257717|NCT01732796|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21257718|NCT05626270|Erchonia Corporation|Travis Sammons|864-531-0064|tsammons@erchonia.com|
21257719|NCT00876187|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21257720|NCT00838331|Emory University|John Roback, MD PhD|404-712-1774|jroback@emory.edu|
21257721|NCT01379274|Rush University Medical Center|Dr. Jamile Shammo|312-CANCER-1|jamile_shammo@rush.edu|
21257722|NCT03200366|Indiana University|Susan M. Rawl, PhD, RN, FAAHB, FAAN|317-278-2217|srawl@iu.edu|
21257723|NCT00405067|Aegerion Pharmaceuticals|Chief Medical Officer|617-500-7867||
21257724|NCT03287219|Cosmo Technologies Ltd|R&D Manager||rjones@cosmopharma.com|
21257725|NCT00930761|Instituto de Puericultura e Pediatria Martagão Gesteira - UFRJ|Dr. Arnaldo Prata Barbosa|+55 21 25904891|arnaldoprata@globo.com|
21257726|NCT03571646|Medtronic|Geraldine Kelly|+353 879840223|geraldine.kelly@medtronic.com|
21257727|NCT01576549|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21257728|NCT04081363|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21257729|NCT03831971|Clinical Center|Masur, Henry|+1 301 496 9320|hmasur@cc.nih.gov|
21257730|NCT01765920|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
21257731|NCT02025907|Janssen Research & Development, LLC|Senior Director, Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
21257732|NCT02017327|Laboratoires Thea|Director of medical operation|+473985089|J.auger@laboratoires-thea.fr|
21257733|NCT02153528|Institute of Tropical Medicine Antwerp|Clinical Trials Unit ITM|0032 32470778|jbuyze@itg.be|
21257734|NCT02411539|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21257735|NCT00939783|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21257736|NCT02189161|Laser Surgery Care|Dr. Stephen E. Goldstone, MD|212-242-6500|segmd@prodigy.net|
21257737|NCT01664559|BWH|Dr. Lynn Ngo, Lead Study Coordinator/investigator|(617)732-8798|llngo@partners.org|
21257738|NCT06290206|University of Utah|Kaila Christini, MsPH, MS|801-587-4565|Kaila.Christini@hci.utah.edu|
21269132|NCT00347776|Johns Hopkins University|Sheila K West|410 955 2606|shwest@jhmi.edu|
21269133|NCT00299546|Centocor Research & Development, Inc.|Associate Director Clinical Research|1-800-457-6399||
21269134|NCT01605539|Icahn School of Medicine at Mount Sinai|Yasmin Hurd, PhD|212-824-9314|yasmin.hurd@mssm.edu|
21269135|NCT00968539|GlaxoSmithKline|GSK Response Center|866-435-7343||
21269136|NCT00396318|Genentech, Inc.|Medical Communications|800-821-8590||
21269137|NCT00326118|GlaxoSmithKline|GSK Response Center|866-435-7343||
21269138|NCT00602927|University of Pennsylvania|Dr. Caryn Lerman|215-746-7141|clerman@mail.med.upenn.edu|
21269139|NCT00296192|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
21269140|NCT03504839|The Ohio State University Medical Center|Clinical Research Coordinator - Adrianne Miller|614-688-8252|adrianne.miller3@osumc.edu|
21269141|NCT03891602|Hackensack Meridian Health|Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN|2018803443|lisa.carterbawa@hmh-cdi.org|
21269142|NCT01741259|OB Anesthesia Associates|Christy Morgan, MD|314-469-6800|christylmorganmd@gmail.com|
21269143|NCT01256086|University of Florida, Department of Pharmacotherapy and Tanslational Research, 100486 Gainesville, FL 32610|Prof. Dr. Leslie Hendeles|+1 352 279|hendeles@cop.ufl.edu|6027
21269144|NCT05604521|Sanaria Inc.|Chief Medical Officer|301-770-3222|sanaria@sanaria.com|
21269145|NCT03065517|Evidence-Based Practice Institute, Inc.|Angela Kelley Brimer|253-279-8659|research@jasprhealth.com|
21269146|NCT02525627|Stryker EU Operations B.V. Herikerbergweg 110 1101 CM Amsterdam The Netherlands|Doug McGurty|+44 (0) 1635 500690|doug.mcgurty@stryker.com|
21269147|NCT00242567|Novartis Pharmaceuticals|Study Director|862-778-8300||
21269148|NCT00630994|Mayo Clinic|Dr. Ruben A. Mesa|507-284-2511|mesa.ruben@mayo.edu|
21269149|NCT05553600|Kimberly-Clark Corporation|Jin Zhang|770-587-8000|jin.zhang@kcc.com|
21269150|NCT01510704|Acacia Pharma Ltd|Dr Gabriel Fox||gabrielfox@acaciapharma.com|
21269151|NCT03710824|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
21237959|NCT02532179|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21237960|NCT00806234|Johns Hopkins University|Dr. Mark Riddle|410-302-6120|mriddle1@jhmi.edu|
21237961|NCT01337674|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21237962|NCT00119405|Case Western Reserve University|Grace McComsey|216-844-3607|mccomsey.grace@clevelandactu.org|
21237963|NCT00939484|St. Jude Children's Research Hospital|Tong Lin (Biostatistician)|9015952048|Tong.Lin@stjude.org|
21237964|NCT04233372|Hospital Clínic of Barcelona|Dr. Alexy Inciarte|+34932275400|ajinciar@clinic.cat|
21237965|NCT04958785|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230|GileadClinicalTrials@gilead.com|GILEAD-0
21237966|NCT03938454|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
21237967|NCT01090310|Novartis|Study Director|862-778-8300||
21237968|NCT00695786|UT MD Anderson Cancer Center|Felipe Samaniego,MD/Professor, Lymphoma-Myeloma|(713) 745-6824|fsamaniego@mdanderson.org|
21237969|NCT01224925|UiT The Arctic University of Norway (Tromsø university)|Associate professor Rita Kundzina|+4777649118|rita.kundzina@uit.no|
21237970|NCT02542839|University of Florida|Aparna Wagle Shukla|3522945400|aparna.shukla@neurology.ufl.edu|
21237971|NCT00791843|University of Pennsylvania|Tyrone Quarterman|215-349-5537|tyroneq@upenn.edu|
21237972|NCT04244396|Abbott_Medical_Devices|Emily Jesser Clinical Research Scientist II|6514482520|emily.jesser@abbott.com|
21237973|NCT00949884|Daiichi Sankyo, Inc.|Robert Dubiel, PharmD|973-944-2963|bdubiel@dsi.com|
21237974|NCT00245102|Memorial Sloan-Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org|
21237975|NCT03717402|Dana-Farber Cancer Institute|Andrea C. Enzinger, MD|617-582-7335|Andrea_Enzinger@DFCI.HARVARD.EDU|
21237976|NCT02565901|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
21237977|NCT02293395|Janssen Research & Development, LLC|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
21237978|NCT04639193|University of California San Diego|Dr Chris Schmickl|8582462154|cschmickl@health.ucsd.edu|
21237979|NCT00224770|Johns Hopkins University|Dr. Daniel F. Hanley|(410) 614-6996|dhanley@jhmi.edu|
21237980|NCT01106430|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21237981|NCT00297115|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21237982|NCT02124889|WakeForest|Dr. Adolfo Fernandez|336-716-6099|afernand@wakehealth.edu|336
21237983|NCT00989092|Amgen Inc.|Study Director|866-572-6436||
21269152|NCT01605370|Mayo Clinic|Marek Belohlavek, M.D., Ph.D.|408-301-6694|belohlavek.marek@mayo.edu|
21269153|NCT01317199|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Channing Paller|410-955-8239|cpaller1@jhmi.edu|
21269154|NCT01353209|University of Cincinnati|Susan McMahan, Clinical Research Manager|513-558-4831|Susan.mcmahan@uc.edu|
21269155|NCT02951182|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21269156|NCT01301625|Abbott Vascular|Jeffrey T. Ellis|(408) 845-8184|jeffrey.ellis@av.abbott.com|
21269157|NCT02684370|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21269158|NCT01509638|Cleveland Clinic Florida|Marylise Boutrous, MD|954-659-5000|canedoj@ccf.org|
21269159|NCT00326625|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21269160|NCT00517868|Vaneltix Pharma, Inc.|CEO|732-354-3217|info@vaneltix.com|
21269161|NCT02277548|University of Pennsylvania|Dr. Erin McMenamin|251-662-2428|Erin.McMenamin@pennmedicine.upenn.edu|
21269162|NCT00323362|Rutgers Cancer Institute of New Jersey|Dr. Joseph Aisner, MD|732-235-8675|aisnerjo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
21237984|NCT03586583|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
21237985|NCT04149925|Lexington Medical Inc.|Annette Dunn|480-313-8505|annette@lexington-med.com|
21237986|NCT02586025|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21269163|NCT00625846|Mayo Clinic|Keith C. Bible, M.D., Ph.D.|507-284-2511|bible.keith@mayo.edu|
21269164|NCT00807040|Icahn School of Medicine at Mount Sinai|Alan Moskowitz, MD|212-659-9568|alan.moskowitz@mountsinai.org|
21257739|NCT01439204|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21257740|NCT02255409|Seqirus|Clinical Study Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
21257741|NCT00336973|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
21257742|NCT03775421|Actelion Pharmaceuticals Ltd|Senior Clinical Leader PH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21257743|NCT02445807|Dr. Reddy's Lab, Inc|Srinivas Sidgiddi, MD|609-375-9900|srinivassidgiddi@drreddys.com|
21257744|NCT02008682|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21257745|NCT02431572|Massachusetts General Hospital|Dr. Elizabeth Gerstner|617-724-8770|EGERSTNER@mgh.harvard.edu|
21257746|NCT02287623|University of Minnesota|Dr. Jacob Hutchins|612-624-9990|hutc0079@umn.edu|
21257747|NCT02700997|TriHealth Inc.|Rachel Pauls MD|513-463-4300|Rachel_Pauls@trihealth.com|
21257748|NCT01441570|Brigham and Women's Hospital|Dr. Steven Gabardi|617-732-7658|sgabardi@partners.org|
21257749|NCT02870309|Grifols Therapeutics LLC|Susan Sorrells|919-316-6582|susan.sorrells@grifols.com|
21257750|NCT00455013|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21257751|NCT01445951|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
21257752|NCT03610724|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21257753|NCT01473563|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21257754|NCT03054922|Nationwide Children's Hospital|David P. Martin, MD|614-722-4200|david.martin@nationwidechildrens.org|
21257755|NCT00786565|Bausch & Lomb|Jon Hayashida|(585) 338-6370|jon.hayashida@bausch.com|
21257756|NCT05513625|AiCuris Anti-infective Cures AG|Information Desk|+4920231763|info@aicuris.com|0
21269165|NCT00544713|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
21269166|NCT00510497|University of Pittsburgh|Sharon A. Riddler, MD, MPH|412-383-1675|riddler@pitt.edu|
21269167|NCT03075826|Weill Cornell Medical College|Dr.Pinkal Desai|646-962-2700|pid4006@med.cornell.edu|
21269168|NCT04190056|University of California, San Francisco|Dr. Pamela Munster, MD|(415) 502-3598|pamela.munster@ucsf.edu|
21269169|NCT04456998|GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.|GB002, Inc. Study Director|1-866-668-4083|ClinicalTrials@gossamerbio.com|
21269170|NCT02080273|Colgate Palmolive Company|Maria Ryan|732-878-7766|maria_ryan@colpal.com|
21269171|NCT04228107|University of Colorado|Heather De Keyser MD MSCS|720-777-4108|heather.dekeyser@childrenscolorado.org|
21269172|NCT00965562|Donaghue Medical Research Foundation|Dr. Kimberly Yonkers|1-203-764-6621|Kimberly.Yonkers@yale.edu|
21269173|NCT04755283|Anthos Therapeutics, a Novartis company|Study Director|+1-888-669-6682|Novartis.email@Novartis.com|
21269174|NCT05487625|Fralin Biomedical Research Institute at VTC|Roberta Freitas Lemos|540 526 2106|rflemos@vtc.vt.edu|
21269175|NCT04342390|Arkansas Children's Research Insitute|Emir Tas|4126928688|tase2@upmc.edu|
21269176|NCT04584294|VA Puget Sound Health Care System|Lisa Callegari (Principal Investigator)|206-277-3129|Lisa.Callegari@va.gov|
21269177|NCT03447015|Mutah University|Dr Reham Khresheh|0791425992|rehamkh@mutah.edu.jo|
21269178|NCT04103645|Weill Cornell Medicine|Joseph Scandura, MD|(212) 746-2072|jms2003@med.cornell.edu|
21269179|NCT00318357|The University of Hull; Department of Cardiology; United Kingdom|John Cleland, Professor|Telephone: 0044 1482 624084||
21269180|NCT04813484|University of Michigan|Kristi Gamarel|7346473178|kgamarel@umich.edu|
21269181|NCT05153629|Stanford University|Simon Conti, MD|650-723-3391|sconti@stanford.edu|
21269182|NCT05403502|Tandem Diabetes Care|Sr. Supervisor of Clinical Operations|+18583666900|clinicalaffairs@tandemdiabetes.com|
21269183|NCT01058707|Takeda|Medical Director|+1-866-835-2233|GlobalOncologyMedinfo@takeda.com|
21269184|NCT00308230|Emory University|Wendy Book|404-778-5545|wbook@emory.edu|
21269185|NCT03722459|University of North Carolina at Chapel Hill|Director, Clinical Research, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
21269186|NCT01255449|IRCCS Azienda Ospedaliera Universitaria San Martino IST - Genova, Italy|Dr. Giovanni Barisione|+39010555|giovanni.barisione@hsanmartino.it|3367
21269187|NCT01979029|First Hospital of Jilin University|Jian Suo|0431-88785605|suojian42@hotmail.com|
21269188|NCT02996266|Becton, Dickinson and Company|Director, Global Clinical Affairs - Urology and Critical Care|9733077325|kirsten.hammitt@bd.com|
21269189|NCT00710840|University of Colorado Denver, Anschutz Medical Center|Dr. Jennifer Stevens-Lapsley|303-724-9170|Jennifer.Stevens-Lapsley@ucdenver.edu|
21269190|NCT00157820|Hospital General Universitario de Valencia, Spain|Dr.A.Quesada||aquesadad@secardiologia.es|
21269191|NCT02207413|GlaxoSmithKline|GSK Response Center|866-435-7343||
21269192|NCT04075656|Emory University|Chia-shi Wang, MD, MS|404-727-5728|chia-shi.wang@emory.edu|
21269193|NCT04938687|Spaulding Rehabilitation Hospital|Qing Mei Wang, MD, PhD|(617) 952-5299|wang.qingmei@mgh.harvard.edu|
21269194|NCT02181673|Janssen Research & Development, LLC|Senior Director Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
21269195|NCT01354015|Tulane University|Dr Vivian Fonseca|5049884026|vfonseca@tulane.edu|
21269196|NCT00337727|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21269197|NCT00320801|Purdue Pharma L.P.|Clinical Leader, Executive Medical Director|800-733-1333||
21269198|NCT01293682|University of Rochester|Luke J Peppone, PhD, MPH|585-275-7827|Luke_Peppone@urmc.rochester.edu|
21269199|NCT00491322|Massachusetts General Hospital|Dr. Sherri-Ann M. Burnett-Bowie|6177245594|sburnett-bowie@mgh.harvard.edu|
21269200|NCT06067191|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269201|NCT03992261|Mayne Pharma|Lee Ann McDowell, PharmD - Director of Medical Affairs|4124776681|leeann.mcdowell@maynepharma.com|
21269202|NCT03664024|Merck Sharp and Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21269203|NCT01157065|Alcon Research, Ltd.|Mehdi Hosseini, Clinical Trial Manager|1-888-451-3937|alcon.medinfo@alcon.com|
21301106|NCT03809104|Ci-Shan Hospital, Health and Welfare of Minister, Taiwan|Ms. Chia-Yu Wei|+886-7-6615523|ivywei@chis.mohw.gov.tw|1729
21257757|NCT02218242|University of Kentucky|Angela Mahan|859 257 4488|angela.mahan@uky.edu|
21301107|NCT04954833|Johnson & Johnson Vision Care, Inc. (JJVC)|Xu Cheng|1-800-843-2020|xcheng6@its.jnj.com|
21237987|NCT01083641|University of Wisconsin Carbone Cancer Center|Dr. Kari Wisinski|608-262-2876|kbwisinski@medicine.wisc.edu|
21237988|NCT03439189|Exalenz Bioscience|Clinical trial manager|00 972 546605412|avrahamh@exalenz.com|
21237989|NCT03412812|University of Alabama at Birmingham|Dr. John Fiveash|205-975-0224|jfiveash@uabmc.edu|
21237990|NCT03837509|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21237991|NCT03722927|Wake Forest Baptist Health|Dr. Christopher Runyan|336-716-4171|crunyan@wakehealth.edu|
21257758|NCT02943564|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
21257759|NCT04143009|University of North Carolina at Chapel Hill|Brian Wells Pence, PhD|+1 919-966-7446|bpence@unc.edu|
21257760|NCT03704142|University of Massachusetts Amherst Dept. of Communication Disorders|Dr. Karen Helfer|413-545-4014|khelfer@comdis.umass.edu|
21257761|NCT01027819|Seoul National University Hospital|Dr. Dongwook Kim|821067395311|daljookim@gmail.com|
21257762|NCT03116698|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|6093759910|srinivassidgiddi@drreddys.com|
21257763|NCT00788372|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387||
21237992|NCT01207570|The Hong Kong Polytechnic University|Dr. Marco Pang|85227667156|Marco.Pang@inet.polyu.edu.hk|
21257764|NCT02572752|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21257765|NCT03921021|Weill Cornell Medicine|Manish Shah, MD|(646) 962-6200|mas9313@med.cornell.edu|
21237993|NCT03548207|Janssen Research & Development, LLC|Vice President Research and Development, Cellular Therapy|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21257766|NCT04048616|Tufts University and Tufts Medical Center|Lisa Ceglia, MD MS|(617) 636-8171|lisa.ceglia@tuftsmedicine.org|
21237994|NCT01756352|Brigham and Women's Hospital|Marcelo DiCarli, MD|(617) 732-6290|mdicarli@bwh.harvard.edu|
21257767|NCT03099187|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21257768|NCT02899689|UTMB|Antonio F Saad|4097720982|afsaad@utmb.edu|
21257769|NCT01210690|UCB|UCB Cares|+1 877 822 9493||
21257770|NCT00470054|Wake Forest University|Antonius Miller||aamiller@wfubmc.edu|
21257771|NCT03310450|Universitas Negeri Semarang|Mahalul Azam|+628122853982|mahalul.azam@mail.unnes.ac.id|
21257772|NCT00528021|Boston Scientific Corporation|Jessie Stockwell|612-618-1136|jessie.stockwell@bsci.com|
21257773|NCT01423851|NS Pharma, Inc.|Medical Affairs|201-986-3860|trialinfo@nspharma.com|+1
21257774|NCT01395394|Emory University|Kathryn Coakley|404-778-1286|kcoakle@emory.edu|
21257775|NCT05121480|Evelo Biosciences, Inc|Duncan McHale, MBBS, MRCP, PhD|+447500128938|duncan@evelobio.com|
21257776|NCT02356562|AbbVie|Global Medical Services|800-633-9110||
21257777|NCT00412750|Novartis Pharmaceuticals|Study Director|862-778-8300||
21257778|NCT01157078|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21257779|NCT03187769|Alkermes|Global Clinical Services|888-253-8008|clinicaltrials@alkermes.com|
21257780|NCT01623271|Massachusetts General Hospital|Jianren Mao, MD, PhD|617-724-6102|jmao@mgh.harvard.edu|
21257781|NCT01611974|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21257782|NCT00522431|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
21257783|NCT03927105|Hoosier Cancer Research Network|Adelai Neal|317-921-2053|aneal@hoosiercancer.org|
21257784|NCT00789529|Manhattan Vision Associates / Institute for Vision Research|Dr. George Zikos|2126884277|gzikos@mvaivr.com|
21257785|NCT01870401|Becton Dickinson|Lisa Erickson|763-463-2897|Lisa.Erickson@bd.com|
21257786|NCT01135498|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21257787|NCT01192022|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21257788|NCT04839978|Emory University|Kelli Komro, PhD|404-727-8742|kkomro@emory.edu|
21257789|NCT03551509|Cleveland Clinic|Dr. Gregory Gilot|786 566-9176|gilotg@ccf.org|
21257790|NCT05396742|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
21257791|NCT00060346|ECOG Statistical Office|Study Statistician|617-632-3012||
21257792|NCT05440539|Houston Methodist Hospital|Dr. Emily Rutledge|713-441-5800|erut@me.com|
21257793|NCT02324920|BIOTRONIK Italiy|Daniele Giacopelli|+39 3491712305|daniele.giacopelli@biotronik.com|
21257794|NCT02004262|Aduro Biotech, Inc.|Corporate Communications|510-848-4400||
21257795|NCT00957008|University of South Carolina|Project director|8037773881|msui@mailbox.sc.edu|
21257796|NCT03345108|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21257797|NCT01709435|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21257798|NCT01157364|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
21257799|NCT01780662|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21257800|NCT01717209|Stanford University|Charles Hill|(650) 725-1930|chill1@stanford.edu|
21257801|NCT02182687|Lahey Hospital & Medical Center|Julia Roache|781-744-3055|julia.roache@lahey.org|
21257802|NCT02788097|Antalya IVF|Kevin Coetzee|090 242 345 4700|kevincoetzee61@yahoo.co.nz|
21257803|NCT01422915|BrighamHospital|Dr. Peter V. Tishler|617-525-2123|repvt@channing.harvard.edu|
21257804|NCT01265797|University of Toledo|Gretchen Tietjen, MD|419-383-3544|gretchen.tietjen@utoledo.edu|
21257805|NCT03631732|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21257806|NCT01378104|the Catholic University of Korea|Dr. Kwon|+82322805886|doctorkwon@catholic.ac.kr|
21257807|NCT01997411|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21257808|NCT04901481|TheraNova, LLC|Director of Clinical|4159268616|clinicalstudy@theranova.com|
21257809|NCT02739620|University of Vermont|Michael J. Toth|802-656-7989|michael.toth@med.uvm.edu|
21257810|NCT02354222|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21257811|NCT02536313|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21269204|NCT00318409|San Francisco Department of Public Health|Moupali Das, MD, MPH|415-437-6204|moupali.das@sfdph.org|
21269205|NCT05275673|Faeth Therapeutics, Inc|Medical Monitor|7084069282|clinicaltrials@Faeththerapeutics.com|
21269206|NCT02325739|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21269207|NCT03426995|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21269208|NCT00227591|ECOG Statistical Office|Study Statistician|617-632-3012||
21269209|NCT02335411|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21269210|NCT03091478|Johns Hopkins Sidney Kimmel Comprehensive Cancer Center|Rachel Levy, MS, CCRP|410-502-8738|rlevy16@jhmi.edu|
21269211|NCT04336189|UCSF|Grant Dorsey|415-310-0525|grant.dorsey@ucsf.edu|
21269212|NCT02316002|University of Pennsylvania (Abramson Cancer Center)|Dr. Joshua Bauml|215-662-4000|melissa.volpe@pennmedicine.upenn.edu|
21269213|NCT03917654|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Patrick E. Duffy|301.761.5089|patrick.duffy@nih.gov|
21269214|NCT05012943|Vinmec Healthcare System|Nguyen Xuan Hung|+84-865438388|v.hungnx1@vinmec.com|
21269215|NCT04881149|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
21269216|NCT00400985|Medtronic BRC, The Netherlands, Maastricht|Director CRDM|+31 43 3566||566
21269217|NCT05382637|Children's National Hospital|Andrew Dauber, MD|202-476-2121|adauber@childrensnational.org|
21269218|NCT05048875|Johns Hopkins School of Public Health Center for Immunization Research|Dr Anna Durbin|410-955-1622|adurbin1@jhu.edu|
21269219|NCT01883141|Medtronic, plc|CRHF Clinical Research|800-328-2518|medtroniccrmtrials@medtronic.com|
21269220|NCT03222570|University of Minnesota|Meredith Gunlicks-Stoessel|612-624-9249|mgunlick@umn.edu|
21269221|NCT03179462|University of Arkansas for Medical Sciences|David D.Church, Ph.D.|5015265709|dchurch@uams.edu|
21269222|NCT00457795|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
21269223|NCT01795534|Bangor University|Dr Jamie Macdonald|+441248383272|j.h.macdonald@bangor.ac.uk|
21269224|NCT03741335|Oregon Health & Science University|Dr. Kerri Winters-Stone|503-494-0813|wintersk@ohsu.edu|
21269225|NCT04049474|NYU Langone Health|Lira Gutierrez|212-263-6181|Lira.Gutierrez@nyulangone.org|
21269226|NCT02970877|University Health Network|Scientific Associate|416-340-5159|kschweng@uhnresearch.ca|
21269227|NCT04410978|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21269228|NCT02684162|The University of Texas MD Anderson Cancer Center|Betul Oran, MD / Stem Cell Transplantation|713-745-2820|BOran@mdanderson.org|
21269229|NCT05125237|Brigham and Women's Hospital|Rishi J Desai, PhD|617-278-0932|rdesai@bwh.harvard.edu|
21269230|NCT04560088|University of Rochester Medical Center|Autumn Gallegos, PhD|5852752824|autumn_gallegos@urmc.rochester.edu|
21269231|NCT04089566|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21269232|NCT01083121|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21269233|NCT02665273|Montefiore|Benjamin W. Friedman|718-920-6626|befriedm@montefiore.org|
21257812|NCT01924182|Medtronic Neuromodulation|Mary Markert Sr Prin Clinical Research Specialist|763-526-8162|mary.a.markert@medtronic.com|
21257813|NCT01080248|Washington University School of Medicine|Joel Picus, M.D.|314-362-5740|jpicus@dom.wustl.edu|
21257814|NCT00993265|Yale University, Child Study Center|Dr. Michael Bloch, MD, MS|203-737-4809|michael.bloch@yale.edu|
21257815|NCT03885089|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269234|NCT03378921|Department of Gastrointestinal surgery, Helsinki University Hospital|Dr. Essi Karjalainen|+358504621853|essi.karjalainen@hus.fi|
21269235|NCT00594009|University of Texas Medical Branch|Victor Cardenas, MD|(409) 772-2436|vcardena@utmb.edu|
21269236|NCT03743571|University of Nevada Reno|Cynthia Lancaster|(775) 682-8144|cynthialancaster@unr.edu|
21269237|NCT04115488|Polpharma Biologics S.A.|Director Clinical Research and Development|+48 607 697 896|clinicaltrials@polpharmabiologics.com|
21269238|NCT00885677|Medtronic EMEA RCC|Valentina Amori|3425417863|valentina.amori@medtronic.com|
21257816|NCT03349099|Cleveland Clinic|Manoj Monga MD|216-445-8678|mongam@ccf.org|
21257817|NCT04869345|Cornell University|Dr. Anthony Ong|6072559993|anthony.ong@cornell.edu|
21257818|NCT00359138|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21257819|NCT01500759|ResMed Germany Inc|Medical Affairs CRS|089990100|ClinicalResearch&Strategy@ResMed.com|
21257820|NCT01290874|Brigham and Women's Hospital|Dr. Elliot Israel|6177328201|eisrael@partners.org|
21257821|NCT00396201|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
21257822|NCT04194528|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|adarke@fredhutch.org|
21257823|NCT04867473|Stanford University|Peter Bayley, PhD|650-493-5000|peter.bayley@va.gov|68653
21257824|NCT00616122|University of California, San Francisco|Hope S. Rugo|877-827-3222|clinicaltrials@ucsf.edu|
21257825|NCT01143727|Healthpoint, Ltd.|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|817-302-3914|jaime.dickerson@healthpoint.com|
21257826|NCT00199914|Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand|Manee Rattanachaiyanont|+66-2419-4657|manee.rat@mahidol.ac.th|
21257827|NCT03077685|NanOlogy, LLC|Mark Mitchell|8179004074|Mark.Mitchell@dfb.com|
21257828|NCT02116777|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21257829|NCT02813551|The University of Texas Health Science Center at Houston|Oscar Andres Viteri Molina, MD|(713) 500-6412|Oscar.A.ViteriMolina@uth.tmc.edu|
21257830|NCT00102960|Perinatal HIV Research Unit, Johannesburg and Children's Infectious Diseases Clinical Research Unit, Cape Town all in South Africa|Dr Avy Violari and Prof Mark Cotton|27 11 989 9702/27 21 938 4219|violari@mweb.co.za|9702/4219
21269239|NCT03884556|Trishula Therapeutics|Trishula Info|(650) 509-5732|info@trishulatx.com|
21269240|NCT00352794|The University of Texas MD Anderson Cancer Center|Dr. Srdan Verstovsek, MD., Professor|713-745-3429|sverstov@mdanderson.org|
21269241|NCT02008396|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
21269242|NCT01233284|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21237995|NCT00415610|University of Minnesota|Adnan I Qureshi, MD|612-624-2431|qureshai@gmail.com|
21269243|NCT02630992|University of Pittsburgh|Nader Shaikh|412-692-8111|nader.shaikh@chp.edu|
21269244|NCT02159872|The University of Texas MD Anderson Cancer Center|Elias Jabbour MD/Professor|713-792-4764|ejabbour@mdaderson.org|
21269245|NCT00516217|University of Chicago|Sonali Smith, M.D.||smsmith@medicine.bsd.uchicago.edu|
21269246|NCT00167414|University of Rochester|Hong Zhang|585-341-6750|hong_zhang@urmc.rochester.edu|
21269247|NCT01593761|CrystalGenomics, Inc.|Seonggu Ro, Ph.D, Chief Technology Officer|82 31 628 2783|sgro@cgxinc.com|
21269248|NCT00795886|Primary Children's Medical Center|Michael Pulsipher, MD|801-662-4732|Michael.Pulsipher@hsc.utah.edu|
21269249|NCT05554471|Cordis|Jenny Jimenez|+1 646 483-6846|jenny.jimenez@cordis.com|
21269250|NCT04814654|Montefiore Medical Center|Dr. Viraj Patel|718-920-5256|vpatel@montefiore.org|
21269251|NCT05405218|Sonex Health, Inc.|Amy Stegner, Vice President Clinical Affairs|(888) 518-8780|astegner@sonexhealth.com|
21269252|NCT03505606|Anglia Ruskin University|Mrs Louisa Haine - Lecturer in Vision Sciences|01223695445|louisa.haine@aru.ac.uk|
21269253|NCT01419028|Alexion International Sarl|Alexion Pharmaceuticals||clinicaltrials@alxn.com|
21269254|NCT04020822|Medtronic Diabetes|Kusal Ahangama, Clinical Study Manager|+18185765023|kusal.c.ahangama@medtronic.com|
21269255|NCT02087865|Cleveland Clinic|Dr. Stephen M. Rao|216 312-4168|raos2@ccf.org|
21269256|NCT01319994|Queen Mary University of London|Prof M Korbonits|+442078826197|m.korbonits@qmul.ac.uk|
21269257|NCT01340794|Mayo Clinic Cancer Center|Keith Bible, M.D., Ph.D.||bible.keith@mayo.edu|
21269258|NCT00741026|American Medical Association|Vance L. Albaugh, Principle Investigator|(800) 243-1455|vance.l.albaugh@vanderbilt.edu|
21269259|NCT03781817|University of Alabama at Birmingham, Department of Pediatrics|James Statler, MD|(205) 638-6048|jstatler@uabmc.edu|
21269260|NCT01568255|Cedars Sinai|Margo Minissian, PhD|310-423-5195|Margo.Minissian@cshs.org|
21269261|NCT03309072|University of Texas at Dallas|Dr. Sven Vanneste, Principal Investigator|972-883-7277|sven.vanneste@utdallas.edu|
21269262|NCT00887965|Amgen Inc.|Study Director|866-572-6436||
21269263|NCT02674568|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21269264|NCT01939834|University of Virginia|Sue Brown|434-924-1825|sab2f@virginia.edu|
21269265|NCT01808508|Children's Hospital of Philadelphia|Carole L. Marcus, MBBCh|267-426-5842|marcus@email.chop.edu|
21269266|NCT01118949|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
21269267|NCT01017731|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21269268|NCT00685763|University of Florida Proton Therapy Institute|Charles Nichols, M.D.|904-588-1800|rnichols@floridaproton.org|
21269269|NCT02712359|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21269270|NCT04476654|Virginia Commonwealth University|Dr. Vanessa Sheppard|804-828-8892|vlbsheppard@vcu.edu|
21269271|NCT00929201|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21269272|NCT00566969|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-932-5711|mehmet.sofuoglu@yale.edu|4809
21269273|NCT03606109|NYU Langone Health|Michael J. Alaia, MD|646-501-7223|Michael.Alaia@nyulangone.org|
21269274|NCT02305329|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21269275|NCT03286426|Duke Eye Center|Dr. Grace Prakalapakorn|+1 919 684 7679|grace.prakalapakorn@duke.edu|
21269276|NCT01817764|GlaxoSmithKline|GSK Response Center|866-435-7343||
21269277|NCT04292171|University of Nevada Las Vegas School of Medicine|Adam V. Levy MD|702-671-2300|adam.levy@unlv.edu|
21269278|NCT04633434|Oregon Research Behavior Intervention Strategies, Inc. dba Influents Innovations|David Smith|541-484-2123|david.smith@influetnsin.com|
21269279|NCT02530320|MFAR|A responsibility person designate by sponsor|934344412|investigacion@mfar.net|
21269280|NCT00471237|GlaxoSmithKline|GSK Response Center|866-435-7343||
21269281|NCT00848965|GlaxoSmithKline|GSK Response Center|866-435-7343||
21269282|NCT02329834|scPharmaceuticals|Sr. Vice President of Clinical Development and Medical Affairs||jmohr@scpharma.com|
21269283|NCT00578448|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21269284|NCT01976104|Eisai Call Center|Eisai Inc.|888-422-4743|esi_medinfo@eisai.com|
21269285|NCT03112720|RWJMS/Rutgers Health|william grubb md|732 235 7827|grubbwr@rwjms.rutgers.edu|
21269286|NCT02920866|University of Colorado Denver|Dr. Jennifer Stevens-Lapsley|303.724.9170|jennifer.stevens-lapsley@cuanschutz.edu|
21269287|NCT01312948|ResMed Ltd|Alison Wimms|+6188842583|alison.wimms@resmed.com.au|
21269288|NCT02686437|Sport and Spine Rehab Clinical Research Foundation|Jena Etnoyer-Slaski|301-251-2777|jslaski@ssrehab.com|838
21269289|NCT01993238|Solta Medical|Director of Clinical Programs|510-259-5284|aloncaric@solta.com|
21269290|NCT03237325|Soligenix, Inc.|Richard Straube, MD/Chief Medical Officer|609-538-8200|rstraube@soligenix.com|
21269291|NCT00552422|Columbia University|David Lederer|212-342-4167|tjb2134@cumc.columbia.edu|
21269292|NCT00627094|Coloplast|Scientific Manager|+4549113557|dkkg@coloplast.com|
21269293|NCT03862469|University of Illinois at Chicago|Ajna Hamidovic|312-355-1713|ahamidov@uic.edu|
21269294|NCT02912507|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
21269295|NCT00433771|Boston Scientific Corporation|Jeremy Bolt|508-683-4006|boltj@bsci.com|
21269296|NCT00138658|OncoGenex Pharmaceuticals|Dr. Patricia Stewart, Vice President Medical Affairs|425-686-1500|psstewartmd@oncogenex.com|
21269297|NCT01965431|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21269298|NCT03046966|University of Arkansas for Medical Sciences|Jennifer Rumpel, MD|501-364-2980|Jarumpel@uams.edu|
21269299|NCT01179191|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269300|NCT01783860|Rasoule-Akram Hospital|Dr. Mohsen Bahmani-Kashkouli|00982166558811|bahmanik@eyeplasticsurgeries.com|
21269301|NCT00258310|Barbara Ann Karmanos Institute|George Yoo, M.D.|(313) 576-9782|yoog@karmanos.org|
21237996|NCT00526630|University of Cincinnati|Alberto Espay, MD|513-403-4600|alberto.espay@uc.edu|
21237997|NCT00337272|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
21237998|NCT03320018|Stony Brook Medicine|Christine Pol|6314449083|christiana.pol@stonybrookmedicine.edu|
21237999|NCT02641392|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|amcclain@celgene.com|
21269302|NCT00661960|UCaliforniaDavis|David Asmuth/Principal Investigator|9167348695|david.asmuth@ucdmc.ucdavis.edu|
21269303|NCT00552812|Johns Hopkins School of Medicine|Dr. Richard E. Ringel|410-614-6745|rringel@jhmi.edu|
21269304|NCT00759668|Alcon Italia SpA|Marcello Fornoni|39.02.81.303.226|marcello.fornoni@alconlabs.com|
21269305|NCT01833897|New York State Psychiatric Institute|Joshua Kantrowitz|646-774-6738|jkantrowitz@nki.rfmh.org|
21238000|NCT02691182|Supernus Pharmaceuticals|Gianpiera Ceresoli-Borroni/ Director Clinical Development|3018382521|gceresoliborroni@supernus.com|
21238001|NCT03026790|University of Minnesota|Erin Krebs|612-629-7558|Erin.Krebs@va.gov|
21269306|NCT00669110|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269307|NCT01139801|Aultman Health Foundation|Jane Sewell|330-363-6793|Jane.Sewell@aultman.com|
21269308|NCT00806416|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
21269309|NCT01596088|Kissei Pharmaceutical Co., Ltd|Clinical Development Division||rinsyousiken@pharm.kissei.co.jp|
21269310|NCT02989922|Jiangsu HengRui Pharmaceuticals Co., Ltd|Linna Wang|+862161053363|linna.wang@hengrui.com|
21269311|NCT01244516|Johnson & Johnson Vision Care|Kathy Osborn, OD|1-904-443-1032|KOsborn@its.jnj.com|
21269312|NCT04035694|innovation Research & Training|Dr. Tracy Scull|(919) 493-7700|tscull@irtinc.us|
21269313|NCT01102972|ViiV Healthcare|GSK Response Center|866-435-7343||
21269314|NCT02024386|Duke University School of Medicine|Richard Moon, MD|919-684-6726|richard.moon@duke.edu|
21269315|NCT01886105|Johns Hopkins University|Dr. Brian H. Ladle|443-287-3534|bladle@jhmi.edu|
21269316|NCT00389168|Karolinska Institutet, Stockholm, Sweden|Thomas Kahan, MD|+46 8 123 568 61|thomas.kahan@ds.se|
21269317|NCT01360021|Astrazeneca|Goran Eckerwall, MD||aztrial_results_posting@astrazeneca.com|
21269318|NCT00530621|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21269319|NCT01465048|University of Oxford|Dr Susanne Sheehy||susanne.sheehy@balliol.ox.ac.uk|
21269320|NCT05444114|University of Colorado Colorado Springs|Lori James|7192554172|ljames@uccs.edu|
21238002|NCT00772590|Kirby Institute, University of New South Wales|Sean Emery|+612 938509900|semery@kirby.unsw.edu.au|
21238003|NCT02799784|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21238004|NCT02954354|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
21238005|NCT05163418|Topmed|Edith Martin|418 683-2104|emartin@topmed.ca|1302
21238006|NCT03440372|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21238007|NCT03945292|Arrowhead Pharmaceuticals, Inc.|Patrick O'Brien, Chief Operating Officer|626-304-3400|PObrien@arrowheadpharma.com|
21238008|NCT00673309|University of Texas Medical Branch|Tina Mack-Moshay- ClinicalTrials.gov Administrator|409-266-6917|tlmackmo@utmb.edu|
21238009|NCT00762450|Colgate Palmolive Co.|William De Vizio|732-878-7901|William_Devizio@colpal.com|
21238010|NCT03721965|Incyte Corporation|Incyte Corporation Call Center|(0)330 100 3677|globalmedinfo@incyte.com|
21238011|NCT01328080|Johns Hopkins Dermatology|Ginette Okoye, MD, Director of Ethnic Skin Program|410-502-7546|ctrep@jhmi.edu|
21238012|NCT02080468|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|617-500-5142|alison.long@aegerion.com|
21238013|NCT01499082|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21238014|NCT02963974|University of North Carolina at Chapel Hill|Lisa Park, AuD, CCC-A|984-215-2871|lisa_park@med.unc.edu|
21238015|NCT02574910|UT Southwestern Medical Center|Dr Perrin White|2146489246|perrin.white@utsouthwestern.edu|
21238016|NCT05380947|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
21238017|NCT01563536|AbbVie|Global Medical Services|800-633-9110||
21238018|NCT01270126|Otto-von-Guericke University of Magdeburg, Medical Faculty, Institute of Medical Psychology, Magdeburg, Germany|Prof. Bernhard A. Sabel|0049 3916721800|bernhard.sabel@med.ovgu.de|
21238019|NCT00058123|North American Brain Tumor Consortium|Susan Chang, MD|410-955-8837|jfisher@jhmi.edu|
21269321|NCT01875731|Hospital General de Niños Pedro de Elizalde|Dr. Fernando Torres|+54 11 43632100|torresfernandoadrian@gmail.com|1014
21269322|NCT02576951|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21269323|NCT03417102|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21269324|NCT03285581|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
21269325|NCT02218619|Columbia University Irving Medical Center|Robin Goland, MD|212-851-5494|rsg2@cumc.columbia.edu|
21269326|NCT02062385|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21269327|NCT03188991|US Biotest, Inc.|Gere S. diZerega, MD|805.595.1300|gere.dizerega@usbiotest.com|
21269328|NCT00223990|Kenya Medical Research Institute|Bernhards R. Ogutu, PhD|254-57-22942|bogutu@kisian.mimcom.net|
21238020|NCT01723722|Eastern Maine Medical Center|Dr Mark S Brown|207-973-8670|mbrown@emh.org|
21238021|NCT02151266|Emory University|Dr. Gary|404-727-8360|ragary@emory.edu|
21269329|NCT01392469|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21285901|NCT04550364|Universoty of Oslo|Psychologist and PhD Bente Sommerfeldt|004793221280|bsommerfeldt@gmail.com|
21269330|NCT00795210|Massachusetts General Hospital|Steven Grinspoon, MD|617-724-9109|sgrinspoon@partners.org|
21269331|NCT02850159|Samsung Medical Center|Dr. Won Hyuk Chang|82234102818|wh.chang@samsung.com|
21269332|NCT03255226|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81363617366|CL_OPCJ_RDA_Team@otsuka.jp|
21285902|NCT03138577|Weill Cornell Medical College|Dr. Tiffany Tedore|212-746-2725|tft9001@med.cornell.edu|
21269333|NCT01035229|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21269334|NCT00511329|Nationwide Children's Hospital|Julie Rice, RN|6143553142|julie.rice@nationwidechildrens.org|
21269335|NCT00648739|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
21269336|NCT02238639|Hospital Ramon y Cajal|David Jimenez|+34913368133|djimenez.hrc@gmail.com|
21269337|NCT00698009|UT MD Anderson Cancer Center|Eugenie S Kleinerman,MD/Professor, Pediatrics - Research|(713) 497-6226|ekleiner@mdanderson.org|
21269338|NCT02060526|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21269339|NCT00564486|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
21269340|NCT03387423|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269341|NCT03572049|University of Alabama at Birmingham|Dr. Peter G. Pappas|2059347292|ppappas@uabmc.edu|
21269342|NCT02195921|Tianjin University of Traditional Chinese Medicine|Acupuncture for Chemotherapy-Induced Nausea and Vomiting: A Randomized Clinical Trial|+86 13920921016|guoyi_168@163.com|
21269343|NCT04362761|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21269344|NCT03126682|DukeUMC|Steven T Szabo|3524540101|steven.szabo@duke.edu|3524540101
21269345|NCT00798707|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269346|NCT01473589|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21269347|NCT01441401|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269348|NCT00896038|National Institute on Alcohol Abuse and Alcoholism|Melanie Schwandt|3014516960|melanies@mail.nih.gov|
21269349|NCT03457727|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21269350|NCT02384239|University of California, San Francisco|Dr. Hope Rugo, MD|(415) 353-7618|Hope.Rugo@ucsf.edu|
21269351|NCT01721200|Yale University|Liana Fraenkel, MD, MPH, Department of Medicine||liana.fraenkel@yale.edu|
21269352|NCT01107834|Washington University|William T. Cade|314-286-1432|tcade@wustl.edu|
21269353|NCT03722849|The University of Melbourne|Dr Stuart Mazzone|+61383446457|stuart.mazzone@unimelb.edu.au|
21269354|NCT03514121|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21269355|NCT04930536|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21269356|NCT01432600|H. Lee Moffitt Cancer Center and Research Institute|Dr. Rachid Baz|813-745-8212|rachid.baz@moffitt.org|
21238022|NCT01169675|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21269357|NCT01900392|UPENN|Catherine Reale|2157464009|catherine.reale@uphs.upenn.edu|
21269358|NCT00315328|Jaeb Center for Health Research|Raymond Kraker|813-975-8690|pedig@jaeb.org|
21269359|NCT00740480|ENTrigue Surgical, Inc.|Gabriele Niederauer, PhD|210-298-6398|gabi.niederauer@entriguesurgical.com|6336
21269360|NCT00448630|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21269361|NCT04662086|Stanford University|Manesha Desai, PhD|(650) 725-1946|manisha.desai@stanford.edu|
21269362|NCT03354143|IEEM|Dr. Rong Zhang|214-345-4245|rongzhang@texashealth.org|
21269363|NCT01005680|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21269364|NCT04305184|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|8008887704|astellas.resultsdisclosure@astellas.com|
21269365|NCT03731325|Washington University in St. Louis|Tina Day|314-286-0079|dayt@wustl.edu|
21269366|NCT04928794|Anesthesiology Department, University of New Mexico|Anesthesiology Research Director|505-272-2610|HSC-Anesthesiology@salud.unm.edu|
21269367|NCT00297882|University of Yaounde 1, Cameroon|Professor Wilfred Mbacham|+237 677579180|wfmbacham@yahoo.com|
21269368|NCT04242264|Cincinnati Children's Hospital Medical Center|Robert W Frenck, Jr, M.D.|513-636-4463|Robert.Frenck@cchmc.org|
21269369|NCT00544778|City of Hope National Medical Center|Paul Frankel, Ph. D.|(626)359-8111|pfrankel@coh.org|65265
21269370|NCT00556972|Coloplast A/S|Thais Benjamin N. Christensen, Senior Clinical Project Manager|+4549112668|dkthc@coloplast.com|
21269371|NCT02116309|Johns Hopkins University|Dr. Vikesh Singh|4106146708|vakshin1@jhmi.edu|
21269372|NCT03292731|University of Pittsburgh|steve caritis|412 641 5256|scaritis@mail.magee.edu|
21269373|NCT00348348|Bausch & Lomb Incorporated|Timothy Comstock|(585) 338-6631|timothy.comstock@bausch.com|
21269374|NCT00659945|University of Pittsburgh|Manuel C. Vallejo, MD|412-641-4260|vallejomc@anes.upmc.edu|
21269375|NCT02525575|Department of Veteran Affairs|Marianne Goodman, MD|718-584-9000|Marianne.Goodman@va.gov|5188
21238023|NCT02354664|University of Florida|Barbara Smith, Assistant Professor|352-294-5315|bksmith@phhp.ufl.edu|
21238024|NCT02816138|Vanderbilt University Medical Center|Warren D. Taylor, MD|6153221073|warren.d.taylor@vanderbilt.edu|
21238025|NCT04839965|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|17204376500|clinicaltrials@ampiopharma.com|
21238026|NCT02355028|Alcon, A Novartis Division|Clinical Scientist, NIBR|1-888-451-3937|alcon.medinfo@alcon.com|
21269376|NCT04221373|Icahn School of Medicine at Mount Sinai|Dr. Chung-Ying Tsai|(212) 241-7073|chung-ying.tsai@mountsinai.org|
21269377|NCT00212446|New York Downtown Hospital (hospital bankrupt/closed)|Dr. Jeffrey Karsdon||JK_MD@yahoo.com|
21269378|NCT02203604|Dana Farber Cancer Institute|Ann Silk, MD|617-632-6571|Ann_Silk@dfci.harvard.edu|
21269379|NCT00561600|DePuy Orthopaedics|Dave Whalen Clinical Portfolio Leader|574-372-7028|dwhalen@its.jnj.com|
21269380|NCT00944528|Assistant Research Practice Manager|Jennifer Mewshaw, MS RN|(919) 668-5211|Jennifer.Mewshaw@duke.edu|
21269381|NCT01165424|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21269382|NCT04139642|The Ohio State University|Dr. Ajit Chaudhari|+1-614-292-0558|chaudhari.2@osu.edu|
21269383|NCT01040624|University of Florida Health Proton Therapy Institute|Nancy P. Mendenhall, MD|904-588-1000|rtoton@floridaproton.org|
21269384|NCT00186875|St. Jude Children's Research Hospital|Sima Jeha, MD|866-278-5833|info@stjude.org|
21269385|NCT03910439|National Cancer Institute|Dr. Mark Roschewski|240-760-6183|mark.roschewski@nih.gov|
21257831|NCT00733954|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
21257832|NCT02663453|Thammasat University|Dr.Wilaiporn Techasatid|66890339442|wilaiporn66@gmail.com|
21257833|NCT01964352|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21257834|NCT03379662|Regulatory Insight, Inc.|Elvira Cawthon|6154475150|elvira@reginsight.com|
21257835|NCT03787472|Johnson & Johnson Vision Care|Thomas R. Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|904-443-3402|TKarkkai@its.jnj.com|
21257836|NCT00919035|Oncolgy Specialists, SC|Sigrun Hallmeyer, MD|847-268-8200|shallmeyer@oncmed.net|
21257837|NCT00874120|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21257838|NCT00477165|Stanford University|Uri Ladabaum, MD, MS||ladabau@stanford.edu|
21257839|NCT01823679|Stanford University Medical Center|Alexander Dimitrios Colevas, MD|650-724-9707|colevas@stanford.edu|
21257840|NCT01977781|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana, MD, MPH|617-573-4331|reza_dana@meei.harvard.edu|
21257841|NCT03955133|Swansea University|Professor Sue Jordan|+44 (0) 1792518541|s.e.jordan@swansea.ac.uk|
21257842|NCT00105443|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21257843|NCT02135692|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21257844|NCT01093027|Mayo Clinic|Virgilio Evidente MD|480-301-8000|evidente.virgilio@mayo.edu|
21257845|NCT02495844|Cares|UCB|+1844599|UCBCares@ucb.com|2273
21257846|NCT03402607|Duke University Health System|Linda Kaltenbach|919-681-6804|Linda.Kaltenbach@duke.edu|
21257847|NCT00623480|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21257848|NCT01594853|Kennedy Krieger Institute|Kathleen Zackowski|443-923-2716|zackowski@kennedykrieger.org|
21257849|NCT00711100|University_of_Minnesota|Dorothy Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu|
21257850|NCT00783094|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21257851|NCT02513329|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.edu|
21257852|NCT03808077|Memorial Sloan Kettering Cancer Center|Dr. Elizabeth Rieth, MD|212-639-5737|riethe@mskcc.org|
21257853|NCT00354770|University of Chicago|Jon E. Grant|773-834-1325|jongrant@uchicago.edu|
21257854|NCT03703102|Kyowa Kirin Co., Ltd.|Research & Development Planning Department, Research & Development Division|+81-3-5205-7200|clinical.info.jp@kyowakirin.com|
21257855|NCT02311153|Vanderbilt University Medical Center|Justin H. Turner, MD, PhD||justin.h.turner@vanderbilt.edu|
21257856|NCT01967628|University of Iowa|Dr. Alicia Gerke|319-356-1869|alicia-gerke@uiowa.edu|
21257857|NCT04086823|Raziel Therapeutics|Racheli Gueta , Director of Clinical trials|97289124670|racheli@raziel-therapy.com|
21257858|NCT01650636|University of Miami|Dr. Michael Antoni|305-284-5466|mantoni@miami.edu|
21257859|NCT01560780|VA North Texas Healthcare System|Shuaib Abdullah|214-857-1458|shuaib.abdullah@va.gov|
21257860|NCT02797808|University of Minnesota|Dr. Gail Bernstein|612-625-1632|berns001@umn.edu|
21257861|NCT02192827|Johns Hopkins all childrens hospital|Meghan Martin|9417373107|mmart163@jhmi.edu|
21257862|NCT01437852|Stratatech Corporation, a Mallinckrodt Company|Mary Lokuta|608-441-8358|mlokuta@stratatechcorp.com|
21257863|NCT01598779|University of Buenos Aires|Dr. Laura Fleider|541159508000|laurafleider@hotmail.com|8582
21257864|NCT04338815|University of Nebraska-Omaha|Philippe Malcolm|617-487-1148|pmalcolm@unomaha.edu|
21257865|NCT00264875|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21257866|NCT01628588|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21269386|NCT00029107|NIAID/NIH|Michael C Sneller, MD|301-496-0491|msneller@niaid.nih.gov|
21269387|NCT03952377|SpineThera|Jeff Missling, CEO|+1(612)-508-4795|jmissling@spinethera.com|
21269388|NCT00131573|Boston Scientific|Director of Clinical Operations|866-360-4747|valerie.lucero-cimmarusti@bsci.com|
21269389|NCT03733301|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21269390|NCT00380861|DePuy Orthopaedics|Tammy O'Dell|574-372-7104|TOdell2@its.jnj.com|
21269391|NCT00577031|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21269392|NCT04635631|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269393|NCT00943826|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21269394|NCT01067339|Mayo Clinic|Amir Lerman, MD|507-284-6429|lerman.amir@mayo.edu|
21269395|NCT03733418|Vanderbilt University Medical Center|Dr. Jin Han|16159360253|jin.h.han@vumc.org|
21269396|NCT01803464|University of Delaware|Dr. Christopher Modlesky|302-831-4185|modlesky@udel.edu|
21269397|NCT03843775|Memorial Sloan Kettering Cancer Center|Dr. Rona Yaeger MD|646-888-5109|yaegerr@mskcc.org|
21269398|NCT00003726|Dartmouth-Hitchcock Medical Center|James Rigas, MD|603-650-6344|james.r.rigas@hitchcock.org|
21269399|NCT00650806|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1 800 526 7736||
21269400|NCT02212834|Group Health Research Institute|Karen J. Wernli, PhD|206-287-2934|wernli.k@ghc.org|
21269401|NCT02222168|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21269402|NCT02596009|Novartis Pharmaceuticals|Study Director|862-778-8300||
21269403|NCT01281475|Boston Children's Hospital|Wen-Hann Tan|617-355 6394|wen-hann.tan@childrens.harvard.edu|
21269404|NCT04611152|Kodiak Sciences Inc|Pablo Velazquez-Martin|6502810850|clinops@kodiak.com|
21269405|NCT00605839|Indiana University School of Medicine|Aaron E. Carroll|3172780552|aaecarro@iupui.edu|
21269406|NCT02255422|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21285903|NCT05464420|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21257867|NCT01500278|Cares|UCB|+1877 822||9493
21257868|NCT01970995|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
21257869|NCT00734799|Durham VAMC|Christi S. Ulmer, PhD|9192860411|christi.ulmer@va.gov|4044
21269407|NCT00602667|St. Jude Children's Research Hospital|Amar Gajjar, MD|866-278-5833|amar.gajjar@stjude.org|
21269408|NCT02339246|Veloxis Pharmaceuticals|Christina Sylvest|+4520553877|csy@veloxis.com|
21269409|NCT03628872|Columbia University College of Dental Medicine|Dr. Philip Y Kang|212-342-5244|pyk2104@cumc.columbia.edu|
21269410|NCT00673712|Halyard Health|Sr. Director Clinical Research|5132538033|alan.dine@hyh.com|
21269411|NCT01489865|Lombardi Comprehensive Cancer Center|Benjamin Weinberg, MD|202-444-2223|baw12@gunet.georgetown.edu|
21269412|NCT00972309|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|hoyoung.maeng@nih.gov|
21269413|NCT04479241|Istari Oncology|Head of Clinical Operations|919-245-7662|info@istarioncology.com|
21269414|NCT00540982|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
21269415|NCT01736527|Bausch & Lomb Incorporated|Raphaële Siou-Mermet, MD, MS|+33160871491|raphaele.siou-mermet@bausch.com|
21269416|NCT01628159|BD|Director of Clinical Affairs|763-445-2385|anna.lovas@bd.com|
21269417|NCT03862807|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
21269418|NCT01771627|MUSC|Dr. Ben Toll|843-792-9162|toll@musc.edu|
21269419|NCT03486327|Bracco Diagnostics Inc.|Giordana Marioni, Clinical Trial Assistant|609-514-2282|giordana.marioni@diag.bracco.com|
21269420|NCT01299272|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21269421|NCT00464308|Janssen-Cilag Pty Ltd|Executive Director, Medical & Scientific Affairs|+61 2 9815 3219|mhandel@its.jnj.com|
21269422|NCT01513759|EKOS Corporation|David Hahn|4254153100|David.Hahn@btgplc.com|
21269423|NCT03926728|Statens Serum Institut|Per Skallerup|+4532688554|PRSK@SSI.dk|
21269424|NCT03669640|F. Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21269425|NCT03993288|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21269426|NCT02729545|Beijing Hospital of Integrated Traditional Chinese and Western Medicine|Dr. Yu Cao|086|howgreenbreeze@126.com|88223667
21269427|NCT03533608|Center for Clinical Managment Research|Dr. Rebecca Sripada|734-222-7432|rebecca.sripada@va.gov|
21269428|NCT00915473|Mayo Clinic|Dr. David Dodick|480-301-5797|dodick.david@mayo.edu|
21269429|NCT01389024|The Johns Hopkins University School of Medicine|Dr. James Casella|410-955-6132|jcasella@jhmi.edu|
21269430|NCT00534209|UM/Sylvester Comprehensive Cancer Center|Luis Raez MD|305-243-4909|lraez@med.miami.edu|
21269431|NCT02056431|Kaiser Permanente Division of Research|Dr. Alyce S. Adams|510-891-5921|Alyce.S.Adams@kp.org|
21269432|NCT03443973|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21269433|NCT01956123|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
21269434|NCT00398632|Stanford University Medical Center, Department of Psychiatry|Lorrin Koran, M.D., Professor of Psychiatry, Emeritus|650 498 5035|lkoran@stanford.edu|
21269435|NCT00267020|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21269436|NCT00704717|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21269437|NCT01245595|Stanford University Medical Center|Dr. David M. Axelrod|650-723-7913|daxelrod@stanford.edu|
21269438|NCT00640614|Allerderm|Kim Sullivan|602-225-0595||
21269439|NCT00529802|The University of Chicago|Walter Stadler, MD|(773) 702-4150|wstadler@medicine.bsd.uchicago.edu|
21269440|NCT00367679|GlaxoSmithKline|GSK Response Center|866-435-7343||
21269441|NCT01476345|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21269442|NCT02209454|Menarini Ricerche S.p.A.|Corporate Director of Clinical Research|0555680|acapriati@menarini-ricerche.it|9990
21269443|NCT00197184|GlaxoSmithKline|GSK Response Center|866-435-7343||
21269444|NCT00366678|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21269445|NCT01387672|Womens' College Hospital|Dr. Sophie Jamal|416-351-3732|sophie.jamal@wchospital.ca|2873
21269446|NCT04465916|ENYO Pharma SA|Pietro Scalfaro|+33437700219|ps@enyopharma.com|
21269447|NCT01150409|The Cleveland Clinic Foundation|Jorge Guzman MD|216-445-5765|guzmanj@ccf.org|
21269448|NCT00826176|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21269449|NCT01687400|Washington University School of Medicine|John Welch, M.D., Ph.D.|314-362-2626|jwelch@wustl.edu|
21269450|NCT03079869|Kaiser Permanente|KPSC PRS Administrator|626-720-7463|RE-CTCAT@kp.org|
21269451|NCT01325701|Pharmacyclics, Inc.|Dr. Darrin Beaupre|855-427-8846|medinfo@pcyc.com|
21269452|NCT00665704|VA Center for Clinical Management Research Health Services Research & Development, VA Ann Arbor Healthcare System, Ann Arbor, MI.|Sonia A. Duffy, Ph.D., R.N., FAAN|734.395.0613|Sonia.Duffy@va.gov|
21269453|NCT04253756|University of Texas Southwestern Medical Center|Sonja Stutzman, Research Programs Manager|214-648-6719|sonja.stutzman@utsouthwestern.edu|
21269454|NCT00568776|Transition Therapeutics Ireland Limited|Aleksandra pastrak, MD, PhD, Vice President, Clinical Development|+1 416 263 1227|apastrak@transitiontherapeutics.com|
21269455|NCT01372254|University of Maryland|Laura MacPherson|6198578425|lauramac.phd@gmail.com|
21269456|NCT04484805|Liberating Technologies, Inc.|Dr. Todd Farrell|774-233-0873|todd.farrell@liberatingtech.com|
21269457|NCT00539006|GlaxoSmithKline|GSK Response Center|866-435-7343||
21269458|NCT02050373|UFGoias|Daniella Salvador|556235583272|danirnsalvador@gmail.com|
21269459|NCT04342130|University of Rochester|Paul Geha|203-752-8256|paul_geha@urmc.rochester.edu|
21269460|NCT04764669|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
21269461|NCT00256217|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
21269462|NCT00557830|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
21269463|NCT02860039|Vanderbilt-Ingram Cancer Center|Natasha Halasa, MD, MPH|800-811-8480|natasha.halasa@vumc.org|
21269464|NCT03170271|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21269465|NCT03466060|Johnson & Johnson Vision Care Inc.|Meredith Bishop, OD, MS, FAAO- Senior Principal Research Optometrist|904-443-1396|MBishop4@its.jnj.com|
21269466|NCT01610284|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21269467|NCT01856257|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21269468|NCT05168657|University of Colorado|Dr. Sean Oser|3037245828|sean.oser@cuanschutz.edu|
21269469|NCT04935931|Children's Mercy Kansas City|Dr. Stephani Stancil|816-234-3000|slstancil@cmh.edu|
21269470|NCT00937859|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
21269471|NCT00077766|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21269472|NCT00357734|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21269473|NCT02057549|The University of Texas Houston Health Science Center|Dr. Carlos J. Roldan MD|713-792 6070|croldan@mdanderson.org|
21269474|NCT02181075|Oncology Clinical Trials Group|Sarah Pearson, Trial Management Director|01865 227160|sarah.pearson@oncology.ox.ac.uk|
21269475|NCT04636437|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
21269476|NCT00816166|Codman Neuro|Jonathan Megerian, MD PhD|508-880-8274|jmegeri1@its.jnj.com|
21269477|NCT01071278|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21269478|NCT02851069|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21285904|NCT01383018|Boston Scientific|Amanda Vail, Clinical Project Manager|612-749-5366|amanda.vail@bsci.com|
21285905|NCT04346199|AstraZeneca|Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21285906|NCT00627926|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com|
21285907|NCT03414229|Memorial Sloan Kettering Cancer Center|Dr. Sanda D'Angelo, MD|646-888-4159|dangelos@mskcc.org|
21285908|NCT00271219|Departments of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology, Johns Hopkins University School of Medicine|Dr. Hendree Jones|919-485-2664|hjones18@jhmi.edu|
21301108|NCT04288661|1st Propaedeutic Surgery Department,Hippocration Hospital,University of Athens, Greece|Dr Maria Malvina Eleftheriou|+30 6945176503|malvina_el@hotmail.com|
21301109|NCT01532986|VA Greater Los Angeles Healthcare System|Eric M Cheng|3102067671|echeng@mednet.ucla.edu|
21301110|NCT00831181|Beth Israel Medical Center|Dr Peter Kozuch|212 844-8282|pkozuch@chpnet.org|
21301111|NCT04313244|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21301112|NCT00927953|MacroGenics, Inc.|Medical Officer||info@macrogenics.com|
21301113|NCT02976038|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
21301114|NCT00724698|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
21301115|NCT04048356|University of New Mexico|Peter Jeppson, site contact for study|505-967-8428|pjeppson@salud.unm.edu|
21301116|NCT05021978|Praxis Precision Medicines|Charmaine Manilay|2243996121|cmanilay@praxismedicines.com|
21301117|NCT00196313|Duramed Research|Duramed Research Protocol Chair|215-293-7279|role_medical_affairs@tevapharm.com|
21301118|NCT00043979|National Cancer Institute, National Institutes of Health|Dr. Terry Fry|301-402-0215|fryt@mail.nih.gov|
21301119|NCT04069702|Duke University|Sarah Kelleher, PhD|9194163405|sarah.kelleher@duke.edu|
21301120|NCT03096288|University of Florida College of Medicine - Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3378|dominick.angiolillo@jax.ufl.edu|
21301121|NCT02690948|Stanford University|Anne Lynn S. Chang, Associate Professor of Dermatology|650-721-7151|alschang@stanford.edu|
21301122|NCT02551887|Indiana University|Dr. Gregory Zimet|317-274-8812|gzimet@iu.edu|
21301123|NCT01411891|University of Wisconsin School of Medicine and Public Health, Department of Anesthesiology|Dr. Kristopher Schroeder|608-263-8100|kmschro1@wisc.edu|
21301124|NCT01995838|Eisai Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
21301125|NCT03196349|Duke University|Dr. Thomas Ortel|919-684-5350 ext 3|thomas.ortel@duke.edu|
21301126|NCT02819804|Northwestern University|Shira Dinner, MD|312-695-6180|shira.dinner@nm.org|
21301127|NCT03967444|Galderma Research & Development, Aesthetics|Director of Clinical Operations|817-961-5655|aestheticclinicaltrials@galderma.com|
21301128|NCT02210039|Massachusetts General Hospital|Guillermo Tearney, PI|617-724-2979|gtearney@partners.org|
21301129|NCT02369796|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21301130|NCT01821118|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21301131|NCT00318643|Halozyme Therapeutics|Chief Medical Officer|855-495-3639|halozyme@EVERSANA.com|
21301132|NCT01812252|Fred Hutch Cancer Center|Bart Lee Scott M.D.|(206)909-0977|bscott@fredhutch.org|
21301133|NCT01216189|Karolinska Institutet|Professor Anna Martling|+46851770000|anna.martling@ki.se|
21301134|NCT03467750|Emory University|Dr. Laura Gilbertson|404-785-6670|laura.gilbertson@emory.edu|
21301135|NCT05673876|Genentech Inc|Medical Communications|800 821-8590|genentech@druginfo.com|
21301136|NCT03529422|UNC Lineberger Comprehensive Cancer Center|Melahat Canter|919-962-0000|Melahat_Canter@med.unc.edu|
21301137|NCT03052829|Medical College of Wisconsin|Amberly Anger|414-955-6708|aanger@mcw.edu|
21301138|NCT05006573|AstraZeneca|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
21301139|NCT02538510|University of Washington|Cristina Rodriguez|2066066748|rodrigcr@uw.edu|
21301140|NCT00811590|Huntsman Cancer Institute|Dr. Randall Burt|801-585-3281|randall.burt@hci.utah.edu|
21301141|NCT04592887|Varian, a Siemens Healthineers Company|Senior Manager, Clinical Trials|437-991-3496|ClinOps@varian.com|
21301142|NCT00414596|NEMA Research, Inc|Jospeph V Pergolizzi, MD|239-597-3564|nemaresearch@aol.com|
21238027|NCT02276222|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
21257870|NCT00414453|University of Rochester|Robert H Dworkin|275-8214|robert_dworkin@urmc.rochester.edu|
21257871|NCT01263639|Vanderbilt Medical Center|Dr. Brent J. Morris Orthopaedic Resident|615-835-0699|brent.j.morris@vanderbilt.edu|
21257872|NCT02370875|University of Florida|Aparna Wagle Shukla|3522945400|aparna.shukla@neurology.ufl.edu|
21257873|NCT03975920|The Restful Jaw Company, LLC|Dr. Eric Schiffman|(651)338-3344|schif001@umn.edu|
21257874|NCT00586495|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21257875|NCT01081249|University of California, San Diego Medical Center, Department of Psychiatry|Dr. Kai MacDonald|619-203-7393||
21257876|NCT00768521|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
21257877|NCT00205855|Boston Scientific Corporation|Natalie Bloom Lyons|763-228-9040|lyonsn@bsci.com|
21257878|NCT02039375|Johns Hopkins University School of Medicine|Victor C. Urrutia, MD|4109552228|vurruti1@jhmi.edu|
21257879|NCT01475175|Medtronic CRDM|AdOpt CRT Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|62736
21257880|NCT00219284|Novartis Pharmaceuticals|Study Director|862-778-8300||
21257881|NCT01692275|Palmer Center for Chiropractic Research|Dr. Cyndy Long|563-884-5157|LONG_C@palmer.edu|
21257882|NCT01916928|Medstar Washington Hospital Center|Cecily A. Clark-Ganheart|202-877-3067|ganheartmd@gmail.com|
21257883|NCT04514523|Yale School of Medicine|Dr. Kasia Lipska|203-737-4853|kasia.lipska@yale.edu|
21257884|NCT03817775|• Department of Anaesthesia and Intensive Care, American Hospital of Paris|Dr Gilles BOCCARA|+33 1 46 41 25 25|gilles.boccara@ahparis.org|
21257885|NCT00640328|GlaxoSmithKline|GSK Response Center|866-435-7343||
21257886|NCT02374099|Celgene Corporation|Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
21257887|NCT01033825|Sunovion|Respiratory Medical Director|1-866-503-6351||
21257888|NCT04294719|Centre for Addiction and Mental Health|Courtney Brennan|4165358501|courtney.brennan@camh.ca|
21257889|NCT01714687|Acclarent, Inc|Patricia Chen|949-453-6408|pchen126@its.jnj.com|
21257890|NCT00278993|Eisai Call Center|Eisai Inc.|888-422-4743||
21257891|NCT02701387|UCLA School of Dentistry|Perry R. Klokkevold, DDS, MS, FACD|310-825-1927|pklokkevold@dentistry.ucla.edu|
21238028|NCT04102579|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
21257892|NCT01439555|UMass Medical School|Elizabeth DeGrush, DO|508-334-1000|elizabeth.degrush@umassmemorial.org|
21257893|NCT00868348|Aarhus University Hospital|Karen V Andersen|51263173|karenand@rm.dk|0045
21269479|NCT00352664|UT MD Anderson Cancer Center|Eduardo Bruera, MD / Professor|713-792-6084||
21269480|NCT03539952|Orphalan SA|Frank Verheggen - Head Clinical Operations|+31625241264|frank.verheggen@orphalan.com|
21269481|NCT02184988|Evolus, Inc|Rui L. Avelar, MD|(805)689-8668|rui@evolusinc.com|
21269482|NCT03075215|Boston Scientific|Clinical Trial Manager|1-800-227-3422|Sara.Veraghtert@bsci.com|
21269483|NCT01821391|Galderma R&D SNC|CTA Coordinator|+33 493 95 70 85|cta.coordinator@galderma.com|
21269484|NCT02146365|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
21269485|NCT01608321|VA Palo Alto Health Care System|Director, WRIISC|650-493-5000|wes.ashford@va.gov|
21269486|NCT06212544|University of Michigan|Kristi Gamarel|7346473178|kgamarel@umich.edu|
21269487|NCT03222856|MedSIR|Scientific Director|+34 611261467|alicia.garcia@medsir.org|
21269488|NCT02513095|Eagle Pharmaceuticals, Inc.|Chief Medical Officer|201 326 5300|medinfo@eagleus.com|
21269489|NCT00467038|James J Peters VAMC|Marianne Goodman, MD|718-584-9000|marianne.goodman@va.gov|5188
21269490|NCT02545868|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21269491|NCT01777191|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21269492|NCT01932801|University of Washington / Washington State University|Dr. Susan Collins|12068327885|susan.collins@wsu.edu|
21269493|NCT03286400|W. L. Gore & Associates|Eric Novak|314-440-2119|enovak@wlgore.com|
21269494|NCT01856686|Spanish Foundation for Neurometrics Development|Dr. Moises Aguilar Domingo|+441615312645|moises@bigdata4brain.co.uk|
21269495|NCT01461369|Iroko Pharmaceuticals, LLC|Daniel Solorio, Executive Director of Clinical Operations|267-546-3150|dsolorio@iroko.com|
21285909|NCT05568797|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21285910|NCT00099632|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21285911|NCT02797678|Philips Respironics|Senior Data Manager|7243877949|Jeff.Jasko@philips.com|
21301143|NCT04639258|Medtronic Structural Heart & Aortic|Robert Waltonen|763-526-0424|robert.waltonen@medtronic.com|
21301144|NCT04614974|UPMC Children's Hospital of Pittsburgh|Dr. Amber Shaffer|412-692-6874|shafferad@upmc.edu|
21301145|NCT01635153|Dartmouth-Hitchcock|Dr C Fordham von Reyn|6036507167|fvr@dartmouth.edu|
21301146|NCT00831480|Baylor College of Medicine|Dr. Gilad E. Amiel|713-798-4079|lhiggins@bcm.edu|
21301147|NCT00658359|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21301148|NCT02558296|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
21301149|NCT02832115|Aultman Hospital|Dr. Prabhakaran Gopalakrishnan|3304548076|prab.gopalakrishnan@aultman.com|
21301150|NCT02919995|Verona Pharma plc|Brian Maurer|+19147675037|brian.maurer@veronapharma.com|
21301151|NCT00275509|New York University Langone Transplant Institute|Robert Montgomery, MD|646-501-2418|Robert.Montgomery@nyumc.org|
21301152|NCT01963078|MUSC|Dr. Megan Moran-Santa Maria|843-817-6233|moranm@musc.edu|
21301153|NCT03388164|Laureate Institute for Brain Research|Teresa Victor|918-502-5108|tvictor@laureateinstitute.org|
21269496|NCT01247974|CorMatrix Cardiovascular|Director, Clinical Development|240-247-1170|clinical@aziyo.com|
21269497|NCT00388674|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21269498|NCT00540007|Washington University School of Medicine|Todd Fehniger, M.D., Ph.D.|314-747-1385|tfehnige@wustl.edu|
21285912|NCT03131687|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21285913|NCT01064362|GlaxoSmithKline|GSK Response Center|866-435-7343||
21285914|NCT00656175|UCLA CARE Center|Dr. Jordan Lake|310-557-9679|jlake@mednet.ucla.edu|
21285915|NCT01868165|Imperial College London|Dr Ruth Peters|07950289662|r.peters@imperial.ac.uk|
21285916|NCT01216332|Vanderbilt|Dr. Natasha Halasa|6153223346|natasha.halasa@vanderbilt.edu|
21285917|NCT01237327|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21285918|NCT03300180|Indiana University School of Medicine; Indiana University Center for Aging Research; Regenstrief Institute, Inc.|Nicole R. Fowler, PhD, MHSA; Associate Professor of Medicine|317-274-9021|fowlern@iu.edu|
21285919|NCT04233671|The University of Alabama|Dr. Mercy Mumba|205-348-6317|mnmumba@ua.edu|
21285920|NCT00461097|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsgov@niaid.nih.gov|
21285921|NCT02557516|Innate Pharma|Dr. Agnes BOYER-CHAMMARD, Medical Director|+33430303030|Agnes.BOYER-CHAMMARD@innate-pharma.fr|
21285922|NCT04776928|University of Michigan|Jennifer Waljee|(734) 936-8925|filip@med.umich.edu|
21285923|NCT00103285|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21285924|NCT02675764|Medical University of South Carolina|Dr. Na Jin Seo|8437920084|seon@musc.edu|
21285925|NCT00335517|University of Rochester|Glenn Rectine, MD|585-275-8780|glenn_rectine@urmc.rochester.edu|
21285926|NCT02245815|Instituto Mexicano del Seguro Social|Dra. Guadalupe Gómez Rodríguez|477 75 23 166|lupitaneonato@gmail.com|
21285927|NCT01919164|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21285928|NCT01398852|Topcon Medical Systems|Bob Gibson|(201) 599-5121|RGIBSON@TOPCON.COM|
21285929|NCT00588146|Mayo Clinic|Karen L. Swanson, D.O.|507-255-3214|swanson.karen@mayo.edu|
21285930|NCT02100839|Linear Clinical Research Ltd|Dr. Janakan Krihnarajah, MBBS (Hons), FRACP|800 393 8820|JKrishnarajah@linear.org.au|
21285931|NCT03442725|Ipsen|Medical Director|See email|clinical.trials@ipsen.com|
21285932|NCT01543568|Retina Consultants of Houston|David Brown, MD|713-524-3434|dmbmd@houstonretina.com|
21285933|NCT03272347|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21285934|NCT00940888|Saint Jude Medical|Grant Kim, Director Clinical Studies|818-493-3147|gkim@sjm.com|
21285935|NCT00678015|University of California, San Francisco|Dr. Terence Friedlander|415-353-7171|terence.friedlander@ucsf.edu|
21285936|NCT00391872|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21301154|NCT00345358|GlaxoSmithKline|GSK Response Center|866-435-7343||
21285937|NCT01409915|"University of Colorado Denver | Anschutz Medical Campus"|John O'Shaughnessy, MS, Clinical Research Services Principal Professional|3037247924|john.oshaughnessy@cuanschutz.edu|
21285938|NCT01239394|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu|
21285939|NCT01476267|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
21285940|NCT02603211|Temple University|Chang-hee Won|2152046158|cwon@temple.edu|
21285941|NCT00308516|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21285942|NCT01666912|UNC_ChapelHill|Amy G. Bryant, Assistant Professor|919-843-5633|amy_bryant@med.unc.edu|
21285943|NCT01000974|GlaxoSmithKline|GSK Response Center|866-435-7343||
21285944|NCT02726789|Replicor Inc.|Chief Scientific Officer|514 733 1998|availlant@replicor.com|
21285945|NCT01307891|University of Alabama at Birmingham|Andres Forero, M.D.|205-934-7167|aforero@uab.edu|
21285946|NCT03365934|JNJWorldwide|Amisha Parikh-Das|973-255-8701|aparikh1@its.jnj.com|
21285947|NCT02937740|Acerus Pharmaceuticals Corporation|Dr. Nathan Bryson, Chief Scientific Officer|1-416-679-0776|nbryson@aceruspharma.com|
21285948|NCT04194489|Mt. Hope Family Center, University of Rochester|Dr. Christie Petrenko|(585) 275-2991|christie.petrenko@rochester.edu|241
21285949|NCT01851655|University of Florida|Dr. Terese Chmielewski|352-273-6104|tchm@ufl.edu|
21285950|NCT02291029|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21285951|NCT00377637|Hoffman-LaRoche|Medical Communications|800-821-8590||
21285952|NCT04147247|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21285953|NCT00823264|Emory University|Dr. Brent Morgan|404-616-4403|bmorg02@emory.edu|
21285954|NCT01714544|Promius Pharma|Director Clinical Operations|609-282-1404|jfraser@drreddys.com|
21285955|NCT00666211|Vanderbilt-Ingram Cancer Center|Nancy Wells, Director of Nursing Research Patient Care Svcs|615-322-6184|nancy.wells@vanderbilt.edu|
21285956|NCT03557918|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
21285957|NCT04575090|UTSouthwestern Medical Center|Zahid Ahmand, MD|214-648-2377|zahid.ahmad@utsouthwestern.edu|
21285958|NCT03373760|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
21285959|NCT04218279|University of Pittsburgh|P. Daniel Patterson|412-864-3830|pdp3@pitt.edu|
21285960|NCT00003537|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
21285961|NCT02907463|Edwards Lifesciences, LLC|Mary Edwards, VP Clinical and Regulatory Affairs, Surgical Structural Heart|949-250-2500|mary_edwards@edwards.com|1536
21285962|NCT02372344|AstraZeneca Pharmaceuticals|Stefan C Carlsson, MD, PhD, Global Clinical Lead|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
21285963|NCT01447407|NovaDigm Therapeutics, Inc.|John P. Hennessey, Jr.|12676405189|john_hennessey@novadigm.net|
21285964|NCT00580957|Vanderbilt University|Italo Biaggioni, M.D. Professor of Medicine|(615) 936-3420|italo.biaggioni@vanderbilt.edu|
21285965|NCT00572260|Duke University Health System|Yong Choi, Clinical Research Coordinator|919-684-7584|yong.choi@duke.edu|
21285966|NCT00875563|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Science & Biostatistics|765-463-7537|SSnyder@medinst.com|
21285967|NCT00313846|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
21285968|NCT03478371|Procter & Gamble Co|Jan Streicher-Scott, PhD, RPh|513-634-5584|streicherscott.jl@pg.com|
21285969|NCT03861780|Bioscience Laboratories|Principal Investigator II/Training Coordinator|(406) 587-5735|cduley@biosciencelabs.com|110
21285970|NCT06060496|University of Kentucky|Gopalkumar Rakesh, MD|8592579402|gopalkumar.rakesh@uky.edu|
21285971|NCT02028507|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
21285972|NCT01556932|Virginia Commonwealth University/ Hospice & Pallative Medicine|Devon S. Flecher, MD|804-828-9723|dsfletcher@mcvh-vcu.edu|
21285973|NCT01960465|Jesse Brown VAMC|Dr. Bharati Prasad|312-569-6343|bharati.prasad@va.gov|
21285974|NCT00991289|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21269499|NCT03576131|Genmab|Clinical Trial Information|+45 7020 2728|clinicaltrials@genmab.com|
21285975|NCT01715948|Capital Health|Dr. Manohar Bance|902-473-5975|m.bance@dal.ca|
21285976|NCT02401035|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21285977|NCT00869128|Shoham Geriatric Medical Center, Pardes Hana, Israel|D. Garfinkel , MD|Tel: 972-4-6375667|dorong@shoham.health.gov.il|
21285978|NCT04693078|Shaare Zedek Medical Center|Dr. Dan Meir Livovsky|+34603833576|danlivo@yahoo.com|
21285979|NCT01118663|Cumberland Pharmaceuticals Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
21285980|NCT00768287|Medexus Pharma, Inc.|Clinical Trial Manager|1-312-548-3125|julissa.leon@medexus.com|
21285981|NCT03046953|CRCTU Birmingham|C Morland Cinical Trial Coordinator|+44 121 371 7862|avail-t@trials.bham.ac.uk|
21285982|NCT03828214|College of St. Scholastica|Dr. Alexandra Borstad|614-395-1708|aborstad@css.edu|
21285983|NCT04039204|Wake Forest University School of Medicine|Bruce Lessey, Ph.D., M.D.|336-713-0380|blessey@wakehealth.edu|
21285984|NCT04283253|UNIVERSITY OF PITTSBURGH|George Wittenberg|4126484178|GEOWITT@PITT.EDU|
21285985|NCT01189461|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21285986|NCT00420628|Bausch & Lomb|Timothy Comstock OD|(585) 338-6631|tcomstock@bausch.com|
21285987|NCT02716584|VA Greater Los Angeles Healthcare System|Dr. Robert Kern|310-478-3711|Robert.Kern2@va.gov|49229
21285988|NCT01830933|University of California, San Francisco|Celia P. Kaplan, Professor|415-502-5601|celia.kaplan@ucsf.edu|
21285989|NCT01888952|CTRC@UTHSCSA|Anand Karnad, MD|210-450-1000|karnad@uthscsa.edu|
21285990|NCT03715452|Osprey Medical, Inc.|Vice President of Clinical Affairs|952.955.8236|kknish@ospreymed.com|
21285991|NCT00395993|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
21285992|NCT00052078|Johns Hopkins University|John Walkup|212-746-1891|jtw9001@med.cornell.edu|
21285993|NCT00578279|Indiana University Medical Center|Julia K. LeBlanc, MD|(317) 948-8125|juleblan@iupui.edu|
21301155|NCT01385293|Duke University|Andrew J. Armstrong, MD ScM FACP|919 668 4667|andrew.armstrong@duke.edu|
21301156|NCT00346697|Johns Hopkins University|Dr Todd Brown, Associate Professor of Medicine and Epidemiology|410-502-2327|tbrown27@jhmi.edu|
21301157|NCT00499083|University of Nebraska Medical Center|Elizabeth Reed|402-559-5166|ereed@unmc.edu|
21301158|NCT00686686|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21301159|NCT01012440|University of Chicago|Dr. Kirti Kulkarni|(773) 702-2781|kkulkarni@radiology.bsd.uchicago.edu|
21301160|NCT01278212|Medical University of South Carolin|Harriet Eldredge-Hindy|8437926382|eldredge@musc.edu|
21301161|NCT01052701|Johns Hopkins School of Medicine|Associate Director, Drug Development Unit|(410) 614-8762|ejfuchs@jhmi.edu|
21301162|NCT00477386|IndianaU|Daniela Matai, MD|317-944-0920|dmatai@iupui.edu|
21301163|NCT01254422|Sanofi Pasteur SA|Director||Contact-US@sanofi.com|
21301164|NCT00643162|Cedars Sinai Medical Center|Felicia Mayes|310-423-0825|mayesf@cshs.org|
21301165|NCT03066947|BriaCell Therapeutics Corporation|Dr. William Williams|1-888-485-6340|williams@briacell.com|
21301166|NCT04587661|University of Pittsburgh|Dr. Charles Jonassaint|+14125869850|cjonassaint@pitt.edu|
21301167|NCT01942694|Division of Endocrinology, Diabetes, and Metabolism, Tufts Medical Center|Dr. Anastassios Pittas|617-636-3232|apittas@tuftsmedicalcenter.org|
21257894|NCT03921424|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21301168|NCT02691507|Johnson & Johnson Consumer, Inc|Amisha Parikh-Das, PhD/Study Director|973-255-8701 USA EST|AParikh1@its.jnj.com|
21301169|NCT02557139|Kadmon Corporation, LLC|Olivier Schueller, Senior Vice President, CMC & Clinical Pharmacology|833-900-5366|olivier.schueller@kadmon.com|
21301170|NCT01378871|Albert Einstein College of Medicine|Dr, Amit Verma||amit.verma@einsteinmed.edu|
21301171|NCT03023397|University of North Carolina at Chapel Hill|Allison Burbank, MD|919-962-5136|allison_burbank@med.unc.edu|
21301172|NCT02387502|Govt. Medical College, Haldwani.|Dr. Geeta Bhandari|8958267145|bhandari_geetantl@rediff.com|
21301173|NCT01146795|Columbia University|Jason Wright, MD|212-305-3410|jw2459@cumc.columbia.edu|
21301174|NCT05375760|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21301175|NCT03853109|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21301176|NCT04032093|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21257895|NCT00867321|Mayo Clinic|Steven R. Alberts, MD MPH|507/284-4918|Alberts.steven@mayo.edu|
21257896|NCT02330978|University São Paulo|Jayter Silva de Paula, MD, PhD|55 16 3602-2499|jspaula@fmrp.usp.br|
21257897|NCT01733628|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
21257898|NCT02589496|Samsung Medical Center|Jeeyun Lee|82234101779|jyunlee@skku.edu|
21257899|NCT01934556|Palmetto Retina Center, LLC|John F. Payne, MD|(803) 931-0077|jpayne@palmettoretina.com|
21257900|NCT03471065|Edwards Lifesciences|Edwards THV Clinical Affairs|949-250-2500|THV_CT.gov@edwards.com|
21257901|NCT05038020|Alkahest, Inc.|Head of Communications|(650) 801-0474|sm-Trials-alkahest@grifols.com|
21257902|NCT02909985|University of New Mexico|L. Olivia Hopkins|(505) 925-7769|LHopkins@salud.unm.edu|
21257903|NCT03416153|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
21257904|NCT03770260|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
21257905|NCT02366611|University of Michigan, School of Dentistry|Alexandre DaSilva|7346153807|adasilva@umich.edu|
21257906|NCT00938314|Stem Cell Therapeutics Corp.|Chief Scientific Officer|403.245.5495|adavidoff@stemcellthera.com|226
21257907|NCT01908101|Seattle Cancer Care Alliance|Stefanie Parker|206-889-0917|parkers@seattlecca.org|
21257908|NCT01394939|Sillajen Biotherapeutics Inc.|Kyoung Soo Ha, Head of Clinical Development|+1-415-281-8886|ksha@kr.sillajen.com|
21257909|NCT00166205|Worldwide Clinical Operations|Sheryl Helsinger, Director|513-337-3079|shelsing@its.jnj.com|
21257910|NCT02831673|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21257911|NCT00150592|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21257912|NCT02227693|Eisai Inc.|Eisai Medical Services|1-888-274-2378|esi_medinfo@eisai.com|
21257913|NCT03615183|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21257914|NCT00141765|University of Michigan Cancer Center|Dr. John E. Levine, MD|734-936-8456|jelevine@umich.edu|
21257915|NCT01097746|UT MD Anderson Cancer Center|Dr. Anil K. Sood, MD/Professor, Gyn Onc & Reproductive Med|(713) 745-5266|asood@mdanderson.org|
21257916|NCT03378076|Flexion Therapeutics|Scott Kelley, Chief Medical Officer|781-305-7142|skelley@flexiontherapeutics.com|
21257917|NCT00772954|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21257918|NCT00665457|University of Nebraska Medical Center|Elizabeth Reed, M.D.|402-559-5388|ereed@unmc.edu|
21257919|NCT03678402|The Ohio State University Wexner Medical Center|Dr. Tammy Moore|6142937847|tammy.moore@osumc.edu|
21257920|NCT01526902|Indiana University|Pete Kollbaum, OD, PhD, FAAO, FBCLA, Principal Investigator|812-856-0108|kollbaum@indiana.edu|
21257921|NCT01659320|Weill Cornell Medical College|Dr. George Alexopoulos, M.D.|914-997-5767|galexopoulos@med.cornell.edu|
21257922|NCT01514682|Maryland Psychiatric Research Center|Robert W. Buchanan, M.D.|410-402-7876|rbuchanan@som.umaryland.edu|
21257923|NCT00590590|KV Pharmaceutical|Jim Joffrion, Sr. Director, Clinical Affairs|314-645-6600|jjoffrion@kvph.com|
21257924|NCT00132132|SEMC|Dr. Shirley Gonzalez|617-926-0114|shirley.gonzalez@steward.org|
21257925|NCT03470493|ResMed|Adam Benjafield|+61 466 634 609|adam.benjafield@resmed.com|
21257926|NCT01667471|Hoffmann-LaRoche or Genentech, Inc|Medical Communications|800-821-8590|genentech@druginfo.com|
21257927|NCT03605680|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21269500|NCT01456000|CardioFocus, Inc.|Burke Barrett, VP Regulatory & Clinical Affairs|508 658-7200|bbarrett@cardiofocus.com|
21238029|NCT05899686|UCaliforniaSF|Pekka Talke|4153063602|pekka.talke@ucsf.edu|
21238030|NCT02170025|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21238031|NCT00572195|NeuroPace, Inc.|Dr. Martha Morrell, Chief Medical Officer|650-237-2776|mmorrell@neuropace.com|
21238032|NCT01525602|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
21238033|NCT03703466|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21238034|NCT03202472|Jonsson Comprehensive Cancer Center|Mark Glover|310 794-8742|mglover@mednet.ucla.edu|
21238035|NCT00715650|Yale University|Dr. Marc Rosen|203-932-5711|marc.rosen@yale.edu|2575
21238036|NCT02563002|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21257928|NCT00647556|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
21257929|NCT02145741|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21269501|NCT03506646|University of Nebraska at Omaha|Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
21269502|NCT02118896|Astellas Pharma Europe Limited|Clinical Trial Disclosure||Astellas.resultsdisclosure@astellas.com|
21269503|NCT00572910|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21269504|NCT02230332|Penn State University Dept of Public Health Sciences|David Mauger, PhD|717.531.3584|dmauger@psu.edu|
21269505|NCT02586909|Axovant Gene Therapies|Yi Mo, PhD|1-929-227-3828|yi.mo@axovant.com|
21269506|NCT02249065|Galderma Laboratories L.P.|Dr. Jean Philippe York|817-961-5468|jp.york@galderma.com|
21269507|NCT01260194|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21269508|NCT00566631|Janssen-Cilag Germany|EMEA Therapeutic Area Leader CNS|+492137955153||
21269509|NCT00877799|Cara Therapeutics Inc.|Frédérique Menzaghi, PhD, Vice President Research & Development|203-567-1502|fmenzaghi@caratherapeutics.com|
21269510|NCT04054011|UCSD Dermatology|Joyce Yuan, MD|(858) 657-8322|joyce.yuan2@ucsf.edu|
21285994|NCT01971567|Wake Forest School of Medicine|Dr. Charles H. Tegeler|+1 (336) 716-7651|ctegeler@wakehealth.edu|
21285995|NCT00511173|Creighton University|Christopher Destache|402-280-4744|destache@creighton.edu|
21285996|NCT04826484|Johns Hopkins University School of Medicine|Andrew T. Gabrielson, MD|410-955-5000|atg@jhmi.edu|
21285997|NCT02250300|Froedtert and the Medical college of Wisconsin|Mehdi Hamadani, MD|414-805-4600|mhamadani@mcw.edu|
21285998|NCT05122624|Johns Hopkins Bloomberg School of Public Health|Dr. Yeonsoo Baik|410-955-2378|ybaik3@jh.edu|
21285999|NCT01845597|Rebound Research and Education Foundation.|Pamela Fairchild|3604498728|pfairchild@reboundmd.com|
21286000|NCT03782987|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21286001|NCT01516736|Sandoz|Strategic Planning, Biopharmaceutical Clinical Development|+49 (0) 8024 476 - 0|biopharma.clinicaltrials@sandoz.com|
21286002|NCT04403113|Marmara University|Assoc. Prof Gonul Acar|5323778878|gonulacar34@gmail.com|+90
21286003|NCT00524771|Center for Epidemiology and Health Research, Germany|Dr. Juergen Dinger|0049 (0)30 945 101 20|dinger@zeg-berlin.de|
21286004|NCT02781818|UNC Dermatology|Dr. Christopher Sayed|984-974-3900|christopher_sayed@email.unc.edu|
21286005|NCT01877668|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021||
21286006|NCT01223404|University of Maryland School of Medicine|Dr. Britta Hahn|4104026112|bhahn@mprc.umaryland.edu|
21286007|NCT00954122|AstraZeneca|Gerard Lynch|4415 09645895|clinicaltrialtransparency@astrazeneca.com|
21286008|NCT03782181|University of Balearic Islands|José Mingorance|+34677602465|josea.mingorance@uib.es|
21286009|NCT01587105|Seattle Children's Hospital|Rita Mangione-Smith, MD, MPH|2068848242|Rita.Mangione-Smith@seattlechildrens.org|
21286010|NCT01957579|MedImmune, LLC|Medical Director||ClinicalTrialTransparency@astrazeneca.com|
21286011|NCT02019550|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21286012|NCT01781208|Cincinnati Children's Hospital Medical Center, Department of Radiology|Jonathan Dillman, MD|513 803-7114|jonathan.dillman@cchmc.org|
21286013|NCT02750332|Cycle Pharmaceuticals Ltd|James Price|+44 1223 803638|james.price@cyclepharma.com|
21286014|NCT01000987|Yale University|Sherry McKee PhD|203-737-3529|sherry.mckee@yale.edu|
21286015|NCT02485483|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21286016|NCT01965002|Stanford Univeristy Medical Center|Pejman Ghanouni, MD, PhD|650-498-4485|ghanouni@stanford.edu|
21286017|NCT00522548|University of Pennsylvania|Roy Bloom, MD|215-662-4643|roy.bloom@uphs.upenn.edu|
21286018|NCT03506438|Duke|Christopher Cox|9196817232|christopher.cox@duke.edu|
21286019|NCT01128296|UPMC CancerCenter|Herbert Zeh, MD|412-692-2852|zehxhx@upmc.edu|
21286020|NCT04155463|Boise State University|Dr. Cynthia Curl|208-426-3924|cynthiacurl@boisestate.edu|
21286021|NCT00113295|Massachusetts General Hospital|Naomi M. Simon, M.D., M.Sc.|(617) 726-7913|nsimon@partners.org|
21286022|NCT01914393|Sunovion Pharmaceuticals Inc.|CNS Medical Director|866-503-6351|ClinicalTrialDisclosure@sunovion.com|
21286023|NCT02806713|University of Massachusetts UMass Memorial|Michael K Flynn|(508) 856-5152|michael.flynn@umassmemorial.org|
21286024|NCT02881658|The University of Hong Kong|Dr Cheung Ching Lung|(852)28315085|lung1212@hku.hk|
21257930|NCT01692964|Rapid Pathogen Screening, Inc.|Robert Sambursky, MD|941-556-1853|rob.sambursky@lumosdiagnostics.com|
21257931|NCT03239574|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
21257932|NCT02181829|Memorial Sloan Kettering Cancer Center|Suzanne Wolden, MD|212-639-5148|woldens@MSKCC.ORG|
21257933|NCT03865706|Columbia University|Daniel E. Freedberg, MD, MS|857-998-9370|def2004@cumc.columbia.edu|
21286025|NCT02999789|University of California, San Francisco|Eddie Cruz-Romero, MD, MPH|(628) 206-2837|Edward.Cruz@ucsf.edu|
21257934|NCT02646982|University of Texas Southwestern|Ihab Hajjar, MD|214-645-9533|ihabhajjar@emory.edu|
21238037|NCT03856515|M.D. Anderson Cancer Center|Jason Robinson|713-792-2265|nicotinestudy@mdanderson.org|
21269511|NCT00592007|UC San Diego, Moores Cancer Center|Lyudmila Bazhenova, MD|858 822 6189|lbazhenova@ucsd.edu|
21269512|NCT00595127|Memorial Sloan Kettering Cancer Center|Farid Boulad, MD, Attending|+1212-639-2429|bouladf@mskcc.org|
21269513|NCT01341067|Rocky Mountain Diabetes and Osteoporosis Center|Mark Sulik, PharmD CCRP|208-528-9642|mark@idahomed.com|
21269514|NCT00538473|GlaxoSmithKline|GSK Response Center|866-435-7343||
21269515|NCT01569074|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
21269516|NCT02424851|Oxford University Hospitals NHS Foundation Trust|Richard Brouwer|441865226950|richard.brouwer@ouh.nhs.uk|
21269517|NCT01410565|Spectrum Pharmaceutical Inc.|Gajanan Bhat|949-743-9219|gajanan.bhat@sppirx.com|
21269518|NCT01940276|Duke University|Daniel George, MD|919-668-4615|daniel.george@duke.edu|
21269519|NCT02723786|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21269520|NCT01143610|School of Dentistry at Bauru - USP|Adriana Campos Passanezi Sant'Ana|00 55 14 3235-8278|acpsantana@usp.br|
21269521|NCT00127192|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21269522|NCT00124579|SWOG|Robert Z. Orlowski, MD, PhD|(713) 792-2860|rorlowsk@mdanderson.org|
21269523|NCT00703261|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21269524|NCT02466776|Kaiser Permanente|Dr. Mary Zaki|503-332-2390|mary.nasry@gmail.com|
21269525|NCT02701049|Brigham and Women's Hospital|Dr. Adil H. Haider|617-525-9280|ahhaider@bwh.harvard.edu|
21269526|NCT00722007|Corin USA Limited|Lucinda Gerber|(772) 321 2478|lucinda.gerber@coringroup.com|
21269527|NCT01036594|University of California, San Francisco|Dr. Terence Friedlander, MD|(415) 514-6380|Terence.Friedlander@ucsf.edu|
21269528|NCT03345485|Mundipharma Research Limited|Mónica Araujo - Senior Programmer, Data Management|+447922223436|monica.araujo@mundipharma-rd.eu|
21269529|NCT00442338|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21269530|NCT01125358|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21269531|NCT00157573|MGH DF/HCC|Richard T Penson MD MCCP|617-726-8566|rpenson@partners.org|
21269532|NCT02115373|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21269533|NCT00962013|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@stryker.com|
21269534|NCT01638416|Australian and New Zealand Intensive Care Research Centre|Dr. Cooper|+61 3 9903 0071|anzicrc@monash.edu|30071
21269535|NCT00424632|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21269536|NCT02628418|Fondazione Salvatore Maugeri|Dr. Palmira Bernocchi|00390308253|palmira.bernocchi@fsm.it|260
21269537|NCT03003793|Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen|Lise Gether, MD||lise.gether.01@regionh.dk|
21269538|NCT01984229|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21269539|NCT02379442|NHLBI, NIH|Sawa Ito, MD|301-326-5233|itos3@upmc.edu|
21269540|NCT02067585|Royal Alexandra Hospital|Xinzhe Shi|7807356735|xinzhe.shi@ahs.ca|
21269541|NCT00118209|Washington University School of Medicine|Nancy Bartlett, M.D.|314-362-5654|nbartlet@wustl.edu|
21269542|NCT01418365|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21269543|NCT03226366|Intermountain Healthcare|Director, Office of Research|(801) 408-1991|officeofresearch@imail.org|
21269544|NCT03319368|University of Maryland School of Medicine|Alison Lydecker, MPH|410-706-0065|alydecke@som.umaryland.edu|
21269545|NCT01267227|University of Mississippi|Dr. Daniel Riche|601-984-2640|driche@umc.edu|
21269546|NCT04150107|Oramed, Ltd.|Miriam Kidron, PhD|+972-2-566-0001|miriam@oramed.com|
21269547|NCT00824993|UT MD Anderson Cancer Center|Lu,Huifang,M.D. PH.D. / General Internal Medicine|713-563-4462|HLU@MDANDERSON.ORG|
21269548|NCT02587117|B.P. Koirala Institute of Health Sciences|Dr. Ramayan Prasad Kushwaha|977-9842207716|visitramayan007@yahoo.com|
21269549|NCT00790270|Stony Brook U|Adam Singer|631 444 7856|adam.singer@stonybrook.edu|
21269550|NCT01339858|Indiana University Psychotic Disorders Program|Alan Breier|317-880-8495|abreier@iupui.edu|
21269551|NCT00996632|University of Trieste|Prof. Nicolò de Manzini|+390403994152|nicolo.demanzini@aots.sanita.fvg.it|
21269552|NCT01598740|Sorbent Therapeutics, Inc.|Howard Dittrich, MD|858-405-1429|hdittrich@sorbent.com|
21269553|NCT01569594|Aziyo Biolgics, Inc.|Clinical Director|510-730-7973|clinical@aziyo.com|
21269554|NCT03069365|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21269555|NCT02886494|Charsire Biotechnology Corp.|R&D associate|+886-6-702-0817|cs42@charsire.com|
21269556|NCT03029104|CXL Ophthalmics, LLC|Chief Clinical Development Officer|339-234-6020|info@cxlophthalmics.com|
21269557|NCT00537056|David Geffen School of Medicine at UCLA|Andrew Quon, M.D. Professor Division of Nuclear Medicine|310-983-1419|aquon@mednet.ucla.edu|
21269558|NCT00535873|The University of Texas M D Anderson Cancer Center|Alessandra Ferrajoli, MD/Associate Professor|713-792-2063|eharriso@mdanderson.org|
21269559|NCT00203892|University of Chicago|Dr. Hedy Kindler|773-702-0360|hkindler@medicine.bsd.uchicago.edu|
21269560|NCT02709759|Brown University|Christopher Kahler|401 863-6651|christopher_kahler@brown.edu|
21269561|NCT01700335|SymBio Pharmaceuticals|Director of Clinical Trials|+81-3-5472-1127|kgoto.34@symbiopharma.com|
21269562|NCT00556166|Columbia University|Dennis Fowler|212-305-9914|dlf91@columbia.edu|
21269563|NCT01612780|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
21269564|NCT05005130|University of North Carolina at Chapel Hill|Michael Herce, MD, MPH, MSc|919-966-2537|michael_herce@med.unc.edu|
21269565|NCT00244881|Dana-Farber Cancer Institute|Dr Harold Burstein|617-632-3800|hburstein@partners.org|
21269566|NCT02985515|Washington University in St. Louis|Pawina JIramongkolchai, MD|314-393-2455|pawina@wustl.edu|
21286026|NCT02824224|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
21286027|NCT00552695|Stony Brook U|Adam Singer|631-444-7857|adam.singer@stonybrook.edu|
21269567|NCT03020966|Hospital for Special Surgery|Dr. Jacques Yadeau|(212) 774-2224|Yadeauj@hss.edu|
21286028|NCT00368108|Eisai Call Center|Eisai Inc.|888-422-4743||
21286029|NCT03180957|University of Oxford|Professor Jagdeep Nanchahal|+44(001865 612633|jagdeep.nanchahal@kennedy.ox.ac.uk|
21238038|NCT03518125|BARDA|Susan Hollingsworth/Regulatory Operations Specialist|202-691-2040|Susan.Hollingsworth@hhs.gov|
21238039|NCT04452877|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
21238040|NCT02650219|St Joseph Hospital Marseille|Dr Christine Serratrice|0041798731474|cserratrice@hotmail.fr|
21238041|NCT05453110|Baylor University Keller Army Community Hospital Division 1 Sports Physical Therapy Fellowship|Dr. Kelly M. Scott|509-595-7263|kmsid119@gmail.com|
21238042|NCT03387579|Indiana University School of Medicine|Dr. Katie Huff|3179449395|huffka@iupui.edu|
21238043|NCT01662063|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21238044|NCT00293267|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21238045|NCT01050816|Eulji General Hospital|Lee Gyeong Tae|+82-11-214-3323|lkt2408@hanmail.net|
21238046|NCT02360319|Vanguard Research Group|Patrica Marcy|3474398035|pmarcy@northwell.edu|
21238047|NCT01123382|MetroHealth Medical Center|Richard WIlson, MD|216-957-3559|rwilson@metrohealth.org|
21238048|NCT02740049|Imperial College London|Dr Coen Wiegman|+44(0)2075947846|c.wiegman@imperial.ac.uk|
21257935|NCT02095535|UBC Department of Anesthesia - BC Women's Hospital|Tashya De Silva|604-875-2158|tashya.desilva@cw.bc.ca|
21257936|NCT00769002|Hackensack University Medical Center|Dr. David Schwartz|551-996-2000|DSchwartz@hackensackumc.org|
21257937|NCT00960661|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21257938|NCT02699892|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21257939|NCT04677712|Endo Pharmaceuticals|Clinical Operations|1-800-462-3636|ClinicalTrials@Endo.com|
21257940|NCT00847912|Providence VA mendical Center|Martin Weinstock MD, PhD|401-457-3333|Martin.Weinstock@va.gov; Martin_Weinstock_MD@brown.edu|
21286030|NCT02363387|Johns Hopkins University School of Medicine|Kenneth Silverman|443-617-6051|ksilverm@jhmi.edu|
21257941|NCT00517595|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
21257942|NCT02083380|Medical University of Vienna, Division of Infectious Diseases and Tropical Medicine|Associate Professor Dr Michael Ramharter|+43140400-44400|michael.ramharter@meduniwien.ac.at|
21257943|NCT02412787|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21257944|NCT00001379|National Cancer Institute|Dr. Christopher J. Melani|240-760-6057|christopher.melani@nih.gov|
21257945|NCT03246958|Dana Farber Cancer Institute (DFCI)|Dr. Kartik Sehgal|617-632-3090|kartik_sehgal@dfci.harvard.edu|
21257946|NCT05525533|University of California, San Francisco|Jenny Liu|6503800762|jenny.liu2@ucsf.edu|
21257947|NCT03405259|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
21257948|NCT01577186|Janssen Research & Development|Medical Director|886 2 23762155||
21257949|NCT01032915|Novartis|Study Director|862-778-8300||
21257950|NCT00811135|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21257951|NCT01118351|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@case.edu|
21257952|NCT00518154|Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán|Dr. Carlos Aguilar Salinas, Director of Ethics in Human Research Committee|5554870900|carlos.aguilars@incmnsz.mx|4524
21257953|NCT01685463|Medical University of south Carolina|Dr. Xingbao Li|8437925729|lixi@musc.edu|
21257954|NCT00535132|Ortho McNeil Janssen Scientific Affairs, LLC|Vice President, Medical Affairs, CNS|609-730-2136||
21257955|NCT00822757|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21257956|NCT00183274|UPENN|Karl Rickels, M.D.|215-746-6417|krickels@mail.med.upenn.edu|
21257957|NCT00708500|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21257958|NCT01242267|Hackensack Meridan Health|Joshua Zenreich|5519964248|Joshua.Zenreich@hmhn.org|
21257959|NCT00595556|UCHC|Albert J. Arias, M.D.|8606794423|alarias@uchc.edu|4423
21257960|NCT00371293|UPenn|Julio Chirinos|2158235800|julio.chirinos@uphs.upenn.edu|
21257961|NCT02631525|Universidade federal de Minas Gerais|Dr Renato Gomez|553134099760|renatogomez2000@yahoo.com.br|
21257962|NCT00794677|Children's Hospital Oakland Research Institute|Ronald M Krauss|510.450.7912|rkrauss@chori.org|
21257963|NCT03882970|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21257964|NCT05284760|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21257965|NCT02863809|Massachusetts Eye and Ear|Odeta Dyrmishi & Joseph Ciolino|7742745014|Odeta_Dyrmishi@meei.harvard.edu; Joseph_Ciolino@meei.harvard.edu|
21257966|NCT00607386|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21257967|NCT03292809|Novaliq GmbH|Dr. Sonja Kroesser|+49 6221 50259|info@novaliq.com|0
21257968|NCT01797575|The University of Texas Health Science Center at Houston|Jair C Soares, MD|713-486-2627|jair.c.soares@uth.tmc.edu|
21257969|NCT04474795|Washington University In St. Louis School of Medicine|Cynthia Herrick, MD, MPHS|3147470278|herrickc@wustl.edu|
21257970|NCT00814775|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
21257971|NCT02980224|Brace Consulting Group Inc.|Jeremy Brace, President|7274582823|jbrace@braceconsultinggroup.com|
21257972|NCT00606320|Otsuka Pharmaceutical Co, Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
21257973|NCT04839380|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21257974|NCT00879645|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
21257975|NCT00513500|Boston University|Kojo Yeboah-Antwi|617-414-1275|kyantwi@bu.edu|
21257976|NCT00749996|Medtronic Spinal & Biologics|Irène Ayer, Clinical research specialist|+41 21 803 84 27|irene.ayer@medtronic.com|
21257977|NCT01227044|Yale School of Medicine|Dr. Lynn Fiellin|203-737-3347|lynn.fiellin@yale.edu|
21257978|NCT04247061|Boston University|Director of Center for Behavioral Science Research|6173583358|belindab@bu.edu|
21238049|NCT02274857|Abbott|Clinical Program Director|651-756-6717|kristin.ruffner@abbott.com|
21257979|NCT00917150|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21269568|NCT02964910|Shandong Center for Disease Control and Prevention, Jinan, China|Shandong Provincial Key Laboratory of Infectious Disease Control and Prevention|0531-82679606|aqxuepi@163.com|
21269569|NCT01060007|Washington University School of Medicine|Parag Parikh, M.D.|314-362-9703|pparikh@radonc.wustl.edu|
21269570|NCT04007406|DAMIAN Pharma AG|Teresa Gerlock/Chief Operations Officer|+41 79 230 8591|teresa.gerlock@damianpharma.com|
21269571|NCT03159611|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
21269572|NCT02072174|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
21269573|NCT05674721|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
21269574|NCT04466956|Barts Health NHS Trust|Dr Anna McDougall|02078827272|anna.mcdougall@nhs.net|
21269575|NCT00091507|Tufts Medical Center|Co-Principal Investigator|617-636-8788|jbeshansky@tuftsmedicalcenter.org|
21269576|NCT00633009|Nielsen BioSciences, Inc.|Stewart Nielsen|858.571.2726|stewart@nielsenbio.com|
21269577|NCT00203931|University of Chicago|Kristen Wroblewski|773-702-7173|kwroblewski@health.bsd.uchicago.edu|
21269578|NCT03506425|Duke University|Richard Bedlack, M.D., Ph.D.|919-668-2839|richard.bedlack@duke.edu|
21269579|NCT03409328|Rosalind Franklin University|Dr. Brian Feinstein|847-578-8736|brian.feinstein@rosalindfranklin.edu|
21269580|NCT02998645|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
21269581|NCT03701516|Johnson & Johnson Vision Care, Inc|Brian Pall, OD, MS, FAAO - Director|1-904-629-2289|BPALL@its.jnj.com|
21269582|NCT00478673|Boston Scientific Corporation|Jim Taufen, Regulatory Affairs Manager|763-255-0683|taufenj@bsci.com|
21269583|NCT03930615|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21269584|NCT01153685|GlaxoSmithKline|GSK Response Center|866-435-7343||
21269585|NCT03506724|Icahn School of Medicine at Mount Sinai|Dr. Dyese Taylor|973-926-5508|Dyesetaylor@gmail.com|
21301177|NCT02377817|Global Innovations for Reproductive Health & Life|Dr. Allan Kember, Director of Programs|+1-902-580-8385|allan.kember@mail.utoronto.ca|
21301178|NCT02364570|The Ohio State University|Richard Bruno, PhD, RD|6142925522|bruno.27@osu.edu|
21269586|NCT03644927|Veterans Administration Boston Healthcare System and BU School of Medicine|Erica R Scioli, PhD|857 364 6293|ericarose.scioli@va.gov|
21301179|NCT00646048|Boston Scientific|Colleen Holthe, Clinical Project Manager|651-581-4632|Colleen.Holthe@bsci.com|
21269587|NCT00956813|Mayo Clinic|Debra L. Barton, RN, PhD, AOCN||barton.debra@mayo.edu|
21269588|NCT02380248|Alcon, A Novartis Division|Clinical Scientific Associate Director, GCRA-GDD|1-888-451-3937|alcon.medinfo@alcon.com|
21269589|NCT04736316|University of Washington|Dr. Kelli O'Laughlin|206-744-2559|kolaugh@uw.edu|
21269590|NCT01275170|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21269591|NCT02864953|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21269592|NCT00981019|Max Planck Institute for Human Development, Harding Center for Risk Literacy|Dr. Odette Wegwarth|+49-30-82406|wegwarth@mpib-berlin.mpg.de|695
21269593|NCT00358670|Merck Sharpe & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21269594|NCT00865306|Massachusetts General Hospital|Dina R. Hirshfeld-Becker, PhD|617-503-1408|dhirshfeld@partners.org|
21269595|NCT05083559|Oregon Health and Science University|Jessica Castle|503-494-7072|castleje@ohsu.edu|
21269596|NCT02656875|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
21269597|NCT02704130|Atrium Health|Blair Stephenson, Research Business Manager|704-446-4845|blair.stephenson@atriumhealth.org|
21269598|NCT02184169|Boston Childrens Hospital|John Kheir|6173556000|john.kheir@childrens.harvard.edu|
21269599|NCT01216319|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@cookbiotech.com|
21269600|NCT02666768|The Lundquist Institute at Harbor-UCLA Medical Center|Dr. Lynda Polgreen|310-222-1961|lpolgreen@lundquist.org|
21269601|NCT03752866|Abbott|Vinny Podichetty, Sr. Director, Global Clinical Affairs|+1 408-845-1639|vinny.podichetty@abbott.com|
21269602|NCT03728257|University of Pittsburgh|Annette DeVito Dabbs|4126245314|ajdst42@pitt.edu|
21269603|NCT04686500|University of Texas Southwestern Medical Center|Dr. David Parsons|214/645-8525|david.parsons@utsouthwestern.edu|
21269604|NCT00905437|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269605|NCT01306968|Uniformed Services University of Health Sciences|Dr. R. Scott Miller, M.D.|301-816-8424|robert.s.miller@us.army.mil|
21269606|NCT05794126|CooperVision Inc.|José A. Vega OD, PhD, MSc, FAAO|+19256213761|jvega2@coopervision.com|
21269607|NCT03252015|Eli Lilly and Company|Cheif Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
21269608|NCT03128931|Masimo Corporation|Vikram Ramakanth|949-297-7416|clinicalresearchdept@masimo.com|
21269609|NCT04993339|University of Miami|Dr. Francesco Travascio|3052842371|f.travascio@miami.edu|
21269610|NCT00903409|GlaxoSmithKline|GSK Response Center|866-435-7343||
21269611|NCT00797316|Novartis Pharmaceuticals|Study Director|862-778-8300||
21269612|NCT02500147|Columbia University|Aviva B Sopher, MD, MS|212-305-9362|ahs32@cumc.columbia.edu|
21269613|NCT01721369|Hospital Vall hebron|Dr. Angel Moya||amoyamitjans@gmail.com|
21269614|NCT02682069|MolecuLight Inc.|Liis Teene|416.542.5530|lteene@moleculight.com|
21301180|NCT01696188|Sidney Kimmel Medical College at Thomas Jefferson University|Dr. Eric Schwenk|215-955-6161|Eric.Schwenk@jefferson.edu|
21301181|NCT02447003|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21301182|NCT03848728|University of California, San Francisco|Douglas Black|4158063016|douglas.black@ucsf.edu|
21301183|NCT05720312|Stanford University|Gregory Sahlem, MD|(650) 434-7844|gsahlem@stanford.edu|
21301184|NCT00536744|SANUWAVE, Inc.|Dr. Daniel Jorgensen, MD|678-578-0116|daniel.jorgensen@sanuwave.com|
21269615|NCT02786810|University of Tennessee Health Science Center|Dr. David Hains|9012874876|dhains@uthsc.edu|
21269616|NCT01819467|NHRMC|Dr. Henry Easley|910. 667-9238|sandy.easley@seahec.net|
21269617|NCT01426828|University of Pennsylvania|CCI @ University of Pennsylvania|(215)662-4000||
21269618|NCT00997672|University Federico II, Naples, Italy|Dr. Francesco Saccà|3470734774|francesco.sacca@unina.it|+39
21269619|NCT00734617|Duke Center for Nicotine & Smoking Cessation Research|Jed E. Rose, Ph.D.|919 668-5093|rose0003@mc.duke.edu|
21269620|NCT00869141|Stein Eye Institute|Dr. Simon K. Law|(310)794-1477|law@jsei.ucla.edu|
21269621|NCT03692078|Altria|Jeffery Edmiston, Functional Director Clinical Research|8043352366|Jeffery.S.Edmiston@altria.com|
21269622|NCT01563029|GlaxoSmithKline|GSK Response Center|866-435-7343||
21269623|NCT02861534|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21269624|NCT02780115|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
21269625|NCT00194116|Univeristy Hospitals Case Medical Center|Dr. Keming Gao|216-844-2865|Keming.Gao@uhhospitals.org|
21269626|NCT00916617|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269627|NCT01177735|University of Arkansas for Medical Sciences|Saad Usmani, MD|501-526-6876||
21269628|NCT00623441|Medtronic Bakken Research Center|Sofia Pateraki, MSc - Sr. Clinical Research Specialist|+31 43 3566785|sofia.pateraki@medtronic.com|
21269629|NCT00769132|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21269630|NCT00499252|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
21269631|NCT01785472|Novartis|Study Director|862-778-8300||
21269632|NCT01327989|Medtronic|Manish Gupta, Sr. Director of Medical Affairs|949-837-3700|manish.gupta@medtronic.com|
21269633|NCT01211873|Guerbet|Jing Hao, MD|+33145915000|jing.hao@guerbet.com|
21269634|NCT01257737|Horizon Therapeutics, LLC|Colleen Canavan, Director|1-224-383-3000|clinicaltrials@horizonpharma.com|
21269635|NCT02822612|Moorfields Eye Hospital NHS Foundation Trust|Pearse Keane|02072533411|pearse.keane@moorfields.nhs.uk|
21269636|NCT01141049|NYSPI|john mariani md|646-774-6140|john.mariani@nyspi.columbia.edu|
21269637|NCT03265483|Vanderbilt University Medical Center|Martha J. Shrubsole|(615)936-0812|martha.shrubsole@Vanderbilt.Edu|
21269638|NCT01771172|Medtronic, Inc.|Medtronic CRDM Clinical Trial Manager|763-505-6000|medtronicCRMtrials@medtronic.com|
21269639|NCT00938015|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269640|NCT01166126|H. Lee Moffitt Cancer Center and Research Institute|Ragini Kudchadkar, M.D.|813-745-8581|ragini.kudchadkar@moffitt.org|
21269641|NCT03509766|Johns Hopkins School of Medicine|Jody Tversky|410-550-5949|jodytversky@jhmi.edu|
21269642|NCT00664066|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21269643|NCT02575807|Aduro Biotech, Inc.|Medical Affairs|510.809.2452|MedicalAffairs@aduro.com|
21269644|NCT02180659|Titan Pharmaceuticals|Kate Beebe DeVarney|650-244-4990|kdevarney@titanpharm.com|
21269645|NCT03000075|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21269646|NCT00440193|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21269647|NCT00834366|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
21269648|NCT03014570|University of Maryland School of Nursing|Barbara Resnick PhD, CRNP Professor and PI among MPIs of the trial|410 706 5178|resnick@umaryland.edu|
21269649|NCT01154673|University of Toronto|Mario Ostrowski, Principal Investigator, Professor of Medicine|416-946-5805|mario.ostrowski@gmail.com|
21269650|NCT01955473|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21269651|NCT00518011|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21269652|NCT00090259|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21269653|NCT02139969|Boston Scientific Corporation|Laura Olson, Clinical Project Manager|9529306428|laura.olson2@bsci.com|
21269654|NCT04797637|Vanderbilt University Medical Center|Lisa C. Zukerwise, MD|9144203838|lisa.zuckerwise@vumc.org|
21269655|NCT03083639|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21269656|NCT01923961|eXcorLab GmbH|'Dr. Horst-Dieter Lemke|+49-6022-812647|horstdieter.lemke@excorlab.de|
21269657|NCT00960687|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21269658|NCT02357173|Medical University of South Carolina|Dr. Matthew Carpenter|843-876-2436|carpente@musc.edu|
21269659|NCT01023022|Institute of Cardiology|Prof. Hanna Szwed|48 22 343 46 00|hszwed@ikard.pl|
21269660|NCT03239340|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21269661|NCT01497860|Children's National Medical Center|Associate Professor|2024765046|ehwang@childrensnational.org|
21269662|NCT02262507|Cincinnati Childrens Hospital Sports Medicine|Dr. Gregory Myer|513-636-0249|greg.myer@cchmc.org|
21269663|NCT01852669|Monash University|Dr Shaun Lee|55145890|shaun.lee@monash.edu|
21269664|NCT05376293|The Miriam Hospital|Dr. Jessica Unick|401-793-7966|junick@brownhealth.org|
21286031|NCT01065571|University of Illinois at Chicago|Joanne Tobacman, MD|312-569-7826|jkt@uic.edu|
21286032|NCT02299388|Tulane University|Dr. Tina Thethi|504-988-5044|tthethi@tulane.edu|
21286033|NCT04391179|University of Michigan|Jason Knight, MD, PhD|734-763-3031|jsknight@med.umich.edu|
21286034|NCT03334188|"University of Colorado | School of Medicine | ACCORDS"|Dr. Larry Allen, Professor of Medicine|303-724-4713|larry.allen@cuanschutz.edu|
21269665|NCT01121224|VA North Texas Health Care System|Dr. Subhash Banerjee|(214) 857-1608|Subhash.Banerjee@va.gov|
21269666|NCT03712462|Drexel University|Dr. Adrienne Juarascio|215-553-7154|adrienne.s.juarascio@drexel.edu|
21286035|NCT00716807|UCSF|Jon Levine MD, PhD|415-476-5108|jon.levine@ucsf.edu|
21286036|NCT01093586|Case Comprehensive Cancer Center|Brenda Cooper MD|216-844-3213|brenda.cooper@uhhospitals.org|
21286037|NCT03442088|University Hospitals Cleveland Medical Center|Dr. Neil Korman, Director Clinical Trials Unit|216-844-8200|Neil.Korman@UHhospitals.org|
21286038|NCT01001520|University of Pennsylvania|Caryn Lerman, PhD|215-746-7141|clerman@mail.med.upenn.edu|
21257980|NCT03891264|Massachusetts General Hospital|Dr. Jodi Gilman|617-643-7293|jgilman1@partners.org|
21257981|NCT01979536|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21257982|NCT02408471|Smith+Nephew, Inc.|Belinda Larson, Director, Global Clinical Strategy (Trauma)||belinda.larson@smith-nephew.com|
21257983|NCT01076049|Irrimax Corporation|Chevy Brown, Clinical Trials Manager|770-807-3355|chevy.brown@irrisept.com|15
21301185|NCT02581410|GlaxoSmithKline|GSK Response Center|866-435-7343||
21257984|NCT05054114|SPP Pharmaclon Ltd.|Julia Isakova|81079055353311|isakova@pharmaclon.ru|
21257985|NCT01806779|Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@duke.edu|
21257986|NCT00805480|Novartis Pharmaceuticals|Study Director|862-778-8300||
21257987|NCT01779024|National Institute on Alcohol Abuse and Alcoholism|Leggio, Lorenzo|+1 301 435 9398|lorenzo.leggio@nih.gov|
21257988|NCT02595450|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21257989|NCT04294901|VA Boston Healthcare System|Amy Linsky, MD, MSc|857-364-2760|amy.linsky@va.gov|
21269667|NCT02332655|Kennedy Krieger Institute|Dr. Anne Comi|4439239172|comi@kennedykrieger.org|3-9172
21269668|NCT01843660|Janssen China, Beijing|Therapeutic Area Physician|+86-10-58218709||
21269669|NCT01977482|GlaxoSmithKline|GSK Response Center|866-435-7343||
21269670|NCT00209560|Eisai Inc|Eisai Medical Services|1-888-422-4743||
21269671|NCT05460832|Modern Biosciences|Chief Scientific Officer|+44 (0) 207 444 0066|IST-06@istesso.co.uk|
21269672|NCT01525407|Fred Hutchinson Cancer Research Center|Dr. Marco Mielcarek|2066672827|mmielcar@fredhutch.org|
21269673|NCT00359073|University of Wisconsin Madison|Gina Crisafi|608-262-5240|gmc@medicine.wisc.edu|
21269674|NCT00684645|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269675|NCT03256526|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269676|NCT01607398|GlaxoSmithKline|GSK Response Center|866-435-7343||
21269677|NCT03291847|Johns Hopkins University School of Medicine|Lauren Jansson|4105504114|ljansson@jhmi.edu|
21269678|NCT01393717|City of Hope National Medical Center|Dr. Robert Chen|626-256-4673|RChen@coh.org|82405
21269679|NCT03515837|Merck Sharp and Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21269680|NCT01964898|The Miriam Hospital|Andrew Busch PhD|4017938189|andrew_busch@brown.edu|
21269681|NCT02325401|University of Cincinnati|Trisha Wise-Draper M.D., Ph.D., Associate Professor of Medicine, Medical Director of the UC Cancer C|(513) 558-2826|wiseth@ucmail.uc.edu|
21269682|NCT00391092|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21269683|NCT03569020|Beth Israel Deaconess Medical Center|Dr. Stephen Juraschek|617-754-1416|sjurasch@bidmc.harvard.edu|
21269684|NCT02428231|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21269685|NCT03151967|University of Washington|Ann Stapleton, MD|2066609981|stapl@uw.edu|
21269686|NCT01838863|Denver Health Medical Center|Dr. Ernest E. Moore|303.602.1820|Ernest.Moore@dhha.org|
21269687|NCT00602979|Weill Cornell Medicine|Michele Steinkamp|212-746-2953|mls9004@med.cornell.edu|
21269688|NCT03976076|Bio-Pharm Solutions Co., Ltd.|Bio-Pharm Solutions Medical Information|NA|conference.clinical@b-psol.com|
21269689|NCT02406742|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21269690|NCT00254488|Weill Cornell Medical College|Robert C. Young, MD, Professor of Psychiatry|914-997-5886|ryoung@med.cornell.edu|
21269691|NCT01053078|University of Minnesota|Elizabeth Seaquist|612 624 9176|seaqu001@umn.edu|
21269692|NCT02367729|Medical College of Wisconsin|Dr. Katja Kovacic|4142663915|kkovacic@mcw.edu|
21269693|NCT00438932|University of Miami Miller School of Medicine|Tamara Isakova, MD, MMSc|305-243-4374|tisakova@med.miami.edu|
21269694|NCT06134128|VA Portland Healthcare System|Kate Shirley, PhD|503-220-8262|kate.shirley@va.gov|52470
21269695|NCT01092676|LHSC Lawson HRI|Rodrick Lim|5198525496|rod.lim@lhsc.on.ca|
21269696|NCT04776135|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp|
21269697|NCT00457418|Merck Sharp & Dohme Corp.|Senior Vice President,Global CLinical Development||ClinicalTrialsDisclosure@merck.com|
21269698|NCT02086968|Luitpold Pharmaceuticals, Inc.|Angelia Butcher|610-650-4200|abutcher@lpicrd.com|811
21269699|NCT03359473|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21269700|NCT02953418|Medtronic MITG-RGI|Director of Clinical Affairs|303-882-6759|Tumordirectedtherapiesclinical@Medtronic.com|
21269701|NCT04101721|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21269702|NCT01215955|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21269703|NCT00445458|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
21269704|NCT03186794|Clinical Center|Leighton Chan|+1 301 496 4733|chanle@cc.nih.gov|
21301186|NCT00658385|Memorial Sloan Kettering Cancer Center|Dr. Farid Boulad|212-639-6684|bouladf@mskcc.org|
21301187|NCT02908672|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21301188|NCT00670748|National Cancer Institute|Dr. Steven A. Rosenberg|301-496-4164|sar@mail.nih.gov|
21301189|NCT01424072|University of São Paulo|Leonice Fumiko Sato Kurebayashi|5511 991126023|fumie_ibez@yahoo.com.br|
21301190|NCT01185080|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21301191|NCT02876601|Medical University of Vienna|Univ.Prof. Dr. Bernd Jilma|+4314040029810|bernd.jilma@meduniwien.ac.at|
21301192|NCT03863080|Immunovant, Inc|Central Study Contact|1-800-797-0414|clinicaltrials@immunovant.com|
21301193|NCT01781728|Johns Hopkins University, Department of Radiation Oncology|Dr. Amol Narang|410-913-3559|anarang2@jhmi.edu|
21301194|NCT06083506|WestVirginiaU|Arif Salman Abdul Shakore|304-293-5831|arifsalman.abdulshakore@hsc.wvu.edu|
21301195|NCT04858035|Montclair State University|Elaine R. Hitchcock|9732293797|hitchcocke@montclair.edu|
21301196|NCT05174416|Peking Union Medical College Hospital|Prof. Shuyang Zhang|+86 13911667211|shuyangzhang103@163.com|
21257990|NCT05472012|Masimo|Chelsea Frank|949-297-7000|studies@masimo.com|
21257991|NCT05159648|Mayo Clinic|Dr Robert Anderson|507-284-4341|anderson.robert2@mayo.edu|
21257992|NCT03657368|Cleveland Clinic Foundation|YanYan Han|216-444-2250|HANY3@ccf.org|
21257993|NCT02239939|WFSM|Dr. Barbara Nicklas|3367138569|bnicklas@wakehealth.edu|
21257994|NCT05634577|M D Anderson Cancer Center|Mouhammed Habra, MD|713-792-2841|mahabra@mdanderson.org|
21257995|NCT01515787|Memorial Sloan Kettering Cancer Center|Dr.Deborah Schrag|617-416-5194|schragd@mskcc.org|
21257996|NCT02631200|Queen's University Belfast|Dr Peter O'Halloran|02890972490|p.ohalloran@qub.ac.uk|
21257997|NCT03124823|Masimo|Tala Harake||studies@masimo.com|
21286039|NCT00357877|Kaiser Permanente Data Coordinating Center|Dr. William Vollmer|503-335-6755|william.vollmer@kpchr.org|
21257998|NCT01496885|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21257999|NCT03273166|Masimo|Chelsea Frank|(949) 297-7000|studies@masimo.com|
21286040|NCT02541422|St. Luke's University Health Network|Holly Stankewicz, D.O.|610-360-2725|holly.stankewicz@gmail.com|
21286041|NCT01051557|Memorial Sloan Kettering Cancer Center|Dr. Thomas Kaley|212-639-5122|kaleyt@mskcc.org|
21286042|NCT04668209|University of Arizona|Jessica Winters|520-780-1882|jwinters1@arizona.edu|
21286043|NCT02958787|University of Michigan Comprehensive Cancer Center|Dr. Daniel Spratt, MD|734-232-5244|sprattda@umich.edu|
21286044|NCT03570047|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21286045|NCT00613366|Oregon Health & Science University|Dr. Alison Edelman|503.494.5949|edelmana@ohsu.edu|
21286046|NCT01936363|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21286047|NCT00268983|GlaxoSmithKline|GSK Response Center|866-435-7343||
21286048|NCT00848757|Yale University School of Medicine|Michelle Van Name|203-785-5831|michelle.vanname@yale.edu|
21286049|NCT02532374|Philip Morris Products S.A.|Loyse Felber Medlin|+41 (58) 242 2686|Loyse.FelberMedlin@pmi.com|
21269705|NCT03597620|University of Alabama at Birmingham|Dr. Boni Elewski|205-502-9960|dermresearch@uabmc.edu|
21286050|NCT01015326|Northwestern University|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu|
21286051|NCT01348139|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21269706|NCT00345969|Washington University School of Medicine|Ellen F. Binder, MD|314-286-2707|ebinder@wustl.edu|
21269707|NCT01329562|Clinvest/A Division of Banyan Group Inc.|Dr. Roger Cady|417-890-7888|jtarrasch@clinvest.com|
21269708|NCT03151226|Wake Forest School of Medicine|Dr. Peter H. Pan|336-718-8278|ppan@wakehealth.edu|
21269709|NCT00061568|National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH)|John Tisdale, M.D.|301.402.6497|johntis@nhlbi.nih.gov|
21269710|NCT01381068|UCSD|Neil Finer||nfiner@ucsd.edu|
21269711|NCT01516684|Wake Forest University Health Sciences|Thomas McLean|336-716-5440|tmclean@wakehealth.edu|
21269712|NCT00402779|UT MD Anderson Cancer Center|Dr. John V. Heymach, PHD/Chair, Thoracic-Head & Neck Med Onc|713-792-6363|jheymach@mdanderson.org|
21269713|NCT02424357|University of Miami|Hilda Capo|305-326-6555|hcapo@med.miami.edu|
21269714|NCT04933708|Hospital of the University of Pennsylvania|Fei Cai|215-313-0656|feicai90@gmail.com|
21269715|NCT01205568|Boston Childrens Hospital|Kathy Jenkins MD MPH|6173557275|kathy.jenkins@childrens.harvard.edu|
21269716|NCT00690573|Abbott|Global Medical Services|800-633-9110||
21269717|NCT00777920|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21269718|NCT02392377|University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr Jennifer Eads|(216) 844-6031|jennifer.eads@uhhospitals.org|
21269719|NCT00939367|Accutest Research Laboratories Pvt. Ltd.|Kedar Joshi|+91 22 27780718||
21269720|NCT01126359|Department of Orthopaedics|Dr. Erik Kubiak|801-587-5404|Erik.Kubiak@hsc.utah.edu|
21269721|NCT00902486|Incyte Corporation|Study Director|855 463-3463||
21269722|NCT00584831|Vistakon|Kurt Moody, OD, FAAO|904-443-3088|kmoody1@its.jnj.com|
21269723|NCT05378269|Dare Bioscience, Inc.|Jessica Hatheway, VP Clinical Operations|858-926-7655|jhatheway@darebioscience.com|
21269724|NCT01371006|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21269725|NCT00891527|Boston Childrens Hospital|Kathy Jenkins MD MPH|6173557275|kathy.jenkins@cardio.chboston.org|
21269726|NCT01186744|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269727|NCT02547779|VANDERBILT UNIVERSITY MEDICAL CENTER|Matthew W. Semler, MD, MSc|(615) 322-3412|matthew.w.semler@vumc.org|
21269728|NCT00858234|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21269729|NCT02957682|Regeneron Pharmaceuticals, Inc|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
21269730|NCT03612713|Yale University School of Medicine|Data Manager|203-737-5430|Theresa.Babuscio@yale.edu|
21269731|NCT00830388|University of Alabama at Birmingham|Wendy Cantrell|205-502-9960|wcantrell@uabmc.edu|
21269732|NCT00149669|Johns Hopkins University School of Medicine|Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
21269733|NCT02458365|Pro-Change Behavior Systems, Inc.|Deborah Levesque, Ph.D.|(401) 360-2975|dlevesque@prochange.com|
21269734|NCT02953262|Center for Healthcare Organization and Implementation Research (CHOIR) United States Department of Veterans Affairs VA Bedford Healthcare System|Stephanie Shimada, PhD|781-687-2208|Stephanie.Shimada@va.gov|
21269735|NCT00934622|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21269736|NCT00468312|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21269737|NCT03336645|Shire|Study Physician|1 866-842-5335|ClinicalTransparency@takeda.com|
21269738|NCT01316523|University of California, Davis|Leslie Garcia|916-734-0156|lesgarcia@ucdavis.edu|
21269739|NCT05041803|Sun Pharmaceutical Industries Limited|Head, Regulatory Affairs|9122 66455645|Clinical.Trial@sunpharma.com|
21286052|NCT02762084|PellePharm, Inc.|Chief Medical Officer|(510) 502-6144|Info@Pellepharm.com|
21286053|NCT03006562|Johns Hopkins Brady Urological Institute|Dr. Mohamad Allaf|410-955-6100|mallaf@jhmi.edu|
21238050|NCT00948298|Charles Drew University of Medicine and Science|Dr. David Martins|323-568-3353|davidmartins@cdrewu.edu|
21269740|NCT03387735|UW Madison|CHESS Statistician|6084772614|ocody@wisc.edu|
21269741|NCT02446496|GlaxoSmithKline|GSK Response Center|866-435-7343||
21269742|NCT06251154|CooperVision, Inc.|José A. Vega OD, MSc, PhD, FAAO|+19256213761|jvega2@coopervision.com|
21269743|NCT00956709|CHU de Nantes|Dr Pham Dang|33 2 53 48 24 15|charles.phamdang@chu-nantes.fr|
21269744|NCT00792142|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
21269745|NCT01346501|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21269746|NCT00756652|Mentor Worldwide, LLC|Sponsor|949-453-6408|mgpas@its.jnj.com|
21269747|NCT02564952|GW Research Ltd|Medical Enquiries|+44 01223 238170; +18778862810|medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
21269748|NCT03491228|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269749|NCT03706209|MetrioPharm Deutschland GmbH|Clinical Disclosure Officer|+49303384395|info@metriopharm.com|
21269750|NCT00686231|UCSF|Andrew Boyle|415-514-0827|aboyle@medicine.ucsf.edu|
21269751|NCT01527942|ST. FRANCIS HOSPITAL AND MEDICAL CENTER|Ioannis Raftopoulos, MD||IRaftopo@stfranciscare.org|
21269752|NCT03972709|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21269753|NCT01523301|UCB|Study Director|+1877 822 9493||
21269754|NCT00728988|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269755|NCT00116207|University of Michigan|Eva L. Feldman, Professor of Internal Medicine|7347637274|efeldman@med.umich.edu|
21269756|NCT01895088|AcuFocus, Inc.|Eugenia Thomas, Director Clinical Trials|9495859511|nthomas@acufocus.com|
21269757|NCT00246441|MUSC|Dr. Sarah Book|8437925200|booksw@musc.edu|
21269758|NCT05013749|Fundación Valle del Lili|Albaro José Nieto Calvache|(+57) 6023319090|albaro.nieto@fvl.org.co|3056 - 305
21269759|NCT01393626|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269760|NCT02426125|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21269761|NCT02858076|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|drcrnet@jaeb.org|
21269762|NCT02643394|UT Southwestern Medical Center|David McDonagh, MD|214-648-8083|david.mcdonagh@utsouthwestern.edu|
21269763|NCT00943384|DePuy Synthes Clinical Affairs|Allyson Morris, PhD, CCRP, Staff Clinical Research Scientist|610-719-5298|morris.allyson@synthes.com|
21269764|NCT00096200|University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Steven Waggoner, MD|216-844-5011|steven.waggoner@uhhospitals.org|
21269765|NCT04193033|Michael E DeBakey VAMC|Dr. Natalie Hundt|713-440-4450|Natalie.Hundt@va.gov|
21269766|NCT02341482|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
21269767|NCT00111007|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21269768|NCT01495793|UCB Pharma|UCB Clinical Trial Call Center|+1877-822||9493
21269769|NCT04828551|Massachusetts General Hospital|Anthony Samir|6178523241|asamir@mgh.harvard.edu|
21269770|NCT02362646|Icahn School of Medicine at Mount Sinai|Annetine Gelijns, PhD|212-659-9567|annetine.gelijns@mssm.edu|
21269771|NCT04141670|ARMGO Pharma, Inc|Eugene Marcantonio MD PhD|2014633634|gmarcantonio@armgo.com|
21269772|NCT03907540|Kadmon Corporation|Olivier Schueller, Senior Vice President, CMC & Clinical Pharmacology|724-778-6170|olivier.schueller@kadmon.com|
21269773|NCT03611751|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21269774|NCT00929864|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21269775|NCT03791619|Johnson & Johnson Surgical Vision|Luis Vargas, MD|714-247-8200|LVarga17@its.jnj.com|
21269776|NCT03940742|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21269777|NCT04176354|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269778|NCT03428217|Calithera Biosciences, Inc|Study Director|650-870-1000|clinicaltrials@calithera.com|
21269779|NCT03889197|Department of Biostatistics and Health Data Science, Indiana University School of Medicine|Kelly Mosesso, MA; Biostatistician II|317-278-5439|kmosesso@iu.edu|
21269780|NCT00621309|University of Washington|Dr. David L. Eaton|206-543-7468|deaton@uw.edu|
21269781|NCT05246111|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21269782|NCT01187511|National Institute on Alcohol Abuse and Alcoholism|Leggio, Lorenzo|+1 301 435 9398|lorenzo.leggio@nih.gov|
21269783|NCT05004181|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
21269784|NCT00379821|Malaria Section, Center for Vaccine Development, University of Maryland School of Medicine|Christopher Plowe, MD, MPH|410-706-2491|cplowe@medicine.umaryland.edu|
21269785|NCT03205163|Bioverativ, a Sanofi company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6
21269786|NCT01298661|Universidade Federal de São Carlos|Juliano Ferreira Arcuri|+55 (16) 33518343|julianoarcuri@gmail.com|
21269787|NCT00526227|Medtronic CRDM|CRDM Core Clinical Organization|800-328-2518|jamie.l.reynolds@medtronic.com|
21269788|NCT01652573|Yale School of Medicine|Dr. Karl Insogna|203-737-2871|karl.insogna@yale.edu|
21269789|NCT03284424|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21269790|NCT01052038|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu|
21269791|NCT03349437|Philips|Biostatistician|412-542-3651|jeff.jasko@philips.com|
21269792|NCT00765999|Allergan, Inc.|Vice President, Clinical Development, Gastrointestinal|1-862-261-7000|IR-CTRegistration@allergan.com|
21269793|NCT03638102|University of Illinois Chicago|Sirimon Reutrakul|3124135357|sreutrak@uic.edu|
21286054|NCT02644278|Merck KGaA Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21286055|NCT02862080|The University of Texas Health Science Center at Houston|Marcie Kern, PT, MSPT|713-799-6995|neurorecoveryresearch@memorialhermann.org|
21286056|NCT02427841|OHSUKCI|Dr. Gina Vaccaro|503-216-6300|vaccarog@ohsu.edu|
21286057|NCT01765296|CrystalGenomics, Inc.|Chief Medical Officer|+82-31-628-2871|sang-yoon.lee@cgxinc.com|
21286058|NCT03257436|BostonScientific|Sharda Mehta|6785967330|sharda.mehta@bsci.com|
21301197|NCT02582775|University of Minnesota, Masonic Cancer Center|Dr. Christen Ebens|(612) 626-5654|ebens012@umn.edu|
21301198|NCT01648751|University of PIttsburgh|Pamela Moalli MD PHD|412-641-6052|moalpa@upmc.edu|
21301199|NCT04194437|TransMedics, Inc.|VP Cliinical Affairs|978-552-0900|ldamme@transmedics.com|
21301200|NCT02000115|Abbott Structural Heart|Daniella Corporan|779-220-7309|daniella.corporan@abbott.com|
21301201|NCT04815824|VA Eastern Colorado Health Care System|Dr. Sarah Wherry|303-704-8054|sarah.wherry@va.gov|
21301202|NCT01967238|Stanford University|Taia Wang|5103873941|taiawang@stanford.edu|
21301203|NCT02484391|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-716-7970|bpowell@wakehealth.edu|
21301204|NCT03123731|University of California, San Diego|Dr. Brook Henry|619-543-4737|blhenry@ucsd.edu|
21301205|NCT03397966|Vanderbilt University Medical Center|Alp Ikizler, Catherine McLaughlin Hakim Chair in Vascular Biology, Professor of Medicine|615-343-7592|alp.ikizler@vumc.org|
21301206|NCT04949490|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
21301207|NCT04721977|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21301208|NCT02864394|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21301209|NCT01136980|EndoGastric Solutions|Adrain Lobontiu|+16504749259|alobontiu@endogastricsolutions.com|
21301210|NCT02605122|Cempra Pharmeuticals, a wholly owned subsidary of Melinta Therapeutics, Inc.|Melissa Allaband|9199140822|mallaband@melinta.com|
21301211|NCT00842751|University of Washington, Dept. of Medicine|John Amory, MD|(206) 616-1727|jamory@u.washington.edu|
21301212|NCT00590772|Penn State University|Timothy Craig|717-531-6525|tcraig@psu.edu|
21301213|NCT01350401|Adaptimmune|Clinical Trials Management||clinicaltrials@adaptimmune.com|
21301214|NCT02273596|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
21301215|NCT02741518|Brigham and Women's Hospital|Dr. Jessica Allegretti|617-732-5500|jallegretti@bwh.harvard.edu|
21301216|NCT02223702|Kocaeli University|Chair and Associate Professor of Periodontology|+902623442222|esragd@yahoo.com|5102
21301217|NCT00476008|Charles E. Schmidt College of Medicine, Florida Atlantic University|Peter Holland, MD|561-297-0164|holland@fau.edu|
21301218|NCT01227018|Vanderbilt-Ingram Cancer Center|Dr. Dana Cardin|615-936-8580|dana.cardin@vanderbilt.edu|
21301219|NCT06131476|Johnson & Johnson Vision Care|Principal Research Optometrist, Clinical Sciences|1 800-843-2020|njoshi30@its.jnj.com|
21301220|NCT02873702|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21301221|NCT00221117|Toronto RI Institute|Dr. Milos Popovic|416-597-3422|milos.popovic@utoronto.ca|6305
21301222|NCT03108469|Clinvest Research|Jim Sly|4178413673|jsly@clinvest.com|
21301223|NCT01229267|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21301224|NCT01189409|BC Cancer|Dr. Philippa Hawley|607-877-6000|PHawley@bccancer.bc.ca|67-2707
21301225|NCT03085797|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21301226|NCT04050202|University of California, San Francisco|Danielle Roubinov, PhD|919-843-5898|danielle.roubinov@ucsf.edu|
21301227|NCT00001213|National Institutes of Health|Rachel J. Bishop, MD, Principal Investigator, National Eye Institute|301-402-3771|bishopra@nei.nih.gov|
21301228|NCT02636595|AbbVie|Global Medical Services|800-633-9110||
21301229|NCT01576809|Novartis Consumer Health|Clinical project Leader|41223633111||
21301230|NCT01695304|Centers for Disease Control and Prevention|Ciara O'Reilly, PhD|404-639-1953|bwf1@cdc.gov|
21301231|NCT05782179|MinervaX|Cornelia Oostvogels/Chief Medical Officer (CMO)|00491515092821|lio@minervax.com|
21301232|NCT06170242|Enanta Pharmaceuticals, Inc.|Medical Monitor|+1 6176070800|enquiries@enanta.com|
21301233|NCT02004093|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21301234|NCT04085289|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21301235|NCT01924949|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21301236|NCT02754440|Terumo BCT, Inc.|Heather Pidcoke, MD, PhD|(303) 231-4805|Heather.Pidcoke@terumobct.com|
21301237|NCT02560558|Emory University|Dr. Idelberto Badell|404-712-6562|ibadell@emory.edu|
21301238|NCT01059435|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21301239|NCT02245217|Huntsman Cancer Institute|Josiah Hawks|8015850601|Josiah.Hawks@hci.utah.edu|
21301240|NCT00533117|NYSPI|Barbara Stanley|6467747582|bhs2@columbia.edu|
21301241|NCT01263197|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21301242|NCT03588884|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
21301243|NCT01967576|National Cancer Institute|Dr. Andrea Apolo|301-480-0536|apoloab@nih.gov|
21301244|NCT03449667|University of California San Diego|Brian M. Ilfeld, MD, MS|(858) 822-0776|bilfeld@health.ucsd.edu|
21301245|NCT02892448|The Ottawa Hospital Research Institute|Dr. Paul E Beaule|613-737-8899|pbeaule@toh.ca|73265
21301246|NCT00131248|UT Houston Medical School|Kathleen A. Kennedy, MD, MPH|713 500-6708|kathleen.a.kennedy@uth.tmc.edu|
21301247|NCT02284243|Recro Pharma|Randall Mack|484-395-2470|rmack@recropharma.com|2406
21301248|NCT01227993|National Eye Institute|Catherine Meyerle, MD|301-435-7821|meyerlec@nei.nih.gov|
21269794|NCT00759174|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269795|NCT01890109|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21269796|NCT01643928|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269797|NCT00720473|McLean Hospital|Dr. Brent Forester|(617) 855-3622|bforester@partners.org|
21269798|NCT05723835|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21269799|NCT05226286|Medtronic|Mylene Champs|7635261627|mylene.champs@medtronic.com|
21269801|NCT00602641|ECOG Statistical Office|Study Statistician|617-632-3012||
21269802|NCT05150340|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21269803|NCT01826201|Moleculin, LLC|Chief Medical Officer|713-953-7676|Carena@moleculin.com|232
21269804|NCT01615822|Medicines for Malaria Venture|Fiona Macintyre, PhD|+41 22 555 0319|macintyref@mmv.org|
21269805|NCT02148835|Preventive Cardiology, University of Munich|Prof. Dr. C. von Schacky|+49 89 44005 2165|clemens.vonschacky@med.uni-muenchen.de|
21269806|NCT01988337|DMG Dental Material Gesellschaft mbH|Manager Clinical Research|04084006|clinicalresearch@mtcompanies.com|232
21269807|NCT02742818|Hospital Israelita Albert Einstein|Dr. Nelson Wolosker|+55 11 2151-5423|nwolosker@yahoo.com.br|
21269808|NCT04701658|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21269809|NCT01294709|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21269810|NCT03099161|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21269811|NCT00110084|Mayo Clinic|Dr. Vivek Roy|507-284-1159|roy.vivek@mayo.edu|
21269812|NCT04854707|IVFarma LLC|General Manager|+74996455342|info@ivfarma.ru|
21269813|NCT01793285|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269814|NCT05302414|National Yang Ming Chiao Tung University, Department of Nursing|Hui-Wen Chen Phd candidate|+886939947807|m513102001@gmail.com|
21269815|NCT00742859|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
21269816|NCT00486642|Bristish Columbia Cancer Agency|Dr. Kim N. Chi|604-877-6000|kchi@bccancer.bc.ca|2746
21269817|NCT02017535|University of Minnesota|Meredith Gunlicks-Stoessel|612-273-9844|mgunlick@umn.edu|
21269818|NCT05511428|Thomas Jefferson University|Adam Binder, MD|215-955-8874|Adam.binder@jefferson.edu|
21269819|NCT04088734|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
21269820|NCT03829462|Institut régional du Cancer de Montpellier|Dr Emmanuelle Samalin|467613136|emmanuelle.samalin@icm.unicancer.fr|+33
21269821|NCT03354169|University of Pennsylvania|Kelly C. Allison, PhD|215-898-2823|kca@pennmedicine.upenn.edu|
21269822|NCT03332212|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21269823|NCT00609115|AMES Technology, Inc.|Dr. Paul Cordo|503 970 6129|pcordo@amesdevices.com|
21269824|NCT05824273|Hackensack Meridian Health - Center for Discovery and Innovation|Ana Vielma|2018803100|ana.vielma@hmh-cdi.org|
21269825|NCT02736695|Mayo Clinic|Keith Josephs, M.D.|507-266-4106|josephs.keith@mayo.edu|
21269826|NCT00417859|University Hospital of Lausanne|Prof Brigitte Jolles|0213149629|brigitte.jolles@chuv.ch|
21269827|NCT03193190|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21269828|NCT03868059|Lipocine|Shadi Mehraban|801-994-7383|sm@lipocine.com|2191
21269829|NCT06232408|Repare Therapeutics Inc|Repare Therapeutics Medical Monitor|1 (857) 340-5402|clininfo@reparerx.com|
21269830|NCT04278872|Sojournix, Inc.|Head of Regulatory Affairs|6174758469|clinicaltrials@sojournixpharma.com|
21269831|NCT05734014|Montana State University|Vanessa Simonds|4069947396|vanessa.simonds@montana.edu|
21269832|NCT02689973|SWPS University of Social Sciences and Humanities|Dr Aleksandra Luszczynska, Principal Investigator|+4877507260|aluszczynska@swps.edu.pl|
21269833|NCT05838755|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
21269834|NCT01283282|Emory University|Dr. Arshed Quyyumi|404-727-3655|aquyyum@emory.edu|
21269835|NCT00096031|SWOG Statistical Center|Study Statistician|206-667-4623||
21269836|NCT00483717|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D|601-650-4200|dbregman@lpicrd.com|828
21269837|NCT00083226|ECOG Statistical Office|Study Statistician|617-632-3012||
21269838|NCT00909857|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21269839|NCT03878108|NIDDK|Kevin Hall, PhD|301-402-8248|kevin.hall@nih.gov|
21269840|NCT04800510|The University of Iowa|Jason M. Wilken, PT, PhD|319-335-6857|jason-wilken@uiowa.edu|
21269841|NCT00604175|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301)-628-3313|ACTGCT.Gov@s-3.com|
21286059|NCT01619852|Northwestern University|Gildasio De Oliveira, M.D.|312-695-4858|gjr@northwestern.edu|
21286060|NCT00970489|Harvard School of Public Health|Namasha Schelling|617-432-1734|nschelling@hsph.harvard.edu|
21286061|NCT02659943|National Cancer Institute|Dr. James N. Kochenderfer|240-760-6062|kochendj@nih.gov|
21286062|NCT01096160|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21286063|NCT00627497|Medtrionic spinal and biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
21286064|NCT05137002|CinCor Pharma|Yuan-Di Halvorsen|617-675-8126|yhalvorsen@cincor.com|
21286065|NCT01351090|Luitpold Pharmaceuticals, Inc.|David Bregamn, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|828
21286066|NCT00028262|National Institute of Child Health and Human Development|Dr. Anil Mukherjee|+1 301 496 7213|mukherja@exchange.nih.gov|
21286067|NCT00130689|Dana-Farber Cancer Institute|Jennifer Ang Chan, MD, MPH|617-632-6315|jennifer_chan@dfci.harvard.edu|
21286068|NCT04878055|Dompé Farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
21286069|NCT01968811|Sahlgrenska university Hospital|Dr Marcus Langenskiöld|+46 709 433160|marcus.langenskiold@vgregion.se|
21269842|NCT01682681|Janssen Korea, Location: 25F, LS , Yongsan Tower, 191, Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702, Korea|Clinical Research Associate, Medical affairs|82-2-2094-4837||
21269843|NCT03515681|Columbia University|Steven J. Shea, MD|212-305-6355|ss35@cumc.columbia.edu|
21269844|NCT02044094|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
21269845|NCT03353415|Joslin Diabetes Center|Mary Elizabeth Patti, MD|6713092635|MaryElizabeth.Patti@Joslin.Harvard.edu|
21269846|NCT00975000|Amgen Inc.|Study Director|866-572-6436||
21269847|NCT00005879|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-588-4523|bkimler@kumc.edu|
21269848|NCT01238172|Moores Cancer Center|J. Kellogg Parsons, M.D., MHS|858-822-7874|jkparsons@ucsd.edu|
21269849|NCT05257109|Yale University|Dr. Danielle Davis|2039747607|danielle.davis@yale.edu|
21269850|NCT02706041|The University of Texas Health Science Center at Houston|John A. Harvin, MD, FACS, Associate Professor|(713) 500-7244|John.Harvin@uth.tmc.edu|
21269851|NCT01208922|Dr. Falk Pharma GmbH|Department of Clinical Research|0049 7611514|zentrale@drfalkpharma.de|0
21269852|NCT01818414|University of Minnesota|Christy Boraas, MD, MPH|612-273-7111|bora0021@umn.edu|
21269853|NCT00981409|GlaxoSmithKline|GSK Response Center|866-435-7343||
21269854|NCT00774202|Weill Cornell Medical College|James B. Bussel, M.D. Professor of Pediatrics|212-746-3474|jbussel@med.cornell.edu|
21269855|NCT03869684|Senju Pharmaceutical Co. Ltd.|Director, Clinical Development|+81 078 777 1018|senju-clinicaltrials@senju.co.jp|
21269856|NCT04056299|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
21269857|NCT03895307|SultanAbdulhamid|Adem Erbirol|+905426608788|aerbirol@hotmail.com|
21269858|NCT01227954|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21269859|NCT02846740|University of Maryland Baltimore|Nithin krishna|4103286661|nkrishna@som.umaryland.edu|
21269860|NCT00078312|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
21269861|NCT01296152|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21269862|NCT03901352|Daiichi Sankyo|Contact of Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21269863|NCT03901339|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21269864|NCT03981614|University of Texas; MD Anderson Cancer Center|Scott Kopetz, M.D.|(507) 266-0800|SKopetz@mdanderson.org|
21269865|NCT00857493|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
21269866|NCT01572428|Indiana University|Rachel Lahr|317-948-0724|rlahr@iu.edu|
21269867|NCT01071083|Biogen Idec Inc|Biogen Idec Medical Director|1-617-679-2000|neurologyclinicaltrials@biogenidec.com|
21269868|NCT00038467|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269869|NCT04732728|Boston Scientific|Thomas Stoltz, Clinical Trial Manager|1-800-CARDIAC|thomas.stoltz@bsci.com|
21269870|NCT01339000|National Cancer Institute|Dr. Ronald Gress|301-496-1791|gressr@mail.nih.gov|
21269871|NCT05349188|Northwell Health|Dr. Mark Butler, PhD|908-414-0238|markbutler@northwell.edu|
21269872|NCT02843308|Stanford University School of Medicine|Carolyn Rodriguez, MD, PhD|650-723-4095|ocdresearch@stanford.edu|
21269873|NCT04971226|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
21269874|NCT00481871|Allos Therapeutics, Inc.|Michael Saunders, MD|303-426-6262|msaunders@allos.com|
21269875|NCT04439149|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21269876|NCT03974516|i Cure Biotech Co., Ltd.|David Liu|+886-955-104-105|white06041983a@gmail.com|
21269877|NCT05264506|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
21286070|NCT03868839|University of Massachusetts Medical School|Xiaoduo Fan|5088563881|xiaoduo.fan@umassmed.edu|
21286071|NCT01178125|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21286072|NCT00369915|NIMH/NIH|Maura Furey, PhD|301-594-7773|mfurey@mail.nih.gov|
21286073|NCT01050946|Medical College of Wisconsin|Jeanne Palmer,MD|414-805-6800|jpalmer@mcw.edu|
21269878|NCT05990075|James A. Haley Veterans' Hospital|Vanessa Panaite, PhD|813-768-2193|vanessa.panaite2@va.gov|
21269879|NCT02494544|restor3d|Tara Mann - Director of Clinical Affairs|(984) 888-0593|clinicalresearch@restor3d.com|
21269880|NCT02032823|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21286074|NCT01749410|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21301249|NCT04269889|National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH)|David J. Young, MD, PhD|301.827.7823|david.young2@nih.gov|
21301250|NCT04987333|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21258000|NCT01294670|Memorial Sloan Kettering Cancer Center|Tanya Trippett, MD|1-833-MSK-KIDS|trippet@mskcc.org|
21258001|NCT04091087|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21258002|NCT04152161|Gates MRI|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
21258003|NCT03363321|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21258004|NCT01897285|Arrowe Park Hospital|Mrs Gwenneth Lawrence|0151 678 5111|gwen.lawrence@nhs.net|8362
21258005|NCT02915523|Syndax Pharmaceuticals, Inc.|Kate Madigan, MD, Chief Medical Officer|858-888-3798|kmadigan@syndax.com|
21258006|NCT00919503|Fred Hutchinson Cancer Research Center|Dr. Lauri Burroughs|206-667-2396|lburroug@fredhutch.org|
21258007|NCT02590588|Boston Medical Center|Mark Sloan MD|617-638-2367|mark.sloan@bmc.org|
21258008|NCT01751308|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21258009|NCT02918773|Emory University|Andi L Shane MD/MPH/MSc|404-727-9880|ashane@emory.edu|
21269881|NCT04521608|Mayo Clinic|Roberto Benzo, M.D.|480-301-8244|benzo.roberto@mayo.edu|
21301251|NCT01654302|Northwestern University|Julia Marks, CRC|312-503-1215|julia.marks@northwestern.edu|
21301252|NCT01569607|Emory University|Dr. Cathrin Buetefisch|404-712-5507|cathrin.buetefisch@emory.edu|
21301253|NCT04539795|University of Alabama at Birmingham (UAB)|Dr. Wells (Study PI)|205-934-5555|LungHealth@uabmc.edu|
21301254|NCT01167504|Institute of Food Research|Professor Peter Wilde|+441603255258|peter.wilde@ifr.ac.uk|
21301255|NCT02699749|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21301256|NCT04139018|Washington University School of Medicine Department of Otolaryngology - Head and Neck Surgery|Jay Piccirillo, M.D., Vice Chair for Research|314-362-8641|piccirij@wustl.edu|
21301257|NCT02565108|GW Research Ltd.|Medical Enquiries||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
21301258|NCT01310075|UT MD Anderson Cancer Center|Dr. Mark W Clemens, Associate Professor, Plastic Surgery|713-794-1247|mwclemens@mdanderson.org|
21301259|NCT04500158|Virginia Commonwealth University|Dr. Caroline Carrico|(804) 828-8328|ckcarrico@vcu.edu|
21301260|NCT04364867|Orthopedic Institute, Norton Healthcare|Ryan Krupp MD|502-394-6341|Ryan.Krupp@nortonhealthcare.org|
21301261|NCT02110069|Boston Children's Hospital|Dr. Denise M. Adans|617-919-6407|adamsdm@chop.edu|
21301262|NCT04774094|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21301263|NCT02374450|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21301264|NCT06714682|Ain Shams university|Dr. Mohamed Ibrahim , Lecturer of anesthesia|01115560811|T.majestic@hotmail.com|002
21301265|NCT05232682|Brown University|Mollie Monnig, PhD|4018633491|mollie_monnig@brown.edu|
21301266|NCT02819011|Baylor College of Medicine|Prof.Bijan Najafi|17137987536|bijan.najafi@bcm.edu|
21301267|NCT01442103|Molnlycke Health Care|Joan wilson|+1 706-650-1012|joan.wilson@molnlycke.com|
21301268|NCT05358353|Reflow Medical|Carolyn Mascho|949-481-0399|cmascho@reflowmedical.com|
21301269|NCT02064582|UT Southwestern Medical Center|Kevin Courtney, MD|214-648-4180|Kevin.Courtney@utsouthwestern.edu|
21301270|NCT02102204|Amgen Inc.|Study Director|866-572-6436||
21301271|NCT03751657|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1)866-867-7178|clinicaltrials@novonordisk.com|
21301272|NCT04603027|Evelo Biosciences, Inc.|Duncan McHale, MBBS, MRCP, PhD|+447500128938|duncan@evelobio.com|
21301273|NCT02248246|Ethicon|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
21301274|NCT01213199|GALDERMA|Fabien AUDIBERT, CPM|+ 33 4 92 95 29 21|fabien.audibert@galderma.com|
21301275|NCT00807001|Idenix Pharmaceuticals, Inc.|John Z. Sullivan-Bolyai, MD, MPH|877-433-6491||
21301276|NCT02269267|Medical College of Wisconsin|Ehab Atallah, MD|414-805-4600|eatallah@mcw.edu|
21301277|NCT03773796|Medical University of Innsbruck|Prof. Klaus Seppi|004351250481553|klaus.seppi@tirol-kliniken.at|
21301278|NCT03805659|Medical College of Wisconsin|Peter Kraegel|414-955-0657|pkraegel@mcw.edu|
21301279|NCT03284307|University of Sydney|Robert Sanders, MBBS, PhD, FRCA|02 9036 3136|robert.sanders@sydney.edu.au|
21301280|NCT01404936|UT MD Anderson Cancer Center|Anas Younes, MD / Professor||CR_Study_Registration@mdanderson.org|
21258010|NCT01780831|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
21269882|NCT04083378|The University of Texas MD Anderson Cancer Center|Dr. Bruno Odisio|(713) 563-1066|bcodisio@mdanderson.org|
21269883|NCT00644228|SWOG Statistical Center|Study Statistician|206-667-4623||
21269884|NCT06078124|Washington University in St. Louis|Dr. Lindsay Stark|314-935-4747|lindsay.stark@wustl.edu|
21269885|NCT00285012|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21269886|NCT04050293|Supernus Pharmaceuticals|Gianpiera Ceresoli-Borroni Director Clinical Research|3018382521|gceresoliborroni@supernus.com|
21269887|NCT02925650|Alzheimer's Disease Cooperative Study|Howard Feldman MDCM, FRCP(C)|858-246-1347|hhfeldman@health.ucsd.edu|
21269888|NCT04223193|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21269889|NCT00597883|Columbia University|Eric J Heyer|212-305-9072|ejh3@cumc.columbia.edu|
21269890|NCT04616768|University of Pennsylvania|Ravi Parikh|3524224285|ravi.parikh@pennmedicine.upenn.edu|
21269891|NCT03532295|Washington University School of Medicine|Dr. Milan Chheda|314-747-7222|mchheda@wustl.edu|
21269892|NCT01907516|John A Burns School of Medicine / University of Hawaii Dept of Obstetrics and Gynecology|Marguerite Lisa Bartholomew MD|808-983-6761|mbarthol@hawaii.edu|
21269893|NCT06474715|Columbia University Irving Medical Center|Lauren Houghton, PhD Msc|212-342-0246|lh2746@cumc.columbia.edu|
21269894|NCT04644237|Daiichi Sanyko, Inc|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21269895|NCT03131817|University of California, San Francisco|Dr. Simon Little|4152995650|simon.little@ucsf.edu|
21269896|NCT01526629|Medtronic|Latifa Foudali|0155381700|latifa.foudali@medtronic.com|
21269897|NCT02061293|NYU Langone Health|Samantha Podrebarac, MSc|212-263-0912|Samantha.Podrebarac@nyulangone.org|
21269898|NCT02181127|Massachusetts General Hospital|Dr Steven J Russell|617-726-1848|sjrussell@partners.org|
21269899|NCT04066894|M D Anderson Cancer Center|Dr. Craig Messick|(713) 745-1544|cmessick@mdanderson.org|
21269900|NCT02949219|Mayo Clinic|Robert R. McWilliams, M.D.|507-266-9161|mcwilliams.robert@mayo.edu|
21269901|NCT05573113|Children's Mercy Kansas City|Sherwin Chan|816-234-3273|sschan@cmh.edu|
21269902|NCT04024254|Rush University Medical Center|Dr Lydia Usha|312-942-5904|Lydia_Usha@rush.edu|
21269903|NCT05022121|University of Minnesota|Brent Leininger|6126266477|lein0122@umn.edu|
21269904|NCT04439110|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21269905|NCT00131937|ECOG Statistical Office|Study Statistician|617-632-3012||
21269906|NCT05073692|Kaiser Permanente Division of Research|Romain Neugebauer|510-891-3234|Romain.S.Neugebauer@kp.org|
21269907|NCT06873867|Adichunchanagiri Institute of Medical Sciences|Dr Naveen N|+91-9980023372|naveen_uno1@yahoo.co.in|
21269908|NCT04647253|Boston Scientific|Patricia O'Mara|518-744-0046|patricia.omara@bsci.com|
21269909|NCT01209234|University of California, Irvine|Susan Huang, Principal Investigator & Medical Director of Epidemiology and Infection Prevention|949-824-5073|sshuang@uci.edu|
21269910|NCT07046403|Adichunchanagiri Institute of Medical Sciences|Dr Naveen N|+91-9980023372|naveen_uno1@yahoo.co.in|
21269911|NCT01211613|University of Pittsburgh, Department of Physical Therapy'|Michael J Schneider, DC, PhD|412-383-6640|mjs5@pitt.edu|
21269912|NCT01020773|Beijing Shijitan Hospital|Department of Respiratory Medicine|86-010-63926385|mayingmin@hotmail.com|
21269913|NCT03853213|Columbia University Irving Medical Center|Dr. Jeffrey Birk|212-342-5503|jlb2287@cumc.columbia.edu|
21269914|NCT03302299|University of California San Francisco|Dr. Judy Hahn|415-476-5815|judy.hahn@ucsf.edu|
21269915|NCT01458132|GlaxoSmithKline|GSK Response Center|866-435-7343||
21269916|NCT00350337|United States Army Medical Materiel Development Activity|Division of Regulated Activities and Compliance Director|301-619-0317|USAMRMCREGULATORYAFFAIRS@amedd.army.mil|
21269917|NCT02038959|University of Rochester|Ray Dorsey, MD|585-276-6824|ray.dorsey@chet.rochester.edu|
21269918|NCT03233737|University of Pennsylvania, School of Dental Medicine|Elliot V Hersh, DMD, Ph.D., Director Clinical Pharmacology Research|215-898-9686|evhersh@pobox.upenn.edu|
21269919|NCT00819091|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21269920|NCT01320826|University of Alberta|Dr. Michael Kolber|(780) 616-8411|mkolber@ualberta.ca|
21269921|NCT01788163|AstraZeneca|Haiyi Jiang/Asia Medical Director|+86 21 60302408|Haiyi.Jiang@astrazeneca.com|
21269922|NCT00545441|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@cookbiotech.com|
21269923|NCT03911960|Hennepin Healthcare|Sandra Japuntich|6128736856|sandra.japuntich@hcmed.org|
21269924|NCT03610646|Viatris|Dr. Prasanna Ganapathi, Head of Global Clinical Strategy and Innovation|+91 80 6672800|prasanna.ganapathi@viatris.com|
21269925|NCT00424515|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu|
21269926|NCT04071366|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21286075|NCT01719380|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21238051|NCT02403180|Alcon Research, Ltd.|Global Medical Affairs Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21238052|NCT00834106|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21301281|NCT02604160|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21301282|NCT02139592|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21238053|NCT04504331|Stanford Medicine at Stanford University|Jennifer Lee Caswell-Jin, MD|1-310-332-6541|caswell@stanford.edu|
21269927|NCT02239692|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21269928|NCT04318535|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21269929|NCT01678924|Allergan plc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21269930|NCT01629134|Allergan, Inc.|Medical Monitor|714-246-4500|clinicaltrials@allergan.com|
21269931|NCT03232749|University of Florida|MaryBeth Horodyski, Ed.D., ATC, LAT, FNATA|352-273-7074|horodmb@ortho.ufl.edu|
21269932|NCT02277639|Children's Hospital of Philadelphia|Nancy Bunin, MD|215-590-2255|buninn@email.chop.edu|
21269933|NCT02156466|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21269934|NCT01784419|University of California, San Francisco|Dennis W. Nielson, MD, PhD||Dennis.Nielson@ucsf.edu|
21269935|NCT00080288|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
21269936|NCT02253654|Amgen Inc.|Study Director|866-572-6436||
21269937|NCT00069160|National Cancer Institute, National Institutes of Health|Susan E. Bates, M.D.|301-402-1357|BatesS@mail.nih.gov|
21269938|NCT03044431|Lung Institute|Melissa Rubio, PhD, APRN|214-504-2117|pidallas@lunginstitute.com|
21269939|NCT03456726|Eisai Co., Ltd|Eisai Inquiry Service|None|eisai-chiken_hotline@hhc.eisai.co.jp|
21269940|NCT01614925|Straumann|Michel Mallaun||michel.mallaun@straumann.com|
21269941|NCT04470622|Heron Therapeutics, Inc.|Sophie Visonneau|858-251-7232|svisonneau@herontx.com|
21269942|NCT02576054|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21269943|NCT00791154|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
21269944|NCT00450177|Weill Cornell Medical College|Philip S. Barie, MD|646-962-2580|pbarie@med.cornell.edu|
21269945|NCT02923115|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21269946|NCT03361917|Indiana University|Rachel Lahr|3179480724|rlahr@iu.edu|
21269947|NCT00835068|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269948|NCT05256992|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
21269949|NCT04803214|Mainstay Medical|Jennifer Tinsley, Director of Clinical Affairs|(877) 702-8488|info@mainstaymedical.com|
21269950|NCT02843529|Altoida Inc.|Ioannis Tarnanas|+18325975076|Ioannis@altoida.com|
21269951|NCT05298345|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
21269952|NCT05711524|Weill Cornell Medicine|Dr. Melissa Cushing|212-746-3527|mec2013@med.cornell.edu|
21269953|NCT05631093|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@MSD.com|
21269954|NCT03732677|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21269955|NCT04824560|University of New Mexico College of Pharmacy|Alexandra Herman|505-272-7630|asible@salud.unm.edu|
21269956|NCT03494816|University of Cambridge|Prof Grant Stewart|01223 256211|gds35@cam.ac.uk|
21269957|NCT04502862|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
21269958|NCT03229941|New York Veterans Affairs Healthcare System, Brooklyn|Panagiotis Kougias|718-836-6600|panagiotis.kougias@va.gov|
21269959|NCT00265239|Kumamoto University|Dr. Kenichi Tsujita|+81-96-373-5175|tsujita@kumamoto-u.ac.jp|
21269960|NCT02803138|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21269961|NCT01733186|MEDIPOST Co., Ltd.|Director of Product Development Department|+82-2-3465-6740|meehyunj@medi-post.co.kr|
21269962|NCT02237118|Clinique Mutualiste du Medoc|Dr Anne Solanilla|+33 5 56 73 11 43|annasolanilla@yahoo.fr|
21269963|NCT00569231|University of Arkansas for Medical Sciences|Mayumi Nakagawa, MD, PhD|(501) 686-8635|mnakagawa@uams.edu|
21269964|NCT04313023|Pulmotect, Inc.|Dr. Brenton Scott, President & COO|713-579-9226|bscott@pulmotect.com|
21269965|NCT00399490|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269966|NCT00044005|Sunovion|Josephine Cucchiaro, PhD|201-592-2050|josepine.cucchiaro@sunovion.com|
21286076|NCT00249873|sanofi-aventis|International Clinical Development, Clinical Study Director||GV-Contact-us@sanofi-aventis.com|
21286077|NCT00412841|NYULMC|Dr. H. Michael Belmont|212-598-6518|michael.belmont@nyumc.org|
21286078|NCT02254772|Stanford Univeristy Medical Center|Ronald Levy, MD, Professor of Medicine|650-725-6452|levy@stanford.edu|
21286079|NCT02697071|Lewis Gale Medical Center|Corey Heitz, MD|5406322364|coreyheitzmd@gmail.com|
21286080|NCT02256696|Vanderbilt University|Dr. Kelly Dooley|(615) 322-8972|kelly.e.dooley@vumc.org|
21286081|NCT03877744|University of Alabama at Birmingham|Dr. David Schwebel|205-934-8745|schwebel@uab.edu|
21286082|NCT03361306|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
21286083|NCT02778152|The Research Institute at Nationwide Children's Hospital|Dr. Peter Minneci|614-722-3066|peter.minneci@nationwidechildrens.org|
21286084|NCT02038179|University of Alabama at Birmingham|Dr. Elizabeth Rahn|205-996-6552|elizabethrahn@uabmc.edu|
21286085|NCT03626701|AVITA Medical|Elizabeth Kirshner|661-877-6869|ekirshner@avitamedical.com|
21286086|NCT00807885|Baxter Healthcare Corporation|George Harb, MD, MPH||george_harb@baxter.com|
21238054|NCT04570436|Viatris|Dik WH Ng|+44 (0)1304 626895|dik.ng@viatris.com|
21269967|NCT00176501|Rutgers Cancer Institute of New Jersey|Dr. Roger Strair, MD, PhD|732-235-8675|strairrk@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
21286087|NCT03489343|Symphogen AS|Medical Director|0045 45265050|info@symphogen.com|
21301283|NCT01014351|SCRI Development Innovations LLC|John D. Hainsworth, M.D.|615-329-7274|asksarah@scresearch.net|
21269968|NCT04723173|Sonova AG|Bernhard Buschle|+41 58 928 44 21|bernhard.buschle@sonova.com|
21269969|NCT00953927|Aeras|Bernard Landry|301-547-2919|blandry@aeras.org|
21269970|NCT01453101|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
21269971|NCT01396161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269972|NCT04604496|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269973|NCT02962739|"University of Colorado | Skaggs School of Pharmacy and Pharmaceutical Sciences"|Dr. Peter Anderson|3037246128|peter.anderson@cuanschutz.edu|
21269974|NCT00414011|U.S. Army Warfighter Refractive Surgery Research Center|Principal Investigator|571-231-1600|rose.sia@us.army.mil|
21269975|NCT00306852|University of Miami|Dr. Steven Gedde|305-326-6435|sgedde@med.miami.edu|
21269976|NCT02307188|Columbia University Medical Center|Abgelo Biviano|212-305-7646|ab542@columbia.edu|
21269977|NCT00817778|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21269978|NCT03343054|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269979|NCT01537549|Weill Cornell Medicine|Dr. Claire Henchcliffe|2127462584|clh2007@med.cornell.edu|
21269980|NCT00883740|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21269981|NCT01286207|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21269982|NCT02556931|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Amy Dezern|410-502-7208|adezern1@jhmi.edu|
21269983|NCT02039817|Conatus Pharmaceuticals|Jean L. Chan, MD|858 376 2632|jchan@conatuspharma.com|
21269984|NCT01875991|Amgen Inc.|Study Director|866-572-6436||
21269985|NCT04840901|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
21269986|NCT01268683|Biogen|Medical Director|866-633-4636|clinicaltrials@biogen.com|
21269987|NCT04661540|CalciMedica|Sudarshan Hebbar, MD (Chief Medical Officer)|(816) 838-7105|sudarshan@calcimedica.com|
21269988|NCT05292053|Baylor Scott & White Research Institute|Clinical Research Manager|214-820-1771|Felicia.Padilla@BSWHealth.org|
21269989|NCT00103259|Eastern Cooperative Oncology Group (ECOG) Statistical Office|ECOG Statistician|617-632-3012||
21269990|NCT03224234|Emory University|Dr. Umpierrez|404-251-8957|geumpie@emory.edu|
21269991|NCT02610842|Unicamp - University of Campinas|Dr. Eduardo de Paiva Magalhaes|+55 (19) 35217113|dreduardomagalhaes@gmail.com|
21269992|NCT02360059|The University of Texas (UT) MD Anderson Cancer Center|Dr. David L. Ramirez, Assistant Professor, Breast Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
21269993|NCT03403712|Helsinn SA|Head of Clinical Development|+41 91 985 2121|info-HHC@helsinn.com|
21269994|NCT02192541|National Cancer Institute|Alice P. Chen, M.D.|(240) 781-3320|chenali@mail.nih.gov|
21269995|NCT02268045|mAbxience|Susana Millan|+34917711500|Susana.Millan@mabxience.com|9284
21269996|NCT00514501|Progenics Pharmaceuticals, Inc.|Senior Director of Clinical Communications|914 784-1825|vdipippo@progenics.com|
21269997|NCT02125734|Novartis Pharmaceuticals|Study Director|862-778-8300||
21269998|NCT01308762|Immodulon Therapeutics, The London Clinic Cancer Centre, London W1G 6JA,|Clinical Trials Co-ordinator|+44 (0)203 219 3568/3572|Ilda@immodulon.com|
21269999|NCT02617446|Windtree Therapeutics, Inc.|Phillip D. Simmons, Executive Director of Biostatistics & Data Management|215-488-9300|psimmons@windtreetx.com|
21270000|NCT03030638|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21270001|NCT01556490|Boston Scientific|Clinical Research Manager|16138011844|chantal.laframboise@bsci.com|
21270002|NCT06065176|University of Utah|Sarang Yoon, PI|801-203-0320|sarang.yoon@hsc.utah.edu|
21270003|NCT02588651|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Study Principal Investigator|1-866-223-8100|TaussigResearch@ccf.org|
21270004|NCT03801369|Oregon Health & Science University - Knight Cancer Institute|Gordon Mills, MD, PhD|503-346-4660|millsg@ohsu.edu|
21270005|NCT03107715|University Hospitals Rainbow Babies and Children's Hospital|Lydia Furman MD, PI|216-844=8260|lydia.furman@uhhospitals.org|
21270006|NCT00094900|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Raphaela Goldbach-Mansky, MD|13014356243|goldbacr@mail.nih.gov|
21270007|NCT03739684|Lantheus Medical Imaging / Progenics Pharmaceuticals|David Myl|914-582-1120|david.myl@lantheus.com|
21270008|NCT03252756|NYU Langone Health|Michael Bogenschutz, PhD|646-501-4026|Michael.Bogenschutz@nyulangone.org|
21270009|NCT02706353|M.D. Anderson Cancer Center|Adi Diab, MD|713-792-2921|MDADiab@mdanderson.org|
21270010|NCT00021229|Pediatric Brain Tumor Consortium|Pediatric Brain Tumor Consortium (James M. Boyett, Ph.D)|901-595-4986|james.boyett@stjude.org|
21270011|NCT02007369|School of Public Health, The University of Hong Kong|Dr. Cheung, Yee Tak Derek|+852 39176652|derekcheung@hku.hk|
21270012|NCT01901146|Amgen Inc.|Study Director|866-572-6436||
21270013|NCT00297492|University of Vermont|Dr. John Hughes|802-656-9610|John.Hughes@uvm.edu|
21270014|NCT02675426|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21270015|NCT03724968|Vanderbilt University Medical Center|Teresa Melton|6159367423|teresa.melton@vumc.org|
21270016|NCT01858558|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Philip Imus, MD|410-955-8873|pimus1@jhmi.edu|
21270017|NCT01336608|GlaxoSmithKline|GSK Response Center|866-435-7343||
21270018|NCT02316678|University of Pennsylvania|James Lewis|215-573-5137|lewisjd@upenn.edu|
21301284|NCT01745822|French National Research Institute for Sustainable Development (IRD)|Gonzague Jourdain|+66818830065|gonzague.jourdain@ird.fr|
21301285|NCT01069900|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21301286|NCT00145158|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21301287|NCT02297373|Ottawa Hospital|Dr Gregoire Le Gal|613-737-8899|glegal@toh.ca|
21301288|NCT00343460|Heron Therapeutics|Robert Geller, M.D.|650-366-2626|rgeller@herontx.com|
21301289|NCT03682770|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21301290|NCT02863419|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21286088|NCT01912950|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
21258011|NCT03524339|Cleveland Clinic|Graham Chapman|440-312-2229|gchapman5@gmail.com|
21258012|NCT02041377|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
21258013|NCT01784861|Washington University School of Medicine|Benjamin Tan, M.D.|314-362-5740|btan@wustl.edu|
21258014|NCT03504410|Cornerstone Pharmaceuticals Inc|Sanejev Luther|585-978-1351|sanjeev.luther@cornerstonepharma.com|
21258015|NCT05051904|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21258016|NCT03015259|KINDEVA DRUG DELIVERY|Lester Harrison, PhD|6122714814|lester.harrison@kindevadd.com|
21258017|NCT01965262|Coopervision|Paul Chamberlain, BSc Honors, Sr. Manager Clinical Research|(925) 730-6754|pchamberlain@coopervision.com|
21258018|NCT01029366|Abramson Cancer Center of the University of Pennsylvania|Noelle Frey, MD|215-662-6901|noelle.frey@uphs.upenn.edu|
21258019|NCT00440947|ViiV Healthcare|GSK Response Center|866-435-7343||
21258020|NCT03341962|Immunic AG|Andreas Muehler, MD|004989|Andreas.Muehler@imux.com|20804770
21258021|NCT01991990|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21258022|NCT01827670|GlaxoSmithKline|GSK Response Center|866-435-7343||
21258023|NCT01142401|Icahn School of Medicine at Mount Sinai|Joseph Sparano, MD|212-241-3300|joseph.sparano@mssm.edu|
21258024|NCT00689572|University of Virginia|Nassima Ait-Daoud Tiouririne, M.D.|(434)243-0570|nat7b@virginia.edu|
21258025|NCT00283075|The Rogosin Institute|Dr. Barry H. Smith, CEO|212-746-1551|bas2005@nyp.org|
21258026|NCT03362970|University of Calgary|Stephen Freedman|403-955-7740|stephen.freedman@ahs.ca|
21258027|NCT00524342|University of Pittsburgh|Dr. Margaret Ragni|412-209-7288|ragni@dom.pitt.edu|
21258028|NCT02813694|Nabriva Therapeutics US, Inc|Jennifer Schranz, M.D., Chief Medical Officer|610 981 2842|jennifer.schranz@nabriva.com|
21258029|NCT01236300|University of Chicago Medical Center|Dr. Vani J.A. Konda|773-702-1460|vkonda@medicine.bsd.uchicago.edu|
21258030|NCT02671136|Loma Linda University Health|Ahmed Khocht|909 558 4000|akhocht@llu.edu|
21258031|NCT00563186|University of Calgary|Dr. John Conly|403-944-8090|John.Conly@albertahealthservices.ca|
21258032|NCT01152021|Department of Anesthesia, Perioperative and Pain Medicine|Rachel Dabek|857-218-5413|rachel.dabek@childrens.harvard.edu|
21258033|NCT00996944|GlaxoSmithKline|GSK Response Center|866-435-7343||
21286089|NCT01630135|GlaxoSmithKline|GSK Response Center|866-435-7343||
21286090|NCT03242941|Medtronic|Lilian Kornet|+31433566710|lilian.kornet@medtronic.com|
21258034|NCT00769184|NeoStrata Co., Inc.|Barbara Green, RPH, MS|(609) 520-0715|bgreen@neostrata.com|
21258035|NCT00517829|Texas Oncology, Tyler Cancer Center|Dr. Donald Richards|903-579-9800|donald.richards@usoncology.com|
21258036|NCT03042715|Massachusetts General Hospital|Areej El-Jawahri|617-724-4000|ael-jawahri@partners.org|
21258037|NCT02250274|Marshfield Clinic Research Foundation|Director of the Center for Clinical Epidemiology & Population Health|715-389-3444|belongia.edward@mcrf.mfldclin.edu|
21258038|NCT00583362|GlaxoSmithKline|GSK Response Center|866-435-7343||
21258039|NCT00446511|Novartis Pharmaceuticals|Study Director|862-778-8300||
21258040|NCT00345176|The EMMES Corporation|Traci Clemons, PhD|301-251-1161|tclemons@emmes.com|212
21258041|NCT01136655|AstraZeneca|Göran Eckerwall, MSD||ClinicalTrialTransparency@astrazeneca.com|
21258042|NCT00063570|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21258043|NCT02461550|Memorial Sloan Kettering Cancer Center|Dr. Stephen Solomon|212-639-5012|solomons@mskcc.org|
21258044|NCT04341441|Henry Ford Health System|John McKinnon, MD, MSc|313-916-8828|jmckinn3@hfhs.org|
21258045|NCT04770389|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
21258046|NCT03765138|Columbia University Medical Center/New York State Psychiatric Institute|Dr. Yuval Neria|646-774-8092|Yuval.Neria@nyspi.columbia.edu|
21258047|NCT00794157|Novartis Pharmaceuticals|Study Director|862 778-8300||
21258048|NCT01970501|Arca biopharma Inc.|Dr. Michael Bristow|7209412100|Michael.Bristow@arcabio.com|
21258049|NCT00708123|GlaxoSmithKline|GSK Response Center|866-435-7343||
21258050|NCT02970292|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261-2897|medicalinformation@acadia-pharm.com|
21258051|NCT01632995|Bridge HIV, San Francisco Department of Public Health|Dr. Albert Liu, Clinical Research Director|415-437-7408|albert.liu@sfdph.org|
21258052|NCT04486950|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21258053|NCT00401375|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
21258054|NCT02821715|Theranexus|Chief medical officer|+33680026779|werner.rein@theranexus.fr|
21258055|NCT03115567|Northwestern University|Dermatology CTU|312-503-5944|NUderm-research@northwestern.edu|
21258056|NCT00350142|Stanford Cancer Center|Dr. Albert Koong|650-498-7703|akoong@stanford.edu|
21258057|NCT01548339|University Hospital Lausanne|Prof. N. Demartines||demartines@chuv.ch|
21270019|NCT00821041|University of Manitoba|Study Coordinator|204-787-5098|NVincent@exchange.hsc.mb.ca|
21258058|NCT00923130|National Cancer Institute|Dr. Ravi Madan|301-496-3493|madanr@mail.nih.gov|
21270020|NCT00786019|University of Colorado|Judith Regensteiner, PhD|303-724-2247|judy.regensteiner@ucdenver.edu|
21270021|NCT02437890|Ablynx|Medical Monitor|+32 (9) 262 00 00|clinicaltrials@ablynx.com|
21270022|NCT02328547|Montefiore Medical Center|Dr. Olga C. Aroniadis, PI|718-920-4846|oaroniad@montefiore.org|
21270023|NCT01190098|Cleveland Clinic|Nancy Foldvary-Schaefer, DO, MS|216-445-2990|foldvan@ccf.org|
21270024|NCT00344305|MedImmune, LLC|Raburn Mallory MD/ Sr Dir Clinical Development|301-398-0000|clinicaltrialenquiries@medimmune.com|
21270025|NCT03978117|Masonic Cancer Center|Dorothy Hatsukami, PhD|(612) 626-2121|hatsu001@umn.edu|
21270026|NCT01999231|Shanghai Public Health Clinical Center|Shuihua Lu|(+86)18930811818|tubercle@gmail.com|
21270027|NCT01586624|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
21270028|NCT00822679|University of Arizona|Sairam Parthasarathy|5206266109|sparthasarathy@deptofmed.arizona.edu|
21270029|NCT03578276|Carolina Eyecare Physicians, LLC|Director of Research|8438813937|hps@cepmd.com|
21270030|NCT04221087|University of PIttsburgh|Dr. Allison Williams|4126925135|williamsae2@upmc.edu|
21270031|NCT02360397|Brigham and Women's Cardiovascular Associates at Kent Hospital|Chester M. Hedgepeth, MD, PhD|(401) 737-7010|chedgepeth@kentri.org|32880
21270032|NCT04256759|Mayo Clinic|Jason Sluzevich, M.D.|904-953-6192|sluzevich.jason@mayo.edu|
21270033|NCT04075292|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21270034|NCT00185731|Stanford University School of Medicine|Alice Fan, MD|650-725-6454|afan@stanford.edu|
21270035|NCT02494583|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21270036|NCT00627458|GlaxoSmithKline|GSK Response Center|866-435-7343||
21270037|NCT03891875|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
21270038|NCT01787188|Iroko Pharmaceuticals, LLC|Daniel Solorio, Executive Director of Clinical Operations|267-546-3150|dsolorio@iroko.com|
21270039|NCT00854607|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21270040|NCT00597727|University of North Carolina at Chapel Hill|Edwin Kim, Director UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
21270041|NCT02009982|Emory University|Dr. David De Lurgio|404-251-1481|ddelurg@emory.edu|
21270042|NCT03151707|McLean Hospital|Dost Ongur|6178553922|dongur@partners.org|
21270043|NCT00646282|Emory University|Dr. Antonio Guasch|404-727-2522|aguasch@emory.edu|
21270044|NCT02328404|Hayat Pharmaceutical industries|DR. ALA' ABU RUQA'A|00962 6 4162607|tbd@hayatpharma.com|225
21270045|NCT04348292|Emory University|Jennifer Carlisle, MD|404-778-2304|jennifer.w.carlisle@emory.edu|
21270046|NCT02181842|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21270047|NCT01652872|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21270048|NCT00758706|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
21270049|NCT03474640|TopAlliance BioSciences|Dr. Kevin Li|301-640-5166|kevin_li@topalliancebio.com|
21270050|NCT04166851|Rutgers School of Public Health|Cui Yang|1-732-235-9754|cui.yang@rutgers.edu|
21270051|NCT03690375|Siperstein Dermatology Group|founder/physician|5613647774|info@sipderm.com|
21270052|NCT00367601|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
21270053|NCT03985293|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21270054|NCT02251431|Baylor Scott & White Research Institute|Biostatistician|8033190755|gelareh.rahimighazikalayeh@bswhealth.org|
21270055|NCT01445873|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21270056|NCT03078192|Duke University Medical Center|Bastiaan Driehuys|919-684-7786|bastiaan.driehuys@duke.edu|
21270057|NCT02873195|Duke University Medical Center|Niharika Bansal Mettu, M.D.|919-681-2954|niharika.mettu@duke.edu|
21270058|NCT03594175|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
21270059|NCT01500434|Boston Scientific|Ruth Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com|
21270060|NCT00633217|GlaxoSmithKline|GSK Response Center|866-435-7343||
21270061|NCT04822701|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21270062|NCT03560466|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21270063|NCT02996448|NIAID, NIH|Alexandra Freeman|301-594-9045|freemaal@mail.nih.gov|
21270064|NCT01284244|Mount Sinai Hospital|Dr. Danny Lovatsis|416-586-4566|danny.lovatsis@sinaihealthsystem.ca|
21270065|NCT01143272|Johns Hopkins Bloomberg School of Public Health|Stephan Ehrhardt|410-502-3872|sehrhard@jhsph.edu|
21270066|NCT00545181|Indiana University School of Medicine|David Haas, MD MS|3176307837|dahaas@iupui.edu|
21270067|NCT01614613|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com|
21270068|NCT01528878|UNC Lineberger Comprehensive Cancer Center|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
21270069|NCT01160198|GlaxoSmithKline|GSK Response Center|866-435-7343||
21270070|NCT00448682|University of Miami Sylvester Comprehensive Cancer Center|Bach Ardalan MD|305-243-6608|bardalan@med.miami.edu|
21270071|NCT01796860|University of Texas Southwestern Medical Center|Karen J McCain, PT, DPT, NCS, Principal Investigator|214-648-1559|karen.mccain@utsouthwestern.edu|
21270072|NCT01408576|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21238055|NCT03882879|Rush University Medical Center|Dr. Jori Fleisher|13125632900|jori_fleisher@rush.edu|
21238056|NCT00594854|Pozen Inc.|Senior Vice President, Clinical Research|919-913-1030|eorlemans@pozen.com|
21238057|NCT01250990|University of Pennsylvania|Richard L Dunbar|215-662-9024|richard.dunbar@uphs.upenn.edu|
21258059|NCT01187953|Veloxis Pharmaceuticals|Christina Sylvest|+4520553877|csy@veloxis.com|
21301291|NCT02362282|North Florida/South Georgia Gainesville VA Medical Center|Janis J Daly, Ph.D., Director Brain Rehabilitation Research Center|352-548-6000|Janis.Daly@va.gov|6603
21301292|NCT01189032|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
21301293|NCT01733680|SUNy Upstate Medical University|Gail P DePalma|3154643260|depalmag@upstate.edu|
21301294|NCT01932437|Elusys Therapeutics, Inc.|Senior Director of Regulatory|973-808-0222|cdillon@elusys.com|
21301295|NCT05126953|Bausch + Lomb Incorporated|Schafer, Jill|0000000|Jill.Schafer@bausch.com|
21301296|NCT01526733|Halozyme Therapeutics, Inc|Vice President, Endocrinology Clinical Development|858-794-8889||
21301297|NCT02839200|Idorsia Pharmaceuticals|Clinical Trial Disclosure Desk|+41 588 441977|clinical-trials-disclosure@idorsia.com|
21301298|NCT02952820|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
21301299|NCT03614156|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
21301300|NCT03857867|Stanford|Peter Tass|650-304-8849|ptass@stanford.edu|
21301301|NCT03070964|Pharma Mar, S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|+34 918466000|clinicaltrials@pharmamar.com|
21301302|NCT01094119|Cleveland Clinc|Daniel Sessler|216-444-4900|DS@OR.org|
21301303|NCT01626872|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21301304|NCT01587924|GlaxoSmithKline|GSK Response Center|866-435-7343||
21301305|NCT01578486|UMass Medical School|Xiaoduo Fan, MD, MPH|508-856-3881|xiaoduo.fan@umassmed.edu|
21301306|NCT02425943|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
21301307|NCT05503823|University of Manitoba|Dr. Zahra Moussavi|204 474-7023|zahra.moussavi@umanitoba.ca|
21301308|NCT01106248|Eisai|Dr. Peter Tarassoff|888-422-4743||
21301309|NCT00357903|Amgen Inc.|Study Director|866-572-6436||
21301310|NCT03181529|Johns Hopkins University|Dr. Roland Griffiths|410-550-0034|rgriff@jhmi.edu|
21301311|NCT01600170|University of Pennsylvania School of Medicine|Ronald G Collman|215-898-0913|collmanr@pennmedicine.upenn.edu|
21301312|NCT01209325|University of California, San Francisco|Dr. Joel M. Palefsky|415-476-1574|jpalefsky@medicine.ucsf.edu|
21301313|NCT00607373|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
21301314|NCT01918306|Vanderbilt-Ingram Cancer Center|Dr. Vandana Abramson|800-811-8480|vandana.abramson@vanderbilt.edu|
21301315|NCT02773576|Braeburn Inc|Christine Kampf|6104678728|ckampf@braeburnrx.com|
21301316|NCT01237197|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
21301317|NCT01160822|Novartis Pharmaceuticals|Study Director|862-778-8300||
21301318|NCT04772560|University of Houston|Kathryn Richdale OD, PhD|713-743-1974|richdale@uh.edu|
21301319|NCT01319552|Columbia University|Dr. Steven Spitalnik|2123425648|eldad.hod@gmail.com|
21301320|NCT00314795|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21301321|NCT03962062|Medicines Development for Global Health|Sally Kinrade, Vice President, Project Leader, Onchocerciasis & Lymphatic Filariasis|+61 3 9912 2400|sally.kinrade@medicinesdevelopment.com|
21301322|NCT02170077|BIAL - Portela & Cª, SA|Head of Clinical Research|+351 22 9866100|clinical.trials@bial.com|
21301323|NCT02015910|Georgetown University Medical Center|Paul J. Kim, DPM, Director of Research|202-444-3059|Paul.J.Kim@gunet.georgetown.edu|
21301324|NCT04546672|Oregon Health & Science University|Dr. Brandon Togioka|503-494-4572|togioka@ohsu.edu|
21301325|NCT01780974|Oregon Health & Science University|Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu|
21301326|NCT00525161|University of Kentucky|Dr. Suleiman Massarweh|8593238043|massarweh@uky.edu|
21301327|NCT01607255|VA Northern California Healthcare Systems - Mather|Joseph W. Leung, MD, Chief of Gastroenterology|916-366-5339|Joseph.Leung2@va.gov|
21301328|NCT01076361|Medtronic|4968 Clinical Trial Leader||medtroniccrmtrials@medtronic.com|
21301329|NCT01397968|SK Life Science|Chief Medical Officer|201-421-3830|mkamin@sklsi.com|
21301330|NCT02970162|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|305-420-3200|gingenito@catalystpharma.com|
21301331|NCT00750438|Imperial College London|Prof Gary Frost|+44 (0)20 7594 0959|g.frost@imperial.ac.uk|
21301332|NCT00787644|University of Vermont|Dr. Anne Dixon|802 656 3525|anne.dixon@uvm.edu|
21301333|NCT02264249|Cleveland Clinic Florida|Dr. Alison Schneider|954-659-5646|schneia2@ccf.org|
21301334|NCT01108185|Abbott|Global Medical Services|1-800-633-9110||
21301335|NCT00298558|New England Research Institutes|Sharon L. Tennstedt, PhD|617-972-3362|stennstedt@neriscience.com|
21301336|NCT01322945|Barrow Neurological Institute|Andrew S. Little, MD|602-406-3181|heidi.jahnke@dignityhealth.org|
21301337|NCT05615922|NYU Langone Health|Leigh Charvet, PhD|929-455-5141|Leigh.Charvet@nyulangone.org|
21301338|NCT00905164|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21301339|NCT04730804|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
21301340|NCT02042872|James J. Peters VA Medical Center|William A. Bauman, M.D.|718-584-9000|william.bauman@va.gov|5428
21301341|NCT03894813|Peking University Shenzhen Hospital|Prof. Shangrong Fan|86-0755-83923333|fanshangrong@163.com|
21301342|NCT00499616|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21301343|NCT04816669|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
21301344|NCT00826462|University of Oslo|Professor Morten Lindbaek|+47-22850646|morten.lindbak@medisin.uio.no|
21301345|NCT00659737|Drexel university|Michael Green|215-762-1524|micheal.green@drexelmed.edu|
21301346|NCT00867815|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21301347|NCT01742117|Mayo Clinic|Dr. Naveen L. Pereira|507-284-4441|Pereira.Naveen@mayo.edu|
21238058|NCT03172702|AstraZeneca|Global Clinical Lead|+18772409479|information.center@astrazeneca.com|
21238059|NCT03292146|Massachusetts General Hospital|Karen K. Miller, MD|617-724-7388|KKMILLER@mgh.harvard.edu|
21238060|NCT03468933|Tulane University|Dr. Fayez Kheir|504-988-3541|fkheir@tulane.edu|
21238061|NCT06134180|Case Western Reserve Unviersity|Kylie Meyer|2163681928|knm77@case.edu|
21238062|NCT03039023|Cleveland Clinic Foundation|Jennifer Wilcox|216-636-6153|kirsopj@ccf.org|
21238063|NCT02340026|The Children's Hospital of Philadelphia|Laura A. Prosser, PT, PhD|215-590-2495|ProsserL@chop.edu|
21238064|NCT02684006|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21238065|NCT04642898|University of Kentucky|Dr. Sauer-Zavala|859-562-1571|ssz@uky.edu|
21238066|NCT04495179|AstraZeneca Clinical Study Information Center|Global Clinical Head|1-877-240-94 79|information.center@astrazeneca.com|
21238067|NCT04280562|David Putrino|Icahn School of Medicine at Mount Sinai|212-824-8369|david.putrino@mountsinai.org|
21238068|NCT02968420|Vaccine Evaluation Center|Dr. Manish Sadarangani|604-875-2422|msadarangani@bcchr.ubc.ca|
21238069|NCT01368965|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
21238070|NCT00162370|Lantheus Medical Imaging|Director, Clinical Operations|978-671-8118|Sandra.Monte@lantheus.com|
21238071|NCT00569582|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
21238072|NCT04559568|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21238073|NCT03678545|Cincinnati Children's Hospital Medical Center|Regina Yearout|513-517-2108|regina.yearout@cchmc.org|
21238074|NCT05103384|Cleveland Clinic|Jay Alberts, PhD|216-445-3222|albertj@ccf.org|
21238075|NCT02612311|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
21238076|NCT05288660|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
21238077|NCT03088267|Tris Pharma, Inc.|Antonio Pardo MD|16107502210|apardo@trispharma.com|
21238078|NCT04085328|Alcon Research, LLC|Expert CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21238079|NCT00514735|Medtronic|Linda Nelson, Director of Clinical Research|763-526-2891|linda.k.nelson@medtronic.com|
21238080|NCT00226239|UPMC Cancer Centers|Rita Johnson, Associate Director of Clinical Research Services|412-647-8571|johnsonr1@upmc.edu|
21238081|NCT00724152|VA Connecticut Healthcare System|Dr. Caroline Schmidt, Co-investigator|203-932-5711|Caroline.Schmidt@va.gov|3391
21238082|NCT03371082|Gan & Lee Pharmaceuticals USA Corp.|Jia Lu, MD, PhD Executive Director of US Clinical Sciences|+1 888-288-5395|Jia.Lu@ganlee.us|
21238083|NCT03266770|University Hospitals Cleveland Medical Center|Dr. Kyle Scarberry|(216)844-3009|Kyle.Scarberry@UHhospitals.org|
21238084|NCT04274894|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21238085|NCT01936857|Oregon Health & Science University|Dr. Todd Korthuis|503-494-8044|korthuis@ohsu.edu|
21286091|NCT04767373|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21286092|NCT01502033|Mayo Clinic|Dr. Paul Croarkin|(507) 293-2557|croarkin.paul@mayo.edu|
21286093|NCT02658669|VA San Diego Healthcare System|Dr. Henry Orff|(858) 642-6492|Henry.Orff@va.gov|
21286094|NCT00838097|Amgen Inc.|Study Director|866-572-6436||
21286095|NCT04457362|NYU Langone Health|Nader Paksima|2122632193|Nader.Paksima@nyulangone.org|
21286096|NCT05279131|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
21286097|NCT00594230|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net|
21286098|NCT04878120|University of Virginia|Dr. Chiara Fabris|4344220240|cf9qe@virginia.edu|
21286099|NCT00333710|VA Boston Healthcare System|Amy Silberbogen, Ph.D.|857-364-4707|amy.silberbogen@va.gov|
21286100|NCT02149264|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21286101|NCT01877161|Seoul National University Bundang Hospital|Nam-Jong Paik|031-787-7731|njpaik@snu.ac.kr|7731
21286102|NCT02487797|Northwestern University, Yale University|Dr. Moeun Son|475-414-5328|moeun.son@yale.edu|
21286103|NCT00672633|Boston Children's Hospital|Dr. Stavroula Osganian, Principal Investigator|8572184728|stavroula.osganian@childrens.harvard.edu|
21286104|NCT02824627|University of Nebraska Medical Center|Soonjo Hwang|402-552-6351|soonjo.hwang@unmc.edu|
21286105|NCT01938846|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21286106|NCT00929344|The Scripps Research Institute|Barbara J. Mason, Ph.D.|858-784-7328|mason@scripps.edu|
21286107|NCT02499120|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21270073|NCT00802529|Imperial College London|Professor Adolfo Bronstein (Clinical professor and Head of neuro-otology group)|(0)20 3313 5525|a.bronstein@imperial.ac.uk|+44
21270074|NCT02476851|Haemonetics Corporation|Jan Hartmann, MD|(781) 348 7396|Jan.Hartmann@haemonetics.com|
21270075|NCT00337129|SWOG Statistical Center|Head and Neck Committtee Statistician|(206)-667-4623||
21270076|NCT00647426|Abramson Cancer Center|Tracey Evans MD|215 614 0861|Christine.Bonney@UPHS.upenn.edu|
21270077|NCT01230502|University of Wisconsin|Professor William Burlingham, PhD|(608) 263-0119|BURLINGHAM@SURGERY.WISC.EDU|
21270078|NCT01508325|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21270079|NCT03870737|University of California, Los Angeles|James J. McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu|
21270080|NCT02613416|Stony Brook University|Caterina Vacchi-Suzzi|631-444-8074|caterina.vacchi-suzzi@stonybrookmedicine.edu|
21270081|NCT01542684|The University of Texas MD Anderson Cancer Center|Zeev Estrov, MD/Professor|713-794-1675|eharriso@mdanderson.org|
21270082|NCT03543046|Orlando Health|Corporate Director of Compliance and Regulations|3218413687|Tara.Roberts@orlandohealth.com|
21270083|NCT00520494|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
21270084|NCT01307631|Dana-Farber Cancer Institute|Jennifer Curtis, MS|617-582-7183|jennifer_curtis@dfci.harvard.edu|
21270085|NCT02748616|NYU Langone Health|Norman Javitt, MD|212-263-6588|Norman.Javitt@nyulangone.org|
21270086|NCT00589693|Janssen R&D US|Sr Director Clinical Development|1 510 248-2310||
21270087|NCT00535301|SCPMG/Kaiser Permanente|John N. Nguyen, MD|562-657-2642|john.n.nguyen@kp.org|
21270088|NCT01447628|Imperial College London|Professor Martin Wilkins|0203 313 8078|jacob.bonner@nhs.net|38078
21270089|NCT00396981|University of California, UCSF Medical Center|S. Claiboren Johnston, MD, PhD|415-502-7487|Clay.Johnston@ucsfmedctr.org|
21270090|NCT05144477|Columbia University Irving Medical Center|Dr. Talea Cornelius|(212) 342-5503|tmc2184@cumc.columbia.edu|
21270091|NCT00639158|Abbott|Global Medical Services|800-633-9110||
21270092|NCT00965263|New York State Psychiatric Institute at Columbia University Medical Center|Margaret Haney, Ph.D.|6467746153|meg.haney@nyspi.columbia.edu|
21270093|NCT02756078|Johnson & Johnson Vision Care, Inc.|Chantal Coles-Brennan - PRINCIPAL RESEARCH OPTOMETRIST|1-904-443-3449|CColesb@its.jnj.com|
21270094|NCT01783483|Zimmer Biomet|Brian M Hatcher, PhD|904-741-4400|brian.hatcher@zimmerbiomet.com|
21270095|NCT01158976|University of Chicago|Kathry Keenan|773-702-4449|kekeenan@uchicago.edu|
21270096|NCT01591499|CooperVision|Caroline Bonneville and Sandrine Cheneau, Study Managers|+33609202762|caroline.bonneville@coopervision-fr.com|
21270097|NCT00530088|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21270098|NCT00397904|Memorial Sloan Kettering Cancer Center|Dr. David Ilson|646-888-4183|ilsond@mskcc.org|
21270099|NCT02058368|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21270100|NCT05899218|University of Pennsylvania|Dr. Jennifer Tran|2158983616|jtgtran@nursing.upenn.edu|
21270101|NCT02587325|Aadi Bioscience, Inc.|Aadi Medical Information|1-888-246-2234|MedInfo@aadibio.com|
21270102|NCT00390572|VA HSRD|Christi S. Ulmer, PhD|9192860411|christi.ulmer@va.gov|4044
21270103|NCT04236635|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|clinicaltrials@endo.com|
21270104|NCT02913261|Novartis Pharmaceuticals|Study Directr|862-778-8300|novartis.email@novartis.com|
21270105|NCT01236053|GlaxoSmithKline|GSK Response Center|866-435-7343||
21270106|NCT02304302|Case Western Reserve University|Melissa Stasko, JD, MA|216-844-7281|Melissa.Stasko@case.edu|
21270107|NCT00391118|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21270108|NCT01892020|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21270109|NCT02493088|Groupe Hospitalier de la Rochelle Ré Aunis|Dr Jérôme SAINT-MARTIN, study director|+33 5 46 45 66 03|jerome.saint-martin@ch-larochelle.fr|
21270110|NCT01115699|Mayo Clinic|Michelle Skime, Supervisor - Senior Clinical Research Coordinator|507-255-0501|skime.michelle@mayo.edu|
21270111|NCT01915498|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21270112|NCT01083901|University of Colorado Denver|Catherine M. Jankowski|303-724-7383|catherine.jankowski@ucdenver.edu|
21270113|NCT00057785|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
21270114|NCT01197456|UC San Diego|Irene Su, MD MSCE|858-822-5986|hisu@ucsd.edu|
21270115|NCT00314262|Emory University School of Medicine|Dong Shin, MD|404-778-2980|dmshin@emory.edu|
21270116|NCT00883129|David Geffen School of Medicine at UCLA|Donald P. Tashkin, M.D.|310-825-5316|dtashkin@mednet.ucla.edu|
21270117|NCT00407966|SKCCC|Judith Karp, MD|410-502-7726|jkarp2@jhmi.edu|
21270118|NCT01966107|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
21270119|NCT01185639|Wake Forest University Health Sciences|Dr. William Blackstock|336-713-6501|ablackst@wakehealth.edu|
21301348|NCT01499277|AstraZeneca-PPD|Yunxia Lu|910-558-4197|Yunxia.Lu@ppdi.com|
21301349|NCT01614392|Jean Mayer USDA HNRCA, Tufts University|Dr. Roger Fielding|6175563083|Roger.Fielding@tufts.edu|
21301350|NCT00790088|Medtronic Int. Trading SaRL|Dr Odile Carrette|+41218038119|odile.osullivan@medtronic.com|
21301351|NCT02015637|Melinta Therapeutics, Inc.|Susan K. Cammarata, M.D. (Chief Medical Officer)|1-844-MELINTA (1-844-635-4682)|clinicaltrials@melinta.com|
21301352|NCT01219881|The Ohio State University|Dr. Joseph Werner|614-293-8487|Joseph.Werner@osumc.edu|
21301353|NCT01491607|Emergent BioSolutions|Dr. Robert Hopkins|(301) 944-0136|hopkinsr@ebsi.com|
21301354|NCT01317277|UCSD HIV Neurobehavioral Research Program (HNRP)|Dr. David J Moore, Professor of Psychiatry|619-543-5093|djmoore@ucsd.edu|
21301355|NCT00774566|Stardtisches Klinikum Karlsruhe, Medizinische Klinik IV|Dr. Armin Luik|0049-721974|armin.luik@klinikum-karlsruhe.de|2901
21301356|NCT02688777|North Florida/South Georgia Veteran's Health System|Dr. Dorian Rose|352-376-1611|dorian.rose@va.gov|105238
21301357|NCT02549365|Imperial College London|Dr Paul Turner|+44 20 3312 7754|p.turner@imperial.ac.uk|
21301358|NCT00912795|Center for Innovative Public Health Research|Dr. Michele Ybarra|877-302-6858|michele@innovativepublichealth.org|1 - 801#
21301359|NCT04896073|National Cancer Institute|Dr. Anish Thomas|240-760-7343|anish.thomas@nih.gov|
21301360|NCT00297258|GlaxoSmithKline|GSK Response Center|866-435-7343||
21301361|NCT00176917|Masonic Cancer Center, University of Minnesota|Paul J. Orchard, M.D.|612-626-2313|orcha001@umn.edu|
21301362|NCT02454517|Fred Hutchinson Cancer Center|Jeannette M. Schenk, PhD|206-667-6860|jschenk@fredhutch.org|
21301363|NCT00473382|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
21301364|NCT03565497|Boston University|Dr. Michael Otto|617-306-1836|mwotto@bu.edu|
21301365|NCT02999672|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21301366|NCT01470326|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21301367|NCT01166282|AbbVie|Global Medical Information|800-633-9110||
21301368|NCT02577718|MD Anderson Cancer Center|Dr. A M Chaftari|7137923491|achaftar@mdanderson.org|
21301369|NCT01075685|Inpes|Juliette Guillemont|+331 49 33 22 55|juliette.guillemont@inpes.sante.fr|
21301370|NCT00531661|CardioMEMS, Inc.|Jordan Bauman|4043458235|jbauman@cardiomems.com|
21301371|NCT02858362|Summit Therapeutics|Clinical Disclosure|Please Email|clinicaltrials@summitplc.com|
21286108|NCT01242241|Baylor College of Medicine|Dr. Olutoyin A. Olutoye|832-824-5800|oao@bcm.edu|
21286109|NCT02477358|University of Nebraska Medical Center|Elisabeth Easley|530-524-6020|eleasley@gmail.com|
21286110|NCT01689441|Brigham and Women's Hospital|David Leaf, MD, MMSc|617-732-5500|deleaf@partners.org|
21286111|NCT02282163|Bracco Diagnostics Inc.|Melda S. Dolan, MD, FACC, FASE, Head, Medical Affairs and Cardiac Ultrasound Programs|1-609-514-2506|Melda.Dolan@diag.bracco.com|
21286112|NCT03472521|Stanford University|Dr. Pamela Flood, MD, MA|201-370-3933|pflood@stanford.edu|
21286113|NCT01603407|University of Rochester|Robert Griggs|585-275-6072|robert_griggs@urmc.rochester.edu|
21286114|NCT03705286|Duke University|Miriam Treggiari|919-681-9933|miriam.treggiari@duke.edu|
21286115|NCT01074177|Massachusetts General Hospital|Lecia Van Damn Sequist|617-724-4000|lvsequist@partners.org|
21286116|NCT01401543|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21286117|NCT01801111|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21286118|NCT01210482|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21286119|NCT01223937|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21286120|NCT03284853|Aerie Pharmaceuticals Inc.|Michelle Senchyna, PhD. Vice President, Clinical Development & Medical Affairs.|+1 908 947 3551|msenchyna@aeriepharma.com|
21286121|NCT05176717|Sepul Bio|Zuhal Butuner - Chief Medical Officer|(905) 599-7887|contact@sepulbio.com|
21286122|NCT00765947|Novartis Pharmaceuticals|Study Director|862-778-8300||
21286123|NCT00765817|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21286124|NCT02308228|University of Kentucky|Douglas Long|859-323-5438|DELONG2@UKY.EDU|
21286125|NCT02143024|UC Davis Department of Psychiatry and Behavioral Sciences|Ladson Hinton, MD|(916) 734-3485|lwhinton@ucdavis.edu|
21286126|NCT06597084|BIAL - Portela & Ca, SA|Responsible of Clinical Operations|+351229866100|clinical.trials@bial.com|
21286127|NCT01043133|USUHS|Ronald W. Gimbel|301-295-3077|rgimbel@usuhs.mil|
21258060|NCT02911922|Weill Cornell Medicine - New York Presbyterian Hospital|Josephine Kang, M.D. Ph.D.|212-746-3607|jok9106@med.cornell.edu|
21286128|NCT06450457|The University of Texas Health Science Center at Houston|Kaitlin Benjamin, PT, DPT|610-639-0431|Kaitlin.Benjamin@memorialhermann.org|
21286129|NCT03999749|NYU Langone Health|Janice Mehnert, M.D.|212-731-5431|janice.mehnert@nyulangone.org|
21286130|NCT00255164|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
21286131|NCT03677869|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|drcrnet@jaeb.org|
21286132|NCT05219968|Lyra Therapeutics|Senior Vice President, Clinical Affairs|617-393-4600|lyraclinical@lyratx.com|
21286133|NCT02735473|University of Minnesota|Jeffrey R Wozniak|612-273-9741|jwozniak@umn.edu|
21286134|NCT04587336|Health Systems Research Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT)|Allison Lewinski, PhD, MPH, RN, FAAN|919-286-0411|Allison.Lewinski@va.gov|174048
21286135|NCT00758498|Cephalon, Inc.|Medical Monitor|1-800-896-5855||
21286136|NCT02317991|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
21286137|NCT00707057|SCOLR Pharma Inc|Stephen Turner, VP and Chief Technical Officer|425-368-1050|sturner@scolr.com|1001
21286138|NCT02492165|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21286139|NCT01697800|Johns Hopkins Medicine|Zubair Khan|410-955-3157|zkhan@jhmi.edu|
21286140|NCT00675987|Brigham and Women's Hospital|Mark A. Creager, MD|617-732-5267|mcreager@partners.org|
21286141|NCT00823134|ResMed Germany Inc|Oliver Munt|0899901|oliver.munt@resmed.de|00
21286142|NCT00078403|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21286143|NCT02922153|AtriCure|Nfii Ndikitum|513-644-8192|nndikintum@atricure.com|
21286144|NCT02880254|Baystate Medical Center|Rushika Conroy MD|413 794 5437|rushika.conroy@bhs.org|
21286145|NCT03979066|Columbia University|Gulam Manji, MD, PhD|212-305-0592|gam2140@columbia.edu|
21238086|NCT00490282|The University of Texas (UT) MD Anderson Cancer Center|Adam Garden, MD/Radiation Oncology Department|(713) 563-2300|agarden@mdanderson.org|
21238087|NCT00101933|Medtronic Neuromodulation|Jim Vollhaber, Clinical Study Manager|763-526-8093|medtronicneurotrials@medtronic.com|
21238088|NCT04510675|Princeton Consumer Research Corp.|Principal Investigator|727-576-7300|bd@princetonconsumer.com|
21238089|NCT00774579|Imperial College Healthcare London|Prof. Desmond Johnston|020 3312 1253|desmond.johnston@imperial.ac.uk|
21238090|NCT00976352|University of Florida|Dr. Barry Byrne, Professor and Associate Chair|352-273-6563|bbyrne@ufl.edu|
21286146|NCT03799614|Virginia Commonwealth University|Dr. Ingrid Pretzer-Aboff|804-828-3340|iaboff@vcu.edu|
21286147|NCT01053741|Johns Hopkins School of Medicine|Associate Director, Drug Development Unit|(410)614-8762|ejfuchs@jhmi.edu|
21286148|NCT00994110|Memorial Sloan Kettering Cancer Center|Dr. Peter Allen|212-639-5132|allenp@mskcc.org|
21286149|NCT00943397|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21286150|NCT02948829|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
21286151|NCT01004978|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21286152|NCT00447772|Ipsen|Medical Director, Neurology||clinical.trials@ipsen.com|
21286153|NCT01576575|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
21286154|NCT05438277|Campbell Foundation|Research Manager|9017595413|mknack@campbell-foundation.org|
21286155|NCT01305811|New England School of Acupuncture|Lisa Conboy|6175581788|lconboy@nesa.edu|145
21286156|NCT01723072|Novartis Pharmaceuticals|Study Director|1-888-669-6682||
21286157|NCT01841970|Medtronic Surgical Innovations|Study Director, Clinical Research|508-452-4028||
21286158|NCT01805895|Augusta University|Dr Jeffrey Switzer|7067211691|jswitzer@augusta.edu|
21286159|NCT00954681|NYSPI/Columbia University|John J. Mariani|6467746140|john.mariani@nyspi.columbia.edu|646
21286160|NCT02050334|Chemigen|Consultant|317 293-0852|farlowds@yahoo.com|
21286161|NCT03335800|Associate Professor of Medicine, Stanford University|Minang (Mintu) Turakhia, Associate Professor of Medicine, Stanford University|(650) 493-5000|mintu@stanford.edu|
21286162|NCT01610037|Novartis Pharmaceuticals|Study Director|862-778-8300||
21286163|NCT01668836|Heart Institute (InCor), University of São Paulo Medical School|Antonio de Padua Mansur - Associate Professor|55-11-26615387|apmansur@usp.br; apmansur@yahoo.com|
21286164|NCT00274742|Amgen Inc.|Study Director|866-572-6436||
21286165|NCT00149396|Medigene|Associate Director Regulatory Affairs|858-586-2252|p.larson@medigeneusa.com|
21286166|NCT00327717|Eisai Co., Ltd.|Takao Ishii, Asia regulatory affairs|81-3-3817-3914||
21286167|NCT02983045|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
21286168|NCT02550743|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD, Principal Investigator|14018633000|kayla_rosati@brown.edu|
21286169|NCT01246895|Piramal Healthcare (Canada) Limited - Bio-Orthopaedics Division|David Castelo, Clinical Research Manager|450-686-2437|david.castelo@piramal.com|313
21286170|NCT03311841|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21286171|NCT00121719|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
21286172|NCT01129245|Oregon Health and Science University|Alison Edelman|503-494-5949|edelmana@ohsu.edu|
21286173|NCT00977613|Beth Israel Cancer Center|Victoria Rosenwald|212 844-8285|vrosenwa@chpnet.org|
21286174|NCT01472445|Stanford University|Melinda Telli, Associate Professor of Medicine (Oncology)|650-724-9533|mtelli@stanford.edu|
21286175|NCT00382785|University of Delaware|Paula Klemm, PhD, RN, OCN|(302) 831-8501|klemmpa@udel.edu|
21286176|NCT01598610|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com|
21286177|NCT03742986|NYU Langone Health - Perlmutter Cancer Center|Maryann Kwa, MD|(212) 731-6364|maryann.kwa@nyulangone.org|
21286178|NCT02925858|Jewish General Hospital|Dr Matthew Cameron|514-340-8222|matthew.cameron@mcgill.ca|25701
21286179|NCT01951118|New York State Psychiatric Institute|Dr. Davangere Devanand|646-774-8658|dpd3@cumc.columbia.edu|
21286180|NCT02017093|University of Haifa|Prof. Eli Carmeli|972-4-8288-397|ecarmeli@univ.haifa.ac.il|
21286181|NCT02989402|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
21286182|NCT03066830|Lexicon Pharmaceuticals, Inc.|Medical Affairs|510-338-6064|medical-information@lexpharma.com|
21286183|NCT02288819|Ziekenhuis Oost-Limburg|Dr. Frederik Verbrugge|0473924199|frederik.verbrugge@zol.be|+32
21286184|NCT02039778|Mount Sinai Beth Israel|Dr. Rahul Parikh|732-253-3939|parikhrr@cinj.rutgers.edu|
21286185|NCT00765856|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|clinicaltrials@endo.com|
21286186|NCT01715233|Baylor University Medical Center Dallas Texas|Ronan J. Kelly MD MBA|214-820-2828|Ronan.Kelly@bswhealth.org|
21286187|NCT03505372|Beth Israel Deaconess Medical Center|Dr Jordana Phillips|617 667 1630|jphilli2@bidmc.harvard.edu|
21286188|NCT03065647|University of Michigan|Robert Neumar|734-936-0253|neumar@umich.edu|
21286189|NCT01678664|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
21286190|NCT00826150|BioCancell Ltd.|VP Clinical|+97225486553|monique.ben-am@biocancell.com|
21286191|NCT01852513|The University of Chicago|Dr. Jayant Pinto, PI|773-702-6727|jpinto@surgery.bsd.uchicago.edu|
21286192|NCT01670045|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21286193|NCT03360019|University of Florida|Glenn Smith|352-273-6556|glennsmith@ufl.edu|
21286194|NCT03801642|University of Kansas Medical Center|Dr. Jeffrey Burns|913-588-0555|jburns2@kumc.edu|
21286195|NCT01462110|Johnson & Johnson Consumer Inc.|Michael Lynch|908-433-6423|mlynch23@ITS.JNJ.com|
21286196|NCT00753675|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21286197|NCT00401518|Globus Medical|Director of Clinical Affairs|610-930-1800|jmyer@globusmedical.com|
21286198|NCT00964028|GlaxoSmithKline|GSK Response Center|866-435-7343||
21286199|NCT02106351|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
21286200|NCT00069823|Johns Hopkins University|Ellen Brown|443-287-3170|ala-acrc@jhsph.edu|
21286201|NCT00534417|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
21286202|NCT02058589|GlaxoSmithKline|GSK Response Center|866-435-7343||
21286203|NCT01575756|Octapharma USA|Director of Clinical Operations|201 604-1149|sylvia.werner@octapharma.com|
21286204|NCT00490971|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Clinical Leader|609-730-2436||
21286205|NCT00593450|CATT Research Group|Dr. Maureen Maguire|215-615-1501|maguirem@mail.med.upenn.edu|
21286206|NCT04754542|University of Colorado Denver|Eric Engebretson|3037244518|eric.engebretson@cuanschutz.edu|
21286207|NCT04570709|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat Canter|9199620000|Melahat_Canter@med.unc.edu|
21286208|NCT01466361|GlaxoSmithKline|GSK Response Center|866-435-7343||
21286209|NCT02358031|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21286210|NCT01212094|NINDS, NIH|Dr. Bibiana Bielekova, Prinicipal Investigator|301-402-4488|bibiana.bielekova@nih.gov|
21286211|NCT01490892|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Flemming Forsberg|215-955-4870|flemming.forsberg@jefferson.edu|
21286212|NCT03621956|Neonatal Research Institute, Sharp Mary Birch Hospital for Women & Newborns|Anup Katheria, M.D.|858-939-4170|anup.katheria@sharp.com|
21286213|NCT05664581|AbbVie|Global Medical Services|001 8006339110|abbvieclinicaltrials@abbvie.com|
21286214|NCT03101150|King Fahd Medical City|Consultant Obstetritian and Gynecologist|00966539417217|amali@kfmc.med.sa|
21286215|NCT05541939|Vogenx|Chief Scientific Officer|919-659-5677|info@vogenx.com|
21286216|NCT02772666|Mashhad University of Medical Sciences|Dr. Amirhossein Vejdani|+9151105411|amirhosein_vejdani@yahoo.com|
21286217|NCT04789382|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21286218|NCT01317641|Orion Pharma, Development, R&D|Head of Oncology|+358 10 4261|mika.mustonen@orionpharma.com|
21286219|NCT04980014|Takeda|Study Director|+1 877-825-3327|TrialDisclosures@takeda.com|
21286220|NCT00715559|Mount Sinai School of Medicine|Dr. James Murrough|212-241-7574|james.murrough@mssm.edu|
21286221|NCT01302418|QIAGEN|Tony Lam|301-944-7090|tony.lam@qiagen.com|
21286222|NCT02749227|Columbia University|Pamela U. Freda, MD|212-305-2254|puf1@cumc.columbia.edu|
21286223|NCT01289548|Department of Anaesthesiology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology|Hua zheng|00862783663173|huaz1980@hotmail.com|
21286224|NCT02787304|Mirum|Study Physician|1 650-667-4085|medinfo@mirumpharma.com|
21286225|NCT02359110|Penn State Milton S. Hershey Medical Center|Timothy Deimling, M.D.|717-531-3503|tdeimling@pennstatehealth.psu.edu|
21301372|NCT03281200|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21286226|NCT01450319|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21286227|NCT04771013|GIMUNICAH|Héctor M. Ramos-Zaldívar|+56934988958|hramos@unicah.edu|
21286228|NCT04754646|TEOXANE SA|Clinical Project Manager|+41(0) 22 344 96 36|clinical@teoxane.com|
21286229|NCT01051921|Conatus Pharmaceuticals Inc.|Vice President, Clinical Development|(858) 457- 7227|MHuyghe@conatuspharma.com|
21286230|NCT00419757|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21286231|NCT02100280|SNUBH|Dr. Bon-wook Koo|+82-10-7227-1379|tendong2@gmail.com|
21286232|NCT03045653|Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative innovation center for Cancer Medicine|Zhongyu Yuan|+8613798027658|yuanzhy@sysucc.org.cn|
21286233|NCT00193414|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21286234|NCT00379834|West Virginia University|Dr. Tony Realini|3045986926|realinia@wvuhealthcare.com|
21286235|NCT01519817|National Cancer Institute|Dr. James Gulley|301-480-8870|gulleyj@mail.nih.gov|
21286236|NCT01116921|Unviersity of Minnesota|Kari D. Roberts, MD|612-625--9577|rober694@umn.edu|
21286237|NCT01325350|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21286238|NCT01460303|UMass Medical School|Dr. Michael K. Flynn||Michael.Flynn@umassmemorial.org|
21286239|NCT02962427|University of Colorado|Cristina Wood, MD|7208483323|cristina.wood@ucdenver.edu|
21286240|NCT01716806|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
21286241|NCT00956839|Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow|Professor Eesh Bhatia|00915222494382|ebhatia@sgpgi.ac.in|
21286242|NCT02692586|Inari Medical|Ashleigh Willson|877-923-4747|ashleigh.willson@inarimedical.com|
21286243|NCT04421040|Mayo Clinic|Dr. Grace Lin|507-255-1267|lin.grace@mayo.edu|
21286244|NCT02189668|Nationwide Children's Hospital|Peter Minneci|6147223066|peter.minneci@nationwidechildrens.org|
21286245|NCT03316586|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-2335|Sara_Tolaney@dfci.harvard.edu|
21286246|NCT01111565|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21286247|NCT04131712|University of Kentucky|Douglas Long|859-323-5438|delong2@uky.edu|
21286248|NCT00766597|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
21286249|NCT01254656|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21286250|NCT02946892|UTSW|Ryan Butts|2144565822|ryan.butts@utsouthwestern.edu|
21286251|NCT00814138|University of Kansas Medical Center|Richard J. Barohn, MD/ Chairman of Neurology|913-588-6094|rbarohn@kumc.edu|
21286252|NCT02381678|Guangdong General Hospital|Dr. Huiming Guo (Chief in Cardiac Surgical Department)|86-13609089789|guohuiming@vip.tom.com|
21286253|NCT02196857|The University of Texas MD Anderson Cancer Center|Ravandi-Kashani,Farhad MD./Professor|713-745-0394|fravandi@mdanderson.org|
21286254|NCT00583908|Vistakon|Kurt Moody, OD FAAO|904-443-3088|kmoody1@its.jnj.com|
21286255|NCT00270296|Harvard TH Chan School of Public Health|Dr. Roger Shapiro|617-432-2334|rshapiro@hsph.harvard.edu|
21286256|NCT01265394|GE Healthcare|Dr. Paul Sherwin|1-609-514-6820|paulsherwin@ge.com|
21286257|NCT01116037|Medtronic|Ryan Palmer|+17635149732|ryan.j.palmer@medtronic.com|
21301373|NCT02194985|Amicus Therapeutics|Medical Affairs|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
21301374|NCT00225732|Cumberland Pharmaceuticals Inc.|Amy Rock, Ph.D.|615-255-0068|arock@cumberlandpharma.com|
21270120|NCT02200614|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
21301375|NCT01155518|suny buffalo|sandeep dhindsa||sandhindsa@yahoo.com|
21301376|NCT02561832|AstraZeneca Pharmaceuticals LP|Carsten Goessl MD|+1 2404490654|Carsten.Goessl@astrazeneca.com|
21301377|NCT02304367|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|Medinfo@ultragenyx.com|
21301378|NCT00594815|Memorial Sloan Kettering Cancer Center|Dr. Antonio Omuro|212-639-7523|omuroa@mskcc.org|
21301379|NCT03527732|Swiss Tropical and Public Health Institute|Prof. Dr. Jennifer Keiser|+41 (61) 284 8218|jennifer.keiser@swisstph.ch|
21301380|NCT03599089|Concentric Analgesics|Head of Clinical Operations|14154847921|nancy@concentricanalgesics.com|
21301381|NCT03214666|GT Biopharma, Inc.|Dr. Gregory Berk|925-719-3531|gb@gtbiopharma.com|
21301382|NCT00272311|Florida Atlantic University|Charles H. Hennekens, M.D.||chenneke@fau.edu|
21301383|NCT02207088|AbbVie|Global Medical Services|800-633-9110||
21301384|NCT03417154|University of Minnesota, Masonic Cancer Center|Dr. Joseph Maakaron|(612) 626-5654|maaka001@umn.edu|
21301385|NCT03511937|University of North Carolina at Chapel Hill|Anna Grummon, PhD|(617) 495-2021|agrummon@hsph.harvard.edu|
21301386|NCT04853017|Elicio Therapeutics, Inc.|Study Director|(857) 209-0050|info@elicio.com|
21301387|NCT00541385|Medicines for Malaria Venture (MMV)|Stephan Duparc, MD, Chief Medical Officer|+41 22 555 0300|duparcs@mmv.org|351
21301388|NCT03155841|University of Pennsylvania|Jose Bauermeister|215-898-9993|bjose@upenn.edu|
21301389|NCT04411667|Sharp HealthCare|Matthew Geriak, PharmD / Research Pharmacist|8589393717|matthew.geriak@sharp.com|
21301390|NCT00949702|Hoffmann-La Roche|Medical Communications|800-821-8590||
21301391|NCT03399552|Memorial Sloan Kettering Cancer Center|Dr. Andreas Rimner, MD|646-608-2449|Rimnera@MSKCC.ORG|
21301392|NCT00734500|Duke University|Michael Cohen-Wolkowiez|9196688812|michael.cohenwolkowiez@duke.edu|
21301393|NCT01286480|University of Alberta|Dr. Andrew Mackie|780-407-8361|andrew.mackie@ualberta.ca|
21301394|NCT00834093|Dana-Farber Cancer Institute|Dr. Glenn Hanna|617.632.6799|GJHANNA@PARTNERS.ORG|
21301395|NCT00606593|Actelion Pharmaceuticals Ltd|Pascal Charef/Clinical Trial Leader|+41 61 565 65 65||
21301396|NCT01724346|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21301397|NCT01642589|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21301398|NCT01393392|Rutgers Robert Wood Johnson Medical School|Dr. Nina Cooperman|732-235-8569|cooperna@rwjms.rutgers.edu|
21301399|NCT03959176|Wake Forest University School of Medicine|Keith Walter, MD|336-716-2144|kwalter@wakehealth.edu|
21301400|NCT00759941|Alcon Research, Ltd.|Head, Global Medical Affairs|800-862-5266|medinfo@alconlabs.com|
21301401|NCT02736578|Stanford University|Eben Rosenthal|650-723-2967|elr@stanford.edu|
21301402|NCT00802945|Nektar|Alison Hannah, MD||AHannah@nektar.com|
21301403|NCT05307692|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21301404|NCT04400643|Hamilton Medical AG|Jean Michel Arnal|+33 1 84 04 97 58|jarnal@hamilton-medical.com|
21301405|NCT02587637|Abbott|Robyn Capobianco|+1 512 286 4274|robyn.capobianco@abbott.com|
21301406|NCT02433366|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
21301407|NCT04098237|Cedars-Sinai Medical Center|Dr. Andrew Hendifar, MD|310-423-2217|andrew.hendifar@cshs.org|
21301408|NCT02633059|Mayo Clinic|Dr. Shaji Kumar|507-284-5096|Kumar.Shaji@mayo.edu|
21301409|NCT01284335|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21301410|NCT02656693|Brigham and Women's Hospital|Heather J. Baer, ScD|617-525-7503|hbaer@bwh.harvard.edu|
21301411|NCT01596062|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21301412|NCT02255435|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21301413|NCT01788358|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21301414|NCT01168219|Washington University School of Medicine|Ravi Vij, MD||rvij@im.wustl.edu|
21301415|NCT01027273|Icahn School of Medicine at Mount Sinai|Carol R Horowitz, MD, MPH|212-659-9567|carol.horowitz@mountsinai.org|
21301416|NCT03249116|Tufts University|Dr. Megan K Mueller|508-887-4543|megan.mueller@tufts.edu|
21301417|NCT02948634|UT Southwestern|Jason Zafereo|14-648-1002|jason.zafereo@utsouthwestern.edu|2146481002
21301418|NCT03762317|Hennepin County Medical Center|Dr. Kunal Gupta|6128732677|kunal.gupta@hcmed.org|
21301419|NCT03007225|Ain Shams University|Dr Iman Montasser, Assistant professor of Tropical Medicine member of HCC clinic and group , Ain Sha|0020201065065333|imanfawzy2@gmail.com|
21301420|NCT01413204|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21301421|NCT01255436|University of the Philippines Manila|Dr. Lia M. Palileo|6325679740|liapalileo@gmail.com|
21301422|NCT01237899|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21301423|NCT00859456|Columbia University|Robert Taub, MD||rntaubipod@gmail.com|
21301424|NCT00880919|University of Minnesota|Dr. S. Charles Schulz, MD|612-273-9820|scs@umn.edu|
21301425|NCT02910986|Mayo Clinic|Celine M. Vachon, Ph.D.|507 293-3247|Vachon.Celine@mayo.edu|
21301426|NCT04902924|Rehabilitation and Exercise Science Laboratory (RESlab), University of Applied Sciences and Arts of Southern Switzerland (SUPSI)|Vanessa Wellauer|0041 81 300 01 78|vanessa.wellauer@supsi.ch|
21301427|NCT02500797|Memorial Sloan-Kettering Cancer Center|Sandra P. D'Angelo, M.D.|646-888-4159|dangelos@mskcc.org|
21301428|NCT02983552|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
21301429|NCT03339219|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21301430|NCT03702283|VANDERBILT UNIVERSITY MEDICAL CENTER|Cosby A Stone, Jr. MD, MPH|6153223412|Cosby.a.stone@vumc.org|
21301431|NCT02902237|Department of Medicine A, University Hospital Muenster, Germany|Prof. Dr. Wolfgang Berdel, Professor of Medicine|+49 251 835|berdel@uni-muenster.de|2672
21301432|NCT01469377|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21301433|NCT00074490|National Cancer Institute|Dr. Steven Pavletic|301-402-4899|steven_pavletic@nih.gov|
21301434|NCT03937999|Montefiore Medical Center|Paul Riska, MD|718-920-6494|priska@montefiore.org|
21286258|NCT00716456|Memorial Sloan Kettering Cancer Center|Dr. Gregory J. Riely|646-888-4199|rielyg@mskcc.org|
21286259|NCT04556760|AstraZeneca Clinical Study Information Center|Global Clinical Head|1-877-240-94 79|information.center@astrazeneca.com|
21286260|NCT05926648|Masimo Corporation|Ahmed Alghazi|949-297-7000|studies@masimo.com|
21286261|NCT02849743|The Children's Hospital of Philadelphia|Dr. Shana McCormack|(215) 590-3174|mccormacks1@chop.edu|
21286262|NCT03677635|King's College London|Dr Clementine Edwards|07557866053|clementine.edwards@kcl.ac.uk|
21286263|NCT03064113|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
21286264|NCT02168491|Medical University Vienna, Austria|Prof. Dr. Michael Krebs|+ 43 1 40400|michael.krebs@meduniwien.ac.at|43120
21286265|NCT00809445|Columbia University, Mailman School of Public Health|Dr. Lisa Metsch|212-305-3577|lm2892@columbia.edu|
21286266|NCT03874013|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
21286267|NCT00972959|"Department of Clinical Therapeutics, University of Athens School of Medicine, Alexandra General Hospital of Athens,"|Prof. M. A. Dimopoulos|0030 210 3381511|mdimop@med.uoa.gr|
21286268|NCT02895035|Penn State Hershey Eye Center|Seth Pantanelli|717-531-5690|spantanelli@pennstatehealth.psu.edu|
21286269|NCT00661089|The Rehabilitation Institute of Chicago|Dr. Christina Marciniak|312-238-1000|cmarciniak@ric.org|
21286270|NCT02572453|Dana-Farber Cancer Institute|Jillian Foreman|1-877-338-7425|jillianM_foreman@dfci.harvard.edu|
21286271|NCT03861091|Wake Forest Baptist Comprehensive Cancer Center|Biostatistician|336-716-5440|blevine@wakehealth.edu|
21286272|NCT00321906|The University of Chicago|Edward Garrity, MD|(773) 834-1119|egarrity@uchicago.edu|
21286273|NCT02899065|UC Davis Medical Center|Larissa May, MD, MSHS, MSPH, Director of Emergency Medicine Innovation and External Partnerships|916-734-1593|lsmay@ucdavis.edu|
21286274|NCT00186485|Stanford University|Dr. Hugh Brent Solvason|650 776 4793|solvason@stanford.edu|
21286275|NCT02247739|Pharming Group NV|VP Clinical Research & Medical Affairs||a.relan@pharming.com|
21286276|NCT03771963|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21286277|NCT01026948|University of Liverpool|Professor Zarko Alfirevic|00 44(1)51 702|zarko@liverpool.ac.uk|4100
21286278|NCT01705977|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21286279|NCT02981914|University of Chicago|Theodore Karrison (Research Professor)|773-702-9326|karrisont@nrgoncology.org|
21286280|NCT02541409|Johns Hopkins University Bloomberg School of Public Health|Dr. Shruti Mehta|443-287-3837|smehta@jhu.edu|
21286281|NCT00520039|West Virginia School of Osteopathic Medicine|Dr. Karen Steele|(304)667-4255|ksteele@osteo.wvsom.edu|
21286282|NCT03560869|University of Delaware|William B. Farquhar|302-831-6178|wbf@udel.edu|
21286283|NCT00325819|Group Health Research Institute|Lisa Jackson, MD, MPH|206-442-5216|jackson.L@ghc.org|
21286284|NCT01545141|Roswell Park Cancer Institute|Kris Attwood|716-845-2300|Kristopher.attwood@roswellpark.org|
21286285|NCT03934216|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21286286|NCT01491022|University of Miami|Dr Corneliu Luca|3052432235|cluca@med.miami.edu|
21286287|NCT03143257|Medtronic Xomed|Sr Manager, Clinical Affairs|904-296-9600|rs.entgm@medtronic.com|
21286288|NCT01095497|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21286289|NCT00619827|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
21286290|NCT03407313|Recros Medica|Head of Clinical Development|925-223-8581|clinical@recrosmedica.com|
21286291|NCT01396083|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21286292|NCT01063855|Janssen Research & Development, LLC|CDTL, Cardiovascular and Metabolism|1 908 704-4648||
21286293|NCT00735709|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21286294|NCT02492802|University Medical Center Groningen|Jan-Willem Alffenaar, PhD|+31503614035|j.w.c.alffenaar@umcg.nl|
21286295|NCT01165307|Mayo Clinic|Dr. Abimbola O. Famuyide|507-284-7035|Famuyide.Abimbola@mayo.edu|
21286296|NCT03234036|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21286297|NCT01126099|VA Puget Sound|Lucy Wang|206-277-5089|wanglucy@u.washington.edu|
21286298|NCT02472730|Baylor College of Medicine|Dr. Kalpesh K. Patel|7137980947|kalpeshp@bcm.edu|
21286299|NCT02163395|Clinical Research|Intsitut Straumann AG|0041619651111|research@straumann.com|
21286300|NCT01195779|GlaxoSmithKline|GSK Response Center|866-435-7343||
21286301|NCT01401595|Perelman School of Medicine at the University of Pennsylvania|Kelly C. Allison, Ph.D.|215-898-2823|kca@mail.med.upenn.edu|
21286302|NCT02537951|Erasmus MC|Joost L.M. Jongen|+31107041415|j.jongen@erasmusmc.nl|
21286303|NCT02683239|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21258061|NCT03449095|University of Illinois at Urbana-Champaign|Dr. Catharine Fairbairn|215-300-5850|cfairbai@illinois.edu|
21258062|NCT02457637|Renji Hospital, Shanghai Jiao Tong University School of Medical|Professor Hai Li , Director of Clinical Trials|+86-13818525494|haili＿17@126.cpm|
21258063|NCT00159861|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21258064|NCT01848184|Medtronic|Michelle DiSalvo|774 284 6089|michelle.v.disalvo@medtronic.com|
21258065|NCT01553136|Yale University|Stephanie Samples O'Malley, PhD, Professor of Psychiatry|(203) 974-7590|stephanie.omalley@yale.edu|
21258066|NCT06080451|University of Michigan|Dr. David Flood|734-647-2892|dcflood@umich.edu|
21258067|NCT01040052|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21258068|NCT03451773|National Cancer Institute|Dr. Udo Rudloff|240-760-6238|rudloffu@mail.nih.gov|
21258069|NCT02068547|Washington University St. Louis|Wilson Z. Ray, MD|314-362-9959|rayz@wustl.edu|
21258070|NCT03657043|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
21258071|NCT04762537|New York Psychiatric Institute|Kenzie Potter|2535920386|kenzie.potter@nyspi.columbia.edu|
21258072|NCT02730884|The University of Texas MD Anderson Cancer Center|Jorge Cortes, MD/Professor|713-794-5783|jcortes@mdanderson.org|
21258073|NCT00631371|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21258074|NCT01661140|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21258075|NCT00781456|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21258076|NCT03174132|Galderma|Reception|+46184749000|reception.seupp@galderma.com|
21258077|NCT01877187|Yale University|Todd Schlachter, MD|(203) 785-5885|todd.schlachter@yale.edu|
21258078|NCT02340585|Stryker|Stacy Phung|678 469 2428|stacy.phung@stryker.com|
21258079|NCT04852848|University of Oregon|Anne Marie Mauricio, Research Associate Professor|602-920-7459|amariem@uoregon.edu|
21258080|NCT05098041|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21258081|NCT00618410|The University of Chicago|Dr. Robert M. Naclerio, MD|(773) 702-1865|rnacleri@surgery.bsd.uchicago.edu|
21258082|NCT03958552|University of Maryland School of Nursing|Dr. Joan Carpenter|443-880-1430|joan.carpenter@umaryland.edu|
21258083|NCT02798536|National Cancer Institute|Dr. Raffit Hassan|240-760-6232|hassanr@mail.nih.gov|
21258084|NCT01297270|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21258085|NCT00714792|University of Rochester|Michael K. Flynn, MD|585-273-3232|michael_flynn@urmc.rochester.edu|
21258086|NCT00382993|Glaxo Smith Kline|GSK Response Center|1-866-435-7343||
21258087|NCT03196076|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
21258088|NCT02461992|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21258089|NCT01479543|Hero Institute for Infant Nutrition|Esther Matencio Hilla|+0034 968 89 89 00|esther.matencio@hero.es|
21258090|NCT00906087|University of Michigan|Sayoko E. Moroi|734-763-3732|smoroi@med.umich.edu|
21258091|NCT02898259|Clevleland|Dr. Brian Hill|1-866-223-8100|TaussigResearch@ccf.org|
21286304|NCT03846544|Brussels IVF|Dr Liese Boudry|024779857|liese.boudry@uzbrussel.be|
21258092|NCT03303794|Montefiore Medical Center|Dr.Singh Nair|7189205932|sinair@montefiore.org|
21286305|NCT00521365|AstraZeneca|Gerard Lynch|09645895|ClinicalTrialTransparency@astrazeneca.com|4415
21270121|NCT00532779|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com|
21270122|NCT02662556|AcelRx Pharmaceuticals, Inc.|Pamela P. Palmer, MD, PhD, Chief Medical Officer|650-216-3504|ppalmer@acelrx.com|
21270123|NCT00788008|Duke University Medical Center|Deborah Attix, PhD|919-668-2846|deborah.koltai@dm.duke.edu|
21270124|NCT02424799|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21270125|NCT00828516|Lynda Jackson Macmillan Centre|Dr Beverley de Valois|+44(0)1923-844456|beverley.devalois@nhs.net|
21270126|NCT00689273|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21270127|NCT02953873|Medical University of South Carolina|Caitlin Schaffner|843-792-7558|schaffne@musc.edu|
21270128|NCT05406596|Seigla Medical|John Schultz|7632133026|jschultz223@gmail.com|
21270129|NCT01456494|University of Chicago|Mary Akel|773-834-4489|makel@medicine.bsd.uchicago.edu|
21270130|NCT02787746|Department of Neurology, Xuan Wu Hospital of Capital Medical University; Freindship Hospital of Capital Medical University|Jianping Jia|+86 10 83188730|jjp@ccmu.edu.cn|
21270131|NCT00834288|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
21270132|NCT00572468|Portland VA Health Care System|Wesley Stoller|503-220-8262|wesley.stoller@va.gov|54931
21270133|NCT03703297|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21270134|NCT04876482|Department of Physical Therapy, Shu-Zen Junior College of Medicine and Management, Kaohsiung, Taiwan|Yi-Ju, Lai|+886963123117|jasmine19900728@gmail.com|
21270135|NCT03877484|Smith and Nephew|Clinical Study Manager|1482673917|rebecca.mcdonald@smith-nephew.com|+44
21270136|NCT01142466|Merck Serono GmbH, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Medical Responsible|+49 6151 72 5200|service@merckgroup.com|
21270137|NCT04084028|University of Vermont Department of Nutrition and Food Sciences|Mattie Alpaugh|8026569526|malpaugh@uvm.edu|
21270138|NCT00700310|Eisai Call Center|Eisai Inc.|888-422-4743||
21270139|NCT02414854|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21270140|NCT01422720|BIAL - Portela & Cª S.A.|Director R&D|+351-229866100|clinical.trials@bial.com|
21270141|NCT00606801|Yale University|Mehmet Sofuoglu, M.D., Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
21270142|NCT02082262|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21270143|NCT01726335|Janssen-Cilag Ltd.|Medical Group Manager|+55 11 30302738||
21270144|NCT01375569|National Cancer Institute|Dr. Tim Greten|301-451-4723|gretentf@mail.nih.gov|
21270145|NCT01557452|Italfarmaco SpA|Paolo Bettica, MD|+39 02 64431|p.bettica@italfarmaco.com|
21270146|NCT02625207|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21270147|NCT02162511|Stanford University|Erica Goodwin|253-508-3556|egood55@stanford.edu|
21270148|NCT03565666|Mass. General Hospital|Dr. Steven J. Russell|617-726-8722|sjrussell@mgh.harvard.edu|
21270149|NCT02016755|AnGes USA, Inc.|Dr. Susan Pitman Lowenthal|240-780-9025|spitmanlowenthal@anges-usa.com|
21270150|NCT01289431|Bausch Health|Study Director||susan.harris@bauschhealth.com|
21270151|NCT00804349|Albert Einstein Healthcare Network|Roberta Costello; Research Compliance|215-456-7225|bcostell@einstein.edu|
21270152|NCT01084603|J&J Consumer and Personal Products Worldwide|Joyce Hauze, Sr Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
21270153|NCT03379246|TriHealth Inc.|Dr. Catrina Crisp|513-463-4300|Catrina_Crisp@trihealth.com|
21270154|NCT01392170|University of Texas (UT) MD Anderson Cancer Center|Alfonso Quintas-Cardama, MD/Professor, Leukemia|713-745-4009|CR_Study_Registration@mdanderson.org|
21270155|NCT00390949|Imperial College London|Professor Simon Gregson|+4402075943279|Sajgregson@aol.com|2075943279
21270156|NCT02535247|Fox Chase Cancer Center|Protocol Development Coordinator|215-728-4097|ryan.romasko@fccc.edu|
21270157|NCT00323635|Brigham and Women's Hospital|Quentin Regestein|617-732-4497|qregestein@partners.org|
21270158|NCT02320838|Universidad de Castilla-La Mancha|Dr. Juan Avendaño Coy|+34 925268800|juan.avendano@uclm.es|5014
21270159|NCT02018042|Columbia University Department of Dermatology Clinical Research Unit|Grace Ulerio, CCRC|212-305-6593|gu2102@cumc.columbia.edu|
21270160|NCT02419469|UT MD Anderson Cancer Center|Rytting,Michael E.,M.D. / PEDIATRICS|713-792-7734|CR_Study_Registration@mdanderson.org|
21270161|NCT01414062|Columbia University Irving Medical Center|Dawn Hershman, MD, MS|212-342-4580|dlh23@cumc.columbia.edu|
21270162|NCT04285983|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21270163|NCT03583931|Denver Health and Hospital Authority|Dr Fredric Pieracci|303-602-1863|Fredric.Pieracci@dhha.org|
21270164|NCT00902265|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21270165|NCT02866695|University of California San Francisco Dept. of Dermatology|Dr. Sarah Arron, MD, PhD|415-353-9684|sarah.arron@ucsf.edu|
21270166|NCT05016765|Washington University School of Medicine|Kevin J. Black, M.D.|1-314-362-5041|kevin@wustl.edu|
21270167|NCT03747939|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21286306|NCT03627832|University of Missouri|Dr. Mary Beth Miller|573-882-1813|millmary@health.missouri.edu|
21286307|NCT01950299|Virginia Commonwealth University|Antonio Abbate, MD, PhD|804-828-0513|antonio.abbate@vcuhealth.org|
21270168|NCT01988493|Merck KGaA Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21286308|NCT03150082|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21286309|NCT01718483|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21286310|NCT03049501|University of Miami|David Loewenstein|305-355-7016|dloewenstein@miami.edu|
21286311|NCT04547140|Grifols Therapeutics LLC|Rhonda Griffin, Clinical Program Leader/Director|+1 919 757 1744|Rhonda.griffin@grifols.com|
21286312|NCT02119299|Scientific Intake|Richard P. Schneider|917-676-6251|rschneider@scientificintake.com|
21286313|NCT00815997|NPO International TRI Network|Sigeru Saito, MD, Principal Investigator|+81-467-461717|saito@shonankamakura.or.jp|10490
21286314|NCT04613739|Harvard Pilgrim Health Care Institute|Dr. Alison Galbraith|617-867-4893|alison_galbraith@harvardpilgrim.org|
21286315|NCT05270980|NYU Langone Health|Dr. Joshua Chodosh|212-263-6768|Joshua.Chodosh@nyulangone.org|
21286316|NCT00735943|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21286317|NCT04033146|Georgia Insitute of Technology|Dr. Gregory S. Sawicki; Professor Mechanical Engineering|919 448 5099|gregory.sawicki@me.gatech.edu|
21286318|NCT00115778|Columbia University Medical Cetner|Selim Arcasoy, MD|212-305-7771|sa2059@columbia.edu|
21286319|NCT01607593|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21286320|NCT00500578|UT MD Anderson Cancer Center|Roy F Chemaly, MD/MPH, MBA /Associate Professor|713-745-1116|rfchemaly@mdanderson.org|
21286321|NCT04428385|Duke University|Wendy Prudhomme - O'Meara, PhD|919-613-4406|wendy.omeara@duke.edu|
21258093|NCT03016325|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
21258094|NCT02941627|Oticon Medical|Clinical Research Director|+33 4 93 95 18 18|mhoe@oticonmedical.com|
21258095|NCT02595723|UT Southwestern Medical Center|E. Sherwood Brown, M.D., Ph.D.|214-645-6950|sherwood.brown@utsouthwestern.edu|
21258096|NCT01087905|University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|608-262-7563|sss@ctri.medicine.wisc.edu|
21258097|NCT02223260|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21258098|NCT03711500|New York State Psychiatric Institute|Dr. Joshua Kantrowitz|6467746738|Joshua.Kantrowitz@nyspi.columbia.edu|
21258099|NCT01902290|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21258100|NCT00385255|GlaxoSmithKline|GSK Response Center|866-435-7343||
21258101|NCT01265550|Dallas VA Medical Center|Stuart Spechler||sjspechler@aol.com|
21258102|NCT01297335|The Center for Clinical Research|Medical Director|3367656181|rrauck@ccrpain.com|
21258103|NCT01929408|Fred Hutchinson Cancer Research Center|Mohamed Sorror, MD, MSc|(206) 667-6298|msorror@fredhutch.org|
21258104|NCT04377711|Covis Pharma|Clinical Trial Interest|1-877-374 -4177|CTInterest@covispharma.com|
21258105|NCT02079987|University of Florida|Donna L. Carden, MD, MPH|352-265-5911|dcarden@ufl.edu|
21258106|NCT01015768|Southern California College of Optometry|Jerry R. Paugh, OD, PhD|714-449-7487|jpaugh@scco.edu|
21258107|NCT01073267|University of Texas (UT) MD Anderson Cancer Center|Bouthaina Dabaja, MD/Associate Professor, Radiation Oncology Department||CR_Study_Registration@mdanderson.org|
21258108|NCT01225731|Merck Sharp & Dohme|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21258109|NCT00577642|Massachusetts General Hospital|Dr Noopur Raje|6177260711|nraje@partners.org|
21258110|NCT01556425|Johns Hopkins University School of Medicine|Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
21258111|NCT01783080|NY State Psychiatric Institute|David J Hellerstein MD, Professor of Clinical Psychiatry, Columbia|646-774-8000|hellers@nypsi.columbia.edu|
21258112|NCT01505634|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21258113|NCT02076997|Baylor College of Medicine|Dr. Jennifer Foster|832-824-4646|jhfoster@texaschildrens.org|
21258114|NCT02533063|University of Wisconsin|Diane Krueger|6082656410|dckruege@wisc.edu|
21258115|NCT00542269|Novartis Pharmaceuticals|Study Director|862 778-8300||
21258116|NCT03873714|Medtronic Neurovascular|Director, Global Clinical Research|949.837.3700|rs.advance@medtronic.com|
21258117|NCT00814892|Mayo Clinic|Dr. Manish Kohli|507-284-2511|kohli.manish@mayo.edu|
21258118|NCT00845650|Emergent Product Development Gaithersburg, Inc.|Study Director||clinicalstudies@ebsi.com|
21258119|NCT02511730|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
21258120|NCT01811875|Bio Products Laboratory Ltd|European Medical Affairs Lead|+44 20 8957 2200|medinfo@bpl.co.uk|
21258121|NCT00531752|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21258122|NCT01181011|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|800-542-6257|clintriage.rdg@boehringer-ingelheim.com|Option 4
21258123|NCT00950664|Seoul National University Hospital|BS Jeon|+82220722876|brain@snu.ac.kr|
21258124|NCT00677014|Boston Scientific|Greg Voss, Clinical Director|651-581-3068|gregory.voss@bsci.com|
21258125|NCT01326546|Institute of Immunology，PLA|Dr.Wu|02368752230|wuyuzhang@yahoo.com|86
21258126|NCT03152019|Hospices Civils de Lyon|Dr Dupuis Girod|427856522|sophie.dupuis-girod@chu-lyon.fr|+33
21258127|NCT00755274|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21258128|NCT00081159|University of Texas (UT) MD Anderson Cancer Center|Shi-Ming Tu, MD|1-877-632-6789|CR_Study_Registration@mdanderson.org|
21258129|NCT03693625|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21258130|NCT00684255|New York Medical College|Dr. Mitchell S. Cairo|914-594-3650|mitchell_cairo@nymc.edu|
21258131|NCT01883635|University of Rochester|Dr. Charles Kamen|585-275-9958|charles_kamen@urmc.rochester.edu|
21258132|NCT01464307|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
21258133|NCT00761514|Abbott|Medical Information Specialist|1-800-633-9110||
21258134|NCT00853671|Massachusetts General Hospital|Dr. Brian B. Ghoshhajra|617-726-3745|bghoshhajra@partners.org|
21301435|NCT06404021|University of Calabria|Antonio Curcio|+390984681889|antonio.curcio.cardio@unical.it|
21301436|NCT04139798|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
21301437|NCT04939415|Krupp Center for Integrative Research, University of California San Diego|Gordon Saxe, M.D./Ph.D.|6195435765|gsaxe@health.ucsd.edu|
21301438|NCT04308291|Medtronic Diabetes|Fabio Di Piazza|+393456172157|fabio.di.piazza@medtronic.com|
21301439|NCT02481219|Given Imaging (a Medtronic company)|Liron Bar Yaakov|+97249097946|liron.bar-yaakov@covidien.com|
21301440|NCT03239106|Washington University School of Medicine|Brian Kim, Associate Professor of Medicine|314-273-1376|briankim@wustl.edu|
21270169|NCT03087773|Medical University of Graz|Univ.-Prof. PD Harald Sourij, MD, MBA|+43 316 385 81310|ha.sourij@medunigraz.at|
21301441|NCT02357368|Emory University|Lisa Haddad, MD|404-778-1385|lisa.haddad@emory.edu|
21270170|NCT02703779|University of Kansas Cancer Center|Dr. Sid Ganguly|913-588-6030|sganguly@kumc.edu|
21270171|NCT03496207|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21258135|NCT01035905|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
21270172|NCT00837031|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21270173|NCT00902278|University of Massachusetts Medical School|Mary Co|5088562927|mary.co@umassmed.edu|
21270174|NCT02618772|MUHC|Dr. Jennifer Turnbull|514-412-4400|jennifer.turnbull@mcgill.ca|23039
21270175|NCT01289990|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdf@boehringer-ingelheim.com|
21270176|NCT04628221|MCRA, LLC|Nicole Harris|202-552-5800|nharris@mcra.com|5823
21270177|NCT02441179|Teleton Institute|Dr. Angela Navarrete-Opazo|+56 0226772075|angelaandrean@gmail.com|
21270178|NCT03454672|Novoxel Ltd|Ifat Klein|+972-52-6009860|ifat@novoxel.com|
21270179|NCT01488071|H. Lundbeck A/S|H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@lundbeck.com|
21270180|NCT02139306|PTC Therapeutics, Inc|Joseph McIntosh|908 912-9138|jmcintosh@ptcbio.com|
21270181|NCT04449354|HidraMed Solutions Ltd|Suzanne Moloney|+353873220509|suzanne@hidramedsolutions.com|
21270182|NCT01220128|GlaxoSmithKline|GSK Response Center|866-435-7343||
21270183|NCT00919932|University of Pittsburgh|Dr Han Liang|412-624-4141|liangh2@upmc.edu|
21270184|NCT02719639|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21270185|NCT02508649|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
21270186|NCT01311505|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21270187|NCT02360124|University of Hong Kong|Prof. E.C.M. Lo|852-2859 0292|edward-lo@hku.hk|
21270188|NCT02737072|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21270189|NCT00567996|Novartis Pharmaceuticals|Study Director|862-778-8300||
21258136|NCT01273883|Mayo Clinic|Dr. Michael J. Cevette|480-301-7020|mcevette@mayo.edu|
21270190|NCT02149199|AstraZeneca AB|Stefan Ivanov|000000000000|information.center@astrazeneca.com|
21270191|NCT02956005|MedStar Georgetown Transplant Institute|Alexander Gilbert|202-444-0621|Alexander.J.Gilbert@gunet.georgetown.edu|
21270192|NCT02762877|Genomic Health, Inc.|Director of Clinical Trials|1.650.569.2042|kgran@genomichealth.com|
21270193|NCT01806259|UoA|Prof Patrice Forget|497 12 28 36|forgetpatrice@yahoo.fr|
21270194|NCT02524665|GlaxoSmithKline|GSK Response Center|866-435-7343||
21270195|NCT04179474|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21270196|NCT01066039|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21270197|NCT03022799|Kainos Medicine, Inc|Dr. JaeMoon Lee|+1 408 202 4017|jlee@kainosmedicine.com|
21270198|NCT02642991|CooperVision, Inc.|Paul Chamberlain|925 730-6754|PChamberlain@coopervision.com|
21301442|NCT01931566|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21301443|NCT00411684|HRA Pharma|Paul Carter - Chief Scientific Officer|+33 1 40 33 11 30|p.carter@hra-pharma.com|
21301444|NCT00611026|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21301445|NCT00760617|GlaxoSmithKline|GSK Response Center|866-435-7343||
21258137|NCT00894556|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21258138|NCT04311502|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
21258139|NCT03040999|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21258140|NCT03468855|Aclaris Therapeutics, Inc.|David Gordon|484-540-6296|Clintrials@aclaristx.com|
21258141|NCT04365465|UPMC Magee-Womens Hospital|Dr. Grace Lim, MD, MSc|412-641-2179|limkg2@upmc.edu|
21258142|NCT00479154|NINDS/NIH|Fatta Nahab|301-496-9526|nahabf@ninds.nih.gov|
21258143|NCT02404103|University Louisville|Nemr Eid, MD|502-852-3772|n.eid@louisville.edu|
21258144|NCT01995071|AbbVie|Global Medical Services|800-633-9110||
21258145|NCT00616109|University of Michigan|Gregory Kalemkerian, M.D.|(734) 936-4991|kalemker@umich.edu|
21258146|NCT00731874|Weill Cornell Medical College/Division of Transplant Surgery|Dr. Meredith J Aull|(212) 746-0727|mea9008@med.cornell.edu|
21258147|NCT01979523|Memorial Sloan Kettering Cancer Center|Dr. Alexander Shoushtari|646-888-4161|shoushta@mskcc.org|
21258148|NCT02586675|H. Lee Moffitt Cancer Center and Research Institute|Dr. Hatem Soliman|813-745-4933|hatem.soliman@moffitt.org|
21258149|NCT03186677|Catalyst Biosciences|Howard Levy, Chief Medical Officer|+1.650.266.6871|hlevy@catbio.com|
21258150|NCT01339559|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21258151|NCT00971945|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21258152|NCT03354663|Abbott|Steven Madej|651-756-2230|steven.madej@abbott.com|
21258153|NCT03354754|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21258154|NCT03962439|University of Texas at Dallas|Joseph Hennessee|408-813-4488|joseph.hennessee@utdallas.edu|
21270199|NCT04881448|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21270200|NCT00683046|University of Chicago Medicine|Dr. Andrew Artz|773-834-8980|aartz@medicine.bsd.uchicago.edu|
21270201|NCT01898884|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21270202|NCT04633187|Enanta Pharmaceuticals|Study Director|617-607-0800|enquiries@enanta.com|
21270203|NCT02771340|Iconic Therapeutics|Gabriela Burian, M.D.|6504371000|gburian@iconictherapeutics.com|
21270204|NCT03958071|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21270205|NCT01355523|Herlev Hospital, Department of Surgery|MD Melissa Voigt Hansen|+45 20661119|melissa.voigt.hansen@regionh.dk|
21270206|NCT00303316|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21270207|NCT01543607|Mass. General Hospital|William R. Brugge|617-724-0578|wbrugge@partners.org|
21270208|NCT01074307|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21270209|NCT01318733|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
21270210|NCT02703454|Abbott|Clinical Program Director|6517566717|kristin.ruffner@abbott.com|
21270211|NCT02284373|New York University Langone Medical Center|Todd Berland, MD|212 263 5060|todd.berland@nyumc.org|
21270212|NCT02413879|Prescient Surgical|Director of Clinical|6504895025|lclaude@prescientsurgical.com|
21270213|NCT00552617|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21270214|NCT04651218|University of Kentucky|Dr. Kyle Flack|5182574351|kyle.flack@uky.edu|
21270215|NCT02533505|AstraZeneca|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
21270216|NCT03940326|Mazandaran University of medical sciences|Nasim Tabrizi|+981133343015|nasimtabrizi@gmail.com|
21270217|NCT01399125|Novartis Pharmaceuticals|Study Director|8627788300||
21270218|NCT00563524|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21270219|NCT03608696|Thomas Jefferson University|Walter Kraft|2159559077|walter.kraft@jefferson.edu|
21270220|NCT01467570|The Medical University of Warsaw|Hanna Szajewska, Malgorzata Piescik-Lech|+48-22-45-23-309|hania@ipgate.pl|
21270221|NCT03712137|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21270222|NCT02626182|National Jewish Health|Jennifer Taylor-Cousar, MD, MSCS, ATSF|3032702764|Taylor-CousarJ@NJHealth.org|
21270223|NCT02267850|Biolux Research Ltd|Clinical Studies Manager|1-604-669-0674|d.skrenes@bioluxresearch.com|
21270224|NCT03005379|VA Cooperative Studies Program|Yuan Huang, Ph.D., Biostatistician|2039325711|yuanhuang1@va.gov|
21270225|NCT02869295|Nektar Therapeutics|Study Director|415-482-5300|medicalaffairs@nektar.com|
21270226|NCT02483481|Children's Mercy Kansas City|Dr. Sherwin Chan|816-234-3273|sschan@cmh.edu|
21270227|NCT02580318|St. Luke's University Health Network|Holly Stankewicz, D.O.|610-360-2725|holly.stankewicz@gmail.com|
21270228|NCT02766088|GlaxoSmithKline|GSK Response Center|866-435-7343|gskclinicalhd@gsk.com|
21270229|NCT01222715|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21270230|NCT03836729|ViiV Healthcare|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|1
21270231|NCT00948025|AxoGen, Inc|Vice President, Clinical and Translational Sciences|3864626829|edevinney@axogeninc.com|
21270232|NCT03061279|Stanford University|Derek Amanatullah, MD, PhD|650-723-2257|dfa@stanford.edu|
21270233|NCT03174925|Stanford University Medical Center|Aya Kamaya, Professor of Radiology|650-725-1812|kamaya@stanford.edu|
21270234|NCT01398982|UHN|Kate Butler|416-340-4800|kbutler@uhnresearch.ca|2343
21270235|NCT03964220|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21270236|NCT04247594|Global Blood Therapeutics, Inc.|Eleanor Lisbon|+1 913 449 4319|elisbon@gbt.com|
21270237|NCT01093482|VENTILA group|Andres Esteban|34916834982|aesteban@ucigetafe.com|
21270238|NCT04440163|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21270239|NCT01117090|Medtronic Restorative Therapies Group - Targeted Drug Delivery|Restorative Therapies Group Clinical Trials||medtronicneurotrials@medtronic.com|
21270240|NCT02229487|Ramathibodii Hospital, Mahidol University|Sirimon Reutrakul|66922011647|sreutrakul@yahoo.com|708
21270241|NCT00068406|NRG Oncology|Linda Gedeon for Wei Deng, PhD.|716-845-1169|lgedeon@gogstats.org|
21270242|NCT02577900|Queen Elizabeth Hospital|Dr. Tsang Ka-Kit|+852-35062610|kktsang3@netvigator.com|
21270243|NCT03231709|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21270244|NCT02609178|Stomatological Hospital of FMMU|Pingting Lin, PhD|+86 15249049902|biu79@hotmail.com|
21270245|NCT01128153|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|
21270246|NCT01954082|University of Rochester|Dale Phelps|(585) 275-2972|dale_phelps@urmc.rochester.edu|
21270247|NCT01682512|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21270248|NCT01377233|H. Lundbeck A/S|Study director||LundbeckClinicalTrials@Lundbeck.com|
21270249|NCT01785875|Amgen Inc.|Study Director|866-572-6436||
21270250|NCT03112993|University of Missouri|Dr. Boris Mraovic, MD, Professor of Clinical Anesthesiology|573-882-2568|mraovicb@health.missouri.edu|
21270251|NCT03137082|Stony Brook University|Dr Helen C Fox|631 632 0057|helen.fox@stonybrookmedicine.edu|
21270252|NCT00417027|Northwestern University Feinberg School of Medicine|Robert J. McCarthy, PharmD|312-926-9015|r-mccarthy@northwestern.edu|
21270253|NCT01017029|Pharmaceuticals|Novartis|+1(862)778-8300||
21270254|NCT02216214|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
21270255|NCT05354206|Washington University in St. Louis|Dr. Ismael Seáñez|3149357665|ismaelseanez@wustl.edu|
21270256|NCT00713830|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21270257|NCT00422058|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21258155|NCT00513409|GlaxoSmithKline|GSK Response Center|866-435-7343||
21258156|NCT03548051|Hope Clinic of the Emory Vaccine Center|Nadine Rouphael|404-377-3719|nroupha@emory.edu|10
21258157|NCT03874377|Children's National Medical Center|Dr. Sarah Hornack|202-895-3860|shornack@childrensnational.org|
21258158|NCT00817531|Baylor College of Medicine|Dr. Mothaffar Rimawi|713-798-1311|rimawi@bcm.edu|
21258159|NCT00812214|MedVadis Research Corporation|Egilius L.H. Spierings, M.D., Ph.D.|617-744-1310|Spierings@MedVadis.com|
21258160|NCT03325673|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21258161|NCT00883337|sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21258162|NCT00763139|Vanderbilt|Dr. Charles Michael Stein|615-936-3420|mike.stein@vanderbilt.edu|
21258163|NCT00713700|Abbott|Ashish Oza|1-818-493-3648|aoza@sjm.com|
21258164|NCT02669017|ADC Therapeutics|ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
21258165|NCT03799458|University of New Mexico Health Sciences Center|Dr. Davin Quinn|505-272-2223|dquinn@salud.unm.edu|
21258166|NCT03621280|Cortendo AB|Valentina Conoscenti, MD|1-877-937-4737|OPTICS@cortendo.com|
21258167|NCT00915681|Meda Pharma GmbH & Co KG (A Viatris company)|Baerbel Fingerhut|+49 6172 888|baerbel.fingerhut@viatris.com|1419
21258168|NCT00919100|MMJ Labs|Dr. Amy Baxter|877-805-2899|abaxter@mmjlabs.com|106
21258169|NCT03221751|VA Puget Sound Health Care System|Hollie Holmes|206-277-6207|Hollie.Holmes@va.gov|
21258170|NCT02559687|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21258171|NCT00003460|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
21258172|NCT03245450|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21258173|NCT04442230|Altimmune, Inc.|Sarah K. Browne, MD/Senior Director, Clinical Development|240-654-1450|sbrowne@altimmune.com|
21258174|NCT01022190|Radboud University Nijmegen Medical Centre|Study director|+31 24 36 13918||
21258175|NCT02599961|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
21258176|NCT00401752|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21258177|NCT02424526|Sacramento State|Katrin Mattern-Baxter, PT, DPT|19162785766|kbaxter@csus.edu|
21258178|NCT00143312|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21258179|NCT02681172|Piramal Imaging|Dr. Juergen Hirschfeld, Head of GRA & PV|+49 30461124615|Juergen.Hirschfeld@piramal.com|
21258180|NCT01850485|Medical Center Leeuwarden|Matty Koopmans, MSc|0031582866738|matty.koopmans@znb.nl|
21258181|NCT01046877|Acclarent|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
21258182|NCT01834274|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
21258183|NCT00967551|Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Bahia, Brasil|Hugo Costa-Ribeiro||hugocrj@ufba.br|
21258184|NCT03350217|Indiana University|Clinical Research Specialist|317-948-0724|rlahr@iu.edu|
21258185|NCT03681119|NYU Langone Health|Abraham Brody, PhD, RN, FAAN|212-992-7341|Abraham.Brody@nyulangone.org|
21258186|NCT00549172|University of Helsinki|Dr. Teppo Järvinen, Head of study chair||teppo.jarvinen@helsinki.fi|
21258187|NCT03761615|Sansum Diabetes Research Institute|Dr. Kristin Castorino|805-682-7638|info@sansum.org|
21258188|NCT04288154|Mayo Clinic|Amir Lerman, M.D.|507-255-2398|lerman.amir@mayo.edu|
21258189|NCT00835237|GlaxoSmithKline|GSK Response Center|866-435-7343||
21258190|NCT03339921|MOMH|Amanda Crawford|7026533583|amanda.j.rawford.ctr@health.mil|
21258191|NCT00606086|GlobeImmune, Inc.|Clinical Operations Manager|3036252700|Alicia.Mattson@globeimmune.com|
21258192|NCT01471457|University of New Mexico|Kate Meriwether|5052495967|meriwet2@salud.unm.edu|
21258193|NCT04352439|Duke University|Dr. Brittany Davidson|+1 919 684 0188|brittany.davidson@duke.edu|
21301446|NCT00638014|Duke University|Elliott Bennett-Guerrero|9196819660|benne011@mc.duke.edu|
21301447|NCT01147874|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21301448|NCT02109497|Prana Biotechnology|Dr Caroline Herd|+6133494906|info@pranabio.com|
21301449|NCT04625101|Neurocrine Biosciences|Neurocrine Medical Information|+1 877-641-3461|medinfo@neurocrine.com|
21301450|NCT02991040|Prollenium Medical Technologies Inc.|Mr. Ario Khoshbin|+1 (905) 508-1469|ario@prollenium.com|
21301451|NCT04287517|Istanbul University Faculty of Medicine Sports Medicine Department|Dr. Sergen Devran, Residency in Istanbul University Sports Medicine Department|00905377782594|sergendevran@gmail.com|
21301452|NCT04150861|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
21301453|NCT03613519|Boston University School of Public Health|Lynn Rosenberg, ScD|617.734.6006|lrosenbe@bu.edu|
21301454|NCT01869764|Wake Forest University Health Sciences|Edward Levine, MD|336-716-5440|elevine@wakehealth.edu|
21301455|NCT02175030|University of Utah|David Turok, MD, PI|801-581-5160|david.turok@hsc.utah.edu|
21301456|NCT02533453|Astrazeneca, Korea|Hyun Jung Kang / Local Study Leader|82 2 2188 0846|hyunjung.kang@astrazeneca.com|0846
21301457|NCT00885534|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646-888-4162|chapmanp@mskcc.org|
21301458|NCT02453711|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21301459|NCT01292629|Hoya Surgical Optics, Inc.|Kees den Besten, Vice President Global Quality, Regulatory Affairs, and Clinical Research|+65 6681 0025|kees.denbesten@HOYA.com|
21301460|NCT03810105|Memorial Sloan Kettering Cancer Center|Dr. Karen Autio, MD|646-422-4632|autiok@mskcc.org|
21301461|NCT03695367|Heron Therapeutics, Inc.|Vice President, Clinical Operations|858-251-7232|svisonneau@herontx.com|
21301462|NCT02506244|Scripps Research Translational Institute|Steven R. Steinhul, MD, Prinicipal Investigator|858-554-5757|steinhub@scripps.edu|
21301463|NCT01493167|Helsinki University Hospital|Dr Nina Linfors|358 9 4711|nina.c.lindfors@hus.fi|
21301464|NCT01958164|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21258194|NCT02692495|MEBO Research|Irene Gabashvili, Scientific Director|(408) 341-9355|irene.gabashvili@meboresearch.org|
21258195|NCT00391222|Janssen Cilag Spain|EMEA Medical Affairs Director|+34 91 7228043||
21258196|NCT01627860|Janssen-Cilag Taiwan|Medical Director|886 2 23762155||
21258197|NCT02613936|University of New Mexico|Dr. Davin Quinn|505-272-2223|dquinn@salud.unm.edu|
21258198|NCT01014689|Galderma|Florence Paliargues / CPM|+33492952957|florence.paliargues@galderma.com|
21258199|NCT02159703|University of Pennsylvania|Alexander Lin, MD|(215) 662-3198|alexander.lin@uphs.upenn.edu|
21258200|NCT02587650|University of California, San Francisco|Dr. Adil Daud|(415) 353-7392|Adil.Daud@ucsf.edu|
21258201|NCT00333359|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
21258202|NCT00939900|SeoulNUBH|Professor|82317877194|khkoo@snu.ac.kr|
21258203|NCT01332357|GlaxoSmithKline|GSK Response Center|866-435-7343||
21258204|NCT01534533|Peking University|Dr. Zhiyong Zou|+8610-13581525193|harveyzou2002@bjmu.edu.cn|
21258205|NCT06706245|Brown University Health|Joshua Kemp, Assistant Professor|4014321466|joshua_kemp@brown.edu|
21258206|NCT05032157|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21258207|NCT01197326|Philips Healthcare|Duane A Young-Kershaw RN, BSN, Clinical Researcher|508-817-7001|duane.young-kershaw@philips.com|
21258208|NCT02627495|Spaulding Rehabilitation Hospital|Prof. Felipe Fregni|+1 (617) 935-2743|Fregni.Felipe@mgh.harvard.edu|
21258209|NCT00880893|Sanofi Pasteur|Director||Contact-US@sanofi.com|
21270258|NCT03250507|Henry Ford Hospital|Christina Fidkowski, MD|313-916-7648|cfidkow1@hfhs.org|
21270259|NCT00068770|Johns Hopkins University|Dr. Stuart A Grossman|410-955-3657|jfisher@jhmi.edu|
21258210|NCT01736579|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21258211|NCT03036293|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
21258212|NCT01783678|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21270260|NCT01754480|Grifols Therapeutics Inc|Henry Li, PhD|+1 919 316 6042|henry.li@grifols.com|
21258213|NCT02543528|Johnson & Johnson Vision|Elizabeth Dow -PRINCIPAL RESEARCH OPTOMETRIST|904-443-1061|edow1@its.jnj.com|
21258214|NCT01042600|Albany Medical Center|Joaquim Pinheiro, MD, MPH|518-262-5421|pinheij@mail.amc.edu|
21258215|NCT03311711|Emory University|Mi-Kyung Song, PhD|404-727-3134|mi-kyung.song@emory.edu|
21258216|NCT01049035|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21258217|NCT01137773|University Louisville|Rainer Lenhardt, MD|502-228-7517|rainer.lenhardt@louisville.edu|
21258218|NCT01500109|Loma Linda University|Chelan Nour, MD|909-558-8493|cnour@llu.edu|
21258219|NCT00493870|US Oncology Research|Taqi Mohammad|281-863-6439|taqi.mohammad@mckesson.com|
21258220|NCT00648375|Yale School of Medicine|Margaret Altemus|646-209-6277|margaret.altemus@yale.edu|
21258221|NCT05594173|University Health Network|Catriona Steele|4165973422|catriona.steele@uhn.ca|7802
21258222|NCT02396732|University of Miami|Kenneth Proctor|305-585-1178|kproctor@med.miami.edu|
21258223|NCT01485627|UNIVERSITY OF ROCHESTER DEPARTMENT OF FAMILY MEDICINE|Ronald Epstein MD|5855069484|ronald_epstein@urmc.rochester.edu|
21258224|NCT01709149|Cytokinetics, Inc.|MD Cytokinetics|650-624-2929|medicalaffairs@cytokinetics.com|
21258225|NCT00763815|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21258226|NCT04951037|Emory University|Fayron Epps, PhD, RN|404-727-6936|fepps@emory.edu|
21258227|NCT05630937|Nerviano Medical Sciences S.r.l.|Alberto Ocana|39 0331 58 1111|DL-Clinicaltrials@nervianoms.com|
21258228|NCT04749459|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21258229|NCT00267748|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21258230|NCT02429414|UT MD Anderson Cancer Center|Jagtar S Heir, Professor, Anesthesiology & PeriOper Med|(713) 745-3793|jsheir@mdanderson.org|
21258231|NCT02214238|Fisher & Paykel Healthcare|Clinical Research Scientist|+6495740123|cpaptrial@fphcare.co.nz|
21258232|NCT00876993|Johns Hopkins All Children's Hospital|Stacie Stapleton|727-767-4176|stacie.stapleton@jhmi.edu|
21258233|NCT01849172|Guang'an Men Hospital, China Academy of Chinese Medical Sciences|Dr.Zhishun Liu|+86 01088002331|liuzhishun@aliyun.com|
21258234|NCT00983983|Massachusetts General Hospital|Dr. Anne-Marie Wills|855-644-6387|awills@partners.org|
21258235|NCT01098071|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21258236|NCT01604265|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
21258237|NCT01903837|Alkermes|Director, Corporate and R&D Communications|781-609-7000|Gretchen.Murphy@alkermes.com|
21258238|NCT02706873|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21258239|NCT01857713|Somna Therapeutics, L.L.C.|James Miller|262-345-5553|jmiller@somnatherapeutics.com|102
21258240|NCT03759665|IntraBio Ltd.|Taylor Fields, Chief Product Development Officer|+44 8081|tfields@intrabio.com|641283
21258241|NCT00705939|Protalix Ltd.|Vice President Product Development|+(972) 4-9889488|einata@protalix.com|137
21258242|NCT03824808|University of Missouri|Dr Boris Mraovic|5738822568|mraovicb@health.missouri.edu|
21258243|NCT01515657|PLx Pharma|Ronald Zimmerman|1-713-842-1249|ron.zimmerman@plxpharma.com|205
21258244|NCT00464334|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21258245|NCT03948178|Orion Corporation|Head of Compliance and UK Study Management, Clinical Operations|+441159487100|clinicaltrials@orionpharma.com|
21258246|NCT02112370|Seoul National University Hospital Department of Surgery|Dr. Kyu Eun Lee|+82)-2-2072-2817|kyueunlee@snu.ac.kr|
21258247|NCT02432235|ADC Therapeutics SA|Clinical Trials Information|954-903-7994|clinical.trials@adctherapeutics.com|954
21258248|NCT01895322|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Research and Development|+81-3-6361-7366||
21258249|NCT05515250|Saint Louis University|Purnima Modi|3149772029|purnima.modi.1@slu.edu|
21258250|NCT02465073|Southwest Regional Wound Care Center|Randall Wolcott|806-793-8869|randy@randallwolcott.com|
21258251|NCT04400474|MFAR|A responsibility person designate by sponsor|934344412|investigacion@mfar.net|
21258252|NCT02728830|Duke Cancer Center|Dr. Angeles Alvarez Secord|919-684-3765|secor002@mc.duke.edu|
21258253|NCT01347554|Yonsei University Wonju College of Medicine|Dr. Seung-Hwan Lee|+82-33-741-0920|carshlee@yonsei.ac.kr|
21258254|NCT03603496|Massachusetts General Hospital|Nancy Rigotti, MD|617-724-3548|nrigotti@partners.org|
21258255|NCT02248727|Optometry Research Group (GIO) University of Valencia|Robert Montes-Mico, O.D., PhD|34-9635-44764|robert.montes@uv.es|
21258256|NCT00004259|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21258257|NCT03594227|Aclaris Therapeutics, Inc.|Marco Cardillo, Clinical Trial Manager|484-540-6299|mcardillo@aclaristx.com|
21258258|NCT00790907|GlaxoSmithKline|GSK Response Center|866-435-7343||
21258259|NCT00774345|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@BMS.com|
21258260|NCT03389854|Mayo Clinic|Dr. Landon Trost|507-284-3728|Trost.Landon@mayo.edu|
21258261|NCT00907101|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5000|elizabeth.nieman@galderma.com|
21258262|NCT03436862|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
21258263|NCT02185404|University of South Florida|Kyle B. Reed|813-974-2385|kylereed@usf.edu|
21258264|NCT02054897|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
21258265|NCT00960843|Ethicon Endo-Surgery Inc.|Michael Schwiers Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
21258266|NCT00652366|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21258267|NCT02069899|Sobi AG|Radmila Kanceva/Senior Medical Director Immunology|+ 41 22 551 91 63|Radmila.Kanceva@sobi.com|
21258268|NCT01967537|Principal Investigator|Dr. Naris Nilubol|301-451-2355|niluboln@nih.gov|
21258269|NCT04703075|Johns Hopkins University School of Medicine|Maria Beatriz Kohler, Senior Research Nurse|4104048921|bkohler@jhmi.edu|
21258270|NCT00610987|University of Missouri, Department of Orthopaedics|Dr. Brett Crist|573-882-6562|cristb@health.missouri.edu|
21258271|NCT00550680|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21270261|NCT03111407|Zimmer Biomet|Emilie Rohmer, Clinical Operations Manager|+41 58 85 48210|Emilie.Rohmer@zimmerbiomet.com|
21270262|NCT04333199|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
21270263|NCT03778190|Kendall Regional Medical Center|Dr. Tony Zitek|305-480-6602|zitek10@gmail.com|
21270264|NCT03959137|MSD Belgium|Stephanie Coulon|0032 485 461 467|stephanie.coulon@merck.com|
21270265|NCT00998582|Minneapolis Medical Foundation|Dr. Jason Baker|612-873-2705|baker459@umn.edu|
21270266|NCT01032330|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
21270267|NCT00190684|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21270268|NCT03304210|Ghent University|Prof|+32(0)93326251|wim.ceelen@ugent.be|
21270269|NCT00810615|San Antonio Military Medical Center, Wilford Hall Ambulatory Surgical Center|Dr. George Wolf, Associate Investigator|210-292-3483|earl.wolf.ctr@us.af.mil|
21270270|NCT02567266|University of Miami|Dr. Amanda Jensen-Doss|+1 (305)284-8332|ajensendoss@miami.edu|
21270271|NCT01542736|University of Colorado Denver|Jennifer Raybin, PhD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
21270272|NCT01766310|Queen Sirikit National Institute of Child Health|Dr. Orawan Iamopas|66-2-354-8415|orawaneamopas@yahoo.com|3327
21270273|NCT01407107|University of Texas Southwestern Medical Center|Dr. Jonathan Dowell|214-648-7097|jonathan.dowell@utsouthwestern.edu|
21270274|NCT02602080|Hospital for Special Surgery|George Birch|212-774-7377|birchg@hss.edu|
21270275|NCT03934437|Johns Hopkins University|Larry Chang|4109551725|lchang8@jh.edu|
21270276|NCT02574260|Amgen, Inc.|Study Director|866-572-6436||
21270277|NCT00752895|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
21270278|NCT03273257|Papworth Hospital NHS Foundation Trust|David Jenkins, MD; Principal Investigator and ICA Board member|+44 1223 638000|david.jenkins1@nhs.net|
21270279|NCT00434148|Novartis Pharmaceuticals|Study Director|862-778-8300||
21270280|NCT02175472|PhotoPharmics, Inc.|Dan Adams|801-770-6960|dan.adams@photopharmics.com|
21270281|NCT02049931|Seoul National University|Professor Jin S. Yeom|82-31-787-7195|highcervical@gmail.com|
21270282|NCT01640964|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21270283|NCT04148508|University of Exeter|Professor Ed Watkins|01392 724692|e.r.watkins@exeter.ac.uk|
21270284|NCT00201734|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii-Saab, MD|614-293-9863|tanios.bekaii-saab@osumc.edu|
21270285|NCT02464059|University of North Carolina at Chapel Hill|Michael Bradley Drummond, MD|919-966-7054|brad_drummond@med.unc.edu|
21270286|NCT00634582|Comprehensive Cancer Center of Wake Forest Univeresity|Gary Schwartz, PhD|336-716-7446|gschwart@wakehealth.edu|
21270287|NCT03067506|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21270288|NCT02499406|VACHS|Investigator|203 932 5711|suzanne.decker@va.gov|
21270289|NCT01485588|Iconic Therapeutics|Gabriela Burian, M.D.|6504371000|gburian@iconictherapeutics.com|
21270290|NCT03591107|RAND|Lisa Meredith, Senior Behavioral Scientist|310.393.0411|seidel@rand.org|7365
21270291|NCT01902134|Menarini Ricerche S.p.A.|Dr. Angela Capriati, Corporate Director of Clinical Research|+3905556809933|ACapriati@menarini-ricerche.it|
21270292|NCT00305110|Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-7476|achang@montefiore.org|
21270293|NCT03141931|University of New South Wales|Dr Jacqueline Tan|+61 (02) 9385 6551|jacqueline.tan@unsw.edu.au|
21270294|NCT01272193|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21270295|NCT02685956|Global BioClinical|Jennifer Maas|206-240-8632|jen.maas@globalbioclinical.com|
21270296|NCT02661282|UT MD Anderson Cancer Center|Shiao-Pei Weathers, MD, Associate Professor, Neuro-Oncology|(713) 792-3906|sweathers@mdanderson.org|
21270297|NCT00350519|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Vice President Medical Affairs COBS|215-325-4464||
21270298|NCT00823459|University of California, San Francisco|Susan Chang, MD|(415) 353-2966|jessica.carlson@ucsf.edu|
21270299|NCT00736099|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21270300|NCT05105477|Edwards Lifesciences|Cristina Johnson|888.713.1564|CC_Clinical_Affairs@edwards.com|
21270301|NCT01331083|Canadian Cancer Trials Group|Lesley Seymour|6135336430|lseymour@ctg.queensu.ca|
21270302|NCT02239601|CancerCare Manitoba|Marshall Pitz|2044751431|Mpitz@cc.umanitoba.ca|
21270303|NCT00566618|UT MD Anderson Cancer Center|Debu Tripathy, Chair, Breast Medical Oncology|(713) 792-2817|dtripathy@mdanderson.org|
21270304|NCT01791127|BIOTRONIK, Inc.|Clinical Studies Engineer Manager|1-800-547-0394|crystal.miller@biotronik.com|
21270305|NCT02353299|Sleep Disorders and Research Center Henry Ford Hospital|Christopher L Drake|248-344-6672|cdrake1@hfhs.org|
21270306|NCT00707174|University of Utah|Glen Bowen, MD|801-581-0255|glen.bown@hci.utah.edu|
21270307|NCT00544557|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21270308|NCT00939705|Gateway Medical Research, Inc.|Walter A Parham|(314) 663-4550||
21270309|NCT01020305|Stanford University Medical Center|Associate Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu|
21270310|NCT00467818|UMDNJ|Sherie Novotny MD|(732) 235-4119|novotnsl@rutgers.edu|
21270311|NCT04936334|Indiana University, Department of Urology|Jennifer Lehman, RN, Senior Research Leader|317-948-9575|jgeck@iu.edu|
21270312|NCT02209272|Mayo Clinic|Dr. Jacob L. Sellon|507-284-2608|sellon.jacob@mayo.edu|
21270313|NCT04057118|Oscotec Inc.|Sungsil Lee/Team Leader of Clinical Development|+82316287624|sslee@oscotec.com|
21286322|NCT00528424|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
21286323|NCT03713684|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21286324|NCT02515630|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21286325|NCT03870334|NImmune|Project Management|(540) 944-4545|pm@nimmun.com|
21286326|NCT01064414|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
21286327|NCT02185417|Boston VAHCS|Dr. Sarah Leatherman|857-364-4201|sarah.leatherman@va.gov|
21286328|NCT02147613|Arizona State University - Downtown Phoenix Campus|Siddhartha S. Angadi, PhD., FACSM|6028272254|sangadi@asu.edu|
21286329|NCT02595502|Johnson & Johnson Vision Care Inc.|Brian Pall, O.D., M.S., F.A.A.O - Senrior Principal Research Optometrist|904-443-1290|BPALL@its.jnj.com|
21286330|NCT00974311|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21286331|NCT03286218|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|ClinicalTrials.gov@lilly.com|
21286332|NCT01164202|FFCD|Mrs Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
21286333|NCT02346708|University of Colorado Denver - Anschutz Medical Campus|Isabelle Buard, PhD|(303)724-5973|Isabelle.Buard@cuanschutz.edu|
21286334|NCT01781962|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21286335|NCT06331507|University of Michigan|Prachi Agarwal|734-232-5132|prachia@med.umich.edu|
21286336|NCT01167569|Rutgers RWJMS|Alan Spotnitz, MD|732-235-9806|spotnitz@rwjms.rutgers.edu|
21286337|NCT02154139|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21286338|NCT02130999|Vince and Associates Clinical Research|Melodie Armstrong, MD, MPH|913-696-1601||
21286339|NCT03075267|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|1-877-240-9479|information.center@astrazeneca.com|
21286340|NCT01566604|Novartis|Study Director|862-778-8300||
21286341|NCT01204203|University of Alabama at Birmingham|Francisco Robert, MD|205-934-5077|pacorobertuab@cs.com|
21286342|NCT01156805|Hospital General de Granollers|Dr. Esteve Llargues|938425000|ellargues@fhag.es|2675
21286343|NCT03421379|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21286344|NCT01951417|Galderma Labratories, L.P.|Elizabeth M Nieman|817-961-5130|elizabeth.nieman@galderma.com|
21286345|NCT01514383|Medline Industries, Inc|Ed Drower, Clinical Project Director|847-643-3874|edrower@medline.com|
21286346|NCT02329327|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
21286347|NCT01367249|Bausch & Lomb Incorporated|James Gow|949-788-6000|james.gow@bausch.com|
21286348|NCT03718429|University of Florida|Dominick Angiolillo, MD,PhD|904-244-3378|dominick.angiolillo@jax.ufl.edu|
21286349|NCT02049983|Levita Magnetics International Corp|Alberto Rodriguez-Navarro, MD|6506557625|info@levita.com|
21286350|NCT03429348|University of Arizona|Jeff Burgess, MD., MS, MPH, Assoc Dean of Research|520-626-4918|jburgess@email.arizona.edu|
21286351|NCT00873730|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21286352|NCT02787499|Massachusetts General Hospital/Harvard Medical School|Mark Siedner|6177264686|msiedner@mgh.harvard.edu|
21286353|NCT00048035|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21286354|NCT04110314|UCLA|Principal Investigator|310-206-6328|pszilagyi@mednet.ucla.edu|
21286355|NCT01099358|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21286356|NCT05137717|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21286357|NCT02619617|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21286358|NCT04685993|Lipocine Inc|Senior Director of Clinical Development|801.994.7383|admin@lipocine.com|
21286359|NCT00509899|Incyte Corporation|Study Director|1-855-463-3463||
21286360|NCT04658797|CooperVision, Inc|Jose Vega, OD, MSc, FAAO|9256213761|JVega2@coopervision.com|
21286361|NCT01711983|W. L. Gore & Associates|Bryan Randall|928-864-4832|BRandall@WLGore.com|
21286362|NCT02326272|Cares|UCB|+1844599|UCBCares@ucb.com|2273
21286363|NCT00737100|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21286364|NCT03131167|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21286365|NCT04553666|University of Rochester Medical Center|Dr. Nikesha Gilmore, Assistant Professor|1-585-275-1275|nikesha_gilmore@urmc.rochester.edu|
21286366|NCT00458003|Northwestern University|Paul Fitzgerald|312-6951064|p-fitzgerald2@northwestern.edu|
21286367|NCT03416270|University Health Network|Dr. David Cherney|416.340.4151|david.cherney@uhn.ca|
21286368|NCT00483652|Acorda Therapeutics, Inc.|Andrew Blight, Chief Scientific Officer|(914) 347-4300|ablight@acorda.com|102
21286369|NCT00928434|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21286370|NCT01687114|Tufts University|Oliver Chen|617-5563128|oliver.chen@tufts.edu|
21286371|NCT01139996|Memorial University Medical Center|Imran Siddiqui, MD|912-350-8707|research2@memorialhealth.com|
21286372|NCT00848016|Mayo Clinic Cancer Center|Michael E. Menefee, M.D.||menefee.michael@mayo.edu|
21286373|NCT05417412|San Diego State University|Dr. V. Robin Weersing|619-594-8892|robin.weersing@sdsu.edu|
21286374|NCT04474483|University at Buffalo, SUNY|Sanjay Sethi MD|7168884864|ssethi@buffalo.edu|
21286375|NCT00496340|H. Lee Moffitt Cancer Center and Research Institute|Marcie Riches, MD|813-745-6284|marcie.riches@moffitt.org|
21270314|NCT02787785|Boston Scientific|Clinical Trial Manager or Director of Clinical Trials (Cardiology Rhythm Management)|1-800-227-3422|jill.leigh@bsci.com|
21270315|NCT01676311|Spaulding Rehabilitation Hospital|Ross Zafonte, DO|617-952-5227|rzafonte@mgh.harvard.edu|
21270316|NCT02030834|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
21270317|NCT01347879|Virginia Clinical Research, Inc.|Dr David Pariser|757-625-0151|dpariser@pariserderm.com|
21238091|NCT00810264|BIOTRONIK|Clinical Studies Engineer Group Manager|800-547-0394|celestial@biotronik.com|
21270318|NCT00663039|MPRC|Elliot Hong|410-402-6828|ehong@mprc.umaryland.edu|
21270319|NCT01850108|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
21270320|NCT03127943|UNC Department of Oral and Maxillofacial Surgery|Raymond P. White Jr DDS, PhD|919-537-3944|ray_white@unc.edu|
21270321|NCT04671329|Hologic, Inc.|Muhammad Waqas, Director of Global Clinical Affairs|(508) 826-7183|ClinicalResearch@Hologic.com|
21270322|NCT01029769|Technische Universitaet Muenchen, Germany|Prof. Dr. Dr. Stefan Leucht|+498941404200|stefan.leucht@tum.de|
21270323|NCT03273712|University of Iowa|M. Sue O'Dorisio, MD, PhD|(319) 335-7234|sue-odorisio@uiowa.edu|
21270324|NCT01468974|Abbott Vascular|Nadia bouhdi||nadia.bouhdi@av.abbott.com|
21270325|NCT00666718|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21270326|NCT05149989|Liverpool University Hospitals NHS Foundation Trust|Dr Tristan Payne|+44(0)1517064553|tristan.payne@liverpoolft.nhs.uk|
21270327|NCT04529096|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21270328|NCT04529499|Dr Reddy's Laboratories Ltd.|Dr. Srinivas Shenoy B.,|49002900|srinivassshenoyb@drreddys.com|
21270329|NCT00683904|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21270330|NCT03091400|Icahn School of Medicine at Mount Sinai|James F Sumowski, PhD|212-241-6854|james.sumowski@mssm.edu|
21270331|NCT00975884|GlaxoSmithKline|GSK Response Center|866-435-7343||
21270332|NCT00363129|Mayo Clinic|Lisa Kottschade, RN, MSN, CNP|507-284-2511|kottschade.lisa@mayo.edu|
21270333|NCT05166512|Johns Hopkins Bloomberg School of Public Health|Dr. Julia Wolfson|410-614-4907|jwolfso7@jhu.edu|
21270334|NCT00420849|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21270335|NCT05789420|Philip Morris Products S.A.|Xavier Jaumont, Global Head of Clinical Development and Operations|+41582421111|ClinicalTrials.PMI@pmi.com|
21270336|NCT02278952|University of California, San Francisco|Dr. John Greenland|415-476-0789|john.greenland@ucsf.edu|
21270337|NCT00659581|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21270338|NCT05473247|Berry College|Kameron Suire|3373968980|ksuire@berry.edu|
21270339|NCT01831596|KCI|VP, Global Clinical Development|210-255-5595|jkhart@mmm.com|
21270340|NCT00446134|Valeant Pharmaceuticals International, Inc.|Senior Director Clinical Development|908-927-1782|ralph.doyle@valeant.com|
21270341|NCT03125629|Stanford University|Andrei Iagaru|650-725-4711|aiagaru@stanford.edu|
21270342|NCT00743119|New York State Psychiatric Institute|Dr. Ziva Cooper|646-774-6129|zc2160@cumc.columbia.edu|
21270343|NCT02989610|Abbott|Tucker Tomlinson, Scientist, Clinical Research|+19725269646|Tucker.Tomlinson@Abbott.com|
21270344|NCT04508621|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 904-0355|Greg.Sullivan@TonixPharma.com|
21270345|NCT00759759|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com|
21270346|NCT00864084|The University of Manitoba|Ms Elizabeth Harvey|204-977-5656|harveye@cc.umanitoba.ca|
21270347|NCT01556165|Email contact via H. Ludbeck A/S|Study director||LundbeckClinicalTrials@lundbeck.com|
21270348|NCT03980561|MUSC|Amanda Wagner|8437920484|wagne@musc.edu|
21270349|NCT02531698|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21270350|NCT01861717|JOHN WAYNE CANCER INSTITUTE|Dr. Daniel Kelly|310-582-7450|Daniel.Kelly2@providence.org|
21270351|NCT02395536|Medtronic, PLC|Lindsay Werder, Senior Clinical Research Specialist|7635268168|lindsay.k.werder@medtronic.com|
21270352|NCT00701558|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21270353|NCT04499391|Penn State College of Medicine|Dr. Jennifer Kraschnewski|717-531-8161|jkraschnewski@pennstatehealth.psu.edu|
21270354|NCT01637961|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
21270355|NCT04006847|Penn State Health|Seema Naik, MD|7175318678|snaik@pennstatehealth.psu.edu|
21270356|NCT02833857|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21270357|NCT02542150|"University of Colorado Denver | Anschutz"|Jody Tanabe, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
21286376|NCT04919317|Temple University Hospital|George Taylor, MD, MS; surgical resident|2678150512|George.Taylor@tuhs.temple.edu|
21270358|NCT01207401|University of California, San Diego|Dr. Sheila Krishnan Mody|(619)543-6777|smody@ucsd.edu|
21270359|NCT01498419|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|(212) 227-7540|Dan.Everitt@tballiance.org|
21270360|NCT03555890|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21286377|NCT02389959|Stanford University|Peter H. Hwang, MD|(650) 723-5281|hwangph@stanford.edu|
21270361|NCT03372369|University of North Carolina at Chapel Hill|Seri Link Anderson, PhD|919-619-0433|seri.link.a@gmail.com|
21270362|NCT01383954|Brigham and Women's Hospital|Ajay D. Wasan, M.D., M.Sc.||awasan@partners.org|
21270363|NCT02177773|Unviersity of California, San Francisco|Dr. Thomas Hope, MD|(415) 221-4810|thomas.hope@ucsf.edu|22648
21270364|NCT04388527|University of Pennsylvania|Regulatory Lead|512-662-4484|psom-ind-ide@pobox.upenn.edu|
21270365|NCT03471182|Yale University School of Medicine|Patrick Worhunsky|203-737-2668|patrick.worhunsky@yale.edu|
21270366|NCT01305265|Dept. of Anesthesia & Perioperative Care, UCSF San Francisco|Kolodzie, Kerstin M.D, PhD, Principal Investigator|4158853647|kolodziek@anesthesia.ucsf.edu|
21270367|NCT00670267|Baylor College of Medicine|N.A. Hanania, M.D.||hanania@bcm.edu|
21270368|NCT03512067|Brigham and Women's Hospital|Dr. Gyorgy Frendl|617-732-5910|gfrendl@bwh.harvard.edu|
21270369|NCT00690924|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
21270370|NCT00406107|Palmetto Retina Center|John A. Wells, III, M.D.|803-931-0077|jackwells@palmettoretina.com|
21270371|NCT03851107|McGill University|Dr. Dana Anaby|15143984400|dana.anaby@mcgill.ca|00394
21270372|NCT02773446|Johns Hopkins University|Kawsar Talaat|410-502-9627|ktalaat@jhu.edu|
21270373|NCT00289731|GlaxoSmithKline|GSK Response Center|866-435-7343||
21270374|NCT04023994|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21270375|NCT01613131|University of Colorado Denver|Chanel Mansfield|303-724-6501|chanel.mansfield@ucdenver.edu|
21270376|NCT02454972|Pharma Mar S.A.|Clinical Development, Department of PharmaMar´s Oncology., Business Unit.|0034 91846 60 00|clinicaltrials@pharmamar.com|
21270377|NCT00780715|University of Dundee|Professor Ewan Pearson|+44 (0) 1382 383387|e.z.pearson@dundee.ac.uk|
21270378|NCT01070966|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21270379|NCT02770716|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-844-2830|clinicaltrials@mnk.com|5
21270380|NCT01725113|NYU Langone Health|Candace Grant|5166632171|Candace.Grant@nyulangone.org|
21270381|NCT00446264|University of Lille|Violeta Raverdy|00 33 3 20 62 34 30|vraverdi@univ-lille2.fr|
21270382|NCT02135874|The University of Texas MD Anderson Cancer Center|Elias Jabbour MD/Proffessor|713-792-4764|eajabbour@mdanderson.org|
21270383|NCT01415921|New York University School of Medicine|Stuart Katz, MD|212-263-3946|stuart.katz@nyumc.org|
21270384|NCT02660385|University of Connecticut/formerly Yale University|Meghan O'Connell, Program Manager|860-634-4152|meghan.oconnell@uconn.edu|
21270385|NCT01830920|Thrasos Therapeutics, Inc.|Jerome Rossert, MD, PhD, Chief Scientific Officer||Jerome.Rossert@thrasos.com|
21270386|NCT01313728|Valeant Pharmaceuticals International Inc|David Lineberry, Associate Director, Clinical Operations|949-973-1153|David.Lineberry@valeant.com|
21270387|NCT00716586|University of Illinois at Chicago|Emeritus Professor of Ophthalmology|312 997-3646|gerafish@uic.edu|
21270388|NCT01080209|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21270389|NCT00572156|Ipsen|Medical Director, Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21270390|NCT01440595|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21270391|NCT03216954|University of Kentucky|William W. Stoops, PhD|859-257-5388|william.stoops@uky.edu|
21270392|NCT00323271|VA Connecticut Healthcare System|Robert Kerns, PhD|203-932-5711|robert.kerns@va.gov|3841
21270393|NCT02981602|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21270394|NCT00963599|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21270395|NCT02492295|Albert Einstein Medical Center|Kamran Mohiuddin, Director Clinical Research Emergency Department|215-456-2313|MOHIUDDK@EISNTEIN.EDU|
21270396|NCT02983227|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21270397|NCT02354976|AstraZeneca|Torbjörn Lundström|46 317064100|Torbjorn.lundstrom@astrazeneca.com|
21270398|NCT01706770|Foresight Regulatory Strategies, Inc.|William J. Gleason, O.D.|(978) 658-6888||151
21270399|NCT02020785|Geisinger|Alex Chang, MD|570-271-8026|achang@geisinger.edu|
21270400|NCT00068445|Mayo Clinic|Charles L. Loprinzi, M.D.|507-284-3731|cloprinzi@mayo.edu|
21270401|NCT01896700|Portland VA Health Care System|Andrea Hildebrand|503-220-8262|hildeand@ohsu.edu|52016
21270402|NCT00423488|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21270403|NCT03835975|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21270404|NCT01362959|Department of Intensive care, Deventer Hospital|Dr. Huub van den Oever|+31 570 535346|h.vandenoever@dz.nl|
21270405|NCT01612702|Joint Reconstruction Center, Seoul National University Bundang Hospital|Dr. TK Kim|82-31-787-7196|osktk@snubh.org|7200
21270406|NCT03070431|Department of Radiation Oncology, University of Lübeck, Lübeck, Germany|Prof. Dr. med. Dirk Rades|0049 451 500|rades.dirk@gmx.net|45400
21270407|NCT00701935|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21270408|NCT03674827|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21270409|NCT00527397|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21270410|NCT03398928|Bnai Zion Medical Center|Prof. Elad Schiff|972-506267243|elad.schiff@b-zion.org.il|
21270411|NCT00947518|Department of Pediatrics, All India Institute of Medical Sciences, New Delhi|Mari Jeeva Sankar|+91-11-26594372|jeevasankar@gmail.com|
21270412|NCT00717873|Barnes Jewish Hospital|Darnetta Clinkscale|(314) 362-1276|MDB3455@bjc.org|
21270413|NCT00370396|GlaxoSmithKline|GSK Response Center|866-435-7343||
21270414|NCT02065791|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21270415|NCT02282111|The Johns Hopkins Hospital|Dr. Mouen A. Khashab|410-502-0064|mkhasha1@jhmi.edu|
21270416|NCT02702271|Boston Scientific|Director of Clinical Trials|1-800-CARDIAC|peter.maurer@bsci.com|
21270417|NCT01494649|GlaxoSmithKline|GSK Response Center|866-435-7343||
21270418|NCT03467971|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21258272|NCT01119248|Rutgers/New Jersey Medical School|Anuradha Patel, MD Director of Pediatric Anesthesiology|973 972-1886|patelan@njms.rutgers.edu|
21258273|NCT01967550|Novartis Consumer Health|Clinical Project Leader pain category|+41223633111||
21258274|NCT00250835|University of New Mexico|Fa-Chyi Lee, MD|5059250405|flee@salud.unm.edu|
21258275|NCT01550562|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
21258276|NCT00106171|Johns Hopkins University|Dr. Joseph Margolick|410-955-1436|jmargoli@jhsph.edu|
21258277|NCT01836783|University of Alabama at Birmingham|Maninder Kaur, BDS, MPH, MS, Principal Investigator|205-9344506|maninder@uab.edu|
21258278|NCT01100437|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21258279|NCT00254462|University of Nebraska Medical Center|Christopher J. Kratochvil|402-552-6005|ckratoch@unmc.ed|
21258280|NCT04099251|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21258281|NCT04874194|The university of Texas MD Anderson Cancer Center|Courtney DiNardo MD, Professor|713-794-1141|cdinardo@mdanderson.org|
21258282|NCT01408147|Cal Poly|Suzanne Phelan|805 756 2087|sphelan@calpoly.edu|
21258283|NCT00621504|Cerexa, Inc|Vice President, Clinical Sciences|(510) 285-9200|clinicaltrials@cerexa.com|
21258284|NCT03936387|BOSTON CHILDREN'S HOSPITAL|ROLAND BRUSSEAU MD|6173557737|roland.brusseau@childrens.harvard.edu|
21258285|NCT03445000|ETOP IBCSG Partners Foundation|Heidi Roschitzki-Voser|+41 31 511 94 00|ALERT-lung@etop.ibcsg.org|
21258286|NCT00706134|Novartis Pharmaceuticals|Study Director|862-778-8300||
21258287|NCT01982292|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21258288|NCT02532231|The University of Texas MD Anderson Cancer Center|Tapan Mahendra Kadia, MD/Professor|713-563-3534|tkadia@mdanderson.org|
21258289|NCT00264004|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21258290|NCT03691974|Regeneron Pharmaceuticals, Inc|Study Director|844-734-6643|clinicaltrials@regeneron.com|
21258291|NCT00691483|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21258292|NCT00746252|University of Marylland, Baltimore|Gloria M. Reeves, M.D.|410-706-3522|greeves@psych.umaryland.edu|
21258293|NCT00439946|United Therapeutics|Remodulin Program Leader|(919) 485-8350|ClinicalRecordsManagement@unither.com|
21258294|NCT01391000|Istituto Ortopedico Rizzoli|Dr Roberta Monesi|0516366694|cristiana.forni@ior.it|0039
21258295|NCT00082888|Mayo Clinic|Thomas E. Witzig, M.D.|507-266-2040|witzig@mayo.edu|
21258296|NCT03860961|NRG Oncology|Wendy Seiferheld|(215) 574-3208|seiferheldw@nrgoncology.org|
21258297|NCT00272038|Oncology Specialists, S.C.|Sigrun Hallmeyer, MD (Director of Research); Chadi Nabhan, MD, FACP (PI)|847-268-8200|shallmeyer@oncmed.net|
21258298|NCT03189446|Stephenson Cancer Center|Dr. Kathleen Moore|405-271-8777|Kathleen-Moore@ouhsc.edu|
21258299|NCT00527605|GlaxoSmithKline|GSK Response Center|866-435-7343||
21258300|NCT01480297|The University of Michigan|Rodica Pop-Busui, MD, PhD|734-763-3056|rpbusui@umich.edu|
21258301|NCT03126760|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
21258302|NCT04312009|University of Minnesota|Christopher Tignanelli|612-626-1968|ctignane@umn.edu|
21258303|NCT03438045|NYU Grossman School of Medicine|Mary E. Northridge, PhD, MPH, Director of Dental Research|(347) 377-4342|Mary.Northridge@nyulangone.org|
21258304|NCT01268293|Eisai Co., Ltd.|Tatsuya Sasaki|81-3-3817-5252||5252
21258305|NCT03468309|VA Puget Sound Health Care System|Dr. Amanda E. Wood; Clinical Research Psychologist, VA PSHCS|253-583-1652|amanda.wood@va.gov|71652
21258306|NCT01695473|University of California, San Francisco|Dr. Won Kim, MD|877-827-3222|Won.Kim@ucsf.edu|
21258307|NCT03548558|University of Southern California|Dr. Jill Luoto|+1-213-764-1581|jluoto@usc.edu|
21258308|NCT00539695|Texas Children's Hospital|Dr. Rayne Rouce|832-824-4716|rouce@bcm.edu|
21258309|NCT03509350|Emory University|Jon Sevransky MD, MHS|404-778-5734|jonathan.sevransky@emoryhealthcare.org|
21258310|NCT01968135|University of Colorado Denver|Chanel Mansfield|303-724-6501|chanel.mansfield@ucdenver.edu|
21258311|NCT00797732|Dana-Farber Cancer Institute|Weidong Lu, PhD, MB, Lic.Ac.|617.632.4350|weidong_lu@dfci.harvard.edu|
21258312|NCT01857869|GlaxoSmithKline|GSK Response Center|866-435-7343||
21258313|NCT04639583|University of New Mexico|Jessie Maxwell, MD, MBA|505-272-3967|JRMaxwell@salud.unm.edu|
21258314|NCT00586209|Emmaus Medical, Inc.|Yutaka Niihara, MD, MPH|310-214-0065|yniihara@emmausmedical.com|
21258315|NCT02199080|Groupe Hospitalier de la Rochelle Ré Aunis|Dr Antoine Milhem|+33546455050|antoine.milhem@ch-larochelle.fr|
21258316|NCT02443883|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
21258317|NCT02018627|Massachusetts General Hospital|Courtney Balliro, BS, RN, CDE|617-726-1242|cballiro@partners.org|
21258318|NCT01179009|Washington University|Michael Yingling|5735791412|yinglinm@wustl.edu|
21258319|NCT02937818|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21258320|NCT02500628|Woodinville Psychiatric Associates|Jon Berner MD PhD|425-481-0429|jonbernermd@gmail.com|
21258321|NCT02873936|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21258322|NCT00490451|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21258323|NCT00619073|Children's Hospital Boston|Alan D. Michelson, M.D.|617-919-2116|alan.michelson@childrens.harvard.edu|
21258324|NCT00254501|University of Florida|Dale Kraemer||Dale.Kraemer@jax.ufl.edu|
21258325|NCT01223703|Department of Experimental and Applied Medicine-Section of Cardiovascular Diseases|Dr Savina Nodari|00390303996|nodari@med.unibs.it|587
21258326|NCT04249687|Galderma Research & Development|Galderma Research & Development|8179615000|clinical.studies@galderma.com|
21258327|NCT01508702|Ardea Biosciences, Inc.|Nihar Bhakta, MD|1-858-652-6671|nbhakta@ardeabio.com|
21286378|NCT01443858|Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@duke.edu|
21286379|NCT03107208|"University of Colorado Denver | Anschutz"|Rebecca Ohman, MD|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
21286380|NCT01272908|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21286381|NCT02221648|Yale University School of Medicine|Bahman Jabbari M.D, , Professor of Neurology|203-737-2464|bahman.jabbari@yale.edu|
21286382|NCT01168921|The University of Texas MD Anderson Cancer Center|William Wierda MD/Professor|713-745-0428|wwierda@mdanderson.org|
21286383|NCT00810069|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21286384|NCT00719160|Yale University|Karl L. Insogna, M.D.|203-737-2871|Karl.insogna@yale.edu|
21286385|NCT00367003|Emory University|Dr. Patricio Riva Posse||privapo@emory.edu|
21286386|NCT00905424|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21286387|NCT00426764|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21286388|NCT00379899|Amgen Inc.|Study Director|866-572-6436||
21286389|NCT02417753|National Cancer Institute|Dr. Tim Greten|301-451-4723|gretentf@nih.gov|
21286390|NCT03113968|Department of Psychiatry, Mass General Brigham, and Harvard Medical School|Dr. Amit Anand|6177266421|aanand7@bwh.harvard.edu|
21286391|NCT01387178|GlaxoSmithKline|GSK Response Center|866-435-7343||
21286392|NCT04805671|INVIVYD, Inc.|Study Inquiry|+1 781-819-0080|ClinicalTrials@invivyd.com|
21286393|NCT03804268|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21286394|NCT02849587|University of California, San Diego; Center for Medicinal Cannabis Research|Thomas D. Marcotte, Phd|619-543-5044|tmarcotte@ucsd.edu|
21286395|NCT00687908|Galderma|Clinical Project Manager|+33 492 95 29 21|jean-charles.dhuin@galderma.com|
21286396|NCT03380377|Cedars Sinai Medical Center|Stan Jordan, MD|3104232641|stan.jordan@cshs.org|
21286397|NCT02716779|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21286398|NCT01871077|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|drricardollamas@gmail.com|1259
21286399|NCT00096538|Memorial Sloan Kettering Cancer Center|Dr. Ariela Noy|212-639-7423|noya@mskcc.org|
21286400|NCT01211756|UCSD|David Feifel||dfeifel@kadimanp.com|
21286401|NCT02465164|Central Clinical Trials Office|Central Clinical Trials Office|3139537454|smarl1@hfhs.org|
21286402|NCT02324361|Partners Healthcare|Study Project Manager|4259856430|szan@mail.harvard.edu|
21286403|NCT03110133|Finch Therapeutics|Dr. Shrish Budree|(857) 322-4646|sbudree@finchtherapeutics.com|646
21286404|NCT03030625|Hospital Universitario de La Princesa|Dr. Almudena Zapatero Laborda|+34 915 20 22 00|almudena.zapatero@salud.madrid.org|
21286405|NCT02223351|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
21286406|NCT00003471|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
21286407|NCT00101868|University of Illinois|James F. Graumlich, MD, Professor of Medicine|309-655-7734|jfg@uic.edu|
21286408|NCT04001803|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21286409|NCT02493517|Ipsen|Medical Director, Oncology||clinical.trials@ipsen.com|
21286410|NCT02249104|Galderma Laboratories L.P.|Dr. Jay Mashburn|817 961 5027|jay.mashburn@galderma.com|
21286411|NCT05404711|University of Pittsburgh School of Medicine|Mary Ellen Vajravelu, MD,MSHP|412-692-6533|vajravelume@upmc.edu|
21286412|NCT00223665|University of Washington|Celestia Higano, MD|206-606-1187|mjcampbe@seattlecca.org|
21286413|NCT00691652|OHSU Knight Cancer Institute|Dr. Craig Okada|503-494-1080|Okadac@ohsu.edu|
21286414|NCT01683604|HoffmannLaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21286415|NCT03430856|Biocon Research limited|Dr. Subramanian L|080-28082808|subramanian.l101@biocon.com|1323
21286416|NCT00962078|Schoen Klinik Berchtesgadener Land, Schoenau am Koenigssee, Germany|Dr. Rainer Gloeckl|+49 8652 931630|rgloeckl@schoen-klinik.de|
21286417|NCT03877224|Astrazeneca|Łyżwa, Dawid|+48 882 345 259|dawid.lyzwa@astrazeneca.com|
21270419|NCT00294632|The University of Texas (UT) MD Anderson Cancer Center|Dr. Michael Wang, Professor, Lymphoma/Myeloma|713-792-2860|miwang@mdanderson.org|
21270420|NCT03707522|University of Nevada, Reno|Martha Zimmermann|7756368067|mzimmermann@nevada.unr.edu|
21270421|NCT00383019|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21270422|NCT01337609|Massachusetts General Hospital|Dr. Maurizio Fava|617-724-2513|mfava@partners.org|
21270423|NCT01619085|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21270424|NCT01345058|Brigham and Women's Hospital|Jong Woo Lee, MD, PhD||JLEE38@BWH.HARVARD.EDU|
21270425|NCT00000135|Johns Hopkins University|Curtis Meinert, PhD|410-955-8198|cmeinert@jhsph.edu|
21270426|NCT03162354|Penn State College of Medicine, Penn State Health Children's Hospital|Kent P. Hymel, MD; Professor of Pediatrics; Study PI|7036748989|kphymel@gmail.com|
21270427|NCT01532349|Johns Hopkins University|Dr. Meredith Atkinson|410-955-2467|matkins3@jhmi.edu|
21270428|NCT01998035|Columbia University Irving Medical Center|Ana Ignat|212-305-3612|ai2111@cumc.columbia.edu|
21270429|NCT00833976|Massachusetts General Hospital|Dr. Marlene Freeman, MD|617-643-6403|mfreeman@partners.org|
21270430|NCT02450760|University of Pennsylvania|Michael Mullen|215-662-3339|Michael.Mullen@Pennmedicine.Upenn.edu|
21270431|NCT00681824|Baxter Healthcare Corporation|Guenter Zuelow, Associate Medical Director||guenter_zuelow@baxter.com|
21270432|NCT02292433|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21270433|NCT03101293|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
21270434|NCT04682639|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21270435|NCT00763269|Colgate Palmolive Co.|William De Vizio|732-878-7901|William_Devizio@colpal.com|
21270436|NCT03333382|Vanderbilt University Medical Center|Sharee Burkeen, Research Program Manager|(615) 875-7515|sharee.k.burkeen@vumc.org|
21270437|NCT03451331|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
21270438|NCT01402115|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Dal-Sik Kim, MD|82-63-276-8284|dskim@chonbuk.ac.kr|
21270439|NCT02572427|University of Arkansas for Medical Sciences|Dr Richard Whit Hall|501-680-7894|HallRichardW@uams.edu|
21270440|NCT04736576|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21270441|NCT00123110|University of Pennsylvania, School of Medicine|Anne R. Cappola, M.D., ScM|(215) 573-5359|ACappola@mail.med.upenn.edu|
21270442|NCT00720304|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Min Yao, MD|1-800-641-2422|CTUReferral@UHhospitals.org|
21270443|NCT01087801|ChiRhoClin, Inc.|Edward Purich, Ph.D.|301-476-8388|mdoerr@chirhoclin.com|
21270444|NCT04330482|Rhode Island Hospital|Geoffrey Tremont|401-444-4500|gtremont@lifespan.org|
21270445|NCT05180630|Sonova USCS|Director of Clinical Research|630-821-5000|phonakaudiologyresearch@gmail.com|
21270446|NCT00996918|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21270447|NCT01382901|Luitpold Pharmaceuticals, Inc.|Mark Falone, MD|601-650-4200|mfalone@luitpold.com|
21270448|NCT01333475|National Cancer Institute|Dr. Shivaani Kummar|301-435-0517|kummars@mail.nih.gov|
21270449|NCT04440007|Sorrento Therapeutics, Inc.|Mike Royal, MD|858-203-4100|mroyal@sorrentotherapeutics.com|4146
21270450|NCT01466673|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-739-7200||5888
21270451|NCT02725671|Johns Hopkins University|Dr. Armin Zadeh|4105020549|arminzadeh@jhu.edu|
21270452|NCT02135094|Pain Management Associates|Dr. Ralph Ortiz|(607) 844-9979|rodoc@cnymail.com|
21270453|NCT04000373|Cleveland Clinic Neurological Institute Mellen Center|Research Nurse Coordinator|216-445-5877|stoughd@ccf.org|
21270454|NCT00657917|Uniformed Services University of the Heralth Sciences|COL Naomi Aronson MC|301-295-3621|naronson@usuhs.mil|
21270455|NCT01632683|Oregon Health & Science University|Michael Aziz, MD|503-494-5581|azizm@ohsu.edu|
21270456|NCT01155284|Sanford Research|Kurt J. Griffin, PhD, MD, Director of Clinical Trials|6053126000|kurt.griffin@sanfordhealth.org|
21270457|NCT00123487|Bristol-Myers Squibb|: Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21270458|NCT03118765|Glenmark Pharmaceuticals Ltd.|Study Director|201-684 8000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
21270459|NCT00802633|Vanderbilt University|Sam Chang|615-322-2101|sam.chang@Vanderbilt.Edu|
21270460|NCT01255722|Section Head Interventional and Cardiac Radiology - Kantonsspital Lucerne, Spitalstrasse, 6006 Lucerne, Switzerland|Prof. Dr. med. Martin HOFFMANN|+41 41 205 4660|martin.hoffmann@luks.ch|
21270461|NCT02164539|GlaxoSmithKline|GSK Response Center|866-435-7343||
21270462|NCT02643966|University of Pittsburgh|Dr. Wendie A. Berg|412-641-1635|bergwa@upmc.edu|
21270463|NCT01946282|University of Texas Southwestern Medical Center, Moncrief Cancer Institute|Dr. Keith Argenbright, Director, Moncrief Cancer Institute|817-288-0070|keith.argenbright@utsouthwestern.edu|
21270464|NCT01493531|Ardea Biosciences, Inc.|Nihar Bhakta, MD|1-858-652-6671|nbhakta@ardeabio.com|
21270465|NCT02245360|Abbott|Dmitri Kazei MD, PhD|+31 294477008|dmitri.kazei@abbott.com|
21270466|NCT03031431|Boston Children's Hospital|Dr. Anne Hansen|(617)-355-6027|Anne.Hansen@childrens.harvard.edu|
21270467|NCT01462695|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21270468|NCT00995488|University of Michigan Comprehensive Cancer Center|Dr. Maha Hussain|734-647-8903|mahahuss@umich.edu|
21270469|NCT00051636|Novartis|Study Director|862-778-8300||
21270470|NCT01656967|The University of Texas Health Science Center at Houston|Dr. Carin A. Hagberg|(713) 500-6240|Carin.A.Hagberg@uth.tmc.edu|
21270471|NCT01174368|The Rogosin Institute|Angelica Nazarian|212-746-1551||
21270472|NCT00479765|Boston Scientific Corporation|Jessie Stockwell|16126181136|jessie.stockwell@bsci.com|
21270473|NCT02580201|FIDEC Corporation|Ricardo Rüttimann|+17863546335|rruttimann@fidec-online.org|
21270474|NCT00725725|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Develpment|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21286418|NCT02481050|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
21258328|NCT03861559|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21258329|NCT02997904|Piedmont Pharmaceuticals|Dr. Kathy Palma|336 544 0320|kpalma@piedmontpharma.com|202
21286419|NCT01386606|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com|
21286420|NCT04159714|Mayo Clinic|Dr. Robert Hyde|507-255-4137|Hyde.Robert1@mayo.edu|
21286421|NCT01548599|University of California, San Francisco|Sheri Weiser|(415) 314-0665|Sheri.Weiser@ucsf.edu|
21286422|NCT03638128|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21286423|NCT00611806|Massachusetts General Hospital|Joshua L. Roffman, MD|617-724-1920|jroffman@partners.org|
21286424|NCT00587067|Memorial Sloan Kettering Cancer Center|Dr. William Jarnagin, MD|212-639-3624|jarnagiw@mskcc.org|
21286425|NCT04152200|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
21286426|NCT04069715|KGK Science Inc.|Malkanthi Evans (Ph.D.), Chief Scientific officer|5194389374|mevans@kgkscience.com|239
21286427|NCT02723188|Tel Aviv University|Yair Bar-Haim|97236406393|yair1@post.tau.ac.il|
21286428|NCT03110354|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21286429|NCT00165503|Brigham and Women's Hospital|Dr. David Sugarbaker|617-732-5004|dsugarbaker@partners.org|
21286430|NCT00643201|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21286431|NCT02976519|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21286432|NCT01278342|Novartis Pharmaceuticals|Study Director|862-778-8300||
21286433|NCT01477762|Emory University|Dr. Tanja Jovanovic|(404) 778-1485|tjovano@emory.edu|
21286434|NCT02276963|Johns Hopkins University|Michael Levy|443-287-4412|mlevy@jhmi.edu|
21258330|NCT00879697|University of São Paulo|Raphael Dias|55 81 9728 6878|raphaelritti@gmail.com|
21258331|NCT02500121|Hoosier Cancer Research Network|Clinical Trials Results Coordinator|317-634-5842|aneal@hoosiercancer.org|21
21258332|NCT03730116|Sevier|Mrdical manager - Yuriy Burtsev|8-495-93707-00|Yuriy.Burtsev@servier.com|1389
21258333|NCT03649061|UZLeuven|Prof. Dr. Patrick Verschueren|+3216342541|patrick.verschueren@uzleuven.be|
21258334|NCT02124564|Cares|UCB|+1844599|UCBCares@ucb.comTokyo|2273
21258335|NCT04489888|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21258336|NCT01003275|University of Washington|Ian H. de Boer, MD, MS, Associate Professor of Medicine|2066165403|deboer@u.washington.edu|
21258337|NCT00631748|VA Puget Sound Health Care System|Andre Tapp, MD|253-589-4176|andre.tapp@va.gov|
21258338|NCT00400881|Texas Tech University|Juan Figueroa-Casas|915 5456626|juan.figueroa@ttuhsc.edu|235
21258339|NCT00456989|University of Louisville, James Graham Brown Cancer Center|University of Louisville, James Graham Brown Cancer Center Clinical Trials|502-562-3429|ctobcc@louisville.edu|
21258340|NCT03829657|Theravance Biopharma Ireland Limited|Medical Monitor|855 633 8479|medinfo@theravance.com|+1
21258341|NCT04418076|Associate Director Domestic Projects|Natalie Kil|203.737.2883|natalie.kil@yale.edu|
21258342|NCT02549209|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 634-5842|fsharmin@hoosiercancer.org|75
21258343|NCT01295216|Institute of Nutrition of Central America and Panama|Manuel Ramirez-Zea|+502 24719913|mramirez@incap.int|
21258344|NCT01452152|University of Maryland School of Medicine|Dr. Alan R. Shuldiner|410-706-1623|ashuldin@medicine.umaryland.edu|
21258345|NCT02380716|W. L. Gore & Associates|Greg Miller|623-234-5910|gmiller@wlgore.com|
21258346|NCT02867995|Boston Medical Center|Dr. Manishi Desai|671-414-8806|Manishi.Desai@bmc.org|
21258347|NCT03368170|Integrative Research Laboratories AB|Joakim Tedroff/Chief Medical Officer|+ 46 707 601691|joakim.tedroff@irlab.se|
21258348|NCT03047980|Kennedy Krieger Institute|Research Assistant|443-923-9569|vedmurthyp@kennedykrieger.org|3-9569
21258349|NCT02164981|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|MFAVA@mgh.harvard.edu|
21258350|NCT02240654|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21258351|NCT01765673|James Madison University|Christy Ludlow|540-937-3007|ludlowcx@jmu.edu|
21258352|NCT02600507|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinicalTrials@itci-inc.com|
21258353|NCT01069562|Post Graduate Institute of Medical Education and Research|Puri GD|91-9914209509|gdpuri007@hotmail.com|
21258354|NCT02684981|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21258355|NCT04623242|Washington University|Administrative Director|(314) 221-8344|DIAN-TUDataRequest@wustl.edu|
21258356|NCT03598166|VA|Anika Zaman|6464190648|anika.zaman@nyulangone.org|
21258357|NCT03300466|Q-Med AB|Clinical Project Manager|+46184749000|reception.seupp@galderma.com|
21258358|NCT00820898|NRG Oncology|Angela Kuras on behalf of James Kauderer|716-845-5702|kurasa@nrgoncology.org|
21258359|NCT01000662|NYU Langone Medical Center|Dr. Silvia Formenti, Chairman, Department of Radiation Oncology|(212) 731-5039|silvia.formenti@nyumc.org|
21258360|NCT00452699|GlaxoSmithKline|GSK Response Center|866-435-7343||
21258361|NCT02921971|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21238092|NCT04557930|Dartmouth-Hitchcock|Dr. Amber E. Barnato|603-646-5609|Amber.Barnato@dartmouth.edu|
21258362|NCT01602692|University of Wisconsin - Madison|Dr. Venkat Rao|(608) 263-1223|rao@surgery.wisc.edu|
21286435|NCT00473655|AstraZeneca|Gerard Lynch|09645895|aztrial_results_posting@astrazeneca.com|44 15
21270475|NCT02392559|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21270476|NCT02820324|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
21270477|NCT02340078|LG Chem|Study Leader|82-2-6987-4148|sodam@lgchem.com|
21270478|NCT00944125|Aurora Health Care|Imran K. Niazi, MD|414-645-6070|imran.niazi@aurora.org|
21270479|NCT04816877|Beth Israel Deaconess Medical Center|Dr. Sunil Sheth|6176675576|ssheth@bidmc.harvard.edu|
21258363|NCT02105454|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21258364|NCT00326898|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
21270480|NCT00995930|Novartis Pharmaceuticals|Study Director|862-778-8300||
21270481|NCT04071392|Oregon Health & Science University|OB/Gyn Regulatory Specialist|503-494-3666|whru@ohsu.edu|
21270482|NCT01246973|University of Rochester|Julie Ryan|585-276-3862|julie_ryan@urmc.rochester.edu|
21270483|NCT02598622|Indiana University|Dr. Chie Schin-Shih|317-944-8784|shih2@iu.edu|
21270484|NCT00581386|UTHSC- Houston Medical School|Dr. Carin A. Hagberg|713.500.6222|maddukuri.vineela@uth.tmc.edu|
21270485|NCT03724916|Takeda|Contact|+1-877-825-3327|medinfoUS@takeda.com|
21270486|NCT04575038|Clear Creek Bio, Inc.|Barbara Powers, Vice President Clinical Operations|16177652252|clinical@clearcreekbio.com|
21270487|NCT00683332|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21270488|NCT00176852|Masonic Cancer Center, University of Minnesota|Dr. Angela Smith|612-626-2778|smith719@umn.edu|
21270489|NCT01416142|Bausch & Lomb Incorporated|Dr. William Reindel|(585) 338-8129|william.reindel@bausch.com|
21270490|NCT00678379|Charlotte Eye Ear Nose and Throat|Jonathan Moss MD|704-295-3000|jmoss@ceenta.com|
21270491|NCT04335110|Oregon Health & Science University|Dr. Allison Lindauer|15034946976|lindauer@ohsu.edu|
21270492|NCT03254719|Palmer Center for Chiropractic Research|Dr. Anna Walden-Cobb|563-949-0676|anna.waldencobb@palmer.edu|
21270493|NCT02513459|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21270494|NCT01430182|Baylor College of Medicine|Neil Bailard|713-798-7356|bailard@bcm.edu|
21270495|NCT00787566|Aviana Consulting, LLC|Vanaja V. Ragavan, M.D.|610-795-7403|vvragavan@comcast.net|
21270496|NCT00661674|Stanford University School of Medicine|Dr. Larry Chu|(650) 723-6632|lchu@stanford.edu|
21270497|NCT01551550|TissueTech|Medical Affairs|(888) 296-8858|info@tissuetech.com|
21270498|NCT00660790|Medical University of Graz|Dr. Norbert Tripolt|+43 316 385|norbert.tripolt@medunigraz.at|78038
21270499|NCT06118359|University of Wisconsin|Angela Ingraham|513-833-5205|aingraham.md.ms@gmail.com|
21270500|NCT04214951|Peking University People's Hospital|Dr. Xiaohui Zhang, Director of Clinical Trials|86-10-88324577|zhangxh@bjmu.edu.cn|
21270501|NCT03202628|Mayo Clinic|Dr. Prashant Kapoor|507-284-2511|Kapoor.Prashant@mayo.edu|
21270502|NCT00686374|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21270503|NCT00618774|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21270504|NCT03903640|Washington University School of Medicine|Dr. George Ansstas|314-508-4426|gansstas@wustl.edu|
21258365|NCT03847987|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21258366|NCT02721355|Immunology Research Institute in Gifu|Dr. Van Sa Nguyen|+819068053288|nguyen@ew-nutrition.co.jp|
21258367|NCT00356278|Emory University|Barbara O. Rothbaum, PhD, ABPP|404-712-8866|brothba@emory.edu|
21258368|NCT01166230|The University of Texas|H. Barton Grossman, MD|713-563-7456|hbgrossman@mdanderson.org|
21258369|NCT00679952|Seoul National University College of Medicine|Clinical instructor|82-2-2072-2817|meejookang@gmail.com|
21258370|NCT01535365|Stony Brook U|Adam Singer|631-444-7856|adam.singer@stonybrook.edu|
21258371|NCT01592760|Universtiy of Wisconsin School of Medicine and Public Health|Richard E. Galgon, MD, MS|608-263-8100|galgon@wisc.edu|
21258372|NCT01008280|VISN 22 Network Office|Peter Hauser, MD, VISN 22 Mental Health Services Lead|562 826 8000|peter.hauser2@va.gov|2629
21258373|NCT01363986|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21258374|NCT01637142|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21270505|NCT02753400|Kubota Vision Inc.|Clinical Trials Helpdesk|2068058310|clinicaltrials@kubotavision.com|
21270506|NCT03989115|Revolution Medicines|Vice-President Clinical Operations|650-779-2300|RMC-4630-02@revmed.com|
21270507|NCT02143947|Quinnipiac University|Juan C Garbalosa, PT, PhD, Director Motion Analysis Laboratory|203 582 8552|juan.garbalosa@quinnipiac.edu|
21270508|NCT04980521|University of North Dakota|Dr. Gary Schwartz|701-777-6598|gary.schwartz@und.edu|
21270509|NCT01244815|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21270510|NCT00697112|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21270511|NCT03007537|Nanjing First Hospital, Nanjing Medical University|Dr. Xiaobin Ji|13705174622|xbji007@126.com|
21270512|NCT04822467|Cleveland Clinic Foundation|Dr. Donald Kirby, MD|216-444-0446|kirbyd@ccf.org|
21270513|NCT03402126|Medtronic Inc|Joy Aso, Clinical Research Specialist|4015454454|joy.a.aso@medtronic.com|
21270514|NCT02261974|Viveve, Inc.|Debbie Wilkerson, PhD, Vice President, Clinical and Medical Affairs|610-209-9980|dwilkerson@viveve.com|
21270515|NCT02011516|University of Pennsylvania|Teresa R. Franklin, Ph.D., Research Associate Professor of Neuroscience in Psychiatry|215-222-3200|teresafr@mail.med.upenn.edu|119
21270516|NCT00709735|Massachusetts General Hospital|Roger K. Pitman, M.D.|617-726-5333|roger_pitman@hms.harvard.edu|
21270517|NCT01032759|Duke University Medical Center|Dr. Ashraf Habib|9196686266|habib001@dm.duke.edu|
21270518|NCT02555618|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
21270519|NCT01431755|Q-Med AB|Head of Medical Affairs|+46 (0) 18 474 90 00|reception.SEUPP@galderma.com|
21270520|NCT05552430|Center for Health Outcomes and Interdisciplinary Research, Massachusetts General Hospital|Dr. Ryan Mace|617-724-7030|rmace@mgh.harvard.edu|
21270521|NCT01890694|NYU Langone Medical Center|Office of Clinical Trials|646-754-7431|clinicaltrials@nyumc.org|
21270522|NCT01166997|EKOS Corporation|Lynn Allen|4254153100|Lynn.Allen@ekoscorp.com|
21270523|NCT01777425|UZ Leuven|Prof. Dr. P. Hellings|+3216332340|peter.hellings@uzleuven.be|
21270524|NCT01021137|James H. Quillen VA Medical Center|Director of Vestibular Laboratory|423-926-1171|faith.akin@va.gov|7376
21270525|NCT02122471|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020||
21270526|NCT00204932|U Wisconsin-Madison|Dale Schoeller Principal Investigator|608-262-1082|dschoell@nutrisci.wisc.edu|
21270527|NCT02731833|GlaxoSmithKline|GSK Response Center|866-435-7343||
21270528|NCT04542330|University of Southern Denmark|Professor Christine Stabell Benn|+45 25883964|cbenn@health.sdu.dk|
21270529|NCT02176642|Duke University|Nazema Siddiqui MD||nazema.siddiqui@duke.edu|
21270530|NCT00727298|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@Merck.com|
21270531|NCT03338673|University of Michigan|Dr. Cynthia Burton|7347639259|czburton@umich.edu|
21270532|NCT01005407|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-848-5100||
21270533|NCT02432456|Medical College of Wisconsin|Thomas Carver|414-955-1733|tcarver@mcw.edu|
21270534|NCT03574818|Montefiore Medical Center|Balazs Halmos|7184058404|bahalmos@montefiore.org|
21270535|NCT00393978|University of Cincinnati, Department of Psychiatry & Behavioral Neuroscience|Melissa P. DelBello, MD|513-558-2989|Melissa.DelBello@uc.edu|
21270536|NCT04583592|Sagent Pharmaceuticals, Inc.|Cynthia Tinkoff, Pharm.D. Manager, Medical Affairs|847-908-6913|ctinkoff@sagentpharma.com|
21270537|NCT04523831|Dhaka Medical College|Dr. Reaz Mahmud, Principal investigator|01912270803|reazdmc22@yahoo.com|+88
21270538|NCT04556838|VivaVision Biotech, Inc.|Joanne Li, M.D.|86-02158598290|joanne.li@vivavisionbio.com|
21270539|NCT02517099|Imperial College London|Professor Sejal Saglani|02075943167|s.saglani@imperial.ac.uk|
21270540|NCT01031134|Weill Cornell Medical College|Patrick Raue, Ph.D.|206-543-3807|praue@uw.edu|
21270541|NCT05788237|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21270542|NCT00918229|BioProtect|Shaul Shohat|+972545423774|Shaul@bioprotect.com|
21270543|NCT01835470|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21270544|NCT01011907|UCSF: EGCRC|Jennifer Mitchell, Clinical Project Director|510-985-3100|jmitchell@gallo.ucsf.edu|
21270545|NCT01222871|SEMC|Dr. Peter catalano|1-617-789-5004|peter.catalano@steward.org|
21270546|NCT00304954|NEI|Dr. Robert Nussenblatt, MD, MPH|301-496-3123|robert.nussenblatt@nih.gov|
21270547|NCT01363401|Hanyang University Seoul Hospital|Seung-Hyun Kim, M.D., Ph.D.|+82-2-2290-8114|kimsh1@hanyang.ac.kr|
21270548|NCT00923195|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
21270549|NCT00525031|UT MD Anderson Cancer Center|Wen-Jen Hwu, MD/Professor, Melanoma Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
21270550|NCT02314520|Penn State Health Milton S. Hershey Medical Center Dept of Neurosurgery|Dr. J. Christopher Zacko|717-531-1279|jzacko@pennstatehealth.psu.edu|
21270551|NCT02140164|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov|
21270552|NCT00775983|UCSF|Abby Sokoloff|4155140440|sokoloffa@obgyn.ucsf.edu|
21270553|NCT02424565|GlaxoSmithKline|GSK Response Center|866-435-7343||
21270554|NCT01173159|Cincinnati Children's Hospital Medical Center|Crystal Slaughter, BA, CCRC|513-636-0137|crystal.slaughter@cchmc.org|
21270555|NCT02786498|University of Maryland Baltimore, School of Medicine, Department of Orthopaedics|Dr Gerard Slobogean|410-28-6280|gslobogean@som.umaryland.edu|
21270556|NCT00374543|Massachusetts General Hospital|Naomi M. Simon, M.D., M.Sc.|(617) 726-7913|nsimon@partners.org|
21270557|NCT01427920|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21270558|NCT04228302|EicOsis|Dr. William Schmidt|650-438-3018|wkschmidt@eicosis.com|
21270559|NCT05795062|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21270560|NCT03066440|UBMD Pediatrics|Dr. Amanda B. Hassinger, Medical Director of the UBMD Pediatrics Sleep Center|716-323-0158|albrooks@buffalo.edu|
21270561|NCT00736333|Merck Sharp & Dohme Corp.|Senior Vice President, Global Cllinical Development||ClinicalTrialsDisclosure@merck.com|
21270562|NCT03723590|Medline Industries|Julie Miller|630-418-6891|jamiller@medline.com|
21270563|NCT04991311|Zealand Pharma A/S|Head of clinical operations|+45 8877 3600|info@zealandpharma.com|
21270564|NCT01990898|Cleveland Clinic|Dr. Daniel Shoskes||dshoskes@gmail.com|
21258375|NCT02111564|Janssen Research & Development, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21258376|NCT00687362|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21258377|NCT00925015|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21258378|NCT04986202|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21258379|NCT03340610|Southeast Retina Center|Dr. Dennis Marcus|706650061|dmarcus@southeastretina.com|
21258380|NCT02698735|University of Southern California Department of Dermatology|Dr. David Woodley|(323)442-0084|dwoodley@med.usc.edu|
21258381|NCT01289015|Merz Pharmaceuticals, LLC|Stefan Plaum, MD Associate Medical Director|800-334-0514|clinicaltrials@merzusa.com|
21258382|NCT04175626|Biotronik, Inc|Crystal Miller|1 800-547-0394|crystal.miller@biotronik.com|
21258383|NCT03494881|Mayo Clinic|Jason Sluzevich, M.D.|904-953-6192|sluzevich.jason@mayo.edu|
21258384|NCT01425203|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21258385|NCT02246062|Faculdade de ciências médicas da Santa Casa de São Paulo|Dr Débora de Oliveira Cumino|+55 11 33617333|comissaocientifica@fcmsantacasasp.edu.br|
21258386|NCT06117319|Topmed|Edith Martin|418 683-2104|emartin@topmed.ca|1302
21258387|NCT00290433|The University of Texas (UT) MD Anderson Cancer Center|Christopher Flowers/Chair, Lymphoma-Myeloma|713-745-6095|crflowers@mdanderson.org|
21258388|NCT03001674|Tufts Medical Center|Dr. Navin Kapur|617 636 0720|nkapur@tuftsmedicalcenter.org|
21258389|NCT00793650|Emory University|Dr. Sagar Lonial|404-727-5572|sloni01@emory.edu|
21258390|NCT02501265|Duke University School of Medicine|Dr. James Davis|919-668-5055|james.m.davis@duke.edu|
21258391|NCT01888640|University of Iowa|Dr. Kathleen A. Sluka|319-335-9791|kathleen-sluka@uiowa.edu|
21258392|NCT00109707|NovartisPharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21258393|NCT01277549|Terumo BCT|Jerome R Bill, M.D.|303-231-4729|jerry.bill@terumobct.com|
21258394|NCT01618214|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21258395|NCT02228590|Sunovion Pharmaceuticals Inc.|CNS Medical Director|866-503-6351|clinicaltrialdisclosure@sunovion.com|
21258396|NCT02109484|Chris Hani Baragwanath Academic Hospital|Michelle J. Groome, MD, PhD|+27 11 983 4283|groomem@rmpru.co.za|
21258397|NCT02111993|UC San Diego School of Medicine|Ulrika Birgersdotter-Green, MD|858-657-5310|ubgreen@ucsd.edu|
21258398|NCT00419380|University of Colorado School of Medicine - Department of Pediatric Otolaryngology|Kenny H. Chan, MD|7207774776|kenny.chan@childrenscolorado.org|
21258399|NCT00796315|Procter & Gamble|Guhan Balan|513.622.2657|balan.g@pg.com|
21258400|NCT00440505|Columbia University|Pamela Flood, MD|212-305-2008|pdf3@columbia.edu|
21258401|NCT04074928|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
21258402|NCT01400451|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21258403|NCT00574275|Sanofi|International Clinical Development Study Director||Contact-Us@sanofi.com|
21258404|NCT02249143|OHSU|Cindy McEvoy, MD|503-494-0223|mcevoyc@ohsu.edu|
21258405|NCT00763750|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org|
21258406|NCT03496428|Implantology Institute|Prof. Dr. Duarte Marques|+351217 210 980|d.marques@institutoimplantologia.com|
21258407|NCT01890642|Medical College of Wisconsin|Maren Lunoe|414-266-2625|mlunoe@mcw.edu|
21258408|NCT00889265|Zimmer Dental|Dr Hai Bo Wen, Director of Research|760-929-4312|haibo.wen@zimmer.com|
21258409|NCT03028870|Purdue Pharma L.P.|Clinical Leader|1-800-733-1333|steven.ripa@pharma.com|
21258410|NCT01618942|Huazhong University of Science&Technology|Xianwei Zhang|027 83662853|ourpain@163.com|
21258411|NCT00317109|GlaxoSmithKline|GSK Response Center|866-435-7343||
21258412|NCT03124771|Masimo|Tala Harake||studies@masimo.com|
21258413|NCT03461757|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
21258414|NCT04011280|Pacific Treatment and Research Center|Dr. Benjamin McKenna|858-534-8817|bmckenna@health.ucsd.edu|
21258415|NCT03221738|Massachusetts General Hospital|Anna Schwartzberg|617-724-7161|aschwartzberg@mgh.harvard.edu|
21258416|NCT03315871|National Cancer Institute|Dr. Ravi A. Madan|301-480-7168|m480i@nih.gov|
21258417|NCT04527185|Yale School of Medicine|Terril Verplaetse|203-737-6496|terril.verplaetse@yale.edu|
21258418|NCT00328627|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21258419|NCT02049944|Memorial Care|Dr. Morgan Swank|5624808460|morganswankmd@gmail.com|
21258420|NCT01761266|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21258421|NCT01662440|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
21258422|NCT00112905|ECOG Statistical Office|Study Statistician|617-632-3012||
21258423|NCT02643004|CooperVision Inc.|Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
21258424|NCT01975922|Vanderbilt University|Ann Kaiser|615-322-8163|ann.kaiser@vanderbilt.edu|
21258425|NCT05048719|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21258426|NCT04541004|ALK-Abelló A/S|David Hal Mollerup, Senior Director|+45 45747576|ClinicalTrials@alk.net|
21258427|NCT00605085|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|1175
21258428|NCT00600015|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
21258429|NCT03257267|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21258430|NCT02229552|SUNY Buffalo|Leonard H Epstein|716-826-3400|ckk@buffalo.edu|
21258431|NCT04872101|LEO Pharma A/S|Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
21258432|NCT00879229|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21258433|NCT02475681|Acerta Clinical Trials|Study Director|18882929613|acertamc@dlss.com|
21258434|NCT02323698|Spaulding Rehabilitation Hospital|Dr. Randy D Trumbower, PI|(617) 952-6953|randy.trumbower@mgh.harvard.edu|
21286436|NCT00891813|Abbott|Global Medical Services|1-800-633-9110||
21270565|NCT00054275|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Paula Silverman, MD|216-844-3951|paula.silverman@uhhospitals.org|
21270566|NCT00755937|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21270567|NCT01106352|Bayer|Therapeutic Area Head||Clinical-Trial-Disclosure@bayer.com|
21270568|NCT03876873|University of Missouri-Columbia|Boris Mraovic|5738822568|mraovicb@health.missouri.edu|
21270569|NCT03547531|Prince of Songkla University|istiyanti Hapsari|+66980493996|istiyantihapsari@gmail.com|
21270570|NCT03944707|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21270571|NCT02649608|H. Lundbeck A/S|Email contact via H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@Lundbeck.com|
21270572|NCT01878500|Johns Hopkins University|Dr. John P Gearhart|410-955-5358|jgearha2@jhmi.edu|
21270573|NCT02117479|Incyte Corporation|Study Director|855 463-3463||
21270574|NCT02444182|Kuwait University - Faculty of Dentistry|Dr. Abrar Alanzi|24636812|aalanzi@hsc.edu.kw|
21270575|NCT01959230|Bausch & Lomb Incorporated|Director, Medical Affairs||Heleen.DeCory@bausch.com|
21270576|NCT01453374|Alkermes|Bernard L. Silverman, MD|781-609-6000|Bernard.Silverman@alkermes.com|
21270577|NCT02577042|Fundació Lluita contra la SIDA|Director of Clinical Trials|+34 93 497 84 14|enegredo@flsida.org|
21270578|NCT02629133|Womene and Infants Hospital|Caron Zlotnick|401-474-3332|czlotnick@butler.org|
21270579|NCT01223196|UT Health Science Center San Antonio|Franco Folli, MD PhD/Professor|210-567-4826|FOLLI@uthscsa.edu|
21270580|NCT02487979|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21270581|NCT00447694|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21270582|NCT01965535|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21270583|NCT01169987|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
21270584|NCT00829439|Boston Children's Hospital|Wen-Hann Tan|617-355 6394|wen-hann.tan@childrens.harvard.edu|
21286437|NCT02076100|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21286438|NCT00243919|Duke University|Pamela W. Duncan, PT, PhD, FAHA, FAPTA|919-681-2060|pamela.duncan@duke.edu|
21286439|NCT02513550|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21301465|NCT03830307|University of Pittsburgh|Dr. Grace Lim|412-641-4260|limkg2@upmc.edu|
21270585|NCT00386100|GlaxoSmithKline|GSK Response Center|866-435-7343||
21270586|NCT02525562|Stryker Orthopaedics|Stryker JR Clinical Research|201-831-5000|StrykerJRClinical@stryker.com|
21301466|NCT00740857|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21301467|NCT02963506|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21301468|NCT03710577|Univerisity of Wisconsin-Madison|Dr. Kelli Koltyn|608-262-4234|koltyn@education.wisc.edu|
21301469|NCT00354432|Wake Forest University School of Medicine|Dr. Doug Case|(336) 716-5425|dcase@wakehealth.edu|
21301470|NCT03843541|Zambon S.p.A.|Valentina Zanin|+39026652441|valentina.zanin@zambongroup.com|
21301471|NCT04301193|University of Maryland|Division Chief of Obstetric Anesthesiology|(410) 328-4229|bkodali@som.umaryland.edu|
21301472|NCT02930018|NoNO Inc.|Michael Tymianski, MD PhD|4165831687|mtymianski@nonoinc.ca|
21301473|NCT03493464|Bracco Diagnostics Inc.|Giordana Marioni, Clinical Trial Assistant|609-514-2282|giordana.marioni@diag.bracco.com|
21301474|NCT02807402|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21301475|NCT04983680|Massachusetts General Hospital/Harvard Medical School|Dr. Christina Luberto|617-643-9453|cluberto@mgh.harvard.edu|
21301476|NCT01006291|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21301477|NCT00684060|UT-Houston School of Public Health|Lemuel Moye, MD, PhD|713-500-9518|Lemmoye@msn.com|
21301478|NCT00702715|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21301479|NCT02641561|Cooper University Hospital|Shaffer R. S. Mok, M.D., M.B.S.|6099804564|mok.shaffer@gmail.com|
21301480|NCT01677377|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
21301481|NCT02260180|Aclaris Therapeutics, Inc.|Judith Schnyder, Senior Director of Clinical Operations|1-484-329-2144|jschnyder@aclaristx.com|
21301482|NCT03180840|Protalix Ltd.|Sari Alon|+972-4-9028100|sari@protalix.com|215
21301483|NCT03059355|University of Miami, Miller School of Medicine - Interdisciplinary Stem Cell Institute (ISCI)|Joshua M Hare, MD|305 243 5579|JHare@med.miami.edu|
21301484|NCT01373671|Siemens Medical Solutions USA, Inc.|Director of Clinical Affairs|610-448-6468|lesley.ewing@siemens.com|
21301485|NCT01079299|Center for Curative and Palliative Wound Care Calvary Hospital|Oscar M. Alvarez / Principal Investigator|718-518-2577|oalvarez@calvaryhospital.org|
21301486|NCT00753649|GlaxoSmithKline|GSK Response Center|866-435-7343||
21301487|NCT03544333|University Hospital of Psychiatry Zurich, Switzerland|Stephanie Homan, PhD|0041 44 384|stephanie.homan@bli.uzh.ch|28 02
21301488|NCT03062540|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 904-0355|greg.sullivan@tonixpharma.com|
21301489|NCT00333762|VA Pittsburgh Healthcare System|Dana Sinciline|412-822-3683|dana.sinciline@va.gov|
21301490|NCT00808080|UC San Diego Moores Cancer Center|Dr. Thomas Lane, Stem Cell Lab Director|858-822-5364|jreiner@Ucsd.edu|
21301491|NCT00423917|Mayo Clinic|Winston Tan MD|507/284-1159|tan.winston@mayo.edu|
21301492|NCT01837823|Mount Sinai Hospital and Icahn School of Medicine at Mount Sinai|Dr. Annapoorna Kini|212-241-4181|annapoorna.kini@mountsinai.org|
21301493|NCT03052400|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu|
21301494|NCT00555061|GlaxoSmithKline|GSK Response Center|866-435-7343||
21301495|NCT00475306|Montefiore Medical Center|Dr. BW Friedman|718-920-6626|befriedm@montefiore.org|
21301496|NCT05801341|UW School of Medicine and Public Health|Ellen Wald, MD|(608) 263-8558|erwald@pediatrics.wisc.edu|
21301497|NCT02405442|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21270587|NCT02328807|H. Lee Moffitt Cancer Center and Research Institute|Dr. Julio M. Pow-Sang|813-745-2226|julio.powsang@moffitt.org|
21270588|NCT00117585|Portland VA Medical Center|Dr. David Hickam|(503) 721-7817|david.hickam@va.gov|
21270589|NCT00886782|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21270590|NCT00849524|University of California, San Diego|Januario Castro, MD|(858) 822-6600|jecastro@ucsd.edu|
21270591|NCT02624518|Stanford Medicine at Stanford University|David G Marcellus|650-723-4547|dmarcel2@stanford.edu|
21270592|NCT03012815|Mayo Clinic|Ruth Bates|507-255-8716|Bates.Ruth@mayo.edu|
21270593|NCT00272961|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21270594|NCT02400905|Veryan Medical|Nick Yeo|+44 1403 258984|nick.yeo@veryanmed.com|
21270595|NCT02964897|Center for Healthcare Organization and Implementation Research, VA Bedford Healthcare System|Keith McInnes, Principal Investigator|617-504-1630|donald.mcinnes@va.gov|
21270596|NCT00879970|GlaxoSmithKline|GSK Response Center|866-435-7343||
21238093|NCT04653766|Bioxodes|Medical Writer|+32 (0)71 239 602|stephanie.demoulin@bioxodes.com|
21238094|NCT00538590|Hospital of Universität Köln|Thomas Dietlein, Ph. D., MD|+49 221 4785862|thomas.dietlein@uk-koeln.de|4300
21238095|NCT01256567|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21238096|NCT02563496|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21258435|NCT02025426|Duke University, School of Medicine, Department of Anesthesiology|Dr. Ashraf Habib|(919) 681-4544|ashraf.habib@duke.edu|
21258436|NCT01578980|University of Virginia|Boris Kovatchev, PhD|434-924-5592|bpk2u@virginia.edu|
21258437|NCT01652287|Georgetown University Medical Center, Department of Family Medicine|Director of Research Programs|202-687-1600|FamilyMedResearch@georgetown.edu|
21258438|NCT02605642|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21258439|NCT02762513|University of Michigan Rogel Cancer Center|Paul Swiecicki, M.D.|734-647-1017|pswiecic@med.umich.edu|
21258440|NCT02165384|Preceptis Medical|CEO|6123274795|steve@preceptismedical.com|
21258441|NCT02354703|University of Maryland School of Medicine|Dr. David Gorelick|410-408-6806|dgorelick@som.umaryland.edu|
21258442|NCT01968460|Pharma 2B LTD|Pninit Litman study director|+972 8 9472672|pninit@pharma2b.com|
21258443|NCT02597855|Yeungnam University College of Medicine|Dr. Min Sagong|82-53-620-4191|msagong@ynu.ac.kr|
21258444|NCT03522324|University of Colorado Boulder|Dr. L. Cinnamon Bidwell|3037355180|lcb@colorado.edu|
21258445|NCT03704194|Washington university in St.louis|Brittany Minor|314-273-4118|bminor@wustl.edu|
21258446|NCT03491384|University of Colorado Boulder|Dr. L. Cinnamon Bidwell|3037355180|CUChange@Colorado.edu|
21238097|NCT00567190|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
21238098|NCT04898231|UCSD|Dr. Adriana Tremoulet|858-246-0012|atremoulet@health.ucsd.edu|
21238099|NCT02306759|The Brooklyn Hospital Center|Director, Emergency Medicine Clinical Research Program|718-250-6250|bsin@tbh.org|
21238100|NCT00636610|Genentech, Inc.|Medical Communications|800-821-8590||
21238101|NCT00416182|Vermont Children's Hospital at Fletcher Allen Health Care|Dr. Thomas Lahiri, Principal Investigator|802-847-8600|thomas.lahiri@vtmednet.org|
21238102|NCT02669784|Milton S. Hershey Medical Center|Rekha Cherian, M.D.|717-531-6735|rcherian@pennstatehealth.psu.edu|
21238103|NCT02412137|Texas Scottish Rite Hospital for Children|Dr. Brandon Ramo|2145597755|brandon.ramo@tsrh.org|
21258447|NCT00179309|National Cancer Institute, National Institutes of Health|Dr. James Gulley, M.D., Ph.D.|301-435-2956|gulleyj@mail.nih.gov|
21258448|NCT04681170|Amryt Pharmaceuticals DAC|Head of Clinical Operations|+35315180200|janet.boylan@amrytpharma.com|
21258449|NCT06414512|University of Minnesota|David Boulware|612-624-9996|idim@umn.edu|
21258450|NCT01394081|Tuscaloosa VA Medical Center|Lori L. Davis, MD|205-554-2000|Lori.Davis@va.gov|3819
21258451|NCT01407926|McMaster University|Maureen Markle-Reid, Associate Professor and Canada Research Chair, School of Nursing|905-525-9140|mreid@mcmaster.ca|22306
21258452|NCT05131204|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21258453|NCT00488982|University of California, San Francisco|Dr. Rahul Aggarwal|(415) 353-9278|Rahul.Aggarwal@ucsf.edu|
21258454|NCT01368835|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
21258455|NCT01885000|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
21258456|NCT01272999|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21258457|NCT04373369|Washington University School of Medicine|Daniel Morgensztern, M.D.|314-362-5817|danielmorgensztern@wustl.edu|
21258458|NCT02363686|University of Colorado|Carrie Higgins|7205603037|carrie.higgins@cuanschutz.edu|
21258459|NCT02952222|Boston Children's Hospital|Dr. Keira Mason|(617) 355-7737|keira.mason@childrens.harvard.edu|
21270597|NCT00524394|University of Texas Health Science Center|James Murphy, PhD|713-500-5714|james.r.murphy@uth.tmc.edu|
21238104|NCT04913363|University of Virginia|Jennifer Roe|434-982-4567|jjr4b@virginia.edu|
21286440|NCT00597818|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
21238105|NCT04506970|Mayo Clinic|Mauro Schenone|5072840210|schenone.mauro@mayo.edu|
21238106|NCT03355326|Indiana University, School of Medicine|Dr. Alan Ladd, Principle Investigator|317-274-4606|aladd@iupui.edu|
21270598|NCT01749033|Northwerstern University|Ling Hu M.D.|312-695-3428|l-hu2@northwestern.edu|
21270599|NCT01256398|University of California San Diego Moores Cancer Center|Matthew Wieduwilt, MD, PhD|858-822-6848|mwieduwilt@ucsd.edu|
21270600|NCT00061945|University of Chicago Medical Center|Wendy Stock, M.D.||wstock@medicin.bsd.uchicago.edu|
21270601|NCT01039584|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
21270602|NCT02740660|Pennington Biomedical Research Center|Dr. Daniel Hsia|225-763-3000|clinicaltrials@pbrc.edu|
21258460|NCT05526833|New York State Psychiatric Institute|Michael Avissar|(646) 774-5431|MichaelAvissarMDPhD@gmail.com|
21258461|NCT02469090|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
21258462|NCT00586573|Massachusetts General Hospital|Craig Surman, MD|617-503-1424|csurman@partners.org|
21258463|NCT03806127|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
21258464|NCT04852120|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
21258465|NCT03446885|Florida International University|Gregory A. Fabiano, Ph.D.|716-359-7823|gfabiano@fiu.edu|
21258466|NCT01390259|University of Virginia|Marc Breton, Ph.D.|434-982-6484|mb6nt@virginia.edu|
21258467|NCT05726318|University of Pittsburgh|Megan Bradley, MD|412-641-3189|bradleym4@upmc.edu|
21258468|NCT04302727|University of North Carolina at Chapel Hill|Thomas Keyserling, MD|984-974-4462|thomas_keyserling@med.unc.edu|
21258469|NCT04283123|Washington University School of Medicine in St. Louis|Susan Stark, PhD, OTR/L, FAOTA|(314)273-4114|sstark@wustl.edu|
21258470|NCT05882318|Valencia Technologies|Dylan Beyer|+1 (661) 775-1414|dbeyer@valenciatechnologies.com|
21258471|NCT05030311|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21258472|NCT03042468|Weill Cornell Medicine|Dr. Scott Tagawa|646-962-2027|stt2007@med.cornell.edu|
21258473|NCT01662895|Beth Israel Deaconess Medical Center|Magdy Selim, MD, PhD|617-63208913|mselim@bidmc.harvard.edu|
21258474|NCT02275338|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
21258475|NCT01665807|Mount Sinai Hospital, IDERU|Brenda L. Coleman, PhD,|416-586-4800|bcoleman@mtsinai.on.ca|4538
21258476|NCT00623428|Hoffman-LaRoche|Medical Communications|800-821-8590||
21258477|NCT01692301|Novartis Pharmaceuticals|Study Directors|862-778-8300|trialandresults.registries@novartis.com|
21258478|NCT01142726|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21258479|NCT01568593|Laboratoires Thea|Dr Pascale POULIQUEN|0473981436|p.pouliquen@laboratoires-thea.fr|
21258480|NCT01097863|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
21258481|NCT05182554|MIT|LISA HO|5106505455|lisaho@mit.edu|
21258482|NCT02788747|Stealth BioTherapeutics Inc.|Jim Carr PharmD Chief Clinical Development Officer|617-600-6888|jim.carr@stealthbt.com|
21258483|NCT01026831|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21258484|NCT01079182|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21258485|NCT04417894|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21270603|NCT04974645|Stanford Prevention Research Center, Department of Medicine, Stanford|Judith J. Prochaska, PhD, MPH|650-724-3608|jpro@stanford.edu|
21286441|NCT04176939|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21286442|NCT02157519|Massachusetts General Hospital Cancer Center|Joseph Greer, PhD|617-643-2143|jgreer2@mgh.harvard.edu|
21286443|NCT01656395|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21286444|NCT03871153|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
21286445|NCT02318849|University of Hawaii|Cheryl Albright, PhD, Prinicipal Investigator|808-956-9716|cherylal@hawaii.edu|
21286446|NCT00230048|Wayne State University|Steven J. Ondersma|313-577-6680|s.ondersma@wayne.edu|
21286447|NCT00676403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21286448|NCT03225170|NHGRI|Dr. Lori Erby|301-443-2635|lori.erby@nih.gov|
21286449|NCT01039467|Fuwai Hospital|Dr. Shu Zhang|861088398833|zsfuwai@vip.163.com|
21286450|NCT00705757|Summa Health System ( at the time of the trial)|Deepak P. Edward, MD|330-780-0399|deepak.edward@gmail.com|
21286451|NCT04742673|Vanderbilt University Medical Center|Christopher Hughes|615-322-5000|christopher.hughes@vumc.org|
21286452|NCT06290089|Scandinavian Biopharma Holding AB / Etvax|Head of Clinical Development|004684705600|info@scandinavianbiopharma.se|
21286453|NCT05017272|Q2i LLC Telephone: 646-660-2151 Email: sjenkins@q2i-group.com|Steve Jenkins|646-660-2151|sjenkins@q2i-group.com|
21286454|NCT04073303|AbbVie|ABBVIE CALL CENTER|844-663-3742|abbvieclinicaltrials@abbvie.com|
21286455|NCT01368263|Washington University School of Medicine|Timothy Pluard, M.D.|314-362-5645|tpluard@saint-lukes.org|
21286456|NCT02937623|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21286457|NCT01158261|Ethicon, Inc|Director of Clinical Development|908-218-2492|jbatill2@its.jnj.com|
21286458|NCT00971867|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials.@bms.com|
21286459|NCT00227539|University of Washington|Renato G. Martins|206-288-6680|rgmart@uw.edu|
21286460|NCT02533934|University of California San Francisco|Rodney Rogers|+14155951226|Rodney.Rogers@ucsf.edu|
21286461|NCT01655719|University of Michigan|Tim Muth|734-615-8914|tmuth@med.umich.edu|
21286462|NCT01922258|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development||DT-inquiry@otsuka.jp|
21286463|NCT00673257|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21286464|NCT01569126|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21286465|NCT01166750|University of Kansas Medical Center|Michael A. Rapoff, PhD., Principal Investigator|913-588-6323|mrapoff@kumc.edu|
21286466|NCT05225389|Cogntion Therapeutics Inc|Chief Medical Officer, Head of R&D|914-221-6730|acaggiano@cogrx.com|
21258486|NCT04472429|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21258487|NCT01180660|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu|
21258488|NCT02425826|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-800-260-1599|ClinicalTrialDisclosure@celgene.com|
21258489|NCT02864368|Duke University Medical Center|Principal Investigator|(919) 684-5301|dukebrain1@duke.edu|
21258490|NCT04036968|Johns Hopkins University School of Medicine|Kelly Dunn, Professor|410-550-2254|kdunn9@jhmi.edu|
21258491|NCT04942925|Alcon Research, LLC|Sr. Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21258492|NCT00802204|Vanderbilt University|Julia Dunn, MD|615-343-8389|julia.dunn@va.gov|
21258493|NCT02043548|University of Pittsburgh|Chester Oddis, MD|412-383-8861|cvo5@pitt.edu|
21258494|NCT01344876|Otsuka Pharmaceutical Co., Ltd|"Leader of Department of Small Global Clinical Development"|+81-3-6361-7366||
21258495|NCT05107765|The University of Texas Health Science Center of Houston|Jin H Yoon, PhD|713-486-2800|jin.ho.yoon@uth.tmc.edu|
21258496|NCT00562588|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21258497|NCT01869647|Yale Emergency Medicine|Dr. Chris L. Moore|(203)737-3313|chris.moore@yale.edu|
21258498|NCT01390909|GlaxoSmithKline|GSK Response Center|866-435-7343||
21258499|NCT01099202|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/794-5783|eharriso@mdanderson.org|
21258500|NCT01484626|Loyola University Medical Center|Scott Smith, M.D., Ph.D.|708-327-3142|ssmith8@lumc.edu|
21258501|NCT01777152|Seagen Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
21258502|NCT03716869|MS Hershey MC|Deepa Sekhar, Associate Professor of Pediatrics, Executive Director Penn State PRO Wellness|7175310003|dsekhar@pennstatehealth.psu.edu|281334
21258503|NCT02163434|University at Buffalo|Dr. Thomas Guttuso, Jr.|7169326080|tguttuso@gmail.com|
21258504|NCT03823391|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21258505|NCT00522795|BrUOG|Kayla Rosati|401-863-3000|Kayla_Rosati@brown.edu|
21258506|NCT01833130|Allergan, Inc|Medical Director,||clinicaltrials@allergan.com|
21258507|NCT03461445|UC Davis Health|Associate Professor of Medicine|916-734-5141|lxchen@ucdavis.edu|
21258508|NCT03557359|Columbia University|Fabio Iwamoto|212-342-0571|fi2146@cumc.columbia.edu|
21258509|NCT00428974|Can-Fite BioPharma Ltd|Pnina Fishman, PhD|011972 3 924 1114|pnina@canfite.co.il|
21258510|NCT05980299|Miami University|Dr. Katherine Abbott|513-529-0869|abbottkm@miamioh.edu|
21258511|NCT02264990|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21258512|NCT02128230|University of Arkansas for Medical Sciences|Frits Van Rhee, MD|501-526-2873|vanrheefrits@uams.edu|
21258513|NCT03031301|Vibrantgastro|clinical trial manager|046663322|service@vibrantgastro.com|
21258514|NCT01294800|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21258515|NCT03326843|Dova Pharmaceuticals|Associate Director, Clinical Operations|919-338-7864|clinical@dova.com|
21258516|NCT05048342|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21258517|NCT00493038|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21258518|NCT01441063|National Cancer Institute|Dr. Robert Yarchoan|240-760-6075|robert.yarchoan@nih.gov|
21258519|NCT02164422|Yale School of Medicine|Dr. Sherry McKee|2037373529|sherry.mckee@yale.edu|
21258520|NCT01558661|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho, MD, PhD|646-888-4235|hoa@mskcc.org|
21258521|NCT03345472|Medtronic Restorative Therapies Group, Spinal Cord Stimulation|Stacie Hallaway/Senior Clinical Research Specialist|763-526-3844|RS.VectorsPM@medtronic.com|
21270604|NCT04380701|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
21270605|NCT03550794|Montefiore Medical Center|Dr. Ari Moskowitz|7189202956|amoskowitz@montefiore.org|
21301498|NCT00673738|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-3050|alberto.chiappori@moffitt.org|
21301499|NCT03830892|Virginia Commonwealth University|Dr. Andrew J. Barnes|804-827-4361|abarnes3@vcu.edu|
21301500|NCT00975689|National Institute of Child Health and Human Development; NIH|Dr. Forbes D Porter, Senior Investigator|(301) 435-4432|fdporter@mail.nih.gov|
21301501|NCT00372593|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21301502|NCT02974543|University of Michigan|Susan Shore, Professor of Otolaryngology|734 647-2116|sushore@umich.edu|
21301503|NCT03534180|City of Hope|Dr. Jasmine Zain, MD|6263598111|jazain@coh.org|
21301504|NCT00220636|NY State Psychiatric Institute|David Hellerstein MD|6467748000|hellers@nyspi.columbia.edu|
21301505|NCT00330967|Phoenix VA Health Care System|Charles Oh|602-277-5551|charles.oh@va.gov|1-5127
21301506|NCT00539942|University of Alabama at Birmingham|Warner K. Huh, MD|205-996-4662|warner.huh@ccc.uab.edu|
21301507|NCT00337675|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21301508|NCT04269265|University of Minnesota|Kevin Escandon, MD MS|612-626-9344|escan012@umn.edu|
21301509|NCT04439136|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21301510|NCT04693234|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21301511|NCT05814367|Johnson & Johnson Vision Care, Inc. (JJVC)|Nabin Joshi|1-800-843-2020|njoshi30@its.jnj.com|
21301512|NCT02578706|Icahn School of Medicine at Mount Sinai|Dr. Meagan O'Brien||Meagan.O'Brien@mssm.edu|
21301513|NCT04849559|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
21270606|NCT01864525|Syracuse University|Dr. Soren Lowell|315-443-9648|slowell@syr.edu|
21270607|NCT01890785|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21270608|NCT03296553|Instituto Nacional de Cancerología|Dr. Patricia Volkow|01 55 5628 0400|pvolkowf@gmail.com|12120
21270609|NCT00558519|University of Chicago|Wendy Stock, MD|773-834-8982|wstock@medicine.bsd.uchicago.edu|
21270610|NCT03001011|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21270611|NCT00065065|University of Pennsylvania|James D. Lewis, MD, MSCE|215-573-5137|lewisjd@mail.med.upenn.edu|
21270612|NCT01050673|Northwestern Medical Faculty Foundation|Dr Robert D Galiano, Assistant Professor of Surgery|312-695-6022|rgaliano@nmh.org|
21270613|NCT04363736|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21258522|NCT01926782|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com|
21270614|NCT03593772|James A. Haley Veteran Hospital Research Service|Dr. Jolie Haun|904-377-6796|Jolie.Haun@va.gov|
21270615|NCT03125915|Hunter College, CUNY|Tyrel Starks, Associate Professor|212-206-7919|tstarks@hunter.cuny.edu|934
21270616|NCT04355767|Stanford University|Kevin Schulman, MD|(650) 724-0543|kevin.schulman@stanford.edu|
21270617|NCT01999322|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
21270618|NCT02033382|NYU Langone Health|Principal Investigator|646-754-4843|donald.goff@nyumc.org|
21270619|NCT00301873|Duke Comprehensive Cancer Center|Mary Lou Affronti, RN, MSN, ANP, MHSc Senior Investigator|919-684-6239|mary.affronti@duke.edu|
21270620|NCT02936479|NYU Langone Health- Transplant Institute|Cecilia Deterville, MS, CCRC|212.263.3620|Cecilia.Deterville@nyulangone.org|
21270621|NCT01440647|Women & Infants Hospital of Rhode Island|Abbot R. Laptook, MD, Professor of Pediatrics The Warren Alpert Medical School of Brown University M|401-274-1122|ALaptook@WIHRI.org|7404
21270622|NCT04036227|Gesynta Pharma AB|Charlotte Edenius|+46733864246|ctg@gesynta.se|
21270623|NCT00524576|GlaxoSmithKline|GSK Response Center|866-435-7343||
21270624|NCT00207714|Centocor Research & Development, Inc.|Director Clinical Research|1-800-457-6399||
21270625|NCT03627195|Sunovion Pharmaceuticals, Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
21270626|NCT02412956|The George Washington University|Dr. Lorien Abroms||lorien@gwu.edu|
21270627|NCT01265966|Tripler Army Medical Center|Dr. Jordan Pinsker|808-433-6338|jordan.pinsker@us.army.mil|
21270628|NCT00361257|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21270629|NCT02096029|Medical University of South Carolina|Amy Boatright, Program Coordinator|843-876-2440|boatrigh@musc.edu|
21270630|NCT04242186|Hebrew SeniorLife|Sarah Berry, MD, MPH|617-971-5355|sarahberry@hsl.harvard.edu|
21270631|NCT05319977|RTI International|Yukiko Washio|9194852794|ywashio@rti.org|
21270632|NCT01577966|UAB|Burt Nabors, MD|205-934-2424|bnabors@uabmc.edu|
21258523|NCT02154386|UT Health Science Center San Antonio (School of Dentistry)|Dr. Brian Mealey|210-567-3567|mealey@uthscsa.edu|
21258524|NCT02615743|Children's Hospital of Philadelphia|Dr. Chen Kenyon, Faculty PolicyLab and Assistant Professor University of Pennsylvania|267-426-6339|kenyonc@email.chop.edu|
21258525|NCT01100944|National Cancer Institute|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov|
21258526|NCT03988335|Aristea Therapeutics|Aristea Therapeutics|858-465-6142|info@aristeatx.com|
21258527|NCT04607733|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21258528|NCT02482675|The Ohio State University|Richard Bruno, PhD, RD|6142925522|bruno.27@osu.edu|
21258529|NCT04668352|Adicet Bio|Nick Harvey|857-315-5528|nharvey@adicetbio.com|
21258530|NCT01639833|Covidien|Michael Rohan|781-839-1757|Michael.Rohan@Covidien.com|
21258531|NCT02365714|Medstar Georgetown University Hospital|Sonali Rudra, M.D.|202-444-3320|sonali.rudra@gunet.georgetown.edu|
21258532|NCT00070941|NYU Parkinson and Movement Disorders Center|Dr. Alessandro Di Rocco|212-263-4838|Alessandro.Dirocco@nyumc.org|
21258533|NCT01232829|University of Colorado Cancer Center|Dr. Wells Messersmith|303-724-3808|wells.messersmith@ucdenver.edu|
21258534|NCT00684788|Hopkins School of Medicine: Department of Psychiatry|Dr. Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
21258535|NCT00075504|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
21258536|NCT01290692|Saint Lukes Hospital KC, Missouri and Washington University School of Medicine, St.Louis Missouri|Michael E. Salacz,MD and David Tran,MD, PH.D|9134922221|gwood@tvaxbiomedical.com|
21258537|NCT03987854|University of Michigan|Laura Saslow|(734) 764-7836|saslowl@umich.edu|
21258538|NCT00265538|Iowa City VA Health Care System|Dr. Peter Kaboli|319-338-0581|Peter.kaboli@va.gov|
21258539|NCT03557892|University of Florence Medical School and AOU Careggi|Dr Ilaria Dicembrini|+393387861041|Ilaria.dicembrini@unifi.it|
21258540|NCT03099707|Brigham and Women's Hospital|Ingrid T. Katz|617-525-8194|ikatz2@bwh.harvard.edu|
21258541|NCT03167073|Washington University of St Louis (where research was conducted). Now at Brown University|Dr. Adam Lewkowitz|401-274-1122|alewkowitz@kentri.org|47447
21258542|NCT00758745|Alcon Research, Ltd.|Director of Clinical Research|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21258543|NCT01097304|University of Arizona|Dr. Sherry Chow|520-626-3358|schow@azcc.arizona.edu|
21258544|NCT00689871|Allergan Medical|Medical Monitor|(805) 961-5000|devicetrials@allergan.com|
21258545|NCT00562354|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21258546|NCT01785134|Karolinska Institutet|Dr Erik Näslund|+46812355017|Erik.Naslund@ki.se|
21258547|NCT02189850|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
21258548|NCT00371865|VA San Diego Healthcare System|Dr. Julie Wetherell, PI|858-552-8585|Julie.Wetherell@va.gov|2752
21258549|NCT03441178|Ethicon Endo-Surgery|Jason Waggoner, PhD|+1 513.337.8310|jwaggon1@its.jnj.com|
21258550|NCT04817111|Children's Hospital of Philadelphia|Dr. Shana McCormack|215-590-3174|mccormacks1@email.chop.edu|
21258551|NCT04205409|University of Washington|Dr. Andrew Cowan|2066067348|ajcowan@fredhutch.org|
21258552|NCT02866279|Montefiore Medical Center|Erika Levi|7184058200|elevi@montefiore.org|
21270633|NCT00550420|GlaxoSmithKline|GSK Response Center|866-435-7343||
21270634|NCT00782275|Beth Israel Deaconess Medical Center|David F. McDermott MD PhD|617-632-9262|dmcdermo@bidmc.harvard.edu|
21270635|NCT00331773|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21270636|NCT04378010|Enanta Pharmaceuticals, Inc|Alaa Ahmad|1-617-607-0800|aahmad@enanta.com|
21270637|NCT01792284|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21270638|NCT02019979|Icahn School of Medicine at Mount Sinai|Dr. Anish Parikh|(212) 241-4705|anish.parikh@mountsinai.org|
21270639|NCT00353938|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corp.|Julie B. Wang, MPH, PhD/ Senior Clinical Data Scientist|(831) 429-6362|juliewang@mapsbcorp.com|
21270640|NCT02732587|Yale University Dept of Psychiatry|Dr Suchitra Krishnan-Sarin|203-974-7595|suchitra.krishnan-sarin@yale.edu|
21270641|NCT00379587|Dana-Farber Cancer Institute|Corey S. Cutler, MD, MPH|617-632-5946|corey_cutler@dfci.harvard.edu|
21270642|NCT00747747|Galsor s.r.l.|Dr. Sandro Soriano/Director of Clinical Trials|0039 0827 601723|sandro.soriano@galsor.it|
21270643|NCT01169649|Memorial Sloan Kettering Cancer Center|Dr. Diane Reidy-Lagunes|646-888-4185|reidyd@mskcc.org|
21270644|NCT02919475|Akros Pharma Inc.|Kazuhiro Okamiya|609-919-6123|okamiya@akrospharma.com|
21270645|NCT02323295|Massachusetts General Hospital|Dr. Joseph Schwab|617-643-0547|JHSCHWAB@PARTNERS.ORG|
21270646|NCT02370784|University of Pittsburgh School of Medicine|Robyn T. Domsic, MD MPH|412-383-8000|rtd4@pitt.edu|
21286467|NCT01585246|Michigan State University|Dr. Gwen Wyatt|517-884-4630|gwyatt@msu.edu|
21286468|NCT04396626|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21286469|NCT00289094|DePuy Orthopaedics, Inc.|Tammy O'Dell, EMT, CCRA|574-372-7104|TOdell2@its.jnj.com|
21286470|NCT02111174|Johns Hopkins SKCCC|Thomas Smith, M.D.|410-955-2091|tsmit136@jhmi.edu|
21286471|NCT04552132|Saint Louis University|Dr. David Bingham|208-851-0618|davidbingham1623@gmail.com|
21286472|NCT01657162|Radius Health, Inc.|Radius Head of Clinical Operations|(617) 551-4700||
21301514|NCT00921518|Wilkes University|Judith Kristeller|570-408-4272|judith.kristeller@wilkes.edu|
21301515|NCT04141839|University of Arizona|Mary Koss|5204818610|mpk@arizona.edu|
21301516|NCT03217058|University of California San Francisco|Dr. Derek Satre, Principal Investigator|415-476-7382|Derek.Satre@ucsf.edu|
21301517|NCT00614432|University of Hawaii|Investigator|808-203-6500|whrc@hawaii.edu|
21301518|NCT00357006|Monash Alfred Psychiatry Research Centre|Prof Jayashri Kulkarni|+61 390766924|j.kulkarni@alfred.org.au|66924
21301519|NCT03710161|University of Nebraska Medical Center|Dr. Laura Graeff-Armas|402-559-6310|laura.armas@unmc.edu|
21301520|NCT02921841|Rhode Island Hospital|Larry K. Brown, MD|(401) 793 - 8808|lkbrown@lifespan.org|
21301521|NCT02637037|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
21301522|NCT01497496|Moffitt Cancer Center|Celeste Bello, MD|813-745-8623|Celeste.Bello@moffitt.org|
21301523|NCT02023697|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21301524|NCT02981446|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
21301525|NCT00003469|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
21301526|NCT00523302|Medical University of South Carolina|Edward B. Short|8437923295|shortb@musc.edu|
21301527|NCT00478023|Grunenthal GmbH|Claudia Leinweber|49 241 569 2509|claudia.leinweber@grunenthal.com|
21301528|NCT03895840|University of Kansas Medical Center|Neil Segal, MD|9135740961|segal-research@kumc.edu|
21301529|NCT02395081|Brigham and Women's Hospital|Dr. Janet Rich-Edwards|617-525-8264|jr33@partners.org|
21301530|NCT03519711|PTC Therapeutics, Inc.|Medical Information|1-866-562-4620|medinfo@ptcbio.com|
21301531|NCT00068419|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21301532|NCT04674761|Albireo AB|Albireo AB|medinfo@albireopharma.com|medinfo@albireopharma.com|
21301533|NCT02469870|Trifoia|Dr. Jordan Pennefather|1-877-874-3642|jordanp@trifoia.com|
21301534|NCT01974635|AMES Technology Inc.|Paul Cordo|15039706129|pcordo@amesdevices.com|
21301535|NCT04845568|Washington University|Ellen Fitzsimmons-Craft|3142862074|fitzsimmonse@wustl.edu|
21301536|NCT00256997|Janssen Inc. Toronto, Ontario, Canada|Director Medical Affairs - CNS|+1-416-382-5094||
21301537|NCT01287741|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21301538|NCT05978713|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21301539|NCT04163016|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21301540|NCT04193189|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
21301541|NCT01077050|SciBase|Director of Clinical Operations|+46841062001|per.svedenhag@scibase.se|
21301542|NCT05475483|SOM Innovation Biotech SA|Chief Medical Officer|+41 79 552 15 78|medori@sombiotech.com|
21301543|NCT02565784|Q-Med AB|Clinical Project Manager|+46184749000|reception.seupp@galderma.com|
21301544|NCT02933450|Emergency Department, Baylor College of Medicine|Dr Zubaid Rafiue|7138732626|zubaidrafique@gmail.com|
21301545|NCT01812668|Barbara Ann Karmanos Cancer Institute|Dr. Elisabeth Heath|313-576-8734|heathe@karmanos.org|
21301546|NCT01193257|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21301547|NCT01089517|Ophthotech|Jeffrey Nau|646-573-7045|jeff.nau@ophthotech.com|
21301548|NCT00689260|EMD Serono, Inc.|Sanja Dragnic, MD|781-681-2337|sanja.dragnic@emdserono.com|
21301549|NCT05780424|University of Minnesota|Greg Grandits|651-528-9491|greg-g@ccbr.umn.edu|
21301550|NCT01170247|University of Iowa|Brett Faine|319-310-8067|brett-faine@uiowa.edu|
21301551|NCT01934647|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21301552|NCT00662298|Imperial College London|Professor Fan Chung|00442075947954|f.chung@imperial.ac.uk|
21301553|NCT03126344|Shanghai ninth people's hospital|Sun Yu|13611895542|dr_sunyu@163.com|+86
21301554|NCT01715857|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21286473|NCT00901342|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@Dendreon.com|
21258553|NCT01430455|Depression Evaluation Service (New York State Psychiatric Institute)|Jonathan W. Stewart|646-774-8070|jws6@nyspi.columbia.edu|
21258554|NCT00858858|VA|Stuart Spechler|214-857-1603|Stuart.Spechler@va.gov|
21258555|NCT02553512|Proteus Digital Health|Lorenzo DiCarlo MD, Vice-President of Clinical and Medical Affairs|+1 650 637 6199|ldicarlo@proteus.com|
21258556|NCT01425008|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21258557|NCT00264238|Stanford University School of Medicine, Dept of Psychiatry|Dr John Barry, Professor|(650) 725-5588|jbarry@stanford.edu|
21258558|NCT02600494|Intra-Cellular Therapies, Inc.|Vice President, Clinical Development|646-440-9333|ITCIClinicalTrials@itci-inc.com|
21258559|NCT03124563|Brandeis University|Dr. Margie E. Lachman|7817363255|lachman@brandeis.edu|
21258560|NCT02452528|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
21258561|NCT05061719|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646 440-9333|ITCIClinicalTrials@itci-inc.com|
21258562|NCT05804877|Chung Shan Medical University|Dr. Yun-Ling Chen|+886958226869|yunling.annie@gmail.com|
21258563|NCT04999267|Duke University - Duke Human Vaccine Institute|Chip Walter|919 620 5346|chip.walter@duke.edu|
21258564|NCT01745146|Moss Rehabilitation Research Institute|Dr. Tessa Hart, PhD|215-663-6153|thart@einstein.edu|
21258565|NCT01262365|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21258566|NCT01265459|Q-Med AB|Head of Medical Affairs|+46 (0) 18 4749000|reception.SEUPP@galderma.com|
21258567|NCT00130832|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21258568|NCT00532480|Indiana University|Dr. Amit Anand|317-944-7422|aanand@iupui.edu|
21258569|NCT00699348|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21258570|NCT04478708|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21258571|NCT05362526|University of Florida|Ashleigh Wehy, MD|9042449440|amweyh@gmail.com|
21258572|NCT01869114|Thomas Jefferson University|Margaret T Kasner, MD|215-955-3202|Margaret.Kasner@jefferson.edu|
21258573|NCT00559507|Memorial Sloan-Kettering Cancer Center|Clifford Hudis, MD|646-888-4551|hudisc@mskcc.org|
21258574|NCT02468648|NIDDK|Marc Ghany, MD, MHSc|301-402-5115|marcg@intra.niddk.nih.gov|
21258575|NCT02118792|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21258576|NCT03963544|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trial Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
21258577|NCT04232696|Neuspera Clinical Research|Mark Vollmer|612-281-4875|mark.vollmer@neuspera.com|
21258578|NCT01678144|Medtentia International Ltd Oy|Olli Keränen / CEO|+358 50 3567090|ok@medtentia.com|
21258579|NCT03118297|WashingtonU|Intervention To End Recurrent Unscheduled bleeding Trial (INTERRUPT): A randomized-controlled trial|3143228697|rachelezig@gmail.com|
21258581|NCT02754726|HonorHealth Research Institute|Erkut Borazanci, MD MS|4803231350|clinicaltrials@honorhealth.com|
21258582|NCT01676714|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu|
21258583|NCT03756038|University of Pittsburgh|Dr. Maria Pacella|412-647-3183|pacellam@upmc.edu|
21258584|NCT05215600|Zimmer Biomet|Carina Hafner|+41797073093|carina.hafner@zimmerbiomet.com|
21258585|NCT05587296|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21258586|NCT03560752|City of Hope|Dr. Ryotaro Nakamura|626-359-8111|rnakamura@coh.org|
21258587|NCT05617911|Gaylord Hospital|John Corbett|203-294-3224|jcorbett@gaylord.org|
21258588|NCT04868903|The University of Chicago|David Meltzer, MD, PhD|7737020836|dmeltzer@bsd.uchicago.edu|
21258589|NCT04589988|Washington University in St. Louis|Dr. Susy Stark|3142734114|sstark@wustl.edu|
21258590|NCT03092726|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
21258591|NCT01084265|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21258592|NCT04418765|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
21258593|NCT02296242|BioMed Valley Discoveries|Dean Welsch, PhD|8163898831|dwelsch@biomed-valley.com|
21258594|NCT02217566|Janssen Research & Development, LLC|Regional Medical Affairs Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21258595|NCT03504397|Astellas Pharma Global Development, Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
21258596|NCT02064387|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21258597|NCT03099486|Fox Chase Cancer Center|Dr. Namrata Vijayvergia|215-214-4283|Namrata.Vijayvergia@fccc.edu|
21258598|NCT02436876|Microbion Corporation|Brett Baker, President and Chief Innovation Officer|4065991190|bbaker@microbioncorp.com|
21258599|NCT03950973|University of Michigan School of Public Health, Department of Health Behavior & Health Education|Minal R. Patel, Ph.D, M.P.H|(734) 763-0087|minalrp@umch.edu|
21258600|NCT01276236|University of California, San Francisco|Dr. Toby Maurer, MD|(628) 206-8680|Toby.Maurer@ucsf.edu|
21258601|NCT03215771|Northwestern University|Dr. Stefania Fatone, Principle Investigator|3125035717|s-fatone@northwestern.edu|
21258602|NCT02685709|Amryt|Asi Haviv, VP Clinical development|972 8 9393888|Asi@amrytpharma.com|
21258603|NCT02340338|Biomedizinische Forschungsgesellschaft mbH|Dr. Martha M. Eibl|+43-1-4081091|martha.eibl@meduniwien.ac.at|
21258604|NCT00343889|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21258605|NCT01951820|University of Michigan School of Dentistry|Dr. Carlos Gonzalez|734-763-3391|carlosgc@umich.edu|
21258606|NCT00558870|University of Texas (UT) MD Anderson Cancer Center|Sriram Yennurajalingam, Palliative Care & Rehabilitation Medicine||CR_Study_Registration@mdanderson.org|
21286474|NCT00910845|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21258607|NCT01294579|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21258608|NCT00137111|St. Jude Children's Research Hospital|Ching-Hon Pui|1-866-278-5833|info@stjude.org|
21258609|NCT00784654|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21258610|NCT00844753|University of Pittsburgh|Ben Handen|412-235-5452|HandenBL@upmc.edu|
21258611|NCT00903175|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21258612|NCT03074474|TELA Bio|Neal Overbeck|484-802-9570|noverbeck@telabio.com|
21258613|NCT02987621|Colorado State University|Manager of Research Operations|9704912242|Laurie.Biela@colostate.edu|
21258614|NCT00713583|The University of Texas Health Science Center at Houston|Joy M. Schmitz, PhD|(713) 486-2867|Joy.M.Schmitz@uth.tmc.edu|
21258615|NCT05073458|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21258616|NCT01545700|NorthShore University HealthSystem|Glenn S. Murphy, MD|847-570-2760|dgmurphy2@yahoo.com|
21258617|NCT05721482|The Ohio State University College of Nursing|Dr. Kathy Wright|614-292-0309|wright.2104@osu.edu|
21258618|NCT01627899|LifeScan Scotland|Mike Grady|+44 01463 721000|MGRADY@its.jnj.com|
21258619|NCT00507559|Medtronic Endovascular|Kristin Schwartz|(763) 514-4000|kristin.schwartz@medtronic.com|
21258620|NCT04818593|NYU Langone Health|Rani Fritz, DO, PhD, FACOG|718-935-9766|rani.fritz@nyulangone.org|
21258621|NCT03809611|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21258622|NCT05429073|Regulus Therapeutics|Kristen Gillotti, Senior Director Clinical Operations|203-313-8185|kgillotti@regulusrx.com|
21258623|NCT03473145|UC San Diego|Sheri Hartman|(858) 534-9235|sjhartman@health.ucsd.edu|
21258624|NCT04179175|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
21258625|NCT01696435|Massachusetts General Hospital|Dr. Olivia Okereke/Study Principal Investigator|(617) 726-2000|olivia.okereke@mgh.harvard.edu|
21258626|NCT03963531|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
21258627|NCT04417699|OHSU Knight-Legacy Health Cancer Collaborative|Dr. Hagen Kennecke|971-262-9600|kennecke@ohsu.edu|
21258628|NCT03215030|Takeda (Note: This product was divested to Teva Pharmaceuticals in 2025)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21258629|NCT05416138|University of Minnesota|Alexander Opitz|612-624-1094|aopitz@umn.edu|
21258630|NCT01284114|Division of Nephrology, Department of Internal Medicine, Jichi Medical University|Dr. Yoshiyuki Morishita|81-285-58-7346|ymori@jichi.ac.jp|
21258631|NCT00598975|Nektar Therapeutics|Study Director||medicalaffairs@nektar.com|
21258632|NCT03676257|Institut Bergonié|Carine Bellera|+33556330495|C.Bellera@bordeaux.unicancer.FR|
21258633|NCT04699539|Changhai Hos|Xiaofei Zhu|86-021-31162222|zhuxiaofei_zxf@163.com|
21258634|NCT05159557|University of California, Berkeley|Robert W. Levenson|510-643-8952|boblev@berkeley.edu|
21258635|NCT03409744|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21258636|NCT00494091|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21258637|NCT00984204|St. Jude Medical|Nabil Kanaan|949-769-5000|nkanaan@sjm.com|
21258638|NCT02848079|Yale University|Dr. Jeremy Kortmansky|1 (203) 407-8002|jeremy.kortmansky@yale.edu|
21258639|NCT00122135|Center for Innovations in Quality, Effectiveness, and Safety (IQuESt), MEDVAMC, Houston, TX|Dr. Ursula Braun|832 687 1645|ubraun@bcm.edu; ursula.braun@va.gov|
21258640|NCT01707472|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21258641|NCT02770326|Memorial Sloan Kettering Cancer Center|Dr. Robin Mendelsohn, MD|212-639-8286|mendelsr@mskcc.org|
21258642|NCT03790683|Sidney Kimmel Medical College, Thomas Jefferson University and Hospitals|Marc C. Torjman, Ph.D.|(215) 955-5275|Marc.Torjman@Jefferson.edu|
21258643|NCT01629797|Northwestern University|Hae Bae|312-695-6829|j-bae@northwestern.edu|
21258644|NCT02814565|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21258646|NCT02792842|Asahi Kasei Pharma Corporation|Contact for Clinical Trial Information|+81-3-6699-3600|ct-info@om.asahi-kasei.co.jp|
21258647|NCT01789814|Tufts Medical Center|Carey Kimmelstiel, MD Director of the Adult Cardiac Catheterization Laboratory|617-636-4504|Ckimmelstiel@tuftsmedicalcenter.org|
21258648|NCT05801809|Spaulding Rehabilitation Hospital|Felipe Fregni, PI|6179526158|fregni.felipe@mgh.harvard.edu|
21258649|NCT01046825|St. Jude Children's Research Hospital|Raul Ribeiro, MD|901-595-3694|raul.ribeiro@stjude.org|
21258650|NCT04735653|University of Michigan Medical School|Dr. Paula Anne Newman-Casey|734-763-6967|panewman@med.umich.edu|
21258651|NCT03975647|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
21258652|NCT03735667|Boston Scientific|Sarah Zanon|+41 79 840 7006|sarah.zanon@bsci.com|
21258653|NCT00999908|Novartis Pharmaceuticals|Study Director|862 778-8300||
21258654|NCT02780648|IndianaU|Dr. Robert Miller|317-944-1317|millro@iu.edu|
21258655|NCT00293579|Ohio State University Comprehensive Cancer Center|Anterpreet Neki|614-257-2900|Anterpreet.Neki@osumc.edu|
21258656|NCT03127384|Q-Med AB|Clinical Project Manager|+46184749000|reception.seupp@galderma.com|
21258657|NCT02703311|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
21270647|NCT00478361|UT MD Anderson Cancer Center, Community Clinical Oncology Program Research Base|Nizar M Tannir, MDChair Ad Interim, Genitourinary Medical Oncology|713-563-7265|ntannir@mdanderson.org|
21270648|NCT01725984|Ludwig Maximilian Universität|Dr. Ricarda Bauer|+49 89 7095|Ricarda.Bauer@med.uni-muenchen.de|
21270649|NCT01155063|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21270650|NCT01663714|GlaxoSmithKline|GSK Response Center|866-435-7343||
21270651|NCT02280421|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
21270652|NCT02184494|Florida State University|Michael J. Ormsbee|6103313126|mormsbee@fsu.edu|
21270653|NCT01872689|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21270654|NCT00183469|University of Texas Health Science Center San Antonio|Charles L. Bowden, M.D. Clinical Professor|210 567 5405|bowdenc@uthscsa.edu|
21270655|NCT01412710|Florida International University|Fatma G. Huffman|305-348-3877|huffmanf@fiu.edu|
21270656|NCT02348619|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
21270657|NCT00751998|Boston Scientific Corporation|Joyce Peetermans, PhD, Director Endoscopy Clinical|508-683-4211|peetermj@bsci.com|
21270658|NCT00459381|Adult Brain Tumor Consortium (ABTC)|Mark Gilbert, MD|410-955-8837|jfisher@jhmi.edu|
21270659|NCT01238822|Cincinnati Children's Hospital Medical Center|Jeff Epstein||jeff.epstein@cchmc.org|
21270660|NCT02598193|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21270661|NCT02410837|Medtronic|Jennifer Wolvers|763-258-9405|Jennifer.Wolvers@Medtronic.com|
21270662|NCT00837577|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21270663|NCT02523274|University of Florida|Dr. Stephen Anton|(352) 273-7514|santon@ufl.edu|
21270664|NCT01825876|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21270665|NCT02128867|vrije universiteit brussel|filip van ginderdeuren|+3224763916|filip.vanginderdeuren@uzbrussel.be|
21270666|NCT01147016|Barbara Ann Karmanos Cancer Institute|Dr. Amy Weise|248-344-6688|aweise3@hfhs.org|
21270667|NCT01027884|University Hospital Leuven-Children Hospital|Dr Gunnar Buyse|+32 016343845|gunnar.buyse@uzleuven.be|
21270668|NCT05149287|University of Kentucky|Austin Stone|(859) 323-5533|austin.stone@uky.edu|
21270669|NCT03636542|University of Minnesota|Jason Habeck|612-625-7675|habe0073@umn.edu|
21270670|NCT03670537|Auerbach Hematology and Oncology|Michael Auerbach|4107804050|mauerbachmd@abhemonc.com|
21270671|NCT02059187|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21270672|NCT03751020|Yale University School of Public Health (Social and Behavioral Sciences)|Dr. John Pachankis|(203) 785-3710|john.pachankis@yale.edu|
21270673|NCT01889862|BioMarin Pharmaceutical Inc|Debra Lounsbury/Sr Principle Scientist, Clinical Sciences|415-506-6348|Dlounsbury@bmrn.com|
21270674|NCT00033631|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21270675|NCT00078819|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21270676|NCT02217345|Massachusetts General Hospital|Dr. Karen K. Miller|617-726-3870|kkmiller@mgh.harvard.edu|
21270677|NCT00971204|CardioFocus, Inc.|Burke Barrett, VP Regulatory & Clinical Affairs|508 658-7200|bbarrett@cardiofocus.com|
21270678|NCT04130919|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21270679|NCT02729194|University of Michigan Rogel Cancer Center|Dr. Ajjai Alva, M.D.|734-936-0091|ajjai@umich.edu|
21270680|NCT00845026|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21270681|NCT01325532|Massachusetts General Hospital, Dept of Psychiatry|Dr David Mischoulon|617-724-5198|dmischoulon@partners.org|
21270682|NCT03216200|DeviceFarm|VP Operations|510-295-5293|timgrammer@devicefarmtech.com|
21270683|NCT03196791|Korea university Anam Hospital|Dr. Shin Hoo Park|+82-10-6735-1824|bulsajo333@hanmail.net|
21270684|NCT01203774|University of Colorado Denver|Director, Clinical Research Administration|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
21270685|NCT02238977|University of Arkansas for Medical Sciences|Pedro Delgado, M.D.|501-526-8100|pldelgado@uams.edu|
21270686|NCT02565485|University Hospitals Cleveland Medical Center|Justin R. Lappen MD|216-844-3787|Justin.Lappen@UHhospitals.org|
21270687|NCT03672396|University of North Carolina at Chapel Hill|Erik Hanson, PhD|19199620816|edhanson@email.unc.edu|
21270688|NCT01254045|Stanford University School of Medicine|Scott S. Hall, PhD|650-498-4799|hallss@stanford.edu|
21270689|NCT00597207|ZOLL Medical Corporation|Sr. Director of Clinical Research|978-421-9655|uherken@zoll.com|
21270690|NCT00520351|Centre for Contact Lens Research|Craig A Woods, Research Manager|519-888-4567|cawoods@sciborg.uwaterloo.ca|36547
21270691|NCT06079853|Columbia University School of Nursing|Allison A. Norful|2123057157|aan2139@cumc.columbia.edu|
21270692|NCT03797222|Children's Hospital of Philadelphia|Lauren Mitteer|215-590-3174|mitteerl@chop.edu|
21270693|NCT03567239|Madonna Rehabilitation Hospital|Chase Pfeifer, Ph.D.|402-413-4504|cpfeifer@madonna.org|
21270694|NCT03077828|Northwestern University|Dr. Jane N. Winter, M.D.|3126954538|j-winter@northwestern.edu|
21270695|NCT02769000|Virginia Commonwealth University|Timothy Harris, MD|804-828-7232|timothy.harris@vcuhealth.org|
21270696|NCT04288115|Central Arkansas Veterans Healthcare System|Spyridoula Maraka, MD, MS|(501) 257-5848|Spyridoula.Maraka@va.gov|
21270697|NCT02720224|Estetra SPRL|Marie Mawet||mmawet@mithra.com|
21270698|NCT00729365|Northwestern University Feinberg School of Medicine|Mark E. Molitch|312 503-4130|molitch@northwestern.edu|
21301555|NCT04657094|City of Hope Medical Center|Dr. Alexey Danilov|6263598111|adanilov@coh.org|
21301556|NCT02563067|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21301557|NCT00839319|University of Washington|Mara Roth, MD|206-221-0519|mylang@u.washington.edu|
21301558|NCT00774267|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21301559|NCT01039519|Synta Pharmaceuticals|VP Clinical Research|781-541-7156|aoneill@syntapharma.com|
21301560|NCT05844007|Montana State University|Dr. Lauren Davis|828-773-6328|lauren.davis6@montana.edu|
21286475|NCT02600923|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21238107|NCT02240108|Bausch Health Americas, Inc.|Director of Clinical Operations|908-927-0873|lindsey.mathew@bauschhealth.com|
21238108|NCT00800839|The University of Texas (UT) MD Anderson Cancer Center|Amin M. Alousi, MD/Stem Cell Transplantation||CR_Study_Registration@mdanderson.org|
21258658|NCT00262873|University of Rochester|Jane Liesveld, M.D.|585-275-4099|Jane_Liesveld@urmc.rochester.edu|
21258659|NCT03440814|Soleno Therapeutics, Inc.|C601 Project Manager|650-353-2051|C601ProjectManager@soleno.life|
21258660|NCT00088374|National Cancer Institute, National Institutes of Health|William M. Linehan, M.D.|301-496-6353|linehanm@mail.nih.gov|
21258661|NCT04397094|Faculty of Dentistry Ain Shams University|Dr. Mariem Wassel|+2 0064871416|mariem.wassel@dent.asu.edu.eg|
21258662|NCT03676010|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Dr Carine Bellera|+33 (0)5 56 33 33 33|c.bellera@bordeaux.unicancer.fr|4495
21258663|NCT03205995|Omeros Corporation|Dr. Andreas Grauer|206-676-5000|ctinfo@omeros.com|
21258664|NCT01227551|Viralytics|Mark Grose|1 647 821 7673|Mark.Grose@Viralytics.com|
21258665|NCT05913232|D. Western Therapeutics Institute, Inc.|Shigenobu Nakazora|+81-52-218-8785|shinakazora@dwti.co.jp|
21258666|NCT00970853|Children's Hospital of Philadelphia|Dr. Jerilynn Radcliffe|215-590-7446|radcliffe@email.chop.edu|
21258667|NCT05103332|Alnylam Pharmaceuticals|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
21258668|NCT04428476|Capricor, Inc.|Mark Awadalla|858-727-1755|clinicaltrialsgov@capricor.com|
21258669|NCT03627403|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
21258670|NCT06232317|Department of Surgery, Houston Methodist Hospital|Dr. Hina Faisal|713-714-4973|hfaisal@houstonmethodist.org|
21258671|NCT04685876|University of Texas, Houston|Dr. Alparslan Turan|713-500-6279|Mehmet.A.Turan@uth.tmc.edu|
21258672|NCT01358864|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21258673|NCT02656485|AOBIOME|Masha Gaber|617-475-1605|mgaber@aobiome.com|
21258674|NCT04042103|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
21258675|NCT04209855|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21258676|NCT00271817|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21258677|NCT03711578|Rhizen Pharmaceuticals|Prajak Barde MD|+41325800175|pjb@rhizen.com|
21258678|NCT01471782|Amgen, Inc|Study Director|866-572-6436||
21258679|NCT00936208|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21258680|NCT04428424|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21258681|NCT01564862|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21258682|NCT00313209|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21258683|NCT02193074|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21258684|NCT07071129|Stanford University|Jeffrey Goldberg, MD, PhD|(650) 723-6137|eye-chair-office@stanford.edu|
21258685|NCT07170488|University of Pittsburgh|Martina Anto-Ocrah|4123352862|maa509@pitt.edu|
21258686|NCT02872311|Marshfield Clinic Research Institute|Project Manager|715-389-5088|king.jennifer@marshfieldresearch.org|
21258687|NCT03142321|Washington University School of Medicine GI Division|Dr. Parakkal Deepak|3143623201|nixd@wustl.edu|
21258688|NCT02523040|Dana-Farber Cancer Institute|Eric Jacobsen, MD|857-215-1405|eric_jacobsen@dfci.harvard.edu|
21258689|NCT01202656|Center for Human Reproduction|Dr. David Barad|212 994-4400|dbarad@theCHR.com|
21258690|NCT02507011|University of Minnesota|Thenappan Thenappan, MD|612-625-2191|cvheart@umn.edu|
21258691|NCT01121393|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21258692|NCT04372927|University of Washington School of Medicine|Dr. Jing Zeng|206-598-4115|jzeng13@uw.edu|
21258693|NCT00577993|UT MD Anderson Cancer Center|Nathan Fowler,MD, Clinical Professor, Lymphoma-Myeloma|(832) 671-3018|nfowler@mdanderson.org|
21258694|NCT01077973|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21258695|NCT02679469|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
21258696|NCT00119158|The Children's Hospital of Philadelphia|Jonathan Spergel|215 590 1000|spergel@email.chop.edu|
21258697|NCT00608985|Actelion Pharmaceuticals Ltd|Ouali Berkani/Clinical Trial Leader|+41 61 565 5342||
21258698|NCT03033745|CSL Behring|Trial Registration Coordinator|610 878-4000|clinicaltrials@cslbehring.com|
21258699|NCT01999582|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21258700|NCT00661271|Johns Hopkins School of Medicine|Erica Sibinga|410-550-4134|esibinga@jhmi.edu|
21258701|NCT00703664|Massey Cancer Center, Virginia Commonwealth University|Dr. Beata Holkova|804-628-2581|bholkova@mcvh-vcu.edu|
21258702|NCT03728309|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21258703|NCT00953758|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21258704|NCT01212302|Cardiology Dep, Ruhr-University Bochum|Dr Horst Neubauer|+49-234-509-2326|Horst.Neubauer@rub.de|
21258705|NCT02342015|University of Padova|Marcello Rattazzi|+300498211867|marcello.rattazzi@unipd.it|
21258706|NCT00927095|University of North Carolina at Chapel Hill|Dr. Susan Girdler|919-966-2179|susan_girdler@med.unc.edu|
21258707|NCT01662583|Columbia University|Melissa Stockwell, MD MPH|212-342-5372|mss2112@columbia.edu|
21258708|NCT01849770|University of Washington|Michael D. Weiss, MD|206-598-7688|mdweiss@uw.edu|
21258709|NCT00044512|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21258710|NCT01539590|Yale University Medical Center|Dr. Joesph Brennan|(203) 483-8300|Brennan.Joesph@yale.edu|
21258711|NCT00470600|Cumberland Pharmaceuticals|Amy Rock, Ph.D.|615-255-0068|arock@cumberlandpharma.com|
21258712|NCT05130463|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
21301561|NCT01330108|University of Alabama at Birmingham|Robert C Bourge|205-934-3624|bbourge@uab.edu|
21301562|NCT02810509|Ilsan Paik Hospital Inje University|Keun-Sik Hong, MD, PhD, Prof|82-31-910-7680|nrhks@paik.ac.kr|
21301563|NCT01662102|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
21301564|NCT00392769|UT MD Anderson Cancer Center|Judith Wolff, MD / Professor||CR_Study_Registration@mdanderson.org|
21270699|NCT02766400|University of Pittsburgh|Elizabeth R. Skidmore, PhD, OTR/L, FAOTA|(412) 383-6617|skidmore@pitt.edu|
21258713|NCT03652662|MUSC|Sarah Miller, PhD, RN|8427921692|millesar@musc.edu|
21258714|NCT00487539|Janssen Research & Development|Senior Director|215-793-7540||
21258715|NCT02751502|NYU Langone Health|Renat Sukhov, MD|347-377-5138|Renat.Sukhov@nyulangone.org|
21258716|NCT00852995|Smith & Nephew|Jamie E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
21258717|NCT03499028|Cleveland Clinic|Anabelle Visperas|216-444-2416|vispera@ccf.org|
21258718|NCT01110200|GlaxoSmithKline|GSK Response Center|866-435-7343||
21258719|NCT01437397|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
21258720|NCT02692209|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
21258721|NCT00866307|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21258722|NCT02573155|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
21258723|NCT01141595|Arkansas Children's Hospital Reseach Insitute|Richard Frye|501-364-5465|REFrye@uams.edu|
21258724|NCT06245551|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21258725|NCT02508194|MedImmune, LLC|Judith Falloon, MD|301-398-0000|clinicaltrialenquiries@medimmune.com|
21258726|NCT00511355|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21258727|NCT01031914|Philips|Dr. David P. White|724 387 4554|Dr.DavidWhite@philips.com|
21258728|NCT00454805|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
21258729|NCT00217087|Mayo Clinic|Kenneth Wang MD|507-255-7495|wang.kenneth@mayo.edu|
21258730|NCT00802685|University of Miami|Ilene R. S. Sosenko, M.D.|305-585-6408|isosenko@miami.edu|
21258731|NCT02772432|Mass General Hospital|Elyse Park|6177246836|epark@mgh.harvard.edu|
21258732|NCT03321097|Chang Gung Memorial Hospital-Kaohsiung Medical Center, Kaohsiung, Taiwan|Jen-Wen Hung, MD|+886975056689|hung0702@cgmh.org.tw|
21258733|NCT04947800|Dartmouth-Hitchcock|james stahl|6036502000|james.e.stahl@hitchcock.org|
21258734|NCT03892746|Cleveland Clinic|Ela Plow, Associate Professor|216-445-4589|plowe2@ccf.org|
21258735|NCT02158091|Dana-Farber Cancer Institute|Matthew Davids, MD|617-632-6331|matthew_davids@dfci.harvard.edu|
21258736|NCT03977467|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|SCRI.InnovationsMedical@scri.com|
21258737|NCT01318109|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
21258738|NCT01328951|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21258739|NCT06485479|UNC|Principal Investigator|(919) 966-3282|ntb@unc.edu|
21270700|NCT01309828|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21270701|NCT00295620|ABCSG|Trial Office Director|+43 1 4089230|info@abcsg.at|
21270702|NCT00217971|Columbia University|Frances R. Levin, M.D.|(212) 543-5896|frl2@columbia.edu|
21270703|NCT02556632|University of Rochester|Julie Ryan Wolf, PhD, MPH; Associate Professor of Dermatology and Radiation Oncology|585-276-3862|julie_ryan@urmc.rochester.edu|
21270704|NCT00808015|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21270705|NCT01397656|Ottawa Hospital Research Institute|Dr. Christian Vaillancourt|613-798-5555|cvaillancourt@ohri.ca|17012
21270706|NCT06610279|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21270707|NCT00084617|National Cancer Institute|Joanna Brell MD|240-276-7050|brelljm@mail.nih.gov|
21270708|NCT01625286|AstraZeneca|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
21301565|NCT04103749|Boston Scientific Corporation|Victoria Lazzari|508-382-9132|victoria.lazzari@bsci.com|
21301566|NCT00439517|Merck KGaA|Merck KGaA Communication Center|+49-6151-75-5200|service@merckgroup.com|
21301567|NCT02058303|Ochsner Health System|Ken Bode|504.842.1936|ken.bode@ochsner.org|
21301568|NCT01262989|GlaxoSmithKline|GSK Response Center|866-435-7343||
21301569|NCT00470275|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21301570|NCT00526071|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
21301571|NCT00459186|Dana-Farber Cancer Institute|Dr. Mary-Ellen Taplin|617-632-3237|Mary_Taplin@dfci.harvard.edu|
21270709|NCT00928135|University of Iowa|Lakshmi Durairaj|3193537968|lakshmi-durairaj@uiowa.edu|
21270710|NCT01458119|Amicus Therapeutics|Medical Affairs|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
21270711|NCT03033069|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21258741|NCT03485820|Washington University in St. Louis|Susy Stark|3142734114|sstark@wustl.edu|
21258742|NCT04289116|Florida State University|Sylvie Naar, PhD; Distinguished Endowed Professor|18506442334|sylvie.naar@med.fsu.edu|
21258743|NCT03194373|University of Michigan Rogel Cancer Center|Paul Swiecicki, M.D.|734-647-1017|pswiecic@med.umich.edu|
21301572|NCT02920242|Novartis Pharmaceuticals|Study Director|862-778-1873|novartisemail@novartis.com|
21258744|NCT00931359|Miramar Labs|Kathy O'Shaughnessy, PhD|408-940-8700|kathyo@miramarlabs.com|
21258745|NCT00861744|GlaxoSmithKline|GSK Response Center|866-435-7343||
21258746|NCT03359759|Institut Bergonié|Simone Mathoulin-Pélissier, Director of Clinical Trials|+33556333333|s.mathoulin@bordeaux.unicancer.fr|
21258747|NCT05568888|CSL Behring|Study Director|16108784000|clinicaltrials@cslbehring.com|
21258748|NCT04671615|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21258749|NCT02396589|Washington University in St. Louis School of Medicine|Dr. Susan Stark|3142734114|sstark@wustl.edu|
21258750|NCT04381650|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21258751|NCT05593016|Duke University School of Medicine|Caroline Dorfman, PhD|919-416-3473|caroline.dorfman@duke.edu|
21258752|NCT04705051|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21258753|NCT00482014|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21258754|NCT03686397|Laboratorios Salvat, S.A|Medical Director|+34933946400|ejimenez@svt.com|
21258755|NCT02257580|Hospital for Special Surgery|Colson Zucker, Research Coordinator|6467146029|zuckerc@hss.edu|
21258756|NCT02896595|Virginia Commonwealth University Health Department of Anesthesiology|Praveen Prasanna|804-828-2207|praveen.prasanna@vcuhealth.org|
21258757|NCT00748579|Cytokinetics, Inc.|Medical Director|(650) 624-3011||
21258758|NCT04161131|Stanford University|Molly Tanenbaum|650-725-3955|mollyt@stanford.edu|
21258759|NCT03733392|Abbott|Emily Jesser, Ph.D.|763-954-1350|emily.jesser@abbott.com|
21258760|NCT02740478|ResMed|Paul Phillips|+44 7789633508|paul.phillips@resmed.com|
21258761|NCT04316585|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21258762|NCT03195517|University of Perugia - Italy|Dr. Rita Lombardini|+39 075 578 4027|rita.lombardini@unipg.it|
21258763|NCT00618748|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21258764|NCT03269344|Henry Ford Cancer Institute|Dr. Andrew Cook|3135568400|acook11@hfhs.org|
21258765|NCT02392013|Washington University in St. Louis|Dr. Susy Stark|3142734114|sstark@wustl.edu|
21258766|NCT01411345|University of Miami|Matthew Abramowitz MD|305-243-4200|mabramowitz@med.miami.edu|
21258767|NCT02479802|Grifols Bioscience Industrial Group|Miquel Barcelo, PhD|+34 935.712.368|Miquel.Barcelo@Grifols.com|
21258768|NCT03371225|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526154|fregni.felipe@mgh.harvard.edu|
21258769|NCT03124784|Masimo Corporation|Tala Harake|949-297-7000|studies@masimo.com|
21258770|NCT05702515|Duke University|Deborah Hutch Allen|919-681-4719|hutch.allen@duke.edu|
21258771|NCT02162732|Penn State Health Children's Hospital|Giselle Sholler, MD|7175310003|gsaulniersholler@pennstatehealth.psu.edu|
21258772|NCT01784965|Stanford Universtiy|Gerald Reaven, Professor Emeritus|650-724-3416|greaven@stanford.edu|
21258773|NCT04580290|Xiros Ltd|Tracey Oxley|07810337555|Tracey.Oxley@xiros.co.uk|
21258774|NCT03757988|University of North Carolina at Chapel Hill|Tonya Elliott|919-966-3915|tonya_elliott@med.unc.edu|
21258775|NCT05289830|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Jordan Winter|216-844-5777|Jordan.winter@uhhospitals.org|
21258776|NCT02847624|Pharmacovigilance Department Otsuka Pharmaceutical Co., Ltd|Investigator in charge|+81-6-6943-7722|komaniwa.satoshi@otsuka.jp|
21258777|NCT05979207|Medicines for Malaria Venture|Director, Program Leadership and Strategy|+41 22 555 03 00|info@mmv.org|
21258778|NCT03382847|NYU LANGONE TRANSPLANT INSTITUTE|Dr. Bonnie Lonze|2122638365|Bonnie.Lonze@nyumc.org|
21258779|NCT01243320|University of Utah|Mark A. Munger, Pharm.D.|8015816165|mmunger@hsc.utah.edu|
21258780|NCT03403205|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
21258781|NCT00706030|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
21258782|NCT05779072|Coopervision|Paul Chamberlain|9257306754|pchamberlain@coopervision.com|
21238109|NCT04676425|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21258783|NCT03847610|Imperial College London|Richard Wilson|02033132732|richard.wilson@imperial.ac.uk|
21258784|NCT02004873|Medtronic Cardiac Rhythm and Heart Failure|Micra Clinical Team|800-328-2518|MedtronicCRMtrials@medtronic.com|
21258785|NCT01445769|Incyte Corporation|Study Director|855 463-3463||
21258786|NCT03104725|National Institutes of Health/NINDS|Dr. David Goldstein|301-496-2103|goldsteind@ninds.nih.gov|
21270712|NCT03053622|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21270713|NCT01246986|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21270714|NCT01447329|Mike O'Callaghan Military Medical Center, Clinical Investigation Program|Amanda Crawford|(702) 653-3583|amanda.j.crawford.ctr@health.mil|
21270715|NCT01407575|University of Pittsburgh|Jordan F. Karp, MD|412-246-6048|karpjf@upmc.edu|
21270716|NCT01406873|University of Rochester|Charles Thornton, MD|585-275-2542|Charles_Thornton@urmc.rochester.edu|
21270717|NCT03990389|The University of Chicago|Dr. David Beiser|773-702-0307|dbeiser@medicine.bsd.uchicago.edu|
21270718|NCT01883999|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com|
21270719|NCT00328042|VA San Diego|Dr. Erik Groessl|858-552-8585|erik.groessl@va.gov|
21258787|NCT02799069|Biofrontera Bioscience GmbH|Dr. Beate Schmitz|+49 214 876 32|b.schmitz@biofrontera.com|41
21270720|NCT03770000|Rhizen Pharmaceuticals AG|Dr. Ajit Nair|+41 32 580 0113|an@rhizen.com|
21270721|NCT02290028|BIOTRONIK, Inc.|Senior Manager, Scientific Affairs|1-800-547-0394|crystal.miller@biotronik.com|
21270722|NCT00833547|Massachusetts General Hospital|Dr. Dara Manoach|617-726-6148|dara@nmr.mgh.harvard.edu|
21270723|NCT01735877|Christian Medical College & Hospital|Dr Jeyaraj D Pandian|09915784750|jeyarajpandian@hotmail.com|
21270724|NCT00686790|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||ClinicalTrialsDisclosure@merck.com|
21270725|NCT00096382|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
21270726|NCT03182920|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21270727|NCT03862625|Istanbul University|Dr. Merve Damla Korkmaz|+905556297264|mervedml@gmail.com|
21270728|NCT01326702|Memorial Sloan Kettering Cancer Center|Dr. John Gerecitano|212-639-3748|gerecitj@mskcc.org|
21270729|NCT02082912|Emory University|Dr. Andrew John Butler|404-413-1415|ajbutle@emory.edu|
21270730|NCT03615079|University of Pennsylvania|Michael Mullen|215-662-3339|Michael.Mullen@Pennmedicine.Upenn.Edu|
21270731|NCT02614703|Dostor's Hospital at Renaissance|Dr Ingrid M Chacon|(956) 362-3636|I.chacon@dhr-rgv.com|
21270732|NCT02402933|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21270733|NCT01110499|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21270734|NCT02580188|SNUBH|Dr. Bon-wook Koo|+82-10-7227-1379|tendong2@gmail.com|
21270735|NCT01835132|National Institutes of Health|H. Nida Sen, MD, MHSc, Principal Investigator, NEI|301-402-3254|senh@nei.nih.gov|
21270736|NCT00856778|Coloplast Corp|Clinical Trial Manager|612-302-4990|usdibe@coloplast.com|
21270737|NCT01681771|Linköping University, Department of social and welfare studies. Linköping University|Prof. RN Peter Johansson|+4613313685|peter.b.johansson@liu.se|
21270738|NCT00265083|Centocor Research and Development, Inc.|Director, Clinical Research|1-800-457-6399||
21270739|NCT03208933|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21270740|NCT03154333|Castle Creek Pharmaceuticals, LLC|Dr. Mary Spellman|862 286 0400|mspellman@castlecreekpharma.com|
21270741|NCT01928446|Boston CSP Coordinating Center|Ryan E. Ferguson, ScD, MPH, Director|1-857-364-4201|Ryan.Ferguson@va.gov|
21270742|NCT00628394|University of Texas Southwestern Medical Center|Carol A. Tamminga, MD|214-645-2789|carol.tamminga@utsouthwestern.edu|
21270743|NCT00830063|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21270744|NCT01814761|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21270745|NCT01059071|NMTRC|Giselle Sholler, MD|6162670335|giselle.sholler@helendevoschildrens.org|
21270746|NCT02962882|Molnlycke Health Care|Global Clinical Research Director|+46 31 722 30 00|info@monlycke.com|
21270747|NCT03763331|Purdue University|Dr. Bruno Roseguini|7654906284|brosegui@purdue.edu|
21270748|NCT00936884|Salix Pharmaceuticals|David Sorscher|919-862-1827|david.sorscher@salix.com|
21270749|NCT04741503|Washington University School of Medicine|Ashley J. Housten, OTD, MSCI|314-454-7958|ahousten@wustl.edu|
21270750|NCT00597584|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
21270751|NCT02797964|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21270752|NCT00272337|Florida Atlantic University|Charles H. Hennekens, M.D.||chenneke@fau.edu|
21270753|NCT02791659|Gastroenterology endoscopy center|Phonthep Angsuwatcharakon, MD|6622564265|borndeb@yahoo.com|
21270754|NCT01456052|Lexicon Pharmaceuticals, Inc.|Manager of Regulatory Affairs|281-863-3260|plogan@lexpharma.com|
21270755|NCT03094806|New York Methodist Hospital|Jeremy A Weingarten, MD|718-780-5835|jaw9031@nyp.org|
21270756|NCT02853929|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21270757|NCT02762565|University of Pennsylvnia|Robyn Broach|215-662-7300|robyn.broach@uphs.upenn.edu|
21270758|NCT01113710|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
21270759|NCT03103581|Braintree Laboratories, Inc.|Head of R&D, GI|7818432202|studydirector@sebelapharma.com|
21270760|NCT01042977|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
21270761|NCT02499354|Auerbach Hematology Oncology Assoc|Dr. Michael Auerbach|410-780-4050|mauerbachmd@abhemonc.com|
21270762|NCT04303845|Mayo Clinic|Rashmi B. Halker Singh, M.D.|480-301-8100|Halker.Rashmi@mayo.edu|
21270763|NCT01677910|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD||plapuerta@lexpharma.com|
21270764|NCT01577537|Starpharma|Dr Jeremy Paull||jeremy.paull@starpharma.com|
21270765|NCT01808209|Opthalmic Research Group, Aston University, Birmingham, UK|Jonathan Walker||JWalker@coopervision.co.uk|
21270766|NCT01703741|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21270767|NCT00368537|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21270768|NCT04248855|Kanyos Bio (A wholly owned subsidiary of Anokion SA)|Medical Director|+1 857-320-6607|clinicaltrials@anokion.com|
21270769|NCT02784925|WanFangH|Ming-Shun Wu|88629307930|mswu@tmu.edu.tw|7923
21270770|NCT00685919|Vanderbilt University Medical Center|Alfredo Gamboa, MD|615-875-1003|alfredo.gamboa@vumc.org|
21270771|NCT01674478|Wake Forest University Health Sciences|Dr. Qing Yang||qyang@wakehealth.edu|
21270772|NCT01717456|University of North Carolina at Chapel Hill|William E. Whitehead, PhD, Professor of Medicine|(919) 843-6961|William_Whitehead@med.unc.edu|
21270773|NCT02281409|Memorial Sloan Kettering Cancer Center|Dr. Jedd Wolchok, MD, PhD|646-888-2315|wolchokj@mskcc.org|
21270774|NCT05784571|Pennington Biomedical Research Center, Baton Rouge, LA|Candida Rebello|2257633159|Candida.Rebello@pbrc.edu|
21270775|NCT02732561|Wake Forest Health Sciences|James Kimball, MD|1 (336) 716-9702|jkimball@wakehealth.edu|
21270776|NCT00919802|UAB|Timothy Ness|205-975-9643|tness@uabmc.edu|
21270777|NCT01602198|Cleveland Clinic|Stephen Rao|216-444-1025|raos2@ccf.org|
21270778|NCT00528879|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21286476|NCT00792909|GlaxoSmithKline|GSK Response Center|866-435-7343||
21270779|NCT00711867|Mayo Clinic|Terrence L Trentman MD|480-301-8000|trentman.terrence@mayo.edu|
21270780|NCT01159769|Alcon Research, Ltd.|Director of Medical Affairs|800-862-5266|medinfo@alconlabs.com|
21270781|NCT01428024|Q-Med AB|Head of Medical Affairs|+ 46 (0) 18 4749000|reception.SEUPP@galderma.com|
21270782|NCT03056001|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
21270783|NCT01374906|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21270784|NCT02795780|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
21270785|NCT00435825|Hoffman-LaRoche|Medical Communications|800-821-8590||
21270786|NCT01189071|University of Missouri-Columbia|Dr. Mark Wakefield|573-882-0496|wakefieldmr@health.nissouri.edu|
21270787|NCT02367781|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21270788|NCT00789828|Novartis Pharmaceuticals|Study Director|862-778-8300||
21270789|NCT02623426|Johns Hopkins Bloomberg School of Public Health|Douglas A Jabs, MD, MBA|410 -955-1254|djabs1@jhmi.edu|
21270790|NCT03751124|Myovant Sciences GmbH|Clinical Trials at Myovant|+1 650 238 0250|clinicaltrials@myovant.com|
21270791|NCT04777591|University of Virginia|John T Stranix, MD|434-924-5078|jts3v@uvahealth.org|
21270792|NCT05458895|OhioSUCCC|Dr. Theodore L. Wagener|614-366-4265|Theodore.Wagener@osumc.edu|
21270793|NCT02322242|Sunnybrook Health Sciences Centre|Dr. Stephen Choi|4164804864|stephen.choi@sunnybrook.ca|
21270794|NCT05166421|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|Information.center@astrazeneca.com|
21270795|NCT00382291|University of Florida|Dr. Regina Bussing|(352) 273-7550|rbussing@ufl.edu|
21270796|NCT01375010|Columbia University|Elizabeth Shane, MD|212-305-6289|es54@cumc.columbia.edu|
21270797|NCT02266706|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21270798|NCT01977352|Icahn School of Medicine at Mount Sinai|Dr. Ali Shariat||alishariatmd@gmail.com|
21270799|NCT00409188|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21270800|NCT02270983|Forest Research Institute, Inc., an affiliate of Allergan|Therapeutic Area Head|862-261-7000|IR-CTRegistration@allergan.com|
21270801|NCT02879747|Queen Silvia Children´s Hospital and University of Gothenburg|Dr Jovanna Dahlgren, PI and director of Department of Pediatrics|+46702750233|jovanna.dahlgren@gu.se|
21270802|NCT00854620|Stanford University, Stanford Cancer Center|Sandy Srinivas, MD|650-725-2078|sandysri@stanford.edu|
21270803|NCT02609737|Memorial Sloan Kettering Cancer Center|Dr. Lisa Bodie, MD, PhD|212-639-6650|bodeil@mskcc.org|
21270804|NCT03237611|Albert Einstein College of Medicine|Dr. Richard Gralla|718-918-6235|richard.gralla@nbhn.net|
21270805|NCT00534092|Medtronic Spine and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
21270806|NCT00275028|Dana-Farber Cancer Institute|Kimberley MacNeill|617-632-2621|kmacneill@partners.org|
21270807|NCT06156969|Spaulding Rehabilitation Hospital|Paolo Bonato, PhD|617-952-6319|PBONATO@mgh.harvard.edu|
21270808|NCT02873481|Virginia Commonwealth University School of Nursing|Dr. Patricia Kinser, Assistant Professor|804-828-9140|kinserpa@vcu.edu|
21270809|NCT01847313|University College Dublin|Prof Carel le Roux|+353 1 716 6831|carel.leroux@ucd.ie|
21270810|NCT00598559|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
21270811|NCT00325403|United Therapeutics Corporation|Kevin Laliberte; Senior Director, Product Development|919-425-8176|klaliberte@unither.com|
21270812|NCT00674219|UCLA Department of Psychiatry|Alexander Bystritsky MD PhD|(310) 206-5133|abystritsky@mednet.ucla.edu|
21270813|NCT00515073|University of Texas MD Anderson Cancer Center|Anuja Jhingran, MD / Professor, Radiation Oncology Department|713-563-6900|CR_Study_Registration@mdanderson.org|
21270814|NCT02764489|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21270815|NCT00881959|Zimmer Dental|Hai Bo Wen|760 929 4312|haibo.wen@zimmer.com|
21270816|NCT03840811|University of North Carolina at Chapel Hill|Marcia M. Hobbs, PhD|(919) 843-6893|mmhobbs@med.unc.edu|
21270817|NCT01904383|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21270818|NCT01625845|Indiana University-Purdue University Indianapolis (IUPUI)|Jesse C. Stewart, Ph.D.|(317) 274-6761|jstew@iupui.edu|
21270819|NCT01294592|GlaxoSmithKline|GSK Response Center|866-435-7343||
21270820|NCT00623623|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21270821|NCT02186808|Nobel Biocare|Head of Clinical Trial Management|+41 43 211 42 00|isabelle.arrighi@nobelbiocare.com|
21270822|NCT00693784|Spinal Restoration, Inc.|Jeff F. Doerzbacher|512 225-0405|jeffdoerzbacher@spinalrestoration.com|
21270823|NCT02265952|Regeneron Pharmaceuticals, Inc.|Clinical Trial Information|844-734-6643|clinicaltrials@regeneron.com|
21270824|NCT01072032|Baltimore Veterans Affairs|Dr. Ron Goodman|410-605-7000|ronald.goodman@va.gov|
21270825|NCT02062606|Stryker Spine|Marissa Conrad, Senior Director of Clinical and Medical Affairs|201-749-8162|marissa.conrad@stryker.com|
21270826|NCT00326885|Fresenius Biotech|Manager, Regulatory Affairs|781-699-4652|bao.le@fresenius-biotech.com|
21270827|NCT04313283|University of Maryland Baltimore|Sarah Dababnah|14107068076|sdababnah@ssw.umaryland.edu|
21270828|NCT04356573|UAMS|Robert Wolfe|501-526-5708|rrwolfe2@uams.edu|
21270829|NCT03650400|Novartis Pharmaceuticals|Study Director|882 778 8300|Novartis.email@Novartis.com|
21270830|NCT01460927|El.En. Electronic Engineering S.p.A.|Alessandro Bizzarri|+39 055 8826807|a.bizzarri@elen.it|
21270831|NCT01170364|NYPInstitute|Dr. Laurel Mayer|646-774-8067|lsm16@columbia.edu|
21270832|NCT04132232|UAB|Christina Blanchard|205-934-7982|ctblanchard@uabmc.edu|
21270833|NCT00892697|University at Buffalo|Andrew Talal, MD|716-888-4737|ahtalal@buffalo.edu|
21270834|NCT05483920|Black Hills State University|Dr. Ashley Pfeiffer|(605) 381-5370|ashley.pfeiffer@bhsu.edu|
21270835|NCT01368276|Amgen, Inc.|Study Director|866-572-6436||
21270836|NCT03341273|Duke University|Ephraim L. Tsalik, MD, MHS, PhD|919-684-3114|e.t@duke.edu|
21270837|NCT02041494|University of California, San Francisco|Dr. Hobart W. Harris, Chief of General Surgery|(415) 514-3891|hobart.harris@ucsf.edu|
21270838|NCT04126733|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21270839|NCT03726437|GEORGIA STATE UNIVERSITY|Dr. Laura Salazar|4044131396|lsalazar1@gsu.edu|
21270840|NCT00267007|Centocor Ortho Biotech Services, LLC (COBS)|Vice President|215 325 4464||
21270841|NCT00580333|Massachusetts General Hospital|Dr. Steven Isakoff|617 726 6500|sisakoff@partners.org|
21270842|NCT01917188|Intermountain Heart Institute|Patti Spencer|8015074700|patti.spencer@imail.org|
21270843|NCT02400073|ResMed|Senior Manager, Medical Affairs|+61 8884 1123|alison.wimms@resmed.com|
21270844|NCT04133519|metaMe Health|Dr. David Recker, Chief Medical Officer|1-888-463-8262|info@metamehealth.com|
21270845|NCT00950599|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
21270846|NCT02372682|Saint Louis University|Anna Hardy, Research Nurse Coordinator|314-268-5785|anna.hardy@health.slu.edu|
21270847|NCT01361607|GW Pharmaceuticals Ltd.|Medical Enquiries||medinfo.USA@gwpharm.com|
21270848|NCT01507831|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21270849|NCT01280981|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21270850|NCT02522949|Enzymatica AB|Enzymatica AB|+46 46 286 31 00|info@enzymatica.com|
21270851|NCT03536819|Inmode Ltd|Maria Shusterman, Clinical Director|9057070975|maria.shusterman@inmodemd.com|
21270852|NCT00676026|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu|
21270853|NCT05037409|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21270854|NCT03499249|Baylor College of Medicine and Texas Children's Hospital|Sanjiv Harpavat|832-824-2099|harpavat@bcm.edu|2144
21270855|NCT04499235|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
21270856|NCT02475980|University of New Mexico Health Sciences Center|Nancy Sokkary, MD|email|HSC-FamilyPlanningResearch@salud.unm.edu|
21270857|NCT01203319|Jiangsu Provincial Center for Disease Control and Prevention|Fengcai Zhu|#86-25-83759418|jszfc@vip.sina.com|
21270858|NCT02094937|GlaxoSmithKline|GSK Response Center|866-435-7343||
21270859|NCT00343642|Rush University Medical Center|Ece A Mutlu, Principal Investigator|312 942 5861|Ece_Mutlu@rush.edu|
21270860|NCT01963676|UNC Chapel Hill|Dr. Flavio Frohlich|(919) 966-4584|flavio_frohlich@med.unc.edu|
21270861|NCT00766506|Janssen-Cilag Ltd. 50-100 Holmers Farm Way, High Wycombe , BUCKS, UK, HP12 4EG|Study Responsible Physician|+44 (0) 1494 567 444||
21270862|NCT02595528|Allergan, Inc|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
21270863|NCT03202511|Division of Clinical Pharmacology, School of Medicine, Indiana University|Dr. Zeruesenay Desta|317-274-2823|zdesta@iu.edu|
21270864|NCT00142454|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
21270865|NCT02460874|UAB|Dr. Hunter Boggs|205-934-5670|dboggs@uabmc.edu|
21270866|NCT04636398|University of California San Francisco|Alison El Ayadi|415-659-8367|alison.elayadi@ucsf.edu|
21270867|NCT02736227|Northwestern University|Josh Levitsky|312-695-4413|j-levitsky@northwestern.edu|
21270868|NCT03947788|NorthShore University HealthSystem|Emily White VanGompel|224-364-7300|ewhitevangompel@northshore.org|
21270869|NCT02199652|Medical College of Georgia; Augusta University|William Vaughn McCall|7067216719|WMCCALL@augusta.edu|
21270870|NCT02951884|Loyola University Medical Center|William Lack, M.D.|708-216-1175|wlack@luc.edu|
21270871|NCT02528318|Windtree Therapeutics, Inc.|Robert Segal, MD, FACP|215-488-9300|rsegal@windtreetx.com|9450
21270872|NCT03870997|Evidation Health|Executive Director, Digital Health Outcomes|650-389-9550|results@evidation.com|
21270873|NCT00986154|Daiichi Sankyo, Inc.|Lee Schwocho, Sr. Director|732-590-5000|lschwocho@dsi.com|
21270874|NCT03840135|NPO Petrovax Pharm, LLC|Nikolay Dodonov, Head of medical department|+7(495) 730-75-45|DodonovNS@petrovax.ru|125
21270875|NCT01827371|Group Health Research Institute|Lisa Jackson, M.D., M.P.H.|206-442-5216|Jackson.L@ghc.org|
21270876|NCT03803085|Brandeis University|Yujun Liu|781-736-3300|lyujun@brandeis.edu|
21270877|NCT03411642|University Medical Center Hamburg-Eppendorf|Prof. Dr. Götz Thomalla|+4940501377410|thomalla@uke.de|
21270878|NCT02273206|Clinical Directors Network|Andrea Cassells, MPH|212-382-0699|acass@cdnetwork.org|227
21270879|NCT02741271|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21270880|NCT02570165|GlaxoSmithKline|GSK Response Center|866-435-7343||
21270881|NCT01455545|SESCAM - HOSPITAL UNIVERSITARIO DE GUADALAJARA|Dr. Carlos Almonacid|+34 655 53 44 75|caralmsan@gmail.com|
21270882|NCT01252238|Brigham and Women's Hospital|Dr. Jonathan Williams|617-278-0882|jwilliams5@partners.org|
21270883|NCT00833781|Mass General Hospital|Dr. Rajesh Gandhi|617-724-9690|rgandhi@partners.org|
21270884|NCT01610167|Salus Research, Inc.|Jeffery L. Milleman, DDS, MPA|(260) 755-1099||
21270885|NCT01190202|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21270886|NCT03029000|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21270887|NCT03276962|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21270888|NCT00411762|Yale University|Howard Hochster||Howard.Hochster@yale.edu|
21270889|NCT04428502|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21270890|NCT01358708|Aptalis Pharma US, Inc.|Robert Winkler MD, VP, Clinical Development and Operations|(908) 429-4479|rwinkler@aptalispharma.com|4175
21270891|NCT00827073|Robert Cizik Eye Clinic|Joseph Selem, MD|713-559-5263|laurabaker@cizikeye.org|
21270892|NCT00904189|University of Rochester Medical Center|Steven Swarts|5852755623|christine_huggins@urmc.rochester.edu|
21270893|NCT01364298|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21301573|NCT00634101|Johnson & Johnson Vision|DIR CLINICAL NEW PRODUCT DEVELOPMENT|1-800-843-2020|KMoody1@its.jnj.com|
21301574|NCT01543633|Neuroscience Statistics Research Laboratory, Massachusetts General Hospital|Dr. Emery N. Brown|(617) 726-8786|enb@neurostat.mit.edu|
21301575|NCT03306173|Fralin Biomedical Research Institute at VTC|Dr. Roberta Freitas-Lemos|540 526 2106|rflemos@vtc.vt.edu|
21301576|NCT00573144|Mayo Clinic|Dr. Horng H. Chen|507-284-1644|chen.horng@mayo.edu|
21258788|NCT02171611|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21258789|NCT04906980|Janssen Research & Development, LLC|GLOBAL MEDICAL LEADER RESPIRATORY INFEC|+12153252489|ClinicalTrialDisclosure@its.jnj.com|
21258790|NCT03212170|UW Carbone Cancer Center|Dr. Amy Fowler, MD, PhD|608-262-9186|afowler@wisc.edu|
21258791|NCT02065154|UAB|Omer Jamy|205-934-9294|omerjamy@uabmc.edu|
21258792|NCT02678390|Research Centre on Aging|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
21258793|NCT02925156|Loyola University Chicago|Amy Luke, Ph.D.|(464) 220-9243|aluke@luc.edu|
21258794|NCT02759172|Michigan State University|Dr. Jennifer Johnson|810-730-6121|jjohns@msu.edu|
21258795|NCT01681433|Hoosier Cancer Research Network|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
21258796|NCT00730639|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21258797|NCT00361595|Cleveland Clinic|Chad Deal|216-444-6575|dealc@ccf.org|
21258798|NCT01632566|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21258799|NCT03208231|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
21258800|NCT03861143|NImmune Biopharma, Inc.|Clinical Development|(540) 218-2262|info@nimmunebio.com|
21258801|NCT06142643|Kylane Laboratoires|Basste Hadjab, Sponsor|0225889611|compliance@kylane.com|
21258802|NCT04982250|Fred Hutchinson Cancer Center|Katrina F Ortblad, ScD, MPH|2066677267|kortblad@fredhutch.org|
21258803|NCT02177201|Adnan Menders University, Anesthesiology and Reanimation Department|Dr. Sinan Yılmaz|+905055954374|dr_snnylmz@hotmail.com|
21258804|NCT02289950|Eisai Inc.|Eisai Medical Information|888-274-2378|esi_oncmedinfo@eisai.com|+1
21258805|NCT04518462|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9729|MedInfo@Pacira.com|
21258806|NCT01003210|University of Washington|Dr. James Taylor|206-6165-1206|uncjat@uw.edu|
21258807|NCT01411085|Geisel School of Medicine at Dartmouth|Alan I Green, MD|603-650-7549|alan.i.green@dartmouth.edu|
21258808|NCT05036083|M.D. Anderson Cancer Center|Olena Weaver|713-471-3613|ooweaver@mdanderson.org|
21258809|NCT04745689|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21258810|NCT02553460|Lucile Packard Children's Hospital|Tanja A. Gruber, MD, PhD|(650) 723-5535|tagruber@stanford.edu|
21258811|NCT03845582|Alkeus Pharmaceuticals, Inc.|Meena Venugopal|877-255-7476|mvenugopal@alkeus.com|
21258812|NCT07099521|South China Normal University|Dr. Yuanyuan Wang|+86 13076729124|angelayuanyuanwang@gmail.com|
21258813|NCT01178138|University of Arkansas for Medical Sciences|W. Brooks Gentry, MD|501 686 6119|gentrywilliamb@uams.edu|
21258814|NCT01790503|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
21258815|NCT03591380|University of Wisconsin - Madison|David Foley, MD|608-263-2527|foley@surgery.wisc.edu|
21258816|NCT02322710|Mylan Medical SAS|Rafik NAMANE MD.|0033146258607|rafik.namane@mylan.com|
21258817|NCT02615990|University of Kentucky|Lisa Fryman|859 323 2060|lisa.fryman@uky.edu|
21258818|NCT03312517|Henry Ford Sleep Research Center|Christopher Drake, PhD|248-344-6672|cdrake1@hfhs.org|
21258819|NCT00808444|GlaxoSmithKline|GSK Response Center|866-435-7343||
21258820|NCT01461044|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21258821|NCT04401267|St. Jude Children's Research Hospital|Seth Karol, MD|(901) 595-1716|seth.karol@stjude.org|
21258822|NCT01846455|RECKITT BENCKISER PHARMACEUTICALS, INC.|Reckitt Benckiser Pharmaceuticals, Inc.|804-379-1090||
21258823|NCT04294459|Sanofi Aventis Recherche & Développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21258824|NCT02787863|Samara State Medical University, Institute of Sera and Vaccines RAS|Professor Andrei Dmitrievich Protasov, Professor Mikhail Petrovich Kostinov|+79277444126|crosss82@mail.ru|
21258825|NCT02450487|Bauru School of Dentistry University of Sao Paulo|Dr. Adriana Calvo|+551432358200|birinjela@yahoo.com.br|
21258826|NCT00825565|Northwestern University|Stephanie Rangel|312-503-5942|stephanie.rangel@northwestern.edu|
21258827|NCT04142983|GCAM / Biomat USA - Grifols|Center Medical Director|956-729-7677|laredomedical@gcamplasma.com|
21258828|NCT01789970|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21258829|NCT01347034|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-3050|alberto.chiappori@moffitt.org|
21258830|NCT01847885|SPR Therapeutics|Clinical Affairs|216-378-9108|support@SPRTherapeutics.com|
21258831|NCT02574637|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21258832|NCT04311086|Medtronic|Sara Dinkins SPYRAL DYSTAL Global Study Manager|303-840-4034|rs.spyraldystal@medtronic.com|
21258833|NCT00355394|CHOP|Dr. Nicholas Abend|215-590-1719|abend@email.chop.edu|
21258834|NCT02499029|MUSC|Sudie Back, PhD|843-792-9383|backs@musc.edu|
21258835|NCT04823949|The Medical University of South Carolina|Dr. Matthew Finneran|(843) 792-4500|finneram@musc.edu|
21258836|NCT00756938|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21258837|NCT00094055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21258838|NCT00441545|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21258839|NCT01707693|University of Arkansas for Medical Sciences|Leanne L. Lefler, PhD, APN, RN Principal Investigator|5012961939|LeflerLeanne@uams.edu|
21258840|NCT04336995|VUMC|Ken Monahan|6153222318|ken.monahan@vanderbilt.edu|
21258841|NCT02556255|Eximo Medical|Oshrat Cohen|97286307639|oshratc@eximomedical.com|
21258842|NCT03115151|UT Southwestern Medical Center|Dr. Enas Kandil|214/648-9374|Enas.Kandil@UTSouthwestern.edu|
21270894|NCT03712228|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
21270895|NCT01964105|WASHINGTON UNIVERSITY SCHOOL OF MEDICINE, SAINT LOUIS|TERENCE MICHAEL MYCKATYN, PI, PROFESSOR, PLASTIC SURGERY|314-362-4263|myckatyn@wustl.edu|
21270896|NCT01721967|Duke University Health System|Andrew Wang, MD|919-681-6197|a.wang@duke.edu|
21270897|NCT02295280|Saint Louis University|Dorothea Mostello, MD, Maternal Fetal Medicine Faculty|314-977-2090|mostello@slu.edu|
21270898|NCT02875067|NYU Langone Health|Catherine Diefenbach, MD|212-731-5670|Catherine.Diefenbach@nyulangone.org|
21270899|NCT01430104|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21270900|NCT01241565|Covidien|Noreen Fahey|203-821-4716|noreen.fahey@covidien.com|
21270901|NCT02713243|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
21270902|NCT03056352|Montefiore Health|Benjamin W. Friedman, MD|718-920-6626|befriedm@montefiore.org|
21270903|NCT02971605|Johns Hopkins University School of Medicine|Frederick Barrett, Ph.D., Principal Investigator|4105509777|fbarret2@jhmi.edu|
21270904|NCT03439293|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21270905|NCT00493181|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/794-5783|eharriso@mdanderson.org|
21270906|NCT00660049|Stanford University|Anne Chang, MD|(650) 721 7151|alschang@stanford.edu|
21270907|NCT00614458|UNC Chapel Hill|Professor of Medicine, Director Translational Research IGHID|919 966 6388|dmargo@med.unc.edu|
21270908|NCT00751972|HeartWare Inc|Director Clinical Project Management|508 739-0867|sbell@heartwareinc.com|
21270909|NCT00869089|University Hospitals Case Medical Center|Neil J. Korman, MD Principal Investigator|216-844-7164|neil.korman@UHHospitals.org|
21270910|NCT04553484|Semler Scientific|Gena Parker|669-230-2729|gparker@semlerscientific.com|
21286477|NCT04865029|Tulane University|Franck Mauvais-Jarvis|504-259-1139|fmauvais@tulane.edu|
21286478|NCT01431339|Durata Therapeutics|Michael Zelasky|203-871-4616|mzelasky@duratatx.com|
21286479|NCT04907214|Vanderbilt University Medical Center|Dr. Mona Mashayekhi|615-936-1760|mona.mashayekhi@vumc.org|
21286480|NCT00385918|University of Maryland Rehabiitation and Orthopaedic Institute|Peter H. Gorman, MD Chief Division of Rehabilitation Medicine|410-448-6261|pgorman@umm.edu|
21286481|NCT00128661|GlaxoSmithKline|GSK Response Center|866-435-7343||
21286482|NCT01261390|Brigham and Women's Hospital|Dr. Susan Redline|617-732-5859|sredline1@rics.bwh.harvard.edu|
21286483|NCT01005576|Washington University School of Medicine|Dr. Shalini Shenoy|314-454-6018|shalinishenoy@wustl.edu|
21286484|NCT04010461|University of Michigan|Stephan Taylor|(734) 936-4955|sftaylor@med.umich.edu|
21286485|NCT03571724|22nd Century Group, Inc.|Karen E. Delaney|716-270-1523|kdelaney@xxiicentury.com|
21286486|NCT00735007|Merck Serono International, S.A., an affiliate of Merck KGaA, Darmstadt, Germany|Elisabetta Verdun di Cantogno|+41 22 414 4887|elisabetta.verdun@merckserono.net|
21286487|NCT00715403|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21286488|NCT00870467|Abbott|Global Medical Services|800-633-9110||
21286489|NCT03839394|Duke University|Nwora Lance Okeke, MD, MPH|919-684-2579|lance.okeke@duke.edu|
21301577|NCT03051178|University of Florida|Dr. Aysegul Gunduz|3522736877|agunduz@bme.ufl.edu|
21301578|NCT02813577|Becton Dickinson|Anna Lovas|763-445-2385|anna.lovas@bd.com|
21301579|NCT00060840|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
21301580|NCT01415882|Mayo Clinic|Shaji Kumar|507-284-5096|Kumar.Shaji@mayo.edu|
21301581|NCT00976560|GlaxoSmithKline|GSK Response Center|866-435-7343||
21301582|NCT00125164|Ipsen|Medical Director, Pediatric Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21301583|NCT01470118|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21301584|NCT01339052|Dana-Farber Cancer Institute|Patrick Y. Wen, MD, Director, DFCI Center for Neuro-Oncology|617-632-2166|pwen@partners.org|
21301585|NCT02722499|Medical College of Wisconsin|Jennifer A. Campbell|414-955-8829|jacampbell@mcw.edu|
21301586|NCT01009619|Katholieke Universiteit Leuven and University Hospital Leuven|Prof. Dr. GM Verleden|+32 16 34 68 08|geert.verleden@uzleuven.be|
21301587|NCT01599637|Novartis Pharmaceuticals|Study Director|862-778-8300||
21301588|NCT00659789|Bionor Pharma ASA|Maja Sommerfelt|+4723010960|ms@bionorpharma.com|
21301589|NCT04476797|Galera Therapeutics|Judy Schnyder|484-870-9625|jschnyder@galeratx.com|
21301590|NCT01436435|Boston Scientific|DeeAnn Tinjum, Clinical Trial Manager|763-494-1927|deeann.tinjum@bsci.com|
21301591|NCT00396253|Genentech, Inc.|Medical Communications|800-821-8590||
21301592|NCT05340478|Michael E. DeBakey VA Medical Center|Dr. Ellen Teng|713 791-1414|Ellen.Teng@va.gov|
21301593|NCT01594216|Abramson Cancer Center|Angela DeMichele, MD|215-615-5329|Angela.DeMichele@pennmedicine.upenn.edu|
21301594|NCT00092443|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21301595|NCT04717336|The National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH)|Georg Aue, MD|301.451.7141|aueg@nhlbi.nih.gov|
21301596|NCT02039843|Tennesse Valley HCS|Joan Richerson|615-574-8198|joan.richerson@va.gov|
21301597|NCT01721837|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21301598|NCT01951963|Health Partners|Dr. Aaron Burnett|651-254-5304|Aaron.M.Burnett@HealthPartners.Com|
21301599|NCT01500720|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21301600|NCT02284035|Hospital Clinic of Barcelona|Dr. Esteban Martínez|+34 93 227 54 00|ESTEBANM@clinic.cat|
21301601|NCT00630838|University of Michigan|Daniel Teitelabum|734-936-8464|dttlbm@umich.edu|
21301602|NCT00928408|Amgen Inc.|Study Director|866-572-6436||
21270911|NCT01364259|Stanford University Cancer Center|Dr. Scott G. Soltys, Assistant Professor|650.724.1569|sgsoltys@stanford.edu|
21301603|NCT01369888|National Cancer Institute|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
21301604|NCT02538354|Universy Medical Center Groningen|dr. J.Z.H. von Martels|0031503616161|j.z.h.von.martels@umcg.nl|
21270912|NCT01164137|Westview Physician Collaborative|Allan Bailey, M.D.; Study Principal Investigator|(780)-975-1131|baileymd@telusplanet.net|
21270913|NCT01880541|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Pr Simone Mathoulin-Pélissier|0556333333|s.mathoulin@bordeaux.unicancer.fr|
21270914|NCT05003167|Purdue University|Jessica Huber, Professor and PI|765-494-3796|jhuber@purdue.edu|
21270915|NCT00430638|Daiichi Sankyo|Global Clinical Leader|1-908-992-6400||
21286490|NCT01733745|Alcon Research, Ltd.|Abayomi Ogundele, Pharm.D, Global Brand Medical Affairs Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21286491|NCT01931397|Oregon Health & Science University|Dr. Amira Al-Uzri , Professor of Pediatrics|503-494-6956|aluzria@ohsu.edu|
21286492|NCT02472262|Washington University School of Medicine in St. Louis|Mark Manary|3144542178|manarymj@wustl.edu|
21286493|NCT02346877|Amgen Inc.|Study Director|866-572-6436||
21286494|NCT00565604|Lake Washington Vascular Surgery|Daniel Pepper, MD|(425) 453-1772||
21286495|NCT00329108|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21286496|NCT00754741|Henry Ford Health System|L. Keoki Williams, MD, MPH|313-874-5454|chphsr@hfhs.org|
21286497|NCT01334086|Princess Margaret Cancer Centre|Dr. Karen Yee, Hematology and Medical Oncology Site Group Lead|416-946-4501|Karen.Yee@uhn.ca|4495
21286498|NCT04969289|Columbia University|Lauren Chernick, MD, MSc|212-305-9825|lc2243@columbia.edu|
21286499|NCT00593814|W.L. Gore and Associates|Tab Bonny|928 864 4275|tbonny@wlgore.com|
21286500|NCT01921517|University of Pennsylvania Perelman School of Medicine|Felix W. Wehrli, Principal Investigator|215-662-7951|felix.wehrli@pennmedicine.upenn.edu|
21286501|NCT00500448|University of Michigan|Riann Palmieri-Smith|7346153154|riannp@umich.edu|
21286502|NCT00991081|Stanford University|Sean P. David, MD, SM, DPhil|650-498-4687|spdavid@stanford.edu|
21286503|NCT02486692|Ralph H. Johnson VAMC|Anouk Grubaugh|843-532-6672|grubaugh@musc.edu|
21286504|NCT00001322|National Institute of Mental Health|Schmidt, Peter|+1 301 496 6120|peterschmidt@mail.nih.gov|
21286505|NCT00116688|Amgen Inc.|Study Director|866-572-6436||
21286506|NCT01640548|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21286507|NCT02864069|UCSD|Dr. Amy Jak|8586423742|ajak@ucsd.edu|
21286508|NCT03593200|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
21286509|NCT01775670|Massachusetts General Hospital|Taylor Pong||tpong1@partners.org|
21286510|NCT01298700|Allergan, Inc|Michael Robinson, MD|714-246-4500|clinicaltrials@allergan.com|
21286511|NCT04006145|Albireo AB|Patrick Horn, MD, PhD|+1 (857) 378- 2035|medinfo@albireopharma.com|
21286512|NCT01001429|Rutgers New Jersey Medical School|Anuradha Patel, MD|973 972-1886|patelan@njms.rutgers.edu|
21286513|NCT01053156|MIND Institute, University of California Davis Medical Center|Randi J. Hagerman MD, Medical Director of the MIND Institute|916-703-0247|randi.hagerman@ucdmc.ucdavis.edu|
21286514|NCT00010257|ECOG Statistical Office|Study Statistician|617-632-3012||
21286515|NCT02169440|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21286516|NCT00643760|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
21286517|NCT00857506|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
21286518|NCT02063672|Lutonix|Heidi Ronhovde|7634632900|heidi.ronhovde@crbard.com|
21286519|NCT01307787|UMCG|G.Breedland||g.breedland@cvr.umcg.nl|
21286520|NCT00313729|UCSF Neuro-Oncology|Susan Chang MD|415-353-2966|Susan.Chang@ucsf.edu|
21286521|NCT01547715|Novartis Vaccines and Diagnostics SRL|Posting Director||RegistryContactVaccinesUS@novartis.com|
21286522|NCT03353792|Associate Professor of Medicine|Raimund Herzog, MD, MHS|(877) 925-3637|raimund.herzog@yale.edu|
21286523|NCT00789321|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
21286524|NCT01965327|Children's Hospital of Philadelphia|David Lynch, MD, PhD|215-590-1719|lynch@email.chop.edu|
21286525|NCT00104052|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21286526|NCT03477162|Dartmouth Hitchcock Medical Center|Joseph Phillips, MD|603-650-5000|Joseph.D.Phillips@hitchcock.org|
21270916|NCT01529749|Hospital Clínic|FELIPE GARCIA ALCAIDE|34619175783|FGARCIA@clinic.cat|
21270917|NCT01133392|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21286527|NCT02498678|Instituto da Criança do Hospital das Clínicas da Universidade de São Paulo|Dr. Ricardo Vieira Carlos|55-11-99911-6677|ricardovieirac@gmail.com|
21258843|NCT01325428|Boehringer Ingelheim (BI)|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21258844|NCT02682901|Eastern Virginia Medical School|Henri Parson|7574467976|parsonhk@evms.edu|
21258845|NCT03870555|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21258846|NCT03713944|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
21258847|NCT01337076|Mayo Clinic, Rochester|Dr. Colin Driscoll|507 266 1965|driscoll.colin@mayo.edu|
21258848|NCT01787916|CHU de Quebec|Weisnagel|4185254444|john.weisnagel@crchul.ulaval.ca|47035
21286528|NCT04735705|Perfect Care Distribution|Mihnea Mihalache, Chief Executive Officer|+40 786 749 087|contact@perfectcare.ro|
21286529|NCT03652818|Nevakar, Inc.|Eric Lang, MD|(908) 367-7400|Clinicaltrials@nevakar.com|
21286530|NCT04789304|Boehringer Ingelheim, Call Centre|Boehringer Ingelheim|018002430127|clintriage.rdg@boehringer-ingelheim.com|
21270918|NCT00378482|AstraZeneca Clinical Study Information Center|Global Clinical Lead|8772409479|information.center@astrazeneca.com|
21270919|NCT03185949|Endobar Solutions LLC|Director, Clinical Affairs|8456800424|nodar@endobarsolutions.com|
21270920|NCT02926053|National Center of Cancer Immune Therapy, Department of Oncology|Troels Holz Borch, MD, PhD, principal investigator|004524460492|troels.holz.borch@regionh.dk|
21270921|NCT00500656|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21270922|NCT00555399|University of Texas M D Anderson Cancer Center|Dr. Vinay K. Puduvalli|(713) 745-2343|vpuduval@mdanderson.org|
21270923|NCT04639310|Xenon Pharmaceuticals Inc|Dr. Noam Butterfield|604 484 3300|nbutterfield@xenon-pharma.com|
21270924|NCT02462382|Orlando Orthopaedic Center|Randy Schwartzberg, MD|407-254-2500|orlandosportsdoc@yahoo.com|
21270925|NCT00860574|Fred Hutch/University of Washington Cancer Consortium|Joachim Deeg|206.667.5985|jdeeg@fredhutch.org|
21270926|NCT02006407|University of Michigan Comprehensive Cancer Center|Dr. Carl Johannes Koschmann, M.D.|734-647-2893|ckoschma@umich.edu|
21270927|NCT02496221|GlaxoSmithKline|GSK Response Center|866-435-7343||
21270928|NCT01335399|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21270929|NCT03262233|UW-Madison|John Curtin|608-262-0387|jjcurtin@wisc.edu|
21270930|NCT01120600|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21270931|NCT00894465|Washington University School of Medicine|Dr. Paul Austin|(314) 454-6034|austinp@wustl.edu|
21270932|NCT01165242|GlaxoSmithKline|GSK Response Center|866-435-7343||
21270933|NCT03877237|Astrazeneca|Łyżwa, Dawid|+48 882 345 259|dawid.lyzwa@astrazeneca.com|
21270934|NCT02464878|Massachusetts General Hospital|James Markmann|617-643-4533|jmarkmann@mgh.harvard.edu|
21270935|NCT03372083|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21270936|NCT00566098|Johns Hopkins University|Ivan Borrello, MD|4109554967|iborrell@jhmi.edu|
21270937|NCT01690520|Deverra Therapeutics|Chief Scientific Officer|206-519-5304|cdelaney@deverratx.com|
21270938|NCT02236754|Columbia University|Dr. Paul Harris|212-305-7363|peh1@cumc.columbia.edu|
21270939|NCT01270841|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com|
21270940|NCT02092961|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
21270941|NCT00124176|Children's Hospital of Philadelphia|Joseph Zorc, MD|215-590-1944|zorc@email.chop.edu|
21270942|NCT01623830|Emory University|Barbara Rothbaum|404-712-8866|brothba@emory.edu|
21238110|NCT03027414|University of Pennsylvania|Nicholas Balderston|2157463058|nicholas.balderston@pennmedicine.upenn.edu|
21258849|NCT01639872|Psychopharmacology Research Group|Dr. Mary Brunette|603-271-5054|mary.f.brunette@hitchcock.org|
21258850|NCT03850912|Dana-Farber Cancer Institute|Michael Hassett|617-726-5200|michael_hassett@dfci.harvard.edu|
21258851|NCT02695628|Stanford University|Rajesh Shah|650-723-0728|rajshah@stanford.edu|
21258852|NCT00720109|Children's Oncology Group|Results Reporting Coordinator|626-241-1546|resultsreportingcoordinator@childrensoncologygroup.org|
21258853|NCT03595553|Summit Therapeutics|Katie Tran|408 677 6503|Katie.Tran@Summitplc.com|
21258854|NCT00903929|University of Rochester|Jane L. Liesveld|585-275-5823|jane_liesveld@urmc.rochester.edu|
21258855|NCT02665286|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|(718)920-6266|befriedm@montefiore.org|
21258856|NCT00425386|OHSU Knight Cancer Institute|Dr. Christopher Ryan|5034946197|ryanc@ohsu.edu|
21258857|NCT00626093|St. Jude Medical|Ashish Oza|818-493-3648|aoza@sjm.com|
21258858|NCT00393874|University of Pittsburgh|Dr. Anne Germain|412-383-2150|GERMAX@upmc.edu|
21258859|NCT05853380|Mindset Medical|Jeremy Markovich|8583055323|jeremy@mindsetmedical.com|
21258860|NCT04338009|University of Pennsylvania|Dr. Jordana Cohen|215-662-4000|jco@pennmedicine.upenn.edu|
21258861|NCT03963011|Children's Mercy Hospital|Erin Opfer, DO|816-324-3273|ekopfer@cmh.edu|
21258862|NCT04153188|Candela Corporation|Medical Director|+1 904 6549629|konikap@candelamedical.com|
21258863|NCT01489527|H. Lee Moffitt Cancer Center and Research Institute|Anna R. Giuliano, Ph.D.|813-745-6820|anna.giuliano@moffitt.org|
21258864|NCT04899232|University of Miami|Enrique Ginzburg, MD|305-585-1178|eginzbur@med.miami.edu|
21258865|NCT00700271|Novartis Pharmaceuticals|Study Director|862-778-8300||
21258866|NCT02406781|Institut Bergonie|Pr Antoine Italiano|0524071947|a.italiano@bordeaux.unicancer.fr|
21258867|NCT02926950|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
21258868|NCT03784079|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21258869|NCT04622046|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
21258870|NCT03505021|Orion Corporation|Director, Clinical Operations|358104261|clinicaltrials@orionpharma.com|
21258871|NCT01844986|AstraZeneca|Elizabeth Lowe|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
21258873|NCT02028455|Seattle Children's Therapeutics|Dr. Colleen Annesley|206-987-7122|ICC-PLAT@seattlechildrens.org|
21258874|NCT02392429|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21258875|NCT01241708|Hackensack Meridian Health|Joshua Zenreich|5519964248|joshua.zenreich@hmhn.org|
21258876|NCT04137887|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21258877|NCT02040298|UCSF|Tracy Tran, BA|415-353-2707|tracy.tran@ucsf.edu|
21258878|NCT04183335|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21258879|NCT00049673|Canadian Cancer Trials Group|Director of Clinical Trials|613-533-6340|jdancey@ctg.queensu.ca|
21258880|NCT02326805|University of Arizona|Sherry Chow, PhD|520-626-3358|schow@azcc.arizona.edu|
21258881|NCT05064059|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21258882|NCT01934140|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21258883|NCT02168686|Adverum Biotechnology, Inc.|Chief Development Officer|650-649-1413|sseyedkazemi@adverum.com|
21258884|NCT02803164|Mayo Clinic|Dr. Mathew Thomas|904-953-2000|thomas.mathew@mayo.edu|
21258885|NCT00200850|UW Madison|Gina Crisafi|608-262-5240|gmc@medicine.wisc.edu|
21258886|NCT01449708|Coastal Anesthesiology|Patrick Ziemann-Gimmel, MD|904-819-4478|pziemann@yahoo.com|
21258887|NCT02889796|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21258888|NCT01414257|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21258889|NCT02421887|NICHD|Esther Eisenberg, NICHD Project Scientist|301-496-6516|esther.eisenberg@nih.gov|
21258890|NCT01882907|Pusan National University Hospital|In Joo Kim|+82-51-240-7224|injkim@pusan.ac.kr|
21258891|NCT01978093|GlaxoSmithKline|GSK Response Center|866-435-7343||
21258892|NCT01467492|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21258893|NCT04269395|Galderma|Clinical Operations|8179615000|Clinical.Studies@galderma.com|1
21270943|NCT01859390|University of Colorado School of Medicine|Dr. Scott Sagel, Professor of Pediatrics|720-777-2522|scott.sagel@ucdenver.edu|
21270944|NCT02655354|University of Washington School of Medicine|Douglas Zatzick|206-744-6701|dzatzick@uw.edu|
21270945|NCT00950833|GlaxoSmithKline|GSK Response Center|866-435-7343||
21270946|NCT04895618|Regulatory Insight, Inc.|Elvira Cawthon|Results Point of Contact Name|elvira@reginsight.com|
21270947|NCT03522584|University of Washington|Cristina Rodriguez|2066066748|rodrigcr@uw.edu|
21270948|NCT01886300|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21270949|NCT00295854|Medicinova Inc|Richard E. Gammans PhD Chief Developing Officer|848-373-1500|gammans@medicinova.com|
21270950|NCT00672620|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21270951|NCT00738673|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21270952|NCT01202994|University of Utah|Dr. Kevin Duff|8015859983|kevin.duff@hsc.utah.edu|801
21270953|NCT02622074|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21270954|NCT01859325|National Institute of Allergy and Infectious Diseases|Sneller, Michael|+1 301 496 0491|MSNELLER@niaid.nih.gov|
21270955|NCT03818919|Henry Ford Health System|Dr. Toufic Jildeh|(517)2308511|touficjildeh@gmail.com|
21270956|NCT01205529|Vanderbilt University Medical Center|Dan Roden|6153220067|dan.roden@Vanderbilt.Edu|
21270957|NCT00667719|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21270958|NCT03082391|Cleveland Clinic Foundation|Dr. Michael Rosen|2164453441|rosenm@ccf.org|
21270959|NCT03063632|Cancer Immunotherapy Trials Network|Anna Wright|206-667-2541|akwright@fredhutch.org|
21270960|NCT00927888|Stanford University|David Drover, MD|6507250364|ddrover@stanford.edu|
21270961|NCT03652961|NYU Langone Health|Gregg J. Silverman, MD MACR|212 263 9440|Gregg.Silverman@nyulangone.org|
21270962|NCT00373685|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21270963|NCT01783496|Solta Medical|Director of Clinical Programs|510-259-5284|aloncaric@solta.com|
21270964|NCT00947011|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
21270965|NCT05266456|Vaxcyte|Vice President of Clinical Development|(650) 585-0029|clinicaltrialsgov@vaxcyte.com|
21270966|NCT00068237|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
21270967|NCT02995694|Alvogen Pine Brook|Meena Venugopal|973-532-7824|meena.venugopal@alvogen.com|
21270968|NCT03124381|Johnson & Johnson Consumer Inc.|Ali Fassih, Ph.D.|908-904-3259|Afassih@its.jnj.com|
21270969|NCT04080882|QMedAB|Clinical Project Manager|(817) 961-5000|aestheticclinicaltrials@galderma.com|
21270970|NCT01365845|University of Florida Proton Therapy Institute|Dr. Julie Bradley|904-588-1800|jbradley@floridaproton.org|
21270971|NCT01190306|Topcon Medical Systems|Robert Gibson|(201) 599-5121|RGIBSON@TOPCON.COM|
21270972|NCT05017493|Hiwa Hospital - KRG|Dr. Dara Omer|+9647701586707|mailto:danaomar1979@gmail.com|
21270973|NCT01154153|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi.com|
21270974|NCT02473510|MedImmune, LLC|Ashwin Swami, MD|+1 301 398 5000|information.center@astrazeneca.com|
21270975|NCT00389649|Universitry of Maryland|Stephen Gottlieb, MD|4103288788|sgottlie@medicine.umaryland.edu|
21270976|NCT03940586|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21270977|NCT00964223|GlaxoSmithKline|GSK Response Center|866-435-7343||
21270978|NCT02006147|Taiwan Liposome Company|Dr. Carl Brown|886-2-2655-7377|tlc_clinicaltrials@tlcbio.com|
21270979|NCT03404206|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
21270980|NCT05478603|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21270981|NCT01010230|St. Jude Children's Research Hospital|Kirsten K. Ness, PT, PhD|866-278-5833|kiri.ness@stjude.org|
21270982|NCT00951899|Mayo Clinic|Dr. Adrian Vella|507-284-3289|vella.adrian@mayo.edu|
21270983|NCT01585831|University of Colorado Denver|Nicole Tartaglia, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
21270984|NCT01123980|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21270985|NCT01225991|University of California, Los Angeles|Dr. Helen Lavretsky,|310-794-4619|hlavretsky@mednet.ucla.edu|
21270986|NCT04444752|Head of Clinical Operations US|Malinda Longphre|+15105203361|Mlongphre@connectpharm.com|
21270987|NCT00579254|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21270988|NCT02557672|Mayo Clinic|Gregory A. Nuttall, M.D.|(507) 255-3298|gnuttall@mayo.edu|
21270989|NCT03705169|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
21270990|NCT01893983|San Francisco VA Healthcare System|Dr. Karen Seal|415-2214810|karen.seal@va.gov|24852
21270991|NCT01725815|Emory University|Dr. Benjamin Druss|404-712-9602|bdruss@emory.edu|
21270992|NCT02544633|Mirati Therapeutics, Inc.|Vanessa Tassell, Vice President, Clinical Science|858-332-3438|tassellv@mirati.com|
21270993|NCT01605461|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21270994|NCT02024698|CooperVision, Inc.|Manager Global Medical/Scientific Affairs|925-621-3761|javega@coopervision.com|
21270995|NCT04364165|Desmond Tutu Health Foundation (DTHF)|Philip Smith|+27 21 650 1895|philip.smith@hiv-research.org.za|
21286531|NCT01294423|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
21286532|NCT01241279|Valeant Pharmaceuticals/Bausch & Lomb|Johnson Varughese|908-927-1162|Johnson.Varughese@valeant.com|
21286533|NCT01145482|The University of Texas at Austin|Dr. Andreana Haley|512-232-0863|haley@psy.utexas.edu|
21286534|NCT04773223|University Clinical Centre of Serbia|Petar Zlatanovic|+381644961020|petar91goldy@gmail.com|
21270996|NCT01014390|Hôpital Erasme|Jacques Devière, MD, PhD|(32) 0-2-555-4697.|Jacques.Deviere@erasme.ulb.ac.be|
21238111|NCT05178121|University of Washington|Doyanne Darnell|206-744-9108|darnelld@uw.edu|
21301605|NCT04693767|Penumbra Inc.|Brooke Lawson|+15109952183|blawson@penumbrainc.com|
21301606|NCT05522153|Virtua Medical Group, PA|Sean McMillan|908-812-7542|smcmillan@virtua.org|
21301607|NCT01104311|Asan Medical Center, University of Ulsan|Sun U. Kwon, MD, PhD, Prof|82-2-3010-3960|sukwon@amc.seoul.kr|
21301608|NCT01864603|University of California, San Francisco|Tamara Clark|628-206-8790|Tamara.Clark@ucsf.edu|
21301609|NCT03848182|Montefiore Medical Center; 1695 Eastchester Road|Dr. Jennifer Chuy, Co-Investigator, Assistant Professor (Oncology)|718-405-8505|jchuy@montefiore.org|
21301610|NCT02914301|George Washington University School of Medicine & Health Sciences- Department of Emergency Medicine|Dr. Andrew C. Meltzer|202-741-2952|ameltzer@mfa.gwu.edu|
21301611|NCT02881567|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
21301612|NCT02950467|UCSF|Michelle Matvey|4152214810|michelle.matvey@ucsf.edu|24117
21301613|NCT00373113|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21301614|NCT03275350|Oregon Health & Science University|Dr. Todd Korthuis|503-494-8044|korthuis@ohsu.edu|
21301615|NCT02173509|University Aveiro|Teresa Herdeiro|+351234370200|teresaherdeiro@ua.pt|
21301616|NCT04661579|PATH|Christian F. Ockenhouse, MD, PhD|1 (206) 285-3500|cockenhouse@path.org|
21301617|NCT03656562|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21301618|NCT04335136|APEIRON Biologics AG|Dr. Romana Gugenberger|+4366488506236|romana.gugenberger@apeiron-biologics.com|
21301619|NCT01396447|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21301620|NCT01743859|University of Colorado|Dr. Daniel Pollyea||daniel.pollyea@ucdenver.edu|
21301621|NCT01402102|Clinical trial center for Functional Food in Chonbuk Nat'l University Hospital|Dr. Dal-Sik Kim|82-63-250-1793|dskim@chonbuk.ac.kr|
21301622|NCT00905645|Sientra|Chief Technology Officer|(805) 562-3500|denise.dajles@sientra.com|
21301623|NCT01056302|Department of Veterans Affairs|Dr. Rebeka Silva|415-221-4810|rebeka.silva@va.gov|22784
21301624|NCT04881942|Altria|Jeffery Edmiston, Functional Director Clinical Research|8043352366|Jeffery.S.Edmiston@altria.com|
21301625|NCT02423902|Alaunos Therapeutics|Jaymes Holland|6502732627|jholland@alaunos.com|
21301626|NCT02136069|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21301627|NCT04838626|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21301628|NCT00408200|University of Pennsylvania|Anthony Killian|215-615-5299|tony.killian@uphs.upenn.edu|
21301629|NCT03901469|Zenith Epigenetics|Zenith Study Team|587-390-7865|ZEN003694-004@zenithepigenetics.com|
21301630|NCT02586207|Sanford Health|Steven F. Powell, MD|605-328-8000|Steven.Powell@sanfordhealth.org|
21301631|NCT03048578|NYU Langone Health - Weight Management Program|Holly F. Lofton, MD|(212) 263-3166|Holly.Lofton@nyulangone.org|
21301632|NCT01409811|City of Hope|Carolyn Behrendt, Ph.D.|626-218-1148|cbehrendt@coh.org|
21301633|NCT01056016|Cincinnati Children's Hospital Medical Center|Jeff Epstein, Ph.D.|5136368296|jeff.epstein@cchmc.org|
21301634|NCT00441064|Novartis Pharmaceuticals|Study Director|862-778-8300||
21301635|NCT00953056|Merck Sharp and Dohme|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21301636|NCT01077076|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21301637|NCT02289157|UTSW Medical Center|Dr. Scott Roberts|214-648-3113|scott.roberts@utsouthwestern.edu|
21301638|NCT01388335|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21301639|NCT03210337|Aclaris Therapeutics|Executive Director, Clinical Operations|4843292144|jschnyder@aclaristx.com|
21301640|NCT01243580|Agile Therapeutics|Lisa Flood|609-683-1880|lflood@agiletherapeutics.com|
21301641|NCT01301027|University of Utah|Srinivansan Beddhu, M.D.|801-585-3810|srinivansan.beddhu@hsc.utah.edu|
21301642|NCT00845897|Washington University School of Medicine|Mary Hastings PT, DPT, ATC|314 286 1433|hastingsmk@wustl.edu|
21301643|NCT03111628|JohnsHopkinsU|Sarbjit S. Saini|410550-2129|ssaini@jhmi.edu|
21301644|NCT01620216|OHSU|Dr. Stephen Spurgeon|5034948950|spurgeos@ohsu.edu|
21301645|NCT03566485|Vanderbilt-Ingram Cancer Center|Teresa Melton|6159367423|teresa.melton@vumc.org|
21301646|NCT03610269|Masimo|Vikram Ramakanth|949-297-7416|clinicalresearchdept@masimo.com|
21301647|NCT01354314|The Johns Hopkins University|Dr. Ned Sacktor|410-550-1045|sacktor@jhmi.edu|
21301648|NCT00369265|Philadelphia ENT Associates|Robert T. Sataloff, M.D., D.M.A., FACS|215-545-3322|rtsataloff@phillyent.com|
21301649|NCT00714870|St. Elizabeth's Medical Center|Dr. Shirley Gonzalez|617-926-0114|shirleyg2008@gmail.com|
21301650|NCT05019521|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
21301651|NCT02721966|Novartis Pharma AG|Study Director|1-888-669-6682|novartis.email@novartis.com|
21301652|NCT01192191|GlaxoSmithKline|GSK Response Center|866-435-7343||
21301653|NCT00467753|UMDNJ|Sherie Novotny, MD|(732) @35-4119|novotnsl@rutgers.edu|
21301654|NCT01047553|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21301655|NCT02037230|University of Michigan Rogel Cancer Center|Theodore Lawrence, M.D., Ph.D.|734-647-9955|tsl@umich.edu|
21301656|NCT01072643|The Children's Hospital of Philadelphia|Dr. Aruna T. Nathan|215-590-1858|aruna.nathan@gmail.com|
21301657|NCT02817464|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
21301658|NCT03008369|Mayo Clinic|Ashish Vitthalrao Chintakuntlawar, MBBS, Ph.D.|5072930504|Chintakuntlawar.Ashish@mayo.edu|
21301659|NCT01273519|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21301660|NCT04292899|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21301661|NCT00948441|University of Pittsburgh|Judith M. Martin, MD|412-692-7028|judy.martin@chp.edu|
21301662|NCT01627288|Duke University Health System|Jennifer Mewshaw, MS RN|(919) 668-5211|Jennifer.Mewshaw@duke.edu|
21301663|NCT03532451|ECOG Stats Center|Xiangying Chu|3472770190|xchu@ds.dfci.harvard.edu|
21286535|NCT02067858|University of Pittsburgh|Karen Holeva|412-623-1275|holevakd@upmc.edu|
21258894|NCT01491178|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21258895|NCT05159596|University of California, Berkeley|Robert W. Levenson|510-643-8952|boblev@berkeley.edu|
21258896|NCT05689047|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21258897|NCT01604512|Memorial Sloan Kettering Cancer Center|Dr. Robert Young, MD|212-639-8196|youngr@mskcc.org|
21258898|NCT01415752|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21258899|NCT03286842|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21258900|NCT00252057|Boston Medical Center|Brian Jack PI|617-414-44675|brian.jack@bmc.org|
21258901|NCT03066102|National Yang Ming University|Dr. Yi-Fen Shih|+886-2-28267340|yfshih@ym.edu.tw|
21258902|NCT01496066|RxSight, Inc.|Maureen O'Connell Vice President, Regulator and Clinical Affairs|978-207-12415|moconnell@rxsight.com|
21258903|NCT02926209|GI View Ltd.|CEO, Dr. Tal Simchony|+97235753199|tal@giview.com|
21258904|NCT01587079|Pearl Therapeutics, Inc|Colin Resiner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
21258905|NCT01764633|Amgen Inc.|Study Director|866-572-6436||
21258906|NCT02268058|McMaster Children's Hospital|Dr. Tina Petrelli|905-521-2100|petrelli@hhsc.ca|75162
21258907|NCT01415427|BioMarin Pharmaceutical Inc.|Peter Slasor/Sr Director, Biostatistics, Global Clinical Sciences|415-506-6765|pslasor@bmrn.com|
21258908|NCT00328770|Liver Transplant Program, University of Alberta Hospitals|Dr. Norman Kneteman|780-407-6168|norm.kneteman@albertahealthservices.ca|
21258909|NCT04781816|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21258910|NCT00643994|Accuray, Inc.|Director of Clinical Affairs|608-824-3421|sgodbold@accuray.com|
21258911|NCT02123485|Department of Affective Disorder, Aarhus University Hospital, Denmark|Dr Poul Erik Buchholtz|21474299|Buchholtz.Hansen@ps.rm.dk|
21258912|NCT00883246|Medtronic|Clinical Program Manager|763-398-7000|michael.p.swierzewski@medtronic.com|
21258913|NCT02706730|Otonomy, Inc.|Otonomy Medical Information Center|1-844-686-4636|medinfo@otonomy.com|
21258914|NCT00794560|Pharmaceutical Care Research Group, University of Basle, Switzerland|Dr. Seraina Mengiardi|061 267 15 29|seraina.mengiardi@unibas.ch|0041
21258915|NCT02347176|MedImmune, LLC|Rene van der Merwe|301-398-4095|information.center@astrazeneca.com|
21258916|NCT01014741|Icahn School of Medicine at Mount Sinai|Dr. Vivek Reddy|212-241-7114|vivek.reddy@mountsinai.org|
21258917|NCT00411554|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21258918|NCT01891331|Viamet Pharmaceuticals Inc|Neil Moore||nmoore@viamet.com|
21258919|NCT01081795|Janssen Pharmaceutical KK Japan|Group Manager|+81-3-4411-5072||
21258920|NCT02462473|Janssen R&D US|DIRECTOR CLINICAL RESEARCH||ClinicalTrialDisclosure@its.jnj.com|
21258921|NCT01536860|RSSL|Rungano Munyuki|+44 118 918 4166|rungano.munyuki@rssl.com|
21258922|NCT03138876|Mayo Clinic|Dr. William O. Tatum|904-953-2498|tatum.william@mayo.edu|
21258923|NCT04600895|Appili Therapeutics Inc|Prasann Bavaniya, MS-BioTech|902-442-4655|pbavaniya@appilitherapeutics.com|5
21258924|NCT03506295|Vanderbilt University Medical Center|Dr. Fabien Maldonado|615-322-3412|fabien.maldonado@vumc.org|
21258925|NCT01543087|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21258926|NCT01665118|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
21258927|NCT04438174|University of Utah|Dr. Giavonni Lewis|801-581-3050|giavonni.lewis@hsc.utah.edu|
21258928|NCT04673786|CELLTRION, Inc.|Head of Clinical Planning|+82-32-850-4160|YunJu.Bae@celltrion.com|
21258929|NCT00143455|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21258930|NCT01298492|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21258931|NCT02902120|Institute of Human Virology, University of Maryland School of Medicine|Lydia Tang|410-706-6567|LydiaTang@ihv.umaryland.edu|
21258932|NCT04926779|Quality Research and Invention LLC|Zanetta Malanowska-Stega|6462718593|jstega@optonline.net|
21258933|NCT03298022|AltruBio|Vice President of Clinical Operations|17142150224|simona.reed@altrubio.com|
21258934|NCT03694925|Cleveland Clinic Arthroplasty Research Group|Alison Klika|4123017914|klikaa@ccf.org|
21258935|NCT01422239|Yale University School of Medicine|Andrea Weinberger, Ph.D.|203-974-7598|andrea.weinberger@yale.edu|
21258936|NCT03467958|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
21258937|NCT01687712|Fertility Biotech AG|Executive VP of Regulatory Affairs||maria.vazquez@fertilitybiotech.com|
21258938|NCT04520113|Johns Hopkins Bloomberg School of Public Health|Dr. Colleen Hanrahan|410-502-9289|chanrah1@jhu.edu|
21258939|NCT00516737|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21258940|NCT01844895|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21286536|NCT01959113|University of California, San Diego|Director of Clinical Trials Unit|858-657-8390|dermstudies@ucsd.edu|
21270997|NCT02451670|HealthPartnersInstitute|Rebecca Rossom|952-883-5466|Rebecca.C.Rossom@HealthPartners.com|
21270998|NCT01151813|UPenn|Dr. Jennifer Plebani|215-222-3200|jplebani@upenn.edu|152
21270999|NCT00521456|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
21271000|NCT01567371|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|Joseph.Tobias@nationwidechildrens.org|
21271001|NCT03549130|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21271002|NCT01078623|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
21271003|NCT00463866|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21271004|NCT00950183|OrthoCarolina|Dr. Robert B. Anderonson|704-323-2000|robert.anderson@orthocarolina.com|
21271005|NCT01084005|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21271006|NCT02883673|Alydia Health|Kathryn Wine, VP Clinical Operations|415-990-4104|kathryn@alydiahealth.com|
21271007|NCT03568500|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21271008|NCT02144259|University of Pennsylvania|Dr. Courtney Schreiber|215-615-5234|courtney.schreiber@uphs.upenn.edu|
21271009|NCT00943800|University of Chicago|Hongtao Liu|773-834-8980|hliu2@medicine.bsd.uchicago.edu|
21271010|NCT01768000|Centre for Addiction and Mental Health|Sean Kidd|416-535-8501|sean.kidd@camh.ca|36295
21271011|NCT00472446|Cantonal Hospital St. Gallen|Thomas Steffen, MD|0041 71 494 1111|thomas.steffen@kssg.ch|
21271012|NCT00910858|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21271013|NCT04169282|Duke University|Loretta Que, MD|919-681-8551|loretta.que@duke.edu|
21271014|NCT00631670|University of Florida, Dept. of Radiation Oncology|Bridget Fitzgerald, Clinical trials coordinator|352-265-0680|fitzgb@shands.ufl.edu|87829
21271015|NCT01165684|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21271016|NCT02008721|Department of Neurology, Ludwig-Maximilians-University Munich, Munich, Germany|Prof. Dr. Johannes Levin||johannes.levin@med.uni-munechen.de|
21271017|NCT01156571|The Medicines Company|Meredith Todd - Sr. Director Program Management|+1.973.290.6088|meredith.todd@themedco.com|
21271018|NCT01797120|PrECOG, LLC|Carolyn Andrews|267-207-4070|candrews@precogllc.org|
21271019|NCT03211156|University of Alabama at Birmingham|Jane Schwebke, MD|205-975-5665|schwebke@uab.edu|
21271020|NCT01095757|Winship Cancer Institute Emory University|Dr. Edmund Waller|404-727-4995|ewaller@emory.edu|
21271021|NCT00208949|Emory University|Dr. Sagar Lonial|404-778-1900|SLONI01@emory.edu|
21271022|NCT04120194|Novavax Inc|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
21271023|NCT02114931|Amgen Inc.|Study Director|866-572-6436||
21271024|NCT03565211|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
21271025|NCT00323609|Medtronic|John Tillman|408-548-6518|tillmj1@mspexcng.medtronic.com|
21271026|NCT00267293|Penn State Children's Hospital|Ian M Paul, MD, MSc|717-531-5656|ipaul@hmc.psu.edu|
21271027|NCT00125931|McLean Hospital|Beth Murphy, MD PhD|617-855-2297|BMurphy5@partners.org|
21271028|NCT00219557|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21271029|NCT01042496|Mayo Clinic|Dr. Mark A. Frye|507-284-6213|MFrye@mayo.edu|
21271030|NCT00676585|Beth Israel Deaconess Medical Center|Dr. Michael Donnino||mdonnino@bidmc.harvard.edu|
21271031|NCT01612156|University of Southern California|Begum Ozel, MD|323-441-9589|ozel@usc.edu|
21271032|NCT00410410|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21271033|NCT01023269|Medtronic International Trading Sarl|Alexandra Delacour, Clinical Research Manager|0041218027622|alexandra.delacour@medtronic.com|
21271034|NCT01953783|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21271035|NCT01789281|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
21271036|NCT00106028|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
21271037|NCT02296606|The University of Texas Southwestern Medical Center|DaiWai Olson|214-648-8946|Daiwai.Olson@UTSouthwestern.edu|
21271038|NCT00814658|Jan-Cil Brazil|Medical Group Manager|55 11 3030-2770||
21271039|NCT05267574|Reneo Pharmaceuticals, Inc.|Alex Dorenbaum, MD, Chief Medical Officer|(415) 328-9115|adorenbaum@reneopharma.com|
21271040|NCT01141283|Purdue Pharma LP|Clinical Leader, Medical Director|800-733-1333||
21271041|NCT04726514|Berendo Scientific, LLC|Eric Kezirian|4152358706|eric.kezirian@gmail.com|
21271042|NCT00545233|Hoffman-LaRoche|Medical Communications|800-821-8590||
21271043|NCT06371079|Basrah Medical College|Loay Abdulmutalib Almusawi|009647705559205|loay.almusawi@uobasrah.edu.iq|
21271044|NCT01238211|The Ohio State University|Guido Marcucci, M.D.||Guido.Marcucci@osumc.edu|
21271045|NCT00449930|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21271046|NCT02746705|NYU Langone Health|Leigh Charvet|929 455 5125|leigh.charvet@nyulangone.org|
21271047|NCT05288673|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|8557522356|clinicaltrials@alexion.com|
21271048|NCT01504867|Mayo Clinic|Dr. Daryl J. Kor|507-284-7678|Kor.Daryl@mayo.edu|
21271049|NCT00571922|NYU Langone Medical Center|The Office of Clinical Trials|212.263.4210|clinicaltrials@nyumc.org|
21271050|NCT01785186|Tropical Institute of the Ludwig-Maximilians University in Munich, Germany|Dr. Norbert Heinrich|0049 89 2180 17605|heinrich@lrz.uni-muenchen.de|
21271051|NCT03210259|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21271052|NCT02533999|Nemours Children's Specialty Care|Kathryn Blake, PharmD|904-697-3806|kathryn.blake@nemours.org|
21271053|NCT02163811|VA Puget Sound Health Care System|Dr. Aaron Turner|(206) 277-6134|Aaron.Turner@va.gov|
21271054|NCT01392859|Children's Mercy Hospital|Dr. Bridgette Jones|816-302-3811|bljones@cmh.edu|
21271055|NCT00345683|GlaxoSmithKline|GSK Response Center|866-435-7343||
21271056|NCT00492089|The University of Texas MD Anderson Cancer Center|Monica Loghin, MD / Assistant Professor|K Hunter, RN 713-745-5769|CR_Study_Registration@mdanderson.org|
21271057|NCT00990093|Coloplast|Kristine Gjødsbøl, PhD|+4549113557|dkkg@coloplast.com|
21238112|NCT01953003|Institut de Recherche Pierre Fabre, Toulouse France|Karim Keddad, Head of Medical Unit|+33.5.34.50.61.69|Karim.keddad@pierre-fabre.com|
21258941|NCT00848354|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21258942|NCT03790280|University of California, Los Angeles (UCLA)|Angela Martinez, Research Manager|310-206-7630|angelamartinez@mednet.ucla.edu|
21258943|NCT00512798|Vanderbilt-Ingram Cancer Center|Jeffrey Sosman, M.D.||jeff.sosman@vanderbilt.edu|
21258944|NCT00915343|Shire|Study Physician|1866-842-5335|clinicaltransparency@shire.com|
21258945|NCT00911989|Ethicon-Endo Surgery|Director of Clinical Operations|1.513.337.3079|SHelsing@its.jnj.com|
21258946|NCT03434977|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21258947|NCT03064841|Boehringer Ingelheim|Boehringer Ingelheim Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21258948|NCT01250379|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21258949|NCT01314716|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21258950|NCT00898560|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21258951|NCT01327157|Master-Pos graduação em Otorrinolaringologia|Dra Rosana de Queiroz Costa|55___11___98579-8799|rosanaqueiroz@msn.com|
21258952|NCT03087955|Drugs for Neglected Diseases|Sandra Rembry, PharmD|+41229077734|srembry@dndi.org|
21258953|NCT02192931|University of Utah|Danielle Boxer|801-587-1549|danielle.boxer@utah.edu|
21258954|NCT06523491|RCBIOFORM|Julia Melentyeva Commercial Director|84952237095|md@bioform.ru|
21258955|NCT03266016|Children's Hospital Los Angeles|Dr. Robinder Khemani, MD. Medical Staff/USC Faculty|3233612376|rkhemani@chla.usc.edu|
21258956|NCT03075085|University of Arkansas for Medical Sciences|Dr. Taren Swindle|870-236-0997|tswindle@uams.edu|
21258957|NCT00403260|Medicines for Malaria Venture|Stephan Duparc, MD|+41 22 555 0300|duparcs@mmv.org|
21258958|NCT02968810|Northwestern University|Dr. Seema A. Khan|312-503-4236|s-khan2@northwestern.edu|
21258959|NCT01535729|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21258960|NCT01294384|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21258961|NCT02944448|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
21258962|NCT04415073|Syndax Pharmaceuticals, Inc.|Kate Madigan, MD|+1-781-419-1400|kmadigan@syndax.com|
21258963|NCT00716976|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21258964|NCT02066792|Institute for Mental Health Research and Department of Psychology, The University of Texas at Austin|Dr. Jasper Smits|512-475-8095|smits@utexas.edu|
21258965|NCT00805740|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21258966|NCT03660878|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
21258967|NCT01282073|Kyungpook National University Hospital|Sun-Hee Park|+82532005547|sh-park@knu.ac.kr|
21258968|NCT04288570|UMissouri|Vicki L Jones|573-882-7583|jonesvicki@health.missouri.edu|
21258969|NCT05227690|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21258970|NCT04033367|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21258971|NCT01191697|Dana-Farber Cancer Institute|Peter C. Enzinger, MD|(877) 442-3342|peter_enzinger@dfci.harvard.edu|
21258972|NCT01534676|Columbia University Medical Center|Eldad Hod, MD|212-342-5648|eh2217@cumc.columbia.edu|
21258973|NCT02634580|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21258974|NCT01396005|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6327|ClinicalTrialsDisclosure@merck.com|
21258975|NCT02653768|Center to Accelerate Discovery and Practice Transformation, Durham VA|Kelli Allen, Associate Director|919-286-0411|kelli.allen@va.gov|177090
21258976|NCT03132636|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21258977|NCT03083886|Brigham and Women's Hospital|Niteesh Choudhry, MD, PhD|617-278-0930|nkchoudhry@bwh.harvard.edu|
21258978|NCT01391507|Janssen Research & Development, LLC|Associate Director Biostatistics||ClinicalTrialDisclosure@its.jnj.com|
21258979|NCT01453855|Alcon Research, Ltd.|Theresa A Landry, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
21258980|NCT04161495|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
21258981|NCT01562548|GlaxoSmithKline|GSK Response Center|866-435-7343||
21258982|NCT03655756|Morphogenesis, Inc|James Bianco, MD - Chief Executive Officer|8138756600|jbianco@morphogenesis-inc.com|104
21271058|NCT00281827|Masonic Cancer Center, University of Minnesota|Arkadiusz Dudek, M.D.|612-624-0123|dudek002@umn.edu|
21271059|NCT04147611|University of Miami|Dr. Hillary Snapp|305-243-4611|hsnapp@med.miami.edu|
21271060|NCT00530439|Odense University Hospital|Dr. Christina Vinter|+45 21782118|c.vinter@dadlnet.dk|
21271061|NCT04929522|AinShams University|Director of Clinical Trials in Endodontics|+2022639083|endohashem@gmail.com|
21271062|NCT04385199|Henry Ford Health System|Dr Geneva Tatem|313-916-2431|gtatem1@hfhs.org|
21271063|NCT00677924|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
21271064|NCT00928252|The Queen's Medical Center|Sandi Kwee, MD, PhD|8086915466|skwee@queens.org|
21271065|NCT02257632|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21271066|NCT02468557|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21271067|NCT04967313|Northwell Health|Joan Duer-Hefele, RN, MA|646-766-7153|jduerhefele@northwell.edu|
21271068|NCT03167099|West Virginia University|Dr. David Hubbard|304-293-3900|dhubbard@hsc.wvu.edu|
21271069|NCT03322462|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
21271070|NCT01393990|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21271071|NCT02060461|Cleveland Clinic|William J Dupps, Jr, MD, PhD|216-444-8396||
21271072|NCT05321810|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21271073|NCT01976390|Division of Transplant Surgery OSUMC|Director of Research Operations|614-293-8021|brenda.cuson@osumc.edu|
21271074|NCT00720798|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21271075|NCT04126057|SightGlass Vision, Inc.|Joe Rappon, OD, MS, FAAC|678-642-9117|joe@sightglassvision.com|
21271076|NCT02806232|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21271077|NCT00803959|New England Research Institutes|Heather Litman, PhD|617 972 3297|hlitman@neriscience.com|
21271078|NCT00434161|Swedish Orphan Biovitrum AB|Medical Director|+4686972000|clinical@sobi.com|
21271079|NCT01312779|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
21271080|NCT00506753|University of Rhode Island|Dr. Lynda Stein, Ph.D.|401-874-5562|lynda_stein@uri.edu|
21258983|NCT01340209|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21271081|NCT01706198|GlaxoSmithKline|GSK Response Center|866-435-7343||
21271082|NCT02415166|LaurateInstitute|Jonathan Savitz|918 502 5104|jsavitz@laureateinstitute.org|
21271083|NCT02480010|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21271084|NCT00606684|GlaxoSmithKline|GSK Response Center|866-435-7343||
21271085|NCT01809054|Sinai Center for Thrombosis Research|Kevin Bliden|4106014795|kbliden@lifebridgehealth.org|
21271086|NCT01759381|Duke|Carlos A. Bagley|919-943-1564|carlos.bagley@gmail.com|
21271087|NCT03377556|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
21271088|NCT00827827|Baltimore VAMC|Frederick M. Ivey|410-375-8419|fivey@grecc.umaryland.edu|
21271089|NCT00698022|Corcept_Therapeutics|Robert Roe, MD|650-688-8812|rroe@corcept.com|
21271090|NCT00621686|Mayo Clinic|Evanthia Galanis, M.D.|507/284-3559|Galanis.evanthia@mayo.edu|
21258984|NCT00253630|City of Hope|Paul Frankel, Ph.D.|626-359-8111|pfrankel@coh.org|65265
21258985|NCT00209339|Abbott Vascular|Jeffrey T Ellis||jeffrey.ellis@av.abbott.com|
21258986|NCT01239160|Tactile Medical|Director of Clinical Research|612-540-5267|astone@tactilemedical.com|
21258987|NCT02062658|Stanford University|Dr. Carolyn Rodriguez, Assistant Professor|6507236158|carolynrodriguez@stanford.edu|
21258988|NCT03545906|University of Rochester|Dr. Jill Halterman|5852755798|jill_halterman@urmc.rochester.edu|
21258989|NCT03423342|University of Washington|Dr. Kevin O'Brien, Study PI|206-529-7802|cardiac@uw.edu|
21258990|NCT01895127|Brigham and Women's Hospital|Anil Chandraker|617-732-7412|achandraker@bwh.harvard.edu|
21258991|NCT04016311|The University of Texas at Austin, School of Nursing|Gayle M. Timmerman PhD, Professor|5124719087|gtimmerman@mail.utexas.edu|
21258992|NCT01568606|Ahmanson-UCLA Cardiomyopathy Center|Tamara Horwich, MD, MS|310-825-8816|thorwich@mednet.ucla.edu|
21258993|NCT00584480|UCSF|Robert L. Hendren, D.O.|415-476-7198|Robert.Hendren@ucsf.edu|
21258994|NCT04029519|Prollenium Medical Technologies|Director Clinical Affairs|1-905-508-1469|, clinicaltrials@prolleniumus.com|
21258995|NCT01175902|Seoul St. Mary's Hospital|Chan Kee Park|82222586208|ckpark@catholic.ac.kr|
21258996|NCT03326141|University of Minnesota|Siobhan McMahon|612-625-3225|skmcmaho@umn.edu|
21258997|NCT00236977|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
21258998|NCT00939692|Gateway Medical Research, Inc.|Walter A Parham|(314) 663-4550||
21258999|NCT02161211|University of Minnesota|Matt Kushner, Ph.D.|612-625-7546|kushn001@umn.edu|
21259000|NCT01307930|TTUHSC|Ronald Hall|2143589009|ronald.hall@ttuhsc.edu|
21259001|NCT00430508|Daiichi Sankyo|James McCarthy / Director Regulatory Operations|732-590-3430|jmccarthy@dsus.com|
21259002|NCT01164722|AIDS Malignancy Consortium|Group Statistician|1-501-526-6712|jylee@uams.edu|
21271091|NCT00447603|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21271092|NCT01275313|University of Pittsburgh|David Brienza, Professor|412-624-6383|DBRIENZA@pitt.edu|
21271093|NCT03818737|Emory University|Kenneth Mautner, MD|404-778-7142|kmautne@emory.edu|
21271094|NCT00322309|BUPA CSU, Boston University School of Medicine|Maryam Afshar, MD|617-414-1990|maryam.afshar@bmc.org|
21259003|NCT03889639|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21259004|NCT01703858|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21271095|NCT01907737|HCFMUSP/FFM|Adriana Conforto|551126617955|adriana.conforto@gmail.com|
21271096|NCT03135379|Brooke Army Medical Center|Benjamin M. Krainin|210-916-0808|Benjamin.M.Krainin.mil@mail.mil|
21238113|NCT02512679|Children's Hospital Los Angeles|Neena Kapoor, M.D.|343-361-2434|nkapoor@chla.usc.edu|
21259005|NCT00993031|University of California, San Francisco|Diane V Havlir, MD|01-415-476-4082|dhavlir@php.ucsf.edu|400
21259006|NCT00465595|Johns Hopkins University School of Medicine|Roland R. Griffiths, Ph.D., Principal Investigator|4105500034|rgriff@jhmi.edu|
21259007|NCT01834729|Mayo Clinic|Dr. Adil E. Bharucha|507-284-2687|bharucha.adil@mayo.edu|
21259008|NCT03403192|Wake Forest Health Science|Benjamin Morris, MD|336.716.6533|bmorris@wakehealth.edu|
21259009|NCT01269710|The University of North Carolina at Chapel Hill|Linmarie Sikich, M.D.|(919) 972-7499|lsikich@med.unc.edu|
21259010|NCT02340663|University of Michigan|Dr. Geoffrey Gerstner|734-763-7717|geger@umich.edu|
21259011|NCT01353703|GlaxoSmithKline|GSK Response Center|866-435-7343||
21259012|NCT03033875|Emory University|Dr. Kenneth Hepburn|404-712-9286|khepbur@emory.edu|
21259013|NCT00281879|OHSU Knight Cancer Institute|Dr. Richard Maziarz|503-494-1551|maziarzr@ohsu.edu|
21259014|NCT03430921|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
21259015|NCT01928381|AstraZeneca Pharmaceuticals LP, Neuroscience Innovative Medicine Unit|Joel Posener, MD - Head Early Clinical Development||CinicalTrialTransparency@astrazeneca.net|
21259016|NCT03376477|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Syed Abbas Ali, MD- Assistant Professor- Division of Hematologic Malignancies|4432877104|sali35@jhmi.edu|
21259017|NCT04484285|University of Florida|Eric Porges, Associate Profressor|(352) 294-5838|eporges@ufl.edu|
21259018|NCT03196180|University of Arizona|Sherry Chow, PhD|520-626-3358|schow@azcc.arizona.edu|
21259019|NCT01227902|GlaxoSmithKline|GSK Response Center|866-435-7343||
21259020|NCT05280756|University of Pittsburgh Medical Center|Dr. Alexandre Paim Diaz|(412) 624-1000|paimdiaza@upmc.edu|
21259021|NCT00768898|Alcon Research, Ltd.|Alison Ramsey, O.D., Manager|817-551-6986|Alison.ramsey@alconlabs.com|
21259022|NCT01636466|Emory University|Dr. Ashtar Chami|404-712-7735|ashtar.chami@emory.edu|
21259023|NCT00542997|CSL Behring|Program Director, Clinical R&D|Use email contact|clinicaltrials@cslbehring.com|
21259024|NCT02388568|The University of Pennsylvania's Center for Weight and Eating Disorders|Dr. Jena Shaw Tronieri|215-746-5045|jena.tronieri@pennmedicine.upenn.edu|
21259025|NCT03160560|Center for Dental Research, Loma Linda University|Yiming Li, DDS, MSD, PhD, Professor and Associate Dean for Research|909-558-8069||
21259026|NCT02303431|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21259027|NCT01777763|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21259028|NCT01664793|University of Pittsburgh|Richard K. Zimmerman|412-383-2355|zimmer@pitt.edu|
21259029|NCT05036681|The University of Texas MD Anderson Cancer Center|Dr. Siqing Fu|(713) 792-4318|siqingfu@mdanderson.org|
21238114|NCT00553501|University of Vermont, Vermont Cancer Center|Barbara Grant, MD||barbara.grant@vtmednet.org|
21286537|NCT01699750|Alcon Research, Ltd.|Jessie Lemp, DrPH|1-888-451-3937|alcon.medinfo@alcon.com|
21286538|NCT01484951|Alcon Global Medical Affairs|Abayomi Ogundele, Pharm.D|1-888-451-3937||
21259030|NCT00898222|Brigham and Women's Hospital|Dr. Shamsah Kazani|617-732-8201|skazani@partners.org|
21259031|NCT02787850|Zeltiq Aesthetics|Kerrie Jiang, Sr. Director of Clinical, Regulatory and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
21259032|NCT03718143|NYU Langone Health - PCC CTO|Rachael Keller, Sr. Regulatory Specialist|929-455-2453|Rachael.Keller@nyulangone.org|
21259033|NCT03905863|Serena Group Inc|Dr Thomas Serena|671-945-5225|serena@serenagroups.com|
21259034|NCT01072344|Memorial Sloan Kettering Cancer Center|Dr. Jun Mao|646-888-0866|maoj@mskcc.org|
21259035|NCT00847587|UUtah|Kirtly Parker Jones|801-581-3834|kirtly.jones@hsc.utah.edu|
21259036|NCT02723201|Medical Director|Takeda|+1-877-825-3327|trialdisclosures@takeda.com|
21259037|NCT03472560|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21259038|NCT04669678|University of Alabama at Birmingham|Rena C Patel|2059348145|renapatel@uabmc.edu|
21259039|NCT00540579|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21259040|NCT02908880|Essential Medical, Inc.|Sam Nardone|6105571009|sam@essmedclosure.com|
21259041|NCT00424827|Universiy of MA Medical School|Bilal Piperdi, MD|508-426-0442|UMMScommunications@umassmed.edu|
21259042|NCT02170662|Duke University Medical Center|Dr. Elise Olsen|919-668-5613|elise.olsen@dm.duke.edu|
21259043|NCT02397473|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21259044|NCT00491179|National Taiwan University Hospital|Chen-Hua Liu|886223123456|jacque_liu@mail2000.com.tw|63572
21259045|NCT02298933|National Heart Lung and Blood Institute|Aue, Georg|+1 301 451 7141|aueg@nhlbi.nih.gov|
21259046|NCT01087541|Jordi Gol i Gurina Foundation|Cecilia Borau|34 934824617|cborau@idiapjgol.org|
21259047|NCT02009878|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21259048|NCT01583894|Boston Scientific Corporation|Nitzan Mekel-Bobrov, Director of Scientific Communications|6619494537|nitzan.mekel-bobrov@bsci.com|
21259049|NCT01790048|Washington University School of Medicine in St. Louis|Dr. Mark Manary|314 454 2178|manarymj@wustl.edu|
21259050|NCT00584233|University of California Davis|Dr. John Boone|(916) 849-3580|jmboone@ucdavis.edu|
21259051|NCT02261727|The George Institute for Global Health|Prof Christine Jenkins|+61280524300|christine.jenkins@sydney.edu.au|
21259052|NCT03178487|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21259053|NCT00857727|Mount Sinai St. Luke's|Dr. Jinu Kim|212-523-6121|JiKim@chpnet.org|
21259054|NCT01445028|MidAtlantic Retina|Richard Kaiser, MD|215-928-3092|research@midatlanticretina.com|
21259055|NCT01262846|University of Pennsylvania|Pablo Tebas|215-6626932|pablo.tebas@uphs.upenn.edu|
21259056|NCT01285908|National Institute of Neurological Disorders & Stroke|Dr. David S. Goldstein||david.goldstein1@nih.gov|
21259057|NCT03529773|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21259058|NCT06219577|Scripps Optometric Group|Dr Jay Mashouf|18585302800|jaymashouf@gmail.com|
21259059|NCT03237065|Pharmacosmos A/S|Clinical trial disclosure desk|+45 5948 5935|trial@pharmacosmos.com|
21259060|NCT00429858|University of California, San Francisco|Dr. Andrew Ko, MD|(415) 353-7286|Andrew.Ko@ucsf.edu|
21259061|NCT03005054|Mallinckrodt|Medical Information Call Center|800-844-2830|clinicaltrials@mnk.com|5
21259062|NCT01537211|Rehabilitation Institute of Chicago|Arun Jayaraman, PT, PhD; Director of Max Nader Lab for Rehabilitation Technologies and Outcomes|3122386875|ajayaraman@ricres.org|
21259063|NCT02475655|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21259064|NCT01877564|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|BScanlan@uams.edu|
21259065|NCT00353418|Hoffmann-La Roche|Medical Communications|800-821-8590||
21259066|NCT00257010|Janssen-Ortho LLC|Vice President, Medical Affairs||ClinicalTrialDisclosure@its.jnj.com|
21259067|NCT00662792|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21259068|NCT02582957|University of Colorado|Dr. Richard Albert|303-602-5011|RICHARD.ALBERT@cuanschutz.edu|
21259069|NCT02474082|Novartis Pharmaceuticals|Study Director|862 -778- 8300||
21259070|NCT03452371|Boston Medical Center/ Boston University Schools of Medicine and Public Health|Karen Lasser|617-414-6688|karen.lasser@bmc.org|
21259071|NCT01463098|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
21259072|NCT04317274|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.havard.edu|
21259073|NCT00699907|University of Arizona|Dr. Setsuko K. Chambers|520-626-0950|schamber@uacc.arizona.edu|
21259074|NCT04409873|University of California San Francisco|Dr. Stuart A. Gansky and Dr. Sepideh Banava|415-502-8094; 415-630-0094|stuart.gansky@ucsf.edu ; sepideh.banava@ucsf.edu|
21259075|NCT01675960|Children's of Minnesota|Scott Schwantes|(612)813-7888|sschwantes@gillettechildrens.com|
21259076|NCT04173429|Qilu Hospital of Shandong University|Professor Gao Yanjing|18560086087|gaoyanjing@sdu.edu.cn|
21259077|NCT06488157|Weill Cornell Medicine|Dr. Veerawat Phongtankuel|212-746-7000|vep9012@med.cornell.edu|
21259078|NCT01459705|DCoE|Gregory A. Gahm, PhD|253-320-5772|gregory.a.gahm.civ@mail.mil|
21259079|NCT03365778|Wills Eye Hospital|Clinical Research Coordinator|215-928-3213|jtran@willseye.org|
21259080|NCT03650192|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
21271097|NCT00330421|Dana-Farber Cancer Institute|Jeffrey A. Morgan, M.D.|617-632-5204|jamorgan@partners.org|
21271098|NCT04549259|Center for AIDS Intervention Research, Medical College of Wisconsin|Dr. Jennifer Walsh and Dr. Andrew Petroll|414-955-7710|jwalsh@mcw.edu|
21271099|NCT00608205|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. David Adelstein|216-444-9310|adelstd@ccf.org|
21271100|NCT01003886|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21271101|NCT04634110|University of Colorado Hospital|Dr. Chad Rusthoven|720-516-0150|chad.rusthoven@cuanschutz.edu|
21271102|NCT00992264|Group Health Research Institute|Jennifer McClure|206-287-2737|mcclure.j@ghc.org|
21271103|NCT00909727|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com|
21271104|NCT01136226|Chesapeake Urology Research Associates|Heather Thomas, Administrator|443.471.5742|hthomas@cua.md|
21271105|NCT01578707|Pharmacyclics, LLC|Anita Szoke|(669) 215-7235|aszoke@pcyc.com|
21271106|NCT02145403|University of Michigan Rogel Cancer Center|Attaphol Pawarode, M.D.|734-936-8785|pawarode@med.umich.edu|
21271107|NCT03124797|Masimo|Tala Harake||studies@masimo.com|
21271108|NCT02662608|The University of Texas (UT) MD Anderson Cancer Center|Dr. Renata Ferrarotto, Asst Professor/Thoracic/Head & Neck Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
21271109|NCT03596918|AMC Statistical and Data Analysis Center|Dr. Jeannette Y. Lee|(501) 526-6712|jylee@uams.edu|
21271110|NCT00475852|Johnson & Johnson Pharmaceutical Research & Development, LLC|Vice President, Franchise Development|610-651-6628||
21271111|NCT02063698|Mayo Clinic|Aminah Jatoi, MD|(507) 284-7202|Jatoi.Aminah@mayo.edu|
21271112|NCT01684722|University of Washington|Ian de Boer, MD, MS|2066165403|deboer@u.washington.edu|
21271113|NCT01664494|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21271114|NCT01172353|Hospital Sao Lucas|Vitor Osório Gomes, MD, PhD|55 51 33203494|pesquisa@cardiarte.com.br|
21271115|NCT02974114|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21271116|NCT03654898|Baylor College of Medicine Childrens Foundation Malawi|Maria Kim|+26599869090|mkim@tingathe.org|
21271117|NCT00973856|Cleveland Clinic Akron General|Eliot Mostow, MD||emostow@akronderm.com|
21271118|NCT00479401|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21271119|NCT02124746|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21271120|NCT01712230|University of Colorado Anschutz Medical Campus|Wendy Kohrt, PhD|303-724-1913|Wendy.Kohrt@CUAnschutz.edu|
21271121|NCT01741480|WashingtonU|Dr. Marin Kollef|314-454-8764|mkollef@dom.wustl.edu|
21271122|NCT03634488|Vanderbilt UniversityVanderbilt-Meharry Center of Excellence in Sickle Cell Disease|Leshana Saint Jean|6158751992|leshana.saint.jean@vumc.org|
21271123|NCT03182686|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
21271124|NCT01154127|Novartis Pharmaceuticals|Study Director|862-778-8300||
21271125|NCT00863369|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
21271126|NCT01697449|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21271127|NCT01169844|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|Novartis.email@novartis.com|
21271128|NCT01565382|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
21271129|NCT00529568|GlaxoSmithKline|GSK Response Center|866-435-7343||
21271130|NCT04049552|UT Health San Antonio|Dean L Kellogg Jr.|210-617-5311|kelloggd@uthscsa.edu|
21271131|NCT03360656|CoolTech|Director of Clinical Operations|2036856352|channan@cooltechcorp.com|
21271132|NCT00738920|University at Buffalo, SUNY|Dr. Jeffrey Lackner|716-898-5671|lackner@buffalo.edu|
21271133|NCT03821324|Venus Concept|Director of Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
21271134|NCT00740727|Massachusetts General Hospital|Stephen H. Thomas MD MPH|6177267622|stephen-thomas@ouhsc.edu|
21259081|NCT04116112|University of Cincinnati|Dr. Eva A. Mistry|513-558-1291|mistryea@ucmail.uc.edu|
21259082|NCT03726164|University College London|Prof Derek Hausenloy|+6584053767|d.hausenloy@ucl.ac.uk|
21259083|NCT02286947|Sarepta Therapeutics, Inc.|Medical Director|+1-888-727-3782|clinicaltrials@sarepta.com|
21259084|NCT01145066|Wake Forest University Health Sciences|Dr. Michael Seeds|3367169811|mseeds@wakehealth.edu|
21259085|NCT03920670|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|Renew.J@mayo.edu|
21259086|NCT03436615|Novan|Cathy White, Vice President, Drug Development Operations|9194858080|clinical@novan.com|
21259087|NCT00573794|AbbVie|Global Medical Services|800-633-9110||
21259088|NCT02270242|Icahn School of Medicine at Mount Sinai|Dr. Roxana Mehran|212-659-9691|roxana.mehran@mountsinai.org|
21259089|NCT01984268|Dartmouth-Hitchcock Medical Center|Director, Office of Research Operations|(603) 650-6340|Barbara.A.Moskalenko@hitchcock.org|
21259090|NCT00939198|George Washington University|Dr. David Diemert|2029942909|ddiemert@gwu.edu|
21259091|NCT02527707|Eiger BioPharmaceuticals, Inc.|SVP Clinical Development|1-650-272-6138|info@eigerbio.com|
21259092|NCT01641939|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21259093|NCT00741156|The Hospital for Sick Children|Dr. Kyong-Jin Lee|416-813-7326|kyong-jin.lee@sickkids.ca|
21259094|NCT01815229|Washington University School of Medicine|Dr. Carlos Puyo|314-747-1709|cpuyo@wustl.edu|
21259095|NCT03037281|University of Leicester|Dr Christopher Hebbes|0116 252 2522|christopher.hebbes@le.ac.uk|
21259096|NCT01029730|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21259097|NCT00975156|Mischer Neuroscience Institute, Memorial Hermann-TMC|Elizabeth Noser||elizabeth.noser@memorialhermann.org|
21259098|NCT05499559|Arthro Therapeutics/Joint Academy|Study Director|+46708971677|leif@jointacademy.com|
21259099|NCT05022641|University of Michigan|Dr. Paul Gauger|734-936-0231|pgauger@med.umich.edu|
21271135|NCT02720952|Diurnal Limited|Dr John Porter||info@diurnal.co.uk|
21271136|NCT00331630|Northwestern University|Virginia Kaklamani|312-695-1301||
21271137|NCT00433381|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
21271138|NCT01133821|University of Pittsburgh School of Medicine|Holly A. Swartz M.D.|412-246-5588|swartzha@upmc.edu|
21271139|NCT03342898|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21271140|NCT01387282|Helsinn Therapeutics (US), Inc.|Richard K. Bourne, Ph.D.|732-603-2852|richard.bourne@helsinn.com|
21271141|NCT02661126|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21271142|NCT03997448|Hoosier Cancer Research Network|Clinical Data Analyst|3179212050|amajumdar@hoosiercancer.org|
21271143|NCT01621490|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21271144|NCT00461500|GlaxoSmithKline|GSK Response Center|866-435-7343||
21271145|NCT01513551|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21301664|NCT02527421|Prosoft Clinical|Robert Babilon President|484 320 2068|b.babilon@prosoftclinical.com|
21271146|NCT02057952|Regenstried Institute|Daniel O. Clark, PhD|317-274-9292|daniclar@iu.edu|
21301665|NCT04200352|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
21301666|NCT02541604|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21301667|NCT00828204|Biogen Idec Inc.|Biogen Idec Medical Director||clinicaltrials@biogenidec.com|
21301668|NCT05220436|South London & Maudsley NHS Foundation Trust|Dr Emilie Bourke|07702686322|emilie.bourke@slam.nhs.uk|
21301669|NCT02840461|Teva Pharmaceuticals Inc. USA|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
21301670|NCT05307965|John Radcliffe Hospital|Giovanni Luigi De Maria|+441865228364|GiovanniLuigi.DeMaria@ouh.nhs.uk|
21301671|NCT04672655|Stanford University|Molly Tanenbaum, PhD|(650) 725-3955|mollyt@stanford.edu|
21301672|NCT03217071|University of California, San Francisco|Dr. Sue Yom, MD, PhD|(415) 353-9893|Sue.Yom@ucsf.edu|
21301673|NCT00427765|UT MD Anderson Cancer Center|Partow Kebriaei, MD/Associate Professor||celsaenz@mdanderson.org|
21301674|NCT00560352|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21301675|NCT00487461|University of Illinois at Chicago|Ali Alaraj, MD|312-996-4842|alaraj@uic.edu|
21301676|NCT03892967|Mayo Clinic|Andrea L. Cheville, MD|507-284-1402|Cheville.Andrea@mayo.edu|
21301677|NCT04434937|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21301678|NCT03079102|Baylor College of Medicine|Cameron Dezfulian|832-826-6210|cameron.dezfulian@bcm.edu|
21301679|NCT02923921|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21301680|NCT00479687|Bioventus LLC|Regulatory and Clinical Affairs|18003964325|CT.gov@bioventusglobal.com|
21301681|NCT01474239|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21301682|NCT01264705|UT Southwestern Medical Center|Adam Yopp, MD|214-648-5870|adam.yopp@utsouthwestern.edu|
21301683|NCT00854113|Theracos|Yuan-Di Halvorsen|617-726-4236|yhalvorsen@ccib.mgh.harvard.edu|
21301684|NCT02082119|Humanitas Cancer Center|Dr. Marta Scorsetti|+390282248524|marta.scorsetti@hunimed.eu|
21301685|NCT00796419|Emory University|Greg Martin, MD, MSc|404-616-0148|greg.martin@emory.edu|
21301686|NCT00539864|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
21301687|NCT01250145|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21301688|NCT04683887|Azienda Unità Sanitaria Locale di Piacenza|Massimo Guasconi|+39-0523-303853|m.guasconi2@ausl.pc.it|
21301689|NCT02840799|University of Pennsylvania|Hannah Maynard|215-662-7580|hannah.maynard@pennmedicine.upenn.edu|
21301690|NCT02642315|University of Missouri Columbia|Pradeep Sahota MD|573-882-6402|sahotap@missouri.edu|
21301691|NCT01760785|Denver Research Institute|Dr. Thomas Beresford|303-399-8020|thomas.beresford@ucdenver.edu|3732
21301692|NCT02687191|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21301693|NCT00943072|Regeneron Pharmaceuticals|Clinical Trials Administrator|914 847 5385|clinicaltrials@regeneron.com|
21301694|NCT01349049|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
21301695|NCT01170533|University of Florida-Jacksonville|Dominick J. Angiolillo, MD, PhD|904-244-3933|dominick.angiolillo@jax.ufl.edu|
21301696|NCT01675544|Creighton University School of Medicine|Dr. Venkata M. Alla|(402) 280-4292|venkataalla@creighton.edu|
21301697|NCT00505778|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
21301698|NCT04857320|LANGFORD RESEARCH INSTITUTE|Managing Director|5614296429|KKirby@Langfordresearch.org|150
21301699|NCT03790696|Washington University School of Medicine|Jennifer Harper / Clinical Research Coordinator|314-286-2697|jenniferharper@wustl.edu|
21301700|NCT04216264|Duke University|Dr. Charles Wood|919-620-4772|charles.wood@duke.edu|
21301701|NCT00243269|University of Rochester|Joseph Roscoe PhD|585 275-9962|joseph_roscoe@urmc.rochester.edu|
21301702|NCT03291964|Oregon Health and Science university|David Sheridan Assistant Prof|5034941691|sheridda@ohsu.edu|
21301703|NCT02936648|Department of Veterans Affairs, CHOIR and BridgeQUERI|Vera Yakovchenko|781.687.3374|vera.yakovchenko@va.gov|
21301704|NCT00485134|US Army Medical Materiel Development Activity (USAMMDA)|Division of Regulated Activies and Compliance|301-619-0317|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil|
21301705|NCT00970684|Case Comprehensive Cancer Center|Nathan Pennell MD|216-445-9285|penneln@ccf.org|
21301706|NCT01175083|GlaxoSmithKline|GSK Response Center|866-435-7343||
21301707|NCT00481091|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21301708|NCT04294680|Campbell Clinic|Principal Investigator|9017595522|tbrolin@campbellclinic.com|
21301709|NCT03565328|National Heart Lung and Blood Institute (NHLBI)|Michael Sack, M.D. Principal Investigator, NIH, NHLBI|301.402.9259|sackm@nhlbi.nih.gov|
21271147|NCT01806597|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21271148|NCT02917447|VA Puget Sound Health Care System|Keren Lehavot, PhD|206-277-1511|keren.lehavot@va.gov|
21271149|NCT03081767|Stanford University|Andrei Iagaru|6507254711|aiagaru@stanford.edu|
21271150|NCT05569148|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21271151|NCT01267266|University of Chicago|Walter M. Stadler|773-702-4150|wstadler@medicine.bsd.uchicago.edu|
21271152|NCT02149303|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
21271153|NCT01335477|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21271154|NCT02275923|Medtronic|Jennifer Seamans, Principal Clinical Research Specialist|7635262835|jennifer.l.seamans@medtronic.com|
21271155|NCT02038634|Medical College of Wisconsin|Karen Gonzalez|414-955-3221|kgonzalez@mcw.edu|
21271156|NCT04160078|Emory University|Dayna Johnson, PhD, MPH, MSW, MS|404-727-8708|dayna.johnson@emory.edu|
21271157|NCT00549198|GlaxoSmithKline|GSK Response Center|866-435-7343||
21271158|NCT03220230|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21271159|NCT01473758|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
21271160|NCT04229303|Zambon SpA|Arnd Mueller, MD|+39 02 665241|clinicaltrials@zambongroup.com|
21271161|NCT01764854|Ardelyx, Inc.|Chief Development Officer|617 513-4929|drosenbaum@ardelyx.com|
21271162|NCT03263195|Department of Pediatrics Ribeirão Preto Medical School|Dr. Marisa Mussi-Pinhata|55-16-3602-2807|mmmpinha@fmrp.usp.br|
21271163|NCT00901628|Joint Reconstruction Center, Seoul National University Bundang Hospital|Tae Kyun Kim|82-31-787-7196|osktk@snubh.org|
21271164|NCT01630200|Ludwig Boltzmann Institute for COPD and Respiratory Epidemiology|Dr. Matthias Urban|+43(0)6508125980|matthias.urban1@gmx.net|
21271165|NCT05751629|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21271166|NCT01909466|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21271167|NCT02231710|Bellicum Pharmaceuticals|Rivogenlecleucel Study Team|(832) 384-1100|clinicaltrials@bellicum.com|
21271168|NCT01339910|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
21271169|NCT00287287|University of Kentucky|Kenneth Ain|8593236652|kenneth.ain@uky.edu|
21271170|NCT00671671|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21271171|NCT02491788|Stanford University|Dr. Jamie Zeitzer|16504935000|jzeitzer@stanford.edu|
21271172|NCT00772577|Novartis Pharmaceuticals|Study Director|862-778-8300||
21271173|NCT02965820|Alcon, A Novartis Division|Head, CDMA Vision Care Franchise|1-888-451-3937|alcon.medinfo@alcon.com|
21271174|NCT01567306|Roxall Medicina España S.A.|Dr. M Cruz Gómez project manager of Roxall Medicina España S.A.|+34 944438000|maricruz.gomez@roxall.es|
21271175|NCT01684566|Camurus AB|Håkan Olsson DDS, PhD|+46 46 2863852|Hakan.Olsson@camurus.com|
21271176|NCT00673361|Duke University Medical Center|Michael A Morse, M.D.|919-681-3480|morse004@mc.duke.edu|
21271177|NCT00829413|Bracco Diagnostics Inc.|Maria Luigia Storto, MD Executive Director X-Ray and Ultrasound Medical Affairs|(609) 514-2200|MariaLuigia.Storto@diag.bracco.com|
21259100|NCT03881007|Institute of Tropical Medicine Antwerp|Dr. Chris Kenyon|+32(0)32470786|ckenyon@itg.be|
21259101|NCT02971202|Vanderbilt University Medical Center|Justin M. Gregory MD MSCI|615-875-9669|justin.m.gregory.1@vumc.org|
21259102|NCT01946178|Mirabilis Medica, Inc.|Director of Clinical Affairs|425-486-8230|patrick@mirabilismedica.com|
21259103|NCT03521505|Chang-Gung Memorial Hospital|Dr Ting-Yu Lin|886 3281200|yuebaoyuebao@gmail.com|8467
21259104|NCT03193398|BlackThorn Therapeutics, Inc.|Jane Tiller, MD; Study Director|(415) 548-5313|jane.tiller@blackthornrx.com|
21259105|NCT01001702|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affair|800 562-3974||
21259106|NCT02494596|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21259107|NCT02222714|Cedars-Sinai Medical Center|Patrick Lyden, MD, FAAN, FAHA|(310) 423-5166|Patrick.Lyden@cshs.org|
21259108|NCT00159432|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist|323-226-6384|victoria.soto@med.usc.edu|
21259109|NCT01970176|Mayo Clinic|Horng H. Chen, M.D.|507-284-8896|chen.horng@mayo.edu|
21259110|NCT03470129|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
21259111|NCT04537208|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21259112|NCT02263833|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21259113|NCT00704964|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21259114|NCT00653861|Allergan Medical|Therapeutic Area Head|(805) 961-5500|devicetrials@allergan.com|
21259115|NCT02161562|Novartis Pharmaceuticals|Study Director|862-778-8300||
21259116|NCT01394705|Boston Children's Hospial|Tracy Curran|617355-5445|tracy.curran@cardio.chboston.org|
21259117|NCT02450578|Medicines for Malaria Venture|Jörg Möhrle|+41 22 555 0330|moehrlej@mmv.org|
21259118|NCT02272686|UT MD Anderson Cancer Center|Issa F. Khouri, MD, Professor, Stem Cell Transplantation|713-745-0049|ikhouri@mdanderson.org|
21259119|NCT00090545|National Cancer Institute, National Institues of Health|William Dahut, M.D.|301-435-8183|dahutw@mail.nih.gov|
21259120|NCT01420146|Institut Jules Bordet|Dr Géraldine Gebhart|025413095|geraldine.gebhart@bordet.be|+32
21259121|NCT00523991|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21259122|NCT00363038|Northwestern University Department of Dermatology|Murad Alam, MD|312-695-6785|m-alam@northwestern.edu|
21271178|NCT04272775|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21271179|NCT00981253|Duke Health|Dr. James A. Blumenthal|919-684-3828|james.blumenthal@duke.edu|
21271180|NCT00004143|Duke University Medical Center|Mitchell Horwitz, MD|919-668-1045|Mitchell.Horwitz@duke.edu|
21286539|NCT02452047|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21286540|NCT00917124|University Hospital Center Zagreb|Zeljko Colak|00385915624189|zcolak2000@yahoo.com|
21286541|NCT00723827|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21286542|NCT05439421|Wake Forest University Health Sciences|Erin L. Sutfin, PhD|336.713.5282|esutfin@wakehealth.edu|
21286543|NCT03760224|University of Hong Kong|Dr. Derek Cheung|39176652|derekcheung@hku.hk|
21286544|NCT03933449|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21286545|NCT02087774|Marshall University|Rebecca Hayes, M.D.|3046173570|hayes79@live.marshall.edu|
21286546|NCT01529606|UTHSC|Professor|901-448-2369|lhong2@uthsc.edu|
21286547|NCT04585919|Harvard TH Chan School of Public Health|James Daly|617-384-8915|jdaly@hsph.harvard.edu|
21286548|NCT05209880|Brigham and Women's Hospital|Kei Ouchi, MD, MPH|6175257771|kouchi@bwh.harvard.edu|
21286549|NCT03675360|Tulane University School of Public Health and Tropical Medicine|Dr. Kirsten Dorans, Assistant Professor, Department of Epidemiology|15049880883|kdorans@tulane.edu|
21286550|NCT03143101|MedImmune, LLC|Raburn Mallory|+1-301-398-5799|information.center@astrazeneca.com|
21286551|NCT02541864|Kaohsiung Veterans General Hospital|Dr. Feng-Woei Tsay|+886-7-3422121|fwchaie@vghks.gov.tw|8233
21286552|NCT01601496|Getinge Group|Elizabeth Bulger|603 880 1433 ext 5368|Elizabeth.Bulger@getinge.com|
21286553|NCT02689804|Columbia University|Carolyn L. Westhoff, MD|212-305-4805|clw3@columbia.edu|
21286554|NCT02782741|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21286555|NCT04157088|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21286556|NCT02421419|Penn State Milton S. Hershey Medical Center|Kenneth Taylor, M.D.|(717) 531-5638|ktaylor2@pennstatehealth.psu.edu|
21286557|NCT00726180|Universtiy of Michigan|Anne F. Schott, MD|734-936-6000|aschott@umich.edu|
21286558|NCT01676701|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21286559|NCT04863872|Kaiser Permanente Washington Health Research Institute|James Ralston, MD, MPH|206-287-2076|James.D.Ralston@kp.org|
21286560|NCT01497067|Alcon Research|Sr. Clinical Trial Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21286561|NCT05117112|UAMS|David Church|5015265769|dchurch@uams.edu|
21286562|NCT04058028|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21286563|NCT02227784|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21286565|NCT00102596|NINDS/NIH|Mark Hallett, M.D.|301-496-9526|hallettm@ninds.nih.gov|
21286566|NCT02108977|Health Services Research & Development, Durham VAMC|Dr. Santanu Datta, Health Sciences Research Specialist, HSR&D|(919) 286-0411|Santanu.Datta@va.gov|7580
21286567|NCT00248651|Mayo Clinic|Dr. Yuri A. Saito Loftus|507-266-9094|saito.yuri@mayo.edu|
21286568|NCT01275144|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21286569|NCT00828113|University of Wisconsin School of Medicine and Public Health|Douglas E. Jorenby, Ph.D.|6082627527|dej@ctri.medicine.wisc.edu|
21286570|NCT01365130|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org|
21286571|NCT05607576|Cincinnati Children's Hospital Medical Center|Deborah Elder; Associate Professor|5136364744|Deborah.Elder@cchmc.org|
21286572|NCT05116202|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21286573|NCT05067972|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21286574|NCT04786691|University of Arkansas for Medical Sciences|Jessica Yeh|(501) 686-6114|jyeh@uams.edu|
21286575|NCT04888494|Northwestern University|A. Vania Apkarian|+1 312 503 0404|a-apkarian@northwestern.edu|
21286576|NCT01900847|University of Arizona|Jaiva Larsen|5039396612|jlarsen@aemrc.arizona.edu|
21286577|NCT02002871|Philips GmbH Innovative Technologies Aachen|Prof. Dr. Matthias Born|+491735321764|matthias.born@philips.com|
21286578|NCT04940156|Oxford University Hospitals NHS Trust|Dr Richard Varini|01865220256|richard.varini@ouh.nhs.uk|
21286579|NCT02357459|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
21286580|NCT03246347|Wake Forest|Danielle Boselli|2017903385|danielle.boselli@atriumhealth.edu|
21286581|NCT02188160|Kala Pharmaceuticals, Inc.|VP, Clinical Development|781-996-5252|results002@kalarx.com|
21286582|NCT04113694|Medtronic Diabetes|Emma Pham, MSHS (Clinical Study Manager)|818 576 4878|emma.pham@medtronic.com|
21286583|NCT00464685|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21286584|NCT00916578|UT MD Anderson Cancer Center|Woodward,Wendy,M.D., PH.D.|713-792-7734|CR_Study_Registration@mdanderson.org|
21286585|NCT04350593|Saint Luke's Hospital of Kansas City|DARE-19 Global Project Manager|816-932-9858|DARE-19@saint-lukes.org|
21286586|NCT03163446|ContraFect|Medical Director|914-207-2300|clinicalstudies@contrafect.com|
21286587|NCT01094288|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21286588|NCT02611882|University of California, San Francisco|Dr. Thomas Hope, MD|(415) 221-4810|Thomas.Hope@ucsf.edu|2264
21286589|NCT01228591|Johnson & Johnson Vision Care|Brian Pall, O.D., M.S., F.A.A.O. Principal Research Optometrist|1 904 443-1290|bpall@its.jnj.com|
21286590|NCT01389232|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21286591|NCT01317940|Children's Hospital Los Angeles|Dr. Etan Orgel|3233612672|eorgel@chla.usc.edu|
21286592|NCT04678284|Hennepin Healthcare|Dr. Katherine Diaz Vickery|612-873-6852|katherine.vickery@hcmed.org|
21286593|NCT02371616|GlaxoSmithKline|GSK Response Center|866-435-7343||
21286594|NCT02576899|VISN 1 MIRECC|Megan M. Kelly, Ph.D.|781-687-3317|Megan.Kelly1@va.gov|
21286595|NCT02699996|Rutgers Cancer Inst. of NJ|Dr. Katie Devine|7322357549|katie.devine@rutgers.edu|
21286596|NCT03205150|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21286597|NCT01095835|Hoffmann-La Roche|Medical Communications|800-821-8590||
21259123|NCT01727895|Radboud UMC|Drs. Jenneke Leentjens|0031-243668420|Jenneke.Leentjens@radboudumc.nl|
21271181|NCT00575328|Depression Clinical and Research Program, Massachusetts General Hospital|Dr. David Mischoulon, Director|617-724-5198|dmischoulon@partners.org|
21271182|NCT01722266|University at Buffalo|Nitesh D Kuhadiya,MD,MPH ;Co-Investigator;Assistant Professor of Medicine, Section of Endocrinology|716-626-7998|niteshku@buffalo.edu|
21271183|NCT04322968|VA Ann Arbor Healthcare System|Dr. Alisher Dadabayev, Pain POC|734-222-7639|Alisher.Dadabayev@VA.GOV|
21259124|NCT03285243|Baylor college of Medicine|Adam Adler|832-8245800|Adam.adler@bcm.edu|
21259125|NCT02971670|Biomedizinische Forschungsgesellschaft mbH|Dr. Martha M. Eibl|+43-1-4081091|martha.eibl@meduniwien.ac.at|
21259126|NCT00288080|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21259127|NCT00379795|Genentech|Genentech||ctg-post-d@gene.com|
21259128|NCT03175549|The Scripps Research Institute|Barbara J. Mason, Ph.D.|858-784-7328|mason@scripps.edu|
21271184|NCT02005354|Plymouth Hospitals NHS Trust|Dr David Tucker|01752 432595|david.tucker1@nhs.net|
21271185|NCT00124449|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21259129|NCT00763321|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21271186|NCT03811249|Refocus Group, Inc.|Linda Stewart, Director of Regulatory and Quality|214-368-0200|lstewart@refocus-group.com|431
21271187|NCT04525157|CLINUVEL PHARMACEUTICALS LTD|Clinical Operations Manager||mail@clinuvel.com|
21271188|NCT00362401|Aarhus University Hospital, Skejby|Dr. Thais A. Pedersen, primary investigator|+45 8949 5484|thais.a.pedersen@ki.au.dk|
21271189|NCT04304950|Rush University Medical Center|Dr. Garth R. Swanson|312-563-3871|Garth_Swanson@rush.edu|33871
21271190|NCT00990561|UCSF|John Koo, Principle Investigator|415-476-4701|john.koo@ucsfmedctr.org|
21271191|NCT00408876|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21271192|NCT01488019|Mylan UK|Dik Ng, PhD, Director Clinical Science|+44 1304626895|dik.ng@mylan.co.uk|
21271193|NCT03654209|Indiana University|Clinical Research Coordinator|317-948-0724|rlahr@iu.edu|
21271194|NCT01337050|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21271195|NCT00003102|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21271196|NCT04643782|Northwestern University|Phyllis Zee, MD|312-503-5944|SleepSensors@northwestern.edu|
21271197|NCT01989195|Stanford University|Phillip C. Yang, MD|650-498-8008|phillip@stanford.edu|
21271198|NCT01559818|Immodulon Therapeutics Ltd|Chief Medical Officer|+44 (0)20 3137 6346|info@immodulon.com|
21271199|NCT00096486|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris|646-888-4205|krism@mskcc.org|
21271200|NCT01512979|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21271201|NCT04071626|University Hospitals Cleveland Medical Center|Dr. Trevor Jenkins|(216)844-1229|Trevor.Jenkins@UHhospitals.org|
21271202|NCT00125359|Dartmouth-Hitchcock Medical Center|Konstantin Dragnev, MD|603-650-6344|Konstantin.H.Dragnev@Hitchcock.org|
21271203|NCT01201356|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21271204|NCT00811070|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21271205|NCT05113901|Rush University Medical Center|Methylprednisolone Taper to Treat Delayed Post-Operative Recovery After Total Knee Arthroplasty: a D|3124322468|anne.debenedetti@rushortho.com|
21271206|NCT04582409|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21271207|NCT00665626|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
21271208|NCT00585039|Phoenix Children's Hospital|Dr Blake Bulloch|602-546-1950|bbulloch@phoenixchildrens.com|
21271209|NCT01799213|Veterans Health Administration, West Haven, CT|Lisa G. Suter, MD|2039325711|lisa.suter@va.gov; lisa.suter@yale.edu|
21271210|NCT01629693|Alcon Research, Ltd.|Jessie Lemp, GMA Affairs Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21271211|NCT03927781|University of Missouri|Dr Katie Murray|573-884-8768|murraykat@health.missouri.edu|
21238115|NCT02597907|Kyungpook National University|Dr Younghoon Jeon|82534205871|jeon68@gmail.com|
21259130|NCT02486757|Massachusetts General Hospital|Dr. Natalie Shaw||natalie.shaw@nih.gov|
21259131|NCT02793232|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21259132|NCT02387580|Medicines for Malaria Venture (MMV)|Fiona Macintyre PhD|+41 22 555 0319|Macintyref@mv.org|
21259133|NCT04849780|Johnson & Johnson Vision Care, Inc.|John R. Buch, OD, MS, FAAO|1-800-846-2020|jbuch@its.jnj.com|
21259134|NCT00725075|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21259135|NCT00087646|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21259136|NCT01331304|Massachusetts General Hospital|Dr. Andrew Nierenberg|617-724-0837|anierenberg@mgh.harvard.edu|
21259137|NCT03979274|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21259138|NCT01128829|Washington University School of Medicine|M. Yanina Pepino|3143628113|ypepino@dom.wustl.edu|
21259139|NCT01060059|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21259140|NCT02302963|University of Virginia Center for Diabetes Technology|Director|434-924-5592|bpk2u@virginia.edu|
21259141|NCT01614093|Morgan State University|Kimberly R. Warren, Ph.D.|443-885-3492|kimberly.warren@gmail.com|
21259142|NCT01407094|University of Texas Southwestern Medical Center|Dr. Madhukar H. Trivedi|214-648-0188|madhukar.trivedi@UTSouthwestern.edu|
21259143|NCT04820309|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
21259144|NCT05165654|BIDMC|Dr. Paulo Lizano|202-776-6708|lizanopl@gmail.com|
21259145|NCT04202679|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21259146|NCT05902364|Alcon Research, LLC|Clinical Project Lead, Dry Eye|1-888-451-3937|alcon.medinfo@alcon.com|
21259147|NCT03864653|Friends Research Institute, Inc.|Jesse B. Fletcher, Ph.D. [Research Scientist]|(323) 463-1601|jfletcher@friendsresearch.org|126
21259148|NCT02482129|Alcon, A Novartis Division|Ophthalmology & Medical Lead, Translational Medicine, NIBR|1-888-451-3937|alcon.medinfo@alcon.com|
21259149|NCT01877083|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21259150|NCT00762515|Colgate Palmolive Co.|William Devizio|732-878-7901|William_Devizio@colpal.com|
21259151|NCT00429585|Boston Medical Center|Paul Tornetta, MD|617-414-6295|paul.tornetta@bmc.org|
21259152|NCT01582308|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21271212|NCT04079842|Masimo Corporation|Ahmed Alghazi|949-297-7000|aalghazi@masimo.com|
21271213|NCT01025193|Hospital of the University of Pennsylvania|Jennifer Trofe-Clark|215-614-4274|jennifer.trofe-clark@uphs.upenn.edu|
21271214|NCT02904200|Mölnlycke Health Care|Global Clinical Research Director|+46 31 722 30 00|info@monlycke.com|
21271215|NCT01901211|Holland Bloorview Kids Rehabilitation Hospital|Darcy Fehlings, MD, MSc, FRCP(C)|416-425-6220|dfehlings@hollandbloorview.ca|3586
21271216|NCT02133352|Boston University|Kimberly Finch|617-638-4475|kimtobin@bu.edu|
21271217|NCT00185211|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21271218|NCT01759537|NYU College of Dentistry|Ismael Khouly|212-998-9800|iek3@nyu.edu|
21271219|NCT00420290|Vanderbilt University|Adriana Hung, MD||adriana.hung@vanderbilt.edu|
21271220|NCT00458302|Jan-Cilag Germany|EMEA Medical Affairs Director Virology|+49 7624 907580||
21271221|NCT02482805|University of Texas at Austin|Michelle Davis|214-470-1371|michelledavis@utexas.edu|
21271222|NCT01144663|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21271223|NCT02763579|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21271224|NCT03015142|Philips|Rami Nachabe|+1-513-926-1486|rami.nachabe@philips.com|
21259153|NCT02017574|Baltimore Veterans Affairs|Jeremy Rietschel, PhD|410-605-7000|jeremy.rietschel@va.gov|3233
21259154|NCT01841333|University of Colorado|Dr. Daniel Pollyea|720-848-8084|DANIEL.POLLYEA@cuanschutz.edu|
21259155|NCT00684957|Columbia University|Pamela Freda, MD|212-305-3725|puf1@columbia.edu|
21259156|NCT04341948|SPR|Clinical Affairs|216-378-9106|support@SPRPainRelief.com|
21259157|NCT03406897|University of Miami, Diabetes Research Institute|Dr. David Baidal|305-243-7740|dbaidal@med.miami.edu|
21259158|NCT06272370|DARTNet Institute|Wilson Pace, MD|800-434-0278|Wilson.pace@dartnet.info|12
21259159|NCT00836355|New York University Langone Medical Center|Saran Jonas|212 263 7591|Saran.Jonas@nyumc.org|
21259160|NCT02363478|"Academic Department of Gastroenterology, LAIKON General Hospital"|Dr. George P. Karamanolis|+30.213.2061307|georgekaramanolis@yahoo.co.uk|
21259161|NCT00930059|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21259162|NCT01966770|Clinical Research Center-UC berkely|Meng C. Lin O.D., PhD, FAAO|510-643-9252|mlin@berkeley.edu|
21259163|NCT01299766|Thomas Jefferson University|Robin Casten|215-503-1250|robin.casten@jefferson.edu|
21259164|NCT04002310|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|18002430127|clintriage.rdg@boehringer-ingelheim.com|
21259165|NCT00352534|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21259166|NCT02090855|GE Healthcare|Paul Sherwin, M.D.|1-609-514-6489|Paul.Sherwin@ge.com|
21259167|NCT00544869|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7314||
21259168|NCT01354028|University of Arkansas for Medical Sciences|Dr Richard W Hall MD, Professor of Neonatology|501-680-7894|HallRichardW@uams.edu|
21259169|NCT02109159|London School of Hygiene and Tropical Medicine|Dr Junko Kiriya|+442076368636|junko.kiriya@lshtm.ac.uk|
21259170|NCT03968419|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
21259171|NCT00935883|University of Miami Miller School of Medicine|Philip J Rosenfeld|305-326-6148|prosenfeld@med.miami.edu|
21259172|NCT03179085|University of New Mexico Health Sciences Center|Vallabh Shah, PhD. Principal Investigator|505-272-9615|VShah@salud.unm.edu|
21259173|NCT02894840|Mahidol university|Prof.Punnee Pitisuttithum|662 6435599|punnee.pit@mahidol.ac.th|
21259174|NCT00804687|Janssen Research and Development|Senior Medical Director|858-784-3111||
21259175|NCT01573273|MUSC|Lisa Nunn|843-792-0476|jenkinli@musc.edu|
21259176|NCT03856255|NYU Langone Health|Mark Pochapin, MD|212-263-9177|Mark.Pochapin@nyulangone.org|
21259177|NCT00323557|UT MD Anderson Cancer Center|Amar Safdar, MD/Professor||CR_Study_Registration@mdanderson.org|
21259178|NCT00197054|Kombewa Clinic, US Army Medical Research Unit, Kisumo Kenya|LTC Mark Polhemus MD, MC|877-379-3788|GSKClinicalSupportHD@gsk.com|
21259179|NCT00684515|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21259180|NCT03244033|University of Illinois at Chicago|Dr. Saul Weiner|312-355-1700|sweiner@uic.edu|
21259181|NCT04428411|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21259182|NCT00634569|Grifols|Paul J. Pinciaro, PhD|410-814-7617|paul.pinciaro@grifols.com|
21259183|NCT01163786|Northwestern University|Clinical Trials at Northwestern University|312-695-6180|cancertrials@northwestern.edu|
21259184|NCT02918019|Hoffmann-La Roche|Medical Comunications|1-800-821-8590|genentech@druginfo.com|
21259185|NCT01212185|UNC_ChapelHill|Dr. Cort Pedersen|919-966-4447|cort_pedersen@med.unc.edu|
21259186|NCT03555266|University of Pittsburgh Medical Center Department of Anesthesiology and Perioperative Medicine|Jacques E. Chelly, MD, PhD, MBA|412-623-6382|chelje@anes.upmc.edu|
21259187|NCT01699087|Alcon, A Novartis Division|Expert Clinical Project Lead, GCRA, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21259188|NCT03370770|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21259189|NCT00510809|University of Kansas Medical Center|James Backes, PharmD|(913) 588-5324|JBACKES@kumc.edu|
21259190|NCT02167945|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21259191|NCT00132730|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21259192|NCT03419078|Imperial College Healthcare NHS Trust|Julie Beckerson|02033131922|julie.beckerson@nhs.net|
21259193|NCT03021642|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21259194|NCT00094757|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21271225|NCT02967133|Duke University Medical Center|Neal Ready MD PhD|(919) 681-6932|neal.ready@duke.edu|
21271226|NCT01034137|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21271227|NCT03572933|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
21271228|NCT00936377|University of Colorado|Robert MacLaren|303 724-2622|rob.maclaren@ucdenver.edu|
21271229|NCT01828255|The New York Eye and Ear Infirmary|Dr Gustavo De Moraes|+1 212 477 7540|demoraesmd@gmail.com|
21271230|NCT00439608|BrUOG|Howard Safran, MD|401-863-3000|Hsafran@lifespan.org|
21271231|NCT01464359|University of Minnesota, Pediatrics Blood and Marrow Transplant|Michael R Verneris|612-626-2961|verneris@umn.edu|
21271232|NCT00815490|Duke University Medical Center|Dr David MacLeod|919-812-3201|david.macleod@duke.edu|
21271233|NCT03051256|Relmada Therapeutics|Chief Medical Officer|646-876-3459|info@relmada.com|
21271234|NCT02203565|Stanford University School of Medicine|Dr. Kathleen Horst|6507256009|kateh@stanford.edu|
21271235|NCT00124020|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
21271236|NCT00268346|Cleveland Clinic Taussig Cancer Institute|David Adelstein MD|216-444-9310|adelstd@ccf.org|
21286598|NCT00871624|Tufts Medical Center|Russel Roberts, PharmD|617-636-4576|rroberts@tuftsmedicalcenter.org|
21259195|NCT01192347|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21259196|NCT02623335|University of Wisconsin, Madison|Gretchen Lee Schwarze, MD, MPP, FACS|(608) 265-2358|schwarze@surgery.wisc.edu|
21259197|NCT00395967|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
21259198|NCT01262976|GlaxoSmithKline|GSK Response Center|866-435-7343||
21259199|NCT01528787|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
21259200|NCT03534427|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
21259201|NCT03433781|NYU Langone|Perla Arriola|347-630-0311|perla.arriola@nyulangone.org|
21259202|NCT00797823|Legacy Health System|W Kenneth Ward MD|503-413-5171|wardk@ohsu.edu|
21259203|NCT02809833|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21259204|NCT00408694|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
21259205|NCT00492973|Lexington Clinic|Cale Jacobs, PhD|859-258-8238|cjaco@lexclin.com|
21259206|NCT03261531|Mayo Clinic|Michael Camilleri, M.D.|507-284-2687|camilleri.michael@mayo.edu|
21259207|NCT01700192|Merck Sharp & Dohme Corp.|Senior Vice President, Global Corporate Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21259208|NCT01158521|Cleveland Clinic|Dr. Brian Rini|(216) 444-9567|rinib2@ccf.org|
21259209|NCT00744874|Medtronic AF Solutions|Linda Nelson, RN, BSN, MBA- AF Solutions Clinical Operations Director|(763)526-2891|linda.k.nelson@medtronic.com|
21259210|NCT00693160|Wake Forest School of Medicine|James C. Eisenach, M.D.|336-716-4498|jimeisenach@gmail.com|
21259211|NCT03522441|Catawba|Zaidoon A. Al-Zubaidy|1-980-242-3977|Zaidoon@catawbaresearch.com|
21259212|NCT00357500|Dana-Farber Cancer Institute|Mark Kieran|(617) 632-4907|mark_kieran@dfci.harvard.edu|
21259213|NCT02301403|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|6082627563|sss@ctri.wisc.edu|
21259214|NCT03528512|William Beaumont Hospitals|Dr. Margaret Menoch|2489897289|margaret.menoch@beaumont.edu|
21259215|NCT01816243|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-792-7200||
21259216|NCT03551743|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
21259217|NCT02317562|LFB|Clinical Information Desk|0033169827010|supportqcm@lfb.fr|
21259218|NCT00603915|Univerisity Health Network|Dr. Lillian Siu|416-946-2911|lillian.siu@uhn.on.ca|
21286599|NCT01204736|Rehabilitation Institute of Chicago|Dr. Wendy Murray|3122386965|w-murray@northwestern.edu|
21286600|NCT05252858|UPMC|Amy Monroe|412-623-6382|monroeal@upmc.edu|
21286601|NCT01405560|Merck Sharp & Dohme Corp|Vice President, Late Stage Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21286602|NCT00710931|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21286603|NCT02169505|UT MD Anderson Cancer Center|Ahmed,Sairah,MD / Stem Cell Transplantation|713-792-7734|sahmed3@mdanderson.org|
21286604|NCT02539992|Stryker European Operations BV|Dr. Eric Garling, Director Medical & Scientific Affairs Europe|+31 20 219 2660|eric.garling@stryker.com|
21286605|NCT01982695|Nationwide Children's Hopsital|Dr. Jerry R. Mendell|(614) 722-5615|Jerry.Mendell@NationwideChildrens.org|
21286606|NCT05044429|GWUniversity|Principal Investigator|202-823-4259|eheinz@mfa.gwu.edu|
21286607|NCT05227118|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21286608|NCT01435759|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21286609|NCT03727841|National Cancer Institute|Dr. Mark Gilbert|240-760-6023|mark.gilbert@nih.gov|
21286610|NCT03126786|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
21286611|NCT03243305|Evofem, Inc.|Chief Medical Officer|858 550 1900|kculwell@evofem.com|
21286612|NCT03758157|Wello, Inc.|Alan C. Heller|469-522-5200|allen.heller@welloinc.com|
21286613|NCT00614172|Loma Linda University Health|David Bush, MD, Vice Chair Clinical Affairs Radiation Medicine|909 558 1000|DBush@llu.edu|
21259219|NCT03891901|Emory University|Dr. Cynthia Giver|404-778-5806|cgiver@emory.edu|
21271237|NCT01799590|Janssen Pharmaceutical KK Japan|Group Manager|+81-3-4411-5072||
21286614|NCT01747499|Washington University School of Medicine|Mark A. Schroeder, M.D.|314-454-8304|markschroeder@wustl.edu|
21286615|NCT02115607|Sidney Kimmel Cancer Center at Thomas Jefferson University|Flemming Forsberg, PhD|215-955-4870|flemming.forsberg@jefferson.edu|
21286616|NCT03377270|Northwestern University|Dr. Bonnie Martin-Harris|847-467-0407|bonnie.martinharris@northwestern.edu|
21286617|NCT05918406|Oyster Point Pharma Inc|Marian Macsai, MD|312-259-2477|marian.macsai@viatris.com|
21286618|NCT00196105|Cook|Scott Snyder|765-463-7537|ssnyder@medinst.com|
21286619|NCT00909064|UC Davis|Gavin Pereira|916-534-0919|gcpereira@ucdavis.edu|
21286620|NCT05616013|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21259220|NCT01724528|Menarini Ricerche S.p.A.|Dr. Angela Capriati, Corporate Clinical Research Director|+39 055 5680|acapriati@menarini-ricerche.it|9933
21271238|NCT00294723|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21271239|NCT01127581|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21271240|NCT01967888|Dompé|Mauro P. Ferrari, Pharm D|+3902583831|info@dompe.com|
21271241|NCT00891774|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
21271242|NCT00730522|Catalyst Pharmaceuticals|Chief Scientific Officer|305-420-3200|gingenito@catalystpharma.com|
21271243|NCT03175120|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21271244|NCT03038113|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21271245|NCT00553540|Cleveland Clinic Florida|Dr. David Westerdahl|954-659-5422|westerd@ccf.org|5422
21271246|NCT01755858|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
21271247|NCT03882047|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21271248|NCT00723554|Actelion Pharmaceuticals, US, Inc.|Wade Benton, PharmD/ Director, Medical Affairs Veletri and Ventavis|(650) 624-6900|wade.benton@actelion.com|
21271249|NCT03421652|Karmanos Cancer Institute|Nitin Vaishampayan, MD|313-576-9624|nvaisham@med.wayne.edu|
21271250|NCT02578732|Brown University Oncology Research Group|Howard Safran, MD|401-863-300|BrUOG@BROWN.EDU|
21271251|NCT01142297|University of Texas Health Science Center at San Antonio|Thomas W. Oates|210-567-3590|oates@uthscsa.edu|
21271252|NCT01614509|Yeungnam University College of Medicine|Dr. Min Sagong|82-53-620-4191|msagong@ynu.ac.kr|
21271253|NCT01894984|XIAN-JANSSEN PHARMACEUTICAL|Medical affairs director|86-10-58218307||
21271254|NCT00827359|Beth Israel Deaconess Medical Center|Rupal Bhatt|6177352060|rbhatt@bidmc.harvard.edu|
21271255|NCT02436135|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21271256|NCT01809314|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21271257|NCT00297479|UT MD Anderson Cancer Center|Dr. Sharon Giordano, MD/Chair, Health Svcs Research-Clinical|713-563-0020|sgiordan@mdanderson.org|
21271258|NCT03263819|Vanderbilt University Medical Center|Dr.Cyndya A. Shibao|6159364584|cyndya.shibao@vumc.org|
21271259|NCT01427803|Bayer HealthCare LLC, Consumer Care|Head Medical Affairs||clinical-trials-contact@bayerhealthcare.com|
21271260|NCT02345486|Vanderbilt University Medical Center|Dr. Matthew Semler|615-322-3412|matthew.w.semler@vumc.org|
21271261|NCT00863057|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21271262|NCT03412019|Tufts Medical Center|Dan Drzymalski, MD|617 636 4526|ddrzymalski@tuftsmedicalcenter.org|
21271263|NCT03979677|Vanderbilt University Medical Center|Richard A. Roberts, Ph.D.|6153227384|richard.a.roberts@vanderbilt.edu|
21271264|NCT03563027|Crescenz Veterans Affairs Medical Center|Dr. Mitesh S. Patel|215-898-3367|mpatel@pennmedicine.upenn.edu|
21271265|NCT01698320|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
21271266|NCT00386724|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
21271267|NCT00686920|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
21301710|NCT01386970|"University of Colorado | Skaggs School of Pharmacy and Pharmaceutical Sciences"|Dr. Peter Anderson|3037246128|peter.anderson@cuanschutz.edu|
21301711|NCT00578292|Baylor College of Medicine/Texas Children's Hospital|Dr. Tami D. John|832-824-4723|tdjohn@texaschildrens.org|
21301712|NCT02675634|Scientific and Regulatory affairs|Sara Gosk|+45 49113568|dksargo@coloplast.com|
21301713|NCT04380519|R-Pharm|Sergey Grishin, Head of Scientific Affairs Department|0074959567937|sa.grishin@rpharm.ru|1506
21301714|NCT03656380|University of North Carolina at Chapel Hill|Lindsay Cortright, MA|919-445-4911|lindsay_cortright@med.unc.edu|
21301715|NCT05300763|Johnson & Johnson Vision Care, Inc.|John R. Buch, Senior Principal Research Optometrist|1-800-843-2020|jbuch@its.jnj.com|
21301716|NCT01485172|GlaxoSmithKline|GSK Response Center|866-435-7343||
21301717|NCT02028208|Allerdern (dba) SmartPractice|Kathryn Shannon|602 225 0595|kshannon@smarthealth.com|7208
21301718|NCT03021343|Khalidi Hospital & Medical Center|Dr. Ramzi Tabbalat|00962795535522|ramzi_md@yahoo.com|
21301719|NCT04995419|Astellas Pharma China, Inc.|Clinical Transparency|+86-(0)10-85216666|astellas.resultsdisclosure@astellas.com|
21301720|NCT02948088|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21301721|NCT00838513|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals Inc||clinicaltrials@alxn.com|
21301722|NCT02416622|AGTC|Dr. Matt Feinsod|386-462-2204|mfeinsod@agtc.com|7202
21301723|NCT00139477|Nemours Children's Clinic|Dr. Nelly Mauras, Chief, Division of Endocrinology|904-697-3674|nmauras@nemours.org|
21301724|NCT00975780|Yale University School of Medicine|Vincent James Quagliarello MD, Professor of Medicine (Infectious Diseases); Clinical Chief, Infectio|(203) 785-7571|vincent.quagliarello@yale.edu|
21301725|NCT00670306|AEterna Zentaris|Daniel Croteau, Medical Manager|418-652-7669|DCroteau@aezsinc.com|272
21301726|NCT01814241|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director of the UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
21301727|NCT00067002|UT MD Anderson Cancer Center|Simrit Parmar, MD/Associate Professor, Stem Cell Transplantation|713-792-7734|SParmar@mdanderson.org|
21301728|NCT01004991|Weill Cornell Medicine|Peter Martin, MD|646.962.2064|amr2017@med.cornell.edu|
21301729|NCT01847027|University of North Texas Health Science Center|Meharvan Singh, PhD|8177355429|meharvan.singh@unthsc.edu|
21301730|NCT01026324|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617-632-5053|stephen_hodi@dfci.harvard.edu|
21301731|NCT01032889|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
21301732|NCT02442804|Brown University|John Bellone, Ph.D.|4012737100|john_bellone@brown.edu|6168
21301733|NCT01640834|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21301734|NCT03523988|University of Washington|Lead Investigator|4254668544|akeith@uw.edu|
21271268|NCT01215123|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21271269|NCT02752256|University of Iowa Hospitals and Clinics|Brett Faine|319-384-6800|brett-faine@uiowa.edu|
21271270|NCT01107535|Abbott|Global Medical Services|1-800-633-9110||
21271271|NCT01155583|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Jason Valent|+1 216-445-7238|VALENTJ3@ccf.org|
21271272|NCT05085613|Johns Hopkins Bloomberg School of Public Health|Caitlin Weiger|301-712-8357|cweiger2@jhmi.edu|
21271273|NCT00198081|Indiana University|Christian M. Schmidt, MD|317-278-8349|maxschmi@iupui.edu|
21271274|NCT02040766|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21271275|NCT00602030|Syndax Pharmaceuticals, Inc.|Michael Meyers, MD, PhD, Chief Medical Officer|+1-646-690-7620|mmeyers@syndax.com|
21271276|NCT01138150|The Johns Hopkins University School of Medicine|Dr. Lee Peterlin|410-550-5452|lpeterlin@jhmi.edu|
21259221|NCT05574062|MedtronicD|Fabio Di Piazza|+393456172157|fabio.di.piazza@medtronic.com|
21259222|NCT00289107|DePuy Orthopaedics|Tammy O'Dell, EMT, CCRA|574-372-7104|TOdell2@its.jnj.com|
21259223|NCT06033079|Vanderbilt University Medical Center|Derek J. Williams, MD, MPH|615-322-2744|derek.williams@vumc.org|
21259224|NCT03512418|Brigham and Women's Hospital|Peter Chai|617-732-5640|pchai@bwh.harvard.edu|
21259225|NCT01031446|Vanderbilt-Ingram Cancer Center|Ingrid A. Mayer, MD|615-936-2033|ingrid.mayer@vanderbilt.edu|
21259226|NCT01355705|Stanford University|Michaela Liedtke, MD|650-498-6000|mliedtke@stanford.edu|
21259227|NCT03631706|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21259228|NCT05442853|Malcom Randall VA Medical Center|Andrew J. Franck|3523761611|Andrew.Franck@va.gov|105771
21259229|NCT00865020|Novartis Pharmaceuticals|Study Director|862-778-8300||
21259230|NCT03303911|Achieve Life Sciences|Daniel Cain, Vice President, Clinical Research|425.686.1546|dcain@achievelifesciences.com|
21259231|NCT00546364|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21259232|NCT03064763|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21259233|NCT02594644|UC Davis Department of Dermatology|Tatyana Petukhova MD||tpetukhova@ucdavis.edu|
21259234|NCT03695913|University of Michigan|Spring Stonebraker|734-649-0219|sprstone@med.umich.edu|
21259235|NCT00619502|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21259236|NCT03720899|University of Alabama at Birmingham|Karen Cropsey|(205) 975-7809|kcropsey@uab.edu|
21259237|NCT00223496|UTHSCSA|Dr. Charles Bowden|210-567-5479|Bowdenc@uthscsa.edu|
21259238|NCT00305578|Indiana University|Dr. Amit Anand||aanand@iupui.edu|
21259239|NCT00374803|University of Cincinnati|Rita Alloway, PharmD|5135581568|rita.alloway@uc.edu|
21259240|NCT05425563|Dartmouth College|Dr. Tor Wager, professor|603-646-2196|tor@dartmouth.edu|
21259241|NCT00997516|University of California, San Francisco|Jonathan T. Carter, MD, FACS|415-476-0974|jonathan.carter@ucsfmedctr.org|
21259242|NCT00929071|Susan H. Weinkle, MD|Susan H. Weinkle, MD|941-794-5432|sweinkle@aol.com|
21259243|NCT01757717|Memorial Sloan Kettering Cancer Center|Josh Yamada, MD|212-639-2950|yamadaj@mskcc.org|
21259244|NCT02624492|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21271277|NCT01580020|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21259245|NCT00883675|Maestro|Michael Mann, MD|650-380-9579|michael.mann@ucsfmedctr.org|
21271278|NCT01068873|Lewis Katz School of Medicine at Temple University|Lisa Landsberg|12157077303|lisa.landsberg@temple.edu|
21259246|NCT05325775|Acer Therapeutics Inc ( a wholly owned subsidiary of Zevra Therapeutics Inc|Chief Medical Officer|844-902-6100|aquartel@zevra.com|
21259247|NCT00343512|Vanderbilt-Ingram Cancer Center|Bapsi Chak, M.D.|615-322-2555||
21271279|NCT02777931|Aevi Genomic Medicine|Garry A Neil, MD|610-254-4208|garry.neil@aevigenomics.com|
21271280|NCT00397839|Hoffmann-La Roche|Medical Communications|800-821-8590||
21271281|NCT01208402|Duke University Medical Center - Department of Anesthesiology|William White / Statistician|919-684-4081|white013@mc.duke.edu|
21271282|NCT02077192|Rigel Pharmaceuticals, Inc.|Director of Clinical Operations|(650) 624-1100|clinicaltrials@rigel.com|
21271283|NCT01571635|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21271284|NCT02868281|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21271285|NCT01335464|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21271286|NCT01783730|AbbVie|Global Medical Services|800-633-9110||
21271287|NCT02151461|NuSirt Biopharma|Barbara Cannon|6156567898|BCannon@nusirt.com|
21271288|NCT00931385|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21259248|NCT02400255|Arog Pharmaceuticals|Edward McDonald|214-593-0500|emcdonald@arogpharma.com|
21259249|NCT02568046|Symphogen A/S|Chief Scientific Officer|+45 8838 2600|info@symphogen.com|
21259250|NCT00193063|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
21259251|NCT03439033|Weill Cornell Medical College|Dr. Kritika Subramanian|212-746-6000|krs9089@nyp.org|
21259252|NCT01127165|Eisai Korea Inc.|Jihee Mun, Pharmacist, Medical Department manager|+82-2-3451-5531|jihee_mun@eisaikorea.com|
21259253|NCT02435849|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21271289|NCT03974152|Eastern Virginia Medical School|Dr. Paul Harrell|757-446-6047|harrelpt@evms.edu|
21271290|NCT01466686|Sidney Kimmel Comprehensive Cancer Center @ Johns Hopkins Medicine|Kristin Redmond, MD|4109556980|kjanson3@jhmi.edu|
21271291|NCT03273387|Department of Cardiology and Vascular Medicine, Universitas Indonesia|dr. Bambang WIdyantoro, FIHA, PhD|+628128164299|bambang_ui@yahoo.com|
21271292|NCT02049359|Campbell University|Jennifer Smith|2522439800|jsmith@cfhcnc.org|224
21271293|NCT01405950|Acorda Therapeutics, Inc.|Herbert Henney, PharmD|914-347-4300|hhenney@acorda.com|5138
21271294|NCT01381900|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
21271295|NCT03877055|Memorial Sloan Kettering Cancer Center|Dr. Gilles Salles, MD, PhD|646-608-4153|SallesG@mskcc.org|
21271296|NCT00387712|Baltimore VAMC|Charlene Hafer-Macko|410-605-7000|charlene.hafer-macko@va.gov|5451
21271297|NCT02030574|Brown Oncology Research Groupl|Kristen M. Mitchell|4018633000|kristen_mitchell@brown.edu|
21271298|NCT01772368|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000||
21271299|NCT02449291|Acacia Pharma Ltd|Gabriel Fox|01-223919764|gabrielfox@acaciapharma.com|
21271300|NCT01411267|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
21271301|NCT02363010|Drexel University|Dr. Meghan Butryn|215-553-7108|mlb34@drexel.edu|
21271302|NCT03347695|Fujian Medical University Union Hospital|Dr. Liangwan Chen|861335825333|chenliangwan@tom.com|
21238116|NCT03701295|Johns Hopkins University|ETCTN Grants Administrative Manager|410-955-4044|jmurra33@jhmi.edu|
21271303|NCT04633837|American Health Network|Brian Badman|317-208-3866|bbadman@gmail.com|
21271304|NCT02668783|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21259254|NCT01017952|GlaxoSmithKline|GSK Response Center|866-435-7343||
21271305|NCT00112489|NRG Oncology - Buffalo Office|Melissa Leventhal|716-341-3408|mleventhal@gogstats.org|
21271306|NCT02462421|University of Maryland School of Medicine|Dr. Simeon Taylor (Professor of Medicine)|410-706-6439|staylor2@som.umaryland.edu|
21271307|NCT02891200|Johns Hopkins University|Principle Investigator|410-637-7152|habouma1@jhmi.edu|
21271308|NCT02117193|Federal University of Rio Grande do Sul|Dr Marco Aurélio Vaz|555133085860|marcovaz@esef.ufrgs.br|
21271309|NCT04467697|Marius Pharmaceuticals, LLC|Nita Nimmons|919-374-1913|Nita@mariuspharma.com|
21271310|NCT03907280|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21271311|NCT03843957|Wake Forest University School of Medicine|Dr. David P. Miller, Jr|336-713-5218|dmiller@wakehealth.edu|
21271312|NCT04480463|SamChunDang Pharm. Co. Ltd.|Byung Jhip Ha, Director of Bio Research Center|+82-31-869-7327|scd411clinical@scd.co.kr|
21271313|NCT01399723|KEMRI-Wellcome Trust Research Prorgamme|Dr. Ambrose Agweyu|254202715160|aagweyu@kemri-wellcome.org|
21271314|NCT00810732|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21271315|NCT03534986|International Biophysics Corporation|VP of Engineering and Quality|512-814-0046|quailty@biophysicscorp.com|
21271316|NCT00752791|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21271317|NCT04535609|Reneo Pharmaceuticals, Inc.|Alex Dorenbaum, MD, Chief Medical Officer|(415) 328-9115|adorenbaum@reneopharma.com|
21271318|NCT01769378|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21271319|NCT01977092|Public Health Institute|Elizabeth Mahoney|(818)310-2684|lmahoney@bhrsca.org|
21271320|NCT01958281|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21271321|NCT05117099|University of Oregon Prevention Science Institute|Dr. Allison Caruthers|503-412-3770|ascaru@uoregon.edu|
21271322|NCT02784106|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21271323|NCT00514137|Mayo Clinic Cancer Center|Shaji Kumar, M.D.||kumar.shaji@mayo.edu|
21271324|NCT02927847|Duke University|Maggie M Sweitzer, PhD|919-668-0094|maggie.sweitzer@duke.edu|
21271325|NCT02004704|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21271326|NCT00417274|Clevland BioLabs|Michael Kurman, MD|716-849-6810|mkurman@cbiolabs.com|
21271327|NCT00175019|Takeda Global Research & Development Center, Inc.|Senior Vice President, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21271328|NCT01405820|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21271329|NCT01665170|PASCOE pharmazeutische Präparate GmbH|Dr. Gabriele Weiß|0641-7960|klinischeforschung@pascoe.de|
21271330|NCT02619799|Rangaraya medical college|Dr.Paleti Sophia|9948599758 ,08842343023|dr.sophia29@gmail.com|
21271331|NCT03255031|National Institute on Alcohol Abuse and Alcoholism (NIAAA)|Dr. Gene-Jack Wang|301-496-5012|gene-jack.wang@nih.gov|
21271332|NCT01092702|Mayo Clinic|J Taylor Hays. MD|507-266-1944|nicotineresearch@mayo.edu|
21271333|NCT02539563|Wake Forest School of Medicine|Lynnette Harris, BSN|336-716-6049|lcharris@wakehealth.edu|
21271334|NCT02087046|Abbott|Clinical Research Scientist|972-309-8000|mike.frassica@abbott.com|
21271335|NCT02444533|Mayo Clinic|Dr. Daniel Price|507-293-4395|Price.Daniel@mayo.edu|
21271336|NCT03567057|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com|
21271337|NCT01413399|Mecklenburg EMS Agency|Jonathan R Studnek PhD|7049436046|jonst@medic911.com|
21271338|NCT00886483|The Ohio State University|L. Eugene Arnold, M.D. M.Ed.|614-685-6708|L.Arnold@osumc.edu|
21271339|NCT01841359|Joslin Diabetes Center|Mary Elizabeth Patti, MD|6173092635|MaryElizabeth.Patti@joslin.harvard.edu|
21271340|NCT02168270|University of Nebraska Medical Center|Dr. Nicole Shonka|402-559-5166|nshonka@unmc.edu|
21271341|NCT00706706|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21271342|NCT00291330|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21271343|NCT00757666|Boston Scientific|Director of Clinical Affairs|651-582-2277|cshd@bsci.com|
21271344|NCT02629965|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21271345|NCT03443869|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21271346|NCT02390219|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21271347|NCT00299728|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21271348|NCT02033876|Mayo Clinic|Dr. Michael Camilleri|507-284-2687|camilleri.michael@mayo.edu|
21271349|NCT00580983|University of Michigan Comprehensive Cancer Center|Dr. Avraham Eisbruch, M.D.|734-936-4302|eisbruch@umich.edu|
21271350|NCT01360632|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21271351|NCT01298596|University of Washington|Dr. Michael H. Chung|‭(206) 302-8361‬|mhchung@uw.edu|
21271352|NCT03740100|MD Anderson Cancer Center|Dr. Faye Johnson|7137922121|fmjohns@mdanderson.org|
21271353|NCT02046369|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
21271354|NCT03120520|Bausch Health Americas, Inc|Clinical Operations Director|908-927-0873|lindsey.mathew@bauschhealth.com|
21271355|NCT03387059|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21271356|NCT00528437|NYU Langone|Dr. Sharon Gardner|212-263-9913|Sharon.Gardner@nyulangone.org|
21271357|NCT00634283|Laboratory of Brain, Behavior, and Pharmacology at UCLA|Director of the Laboratory of Brain|310-825-0207|info@brain.ucla.edu|
21271358|NCT01743677|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21238117|NCT01464021|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21238118|NCT04672096|Neuronoff, Inc.|Jasmine Wilson|408-858-2612|jasmine@neuronoff.com|
21238119|NCT03391765|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21238120|NCT00944658|Imperial College London|Peter Taylor|+44 (0) 2075941872|jrco@imperial.ac.uk|
21238121|NCT01272960|University of Alabama School of Medicine|Dr. Lorie Harper|205-975-0515|lmharper@uabmc.edu|
21238122|NCT03496974|XBiotech|Ashley Otero, Corporate and Clinical Relations Manager|512-386-2930|aotero@xbiotech.com|
21238123|NCT00990964|Medtronic, Inc.|Attain Success Clinical Trial Leader|800-328-2518|medtronicCRMtrials@medtronic.com|62864
21238124|NCT04682119|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21259255|NCT01064167|Cardiovascular Institute & Fuwai Hospital|Guyan Wang|86-10-88398377|guyanwang2006@163.com|
21259256|NCT01983787|Aarhus University Hospital, Department of infectious diseases|Kristina Öbrink-Hansen|+4578452845|krisoebr@rm.dk|
21259257|NCT02194439|IndianaU|Sophie Paczesny|317-278-5487|sophpacz@iu.edu|
21259258|NCT03984305|Global Kinetics Corporation|Director of Clinical Affairs|612.240.2437|karen.krygier@globalkineticscorp.com|
21259259|NCT00352105|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. David Adelstein|216-444-9310|adelstd@ccf.org|
21259260|NCT03076983|Drägerwerk AG & Co. KGaA|Mr. Robin Hüwel|+49 451 882 6830|ClinicalAffairs@draeger.com|
21259261|NCT02979431|Ablynx NV|Medical Monitor|+32 (0)9262 00 00|clinicaltrials@ablynx.com|
21259262|NCT01656434|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21259263|NCT01727258|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
21259264|NCT00868101|Universidade de Sao Paulo|Marcos Alves Pavione|55 79 9199 9576|mapavione@hotmail.com|
21259265|NCT02642094|University of Texas Health Science Center|LUZHE SUN, Ph.D.|210-567-5746|sunl@uthscsa.edu|
21259266|NCT02082678|UT Southwestern|E. Sherwood Brown. MD, PhD, MBA|(214) 645-6950|Sherwood.Brown@UTSouthwestern.edu|
21259267|NCT01099969|The University of Texas Health Science Center at Houston|Dr. Davide Cattano|713.500.6235|davide.cattano@uth.tmc.edu|
21259268|NCT01818726|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21259269|NCT02882633|University of Pennsylvania|Ignacio Badiola|215-893-7251|Ignacio.Badiola@uphs.upenn.edu|
21259270|NCT00630955|Yale University|Dr. Suchitra Krishnan-Sarin, Associate Professor of Psychiatry|203-974-7595|suchitra.krishnan-sarin@yale.edu|
21259271|NCT00993928|Mayo Clinic|Charles Lawrence Loprinzi, M.D.||cloprinzi@mayo.edu|
21259272|NCT04871711|LEO Pharma A/S|Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
21259273|NCT01920711|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21259274|NCT01478854|Johns Hopkins University School of Medicine|Kristin Redmond, MD|410-955-6980|kjanson3@jhmi.edu|
21259275|NCT02319044|AstraZeneca LP|Jean Fan, MD, Global Clinical Lead|1-301-398-5080|jean.fan@astrazeneca.com|
21259276|NCT02105415|Mayo Clinic|Dr. Nathan Smischney|507-255-4305|smischney.nathan@mayo.edu|
21259277|NCT02026063|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD|281-863-3000|plapuerta@lexpharma.com|
21259278|NCT00723788|Children's National Health System|Pranav Vyas, MD|2024760186|PVyas@childrensnational.org|
21259279|NCT02154087|Smith & Nephew, Inc|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
21259280|NCT01658657|UNC Chapel Hil|Anthony Viera|919-966-0758|viera@med.unc.edu|
21259281|NCT00466310|DUMC|Rima Kaddurah-Douk, Associate Professor|919-684-2611|rima.kaddurah-daouk@duke.edu|
21259282|NCT01493180|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
21259283|NCT04556617|Opna Bio|Kerry Inokuchi|650-204-4065|info@opnabio.com|
21259284|NCT04949841|LEO Pharma|Clinical Disclosure|+4544945888|disclosure@leo-pharma.com|
21259285|NCT01211600|Geisinger|Dr. A. Dhanya Mackeen|570-714-1099|admackeen@geisinger.edu|
21259286|NCT05702736|Ege University|Dr. Merve UGURYOL UNAL|+902323115545|merve.uguryol.unal@ege.edu.tr|
21259287|NCT01172652|VA Palo Alto Health Care System|Dr. Trisha Suppes, MD PhD|(650) 493-5000|tsuppes@va.gov|67576
21259288|NCT04811716|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21259289|NCT00546052|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21271359|NCT01715415|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
21271360|NCT01038557|Oregon Health & Science University|Dr. Martin A. Schreiber|503-494-8324|schreibm@ohsu.edu|
21271361|NCT00996866|Winthrop-University Hospital|John Aloia, MD|516-663-2442|jaloia@winthrop.org|
21271362|NCT02203747|Abbott Medical Optics|Carrie Garufis|714-566-3728|carrie.garufis@abbott.com|
21271363|NCT02884206|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21271364|NCT02322879|BIDMC|Michael Ganetsky, MD|617-754-2323|mganetsk@bidmc.harvard.edu|
21271365|NCT03487796|Rhode Island Hospital|Larry K. Brown, MD|(401) 793-8808|lkbrown@lifespan.org|
21271366|NCT01090765|National Cancer Institute|Dr. William Dahut|301-496-4251|dahutw@mail.nih.gov|
21271367|NCT00678392|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21271368|NCT03341507|Iuliu Hatieganu University of Medicine and Pharmacy- Cluj Napoca Romania|Dr Ioan Florin Marchis|+40757065205|marchis.ioan@umfcluj.ro|0757065205
21271369|NCT00718159|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21271370|NCT03151499|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21271371|NCT00415532|Amgen Inc.|Study Director|866-572-6436||
21301735|NCT02624986|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21271372|NCT01798485|Synta Pharmaceuticals|President, Chief Executive Officer|781-541-7261||
21271373|NCT01952574|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21271374|NCT01189240|Adult Brain Tumor Consortium (ABTC)|Dr. Edward Pan||Edward.Pan@UTSouthwestern.edu|
21271375|NCT03687125|Mundipharma Research Limited|Terry Nichols|(0044)1223424444|terry.nichols@mundipharma-rd.eu|
21271376|NCT00770991|Cleveland Clinic|Dr. Carol Burke|216 444-6864|burkec1@ccf.org|
21271377|NCT01992107|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21271378|NCT02022007|Woman''s Hospital|Dr Karen Elkind-Hirsch|225-231-5275|karen.elkind-hirsch@womans.org|
21271379|NCT02159859|Beaumont Health|Lama Hsaiky, Pharm.D. (Primary investigator)|313-593-7264|lama.hsaiky@beaumont.org|
21271380|NCT01001169|GlaxoSmithKline|GSK Response Center|866-435-7343||
21271381|NCT01608295|UCLA|Helen Lavretsky, M.D.|310-794-4619|hlavretsky@mednet.ucla.edu|
21271382|NCT02536378|Silk Road Medical, Inc.|Ric Ruedy, Executive VP, Clinical, Regulatory and Quality Affairs|408-585-2112|ric@silkroadmed.com|
21271383|NCT01271933|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21271384|NCT03156270|Dept. of Otolaryngology-Head and Neck Surgery, The Ohio State University|Kai Zhao, PhD.|614-293-3857|zhao.1949@osu.edu|
21271385|NCT00871169|University of New Mexico Comprehensive Cancer Center|Fa-chyi Lee, MD|505-925-0405|flee@salud.unm.edu|
21271386|NCT03764059|Peking University Hospital of Stomatology|Xiaoyan Wang|010-82195525|wangxiaoyanpx@163.com|
21271387|NCT01102777|VA Ann Arbor Center for Clinical Management Research|Fatima Makki|+1 (734) 845-3623|Fatima.Makki@va.gov|
21271388|NCT01943461|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21271389|NCT02175966|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
21271390|NCT01752920|Basilea Pharmaceutica International Ltd.|Study Director|+41 79 701 0551|marc.engelhardt@basilea.com|
21271391|NCT01665053|Boston Scientific|Patricia O'Mara, Clinical Trial Manager|518-792-5673|patricia.o'mara@bsci.com|
21271392|NCT01033383|Yale University|Dr. Manisha Juthani-Mehta|(203)785-7571|manisha.juthani@yale.edu|
21271393|NCT00947856|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
21271394|NCT00771901|Washington University School of Medicine in Saint Louis, Missouri|Samuel Klein, M.D.|314-362-8708|sklein@wustl.edu|
21271395|NCT02611206|University of Minnesota|Kathryn Cullen|612-625-3403|rega0026@umn.edu|
21271396|NCT02280356|Memorial Sloan Kettering Cancer Center|Dr. Marisa Kollmeier, MD|212-639-3952|KollmeiM@mskcc.org|
21271397|NCT01086215|Boston Scientific Corporation|DeeAnn Tinjum|763-450-8707|deeann.tinjum@bsci.com|
21271398|NCT01033864|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21271399|NCT02524106|University of California San Francisco|Priscilla Hsue, PI|415-206-8257|priscilla.hsue@ucsf.edu|
21271400|NCT03493698|Spring Bank Pharmaceuticals, Inc.|Don Mitchell, Vice President, Operations & Corporate Development|(508) 689-9737|dmitchell@springbankpharm.com|
21271401|NCT00566709|"University Hospital Virgen del Rocío"|Santiago R Leal-Noval, MD, PhD|0034954012528|srlealnoval@gmail.com|
21271402|NCT01829295|F.I. Proctor Foundation, UCSF|Dr. Nisha Acharya|4154768131|Nisha.Acharya@ucsf.edu|
21271403|NCT03331965|Duke University Medical Center|Dr. James Ronald|919.684.7299|james.ronald@duke.edu|
21271404|NCT01855126|Rensselaer Polytechnic Institute|Mariana Figueiro|(518)687-7142|figuem@rpi.edu|
21271405|NCT02230085|Fisher & Paykel Healthcare|Clinical Research Scientist|+6495740123|cpaptrial@fphcare.co.nz|
21271406|NCT01491490|GW Research Ltd.|Mr Colin Stott|+44 (0)1980 557000|cgs@gwpharm.com|
21271407|NCT02173301|Dr Reddy's Laboratories Ltd.|Dr. Srinivas Shenoy B.,|49002900|srinivassshenoyb@drreddys.com|
21271408|NCT02340156|SynerGene Therapeutics, Inc.|Senior Consultant|301-706-1509|clinicaltrial@synergeneus.com|
21271409|NCT04345471|Mochida Pharmaceutical Company, Ltd.|Director of Clinical Research Department|+81332256331|clinical.trials.contact@mochida.co.jp|
21286621|NCT04391842|Medical Pain Consultants|Dr. Ralph Ortiz|(607) 844-9979|drortizmpc@gmail.com|
21286622|NCT00810199|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21286623|NCT01121939|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21286624|NCT00992017|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|919-405-1429|mallen@fhi360.org|
21286625|NCT02864407|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21286626|NCT02992119|MORU|Lorenz von Seidlein|662036663|Lorenz@tropmedres.ac|
21286627|NCT02686164|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21286628|NCT01691378|Rocky Mountain MIRECC|Lisa Brenner|720-723-6488|lisa.brenner@va.gov|
21238125|NCT03364348|Stanford Medicine at Stanford University|Sinyoung Park|650-721-4485|sinyoung@stanford.edu|
21238126|NCT01768832|Washington University in St. Louis|Dr. Gammon M. Earhart|314-286-1407|earhartg@wustl.edu|
21238127|NCT01580072|Landeskrankenanstalten-Betriebsgesellschaft|Dr. Hannes Steinberger|+4346355212 50303|hannes.steinberger@kabeg.at|
21238128|NCT01705496|Biomed valley discoveries|Dr. Michelle Zhang, Executive Director|7815339412|mzhang@biomed-valley.com|
21238129|NCT01746095|Savara Inc.|Head of Clinical Development|+45 7930 1414|info@savarapharma.com|
21271410|NCT01710306|Department of Veteran's Affairs- Office of Research and Development|Anne G. Sadler, Ph.D., R.N.|319-338-0581|anne.sadler@va.gov|7992
21271411|NCT02457728|St John of God Hospital Vienna|Bernhard Dauser, MD, PhD|+4321121|b.dauser@hotmail.com|5098
21238130|NCT03315143|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
21271412|NCT02378506|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21238131|NCT01242748|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21238132|NCT01904864|Baylor College of Medicine|Jacquelyn M. Powers, MD||jacquelyn.powers@bcm.edu|
21238133|NCT03724487|Case Western Reserve University|Dr. Carolyn Still, Assistant Professr|216-368-6338|cwh11@case.edu|
21238134|NCT00832767|Covidien|Jessica Carlson|203-821-4734|jessica.carlson@covidien.com|
21238135|NCT03043079|University of Pennsylvania|Dr. John P Fischer|2156627300|john.fischer2@uphs.upenn.edu|
21238136|NCT00549757|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21238137|NCT00105235|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21271413|NCT02123459|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21238138|NCT02052310|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1200|063study@fibrogen.com|
21271414|NCT01191255|Keryx Biopharmaceuticals Inc|Medical Information|1-844-44-KERYX (1-844-445-3799|medicalinfo@keryx.com|
21238139|NCT01964326|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21271415|NCT02196506|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21238140|NCT04647032|University of California San Francisco|Dr. Theodore Zanto|415-502-7322|theodore.zanto@ucsf.edu|
21238141|NCT03708588|Aurora Health Care|Suhail Allaqaband, MD|414-469-3491|suhail.allaqaban@aah.org|
21271416|NCT01606137|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
21238142|NCT02416492|SanBio, Inc.|Bijan Nejadnik M.D.; Chief Medical Officer|650-625-2205|Bijan.Nejadnik@sanbio.com|
21238143|NCT02093663|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21271417|NCT00254397|University of Texas MD Anderson Cancer Center|Patrick Hwu, MD / Professor, Melanoma Medical Oncology|713-792-2921|phwu@mdanderson.org|
21271418|NCT01070394|NYU School of Medicine|Dr. Lenard Adler|(212) 263-3580|lenard.adler@nyumc.org|
21238144|NCT02094443|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
21286629|NCT02731300|Department of Physiology; Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.|Paradee Auvichayapat|66896222624|aparad@kku.ac.th|
21238145|NCT05906368|UPMC, University of Pittsburgh|Dr. Katherine Grace Lim|412-641-1778|limkg2@upmc.edu|
21238146|NCT02629991|Albert Einstein College of Medicine|Bonnie Taylor|7188397530|botaylor@montefiore.org|
21286630|NCT01827592|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21238147|NCT00595504|Massachusetts General Hospital|David C. Henderson, M.D.|617-912-7800|dchenderson@partners.org|
21238148|NCT01477853|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21238149|NCT01804816|Cleveland Clinic Foundation|Dr. W.H. Wilson Tang, MD|(216) 444-2121||
21238150|NCT01235546|University of Alabama at Birmingham, Maternal & Fetal Medicine|Alan Tita, MD|205-934-9616|atita@uab.edu|
21238151|NCT01256411|Novartis Pharmaceuticals|Study Director|862-778-8300||
21238152|NCT00330915|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21238153|NCT01445652|Alcon Research, Ltd.|Jami Kern, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
21238154|NCT00929162|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21238155|NCT04225533|Serpin Pharma, LLC|Dr. Cohava Gelber|7033433258|cgelber@serpinpharma.com|
21238156|NCT00658567|ACADIA Pharmaceuticals Inc.|Roger Mills, MD|858-202-7563|rmills@acadia-pharm.com|
21238157|NCT01755702|GlaxoSmithKline|GSK Response Center|866-435-7343||
21259290|NCT03048422|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
21259291|NCT00500682|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21259292|NCT04663945|University of Colorado Denver|Dr. Jennifer Stevens-Lapsley|303.724.9170|PT.studies@cuanschutz.edu|
21259293|NCT00772668|UM/Sylvester Comprehensive Cancer|Denise Pereira MD|305-243-9127|dpereira2@med.miami.edu|
21259294|NCT01879345|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21259295|NCT02002975|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21259296|NCT04660643|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21259297|NCT03988907|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21259298|NCT01276171|University of Iowa Hospitals and Clinics|Dr. Kenichi Ueda|319-356-2633|kenichi-ueda@uiowa.edu|48517
21259299|NCT03609619|Aevi Genomic Medicine|Garry A. Neil, MD|610-254-4208|garry.neil@aevigenomics.com|
21259300|NCT05162066|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
21271419|NCT03501550|Cocrystal Pharma Inc|Luz Pascual|9083611678|lpascual@cocrystalpharma.com|
21238158|NCT00691938|Washington University School of Medicine|Geoffrey Uy, M.D.|314-454-8304|guy@wustl.edu|
21259301|NCT00568555|Stanford University School of Medicine|Jarred Younger, PhD|650-724-2795|jyounger@stanford.edu|
21286631|NCT01481558|University of Sao Paulo|Claudia Kimie Suemoto|551130618249|cksuemoto@usp.br|
21259302|NCT01220414|University of Wisconsin-Madison|Kelli F. Koltyn|608 262-4234|kelli.koltyn@wisc.edu|
21259303|NCT00445887|NRG Oncology|Linda Gedeon for James Kauderer, MA|716-845-1169|lgedeon@gogstats.org|
21271420|NCT01386879|University of Missouri Columbia|Boris Mraovic|573-882-2568|mraovicb@health.missouri.edu|
21271421|NCT01015612|Medtronic|Dr Deama Amr (PhD)|+61 2 9857 9157|deama.amr@medtronic.com|
21271422|NCT00066807|IBCSG|Rudolf Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org|
21271423|NCT05028751|Kronos Bio, Inc.|VP, Corporate Affairs|+16507815200|media@kronosbio.com|
21271424|NCT03092089|University of Alberta Hospital|Dr Kevin Bainey|780-407-2176|Kevin.Bainey@albertahealthservices.ca|
21271425|NCT03586830|Janssen Research & Development, LLC|Senior Director Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21271426|NCT04578548|Galapagos NV|Galapagos Medical Information|+3215342900|medicalinfo@glpg.com|
21271427|NCT02248285|BioFire Diagnostics|Director of Clinical Affairs|8017366354|kevin.bourzac@biofiredx.com|
21271428|NCT00395083|VA Boston Healthcare System - MAVERIC|Dr. Sarah Leatherman|857-364-4220|sarah.leatherman@va.gov|
21271429|NCT00972153|Nimbic Systems|Sean Self|281-565-5715|self@nimbicsystems.com|
21271430|NCT04192799|The Dartmouth Institute for Health Policy & Clinical Practice|Stephanie Acquilano, Research Project Director|603-646-5937|stephanie.acquilano@dartmouth.edu|
21271431|NCT01077713|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
21271432|NCT04136626|Massachusetts General Hospital|Dr. Sabine Wilhelm, Chief of Psychology|617-724-6146|swilhelm@mgh.harvard.edu|
21271433|NCT00628745|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21238159|NCT01319799|Sahlgrenska University Hospital,Cardiothoracic Anesthesia, 41345 Gothenburg ,SWEDEN|Dr Bjorn Reinsfelt|0046702954263|bjorn.reinsfelt@gu.se|
21271434|NCT00982410|Ann Arbor Veteran Affairs|Dr. Mark Ilgen|(734) 845-3646|Mark.Ilgen@va.gov|
21271435|NCT01016652|Johnson & Johnson Vision Care|Thomas R. Karkkainen OD, MS, FAAO Senior Principal Research Optometrist|(904)443-3402|TKarkkai@its.jnj.com|
21271436|NCT02034799|Ethicon, Inc|Senior Director of Ethicon Clinical R&D|(908) 218-2492|jbatill2@its.jnj.com|
21259304|NCT00623831|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21259305|NCT01276821|Department of Child Health, Tribhuvan University Teaching Hospital, Institute of Medicine.|Dr. Aayush Khanal|977-1-4421532|aayush_khanal@yahoo.com|
21259306|NCT03068325|New York State Psychiatric Institute|Yuval Neria|646-774-8092|ny126@cumc.columbia.edu|
21259307|NCT00066690|ETOP IBCSG Partners Foundation|Dr. Heidi Roschitzki-Voser, Head Trial Activities/Deputy Director|+41 31 511 94 00|heidi.roschitzki@etop.ibcsg.org|
21259308|NCT02939131|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
21259309|NCT02408692|Oregon Health & Science University|Dr. Alison Edelman|503-494-3666|whru@ohsu.edu|
21301736|NCT03433040|University of South Florida|Wendy Duncan, QA/QI Research Compliance Manager|8139747454|wduncan3@usf.edu|
21259310|NCT03569202|Finnsusp Ltd.|Dr. Jarmo Laihia, Manager of Clinical & Formulation Development|358 50 377 1212|jarmo.laihia@piiloset.fi|
21259311|NCT01668654|GlaxoSmithKline|GSK Response Center|866-435-7343||
21259312|NCT03634800|Weill Cornell Medicine|Dr. Himanshu Nagar|212-746-3704|hnagar@med.cornell.edu|
21259313|NCT01114529|Novartis Pharmaceuticals|Study Director|+1(862)778-8300|trialandresults.registries@novartis.com|
21301737|NCT02116205|WRAIR Clinical Trials Center|Dr. Kristin Mills, Principal Investigator|301-319- 2039|Kristin.t.mills.ctr@mail.mil|
21259314|NCT01076348|Medtronic, Inc.|Stefanie Lorinser, Sr. Clinical Research Specialist|763-526-2742|stefanie.lorinser@medtronic.com|
21259315|NCT01235962|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21259316|NCT01580397|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
21259317|NCT02883244|Sunstar Americas, Inc.|Senior Manager of R&D|8477944276|akane.takemura@us.sunstar.com|
21301738|NCT02561338|Hua Medicine|Yi Zhang|+86-21-58869997|yzhang@huamedicine.com|3269
21259318|NCT02435914|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21259319|NCT01405053|Eisai Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
21301739|NCT00993148|Northwestern University|Dr. Babafemi Taiwo|312-695-5085|b-taiwo@northwestern.edu|
21259320|NCT04063371|The Ohio State University|Dr. Douglas Scharre|614-293-4969|Doug.Scharre@osumc.edu|
21259321|NCT00535925|University of Campania|Prof. Ferdinando Carlo Sasso. MD, PhD|+39-081-5665010|ferdinandocarlo.sasso@unicampania.it|
21259322|NCT00836433|Durham VA GRECC|Dr. Cathleen Colon-Emeric|9192860411|cathleen.colonemeric@va.gov|6777
21259323|NCT00464178|Hackensack University Medical Center|Dr. David Siegel|551-996-2000|DSiegel@hackensackumc.org|
21259324|NCT02420873|The University of Texas MD Anderson Cancer Center|Naval Daver, MD/ Associate Professor|713-794-4392|ndaver@mdanderson.org|
21259325|NCT02180893|NYU Langone Medical Center|Peter Neuberger|212 263 5821|Peter.Neuburger@nyumc.org|
21301740|NCT00806819|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21301741|NCT02373683|Case Western Reserve University|Katherine Slain|12168443310|katherine.slain@uhhospitals.org|
21301742|NCT06139887|White River Junction VA Medical Center|Dr. Natalie Riblet|1-802-295-9363|natalie.riblet@va.gov|5893
21259326|NCT02838407|GlaxoSmithKline|GSK Response Center|866-435-7343||
21259327|NCT01972074|Massachusetts General Hospital|Gagan Joshi, MD|(617) 724-1541|joshi.gagan@mgh.harvard.edu|
21259328|NCT03550066|Kaiser Permanente Northern California|Dr. Susan D. Brown|5108913544|susan.d.brown@kp.org|
21259329|NCT00742469|Valeant Pharmaceuticals|Valeant Pharmaceuticals|(866) 246-8245||
21301743|NCT01737502|Mayo Clinic in Florida|Yanyan Lou, MD|904-953-0315|lou.yanyan@mayo.edu|
21301744|NCT03801044|Sisli Hamidiye Etfal Training and Research Hospital|Mustafa Sevinc|00905309291239|musevinc@hotmail.com|
21301745|NCT01326104|University of Florida|Kristine Wynne|352-273-9727|kristine.wynne@neurosurgery.ufl.edu|
21301746|NCT05064358|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21301747|NCT04421027|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
21301748|NCT04549545|Aerin Medical|Tien Dang Sr. Clinical Affairs Manager|669-256-6596|tdang@aerinmedical.com|
21301749|NCT02685267|PCCTC|Jake Vinson|646-422-4383|vinsonj@mskcc.org|
21301750|NCT01865552|Samsung Bioepis|Director of Clinical Development|+82 31 8061 4534|sbregistry@samsung.com|
21301751|NCT03083873|Iovance|Sr. Medical Director, Rana Fiaz|661-645-3572|rana.fiaz@iovance.com|
21301752|NCT00295880|Masonic Cancer Center, University of Minnesota Blood and Marrow Transplant Program|John E. Wagner, M.D.|612-626-2961|wagne002@umn.edu|
21301753|NCT00611403|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21301754|NCT03983317|TheraNova, LLC|Vice President of Research and Development|415-926-8616|clinicalstudy@theranova.com|
21301755|NCT04990804|Vanderbilt University Medical Center|Research Coordinator|615-936-7107|kennadie.long@vumc.org|
21301756|NCT04202419|Miami Dermatology and Laser Institute|Dr. Jill Waibel|(305) 615-2393|info@miamidermlaser.com|
21301757|NCT01717053|Duke University|Dr. Bridget Koontz|919-668-5213|bridget.koontz@duke.edu|
21301758|NCT00552188|Tallikut Pharmaceuticals, Inc.|Brian Cunningham, MD|312-505-0420|brian@baycitycapital.com|
21301759|NCT01256294|Novartis Pharmaceuticals|Study Director|862-778-8300||
21301760|NCT03887702|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|adarke@fredhutch.org|
21301761|NCT01643772|Mundipharma (China) Pharmaceutical Co.Ltd|Ms. Dan Zhu, Clinical operation and quality lead of the study|+8610 6563 6891|dan.zhu@mundipharma.com.cn|
21301762|NCT04329806|Vanderbilt University Medical Center|Dr. Alfredo Gamboa|615 875 1003|alfredo.gamboa@vumc.org|
21301763|NCT01349959|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Clinical Research Office|410-955-8866|jhcccro@jhmi.edu|
21301764|NCT00811018|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21301765|NCT01727024|Novartis Pharmaceuticals|Study Director|862-778-8300||
21238160|NCT04860518|Faron|Dr Juho Jalkanen|+358407071046|juho.jalkanen@faron.com|
21259330|NCT03618056|Fred Hutchinson Cancer Research Center|Jessica Andriesen|206-667-5812|jandries@fredhutch.org|
21271437|NCT03827213|Montefiore Medical Center|Elilary Medilla Medrano|(718) 920-4316|emontill@montefiore.org|
21271438|NCT01956279|Durham VA Medical Center|Christine Marx, MD MA|919-286-0411|marx0001@mc.duke.edu|3626
21271439|NCT02265848|Center for Clinical Research / Carolinas Pain Institute|Dr. James North MD|3367656181|jhong@ccrpain.com|
21271440|NCT00671879|Meda Pharma US|David Ginsberg, DO Sr Dir Medical Scientific Affairs|732 564 2347|david.ginsberg@meda.us|
21271441|NCT01628120|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21271442|NCT01172600|Cleveland Clinic|Alparslan Turan, MD|216-445-9857|turana@ccf.org|
21271443|NCT01927757|Amgen Inc.|Study Director|866-572-6436||
21271444|NCT00444795|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@Pfizer.com|
21271445|NCT00988169|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris|646-888-4205|krism@mskcc.org|
21271446|NCT04690413|NOWDiagnostics|Beth Cobb|479-966-4531|beth.cobb@nowdx.com|
21271447|NCT02637076|CAMH|Dr. Stephen Kish|416-535-8501|stephen.kish@utoronto.ca|36256
21271448|NCT00130520|Arizona Cancer Center, University of Arizona|Setsuko K. Chambers, M.D.|520-626-0950|schambers@azcc.arizona.edu|
21271449|NCT01464827|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21271450|NCT00613574|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21271451|NCT00176904|Masonic Cancer Center, University of Minnesota|Paul Orchard, M.D.|612-626-2313|orcha001@umn.edu|
21271452|NCT04604184|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21271453|NCT00582036|University of Oklahoma Health Sciences Center|George Selby, MD|405-271-4022|george-selby@ouhsc.edu|
21271454|NCT02711956|Zenith Epigenetics Ltd|Zenith Study Team|(415) 470-5600|ZEN003694-002@zenithepigenetics.com|
21286632|NCT01105312|Mayo Clinic|Winston Tan MD|507-284-1159|tan.winston@mayo.edu|
21259331|NCT03687502|Children's Mercy Hospital|Dr. Tolulope Oyetunji|816-234-3575|taoyetunji@cmh.edu|
21259332|NCT00604968|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21259333|NCT00486278|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21259334|NCT00931489|University of California Davis, Department of Ophthalmology & Vision Science|Lawrence S. Morse, MD, PhD|916 734 6074|lsmorse@ucdavis.edu|
21259335|NCT02183519|University of Florida Communicative Disorders|Karen Hegland, PhD|352-273-3710|kwheeler@ufl.edu|
21259336|NCT03042936|UTHSC|Joan Han|9012876408|jhan14@uthsc.edu|
21259337|NCT01777581|Duke University Medical Center|David Marks, MD|919 668-2859|d.marks@duke.edu|
21259338|NCT05168267|University of Wisconsin Madison - Incarceration and Mental Health Lab|Michael Koenigs|(608) 263-1679|mrkoenigs@wisc.edu|
21259339|NCT02887521|Mayo Clinic|Roberto Benzo, MD, MSc|(507) 284-0561|benzo.roberto@mayo.edu|
21259340|NCT00695565|Arcion Therapeutics, Inc.|Dr. James Campbell|(410) 522-8701|jcampbell@arciontherapeutics.com|
21259341|NCT02937350|University of Washington|Dr. Ian de Boer|206-616-5403|IDeBoer@Nephrology.washington.edu|
21259342|NCT01462266|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21259343|NCT01106846|Northwestern University|Shireen Ahmad, M.D.|321-472-3585|sah704@northwestern.edu|
21238161|NCT01965782|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21238162|NCT04026529|Omaha VA Medical Center|Dr. Debra Romberger|4025597539|debra.romberger@va.gov|
21238163|NCT03701399|Biohaven Pharmaceuticals|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
21259344|NCT03502993|Imperial College London|Dr J Herberg|0207 594 3900|j.herberg@imperial.ac.uk|
21259345|NCT01119456|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21259346|NCT03382574|UT MD Anderson Cancer Center|Dr. Powel Brown, Chair, Clinical Cancer Prevention|(713) 745-3672|phbrown@mdanderson.org|
21259347|NCT02288273|AstraZeneca, PLL|Sergey Zhuplatov MD, PhD|215-542-3222|Sergey.Zhuplatov@astrazeneca.com|
21259348|NCT03110900|University of Arkansas for Medical Sciences|Michael Wilson, M.D.|(501) 686-5515|mpwilso1@outlook.com|
21259349|NCT02321436|Ipsen|Medical Affairs Director, Neurology||clinical.trials@ipsen.com|
21259350|NCT00644787|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387||
21259351|NCT03355300|Radius Pharmaceuticals, Inc.|Tarek El Akkad, Head of Clinical Development|6175514000|telakkad@radiuspharm.com|
21259352|NCT01680900|University of Pennsylvania|Dr. Ellen Freeman|215-662-3329|freemane@mail.med.upenn.edu|
21259353|NCT00502216|Yale University School of Medicine|Benjamin Toll, Ph.D.|203-974-5767|benjamin.toll@yale.edu|
21259354|NCT02549755|Indiana University School of Medicine|Justin Sims, M.D.|317 948-6340|simsjb@iupui.edu|
21259355|NCT02542761|Mayo Clinic|Kenton Kaufman, Ph.D.|507-266-0136|Kaufman.Kenton@mayo.edu|
21259356|NCT04247425|Oregon Health & Science University|Lara Davis, MD|5034948423|davisla@ohsu.edu|
21259357|NCT02247193|The University of Texas Health Science Center at Houston|Matthew R. Greives, MD|713-500-7275|Matthew.R.Greives@uth.tmc.edu|
21259358|NCT00692211|New Mexico VA Health Care System|Richard Hoffman, MD|505-265-1711|richard.hoffman2@va.gov|5318
21259359|NCT02851173|University of Texas at Austin|Andreana Haley|512-232-0863|haley@austin.utexas.edu|
21259360|NCT02531646|Carestream Health, Inc.|Susan Pate, RN, MS, RAC, Senior Clinical Manager|585-627-6557|susan.pate@carestream.com|
21259361|NCT00578305|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21259362|NCT03344003|Octapharma AG|Dr. Sigurd Knaub, Senior VP CR&D Haematology|01554512141|Sigurd.Knaub@octapharma.com|
21259363|NCT01182428|Abbott Vascular|Ellen Travis, Clinical Science|408-845-3000|Ellen.Travis@av.abbott.com|
21259364|NCT05027932|Clinical Studies Unit, Laboratory of Infectious Diseases, NIAID, NIH|Luca Giurgea|301-538-5235|Luca.giurgea@nih.gov|
21259365|NCT05888103|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21259366|NCT05900115|innovation Research & Training|Tracy Scull, PhD|9194937700|tscull@irtinc.us|
21259367|NCT02554929|The Hospital for Sick Children|Dr. Suneeta Monga|416-813-8954|suneeta.monga@sickkids.ca|
21259368|NCT01916980|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21259369|NCT02324270|Teva Pharmaceuticals USA, Inc|Senior Director, Global Gx Clinical R&D- PD/CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
21259370|NCT03521791|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
21259371|NCT04024501|AstraZeneca|AstraZeneca information Centre|1-877-240-9479|information.center@astrazeneca.com|
21259372|NCT00680836|George E. Wahlen V.A. Medical Center, Salt Lake City, UT|Ashok Tuteja, M.D.|801-582-1565|ashok.tuteja@va.gov|4019
21271455|NCT05487456|Philip Morris Products S.A.|Christelle Haziza, Global Head Clinical Research and Execution|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
21271456|NCT01924871|Chung-Ang University Hospital|Dr. Chong Wha Baek|82-2-6299-2579|nbjhwa@naver.com|
21271457|NCT01625377|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21271458|NCT03513497|University of North Carolina at Chapel Hill|Julie Marchesan, DDS, PhD|919-537-3853|julie_marchesan@unc.edu|
21271459|NCT02043366|Tianjin Medical University General Hospital|Dr. Guolin Wang|+8615822855556|wangguolinghad@hotmail.com|
21271460|NCT01412541|Becton Dickinson|Anna Lovas|7634452382|anna.lovas@bd.com|
21271461|NCT03294538|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
21271462|NCT03295643|Pivot Health Technologies Inc.|Senior Director of Clinical Affairs and Data Science|650-906-4255|craig@pivot.co|
21271463|NCT01489956|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21271464|NCT00422656|Dana-Farber Cancer Institute|Irene M. Ghobrial, MD|617-632-4198|irene_ghobrial@dfci.harvard.edu|
21271465|NCT01787825|CapsoVision, Inc.|Director of Clinical Affairs|408-624-1488|andra.thomas@capsovision.com|117
21271466|NCT04394754|Yale University|Francis Perry Wilson|203-737-1704|francis.p.wilson@yale.edu|
21271467|NCT01462565|GlaxoSmithKline|GSK Response Center|866-435-7343||
21271468|NCT00928083|Medicines for Malaria Venture|Dr. Joerg Moehrle|+41 22 555 0330|moehrlej@mmv.org|
21271469|NCT01224210|Tufts Medical Center|Ioana Preston MD|617-636-7609|ipreston@tuftsmedicalcenter.org|
21271470|NCT01401478|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21271471|NCT01814137|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21271472|NCT01214603|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21271473|NCT01507896|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21271474|NCT00490061|Stanford University|Quynh Le|650-498-5032|qle@stanford.edu|6506370734
21271475|NCT00621179|Colorado Center for Reproductive Medicine|Eric Surrey|303-788-8300|esurrey@colocrm.com|
21271476|NCT01982383|Medical Faculty Associates|Nicole Swanson|202-741-2437|nswanson@mfa.gwu.edu|
21271477|NCT01945138|University of Minnesota|Dr. Melena Bellin|612-624-5409|bell0130@umn.edu|
21271478|NCT02746263|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
21271479|NCT01523964|DART Therapeutics|Chief Operating Officer|415-341-5783|egoldstein@dartrx.com|
21271480|NCT01620983|Virginia Commonwealth University|Dr. Daniel L. Riddle|804-828-0234|dlriddle@vcu.edu|
21271481|NCT03944486|Imperial College London|Research Integrity Officer|+44 (0)20 7594 1872|e.magnusson@imperial.ac.uk|
21271482|NCT00798889|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21271483|NCT00617461|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
21271484|NCT01724359|Jan-Cil Mexico|GERENTE MEDICO REGIONAL|52 55 5237 3410||
21271485|NCT05085964|Sepul Bio|Zuhal Butuner - Chief Medical Officer|(905) 599-7887|contact@sepulbio.com|
21271486|NCT01534975|Los Angeles Biomedical Research Institute|Matthew Budoff|3102224107|mbudoff@labiomed.org|310
21271487|NCT00591253|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21301766|NCT01587014|Medical Center of the Rockies|Dr. Julie Dunn|970-624-1680|julie.dunn@uchealth.org|
21271488|NCT00707915|Minami-hanno Hospital|Director of clinical trials|81.42.972.7111|haloperidol1mg@hotmail.com|
21271489|NCT00252187|Mayo Clinic|Dr. Horng H. Chen|507-778-2354|chen.horng@mayo.edu|
21271490|NCT01875445|University of Chicago|Dr. Jon Grant|773-834-3778|jongrant@uchicago.edu|
21271491|NCT00593333|Department of Surgery/Division of Orthopaedics|Taylor Vlack, Research Nurse Coordinator|205-996-6781|tmwebb@uabmc.edu|
21271492|NCT01738581|University of Minnesota|Dr. Teresa Kimberley|612-626-4096|tjk@umn.edu|
21271493|NCT00210626|Centocor Ortho Biotech Services, LLC (COBS)|Vice President Medical Affairs|215-325-4464||
21271494|NCT02191579|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21271495|NCT00769015|Thomas Jefferson University|Robin Casten|215-503-1250|Robin.Casten@jefferson.edu|
21271496|NCT02862535|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21271497|NCT00947765|Dr. Chetan Muralidhara Rao Dojode. Resident in Orthopaedics and Traumatology.|Dr. Chetan Muralidhara Rao Dojode, MBBS,MS(Ortho)|91 9844592532|docchetanmd@yahoo.co.in|
21271498|NCT01965652|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|1454
21271499|NCT01121900|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
21286633|NCT00441285|Universidad Peruana Cayetano Heredia|Hector H. Garcia, MD, PhD|+511 3287360|hgarcia@jhsph.edu|
21301767|NCT01491984|IWK Health Centre|Dr. Ronald George|902-470-6627|rbgeorge@dal.ca|
21301768|NCT03962504|National Center for PTSD at VA Boston Healthcare System|Dr. Denise Sloan|857-364-6333|denise.sloan@va.gov|
21301769|NCT01976741|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
21301770|NCT04999852|Indiana University|Clarissa Tokash|(812) 855-7686|catokash@iu.edu|
21301771|NCT05626322|Pfizer Inc.|Pfizer CT.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21271500|NCT03469271|Mayo Clinic|Aminah Jatoi, M.D.|507-266-0984|huyber.christine@mayo.edu|
21286634|NCT00952315|IU Health Physicians Urology|James Lingeman, MD|317-962-3700||
21286635|NCT02573259|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21286636|NCT00751140|H. Lee Moffitt Cancer Center and Research Institute|Philippe E. Spiess, M.D.|813-745-8343|philippe.spies@moffitt.org|
21286637|NCT03160716|Q-Med AB|Reception|+46184749000|reception.seupp@galderma.com|
21286638|NCT01628848|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6131-7366||
21301772|NCT03776812|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
21259373|NCT03786432|William Beaumont University Hospital|Grace San Agustin|248 551 6679|grace.sanagustin@beaumont.org|
21259374|NCT00388947|Whitinsville Medical Center|Dr Samuel Zylstra|508-243-6260|samuelzylstra@milreg.org|
21259375|NCT03038308|Columbia University|Gabrielle Page-Wilson, MD|212-305-3725|gp2287@cumc.columbia.edu|
21259376|NCT04187092|University of Virginia|Joe M Hart|434.243.0256|jmh3zf@virginia.edu|
21259377|NCT00278876|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
21259378|NCT00771472|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21259379|NCT00845195|Alcon Research Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21259380|NCT04793399|ZERO LMC|Valentín García|91 336 86 86|jvalentingg@gmail.com|
21259381|NCT00880750|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21259382|NCT01246206|Barbara Ann Karmanos Cancer Institute|Dr. Zaid Al-Kadhimi|800-527-6266|zalkadh@emory.edu|
21259383|NCT04391959|Azura Ophthalmics|Chief Medical Officer|17145598435|charles.bosworth@azuraophthalmics.com|
21259384|NCT01231555|ViiV Healthcare|GSK Response Center|866-435-7343||
21259385|NCT00688909|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21259386|NCT03793439|Oregon Health & Science University|Dr. Marcia Friedman|5034948637|friedmam@ohsu.edu|
21259387|NCT00669617|Novartis Pharmaceuticals|Study Director|862-778-8300||
21259388|NCT01748071|Huazhong University of Science&Technology|Xianwei Zhang|027 83662853|ourpain@163.com|
21259389|NCT00700180|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21259390|NCT01613326|Novartis Pharmaceuticals|Study Director|4 161 324 1111||
21259391|NCT02088385|Changi General Hospital|Dr Andrew Kwek Boon Eu|6788 8833|andrew_kwek@cgh.com.sg|
21259392|NCT00420511|Leadership Sinai Centre for Diabetes, Mount Sinai Hospital|Dr. Ravi Retnakaran|416-586-4800|rretnakaran@mtsinai.on.ca|3941
21259393|NCT02415712|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21259394|NCT04557384|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21259395|NCT00454779|Amgen Inc.|Study Director|866-572-6436||
21259396|NCT01418001|Memorial Sloan Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org|
21259397|NCT01337973|VA Ann Arbor|Stephen Chermack, Ph.D.|734 845-5046|chermack@umich.edu|
21259398|NCT03256045|University of Washington|Dr. Andrew Cowan|206-606-7348|ajcowan@seattlecca.org|
21259399|NCT05210504|VUMC|Dr. Jane Ferguson|6158759896|jane.f.ferguson@vumc.org|
21259400|NCT02522767|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21259401|NCT00254566|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21259402|NCT03222427|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
21259403|NCT00548548|Hoffman-LaRoche|Medical Communications|800-821-8590||
21259404|NCT00358657|Fred Hutchinson Cancer Research Center|Dr. Kanwaldeep Mallhi|206-667-2014|kmallhi@fredhutch.org|
21259405|NCT01044966|Medical University of South Carolina|Dr. Bruce Frankel|8437922052|frankel@musc.edu|
21259406|NCT01705691|NSABP Foundation, Inc.|Diana Gosik|412-339-5333|diana.gosik@nsabp.org|
21259407|NCT02658448|Oncternal|Mary Breitmeyer|858-434-1113|MBreitmeyer@oncternal.com|
21259408|NCT00191451|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21259409|NCT00964431|Iroko Pharmaceuticals, LLC|Steven Jensen|267-546-3003|sjensen@iroko.com|
21259410|NCT00272987|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
21259411|NCT02614079|University of Toledo Medical Center|Joseph Atallah, MD|419-383-6699|joseph.atallah@utoledo.edu|
21259412|NCT00566930|UQTR|Martin Descarreaux|819 376-5011|martin.descarreaux@uqtr.ca|3077
21259413|NCT01893567|Galderma Laboratories, L.P.|Senior Clinical Project Manager|817-961-5000|jay.mashburn@galderma.com|
21259414|NCT03604445|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
21259415|NCT00130286|Weill Cornell Medical College|Dr. Marshall J. Glesby|212-746-4177|mag2005@med.cornell.edu|
21259416|NCT05787847|University of Vermont|Dr. Richard Rawson|‭+1 (310) 951-9091‬|richard.rawson@uvm.edu|
21259417|NCT00611247|Stanford University Medical Center|Bruno C Medeiros, MD|650-498-6000|bruno.medeiros@stanford.edu|
21259418|NCT00243659|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21259419|NCT01890421|Bayer|Therapeutic Area Head|+1 888-8422937|clinical-trials-contact@bayer.com|
21259420|NCT00268242|The Cleveland Clinic|Anjali S. Advani, MD|216-445-5330|advania@ccf.org|
21259421|NCT01665144|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21259422|NCT01913483|Miami Cardiac & Vascular Institute, Baptist Health South Florida|Chief Medical Executive|800-273-2700|MCVI@BaptistHealth.net|
21259423|NCT03969888|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21259424|NCT04506294|Children's Hospital of Philadelphia|Nancy Kassam-Adams, PhD (Principal Investigator)|215-590-3118|adamsn@chop.edu|
21259425|NCT02067039|CDC|Robin MacGowan|404-639-1920|rmacgowan@cdc.gov|
21259426|NCT01469000|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21259427|NCT04033419|University of North Carolina at Chapel Hill, Department of Psychiatry|Zev Nakamura, MD|(984) 974-3829|zev_nakamura@med.unc.edu|
21259428|NCT02558374|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director of Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
21259429|NCT00769119|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
21259430|NCT00632853|Mayo Clinic|Dr. Steven Schild|480-301-9692|sschild@mayo.edu|
21259431|NCT03564626|Virginia Commonwealth University|Dr. Jasmohan Bajaj|(804) 828-4060|jasmohan.bajaj@vcuhealth.org|
21259432|NCT01821300|The Children's Hopsital of Philadelphia|Dr. Andrea Kelly|215590-3174|kellya@email.chop.edu|
21259433|NCT06228586|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21259434|NCT02065453|Saint Louis University|M. Brigid Holloran-Schwartz, MD|314-781-8605|holloran@slu.edu|1
21259435|NCT03267004|University of Tennessee|Hollie Raynor|865-974-6259|hraynor@utk.edu|
21301773|NCT04950816|The University of Texas Health Science Center at Houston|Diane Santa Maria, DrPH|713-500-2187|diane.m.santamaria@uth.tmc.edu|
21259436|NCT02490293|SeoulStmary's hospital|Tae-ho Hong|010-5206-5266|gshth@catholic.ac.kr|
21259437|NCT05556525|Mayo Clinic|Dr. Sebastian Fernandez-Bussy|904-953-6320|Fernandez-Bussy.Sebastian@mayo.edu|
21259438|NCT03694392|Kaiser Permanente Vaccine Study Center|Amber Hsiao Hyman, Senior Research Project Manger|510-267-7517|Amber.Hyman@kp.org|
21259439|NCT02949128|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
21259440|NCT01602341|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|001-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21259441|NCT02152345|Columbia University Irving Medical Center|Dr. Mark A. Hardy|(212) 305-5502|mah1@cumc.columbia.edu|
21259442|NCT01641120|Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital|Lindsay Tuttle, MPH|860-714-2149|LTuttle@stfranciscare.org|
21259443|NCT00483327|Perlmutter Cancer Center at NYU Langone|Stephanie Blank, MD|212-731-5705|stephanie.blank@nyumc.org|
21259444|NCT01390389|McLean Hospital|Cara McCabe|617-855-2410|cfmccabe@partners.org|
21259445|NCT03593915|Sumitomo Oncology|Holly Beever|210-365-9014|holly.beever@oncology.sumitomo-pharma.com|
21259446|NCT01583179|University of Wisconsin-Madison|Melanie Donnelly|720-848-0000|melanie.donnelly@ucdenver.edu|
21301774|NCT04758637|University of Southern California|Jason Doctor|213.821.8142|jdoctor@usc.edu|
21259447|NCT03363633|Duke University Medical Center|Ellen D. Dillavou, MD, FACS||ellen.dillavou@duke.edu|
21259448|NCT00772629|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21259449|NCT04866290|Merit Medical Systems, Inc.|Vicky Brunk RN, Vice President, Medical Affairs, Merit Medical|+1 (717) 873-3309|vicky.brunk@merit.com|
21259450|NCT01322022|Children's Hospital of Pittsburgh/University of Pittsburgh|Dr. Cynthia Johnson|412-692-8404|cynthia.rheney.johnson@gmail.com|
21259451|NCT03760484|University of Alberta|Dr. Dina Kao|780-233-6025|dina.kao@ualberta.ca|
21259452|NCT05197803|Sonova AG|Study Manager|519 895 0100|carolina.rubiano@sonova.com|2135
21259453|NCT01171820|Abbott Vascular|Robert Smith Jr, Ph.D., Sr Clinical Research Scientist|408-845-8265|robert.smithjr@av.abbott.com|
21301775|NCT02879812|Emory University|Dr. Rachel Patzer|404-727-6047|rpatzer@emory.edu|
21259454|NCT01871090|St Jude Medical, Inc.|Todd Stirman, Clinical Manager|(972) 526-9625|Tstirman@sjm.com|
21259455|NCT01307033|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21259456|NCT03065179|UT Southwestern Medical Center|Dr. Hans Hammers|214/645-7445|Hans.Hammers@UTSouthwestern.edu|
21259457|NCT00806221|Oregon Health & Science University|Eric Simpson, MD, MCR|503-494-2121|simpsone@ohsu.edu|
21259458|NCT02707770|Imperial college healthcare NHS trust|vijay padmanaban|02033122349|vijay.padmanaban@nhs.net|
21259459|NCT03588741|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21259460|NCT00605267|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21259461|NCT00793793|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21259462|NCT01445535|National Cancer Institute|Dr. Wyndham Wilson|240-760-6092|wyndham_wilson@nih.gov|
21259463|NCT03216382|Ryerson University|Dr. Naomi Koerner|416-979-5000|naomi.koerner@ryerson.ca|ext. 5521
21259464|NCT05130008|Massachusetts General Hospital|Dr. Jocelyn Carter|617 724 9000|jcarter0@mgh.harvard.edu|
21259465|NCT00883493|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21259466|NCT01622569|OptiNose|Vice President Global Clinical Operations & Outsourcing|267-364-3508|jennifer.carothers@optinose.com|
21259467|NCT01505894|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21259468|NCT04173741|Hacettepe University|Dr. Asli Melek|+905376636789|aslimelek121@gmail.com|
21259469|NCT03378479|UZ Leuven|Prof. Dr. Joost Wauters - Intensivist|016344275|joost.wauters@uzleuven.be|
21301776|NCT03350672|Philadelphia FIGHT Community Health Centers|Linden Lalley-Chareczko|2155258695|lchareczko@fight.org|
21301777|NCT02622178|Wills Eye Hospital, Glaucoma Research Center|Dr. L. Jay Katz|215-928-3123|ljkatz@willseye.org|
21301778|NCT00048074|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21301779|NCT02873377|University of Miami|Taghrid Asfar|305-243-3826|tasfar@med.miami.edu|
21301780|NCT04473469|University of Michigan|Timothy Bruns|(734) 647-8727|bruns@umich.edu|
21301781|NCT05036733|University of Michigan|Yvonne J Huang MD|734-936-5047|yvjhuang@med.umich.edu|
21301782|NCT05407064|Mind Medicine Inc|Medical Affairs|1-332-245-4732|MedAffairs@mindmed.co|
21301783|NCT02285439|Children's Hospital Los Angeles|Dr. Nathan Robison|323.361.2121|mek162@chla.usc.edu|
21301784|NCT06019611|Mayo Clinic|Dr. Kristin Zhao, Director of the Assistive and Restorative Technologies Laboratory|507-284-8942|zhao.kristin@mayo.edu|
21301785|NCT02219659|MemorialCare Long Beach|Division of Pulmonary and Critical Care|(562) 933-2000|mtanios@yahoo.com|
21301786|NCT03568461|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21301787|NCT05603312|MeiraGTx, LLC|Program Manager|646-860-7982|patients@meiragtx.com|
21301788|NCT03387085|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
21301789|NCT04695977|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21301790|NCT01027806|School of Medicine, University of Missouri Health|Leila Kheirandish-Gozal, M.D., M.Sc.|(573) 884-3229|gozall@health.missouri.edu|
21301791|NCT01243242|Alcobra|Dr Yaron Daniely CEO|972-072-2204662|yaron@alcobra-pharma.com|
21301792|NCT00578734|Penn State Children's Hospital|Dr. Neal J. Thomas|717-531-5337|nthomas@hmc.psu.edu|
21301793|NCT00662675|Johnson & Johnson Pharmaceutical Research & Development, LLC|Director, Clinical Team Leader|609-730-3158||
21301794|NCT04681352|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
21259470|NCT01940484|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21271501|NCT03760510|Vanderbilt University Medical Center|Janna Landsperger|6153223412|janna.landsperger@vumc.org|
21271502|NCT03361956|Janssen Sciences Ireland UC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21271503|NCT03198988|ART MEDICAL|Mrs Shirly Steinlauf|972-54-5804242|shirly@artmedical.com|
21271504|NCT04147715|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
21271505|NCT00235833|Abbott|Medical Information Specialist|800-633-9110||
21271506|NCT02418910|Biomedical Development Corporation|Gregg Siegel|2108638053|gsiegel@biodevcorp.com|
21271507|NCT03867383|Stanford University|Dr. Jessica Ansari|760-845-0328|jansari@stanford.edu|
21271508|NCT00895583|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21271509|NCT01986790|Washington University's School of Medicine|Mary C. Politi, PhD|314-747-1968|politim@wudosis.wustl.edu|
21271510|NCT03016078|Mölnlycke Health Care|Global Clinical Research Director|+46 31 722 30 00|info@monlycke.com|
21271511|NCT02322528|University of Rochester|Dr. James V. Aquavella|585-276-7439|rick_barrett@urmc.rochester.edu|
21271512|NCT03381248|Avanos Medical|David Curd|470-448-5178|david.curd@avanos.com|
21271513|NCT01717898|University of California, San Francisco|Charles Ryan, MD|877-827-3222|clinicaltrials@ucsf.edu|
21271514|NCT05188521|Mayo Clinic|Dr. Aaron R. Mangold, Principal Investigator|480-301-9196|mangold.aaron@mayo.edu|
21271515|NCT04582266|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
21271516|NCT01341639|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21271517|NCT02224456|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21271518|NCT01241461|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21271519|NCT00202449|VA PSHCS|Murray Raskind, MD|206-764-2702|Murray.Raskind@va.gov|
21271520|NCT01379781|Columbia University Medical Center|Catherine Monk, Ph.D., Assoc Professor|(646) 774-8941|cem31@columbia.edu|
21271521|NCT02247479|Hoffmann-La Roche|Medical Communications|800 821 - 8590|genentech@druginfo.com|
21271522|NCT04942379|UMass Chan Medical School|Dr. Michelle Trivedi|7744418086|Michelle.Trivedi3@umassmed.edu|
21271523|NCT02497391|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21271524|NCT01664052|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21271525|NCT03740698|Imperial College London|Prof Nick Oliver|+44 (0)20 7594 1796|nick.oliver@imperial.ac.uk|
21271526|NCT02625766|University of Maryland Medical Center|Research Administrator|4103289579|NO'Hara@som.umaryland.edu|
21271527|NCT01467063|Nemours Children's Health System|Dominique Darmaun|904-697-3674|Ddarmaun@nemours.org|
21271528|NCT02802514|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21271529|NCT01045499|Columbia University|Jeffrey Zitsman, MD|212-305-8862|jlz2@cumc.columbia.edu|
21271530|NCT05216978|Brigham and Women's Hospital|Dr. Hermioni Amonoo, Director of Well-Being and Cancer Research Program|‭617-525-7472‬|hermioni_amonoo@dfci.harvard.edu|
21271531|NCT02429869|University of California, San Francisco|Rodney Rogers|415-514-6454|Rodney.Rogers@ucsf.edu|
21271532|NCT00658320|Novartis Pharmaceuticals|Study Director|862-778-8300||
21271533|NCT03467412|Follicum AB|CEO Jan Alenfall|+46 (0)70 931 51 15|jan.alenfall@follicum.com|
21271534|NCT01717014|Covidien|Julie Doyle|781-839-1729|Julie.Doyle@Covidien.com|
21271535|NCT01975090|Novate Medical|Gordon Crowley|+353 91 750 030|gordon.crowley@novate.ie|
21271536|NCT02410252|Partners Connected Health Innovations|Amanda Centi|6177242158|acenti@partners.org|
21271537|NCT00746668|Jesse Brown VAMC|Dr. Janet P. Szlyk, PhD|312-997-3644|Janet.Szlyk@va.gov|
21271538|NCT01007916|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
21271539|NCT01162499|Children's Hospital of Philadelphia|Diva De Leon, MD|267-426-5529|DELEON@email.chop.edu|
21271540|NCT02058628|GlaxoSmithKline|GSK Response Center|866-435-7343||
21271541|NCT00704418|ISTA Pharmaceuticals, Inc.|Tim McNamara, Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com|
21271542|NCT02710071|University of California San Diego|Michael G. Ziegler, M.D.|619 543 2885|mziegler@ucsd.edu|
21271543|NCT03352427|University of Michigan|Carl Koschmann, MD|734-615-2736|ckoschma@umich.edu|
21271544|NCT01238848|Hospital General de Niños Pedro de Elizalde|Maria I. Espelt, MD|541146136968|cespelt@fibertel.com.ar|
21271545|NCT00782509|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21271546|NCT03222141|Edwards Lifesciences|Edwards THV Clinical Affairs|(949) 250-2500|THV_CT.gov@Edwards.com|
21271547|NCT03291509|University of Kansas Medical Center|Dr. Lauren Ptomey|913-588-7983|lptomey@kumc.edu|
21271548|NCT01418352|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21271549|NCT00585351|University of Iowa|Enrique Leira, MD, MS|319-356-8755|enrique-leira@uiowa.edu|
21271550|NCT01821625|UT Southwestern Medical Center at Dallas|William M Lee, MD|214 645 6111|william.lee@utsouthwestern.edu|
21286639|NCT01377636|New York University Langone Medical Center, Anesthesiology|Patrick Linton, MD, Director of Adult Off-Site Anesthesia Services|212-263-5072|Patrick.Linton@nyumc.org|
21286640|NCT00808067|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21286641|NCT00689338|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21286642|NCT01939314|Indiana University School of Medicine|Jason Schaffer, MD|317-962-8026|jtschaff@iupui.edu|
21286643|NCT00078286|Duke University|Dr. Ranga Krishnan|919-668-3647|krish001@mc.duke.edu|
21286644|NCT02104895|Radiation-Oncology Unit, AOU Careggi, Florence University, Florence, Italy|Dr. Icro Meattini|+39055794|icro.meattini@unifi.it|7719
21286645|NCT00969228|GlaxoSmithKline|GSK Response Center|866-435-7343||
21286646|NCT02951312|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
21286647|NCT02371876|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
21286648|NCT02284386|Pacira|James B. Jones, MD, PharmD|(973) 254-3560|jim.jones@pacira.com|
21286649|NCT01815502|MUSC|Dr. Andrew M Atz|843-876-1698|atzam@musc.edu|
21286650|NCT01107925|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21286651|NCT03311945|Hospital Clinic of Barcelona|Esteban Martínez|+34 93 227 54 00|estebanm@clinic.cat|
21286652|NCT04235504|Medtronic Diabetes|Javier Castaneda|+31 433566566|javier.castaneda@medtronic.com|
21286653|NCT04877990|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21286654|NCT05254340|Indiana University|Dr. Huiping Xu|317-278-6735|huipxu@iu.edu|
21286655|NCT02532283|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21286656|NCT00418028|GEICAM (Grupo Español de Investigación en Cancer de Mama)|The Oncologist 2015;20:1-2 http://www.theoncologist.com/ Scientific Director and CEO|+34916592870|geicam@geicam.org|
21286657|NCT01945944|Rainbow Babies and Children's Hospital|Steven Shein, MD|216-844-3310|drstevenshein@gmail.com|
21286658|NCT01817075|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21286659|NCT00816777|Generic Devices Consulting, Inc|John Greenbaum|772-353-5301|genericd@bellsouth.net|
21286660|NCT04376515|University of California, Irvine|Dr. Dominic Ugarte|949-508-0135|dugarte@hs.uci.edu|
21286661|NCT03811821|Mayo Clinic|Adil Bharucha, M.B.B.S., M.D.|507-266-6931|bharucha.adil@mayo.edu|
21286662|NCT06236113|North Memorial Health Robbinsdale Hospital|Michaela A West, MD, PhD|763-581-3704|Michaela.West@NorthMemorial.com|
21286663|NCT01395810|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
21286664|NCT05630196|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21286665|NCT03438266|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21286666|NCT00934375|Eisai Inc.|Anita Murthy, Study Director|201-692-1100||
21286667|NCT02674503|Birmingham VA - GRECC Director; Professor at UAB|Dr. Alayne Markland|205-558-7067|alayne.markland@va.gov|
21286668|NCT01022203|Southeast Louisiana Veterans Health Care System (SLVHCS)|Frederic Sautter, Ph.D.|504-988-3026|Fsautter@tulane.edu|
21286669|NCT00903201|GlaxoSmithKline|GSK Response Center|866-435-7343||
21286670|NCT00563290|The Ohio State University Comprehensive Cancer Center|Thomas Olencki, DO|614-293-2886|Thomas.Olencki@osumc.edu|
21286671|NCT00945243|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com|
21286672|NCT03256578|Leiden University Medical Center|Dr. Arjan te Pas|+31 71 5265839|a.b.te_pas@lumc.nl|
21286673|NCT03028142|Verona Pharma plc|Brian Maurer|+19147675037|brian.maurer@veronapharma.com|9147675037
21286674|NCT01198002|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21286675|NCT00129441|University of Pittsburgh|David A. Lewis, MD|(412) 246-6010|lewisda@upmc.edu|
21286676|NCT02812186|Stony Brook University|Dr. Ruchir Gupta|917-443-1263|gupta2005@yahoo.com|
21286677|NCT01162343|Vanderbilt University Medical Center|Dr. Jin Han, MD|615-936-0253|jin.h.han@vanderbilt.edu|
21286678|NCT03964207|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21286679|NCT01968421|Peking Union Medical College Hospital|Dr. Jinming Gao, Director of Clinical Trials|8610691550549|gjinming@yahoo.com|
21286680|NCT00830219|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21286681|NCT01130272|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21286682|NCT00239720|University of Chicago|Marcus Clark, MD|773-702-0202|mclark@medicine.bsd.uchicago.edu|
21286683|NCT00565461|Valneva Austria GmbH|Head Clinical Development|0043120620|info@valneva.com|0
21286684|NCT01783743|Johns Hopkins University|Sheila K West|410 955 2606|shwest@jhmi.edu|
21286685|NCT02771275|Edwards Lifesciences, LLC|Sabrina Hundt, Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Sabrina_Hundt@edwards.com|
21286686|NCT05556148|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
21271551|NCT02950753|UMCSouthernNevada|Dr. Tony Zitek|702-383-7885|zitek10@gmail.com|3
21271552|NCT03503474|University of Leeds|Professor Mark Wilcox|+441133926818|mark.wilcox@nhs.net|
21271553|NCT03559010|HRA Pharma|Christine VENARD|33 1 84 13 92 44|c.venard@hra-pharma.com|
21271554|NCT00457665|UTSouthwestern Medical Center|Dr. Abhimanyu Garg|214-648-2895|abhimanyu.garg@utsouthwestern.edu|
21271555|NCT00446654|Progen Pharmacauticals Ltd|Director of Clinical Trials|+61 7 32739133||
21271556|NCT02535000|Serviço de Anestesiologia de Joinville|Antonio Bedin|+554734331666|abjoimailbox-ct@yahoo.com|
21271557|NCT00168337|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21271558|NCT01620489|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21271559|NCT03929224|Michigan Ear Institute|Seilish Babu, MD|(248) 865-4444|sbabu04@gmail.com|
21271560|NCT01328054|GlaxoSmithKline|GSK Response Center|866-435-7343||
21271561|NCT00871728|Clinical Research Team, Medical Affairs, Medical Dept. Janssen Korea|Clinical Research Associate|+82-2-2094-4879||
21271562|NCT01288833|San Francisco VA Medical Center|Dr. Tonya Kaltenbach|415-221-4810|tonya.kaltenbach@va.gov|94121
21271563|NCT00686803|Palatin Technologies, Inc.|Robert Jordan, Executive Director of Clinical Operations|609.495.2200|rjordan@palatin.com|
21271564|NCT00140556|Duke University Medical Center, Dept Radiation Oncology|David Brizel, MD|919 668-5637|david.brizel@duke.edu|
21271565|NCT02472977|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Clinical.Trials@bms.com|Clinical.Trials@bms.com|
21271566|NCT02707432|University of North Carolina at Chapel Hill|Stephanie Hoover, PhD|919-966-1649|stephanie_hoover@med.unc.edu|
21271567|NCT01957657|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21271568|NCT02668302|Collin County ENT|Keith E Matheny, MD (Principal Investigator)|(972) 596-4005|kmatheny618@gmail.com|
21271569|NCT03775681|UT MD Anderson Cancer Center|Katherine Hagan, Associate Professor, Anesthesiology & PeriOper Med|(713) 794-5945|khagan@mdanderson.org|
21271570|NCT03558997|Regeneron Pharmaceuticals, Inc|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
21271571|NCT00616928|GlaxoSmithKline|GSK Response Center|866-435-7343||
21271572|NCT01149616|Beth Israel Deaconess Medical Center|Dr Lauren Fisher|6176671853|lauren_fisher@dmgaz.org|
21271573|NCT04326842|The First Affiliated Hospital of Harbin Medical University|Dr. Hong Zhang|+86 0451-85553952|2315186458@qq.com|
21271574|NCT00961051|Abbott Medical Optics|Eugenia Thomas, O.D.|714-247-8723|eugenia.thomas@amo.abbott.com|
21271575|NCT01357356|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
21271576|NCT03944785|Supernus Pharmacueticals|Gianpiera Ceresoli-Borroni|301-838-2521|gceresoliborroni@supernus.com|
21271577|NCT04535583|Geisel School of Medicine at Dartmouth|Dr. Lisa A. Marsch|603-646-7092|lisa.a.marsch@dartmouth.edu|
21271578|NCT01078090|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21271579|NCT00924066|National Cancer Institute|Antonio Fojo, M.D.|301-496-2631|fojot@mail.nih.gov|
21271580|NCT01748890|Massachusetts General Hospital|Anthony E. Samir|6178523241|asamir@partners.org|
21271581|NCT02669264|ADC Therapeutics|ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
21271582|NCT03529955|Tulane University|Carole Bitar, MD, FAAD|202-642-8122|cbitar@tulane.edu|
21271583|NCT04128696|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21271584|NCT03507439|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
21271585|NCT00401882|Beaumont|David Haines, MD|248-898-4198|david.haines@beaumont.edu|
21271586|NCT00557882|MedStar Washington Hospital Center|Andrew Sokol, MD|2028776526|andrew.i.sokol@medstar.net|
21271587|NCT03433001|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
21271588|NCT03043274|University of Kentucky|Dr. Khaled M. Ziada|8593236036|khaled.ziada@uky.edu|
21271589|NCT00820235|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
21271590|NCT01299038|Beth Israel Deaconess Medical Center|Jeffrey Zwicker, MD|617-667-9299|jzwicker@bidmc.harvard.edu|
21271591|NCT00006170|University of Pittsburgh|Dr. Michele Levine|412-647-0703|levinem@upmc.edu|
21271592|NCT00322556|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
21271593|NCT02040428|Ethicon, Inc.|Richard Kocharian, MD, PhD|1 (908) 218-2013|rkochar1@ITS.JNJ.com|
21301795|NCT04432727|Tactile Medical|Michelle Wetherby|612-230-4576|mwetherby@tactilemedical.com|
21271594|NCT00832078|Coloplast|Scientific Manager|+4549113557|dkkg@coloplast.com|
21271595|NCT02961920|Department of Anesthesiology and Pain Medicine, Gil Medical Center, Gachon University|Dr Junju Choi|82324603624|jjchoi2@gilhospital.com|
21271596|NCT01452529|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
21271597|NCT03551730|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
21271598|NCT00955032|Center for Neurological Restoration Cleveland Clinic|Dr. Hubert Fernandez|(216) 445-1108|fernandez@neurology.ufl.edu|
21271599|NCT04527471|Verona Pharma|Margot MacDonald-berko|833-417-0262|margot.macdonald-berko@veronapharma.com|
21271600|NCT03158298|Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany|Dr. Benjamin Schleenvoigt|+49 3641 9 32 46|benjamin.schleenvoigt@med.uni-jena.de|70
21271601|NCT01259427|VISN 5 MIRECC|Amy Drapalski|410-637-1855|amy.drapalski@va.gov|
21271602|NCT01492582|University of Alabama at Birmingham|Dr. Wendy Landier, Deputy Director, Institute for Cancer Outcomes and Survivorship|(205) 638-2120|wlandier@peds.uab.edu|
21271603|NCT01165996|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Yogen Saunthararajah, MD|216-444-8170|saunthy@ccf.org|
21271604|NCT00096265|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org|
21301796|NCT03860818|Ralph H. Johnson VA Healthcare System|Dr. David J. Taber|843.789.6624|David.Taber2@va.gov|
21301797|NCT00792571|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director|301-608-9292||
21301798|NCT02600819|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21271605|NCT01506323|VA San Diego Healthcare System|Dr. Jill E. Bormann|858-552-8585|jill.bormann@va.gov|x2378
21301799|NCT02631590|Moffitt Cancer Center|Richard Kim, MD, Principal Investigator|813-745-1277|Richard.Kim@moffitt.org|
21301800|NCT01621802|GlaxoSmithKline|GSK Response Center|866-435-7343||
21301801|NCT01149148|UmichiganHS|Dr. Wei C. Lau|734 9369479|weiclau@med.umich.edu|
21301802|NCT03436082|Yale School of Medicine|Joseph Ross, MD, MHS|203-785-2987|joseph.ross@yale.edu|
21301803|NCT04896086|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
21301804|NCT02917642|University of São Paulo|Dr. Ericka T. Pinheiro|551126488293|erickapinheiro@usp.br|
21301805|NCT02249832|Feinstein Institutes for Medical Research|Bruce T. Volpe, MD|(516) 562-3384|bvolpe1@northwell.edu|
21301806|NCT03010488|New York State Psychiatric Institute|David Hellerstein|646-774-8069|david.hellerstein@nyspi.columbia.edu|
21301807|NCT02078960|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21301808|NCT00859638|McMaster University|Dr. Julie Richardson|(905) 525-9140|jrichard@mcmaster.ca|27811
21301809|NCT01147627|The Third Affiliated Hospital of Sun Yat-sen University|Dr. Jianping Weng|86-20-85253162|wjianp@mail.sysu.edu.cn|
21301810|NCT04643158|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21301811|NCT02197078|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21301812|NCT00622440|University of California, San Francisco|Naomi Jay, PhD|415-353-7443|Naomi.Jay@ucsf.edu|
21301813|NCT02223377|Department of Anesthesia, McMaster University, Canada|Dr. Thuvaraha Vanniyasingam|(905) 525-9140|tvanniya@stjosham.on.ca|21736
21301814|NCT00771953|University of Maryland Baltimore Greenebaum Cancer Center|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu|
21301815|NCT03328208|Hypnalgesics, LLC|Elvira V. Lang, MD, CEO|6177349087|drevlang@comforttalk.com|
21301816|NCT00947193|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
21301817|NCT04364984|Medical Practice Prof D.Ivanov|Prof Dmytro Ivanov|0504448788|drivanovdd@gmail.com|+38
21301818|NCT02867384|Dana-Farber Cancer Institute|Corey Cutler, MD|6176323470|corey_cutler@dfci.harvard.edu|
21301819|NCT01652534|Northwestern University|Dr. Tanya Simuni|312-503-2970|tsimuni@nm.org|
21301820|NCT01941186|Child Health Institute of New Jersey|Manuel Jimenez, MD, MS|732-235-6230|jimenema@rwjms.rutgers.edu|
21301821|NCT02105961|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21301822|NCT01976091|Sarepta Therapeutics, Inc|Medical Information|1-800-690-2003|SareptAlly@sarepta.com|
21301823|NCT02722304|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21301824|NCT00934362|University of North Carolina at Chapel Hill|Dr. Scott Donaldson|919-966-9198|scott_donaldson@med.unc.edu|
21301825|NCT02566369|Galderma S.A.|Anne Fulton|+1 817-961-5203|anne.fulton@galderma.com|
21301826|NCT04154189|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21301827|NCT01092117|Endologix|Manager, Clinical Affairs|864-270-8524|nsmith@endologix.com|
21301828|NCT04173494|Sierra Oncology LLC - a GSK company|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21301829|NCT01623050|SinuSys Corporation|Janie Mandrusov, Director of Pre-Clinical and Clinical Development|4084104411|emandrusov@sinusys.com|
21301830|NCT02283827|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21301831|NCT02147561|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21301832|NCT01191762|Kenneth R. Phelps, M.D.|Kenneth R. Phelps, M.D.|518-626-5641|kenneth.phelps@va.gov|
21301833|NCT03898557|University of Pennsylvania|Alison M. Buttenheim, PhD MBA|215.573.5314|abutt@nursing.upenn.edu|
21301834|NCT03023813|Cleveland Clinic|Glen Taksler PhD|216-445-7499|taksleg@ccf.org|
21301835|NCT00393861|IndianaU|Lawrence H. Einhorn, M.D.|(317) 944-0920|leinhorn@iu.edu|
21301836|NCT03710083|Medtronic Minimed|Vivian Chen, Statistician|8185763309|vivian.chen@medtronic.com|
21301837|NCT02123472|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21301838|NCT03801031|University of Iowa|David Bender, MD|319-356-2015|david-bender@uiowa.edu|
21301839|NCT04625517|UT Southwestern Medical Center|Kelli Key, Ph.D.|214-648-8152|Kelli.Key@UTSouthwestern.edu|
21301840|NCT01598506|Emory University|Dr. Grant Lynde|404-778-3900|glynde@emory.edu|
21301841|NCT02471326|National Institute of Allergy and Infectious Diseases|Sneller, Michael|+1 301 496 0491|MSNELLER@niaid.nih.gov|
21301842|NCT00078897|University of Arizona|Dr. Elizabeth Jacobs|(520) 626-0341|jacobse@email.arizona.edu|
21301843|NCT03865381|Verily Life Sciences|Head of Clinical Science|(650) 253-0000|info@verily.com|
21301844|NCT00104520|Gilead Sciences, Inc.|Mark Bresnik, MD, Director, Clinical Research|(650) 522-5934|mark.bresnik@gilead.com|
21301845|NCT04073225|Johns Hopkins University|Michelle Carlson|(410) 790-8205|mcarlso2@jhu.edu|
21301846|NCT05186805|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
21301847|NCT00124306|University of Pennsylvania|J. Richard Landis, PhD|215-5734922|hultman@upenn.edu|
21301848|NCT04238819|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21301849|NCT05767749|Weill Cornell Medicine|Dr. Kira Minkis|(646) 962-3376|kim9036@med.cornell.edu|
21259471|NCT03106779|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
21259472|NCT04233229|Air Liquide Santé International|Marie-Danielle MILCENT / Clinical Project Manager|+33 (0)1 84 76 42 39|fralsi-ctpublication@airliquide.com|
21259473|NCT02288247|Astellas Pharma Europe Ltd. (APEL)|Clinical Trial Disclosure|+44 (0) 20 3379 8000|astellas.resultsdisclosure@astellas.com|
21259474|NCT04652804|Johns Hopkins Bloomberg School of Public Health|Shruti H. Mehta|443-287-3837|smehta@jhu.edu|
21259475|NCT00584194|USAMRIID Medical Division|Janice Rusnak, MD|301-619-4156|janice.rusnak@amedd.army.mil|
21259476|NCT04093531|University of Rochester|Ummara Shah, MD|585-275-1643|ummara_shah@urmc.rochester.edu|
21259477|NCT00841763|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21259478|NCT03473561|Abbott Laboratories|Suntje Sander, PhD|0049 - 511 - 6750 3254|suntje.sander@abbott.com|
21259479|NCT02876887|Northwestern University|Mary McDermott, MD, Jeremiah Stamler Professor|1 312 503 6419|mdm608@northwester.edu|6419
21259480|NCT00356031|Massachusetts General Hospital|Dr. Sam S. Yoon, Principal Investigator|617 643-9475|syoon@partners.org|
21259481|NCT01872338|VA New Jersey Healthcare System|Alejandro Interian, PHD|908-647-0180|alejandro.interian@va.gov|4617
21259482|NCT01284504|Stanford University|Anthony Doufas, MD, PhD|1-650-498-7699|agdoufas@stanford.edu|
21259483|NCT01109940|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21259484|NCT02769624|Cincinnati Children's Hospital Medical Center|Katy Fischesser|513-803-5191|katy.fischesser@cchmc.org|
21259485|NCT00179959|Children's Memorial Hospital|Amy Paller, MD|312-695-6829|apaller@nmff.org|
21259486|NCT00236080|Cephalon, Inc.|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
21259487|NCT01214044|Oregon Health & Science University and VA Portland Health Care System|Jonathan Emens, M.D.|503-220-8262|emensj@ohsu.edu|58490
21259488|NCT04698525|Medicine Faculty, Universidad Autónoma de San Luis Potosi|Ildefonso Rodriguez-Leyva MD, PhD|4442043016|ildefonso.rodriguez@uaslp.mx|
21259489|NCT01961544|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
21259490|NCT03543410|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
21259491|NCT02211261|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21259492|NCT02817087|Houston Methodist Neurological Institute|David Chiu, M.D.|713-441-5801|dmccane@houstonmethodist.org|
21259493|NCT06468059|Kennesaw State University|Mark Geil|(470) 578-4805|mgeil@kennesaw.edu|
21259494|NCT00480857|University of Michigan Comprehensive Cancer Center|Dr. Daniel Hamstra|(734) 936-4300|dhamm@umich.edu|
21259495|NCT02199197|Huntsman Cancer Institute Research Compliance Office|Data Manager|801-585-0601|compliance@hci.utah.edu|
21259496|NCT02551159|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21259497|NCT06098729|Yale University|Garrett Ash|2034443079|garrett.ash@yale.edu|
21259498|NCT02129660|Dermira, Inc.|Eugene A. Bauer, MD, Chief Medical Officer|650-421-7202|eugene.bauer@dermira.com|
21259499|NCT00956254|Insys Therapeutics, Inc.|Larry Dillaha, M.D., Chief Medical Officer|602 910-2617|ldillaha@insysrx.com|
21259500|NCT02175680|CytoDyn Inc.|Joseph Meidling, Sr. Director Clinical Operations|(360) 980-8524|jmeidling@cytodyn.com|
21259501|NCT02052557|Des Moines University|Grants and Contracts Manager|5152711657|mlyon@dmu.edu|
21259502|NCT00874250|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com|
21259503|NCT01116544|Oregon Health & Science University|Dr. Paul Cordo|503 418 2520|cordop@ohsu.edu|
21271606|NCT02232074|Boston Medical Center|Tracy Battaglia|617.638.8036|tracy.battaglia@bmc.org|
21271607|NCT00017563|OHSU Knight Cancer Institute|Tomasz Beer, M.D.|503-494-1080|beert@ohsu.edu|
21271608|NCT04081337|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21271609|NCT01579474|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21271610|NCT02642627|Suneva Medical|Director of Clinical Affairs|858-324-6268|alehman@sunevamedical.com|
21271611|NCT02295774|Humanitas Research Hospital & Humanitas University|Alessandro Repici MD|00390282247493|alessandro.repici@hunimed.eu|
21271612|NCT01075763|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21271613|NCT00586521|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21271614|NCT00580853|Yale University|Sherry McKee PhD|203-737-3529|sherry.mckee@yale.edu|
21259504|NCT02419508|Alcon, A Novartis Division|Brand Medical Director Ophtha, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com|
21259505|NCT01332071|GlaxoSmithKline|GSK Response Center|866-435-7343||
21259506|NCT00494143|VA Puget Sound Health Care System|Dr. Joseph Czerniecki|206 277 5188|joseph.czerniecki@va.gov|
21259507|NCT01738971|University of Edinburgh|Dr Lucy Michie|0131 5361542|michieluc@yahoo.co.uk|
21259508|NCT03219866|Wake Forest Health Science|Jill Ohar, MD|336-716-1210|johar@wakehealth.edu|
21259509|NCT04698629|University of Washington|Dr. Judith Tsui|206-744-1835|tsuij@uw.edu|
21259510|NCT02320487|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21259511|NCT05523973|University of Cincinnati|Dr. Brittany Krekeler, PI|5132272759|krekelby@ucmail.uc.edu|
21259512|NCT01903265|Tonix Pharmaceuticals|Gregory M. Sullivan, MD, Chief Medical Officer|212 980 9155|Gregory.Sullivan@TonixPharma.com|117
21259513|NCT01475734|GlaxoSmithKline|GSK Response Center|866-435-7343||
21259514|NCT03054363|University of Colorado Hospital|Elena Shagisultanova, MD, PhD|7208480300|elena.shagisultanova@cuanschutz.edu|
21259515|NCT03242954|Indiana University School of Nursing|Amy Knopf|206-356-9430|asknopf@iu.edu|
21259516|NCT04690699|Istari Oncology|Head of Clinical Operations|919-245-7662|info@istarioncology.com|
21259517|NCT00667576|Abbott Japan Co., Ltd.|Global Medical Services|800-633-9110||
21259518|NCT02265913|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
21259519|NCT00670007|CSL Behring|Clinical Trial Disclosure Manager|Use Email contact|clinicaltrials@cslbehring.com|
21259520|NCT00618722|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
21259521|NCT00925600|Amgen Inc.|Study Director|866-572-6436||
21259522|NCT00624221|Cornea Research Foundation of America|Marianne O. Price, PhD|317-814-2990|mprice@cornea.org|
21259523|NCT04785612|hVIVO|Alex Mann|+44(0)7738321671|a.mann@hvivo.com|
21259524|NCT00127127|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21259525|NCT00200057|Medtronic Neuromodulation|Chad Giese|763-377-5955|chad.giese@medtronic.com|
21259526|NCT03652909|Ascending Hearing Technologies, LLC|Christina Runge|2623523478|chrunge@mcw.edu|
21259527|NCT01059448|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21259528|NCT00778830|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21259529|NCT05512949|St. Louis University|Sharon E. Frey, M.D.|314-977-5500|sharon.frey@health.slu.edu|
21259530|NCT01891643|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21259531|NCT01542307|Massachusetts General Hospital|Aneesh Singhal, MD|6177268459|asinghal@partners.org|4
21259532|NCT02810964|Sheppard Pratt|Dr. Faith Dickerson|410-938-4359|fdickerson@sheppardpratt.org|
21271615|NCT03083483|Duke University|Hannah Palmer|919-613-7665|hlp14@duke.edu|
21271616|NCT01633827|Brigham and Women's Hospital|David Andrew Wellman|617-732-8483|awellman@rics.bwh.harvard.edu|
21271617|NCT01626820|GlaxoSmithKline|GSK Response Center|866-435-7343||
21271618|NCT03581474|Ambu A/S|Anna Charlotte Lundgaard|+4529643748|aclu@ambu.com|
21271619|NCT02588573|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com|
21271620|NCT00449072|sanofi-aventis|Trial Transparency Team||Contact-Us@sanofi.com|
21271621|NCT02623959|UT MD Anderson Cancer Center|Ost,David,M.D. / DOST@MDANDERSON.ORG|713-745-8775|DOst@mdanderson.org|
21271622|NCT00989261|Contact for Clinical Trial Information|Daiichi Sankyo|1-908-992-6400|CTRinfo@dsi.com|
21271623|NCT06076681|TenNor Therapeutics (Suzhou) Limited.|TenNor Medical Information|0512-86861979|info@tennorx.com|
21271624|NCT00441584|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21271625|NCT00368966|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21271626|NCT01584609|Penumbra, Inc.|Michaella Corso|(510) 748-3200|mcorso@penumbrainc.com|
21271627|NCT01694485|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21271628|NCT02907203|W. L. Gore and Associates|Rizwan Afzal|6236404888|rafzal@wlgore.com|
21271629|NCT00619619|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21271630|NCT01689974|New York University School of Medicine|Sylvia Formenti, MD|646.962.4073|formenti@med.cornell.edu|
21271631|NCT00804609|Stanford University|Brendan Carvalho|650-861-8607|bcarvalho@stanford.edu|
21271632|NCT01388647|Vector Oncology|Vice President of Scientific Affairs|901-435-5550|mwalker@vectoroncology.com|1759
21271633|NCT01006707|Stanford University School of Medicine|Dr. Larry Chu|(650) 723-6632|lchu@stanford.edu|
21271634|NCT00952484|Alexion Pharma GmbH|Alexion Pharma GmbH|(617) 494-1393|ClinicalTrials@alxn.com|
21271635|NCT02422290|New York State Psychiatric Institute|Pablo H. Goldberg, MD|646-774-6318|Pablo.Goldberg@nyspi.columbia.edu|
21286687|NCT02654639|Levine Cancer Institute-Concord|Mohamed Salem, MD|704-403-1370|mohamed.salem@lcic.edu|
21271636|NCT00192296|MedImmune|Joseph Parker, MD|301-398-0000|parkerj@medimmune.com|
21271637|NCT00897897|Philips Healthcare|Director, Clinical and Regulatory Affairs|425-487-7665|sarah.baxter@philips.com|
21286688|NCT04821063|Italfarmaco SpA|Maurizio Caserini, MD|+39 02 6443 2575|m.caserini@italfarmacogroup.com|
21259533|NCT03523351|Memorial Sloan Kettering Cancer Center|Dr. Divya Yerramilli, MD|646-449-1931|yerramid@mskcc.org|
21271638|NCT01110681|Q-Med AB|Head of Medical Affairs|+ 46 (0)18 4749000|reception.SEUPP@galderma.com|
21271639|NCT00565370|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
21271640|NCT01847196|BiO2 Medical|Margaret Tumas, VP of Clinical Affairs|720-635-3232|mtumas@bio2medical.com|
21271641|NCT03267030|NOPHO|Dr Birgitte Klug Albertsen|+45 20224643|biralber@rm.dk|
21271642|NCT00696709|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21271643|NCT02462070|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
21271644|NCT00443352|Thomas Jefferson University|William B Young, MD|215-955-2243|william.b.young@jefferson.edu|
21271645|NCT00321711|Amgen Inc.|Study Director|866-572-6436||
21271646|NCT01227668|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21271647|NCT03979209|Rush UMC|Bobby Tajudeen, MD|312-942-6100|Bobby_Tajudeen@rush.edu|
21271648|NCT01261325|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493||
21271649|NCT01878656|Chung-Ang University Hospital|Dr. Chong Wha Baek|82-2-6299-2579|nbjhwa@naver.com|
21271650|NCT01505465|HSS|Dr. Memtsoudis|(212) 606-1000|MemtsoudisS@hss.edu|
21271651|NCT02330081|Terumo BCT|Beth Crump|+1 303 231-4606|beth.crump@terumobct.com|
21271652|NCT02277769|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
21271653|NCT01626885|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21271654|NCT00526890|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21271655|NCT01688037|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
21271656|NCT03035227|Kansas City Heart Rhythm Institute|Dr. Dhanunjaya Lakkireddy|913-449-1297|dhanunjaya.lakkireddy@hcahealthcare.com|
21271657|NCT02100956|Wake Forest University School of Medicine|Professor James C. Eisenach, MD|336-716-4182|jimeisenach@gmail.com|
21271658|NCT02220907|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21271659|NCT01983020|Beth Israel Medical Center|Ronald Kaplan, MD||rkaplan@chpnet.org|
21271660|NCT01098240|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21271661|NCT03280537|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21271662|NCT01588106|GWT-TUD GmbH|Dr. Carsta Köhler|+49 (0) 351 25933 100|contact@gwtonline.de|
21271663|NCT03083132|University of Arkansas for Medical Sciences|Dr. Tuhin Virmani|501-686-7235|tvirmani@uams.edu|
21271664|NCT02995837|University of Miami|Ignacio Tapia, MD|3052439885|itapia@miami.edu|
21271665|NCT03118739|AstraZeneca R&D|Fredrik Erlandsson, Global Clinical Lead|+46317762365|Fredrik.Erlandsson@astrazeneca.com|
21271666|NCT01859702|Alcon Research, Ltd.|Abayomi Ogundele, Global Medical Affairs Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21271667|NCT01893138|Cook MyoSite, Inc.|Ron Jankowski, PhD|412-963-7380|Ron.Jankowski@CookMyosite.com|
21271668|NCT01326026|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21271669|NCT01170260|University of New Mexico Health Sciences|Hadya Khawaja|505-272-7028|hkhawaja@salud.unm.edu|
21271670|NCT04317053|NYU Langone Health|Kelly Doran, MD, MHS|212-263-5850|Kelly.Doran@nyulangone.org|
21271671|NCT00289458|University of Saskatchewan|Dr. Cathy M. Arnold|306 966 6588|cathy.arnold@usask.ca|
21271672|NCT04274192|University of Arkansas for Medical Sciences|Dr. Sherry Courtney|501-364-1028|SECourtney@uams.edu|
21271673|NCT00874757|University of Nebraska Medical Center|Timothy R McGuire|402-651-2496|trmcguir@unmc.edu|
21271674|NCT00974142|University of Pittsburgh Medical Center|Michael Donahoe MD|412-648-9636|donahoem@upmc.edu|
21271675|NCT03369756|B. Braun Medical Inc.|Dr. Diana Valencia|610-596-2875|diana.valencia@bbraunusa.com|
21271676|NCT01132118|Brigham and Women's Hospital|Dr. Daniel H. Solomon|617-525-8127|dsolomon@partners.org|
21271677|NCT03287050|University of Michigan|Zachery Reichert|764-3066|zreiche@med.umich.edu|
21271678|NCT00313703|Montefiore Medical Center|Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
21271679|NCT01060670|Integra LifeSciences, Inc.|Katie Bush, PhD- Manager, Global Medical Affairs- Tissue Technology|617-268-1616|katie.bush@integralife.com|267
21271680|NCT00094302|New England Research Institutes|Brian Harty|617-972-3224|bharty@neriscience.com|
21271681|NCT04089982|Duke University|James M. Davis, MD|919-668-5055|james.m.davis@duke.edu|
21271682|NCT03889756|Yale University|Dr. Michael Bloch|203 7374809|michael.bloch@yale.edu|
21271683|NCT01535326|Dalin Tzu Chi Hospital|Dr. Yu-Hsi Hsieh|88652648000|hsieh.yuhsi@msa.hinet.net|5241
21271684|NCT00929500|Beth Israel Deaconess Medical Center|Dr. Vera Novak|617-632-8680|vnovak@bidmc.harvard.edu|
21271685|NCT01469364|Duke University|Dr. Scott Palmer|919-684-0245|palme002@mc.duke.edu|
21271686|NCT00958581|NYU hospital for Joint Diseases|Dr. Thomas Errico (Chief of Spine), Dr. Kushagra Verma (Co-investigator)|212-598-6076|thomas.errico@nyumc.org; vermak01@gmail.com|
21271687|NCT01236170|VA Pittsburgh Healthcare System|Dr. Larissa Myaskovsky|4123602241|Larissa.Myaskovsky@va.gov|
21271688|NCT02442856|University of Pennsylvania|Michael Mullen|215-662-3339|mmullen@pennmedicine.upenn.edu|
21271689|NCT00958256|University of Texas (UT) MD Anderson Cancer Center|Jorge Romaguera, MD/Professor, Lymphoma/Myeloma|713-792-2860|CR_Study_Registration@mdanderson.org|
21271690|NCT01769209|Stanford University Medical Center|Michaela Liedtke, MD|650-498-6000|mliedtke@stanford.edu|
21271691|NCT05431153|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21271692|NCT02324972|Aquinox Pharmaceuticals (Canada) Inc.|Clinical|+1 604-629-9223|clinical@aqxpharma.com|
21271693|NCT01082952|King Saud University|Dr. Rabih Halwani|00966551307134|rhalwani@ksu.edu.sa|
21271694|NCT00576901|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21271695|NCT01259869|Canadian Cancer Trials Group|Lesley Seymour|6135336430|lseymour@ctg.queensu.ca|
21271696|NCT00118053|Cancer Institute of New Jersey|Deborah Toppmeyer, MD|732-235-8675|toppmede@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
21271697|NCT00220701|NY State Psychiatric Institute|David Hellerstein MD|6467748000|hellers@nyspi.columbia.edu|
21271698|NCT02140957|St. Michael's Hospital|Dr. Jonathon Maguire|(416) 919-3462|jonathon.maguire@utoronto.ca|
21271699|NCT02971956|Dana-Farber Cancer Institute|Peter C. Enzinger MD|(877) 442-3324|Peter_Enzinger@dfci.harvard.edu|
21271700|NCT03256968|Universtiy of Alabama at Birmingham|Steven Rowe|205-975-9776|srowe@uabmc.edi|
21271701|NCT02363907|Dexcom|Eileen Casal, RN, MSN|8588759774|ecasal@dexcom.com|
21271702|NCT00634907|University of Utah|Dr. Gwen McMillin/Principal Investigator|801-583-2787|gwen.mcmillin@aruplab.com|2671
21271703|NCT01617577|University of South Florida|Professor Juan Sanchez-Ramos|813-974-5841|jsramos@health.usf.edu|
21271704|NCT04041570|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
21271705|NCT01338636|Brigham and Women's Hospital Heart and Vascular Center|Aaron B. Waxman|617-525-9733|abwaxman@partners.org|
21271706|NCT02385526|Cyberonics, Inc.|Peter Sears, Clinical Project Manager|(281) 228-7597|peter.sears@cyberonics.com|
21271707|NCT02498522|AinShamsU|Dr. Ahmed kotb|1008681999|ahmedmkotp@hotmail.com|+20
21271708|NCT03532009|Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21271709|NCT02866175|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21301850|NCT00114517|University of Southern California|Howard N. Hodis, M.D., Director, Atherosclerosis Research Unit|323-442-1478|athero@usc.edu|
21301851|NCT03760718|Oregon Health & Science University|Brandon Togioka, MD|503-494-4572|togioka@ohsu.edu|
21301852|NCT04236141|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21259534|NCT01734655|Pennington Biomedical Research Center|Dr. Corby K. Martin|225-763-2585|corby.martin@pbrc.edu|
21259535|NCT01430442|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
21259536|NCT04051957|The University of Texas Health Science Center at Houston|Jaya Kala, MD|713-500-6868|jaya.kala@uth.tmc.edu|
21259537|NCT01929057|UCSD Dermatology Clinical Trials|Dermatology Clinical Trial Manage|(858)657-8390|dermstudies@ucsd.edu|
21259538|NCT00132041|American College of Radiology Imaging Network|Donna Harfeil, Director of Protocol Management|215-717-2765|Donna Hartfeil <dhartfeil@acr.org>|
21259539|NCT03969875|Icahn School of Medicine at Mount Sinai|Dr. Poonam Pai|212-523-4000|poonam.paibantwalhebbalasankatte@mountsinai.org|
21259540|NCT00167245|University of Pennsylvania|Dr. Kyle Kampman|2152223200|kampman@mail.med.upenn.edu|109
21259541|NCT03057366|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21259542|NCT02911688|Center for Environmental Medicine Asthma and Lung Biology|Carole Robinette Assistant Director of Clinical Research|919 966-5638|carole_robinette@med.unc.edu|
21259543|NCT04201717|FIrst Hospital of Jilin University|Dr. Quan Wang|+86 ‭15843073207‬|wquan@jlu.edu.cn|
21259544|NCT02274688|University of Washington|Douglas Zatzick|2067446701|dzatzick@uw.edu|
21259545|NCT03562663|Moss Rehabilitation Research Institute|Dylan Edwards|(215) 663-6411|EdwardDy@einstein.edu|
21259546|NCT00947531|EVERNeuro Pharma|Head of R&D|+43 7665 20555|stefan.winter@everpharma.com|0
21259547|NCT03856944|Gainesville Eye Associates|Clayton Blehm, MD|770-532-4444|claytonblehm@gmail.com|
21259548|NCT01773421|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
21259549|NCT02327260|University of Missouri, Kansas City|Dr. Kym Bennett|816-235-6370|bennettkk@umkc.edu|
21259550|NCT03502330|Harvey and Kate Cushing Professor of Medicine (Oncology) and of Dermatology; Director, Yale SPORE in Skin Cancer, Yale Cancer Center|Harriet Kluger, MD|(203) 200-6622|harriet.kluger@yale.edu|
21259551|NCT01936389|NYGRI|Jessica Jasien, MEn|2124777540|jjasien.ganyresearch@gmail.com|371
21259552|NCT01496157|Johns Hopkins University|Steven Rowe, M.D, Ph.D|4105021520|srowe8@jhmi.edu|
21259553|NCT02804763|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21259554|NCT00445302|Genzyme Corporation|Genzyme Medical Information|1-800-745-4447||
21259555|NCT01400932|GlaxoSmithKline|GSK Response Center|866-435-7343||
21259556|NCT00860158|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
21259557|NCT02472847|University of Illinois at Chicago|Dr. K. Luan Phan|312-355-5954|klphan@psych.uic.edu|
21259558|NCT04656990|University of South Carolina|Director, USC Office of Research Compliance|803 777-6670|lisaj@mailbox.sc.edu|
21259559|NCT03244059|University of Alabama at Birmingham|Mark Dransfield MD|205-934-5425|mdransfield@uabmc.edu|
21259560|NCT05499520|University of Pennsylvania|Andy Tan|2157466546|andy.tan@asc.upenn.edu|
21259561|NCT00006227|NRG Oncology|Christopher Purdy on behalf of Mark Brady PhD|(716)845-1300|purdyc@nrgoncology.org|2296
21259562|NCT00840827|Weill Cornell Medicine|Clinical Trials Administrator|212-746-0284|ray2013@med.cornell.edu|
21259563|NCT05195528|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-7428|medicalinformation@phathompharma.com|
21259564|NCT02487108|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21259565|NCT02720757|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21259566|NCT01175005|Phoenixchildrens|Amanda Kasem|6025461910|akasem@phoenixchildrens.com|
21259567|NCT00168831|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21259568|NCT00059202|Mayo Clinic|Dr. Keith Lindor|507-284-2511||
21259569|NCT00648167|Keryx Biopharmaceuticals Inc|Medical Information|1-844-44-KERYX (1-844-445-3799|medicalinfo@keryx.com|
21259570|NCT00927368|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
21271710|NCT01602614|University of Alabama at Birmingham|David Kimberlin, MD|205 934-2424|Dkimberlin@peds.uab.edu|
21238164|NCT00448448|University of Iowa Dept of Orthopaedics and Rehabilitation|Dr. Lori A. Dolan|319-356-1075|lori-dolan@uiowa.edu|
21238165|NCT00946296|UMass Medical School|Dr. Giles Whalen|508-334-5202|Giles.Whalen@umassmemorial.org|
21238166|NCT02676375|Department of Psychiatry, University of California San Diego|Dr. Arthur Brody|8585528585|abrody@ucsd.edu|3775
21238167|NCT04751942|Univeristy Hosptials Cleveland Medical Center|Rachael Kilkenny|216-545-4850|Rachael.Kilkenny@UHhosptials.org|
21238168|NCT01422408|Knight Cancer Institute, Oregon Health & Science University|Emile Latour|503-418-9601|latour@ohsu.edu|
21238169|NCT02954523|Georgetown University|Chul Kim|12024442223|Chul.Kim@gunet.georgetown.edu|
21301853|NCT01925131|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|amoseley@fredhutch.org|
21238170|NCT02038894|Cincinnati Children's Hospital Medical Center|Dr. Mario Patino|5132538190|mario.patino@cchcm.org|
21238171|NCT03124979|Masimo|Tala Harake||studies@masimo.com|
21238172|NCT04209075|NIDDK|Dr. Stephanie Chung|301-402-2122|Stephanie.Chung@NIH.gov|
21238173|NCT03599349|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 865|clinicaltrials@merz.com|
21238174|NCT04639128|The Permanente Medical Group|Dr. Adrian Hinman|510-454-7292|adrian.d.hinman@kp.org|
21259571|NCT00592475|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
21259572|NCT01482910|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21301854|NCT03390114|Indiana University School of Medicine|Samir K. Gupta, MD, MS|3172747926|sgupta1@iu.edu|
21301855|NCT03036215|HealthPartners Institute|James Fricton, DDS, Senior Research Investigator|6126191678|james.r.fricton@healthpartners.com|
21301856|NCT01395524|AstraZeneca|Mark Sostek||aztrial_results_posting@astrazeneca.com|
21301857|NCT01657461|Medtronic|Manish Gupta, Sr. Director of Medical Affairs|949 297 5494|manish.s.gupta@medtronic.com|
21259573|NCT00331409|Oregon Health and Science University|Christopher W. Ryan|503-494-1951|ryanc@ohsu.edu|
21259574|NCT03222349|Aquestive Therapeutics|Director of Clinical Operations|908-941-1887|denis.scheper@aquestive.com|
21259575|NCT03739528|NTC srl|Alessandro Colombo|+390243850490|alessandro.colombo@ntcpharma.com|
21259576|NCT01110395|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
21259577|NCT00506857|UT MD Anderson Cancer Center|Richard E. Champlin/Professor||ytdinh@mdanderson.org|
21259578|NCT05099640|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
21259579|NCT01552681|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21259580|NCT03075163|UC Davis Anesthesiology & Pain Medicine|Neal Fleming, MD, PhD|916 734-5046|nwfleming@ucdavis.edu|
21259581|NCT00923117|National Cancer Institute, National Institutes of Health|Dr. Teri Kreisl|301-402-3423|kreislt@mail.nih.gov|
21259582|NCT01731678|University of Calgary|Frank MacMaster, PI of the project|403-955-2784|fmacmast@ucalgary.ca|
21286689|NCT00126594|University of Texas (UT) MD Anderson Cancer Center|Eric Jonasch, MD/Associate Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org|
21286690|NCT00853762|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21286691|NCT02000921|University of Minnesota|Dorothy Hatsukami|612 626-2121|hatsu001@umn.edu|
21286692|NCT01607658|Acerus Pharmaceuticals Corporation|Dr. Nathan Bryson, Chief Scientific Officer|1-416-679-0776|nbryson@aceruspharma.com|
21286693|NCT01290718|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21286694|NCT00915590|Massachusetts Eye and Ear Infirmary|Reza Dana, MD, MPH, MSc|617-573-3313|Cornea_Research@meei.harvard.edu|
21286695|NCT02631941|Zambon S.p.A.|Isabella Salerio, PhD|+3902665241|clinicaltrials@zambongroup.com|
21286696|NCT00501631|Alkermes, Inc.|Bernard L. Silverman, MD|1-781-609-6000|bernard.silverman@alkermes.com|
21286697|NCT00719901|Mayo Clinic|A. Keith Stewart|480-301-4411|stewart.keith@mayo.edu|
21286698|NCT03836586|University of Florida|Dr. Ellen Terry|352-273-6441|elterry@ufl.edu|
21286699|NCT04456686|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21286700|NCT02532036|University of Oxford|Professor Helen McShane|+44 (0)1865 617606|helen.mcshane@ndm.ox.ac.uk|
21286701|NCT02858401|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21286702|NCT00685516|UCLA|Susanne Henning, Ph.D., Principal Investigator|310-825-9345|shenning@mednet.ucla.edu|
21286703|NCT03250689|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21301858|NCT04075812|The Ohio State University|Marcia Bockbrader MD PhD|6142933127|bockbrader.13@osu.edu|
21301859|NCT01574183|MUSC|Aimee McRae-Clark, PharmD|843-792-5216|mcraeal@musc.edu|
21301860|NCT00147069|Imperial College London|Professor Louise Donnelly|+44 (0)20 7594 7895|l.donnelly@imperial.ac.uk|
21301861|NCT02175199|Alcon Research, Ltd.|Global Brand Lead, GCRA, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21301862|NCT00122980|Baylor College of Medicine|Russell E. Ware, MD, PhD, Director, Texas Children's Hematology Center|(832) 824-1368|reware@bcm.edu|
21301863|NCT00459732|Children's Hospital & Research Center, Oakland|Ellen Fung, PhD RD CCD|510-428-3885|efung@mail.cho.org|4939
21301864|NCT01124864|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21301865|NCT03093662|Brooke Army Medical Center|Dr. Derek Brown|2109160808|Derek.J.Brown1.mil@mail.mil|
21301866|NCT05480111|The University of Texas Health Science Center at Houston|Randa J Jalloul, MD|713-566-5749|Randa.J.Jalloul@uth.tmc.edu|
21301867|NCT01322841|Indiana University School of Medicine|Aaron Carroll|3172789616|aaecarro@iu.edu|
21301868|NCT01761162|Biotronik, Inc.|Clinical Studies Engineer|503-927-7230|justin.michalski@biotronik.com|
21301869|NCT01077921|Duke University Medical Center|Laura De Castro, MD, MHSc|(412) 623-7026|laura.decastro@dm.duke.edu|
21301870|NCT01505764|Department of Veterans Affairs|Jose M Garcia MD, PhD, Clinician Investigator|206-7642984|jose.garcia@va.gov|
21301871|NCT00724711|Gilead Sciences|Dara Wambach, MA, Associate Director, Regulatory Affairs|650 522 5163|Dara.Wambach@gilead.com|
21301872|NCT00745849|University of Texas Southwestern|Ganesh Shanmugam, MD|9797036112|ganesh01@yahoo.com|
21271711|NCT03463525|AstraZeneca|Global Clinical Lead|+1 877-240-9479|information.center@astrazeneca.com|
21271712|NCT00681863|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21271713|NCT01333033|Alliance for Clinical Trials in Oncology|Karyn Goodman, M.D.|(212) 639-3983|goodmank@mskcc.org|
21271714|NCT02750306|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21271715|NCT00760383|Human Physiology, University of Oregon|Hans C. Dreyer, PT, PhD|541-346-5775|hcdreyer@uoregon.edu|
21271716|NCT02659202|Mayo Clinic|Dr. Bruce Johnson|507-284-4375|johnson.bruce@mayo.edu|
21271717|NCT01842958|Straumann USA, LLC|Kelly Jork|978-747-2533|kelly.jork@straumann.com|
21271718|NCT03361423|Theranica Bio-Electronics Ltd|Dr Dagan Harris. VP Clinical & Regulatory Affairs|+972723909755|daganh@theranica.com|
21271719|NCT00818623|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21271720|NCT04317781|The University of Texas MD Anderson Cancer Center|Qaiser Bashir, M.D. / Stem Cell Transplantation and Cellular Therapy Department|713-794-4422|qbashir@mdanderson.org|
21271721|NCT02087059|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
21271722|NCT05425966|University of California San Francisco|Lauren Haack, PhD|415-502-8060|lauren.haack@ucsf.edu|
21271723|NCT01851590|Department of Cardiac Surgery, Heart and Lung Centre, Helsinki University Hospital, Finland|Janne Jokinen, MD, PhD, Consultant Cardiothoracic Surgeon|50 554 8103|janne.jokinen@helsinki.fi|+358
21271724|NCT00310856|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21271725|NCT02843074|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
21271726|NCT01564758|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21271727|NCT01186978|Duke University Health System|Assistant Research Practice Manager (ARPM) for Clinical Trials|919-668-5211|Jennifer.Mewshaw@duke.edu|
21271728|NCT01306253|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
21271729|NCT00543439|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21271730|NCT04749524|Intelligent Hearing Systems Corp|Dr. Rafael E. Delgado|305-668-6102|redelgado@ihsys.com|
21271731|NCT01709383|Georgetown University|Elizabeth H. Lacey, PhD, Study Coordinator|202-877-1124|ehl4@georgetown.edu|202
21271732|NCT03264066|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21271733|NCT01484028|Vistakon, Johnson and Johnson Vision Care|Dr. Michael Mayers, O.D., FAAO, Senior Research Optometrist|1 904 443 3252|mmayers@its.jnj.com|
21271734|NCT02400710|Center for Integrated Healthcare, Syracuse Veterans Affairs Medical Center|Kyle Possemato, Ph.D.|315-425-4400|kyle.possmato@va.gov|53551
21271735|NCT02922959|University of Cincinnati Addiction Sciences Division|Theresa Winhusen|5135858292|winhust@ucmail.uc.edu|
21271736|NCT03187080|University of Wisconsin School of Medicine and Public Health|Venkat Rao, MD, MBA|(608) 263-1223|rao@surgery.wisc.edu|
21271737|NCT03872700|Montefiore Medical Center|Dr. Benjamin W Friedman|718-920-6626|befriedm@montefiore.org|
21271738|NCT00492206|University of Pittsburgh Cancer Institute|Ahmad Tarhini, MD|412-648-6507|tarhiniaa@upmc.edu|
21271739|NCT01193517|UT MD Anderson Cancer Center|Dr. Michael J Overman/ Professor, GI Medical Oncology|713-792-2828|moverman@mdanderson.org|
21271740|NCT00722111|VAHSRD|Dr. JoAnne Robbins|608-256-1901|bert.landreth@va.gov|11697
21271741|NCT04014959|University of Pennsylvania|Dr. Desmond Oathes, Principal Investigator|215-573-9390|oathes@pennmedicine.upenn.edu|
21271742|NCT05286528|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21271743|NCT02004847|Philips GmbH Innovative Technologies Aachen|Prof. Dr. Matthias Born|+491735321764|matthias.born@philips.com|
21271744|NCT00759148|Alcon Research, Ltd.|Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21271745|NCT01644890|Nippon Kayaku Co., Ltd.|Pharmaceuticals Group|+81-3-6731-5200||
21271746|NCT02452060|NYU Langone Medical Center|Jing Wang|212-460-0176|jing.wang@nyulangone.org|
21271747|NCT03031899|The Oxford Dental college|Dr. Anisha Yaji|9480718531|dr.anishayaji@gmail.com|
21271748|NCT03705351|Providence Health & Services|Chiayi Chen / Director of PBSI and WC Clinical Research Program|(503) 216-1012|Chiayi.Chen@providence.org|
21271749|NCT00494975|Dermatology|Ko Mei-Ju|886-223123456|kmjmay@gmail.com|2141
21271750|NCT00633152|Cerexa, Inc.|Vice President, Clinical Sciences|510-285-9200|clinicaltrials@cerexa.com|
21271751|NCT02180061|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21271752|NCT02557945|New York State Psychiatric Institute|Scott Small, MD|212-305-1269|sas68@cumc.columbia.edu|
21271753|NCT00056160|Celgene Corporation|Robert Knight, M.D.|908-673-9749|rknight@celgene.com|
21271754|NCT00789802|Washington University|Dr. Tessa Madden|3147471331|maddent@wustl.edu|
21271755|NCT01590433|Beth Israel Deaconess Medical Center|Jody Dushay|617-667-9344|jdushay@bidmc.harvard.edu|
21271756|NCT00555009|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21271757|NCT02243020|MicroTransponder Inc.|VP Clinical Affairs|5123714160|brent@microtransponder.com|
21271758|NCT05432271|University of Pennsylvania|Dr. Laura Gibson|215-898-7093|gibla@pennmedicine.upenn.edu|
21271759|NCT03020472|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
21271760|NCT03731182|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21271761|NCT01751412|Massachusetts General Hospital|Thomas F. DeLaney, MD|617-726-6876|TDELANEY@mgh.harvard.edu|
21271762|NCT01711021|Noven Pharmaceuticals, Inc.|Study Director|(305) 253-5099|ClinicalTrials@noven.com|
21271763|NCT03734237|USUHS|Timothy Burgess, MD, MPH|(301) 295-9792|timothy.burgess@usuhs.edu|
21271764|NCT01844583|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21271765|NCT02207621|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director of Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
21271766|NCT02833415|University of Texas Southwestern Medical Center|Ian J. Neeland MD|214-645-1267|ian.neeland@utsouthwestern.edu|
21271767|NCT03036579|University of Michigan|Dennis J. Fasbinder, DDS|7346474450|djfas@umich.edu|
21271768|NCT03996603|University of Alabama at Birmingham|Kyle Norris, MD Principal Investigator|(205) 934-1704|kyleparkernorris@gmail.com|
21271769|NCT02207309|Ludwigs-Maximilians-Universtity of Munich|Lars Lindner|0049894400|Lars.Lindner@med.uni-muenchen.de|74768
21271770|NCT02398188|Neothetics, Inc.|Neothetics Clinical|858-550-1900||
21271771|NCT03209570|Insight Therapeutics, LLC|H. Edward Davidson, PharmD, MPH|7576246040|EDavidson@inther.com|
21271772|NCT01176448|University of Virginia Dept of Otolaryngology Head and Neck Surgery|J. Jared Christophel MD|434-243-9391|jjchristop@gmail.com|
21271773|NCT00755326|University of Maryland Center for Integrative Medicine|Brian M. Berman|410706-6181|bberman@som.umaryland.edu|
21271774|NCT03119064|Brown University Oncology Research Group|Heinrich Elinzano, MD|401-863-3000|BrUOG@BROWN.EDU|
21271775|NCT01829477|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21271776|NCT03465891|Memorial Sloan Kettering Cancer Center|Dr. Lia Palomba|646-608-3711|palombam@mskcc.org|
21271777|NCT00710203|UC Davis, Department of Dermatology|Daniel Eisen, M.D.|916-734-6479|dbeisen@ucdavis.edu|
21271778|NCT02737306|CytoDyn|Joseph Meidling Executive Director Clinical Operations|(360) 980-8524|jmeidling@cytodyn.com|
21271779|NCT01336894|Boston Medical Center|Hiran C. Fernando, MD|617-638-5600|hiran.fernando@bmc.org|
21271780|NCT05034731|Advanced Bionics|Ankur Kaushal, VP of Global Regulatory Affairs|6613621400|clinicalresearch@advancedbionics.com|
21271781|NCT03937466|Wake Forest University School of Medicine|Nancy Avis, PhD|336-716-6974|navis@wakehealth.edu|
21271782|NCT00622908|Bausch & Lomb Incorporated|Timothy Comstock|(585) 338-6631|timothy.comstock@bausch.com|
21271783|NCT00868309|Instituto Bioclon S.A. de C.V.|Walter Garcia|+52 (55)54883700|wgarcia@silanes.com.mx|3785
21271784|NCT00299156|The University of Texas MD Anderson Cancer Center|Hagop Kantarjian, MD /Professor|713-792-7026|eharrison@mdanderson.org|
21271785|NCT01725451|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21271786|NCT00455663|UTHSCSA|Dawn I. Velligan|210-567-5508|velligand@uthscsa.edu|
21271787|NCT00358826|Tallikut Pharmaceuticals, Inc.|Brian Cunningham, MD|312-505-0420|brian@baycitycapital.com|
21271788|NCT01684410|Grifols Therapeutics Inc.|Henry Li, PhD|919-316-6042|henry.li@grifols.com|
21271789|NCT00903383|Lexicon Pharmaceuticals, Inc.|Joel Freiman, MD, MPH|281-863-3070||
21271790|NCT01195922|University of California San Diego|D. J. Silvio Gutkind|(858) 534 5980|sgutkind@ucsd.edu|
21271791|NCT01934296|University of California San Francisco|Dr. Sarah Wang, Director of Clinical Research|416-353-7885|Sarah.Wang@ucsf.edu|
21271792|NCT00482547|C. R. Bard|Vanessa Dell Clinical Research Scientist|908-277-8094|vanessa.dell@crbard.com|
21271793|NCT02015793|AbbVie|Global Medical Services|800-633-9110||
21271794|NCT00320593|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-875-8690|pedig@jaeb.org|
21271795|NCT00283686|Emory University|Dr. Arlene Chapman|(404) 712-1993|abchapm@emory.edu|
21271796|NCT01076166|Abbott|Global Medical Services|1-800-633-9110||
21271797|NCT04177810|SKCCC Johns Hopkins Medical Institution|Dung Le, MD|443-287-0002|Dle@jhmi.edu|
21271798|NCT04756141|Mayo Clinic|Adrian G. Dumitrascu, M.D.|904-956-0081|Dumitrascu.Adrian@mayo.edu|
21271799|NCT01211769|UNIFESP|José Carlos Fernandes Galduróz|55 11 21490168|galduroz@psicobio.epm.br|
21271800|NCT00947427|Benaroya Research Institute|Carla Greenbaum||cjgreen@benaroyaresearch.org|
21271801|NCT01360450|Johns Hopkins Medical Institution|Estelle B Gauda|4106140151|egauda1@jhmi.edu|
21271802|NCT02115256|Icahn School of Medicine at Mount Sinai|Dr. Yaakov Beilin|212-241-7467|yaakov.beilin@mountsinai.org|
21271803|NCT00146770|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
21271804|NCT02427607|Eisai Co., Ltd.|Hidetaka Hiramatsu|+81-3-3817-5245|esi_medinfo@eisai.com|
21271805|NCT02826603|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
21271806|NCT00905489|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21271807|NCT00583596|St. Jude Medical Formally AGA Medical Corporation|Jeffrey Mifek|6517565586|jmifek@sjm.com|
21271808|NCT03621085|University of Texas Southwestern Medical Center|Dr. Craig Crandall|2143454623|craigcrandall@texashealth.org|
21271809|NCT01533428|Astellas Pharma Global Development|Medical Science Director, Global Medical Science|+31(0)715454002|Astellas.resultsdisclosure@astellas.com|
21271810|NCT02473991|ain shams university maternity hospital|prof Dr khaled ebrahim abdalla|00201023220701|drkhaled_abdallah@med.asu.edu.eg|
21271811|NCT00859469|Columbia University|Joshua Leinwand|212-305-4076|jcl2125@columbia.edu|
21271812|NCT02099266|University of Kansas Cancer Center|Dr. Omar Aljitawi|(913) 588-6030|SWILLIAM@kumc.edu|
21271813|NCT01841606|UBC Department of Anesthesia - BC Women's Hospital|Mr. James Taylor|604-875-2424|james.taylor1@phsa.ca|6076
21271814|NCT02102490|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21271815|NCT03065283|Department of Physical Therapy|Prof. Dr. Pedro Lima|558533668091|pedrolima@ufc.br|
21271816|NCT00095199|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21271817|NCT02525029|University of Minnesota, Masonic Cancer Center|Dr. Shernan Holtan, MD|(612) 626-5654|sgholtan@umn.edu|
21271818|NCT01890707|Northwestern University|Shireen Ahmad MD|312-472-3585|sahmad@northwestern.edu|
21271819|NCT00669955|Axcan Pharma Inc.|Monique Giguere, PhD, Programs Director,|1-800-565-3255||2078
21271820|NCT00717977|Jaeb Center for Health Research|Roy W. Beck, M.D., Ph.D.|813-975-8690|rbeck@jaeb.org|
21271821|NCT00385541|Columbia University|Dr. Pamela Flood|201-370-3933|pflood@stanford.edu|
21271822|NCT00824460|Vifor Pharma|Medical Information|41 58 851 8222|medinfo@viforpharma.com|
21271823|NCT01557595|UAB|Dr. Rachel Fargason|205-934-5151|rfargason@uab.edu|
21271824|NCT01073020|Joslin Diabetes Center|Mary Elizabeth Patti MD|617 309 1966|mary.elizabeth.patti@joslin.harvard.edu|
21271825|NCT04642950|Nobel Pharma Co. Ltd.|Information Desk|+81-3-6670-3800|taniguchi.masaki@nobelpharma.co.jp|
21286704|NCT02869789|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21286705|NCT03506048|Emory University|Dr. Taofeek Owonikoko|412-647-9975|owonikokotk2@upmc.edu|
21286706|NCT00297648|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
21286707|NCT02048722|Northwestern University|Mary Mulcahy, MD|312 695 4440|m-mulcahy@northwestern.edu|
21286708|NCT01575080|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com|
21286709|NCT01746862|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21286710|NCT04074265|University of California, Los Angeles|Rachel Thompson|8472200324|rathompson@mednet.ucla.edu|
21286711|NCT02233530|University of Ibadan, Ibadan, Nigeria|Dr Adesola Ogunniyi|+2348038094173|aogunniyi892@gmail.com|
21286712|NCT00731822|GlaxoSmithKline|GSK Response Center|866-435-7343||
21286713|NCT03519009|Johns Hopkins University|Professor|4436176051|ksilverm@jhmi.edu|
21286714|NCT02127658|Indiana University|Dr. Paul Musey|(317) 880-3900|pmusey@iu.edu|
21286715|NCT03834493|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21286716|NCT05796791|Medical University of South Carolina|Emily Amador|916-279-6481|emmcamador@gmail.com|
21286717|NCT03437694|University of North Texas Health Science Center|Crystal Hodge|8177350131|crystal.hodge@unthsc.edu|
21286718|NCT04144322|University of Michigan|Dr. Tae-Ju Oh|7346473320|taejuoh@umich.edu|
21286719|NCT02277028|now at Northwestern University, Department of PM&R|Mary Ellen Stoykov|312-503-3106|mstoykov@sralab.org|
21286720|NCT02718911|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21286721|NCT04817332|University of Dundee, UK|Professor James D Chalmers|01382660111|jchalmers@dundee.ac.uk|
21286722|NCT01867008|Cochlear Americas|Clinical Project Manager|303-264-2340|knix@cochlear.com|
21286723|NCT00983372|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21286724|NCT05635045|Columbia University Medical Center|Mathew Maurer|2123058274|msm10@cumc.columbia.edu|
21286725|NCT01898403|Stanford University Medical Center|Dana T Lin, MD; Clinical Assistant Professor|650-498-6000|danalin@stanford.edu|
21286726|NCT03077893|Regenesis Biomedical|Heather M Vander Ploeg|602-428-7041|heather.vanderploeg@regenesisbio.com|
21286727|NCT02554760|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
21286728|NCT02078193|East Carolina University, Division of Nephrology|Austin Rice|252-744-1904|riceau15@ecu.edu|
21286729|NCT04458675|Vibrant LTD|Tal Malina / Clinical trials manager|+972 046663322|tal.m@vibrantgastro.com|
21286730|NCT01579513|Medical University of South Carolina|Eric Graham, MD|843-792-9570|grahamem@musc.edu|
21286731|NCT00936455|University of California San Diego|Dr Brett Meyer|619-543-7760|bcmeyer@ucsd.edu|
21286732|NCT00570401|Memorial Sloan Kettering Cancer Center|Dr. Gregory Riely|646-888-4199|rielyg@mskcc.org|
21286733|NCT00871234|Indiana University School of Medicine|Samir K. Gupta, MD, MS|317-274-7926|sgupta1@iupui.edu|
21286734|NCT01710020|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21286735|NCT00427908|GlaxoSmithKline|GSK Response Center|866-435-7343||
21286736|NCT01764841|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21286737|NCT03973996|Ohio State University|Dr. Richard Bruno|8603358494|bruno.27@osu.edu|
21286738|NCT04070989|JnJ MedTech|Mary Panozzo|+15744049398|MPanozzo@its.jnj.com|
21286739|NCT03635333|Yale University School of Medicine|Danielle Davis|2039747607|danielle.davis@yale.edu|
21286740|NCT00641056|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21286741|NCT03041441|Duke University Dept of Radiology|Research Coordiantor|(919) 684-7732|christopher.vallanat@duke.edu|
21286742|NCT01811732|Melinta Therapeutics, Inc.|Sue Cammarata (Chief Medical Officer)|1-844-MELINTA (1-844-635-4682)|clinicaltrials@melinta.com|
21286743|NCT01962675|Shepherd Center|Edelle Field-Fote|404-603-4274|edelle_field-fote@shepherd.org|
21286744|NCT01878799|National Institute of Allergy and Infectious Diseases|Dr. Shyam Kottilil|+1 301 435 0936|skottilil@niaid.nih.gov|
21286745|NCT02026141|University of Saskatchewan-Department of Anesthesia|Dr. Ian Chan|306-717-8028|iac549@mail.usask.ca|
21286746|NCT01249417|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21286747|NCT01248455|National Cancer Institute|Dr. Dickran Kazandijian|301-480-0532|kazandjiandg@mail.nih.gov|
21286748|NCT02035553|ACADIA Pharmaceuticals Inc.|James Youakim, Vice President, Clinical Development|609-250-6900|jyouakim@acadia-pharm.com|
21286749|NCT04539964|SetPoint Medical|VP of Clinical Affairs|661.750.6140|info@setpointmedical.com|
21286750|NCT02735980|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21286751|NCT01854697|AbbVie|Global Medical Information|800-633-9110||
21286752|NCT02337062|Acacia Pharma Ltd|Dr Gabriel Fox|44-(0)1223-919764|GabrielFox@acaciapharma.com|
21286753|NCT00468585|Memorial Sloan Kettering Cancer Center|Dr. Tiffany Traina|646-888-4558|trainat@mskcc.org|
21286754|NCT01232790|Yale University School of Medicine, Department of Psychiatry|Cenk Tek MD, Associate Professor of Psychiatry; Director, Psychosis Program, CMHC|(203) 974-7484|cenk.tek@yale.edu|
21286755|NCT03769649|InMode|Maria Shusterman|855.411.2639|marias@inmodemd.com|
21286756|NCT03322293|University of California San Francisco Dept. of Dermatology|Dr. Sarah Arron, MD, PhD|415-353-9684|sarah.arron@ucsf.edu|
21286757|NCT01421498|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21286758|NCT00083915|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|pettynathanm@uams.edu|2461
21286759|NCT01239797|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21286760|NCT03059914|Loma Linda University Health|Sarat Ummethala|909 558 4983|saratdoc@yahoo.com|
21286761|NCT00956085|Stanford University|Carolyn Rodriguez, MD, PhD, Assistant Professor|6507236158|cr2163@stanford.edu|
21286762|NCT00578903|Baylor College of Medicine|Kathryn Leung|832-824-4269|kleung@bcm.edu|
21286763|NCT03722576|Mayo Clinic|Elizabeth J. Carey, M.D.|480-342-1094|Carey.Elizabeth@mayo.edu|
21286764|NCT01240382|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
21286765|NCT02643693|Philip Morris Products S.A.|Christelle Haziza, PhD|+41 (58) 242 11 11|ClinicalTrials.PMI@pmi.com|
21286766|NCT02059239|Weill Cornell Medicine|Dr. Tsiporah Shore|646-962-7950|tbs2001@med.cornell.edu|
21286767|NCT00193453|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|askSarah@scresearch.net|
21286768|NCT01408706|Wheaton Franciscan Healthcare - All Saints|Dr. James Taylor|262-687-5000|james.taylor@wfhc.org|
21286769|NCT01268267|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com|
21286770|NCT01222104|St Jude Medical|Andrew Campbell|651-756-5538|acampbell2@sjm.com|
21286771|NCT01307956|University of Nebraska Medical Center|Jean L Grem|402-559-5166|jgrem@unmc.edu|
21286772|NCT00888654|Barbara Ann Karmanos Cancer Institute|Elisabeth Heath, M.D.|313-576-8715|heathe@karmanos.org|
21286773|NCT01418339|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21286774|NCT00685815|Luitpold Pharmaceuticals, Inc.|Angie Butcher|610-650-4200|abutcher@lpicrd.com|
21286775|NCT02204917|Children's Hospital of Philadelphia|Dr. Kassa Darge, MD, PhD, Radiologist-in-Chief|267-425-7110|DARGE@email.chop.edu|
21286776|NCT02219685|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21286777|NCT00698815|Massachusetts General Hospital|Rebecca S. Heist, MD||rheist@partners.org|
21286778|NCT02577640|Ohio State University|Casey McClurkin|614-293-6255|casey.mclurkin@osumc.edu|
21286779|NCT04003103|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21286780|NCT00359203|Medtronic Italia SpA|Silvia Giuli|003932814224|silvia.giuli@medtronic.com|
21286781|NCT01218542|Emory University|Dr. Hui-Kuo Shu|404-778-2161|hgshu@emory.edu|
21286782|NCT02131064|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21286783|NCT01062893|Wake Forest University School of Medicine|Peter H. Pan, MD|336-718-8278|ppan@wakehealth.edu|
21286784|NCT00593918|University of Wisconsin-Madison|Theresa Guilbert, MD|608-263-9608|tguilbert@wisc.edu|
21286785|NCT02638974|University of Manchester|Dr Kerry Gutridge, Trial Manager|0161-306-7931|kerry.gutridge@manchester.ac.uk|
21286786|NCT04663685|UBC/Arthritis Research Canada|Ellen Wang|2266980999|ewang@arthritisresearch.ca|
21286787|NCT00394888|Medical College of Wisconsin|Dr. Beth Drolet|414-266-1569|bdrolet@mcw.edu|
21286788|NCT04202497|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21286789|NCT02155699|Northwestern University|Dr. Vijay A Mittal|847-467-3880|vijay.mittal@northwestern.edu|
21286790|NCT05547386|Mayo Clinic|Geoffrey Johnson, M.D., Ph.D.|507-284-4104|johnson.geoffrey@mayo.edu|
21286791|NCT03834506|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21286792|NCT01720316|McLean Hospital|Dr. Deborah L. Levy|617-855-2854|dlevy@mclean.harvard.edu|
21286793|NCT02713178|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
21286794|NCT01298167|Yale University|David Leffell, MD|203 785 7999|david.leffell@yale.edu|
21286795|NCT05502302|University of Minnesota, Masonic Cancer Center|Dr. Rachel Vogel|612-624-6928|isak0023@umn.edu|
21286796|NCT02998151|Cincinnati Children's Hospital Medical Center|Dr. Craig Erickson|513-636-0523|craig.erickson@cchmc.org|
21286797|NCT02667301|StratejikYG|Murat Haluk Ozkul|0905327777842|kbbhaluk@gmail.com|
21286798|NCT01619878|Novartis Pharmaceuticals|Study Director|862-778-8300||
21286799|NCT02895295|Stanford University|Dr. M. Kate Bundorf|6507250067|bundorf@stanford.edu|
21286800|NCT04414787|Duke University|Christopher Cox|919-681-7232|christopher.cox@duke.edu|
21286801|NCT03574974|Yale University|Ilan Harpaz-Rotem Professor|203-937-4760|ilan.harpaz-rotem@yale.edu|
21286802|NCT04369833|Pusan national university hospital|Dr. Sang Soo Kim|+82-51-240-7837|drsskim7@gmail.com|
21286803|NCT00447902|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21286804|NCT01496976|Moffitt Cancer Center|Celeste M. Bello, MD|813-745-8623|Celeste.Bello@moffitt.org|
21286805|NCT04579380|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21286806|NCT05814419|UCHealth|Gary J Luckasen, MD|970-624-1680|gary.luckasen@uchealth.org|
21286807|NCT06088784|HPI, Inc.|Sr. Director, Clinical Development Operations|301-738-3980|mary.bearkland@hanall.com|
21286808|NCT05556616|Takeda (Note: This product was divested to Teva Pharmaceuticals in 2025)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21286809|NCT05428436|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
21286810|NCT00896493|Stanford University Medical Center|Wen-Kai Weng, Associate Professor of Medicine|650-723-7689|wkweng@stanford.edu|
21286811|NCT05310877|The Miriam Hospital|Emily Gathright, PhD|401-793-8271|Emily.Gathright@lifespan.org|
21286812|NCT01657617|University of Kentucky|Ronald McGarry|859 323 6486|rcmcga2@email.uky.edu|
21286813|NCT01868646|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical Research and Medical Information Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
21286814|NCT01831427|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21286815|NCT01171898|Aragon Pharmaceuticals, Inc.|Senior Medical Director, WC Clinical Oncology Department|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21286816|NCT03191799|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21286817|NCT03843372|Sleep Center, Chang Gung Memorial Hospital, Keelung, Taiwan|Dr. Chung-Chieh Yu|886+22432-9292|terminatorchieh@yahoo.com.tw|2658
21286818|NCT00902577|ACRIN|Donna Harfeil, Director of Protocol Management|215-717-2765|dhartfeil@acr.org|
21286819|NCT01319565|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|sar@mail.nih.gov|
21271826|NCT00836927|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21271827|NCT04064229|ivWatch, LLC|Jason Naramore|1-855-489-2824|jason.naramore@ivwatch.com|7019
21271828|NCT00614055|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21271829|NCT02958956|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21271830|NCT00093964|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21271831|NCT00747552|University of Utah|Donald Null M.D.|801.588-3865|donald.null@imail.org|
21271832|NCT02261428|"Attikon General University Hospital of Athens"|Mr. Konstantinos Grigoriadis ICU Physical Therapist|00302105832489|grigoriakost@gmail.com|
21271833|NCT01095003|Institut de Recherche Pierre Fabre|Karim Keddad|+33.5.34.50.61.69|Karim.keddad@pierre-fabre.com|
21271834|NCT04579926|Klein Buendel, Inc.|Julia Berteletti|3035654321|jberteletti@kleinbuendel.com|
21271835|NCT02637557|Ironwood Pharmaceuticals, Inc.|IW-3718-202 Study Chair|1 (617) 621-7722|Info@ironwoodpharma.com|
21271836|NCT02006706|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21271837|NCT01673009|Indiana University|Kent Robertson MD PhD|317-944-8784|krobert@iu.edu|
21271838|NCT04161144|Medical University of South Carolina|Dr. Michael Saladin|8437925306|saladinm@musc.edu|
21271839|NCT03617692|University of Colorado Boulder|Angela Bryan, PhD|3034929549|Angela.Bryan@Colorado.EDU|
21271840|NCT00049036|AIDS Malignancy Consortium|Jeannette Lee|501-526-6712|jylee@uams.edu|
21271841|NCT02848599|University Hospital Osijek, Croatia|Dr. Gordana Kristek|+385915115746|gordanaldrmed@yahoo.com|
21271842|NCT04828161|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
21271843|NCT02352337|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
21271844|NCT04488575|Evelo Biosciences Inc|Duncan McHale, MBBS, MRCP, PhD|+447500128938|duncan@evelobio.com|
21271845|NCT02458638|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21271846|NCT01908127|Tehran University of Medical Sciences|Dr. Mehrsa Paryab|00989121091675|drmparyab@yahoo.com|
21271847|NCT03495648|University of Kentucky|Ann Koempel|(859) 257-3800|ann.koempel@uky.edu|
21271848|NCT02236338|Virginia Commonwealth University|Dr. Malcolm Sydnor|(804) 828-0534|malcolm.sydnor@vcuhealth.org|
21271849|NCT02401542|Rainier Therapeutics|Chief Medical Officer|510-878-2486|Sabella@RainierRx.com|
21271850|NCT00135707|Dept of Obstetrics and Gynecology, University of Pittsburgh|Dr. James Roberts|412-641-1427|RSIJMR@mwri.magee.edu|
21271851|NCT02850068|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
21238175|NCT02638948|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb Study Director|Please email|clinical.trials@bms.com|
21271852|NCT01681030|Ethicon, Inc|Richard Kocharian, MD, PhD|+1-908-218-2013|rkochar1@its.jnj.com|
21271853|NCT02743702|University of Seville|Dr. Jose J. Jimenez-Rejano|+34667309369|jjjimenez@us.es|
21271854|NCT00795665|University of California Davis|Analyst|916-734-8053|nlogihara@ucdavis.eduu|
21271855|NCT01612000|Protein Sciences Corproation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
21271856|NCT02173704|GlaxoSmithKline|GSK Response Center|866-435-7343||
21271857|NCT03106870|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
21271858|NCT02627742|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
21271859|NCT01645306|advanceCOR GmbH|Prof. Dr. Götz Münch, CRP & CEO|+4989200020410|muench@advancecor.com|
21271860|NCT02584140|UCSD Medical Center, Antiviral Research Center|Jill Blumenthal, MD|(619) 471-3913|jblumenthal@health.ucsd.edu|
21271861|NCT03445195|Entasis Therapeutics|Chief Medical Officer|781-810-8940|Enquiries@entasistx.com|
21271862|NCT01180244|Department of Mechanical Engineering, Kettering University|Dr. Jeffrey B. Hargrove||jhargrov@kettering.edu|
21271863|NCT00906425|Institut Straumann|Michael Hotze, PhD|+4161965|michael.hotze@straumann.com|1235
21271864|NCT00620763|United States Department of Agriculture Grand Forks Human Nutrition Research Center|Brenda Ling|701-795-8300|brenda.ling@ars.usda.gov|
21271865|NCT01595009|Novartis Pharmaceuticals|Study Director|862-778-1873||
21271866|NCT04956666|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33 1 55 72 60 00|scientificinformation@servier.com|
21271867|NCT00729859|University of Washington|Stephanie T. Page, MD, PhD|206-616-0483|page@u.washington.edu|
21271868|NCT00506909|UCSD|David Feifel||dfeifel@kadimanp.com|
21271869|NCT03172780|Mylan Pharmaceuticals Pvt Ltd.|Dr. Prasanna C Ganapathi, Associate Vice President, Global Clinical Sciences|08066728952|PrasannaC.Ganapathi@mylan.in|28952
21271870|NCT01111110|University of Florida|Dr.Sreekala Prabhakaran. Clinical Assistant Professor Pediatrics|352-273-8381|sprabhakaran@peds.ufl.edu|
21271871|NCT03758365|MC2 Therapeutics|Birgitte Vestbjerg|+45 2077 2575|bve@mc2therapeutics.com|
21271872|NCT02623829|Icahn School of Medicine at Mount Sinai|Dr. Daniel Bernstein|212-731-3311|daniel.bernstein@mountsinai.org|
21271873|NCT00662025|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21271874|NCT03588390|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21271875|NCT00384033|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21271876|NCT01544166|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21271877|NCT00780026|University of Michigan|Subramanian Sathishkumar||ssatish@med.umich.edu|
21271878|NCT02162758|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21238176|NCT05007392|Eisai Co., Ltd.|Eisai Inquiry Service|none|eisai-chiken_hotline@hhc.eisai.co.jp|
21238177|NCT01218126|GlaxoSmithKline|GSK Response Center|866-435-7343||
21238178|NCT02411565|H. Lee Moffitt Cancer Center and Research Institute|Dr. Hye Sook Chon|813-745-7205|hyesook.chon@moffitt.org|
21238179|NCT01860703|ApoPharma Inc.|Fernando Tricta, MD|416-401-7332|ftricta@apopharma.com|
21259583|NCT03665285|NextCure, Inc.|Chief Medical Officer|(240) 399-4900|NCClin@nextcure.com|
21259584|NCT00354601|Wake Forest University Health Sciences|Doug Case Biostatistician|336-716-1048|dcase@wfubmc.edu|
21238180|NCT00072761|Vanderbilt University School of Medicine|Michael R. DeBaun, MD, MPH|615-875-3040|m.debaun@vanderbilt.edu|5-3040
21259585|NCT03640832|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21259586|NCT00820755|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21259587|NCT02251912|University of North Carolina at Chapel Hill|Dr. Cort Pedersen|919-923-3284|cort_pedersen@med.unc.edu|
21259588|NCT01286493|Queen Saovabha Memorial Institute|Dr.Suda Sibunruang|+66 2 2520161|sudapunrin@gmail.com|125
21259589|NCT03434379|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21259590|NCT03122431|Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo|Prof Eloisa Bonfa|551130617490|eloisa.bonfa@hc.fm.usp.br|
21259591|NCT02385279|European Cardiovascular Research Institute|Dr. E. Spitzer|+31102062828|E.Spitzer@ECRI-Trials.com|
21259592|NCT00686647|AngioScore|Gary Gershony, MD/ Chief Medical Officer|510-933-7900|gary@angioscore.com|
21259593|NCT02022826|Medtronic|Michal Kedar-Datel|+972-4-9097952|michal.kedar-datel@medtronic.com|
21259594|NCT03179436|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21259595|NCT01634555|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
21259596|NCT01811147|Cleveland Clinic Foundation|Dr. Amit Anand|216-636-2840|ananda@ccf.org|
21259597|NCT00809328|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21259598|NCT03657459|Cleveland Clinic|Nancy M. Albert PhD, CCNS, CHFN, CCRN, NE-BC, FAHA, FCCM, FHFSA, FAAN|216-444-7028|albertn@ccf.org|47028
21259599|NCT00282243|Astellas Pharma Global Development, Inc.|Vice President, Therapeutic Area Head, Transplantation||ClinicalTrials.Disclosure@us.astellas.com|
21259600|NCT00270894|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
21259601|NCT00686127|University of California, San Francisco|Dr. Christine Miaskowski, PI|415-476-9407|chris.miaskowski@nursing.ucsf.edu|
21259602|NCT06062264|UCLA|Principal Investigator|310-206-6328|pszilagyi@mednet.ucla.edu|
21259603|NCT05256888|University of Maryland School of Nursing|Amber Kleckner, PhD|410-706-5961|amber.kleckner@umaryland.edu|
21259604|NCT01072409|University of Michigan|Teresa Zwolan, Ph.D.|(313) 618-9669|zwolan@umich.edu|
21259605|NCT03580616|Dartmouth-Hitchcock Medical Center|Dr. Elijah Stommel|6036505104|elijah.w.stommel@hitchcock.org|
21259606|NCT01552902|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21259607|NCT04088409|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21259608|NCT00400400|Novartis Pharmaceuticals|Study Director|862-778-8300||
21259609|NCT00364689|University of Miami|Clinical Trial Disclosure Manager|305-243-0494|y.p.davis@med.miami.edu|
21259610|NCT03887299|University of Texas Medical Branch Galveston|Antonio F Saad|4097476646|afsaad@utmb.edu|
21259611|NCT00305942|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21259612|NCT04137783|Children's Hospital of Chongqing Medical University|Dr. Jianhui Wang|13678428167|wangjh@cqmu.edu.cn|
21259613|NCT01016873|Oraya Therapeutics Inc.|Denis O'Shaugnessy, Ph.D.|917-417-3974|doshaughnessy@orayainc.com|
21259614|NCT03653390|University of Washington|Dr. Ivan Molton, PhD|2065433602|imolton@uw.edu|
21259615|NCT03118947|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
21259616|NCT01261819|Florida Hospital|Katherine Kratz, M.D.||katiegoodrich@gmail.com|
21259617|NCT04451330|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
21259618|NCT00536172|University of Nebraska|William Burke MD|4025526005|wjburke@Unmc.edu|
21259619|NCT04139122|Senju Pharmaceutical Co. Ltd.|Director, Clinical Development|+81 078 777 1018|senju-clinicaltrials@senju.co.jp|
21259620|NCT01987908|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21259621|NCT00849667|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21259622|NCT00189462|West Penn Allegheny Health System|David Skoner, MD|4123594099|dskoner@wpahs.org|
21259623|NCT01869348|The University of Texas Medical Branch|Eloisa Martinez|4092669643|esmartin@utmb.edu|
21259624|NCT02789657|BrUOG|Brown University Oncology Research Group|4018633000|BrUOG@Brown.edu|
21259625|NCT02055404|Alcon Research, Ltd.|Joachim Nick, Dipl. Ing.|1-888-451-3937|alcon.medinfo@alcon.com|
21259626|NCT00384241|Medical College of Georgia, Georgia Regents University|Haidong Zhu MD, PhD, Assistant Professor|706 721 5470|hzhu@gru.edu|
21259627|NCT05384041|Climb Technologies, Inc.|Julia Lanoha|(925) 405-5458|julia@climb.care|
21259628|NCT02086331|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
21259629|NCT02266108|UCSDMED|Elizabeth Reed, Associate Professor|5082121517|elizared7@gmail.com|
21259630|NCT00510276|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21271879|NCT00963157|Group Health Research Institute|Lisa Jackson, MD, MPH|206-442-5216||
21271880|NCT01166568|Refocus Group, Inc.|Director of Regulatory & Quality|214-368-0200|lstewart@refocus-group.com|431
21271881|NCT01716754|Novartis Pharmaceuticals|Study Director|862-778-8300||
21271882|NCT04371419|Massachusetts Institute of Technology|Pierre-Luc Vautrey|(617) 258-7013|vautrey@mit.edu|
21271883|NCT02110706|Yale School of Medicine|Dr. Richard Nowak, MD,MS|203-785-4085|richard.nowak@yale.edu|
21271884|NCT04992052|Northwell Health System|Nancy Dengler, Clinical Research Nurse|516-496-2637|ndengler@northwell.edu|
21271885|NCT02354378|Boston Children's Hospital|Keira Mason, MD|6173552339|keira.mason@childrens.harvard.edu|
21271886|NCT05105711|University of North Carolina at Chapel Hill|Melissa Gilkey, PhD|919-966-8650|gilkey@email.unc.edu|
21271887|NCT01348542|Penn State University College of Medicine|Alexandros Vgontzas|717 531-7278|vgontzas@pennstatehealth.psu.edu|
21271888|NCT04738279|NorthShore University HealthSystem|Nirav Shah, MD, MPH|(847) 570-1236|nshah2@northshore.org|
21271889|NCT00891878|Mayo Clinic|Aminah Jatoi, M.D|(507) 284-5352|jatoi.aminah@mayo.edu|
21271890|NCT04616417|University of Illinois at Chiago|Principal Investigor|312-355-3245|Sana.Salih@bsd.uchicago.edu|
21271891|NCT01297257|Clinical Research Director|Frank van Leeuwen, M.D.|+31433566622|frank.van.leeuwen@medtronic.com|
21271892|NCT01789320|Clearside Biomedical, Inc.|Thomas Ciulla, MD|(678) 392-2318|thomas.ciulla@clearsidebio.com|
21271893|NCT00494806|MD Anderson Cancer Center|Robert L. Massey, PhD, RN|713-792-3704|rlmassey@mdanderson.org|
21271894|NCT01103505|Notal Vision|Grace Chang, MD, PhD|571-719-6416|Grace.Chang@NotalVision.com|
21271895|NCT00656019|StanfordU|Dr. Melinda Telli|650-724-9533|steinhau@stanford.edu|
21271896|NCT02407756|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
21271897|NCT02387814|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21271898|NCT01166971|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21271899|NCT01309919|Baystate Medical Center|Dr. Katharine White|413-794-5256|katharine.white@bhs.org|
21271900|NCT03896490|Queen's University Belfast|Dr Oliver Perra|+44289097|o.perra@qub.ac.uk|2313
21286820|NCT05953363|Becton, Dickinson and Company|Gloria Viti/Clinical Project Manager|00393452237718|gloria.viti@bd.com|
21286821|NCT03387267|Nestlé Health Science|Kemuel Reyes|(908) 333-9379|Kemuel.Reyes@us.nestle.com|
21286822|NCT05696392|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21286823|NCT03904693|Actelion Pharmaceuticals Ltd.|Clinical Scientific Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21286824|NCT03180736|EMN|Sarah Lonergan, Trial lead|+44 7767565020|sarah.lonergan@emn.life|
21286825|NCT03258593|National Cancer Institute|Dr. Raju Chelluri|240-858-3700|raju.chelluri@nih.gov|
21286826|NCT06228703|Rush University|Jie Li|3125634643|Jie_Li@rush.edu|
21286827|NCT02036931|Zimmer Biomet|Oliver Marti|+41 79 576 31 98|oliver.marti1@zimmerbiomet.com|
21286828|NCT05457257|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21286829|NCT04464707|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
21286830|NCT04831138|UT Southwestern Medical Center|Dr. Ananth Madhuranthakam|214-648-7737|ananth.madhuranthakam@utsouthwestern.edu|
21286831|NCT00866905|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21286832|NCT04344301|Dartmouth College|Dr. Paul Barr|+1-603-653-0863|paul.j.barr@dartmouth.edu|
21286833|NCT00072410|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21286834|NCT02903446|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Angelo Gaffo, MD; Associate Professor|205-996-6086|agaffo@uab.edu|
21286835|NCT05590377|Takeda (Note: This product was divested to Teva Pharmaceuticals in 2025)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21286836|NCT03389620|Duke University|Timothy J. Amrhein, M.D.|919-684-1909|timothy.amrhein@duke.edu|
21286837|NCT00549549|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21286838|NCT05852353|Stanford University|Kathleen Kan, MD|(650) 497-8000|kkan@stanford.edu|
21286839|NCT03509467|Moffitt Cancer Center|Peter Kanetsky, PhD, MPH|813-745-3988|Peter.Kanetsky@moffitt.org|
21271901|NCT05780541|University of Minnesota|Greg Grandits|651-528-9491|greg-g@ccbr.umn.edu|
21271902|NCT03329027|Vibrantgastro|Clinical trials manager|046663322|service@vibrantgastro.com|
21271903|NCT02761980|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21271904|NCT02929979|VA Palo Alto Healthcare System|Adrienne Heinz|9196306847|adrienneheinz@gmail.com|
21271905|NCT01806688|Agriculture and Agri-Food Canada|Dr. Heather Blewett|204 237-2954|hblewett@sbrc.ca|
21271906|NCT01104207|VA Portland Medical Center|Robert L. Folmer, Ph.D.|503-220-8262|Robert.Folmer@va.gov|51868
21271907|NCT00101582|Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com|
21271908|NCT01907087|BioMarin Pharmaceutical Inc.|Peter Slasor/Sr Director, Biostatistics, Global Clinical Sciences|415-506-6765|PSlasor@bmrn.com|
21271909|NCT01551095|Johns Hopkins University|Mouen Khashab|443-287-1960|mkhasha1@jhmi.edu|
21271910|NCT01919190|Pacira Pharmaceuticals, Inc.|Paci|1-855-793-9727|MedInfo@pacira.com|
21271911|NCT01767597|Service des maladies infectieuses et tropicales - Hôpital Saint-Antoine|Dr. Julie Bottero|+33 1 49 28 04 24|julie.bottero@aphp.fr|
21271912|NCT03355742|Clinical Affairs, Abbott Vascular|Siok Hwee Tan, PhD, Principal Clinical Research Scientist|+1 408-845-3581|siokhwee.tan@abbott.com|
21271913|NCT02518230|Children's Mercy Hospital|Winston Manimtim|816-234-3000|wmmanimtim@cmh.edu|
21271914|NCT04820842|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21271915|NCT01691508|GlaxoSmithKline|GSK Response Center|866-435-7343||
21271916|NCT01296932|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21271917|NCT02337933|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
21271918|NCT03093454|Duke Health|Scott Hollenbeck, MD|919-681-5079|scott.hollenbeck@duke.edu|
21271919|NCT00100165|University of Colorado, Denver|Dr. Robert Freedman|303 724-4940|robert.freedman@ucdenver.edu|
21271920|NCT02524379|The Ohio State University|Shelby Miracle|614-366-1648|shelby.miracle@osumc.edu|
21271921|NCT01829464|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21271922|NCT00635778|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21271923|NCT00812253|The Ohio State University|Kathleen Dungan|6146853333|kathleen.dungan@osumc.edu|
21271924|NCT01884025|Central Arkansas Veterans Healthcare System|Dr. Kristen Viverito|501-257-1699|KRISTEN.VIVERITO@VA.GOV|
21271925|NCT02909140|Wilmer Eye Institute|Dr. Fasika Woreta|(410) 955-5650|fworeta1@jhmi.edu|
21271926|NCT05380635|Soligenix, Inc.|Richard Straube, MD/Chief Medical Officer|609-538-8200|rstraube@soligenix.com|
21271927|NCT01700621|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
21271928|NCT02869646|Tibor Rubin VA Medical Center|Michael Hollifield, M.D.|562 826-8000|michael.hollifield@va.gov|4324
21271929|NCT02035137|New Advances in Neuroblastoma Therapy|NANT Medical Director|3233615687|nantops@chla.usc.edu|
21271930|NCT01288859|University of Naples|Prof. Vincenzo Fogliano|+39 0812539356|fogliano@unina.it|
21271931|NCT03349333|Mundipharma(China) Co.,Ltd|clinical study manager|8610-65636856|guodong.lu@mundipharma.com.cn|
21271932|NCT02985151|Dermatology SLUCare Physician Group|Research Manager/Coordinator|314 977-1794|rhonda.lebbing@health.slu.edu|
21271933|NCT02300025|Genentech|Medical Communications|800-821-8590|genentech@druginfo.com|
21271934|NCT02116803|Novartis Pharmaceuticals|Study Director|862-778-8300||
21271935|NCT03213210|Sunstar Americas, Inc.|Akane Takemura|8477944276|akane.takemura@us.sunstar.com|
21271936|NCT02540356|Baxalta, now part of Shire|Clinical Trial Registries and Results Disclosure||ClinicalTrialsDisclosure@baxalta.com|
21271937|NCT00684671|GlaxoSmithKline|GSK Response Center|866-435-7343||
21271938|NCT02755545|Galderma|Director, Medical Affairs and Clinical Development|8179615325|matthew.meckfessel@galderma.com|
21271939|NCT00481247|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21271940|NCT02931565|Cyclerion Therapeutics, Inc.|Senior Medical Director|1-857-327-8778|info@cyclerion.com|
21271941|NCT02649231|University of Exeter|Professor Celia Morgan|01392 724649|Celia.Morgan@exeter.ac.uk|
21271942|NCT02970669|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21271943|NCT01714505|University of Virginia|Boris Kovatchev, PhD|434-924-5592|boris@virginia.edu|
21271944|NCT02611752|Braeburn|Sonnie Kim|1 610 467 8717|sonnie@braeburnrx.com|
21271945|NCT01214330|Mike O'Callaghan Military Medical Center|Amanda Crawford|702-653-3583|amanda.j.crawford.ctr@health.mil|
21271946|NCT00249821|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21271947|NCT01411995|Washington University School of Medicine|Dr Colleen McNicholas|314-747-1331|mcnicholasc@wudosis.wustl.edu|
21271948|NCT01185288|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21271949|NCT00278512|Northwestern University|Dr Richard Burt|312-695-4960|rburt@northwestern.edu|
21271950|NCT01626859|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21271951|NCT01620177|National Advanced Driving Simulator|Dr. Timothy L. Brown, Co-PI|319-335-4785|timothy-l-brown@uiowa.edu|
21271952|NCT00310427|NIH/National Institute on Alcohol Abuse and Alcoholism|Markus A. Heilig, M.D., Ph.D.|301-435-9386|mheilig@mail.nih.gov|
21286840|NCT01005745|H. Lee Moffitt Cancer Center and Research Institute|Amod Sarnaik, M.D.|813-745-8581|amod.sarnaik@moffitt.org|
21271953|NCT03520283|Wake Forest University Health Sciences|Study coordinator|336-716-9055|megreen@wakehealth.edu|
21271954|NCT00814320|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21271955|NCT00491504|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21271956|NCT02789111|University of Virginia Department of Aneshtesiology|Bhiken Naik MD|434-924-2283|BIN4N@hscmail.mcc.virginia.edu|
21271957|NCT01965561|USAISR|John Kragh, MD|210.539.2210|john.f.kragh.civ@mail.mil|
21271958|NCT03271528|Boston Medical Center|Dr. Eric Devine|617-638-7888|eric.devine@bmc.org|
21271959|NCT04523142|Novaliq GmbH|Sonja Krösser|+49 6221 50259|info@novaliq.com|0
21271960|NCT01618305|Westat|Lauren Laimon, Project Manager|240-453-2987|laurenlaimon@westat.com|
21271961|NCT01960816|Aerin Medical, Inc.|Scott Wolf, M.D., President and Chief Medical Officer|650-434-3247|scott@aerinmedical.com|
21271962|NCT02286518|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21271963|NCT02938494|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
21271964|NCT01736553|The Ohio State Unviersity Wexner Medical Center|Dr. Stephen Kolb|614-366-9050|stephen.kolb@osumc.edu|
21271965|NCT01879800|Baylor College of Medicine|Dr. Lilian Dindo|713-791-1414|lilian.dindo@bcm.edu|10296
21301873|NCT01139008|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
21259631|NCT03329378|Icahn School of Medicine at Mount Sinai|Dr. Aarti Bhardwaj|(212) 824-8578|Aarti.Bhardwaj@mountsinai.org|
21301874|NCT05111301|Tandem Diabetes Care|Supervisor, Clinical Operations|(877) 801-6901|clinicalaffairs@tandemdiabetes.com|
21301875|NCT02100696|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21301876|NCT05110872|Fralin Biomedical Research Institute at Virginia Tech Carilion|Dr. Freitas-Lemos|540-526-2106|rflemos@vtc.vt.edu|
21301877|NCT04518358|Guiding Technologies Corp.|John Nosek|609-605-9273|john.nosek@guidingtechnologies.com|
21301878|NCT01583296|Ferkauf Graduate School of Psychology, Yeshiva University|Jonathan M. Feldman|6465924508|jonathan.feldman@einstein.yu.edu|
21301879|NCT01063283|Inova|Michael Maitland, MD, PhD|571-472-4724|Michael.Maitland@inova.org|
21301880|NCT00356304|VA New Jersey Healthcare System|Alejandro Interian, Principal Investigator|908-647-0180|alejandro.interian@va.gov|4617
21301881|NCT02504216|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
21301882|NCT00223080|Department of Disease Control, Ministry of Public Health|Dr. Supachai Rerks-Ngarm|66-2-590-3006|supachai@health.moph.go.th|
21301883|NCT02598583|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
21301884|NCT03237286|University of Pittsburgh|Dr. Rebecca Price|412-383-2150|pricerb@upmc.edu|
21301885|NCT03193593|Bonti|Wajdie Ahmad|9493796569|wajdie@bonti.com|
21301886|NCT02792829|Eisai Inc.|Eisai Medical Research Inc.|1-888-422-4743|esi_medinfo@eisai.com|
21301887|NCT02797613|Memorial University|Peter Daley|7097250240|pkd336@mun.ca|
21301888|NCT01151904|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21301889|NCT02282514|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
21301890|NCT03043105|Peking Union Medical College Hospital|Dr. Jian Li|86-010-69155027|lijian@pumch.cn|
21301891|NCT01010867|Columbia University Medical Center|Monica Bhatia, MD|2123055808|mb2476@cumc.columbia.edu|
21259632|NCT01500057|Brooklyn Urology Research Group|Ivan Grunberger, M.D. Medical Director|718-230-7788|ivg9002@nyp.org|
21259633|NCT01225341|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
21259634|NCT03715426|University of Michigan|Michelle Munro-Kramer|734-904-4600|mlmunro@umich.edu|
21259635|NCT00888355|Merck & Co., Inc.|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
21259636|NCT00880360|University of Texas Health Science Center at San Antonio|Dr. Tyler Curiel|210-450-1000|curielt@uthscsa.edu|
21259637|NCT00638937|The Ottawa Hospital Cancer Centre|Dr. Scott Laurie|613-737-7700|slaurie@ottawahospital.on.ca|70175
21259638|NCT01242644|University of South Alabama|Office of Research Compliance|251-460-7573|swhite@southalabama.edu|
21259639|NCT03157531|Eximo Medical|Oshrat Cohen|97286307639|oshratc@eximomedical.com|
21259640|NCT03603652|ETHICON|Erin Meyers|937-681-0322|eprifog1@its.jnj.com|
21259641|NCT03213366|Albert Einstein College of Medicine|Dr. Viraj V Patel|718.920-7102|vpatel@montefiore.org|
21259642|NCT00666926|Verastem, Inc.|Mitchell Keegan|617-252-9300|mkeegan@verastem.com|
21259643|NCT01960855|AbbVie|Global Medical Services|800-633-9110||
21259644|NCT02058147|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21259645|NCT01318122|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
21259646|NCT01486199|University of Pittsburgh|Tim Corcoran|412-624-8918|corcorante@upmc.edu|
21259647|NCT02063035|Massachusetts General Hospital, Boston, MA, USA|Dr. Kirkham B. Wood|617-726-2000|kbwood@stanford.edu|+1
21259648|NCT01539980|Faculty of Pharmaceutical Sciences, Chulalongkorn University|Professor Pornanong Aramwit, Pharm.D., Ph.D.|+66899217255|aramwit@gmail.com|
21259649|NCT01815645|Federal University of Sao Paulo|Andre Q. C. Miguel|005511 965884111|aqcmiguel@gmail.com|
21259650|NCT02154425|Cares|UCB|+1877 822||9493
21259651|NCT00773279|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21259652|NCT03543085|China Medical University Hospital (in Taiwan)|Dr. Yeong-Ray Wen (Department of Anaesthesia)|+886 4 2205-2121|yray.wen@gmail.com|
21301892|NCT01668589|Amgen Inc.|Study Director|866-572-6436||
21301893|NCT00233064|MedImmune, LLC|Hasan S. Jafri, MD|301-398-0000||
21238181|NCT02532556|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
21259653|NCT01920802|New York State Psychiatric Institute|Jeffrey A. Lieberman, MD|646-774-8436|jlieberman@columbia.edu|
21259654|NCT01750255|Universidad de Antioquia|Pedro Amariles Muñoz|57 4 2195456|pedro.amariles@udea.edu.co|
21259655|NCT01133171|Department of Veterans Affairs|Dawn M. Bravata, MD|317-988-2676|dawn.bravata2@va.gov|
21259656|NCT02526550|Siriraj Hospital|Prof.Kulkanya Chokephaibulkit|662 4195695|kulkanya.cho@mahidol.ac.th|
21259657|NCT03875950|University of Washington|Pamela Kohler|206.221.5746|pkohler2@uw.edu|
21259658|NCT01260454|University of Rochester|R. James White, MD, PhD|585-486-0869|jim_white@urmc.rochester.edu|
21259659|NCT04062214|Yale University|Marc Rosen, MD|2039325711|marc.rosen@yale.edu|12112
21259660|NCT00091832|Amgen Inc.|Study Director|866-572-6436||
21259661|NCT02604940|West Virginia University|Pavithra Ranganathan Ellison, MD|304-598-4929|pavithra.ellison@wvumedicine.org|
21259662|NCT02349178|Medical College of Wisconsin|Michael J Burke, MD|414-955-4170|mmburke@mcw.edu|
21259663|NCT01557166|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21259664|NCT00946309|Fred Hutchinson Cancer Research Center|Dr. Daniel Lin|206-221-0797|dwlin@uw.edu|
21259665|NCT02986230|HealthPartners Institute|Dr. Tom Elliott|218-525-7268|elliottt793@gmail.com|
21259666|NCT01465659|Northwestern University|Sheetal Kircher, MD|312-695-0990|sheetal.kircher@nm.org|
21259667|NCT00282841|University of California San Diego|Thilo Hoelscher, MD|619-543-5251|thoelscher@ucsd.edu|
21259668|NCT00374244|Yale University School of Medicine, Dept of Psychiatry|Handan Gunduz-Bruce MD|(203) 932-5711|handan.gunduz-bruce@yale.edu|4130
21301894|NCT02302339|Celldex Therapeutics|Head of Regulatory Affairs|844-723-9363|info@celldex.com|
21271966|NCT01896297|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21271967|NCT00003782|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600||
21271968|NCT02743442|Fondation Ophtalmologique A. de Rothschild|Dr Amélie Yavchitz (deputy head of the clinical research unit)|+33148036454|ayavchitz@for.paris|
21271969|NCT00929708|AstraZeneca|Carin Jorup, MSD||clinicaltrialtransparency@astrazeneca.com|
21271970|NCT02154529|Kadmon Corporation|Associate Vice President, Clinical Operations|833-900-5366|karin.herrera@kadmon.com|
21271971|NCT02146430|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|+1 (908) 992-6400|CTRinfo@DSI.com|
21238182|NCT06213701|Center for Healthy Minds|Simon Goldberg|(608) 265-8986|sbgoldberg@wisc.edu|
21238183|NCT02721082|U. Kansas Medical Center|Dr. Kimber Richter|9134490157|krichter@kumc.edu|
21238184|NCT02453685|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
21238185|NCT00453986|GlaxoSmithKline|GSK Response Center|866-435-7343||
21271972|NCT03312530|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21271973|NCT03093324|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
21271974|NCT01693484|LSU Health Science Center Shreveport|Dr Todd Jaeblon|318 675 6180|tjaebl@lsuhsc.edu|419
21271975|NCT04583579|Lexitas Pharma Services|Dr. Andrew Pucker|9205792900|andrewpucker@hotmail.com|
21271976|NCT00761592|Allergan, Inc.|Vice President Medical Affairs|(714)246-4500|clinicaltrials@allergan.com|
21271977|NCT04700449|Suzhou Connect Biopharmaceuticals, Ltd|John Guo, Director of Clinical Operation|051253577866|jwguo@connectpharm.com|
21271978|NCT00356200|Tufts Medical Center|Alice B Gottlieb, MD, PhD|617 636 4802|agottlieb@tuftsmedicalcenter.org|
21271979|NCT01000337|Aretaieio Hospital, University of Athens|Argyro Fassoulaki|+30210 7286334|fassoula@aretaieio.uoa.gr|
21271980|NCT02909673|UT Health Houston|Melanie Thiel|713-818-6281|melanie.thiel@uth.tmc.edu|
21271981|NCT02752776|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21271982|NCT01816477|Mayo Clinic|Dr. Dawn E. Jaroszewski|480-301-7865|Jaroszewski.Dawn@mayo.edu|
21271983|NCT04471935|Flint Rehabilitation Devices|Ian Russell|3392232676|irussell@flintrehab.com|
21271984|NCT01399736|Maasstad Hospital|Dr.Pieter Smits|+31102913322|SmitsP@maasstadziekenhuis.nl|
21271985|NCT03335371|vTv Therapeutics LLC|Study Director|336-841-0300|clinicaltrials@vtvtherapeutics.com|
21271986|NCT04128007|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
21271987|NCT04571242|SGX Medical|VP of Clinical Affairs|818-527-2710|clinical@sgxmedical.com|
21271988|NCT00638157|Cubist Pharmaceuticals|Ed Campanaro / Vice President, Clinical Operations|781-860-8318|ed.campanaro@cubist.com|
21271989|NCT00437281|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21286841|NCT02287038|Ralph H. Johnson VA Medical Center|Dr. Zhewu Wang|8437897949|zhewu.wang@va.gov|
21286842|NCT05770713|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21286843|NCT04000438|Dilafor AB|Gunvor Ekman-Ordeberg|+467060833111|gunvor.ekman-ordeberg@dilafor.com|
21286844|NCT04037358|Johns Hopkins University School of Medicine|Dr. Ana P. Kiess|443-287-7528|akiess1@jhmi.edu|
21286845|NCT04112368|University of Illinois Chicago|Tory Eisenlohr-Moul|859-317-0503|temo@uic.edu|
21286846|NCT04157517|Takeda (Note: This product was divested to Teva Pharmaceuticals in 2025)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21286847|NCT03433898|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21286848|NCT05027815|University of California, San Francisco|Jonathan Esensten MD, PhD|415-502-3785|Jonathan.Esensten@ucsf.edu|
21286849|NCT03574038|Study's principal investigator|Dr. Mersedeh Bahr-Hosseini|3107941195|MBahrHosseini@mednet.ucla.edu|
21286850|NCT00674206|Emory University|Dr. Amelia Zelnak|404-778-1900|amelia.zelnak@emoryhealthcare.org|
21286851|NCT00536510|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21286852|NCT02062437|Tornier SAS|Nathalie Trétout|+33 4 76 71 35 00|nathalie.tretout@tornier.com|
21286853|NCT01674725|AbbVie|Global Medical Information|800-633-9110||
21286854|NCT03102762|Cairo University|Dr. Hussein Ghanem, Directer of this clinical trial|01001176111|hmhghanem@gmail.com|
21286855|NCT02779491|Bournemouth University|Prof. Katherine Appleton|+441202965985|k.appleton@bournemouth.ac.uk|
21286856|NCT03074695|Duke University|Ashraf Habib, M.D.|919-681-4544|ashraf.habib@duke.edu|
21286857|NCT01774981|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21286858|NCT00960193|Mutual Pharmaceutical Company, Inc.|Medical Drector|215-697-1743|clinicaltrials@urlmutual.com|
21286859|NCT03362944|Frohlich Lab - University of North Carolina at Chapel HIll|Trevor McPherson|919-966-4755|trevor_mcpherson@med.unc.edu|
21286860|NCT01324102|VA Boston Healthcare System|Jennifer Moye|774-826-3721|jennifer.moye@va.gov|
21286861|NCT00728494|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21238186|NCT03221387|Lewis Katz School of Medicine at Temple University|Adam Nester, JD, MS|215-707-1986|coisom@temple.edu|
21238187|NCT00522626|Johns Hopkins University School of Medicine|Dr. Lauren Jansson|410-550-5438|ljansson@jhmi.edu|
21271990|NCT02531022|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh S. Patel|215-898-3367|mpatel@pennmedicine.upenn.edu|
21286862|NCT00001566|National Cancer Institute (NCI), National Institutes of Health (NIH)|Crystal Mackall, M.D.|301-402-5940|mackallc@mail.nih.gov|
21286863|NCT03669549|Millendo Therapeutics|Clinical Trial Information|+1 734-845-9000|millendo@millendo.com|
21286864|NCT00909844|Ipsen Pharma|Medical Director, Endocrinology||clinical.trials@ipsen.com|
21286865|NCT04023578|Ossur Iceland ehf|Kristleifur Kristleifsson|6641112|kkristjansson@ossur.com|+354
21286866|NCT00706004|University of Arkansas for Medical Sciences|Catherine O'Brien|501-364-1828|obriencatherinee@uams.edu|
21286867|NCT01535118|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21286868|NCT03575702|R-Pharm|Georgiy Sharvadze, Medical Advisor|0074959567937|sharvadze@rpharm.ru|1175
21286869|NCT01701674|H. Lee Moffitt Cancer Center and Research Institute|Dr. Amod Sarnaik|813-745-8581|amod.sarnaik@moffitt.org|
21286870|NCT05276973|NRG Oncology|Helen Huang on behalf of Wei Deng, PhD.|(716) 845-1300|huangh@nrgoncology.org|2318
21286871|NCT01946204|Janssen Research & Development, LLC|Senior Medical Director, WC Clinical Oncology Department|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21286872|NCT04782180|University of Miami|Hansel Tookes, Professor of Medicine|305-689-7030|hetookes@miami.edu|
21286873|NCT04379921|Stanford University|Corinna Zygourakis, MD|(650) 723-6469|corinnaz@stanford.edu|
21286874|NCT06077773|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21286875|NCT04275973|University of Wisconsin - Madison|Peter Adamczyk|(608) 263-3231|peter.adamczyk@wisc.edu|
21286876|NCT06110754|Emory University|Soumitri Sil, PhD|404-727-2712|soumitri.sil@emory.edu|
21238188|NCT00803452|University of Louisville|Professor Douglas Borchman|502 852 7435|borchman@louisville.edu|
21238189|NCT03987841|University of Alabama at Birmingham|Caroline Presley|205-934-7609|capresley@uabmc.edu|
21238190|NCT02365519|Alcon, A Novartis Division|Ophthalmology & Medical Lead, Translational Medicine, NIBR|1-888-451-3937|alcon.medinfo@alcon.com|
21238191|NCT01971723|Florida State University|Dr. Michael J. Ormsbee|(850) 644-4793|mormsbee@fsu.edu|
21238192|NCT04648150|Hopital fondation Rothschild|Dr Amélie YAVCHITZ|+33148036454|ayavchitz@for.paris|
21238193|NCT01880723|University of Arizona|Courtney Wheatley|507-266-2696|wheatley.courtney@mayo.edu|
21238194|NCT03289234|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please Email|cti-inq-ml@ml.mt-pharma.co.jp|
21238195|NCT02821403|The Hong Kong Polytechnic University|Dr. Tsz Wing Leung|27664268|jeffrey.TW.leung@polyu.edu.hk|
21238196|NCT03076970|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21238197|NCT01364922|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21238198|NCT00963911|Institut Bergonié|Pr Pierre Soubeyran|33(0)556333333|p.soubeyran@bordeaux.unicancer.fr|
21238199|NCT01289418|Laval University|Gaston De Serres|418-666-7000|gaston.deserres@ssss.gouv.qc.ca|274
21238200|NCT01352585|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21238201|NCT00838682|The Catholic University of Korea, Uijeongbu St. Mary's Hospital|Hiun-Suk Chae|82-31-820-3019|chs@catholic.ac.kr|
21238202|NCT03928028|Children's Hospital of Philadlephia|C. Alix Timko|2674265467|timkoc@chop.edu|
21238203|NCT02802501|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21238204|NCT02012192|Medical University of Innsbruck|Prof. Dr. Nicole Concin|+43 512 504|nicole.concin@i-med.ac.at|81433
21259669|NCT01698528|Joslin Diabetes Center|Dr William Hsu|617-309-5803|william.hsu@joslin.harvard.edu|
21259670|NCT02445586|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21286877|NCT03383874|University of Texas Southwestern Medical Center|Dr. E. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
21301895|NCT03564678|The University of Texas MD Anderson Cancer Center|Elias Jabbour MD/Professor|713-792-4764|ejabbour@mdanderson.org|
21301896|NCT04420325|UZ Leuven|Lennert Minten|+32496397568|lennert.minten@gmail.com|
21301897|NCT04393454|Albert Einstein College of Medicine|Dr. Chaoyuan Kuang|718-430-3516|chaoyuan.kuang@einsteinmed.edu|
21301898|NCT04016623|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
21301899|NCT02752165|University of Rochester|Jill Halterman|5852755798|jill_halterman@urmc.rochester.edu|
21301900|NCT01120964|Asklepion Pharmaceuticals, LLC|Gurdyal Kalsi, MD, MFPM (Hon)|+1 410.736.3750|gurdyal.kalsi@asklepionpharm.com|
21259671|NCT00428597|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21301901|NCT01003769|Mayo Clinic|Asher Alban Chanan-Khan, M.D.|(716) 845-3221|chanan-khan.asher@mayo.edu|
21301902|NCT00826202|Nathan Kline Institute|Daniel Javitt MD, PhD|845-398-6534|javitt@nki.rfmh.org|
21301903|NCT01704599|Dept. Dermatology Wayne StateUniversity|Peter J. Aronson, MD|(313)_745-7845|paronson@med.wayne.edu|
21259672|NCT00578643|Baylor College of Medicine|Robert Krance, MD|(832) 824-4661|rakrance@txch.org|
21259673|NCT01725750|Icahn School of Medicine at Mount Sinai|Jacob Greisman|212-241-4886|Jacob.greisman@mountsinai.org|
21259674|NCT01831960|Cassiopea, SpA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
21259675|NCT03828487|Masimo Corporation|Vikram Ramakanth|949-297-7416|clinicalresearchdept@masimo.com|
21259676|NCT02447848|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
21286878|NCT02499146|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21301904|NCT00912197|Imperial College London|Prof Gary Frost|+44 (0)20 7594 0959|g.frost@imperial.ac.uk|
21301905|NCT02267837|Shaughnessy Orthodontics|Dr. Timothy Shaughnessy|770-495-9590|staff@straightteethdoc.com|
21301906|NCT00756613|VA|Tamara Paine|7082028387|tamara.paine@va.gov|25785
21301907|NCT03304249|University of Kansas Medical Center|Megan Olalde|913-588-2042|molalde@kumc.edu|
21238205|NCT04525547|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21238206|NCT00800202|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21259677|NCT02307370|Spectranetics, LLC now a part of Philips Image Guided Therapy Devices|Nicolas Aguirre, Senior Manager, Clinical Operations|612-297-6655|nicolas.aguirre@philips.com|
21259678|NCT01506882|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
21259679|NCT04320407|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
21259680|NCT02591615|NorthShore Medical Group|Thomas Hensing|847.570.2112|thensing@northshore.org|
21259681|NCT02863068|Albert Einstein College of Medicine|Dr. Caterina Minniti|240-498-8684|bloodconsultant@gmail.com|
21259682|NCT04047797|MD Anderson Cancer Center|Hun J Lee, MD|713-792-2860|hunlee@mdanderson.org|
21259683|NCT00325078|National Institute of Allergy and Infectious Diseases|De Ravin, SukSee|+1 301 496 6772|sderavin@mail.nih.gov|
21259684|NCT03932799|University of Washington|Andrea Elmore|206-685-7194|aelmore@uw.edu|
21259685|NCT01097629|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21259686|NCT00956943|University of Pennsylvania|Robert A. Schnoll, Ph.D.|215-746-7143|schnoll@mail.med.upenn.edu|
21259687|NCT02663895|Stanford University|Dr. Lorinda Chung|(650) 723-6961|shauwei@stanford.edu|
21259688|NCT01793792|MicroVention, Inc|Anne Hurley|714-247-8000|anne.hurley@microvention.com|
21259689|NCT00709826|Tragara Pharmaceuticals|Tracy Parrott|760-208-6919|tparrott@tragarapharma.com|
21259690|NCT00851903|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi.com|
21301908|NCT04901715|University of North Carolina at Chapel Hill|Kelli Sullivan, MPH|919-962-9786|kelli_sullivan@med.unc.edu|
21301909|NCT04022499|Denver Health and Hospital Authority|Rocio Pereira, Medical Director, Community Integrated Health Care|303-436-6000|rocio.pereira@dhha.org|
21301910|NCT00494676|Schepens Eye Research Institute|Alex Bowers|617-912-2512|alex_bowers@meei.harvard.edu|
21301911|NCT04976192|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
21301912|NCT02621151|NYU Langone Health|Minas Economides, MD|2127315413|minas.economides@nyulangone.org|
21301913|NCT04198714|MetroHealth Medical Center|Dr. Jeffrey Mangel|216-778-5595|jmangel@metrohealth.org|
21301914|NCT02529553|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21301915|NCT04917757|University Hospital Würzburg|Prof Dr. Martin Fassnacht|4993120139021|fassnacht_m@ukw.de|
21301916|NCT03704389|Northwestern University|Stephen D. Persell, MD, MPH, FACP|312-503-6464|spersell@nm.org|
21301917|NCT01754727|AbbVie|Global Medical Information|800-633-9110||
21301918|NCT02785770|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21301919|NCT03968939|UMissouri - Missouri Orthopaedic Institute|Vicki L Jones|573-882-7583|jonesvicki@health.missouri.edu|
21301920|NCT04838977|University of Utah|Heather Keenan|8015877567|heather.keenan@hsc.utah.edu|
21301921|NCT05367492|Massachusetts General Hospital|A. Eden Evins, MD, MPH|617-643-4679|aeevins@mgh.harvard.edu|
21301922|NCT00353470|Albert Einstein College of Medicine|Barbara Milrod, M.D., PI|212-595-0806|bmilrod@montefiore.org|
21301923|NCT01088048|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21301924|NCT00950859|ViiV Healthcare|GSK Response Center|866-435-7343||
21301925|NCT01971086|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21301926|NCT01343693|Zimmer Biomet Spine|Zimmer Biomet Spine Clinical Affairs|303-501-8571|spinemedinfo@zimmerbiomet.com|
21301927|NCT00265148|GlaxoSmithKline|GSK Response Center|866-435-7343||
21301928|NCT01463007|BrUOG-Brown University Oncology Research Group|Dr. Jaroslaw Hepel|4018633000|kristen_mitchell@brown.edu|
21301929|NCT03583385|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21301930|NCT04780919|Charles University, 2nd Faculty of Medicine|Jakub Katolicky|+420 739 081 676|jakub@katolicky.eu|
21301931|NCT01320137|GlaxoSmithKline|GSK Response Center|866-435-7343||
21301932|NCT00857714|IndianaU|Sunil Badve, MD|317-491-6417|sbadve@iupui.edu|
21301933|NCT00545272|Novartis Pharmaceuticals|Study Director|862-778-8300||
21301934|NCT02314637|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21301935|NCT02934503|NYU Langone|Dr. Joshua Sabari|212-731-6363|Joshua.Sabari@nyulangone.org|
21301936|NCT04126278|NYU Langone Health|Mehul Shah|616-501-7223|Mehul.Shah@nyulangone.org|
21301937|NCT00724867|GlaxoSmithKline|GSK Response Center|866-435-7343||
21301938|NCT01421472|Merrimack Pharmaceuticals|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
21301939|NCT00436345|GlaxoSmithKline|GSK Response Center|866-435-7343||
21301940|NCT01296672|UT Health|Jonathan Gelfond|210 567-0836|gelfondjal@uthscsa.edu|
21301941|NCT04027608|University at Buffalo|Jennifer Temple, Principle Investigator|7168295593|jltemple@buffalo.edu|
21301942|NCT00856232|UMDNJ|Dr. Boris Veysman|732-235-8717|veysmabo@umdnj.edu|
21301943|NCT04248491|Beaumont Health|Director Urology Research|2485511488|bernadette.zwaans@Corewellhealth.org|
21301944|NCT04605991|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21301945|NCT01311024|head of Clinical Research Unit, National Institute for Health and Welfare|Arto Palmu, MD, PhD Research manager,|+358295247910|arto.palmu@thl.fi|
21301946|NCT01737593|UCLA|Dr. Wendy Ren|310.267.8678|wren@mednet.ucla.edu|
21301947|NCT00787618|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
21301948|NCT00621348|AIIMS|Rakesh Lodha|91 11 26593621|rakesh_lodha@hotmail.com|
21301949|NCT01652469|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki-Voser, Lead Trial Activities|+41 31 511 94 18|Heidi.Roschitzki@etop-eu.org|
21301950|NCT01049009|Emory University School of Medicine|Dr. Arshed A. Quyyumi|404-727-3655|aquyyum@emory.edu|
21301951|NCT02910505|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
21301952|NCT01092546|GE Healthcare|Paul Sherwin, M.D.|609-514-6820|Paul.Sherwin@ge.com|
21301953|NCT03860259|University of Pittsburgh Medical Center Department of Anesthesiology and Perioperative Medicine|Jacques E. Chelly, MD, PhD, MBA|412-623-6382|chelje@anes.upmc.edu|
21271991|NCT00876733|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21259691|NCT01070329|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21271992|NCT03521999|Ralph H. Johnson VA Medical Center|Research Coordinator|843-301-9917|sarah.szafranski@va.gov|
21271993|NCT01832090|Merz North America, Inc.|Ashlee Duncan|984-222-6040|ashlee.duncan@merz.com|
21271994|NCT05476679|Raziel Therapeutics|Racheli Gueta, Director of Clinical Trials|972-8-9126941|racheli@raziel-therapy.com|
21271995|NCT03402893|Skin Sciences, PLLC|M. McAllister|5024519000|mmdermresearch@yahoo.com|
21259692|NCT02863848|Universitat Rovira i virgili|Dr. Joaquin Escribano|+ 34 977 759364|joaquin.escribano@urv.cat|
21259693|NCT06441877|Topmed|Edith Martin|418 683-2104|emartin@topmed.ca|1302
21259694|NCT03980938|EIP Pharma, Inc|Jennifer Conway|(617) 744-4400|jconway@eippharma.com|
21259695|NCT03706365|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21259696|NCT03116113|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21259697|NCT02932787|Sheffield Hallam University|Martin Lamb|01142552782|m.lamb@shu.ac.uk|
21259698|NCT00289913|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
21259699|NCT03822884|Biosidus S.A.|Clinical Trial Manager - Dr. Roberto A. Diez|+5411 4909 8000|r.diez@biosidus.com.ar|
21259700|NCT02620904|Montefiore Einstein|Jessica Maria Atrio|7184058260|jatrio@montefiore.org|
21259701|NCT02633371|University of Colorado|Dr. Anna Bruckner|720-777-0955|anna.bruckner@ucdenver.edu|
21259702|NCT01989221|TempleU|Dr. Henry Parkman|2157072498|henry.parkman@temple.edu|
21259703|NCT02411448|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21259704|NCT02631538|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21259705|NCT01688050|Cook Research Incorporated|Alan Saunders,MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
21259706|NCT01848145|SCRI Development Innovations|Charles Davis, RAC|615-524-4341|Charles.Davis2@scri-innovations.com|
21259707|NCT01554579|Afferent Pharmaceuticals|Clinical Development|650-286-1276|info@afferentpharma.com|
21259708|NCT00234039|SWOG Statistical Center|Study Statistician|206-667-4623||
21259709|NCT03683394|The University of California, San Francisco|Dr. Kristine Yaffe|(415) 476-7307|kristine.yaffe@ucsf.edu|
21259710|NCT03897751|Bausch & Lomb|Johnson Varughese|9089271162|Johnson.Varughese@bauschhealth.com|
21259711|NCT03072160|National Cancer Institute|Dr. Ravi Madan|301-480-7168|rm480i@nih.gov|
21259712|NCT04426695|Regeneron Pharmaceuticals, Inc|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
21259713|NCT04303000|University of Alabama at Birmingham|Melinda Clarke|205-975-7809|melindaclarke@uabmc.edu|
21259714|NCT01058096|Allergan, Inc.|Therapeutic Area Head|714-246-4500||
21259715|NCT05655377|Flint Rehabilitation Devices|Ian Russell|9496670140|irussell@flintrehab.com|
21259716|NCT02516670|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Channing Paller Associate Professor Urologic Oncology|4109558239|cpaller1@jhmi.edu|
21259717|NCT02769728|Medical University of Graz|Prof. Harald Sourij|0316 385 81310|ha.sourij@medunigraz.at|
21259718|NCT00553163|Barts Health NHS Trust|Prof D S Rampton|+442035943300|d.rampton@qmul.ac.uk|
21259719|NCT00553462|Yale Cancer Center|Rogerio Lilenbaum, M.D.||Rogerio.lilenbaum@yale.edu|
21259720|NCT01262625|American College of Radiology|Director Clinical Research Administration|215-574-3150|info@acr.org|
21259721|NCT03711604|Rhizen Pharmaceuticals AG|Dr.Prajak Barde|9820503970|pjb@rhizen.com|
21259722|NCT00110994|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21259723|NCT02395991|Seoul National University Hospital|Professor Jeong Min Lee|82-2-2072-3154|jmsh@snu.ac.kr|
21259724|NCT02772757|Mountain Home VA Medical Center|Sherri L. Smith, Au.D., Ph.D.|423.926.1171|sherri.smith@va.gov|7569
21259725|NCT00531960|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21259726|NCT01564706|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
21259727|NCT00579813|University of Arkansas for Medical Sciences|Robert E. McGehee Jr., Ph.D.|501-603-1998|rem@uams.edu|
21259728|NCT03450083|Johns Hopkins University School of Medicine|Jody Tversky, MD|410-550-8017|hoddin1@jhmi.edu|
21259729|NCT02471716|FivePrime Theraputics|Medical|415-365-5600|nick.mahasuwan@fiveprime.com|
21259730|NCT00626743|INJE University Pusan Paik Hospital|Jae Gook Shin, MD,PhD|+82-51-890-8954|phshinjg@paik.ac.kr|
21259731|NCT02981069|University of Texas Health San Antonio|Professor|12103587200|cersosimo@uthscsa.edu|
21259732|NCT01154933|State University of NY at Buffalo|Paresh Dandona|7165351850|dandona@buffalo.edu|
21259733|NCT01558063|Columbia University|J. John Mann, MD|646-774-7553|jjm@columbia.edu|
21259734|NCT04178772|Johnson & Johnson VIsion Care, Inc.|Thomas Karkkanien - Sr. Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
21259735|NCT01751971|Brigham and Women's Hospital|Scott Sands, PhD|6172780911|sasands@bwh.harvard.edu|
21259736|NCT00165958|Emory University|Dr. Suephy Chen|4047783084|schen2@emory.edu|
21259737|NCT01481896|Anderson Orthopaedic Research Institute|Robert H. Hopper, Jr., PhD|(703) 619-4411|research@aori.org|
21259738|NCT01649947|Rutgers Cancer Institute of New Jersey|Joseph Aisner, MD|732-235-7401|aisnerjo@cinj.rutgers.edu|
21259739|NCT01162421|AbbVie|Global Medical Information|800-633-9110||
21271996|NCT01569828|Novartis Pharmaceuticals|Study Director|862-778-8300||
21271997|NCT00686036|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21259740|NCT03336502|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21259741|NCT01054079|Comprehensive Cancer Center of Wake Forest University|Dr. K.C. Balaji|336-618-2272|kbalaji@wakehealth.edu|
21271998|NCT01937364|Essentia Health|Jeffrey E. Lyon, M.D.|218-786-2802|jeffrey.lyon@essentiahealth.org|
21271999|NCT00467584|Mayo Clinic|Dr. Dean M. Wingerchuk|480-301-6328|wingerchuk.dean@mayo.edu|
21272000|NCT02482571|University of Minnesota|Silvia Mangia, PhD|6126254920|mangia@umn.edu|
21272001|NCT01636297|Cleveland Clinic|Dr. Jay Alberts|216-445-3222|albertj@ccf.org|
21272002|NCT00926289|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21272003|NCT01498484|Atara Biotherapeutics|Study Director|650-278-8930|clinicalstudies@atarabio.com|1
21272004|NCT04104646|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
21272005|NCT00319956|University of Kentucky Medical Center|Dr. Hubert O. Ballard|859-323-1496|hoball2@uky.edu|
21272006|NCT01199601|Columbia University|Dr. Catherine Todd|212-305-4805|cst2121@columbia.edu|
21272007|NCT00753714|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21272008|NCT02607800|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21272009|NCT03387098|Immunitybio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
21272010|NCT02974153|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
21272011|NCT01202747|TearScience, Inc. (formerly Kolis Scientific)|Christy Stevens, OD|919-459-4815|cstevens@tearscience.com|
21238207|NCT00180479|Abbott Vascular|Ellen Travis, Clinical Science|408-845-1512|Ellen.Travis@av.abbott.com|
21238208|NCT02459262|MinervaX ApS|Per Fisher DPhil|+45 20 25 20 38|pbf@minervax.com|
21238209|NCT05168579|University of Pittsburgh|Dr. Deepika Mohan|404-375-9325|dem73@pitt.edu|
21238210|NCT00840801|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21238211|NCT00508404|Amgen Inc.|Study Director|866-572-6436||
21238212|NCT01505387|Analyze & Realize|Felix Alt|+49 30 40008100|Falt@a-r.com|
21238213|NCT01424930|Janssen R&D US|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
21238214|NCT03685396|Azienda Ospedaliera San Paolo - Università degli Studi di Milano|Dr.Fulvio Gatti|3396441920|fudy@libero.it|
21238215|NCT01197508|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21238216|NCT03286751|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
21238217|NCT01621880|Sun Yat-sen Memorial Hospital, Sun Yat-sen University|Yamei Tang|08613556001992|yameitang@hotmail.com|
21238218|NCT01422135|Agile Therapeutics|Joseph Chiodo III, Senior Medical Director|609-683-1880|jachiodo@agiletherapeutics.com|
21238219|NCT03086330|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21238220|NCT00645164|DFB Pharmaceuticals|Herbert B. Slade MD, FAAAAI|817.302.3919|bert.slade@dfbpharmaceuticals.com|
21238221|NCT03673306|IRCCS Ospedale Policlinico San Martino, Genoa, Italy|Matteo Lambertini|+39 010 555 4254|matteo.lambertini@unige.it|
21238222|NCT03338829|University of Minnesota|Sarah A. Wernimont MD, PhD|612-301-3408|swernimo@umn.edu|
21238223|NCT04283448|Montana State University|Mary P Miles|406 994-6678|mmiles@montana.edu|
21238224|NCT03434678|Memorial Sloan Kettering Cancer Center|Dr. Florence Grant, MD|212-639-8829|moses-gf@mskcc.org|
21238225|NCT06060457|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
21238226|NCT02061202|Icahn School of Medicine at Mount Sinai|Dr. Jeffrey Glassberg|212-241-3650|jeffrey.glassberg@mountsinai.org|
21238227|NCT03628287|City University of New York, School of Public Health|Denis Nash, PhD|347-331-6554|denis.nash@sph.cuny.edu|
21238228|NCT05656040|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21259742|NCT00989989|Novartis Pharmaceuticals|Study Director|41 61 324 1111||
21259743|NCT01107444|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21259744|NCT02284165|Duke Clinical Resarch Institute|Janet Prvu Bettger, ScD|617-901-0277|janet.bettger@duke.edu|
21259745|NCT03310970|University of Iowa|Nicole Brogden, Associate Professor|319-335-8752|nicole-brogden@uiowa.ed|
21259746|NCT01446419|Relievant Medsystems, Inc.|V.P. of Clinical & Regulatory Affairs|650-261-2259|lhook@relievant.com|
21259747|NCT04025632|UCB BIOSCIENCES GmbH|Clin Trial Reg & Results Disclosure|Please email|clinicaltrials@ucb.com|
21259748|NCT01678976|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|francisco.rocha@bial.com|
21259749|NCT02159807|Icahn School of Medicine at Mount Sinai|Dr. Barbara Orlando|917-496-7490|barbara.orlando@mountsinai.org|
21259750|NCT00950170|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21259751|NCT02064764|Medtronic, Inc.|Vanessa DeBruin|6123607687|vanessa.debruin@medtronic.com|
21259752|NCT02367521|Johns Hopkins University School of Medicine|Vani Rao, MD|4105502288|vrao@jhmi.edu|
21259753|NCT00600171|GlaxoSmithKline|GSK Response Center|866-435-7343||
21259754|NCT00469612|The Ohio State University|Dr. Don Mutti|614-247-7057|mutti.2@osu.edu|
21259755|NCT00542191|Leo W. Jenkins Cancer Center|Dr. Paul Walker|252-744-1015|walkerp@ecu.edu|
21259756|NCT03990870|Posit Science Corporation|Dr. Kyu Lee|415-528-7235|kyu.lee@positscience.com|
21259757|NCT02357420|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21259758|NCT04933123|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
21259759|NCT03118596|University Hospitals Coventry & Warwickshire NHS Trust|Dr Cyprian Mendonca|02476964000|cyprian.mendonca@hotmail.com|25871
21259760|NCT00440726|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
21259761|NCT01808612|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21259762|NCT00110019|ECOG Statistical Office|Study Statistician|617-632-3012||
21259763|NCT02239263|cochlear|Lori O'Neill Director of Research|8005235798|loneill@cochlear.com|
21259764|NCT01046695|Mayo Clinic|Deborah J. Engen, OT, CMT|507-255-5504|engen.deborah@mayo.edu|
21272012|NCT01446913|Yale University School of medicine|Henry Klar Yaggi, MD (PI)|203-785-4163|henry.yaggi@yale.edu|
21272013|NCT02521948|Essential Medical, Inc|Director of Operations|610-557-1009|todd@essmedclosure.com|
21272014|NCT00423800|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21272015|NCT02292238|Weill Cornell Med/ Burke Neurological Institute|Gary E Gibson, Professor of Neuroscience|9145972291|ggibson@med.cornell.edu|
21272016|NCT04000009|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261|medicalinformation@acadia-pharm.com|2897
21272017|NCT00756964|University of Florida|A. Ahsan Ejaz, M.D.|3522735328|ejazaa@medicine.ufl.edu|
21272018|NCT01754259|Brigham and Women's Hospital|Dr. Marcelo Di Carli|617-732-6291|mdicarli@partners.org|
21272019|NCT00619385|Repros Therapeutics|Jennifer Wike|2817193402|jwike@reprosrx.com|
21272020|NCT02255513|Ironshore Pharmaceuticals and Development, Inc.|Chief Scientific Officer|13457498174|bev@ironshorepharma.com|
21272021|NCT02041702|Abbott (formerly St. Jude Medical)|Clinical Project Leader Asia|0085229967605|lyim@sjm.com|
21272022|NCT00203307|Thomas Jefferson University/ Jefferson Headache Center|Stephen D. Silberstein, M.D.- Principal Investigator|215-955-2243|stephen.silberstein@jefferson.edu|
21272023|NCT03730103|The Cleveland Clinic|Lynn Borzi, Research Administrator|216-445-3158|borzil@ccf.org|
21272024|NCT01488578|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21272025|NCT02308111|Intercept Pharmaceuticals, Inc.|Medical Information|+1 884-782-4278|medinfo@interceptpharma.com|
21272026|NCT00717756|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org|
21272027|NCT01483872|UCSD|Saima Aslam|858 657 7463|saslam@ucsd.edu|
21272028|NCT00929357|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21272029|NCT01873859|Cardiovascular research center, Shahid Beheshti University of Medical Sciences|Dr. Saeed Alipour Parsa, director of clinical trial|+9821 2208 3106|s_alipour@sbmu.ac.ir|
21272030|NCT01364870|University of Iowa College of Nursing|Barbara Rakel, PhD, RN, FAAN|319-335-7036|barbara-rakel@uiowa.edu|
21272031|NCT03977584|Hoffmann-La Roche|BN40199|888-662-6728 (U.S. Only)|global-roche-genentech-trials@gene.com|
21272032|NCT01042366|University of Pittsburgh|John Kirkwood, MD|(412) 623-7707|KirkwoodJM@upmc.edu|
21272033|NCT00745251|Vivus, Inc|Wesley W. Day, PhD|650-934-5200|day@vivus.com|
21272034|NCT03850509|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21272035|NCT02666430|Director Global Clinical Operations, General Medicine|Keri L Vaughan|+1 267.980.5015|keri.vaughan@mylan.com|
21272036|NCT03828461|Stanford University|Carolyn Rodriguez, MD, PhD|650-723-4095|cr2163@stanford.edu|
21272037|NCT01565083|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21272038|NCT01118728|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21272039|NCT04555525|Skin Sciences, PLLC|Senen Pena|502-451-9000|spdermresearch@yahoo.com|
21272040|NCT01323998|GlaxoSmithKline|GSK Response Center|866-435-7343||
21272041|NCT03482713|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-80-672-6372|ClinicalTrialsDisclosure@merck.com|
21272042|NCT03495869|Virginia Commonwealth University|Lori Keyser-Marcus, PhD|(804) 828-4164|lori.keysermarcus@vcuhealth.org|
21272043|NCT04680052|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21272044|NCT02638090|Moffitt Cancer Center|Dr. Jhanelle E. Gray|813-745-7282|Jhanelle.Gray@Moffitt.org|
21272045|NCT05342753|Galderma Research & Development, LLC|Sponsor|8179615000|aestheticclinicaltrials@galderma.com|
21272046|NCT02489318|Aragon Pharmaceuticals, Inc.|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21272047|NCT05218655|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
21272048|NCT03901963|Janssen Research & Development|Director Clinical Research Scientist|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21272049|NCT02854436|Janssen Research & Development, LLC|EXECUTIVE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21272050|NCT05014204|Endogenex|Chris Sorli, CMO|(763) 251-6820|csorli@endogenex.com|
21272051|NCT04033445|Janssen Research & Development, LLC|Medical Director IMM|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21272052|NCT02985957|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1(800) 332-2056|Clinical.Trials@bms.com|
21272053|NCT05845645|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21272054|NCT02893267|MetroHealth Medical Center|Dr. Richard Wilson|216-957-3559|rwilson@metrohealth.org|
21272055|NCT03748641|Janssen Research & Development, LLC|Executive Medical Director Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21272056|NCT02549495|Brigham and Women's Hospital|Daniel Palazuelos, MD, MPH|617-521-3381|dpalazuelos@bwh.harvard.edu|
21272057|NCT03495986|University of Miami Miller School of Medicine|Dr. Eduard Tiozzo|3052431633|etiozzo@miami.edu|
21272058|NCT02365597|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21272059|NCT04309474|AbbVie|ABBVIE CALL CENTER|844-663-3742|abbvieclinicaltrials@abbvie.com|
21272060|NCT04670068|UNC Lineberger Comprehensive Cancer Center|Kelly Hoye, MS, CCRP Study coordinator - Clinical Immunotherapy Program|919-445-9676|khoye@email.unc.edu|
21259765|NCT00822107|Oregon Health & Science University|Dr. David H. Ellison|5034944465|ellisond@ohsu.edu|
21259766|NCT01577238|Starpharma|Dr Jeremy Paull||jeremy.paull@starpharma.com|
21259767|NCT00559273|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21259768|NCT01256177|AstraZeneca|Dhaval Desai (MSD, Seroquel)|+13028857643|aztrial_results_posting@astrazeneca.com|
21259769|NCT03501966|Jaeb Center for Health Research|Colleen Bauza|813-975-8690|cbauza@jaeb.org|
21259770|NCT01728779|Johns Hopkins University|Dana Kaplin|410-614-3950|dkaplin1@jhmi.edu|
21259771|NCT00448708|Angiotech Pharmaceuticals|Dr. Trudy Estridge|604-221-7676|testridge@angio.com|
21259772|NCT01925209|Novartis Pharmaceuticals|Study Director|862-778-8300||
21272061|NCT04684524|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
21272062|NCT05120570|Masonic Cancer Center|Punita Grover, MBBS|(612) 273-8383|groverp@umn.edu|
21272063|NCT04182204|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21272064|NCT05876091|Roswell Park Comprehensive Cancer Center|Brian Fix|716-845-2300|Brian.Fix@roswellpark.org|
21272065|NCT03466411|J&J Innovative Medicine|Senior Medical Leader PEDIATRICS IMM|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21272066|NCT03462719|Janssen Research & Development, LLC|EXECUTIVE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21272067|NCT02829918|Moffitt Cancer Center|Richard D. Kim, MD|813-745-1277|Richard.Kim@Moffitt.org|
21272068|NCT02257736|Aragon Pharmaceuticals, Inc.|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21272069|NCT04234568|University of Kentucky|Dr. Susanne Arnold|859-323-8043|susanne.arnold@uky.edu|
21272070|NCT03071406|Moffitt Cancer Center|Sungjune Kim, MD, PhD|813-745-1898|sungjune.kim@moffitt.org|
21272071|NCT05202093|Sun Yat-sen University|Dr. Hongchun Liu|86-13826189071|hongchun_liu@vip.sina.com|
21272072|NCT05856123|Mayo Clinic|Deanna Covelli|480-342-5284|covelli.deanna@mayo.edu|
21272073|NCT05514119|Mayo Clinic|Channa Jayasekera, M.D.|480-342-1095|jayasekera.channa@mayo.edu|
21272074|NCT02396381|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
21272075|NCT03500484|Yale University / Yale School of Medicine|Ania Jastreboff, MD, PhD|203 737 1932|ania.jastreboff@yale.edu|
21272076|NCT00948675|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21272077|NCT02296775|Dr. Reddy's Laboratories Ltd, Biologics Survey No. 47, Bachupally Village, Bachupally Mandal, Medchal Malkajgiri District Telangana, India - 500 090|Dr. Ankit Ranpura, MD (Associate Director- Clinical Development)|040 4464 4000|ankitr@drreddys.com|
21272078|NCT01654380|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21272079|NCT01575522|Dana-Farber Cancer Institute|Sara M. Tolaney, MD, MPH|617.632.5743|Sara_Tolaney@dfci.harvard.edu|
21272080|NCT04041609|Lyra Therapeutics|Lyra Clinical|617-393-4600|lyraclinical@lyratx.com|
21272081|NCT01576588|Vilnius University Hospital Santaros Klinikos|Regina Pileckyte, investigator|+370 5 2501384|regina.pileckyte@santa.lt|
21272082|NCT04471428|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21272083|NCT03290079|Moffitt Cancer Center|Jonathan Strosberg, MD|813-745-5553|jonathan.strosberg@moffitt.org|
21272084|NCT03390504|Janssen Research & Development, LLC|SR DIRECTOR ONCOLOGY CDTL|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21272085|NCT03095352|University of California, San Francisco|Dr. Laura Huppert, MD|(415) 476-1000|Laura.Huppert@ucsf.edu|
21272086|NCT02779855|Moffitt Cancer Center|Hatem Soliman, MD|813-745-4985|hatem.soliman@moffitt.org|
21272087|NCT06310005|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21272088|NCT05431686|Children's National Hospital|Dr. Jody Grundman|2024762121|jgrundman@childrensnational.org|
21272089|NCT05328375|Columbia University Irving Medical Center|Dr. Andrea T. Duran, Assistant Professor of Medical Sciences|212.342.4491|atd2127@cumc.columbia.edu|
21272090|NCT04849845|MannKind Corporation|Johanna Ulloa|818-661-5000|contact@mannkindcorp.com|
21272091|NCT02178709|IndianaU|Dr. Amikar Sehdev|(317) 274-0339|asehdev@iupui.edu|
21272092|NCT02946385|GlaxoSmithKline|GSK Response Center|866-435-7343|anand.n.harpalani@gsk.com|
21272093|NCT01526538|Johns Hopkins University|Matthew Johnson Ph.D.|4105500056|mwj@jhu.edu|
21272094|NCT04849988|AEON Biopharma, Inc.|Dana Testa, PharmD|949-354-6499|dt@aeonbiopharma.com|
21272095|NCT03185065|Johns Hopkins University|Dr. Bardia Nourbakhsh|4106141522|bnourba1@jhmi.edu|
21272096|NCT02780661|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21272097|NCT01893905|Complejo Hospitalario de La Coruña (CHUAC)|Dr Francisco Blanco, study coordinator|981 17 80 00|fblagar@sergas.es|
21272098|NCT01768858|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21272099|NCT01581970|Masonic Cancer Center, University of Minnesota|Dr. Gautam Jha|612-624-5373|jhaxx014@umn.edu|
21272100|NCT02742090|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
21272101|NCT02708290|ImagiRation LLC|Dr. Andrey Vyshedskiy, Founder|6174338577|vysha@bu.edu|
21272102|NCT03229252|Spyryx Biosciences|Dr. Rob Tarran|919-966-7052|rtarran@spyryxbio.com|
21272103|NCT01797471|University of Miami|Jean L. Wright MD|305-243-5965|jwright3@med.miami.edu|
21272104|NCT02192905|University of Massachusetts Medical School|Sherry Pagoto, Professor|508-856-5159|study@umassmed.edu|
21272105|NCT00974493|Oxford University Hospitals NHS Trust|Matthew Scarborough|07872436461|matthew.scarborough@ouh.nhs.uk|
21272106|NCT00862979|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
21272107|NCT00132002|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
21272108|NCT02688400|Arthrolab inc.|Dr.Jean-Pierre Pelletier|+1 (514) 992-4939|dr@jppelletier.ca|
21272109|NCT01027143|Duke University Medical Center|Jason Lang, MD|919-684-9590|jason.lang@duke.edu|
21272110|NCT03493126|The Ohio State University|Dr. Andrew Hundley|614-293-4647|andrew.hundley@osumc.edu|
21272111|NCT00992407|R&D Clinical Research, Seoul KOREA|Clinical Research Director|+82 2 2094 -4518||
21272112|NCT03738332|University of Pennsylvania|Dr. Jie Deng|215-573-2393|jiedeng@nursing.upenn.edu|
21272113|NCT01521559|Regeneron|Clinical Trials Administrator|914 847 5385|clinicaltrials@regeneron.com|
21272114|NCT02336737|Endomag|Clinical Develoment Director|+44 7851 247439|mwomack@endomag.com|
21272115|NCT02228382|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21272116|NCT02337465|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|Dr. Ping Xia|1-866-223-8100|TaussigResearch@ccf.org|
21272117|NCT00275002|Pediatric Brain Tumor Consortium|Dana Wallace|901-595-2617|dana.wallace@stjude.org|
21272118|NCT03197064|Stanford University|Dr. Mark Burbridge|(650) 353-8484|markburb@stanford.edu|
21272119|NCT02918162|Columbia University|Gulam Manji, MD, PhD|212-305-7115|gam2140@cumc.columbia.edu|
21272120|NCT00395226|Essentia Institute of Rural Health|Brian Johnson|218-786-8856|bjohnson3@eirh.org|
21272121|NCT02059993|State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College|Zhihong Liu|+86-01088398196|zhihongliufuwai@163.com|
21272122|NCT02655237|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
21272123|NCT03679741|Johnson & Johnson Vision Care|John Buch, O.D., M.S. Sr. Prinicpal Research Optometrist|904 443-1707|JBUCH@its.jnj.com|
21272124|NCT02456532|Henry Ford Health System|Timothy Roehrs|13138026681|troehrs1@hfhs.org|
21272125|NCT02227862|Mylan Inc.|David Gillogly, Head of Global Clinical Operations|+1 (724) 4856581|david.gillogly@mylan.com|
21272126|NCT00783796|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
21272127|NCT02959775|Shanxi Medical University|Suping Wang, PhD|#86-351-4135103|spwang88@163.com|
21272128|NCT01215942|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21272129|NCT03305055|Johns Hopkins University|James A. Fauerbach|410-550-0890|jfauerb1@jhmi.edu|
21272130|NCT00113490|MedImmune|M. Pamela Griffin, MD/ Clinical Development|301-398-0000|clinicaltrialenquiries@medimmune.com|
21272131|NCT00819247|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21272132|NCT02795104|The Ohio State University Comprehensive Cancer Center|Ryan Baltic|614-293-4121|ryan.baltic@osumc.edu|
21272133|NCT02582970|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21272134|NCT04652453|Department of Internal Medicine: Yale School of Medicine|Lauren Ferrante, MD, MHS|(203) 785-3207|lauren.ferrante@yale.edu|
21272135|NCT04543136|Coloplast A/S|Vice President, Medical Affairs|+4549111111|clinical-studies@coloplast.com|
21272136|NCT00711464|University of California, Los Angeles|Michael Minzenberg, MD|(310) 825-7642|MMinzenberg@mednet.ucla.edu|
21272137|NCT00585780|YALE UNIVERSITY SCHOOL OF MEDICINE|Dr. Rajita Sinha|2038592840|rajita.sinha@yale.edu|
21272138|NCT06331156|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21272139|NCT02901899|Northwestern University|Daniela Matei, MD|312.472.4684|daniela.matei@northwestern.edu|
21272140|NCT00546390|University of Alb erta|Dr B Finegan|7809701302|bfinegan@ualberta.ca|780
21272141|NCT00855842|Boston University|Lynn Borgatta, MD|617-414-3440|lynn.borgatta@bmc.org|
21272142|NCT02978326|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21272143|NCT02024087|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21272144|NCT00601354|Stanford University|Dr. Debra L Safer|650-723-7928|dlsafer@stanford.edu|
21272145|NCT04799158|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-PHAT|medicalinformation@phathompharma.com|7426
21272146|NCT00936975|ECOG-ACRIN Cancer Research Group|Results Reporting Statistician|401-863-9188|bherman@stat.brown.edu|
21272147|NCT00440596|Kent State University|Joel Hughes|330-672-7721|jhughes1@kent.edu|
21272148|NCT01592799|GlaxoSmithKline|GSK Response Center|866-435-7343||
21272149|NCT01656889|Smith & Nephew|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
21272150|NCT02486796|Midwestern Regional Medical Center, Inc.|Director of ClinicalResearch|847-731-1648|Bruce.Steinert@CTCA-Hope.com|
21272151|NCT00679783|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21272152|NCT02626949|Icahn School of Medicine at Mount Sinai|Jeffrey Weiss, PhD, MS|212-824-7575|Jeffrey.Weiss@mountsinai.org|
21272153|NCT01463683|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21272154|NCT01691859|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21272155|NCT00278200|Johns Hopkins University|Richard Ambinder, MD, PhD|4109558839|rambind1@jhmi.edu|
21272156|NCT00976664|National University of Health Sciences|Dr. Jerrilyn Cambron|630-889-6536|jcambron@nuhs.edu|
21272157|NCT01568008|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21272158|NCT02767388|University of Nebraska Medical Center|David Anderson|402-559-6870|david.anderson@unmc.edu|
21272159|NCT03467477|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
21272160|NCT03519256|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21272161|NCT00421174|The EMMES Corporation|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|221
21272162|NCT01631864|Novartis Pharmaceuticals|Study Director|862-778-8300||
21272163|NCT01031537|Division of Occupational Health and Safety, NIH|Dr. James M. Schmitt|301-496-4411|james_schmitt@nih.gov|
21272164|NCT03238677|Syracuse University|Jonathan Preston|3154433143|jopresto@syr.edu|
21272165|NCT00928954|Case Western Reserve University|R. John Leigh, M.D.|216-844-3190|rjl4@case.edu|
21272166|NCT02433665|Duke University Medical Center|Dr. Daniele Marin|919.684.7709|daniele.marin@duke.edu|
21272167|NCT00757601|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21272168|NCT00650936|Abbott|Maren Wagner, Clinical Program Director|7517565585|maren.wagner@abbott.com|
21272169|NCT02750761|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21272170|NCT01860976|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21272171|NCT00231868|Montefiore Medical Center|Dr. Dennis Yi-Shin Kuo|718-405-8082|DYKUO@montefiore.org|
21272172|NCT01506947|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
21272173|NCT03104205|Dartmouth-Hitchcock|John A. Batsis|6036505000|john.a.batsis@hitchcock.org|
21272174|NCT02511236|University of Miami Miller School of Medicine|David J. Lee|305-243-9680|dlee@med.miami.edu|
21272175|NCT01802879|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
21272176|NCT00266409|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
21272177|NCT01948505|Pacific Neuroscience Institute|Dr. Walavan Sivakumar|424-212-5361|walavan.sivakumar@gmail.com|
21272178|NCT05343156|Oculis SA|Bastian Dehmel, Chief Development Officer|0041 21 711 39 70|bastian.dehmel@culis.com|
21272179|NCT00670956|University of California San Francisco|Hanmin Lee, MD|415-476-4086|hanmin.lee@ucsf.edu|
21272180|NCT01766921|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
21272181|NCT01060592|Crospon|John O'Dea PhD|+353-91-519880|jodea@crospon.com|
21272182|NCT01901055|University of Pittsburgh|Eileen R. Chasens, PhD, Professor of Nursing|412-624-9380|chasense@pitt.edu|
21272183|NCT01807871|University of Vermont|Dr. John Hughes|802-656-1640|John.Hughes@med.uvm.edu|
21272184|NCT03019965|CISMexico|Dr. Yazmín Fuentes|55276900|yazmin_fuentes@hotmail.com|22462
21272185|NCT01179919|University of Michigan|Manjunath Pai|7346473466|amitpai@med.umich.edu|
21272186|NCT01325207|Northwestern University|Jeffrey Raizer, MD||Jeffrey.Raizer@nm.org|
21272187|NCT00698685|University of Arizona, Arizona Cancer Center|Andrew M. Yeager, MD|520-626-0662|ayeager@azcc.arizona.edu|
21272188|NCT00708422|Alcon Research, Ltd.|Director of Medical Affairs|1-800-862-5266|medinfo@alconlabs.com|
21272189|NCT01254409|Promedior, Inc.|Dr. Bernt van den Blink|781-538-4203|bvandenblink@promedior.com|
21272190|NCT01654107|Rutgers Robert Wood Johnson Medical School|Marc L. Steinberg, Ph.D.|7322354341|marc.steinberg@rutgers.edu|
21272191|NCT00337571|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21272192|NCT00638365|KaloBios Pharmaceuticals, Inc.|Nestor A. Molfino, MD., MSc|650-243-3103|nmolfino@kalobios.com|
21272193|NCT01569451|University of Colorado|Stefan Sillau|303-724-8657|stefan.sillau@ucdenver.edu|
21272194|NCT01974895|GlaxoSmithKline|GSK Response Center|866-435-7343||
21272195|NCT00635154|Mayo Clinic|Dr. John Lust||lust.john@mayo.edu|
21272196|NCT01513148|Shenandoah University|Dr. Todd Telemeco|540-545-7398|ttelemec@su.edu|
21272197|NCT03552757|Novo Nordisk A/S|Clinical Transparency Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21272198|NCT00571428|Sunovion|Brovana Medical Director|1-866-503-6351||
21272199|NCT02192099|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
21272200|NCT00386009|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21272201|NCT00998023|University of Florida|J Mocco, M.D.|352-273-9000|jmocco@neurosurgery.ufl.edu|
21272202|NCT02026453|Cedars-Sinai Medical Center|Dr. Joshua M. Pevnick|310-423-6976|Joshua.Pevnick@cshs.org|
21272203|NCT02129348|New York State Psychiatric Institute|Davangere Devanand, MD|646.774.8656|dpd3@cumc.columbia.edu|
21272204|NCT02327195|The Ohio State University Wexner Medical Center|Nicoleta Stoicea|614-293-3559|nicoleta.stoicea@osumc.edu|
21272205|NCT02597543|UCSD|Paul Kim, MD|3104907217|pjk017@ucsd.edu|
21272206|NCT01862328|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21272207|NCT03276975|Duke University Medical Center|Timothy J. Amrhein, MD|9196841909|timothy.amrhein@duke.edu|
21272208|NCT02114307|Imperial College London|Dr Tristan Lane|02033117317|tristan.lane@imperial.ac.uk|
21272209|NCT01485536|The University of Texas (UT) MD Anderson Cancer Center|Yasuhiro Oki, Associate Professor, Lymphoma/Myeloma|713-792-7734|CR_Study_Registration@mdanderson.org|
21272210|NCT00306384|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21272211|NCT00673790|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21272212|NCT00601484|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21272213|NCT03504852|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21272214|NCT02928848|University of Pennsylvania|Dr. H. Branch Coslett|2156623606|hbc@pennmedicine.upenn.edu|
21272215|NCT00969332|UCLA|Dr. Kara L. Calkins|310-825-9330|KCalkins@mednet.ucla.edu|
21272216|NCT00576199|Hoffmann-La Roche|Medical Communications|800 821-8590||
21272217|NCT00630565|University of Minnesota, Masonic Cancer Center|Dr. Daniel Weisdorf, MD|+1 612-624-3101|weisd001@umn.edu|
21272218|NCT00663871|University of Pittsburgh, Heart and Vascular Institute|Matthew F. Muldoon, MD, MPH|412-624-8798|mfm10@pitt.edu|
21272219|NCT00582309|UNM|Gary Iwamoto|505-272-4751|giwamoto@salud.unm.edu|
21272220|NCT03922477|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21272221|NCT03123822|UAB|Katherine Weise|2059752020|kweise@uab.edu|
21272222|NCT03111147|William Beaumont Hospitals|Pamela Sloan, Clinical Research Manager|248-551-6059|pamela.sloan@corewellhealth.org|
21272223|NCT00669578|Mayo Clinic|Ayalew Tefferi, M.D.||tefferi.ayalew@mayo.edu|
21272224|NCT03384745|Avillion LLP|Chief Medical Officer|+44 (0)203 764 9530|avillion@avillionllp.com|
21272225|NCT01058421|University of Colorado|Dr. Marc Moss|303-724-6079|marc.moss@ucdenver.edu|
21272226|NCT02984683|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|option 6
21272227|NCT01050231|University of California Irvine|Dr David Reinkensmeyer|(949) 824-5218|dreinken@uci.edu|
21272228|NCT00455533|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21272229|NCT00955747|University of Kentucky|Robert Lodder|859-955-0845|lodder@uky.edu|
21272230|NCT04634409|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21272231|NCT01739790|Minneapolis VA Healthcare System|Dennis E. Niewoehner, MD|612-467-4412|niewo001@umn.edu|
21272232|NCT02122796|Allina Health|Director of Integrative Health Reseach Center|612-262-2354|jeffery.dusek@allina.com|
21272233|NCT00590395|Cedars Sinai Medical Center|Alan Waxman, M.D.|310-423-8000|Alan.Waxman@cshs.org|
21272234|NCT00234078|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
21272235|NCT03471078|Dova|VP of Global Drug Development|9193387864|clinical@dova.com|
21272236|NCT01544361|MedImmune, LLC.|Joseph M. Parker, Director, Clinical Development|301-398-0000|parkerj@medimmune.com|
21272237|NCT05568225|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21272238|NCT02405325|UCSD|Loki Natarajan|8588224763|lnatarajan@ucsd.edu|
21272239|NCT05456529|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21272240|NCT02624843|South Florida Family Health & Research|Elisabeth Rivera|3053870051|elisabeth@sffhrc.com|
21272241|NCT01747850|CAMH|Dr. Jose Trigo|416.535.8501|jose.trigo@camh.ca|30021
21272242|NCT00576381|The Children's Hospital of Philadelphia|Dr Athena Zuppa|267-426-5753|zuppa@email.chop.edu|
21272243|NCT00797108|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21272244|NCT02518113|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21272245|NCT00287118|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21272246|NCT02324465|Vanderbilt University Medical Center|Doug Hester|6153439419|doug.hester@vanderbilt.edu|
21272247|NCT00419926|Novartis Pharmaceuticals|Study Director|862-778-8300||
21272248|NCT03256799|UAB|Steven M. Rowe|205-975-9776|smrowe@uab.edu|
21272249|NCT02153398|Biometrics Department, Science Affairs Division, R&D, AstraZeneca Japan|Masahiro Nii||Masahiro.Nii@astrazeneca.com|
21272250|NCT02374918|University of Arizona|"Dr. William Scott Killgore"|(520) 621-0605|killgore@psychiatry.arizona.edu|
21272251|NCT02204371|GlaxoSmithKline|GSK Response Center|866-435-7343||
21272252|NCT02922868|Wake Forest|Dr Gopal Badlani|3367165928|gbadlani@wakehealth.edu|
21272253|NCT03594123|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21272254|NCT02483975|GlaxoSmithKline|GSK Response Center|866-435-7343||
21272255|NCT03365375|Indiana University|Paul Musey|317-880-3900|pmusey@iu.edu|
21272256|NCT00818883|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21272257|NCT00939653|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
21272258|NCT03879239|Vibrant LTD|Tal Malina / Clinical trials manager|+972 046663322|tal.m@vibrantgastro.com|
21272259|NCT00290745|Duke University and Duke Cancer Institute|Dr. E. Shelly Hwang, MD, MPH|(919) 684-6849|shelley.hwang@duke.edu|
21272260|NCT02226796|University of Minnesota Duluth|Sharyl Samargia-Grivette|218-726-8347|samargia@d.umn.edu|
21272261|NCT00108732|ECOG Statistical Office|Study Statistician|617-632-3012||
21272262|NCT02187042|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21272263|NCT01659567|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21272264|NCT02983448|University of Oklahoma Health Sciences Center|Dr. Stavros Stavrakis|405-271-4742|stavros-stavrakis@ouhsc.edu|37507
21272265|NCT01650324|Taipei Medical University - Wanfang Hospital|Dr. Yi-Jen Chen|886-2-2930-7930|yjchen@tmu.edu.tw|2543
21272266|NCT01586741|Karolinska University Hospital|D. Peter Emanuelsson|+46851770000|peter.emanuelsson@sll.se|
21272267|NCT01915732|GlaxoSmithKline|GSK Response Center|866-435-7343||
21272268|NCT03309449|SUNY Upstate Medical University|William Eggleston|315-464-8906|egglestw@upstate.edu|
21272269|NCT02356471|Wake Forest University Health Sciences|Dr. Clancy Clark|336-716-7207|cjclark@wakehealth.edu|
21272270|NCT01491620|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
21272271|NCT00449150|AEterna Zentaris|Daniel Croteau, Medical Manager|418-652-7669|DCroteau@aezsinc.com|272
21272272|NCT02246478|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.||toiawase@taiho.co.jp|
21272273|NCT02019940|Yale School of Medicine|Chadi Abdallah|347-987-0717|chadi.abdallah@yale.edu|
21272274|NCT00429923|Sirion Therapeutics, Inc.|Jeremy Brace|813-496-7325|jbrace@siriontherapeutics.com|343
21272275|NCT00662129|Mayo Clinic|Donald W. Northfelt, MD, FACP|507/284-1159|northfelt.donald@mayo.edu|
21272276|NCT01055223|GlaxoSmithKline|GSK Response Center|866-435-7343||
21272277|NCT03387033|Duke University|Nirmish Shah, MD|919-668-5178|nirmish.shah@duke.edu|
21272278|NCT00329602|GlaxoSmithKline|GSK Response Center|866-435-7343||
21272279|NCT02579096|Boston CSP Coordinating Center|Ryan E. Ferguson, ScD, MPH, Director|1-857-364-4201|Ryan.Ferguson@va.gov|
21272280|NCT04107493|ResMed|maureen crocker|+1 8588366653|maureen.crocker@resmed.com|
21272281|NCT02729896|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21272282|NCT00918671|NTNU|Professor Knut Hagen|+4772575080|knut.hagen@ntnu.no|
21272283|NCT01924390|UTHSCSA Periodontics|Brian L. Mealey|210-567-3589|mealey@uthscsa.edu|
21272284|NCT01592370|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21272285|NCT02415959|Abbott|Suntje Sander-Struckmeier|+49 (0) 511 6750 3254|suntje.sander@abbott.com|
21272286|NCT01048333|Astra Zeneca|Gerard Lynch|+44 1509 645895|ClinicalTrialTransparency@astrazeneca.com|
21272287|NCT02042911|SymBio Pharmaceuticals|Toshihiko Nagase|+81-3-5472-1127||
21272288|NCT03131999|Medical University of South Carolina|Charlton Strange, MD|843-792-3174|strangec@musc.edu|
21272289|NCT02260492|Oriel Therapeutics, a Novartis Company|Malinda Longphre PhD, Director Clinical Reserach|9193131290|mlongphre@orieltherapeutics.com|114
21272290|NCT00996736|F.I. Proctor Foundation, University of Califonia, San Francisco|Dr. Thomas Lietman|415-502-2662|tom.lietman@ucsf.edu|
21272291|NCT01693783|University Health Network - Princess Margaret Cancer Centre|Dr. Amit Oza|416-946-4501|Amit.Oza@uhn.ca|3911
21272292|NCT02346201|Johns Hopkins School of Public Health|Jennifer Jones, Research Coordinator|44377086812|jejones@jhu.edu|
21272293|NCT01497938|Medtronic|Thomas Troub|(818) 576-3142|thomas.troub@medtronic.com|
21272294|NCT03708211|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21272295|NCT00097695|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21272296|NCT00462982|Memorial Sloan Kettering Cancer Center|Dr. Robert Motzer|646-422-4312|motzerr@mskcc.org|
21272297|NCT00905125|Medicine and Molecular Virology & Microbiology, Baylor College of Medicine|Shital M. Patel, M.D.|713-798-3793|shitalp@bcm.edu|
21272298|NCT05200858|Baylor College of Medicine|Prof. Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
21272299|NCT02683187|Duke University Medical Center|Dr. David D'Alessio|919-684-5778|david.d'alessio@duke.edu|
21272300|NCT06611410|CooperVision|Lee Hall|+19256604365|LHall@coopervision.com|
21272301|NCT01402908|Medigen Biotechnology Corp.|Clinical Research Manager|886-2-77361234|Doyce.Chen@medigen.com.tw|
21272302|NCT02581345|Momenta|Jim Jin|+16173954905|jjin@momentapharma.com|
21272303|NCT03068273|Scripps Health|Athena Philis-Tsimikas|858-678-7077|philis-tsimikas.athena@scrippshealth.org|
21272304|NCT03901573|NeoImmuneTech,INC|Alex Oh|301-337-2283|aho@neoimmunetech.com|
21272305|NCT02207231|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
21272306|NCT02258256|Rice 360: Institute for Global Health|Dr. Rebecca Richards-Kortum|713-348-3823|rkortum@rice.edu|
21272307|NCT04637997|University Hospital Erlangen, Vascular Surgery|Dr. med. Antje Mükke|+4991318532968|antje.muekke@uk-erlangen.de|
21272308|NCT01290263|Dana-Farber Cancer Institute|David A. Reardon, MD|617-632-2166|dreardon3@partners.org|
21272309|NCT02675543|University of Brescia|Francesco Semeraro|+30 030 3995308|francesco.semeraro@unibs.it|
21272310|NCT02309099|University of North Carolina at Chapel Hill|Dr. Meredith Rooth|919-966-5251|meredith_rooth@med.unc.edu|
21272311|NCT03012477|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|(877) 442-3324|Sara_Tolaney@dfci.harvard.edu|
21272312|NCT02819362|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
21272313|NCT01545076|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
21272314|NCT00262600|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21272315|NCT02710123|SUNY Buffalo|John Leddy MD|7162043200|leddy@buffalo.edu|
21272316|NCT05381948|EyePoint Pharmaceuticals, Inc.|Ramiro Ribeiro, MD, PhD|908-440-0979|rribeiro@eyepointpharma.com|
21272317|NCT04471207|Medical University of South Carolina|Stacey Sellers|843-792-5807|sellersst@musc.edu|
21272318|NCT06046482|The University of Texas MD Anderson Cancer Center|Renata Ferrarotto, MD|(713) 745-6774|rferrarotto@mdanderson.org|
21272319|NCT02132247|IBSA Pharma Inc.|Christopher Jones, Ph.D.|(202) 753-6475|chris.jones@ibsapharma.com|7005
21272320|NCT00724568|University of Michigan Comprehensive Cancer Center|Dr. Moshe Talpaz|734-764-8195|mtalpaz@umich.edu|
21272321|NCT00561730|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
21272322|NCT02841774|Northwestern University|Dr. Matthew Feinstein|3126643278|matthewjfeinstein@northwestern.edu|
21272323|NCT04908748|Teikoku Seiyaku Co.,Ltd.|Hirofumi Fujiwara|+81362649123|hirofumi-fujiwara@teiyaku.co.jp|
21272324|NCT00520741|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
21301954|NCT02280408|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21301955|NCT01068600|Novartis Pharmaceuticals|Study Director|862-778-8300||
21301956|NCT06026124|Purdue University|Dr. Patricia Deevy, Research Associate|765-496-1821|deevy@purdue.edu|
21301957|NCT01519869|University of Kentucky|Rachel Miller|859-323-2169|raware00@uky.edu|
21301958|NCT02283762|Bayer|Therapeutic Area Head|+1 888-8422937|clinical-trials-contact@bayer.com|
21301959|NCT00974480|Innovaderm Research Inc|Annie Levesque|514-521-4285|alevesque@innovaderm.ca|222
21301960|NCT01474018|Baylor Endocrine Center|Dr. Erin D. Roe|214-820-3466|edr@roemd.com|
21301961|NCT01594528|Centre Hospitalier Esquirol|Dr Murielle Girard|0033555431028|murielle.girard@ch-esquirol-limoges.fr|
21301962|NCT00486291|Vivus, Inc|Wesley W. Day, PhD|650-934-5200|day@vivus.com|
21301963|NCT01209702|Hoffman-LaRoche|Medical Communications|800-821-8590||
21301964|NCT00126490|H. Lee Moffitt Cancer Center and Research Institute|Mayer Fishman, M.D., Ph.D.|813-745-8311|mayer.fishman@moffitt.org|
21301965|NCT04036292|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
21301966|NCT03462511|Columbia University School of Nursing|Arlene Smaldone, PhD, RN|212-342-3048|ams130@columbia.edu|
21301967|NCT00200356|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21301968|NCT02367833|Penn State University|Dr. Mary Jane De Souza|8148630045|mjd34@psu.edu|
21301969|NCT03001817|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
21301970|NCT03855059|University of Arizona/Deptartment of Anesthesiology|Peter Lichtenthal, MD|5206267221|plich@arizona.edu|
21301971|NCT00035932|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21301972|NCT02268175|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-7221|mary_taplin@dfci.harvard.edu|
21301973|NCT00889720|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21301974|NCT04080167|St. Jude Children's Research Hospital|Jane Hankins, MD|(901) 595-4974|jane.hankins@stjude.org|
21301975|NCT02167139|Samsung Bioepis|Director, Clinical Development|+82 31 8061 4534|dh01.shin@samsung.com|
21301976|NCT02067676|Enteric Disease Department, Naval Medical Research Center|Ramiro Gutierrez, MD|301-319-3193|ramiro.l.gutierrez.mil@mail.mil|
21301977|NCT00996333|Columbia University|Paul Oberstein|212-305-0592|po2178@cumc.columbia.edu|
21301978|NCT00476229|UT MD Anderson Cancer Center|Chitra M. Hosing, MD/Associate Professor||gmccormi@mdanderson.org|
21272325|NCT01505530|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21301979|NCT02164461|Advaxis, Inc.|Sumitra Sheeri|609-423-2528|Sheeri@advaxis.com|
21272326|NCT01153984|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21272327|NCT00973700|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com|
21272328|NCT04763876|William Beaumont Army Medical Center Department of Emergency Medicine|Nathaniel James Turner|915-742-6228|nathaniel.j.turner3.mil@mail.mil|
21272329|NCT03179345|Depomed|Clinical Operations|510-744-8000|clinicaltrials@depomed.com|
21272330|NCT02585700|Clinical Center of Serbia-Clinic for Infectious and Tropical Diseases|Dr. Goran Stevanovic|+381 64 1703059|goran_ste@yahoo.com|
21272331|NCT01618266|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21272332|NCT00626925|University of Pennsylvania Perelman School of Medicine|Henry R. Kranzler, M.D.|215-386-6662|kranzler@mail.med.upenn.edu|
21272333|NCT00625807|Massachusetts General Hospital|Sara Lazar|617-724-2256|slazar@mgh.harvard.edu|
21272334|NCT01966042|Federal University of Sao Paulo (UNIFESP)|Dr. Nelson Americo Hossne Junior|+55 11 5571-2719|nelson.hossne@gmail.com|
21272335|NCT03267264|Becton Dickinson|Michael Gibney|201-847-6170|michael_gibney@bd.com|
21272336|NCT02492958|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21272337|NCT03522948|Boston University|Tibor Palfai|617-353-9345|palfai@bu.edu|
21272338|NCT00712010|Clinical Development Unit / Metabolic Unit|Dr Maurice Beaumont|+41217858054|maurice.beaumont@rdls.nestle.com|
21272339|NCT01946165|UT MD Anderson Cancer Center|Christopher J. Logothetis M.D. / Genitourinary Medical Oncology|713-792-2830|clogothe@mdanderson.org|
21272340|NCT04582396|Columbia University|Dr. Sachin Agarwal|2123421335|sa2512@cumc.columbia.edu|
21272341|NCT02114697|Emory University|John Oshinski PhD|404-727-5894|jnoshin@emory.edu|
21272342|NCT00424489|Northwestern University|Dr. Richard Burt|312-695-4960|rburt@northwestern.edu|
21272343|NCT01984242|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21272344|NCT00536575|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21272345|NCT02334059|Penn State Health Anesthesiology and Perioperative Medicine|Sanjib D Adhikary|717-531-6597|sadhikary1@pennstatehealth.psu.edu|
21272346|NCT01598701|University of Texas Health Science Center at Houston|Carlos Artime, MD|713-500-6200|Carlos.Artime@uth.tmc.edu|
21272347|NCT01709032|Children's Hospital of Philadelphia|Janet Kwiatkowski, MD|215-590-3437|kwiatkowski@email.chop.edu|
21272348|NCT02566135|Medical College, Baroda.|Dr Aditi Amrutlal Dhimar|09825334605|dhimaraditi@yahoo.in|
21272349|NCT00865709|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21272350|NCT01265784|La Jolla Pharmaceutical Company|Chief Development Officer|+1.617.715.3600|ljpcregulatory@ljpc.com|
21272351|NCT03644095|Reckitt Benckiser Inc.|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
21272352|NCT04333095|Baylor Scott & White Research Institute|Sarah Hale, Project Manager|469-814-4845|Sarah.Hale@BSWHealth.org|
21272353|NCT00984295|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21272354|NCT03740165|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21272355|NCT03049618|University of Southern California|Victoria Soto|323-865-3441|victoria.soto@med.usc.edu|
21272356|NCT04582539|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21272357|NCT06052566|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21272358|NCT01004770|GE Healthcare|Rubin Sheng, MD|1-609-514-6899|rubin.sheng@ge.com|
21272359|NCT00788957|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
21272360|NCT02275364|GlaxoSmithKline|GSK Response Center|866-435-7343||
21272361|NCT00510510|Novartis Pharmaceuticals|Study Director|862-778-8300||
21272362|NCT01200394|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21272363|NCT00319449|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21272364|NCT00365352|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
21272365|NCT02109133|Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine,Severance Hospital, Yonsei University Health System|Dr. Sun-Jun, Bae|+82-02-2228-4438|SJBAI1@yuhs.ac|
21272366|NCT02448771|Dana-Farber Cancer Institute|Rinath Jeselsohn|617.632.6887|rinath_jeselsohn@dfci.harvard.edu|
21272367|NCT03968224|UIM Enfermedades Endocrinas. Hospital de Especialidades Centro Médico Nacional Siglo XXI|Aldo Ferreira Hermosillo|+(52)15556276900|aferreira@endocrinologia.org.mx|21913
21272368|NCT03457909|Department of Gastroenterology|Changhai Hospital|86-21-31161004|liaozhuan@smmu.edu.cn|86-21-6549
21272369|NCT00770315|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21272370|NCT04256421|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21272371|NCT02785913|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
21272372|NCT01052116|ALA - ACRC|Robert A. Wise|(410) 550-0545|rwise@jhmi.edu|
21272373|NCT00502775|GlaxoSmithKline|GSK Response Center|866-435-7343||
21272374|NCT03392974|BioMarin Pharmaceutical Inc.|Medical Manager, Clinical Science|415-996-2917|divya.reddy@bmrn.com|
21272375|NCT04815863|Renji Hospital, Shanghai Jiaotong University School of Medicine|Dr. Meng Jiang|+86 13788912766|jiangmeng0919@163.com|
21272376|NCT02270736|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
21272377|NCT06132919|MC2 Therapeutics|Chief Medical Officer|+45 2018 1111|info@mc2therapeutics.com|
21272378|NCT04373434|Emory University|Michelle C. Kegler, MPH, DrPH|404-712-9957|mkegler@emory.edu|
21286879|NCT04325828|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21286880|NCT05115630|University of Texas MD Anderson Cancer Center|Jeremy Ramdial, MD./ Stem Cell Transplantation Department|713-745-0146|JLRamdial@mdanderson.org|
21286881|NCT05093933|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21286882|NCT06729177|University of Tennessee, Knoxville|Leala Holcomb|415-307-6410|lholcom5@utk.edu|
21272379|NCT03702621|Indiana University|Dr. Yar Luan Yeap|317-274-0275|yyeap@iupui.edu|
21272380|NCT00527423|Regeneron Pharmaceuticals|Clinical Trials Administrator||clinicaltrials@regeneron.com|
21272381|NCT00067236|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com|
21272382|NCT03194464|VA Northern California Health Care System|Dr. Carolynn Patten (Principal Investigator)|916.724.5029|carolynn.patten@va.gov|
21272383|NCT02446132|Otsuka Pharmaceutical Development & Commercialization, Inc.|Clinical Transparency|08446878522|clinicaltransparency@otsuka-us.com|
21272384|NCT03444038|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
21272385|NCT02892500|Sanford Health|Christie Ellison|605-312-6030|christie.ellison@sanfordhealth.org|
21272386|NCT02354586|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21272387|NCT02606500|University medical centre Ljubljana|Professor Eda Vrtacnik Bokal|+38615226060|eda.bokal@guest.arnes.si|
21272388|NCT01957488|Coloplast|Medical Director|+45 4911 1395|dkbir@coloplast.com|
21272389|NCT03104322|patientMpower|Chief Scientific Officer|+353872599131|colin@patientmpower.com|
21272390|NCT00721409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21272391|NCT01134081|University of Michigan|Dr. William Giannobile|734 763 2105|wgiannob@umich.edu|
21272392|NCT02402166|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21272393|NCT00810368|Georgetown University Medical Center|Dr. James N Baraniuk|202-687-8231|baraniuklab@gmail.com|
21272394|NCT00623103|Novartis Pharmaceuticals|Study Director|862-778-8300||
21272395|NCT01141725|FHCRC/UWMC|Elihu Estey, MD, Director of AML Program|206-288-7176|eestey@uw.edu|
21272396|NCT01024738|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
21272397|NCT02362594|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21272398|NCT03803943|Northwestern University|Megan Roberts|(847) 491-3066|megan.y.roberts@northwestern.edu|
21272399|NCT01781286|University of Missouri|Dr. Heather Leidy|(573) 882-4288|leidyh@health.missouri.edu|
21272400|NCT00995410|POZEN|John Fort, MD / Chief Medical Officer|919-913-1030|jfort@pozen.com|
21272401|NCT02166697|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21272402|NCT01556009|Children's Hospital of Oakland Research Institute, Oakland|Ervin H Epstein Jr., MD|510-450-5688|eepstein@chori.org|
21272403|NCT02720510|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21272404|NCT01105650|Masonic Cancer Center, University of Minnesota|Dr. Melissa Geller|612-626-3111|gelle005@umn.edu|
21272405|NCT01047345|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21272406|NCT00806156|Nektar Therapeutics|Study Director||medicalaffairs@nektar.com|
21272407|NCT00282256|Astellas Pharma Global Development, Inc.|Vice President, Therapeutic Area Head, Transplantation||ClinicalTrials.Disclosure@us.astellas.com|
21272408|NCT02106065|VA Palo Alto Health Care System|Dr. Kaci Fairchild|6504935000|jenniferkaci.fairchild@va.gov|63432
21272409|NCT01095510|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21272410|NCT01890915|James J. Peters VA Medical Center|Dr. John P. Handrakis|718-584-9000|john.handrakis@va.gov|5439
21272411|NCT03312257|Ohio State University|Jeffrey Walline|614-247-6840|walline.1@osu.edu|
21272412|NCT04558554|Fred Hutchinson Cancer Center|Katrina Ortblad|206.667.7267|kortblad@fredhutch.org|
21272413|NCT00982553|Imperial College|Dr Alan Winston|+44 (0)20 3312 1603|a.winston@imperial.ac.uk|
21272414|NCT00770510|Eisai Co., Ltd.|Atsushi Kamijo, Study Director|+81-3-3817-5245|a-kamijo@hhc.eisai.co.jp|
21272415|NCT04087395|TEOXANE SA|Clinical Project Manager|+41(0) 22 344 96 36|clinical@teoxane.com|
21272416|NCT02348385|Yale|Kelly Cosgrove|203-737-6969|kelly.cosgrove@yale.edu|
21272417|NCT01085344|The Hospital for Sick Children|Dr. Brian Feldman|416-813-5828|brian.feldman@sickkids.ca|
21272418|NCT04026126|University of Kansas Medical Center|Paige Geiger, PhD|913-588-7408|pgeiger@kumc.edu|
21272419|NCT00767507|The Medicines Company|Meredith Todd - Sr. Director Program Management|+1.973.290.6088|meredith.todd@themedco.com|
21272420|NCT00966953|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
21272421|NCT05030753|Univeristy of Virginia|Jamie Zoellner|434-962-4488|jz9q@virginia.edu|
21272422|NCT03580343|Washington University in St. Louis|Lynn Hassman, Assistant Professor and Study PI|3142730341|lhassman@wustl.edu|
21272423|NCT02099461|Amgen Inc.|Study Director|866-572-6436||
21272424|NCT03277183|NFSGVA|Dr. Mark Segal|3523761611|mark.segal@va.gov|104496
21286883|NCT01949142|Otonomy, Inc|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
21286884|NCT05069259|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21286885|NCT00870727|Indiana University|Christopher J. McDougle, MD|781-860-1783|cmcdougle@partners.org|
21286886|NCT01712516|Novartis Pharmaceuticals|Study Director|862-778-8300||
21286887|NCT01251952|Barbara Ann Karmanos Cancer Institute|Zaid Al-Kadhimi, M.D.|(313) 576-8022|alkadhiz@karmanos.org|
21286888|NCT00496769|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21286889|NCT00869414|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
21238229|NCT05608499|Icahn School of Medicine at Mount Sinai|Giselle Singer|212-241-3288|giselle.singer@mssm.edu|
21238230|NCT02865720|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21286890|NCT00607243|Seoul National University Hospital|Myoung-don Oh, M.D.|+82-2-2072-2945|mdohmd@snu.ac.kr|
21286891|NCT02224625|Bioscience Labs|C Beausoleil|406-587-5735|cbeausoleil@bioscience.com|
21286892|NCT00729521|Medical College of Wisconsin|Peter Layde, MD, MSc|414-955-8113|playde@mcw.edu|
21238231|NCT02660827|Medtronic Minimed|Vivian Chen, Statistician|8185763309|vivian.chen@medtronic.com|
21272425|NCT00809809|Integrative Medicine Institute|David Riley, MD|505 690-0688|dsriley@integrativemed.org|
21286893|NCT01433159|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
21272426|NCT00720122|Massachusetts General Hospital|Madhusmita Misra, M.D., Associate Professor in Pediatrics, Assistant Pediatrician|617-724-5602|mmisra@partners.org|
21272427|NCT03072459|Smith & Nephew, Inc.|Salima Reddy|817-916-2233|salima.reddy@smith-nephew.com|
21272428|NCT03177603|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21272429|NCT02097121|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21272430|NCT03595657|CStone Pharmaceuticals|Zhang Wenyun|+86 021-60333416|CstoneRA@cstonepharma.com|
21272431|NCT01066052|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
21272432|NCT01835145|Alliance for Clinical Trials in Oncology|Jason J. Luke, M.D.||jluke@medicine.bsd.uchicago.edu|
21272433|NCT04094870|University of North Carolina at Chapel Hill|Elizabeth Stringer, MD, MSc|919-966-1601|elizabeth_stringer@med.unc.edu|
21272434|NCT02708277|The First Affiliated Hospital of Sun Yat-sen University|Yuqing Chen|+86 020-87755766-8341|fangchenyq@163.com|
21272435|NCT02742181|University Hospitals Cleveland Medical Center|Sharon Stein|(216)844-2873|Sharon.Stein@UHhospitals.org|
21272436|NCT02739984|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21272437|NCT02785172|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
21272438|NCT03363581|Imperial College London|Prof Carel le Roux|07970719453|carel.leroux@nhs.net|
21272439|NCT00409578|Novartis Pharmaceuticals|Study Director|862 778-8300||
21272440|NCT01298570|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
21272441|NCT02841709|Idorsia Pharmaceuticals Ltd|Clinical Trials Disclosure Desk|+41 588 441977|clinical-trials-disclosure@idorsia.com|
21272442|NCT01929109|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21272443|NCT00076102|National Cancer Institute (NCI), National Institutes of Health (NIH)|Brigitte C. Widemann, M.D.|301-496-7387|widemanb@mail.nih.gov|
21272444|NCT01076972|Abbott|Global Medical Services|800-633-9110||
21272445|NCT03165058|GI Clinical Research Enterprise|Tina Higginbotham|615-322-4643|tina.higginbotham@vumc.org|
21272446|NCT03252964|Savvysherpa, Inc.|Jared Jones, PhD|7635493540|JaredJones@savvysherpa.com|8116
21272447|NCT01315145|Vertos Medical|VP of Clinical Affairs|9493490008|kdavis@vertosmed.com|
21272448|NCT00655642|Vanderbilt University|Dr. Tyler Barrett|6159360253|tyler.barrett@vanderbilt.edu|
21272449|NCT02016300|Stanford University|Jason Dragoo, MD|650-721-3430|jdragoo@stanford.edu|
21272450|NCT05301751|Allgenesis Biotherapeutics Inc.|Tan Nguyen, Vice President of R&D|+886-2-87871232|tan.nguyen@allgenesis.com|105
21272451|NCT06165744|Alcon Research, LLC|Sr. Principal Clinical Project Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21272452|NCT01546987|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21272453|NCT02134756|University of South Florida|Marcus Kilpatrick|(813) 362-6696|mkilpatrick@usf.edu|
21272454|NCT00583700|West Virginia University|Geraldine Jacobson, MD, MBA, MPH, FACR|(304) 293-7227|GMJACOBSON@hsc.wvu.edu|
21272455|NCT01385033|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21272456|NCT01424722|Abbott Medical Devices|Clinical Program Director|972-309-8087|clay.cohorn@abbott.com|
21272457|NCT02684578|University of California, San Francisco|Dr. Jay Stewart|628-206-3123|jay.stewart@ucsf.edu|
21272458|NCT03622658|Kinevant Sciences Inc. on behalf of Kinevant Science GmbH|Dr. Simon Lowry, Chief Medical Officer|646-495-5368|simon.lowry@roivant.com|
21272459|NCT03499964|Urotronic, Inc|Vice President of Clinical Affairs|763-285-7489|info@urotronic.com|
21272460|NCT02224391|UT MD Anderson Cancer Center|Dr. Jason Robinson, PHD- Associate Professor, Behavioral Science|(713) 792-0919|jdrobinson@mdanderson.org|
21272461|NCT03718455|Mayo Clinic|Genevieve A. Woodard, M.D., Ph.D.|507-538-3945|Woodard.Genevieve@mayo.edu|
21272462|NCT00084084|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21272463|NCT01933295|Henry Ford Health|Christopher Drake|(248) 344-6672|cdrake1@hfhs.org|
21272464|NCT02236130|University of Mississippi Medical Center|Madhankumar Sathyamoorthy|6018157066|msathyamoorthy@umc.edu|
21272465|NCT00454636|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21272466|NCT01400113|St. Joseph's Hospital Health Center|Michael Pratts, MD|315-726-8610|michael.pratts@sjhsyr.org|
21272467|NCT01025037|Tornier, Inc.|Manager of Clinical Operations|952-426-7674|serickson@tornier.com|
21272468|NCT01346852|GlaxoSmithKline|GSK Response Center|866-435-7343||
21272469|NCT02660242|Jaeb Center for Health Research|Stephanie DuBose|813.975.8690|sdubose@jaeb.org|
21272470|NCT02796664|Asan Medical Center|Dr. Dae Chul Suh|+82-2-3010-4366|dcsuh@amc.seoul.kr|
21272471|NCT01189123|Vanderbilt University Medical Center|Dr. Keipp Talbot|6153222035|keipp.talbot@vanderbilt.edu|
21272472|NCT02115646|MGH Wellman Center|Kachiu Lee, MD|4018303128|klee52@partners.org|
21272473|NCT01089647|University of Cincinnati|Dr. Ann Romaker|513-475-7500|romakean@ucmail.uc.edu|
21272474|NCT00995553|Minneapolis VA Health Care System|Dr. Tasha Nienow|612-467-1004|Tasha.Nienow@va.gov|
21272475|NCT01531205|H. Lee Moffitt Cancer Center and Research Institute|Julio Pow-Sang, M.D.|813-745-2226|julio.powsang@moffitt.org|
21272476|NCT00006156|National Institute of Child Health and Human Development|Nelson, Lawrence Merle|+1 301 402 6608|nelsonl@mail.nih.gov|
21272477|NCT00198029|Hospital for Special Surgery|Dr. Lisa Mandl|212-774-2555|MandlL@hss.edu|
21272478|NCT02465567|Pearl Therapeutics Inc|Pearl Therapeutics Inc|1-877-240-9479|information.center@astrazeneca.com|
21272479|NCT02001558|University of Alabama at Birmingham|Yuying Chen, MD, PhD|205-934-3329|yuyingchen@uabmc.edu|
21272480|NCT04117607|ICON CRU|Dr. Dennis Ruff, Senior Medical Director|210-283-4572|Dennis.Ruff@iconplc.com|
21301980|NCT04059159|Spinal Singularity|Derek Herrera|949-436-7974|dherrera@urodevmedical.com|
21301981|NCT01262820|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
21301982|NCT00452361|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21301983|NCT02954172|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+86 13382419112|jessica.yi@innoventbio.com|
21301984|NCT00924027|National Cancer Institute|Dr. Deborah E. Citrin|240-760-6206|citrind@mail.nih.gov|
21238232|NCT04672941|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21272481|NCT01807637|University of Arkansas for Medical Sciences|Mark Mennemeier, PhD|15015267773|msmennemeier@uams.edu|
21272482|NCT00950807|GlaxoSmithKline|GSK Response Center|866-435-7343||
21272483|NCT01434121|Virginia Commonweath University|Alpha A. Fowler, III, MD|804-628-5710|afowler@mcvh-vcu.edu|
21272484|NCT01492400|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21272485|NCT00659607|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21272486|NCT02349893|Olympus Europa SE & Co. KG|Dr Samuel Faran|0049 1607168798|samuel.faran@olympus.com|
21272487|NCT06179108|LB Pharmaceuticals Inc|Leslie Callahan, Head, Clinical Operations|9086556884|leslie@lbpharma.us|
21272488|NCT04894994|RAPT Therapeutics|William Ho|650-489-9037|bill.ho@RAPT.com|
21272489|NCT02532010|Weill Cornell Medicine|Dr. Sangmin Lee|646-962-2700|sal9053@med.cornell.edu|
21272490|NCT02364557|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21272491|NCT04347239|CytoDyn Inc.|Bernie Cunningham, PhD, MRPharmS; VP Operations|5164060197|bcunningham@cytodyn.com|
21272492|NCT03076255|Thomas Jefferson University|Voichita Bar-Ad, MD|215-955-6702|Voichita.BarAd@jefferson.edu|
21272493|NCT04552704|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
21272494|NCT01822548|Azienda ospedaliero-universitaria di Parma|Prof.ssa Ivana Zavaroni|+390521033306|ivana.zavaroni@unipr.it|
21272495|NCT03845933|Evergreen General Hospital|Dr Chi-Liang Cheng|0919768058|chiliang.cheng@gmail.com|
21272496|NCT00696449|Wake Forest University Health Sciences|Steven Feldman|3367167740|sfeldman@wakehealth.edu|
21272497|NCT03978403|Zosano Pharma Corporation|Dr. Don Kellerman, Sr. VP, Clinical Development and Medical Affairs|+1 (510) 745-4004|dkellerman@zosanopharma.com|
21272498|NCT02153736|Virginia Commonwealth University|Stacey Dusing, PT, PhD, PCS, Director Motor Development Lab|804-628-3632|scdusing@vcu.edu|
21272499|NCT02568384|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
21272500|NCT00796510|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21272501|NCT01734772|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21272502|NCT01139164|Medical University of South Carolina|Dr. Robert K Stuart|843-792-4271|stuartrk@musc.edu|
21272503|NCT01790568|University of Michigan Comprehensive Cancer Center|Dr. Pavan Reddy, M.D.|734-936-8785|reddypr@umich.edu|
21272504|NCT03184441|Boston Children's Hospital|Michele DeGrazia|617-919-1222|michele.degrazia@childrens.harvard.edu|
21272505|NCT02994056|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21272506|NCT00979628|EUSOM|Guillermo Umpierrez|4047781665|geumpie@emory.edu|
21272507|NCT00911859|Janssen R&D BE|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
21272508|NCT01396044|Northwestern University|Dr. Curtis Weiss|(312) 695-6439|curtisweiss@northwestern.edu|
21272509|NCT03008460|Ipsen|Ipsen Medical Director|use email|clinical.trials@ipsen.com|
21272510|NCT01880099|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
21272511|NCT00767325|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21272512|NCT03538756|RxFunction, Inc.|Lars Oddsson, PhD|612-358-2140|loddsson@rxfunction.com|
21272513|NCT00752856|UCSD|Sheldon Morris|8583364088|shmorris@ucsd.edu|
21272514|NCT02688608|Stanford Medicine at Stanford University|Saad A Khan, MD|650-507-5624|Saad.A.Khan@stanford.edu|
21272515|NCT00764309|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21272516|NCT04529109|Johnson & Johnson Vision Care|Meredith Bishop, OD, MS, FAAO-Sr. Principal Research Optometrist|904-443-1783|mbishop4@its.jnj.com|
21272517|NCT01179490|Symbio Pharmaceuticals|Toshihiko Nagase|81-3-5472-1127|tnagase.331@symbiopharma.com|
21272518|NCT01508936|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21272519|NCT00679367|Boston Medical Center|Vaishali Sanchorawala|617-638-8265|vaishali.sanchorawala@bmc.org|
21272520|NCT03365947|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400|info@arrowheadpharma.com|
21272521|NCT05665595|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21272522|NCT03815942|University of Oxford|Dr Mark Tuthil|01865 227042|mark.tuthill@oncology.ox.ac.uk|
21272523|NCT03717064|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21272524|NCT01483352|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21272525|NCT03480425|University of Saskatchewan|Dr. William P. McKay|306 250 5344|bill.mckay@usask.ca|
21272526|NCT01244126|Baylor College of Medicine, Department of Anesthesiology|Dr. Helena Karlberg Hippard|832-824-5800|hxkarlbe@texaschildrens.org; karlberg@bcm.edu|
21272527|NCT05920161|Yale School of Medicine|Elizabeth Goldfarb, PhD|203-737-6365|elizabeth.goldfarb@yale.edu|
21259773|NCT04398732|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21259774|NCT01299727|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21259775|NCT00486447|GE Healthcare|Angela N. Johnson, Senior Manager Clinical Affairs Operations|262-226-9495|angela.johnson@ge.com|
21259776|NCT03882424|Zhejiang Teruisi Pharmaceutical Inc.|Yilin Li, Medical Director|13601247168|yilin.li@teruisipharm.com|
21259777|NCT00947284|UCaliforniaSF|Jon Levine MD, PhD|415-476-5108|jon.levine@ucsf.edu|
21259778|NCT01727089|City of Hope|Jeff Longmate, Ph.D.|626-218-2478|jlongmate@coh.org|
21259779|NCT01596257|Memorial Sloan Kettering Cancer Center|Dr. Sergio Giralt, MD|646-608-3731|GiraltS@mskcc.org|
21259780|NCT00602355|Women and Infants Hospital|Caron Zlotnick|401-455-6529|czlotnick@butler.org|
21259781|NCT01570244|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21259782|NCT00464204|Fresenius Kabi Aktiengesellschaft|Professor Dr. Martin Westphal|+49 6172 686|martin.westphal@fresenius-kabi.com|7280
21272528|NCT02303548|Asan Medical Center|Director of Clinical Trials|8230103350|wonpia73@naver.com|
21272529|NCT05216081|Yale University|Fuad Abujarad|+1 (203) 737-5088|fuad.abujarad@yale.edu|
21272530|NCT00863746|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21272531|NCT00531206|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21272532|NCT05227820|The Regenesis Project|Chief Research Coordinator|(989) 245-9205|jharoon@theneuroassociates.com|
21272533|NCT00977106|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21272534|NCT02773836|European Network for Smoking and Tobacco Prevention|Dr Constantine Vardavas|+306937281680|vardavas@tobcontrol.eu|
21272535|NCT00436007|GlaxoSmithKline|GSK Response Center|866-435-7343||
21272536|NCT01439165|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21272537|NCT02419313|Yale-Department of Neurology|Bahman Jabbari M.D , Professor Emeritus- Neurology|914-482-8542|bahman.jabbari@yale.edu|
21272538|NCT03331042|Sequential Medicine Ltd|Thomas Dahl|617-818-2735|tadahl@outlook.com|
21272539|NCT00825227|Cephalon, Inc.|Vice President, Clinical Research|1-800-896-5855||
21272540|NCT00376948|Barbara Ann Karmanos Cancer Institute|Almhanna Khaldoun, M.D.|313-576-8746|almhanna@karmanos.org|
21272541|NCT03239522|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21272542|NCT02433678|University at Buffalo|Dr. Paresh Dandona|716-535-1850|dandona@buffalo.edu|
21272543|NCT00235456|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
21272544|NCT00927810|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
21272545|NCT01626079|Abbott|Sripad Bellary|4088458114|sripad.bellary@abbott.com|
21272546|NCT00337077|ECOG Statistical Office|Study Statistician|617-632-3012||
21272547|NCT02899338|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21272548|NCT01457053|University of Cincinnati Medical Center|Dr. Myron C. Gerson/Professor of Medicine|5135583074|myron.gerson@uc.edu|
21272549|NCT00814463|Duke University Medical Center|Denise Lally-Goss, NP|919-684-3862|denise.lallygoss@dm.duke.edu|
21272550|NCT01370408|Blood and Marrow Transplant Group of Georgia|Dr. Scott Solomon|404-255-1930|ssolomon@bmtga.com|
21272551|NCT02073643|Rush University Medical Center|Brad Appelhans, PhD|312-942-3477|brad_appelhans@rush.edu|
21272552|NCT02665143|Yale School of Medicine|Thomas Prebet, MD, PhD|(203) 200-4363|thomas.prebet@yale.edu|
21272553|NCT02430870|Takeda|Medical Director Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
21272554|NCT02780687|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21272555|NCT05723822|RxFunction|Clinical Research Specialist|612-358-2141|Yvonne.Rumsey@rxfunction.com|
21272556|NCT02353169|British Columbia Children's Hospital Research Institute|Simon D. Whyte|604-875-2711|swhyte@cw.bc.ca|
21272557|NCT00414765|Novartis Pharmaceuticals|Study Director|18627788300|Novartis.email@novartis.com|
21272558|NCT05694013|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21272559|NCT04817891|University of Michigan|Dr. Benjamin Hampstead|734-936-6185|bhampste@med.umich.edu|
21272560|NCT03982433|Boston University|Tibor Palfai, PhD|6173539345|palfai@bu.edu|
21272561|NCT04981912|UCSD|Michael Choi|8585341765|mychoi@ucsd.edu|
21272562|NCT05049460|University of Kentucky, Lexington|Gopalkumar Rakesh MD|859-257-9402|gopalkumar.rakesh@uky.edu|
21272563|NCT00918567|SUNY Buffalo|James Waxmonsky M.D.|305 348 3258|jwaxmons@fiu.edu|
21272564|NCT05275998|TaiMed Biologics|Dr. Kuei-Ling Kuo|+886-2-26580058|kkuo@taimedbio.com|118
21272565|NCT03641742|Columbia University Irving Medical Center|Dr. Christine Kim Garcia|2123058203|ckg2116@cumc.columbia.edu|
21272566|NCT01867242|University of Minnesota|Dorothy Hatsukami, PhD|612-626-2121|hatsu001@umn.edu|
21272567|NCT00661999|Mayo Clinic Rochester|Dr. Charles L. Loprinzi|507-284-8666|cloprinzi@mayo.edu|
21272568|NCT03066999|PUR Clinic|Dr Sijo Parekattil|3525368761|sijo@orlandohealth.com|
21272569|NCT04068142|UAMS|Dr Michael Wilson|501-686-7000|MPWilson@uams.edu|
21272570|NCT01361126|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
21272571|NCT00264810|NeuroPace, Inc.|Dr. Martha Morrell, Chief Medical Officer|650-237-2776|mmorrell@neuropace.com|
21272572|NCT02969499|University of British Columbia|Dr. Simon Woo|604-520-4662|simon.woo@fraserhealth.ca|
21272573|NCT00205049|University of Wisconsin|Research Program Manager - Kelly Richie|608-262-5404|kr2@medicine.wisc.edu|
21272574|NCT00182091|Massachusetts General Hospital|Dr. Anne Klibanski|617-726-3870||
21272575|NCT02199509|National Institutes of Health|Dr. Mark Hallett||hallettm@ninds.nih.gov|
21272576|NCT00483496|Orfagen|Clinical project manager|0033534506462|caroline.miklaszewski@orfagen.com|
21272577|NCT01658943|SWOG Statistical Center|SWOG Statistician|206-667-4408||
21272578|NCT02625545|NeoTract/Teleflex|Emily Hergenreter, Sr. Director of Clinical Affairs|650-793-5570|Emily.Hergenreter@Teleflex.com|
21301985|NCT02635425|Ain Shams university|Dr. Ahmad Hussieny Salama|00201223114626|ahmdhsf@hotmail.com|
21301986|NCT03278067|GlaxoSmithKline|GSK Response Center|866-435-7343|emily.p.lu@gsk.com|
21301987|NCT01217307|University Medical Center Groningen|Dr. I.C.C. van der Horst||i.c.c.van.der.horst@umcg.nl|
21301988|NCT01868542|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21301989|NCT00130247|Case Western Reserve University, Tuberculosis Research Unit|John L. Johnson, M.D., Principal Investigator|(216) 368-1949|jlj@case.edu|
21301990|NCT02609113|Wake Forest Baptist Health|Vanessa Baute, MD|336-716-8140|vbaute@wakehealth.edu|
21272579|NCT02576990|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21272580|NCT05905783|Acelyrin Inc.|Clinical Trials Information Desk|(650) 231 6625|info@alumis.com|
21301991|NCT00843284|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21272581|NCT02739542|UT Southwestern Medical Center|Darin T. Okuda, M.D.|214-645-8800|darin.okuda@utsouthwestern.edu|
21272582|NCT02768298|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@@novartis.com|
21272583|NCT01611090|Janssen Research & Development, LLC|Medical Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21272584|NCT05771428|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21272585|NCT04025229|UNC Lineberger Comprehensive Cancer Center|Luz Andrea Cuaboy|1-919-843-1177|luz_cuaboy@med.unc.edu|
21272586|NCT00788125|City of Hope National Medical Center|Dr. Judith Sato|626-218-5430|jsato@coh.org|
21272587|NCT03724149|Perelman School of Medicine|Dr. Peter Reese|215-900-3782|amussell@upenn.edu|
21272588|NCT02051309|Yale School of Medicine|Sherry McKee PhD|2037373529|sherry.mckee@yale.edu|
21272589|NCT01669538|University of Pennsylvania|Rebecca Ashare|2157465789|rlashare@pennmedicine.upenn.edu|
21272590|NCT03581448|Florida Atlantic University|Dr. Erik Engeberg|5612970530|eengeberg@fau.edu|
21272591|NCT02180711|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21272592|NCT03900624|Johns Hopkins All Children's Hospital|Dr. Anthony Sochet|7277672912|Anthony.Sochet@jhmi.edu|
21272593|NCT00872079|University of Louisville|Michael Brier|502-852-0246|mbrier@louisville.edu|
21272594|NCT00444145|Vanderbilt University|Dr. Michael Vaezi|615-322-3739|tina.higginbotham@vanderbilt.edu|
21272595|NCT01619800|Icahn School of Medicine at Mount Sinai|Vivek Reddy|212-241-7114|vivek.reddy@mountsinai.org|
21272596|NCT00927992|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21272597|NCT00414466|Medtronic Neuromodulation|Robert Spencer, Clinical Research Manager|(763) 514-0253|robert.j.spencer@medtronic.com|
21272598|NCT04526210|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
21272599|NCT01781637|Boston Children's Hospital|Lynda Schneider|617-355-6180|lynda.schneider@childrens.harvard.edu|
21272600|NCT02637232|Galderma|Stéphanie Leclerc|+33492386706|stephanie.leclerc@galderma.com|
21272601|NCT02999178|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21272602|NCT00090857|Dana-Farber Cancer Institute|Judy E. Garber, MD, MPH|617.632.2282|Judy_Garber@dfci.harvard.edu|
21272603|NCT00458848|GIMEMA|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it|
21272604|NCT05097326|Stanford University|Principal Investigator|(650) 497-5175|gynresearch@stanford.edu|
21272605|NCT02473640|Synthetic Biologics Inc.|Michael Kaleko, M.D.|(240) 238-3862|mkaleko@syntheticbiologics.com|
21272606|NCT02395822|University of Minnesota Masonic Cancer Center|Yumna Akhtar - Ct.gov Manager|612-624-6313|akhta012@umn.edu|
21272607|NCT02127281|Cleveland Clinic|Alison K. Klika, MS, Research Manager, Department of Orthopaedic Surgery|(216) 444-4954|klikaa@ccf.org|
21272608|NCT00153803|Dartmouth-Hitchcock Medical Center|Clinical Research Office||Cancer.Research.Nurse@Dartmouth.edu|
21272609|NCT03292653|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
21272610|NCT04720664|Georgetown University|Nadia Ashai, MD|202-444-2223|nadia.ashai@medstar.net|
21272611|NCT05343715|Biosidus S.A.U.|Director of Clinical Trials|+541149098044|v.berstein@biosidus.com.ar|
21272612|NCT04347291|Vanderbilt University Medical Center|Dr. Lindsay Mayberry|615-875-5821|lindsay.mayberry@vumc.org|
21272613|NCT03311646|Medical University of South Carolina|Dr. Tracy Smith|843-792-5164|smithtra@musc.edu|
21272614|NCT03103100|University of Alabama at Birmingham|Dr. Mark Powell|205-975-3328|mfpowell@uabmc.edu|
21272615|NCT02906709|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21272616|NCT00920140|GlaxoSmithKline|GSK Response Center|866-435-7343||
21272617|NCT01124149|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21272618|NCT02460159|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21272619|NCT00243932|Columbia University|Hiroshi Mitsumoto, MD|2123052940|hm264@cumc.columbia.edu|
21272620|NCT05518487|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21272621|NCT02003053|University of Kentucky|Dr. Peter Morris|8593235045|peter.morris@uky.edu|
21272622|NCT01931033|Massachusetts General Hospital|Gagan Joshi, MD|617-726-1541|gjoshi@mgh.harvard.edu|
21272623|NCT01362998|University Hospitals of Cleveland|Evan Goodman, principal investigator|2168445300|evan.goodman@uhhospitals.org|
21272624|NCT01458405|Capricor, Inc.|Vice President of Clinical Research and Development Operations|858-727-1755|clinicaltrialsgov@capricor.com|
21272625|NCT02497781|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21272626|NCT02674334|West Virginia University Department of Orthopaedics|Dr. George K Bal|304-293-1310|gbal@hsc.wvu.edu|
21272627|NCT00600925|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
21272628|NCT00979732|Illinois Institute of Techology|Britt Burton-Freeman|708-341-0178|bburton@iit.edu|
21272629|NCT05014412|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21272630|NCT03356821|UMC Utrecht, The Netherlands|Prof. M.J.N.L. Benders, MD, PhD, neonatologist|+31 88 755 5555|m.benders@umcutrecht.nl|
21272631|NCT00486837|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
21272632|NCT05295953|University of Kentucky, Lexington|Gopalkumar Rakesh MD|859-257-9402|gopalkumar.rakesh@uky.edu|
21272633|NCT04559854|Oregon State University|Jessica Gorman|541-737-2323|Jessica.Gorman@oregonstate.edu|
21272634|NCT04257929|Harmony Biosciences|Sharon Wolfe-Schwartz, Executive Director, Medical and RegulatoryWriting|267-965-0270|swolfe-schwartz@harmonybiosciences.com|
21272635|NCT05630547|Sanofi aventis recherche & développement|Trial Transparency Team|8006331610|Contact-US@sanofi.com|6#
21272636|NCT05065502|VA Ann Arbor Health Care System|Jeremy Sussman, MD, MS, Corresponding Principal Investigator|N/A|Jeremy.Sussman@va.gov|
21238233|NCT00045305|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
21238234|NCT01160848|Photocure ASA|Project Director|+47 22062210|pf@photocure.no|
21272637|NCT03257462|Spruce Biosciences, Inc.|Spruce Clinical Trials|415-655-4169|clinicaltrials@sprucebio.com|
21272638|NCT00796822|Indiana University School of Medicine|Dr. Samir K. Gupta|317-274-7926|sgupta1@iu.edu|
21272639|NCT00368277|Novaris Phamaceuticals|Study Director|862-778-8300||
21272640|NCT03978624|UNC Lineberger Comprehensive Cancer Center|Melahat Canter|919-962-0000|Melahat_Canter@med.unc.edu|
21272641|NCT05097989|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1-855-752-2356|clinicaltrials@alexion.com|
21272642|NCT00143819|UMDNJ-Robert Wood Johnson Medical School|Dr M Magliocco||maglioma@yahoo.com|
21272643|NCT02698800|Columbia University Medical Center|Dr. Ari Shechter, Principal Investigator|212-342-4487|as4874@cumc.columbia.edu|
21272644|NCT03587207|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21272645|NCT03283709|University of Kentucky|Hiroko Nagaoka|859-257-2101|h.nagaoka@uky.edu|
21272646|NCT00117949|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21272647|NCT01600495|University of São Paulo.|Prof. Alessandra Cristina Marcolin|Tel.: (16) 36022587|dralemar@uol.com.br|55 +
21272648|NCT00406848|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21272649|NCT04803357|university of Washington Diabetes Institute|Dr, Nicole Ehrhardt|2404479566|nehrhard@uw.edu|
21272650|NCT05932654|Biosion, Inc.|Kathy Zhang|+86 18801904945|kathy.zhang@biosion.com|
21272651|NCT02879643|Therapeutic Advances in Childhood Leukemia and Lymphoma|Ellynore Florendo, CCRP|323-361-3022|eflorendo@chla.usc.edu|
21272652|NCT01346410|Mercy|Dr Kathy Baglan|3144345886|kathy.baglan@mercy.net|
21272653|NCT00936390|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21272654|NCT02093689|Omeros Corporation|Medical Monitor|206-676-5000|info@omeros.com|
21272655|NCT00634179|Emory University|Christopher R. Flowers, MD, MS|404-778-3935|crflowe@emory.edu|
21272656|NCT04947579|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21272657|NCT00539539|Resusciatation Outcomes Consortium, University of Washington|Susanne May, Ph.D.|206-685-1302|sjmay@uw.edu|
21272658|NCT04272801|University of Virginia|Dr. Shayna Showalter|434-956-8032|snl2t@uvahealth.org|
21286894|NCT01100853|University of Pennsylvania|Dr. Helen Pettinati|215-222-3200|helenp@mail.med.upenn.edu|139
21286895|NCT01384877|BC Cancer|Dr. Philippa Hawley|604-877-6000|phawley@bccancer.bc.ca|67-2752
21259783|NCT03486392|Janssen Research & Development, LLC|Senior Director Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21259784|NCT00441792|Advocate Christ Medical Center|Erik Kulstad, MD, MS|7086843889|kulstad@uic.edu|
21259785|NCT01290627|The University of Tennessee|Richard Komistek, Ph. D.|86598744159|rkomiste@utk.edu|
21259786|NCT02532855|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21259787|NCT00756548|Braintree Laboratories, Inc.|John McGowan, Director, Clinical Research|781-843-2202|jmcgowan@braintreelabs.com|
21259788|NCT01879410|GlaxoSmithKline|GSK Response Center|866-435-7343||
21259789|NCT01012492|Emory University School of Medicine|Leslie S Kean|404-376-0187|Leslie.kean@emory.edu|
21259790|NCT01360645|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
21259791|NCT02808390|PPM Services|Salvatore Bellinvia|+41916961710|sbellinvia@ppmservices.ch|
21259792|NCT03002974|Swedish Orphan Biovitrum|Kineret Clinical Program Leader|+46(8)6972000|info@sobi.com|
21259793|NCT01737931|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
21259794|NCT02041962|University of Michigan|Amy Kilbourne, PhD|734-845-3452|amykilbo@umich.edu|
21259795|NCT00330187|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
21259796|NCT01573910|Alcon Research, Ltd.|Firoz Vohra, Project Head, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
21272659|NCT00475020|UT MD Anderson Cancer Center|Popat,Uday,M.D. / Stem Cell Transplantation|713-745-3055|UPOPAT@MDANDERSON.ORG|
21272660|NCT03481309|University of North Carolina at Chapel Hill|Dr. Sangtae Ahn|9195233127|sangtae_ahn@med.unc.edu|
21272661|NCT01575054|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21272662|NCT01566409|Pediatric Department, Hospital Lillebaelt, Kolding|Dr. Line Modin|0045 61386349|line.modin@rsyd.dk|
21272663|NCT02130466|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21272664|NCT02518685|BAROnova, Inc|Lian Cunningham, MD, PhD|650.638.9796|lcunningham@baronova.com|22
21272665|NCT01922349|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21238235|NCT03848403|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21272666|NCT00922779|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21272667|NCT05109234|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21286896|NCT01548404|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
21286897|NCT00426270|Octapharma USA|Michael Eppolito|201 604-1155|michael.eppolito@octapharma.com|
21286898|NCT01117870|McMaster University/ St. Joseph's Healthcare Hamilton|Dr. Harsha Shanthanna|905-522-1155|harshamd@gmail.com|
21286899|NCT00896064|GlaxoSmithKline|GSK Response Center|866-435-7343||
21286900|NCT00433836|Novartis Pharmaceuticals|Study Director|862-778-8300||
21286901|NCT00748241|Astra Tech AB|Head of Clinical Research Area Dental|+46317763000||
21286902|NCT02456727|Albert Einstein College of Medicine|Diane McKee|718-430-2952|Diane.Mckee@einstein.yu.edu|
21286903|NCT00492297|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21286904|NCT00113607|Janssen R&D US|Director Clinical Research Medical Leader|908 704 5779||
21286905|NCT02974868|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21286906|NCT02674516|Nanyang Technological University|Dr. Olivia Choy|(65) 65921522|oliviachoy@ntu.edu.sg|
21286907|NCT01064479|UT MD Anderson Cancer Center|Dr. Xiuning Le, MD, Assistant Professor, Thoracic-Head & Neck Med Onc|(713) 792-6980|xle1@mdanderson.org|
21286908|NCT00749398|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21286909|NCT02634073|GlaxoSmithKline|GSK Response Center|866-435-7343||
21286910|NCT01639352|University of Miami|Lynn Feun, M.D.|305-243-4909|lfeun@med.miami.edu|
21286911|NCT01663402|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1
21286912|NCT00678418|Alkermes, Inc.|Bernard L. Silverman, MD|1-781-609-6000|bernard.silverman@alkermes.com|
21286913|NCT03903172|Wright State University|Sheela Barhan, MD|937-208-2850|sheela.barhan@wright.edu|
21286914|NCT01900444|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21286915|NCT00072384|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21272668|NCT00336024|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|Resultsreportingcoordinator@childrensoncologygroup.org|
21286916|NCT02425306|University of Virginia|Craig Slingluff, MD, Professor of Surgery|434-924-9311|cls8h@virginia.edu|
21286917|NCT01825200|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
21286918|NCT00490035|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
21272669|NCT03946449|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|1 (626) 304-3400|info@arrowheadpharma.com|
21272670|NCT03533946|Huntsman Cancer Institute/University of Utah|Clinicaltrials.gov and CTRP Specialist|8012136215|IITDataManagement@hci.utah.edu|
21272671|NCT05067504|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
21272672|NCT01374919|Auerbach Hematology Oncology Assoc|Dr. Michael Auerbach|410-780-4050|mauerbachmd@abhemonc.com|
21272673|NCT03805438|Duke University|Riley Landreth, DO|919-684-8111|riley.landreth@duke.edu|
21272674|NCT00366899|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21272675|NCT02446626|National Institute of Allergy and Infectious Diseases|Marques, Adriana|+1 301 435 7668|amarques@niaid.nih.gov|
21272676|NCT02684344|University of Rochester|Edward Messing|585 - 275 - 0998|edward_messing@urmc.rochester.edu|
21272677|NCT01451762|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu|
21272678|NCT03469297|MicroOptx|VP of Clinical|888-591-2784|info@microoptx.com|
21272679|NCT02696070|Regenesis Biomedical|Heather Vander Ploeg|602-428-7041|heather.vanderploeg@regenesisbio.com|
21286919|NCT06058390|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21286920|NCT02265965|University of California, San Francisco|Jennifer Lucero, MD|415-476-5535|jennifer.lucero@ucsf.edu|
21286921|NCT03585270|Idorsia Pharmaceutical Ltd|Idorsia Clinical Trial Information|+1 856 661 3721|idorsiaclinicaltrials@idorsia.com|
21286922|NCT05559905|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21286923|NCT02783898|NHS Lothian|Dr Matt Reed|+44 131 242 1448|Matthew.Reed@nhslothian.scot.nhs.uk|
21238236|NCT02279043|University of California, San Francisco|Edith Fox|4152062544|edith.fox@ucsf.edu|
21238237|NCT00168038|CSL Behring|Clinical Trial Disclosure Manager||clinicaltrials@cslbehring.com|
21286924|NCT04195061|Massachusetts General Hospital|Melanie S. Haines, MD|617-726-3870|mshaines@mgh.harvard.edu|
21238238|NCT02386995|Toronto Western Hospital/UHN|Emad Al Azazi|416-603-8500|emad.alazazi@uhnresearch.ca|6237
21286925|NCT02201342|Mezzion Pharmaceuticals|Won Geun Kim|3128980292|wg.kim@mezzion.com|
21286926|NCT00485069|GlaxoSmithKline|GSK Response Center|866-435-7343||
21238239|NCT00490256|Emory University|Paul Kirshbom, MD|404-785-6330|pkirshb@emory.edu|
21238240|NCT02657031|University Medical Center Emergency Department|Dr. Tony Zitek|7022247124|zitek10@gmail.com|
21238241|NCT04198805|Indiana University School of Medicine|Naga Chalasani, MD|(317) 278-0414|nchalasa@iu.edu|
21259797|NCT00364182|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21259798|NCT02601573|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21259799|NCT00974220|Queen's University, Kingston, ON, Canada|Dr. Denis O'Donnell|1-613-548-2339|odonnell@queensu.ca|
21259800|NCT01850615|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
21259801|NCT00706628|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21259802|NCT02921425|University of Miami|Dr. Joseph Sharit|305-284-6472|jsharit@miami.edu|
21259803|NCT01227967|Leidos Biomedical Research, Inc. is support to the National Institute of Allergy and Infectious Diseases (NIAID)|John Beigel, M.D.|301-451-9881|jbeigel@niaid.nih.gov|
21259804|NCT01948830|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21259805|NCT01145560|AstraZeneca|Justin Lindemann||ClinicalTrialTransparency@astrazeneca.com|
21259806|NCT00928421|BTG International Inc|David Wright MB FRCS|610-943-3513|david.wright@btgplc.com|
21259807|NCT02149810|London Health Sciences Centre|Dr. Akshya Vasudev|519-685-8500|akshya.vasudev@lhsc.on.ca|75504
21259808|NCT00622895|Fred Hutchinson Cancer Research Center|George E. Georges MD|206-667-6886|ggeorges@fredhutch.org|
21259809|NCT01578031|University of Pennsylvania|Samuel T. Kuna, MD|215-823-4400|skuna@mail.med.upenn.edu|
21259810|NCT03497845|BARDA|Silvija Tresnjak-Smith, Regulatory Operations Branch Chief, Regulatory and Quality Affairs Division|202-557-1993|Silvija.Tresnjak-Smith@hhs.gov|
21259811|NCT04082663|Washington University School of Medicine|Dr. Gammon Earhart|314-286-1407|earhartg@wustl.edu|
21259812|NCT02542072|CooperVision Inc.|Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
21259813|NCT01285427|Life Technologies|Deanna Vella, Staff Regulatory Engineer|760-918-3000|deanna.vella@lifetech.com|
21259814|NCT05032950|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21259815|NCT01990261|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21259816|NCT03404648|Mayo Clinic|Dr. Ming Yang|480-342-0988|Yang.Ming@mayo.edu|
21259817|NCT01784796|Edward Hines VA Hospital|Karen Saban, PhD|708-202-5264|Karen.Saban@va.gov|
21259818|NCT02474329|Radboudumc|Marjan Meinders|+00000000|Marjan.Meinders@radboudumc.nl|
21259819|NCT01356589|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21259820|NCT04343651|CytoDyn Inc.|Dr. Scott Kelly, Chief Medical Officer|(360) 980-8524|skelly@cytodyn.com|
21272680|NCT01771965|MUSC|Tracy Stecker, PhD|843.792.7287|stecker@musc.edu|
21238242|NCT04188067|Massachusetts General Hospital|Dr. Alexandra Touroutoglou PhD|6176436348|ATOUROUTOGLOU@mgh.harvard.edu|
21238243|NCT03184792|University of Washington|Dr. Fatma Inanici|2067872692|finanici@uw.edu|
21238244|NCT02495025|University of California Los Angeles|Principal Research Manager, Health Services Research Program|310-825-8624|lindseythompson@mednet.ucla.edu|
21238245|NCT03818672|Bausch Health Americas, Inc|Study Director|7072851528|Varsha.Bhatt@bauschhealth.com|
21238246|NCT00313820|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21238247|NCT00251862|Boston Medical Center|Dr. Paul C. Schroy III|617-638-8335|paul.schroy@bmc.org|
21238248|NCT02134587|School of Pharmaceutical Scientes of Universidade Estadual Paulista Júlio de Mesquita Filho, Araraquara, SP (Brazil)|Fabiana Rossi Varallo|5516997629496|varallo.f.r@gmail.com|
21238249|NCT00265889|Case Comprehensive Cancer Center|Brian Bowell, MD|216-444-6922|bolwelb@ccf.org|
21238250|NCT00303862|University of Chicago|Theodore Karrison, PhD|773-702-9326|tkarrison@health.bsd.uchicago.edu|
21238251|NCT02925611|PGIMER|Dr. Steve Joys|7087617352|stevejoys@gmail.com|91
21238252|NCT01001052|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21238253|NCT02778100|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21238254|NCT05238233|Prisma Health|Aimee Hanvey|864-760-7350|aimee.hanvey@prismahealth.org|
21259821|NCT01542645|NorthShore University HealthSystem|Glenn Murphy, MD|847-570-2760|dgmurphy2@yahoo.com|
21272681|NCT02424188|Johns Hopkins University School of Medicine|Gail Daumit, MD, MHS|410-614-6460|gdaumit@jhmi.edu|
21272682|NCT00630305|Johnson & Johnson Vision Care, Inc.|Kurt Moody, OD|1-904-443-3088|kmoody1@its.jnj.com|
21272683|NCT01085045|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
21272684|NCT02753842|Emory University|Aaron Siegler|404-712-9733|asiegle@emory.edu|
21272685|NCT01494506|Merrimack Pharmaceuticals, Inc.|Dr. Eliel Bayever|6174411000|EBayever@merrimack.com|7676
21272686|NCT02924038|University of California, San Francisco|Dr. Nicholas Butowski, MD|415-353-7500|Nicholas.Butowski@ucsf.edu|
21272687|NCT02248597|Wake Forest Baptist Comprehensive Cancer Center|Study Nurse|336-716-4761|krike@wakehealth.edu|
21272688|NCT02472522|Tata Main Hospital, Jamshedpur, India|Specialist, Anaesthesia & Critical Care|91-9431166582|debsanjay@gmail.com|
21272689|NCT02777528|WL Gore|Meier Hsu|928-864-3338|mhsu@wlgore.com|
21272690|NCT00453362|Hoffman-LaRoche|Medical Communications|800-821-8590||
21272691|NCT04885296|Johnson & Johnson Vision Care, Inc.|John R. Buch, O.D., M.S., F.A.A.O.|904-608-7238|jbuch@its.jnj.com|
21272692|NCT00433147|Patient Advocacy|Amicus Therapeutics|+1-609-662-2000|Clinicaltrials@Alexion.com|
21272693|NCT01882647|Therapeutics, Inc.|Clinical Research, Therapeutics Inc.|585-571-1800|clinicalreseach@therapeuticsinc.com|
21272694|NCT03601637|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21272695|NCT00038675|University of Texas (UT) MD Anderson Cancer Center|Hagop M Kantarjian,MD/Chair, Leukemia|(713) 792-7026|hkantarjian@mdanderson.org|
21272696|NCT05037097|Arcturus Therapeutics, Inc.|Arcturus Therapeutics, Inc.|858-900-2660|clinicaltrials@arcturusrx.com|
21272697|NCT02322047|Veterans Affairs Puget Sound Health Care System|Tracy Simpson, PhD|206-277-3337|tracy.simpson@va.gov|
21272698|NCT01059500|indiana university school of medicine|jeffrey kline|317 880 3869|jefkline@iu.edu|
21272699|NCT00376220|Johns Hopkins University School of Medicine|Jennifer L. Payne M.D.|410-502-0050|jpayne5@jhmi.edu|
21272700|NCT02564263|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21272701|NCT01644500|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21272702|NCT00683020|University of California, San Francisco|Dean Schillinger, MD/Study Principal Investigator|415-206-8940|dschillinger@medsfgh.ucsf.edu|
21272703|NCT03204526|UC Davis Health|Kiarash Shahlaie, MD, PhD, FAANS, Bronte Professor of Neurological Surgery|916-734-6342|krshahlaie@ucdavis.edu|
21272704|NCT01400425|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
21272705|NCT00688064|Galderma|Jean-Charles Dhuin, Clinical Project Manager|+33 4 92 95 29 21|jean-charles.dhuin@galderma.com|
21272706|NCT00720096|H. Lee Moffitt Cancer Center and Research Institute|Robert Wenham, M.D., via Moffitt Cancer Center|813-745-4933|robert.wenham@moffitt.org|
21272707|NCT03272139|Department of Anesthesiology, Critical Care & Pain Management|Dr. David Kim|212-606-1206|kimd@hss.edu|
21259822|NCT04714372|University of Minnesota, Masonic Cancer Center|Dr. Joseph Maakaron|612-624-5109|maaka001@umn.edu|
21259823|NCT02010203|Clinical Development|Lori McDermott|9197948950|lmcdermott@heatbio.com|9197948950
21259824|NCT04188197|Rose Research Center|Dr. Jed E. Rose|9193282345|jed.rose@roseresearchcenter.com|
21259825|NCT02613208|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21259826|NCT03220412|The Ohio State University|Dr. Brad Bushman|614-688-8779|bushman.20@osu.edu|
21259827|NCT05742984|Cinclus Pharma|Cinclus Pharma Holding AB|+46 8 13 33 10|gosta.hiller@cincluspharma.com|
21259828|NCT02162862|University of Pittsburgh Medical Center|Dr. Eva Szigethy|412-802-6696|szigethye@upmc.edu|
21259829|NCT02104414|Mount Sinai St. Luke's|Dr. Ali Shariat|914-409-5023|alishariatmd@gmail.com|
21259830|NCT01279057|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21259831|NCT01196442|Virginia Commonwealth University|Dr. Craig W. Swainey|804-828-9723|cswainey@mcvh-vcu.edu|
21259832|NCT01427309|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21259833|NCT00542620|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21259834|NCT03617705|University of Florida|Dr. Yan Wang|3522945942|ywang48@ufl.edu|
21259835|NCT00849017|GlaxoSmithKline|GSK Response Center|866-435-7343||
21259836|NCT00214461|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21259837|NCT01492673|Memorial Sloan Kettering Cancer Center|Dr. Tanya Trippett, MD|212-639-8267|trippet1@mskcc.org|
21259838|NCT02908100|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21259839|NCT02024971|Takeda Pharmaceuticals Company Limited|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
21259840|NCT05254418|Vanderbilt University Medical Center|Dr. Talat Alp Ikizler|6159366646|alp.ikizler@vumc.org|
21259841|NCT04130646|Medical University of South Carolina|Associate Professor-Faculty|(843) 792-6076|badran@musc.edu|
21259842|NCT06118385|Benevolent|Judit Molnar, MD, PhD|+44 20 3781 9360|judit.molnar.md@benevolent.ai|
21259843|NCT02318784|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
21259844|NCT00331006|New England Research Institutes, Inc.|Susan F. Assmann, PhD|617-972-3048|sassmann@neriscience.com|
21259845|NCT00109473|Cincinnati Children's Hospital Medical Center|Lee A. Denson|513-636-7575|lee.denson@cchmc.org|
21259846|NCT01950819|Novartis Pharma|Study Director|8627788300|Novartis.email@novartis.com|
21259847|NCT00820573|University of Texas HSC at San Antonio|Eugenio Cersosimo, MD PhD|210 358 7200|Eugenio.cersosimo@uhs-sa.com|
21259848|NCT01014585|Forest Research Institute, Inc., a subsidiary of Forest Laboratories, Inc.|Joel Trugman, MD|201-427-8681|joel.trugman@frx.com|
21272708|NCT04557124|VA Connecticut Healthcare System|Joanna Fiszdon, Principal Investigator|203-932-5711|Joanna.fiszdon@va.gov|
21259849|NCT04897867|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21259850|NCT00508391|BIOTRONIK, Inc.|Clay Cohorn|503-387-2614|clay.cohorn@biotronik.com|
21259851|NCT01958645|AstraZeneca|Anders Berggren, MD, PhD||clinicaltrialtransparency@astrazeneca.com|
21272709|NCT00001849|NIDDK, NIH|Lynnette Nieman MD|301-496-8935|NiemanL@nih.gov|
21272710|NCT00442936|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21272711|NCT01449266|Guerbet|Dr. Pierre Desché, MD - VP Development, Medical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
21272712|NCT01626664|Kyowa Kirin Inc|Fiona Herr, Associate Director, Medical Communications|1 (908) 234-1096|medinfo-US@kyowakirin.com|
21272713|NCT00524459|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21272714|NCT02428699|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21272715|NCT03127137|Northwestern University|Paul C. Fitzgerald RN, BSN, MS|312-695-1064|p-fitzgerald2@northwestern.edu|
21272716|NCT04424407|Stanford University|Andrea Goldstein-Piekarski, PhD|650-721-4780|agoldpie@stanford.edu|
21272717|NCT02747615|Ain-Shams University Hospitals|Dr. Ibrahim Mamdouh Esmat|01001241928|ibrahim_mamdouh@med.asu.edu.eg|
21272718|NCT03209882|University of Texas at Arlington|Fenghua Tian|8178075271|fenghua.tian@gmail.com|
21272719|NCT01574248|Vanderbilt University Medical Center|Nancy J. Brown, M.D.|6153438701|nancy.j.brown@vanderbilt.edu|
21272720|NCT00290147|Naval Medical Research Center, Viral Diseases Department|Charmagne Beckett, LCDR, MC, USNR|301-295-6400|charmagne.beckett@med.navy.mil|
21259852|NCT00880256|VA Puget Sound Health Care System|Dr. David Kearney|206-764-2285|david.kearney@va.gov|
21259853|NCT01686568|Mayo Clinic|Dr. Ian R. Lanza|507-255-8147|lanza.ian@mayo.edu|
21259854|NCT01838044|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21259855|NCT01413958|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21259856|NCT02908516|Yale School of Medicine, Department of Orthopaedics and Rehabilitation|Dr. Michael P. Leslie|(203) 737-6358|michael.leslie@yale.edu|
21259857|NCT01225562|AstraZeneca AB|Anders Himmelmann, MD PhD|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
21272721|NCT00264797|Univ of Colorado Denver; Univ of Cincinnati|Dr. Paula Riggs; Dr. Theresa Winhusen|303-724-2235; 513-487-7800|paula.riggs@ucdenver.edu; winhusen@carc.uc.edu|
21272722|NCT00733330|DePuy International|Kimberly Dwyer||kdwyer2@its.jnj.com|
21272723|NCT01604850|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21272724|NCT01703832|Biologische Heilmittel Heel GmbH|Christine Frank, PhD|+49 7221 501 3188|christine.frank@heel.com|
21272725|NCT01193608|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21272726|NCT01632709|Rehabilitation Institute of Chicago|Center for Pain Studies|312.238.5654|centerforpainstudies@ric.org|
21272727|NCT00864097|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21286927|NCT00086190|University of Rochester Medical Center|Irene H. Richard, MD|585-341-7500|irene_richard@urmc.rochester.edu|
21286928|NCT00249834|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21286929|NCT02688933|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21286930|NCT06034457|Cleveland Clinic|Dr. Leslie Heinberg, Vice Chair for Psychology, Department of Psychiatry and Psychology|216 445-1986|heinbel@ccf.org|
21286931|NCT05047536|Kezar Life Sciences, Inc.|Regulatory Affairs|650-822-5600|clinicaltrials@kezarbio.com|
21286932|NCT04802161|University of North Carolina, Lineberger Comprehensive Cancer Center|Dr. Joshua F. Zeidner|919-962-5164|Joshua_Zeidner@med.unc.edu|
21286933|NCT06831344|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-7428|medicalinformation@phathompharma.com|
21286934|NCT07116759|University of Pennsylvania|Rodney Wiersma, PhD|773-623-9820|Rodney.Wiersma@pennmedicine.upenn.edu|
21286935|NCT00641563|University Hospital Bern, Switzerland|Dr. M. Hänggi|0316323029|matthias.haenggi@insel.ch|
21286936|NCT01655901|CHEO Research Institute|Dr. Jean-Philippe Chaput|613-737-7600|jpchaput@cheo.on.ca|3683
21286937|NCT00352118|Masonic Cancer Center, University of Minnesota|Frank Ondrey, M.D.|612-625-3200|ondre002@umn.edu|
21286938|NCT02997163|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21259858|NCT04244370|BD|Heather Vander Ploeg|602-751-3268|heather.vander.ploeg@bd.com|
21286939|NCT00922636|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21286940|NCT02308046|Curatek Pharmaceuticals|Vice President|847-806-7680|info@curatek.com|
21286941|NCT01181167|Daiichi Sankyo Co., Ltd.|Masayuki Fukuzawa, Associate Director|81-90-5584-2197|fukuzawa.masayuki.gn@daiichisankyo.co.jp|
21286942|NCT01996371|OhioU|Shelby Miracle|614-366-1648|shelby.miracle@osumc.edu|
21286943|NCT01573000|GlaxoSmithKline|GSK Response Center|866-435-7343||
21286944|NCT01125098|Department of Oncology Haematology and Respiratory Diseases|Leonardo Fabbri|+39 059422|leonardo.fabbri@unimore.it|4227
21286945|NCT03885908|Memorial Sloan Kettering Cancer Center|Dr. Armin Shahrokni, MD, MPH|646-888-3651|shahroka@mskcc.org|
21286946|NCT03817606|Riverside Medical Center|Cynthia Koehn, Clinical Research Nurse|815-933-1671|ckoehn@rhc.net|
21286947|NCT03924323|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21286948|NCT01545388|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21286949|NCT03041636|The University of Texas MD Anderson Cancer Center|Zeev Extrov MD./Professor|713-794-1675|zestrov@mdanderson.org|
21286950|NCT05002972|University of Kentucky|Dawn Brewer|859-257-1661|dawn.brewer@uky.edu|
21286951|NCT01664091|Dana-Farber Cancer Institute|Julia Wong, MD|617-632-3591|JWONG@LROC.HARVARD.EDU|
21286952|NCT04195594|TRCGEN+ (managed by Trans Russian Co)|Nikolaos Tzenios|+447583902071|Nicolas@trccolleges.com|
21286953|NCT01447888|Allina Health|John Mrachek, MD|612-871-7639|John.Mrachek@allina.com|
21286954|NCT01172873|New York State Psychiatric Institute/Columbia University|Moira A. Rynn, M.D.|646-774-5805|RynnM@nyspi.columbia.edu|
21286955|NCT02240667|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21286956|NCT01578772|UCLA|Dr. Jordan Lake|310-557-2273|jlake@mednet.ucla.edu|
21286957|NCT05518539|Newsom Eye|T Hunter Newsom|813-908-2020|hunter@newsomeye.net|
21286958|NCT02053493|Duke Clinical Research Insitute|Dr. Adrian Hernandez|919-668-7515|Adrian.Hernandez@duke.edu|
21286959|NCT01619865|University of Iowa Holden Comprehensive Cancer Center|Sue O'Dorisio, MD, PhD|319-356-7873|sue-odorisio@uiowa.edu|
21286960|NCT01494818|Alcon Research, Ltd.|Renee Garofalo, OD, FAAO|1-888-451-3937|alcon.medinfo@alcon.com|
21286961|NCT01211145|AstraZeneca|Jamie Mullen, Medical Science Director|781-472-5032|jamie.mullen@astrazeneca.com|
21286962|NCT00791999|Medical Advisor of the Clinical Trial|Dr. Kazuhiko Yamamoto, Medical Advisor of the Clinical Trial|+81 3 5800 8825|yamamoto-tky@umin.ac.jp|
21286963|NCT00617357|LifeCell|Dr Michael Franz|908 947 1100|mfranz@lifecell.com|
21286964|NCT03976752|Emory University|Dr. Colleen Kelley|404-712-1823|colleen.kelley@emory.edu|
21286965|NCT00004547|National Cancer Institute, National Institutes of Health|Marybeth S. Hughes, M.D.|301-594-9341|hughesm@mail.nih.gov|
21286966|NCT04622969|University of South Carolina|Director, Office of Research Compliance|8037777095|lisaj@mailbox.sc.edu|
21286967|NCT04467515|Precirix|Jonathan Delara, Clinical Trial Manager|+1 (512) 589-2114|jonathan.delara@precirix.com|
21286968|NCT04252625|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
21286969|NCT00791219|Mayne Pharma|Stuart Mudge, VP Scientific Affairs|+613 8614 7704|stuart.mudge@maynepharma.com|
21286970|NCT02155985|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21286971|NCT01533116|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21286972|NCT04460326|Boston Medical Center|Sara M Alexanian, MD|617-638-8545|sara.alexanian@bmc.org|
21286973|NCT02864732|University of Pittsburgh|Research Assistant|412 4822283|mza7@pitt.edu|
21286974|NCT04794751|Johnson & Johnson Vision Care, Inc.|Thomas R. Karkkainen, OD, MS, FAAO|1-800-843-2020|TKarkkai@its.jnj.com|
21286975|NCT01687218|Division of Infectious Diseases - UPMC|Ross D. Cranston, MD, FRCP|412-383-2054|rdc27@pitt.edu|
21286976|NCT02421354|The University of Texas MD Anderson Cancer Center|Dr. Srdan Verstovsek, MD. Professor|713-745-3429|sverstov@mdanderson.org|
21286977|NCT03301636|Lumos Pharma Inc. (Formerly NewLink Genetics)|Lumos Pharma|515-598-2921|clinical.trials@lumos-pharma.com|
21286978|NCT01645059|Hospital San Pedro Alcántara|Dr. Santiago González Santiago||santidatvs@hotmail.com|
21286979|NCT03528551|Novo Nordisk A/S|Clinical Transparency Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21286980|NCT00974363|GlaxoSmithKline|GSK Response Center|866-435-7343||
21286981|NCT00846586|Novartis Pharmaceuticals|Study Director|862 778-8300||
21286982|NCT03459625|Loma Linda University|Cameron Leigh Neece|909 558 4000|cneece@llu.edu|
21286983|NCT01789047|Rush University Medical Center|Director of Clinical Research|312 942 8002|Teresa_Chmura@rush.edu|
21286984|NCT03644017|Merit Medical Systems, Inc.|Casey Holland, Senior Director Clinical Operations|+1 (617) 842-0251|casey.holland@merit.com|
21286985|NCT01204671|GlaxoSmithKline|GSK Response Center|866-435-7343||
21286986|NCT02700048|University of Minnesota|Amir Moheet|6126249990|mohee002@umn.edu|
21286987|NCT02175225|Beth Israel Deaconess Medical Center|Magdy Selim, MD, PhD|617-632-8913|mselim@bidmc.harvard.edu|
21286988|NCT02340000|Albany Medical College|Paul Sorum, MD|5182627500|sorump@mail.amc.edu|
21286989|NCT02668640|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21286990|NCT02530437|University of Texas MD Anderson Cancer Center|Dr. Jaffer Ajani|(713) 792-2828|jajani@mdanderson.org|
21286991|NCT01883895|UW Madison|Nalini Sehgal|608-263-8639|sehgal@rehab.wisc.edu|
21286992|NCT04344028|University of Wisconsin - Madison|Dr. C. Shawn Green|(608) 263-4868|csgreen2@wisc.edu|
21286993|NCT01526785|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21238255|NCT00825266|Stanford University|Roham Zamanian|650-725-5495|roham.zamanian@stanford.edu|
21286994|NCT05163392|UCSF|Sylvie Baudart|415-203-4027|sylvie.baudart@ucsf.edu|
21286995|NCT01121263|Icahn School of Medicine at Mount Sinai|Deborah Ascheim, MD|212-659-9567|deborah.ascheim@mssm.edu|
21301992|NCT04458090|University of Colorado Anschutz Medical Campus|Dr. Channing Tate, Assistant Professor|3037248985|channing.tate@cuanschutz.edu|
21301993|NCT02160899|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
21301994|NCT04129151|Dana-Farber Cancer Institute|David S Shulman, MD|617-632-6670|david_shulman@dfci.harvard.edu|
21301995|NCT04473235|Universidade Federal de Minas Gerais|Elisa de Paula França Resende|+55 31 3307 9417|elisa.resende@gbhi.org|
21301996|NCT02726542|Massachusetts General Hospital|Takara Stanley, MD|617-726-5312|tstanley@mgh.harvard.edu|
21301997|NCT00798759|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
21301998|NCT03387111|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
21301999|NCT01945710|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
21272728|NCT04457310|Yale University|John Krystal, MD|203-785-6396|john.krystal@yale.edu|
21272729|NCT00320112|VA HSRD|Fatima Makki|734 845 3623|Fatima.Makki@va.gov|
21302000|NCT02730195|Emory University|William Blum, MD|404-778-1900|william.g.blum@emory.edu|
21272730|NCT04354012|Wake Forest|Research Administrative Coordinator|336-716-2903|irichard@wakehealth.edu|
21272731|NCT01199861|Novartis Pharmaceuticals|Study Director|862-778-8300||
21302001|NCT00588159|Mayo Clinic|Dr. Michelle A. O. Kinney|507-266-9877|kinney.michelle@mayo.edu|
21302002|NCT01368562|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
21302003|NCT02491944|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
21302004|NCT00727441|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Daniel Laheru|410-955-8974|laherda@jhmi.edu|
21302005|NCT01239992|University Munich|Klaus G. Parhofer|+49-89-7095-3010|klaus.parhofer@med.uni-muenchen.de|
21302006|NCT00535288|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21302007|NCT02810444|Biotest AG|Dr. med. Andrea Wartenbrg-Demand|+49 6103 801|andrea.wartenberg-demand@biotest.com|0
21302008|NCT04540510|Nuvance Health (formerly Western Connecticut Health Network)|Joann Petrini|203-739-6882|Joann.Petrini@wchn.org|
21302009|NCT02848729|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
21302010|NCT01904773|AstraZeneca Pharmaceuticals LP, Neuroscience Innovative Medicines Unit|Joel Posener, MD - Head, Early Clinical Development||ClinicalTrialTransparency@astrazeneca.net|
21302011|NCT04518995|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
21272732|NCT00661505|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21272733|NCT04534283|IndianaU|Dr. Anita Turk|(317) 274-0335|aaturk@iu.edu|
21272734|NCT01041781|Fox Chase Cancer Center|Martin J. Edelman, M.D.|(215) 728-4790|martin.edelman@fccc.edu|
21272735|NCT00977470|Mass General Hospital Cancer Center|Maria Kempner|508-533-4132|mkempner@partners.org|
21272736|NCT01004172|Dana-Farber Cancer Institure|Nancy Lin, MD|617.632.2335|nlin@partners.org|
21272737|NCT00615784|abramsoncc, University of Pennsylvania|Harjeet Sembhi, research program director|215-220-9688|harjeet.sembhi@pennmedicine.upenn.edu|
21272738|NCT03676803|UCLA Center for Human Nutrition|Zhaoping Li, MD, PhD|310-206-1987|zli@medent.ucla.edu|
21272739|NCT01355081|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21272740|NCT02719522|Medtronic Neurovascular|Claudia Campo|0039 0224137325|claudia.campo@medtronic.com|
21272741|NCT02456909|Medical College of Wisconsin|Keri R. Hainsworth, PhD|414-266-6306|khainswo@mcw.edu|
21272742|NCT03309956|Columbia University|Leonardo Liberman, MD|212-305-8509|ll202@cumc.columbia.edu|
21272743|NCT04603937|Kodiak Sciences Inc|Pablo Velazquez-Martin|1 (650) 281-0850|ClinOps@kodiak.com|
21272744|NCT00993616|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
21272745|NCT04533646|University of Pittsburgh Medical Center|Associate Professor of Medicine|4125869700|ullalj@upmc.edu|
21272746|NCT01210001|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21272747|NCT02445456|Oxford University Hospitals NHS Foundation Trust|Miss Helen Jones|01865 235657|helen.jones3@ouh.nhs.uk|
21272748|NCT02352298|Barbara Davis Center for Childhood Diabetes|Dr. Satish K. Garg|303-724-6761|satish.garg@ucdenver.edu|
21272749|NCT00419770|Los Angeles Biomedical Research Institute|Brad Spellberg|310-781-3680|bspellberg@dhs.lacounty.gov|
21272750|NCT02848326|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21272751|NCT01701024|Exec Dir Clinical Dir|Johnson Varughese|908-927-1162|johnson.varughese@valeant.com|
21272752|NCT01269801|AboutSkin|Joel L. Cohen, MD|303-756-7546|research@aboutskinderm.com|
21272753|NCT03718234|University of Minnesota|Kyriakie Sarafoglou|6126245965|saraf010@umn.edu|
21272754|NCT02937701|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21272755|NCT02683083|Camel-IDS|Tony Lahoutte|0032 24799360|tony.lahoutte@camel-ids.com|
21272756|NCT00416520|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21272757|NCT01108094|Stanford University Medical Center|Jean Tang MD PhD, Associate Professor of Dermatology|650-723-6316|tangy@stanford.edu|
21272758|NCT01137539|Michigan Institute of Women's Health|Salil Khandwala/Medical Director|313-982-0200||
21272759|NCT03290326|BIDMC|Principal Investigator - Emiliano Santarnecchi|617-667-0326|esantarn@bidmc.harvard.edu|
21272760|NCT05086835|McLean Hospital|Dr. Roger Weiss|617-855-2242|rweiss@mclean.harvard.edu|
21302012|NCT04565327|University of California, San Francisco|Dr. Zhen Wang, MD|(415) 476-3767|Zheng.Wang@ucsf.edu|
21286996|NCT03810456|Michael E. DeBakey VA Medical Center|Dr. Ellen Teng|(713) 578-5513|Ellen.Teng@va.gov|
21272761|NCT00088829|Georgetown University Medical Center|Claudine Isaacs, MD|202-444-3677|isaacsc@georgetown.edu|
21272762|NCT05818137|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21272763|NCT01367275|University of Texas (UT) MD Anderson Cancer Center|Dr. Michael Overman, Associate Professor, GI Medical Oncology|713-792-2828|CR_Study_Registration@mdanderson.org|
21272764|NCT04510857|Barron Associates, Inc.|Richard Adams|4348253435|adams@bainet.com|
21272765|NCT00322491|Genzyme Corporation|Genzyme Medical Information||medinfo@genzyme.com|
21272766|NCT02319148|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21272767|NCT00048048|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21272768|NCT03992196|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21272769|NCT01880073|Center for Reproductive Medicine|Dr. Steven Spandorfer|646-962-3638|sdspando@med.cornell.edu|
21272770|NCT00755196|Pfizer,Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21272771|NCT02388763|Alcon, A Novartis Division|GMA Franchise Head - Vision Care, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
21286997|NCT01702909|Western Regional Medical Center|Jessica L. Coats|623-207-3899|jessica.coats@ctca-hope.com|
21286998|NCT02007720|Novartis Pharma AG|Study Director|+41613241111|novartis.email@novartis.com|
21286999|NCT00738426|Cosmetic Surgery|Dr. Robert F. Jackson|765-662-8303|rjlipodr@comteck.com|
21287000|NCT00490919|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
21287001|NCT01461733|The Ottawa Hospital Research Institute|Salmaan Kanji|613-737-8899|skanji@toh.on.ca|78159
21287002|NCT04350827|The Ohio State University|Dr. Michael Baria|614-293-8196|michael.baria@osumc.edu|
21287003|NCT01249131|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21287004|NCT02915835|University of Michigan|Dr. Cathie Spino|7346155469|spino@umich.edu|
21287005|NCT03426345|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21287006|NCT02431598|Duke University Medical Center|Dr. Mustafa Bashir|919-684-8111|mustafa.bashir@duke.edu|
21287007|NCT02446691|GlaxoSmithKline|GSK Response Center|866-435-7343|sss42438@gsk.com|
21287008|NCT00192114|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21287009|NCT00466817|University of Alabama in Birmingham|David Kimberlin, MD|205-934-2424|dkimberlin@peds.uab.edu|
21287010|NCT00286182|Columbia University|Mathew Maurer, MD, Professor of Medicine at the Columbia University Medical Center|212-305-9808|msm10@cumc.columbia.edu|
21287011|NCT00289211|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21287012|NCT02666222|Envoy Medical Corp.|Elizabeth Anderson, PhD|651-361-8080|landerson@envoymedical.com|
21287013|NCT01474486|Phoenix VA Health Care System|Diane J. Parrington|602-277-5551|diane.parrington@va.gov|7532
21287014|NCT01255163|National Institute on Aging (NIA/NIH)|Dimitrios Kapogiannis, Clinical Investigator|410-350-3953|kapogiannisd@mail.nih.gov|
21287015|NCT00898937|Georgetown University Medical Center - Lombardi Comprehensive Cancer Center|Claudine Isaacs|202-444-3677|isaacsc@georgetown.edu|
21287016|NCT01380366|Northwestern University|Dr. Jonathan Fryer, MD|312-695-2125|jfryer@nmh.org|
21287017|NCT03504917|www.roche.com/about_roche/roche_worldwide.htm|Reference Study ID Number: WN39434|888-662-6728 (U.S. Only)|global-roche-genentech-trials@gene.com|
21287018|NCT04219189|Virginia Commonwealth University|Dr. Caroline Cobb|(804) 827-3562|cobbco@vcu.edu|
21287019|NCT03863353|University of Michigan|Dr. Terri Voepel-Lewis|734-6466803|terriv@umich.edu|
21287020|NCT02495389|Loyola University Chicago|Alan Wolfe, Ph.D.|708-216-5814|awolfe@luc.edu|
21287021|NCT00966433|Wake Forest University Health Sciences|Dr. Thomas Templeton, MD|336-716-4285|ttemplet@wakehealth.edu|
21287022|NCT04079790|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21287023|NCT01297283|Medtronic|Latifa Foudali|+33 631992144|latifa.foudali@medtronic.com|
21287024|NCT01924533|AstraZeneca|Gershon Locker Global Clinical Lead (GCL)||gershon.locker@astrazeneca.com|
21287025|NCT05817669|Argenx|Regulatory manager|Please email:|regulatory@argenx.com|
21287026|NCT04233879|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21287027|NCT03918811|Hospitalsantojanni|Professor Mauro Andreu|+541168788298|mfandreu@gmail.com|
21287028|NCT03292016|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
21287029|NCT02184208|Boston Children's Hospital|Brian Kendall Walsh|617-919-3692|brian.walsh@childrens.harvard.edu|
21287030|NCT01802385|University of Minnesota|Joshua Rhein|612-624-1966|joshua.rhein@gmail.com|
21287031|NCT03810183|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21287032|NCT02756910|Peking Union Medical College Hospital|Lijian Pei|＋86 10 69152020|hazelbeijing@vip.163.com|
21287033|NCT00323063|Rutgers Cancer Institute of|Deborah Toppmeyer, MD|732-235-6789|toppmede@cinj.rutgers.edu|
21287034|NCT04683640|University of Florida|Yenisel Cruz-Almeida|(352) 294-5845|cryeni@ufl.edu|
21287035|NCT04275336|Children's Hospital of Fudan University|Ms.Yu Zhuowen|18017591126|yzw100@126.com|
21287036|NCT03055936|Orion Corporation, Orion Pharma|Clinical Study Director|+358104264184|clinicaltrials@orionpharma.com|
21287037|NCT04664205|University of North Carolina at Chapel Hill|Abbie Smith-Ryan, PhD|919-962-2574|abbsmith@email.unc.edu|
21287038|NCT02115984|Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences|Dr. Sergey S. Bogachev|+7-963-946-57-69|labmolbiol@mail.ru|
21272772|NCT00543309|Ann & Robert H. Lurie Children's Hospital of Chicago|John M. Costello, M.D., M.P.H.|312 227 1551|jmcostello@luriechildrens.org|
21272773|NCT04084483|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
21272774|NCT02194998|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21272775|NCT01249664|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21272776|NCT00525590|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
21272777|NCT01307098|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
21272778|NCT03977051|Imperial College London|Dawn Goodall|+44 (0) 203 313 4268|dawn.goodall1@nhs.net|
21272779|NCT01652001|University of Granada|Dr. Gómez-Moreno|+34000000000|ggomez@ugr.es|
21272780|NCT00860405|Fresenius Kabi Aktiengesellschaft, Else-Kröner-Str. 1, 61352 Bad Homburg, Germany|Professor Dr. Martin Westphal, Chief Medical Officer|+49 6172 686 7280|martin.westphal@fresenius-kabi.com|
21272781|NCT05194839|Aristea Therapeutics|Aristea Therapeutics|858-465-6142|info@aristeatx.com|
21272782|NCT01074554|Vanderbilt University School of Medicine|Dr. Wonder Drake|615-322-2035|wonder.drake@vanderbilt.edu|
21272783|NCT00497796|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21272784|NCT01351506|Chiang Mai University|Dr.Kaweesak Chittawatanarat|+66815951259|kchittaw@gmail.com|
21272785|NCT00220337|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21272786|NCT03661528|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
21272787|NCT04276883|Bioxcel Therapeutics|Vice President Head of Clinical Operations|(475) 355 5177|cgommoll@bioxceltherapeutics.com|
21272788|NCT02732210|Amgen Inc.|Study Director|866-572-6436||
21272789|NCT01876706|NeoTract|Monica Ransom Director of Clinical Operations|4159648770|Monica.Ransom@Teleflex.com|
21272790|NCT00604500|Merck Sharp and Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsresultsdisclosure@merck.com|
21272791|NCT05233163|Columbia University Irving Medical Center|Ani Nalbandian, MD|646-906-2255|an2558@cumc.columbia.edu|
21272792|NCT02120443|ivWatch, LLC|Garret T. Bonnema|1.855.489.2824|garret.bonnema@ivwatch.com|7018
21272793|NCT03124966|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
21272794|NCT03696225|VA Portland Health Care System|Dr. Maya E. O'Neil, Principal Investigator|503-220-8262|Maya.Oneil@va.gov|54522
21272795|NCT03130699|Scripps Health|Athena Philis-Tsimikas, MD, Co-Principal Investigator|858-678-7045|philis-tsimikas.athena@scrippshealth.org|
21272796|NCT00365261|University of California, San Diego|Joel Dimsdale, M.D., Principal Investigator|619 543-5592|jdimsdale@ucsd.edu|
21272797|NCT02096718|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21272798|NCT03682900|Oregon Research Behavioral Intervention Strategies, Inc.|Judy A. Andrews, Senior Scientist|541-484-2123|Judy.Andrews@Influentsin.com|
21272799|NCT06354270|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
21272800|NCT03441581|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
21272801|NCT02809183|Tricida, Inc.|Medical Information|415-429-7800|medinfo@tricida.com|
21272802|NCT02933866|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
21272803|NCT01430741|Bedford VA|Dr. David Smelson, Professor|781-570-1903|david.smelson@va.gov|
21272804|NCT04028843|Pennington Biomedical Research Center|Dr. Leanne Redman|2257630947|Leanne.Redman@pbrc.edu|
21272805|NCT02494713|The University of Texas Health Science Center at Houston|Marka Lyons, Research Manager|713-500-6919|Marka.Lyons@uth.tmc.edu|
21272806|NCT01968382|Virginia Commonwealth University|Stephanie Taylor MSN, RN|804-828-9311|stephanie.taylor@vcuhealth.org|
21272807|NCT01606306|Penn State University Dept of Public Health Sciences|David Mauger, PhD|717.573.0336|dmauger@psu.edu|
21272808|NCT01434342|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
21272809|NCT00950872|Covidien|Noreen Fahey, Director, Clinical Program Management|203-821-4716|noreen.fahey@covidien.com|
21272810|NCT00860028|Yale School of Medicine|Dr. Stephanie O'Malley|203-974-7590|stephanie.omalley@yale.edu|
21272811|NCT02585258|Amsterdam UMC, Vrije Universiteit|Prof Maarten Boers|+3120-4444474|eb@amsterdamumc.nl|
21272812|NCT05125952|Duke University School of Medicine|Elias Pratt|919-684-8111|elias.pratt@duke.edu|
21272813|NCT02086188|EvergreenHealth|Theodore Brown, MD|4258995350|TRBrown@evergreenhealthcare.org|
21272814|NCT00890981|Amgen Inc.|Study Director|866-572-6436||
21272815|NCT03348423|Baudax Bio, Inc.|Development|484-395-2440|info@baudaxbio.com|
21272816|NCT00248638|Emory University|Thomas R. Ziegler M.D.|4047277354|Tzieg01@emory.edu|
21272817|NCT02918877|Beth Israel Deaconess Medical Center|Dr. Brian P. O'Gara|617-549-2974|bpogara@bidmc.harvard.edu|
21272818|NCT01699607|Yale|Dr. Kelly Cosgrove, Ph.D.|203-737-6969|kelly.cosgrove@yale.edu|
21272819|NCT05346055|Weill Cornell Medical College|Jo Anne Sirey|914-997-4333|jsirey@med.cornell.edu|
21272820|NCT01347788|Massachusetts General Hospital|Matthew R Smith, MDPhD|617-763-3748|smith.matthew@mgh.harvard.edu|
21272821|NCT02774798|University Hospital of South Manchester|Nick Heywood|+447739002473|nheywood@doctors.org.uk|
21272822|NCT01365650|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|828
21272823|NCT00728949|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21272824|NCT01346085|Ospedale San Raffaele|Dr Lorenzo Piemonti|+390226432706|piemonti.lorenzo@hsr.it|
21272825|NCT01996033|Abbott|Steven Madej|651-756-2230|steven.madej@abbott.com|
21272826|NCT02252562|Dartmouth-Hitchcock Medical Center|Matthew D. Koff, MD Staff Physician, Anesthesiology|(603) 650-5922|Matthew.D.Koff@hitchcock.org|
21272827|NCT02735174|Cincinnati Children's Hospital Medical Center|Theresa Guilbert, MD, MS|(513) 636-6771|Theresa.Guilbert@cchmc.org|
21272828|NCT04818242|Emory University|Dr. Guillermo E. Umpierrez|(404) 778-1663|geumpie@emory.edu|
21272829|NCT00771537|Indiana University|Gregory D Zimet|317-274-8812|gzimet@iupui.edu|
21287039|NCT01909804|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21287040|NCT03569397|University of Alabama at Birmingham|Adam Sturdivant, MPH|205-934-4042|Adamsturdivant@uabmc.edu|
21287041|NCT04613518|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21287042|NCT03589807|Emory Children's Center|Evan J. Anderson, MD|404-727-5642|evanderson@emory.edu|
21287043|NCT05057221|University of Michigan|Lena M. Napolitano MD|734-615-4775|lenan@med.umich.edu|
21287044|NCT01076543|University of Chicago|Dr. Sonali Smith, Professor of Medicine|773-834-2895|smsmith@medicine.bsd.uchicago.edu|
21287045|NCT00338741|EMD Serono|Liz Gedney/Clinical Trial Leader|+781 681-2179||
21287046|NCT01534273|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21287047|NCT03586050|ETHICON|Jaclyn Calia Stanziola|908-808-6380|jcalia@its.jnj.com|
21287048|NCT00904007|Veterans Affairs Boston Healthcare System|Dr. B. Price Kerfoot|7742869230|price.kerfoot@gmail.com|
21287049|NCT00549393|Johns Hopkins University|Dr. Aaron Milstone|4106143917|amilsto1@jhmi.edu|
21287050|NCT01791985|Imperial College London|Michael Seckl|+44 (0)20 3311 1421|m.seckl@imperial.ac.uk|
21287051|NCT04406714|University of North Carolina Lineberger Comprehensive Cancer Center|Alexis Moore|+1 919-962-5409|alexis.moore@unc.edu|
21287052|NCT01787006|Department of Radiation Oncology, University of Lübeck, Germany|Prof. Dr. med. Dirk Rades|0049 451 500|dirk.rades@uksh.de|45401
21287053|NCT03902613|Columbia University Irving Medical Center|Dr. Martin Lan|646 774 7610|martin.lan@nyspi.columbia.edu|
21287054|NCT01091246|MedImmune, LLC|Judy Falloon, MD/ Sr Director Clinical Development|301-398-0000|falloonj@medimmune.com|
21287055|NCT04577794|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
21287056|NCT01676012|Radboudumc|Dr. Erik van der Heijden|0031243614579|Erik.vanderHeijden@radboudumc.nl|
21287057|NCT01217827|VA Palo Alto HCS|Paul Heidenreich|650-849-1205|paul.heidenreich@va.gov|
21287058|NCT00596271|Valneva Austria GmbH|Katrin Dubischar-Kastner|+43 1 206 20|info@valneva.com|0
21287059|NCT00953290|Cutera Inc.|Ayse Turley, Clinical Development Researcher|415-657-5665|aturley@cutera.com|
21287060|NCT03372798|Oxford University Hospitals NHS Foundation Trust|Dr Tim Betts|0044 01865 220256|ep.doctors@ouh.nhs.uk|
21287061|NCT00767572|UCSF|Dr. Doreen DeFaria Yeh|617-643-7024|ddefariayeh@partners.org|
21287062|NCT01405898|Queen Mary University London|Professor Amrita Ahluwalia|02078825720|a.ahluwalia@qmul.ac.uk|
21287063|NCT02283658|Mayo Clinic|Gerardo Colon-Otero, M.D.|(904) 953-2000|gcolonotero@mayo.edu|
21287064|NCT01835912|BrockU|Panagiota Klentrou|19056885550|nklentrou@brocku.ca|4538
21287065|NCT03608826|Medtronic|Nicole Wood|8006338766|nicole.wood@medtronic.com|
21287066|NCT00875810|MedtronicSpineECA|Cristina Faria|+41 21 802 70 00|cristina.faria@medtronic.com|
21287067|NCT00780975|Pharma Mar, S.A.|Clinical Development Department of PharmaMar´s Oncology,Business Unit.,|+34 918466000|clinicaltrials@pharmamar.com|
21287068|NCT01061606|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
21287069|NCT01305564|Bard Peripheral Vascular|Ryan Melloy|480-350-6074|ryan.melloy@crbard.com|
21287070|NCT04541355|University of California, San Francisco|Dr. Hyunseok Kang, MD|(888) 689-8273|hyunseok.kang@ucsf.edu|
21287071|NCT02322749|AstraZeneca|Information Centre||Information.centre@astrazeneca.com|
21287072|NCT02121860|Conatus Pharmaceuticals|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
21287073|NCT00073918|Fred Hutchinson Cancer Research Center|Ajay K. Gopal, MD|206-288-2037|agopal@u.washington.edu|
21287074|NCT01409239|The Ohio State University|Kathleen Dungan|614-685-3333|kathleen.dungan@osumc.edu|
21287075|NCT01190813|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
21287076|NCT02033759|Mercy Integrative Medicine|Sarah Stolker, MSPT, CLT-LANA|13145402858|sarah@stolker.com|
21287077|NCT04347408|Queen's University Belfast|Dr Thomas Waterfield|028 9024 5133|t.waterfield@qub.ac.uk|
21287078|NCT01190085|Brown University|Dr. Lorenzo Leggio|401-863-1000|Lorenzo_Leggio@Brown.edu|
21287079|NCT00807365|Johns Hopkins University|Johns Hopkins ClinicalTrials.gov Program|4105506484|registerclinicaltrials@jhmi.edu|
21287080|NCT00060606|George Washington University Biostatistics Center|Dr. Elizabeth A Thom|301-881-9260|e_thom@bsc.gwu.edu|8035
21287081|NCT04821830|University of Michigan|Dr. Roger Albin|734-936-9115|ralbin@med.umich.edu|
21287082|NCT04853043|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
21287083|NCT00919633|Medtronic, Inc.|Study Trial Manager|763-505-4594|sarah.mische@medtronic.com|
21287084|NCT00545623|Boston University|Bei-Hung Chang|508-856-8959|bhchang@bu.edu|
21287085|NCT02100124|Penn State College of Medicine|Dr. Cynthia Chuang|7175318161|CChuang@psu.edu|
21287086|NCT04265261|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21287087|NCT04059250|University of California San Francisco|Dr. Peter Rechmann|4155143225|Peter.Rechmann@ucsf.edu|
21287088|NCT00557466|Novartis Pharmaceuticals|Study Director|862-778-8300||
21287089|NCT03268343|Achieve Life Sciences|Daniel Cain, Senior Director Clinical Research|425.686.1546|dcain@achievelifesciences.com|
21287090|NCT02810418|National Cancer Institute|Dr. Christine C. Alewine|240-760-6146|christine.alewine@nih.gov|
21287091|NCT03342001|University of Maryland School of Medicine|Dr. Kashif Munir|443-682-6873|kmunir@som.umaryland.edu|
21287092|NCT04161391|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
21287093|NCT01507181|Mood and Anxiety Disorders Program, Department of Psychiatry, Icahn School of Medicine at Mount Sinai|Dr. J. W. Murrough|212-241-7574|james.murrough@mssm.edu|
21287094|NCT01929889|Northwestern University|Dr. John Csernansky|312-503-9096|jcsernan@nmff.org|
21287095|NCT00702780|Seoul National University Hospital|Young Min Choe|82-2-2072-1730|howlow44@daum.net|
21259859|NCT03403400|Advent Health|Amie Jasper|407-303-8626|amiemarie.jasper@adventhealth.com|42
21259860|NCT03709602|Duke University|Dr. Lisa Mansfield|919-681-9198|lisa.mansfield@duke.edu|
21259861|NCT00712348|Protalix Ltd.|VP Medical Affairs|+972-4-9028100|raul@protalix.com|
21259862|NCT02678429|VUMC|Fenna Phibbs|614-936-0060|fenna.phibbs@vumc.org|
21259863|NCT01273064|Conatus Pharmaceuticals Inc.|MiRa Huyghe, Vice President, Clinical Development|(858) 457-7227|mhuyghe@conatuspharma.com|
21259864|NCT04666038|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21259865|NCT03357393|Region Östergötland|Lena Nilsson|+46 10 103 00 00|lena.nilsson@regionostergotland.se|1838
21259866|NCT02602223|Oregon Health & Sciences University|Dr. Sivaraman Prakasam|503-346-4711|prakasam@ohsu.edu|
21259867|NCT01375764|Amgen Inc.|Study Director|866-572-6436||
21259868|NCT01228903|University of Colorado|Diana Jalal|3037244867|diana.jalal@ucdenver.edu|
21259869|NCT02867761|University of Michigan|Meilan K. Han|734 615-9772|mrking@med.umich.edu|
21259870|NCT03595280|Georgetown University|Darren Mays|2026878937|dmm239@georgetown.edu|
21259871|NCT02411747|Copenhagen Academy for Medical Education and Simulation, Rigshospitalet, Copenhagen University Hospital|Dr. Sarah Bube, director of the CYSTOSIM project|+4561339183|sarahbube@gmail.com|
21259872|NCT01176916|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21259873|NCT00675597|Memorial Sloan Kettering Cancer Center|Dr. Mark G. Kris|646-888-4205|Krism@mskcc.org|
21259874|NCT01014403|UT Southwestern Medical Center|Dr. Herb Phelan|214-648-6841|herb.phelan@utsouthwestern.edu|
21259875|NCT03158220|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21259876|NCT00560755|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21259877|NCT01439945|Mayo Clinic|Charles Lawrence Loprinzi, M.D.||cloprinzi@mayo.edu|
21272830|NCT03831451|University of Michigan|Dr. Lesli Skolarus|734-936-9075|lerusche@umich.edu|
21272831|NCT02148302|SerenaGroup|Thomas E. Serena, MD|617-945-5225|serena@serenagroups.com|
21272832|NCT01767064|USCalifornia|Jason Doctor|213.821.8142|jdoctor@usc.edu|
21272833|NCT02143102|Elucid Bioimaging|Andrew J. Buckler|978-468-0508|andrew.buckler@elucidbio.com|
21272834|NCT03027661|University of Tennessee Health and Science Center|Elaine Todd, Director of Sponsored Programs - Contracts and research agreements|9014483303|ElaineTodd@uthsc.edu|
21272835|NCT01345019|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21272836|NCT02636907|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21272837|NCT00762086|A. Stein Regulatory Affairs Consulting|Shmulik Adler|972-9-767-0002|shmulik@asteinrac.com|
21259878|NCT03961360|The University of Texas Health Science Center at Houston|Farah Amro, MD|713-500-6421|farah.h.amro@uth.tmc.edu|
21272838|NCT00708019|University of California, San Francisco|Christine Miaskowski|415-476-9407|chris.miaskowski@nursing.ucsf.edu|
21272839|NCT00369590|Adult Brain Tumor Consortium|Stuart A Grossman, MD Director of ABTC|410-955-8837|grossman@jhmi.edu|
21272840|NCT03830164|UT MD Anderson Cancer Center|Dr. Chad Tang, Associate Professor, Radiation Oncology Department|(713) 745-7179|ctang1@mdanderson.org|
21272841|NCT04099888|PCI Biotech AS|Chief Executive Officer|(+47) 67 11 54 00|post@pcibiotech.no|
21272842|NCT00023309|National Institute of Diabetes and Digestive and Kidney Diseases, NIH|Marc G. Ghany, M.D|3014961721|marcg@mail.nih.gov|
21272843|NCT01076452|Hines Veterans Affairs Hospital Center for Management of Complex Chronic Care|Frances M. Weaver, Ph.D|708-202-8387|frances.weaver@va.gov|25866
21272844|NCT01661114|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski, M.D.|734-615-3969|zalupski@umich.edu|
21272845|NCT02731157|Duke University|Ian Welsby, M.D.|919-681-6752|ian.welsby@duke.edu|
21272846|NCT01014728|University of Chicago|Dr. Robert Naclerio|773-702-0080|rnacleri@surgery.bsd.uchicago.edu|
21272847|NCT01856309|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Associate Director, Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21272848|NCT00832377|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21272849|NCT01050647|Stanford University|Dr. Anna Girsen|6507255720|agirsen@stanford.edu|
21272850|NCT01273181|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
21302013|NCT03390101|BIOCAD|Nikiforova Aleksandra|+7(812) 380 49 33|nikiforovaan@biocad.ru|6254
21302014|NCT04590248|AstraZeneca Clinical Study Information Centre|Global Clinical Head|+1-877-240-94 79|information.center@astrazeneca.com|
21302015|NCT02052414|The Center for Clinical Research|James M. North MD|3367656181|jnorth1@ccrpain.com|
21302016|NCT01816711|Aarhus University Hospital|Mette Abildgaard Pedersen|31411180|meabpe@rm.dk|
21302017|NCT01303003|Steward St. Elizabeth's Medical Center|Meghan Cashman, IRB Manager|617-789-2804|meghan.cashman@steward.org|2804
21302018|NCT05011279|Dana-Farber Cancer Institute|Catherine Marinac|617-632-4703|CatherineR_Marinac@dfci.harvard.edu|
21302019|NCT02891070|Baxter Healtcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
21302020|NCT02516969|UPMC Hillman Cancer Center|Barbara M. Stadterman, MPH, MSCR, CCRP|412-647-5554|stadtermanbm@upmc.edu|
21302021|NCT01588418|University of Texas Health Science Center at San Antonio|Dr. Ralph DeFronzo|210-567-6691|defronzo@uthscsa.edu|
21302022|NCT01716052|UTHSCSA @CTRC|Dr. Kenneth Kist|210-450-5600|KIST@UTHSCSA.EDU|
21302023|NCT00093379|The University of Texas (UT) MD Anderson Cancer Center|Cathy Eng, MD/ Professor||CR_Study_Registration@mdanderson.org|
21302024|NCT03241030|Baylor College of Medicine|Nidhi Singh, MD|832-824-2771|nidhi.singh@bcm.edu|
21302025|NCT01068964|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21302026|NCT02453347|Audie L. Murphy Veterans Administration Hospital|Dr. Carlos Jaramillo|210-617-5300|jaramilloc3@uthscsa.edu|15773
21302027|NCT02597478|UT MD Anderson Cancer Center|David Hui, MD/ Associate Professor, Palliative Care Medicine|(713) 792-6258|dhui@mdanderson.org|
21302028|NCT05043142|Yuria-Pharm|Tetiana Sprynsian|+380665134849|Tetiana.Sprynsian.pm@pharmaxi.com.ua|
21272851|NCT00944697|Mundipharma Research GmbH|Director of Medical Operations|44 01223424900|info@contact-clinical-trials.com|
21272852|NCT03249584|MedtronicNeuro|Eric Grovender|763-514-4000|eric.a.grovender@medtronic.com|
21272853|NCT02649387|Mayo Clinic|Asher Alban Chanan Khan|904-953-0450|Chanan-Khan.Asher@mayo.edu|
21272854|NCT02724800|VA Pittsburgh Healthcare System|Adam Bramoweth, PhD|412-360-2806|Adam.Bramoweth@va.gov|
21272855|NCT02468778|Abbott Vascular|Sandeep Pingle, Principal Clinical Scientist|408-845-2111|Sandeep.pingle1@abbott.com|
21259879|NCT02959814|Skejby University Hospital, Denmark|Niels Ramsing Holm, MD|004526849066|Niels.holm@clin.au.dk|
21259880|NCT05243628|Mannkind Corporation|Jennifer Pleitez, Director of Clinical Operations|818-661-5032|endocrineresearch@mannkindcorp.com|
21259881|NCT01609842|VHA Eastern Colorado Health Care System|Marina McCreight|720-857-2785|marina.mccreight@va.gov|
21259882|NCT03186989|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
21259883|NCT01583374|Celgene Corporation|Anne McClain, Senior Study Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
21259884|NCT01265524|Sorbent Therapeutics|Howard Dittrich, MD FACC|858-405-1429|hdittrich@sorbent.com|
21259885|NCT00821678|VA HSR&D|John Fortney|206.764.2821|john.fortney@va.gov|
21259886|NCT03036527|University of Louisville|Charles Hubscher|502-852-3058|charles.hubscher@louisville.edu|
21259887|NCT02281591|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21259888|NCT03219164|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21259889|NCT00376961|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623||
21259890|NCT02216695|Derby Teaching Hospital NHS Trust|Nitin V Kolhe|01332788266|nitin.kolhe@nhs.net|
21259891|NCT04574999|Italfarmaco|Dr. Concepción Nieto|+34 91 657 23 23|cnieto@itfsp.com|
21259892|NCT03631927|Tata Memorial Hospital|Dr. Jigeeshu Divatia|+919869077435|jdivatia@yahoo.com|
21259893|NCT00008385|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
21259894|NCT05148884|Neurolixis|Adrian Newman-Tancredi, PhD, DSc, CEO|(+33) 605 14 09 64|contact@neurolixis.com|
21259895|NCT00999830|HOPITAL DE PURPAN Service Hematologie|Dr Michel ATTAL|+33 (0)5.61.77.77.84|attal.m@chu-toulouse.fr|
21259896|NCT00317044|AstraZeneca|ClinicalTrialTransparency||ClinicalTrialTransparency@astrazeneca.com|
21259897|NCT04647110|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21259898|NCT04317690|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.havard.edu|
21272856|NCT00147030|National Perinatal Epidemiology Unit, University of Oxford|Director of NPEU Clinical Trials Unit|01865 289700|ctu@npeu.ox.ac.uk|89728
21272857|NCT01929642|Boling Center for Developmental Disabilities|Dr. Tanjala Gipson|901-448-6512|sbarden@uthsc.edu|
21272858|NCT02458469|JOHN D DINGELL VA MEDICAL CENTER|Dr. Abdulghani Sankari Principal Investigator|13135761000|abdulghani.sankari@va.gov|63105
21272859|NCT02412228|Brown University Oncology Research Group|John Reagan, MD|401-863-3000|BrUOG@Brown.edu|
21272860|NCT03561883|Ironwood Pharmaceuticals, Inc.|Ironwood Study Chair|(617) 621-7722|Info@ironwoodpharma.com|
21272861|NCT05956665|Vanderbilt University School of Nursing|Jennifer Kim, DNP, GNP-BC|615-936-0739|jennifer.kim@vanderbilt.edu|
21272862|NCT02603952|MedImmune, LLC|Raburn Mallory|301-398-4095|information.center@astrazeneca.com|
21272863|NCT05215951|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21272864|NCT02070237|Memorial Care|Dr. Jennifer McNulty|562-933-2730|jjmcnulty@sbcglobal.net|
21272865|NCT04646109|Afyonkarahisar Health Sciences University|Prof. Dr. Nurullah Okumuş|+90 532 4372406|drnuri@hotmail.com|
21272866|NCT01226797|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21272867|NCT03571048|University of Colorado School of Medicine|Elizabeth Thomas, MD|303-724-9083|elizabeth.thomas@cuanschutz.edu|
21302029|NCT01305577|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
21302030|NCT00796978|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Cynthia Owusu|+1 216-844-7670|cynthia.owusu@uhhospitals.org|
21302031|NCT01256190|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
21302032|NCT02834793|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
21302033|NCT02364336|NIDDK|Dr. Marc Ghany|301-402-5115|mg228m@nih.gov|
21272868|NCT00577460|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21272869|NCT00162123|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21272870|NCT00582400|University of Texas Medical Branch at Galveston|Dr. Avi B. Markowitz|4097721164|abmarkow@utmb.edu|
21272871|NCT01318499|Alcon Research|Dana Sager, Clinical Manager Group Leader|1-817-551-8603|dana.sager@alconlabs.com|
21272872|NCT01641445|Brown University|Dr. Robert Miranda|401.863.6658|Robert_Miranda_Jr@brown.edu|
21272873|NCT01347710|Lantheus Medical Imaging|CMO|978-671-8544|c.orlandi@lantheus.com|
21272874|NCT04591626|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21302034|NCT01731938|Grifols Therapeutics, Inc.|Henry Li, PhD, RAC|1-919-316-6042|Henry.Li@Grifols.com|
21302035|NCT04931888|Yale University|Julia Rosenberg, MD MHS|2037777411|julia.rosenberg@yale.edu|
21302036|NCT03179202|SPR Therapeutics|Clinical Affairs|216-378-9106|support@sprtherapeutics.com|
21302037|NCT02969408|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21302038|NCT02350478|Medical University of Graz|Assoz.-Prof. Dr. Harald Sourij|+43316385|ha.sourij@medunigraz.at|81310
21302039|NCT02779556|University of Arkansas for Medical Sciences|Kristie Hadden, PhD/Associate Professor|501-993-3178|KBHADDEN@uams.edu|
21302040|NCT04726969|Swiss Tropical and Public Health Institute|Prof Dr Jennifer Keiser|+41 61 284 82 18|jennifer.keiser@swisstph.ch|
21302041|NCT01667419|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21302042|NCT00856518|North Florida/South Georgia Veterans Health System|Dr. Janis Daly|352-376-1611|janis.daly@neurology.ufl.edu|5223
21287096|NCT01669434|University of Nebraska Medical Center|Dr. Jason Shiffermiller|402-559-7299|jshiffermiller@unmc.edu|
21287097|NCT01003106|Wilmer Eye Institute, Johns Hopkins University School of Medicine|Peter A. Campochiaro, MD|(410) 955-5106|pcampo@jhmi.edu|
21287098|NCT02860988|University of Kentucky|Dr. Joseph Calvert|(859) 323-5771|joe.calvert@uky.edu|
21287099|NCT02579629|Emory University|Katherine Egan|404-727-8463|kfegan@emory.edu|
21287100|NCT01930539|University of Nebraska Medical Center|Lynn Mack|402-559-6276|lmack@unmc.edu|
21287101|NCT02870868|Vanderbilt University Medical Center|Alfredo Gamboa|(615) 322-5000|alfredo.gamboa@vumc.org|
21287102|NCT03657069|Stanford University|Dung Nguyen, MD, PharmD, FACS|(650) 498-6004|nguyendh@stanford.edu|
21287103|NCT00883181|Amgen Inc.|Study Director|866-572-6436||
21287104|NCT04040439|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21287105|NCT00526474|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21287106|NCT03845894|Wake Forest School of Medicine|Jonathan Doug Jaffe DO|336-716-4498|jjaffe@wakehealth.edu|
21287107|NCT01450813|Fletcher Allen Health Care at The University of Vermont|Donald Mathews, M.D.|(802) 847-2415|Donald.Mathews@vtmednet.org|
21287108|NCT01309386|Neuroscience department, Clinical science department, R&D in Janssen, Chiyodaku, Tokyo 101-0065, Japan|Manager|+81-3-4411-5509||
21287109|NCT02709746|H. Lundbeck A/S|Email contact via|+45 36301311|LundbeckClinicalTrials@Lundbeck.com|
21287110|NCT00752089|GlaxoSmithKline|GSK Response Center|866-435-7343||
21287111|NCT02089347|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21287112|NCT00458237|Beth Israel Deaconess Medical Center|Gerburg Wulf|(617) 667-1910|gwulf@bidmc.harvard.edu|
21287113|NCT02914834|University of Illinois Chicago|Judith Schlaeger, PhD|3124134669|jschlaeg@uic.edu|
21287114|NCT03060473|University of Texas Medical Branch|Dr. Nkechinyere Emezienna|4097476651|nkemezie@utmb.edu|
21287115|NCT03108482|Esteve Pharmaceuticals, S.A.|Dr. Neus Gascon|+34934446000|ngascon@esteve.com|
21287116|NCT00975416|National Institute on Drug Abuse|Mary R. Lee, M.D.|301-825-0545|leemary@mail.nih.gov|
21287117|NCT01245101|University of Miami|Rafael E. Campo|305-689-7030|rcampo@med.miami.edu|
21287118|NCT01225549|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21287119|NCT02730962|University of Minnesota|Dr. Alexander Khoruts|612-624-2101|khoru001@umn.edu|
21287120|NCT00473083|BC Cancer Agency|Dr. Barbara Melosky, Principal Investigator|604-877-6000|BMelosky@bccancer.bc.ca|
21287121|NCT01184872|Novartis Pharmaceutical|Study Director|862 778 8300||
21287122|NCT03194334|University Ghent|Prof. Wim Derave|+32/9/2646326|wim.derave@ugent.be|
21287123|NCT05222880|Johnson & Johnson Vision Care, Inc. (JJVC)|Thomas R. Karkkainen|(904)254-0152|TKarkkai@its.jnj.com|
21287124|NCT02886923|Johnson & Johnson Vision|Ross Franklin - PRINCIPAL RESEARCH OPTOMETRIST|904 4431768|RFrankl1@its.jnj.com|
21287125|NCT01077323|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21287126|NCT02153918|National Cancer Institute|Dr. Peter Pinto|301-496-6353|pintop@nih.gov|
21287127|NCT02144701|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu|
21287128|NCT03327324|NYU Langone Health|Joshua Chodosh, MD, MSHS|(212) 263-6768|Joshua.Chodosh@nyulangone.org|
21287129|NCT04536701|Ohio State University|Dr. Karen Rose|614-292-4844|rose.1482@osu.edu|
21287130|NCT03886272|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21287131|NCT03014206|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21287132|NCT03177148|University of Michigan|Mx. Emerson Delacroix|734-764-2014|emmed@med.umich.edu|
21287133|NCT03724357|University of Maryland, Baltimore|Marcelo Sztein, MD|410-706-5328|msztein@som.umaryland.edu|
21287134|NCT02408198|King's College London|Dr Amy Hardy|0207 848 0033|amy.hardy@kcl.ac.uk|
21287135|NCT02848664|James Madison University|Dr. Erin Kamarunas|540-568-8846|kamaruee@jmu.edu|
21287136|NCT02849080|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21287137|NCT00965237|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
21287138|NCT01819727|BioMarin Pharmaceutical Inc.|Principal Scientist I, Clinical Sciences|415-506-6348|dlounsbury@bmrn.com|
21287139|NCT02569892|Stanford University School of Medicine|Steven Sanislo, MD|650-723-6995|ssanislo@stanford.edu|
21287140|NCT00732069|Vanderbilt University|Dr. Nancy J. Brown|615-343-8701|nancy.j.brown@vanderbilt.edu|
21287141|NCT00402727|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21287142|NCT00577317|NRG Oncology|Linda Gedeon for Helen Huang, MS.|716-845-1169|Linda.gedeon@roswellpark.org|
21287143|NCT01831895|Vascular Dynamics|VP Clinical Affairs|949-942-1640|clinical@vasculardynamics.com|
21287144|NCT02360488|UCLA|Steve Cramer|424-522-7273|sccramer@mednet.ucla.edu|
21287145|NCT02084511|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21287146|NCT00461734|Princess Alexandra Hospital|Dr. Gerald Kaye|07 3176 2111|gerald.kaye@health.qld.gov.au|
21272875|NCT02003183|UCLA Semel Institute for Neuroscience and Human Behavior|Dr. Gary Small|3108250291|gsmall@mednet.ucla.edu|
21272876|NCT03104738|The Ohio State University|Ana Mavarez-Martinez, PostDoctoral Reseacher|614-293-3559|ana.mavarezmartinez@osumc.edu|
21272877|NCT01759290|Abbott Vascular|Kunal Sampat|408-845-0746|kunal.sampat@av.abbott.com|
21272878|NCT00841100|University of Miami|Judy Schaechter|305-243-3993|JSchaech@med.miami.edu|
21272879|NCT01661270|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21272880|NCT03338972|Fred Hutchinson Cancer Center|Dr. Damian Green|2066675398|dgreen@fredhutch.org|
21272881|NCT02589171|The University of Texas Health Science Center at Houston|Associate Professor|(713) 500-7277|Shinil.K.Shah@uth.tmc.edu|
21272882|NCT06096168|SERF|Sponsor|0472056010|clinical@serf.fr|
21272883|NCT01868009|GlaxoSmithKline|GSK Response Center|866-435-7343||
21272884|NCT01046253|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21272885|NCT02339909|Imperial College London|Colin Bicknell|02078866666|colin.bicknell@imperial.ac.uk|6072
21272886|NCT02519322|M D Anderson Cancer Center|Dr. Rodabe Amaria|(713) 792-2921|rnamaria@mdanderson.org|
21272887|NCT01054599|VA New York Harbor Healthcare System, NYU|Beth Leeman-Markowski, MD|212-686-7500|beth.leeman-markowski@nyumc.org|
21272888|NCT01648166|University of Kentucky|Dr. Susanne Arnold|8592579568|smarno0@uky.edu|
21272889|NCT00883090|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
21272890|NCT02215161|University of California, San Francisco|Charles Ryan, MD|877-827-3222|clinicaltrials@ucsf.edu|
21272891|NCT03831048|TransMedics, Inc.|Laura Damme|9785520900|ldamme@transmedics.com|
21272892|NCT01087970|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21272893|NCT04538170|Department of Anaesthesiology and Intensive Care Medicine, Eberhard-Karls-University,Tuebingen, Germany|Dr. Barbara Schlisio|+4970712985535|barbara.schlisio@med.uni-tuebingen.de|
21272894|NCT03002597|Children's Hospital of Pittsburgh UPMC|Dr. Kanwal Nischal|4126928940|nischalkk@upmc.edu|
21287147|NCT01733277|ArthroLab Inc.|Dr Jean-Pierre Pelletier|15148908000|dr@jppelletier.ca|26666
21238256|NCT00860379|Shriners Hospitlas for Children|Maggie Dylewski Begis|617-872-8567|mdylewski@shrinenet.org|
21238257|NCT01515748|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21272895|NCT01682083|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21272896|NCT02932878|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
21287148|NCT02008526|Friends Research Institute|Dr. Cathy Reback|3234631601|reback@friendsresearch.org|
21272897|NCT01866319|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21272898|NCT03433430|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
21272899|NCT02576249|Mayo Clinic|Dr. Jacob Sellon|507-255-1141|sellon.jacob@mayo.edu|
21272900|NCT00784849|LSU Dept of Surgery|Dr. Eugene Woltering|504 464-8500|ewolte@lsuhsc.edu|
21272901|NCT03629925|Innovent Biologics (Suzhou) Co., Ltd|YiBo|+86 13382419112|jessica.yi@innoventbio.com|
21272902|NCT01225146|Retina Consultants of Houston|David M. Brown, MD|713-524-3434|dmbmd@houstonretina.com|
21272903|NCT05150964|Sonova USCS|Director of Clinical Research|630-821-5000|phonakaudiologyresearch@gmail.com|
21272904|NCT00623779|AstraZeneca|Gerard Lynch|+44 1509 645895|aztrial_results_posting@astrazeneca.com|
21272905|NCT02597998|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21272906|NCT01334827|The Miriam Hospital|Dr Kate Guthrie, Co-Investigator, Project MIST Lead Investigator|401-793-8180|kate.guthrie@lifespan.org|
21272907|NCT00262964|Washington University School of Medicine|Elisa Fabbrini, MD|314-362-8156|efabbrini@dom.wustl.edu|
21272908|NCT03912337|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21272909|NCT02545998|Oxshott Medical Practice|Dr Sarah Glynne|01372 844000|sarah.glynne@nhs.net|
21272910|NCT03118466|Massachusetts General Hospital|Andrew Brunner MD|6177241124|abrunner@mgh.harvard.edu|
21272911|NCT02789033|Universidad de Guadalajara|PhD. Leonel García Benavides|+52 (33) 20 00 23 00|drleonelgb@hotmail.com|64096
21272912|NCT00301756|Princess Margaret Cancer Centre|Dr. Amit Oza|416-946-2818|amit.oza@uhn.ca|
21272913|NCT00958243|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
21272914|NCT06176768|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21272915|NCT02016170|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu|
21272916|NCT00534703|Imperial College London|Dr Alexander Lyon|+442075943409|a.lyon@imperial.ac.uk|
21272917|NCT01936948|White River Junction VA Medical Center|Heiko Pohl|802-295-9363|heiko.pohl@va.gov|5591
21272918|NCT02365207|University of Texas Health San Antonio|Robert Svatek|210-567-5676|svatek@uthscsa.edu|
21272919|NCT03006978|Sight Sciences|Jaime Dickerson|(877) 266-1144|jdickerson@sightsciences.com|
21272920|NCT01395030|The Queen's Medical Center|Program Director for PET Research|808-691-5466|skwee@queens.org|
21272921|NCT01988922|Washington University in St. Louis School of Medicine|Dr. Lesley K Rao|3143690683|raol@wustl.edu|
21272922|NCT01974141|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21272923|NCT01607645|FHCRC|Derek L. Stirewalt|2066675386|dstirewa@fhcrc.org|
21272924|NCT02327130|Isomark, LLC|Dr. Daniel Butz, Chief Scientific Officer|(608) 561-1895|daniel.butz@isomark.com|
21272925|NCT00493831|University of Nebraska Medical Center|Stephen Rennard|402-559-7313|srennard@unmc.edu|
21272926|NCT05214560|Becton, Dickinson and Company|Clinical Project Manager|00393452237718|gloria.viti@bd.com|
21287149|NCT01062308|Christian Medical College and Hospital, Ludhiana, Punjab, India|Jeyaraj D Pandian|09915784750|jeyarajpandian@hotmail.com|
21287150|NCT01414244|Tulane University|QiQi Zhou|988-7800|qiqi06@gmail.com|
21287151|NCT00960804|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21287152|NCT02337764|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21287153|NCT02990000|University of Massachusetts Amherst|Dr. Michael J. Constantino|4135451388|mconstantino@psych.umass.edu|
21287154|NCT01446705|Center for Health Information and Communication, Roudebush VA Medical Center|Dr. David A. Haggstrom|317-988-2067|dahaggst@iu.edu|
21287155|NCT03653741|Weill Cornell Medical College|David Chuang, MD|212-746-5519|dtc9002@med.cornell.edu|
21287156|NCT02349438|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan, PRINCIPAL RESEARCH OPTOMETRIST|904-443-3449|CColesb@ITS.JNJ.com|
21287157|NCT01949545|Amgen, Inc.|Study Director|866-572-6436||
21287158|NCT01050153|Denver Health Medical Center|Ernest E. Moore|303.602.1820|Ernest.Moore@dhha.org|
21287159|NCT03631641|The Ohio State University Comprehensive Cancer Center|Dr. John Hays|614-293-6529|John.Hays@osumc.edu|
21287160|NCT01831219|Think Surgical|Senior Manager of Clinical Applications|510-249-2339|nnetravali@thinksurgical.com|
21287161|NCT00161213|UMDNJ|Dr. Susan Goodin (Deputy Director, Associate Director for Clinical Science)|732-235-6783|goodin@umdnj.edu|
21287162|NCT03103503|BIOTRONIK|Clinical Studies Engineer Manager|800-547-0394|crystal.miller@biotronik.com|
21287163|NCT00194129|UHCMC Mood Disorders Program|David Kemp, MD|216-844-2865|David.Kemp@UHhospitals.org|
21272927|NCT04977336|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21272928|NCT03298451|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1 8772409479|information.center@astrazeneca.com|
21272929|NCT04538040|Gilead Sciences|Lisa Sterman, MD, MPH|415-407-8434|Lisa.Sterman@Gilead.com|
21272930|NCT03339349|University of Utah|Daniel Jones|801-581-2121|daniel.jones2@gmail.com|
21272931|NCT02672553|Edwards Lifesciences, LLC|Mary Edwards, VP Clinical and Regulatory Affairs, HVT|949-250-2500|mary_edwards@edwards.com|1536
21272932|NCT00159965|Rhode Island Hospital|W. Curt LaFrance, Jr., MD, MPH|401-444-3534|William_LaFrance_Jr@Brown.edu|
21272933|NCT00970281|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21272934|NCT00878995|University of Texas Medical Branch|Melinda Sheffield-Moore|409-772-8707|melmoore@utmb.edu|
21272935|NCT02480764|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21272936|NCT03629249|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21272937|NCT00352690|Washington University School of Medicine|Ramaswamy Govindan, M.D.|314-362-5737|rgovinda@dom.wustl.edu|
21272938|NCT00448175|Uroplasty, Inc|Clinical Study Manager|952-426-6153|megan.otoole@uroplasty.com|
21272939|NCT03633721|Albert Einstein College of Medicine|Dr. Anjali Sharma|7185152593|anjali.sharma@einsteinmed.edu|
21272940|NCT03054103|Wake Forest University Health Sciences|Dr. Timothy Harwood|3367164498|tharwood@wakehealth.edu|
21272941|NCT01475474|Renew Medical, Inc.|Victoria Mackinnon, Vice President, Regulatory, Clinical & Quality|1-888-987-2929|victoria@renew-medical.com|
21272942|NCT02343120|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
21272943|NCT01765530|Massachusetts General Hospital|Robert M Kacmarek PhD, RRT|617-724-4490|rkacmarek@partners.org|
21272944|NCT02134522|Yale University|Nicola Santoro|2037376356|nicola.santoro@yale.edu|
21272945|NCT01333527|Research Associate|Anelise Silveira|780-492-2398|anelise.silveira@ahs.ca|
21272946|NCT02914795|Medical University of Grazt|Assoc. Prof. Dr. Dirk von Lewinski|+43 316 385|dirk.von-lewinski@medunigraz.at|80684
21272947|NCT01993875|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
21272948|NCT02534493|Pressure Profile Systems|Jae Son|3106418100|jaeson@pressureprofile.com|
21272949|NCT01264952|Institute of Oncology Ljubljana|Gregor Sersa, PhD|+386 1 5879 434|gsersa@onko-i.si|
21272950|NCT04183231|Advantage Silver Dental Arrest, LLC|Dr. Peter Milgrom|206-2516831|drmilgrom@silverarrest.com|
21272951|NCT01766778|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21272952|NCT01104662|Cubist Pharmaceuticals, Inc.|Vice President, Clinical Research|1.781.860.8660||
21272953|NCT01478620|"Kiev regional City Hospital"|Ivanov, Dmitry|+38 (039) 247 12 36|ivanovdd@i.kiev.ua|
21272954|NCT03218592|University of North Carolina at Chapel Hill|Dr. Angela Kashuba|9199969998|akashuba@unc.edu|
21272955|NCT02514174|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21272956|NCT02098993|University of Pittsburgh|Craig Seaman, MD|412-209-7308|seamanc@upmc.edu|
21272957|NCT00672854|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
21272958|NCT02888171|University of Alabama at Birmingham|Orlando M. Gutierrez, MD|205-996-2736|ogutierrez@uabmc.edu|
21272959|NCT00479258|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21272960|NCT00373217|University of Virginia|Craig Slingluff MD, Professor of Surgery|4349249311|cls8h@virginia.edu|
21272961|NCT00934934|CERU Queens University|Dr.Daren Heyland|403-915-5573|dkh2@queensu.ca|
21272962|NCT02087514|Columbia University Medical Center|Dr. Eldad Hod|(212) 342-5648|eh2217@cumc.columbia.edu|
21272963|NCT04349917|University of North Carolina at Chapel Hill|Jessica R. Cohen, PhD|(919) 843-3753|jrcohen@unc.edu|
21272964|NCT00633399|Massachusetts General Hospital CNTI|George I Papakostas, M.D. - Scientific Director|6177266697|gpapakostas@partners.org|
21238258|NCT04450108|Bosch Healthcare Solutions|Dr. Klaus Müller, Study director|+49 160 90816081|klaush.mueller@de.bosch.com|
21238259|NCT01031810|New York State Psychiatric Institute|Dr. Patrick J. McGrath|(646) 774-8076|mcgrath@nyspi.columbia.edu|
21238260|NCT01024608|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21238261|NCT04349280|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21238262|NCT04574882|University of Pennsylvania|Director of Research|2674280125|digitalhealth@pennmedicine.upenn.edu|
21238263|NCT05809596|Boston Scientific|Nicole Kelly, Clinical Trial Manager|1-800-CARDIAC|Nicole.Kelly2@bsci.com|
21238264|NCT06916468|University Hospitals Cleveland Medical Center|Dr. Bryan Carroll|(216)844-8200|Bryan.Carroll@UHhospitals.org|
21238265|NCT03770494|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21238266|NCT04295005|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21238267|NCT00791323|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
21238268|NCT04620681|Moffitt Cancer Center|Dr. Joseph Pidala|813-745-2556|joseph.pidala@moffitt.org|
21238269|NCT00608582|VA Boston Healthcare System and Boston University School of Medicine|Margaret Naeser, PhD|857-364-4030|mnaeser@bu.edu|
21238270|NCT04922554|Paratek Pharmaceuticals Inc|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
21238271|NCT01984697|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21238272|NCT01345630|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21238273|NCT01410058|University of Zimbabwe College of Health Sciences|Tsitsi G Monera-Penduka|307148|moneratg@yahoo.co.uk|
21238274|NCT00949715|Medtronic CRDM|Rachael Rose|763-526-2332|rachael.k.rose@medtronic.com|
21238275|NCT01582789|CooperVision, US|Don Siegel, OD|623-544-3877|dsiegel@coopervision.com|
21238276|NCT01255592|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21238277|NCT01920282|Virginia Tech|Dr. Kevin Davy|(540) 231-3487|kdavy@vt.edu|
21238278|NCT04372628|Vanderbilt University Medical Center|Clinical Trials Operations Manager|(615) 875-3080|kelly.walsh@vumc.org|
21238279|NCT05067439|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21238280|NCT01783418|Ste-Justine's Hospital|Catherine Malboeuf-Hurtubise, Post-doctoral fellow|514-343-6111|catherine.malboeuf-hurtubise@umontreal.ca|4594
21238281|NCT00089141|Fred Hutchinson Cancer Research Center (FHCRC)|Paul J. Martin, M.D.|206-667-4798|pmartin@fhcrc.org|
21238282|NCT01559948|Texas Woman's University|Dr. Kelli Brizzolara|214-689-7722|kbrizzolara@twu.edu|
21238283|NCT00508261|GlaxoSmithKline|GSK Response Center|866-435-7343||
21272965|NCT01759277|University of California San Diego|Brian Ilfeld|858-822-2171|bilfeld@ucsd.edu|
21238284|NCT04082884|Yale School of Medicine|Laura Marie Nally, MD|(877) 925-3637|laura.nally@yale.edu|
21238285|NCT00827541|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21238286|NCT01649232|Spanish Neurometrics Foundation|Dr. Moises Aguilar-Domingo, Chairman of Spanish Neurometrics Foundation|+34 634548720|moises.aguilar@gmail.com|
21238287|NCT02347657|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21238288|NCT03662074|Wake Forest Baptist Comprehensive Cancer Center|Study Nurse|336-716-0230|saverill@wakehealth.edu|
21238289|NCT01078155|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
21238290|NCT01119768|AstraZeneca|Gerard Lynch||az_trials_posting@astrazeneca.com|
21238291|NCT01301391|CLIOSS S.r.l.|Dr. Davite Cristina|+39 0031 58|regulatory@clioss.com|1482
21238292|NCT01059643|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21238293|NCT01949870|AstraZeneca|Dr Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com|
21238294|NCT01532128|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21238295|NCT00580814|UCaliforniaIrvine|Tim Wigal, Ph.D., director UCI CHild Development Center|949-824-1812|tlwigal@uci.edu|
21272966|NCT00441467|Eleison Pharmaceuticals|VP Clinical Development|6097211227|matthew.parris@eleison-pharma.com|
21238296|NCT04044456|Malcom Randall VAMC|Health Science Specialist|352-376-1611|julia.waid-ebbs@va.gov|105224
21238297|NCT00330174|Medical University of South Carolina|Susan Sonne, PharmD, BCPP|843.792.5221|sonnesc@musc.edu|
21238298|NCT01032733|University of Florida|Stephen Anton|352-273-7514|santon@ufl.edu|
21238299|NCT02316769|Vanderbilt University|Bret Alvis|6159365836|bret.d.alvis@vanderbilt.edu|
21238300|NCT02643862|Stanford|Dr. Kari Nadeau|650-867-4592|knadeau@stanford.edu|
21238301|NCT01281644|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
21238302|NCT01895972|Bausch + Lomb, a division of Valeant Pharmaceuticals|H. DeCory, Director Medical Affairs|585 732-3284|heleen_H_decory@bausch.com|
21238303|NCT04393441|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21238304|NCT02782169|University of Hawaii|Family Planning Department|808-983-6000|hawaiimedab@gmail.com|
21238305|NCT04003610|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21272967|NCT02289963|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21272968|NCT03514420|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
21272969|NCT01042522|NRG Oncology|Christopher Purdy on behalf of Austin Miller PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
21272970|NCT01978743|Boston University School of Medicine|Dr. Nina Lin|617-414-5242|nina.lin@bmc.org|
21272971|NCT00745420|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
21272972|NCT01941095|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21272973|NCT04486066|VA Puget Sound|Dr. Tracy Simpson|(206) 277-3337|tracy.simpson@va.gov|
21272974|NCT00726739|Masonic Cancer Center, University of Minnesota|Arkadiusz Dudek, M.D.|612-624-0123|dudek002@umn.edu|
21272975|NCT01532141|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21272976|NCT00594685|New England Research Institutes|Susan Assmann|617-923-7747|sassmann@neriscience.com|548
21272977|NCT03344510|Perelman School of Medicine at the University of Pennsylvania|Dr. Joseph Sobanko|215.360.0909|joseph.sobanko@uphs.upenn.edu|
21272978|NCT03164772|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21272979|NCT01453075|VA ORD|Mary Jane Burton|6013624471|mary.burton2@va.gov|1251
21272980|NCT00637299|Fondazione Salvatore Maugeri|Ercole Zanotti|39 385 247|ercole.zanotti@fsm.it|324
21272981|NCT00849901|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21272982|NCT03828734|University of North Carolina at Chapel Hill|Justin Riddle, PhD|919-966-4755|justin_riddle@med.unc.edu|
21272983|NCT00262223|The City College of New York|Denise A. Hien, Ph.D.|(212) 650-5666|dhien@ccny.cuny.edu|
21272984|NCT00437658|AbbVie|Global Medical Services|800-633-9110||
21272985|NCT03952143|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21272986|NCT02152566|Fisher & Paykel Healthcare|Dr Rachel Vicars|09 574 0123|rachel.vicars@fphcare.co.nz|7759
21272987|NCT01328093|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21272988|NCT04421508|Bellerophon Therapeutics|Bobae Kim|(917) 675-2254|bobae.kim@bellerophon.com|
21272989|NCT00760266|Novartis Pharmaceuticals|Study Director|862-778-8300||
21272990|NCT03657160|Takeda|Study Director|+1-877-825-3327|medinfoUS@takeda.com|
21272991|NCT00488865|Rex Medical|James Bressler|610-940-0665|ebressler@rexmedical.com|
21272992|NCT00686959|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21272993|NCT02191891|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21272994|NCT02339233|University of Lousiville|Dr. Susan Harkema|502-581-8675|susan.harkema@louisville.edu|
21272995|NCT00765648|Cleveland Clinic|Frank Peacock MD|(216) 445-4557|peacocw@ccf.org|
21272996|NCT01448057|Novartis consumer Health a GSK Consumer Healtcare company|Director Clinical research Respiratory|(1) 5512065988|anna.x.grinienko@gsk.com|
21272997|NCT02921737|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
21272998|NCT03472365|Jiangsu Hengrui Pharmaceuticals Co., Ltd.|Medical Director: Linna Wang|+86-13581990612|linna.wang@hengrui.com|
21272999|NCT03883906|Cincinnati Children's Hospital Medical Center|Michael Grimley, MD|513-803-3218|Michael.Grimley@cchmc.org|
21273000|NCT00924326|National Cancer Institute|Steven Rosenberg, M.D., Ph.D.|240-858.3080|sar@nih.gov|
21273001|NCT02107092|ZS Pharma, Inc.|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21273002|NCT00537030|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21273003|NCT03325426|UCSF|Elaine Ku|415-502-7760|elaine.ku@ucsf.edu|
21273004|NCT01939197|AbbVie|Global Medical Services|800-633-9110||
21273005|NCT02688556|Sun Pharma Advanced Research Company Limited|SPARC|+912266455645|clinical.trials@sparcmail.com|
21273006|NCT02385097|Sintetica SA|Dr.Elisabetta Donati, Corporate Director Scientific Affairs|+41.91.640.42.50|edonati@sintetica.com|
21273007|NCT00680121|University of Kansas Medical Center|Ann Manzardo, PhD|(913) 588-6473|amanzardo@kumc.edu|
21273008|NCT02849652|University of Pennsylvania|Dr. Robert Schnoll|2157467143|schnoll@pennmedicine.upenn.edu|
21273009|NCT02942966|Philips Image Guided Therapy|Nicolas Aguirre|(612) 297-6655|nicolas.aguirre@philips.com|
21273010|NCT00777829|UCSD|Dr. Sara C. Mednick|8586423192|mednicks@uci.edu|
21273011|NCT00408902|Case Comprehensive Cancer Center|Jorge Garcia MD|216-444-7774|garciaj4@ccf.org|
21273012|NCT02457832|Associate Professor of Medicine Emory University School of Medicine, Department of Medicine, Division of Geriatrics and Gerontology; Research Health Scientist Atlanta VA Health Care System, Center for Visual and Neurocognitive Rehabilitation|Madeleine E. Hackney, Ph.D.|404-315-4100|mehackn@emory.edu, madeleine.hackney@va.gov|373141
21273013|NCT01030965|GlaxoSmithKline|GSK Response Center|866-435-7343||
21273014|NCT02097290|Boston Scientific|Gregory Voss|6515813068|Gregory.Voss@bsci.com|
21273015|NCT03069937|Medical University of South Carolina|Principal Investigator|843-792-4271|gourdith@musc.edu|
21273016|NCT02467621|Copenhagen University Hospital Rigshospitalet, Dept. of Intensive Care 4131|Dr. Morten Hylander Møller|22555343|mortenhylander@gmail.com|+45
21273017|NCT03086356|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21273018|NCT00981305|SeoulNUH|Myung Jae Jeon|82-2-2072-1916|jeonmj@snu.ac.kr|
21273019|NCT00591630|University of Texas MD Anderson Cancer Center|Issa F. Khouri, MD / Stem Cell Transplantation|713-792-8750|ikhouri@mdanderson.org|
21273020|NCT01691248|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21273021|NCT02863575|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21273022|NCT01387737|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21273023|NCT01248247|UT MD Anderson Cancer Center|Dr. Marcelo Vailati Negrao, MD, Assistant Professor, Thoracic-Head & Neck Med Onc|(713) 614-4938|mvnegrao@mdanderson.org|
21273024|NCT00911898|South Texas Accelerated Research Therapeutics|Dr. Muralibhar Beeram|210-593-5921|murali.beeram@stoh.com|
21273025|NCT04188106|Rose Research Center|Perry Willette, MD|919.908.0945|perry.willette@roseresearchcenter.com|
21273026|NCT01746017|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21273027|NCT01507051|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21238306|NCT00771810|Tarix Pharmaceuticals|Elizabeth Wagner|6178760223|elizabeth.wagner@tarixpharma.com|
21273028|NCT02311361|National Cancer Institute|Dr. Tim Greten|240-760-6114|tim.greten@nih.gov|
21273029|NCT05628675|King's College London/South London and Maudsley NHS|Dr Rebecca Cockburn|02032288800|rebecca.cockburn@kcl.ac.uk|
21273030|NCT04455633|Lexicon Pharmaceuticals, Inc.|Medical Affairs|510-338-6064|medical-information@lexpharma.com|
21273031|NCT02532764|ProQR Therapeutics|Medical Monitor|+31 6 20 183 437|clinical@proqr.com|
21273032|NCT03527745|Swiss Tropical and Public Health Institute|Jennifer Keiser, PhD|+41 (61) 284 8218|jennifer.keiser@swisstph.ch|
21273033|NCT01475838|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21273034|NCT03765502|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21273035|NCT01717976|Durham VA HSR&D|Susan N. Hastings|919-286-0411|susan.hastings@va.gov|4033
21273036|NCT00048568|Bristol Myers-Squibb|BMS Study Director||clinical.trials@bms.com|
21273037|NCT00560235|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21273038|NCT04015232|Lambda Therapeutic Research Ltd.|Dr. Adarsh Kumar Garg, M.B.B.S. Principal Investigator|+91-79-40202020|adarshgarg@lambda-cro.com|
21273039|NCT01027780|University of Rochester|Dr. Jan Moynihan|585-275-4648|jan_moynihan@urmc.rochester.edu|
21273040|NCT02896361|Abbott Neuromodulation|Filippo Agnesi, PhD|972-526-4860|filippo.agnesi@abbott.com|
21273041|NCT01029353|Vanderbilt University Medical Center|Martin L Blakely, MD|615-936-7211|martin.blakely@vumc.org|
21273042|NCT00959660|Wake Forest School of Medicine|Dalane W. Kitzman, M.D.|336-716-3274|dkitzman@wakehealth.edu|
21238307|NCT00765232|Mayo Clinic|Mitchell R. Humphreys MD|480-301-8000|humphreys.mitchell@mayo.edu|
21273043|NCT00496964|Virginia Commonwealth University|Dr. Sheryl Finucane|804-628-3639|sfinucan@vcu.edu|
21273044|NCT02942264|National Cancer Institute|Dr. Jing Wu|240-760-6036|jing.wu3@nih.gov|
21273045|NCT03980483|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21273046|NCT04622709|University of North Carolina, Chapel Hill|Jennifer E. Flythe, MD, MPH|(919) 445-2656|jflythe@med.unc.edu|
21273047|NCT02005536|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21273048|NCT01062256|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com|
21273049|NCT03049488|Vaccine Research Center, NIAID, NIH|Martin Gaudinski, MD|(301) 451-8715|martin.gaudinski@nih.gov|
21273050|NCT00208026|The Children's Hospital of Philadelphia|Albert C. Yan, M.D.|(215) 590-2158|Yana@email.chop.edu|
21273051|NCT03099538|Mayo Clinic|Aaron R. Mangold, MD|480-301-4256|mangold.aaron@mayo.edu|
21273052|NCT00891293|GlaxoSmithKline|GSK Response Center|866-435-7343||
21273053|NCT00440557|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Sr Director of Clinical Research|908-927-2116||
21273054|NCT01572948|University of Alabama at Birmingham, Division of Pulmonary, Allergy, and Critical Care Medicine|J. Michael Wells, M.D.|205-934-6047|jmwells@uab.edu|
21273055|NCT01973348|Indiana University|Dr. Daniel Neely, PI|3172741214|deneely@iupui.edu|
21273056|NCT01126736|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21273057|NCT01270919|Stryker Orthopedics|Director of Clinical Research|201-831-5401|ellen.axelson@stryker.com|
21273058|NCT00874237|Alexza Pharmaceuticals, Inc|Chief Scientific Officer|650.944.7777|jcassella@alexza.com|
21273059|NCT02828917|Medinol|Dina Kofler, VP Clinical Affairs|+97237679032|dinak@medinol.com|
21273060|NCT01496183|The State University of New York at Buffalo|Dr. Elsa Daurignac, Research Assistant Professor|716-898-4540|ecd3@buffalo.edu|
21273061|NCT02370407|Johns Hopkins University|Dr. Lauren Thomaier|410-955-6710|lthomai1@jhmi.edu|
21273062|NCT00669864|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21273063|NCT01629381|University of Padua|Dr. Giuseppe Camporese|049 8212882|giuseppe.camporese@aopd.veneto.it|+39
21273064|NCT02158494|University of Wisconsin - Madison|Mitchell Tyler|608-262-5112|metyler1@wisc.edu|
21273065|NCT00906347|University of Texas Southwestern Medical Center|Dr. April Bleich|214-648-2316|april.bleich@gmail.com|
21273066|NCT00802100|Columbia University|Scott Stroup|(212) 543-5676|stroups@nyspi.columbia.edu|
21273067|NCT04448886|DFCI|Se Eun Kim|9196228080|seeunk@ds.dfci.harvard.edu|
21273068|NCT00472290|Amgen Inc.|Study Director|866-572-6436||
21273069|NCT04567342|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
21273070|NCT00745095|JJPVAMC National Center of Excellence for the Medical Consequeunces of Spinal Cord Injury|Dr. Mark A. Korsten, Chief of Gastroenterology|718-584-9000|mark.korsten@va.gov|6753
21273071|NCT01353495|Wright Medical Technology, Inc.|Jonette Hodge, MSN, RN, CCRP, Director, Medical Affairs|8002387188|jonette.hodge@wmt.com|4747
21273072|NCT03117569|Viral Hepatitis Clinical Research Program Kirby Institute|Clinical Trials Manager|+61 9385 0900|pmarks@kirby.unsw.edu.au|
21273073|NCT05277389|Arizona State University|Claire Honeycutt, Associate Professor|4809658453|claire.honeycutt@asu.edu|
21273074|NCT03144687|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21273075|NCT01523899|University of California-Davis|Larissa May, MD|9167345000|lsmay@ucdavis.edu|
21287164|NCT05088772|University of Toronto|Dr. Connor Brenna|416 340 3598|connor.brenna@mail.utoronto.ca|
21287165|NCT00452374|The University of Texas M. D. Anderson Cancer Center|William Wierda, M.D./Associate Professor|713-745-0428|eharriso@mdanderson.org|
21287166|NCT01926028|NovaDigm Therapeutics, Inc.|Chief Scientific Officer|2676405189|john_hennessey@novadigm.net|
21287167|NCT00301834|University of California San Francisco|Dr. Morton Cowan|4154762188|mcowan@peds.ucsf.edu|
21273076|NCT00683293|Kantonsspital Aarau|Dimtri SARLOS|00418384141|la.kots@ksa.ch|
21273077|NCT02126306|HMO|Dr Gadi Lalazar|97226777337|lalazar@hadassah.org.il|
21273078|NCT00743197|Northwestern University|Dr. Martha Gulati, Principal Investigator|312-695-4965|mgulati@nmh.org|
21287168|NCT00744939|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21287169|NCT01739335|Bronx VA Medical Center|Dr. Julia Golier; Chief of Psychiatry|718-584-9000|julia.golier@va.gov|6587
21287170|NCT00288912|Durham VA HSR&D|Dr. Kelli Allen|919-286-0411|kelli.allen@va.gov|7090
21287171|NCT02105324|Massachusetts General Hospital|Dr. Steven J. Russell|617.726.1848|sjrussell@partners.org|
21287172|NCT00183430|VA Puget Sound HCS|Murray A. Raskind, MD|206-277-3797|Murray.Raskind@va.gov|
21287173|NCT00843349|University of Miami|Dr. Myles Wolf, Associate Professor of Medicine, Chief-Division of Nephrology and Hypertension|305-243-7745|mwolf@med.miami.edu|
21287174|NCT02124824|VAMC SLC|Scott Capps|8015821565|Scott.Capps@hsc.utah.edu|
21287175|NCT02659501|Loma Linda University, Department of Plastic Surgery|Saba Motakef, Resident Physican|714-925-8932|smotakef@llu.edu|
21287176|NCT01863771|Janssen Pharmaceutical K.K.|Senior Director Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
21287177|NCT03636256|US Biotest, Inc.|Dr. Gere diZerega|805.595.1300|gere.dizerega@usbiotest.com|
21287178|NCT01218308|GlaxoSmithKline|GSK Response Center|866-435-7343||
21287179|NCT02426684|Cedars Sinai Medical Center|Dr. Stanley C. Jordan, MD|310-423-2641|sjordan@cshs.org|
21287180|NCT00879190|Stanford University, Department of Obstetrics & Gynecology|Anna Girsen, Manager of Maternal-Fetal Medicine Research Operations|(650) 725-0499|agirsen@stanford.edu|
21287181|NCT00723229|University of Washington|Dr. Christine Johnston|206-520-4340|cjohnsto@u.washington.edu|
21287182|NCT00977197|Mayo Clinic|Yuri A. Saito Loftus, M.D.|507-284-2687|saito.yuri@mayo.edu|
21287183|NCT02900352|Virginia Commonwealth University|Dr. Albert Arias|8048285793|albert.arias@vcuhealth.org|
21287184|NCT01235065|R Adams Cowley Shock Trauma Center|Dale Yeatts, Principal Investigator|443-909-0648|djyeatts@gmail.com|
21287185|NCT00386334|Sepracor Inc.|Lunesta Medical Director|1-866-503-6351||
21287186|NCT00785356|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
21287187|NCT04753034|Aditum Bio|VP, Clinical Operations|(510) 227-2102|Chris.resburg@aditumbio.com|
21287188|NCT00379145|NRG Oncology|Angela Kuras on behalf of James Kauderer|716-845-5702|kurasa@nrgoncology.org|
21287189|NCT04210986|Vice President of Operations|Suzanne Liv Page|970-401-8770|spage@sprivail.org|
21287190|NCT02378662|Aevi Genomic Medicine|Garry A. Neil, MD|610-254-4208|garry.neil@aevigenomics.com|
21287191|NCT02295644|University at Buffalo, School of Dental Medicine, Oral Diagnostic Sciences|Dr. Willard D McCall|(716)829-3559|wdmccall@buffalo.edu|
21287192|NCT03101020|Faculdade de Ciências Médicas da Santa Casa de São Paulo|Lucas Villalta Santos|+5515998197899|lucasvillalta.s@gmail.com|
21287193|NCT02616783|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21287194|NCT01103323|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21287195|NCT00372424|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21287196|NCT01342354|The University of Chicago|Dr. Stanley Liauw|(773) 702-0817|Stanley.Liauw@uchospitals.edu|
21287197|NCT02956382|Seattle Cancer Care Alliance|Chaitra Ujjani, MD|(206) 606-1955|ujjani@uw.edu|
21287198|NCT05214118|Virginia Commonwealth University|Dr. Caitlin E. Martin|(804) 628-7023|caitlin.martin@vcuhealth.org|
21287199|NCT02439164|Beijing Tiantan Hospital|Dr. Nan Lin|861067096658|linnan127@163.com|
21287200|NCT03797898|Seattle Children's|Tumaini R. Coker, MD, MBA|206-884-0559|Tumaini.Coker@seattlechildrens.org|
21287201|NCT02314728|Montefiore Medical Center|Kafui A. Demasio, MD, MPH, Maternal Fetal Medicine, Dept of Obstetrics/Gynecology and Women's Health|718-920-2767|kdemasio@montefiore.org|
21287202|NCT03080935|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21287203|NCT03118934|Alcon, A Novartis Division|Head, CDMA Vision Care Franchise|1-888-451-3937|alcon.medinfo@alcon.com|
21287204|NCT01614470|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21287205|NCT04232839|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21287206|NCT03217591|Akebia Therapeutics|Akebia Therapeutics|6178446128|trials@akebia.com|
21287207|NCT05324306|Medical University of South Carolina|Dr. Konrad Rajab|843-792-1414|tkrajab@uams.edu|
21273079|NCT00824265|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
21273080|NCT02380183|Montefiore Medical Center|Dr. Amaresh Vydynathan|718-920-4316|avydynathan@montefiore.org|
21273081|NCT01411332|University of Miami|Alan Pollack MD, PhD|305-243-4916|apollack@med.miami.edu|
21273082|NCT02170688|Duke University Medical Center|Lisa Ho, MD|919-684-7890|lisa.ho@duke.edu|
21273083|NCT01894178|Baylor College of Medicine|Dr. Lee Chang|713-873-4321|lcchang@bcm.edu|
21273084|NCT02079532|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21273085|NCT02920996|Dana-Farber Cancer Institute|Mark Awad, MD, PhD|(617) 632-3468|mark_awad@dfci.harvard.edu|
21273086|NCT01402947|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21273087|NCT02218164|H. Lee Moffitt Cancer Center and Research Institute|Dr. Christine Chung|813-745-5061|christine.chung@moffitt.org|
21273088|NCT01471522|NYU Langone Health|Anna Naumova|212.263.6927|Anna.Naumova@nyulangone.org|
21273089|NCT01432171|Dana-Farber Cancer Institute|Dr. Andrew Norden, M.D., M.P.H. - Lead Principal Investigator|617-632-2166|anorden@partners.org|
21273090|NCT00993187|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372||
21273091|NCT00633256|Yale University|James Poling, Ph.D.|203-937-4830|james.poling@yale.edu|
21273092|NCT02817841|Estetra SPRL|Mithra Pharmaceuticals SA Pharma Department|+3243492822|clinical.trials@mithra.com|
21273093|NCT00705536|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|(858) 794-8889||
21273094|NCT00318812|Ottawa Hospital Research Institute|Dr Deborah Zimmerman, principal investigator|613-738-8400|dzimmerman@toh.on.ca|82534
21273095|NCT01458561|CryoLife, Inc.|Scott B. Capps, Vice President, Clinical Research|770-419-3355|capps.scott@cryolife.com|
21273096|NCT03422653|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
21273097|NCT01675622|Mundipharma (China) phamaceutical CO. LTD|Director of R&D|0086-10-65636800||
21273098|NCT04032977|Prollenium Medical Technologies|Director Clinical Affairs|1-905-508-1469|clinicaltrials@prolleniumus.com|
21273099|NCT01101022|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21273100|NCT03075761|The University of Texas Southwestern Medical Center|Ayesha Zia, MD|214-456-7000|Ayesha.Zia@UTSouthwestern.edu|
21273101|NCT01519661|Novartis Pharmaceuticals|Study Director|862-778-8300||
21273102|NCT01139047|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
21273103|NCT00581139|University of California, Irvine|Dr. Zeev Kain|714-480-0039|zkain@uci.edu|
21287208|NCT00535652|University of Ulm|Prof. Dr. Henne-Bruns, PI|++4973150053500|doris.henne-bruns@uniklinik-ulm.de|
21287209|NCT01036802|University of North Carolina, Chapel Hill|Kenneth I. Ataga, MD|919-843-7708|kataga@med.unc.edu|
21273104|NCT02606708|New York University School of Medicine|Carmen Perez, MD|212 731 5003|carmen.perez@nyumc.org|
21273105|NCT00420303|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21273106|NCT00840632|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21273107|NCT00485472|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
21273108|NCT01492361|Amarin Pharma, Inc.|Dr. Alexander Giaquinto, Executive Director, Regulatory Affairs|908-326-1324|alex.giaquinto@amarincorp.com|
21273109|NCT04083859|Wake Forest University School of Medicine|Dr. David P. Miller, Jr|336-713-5218|dmiller@wakehealth.edu|
21273110|NCT01595503|University of Michigan|stephan taylor|7349364955|sftaylor@umich.edu|
21273111|NCT03227445|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21273112|NCT03538587|National Cancer Institute|Staci M. Peron, Ph.D.|240-760-6025|martins@mail.nih.gov|
21273113|NCT00365300|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21273114|NCT01991470|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
21273115|NCT00324168|F.I. Proctor Foundation, University of Califonia, San Francisco|Dr. Thomas Lietman|415-502-2662|tom.lietman@ucsf.edu|
21273116|NCT01203878|Tennessee Clinical Research Center|Medical Director|615-383-2400|jbiron@tnclinicalresearch.com|
21273117|NCT00528606|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
21273118|NCT02475954|Rutgers - Robert Wood Johnson Medical School|Roseanne D. Dobkin|732-235-4051|dobkinro@rutgers.edu|
21273119|NCT03503578|Massachusetts General Hospital DACCPM|Dr. Oluwaseun Johnson-Akeju|617-724-7200|oluwaseun.akeju@mgh.harvard.edu|
21273120|NCT01918397|Boston University School of Public Health|Charles R Horsburgh, MD|617-414-1282|rhorsbu@bu.edu|
21273121|NCT01423760|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21273122|NCT01239121|James J. Peters VA Medical Center|Kenneth Boockvar|718-584-9000|kenneth.boockvar@va.gov|3807
21273123|NCT00643578|University of Florida Asthma Research Lab|Dr. Leslie Hendeles|352-273-6027|hendeles@cop.ufl.edu|
21273124|NCT01434693|Coronado Biosciences|Vice President Clinical Operations|781.652.4516|nsilver@coronadobio.com|
21273125|NCT04006171|Near East University|Dr.Ali Cenk Ozay|00905428583248|dr.alicenk@hotmail.com|
21273126|NCT00912288|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21273127|NCT02506309|Brno University Hospital|dr. Martin Huser|+420532233843|huser.martin@fnbrno.cz|
21273128|NCT02087904|AbbVie|Global Medical Services|AbbVie|abbvieclinicaltrials@abbvie.com|
21273129|NCT02178722|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21273130|NCT03752528|Indivior, Inc.|Global Director, Clinical Development|804-379-1090|Robert.Dobbins@Indivior.com|
21273131|NCT04213326|Exact Sciences|Adriann Kern|4843563027|akern@exactsciences.com|
21273132|NCT03205553|University of Arkansas for Medical Sciences|Dr. Patrick Bonasso|(501) 364-2943|PCBonasso@uams.edu|
21273133|NCT04826809|Mayo Clinic|Dr. Janielle R. Nordell|507-594-4700|Nordell.Janielle@mayo.edu|
21273134|NCT02461771|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
21273135|NCT00854308|Hoffman-LaRoche|Medical Communications|800-821-8590||
21273136|NCT04448678|University of Utah|Anne Kirchhoff|801-587-4084|Anne.Kirchhoff@hci.utah.edu|
21273137|NCT02079766|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
21273138|NCT02781727|Ascendis Pharma, Inc.|Aimee D Shu, MD|+1 650 352 8389|ADS@ascendispharma.com|
21273139|NCT01106326|University of Rochester|Maria Fagnano|5852758220|maria_fagnano@urmc.rochester.edu|
21273140|NCT01044732|Avantis Medical Systems|Jack Higgins, MD - Chief Medical Officer|6508239216|jhiggins@avantismedical.com|
21273141|NCT02304432|McLean Hospital|Dr. Deborah Levy|617-855-2854|dlevy@mclean.harvard.edu|
21273142|NCT03991494|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21273143|NCT00098371|The Ohio State University Comprehensive Cancer Center|John Byrd, MD|614-293-9869|John.Byrd@osumc.edu|
21273144|NCT02419690|Denver Health & Hospital Authority|Deborah Rinehart|303-602-2743|deborah.rinehart@dhha.org|
21273145|NCT02405195|Västra Götalandsregionen|Lukas Lannemyr|46313428860|lukas.lannemyr@vgregion.se|
21273146|NCT02507375|Hoffmann-La Roche|Medical Communications|800-821-8590||
21273147|NCT01706926|MedImmune, LLC|Marius Albulescu, Associate Medical Director|301-398-0000|albulescum@medimmune.com|
21273148|NCT04742283|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
21273149|NCT00397488|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org|
21273150|NCT02158572|Agile Therapeutics|Michelle Previtera, Associate Director of Clinical Development|609-683-1880|mprevitera@agiletherapeutics.com|
21273151|NCT02943447|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21273152|NCT00722124|Mayo Clinic|Amit Sood, MD|507-266-1944|nicotineresearch@mayo.edu|
21273153|NCT01907334|University of Florida|Leslie Hendeles, PharmD|352-273-6027|hendeles@cop.ufl.edu|
21273154|NCT05017480|Suzhou Connect Biopharmaceuticals, Ltd|John Guo, Director of Clinical Operation|051253577866|jwguo@connectpharm.com|
21273155|NCT01794039|Mayo Clinic|Shaji K. Kumar, M.D.|(507) 284-2017|kumar.shaji@mayo.edu|
21273156|NCT04927013|Emory University|Yue Guan, PhD|404-712-1671|yue.guan@emory.edu|
21273157|NCT02653664|University of Washington|Dr. Mark Jensen|206-543-3185|mjensen@uw.edu|
21273158|NCT01721681|Bio Products Laboratory Ltd|Head of Medical Affairs|+44 20 8957 2200|medinfo@bpl.co.uk|
21273159|NCT01315249|Novartis|Study Director|41 61 324 1111||
21273160|NCT00556049|MGH Cancer Center|Dr. M. Dror Michaelson|617-726-1594|dmichaelson1@partners.org|
21273161|NCT02831569|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21273162|NCT00954915|MacroGenics, Inc.|Teplizumab Program Manager||info@macrogenics.com|
21238308|NCT05198466|Baylor College of Medicine|Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
21238309|NCT02953938|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
21273163|NCT01287013|National Institutes of Health|Bradford Wood, MD|(301) 496-7739|bwood@nih.gov|
21273164|NCT03247556|Supernus|Joseph Hull, PhD, Associate Director Clinical Research|240-403-5324|jhull@supernus.com|
21273165|NCT02031978|USDA Food and Nutrition Service|Courtney Paolicelli|7036054370|Courtney.Paolicelli2@usda.gov|
21273166|NCT00051025|Eisai Call Center|Eisai Inc|888-422-4743||
21273167|NCT01900730|UT MD Anderson Cancer Center|Dr. Wendy Woodward, PHD/ Professor, Radiation Oncology Department|713-563-8481|wwoodward@mdanderson.org|
21273168|NCT01179048|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
21273169|NCT02109042|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21273170|NCT03203447|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
21273171|NCT01163760|Vistakon|Kurt Moody OD, FAAO|904-443-3088||
21287210|NCT00069264|Eisai Inc.|Dr. Peter Tarassoff|888-422--4743||
21287211|NCT01251042|Wellspect HealthCare|Emma Tällberg, Clinical Research Manager|+46313764000||
21287212|NCT04249427|Duke University|David Jang, MD|919-613-6407|david.jang@duke.edu|
21287213|NCT03974282|Virginia Commonwealth University|David Chester|8048287624|dschester@vcu.edu|
21287214|NCT02895347|GWU Medical Faculty Associates|Dr. Gaby Moawad|202-741-2500|jebert@mfa.gwu.edu|
21287215|NCT02589145|UT MD Anderson Cancer Center|Dr. Yago Nieto/Professor, Stem Cell Transplantation|713-792-2466|ynieto@mdanderson.org|
21287216|NCT01673178|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21287217|NCT02557399|GlaxoSmithKline|GSK Response Center|866-435-7343||
21287218|NCT02456194|NSHA|Ross Leighton|1-902-473-4035|Ross.Leighton@nshealth.ca|
21287219|NCT03204643|Atrium Health|Dr. Jason Roberge|704-355-0268|Jason.Roberge@AtriumHealth.org|
21287220|NCT01257347|Columbia University Medical Center|Ian Kronish, MD, MPH|2123421335|ik2293@columbia.edu|
21287221|NCT01768325|Indiana University School of Medicine|John DeWitt, MD|317-944-1113|jodewitt@iu.edu|
21287222|NCT02743364|Northwestern University|Seema A. Khan, MD|312-503-4236|s-khan2@northwestern.edu|
21287223|NCT03106077|UT MD Anderson Cancer Center|Stacy Moulder, Professor, Breast Medical Oncology|(713) 792-2817|smoulder@mdanderson.org|
21287224|NCT00606307|Italfarmaco S.p.A.|Tiziano Oldoni, MD|+39 02 6443|t.oldoni@italfarmaco.com|2540
21287225|NCT01274533|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
21287226|NCT02563899|GlaxoSmithKline|GSK Response Center|866-435-7343||
21287227|NCT03669588|argenx BVBA|Regulatory Manager|+32 93103400|regulatory@argenx.com|
21287228|NCT03781726|University of Pennsylvania|Peter Reese|215-573-8070|Peter.Reese@pennmedicine.upenn.edu|
21287229|NCT02949947|UT MD Anderson Cancer Center|Saroj Vadhan,Clinical Professor, Cytokine & Supportive Oncology|(713) 792-7966|svadhanr@mdanderson.org|
21287230|NCT01973218|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21287231|NCT00492726|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21287232|NCT01100502|Seagen Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
21287233|NCT04386902|Neurosteer|Nathan Intrator, Prof.|+1 (401) 837-0351|nathan@neurosteer.com|
21297093|NCT01717326|Merck Sharp & Dohme Corp.|Results Point of Contact* Name or Official Title Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21297094|NCT01431391|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@dendreon.com|
21273172|NCT00274937|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21273173|NCT00445003|Jaeb Center for Health Research|Adam R. Glassman, Director DRCR.net Coordinating Center|813-975-8690|aglassman@jaeb.org|
21297095|NCT00753363|Baltimore VAMC|Dr. Alice Ryan|410-605-7851|aryan@grecc.umaryland.edu|
21302043|NCT04975230|Case Western Reserve University|Stephanie Griggs|404-544-9915|stephanie.griggs2@emory.edu|
21302044|NCT03364270|Cedars-Sinai Medical Center|Balaji Tamarappoo, MD|3104232219|Balaji.Tamarappoo@cshs.org|
21302045|NCT04915950|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21302046|NCT02644109|Nutrition and Food Technology Institute, University of Chile|Dr. Sandra Hirsch|+56229781495|shirsch@inta.uchile.cl|
21302047|NCT02474069|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
21302048|NCT00536913|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21302049|NCT00202878|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21302050|NCT01421355|Brigham and Women's Hospital|Joshua Beckman, MD|617-732-6320|jbeckman@partners.org|
21302051|NCT00918736|Veterans General Hospital, Kaohsiung, Taiwan|Shu-Fen Sun|886-73422121|sfsun.tw@yahoo.com.tw|4210
21302052|NCT00577798|University of Nebraska Medical Center|Thomas Porter, MD|+1 (402) 559-8150|trporter@unmc.edu|
21302053|NCT02433080|University College London|Dr Anne Lanceley|+442076796807|a.lanceley@ucl.ac.uk|
21302054|NCT03563183|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21273174|NCT00874887|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
21273175|NCT03656783|Brigham and Women's Hospital|Marcelo Di Carli, MD|6177326290|mdicarli@bwh.harvard.edu|
21273176|NCT00880568|Merck Sharp & Dohme|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21302055|NCT01942733|Email contact via H. Ludbeck A/S|Study director||LundbeckClinicalTrials@lundbeck.com|
21302056|NCT00528450|Memorial Sloan Kettering Cancer Center|Dr. Peter Maslak|212-639-5518|maslakp@mskcc.org|
21273177|NCT00620022|Novartis Pharmaceuticals|Study Director|862 778-8300||
21273178|NCT02006160|UBMD Neurology|Dr. Ralph Benedict|7163230556|benedict@buffalo.edu|
21273179|NCT01469767|Wake Forest University Health Sciences|Steve Feldman MD|336-716=3775|sfeldman@wakehealth.edu|
21273180|NCT01541891|Laboratorios Sophia, SA de CV|Baiza-Duran Leopoldo, Medical Director|+52 (33)30014200|leopoldo.baiza@sophia.com.mx|
21273181|NCT03478397|CEDES|Dr. Silvina Arrossi|541148651007|silviarrossi2020@gmail.com|
21273182|NCT03988803|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21273183|NCT01617668|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21273184|NCT00925769|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21273185|NCT03138330|Danone Nutricia Research|Dr Elena Sandalova|6568309433|elena.sandalova@danone.com|
21273186|NCT01735630|Transition Therapeutics Ireland Limited|Aleksandra Pastrak, MD, PhD, Vice President Clinical Development|+1 416 263 1227|apastrak@transitiontherapeutics.com|
21273187|NCT01327963|EndoGastric Solutions|Adrian Lobontiu, Chief Medical Officer|1 650-474-9259|alobontiu@endogastricsolutions.com|
21273188|NCT04753710|Sintetica SA|Roberta Bianchi|0041 91 640 42 50|rbianchi@sintetica.com|
21273189|NCT01720264|IndianaU|Dr. Sherif Farag|(317) 278-0460|ssfarag@iu.edu|
21273190|NCT00877032|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21273191|NCT00813293|Beth Israel Deasoness Medical Center|Andrea Bullock MD, MPH||abullock@bidmc.harvard.edu|
21273192|NCT00533273|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
21287234|NCT01794702|The University of Texas MD Anderson Cancer Center|Nitin Jain, MD./Associate Professor|713-745-6080|njain@mdanderson.org|
21287235|NCT00623181|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21238310|NCT03365154|Libra Medical|Phil Zhang, MD|6692039308|pzhang@libramed.com|
21302057|NCT02925416|Melinta Therapeutics|Study Director|1-844-633-6568|medinfo@melinta.com|
21302058|NCT02625909|The Kirby Institute|Pip Marks, Clinical Trials Manager|+61 2 9385 0886|pmarks@kirby.unsw.edu.au|
21238311|NCT02440633|Otsuka Pharmaceutical Co., Ltd.|Study Director, Yoshitaka Kotobuki, Mr|+81-3-6361-7366||
21302059|NCT01980589|Amgen, Inc.|Study Director|866-572-6436||
21302060|NCT02577445|Livanova|Clinical Project Manager|0032498644704|renske.dezwaef@livanova.com|
21302061|NCT01297491|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21302062|NCT01805791|Hutchison MediPharma Ltd|Dr. Rongjun Liu|+86 21 2067 3203|rongjunl@hmplglobal.com|
21302063|NCT00518089|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
21302064|NCT02355184|CytoDyn|Joseph Meidling|(360) 980-8524|jmeidling@cytodyn.com|
21302065|NCT01109056|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21302066|NCT00813943|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21302067|NCT04978454|Duke University Medical Center|Christopher Woods|919-684-7916|chris.woods@duke.edu|
21302068|NCT02704143|Changhai Hospital affiliated to Navy Medical University|Dr. Huojun Zhang|86-021-31162207|chyyzhj@163.com|
21302069|NCT01235598|UCB|UCB Clinical Trials Call Center|+1 877 822 9493||
21302070|NCT02551991|Ipsen Bioscience, Inc.|Medical Director|see email|clinical.trials@ipsen.com|
21302071|NCT00395343|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21302072|NCT05525078|Medical University of South Carolina|Tracy Smith, PhD|843 792 5164|smithtra@musc.edu|
21302073|NCT02507960|University of Maryland Medical Center|Elizabeth Nichols|4103287586|enichols1@umm.edu|
21302074|NCT00942994|Novartis Pharmaceuticals|Study Director|862-778-8300||
21302075|NCT00387790|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
21302076|NCT00296296|Stanford University|Stephan Busque, MD|650-498-6189|sbsuque@stanford.edu|
21302077|NCT03029988|Navidea Biopharmaceuticals|Bonnie Abbruzzese Senior Director|614.793.7500|babbruzzese@navidea.com|147
21302078|NCT03539549|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
21302079|NCT02191865|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
21302080|NCT03598114|Washington University School of Medicine|Sarah Moreland-Russell, Ph.D., MPH|314-935-8382|smoreland-russell@wustl.edu|
21302081|NCT02527200|Novo Nordisk A/S|Clinical Transparency and Medical Writing Office (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21302082|NCT04540198|Baylor Scott & White Health Research Institute|Dr. Alan Stevens|254-215-9885|alan.stevens@bswhealth.org|
21302083|NCT03110770|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
21302084|NCT00260962|Ottawa Hospital Research Institute|Dr. Hany Bissada|613-798-5555|hbissada@ottawahospital.on.ca|78042
21302085|NCT01179113|Cedars Sinai Medical Center|Dr. Roya Yumu', Anesthesiology Program Director|310-423-1682|Roya.Yumul@cshs.org|
21302086|NCT01996839|Bausch Health|Study Director||susan.harris@bauschhealth.com|
21302087|NCT02082340|American University of Armenia|Dr. Harutyunyan||aharutyunyan@aua.am|
21302088|NCT01625260|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
21302089|NCT04195893|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
21302090|NCT02745145|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21302091|NCT04413617|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21302092|NCT00775593|GIMEMA|Edoardo La Sala|+39 06 70390524|e.lasala@gimema.it|
21302093|NCT03152929|Spectrum Health|Marianne Melnik|616-486-6333|marianne.melnik@corewellhealth.org|
21302094|NCT02511106|AstraZeneca AB|Global Clinical Leader|+447920183730|ClinicalTrialTransparency@astrazeneca.com|
21273193|NCT02870920|Canadian Cancer Trials Group|Chris O'Callaghan|6135336430|cocallaghan@ctg.queensu.ca|
21273194|NCT02794974|HELIOS Medical Center Schwerin, Germany|Ronald Seidel|+49 385 5204251|ronald.seidel@helios-kliniken.de|
21273195|NCT05194722|Washington University School of Medicine|Abby Cheng, MD, PI|314-747-2823|chengal@wustl.edu|
21273196|NCT01873586|SeaSpine|Director Clinical Affairs||tish.mikoczi@seaspine.com|
21273197|NCT02202850|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21273198|NCT00615069|W.L. Gore and Associates|Jennifer Gorman|928 864 3381|jgorman@wlgore.com|
21273199|NCT00669942|Novartis|Study Director|862-778-8300||
21273200|NCT04056182|New York State Psychiatric Institute|Frances R Levin, MD|6467746137|frances.levin@nyspi.columbia.edu|
21273201|NCT00581971|UAB Hospital|Dr. Sharon Spencer Professor of Radiation Oncology|205-934-2762|sspencer@uabmc.edu|
21273202|NCT01789905|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21273203|NCT02549092|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21273204|NCT01390233|University of Arizona (Investigator has changed institutions - study completed at University of South Carolina)|Meg Hill, MBBS|520 626 6174|meghanhill@obgyn.arizona.edu|
21273205|NCT03959683|INDIANA UNI SCHOOL OF MEDICINE|Erica Sahm|317-274-3560|esahm@iuhealth.org|
21273206|NCT03002077|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
21259899|NCT01719757|Suyoun Yang|CR head|82-2-527-9219|suyoun.yang@mundipharma.co.kr|
21259900|NCT02626338|AROG Pharmaceuticals Inc.|Edward McDonald|214-593-0500|emcdonald@arogpharma.com|
21259901|NCT01099111|KFMC|Dr. Ahmed Al Omair|+96612889999|aalomair@kfmc.med.sa|8771
21259902|NCT03312218|McGill University|Dr. Roland Grad|514-947-3718|roland.grad@mcgill.ca|
21259903|NCT01901224|Brigham and Women's Hospital|Mark A. Creager, MD|603-650-8283|mark.a.creager@hitchcock.org|
21259904|NCT01910792|Vitamin D, Skin, and Bone Research Laboratory|Dr. Michael F Holick|6176384546|mfholick@bu.edu|
21259905|NCT06415305|Sun Pharmaceutical Industries Limited|Head-Regulatory Affairs|2266455645|Clinical.Trial@sunpharma.com|5689
21259906|NCT01254669|Boston Medical Center|Dr. Natalie Joseph|1-617-414-5202|napierre@bu.edu|
21259907|NCT00103012|National Institutes of Health, Clinical Center, Department of Pharmacy|Scott Penzak|301-496-2997|spenzak@cc.nih.gov|
21259908|NCT03051633|Colorado State University|Dr. Meghan Crabtree|2105875584|meghan.crabtree@colostate.edu|
21259909|NCT05211336|National Cancer Institute|Dr. Mark J. Roschewski|240-760-6183|mark.roschewski@nih.gov|
21259910|NCT01834235|Precision Biologics Inc.|Dr. Philip Arlen President and CEO|3015008646|philip.arlen@precision-biologics.com|
21259911|NCT01790490|NYSPI|Elias Dakwar, MD|(646) 774-8728|dakware@nyspi.columbia.edu|
21259912|NCT00393718|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21259913|NCT04271761|Cochlear|Ruth English|0386633105|REnglish@cochlear.com|3105
21259914|NCT01084551|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
21259915|NCT03902080|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
21259916|NCT04684420|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49 6151 72 5200|service@emdgroup.com|
21259917|NCT00463476|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
21287236|NCT01190891|Madigan Army Medical Center|Troy Patience, Research Operations Service|(253) 968-1160|usarmy.jblm.medcom-mamc.mbx.dci@mail.mil|
21287237|NCT00737048|JANSSEN PHARMACEUTICAL. K.K. , Neuroscience Department, Clinical Science Division|Medical Director|+81-3-4411-5509||
21287238|NCT04635839|University of California, Los Angeles|Dr. Thalia Mok|310-794-7274|tmok@mednet.ucla.edu|
21287239|NCT02737358|Medical University of South Carolina|Erin A. McClure, Ph.D.|843-792-7192|mccluree@musc.edu|
21259918|NCT04226469|University of Illinois Chicago|Phimon Atsawasuwan|3124132651|patsawas@uic.edu|
21259919|NCT01703000|Boston Scientific|Peter Maurer, Director Clinical Trials|508-683-6678|Peter.Maurer@bsci.com|
21259920|NCT00434967|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
21259921|NCT03502187|University of Tennessee Health Science Center|Dr. Laura Talbot|901-448-3630|ltalbot@uthsc.edu|
21259922|NCT02913313|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21259923|NCT01841619|UC Irvine Dermatology Research Center|Sergei A. Grando|949 824 7103|sgrando@uci.edu|
21259924|NCT04276207|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21287240|NCT02280252|NYU Langone Health|Dr. Nelly Huppert|(212) 731-5003|Nelly.Huppert@nyulangone.org|
21287241|NCT03238417|VA Greater Los Angeles Healthcare System|Elizabeth M. Yano, PhD, MSPH|818-891-7711|elizabeth.yano@va.gov|36031
21287242|NCT01206465|University of Nebraska Medical Center|Jean L Grem|402-559-5166|jgrem@unmc.edu|
21287243|NCT02461693|University of Alabama at Birmingham|Dr. David Allison, PI|205-975-9169|dallison@uab.edu|
21287244|NCT03439137|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608 Japanese only|cti-inq-ml@ml.mt-pharma.co.jp|
21287245|NCT00106002|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21273207|NCT02495467|Richmond Pharmacology Limited|Dr Jorg Taubel|020 8664 5200|j.taubel@richmondpharmacology.com|
21238312|NCT06821412|Liberating Technologies, Inc.|Jen Johansson|774-233-0874|jen.johansson@liberatingtech.com|
21273208|NCT03611608|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21273209|NCT04625114|University Hospital Ghent|Dr Marie-Angélique De Scheerder|+32 9 33 21349|marie-angelique.descheerder@uzgent.be|
21273210|NCT02359305|Nationwide Children's Hospital - Dept. of Anesthesiology & Pain Medicine|Dr. Arlyne Thung|614-722-4200|Arlyne.Thung@nationwidechildrens.org|
21273211|NCT01390844|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21273212|NCT00076050|University of Miami|Silvina Levis MD|305-575-3388|slevis@med.miami.edu|
21273213|NCT02980978|Minneapolis Heart Institute Foundation|Population Health Program Manager|612-863-4222|gbenson@mhif.org|
21273214|NCT03048500|Northwestern University|Young Chae, MD|312-695-1301|young.chae@northwestern.edu|
21273215|NCT04166032|Cleveland Clinic|Kimberly Jenkins, Research Administrator|216-445-4791|jenkink@ccf.org|
21273216|NCT03018249|NRG Oncology|Linda Gedeon for Virginia Filiaci, PhD|716-845-1169|linda.gedeon@roswellpark.org|
21273217|NCT00860314|University Hospital Hamburg-Eppendorf, Heart Center|Tim Risius, MD|+49-40-42803|risius@uke.uni-hamburg.de|4142
21273218|NCT02158936|Novartis Pharma AG|Study Director|862-778-8300||
21273219|NCT00522457|Fresenius Biotech North America|Manager of Regulatory Affairs|781-699-4652|bao.le@fresenius-biotech.com|
21273220|NCT00549718|Sunovion Pharmaceuticals Inc.|Josephine Cucchiaro|201-592-2050|josephine.cucchiaro@sunovion.com|
21273221|NCT02424097|UCSF - School of Dentistry|Dr. Peter Rechmann|415 514 3225|Peter.Rechmann@ucsf.edu|
21273222|NCT02880761|Continuous Quality Improvement Experts Congress of Changping District|Director of Continuous Quality Improvement Experts Congress of Changping District|+861069006549|zhangdongliang@pkuih.edu.cn|1069006789
21273223|NCT03597256|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
21273224|NCT02106156|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21273225|NCT01136382|AstraZeneca|Geoff Gilmartin||ClinicalTrialTransparency@astrazeneca.com|
21273226|NCT00963482|Divsion Substance Use Disorder, Psychiatric Hospital of the Univeristy of Basel|M. Sc. S. Müller (Site-investigator) Prof. G. A. Wiesbeck (PI)|+41 61 325 53 33|sandra.mueller@upkbs.ch|
21273227|NCT02562378|Medica Scientia Innovation Research (MEDSIR)|Scientific director|+34 93 221 41 35|trialsregister.medsir@medsir.org|
21273228|NCT04503603|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21273229|NCT01725529|Janssen R&D US|ASSOCIATE DIRECTOR, MEDICAL DEPARTMENT||ClinicalTrialDisclosure@its.jnj.com|
21273230|NCT01104025|Cincinnati Children's Hospital Medical Center|Michael Jordan, MD|513-803-9063|Michael.Jordan@cchmc.org|
21273231|NCT00746798|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21273232|NCT00878878|GE Healthcare|Ruben Sheng, M.D.|1-609-514-6899|Rubin.Sheng@ge.com|
21273233|NCT00633594|Sarah Cannon Research Institute|Ian Flinn, MD|1-877-691-7274|asksarah@scresearch.net|
21273234|NCT02055963|UT MD Anderson Cancer Center|Dr. Juan P. Cata, MD-Associate Professor, Anesthesiology & PeriOper Med|(713) 792-7452|jcata@mdanderson.org|
21273235|NCT02028715|Aultman Hospital|Director of Research Programs|330-363-7274|mary.amos@aultman.com|
21273236|NCT04915755|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21273237|NCT02091882|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21273238|NCT03655106|William Beaumont Hospitals|Amit Bahl, MD|2488982245|amit.bahl@beaumont.edu|
21273239|NCT01191320|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com|
21273240|NCT00727571|Amgen Inc.|Study Director|866-572-6436||
21273241|NCT02189941|ApoPharma Inc.|Fernando Tricta, MD|416-401-7332|ftricta@apopharma.com|
21273242|NCT00358449|GlaxoSmithKline|GSK Response Center|866-435-7343||
21273243|NCT01804270|Mayo Clinic|Paul E. Croarkin, D.O., M.S.|507-293-2557|Croarkin.Paul@mayo.edu|
21273244|NCT02188303|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21273245|NCT02589808|Imperial College|Petros Nihoyannopoulos|020 3311 3311|p.nihoyannopoulos@imperial.ac.uk|
21273246|NCT04206332|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
21273247|NCT02334722|University of Florida|Kristine Wynne|352-273-9727|kristine.wynne@neurosurgery.ufl.edu|
21273248|NCT01644058|Université de Montréal|Elham Emami, DDS, MSc, PhD|514-343-6111|elham.emami@umontreal.ca|6053
21273249|NCT00840099|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21273250|NCT00856388|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21273251|NCT00705003|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|mfava@partners.org|
21273252|NCT02017964|Children's Oncology Group|Results Reporting Coordinator|626-446-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21273253|NCT01171690|Mayo Clinic|Marius Stan, MD|507-284-2463|stan.marius@mayo.edu|
21273254|NCT01038856|University of Oklahoma|Research Regulatory Specialist III|405-271-8777|sharon-ross@ouhsc.edu|48394
21273255|NCT00193037|Sarah Cannon Research Institute|John D. Hainsworth, MD|615-329-7274|jhainsworth@tnonc.com|
21273256|NCT02300103|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21273257|NCT04091971|NYSPI|Jeffrey Miller, M.D.|646-774-7613|jeffrey.miller@nyspi.columbia.edu|
21273258|NCT01391793|UPMC Children's Hospital of Pittsburgh|Nader Shaikh, MD, MPH|412-692-8111|nader.shaikh@chp.edu|
21238313|NCT03419364|University of North Carolina at Chapel Hill|Kim Boggess, MD|919-966-1601|kboggess@med.unc.edu|
21238314|NCT02073461|Galderma K.K.|Clinical Project Manager|+81 3 5937 3850|GaldermaKK.ClinDev@galderma.com|
21273259|NCT00150462|Amgen, Inc.|Study Director|866-572-6436||
21273260|NCT01212874|Loma Linda University Anesthesiology|Patricia Moore|1-909-558-4475|pamoore@llu.edu|
21287246|NCT01997125|The Ohio State University|Marcia Bockbrader MD PhD|6142937604|bockbrader.13@osu.edu|
21273261|NCT01666730|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. David Bajor|1-800-641-2422|CTUReferral@UHhospitals.org|
21273262|NCT04638153|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21273263|NCT02829268|Washington University School of Medicine, Department of Medicine, Division of Endocrinology|Fumihiko Urano, MD, PhD|314-362-8683|urano@wustl.edu|
21273264|NCT01440283|St. Jude Children's Research Hospital|Chia-ho Hua, PhD|901-595-3610|chia-ho.hua@stjude.org|
21273265|NCT01449630|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21273266|NCT03553823|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21273267|NCT03340727|RTI International|Abhik Das|301-770-8214|adas@rti.org|
21273268|NCT01389102|KV Pharmaceutical Company|Jim Joffrion|314-645-6600|jjoffrion@kvph.com|3410
21273269|NCT01878825|GlaxoSmithKline|GSK Response Center|866-435-7343||
21273270|NCT01661686|Erasmus University Medical Center|Dr. V.M.C.W. Spaander|0031 10 703 5643|v.spaander@erasmusmc.nl|
21273271|NCT00784823|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|Joshua.Zenreich@hmhn.org|
21273272|NCT04869787|Cincinnati Children's Hospital Medical Center|Dr. Stuart L.Goldstein|513-636-4837|stuart.goldstein@cchmc.org|
21273273|NCT00454909|GlaxoSmithKline|GSK Response Center|866-435-7343||
21273274|NCT02996682|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21273275|NCT01981720|Protalix Ltd.|Sari Alon MSc|+972-4-9028100|sari@protalix.com|215
21273276|NCT00282048|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21273277|NCT02703948|Galderma R&D, LLC|US A&C Clinical Operations|8179615111|courtney.maguire@galderma.com|
21273278|NCT00259012|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21273279|NCT03522675|NeXtGen Biologics, Inc|Dayna Healy|352-215-9961|Dhealy@nextgenbiologics.com|
21287247|NCT04896216|University of Minnesota|Kumi Smith|612.301.3051|smi00831@umn.edu|
21287248|NCT01329198|University of Florida Center for Movement Disorders & Neurorestoration|Assistant Director of Clinical Trials|352-294-5000|stacy.merritt@neurology.ufl.edu|
21302095|NCT01015638|GlaxoSmithKline|GSK Response Center|88-435-7343||
21273280|NCT00707161|Huntsman Cancer Institute|Dennis Shrieve, MD|801-581-8793|dennis.shrieve@hci.utah.edu|
21302096|NCT00984620|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21302097|NCT04296448|Johns Hopkins University Department o Peidaitrics Division of Pediatric Emergency Medicne|Dr. Therese Canares|(410) 955-6146‬|therese.canares@jhmi.edu|
21302098|NCT00947167|Stanford University School of Medicine|Pamela L. Kunz, MD, Leader GI Oncology Research Group|650-725-8738|pkunz@stanford.edu|
21302099|NCT00324961|GlaxoSmithKline|GSK Response Center|866-435-7343||
21302100|NCT00344487|University of Maryland Institute of Human Virology|Charles E. Davis, Jr. MD|410-706-1684|cdavis@ihv.umaryland.edu|
21302101|NCT01719744|Princess Margaret Cancer Centre|Dr. ALBIRUNI RAZAK|416-586-4800|Albiruni.Razak@uhn.ca|5371
21302102|NCT05854784|CLINUVEL UK LTD|Director, Global Clinical Affairs|+4401372860765|mail@clinuvel.com|
21302103|NCT01703754|Alaunos Therapeutics|Jaymes Holland|6502732627|jholland@alaunos.com|
21302104|NCT05487196|UPMC Magee Women's Hospital|Dr. Grace Lim, MD, MSc|412-641-1778|limkg2@upmc.edu|
21302105|NCT01459497|University of Texas Southwestern Medical Center|Dr. Puneeth Iyengar|214-645-7603|puneeth.iyengar@utsouthwestern.edu|
21302106|NCT03530124|Duke University|Dr. Rachel Greenberg|919 668 4725|rachel.greenberg@duke.edu|
21302107|NCT05188053|Mayo Clinic|Gabriel Schouten - Clinical Research Coordinator|507-266-5895|schouten.gabriel@mayo.edu|
21302108|NCT00794313|Oregon Health & Science Universtiy|Kathyrn Chung MD|503 721 - 1091|chungka@ohsu.edu|
21302109|NCT02379637|Novartis|Dr Marianna Armogida Director Clinical Research Innovation|+41223635182|marianna.armogida@novartis.com|
21302110|NCT03686007|City of Hope Medical Center|Dr. Virginia Sun|626-359-8111|VSun@coh.org|
21273281|NCT02674477|Johns Hopkins University|Dr. Alexis Hammond|410-550-0045|ahammon9@jhmi.edu|
21302111|NCT03849118|Telix Pharmaceuticals (Innovations) Pty Ltd|Dr. Kavita Vadali, Sr. Clinical Project Manager|+1 919-924-8887|kavita.vadali@telixpharma.com|
21302112|NCT06057727|University of Pennsylvania|Dr. Shivan Mehta|2679726027|shivan.mehta@pennmedicine.upenn.edu|
21302113|NCT01561313|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21302114|NCT04535453|Janssen Vaccines & Prevention B.V.|SENIOR ADVISOR CLINICAL DEVELOPMENT|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21302115|NCT04449263|CooperVision, Inc|Jose Vega, OD, MSc, FAAO|9256402964|javega2@coopervision.com|
21302116|NCT01742286|Study Director|Study Director|862-778-8300|novartis.email@novartis.com|
21302117|NCT02878798|Virginia Commonwealth University|Dr. A. Gordon Smith|801-828-9869|gordon.smith@vcuhealth.org|
21302118|NCT01309282|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21302119|NCT02087423|AstraZeneca|Phillip Dennis, MD, PhD|+1 301 398-5549|ClinicalTrialTransparency@astrazeneca.com|
21302120|NCT01387542|Janssen-Cilag Ltd.: 106 Moo 4 Lad Krabang Industrial Estate, Chalongkrung Rd., Lamplatew, Lad Krabang, Bangkok 10520|Medical Affairs Director|+66 2 7397200||5888
21273282|NCT04005859|Atrium Health|Dr. Kevin Kasten|704-355-1813|kevin.kasten@atriumhealth.org|
21273283|NCT01954264|GlaxoSmithKline|GSK Response Center|866-435-7343||
21273284|NCT02511782|Cincinnati Children's Hospital Medical Center|Pooja Khandelwal, MD|513-803-4762|Pooja.Khandelwal@cchmc.org|
21273285|NCT01173692|UT MD Anderson Cancer Center|Brandon Gunn, MD/ Associate Professor, Radiation Oncology Department|(713) 563-2562|gbgunn@mdanderson.org|
21273286|NCT03287310|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|1
21273287|NCT01479439|Cincinnati Children's Hospital Medical Center|Dr. Charles Quinn|5138033086|charles.quinn@cchmc.org|
21273288|NCT01884740|Weill Cornell Medicine|Jeffery Greenfield, MD PhD|212-746-2363|jpgreenf@med.cornell.edu|
21273289|NCT00113425|University of Michigan Dept of Dermatology|Dr. Jeffrey Orringer|734-936-4075|jorringe@umich.edu|
21273290|NCT00870870|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21273291|NCT01215981|Masonic Cancer Center, University of Minnesota|Michael Verneris, M.D.|612-626-2961|verneris@umn.edu|
21273292|NCT04657770|UCLA|Steve Cramer|424-522-7273|SCCramer@mednet.ucla.edu|
21273293|NCT03497897|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@novartis.com|
21273294|NCT02962934|University of Queensland Center for Clinical Research|Professor Jason Roberts|+61 7 334 65032|j.roberts2@uq.edu.au|
21273295|NCT01471093|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21273296|NCT01710657|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
21273297|NCT03334825|New York City Department of Health and Mental Hygiene|Dr. Ellen Wiewel|347-396-7653|ewiewel@health.nyc.gov|
21273298|NCT00978822|Albany Medical Center|Panayiotis Varelas|2488739855|varelap@amc.edu|
21273299|NCT05087524|University of Wisconsin - Madison|Dr. Ellen Wald|(608) 263-8558|erwald@pediatrics.wisc.edu|
21273300|NCT00546897|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
21273301|NCT01297348|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21273302|NCT01367457|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|001
21273303|NCT02495857|Teva Pharmaceuticals Inc. USA|Senior Director, Clinical R&D|1-888-483-8279|USMedinfo@tevapharm.com|
21273304|NCT04407806|William Beaumont Hospital|Dr. Graham Krasan, Pediatric Infectious Disease Specialist|248-551-0046|graham.krasan@beaumont.org|
21273305|NCT03447262|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21273306|NCT02058498|Mayo Clinic Jacksonville|Jennifer Serotta, DNP, ARNP|904-956-3200|serotta.jennifer@mayo.edu|
21273307|NCT05327491|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21273308|NCT05612724|Rutgers School of Dental Medicine, Newark, New Jersey, United States|Gayathri Subramanian, PhD, DMD|732 824 7241|subramga@sdm.rutgers.edu|
21273309|NCT01969747|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21273310|NCT03112863|UC Davis Dermatology|Iryna Rybak|916-551-2636|irybak@ucdavis.edu|
21273311|NCT04000815|Dr.Ali Cenk Ozay|Dr.Ali Cenk Ozay|00905428583248|dr.alicenk@hotmail.com|
21273312|NCT00239577|GlaxoSmithKline|GSK Response Center|866-435-7343||
21273313|NCT02631772|Medical University of South Carolina|Dr. Derek Dubay|843-792-3368|dubay@musc.edu|
21273314|NCT02422264|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21273315|NCT00603187|University of Washington|Dr. John K. Amory|206.616.1727|jamory@u.washington.edu|
21273316|NCT03021018|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21273317|NCT01032083|Imperial College London|Professor Thomas Barnes||t.r.barnes@imperial.ac.uk|
21273318|NCT01173211|Baylor College of Medicine|Shital M. Patel, M.D.|713-798-3793|shitalp@bcm.edu|
21273319|NCT02016612|Bengtson Center|Dr Bradley Bengtson|616 588 8880|drb@bengtsoncenter.com|
21273320|NCT00050778|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21273321|NCT01536574|GlaxoSmithKline|GSK Response Center|866-435-7343||
21273322|NCT00834756|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21273323|NCT00656305|InSightec|Nadir Alikacem|214-630-2000|nadira@insightec.com|
21273324|NCT02193165|Colgate Palmolive|William Devizio|732-878-7901|william_devizio@colpal.com|
21273325|NCT00579670|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21273326|NCT00986245|Seoul National University Hospital|BS Jeon|82-2-2072-2876|brain@snu.ac.kr|
21273327|NCT01157091|City of Hope|Dr. Sumanta Pal|626-359-8111|SPal@coh.org|
21273328|NCT01941030|Cardiovascular Systems, Inc.|Clinical Trials Manager|651.259.2500|clinicaltrials_csi@csi360.com|
21273329|NCT00360360|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-MY-1-SCRI|asksarah@scresearch.net|
21273330|NCT02597101|Allegheny Health Network|Dr. Nick Giannoukakis|412-359-6394|nick.giannoukakis@ahn.org|
21273331|NCT01722877|Midwest Cardiovascular Research Foundation|Dr Nicolas W Shammas|5633200263|shammas@mchsi.com|
21273332|NCT03693430|Novo Nordisk A/S|Clinical Reporting Office (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21273333|NCT00585689|University of Michigan Comprehensive Cancer Center|Dr. David Smith, M.D.|734-936-6884|dcsmith@umich.edu|
21273334|NCT00985257|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
21273335|NCT02930005|The University of Texas Health Science Center at Houston|Dr. Olaoluwa O. Okusaga|(713) 741-3952|Olaoluwa.O.Okusaga@uth.tmc.edu|
21273336|NCT02373098|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email.@novartis.com|
21273337|NCT05067647|Ethicon Endo-Surgery, Inc.|MEDICAL DIRECTOR LCM Compliance|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21273338|NCT03252353|Chiasma|Asi Haviv, VP Clinical development|972-8-939-3888|Asi@chiasmapharma.com|
21273339|NCT01313416|Georgetown University|Dr. Samir Khleif|(202) 687-0100|snk48@georgetown.edu|
21273340|NCT00487669|Dartmouth-Hitchcock Medical Center|James Rigas, MD|603-650-6344|james.r.rigas@hitchcock.org|
21273341|NCT01918800|Portland VA Medical Center|Cinda Hugos|503-220-8262|hugosc@ohsu.edu|52338
21273342|NCT03639311|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21273343|NCT01874756|Indiana University|Dr. Alan Breier|3178808495|abreier@iupui.edu|
21273344|NCT01853553|University of Colorado|Dr. Michel Chonchol|303-724-7796|Michel.Chonchol@ucdenver.edu|
21273345|NCT00855738|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21273346|NCT03151057|Northwell Health Cancer Institute|Dr. Douglas Gladstone|(516) 734-8900|msteve35@jhmi.edu|
21273347|NCT04881968|The Dartmouth Institute|Dr. Amber Barnato|603-646-5237|amber.barnato@dartmouth.edu|
21273348|NCT00304083|SARC|Research Project Manager|734-930-7600|sarc@sarctrials.org|
21273349|NCT03929393|University of Minnesota|Brent Leininger|(612) 626-6477|lein0122@umn.edu|
21273350|NCT01320696|Resilience Inc.|Wael El-Amin, M.D.|(240)885-1221|Wael.el-amin@resilience.com|
21273351|NCT03883607|Genfit SA|Clinical Head|+33320164000|clinicaltrial@genfit.com|
21273352|NCT01023074|Portland VA Medical Center|Robert Folmer, Ph.D.|503-220-8262|Robert.Folmer@va.gov|51868
21287249|NCT01122173|Auris Health, Inc.|Emir Deljkich/Sr. Director, Clinical Affairs|650-397-2677|emir.deljkich@aurisrobotics.com|
21287250|NCT02265510|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21287251|NCT02530385|Massachusetts General Hospital Endocrine Unit|Dr. Elaine Yu|617-726-6723|ewyu@mgh.harvard.edu|
21287252|NCT03613493|University of Miami|Dr. Susan Morgan|7654094919|semorgan@miami.edu|
21287253|NCT00116142|Dana Farber Cancer Institute|Anthony D'Amico|617.732.6310|ADAMICO@LROC.HARVARD.EDU|
21287254|NCT00644059|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21287255|NCT02133508|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21302121|NCT03601117|Stanford University|Dr Nolan Williams|(650)800-6920|nolanw@stanford.edu|
21302122|NCT01761240|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21302123|NCT01233232|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21302124|NCT02762370|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
21302125|NCT00268853|Institut de Recherches Internationales Servier|Anton Egorov, Associate Project Director Clinical Development|+33 1 55 72 31 94|anton.egorov@servier.com|
21302126|NCT02917122|National Cheng Kung University|Dr. Kao Chin Chen|+886-6-2353535|andchen@mail.ncku.edu.tw|5213
21273353|NCT00694551|H. Lee Moffitt Cancer Center and Research Institute|Mayer Fishman, M.D., Ph.D.|813-745-4398|mayer.fishman@moffitt.org|
21273354|NCT03486990|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21273355|NCT01874951|Depression Clinical and Research Program, Massachusetts General Hospital|David Mischoulon, MD, PhD, Director of Research|617-724-5198|dmischoulon@partners.org|
21273356|NCT01569152|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinialTrialsDisclosure@merck.com|
21273357|NCT03262012|AstraZeneca|Paul M. Dorinsky, MD|1-877-240-9479|information.center@astrazeneca.com|
21287256|NCT04081688|Cancer Institute of New Jersey Rutgers|Dr. Jabbour|732-757-9840|jabbousk@cinj.rutgers.edu|
21287257|NCT01026493|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21287258|NCT00514618|MemorialCare Health Services LBMC|Lorna Camfield, Research Compliance Analyst|714-377-3227|lcamfield@memorialcare.org|
21287259|NCT00000575|Johns Hopkins Bloomberg School of Public Health, Dept of Epidemiology|Alice Sternberg|410-955-3752|asternbe@jhsph.edu|
21287260|NCT03871556|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
21287261|NCT00072449|Johns Hopkins University|Dr. Stuart A Grossman|410-955-3657|jfisher@jhmi.edu|
21287262|NCT03167242|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21287263|NCT03786380|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21287264|NCT02414698|Montefiore Medical Center|Sayed E Wahezi, MD|7189207246|swahezi@montefiore.org|
21287265|NCT01038687|Mayo Clinic|Michael Camilleri, MD|507-266-2305|camilleri.michael@mayo.edu|
21287266|NCT05401565|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21287267|NCT02984982|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21287268|NCT02343224|Emory University|Dolly Aguilera MD|404-785-3515|Dolly.Aguilera@choa.org|
21287269|NCT02175121|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21287270|NCT02037893|Pernix Therapeutics|Senior Director, Medical and Scientific Affairs|8007932145|egould@pernixtx.com|
21287271|NCT00931632|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
21287272|NCT01419314|Texas Woman's University|Roberto Sandoval PT|713-859-9351|rsandoval@mail.twu.edu|
21287273|NCT01328964|GlaxoSmithKline|GSK Response Center|866-435-7343||
21287274|NCT03139552|University of Colorado Anschutz Health and Wellness Center|John C. Peters, PhD|303-724-9160|john.c.peters@ucdenver.edu|
21287275|NCT02236000|NSABP Foundation, Inc.|Judy Langer, Director of Regulatory Affairs|412-339-5300|judy.langer@nsabp.org|
21287276|NCT01754519|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21287277|NCT00944710|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
21287278|NCT01085643|Cedars-Sinai Medical Center|Edy Soffer, MD|(310) 423-6143|edy.soffer@cshs.org|
21287279|NCT00887484|GlaxoSmithKline|GSK Response Center|888-435-7343||
21287280|NCT00381628|Riley Hospital for Children|Dr. James Chmiel|317-948-7180|jfchmiel@iu.edu|
21287281|NCT04054544|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21287282|NCT03044314|Duke University Medical Center|Richard Krasuski|919-681-6195|richard.krasuski@duke.edu|
21287283|NCT03122171|Rutgers-New Jersey Medical School|Alice Chu, MD|(973) 972-2076|chual@njms.rutgers.edu|
21287284|NCT01316224|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21287285|NCT00264147|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21287286|NCT03234465|Oragenics, Inc.|Dr. Alan Jolyn|+ 1 813-286-7900|info@oragenics.com|
21287287|NCT00465530|University of Kansas Medical Center|Dr. Julie Wei|(913) 588-6664|jwei@kumc.edu|
21287288|NCT00449163|UM/Sylvester Comprehensive Cancer Center|Bach Ardalan MD|305-243-4909|bardalan@med.miami.edu|
21287289|NCT00541242|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21287290|NCT00597272|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646-888-4162|chapmanp@mskcc.org|
21287291|NCT00628407|Children's Hospital of Philadelphia|Vinay Nadkarni, MD|215-590-7430|nadkarni@email.chop.edu|
21287292|NCT03368807|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21287293|NCT01035749|GlaxoSmithKline|GSK Response Center|866-435-7343||
21287294|NCT00948090|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21287295|NCT02845674|Sun Pharma Advanced Research Company Limited|SPARC|+912266455645|Clinical.Trials@Sparcmail.com|
21287296|NCT02139397|Beat Childhood Cancer|Giselle Sholler, MD|7175310003|gsaulniersholler@pennstatehealth.psu.edu|
21287297|NCT00369343|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21287298|NCT02247466|Department of Anaesthesiology, Herlev Hospital, University of Copenhagen|Roar Borregaard Medici, MD, Research Assistant|+4526390068|roar.borregaard.medici.01@regionh.dk|
21287299|NCT04356937|Massachusetts General Hospital|DRAI Director of Clinical Trials|617-726-7938|JHSTONE@mgh.harvard.edu|
21287300|NCT00617279|W. L. Gore & Associates, Inc.|Chad Badorek, Clinical Study Manager|928.864.3486|cbadorek@wlgore.com|
21287301|NCT02351934|Mayo Clinic|Ilya Danelich, Pharm.D., R.Ph.|507-255-5732|Danelich.Ilya@mayo.edu|
21287302|NCT02683109|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21287303|NCT01115452|GlaxoSmithKline|GSK Response Center|866-435-7343||
21287304|NCT03159143|University of Pittsburgh|Leonard Appleman, MD|412-648-6538|applemanlj@upmc.edu|
21287305|NCT03312738|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
21287306|NCT01130844|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21287307|NCT00612235|Beth Israel Deaconess Medical Center|Andrew G. Herzog M.D., M.Sc.|781-431-0277|aherzog@bidmc.harvard.edu|
21287308|NCT02669849|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21287309|NCT03408899|Johns Hopkins University|Craig Hendrix, MD|4109559707|chendrix@jhmi.edu|
21287310|NCT00606008|H. Lee Moffitt Cancer Center and Research Institute|Dr. Edward Pan|813-745-3871|edward.pan@moffitt.org|
21287311|NCT04745351|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21302127|NCT03574181|Boston Medial Center|Dr. Eric Devine|617-638-7888|eric.devine@bmc.org|
21302128|NCT03632954|Integra LifeSciences|Allison Matthews|(443) 766-3869|allison.matthews@integralife.com|
21302129|NCT01708902|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21302130|NCT00442364|BTG International Inc|David DI Wright MB BS|610-278-1660|david.wright@btgplc.com|
21273358|NCT01096290|University of South Alabama|Jack DiPalma, MD|251-660-5555|jdipalma@health.southalabama.edu|
21273359|NCT02228174|Gynesonics|Taraneh G. Farazi, Ph.D. (Vice President, Clinical Affairs)|650-216-3878|tfarazi@gynesonics.com|
21273360|NCT02682602|University of Tennessee|Richard Komistek, Principal Investigator|8659742093|rkomiste@utk.edu|
21273361|NCT03921294|Indiana Hemophilia & Thrombosis Center|Kat Molitor|3178710011|kmolitor@ihtc.org|
21273362|NCT04257474|Moffitt Cancer Center|Susan T. Vadaparampil, PhD, MPH|813-745-1997|Susan.Vadaparampil@moffitt.org|
21273363|NCT00374335|Children's Mercy Hospitals and Clinics|Dr. Kimberly Horii|816-234-3924|kahorii@cmh.edu|
21273364|NCT00377260|Children's Hospital of Pittsburgh of UPMC|Efficacy of Antimicrobials in Young children with Acute Otitis Media|412-692-5249|Hoberman@chp.edu|
21273365|NCT01015625|ABCSG (Austrian Breast & Colorectal Cancer Study Group)|Trial Office Director|+43 1 4089230|info@abcsg.at|
21273366|NCT00569374|University of Arkansas for Medical Sciences Center for Addiction Research|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu|
21273367|NCT03021538|Cleveland Clinic|Michael Tong, M. D.|216-445-0807|tongz@ccf.org|
21273368|NCT01196052|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21273369|NCT03603314|Sensorion|Director of Regulatory Affairs|+33467207720|contact@sensorion-pharma.com|
21273370|NCT03450070|Johnson & Johnson Consumer Inc.|Heather Smith|908-874-1235|HSmith21@its.jnj.com|
21273371|NCT02910037|The University of California, San Francisco|Dr. Charles Chiu|(415) 514-8219|charles.chiu@ucsf.edu|
21238315|NCT03188055|University of Wisconsin, Madison|Margaret Lee Schwarze, MD, MPP, FACS|(608) 265-2358|schwarze@surgery.wisc.edu|
21273372|NCT01035060|University of Florida|Dr. Thomas Buford|352-273-5918|tbuford@ufl.edu|
21238316|NCT03017079|THE SECOND AFFILIATED HOSPITAL ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE|Dr|18817821529|hm198699@126.com|
21238317|NCT03657277|University of Iowa|Nicole Brogden|3193358752|nicole-brogden@uiowa.edu|
21238318|NCT00566579|Department of OBGYN, Faculty of Medicine, Khon Kaen University, 40002, THAILAND|Bandit Chumworathayi|66818733327|bunchu@kku.ac.th|
21238319|NCT01774149|Norwegian Center for Integrated Care and Telemedicine|Dr. Stein Olav Skrøvseth|+4795805841|stein.olav.skrovseth@telemed.no|
21238320|NCT00657618|WRAIR|Roseanne A. Resnner, MD|301-295-6400|rose.resnner@us.armyh.mil|
21238321|NCT04120233|University of Kentucky|Dr. Linda J. Van Eldik|1-859-257-5566|linda.vaneldik@uky.edu|
21238322|NCT03764774|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21238323|NCT02287350|Depomed|Clinical Operations|510-744-8000|clinicaltrials@depomed.com|
21238324|NCT00861614|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21238325|NCT02259517|Duke University|Jonathan Posner, MD|1 919 684 2403|jonathan.posner@duke.edu|
21238326|NCT00551070|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
21238327|NCT00605202|Oulu University Hospital, Department of Internal Medicine|Janne Hukkanen|+358-8-315 6212|janne.hukkanen@oulu.fi|
21238328|NCT02276066|University of Florida Board of Trustees Contracts & Grants|Mark S. Segal|352-273-5357|segalms@medicine.ufl.edu|
21238329|NCT05050578|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21238330|NCT02243280|AbbVie|Global Medical Services|800-633-9110||
21238331|NCT03386032|The Procter & Gamble Company|Laurie Moulton, M.S., Statistical Group Scientist|+1-513-544-3636|moulton.lt@pg.com|
21238332|NCT01807156|Emory University|Bassel El-Rayes, MD|404-778-1900|bassel.el-rayes@emoryhealthcare.org|
21238333|NCT03276637|Baylor College of Medicine|Jill Robinson|7137985848|jill.robinson@bcm.edu|
21238334|NCT04082442|Johns Hopkins University|Thorsten Leucker, MD|410-502-0469|tleucke1@jhmi.edu|
21238335|NCT02710292|Alcon Japan Ltd.|Clinical Manager|1-888-451-3937|alcon.medinfo@alcon.com|
21238336|NCT03122119|Star Spine and Sports|Dr. Douglas Hemler, Prinical Investigator|3035701834|dhemler@starcolorado.com|
21238337|NCT02803125|VA Boston Healthcare System|Anica Pless Kaiser, PhD|857-364-5309|Anica.PlessKaiser@va.gov|
21238338|NCT01493687|Galderma R&D, LLC|Clinical Science Director|609-409-7701||
21238339|NCT00705133|UC Los Angeles|Rajan Saggar|310-206-6766|rsaggar@mednet.ucla.edu|
21238340|NCT03135535|Baylor College of Medicine|Prof.|17137987536|bijan.najafi@bcm.edu|
21238341|NCT02364180|The University of Toledo|Shashi Bhatt, MD|419-383-3556|Shashi.Bhatt@utoledo.edu|
21238342|NCT02323646|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21238343|NCT00521144|Memorial Sloan-Kettering Cancer Center|Dr. Lee Krug|646 888 4201|krugl@mskcc.org|
21238344|NCT02901626|Christiana Care Health System, Department of Obstetrics & Gynecology|Matthew Hoffman, MD, MPH|(302) 301-3350|mhoffman@christianacare.org|
21238345|NCT03687190|Changhua Christian Hospital|Chung-Min Chiu|*886-982-506-067|shongdiah@gmail.com|
21238346|NCT00659490|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21238347|NCT05674890|University of Iowa Hospitals and Clinics Department of Ophthalmology and Visual Sciences|Dr. Andrew Pouw|3193562928|andrew-pouw@uiowa.edu|
21238348|NCT01750879|Massachusetts General Hospital|Dr. Wayne Shreffler|617-726-6147|WSHREFFLER@mgh.harvard.edu|
21238349|NCT02421666|Center for Asian Health, Lewis Katz School of Medicine, Temple University|Dr. Grace X. Ma|2157078823|grace.ma@temple.edu|
21238350|NCT00338598|Yale University|Elizabeth Ralevski Assistant Professor of Psychiatry|+1 203-932-5711|elizabeth.ralevski@yale.edu|4282
21238351|NCT01226511|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21238352|NCT02579876|The Children's Hospital of Philadelphia|Jonathan Spergel|215 590 1000|spergel@email.chop.edu|
21238353|NCT02923739|M D Anderson Cancer Center|Dr. Anil Sood|713-745-5266|asood@mdanderson.org|
21238354|NCT00248781|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
21238355|NCT00677352|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21238356|NCT02182973|University of Louisville|Paula Radmacher|5028525532|paula.radmacher@louisville.edu|
21238357|NCT00948974|Drexel University|Evan Forman|215.553.7113|evan.forman@drexel.edu|
21238358|NCT01814748|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21238359|NCT01972529|Eisai Inc|Eisai Medical Services|1-888-274-2378|esi_medinfo@eisai.com|
21273373|NCT02015390|Texas Medical Branch, University of, Galveston|Study PI|409-747-5760|zgugala@utmb.edu|
21273374|NCT00064753|University of North Carolina at Chapel Hill|Dr. Myra Carpenter|9199429408|myra_carpenter@unc.edu|
21273375|NCT01346397|Boris Petrovsky research cener od surgery|Dr Michael Kaabak|+74992481344|kaabak@hotmail.com|
21273376|NCT02193880|University of Alabama at Birmingham|Tiffany D Hill|205-996-8023|tiffanydhill@uabmc.edu|
21273377|NCT01361048|UAB|Dr. Jane Schwebke|205-975-5665|schwebke@uab.edu|
21273378|NCT02914600|Galapagos NV|Galapagos Medical Information|+3215342900|medicalinfo@glpg.com|
21273379|NCT02457520|SPIL|Clinical Trials|912266455645|Clinical.Trials@sparcmail.com|
21287312|NCT01248416|Nemours Children's Clinic|Dr. Nelly Mauras|904-697-3674|nmauras@nemours.org|
21273380|NCT01772537|The Johns Hopkins University|Dr. Charles Brown|410-955-0994|cbrown@jhmi.edu|
21287313|NCT02014272|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21238360|NCT00939874|St Vincents Hospital|Professor Andrew Carr|+61 2 8382 3359|andrew.carr@svha.org.au|
21238361|NCT00053495|Emergent BioSolutions|Eddie Darton, Medical Director|240-631-3688|dartone@ebsi.com|
21238362|NCT02231177|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21238363|NCT01376323|GlaxoSmithKline|GSK Response Center|866-435-7343||
21238364|NCT04681729|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21238365|NCT02436811|Universidade Federal do Paraná|Dr Luciana Reichert Assunção Zanon|554133604025|lurassuncao@yahoo.com.br|
21238366|NCT02227875|Mylan, Inc.|Keri L. Vaughan, Director Global Clinical Operations, General Medicine||keri.vaughan@mylan.com|
21238367|NCT04209725|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
21287314|NCT03499795|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
21287315|NCT00547339|University of Texas Southwestern Medical Center Dallas|Dr. Robert Timmerman|214-645-8525|Robert.Timmerman@UTSouthwestern.edu|
21287316|NCT03736967|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21287317|NCT02369653|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21287318|NCT03587636|University of Minnesota|James Flaherty|612-625-7675|jflahert@umn.edu|
21287319|NCT01587885|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21287320|NCT01458587|DUSA Pharmaceuticals, Inc.|Anna Houlihan|9147608796|houlihana@dusapharma.com|
21287321|NCT01603602|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@Allergan.com|
21287322|NCT02209064|EpiEP|Pam Bunes CEO & Founder|+1 864 423 2526|pbunes@epiep.com|
21287323|NCT01040819|Baylor College of Medicine|Dr. Yochai Birnbaum|713-798-0273|ybirnbau@bcm.edu|
21287324|NCT04748718|Northern Vermont University|Dr. Eleanor Beltz|802-635-1329|Eleanor.Beltz@NorthernVermont.edu|
21287325|NCT00316004|Clinical Trial Center, University of Washington, Seattle, WA|Susanne May, PhD|206-685-1302|sjmay@uw.edu|
21287326|NCT01118299|Abbott|Sripad Bellary|408845814|sripad.bellary@abbott.com|
21287327|NCT02090881|Imperial College Healthcare NHS Trust|Dr Mohammed Aslam|02083831000|m.aslam@imperial.ac.uk|1541
21287328|NCT01935089|The Wistar Institute|Luis J. Montaner|+1 (215) 898-9143|montaner@wistar.org|
21287329|NCT02932943|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
21287330|NCT00250484|Beth Israel Deaconess|Steven D. Freedman, MD Phd|631-667-2132|sfreedma@bidmc.harvard.edu|
21273381|NCT00450190|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21287331|NCT02665117|UT Southwestern Medical Center|Dr. Wanpen Vongpatanasin|214-648-9078|wanpen.vongpatanasin@utsouthwestern.edu|
21287332|NCT04236284|The University of Texas Health Science Center at Houston|Melba Hernandez Tejada, PhD, DHA|7134862729|Melba.A.HernandezTejada@uth.tmc.edu|
21287333|NCT02271451|Cincinnati Children's Hospital|Dr. Gregory Myer|513-636-4366|gregory.myer@cchmc.org|
21287334|NCT02337491|Dana-Farber Cancer Institute|David A. Reardon, MD|617-632-2166|dreardon3@partners.org|
21287335|NCT01432951|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21287336|NCT02025075|Massachusetts General Hospital|Marcos Vidal Melo, MD, PhD|617-726-8980|VidalMelo.Marcos@mgh.harvard.edu|
21287337|NCT03785028|University of Wisconsin - Madison|Brad Postle, PhD|608-262-4330|postle@wisc.edu|
21287338|NCT01079780|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21287339|NCT02783066|Baylor College of Medicine|Prof.Bijan Najafi|17137987536|bijan.najafi@bcm.edu|
21287340|NCT03712280|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
21287341|NCT00551369|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21287342|NCT01663623|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21287343|NCT02251275|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
21287344|NCT01004614|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21287345|NCT03044418|University of Pecs|Dr. Timea Bocskai|+36 72 507374|timokeri@gmail.com|
21287346|NCT01569022|VA Western New York|Ali El Solh|716-862-6525|ali.el-solh@va.gov|
21287347|NCT02111083|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21287348|NCT01302899|Novartis Pharmaceuticals|Study Director|862-778-8300||
21287349|NCT02834975|University of Miami|Abdulrahman Sinno, MD|+1 (305) 2432233|ak.sinno@med.miami.edu|
21287350|NCT01856933|Brown University Oncology Research Group (BrUOG)|Heinrich Elinzano, MD|4018633000|kayla_rosati@brown.edu|
21287351|NCT03482024|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21287352|NCT00472420|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21287353|NCT01658839|Alcon Research, Ltd.|Theresa Landry, Project Head, Clinical Trial Management|1-888-451-3937|alcon.medinfo@alcon.com|
21287354|NCT00686972|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
21287355|NCT03093181|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21287356|NCT03154086|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21287357|NCT04076917|BIOTRONIK, Inc.|Senior Manager, Scientific Affairs|800-547-0394|crystal.miller@biotronik.com|
21287358|NCT03148262|UT Southwestern Medical Center|Dr. Christina Riccio|214-590-7284|Christina.Riccio@UTSouthwestern.edu|
21287359|NCT01701245|electroCore LLC|Annelie Andersson|+46 721 803076|annelie.andersson@electrocorellc.com|
21287360|NCT01774591|University of Chicago|George L. Bakris, MD|773-702-7936|bbrisky@medicine.bsd.uchicago.edu|
21287361|NCT01159574|Weill Cornell Medical College|Jennifer Hess|6469629440|jmh2004@med.cornell.edu|
21287362|NCT01183923|Johns Hopkins University School of Medicine|Elizabeth Matsui, MD MHS|410-502-3858|ematsui@jhmi.edu|
21287363|NCT01787552|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21287364|NCT00630916|Sorin Group USA|Director of Clinical and Medical Affairs|512-435-3602|barbara.mathews@sorin.com|
21287365|NCT02147626|Brigham and Women's Hospital|Dr. Janet Rich-Edwards|6175258264|jr33@partners.org|
21287366|NCT00572832|University of Pittsburgh|Richard Zimmerman|412-383-2354|zimmer@pitt.edu|
21287367|NCT00324155|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21287368|NCT00390689|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21287369|NCT01253161|Moffitt Cancer Center|Jonathan Strosberg, MD|813-745-6585|Jonathan.Strosberg@moffitt.org|
21287370|NCT00349336|Hoffmann-La Roche|Medical Communications|800-821-8590||
21287371|NCT01721447|University of Utah Division of Cardiovascular Medicine|Dr. Brent Wilson|801-585-2341|brent.wilson@hsc.utah.edu|
21287372|NCT00843492|GlaxoSmithKline|GSK Response Center|866-435-7343||
21287373|NCT00720499|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21287374|NCT00828711|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21287375|NCT01618968|Antares Pharma Inc.|Jonathan Jaffe, MD; Vice President Clinical Development|609-359-3020|jjaffe@antarespharma.com|324
21287376|NCT01004939|GlaxoSmithKline|GSK Response Center|866-435-7343||
21287377|NCT01621009|University of Wisconsin Center for Tobacco Research and Intervention|Timothy Baker, PhD, Director of Research|(608) 262-7568|tbb@ctri.wisc.edu|
21287378|NCT00721799|The University of Iowa Department of Radiology|Yusuf Menda, MD|319-356-3214|yusuf-menda@uiowa.edu|
21273382|NCT01376167|GlaxoSmithKline|GSK Response Center|866-435-7343||
21273383|NCT04365153|Cleveland Clinic|Paul C. Cremer, MD|216-444-6765|cremerp@ccf.org|
21273384|NCT00296647|UW-Center for Tobacco Research and Intervention|Stevens Smith, PhD|608-262-7563|sss@ctri.medicine.wisc.edu|
21273385|NCT01863745|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
21273386|NCT02543554|Washington University in St. Louis|Brian M Fuller|3147475368|fullerb@wustl.edu|
21273387|NCT00610363|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
21273388|NCT05093205|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21273389|NCT03221374|Carnegie Mellon University|Dr. Bin He|412-268-9857|bhe1@andrew.cmu.edu|
21273390|NCT00818337|Creighton University|Kathleen Packard, PharmD|402-280-2668|kpackard@creighton.edu|
21273391|NCT03361228|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21273392|NCT00401778|Emory University|Suresh S. Ramalingam, MD|404-778-5378|ssramal@emory.edu|
21273393|NCT02979353|Vanderbilt University Medical Center|Sandra F Simmons, PhD, Principle Investigator|615-343-6729|sandra.simmons@vumc.org|
21273394|NCT03005522|Banner University Medical Center|Dr Noah Tolby|520-694-8888|ntolby@aemrc.arizona.edu|
21273395|NCT01709474|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21273396|NCT00822926|Stanford University School of Medicine|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu|
21273397|NCT01378975|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21273398|NCT00323193|VA VISN 5 Mental Illness Research, Education and Clinical Center|Richard W. Goldberg, Ph.D.|410-637-1851|richard.goldberg@va.gov|
21273399|NCT01314742|Vanderbilt University Sch of Medicine|Dr. Beatrice Stefanescu|6159365933|beatrice.stefanescu@Vanderbilt.edu|
21273400|NCT02268500|University of Minnesota|Orly Vardeny, Associate Professor of Medicine|612.467.4586|ovardeny@umn.edu|
21273401|NCT03125200|ADC Therapeutics|ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
21273402|NCT00119379|University Hospitals Case Medical Center|Dr. Grace McComsey|216-844-2739|mccomsey.grace@clevelandactu.org|
21273403|NCT01312922|ANeuroTech|Dr. E. Buntinx, MD|+32 (0) 473 861 079|erik.buntinx@aneurotech.com|
21273404|NCT00720330|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
21273405|NCT03929367|Wake Forest Health Sciences|Dr. James Eisenach|3367164182|eisenach@wakehealth.edu|
21273406|NCT00515203|Amgen Inc.|Study Director|866-572-6436||
21273407|NCT01937390|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21273408|NCT03544138|Preceptis Medical|Steve Anderson|612-327-4795|steve@preceptismedical.com|
21273409|NCT01706536|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
21273410|NCT04190693|Imcyse SA|Jean Van Rampelbergh|+3243251100|j.vanrampelbergh@imcyse.com|
21273411|NCT03154658|University of Texas Southwestern|Anthony Machi M.D.|2146486400|anthony.machi@utsouthwestern.edu|
21273412|NCT04753437|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21273413|NCT00385684|Tuscaloosa VA Medical Center|Andrea L. Snow|205-554-2000|lynn.snow@va.gov|2260
21273414|NCT00154102|Merck Serono|Monika Foerster/Clinical Trial Leader|+496151729517|monika.foerster@merck.de|
21273415|NCT00463606|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21273416|NCT03567174|Johns Hopkins University|Gregory M. Lucas|410 614 0560|glucas@jhmi.edu|
21273417|NCT02140060|Alcon Research, Ltd.|Clinical Project Lead, GCRA, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
21273418|NCT03325114|University of Rochester|Carrie Dykes|15852750736|carrie_dykes@urmc.rochester.edu|
21273419|NCT00723528|Janssen Research & Development, LLC|Senior Director, Clinical Development|793-7633||215
21273420|NCT02627924|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21273421|NCT00667862|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21273422|NCT03979079|Institut Bergonié|Dr Carine Bellera|33 0 5 56 33 04 95|c.bellera@bordeaux.unicancer.fr|
21273423|NCT00987948|Hawaii Center for AIDS, University of Hawaii|Dr. Cecilia M Shikuma|8086921328|shikuma@hawaii.edu|
21273424|NCT02440308|Stanford Healthcare|Dr. Andrei Iagaru, Chief of the Division of Nuclear Medicine and Molecular Imaging|650-725-4711|aiagaru@stanford.edu|
21273425|NCT00667095|Mayo Clinic|Dr. Steven P. Petrou|904-953-7330|peterou.steven@mayo.edu|
21273426|NCT01375660|Jesse Brown VA Medical Center|Dr. Barengolts, Attending Endocrinologist, Chief, Section of Endocrinology|312-569-7651|Elena.Barengolts@va.gov|
21273427|NCT00654030|University of Kentucky|Dr. Edward Hirschowitz|859-323-5045|eahirs2@uky.edu|
21273428|NCT01435265|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-7740|sfeldman@wakehealth.edu|
21273429|NCT04605094|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21273430|NCT02724462|Fred Hutchinson Cancer Research Center|Dr. Jonathan Bricker|206-667-5077|jbricker@fredhutch.org|
21273431|NCT00979303|Children's Hospital Boston|Christina Miyake|832-826-5650|cymiyake@bcm.edu|
21273432|NCT00469417|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
21273433|NCT02059070|Wayne State University, School of Medicine|Pranav Patel|313-745-7233|gmckelve@dmc.org|
21273434|NCT05038293|University of Washington Department of Periodontics|Dr. Diane Daubert|206-685-3766|ddaubert@uw.edu|
21273435|NCT02163837|Chu St Pierre|Dr Marie Bruyneel|003225354219|marie_bruyneel@stpierre-bru.be|
21273436|NCT01171989|GlaxoSmithKline|GSK Response Center|866-435-7343||
21273437|NCT02339558|Prince of Wales Hospital|Brigette B.Y. Ma|(852) 26321042|brigette@clo.cuhk.edu.hk|
21273438|NCT01247701|Baylor College of Medicine/Texas Children's Hospital|Caridad A. Martinez|832-824-4692|camartin@texaschildrens.org|4670
21273439|NCT01034358|Mayo Clinic|Jeanne Tung, MD|507-266-0114|tung.jeanne@mayo.edu|
21273440|NCT01838941|McGill University Health Centre|Dr. Nancy Braverman, Associate Professor, Human Genetics and Pediatrics|(514) 934-1934|nancy.braverman@mcgill.ca|23404
21273441|NCT02822235|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21273442|NCT02968992|Johns Hopkins University|Jeremy D. Waltson, MD|410-550-1003|jwalston@jhmi.edu|
21273443|NCT02535611|Mazandaran University of medical sciences|Nasim Tabrizi|+981133343015|nasimtabrizi@gmail.com|
21273444|NCT00829530|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21273445|NCT05439252|University of Bath|Dr Oliver Perkin|01225384356|o.j.perkin@bath.ac.uk|
21273446|NCT05600322|Photocure ASA|Clinical Director|+4722062210|research@photocure.com|
21273447|NCT04466111|SGX Medical|VP of Clinical|818-527-2710|clinical@sgxmedical.com|
21273448|NCT00105196|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21273449|NCT00893464|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21273450|NCT00999037|University of California at Los Angeles|Katherine Wesseling-Perry|310-206-6987|kwesseling@mednet.ucla.edu|
21273451|NCT02770625|ISU ABXIS Co., Ltd.|Taekseung Kim|+82.31.696.4715|kimts@isu.co.kr|
21273452|NCT01382719|Palatin Technologies, Inc.|Jeffrey Edelson, MD, FRCPC|(609) 495-2200|jedelson@palatin.com|
21273453|NCT00425672|University of Washington|Principal Investigator||TrialTVG@medicine.washington.edu|
21273454|NCT02605395|GlaxoSmithKline|GSK Response Center|866-435-7343||
21273455|NCT00819507|Oregon Health & Science University|Eric Simpson|503-494-2121|simpsone@ohsu.edu|
21273456|NCT02661295|NYU Langone Health|Candace Grant, MD|516-663-0333|candace.grant@nyulangone.org|9054
21273457|NCT02336165|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
21273458|NCT00267644|Maimonides Medical Center|Dr. Eitan Dickman, MD; Principal Investigator|718-283-6057|edickman@maimonidesmed.org|
21273459|NCT00910663|TEVA Pharmaceuticals USA|Associate DIrector, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21273460|NCT02726581|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21273461|NCT02024646|Bausch Health|Director of Clinical Trials|310-770-7750|anya.loncaric@bauschhealth.com|
21273462|NCT01844375|Faculty of Medicine siriraj Hospital|Dr.Mingkwan Wongyingsinn|6624197995|mingkwan.won@mahidol.ac.th|
21273463|NCT04239872|University of Michigan School of Dentistry|Dr. Livia Tenuta|734-763-3703|litenuta@umich.edu|
21273464|NCT03541941|Cleveland Clinic Foundation|Dr. Michael Rosen|216-445-3441|rosenm@ccf.org|
21273465|NCT01498120|UCB BIOSCIENCES GmbH|Clinical Trial Registries and Results Disclosure|40789+49 2173 48|clinicaltrials@ucb.com|15 15
21273466|NCT01472341|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21273467|NCT00112463|Wake Forest School of Medicine|Dr. Doug Case|336-716-1048|dcase@wakehealth.edu|
21273468|NCT03506386|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21273469|NCT04060147|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21273470|NCT00565448|sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21273471|NCT00193609|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21273472|NCT00735904|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21273473|NCT03204539|UC Davis|Dr. Jonathan Ducore|916-734-3461|jmducore@ucdavis.edu|
21273474|NCT02567968|University of Chicago|Aaron Fox, PhD|7737020021|aaronfox@uchicago.edu|
21273475|NCT03660839|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21273476|NCT02265783|Medtronic|Michael Luna-Victoria|3033052463|michael.luna-victoria@medtronic.com|
21273477|NCT00550537|Vanderbilt-Ingram Cancer Center|Dr. Leora Horn, Principal Investigator||leora.horn@vanderbilt.edu|
21273478|NCT02008565|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
21273479|NCT00268905|Eisai|Prash Krishna, Study Director|888-422-4743||
21273480|NCT00617305|Gilead Sciences|Ellen Shen, PhD, Senior Manager, Regulatory Affairs|+1 (650) 522-5278|Ellen.Shen@gilead.com|
21273481|NCT00857623|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21273482|NCT04185909|Apyx Medical|Kari Larson, MBA, Sr. Director, Clinical Affairs|8012440058|kari.larson@apyxmedical.com|
21273483|NCT02193178|CooperVision, Inc.|Sr. Manager, Clinical Research|9257306754|pchamberlain@coopervision.com|
21273484|NCT04510285|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian,MD|646-888-4186|janjigiy@mskcc.org|
21273485|NCT00048581|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21273486|NCT03897088|Sun Pharmaceutical Industries Limited|Head-Clinical Development|2266455645|clinical.trial@sunpharma.com|5689
21273487|NCT03097783|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
21273488|NCT00699491|Washington University School of Medicine|Cynthia Ma, M.D., Ph.D.||cma@im.wustl.edu|
21273489|NCT00319735|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
21273490|NCT02227121|Medtronic Cardiac Rhythm and Heart Failure|Griet Wouters|800-328-2518|MedtronicCRMtrials@medtronic.com|
21273491|NCT02216071|Exela Pharma Sciences|Aruna Koganti, VP Clinical Programs|828-758-5474|akoganti@exela.us|
21273492|NCT03187002|Stanford University|Research Manager|6507211567|fpresearch@stanford.edu|
21273493|NCT01469546|University of Michigan Comprehensive Cancer Center|Dr. Francis Worden, M.D.|734-936-0453|fworden@umich.edu|
21273494|NCT02801877|Northwestern University|Mary Kwasny|312-503-2294|m-kwasny@northwestern.edu|
21273495|NCT04298918|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21273496|NCT01066143|McLean|Igor Elman, PI|(800) 333-0338|ielman@partners.org|
21273497|NCT01294787|Novartis Pharmaceuticals|Study Director|41 61 324 1111||
21273498|NCT05376319|Mayo Clinic|Ulrich Specks, M.D.|507-284-2494|specks.ulrich@mayo.edu|
21273499|NCT01124175|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21273500|NCT00942968|Pfizer, Inc.|Pfizer ClinicalTrials.gov|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21273501|NCT01948258|SPD Swiss Precision Diagnostics GmbH/SPD Development Company Ltd|Dr Sarah Johnson, Head of Clinical and Regulatory Affairs|01234835486|sarah.johnson@spdspark.com|
21273502|NCT00834535|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21273503|NCT04408586|Mayo Clinic|Andres J. Acosta, M.D., Ph.D.|507-266-6931|Acosta.Andres@mayo.edu|
21273504|NCT00428298|Johns Hopkins UNiversity School of Medicine|Jennifer L. Payne MD|410-502-0050|jpayne5@jhmi.edu|
21273505|NCT01340495|Massachusetts General Hospital|Shannon MacDonald, MD|617-643-7250|SMACDONALD@mgh.harvard.edu|
21273506|NCT01811953|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21273507|NCT02110277|UConn Health|Dr.Molly Brewer|860-679-2100||
21287379|NCT01441973|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21287380|NCT00733278|LA BioMed|Dr. Anita Nelson||anitanelsonwhc@earthlink.net|
21287381|NCT02873689|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21287382|NCT00350545|Stanford University|David B. Miklos|650 725-4959|dmiklos@stanford.edu|650
21287383|NCT00434252|Genentech, Inc.|Medical Communications|800-821-8590||
21287384|NCT02097732|University of Michigan Comprehensive Cancer Center|Dr. Christopher Lao, MD, MPH|(734) 936-4498|clao@med.umich.edu|
21287385|NCT00737178|Columbia University|Anne Davis, MD|2123054951|ard4@columbia.edu|
21287386|NCT01477567|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21287387|NCT00750269|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21287388|NCT01677286|Boston Medical Center|John Berk, MD|617-638-4494|jberk@bu.edu|
21287389|NCT03630393|OhioHealth|Dr. Ryan Hedgepeth|614-788-2870|ryan.hedgepeth@ohiohealth.com|
21287390|NCT00408499|University of California, Davis|Data Manager|916-734-8381|nmahaffey@ucdavis.edu|
21287391|NCT01042795|University of Michigan|Cheryl T. Lee|614-685-6666|cheryl.lee@osumc.edu|
21287392|NCT01586195|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21287393|NCT00997334|Dana-Farber Cancer Institute|David M. Jackman, MD|617.632.3468|David_Jackman@dfci.harvard.edu|
21273508|NCT00070291|ECOG Statistical Office|Study Statistician|617-632-3012||
21273509|NCT00520130|National Cancer Institute|Dr. Steven Z. Pavletic|301- 402-4899|sp326h@nih.gov|
21273510|NCT02533258|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21273511|NCT00517530|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21273512|NCT01520909|GlaxoSmithKline|GSK Response Center|866-435-7343||
21273513|NCT01882257|University of Michigan Health System|Robert G. Sitrin, M.D.|(734) 936-5201|rsitrin@umich.edu|
21273514|NCT00830206|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21273515|NCT01832259|Huntsman Cancer Institute / University of Utah|Josiah Lyn Hawks|801-585-0601|Josiah.Hawks@hci.utah.edu|
21273516|NCT03351335|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
21273517|NCT01900691|Cook Research Incorporated|Alan Saunders, MDR, RAC; Manager, Biostatistics|765-463-7537|alan.saunders@cookmedical.com|321204
21273518|NCT01149473|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21273519|NCT01954394|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21273520|NCT02128997|UPENN|Valerie Riis|2154989099|valerie.armendariz@uphs.upenn.edu|215
21273521|NCT04123548|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
21273522|NCT00645762|Entellus Medical|Entellus Medical|763-463-1599||
21273523|NCT04166630|Emory University|Randi Smith|404-251-8914|randi.smith@emory.edu|
21273524|NCT00096447|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
21273525|NCT00627016|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21273526|NCT01534663|University Hospital Jena|Christian Schulze, MD, PhD|03641-9 32 41 04|christian.schulze@med.uni-jena.de|
21273527|NCT04088760|Cincinnati Children's Hospital Medical Center|Rebecca Marsh, MD|(513) 803-1139|Rebecca.Marsh@cchmc.org|
21273528|NCT00840866|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21273529|NCT01643707|Medtronic|Sr Clinical Research Program Manager|+1 (651) 308 3608|jennifer.tinsley@medtronic.com|
21273530|NCT04112823|Montefiore Medical Center|Dr. Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
21273531|NCT03107091|BioVie|Penelope Markham|17035989972|pmarkham@biovieinc.com|
21273532|NCT03049215|Vanderbilt University Medical Center|Sharee Burkeen, Research Program Manager|(615) 875-7515|sharee.k.burkeen@vumc.org|
21273533|NCT00436553|Novartis Pharmaceuticals|Study Director|862 778-8300||
21273534|NCT02379247|University of Kansas Medical Center|Dr. Priyanka Sharma|9135886079|psharma2@kumc.edu|
21273535|NCT00625443|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
21273536|NCT02728102|The Emmes Company|Adam Mendizabal, PhD|301-284-1798|amendizabal@emmes.com|
21273537|NCT00830232|Dallas VA Medical Center|Dr. Carlos H Timaran|2148570336|carlos.timaran@va.gov|
21273538|NCT03834870|Yale University|Fuad Abujarad|+1 (203) 737-5088|fuad.abujarad@yale.edu|
21273539|NCT00672178|Duke University Medical Center|John Kirkpatrick, MD, PhD|919 668-7342|kirkp001@mc.duke.edu|
21273540|NCT02419937|United States Air Force|Dr. Matthew B. Carroll|228-376-3829|mcar100210@yahoo.com|
21273541|NCT00553280|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21273542|NCT01182415|Massachusetts General Hospital|Dr. Yi-Bin Chen|617-726-0187|YCHEN6@PARTNERS.ORG|
21273543|NCT01544127|Canandaigu VA Medical Center|Dr. Peter Britton|585-393-7926|peter.britton@va.gov|
21273544|NCT01437501|Johns Hopkins Bloomberg School of Public Health|Thomas W. Kensler, PhD|410-955-1292|tkensler@jhsph.edu|
21273545|NCT01256684|Endoceutics|Director of Data Analysis|418-653-0033|celine.martel@endoceutics.com|215
21287394|NCT01855958|Hospital de Clínicas de Porto Alegre|Wolnei Caumo, MD,PhD.|+555133598430|caumo@cpovo.net|
21287395|NCT01507350|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
21273546|NCT05452798|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21273547|NCT02587962|Medivir AB|Chief Medical Officer|+46854683100|info@medivir.com|
21273548|NCT00184600|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21273549|NCT02763865|Medical University of South Carolina|Gonzalo REvuelta|843-792-7262|revuelta@musc.edu|
21273550|NCT00696020|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21273551|NCT00624065|GlaxoSmithKline|GSK Response Center|866-435-7343||
21273552|NCT01972204|Mirai Iryo Research Center|Tomoko Machida (Director)|81-3-3263-4801|machida@mirai-iryo.com|
21273553|NCT03627091|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21273554|NCT00102440|Takeda Global Research & Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21273555|NCT01314417|National Institutes of Health|H. Nida Sen, MD, MHSc, Principal Investigator, NEI|301-402-3254|senh@nei.nih.gov|
21273556|NCT01010542|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21273557|NCT03115177|Rush University Medical Center|Dr. Allison Rao|608-445-0545|allison.rao@gmail.com|
21273558|NCT00678639|Wake Forest University Baptist Medical Center|Chadwick Miller, MD|336-716-1740|cmiller@wfubmc.edu|
21273559|NCT02642835|Medway NHS Foundation Trust|Professor Jonaathan Duckett -Consultant Urogynaecologist|01634|jraduckett@hotmail.com|835154
21273560|NCT01546545|Pennington Biomedical Research Center|Jeffrey Gimble, MD, PhD|225-763-3000|doctors@pbrc.edu|
21273561|NCT01214850|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21273562|NCT02729714|EvergreenHealth Medical Center|Dr. Daniel Burdick|4258993108|djburdick@evergreenhealthcare.org|
21273563|NCT03865654|Dana-Farber Cancer Institute|Rachel Freedman, M.D., M.P.H.|617-632-3800|rafreedman@partners.org|
21273564|NCT01171963|GlaxoSmithKline|GSK Response Center|866-435-7343||
21273565|NCT02519491|University of Ottawa Heart Institute|Dr. Benjamin Hibbert, Cardiologist|613-696-7000|bhibbert@ottawaheart.ca|
21273566|NCT00302952|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21273567|NCT00336479|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com|
21273568|NCT01658228|New York State Psychiatric Institute|Dr. Davangere Devanand|646-774-8658|dpd3@cumc.columbia.edu|
21273569|NCT03435081|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21273570|NCT02601560|MedImmune, LLC|Richard George, MD, Director, Clinical Development|+1-301-398-5681|information.center@astrazeneca.com|
21273571|NCT01406795|Stanford University|Rusty Hofmann|6507366096|lhofmann@stanfordhealthcare.org|
21273572|NCT04320849|Duke University Medical Center|Dr. Jonathan Piccini|919-668-8049|jonathan.piccini@duke.edu|
21273573|NCT02421952|Baylor College of Medicine|Dr. Mary Felberg|832-824-5800|mafelber@texaschildrens.org|
21273574|NCT05665426|Zhejiang Chhinese Medicial University|Siyi Zheng|+86159 9008 8547|zsy980714@gmail.com|
21273575|NCT03857919|Sight Sciences|Tommie Rodriguez, Senior Clinical Research Manager|18186873310|trodriguez@sightsciences.com|
21273576|NCT04934722|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21273577|NCT06358820|Gaozhou People's Hospital|Shanshan Deng|13927596600|276531255@qq.com|
21273578|NCT03547622|Yale University|Theresa Babuscio Data Manager|203 737 5430|theresa.babuscio@yale.edu|
21273579|NCT01045096|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21273580|NCT00156247|UMDNJ-Robert Wood Johnson Medical School|Melissa Magliocco, MD|(732) 235-5735|maglioma@umdnj.edu|
21273581|NCT01511939|Arthritis Treatment Center|Manager, Clinical Research Department|301-624-1168|tgillis@arthritistreatmentcenter.com|
21273582|NCT03649841|University of Washington|Dr. Jing Zeng|2065984110|jzeng13@uw.edu|
21273583|NCT03618147|Kuwait Society of Allergy & Clinical Immunology|Kuwait Society of Allergy & Clinical Immunology|0096524636478|walherz@hsc.edu.kw|
21273584|NCT01529060|Baylor|Alyssa Tran, BS|832-822-4264|alyssat@bcm.edu|
21273585|NCT01993030|The Second Xiangya Hospital of Central South University|Dr. Li Qian|+86-13958104032|649418291@qq.com|
21273586|NCT03785548|TriHealth Inc.|Tiffanie Tam, Md|513-463-4300|Tiffanie_Tam@trihealth.com|
21273587|NCT01033565|University of Nebraska|Howard Needelman MD|402-559-4097|hneedelm@unmc.edu|
21273588|NCT01591785|Icahn School of Medicine at Mount Sinai|Gary Goldenberg, MD|212-241-6500|garygoldenbergmd@gmail.com|
21273589|NCT01819597|Cedars-Sinai Medical Center|Nestor Gonzalez, MD. Professor of Neurosurgery|310 423 0783|nestor.gonzalez@cshs.org|
21273590|NCT00396279|Amgen Inc.|Study Director|866-572-6436||
21273591|NCT02883452|Celltrion, Inc.|SungHyun Kim|+82 32 850 5778|sunghyun.kim@celltrion.com|
21273592|NCT01199848|Illinois Institute of Techology|Britt Burton-Freeman|708-341-0178|bburton@iit.edu|
21273593|NCT00487565|DePuy Orthopaedics, Inc.|Tammy O'Dell|574-372-7104|TOdell2@its.jnj.com|
21273594|NCT00905346|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21273595|NCT00909610|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21273596|NCT03585790|IU School of Optometry|Pete Kollbaum|812-856-0108|kollbaum@iu.edu|
21273597|NCT02337218|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
21287396|NCT02863666|University of Buffalo|Brooke Lerner PHD,|716.390.3509|lerner@buffalo.edu|
21287397|NCT02420639|Department of Anesthesiology & Intensive Care Medicine, Dnipropetrovsk Medical Academy|Alexander Tsarev|+38 057 701 52 00|tsarev03@rambler.ru|
21287398|NCT01951950|Northwestern University|John F. Bebawy, MD, Principal Investigator|312-695-0061|j-bebawy@northwestern.edu|
21287399|NCT01483118|Columbia University, Department of OBGYN|Roger A. Lobo M.D.|212-3056337|ral35@columbia.edu|
21273598|NCT01026623|Memorial Sloan Kettering Cancer Center|Dana Rathkopf|646-422-4379|rathkopd@mskcc.org|
21273599|NCT02736721|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21273600|NCT02196766|Coopervision Japan|Taku Muraoka, OD, Director Professional Services Organization|81-3-5449-6619|taku.muraoka@jp.coopervision.com|
21273601|NCT03342157|Advocate Aurora Health|Dr. Bradley Gose|414-385-2590|bradley.gose@aah.org|
21273602|NCT00418184|Enzymotec Ltd|Yael Richter Ph.D|+972 74 7177 177|Yaelr@enzymotec.com|144
21287400|NCT01178294|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21287401|NCT05052580|Duke Clinical Research Institute|Tara Mann, PhD, RN|(919) 668-5111|schoolSETstudy@duke.edu|
21287402|NCT05379920|University at Buffalo|Haley Chizuk|7162043200|haleychi@buffalo.edu|2188
21287403|NCT01267279|Spokane Joint Replacement Center|Principal Investigator|509-466-6393|dfscott@mac.com|
21287404|NCT03176771|Mitsubishi Tanabe Pharma Corporation|Mitsubishi Tanabe Pharma Corporation Clinical Trials, Information Desk|Please e-mail|cti-inq-ml@ml.mt-pharma.co.jp|
21287405|NCT03530293|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
21287406|NCT00667511|NxStage Medical, Inc.|Kristen Sheppard|978-687-4700||
21287407|NCT02152007|TransDerm, Inc.|Roger Kaspar, PhD|831-420-1684|roger.kaspar@transderminc.com|
21287408|NCT00447083|Wake Forest University Health Sciences|Steve feldman, MD|336-716-3775|sfeldman@wakehealth.edu|
21287409|NCT02497469|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21287410|NCT03558516|Department of Anesthesiology, Faculty of medicine, Siriaj hospital, Mahidol University|Assoc. Prof. Manee Raksakietisak|+66814880620|manee95@hotmail.com|
21287411|NCT02714153|Yale School of Medicine|Jude Clancy, MD Associate Professor Term; Director, Lead Management Program|(203) 785-4126|jude.clancy@yale.edu|
21287412|NCT01901185|Amgen Inc.|Study Director|866-572-6436||
21287413|NCT02318264|SUNY Upstate Medical|Michelle Dolphin, Associate Professor|315 464 6917|dolphinm@upstate.edu|
21287414|NCT02065557|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21287415|NCT03144232|Stanford University|Gregory Sahlem|650-724-0444|gsahlem@stanford.edu|
21287416|NCT01462942|AstraZeneca|Esther Garcia||ClinicalTrialTransparency@astrazeneca.com|
21287417|NCT02449434|King's College London|Prof David Bartlett|02071887462|david.bartlett@kcl.ac.uk|
21287418|NCT02737722|Lakewood Amedex|Chief Medical Officer|941 928 7774|poconnor@lakewoodamedex.com|
21287419|NCT02662569|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21287420|NCT00305162|The Medicines Company|Meredith Todd|+19732906088|meredith.todd@themedco.com|
21287421|NCT04710004|Emory University|Dr. Robert Gross|404-727-2354|rgross@emory.edu|
21287422|NCT01690663|the University of Pennsylvania|Jiabin Liu, MD, PhD|215-573-8208|jiabin.liu@uphs.upenn.edu|
21287423|NCT03555149|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21287424|NCT02219256|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21287425|NCT02965924|Mayo Clinic|Arthur J. Sit, MD|507-284-2787|Sit.Arthur@mayo.edu|
21287426|NCT02785939|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
21287427|NCT04465422|Taipei City Hospital|Shu Chun Lee|+886 2 27263141|A1057@tpech.gov.tw|1004
21273603|NCT00834249|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21273604|NCT00851877|UT Southwestern Medical Center|Director of Clinical Trial||ClinicalTrials@utsouthwestern.edu|
21273605|NCT00620074|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21273606|NCT02332863|University of Colorado - Anschutz Medical Campus|Dr. Sachin Wani|720-848-2786|sachin.wani@cuanschutz.edu|
21273607|NCT03025880|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
21273608|NCT01275586|Indiana University|Dr. Melissa Markel|317-944-4969|memarkel@iu.edu|
21273609|NCT03136380|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21273610|NCT04121364|RevBio|Dr. Alan Pollack|9145226972|apollack@revbio.com|
21273611|NCT02377947|Abbott|Dr. Shubhangi Desai|+91 22 7175 7408|shubhangi.desai@abbott.com|
21273612|NCT01185548|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21273613|NCT00086996|SWOG Statistical Center|Study Statistician|206-667-4623||
21273614|NCT00234286|Birmingham VA Medical Center|Kathryn L. Burgio, PhD|205-558-7064|kburgio@uabmc.edu|
21273615|NCT01422538|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
21273616|NCT02770820|FHCRC|Dr. Aude Chapuis|2066674369|achapuis@fredhutch.org|
21273617|NCT03257722|Augusta University|Asha Nayak, MD|706-721-2505|anayak@augusta.edu|
21273618|NCT01387022|CAPRISA|Head of Statistics and Data Management|+27 31 260 4392|nonhlanhla.yende@caprisa.org|
21273619|NCT02076022|University of Pittsburgh Plastic Surgery|Patsy Simon|412-648-9207|simopa@upmc.edu|
21273620|NCT00524264|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
21273621|NCT00286754|Department of Veterans Affairs|Sundar Natarajan, MD, Staff Physician|212-686-7500|Sundar.Natarajan@va.gov|3287
21273622|NCT01536405|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21273623|NCT01061866|National Institute of Neurology and Neurosurgery of Mexico|Julio Sotelo|5255-5652-8285|jsotelo@unam.mx|
21273624|NCT04786184|Columbia University|Annamaria Norweg, PhD|212-305-1651|amn2212@cumc.columbia.edu|
21273625|NCT02512393|The University of Texas Health Science Center at Houston|Hyochol Ahn, PhD, ARNP|713-500-2179|Hyochol.Ahn@uth.tmc.edu|
21287428|NCT02668003|University of Aberdeen|Professor Gary Macfarlane|01224 437 143|g.j.macfarlane@abdn.ac.uk|
21302131|NCT01430169|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
21302132|NCT02633020|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21302133|NCT00934440|University of Kansas Cancer Center|Dr. Peter Van Velduizen|(913) 945-5059|SWILLIAM@kumc.edu|
21302134|NCT05661851|Johnson & Johnson Vision Care, Inc. (JJVC)|Principal Research Optometrist|(347) 903-5029|njoshi30@its.jnj.com|
21302135|NCT02152956|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
21273626|NCT02420210|University of Chicago|Theodore Karrison|773-702-9326|tkarrison@health.bsd.uchicago.edu|
21273627|NCT01185821|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21302136|NCT00530816|Onyx Pharmaceuticals, Inc.|Onyx Medical Information|1-877-ONYX-121|medinfo@onyx.com|
21273628|NCT01534520|UPittsburgh|Dionne Best|412-641-5496|dbest@upmc.edu|
21273629|NCT01783561|Neonatal Research Institute, Sharp Mary Birch Hospital for Women and Newborns|Anup Katheria, M.D.|858-939-4170|anup.katheria@sharp.com|
21273630|NCT05615935|National Taiwan University|Dr. Piao-Yi Chiou|02-2312-3456|piaoyi@ntu.edu.tw|288427
21273631|NCT00420238|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21273632|NCT03555305|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21273633|NCT02287675|Kettering Health Network|Dr. Arash Kardan|937-395-8611|arash.kardan@ketteringhealth.org|
21273634|NCT03135834|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21273635|NCT03966365|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
21273636|NCT00214422|National Cancer Institute|Dr. Kevin Camphausen|240-760-6205|camphausen@nih.gov|
21273637|NCT01073657|Veterans Health Adminstration|Marsha Langer Ellison, Ph.D.|781 687 3401|Marsha.Ellison@va.gov|
21273638|NCT02744352|University of Pennsylvania|Anmol Madaan, Clinical Research Coordinator|2156623778|Anmol.Madaan@Pennmedicine.Upenn.edu|
21273639|NCT01223365|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21273640|NCT02865122|Elgan Pharma Ltd.|Miki Olshansky, Chief Executive Officer|972-4-6098600|Miki@elganpharma.com|
21273641|NCT06090461|Currax Pharmaceuticals LLC|SVP, Chief Medical Officer|708.834.8254|mkyle@curraxpharma.com|
21273642|NCT05369208|Sobi Inc.|Medicine Development Leader|1-781-786-7370|medinfo.us@sobi.com|
21273643|NCT02262377|Boston Medical Center|Paula Gardiner|414-6267|Paula.GardinerMD@gmail.com|617
21273644|NCT00371839|Portland VAMC|Dr. Marjorie R. Leek|(909)825-7084|Marjorie.Leek@va.gov|7293
21273645|NCT00210223|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
21273646|NCT01049334|Reckitt Benckiser Inc.|Gail Solomon, Director, Clinical Development|973-404-2752|gail.solomon@rb.com|
21273647|NCT04089735|AimMax Therapeutics Inc.|Chief Medical Officer|919-797-1146|admin@aimmaxrx.com|
21273648|NCT02071108|Shockwave Medical, Inc.|Gheda Sahyun, Director of Clinical Affairs|510-624-9073|gsahyun@shockwavemedical.com|
21273649|NCT00773422|Yale School of Medicine|Sherry McKee, PhD|2037373529|sherry.mckee@yale.edu|
21273650|NCT00561834|Rocky Mountain Lions Eye Institute, Dept. of Ophthalmology|Dr. Naresh Mandava, M.D.|720-848-2500|Naresh.mandava@ucdenver.edu|
21273651|NCT02393417|Nielsen BioSciences Inc.|David Burney, PhD, MBA|858-571-2726|david@nielsenbio.com|
21273652|NCT01439880|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21273653|NCT00328926|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21273654|NCT00573066|Children's Hospital of Philadelphia|Athena Zuppa|267-426-7359|zuppa@email.chop.edu|
21273655|NCT02473718|University of Texas Southwestern Medical Center|Catherine Chen|214-648-9095|catherine.chen@utsouthwestern.edu|
21273656|NCT02246166|GlaxoSmithKline|GSK Response Center|866-435-7343||
21273657|NCT00834743|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21273658|NCT01036009|Benioff Children's Hospital at UCSF|Biljana Horn|415 476 2188|hornb@peds.ucsf.edu|
21273659|NCT00376623|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21273660|NCT02331394|Jewish General Hospita;|Goulnar Kasymjanova|514-340-8222|gkasymja@jgh.mcgill.ca|24312
21273661|NCT04247282|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|hoyoung.maeng@nih.gov|
21273662|NCT00301366|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
21273663|NCT01371786|Sunovion|Respiratory Medical Director|1-866-503-6351||
21273664|NCT01313273|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21273665|NCT01054586|GlaxoSmithKline|GSK Response Center|866-435-7343||
21273666|NCT02865850|Akebia Therapeutics, Inc.|Clinical Trial Information Desk|+1 617-844-6128|trials@akebia.com|
21273667|NCT00552669|Centro de Estudios en Cardiologia Intervencionista|Alfredo Rodriguez, MD, PHD|541149648721|rodrigueza@sanatorio-otamendi.com.ar|
21273668|NCT03687736|Q-Med AB|Clinical Project Manager|(817) 961-5000|aestheticclinicaltrials@galderma.com|
21273669|NCT00176306|University of Kentucky|Aaron Cook|8593239258|amcook0@email.uky.edu|
21273670|NCT02098876|Northeast Georgia Health System|Habib Samady|770-297-3549|Habib.Samady@nghs.com|
21273671|NCT03195491|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21273672|NCT01263704|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21273673|NCT02514122|University of Saskatchewan|Dr. William P. McKay|1 306 655 1202|bill.mckay@usask.ca|
21273674|NCT01792635|Pfizer, Inc.|Pfizer ClnicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21273675|NCT01118312|Johns Hopkins University|Razan Yasin|443-287-5796|ryasin1@jhu.edu|
21302137|NCT01014910|Children's Mercy Hospital Kansas City|Dr. Russell McCulloh|816-234-3061|rmcculloh@cmh.edu|
21302138|NCT02445794|Retrotope, Inc|Frederic Heerinckx/VP Clinical Operations|650-437-0700|frederic@retrotope.com|109
21302139|NCT01136785|The University of Chicago|Dr. Eve Van Cauter/Dr. Babak Mokhlesi|773-702-0169 or 773-702-2181|evcauter@medicine.bsd.uchicago.edu; bmokhles@medicine.bsd.uchicago.edu|
21302140|NCT01388985|Institute of Tropical Medicine Antwerp|Dr. Patrick Soentjens|+32 3 247 66 41|psoentjens@itg.be|
21302141|NCT03761368|Medical University of Łódź|Karolina Stokfisz|+48422014260|stokfisz.karolina@gmail.com|
21302142|NCT01519167|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com|
21302143|NCT00556504|TCM Biotech International|Dr. Ya-Chun Wang, EVP/CSO|886-2-26581677|yachunwang@tcmbio.com|733
21302144|NCT01516034|Dr David Friedman Laser & Skin Center|David J. Friedman, Principal Investigator|+972-2-5635673|drfriedmanlaser@gmail.com|
21302145|NCT00580671|Geisel School of Medicine at Dartmouth|Alan J. Budney, PhD|855-290-2822|alan.j.budney@dartmouth.edu|
21302146|NCT01221311|Medical University of South Carolin|Gregory Cote|843-876-4261|cotea@musc.edu|
21302147|NCT00870584|Novartis Pharmaceuticals|Study Director|862-778-8300||
21302148|NCT01497366|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21302149|NCT02703337|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21302150|NCT01303224|Menarini Ricerche S.p.A.|Angela Capriati MD PhD, Corporate Director of Clinical Research|+39 055 5680|acapriati@menarini-ricerche.it|9933
21302151|NCT01888432|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21302152|NCT03844945|Aerie Pharmaceuticals Ireland Limited, Japan Branch|Clinical Research, Japan|+81-3-6860-8410|JapanCS208@aeriepharma.com|
21302153|NCT03159260|Sport and Spine Rehab Clinical Research Foundation|Jena Slaski|301-251-2777|jslaski@ssrehab.com|838
21302154|NCT01856218|Ultragenyx Pharmaceutical Inc|Kim Mooney, Associate Director, Patient Advocacy Medical Services|408-981-3526|kmooney@ultragenyx.com|
21273676|NCT02834663|Wonkwang University Hospital|Dr. Seung Joon Lee|010-5004-8165|eunilsa@hanmail.net|
21302155|NCT03718091|Massachusetts Genera Hospital|Gregory M Cote MD PhD|6177244000|gcote@partners.org|
21302156|NCT02490670|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21302157|NCT01043939|Masonic Cancer Center, University of Minnesota|Cindy K. Blair, MPH|612-624-9668|blair016@umn.edu|
21302158|NCT02603666|Karolinska University Hospital, Huddinge, 141 86 Stockholm|Ferenc Karpati M.D., Ph.D., Senior Consultant|+46858580000|ferenc.karpati@karolinska.se|81656
21302159|NCT01794338|Carolinas HelathCare System|Research Director|704-355-3168|Amy.Lincourt@carolinashealthcare.org|
21302160|NCT01754402|Duke University Medical Center|Cristina Gasparetto, MD|919-668-1017|cristina.gasparetto@duke.edu|
21302161|NCT01282463|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21302162|NCT01954927|St. Jude Children's Research Hospital|Doralina Anghelescu, MD|(901) 595-4034|doralina.anghelescu@stjude.org|
21302163|NCT02156271|Duke University Medical Center|Dr. Andrew Krystal|919-681-8742|andrew.krystal@duke.edu|
21302164|NCT03320824|QMedAB|Clinical Project Manager|(817) 961-5000|aestheticclinicaltrials@galderma.com|
21302165|NCT00955305|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
21302166|NCT00109590|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
21302167|NCT02123251|University of Hawaii, Center on Disability Studies|Dr. Chuan Chinn|8089565379|chuanc@hawaii.edu|
21302168|NCT01221285|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21302169|NCT00407381|University of Nebraska|Quan Dong Nguyen, MD, MSc|4025591855|quan.nguyen@unmc.edu|
21302170|NCT00375609|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
21302171|NCT03254459|Insys Therapeutics, Inc.|Director, Clinical Development|4805003105|gdecastro@insysrx.com|
21302172|NCT01511055|Mayo Clinic|Sean C. Dowdy, M.D.|507-266-0225|Dowdy.Sean@mayo.edu|
21302173|NCT00480987|The University of Texas M. D. Anderson Cancer Center|Gautam Borthakur, MBBS / Assistant Professor|713-792-7305|eharriso@mdanderson.org|
21302174|NCT00395057|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21302175|NCT00669409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21287429|NCT00243243|US Army Institute of Surgical Research|David G. Baer, PhD, Director Research|210-539-4327|david.g.baer@us.army.mil|
21287430|NCT02443623|Emergent Biosolutions Inc.|Clinical Development Representative|(204) 275-4196|ctgov@ebsi.com|
21287431|NCT01299584|GlaxoSmithKline|GSK Response Center|866-435-7343||
21287432|NCT02679976|Johnson & Johnson Vision Care Inc.|Tom Karkkainen SR. PRINCIPAL RESEARCH OPTOMETRIST|904-443-3500|TKarkkai@its.jnj.com|3402
21287433|NCT05412134|Duke University|Jason Lang, MD|919-684-3364|jason.lang@duke.edu|
21287434|NCT03072186|Ohio State University Wexner Medical Center|Dr. Daniel Prevedello, MD|(614) 293-7190|Daniel.Prevedello@osumc.edu|
21287435|NCT00477685|Grewal Eye Institute|S.P.S Grewal, MD|+91-172-5056969|drgrewal@gmail.com|
21287436|NCT03444584|MedImmune, LLC|Armando Flor|+1-301-398-1955|information.center@astrazeneca.com|
21287437|NCT02709317|University of Pennsylvania|James McKay|215-746-7704|jimrache@upenn.edu|
21287438|NCT00423046|GlaxoSmithKline|GSK Response Center|866-435-7343||
21287439|NCT01604785|Oregon Health & Science University|David Sheridan|503 494-8311|sheridda@ohsu.edu|
21287440|NCT00808340|Vistakon|Tom Karkkainen, OD|904-443-3402||
21287441|NCT02783911|LomaLindaU|Dr. Jung-Wei Chen, Program director|9095584690|jwchen@llu.edu|85909
21287442|NCT00467519|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21287443|NCT01439035|Massachusetts General Hospital|Dr. Gary Tearney PI|617-724-2979|gtearney@partners.org|
21287444|NCT01118052|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|lgedeon@gogstats.org|
21287445|NCT01339416|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21287446|NCT01677741|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21287447|NCT00794664|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
21287448|NCT00457730|MS Center at Evergreenhealth Care|Theodore R. Brown, MD Principle Investigator|425-899-5350|trbrown@evergreenhealth.com|
21287449|NCT02230891|Michael E DeBakey Veterans Affairs Hospital|Vijay Nambi|713-794-7300|vijay.nambi@va.gov|
21287450|NCT00525837|Butler Hospital|Noah S. Philip MD|401-455-6258|noah_philip@brown.edu|
21287451|NCT03087058|Vifor Pharma, Inc.|EMERALD Clinical Study Team|+41 588 518 000|EMERALD.study@viforpharma.com|
21287452|NCT05158140|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21287453|NCT00921024|Cubist Pharmaceuticals, Inc.|Dr. Obi Umeh, Vice President Global Medical Sciences|781-860-8415|obiamiwe.umeh@cubist.com|
21287454|NCT04166214|NYU Langone Health - Hansjörg Wyss Department of Plastic Surgery|Mary E. Northridge, PhD, MPH, Director of Dental Research|347-377-4342|Mary.Northridge@nyulangone.org|
21287455|NCT02470741|University of California, San Francisco|Lisa Abinanti, Project Director|415-353-9978|lisa.abinanti@ucsf.edu|
21287456|NCT00485836|Genentech, Inc.|Medical Communications|800-821-8590||
21287457|NCT01898078|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21287458|NCT03813108|Radboud university medical center|Matthew McCall, MD, PhD|+3124 3615363|Matthew.mccall@Radboudumc.nl|
21287459|NCT00720278|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us|
21287460|NCT03946059|University of California San Diego|Dr. Jyoti Mishra|8582322855|jymishra@ucsd.edu|
21287461|NCT00266708|Montefiore Medical Center|Maria Coco, MD|718-920-4136|mcoco@montefiore.org|
21287462|NCT02791269|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21287463|NCT00368251|UCB|UCB Cares|+1877 822||9493
21287464|NCT00499122|UM/Sylvester Comprehensive Cancer Center|Alberto Montero MD|305-243-3771|amontero2@med.miami.edu|
21287465|NCT03895801|InflaRx GmbH|Prof. Niels C. Riedemann|+49 3641-508-180|niels.Riedemann@inflarx.de|
21273677|NCT03965091|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
21273678|NCT03999684|Dana-Farber Cancer Institute|Dr. Glenn Hanna|6176323090|glenn_hanna@dfci.harvard.edu|
21273679|NCT01416584|Johns Hopkins University School of Medicine|Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
21273680|NCT01624363|Indiana Universtiy Schol of Medicine|John DeWitt, MD, Director, Endoscopic Ultrasound|317-944-1113|jodewitt@iu.edu|
21273681|NCT01650350|Brown University Oncology Research Group|Maria Constantinou, MD|401-863-3000|Kayla_rosati@brown.edu|
21273682|NCT00537979|Abbott|Global Medical Services|800-633-9110||
21273683|NCT02082392|New York State Psychiatric Institute|Bret Rutherford|6467748660|brr8@cumc.columbia.edu|
21273684|NCT01417078|Acorda Therapeutics, Inc.|Executive Medical Director - Clinical Development & Medical Affairs|914-347-4300|dsquillacote@acorda.com|5367
21273685|NCT00626548|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21273686|NCT01234103|University of California, San Francisco|Cherrie B. Boyer, PhD|4154762184|Cherrie.Boyer@ucsf.edu|
21273687|NCT00580138|University of Arkansas for Medical Sciences Medical Center|Gary McCullough|501-852-7886|mcculloughgaryh@uams.edu|
21273688|NCT01059903|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
21273689|NCT02563808|University of Pennsylvania Hospital|Lee Fleisher|2156623738|lee.fleisher@uphs.upenn.edu|
21273690|NCT02392000|Edith Nourse Rogers Memorial VA Hospital|Karen S. Quigley|781-687-2273|karen.quigley@va.gov|
21273691|NCT04384978|DreamFace Technologies, LLC|President and CEO|7202015694|mmahoor@dreamfacetech.com|
21273692|NCT00385593|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21273693|NCT04544787|University of Antwerp|Pierre Van Damme, MD, PhD|+32 3 265 21 30|pierre.vandamme@uantwerpen.be|
21273694|NCT00925054|BioMarin Pharmaceutical Inc.|Medical Director|415-475-5854|ari.gershman@bmrn.com|
21273695|NCT00858845|University of California, Los Angeles (UCLA)|Dr. Holly R. Middlekauff|310-206-6672|hmiddlekauff@mednet.ucla.edu|
21273696|NCT04841317|Stanford University|Paul J. Wang, MD|(650) 723-7111|Paul.J.Wang@stanford.edu|
21273697|NCT04916548|University of Pittsburgh|Dr. Rebecca Price|412-383-2150|pricerb@upmc.edu|
21273698|NCT02100228|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21273699|NCT01964092|University of Oslo|Silje Endresen Reme|22845236|s.e.reme@psykologi.uio.no|+47
21273700|NCT00998374|Lenox Hill Hospital|Dr. Mitchell Roslin|212-434-3285|MRoslin@NSHS.edu|
21287466|NCT02305316|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21273701|NCT00322465|University of Alabama at Birmingham|Jane R. Schwebke, MD|(205) 975-5665|schwebke@uab.edu|
21273702|NCT00854100|Allergan, Inc|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
21273703|NCT00183794|USC/Norris Cancer Comprehensive Cancer Center|Agustin Garcia, MD|323-865-3900|aagarcia@usc.edu|
21273704|NCT00389064|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
21273705|NCT03616106|University of Colorado College of Nursing|Samantha Stonbraker, Assistant Professor|720-880-8194|Samantha.Stonbraker@Cuanschutz.edu|
21273706|NCT01880593|Icahn School of Medicine at Mount Sinai|Dr. James Murrough|212-241-7574|james.murrough@mssm.edu|
21273707|NCT02779543|Weill Cornell Medical College|Dr. Ana Krieger|6469629316|ack2003@med.cornell.edu|
21273708|NCT02298322|Zeltiq Aesthetics, Inc. an Allergan Affiliate|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
21273709|NCT05275205|Unity Biotechnology, Inc.|Study Director|650-513-0096|UBX1325_medicalmonitor@unitybiotechnology.com|
21273710|NCT02629094|National Institute of Allergy and Infectious Diseases|Hadigan, Colleen|+1 301 594 5754|hadiganc@mail.nih.gov|
21273711|NCT03041025|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21273712|NCT03962348|Columbia University Irving Medical Center|Dr. Michael Compton|646-774-8476|mtc2176@cumc.columbia.edu|
21273713|NCT02963259|Abbott|Erika Ross|+19725268207|Erika.ross@abbott.com|
21273714|NCT00091260|Boston Medical Center|Vaishali Sanchorawala|6176386521|vaishali.sanchorawala@bmc.org|
21273715|NCT03243630|Yale University|Mehmet Sofuoglu|203-932-5711|mehmet.sofuoglu@yale.edu|4809
21273716|NCT00939003|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21273717|NCT02648880|University of Colorado|Ryan Marker|3037240819|ryan.marker@cuanschutz.edu|
21273718|NCT02131129|IndianaU|Dr. Michael Francis|317-880-8495|mmfranci@iupui.edu|
21273719|NCT03707912|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
21273720|NCT03880266|Dermira, Inc|Jordan Adajar|650-421-2919|jordan.adajar@dermira.com|
21273721|NCT00467896|Actelion Pharmaceuticals, US, Inc.|Wade Benton, Pharm D / Director, Medical Affairs Veletri and Ventavis|(650) 624-6900|wade.benton@actelion.com|
21273722|NCT00486863|Warren Alpert Medical School of Brown University, Lifespan Center for International Health Research|Jennifer Friedman, M.D., Ph.D|(401) 444-7449|jennifer_friedman@brown.edu|
21273723|NCT03797872|University of Oxford|Professor Laura Coates|+447870257823|laura.coates@ndorms.ox.ac.uk|
21273724|NCT03818581|Massachusetts General Hospital|Dr. John Winkelman|617-643-9101|jwwinkelman@mgh.harvard.edu|
21273725|NCT00355797|BIOTRONIK, Inc.|CLEAR Study CSE|503-451-8051||
21273726|NCT01686451|Department of Cardiology, the Second Affiliated Hospital, Wenzhou Medical University, Zhejiang province, Wenzhou, 325000, China|Dr. JiFei Tang|+8615968766021|jiftang@126.com|
21273727|NCT01466166|Horizon Pharma Rheumatology LLC|Jeffery Nieves, PharmD|224-383-3000|clinicaltrials@horizonpharma.com|
21273728|NCT02096211|Johnson & Johnson MedTech|Dave Whalen|574-404-9399|dwhalen@its.jnj.com|
21273729|NCT01281501|Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital.|Khrongwong Musikatavorn, MD|+662-256-4000|kmusikatavorn@yahoo.com|4553-5
21287467|NCT04539275|Palo Alto Cooperative Studies Program Coordinating Center|Lisa Zehm, Project Manager|(650)493-5000|lisa.zehm@va.gov|28805
21287468|NCT02466399|Peregrine Ophthalmic Pte Ltd|Chief Operating Officer|65 97914382|jchua@peregrineop.com|
21287469|NCT00183339|University of North Carolina|Linmarie Sikich, MD|919 966 8653|Lsikich@med.unc.edu|
21287470|NCT01715831|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21273730|NCT02269657|Children's Hospital of Philadelphia|Saba Pasha, PhD|215-590-1815|pashas@email.chop.edu|
21273731|NCT03612960|Pennsylvania State University|Dr. Andrea Hobkirk|7175310003|ahobkirk@pennstatehealth.psu.edu|286415
21273732|NCT02956460|CooperVision|Jose Vega, O.D., MSc., FAAO|925-621-3761|JVega2@coopervision.com|
21273733|NCT00829673|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21273734|NCT00272779|Bristol-Myers Squibb|BMS Study Director||ClinicalTrials@bms.com|
21273735|NCT03199872|RhoVac ApS|Steven Glazer, MD|+4525674434|sgl@rhovac.com|
21273736|NCT01631331|Stanford University|Dr. Gina Kwon|650-724-3859|gkwon@stanford.edu|
21273737|NCT03450057|General Hospital of Athens 'Alexandra', Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine|Prof. Evangelos Terpos|+302102162540|eterpos@med.uoa.gr|
21273738|NCT04129346|Northwestern University Feinberg School of Medicine|Siobhan Phillips|312-503-4235|smphillips@northwestern.edu|
21273739|NCT05755282|Medline Industries, LP|Julie Miller|630-418-6891|jamiller@medline.com|
21273740|NCT02924883|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21273741|NCT00004562|New York University School of Medicine|Judith S. Hochman, M.D.|212-263-6927|judith.hochman@nyumc.org|
21273742|NCT00312663|WRAIR|James Cummings, MD|301-319-9312|james.cummings@us.army.mil|
21273743|NCT02841033|Boston Medical Center|Vaishali Sanchorawala, MD|617-638-8213|vaishali.sanchorawala@bmc.org|
21273744|NCT02566239|Oregon Health & Science University|Dr. Jeffrey Kaye|503 494 6695|kaye@ohsu.edu|
21273745|NCT03496623|United Therapeutics|United Therapeutics Global Medical Information|240-821-1881|304perfectstudy@lungbiotechnology.com|
21273746|NCT02543203|The Ohio State University Nisonger Center|Dr. Jill Ann Hollway|614-688-3848|Jill.Hollway@osumc.edu|
21273747|NCT01270503|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21273748|NCT02459951|Albert Einstein Healthcare Network|Nathaniel Mayer MD|215 663 6681|nmayer@einstein.edu|
21273749|NCT00724477|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21273750|NCT00904345|University of Michigan Rogel Cancer Center|Shruti Jolly, M.D.|734-936-4302|shrutij@med.umich.edu|
21273751|NCT00772941|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21273752|NCT02255097|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21273753|NCT00783367|University of Pennsylvania, Clinical Research Unit, Lymphoma Group|Ellen Napier, CRNP|215.279.1972|Ellen.Napier@pennmedicine.upenn.edu|
21273754|NCT02294253|NYS Psychiatric Institute|Adam Bisaga MD|646-774-6155|adam.bisaga@nyspi.columbia.edu|
21273755|NCT01808794|Tufts University|Associate Vice Provost for Research Administration & Development|617-627-7000|tss@tufts.edu|
21273756|NCT01745120|bluebird bio, Inc.|Study Medical Director|339-499-9300|medinfo@bluebirdbio.com|
21273757|NCT02714062|VIVUS|Sr. Director, Clinical Research|650-934-5200||
21273758|NCT03956862|GB001, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.|GB001, Inc. Study Director|1-866-668-4083|ClinicalTrials@gossamerbio.com|
21273759|NCT01780870|Beth Israel Deaconess Medical Center|Dr. Christos Mantzoros|6176678633|cmantzor@bidmc.harvard.edu|
21273760|NCT03861845|Florida International University|Dr. Jaclyn Schwartz|305-348-3106|jschwart@fiu.edu|
21273761|NCT03025945|Arizona Eye Consultants|Sean McCafferty, MD|520-327-3487|sjmccafferty66@hotmail.com|
21273762|NCT02819323|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
21287471|NCT00900562|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|0034 91846 60 00|clinicaltrials@pharmamar.com|
21287472|NCT03563222|Fresenius Kabi Germany|Jean-Marc Lohse, PhD|+49 6172|jean-marc.lohse@fresenius-kabi.com|4911
21287473|NCT01516216|Dana-Farber Cancer Institute|Kimmie Ng, MD, MPH|617-632-4150|Kimmie_Ng@dfci.harvard.edu|
21287474|NCT03098979|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
21287475|NCT02419807|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Stephen Grobmyer|1-866-223-8100|TaussigResearch@ccf.org|
21287476|NCT01006629|Abbott|Global Medical Services|800-633-9110||
21287477|NCT01065818|Columbia University|K.S. Clifford Chao, MD|212-305-9987|ksc2119@cumc.columbia.edu|
21287478|NCT02202252|Diskapi Training and Research Hospital|Melih Akinci, MD, Associate Prof|90 312 5962080|melihakinci@yahoo.com|
21287479|NCT03157089|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21287480|NCT00784875|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21287481|NCT00958074|University of Washington|Dr. Andrei Shustov|206-288-6744|ashustov@uw.edu|
21287482|NCT00470548|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu|
21287483|NCT00941928|University of Texas MD Anderson Cancer Center|Anna Franklin, MD, Assistant Professor|713-792-3497|rnjackso@mdanderson.org|
21287484|NCT03073486|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21287485|NCT02300610|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jingsong Zhang|813-745-3973|jingsong.zhang@moffitt.org|
21287486|NCT00095979|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
21287487|NCT01829347|Vital Therapies, Inc.|Robert Ashley|858-673-6840|rashley@vitaltherapies.com|
21287488|NCT03248297|University of Alabama at Birmingham|Alan Tita, MD|205-934-5612|atita@uab.edu|
21287489|NCT02051296|VA HCS Palo Alto|Dr Catherine Curtin|650-493-5000|ccurtin@stanford.edu|
21287490|NCT03316105|Mayo Clinic|Michael Camilleri, M.D.|507-284-2687|camilleri.michael@mayo.edu|
21238368|NCT01804101|Fred Hutchinson Cancer Center|Dr. Roland B. Walter|206-667-3599|rwalter@fredhutch.org|
21302176|NCT04491604|Krystal Biotech|Dr. Hubert Chen, MD, Senior Vice President of Clinical Development|(412) 586-5830|inquiries@krystalbio.com|
21302177|NCT01874340|Novartis|Study Director|862-778-8300||
21302178|NCT03263702|Icahn School of Medicine at Mount Sinai|Sam Cammack|212-824-8931|sam.cammack@mountsinai.org|
21302179|NCT03236662|UC Davis Health|Dr. Craig McDonald, Professor and Chair|(916) 734-4293|cmmcdonald@ucdavis.edu|
21302180|NCT02888119|NYU Langone Health|Dr. Ravinder Regatte|(212) 263-4857|Ravinder.Regatte@nyulangone.org|
21302181|NCT03330002|Essential Medical, a wholly owned subsidiary of Teleflex, Inc.|Darra Bigelow, Clinical Trials Manager|610-331-7299|darra.bigelow@teleflex.com|
21302182|NCT05573386|Andrews Research & Education Foundation|Director of Research|8509168570|jessica.truett@andrewsref.org|
21302183|NCT03899805|Dana Farber Cancer Institute|Suzanne George MD, PI|6176326826|suzanne_george@dfci.harvard.edu|
21302184|NCT05246514|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21302185|NCT03646123|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21302186|NCT02209532|Novadaq Technologies|Alicia Wilton|416-949-4992|alicia.wilton@stryker.com|
21302187|NCT04075734|Rutgers Cancer Institute of NJ|Dr. Katie Devine|7322357549|katie.devine@rutgers.edu|
21302188|NCT01802073|Stanford University|Dr. Kenneth Cox|(650) 723-5070|KCox@stanfordchildrens.org|
21302189|NCT00332722|Pain Management Center of Paducah|Dr. Laxmaiah Manchikanti, MD|2705548373|drlm@thepainmd.com|101
21302190|NCT02291016|University of Tennessee Graduate School of Medicine|Clinical Trials Coordinator|865-305-7975|jferris@utmck.edu|
21302191|NCT01776307|Sumitomo Dainippon Pharma Oncology|Tegan Nguyen|617-674-8745|tnguyen@bostonbiomedical.com|
21302192|NCT01584544|Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College|Dr. Jing Jin|8601087788122|jingjin1025@163.com|
21302193|NCT01327482|Massachusetts General Hospital|Dr. Caroline Mitchell|617-724-2182|caroline.mitchell@mgh.harvard.edu|
21302194|NCT00312195|Purdue Pharma L.P.|Clinical Leader, Executive Medical Director|800-733-1333||
21302195|NCT01018810|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21302196|NCT02902484|UT Southwestern Medical Center|Dr. Salwan Al Mutar|214-648-4008|salwan.almutar@utsouthwestern.edu|
21302197|NCT05871450|German University of Health and Sports|Wolfgang Ruf|+49 (030) 577 97 37 370|wolfgang.ruf@dhgs-hochschule.de|
21302198|NCT02872935|University of Iowa|Dr. Kokila Thenuwara|319-384-5876|kokila-thenuwara@uiowa.edu|
21302199|NCT01247272|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21302200|NCT03179319|Brown University|Katie Biello|401-863-3082|katie_biello@brown.edu|
21273763|NCT02017223|University of Southern California|Donna Spruijt-Metz, MFA PhD|310-577-6248|dmetz@usc.edu|
21273764|NCT01401647|University of Washington, Resuscitation Outcomes Consortium|Dr. Susanne May|206-685-1302|rochelp@uwctc.org|
21273765|NCT01837654|Assaf Harofhe MC|Dr. Kobi Stav|972-8-9779409|stavkobi@yahoo.com.au|
21273766|NCT05169710|Sumitomo Pharma America Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@suniovion.com|
21273767|NCT00221299|Unversity of California Davis|Nancy E. Lane MD, Director, Center for Musculoskeletal Health|916 734-0753|nancy.lane@ucdmc.ucdavis.edu|
21273768|NCT04107675|Zambon SpA|Ferdinando Ceravolo, MD|02 665241|ferdinando.ceravolo@zambongroup.com|
21273769|NCT02711852|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
21273770|NCT02431494|Nova Southeastern University|Sue Breno|9542621447|sb1382@nova.edu|
21302201|NCT01120717|Novartis Pharmaceuticals|Study Director|862 778-8300||
21273771|NCT03459807|University of California, San Francisco|Dr. Chi-yuan Hsu|415-476-2172|chi-yuan.hsu@ucsf.edu|
21273772|NCT03286465|The University of Texas Health Science Center at Houston|Javier Barreda Garcia, MD|713-500-6838|Javier.BarredaGarcia@uth.tmc.edu|
21273773|NCT03586726|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21273774|NCT00576056|University of Pittsburgh Medical Center|Dr. David Geller|412-692-2001|gellerda@upmc.edu|
21273775|NCT03197883|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21273776|NCT03031847|UPMC Presbyterian Hospital|Eric Pasquantonio|4126478210|pasquantonioej@upmc.edu|
21302202|NCT03117140|Univesity of Iowa Hospitals and Clinics|Melinda Seering|3193561616|melinda-seering@uiowa.edu|
21302203|NCT00947882|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21302204|NCT00329797|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21302205|NCT02093819|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21273777|NCT03273153|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21302206|NCT01966718|Arthritis Treatment Center|Dr. Nathan Wei|301-694-5800|nwei@arthritistreatmentcenter.com|
21302207|NCT02447302|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
21302208|NCT02791763|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|7343
21302209|NCT05334212|University Hospitals Cleveland Medical Center|Dr. Gabriel Smith|(440)827-5088|Gabriel.Smith@UHhospitals.org|
21302210|NCT00910299|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21273778|NCT02512900|MedImmune, LLC|Rene van der Merwe, Senior Director, Clinical Development, Respiratory, and Inflammation|301-398-0000||
21273779|NCT00838539|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
21273780|NCT01908205|Holland Bloorview Kids Rehabilitation Hospital|Lisa Genore|416-425-6220|lgenore@hollandbloorview.ca|6443
21238369|NCT01201811|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21273781|NCT03458871|The University of Texas Health Science Center at Houston|Dr. Argyrios Stampas|713-797-5938|argyrios.stampas@uth.tmc.edu|
21273782|NCT02612337|Otonomy, Inc.|Otonomy Medical Information Center|1-844-686-4636|medinfo@otonomy.com|
21273783|NCT03420300|National Taiwan University Hospital|Dr. Chen-Hua Liu|+886-223123456|jacque_liu@mail2000.com.tw|63572
21273784|NCT01790581|UNC Charlotte|Erik Wikstrom|704-778-5784|ewikstrom@uncc.edu|
21273785|NCT01944930|Lahey Hospital and Medical Center|Thomas Schnelldorfer|781-744-5100|thomas.schnelldorfer@lahey.org|
21273786|NCT04234997|The University of Texas Health Science Center at Houston|Robert Suchting, MD|713-486-2521|Robert.Suchting@uth.tmc.edu|
21273787|NCT02242201|Mayo Clinic|Dr. Rebecca L. Johnson|507-266-2049|Johnson.Rebecca1@mayo.edu|
21273788|NCT01379664|Cleveland Clinic Foundation|Daniel Sessler|216-444-4900|DS@OR.org|
21273789|NCT01424644|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21273790|NCT02372630|State University of NY at Buffalo|Paresh Dandona, B.Sc., M.B. B.S., D.Phil., F.R.C.P|71653518520|dandona@buffalo.edu|
21287491|NCT02330341|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
21287492|NCT00706797|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21287493|NCT02368132|Corporal Michael J Crescenz VA Medical Center|Dr. Shahrzad Mavandadi|215.823.5211|shahrzad.mavandadi@va.gov|
21287494|NCT01791595|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
21287495|NCT01776554|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
21287496|NCT01041859|Janssen Research&Development|Director, Clinical Leader|609-730-6777||
21287497|NCT03329885|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|clinical.trials@bms.com|
21287498|NCT01991795|Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
21287499|NCT02027025|Sun Pharma Advanced Research Company Limited|Mudgal Kothekar|912266455645|mudgal.kothekar@sparcmail.com|
21287500|NCT02643875|The Hong Kong Polytechnic University|Prof Pauline Cho|(852) 2766-6100|sopaulin@polyu.edu.hk|
21287501|NCT03883386|University of Michigan Medical School|Professor Kelly Walkovich|734-647-2893|kwalkovi@med.umich.edu|
21287502|NCT01326871|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
21287503|NCT01589315|Medical University of South Carolina|Mark S. George, MD|1843876 5142|georgem@musc.edu|
21287504|NCT01712711|Tehran University of Medical Sciences|Professor Raika Jamali|00982163120000|jamalira@tums.ac.ir|411
21287505|NCT01387269|Helsinn Therapeutics (US), Inc.|Richard K. Bourne, Ph.D.|732-603-2852|richard.bourne@helsinn.com|
21287506|NCT01200329|UT MD Anderson Cancer Center|Yago Nieto/Stem Cell Transplantation and Cellular Therapy|713-792-8750|ynieto@mdanderson.org|
21287507|NCT00677898|VA VISN 5 Mental Illness Research, Education and Clinical Center|Julie Kreyenbuhl, Pharm.D., Ph.D.|410-637-1864|Julie.Kreyenbuhl@va.gov|
21287508|NCT03400449|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
21287509|NCT01502085|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
21287510|NCT03684408|University of Missouri|Megha Garg MD|573-882-1026|gargmeg@health.missouri.edu|
21287511|NCT05994963|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21287512|NCT04158219|Hennepin Healthcare|Dr. Andrew Busch|6128736681|andrew.busch@hcmed.org|
21287513|NCT02374320|Ochsner Health System|Ken Bode|504.842.1936|ken.bode@ochsner.org|
21287514|NCT01814007|Zeltiq Aesthetics|Kerrie Jiang, Executive Director Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
21287515|NCT01324947|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
21287516|NCT01296412|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21287517|NCT02160626|Aclaris Therapeutics Inc.|Judith Schnyder|+1-484-329-2144|jschnyder@aclaristx.com|
21287518|NCT03415152|Abbott Laboratories|Irina Solnyshkina|+7 (495) 258-42 80|irina.solnyshkina@abbott.com|
21287519|NCT05471505|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21287520|NCT01778413|Hospital Clínic de Barcelona|Dr. Esteban Martinez|932275400|estebanm@clinic.cat|
21287521|NCT04194814|University of Sheffield|Dr Simon Danby|0114 2268515|s.danby@sheffield.ac.uk|
21287522|NCT01113749|University of North Carolina Chapel Hill|Laura C. Hanson, MD, MPH|9199665945|lhanson@med.unc.edu|
21287523|NCT02034006|Novartis Pharmaceuticals|Study Director|862-778-8300||
21287524|NCT02934178|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
21287525|NCT00542308|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
21287526|NCT02340676|Dana-Farber Cancer Institute|Dr. John Koreth, MBBS, DPhil|(617) 632-2949|John_Koreth@dfci.harvard.edu|
21287527|NCT01075048|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21287528|NCT03944616|University of California, Irvine|Dr. Andrew Odegaard|949-824-8544|aodegaar@hs.uci.edu|
21287529|NCT04596293|Bridge Biotherapeutics, Inc.|Clinical Trial Lead|031-8092-3280|clinicaltrials.gov_inquiries@bridgebiorx.com|
21287530|NCT01258374|Hospital Clinic|Dr. Josep Mallolas Masferrer|00 44 93 227 54 00|mallolas@clinic.cat|3312
21287531|NCT01287936|SanBio, Inc.|Bijan Nejadnik M.D.; Chief Medical Officer|650-625-2205|Bijan.Nejadnik@sanbio.com|
21287532|NCT00296244|Thomas Jefferson University|Carlo Gerardo B Ramirez, MD|215-955-5909|carlo.ramirez@jefferson.edu|
21287533|NCT00761319|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
21287534|NCT00607893|Case Western Reserve University|Reena Mehra|216-445-1698|mehrar@ccf.org|
21287535|NCT01373164|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21287536|NCT01799941|Avanir Pharmaceuticals|Nadine Knowles; Executive Director, Research & Development Operations|1-949-268-8972|nknowles@avanir.com|
21287537|NCT01605903|Massachusetts Eye and Ear Infirmar|Gillian Diercks, MD, MPH|617-573-3190|gillian_diercks@meei.harvard.edu|
21287538|NCT04596319|Armata Pharmaceuticals, Inc.|Mina Pastagia, MD|(310) 665-2928|mpastagia@armatapharma.com|
21287539|NCT01244477|Michael E DeBakey VAMC|Wright Williams, PhD, ABPP|713-794-7629|wright.williams@va.gov|
21287540|NCT02741284|Washington University in St Louis|Dr Nandini Raghuraman|314 362 7300|nraghuraman@wustl.edu|
21287541|NCT03617588|Theragnostics Ltd|Director of Clinical Operations|+44 330 606 7437|archie.hale@theragnostics.com|
21287542|NCT01499511|Imperial College London|Professor Peter Sever|02075941100|p.sever@imperial.ac.uk|
21287543|NCT03424304|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
21287544|NCT04459338|Mayo Clinic|Adrian Vella|507-284-3754|vella.adrian@mayo.edu|
21287545|NCT00853385|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21287546|NCT03181308|TRACON Pharmaceuticals Inc|Medical Monitor|8585500780|clinicaltrials@traconpharma.com|
21287547|NCT02515227|University of Virginia|Craig Slingluff, MD|434 924-9311|cls8h@uvahealth.org|
21287548|NCT00513799|Washington University|Stephanie Fritz|314-454-6050|fritz_s@kids.wustl.edu|
21273791|NCT02934347|Glan Clwyd Hospital, Betsi Cadwaladr University Health Board|Dr Raj Reddy|01745 583910|Rajashekhar.Reddy@wales.nhs.uk|
21273792|NCT02350647|Hawkins Foundation|Kyle Adams, Research Coordinator|864-454-7458|kyle.adams@hawkinsfoundation.com|
21273793|NCT00831428|University of Dundee|Dr Karine Clearie|01382 496440|k.clearie@dundee.ac.uk|
21273794|NCT01577381|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21273795|NCT05472038|BioNTech clinical trials patient information|BioNTech SE|6131 90840|patients@biontech.de|
21273796|NCT00539071|Northwestern University|Dr. Herbert Meltzer|(312) 503-0309|h-meltzer@northwestern.edu|
21273797|NCT03235739|Cleveland Clinic|Alparslan Turan, MD|216-4459857|turana@ccf.org|
21273798|NCT02996591|Hospital for Special Surgery|George Birch|2127747377|birchg@hss.edu|
21273799|NCT02378935|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21273800|NCT02440711|University of Washington|Dr. Brian Hafner|206-685-0214|bhafner@uw.edu|
21273801|NCT01980771|State University of New York, Downstate Medical Center|Tracey Wilson, Principal Investigator|718 270 2105|Tracey.Wilson@downstate.edu|
21273802|NCT04089917|Department of Interventional Neuroradiology, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain|Mariano Espinosa de Rueda|+34 968 36 96 42|mm.espinosa@gmail.com|
21273803|NCT00829790|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21273804|NCT03214952|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21273805|NCT03935880|University of Wisconsin - Madison|Andrew Brooks|248-953-9777|abrooks2@uwhealth.org|
21273806|NCT02476994|Baxter Healthcare|Clinical Trials Disclosure Group||joe_archer@baxter.com|
21273807|NCT02563561|Spectrum Pharmaceuticals, Inc. Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|(949) 788-6700|shanta.chawla@sppirx.com|
21273808|NCT03122535|University of Utah|Elizabeth Nuttall|8012133461|elizabeth.nuttall@hsc.utah.edu|
21273809|NCT01693523|UT MD Anderson Cancer Center|Dr. David Fogelman/ Associate Professor, GI Medical Oncology|832-710-7754|dfogelman@mdanderson.org|
21273810|NCT00200785|Silliker, Inc./Plant Bioactives Research Institute, Inc.|Larry D. Lawson|801-226-3041|larry.lawson@silliker.com|
21273811|NCT00280904|Codman & Shurtleff|J. Thomas Megerian|1-508-828-8274|jmegeri1@its.jnj.com|
21273812|NCT04459585|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21273813|NCT03020615|St. Jude Children's Research Hospital|Jeremie Estepp, MD|(901) 595-5703|jeremie.estepp@stjude.org|
21273814|NCT01273805|Dana-Farber Cancer Institute|Brian M. Wolpin|617.632.6942|Brian_Wolpin@dfci.harvard.edu|
21273815|NCT02647944|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
21273816|NCT00252720|AstraZeneca|Niklas Berglind, GPS Atacand|+46 31 7766310|ClinicalTrialTransparency@astrazeneca.com|
21273817|NCT02062580|University of Cape Town and University of Washington|Heather Jaspan|+2721 4066823|hbjaspan@gmail.com|
21273818|NCT05704426|Hackensack Meridian Health|Sameer Jamal, MD|15519962997|Sameer.Jamal@hmhn.org|
21273819|NCT02077465|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21273820|NCT02481830|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1(800) 332-2056|Clinical.Trials@bms.com|
21273821|NCT04627038|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21273822|NCT02325531|Kaiser Permanente Center for Health Research|Rachel Gold|5033352400|rachel.gold@kpchr.org|
21273823|NCT02760368|R-Pharm|Maria Lemak, Scientific Advisor|0074959567937|lemak@rpharm.ru|1408
21273824|NCT00794963|North Shore Long Island Jewish Health System, Zucker Hillside Hospita, Glen Oaks, NY|Peter Manu, MD|718 470-8290 pmanu@nshs.edu||
21273825|NCT01037114|GlaxoSmithKline|GSK Response Center|866-435-7343||
21273826|NCT01602419|Octapharma AG|Sigurd Knaub/SVP CR&D Haematology|+41 55 4512141|Sigurd.Knaub@octapharma.com|
21273827|NCT01565902|Novartis Pharmaceuticals|Study Director|862-778-8300||
21273828|NCT04314362|Azura Ophthalmics|Charles Bosworth|17145598435|charles.bosworth@azuraophthalmics.com|
21273829|NCT02294604|Shuang Ho Hospital, Taipei Medical University|Dr. Ka-Wai Tam|886-2-22490088|kelvintam@h.tmu.edu.tw|8860
21273830|NCT02251886|Herning Hospital|Finn Lauszus|+45 78434614|finlau@rm.dk|
21273831|NCT01675765|Aduro Biotech, Inc.|Corporate Communications|510-848-4400|press@aduro.com|
21273832|NCT01010932|Guerbet|Dr Pierre Desché, MD - VP Head of Development, Medical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
21273833|NCT00982397|Medtronic, plc|CRHF Clinical Research|800-328-2518|medtroniccrmtrials@medtronic.com|
21273834|NCT00204373|The University of Alabama at Birmingham|Dr. C. Mel Wilcox|205-934-6060|melw@uab.edu|
21273835|NCT00578552|Mayo Clinic|Amit Sood|507-266-1944|nicotineresearch@mayo.edu|
21273836|NCT02057458|Augusta University|Ryan Harris, PhD|7067215998|ryharris@augusta.edu|
21273837|NCT04263649|Becton, Dickinson and Company|Clinical Project Manager|00393452237718|gloria.viti@bd.com|
21273838|NCT04503174|Tandem Diabetes Care|Clinical Affairs|877-801-6901|clinicalaffairs@tandemdiabetes.com|
21273839|NCT00693628|Department of Orthopedic Surgery & Rehabilitation, Orthotics and Prosthetics Division|Jonathan Day||jonathan-day@ouhsc.edu|
21273840|NCT00836056|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21273841|NCT03226522|Axsome Therapeutics|Study Director|212-332-5061|cstreicher@axsome.com|
21273842|NCT00846495|Clinvest|Rebecca Browning|417-841-3664|rbrowning@clinvest.com|
21273843|NCT01079988|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21273844|NCT03546842|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21273845|NCT02352259|Institute of Oncology Ljubljana|Dr Gregor Serša|+38615874343|gsersa@onko-i.si|
21273846|NCT02158663|James A. Haley VA Hospital|F. Andrew Kozel|(813) 972-2000|FRANK.KOZEL@VA.GOV|
21273847|NCT01265056|The University of Iowa|Jennifer Lassner|319-335-2123|jennifer-lassner@uiowa.edu|
21302211|NCT01456897|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials||CL_OPCJ_RDA_Team@otsuka.jp|
21302212|NCT02695420|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21302213|NCT00916929|St Jude Medical|Tamara Shipman|408 522-6410|tshipman@sjm.com|
21302214|NCT02929407|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
21273848|NCT00965185|Massachusetts General Hospital|Dr. Steven K Grinspoon|617-724-9109|sgrinspoon@mgh.harvard.edu|
21302215|NCT04530136|Pharming Technologies BV|Anurag Relan, MD|0031 (0)71 5247400|a.relan@pharming.com|
21302216|NCT01442844|Massachusetts General Hospital|Dr. Alexandra Kimball|617-726-5066|harvardskinstudies@partners.org|
21302217|NCT01057589|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21273849|NCT05323396|University of North Carolina at Chapel Hill|Melisa Reimer-McAtee, MD|265 175 5056|melissa_reimer-mcatee@med.unc.edu|
21302218|NCT02055118|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21302219|NCT03098615|UAB|Leslie Roop|2059754917|lmroop@uabmc.edu|
21302220|NCT02281383|Memorial Sloan Kettering Cancer Center|Dr. Harry Herr, MD|646-422-4411|herrh@MSKCC.ORG|
21302221|NCT03800420|Clinical Trials_inquiries|Clinical Trials_inquiries|+82-31-8092-3280|clinicaltrials.gov_inquiries@bridgebiorx.com|
21302222|NCT03911102|Revance Therapeutics, Inc.|Todd Gross, PhD, VP, Clinical Development & Data Science|510-742-3400|tgross@revance.com|
21302223|NCT00419445|CoMentis (formerly Athenagen)|Carl Grove|650-869-7600|cgrove@comentis.com|
21273850|NCT00584922|University of Oklahoma Health Science Center|Sunny Po, MD, PhD|405-271-9696|Sunny-Po@ouhsc.edu|
21302224|NCT03508908|Aurum Institute|Dr. Eduard Sanders|254723593762|ESanders@auruminstitute.org|
21302225|NCT00329524|UAMS Department of Otolaryngology|John Dornhoffer, MD|501-686-7000|dornhofferjohnl@uams.edu|
21302226|NCT01881828|Jaeb Center for Health Research|Kellee Miller|15310 Amberly Drive|t1dstats@jaeb.org|
21302227|NCT00472030|University of Iowa|Janet Fairley, M.D.|319-384-8560|janet-fairley@uiowa.edu|
21302228|NCT00829504|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21302229|NCT05283031|Imperial College Ophthalmology Research Group|Jamie Spofforth|020 3312 6666|Jamiespofforth@nhs.net|
21302230|NCT01031836|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21302231|NCT03054129|Dr. İsmail Atabek Physical Therapy and Rehabilitation Center|Ertan Şahinoğlu, PT, PhD|+90 5326478653|ertan.sahinoglu@hotmail.com|
21302232|NCT01696929|Georgia Regents University|Dr. Brian Miller|706-721-4445|brmiller@gru.edu|
21302233|NCT02051933|CarolinasHS|Christine Churchill|704-355-6947|christine.churchill@carolinashealthcare.org|
21273851|NCT00408070|UCHC|Paige Dunion|860-679-6571|pdunion@uchc.edu|
21273852|NCT03681470|Icahn School of Medicine at Mount Sinai|Ingrid Sanabria-Gonzalez|212-523-3812|ingrid.sanabria@mountsinai.org|
21273853|NCT00762307|Zeltiq Aesthetics|Kerrie Jiang, Director of Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
21273854|NCT03500692|Abbott|Sripad Bellary|6503531726|sripad.bellary@abbott.com|
21273855|NCT04149964|William Beaumont Hospitals|Mitchell Shecter, DO|2487629363|mitchell.shecter@corewellhealth.org|
21273856|NCT01697696|Novartis Pharmaceuticals|Study Director|862-778-8300||
21273857|NCT04732195|Emory University|Dr. Lokesh Guglani|404-712-2324|lokesh.guglani@emory.edu|
21273858|NCT02066922|Alcon Research, Ltd.|Clinical Lead, Vision Care Development|1-888-451-3937|alcon.medinfo@alcon.com|
21273859|NCT03238781|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21273860|NCT03161405|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21273861|NCT01313780|Seoul Asan Hospital|Taewon Kim|82-2-3010-3910|twkimmd@amc.seoul.kr|
21273862|NCT02847650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21273863|NCT03772522|MAP Centre for Urban Health Solutions, Unity Health Toronto|Dr. Naomi Thulien|647-460-0781|ThulienN@mcmaster.ca|
21273864|NCT00218257|University of Minnesota|Dr. Sheila Specker|612-273-9806|speck001@umn.edu|
21273865|NCT02517294|Nemours|Dr Katrin Post-Martens|904-330-9942|Katrin.Post-Martens@nemours.org|
21273866|NCT03255733|Guided Therapy Systems|Rich Amodei, RDMS|480-649-8587|r.amodei@guidedtherapy.com|
21273867|NCT00875550|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com|
21273868|NCT01163461|VAMC Puget Sound|Dr. Diane Kendall (PI)|206-762-1010|diane.kendall@va.gov|
21273869|NCT03769896|Medical University of Innsbruck|Prof. Klaus Seppi|004351250481553|klaus.seppi@tirol-kliniken.at|
21273870|NCT01015703|BTG International Inc.|SVP Clinical Development|610-278-1660|angela.ogden@btgplc.com|
21273871|NCT02646124|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|(718)920-6266|befriedm@montefiore.org|
21273872|NCT05025345|Johnson & Johnson Surgical Vision|Luis Vargas, MD|714-247-8200|LVarga17@ITS.JNJ.com|
21273873|NCT00857454|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21273874|NCT00365365|Sanofi|Trial Transparency Team||Contact_Us@sanofi.com|
21273875|NCT00984022|Maricopa Integrated Health System|David Drachman|602-344-5161|david.drachman@mihs.org|
21273876|NCT01153503|University of Texas Southwestern Medical Center|Irina Gasanova, MD, PhD|214-590-0064|Irina.Gasanova@UTSouthwestern.edu|
21273877|NCT00573443|Avanir Pharmaceuticals|Nadine Knowles; Executive Director, Research & Development Operations|1-949-268-8972|nknowles@avanir.com|
21273878|NCT00418561|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21302234|NCT00594945|Jazz Pharmaceuticals, Inc.|Executive Director, Clinical Development|650 496 3777||
21302235|NCT00588861|Biomet Manufacturing|Nick Higdon, Clinical Research Specialist|1-800-348-9500|nicholas.higdon@biomet.com|3047
21302236|NCT02438358|Lumicell|Jorge Ferrer, Ph.D.|617-571-0592|jmferrer@lumicell.com|
21302237|NCT00923949|National Cancer Institute|Giuseppe Giaccone M.D.|301-496-4916|giacconeg@mail.nih.gov|
21273879|NCT01796171|Nordic Nanovector|Head of Clinical Operations|+47 22 18 33 01|mail@nordicnanovector.com|
21273880|NCT00829309|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21273881|NCT02322593|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.||toiawase@taiho.co.jp|
21273882|NCT01083693|Abbott|Global Medical Services|1-800-633-9110||
21238370|NCT02856113|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21273883|NCT00834418|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21273884|NCT00085293|University of Texas MD Anderson Cancer Center|Steven I. Sherman, MD / Professor|713-792-2841|sisherma@mdanderson.org|
21273885|NCT04567186|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, OD, MS, FAAO, Sr. Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
21273886|NCT01707420|University of Colorado|Thomas Notides|720-777-6005|thomas.notides@childrenscolorado.org|
21273887|NCT04860804|Maimonides Medical Center|Dr. Sergey Motov|718-283-8693|smotov@maimonidesmed.org|
21273888|NCT00448019|The University of Texas (UT) MD Anderson Cancer Center|MD Anderson Cancer Center Leukemia Department|713-792-7734|CR_Study_Registration@mdanderson.org|
21273889|NCT00089661|Amgen Inc.|Study Director|866-572-6436||
21273890|NCT00850174|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21273891|NCT01363765|InCo-TB project, Gama Filho University|Anete Trajman|5521-82189194|atrajman@gmail.com|
21273892|NCT00635492|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21273893|NCT03617523|Sanofi Pasteur Inc.|Medical Director|800-633-1610|Contact-US@sanofi.com|1#
21273894|NCT02682784|Medical University of South Carolina|Lisa Nunn|843-792-0476|jenkinli@musc.edu|
21273895|NCT01702987|Beth Israel Deaconess Medical Center|Jim Wu|617-754-2390|jswu@bidmc.harvard.edu|
21273896|NCT00467363|NICHD|Dr Enrique Schisterman|(301) 435-6893|schistee@mail.nih.gov|
21238371|NCT03494166|University of Arizona College of Nursing|Terry Badger, PhD (MPI) and Alla Sikorskii, PhD (MPI)|520-626-6058|tbadger@arizona.edu|
21273897|NCT04533594|JOHNS HOPKINS HOSPITAL|Dulce M. Cruz-Oliver, MD|4109558305|dcruzoli@jhmi.edu|
21273898|NCT00717405|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21273899|NCT02757105|RedHill Biopharma Ltd.|Dr. Terry F. Plasse|972-(0)3-541-3131|terry@redhillbio.com|
21273900|NCT00752973|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914 345 9001|natalie.yantovskiy@taro.com|
21273901|NCT05428020|Rush University Medical Center|Anne DeBenedetti, Director of Research, Adult Reconstruction|3124322468|anne.debenedetti@rushortho.com|
21273902|NCT00473330|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
21273903|NCT03502148|Privo Technologies|Dr. Manijeh Goldberg|9785872322|mgoldberg@privotechnologies.com|
21273904|NCT01975948|Dalhousie University, Department of Psychiatry|Dr. Bianca Lauria-Horner|902-473-5633|bianca.horner@dal.ca|
21273905|NCT00365846|Emory University|Stuart Knechtle, MD|404-727-8465|stuart.knechtle@emoryhealthcare.org|
21273906|NCT00904215|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21273907|NCT00640562|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
21273908|NCT00448591|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21273909|NCT02937870|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21273910|NCT00244764|GlaxoSmithKline|GSK Response Center|866-435-7343||
21273911|NCT02701556|Valeant Pharmaceuticals|Johnson Varughese|908 927-1162|johnson.varughese@bauschhealth.com|
21273912|NCT04022954|Abbott|Principal Scientist Clinical Research|1 202 253 5981|eric.horvath@abbott.com|
21273913|NCT03017885|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21273914|NCT04400890|formerly of Mount Carmel Health Systems|Marvin McCreary, MD|614-526-8492|Marvin.McCreary+RCT@gmail.com|
21273915|NCT03925532|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|7168451300|adrienne.groman@roswellpark.org|
21287549|NCT03451071|University of Alabama at Birmingham|Haller Smith|205-934-4986|hjsmith@uabmc.edu|
21287550|NCT00217490|Kaiser Permanente Center for Health Research|Victor J. Stevens, PhD|503 335 6751|victor.j.stevens@kpchr.org|
21287551|NCT03363906|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21287552|NCT00676143|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21287553|NCT00929669|University of Pennsylvania|Peter J. Snyder, MD|215-898-0208|pjs@mail.med.upenn.edu|
21287554|NCT00250588|CCHMC|Michael Seid|5138030083|michael.seid@cchmc.org|
21287555|NCT03502798|Duke University|Dr. Adam Wax|919-660-5143|a.wax@duke.edu|
21287556|NCT01391611|Stanford University Medical Center|Kristen Ganjoo, MD|650-725-6413|kganjoo@stanford.edu|
21287557|NCT01027845|GlaxoSmithKline|GSK Response Center|866-435-7343||
21287558|NCT03306199|Cardiovascular Institute of the South|Research Team Leader|(985) 873-5613|Deanna.Benoit@cardio.com|
21287559|NCT01670292|Palmer Center for Chiropractic Research|Dr. Ting Xia|563-884-5161|ting.xia@palmer.edu|
21287560|NCT01308619|Galderma Laboratories|Dr. Warren Winkelman|817-961-5494|warren.winkelman@galderma.com|
21287561|NCT01603277|KaloBios Pharmaceuticals Inc.|Nestor Molfino, MD|650-243-3100|nmolfino@kalobios.com|
21287562|NCT00087178|NRG Oncololgy|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
21287563|NCT02667639|Monitor CRO|Murat Özdemir|902122341260|murato@monitorcro.com|
21287564|NCT01692119|ABDA, Department of Medicine|Dr. Martin Schulz|+49 30 40004-514|arzneimittel@abda.de|
21287565|NCT02465450|Corbus Pharmaceuticals|Ajay Aggarwal, MD|781-250-9176|aaggarwal@corbuspharma.com|
21287566|NCT02182804|Division of Gastroenterology. Department of Medicine. Faculty of Medicine. Chulalongkorn University.|Dr. Piyapan Prueksapanich|6622564000|mpkus1@gmail.com|81001
21287567|NCT01258049|Xidea Solutions Limited|Dr Daryl Bendel||daryl@xideasolutions.com|
21287568|NCT01192815|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Panayiotis Savvides, MD|216-844-5946|Panayiotis.Savvides@uhhospitals.org|
21287569|NCT03451045|Corbus Pharmaceuticals, Inc.|Head of Clinical Operations|6179630100|info@corbuspharma.com|
21287570|NCT04142242|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21287571|NCT01092767|Medtronic, Inc., Aortic and Peripheral Vascular|Laura Regan, MPH - Study Lead|707-591-2743|laura.e.regan@medtronic.com|
21287572|NCT01048424|University of California, San Francisco|Alison Huang, MD|415-353-9751|ahuang@medicine.ucsf.edu|
21287573|NCT05597865|Washington University in St. Louis|Rachel Brathwaite|3147282869|rachel.brathwaite@yahoo.com|
21287574|NCT05063448|Colorado State University|Dr. Stephanie Rayburn|970-988-6306|Stephanie.Rayburn@colostate.edu|
21287575|NCT02475369|BIDMC|Caitlin Barrett|617-667-8266|cbarret5@bidmc.harvard.edu|
21287576|NCT00595361|Brigham and Women's Hopsital|Elliot Israel, MD|617-732-8110|eisrael@partners.org|
21287577|NCT02075125|Department of Cardiology, College of Medicine, Dong-A University.|Dr. Moo Hyun Kim; Director of Global Clinical Trial Center Dong-A University Hospital.|+82 (51) 240-2976|kimmh@dau.ac.kr|
21287578|NCT00982345|Indiana University|Dr. Amit Anand|317-274-7422|aanand@iupui.edu|
21287579|NCT06119854|CityUNYSPH|Denis Nash|3473316554|denis.nash@sph.cuny.edu|
21287580|NCT04798027|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21287581|NCT03210714|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21287582|NCT00803179|UMass Medical School|Michael Stalvey, MD, Principal Investigator|508-856-4280|mstalvey@peds.uab.edu|
21287583|NCT04609514|Duke University|Roger Vilardaga Viera, PhD|919-684-3441|roger.vilardaga@duke.edu|
21287584|NCT00193375|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net|
21287585|NCT02717195|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
21287586|NCT01141608|UT Southwestern Medical Center|Dr. Madhukar H Trivedi|214-648-0188|madhukar.trivedi@utsouthwestern.edu|
21273916|NCT05244421|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
21273917|NCT00424619|McMaster University|Dr. Alexandra Papaioannou|905-521-2100|papaioannou@hhsc.ca|77715
21273918|NCT01001208|Amgen Inc.|Study Director|866-572-6436||
21273919|NCT02739997|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21273920|NCT01723397|University of Chicago|Dr. Robert Naclerio|773-702-0080|rnacleri@surgery.bsd.uchicago.edu|
21273921|NCT00833937|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21273922|NCT01985308|Wave Neuroscience, Inc.|Mazaya Soundra, Clinical Trials Manager|9492292869|mazaya@waveneuro.com|
21273923|NCT01353664|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21273924|NCT03206177|University of Oklahoma Health Sciences Center, Stephenson Cancer Center|Dr. Kathleen Moore|405-271-8777|Kathleen-Moore@ouhsc.edu|
21273925|NCT00837486|Medtronic Neuromodulation|Eric Williamson, Clinical Evidence Specialist|763-526-7982|medtronicneurotrials@medtronic.com|
21273926|NCT02655679|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21273927|NCT00731783|Washington University|Stephanie A. Fritz, M.D., M.S.C.I.|314-454-6050|fritz_s@kids.wustl.edu|
21273928|NCT03154047|Prothena Biosciences|Wendy Curlin|650 837 8550|clinicaltrials@prothena.com|
21273929|NCT03591458|University of Utah|Scott Low|801-585-1380|scott.low@hsc.utah.edu|
21273930|NCT01705574|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21273931|NCT01215279|AstraZeneca|Anna Malmgren||ClinicalTrialTransparency@astrazeneca.com|
21273932|NCT00274781|The Cleveland Clinic|Mikkael Sekeres, MD, MS|216-445-9353|sekerem@ccf.org|
21273933|NCT02472366|Hopital Lariboisiere|Professor Pascale Massin|0149 95 24 74|pascale.massin@lrb.aphp.FR|
21273934|NCT03699020|University of California San Diego|Maile Young Karris|1-619-543-5039|m1young@health.ucsd.edu|
21273935|NCT04274686|University of New Mexico|Dr. Neal Gerstein|505-272-2610|ngerstein@salud.unm.edu|
21273936|NCT00905840|Johannes-Gutenberg-University Mainz|Prof. Dr. Dr Bilal Al-Nawas, Principal Investigator|0049 6131 17|al-nawas@mkg.klinik.uni-mainz.de|3083
21273937|NCT01827163|Memorial Sloan Kettering Cancer Center|Dr. Chau Dang, MD|914-367-7181|dangc@mskcc.org|
21273938|NCT03375463|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21273939|NCT03645785|Albany Medical Center|Vikas Bhatt|5182623341|bhattv@amc.edu|
21273940|NCT03075553|Mayo Clinic|Stephen M Ansell MD PhD|507/284-2511|ansell.stephen@mayo.edu|
21273941|NCT03620747|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21273942|NCT04920929|Access Vascular Inc.|Brian Hanley|1-781-538-6594|bhanley@accessvascularinc.com|101
21273943|NCT02129426|University of Louisville|John W. Berkenbosch|502-852-3720|john.berkenbosch@louisville.edu|
21273944|NCT01860521|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy|Dr. Umberto Leone Roberti Maggiore|00393289461340|ulrm@libero.it|
21273945|NCT00904423|Stanford Cancer Institute, Stanford University|Mark D Pegram, MD|650-723-5801|mpegram@stanford.edu|
21273946|NCT02214615|VAMC and Yale University|Stephen Waxman|203-937-3802|stephen.waxman@yale.edu|
21273947|NCT01513174|Fundación GECP|Eva Pereira|+34 934302006|gecp@gecp.org|
21273948|NCT02413320|University of Kansas Medical Center|Dr. Priyanka Sharma|913-588-6029|psharma2@kumc.edu|
21273949|NCT01900626|University of Wisconsin School of Medicine and Public Health|Benjamin J. Walker, MD|608/262-8858|bjwalker2@wisc.edu|
21273950|NCT03181594|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
21273951|NCT01200810|Rutgers Cancer Institute of New Jersey|Mark Stein, MD|(732) 235-8675|steinmn@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu|
21273952|NCT02477202|Memorial Sloan Kettering Cancer Center|Dr. Dennis Chi, MD|212-639-5016|chid@MSKCC.ORG|
21273953|NCT00003659|Memorial-Sloan Kettering Cancer Center|Dr. David Scheinberg|646-888-2190|scheinbd@mskcc.org|
21273954|NCT04405570|Ridgeback Biotherapeutics|Dr. Wendy Painter|786-687-2495|EIDD2801@ridgebackbio.com|
21273955|NCT00723710|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21273956|NCT04499963|Duke University|Richard Bedlack, MD, PhD|919-668-2839|richard.bedlack@duke.edu|
21273957|NCT00501345|UT MD Anderson Cancer Center|Jean-Bernard Durand, MD / Professor||CR_Study_Registration@mdanderson.org|
21273958|NCT01870856|Alcon Research, Ltd.|Anne Brobst, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21273959|NCT00359281|Aegerion Pharmaceuticals|Mark Sumeray, MD, Chief Medical Officer|617-500-7867|msumeray@aegerion.com|
21273960|NCT04419311|Aksaray University Training and Research Hospital|Dr. Erdem Aras Sezgin|+905057777697|sezginmd@hotmail.com|
21273961|NCT02155465|Memorial Sloan Kettering Cancer Center|Dr. Helena Yu, MD|646-888-4274|YuH@mskcc.org|
21273962|NCT04395222|Weill Cornell Medicine|Alexandra Gomez Arteaga, MD|646-962-7950|alg9117@med.cornell.edu|
21273963|NCT00925119|University of Maryland|Dr. Amber Beitelshees|410-706-0118|abeitels@medicine.umaryland.edu|
21273964|NCT01302548|University of Florida|Richard F Petrik, MD|352-265-5911|rpetrik@ufl.edu|
21273965|NCT01237054|National Cancer Institute|Dr. Peter Choyke|301-402-8409|pchoyke@mail.cc.nih.gov|
21273966|NCT01114893|Alcon Research, Lt.d|Alcon Clinical|888.451.3937|medinfo@alconlabs.com|817.568.67
21273967|NCT00913627|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21287587|NCT02577029|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
21287588|NCT02078817|University of Minnesota|Katherine Cullen|612-273-9732|rega0026@umn.edu|
21287589|NCT01274351|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21287590|NCT00535613|University of Wisconsin|Cari Meyer|(608) 265-5980|cmeyer@wisc.edu|
21287591|NCT02936999|Inova Health Services|Regulatory Research Coordinator|(571) 472-0239|elizabeth.gebregeorgis@inova.org|
21287592|NCT00959751|NeurAxon, Inc.|Thomas Lategan, PhD|417-673-6697|tlategan@neuraxon.com|
21287593|NCT03737994|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21287594|NCT01750502|Department of Cardiology, the Second Affiliated Hospital, Wenzhou Medical University, Zhejiang province, Wenzhou,China|Dr. JiFei Tang|15968766021|jiftang@126.com|
21287595|NCT03861039|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21287596|NCT03427892|UTexasSouthwestern|Dr. E. Sherwood Brown|(214) 645-6950|Sherwood.Brown@UTSouthwestern.edu|
21287597|NCT03255187|Department of Environmental Health, School of Public Health, Fudan University|Dr. Haidong Kan|86-21-54237908|kanh@fudan.edu.cn|
21287598|NCT04323592|University of Trieste|Prof. Marco Confalonieri|+393356895168|mconfalonieri@units.it|4667
21287599|NCT04319224|Jounce Therapeutics, Inc.|Stew Kroll, Chief Development Officer|(650) 576-9679|skroll@jouncetx.com|
21287600|NCT03261401|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21287601|NCT03703895|Center for Clinical and Cosmetic Research|Dr. Mark Nestor|3059336716|nestormd@admcorp.com|
21287602|NCT02879032|Bangabandhu Sheikh Mujib Medical University|Dr. Md. Mashiul Alam|+8801724490475|mashiull@gmail.com|
21287603|NCT02423408|Tonix Pharmaceuticals|Judith Gendreau, Senior Medical Director|858-433-5574|judy.gendreau@tonixpharma.com|
21287604|NCT00296335|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
21287605|NCT01142336|University of Washington|Ge Li, MD, PhD|(206) 764-2485|gli@uw.edu|
21287606|NCT01704261|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21287607|NCT02722967|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development||DT-inquiry@otsuka.jp|
21287608|NCT02391337|University of Birmingham|Prof. Dipak Kotecha|+44 (0) 7974 115676|d.kotecha@bham.ac.uk|
21287609|NCT04182958|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21287610|NCT04002791|Apex Heart Institute|Chairman|011 91 9824030576|theheartworld@gmail.com|
21287611|NCT00830128|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21287612|NCT00773357|Yale School of Medicine|Sherry McKee|2037373529|sherry.mckee@yale.edu|
21287613|NCT00846053|Washington University|Thomas Ferkol, MD|314 454 6000||
21287614|NCT01307813|University Hospitals Cleveland Medical Center|Jeffrey Marks, MD - General Surgeon|216-983-4930|Jeffrey.Marks@uhhospitals.org|
21287615|NCT00747214|Zalicus|Margaret Lee, PhD|617-301-7142|mlee@zalicus.com|
21287616|NCT01123655|Memphis VAMC|Arnold E. Postlethwaite,MD Principal Investigator|901 448 5774|apostlet@uthsc.edu|
21287617|NCT00062166|National Cancer Institute|Dr. Naris Nilubol|301-451-2355|niluboln@nih.gov|
21287618|NCT01894906|Rockwell Medical|Senior Director, Clinical Research & Operations|248-960-9009|rd@rockwellmed.com|
21287619|NCT04373031|Providence Portland Medical Center|Dr. David Page|503-215-1979|canrsrchstudies@providence.org|
21287620|NCT04158648|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21287621|NCT02121210|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21287622|NCT00885118|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21287623|NCT02816723|VA Northern California Health Care System|Juliana Baldo|925-372-4649|Juliana.Baldo@VA.gov|
21287624|NCT02873975|Dana-Farber Cancer Institute|Geoffrey Shapiro M.D., PhDDana-Farber Cancer Institute|617-632-6594|Geoffrey_Shapiro@dfci.harvard.edu|
21287625|NCT03638323|Groupe Hospitalier de la Rochelle Ré Aunis|Marie-Laure Vignaud, neuropsychologist|+33 (0)5 46 45 63 70|marie-laure.vignaud@ght-atlantique17.fr|
21287626|NCT00251758|Takeda Global Research & Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
21287627|NCT02147301|University of California, San Francisco|Curt Johanson|415-353-2310|curt.johanson@ucsf.edu|
21238372|NCT02831257|Massachusetts General Hospital|Scott Plotkin|617-724-5369|splotkin@mgh.harvard.edu|
21302238|NCT01129583|Columbia University Medical Center|TTC research fellow|212-305-3912|ttc@gmail.com|
21302239|NCT02338882|University of Plymouth|Dr Phillip Buckhurst|01752 588884|phillip.buckhurst@plymouth.ac.uk|
21302240|NCT01328405|University of Wisconsin School of Medicine and Public Health|Dr. Kristopher Schroeder|608-263-8100|kmschro1@wisc.edu|
21302241|NCT04672954|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21302242|NCT02165839|Stanford University|Oxana Palesh, Associate Professor of Psychiatry and Behavioral Sciences|(650) 725-7011|oxana.palesh@stanford.edu|
21302243|NCT02617485|Mabion S.A.|Adam Tuszyner|+48504441105|a.tuszyner@mabion.eu|
21302244|NCT03861988|Stanford University|Boris Heifets, MD, PhD|(650) 497-8057|bheifets@stanford.edu|
21302245|NCT00220779|Talecris Biotherapeutics|Ralph Kantor, PhD|1-800-520-2807|ralph.kantor@talecris.com|
21302246|NCT00791076|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
21302247|NCT04434846|NIH|Jessica Manning|+85561856557|Jessica.manning@nih.gov|
21302248|NCT01049945|Mayo Clinic|Shaji K. Kumar, M.D.||kumar.shaji@mayo.edu|
21302249|NCT02248675|VA Center of Excellence for Suicide Prevention|Wilfred R. Pigeon, PhD|(585) 393-7945|wilfred.pigeon2@va.gov|
21302250|NCT00830869|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21302251|NCT00617669|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21302252|NCT02506985|University of Kentucky|Susan Smyth|859-323-2274|susansmyth@uky.edu|
21302253|NCT03745820|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21302254|NCT00281658|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21302255|NCT00507728|UT MD Anderson Cancer Center|Paul M Cinciripini, MD, Chair, Behavioral Science|(713) 745-1868|pcinciri@mdanderson.org|
21302256|NCT02151773|Takeda|Takeda Study Registration Call Center|+1-877-825-3327|medicalinformation@tpna.com|
21302257|NCT03101111|Themis Bioscience|Christiane Thomasser|01 236 7151|christiane.thomasser@themisbio.com|
21302258|NCT03619811|UCSD|Clinical Research Coordinator|858-246-5236|mgreytak@ucsd.edu|
21302259|NCT00095940|Pediatric Brain Tumor Consortium|Assistant Director Operations and Biostatistics Center|901-595-2617|dana.wallace@stjude.org|
21302260|NCT00641641|University of New South Wales|Sean Emery|9385 0900|semery@kirby.unsw.edu.au|
21302261|NCT01290913|Boston Children's Hospital|Clinical Coordinator|6173556127|sara.little@childrens.harvard.edu|
21302262|NCT02864862|The University of Texas Health Science Center at Houston|Chun-Teh Lee|713-486-4384|Chun-Teh.Lee@uth.tmc.edu|
21302263|NCT01523275|University of California, San Francisco|Jolie Chang|415-353-2203|jolie.chang@ucsf.edu|
21302264|NCT01734889|Swedish Orphan Biovitrum|Medical Director|+46 8 697 20 00|erik.brouwer@sobi.com|
21302265|NCT00966875|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21302266|NCT01206322|Beth Israel Deaconess Medical Center|Dr. Vera Novak|617-632-8680|vnovak@bidmc.harvard.edu|
21302267|NCT00689117|GlaxoSmithKline|GSK Response Center|866-435-7343||
21302268|NCT00444678|NYU Langone Health|Deirdre Cohen, MD|212-731-5656|Deirdre.Cohen@nyulangone.org|
21302269|NCT01324518|Orion Global Clinical Operations|Clinical Study Director||jutta.hanninen@orionpharma.com|
21302270|NCT04250077|We The Village|Jane Macky, CEO|9176844267|jane@wethevillage.co|
21302271|NCT04693052|Northwestern University|Dr. Jeffrey Rado, MD,MPH,FAPA|312-695-5060|jeffrey.rado@nm.org|
21302272|NCT03319745|The University of Texas MD Anderson Cancer Center|Dr. Neema Navai|(713) 792-3250|nnavai@mdanderson.org|
21302273|NCT00870103|Alcon Research Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21302274|NCT01317550|MD Anderson Cancer Center|Dr. Zhongxing Liao, MD/Professor, Radiation Oncology Department|713-563-2300|zliao@mdanderson.org|
21302275|NCT01767142|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
21302276|NCT00926029|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
21302277|NCT03206788|Kansas University Medical Center|Dr. Matthias Salathe|913 588 6045|msalathe@kumc.edu|
21302278|NCT02471612|Tata Main Hospital|Dr.Deb Sanjay Nag|+91-7763807101|debsanjay@gmail.com|
21302279|NCT00833417|Genentech, Inc.|Medical Communications|800-821-8590||
21302280|NCT03236155|Rush University Medical Center|Anne DeBenedetti, CRC|3124322468|anne.debenedetti@rushortho.com|
21302281|NCT00862082|Proacta, Inc.|Director of Clinical Development|858-642-0386|clinicalops@proacta.com|
21302282|NCT01901250|Case Western Reserve University|Dr. Suchitra Nelson|216-368-3469|sxn15@case.edu|
21302283|NCT01396070|Stanford University Medical Center|Youn H Kim, MD|650-521-3545|younkim@stanford.edu|
21302284|NCT01400880|University of Florida|Dr. Tony Gregg|352-265-0111|greggar@ufl.edu|
21302285|NCT04254913|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp|
21302286|NCT01396057|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21302287|NCT02428478|Brigham and Women's Hospital|Andrew Wellman, MD, PhD||awellman@rics.bwh.harvard.edu|
21302288|NCT01324401|Harvard Medical School / Massachusetts General Hospital|Wayne Shreffler|617-726-6147|wshreffler@mgh.harvard.edu|
21302289|NCT01980485|Penn State University|Jonathan Foulds|717-531-3504|jfoulds@psu.edu|
21302290|NCT02873429|University of Pittsburgh|Carol M. Greco, Associate Professor of Psychiatry|412-623-6873|grecocm@upmc.edu|
21302291|NCT00744042|Alexion Pharma GmbH|Alexion Pharma GmbH||ClinicalTrials@alxn.com|
21302292|NCT00853567|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
21302293|NCT02654769|Teva Pharmaceuticals Inc., USA|Senior Director, Clinical R&D|1-888-483-8279|USMedinfo@tevapharm.com|
21302294|NCT02252939|Massachusetts General Hospital|Rachel Gottlieb, Research Coordinator|617-726-1569|rgottileb3@mgh.harvard.edu|
21302295|NCT01033448|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21302296|NCT02560025|Massachusetts General Hospital|Amir Fathi, MD|617-724-1124|AFATHI@mgh.harvard.edu|
21302297|NCT00746512|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21273968|NCT03254420|INSTITUT REGIONAL DU CANCER DE MONTPELLIER Cancer de Montpellier|Mme Aurore Moussion, Director of Direction of Clinical Research and Innovation|0467613102|drci-icm105@icm.unicancer.fr|+33
21273969|NCT02124122|Tulane SPHTM|Richard Oberhelman|5049882511|oberhel@tulane.edu|
21273970|NCT02089997|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21273971|NCT02444715|Luxembourg Institute of Science and Technology|Dr. Lübomira Spassova|+352 275 888 1|lubomira.spassova@list.lu|
21273972|NCT00095212|Massachusetts General Hospital|Steven Grinspoon, MD|617 724 9109|sgrinspoon@partners.org|
21273973|NCT00017953|Wake Forest School of Medicine|Dr. Mark Espeland, Principal Investigator|336-922-2072|mespelan@wakehealth.edu|
21273974|NCT02374853|University of Alberta|Dr. John Mullen|780-902-6327|jmullen@ualberta.ca|
21273975|NCT05844553|Imperial College London, National Heart & Lung Institute and RBH|Prof. Omar Usmani|02073518053|o.usmani@imperial.ac.uk|
21273976|NCT02281084|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21273977|NCT02305758|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21273978|NCT05593965|University of North Carolina at Chapel Hill|Justin Riddle, PhD|(919) 966-4584|justin_riddle@med.unc.edu|
21273979|NCT02272777|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21273980|NCT00440297|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21273981|NCT02445339|NYU Langone Health|Ryan P. McCormack, MD|212-562-6561|Ryan.McCormack@nyulangone.org|
21273982|NCT02024932|Novartis Pharmaceuticals|Study Director|862-778-1873||
21273983|NCT03020641|Ramon y Cajal University Hospital|Characterization of changes in peritoneal cells gene expression after standard versus low pressure l|610 312962|aserranor@salud.madrid.org|+34
21273984|NCT02851992|Zimmer Biomet|Lisette Smid, Clinical Project Lead|+31 62 395 6378|lisette.smid@zimmerbiomet.com|
21273985|NCT00727961|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21273986|NCT01421277|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6327|ClinicalTrialsDisclosure@merck.com|
21273987|NCT02186821|Novartis Pharmaceuticals|Study Director|1-888-669-6682|Novartis.email@novartis.com|
21273988|NCT02039908|Florida International University|William E. Pelham, Jr., Ph.D.|305-348-0477|wpelham@fiu.edu|
21273989|NCT01597245|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21273990|NCT01802320|The University of Texas MD Anderson Cancer Center, Clinical Research Operations|Dr. Scott Kopetz/Associate Professor, GI Medical Oncology|713-792-2828|SKopetz@mdanderson.org|
21273991|NCT04115293|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21273992|NCT02674152|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21273993|NCT02571907|Cook Research Incorporated|Alan Saunders, MS, Senior Manager, Biostatistics|765-463-7537|alan.saunders@cookmedical.com|321204
21273994|NCT03071575|Centers for Disease Control and Prevention|Dr. Takudzwa SAYI|404-718-3797|prp2@cdc.gov|
21273995|NCT00579345|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21273996|NCT01921894|University of Pittsburgh|Dr. Juan C. Celedon, Niels K. Jerne Professor of Pediatrics|412-692-8429|juan.celedon@chp.edu|
21273997|NCT00462345|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21273998|NCT03909607|Maimonides Medical Center|Sergey Motov MD|718-283-8693|smotov@maimonidesmed.org|
21273999|NCT02267187|University of Pittsburgh|Patsy Simon|412-648-9207|simonpa@upmc.edu|
21274000|NCT00508651|MedImmune, LLC|Judith Falloon, MD|301 398 0000|falloonj@medimmune.com|
21274001|NCT01530880|Columbia University|Michael Schmidt|212-305-8745|mjs2134@columbia.edu|
21274002|NCT02713425|Mayo Clinic|Stephen P. Whiteside, PhD, LP|507-284-2933|Whiteside.Stephen@mayo.edu|
21274003|NCT00738049|University of Texas Medical School at Houston|K. Lance Gould, MD|713-500-6611|K.Lance.Gould@uth.tmc.edu|
21274004|NCT03874715|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21274005|NCT00461786|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21274006|NCT00934050|Transition Therapeutics Ireland Limited and Transition Therapeutics USA Inc.|Susan Abushakra, MD, Chief Medical Officer|+1 650 425 6370|susan.abushakra@tthi.us|
21274007|NCT03161158|Fresenius Medical Care Deutschland GmbH|Dr. Jennifer Braun|+49 6172 609 93488|Jennifer.Braun@fmc-ag.com|
21274008|NCT00835991|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274009|NCT03570749|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
21274010|NCT02146105|McMaster University|Dr. Monica Maly|905-525-9140|mmaly@mcmaster.ca|27823
21274011|NCT04347018|University at Buffalo|Mohammed Al-Zainal|7168292845|malzaina@buffalo.edu|
21274012|NCT02718326|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
21274013|NCT03040362|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21274014|NCT00101647|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21274015|NCT00583453|University of Iowa|Douglas Van Daele|319-353-8162|douglas-van-daele@uiowa.edu|
21274016|NCT00455312|Masonic Cancer Center, University of Minnesota|Dr. Jakub Tolar, MD||tolar003@umn.edu|
21274017|NCT03868891|UPMC Children's Hospital of Pittsburgh|Dr. Amber Shaffer|412-692-6874|shafferad@upmc.edu|
21274018|NCT00777023|Depomed|Head of R&D|650-462-5900|msweeney@depomed.com|108
21274019|NCT02659150|Massachusetts General Hospital|Ahmed Tawakol, MD|617-724-3699|atawakol@mgh.harvard.edu|
21274020|NCT02246920|Teva Pharmaceuticals USA|Director, PD/CE Studies|1-888-483-8279|usmedinfo@tevapharm.com|
21274021|NCT02678286|Recro Pharma|Randall Mack|484-35-2470|rmack@recropharma.com|2406
21274022|NCT04111965|Laboratorios Sophia|Alejandra Sanchez-Ríos M.D.|:+52 (33) 3001 4200|alejandra.sanchez@sophia.com.mx|
21274023|NCT05342597|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp|
21274024|NCT02909907|Cleveland Clinic Foundation|Hubert H Fernandez|2164451108|FERNANH@ccf.org|
21274025|NCT02902211|University of Nebraskat at Omaha|Sara Myers|402-554-3246|samyers@unomaha.edu|
21302298|NCT02745080|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21302299|NCT05073432|University of Rochester|Dr. Allison Magnuson|585-602-5085|allison_magnuson@urmc.rochester.edu|
21302300|NCT04237116|Novartis Pharma GmbH|Study Director|(862) 778-8300|novartis.email@novartis.com|
21302301|NCT01821560|University of Pennsylvania|Dr. Teresa R. Franklin|215-746-1883|teresafr@pennmedicine.upenn.edu|
21302302|NCT01224145|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
21302303|NCT04189224|Johnson & Johnson Vision Care, Inc.|Thomas R Karkkainen.|1-800-843-2020|tkarkkai@its.jnj.com|
21302304|NCT00490529|Stanford University|Ronald Levy|650-725-6452|levy@stanford.edu|
21302305|NCT00802113|Columbia University|Prakash Satwani, MD|(212) 305-0223|ps2087@cumc.columbia.edu|
21302306|NCT01589653|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21302307|NCT01536067|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21302308|NCT02747433|MGH Institute of Health Professions|Susan Fasoli, ScD OTR/L, Associate Professor|617-643-4777|sfasoli@mghihp.edu|
21302309|NCT02386189|Iowa City VA Health Care System|Dr. Carolyn Turvey|319 358 9501|carolyn.turvey@va.gov|7714
21302310|NCT00606905|University of Chicago|Mary D. Stephenson, M.D. MSc|773 834-1167|mstephen@babies.bsd.uchicago.edu|
21302311|NCT04657666|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
21302312|NCT03120351|ClevelandCF|Bruce Vrooman|216-444-2200|vroomab@ccf.org|
21302313|NCT01651806|Rush University Medical Center|Brett Levine, MD|708.236.2664|levine.research@rushortho.com|
21302314|NCT01790243|Becton Dickinson|Anna Lovas|7634452382|anna.lovas@bd.com|
21302315|NCT01558128|Weill Cornell Medicine, Department of Anesthesiology|Michele Steinkamp, Research Nurse Specialist|212-746-2953|mls9004@med.cornell.edu|
21302316|NCT01022398|Creighton University|Cardiology Research Manager|402-280-4566|tammyburns@creighton.edu|
21274026|NCT02355886|University of Washington|George Schade|2065986190|grschade@uw.edu|
21274027|NCT02576938|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21274028|NCT03500341|Masimo Corporation|Chelsea Frank|949-297-7000|studies@masimo.com|
21274029|NCT01010555|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
21274030|NCT01593852|Catharina Hospital Eindhoven|Lukas Dekker, MD, PhD|+31 40 239 7000|lukas.dekker@catharina_ziekenhuis.nl|
21274031|NCT00838630|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274032|NCT02699866|Institut Straumann AG|Dr. Michael McCaskey, Team Leader Clinical Research|+41619651741|michael.mccaskey@straumann.com|
21274033|NCT03749252|Guerbet|Global Head of Medical Affairs & Clinical Development|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
21274034|NCT03098394|University of Maryland School of Medicine|Richard Gentry Wilkerson|4103285555|gwilkerson@som.umaryland.edu|
21274035|NCT01885117|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21274036|NCT01518972|VA Puget Sound Health Care System|Tracy L. Simpson, Ph.D.|206-277-3337|tracy.simpson@va.gov|
21274037|NCT03140631|Michigan Medicine|Dr. Hakan Oral|734-936-8214|oralh@med.umich.edu|
21274038|NCT01294917|Centre for Contact Lens Research|Clinical Scientist|519-888-4567|marc.schulze@uwaterloo.ca|36590
21274039|NCT02169115|Charité- Dpt. of Dermatology and Allergy|Professor Martin Metz|+49 30 450 518 159|martin.metz@charite.de|
21302317|NCT03255629|Joslin Diabetes Center|Mary Elizabeth Patti, MD|(617) 309-2635|MaryElizabeth.Patti@joslin.harvard.edu|
21302318|NCT01086358|Cleveland Clinic Foundation|Jennifer Kriegler, MD|216-444-8265|krieglj@ccf.org|
21302319|NCT03317405|Northwestern University|Seema A. Khan|312-503-4236|s-khan2@northwestern.edu|
21274040|NCT02159950|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21274041|NCT00575159|GlaxoSmithKline|GSK Response Center|866-435-7343||
21274042|NCT01499147|University of Illinois Cancer Center|Damiano Rondelli, MD|312-996-6179|drond@uic.edu|
21274043|NCT03285594|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
21274044|NCT00958334|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
21274045|NCT03733444|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
21274046|NCT02648438|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
21274047|NCT03138967|UT MD Anderson Cancer Center|Dr. Farzin Goravanchi / Anesthesiology & Perioperative Medicine|713-291-1163|fgoravan@mdanderson.org|
21274048|NCT02448862|Gangnam Severance hospital, Seoul, Korea|Dr. Jae Chul Koh, MD|82-01087023931|aneskoh@yuhs.ac|
21274049|NCT04604275|University of Miami|Amanda Fifi|305-243-3166|amandacfifi@gmail.com|
21274050|NCT02258074|Cleveland Clinic Foundation|Jennifer J. Gassman, PhD|216-444-9938|gassmaj@ccf.org|
21274051|NCT05446870|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21274052|NCT03444090|Evergreen General Hospital, Taoyuan, Taiwan|Dr. Chi-Liang Cheng|+886-3-4631230|chiliang.cheng@gmail.com|1510
21274053|NCT01208337|University of Pittsburgh|Dr. Rakesh Sindhi|412-692-6110|rakesh.sindhi@chp.edu|
21274054|NCT02399917|The University of Texas MD Anderson Cancer Center|Naval Daver, MD./Associate Professor|713-794-4392|NDaver@mdanderson.org|
21274055|NCT00984126|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
21274056|NCT01029340|BAYER|Therapeutic Area Head||clinical-trial-contact@bayerhealthcare.com|
21274057|NCT02648347|Akebia Therapeutics, Inc.|Clinical Trial Information Desk|+1 617-844-6128|trials@akebia.com|
21274058|NCT03335761|Medtronic|Mylène Champs (Sr Clinical Research Specialist)|+17635261627|mylene.champs@medtronic.com|
21274059|NCT01639222|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21274060|NCT01884519|GlaxoSmithKline|GSK Response Center|866-435-7343||
21274061|NCT02196675|Ethicon|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
21274062|NCT02009163|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21274063|NCT01415986|Roswell Park Cancer Institute|Gal Shafirstein, D.Sc.|716-845-4025|Gal.Shafirstein@RoswellPark.org|
21274064|NCT03122457|Icahn School of Medicine at Mount Sinai|Dr. Anjali Vekaria|212-241-3288|anjali.shroff@mssm.edu|
21274065|NCT03373162|University of California, Irvine|Dr. Craig Stark, Professor|949-824-4201|cestark@uci.edu|
21274066|NCT03686033|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
21274067|NCT02335658|Sumitomo Dainippon Pharmaceutical|Clinical Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
21274068|NCT02032888|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21274069|NCT03110003|University of Alabama at Birmingham|Dr. Mark Powell|205-975-3328|mfpowell@uabmc.edu|
21274070|NCT01754597|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
21274071|NCT00819741|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21274072|NCT01343004|Radius Health, Inc.|Program Director|(617) 551-4700|info@radiuspharm.com|
21274073|NCT03447353|National Advanced Driving Simulator, University of Iowa|Timothy Brown|3193354785|timothy-l-brown@uiowa.edu|
21274074|NCT02175095|Asan Medical Center|Yong Sang Hong, M.D., Ph.D.|+82-2-3010-3227|yshong@amc.seoul.kr|
21274075|NCT02635750|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21274076|NCT04196907|Masimo Corporation|Vikram Ramakanth|949-297-7000|clinicalresearchdept@masimo.com|
21274077|NCT02642653|University of California Davis|Dr. Randi Hagerman|9167030247|rjhagerman@ucdavis.edu|
21274078|NCT02875392|Taipei Municipal Wanfang Hospital|Ming-Shun Wu|+886229307930|vw1017@gmail.com|
21274079|NCT02392286|Yale|Dr. Loren Laine|203-785-7312|loren.laine@yale.edu|
21274080|NCT04974684|IKEM Prague|Dr. Zuzana Tucanova|+420 776292211|zuzana.tucanova@ikem.cz|
21274081|NCT01660243|Toray Industries, Inc|Clinical Trials Information Desk||clinical-trials.toray.mb@mail.toray|
21274082|NCT04299087|University of Florida|Dr. David Vaillancourt|(352) 294 - 1770|vcourt@ufl.edu|
21274083|NCT03025087|Duke University|Joseph Mathew, MD|919-681-6646|joseph.mathew@duke.edu|
21274084|NCT00594035|Integra LifeSciences|Director, Medical Affairs|609-275-0500||
21274085|NCT00795821|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21274086|NCT01285713|New York University, Langone Medical Center|Dr. Kari Posner|212-263-7300|kariposner@gmail.com|
21274087|NCT04210557|Yale University|Dr. Philip Corlett|203 974 7866|belieflab@yale.edu|
21274088|NCT03821675|Baylor College of Medicine|Prof. Bijan Najafi|17137987536|bijan.najafi@bcm.edu|
21274089|NCT00712959|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21274090|NCT00905606|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274091|NCT01558635|Medtronic, Bakken Research Center, Coronary and Structural Heart Disease Management (CSH), Endepolsdomein 5, 6229 GW Maastricht, The Netherlands|Ber Kleijnen, Sr Clinical Research Manager|+31653227763|ber.kleijnen@medtronic.com|
21274092|NCT01246076|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
21274093|NCT01727180|Far Eastern Memorial Hospital|Hon-Yen Wu, MD, PHD|+886-2-8966-7000|honyenwu@gmail.com|1164
21302320|NCT01137604|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
21302321|NCT00591318|New York State Psychiatric Institute|Brian Fallon|646-774-8052|brian.fallon@nyspi.columbia.edu|
21302322|NCT01024309|OrthoCarolina Research Institute|Dr. Susan Odum|704.323.2265|Susan.Odum@OrthoCarolina.com|
21302323|NCT00435045|GlaxoSmithKline|GSK Response Center|866-435-7343||
21274094|NCT00202722|Sorlandet Hospital HF|Tor Tveit|+4738073608|tor.tveit@sshf.no|
21274095|NCT03247972|Sinai Center for Thrombosis Research|Director of Clinical Trials|443-244-1497|kbliden@lifebridgehealth.org|
21274096|NCT00968812|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
21274097|NCT00609674|GlaxoSmithKline|GSK Response Center|866-435-7343||
21274098|NCT00571064|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
21274099|NCT02362997|Dana-Farber Cancer Institute|Philippe Armand, MD, PhD|617-632-2305|philippe_armand@dfci.harvard.edu|
21274100|NCT03410862|Cleveland Clinic|Jeff Negrey Study Coordinator|2166365504|negreyj2@ccf.org|
21274101|NCT02600403|Wills Eye Hospital|Michael Waisbourd|2159283000|MWaisbourd@willseye.org|
21274102|NCT02363803|Washington University in St. Louis|Dr. Simon Haroutounian|3143622628|sharout@wustl.edu|
21274103|NCT03872128|Yale University|Nia Fogelman|(917)861-9865|nia.fogelman@yale.edu|
21274104|NCT02926677|Stanford University|Hilit Kletter|650-723-5511|hkletter@stanford.edu|
21274105|NCT03702608|Medinol|Dina Kofler, VP Clinical Affairs|+97237679032|dinak@medinol.com|
21274106|NCT04267276|Boehringer Ingelheim|Boehringer Ingelheim|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21274107|NCT00746395|University of South Alabama|Jack A. DiPalma, M.D.|251-660-5555|jdipalma@usouthal.edu|
21287628|NCT01471626|CHU St Pierre|Dr Marie Bruyneel|003225354219|marie_bruyneel@tpierre-bru.be|
21274108|NCT00834431|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274109|NCT01312844|Massachusetts General Hospital|Dr. John Matthews|617-643-9095|jmatthews@partners.org|
21274110|NCT03637764|Sanofi Aventis Recherche & Développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21274111|NCT02689505|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21274112|NCT04108858|University of Texas M D Anderson Cancer Center|Dr. Senthil Damodaran, MD. PhD.|(832) 829-4307|sdamodaran@mdanderson.org|
21274113|NCT02107300|Medical University of South Carolina|Chitra Lal|(843) 792-7776|lalch@musc.edu|
21274114|NCT03663179|University of Pennsylvania|Leah Bernardo|2157467162|lleah@pennmedicine.upenn.edu|
21274115|NCT01615198|Novartis|Study Director|862-778-8300||
21274116|NCT01686438|Crescenz VA Medical Center|Dr. Samuel T. Kuna|215-823-4400|Samuel.Kuna@va.gov|
21274117|NCT01938066|The Ohio State University|Gayle Gordillo|6142938566|gayle.gordillo@osumc.edu|
21274118|NCT01864174|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21274119|NCT00468286|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
21274120|NCT02308475|Medical University of South Carolina|Brian Jacobs - Program Assistant|843-876-4922|jacobsbr@musc.edu|
21274121|NCT03117296|Henry Ford Hospital|Adele Myszenski, PT, DPT|313-916-1334|amyszen1@hfhs.org|
21274122|NCT02453386|Acorda Therapeutics|Christopher Kenney, Senior Vice President - Medical Affairs|914-326-5775|ckenney@acorda.com|
21274123|NCT02601625|AstraZeneca AB|Anifrolumab Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
21274124|NCT01935934|University Health Network - Princess Margaret Cancer Centre|Dr. Neesha Dhani|416-946-4501|neesha.dhani@uhn.ca|2361
21274125|NCT01289262|DrLutfiKirdarTRH|DR CEM TURAN|00905323513423|cemturan@gmail.com|
21274126|NCT00833586|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274127|NCT00838279|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274128|NCT04608188|University of South Carolina|Robert Weaver|8037775605|weaverrg@mailbox.sc.edu|
21274129|NCT03380845|MGH|Dr. Sandeep Saluja|6466621084|sandeep.s.saluja@gmail.com|
21274130|NCT00304187|New York State Psychiatric Institute|Dr. Michael Devlin|212-543-5748|mjd5@columbia.edu|
21274131|NCT01474551|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646-888-4162|chapmanp@mskcc.org|
21274132|NCT01921062|University Medical Center Groningen|Dieuwke Broekstra, PhD; postdoctoral researcher|0031503613531|d.c.broekstra@umcg.nl|
21274133|NCT01045161|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
21274134|NCT01854047|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21274135|NCT00773253|University of California San Francisco|Graham A. Glass, MD|415-353-2311|Graham.Glass@ucsf.edu|
21274136|NCT05178927|UF Health Proton Therapy Institute|Dr. Perry Johnson|904-588-1253|PBJohnson@floridaproton.org|
21274137|NCT03670017|Washington University School of Medicine|Grant Bochicchio, Harry Edison Professor of Surgery, Chief of Acute and Critical Care Surgery|314-362-9347|gbochicchio@wustl.edu|
21274138|NCT03173547|Therapeutics, Inc.|Clinical Project Manager|858-571-1800|ClinicalResearch@therapeuticsinc.com|
21274139|NCT00657553|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-569-6990|pettynathanm@uams.edu|2461
21274140|NCT01169558|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21274141|NCT02911701|University of New Mexico, Division of Maternal-Fetal Medicine|Dr. Nathan Blue|505-272-6309|nblue1297@gmail.com|
21274142|NCT00852696|Cleveland Clinic Florida|Cecilia Calvo|954-659-5637|calvoc@ccf.org|
21274143|NCT02409355|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21274144|NCT03134222|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21274145|NCT03482882|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
21274146|NCT00520234|Mycoses Study Group|Luis Ostrosky-Zeichner, MD|(713) 500-6733|Luis.Ostrosky-Zeichner@uth.tmc.edu|
21274147|NCT01110005|Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-6210|rsl1@psu.edu|
21274148|NCT02957942|University of Minnesota|Mo Chen|612-624-5220|mchen@umn.edu|
21274149|NCT04494867|Attune Medical|Erik Kulstad, MD|+1-708-651-0736|ekulstad@gmail.com|
21274150|NCT04611789|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21274151|NCT02538523|Regulatory Insight, Inc.|Elvira Cawthon|6154475150|elvira@reginsight.com|
21274152|NCT02820350|SeaStar Medical|Eric Schlorff, CEO|844-427-8100|eric@seastarmed.com|
21274153|NCT03801707|The Ohio State University|Brenda Cuson|614-293-6883|Brenda.Cuson@osumc.edu|
21274154|NCT05265624|University of Utah Moran Eye Center|Paul Bernstein, Principal Investigator|801-585-7231|Paul.Bernstein@hsc.utah.edu|
21274155|NCT00001703|National Cancer Institute, National Institutes of Health|Samir N. Khleif, M.D.|301-496-0901|khleifs@mail.nih.gov|
21274156|NCT03666026|UCLA|Principal Investigator|(310) 206-6328|pszilagyi@mednet.ucla.edu|
21274157|NCT02286739|Stryker|Kevin Barga|201 831 5073|kevin.barga@stryker.com|
21274158|NCT00834795|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274159|NCT01414153|Lpath, Inc.|Susan E. Hazel|858-926-3205|shazel@lpath.com|
21274160|NCT00089011|Fred Hutch|David G Maloney, MD PhD|(206) 667-5616|dmaloney@fredhutch.org|
21274161|NCT02057835|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21274162|NCT00834717|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274163|NCT02222818|Medtronic Cardiac Rhythm and Heart Failure|CRTee Clinical Team|800-328-2518|MedtronicCRMtrials@medtronic.com|
21274164|NCT03155425|Jiangsu Hengrui Pharmaceuticals Co., Ltd.|Clinical Operation Director: Chenglei Qiao|+86-18036618600|chenglei.qiao@hengrui.com|
21287629|NCT01981616|Millennium Pharmaceuticals Inc.|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
21287630|NCT02404545|Baptist Health South Florida - Miami Cancer Institute|Murugesan Manoharan MD, FRCS (Eng), FRACS (Urol)|305-595-2141|mmanoharan@baptisthealth.net|
21287631|NCT03641508|University of Iowa|Dr. Ericka Lawler|3193563943|ericka-lawler@uiowa.edu|
21287632|NCT03642990|University of Iowa|Donna L. Hammond, Ph.D Professor|319-335-9595|donna-hammond@uiowa.edu|
21287633|NCT00094445|University of Texas (UT) MD Anderson Cancer Center|Vivek Subbiah, MD / Assistant Professor, Investigational Cancer Therapeutics|713-563-0393|CR_Study_Registration@mdanderson.org|
21287634|NCT00855218|BAYER|Therapeutic Area Head||clinical-trial-contact@bayerhealthcare.com|
21287635|NCT00942786|Department of Anesthesiology and Intensive Care Medicine, Medical University of Graz, Austria|Elisabeth Mahla, MD|++43316385|elisabeth.mahla@medunigraz.at|13027
21287636|NCT00769561|Department of Clinical Psychology and Psychotherapy, Philipps University of Marburg, Germany|Dr. Meike Shedden Mora|+49-6421-282|m.shedden@staff.uni-marburg.de|3657
21287637|NCT02753881|Yale University|Todd Schlachter, MD|(203) 785-5885|todd.schlachter@yale.edu|
21287638|NCT00506675|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-975-8690|pedig@jaeb.org|
21287639|NCT02858908|AMO Pharma Ltd.|Dr. Mike Snape, Chief Scientific Officer|+44 (0) 7775915639|mike.snape@amo-pharma.com|
21287640|NCT03191552|Department of Physical medicine and Rehabilitation, Marmara University School of Medicine, Istanbul,Turkey|Esra Giray|+90216624545|girayesra@hotmail.com|6515
21287641|NCT04865588|Icahn School of Medicine at Mount Sinai|Director of The Zena and Michael A. Wiener Cardiovascular Institute|(212) 241-4021|samin.sharma@mountsinai.org|
21287642|NCT02370511|Mayo Clinic|Dr. Mayra Guerrero|507-255-1267|Guerrero.Mayra@mayo.edu|
21287643|NCT01149655|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21287644|NCT01162733|Christiana Care Health System|Deb Marco|302 733-4130|dmarco@christianacare.org|
21287645|NCT01265498|Johns Hopkins Data Coordinating Centers|Mark Van Natta|410-614-1362|mvannat1@jhu.edu|
21287646|NCT03092752|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21287647|NCT00545025|GlaxoSmithKline|GSK Response Center|866-435-7343||
21287648|NCT02764801|Thomas Jefferson University|John Eisenbrey, PhD|(215) 503-5188|John.Eisenbrey@jefferson.edu|
21287649|NCT03882918|Ovid Therapeutics Inc|Julia Tsai, PhD|(203) 623-1996|jtsai@ovidrx.com|
21287650|NCT06996301|Doc Lab Inc|Roel Chavez|971 570-4008|roel@doclabinc.com|
21287651|NCT04030598|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
21287652|NCT03658980|Hiroshima University|Zara Khair|+8801715342168|zara.oikee@gmail.com|
21287653|NCT05117060|LEO Pharma A/S|Clinical Disclosure|+45 44945888|disclosure@leo-pharma.com|
21287654|NCT03141359|Atrium Health Levine Cancer|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
21287655|NCT05079321|Centre for Ocular Research and Education|Lyndon Jones|(519) 888-4567|lwjones@uwaterloo.ca|35030
21287656|NCT02097823|Prevea Health/St Vincent Hospital|Dr. Catherine Long|9204338670|cathy.long@prevea.com|
21287657|NCT01081626|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21287658|NCT02003144|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
21287659|NCT00747916|Titus Regional Medical Center|Dr. Gordon Downie|903-572-9050|downieg@trhta.net|
21287660|NCT01419535|NIDDK, NIH|Lynnette Nieman MD|301-496-8935|NiemanL@nih.gov|
21287661|NCT00929838|Medical College of Wisconsin|Jennifer Campbell|414-955-8829|jacampbell@mcw.edu|
21287662|NCT02344316|UCSF Pediatric Headache Program|Amy Gelfand, MD|415-885-7832|Amy.Gelfand@ucsf.edu|
21287663|NCT05965752|Duke University|Daniel Laskowitz, MD|919-684-0056|daniel.laskowitz@duke.edu|
21287664|NCT05619471|Enspectra Health|President|650 480-6022|clinical@enspectrahealth.com|
21287665|NCT00032591|Palo Alto CSPCC|Bob Edson|(650) 493-5000|Bob.Edson@va.gov|22250
21287666|NCT04239924|BerbeeWalsh Department of Emergency Medicine|Dr. Manish Shah|608-263-9174|mnshah@medicine.wisc.edu|
21287667|NCT02839707|NRG Oncology|Christopher Purdy on behalf of Mike Sill, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
21287668|NCT04817189|Helsinn|Alessandro Alonzi, Medical Advisor|+41793262091|Alessandro.Alonzi@helsinn.com|
21287669|NCT00703534|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21287670|NCT00427934|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21287671|NCT02058095|Mayo Clinic|Horng H. Chen, M.D.|507-284-8896|chen.horng@mayo.edu|
21287672|NCT03860753|The University of Texas Health Science Center at Houston|Jin Ho Yoon, PhD|713-486-2800|jin.ho.yoon@uth.tmc.edu|
21287673|NCT00998946|Spectrum Pharmaceuticals, Inc|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
21287674|NCT01653418|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
21287675|NCT00148798|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21287676|NCT04452045|University of California, San Francisco|Lauren Asarnow|(415) 353-2273|lauren.asarnow@ucsf.edu|
21287677|NCT00915525|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21287678|NCT00577408|New York State Psychiatric Institute|Edward V. Nunes, MD|646-774-6122|edward.nunes@nyspi.columbia.edu|
21287679|NCT01289522|Centre Antoine Lacassagne|Pr. Joël GUIGAY|+33492031000|joel.guigay@nice.unicancer.fr|
21287680|NCT01708603|Bausch Health|Study Director|510-259-5284||
21287681|NCT02765035|Otto Bock Healthcare GmbH|Director of Clinical Research and Services Vienna|+4315233786733|Milana.Mileusnic@Ottobock.com|
21287682|NCT01604772|Memorial Sloan Kettering Cancer Center|Alan Ho, M.D.||hoa@mskcc.org|
21238373|NCT02277990|Medtronic|Daniel Lexcen, Sr. Clinical Program Manager|+17635269702|daniel.lexcen@medtronic.com|
21238374|NCT03821337|VA Medical Center|Program Manager|843-792-0476|lisa.nunn@va.gov|
21238375|NCT04179032|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21238376|NCT05417620|Johns Hopkins Bloomberg School of Public Health|Dr. Sheree Schwartz|443-983-2564|sschwartz@jhu.edu|
21238377|NCT03531320|InnoPharmax Inc.|Staff of Medical Affairs|886-2-8797-7607|yuan.lin@innopharmax.com|
21238378|NCT00386022|Massachusetts General Hospital|Dr. Janet E. Hall|617-877-1112|hall.janet@mgh.harvard.edu|
21238379|NCT03078816|UCSF Movement Disorders|Aaron Viser|415 353 9453|aaron.viser@ucsf.edu|
21238380|NCT02114151|Janssen Infectious Diseases - Diagnostics BVBA|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
21238381|NCT04992546|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21238382|NCT03063294|Veterans Affairs Greater Los Angeles Healthcare System|David Avram Ganz, MD, PhD|310-478-3711|David.Ganz@va.gov|
21238383|NCT01811212|The Ohio State University Compreshive Cancer Center|Manisha Shah, MD|614-366-6994|manisha.shah@osumc.edu|
21238384|NCT01659151|Moffitt Cancer Center|Amod Sarnaik, M.D.|813-745-8581|Amod.Sarnaik@moffitt.org|
21238385|NCT05774197|Harvard Medical School|Desiree Azizoddin, PsyD|4052718001|desiree_azizoddin@dfci.harvard.edu|50516
21238386|NCT01387139|Ucolorado|Keith Weisz|303-724-2592|keith.weisz@childrenscolorado.org|
21238387|NCT04981678|MaineHealth, Department of Anethesiology|Lead Research Coordinator|207-662-2862|janelle.richard@mainehealth.org|
21238388|NCT03421808|Medical University of South Carolina|Mark S. George, MD|18438765142|georgem@musc.edu|
21238389|NCT02235545|Abbott|Nicole Harbert, Program Director|1 972-526-4841|nicole.harbert@abbott.com|
21238390|NCT02760056|OHSU|Anna Orban|503-494-3549|orban@ohsu.edu|
21238391|NCT05377359|Sonova|Bilal Sheikh, Research Audiologist|2268083260|bilal.sheikh@sonova.com|
21238392|NCT01370525|AstraZeneca|Gerard Lynch|1625 518062|aztrial_results_posting@astrazeneca.com|+44
21274165|NCT06284525|Northern Arizona University|Principal investigator|928-523-1787|Zachary.Lerner@nau.edu|
21238393|NCT04791761|UPMC Children's Hospital of Pittsburgh|Dr. Amber Shaffer|4126926874|shafferad@upmc.edu|
21238394|NCT00335452|sanofi-aventis|Trial Information Transparency Team||GV-Contact-us@sanofi-aventis.com|
21238395|NCT02943941|Medtronic Inc|Verla Laager|(800) 328.2518|verla.l.laager@medtronic.com|
21238396|NCT02736825|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
21238397|NCT00790452|UT MD Anderson Cancer Center|Victor A Levin, MD, BS / Professor||CR_Study_Registration@mdanderson.org|
21238398|NCT02940574|KU Leuven|Prof. Dr. Kaat Alaerts|16 37 64 46|kaat.alaerts@kuleuven.be|+32
21238399|NCT00387894|University of California San Francisco|Michael Prados, MD|415-353-7500|PradosM@neurosurg.ucsf.edu|
21238400|NCT04810221|Life Meter Srl|Dr. Fernando De Benedetto/President|+39 391 4334 090|fernando.debenedetto@lifemetersrl.com|
21238401|NCT03642938|Duquesne University (now at University of Texas at Dallas)|Benedict Kolber|972-883-7225|Benedict.kolber@utdallas.edu|
21238402|NCT01566331|University of Padua|Dr. Erich Cosmi|+393398146745|ecosmi@hotmail.com|
21238403|NCT01583686|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|sar@nci.nih.gov|
21238404|NCT00643123|Cedars Sinai Medical Center|Felicia Mayes|310-423-0825|mayesf@cshs.org|
21238405|NCT02167217|Washington University School of Medicine|Anne M. Connolly, MD FAAN|314-362-6981|connollya@wustl.edu|
21238406|NCT02133872|University of Florida|Dr. Carl J. Pepine|(352) 339-0696|carl.pepine@medicine.ufl.edu|
21238407|NCT02573402|The University of Texas Health Science Center at Houston|Argyrios Stampas, MD|(713) 797-5007|Argyrios.Stampas@uth.tmc.edu|
21238408|NCT02623855|UCSF Benioff Children's Hospital Oaland|Dr. Nooshin Razani, Principal Investigator|415-428-3129|nrazani@mail.cho.org|
21238409|NCT01446666|Asan Medical Center, University of Ulsan College of Medicine|Professor Young-Suk Lim|+82-02-3010-5933|limys@amc.seoul.kr|
21238410|NCT00238433|Oregon Health & Science University|Richard Maziarz, MD|503-494-6365|maziarzr@ohsu.edu|
21274166|NCT02149420|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21238411|NCT03581084|UCSF Airway Clinical Research Center|Ariana Lowman|14155141539|ariana.baum@ucsf.edu|
21238412|NCT00409682|Abbott|Global Medical Services|800-633-9110||
21238413|NCT04710927|University Malaya Kuala Lumpur, Malaysia|Dr Tengku Nurfarhana Nadirah Tengku Hamzah|0379674802|tengkunurfarhana@um.edu.my|4865
21238414|NCT00118716|GlaxoSmithKline|GSK Response Center|866-435-7343||
21274167|NCT02598089|IVAC|Dr. Le Van Be||ivaclevanbe@gmail.com|
21274168|NCT00834067|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274169|NCT00440518|UCB Clinical Trial Call Center|Study Director|+1 877 822 9493||
21274170|NCT00561015|Janssen Research & Development, LLC|Clinical Leader|609-730-3174||
21274171|NCT03616535|NYU Grossman School of Medicine and Langone Health|Dr. Mara McAdams DeMarco|1-646-987-1358|mara.mcadamsdemarco@nyulangone.org|
21274172|NCT02303405|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu|
21274173|NCT03086460|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
21274174|NCT02436005|CooperVision Inc.|Paul Chamberlain|925 730-6754|PChamberlain@coopervision.com|
21238415|NCT00801801|UAB|Dr. Francisco Robert|205-934-5077|pacorobertuab@cs.com|
21274175|NCT04512781|Vapotherm|Amy Bergeski|570-351-6966|Abergeski@vtherm.com|
21287683|NCT01381120|Barrie Urology Associates|Dr. Joseph Zadra||joezadra@rogers.com|
21287684|NCT02732639|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21274176|NCT00804856|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21238416|NCT00855062|Harvard School of Public Health|Sachiko Miyahara|617-432-2837|miyahara@sdac.harvard.edu|
21238417|NCT03357614|Iterum Therapeutics|Senior Director, Clinical Development|18606614035|saronin@iterumtx.com|
21274177|NCT04994535|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21259925|NCT02690194|Boston Children's Hospital|Greggory Kobelski|7812161093|Greggory.Kobelski@childrens.harvard.edu|
21259926|NCT03624946|Emergent BioSolutions Canada Inc.|Jason Richardson, Senior Scientist, Clinical Research|204-275-4266|jrichardson@ebsi.com|
21302324|NCT00567255|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com|
21302325|NCT05037578|University of Kansas Alzheimer's Disease Research Center|Jaime Perales Puchalt|913-588-3716|jperales@kumc.edu|
21302326|NCT01743001|Actelion Pharmaceuticals Ltd|Clinical Trial Disclosure Desk||clinical-trials-disclosure@actelion.com|
21302327|NCT03194737|Teleflex/NeoTract|Emily Friedland, Director, Global Clinical Operations|925.387.6014|emily.friedland@teleflex.com|
21302328|NCT03052426|West Virginia University|Dr. Brandy Brown|304-293-1955|bkenned2@hsc.wvu.edu|
21302329|NCT05387434|University of Kansas Medical Center|Dr. Anna Gorczyca|913-588-9077|agorczyca@kumc.edu|
21302330|NCT03083990|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+86 13382419112|jessica.yi@innoventbio.com|
21302331|NCT02657408|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21302332|NCT01838980|Motus GI Medical Technologies Ltd.|Medical Consultant|+972-4-6214446|rose@motusgi.com|104
21302333|NCT02160041|Novartis Pharmaceuticals|Study Director|+1 (800) 778-8300|novartis.email@novartis.com|
21302334|NCT01403948|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21302335|NCT01090323|Novartis Pharmaceuticals|Study Director|862-778-8300||
21302336|NCT05498701|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21302337|NCT02424578|Iroko Pharmaceuticals|SVP Medical Affairs, Pharmacovigilance and Medical Information|2675463003|eoimagosie@iroko.com|3182
21302338|NCT03179605|Prosoft Clinical|Robert Babilon President|4843202068|b.babilon@prosoftclinical.com|
21302339|NCT00711477|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com|
21302340|NCT02448641|SanBio, Inc.|Bijan Nejadnik M.D.; Chief Medical Officer|650-625-2205|Bijan.Nejadnik@sanbio.com|
21302341|NCT00335764|Adult Brain Tumor Consortium (ABTC)|Mark Gilbert, MD|410-955-3657|jfisher@jhmi.edu|
21302342|NCT00597597|Rush University Medical Center|Ruta Rao|312-942-3324|ruta_d_rao@rush.edu|
21302343|NCT00612807|Duke University Medical Center|Jill Compton, Ph.D.|919-416-2089|compton@duke.edu|
21302344|NCT00800254|University of Colorado Denver|Jennifer Stevens-Lapsley, PhD|303-724-9170|jennifer.stevens-lapsley@ucdenver.edu|
21302345|NCT01567839|The Ohio State University, Division of Endodontics|Dr. John Nusstein|614-292-9412|nusstein.1@osu.edu|
21302346|NCT02645019|Nationwide Children's Hospital|Mineto Kamada|6147224200|mineto.kamata@gmail.com|
21302347|NCT00782834|Fox Chase Cancer Center|Margaret von Mehren, M.D., Director of Sarcoma Oncology|215-728-2814|margaret.vonMehren@fccc.edu|
21302348|NCT01955629|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21259927|NCT00624520|Department of Veterans Affairs|Dr Douglas C Russell|608-256-1901|Dcrussel@facstaff.wisc.edu|
21259928|NCT00675025|Eisai Inc|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
21259929|NCT02002702|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
21259930|NCT00556426|C.R. Bard|John Reviere, Director of Clinical Affairs|480-303-2644|john.reviere@crbard.com|
21259931|NCT01589484|University of Sao Paulo Medical School|Dr. Fabio Torricelli|+55 11 94308951|fabio_torri@yahoo.com.br|
21259932|NCT00944034|Novartis Vaccines|Posting Director|+39 0577 245863|anh.phung@novartis.com|
21274178|NCT01158118|Washington University School of Medicine|Mark Schroeder, M.D.|314-454-8304|markschroeder@wustl.edu|
21274179|NCT02157623|Cleveland Clinic|Edward Maytin, MD, PhD|216-445-6676|maytine@ccf.org|
21274180|NCT04238754|Johns Hopkins Univeristy|Cecilia Bergeria|410-550-1979|cberge21@jhmi.edu|
21274181|NCT01175018|Virginia Commonwealth University|Antonio Abbate|804-828-0513|aabbate@mcvh-vcu.edu|
21274182|NCT02558491|University of Virginia Center for Diabetes Technology|Daniel R. Chernavvsky, MD|434-982-0602|mc7m@virginia.edu|
21274183|NCT01788423|Indiana University, Department of Speech and Hearing Sci|Larry E. Humes|812-855-3507|humes@indiana.edu|
21274184|NCT03169062|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
21274185|NCT03359356|Icahn School of Medicine at Mount Sinai|Dr. Emma Guttman|212-241-9728|emma.guttman@mountsinai.org|
21274186|NCT03792477|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21274187|NCT01681745|Pacira Cryotech, Inc.|Kent Jones/ Sr. Director Quality and Medical Affairs|(510)933-1513|kent.jones@pacira.com|
21274188|NCT00840411|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274189|NCT05239754|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
21274190|NCT01424293|Maimonides Medical Center|Danny Sherwinter|7182837952|dsherwinter@maimonidesmed.org|
21274191|NCT01576042|Duke Clinical Research Institute|Sana M. Al-Khatib, MD, MHS|919-668-8649|sana.alkhatib@dm.duke.edu|
21274192|NCT03233724|National Cancer Institute|Dr. David S. Schrump|240-760-6239|david_schrump@nih.gov|
21274193|NCT02252133|Alcon Research, Ltd.|Senior Manager, Clinical Development, Japan|1-888-451-3937|alcon.medinfo@alcon.com|
21274194|NCT00651820|Healthpoint, Ltd.|Herbert B. Slade, M.D., FAAAI|817-900-4000|bert.slade@healthpoint.com|
21274195|NCT02388191|Planned Parenthood League of Massachusetts|Principal Investigator|6176298603|jfortin@pplm.org|
21274196|NCT01911676|Yale University|Christina Luddy|203-932-5711|christina.luddy@yale.edu|4549
21274197|NCT01566721|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
21274198|NCT00446563|Novartis Pharmaceuticals|Study Director|862-778-8300||
21274199|NCT03769025|Perelman School of Medicine|Kyle M Kampman MD Principal Investigator|215 746 2764|kampman@pennmedicine.upenn.edu|
21274200|NCT00398983|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani, MD / Associate Professor|713-745-0394|eharrison@mdanderson.org|
21274201|NCT03374176|Centro Universitario de Tonalá, Universidad de Guadalajara|Dr. Arieh Roldán Mercado Sesma|+52 (33) 20 00 23 00|arieh.mercado@academicos.udg.mx|6400
21274202|NCT05528588|UT Southwestern Medical Center|Ambarish Pandey, Principal Investigator|2146200286|Ambarish.pandey@utsouthwestern.edu|
21274203|NCT00906165|UCL Eastman Dental lnstitute University College London|Professor N Donos|+4420 3456 1075|n.donos@eastman.ucl.ac.uk|
21274204|NCT04659603|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21274205|NCT04646213|Virginia Commonwealth University|Dr. Ashlee Loughan|804-828-4178|ashlee.loughan@vcuhealth.org|
21274206|NCT01085825|Planned Parenthood of NYC|Research Director|212-274-7255|cti@ppnyc.org|
21274207|NCT02441309|University of Oxford|Joint Research Office|+441865572245|ctrg@admin.ox.ac.uk|
21274208|NCT01594047|Fondazione IRCCS Istituto nazionale dei Tumori|Tognoli Emiliano MD|+39 0223902282|Emiliano.Tognoli@istitutotumori.mi.it|
21274209|NCT01051570|Barbara Ann Karmanos Cancer Institute|Elisabeth I. Heath M.D.|313-576-8717|vaishamu@karmanos.org|
21274210|NCT03290781|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
21274211|NCT01077596|GlaxoSmithKline|GSK Response Center|866-435-7343||
21274212|NCT01462279|Beth Israel Deaconess Medical Center|Dr. Michael W. Donnino|6177542341|mdonnino@bidmc.harvard.edu|
21274213|NCT04044521|University of Wisconsin-Madison|Dr. Andrew Quanbeck|608-609-7308|andrew.quanbeck@fammed.wisc.edu|
21274214|NCT00811655|Duke University Medical Center|Denise Lally-Goss, NP|919-684-3862|denise.lallygoss@dm.duke.edu|
21274215|NCT01258933|The University of Texas MD Anderson Cancer Center|William Wierda, MD./Professor|713-745-0428|wwierda@mdanderson.org|
21274216|NCT04189848|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21274217|NCT04322500|University of Molise|Prof. Ciro Costagliola|+39 0874 404861/ 0874 404896|ciro.costagliola@unimol.it|
21274218|NCT00119015|University of Chicago|Robert Naclerio|(773) 702-0080|rnacleri@surgery.bsd.uchicago.edu|
21274219|NCT02608177|Kidney Research Institute, University of Washington|Dr. Ian de Boer, Associate Director|2067444029|IDeBoer@Nephrology.washington.edu|
21274220|NCT03429712|Duke University Medical Center|Daniele Marin|919-684-2711|daniele.marin@duke.edu|
21274221|NCT00526188|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21274222|NCT02798458|Massachusetts General Hospital|Dr. Braden Kuo and Dr. Claire-Zar-Kessler|617-724-6038|bkuo@mgh.harvard.edu, czarkessler@mgh.harvard.edu|
21274223|NCT02255149|University of Michigan|Dr. Hsun-Liang Chan|734-763-3325|hlchan@umich.edu|
21274224|NCT01376037|Center for Clinical and Cosmetic Research|Mark S. Nestor, M.D., Ph.D|305-933-6716|nestormd@ADMCORP.com|
21274225|NCT02328040|Children's Hospital at Montefiore|Dr. Rubina Heptulla|718-920-7004|rheptull@montefiore.org|
21274226|NCT00238615|Stanford University|Dr. Heather Wakelee|650-736-7221|hwakelee@stanford.edu|
21274227|NCT05604170|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
21274228|NCT05700383|Massachusetts General Hospital|Ana-Maria Vranceanu, PhD|617-724-4977|avranceanu@mgh.harvard.edu|
21274229|NCT04726345|Columbia University|Ezra J. Margolin, MD|212-305-0114|ejm2182@cumc.columbia.edu|
21274230|NCT03697109|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
21274231|NCT03032172|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21274232|NCT05244447|Midwest Evaluation and Research|Dr. Matthew Shepherd|833-643-9377|matt.shepherd@midwestevaluation.com|
21274233|NCT04516967|Sobi Inc.|Medicine Development Leader|1-781-786-7370|medinfo.us@sobi.com|
21274234|NCT00519194|St. Jude Medical|Sue Walgren, Manager Sr., Clinical Project|6517563210|swalgren@sjm.com|
21274235|NCT03165994|Pyxis Oncology, Inc.|Pyxis Oncology Clinical Operations|(339) 545 8252|clinicaltrials@pyxisoncology.com|
21274236|NCT00665470|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
21274237|NCT02301975|GlaxoSmithKline|GSK Response Center|866-435-7343||
21274238|NCT01379222|Medtronic|Thushari Alahapperuma|763.526.8119|thushari.r.alahapperuma@medtronic.com|
21274239|NCT01111461|Eisai, Inc.|Eisai Medical Services|18884224743|esi_medinfo@eisai.com|
21274240|NCT04278560|Hebrew SeniorLife|On-Yee Lo|6179715331|AmyLo@hsl.harvrd.edu|
21274241|NCT01415232|UPittsburgh'|Dr. Manuel Vallejo|4126414260|vallejomc@anes.upmc.edu|
21274242|NCT00163657|Baylor University Medical Center|Goran Klintmalm, MD Director|214-820-2050|michelle.acker@baylorhealth.edu|
21274243|NCT01319383|UNC Chapel Hill School of Medicine|Dr. David Margolis|919-966-6388|dmargo@med.unc.edu|
21274244|NCT01867164|Global Clinical Operations Mexico|Clinical Research Director|+52 55 5484 3184||
21274245|NCT01531894|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21274246|NCT06195579|University of Lincoln|Dr Nima Moghaddam|01522882000|nmoghaddam@lincoln.ac.uk|
21274247|NCT02545283|www.roche.com/about_roche/roche_worldwide.htm|Reference Study ID Number: WO29519|888-662-6728 (U.S. Only)|global-roche-genentech-trials@gene.com|
21274248|NCT04523168|Mayo Clinic|Dr. Amir Lerman|507-255-2446|lerman.amir@mayo.edu|
21274249|NCT03343535|TransMedics, Inc.|VP, Clinical Affairs|978-552-0900|ldamme@transmedics.com|
21274250|NCT00604162|Given Imaging|Hila Debby|+972 4 9097774|Hila.Debby@givenimaging.com|
21274251|NCT04808362|Peptomyc|Dr Niewel|+34932543450|mniewel@peptomyc.com|8684
21274252|NCT01909713|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5130|elizabeth.nieman@galderma.com|
21274253|NCT00736190|Gilead Sciences, Inc.|Eduardo Bruno Martins, MD, DPhil, Sr. Director, Medical Affairs - Hepatitis|650-522-5792|eduardo.martins@gilead.com|
21274254|NCT05014828|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21274255|NCT01450189|University of North Carolina at Chapel Hill|William C Miller|9199669407|bill_miller@unc.edu|
21274256|NCT01370317|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21274257|NCT00075478|Fred Hutchinson Cancer Research Center/|Dr. Brenda Sandmaier|206-667-4961|bsandmai@fhcrc.org|
21274258|NCT00002601|City of Hope|Paul Frankel, Ph.D.|(626)256-4673|pfrankel@och.org|65265
21274259|NCT00960297|Study Chair|David R. Spigel, M.D.|1-877-MY-1-SCRI|David.Spigel@scresearch.net|
21274260|NCT05763147|BD China|MA manager of Clinical Trial|0086 21 2325 4853|justina.zhu@bd.com|
21274261|NCT01299454|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800-562-3974||
21274262|NCT01891994|National Heart Lung and Blood Institute|Dunbar, Cynthia|+1 301 827 1164|dunbarc@nhlbi.nih.gov|
21274263|NCT01667679|Avanir Pharmaceuticals|Nadine Knowles; Executive Director, Research & Development Operations|1-949-268-8972|nknowles@avanir.com|
21274264|NCT03302780|University of Texas McGovern Medical School - Houston|Sheng Li, MD, PhD|7137977125|sheng.li@uth.tmc.edu|713
21274265|NCT01124305|AORI|Knee Project Director|7036194423|nparks@aori.org|
21274266|NCT00620711|Vanderbilt university|William F Walsh|615-322-0545|bill.walsh@vanderbilt.edu|
21274267|NCT00835263|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274268|NCT03856320|William S. Middleton VA Hospital|Dr. Luke Funk|608-256-1901|Luke.Funk@va.gov|17899
21274269|NCT03987191|University of Colorado Anschutz Medical Campus|Dr. Viral Shah, Principal Investigator|303-724-8186|viral.shah@cuanschutz.edu|
21274270|NCT00214097|University of Wisconsin|Diana Trask|608-263-9528|trask@humonc.wisc.edu|
21274271|NCT00741858|university of illinois at chicago|k.v. slavin|312-996-4842|kslavin@uic.edu|
21274272|NCT01341730|The Catholic University of Korea|Dr. Eun Ho Choo|82-10-8500-4569|cmcchu@catholic.ac.kr|
21274273|NCT01940341|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21274274|NCT03552393|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21274275|NCT05646251|Geisinger|Dr Pugazhendhi Vijayaraman|5708086020|pvijayaraman1@geisinger.edu|
21274276|NCT00465270|Abbott|Dr. Laura O'Brien||laura.obrien@abbott.com|
21274277|NCT01141374|University of São Paulo|Leonice Fumiko Sato Kurebayashi|55-11-91126023|fumie_ibez@yahoo.com.br|
21274278|NCT02605928|Department of Medicine, Division of Rheumatology, Helsinki University Central Hospital and University of Helsinki, Finland|PhD MD Ritva Peltomaa||ritva.peltomaa@hus.fi|
21274279|NCT01231906|Children's Oncology Group|Results Reporting Coordinator|6264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21274280|NCT05341622|University of Pennsylvania|Shivan Mehta|215-898-9807|shivan.mehta@pennmedicine.upenn.edu|
21274281|NCT02658084|University of Miami|Dr. Reshma Mahtani|954-698-3639|rmahtani@miami.edu|
21274282|NCT02324660|Azienda Ospedaliera Universitaria di Ferrara|Gianluca Campo, PI of the study|0532237079|cmpglc@unife.it|+39
21274283|NCT03600805|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21274284|NCT03635320|Johnson & Johnson Medical (Shanghai) Ltd.|Jie, Zhou|+86 18600551010|JZHOU138@its.jnj.com|
21274285|NCT03049748|Johns Hopkins University (Former Faculty at University of Michigan)|Dr. Jesus Casida|3132047665|jcasida1@jhu.edu|
21274286|NCT01471353|University of Florida|Dr. Thomas J. George, Jr.|352-273-8008|thom.george@medicine.ufl.edu|
21274287|NCT01735994|Pennington Biomedical Research Center|Dr. Tiffany Stewart, Director, Behavior Technology Laboratory|2257632554|tiffany.stewart@pbrc.edu|
21274288|NCT03123094|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21274289|NCT04162899|ReistoneBiopharma|Roger Liu, Medical Director|8613917512446|roger.liu@reistonebio.com|
21274290|NCT01011413|University of New South Wales|Sean Emery|02 9385 0900|semery@kirby.unsw.edu.au|
21274291|NCT02682238|Botanix Pharmaceuticals|Anthony Robinson, MS, CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
21274292|NCT01688609|St. Luke's International Hospital|Dr. Teruo Yamauchi|+81-3-3541-5151|tryhi@luke.ac.jp|
21302349|NCT01215097|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21302350|NCT02259088|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21302351|NCT00932828|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director of the UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
21302352|NCT04270370|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21302353|NCT00899431|The University of Texas MD Anderson Cancer Center|Dr. Issa F. Khouri, MD/Professor, Stem Cell Transplantation|713- 745-0049|ikhouri@mdanderson.org|
21302354|NCT03212144|Columbia University|Dr. Richard Sloan|6467748947|rps7@columbia.edu|
21259933|NCT03176316|Loyola University Medical Center|Russell Nockels, M.D.|847-618-9565|neurocare@nch.org|
21302355|NCT05688670|Duke University Medical Center|Lisa Einhorn, M.D.|(919) 668-4000|lisa.einhorn@duke.edu|
21302356|NCT00488683|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21302357|NCT03818035|Janssen Research & Development LLC|GUIDE-Study Responsible Physician|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21302358|NCT04507373|UT Southwestern Medical Center|Dr. Zahid Ahmad|214/648-2377|ZAHID.AHMAD@UTSouthwestern.edu|
21302359|NCT02793856|West China Hospital, Sichuan University|You Lu|+862885423571|283494287@qq.com|
21302360|NCT01248104|Loma Linda University Medical Center|Dr. Jason Gatling|909-558-4475|jgatling@llu.edu|44475
21302361|NCT02894502|University of Rome Tor vergata, Rome, Italy|Dr. Ercole Vellone|+393387491811|ercole.vellone@uniroma2.it|
21302362|NCT01410357|Case Western Reserve University School of Medicine and Neurological Institute|Dr. Martha Sajatovic|216-844-2808|martha.sajatovic@uhhospitals.org|
21302363|NCT00615901|Memorial Sloan Kettering Cancer Center|Dr. Pamela Drullinksy|516-256-3955|drullinp@mskcc.org|
21302364|NCT03630770|Women & Infants Hospital|Dr. Joseph Bliss|4012741100|jbliss@wihri.org|
21302365|NCT01710137|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@pennmedicine.upenn.edu|
21302366|NCT04620213|Ocuphire Pharma, Inc.|Drey Coleman|8134041993|dcoleman@ocuphire.com|
21302367|NCT00668733|Graceway Pharmaceuticals|Sharon F. Levy, MD / Sr. VP, Clinical Product Development|267-948-0400|sharon.levy@gracewaypharma.com|
21302368|NCT03467152|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
21302369|NCT04583709|Geisinger Heart Institute|Pugazhendhi Vijayaraman|5708085444|pvijayaraman1@geisinger.edu|
21302370|NCT00945906|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
21302371|NCT03700684|University of Massachusetts Amherst|Kelly Richardson|413-545-2007|krichardson@umass.edu|
21302372|NCT01120782|Johnson & Johnson Vision Care|Ross Franklin, OD|1-904-443-1379|RFrankl1@its.jnj.com|
21302373|NCT04140227|Bausch and Lomb|Johnson Varughese VP Clinical Services|908-927-1162|johnson.varughese@bausch.com|
21302374|NCT01331213|Mayo Clinic|Dr. Michael Camilleri|507-266-2305|camilleri.michael@mayo.edu|
21302375|NCT04586387|Virginia Commonwealth University|Carrie Peterson|804 827 5270|clpeterson@vcu.edu|
21302376|NCT00361634|Amgen Inc.|Study Director|866-572-6436||
21302377|NCT00635219|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
21302378|NCT01999517|Mount Sinai Medical Center|Gervasio Lamas, MD|305-674-2162|gervasiolamas@gmail.com|
21302379|NCT02420015|Duke University School of Medicine|Angela Kirby|919-286-0411|angela.kirby@duke.edu|175526
21302380|NCT04145219|ALK-Abelló A/S|Vice President, Clinical Operations Strategy|+45 4574 7576|clinicaltrials@alk.net|
21302381|NCT01640314|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21302382|NCT03672097|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21302383|NCT01290796|Bard Medical Division|Jaime Ritter, MPH, CCRP, CIC|770-784-6437|jaime.ritter@crbard.com|
21302384|NCT01632267|AssureRx|Joel Winner, MD|513-234-0510|jwinner@assurerxhealth.com|
21302385|NCT02709538|Glenmark Pharmaceuticals Ltd.|Study Director|201-684 8000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
21302386|NCT05099263|Aerin Medical|Anais Laborde, Sr. Director of Clinical Operations|6505189624|alaborde@aerinmedical.com|
21302387|NCT00835211|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21302388|NCT02343549|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
21302389|NCT03087617|Imbio, Inc|Director of Engineering|612520360|laurenkeith@imbio.com|2142
21302390|NCT01896206|Nationwide Children's Hospital|Joseph D. Tobias, MD|6147224200|Joseph.Tobias@nationwidechildrens.org|
21302391|NCT04450381|Masimo Corporation|Vikram Ramakanth|949-297-7000|clincalresearchdept@masimo.com|
21302392|NCT01864005|Astrazeneca|Judith Hsia|1-301-398-0102|judithhsia@astrazeneca.com|
21302393|NCT03899467|Suzhou Kintor Pharmaceuticals,Inc.|Millie Gu|+8651262639938|PR@kintor.com.cn|
21302394|NCT01962961|Indiana University School of Medicine|Samir K. Gupta|317-274-7926|sgupta1@iu.edu|
21302395|NCT03764293|Jiangsu Hengrui Pharmaceuticals Co., Ltd.|Yongli Xie|18581831003|yongli.xie@hengrui.com|
21302396|NCT02184572|GlaxoSmithKline|GSK Response Center|866-435-7343||
21302397|NCT00763698|St. Jude Medical|Director, Clinical Affairs|(408) 522-6410|tshipman@sjm.com|
21302398|NCT02495038|Yonsei University Wonju college of medicine|Dr. Wooyoung Park|563664250|wongulung28@gmail.com|971
21302399|NCT00006409|University of North Carolina - Chapel Hill|June Stevens|919-966-7218|june_stevens@unc.edu|
21302400|NCT05051631|Vanderbilt University Medical Center|Dr. Lucy Spalluto|615-875-5649|lucy.b.spalluto@vumc.org|
21302401|NCT03679754|Alaunos Therapeutics|Jaymes Holland|6502732627|jholland@alaunos.com|
21302402|NCT00964171|Institut Bergonié|Dr Marianne Fonck|05.56.33.32.42|m.fonck@bordeaux.unicancer.fr|
21302403|NCT00080899|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|: 60094
21259934|NCT01349140|University California San Diego|Brian Ilfeld, MD, MS|1-858-444-5949|bilfeld@ucsd.edu|
21259935|NCT02673333|Memorial Sloan Kettering Cancer Center|Diane Reidy-Lagunes, MD|646-888-4185|reidyd@mskcc.org|
21302404|NCT04615832|Fisher & Paykel Healthcare Ltd.|Bhavi Ogra|+64 9 574 0123|bhavi.ogra@fphcare.co.nz|7882
21274293|NCT00462228|Department of Physical Medicine and Rehabilitation, University of Missouri|Dr. S. Jon Rupright|573-882-3101|RuprightJ@health.missouri.edu|
21274294|NCT00567320|Yale University|Mehmet Sofuoglu, M.D., Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
21274295|NCT00824291|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21274296|NCT02115347|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21274297|NCT02849457|University of Alabama at Birmingham|E. Martina Bebin M.D., M.P.A.|205-975-2890|ebebin@uabmc.edu|
21274298|NCT00392665|Massachusetts General Hospital|Lori J. Wirth, MD|617-724-4000|LWIRTH@mgh.harvard.edu|
21274299|NCT02599558|Mayo Clinic|Jeffrey A. Alexander, M.D.|507+284-0474|Alexander.Jeffrey14@mayo.edu|
21274300|NCT02197481|The Second Affiliated Hospital of Anhui Medical University|Dr.Jiang-ming Chen|15855518651|chenjm10@126.com|86
21238418|NCT00530062|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21238419|NCT03059901|Klein Buendel|Valerie Myers, PhD|3035654343|vmyers@kleinbuendel.com|
21238420|NCT03595332|Northern Arizona University|Dr. Hendrik de Heer|9285231499|dirk.deheer@nau.edu|
21238421|NCT01155154|SUNY Downstate Medical Center|Shahriar Zehtabchi|718-245-2973|shahriar.zehtabchi@downstate.edu|
21238422|NCT01069354|Merz North America, Inc.|Ashlee Duncan|984-222-6040|ashlee.duncan@merz.com|
21238423|NCT03477279|University of North Carolina at Chapel Hill|Nora Rosenberg, PhD, MSPH|919-843-6580|nora_rosenberg@unc.edu|
21238424|NCT02202746|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
21238425|NCT03138733|Basilea Pharmaceutica|Dr Marc Engelhardt, MD|+41 79 701 0551|marc.engelhardt@basilea.com|
21238426|NCT02969837|University of Chicago|Member of the Biostatistics Lab|773.702.2453|slee@health.bsd.uchicago.edu|
21238427|NCT02098538|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho, MD, PhD|646-608-3774|hoa@mskcc.org|
21238428|NCT04723823|University of Pittsburgh|Debbie Harrington, CCRP|412-383-1355|debbie.harrington@pitt.edu|
21238429|NCT05107960|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21274301|NCT03673670|Verona Pharma plc|Brian Maurer|+19147675037|brian.maurer@veronapharma.com|9147675037
21274302|NCT04408794|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
21274303|NCT00187720|UCSF|Kathy Giacomini, Ph.D|4154761936|Kathy.Giacomini@ucsf.edu|
21274304|NCT03437265|Norgine|Lucy Clayton|+441895826669|LClayton@norgine.com|
21274305|NCT00252967|Brown University|Samuel Dudley, MD, PhD|4014443024|samuel_dudley@brown.edu|
21274306|NCT02294786|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21287685|NCT01668797|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21287686|NCT00827567|Penn State|Allan Lipton, MD|717-531-5960|alipton@psu.edu|
21287687|NCT05998967|VA San Diego HCS|Ariel J Lang, PhD, MPH|(858) 552-8585|ariel.lang@va.gov|
21287688|NCT01259245|Kwong Wah Hospital|Dr Lorna Ng|(852) 23322311|ngl@ha.org.hk|
21287689|NCT03261999|Foresee Pharmaceuticals Co., Ltd|John Mao|+886 2-7750-0188|john.mao@foreseepharma.com|
21238430|NCT05735587|Hebrew Rehabilitation Center|Dr. Courtney Millar|6179715531|courtneymillar@hsl.harvard.edu|
21287690|NCT05169905|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21274307|NCT01778010|New York State Psychiatric Institute at Columbia University Medical Center|Margaret Haney, Ph.D.|646-774-6153|meg.haney@nyspi.columbia.edu|
21274308|NCT04859517|INVIVYD, Inc.|Study Inquiry|17818190080|ClinicalTrials@invivyd.com|
21274309|NCT00840073|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21238431|NCT02618967|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21238432|NCT01533493|Massachusetts General Hospital|Joseph Biederman|617-724-1743|jbiederman@partners.org|
21274310|NCT00556322|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21274311|NCT03249454|The University of Texas Health Science Center at Houston|Radha Korupolu, MD, MS|713-797-6976|Radha.Korupolu@uth.tmc.edu|
21274312|NCT01913405|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21274313|NCT01020474|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21274314|NCT03450850|Chao Family Comprehensive Cancer Center, University of California, Irvine|Chao Family Comprehensive Cancer Center, University of California, Irvine|1-877-UC-STUDY|ucstudy@uci.edu|
21259936|NCT02737163|Johns Hopkins All Children's Hospital|Gerald Tuite, MD|7277678181|gtuite1@jhmi.edu|
21259937|NCT00701714|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com|
21259938|NCT01175798|Icahn School of Medicine at Mount Sinai|Anita Mehrotra MD|2122415153|anita.mehrotra@mssm.edu|
21259939|NCT02347631|UT Southwestern Medical Center|Danielle Robertson|214-648-3416|danielle.robertson@utsouthwestern.edu|
21259940|NCT03062657|Medtronic|Rhys Jones, PhD; Senior Clinical Research Specialist|+44 7826874430|rhys.j.jones@medtronic.com|
21259941|NCT00238264|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21259942|NCT00713219|Memorial Sloan Kettering Cancer Center|Dr. Matthew Fury|646-888-4233|furym@mskcc.org|
21259943|NCT01814787|Indiana University School of Medicine|Aaron E. Carroll, MD, MS|3172789616|aaecarro@iu.edu|
21259944|NCT00802360|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21259945|NCT03773302|QED Therapeutics, Inc.|Acting Chief Medical Officer|1-877-280-5655|PROOF301.ct@qedtx.com|
21259946|NCT02978222|Marker Therapeutics|Gerald Garrett|713.400.6400|ggarrett@markertherapeutics.com|
21259947|NCT01916629|Physicians Institute|Sharon Keene, MD|(520) 290-5555|monican@appliedbiology.com|
21259948|NCT03258814|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21259949|NCT01900002|UT MD Anderson Cancer Center|Dr. Ahmed Kaseb, MD, Professor, GI Medical Oncology|(713) 792-2828|akaseb@mdanderson.org|
21259950|NCT04591054|Penn State Hershey Medical Center|Seth Pantanelli MD|717-531-4696|spantanelli@pennstatehealth.psu.edu|
21259951|NCT03382509|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21259952|NCT01662648|Janssen China|Regional Medical Franchis Director AP|+86 10 582 187 66||
21259953|NCT01261559|University of Washington|Dr. Claire Sandstrom|206-744-3561|cks13@uw.edu|
21259954|NCT02928952|VAPHS, Center for Heath Equity Research and Promotion|Monica DiNardo PhD, Primary Investigator|412 360-2262|monica.dinardo@va.gov|
21259955|NCT02292212|Asahi Kasei Medical Co., Ltd.|Masaharu Aritomi, Ph.D.||aritomi.mb@om.asahi-kasei.co.jp|
21259956|NCT04957290|Noxopharm|Lorena, Director Clinical Operations|+ 61 2 9144 2223|lorena.figueroa@noxopharm.com|
21259957|NCT00896532|Amgen Inc.|Study Director|866-572-6436||
21259958|NCT00848120|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21259959|NCT02525549|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
21259960|NCT03219073|University of Iowa|Thorsten Rudroff|17205323701|thorsten-rudroff@uiowa.edu|
21259961|NCT02238847|Boston Scientific Corporation|Lina Ginnetti, Clinical Endoscopy Director|508-683-4512|lina.ginnetti@bsci.com|
21259962|NCT01961115|Fred Hutchinson Cancer Research Center|Dr. Martin A. Cheever|206-667-4141|mcheever@fredhutch.org|
21302405|NCT05343624|University Hospitals Cleveland Medical Center|Dr. Tanureet Arora|(440)892-6424|Tanureet.Arora@UHhospitals.org|
21259963|NCT01734317|Mölnlycke Health Care|Joan Wilson|+1 706-650-1012|joan.wilson@molnlycke.com|
21259964|NCT01083667|HSS/WCMC|Dale Lange|6467978917|langed@hss.edu|
21259965|NCT00360399|Emory University|Helen Mayberg|404-727-6740|hmayber@emory.edu|
21259966|NCT00705263|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
21259967|NCT05501119|Medical University of South Carolina|Dr. Diana Layne|(843) 792-8515|layne@musc.edu|
21259968|NCT01752023|SKCCC at Johns Hopkins|Ronan Kelly, MD|443-287-0005|rkelly25@jhmi.edu|
21259969|NCT02899156|University of California Davis Medical Center|Kendra Schomer, PharmD|916-734-2243|kjschomer@ucdavis.edu|
21259970|NCT02440581|University of Kentucky|Division Administrator|859-218-4943|daniel.ormond@uky.edu|
21259971|NCT01468987|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21259972|NCT00787787|Cancer Consortium|Medical Director, Clinical Research Support|206-667-5767|lmendels@fredhutch.org|
21259973|NCT00299988|Weill Cornell Medical College|Norman Relkin, MD, PhD|212-746-9882|nrelkin@med.cornell.edu|
21259974|NCT01889602|University of Minnesota|Dr. Susan Marino|612-624-2964|marin007@umn.edu|
21259975|NCT03120832|Senseibio|Ramzi Melhem MD Medical Director|9168336928|rmelhem@senseibio.com|
21259976|NCT01078805|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21259977|NCT02246621|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
21259978|NCT01943565|Brigham and Women's Hospital|Dirk J Varelmann, MD|617-732-8280|dvarelmann@partners.org|
21259979|NCT01292057|Medical University of South Carolina|Joseph Schacht, Ph.D.|(843) 792-7497|schacht@musc.edu|
21259980|NCT03639948|University of Kansas Medical Center|Dr. Priyanka Sharma|913-588-6029|psharma2@kumc.edu|
21259981|NCT04533711|University of North Carolina at Chapel Hill|Kelli Allen, PhD|919-966-0558|kdallen@email.unc.edu|
21259982|NCT04585763|Shockwave Medical|Birgit Greschner|650-575-6199|bgreschner@shockwavemedical.com|
21259983|NCT02561897|Electrophysiology Research Foundation|Sanjeev Saksena|7323029990|eprf@aol.com|
21259984|NCT01974817|Michigan State University|Dr Subhashis Mitra|517-353-3128|mitrasub@msu.edu|
21259985|NCT03658889|ChugaiPF|Isabelle Idier, Rheumatology Medical Leader|+33 (0) 1 56 37 44 89|idier@chugai-pharm.fr|
21259986|NCT02923271|University of Pennsylvania|Dr. M. Kit Delgado|215-746-8256|Mucio.Delgado@uphs.upenn.edu|
21259987|NCT03021577|Columbia University Irving Medical Center|Ziad A. Ali, MD Assistant Professor of Medicine|212-305-7060|zaa2112@cumc.columbia.edu|
21259988|NCT01524991|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-643-5842|jsmith@hoosiercancer.org|41
21259989|NCT01805180|Terumo BCT|Raymond P. Goodrich, PhD / VP, Scientific and Clinical Affairs; Chief Science Officer-BBT|303.205.2680|Ray.Goodrich@terumobct.com|
21259990|NCT01922921|University of Washington|Director of Clinical Operations|2066162305|childj@u.washington.edu|
21259991|NCT00206726|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21259992|NCT00595231|Acorda Therapeutics|Christopher Kenney, Senior Vice President - Medical Affairs|9143265775|ckenney@acorda.com|
21259993|NCT01341457|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21259994|NCT00365989|InSightec|Nadir Alikacem|214-630-2000|nadira@insightec.com|
21259995|NCT00832819|Eisai Co., Ltd.|Wataru Yusa|+81 3-3817-5252||5252
21259996|NCT02318095|Regulatory Coordinator|Linda Kaltenbach, PhD|(919) 681-6804|Linda.Kaltenbach@duke.edu|
21259997|NCT01717638|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21259998|NCT00254410|The University of Texas MD Anderson Cancer Center|Wierda,William G, MD./Professor|713-745-0428|wwierda@mdanderson.org|
21259999|NCT01061008|UWalesBangor|Dr. Jamie Macdonald|+441248383272|j.h.macdonald@bangor.ac.uk|
21260000|NCT00544830|City of Hope|Dr. Cy Stein|626-359-8111||
21260001|NCT04067518|Institut de Recherches Internationales Servier|Clinical Studies Department|+33 1 55 72 43 66|scientificinformation@servier.com|
21260002|NCT00862251|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21260003|NCT02796755|Emory University|Andrew H Miller, MD|404-727-8260|amill02@emory.edu|
21260004|NCT01509625|Hospital Clínico San Cecilio Granada|Dr Isabel Blancas|+34 958023498|blancaslb@hotmail.com|
21260005|NCT02304926|FISABIO-University Hospital Dr Peset|Dr Antonio Hernández|961622492|hernandez_antmij@gva.es|
21260006|NCT04258579|Weill Cornell Medical College|Dr. Jo Anne Sirey|914-997-4333|jsirey@med.cornell.edu|
21260007|NCT04007159|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21260008|NCT01963481|NYU Langone Health|Sylvia Adams|212 731 5795|Sylvia.Adams@nyulangone.org|
21260009|NCT01510327|Boston Scientific|Ruth Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com|
21260010|NCT02076165|VA Greater Los Angeles Healthcare System|Dr. Jennifer Martin|818 891-7711|Jennifer.Martin@va.gov|36080
21260011|NCT03804684|Wills Eye Hospital|M. Reza Razeghinejad, MD|12159283197|reza@willseye.org|
21260012|NCT04340050|University of Chicago|Leila Yazdanbakhsh|773-834-5087|leila.yazdanbakhsh@bsd.uchicago.edu|
21260013|NCT03183128|Seres Therapeutics|Lisa von Moltke, MD, Chief Medical Officer|617-945-9626|clinicalstudies@serestherapeutics.com|
21260014|NCT03670030|Ochsner Medical Center|Robert Ramirez, DO|504-464-8500|awendt@ochsner.org|
21260015|NCT02266433|New York University School of Medicine - Division of Hand Surgery|Anthony Sapienza, MD / Assistant Professor|212 737 3301|Anthony.Sapienza@nyulangone.org|
21260016|NCT02658812|UT MD Anderson Cancer Center|Dr. Naoto T. Ueno, MD-Professor Breast Medical Oncology|713-792-8754|nueno@mdanderson.org|
21260017|NCT03400800|Novartis|Vice-President, Regulatory Operations|973-985-0597|frank.bosley@novartis.com|
21260018|NCT01512264|Universtiy of Alabama at Birmingham|Dr. Jerzy P. Szaflarski|205.975.5587|jszaflarski@uabmc.edu|
21260019|NCT01194440|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|443-287-6489|HopkinsBreastTrials@jhmi.edu|
21260020|NCT01931059|Northwell Health|Dr. Miklos Argyelan|718-470-8175|margyela@northwell.edu|
21302406|NCT02640508|UT Health San Antonio|Virginia Kaklamani, MD|210-450-3838|kaklamani@uthscsa.edu|
21287691|NCT04232137|Vanderbilt University Medical Center|Dr. Tobias Limperg|(615) 343-6710|tobias.limperg@vumc.org|
21287692|NCT01206764|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
21238433|NCT01456299|Ajou University|Dr.Kim|82-32-460-3400|kjyeop@ajou.ac.kr|
21238434|NCT00525525|University of California San Francisco|Michael D. Prados, MD, FACP|415-353-2383|pradosm@neurosurg.ucsf.edu|
21260021|NCT01239355|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
21260022|NCT01859247|The University of New Mexico Health Sciences Center|Dr. Sarah Pirio Richardson, MD|505-272-3342|spiriorichardson@salud.unm.edu|
21260023|NCT02675075|James A. Haley VA Hospital|Dr. Sam Phillips|813 558 3995|samuel.phillips@va.gov|
21260024|NCT03686969|CRMG|Mikaela Raymond|866-337-1868|ctgov@cllinicalresearchmgt.com|
21260025|NCT01144598|Abbott|Global Medical Services|1-800-633-9110||
21260026|NCT02344225|SUNY Downstate Medical Center|Jacob V. Aranda, MD, PhD, FRCPC, Principal Investigator|718-270-1912|jaranda@downstate.edu|
21260027|NCT01988090|Baylor College of Medicine|Tao Wang|7137985388|taow@bcm.edu|
21260028|NCT04870671|Eastern Virginia Medical School|Dr. Terry Jacot|757-446-7056|jacotta@evms.edu|
21260029|NCT03887130|Pierre Fabre|Gustavo Villanova M.D|+33149108265|gustavo.villanova@pierre-fabre.com|
21260030|NCT00927563|University of Chicago|Dr. Jon Grant|773-834-1325|jongrant@uchicago.edu|
21260031|NCT00777179|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21260032|NCT02497001|Pearl Therapeutics Inc.|Pearl Therapeutics Inc.|1-877-240-9479|information.center@astrazeneca.com|
21260033|NCT02730260|Washington University School of Medicine|Dr. Walton Sumner|314-454-8164|wsumner@dom.wustl.edu|
21260034|NCT00654498|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21260035|NCT03135249|UT Southwestern Medical Center|Dr. Olaf Stuve, Principal Investigator|12146484559|olaf.stuve@utsouthwestern.edu|
21260036|NCT03430986|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21260037|NCT03257189|MC10 Inc|Chief Medical Officer|8572145600|ACombs@mc10inc.com|
21260038|NCT01412957|Amgen Inc.|Study Director|866-572-6436||
21260039|NCT01245673|University of Pennsylvania|Liz Veloso|215|eveloso@pennmedicine.upenn.edu|
21260040|NCT00954109|Harry S Truman Memorial VA Hospital and University of Missouri|John Thyfault, Associate Professor|573-814-6000|thyfaultj@health.missouri.edu|53742
21287693|NCT04494646|NYU Langone Health|Sripal Bangalore, MD, MHA|(212) 263 3540|Sripal.Bangalore@nyulangone.org|
21302407|NCT05405257|Baylor College of Medicine|Keren Machol|7137987359|machol@bcm.edu|
21302408|NCT00776919|GlaxoSmithKline|GSK Response Center|866-435-7343||
21302409|NCT02371941|The University of Tennessee Health Science Center|Dr. Jay Lieberman|901-287-7337|jlieber1@uthsc.edu|
21302410|NCT01472718|Cardiac Catheterization Laboratory, Cardiothoracic and Vascular Department, Azienda Ospedaliero-Universitaria Pisana,|Marco De Carlo, MD, PHD|+39 050995326|marcodecarlo@gmail.com|
21302411|NCT01469715|University of Virginia|Stacey Anderson, MD||sg4c@virginia.edu|
21302412|NCT01454258|University Hospital Frankfurt|Prof Dr Dr Kai Zacharowski, FRCA|004969630186668|kai.zacharowski@kgu.de|
21302413|NCT02751385|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21302414|NCT03091348|Men|Abraham Morgentaler|617-277-5000|research@menshealthboston.com|
21302415|NCT04534686|University of Illinois at Chicago|Tanvi Bhatt|3123554443|tbhatt6@uic.edu|
21302416|NCT00635999|Penn State University|Michelle G. Newman|814-863-1148|mgn1@psu.edu|
21302417|NCT02636361|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21302418|NCT02413151|University of Lisbon|Maria Helena Santa-Clara Pombo Rodrigues|00351917377277|santaclara@fmh.ulisboa.pt|
21302419|NCT00850421|Park Nicollet Institute|Park Nicollet Institute|952-993-3123||
21302420|NCT03037580|United Therapeutics|Louis Holdstock|919-425-8866|lholdstock@unither.com|
21302421|NCT02036853|Cook Children's Health Care System|Director of Research Operations|682-885-2103|CookChildrensResearch@cookchildrens.org|
21302422|NCT00228553|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
21302423|NCT00824733|The Ohio State University Comprehensive Cancer Center|Bhuvaneswari Ramaswamy, MD|614-293-8858|Bhuvaneswari.Ramaswamy@osumc.edu|
21302424|NCT02692391|Ohio State University|Georgios Papachristou, MD PhD|6142836255|georgios.papachristou@osumc.edu|
21287694|NCT02456896|AIIMS, Bhubaneswar, India|Dr. Rituparna Maiti|9438884191|rituparnamaiti@gmail.com|
21287695|NCT05569174|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|novartis.email@Novartis.com|
21287696|NCT00112957|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21287697|NCT00961415|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21287698|NCT02309359|Ablynx NV|Medical Monitor|+32 (0)9 262 00 00|clinicaltrials@ablynx.com|
21287699|NCT01151436|Galderma|Ma May|+33 4 92 38 67 33|may.ma@galderma.com|
21287700|NCT04456920|INSTITUT REGIONAL DU CANCER DE MONTPELLIER|Mme Aurore Moussion, Director of Direction of Clinical Research and Innovation|0467613102|drci-icm105@icm.unicancer.fr|+33
21287701|NCT03895086|Maison de la Recherche en Santé|Mr Thomas RULLEAU|6 35 55 03 35|thomas.rulleau@chu-nantes.fr|+33
21287702|NCT04656652|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo_us@daiichisankyo.com|
21287703|NCT03307174|University of California San Francisco|Paul Su|415-885-7246|paul.su@Ucsf.edu|
21287704|NCT00863707|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
21287705|NCT03704064|University of Florida|Dr. Rebecca Pearl, Assistant Professor|352-294-5405|rebecca.pearl@ufl.edu|
21287706|NCT01286129|IUCPQ|Louis-Philippe Boulet, principal investigator|418-656-4747|lpboulet@med.ulaval.ca|
21287707|NCT02111200|Baylor|Mahshid Azamian|832-822-1529|azamian@bcm.edu|
21287708|NCT02326064|Centre Hospitalier Départemental Vendée|Dr. Guillaume DUCARME|0251446161|guillaume.ducarme@ght85.fr|
21287709|NCT03040726|The University of Texas MD Anderson Cancer Center|Dr. David Hui|(713) 792-6258|dhui@mdanderson.org|
21287710|NCT03025035|Cedars-Sinai Medical Center|Yuan Yuan, MD, PhD|3108888680|yuan.yuan@cshs.org|
21287711|NCT01218802|Case Western Reserve University|Grace McComsey, MD|2168442739|gam9@case.edu|
21287712|NCT04264208|Stanford University|Andrei Iagaru, MD|(650) 725-4711|aiagaru@stanford.edu|
21287713|NCT03104374|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21287714|NCT02941640|University Clinical Center Tuzla|Samir Delibegovic|+387 61 149 131|delibegovic.samir@gmail.com|
21287715|NCT01884597|Retina Consultants of Hawaii, Inc.|Gregg Kokame, MD|(808) 487-8928|retinahi@aol.com|
21287716|NCT02074514|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21287717|NCT00666237|University of Miami|Steven Gedde, MD|305-326-6435|sgedde@med.miami.edu|
21287718|NCT05366725|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49 06151725200|service@emdgroup.com|
21287719|NCT02543840|VA Boston Healthcare System- Center for Healthcare Organization and Implementation Research|Dr. Mark S. Bauer, MD|857-364-6380|mark.bauer@va.gov|
21287720|NCT03759379|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
21287721|NCT05399680|Cordis|Rajesh Nathan|(908) 528-3931|rajesh.nathan@cordis.com|
21287722|NCT02659865|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21287723|NCT03675308|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21287724|NCT02325414|Northwestern University|Dr. Thomas Schnitzer|312-503-4043|tjs@northwestern.edu|
21287725|NCT05722522|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21287726|NCT05032183|The Univeristy of Texas MD Anderson Cancer Center|Ghayas Issa MD./Associate Professor|713-745-6798|GCIssa@mdanderson.org|
21287727|NCT02775851|SWOG Statistics and Data Management Center|Melanoma Committee Statistician|2066674623|sbellasea@fredhutch.org|
21287728|NCT02194465|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21287729|NCT01125930|University of Michigan|Dr. Lisa Maier|734-936-4192|maierl@med.umich.edu|
21287730|NCT01715298|Novartis Pharmaceuticals|Study Director|862-778-8300||
21287731|NCT01454284|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21287732|NCT02842866|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21287733|NCT01432327|Katholieke Universiteit Leuven|Karen Van Hoye|0032498617141|Karen.Vanhoye@faber.kuleuven.be|
21302425|NCT03500224|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21287734|NCT03248037|Cornea Research Foundation of America|Marianne Price|3178142990|mprice@cornea.org|
21238435|NCT05614089|University of Pittsburgh|Dr. Jing Luo, MD, MPH, Associate Professor of Medicine|412-383-3559|luoj@pitt.edu|
21287735|NCT03720119|Sofar|Dr Laura Patrucco|+39 02909362|laura.patrucco@sofarfarm.it|1
21287736|NCT01944423|Univeristy of Texas at Austin|Dr. Jasper Smits|512-475-8095|smits@utexas.edu|
21287737|NCT02897349|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21287738|NCT03113955|Zhongda Hospital Southeast University|Dr. Gaojun Teng|13805171500|gjteng@vip.sina.com|+86
21287739|NCT03055013|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21287740|NCT03435055|University of Michigan|Richard Harris|734-998-6996|reharris@umich.edu|
21287741|NCT03817528|New York State Psychiatric Institute|Marlene Carlson, MPH|646-774-5340|marlene.carlson@nyspi.columbia.edu|
21287742|NCT00906243|University of Florida|Dr. Johannes Vieweg|352 273-6815|j.vieweg@urology.ufl.edu|
21287743|NCT03177395|Pharmacology, Therapeutics and Toxicology Unit, Centre for Cardiovascular Science, University of Edinburgh, UK|Dr James Dear|+44(0)131 242 9214|james.dear@ed.ac.uk|
21287744|NCT00671749|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5000|elizabeth.nieman@galderma.com|
21287745|NCT04418947|University of Pennsylvania|Dr. Anne Cappola|2155735359|acappola@pennmedicine.upenn.edu|
21287746|NCT03937778|National Center for Complementary and Integrative Health|Chesler, Alexander|+1 301 594 1049|alexander.chesler@nih.gov|
21287747|NCT01200355|Memorial Sloan Kettering Cancer Center|Dr. Genovefa Papanicolaou MD|212-639-8361|papanicg@mskcc.org|
21287748|NCT00485303|Janssen Research & Development, 10990 Wilshire Blvd, Suite 1200, Los Angeles, California 90024|Senior Director, Clinical Research|(310) 943-8040||2917
21287749|NCT00754923|OSU|Miguel Villalona|614-366-5068|miguel.villalona@osumc.edu|
21287750|NCT01281306|Novartis|Study Director|862-778-8300||
21287751|NCT02410629|University of California Irvine|Dr An Do|(714) 456-2332|and@uci.edu|
21287752|NCT06129149|The Ohio State University|Christine Kimpel|614-247-1195|kimpel.28@osu.edu|
21287753|NCT04649359|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21287754|NCT05911841|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21287755|NCT05595369|Duke University|Kanecia Zimmerman, MD, PhD, MPH|919-668-8651|kanecia.zimmerman@duke.edu|
21287756|NCT01641042|GlaxoSmithKline|GSK Response Center|866-435-7343||
21287757|NCT01032928|Ralph H Johnson VA Medical Center|Dr. Bonnie Martin Harris|843-792-0879|Bonnie.Martin-Harris@va.gov|
21287758|NCT01225055|Northwestern University|Dr. Thomas Schnitzer|312-503-2315|tjs@northwestern.edu|
21287759|NCT00111761|Amgen Inc.|Study Director|866-572-6436||
21287760|NCT05892341|ConvaTec Inc.|Cristin Taylor, Senior Director, Medical Affairs, Advanced Wound Care|1-800-422-8811|cristin.taylor@convatec.com|
21287761|NCT00471497|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21287762|NCT04004000|Fulcrum Therapeutics|Call Center|617-651-8853|clinicaltrials@fulcrumtx.com|
21287763|NCT06121609|Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital, Tongji Medical College, Huazhong University of Scien|aijun xu|+8618627784217|ajxu@tjh.tjmu.edu.cn|
21287764|NCT06494761|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
21287765|NCT05432232|HistoSonics, Inc.|Vice President of Clinical Affairs|(877) 740-0543|clinicaltrials@histosonics.com|
21287766|NCT04865289|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21287767|NCT02867592|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21287768|NCT00909870|Shire Regenerative Medicine|Mollie Carter, MD, Medical Director|(858) 754-5678|mcarter@shire.com|
21287769|NCT00943436|Healthy Eating and Activity Laboratory- University of Tenneessee|Emily Jokisch|865-974-0754|ejokisch@utk.edu|
21287770|NCT01232283|Celgene Corporation|Anne McClain|888-260-1599|ClinicalTrialDisclosure@celgene.com|
21287771|NCT03824561|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21287772|NCT03512652|University of Applied Sciences and Arts of Southern Switzerland (SUPSI)|Dr Erich Hohenauer|+41 81 300 01 75|erich.hohenauer@supsi.ch|
21287773|NCT01773928|Alachua Government Services, Inc.|Angie Kimbler|386-418-8751|angie.kimbler@resilience.com|
21287774|NCT03054428|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
21287775|NCT03225287|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21287776|NCT03036267|Columbia University School of Nursing|Dr. Maureen George|2123051175|mg3656@cumc.columbia.edu|
21287777|NCT01499810|Research Institute of Cradiology, Siberian Branch of Russian Academy of Sciences|Dr. Stanislav Pekarskiy|+73822558122|pekarski@cardio-tomsk.ru|
21287778|NCT03114150|The University of Iowa|Dr. Michelle Voss, Study Principal Investigator|319-335-2057|michelle-voss@uiowa.edu|
21287779|NCT03834961|Children's Oncology Group|Results Reporting Coordinator|6262411500|resultsreportingcoordinator@childrensoncologygroup.org|
21302426|NCT00499590|OPKO Health, Inc.|Jane Hsiao, PhD, MBA|305-575-6004|jhsiao@opko.com|
21302427|NCT01818752|Amgen Inc.|Study Director|866-572-6436||
21302428|NCT01324141|National Cancer Institute|Dr. Deborah E. Citrin|301-496-5457|citrind@mail.nih.gov|
21274315|NCT01103713|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21274316|NCT02645409|Indiana University|Courtney Dhondt, Clinical Research Nurse|317-274-1791|cgerler@iu.edu|
21274317|NCT02089685|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21274318|NCT02738086|University of Colorado Denver|Cory L. Christiansen|303-724-9101|cory.christiansen@cuanschutz.edu|
21274319|NCT00539110|Shriners Hospitals for Children|Michele Gottschlich PhD|513-872-6298|mgottschlich@shrinenet.org|
21274320|NCT01910688|Columbia University Medical Center|Dr. Julian Abrams|(212) 235-1496|ja660@cumc.columbia.edu|
21302429|NCT00282308|Genentech, Inc.|Medical Communications|800 821-8590||
21274321|NCT04887415|University of Florida|Emily K. Plowman, Ph.D. CCC-SLP|(352)273-8632|eplowman@ufl.edu|
21274322|NCT00841698|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274323|NCT00191815|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21274324|NCT03435835|Purdue University/Indiana University|Dr. Bruno Roseguini|7654962612|brosegui@purdue.edu|
21274325|NCT01218867|National Cancer Institute|Dr. Steven Rosenberg|301- 496-4164|sar@mail.nih.gov|
21274326|NCT00251979|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
21274327|NCT00284518|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21274328|NCT06185088|University of Michigan|Meghan Arnold|734-936-8978|meghanar@med.umich.edu|
21274329|NCT01304641|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21274330|NCT01878292|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
21274331|NCT02530905|Sarepta Therapeutics, Inc.|Medical Director|1-800-690-2003|clinicaltrials@sarepta.com|
21274332|NCT00322439|Amgen Inc.|Study Director|866-572-6436||
21274333|NCT00803686|Tarsa Therapeutics, Inc|Nicholas LaBella, Jr. Vice-President Global RA/QA|267-273-7944|nlabella@tarsatherapeutics.com|
21274334|NCT00415363|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21274335|NCT03123471|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
21274336|NCT01641380|Johns Hopkins University School of Medicine|Maria Trent, MD, MPH, Principal Investigator|443-287-8945|mtrent2@jhmi.edu|
21274337|NCT01863030|University of Kentucky Medical Center|Scott Roth M.D.|859-323-6346|sroth@uky.edu|240
21274338|NCT01136174|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21274339|NCT01471041|Vital Access|Mark Crawford|8014339390|mcrawford@vital-access.com|
21274340|NCT02233985|Instituto Mexicano del Seguro Social|Dr. Gloria Patricia Sosa-Bustamante|01 52 4777174800|patriciasosab@hotmail.com|31828
21274341|NCT01249651|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21274342|NCT01581658|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21274343|NCT00813592|Huntsman Cancer institute|Randy Jensen, MD, PhD|801-585-0255|randy.jensen@hci.utah.edu|
21274344|NCT03682653|UCSF FI Proctor|Dr. Thomas Lietman|(414) 476-1442|tom.lietman@ucsf.edu|
21274345|NCT01391273|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21274346|NCT01588236|Jiangsu Kanion Pharmaceutical Co. Ltd|Weiyi Liu, MD|3016533500|liuweiyi65@hotmail.com|
21274347|NCT03873272|Columbia University Irving Medical Center|Melissa Accordino, MD|646-317-4692|mkg2134@cumc.columbia.edu|
21274348|NCT00787254|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21274349|NCT05302908|Wake Forest School of Medicine|Scott Rhodes, Ph.D|336-713-5080|srhodes@wakehealth.edu|
21274350|NCT03761173|Inari Medical, Now Part of Stryker|Ashleigh Willson|925-330-3446|Ashleigh.Willson@Stryker.com|
21274351|NCT00316186|GlaxoSmithKline|GSK Response Center|866-435-7343||
21274352|NCT06907719|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
21274353|NCT00859430|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274354|NCT03423654|VA|April Maa|4043216111|april.maa2@va.gov|206817
21302430|NCT01001325|Mount Sinai Hospital|Dr. Brenda Coleman|416-586-4800|bcoleman@mtsinai.on.ca|4161
21274355|NCT04310345|Vanderbilt School of Nursing|Dr. Mary Jo Gilmer|6153430938|maryjo.gilmer@vanderbilt.edu|
21274356|NCT00828295|Helsinn Healthcare SA|Salvatore Chessari|+41 91 985 21 21|salvatore.chessari@helsinn.com|
21274357|NCT01402050|Phoenix Perinatal Associates - Mednax|Ana Braescu|602-614-0488|ana_braescu@mednax.com|
21274358|NCT03581097|Ospedale Regionale di Bellinzona e Valli (ORBV)|Dr. med. Andrea Saporito, Vice-Chair Department of Anesthesia|091/811.91.11|andrea.saporito@eoc.ch|
21274359|NCT03220958|Montefiore|Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
21274360|NCT01881763|Northwell Health|Georgios Petrides, MD, PI|718-470-8569|gpetride@northwell.edu|
21302431|NCT02758184|Duke University|Sergio Mendoza Lattes, M.D.|919-684-2023|sergio.mendoza@duke.edu|
21274361|NCT03098485|Washington University in St. Louis School of Medicine|Kimberly Reske, MPH|3147474041|kreske@wustl.edu|
21274362|NCT04200833|Medical University of Graz|PD MD Andrea Skrabl-Baumgartner|+43 316 385|andrea.skrabl-baumgartner@medunigraz.at|111
21274363|NCT01361633|Anxiety Disorders Center, Institute of Living/Hartford Hospital|Gretchen Diefenbach, Ph.D.|860-545-7685|gdiefen@harthosp.org|5-7396
21274364|NCT00373256|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21302432|NCT01584440|Avanir Pharmaceuticals, Inc.|Avanir Medical Information|855-572-2722|medinfo@avanir.com|
21302433|NCT00661427|Memorial Sloan Kettering Cancer Center|Dr. David Pfister|646-888-4237|pfisterd@mskcc.org|
21302434|NCT00599339|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
21260041|NCT02153099|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21260042|NCT04722991|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21260043|NCT03057795|City of Hope Medical Center|Dr. Alex Herrera|626-359-8111|aherrera@coh.org|
21260044|NCT01370460|Henry Ford Health System|Andrew Georgiadis, MD|313-916-7520|ageorgi1@hfhs.org|
21260045|NCT01445678|Cubist Pharmaceuticals, Inc.|Dr. Obi Umeh, Vice President Global Medical Sciences|781-860-8415|obiamiwe.umeh@cubist.com|
21260046|NCT04152824|Oregon Health & Science University|Dr. Leslie Hammer|503-494-9313|hammerl@ohsu.edu|
21260047|NCT01459614|Sidney Kimmel Comprehensive Cancer Center|Dr. Dung Le|443-287-0002|dle2@jhmi.edu|
21274365|NCT02925884|Pacific University|Yu-Chi Tai|503-352-2289|ytai@pacificu.edu|
21274366|NCT04516434|Duke University Medical Center|Cindy Amundsen, MD|919-401-1000|cindy.amundsen@duke.edu|
21302435|NCT05564052|Janssen Research & Development, LLC|Sr. Director Clinical Sciences Onc|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21274367|NCT05292963|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
21274368|NCT00834522|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274369|NCT04757298|University of Illinois Urbana Champaign|Dr. Liliane Windsor|217-300-1782|lwindsor@illinois.edu|
21274370|NCT00033917|Yale University School of Medicine|Dr. Laura Ment|203-785-5708|laura.ment@yale.edu|
21274371|NCT00835484|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274372|NCT03128723|JnJ Worldwide|Gboyega Adenaike|908-874-1214|aadenaike@its.jnj.com|
21274373|NCT03270462|"University of Colorado Denver | Anschutz"|Larry Chan|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
21274374|NCT00673660|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21274375|NCT00123734|AGEN Biomedical Ltd|Dr Michael Gerometta|+61 408 885 416|mgerometta@agenix.com|
21274376|NCT00113386|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org|
21274377|NCT00834340|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274378|NCT00395694|GlaxoSmithKline|GSK Response Center|866-435-7343||
21274379|NCT05956925|University of Nevada, Las Vegas|Dieu-My Tran (PI)|17028953371|dieu-my.tran@unlv.edu|
21274380|NCT01068821|Mayo Clinic, Florida|Dr. Mary Ellen Wechter|904 412 7351|wechter.mary@mayo.edu|
21274381|NCT02159183|ZMK University of Bern, Clinic of Periodontology|Prof. Dr. med. dent., Dr. h.c., M.S. Anton Sculean|004131 632 25 72|anton.sculean@zmk.unibe.ch|77
21274382|NCT02154672|Yale University School of Medicine|Dr. Preston Sprenkle|2037852815|preston.sprenkle@yale.edu|
21274383|NCT03517085|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
21274384|NCT01444378|Abbott Vascular|Robert McGreevy|408-845-3932|Robert.mcgreevy@abbott.com|
21274385|NCT01244620|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21274386|NCT01663233|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300||
21274387|NCT02321098|Galderma|Farzaneh Sidou Clinical Project Manager|04 93 95 70 51|farzaneh.sidou@galderma.com|33
21274388|NCT00840476|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274389|NCT00796328|IWK Health Centre|Dr. Ron George|470-6627|rbgeorge@dal.ca|
21274390|NCT03261167|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21274391|NCT00835146|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274392|NCT03669861|Massachusetts General Hospital|DRAI Director of Clinical Trials|6176920668|JHSTONE@mgh.harvard.edu|
21274393|NCT04813354|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21274394|NCT02760927|Hollister Incorporated|Stacy Haddad, Director Global Clinical Affairs|+1.847.680.2837|stacy.haddad@hollister.com|
21274395|NCT03259139|The Ohio State University|Dr. Brad Bushman|614-688-8779|bushman.20@osu.edu|
21274396|NCT00064038|SWOG|Robert Z. Orlowski, MD, PhD|(713) 792-2860|rorlowsk@mdanderson.org|
21274397|NCT03406156|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21274398|NCT03359863|University of California at San Francisco|Aida Venado, MD, MAS|4153532577|aida.venado@ucsf.edu|
21274399|NCT02838420|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21274400|NCT02964039|Ralph H. Johnson VAMC / MUSC|Jesse Dean|8437929566|deaje@musc.edu|
21274401|NCT05479058|Galapagos N.V.|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
21274402|NCT05630885|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
21274403|NCT03419403|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21274404|NCT02068820|Florida Hospital Gynecologic Oncology|Robert W. Holloway|407-303-2400|robhollowaymd@gmail.com|
21274405|NCT00796653|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21274406|NCT02414152|Northwell Health|Dr. Andrea Vambutas|718-470-7550|avambuta@northwell.edu|
21274407|NCT00838136|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274408|NCT01250912|University of Maryland, Baltimore|Dr. Timm-Michael Dickfeld|410-328-7801|tdickfel@som.umaryland.edu|
21274409|NCT01348789|Northwestern Memorial Hospital|Dr. Jerome M. Garden|312-280-0891|j-garden@northwestern.edu|
21274410|NCT00323882|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21274411|NCT04544410|Spruce Biosciences|Spruce Clinical Trials|415-655-4169|clinicaltrials@sprucebio.com|
21274412|NCT01030133|Medical University of South Carolina|Dr. Jeffery J Borckardt|843.792.3127|borckardt@musc.edu|
21274413|NCT02740413|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21274414|NCT04493684|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21274415|NCT03331289|UTexas_SanAntonio|Ralph A DeFronzo|2105676691|defronzo@uthscsa.edu|
21302436|NCT01338298|Maryland Psychiatric Research Center|AnnMarie Kearns, MS|4104066854|akearns@som.umaryland.edu|
21302437|NCT02872285|Lycera Corp.|H. Jeffrey Wilkins MD, Chief Medical Officer|484-243-6222|wilkins@lycera.com|
21302438|NCT00531427|Purdue Pharma|Clinical Leader, Executive Medical Director|800-733-1333||
21302439|NCT02902146|HHRI|Audrey Hendrickson|6128737448|audrey.hendrickson@hcmed.org|
21274416|NCT04037969|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
21274417|NCT05152576|AbbVie|ABBVIE CALL CENTER|844-663-3742|abbvieclinicaltrials@abbvie.com|
21274418|NCT01718301|Infetious disesases|Dr Josep Mallolas Masferrer|932275400|jmallolas@clinic.ub.es|3312
21302440|NCT01253577|Intersect ENT|James Stambaugh, Vice President Clinical Affairs|650-641-2103|jstambaugh@intersectent.com|
21260048|NCT04451707|Groupe Hospitalier La Rochelle Ré Aunis|Dr Florence Hoefler|+330546455050|florence.hoefler@ch-troyes.fr|
21260049|NCT02587338|Universitätsklinikum Würzburg|Prof. Dr. Martin Herrmann|+4993120176650|Herrmann_m@ukw.de|
21260050|NCT00630331|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21260051|NCT01302808|UT Southwestern Medical Center|David Gerber, MD|2146484180|david.gerber@utsouthwestern.edu|
21260052|NCT06120530|Indiana University School of Medicine|Jose Lazaro|7274241947|jlazarow@iu.edu|
21260053|NCT01929135|Universidad de los Andes|Dra. Catherine Andrade|056-972862308|catherine.perio@gmail.com|
21260054|NCT02425098|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21260055|NCT02078219|Study Information Center AstraZeneca|Fredrik Erlandsson, MD|+1 877-240-9479|information.center@astrazeneca.com|
21260056|NCT03641560|Astellas Global Development, Inc. (APGD)|Clinical Transparency|800-888-7704|astellas.resultsdisclosure@astellas.com|
21260057|NCT02237235|Northwestern University|Herbert Y. meltzer|312-503-0309|h-meltzer@northwestern.edu|
21260058|NCT04439279|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21260059|NCT02689492|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21260060|NCT02732951|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21260061|NCT01750918|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21260062|NCT00460993|Atlanta VA Medical Center|Dr. Patricia C. Griffiths|404-321-6111|Patricia.Griffiths@va.gov|7138
21274419|NCT01952691|Hacettepe University|Gul Oznur Karabicak|+90 505 3569409|guloznur@gmail.com|
21274420|NCT00199901|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
21274421|NCT01279109|Wake Forest School of Medicine|Dr. Sabina B. Gesell|336-713-8738|sgesell@wakehealth.edu|
21274422|NCT05776901|University of California, Irvine|Dr. Melissa Pinto, Associate Professor, Sue & Bill Gross School of Nursing|949-824-9272|mdpinto@uci.edu|
21274423|NCT00917735|University of Minnesota|Dr. Mindy Kurzer|612-624-9789|mkurzer@umn.edu|
21274424|NCT04517604|Edward Hines Jr., VA Hospital|Dr. Amy Herrold|708-202-5867|amy.herrold@va.gov|
21274425|NCT04336332|Cancer Institute of New Jersey|Dr. Sabiha Hussain|+1 732-718-3253|hussaisa@rwjms.rutgers.edu|
21274426|NCT02225106|University of Pennsylvania|Ramon Diaz-Arrastia|215-662-9732-|Ramon.Diaz-Arrastia@uphs.upenn.edu|
21274427|NCT01958294|Silk Road Medical, Inc.|Ric Ruedy, Exec VP, Clinical Affairs|408-585-2112|ric@silkroadmed.com|
21274428|NCT00682461|GlaxoSmithKline|GSK Response Center|866-435-7343||
21274429|NCT04377087|UPMC|Barbara Stadterman, MPH, CCRP|7245532539|stadtermanbm@upmc.edu|
21274430|NCT00665925|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
21274431|NCT04035187|University of Maryland Baltimore|Dr. James Polli|410-706-8292|jpolli@rx.umaryland.edu|
21274432|NCT02028221|University of Arizona|Sherry Chow, PhD|5206263358|schow@azcc.arizona.edu|
21274433|NCT06144424|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21274434|NCT02776774|Surgical Outcomes Research Center - SORCE|Dr. Amy Cizik - Research Assistant Professor, Ph.D., M.P.H.,|206-744-4631|amorgan2@uw.edu|
21274435|NCT02651272|Bosotn Medical Center|Elizabeth Klings, MD|617-638-7480|elizabeth.klings@bmc.org|
21274436|NCT00835575|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274437|NCT02557035|Helsinn Healthcare SA|Daniel Voisin|+41 91 985 2121|daniel.voisin@helsinn.com|
21274438|NCT00761813|University of Minnesota|Principal Investigator|612.273.8000|swion001@umn.edu|
21274439|NCT00834132|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274440|NCT05058430|Saliwell Ltd.|Dr. Andy Wolff|+972508801852|awolff@saliwell.com|
21274441|NCT01515891|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21274442|NCT02768701|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat G. Canter MD MS ACRP-CP, Clinical Trial Analyst|(919) 962-0000|Melahat_Canter@med.unc.edu|
21274443|NCT02718963|Seoul National University Bundang Hospital, Seoul National University College of Medicine|Ju Seok Ryu|82-31-787-7739|jseok337@snu.ac.kr|
21274444|NCT03415308|Duke Center for Research to Advance Healthcare Equity|Alesha Majors|919-660-7545|alesha.majors@duke.edu|
21274445|NCT00836472|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274446|NCT01695239|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21274447|NCT04383587|Mayo Clinic|Mark A. Parkulo, MD|9049532000|parkulo.mark@mayo.edu|
21287780|NCT02555254|CHU Nantes|Jean-Baptiste Lascarrou|+33251446572|jeanbaptiste.lascarrou@chu-nantes.fr|
21287781|NCT04736199|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21287782|NCT03370172|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21287783|NCT05918055|National Cancer Institute|Dr. Najla El Jurdi|240-992-4033|najla.eljurdi@nih.gov|
21287784|NCT04771754|Chelsea and Westminster Hospital NHS Foundation Trust|Dr Ruth Byrne|02033152560|ruthbyrne@nhs.net|
21287785|NCT05610605|University of Cadiz|Cristina Casals|956016216|cristina.casals@uca.es|
21287786|NCT00753519|Department of Neurology, Centre Hospitalier Universitaire Vaudois|David H. Benninger, MD||David.Benninger@chuv.ch|
21287787|NCT01171534|University of Missouri, Department of Orthopaedic Surgery|Gregory J. Della Rocca, MD, PhD, FACS|573-882-6562|dellaroccag@health.missouri.edu|
21287788|NCT00548327|Clinical Brain Disoders Branch-National Institute of Mental Health (NIMH)-National Institute of Health (NIH)|Jose A. Apud MD, PhD|301 5946561|apudj@mail.nih.gov|
21287789|NCT02100631|Emergent BioSolutions Canada Inc.|David Cassie, Scientist, Clinical Research||dcassie@ebsi.com|
21287790|NCT01316614|Washington University School of Medicine|Daniel K. Mullady, M.D.|314-362-8546|dmullady@dom.wustl.edu|
21287791|NCT00089648|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21287792|NCT00420745|GlaxoSmithKline|GSK Response Center|866-435-7343||
21287793|NCT00423605|Jazz Pharmaceuticals, Inc.|Grace Wang, MD, Director Clinical Development & Medical Monitor|650-496-3777||
21287794|NCT00409825|University of Pittsburgh|Steve N. Caritis, MD|412-641-4874|scaritis@mail.magee.edu|
21287795|NCT00726453|Medtronic Vascular|K. Bogdanovich||rs.medtroniccardiovascularclinicaltrials@medtronic.com|
21287796|NCT02019069|Stanford University|Rondeep Singh Brar|(650) 498-6000|rbrar@stanford.edu|
21287797|NCT01588509|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21287798|NCT01951066|Wilmer Eye Institute, Johns Hopkins University School of Medicine|[Peter A. Campochiaro|(410) 955-5106|pcampo@jhmi.edu|
21287799|NCT00204737|University of Wisconsin - Madison|Catherine Johnson|608-280-7084|catherine.johnson2@va.gov|
21287800|NCT00368550|University of Pennsylvania|Henry R. Kranzler, M.D.|215-222-3200|kranzler_h@mail.trc.upenn.edu|137
21287801|NCT01401322|Stanford University|Bruno C. Medeiros|650-498-6000||
21287802|NCT03072550|DeviceFarm|Jeffrey N Roe|925-895-1584|jeffnroe1@devicefarmtech.com|
21287803|NCT05282823|Boston Scientific|Clinical Trial Manager|+6564188833|jamie.kwek@bsci.com|
21287804|NCT00997893|University of Illinois at Chicago|Dr. Pauline Maki|312 996-6941|pmaki1@uic.edu|
21287805|NCT06290180|Cambridge Health Alliance|Heather Gray|(617) 575-5612|hgray@cha.harvard.edu|
21274448|NCT03502811|Abbott|Nadia Bouhdi|32-479-94-10-37|nadia.bouhdi@abbott.com|
21274449|NCT05239195|Vanderbilt University Medical Center|Jonathan D Casey, MD, MSc|615-875-4681|Jonathan.d.Casey@vumc.org|
21287806|NCT05469438|University Hospitals Cleveland Medical Center (Case Western Reserve University)|Kylie Phillips (Clinical Research Regulatory Specialist III)|(440)328-7964|kylie.phillips@uhhospitals.org|
21260063|NCT02031679|Johns Hopkins University School of Medicine|Dr. Eric Oliver|410-550-2300|eolive15@jhmi.edu|
21274450|NCT03382925|University of Utah, Department of Physical Medicine and Rehabilitation|Dr. Zachary McCormick|801-587-5432|PMR.Research@hsc.utah.edu|
21302441|NCT00721968|Glaukos|Jeff Wells. Sr VP, Clinical, Regulatory, and Quality Affairs|949-367-9600|jwells@glaukos.com|227
21302442|NCT01948193|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21302443|NCT00843778|UCB|UCB Clinical Trial Call Center|+1 877 822||9493
21260064|NCT00654927|Acorda Therapeutics, Inc.|Andrew Blight, PhD Chief Scientific Officer|914-347-4300|ablight@acorda.com|4102
21260065|NCT02338843|La Jolla Pharmaceutical Company|George Tidmarsh, MD, PhD|858-207-4264|gtidmarsh@ljpc.com|
21260066|NCT02828267|Duke University Medical Center|Catherine Staton|9196845537|catherine.staton@duke.edu|
21260067|NCT00110305|Janssen-Virco BE|Director|32 14 641418||
21260068|NCT03338556|PrEP Biopharm Limited|Chief Medical Officer|8666207176|info@prepbiopharm.com|0
21260069|NCT00961532|Northwestern Medicine|Andrew M Naidech|312-503-3335|a-naidech@northwestern.edu|
21260070|NCT00937235|University of Pennsylvania|Dr. Edna Foa|2157463327|foa@mail.med.upenn.edu|
21260071|NCT05047523|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
21260072|NCT00224016|Watson Laboratories, Inc|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
21260073|NCT00391599|Edith Wolfson Medical Center|Investigator|+972-35028329|lurie@wolfson.health.gov.il|
21260074|NCT00582556|University of Wisconsin Carbone Cancer Center|Dr. Douglas McNeel|608-263-4198|dm3@medicine.wisc.edu|
21260075|NCT01993888|Ethicon, Inc.|Senior Director of Ethicon Clinical R&D|908-218-2492|jbatill2@its.jnj.com|
21260076|NCT01676831|Hospital of the University of Pennsylvania|Study Coordinator|215-662-6722|deborah.leahy@uphs.upenn.edu|
21260077|NCT04486560|Johns Hopkins University|Dr. Lonny Yarmus|410-502-5224|lyarmus@jhmi.edu|
21260078|NCT02747927|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21260079|NCT04801758|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
21260080|NCT00522392|ECOG Statistical Office|Study Statistician|617-632-3012||
21260081|NCT00687453|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu|
21260082|NCT00430755|Robert-Bosch-Hospital|Prof. Dr. Mark Dominik Alscher|+4971181013496|dominik.alscher@rbk.de|
21260083|NCT00988247|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21260084|NCT01409928|UTSW|Olga T. Gupta|(214) 648-8718|olga.gupta@utsouthwestern.edu|
21260085|NCT01354132|Beth Israel Deaconess Medical Center|Larry Seidman, PhD|617 754-1238|lseidman@bidmc.harvard.edu|
21260086|NCT00582517|University of Alabama at Birmingham|Taylor Vlack, RN|205-996-6781|tmwebb@uabmc.edu|
21260087|NCT00928070|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21260088|NCT02360098|TORONTO WESTERN HOSPITAL/UHN|Emad Al Azazi|416-603-5800|emad.alazazi@uhnresearch.ca|6237
21260089|NCT04355013|University Hospital of Salamanca|Dr. José A. Sastre|+34923291100|jasastre@saludcastillayleon.es|55580
21260090|NCT01479348|National Cancer Institute|Dr. Karen Kurdziel|804-897-1207|kurdziek@nih.gov|
21260091|NCT00412529|Novartis Pharmaceuticals|Study Director|862-778-8300||
21260092|NCT01919307|Denver Health and Hospital Authority|Edward Maa|303-602-5099|Edward.Maa@dhha.org|
21260093|NCT01551979|Beth Israel Deaconess Medical Center|Mark Halko|6176670367|mhalko@bidmc.harvard.edu|
21260094|NCT02771522|Calcivis Ltd|Director of Clinical Research|+44 131 658 5152|mwillins@calcivis.com|
21260095|NCT02388295|AstraZeneca Pharmaceuticals LP|Jamie Mullen MD||Clinicaltrialtransparency@astrazeneca.net|
21260096|NCT01551693|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu|
21260097|NCT02429856|UAlberta|Director of NACTRC|780-407-8007|ron.welch@ahs.ca|
21260098|NCT03700047|QMedAB|Clinical Project Manager|(817) 961-500|aestheticclinicaltrials@galderma.com|
21260099|NCT04134494|BIDMC|Roger Lefevre|6176674070|rlefevre@bidmc.harvard.edu|
21260100|NCT00781365|HealthPartners Institute for Education and Research|Dr. Karen Margolis, MD MPH|952-967-7301|karen.l.margolis@healthpartners.com|
21260101|NCT03954626|Novartis Pharmaceuticals|Study Director|862 778 8300|Novartis.email@Novartis.com|
21260102|NCT01647737|Georgia Regents University|Dr. Scot DeRossi, Chairman of the ORal Medicine & Diagnostic Sciences Department|706-721-2607|Sderossi@gru.edu|
21260103|NCT00495157|Penn State Hershey College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu|
21260104|NCT00754156|University of Kentucky Medical Center|Phillip Chang, M.D. PI or Anna Rockich, Pharm.D. GSRP Director|859-323-6346|arockich@uky.edu|247
21260105|NCT03705481|Corindus, Inc.|John Van Vleet, VP Clinical and Regulatory Affairs|260-615-8892|john.vanvleet@corindus.com|
21260106|NCT00348140|GlaxoSmithKline|GSK Response Center|866-435-7343||
21260107|NCT00516919|Yale University School of Medicine|Dr. Carlos Grilo|203-785-2792|carlos.grilo@yale.edu|
21260108|NCT00868790|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21260109|NCT01264939|Genentech, Inc.|Medical Communications|800 821-8590||
21260110|NCT01167608|Rutgers-Robert Wood Johnson Medical School|Dr. Roseanne Dobkin, Associate Professor of Psychiatry|732-235-4051|dobkinro@rutgers.edu|
21260111|NCT03251326|New York State Psychiatric Institute|Margaret Haney, Ph.D.|646-774-6129|meg.haney@nyspi.columbia.edu|
21260112|NCT00737529|Celgene Corporation|Senior Manager, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialsdisclosure@celgene.com|
21260113|NCT00125034|Merck Serono|Inmaculada Ollero/Clinical Trial Manager|+34935655433|iollero@merck.es|
21260114|NCT00854828|Washington University|Keith H. Bridwell, MD|314-747-2655|bridwellk@wustl.edu|
21260115|NCT01282229|Millenium Dental Technologies, Inc|Dr. David Harris|510-502-3345|dharris@LANAP.com|
21260116|NCT01671280|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21260117|NCT00996203|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21302444|NCT03338959|University of Washington|Lee Cranmer, MD, PhD, Sarcoma Program Director|206-606-7439|ldcranme@fredhutch.org|
21302445|NCT00409331|UT MD Anderson Cancer Center|Mark Chambers, DMD / Associate Professor|713-745-2672||
21302446|NCT02184455|DeCell Technolpogies Inc.|Dr. Paul F. Gratzer, CSO|902-223-2179|pfgratzer@decelltechnologies.com|
21302447|NCT02933671|Duke University|W. Michael Bullock, MD, PhD|919-668-2024|william.bullock@duke.edu|
21302448|NCT04601454|Medtronic|DTM-LE Clinical Research Study Team|763-514-4000|rs.scsresearch@medtronic.com|
21302449|NCT00730028|San Francisco General Hospital, UCSF|Henry F. Chambers, MD|(415) 206 - 5437|hchambers@medsfgh.ucsf.edu|
21302450|NCT03680742|Cerus Endovascular|Lori E Adels, Ph.D.|510-651-4000|lori.adels@cerusendo.com|109
21302451|NCT02204124|Washington University School of Medicine|William Hawkins, M.D.|314-286-0702|hawkinsw@wustl.edu|
21302452|NCT01250496|Rush University Medical Center|Dr. Rami Doukky; Director of Nuclear Cardiology|312-942-4655|rami_doukky@rush.edu|
21302453|NCT00003590|SWOG Statistical Center|Study Statistician|(206)667-4623||
21302454|NCT01491113|UCB|UCB Clinical Trials Call Center|+1 877 822 9493||
21302455|NCT01425463|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
21302456|NCT01236547|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21302457|NCT05408637|Massachusetts General Hospital and Harvard Medical School|Dr. Paolo Cassano|617-643-9622|pcassano@mgh.harvard.edu|
21302458|NCT01989208|Sulfagenix|President and CEO|1-318-349-3851|tgiordano@sulfagenix.com|
21302459|NCT02693132|University of Colorado Denver|Seth Creasy|720-848-6477|seth.creasy@ucdenver.edu|
21302460|NCT04343235|Wright State University|Sheela Barhan, MD|937-208-2850|sheela.barhan@wright.edu|
21302461|NCT00787267|Duke University Medical Center|Michael Kelley , MD|919-286-0411|kelleym@duke.edu|7326
21302462|NCT01763996|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
21302463|NCT00865280|Paratek Pharmaceuticals, Inc.|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
21302464|NCT02246413|Univeristy of Illinois, Chicago|Nan Lv, PhD, Research Scientist|312-802-1072|lvn2017@uic.edu|
21302465|NCT01788215|University of Rochester|Kathleen Hoeger MD MPH|585-275-7891|kathleen_hoeger@urmc.rochester.edu|
21302466|NCT03116152|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+8613382419112|jessica.yi@innoventbio.com|
21302467|NCT02299791|KaiserPermanente Center for Health Research|Rachel Gold|503-528-3902|rachel.gold@kpchr.org|
21302468|NCT00862641|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
21302469|NCT01146457|BIDMC|Philip Hess|617-667-3353|phess@bidmc.harvard.edu|
21302470|NCT01748240|academic group|Groupe Francophone des Myelodysplasies|+ 33 (0)1 71 20 70 59|fatiha.chermat@aphp.fr|
21260118|NCT01959165|Biometrics|Nii Masahiro|+81 6 7711 4571|Masahiro.Nii@astrazeneca.com|4571
21260119|NCT00961961|UPenn|Dr. Robert J. DeRubeis|215-573-5804|derubeis@psych.upenn.edu|
21260120|NCT03035760|University of Iowa|Patricia Winokur, MD|319-384-1735|patricia-winokur@uiowa.edu|
21260121|NCT01552343|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21260122|NCT01870739|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21260123|NCT01629615|SOLTI|Scientific Manager|(+34) 93 343 63 02|pamela.celiz@gruposolti.org|
21260124|NCT01926626|Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@duke.edu|
21260125|NCT02761967|University of Granada|Dr. Rodríguez-Blanque|+34644322567|rarobla@gmail.com|
21260126|NCT03283085|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21260127|NCT03136107|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21260128|NCT00891202|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21260129|NCT05070338|RAND Corporation|Katherine E. Watkins|310-393-0411|kwatkins@rand.org|6509
21260130|NCT02292771|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21260131|NCT01468311|National Cancer Institute|Dr. Kevin C. Conlon|240-858-3570|gconlonkc@mail.nih.gov|
21260132|NCT00659295|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21260133|NCT04840667|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
21274451|NCT04665375|University Health Network|Sharon Walmsley|416-340-5077|sharon.walmsley@uhn.ca|
21302471|NCT03753789|Ethicon|Erin Meyers|937-681-0322|eprifog1@its.jnj.com|
21260134|NCT03340350|VA Nebraska-Western Iowa Health Care System|Sriram Ramaswamy, MD|402-995-4712|Sriram.Ramaswamy@va.gov|
21287807|NCT04108468|Leeds Teaching Hospital Trust|Professor Helena Marzo-Ortega|+44 (0) 113 392 4848|H.Marzo-Ortega@leeds.ac.uk|
21287808|NCT04386785|Venclose|Mai-Ly Wilcox|415-254-1930|mwilcox@venclose.com|
21287809|NCT05816070|IVIEW Therapeutics Inc.|Bo Liang, PhD|609 773 8580|info@iviewinc.com|
21287810|NCT00848497|Baylor College of Medicine|Mohit Khera, MD|713-798-6593|mkhera@bcm.edu|
21287811|NCT02139540|Washington University|Principal Investigator|7737022544||
21287812|NCT03699748|Stanford University|Dr. Manali Patel|6504859462|manalip@stanford.edu|
21287813|NCT01222299|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
21287814|NCT01132508|Synthes GmbH|Clinical Research Scientist|+41619656592|clinicalaffairs.emea@synthes.com|
21287815|NCT01420536|Araraquara Dental School -Universidade Estadual Paulista (Sao Paulo State University)|Prof. Marco Antonio Compagnoni|+55-16-3331-6411|compagno@foar.unesp.br|
21287816|NCT04711005|Duke University School of Medicine|Michelle Mack|919 613 1107|michelle.mack@duke.edu|
21287817|NCT00764790|GlaxoSmithKline|GSK Response Center|866-435-7343||
21287818|NCT04935879|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21287819|NCT01652690|Amgen Inc.|Study Director|866-572-6436||
21287820|NCT03533751|AnaptysBio, Inc.|Clinical Project Leader|858-362-6295|info@anaptysbio.com|
21287821|NCT01899911|University of California, San Francisco (UCSF)|Philip E. Bickler, MD, PhD, Professor of Anesthesia|415-476-1411|Philip.Bickler@UCSF.edu|
21287822|NCT05462821|Jaeb Center for Health Research - Pediatric Eye Disease Investigator Group|Victoria Woodard, Publications Manager|813-975-8690|pedigpublications@jaeb.org|
21287823|NCT06070610|Boehringer Ingelheim, Call Centre|Boehringer Ingelheim|18002430127|clintriage.rdg@boehringer-ingelheim.com|
21287824|NCT05706610|Cincinnati Children's Hospital Medical Center|Dr. Meghan McGrady|513-803-8044|meghan.mcgrady@cchmc.org|
21287825|NCT03540771|Albert Einstein Healthcare Network|Manisha Verma, MD, MPH. Director, Research|2154561026|Manisha.Verma@jefferson.edu|
21287826|NCT02634710|Froedtert and the Medical college of Wisconsin|Ciani Ellison, MD|414-805-4400|cellison@mcw.edu|
21287827|NCT04530630|Weill Cornell Medicine|Catherine Small, MD|212-746-9803|cbs9003@med.cornell.edu|
21287828|NCT06125964|University of Southern California|Genevieve Dunton (Principal Investigator)|323-442-8224|dunton@usc.edu|
21287829|NCT04006457|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21287830|NCT04780659|Karolinska University Hospital|Soo Aleman Sponsor representative|+46 72595 7225|soo.aleman@regionstockholm.se|
21287831|NCT05507437|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
21287832|NCT06583096|University of Michigan|Adam Horwitz|(734) 764-0231|ahor@med.umich.edu|
21287833|NCT03729362|Amicus Therapeutics, Inc.|Patient advocacy|001 6096622000|clinicaltrials@amicusrx.com|
21287834|NCT03405870|University of Florida College of Medicine|Dr. Faheem Guirgis, MD|352-733-1469|fguirgis@ufl.edu|
21287835|NCT05172609|University of Pennsylvania|Dr. Emily Becker-Haimes|215-573-5614|emily.haimes@pennmedicine.upenn.edu|
21287836|NCT00109343|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21287837|NCT04953338|Pfizer Ltd|John Nesnas|01304 616161|john.nesnas@pfizer.com|
21287838|NCT01721798|FHI 360|Catherine Todd|+1-919-544-7040|ctodd@fhi360.org|
21287839|NCT00715208|Millennium Pharmaceuticals|Carol Ann Satler, MD, PhD|617- 551-3729|carol.satler@mpi.com|
21287840|NCT00076570|NIDDK, National Institutes of Health|Dr. Monique Cho|3014355058|moniquec@intra.niddk.nih.gov|
21287841|NCT00903968|Dana-Farber Cancer Institute|Irene M. Ghobrial, MD|617-632-4198|Irene_Ghobrial@dfci.harvard.edu|
21274452|NCT00933686|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merck.de|
21274453|NCT01058668|Allergan, Inc.|Therapeutic Area Head|714-246-4500||
21287842|NCT02156258|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
21287843|NCT02631057|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21287844|NCT01983930|UCLA|Helen Lavretsky, M.D.|310-794-4619|hlavretsky@mednet.ucla.edu|
21287845|NCT00393367|The Children's Hospital of Philadelphia|Cynthia J. Mollen|215-590-4410|mollenc@email.chop.edu|
21287846|NCT00795340|Division of Medical Oncology, the Ottawa Hospital, Ottawa, Ontario, Canada|Dr. Scott Laurie|1-613-737-7700|slaurie@toh.on.ca|
21287847|NCT01027949|United Therapeutics|Louis Holdstock, PhD|919-425-8866|lholdstock@unither.com|
21287848|NCT03315949|College of Medicine, The Catholic University of Korea|Dr. Tae-Geun Gweon|82 32 340 2228|gweontae@naver.com|
21287849|NCT02052635|AstraZeneca AB|Anders Himmelmann, MD PhD|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
21287850|NCT00091819|Theravance, Inc.|Steven Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
21287851|NCT00856180|Dana-Farber Cancer Institute|Ursula A. Matulonis, MD|617-632-2334|umatulonis@partners.org|
21287852|NCT00481676|Novartis Pharmaceuticals|Study Director|862 778-8300||
21287853|NCT02911116|National Institutes of Health|H. Nida Sen, MD, MHSc, Principal Investigator, NEI|301-402-3254|senh@nei.nih.gov|
21287854|NCT04796415|Indiana University School of Nursing|Yvonne Lu, PhD, RN, FGSA, FAAN, Professor, Science of Nursing Care Department|3172782042|yuelu@iu.edu|
21287855|NCT01513590|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21287856|NCT04810962|AimMax Therapeutics Inc.|Chief Medical Officer|919-797-1146|admin@aimmaxrx.com|
21287857|NCT00486044|University of Wisconsin School of Medicine and Public Health|Cynthia M. Carlsson, MD, MS|608-280-7000|cmc@medicine.wisc.edu|
21287858|NCT00890721|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
21287859|NCT03466346|University of California San Francisco|Susan Meffert MD, MPH; Professor of Psychiatry; MPI|4158765455|susan.meffert@ucsf.edu|
21287860|NCT02567422|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
21287861|NCT02701634|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21287862|NCT00537277|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21287863|NCT03620162|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21287864|NCT02767531|UT Southwestern Medical Center|Abhimanyu Garg, MD|2146482895|abhimanyu.garg@utsouthwestern.edu|
21287865|NCT05824026|Coloplast A/S|Clinical Strategy Project Manager: Johanne Louise Gotfredsen|004549113350|dkjoat@coloplast.com|
21287866|NCT00534469|City of Hope Medical Center|Dr. Anthony Stein|626-5375748|AStein@coh.org|
21287867|NCT03431584|Centre Hospitalier Departemental Vendée|Dr. Grégoire CORMIER|251446197|gregoire.cormier@ght85.fr|+33
21287868|NCT04530552|University of Arizona|Betsy Wertheim|5207771666|betsy@arizona.edu|
21287869|NCT00071981|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
21287870|NCT00843466|Unilever|Jamie Regan|203-381-4448|Jamie.Regan@unilever.com|
21287871|NCT00465179|The University of Texas (UT) MD Anderson Cancer Center|Nizar M Tannir, MD, Professor, Genitourinary Medical Oncology||CR_Study_Registration@mdanderson.org|
21287872|NCT00976339|Columbia University|Dr. Katherine Crew|212-305-1732|kd59@cumc.columbia.edu|
21274454|NCT02911792|University of Texas Health Science Center at San Antonio|Ralph DeFronzo, MD - Chief Diabetes Division - Medicine|210 567 6706|defronzo@uthscsa.edu|
21274455|NCT00705666|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21274456|NCT00374231|University of Cincinnati|E. Steve Woodle, MD|(513) 558-6001|woodlees@uc.edu|
21274457|NCT02105272|Otsuka Pharmaceutical Co., Ltd.|Deputy General Manager, Headquarters of Clinical Development|+81-3-6361-7366||
21274458|NCT03256695|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21274459|NCT05454956|Tarsus Pharmaceuticals, Inc.|Kavita Dhamdhere, Vice President of Clinical Development|650-223-4062|kdhamdhere@tarsusrx.com|
21274460|NCT03703791|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
21274461|NCT01552317|University of Oxford|Principal Investigator|+441865287794|chris.ocallaghan@ndm.ox.ac.uk|
21274462|NCT00545506|Dep. Anesthesia And Intensive Care|Helmut Hager|+43 1 40400 4102|helmut.hager@meduniwien.ac.at|
21274463|NCT04078022|University of Maryland, Baltimore Center for Vaccine Development and Global Health (CVD)|Dr. Wilbur Chen|410-706-5328|wchen@som.umaryland.edu|
21274464|NCT01929863|GlaxoSmithKline|GSK Response Center|866-435-7343||
21274465|NCT05168735|University of Pittsburgh|Dr. Rebecca Price|412-383-2150|pricerb@upmc.edu|
21274466|NCT00429416|Thomas Jefferson University|John Wagner, MD|215-955-8874|John.Wagner@jefferson.edu|
21274467|NCT02152163|Delray Medical Center|Russell Weisz, MD|561-213-9371|rdweisz@gmail.com|
21302472|NCT01012089|University of Oklahoma College of Pharmacy|Teresa Lewis Pharm D|405-271-2859|Teresa-Lewis@ouhsc.edu|
21274468|NCT02358538|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
21302473|NCT02037555|Grifols Therapeutics, LLC|Miquel Barceló, PhD|+34 935.712.368|Miquel.Barcelo@grifols.com|
21302474|NCT00145977|The University of Chicago|Tamara Vokes, MD|773-702-1465|tvokes@medicine.bsd.uchicago.edu|
21302475|NCT03435783|Brown University School of Public Health|Tyler Wray|401-863-6659|tyler_wray@brown.edu|
21302476|NCT01578850|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21302477|NCT00601952|San Diego State University/University of California Joint Doctoral Program in Clinical Psychology|Dr. Nader Amir|6192293740|namir@mail.sdsu.edu|
21302478|NCT01573052|VA Salt Lake City Medical Center|Dr. Christopher Stock|801-582-1565|christopher.stock@va.gov|1172
21274469|NCT01686477|ImperialC|Luke Mills|+447989748017|l.mills@imperial.ac.uk|
21274470|NCT06999265|University of Michigan at Ann Arbor|Tim Bruns|(734) 647-8727|bruns@umich.edu|
21274471|NCT00730691|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21274472|NCT02178787|Beth Israel Deaconess Medical Center|Dr. Vera Novak|617-632-8680|vnovak@bidmc.harvard.edu|
21274473|NCT02554890|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21302479|NCT01711216|Abbott|Senior Global Medical Director|+49 160 749 0615|Claire.Pexman-Fieth@abbott.com|
21302480|NCT03060551|Department of Plastic Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea|Suk-Ho Moon|821090803527|nasuko@catholic.ac.kr|
21260135|NCT03890679|Tufts Medical Center|Dr. Jonathan Davis|6176365322|jdavis@tuftsmedicalcenter.org|
21260136|NCT04854499|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21260137|NCT04646148|Butler Hospital|Dr. Lisa Uebelacker|401-455-6381|luebelacker@butler.org|
21260138|NCT00398112|Mayo Clinic|Tait Shanafelt||shanafelt.tait@mayo.edu|
21260139|NCT03802721|Oregon State University|David E. Williams, PhD|541-737-3277|david.williams@oregonstate.edu|
21260140|NCT02300129|Galderma R&D|Galderma CPM|00 33 4 93 95 70 70|clinicaltrials@galderma.com|
21260141|NCT02924896|Imperial College London|Prof Gary Frost|020 7589 5111|g.frost@imperial.ac.uk|
21260142|NCT03932812|University of Iowa|Sato Ashida|319-384-1477|sato-ashida@uiowa.edu|
21260143|NCT00970606|Vanderbilt University Medical Center|Gordon R. Bernard, MD, Associate Vice Chancellor for Research|615-343-0077|gordon.bernard@vanderbilt.edu|
21260144|NCT02472457|The Children's Hospital of Philadelphia|Ronen Stein, MD|215-590-7801|ibdresearch@email.chop.edu|
21260145|NCT01154101|GlaxoSmithKline|GSK Response Center|866-435-7343||
21260146|NCT05019131|University of California, San Francisco|Dr. Patience Afulani|(415) 476-1000|Patience.Afulani@ucsf.edu|
21260147|NCT03575104|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 58 844 00 00|clinical-trials-disclosure@idorsia.com|
21260148|NCT02661594|Acacia Pharma Ltd|Dr Gabriel Fox|+44-(0)1223-919764|GabrielFox@acaciapharma.com|
21260149|NCT00432237|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
21260150|NCT00956930|Northwestern University|Riad Salem MD|312-695-6371|rsalem1@nm.org|
21260151|NCT03742427|Marmara University|Sinan KARACABEY|+902166254545|karacabeysinan@gmail.com|
21260152|NCT03049449|National Cancer Institute|Dr. James N. Kochenderfer|240-760-6062|kochendj@mail.nih.gov|
21260153|NCT04354428|University of Washington|Christine Johnston|206-520-4340|cjohnsto@uw.edu|
21260154|NCT00670709|UCLA|Jennifer Villalobos|310-825-3351|info@brain.ucla.edu|
21274474|NCT01521780|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21274475|NCT00834275|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274476|NCT03649477|Levo Therapeutics|Vice President of Clinical Development|1-847-901-9260|contactus@levotx.com|
21274477|NCT02430480|National Cancer Institute|Dr. Fatima Karzai|301-480-7174|karzaifh@mail.nih.gov|
21274478|NCT01097577|US Air Force|Julie Meek, Clinical Pharmacist|210-808-2200|julie.m.meek.mil@mail.mil|
21274479|NCT03190005|taipei city hospital|chen yueh-chung|88627093600|chenyuehchung.tw@yahoo.com.tw|3741
21274480|NCT00748072|University of Bari|Dr. Carlo Manno|390805478878|c.manno@nephro.uniba.it|
21274481|NCT01963728|Inova Health Care System|Anne Whitney Brown, MD Principal Investigator|703.776.3067|anne.brown@inova.org|
21274482|NCT04870606|Suzhou Kintor Pharmaceuticals,Inc.|Millie Gu|+86- 512 6263 9938|PR@kintor.com.cn|
21274483|NCT05780788|UConn Health - Department of Orthodontics|Dr. Flavio Uribe (Study principal investigator)|8606792550|furibe@uchc.edu|
21274484|NCT05635019|University of Pennsylvania and Johns Hopkins University|Ariana Chao|443-287-6223|ariana.chao@jhu.edu|
21274485|NCT06298396|Cochlear Limited|PRS Specialist|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
21274486|NCT06137781|Royal United Hospitals Bath NHS Foundation Trust|Alec Snow|07793554479|alec.snow@nhs.net|
21274487|NCT02591420|Data Coordinating and Analysis Center, HJF Global Infectious Diseases|Dr. Glenna Schluck|3015003824|gschluck@global-id.org|
21274488|NCT03056755|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
21274489|NCT00836004|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274490|NCT01528696|University of Michigan|Mark Chames|734 764-1406|mchames@med.umich.edu|
21274491|NCT01056484|University of Wisconsin Madison|Aleksandra Zgierska, MD PhD|(608) 263-7882|aleksandra.zgierska@fammed.wisc.edu|
21274492|NCT00446966|Carient Heart and Vascular|Dr Chirag Sandesara|7033358750|csandesara@carient.org|
21274493|NCT01547286|Massachusetts General Hospital|Dr. Robert Scott Harris, MD|617-726-9429|rsharris@mgh.harvard.edu|
21274494|NCT00540995|City of Hope Medical Center|Dr. Anthony Stein|626-359-8111||
21274495|NCT02007863|University of Miami|Martin Andreansky MD|305-243-0850|mandreansky@med.miami.edu|
21274496|NCT02241551|University of Pittsburgh Cancer Institute|Nathan Bahary, MD|412-864-7764|baharyn@upmc.edu|
21274497|NCT00081653|Hoffmann-La Roche|Clinical Trials Study Director|+1 973 235 5000||
21274498|NCT00529191|Children's Hospital of Philadelphia|Steven Willi, MD|215-590-3174|willi@chop.email.edu|
21274499|NCT03246503|BiliCam, LLC|James Taylor|2064194923|uncjat@google.com|
21274500|NCT02331108|Albert Einstein Healthcare Network|Jonathan Roth, M.D.|2154567979|rothj@einstein.edu|
21274501|NCT01556906|Aegerion Pharmaceutical|Chief Medical Officer|617-500-7867||
21274502|NCT02751424|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21260155|NCT03304522|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21260156|NCT00863551|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
21260157|NCT02649634|University of Calgary|Dr. Kristin von Ranson|403.220.7085|kvonrans@ucalgary.ca|
21260158|NCT00680225|New England Retina Associates|Dr. Peter Liggett|203-288-2020|neretina@msn.com|
21260159|NCT00763009|UCHC|Michael Azrin|8606793343|azrin@uchc.edu|
21260160|NCT01111604|Eli Lilly and Compnay|Chief Medical Officer|800-545-5979||
21260161|NCT02494570|Aadi Bioscience|Medical Information|1-888-246-2234|MedInfo@aadibio.com|
21260162|NCT01295125|University Hosptials Cleveland Medical Center|Dr. Michael Rosen|216-396-9937|rosenm@ccf.org|
21260163|NCT02547623|Icon Bioscience, Inc.|Vice President, Quality and Compliance|510-933-8381||
21260164|NCT01355289|Eisai Call Center|Eisai Inc.|888-422-4743||
21260165|NCT00481845|Stanford Cancer Institute, Stanford University|Mark Daniel Pegram; Susy Yuan-Huey Hung Professor|650-723-5801|mpegram@stanford.edu|
21260166|NCT02849639|University of Kentucky|Daniela C Moga MD PhD, Associate Professor|859-323-9682|daniela.moga@uky.edu|
21260167|NCT01756456|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
21260168|NCT01379625|Oregon Health & Science University|Dr. Melanie Gillingham|503-494-1682|gillingm@ohsu.edu|
21260169|NCT03838484|Vanderbilt University Medical Center|Alan S. Lewis, M.D., Ph.D.|615-875-4027|alan.s.lewis@vumc.org|
21260170|NCT00813995|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21260171|NCT02507349|UPMC Center for High-Value Health Care|Kelly Williams, Program Administrator|412-454-1198|Williamsk17@upmc.edu|
21260172|NCT01614964|Tulane University|Jeffrey G Shaffer|504-988-1142|jshaffer@tulane.edu|
21260173|NCT03618030|Purdue Pharma L.P.|Clinical Leader|1-800-733-1333|Sailaja.Bhaskar@ImbriumThera.com|
21260174|NCT00860470|JHSPH|Keith P. West, Jr.|4109552061|kwest@jhsph.edu|
21260175|NCT03689192|National Center for Cancer Immune Therapy|Cathrine Lund Lorentzen|004538683868|cathrine.lund.lorentzen@regionh.dk|
21260176|NCT02700984|Alcon Research|Sr Clinical Project Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21260177|NCT01032629|Janssen- Cilag International NV|Senior Director Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21260178|NCT03371355|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
21260179|NCT02633540|Fox Chase Cancer Center|Dr. Thomas Galloway|215-728-5536|Thomas.Galloway@fccc.edu|
21260180|NCT00661583|University of Colorado Denver|Dr.Malik Kahook|720-848-2020|malik.kahook@ucdenver.edu|
21260181|NCT00619957|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
21274503|NCT02197416|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21260182|NCT00723957|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21302481|NCT03562988|Church & Dwight Co., Inc|Dr. Annahita Ghassemi, PhD|609-806-1200|annahita.ghassemi@churchdwight.com|
21302482|NCT04629066|Duke Clinical Research Institute|Marjan Cobbaert|919-668-9740|mr157@duke.edu|
21302483|NCT05225805|Nabriva Therapeutics US, Inc.|Christine Guico-Pabia, MD, MBA, MPH|610-981-2874|christine.guico-pabia@nabriva.com|
21302484|NCT02369172|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
21302485|NCT00610480|UT Southwestern Medical Center|Peter Chen|214-648-3837|peter.chen@utsouthwestern.edu|
21302486|NCT05477108|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-94 79|information.center@astrazeneca.com|
21302487|NCT02660983|Eisai Co., Ltd.|Inquiry Service||eisai-chiken_hotline@hhc.eisai.co.jp|
21302488|NCT04410133|Blue Earth Diagnostics|Head of Research and Development|+44 (0) 1865 784 186|matthew.miller@blueearthdx.com|
21302489|NCT00334113|VA Boston Healthcare System|Dr. DeAnna Mori|857-364-4121|deanna.mori@va.gov|
21302490|NCT02083861|Pain Management Associates|Dr. Ralph Ortiz|(607) 844-9979|rodoc@cnymail.com|
21302491|NCT03376295|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21302492|NCT02509026|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21302493|NCT04947085|Maimonides Medical Center|Sergey Motov|718-283-6000|smotov@maimo.org|
21302494|NCT00167219|University of Minnesota, Masonic Cancer Center|Dr. Margaret MacMillan, MD|+1 612-626-2961|macmi002@umn.edu|
21302495|NCT00243841|Indiana University|Amy Miller Research Manager|317 944 1242|amym@iu.edu|
21302496|NCT05601544|Johnson & Johnson Vision Care, Inc. (JJVC)|Senior Principal Research Optometrist|904-608-7238|jbuch@its.jnj.com|
21302497|NCT04303195|Neurogastrx|Chief Scientific Officer|17817304040|info@neurogastrx.com|
21302498|NCT01064947|DermResearch, PLLC|Leon H. Kircik, M.D.|502-451-9000|wedoderm@yahoo.com|
21302499|NCT02970942|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21302500|NCT06457204|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
21302501|NCT00508196|University of Dundee|DR Anna Maria Choy|01382 383482|a.choy@dundee.ac.uk|
21302502|NCT01065454|Bayer|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21302503|NCT00773604|University of California, San Francisco|Jill Ostrem|415-353-7885|Jill.Ostrem@ucsf.edu|
21302504|NCT01601652|UC Davis|Arthur J de Lorimier, Director of Pediatric Gastroenterology|916-734-3112|adelorimier@ucdavis.edu|
21274504|NCT01492439|Centre for Addiction and Mental Health|Dr. Sean A. Kidd|416-535-8501|sean.kidd@camh.ca|6295
21274505|NCT00716625|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21302505|NCT00273793|UTexas_SanAntonio|Dr. RJ Lamb|210-567-5480|lamb@uthscsa.edu|
21302506|NCT03524729|VA|Dr. Sangeorzan|206-516-3261|bruce.sangeorzan@va.gov|
21302507|NCT01548833|Alcon Research, Ltd.|Jami Kern, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
21302508|NCT00982423|Mayo Clinic|Dr. Horng Chen|507-538-2354|chen.horng@mayo.edu|
21302509|NCT03374202|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
21302510|NCT02712047|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21302511|NCT05286749|UW School of Medicine and Public Health|Tana Chongsuwat, MD, MPH|224-260-1666|tana.chongsuwat@fammed.wisc.edu|
21302512|NCT00336856|University of Pittsburgh|Nathan Bahary, MD|412-864-7764|baharyn@upmc.edu|
21302513|NCT01325337|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21302514|NCT03483922|HKG Epitherapeutics|David Cheishvili|5142601972|david.cheishvili@hkgepitherapeutics.com|
21302515|NCT04313647|Ruijin Hospital , Shanghai Jiao Tong University School of Medicine|Dr. Qu|(+86)2164370045|jmqu0906@163.com|
21302516|NCT03381742|Department of Cardiology, the First Affiliated Hospital, Harbin Medical University, Harbin, China|Dr. Yue Li|86-451-85555673|ly99ly@vip.163.com|
21302517|NCT01332799|University of Iowa|Dr. Roberto Kalil|319-355-6564|roberto-kalil@uiowa.edu|
21302518|NCT02908490|University of Pittsburgh|Kimberly P. Liang, MD, MS|412-586-3550|liangkp@upmc.edu|
21302519|NCT00538785|MedImmune, LLC|Pamela Griffin, Senior Director, Clinical Development|301 398 0000|griffinp@medimmune.com|
21302520|NCT04022733|Ajou University|Associate professor in Anesthesiology Department|82-31-2195689|beye98@aumc.ac.kr|
21302521|NCT04144127|Emory University|Dr. Felipe Lobelo|(770) 488-5737|felipelobelo@emory.edu|
21302522|NCT04941443|Boston Medical Center, Department of Anesthesiology|Rachel Achu, MD|(617) 414-2000|rachel.achu@bmc.org|
21302523|NCT03897439|University of Kanas Medical Center|Dr. Nicole Nollen|913-588-3784|nnollen@kumc.edu|
21302524|NCT03124927|Masimo Corporation|Vikram Ramakanth||clinicalresearchdept@masimo.com|
21302525|NCT02047344|Golden Biotechnology Corp.|Howard Cheng|+886-2-28086006|howard@goldenbiotech.com|
21302526|NCT05315908|University of California San Diego|Dr. Jesse Nodora|(858) 822-3686|jnodora@health.ucsd.edu|
21302527|NCT00280384|Eisai Co., Ltd.|Hiroki Shimizu, Study Director|81-3-3817-5235|h3-shimizu@hhc.eisai.co.jp|
21302528|NCT01598129|Oncos Therapeutics|Director, Clinical Operations||info@oncos.com|
21274506|NCT01204294|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21274507|NCT02075463|GlaxoSmithKline|GSK Response Center|866-435-7343||
21302529|NCT00505076|Semel Institute at UCLA|Stephen R. Marder|310-268-3647|marder@ucla.edu|
21302530|NCT02250703|University of Mississippi Medical Center|Madhankumar Sathyamoorthy. PI|6018157066|msathyamoorthy@umc.edu|
21302531|NCT04093024|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21302532|NCT03145818|Providence VA Medical Center|James Rudolph, MD, Principal Investigator|401-273-7100|James.Rudolph@va.gov|6406
21302533|NCT00647270|Abbott|Global Medical Services|800-633-9110||
21302534|NCT03615040|University of Leicester|Professor Chris Brightling|+44 116 250 2704|ceb17@le.ac.uk|
21302535|NCT00945295|New Mexico VA Healthcare System|JoAnn Harnar, Research Nurse|505-256-5701|Joann.Harnar@va.gov|
21274508|NCT01527006|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
21274509|NCT01383486|Bayer HealthCare LLC, Consumer Care|Head Clinical and Medical Affairs||clinical-trials-contact@bayerhealthcare.com|
21274510|NCT00245063|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
21274511|NCT01370369|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21274512|NCT01776190|University of Texas Southwestern Medical Center|Benjamin Chong, MD|214-645-2400|ben.chong@utsouthwestern.edu|
21274513|NCT01839279|Acorda Therapeutics, Inc.|Executive Medical Director|914-437-4300|paupperle@acorda.com|5263
21274514|NCT01907607|Institut Bergonié|Pr Antoine Italiano|33 5 56 33 33 33|a.italiano@bordeaux.unicancer.fr|
21274515|NCT01505933|Penn State Health Milton S. Hershey Medical Center|Dr. Uma R Parekh, MBBS, DNB, FRCA, FFARCSI|717531-4264|uparekh@pennstatehealth.psu.edu|
21274516|NCT05373173|Vanderbilt University Medical Center|Zachary Warren, Ph.D.|615-875-3085|zachary.e.warren@vumc.org|
21274517|NCT02777580|KU Leuven|Prof Frans Van de Werf|003216342111|frans.vandewerf@kuleuven.be|
21274518|NCT00529464|UT MD Anderson Cancer Center|Helen E. Rhodes, MD / Assistant Professor|713-792-2933|CR_Study_Registration@mdanderson.org|
21274519|NCT00466167|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21274520|NCT03199963|Besins Healthcare Ireland Ltd|Global Chief Medical Officer|+353 87 1039215|clinicaldevelopment@besins-healthcare.com|
21274521|NCT01144494|University of Nebraska Medical Center|Carol Toris|402-559-1852|ctoris@unmc.edu|
21274522|NCT00107991|UPenn|Jennifer Goldfarb|215-662-2540|jennifer.goldfarb@uphs.upenn.edu|
21274523|NCT03930732|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21274524|NCT04708028|University of North Carolina at Chapel Hill|Laura Jacox, DMD, PhD|919-966-9731|ljacox@live.unc.edu|
21260183|NCT01508455|Hospira|Dr. Marcelo Garcia da Rocha|224-212-4424|marcelo.rocha@hospira.com|
21260184|NCT01231412|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
21260185|NCT01360996|Woman's Hospital|Dr Karen Elkind-Hirsch|225-231-5275|karen.elkind-hirsch@womans.org|
21260186|NCT01763164|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21260187|NCT03377634|Wake Forest University School of Medicine|Amber Brooks, MD|336-716-4498|akbrooks@wakehealth.edu|
21260188|NCT02965378|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
21260189|NCT04964258|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21260190|NCT03384329|Institute of Physiology and Basic Medicine|Dr. Lyubomir Aftanas|+7-913-912-2228|liaftanas@gmail.com|
21260191|NCT01384292|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21260192|NCT01171612|Corporacion Sanitaria y Universitaria Parc Tauli|Anna Rodriguez-Pont|0034937231010|anna.r.pont@gmail.com|21283
21260193|NCT04525703|University of Wisconsin - Madison|Pajarita Charles, PhD|608-263-3834|paja.charles@wisc.edu|
21260194|NCT01285349|Social Intervention Group|Dr. Nabila El-Bassel|212-851-2391|ne5@columbia.edu|
21260195|NCT02909153|Rockwell Medical|clinical project manager|248-960-9009|sgrimberg@rockwellmed.com|
21260196|NCT00565617|Medical University of South Carolina|Gregory Sahlem|843-792-5716|sahlem@musc.edu|
21260197|NCT03040024|Emory University|Dr. Amit Prabhakar|404-686-2747|amit.prabhakar@emory.edu|
21260198|NCT00909155|University of Wisconsin|Dr. Michael Peterson|608 265 8130|mpeterson2@wisc.edu|
21260199|NCT00484315|Boston Scientific|Andrey Nersesov, Clinical Project Manager|508-683-4988|andrey.nersesov@bsci.com|
21260200|NCT00943683|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21260201|NCT00524537|AbbVie|Global Medical Information|800-633-9110||
21260202|NCT01565980|Michigan State University College of Nursing|Rebecca H. Lehto, PhD, Assistant Professor|517-353-4757|rebecca.lehto@hc.msu.edu|
21260203|NCT05391438|Children's Hospital Los Angeles|Alaina Vidmar|3236614606|avidmar@chla.usc.edu|
21260204|NCT00895830|Acacia Pharma Ltd|Dr Gabriel Fox||gabrielfox@acaciapharma.com|
21260205|NCT00288574|NYSPI|BT Walsh, MD|646-774-8066|edru@nyspi.columbia.edu|
21260206|NCT00382031|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
21260207|NCT01817790|GlaxoSmithKline|GSK Response Center|866-435-7343||
21260208|NCT01671345|Jesse Brown VA Medical Center|Howard S. Gordon, MD|312-569-7331|howard.gordon2@va.gov|
21260209|NCT03636906|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21260210|NCT04596891|New York State Psychiatric Institute|Dr. Yuval Neria|646-774-8092|ny126@cumc.columbia.edu|
21260211|NCT03690869|Regeneron Pharmaceuticals Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21260212|NCT04280081|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
21260213|NCT04022343|Emory University|Mehmet Asim Bilen, MD|404-778-1900|mehmet.a.bilen@emory.edu|
21260214|NCT03263806|Beaumont Hospitals|Korana Stakich-Alpirez|248 898 0315|Korana.Stakich-Alpirez@beaumont.org|
21260215|NCT04544566|Coloplast A/S|Head of Scientific Affairs|+45 4911 1111|clinicaltrialsgovSA@coloplast.com|
21260216|NCT00023322|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Theo Heller, M.D.|(301) 402-7147|Theoh@mail.nih.gov|
21260217|NCT00142506|MEMORIAL SLOAN KETTERING CANCER CENTER|MICHAEL J ZELEFSKY|+1212-639-6802|zelefskm@MSKCC.ORG|
21260218|NCT01495819|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-932-5711|mehmet.sofuoglu@yale.edu|4809
21260219|NCT04246554|UH Cleveland Medical Center|Dr. Michael Karns|216-844-7200|srmengers@gmail.com|
21260220|NCT01609933|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21260221|NCT01252966|University of Pennsylvania (Perelman School of Medicine)|Benjamin Albelda (Project Manager)|2157467173|albeldab@mail.med.upenn.edu|
21260222|NCT03275870|Beth Israel Lahey Health|Dr. Elena Gonzalez Brant, PI|6173191221|emgbrant@gmail.com|
21260223|NCT01133639|Mount Auburn|Emily Cook|(617) 354-3131|ecook@mah.harvard.edu|
21274525|NCT02825680|VA Center for Clinical Management Research|Laura Damschroder|734-845-3603|Laura.Damschroder@va.gov|
21274526|NCT02913924|New York State Psychiatric Institute|John Mariani MD|646-774-8181|john.mariani@nyspi.columbia.edu|
21274527|NCT00318461|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21274528|NCT03084471|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21274529|NCT00505622|Eisai Call Center|Eisai Inc.|888-422-4743||
21274530|NCT02354339|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uice@prodigy.net.mx|34212
21274531|NCT03393208|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21274532|NCT04405765|University of Texas Southwestern Medical Center|Tara Kristof - research coordinator|214-648-9007|tara.kristof@utsouthwestern.edu|
21274533|NCT00868374|University Hospitals Cleveland Medical Center|Dr. Keming Gao|216-844-2865|keming.gao@UHhospitals.org|
21274534|NCT01757392|Nielsen Biosciences, Inc|David Burney|858-571-2726|david@nielsenbio.com|
21274535|NCT01218672|Boston Scientific Corporation|Teresa Takle-Flach, Director, Clinical Operations|(952)930-6000|teresa.takle-flach@bsci.com|
21274536|NCT00207090|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21274537|NCT00835692|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274538|NCT01149733|Teva Pharmaceuticals USA|Associate Director, Biopharmaceutics|866-384-5525|clinicaltrialqueries@tevausa.com|
21274539|NCT01169753|University of Texas (UT) MD Anderson Cancer Center|Carmen Escalante, MD / Chair, General Internal Medicine||CR_Study_Registration@mdanderson.org|
21287873|NCT01434511|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21287874|NCT00833755|Massachusetts General Hospital|Dr. Jianren Mao|6177246102|mghpainresearch@partners.org|
21287875|NCT00262925|ECOG Statistical Office|Study Statistician|617-632-3012||
21287876|NCT00560404|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21287877|NCT03260023|Transgene|Director of Medical Affairs|+ 33 3 88 27 91 00|clinical.trials@transgene.fr|
21287878|NCT05035407|National Cancer Institute|Dr. Scott Norberg|301-275-9668|scoot.norberg@nih.gov|
21287879|NCT04220021|University of Florida|Laura P.W. Ranum, PhD|(352) 294-5209|ranum@ufl.edu|
21287880|NCT04513366|Swedish Orphan Biovitrum AB (publ)|Blank Clinical Study Physician, MD|+46 8 697 20 00|medical.info@sobi.com|
21287881|NCT02187783|Novartis Pharmaceuticals|Study Director|1-888-669-6682|Novartis.email@novartis.com|
21287882|NCT00171249|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21287883|NCT02908347|MetrioPharm Deutschland GmbH|Clinical Disclosure Officer|+49303384395|info@metriopharm.com|36
21287884|NCT02866643|Stanford University|Clinical Research Manager|6507247826|gynresearch@stanford.edu|
21287885|NCT03082729|University of Pennsylvania|Joel Gelfand, MD, MSCE|215-662-2737|joel.gelfand@pennmedicine.upenn.edu|
21287886|NCT04176224|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp|
21287887|NCT05335161|Purdue University|Bruno Tesini Roseguini|7654962612|brosegui@purdue.edu|
21287888|NCT00042289|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
21287889|NCT01950663|Dean McGee Eye Institute / University of Oklahoma Health Sciences Center|Dr. Stephen R. Fransen|405-271-1092|stephen-fransen@dmei.org|
21287890|NCT00498550|Dartmouth Medical School|Christopher OKeefe|603-271-5287|chris.okeefe@hitchcock.org|
21287891|NCT00863122|Johns Hopkins School of Medicine|Jaishri Blakeley|410-955-6827|jblakel3@jhmi.edu|
21287892|NCT03150043|UTMB|Katherine Jelliffe|2146635394|katherine.emilie@gmail.com|
21287893|NCT01673386|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|857-400-0101|Clinical@aveooncology.com|
21287894|NCT03042546|Harboview|research coordinator|206.744.4406|bagel@uw.edu|
21287895|NCT01140906|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
21287896|NCT00336544|Advanced Life Sciences|David Eiznhamer, PhD, Executive Vice President, Clinical Development|630-739-6744|deiznhamer@advancedlifesciences.com|
21287897|NCT01649765|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21287898|NCT00961064|National Heart Lung and Blood Institute|Bhavisha Patel, MD|301.402.3477|bhavisha.patel@nih.gov|
21287899|NCT01408641|FDA|Bernard Fischer, M.D.|240-402-4511|Bernard.Fischer@fda.hhs.gov|
21287900|NCT00576758|Hoffman-LaRoche|Medical Communications|800-821-8590||
21287901|NCT01648764|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21287902|NCT03427411|National Cancer Institute|Dr. Julius Strauss|240-858-3999|julius.strauss@nih.gov|
21287903|NCT01294046|Cleveland Clinic|Kathryn O'Connor||oconnok@ccf.org|
21287904|NCT03979313|Astrazeneca|Global Clinical Lead|+1 877-240-9479|information.center@astrazeneca.com|
21287905|NCT03183908|Duke University|Dr. Kenneth Schmader|919-660-7572|kenneth.schmader@duke.edu|
21287906|NCT03738696|University of Alabama at Birmingham, Department of Orthopaedics|Dr. Amit Momaya|205-930-8339|amomaya@uabmc.edu|
21287907|NCT01712178|AbbVie|Global Medical Services|800-633-9110||
21287908|NCT05001620|University of Maryland School of Nursing|Dr. Joan G. Carpenter|443-880-1430|joan.carpenter@umaryland.edu|
21287909|NCT00819039|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21287910|NCT01056276|Sarah Cannon Development Innovations|Charles Davis, RAC||charles.davis2@scri-innovations.com|
21287911|NCT00397579|University of Texas Southwestern Medical Center at Dallas|Clinical Research Office|214-648-7097|studyfinder@utsouthwestern.edu|
21287912|NCT02054156|Seattle Children's Hospital|Margaret Kloster|2068847862|margaret.kloster@seattlechildrens.org|
21287913|NCT02524119|UT Southwestern Medical Center|Dr. Muhammad Beg|2146484180|Muhammad.Beg@UTSouthwestern.edu|
21287914|NCT04154956|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21287915|NCT04424901|UConnHealth|Ellen Ciesielski|860-679-6004|eciesielski@uchc.edu|
21274540|NCT03644550|National Cancer Institute|Dr. Raffit Hassan|240-760-6232|hassanr@mail.nih.gov|
21274541|NCT00099047|Cleveland Clinic|Matt Kalaycio, MD|216-444-3705|kalaycm@ccf.org|
21274542|NCT00835536|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274543|NCT01668602|Emory University|Trisha Kesar, PT, PhD|404-712-5803|trisha.m.kesar@emory.edu|
21274544|NCT01636661|University of Minnesota|Dr. Bernadette Gillick|612.626.6415|brown029@umn.edu|
21274545|NCT00830024|Teva Pharmaceuticals USA|Manger, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274546|NCT00950989|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21274547|NCT03804983|University of Virginia Center for Diabetes Technology|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
21274548|NCT01440465|Centre François Baclesse|Alexandra LECONTE|0231455002|a.leconte@baclesse.unicancer.fr|
21274549|NCT04825275|Penn State College of Medicine|Alireza Mansouri, MD|717-763-2559|connect@mansourimd.com|
21274550|NCT02566850|Ekso Bionics|Katherine Strausser PhD|(510) 529-2529|kstrausser@eksobionics.com|
21260224|NCT02660580|Fresenius Kabi SwissBioSim GmbH|Eugenia Kunina, senior clinical development manager|+41791093376|clinical.development@fresenius-kabi.com|
21274551|NCT05005442|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21274552|NCT05932134|Linkou Chang Gung Memorial Hospital|M.D|+886-3-3281200|pitiful1984@gmail.com|8467
21274553|NCT04688658|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
21274554|NCT03696160|Research Organisation (KC) Ltd|Project Manager|+44 (0) 7508 439711|LAPTOP@rokcservices.com|
21274555|NCT03946111|Yale School of Medicine|Dr. Carlos M. Grilo|2037857210|carlos.grilo@yale.edu|
21287916|NCT00147238|UT MD Anderson Cancer Center|Haesun Choi, MD / Professor|713-745-4693||
21287917|NCT01348269|University Hospital Wuerzburg - Department of Orthopaedics (Clinical Study Unit)|Dr. Lothar Seefried|+499318033590|l-seefried.klh@uni-wuerzburg.de|
21287918|NCT00805532|VA Portland Health Care System|Amy W. Wagner, Ph.D.|(503) 220-8262|amy.wagner@va.gov|33365
21287919|NCT01859741|OncoMed Pharmaceuticals, Inc.|Manager, Regulatory Affairs|6509958322|imran.chaudhry@oncomed.com|
21287920|NCT02412657|MaisonneuveRH|Dr Veronique Brulotte|(514)252-3400|veronique.brulotte@umontreal.ca|
21287921|NCT00154466|National Taiwan University Hospital|Dr. Bai-Chin Lee|0223123456|lebai@ntu.edu.tw|63352
21287922|NCT03185208|University of Pittsburgh|Ariel Gildengers, M.D.|412-246-6002|ariel.gildengers@pitt.edu|
21287923|NCT03834350|University of Chicago|Dr. Valerie Press|773-702-5170|vpress@bsd.uchicago.edu|
21287924|NCT04009837|University of Delaware|Dr. Gregory Hicks, PT, PhD, FAPTA, FGSA|(302) 831-2690|ghicks@udel.edu|
21287925|NCT03134768|Danone Nutricia Research|Dr Elena Sandalova|6568309433|elena.sandalova@danone.com|
21287926|NCT05352815|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21287927|NCT00226655|Celtic Pharma Development Services America Inc|Director Medical Sciences|(212) 616 4016|henk-andre.kroon@dev.celticpharma.com|
21287928|NCT05144945|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21287929|NCT02855268|Sanofi-Aventis Recherche & Développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21287930|NCT00465517|Marinus Pharmaceuticals, Inc.|Marinus|(484) 801-4670|clinicaltrials@marinuspharma.com|
21287931|NCT05033041|Northwestern University|Paul C. Fitzgerald,RN,BSN,MS|312-695-1064|p-fitzgerald2@northwestern.edu|
21287932|NCT04287816|Ohio State University|Dr. Richard Bruno|6142925522|bruno.27@osu.edu|
21260225|NCT05415449|Children's Medical Center|Maria Leal|2144560276|Maria.leal@childrens.com|
21260226|NCT05428332|Stanford University|Allen Seo|9254939732|allenseo@stanford.edu|
21260227|NCT03455673|Groupe Hospitalier de la Rochelle Ré Aunis|Caroline Allix-Béguec, manager of clinical trials|+33546455050|caroline.allix-beguec@ght-atlantique17.fr|
21260228|NCT02185521|Philips Healthcare|Dr. Szymon Bieganski|978-284-3271|szymon.bieganski@philips.com|
21260229|NCT01169779|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21260230|NCT03293654|mAbxience|Susana Millan|+34917711500|susana.millan@mabxience.com|
21260231|NCT02348099|Gerontology Research Lab|Mr Boris Feldman, Research Associate|16048755115|boris.feldman@vch.ca|
21260232|NCT05052723|University of Kentucky|Dr. Joseph Kim|859-257-4490|joseph.kim@uky.edu|
21260233|NCT01933932|AstraZeneca Research and Development|Dr Gabriella Mariani|+44 (0)1763 263801|ClinicalTrialTransparency@astrazeneca.com|
21260234|NCT04526730|Moffitt Cancer Center|Ahmad Tarhini, MD, PhD|813-745-8581|Ahmad.Tarhini@moffitt.org|
21260235|NCT03155997|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21260236|NCT01111305|NIAID/NIH|Dr. Amy Klion|301-435-8903|aklion@niaid.nih.gov|
21260237|NCT02371850|University of Maryland School of Pharmacy|Audra Stinchcomb, PharmD|410-706-2646|astinchc@rx.umaryland.edu|
21260238|NCT05617521|Hospital Central Norte PEMEX|Dr. Antonio Marmolejo|+526142231826|dr.marmolejo.ch@gmail.com|
21260239|NCT00891995|Jaeb Center for Health Research|Katrina Ruedy|8139758690|kruedy@jaeb.org|
21260240|NCT02054702|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21260241|NCT00934102|University of Waterloo|Craig Woods, PhD, FAAO / Research Manager|1-519-888-4742|cclr2@uwaterloo.ca|
21260242|NCT01262898|GlaxoSmithKline|GSK Response Center|866-435-7343||
21260243|NCT00792298|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21260244|NCT00499109|H. Lee Moffitt Cancer Center and Research Institute|Charles C. Williams, M.D., Study Chair|813-745-7282|charles.williams@moffitt.org|
21260245|NCT00486603|Adult Brain Tumor Consortium|Director of ABTC|410-955-3657|jfisher@jhmi.edu|
21260246|NCT01221857|Gamida Cell|Kelly Myers|+972-2-659-5631|clinicaltrials@gamida-cell.com|
21274556|NCT04970810|University of Chicago|Jacqueline Kanoon|773-834-3419|kanoon@bsd.uchicago.edu|
21274557|NCT05056376|Johns Hopkins University, School of Medicine|Nestoras Mathioudakis, MD MHS|667-306-8085|nmathio1@jhmi.edu|
21274558|NCT04742491|HPTN Statistical & Data Management Center|HPTN Statistical Manager|206-667-4004|HPTN-Data-Access@scharp.org|
21274559|NCT04851184|George Washington University|Karen Goodman|202-994-0705|karengoodman@gwu.edu|
21274560|NCT03317899|Thomas Jefferson University|Dolores Grosso|848-256-5751|dag104@jefferson.edu|
21274561|NCT04534010|Stanford University|Arash Momeni, MD, FACS|(650) 723-6189|amomeni@stanford.edu|
21274562|NCT01440803|Columbia University|Elizabeth Shane, MD|212-305-7225|es54@cumc.columbia.edu|
21274563|NCT02342535|Northwestern University|Dr. Namratha Kandula|312-503-6470|nkandula@nm.org|
21274564|NCT03913377|Johnson & Johnson Vision Care|Elizabeth Dow, PRINCIPAL RESEARCH OPTOMETRIST|+1800-843-2020|edow1@its.jnj.com|
21274565|NCT04349267|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21274566|NCT03689400|Rehabilitation and Exercise Science Laboratory (RESlab), Department of Business Economics, Health and Social Care (DEASS), University of Applied Sciences and Arts of Southern Switzerland (SUPSI), Landquart, Switzerland|Giannina Bianchi|00418 300 01 78|giannina.dias@supsi.ch|
21274567|NCT04618211|Pharvaris Netherlands B.V.|Pharvaris Clinical|31 712036410|clinical@pharvaris.com|
21274568|NCT01648582|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21274569|NCT04614168|University of Edinburgh|Prof. Shareen Forbes|0131 242 6740|shareen.forbes@ed.ac.uk|
21274570|NCT00908128|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274571|NCT03534193|Hackensack Meridian Health|Steven Ghanny, MD|5519965329|steven.ghanny@hmhn.org|
21274572|NCT05797961|Mahidol University Faculty of Social Sciences and Humanities|Chair of the Institutional Review Board|+662-441-9180|mussirb310@gmail.com|
21274573|NCT06539676|Dentsply IH AB d.b.a Dentsply Sirona Implants|Clinical Research Manager|+4631 3763191|freja.freedman@dentsplysirona.com|
21274574|NCT01172145|Brown University|Laura L. Frakey|401-729-3163|lfrakey@gmail.com|
21274575|NCT04134091|Lipocine Inc|Senior Director of Clinical Development|801-994-7383|admin@lipocine.com|
21274576|NCT01154231|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21274577|NCT00128219|University of Pittsburgh School of Medicine|Sharon Hillier, Ph.D.|412-641-6435|hillsl@mwri.magee.edu|
21274578|NCT05710718|Becton, Dickinson and Company|Director Clinical Affairs and Medical Affairs Strategy|551-225-1164|Kirsten.Hammitt@bd.com|
21274579|NCT04372238|Brown University School of Public Health|Brandon DL Marshall, PhD|4018636427|brandon_marshall@brown.edu|
21274580|NCT04241458|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21274581|NCT00334815|SWOG Statistical Center|Lung Committee Statistician|206-667-4623|jmoon@fhcrc.org|
21274582|NCT05919823|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
21274583|NCT06107725|Maimonides Medical Center|Dr. QingL Tony Wang|718.283.7670|qwang@maimo.org|
21274584|NCT02927639|Children's Hospital of Philadelphia|Tara Kaushal, MD|6177322603|tara.kaushal@joslin.harvard.edu|
21274585|NCT04414930|UCSD|Neal R. Swerdlow, M.D., Ph.D.|6194719455|nswerdlow@health.ucsd.edu|
21274586|NCT05470699|City of Hope|Paul Frankel, Ph.D.|6262185265|pfrankel@coh.org|
21274587|NCT04128761|Virginia Tech|Stephen LaConte|5405262008|slaconte@vtc.vt.edu|
21274588|NCT06682403|University of Pennsylvania|Dr. Mucio Kit Delgado|2157468256|mucio.delgado@pennmedicine.upenn.edu|
21274589|NCT03926052|Yale University School of Medicine|Dr. Carlos Grilo|2037857210|carlos.grilo@yale.edu|
21274590|NCT03466866|Thomas Jefferson University|Barry Rovner,MD|215-503-1243|Barry.Rovner@Jefferson.edu|
21274591|NCT01848938|Umeå University, Umeå, Sweden|Dr. Eva Samuelsson|+46706966440|eva.samuelsson@umu.se|
21274592|NCT03077451|Statistical and Data Analysis Center, AIDS Malignancy Consortium|Deukwoo Kwon|(713) 500-7964|deukwoo.kwon@mountsinai.org|
21274593|NCT04603495|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
21274594|NCT01983969|UT MD Anderson Cancer Center|Nieto, Yago / Stem Cell Transplantation and Cellular Therapy|713-792-8750|ynieto@mdanderson.org|
21274595|NCT02619682|Fred Hutchinson Cancer Care Center|Dr Leona A Holmberg|206-667-6447|lholmber@fredhutch.org|
21274596|NCT00268203|GlaxoSmithKline|GSK Response Center|866-435-7343||
21274597|NCT04589650|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21274598|NCT03600376|Eagle Pharmaceuticals, Inc.|Chief Medical Officer|201-326-5300|medinfo@eagleus.com|
21274599|NCT02067611|Techfields|Dr. Chongxi Yu|571 276 5371|chongxiyu@hotmail.com|
21274600|NCT05655520|Supernus Pharmaceuticals, Inc.|Gianpiera Ceresoli-Borroni PhD|3018382521|gceresoliborroni@supernus.com|
21274601|NCT05980286|University of California, San Francisco|Julene Johnson, Professor|415-476-1106|Julene.Johnson@ucsf.edu|
21274602|NCT03114891|University of Pennsylvania|Dr. Desmond Oathes, Principal Investigator|215-573-9390|oathes@pennmedicine.upenn.edu|
21274603|NCT02294981|UCSF Psoriasis and Skin Treatment Center|Tina Bhutani|4159147618|psoriasis@ucsf.edu|
21274604|NCT00911274|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274605|NCT00909753|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274606|NCT00702377|Alcon Research Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21274607|NCT00185458|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21238436|NCT02521285|UT MD Anderson Cancer Center|Robert S. Bresalier, MD- Professor, Gastroenterology Hepat & Nutr|(713) 745-4340|rbresali@mdanderson.org|
21238437|NCT02499679|HeartFlow|Sarah Mullen|650-241-1221|smullen@heartflow.com|
21238438|NCT05701995|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21238439|NCT00715429|University of Wisconsin School of Pharmacy|Dr. Mary Elliott|608-695-7501|meelliott@pharmacy.wisc.edu|
21238440|NCT00406133|Jaeb Center for Health Research|Roy W. Beck, M.D., Ph.D., Director|813-975-8690|rbeck@jaeb.org|
21238441|NCT04899245|University of Wisconsin School of Medicine and Public Health|Dr. Ryan Coller|608-263-9408|rcoller@pediatrics.wisc.edu|
21238442|NCT04880395|Fundación Huésped - Buenos Aires|Dr. María Inés Figueroa|+54 11 2120-9999|maria.figueroa@huesped.org.ar|
21238443|NCT03933826|University of Washington|Dr. John Gore|206-543-9926|cistopm@uw.edu|
21260247|NCT02706938|Universidad Nacional de Colombia|Dr. Ivan Mauricio Villamil Morales|+573178755369|imvillamilm@unal.edu.co|
21287933|NCT01090180|Veterans Affairs North Texas Health Care System|Alina Suris|817-715-0625|alina.suris@va.gov|
21287934|NCT00289276|Medtronic CRDM Clinical Research|CRDM Core Clinical|800-328-2518|medtroniccrmtrials@medtronic.com|
21287935|NCT00726609|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21287936|NCT03084237|Shanghai Henlius Biotech|Head of Clinical Development|+86 021-33395800|contact@henlius.com|
21287937|NCT01067586|University of Minnesota|Dorothy Hatsukami, PhD|612-626-2121|hatsu001@umn.edu|
21287938|NCT00706563|GlaxoSmithKline|GSK Response Center|866-435-7343||
21287939|NCT00746551|Mahidol University, Department of Obstetrics and Gynaecology, Division of Maternal Fetal Medicine, Faculty of Medicine, Siriraj Hospital|Pharuhas Chanprapaph|+66819920053|pharuhasc@gmail.com|
21287940|NCT00914069|Bard Access Systems, Inc.|Gina Gilbert|407-489-0835|Gina.Gilbert@crbard.com|
21287941|NCT02029417|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21287942|NCT04458922|National Cancer Institute|Alice P. Chen|240-781-3274|chenali@mail.nih.gov|
21287943|NCT04062227|HealthPartners Institute|Bhavani Kashyap, MBBS, PhD|651-495-6363|Bhavani.X.Kashyap@HealthPartners.com|
21287944|NCT04682301|Fred Hutchinson Cancer Center|Madison Snidarich, Clinical Research Coordinator|2066674589|msnidari@fredhutch.org|
21287945|NCT05219162|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21287946|NCT06015490|Virginia Polytechnic Institute and State University|Alexandra DiFeliceantonio|540-526-2285|dife@vt.edu|
21287947|NCT02642042|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|jmiao@fredhutch.org|
21287948|NCT03506061|Emory University|Eric Sorscher, MD|205-612-1327|esorscher@emory.edu|
21287949|NCT00392223|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21287950|NCT03344757|University of Miami|Dr. Frank Penedo|305-284-4290|fpenedo@miami.edu|
21287951|NCT01316575|University of Saskatchewan|Dr. William McKay|306-655-1202|william.mckay@saskatoonhealthregion.ca|
21287952|NCT03043053|Massachusetts General Hospital|Elizabeth A. Lawson, MD, MMSc|617-726-3870|ealawson@mgh.harvard.edu|
21238444|NCT00500903|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21260248|NCT00888238|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21287953|NCT02792504|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21287954|NCT01535924|The Ohio State University|Dr. Beth Christian|614-293-7807|Beth.Christian@osumc.edu|
21287955|NCT01832766|University of Colorado Denver|Lynn Johnson, Pharm.D.|303 724 6221|lynn.johnson@ucdenver.edu|
21287956|NCT01114724|Medtronic Inc., Aortic and Peripheral Vascular|Celeste Claudy - Study Lead|763-514-0130|celeste.m.claudy@medtronic.com|
21287957|NCT02814526|Alzheimer's Disease Cooperative Study (ADCS)|Clinical Operations|858-246-1333|alzinfo@ucsd.edu|
21287958|NCT04585893|UNC Lineberger Comprehensive Cancer Center|Matthew S Painschab|919-966-4431|matthew_painschab@med.unc.edu|
21287959|NCT07000981|Inonu University|Asst. Prof. Gürkan ÖZDEN|+90 505 715 62 65|gurkan.ozden@inonu.edu.tr|
21287960|NCT02485860|Centre Hospitalier Departemental Vendée|Dr. Emeric ABET|02 51 44 61 48|emeric.abet@ght85.fr|+33
21287961|NCT01191749|University of Texas (UT) MD Anderson Cancer Center|Tapan Kadia, MD|1-877-632-6789|CR_Study_Registration@mdanderson.org|
21287962|NCT03454555|RTI International|Dr. Lauren McCormack|919-541-6277|lmac@rti.org|
21287963|NCT00850642|GlaxoSmithKline|GSK Response Center|866-435-7343||
21287964|NCT06128954|Orphalan SA|Carla Bennett|07918380893|carla.bennett@orphalan.com|
21287965|NCT05352763|Cassava Sciences|Project Manager|5125013180|closedstudyinfo@cassavasciences.com|
21287966|NCT05019430|University of Kentucky|William W. Stoops|8592575388|william.stoops@uky.edu|
21287967|NCT04770753|Agios Pharmaceuticals, Inc .|Agios Medical Affairs|833-228-8474|medinfo@agios.com|
21287968|NCT02987868|Pennington Biomedical Research Center|Dr. Frank Greenway, Chief of Outpatient Clinic|225-763-2578|Frank.Greenway@pbrc.edu|
21287969|NCT00849056|GlaxoSmithKline|GSK Response Center|866-435-7343||
21287970|NCT04588259|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21287971|NCT00274456|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21287972|NCT02314546|Bassett Healthcare Network|David A. Ullman, MD, Senior Attending Anesthesiologist|607-547-3153|david.ullman@bassett.org|
21287973|NCT04460885|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21287974|NCT02688803|Ottawa Hospital Research Institute|Dr. John Hilton|613-737-7700|jfhilton@toh.ca|70170
21287975|NCT00396292|Luitpold Pharmaceuticals, Inc.|Marc Tokars|610-650-4200|mtokars@lpicrd.com|
21287976|NCT04889040|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21287977|NCT03837847|Mayo Clinic|Roberto P. Benzo, M.D.|507-284-0561|Benzo.Roberto@mayo.edu|
21287978|NCT03801252|University of Oklahoma Health Sciences Center|Dr. Stephanie Pierce|(405) 271-8787|stephanie-pierce@ouhsc.edu|
21287979|NCT02690727|Algorithme Pharma Inc.|Dr. Eric Sicard|(514) 858-6077|esicard@algopharm.com|
21238445|NCT01648348|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-1370|galanis.evanthia@mayo.edu|
21274608|NCT02709018|University of California San Diego|Murray B. Stein MD, MPH|858-534-6451|mstein@health.ucsd.edu|
21274609|NCT04050735|Brown University|Dr. Mollie Monnig|401-863-3491|mollie_monnig@brown.edu|
21274610|NCT01838681|H. Lundbeck A/S|Email contact via||LundbeckClinicalTrials@lundbeck.com|
21274611|NCT00796562|Johns Hopkins University|Heather Symons, MD|4105029961|hsymons2@jhmi.edu|
21274612|NCT00424047|Celgene Corporation|Anne McClain, Senior Manager|1-866-260-1599|ClinicalTrialDisclosure@celgene.com|
21274613|NCT02664961|TRACON Pharmaceuticals|Medical Monitor|8585500780|ctheuer@traconpharma.com|
21274614|NCT05248204|Solventum US LLC|Paula Myhre|6513948069|pemyhre1@solventum.com|
21274615|NCT03100344|Galderma|Kenny Frazier|817-961-5120|Kenny.frazier@galderma.com|
21274616|NCT01010503|Hoffmann- LaRoche.|Medical Communications|800-821-8590|genentech@druginfo.com|
21274617|NCT06336356|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21274618|NCT04827394|University of Oklahoma Health Sciences Center|Birju Shah, MD|405-271-5215|birju-shah@ouhsc.edu|42167
21274619|NCT05871151|University of Alabama at Birmingham|Alexandra Evancho|(205)975-5221|amelgin@uab.edu|
21274620|NCT06041256|Aurion Biotech, Inc.|Study director|+1-857-639-4143|clinicalaffairs@aurionbiotech.com|
21274621|NCT03215706|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21274622|NCT04375514|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|1 (626) 304-3400|info@arrowheadpharma.com|
21274623|NCT02324335|Innovation Pharmaceuticals Inc.|Arthur P. Bertolino MD, PhD, MBA|978.921.4125|abertolino@IPharmInc.com|
21274624|NCT00640341|Bausch & Lomb Incorporated|Gerard Cairns|(585) 338-5170|gerard.cairns@bausch.com|
21274625|NCT03578809|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21274626|NCT00830258|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274627|NCT00798603|Roswell Park Cancer Institute|Grace K. Dy, M.D.|507-284-9265|grace.dy@roswellpark.org|
21274628|NCT00835705|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274629|NCT01750294|Indiana University & Richard L Roudebush VA Medical Center|Rajiv Agarwal, MD, FAHA, FASN, FASH|317-988-2241|ragarwal@iu.edu|
21274630|NCT01002287|Integra LifeSciences|Stefani Battaglia|44 7880 732691|stefani.battaglia@integralife.com|
21274631|NCT01116739|University of Colorado Denver|Patricia A. Braun|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
21274632|NCT01624233|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21274633|NCT05090839|University of Miami|Dr. Roger McIntosh|3052435166|r.mcintosh@miami.edu|
21274634|NCT03256227|Minneapolis VA Health Care System|Laura Meis, PhD|612-467-4516|laura.meis@va.gov|
21274635|NCT03121586|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|844-422-2342|medicalinformation@acadia-pharm.com|
21274636|NCT06381102|University of Miami|Marlon Wong, Associate Professor of Clinical|3052842670|mwong2@miami.edu|
21274637|NCT03119025|Institute of Fundamental and Clinical Immunology|Alexander A Ostanin, MD, PhD Study Principal Investigator|383-236-03-29|ct_lab@mail.ru; ostanin62@mail.ru|+7
21274638|NCT02832063|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
21274639|NCT03733730|Alcon Research, LLC|Sr. Clinical Project Lead, CRD Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21274640|NCT01987765|Allergan, Inc|Vice President GSE,|714-246-4500|clinicaltrials@allergan.com|
21274641|NCT00772603|Supernus Pharmaceuticals, Inc|Stefan Schwabe, M.D., Ph.D., Chief Medical Officer|301-838-2500|sschwabe@supernus.com|2527
21274642|NCT00443651|Genentech, Inc.|Medical Communications|800-821-8590||
21274643|NCT01564394|Huntsman Cancer Institute, University of Utah|Anita Y. Kinney, PhD|801-585-1151|anita.kinney@hci.utah.edu|
21274644|NCT02826694|The University of North Carolina at Chapel Hill|Dr. Cynthia M. Powell|9199667646|powellcm@med.unc.edu|
21274645|NCT01988376|Far Eastern Memorial Hospital|Hsiao, Sheng-Mou|(02)89667000|smhsiao2@gmail.com|1424
21274646|NCT03606174|Mirati Therapeutics|Director, Clinical Operations|858-381-5289|LatvenL@Mirati.com|
21274647|NCT00859521|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274648|NCT02125461|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21287980|NCT02030600|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
21287981|NCT01240694|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21287982|NCT01881425|InnFocus, Inc. (a Santen Company)|Sharon Herbert, Director of Global Clinical Operations|(415) 268-9059|sharon.herbert@santen.com|
21287983|NCT00701363|Ipsen|Medical Director, Clinical Endocrinology and Metabolism|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21287984|NCT04759131|Bioverativ Therapeutics Inc. (a Sanofi Company)|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
21287985|NCT06831786|prince of songkla university|Sarunyou Chusri|+66897340446|sarunyouchusri@hotmail.com|
21297096|NCT00428844|Cubist Pharmaceuticals, Inc.|Ed Campanaro, VP Clinical Operations|781-860-8318|ed.campanaro@cubist.com|
21274649|NCT02305732|Cerus|Carol Moore, Senior VP Regulatory Affairs & Quality|925-288-6361|cmoore@cerus.com|
21274650|NCT01246258|Imperial Health|Joanne Rimmer|0061402931120|rimmer.joanne@gmail.com|
21274651|NCT03170219|Duke Clinical Research Institute|Rachel Olson, Project Leader|919-668-5590|rachel.e.olson@duke.edu|
21274652|NCT03552484|Rush University Medical Center|Jori Fleisher, MD MSCE|3125632900|jori_fleisher@rush.edu|
21274653|NCT03499353|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21274654|NCT01592240|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21274655|NCT00862563|Department of Psychiatry, Boston Univ School of Medicine|Dr. Domenic A Ciraulo, Professor|617-414-1990|dciraulo@bu.edu|
21274656|NCT00469898|Vanderbilt-Ingram Cancer Center|Leora Horn, M.D.|615-322-4967|leora.horn@vanderbilt.edu|
21274657|NCT01426360|Sun Yat-sen University|Dr. Liu Hongchun|86-0-13826189071|hongchun751@sina.com|
21274658|NCT01205035|Eye Center of Northern Colorado, PC|Dr. Arthur Korotkin, MD|970-221-2222|retina@eyecenternoco.com|
21274659|NCT02663349|Minneapolis VA Health Care System|Tasha Nienow, PhD|612-467-1004|tasha.nienow@va.gov|
21274660|NCT01896934|Vanderbilt University Medical Center|Dr. Warren D Taylor|615-936-3555|warren.d.taylor@vanderbilt.edu|
21274661|NCT01557751|University of Pittsburgh Medical Center (UPMC)|Dr. Jacques Chelly, MD, PHD MBA|412-623-6382|chelje@anes.upmc.edu|
21274662|NCT00721162|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21274663|NCT04590027|University of Tuebingen, Department of Anaesthesiology and Intensive Care Medicine|Dr. Barbara Schlisio|+4970712985535|barbara.schlisio@med.uni-tuebingen.de|
21274664|NCT03276754|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21274665|NCT00316277|McLean Hospital/Harvard Medical School|Roger D. Weiss, M.D.|617-855-2242|rweiss@mclean.harvard.edu|
21274666|NCT00848536|Alcon Research, Ltd.|Director Alcon Clinical|888.451.3937 or 817.568.6725||
21274667|NCT04089553|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21274668|NCT01175135|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21274669|NCT01447017|Centre for Clinical Studies in Malmö|Dr. Pekka Koskinen|+46 (0)40 97 12 60|pekka@clsm.se|
21274670|NCT01572662|The University of Texas MD Anderson Cancer Center|Uday Popat, M.D. / Stem Cell Transplantation|713-792-8750|upopat@mdanderson.org|
21274671|NCT03364192|VA Center for Integrated Healthcare|Emily M. Johnson, Ph.D., PI|315-425-4400|Emily.Johnson1@va.gov|53487
21274672|NCT03317444|Tricida, Inc.|Medical Information|415-429-7800|medinfo@tricida.com|
21274673|NCT04692155|UAB|Amitkumar Mehta|2059968400|amitkumarmehta@uabmc.edu|
21274674|NCT04547192|KWAME NKRUMAH UNIVERSITY/SCIENCE/TECH|Dr Adam Gyedu|+233248228838|drgyedu@gmail.com|
21274675|NCT01535222|The Medicines Company|Andreas van de Locht|+4989244180862|andreas.locht@themedco.com|
21274676|NCT02479763|Montreal General Hospital|Dr. De QH Tran|514-934-1934|de_tran@hotmail.com|43261
21274677|NCT00935012|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21274678|NCT01442155|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21274679|NCT04626414|Shield Therapeutics|Jackie Mitchell|+44 (0) 191 511 8500|jackie.mitchell@shieldtx.com|
21274680|NCT02284867|Ain Shams university (AinShamsU)|Ahmed Mohammed Abass , Ass.lecturer in faculty of medicine|002-01066903903|ahmedmams@hotmail.com|
21274681|NCT01590563|Synexus Hungary|Dr. Beata Szoczei, MD|+36 1 436 7330||
21274682|NCT02699463|ResMed Ltd|Dr Alison Wimms|+61 8884 1123|alison.wimms@resmed.com|
21274683|NCT01108445|Duke University Medical Center|Dr. Andrew J Armstrong|919-668-4615|andrew.armstrong@duke.edu|
21274684|NCT02488239|Boston Scientific|Caroline Beaudoint|+32479904163|Caroline.Beaudoint@bsci.com|
21274685|NCT03283982|Cleveland Clinic Foundation|Dr. Ajita Prabhu|2164444790|prabhua@ccf.org|
21274686|NCT05283148|University of California Davis Comprehensive Cancer Center|Oyebimpe Adesina, MD, MS|9167035166|adesina@ucdavis.edu|
21274687|NCT01370733|University of California Los Angeles|Dr. Andrew Leuchter, MD|(310) 825-0207|afl@ucla.edu|
21274688|NCT03325881|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21274689|NCT03676634|California Department of Public Health|Stephen S. Arnon, M.D., M.P.H., Chief, Infant Botulism Treatment and Prevention Program|510-231-7600|Stephen.Arnon@cdph.ca.gov|
21274690|NCT03279250|UT MD Anderson Cancer Center|Dr. Christopher Logothetis, MD-Professor, Genitourinary Medical Oncology|(713) 563-7210|clogothe@mdanderson.org|
21274691|NCT00909038|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21274692|NCT01640197|Northumbria University|Emma Wightman|(+44) 0191 2437253|emma.l.wightman@northumbria.ac.uk|
21274693|NCT01370811|Quest Research Institute|Aaron L. Ellenbogen, OD, MPH|+1 248 644 7770|aellenbogen@comcast.net|
21274694|NCT01895335|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21274695|NCT03480763|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21274696|NCT01647828|OncoMed Pharmaceuticals, Inc.|Manager, Regulatory Affairs|6509958322|imran.chaudhry@oncomed.com|
21274697|NCT01718873|National Cancer Institute, IRCCS, G. Pascale Foundation|Antonio Avallone, Dierctor of Experimental Abdominal Medcial Oncology|+390815903629|a.avallone@istitutotumori.na.it|
21274698|NCT00115063|PenningtonBRC|Tiffany Prather, RN, CDE|225-763-2979|tiffany.prather@pbrc.edu|
21274699|NCT03808376|Senseonics|Vice President, Clinical Sciences|301-515-7260|katherine.tweden@senseonics.com|
21274700|NCT03734861|Connecticut Children's Medical Center, Asthma Center|Dr. Jessica Hollenbach, PhD|860-837-5333|jhollenbach@connecticutchildrens.org|
21274701|NCT03503318|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21274702|NCT02687126|Shahid Gangalal National Heart Centre|Santosh Sharma Parajuli|+9779806532132|santoshparajuli77@hotmail.com|
21274703|NCT02433977|University of Pittsburgh|Stacy Gelhaus Wendell|412-648-1351|gstacy@pitt.edu|
21274704|NCT01251393|Universidade Federal de São Paulo|PhD José Carlos F. Galduróz||galduroz@unifesp.br|
21274705|NCT01541215|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21274706|NCT03599193|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
21302536|NCT01541397|The University of Texas Health Science Center at Houston|Heather Saavedra|713-500-7098|Heather.Saavedra@uth.tmc.edu|
21302537|NCT00807560|Icahn School of Medicine at Mount Sinai|Katharine Loeb, PhD|212-659-8724|Katharine.Loeb@mssm.edu|
21302538|NCT01128621|GlaxoSmithKline|GSK Response Center|866-435-7343||
21302539|NCT00233454|Stanford University Medical Center|Jason R Gotlib, MD, Associate Professor of Medicine (Hematology)|650-867-2823|jason.gotlib@stanford.edu|
21302540|NCT02737891|Saniona A/S|Kim Krogsgaard|20148384|kim.krogsgaard@saniona.com|0045
21302541|NCT00388583|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21302542|NCT05194579|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21302543|NCT01988584|The University of Texas Health Science Center at Houston|Charles S. Cox, MD, Professor|713-500-7300|charles.s.cox@uth.tmc.edu|
21302544|NCT03595228|Bavarian Nordic A/S|Bavarian Nordic Call Center|1-844-422|medical.information_us@bavarian-nordic.com|8274
21302545|NCT01639729|AcelRx|Pamela Palmer|650-216-3500|ppalmer@acelrx.com|
21302546|NCT03232333|Miromatrix|Head of Clinical Affairs|952.942-6000|mmacenski@miromatrix.com|
21302547|NCT01253811|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21302548|NCT00759564|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21302549|NCT04233918|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21302550|NCT00514852|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
21302551|NCT04975438|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21302552|NCT04973436|Duke University School of Medicine|Tamara Somers, PhD|9194163408|tamara.somers@duke.edu|
21238446|NCT00696410|University of Michigan|Jennifer Cowger, MD, Assistant Professor|734 936-5265|jennmatt@med.umich.edu|
21238447|NCT05340855|Mayo Clinic|Christi A Patten, Ph.D.|507-266-2554|patten.Christi@mayo.edu|
21238448|NCT03407794|University of North Florida|Andrea Arikawa|9044798995|andrea.arikawa@unf.edu|
21238449|NCT01951638|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21238450|NCT00552084|Vanderbilt University Medical Center|Dr. C Michael Stein|615-936-3420|mike.stein@vanderbilt.edu|
21238451|NCT01338025|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
21238452|NCT04549363|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21238453|NCT02286089|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21238454|NCT05460325|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21238455|NCT05073133|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21238456|NCT05878197|Ghent University|drs. Anke Adriaansen|0471028622|anke.adriaansen@ugent.be|
21238457|NCT05002218|Columbia University Irving Medical Center|Scott Barbuto, MD|518-275-9588|sb3779@cumc.columbia.edu|
21238458|NCT06223373|Wake Forest University Health Sciences|Kristen Faith Nicholson, PhD|704-355-2000|Kristen.Nicholson@advocatehealth.org|
21238459|NCT01165775|Stanford School of Medicine|Yasser El-Sayed, MD|(650) 723-3198|Yasser.el-sayed@stanford.edu|
21238460|NCT03520322|University of Rochester Medical Center|Otolaryngology Research Program Manager|5852751186|paul_allen@urmc.rochester.edu|
21238461|NCT01728792|Takeda|Takeda Study Registration Call Center, Central Contact|+1-877-825-3327|medicalinformation@tpna.com|
21238462|NCT03559218|KeraNetics|Ryan Clohessy, PhD|4102513940|rclohessy@keranetics.com|
21238463|NCT04277455|Mercy Research|Dr. Johnson Thomas|417-888-5660|johnson.thomas@mercy.net|
21238464|NCT01936896|Virginia Commonwealth University|Antonio Abbate|8048280513|antonio.abbate@vcuhealth.org|
21238465|NCT03810534|University of North Carolina at Chapel Hill|Mark Toles, MPH|919-966-5684|mtoles@email.unc.edu|
21238466|NCT04737109|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
21238467|NCT03092375|UF Hepatology Research at CTRB|Lauren Morelli|3522739508|LAUREN.MORELLI@MEDICINE.UFL.EDU|
21238468|NCT01679301|Philips Respironics|Chuck Cain|+1 724 7335835|chuck.cain@philips.com|
21238469|NCT03328143|Aurora Neuroscience Innovation Institute|Richard A Rovin, MD|4143851922|richard.rovin@aurora.org|
21238470|NCT02305381|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
21238471|NCT01042509|Hospital Universitario|Dr. David Gomez-Almaguer|5281-83488510|hematohu@yahoo.com|
21238472|NCT01007656|PingTung Christian Hospital Ruiguang Branch|Dr. Choo-Aun Neoh|886-8-736-8686|neohca@gmail.com|5310
21238473|NCT04857034|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email|Clinical.Trials@bms.com|
21238474|NCT00520975|ECOG-ACRIN Statistical Office|ECOG-ACRIN statistician|617-632-3012||
21238475|NCT00642902|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21238476|NCT03953898|Yale School of Medicine|Rory Shallis, MD|(203) 200-4363|rory.shallis@yale.edu|
21260249|NCT02868892|WRMC|Jessica L. Coats|6233417220|jessica.coats@ctca-hope.com|
21302553|NCT01276054|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist, Clinical Investigations Support Office|323-226-6384|victoria.soto@med.usc.edu|
21302554|NCT01168986|University of Florida|Joel Bialosky, PT, PhD|352-273-8636|jbialosky@phhp.ufl.edu|
21302555|NCT01419197|Hoffmann-La Roche|Medical Communications|800 821-8590||
21302556|NCT00146848|Clinical Affairs|Kira Stolen|1 800 CARDIAC|cshd@bsci.com|
21302557|NCT01798849|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
21302558|NCT00717236|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
21302559|NCT00743106|Cleveland Clinic Foundation|Jerome O'Hara, MD|216-444-8278|oharaj@ccf.org|
21302560|NCT04556383|GB004, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.|GB004, Inc. Study Director|1-866-668-4083|ClinicalTrials@gossamerbio.com|
21302561|NCT00884741|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21302562|NCT01994889|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21302563|NCT04525885|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21302564|NCT02717832|University of Michigan|Dr. Jeffrey Horowitz|734-647-1076|jeffhoro@umich.edu|
21302565|NCT00750152|Merz Pharmaceuticals, LLC|Merz Pharmaceuticals, LLC|800-334-0514||
21302566|NCT02537015|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21302567|NCT01808092|AstraZeneca|David Wilson, Statistical Team Leader - Infection|+44 1625 517830|David.wilson2@astrazeneca.com|
21302568|NCT04219085|Yale University|Audrey Merriam|203-785-7813|audrey.merriam@yale.edu|
21302569|NCT04469998|AxeroVision, Inc.|Dr. Houman Hemmati|+1 (310) 600-4123|houman@axerovision.com|
21302570|NCT01097005|Mylan EPD Japan|Takao Miki, Medical Affairs||takao.miki@mylan.com|
21302571|NCT01909011|Mount Sinai Beth Israel|Igor Galynker MD PhD|212-420-4535|igalynke@chpnet.org|
21302572|NCT03425253|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21302573|NCT04614324|Aerin Medical|Anais Laborde Sr. Director of Clinical Affairs|650-518-9624|alaborde@aerinmedical.com|
21302574|NCT04627285|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
21302575|NCT00294762|Astellas Pharma Global Development|Medical Monitor||clinicaltrials@us.astellas.com|
21302576|NCT02937584|AstraZeneca|Stephan Stenglein, MD|+46 (0)31 776 1000|stephan.stenglein@astrazeneca.com|
21302577|NCT02238080|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21302578|NCT00583713|Braintree Laboratories, Inc.|Russell Pelham, PhD|781-843-2202|rpelham@braintreelabs.com|
21302579|NCT04224688|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21302580|NCT04074161|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21302581|NCT02317744|Yale School of Medicine|Dr. Carlos Grilo|203-785-2792|carlos.grilo@yale.edu|
21302582|NCT00796445|GlaxoSmithKline|GSK Response Center|866-435-7343||
21302583|NCT02500056|Tartu University Hospital|Ceith Nikkolo|+37253319082|ceith.nikkolo@kliinikum.ee|
21302584|NCT01087736|University of California, San Francisco|David L. Pennington, PhD (Research Psychologist II)|415-221-4810|david.pennington2@va.gov|4504
21302585|NCT03495856|University of North Carolina School of Medicine|Carrie Brintz|919-445-6109|carrie_brintz@med.unc.edu|
21302586|NCT01565343|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
21302587|NCT01012674|Guerbet|Dr Pierre Desché, MD - VP Head of Development, Medical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
21302588|NCT01853839|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21302589|NCT00638183|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21302590|NCT02059291|Novartic Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21274707|NCT05511935|KDH Research & Communication Inc.|President|4043958711|kholtz@kdhrc.com|
21274708|NCT04102345|HealthPartners Neuroscience Research|Bhavani Kashyap, MBBS, PhD|651-495-6358|bhavani.x.kashyap@healthpartners.com|
21274709|NCT00834964|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274710|NCT01609257|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21274711|NCT02645253|AstraZeneca AB|AZD7594 Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
21274712|NCT02741687|Emory University|Maya Fayfman, MD|404-778-1664|maya.fayfman@emory.edu|
21274713|NCT01015287|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21274714|NCT01117623|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21274715|NCT03264092|Texas Tech University Health Sciences Center|Dr. Antonio Mendoza Ladd|9152154678|antonio.mendoza-ladd@ttuhsc.edu|
21274716|NCT04145635|Procyrion, Inc.|Rubi Reyes-Fuentez, Clinical Research Associate II|-|rubi@procyrion.com|
21274717|NCT02727192|Oslo University Hospital|Professor Lars Gullestad|+4797644772|lars.gullestad@medisin.uio.no|
21274718|NCT00928057|BD Medical, Medical Affairs|Kenneth Kassler-Taub, MD|201 847 6729|kenneth_kassler-taub@bd.com|
21274719|NCT03206749|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21274720|NCT02451696|NYU Langone|Dr. Orrin Devinsky|646-558-0800|od4@nyu.edu|
21274721|NCT03674892|Tufts Medical Center|Pedram Hamrah, MD|617-636-5720|pedram.hamrah@tuftsmedicine.org|
21274722|NCT05099380|Johnson & Johnson Vision Care, Inc.|John R. Buch-Sr. Principal Research Optometrist|1-800-843-2020|jbuch@its.jnj.com|
21274723|NCT00041392|Duke University|Dr. Mark F. Newman|919-681-6646|newma005@mc.duke.edu|
21274724|NCT01384591|University of Texas Medical Branch|Melinda Sheffield-Moore|409-772-8126|melmoore@utmb.edu|
21274725|NCT01959672|University of Nebraska Medical Center|Chi Lin|402-552-3844|clin@unmc.edu|
21274726|NCT02392195|Boston Children's Hospital|Michele DeGrazia|617-919-1222|michele.degrazia@childrens.harvard.edu|
21274727|NCT00840216|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274728|NCT00907907|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274729|NCT00545792|Dana-Farber Cancer Institute|Akila N. Viswanathan, MD, MPH|617-732-6331|aviswanathan@lroc.harvard.edu|
21274730|NCT02891863|Boston Scientific CRM|Greg Voss|651-581-3068|gregory.voss@bsco.com|
21274731|NCT05041361|University of California, San Francisco|Ashley Mason, PhD|415 514 6820|ashley.mason@ucsf.edu|
21274732|NCT01642277|Loyola University Chicago, Microbiology and Immunology|Dr. Alan J. Wolfe|224-392-4002|awolfe@luc.edu|
21274733|NCT03679598|University of Alabama at Birmingham|Dr. James Wells|2059345555|LungHealth@uabmc.edu|
21274734|NCT00927069|Innovaderm Research, Inc.|Annie Levesque|514 521 4285|alevesque@innovaderm.ca|222
21274735|NCT00629122|Weill Cornell Medical College|Meredith J. Aull, Pharm.D.|(212) 746-8720|mea9008@med.cornell.edu|
21287986|NCT00284856|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21287987|NCT03207399|Duke University Medical Center|Dr. Omar Mohamedaly|919-684-4589|omar.mohamedaly@duke.edu|
21287988|NCT02592824|Linköping University Hospital|Dr Jonas Holm|+46101034498|jonas.holm@regionostergotland.se|
21287989|NCT05082025|The University of Texas MD Anderson Cancer Center|Dr. Timothy Yap|(713) 839-5458|tyap@mdanderson.org|
21287990|NCT01451372|Medtronic Minimed|Suiying Huang, Statistician|8184763319|suiying.huang@medtronic.com|
21287991|NCT01498549|Yale University|Dr. Mehmet Sofuoglu, Professor of Psychiatry; Director of VA New England Mental Illness Research, Ed|(203) 937-4809|mehmet.sofuoglu@yale.edu|
21287992|NCT00269152|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21302591|NCT03180619|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21274736|NCT02842853|Sanofi Pasteur Inc.|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21274737|NCT01798264|Intarcia|Michelle Braon|510-782-7800||
21274738|NCT03682601|GTO Pharma|Clinical Trial Coordinator|9175436934|akhmea01@gmail.com|
21274739|NCT01403194|Mayo Clinic|Dr. Seema Kumar|507-538-2724|kumar.seema@mayo.edu|
21274740|NCT03428750|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|clinicaltrials@endo.com|
21274741|NCT02944617|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
21274742|NCT00274651|Topotarget A/S|PRS Admnistrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com|
21274743|NCT05133180|Dompé farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
21274744|NCT04342663|Washington University School of Medicine|Dr. Eric Lenze|314-362-5154|lenzee@wustl.edu|
21274745|NCT01188681|Emergent BioSolutions|Scott C. Stromatt|206-859-6675|sstromatt@ebsi.com|
21274746|NCT04345653|JFK University Medical Center - Hackensack Meridian Health|Dr. Jawad Kirmani|7327745805|jawad.kirmani@hmhn.org|
21274747|NCT03214588|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
21274748|NCT00418938|Amgen Inc.|Study Director|866-572-6436||
21274749|NCT00205777|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21274750|NCT04428307|Duke University|Wendy Prudhomme-O'Meara, PhD|919-613-4406|wendy.omeara@duke.edu|
21274751|NCT00700739|DePuy Synthes Spine|Mark Lotito|(508) 880-8045|Mlotito@its.jnj.com|
21274752|NCT02314403|Massachusetts General Hospital|Tatsuo Kawai, MD PhD|617-726-0289|tkawai@mgh.harvard.edu|
21274753|NCT01794845|University of Miami|Matthew C. Abramowitz MD|305-243-4319|MAbramowitz@med.miami.edu|
21274754|NCT02139826|Ixchelsis Limited|Chief Medical Officer|44(0)1227-832760|ian.osterloh@ixchelsis.com|
21274755|NCT05604209|University of North Carolina at Chapel Hill|Cynthia Gay, MD, MPH|919-843-2726|cynthia_gay@med.unc.edu|
21274756|NCT01004510|Rochester General Hospital|Todd Sheppard, MD|585-922-4409|todd.sheppard@rochestergeneral.org|
21274757|NCT02096692|Biotronik, Inc.|Clinical Studies Engineer|503-451-8049|justin.michalski@biotronik.com|
21274758|NCT01824576|Advanced Circulatory|Sr. Clinical Research Associate|651.403.5606|nburkhart@zoll.com|
21274759|NCT00351039|Fox Chase Cancer Center (formerly at H. Lee Moffitt Cancer Center & Research Institute)|George Simon, M.D.|215-728-2509|george.simon@fccc.edu|
21274760|NCT02911025|Brigham and Women's Hospital|Dr. Milena Pavlova|6174772129|mpavlova@bwh.harvard.edu|
21274761|NCT03719040|Abbott|Dr. Kwangdeok Lee|9725269673|kwangdeok.lee@abbott.com|
21274762|NCT06647173|Emory University|Dr. Aaron Siegler|404-712-9733|asiegle@emory.edu|
21274763|NCT02923349|Incyte Corporation Call Centre|Incyte Biosciences International Sàrl|8554633463|RA@incyte.com|
21274764|NCT00363077|GlaxoSmithKline|GSK Response Center|866-435-7343||
21274765|NCT01120028|University of Oxford|Prof Peter Friend|01865223872|ccc@ctsu.ox.ac.uk|
21274766|NCT01248728|Holland Bloorview Kids Rehabilitation Hospital|Dr. Evdokia Anagnostou|416-425-6220|eanagnostou@hollandbloorview.ca|6005
21274767|NCT01841554|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
21287993|NCT04622345|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
21274768|NCT00312897|Icahn School of Medicine at Mount Sinai|Dr. Vilma Gabbay|212-659-1661|vilma.gabbay@mssm.edu|
21274769|NCT00725322|Stanford University School of Medicine|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu|
21274770|NCT03527485|Yale School of Medicine|Gustavo A. Angarita, MD, MHS|(203) 974-7536|gustavo.angarita@yale.edu|
21274771|NCT05350137|Tongji Hospital affiliated Tongji Medical College of Huazhong University of Science and Technology|Dr. Wei Ping|+8613437101581|247046170@qq.com|
21274772|NCT03944057|Antengene Corporation|Shimin Sun|+8613701803117|jasmine.sun@antengene.com|
21274773|NCT02973269|Revance Therapeutics, Inc.|Todd Gross, PhD, VP, Clinical Development & Data Science|510-742-3400|tgross@revance.com|
21274774|NCT00258856|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21274775|NCT03247686|Resolve Therapeutics LLC|James Posada|208 727 7010|jp@resolvebio.com|
21274776|NCT00159419|Indiana University School of Medicine|Dr. Linda DiMeglio|317-944-3889||
21274777|NCT03930849|Department of Veterans Affairs|Carolyn Turvey, Ph.D.|319 338 0581|Carolyn.Turvey@va.gov|637714
21274778|NCT02488109|University of California, San Francisco, Department of Pediatrics|Andrea Garber, PhD, RD|415-514-2180|andrea.garber@ucsf.edu|
21274779|NCT02302716|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21274780|NCT03232736|University of Colorado Anschutz Medical Campus|William Cornwell|16142961686|william.cornwell@ucdenver.edu|
21274781|NCT02906813|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21274782|NCT03102879|Universidad de los Andes|Claudia Brizuela|56 2 26181166|clau@cibrizuela.com|
21274783|NCT00557245|University of Washington|Dr. Connie Celum|206-520-3824|ccelum@uw.edu|
21274784|NCT01127087|Mayo Clinic|Dr. John C. Lieske|507-266-7960|lieske.john@mayo.edu|
21274785|NCT01275664|NRG Oncology|Linda Gedeon for Helen Huang, MS|716-845-1169|lgedeon@gogstats.org|
21274786|NCT00521586|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21274787|NCT00828321|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274788|NCT00365053|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
21274789|NCT03390257|SF Otolaryngology|Dr. Jacob Johnson|4153625443|jjohnson@sfotomed.com|
21274790|NCT04406194|Farmagen|Aydin Erenmemisoglu|+90 532 551 0082|a.erenmemisoglu@farmagenarge.com|
21274791|NCT02888756|Erasmus MC|Dr R.A. Gruters|+31 10 7032100|r.gruters@erasmusmc.nl|
21274792|NCT02722239|Biocard Research LLC|Nadiya Rizvanova|+74993088278|n.rizvanova@biocard.com|
21274793|NCT00491738|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
21274794|NCT00433745|Hematology Branch, NHLBI|Minoo Battiwalla, MD|301 827 0939|battiwam@nhlbi.nih.gov|
21274795|NCT02920476|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
21274796|NCT02752074|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
21274797|NCT00488774|Janssen Research & Development|Senior Director|215-793-7540||
21274798|NCT03605342|VA Connecticut Healthcare System|Dr Ismene Petrakis|203-932-5711|Ismene.Petrakis@va.gov|1-2244
21287994|NCT05516758|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21287995|NCT00402831|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21287996|NCT03818854|University of California San Francisco|Dr. Michael Matthay|415-476-1079|michael.matthay@ucsf.edu|
21287997|NCT02431299|Indiana University Purdue University Indianapolis|Dr. Alan B. McGuire|3179882725|abmcguir@iupui.edu|
21287998|NCT03880474|Vaccitech Ltd.|Tom Evans, MD|+44 01865 591 445|enquiries@vaccitech.co.uk|
21287999|NCT06178991|BioNTech SE|BioNTech clinical trials patient information|+49 6131 90840|patients@biontech.de|
21288000|NCT01526408|House Institute Foundation|Mahta Marefat|(213) 770-1808|mmarefat@hifla.org|
21274799|NCT01604941|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21274800|NCT03366792|NYU Langone Health - Perlmutter Cancer Center|Samir S. Taneja, MD|(212) 263-6301|Samir.Taneja@nyulangone.org|
21274801|NCT03497130|Department of Dermatology at Johns Hopkins University|Dr. Anna Chien|410-502-7546|achien3@jhmi.edu|
21274802|NCT00158925|Boston Scientific|Elke Sommerijns|+32 479 76 71 56|elke.sommerijns@bsci.com|
21274803|NCT01484912|Sinphar Pharmaceutical Co., Ltd. Taiwan|Justine Tang||justine@sinphar.com.tw|
21274804|NCT00829712|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274805|NCT02277093|Washington University School of Medicine|Benjamin R. Tan|314-362-9915|btan@wustl.edu|
21274806|NCT00003470|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
21274807|NCT04667338|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21274808|NCT00867360|Stanford University|Dr. Alan Schatzberg|650-723-6811|afschatz@stanford.edu|
21274809|NCT03275623|The University of Texas Health Science Center at Houston|Jerrie S. Refuerzo, MD|(713) 500-6416|Jerrie.S.Refuerzo@uth.tmc.edu|
21274810|NCT00112437|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21274811|NCT00659828|University of Miami|Richard Bookman|305-243-0494|y.p.davis@med.miami.edu|
21274812|NCT01125163|UTexas_Houston|Dr. Kathleen A. Kennedy|713-500-6708|Kathleen.A.Kennedy@uth.tmc.edu|
21274813|NCT03703258|University of Washington School of Medicine|Dr. Emily R. Dworkin|206-221-6932|edworkin@uw.edu|
21274814|NCT03218787|Abbott|Lijuan Jenn Wang, Advisor, Clinical Affairs|01-408-8453133|Lijuan.wang1@abbott.com|
21274815|NCT00436163|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21274816|NCT01910831|Center for Clinical and Cosmetic Research|Andrew Frisina, Clinical Research Coordinator|305 933 6716|A.Frisina@admcorp.com|
21274817|NCT03250117|Titan Pharmaceuticals, Inc.|Kate Beebe DeVarney, PhD|650-244-4990|medinfo@titanpharm.com|
21274818|NCT04063878|Dentsply IH AB d.b.a Dentsply Sirona Implants|Clinical Research Manager|+46 31 376 44 11|marie.ahlson@dentsplysirona.com|
21274819|NCT02751827|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
21274820|NCT00815087|Wang tyng|Dr.Wang TG|+886-2-23123456|patty.jt@gmail.com|67587
21274821|NCT01229150|National Cancer Institute|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov|
21274822|NCT04633564|Mylan GmbH|Keri Vaughan, Senior Director|+215.280.2846|keri.vaughan@viatris.com|
21274823|NCT01279486|SPD Swiss Precision Diagnostics GmbH/SPD Development Company Ltd|Dr Sarah Johnson, Head of Clinical and Regulatory Affairs|01234835486|sarah.johnson@spdspark.com|
21274824|NCT00926887|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
21274825|NCT04198363|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21274826|NCT02584608|Indiana Univerity School of Medicine|Micheal Econs|317-274-1339|mecons@iu.edu|
21274827|NCT05344118|Nationwide Children's Hospital|Dr. Joseph D Tobias|614-722-4200|joseph.tobias@nationwidechildrens.org|
21274828|NCT03067987|University of Miami|Ranjith Ramasamy|3052434873|ramasamy@miami.edu|
21274829|NCT03442322|University of Pittsburgh|Natalie Leland|(412) 383-3405|NEL24@pitt.edu|
21260250|NCT01007526|Samsung Medical Center|Won Seog Kim|82234106548|wskimsmc@skku.edu|
21260251|NCT01454076|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21274830|NCT01885949|MGH Cancer Center|Dr. Dror Michaelson|6177244000|dmichaelson1@mgh.harvard.edu|
21288001|NCT01366092|Dana-Farber Cancer Institute|John Koreth, MBBS, DPhil|617-632-2949|JKoreth@partners.org|
21288002|NCT02394769|Massachusetts General Hospital|Andrew T. Chan, MD, MPH|(617) 726-3212|achan@partners.org|
21260252|NCT02278783|Huntsman Cancer Institute|Theresa Werner|801-587-3486|theresa.werner@hci.utah.edu|
21260253|NCT00096161|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
21260254|NCT03056443|West Virginia University|Robert Stansbury, MD|304-293-4661|rstansbury@hsc.wvu.edu|
21260255|NCT01526148|University Hospitals Cleveland Medical Center|Keming Gao, MD, PhD|216-844-2865|keming.gao@UHhospitals.org|
21260256|NCT01173653|Vanderbilt University Emergency Medicine Department|Benjamin Heavrin, MD|615-936-0253-|benjamin.heavrin@vanderbilt.edu|
21260257|NCT00291551|Paracor Medical, Inc.|Michael Kolber, General Manager, VP, Regulatory Affairs|408-734-6000|info@paracor.com|
21260258|NCT02452762|Children's Hospital of Eastern Ontario|James Dayre McNally, Principal Investigator and Pediatric Intensivist|613-737-7600|dmcnally@cheo.on.ca|3553
21260259|NCT00584870|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21260260|NCT00631137|Johns Hopkins|Jaishri Blakeley|410-955-8837|jblakel3@jhmi.edu|
21260261|NCT03682120|St Louis University School of Medicine|Sharon Frey, MD|314-997-5500|sharon.frey@health.slu.edu|
21260262|NCT01015833|Memorial Sloan-Kettering Cancer Center|Ghassan Abou-Alfa, MD|646-888-4184|abou-alg@mskcc.org|
21260263|NCT02844998|Ankara TRH|Dr. Muhammet Fatih Kilinc|+90 312 595 3700|mdfatihkilinc@yahoo.com|3724
21260264|NCT03633084|Ribomic USA|Yusuf Ali, Ph.D.|(707) 287-4313|yusuf.ali@ribomic.com|
21260265|NCT02914509|Ocular Therapeutix, Inc.|Clinical Project Manager|781-357-4000|clinicalaffairs@ocutx.com|
21260266|NCT03529409|University of Maryland, College Park|Dr. Jessica Magidson|301-405-5095|jmagidso@umd.edu|
21274831|NCT03500094|Amicus Therapeutics|Medical Affairs|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
21274832|NCT03506633|University of Nebraska at Omaha|Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
21274833|NCT02997176|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21274834|NCT04039022|Axsome Therapeutics, Inc.|Caroline Streicher, Senior Director, Clinical Operations|212-332-5061|cstreicher@axsome.com|
21274835|NCT02985749|Massachusetts General Hospital|Gagan Joshi, MD|617-724-1541|gjoshi@mgh.harvard.edu|
21274836|NCT01630616|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21274837|NCT01993186|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
21274838|NCT00691704|Duke University Medical Center|Cristina Gasparetto, MD|919-668-1017|cristina.gasparetto@duke.edu|
21274839|NCT04523480|University of Miami, Miller School of Medicine - Desai Sethi Urology Institute|Ranjith Ramasamy, MD|3052434562|ramasamy@miami.edu|
21274840|NCT02244554|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
21274841|NCT00385736|Abbott|Global Medical Services|800-633-9110||
21274842|NCT01662960|Albert Einstein Healthcare Network|Dr. Steven Jax|215-870-0196|stevenandrewjax@gmail.com|
21274843|NCT02109458|Johns Hopkins University School of Medicine|Dr. Lonny Yarmus|4105025224|lyarmus@jhmi.edu|
21274844|NCT05497557|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21274845|NCT00845130|Univeristy of Kansas Medical Center|In-Young Choi, Ph.D.|913-588-0174|ichoi@kumc.edu|
21274846|NCT00198133|IndianaU|Patrick J. Loehrer, Sr., M.D.|(317)944-0920|ploehrer@iu.edu|
21274847|NCT05523895|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2289|medicalinformation@acadia-pharm.com|
21274848|NCT01380782|Dana-Farber Cancer Institute|Patrick Y. Wen, MD|6176322166|pwen@partners.org|
21274849|NCT01701063|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21274850|NCT01919112|Beth Israel Deaconess Medical Center|Sandeep Kumar, MD|617-632-8917|skumar@bidmc.harvard.edu|
21274851|NCT02043132|Beaumont Health|Dr. J. Michael Wiater|248-551-3140|J.Michael.Wiater@beaumont.edu|
21274852|NCT04474405|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
21274853|NCT02518945|State University of NY at Buffalo|Paresh Dandona|7165351852|dandona@buffalo.edu|
21274854|NCT00918645|University of California, Davis|Data Manager|916-734-8381|nmahaffey@ucdavis.edu|
21274855|NCT03446768|University of California, San Diego, La Jolla, CA|Carl Stepnowsky, PhD|858-642-1240|cstepnowsky@health.ucsd.edu|
21274856|NCT00635648|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21274857|NCT04194801|CStone Pharmaceuticals|Hua Hu|+86 021-60333416|CstoneRA@cstonepharma.com|
21274858|NCT02511535|Med Uni Wien, Institut für Spezifische Prophylaxe und Tropenmedizin|Erika Garner-Spitzer, PhD|0043 1 40160|erika.garner-spitzer@meduniwien.ac.at|38255
21274859|NCT03827395|Emory University|Evan J. Anderson, MD|404-727-1746|evanderson@emory.edu|
21274860|NCT04723693|Oxford university Hospitals NHS Foundation Trust|Simon Fletcher|01865 225316|simon.fletcher@ouh.nhs.uk|
21274861|NCT00294047|GlaxoSmithKline|GSK Response Center|866-435-7343||
21274862|NCT02157974|University of Colorado Anschutz Medical Campus|Melanie Cree-Green, PI|720-777-5743|melanie.green@childrenscolorado.org|
21274863|NCT00538031|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
21274864|NCT00506831|Stanford University|Lorinda Chung|650-493-5000|shauwei@stanford.edu|62042
21274865|NCT02464657|The University of Texas MD Anderson Cancer Center|Dr. Farhad Ravandi-Kashani, MD/Professor|(713)745-0394|fravandi@mdanderson.org|
21274866|NCT01410227|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21274867|NCT01165047|Aurora Health Care|Katernie Slotke|414-649-2615|katherine.Slotke@aurora.org|
21274868|NCT00606281|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
21274869|NCT00617396|UNC Chapel Hill|Dr. Douglas Drossman|919-966-0141|douglas_drossman@med.unc.edu|
21274870|NCT03131895|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21274871|NCT00540423|GlaxoSmithKline|GSK Response Center|866-435-7343||
21274872|NCT01339247|GlaxoSmithKline|GSK Response Center|866-435-7343||
21274873|NCT03556618|University of California, Los Angeles|Dr. Elizabeth Barnert, Principal Investigator, Associate Professor|(310) 206-1483|ebarnert@mednet.ucla.edu|
21274874|NCT02213263|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21274875|NCT00263588|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
21274876|NCT02960295|Kaiser Permanente Southern California|Steven Jacobsen MD, PhD. Director, Department of Research and Evaluation|626-564-3470|Steven.J.Jacobsen@nsmtp.kp.org|
21274877|NCT00918684|Weill Cornell Medical College|Dr. George Alexopoulos, M.D.|914-997-5767|galexopoulos@med.cornell.edu|
21274878|NCT03629054|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21274879|NCT04029545|Prollenium Medical Technologies|Director Clinical Affairs|19055081469|clinicaltrials@prolleniumus.com|
21274880|NCT00924638|Medtronic, Inc.|Medtronic CRDM clinical trial manager|763-505-6000|medtronicCRMtrials@medtronic.com|
21288003|NCT02273167|Norgine Ltd|Lucy Clayton|+44-1895-826669|LClayton@norgine.com|
21260267|NCT01497262|Novartis Pharmaceuticals|Study director|862-778-8300||
21260268|NCT01656772|Stereotaxis, Inc.|Qun Sha M.D. (Study Director)|314-678-6143|qun.sha@stereotaxis.com|
21260269|NCT03898063|University of Miami|Nick Carcioppolo|3052845633|n.carcioppolo@miami.edu|
21260270|NCT01651780|The Medicines Company|Global Health Science Center|800-388-1183||
21260271|NCT02949830|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
21260272|NCT01290887|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21260273|NCT01628926|Otsuka Pharmaceutical Co, Lts.|Director of Clinical Research and Development|+81-3-6361-7366||
21260274|NCT02116621|University of California, Davis|Richard Kravitz, MD, MSPH|916-734-1248|rlkravitz@ucdavis.edu|
21260275|NCT03437447|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21260276|NCT04492566|Sansum Diabetes Research Institute|Dr. Kristin Castorino|805-682-7638|info@sansum.org|
21260277|NCT04752384|Medical College of Wisconsin|Stuart J. Wong, MD|414-805-4600|swong@mcw.edu|
21260278|NCT03726268|Duke University|Evan Kharasch, MD, PhD|919-613-1154|evan.kharasch@duke.edu|
21260279|NCT01986062|Arbor Pharmaceuticals|Dr. Steve Caras|(470) 235-2327|scaras@arborpharma.com|
21260280|NCT03538743|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21260281|NCT00667615|Memorial Sloan Kettering Cancer Center|David Straus MD|212-639-8365|strausd@mskcc.org|
21260282|NCT01955707|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21260283|NCT01905956|InQpharm Europe Ltd|Pee-Win Chong|+603 6201 9690|pwchong@inqpharm.com|358
21260284|NCT03431467|The Hospital of the University of Pennsylvania|Dr. Christian Bermudez|2153165151|christian.bermudez@pennmedicine.upenn.edu|
21260285|NCT03812172|Columbia University Irving Medical Center|Mathew Maurer|2123058274|msm10@cumc.columbia.edu|
21260286|NCT06001307|Illinois Institute of Technology|Arryn Guy|312-567-6467|aguy1@iit.edu|
21260287|NCT03532100|CLiMB|Glenn Klute, PhD|206.277.6724|Glenn.Klute@va.gov|
21260288|NCT03896581|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21260289|NCT00960076|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21260290|NCT02029976|George Mason University, College of Health and Human Services|Dr. Martha Y Kubik, Professor and Director School of Nursing|703-993-1971|mkubik@gmu.edu|
21274881|NCT01316055|Vice President - Clinical Development & Medical Affairs (CDMA)|Herbert Henney, PharmD|(914) 347-4300|hhenney@acorda.com|5138
21274882|NCT02992067|Zhejiang Cancer Hospital|Yu Xingfei|057188122001|yuxf1177@zjcc.org.cn|+86
21302592|NCT01433289|Baylor|Supriya Parikh|832-824-2589|supriya.parikh@bcm.edu|
21274883|NCT02679729|AstraZeneca AB|Global Clinical Leader|+46 766 346712|ClinicalTrialTransparency@astrazeneca.com|
21274884|NCT00748566|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21274885|NCT01124786|Clovis Oncology, Inc.|VP Clinical Development|415-409-5440|clinicaltrialinfo@clovisoncology.com|
21302593|NCT00244140|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21302594|NCT02673541|Dartmouth-Hitchcock Medical Center|Dr Jeffrey Adler|603-650-5261|Jeffrey.m.adler@hitchcock.org|
21302595|NCT02410343|Teva Branded Pharmaceutical Products|Director of Clinical Trials|215-591-3000|Public_CTD@tevapharm.com|
21302596|NCT02663934|Washington University in St. Louis|Brittany Nelson, Senior Clinical Research Coordinator|314-747-8425|bmnelson@wustl.edu|
21302597|NCT03704636|Masimo Corporation|Chelsea Frank|949-297-7000|studies@masimo.com|
21302598|NCT02720042|Becton, Dickinson and Company|Sandra van Guldener|+31 6 46900840|sandra.vanguldener@bd.com|
21302599|NCT00539188|Yale University School of Medicine|Christopher Pittenger, MD Ph.D|203-974-7675|christopher.pittenger@yale.edu|
21302600|NCT02356900|Duke University Medical School|Richard Moon, MD|919-684-6726|richard.moon@duke.edu|
21302601|NCT04784442|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81363617366|CL_OPCJ_RDA_Team@otsuka.jp|
21302602|NCT00509145|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21302603|NCT00246740|Departments of Pediatrics and Pharmacology, University of Alberta|Dr Richard Schulz|780-492-6581|richard.schulz@ualberta.ca|
21302604|NCT00125528|Northwestern Universiyt|Dr. Thomas Schnitzer|312-503-2315|tjs@northwestern.edu|
21302605|NCT00101452|Massachusetts General Hospital|Maurizio Fava|617-724-2513|mfava@partners.org|
21302606|NCT02969655|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21302607|NCT02646371|LimmaTech Biologics AG|Director of Clinical Trials|+41 44 733 8585|info@lmtbio.com|
21302608|NCT00929643|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21302609|NCT01536392|UT MD Anderson Cancer Center|Michael Frumovitz, Professor, Gyn Onc & Reproductive Med|(713) 792-9599|mfrumovitz@mdanderson.org|
21302610|NCT00574236|University of Wisconsin Carbone Cancer Center|Dr. Anne Traynor|608-262-5092|amt@medicine.wisc.edu|
21302611|NCT02874144|Northwestern|Anju Peters|3126950513|anju.peters@northwestern.edu|
21302612|NCT02975557|Ophthalmology and Visual Sciences, University of Illinois, Chicago, IL|Dr. Sandeep Jain|312-996-4476|jains@uic.edu|
21302613|NCT00852371|Makerere University Kampala|Nankabirwa Joaniter|+256772676429|jnankabirwa@yahoo.co.uk|
21302614|NCT03158285|Janssen Research & Development, LLC|Head Rheumatology Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21302615|NCT03753113|Tabriz University of Medical Sciences|Dr. Farid Masoud|+989036859062|faridmasoud@gmail.com|
21302616|NCT02744040|Fred Hutchinson Cancer Research Center|Ann C Duerr, MD, PhD, MPH, Member|206-667-7938|aduerr@fredhutch.org|
21302617|NCT01642615|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21302618|NCT01094522|Stanford University School of Medicine|Dr. Gregory Hammer|6507367359|ham@stanford.edu|
21302619|NCT00402740|Abbott Vascular|Ellen Travis, MS, NFP|408 845-1512|Ellen.Travis@av.abbott.com|
21302620|NCT02140593|Herlev and Gentofte Hospital University of Copenhagen|Dr. Matias Vested Madsen|+4538683868|matias.vested.madsen@regionh.dk|
21302621|NCT01214395|PathWest Laboratory Medicine WA|Dr Kerry Carson Trial Manager|+61 8 93464092|kerry.carson@uwa.edu.au|
21302622|NCT04166240|VAORD|Hardeep Singh|713 7948515|hardeep.singh@va.gov|
21302623|NCT00946153|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
21302624|NCT03456882|Istituto di Ricerche Farmacologiche Mario Negri IRCCS|Elisabetta Pupillo|+390239014605|elisabetta.pupillo@marionegri.it|
21302625|NCT03698591|Duke University|Dr. Kevin LaBar, PhD.|(919)668-2424|klabar@duke.edu|
21302626|NCT03009396|Redhill Biopharma|Reza Fathi, Sn. VP Research and Development|972-(0)3-541-3131|reza@redhillbio.com|
21302627|NCT02973438|University of Miami|Mark S. Nash, Ph.D.|3052433628|mnash@med.miami.edu|
21302628|NCT00238355|OHSU Knight Cancer Institute|Dr. Lynne Strasfeld|503-494-1551|strasfel@ohsu.edu|
21302629|NCT00893815|Henry Jackson Foundation|Infectious Diseases Clinical Research Program||contactus@idcrp.org|
21302630|NCT01165216|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21302631|NCT03255083|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21302632|NCT06221826|Pharmasoft|Meshcherskiy Y.E., Medical director|+7(495)626-47-55|meshcherskiy_y@pharmasoft.ru|140
21302633|NCT04180540|Emory University|Michael lloyd|404-712-4063|mlloyd@emory.edu|
21302634|NCT01457352|Sun Pharma Advanced Research Company Limited|SPARC|912266455645|Clinical.Trials@Sparcmail.com|
21302635|NCT02626624|CarboFix Orthopedics Ltd.|Dvir Sherpsky, Director of Clinical Trials|+972-54-770-9920|dvir@carbo-fix.com|
21302636|NCT00695097|University of California, San Francisco|Flavio Vincenti|415-353-1322|flavio.vincenti@ucsfmedctr.org|
21302637|NCT04174365|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21302638|NCT03472547|Castle Creek Pharmaceuticals, LLC|Dr. Mary Spellman; Chief Medical Officer|862 286 0400|mspellman@castlecreekpharma.com|
21302639|NCT05141448|Johnson & Johnson Vision Care, Inc. (JJVC)|Principal Research Optometrist|614-531-6781|anixon1@its.jnj.com|
21302640|NCT02695160|Sangamo Therapeutics|Medical Monitor|+1 510 307 7266|clinicaltrials@sangamo.com|
21302641|NCT01106092|GlaxoSmithKline|GSK Response Center|866-435-7343||
21302642|NCT01371032|Cedars Sinai Medical Center|Dr. Roya Yumul, MD, PhD|310-423-1682|Roya.Yumul@cshs.org|
21302643|NCT02434471|Duke University|Mustafa R. Bashir, M.D.|919-684-7366|mustafa.bashir@duke.edu|
21302644|NCT01473368|Beth Israel Deacones Medical Center|Ciaran Kelly, MD|617-667-1272|ckelly2@bidmc.harvard.edu|
21274886|NCT00883233|Galderma|Jean-Charles Dhuin|+33492952921|jean-charles.dhuin@galderma.com|
21274887|NCT01442376|Helsinn Healthcare SA|Spinelli Tulla|+4191985 21 21|tulla.spinelli@helsinn.com|
21274888|NCT04404725|CooperVision, Inc|Jose Vega, OD, MSc, FAAO|9256213761|JVega2@coopervision.com|
21274889|NCT01075516|Department of Cardiology, San Filippo Neri Hospital - Rome|Dr. Renato P. Ricci||renatopietroricci@tin.it|
21274890|NCT02252016|Merck Sharp & Dohme Corp.|Senior Vice President, Glocal Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21274891|NCT04631562|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1-855-752-2356|clinicaltrials@alexion.com|
21274892|NCT02319824|Fred Hutchinson Cancer Research Center|Seth Pollack|206-667-6629|spollack@fhcrc.org|
21274893|NCT01825798|Holland Bloorview Kids Rehabilition Hospital|Dr. Evdokia Anagnostou|416-753-6005|eanagnostou@hollandbloorview.ca|
21274894|NCT04171115|Resilience Government Services|Angie Kimbler|386-418-8751|angie.kimbler@resilience.com|
21274895|NCT00834873|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274896|NCT02055547|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21274897|NCT01457196|UNC Lineberger Comprehensive Cancer Center|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
21274898|NCT03498560|Massachusetts General Hospital DACCPM|Dr. Oluwaseun Johnson-Akeju|617-724-7200|oluwaseun.akeju@mgh.harvard.edu|
21274899|NCT02896296|Indivior, Inc.|Global Director, Clinical Development|804-379-1090|Robert.Bauer@Indivior.com|
21274900|NCT02597049|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21238477|NCT00246337|Merck Sharp & Dohme Corp|Vice President of Late Stage Development|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com|
21238478|NCT03525548|Vertex Pharmaceuticals Incorporated|Medical Monitor|617 341 6777|medicalinfo@vrtx.com|
21260291|NCT01445171|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
21297097|NCT02684188|University of Montana|Tom Seekins, Ph.D.|2432654|TOm.Seekins@UMontana.edu|406
21297098|NCT02292706|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21297099|NCT01229722|Dimagi Inc.|Dr. Vikram Kumar|6176492214|information@dimagi.com|
21297100|NCT01990612|Northwestern University|Dr. William Grobman|312-472-4661|w-grobman@northwestern.edu|
21297101|NCT03595527|Centre hospitalier de l'Université de Montréal|Valréie Martel-Laferrière, MD|5148908000|valerie.martel-laferriere.med@ssss.gouv.qc.ca|
21297102|NCT02188849|Institute of Nutrition and Food Technology University of Chile|Sandra Hirsch MD|+56 229781485|shirsch@inta.uchile.cl|
21297103|NCT04365452|Indiana Univiersity|Theresa Joyce, Quality Improvement Consultant, Research Complaince|3172921882|tajoyce@iu.edu|
21297104|NCT03208088|Johnson & Johnson Vision Care, Inc.|Thomas Karkkainen SR Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
21297105|NCT02508324|Weill Cornell Medicine|Alexandra Gomez Arteaga, MD|646-962-7950|alg9117@med.cornell.edu|
21297106|NCT00812565|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201-604-1155|michael.eppolito@octapharma.com|
21297107|NCT01369732|Yonsei University College of Medicine|Dr. Yon Hee Shim|82220193547|tren125@yuhs.ac|
21297108|NCT00422383|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21297109|NCT00566254|Eisai Call Center|Eisai Inc.|888-422-4743||
21297110|NCT01793883|Aviragen Therapeutics, Inc.|Anna Novotney-Barry|678-221-3356|abarry@aviragentherapeutics.com|
21297111|NCT05399290|Michigan State University|Erika Malana|5173038716|malanaer@msu.edu|
21297112|NCT00687531|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21297113|NCT02353728|Weill Cornell Medical College|Dr.Ellen K.Ritchie|646-962-2700|ritchie@med.cornell.edu|
21297114|NCT00895310|University of California Davis|Analyst|9167340294|pkaujla@ucdavis.edu|
21297115|NCT00659230|Tuscaloosa VA Medical Center|Lori L. Davis, MD|205-554-2000|lori.davis@va.gov|3819
21297116|NCT05066165|Intellia Therapeutics|Trial Manager|833-888-0387|clinicalscience@intelliatx.com|
21297117|NCT02467582|SAKK|Regulatory affairs|+41 31 389 91 91|regulatory@sakk.ch|
21297118|NCT01370265|Mayo Clinic|Dr. Panithaya Chareonthaitawee|507-284-1648|chareonthaitawee.panithaya@mayo.edu|
21297119|NCT03343626|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21297120|NCT00703924|Institute Pasteur Tunisia|Afif Ben Salah, MD, PhD|216-71-792-429|afif.bensalah@pasteur.rns.tn|
21297121|NCT05388617|Cynosure|Jamie Trimper|9782564200|jamie.trimper@cynosure.com|
21297122|NCT01031979|Ralph H. Johnson VAMC|Dr. Peter Tuerk|(843) 789-6188|peter.tuerk@va.gov|
21297123|NCT00301418|Feinstein Institute for Medical Research|John Boockvar, MD|212-434-3900|jboockvar@northwell.edu|
21297124|NCT03592368|University of Colorado, Anschutz Medical Campus|Joel Stoddard|(720) 777-5702|joel.stoddard@cuanschutz.edu|
21297125|NCT03831100|Medical University of South Carolina|Evan Graboyes|843-792-0719|graboyes@musc.edu|
21288004|NCT00763360|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21288005|NCT04066374|Cleveland Clinic|Yuki Kuramochi, BSN, RN|216-445-4063|kuramoy@ccf.org|
21288006|NCT00834041|Novartis Pharmaceuticals|Study Director|862 778-8300||
21288007|NCT03074500|Marmara University School of Medicine|Gulseren Derya Akyuz|+90 216 657 06 06|girayesra@hotmail.com|1628
21288008|NCT02634177|Genomind|Chief Medical Officer|267-989-3461|dkrause@genomind.com|
21288009|NCT01416571|GlaxoSmithKline|GSK Response Center|866-435-7343||
21288010|NCT03608163|Albert Einstein College of Medicine|Dr. Meredith Hawkins|718-430-2903|meredith.hawkins@einsteinmed.edu|
21288011|NCT03914612|NRG Oncology|Christopher Purdy on behalf of Mike Sill, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
21288012|NCT04320888|Children's Oncology Group|Results Reporting Coordinator|6262411500|resultsreportingcoordinator@childrensoncologygroup.org|
21288013|NCT03353220|Columbia University|Sharon Wardlaw, MD|212-305-3725|sw22@cumc.columbia.edu|
21288014|NCT03586479|University of Kansas|Rebecca Swinburne Romine|7857668612|swin0024@ku.edu|
21260292|NCT00162773|Johns Hopkins University School of Medicine|Clinical Trials Program JHU ICTR|410-550-6484|registerclinicaltrials@jhmi.edu|
21288015|NCT01533259|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21288016|NCT06649409|Santhera Pharmaceuticals LTD|Shabir Hasham MD, Chief Medical Officer|+41 79 520 95 18|shabir.hasham@santhera.com|
21288017|NCT03857256|Montreal Heart Institute|Dr Jean-Claude Tardif|514-376-3330|jean-claude.tardif@icm-mhi.org|3612
21288018|NCT03836053|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21288019|NCT00788671|UT MD Anderson Cancer Center|Dr. Shannon N. Westin, MD, Associate Professor, Gyn Onc & Reproductive Med|(713) 794-4314|swestin@mdanderson.org|
21288020|NCT00375752|Novartis Pharmaceuticals|Study Director|862-778-8300||
21288021|NCT03588624|Sight Sciences|VP Medical and Clinical Affairs|(877) 266-1144|info@sightsciences.com|
21288022|NCT02469233|Department of Psychology, University of California, Berkeley|Professor of Clinical Psychology|5104736490|aharvey@berkeley.edu|
21288023|NCT03726476|University of New Mexico Health Sciences Center|Cassandra Darley|505-967-8428|cjdarley@salud.unm.edu|
21288024|NCT00855582|Eli Lilly and Company|Chief Medical Office|800-545-5979||
21288025|NCT02612857|Idera|Senior Development Operations Director|877-888-6550|clinicaltrials@iderapharma.com|2
21288026|NCT04757636|Opthea Limited|Chief Officer|+61 (0) 3 9826 0399|info@opthea.com|
21288027|NCT02443077|University of California|Dr. Charalambos Andreadis|415-353-8363|candreadis@medicine.ucsf.edu|
21288028|NCT01732692|Takeda|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
21302645|NCT01604278|Novartis Pharmaceuticals|Study Director|862-778-8300||
21302646|NCT02870933|National Cardiovascular Center Harapan Kita|Tri Wisesa Soetisna, M.D, MHA, PhD|+62215684093|tricts2000@yahoo.com|
21302647|NCT01252667|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fredhutch.org|
21302648|NCT01738646|Duke Univeristy Medical Center|Katherine Peters|919 684-3914|katherine.peters.@dm.duke.edu|
21302649|NCT03642132|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21302650|NCT00856414|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
21302651|NCT02577887|Abbott (previously St Jude Medical)|Grant Kim|818-493-3147|grant.kim@abbott.com|
21302652|NCT01155011|UCSD|Jacqueline Kerr|858-534-9305|jkerr@ucsd.edu|
21302653|NCT04987788|Icahn School of Medicine at Mount Sinai|Sarah Miller|(212) 824-7783|sarah.miller@mssm.edu|
21302654|NCT01038869|DermResearch, PLLC|Leon Kircik, M.D.|502-451-9000|wedoderm@yahoo.com|
21302655|NCT02238067|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21302656|NCT02010151|Seoul National University Hospital|Dr. Sun Young Lee|+82-10-9269-2376|sy2376@gmail.com|
21302657|NCT02743611|Bellicum|Contact for Clinical Trials|(832) 384-1100|clinicaltrials@bellicum.com|
21302658|NCT00600119|AstraZeneca|Mark Sostek||ClinicalTrialTransparency@astrazeneca.com|
21302659|NCT00729469|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
21302660|NCT00470834|GlaxoSmithKline|GSK Response Center|866-435-7343||
21302661|NCT00561977|UMass Medical School|Barbara Olendzki, RD MPH LDN|508-856-5195|barbara.olendzki@umassmed.edu|
21302662|NCT00566696|St. Jude Children's Research Hospital|Brandon Triplett, MD|866-278-5833|referralinfo@stjude.org|
21302663|NCT03048006|Guerbet GmbH|Oliver Heine, MD, Radiology & Scientific Affairs Manager|+49 6196 76250|oliver.heine@guerbet-group.com|
21302664|NCT01462253|GIMEMA|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it|
21302665|NCT01518270|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21302666|NCT00275340|University of Toronto|Monica Parry, RN, PhD, CCN(C)||parrym@kgh.kari.net|
21302667|NCT01950013|Indiana University, Dept of Speech & Hearing Sci|Larry Humes|812-855-3507|humes@indiana.edu|
21302668|NCT02365480|Northwestern University|Seema A. Khan, MD|312-503-4236|s-khan2@northwestern.edu|
21302669|NCT00706342|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
21302670|NCT01034670|Stanford University|Shai Friedland, MD|(650) 617-2732|shaif@stanford.edu|
21302671|NCT04762719|Mayo Clinic|Madhusudan (Madhu) Grover, M.B.B.S.|507-293-2698|Grover.Madhusudan@mayo.edu|
21302672|NCT01781299|University of Pittsburgh Plastic Surgery|Kenneth Shestak|412-641-1487|shestakkc@upmc.edu|
21302673|NCT03163017|The University of Texas Health Science Center at Houston|Joshua Gary, MD|713-486-6500|Joshua.L.Gary@uth.tmc.edu|
21302674|NCT01099449|Mayo Clinic|Charles Loprinzi, M.D.|(507) 284-3731|cloprinzi@mayo.edu|
21302675|NCT02395172|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21302676|NCT00653939|OXiGENE, Inc.|Chief Executive Officer|650-635-7000|info@oxigene.com|
21302677|NCT02032238|OD-OS GmbH|Ulrike Weber|+49 332831282|ulrike.weber@od-os.com|100
21302678|NCT00612105|Valeant Pharmaceuticals International, Inc.|Associate Director Clinical Operations|919-294-3080|david.lineberry@valeant.com|
21302679|NCT01105767|USUHS|LTC Michael Ellis|301-295-2254|Michael.Ellis@usuhs.edu|
21302680|NCT00475982|VA Medical Center Greater Los Angeles Healthcare System|William Aronson, MD|3102683446|waronson@ucla.edu|
21302681|NCT02778113|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21274901|NCT02463487|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
21274902|NCT03329209|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
21274903|NCT00227370|Duke Clinical Research Institute|Scott M. Palmer, MD, MHS|919 684 0254|scott.palmer@duke.edu|
21274904|NCT00147498|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21274905|NCT01767103|ApoPharma Inc.|Fernando Tricta, MD|416-401-7332|ftricta@apopharma.com|
21274906|NCT01473953|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21274907|NCT01278953|Abbott|Lori Rusch, Ph.D.|651-756-2668|lori.rusch@abbott.com|
21274908|NCT02011945|Bristol-Myers squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@BMS.com|
21274909|NCT00902538|Daiichi Sankyo Europe GmbH|Bettina Ammentorp|0049 89 7808 0|bettina.ammentorp@daiichi-sankyo.eu|585
21274910|NCT03531827|National Cancer Institute|Dr. Ravi Madan|301.480-7168|madanr@mail.nih.gov|
21274911|NCT01935674|Hospital Clinic of Barcelona|Dr. Esteban Martínez|+34 93 227 54 00|estebanm@clinic.cat|
21274912|NCT01494532|GlaxoSmithKline|GSK Response Center|866-435-7343||
21274913|NCT00849797|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274914|NCT00679081|Organogenesis Inc.|Director of Clinical Operations|781-575-0775|clinicaltrials@organo.com|
21274915|NCT01404988|VA New York Harbor Healthcare System|Sundar Natarajan, MD, M.Sc.|212-951-3395|sundar.natarajan@va.gov|
21274916|NCT00829764|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274917|NCT05259852|Case Western Reserve University|Jin Kim-Mozeleski|216-368-6793|jin.kim-mozeleski@case.edu|
21274918|NCT02633241|Boston Children's Hospital|Joseph P. Cravero|617-355-4292|Joseph.Cravero@childrens.harvard.edu|
21274919|NCT00754052|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
21274920|NCT01086228|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
21274921|NCT00697801|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
21274922|NCT02485158|University of Chicago|Dr. Harriet de Wit|773-702-1537|hdew@uchicago.edu|
21274923|NCT01098851|Covidien|Fran Haury|303 305-2314|fran.haury@covidien.com|
21274924|NCT00851409|Pharming Technologies BV|Medical Affairs Department|+31715247400|medicalinfo@pharming.com|
21274925|NCT02316223|Icahn School of Medicine at Mount Sinai|Dr. Alex Federman|212-824-7565|alex.federman@mountsinai.org|
21274926|NCT00529763|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21274927|NCT03669250|Cerevance|Michelle Charles, Executive Director Regulatory Affairs|(408) 220-5722|michelle.charles@cerevance.com|
21274928|NCT01472432|Second University Naples|Dr Raffaele Marfella|++390815665110|raffaele.marfella@unina2.it|
21274929|NCT03234907|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21274930|NCT00414726|Massachusetts General Hospital|Aneesh B. Singhal, MD|617 726 8459|asinghal@partners.org|
21274931|NCT02107196|MENARINI Group|Angela Capriati, MD PhD - Corporate Director Clinical Research|+39 055 5680|acapriati@menarini-ricerche.it|9990
21274932|NCT04158687|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
21274933|NCT00640393|Innovaderm Research Inc|Annie Levesque|514-521-4285|alevesque@innovaderm.ca|222
21274934|NCT02554877|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21274935|NCT00835666|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21274936|NCT01537887|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21274937|NCT01808651|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21274938|NCT00585286|University of California, Irvine|Christopher Zachary, FRCP, MBBS/Prinicipal Investigator|(949) 824-7103|czachary@uci.edu|
21274939|NCT04188392|Baylor College of Medicine|Melissa B Jones, MD|713-791-1414|melissa.jones2@bcm.edu|24747
21274940|NCT00095784|University of Chicago|Olatoyosi Odenike, MD|773-702-3354|todenike@medicine.bsd.uchicago.edu|
21274941|NCT01161420|Inspire Medical Systems|Quan Ni|763-205-7968|quanni@inspiresleep.com|
21288029|NCT00656617|University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor, Leukemia Department|713-745-3428|CR_Study_Registration@mdanderson.org|
21288030|NCT02805998|UCSF|Dr. Jennifer Felder|415-476-7014|jennifer.felder@ucsf.edu|
21288031|NCT01107015|University of Maryland, Baltimore|Cindy Geppi|4107062406||
21288032|NCT01155323|Johnson and Johnson K.K.|Wakana Katabami|81-34411-8040|wkatabam@its.jnj.com|22025
21288033|NCT01208051|University of Chicago|Chih-Yi Liao, MD|(773) 702-6241|andyliao@medicine.bsd.uchicago.edu|
21288034|NCT00973973|AbbVie|Global Medical Services|800-633-9110||
21288035|NCT02471339|National Cancer Institute|Staci M. Peron, Ph.D.|240-760-6025|martins@mail.nih.gov|
21288036|NCT06057064|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21288037|NCT02240329|University of Florida|Erin Pearson Ph.D CCC/SLP|352-339-4100|epearson@ufl.edu|
21288038|NCT00851591|Texas Tech University Health Sciences Center|Thomas Hale, PhD.|806-354-5528|thomas.hale@ttuhsc.edu|
21288039|NCT01038765|Radboud University Medical Centre|Anne E.M. Speckens|0031243610449|a.speckens@psy.umcn.nl|
21288040|NCT02736617|Oregon Health and Sciences University, Knight Cancer Institute|Dr. Stephen E. Spurgeon, Associate Professor of Medicine|503-494-8950|spurgeos@ohsu.edu|
21288041|NCT01718691|SymBio Pharmaceuticals|Toshihiko Nagase|+81-3-5472-1125||
21288042|NCT02110693|Friends Research Institute|Robert Schwartz|410-837-3977|rschwartz@friendsresearch.org|276
21288043|NCT00920816|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21288044|NCT01180777|Johnson & Johnson Vision Care|Michael S. Mayers, O.D., FAAO|1-904-443-3252|MMayers@its.jnj.com|
21288045|NCT02606253|Lipscomb University College of Pharmacy|Dr. Zachary Cox, Associate Professor|6159667163|zac.cox@lipscomb.edu|
21288046|NCT02366871|University of Colorado, Anschutz Medical Campus|Dr. Saketh Guntupalli|303-724-2033|saketh.guntupalli@cuanschutz.edu|
21288047|NCT02841046|Guangzhou Panyu central Hospital|Dr. Yang Lin|+8615915721012|salinyangyl@163.com|
21288048|NCT01311661|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21288049|NCT05853120|Emory University|Colleen Kelley|404-712-1823|scolleen.kelley@emory.edu|
21288050|NCT03426878|Kaiser Permanente Center for Health Research|Joanna Bulkley, PhD|5033352400|joanna.e.bulkley@kpchr.org|
21288051|NCT06469372|Columbia University Irving Medical Center|Timothy J. Poterucha, MD|(212) 932-4537|tp2558@cumc.columbia.edu|
21288052|NCT00869960|UAB|Jennifer King|205-934-2696|jenking@uab.edu|
21288053|NCT02921256|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5261|langerj@nrgoncology.org|
21288054|NCT04773028|Kartal Kosuyolu Hihg Speciality Training and Research Hospital|Dr.Ahmet Zengin|+905365022173|dr.zenginahmet@gmail.com|
21274942|NCT00608322|Cooper University Hospital|Stephen Trzeciak, MD, MPH|856-342-3342|trzeciak-stephen@cooperhealth.edu|
21274943|NCT04002648|IRCCSSRaffaele|Prof. Michele De Bonis|+390226437102|debonis.michele@hsr.it|
21274944|NCT04313751|University of North Carolina at Chapel Hill|Yamnia Cortes, PhD, MPH, RN|319-335-1131|yamnia-cortes@uiowa.edu|
21274945|NCT03060486|AOU Careggi|Riccardo Pace, DMD|00390557945608|riccardo.pace@unifi.it|
21274946|NCT02121067|University of North Carolina|Matthew Zerden, MD, MPH|6179352394|mzerden@gmail.com|
21274947|NCT05752721|NYU Langone Health|Pasquale Rummo|646-501-3371|Pasquale.Rummo@nyulangone.org|
21238479|NCT02696564|School of Medicine, Johns Hopkins University|Robert A. Wise, M.D.|410-550-0545|rwise@jhmi.edu|
21238480|NCT02032212|Imperial Tobacco Group|Tanvir Walele|0044 177 933 7589|tanvir.walele@uk.imptob.com|
21238481|NCT05267600|argenx BV|Regulatory Manager|+32 93103400|regulatory@argenx.com|
21238482|NCT03633929|Biomedical Development Corporation|Gregg Siegel|2108638053|gsiegel@biodevcorp.com|
21238483|NCT01537302|Austin Heart|Matthew Selmon, MD|512-788-2692|matthew.selmon@hcahealthcare.com|
21238484|NCT02162680|Duke University Medical Center|Julia Aucoin, DNS|1 919 613 6406|julia.aucoin@dm.duke.edu|
21238485|NCT00106184|University of Pittsburgh|Chester V. Oddis, MD|412-383-8861|cvo5@pitt.edu|
21238486|NCT01722162|Washington University School of Medicine|Manik A. Amin, M.D.|314-362-9115|manikamin@wustl.edu|
21238487|NCT05292534|Sonova|Dr. Ieda Ishida|6472847562|ieda.ishida@sonova.com|
21238488|NCT01538472|University of Texas (UT) MD Anderson Cancer Center|Issa Khouri, MD / Professor, Stem Cell Transplant|713-745-2803|CR_Study_Registration@mdanderson.org|
21238489|NCT02309112|University of Oxford|Marcy McCall, Lead Researcher|+441865 289300|marcy.mccall@kellogg.ox.ac.uk|
21238490|NCT01889186|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21238491|NCT05711537|Wake Forest School of Medicine|Heather Columbano, MD|336-716-4498|hcolumba@wakehealth.edu|
21238492|NCT01896869|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Dung Le|443-287-0002|dle2@jhmi.edu|
21238493|NCT01691833|Carolinas Healthcare System|Dr. Rachel Seymour|704-355-2000|Rachel.Seymour@carolinas.org|
21238494|NCT03319537|Memorial Sloan Kettering Cancer Center|Dr. Marjorie Zauderer, MD|646-608-3790|zauderem@mskcc.org|
21238495|NCT00252538|VA Long Beach Healthcare System|Peter Hauser|562 826 8000|peter.hauser2@va.gov|2629
21238496|NCT00454571|The University of Chicago|Walter M. Stadler, MD|(773) 702-6149|wstadler@medicine.bsd.uchicago.edu|
21238497|NCT01960725|Duke University School of Medicine|Dr. Dennis Clements|919-684-7790|dennis.clements@duke.edu|
21238498|NCT02470494|Earlens Corporation|Dr. Suzanne Levy, Director of Clinical Research|650-739-4447|Suzanne.Levy@Earlens.com|
21238499|NCT00723099|Fred Hutchinson Cancer Research Center|Rachel Salit|206-667-1317|rsalit@fredhutch.org|
21274948|NCT00493805|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21274949|NCT02287480|Geneva University Hospitals|Prof. Claire-Anne Siegrist|0041 22 379 5778|claire-anne.siegrist@unige.ch|
21274950|NCT00216736|Joseph Epstein Centre for Emergency Medicine Research|Prof Anne-Maree Kelly|+61383456666|anne-maree.kelly@wh.org.au|
21274951|NCT01528150|St. Jude Medical|Director Clinical Studies|+1 818 493 3648|aoza@sjm.com|
21274952|NCT00807495|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21238500|NCT01058304|Health Services Research & Development, Durham VAMC|Kelli D. Allen|919-286-0411|kelli.allen@va.gov|7090
21274953|NCT00841542|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21238501|NCT02496767|Cytokinetics, Inc.|MD Cytokinetics|650-624-2929|medicalaffairs@cytokinetics.com|
21274954|NCT01906372|University of Pittsburgh, Division of Rheumatology|Rohit Aggarwal, MD|412-647-2840|aggarwalr@upmc.edu|
21274955|NCT02462837|Southern Illinois University School of Medicine|Dr. Danuta Dynda|217-545-7443|ddynda@siumed.edu|
21274956|NCT00906399|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
21274957|NCT00624286|Novartis Pharmaceuticals|Study Director|862 778-8300||
21274958|NCT00075608|Boston Medical Center|Principal Investigator|617-638-8261|sfenness@bu.edu|
21274959|NCT02177617|University of Florida|Aparna Wagle Shukla|3522945400|aparna.shukla@neurology.ufl.edu|
21274960|NCT02845336|Johns Hopkins University|Timothy J McCulley, MD|4105503000|tmccull5@jhmi.edu|
21274961|NCT01665508|Massachusetts General Hospital|Nandita S. Scott|6177241739|nsscott@partners.org|
21260293|NCT02511522|Canadian Cancer Trials Group|Dr. Chris O'Callaghan|6135336430|cocallaghan@ctg.queensu.ca|
21260294|NCT05194345|University of South Florida|Heewon Gray|(813) 974-9881|hlgray@usf.edu|
21260295|NCT00951821|Brown University|Anthony Spirito|401-444-1929|anthony_spirito@brown.edu|
21260296|NCT04628936|Kezar Life Sciences, Inc|Regulatory Affairs|650-822-5600|clinicaltrials@kezarbio.com|
21260297|NCT03124459|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21260298|NCT01028352|University of Michigan Comprehensive Cancer Center|Dr. Norah L. Henry|734-936-4991|norahh@umich.edu|
21260299|NCT01903876|Georgia State University|Dr. Laura Salazar|404-413-1396|lsalazar1@gsu.edu|
21260300|NCT03062917|Imperial College NHS trust|Study PI Simon Nadel|02033126202|s.nadel@imperial.ac.uk|
21260301|NCT00673855|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21274962|NCT03488108|Mayo Clinic|Alison J. Bruce, M.B., Ch.B|904-953-6412|Bruce.Alison@mayo.edu|
21274963|NCT00863330|Aurora Health Care|IIR regulatory specialist|414-219-7886|jackie.blundon@aurora.org|
21302682|NCT00817596|Medasys, Inc.|Clinical Trials Manager|973-426-9229|jarrambide@medasyspumps.com|
21302683|NCT00993226|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
21302684|NCT00783198|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21302685|NCT00946985|Ortho-McNeil Janssen Scientific Affairs, LLC|Clinical Project Scientist|609-730-3229||
21302686|NCT00271505|UT MD Anderson Cancer Center|Dr. John V Heymach, PHD/ Chair, Thoracic-Head & Neck Med Onc|713-792-6363|jheymach@mdanderson.org|
21302687|NCT00119678|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21302688|NCT00791817|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com|
21302689|NCT01134705|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21302690|NCT01510769|Ardea Biosciences, Inc.|Maple Fung, MD|1-858-652-6671|mfung@ardeabio.com|
21302691|NCT02674204|Cedars-Sinai Medical Center|Marc Goodman, PhD|310-423-6188|Marc.Goodman@cshs.org|
21302692|NCT01008423|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
21302693|NCT01809639|Spartanburg Regional Healthcare System|John Lucas|423-309-5646|jlucas@srhs.com|
21302694|NCT02453672|Samsung Bioepis|Director of Clinical Development|+82 31 8061 4534|sbregistry@samsung.com|
21302695|NCT00978757|Francisco C. Bonofiglio|MD|541149590200|francisco.bonofiglio@hospitalitaliano.org.ar|4949
21302696|NCT01028300|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com|
21302697|NCT00715910|GlaxoSmithKline|GSK Response Center|866-435-7343||
21302698|NCT01185353|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21302699|NCT01030666|JWGUniversity|Prof. Dr. Peter Eickholz|+496963015642|eickholz@med.uni-frankfurt.de|
21302700|NCT01254760|Alcon Research, Ltd.|Director of Alcon Clinical|1-800-241-7629||
21302701|NCT03952039|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21302702|NCT03865316|Masimo Corporation|Cristina Johnson|949-297-7000|ClinicalResearchDept@masimo.com|
21302703|NCT04084561|Center for Asian Health, Temple University|Dr. Grace X. Ma|215-707-6493|grace.ma@temple.edu|
21302704|NCT03137069|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21302705|NCT03225859|Minneapolis VA Medical Center|Shannon Kehle-Forbes, PhD|612-467-4772|Shannon.Kehle-Forbes@va.gov|
21302706|NCT02043899|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
21302707|NCT02720107|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21302708|NCT02522624|Washington University's School of Medicine|Mary C. Politi, PhD|314-747-1968|politim@wudosis.wustl.edu|
21302709|NCT00369629|Northwestern University|Barbara Pro||barbara.pro@nm.org|
21302710|NCT04839562|Massachusetts General Hospital|Dr. Craig Surman|6176808489|csurman@partners.org|
21302711|NCT00877773|University of Texas (UT) MD Anderson Cancer Center|Daniel Karp, MD / Professor, Investigational Cancer Therapeutics||CR_Study_Registration@mdanderson.org|
21302712|NCT01347580|AstraZeneca|Dr Tomas Andersson MD|00 46 31 77 61966|tomas.lg.andersson@astrazeneca.com|
21302713|NCT01964755|University of Miami|Juan C. Ramos MD|305-243-1326|jramos2@med.miami.edu|
21302714|NCT03035487|Exact Imaging|Manager, Clinical Research|905-415-0030|bwodlinger@exactimaging.com|204
21302715|NCT01659554|Columbia University Medical Center|Reena M. Vattakalam, CCRP|212-342-6895|rmv2110@cumc.columbia.edu|
21302716|NCT00522925|Ligand Pharmaceuticals, Inc.|Ram Kapil, PhD/ Sr. Director, Clinical Pharmacology|858-550-7603|rkapil@ligand.com|
21238502|NCT04035200|Imbrium Therapeutics|Medical Information|1-888-726-7535|Purduemedinfo@pharma.com|
21302717|NCT02558829|Aeterna Zentaris|Dr. Nicola Ammer|+496942602|nammer@aezsinc.com|3472
21302718|NCT00097981|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Medical Director|1 215 325-5329||
21302719|NCT00412373|Ortho McNeil Janssen Scientific Affairs, LLC|Vice President, Medical Affairs, CNS|609-730-2136|jhulihan@its.jnj.com|
21302720|NCT02248688|Dayton Interventional Radiology-Research|Mubin Syed, MD|937-215-0878|mubinsyed@aol.com|
21302721|NCT00576680|Dana-Farber Cancer Institute|Dr. Jennifer Chan|617-632-6315|jang@partners.org|
21302722|NCT00955201|Edward Hines Jr. VA Hospital|Evan Stubbs|708-202-3507|evan.stubbs@va.gov|
21302723|NCT03032380|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
21302724|NCT00864916|Indiana University School of Medicine|Samir K. Gupta, MD|317-274-7926|sgupta1@iu.edu|
21302725|NCT03816709|North Dakota State University|Kara Gange, Associate Professor|701-231-5777|kara.gange@ndsu.edu|
21302726|NCT03890666|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
21302727|NCT01816945|Yale University|Megan Smith Associate Professor|203 764 8655|megan.smith@yale.edu|
21302728|NCT02331095|The Ohio State University|Dr. Tzu-Fei Wang|614-366-8366|tzufeiwang@gmail.com|
21302729|NCT02122783|MossRehab|Mukul Talaty|2156636682|mctalaty@einstein.edu|
21302730|NCT01214057|The University of Texas Health Science Center at Houston|Davide Cattano, MD|(713) 500-6200|Davide.Cattano@uth.tmc.edu|
21302731|NCT00322621|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21302732|NCT00700141|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
21274964|NCT00794547|University of Michigan Comprehensive Cancer Center|Dr. Nithya Ramnath|734-647-1417|nithyar@umich.edu|
21274965|NCT00674128|Mayo Clinic|Gregory Altemose MD|480-301-8000|altemose.gregory@mayo.edu|
21302733|NCT02213133|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
21302734|NCT02350764|Memorial Sloan Kettering Cancer Center|Dr. Adam Schoenfeld, MD|646-608-4042|schoenfa@mskcc.org|
21302735|NCT00977080|Abbott|Global Medical Services|800-633-9110||
21302736|NCT00313781|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21302737|NCT01546623|Takeda|Medical Director, Clinical Science|800-778-2860|trialdisclosures@takeda.com|
21302738|NCT03567343|The University of Arizona|Dr Michael Grandner|15206266346|grandner@email.arizona.edu|
21302739|NCT02466659|Indiana University|Daniel Neely|3172741214|deneely@iupui.edu|
21302740|NCT00486811|Grünenthal GmbH|Claudia Leinweber|+49 241 569 2509|claudia.leinweber@grunenthal.com|
21302741|NCT02369744|Albert Einstein Medical Center|Kamran Mohiuddin; Director ED Clinical Research|2154562313|MOHIUDDK@EISNTEIN.EDU|
21302742|NCT01590758|Dipexium Pharmaceuticals, Inc|Robert J DeLuccia|+19145226503|delucciarj@gmail.com|
21302743|NCT02756806|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
21302744|NCT02228980|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21302745|NCT02929498|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21302746|NCT02057081|VISN 5 Mental Illness Research, Education, and Clinical Center|Dr. Amy Drapalski|410-637-1855|amy.drapalski@va.gov|
21302747|NCT00096356|Wake Forest University Comprehensive Cancer Center|Dr. Glenn Lesser|(336) 713-5440|glesser@wakehealth.edu|
21302748|NCT02878057|Department of Breast Oncology, Peking University Cancer Hospital and Institute|Dr. Huiping Li|86-10-88196739|huipingli2012@hotmail.com|
21302749|NCT03288142|Northwestern University Feinberg School of Medicine|Stephen D. Persell, MD, MPH, FACP|312-503-6464|spersell@nm.org|
21302750|NCT02034409|VA Salt Lake City Health Care System|Daniel Clegg, MD|801-582-1565|daniel.clegg@va.gov|
21302751|NCT01294098|Washington University School of Medicine|Lauren Westlund|314-454-5345|davislauren@wustl.edu|
21302752|NCT02270944|GlaxoSmithKline|GSK Response Center|866-435-7343||
21302753|NCT01699867|Johns Hopkins Medicine|Lisa K. Jacobs, M.D.|410-502-0880|ljacob14@jhmi.edu|
21302754|NCT00183729|Washington University School of Medicine|Eric Lenze|314-362-1671|lenzee@wustl.edu|
21302755|NCT00796926|Singapore National Eye Center|Dr Louis Tong|65 62277255|Louis.tong.h.t@snec.com.sg|
21302756|NCT03512457|Northwestern University|Dr. June Robinson|312-503-5941|june-robinson@northwestern.edu|
21302757|NCT04160975|Harvard University|Dr. Marcella Alsan|617-496-1770|marcella_alsan@hks.harvard.edu|
21302758|NCT04002908|Ariadne Labs|Katherine Semrau|6177805311|ksemrau@ariadnelabs.org|
21302759|NCT00530504|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
21302760|NCT00006289|National Institute of Nursing Research|Dr. Leorey Saligan (Principal Investigator, former PI: Dr. Raymond Dioone)|301-451-1685|saliganl@mail.nih.gov|
21302761|NCT02043808|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21302762|NCT00548652|VANebraska|Cyrus Desouza|4023468800|cyrus.desouza@va.gov|5506
21302763|NCT02465099|Ethicon Inc|Jason Waggoner|(513) 337-8130|jwaggon1@its.jnj.com|
21302764|NCT00582075|University of Alabama at Birmingham|John Fiveash, MD|205-975-0224|jfiveash@uabmc.edu|
21302765|NCT04359901|VA Boston Healthcare System|Westyn Branch-Elliman, MD, MMSc|857-203-5116|westyn.branch-elliman@va.gov|
21302766|NCT04784065|Baylor College of Medicine|Dr. Grace Lo, Associate Professor of Medicine|713-791-1414|ghlo@bcm.edu|227804
21302767|NCT00557856|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21302768|NCT05092360|Mural Oncology, Inc.|Study Director|+1 (781) 614-0100|clinicaltrials@muraloncology.com|
21302769|NCT01675167|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
21302770|NCT01379508|Novartis|Clinical Disclosure Office|862-778-8300||
21302771|NCT01330017|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21302772|NCT04096482|Emory University|Joshua M Levy|(404) 778-3381|joshua.levy2@emory.edu|
21302773|NCT01122264|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21302774|NCT00640224|Children's Hospital of Pittsburgh of UPMC|Dr. Silva Arslanian|412-692-6935||
21302775|NCT00422513|Hoffman-LaRoche|Medical Communications|800-821-8590||
21302776|NCT03135119|Penn State College of Medicine|Dr. Brian Allen|7175314100|ballen1@pennstatehealth.psu.edu|
21274966|NCT00685477|Temple University|Alan Maurer, MD|215-707-8269|amaurer@temple.edu|
21274967|NCT01001403|Seoul National University Hospital|CW Jung|82-2-2072-2467|spss@snuh.org|9
21274968|NCT02615249|Allerderm (dba) SmartPractice|Kathryn Shannon|6022250595|kshannon@smartpractice.com|7208
21274969|NCT00178178|University of Rochester|Dr. Robert Bronstein|585-275-1024|robert_bronstein@urmc.rochester.edu|
21274970|NCT02471807|Edwards Lifesciences|Ted Feldman, MD|949-250-2500|Feldman_Info@edwards.com|
21274971|NCT01559363|Kadmon, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
21274972|NCT02811003|Smith+Nephew, Inc.|Samantha Andrews|978.971.8990|samantha.andrews@smith-nephew.com|
21274973|NCT05327777|Thomas Jefferson University Hospital|Research Resident|516-547-7676|ryan.lamm@jefferson.edu|
21274974|NCT05098743|Vanderbilt University|Dr. Christa Hartch, PI|203-979-2044|christahartch@me.com|
21274975|NCT01456221|Coordinacion de Investigacion en Salud, Mexico|Dr. Mardia Guadalupe Lopez Alarcon||marsau2@prodigy.net.mx|
21302777|NCT01478048|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21274976|NCT02272803|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
21302778|NCT02766582|Medical College of Wisconsin|D. Denise Uyar|414-805-6606|duyar@mcw.edu|
21302779|NCT01369329|Janssen Research & Development, LLC|Vice President||ClinicalTrialDisclosure@its.jnj.com|
21302780|NCT04644315|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21260302|NCT02357992|UT MD Anderson Cancer Center|Dr. Jack Roth, MD- Professor, Thoracic & Cardio Surgery-Rsch|(713) 792-7664|jroth@mdanderson.org|
21260303|NCT00826748|Weill Cornell Medicine|Grace Mammen|646-962-2672|gwm2004@med.cornell.edu|
21260304|NCT01887912|Sanofi Pasteur|Medical Director|800-633-1610|Contact-US@sanofi.com|1#
21260305|NCT04462536|NoNO Inc.|Michael Tymianski|6472932232|mtymianski@nonoinc.ca|
21260306|NCT04033926|Kezar Life Sciences, Inc|Regulatory Affairs|650-822-5600|clinicaltrials@kezarbio.com|
21260307|NCT00450580|GlaxoSmithKline|GSK Response Center|866-435-7343||
21260308|NCT06331884|4TEEN4 Pharmaceuticals|Kathleen Richter|0049 1784027078|richter@4teen4.de|
21260309|NCT00332709|Novartis Pharmaceuticals|Study Director|862-778-8300||
21260310|NCT01989130|University of California-Davis|Larissa May, MD|916-736-5010|lsmay@ucdavis.edu|
21260311|NCT00893516|Emergent Biosolutions|Clinical Development Representative||ctgov@ebsi.com|
21260312|NCT00191854|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21274977|NCT02611323|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21238503|NCT01089374|Dartmouth-Hitchcock Medical Center|Dr. Richard Barth|603-650-9479|Richard.J.Barth.Jr@hitchcock.org|
21238504|NCT05887947|University of Kansas Medical Center|Eleanor Leavens|913-945-7875|eleavens@kumc.edu|
21238505|NCT03459287|Cerus Corp|Richard Benjamin, M.D., Ph.D.|925 288 6000|rbenjamin@cerus.com|
21274978|NCT03124758|Masimo|Tala Harake||studies@masimo.com|
21260313|NCT02601950|Epizyme, Inc.|Medical Lead or Designee|(855) 500-1011|clinicaltrials@epizyme.com|
21260314|NCT03289416|Andrews Research and Education Foundation|Jessica Truett|8509168570|jessica.truett@andrewsref.org|
21274979|NCT01899053|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21274980|NCT01345539|UPMC Hillman Cancer Center|Barbara M. Stadterman, MPH, MSCR|412-647-5554|stadtermanbm@upmc.edu|
21274981|NCT02452463|Roswell Park|CTRP/CT.gov Registry Coordnator|716-845-1073|KIM.BROSIUS@ROSWELLPARK.ORG|
21274982|NCT01073631|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21274983|NCT02153645|Osmotica Pharmaceuticals|George Wagner, VP of Regulatory Affairs|908-809-1357|gwagner@osmotica.ccom|
21274984|NCT00860938|University Hospital Basel, Switzerland|Jörg D. Leuppi, MD PhD, principle investigator|+41-61-2654294|jleuppi@uhbs.ch|
21274985|NCT04594252|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
21302781|NCT01836276|University of Kansas Medical Center|Dr. Nicole Nollen|913-588-3784|nnollen@kumc.edu|
21302782|NCT01847131|Faculty of Medicine Siriraj Hospital, Mahidol University|Torpong Thongngarm, M.D.|66-2-419-8263|torpong.tho@mahidol.ac.th|
21302783|NCT01561898|Janssen Pharm KK Japan|Medical Director|03-4411-5067||
21302784|NCT00331552|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
21302785|NCT01883453|Umeå University|Dr Krister Tano|0046705569043|krister.tano@umu.se|
21302786|NCT01707238|Visioncare Research Ltd.|Graeme Young|01252 718719|g.young@visioncare.co.uk|207
21302787|NCT04497038|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
21302788|NCT01839604|AstraZeneca Pharmaceuticals LP|Martin Scott, MD/PhD|Martin.Scott@astrazeneca.com|Martin.Scott@astrazeneca.com|
21260315|NCT02157883|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
21260316|NCT01323478|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
21260317|NCT02073487|Houston Methodist|Jenny Chang|713-441-0681|jcchang@houstonmethodist.org|
21260318|NCT00848744|Northwestern University|Dermatology CTU|312-503-5944|NUdermatologyCTU@northwestern.edu|
21260319|NCT01756274|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
21260320|NCT01474590|University of Western Ontario and Windsor Clinical Research Inc., 2224 Walker Rd. Suite 300, Windsor, ON, Canada|Dr. Jerry Tan||jerrytan@bellnet.ca|
21260321|NCT03367871|University of Miami|Abdulrahman Sinno MD|+1 (305) 243-2233|ak.sinno@med.miami.edu|
21260322|NCT03837184|Novartis Gene Therapies EU Limited|EMEA Medical Information|+353 (1) 566-2364|medinfoemea.gtx@novartis.com|
21274986|NCT00477594|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
21274987|NCT01109849|Penn State College of Medicine|James Waxmonsky MD|7175318646|jwaxmonsky@pennstatehealth.psu.edu|
21274988|NCT03969641|Duke University|Dr. Geeta Swamy|919.681.5220|geeta.swamy@duke.edu|
21274989|NCT05157048|University of Pennsylvania|Victoria Constantine|215-746-4069|vmcl@pennmedicine.upenn.edu|
21274990|NCT01006967|Geisel School of Medicine at Dartmouth|Jon D. Lurie, MD, MS|603 653-3575|jon.d.lurie@dartmouth.edu|
21274991|NCT01023776|University of Rochester|John Treanor< M.D.|585-275-5871|john_treanor@urmc.rochester.edu|
21302789|NCT04493892|Columbia University|Jasmine A. McDonald|12123053586|jam2319@cumc.columbia.edu|
21302790|NCT01566084|University of Colorado Denver|Dr. Kristen Jablonski|303-724-4842|KRISTEN.NOWAK@UCDENVER.EDU|
21302791|NCT02267317|University of Texas Health San Antonio|Hanyu Liang|210-617-5300|liangh0@uthscsa.edu|15197
21302792|NCT00947791|Icahn School of Medicine at Mount Sinai|Dr. James W. Murrough|212-241-6539|james.murrough@mssm.edu|
21302793|NCT02208063|Cumberland Pharmaceuticals Inc.|Senior Director of Clinical and Regulatory Affairs|615-255-0068|ahaeberle@cumberlandpharma.com|
21302794|NCT00913458|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21302795|NCT02366091|Johns Hopkins Hospital|Robert G. Weiss, MD|410-955-1703|rweiss@jhmi.edu|
21302796|NCT03595618|Galapagos NV|Galapagos Medical Information|+32 15342900|medicalinfo@glpg.com|
21302797|NCT02338232|Hackensack Meridian Health|Joshua Zenreich|5519964248|joshua.zenreich@hmhn.org|
21302798|NCT02279407|AstraZeneca|Stefan Carlsson||Stefan.C.Carlsson@astrazeneca.com|
21302799|NCT00766753|University of Pittsburgh Cancer Institute|Frank Lieberman|(412) 648-6507|liebermanf@upmc.edu|
21302800|NCT01105065|Massachusetts Eye and Ear Infirmary|Louis R. Pasquale, MD|617-573-4270|Louis_Pasquale@meei.harvard.edu|
21302801|NCT00422084|Medicines for Malaria Venture (MMV)|Stephan Duparc, MD, Chief Medical Officer|+41 22 555 0300|duparcs@mmv.org|351
21302802|NCT03774823|Venus Concept Ltd.|Director, Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
21302803|NCT01323855|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21302804|NCT00329849|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21302805|NCT03996369|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
21302806|NCT00618098|CRMG|Patrick Murphy|4138210022|p.murphy@crmg-usa.com|
21302807|NCT00740376|Corin|Global Regulatory Affairs and Clinical Director|+44 (0)1285 659866||
21302808|NCT00362128|Albert Einstein College of Medicine|Judith Wylie-Rosett|718-430-3345|Judith.Wylie-Rosett@einstein.yu.edu|
21302809|NCT01579812|UPMC Hillman Cancer Center|Dr. Ronald Buckanovich, MD, PhD|412-641-4721|buckanovichrj@mwri.magee.edu|
21302810|NCT05168501|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.Strauss@fda.hhs.gov|
21302811|NCT00653432|Anika Therapeutics, Inc.|Kara Mezger, Exec Director Clinical Affairs|781.457.9000|kmezger@anika.com|
21302812|NCT05277337|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
21302813|NCT03726996|Yale University|Yong-Hui Jiang, MD, PhD|203-785-2660|yong-hui.jiang@yale.edu|
21302814|NCT02012582|vasopharm GmbH|Dr. Reinhard Schinzel|+49 931 359099|schinzel@vasopharm.de|115
21302815|NCT03531632|MacroGenics, Inc.|Stephen Eck, M.D., Chief Medical Officer|301 251-5172|ecks@macrogenics.com|
21302816|NCT00568633|Stanford University|Robert Lowsky, Professor of Medicine (Blood and Marrow Transplantation)|650-725-8950|rlowsky@stanford.edu|
21302817|NCT01224782|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21302818|NCT03554486|Stanford|Bruce Buckingham|6508040476|buckingham@stanford.edu|
21302819|NCT01534897|Massachusetts General Hospital Cancer Center|Dr. Lori J. Wirth|617 724 4000|lwirth@mgh.harvard.edu|
21302820|NCT01616693|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
21302821|NCT02080819|Virginia Commonwealth University|Dr. Liangsuo Ma|8048282871|liangsuo.ma@vcuhealth.org|
21302822|NCT02925338|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21302823|NCT01332461|GlaxoSmithKline|GSK Response Center|866-435-7343||
21302824|NCT00597896|Mount Sinai School of Medicine|Katherine E. Burdick, PhD||katherine.burdick@mssm.edu|
21302825|NCT00029146|University of North Carolina at Chapel HIll|William J. Powers, MD||powersw@neurology.unc.edu|
21302826|NCT01765218|University of California, Davis|Kristin Hoffman, MD|916-205-2755|krhoffman@ucdavis.edu|
21302827|NCT01011309|IDRI|Jill Ashman, MSc, Associate Director of Clinical Operations|206-858-6041|jill.ashman@idri.org|
21302828|NCT01085006|Tehran University of Medical Sciences|Dr. Laleh Eslamian|+982184902415|leslamian@tums.ac.ir|
21302829|NCT03602560|CymaBay Therapeutics, Inc.|Elaine Watkins, DO, MSPH, Vice President of Clinical Development|510-293-8800|medinfo@cymabay.com|
21302830|NCT00222131|Texas Tech|Jerzy Sarosiek, MD, PhD, AGAF, FACG|915-215-5255|jerzy.sarosiek@ttuhsc.edu|
21302831|NCT01525225|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21302832|NCT00363545|GlaxoSmithKline|GSK Response Center|866-435-7343||
21302833|NCT01182844|Medical University of Graz|Dr. Norbert Tripolt|+43 316 385|norbert.tripolt@medunigraz.at|78038
21302834|NCT03048383|University of Utah|Dr. P. Daniel Ward|801-581-8471|PDanielWard@hsc.utah.edu|
21302835|NCT05009979|National Cancer Institute|Dr. Esther Mena Gonzalez|240-760-6111|esther.menagonzalez@nih.gov|
21302836|NCT02957968|Virginia Commonwealth University Massey Cancer Center|Massey CTO Breast Team|804-628-6430|masseyctbrst@vcu.edu|
21302837|NCT00918931|Organization: The University of Texas M. D. Anderson Cancer Center|Srdan Verstovsek M.D./Associate Professor|713-792-7305|eharriso@mdanderson.org|
21302838|NCT01350544|RAND Corporation|Laura M. Bogart, PhD|(310) 393-0411|lbogart@rand.org|7281
21302839|NCT00910624|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21302840|NCT00594425|Virginia Clinical Research, Inc|David Pariser MD|757-625-0151|dpariser@pariserderm.com|
21302841|NCT04585009|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21302842|NCT01104376|Indiana University|Zeruesenay Desta, PhD|317-630-8860|zdesta@iupui.edu|
21302843|NCT01673347|William Beaumont Hospital|Erin Baker, PhD|248-551-1816|erin.baker@beaumont.org|
21302844|NCT02528721|Exalenz Bioscience|VP of Clinical Affairs|972-8-9737502|melinaa@exalenz.com|
21302845|NCT00813176|University of Iowa|Dr Javier H Campos|3193567208|javier-campos@uiowa.edu|
21302846|NCT00895011|Vivus, Inc.|Wesley W Day, PhD|650-934-5200|medaffairs@vivus.com|
21302847|NCT03859973|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21302848|NCT03085914|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21302849|NCT01910311|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21302850|NCT01445548|National Eye Institute|Wai T. Wong, MD, PhD|301-496-7566|wongw@nei.nih.gov|
21302851|NCT02204761|University of Washington Medical Center|Dr. Jing Zeng|2065984110|jzeng13@uw.edu|
21302852|NCT03560518|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
21302853|NCT00159822|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21302854|NCT00275821|Novartis Pharmaceuticals|Study Director|862-778-8300||
21302855|NCT01215916|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21302856|NCT00915499|ResMed|June Mendoza|1-800-424-0737|june.mendoza@resmed.com|
21302857|NCT01568528|Emory University|Dr. Erica Duncan|404-321-6111|eduncan@emory.edu|
21302858|NCT00958438|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
21302859|NCT01410344|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
21302860|NCT02788279|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21302861|NCT00924040|National Cancer Institute, National Institutes of Health|Robert J. Kreitman, M.D.|301-496-6947|kreitman@mail.nih.gov|
21302862|NCT01133990|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21302863|NCT01782469|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
21302864|NCT01185301|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21302865|NCT04987944|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21302866|NCT02614469|Massachusetts General Hospital|Dr. Michael Schwarzschild|617-764-9611|michaels@helix.mgh.harvard.edu|
21302867|NCT00345332|University of Rochester|Division of Urogynecology|585-273-3232|amy_keller@urmc.rochester.edu|
21302868|NCT00357760|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
21302869|NCT04136444|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21302870|NCT01328444|GlaxoSmithKline|GSK Response Center|866-435-7343||
21302871|NCT03207438|University of Saskatchewan|Evyn Peters|13068441312|evyn.peters@usask.ca|
21302872|NCT03241368|Medtronic GIH|Amanda Wenisch, Clinical Resaerch Coordinator / Study Manager|1-206-225-4025|amanda.m.wenisch@medtronic.com|
21302873|NCT04740905|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21302874|NCT02535572|Medical University of South Carolina|Morgan Dancy|843-876-5141|maddoxm@musc.edu|
21302875|NCT01534182|Novartis|Study Director|+1 (862) 778-8300||
21302876|NCT03077087|Regions Hospital|Joshua S Rosenzweig / Study Coordinator|651-254-3351|joshua.s.rosenzweig@healthpartners.com|
21302877|NCT02412488|Medtronic, PLC|Lindsay Werder, Senior Clinical Research Specialist|7635268168|lindsay.k.werder@medtronic.com|
21288055|NCT00671788|Gynecologic Oncology Group Statistical and Data Center|Jessalyn Reboy|716-845-7738|reboyj@nrgoncology.org|
21288056|NCT01035138|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21288057|NCT02966834|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21288058|NCT00655889|Biologics Consulting Group|Dr. Joseph Fratantoni|(301) 340-8432|jfratantoni@bcg-usa.com|
21288059|NCT04739800|NRG Oncology|Christopher Purdy on behalf of Austin Miller, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
21288060|NCT01749956|SCRI Development Innovations|Charles Davis, RAC|615-524-4341|charles.davis2@scri-innovations.com|
21288061|NCT03415178|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21288062|NCT03456245|Harvard TH Chan School of Public Health|Dr. David Bloom|6174320650|dbloom@hsph.harvard.edu|
21288063|NCT03321721|St. Louis University School of Medicine|Dr. Trevor L. Tredway|314-577-5630|trevor.tredway@health.slu.edu|
21288064|NCT00315341|University of California, Los Angeles|Walter Ling, M.D.|(310) 933-8111|lwalter@ucla.edu|
21288065|NCT00661388|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21288066|NCT01509105|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21288067|NCT01288430|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21288068|NCT05493111|Alcon Research, LLC|Scientific Advisor, Clinical Research and Development|1-888-451-3937|alcon.medinfo@alcon.com|
21288069|NCT05539131|Yongin Severance Hospital|Woo Jung Kim|01092827943|woojungkim@yuhs.ac|
21288070|NCT04486716|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21288071|NCT02807259|Karnataka Health Promotion Trust|Prakash Javalkar|+91 80 4040 0200|prakashj@khpt.org|
21288072|NCT02332707|Merck Sharp & Dohme Corp.|Senior VIce President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21288073|NCT01473134|Clinical Affairs Associate Director|Hillary Overholser|574-933-4180|hillary.overholser@zimmerbiomet.com|
21288074|NCT03643848|Florida International University|Dana L. McMakin, PhD, ABPP|305-348-0042|dmcmakin@fiu.edu|
21288075|NCT04761822|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21288076|NCT02233413|Massachusetts General Hospital|Dr. Rajiv Gupta|617-726-0369|rgupta1@mgh.harvard.edu|
21288077|NCT03265964|VA Salt Lake City Health Care System, VISN 19 Rocky Mountain MIRECC for Veteran Suicide Prevention|Dr. Douglas Kondo|801-587-1549|douglas.kondo@va.gov|
21288078|NCT00890162|National Institute of Allergy and Infectious Diseases|Carter, Melody|+1 301 496 8772|mc396j@nih.gov|
21288079|NCT04476043|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21288080|NCT02349386|Besins Healthcare Ireland Ltd|Global Chief Medical Officer|+353 87 1039215|clinicaldevelopment@besins-healthcare.com|
21288081|NCT04167462|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
21288082|NCT02765165|Proximagen, LLC|Chief Medical Officer|952-658-7440|tcmeng@proximagen.com|
21288083|NCT01189266|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21288084|NCT00410163|GlaxoSmithKline|GSK Response Center|866-435-7343||
21288085|NCT02674659|Harapan Kita National Cardiovascular Center|Bambang Dwiputra, MD, FIHA|0215684093|bambangdwiputra@gmail.com|
21288086|NCT05452239|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
21288087|NCT03692949|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21288088|NCT06309394|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21288089|NCT04431206|Wake Forest University School of Medicine|Dr. James Eisenach|3367164182|james.eisenach@advocatehealth.org|
21288090|NCT03350919|University of Rochester|Steven E. Feldon, MD|585-273-1050|Steven_Feldon@urmc.rochester.edu|
21288091|NCT04428151|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21288092|NCT01426581|University of Chicago|Valerie G. Press, MD, MPH|73-702-5170|vpress@medicine.bsd.uchicago.edu|
21288093|NCT02783690|Mayo Clinic|Robert Mutter, M.D.|507-284-2511|mutter.robert@mayo.edu|
21288094|NCT02421939|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
21288095|NCT05881733|Erasmus MC|Dr. Sing-Chien Yap|+31650031551|s.c.yap@erasmusmc.nl|
21288096|NCT05227677|Nagase Diagnostics Co.,Ltd.|Takuji Kohzuma|09080045463|takuji.kohzuma@nagase.co.jp|
21288097|NCT03573297|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21288098|NCT04880850|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21288099|NCT03907488|SWOG|Hongli Li|206-667-6077|hongli@fredhutch.org|
21288100|NCT01093846|Novartis Pharmaceuticals|Study Director|862-778-8300||
21288101|NCT04240314|Nationwide Children's Hospital|Megan Waldrop, Sponsor-Investigator|614-722-2231|megan.waldrop@nationwidechildrens.org|
21288102|NCT07169032|First Affiliated Hospital of Jinan University|LI ZHEN ZHONG|+8613711706774|nicolezlz@foxmail.com|
21288103|NCT03846479|Icahn School of Medicine at Mount Sinai|Dr. John Levine|212-241-6021|john.levine@mssm.edu|
21288104|NCT01566370|Yale/VA Connecticut Healthcare system|Albert Arias|2039325711|albert.arias@va.gov|8155
21288105|NCT00362232|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21288106|NCT02700841|University of Nebraska Medical Center|IIT Office|402-559-4596|IITOffice@unmc.edu|
21288107|NCT00090103|GlaxoSmithKline|GSK Response Center|866-435-7343||
21288108|NCT02515253|University of Portsmouth|Dr Emma Sharland||emma.sharland@port.ac.uk|
21288109|NCT01799889|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21260323|NCT01670994|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
21260324|NCT02013544|Endoceutics|Director of Data Analysis|418-653-0033|celine.martel@endoceutics.com|215
21260325|NCT02036320|Johnson and Johnson Vision Care Inc.|Meredith Jansen,O.D.,M.S., FAAO|904-443-3500|mjanse12@ITS.JNJ.com|1396
21260326|NCT00891735|Genentech, Inc.|Medical Communications|800-821-8590||
21260327|NCT00481065|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21260328|NCT02630953|Brown University|Dr. Bess Marcus, Principle Investigator|401-863-6950|bess_marcus@brown.edu|
21274992|NCT02466087|University of Vermont|Emily Tarleton, MS, RD|802-847-4730|emily.tarleton@uvm.edu|
21274993|NCT02658019|University of Miami|Lynn G. Feun, MD|305-243-6606|lfeun@med.miami.edu|
21274994|NCT03087786|Niconovum USA|Dr. Abraham Varghese|336-741-2315|varghea@rjrt.com|
21238506|NCT04421092|Medical University of South Carolina - Department of Otolaryngology|Shaun A. Nguyen, MD - Director of Clinical Research|8437921356|nguyensh@musc.edu|
21238507|NCT03641313|Vanderbilt-Ingram Cancer Center|Jordan Berlin|6153434128|jordan.berlin@vumc.org|
21238508|NCT03033225|Mayo Clinic|Kenneth K. Wang, MD|507-284-2511|wang.kenneth@mayo.edu|
21238509|NCT05163522|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21238510|NCT01712477|Michigan State University|Chet A Morrison, M.D.|9897901001|chet.morrison@cmich.edu|
21238511|NCT04686422|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
21238512|NCT03937219|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
21238513|NCT04475432|Tarsus Pharmaceuticals, Inc.|Mark Holdbrook, Senior Vice-President of Clinical Development|408-431-6613|mark@tarsusrx.com|
21274995|NCT02986139|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21238514|NCT04029129|UConnHealth|Dr. Douglas Brugge|860-679-8814|brugge@uchc.edu|
21238515|NCT00031486|University of Alabama at Birmingham|Penny Jester|(877) 975-7280|pjester@peds.uab.edu|
21238516|NCT02003508|Melbourne Sexual Health Centre|A/Prof Marcus Chen|+613 93416260|mchen@mshc.org.au|
21238517|NCT03685591|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21238518|NCT01685138|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21238519|NCT01714804|SeaSpine|Vice President, Orthobiologics Research & Development|760.216.5138|frank.vizesi@seaspine.com|
21238520|NCT03988166|Teleflex|Ricardo De Medeiros, Director Scientific Clinical Affairs|612.812.5008|ricardo.demedeiros@teleflex.com|
21238521|NCT04506775|UMass Chan Medical School|J. Aaron Scott, DO|774-303-4156|jamesaaron.scott@umassmemorial.org|
21238522|NCT02703922|Groupe Hospitalier de la Rochelle Ré Aunis|Caroline Allix-Béguec, clinical research manager|+33516494246|caroline.allix-beguec@ght-atlantique17.fr|
21238523|NCT03934736|Dynavax Technologies Corporation|Robert Janssen, MD, Senior Vice President & Chief Medical Officer|5106650414|rjanssen@dynavax.com|1414
21238524|NCT00818116|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21238525|NCT00079001|Massachusetts General Hospital|Matthew Smith, MD, PhD||smith.matthew@mgh.harvard.edu|
21238526|NCT05070416|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
21238527|NCT05805657|University of California, Berkeley|Dr. Allison Harvey, Professor of Clinical Psychology|5104736490|aharvey@berkeley.edu|
21238528|NCT04058353|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21238529|NCT00985010|Materno-Perinatal Hospital of the State of Mexico|Hugo Mendieta Zerón|+52-722-2176605|mezh_74@yahoo.com|
21238530|NCT00316173|GlaxoSmithKline|GSK Response Center|866-435-7343||
21238531|NCT02390531|Jaeb Center for Health Research|Raymond Kraker, PEDIG Coordinating Center Director|8139758690|rkraker@jaeb.org|
21238532|NCT03779906|Bracco Diagnostics Inc.|Maria Luigia Storto, MD, Executive Director Medical Planning and Management X-ray products|609-514-2262|MariaLuigia.Storto@diag.bracco.com|
21274996|NCT00660660|AstraZeneca|Clinical Trial Transparency||ClinicalTrialTransparency@astrazeneca.com|
21238533|NCT01266447|NRG Oncology|Linda Gedeon, Clinical Data Coordinator|716-845-1169|lgedeon@gogstats.org|
21238534|NCT00847405|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21238535|NCT01909570|University Hospital Virgen de las Nieves|Dr. Ana Clavero|0034958020482|anaclaverogilabert@gmail.com|
21238536|NCT02790073|Sanifit|Rekha Garg MD MS|18582815978|rekha.garg@sanifit.com|
21238537|NCT02882282|MD Anderson Cancer Center|Renata Ferrarotto, MD|713-792-6363|rferrarotto@mdanderson.org|
21238538|NCT00514683|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21238539|NCT02487498|Novartis Pharmaceuticals|Study Director|862-778-1873||
21238540|NCT01163643|Bausch Health|Study Director||susan.harris@bauschhealth.com|
21238541|NCT00676130|Brigham and Women's Hospital|Daniel J. Pallin, MD, MPH|617-525-6614|dpallin@partners.org|
21238542|NCT01564368|American College of Radiology|Senior Director Clinical Research Administration|215-574-3150|info@acr.org|
21274997|NCT02015832|European Cardiovascular Research Institute|Dr. Ernest Spitzer|+31102062828|E.Spitzer@ECRI-Trials.com|
21238543|NCT01802437|University of Minnesota|Meredith Gunlicks-Stoessel|612-273-9844|mgunlick@umn.edu|
21274998|NCT02313558|Guanghua School of Stomatology, Sun Yat-sen University,|Dr. Hongchun Liu|0086-0-13826189071|hongchun751@sina.com|
21302878|NCT01989468|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21302879|NCT01640327|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21302880|NCT01054183|Akron Children's Hospital|Michael T. Bigham, MD|330-543-8639|MBigham@chmca.org|
21302881|NCT01960907|RESTECH srl|Dr. Pasquale Pio Pompilio, R&D manager|+39 02 3659 3690|p.pompilio@restech.it|
21302882|NCT00324259|Washington University School of Medicine|Dr. Matthew Ellis|314-362-8866|mjellis@bcm.edu|
21302883|NCT00065429|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
21302884|NCT02775240|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21302885|NCT04114617|University Health Network|Director, Swallowing Rehabilitation Research Laboratory|416 597 3422|tri-swallowinglab@uhn.ca|7802
21302886|NCT00441116|GlaxoSmithKline|GSK Response Center|866-435-7343||
21302887|NCT00636363|Bausch & Lomb|Robert Steffen|(585) 338-6399|robert.steffen@bausch.com|
21302888|NCT01144299|GlaxoSmithKline|GSK Response Center|866-435-7343||
21302889|NCT03353233|Duke University Medical Center|W. Michael Bullock, MD, PhD|919-681-6437|william.bullock@duke.edu|
21302890|NCT02342418|University of Michigan|Manjunath Pai, Associate Professor|7346470006|amitpai@med.umich.edu|
21302891|NCT04255394|Zimmer Biomet|Linda Meijer|+31627933741|linda.meijer@zimmerbiomet.com|
21302892|NCT00528541|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
21302893|NCT03612856|Aronora, Inc.|Christina U. Lorentz|503-964-0250|christina.lorentz@aronorabio.com|
21302894|NCT01181986|Phoenix VA Health Care System|Dr. Juraj Koska|602-277-5551|juraj.koska@va.gov|7685
21302895|NCT01055067|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21302896|NCT00831493|UT MD Anderson Cancer Center|Sunil Krishnan, MD / Associate Professor||mclemons@mdanderson.org|
21302897|NCT00678743|Biofortis Research (formerly Provident)|John Marshall, General Manager|630-748-5339|john.marshall@mxns.com|
21302898|NCT03658876|Imperial Healthcare NHS Trust|Dr Damien Ashby||d.ashby@imperial.ac.uk|
21302899|NCT00576420|BAXTER INNOVATIONS GmbH|Edith Hantak, Dir, Global Therapeutic Area, BioSurgery||edith_hantak@baxter.com|
21302900|NCT02616146|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21302901|NCT02000154|SymBio Pharmaceuticals|Katsuhisa Goto|+81-3-5472-1127||
21302902|NCT01221272|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21302903|NCT01340872|Shield Therapeutics|Jackie Mitchell MA DPhil|+44 (0) 191 511 8515|jmitchell@shieldtx.com|
21302904|NCT01502332|USaoPaulo|Dr Alcino Costa Leme|55 11 989044014|costaleme@uol.com.br|
21302905|NCT03521102|Montefiore Medical Center|Dr. Benjamin Friedman|718-920-6626|bfriedm@montefiore.org|
21302906|NCT03039621|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
21302907|NCT03254108|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21302908|NCT01771809|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21302909|NCT00362180|Kastle Therapeutics, LLC|Christopher Bryant, Ph.D.|8152633913|cbryant@kastletx.com|
21302910|NCT03930264|Nova Laboratories Limited|Dr Hussain Mulla|+44 (0)116 223 0100|hussain.mulla@novalabs.co.uk|
21302911|NCT02656680|University of Connecticut|Dr. Sherry Pagoto|8604868979|sherry.pagoto@uconn.edu|
21302912|NCT01215929|UAMS|Michael J Mancino MD|501-526-8440|mjmancino@uams.edu|
21302913|NCT02600871|University of Texas Health San Antonio|Dr. Adriana Segura Olson|2152649796|adriana.s.olson@gmail.com|
21302914|NCT00002931|City of Hope|Paul Frankel, Ph.D.|626-359-8111|pfrankel@coh.org|65265
21302915|NCT02361476|Rigshospitalet|Mogens Ydemann, MD|+45 35455620|mogens@ydemann.dk|
21302916|NCT01246466|AtriCure|Vice President, Clinical Affairs and Biometrics|1-513-644-8192|nndikintum@atricure.com|
21302917|NCT00911443|R&D Department - Sigma-Tau SpA|Roberto Camerini|+390691393562|roberto.camerini@sigma-tau.it|
21302918|NCT01142089|Cosmo Technologies Ltd.|Richard Jones|+35318170370|RJones@cosmopharma.com|
21302919|NCT00789074|Queen Mary University of London|Professor Peter Hajek|+44 207 882 8231|p.hajek@qmul.ac.uk|
21302920|NCT01974765|Memorial Sloan Kettering Cancer Center|Dr. Rachel Grisham, MD|646-888-4653|grishamr@mskcc.org|
21302921|NCT00762424|WellSpan Health|Barbara Stahlman MS, Clinical Research Associate|717-851-2450|bstahlman@wellspan.org|
21302922|NCT01949337|Memorial Sloan-Kettering Cancer Center|Michael J. Morris, MD|646-422-4469|morrism@mskcc.org|
21302923|NCT00003472|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
21302924|NCT01012219|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21302925|NCT00874939|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21302926|NCT01909791|Jaeb Center for Health Research|Adam Glassman|8139758690|drcrnet@jaeb.org|
21302927|NCT02168387|Duke University Medical Center|Ira M. Cheifetz, MD, FCCM, FAARC|919-681-4080|ira.cheifetz@dm.duke.edu|
21302928|NCT01561703|University of Missouri - Department of Otolaryngology - Head and Neck Surgery|Research Coordinator|5738822549|schneiderri@health.missouri.edu|
21302929|NCT01444092|Perrigo|Beatriz North|718-960-0163|beatriz.north@perrigo.com|
21302930|NCT01328366|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
21302931|NCT00603590|Tehran University of Medical Sciences|Mansoor Rastegarpanah|+989121255960|rastegar@sina.tums.ac.ir|
21302932|NCT03005873|Taiwan Liposome Company|Dr. Carl Brown|886-2-2655-7377|tlc_clinicaltrials@tlcbio.com|
21302933|NCT02882152|University of São Paulo|Dr. Joaquim Edson Vieira|+55 11 3061 8716|joaquimev@usp.br|
21302934|NCT02871882|Mayo Clinic|Andres Acosta|15072666931|acosta.andres@mayo.edu|
21274999|NCT02856594|Massachusetts General Hospital|Dr, Oluwaseun Johson-Akeju|617-724-7200|oluwaseun.akeju@mgh.harvard.edu|
21275000|NCT01370083|Toronto Rehabilitation Institute - University Health Network|Prof. Catriona Steele|4165973422|catriona.steele@uhn.ca|7603
21275001|NCT02450539|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21275002|NCT02052895|Mochida Pharmaceutical|Hironori Sato|+81-3-3225-6331|hnsato@mochida.co.jp|
21275003|NCT05780463|University of Minnesota|Greg Grandits|651-528-9491|greg-g@ccbr.umn.edu|
21275004|NCT00835614|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21288110|NCT06217380|Masimo|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
21302935|NCT00791973|University of Chicago|Dr. Robert Naclerio|(773) 702-0080|rnacleri@surgery.bsd.uchicago.edu|
21302936|NCT00797966|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
21302937|NCT01514786|UMichigan|Dr. Masahito Jimbo|734-998-7120|mjimbo@med.umich.edu|
21302938|NCT01002820|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
21302939|NCT01031420|Fox Chase Cancer Center|Elizabeth Plimack|215-728-3889|Elizabeth.Plimack@fccc.edu|
21302940|NCT01430754|Vanda Pharmaceuticals Inc.|Marlene Dressman, Ph.D.|202-734-3462|marlene.dressman@vandapharma.com|
21238544|NCT01342458|University of Sao Paulo|Dr. Francis Trombini-Souza|55 11 3091 8426|trombinisouza@usp.br|
21238545|NCT01682213|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman, MD|646-888-4162|chapmanp@mskcc.org|
21238546|NCT01181726|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21238547|NCT04998604|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21238548|NCT00429663|Boston Medical Center|Paul Tornetta III, MD|617-414-6295|paul.tornetta@bmc.org|
21238549|NCT05383417|University of California San Diego Health|Dr. Andrew Vahabzadeh-Hagh|858-249-4070|avahabz@health.ucsd.edu|
21238550|NCT02466646|Marmara University Faculty of Dentistry, Department of Periodontology|Prof. Dr. Basak Dogan|00905332621170|basak.sdogan@gmail.com|
21238551|NCT03261271|University of Kansas Medical Center|Dr. Jill Hamilton-Reeves|913-588-7650|jhamilton-reeves@kumc.edu|
21238552|NCT03420781|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21238553|NCT04067401|University of Rochester Medical Center, Psychiatry Dept|Dr. Peter Wyman|5852733372|peter_wyman@urmc.rochester.edu|
21238554|NCT02657317|University of Texas Health Science Center at San Antonio|Donald McGeary, PhD|210-567-5454|mcgeary@uthscsa.edu|
21238555|NCT02857426|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
21238556|NCT02110901|Proteon Therapeutics, Inc|Steven Burke, MD|781-890-0102|Clinical@ProteonTx.com|
21238557|NCT02634788|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
21275005|NCT04077645|University of Illinois Urbana Champaign|Dr. Sean P Mullen|217-244-4502|spmullen@illinois.edu|
21288111|NCT02385318|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
21288112|NCT03095287|Grifols Therapeutics LLC|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
21288113|NCT02471183|Actelion Pharmaceuticals Ltd|Global Post approval studies Director||lperchen@its.jnj.com|
21288114|NCT02478671|Terumo Medical Corporation|Robert Gash, Director of Clinical Affairs|732-302-4931|robert.gash@terumomedical.com|
21288115|NCT06094647|University of North Carolina at Chapel Hill|Kelsey Ludwig, PhD|919-962-1401|kelsey_ludwig@med.unc.edu|
21288116|NCT03556683|University of North Carolina at Chapel Hill|Carole Robinette|919-966-5638|carole_robinette@med.unc.edu|
21288117|NCT02018107|Brigham & Women's Hospital INC|Paul Shyn, MD|6177326304|PSHYN@BWH.HARVARD.EDU|
21302941|NCT02617901|Sheffield Children's NHS Foundation Trust|Dr Amaka C Offiah|0114 271 7557|a.offiah@sheffield.ac.uk|
21302942|NCT00177047|Masonic Cancer Center, University of Minnesota|Dr.Claudio G. Brunstein MD, PhD|612-625-3918|bruns072@umn.edu|
21302943|NCT00052442|Memorial Sloan-Kettering Cancer Center|Owen A. O'Connor, MD, PhD|212-639-8889|oo2130@columbia.edu|
21302944|NCT02661178|Drugs for Neglected Diseases initiative|Sophie Delhomme|+41229069230|sdelhomme@dndi.org|
21302945|NCT05338671|University of Washington|Avina Paranjpe|206-543-5044|avina@uw.edu|
21302946|NCT01733212|New York Methodist Hospital|Sandip Darji|718/780-3779|darji_sandip2005@yahoo.com|
21302947|NCT02855541|University of Colorado Boulder|James Peterman, PhD|303-735-0358|james.peterman@colorado.edu|
21302948|NCT01242813|Novartis Pharmaceuticals|Study Director|862-778-8300||
21302949|NCT00701662|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
21302950|NCT02307253|Fondazione Policlino Universitario A Gemelli IRCCS|Dr Alberto Larghi|0630156580|alberto.larghi@yahoo.it|
21260329|NCT00650858|Johns Hopkins University|Daniel F. Hanley, MD|410-614-6996|dhanley@jhmi.edu|
21260330|NCT03094195|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
21260331|NCT01957137|Pelvic Health and Gastric Therapies|Rachael McNamara / Clinical Research Specialist|763.526.8107|rachael.m.mcnamara@medtronic.com|
21260332|NCT00054132|Memorial Sloan Kettering Cancer Center|Dr. Maura Dickler|646-888-4560|dicklerm@mskcc.org|
21260333|NCT03359902|University of Florida|John Williamson|352-548-6920|john.williamson@ufl.edu|
21260334|NCT00323284|Glaukos|Jeff Wells, Sr. VP, Clinical, Regulatory, and Quality Affairs|949-367-9600|jwells@glaukos.com|227
21260335|NCT01795547|Email contact via H. Ludbeck A/S|Study director||LundbeckClinicalTrials@lundbeck.com|
21260336|NCT01272583|Academic Medical Center|Dr. Josefine E. Schopman|+31 20 5669111|j.e.schopman@amc.uva.nl|
21260337|NCT02549716|Milton S. Hershey Medical Center|Sprague W. Hazard III, M.D.|717-531-0003|shazard@pennstatehealth.psu.edu|311253
21260338|NCT00591734|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21260339|NCT00382148|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
21260340|NCT00784758|University of California, Los Angeles|Dr. Eric Kleerup|310-794-6593|ekleerup@mednet.ucla.edu|
21260341|NCT02040142|Montefiore Medical Center|Dr. John McAuliffe, Associate Professor Department of Surgery and Department of Pathology|718-379-6865|jomcauli@montefiore.org|
21260342|NCT02797470|Statistical and Data Analysis Center, AIDS Malignancy Consortium|Deukwoo Kwon|(713) 500-7964|deukwoo.kwon@mountsinai.org|
21260343|NCT05142826|Florida International University|Gregory A. Fabiano, Ph.D.|716-359-7823|gfabiano@fiu.edu|
21260344|NCT04439331|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21260345|NCT00888511|Odense University Hospital|Olfred Hansen|+45 2424 1588|olfred.hansen@rsyd.dk|
21260346|NCT04828330|VA Puget Sound Health Care System|Dr. Pradeep Suri|207-762-1010|pradeep.suri@va.gov|
21260347|NCT00413959|Oncology Specialists SC|Sigrun Hallmeyer, MD Director of Research|847-268-8200|shallmeyer@oncmed.net|
21260348|NCT04291560|University of North Carolina at Chapel Hill|Jamie Crandell, PhD|919-966-5803|jcrandell@unc.edu|
21260349|NCT01707992|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|info.era-clinical@teva.de|
21260350|NCT03498521|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21260351|NCT04981223|Stanford University|Dr. Geoffrey Sonn|(650) 498-6000|gsonn@stanford.edu|
21275006|NCT00731939|Coloplast Corp|Clinical Trial Manager|612-302-4990|usdibe@coloplast.com|
21275007|NCT02280863|Stanford University|Dr. Bruce Buckingham, MD||buckingham@stanford.edu|
21275008|NCT02903407|Duke University|Angela Lowenstern|919-684-0111|angela.sandelin@duke.edu|
21275009|NCT02890992|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21275010|NCT02622386|University of Michigan|Johann Gudjonsson|(734) 615-4508|johanng@med.umich.edu|
21275011|NCT03236311|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21275012|NCT00669162|University of Kansas Cancer Center|Xinglei Shen, MD|913-588-3600|ctnursenav@kumc.edu|
21275013|NCT02704091|Ipsen Pharma SAS|Medical Director|see email|clinical.trials@ipsen.com|
21238558|NCT00758459|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21275014|NCT00985439|Iroko Pharmaceuticals, LLC|Steven Jensen|267-546-3003|sjensen@iroko.com|
21275015|NCT05274763|Emory University|Dr. Jennifer Mascaro|404-727-4301|jmascar@emory.edu|
21275016|NCT01174186|Silkeborg Regional Hospital|René Oestgaard|0045 78 41 50 00|ostgard@immunology.au.dk|
21288118|NCT03286504|Weill Cornell Medicine|Dr. Daniel Fitzgerald|646-962-8140|dwf2001@med.cornell.edu|
21288119|NCT05350423|Icahn School of Medicine at Mount Sinai|Dr. Mantu Gupta|212-241-1272|Mantu.Gupta@mountsinai.org|
21288120|NCT02097277|Bristol-Myers Squibb|Study Director||clinical.trials@bms.com|
21288121|NCT01890577|Amgen Inc.|Study Director|866-572-6436||
21288122|NCT02730130|Memorial Sloan Kettering Cancer Center|Christopher Barker, MD|212-639-8168|barkerc@mskcc.org|
21288123|NCT00141921|Amgen Inc.|Study Director|866-572-6436||
21288124|NCT03320369|Northwestern University|Nirmala Gonsalves|312-695-4054|n-gonzalves@northwestern.edu|
21288125|NCT00621530|Wake Forest School of Medicine|Dr. James C. Eisenach|336-716-4498|jimeisenach@gmail.com|
21288126|NCT04398966|University of North Carolina at Chapel Hill|Markeela Lipscomb|919-843-3670|markeela_lipscomb@med.unc.edu|
21288127|NCT02081807|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21288128|NCT03104413|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21288129|NCT02721069|Neurelis, Inc.|Cyndi Guerra|9736156258|cguerra@neurelis.com|
21288130|NCT03340883|Chinook Therapeutics, Inc.|Chinook Therapeutics, Inc. (formerly Aduro Biotech, Inc.)|206-485-7051|clinicaltrials@chinooktx.com|
21288131|NCT01675778|Jacobi Medical Center|Dr. Shujun Xia|718-918-5800|shujun.xia@nbhn.net|
21288132|NCT03473197|Castle Creek Pharmaceuticals, LLC|Dr. Mary Spellman|862 286 0400|mspellman@castlecreekpharma.com|
21302951|NCT02683746|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21302952|NCT01213576|University of Liverpool|Professor Neil French|+441517959630|french@liv.ac.uk|
21302953|NCT00606047|The Ottawa Hospital Research Institute|Dr Paul Beaule|613-737-8920|pbeaule@toh.ca|
21302954|NCT04121078|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21302955|NCT02353143|Menarini Ricerche|Director of Clinical Sciences|003905556809990|acapriati@menarini-ricerche.it|
21302956|NCT02599051|Cleveland Clinic Florida|G W Davila|9546595559|davilag@ccf.org|
21302957|NCT02946931|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21302958|NCT03492840|Raziel Therapeutics|Racheli Gueta|97289126941|racheli@raziel-therapy.com|
21302959|NCT00869778|Institute of Immunology，PLA|Dr.Wu|02368752230|wuyuzhang@yahoo.com|86
21302960|NCT03339297|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-870-9177|ClinicalTrialDisclosure@JazzPharma.com|
21302961|NCT01844479|University of Michigan|James Wrobel, DPM, MS|734-647-4940|jswrobel@med.umich.edu|
21302962|NCT01976988|Cedars Sinai Medical Center|Phillip Fleshner MD|310-289-9224|pfleshner@aol.com|
21302963|NCT01512667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21302964|NCT01566214|Iowa City VA Health Care System|Mark Vander Weg|319-338-0581|mark.vanderweg@va.gov|7717
21302965|NCT03051620|Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Denmark|Anne Sophie Sølling|+45 78 45 54 75|annesoel@rm.dk|
21302966|NCT04132804|Massachusetts General Hospital|Dr. Kyle Staller|617-726-5565|kstaller@mgh.harvard.edu|
21302967|NCT00393510|Institute of Chinese Medicine, Chinese University of Hong Kong|Prof. Leung Ping Chung|(852)2252 8863|pingcleung@cuhk.edu.hk|
21302968|NCT02700334|INSTITUTO DE TERAPUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
21302969|NCT00770146|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
21302970|NCT01023477|Inova Health Care|Kirsten Edmiston, MD|703-850-9555|Kirsten.edmiston@inova.org|
21302971|NCT04620798|Indiana University Bloomington School of Public Health|Molly Rosenberg, MPH, PhD|(812) 856-2509|rosenmol@indiana.edu|
21302972|NCT04821362|Ege University|Dr. Sercan Yalçınlı|+90 505 537 41 01|sercan.yalcinli@ege.edu.tr|
21302973|NCT01967784|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21302974|NCT00674154|Aarhus University Hospital|Lars Rolighed|004520677876|larsrolighed@gmail.com|
21302975|NCT03222492|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21302976|NCT00816023|Cubist Pharmaceuticals, Inc.|Alistair Wheeler, MD, MFPM, Senior Director Clinical Research|781-860-8660|awheeler@cubist.com|
21302977|NCT02930980|Medtronic EMEA RCC|Valentina Amori, Medical Writer|+39 06 32814236|valentina.amori@medtronic.com|
21302978|NCT01145638|Pharmacosmos A/S|Vice President Research & Development Department|+45 59485959|llt@pharmacosmos.com|
21302979|NCT02907892|University of Minnesota|Dr. Rachel Vogel|6513345982|isak0023@umn.edu|
21302980|NCT04531462|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21302981|NCT04175509|Aultman Hospital|Dr. Michaela Beynon|2488218826|michaelabeynon@gmail.com|
21302982|NCT00348933|University of California and Rady Children's Hospital, San Diego|Lynne M. Bird, MD|858-966-5840|Lbird@rchsd.org|
21302983|NCT01489111|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21302984|NCT01727700|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21288133|NCT02832037|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21288134|NCT02326883|Kaiser Permanente Washington Health Research Institute|Gregory Simon, Investigator|206-287-2979|gregory.e.simon@kp.org|
21288135|NCT04773795|Nitinotes Ltd.|Ravit Peled- Director of clinical operations|0526145354|ravit@nitinotesurgical.com|
21288136|NCT00634504|BTG International Inc.|SVP, Clinical Development|610-278-1660|angela.ogden@btgplc.com|
21288137|NCT03329989|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|ClinicalTrials@Endo.com|
21288138|NCT01401166|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21288139|NCT04383132|Şehit Prof. Dr. İlhan Varank Eğitim Ve Araştırma Hastanesi|Dr. Beslen Göksoy|05349530112|beslengoksoy@gmail.com|
21288140|NCT03901300|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|2257632500|amanda.staiano@pbrc.edu|
21288141|NCT01928849|Duke University Department of Anesthesiology|Thomas Buchheit, MD Division Chief, Pain Medicine|9196811924|Thomas.Buchheit@duke.edu|
21288142|NCT00297167|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1- 800- 472- 2634||
21288143|NCT02320396|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21288144|NCT02511717|Lawson Health Institute|Dr Blayne Welk|5196466000|lawson@lawsonsresearch.com|
21288145|NCT02441283|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21288146|NCT02382939|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
21288147|NCT00142415|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21288148|NCT04342169|University of Utah School of Medicine Division of Infectious Diseases|Dr. Adam Spivak|8015871964|adam.spivak@hsc.utah.edu|
21288149|NCT02026297|Brigham and Women's Hospital|Dr. Michaela K. Farber|6177591609|mfarber@bwh.harvard.edu|
21288150|NCT00321763|GlaxoSmithKline|GSK Response Center|866-435-7343||
21288151|NCT01572792|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
21275017|NCT01051349|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
21275018|NCT00402103|Novartis Pharmaceuticals|Study Director|862-778-8300||
21275019|NCT00484679|University of Minnesota|Maria Hordinsky, MD|612-624-5721|hordi001@umn.edu|
21275020|NCT02351700|Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center|Andrew S. Little, MD|602-406-3181|neuropub@dignityhealth.org|
21275021|NCT00418145|Icahn School of Medicine at Mount Sinai|Dr. Fred Lublin|212-241-6854|fred.lublin@mssm.edu|
21275022|NCT00425308|Novartis Pharmaceuticals|Study Director|862-778-8300||
21275023|NCT01631552|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21275024|NCT00463684|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
21275025|NCT05143801|University of New Mexico|Dr. Christine Mermier|5052772664|cmermier@unm.edu|
21275026|NCT01075282|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21275027|NCT00367133|Jaeb Center for Health Research|Adam R. Glassman, Director DRCR.net Coordinating Center|813-975-8690|drcrnet@jaeb.org|
21275028|NCT00847535|Cook MyoSite, Inc.|Ron Jankowski, PhD|412-963-7380|Ron.Jankowski@CookMyosite.com|
21288152|NCT03530696|George Washington Cancer Center|Dr. Pavani Chalasani|(202) 741-2277|pavani.chalasani@email.gwu.edu|
21288153|NCT01129128|University of Washington|James A Taylor, MD|206-616-1206|uncjat@uw.edu|
21288154|NCT06438601|CooperVision, Inc.|Jose A. Vega, OD, MSc, PhD|925-621-3761|javega@coopervision.com|
21288155|NCT01900314|University of Michigan|Stephan Taylor|734-936-4955|sftaylor@umich.edu|
21288156|NCT02013414|Emory University|Baowei Fei, PhD|972-883-7239|bfei@utdallas.edu|
21288157|NCT01385176|Institut Lorrain du Coeur et des Vaisseaux, CHU de Nancy, France|Principal Investigator of the Study, Prof. Faiez Zannad|+33 3 83 15 73 22|f.zannad@chu-nancy.fr|
21288158|NCT01056536|Travel Clinic, Department of Ambulatory Care and Community Medicine, University Hospital of Lausanne|Dr Serge de Vallière|+41 79 556 43 12|serge.de-valliere@unisante.ch|
21288159|NCT04497883|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
21260352|NCT02612909|IVAC|Le Van Be|(+84 90) 3501529|ivaclevabe@dng.vnn.vn|
21288160|NCT00957359|NYU Langone Health|Stephen Ross, MD|212-263-7264|Stephen.Ross@nyulangone.org|
21288161|NCT03034967|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21288162|NCT03806296|University of Pittsburgh School of Medicine|Brant Hasler, PhD|412-246-6413|haslerbp@upmc.edu|
21288163|NCT03136198|Indiana University|Peter S. Pang|317-880-3900|ppang@iu.edu|
21288164|NCT04848480|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21288165|NCT02781324|Children's Hospital Colorado|Eun Kim, Spine Research Assistant|720-777-8026|eun.kim@childrenscolorado.org|
21288166|NCT03570892|Novartis Pharmaceuticals|Study Director|862-778-3000|novartis.email@novartis.com|
21288167|NCT06023563|Indiana University|Dr. Georgia Frey, Faculty, Department of Kinesiology|(812) 855-1262|gfrey@iu.edu|
21288168|NCT05423743|Division of Infectious Diseases, University of California Irvine School of Medicine|Dr. Shruti Gohil, MD, MPH|(714) 456-7890|skgohil@hs.uci.edu|
21288169|NCT05020015|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21288170|NCT06633965|Center for Diabetes Technology|Dr. Marc Breton|434-982-6484|mb6nt@virginia.edu|
21260353|NCT04214080|Marmara University|Assoc. Prof Aysel Yıldız Ozer|5334674433|aysel.yildiz@marmara.edu.tr|+90
21260354|NCT05067127|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
21260355|NCT04091347|Johns Hopkins School of Nursing|Janiece Taylor|443-287-4503|jwalke90@jhu.edu|
21260356|NCT02354833|West Virginia University|Dr. Manuel C. Vallejo, Chair of Department of Anesthesiology|304-598-4929|mvallejo@wvumediciane.org|
21260357|NCT05540652|Brown University|Shufang Sun|401-863-5735|shufang_sun@brown.edu|
21260358|NCT05113940|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21260359|NCT01701258|McLean Hospital|Diego Pizzagalli, Ph.D.|617-855-4230|dap@mclean.harvard.edu|
21288171|NCT00320086|University of New Mexico|Aaron Jacobs, MD|(505)272-5551|Ajacobs@salud.unm.edu|
21288172|NCT04213261|Castle Creek Biosciences|Associate VP of Clinical Trials|16506901024|rblumenthal@castlecreekbio.com|
21275029|NCT01252953|Nuffield Department of Population Health, University of Oxford|Prof Martin Landray|+44 (0)1865 743743|martin.landray@ndph.ox.ac.uk|
21238559|NCT01238640|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|928-277-0715|jhaue@its.jnj.com|
21275030|NCT00840203|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21275031|NCT03393754|VBI Vaccines, Inc.|Vlad Popovic|416-418-4713|vpopovic@vbivaccines.com|
21275032|NCT03349567|Iowa City VA Health Care System|Daniel Livorsi|319-688-3871|daniel-livorsi@uiowa.edu|
21275033|NCT00989950|CoxHealth|Arie Ashkenasi, MD|011 972 50 3007477|ashkenasi1@gmail.com|
21275034|NCT00101439|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21275035|NCT01851772|Xoft, Inc.|Crystal Leonard, CCRP|9375038588|cleonard@icadmed.com|
21275036|NCT04739735|Faculty of dentistry, Alexandria University, Egypt|Dr. Rodaina Helmy|00201100001193|rodaina.helmy@alexu.edu.eg|
21238560|NCT03467932|Oramed Pharmaceuticals|Miriam Kidron, Ph.D.|+972-2-566-0100|miriam@oramed.com|
21275037|NCT00073307|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21302985|NCT01546402|Post Graduate Institute of Medical Education and Research|Aniruddha Agarwal|+911722756111|aniruddha9@gmail.com|
21302986|NCT01757691|Novartis|Study Director|862-778-8300||
21302987|NCT03699475|Bellicum|Contact for Clinical Trial Information|(832) 384-1100|clinicaltrials@bellicum.com|
21302988|NCT01713933|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
21302989|NCT00918125|Duke University Medical Center|Dr. Kevin Thomas|919-668-7857|kevin.thomas@dm.duke.edu|
21302990|NCT00528970|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
21302991|NCT01009840|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affairs|800 562-3974||
21302992|NCT04240678|UC Davis Medical Center|Eric Chak|916-734-3751|echak@ucdavis.edu|
21302993|NCT00541190|University of Pittsburgh|Tim Corcoran|412-624-8918|corcorante@upmc.edu|
21302994|NCT00732901|Virginia Commonwealth University|F. Gerard Moeller|804-828-4134|fgmoeller@vcu.edu|
21302995|NCT01486043|Children's Hospital Los Angeles|Dr. Jamie Wood|323-361-7388|jawood@chla.usc.edu|
21302996|NCT01011478|NSABP Foundation|Director, Department of Regulatory Affairs|412-339-5300||
21302997|NCT04461600|Ayala Pharmaceuticals|Chief Medical Officer|+1-857-444-0553|info@ayalapharma.com|
21302998|NCT01020006|Pharmacyclics|Dr. Laurence Elias|855-427-8846|pharmacyclics@medcomsol.com|
21302999|NCT00253708|Beth Israel Deaconess Medical Center|Russell S. Phillips, MD|6174322222|Russell_phillips@hms.harvard.edu|
21303000|NCT01981057|Medical University of Vienna|Nadja Haiden M.D.|+4314040032320|nadja.haiden@meduniwien.ac.at|
21303001|NCT04905498|University of Kansas Medical Center|Amanda S. Bruce|4014990576|abruce2@kumc.edu|
21303002|NCT02126748|Vrije Universiteit Brussel|Filip Van Ginderdeuren|+3224763916|filip.vanginderdeuren@uzbrussel.be|
21303003|NCT01525901|Icahn School of Medicine at Mount Sinai|Alexander Kolevzon, MD|(212) 659-9134|alexander.kolevzon@mssm.edu|
21303004|NCT04449029|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21303005|NCT02486627|Achaogen, Inc.|Clinical Trials Registration Group||clinical-trials@achaogen.com|
21303006|NCT02189954|DorkuzEU|Anaesthesiology and Reanimation, Dr. Sule Ozbilgin|0905055252901|ozbilginsule@gmail.com|
21303007|NCT02112045|Washington University School of Medicine|Meagan Jacoby, M.D., Ph.D.|314-454-8304|mjacoby@wustl.edu|
21303008|NCT01073462|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21303009|NCT01544088|VA Boston Healthcare System|Denise Sloan, Ph.D.|(857) 364-6333|denise.sloan@va.gov|
21303010|NCT01126671|Boston Children's Hospital|Dr. Sarah Pitts|617-355-3732|sarah.pitts@childrens.harvard.edu|
21303011|NCT00247611|Center for Health, Intervention & Prevention|Dr. Jeffrey Fisher, Principal Investigator|(860) 486-4940|jeffrey.fisher@uconn.edu|
21303012|NCT05395091|Alvotech Swiss AG|Clinical Development and Medical Lead|+41 78 659 89 89|alvotech.clinical@alvotech.com|
21303013|NCT00445588|Adult Brain Tumor Consortium|David Peereboom, MD|216-445-6068|peerebd@ccf.org|
21303014|NCT01509053|Otsuka Pharmaceutical Development & Commercialization, Inc.|Medical Affairs|800-562-3974||
21303015|NCT02992197|The University of Vermont College of Medicine|Benjamin Lee|8026567748|blee7@uvm.edu|
21303016|NCT03192358|University Health Network|Director, Swallowing Rehabilitation Research Laboratory|416 597 3422|tri-swallowinglab@uhn.ca|7802
21303017|NCT01915303|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21303018|NCT00637780|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21303019|NCT02509117|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21303020|NCT00832624|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21303021|NCT00568386|Alcon Research|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21303022|NCT00548184|Baylor College of Medicine|Dr. Mothaffar Rimawi|713-798-1311|rimawi@bcm.edu|
21303023|NCT05396599|Johnson & Johnson Surgical Vision|Luis Vargas, MD|714-247-8200|LVarga17@ITS.JNJ.com|
21303024|NCT00280748|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
21303025|NCT01433250|Novartis Pharmaceuticals|Study Director|862-778-8300||
21303026|NCT03148691|Aclaris Therapeutics|Executive Director, Clinical Operations|4843247933|jschnyder@aclaristx.com|
21303027|NCT03467685|UPMC Dermatology|Dr. Rashek Kazi|5167105208|kazir@upmc.edu|
21303028|NCT02252744|Western University of Health Sciences|Jasmine Wong Yumori OD FAAO|(909) 706-3886|jyumori@westernu.edu|
21303029|NCT01876329|Keesler Medical Center|Matthew B. Carroll, MD|228-376-3629|matthew.carroll.1@us.af.mil|
21303030|NCT00321646|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-8313|mary_taplin@dfci.harvard.edu|
21303031|NCT03208985|HRA Pharma|Christine VENARD|+33184139244|c.venard@hra-pharma.com|
21303032|NCT00684541|SDSU|Professor Nader Amir|6192293744|namir@mail.sdsu.edu|
21303033|NCT00392379|Mayo Clinic|Jon O. Ebbert, MD|507-266-1944|nicotineresearch@mayo.edu|
21303034|NCT02184624|GlaxoSmithKline|GSK Response Center|866-435-7343||
21303035|NCT01700387|Clinvest/A Division of Banyan Group Inc.|Dr. Roger Cady|417-883-7889|rcady@banyangroupinc.com|
21303036|NCT03417713|Hamilton General Hospital|Dr. Theodore Rapanos|905-521-2100|rapanost@mcmaster.ca|44652
21303037|NCT01295879|Brigham and Women's Hospital|David E. Leaf, M.D., Renal Fellow|617-732-5951|DELEAF@partners.org|
21303038|NCT00934843|Medical University of South Carolina|Dr. Eric Graham|843-792-8704|grahamem@musc.edu|
21303039|NCT00428584|EMD Serono, Inc.|Fernando Dangond, MD|781-681-2348|fernando.dangond@emdserono.com|
21303040|NCT03259620|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
21303041|NCT00985829|skin research center|Zohreh Tehranchi-nia, assist. prof|+989121029415|zohreh_tehranchi@yahoo.com|
21303042|NCT01059929|University of Chicago|John Kress|773-702-6790|jkress@medicine.bsd.uchicago.edu|
21303043|NCT01375075|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21303044|NCT01576159|Middle East Technical University|Ozgur Celik PhD.|+903122104016|ozgur@udel.edu|3663
21288173|NCT00947544|Hyperion Therapeutics|Craig James-Associate Director, Clinical Operations|650-745-7840|craig.james@hyperiontx.com|
21288174|NCT00300053|Caladrius Biosciences|William Sietsema|9495352391|bsietsema@caladrius.com|
21288175|NCT02566005|Mount Sinai Health Systems|Dr. Zainab Al-Ibraheemi||Zainab.Al-ibraheemi@mountsinai.org|
21288176|NCT02594111|VA NY Harbor Healthcare System|Dr. Binita Shah|212-686-7500|binita.shah@va.gov|
21288177|NCT01294514|Covidien|Ulf Borg, Director of Clinical Affairs|303 305 2400|ulf.borg@covidien.com|
21288178|NCT01963611|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21288179|NCT00867932|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.||ClinicalTrials@Alexion.com|
21288180|NCT01126424|Astellas Pharma Europe Ltd.|Associate Medical Director Urology||clinicaltrials@us.astellas.com|
21288181|NCT02127671|Johns Hopkins University School of Medicine|Gail Daumit, MD, MHS|410-614-6460|gdaumit@jhmi.edu|
21288182|NCT02394275|St. Joseph's Healthcare Hamilton, ON|Dr. Marek Smieja|905 521 6021|smiejam@mcmaster.ca|
21288183|NCT00248560|Barbara Ann Karmanos Cancer Institute|Ammar Sukari, M.D.|313-576-8751|sukaria@karmanos.org|
21288184|NCT00782067|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21288185|NCT02328105|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
21288186|NCT00614393|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21288187|NCT03813654|Brigham and Women's Hospital|Jeanne F. Duffy, Principal Investigator|617-732-7995|jduffy@bwh.harvard.edu|
21288188|NCT00984867|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
21275038|NCT00858780|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21275039|NCT01964950|Takeda Pharmaceutical Company Limited|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21275040|NCT03499873|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
21275041|NCT01149057|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
21275042|NCT01297504|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21275043|NCT03602339|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21275044|NCT00834405|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21275045|NCT04025021|MetroHealth Medical Center|Stephanie Merlino Barr|216-778-3269|SMERLINO@METROHEALTH.ORG|
21275046|NCT02047305|Medtronic MITG-RGI|Senior Director of Clinical Affairs|303-581-7064|Tumordirectedtherapiesclinical@Medtronic.com|
21275047|NCT01986647|University of Pittsburgh|Jennifer S. Brach, PhD, PT|412-383-6533|jbrach@pitt.edu|
21275048|NCT00868998|Columbia University|Robert Fine|212-305-1168|rlf20@columbia.edu|
21275049|NCT01483820|NMTRC|Giselle Sholler, MD|6162670335|giselle.sholler@helendevoschildrens.org|
21275050|NCT00838162|Jan-Cil UK|VP Head of Discovery & Early Development|44 1494 553458|ksimmen1@its.jnj.com|
21275051|NCT01507662|University of Iowa|Dr. Fredric Wolinsky|(319) 384-3821|fredric-wolinsky@uiowa.edu|
21275052|NCT04541173|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
21275053|NCT03985657|Johns Hopkins University|Mudiaga Sowho|4105506264|msowho1@jhmi.edu|
21275054|NCT01790685|Johns Hopkins|Dr. Peter A. Campochiaro|410-955-5106|pcampo@jhmi.edu|
21275055|NCT03541252|Bispebjerg Hospital|Dr. Emily Wenande, MD, PhD|+4540505590|emily.cathrine.wenande@regionh.dk|
21275056|NCT03349632|Alcon, A Novartis Division|Senior Clinical Project Lead, GCRA - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21275057|NCT01960296|Icahn School of Medicine at Mount Sinai|Dr. Celia M. Divino|212-241-5499|celia.divino@mountsinai.org|
21275058|NCT02003391|Alcon Research, Ltd.|Global Brand Leader, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
21288189|NCT00626639|Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com|
21288190|NCT01461551|Ruijin Hospital|Dr. Lijie Jia|13916667704|litery0301@163.com|
21288191|NCT01155141|Stanford University|Dr. Richard Lafayette|650-498-6063|czar@stanford.edu|
21288192|NCT00303186|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21288193|NCT02020941|IndianaU|Dr. Attaya Suvannasankha|317-944-0920|asuvanna@iu.edu|
21288194|NCT01114555|Memorial Sloan Kettering Cancer Center|Dr. Shakeel Modak, MD|212-639-7623|modaks@mskcc.org|
21288195|NCT02469857|Atox Bio, Ltd.|Wayne M Dankner, MD, Chief Medical Officer|1-919-219-6377|wayned@atoxbio.com|
21288196|NCT00937950|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21288197|NCT02210195|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
21288198|NCT01531153|Yale University|Dr. Mehmet Sofuoglu, Professor of Psychiatry; Director of VA New England Mental Illness Research, Ed|(203) 937-4809|mehmet.sofuoglu@yale.edu|
21288199|NCT03483103|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|855-907-3286|Clinical.Trials@bms.com|
21288200|NCT00435942|Bolton Medical, Inc.|Annie Weiller|954-838-9699|AWeiller@boltonmedical.com|
21288201|NCT02378181|Public Health Management Corporation|Adam C. Brooks, Ph.D.|215-399-0636|abrooks@tri.phmc.org|
21288202|NCT03988647|Stanford University|Susan J Knox, Associate Professor of Radiation Oncology|650-725-2720|sknox@stanford.edu|
21288203|NCT01898130|Northwestern University|Priya Kumthekar, MD|312-503-1818|p-kumthekar@northwestern.edu|
21288204|NCT04491994|Pak Emirates Military Hospital (PEMH) Rawalpindi|Sultan Mehmood Kamran|+923008501100|sultanmajoka79@hotmail.com|
21288205|NCT03282097|Indiana University School of Medicine; Indiana University Center for Aging Research; Regenstrief Institute, Inc.|Nicole R. Fowler, PhD, MHSA; Associate Professor of Medicine|317-274-9021|fowlern@iu.edu|
21288206|NCT03197129|Hadassah School of Dental Medicine, P.O.Box 12272|Dr. Avia Fux-Noy|+972-2-6776135|fuxavia@gmail.com|
21288207|NCT05233761|Defined Research Institute|Paul Muchowski|415-413-8666|paul.muchowski@definedresearch.org|
21288208|NCT01285518|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21275059|NCT00858403|H. Lee Moffitt Cancer Center and Research Institute|Eric Haura, M.D., via Moffitt Cancer Center|813-745-6827|eric.haura@moffitt.org|
21275060|NCT00243347|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
21275061|NCT02264977|W.L. Gore & Associates|Jennifer Gorman|928-863-8483|jgorman@wlgore.com|
21275062|NCT03573544|OBI Pharma, Inc.|Dr. Wayne Saville, Chief Medical Officer|619-537-7821|waynesaville@obipharmausa.com|
21275063|NCT04364191|University of Pennsylvania|Miranda McPhillips|215-898-8281|mvarr@nursing.upenn.edu|
21275064|NCT03846193|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21275065|NCT04693429|Laboratorios Sophia|Alejandra Sanchez-Ríos M.D.|:+52 (33) 3001 4200|alejandra.sanchez@sophia.com.mx|
21275066|NCT00412464|Children's Hospital Los Angeles|Guy Young|323-361-5507|gyoung@chla.usc.edu|
21275067|NCT01730846|Yale School of Medicine|Sherry McKee, PhD|203-737-3529|sherry.mckee@yale.edu|
21275068|NCT01891357|on behalf of Westdeutsche Studiengruppe GmbH|Anja Braschoss, Consultant Clinical Research and Medical Writing|0049-176-82119153|anja.braschoss@wsg-online.com|
21275069|NCT03733145|Atrium Health Wake Forest Baptist|Rohesh J. Fernando, MD|336.716.2712|rfernan@wakehealth.edu|
21275070|NCT00527098|University of Miami|Kenneth Proctor, PhD|305-243-4694|kproctor@med.miami.edu|
21275071|NCT02583048|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
21275072|NCT02155257|Wake Forest University Health Sciences|Dr. James Eisenach|3367164182|eisenach@wakehealth.edu|
21275073|NCT00516295|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21275074|NCT01851876|Karadeniz Technical University, School of Medicine, Dept Obs and Gyn.|Dr. Suleyman Guven, Director of clinical trial|+904623775869|drsuleymanguven@yahoo.com|
21275075|NCT02132910|DVCIPM|Chester Buckenmaier|301-816-4710|cbuckenmaier@dvcipm.org|
21275076|NCT01911429|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
21275077|NCT03540160|Menlo Therapeutics, Inc.|Iain Stuart, PhD|1-800-775-7936|Iain.Stuart@foamix.com|
21275078|NCT02837913|Cedars-Sinai Medical Center|Dr. Mark Zakowski|310-423-5841|mark.zakowski@cshs.org|
21275079|NCT06078501|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
21275080|NCT03599362|NYU Langone Health|Fraustina Hsu|6467547124|Fraustina.Hsu@nyulangone.org|
21275081|NCT01923740|Abbott Vascular|Siok Hwee Tan|+1 408-845-3581|siokhwee.tan@abbott.com|
21275082|NCT03707587|National Cancer Institute|Dr. Scott Norberg|301-275-9668|scott.norberg@nih.gov|
21275083|NCT00834444|Manager, Biopharmaceutics|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21275084|NCT05143047|Vanderbilt University Medical Center|Alison Carroll, MD, MPH|615-875-5025|alison.carroll@vumc.org|
21275085|NCT03158727|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
21275086|NCT02412852|TheraVasc Inc.|Tony Giordano|3183493851|tgiordano@theravasc.com|
21275087|NCT00472212|The Ohio State University College of Optometry|Marjean Kulp|614-688-3336|kulp.6@osu.edu|
21275088|NCT01447511|University of Minnesota|Dr. Richard Brundage|612-624-3115|brund001@umn.edu|
21275089|NCT02336074|Imperial College London|Professor Sarah Fidler|004420331|s.fidler@imperial.ac.uk|26790
21275090|NCT00114504|Kurume University|Hisashi Kai|+81-942-31-7562|naikai@med.kurume-u.ac.jp|
21275091|NCT00958724|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
21275092|NCT01026402|AstraZeneca|Bryony Harrop|01625 582828|ClinicalTrialTransparency@astrazeneca.com|
21275093|NCT05604014|Mt. Hope Family Center, University of Rochester|Christie L. M. Petrenko, Ph.D.|5852752991|christie_petrenko@urmc.rochester.edu|241
21275094|NCT00836758|University of Florida|Richard B. Berry, MD|352-262-1575|sleep_doc@msn.com|
21275095|NCT03616379|McLean Hospital|Dr. R. Kathryn McHugh|617-855-2000|kmchugh@mclean.harvard.edu|
21275096|NCT02121184|Northwestern University|Paul Fitzgerald|312 695 1064|p-fitzgerald2@northwestern.edu|
21275097|NCT00979147|Minneapolis VAMC|Terence Gioe M.D.|612-467-1780|tjgioe@gmail.com|
21275098|NCT02674711|Brooke Army Medical Center|Dr Dan Rhon|210-916-3303|daniel.i.rhon.ctr@mail.mil|
21275099|NCT03272685|University of Minnesota|Dorothy Hatsukami|612-626-2121|hatsu001@umn.edu|
21275100|NCT02054715|University of Rochester Medical Center|Gary R. Morrow, PhD, MS; Deans Professor of Oncology|585-275-9961|Gary_Morrow@urmc.rochester.edu|
21275101|NCT02463981|UESTC|Prof. Keith Kendrick|+86028-61830811|k.kendrick.uestc@gmail.com|
21275102|NCT01438060|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21275103|NCT00840281|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21275104|NCT00076622|University of Pennsylvania|Joel Streim||Joel.Streim@uphs.upenn.edu|
21275105|NCT01190865|Smith & Nephew|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
21275106|NCT00326872|Mayo Clinic|Dr. Dusica Babovic-Vuksanovic||dbabovic@mayo.edu|
21275107|NCT03867838|Stanford University|Cole Simpson|4049077708|cole.simpson@stanford.edu|
21275108|NCT00574847|Duke University Medical Center|Wei Jiang, MD|919-668-0762|jiang001@mc.duke.edu|
21275109|NCT00881751|Medical University of South Carolina|Kate Anderton, MPH, CCRP|anderton@musc.edu|anderton@musc.edu|
21275110|NCT00957021|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@Stryker.com|
21288209|NCT02373865|GWT-TUD GmbH, Study center Prof. Hanefeld|Prof. Dr. Markolf Hanefeld|+49 351 44005|Markolf.Hanefeld@gwtonline.de|82
21288210|NCT00879658|Novartis Pharmaceuticals|Study Director||Novartis.email@novartis.com|
21288211|NCT01052948|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21288212|NCT00639509|Memorial Sloan-Kettering Cancer Center|Ghassan K. Abou-Alfa, MD|646-888-4184|abou-alg@mskcc.org|
21288213|NCT01394276|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21288214|NCT01933594|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21288215|NCT03836066|Fundación GECP|Eva Pereira|+34 934302006|gecp@gecp.org|
21288216|NCT04770779|Agios Pharmaceuticals, Inc.|Agios Medical Affairs|833-228-8474|medinfo@agios.com|
21275111|NCT00932477|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21288217|NCT02799602|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
21275112|NCT01807026|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21275113|NCT01087502|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21275114|NCT01653704|The Ottawa Hospital|Dr. Sylvain Boet|6137985555|sboet@toh.on.ca|14775
21275115|NCT02705716|GlaxoSmithKline|GSK Response Center|866-435-7343||
21275116|NCT00562718|UT Southwestern Medical Center|ann spangler|(214) 648-3111|ResearchRegistry@utsouthwestern.edu|
21275117|NCT01151618|Philips Respironics|Bob Romano, Biomedical Engineer|724-387-7781|bob.romano@philips.com|
21275118|NCT02227238|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21275119|NCT01608906|University of Colorado Denver|Director, Clinical Research Administration|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
21275120|NCT03966911|Medtronic Diabetes|Robin Mottackel|8185764886|robin.e.mottackel@medtronic.com|
21275121|NCT00985751|GlaxoSmithKline|GSK Response Center|866-435-7343||
21275122|NCT01663896|St. Jude Medical|Sr. Manager, Global Clinical Affairs|651-756-5585|mwagner2@sjm.com|
21275123|NCT01780350|University of Texas Health Science Center San Antonio|David Wampler, PhD|210.567.7598|wamplerd@uthscsa.edu|
21275124|NCT02701101|Bruin Biometrics|Vignesh Iyer|3102689494|viyer@bruinbiometrics.com|
21275125|NCT00474188|Celgene Corporation|Robert Kinght, M.D.|908-673-9749|rknight@celgene.com|
21288218|NCT06006208|Thomas Jefferson University|Associate Professor|3059784358|moritayoshihisa2016@gmail.com|
21288219|NCT05430204|The University of Texas Health Science Center at Houston|Michal Fishel Bartal, MD|713-500-6421|Michal.F.Bartal@uth.tmc.edu|
21288220|NCT02251821|Fred Hutchinson Cancer Center|Rachel Salit|206-667-1317|rsalit@fredhutch.org|
21288221|NCT03133676|Calibr, a Division of Scripps Research|Study Director|(858) 242 1000|KA34ph1@scripps.edu|
21288222|NCT01925417|Rebiotix|Sarah Mische PhD, Associate Director of Clinical Research|6512122839|smische@rebiotix.com|
21288223|NCT04084015|Massachusetts General Hospital|Dr. David D'Alessandro|617-726-8841|DADALESSANDRO@MGH.HARVARD.EDU|
21288224|NCT02696798|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21288225|NCT04091451|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21288226|NCT00055237|National Cancer Institute, National Institutes of Health|Robert Yarchoan, M.D.|301-496-0328|Robert.Yarchoan@nih.gov|
21288227|NCT04601506|University of Minnesota|Ezra Golberstein|612-626-2572|egolber@umn.edu|
21288228|NCT03345004|Diamyd Medical AB|Director of Clinical Development|+46 (0) 8 661 00 26|clinicaltrials@diamyd.com|
21288229|NCT01104285|Maimonides Medical Center|Yizhak Kupfer MD|718-283-8380|ykupfer@maimonidesmed.org|
21288230|NCT01013753|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21288231|NCT00835926|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21260360|NCT00758784|Bausch Health|Study Director||susan.harris@bauschhealth.com|
21260361|NCT00885365|Chiesi Farmaceutici S.p.A.|Chiesi Clinical Trials||clinicaltrials_info@chiesi.com|
21260362|NCT01824979|Fisher and Paykel Healthcare|Clinical Research Scientist|+ 64 09 574 0100|CPAPtrial@fphcare.co.nz|
21260363|NCT00004054|NRG Oncology|Wendy Seiferheld||wseiferheld@nrgoncology.org|
21260364|NCT01365156|UT MD Anderson Cancer Center|Michael Frumovitz,Professor, Gyn Onc & Reproductive Med|(713) 792-9599|mfrumovitz@mdanderson.org|
21260365|NCT02198833|Baylor College of Medcine|Rabih Darouiche, MD|713-794-8858|rabihd@bcm.edu|
21260366|NCT04552470|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21260367|NCT00620061|Sucampo Pharma Americas, LLC|VP, Clinical Development|301-961-3400|info@sucampo.com|
21260368|NCT01193686|VA Puget Sound Health Care System|Rhonda Williams, Ph.D.|206-277-6290|Rhonda.Williams1@va.gov|
21260369|NCT05003115|Vanderbilt University Medical Center|Dr. Ebele Umeukeje|615-322-3221|ebele.m.umeukeje@vumc.org|
21260370|NCT03757039|Alcon Research, LLC|Sr. CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21260371|NCT04373460|Johns Hopkins University Bloomberg School of Public Health|David J. Sullivan|410-502-2522|dsulliv7@jh.edu|
21260372|NCT00454207|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21260373|NCT01672957|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21260374|NCT00151892|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21260375|NCT02901431|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21260376|NCT03440944|Boston University School of Medicine|Joseph Pare, MD|6174144925|Joseph.pare@bmc.org|
21260377|NCT04672083|Navigen, Inc.|Alan L. Mueller, VP Research|801-243-9703|amueller@nvgn.com|
21260378|NCT01551745|Gradalis, Inc.|Director of Clinical Trials|2144428124|info@gradalisinc.com|
21260379|NCT01661790|China PLA General Hospital|Dr. Nan Du|86-13911599657|dunan05@aliyun.com|
21260380|NCT02764541|Dana-Farber Cancer Institute|Otto Metzger|6176323800|otto_metzger@dfci.harvard.edu|
21260381|NCT02536248|Laval university|Dr. Patrick Couture MD, PhD, FRCP|418-654-2106|patrick.couture@crchul.ulaval.ca|
21260382|NCT02048904|University of Missouri|Principal Investigator|573-882-2273 lastrag@healt|lastrag@health.missouri.edu|
21260383|NCT00749190|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21260384|NCT04336397|Alaska Native Tribal Health Consortium|Dr. Diana Redwood|907-729-3959|dredwood@anthc.org|
21260385|NCT02330419|Department of Community Health Systems, University of California at San Francisco|Glenn-Milo Santos, Associate Professor|(628) 2177-6231|glenn-milo.santos@ucsf.edu|
21275126|NCT02818894|Emory University|Thomas L. Bradbury, MD|404-759-3912|tombradburymd@gmail.com|
21275127|NCT05412121|University of Michigan|Anne Murphy|734-936-5566|aemurph@med.umich.edu|
21275128|NCT04476277|National Heart, Lung, and Blood Institute (NHLBI)|Mathew Hsieh, M.D.|301.402.7687|matthewhs@nhlbi.nih.gov|
21275129|NCT01962298|Antwerp University Hospital|Dr Tom Schepens|003238213265|tom.schepens@uza.be|
21275130|NCT01576705|Institut Jérôme Lejeune|Dr Clotilde Mircher|00 33 1 56 58 63 00|clotilde.mircher@institutlejeune.org|
21275131|NCT03727139|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21275132|NCT00566722|Abbott|Global Medical Services|800-633-9110||
21275133|NCT03961204|Merck Healthcare KGaA, Darmstadt, Germany|Communication Center|+49 6151-72-5200|service@emdgroup.com|
21275134|NCT02218216|GE Healthcare|Chief Medical Officer - Head Health Initiative|262-544-3633|Victor.Miranda@ge.com|
21275135|NCT03111381|Yale Urology|Jamil Syed|2037852815|Jamil.syed@yale.edu|
21260386|NCT04370509|University of California, San Francisco|Dr. David Oh, MD, PhD|(415) 476-1000|david.oh@ucsf.edu|
21275136|NCT00787124|Duke University Medical Center|Brian Smith|9196688951|brian.smith@duke.edu|
21275137|NCT05740098|University of Vermont|Stephen T. Higgins, PhD., P.I.|802-656-9615|stephen.higgins@uvm.edu|
21275138|NCT01131260|The George Washington University Biostatistics Center|Rebecca Clifton, Ph.D.|301-881-9260|rclifton@bsc.gwu.edu|
21275139|NCT03544216|Marshall B. Ketchum University (The Ohio State University during study data collection)|Erin Rueff, OD, PhD|7654145644|em.rueff@gmail.com|
21275140|NCT01222234|University of Kansas Medical Center|Dr. Jason Stubbs|913-588-9252|jstubbs@kumc.edu|
21275141|NCT01968031|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
21275142|NCT04573309|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
21275143|NCT00605150|Carolinas Healthcare System|David Iannitti, MD|704-446-4838|jessica.drummond@carolinashealthcare.org|
21275144|NCT01487499|University of Florida|Michael A. Jantz, MD|352-273-8737|michael.jantz@medicine.ufl.edu|
21275145|NCT01691430|Yale University|Dr. Manisha Juthani-Mehta|(203)785-4140|manisha.juthani@yale.edu|
21275146|NCT01894230|Duke University|Dr. Deepak Voora|919-668-1755|Deepak.vorra@duke.edu|
21275147|NCT02756949|World Bank|Ms Marelize Gorgens|0012024730547|mgorgens@worldbank.org|
21275148|NCT02219009|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21275149|NCT00660387|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21275150|NCT02259348|St. Jude Children's Research Hospital|Brandon M. Triplett, MD|901-595-2766|brandon.triplett@stjude.org|
21275151|NCT01622660|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org|
21275152|NCT04211766|Fred Hutchinson Cancer Center|Dr. Johanna Lampe|(206) 667-6580|JLampe@fredhutch.org|
21275153|NCT00642993|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21275154|NCT04661202|National Cheng Kung University|Dr. Kuan-Yin Lin|06-2353535|10802003@gs.ncku.edu.tw|6737
21275155|NCT02725515|Xencor, Inc.|Vice President, Biometrics|858-480-3414|bburington@xencor.com|
21275156|NCT02297230|New York University School of Medicine|Sylvia Formenti|646.962.4073|lao2003@med.cornell.edu|
21275157|NCT00183196|Medical University of South Carolina|Raymond F. Anton, MD|843-792-1226|antonr@musc.edu|
21275158|NCT01944722|Becton, Dickinson and Company|Clinical Study Manager|410-316-4000|BDClinicalTrials@bd.com|
21275159|NCT01310855|UCL and CTC Cancer Trials Centre|Mark Phillips|0207 679 9139|ctc.doric@ucl.ac.uk|
21260387|NCT04743856|University of Pittsburgh|Bonny Rockette-Wagner|4126240188|bjr26@pitt.edu|
21260388|NCT04696861|Duke University School of Nursing|Brandon Knettel|1 919 660 1218|brandon.knettel@duke.edu|
21260389|NCT04439188|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21260390|NCT01813890|Janssen Research & Development, L.L.C.|Mila Etropolski, Clinical Leader|609-730-4537|MEtropol@its.jnj.com|
21260391|NCT04482647|UT MD Anderson Cancer Center|Santhosshi Narayanan, MD-Assistant Professor, Integrative Medicine Program|(346) 228-6676|snarayanan2@mdanderson.org|
21260392|NCT03952559|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
21260393|NCT02875223|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21260394|NCT01997463|University of Arizona|Clara Ehrman|520-621-5439|csehrman@email.arizona.edu|
21260395|NCT01827384|National Cancer Institute|Dr. Alice P. Chen|240-781-3274|chenali@mail.nih.gov|
21260396|NCT01110252|Labcel|João Tadeu Ribeiro Paes|55 18 3302 5800|labcel.tronco@gmail.com|5856
21275160|NCT01085539|Covidien|Fran Haury, RRT Research Coordinator|303 305-2314|fran.haury@covidien.com|
21275161|NCT02906917|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21275162|NCT00687739|University of Colorado Anschutz Medical Campus|Wendy M Kohrt, PhD|3037241913|wendy.kohrt@ucdenver.edu|
21275163|NCT02542462|Cincinnati Childrens Hospital Medical Center|Nancy Back RN MPH|513-636-2479|Nancy.Back@cchmc.org|
21275164|NCT02312154|Konkuk University|Yang Won Lee|8220305172|20130112@kuh.ac.kr|
21275165|NCT01167829|University of Washington, Dept. of Medicine|John Amory, MD|(206) 616-1727|jamory@u.washington.edu|
21275166|NCT03358147|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|1-877-240-9479|information.center@astrazeneca.com|
21275167|NCT02072096|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21275168|NCT01634139|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21275169|NCT01044537|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21275170|NCT01007994|Northwell|Christine Sethna|7184703423|csethna@northwell.edu|
21275171|NCT01694563|Atricure Inc.|Nfii K. Ndikintum, PhD, MBA / VP, Clinical Affairs and Biometrics|513-644-8192|NNdikintum@atricure.com|
21275172|NCT04567329|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
21275173|NCT02933060|Cooper University Health System|Dr. Christopher Jones|856-342-2627|jones-christopher@cooperhealth.edu|
21275174|NCT01945580|Boston Scientific|Director, Clinical Operations|952-930-6000|teresa.takle-flach@bsci.com|
21275175|NCT04411680|Partner Therapeutics, Inc.|Medical Information|1-888-479-5385|PartnerTx@medcomminc.com|
21275176|NCT05034874|InterveXion Therapeutics, LLC|Chief Operating Officer|501-554-2377|intervexion@gmail.com|
21275177|NCT02426918|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
21275178|NCT01496118|Sarah Cannon Development Innovations, LLC|Dr. Jesus Berdeja|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
21275179|NCT00495222|Ethicon Endo-Surgery|Susan Knippenberg|513 337-3452|sknippen@its.jnj.com|
21275180|NCT04608448|UT Health San Antonio|Ellen Kraig, PhD|210-567-3818|kraig@uthscsa.edu|
21275181|NCT04431518|Indiana University School of Medicine|Samir K. Gupta|3172747926|sgupta1@iu.edu|
21275182|NCT04060251|Brigham Health|Dr. Wolfgang Fitz|617-732-9501|wfitz@bwh.harvard.edu|
21275183|NCT00487435|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
21275184|NCT01155531|Theracos, Inc|Monica Tettamanti, MSc|617-643-5696|mtettamanti@ccib.mgh.harvard.edu|
21275185|NCT03486938|agenebio|Richard Mohs|317-997-3241|richard.mohs@agenebio.com|
21275186|NCT00999687|Chang Gung Memorial Hospital|Lin Yin-Ku MD.Ph.D.|886-2-24313131|lin1266@adm.cgmh.org.tw|2127
21275187|NCT03614728|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21275188|NCT01533038|NeoTract|Director of Clinical Affairs|925-401-0641|ehergenreter@neotract.com|
21288232|NCT00671060|Gynuity Health Projects|Hillary Bracken|2124481230|hbracken@gynuity.org|
21288233|NCT01541748|Coloplast|Cathy Bartz|612-834-3127|uscmba@coloplast.com|
21288234|NCT00267670|Northwestern University|Mary E. Rinella, MD|312-503-4592|m-rinella@northwestern.edu|
21288235|NCT00785629|Denver Nephrologists, P.C.|Geoffrey A. Block, MD|303-364-4775|gablock@denverneph.net|
21288236|NCT02107898|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21288237|NCT01283386|Hoffmann-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21288238|NCT04727749|University of Saskatchewan|Dr. Colleen Dell|306-966-5912|Colleen.Dell@usask.ca|
21288239|NCT03823131|University of California, San Francisco|Dr Chase Heaton, MD|(415) 502-1889|Chase.Heaton@ucsf.edu|
21288240|NCT01953237|University of Maryland, Baltimore|Julie Kreyenbuhl|410-637-1864|jkreyenb@som.umaryland.edu|
21288241|NCT03331562|Translational Genomics Research Institute (TGen) An Affiliate of City of Hope|Derek Cridebring, PhD. Director, Molecular Medicine Division|6023438629|dcridebring@tgen.org|
21288242|NCT03718000|University of Georgia|Dr. Jamie Cooper, Associate Professor|706-542-4903|jamie.cooper@uga.edu|
21288243|NCT02234180|Memorial Sloan-Kettering Cancer Center|Yelena Y. Janjigian MD|646-888-4186|janjigiy@mskcc.org|
21288244|NCT02475213|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
21288245|NCT01186770|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
21288246|NCT00505921|UT MD Anderson Cancer Center|Issa F. Khouri, MD / Associate Professor|713-792-8848|pmcadams@mdanderson.org|
21288247|NCT02567188|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21288248|NCT01033136|Michael E. DeBakey VA Medical Center|Dr. Ellen Teng|(713) 578-5513|Ellen.Teng@va.gov|
21288249|NCT00630292|University of North Carolina|William Irvin, Jr. MD / Co-Principal Investigator|919-966-6735|william_irvin@med.unc.edu|
21288250|NCT05383209|EyePoint Pharmaceuticals, Inc.|Ramiro Ribeiro, MD, PhD|908-440-0979|rribeiro@eyepointpharma.com|
21288251|NCT02411643|Northwestern University|Stephanie Rangel|3125035942|stephanie.rangel@northwestern.edu|
21288252|NCT00717886|Memorial Sloan Kettering Cancer Center|Dr. Leslie Montgomery|(212) 639-5386|Montgoml@mskcc.org|
21288253|NCT00716417|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21288254|NCT01553851|Washington University School of Medicine|Dr. Douglas Atkins|314-747-8475|datkins@dom.wustl.edu|
21288255|NCT02101294|Finger Relief|Molly Choate Summers|703-517-8951|summers.molly@gmail.com|
21288256|NCT00797563|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
21288257|NCT03416179|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21288258|NCT00688597|Patient Advocacy|Amicus Therapeutics|+1-609-662-2000|clinicaltrials@amicusrx.com|
21288259|NCT02709369|Wake Forest School of Medicine|Dr. Charles H. Tegeler|+1 (336) 716-7651|ctegeler@wakehealth.edu|
21288260|NCT01732211|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21288261|NCT02755090|University of New Mexico|Sharla Biefeld Research Coordinator|505-272-9703|hsc-familyplanningresearch@salud.unm.edu|
21288262|NCT00207740|Centocor Research & Development, Inc.|Director Clinical Research|1-800-457-6399||
21303045|NCT00311584|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21303046|NCT01454778|Sanford Health|Dr. Patrick Kelly|605-312-7300|Patrick.Kelly@SanfordHealth.org|
21303047|NCT00178503|University of Texas Medical School at Houston|Deborah A. Pearson, Ph.D.|713-486-2588|Deborah.A.Pearson@uth.tmc.edu|
21303048|NCT03616223|Frequency Therapeutics|Carl LeBel, PhD, CDO|781-315-4600|clinicaltrialsinformation@frequencytx.com|
21288263|NCT04797169|Icahn School of Medicine at Mount Sinai|Thomas B Hildebrandt, Psy.D.|(212) 659-8673|tom.hildebrandt@mssm.edu|
21288264|NCT03916926|Case Western Reserve University|Suchitra Nelson|216-368-3469|suchitra.nelson@case.edu|
21303049|NCT01475071|Galderma|Cyril Moulin|+33 4 92 38 30 14|cyril.moulin@galderma.com|
21303050|NCT02278471|UT southwestern|Dr. Thomas J Wang|6159361717|thomas.wang@UTsouthwestern.edu|
21303051|NCT01408329|Stanford University|Anne L Friedlander|650-725-7531|afriedlanderCW@gmail.com|
21275189|NCT00842309|Massachusetts General Hospital|Dr. Hilary Weingarden|617-643-6206|hilary_weingarden@mgh.harvard.edu|
21275190|NCT03105297|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21275191|NCT01390948|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21303052|NCT01437995|Johns Hopkins University|Alexis Rea|4432878496|area5@jhu.edu|
21303053|NCT04618770|Stryker|Kevin Barga|2018315073|kevin.barga@stryker.com|
21303054|NCT04456673|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
21303055|NCT04391049|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21303056|NCT03874429|Laboratoires Thea|Corentin Le Camus|0680382020|corentin.lecamus@theapharma.com|+33
21303057|NCT03337490|Mayne Pharma LLC|Associate Director, Clinical Operations|9195737948|phoevos.hughes@maynepharma.com|
21303058|NCT01689532|Janssen Pharmaceutical K.K.|Senior Manager||ClinicalTrialDisclosure@its.jnj.com|
21303059|NCT01363349|BioLineRx LTD|Dr. Arnon Aharon|972-2-548-9100|arnona@biolinerx.com|135
21303060|NCT01958489|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21303061|NCT00917644|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21303062|NCT01101308|Purdue Pharma L.P.|Stephen Harris, MD|203-588-7592|Stephen.Harris@Pharma.com|
21303063|NCT02280122|JWGUniversity|Prof. Dr. Peter Eickholz|+49696301|eickholz@med.uni-frankfurt.de|5642
21303064|NCT03271983|University of Maryland, Baltimore|Dr. Audra Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
21303065|NCT02282345|UT MD Anderson Cancer Center|Dr. Jennifer Litton,VP, Clinical Research, VP Clinical Research|(713) 792-2817|jlitton@mdanderson.org|
21303066|NCT00711516|Cephalon, Inc.|Sponsor's Medical Expert, Clinical Research|1-800-896-5855||
21303067|NCT04575597|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21303068|NCT02921061|Fred Hutchinson Cancer Research Center|Roland B. Walter|1-206-667-3599|rwalter@fredhutch.org|
21303069|NCT01280201|Group for Neuroendocrine Tumors (GETNE)|Dr. Enrique Grande (Hospital Universitario Ramón y Cajal)|931780742|getne@getne.org|201
21303070|NCT02095132|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21303071|NCT01029405|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21303072|NCT00409175|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21303073|NCT00430183|Memorial Sloan-Kettering Cancer Center|James A. Eastham, MD|646-422-4390|easthamj@mskcc.org|
21303074|NCT02596750|UC Davis Department of Dermatology|Raja Sivamani MD|916-703-5145|dermstudies@ucdavis.edu|
21303075|NCT02108262|CSLBehring|Trial Registration Coordinator|610-878-4000|clinicaltrials@cslbehring.com|
21303076|NCT01119937|Novartis Pharmaceuticals|Study Director|862-778-8300||
21303077|NCT03316911|University of Michigan|Michelle Munro-Kramer|734-904-4600|mlmunro@umich.edu|
21303078|NCT01270802|Indiana University School of Medicine|Dr. Samir K. Gupta, Principal Investigator|317-274-7926|sgupta1@iu.edu|
21303079|NCT01883856|University of Virginia|Peter A. Netland, MD, PhD|4349821086|pan9c@virginia.edu|
21303080|NCT02312882|Stanford University|Anthony E Oro, M.D., Ph.D.||oro@stanford.edu|
21303081|NCT01229462|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21303082|NCT01476202|GlaxoSmithKline|GSK Response Center|866-435-7343||
21303083|NCT00641316|University of Alabama at Birmingham|Nicolaas Geurs, DDS,MS|2059344506|ngeurs@uab.edu|
21303084|NCT05027971|Boston Scientific|Winnie Chen|952-930-6000|FlexivaPulseRegistry@bsci.com|
21303085|NCT02025556|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21303086|NCT00968032|pfm medical ag|Christof Schmeer|+49 6873 9011|christof.schmeer@pfmmedical.com|41
21303087|NCT00627445|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21303088|NCT00081861|U.T. M.D. Anderson Cancer Center|Barbara Pro, MD / Associate Professor||CR_Study_Registration@mdanderson.org|
21303089|NCT01238588|Brigham and Women's Hospital|Kambiz Zandi-Nejad|617-732-5500|kzandinejad@partners.org|34769
21275192|NCT05203146|University Hospitals of Geneva|Dr Johan N. Siebert|+41795534072|Johan.Siebert@hcuge.ch|
21275193|NCT01189747|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21275194|NCT03867760|University of Washington Bothell|Dr. Linda Eaton|4253523645|lineaton@uw.edu|
21303090|NCT01251536|UZ Leuven|Prof Dr Eric Van Cutsem|003216344218|eric.vancutsem@uzleuven.be|
21303091|NCT01764919|Biomed valley discoveries|Dr. Michelle Zhang, Executive Director|7815339412|mzhang@biomed-valley.com|
21303092|NCT00796991|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21303093|NCT02199717|Hospital for Sick Children|Vanessa Bouskill NP|4168135871|vanessa.bouskill@sickkids.ca|
21303094|NCT00834080|Alkermes, Inc.|Bernard L. Silverman, MD|781-609-6000|Bernard.Silverman@alkermes.com|
21303095|NCT03396952|University of California, San Francisco|Dr. Adil Daud, MD|(415) 353-7392|Adil.Daud@ucsf.edu|
21303096|NCT04345367|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21260397|NCT02921386|Clarus Therapeutics Inc.|Theodore Danoff, MD, PhD|847-562-4300|tdanoff@clarustherapeutics.com|
21303097|NCT00796523|University of Toledo|Jonna M. McRury, M.D.|419-389-1118|jmcrury@aol.com|
21260398|NCT03866200|The University of Texas Health Science Center at Houston|Karen Posey, PhD|713-500-5786|karen.posey@uth.tmc.edu|
21303098|NCT02431260|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21303099|NCT01522937|University of Michigan Comprehensive Cancer Center|Dr. Kyle Cuneo, M.D.|734-936-4300|kcuneo@umich.edu|
21303100|NCT00439738|Novartis Pharmaceuticals|Study Director|1-862-778-8300||
21260399|NCT04167345|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21260400|NCT04375761|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21260401|NCT03797001|Virginia Commonwealth University|Benjamin Van Tassell|8048284583|bvantassell@vcu.edu|
21260402|NCT05404776|University of Texas Medical Branch|Meagan Benson, DO|409-772-0982|meaganbenson88@gmail.com|
21260403|NCT04840836|Columbia University|Samantha Garbers, PhD, Principal Investigator|212-305-0123|svg2108@cumc.columbia.edu|
21260404|NCT03697564|University of California, San Diego|Dr. Hitendra Patel|(858) 822-5354|CancerCTO@health.ucsd.edu|
21260405|NCT05105243|Cerevance|Michelle Charles, Executive Director Regulatory Affairs|(408) 220-5722|Michelle.Charles@cerevance.com|
21260406|NCT00500266|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21260407|NCT01431287|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21260408|NCT01871506|Elyse Park|Associate Professor|617-724-6836|epark@mgh.harvard.edu|
21303101|NCT03774719|Washington University in Saint Louis|Gonzalo Matzumura|3143627211|g.matzumuraumemoto@wustl.edu|
21303102|NCT00400803|Masonic Cancer Center, University of Minnesota|Arkadiusz Dudek, M.D.|612-624-0123|dudek002@umn.edu|
21303103|NCT01227824|GlaxoSmithKline|GSK Response Center|866-435-7343||
21303104|NCT02576145|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21303105|NCT00781885|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director|301-608-9292||
21303106|NCT01755026|west virginia university|michael stitely|304-293-5631|mstitely@hsc.wvu.edu|
21303107|NCT00875589|Daroff-Dell'Osso Ocular Motility Laboratory|Jonathan Jacobs, PhD|216-791-3800|jxj24@case.edu|2947
21303108|NCT02730793|Virginia Commonwealth University|Bruce K. Rubin MEngr, MD, MBA, FRCPC|804 828 9604|bruce.rubin@vcuhealth.org|
21303109|NCT02365233|University of Texas Medical Branch|Nicola Abate, MD - Professor and Director of Endocrinology Division|409 772 1922|niabate@utmb.edu|
21303110|NCT00160667|Cares|UCB|+1844599|UCBCares@ucb.com|2273
21303111|NCT01779219|Wroclaw University Hospital, Department of Neurosurgery|Dr. Marcin Czyz|+48 734-34-00|mt.czyz@gmail.com|
21303112|NCT00995566|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21303113|NCT02390791|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
21303114|NCT01264601|University of Michigan|Matthew Greenhawt, MD, MBA|734/936-5634|mgreenha@umich.edu|
21303115|NCT00384111|Spectrum Pharmaceuticals, Inc, Research and Development Office 157 Technology Drive Irvine, CA 92618|Gajanan Bhat|949-743-9219|gajanan.bhat@sppirx.com|
21303116|NCT00575146|Dr. Senckenberg Institute of Neurooncology|Dr. Johannes Rieger|+49 69 6301|johannes.rieger@med.uni-frankfurt.de|87711
21303117|NCT01227629|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21303118|NCT00645450|Manchester VA Medical Center|Dr. Scott P. Orr|603-624-4366|scott.orr@va.gov|6565
21303119|NCT01588470|UT Health Science, San Antonio|Dr. Muhammad Abdul-Ghani, MD|210-567-6691|abdulghani@uthscsa.edu|
21303120|NCT03708393|Seno Medical|Shaan Schaeffer VP of Clinical Operations|610-698-3259|sschaeffer@senomedical.com|
21303121|NCT00833664|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21303122|NCT02055365|Icahn School of Medicine at Mount Sinai|Brad Rosenberg, MD, PhD||brad.rosenberg@mssm.edu|
21303123|NCT03050775|Mayo Clinic|Jean M. Guyer, DNP|507-255-5716|guyer.jean@mayo.edu|
21303124|NCT01258998|The University of Texas (UT) MD Anderson Cancer Center|Christopher R Flowers,Chair, Lymphoma-Myeloma|713- 745-6095|crflowers@mdanderson.org|
21303125|NCT03224598|Aclaris Therapeutics|Executive Director Clinical Operations|4843247933|jschnyder@aclaristx.com|
21303126|NCT02197455|Yale Univ School of Medicine|Brett King, MD|2037854092|brett.king@yale.edu|
21303127|NCT00830791|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|(800) 672-6372|ClinicalTrialsDisclosure@merck.com|
21303128|NCT00456807|GlaxoSmithKline|GSK Response Center|866-435-7343||
21303129|NCT01264081|National Cancer Institute|Dr. Udo Rudloff'|301-496-3098|rudloff@nih.gov|
21303130|NCT02716896|University of Texas Health San Antonio|Dharam Kaushik|210-567-5676|kaushik@uthscsa.edu|
21303131|NCT01631656|WakeForest University Health Sciences|Dr Amy McMichael|336-716-3775|amcmicha@wakehealth.edu|
21303132|NCT02641483|VAORD|Dennis Bourbeau|2167913800|dennis.bourbeau@va.gov|
21303133|NCT02484859|Recep Tayyip Erdoğan Üniversitesi|Dr. Başar Erdivanlı|04642130491|berdivanli@gmail.com|2128
21303134|NCT02054481|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21303135|NCT02320903|Evidence-Based Practice Institute|Linda Dimeff, PhD|206-455-7934|grants@ebpi.org|
21275195|NCT02589067|The Lundquist Institute at Harbor-UCLA|Dr. Loren G. Miller|310-222-3775|lmiller@lundquist.org|
21275196|NCT01401062|NYU Langone Medical Center|Nelly Huppert|212-731-5003|Nelly.Huppert@nyumc.org|
21288265|NCT05473039|SEID|Ana Gavilán|+34 630928812|agavilan@lab-seid.com|
21275197|NCT00755235|Group Health Research Institute|Gregory Simon, Principal Investigator|206-287-2979|simon.g@ghc.org|
21275198|NCT00438750|Orthopaedic Hand and Upper Extremity Service, Massachusetts General Hospital|David Ring, MD, PhD|617-724-3953|dring@partners.org|
21275199|NCT01165450|University of Maryland School of Medicine|Bennie H. Jeng, MD, MS|667-214-1111|bjeng@som.umaryland.edu|
21275200|NCT03684928|CooperVision,Inc.|Jose A. Vega, O.D., MSc., FAAO|925 621 3761|javega@coopervision.com|
21275201|NCT01018862|Meda Pharmaceuticals Inc|Sr.Director Medical Scientific Affairs|732 564 2200|David.ginsberg@meda.us|
21275202|NCT00840879|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21275203|NCT03086135|Radboud University Medical center, Nijmegen|Professor Emmanuel Mylanus|+31 24 361 49 34|Emmanuel.Mylanus@radboudumc.nl|
21303136|NCT02564432|Department of Veterans Affairs|James Peter Beck|801-231-6309|james.beck@hsc.utah.edu|
21303137|NCT03493815|The Pennsylvania State Univ College of Medicine, The Milton S. Hershey Medical Center|Stephanie Estes, M.D.|717-531-8478|sestes@pennstatehealth.psu.edu|
21303138|NCT02415842|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21303139|NCT00883688|The University of Texas (UT) MD Anderson Cancer Center|MD Anderson Multicenter coordinating for Collaborative Ependymoma Research Network Study (CERN)||CR_Study_Registration@mdanderson.org|
21303140|NCT03811093|Vidantis Technologies, Inc|Thomas A. Namynanik - Consultant to invisa-RED Technologies|404 915-5938|andyn997@vidantis.com|
21303141|NCT01095094|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|David Peereboom, MD|216-445-6068|peerebd@ccf.org|
21303142|NCT00464490|University of California San Francisco|Julin F. Tang, MD, MS|415-206-5274|tangj@anesthesia.ucsf.edu|
21303143|NCT02396160|University of Queensland|Dr Niikee Schoendorfer|0413122076|n.schoendorfer@uq.edu.au|
21303144|NCT03188042|NYU Langone Health|Joel Schuman, MD, FACS|929-455-5030|Joel.Schuman@nyu.edu|
21303145|NCT00925938|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21303146|NCT01634256|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Sang-Wook Kim, MD|82-63-276-8284|clickm@jbnu.ac.kr|
21303147|NCT00874614|Progenics Pharmaceuticals, Inc|Jessica D Jensen, MPH|646-975-2513|jjensen@progenics.com|
21303148|NCT00137839|Dana-Farber Cancer Institute|David Jackman, MD|617-632-6049|DJACKMAN@PARTNERS.ORG|
21303149|NCT02446743|GlaxoSmithKline|GSK Response Center|866-435-7343||
21303150|NCT03086967|Atrium Health|Dr. Susan Bliss|(704)562-4860|Susan.Bliss@atriumhealth.org|
21303151|NCT01556347|Tim Icenogle MD PLLC|Timothy B Icenogle MD|509-220-1900|timicenogle@comcast.net|
21303152|NCT01752036|SKCCC|Terrence Caldwell|443-287-1889|caldwte@jhmi.edu|
21303153|NCT02230527|Cleveland Clinic|Joseph Campbell, MD|216-444-9836|campbej10@ccf.org|
21303154|NCT01661088|University of Michigan Rogel Cancer Center|Mark Zalupski, M.D.|734-647-8902|zalupski@med.umich.edu|
21303155|NCT01205581|St. Jude Children's Research Hospital|Jon McCullers, MD|866-278-5833|info@stjude.org|
21303156|NCT00636220|Chembio Diagnostic Systems, Inc.|Javan Esfandiari|(631) 924-1135|jesfandiari@chembio.com|112
21303157|NCT04896229|Oregon Research Behavior Intervention Strategies, Inc. dba Influents Innovations|David Smith|541-484-2123|david.smith@influetnsin.com|
21303158|NCT00045942|Novartis|Study Director|862-778-8300||
21303159|NCT05508074|InFlectis Bioscience|Beatrice Lejeune|+33 668919060|beatricelejeune@inflectisbioscience.com|
21303160|NCT02395302|Tactile Medical|Clinical Research Manager|(612)355-5123|mbroich@tactilemedical.com|
21303161|NCT01806662|Rockefeller University|James Krueger|2123278333|gilleap@mail.rockefeller.edu|
21288266|NCT02337829|Acerta Pharma B.V.|Acerta Clinical Trials|1-888-292-9613|acertamc@dlss.com|
21288267|NCT04279483|University of Pennsylvania|Emily Falk|215-573-9901|emilybfalk@falklab.org|
21288268|NCT01998360|University of New England|Peter S. Millard, MD, PhD|2078663503|pmillard@mac.com|
21288269|NCT04613453|Yale University|Brooke Rivera|203-974-2241|Brooke.rivera@yale.edu|
21288270|NCT02084797|Oakland University|Tamara Hew-Butler|248-364-8686|hew@oakland.edu|
21288271|NCT02763566|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21288272|NCT00790036|Novartis Pharmaceuticals|Study Director|862-778-8300||
21288273|NCT02442349|AstraZeneca|Global Clinical Lead, Yuri Rukazenkov|+441625231825||
21288274|NCT01551173|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21288275|NCT04530344|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21288276|NCT01402700|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
21288277|NCT03507790|Cogntion Therapeutics Inc|Dr. Anthony Caggiano|914-221-6730|acaggiano@cogrx.com|
21288278|NCT03279952|Penn State College of Medicine|Raman Baweja, MD|7175318521|rbaweja@pennstatehealth.psu.edu|
21288279|NCT00157755|Medtronic Neuromodulation|Clinical Program Manager|763-526-8172|medtronicneurotrials@medtronic.com|
21288280|NCT01719653|Gastroenterology Services, Ltd|David Gerard, MD|630 969 1167|davidpgerard@comcast.net|
21288281|NCT00168298|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
21288282|NCT03869268|The University of Sheffield|Dr William Parker|01142266159|w.parker@sheffield.ac.uk|
21288283|NCT05457855|Brigham and Women's Hospital|Rishi J Desai, PhD|617-278-0932|rdesai@bwh.harvard.edu|
21288284|NCT03331341|University of Washington|Dr. Ryan Lynch, Associate Professor|206-606-1739|rclynch@uw.edu|
21288285|NCT05352399|Yale School of Medicine|Cameron Gettel|717-228-7759|cameron.gettel@yale.edu|
21288286|NCT02657551|Dana-Farber Cancer Institute|Kartik Seghal|000-000-0000|Kartik_Sehgal@dfci.harvard.edu|
21303162|NCT00043550|Adelphi University, The Derner Institute of Advanced Psychological Studies|Jacques P.Barber, PhD, Dean and Professor|516.877.4807|jbarber@adelphi.edu|
21303163|NCT01479426|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Jong-Kwan Park, MD|82-63-276-8284|rain@chonbuk.ac.kr|
21303164|NCT02285062|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21303165|NCT01905423|Washington University in St Louis Medical School|Peter Fischer|+1 (314) 747-5198|pufischer@wustl.edu|
21303166|NCT00545129|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21303167|NCT00821509|National Institute for Health and Welfare|Tapani Hovi, Project Leader|+358 400 517299|tapani.hovi@thl.fi|
21303168|NCT03127098|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
21303169|NCT00807573|Memorial Sloan Kettering Cancer Center|Dr. Maria Pietanza, Assistant Attending|+1646-888-4203|PietanzM@mskcc.org|
21303170|NCT01551420|Providence VA Medical Center|Linda Resnik, Research Career Scientist|401-273-7100|Linda.Resnik@va.gov|2368
21303171|NCT00169442|GlaxoSmithKline|GSK Response Center|866-435-7343||
21303172|NCT01426789|Novartis Pharmaceuticals|Study Director|862-778-8300||
21303173|NCT04054947|White River Junction VA Medical Center|Dr. Brian Shiner|802-295-9363|brian.shiner@va.gov|6070
21303174|NCT00223236|The University of Texas Southwestern Medical Center|E. Sherwood Brown, M.D., Ph.D., Professor|214-645-6950|sherwood.brown@utsouthwestern.edu|
21303175|NCT04463069|Hong Kong Baptist University|Dr. Yang Gao|+852 3411 3082|gaoyang@hkbu.edu.hk|
21303176|NCT00620503|Repros Therapeutics Inc, an Allergan Affiliate|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
21303177|NCT03073733|jCyte, Inc.|Robert Beathard|9492430687|rob.beathard@jcyte.com|
21303178|NCT00835731|Planned Parenthood League of Massachusetts|Principal Investigator|6176161600||
21303179|NCT00348881|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21303180|NCT00129311|Yale Unviersity|Dr. Andrea Weinberger|203-974-7598|andrea.weinberger@yale.edu|
21303181|NCT03207035|Cork University Hospital|Dr Anil Ranganath||drmrak.2@gmail.com|
21303182|NCT00881868|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
21303183|NCT01981551|National Cancer Institute|Dr. Geraldine H O'Sullivan Coyne|240-781-3371|osullivancoyngh@nci.nih.gov|
21303184|NCT02880956|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21288287|NCT04058717|Penn State College of Medicine|Nicolle Krebs|7175315673|nkrebs@pennstatehealth.psu.edu|
21288288|NCT04356833|Royal Free London NHS Foundation Trust|Professor Pratima Chowdary|0207 794 0500|p.chowdary@nhs.net|35921
21288289|NCT04817410|Rutgers New Jersey Medical School|Ethan Cowan|917-447-4964|ethan.cowan@rutgers.edu|
21288290|NCT03595748|Albert Einstein College of Medicine|Dr. Ladan Golestaneh|718-920-5442|lgolesta@montefiore.org|
21288291|NCT04809974|Massachusetts General Hospital|Edmarie Guzmán-Vélez|6176436107|eguzman-velez@mgh.harvard.edu|
21288292|NCT03166709|Center for Suicide Prevention and Recovery, University of Washington|Dr. Katherine Anne Comtois|206-744-1752|uwcspar@uw.edu|
21288293|NCT04070703|Oregon Research Institute|Fuzhong Li|5414842123|fuzhongl@ori.org|
21288294|NCT00549055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21288295|NCT01080261|Boston Scientific Corporation|Ruth Starzyk, Ph.D.|508-683-6577|ruth.starzyk@bsci.com|
21288296|NCT02472405|University of Miami|Keyvan Nouri MD|305-243-3380|KNouri@med.miami.edu|
21288297|NCT01431976|GlaxoSmithKline|GSK Response Center|866-435-7343||
21288298|NCT03834168|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Dr. Pankaj Arora|2059754720|parora@uabmc.edu|
21288299|NCT01134042|GlaxoSmithKline|GSK Response Center|866-435-7343||
21288300|NCT00764517|Knight Cancer Institute, Oregon Health & Science University|Dr. Stephen E. Spurgeon MD|503-494-4606|spurgeos@ohsu.edu|
21288301|NCT00520468|The University of Texas M. D. Anderson Cancer Center|Gautam Borthakur, MBBS / Assistant Professor|713-792-7305|eharriso@mdanderson.org|
21288302|NCT00674297|Hospital for Special Surgery|Doruk Erkan, MD|212 774-2291|erkand@hss.edu|
21288303|NCT01433913|University of Arizona|Dr. Sherry Chow|520-626-3358|schow@azcc.arizona.edu|
21288304|NCT04706221|Zynex Monitoring Solutions|Donald Gregg|(800) 495-6670|dgregg@zynex.com|3802
21288305|NCT01091259|Perlmutter Cancer Center at NYU Lagone|Franco Muggia, MD|212-263-6485|Franco.Muggia@nyumc.org|
21288306|NCT00770367|Medical University of South Carolina|Dana King MD|843-792-8112|kingde@musc.edu|
21288307|NCT04115059|Dana-Farber Cancer Institute|Jorge Castillo|617-632-2681|jorgej_castillo@dfci.harvard.edu|
21288308|NCT03589703|Johns Hopkins University|Nada Lukkahatai, PhD, MSN, RN, CNE, FAAN|410-614-5297|nada.lukkahatai@jhu.edu|
21288309|NCT01088789|SKCCC Johns Hopkins Medical Institution|Daniel Laheru, MD|410-955-8974|Laherda@jhmi.edu|
21288310|NCT03517137|EORTC|Catherine Fortpied|+32 2 774 1681|catherine.fortpied@eortc.org|
21288311|NCT03575364|Inari Medical|Ashleigh Willson|925-330-3446|ashleigh.willson@inarimedical.com|
21288312|NCT01369433|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|857-400-0101|Clinical@aveooncology.com|
21288313|NCT01807455|Q-Med AB|Chief Medical Officer|+ 46 (0) 18 474 90 00|Reception.SEUPP@galderma.com|
21288314|NCT02321527|The University of Texas (UT) MD Anderson Cancer Center|Dr. Basak Dogan/Diagnostic Radiology|713-792-7734|CR_Study_Registration@mdanderson.org|
21288315|NCT02472353|Avera|Stacy Kehoe|605.322.3082|Stacy.Kehoe@avera.org|
21288316|NCT00149643|University of Pittsburgh|Jack R. Cornelius, M.D.|412-246-6906|corneliusjr@upmc.edu|
21288317|NCT02196831|Massachusetts General Hospital|Steven Grinspoon, MD|617-724-9109|sgrinspoon@mgh.harvard.edu|
21288318|NCT02313155|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21288319|NCT01654887|Icahn School of Medicine at Mount Sinai|Dr. James Tsung|212-241-6272|james.tsung@mountsinai.org|
21288320|NCT00475332|University of Florida|Bridget Fitzgerald, Clinical trials coordinator|(352) 265-0680|fitzgb@shands.ufl.edu|87829
21288321|NCT01101100|Valeant Pharmaceuticals International|Lindsey Mathew|908|lindsey.mathew@valeant.com|
21288322|NCT03822416|University of Minnesota|Harry Lando, PhD|612-624-1877|lando001@umn.edu|
21288323|NCT04666298|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21288324|NCT01532089|Duke University|Thomas E. Stinchcombe, M.D.|507/284-4565|thomas.stinchcombe@duke.edu|
21288325|NCT00844519|University of California San Francisco|Dr. Priscilla Hsue|415-206-8257|phsue@medsfgh.ucsf.edu|
21288326|NCT01341470|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21288327|NCT05850494|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21288328|NCT05653843|Boston Scientific|Andrea Burbage, Principal Clinical Trial Manager|7812544679|andrea.burbage@bsci.com|
21288329|NCT03188822|UR Medicine Otolaryngology|Research Program Manager|5852751186|paul_allen@urmc.rochester.edu|
21288330|NCT02340949|MFAR Clinical Research|Pau Doñate Macian|0034934344412|investigacion@mfar.net|
21288331|NCT00296517|GlaxoSmithKline|GSK Response Center|866-435-7343||
21288332|NCT03513952|Fred Hutchinson Cancer Center|Cancer Immunotherapy Trials Network Trial Manager|514-718-2858|citn@fredhutch.org|
21288333|NCT01093417|University Hospitals Case Medical Center|Grace McComsey, MD|2168443607|gam9@case.edu|
21275204|NCT00960154|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
21275205|NCT00757705|Janssen Research & Development|Medical Director|886 2 23762155||
21275206|NCT03544242|University of Alabama at Birmingham|Adam Sturdivant, MPH|205-934-4042|Adamsturdivant@uabmc.edu|
21275207|NCT02651987|Ipsen|Ipsen Medical Director|see email|clinical.trials@ipsen.com|
21275208|NCT04408924|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21275209|NCT00486434|Nordic Bioscience A/S|Bente Juel Riis, Medical Director|+4522901317|bjr@nordicbioscience.com|
21275210|NCT02218541|University of North Carolina at Chapel Hill|Gidgetta Jenkins|919-537-3968|gidget_jenkins@unc.edu|
21275211|NCT00856349|Medtronic Cardiac Rhythm Disease Management|Daniel Lexcen, Clinical Research Specialist|763-526-9702|daniel.lexcen@medtronic.com|
21275212|NCT02578641|Tessa Therapeutics|Khong-Bee Kang, Senior Manager Clinical Development|+65 6978 6594|kangkhongbee@tessacell.com|
21275213|NCT01981044|Allergan Medical|Marcio Torre, M.D., M.A., Medical Monitor|805-683-6761|torre_marcio@allergan.com|
21275214|NCT02694536|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21275215|NCT05485662|UT Health San Antonio|Bennett Amaechi, BDS, MD, PhD|210 567 3185|amaechi@uthscsa.edu|
21275216|NCT01439620|Massachusetts General Hospital|Gary Tearney, MD|Optical Frequency Domain Imagi|gtearney@partners.org|
21275217|NCT00726830|University of Texas MD Anderson Cancer Center|Michael J. Fisch, MPH/Clinical Professor, General Oncology|(713) 563-9905|mfisch@mdanderson.org|
21275218|NCT03056144|The Hong Kong Polytechnic University|Dr Tamis W Pin|85227666751|tamis.pin@polyu.edu.hk|
21275219|NCT01168856|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21275220|NCT01266902|Janssen Research & Development, LLC|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21275221|NCT02484807|Centre for pulmonary hypertension of the Thoraxclinic at the University Hospital Heidelberg|Professor Dr. med. Ekkehard Grünig|+4962213968053|ekkehard.gruenig@med.uni-heidelberg.de|
21275222|NCT05562011|Wake Forest University School of Medicine|Timothy Harwood, M.D.|336.716.8830|tharwood@wakehealth.edu|
21275223|NCT00387153|Myriad Therapeutics, Inc.|Richard Wenstrup, MD, VP Chief Medical Officer|801-584-3009|rwenstru@myriad.com|
21275224|NCT03068780|Amryt Research Limited|Janet Boylan|+3531518|Janet.boylan@amrytpharma.com|0200
21275225|NCT04540094|University of Edinburgh|Prof Alasdair Gray|0131 242 1340|alasdair.gray@ed.ac.uk|
21275226|NCT01867658|C.R. Bard Inc.|Dawn Heimer|401-825-8681|Dawn.Heimer@crbard.com|
21275227|NCT03101358|US Biotest, Inc.|Gere diZerega, MD|805.595.1300|gere.dizerega@usbiotest.com|
21275228|NCT00474058|UCB|UCB Clinical Trial Call Center|+1877 822 9493||
21275229|NCT02640235|Baxter Healthcare Corporation|Clinical Trials Disclosure Group|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
21275230|NCT02045108|The Mind Research Network|Dr. Eric Claus|505-272-5028|eclaus@mrn.org|
21275231|NCT00841659|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21275232|NCT03810703|University of Chicago|Dave Arndt|7737023560|dewitlab@yoda.bsd.uchicago.edu|
21238561|NCT00855595|Intendis GmbH|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21275233|NCT00654186|Oncology Specialists, SC|Sigrun Hallmeyer, MD|847-268-8200|shallmeyer@oncmed.net|
21238562|NCT01780935|Novartis Pharmaceuticals|Study Director|862-778-8300||
21288334|NCT01143324|MedtronicSpineECA|Christel Van Dam|+31433566523|christel.van.dam@medtronic.com|
21288335|NCT00596635|Yale University School of Medicine|Manisha Juthani-Mehta, MD|(203)785-4140|manisha.juthanimehta@yale.edu|
21288336|NCT01484340|Johns Hopkins University School of Medicine|Dr. Jonathan E. Golub|443-287-2969|jgolub@jhmi.edu|
21260409|NCT00278629|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
21260410|NCT02863263|Mundipharma Singapore Holding Pte. Limited|Valerie Anne Leck|+65 6511 1165|info.rma@mundipharma.com.sg|
21260411|NCT05224258|Medtronic Diabetes|Thomas Troub, Sr Clinical Research Program Manager|8052089091|thomas.troub@medtronic.com|
21260412|NCT01499173|University of Michigan, Neurology|Dr. Lesli Skolarus|734-936-9075|lerusche@umich.edu|
21288337|NCT02630030|Emory University|Dr. Jeffrey Olson|404-778-5770|jolson@emory.edu|
21288338|NCT01010763|Zimmer Biomet G.K.|Manager of Clinical Affairs|+81-3-6402-6610|takahito.nakai@zimmerbiomet.com|
21288339|NCT01850641|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
21288340|NCT00141817|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21288341|NCT00846365|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21288342|NCT05203185|NYU Langone Health|Safiya Richardson, MD, MPH|212-263-8313|Safiya.Richardson@nyulangone.org|
21288343|NCT04376567|University of Arizona|Tze-Woei Tan|3234426835|tze-woei.tan@med.usc.edu; ttan@arizona.edu|
21288344|NCT02072200|Mundipharma Korea Ltd|Kim Bu Yeon|+82 2 568 5689|BuYeon.Kim@mundipharma.co.kr|
21288345|NCT03261193|UPMC|Nicholas Schott, MD|412-692-4503|schottnj@upmc.edu|
21288346|NCT01277861|University of Texas Southwestern Medical Center at Dallas|Girish P. Joshi, MD|214-590-7259|girish.joshi@utsouthwestern.edu|
21288347|NCT05032196|Wave Life Sciences USA, Inc|Medical Director, MD|+1 617-949-2900|info@wavelifesci.com|
21288348|NCT00857389|UT MD Anderson Cancer Center|Kris M Mahadeo, Associate Professor, Pediatrics - Patient Care|(713) 792-2873|kmmahadeo@mdanderson.org|
21288349|NCT05260008|Allay Therapeutics, Inc|Study Director|669-679-5081|clinicaltrialsinfo@allaytx.com|
21288350|NCT03308669|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21288351|NCT00001305|National Institute of Child Health and Human Development|Marini, Joan|+1 301 594 3418|marinij@mail.nih.gov|
21288352|NCT04584788|Masimo Corporation|Cristina Johnson|(949) 297-7576|clinicalresearchdept@masimo.com|
21288353|NCT00505635|UT MD Anderson Cancer Center|Nicholas E. Papadopoulos, MD / Professor|713-792-2921|CR_Study_Registration@mdanderson.org|
21288354|NCT04284774|Children's Oncology Group|Results Reporting Coordinator|6264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21288355|NCT01240746|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21288356|NCT01733953|University of Minnesota|Cameron Naughton|612-625-3623|naug0009@umn.edu|
21288357|NCT01137786|Bracco Diagnostics Inc.|Maria Luigia Storto, M.D.|609-514-2262|MariaLuigia.Storto@diag.bracco.com|
21288358|NCT01869374|New York State Psychiatric Institute|Stefan Rowny, MD|(646) 774-5417|stefan.rowny@nyspi.columbia.edu|
21288359|NCT01303419|GE Healthcare|Jean-Paul Antonini|+33 130709703|Jean-Paul.antonini@ge.com|
21288360|NCT01995201|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21288361|NCT03329001|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21288362|NCT00622518|University of Washington|James A. Taylor, MD|206-616-1206|uncjat@u.washington.edu|
21288363|NCT01138046|GlaxoSmithKline|GSK Response Center|866-435-7343||
21288364|NCT02178956|Sumitomo Dainippon Pharma Oncology|Marilyn Fontaine|617-674-8556|mfontaine@bostonbiomedical.com|
21288365|NCT03769493|Brown University|Ethan Moitra, Ph.D.|4014441949|ethan_moitra@brown.edu|
21288366|NCT03149770|University of Minnesota|Anjali Kumar|612-301-7040|studydiabetes@umn.edu|
21288367|NCT00963235|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21288368|NCT00585182|University of Utah|Dr Robert Pendleton|801 581 7818|robert.pendleton@hsc.utah.edu|
21288369|NCT04057235|Integrity Implants Inc|Lauren Kamer, Senior Director of Regulatory and Clinical Affairs|+1.561.529.3861|lkamer@integrityimplants.com|
21288370|NCT01136915|Bracco Diagnostics, Inc.|Maria Luigia Storto, M.D.|609-514-2262|MariaLuigia.Storto@diag.bracco.com|
21288371|NCT03225482|VA San Diego Healthcare System|Elizabeth Twamley, PhD|858-642-3848|Elizabeth.Twamley@va.gov|
21288372|NCT01234116|Henry Ford Health Sytem|Indira Brar, MD|313-916-2565|ibrar1@hfhs.org|
21288373|NCT03965923|Fred Hutchinson Cancer Center|Daniel Szydlo|2066677451|dszydlo@fredhutch.org|
21288374|NCT02452190|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21288375|NCT04635345|Barts Health NHS Trust|Jessica Gaddie|020 7480 4737|j.gaddie1@nhs.net|
21288376|NCT00743093|Denver Heatlh Rocky Mountain Poison and Drug Center|Jody Green, PhD|303-389-1246|jody.green@rmpdc.org|
21288377|NCT02327078|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21288378|NCT02226159|OrthoCarolina Research Institute|Susan Odum|7049457710|susan.odum@orthocarolina.com|
21288379|NCT01138735|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
21288380|NCT06001866|Purdue University|Dr. Patricia Deevy, Research Associate|765-496-1821|deevy@purdue.edu|
21260413|NCT03804671|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21260414|NCT02935738|Barz IVF Center for Embryo Research and Infertility Treatment|Dr. Saeeda A. Muhsen-Alanssari|9798201303|barzivfcenter@gmail.com|
21260415|NCT00469508|UCLA Center for Behavioral and Addiction Medicine|Steven Shoptaw PhD|310 794 0619|sshoptaw@mednet.ucla.edu|225
21260416|NCT03615222|CTX VA|Suzannah Creech|254-654-7241|suzannah.creech@va.gov|
21260417|NCT01552057|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21260418|NCT04572633|HistoSonics, Inc.|Vice President of Clinical Affairs|(877) 740-0543|clinicaltrials@histosonics.com|
21260419|NCT03480802|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21303185|NCT02081859|Cleveland Clinic|Lynn Borzi (Research Administrator)|216-445-3158|BORZIL@ccf.org|
21303186|NCT00336583|Asan Medical Center|Cheolwon Suh|82 2 3010 3209|csuh@amc.seoul.kr|
21303187|NCT03603509|Mayo Clinic|Richard Kennedy, PhD|507-284-0708|Kennedy.Rick@mayo.edu|
21303188|NCT02248558|UNC Project-China|Weiming Tang|+86-15920567132|weimingtangscience@gmail.com|
21303189|NCT01143389|Cornea Research Foundation of America|Marianne Price, PhD|317-814-2990|mprice@cornea.org|
21303190|NCT04966910|University of Washington|Michael Pullmann|206-685-0408|pullmann@uw.edu|
21303191|NCT00636701|Atlanta VA Medical Center|Dr. Andrew Butler|404-413-1415|andrewbutler@gsu.edu|
21303192|NCT02446171|AstraZeneca AB|Ian Wogan|+1 301 398 0670|ClinicalTrialTransparency@astrazeneca.com|
21303193|NCT03328182|Hollister Incorporated|Director Global Clinical Affairs|8476802837|stacy.haddad@hollister.com|
21303194|NCT00504582|UT MD Anderson Cancer Center|Dr. Paul F Mansfield, Professor, Surgical Oncology|(713) 794-5499|pmansfie@mdanderson.org|
21303195|NCT02404532|Otsuka Pharmaceutical Development & Commercialization, Inc|Tim Peters-Strickland|800 562-3974||
21303196|NCT00773383|Hoffman-LaRoche|Medical Communications|800-821-8590||
21303197|NCT03386253|University of Minnesota|Michael Kotlyar|612-625-1160|kotly001@umn.edu|
21303198|NCT02984943|David Grant Medical Center, Travis Air Force Base|Dr. Michelle Sit|707-423-3875|michelle.t.sit.mil@mail.mil|
21303199|NCT02480712|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21303200|NCT02324543|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University|Dung Le, MD|443-287-0002|dle@jhmi.edu|
21303201|NCT01860846|AbbVie|Global Medical Services|800-633-9110||
21303202|NCT00466687|Vanderbilt-Ingram Cancer Center|Jeffrey Sosman, M.D.||jeff.sosman@vanderbilt.edu|
21303203|NCT04964193|Pharma Metric Labs, Indonesia|Pharma Metric Labs|+62 21 4265310|nabila.sutanto@pharmametriclabs.com|
21303204|NCT00853996|University of Kansas Mecical Center|Bruce F. Kimler Ph.D|913-588-4523|bkimler@kumc.edu|
21303205|NCT01944839|Ophthotech|Denise Teuber||denise.teuber@ophthotech.com|
21303206|NCT00171834|Novartis Pharmaceuticals|Study Director|862-778-8300||
21303207|NCT01037192|Fraser Health Authority|Anna Yuen, BSc. Pharm|604-520-4005|anna.yuen@fraserhealth.ca|
21303208|NCT01284491|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
21303209|NCT01978938|La Jolla Pharmaceutical Company|Chief Development Officer|617-715-3600|ljpcregulatory@ljpc.com|
21303210|NCT02694757|11 Health|Michael Seres|+16572660570|michael@11health.com|
21303211|NCT02650921|Galderma Research & Development, LLC|Assoc Director of Clinical Operations|817-961-5000|courtney.maguire@galderma.com|
21303212|NCT00783302|GE Healthcare|Paul Gordon, PhD|011-47-2318-5822|paul.gordon@ge.com|
21303213|NCT01087788|Cares|UCB|+1877 822||9493
21303214|NCT00200343|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21303215|NCT00300430|Abbott|Medical Information Specialist|800-633-9110||
21303216|NCT01917656|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21303217|NCT02015221|Tactile Medical|Director of Clinical Research|6123555121|shoy@tactilemedical.com|
21303218|NCT01306929|Prilenia|Prilenia|+972 775558|info@prilenia.com|482
21303219|NCT03709576|Penn State Cancer Institute|Michelle Stojanovic|7175310003|mstojanovic1@pennstatehealth.psu.edu|287412
21303220|NCT00270842|James A. Haley VA|Dr. Patricia A. Quigley|8135583912|patricia.quigley@va.gov|
21303221|NCT00368290|University of Pennsylvania|Dr. Kyle Kampman|215-222-3200|kampman@mail.med.upenn.edu|109
21303222|NCT01143701|Cincinnati Children's Hospital Medical Center|Jeff Epstein, Ph.D.|5136368296|jeff.epstein@cchmc.org|
21303223|NCT03041129|University of Colorado|Melanie Cree-Green, PI|720-777-5743|melanie.green@childrenscolorado.org|
21303224|NCT03608150|Luminopia, Inc.|VP of Clinical Development|9788067080|endri@luminopia.com|
21303225|NCT00510653|The University of Texas (UT) MD Anderson Cancer Center|David Gershenson, MD / Professor||CR_Study_Registration@mdanderson.org|
21303226|NCT04355728|University of Miami|Camillo Ricordi|305-243-6913|ricordi@miami.edu|
21303227|NCT00483756|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21303228|NCT00710762|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21303229|NCT00436501|UT MD Anderson Cancer Center, Office of Multicenter Clinical Research|Robert Coleman, MD / Professor||RColeman@mdanderson.org|
21303230|NCT00495040|UT MD Anderson Cancer Center|Chang,Joe Y.,M.D. / Radiation Oncology|713-563-2337|jychang@mdanderson.org|
21303231|NCT01390064|University of Arkansas for Medical Sciences|Dr. Laura Hutchins|5016868274|hutchinslauraf@uams.edu|
21303232|NCT04157673|University at Buffalo|Leonard H. Epstein, PhD|7168293400|lhenet@buffalo.edu|
21303233|NCT02452931|Tolmar, Inc.|Vice President of Clinical Development|970-212-4500|info@tolmar.com|
21303234|NCT03011892|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21288381|NCT04725188|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21288382|NCT00390013|University of Iowa|Colleen Kennedy Stockdale, MD, MS|319-384-6849|colleen-stockdale@uiowa.edu|
21288383|NCT04291131|VA Boston Healthcare System|Marilyn Moy, MD, MSc|857-203-6622|marilyn.moy@va.gov|
21288384|NCT04221490|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
21288385|NCT04325386|University of Maryland, Baltimore|Dr Deanna L. Kelly, PharmD, BCPP|410-402-6861|dlkelly@som.umaryland.edu|
21288386|NCT00722020|Winthrop University|Jon Roberts, MD|516-663-4600|jroberts@winthrop.org|
21303235|NCT02282293|UCSF|Dr. Grant Dorsey|415-206-4680|grant.dorsey@ucsf.edu|
21260420|NCT02557178|Mayo Clinic|Johanna Hoult|507-293-1989|hoult.johanna@mayo.edu|
21288387|NCT04537299|Mayo Clinic|Brandon Verdoorn, M.D.|507-266-6201|Verdoorn.Brandon@mayo.edu|
21303236|NCT00562315|Emory University|David M. Schuster, MD|404-712-4859|dschust@emory.edu|
21303237|NCT03381729|Novartis Gene Therapies EU Limited|EMEA Medical Information|+353 (1) 566-2364|medinfoemea.gtx@novartis.com|
21303238|NCT02000908|University of Minnesota|Peter Argenta MD|612-626-3111|argenta@umn.edu|
21303239|NCT00906971|Universidade Federal de Pernambuco|Carlos André Gomes Silva|+55 83 9913-4949|carlosandrejpa@hotmail.com|
21303240|NCT00878436|NYU Langone Medical Center|Fraustina Hsu|646 754 712|fraustina.hsu@nyumc.org|
21303241|NCT03678870|Vanderbilt University Medical Center|Sarah Osmundson, Assistant Professor of Obstetrics and Gynecology|(615) 343-7869‬|sarah.osmundson@vumc.org|
21303242|NCT03104816|USCalifornia|Eugenia Ayrian|8186363161|eayrian@med.usc.edu|
21275234|NCT05616728|Enanta Pharmaceuticals, Inc.|Justin Aubin|857-760-0591|jaubin@enanta.com|
21275235|NCT00690495|B.Braun Melsungen AG|Study manager|+49 5661 71|studies@bbraun.com|0
21275236|NCT01024855|Abbott Medical Optics, Inc.|Nick Tarantino, Head, Clinical Research and Development|714-247-8613|nicholas.tarantino@amo.abbott.com|
21275237|NCT01003938|NYU Cancer Institute|Franco Muggia, MD|212-263-6485|franco.muggia@nyumc.org|
21275238|NCT03306277|AveXis, Inc|US Medical Information|833-828-3947|medinfo@avexis.com|
21275239|NCT04224753|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
21275240|NCT03209505|University of Houston College of Optometry|Eric Ritchey, OD, PhD|713-743-1933|erritche@central.uh.edu|
21275241|NCT04306952|Northwestern University|Jennifer Mundt PhD|312-503-2846|jennifer.mundt@nm.org|
21275242|NCT00875524|Sanofi Pasteur SA|Medical Director||Contact-US@sanofi.com|
21275243|NCT00829452|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21275244|NCT01370863|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21275245|NCT03082586|Department of Radiation Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China|Dr tingfeng Chen|86-021-37798364|tingfeng138138@163.com|
21275246|NCT01296841|VA Palo Alto|Roy Soetikno|650-493-5000|soetikno@earthlink.net|64800
21275247|NCT02436200|Imperial College London|Professor Alun Davies, Professor of Vascular Surgery|+44 (0)20 3311 7309|a.h.davies@imperial.ac.uk|
21275248|NCT00746421|Emory University|Jeffrey Rakofsky, MD|404-712-5083|jrakofs@emory.edu|
21275249|NCT03053245|Indiana University|Babar Khan, MD, MS|(317) 274-9132|bakhan@iu.edu|
21275250|NCT01968551|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21275251|NCT00645853|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21275252|NCT00819169|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
21275253|NCT01822119|The HEARing CRC & Hearworks, Audiology Hearing and Speech Science, Melbourne, Australia|Professor Robert Cowan|+61 3 9035 5346|r.cowan@unimelb.edu.au|
21275254|NCT03031795|OhioHealth|John O. Elliott PhD, MPH Research Specialist Medical Education|614-566-3643|john.elliott@ohiohealth.com|
21275255|NCT01991548|Medtronic Diabetes|Clinical Research Manager|818-576-5000||
21275256|NCT03885934|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21275257|NCT00406393|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
21275258|NCT00380588|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21275259|NCT02096705|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
21275260|NCT02905435|PolyNovo Biomaterials Pty Ltd|Tim Barker, PhD|+61386814054|tim.b@polynovo.com|
21275261|NCT00595153|University of California, San Francisco|John V. Fahy, MD, MSc|4154769940|john.fahy@ucsf.edu|
21275262|NCT02377349|GlaxoSmithKline|GSK Response Center|866-435-7343|en736091@gsk.com|
21288388|NCT00392041|Princeton University|Lesley Allen, Ph.D.|609-924-9213|lesleyaallen@gmail.com|
21288389|NCT00314145|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21288390|NCT03314935|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21288391|NCT05252702|Abbott Medical Devices, Cardiac Rhythm Management|Nicole Harbert, Director of Clinical Research|972-526-4841|nicole.harbert@abbott.com|
21288392|NCT03834688|Dana-Farber Cancer Institute|Opeyemi Jegede, Statistician|(617) 582-7613|ojegede@ds.dfci.harvard.edu|
21288393|NCT01654276|University of Texas Southwestern Medical Center|Naim Maalouf. MD|214-648-2954|naim.maalouf@utsouthwestern.edu|
21260421|NCT04439266|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21260422|NCT02516657|Jacobs School of Medicine and Biomedical Sciences, Department of Pediatrics|Lucy D. Mastrandrea|716-323-0170|ldm@buffalo.edu|
21260423|NCT06161012|Johnson & Johnson Vision Care, Inc. (JJVC)|David Murakami, OD, MPH, FAAO|1-800-843-2020|dmuraka2@its.jnj.com|
21303243|NCT00729846|California Retina Consultants|Director of Research|8059631648|gabe@californiaretina.com|3034
21303244|NCT01894568|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21303245|NCT03720652|University of North Carolina at Chapel Hill|Philip D. Sloane, MD, MPH|+1 (919) 966-4439|philip_sloane@med.unc.edu|
21303246|NCT03068091|University of Missouri|Talissa Altes|573 882 1026|ALTEST@HEALTH.MISSOURI.EDU|
21303247|NCT01439815|Ora|Caitlin Pearson|978-685-8900|cpearson@oraclinical.com|
21303248|NCT03353740|University of California, San Francisco|Dr. Thomas Hope, MD|(415) 221-4810|thomas.hope@ucsf.edu|
21303249|NCT03976648|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
21303250|NCT01155167|UCSF|Andrew Boyle MD|4153533817|aboyle@medicne.ucsf.edu|
21303251|NCT01481129|Centre Léon Bérard (now CHLS)|Dr Hervé Ghesquieres|0426556824|herve.ghesquieres@chu-lyon.fr|
21303252|NCT02276027|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21303253|NCT01845103|CryoLife, Inc.|Scott Capps, MS/ Vice President, Clinical Research|800-438-8285|clinicaltrialregistration@cryolife.com|
21303254|NCT00003830|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org|
21303255|NCT03860935|Eidos Therapeutics, Inc., a BridgeBio Company|VP, Clinical Operations|415-887-1471|info@bridgebio.com|
21303256|NCT00266851|Wisconsin Resaerch & Education Network|Dr. David Hahn|608-234-3212|dlhahn@wisc.edu|
21303257|NCT01122394|VA New York Harbor Healthcare System|Jennifer Friedberg, Ph.D.|212-951-3314|jennifer.friedberg@va.gov|
21303258|NCT03739242|A. Menarini Industrie Farmaceutiche Riunite SrL|Dr Paolo Fabrizzi Clinical Operation Director|+39 055 5680459|pfabrizzi@menarini.it|
21303259|NCT00039871|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21303260|NCT03361176|Maryland Laser Skin and Vein|Robert A. Weiss, MD|4106662839|cmyers@mdlsv.com|
21303261|NCT02478398|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21303262|NCT02531971|University of Maryland, Baltimore|Dr. Audra Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
21303263|NCT02160002|Wayne State University|Seetha Shankaran|(313) 745-1436|sshankar@med.wayne.edu|
21303264|NCT00704522|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21303265|NCT04395001|Wake Forest School of Medicine|Dennis C. Ang|3367058701|dang@wakehealth.edu|
21303266|NCT04418661|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21303267|NCT03442868|Texas Woman's University|Hui-Ting Goh|2146897723|HGoh1@twu.edu|
21303268|NCT00992589|Janssen R&D US|PORTFOLIO/CDT LEADER|1 609 730-2548||
21303269|NCT02142387|Laboratory of Emergency Medical Services, Seoul National University Hospital Biomedical Research Institute|Dr. Gwan Jin Park|82-10-7477-3293|pkj83531@naver.com|
21303270|NCT00880464|Mass General Brigham|Beth Overmoyer|617 632 3800|Beth_Overmoyer@DFCI.HARVARD.EDU|
21303271|NCT01431209|University of Nebraska Medical Center|Dr. Julie M. Vose|402-559-3848|jmvose@unmc.edu|
21303272|NCT01895361|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21303273|NCT01887743|Children's Mercy Kansas City|Valentina Shakhnovich, MD|816-302-3068|vshakhnovich@cmh.edu|
21303274|NCT01209832|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21303275|NCT01268579|Memorial Sloan Kettering Cancer Center|Dr. David Pfister MD|646-888-4237|pfisterd@MSKCC.ORG|
21303276|NCT02692651|University of Michigan|Krishna Rao|734 615-9730|krirao@med.umich.edu|
21303277|NCT03490981|VA Center for Integrated Healthcare|Dr. Gregory P. Beehler, Associate Director of Research|716-862-7934|gregory.beehler@va.gov|
21303278|NCT05463198|Zynex Monitoring Solutions|ZMS Clinical|800-495-6670|clinical@zynexmonitoring.com|
21303279|NCT01856764|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21303280|NCT02239120|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21303281|NCT01535976|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu|
21303282|NCT00046891|Mayo Clinic|Debra L. Barton, R.N., Ph.D.|507-266-6247|barton.debra@mayo.edu|
21303283|NCT01982968|University of California, San Francisco|Harold Collard, MD|415 4761000|Harold.Collard@ucsf.edu|
21275263|NCT03504020|Medtronic CRM Clincial Research|CRM Clinical|800-328-2518|medtroniccrmtrials@medtronic.com|
21275264|NCT01395017|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21275265|NCT02235870|Obalon Therapeutics, Inc.|Amy VandenBerg, Vice-President, Clinical Affairs and Regulatory Affairs|760.795.6551|avandenberg@obalon.com|
21275266|NCT03366428|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21275267|NCT00804973|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21275268|NCT01046084|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21275269|NCT02166606|Boston Scientific|Dipl.-Ing. (FH) Jens Goetzke|+49171|jens.goetzke@bsci.com|5426813
21303284|NCT00420641|GlaxoSmithKline|GSK Response Center|866-435-7343||
21275270|NCT02083809|University of Hawaii|Dr.|8082036500|whrc@ucera.org|
21275271|NCT01958476|Tufts Medical Center Floating Hospital for Children|Jonathan M. Davis, MD|(617) 636-5322|jdavis@tuftsmedicalcenter.org|
21303285|NCT01653028|Memorial Sloan Kettering Cancer Center|Mark Andrew Dickson M.D.|6468884164|dicksonm@mskcc.org|
21275272|NCT02670551|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21275273|NCT01971645|Nationwide Children's Hospital|Giorgio Veneziano, MD|6147224200|Giorgio.Veneziano@nationwidechildrens.org|
21303286|NCT02586506|GlaxoSmithKline|GSK Response Center|866-435-7343||
21303287|NCT00181623|Massachusetts General Hospital|Corrine Welt, MD|617-716-8437|cwelt@partners.org|
21275274|NCT00714051|Edward Hines Jr., VA Hospital|Eileen Collins PhD, RN|708-202-3525|eileen.collins@va.gov|
21275275|NCT03868631|Point Loma Nazarene University|Dr. Heidi Lynch|619-806-3306|hlynch@pointloma.edu|
21303288|NCT01367080|Dong Wha Pharm. Co. Ltd.|Cheol-Hee Lim. Clinical Research Manager (CRM)|+82-2-2021-9300|cheolhee.lim@dong-wha.co.kr|551
21275276|NCT02286466|Massachusetts General Hospital Cancer Center|Joseph Greer, PhD|617-643-2143|jgreer2@mgh.harvard.edu|
21303289|NCT02815280|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
21275277|NCT00835081|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21303290|NCT00603642|Amgen Inc.|Study Director|866-572-6436||
21303291|NCT00654147|University of Miami School of Medicine|Director AIDS Clinical Research Unit|305-243-3838|mfischl@med.miami.edu|
21275278|NCT01675596|Edwards Lifesciences|Tenley Koepnick||tenley.koepnick@edwards.com|
21303292|NCT01230177|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21303293|NCT02538783|UPenn|Catherine Reale|215-746-4009|catherine.reale@uphs.upenn.edu|
21303294|NCT02514473|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21275279|NCT04236596|University of Michigan|Timothy Bruns|(734) 647-8727|bruns@umich.edu|
21275280|NCT05984290|Bausch & Lomb Incorporated|Director, Medical Affairs, Vision Care R&D|585-413-6397|marjorie.rah@bausch.com|
21275281|NCT03388008|Washington University in St. Louis|Ramsey Hachem, MD|(314) 454-7953|Rhachem@wustl.edu|
21275282|NCT01520987|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21275283|NCT02005562|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21303295|NCT02158364|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21303296|NCT01607203|AZ JAN PALFIJN|dr.Decleer Wim|+32 9 325 92 20|wim.decleer@janpalfijngent.be|092248851
21303297|NCT04381988|Memorial Sloan Kettering Cancer Center|Dr. Nancy Lee, MD|212-639-3341|leen2@MSKCC.ORG|
21275284|NCT02300987|Novartis Pharmaceuticals|Study Director|1-888-669-6682|novartis.email@novartis.com|
21303298|NCT00609362|University of Aarhus|Torben Harsløf, MD|+4589497681|torbhars@rm.dk|
21303299|NCT05093790|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21303300|NCT01624870|Medtronic Bakken Research Center|Maarten Hollander|+31620534428|maarten.hollander@medtronic.com|
21275285|NCT01023061|University of Washington|Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
21275286|NCT02966340|UW Madison|John J. Curtin|608-262-0387|jjcurtin@wisc.edu|
21275287|NCT00929981|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21275288|NCT02664415|MHRP|Biostatistician|3015003715|spinyakorns@hivresearch.org|
21275289|NCT02560051|The University of Texas Health Science Center at Houston|Marka Lyons, Research Manager|713-500-6919|Marka.Lyons@uth.tmc.edu|
21275290|NCT02034513|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21275291|NCT02308241|Memorial Sloan Kettering Cancer Center|Dr. David Pfister MD|646-888-4237|pfisterd@MSKCC.ORG|
21275292|NCT00659815|Bausch & Lomb Incorporated|Gerard Cairns|(585) 338-5170|gerard.cairns@bausch.com|
21275293|NCT02889393|University of Miami|Dr. D. Dante Yeh|3055851178|dxy154@med.miami.edu|
21275294|NCT04707846|Northwell Health|Joan Duer-Hefele, RN, MA|646-766-7153|jduerhefele@northwell.edu|
21275295|NCT01759251|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
21275296|NCT02998541|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21303301|NCT00827931|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21303302|NCT01453387|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21303303|NCT02312687|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
21238563|NCT00611858|Dana-Farber Cancer Institute|Jeffrey Meyerhardt, MD, MPH|617-632-6855|Jeffrey_Meyerhardt@dfci.harvard.edu|
21238564|NCT01844284|Abbott Vascular|Hajime Kusano|408-845-1626|hajime.kusano@av.abbott.com|+1
21238565|NCT01820559|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
21238566|NCT02755597|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21238567|NCT00166296|Hospital Universitari Germans Trias i Pujol, Autonomous University of Barcelona|Crisanto Diez-Quevedo|+34934978814|cdiezquevedo.germanstrias@gencat.cat|
21238568|NCT03351738|MedImmune, LLC|Richard George|+1-301-398-5681|information.center@astrazeneca.com|
21238569|NCT03997513|VA Pittsburgh Healthcare System|Dr. Jessica Bon Field|412-360-6823|jessica.field@va.gov|
21288394|NCT04478266|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21238570|NCT02597036|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21238571|NCT06351371|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21238572|NCT03759834|Mayo Clinic|Matthew Carlson, M.D., M.B.A.|507-284-8532|Carlson.Matthew@mayo.edu|
21238573|NCT02515279|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21238574|NCT01800968|Duke Clinical Research Institute|Adrian Hernandez, MD|919-668-7515|adrian.hernandez@duke.edu|
21238575|NCT02257099|UBMD Orthopaedics and Sports Medicine|John Marzo, MD|7168292982|jmmarzo@buffalo.edu|
21238576|NCT04987762|Purdue Pharma L.P.|Clinical Leader|1-800-745-7445|nelson.sessler@imbriumthera.com|
21238577|NCT03185481|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21238578|NCT02303184|Clearside Biomedical, Inc.|Thomas Ciulla, MD|(678) 392-2318|thomas.ciulla@clearsidebio.com|
21238579|NCT02620917|University of Padova|Daniela Bruttomesso|0039 049/8212183|daniela.bruttomesso@unipd.it|
21238580|NCT02044991|Loyola University|Colleen Fitzgerald, M.D., M.S.|708-216-2180|cfitzgerald@lumc.edu|
21238581|NCT00701038|The Ohio State Universtiy|Rami Khayat|614-247-7707|rami.khayat@osumc.edu|
21238582|NCT01398280|UCSD Dermatology Clinical Trials|UCSD Dermatology Clinical Trials Manager|(858)657-8390|dermstudies@ucsd.edu|
21238583|NCT00057551|Weill Cornell Medical College|James H. Kocsis, M.D.|212-746-5913|jhk2002@med.cornell.edu|
21238584|NCT03371940|Indiana University School of Medicine|Dr. Mary de Groot|317-278-1965|mdegroot@iu.edu|
21238585|NCT05099926|Columbia University Irving Medical Center|Dr. Andrea T. Duran|212-342-4491|atd2127@cumc.columbia.edu|
21275297|NCT01876992|Johns Hopkins University|Sally Radovick|7322359524|sradovick@jhmi.edu|7733073353
21275298|NCT01134549|Amgen, Inc|Study Director|866-572-6436||
21275299|NCT01513239|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21288395|NCT01192178|GlaxoSmithKline|GSK Response Center|866-435-7343||
21288396|NCT01579214|Massachusetts General Hospital|Dr. Mark Siedner|617-726-4686|msiedner@mgh.harvard.edu|917
21288397|NCT02164916|SWOG Statistics & Data Management Center|SWOG Statistician|206-667-4408|smcdonou@fredhutch.org|
21288398|NCT03229499|Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine|Dr. Steven M Kawut, MD, MS|646-352-1654|kawut@upenn.edu|
21288399|NCT00964782|Milton S. Hershey Medical Center|Compliance Specialist|7175310003|clinicaltrials.gov@pennstatehealth.psu.edu|287544
21288400|NCT01101178|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
21288401|NCT00127803|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21288402|NCT01643213|Boston Scientific|Clinical Research Information|855-213-9890|BSNClinicalTrials@bsci.com|
21288403|NCT00944554|Johns Hopkins University|Maxine Stitzer, PhD|410-550-0042|mstitze1@jhmi.edu|
21288404|NCT00858988|Washington University School of Medicine in St. Louis|Dr. Mark Manary|314 454-2178|manary@kids.wustl.edu|
21288405|NCT02525523|Atlantic Pharmaceuticals|Dr Chris Dunk, Director of Clinical Development|+44 1799 513391|chris.dunk@atlantichc.com|
21288406|NCT01020123|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21288407|NCT01349595|Mayo Clinic|Dr. Mark Stegall|507-266-2812|Stegall.Mark@mayo.edu|
21288408|NCT02587936|UT Southwestern Medical Center|Miguel A Vazquez|214-648-8884|Miguel.Vazquez@UTSouthwestern.edu|
21275300|NCT00396162|University of Michigan|Jeffrey E. Terrell|734 936 7633|terrelj@umich.edu|
21275301|NCT05293106|Weill Cornell Medicine|Marianne Nellis, MD|2127463056|man9026@med.cornell.edu|
21275302|NCT01741545|Bristol Myers Squibb|Bristol Myers Squibb Study Director|Please email|clinical.trials@bms.com|
21275303|NCT01456962|University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences|Peter Anderson, Pharm D|303-724-6128|peter.anderson@ucdenver.edu|
21275304|NCT03387462|Bridge HIV, San Francisco Department of Public Health|Dr. Susan Buchbinder|628-217-7479|susan.buchbinder@sfdph.org|
21275305|NCT01460628|Brigham & Women's Hospital|Dr. Hadine Joffe|617-732-4906|hjoffe@partners.org|
21275306|NCT03820258|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21275307|NCT04179396|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
21275308|NCT01664039|Alcon Research, Ltd|Global Brand Lead, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
21275309|NCT01853176|Emory University|Albert Losken MD|404-686-8143|alosken@emory.edu|
21275310|NCT01095887|Mayo Clinic|Dr. Mark D. Stegall|507-266-2812|stegall.mark@mayo.edu|
21275311|NCT00874822|University of Nebraska Medical Center|Jason Shiffermiller, MD, MPH|402-559-7299|jshiffermiller@unmc.edu|
21275312|NCT02854800|West Virginia University|Dr. Melissa Blank|304-293-8341|Melissa.Blank@mail.wvu.edu|
21275313|NCT04442503|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21275314|NCT03334734|Nearmedic Plus|Viсtoria Shcherbakova|+7 (495) 741 49 89|Viktoriya.Shcherbakova@nearmedic.ru|3869
21275315|NCT01322633|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21275316|NCT02974907|ReGenTree, LLC|Shinwook Kang|609-649-5505|swkang@regentreellc.com|
21275317|NCT01545193|NorthShore University HealthSystem|Glenn S. Murphy,MD|847-570-2760|dgmurphy2@yahoo.com|
21275318|NCT02420353|Hopsital For Special Surgery and University of Michigan|Dr. Christopher Mendias|212-249-2373|mendiasc@hss.edu|
21275319|NCT00503867|Sirtex Medical|Medical Director|011 61 2 9964 8470|dcade@sirtex.com|
21275320|NCT00577655|Teval Global Respiratory Research LLC|Teva Study Physician|215-293-6482||
21275321|NCT02016235|Mayo Clinic|John C. Lieske, M.D.|507-266-7960|Lieske.John@mayo.edu|
21275322|NCT01852799|Shanghai Changzheng Hospital|Jian Hou, PhD|86021-63610109-73221|houjian@medmail.com.cn|
21275323|NCT02761915|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
21303304|NCT04545944|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-PHAT (7428)|medicalinformation@phathompharma.com|
21303305|NCT00599131|University of Michigan Comprehensive Cancer Center|Dr. Francis Worden|734-936-0453|fworden@umich.edu|
21275324|NCT03276559|Weill Cornell Medicine|Hillary Winoker|646-962-7143|hiw4002@med.cornell.edu|
21275325|NCT02911909|University of Missouri|Ennio Rizzo|573-882-7615|eardvb@health.missouri.edu|
21275326|NCT01926119|Stanford University|Kevin Johnson, PhD RN|(650) 721-1988|johnsk@stanford.edu|
21275327|NCT02442687|Duke University|Dr. Manal F. Abdelmalek|919-684-8356|manal.abdelmalek@duke.edu|
21275328|NCT00009945|NSABP Foundation, Inc.|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org|
21275329|NCT02654145|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21275330|NCT00672984|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21275331|NCT00354835|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21275332|NCT00431041|Astellas Pharma Global Development|Astellas Medical Monitor||ClinicalTrials@us.astellas.com|
21275333|NCT02637141|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21275334|NCT05248399|The University of Texas Health Science Center at Houston|Maria E Fernandez Esquer, PhD|(713) 500-9657|Maria.E.Fernandez-Esquer@uth.tmc.edu|
21275335|NCT00379353|University of Texas M.D. Anderson Cancer Center|Dr. Eduardo Bruera, Professor|713-563-4157|ammarin@mdanderson.org|
21275336|NCT01377441|NYU School of Medicine|Lisa Doan, MD|212.263.5072|lisa.doan@nyumc.org|
21275337|NCT02943096|New York State Psychiatric Institute|Dr. Bret R. Rutherford|646-774-8660|brr8@cumc.columbia.edu|
21275338|NCT05065619|Medicago|Medical Director|+1 418-658-9393|clinicaltrialinquiries@medicago.com|
21303306|NCT01514370|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21275339|NCT00570128|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
21275340|NCT01139762|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21275341|NCT00874276|University of Florida|Dr. Peter Stacpoole/Principal Investigator|1-352-273-9023|pws@ufl.edu|
21275342|NCT00919113|Watson Laboratories, Inc.|Gary Hoel, RPh PhD, VP Global Brands Clinical Research|801 588-6641|gary.hoel@watson.com|
21275343|NCT02957331|UCHealth|Thomas J. Schroeppel, MD, MS|719 365 2422|thomas.schroeppel@uchealth.org|
21275344|NCT02588339|Moffitt Cancer Center|Lia E. Perez, MD|813-745-3665|Lia.Perez@moffitt.org|
21275345|NCT03922490|Hospital for Special Surgery|Jessica Rios|212-774-7321|riosj@hss.edu|
21303307|NCT01089361|Beth Israel Deaconess Medical Center|Dr. Daniel Talmor|617-754-2675|dtalmor@bidmc.harvard.edu|
21275346|NCT04590781|Xencor, Inc|Benjamin Thompson, MD, PhD|858-480-3133|bthompson@xencor.com|433
21275347|NCT04313296|Pen Bay Medical Center|Caroline Knight|207-301-8959|caroline.knight@mainehealth.org|
21303308|NCT01634191|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21275348|NCT01863186|USWM, LLC|Medical Affairs|1-888-900-8796|medinfo@usworldmeds.com|
21303309|NCT03645434|AstraZeneca AB|AstraZeneca AB|1-877-400-4656|clinicaltrialtransparency@astrazeneca.com|
21275349|NCT01120899|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov|
21275350|NCT00452348|GlaxoSmithKline|GSK Response Center|866-435-7343||
21303310|NCT02654717|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|6093759900|srinivassidgiddi@drreddys.com|
21275351|NCT01490190|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21275352|NCT03119662|GE Healthcare|Francois Tranquart, M.D., Ph.D.|00-44-1494-543037|francois.tranquart@ge.com|
21275353|NCT02817828|Estetra SPRL|Mithra Pharmaceuticals SA Pharma Department|+3243492822|clinical.trials@mithra.com|
21303311|NCT05486416|Haisco-USA Pharmaceuticals, Inc.|Yu-Ling Lai|858-263-4239|yuling.lai@haisco-usa.com|
21303312|NCT00960570|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21275354|NCT04956289|NS Pharma, Inc.|Medical Affairs|+1(201) 986-3860|trialinfo@nspharma.com|
21275355|NCT03123874|Cornell University|Sarah Reyes|208-921-4967|smr296@cornell.edu|
21275356|NCT01186458|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
21275357|NCT04281472|Argenx|Regulatory manager|Please email:|regulatory@argenx.com|
21275358|NCT05053360|Inova Health System|Jaimee Robinson, Labor and delivery Clinical Nurse Educator|7038586028|jaimee.robinson@inova.org|
21303313|NCT01451437|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21303314|NCT02076425|Early Emotional Development Program at Washington University School of Medicine|Dr. Joan Luby|3142862730|lubyj@wustl.edu|
21303315|NCT01252732|Melinta Therapeutics, Inc.|Karen Fusaro|6098270956|kfusaro@melinta.com|
21303316|NCT00156936|Alkermes, Inc.|Bernard L. Silverman / VP, Clinical Development|781-609-6000|bernard.silverman@alkermes.com|
21303317|NCT02491359|H. Lee Moffitt Cancer Center|Dr. Joseph Pidala|813-745-2556|joseph.pidala@moffitt.org|
21303318|NCT00853970|ISTA Pharmaceuticals, Inc.|Tim McNamara, Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com|
21303319|NCT05347147|Executive Director Invex Australia|Tom Duthy|+61 (08) 6382 0137|tduthy@invextherapeutics.com|
21303320|NCT01440543|Digestive Diseases Center, Vitkovice Hospital, Ostrava, Czech Republic|Premysl Falt MD|+420602689561|faltprem@centrum.cz|
21303321|NCT02013141|Cumberland Pharmaceuticals Inc|Clinical Scientist|615-255-0068|bgibson@cumberlandpharma.com|229
21303322|NCT02713256|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
21303323|NCT00923364|National Cancer Institute|Dr. Dennis Hickstein|301-594-1718|hicksted@mail.nih.gov|
21238586|NCT02362048|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
21260424|NCT00408005|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21260425|NCT05424276|ABLi Therapeutics|Milton Werner|9174940831|info@ablitherapeutics.com|
21260426|NCT05023252|Veterans Health Administration, Greater Los Angeles Veterans Healthcare Center|Alexander Young MD|310-478-3711|alexander.young@va.gov|
21260427|NCT04454489|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336 -713-5440|mporosnicu@wakehealth.edu|
21260428|NCT00501228|U.T. M.D. Anderson Cancer Center|Martin Korbling, MD / Professor|713-745-3219||
21260429|NCT01147926|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21260430|NCT03514914|University of California San Diego|Dr. Anita Raj|(858) 246-0066|anitaraj@health.ucsd.edu|
21260431|NCT03926143|Bayer AG|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
21303324|NCT04352127|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|Renew.J@mayo.edu|
21303325|NCT03023046|University of Washington|Ryan Cassaday, MD|2066061202|cassaday@seattlecca.org|
21303326|NCT00640835|Reckitt Benckiser Pharmaceuticals, Inc.|Rolley E. Johnson, PharmD, Vice President, Clinical, Scientific and Regulatory Affairs|804-379-1090|ed.johnson@reckittbenckiser.com|7089
21303327|NCT00775203|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
21303328|NCT01203644|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
21303329|NCT00635024|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
21303330|NCT00713310|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
21303331|NCT00779259|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21303332|NCT00686634|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu|
21303333|NCT00799773|New England Research Institutes, Inc.|Susan F. Assmann, PhD|617-923-7747|sassmann@neriscience.com|548
21303334|NCT03312751|Swedish Orphan Biovitrum AG|Radmila Kanceva, MD, Medicine Development Lead|+41 793048899|Radmila.Kanceva@sobi.com|
21303335|NCT00282464|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21303336|NCT00684047|Grifols Biologicals Inc.|Paul Pinciaro|443-375-8825|Paul.Pinciaro@grifols.com|
21303337|NCT00625703|University of Texas Southwestern Medical Center|Lus Stella Muniz, MD|214-648-3111|irb@utsouthwestern.edu|
21303338|NCT04098224|ART MEDICAL|Mrs. Shirly Steinlauf|972-54-5804242|Shirly@artmedical.com|
21303339|NCT02181517|Allergan, Inc|Clinical Trials Registry Team|1-800-347-4500|IR-CTRegistration@allergan.com|
21303340|NCT00787904|Emory University|Vin Tangpricha|404-727-7254|vin.tangpricha@emory.edu|
21303341|NCT02548728|University of North Carolina at Chapel Hill|Cort Pedersen, MD|919-923-3284|cort_pedersen@med.unc.edu|
21303342|NCT06054269|CDC|Perrine Marcenac|6782830242|pmarcenac@cdc.gov|
21260432|NCT02639351|GlaxoSmithKline|GSK Response Center|866-435-7343|kt144805@gsk.com|
21260433|NCT00473876|University of Dundee|Professor Chim C Lang|0044(0)1382 496375|c.c.lang@dundee.ac.uk|
21260434|NCT01276288|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21303343|NCT01587898|GlaxoSmithKline|GSK Response Center|866-435-7343||
21303344|NCT01738477|GlaxoSmithKline|GSK Response Center|866-435-7343||
21303345|NCT02437110|National Institutes of Health|Dr. Avi Nath|301-496-1561|natha@mail.nih.gov|
21303346|NCT03735238|Baylor College of Medicine|Jasvinder Singh, MD, MPH; Senior Faculty and Chief of Immunology, Allergy, and Rheumatology|713.798.1365|jasvinder.md@gmail.com|
21303347|NCT01261780|University of Wisconsin Carbone Cancer Center|Toby Campbell|608-263-3962|tcc@medicine.wisc.edu|
21260435|NCT03401749|University of Alabama at Birmingham|Ashish Shah|205-930-6722|ashishshah@uabmc.edu|
21260436|NCT03406962|Magenta Therapeutics|Medical Director|(857) 242-0170|clinicaltrials@magentatx.com|
21260437|NCT03853694|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
21260438|NCT01818297|Medtronic Neuromodulation|Neuro Clinical Trials||medtronicneurotrials@medtronic.com|
21260439|NCT03896295|Momenta Pharmaceuticals, Inc.|DIRECTOR CLINICAL RESEARCH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21260440|NCT03029832|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21260441|NCT01412229|UNC Lineberger|Robin Johnson|(919) 966-1125|Robin_V_Johnson@med.unc.edu|
21260442|NCT02553135|University of Miami|Byron Lam , MD|305-326-6021|blam@med.miami.edu|
21260443|NCT00700804|United States Department of Agriculture (USDA) Grand Forks Human Nutrition Reserch Center|Janet Hunt, PhD|701-795-8353|janetrhunt@gmail.com|
21260444|NCT04223609|Mayo Clinic|Gaurav N. Pradhan, PhD|480-301-5351|Pradhan.Gaurav@mayo.edu|
21260445|NCT02413203|Univesrity of Pennsylvania|Garret A. FitzGerald|215-898-1185|garret@upenn.edu|
21260446|NCT03832387|HOSPITAL GENERAL UNIVERSITARIO DE CASTELLÓN|Dr. ALBERTO BELENGUER MUNCHARAZ|96472500|belengueralberto8@gmail.com|
21260447|NCT05775289|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21260448|NCT01984515|Center for Integrated Healthcare|Dr. Kyle Possemato|315-425-4400|kyle.possemato@va.gov|53551
21260449|NCT00490542|Tufts Medical Center|S. Nassir Ghaemi, MD, MPH|617-636-5735|nghaemi@tuftsmedicalcenter.org|
21260450|NCT01438008|Children's Hospital of Eastern Ontario|Dr. Denise Harrison|6137377600|dharrison@cheo.on.ca|6045
21260451|NCT04977037|The University of Texas Health Sciences Center at Houston|Nuray Yozbatiran, PhD, PT|7137975282|Nuray.Yozbatiran@uth.tmc.edu|
21260452|NCT02848833|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21260453|NCT02847598|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21260454|NCT03783195|University of North Carolina at Chapel Hill|Saroja Voruganti, PhD|704-250-5009|saroja@unc.edu|
21260455|NCT00215150|Duke University Medical Center|Wei Zhang, MD|(919) 684 5645|wei.zhang@duke.edu|
21260456|NCT02251743|Ohio State University|Dr. L Eugene Arnold|614-685-6701|L.Arnold@osumc.edu|
21303348|NCT01239732|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21303349|NCT02971033|Edward Hines Jr. Veterans Administration Hospital|Susan L. Uprichard|(336) 402-1086|susan.uprichard@va.gov|
21303350|NCT01247298|University of Alabama at Birmingham (UAB)|Rojymon Jacob, MD|205-975-9704|rjacob@uabmc.edu|
21303351|NCT02489422|Wake Forest University Health Sciences|Study coordinator|336-716-9055|megreen@wakehealth.edu|
21303352|NCT00095147|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21303353|NCT03400956|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
21303354|NCT02048241|New York State Psychiatric Institute|Stephen J. Donovan, MD|646-774-8078|sd45@columbia.edu|
21303355|NCT00534313|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21303356|NCT00402233|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21303357|NCT00927940|Medtronic Japan Co.,Ltd|Hiroko Okubo|+81-3-6430-7017|rs.medtroniccardiovascularclinicaltrials@medtronic.com|
21303358|NCT03493932|Emory University|Edjah K. Nduom, MD, FAANS|404-778-5770|edjah.k.nduom@emory.edu|
21303359|NCT03007888|Impax Laboratories, LLC|Pamela Fitzpatrick, Director, Specialty Regulatory Affairs|631-633-2104|pfitzpatrick@amneal.com|
21275359|NCT05109104|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
21288409|NCT03479905|UTexasSouthwestern|Christina Riccio|214-590-7284|Christina.Riccio@utsouthwestern.edu|
21288410|NCT00862992|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21288411|NCT00720759|VAHSRD|Stephen E. Nadeau|352-374-6082|stephen.nadeau@va.gov|
21288412|NCT02318940|Universidad de Chile|Dr. Pietro Pietroboni Fuster|+56982261539|pietroboni@gmail.com|
21288413|NCT01706328|GlaxoSmithKline|GSK Response Center|866-435-7343||
21288414|NCT03100747|University of North Carolina at Chapel Hill|Emily Gower, PhD|919-966-1420|egower@unc.edu|
21288415|NCT00658619|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21288416|NCT01157845|Virginia Commonwealth University|R. Todd Stravitz|804-828-8514|rstravit@vcu.edu|
21288417|NCT03311555|Duke University|Andrew Armstrong, MD|919-668-8797|andrew.armstrong@duke.edu|
21288418|NCT01740206|Nationwide Children's Hospital|Richard Cartabuke, MD|614-722-4200|Richard.Cartabuke@nationwidechildrens.org|
21288419|NCT04609553|Rutgers University|Manuel Jimenez, MD, MS|732-235-9300|jimenema@rwjms.rutgers.edu|
21288420|NCT04390750|New York University|Bei Wu|12129925951|bw75@nyu.edu|
21288421|NCT02239328|Washington University|Dr. Benjamin Kozower|314-362-8089|kozower@wustl.edu|
21288422|NCT01989975|Medtronic Minimed|Suiying Huang, Statistician|8184763319|suiying.huang@medtronic.com|
21288423|NCT00460798|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21288424|NCT06525727|Marmara University School of Medicine|Dr. Emre Kudu|+902166254545|dr.emre.kudu@gmail.com|
21288425|NCT01545336|University of Pennsylvania|Dr. Steven M. Kawut|215-573-0258|kawut@upenn.edu|
21288426|NCT03881371|Zambon S.p.A|Valentina Zanin|+39 02 665241|valentina.zanin@zambongroup.com|
21288427|NCT02508389|Galera Therapeutics, Inc.|Kara Terry|610-725-1500|kterry@galeratx.com|
21288428|NCT01104766|Allergan|Medical Director|877-277-8566|IR-CTRegistration@Allergan.com|
21288429|NCT01756235|AbbVie|Global Medical Information|800-633-9110||
21288430|NCT05376358|University of Pittsburgh|Dr. Ana Radovic|4126927227|anr94@pitt.edu|
21288431|NCT04225832|RAND|Laura Bogart, PhD|3103830411|lbogart@rand.org|7281
21288432|NCT00311168|Abbott|Clay Cohorn - Director, Clinical Research|469-929-7116|clay.cohorn@abbott.com|
21288433|NCT05658887|University of Iowa Hospitals and Clinics|Dr. Colin Johnson|3193561616|colin-johnson@uiowa.edu|
21288434|NCT06001021|University of Gujrat|Dr. Sameera Shafiq (Lecturer, M. Phil, QAU; Ph.D., UOG)|923345116648|sameera.shafiq@uog.edu.pk|
21288435|NCT04940221|Christiana Care Health System|Heather Bittner Fagan, MD MPH|302 320 4110|hbittner-fagan@christianacare.org|
21288436|NCT04341636|King Abdulaziz University|Dr. Zuhair Natto|9666943899|znatto@kau.edu.sa|
21288437|NCT03112603|Call Center|Incyte Corporation|1.855.463.3463|medinfo@incyte.com|
21288438|NCT02236364|University of Toledo|Basil Akpunonu, MD|419-383-4909|Basil.Akpunonu@utoledo.edu|
21288439|NCT03839641|Pennington Biomedical Research Center|Dr. David McDougal|2257630278|DAVID.MCDOUGAL@PBRC.EDU|
21288440|NCT03981055|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526158|fregni.felipe@mgh.harvard.edu|
21288441|NCT04297917|Vaccitech Plc|Tom Evan, MD|+44 01865 591 445|enquiries@vaccitech.co.uk|
21288442|NCT00876343|Otsuka Pharmaceutical Co., Ld.|Director of Clinical Research and Development|+81-3-6361-7366||
21288443|NCT04926233|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21288444|NCT04800627|UT MD Anderson Cancer Center|Dr. Michael Overman,MD- Assoc VP, CN Research, SVP, Cancer NW Clin & Acad Dev|(713) 792-2828|moverman@mdanderson.org|
21288445|NCT02802228|Cumberland Pharmaceuticals|Jerry Fox, DVM|615-255-0068|jfox@cumberlandpharma.com|
21288446|NCT05984030|UNC Institute for Global Health and Infectious Diseases|Sarah Rutstein, MD, PhD|919-966-2537|sarah_rutstein@med.unc.edu|
21288447|NCT00695019|Amarillo Biosciences, Inc.|Martin J. Cummins, Director of Clinical & Regulatory Affairs|806-376-1741|mcummins@amarbio.com|14
21288448|NCT00924898|The University of North Carolina|Dr. Cynthia Gay|919-843-2726|cynthia_gay@med.unc.edu|
21288449|NCT03116230|Stanford University|Thomas Andriacchi|650-|tandriac@stanford.edu|
21288450|NCT04896385|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21288451|NCT05258721|Arcadia Consumer Healthcare, Inc.|Jai Shewale|504-913-4344|jshewale@arcadiach.com|
21288452|NCT04512924|Medical University of South Carolina|Dr. Brantlee Broome|843-792-3370|broomeb@musc.edu|
21288453|NCT05291689|Morphic Therapeutic Inc.|Head of Clinical Development|781-996-0955|clinicaltrials@morphictx.com|
21288454|NCT01931098|National Cancer Institute|Dr. Kevin Camphausen|240-760-6205|camphauk@nih.gov|
21275360|NCT04697173|Virginia Commonwealth University|Nikki Miller Ferguson MD|804-828-4080|nikki.millerferguson@vcuhealth.org|
21275361|NCT01632423|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21275362|NCT04848688|Swiss Tropical and Public Health Institute|Prof Dr Jennifer Keiser|+41 61 284 82 18|jennifer.keiser@swisstph.ch|
21275363|NCT00582205|University of Oklahoma|Dr. Joan Walker|405-271-8707|joan-walker@ouhsc.edu|
21275364|NCT01717313|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21275365|NCT05004649|University of Pennsylvania|Dr. David Brainard|215-573-7579|brainard@psych.upenn.edu|
21275366|NCT00301964|NRG Oncology, Statistics and Data Management Center, Buffalo Office|Jessalyn Reboy|716-845-7738|ReboyJ@nrgoncology.org|
21275367|NCT02385708|Vanderbilt University Medical Center|Steven Klintworth|615-936-3298|steven.klintworth@vumc.org|
21288455|NCT00230737|University of Pennsylvania|Dr. Nalaka Gooneratne|2674083789|ngoonera@upenn.edu|
21288456|NCT02278354|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
21288457|NCT00562328|Mayo Clinic|Timothy G. Call, M.D.|507-266-4671|Call.Timothy@mayo.edu|
21288458|NCT00848185|IVI Madrid|Dra Cerrillo|911802900|maria.cerrillo@ivi.es|
21275368|NCT01859637|Sandoz Biopharmaceutical, Hexal AG|Roumen Nakov|+49 8024 4764704|roumen.nakov@sandoz.com|
21260457|NCT02240134|University of Montana|Curtis Noonan, PhD|406-243-4957|curtis.noonan@umontana.edu|
21260458|NCT00476086|Dana-Farber Cancer Institute|Susana M. Campos, MD, MPH|617-632-5269|susanna_campos@dfci.harvard.edu|
21260459|NCT02900092|Massachusetts General Hospital|Karen K. Miller, MD|617-726-3870|KKMiller@mgh.harvard.edu|
21260460|NCT03895203|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21260461|NCT01389245|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
21260462|NCT03905928|Pennsylvania State University College of Medicine|Andrea Hobkirk|717-531-7279|alh98@psu.edu|
21260463|NCT00378326|Rockefeller University|Robert B. Darnell, MD, PhD|212-327-7474|darnelr@rockefeller.edu|
21260464|NCT02542267|W. L. Gore & Associates|Eric Novak|314-440-2119|enovak@wlgore.com|
21260465|NCT00442598|Eleison Pharmaceuticals|VP Clinical Development|6097211227|matthew.parris@eleison-pharma.com|
21260466|NCT03093402|DAIT/NIAID|Director, Clinical Research Operations Program|3015947669|DAITClinicalTrialsGov@niaid.nih.gov|
21260467|NCT02886702|Fougera Pharmaceuticals Inc.|Angela C Kaplan|631-659-2256|angela.kaplan@sandoz.com|
21260468|NCT01276184|University of Maryland School of Medicine|Dr. J. Kathleen Tracy, PhD|410-706-1205|ktracy@som.umaryland.edu|
21260469|NCT01808560|TearScience, Inc.|Manager of Clinical and Medical Affairs|919-459-4842|LJi4@its.jnj.com|
21260470|NCT00887458|Johns Hopkins University|Dr. Michael Carducci|410-614-3977|carducci@jhmi.edu|
21260471|NCT00054847|Southern Arizona VA Health Care System|Steven Goldman, MD|(520) 792-1450|Steven.Goldman@va.gov|4624
21260472|NCT01147497|Emory University|Eva Lathrop, MD, MPH|404-778-1379|elathro@emory.edu|
21260473|NCT02991599|Shanxi Medical University|Suping Wang, PhD|#86-351-4135103|spwang88@163.com|
21260474|NCT02731742|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21260475|NCT01316042|Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-8478|rlegro@hmc.psu.edu|
21260476|NCT02673229|The University of Kansas Health System|Suzanne Mitchell, PhD, ARNP, FNP-BC, CWS|913-588-5000|smitchell3@kumc.edu|6562
21260477|NCT04485455|University of North Carolina at Chapel Hill|Shahzad Ali, MD|984-974-0033|shali@med.unc.edu|
21260478|NCT01110187|University of Alabama at Birmingham|Jerzy P. Szaflarski, MD|205-934-3866|szaflaj@uab.edu|
21260479|NCT00422279|Nobel Biocare|Isabelle Arrighi, Head Clinical Trial Management|+41 43 211 42 00|isabelle.arrighi@nobelbiocare.com|
21260480|NCT02561156|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21260481|NCT00967941|CAMC Health System|Patrick Stone, MD|304-388-8250|pstone0627@yahoo.com|9901
21260482|NCT01071070|Abbott|Global Medical Services|800-633-9110||
21260483|NCT02207907|GlaxoSmithKline|GSK Response Center|866-435-7343||
21260484|NCT00691665|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21260485|NCT03952286|University of Arizona Asthma & Airway Disease Research Center|Dr. Ashley A. Lowe|5206268814|aaray@email.arizona.edu|
21260486|NCT03545282|University of Washington|India Ornelas|206-685-8887|iornelas@uw.edu|
21260487|NCT00755079|VAHSRD|Joshua Hobson, MS|(718) 584-9000|joshua.hobson@va.gov|3129
21260488|NCT02209506|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21260489|NCT01834404|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
21260490|NCT00629083|Contura International A/S|Ieva Ankorina-Stark, Ph D, Chief Scientific Officer|011 45 8110 0900|ieva.ankorina-stark@contura.com|
21260491|NCT00805207|Washington University in St Louis|Gordon Smith, PhD|314-362-4375|gsmith@wustl.edu|
21260492|NCT00064701|Astellas Pharma Global Development, Inc.|Vice President, Therapeutic Area Head, Transplantation||ClinicalTrials.Disclosure@us.astellas.com|
21260493|NCT03308188|University of Cincinnati|T. John Winhusen, PhD.|513-585-8292|winhust@ucmail.uc.edu|
21260494|NCT00772447|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21260495|NCT00552110|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21260496|NCT00582894|University of Oklahoma Health Sciences Center|George Selby, MD|405/271-4022|george-selby@ouhsc.edu|
21260497|NCT01557790|University of Pennsylvania|Justin E. Bekelman, MD|(215)662-7292|bekelman@xrt.upenn.edu|
21260498|NCT00046228|Centocor Inc.|Executive Director Clinical Research|1-800-972-9063|EBarnath@ITS.JNJ.COM|6171
21260499|NCT00655928|Imperial College LOndon|Mark J Griffiths|+44 (0) 2073518523|m.griffiths@imperial.ac.uk|
21260500|NCT04108429|Northwestern University|Dr. Emily Lattie|312-503-5509|emily.lattie@northwestern.edu|
21260501|NCT00998738|Mayo Clinic|Dr. Charles Loprinzi|507-266-6247|cloprinzi@mayo.edu|
21260502|NCT02963376|NuvOx Pharma|Evan Unger, MD|520-624-6688|eunger@nuvoxpharma.com|
21260503|NCT01291017|University of Florida|Priya K Gopalan, MD|352-273-8699|gopalpk@ufl.edu|
21260504|NCT04980391|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21260505|NCT02091440|Osaka University Hospital|Prof. Yoshiki Sawa|+81 668793160|sawa@surg1.med.osaka-u.ac.jp|
21260506|NCT00783289|MedImmune, LLC.|Rene van der Merwe, MBChB/Senior Director, Clinical Development|301-398-0000|vandermerwer@medimmune.com|
21260507|NCT03739619|Emory University|Jonathon Cohen, MD|404-778-2214|jonathon.cohen@emory.edu|
21260508|NCT04053387|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
21260509|NCT03095703|Amsterdam UMC, location Academic Medical Center|Prof. dr. Evelien Dekker|+3120-5663534|e.dekker@amsterdamumc.nl|
21260510|NCT03370757|Duke University School of Nursing|Dr. Debra Brandon|919-681-3813|debra.brandon@duke.edu|
21260511|NCT02443402|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
21260512|NCT00318292|Mayo Clinic|Michaele Menghini|480-301-6651|menghini.michaele@mayo.edu|
21260513|NCT01562028|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki-Voser|+41 31 511 94 18|belief@etop-eu.org|
21260514|NCT00364793|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21260515|NCT00391976|Novartis Pharmaceuticals|Study Director|862 778-8300||
21260516|NCT02724033|Department of Otolaryngology, Indiana University School of Medicine|Dr. Charles Yates, Primary Investigator|317-278-1286|cwyates@iupui.edu|
21260517|NCT00775021|Vistakon|Kurt Moody, Director Design R&D|904-443-3088||
21260518|NCT03193866|Karolinska Institutet|Professor Fredrik Piehl|+46-(0)8-517 798 40|fredrik.piehl@ki.se|
21260519|NCT03464045|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21260520|NCT03878147|Michigan State University|Michael J. Boivin|+15178840281|boivin@msu.edu|
21260521|NCT05817045|EmitBio|Director of Clinical Trials|919-321-1734|info@emitbio.com|
21260522|NCT01506141|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21260523|NCT04889209|Baylor College of Medicine|Dr. Robert L. Atmar|713-798-6849|ratmar@bcm.edu|
21260524|NCT04607408|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|2066675812|hvtn.covpn.sdmc@hvtn.org|
21260525|NCT02148029|Veterans Administration of Baltimore Maryland|Dr. Brajesh K. Lal|410-328-5840|blal@som.umaryland.edu|
21260526|NCT01725165|M D Anderson Cancer Center|Dr, Chad Tang|(713) 745-7179|ctang1@mdanderson.org|
21260527|NCT05039086|Brigham and Women's Hospital|Rishi J Desai, PhD|617-278-0932|rdesai@bwh.harvard.edu|
21260528|NCT02688647|Kadmon Corporation|Karin Herrera, Vice President, Clinical Operations|1-724-778-6134|karin.herrera@kadmon.com|
21260529|NCT03619213|AstraZeneca AB|AstraZeneca Clinical Study Information Center|877-240-9479|Information.center@astrazeneca.com|+1
21260530|NCT00382967|GE Healthcare|Igor Grachev, MD|1-609-514-6857|igor.grachev@ge.com|
21260531|NCT04026568|Penn State Hershey Medical Center|Kenneth Taylor, MD, Professor of Orthopaedics and Rehabilitation|717-531-2948|ktaylor3@pennstatehealth.psu.edu|
21260532|NCT00461175|Center for Epidemiology and Health Research, Germany|Dr. Klaas Heinemann|0049 (0) 30 945 101 20|k.heinemann@zeg-berlin.de|
21260533|NCT00331760|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
21260534|NCT02514044|University of Texas Health Science Center at Houston (UTHealth)|Dr. Gerard E. Francisco, Chairman and Professor, Physical Medicine and Rehabilitation|713.797.5246|gerard.e.francisco@uth.tmc.edu|
21260535|NCT03093155|Yale School of Medicine/Yale Cancer Center|Alessandro Santin, MD|(203) 737-4450|alessandro.santin@yale.edu|
21260536|NCT01773473|Eli Lilly and Company|Medical Officer|800-545-5979||
21238587|NCT00689026|Georgia Regent University|Dr. Sherman M. Chamberlain, Professor of Medicine|706-721-2238|schamberlain@gru.edu|
21260537|NCT00826514|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21238588|NCT02618616|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21260538|NCT01085682|The Catholic University of Korea|Kun-Ho Yoon, professor|82-2-2258-8281|yoonk@catholic.ac.kr|
21260539|NCT03862027|University of North Carolina at Chapel Hill|Amanda Kovacich, MD|919-966-2532|amanda.kovacich@unchealth.unc.edu|
21260540|NCT04579549|University of Wisconsin - Madison|Kristi Hall|608-890-0844|klhall1@wisc.edu|
21260541|NCT01053312|GE Healthcare|Paul Sherwin, MD|1-609-514-6820|paulsherwin@ge.com|
21260542|NCT00158184|Substance Use Research Center|Dr. Sandra D. Comer|212-543-5981|sdc10@columbia.edu|
21260543|NCT02620020|Regeneron Pharmaceuticals|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
21260544|NCT02589977|Vanderbilt University Medical Center|Marvin Kronenberg, MD|615-322-2318|marvin.w.kronenberg@vumc.org|
21260545|NCT01025635|Bayer HealthCare Pharmaceuticals, Inc. (formerly Intendis GmbH)|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21260546|NCT02393209|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21260547|NCT00727402|Case Western Reserve University Dept Ophthalmology & Visual Sciences|Loretta Szczotka-Flynn OD, PhD|216-844-3609|loretta.szczotka@uhhospitals.org|
21260548|NCT03751111|Xiangya Hospital, Central South University|Dr. Minxue Shen|86-15973164022|shenmx1988@csu.edu.cn|
21260549|NCT02582671|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21260550|NCT01755169|MUSC|Dr. Amy-Lee Bredlau|843-876-0444|bredlau@musc.edu|
21260551|NCT01287104|National Cancer Institute|Dr. Nirali N. Shah|301-451-0390|shahnn@nih.gov|
21260552|NCT00098787|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
21260553|NCT00296322|Asan Medical Center, University of Ulsan College of Medicine|Dr. Yoon-Koo Kang|+82-2-3010-3230|ykkang@amc.seoul.kr|
21260554|NCT00278525|Northwestern University|Dr. Richard Burt|312-908-0059|rburt@northwestern.edu|
21260555|NCT03496701|CooperVision, Inc|Jose A. Vega|925-640-2964|javega2@coopervision.com|
21260556|NCT00195650|Abbott|Global Medical Services|800-633-9110||
21260557|NCT01478958|University of Reading|Professor Julie Lovegrove|+44 (0)118 3786418|j.a.lovegrove@reading.ac.uk|
21260558|NCT01147809|GlaxoSmithKline|GSK Response Center|866-435-7343||
21260559|NCT01307423|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21260560|NCT01499290|AstraZeneca|Paul Newell, Medical Science Director|+44 1625 515727|paul.newell@astrazeneca.com|
21260561|NCT00707577|Massachusetts General Hospital|Dr. Anne Thorndike|617-724-4608|athorndike@mgh.harvard.edu|
21260562|NCT00190775|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21260563|NCT01794780|Novartis Pharmaceutical|Study Director|862-778-8300||
21260564|NCT03333577|Cochlear|George Cire|303 885 5440|gcire@msn.com|
21260565|NCT02209766|CO RIA TA, R&D|Hideo Negi|+81 6 4803 3533|H.Negi@astrazeneca.com|4716
21260566|NCT00327444|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
21260567|NCT02249052|Dr. Zachary E. Gerut|Dr. Zachary E. Gerut, Sponsor/Investigator|516 295-2100|zger@optonline.net|
21260568|NCT01791855|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21260569|NCT01709331|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21260570|NCT04439344|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21260571|NCT03770403|argenx BVBA|Regulatory Manager|+32 93103400|regulatory@argenx.com|
21260572|NCT03185546|Wake Forest School of Medicine|Eric Donny, PhD|336-713-1520|edonny@wakehealth.edu|
21260573|NCT01207466|CIBA VISION|Joe Rappon, OD, MS, FAAO / Head, Clinical Trial Management|1-678-415-3343|joseph.rappon@cibavision.com|
21260574|NCT00642642|Biologics Consulting Group|Dr/ Joseph Fratantoni|(301) 340-8432|jfratantoni@bcg-usa.com|
21260575|NCT02500537|Medtronic|Michelle DiSalvo|774.284.6089|michelle.v.disalvo@medtronic.com|
21260576|NCT00355121|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21260577|NCT01587989|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21260578|NCT03313050|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21260579|NCT04211337|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
21260580|NCT07145541|AION Biosystems|Samara Barend|9079024986|sam@aionbiosystems.com|
21260581|NCT05654714|Baxter|Jessica Gregory|N/A|jessica_gregory@baxter.com|
21260582|NCT05630846|GlaxoSmithKline Biologicals SA|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
21260583|NCT03019549|Eli Lilly and Compnay|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
21260584|NCT04030195|Precision BioSciences|Michael Karg, Senior Director, Clinical Operations|919-324-5512|michael.karg@precisionbiosciences.com|1574
21260585|NCT01412879|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623||
21260586|NCT00608465|Vanderbilt University Medical Center|James Muldowney|615-936-1720|james.muldowney@vanderbilt.edu|
21260587|NCT01056107|Mayo Clinic|Dr. Michael Camilleri|507-266-2305|camilleri.michael@mayo.edu|
21260588|NCT00377962|Novartis Pharmaceuticals|Study Director|862 778-8300||
21260589|NCT01225263|BIDMC|Catherine Buettner, MD MPH|617-754-9600|cbuettne@bidmc.harvard.edu|
21260590|NCT01380899|Facultad de Medicina, Universidad Autonoma de San Luis Potosi|Ildefonso Rodriguez-Leyva|+52 4442043016|ildefonso.rodriguez@uaslp.mx|
21260591|NCT02364778|Icahn School Of Medicine at Mount Sinai|Dr. Annapoorna Kini||annapoorna.kini@mountsinai.org|
21260592|NCT02718820|Medical University of Vienna|Thorsten Fuereder|+43140400|thorsten.fuereder@meduniwien.ac.at|44450
21260593|NCT00260208|Novartis Pharmaceuticals|Study coordinator|862-778-8300||
21260594|NCT03323749|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
21260595|NCT03263091|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|082MDSstudy@fibrogen.com|
21260596|NCT01821963|University of Texas (UT) MD Anderson Cancer Center|Harrys A. Torres, MD/Assistant Professor, Infectious Diseases|(713) 792-6503|htorres@mdanderson.org|
21260597|NCT00506389|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21288459|NCT01901562|Montefiore Medical Center|Dr. Sheldon Feldman, Chief Breast Surgery and Breast Surgery Oncology|929-246-6300|sfeldman@montefiore.org|
21288460|NCT01925794|CeloNova BioSciences Inc.|Mark Barakat, MD|(210) 489-4004|mbarakat@celonova.com|
21288461|NCT02612155|Duke University|Dr. Kim Fisher, Ph.D., FNP-BC|919-681-4913|kimberley.fisher@duke.edu|
21288462|NCT03073759|Johns Hopkins University|Mohammad Khoshnoodi|410-955-5460|mkhoshn1@jhmi.edu|
21288463|NCT01014091|GlaxoSmithKline|GSK Response Center|866-435-7343||
21288464|NCT01564407|University of Pittsburgh|Amy Steele, RN, MSN, CCRC|412-641-3728|steeleam@upmc.edu|
21288465|NCT06026813|UT Southwestern Medical Center|Dr. Peter Crisologo|214/648-7284|Peter.Crisologo@UTSouthwestern.edu|
21288466|NCT04235374|University of Maryland|Barbara Resnick|410 706 5178|resnick@umaryland.edu|
21288467|NCT00294658|University of Alabama at Birmingham|Dr. Gary Cutter, Professor|205-975-5048|cutter@uab.edu|
21260598|NCT03539432|The Mind Research Network|Dr. Eric Claus|5055151556|eclaus@mrn.org|
21260599|NCT01381094|Akebia Therapeutics, Inc.|Akebia Therapeutics, Inc.|+1 617-844-6128|trials@akebia.com|
21260600|NCT04092257|UNC Lineberger Comprehensive Cancer Center|Melahat Garipagaoglu|919-962-0000|Melahat_Canter@med.unc.edu|
21260601|NCT02241486|Loyola University Medical Center|Dr. Joseph R. Holtman|7082168563|jholtman@luc.edu|
21260602|NCT02770521|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21260603|NCT01934504|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21260604|NCT02665689|Charité University, Berlin|Prof. Dr. Antonia Joussen|+49 30 84452331|antonia.joussen@charite.de|
21260605|NCT00824564|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21260606|NCT03198221|Cleveland Clinic|Dr. Carol Burke|216-444-6864|BurkeC1@ccf.org|
21260607|NCT01035151|University of South Caroina|Jeannette Andrews|803 777 3862|j.andrews@sc.edu|
21260608|NCT04504318|Stanford University|Dr. Arash Momeni|650-723-6189|amomeni@stanford.edu|
21260609|NCT00996840|GlaxoSmithKline|GSK Response Center|866-435-7343||
21260610|NCT00603239|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21260611|NCT02292849|Weill Cornell Medical College|Patrick Raue, Ph.D.|206-543-3807|praue@uw.edu|
21260612|NCT02988856|Massachusetts Eye and Ear|Kevin Houston|617-573-4177|kevin_houston@meei.harvard.edu|
21260613|NCT04125680|University of Michigan|Emily Feuerherm|810-766-6725|feuerher@umich.edu|
21260614|NCT00097539|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21260615|NCT05127486|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
21260616|NCT00049127|Mayo Clinic|Kurt A. Jaeckle, M.D.|5072841370|jaecle.kurt@mayo.edu|
21260617|NCT02582515|Johns Hopkins University School of Medicine|Assistant Professor|443-287-5143|jfmcguire@jhmi.edu|
21260618|NCT00363415|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21260619|NCT04802837|Summit Therapeutics|Katie Tran|4086776503|Katie.Tran@Summitplc.com|
21260620|NCT01287754|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21260621|NCT00001337|National Cancer Institute|Dr. Mark J. Roschewski|240-760-6183|mark.roschewski@nih.gov|
21260622|NCT03826875|University of Washington|Professor of Neurological Surgery|2067449330|mlevitt@uw.edu|
21260623|NCT04586504|Columbia University|Daniel Tsze MD MPH|212-317-0997|dst2141@cumc.columbia.edu|
21260624|NCT00809133|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21275369|NCT03504085|UC San Diego|Erik Groessl, PhD|858-642-6347|egroessl@ucsd.edu|
21275370|NCT01143337|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21275371|NCT04133311|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
21275372|NCT00834561|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21275373|NCT05533411|Eli Lilly and Company|Chief Medical Officer|8005955979|ClinicalTrials.gov@lilly.com|
21275374|NCT05032807|King's College London|Dr Edward Chesney|+44 (0)20 7848 0728|edward.chesney@kcl.ac.uk|
21275375|NCT00728754|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
21275376|NCT01859598|The George Institute for Global Health at Peking University Health Science Center|Pro. Linong Ji|82800577|jiln@bjmu.edu.cn|
21275377|NCT00270634|Isotechnika Pharma Inc.|Robert Huizinga|780 487 1600|robert.huizinga@isotechnika.com|223
21275378|NCT00573313|University of California Davis|Dr. Charles H. Halsted|530-752-4054|chhalsted@ucdavis.edu|
21275379|NCT00835588|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21275380|NCT03255980|Helsinn Healthcare SA|Dr. Fabio Macchi|0041919852121|fabio.macchi@helsinn.com|
21275381|NCT01597791|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.eud|
21275382|NCT02611362|Rhode Island Hospital|Dr. Larry K. Brown|(401) 793-8808|lkbrown@lifespan.org|
21275383|NCT00354159|Medtronic CRDM|REDUCEhf Clinical Research Specialist|1-800-328-2518|medtronicCRMtrials@medtronic.com|62736
21275384|NCT02229084|University of Arkansas for Medical Sciences|Sorena Lo|5016868274|SBLo@uams.edu|
21275385|NCT05128058|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21275386|NCT01728116|GI Dynamics, Inc|Brian Callahan|781.357.3302|bcallahan@gidynamics.com|
21275387|NCT03277248|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
21275388|NCT03515044|Bausch Health Americas, Inc|Study Director|19083009920|susan.harris@bauschhealth.com|
21275389|NCT01993940|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|1454
21275390|NCT03922750|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21275391|NCT01451541|Sunovion|Respiratory Medical Director|1-866-503-6351||
21275392|NCT04164758|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261|medicalinformation@acadia-pharm.com|2897
21275393|NCT00325780|Kowa Research Institute|Bill Arana|919 433 1600|barana@kowaus.com|
21275394|NCT02248714|6thShanghaiJiaotongU|Dr. Yuqian Bao|(021)64369181|byq522@163.com|
21275395|NCT00533507|GlaxoSmithKline|GSK Response Center|866-435-7343||
21275396|NCT01050764|Stanford University Medical Center|Everett H Meyer, MD, PhD; Assistant Professor of Medicine|650-725-5816|evmeyer@stanford.edu|
21275397|NCT03790137|Massachusetts General Hospital|Dr. Elizabeth Thiele|6177266540|ethiele@mgh.harvard.edu|
21275398|NCT00924053|Theracos, Inc|Yuan-Di Halvorsen|617 726-4236|yhalvorsen@ccib.mgh.harvard.edu|
21275399|NCT00758758|Zimmer, Inc|Laura Herdrich, Sr. CRA|952-830-6224|laura.herdrich@zimmer.com|
21275400|NCT03555695|Rush University Medical Center|Dr. Jori Fleisher|312-563-2900|jori_fleisher@rush.edu|
21275401|NCT02161705|Johns Hopkins University School of Medicine|Dr. Pathik Aravind|4437879385|paravin1@jhmi.edu|
21275402|NCT01426854|Alcon (China) Ophthalmic Product Co., Ltd.|Terence Li, Clinical Research Manager, Development & Medical Affairs, China|+86 10 5829 1452|Terence.li@alcon.com|
21275403|NCT04116957|University of Missouri|Jung Hyup Kim|5738840354|kijung@missouri.edu|
21275404|NCT04203823|Medtronic|Clinical Study Manager|8185765849|carrie.corrigan@medtronic.com|
21275405|NCT03193021|Cardiva Medical|Terry Alverson, Director of Regulatory and Clinical|650-207-0563|Terry_Alverson@cardivamedical.com|
21275406|NCT02233751|Antares Pharma, Inc.|Jonathan Jaffe, MD|609-359-3020|jjaffe@antarespharma.com|
21275407|NCT05471349|University of Wisconsin - Madison|Mark Zehner|608-262-7568|mark.zehner@wisc.edu|
21303360|NCT03471624|Stanford University|Mindie H Nguyen, Professor of Medicine, GI & Hepatology, Liver Transplant|650-498-6084|mindiehn@stanford.edu|
21275408|NCT00685334|New York State Psychiatric Institute|Evelyn Attia, MD|212-253-5923|ea12@columbia.edu|
21275409|NCT02400463|University of Michigan Rogel Cancer Center|Ryan Wilcox|734-615-1482|rywilcox@umich.edu|
21275410|NCT00820599|Edwards Lifesciences|Edwards THV Clinical Affairs|949-250-2500|THV_CT.gov@edwards.com|
21275411|NCT03686215|Lumicell|Jorge Ferrer, PhD|617-571-0592|jmferrer@lumicell.com|
21275412|NCT00202839|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21275413|NCT04768296|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21275414|NCT00522041|Allergan plc|Susan Fox, PhD|201-427-8225|susan.fox@allergan.com|
21275415|NCT00544167|Sarah Cannon Research Institute|John Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
21275416|NCT00874549|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21275417|NCT03343639|Chief Scientific Officer|Paul Kwon|650-486-1416|pkwon@menlotx.com|
21275418|NCT00735696|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21275419|NCT00084864|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21275420|NCT00831987|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21275421|NCT02655224|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21303361|NCT00492063|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21303362|NCT01870076|Shriners Hosptials for Children|Laura Fowler/Clinical Research Coordinator|513-872-6000|lfowler@shrinenet.org|6249
21303363|NCT02589600|University of Pittsburgh|Susan Greenspan|4126922477|greenspn@pitt.edu|
21303364|NCT01402427|State Health Center, Hungary|Istvan Hizoh, MD, PhD / Senior Consultant|+36 1 4651800|ihizoh@web.de|71773
21303365|NCT00890045|Houston Methodist Hospital|George M. Nassar M.D.|713-790-1963|georgemnassar@gmail.com|
21288468|NCT02141555|University of California, San Diego|Dr. Sheila Mody||smody@ucsd.edu|
21288469|NCT05049122|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21288470|NCT01910441|Novartis|Study Director|862-778-8200||
21288471|NCT05168800|Dartmouth College|Glyn Elwyn|(603) 646-5623|glynelwyn@gmail.com|
21288472|NCT04153864|Sinai Health System (Canada)|Dr. Daisy R Singla|416-535-8501|daisy.singla@utoronto.ca|39423
21288473|NCT06442800|University of North Carolina at Chapel Hill|Marissa Hall, PhD|919-445-1310|mghall@unc.edu|
21288474|NCT04279522|Neurolief Ltd.|Yaron Gruper, Director of Clinical affairs|+972-544330712|Yaron.Gruper@neurolief.com|
21288475|NCT04717557|Duke University|Dr. Richard Moon|919-684-8762|richard.moon@duke.edu|9199065651
21275422|NCT02951195|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21288476|NCT05277207|Durham VA Health Care System|Angela Kirby|919-824-7729|angela.kirby@va.gov|
21275423|NCT00063258|University of Texas M.D. Anderson Cancer Center|Mellanie Price, B.S.|713-792-4392|mejprice@mdanderson.org|
21275424|NCT02754492|Terumo BCT, Inc.|Heather Pidcoke, MD, PhD|(303) 231-4805|Heather.Pidcoke@terumobct.com|
21275425|NCT00217724|OHSU Knight Cancer Institute|Joseph Bublao|503-494-1054|bubaloj@ohsu.edu|
21275426|NCT05387408|Washington University|Dr. Ann Marie Dale, Principal Investigator|3144548470|amdale@wustl.edu|
21275427|NCT00496860|Altor Bioscience|Hing C. Wong, Chief Clinical Officer|9544438600|hingwong@altorbioscience.com|
21275428|NCT04462198|Pipeline Therapeutics, Inc.|Stephen Huhn, MD|858-333-5280|SHuhn@pipeline-tx.com|
21275429|NCT01202253|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21275430|NCT00000136|The Johns Hopkins University|Curtis Meinert, PhD|410-955-8198|cmeinert@jhsph.edu|
21275431|NCT01897077|Johns Hopkins School of Medicine|Corinne Keet|410-955-5883|ckeet1@jhmi.edu|
21275432|NCT02786953|Vanderbilt University Medical Center|Sarah S Jaser|6153436775|sarah.jaser@vumc.org|
21275433|NCT05014438|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21275434|NCT02627963|AVEO Pharmaceuticals, Inc.|AVEO Clinical Trial Office|857-400-0101|Clinical@aveooncology.com|
21275435|NCT03073798|Johns Hopkins University|Nadia N Hansel, MD MPH|410-550-2935|nhansel@jhmi.edu|
21275436|NCT05278858|University Hospitals Cleveland Medical Center|Dr. Sonal Shah, Director of Pediatric Dermatology|216-286-7285|Sonal.Shah@UHhospitals.org|
21275437|NCT00840658|University of California, San Diego|Steffanie Strathdee, PhD|(858) 822-1952|sstrathdee@ucsd.edu|
21275438|NCT02372006|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21275439|NCT01055834|Eisai Co., Ltd.|Kenya Nakai, Study Director|+81-3-3817-3865|k3-nakai@hhc.eisai.co.jp|
21275440|NCT00295490|University of Southampton|Dr Sarah Brien|07870642667|sbb@southampton.ac.uk|
21288477|NCT05484778|IstanbulU|Aysen Elif YILMAZ|+905059466301|aysen.elif4@gmail.com|
21288478|NCT06354257|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21288479|NCT02685735|Wake Forest University School of Medicine|Dr. James Eisenach|336-716-4182|jimeisenach@gmail.com|
21288480|NCT03133156|Joslin Diabetes Center|Laura Simpson|617-735-3924|laura.simpson@joslin.harvard.edu|
21288481|NCT01977846|Foundation Fighting Blindness|Chief Scientific Officer|410-423-0600|info@FightBlindness.org|
21288482|NCT01047319|Teva Pharmaceutical Industries, Ltd|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21288483|NCT06481579|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21288484|NCT01120197|Faculty of Health Sciences, Oslo University College, Oslo, Norway|Professor, Ph. D, Researcher. Astrid Bergland.|+4722452507|astrid.bergland@hf.hio.no|
21288485|NCT04175639|Duke University School of Medicine|Tamara Somers, PhD|919-416-3408|tamara.somers@duke.edu|
21288486|NCT04338581|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21288487|NCT03481049|Washington State University|Michael G. McDonell|509-368-6967|mmcdonell@wsu.edu|
21275441|NCT00458822|Memorial Sloan Kettering Cancer Center|Dr. Heather Landau|212-639-8808|LandauH@mskcc.org|
21275442|NCT04090658|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21288488|NCT00770809|University of North Carolina - Lineberger Comprehensive Cancer Center|Lisa Carey, M.D.||lisa_carey@med.unc.edu|
21288489|NCT05028569|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21288490|NCT01136954|Eisai Call Center|Eisai Inc.|888-422-4743||
21288491|NCT01035788|Department of Veterans Affairs|Dr. Louanne Davis|317-988-4523|louanne.davis@va.gov|
21288492|NCT00410488|UT MD Anderson Cancer Center|Saroj Vadhan-Raj, MD / Professor||CR_Study_Registration@mdanderson.org|
21275443|NCT03405363|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21275444|NCT01328782|Children's Hospital Colorado|Gaia Georgopoulos, MD|720-777-2588|Gaia.Georgopoulos@childrenscolorado.org|
21275445|NCT00630253|Masonic Cancer Center, University of Minnesota|Margaret L. MacMillan, M.D.|612-273-2800|macmi002@umn.edu|
21275446|NCT00400634|Ceregene, Inc.|Raymond T. Bartus, Executive Vice President and Cheif Scientific Officer|858-458-8823|rtbartus@ceregene.com|
21275447|NCT01559116|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21275448|NCT01532908|MassBiologics|Director of Clinical Affairs|617-474-3000|Mblclinicaldirector@Umassmed.edu|
21275449|NCT01868243|Hospital Ana Nery|Andre Rodrigues Duraes|+557191888399|andreduraes@gmail.com|
21275450|NCT01632306|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21275451|NCT00994604|Johns Hokpins Medical Institutions|Dr. Robert Brown|410-614-5451|rbrown2@jhmi.edu|
21275452|NCT00467597|Portland VA Health Care System (PORVAHCS)|Kathryn Chung, MD|503.220.8262|CHUNGKA@OHSU.EDU|51091
21275453|NCT01156987|University of MN|Curt Corum|(612) 625-5000|corum003@umn.edu|
21275454|NCT01745094|Astellas Pharma Inc.|Medical Director|+81-3-3244-0512 Ext:|motoko.ida@astellas.com|
21275455|NCT04610580|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
21275456|NCT01170715|Rockefeller University|James G. Krueger MD, PhD|212-327-7730|kruegej@rockefeller.edu|
21275457|NCT03480022|Woman's Hospital|Director of Research|12252315278|karen.elkind-hirsch@womans.org|
21275458|NCT00881569|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21275459|NCT02948426|National Cancer Institute|Dr. Kevin Conlon|240-858-3570|conlonkc@mail.nih.gov|
21275460|NCT00668395|Indiana University School of Medicine|Zeruesenay Desta, PhD|317-274-2823|zdesta@iu.edu|
21275461|NCT03660787|Pharmasyntez|Mikhail Shurygin|+7 3952 550 355|m.shurygin@pharmasyntez.com|1150
21275462|NCT01670097|UT MD Anderson Cancer Center|David Hui, MD/ Associate Professor, Palliative Care Medicine|(713) 792-6258|dhui@mdanderson.org|
21275463|NCT01949532|Amgen, Inc.|Study Director|866-572-6436||
21275464|NCT05665387|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
21275465|NCT01824498|USDA, GFHNRC|Susan Raatz, PhD, RD|701-795-8294|susan.raatz@ars.usda.gov|
21288493|NCT03829475|Brigham and Women's Hospital|Jessica Allegretti MD MPH|617-525-7322|jallegretti@bwh.harvard.edu|
21288494|NCT03841513|TMC|Dr Tsung Mou|6176365890|tmou@tuftsmedicalcenter.org|
21288495|NCT01838876|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21288496|NCT00689936|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
21288497|NCT01682031|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21288498|NCT01932606|Mayo Clinic|Dr. Barry A. Borlaug|507-284-6704|Borlaug.Barry@mayo.edu|
21288499|NCT00933933|Abbott Diagnostic Division|Barbara Kaesdorf, Associate Director Clinical Affairs|847-937-8702|barbara.kaesdorf@abbott.com|
21288500|NCT04703192|Daiichi Sanyko, Inc|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21288501|NCT05219552|University of California School of Nursing|Dr. Emily Tuthill|2078411983|emily.g.tuthill@gmail.com|
21288502|NCT03330197|Alaunos Therapeutics|Jaymes Holland|650 273-2627|jholland@alaunos.com|
21275466|NCT01567527|Otsuka Pharmaceutical Development & Commercialization, Inc.|Joan Amatniek, Senior Director, Global Clinical Development|(609) 512-4464|joan.amatniek@otsuka-us.com|
21275467|NCT02311894|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21275468|NCT00884390|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21275469|NCT01152112|Hologic, Inc.|Christina Mastandrea / Clinical Research manager|5082638772|christina.mastandrea@hologic.com|
21275470|NCT01691612|Brigham & Women's Hospital|Elliot Israel, M.D.|617-732-8110|eisrael@partners.org|
21275471|NCT02099318|University Hospitals Cleveland Medical Center|Valerie Cwiklinski Clinical Research Nurse|216-983-5144|valerie.cwiklinski1@uhhospitals.org|
21275472|NCT00939523|Cedars-Sinai Medical Center|Odelia Cooper|310-423-4774|coopero@cshs.org|
21275473|NCT03786770|Revance Therapeutics, Inc.|Domenico Vitarella, Sr. Director, Clinical Development|510-742-3400|dvitarella@revance.com|
21275474|NCT02119936|UNC Chapel Hill|Holly Krohn|919-445-0218|holly_krohn@med.unc.edu|
21275475|NCT02243579|Fred Hutchinson Cancer Research Center|Asa Davis|206-667-5300|akdavis@fredhutch.org|
21275476|NCT00757172|Washington University School of Medicine|Dr. A. Craig Lockhart|314-454-8306|alockhar@dom.wustl.edu|
21275477|NCT01971554|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21275478|NCT03505151|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21275479|NCT01942135|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21275480|NCT01499043|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
21275481|NCT01912807|University of Saskatchewan|Andrea Vasquez Camargo|306 7660444|a.vasquez@usask.ca|
21275482|NCT04750239|Y-mAbs Therapeutics|Joris Wilms|+4570261414|clinicaltrials@ymabs.com|
21275483|NCT00903877|Stanford University|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu|
21275484|NCT02535923|Department of Veterans Affairs|Elizabeth A Klingaman PhD|410-259-7810|elizabeth.klingaman@va.gov|
21275485|NCT02282722|Dana-Farber Cancer Institute|Dr. Deb Schrag|617-582-8301|deb_schrag@dfci.harvard.edu|
21275486|NCT05194202|Children's Mercy Hospital|Dr. Kimberly Randell|816-302-3503|karandell@cmh.edu|
21275487|NCT04729101|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-PHAT (7428)|medicalinformation@phathompharma.com|
21275488|NCT00274625|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@cookbiotech.com|
21275489|NCT01639664|Istituto di Ricerche Farmacologiche Mario Negri IRCCS|Dr. Guido Bertolini|035 4535 313|guido.bertolini@marionegri.it|
21275490|NCT00762411|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21275491|NCT02959840|Rutgers-Robert Wood Johnson Medical School|Dr. Shaul Cohen, M.D., Professor of Clinical Anesthesiology, Director of Obstetric Anesthesia|732-937-8841|cohensh@rwjms.rutgers.edu|
21275492|NCT02710214|University of California, San Francisco|Dr. Riley Bove|415-595-2795|riley.bove@ucsf.edu|
21275493|NCT02832167|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21275494|NCT01754376|MGH Cancer Center|Ryan Sullivan|617-724-4000|rsullivan7@mgh.harvard.edu|
21275495|NCT04556734|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21275496|NCT02497235|Medical Director|Takeda|+1-877-825-3327|trialdisclosures@takeda.com|
21275497|NCT04264819|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21275498|NCT02937506|Mount Carmel Health System|Anantha Padmanabhan, MD|614-234-1079|apadmanabhan@mchs.com|
21275499|NCT00769314|BioAlliance Pharma|Dr Pierre ATTALI|+33145587600|pierre.attali@bioalliancepharma.com|
21275500|NCT00704496|milton s hershey medical center|timothy craig,|717-531-6525|tcraig@psu.edu|1
21275501|NCT01662024|Brigham and Women's Hospital|Christopher C. Thompson, MD, MSc|617-525-8266|ccthompson@bwh.harvard.edu|
21275502|NCT00108628|Philadelphia VA Medical Center|Dr. Richard Ross|(215) 823-4046|Richard.Ross2@va.gov|
21275503|NCT01390415|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21275504|NCT01151280|Boston Scientific Corporation|Alexis James, Clinical Project Manager|508-683-4074|jamesa@bsci.com|
21275505|NCT02435433|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|ClinicalTrials.gov@Lilly.com|
21275506|NCT02898740|VA Boston Healthcare System|Dr. David Sparrow|857-364-6400|david.sparrow@va.gov|
21275507|NCT02413034|Hospital del Mar|Daniel Pérez-Prieto|0034932483196|dperezprieto@hospitaldelmar.cat|
21275508|NCT00076245|Department of Psychology, University of Vermont|Kelly J. Rohan, Ph.D.|802-656-0798|kelly.rohan@uvm.edu|
21275509|NCT03538795|University of Alabama of Birmingham|Gitendra Uswatte|205-975-5089|guswatte@uab.edu|
21275510|NCT02460835|University of Michigan Rogel Cancer Center|Dr. Theodore Lawrence|734-647-9955|tsl@umich.edu|
21275511|NCT01151449|Princess Margaret Cancer Centre|Dr. Srikala Sridhar|416-946-2662|srikala.sridhar@uhn.ca|
21275512|NCT01327976|EnteroMedics|Director of Clinical Research|651-634-3209|mbroich@enteromedics.com|
21275513|NCT02483416|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21275514|NCT04808908|University of Minnesota|Kevin Escandón|612-626-9344|escan012@umn.edu|
21275515|NCT02587143|Servicio de Urgencias, Hospital de Basurto, Bilbao, España|Dr. Ballesteros-Peña|(+34)946012804|sendoa.ballesteros@ehu.eus|
21275516|NCT01119625|GlaxoSmithKline|GSK Response Center|866-435-7343||
21275517|NCT03237156|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21288503|NCT05561400|University of Minnesota|Sharyl Samargia-Grivette|218-726-8347|samargia@umn.edu|
21288504|NCT01670006|Cochlear|PRS Specialist, Clinical Affairs|+612 9428 6555|cltd-prs-admin@cochlear.com|
21288505|NCT01601977|GSTT|Gill Arbane, Clinical trials coordinator|02071888070|gill.arbane@gstt.nhs.uk|
21288506|NCT02879695|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
21288507|NCT05007925|Shockwave Medical|Denise Winn|410-991-9311|dwinn@its.jnj.com|
21288508|NCT03126110|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21288509|NCT00208975|Emory University|Dr. Christopher Flowers|404-778-3942|crflowe@emory.edu|
21288510|NCT04612400|The University of Arkansas for Medical Sciences|Katie Rose Hisrch, Ph.D.|5015265708|krhirsch@uams.edu|
21288511|NCT04435626|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21288512|NCT03837704|Philip Morris Products S.A.|Global Head Clinical Development & Operations|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
21288513|NCT05845619|University of California San Francisco|Pamela Murnane|4155021000|pamela.murnane@ucsf.edu|
21288514|NCT03621592|University of Miami|Hadar Lev-Tov, MD|305-243-4472|hlevtov@med.miami.edu|
21288515|NCT04967222|Icahn School of Medicine at Mount Sinai|Dr. Harold W Koenigsberg|(718) 584-9000|harold.koenigsberg@mssm.edu|
21288516|NCT01149083|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
21288517|NCT04958707|University of Medicine and Pharmacy at Ho Chi Minh City|Dr. Nguyen Tran To Tran|+84 979635889|nguyentrantotran@ump.edu.vn|
21288518|NCT02489539|W.L. Gore & Associates|Charee Robe|928-864-4048|crobe@wlgore.com|
21288519|NCT02629159|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21288520|NCT05360056|The Ohio State University|Dr. Kathleen Dungan|6146853333|kathleen.dungan@osumc.edu|
21288521|NCT00278408|Saarland University Medical School|Dr. Viola Poeschel|+4968411615014|dshnhl@uks.eu|
21288522|NCT03033355|houston methodist Hospital|Dr. Rose Khavari|713-363-9154|rkhavari@houstonmethodist.org|
21288523|NCT05523297|Toronto General Hospital|Dr Keyvan Karkouti|(416) 340-8597|keyvan.karkouti@uhn.ca|
21288524|NCT02401230|Emory University|Dr. Colleen Kelley|404-712-1823|colleen.kelley@emory.edu|
21288525|NCT04812015|Wayne State University|Danielle Taylor, PhD|6166486793|dtaylo@med.wayne.edu|
21288526|NCT00831844|Children's Oncology Group|Results Reporting Coordinator|626-241-0064|Resultsreportingcoordinator@childrensoncologygroup.org|
21303366|NCT01947855|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21303367|NCT01816451|University of Trás-os-Montes and Alto Douro|Ph.D. Laura Castro de Garay|+55 21 22275084|laura@virtualsoftware.com.br|
21303368|NCT01892384|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21303369|NCT01700439|Edwards Lifesciences, LLC|Jennifer Currin, Senior VP of Medical and Clinical Affairs, Surgical Structural Heart|949-250-2500|Jennifer_Currin@edwards.com|
21303370|NCT00592774|Eisai Call Center|Eisai Inc.|888-422-4743||
21303371|NCT01872325|Ottawa Hospital Research Institute|Dr. Christian Vaillancourt|613-798-5555|cvaillancourt@ohri.ca|17012
21303372|NCT00714571|VA Ann Arbor Healthcare System|Dr. Benjamin M. Hampstead|734-763-9259|Benjamin.Hampstead@va.gov|
21303373|NCT00621621|Medtronic- AF Solutions|Adam Cline, MD, MSc.- Sr. Clinical Research Specialist|763-526-9601|adam.cline@medtronic.com|
21303374|NCT01829243|Duke University Medical Center|Ashwin A. Patkar, MD|919-668-3626|ashwin.patkar@duke.edu|
21275518|NCT01721772|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21275519|NCT04542694|A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of the Russian Federation|Academician Dmitry Pushkar|+7495-609-67-00|dmitry.pushkar@gmail.com|
21275520|NCT00969124|Avantis Medical Systems , Inc.|Jack Higgins, MD - Chief Medical Officer|4086367226|jhiggins@avantismedical.com|
21275521|NCT00210639|Janssen R&D US|Director, Clinical Research|1 609 730-3158||
21275522|NCT04436198|Regional Clinical Investigation Program|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
21275523|NCT00743145|New York State Psychiatric Institute|Margaret Haney, PhD|646-774-6153|mh235@cumc.columbia.edu|
21275524|NCT03617419|GE Healthcare|Sr. Clinical Affairs Project Manager|2624095722|kevin.r.siewert@ge.com|
21275525|NCT01211262|Immunocore, LLC|Chris Holland, Executive Director Head of Biostatistics|1-267-589-9204|chris.holland2@immunocore.com|
21275526|NCT01277510|Amgen Inc.|Study Director|866-572-6436||
21275527|NCT04736537|Mayo Clinic|Tyson Scrabeck|507-538-1016|scrabeck.tyson@mayo.edu|
21275528|NCT00537095|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21275529|NCT00021541|National Institutes of Health, National Cancer Institute|Brigitte Widemann, M.D.|301-496-7387|widemanb@mail.nih.gov|
21275530|NCT01874535|Kaohsiung Chang Gung Memorial Hospital, Taiwan|Dr. Seng-Kee Chuah and Dr. Wei-Chen Tai|886-975056007|chuahsk@seed.net.tw|
21275531|NCT05263505|Washington University School of Medicine|Dr. Michael Paley, Director of the Ocular Rheumatology Clinic|314-273-7556|paleym@wustl.edu|
21275532|NCT02616380|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21275533|NCT01929681|McLean Hospital|Dr. Michael Rohan|617-855-3127|mrohan@mclean.harvard.edu|
21288527|NCT02512419|Brown University|Dr. Bess Marcus|401-863-9858|bess_marcus@brown.edu|
21288528|NCT04133909|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21288529|NCT00315445|Purdue Pharma L.P.|Medical Director|800-733-1333||
21288530|NCT03980223|University of California, San Francisco|Anne Luetkemeyer|415-502-5753|annie.luetkemeyer@ucsf.edu|
21288531|NCT00434434|Genentech, Inc.|Medical Communications|800-821-8590||
21288532|NCT02460289|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
21288533|NCT01155570|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21288534|NCT02916927|Alameda Health Systemt - Highland Hospital|Dr. Andrew Herring|(510) 437-4564|aherring@alamedahealthsystem.org|
21288535|NCT02774889|University of Wisconsin-Madison|Associate Research Specialist|6082631105|wpalmer3@wisc.edu|
21288536|NCT01069939|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21288537|NCT00724945|Vistakon|Thomas Karkkainen OD|904-443-3402|tkarkkai@its.jnj.com|
21275534|NCT05315713|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21275535|NCT01528735|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21275536|NCT00556673|Novartis Pharmaceuticals|Study Director|862-778-8300||
21303375|NCT04850781|Johns Hopkins University|Kali Thomas|(410) 955-4766|kali.thomas@jhu.edu|
21303376|NCT00608569|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21303377|NCT03445156|The Ohio State University|Dr. Brad Bushman|614-688-8779|bushman.20@osu.edu|
21303378|NCT04456153|UT Southwestern Medical Center|Dr. Mamta K. Jain|2140648-9914|mamta.jain@utsouthwestern.edu|
21303379|NCT03758755|Inova Health System|Dr. Edward Chang|571-472-0464|edward.chang@inova.org|
21303380|NCT03985878|Sarepta Therapeutics, Inc.|Medical Director|1-888-SAREPTA (1-888-727-3782)|SareptAlly@sarepta.com|
21303381|NCT01606878|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21275537|NCT01717040|Univeristy Hospitals Cleveland Medical Center|Carla Conroy, MPH|216-844-2871|carla.conroy@UHhospitals.org|
21275538|NCT00538863|Insys Therapeutics, Inc.|Larry Dillaha, M.D., Chief Medical Officer|602-910-2617|ldillaha@insysrx.com|
21275539|NCT01596127|The University of Texas MD Anderson Cancer Center|Elias Jabbour MD/Associate Professor|713-792-7734|CR_Study_Registration@mdanderson.org|
21275540|NCT01566435|Washington University School of Medicine|Douglas Adkins, M.D.|314-747-7402|dadkins@wustl.edu|
21275541|NCT00438633|Massachusetts General Hospital|Dr. Neal Chen|6177264700|nchen1@partners.org|
21275542|NCT00421304|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
21275543|NCT03196284|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21275544|NCT02614196|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21275545|NCT00919711|Amgen Inc.|Study Director|866-572-6436||
21275546|NCT03018925|Institut d'Investigació Biomèdica de Girona - Hosp Univ Dr Josep Trueta|MD PhD X Aldeguer|34972940200|xaldeguer.girona.ics@gencat.cat; abahi@idibgi.org|2401
21275547|NCT00087529|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21275548|NCT01562613|Abbott|Taco Baardman||taco.baardman@abbott.com|
21275549|NCT04388787|Virginia Commonwealth University|Olivier Rolin, MD, PhD|(804) 828-4230|olivier.rolin@vcuhealth.org|
21275550|NCT00663234|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
21275551|NCT00840840|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21275552|NCT01253564|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
21275553|NCT01723202|The Ohio State University Comprehensive Cancer Center|Dr. Bhavana Konda|614-366-5068|Bhvana.konda@osumc.edu|
21275554|NCT03694197|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21275555|NCT01800838|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Elma Baron|216-368-4971|elma.baron@uhhospitals.org|
21275556|NCT02940522|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
21275557|NCT05135273|Laboratory of Malaria Immunology and Vaccinology, NIAID/NIH|Dr. David Cook|240.627.3066|david.cook@nih.gov|
21275558|NCT01680016|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21275559|NCT02569541|Arrevus, Inc.|Carl Kraus, MD (CEO)|9193665503|ckraus@arrevus.com|
21275560|NCT03460990|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21275561|NCT01958060|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21275562|NCT00377572|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21275563|NCT01273857|Okayama University Hospital|Prof. Hidemasa Oh|+81-086-235-6506|hidemasa@md.okayama-u.ac.jp|
21275564|NCT03480685|Avinger, Inc.|Thomas Lawson, PhD|650-241-7030|tlawson@avinger.com|
21275565|NCT04980456|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21303382|NCT01007253|The University of Chicago|Dr. Robert M. Naclerio, MD|(773) 702-1865|rnacleri@surgery.bsd.uchicago.edu|
21238589|NCT03479697|Atrium Wake Forest Baptist Health School of Medicine|Charles Tegeler, MD|336-716-9447|BBRP@wakehealth.edu|
21275566|NCT01134198|new york state psychiatric institute|wilfrid raby, md|212-923-3031|wilfrid.raby@nyspi.columbia.edu|
21275567|NCT02846883|Roudebush VA Medical Center|Michael P. Murphy, MD|317-988-4049|mipmurph@iupui.edu|
21275568|NCT00927251|Medtronic, Bakken Research Center|Model 4296 Left Ventricular (LV) Lead Study Sr. CRS|+31-43-3566602|margriet.kruijshoop@medtronic.com|
21275569|NCT01550367|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS|412-647-5554|stadtermanbm@upmc.edu|
21275570|NCT04492397|Coopervision|Jose A. Vega, O.D., MSc, FAAO|9256213761|JVega2@coopervision.com|
21275571|NCT00442351|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21275572|NCT05353036|Nationwide Children's Hospital|Dr. Joseph D. Tobias|614-722-4200|joseph.tobias@nationwidechildrens.org|
21275573|NCT03023709|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
21275574|NCT00122447|Emory University School of Medicine|Mary Rhee, M.D.|404-778-1660|mrhee@emory.edu|
21275575|NCT01074008|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
21275576|NCT00578968|Mayo Clinic|Bruce D. Johnson, PhD|507-284-4441|johnson.bruce@mayo.edu|
21275577|NCT00945334|Cedars-Sinai Medical Center|Mark Pimentel|3104233792|chuak@cshs.org|
21275578|NCT00603564|IRCCS Fondazione Po.Ma.Re, Milan, Italy|Roberto Cosentini, MD|00390255033602|roberto.cosentini@policlinico.mi.it|
21275579|NCT04489303|Photozig, Inc.|Bruno Kajiyama|6506947496|info@photozig.com|
21275580|NCT01453153|Halozyme Therapeutics|Dimitrios Chondros, M.D., Chief Medical Officer|858-794-8889|dchondros@halozyme.com|
21303383|NCT00123643|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
21275581|NCT01350934|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21275582|NCT03547635|Integra LifeSciences|Jessica Knowlton, Sr Mgr, Clinical Research & PMCF Strategy|609-325-0111|jessica.knowlton@integralife.com|
21275583|NCT01813435|Jessa Ziekenhuis, Hasselt, Belgium|Dr. Pascal Vranckx|+32 11 30 9589|pascal.vranckx@jessazh.be|
21275584|NCT01435824|The Hospital for Sick Children|Dr. Shinya Ito|416-813-5776|shinya.ito@sickkids.ca|205776
21275585|NCT01011335|Uniformed Services University of the Health Sciences|David Tribble, MD, DrPH|301-816-8404|dtribble@idcrp.org|
21275586|NCT03028896|SNUBH|Dr. Bon-wook Koo|+82-10-7227-1379|tendong2@gmail.com|31
21275587|NCT00275275|University of Kansas Medical Center|Kelly E. Lyons, PhD|913-588-7159|klyons@kumc.edu|
21275588|NCT02415387|Center for Biostatistics, The Ohio State University|Juan Peng|614-293-5869|juan.peng@osumc.edu|
21275589|NCT00117806|James A. Haley Veterans' Hospital|Lisa Ottomanelli, PhD|813-558-3917|lisa.ottomanelli@va.gov|
21275590|NCT01765751|Palmer College of Chiropractic|Maruti R. Gudavalli, PhD|563-884-5260|gudavalli_r@palmer.edu|
21275591|NCT01243151|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21275592|NCT00072514|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org|
21275593|NCT01579006|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21275594|NCT01710358|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21275595|NCT02383706|Duke University Medical Center|Dr Jennifer Dominguez|(919) 668-2024|jennifer.dominguez@dm.duke.edu|
21275596|NCT00799708|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21275597|NCT00880334|Dana-Farber Cancer Institute|Toni Choueiri, MD|617-632-5456|toni_choueiri@dfci.harvard/edu|
21275598|NCT00859040|Dana-Farber Cancer Institute / Brigham & Women's Hospital|Patrick Y. Wen, MD|617-632-2166|pwen@partners.org|
21275599|NCT01149434|Huntsman Cancer Institute Unversity of Utah|Sunil Sharma, MD|801-585-0255|sunil.sharma@hci.utah.edu|
21275600|NCT02274558|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
21275601|NCT02318550|Lancaster General Health|Project Manager|7175447395|Tawnya.Vernon@pennmedicine.upenn.edu|
21275602|NCT00963430|Group Health Research Institute|Lisa Jackson, MD, MPH|206-442-5216||
21275603|NCT03167606|Columbia University|Dr. Rebecca Schnall, RN, MPH, PhD, Professor of Disease Prevention and Health Promotion (in Nursing)|212-342-6886|rb897@cumc.columbia.edu|
21275604|NCT03314857|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@edwards.com|
21275605|NCT00555893|Marshfield Clinic Research Foundation|Edward Belongia, MD|715-389-3783|belongia.edward@mcrf.mfldclin.edu|
21275606|NCT00397254|Clinvest|M.E. Beach|417-841-3618|mbeach@clinvest.com|
21275607|NCT01250730|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21275608|NCT00152451|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21275609|NCT00897676|The Children's Hospital of Philadelphia|Diva DeLeon, MD|267-426-5529|deleon@email.chop.edu|
21275610|NCT00323258|Duke University Medical Center|Sara Calvert, PharmD|919-668-7540|sara.calvert@duke.edu|
21275611|NCT01943435|University of Pittsburgh|Michael Schneider, PhD, DC - Associate Professor and Principal Investigator|412-383-6640|mjs5@pitt.edu|
21275612|NCT01412281|Crucell Switzerland|Medical Affairs Director|+41(0)319806111|info@crucell.com|
21275613|NCT01728636|Northwestern University|Luanne Carabini MD|312-695-0061|l-carabini@northwestern.edu|
21275614|NCT01936662|IndianaU|Nicole Horn, MD|3179449981|ndhorn@hotmail.com|
21275615|NCT04473326|Brigham and Women's Hospital|Julie Lauffenburger, PharmD, PhD|617-525-8865|jlauffenburger@bwh.harvard.edu|
21275616|NCT02046122|Duke University|Anthony Sung, MD|919-668-1002|anthony.sung@duke.edu|
21275617|NCT04535986|Verona Pharma plc|Chief Medical Officer|See email|info@veronapharma.com|
21275618|NCT02533466|GlaxoSmithKline|GSK Response Center|866-435-7343||
21275619|NCT00252564|US Oncology|Allen L. Cohn|303- 388-4876|Allen.Cohn@USOncology.com|
21275620|NCT01097694|Brigham and Women's Hopsital|Elliot Israel, MD|617-732-8110|eisrael@partners.org|
21275621|NCT02179190|Medtronic Plc|Senior Manager, Clinical Project Management|949-680-1274|darren.j.lacour@medtronic.com|
21275622|NCT02571634|Womack Army Medical Center|Michael Bartoszek, MD|910-907-6000|michael.w.bartoszek.mil@mail.mil|
21275623|NCT00697827|Synthes|Ann Marie Simon|610-719-5418|simon.annmarie@synthes.com|
21275624|NCT04207333|University of North Carolina at Chapel Hill|Lee Stoner, PhD, MPH|919-962-0534|stonerl@unc.edu|
21275625|NCT04049097|Zevra Denmark A/S|Medical Affairs|+1-888-289-5607|medicalaffairs@zevra.com|
21275626|NCT04194151|Hospital Central de la Defensa Gomez Ulla|Dr. Paula Agostina VULLO|+34681054151|agosvullo@hotmail.com|
21275627|NCT00968019|Johnson and Johnson Medical Iberia|Mayda Lopez-Belmonte, PhD|+34 91 7228481|tlopezbe@its.jnj.com|
21275628|NCT01109576|VHAPORHCS|Mitchel Turbin, PhD|503-220-8262|Bonnie.Becker@va.gov|
21275629|NCT01188226|UCLA|Neal Garrett, MD||ngarrett@ucla.edu|
21275630|NCT02293460|LFB Biotechnologies|Clinical trial information desk|0033169827010|supportqcm@lfb.fr|
21275631|NCT01427881|Fred Hutchinson Cancer Research Center|Marco Mielcarek, MD|206-667-2827|mmielcar@fredhutch.org|
21275632|NCT00500318|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
21275633|NCT00706719|Repros Therapeutics, Inc|Ronald Wiehle, PhD|281.719.3406|rwiehle@reprosrx.com|
21275634|NCT04284553|Brigham and Women's Hospital|Niteesh Choudhry, MD, PhD|617-278-0930|nkchoudhry@bwh.harvard.edu|
21275635|NCT04225260|Galderma Research & Development|Galderma Research & Development|817-961-5000|clinical.studies@galderma.com|
21275636|NCT00224484|GlaxoSmithKline|GSK Response Center|866-435-7343||
21275637|NCT02805309|Hebrew SeniorLife Marcus Institute for Aging Research|Dr. Dae Hyun Kim, Associate Scientist|617-632-5362|daehyunkim@hsl.harvard.edu|
21275638|NCT01196117|Medical College of Wisconsin|B. Tucker Woodson|414-805-7667|bwoodson@mcw.edu|
21303384|NCT01159431|UCLA|Dr. Christopher DeGiorgio|310-206-3753|cmd@mednet.ucla.edu|
21303385|NCT02103153|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
21303386|NCT01484288|CVRx|Vice President, Global Clinical Research|763-416-2876|egalle@cvrx.com|
21303387|NCT02232880|Vanderbilt University|David Harrison||david.g.harrison@Vanderbilt.Edu|
21303388|NCT00604214|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21303389|NCT00534599|AstraZeneca|Gerard Lynch||AZtrial_results_posting@astrazeneca.com|
21303390|NCT01543581|Loma Linda University Health, Department of Dermatology|Dr. Abel Torres, PI|(909) 558-2055|atorres@llu.edu|
21303391|NCT00167778|Dept. of Veterans Affairs, Rehabilitation Research & Development Service|Glenn K. Klute, PhD|206-277-6724|Glenn.Klute@va.gov|
21303392|NCT04133064|Pivot Health Technologies Inc.|VP of Clinical and Medical Affairs|415-757-7696|marler@pivot.co|
21303393|NCT00814333|University of Kansas Medical Center|Kevin Sykes, PhD|913-588-7154|ksykes@kumc.edu|
21288538|NCT05166876|Clear Creek Bio, Inc.|Vikram Sheel Kumar|(617) 765-2252|kumar@clearcreekbio.com|
21288539|NCT00658528|Eisai Call Center|Eisai Inc.|888-422-4743||
21288540|NCT04901624|University of Southern California|Dr. Jason Doctor|213.821.8142|jdoctor@usc.edu|
21288541|NCT03654417|Duke University|Dr. Laura Havrilesky|(919) 684-0188|laura.havrilesky@duke.edu|
21288542|NCT01147458|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21288543|NCT02811159|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21288544|NCT01859091|Zeltiq Aesthetics|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
21288545|NCT05759338|Wake Forest University Health Sciences|Amy McMichael|704-355-2000|Amy.Mcmichael@Advocatehealth.org|
21288546|NCT04409002|Massachusetts General Hospital|Theodore Hong, MD|617-726-6050|TSHONG1@mgh.harvard.edu|
21288547|NCT01471639|Cleveland Clinic Healthcare System|Sharon Mace MD|216-445-4598|maces@ccf.org|
21288548|NCT04611126|National Center for Cancer Immune Therapy (CCIT-DK)|MD, PhD Tine Juul Monberg|38682983|tine.monberg@regionh.dk|
21288549|NCT02546570|National Center for PTSD|Dr. Lauren Sippel|802-295-9363|lauren.m.sippel@dartmouth.edu|6082
21288550|NCT02199496|NIAID - LCIM|Fuss, Ivan|+1 301 496 9663|ifuss@niaid.nih.gov|
21288551|NCT04190225|Brown University|Dr. Shira Dunsiger, Biostatistician|401-863-6747|shira_dunsiger@brown.edu|
21288552|NCT02362451|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|hoyoung.maeng@nih.gov|
21288553|NCT00884065|Catalan Institut of Health - Servei de Rhb Sant Ildefons|Martín Eusebio Barra López||martinbarra@gmail.com|
21288554|NCT01732783|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21288555|NCT04429971|Rutgers New Jersey Medical School|Ethan Cowan, MD, MS, FACEP|917-447-4964|ethan.cowan@rutgers.edu|
21288556|NCT01866592|University of Pennsylvania|Suzette Baez VanderBeek, MPH|2156623514|suzette.baezvanderbeek@uphs.upenn.edu|
21288557|NCT00626236|Supernus Pharmaceuticals|Gianpiera Ceresoli-Borroni Director Clinical Research|3018382521|gceresoliborroni@supernus.com|
21288558|NCT05522751|University of California San Francisco|Khaled Moussawi|415-502-6343|khaled.moussawi@ucsf.edu|
21288559|NCT06487390|University of Alabama at Birmingham|Dr. Lynn Matthews|2059348148|lynnmatthews@uabmc.edu|
21288560|NCT04044690|CSL Behring|Study Director|16108784697|clinicaltrials@cslbehring.com|
21288561|NCT01582451|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21288562|NCT03318341|MUSC|Na Jin Seo, PhD|8437920084|seon@musc.edu|
21288563|NCT05472142|University of Kentucky|Mary E. Lacy, PhD, Study PI|8595621126|mary.lacy@uky.edu|
21288564|NCT04092777|Massachusetts General Hospital|Dr. Margarita Alegria|617-724-1237|malegria@mgh.harvard.edu|
21288565|NCT02550795|Gil hospital|Dr. Youn Yi Jo|82324603636|endless37@gilhospital.com|
21288566|NCT02225587|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21288567|NCT04063163|ShanghaiHenliusBiotech|Fan Zhang|021-33395800*6334|Fan_Zhang2@henlius.com|
21303394|NCT01879579|New York University School of Medicine|Dr. Natalie Levy|2122638924|Natalie.Levy@nyumc.org|
21303395|NCT02927067|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21303396|NCT01695668|University of Michigan|Dr Shahzad Mian|734-647-8397|smian@med.umich.edu|
21303397|NCT00134784|Institute for Neurodegenerative Disorders|Principal Investigator|203 401 4300|kmarek@indd.org|
21303398|NCT03384693|University of California, San Francisco|Dr. Christine Higham|415-476-2188|christine.higham@ucsf.edu|
21303399|NCT02057042|VA Center for Clinical Managment Research|Paul Pfeiffer|7348453649|paul.pfeiffer@va.gov|
21303400|NCT01099709|Purdue Pharma LP|Stephen C. Harris, MD|203-588-7592|Stephen.Harris@pharma.com|
21303401|NCT01276197|CHOIR|Dr. Thomas K. Houston|781-687-2884|thomas.houston2@va.gov|
21303402|NCT01275339|Washington University School of Medicine|Brian R. Lindman, MD|615-936-5949|brlindman@wustl.edu|
21303403|NCT03718299|Sun Pharmaceutical Industries Limited|Head-Clinical Development|2266455645|clinical.trials@sunpharma.com|5689
21303404|NCT04389970|University of Alabama at Birmingham|Brooks Wingo|2059345982|bcwingo@uab.edu|
21303405|NCT03123185|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21303406|NCT02153476|Allegro Ophthalmics, LLC|Director of Clinical Research|949-444-5722|lkarageozian@allegroeye.com|
21303407|NCT00357032|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
21303408|NCT01397825|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21303409|NCT00976508|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21303410|NCT01993836|Duke University|Miles Berger, MD, PhD|919-684-8679|miles.berger@duke.edu|
21303411|NCT02677324|DFCI|Jorge J. Castillo|617-632-2681|jorgej_Castillo@dfci.harvard.edu|
21303412|NCT00461331|Tulane University Health Sciences Center|Tina K. Thethi, MD, MPH|504-988-5044|tthethi@tulane.edu|
21303413|NCT00761150|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21303414|NCT00475423|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21303415|NCT01214174|Icon Bioscience, Inc.|Wendy Murahashi, MD|650-369-4049|wendymurahashi@iconbioscience.com|
21303416|NCT00290407|James Graham Brown Cancer Center|Roger H Herzig, MD|502/396-3119|rhherz01@louisville.edu|
21303417|NCT01076296|GE Healthcare|Anita Johnson|262-548-2825|Anita.Johnson@ge.com|
21303418|NCT01925989|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21303419|NCT01499862|Department of Physical Therapy and Rehabilitation, University of California San Francisco|Dr. Nancy N. Byl|415-514-4816|byln@ptrehab.ucsf.edu|
21303420|NCT00868517|Department of Veterans Affairs|Michelle Kennedy Prisco|202-745-8000|michelle.prisco@va.gov|56235
21303421|NCT05072470|Sonova USCS|Research Audiologist|630-821-5000|phonakaudiologyresearch@gmail.com|
21303422|NCT02496676|National Institute of Allergy and Infectious Diseases|Ravell Aumaitre, Juan|+1 301 761 6669|juan.ravell@nih.gov|
21303423|NCT05442775|Cytokinetics|Cytokinetics MD|650-624-2929|medicalaffairs@cytokinetics.com|
21303424|NCT03723603|Medline Industries, Inc|Stephanie Martynenko|2242163822|smartynenko@medline.com|
21275639|NCT01636934|UT MD Anderson Cancer Center|Zhongxing Liao, MD/ Professor, Radiation Oncology Department|(713) 563-2300|zliao@mdanderson.org|
21275640|NCT03239496|FIDEC Corporation|Ricardo Rüttimann|+17863546335|rruttimann@fidec-online.org|
21275641|NCT03035890|WVCTSI|Tara Riddle|304-581-1829|tlr0011@hsc.wvu.edu|
21275642|NCT03243396|Duke University|Kathryn Whetten, PhD, MPH|919-613-5313|k.whetten@duke.edu|
21275643|NCT03687242|Spruce BioSciences Inc.|Spruce CMO, MD|415-655-4169|clinicaltrials@sprucebio.com|
21303425|NCT03459690|Beth Israel Deaconess Medical Center|Balachundhar Subramaniam|617-634- 2721|bsubrama@bidmc.harvard.edu|
21303426|NCT02963831|Ludwig Institute for Cancer Research|Jonathan Skipper|12124501539|jskipper@lcr.org|
21303427|NCT01966432|Duke University, Dept. of Psychiatry and Behavioral Sciences|Dr. Li-Tzy Wu, Professor in Psychiatry|(919) 889-9369|litzy.wu@duke.edu|
21303428|NCT01361854|CHU St Pierre|Dr Marie Bruyneel|003225354219|Marie_BRUYNEEL@stpierre-bru.be|
21303429|NCT00040846|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
21303430|NCT02830438|AlbertEHN|Mario Naranjo-Tovar|2157965542|mario.edu6@hotmail.com|
21303431|NCT02536404|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
21303432|NCT03915860|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
21303433|NCT04559529|Vanderbilt University Medical Center|Stephan Heckers, MD; Principal Investigator|6153222665|stephan.heckers@vumc.org|
21303434|NCT01009281|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21303435|NCT00579436|University of Kentucky|Phillip Kern|859 323 4933|pake2222@uky.edu|
21303436|NCT03901456|University of Minnesota|Joseph Gaugler, PhD|612-626-2485|gaug0015@umn.edu|
21303437|NCT02217527|Univ of Pittsburgh|Dr. Kenneth A. Perkins, Prof of Psychiatry|412-246-5395|perkinska@upmc.edu|
21303438|NCT01203852|University of Florida|Dr. Julie A. Johnson|(352) 273-6309|johnson@cop.ufl.edu|
21303439|NCT02582684|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21303440|NCT01878149|Baxano Surgical®|Sr. Director of Clinical Affairs|919.899.9760|teresa.schroeder@baxsurg.com|
21303441|NCT05478681|The University of Texas Health Science Center at Houston|Kendra M Anderson, PhD|713-486-0513|Kendra.M.Anderson@uth.tmc.edu|
21303442|NCT01431300|Duke University Medical Center|Charles Kim|919-684-7284|charles.kim@duke.edu|
21303443|NCT06390839|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21303444|NCT01495676|INSTITUT REGIONAL DU CANCER DE MONTPELLIER|Mme Aurore Moussion, Director of Direction of Clinical Research and Innovation|0467613102|drci-icm105@icm.unicancer.fr|+33
21303445|NCT00502203|UT MD Anderson Cancer Center|Lois M. Ramondetta, MD / Professor||CR_Study_Registration@mdanderson.org|
21303446|NCT02720094|HPTN Statistical & Data Management Center|HPTN Statistical Manager|206-667-4004|HPTN-Data-Access@scharp.org|
21303447|NCT02055638|Azevan Pharmaceuticals, Inc.|Dr. Neal Simon, CEO|(610) 419-1057|ngsimon@azevan.com|
21303448|NCT01911910|Queen Mary University London/ Barts Health NHS Trsut|Dr Mohammed Khanji|020 7363 8079|m.khanji@qmul.ac.uk|
21303449|NCT01431638|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21303450|NCT03836001|Stanford University|Albert Chiou|(650) 721-8418|achiou@stanford.edu|
21303451|NCT01381562|GlaxoSmithKline|GSK Response Center|866-435-7343||
21303452|NCT02660138|Ipsen|Medical Director|See email|clinical.trials@ipsen.com|
21303453|NCT04876690|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21303454|NCT00308581|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
21303455|NCT02438475|Medstar Health Research Institute|Megan Rowland|202-877-2959|megan.e.rowland@medstar.net|
21303456|NCT00899353|Marshall University Joan C. Edwards School of Medicine|Dr. W. Elaine Hardman|304-696-3721|hardmanw@marshall.edu|
21303457|NCT04475198|SiteOne Therapeutics|John Mulcahy|+1 (650) 392-0419|john.mulcahy@site1therapeutics.com|
21303458|NCT04604132|Basilea Pharmaceutica International Ltd, Allschwil|Manuel Häckl, MD|+41 76 302 53 10|manuel.haeckl@basilea.com|
21303459|NCT00952380|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21303460|NCT03235180|Mayo Clinic|Shigao Chen, Ph.D.|507-284-3703|Chen.Shigao@mayo.edu|
21303461|NCT00053898|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org|
21303462|NCT03848871|Skin Sciences, PLLC|Maureen McAllister|5024519000|mmdermresearch@yahoo.com|
21303463|NCT03705273|Vanderbilt University School of Medicine|Donald H. Arnold, MD, MPH|16155790516|don.arnold@vumc.org|
21275644|NCT04578132|An organization designated by the Sponsor|A person designated by the Sponsor|+34934344412|investigacion@mfar.net|
21303464|NCT00830076|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21303465|NCT04085367|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
21275645|NCT04632641|Aurora Health Care|Dr. Mahmoud Ali|(262) 948-6630|mahmoud.ali@aah.org|
21275646|NCT00288704|Regeneron Pharmaceuticals|Doug Nadler, MS Statistics|914 345 7905|clinicaltrials@regeneron.com|
21275647|NCT02473393|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21275648|NCT02153723|Montefiore Medical Center|Aleksandra Djukic|718 920 4378|adjukic@montefiore.org|
21275649|NCT01257581|Massachusetts General Hospital|Nazem Atassi, MD|617-643-1807|natassi@partners.org|
21275650|NCT01157234|University of Florida|Alfonso H. Santos Jr, M,D,|352-273-6374|Alfonso.santos@medicine.ufl.edu|
21275651|NCT03033134|Boston Scientific Japan|Yutaka Gomi|+81.3.6853.7500|Yutaka.Gomi@bsci.com|
21275652|NCT02212106|bioCSL PTY LTD|Clinical Program Director||bioCSL.ClinicalTrials@biocsl.com.au|
21275653|NCT02509260|Cleveland Clinic Foundation|Dr. David Liska|1-216-444-9219|liskad@ccf.org|
21275654|NCT01853371|Ministry of Health|Dr. Nouran Aleyeidi|00966504304577|dr.nouran@live.com|
21275655|NCT01876953|City of Hope Medical Center|Ahmed Aribi|626-359-8111|aaribi@coh.org|
21275656|NCT02733627|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21275657|NCT00059332|UCLA, David Geffen School of Medicine|Dr. Jeffrey Saver|310-794-6379|jsaver@mednet.ucla.edu|
21275658|NCT01286805|Hospital for Special Surgery|Dr. Jacques YaDeau|212-606-1206|yadeauj@hss.edu|
21275659|NCT01408888|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21275660|NCT03490916|UMass Medical School|Principal Investigator|4136279111|vincent.kan08@gmail.com|
21238590|NCT03764072|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21275661|NCT02181140|Interdisciplinary Endoscopy Department and Clinic University Hospital Hamburg-Eppendorf|Professor Dr. Thomas Rösch|+4940 7410|t.roesch@uke.de|50098
21238591|NCT00766675|Janssen Pharmaceutics Taiwan|Medical Affairs Director|+886-2-23762155||
21238592|NCT03308825|Sanofi Pasteur Inc.|Medical Director|800-633-1610|RegistryContactUs@sanofipasteur.com|1#
21238593|NCT05650164|Merck Healthcare KGaA, DarmstadtGermany, an affiliate of Merck KGaA,Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21238594|NCT02044848|Novartis Pharmaceuticals|Study Director|862-778-8300||
21238595|NCT00045708|Johns Hopkins - Adult Brain Tumor Consortium (ABTC)|Director Adult Brain Tumor Consortium|410-955-8837|jfisher@jhmi.edu|
21238596|NCT00278538|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
21238597|NCT00685945|Vanderbilt University|Dr. Mias Pretorius|615-343-0665|mias.pretorius@vanderbilt.edu|
21238598|NCT03183388|Yale School of Medicine|Dr. Hilary Blumberg|203-785-6180|hilary.blumberg@yale.edu|
21275662|NCT01207752|Southern California College of Optometry at MBKU|Jerry Paugh, OD, PhD|714-449-7487|jpaugh@ketchum.edu|
21288568|NCT05495997|Yale School of Medicine|Sule Tinaz|203-737-6158|sule.tinaz@yale.edu|
21238599|NCT01679236|University of Wisconsin|James M. Davis MD, Assistant Professor, Duke University|608-217-9405|jjamesdavis@hotmail.com|
21238600|NCT05418777|William Beaumont Hospitals|Maureen Cooney, RN Clinical Research Manager|2485510099|maureen.cooney@corewellhealth.org|
21238601|NCT00201864|The Ohio State University|Ewa Mrozek|614-293-7956|Ewa.Mrozek@osumc.edu|
21238602|NCT00071721|Alzheimer's Disease Cooperative Study|Paul Aisen|858-622-2028|paisen@ucsd.edu|
21238603|NCT02882711|The University of Texas Health Science Center at Houston|Salih Selek, M.D.|713-741-3936|salih.selek@uth.tmc.edu|
21238604|NCT02597790|David Geffen School of Medicine at UCLA|Kara Chew, MD, MS|310-825-0796|kchew@mednet.ucla.edu|
21238605|NCT00299000|BioMarin Pharmaceutical Inc.|Medical Information Services|800-983-4587|medinfo@bmrn.com|
21275663|NCT01586039|Brigham and Women's Hospital|Dr. Steven W. Lockley|617-732-4977|slockley@hms.harvard.edu|
21288569|NCT02572167|Seagen Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
21288570|NCT00580840|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
21288571|NCT00976027|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21288572|NCT00261040|The Ottawa Hospital - Ottawa Hospital Research Institute|Dr Paul Kim|613-737-8920|pkim@toh.ca|
21288573|NCT06407375|University Hospital Zurich|Dr. Toni Rabadi|043 254 41 10|radiologie@usz.ch|
21288574|NCT06181799|I.M. Sechenov First Moscow State Medical University (Sechenov University)|Basheer Abdullah Marzoog|+7(996) 960 28 20|marzug@mail.ru|
21288575|NCT01771107|Emmes Company|Kimberly Mosby-Griffin|301 251-1161|kmosby@emmes.com|10158
21288576|NCT01160614|Purdue Pharma L.P.|Medical Services|888-726-7535, option 1||
21288577|NCT03805841|Rain Oncology Inc.|Chief Medical Officer|(510) 953-5559|info@rainoncology.com|
21288578|NCT05248386|Grünenthal GmbH|Grünenthal Clinical-Trials Helpdesk|000|clinical-trials@grunenthal.com|000
21288579|NCT01723774|Washington University School of Medicine|Cynthia X. Ma, M.D., Ph.D.|314-362-9383|cynthiaxma@wustl.edu|
21288580|NCT02964182|MD Anderson Cancer Center|Jason Robinson, PhD|713-792-2265|nicotinestudy@mdanderson.org|
21303466|NCT00130442|Progen Pharmaceuticals Ltd|Director of Regulatory Affairs and Clinical Development|+61 (0)7 38423333|darrynb@progen-pharma.com|
21303467|NCT02233946|Boston Children's Hospital|Dr. Sion Kim Harris|8572184304|sion.harris@childrens.harvard.edu|
21303468|NCT00910247|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
21303469|NCT02292784|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21303470|NCT00622739|Baylor College of Medicine|Kirti Saxena|832-822-4065|kxsaxen1@texaschildrens.org|
21303471|NCT02519855|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21288581|NCT02595892|Dana-Farber Cancer Institute|Panagiotis Konstantinopoulos, MD, PhD|617-632-5269|panagiotis_konstantinopoulos@dfci.harvard.edu|
21303472|NCT01206387|Taro Pharmaceuticals U.S.A., Inc|Director, Clinical Research|914-345-9001|natalie.yantovskiy@taro.com|
21303473|NCT02155946|VA Ann Arbor|Dr. Benjamin Hampstead|734-763-9259|bhampste@med.umich.edu|
21303474|NCT00706849|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
21303475|NCT01611454|Baptist Health South Florida|Raul Herrera, MD. Director Miami Cardiac and Vascular Institute|786-596-3505|raulh@baptisthealth.net|
21303476|NCT02873585|University of North Carolina at Chapel Hill|Angela Broome, DDS, MS|9195373160|abroome@unc.edu|
21303477|NCT00920907|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21303478|NCT02616601|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
21303479|NCT00718081|AcelRx|Dr. Pamela Palmer|650-216-3500|ppalmer@acelrx.com|
21303480|NCT01555957|University of Rochester|Sanjiv Amin|585-273-2696|sanjiv_amin@urmc.rochester.edu|
21303481|NCT01931670|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21303482|NCT00815516|Astellas Pharma Global Development, Inc. (APGD)|Senior Medical Director, Global Medical Science||Astellas.resultsdisclosure@astellas.com|
21303483|NCT01689909|Medical College of Georgia; Augusta University|William Vaughn McCall|706-721-6719|WMCCALL@augusta.edu|
21303484|NCT00244842|Aurinia Pharmaceuticals Inc.|Robert Huizinga|250-708-4322|rhuizinga@auriniapharma.com|
21303485|NCT02415855|University of Alberta|Dr. Kenneth Butcher|780-407-4366|ken.butcher@ualberta.ca|
21303486|NCT03042702|Innovation Pharmaceuticals|Arthur P. Bertolino MD, PhD, MBA|9789214125|abertolino@IPharmInc.com|
21303487|NCT01063712|"Cardiology Medical Center Kardiozentrum"|Alexandra Heath MD Ph.D|005912 2785037|draheath@gmail.com|
21303488|NCT00329901|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21303489|NCT05028361|Duke Human Vaccine Institute|Emmanuel Walter|919 620 5346|chip.walter@duke.edu|
21303490|NCT02195687|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21303491|NCT02288377|FFCD|Karine Le Malicot|+ 33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
21303492|NCT02296138|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21303493|NCT04369924|University of Miami|Amanda Jensen-Doss|3052848332|ajensendoss@miami.edu|
21303494|NCT01653132|Beth Israel Deaconess Medical center|Dr. Pushpa Narayanaswami|617-667-8130|pnarayan@bidmc.harvard.edu|
21303495|NCT03828370|Klein Buendel Inc.-|Dr. W. Gill Woodall, Ph. D.|5053829796|gwoodall@kleinbuendel.com|
21303496|NCT04739865|COMPASS Pathways|Chief Medical Officer|07443136539|info@compasspathways.com|
21303497|NCT00584740|Novartis|Study Director|862-778-8300||
21303498|NCT02106923|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21303499|NCT03485495|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
21303500|NCT01178827|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21303501|NCT01107379|Acclarent, Inc.|Clinical Director|650-687-5888|lenglan1@its.jnj.com|
21303502|NCT00548405|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21288582|NCT01139879|Wolcott and Associates|Randy Wolcott|806-793-8869|lisa@randallwolcott.com|
21288583|NCT03636477|Alaunos Therapeutics|Jaymes Holland|6502732627|jholland@alaunos.com|
21288584|NCT05807477|UCSF Hypoxia Research Laboratory|Dr. Philip Bickler|1-415-476-1411|philip.bickler@ucsf.edu|
21288585|NCT02382380|Loyola University Medical Center|Ari Goldberg, M.D.|708-216-2229|argoldberg@lumc.edu|
21288586|NCT01295944|National Cancer Institute|Dr. Kevin Camphausen|240-760-6205|camphauk@mail.nih.gov|
21288587|NCT03275168|Johns Hopkins University|Dr Maria Trent|4109552910|mtrent2@jhu.edu|
21288588|NCT04383223|Emory University|Dr. Sophia Hussen|404-727-2446|sophia.ahmed.hussen@emory.edu|
21288589|NCT03036254|Icahn School of Medicine at Mount Sinai|Dr. Mary Sano|(212) 659-8838|mary.sano@mssm.edu|
21288590|NCT02783274|Johnson & Johnson MedTech|Kirstin Cosgrove|+1 574 4049398|kcosgro1@its.jnj.com|
21288591|NCT03013751|Mezzion Pharmaceuticals, Inc|Director of Clinical Operatons|3128980292|wg.kim@mezzion.com|
21288592|NCT02213003|Diabetes Research Institute/University of Miami|Rodolfo Alejandro, MD|305-243-3389|Ralejand@med.miami.edu|
21288593|NCT05722015|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21288594|NCT01802281|RTI International|Marie Gantz|919-541-5110|mgantz@rti.org|
21288595|NCT04798768|Boston Scientific|Julie West|651-582-4721|Julie.West@bsci.com|
21288596|NCT05020743|Vigil Neuro|VP, Clinical & Medical Sciences|+18572280538|jchavez@vigilneuro.com|
21288597|NCT03488524|Amylyx Pharmaceuticals, Inc.|Chief Medical Officer|(877) 374-1208|medinfo@amylyx.com|
21288598|NCT00830765|UMississippi|Dr John Morrison|601-984-5300|jmorrison@umc.edu|
21288599|NCT02390284|University of Miami|Dr. Vittorio Porciatti|3053266050|vporciatti@med.miami.edu|
21288600|NCT01299909|University of Wisconsin|Stevens S. Smith, Ph.D.|608-262-7563|sss@ctri.wisc.edu|
21288601|NCT01811238|Samsung Medical Center|Dr.Sungsoo Chung|82-3410-1226|ssc0385@skku.edu|
21275664|NCT02518139|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
21275665|NCT02429583|The Rockefeller University|Aileen O'Connell, Laboratory Manager|212-327-7047|aoconnell@rockefeller.edu|
21303503|NCT00924170|National Cancer Institute|Dr. Robert Kreitman|301-496-6947|Robert_Kreitman@nih.gov|
21275666|NCT01698554|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21303504|NCT05318183|The Ohio State University|Richard Bruno|614.292.5522|bruno.27@osu.edu|
21275667|NCT01617096|International Partnership for Microbicides|Dr John Steytler|+27218602300|jsteytler@ipmglobal.org|
21275668|NCT01753362|University at Buffalo|Dr. Paresh Dandona|716-535-1850|dandona@buffalo.edu|
21275669|NCT00106106|NIH/National Institute on Alcohol Abuse and Alcoholism|Markus A. Heilig, M.D., Ph.D.|301-435-9386|mheilig@mail.nih.gov|
21275670|NCT01196390|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21275671|NCT01632215|Federal University of São Paulo|Dr. Rioko K. Sakata|055 11 5084 7463|riokoks.dcir@epm.br|
21275672|NCT01885897|Masonic Cancer Center, University of Minnesota|Dr. Jeffrey Miller|612-626-4024|mille011@umn.edu|
21275673|NCT03141151|Vanderbilt University Medical Center|William Heerman, MD MPH|615-322-7080|bill.heerman@vumc.org|
21275674|NCT04561115|Grifols Therapeutics LLC|Rhonda Griffin|+1 919 757 1744|rhonda.griffin@grifols.com|
21275675|NCT03259165|Indiana University School of Medicine|Peter S. Pang|317-880-3900|ppang@iu.edu|
21303505|NCT06400251|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21303506|NCT04672252|NYU Langone Health|Michael J. Alaia, MD|(646) 501-7223|Michael.Alaia@nyulangone.org|
21303507|NCT00899392|Children's Hospital of Philadelphia/OHSU/Doernbecher Children's Hospital|Joel A Friedlander|503-494-1078|friedlan@ohsu.edu|
21303508|NCT01903252|Tillotts Pharma AG|Dr. Robert Hofmann, MD PhD|+4161 935 27 14|robert.hofmann@tillotts.com|
21303509|NCT01642732|University of Michigan Hospital|Dr. Daniel Hamstra, Associate Professor of Radiation Oncology|734-936-4300|dhamm@umich.edu|
21303510|NCT02805504|Loma Linda University Health|Duane Baldwin, MD Director of Urologic Research|909 558 4196|dbaldwin@llu.edu|
21303511|NCT01230125|Bausch Health|Study Director||susan.harris@bauschhealth.com|
21303512|NCT01138917|AVITA Medical|Director of Clinical Research|661-367-9170|clinicaltrial@avitamedical.com|
21303513|NCT02819908|Eye Center of N Florida|Christina Menck|8507843937|eyenerdgyrl1@gmail.com|1124
21303514|NCT04658940|Acutus Medical|Karen Stephens, Director Clinical Affairs|442-232-6080|karen.stephens@acutus.com|
21303515|NCT03579602|Blaze Bioscience|Dr. Kristi Harrington|206-535-8144|Clinical.trials@blazebioscience.com|
21303516|NCT03044574|Pirogov Russian National Researching Medical University|Dr. Kirill Lobastov, Associated professor at the Department of General Surgery and Radiology|+7-985-211-63-31|lobastov_kv@hotmail.com|
21303517|NCT01254942|The University Of British Columbia|Associate Professor MC Ashe|604-675-2574|maureen.ashe@ubc.ca|
21303518|NCT01077375|Forest Research Institute|Allan Spera, Director, Clinical Development|(201) 427-8399|Allan.Spera@frx.com|
21303519|NCT03720392|Massachusetts General Hospital|Zachariah DeFilipp, MD|617-643-3944|ZDEFILIPP@MGH.HARVARD.EDU|
21303520|NCT01924429|Icahn School of Medicine at Mount Sinai|Dr. Jeffrey Newcorn|212-659-8775|Jeffrey.newcorn@mssm.edu|
21275676|NCT03174158|Massachusetts General Hospital|Dr. Gina Kruse|6177243157|gkruse@partners.org|
21275677|NCT03732833|Medytox Inc.|Young Ryu|+82-2-6901-5424|aab005@medytox.com|
21275678|NCT05068661|Duke University School of Medicine|Dr. Ashraf Habib|9196682024|habib001@mc.duke.edu|
21275679|NCT02004691|Sanofi-Aventis Recherche & Développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21275680|NCT02623218|AOMA Graduate School of Integrative Medicine|Dr. John Finnell|512-492-3057|jfinnell@aoma.edu|
21275681|NCT01726803|University of Utah|Julie Fritz|801-581-6861|julie.fritz@hsc.utah.edu|
21275682|NCT00759707|Brigham and Women's Hospital|Dr. Joshua Beckman|6175257053|jbeckman@partners.org|
21288602|NCT02517658|Nationwide Children's Hospital|Clinical Research Coordinator|6147222997|heather.dellinger@nationwidechildrens.org|
21288603|NCT01922934|Denver Health|Dr. Daniel H. Bessesen|303-602-5021|daniel.bessesen@ucdenver.edu|
21288604|NCT02290184|University of California San Francisco|Melinda Sarmiento Bender, PhD, RN|415 502 5668|melinda.bender@ucsf.edu|
21288605|NCT02530541|BSL|C. Beausoleil|406-587-5735|cbeausoleil@biosciencelabs.com|
21288606|NCT02353780|University of Pittsburgh|Larry Moreland, MD|412-648-4098|lwm5@pitt.edu|
21288607|NCT02354118|TriHealth|Rachel Baker, Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
21288608|NCT01034553|Mayo Clinic|Alexander Keith Stewart, M.B.CH.B|(480)301-4411|stewart.keith@mayo.edu|
21288609|NCT01270659|University of Oklahoma Health Sciences Center Tulsa|Dr. Nasir Mushtaw|918/660-3680|Nasir-Mushtaq@ouhsc.edu|
21288610|NCT04603066|Washington University in St Louis|Simon Haroutounian|3132861715|sharout@wustl.edu|
21288611|NCT02328014|Acerta Pharma|Global Clinical Lead|1-877-240-9497|information.center@astrazeneca.com|
21288612|NCT01092923|Austin Health|Dr Phil Peyton|9496 5000|phil.peyton@austinhealth.org.au|5704
21288613|NCT00177671|University of Pittsburgh|Charles F. Reynolds III, MD|412-246-6414|reynoldscf@upmc.edu|
21288614|NCT00255177|VGX Pharmaceuticals, LLC|Mary Giffear, Sr. Clinical Scientist|267 440 4220|mgiffear@inovio.com|
21288615|NCT01325441|Sumitomo Pharma Oncology|Tegan Nguyen|6176748745|tegan.nguyen@oncology.sumitomo-pharma.com|
21288616|NCT03765073|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21288617|NCT04426656|University of North Carolina at Chapel Hill|Chunyan Li, MSc|919-966-6695|chunyli@live.unc.edu|
21288618|NCT00619528|Northwestern University|Joseph Leventhal MD, PhD|312-695-0427|jleventh@nm.org|
21288619|NCT02296125|AstraZeneca AB|Global Clinical Leader|+46 766 346712|ClinicalTrialTransparency@astrazeneca.com|
21303521|NCT02889562|Sanford Health|Todd Chapin PharmD|701-417-2351|todd.chapin@sanfordhealth.org|
21288620|NCT00984399|Memorial Sloan Kettering Cancer Center|Dr. Shari Goldfarb, MD|646-888-5080|goldfars@mskcc.org|
21275683|NCT02805517|Loma Linda University Health|Dr. Duane Baldwin|909-588-4000|dbaldwin@llu.edu|44196
21275684|NCT01970592|Medical University of South Carolina|Chris Gregory|8437921078|gregoryc@musc.edu|
21275685|NCT00499473|The Ohio State University Comprehensive Cancer Center|Robert Cavaliere, MD|614-293-4968|Robert.Cavaliere@osumc.edu|
21275686|NCT03980522|Kiniksa Pharmaceuticals (UK), Ltd. c/o Kiniksa Pharmaceuticals Corp.|Clinical Operations Study Director|1-781-431-9100|studyinfo@kiniksa.com|
21275687|NCT01320722|Brigham and Women's Hospital|John P Forman, MD||jforman@partners.org|
21275688|NCT01091363|University of Massachusetts Medical School|Dr. Sun S Kim|201-388-2656|sun.kim@umb.edu|
21275689|NCT00784095|VA Health Services Research and Development|Dr. Karen Steinhauser|9196682148|karen.steinhauser@va.gov|
21275690|NCT01689155|Sanofi Pasteur Inc|Medical Drector||RegistryContactus@sanofipasteur.com|
21275691|NCT01215721|UC Irvine|Thomas Ahlering, MD|714-456-6068|tahlerin@uci.edu|
21275692|NCT00045162|SWOG Statistical Center|Lung Committee Statistician|206-667-4623||
21275693|NCT01044433|Abramson Cancer Center|Dr. Corey Langer|215-615-5121|Corey.Langer@uphs.upenn.edu|
21275694|NCT00826241|National Cancer Institute|Dr. Mark Gilbert|240-760-6023|gilbertmr@nih.gov|
21275695|NCT03407729|Case Western Reserve University|Dr. Michael J. Decker|2163682467|mjd6@case.edu|
21275696|NCT00193492|Sarah Cannon Research Institute|John Hainsworth MD|1-877-691-7274|asksarah@scresearch.net|
21275697|NCT00830167|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21275698|NCT00494013|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21275699|NCT01539239|Ivantis|Richard Hope|949-333-1310|rhope@ivantisinc.com|
21275700|NCT02179788|University of Cincinnati|Dr. Laurie Nommsen-Rivers|513-558-0461|laurie.rivers@uc.edu|
21288621|NCT04357795|Sun Pharmaceutical Industries Limited|Head-Clinical Development|2266455645|clinical.trial@sunpharma.com|5689
21288622|NCT03785366|Sebela Women's Health|Elizabeth Gray|760.593.8383|Elizabeth.Gray@sebelapharma.com|
21288623|NCT03240874|Northwestern University|Lynn Yee, MD, MPH|312-472-4685|lynn.yee@northwestern.edu|
21288624|NCT01964404|Dartmouth Hitchcock|Dr. Mary F. Brunette|603-646-7019|Mary.F.Brunette@Hitchcock.org|
21288625|NCT05528510|Janssen Research & Development, LLC|Senior Medical Leader Pediatrics Immunology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21288626|NCT00927472|Taro Pharmaceuticals U.S.A.,|Director, Clinical Research|914-345-9001|Natalie.Yantovskiy@Taro.com|
21288627|NCT03771716|AdventHealth Research Institute|Dr. Kirk I. Erickson|4125763724|Kirk.Erickson@adventhealth.com|
21288628|NCT05317546|Medical University of South Carolina|Dr. Lindsay Squeglia|843-792-5454|squegli@musc.edu|
21288629|NCT05350202|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21288630|NCT04707469|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21275701|NCT00633022|GlaxoSmithKline|GSK Response Center|866-435-7343||
21303522|NCT01943474|C. R. Bard|Gina Gilbert|407-489-0835|gina.gilbert@crbard.com|
21275702|NCT00987480|Memorial Sloan Kettering Cancer Center|Dr. Farid Boulad|212-639-2429|bouladf@mskcc.org|
21303523|NCT02162576|Propeller Health|Dr. Meredith Barrett|415-409-9258|meredith.barrett@propellerhealth.com|
21303524|NCT00217464|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21303525|NCT01629771|Northwestern University|Clinical Trials Unit Coordinator|312-695-6829|j-bae@northwestern.edu|
21303526|NCT00056498|Maryland Psychiatric Research Center|Robert W. Buchanan, MD|410-402-7876|rwbuchanan@mprc.umaryland.edu|
21303527|NCT00278915|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
21303528|NCT05214573|Mayo Clinic|Rozalina McCoy, M.D., M.S.|507-538-7955|mccoy.rozalina@mayo.edu|
21303529|NCT02520089|Universidad Autonoma de Nuevo Leon|Dr. Carlos Alberto Acosta-Olivo|+528183476698|dr.carlosacosta@gmail.com|
21303530|NCT00884377|Walter Reed Army Medical Center|Dr. Naomi Aronson, Principal Investigator|202-782-8691|naronson@usuhs.mil|
21303531|NCT03274999|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21303532|NCT01527357|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
21303533|NCT01752712|Maryland Psychiatric Research Center|Robert W. Buchanan, M.D.|410-402-7876|rwbuchanan@mprc.umaryland.edu|
21303534|NCT02919969|Dana Farber Cancer Institute|James Cleary|617-632-6073|james_cleary@dfci.harvard.edu|
21303535|NCT03621475|University of Vermont|Renee Stapleton, MD, PhD|(802) 656-7975|renee.stapleton@med.uvm.edu|
21303536|NCT04179409|Abigail Wexner Research Institute, Nationwide Children's Hospital|Dr. Kevin Flanigan, Center for Gene Therapy Director|614-722-5615|kevin.flanigan@nationwidechildrens.org|
21303537|NCT02093351|AstraZeneca Pharmaceuticals|Dr Carsten Goessl, Indication Lead||clinicaltrialtransparency@astrazeneca.com|
21303538|NCT03565367|Stanford University|Lawrence Recht, MD|(650) 725-8630|lrecht@stanford.edu|
21303539|NCT01992159|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21303540|NCT01198158|Georgetown University Hospital|George Philips MBBS, MD, MPH, FACP|202-444-2198|George.K.Philips@gunet.georgetown.edu|
21303541|NCT05478174|Haisco-USA Pharmaceuticals, Inc.|Yu-Ling Lai|858-263-4239|yuling.lai@haisco-usa.com|
21260625|NCT00619229|UCB|UCB Clinical Trial Call Center|+ 1 877 822 9493 (UCB)||
21260626|NCT03417440|University of Southern California Chan Division of OS-OT|Stacey Schepens Niemiec|3234422069|schepens@usc.edu|
21260627|NCT02786901|Bausch Health|Study Manager|(908) 242-8287|sandra.narain@bauschhealth.com|
21260628|NCT01687790|University of Pittsburgh|Dr. Christiane Hakim|412-641-1965|chakim@magee.edu|
21260629|NCT00607048|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21260630|NCT00699192|Novartis Pharmaceuticals|Study Director|862 778-8300||
21260631|NCT04336163|University of California, Irvine|Kristen Kelly, MD|949-824-6550|kmkelly@uci.edu|
21260632|NCT00673595|Mayo Clinic|Dr. John H. Eisenach|507-266-8715|eisenach.john@mayo.edu|
21260633|NCT03663166|Moffitt Cancer Center|Bradford A. Perez, MD|813-745-4380|bradford.perez@moffitt.org|
21260634|NCT03456115|Johns Hopkins University Hospital|Christopher Razavi, MD|410-955-2307|crazavi1@jhmi.edu|
21260635|NCT00929240|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21260636|NCT02203149|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21260637|NCT00684814|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21260638|NCT02537678|University of South Florida|Alison Salloum|8139741535|asalloum@usf.edu|
21260639|NCT04348851|North Florida/South Georgia Veterans Health System|Dr. Constance Uphold|352-548-6000|connie.uphold@va.gov|106893
21260640|NCT00432809|Cleveland Clinic|Dr. Philip Schauer|216-444-4794|schauep@ccf.org|
21260641|NCT04052139|Boston Medical Center|Dr. Jeffrey H. Samet|617-414-7288|jsamet@bu.edu|
21260642|NCT01658514|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com|
21260643|NCT00144170|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21260644|NCT00981526|UMass Medical School|Dr. Xiaoduo Fan|508-856-3881|xiaoduo.fan@umassmed.edu|
21260645|NCT00332202|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21260646|NCT00957853|UT MD Anderson Cancer Center|Dr. Maura Gillison, PHD/Professor, Thoracic-Head & Neck Med Onc|713-792-6363|mgillison@mdanderson.org|
21260647|NCT02901314|Cleveland Clinic|Nancy M. Albert, PhD, CCNS, CCHFN, CCRN, NE-BC, FAHA, FCCM, FHFSA, FAAN|216-444-7028|albertn@ccf.org|47028
21260648|NCT02495948|Alcon, A Novartis Division|Global Medical Affairs Brand Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21260649|NCT01701622|University of Mississippi Medical Center|Debbie Minor|601-984-6888|DMinor@umc.edu|
21260650|NCT00100048|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21260651|NCT03878485|Washington University School of Medicine|Dr. Clifford Robinson|314-362-8567|clifford.robinson@wustl.edu|
21260652|NCT05818124|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21260653|NCT00496366|Rutgers Cancer Institute of New Jersey|Deborah Toppmeyer, MD|732-235-6789|toopmede@cinj.rutgers.edu|
21260654|NCT00768222|J&J Medical, China Ltd.|Xiaowei SUN, MD PhD|86 10 5952 3103|xsun5@its.jnj.com|
21260655|NCT03576144|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21260656|NCT01444716|The University of Texas MD Anderson Cancer Center|Allessandra Ferrajoli, MD./Professor|713-792-2063|aferrajo@mdanderson.org|
21260657|NCT04938648|Johns Hopkins University|Dr. Ariel Green|(410) 550-6733|ariel@jhmi.edu|
21260658|NCT05027802|Ipsen Bioscience Inc.|Medical Director|see email|clinical.trials@ipsen.com|
21260659|NCT00502840|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21260660|NCT01974323|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21275703|NCT01994980|Denver Health|Dr Fredric Pieracci|303-436-4029|Fredric.Pieracci@dhha.org|
21303542|NCT01545843|University of Michigan|Dr. J. Todd Arnedt|734-764-1234|tarnedt@med.umich.edu|
21303543|NCT00470158|AHRQ|Stephanie Chang|301 427-1490|stephanie.chang@ahrq.hhs.gov|
21275704|NCT01751087|Planned Parenthood League of Massachusetts, Inc.|Principal Investigator|617.616.1600||
21275705|NCT02061358|Emergent BioSolutions|Clinical Development Representative||ctgov@ebsi.com|
21275706|NCT05113563|NYSPI|Diana Martinez|646-771-7774|dm437@cumc.columbia.edu|
21303544|NCT00880685|University of Chicago|Dr. Jon Grant|773-834-1326|jongrant@uchicago.edu|
21275707|NCT00964353|University of Chicago|Dr David Meltzer|773-702-0836|dmeltzer@medicine.bsd.uchicago.edu|
21303545|NCT04179890|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21275708|NCT05393271|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21275709|NCT02048813|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21275710|NCT01708954|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
21275711|NCT05996198|NYU Langone Health|Heidi Schambra, MD|212-598-6000|Heidi.Schambra@nyulangone.org|
21275712|NCT01192776|Wayne State University|Seetha Shankaran|(313) 745-1436|sshankar@med.wayne.edu|
21275713|NCT03542344|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21275714|NCT00413049|Novartis Pharmaceuticals|Study Director|862 778-8300||
21275715|NCT01884844|Department of Psychiatry, Universtity of Massachusetts|Director of the Bipolar Disorders Specialty Clinic|508-334-5052|wendy.marsh@umassmemorial.org|
21303546|NCT01236118|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21303547|NCT04535167|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21275716|NCT00287053|Pennington Biomedical Reseach Center|Corby Martin, Ph.D.; Assistant Professor|225-763-2585|martinck@pbrc.edu|
21275717|NCT00487695|Johns Hopkins University School of Medicine Division of Gastroenterology and Hepatology|Dr. Marcia Canto.|410-614-5388|mcanto@jhmi.edu|
21275718|NCT02104817|AstraZeneca|AstraZenenca Information Center|1-877-240-9479|information.center@astrazeneca.com|
21303548|NCT00978432|Duke University Medical Center|Anne Beaven, MD|919-684-8964|anne.beaven@duke.edu|
21303549|NCT02579928|Yale University|Dr. Michael H. Bloch|2037374539|michael.bloch@yale.edu|
21275719|NCT04633642|Diabetic Foot Unit, Clínica Universitaria de Podología, Facultad de Enfermería, Fisioterapia y Podología, Universidad Complutense de Madrid, 28040 Madrid, Spain|Dr. Francisco Javier Álvaro Afonso|913-941-502|alvaro@ucm.es|+34
21275720|NCT00611884|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21275721|NCT00981799|Therapeutic Advancements of Childhood Leukemia and Lymphoma|Clinical Research Coordinator, Consortia|323-361-5312|rleong@chla.usc.edu|
21275722|NCT00160524|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
21275723|NCT04892147|Duke University|Guy G. Potter, PhD|919-668-1269|guy.potter@duke.edu|
21275724|NCT01816230|Gamida Cell|Kelly Myers|026595631|kelly@gamida-cell.com|
21275725|NCT01067521|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|001-215-591-3000|info.era-clinical@teva.de|
21275726|NCT00936351|Roudebush VA Medical Center|Louanne W. Davis PsyD|317-988-4523|louanne.davis@va.gov|
21275727|NCT01540045|Instituto Nacional de Cancerología de México|Dr. Oscar Arrieta|5628-0400|ogarrieta@gmail.com|832
21275728|NCT01547728|Mayo Clinic Rochester|Dr. William Oliver|507-255-4240|oliver.william@mayo.edu|
21275729|NCT03828539|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21275730|NCT01341405|CrystalGenomics, Inc|Sang-Yoon Lee, M.D.|82-31-628-2871|sang-yoon.lee@cgxinc.com|
21275731|NCT02760433|R-Pharm|Maria Lemak, Scientific Advisor|0074959567937|lemak@rpharm.ru|1408
21275732|NCT00766493|W. L. Gore & Associates|Bryan Randall|(800) 437-8181|BRandall@WLGore.com|
21275733|NCT04721145|Johns Hopkins Medicine|Dr. Risa Wolf|410-955-6463|rwolf@jhu.edu|
21275734|NCT01849458|Tornier Inc.|Marcela Bravo|9526837481|marcela.bravo@tornier.com|
21275735|NCT04387617|Mayo Clinic|Karen L. Stern, M.D.|480-342-3868|Stern.Karen@mayo.edu|
21275736|NCT00024258|Memorial Sloan Kettering Cancer Center|Dr. Brian Kushner|212-639-6793|kushnerb@mskcc.org|
21275737|NCT03950674|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21275738|NCT02224053|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
21275739|NCT01898598|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21275740|NCT03833427|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21275741|NCT00176891|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|(612) 626-2313|orcha001@umn.edu|
21275742|NCT03448692|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21275743|NCT03711396|University of Colorado School of Medicine|Dr. Hillary D. Lum|303-724-1911|hillary.lum@cuanschutz.edu|
21275744|NCT03428945|Yale University|Dr. Kevan Herold|203-785-6507|Kevan.Herold@yale.edu|
21275745|NCT00982228|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21303550|NCT02352922|Center for Advanced Gynecology, PLLC|Dr. Kenneth I Barron|5088876896|kenneth.barron.md@gmail.com|
21275746|NCT03231345|University Medical Center of Southern Nevada|Dr. Zitek|702-383-7885|zitek10@gmail.com|
21303551|NCT05822531|Penn State College of Medicine|Ian Paul|(717) 531-8006|ipaul@pennstatehealth.psu.edu|
21275747|NCT04841967|University of Illinois Chicago|Patricia Hershberger|3129961305|phersh@uic.edu|
21275748|NCT00360490|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21275749|NCT02289820|MedImmune LLC|Judith Falloon, MD, FACP, FIDSA, Senior Director, Clinical Development|+1-301-398-4010|information.center@astrazeneca.com|
21275750|NCT02005276|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh Patel||mpatel@upenn.edu|
21275751|NCT02054754|e-Therapeutics Plc|Clinical Operations Manager|+44 1993 880000|contact@etherapeutics.co.uk|
21275752|NCT02786927|GlaxoSmithKline|GSK Response Center|866-435-7343||
21275753|NCT01801917|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21275754|NCT01924364|University of Pittsburgh Plastic Surgery|Danielle Minteer|412-383-4804|minteerdm@upmc.edu|
21275755|NCT00265785|SWOG Statistical Center|Study Statistician|206-667-4623||
21275756|NCT03919695|San Diego State University|Assist. Vice President Research Support Services|619-594-5938|rgulizia@sdsu.edu|
21275757|NCT01688882|Novartis Pharmaceuticals|Study Director|862-778-8300||
21275758|NCT01706263|GlaxoSmithKline|GSK Response Center|866-435-7343||
21275759|NCT02416934|West Virginia University Department of Orthopaedics|Dr. Sanford Emery|304-293-1170|semery@hsc.wvu.edu|
21275760|NCT00591760|Federico II University|Prof. Antonio Cittadini|0039(0)817464375|antonio.cittadini@unina.it|
21275761|NCT00950300|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21275762|NCT00124618|Mayo Clinic|Aminah Jatoi, M.D.|507/538-0268|jatoi.aminah@mayo.edu|
21275763|NCT00608634|Arizona Cancer Center|Steven P. Stratton, PhD|520-626-9295|sstratton@azcc.arizona.edu|
21275764|NCT03490227|Pennington Biomedical Research Center|Dr. Leanne Redman|225-763-0947|leanne.redman@pbrc.edu|
21275765|NCT03201003|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
21275766|NCT00834613|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21275767|NCT03646162|Veru|Gary Barnette PhD CSO|9194263611|gbarnette@verupharma.com|
21275768|NCT01709903|Novartis Pharmaceuticals|Study Director|862-778-8300||
21275769|NCT06891729|Next Life Sciences|Darlene Walley|415-407-5229|darlene.walley@nextlifesciences.org|
21275770|NCT00697619|Sun Yat-sen University Cancer Centre|Dr. Li Zhang|86-20-87343458(O)|zhangli6@mail.sysu.edu.cn|
21275771|NCT05590039|Cynosure|Jamie Trimper|(201) 479-9612|jamie.trimper@cynosure.com|
21288631|NCT04431960|University of Connecticut|Ock K. Chun|18604866275|ock.chun@uconn.edu|
21288632|NCT02402062|MFAR Clinical Research|Federico Nepote|0034934344412|investigacion@mfar.net|102
21288633|NCT04685811|Weill Cornell Medical College|Dr. Juana Martinez Zuloaga|212-746-6000|jum4005@med.cornell.edu|
21288634|NCT01525589|Pharma Mar S.A.|Pharma Mar S.A.|00 34 91846 60 00|clinicaltrials@pharmamar.com|
21288635|NCT02924376|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21288636|NCT04835441|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21288637|NCT05666245|Center for Vaccine Development and Global Health (CVD)|Wilbur Chen, MD, MS|410-706-5328|wilbur.chen@som.umaryland.edu|
21288638|NCT03069989|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21288639|NCT06910332|Acıbadem University, Department of Physiotherapy and Rehabilitation|Ali Ömer ACAR|+90 216 500 44 44|aliomer.acar@acibadem.edu.tr|3578
21288640|NCT06910202|Fralin Biomedical Research Institute at VTC|Dr. Roberta Freitas Lemos|5405262106|rflemos@vtc.vt.edu|
21288641|NCT02145390|University of Miami|Adrian Ishkanian MD|305-243-4200|aishkanian@miami.edu|
21288642|NCT02293499|University of Rochester School of Nursing|Hyekyun Rhee PhD, RN, FAAN|585-276-3775|Hyekyun_Rhee@urmc.rochester.edu|
21288643|NCT01787838|Carilion Clinic|Rebecca Culver Clark|540-588-8184|rcclark@carilionclinic.org|
21288644|NCT00458835|Covis Pharma|Clinical Trials Interest|1-877-374 -4177|CTInterest@covispharma.com|
21288645|NCT00356590|Amgen Inc.|Study Director|866-572-6436||
21288646|NCT02696616|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21288647|NCT01970371|Achaogen, Inc.|Clinical Trials Registration Group||clinical-trials@achaogen.com|
21288648|NCT01481779|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21288649|NCT02145676|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21288650|NCT00350220|University of Rochester Medical Center|Jill M. Cholette MD|585-275-0189|Jill_Cholette@urmc.rochester.edu|
21288651|NCT03755076|Albert Einstein Healthcare Network|Dr. Shailesh Kantak|562-385-7111|skantak@ranchoresearch.org|
21288652|NCT06420232|University of Texas Medical Branch, Galveston|Heather Celkis, OTR, PPOTD|409-|hdcelkis@UTMB.EDU|
21288653|NCT00487188|Hoffman-LaRoche|Medical Communications|800-821-8590||
21288654|NCT05075200|Sunnybrook Health Sciences Centre|Dr. Angela Jerath|416-480-4864|angela.jerath@sunnybrook.ca|
21288655|NCT04225039|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
21288656|NCT02242630|Keesler Medical Center|Matthew B. Carroll|228-376-3629|matthew.carroll.1@us.af.mil|
21288657|NCT00975923|Vanderbilt University School of Medicine|Dr. Theodore Speroff|615-636-9476|ted.speroff@vanderbilt.edu|
21288658|NCT03483584|The Chinese University of Hong Kong|Prof. Grace Lui|+852 35051716|gracelui@cuhk.edu.hk|
21288659|NCT00005047|University of Southern California|Dr. Susan Groshen|323-865-0375|Susan.Groshen@med.usc.edu|
21288660|NCT05567172|Boston Scientific|Nilou Zilinek|5086836127|nilou.zilinek@bsci.com|
21288661|NCT05965427|Research Organization (KC) Ltd|MASH1 Clinical Project Manager|+44 (0) 7494 795 982|mash1@rokcservices.com|
21303552|NCT03404960|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
21303553|NCT02642744|University of Pennsylvania|Laura Stein|215-662-6214|laura.stein@pennmedicine.upenn.edu|
21303554|NCT00075270|GlaxoSmithKline|GSK Response Center|866-435-7343||
21303555|NCT00246571|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21303556|NCT06312462|Jiangsu Institute of Parasitic Diseases|Dr. Huang Yuzheng|19941716698|huangyuzheng@jipd.com|
21303557|NCT05247398|University of Minnesota|Corey McGee|612-626-5645|mcge0062@umn.edu|
21303558|NCT04251156|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21303559|NCT02455557|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
21303560|NCT04656275|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21303561|NCT00300742|UVA Center for Addiction Research and Education|Dr. Nassima Ait-Daoud|434-243-0541|uvacare@virginia.edu|
21275772|NCT03403439|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21275773|NCT00851006|University of Utah|Douglas Kondo, M.D.|801-587-1549|doug.kondo@hsc.utah.edu|
21275774|NCT04662710|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21275775|NCT02722616|Johns Hopkins, East Baltimore|Dr. Amol Narang|410-913-3395|anarang2@jhmi.edu|
21275776|NCT01705717|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21260661|NCT01700829|NY State Psychiatric Institute-Columbia University Medical Center|Michael Grunebaum, MD|646-774-7573|michael.grunebaum@nyspi.columbia.edu|
21260662|NCT01075178|Abbott|Global Medical Services|800-633-9110||
21260663|NCT00316264|MedImmune|Pamela Griffin|301 398 0000|clinicaltrialenquiries@medimmune.com|
21260664|NCT00355264|BioMarin Pharmaceutical Inc.|Joshua Lilienstein|651-523-0310|MEDINFO@bmrn.com|
21260665|NCT01451645|Regeneron|Clinical Trials Administrator|914 847 5385|clinicaltrials@regeneron.com|
21260666|NCT04927312|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21260667|NCT03424161|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
21260668|NCT04919564|National Cardiovascular Center Harapan Kita Jakarta|Prieta Adriane, MD|+62 852-2004-0006|prietaadriane@gmail.com|
21260669|NCT01748799|Centre for Addiction and Mental Health (CAMH)|Bernard Le Foll|416.535.8501|bernard.lefoll@camh.ca|34772
21260670|NCT03624816|QMedAB|Clinical Project Manager|(817) 961-5000|aestheticclinicaltrials@galderma.com|
21260671|NCT00446030|sanofi-aventis|Trial Transparency Team||Contact-us@sanofi-aventis.com|
21260672|NCT00858832|USF Health Department of Obstetrics and Gynecology|Patrick Teefey MD|813-259-8680|ObGynClinicalResearch@health.usf.edu|
21260673|NCT05292755|University of Florida|Dr. Yujia Zhou|3053429166|yzhou1996@ufl.edu|
21260674|NCT02696083|Regenesis Biomedical|Clinical Operations Manager|602-428-7041|heather.vanderploeg@regenesisbio.com|
21260675|NCT00519077|The University of Chicago|Tanguy Lim-Seiwert|773-702-2452|seiwert@uchicago.edu|
21260676|NCT01967225|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21260677|NCT02305563|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
21260678|NCT02643095|The Ohio State University College of Optometry|Jennifer Fogt|614-292-2020|Fogt.78@osu.edu|
21260679|NCT02930174|University of Michigan Health System|Carl Haas|734-936-5234|chaas@med.umich.edu|
21260680|NCT04214652|Bausch Health Americas, Inc|Study Director|7072851528|Varsha.Bhatt@bauschhealth.com|
21260681|NCT01275222|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21260682|NCT02823457|GV Sonny Montgomery VAMC|Mary Jane Burton|6013624471|mary.burton2@va.gov|
21260683|NCT01243268|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21260684|NCT00518349|NorwegianDohsa|Dr. Geir Hoff|+4791866762|hofg@online.no|
21260685|NCT04174599|Evivebiotech|Catrina Wang|021-61760866|catrina.wang@evivebiotech.com|
21260686|NCT01822561|Tufts Medical Center|Andre Witkin|6176367950|awitkin@tuftsmedicalcenter.org|
21260687|NCT01444300|Oregon Health & Science University|Dr. Michelle Cameron|503-218-1971|cameromi@ohsu.edu|
21260688|NCT02722044|Momenta|Jim Jin|+16173954905|jjin@momentapharma.com|
21260689|NCT03658954|Yale University School of Medicine|Lisa Fucito, PhD|(203) 200-1470|lisa.fucito@yale.edu|
21260690|NCT00818259|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21260691|NCT00825370|Department of Emergency Medicine, Albert Einstein College of Medicine|Andrew Chang, MD, MS|7189207464|achang@montefiore.org|
21260692|NCT00682630|Shin Poong Pharmaceutical Co., Ltd.|Jansik Shin|+82-2-2189-3468|jsshin@shinpoong.co.kr|
21260693|NCT02226965|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21260694|NCT03481270|Stanford University|Marcella Alsan, Associate Professor of Medicine|(650) 721-1352|malsan@stanford.edu|
21260695|NCT02970929|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1 866-503-6351|clinicaltrialdisclosure@sunovion.com|
21260696|NCT04188730|USWM, LLC|Medical Affairs|1-888-900-8796|medinfo@usworldmeds.com|
21260697|NCT02370121|Institute of Experimental and Clinical Therapeutics|Dra. Esperanza Martínez Abundis|+52-33-10-58-52-00|esperanzamartnezabundi@yahoo.com|34211
21260698|NCT00342355|National Institute of Allergy and Infectious Diseases, Dvision of Clinical Research|Michael A Polis, MD, MPH|301-496-8027|mpolis@niaid.nih.gov|
21260699|NCT04551014|Stanford University|Shai Friedland, MD|650-723-4000|shaif@stanford.edu|
21260700|NCT01523873|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical Writing|+33 (0) 1 45 91 51 84|corinne.dubourdieu@guerbet-group.com|
21260701|NCT02654002|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21260702|NCT02570672|UT Health San Antonio|Sara Espinoza|210 617 5197|Sara.Espinoza@cshs.org|
21275777|NCT00673764|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21275778|NCT02339415|Hennepin Healthcare Research Institute|Jason Baker|612-873-2705|baker@umn.edu|
21288662|NCT03168672|DePuy Synthes|Dave Whalen|574-404-9399|dwhalen@its.jnj.com|
21288663|NCT00433537|ECOG Statistical Office|Study Statistician|617-632-3012||
21288664|NCT04115098|The University of Texas Health Science Center at Houston|Mark C. Hwang, MD|(713) 500-6597|Mark.C.Hwang@uth.tmc.edu|
21288665|NCT04635423|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21288666|NCT05556057|The University of Texas Health Science Center at Houston|Radha Korupolu, MD|713-797-5233|Radha.Korupolu@uth.tmc.edu|
21288667|NCT05748626|Northwestern University|Paul C. Fitzgerald, RN, BSN,MS|312-695-1064|p-fitzgerald2@northwestern.edu|
21288668|NCT03824158|University of Pittsburgh|Yael Schenker, MD, MAS, FAAHPM|415-254-9958|yas28@pitt.edu|
21288669|NCT04364646|Center for Sleep and Circadian Rhythms, AHWFB|Katherine M. Sharkey, MD, PhD|336-716-4657|katherine.sharkey@advocatehealth.org|
21288670|NCT02003924|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21288671|NCT01017250|Duke University Radiation Oncology|John Kirkpatrick, MD, PhD|919 668-7342|robert.clough@dm.duke.edu|
21288672|NCT00832975|Hospital Clínico Universitario Puerta de Hierro|Dr Ignacio Fernández Lozano|913445000|iflozano@secardiologia.es|
21288673|NCT03160170|University of Miami Miller School of Medicine|Ian Cote|305-256-4492|Icote@med.miami.edu|
21288674|NCT06081829|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33 1 55 72 60 00|scientificinformation@servier.com|
21288675|NCT03608033|Omeros|Skylar Liles|206-676-5000|ctinfo@omeros.com|
21288676|NCT03483012|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-5743|Sara_Tolaney@dfci.harvard.edu|
21288677|NCT05253807|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21288678|NCT02900976|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21288679|NCT04735367|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21288680|NCT02360579|Iovance Biotherapeutics|Rana Fiaz, Executive Medical Director|661-645-3572|rana.fiaz@iovance.com|
21288681|NCT05423756|Division of Infectious Diseases, University of California Irvine School of Medicine|Dr. Shruti Gohil, MD, MPH|(714) 456-7890|skgohil@hs.uci.edu|
21288682|NCT05708924|Masonic Cancer Center|Dr. Melissa Geller|612-626-3111|gelle005@umn.edu|
21288683|NCT04550936|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21288684|NCT03682848|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21288685|NCT06231511|Shirley Ryan Abilitylab|Sara Prokup PT, DPT|312-238-1355|sprokup@sralab.org|
21288686|NCT03421561|Philips|Nicolas Aguirre|612-297-6655|nicolas.aguirre@philips.com|
21288687|NCT00639093|GRAP, Clinique de Psychologie au Travail|Benoît Girard|418-542-2030|g.r.a.p@videotron.ca|
21288688|NCT01089595|Fox Chase Cancer Center|Margaret von Mehren, Principal Investigator|215-728-4300|margaret.vonmehren@fccc.edu|
21288689|NCT00143507|Institut de Recherches Internationales Servier (I.R.I.S.)|Therapeutic Innovation Pole|+33155724366|clinicaltrials@servier.com|
21288690|NCT00690898|Ipsen|Medical Director, Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21288691|NCT05977868|West Virginia University|Dr. Joy J. Juskowich|304-293-3306|jjuskowi@hsc.wvu.edu|3
21288692|NCT05370326|Yale School of Medicine|Melissa B. Weimer, DO, MCR, DFASAM|(203) 859-2962|melissa.weimer@yale.edu|
21288693|NCT04385888|George Washington University|Allison Sylvetsky|202-994-5602|asylvets@gwu.edu|
21288694|NCT00000142|Johns Hopkins Bloomberg School of Public Health|Dr. Curtis Meinert|410-955-8175|cmeinert@jhsph.edu|
21288695|NCT02606305|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
21288696|NCT01991314|Barts Health NHS Trust|Prof David Rampton|+442035943500|d.rampton@qmul.ac.uk|7885
21288697|NCT00879359|Cleveland Clinic|Lynn Borzi|2164453158|borzil@ccf.org|
21288698|NCT00970944|Spaulding Rehabilitation Hospital|Joseph T Giacino, PhD|617-573-2757|jgiacino@partners.org|
21288699|NCT02008370|Maimonides Medical Center|Dr G Trunfio|718-283-6000|gtrunfio@maimonidesmed.org|
21288700|NCT00972738|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21288701|NCT03915067|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21288702|NCT03317496|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21288703|NCT02693418|Evofem Biosciences|Kelly Culwell, MD, MPH, FACOG|858-550-1900|kculwell@evofem.com|225
21288704|NCT01199614|Columbia University|John P. Bilezikian, MD|212-305-6257|jpb2@cumc.columbia.edu|
21288705|NCT01988415|Abbott Medical Optics|Janice Tarrant|408-273-4163|janice.tarrant@abbott.com|
21288706|NCT01750346|National Institutes of Health|Dr. Codrin Lungu|301-402-0976|lunguci@ninds.nih.gov|
21288707|NCT00704353|Luitpold Pharmaceuticals, Inc.|Mark Falone, MD|610-650-4200|mfalone@luitpold.com|
21288708|NCT01001104|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21288709|NCT02034591|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21288710|NCT00599313|Texas Oncology Cancer Center|Dr. Guru Sonpavde|2813327505|Guru.Sonpavde@USOncology.com|
21288711|NCT01793935|University of Pittsburgh|Dr. K.N. Roy Chengappa - PI|412-246-5006|chengappakn@upmc.edu|
21288712|NCT01121926|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
21288713|NCT02782468|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21288714|NCT01149785|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21288715|NCT00817063|GlaxoSmithKline|GSK Response Center|866-435-7343||
21288716|NCT01496456|UMichigan|Dr. Mathilde C Peters||mcpete@umich.edu|
21275779|NCT00517192|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21275780|NCT01775722|University of California, Irvine. Beckamn Laser Institute|J Stuart Nelson|9498247997|jsnelson@uci.edu|
21275781|NCT02246764|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
21275782|NCT03433703|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21275783|NCT03223909|Laboratorios Sophia|Ricardo Alonso Llamas Velázquez (clinical safety pharmacologist)|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
21275784|NCT03971578|Intelligent Hearing Systems|Dr. Rafael E. Delgado, Director of Research & Development|305-668-6102|redelgado@ihsys.com|
21275785|NCT00098475|ECOG Statistical Office|Study Statistician|617-632-3012||
21275786|NCT03422068|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21275787|NCT01583530|GlaxoSmithKline|GSK Response Center|866-435-7343||
21275788|NCT02416180|GlaxoSmithKline|GSK Response Center|866-435-7343||
21275789|NCT02985398|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
21275790|NCT04404907|Northwestern University|Dr. June Robinson|312-503-5941|june-robinson@northwestern.edu|
21275791|NCT01653405|Rand Corporation|Dr. Adam Rose|617-338-2059|arose@rand.org|8672
21275792|NCT00046839|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
21275793|NCT02472639|Cedars Sinai Medical Center|Karen Zaghiyan, MD|310-289-9224|kzaghiyan@yahoo.com|
21275794|NCT01282086|Abbott (Ukraine)|Global Medical Services|1-800-633-9110||
21275795|NCT01181596|University of California - San Diego|Jae Kim, MD|619-543-3759|neojae@ucsd.edu|
21275796|NCT00751023|Medical University of South Carolina|Bryan K. Tolliver, MD PhD|843-792-4869|tollive@musc.edu|
21275797|NCT02050321|University of Arizona Cancer Center|Dr. Lee Cranmer|520 626-0501|lcranmer@uacc.arizona.edu|
21275798|NCT01176981|Hospital for Sick Children|Dr. Abha Gupta|14168137744|abha.gupta@sickkids.ca|
21275799|NCT04768114|Washington University School of Medicine|Alex T. Ramsey, Ph.D.|314-362-5370|aramsey@wustl.edu|
21275800|NCT01321177|Northwell Health|Patricia Marcy|347-439-8035|pmarcy@northwell.edu|
21275801|NCT03720704|W. L. Gore & Associates|Austin Phillips|+1 928 864 3641|agphilli@wlgore.com|
21275802|NCT02013050|Soligenix, Inc.|Dr. Richard Straube||rstraube@soligenix.com|
21275803|NCT00715676|Deltanoid Pharmaceuticals|Hector F. DeLuca, President and Chief Executive Officer|608-238-7710|info@deltanoid.com|
21275804|NCT01963260|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21275805|NCT00057941|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
21275806|NCT02413008|ITF Research Pharma SLU|Concepción Nieto Magro|0034916572323|concepcion@itfsp.com|
21275807|NCT01863433|Seqirus|Clinical Trial Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
21275808|NCT02707276|McLean Hospital|Dr. Michael Rohan|617-855-3127|mrohan@mclean.harvard.edu|
21275809|NCT00860262|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21275810|NCT05467540|AORN Cardarelli|Dr. Prof. Mario Muto|+39800019774|mutomar2@gmail.com|
21275811|NCT03061903|Columbia University|Roshan P. Shah, MD|212-305-8193|rs3464@cumc.columbia.edu|
21275812|NCT04315272|UCSF FI Proctor Foundation|Dr Catherine Oldenburg|(415) 502-8843|catherine.oldenburg@ucsf.edu|
21275813|NCT06107036|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
21275814|NCT00804999|University of Iowa|Dr. Christine W. Sindt|319-356-2916|christine-sindt@uiowa.edu|
21275815|NCT03382041|The University of Alabama at Birmingham (UAB)|Dr. Clay Spitler|205-934-6413|caspitler@uabmc.edu|
21275816|NCT00789776|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fredhutch.org|
21275817|NCT01374451|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21275818|NCT00089973|GlaxoSmithKline|GSK Response Center|866-435-7343||
21275819|NCT02627001|San Antonio Military Medical Center|Dr. Michael D. April|(210) 916-0808|Michael.D.April@post.harvard.edu|
21275820|NCT03297541|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|2257632500|amanda.staiano@pbrc.edu|
21275821|NCT03493919|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21275822|NCT01337596|Eli Lilly Company|Chief Medical Officer|1-800-545-5979||
21275823|NCT04640194|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21275824|NCT02946255|Centre for Addiction and Mental Health|Dr. Sean Kidd|416-535-8501|sean.kidd@camh.ca|36295
21275825|NCT00096460|The EMMES Corporation|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|221
21275826|NCT04490057|Yale University|E. Jennifer Edelman, MD, MHS|203-727-7115|ejennifer.edelman@yale.edu|
21275827|NCT04771286|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21275828|NCT04584983|The University of Texas Health Science Center at Houston|Lindsay F Holzapfel, MD, MS|713-500-6422|Lindsay.N.Fleig@uth.tmc.edu|
21275829|NCT05377489|Grünenthal GmbH|Grünenthal Clinical-Trials Helpdesk|000|clinical-trials@grunenthal.com|
21275830|NCT00724958|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialDisclosure@merck.com|
21275831|NCT03093025|Taisho Pharmaceutical R&D Inc.|Taisho Pharmaceutical R&D Inc. Study Director|800-602-0203|ClinicalTrials@taisho-rd.com|
21275832|NCT05186415|Nemours Children's Hospital, Delaware|Shannon Nees, MD|302-651-6600|shannon.nees@nemours.org|
21275833|NCT05480800|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21275834|NCT01528293|Georgetown University Medical Center|Paul J. Kim, DPM, Director of Research, MGUH Center for Wound Healing and HBOT|202-444-3059|Paul.J.Kim@gunet.georgetown.edu|
21275835|NCT00324896|UMDNJ - RWJMS|Matthew Menza, MD|732-235-4440|menza@umdnj.edu|
21275836|NCT00676650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21275837|NCT00292591|Medical University of South Carolina|Dr. Carol Wagner|18437922112|wagnercl@musc.edu|
21275838|NCT02297841|Church & Dwight Co., Inc.|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
21275839|NCT05061992|University of Michigan|Dr. Elliot Tapper|734-647-9252|etapper@med.umich.edu|
21275840|NCT01891812|Columbia University Irving Medical Center|Dr. Daniel Tsze, Professor of Pediatrics|212 305 9825|dst2141@cumc.columbia.edu|
21275841|NCT01833754|Amgen Inc.|Study Director|866-572-6436||
21275842|NCT03978598|UNM Obstetrics & Gynecology|Family Planning Research Team|505-205-4118|HSC-FamilyPlanningResearch@salud.unm.edu|
21275843|NCT02824640|Prisma Health|Megan Groome|864-382-1023|megan.groome@primsahealth.org|
21275844|NCT03807661|LimFlow SA|Kristi McCaffrey|+1 559 970-1012|kristi.mccaffrey@stryker.com|
21275845|NCT05661344|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21275846|NCT05212948|Shionogi|Shionogi Clinical Trials Administrator Clinical Support Help Line|1-800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
21275847|NCT05347693|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21275848|NCT00264381|University of Oklahoma Health Sciences Center|Suman Rathbun MD,MS|405271-4742|suman-rathbun@ouhsc.edu|44773
21275849|NCT00695110|Clarus Therapeutics, Inc.|Robert E. Dudley, PhD, CEO and President|847-562-4300|rdudley@clarustherapeutics.com|
21275850|NCT03211039|Rady Children's Institute for Genomic Medicine|Dr. Stephen F. Kingsmore|816 854 0882|skingsmore@rchsd.org|
21275851|NCT04675775|University of Michigan|Elliot Tapper|734-647-9252|etapper@med.umich.edu|
21275852|NCT00784030|New York University School of Medicine|Dr. Irina Barash|212.263.5851|irina.barash@nyumc.org|
21275853|NCT05431777|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21275854|NCT04941768|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21275855|NCT03302078|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21275856|NCT05148299|Swedish Orphan Biovitrum AB|Medical Director|+4686972000|medical.info@sobi.com|
21275857|NCT02161549|MotusGI|Ravit Peled -Director of Clinical Trial|+972 (0)4 6214447|ravit@motusgi.com|203
21275858|NCT02340780|Canadian Cancer Trials Group|Bingshu Chen|613-533-2430|bchen@ctg.queensu.ca|
21275859|NCT01957150|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21275860|NCT01856192|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21275861|NCT01405469|University Hospital Hamburg-Eppendorf|Prof. Dr. Thomas Rösch, Principal Investigator|+49 40 7410 50098|t.roesch@uke.de|
21275862|NCT05633862|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
21275863|NCT00640926|Melinta Therapeutics, Inc.|Sue Cammarata, MD|(203) 624-5606|scammarata@melinta.com|
21275864|NCT01841073|Imperial College London|Prof Gary Frost|+44 (0)20 7594 0959|g.frost@imperial.ac.uk|
21275865|NCT02564016|Medical University of South Carolina|Laura L Roberts MD, Assistant Professor|843 792 2322|roberll@musc.edu|
21275866|NCT02858037|International Partnership for Microbicides|Dr John Steytler|+27 21 860 2300|jsteytler@ipmglobal.org|
21275867|NCT00283842|Wyeth|U.S. Contact Center||clintrialresults@wyeth.com|
21275868|NCT00550147|Indiana University School of Medicine|David W. Dunn, MD|317-944-8162|ddunn@iupui.edu|
21275869|NCT04320745|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21275870|NCT01685008|MorphoSys AG|Medical Information|+1 844 667-1992|medinfo@morphosys.com|
21275871|NCT01285076|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21275872|NCT04994431|UMass Memorial Health Care|Feiran Lou|5083348996|feiran.lou@umassmemorial.org|
21275873|NCT01837537|Medtronic|Michael Luna-Victoria|303 305 2463|michael.luna-victoria@medtronic.com|
21275874|NCT02667951|School of Nursing, College of Medicine, Chang Gung University, Taoyuan, Taiwan|Dr. Yea-Ing L. Shyu|+886-3-211 8800|yeaing@mail.cgu.edu.tw|5275
21275875|NCT02151149|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
21275876|NCT05653362|Indiana University School of Medicine|Claire Edelman|3176509107|ceedelma@iu.edu|
21275877|NCT03419962|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21275878|NCT04142658|Artivion|Melissa Thalin, Director, New Indications|770-419-3355|melissa.thalin@artivion.com|
21275879|NCT01781234|University of Illinois College of Pharmacy|Dr. Ajna Hamidovic|312-355-1713|ahamidov@uic.edu|
21275880|NCT03439085|UT MD Anderson Cancer Center|Dr. Michael Frumovitz, Chief Patient Experience Ofc, Ofc of Chief Operating Officer|(713) 792-9599|mfrumovitz@mdanderson.org|
21303562|NCT03390842|Tricida, Inc.|Medical Information|415-429-7800|medinfo@tricida.com|
21303563|NCT05954143|Bolt Biotherapeutics, Inc.|Director of Clinical Development Operations|1-650-434-8640|clinicaltrials@boltbio.com|
21303564|NCT03702244|Heartflow Inc|Director, Clinical Operations|877-478-3569|whuey@heartflow.com|
21275881|NCT04720547|Wayne State University|Dr. Abdulghani Sankari|313-576-3548|atarbich@med.wayne.edu|
21275882|NCT02585245|ThedaCare|Lori Hartz MS, RDN Manager of Nutrition and Diabetes Education|920 831-5077|lori.hartz@thedacare.org|
21275883|NCT01499160|University of Maryland Baltimore Greenebaum Cancer Center|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu|
21275884|NCT02361736|Tianjin Medical University General Hospital|Dr. Yuanyuan Zhang|13821685913|doctorkelly@126.com|
21275885|NCT02287636|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Philipp Frank Graner|+1 216-844-8275|philipp.graner@uhhospitals.org|
21275886|NCT01438476|UT MD Anderson Cancer Center|Dr. Jean-Nicolas Vauthey,MD/Professor, Surgical Oncology|713- 792-2022|jvauthey@mdanderson.org|
21275887|NCT03538262|Massachusetts General Hospital|Dr. Michael Schwarzschild|617-724-9611|michaels@helix.mgh.harvard.edu|
21275888|NCT03566238|Albireo AB|Patrick Horn, MD, PhD|+1 (857) 378- 2035|medinfo@albireopharma.com|
21275889|NCT02095340|University of Houston|Andres G Viana, Ph.D., Associate Professor|832-842-0234|agviana@uh.edu|
21275890|NCT00268762|University of Texas Health Science Center at Houston|Andrew D. Barreto, MD|713-500-7002|andrew.d.barreto@uth.tmc.edu|
21275891|NCT03370510|Yale Child Study Center|Dr. Pamela Ventola|(203) 737-4378|ventolalab@yale.edu|
21275892|NCT00688844|Emory University|Rani H. Singh|404-448-8519|rsingh@emory.edu|
21275893|NCT01475487|Department of Anesthesia and Pain Management, Mount Sinai Hospital Toronto, Canada|Dr Naveed Siddiqui|4165864800|naveed.siddiqui@uhn.ca|5270
21275894|NCT02528409|University of Chicago|Dr. Jon E. Grant|773-834-1325|jongrant@uchicago.edu|
21275895|NCT00857818|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21275896|NCT01049581|ChangGungMH|Dr Chia- Ling Chen|886-3-3281200|clingchen@gmail.com|3846
21275897|NCT01745952|UZ Leuven|Prof W Van Paesschen & Dr L Seynaeve|+3216349062|laura.seynaeve@uzleuven.be|
21275898|NCT02129062|UT MD Anderson Cancer Center|Jan Burger, MD/ UT MD Anderson Associate Professor, Leukemia|713-794-4329|CR_Study_Registration@mdanderson.org|
21275899|NCT02031237|University of Michigan Comprehensive Cancer Center|Dr. Yue Cao|(734) 936-8695|yuecao@umich.edu|
21275900|NCT01474915|The Ohio State University Department of Anesthesiology|Andrew Otey|6142933559|Andrew.otey@osumc.edu|
21275901|NCT01841736|UCSF Helen Diller Family Comprehensive Cancer Center|Emily Bergsland, M.D.|415-353-9888|emily.bergsland@ucsf.edu|
21275902|NCT00003404|Dartmouth Hitchcock Medical Center|Richard J. Barth Jr., MD|(603) 650-9479|Richard.J.Barth.Jr@hitchcock.org|
21275903|NCT00377156|Mayo Clinic|Paul Brown, M.D.|507-538-0948|Brown.Paul@mayo.edu|
21275904|NCT01802216|University of California, San Francisco|Dr. Vanessa Grubbs|415-206-5649|Vanessa.Grubbs@ucsf.edu|
21275905|NCT02459418|Fertility Biotech AG|Executive VP of Regulatory Affairs||maria.vazquez@fertilitybiotech.com|
21275906|NCT00653159|The University of Chicago Department of Health Studies, Biostatistics Laboratory|Dr. Sydeaka Watson, PhD|773-834-2378|swatson@health.bsd.uchicago.edu|
21275907|NCT01872715|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5000|elizabeth.nieman@galderma.com|
21275908|NCT00683592|PGxHealth, LLC|Director of Medical Affairs|203-786-3400||
21275909|NCT02814708|Biomedizinische Forschung & Bio-Produkte AG|Dr. Martha M. Eibl|+43-1-4081091|martha.eibl@meduniwien.ac.at|
21275910|NCT00381849|Mayo Clinic|Beverly Tietje, Study Coordinator|507-255-0401|tietje.beverly@mayo.edu|
21275911|NCT01504711|Barbara Ann Karmanos Cancer Institute|Dr. Philip A. Philip, M.D., Ph.D., F.R.C.P|(313)576-8624|philipp@karmanos.org|
21275912|NCT02315261|Faculty of Medicine Siriraj Hospital|Dr.Mingkwan Wongyingsinn|66824197995|minkcheerful@hotmail.com|81
21275913|NCT02426541|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
21275914|NCT00745134|M D Anderson Cancer Center|Dr. Jillian Gunther|832-710-7864|JGunther@mdanderson.org|
21275915|NCT01503333|Michigan State University College of Nursing|Dr. Lorraine Robbins|517-353-3011|Lorraine.Robbins@hc.msu.edu|
21275916|NCT02674633|Akili Interactive Labs|Kathryn Jenkins|8572543399|kjenkins@akiliinteractive.com|
21275917|NCT04167618|Y-mAbs Therapeutics|Joris Wilms|+4570261414|clinicaltrials@ymabs.com|
21275918|NCT02994394|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21275919|NCT05693805|BUCA School of Medicine, Psychiatry; Boston Veterans Administration|Barbara L Niles, PhD|857-364-4128|barbara.niles@va.gov|
21275920|NCT02877017|Boston Children's Hospital|Alisa Khan, MD, MPH|6173552565|alisa.khan@childrens.harvard.edu|
21275921|NCT05707403|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21275922|NCT04982445|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21275923|NCT02152982|Mayo Clinic|Jann N. Sarkaria, MD|507-284-8227|Sarkaria.jann@mayo.edu|
21275924|NCT00527475|Texas Retina Associates|David Callanan, MD|817-261-9625|dcallanan@texasretina.com|
21275925|NCT03230487|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21275926|NCT03408730|VBI Vaccines, Inc.|Vlad Popovic|416-418-4713|vpopovic@vbivaccines.com|
21275927|NCT01755975|Memorial Sloan Kettering Cancer Center|Dr. Steven Horwitz, MD|646-608-2680|horwitzs@mskcc.org|
21275928|NCT03653026|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21275929|NCT05560555|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21275930|NCT01933919|AbbVie|Global Medical Services|800-633-9110||
21275931|NCT00852917|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
21275932|NCT02575339|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
21275933|NCT01358877|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21275934|NCT02510261|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
21260703|NCT00275561|Mayo Clinic|Jeffrey A. Alexander, MD, Assistant Professor of Medicine|507-538-2403|alexander.jeffrey14@mayo.edu|
21260704|NCT01769105|Department of ophthalmology, University of Duesseldorf|Dr. David Finis|+49 211 8117320|David.Finis@med.uni-duesseldorf.de|
21260705|NCT01530243|Seyyed-al-Shohada Heart Center, Urmia University of Medical Sciences|Yousef Rezaei|+989126231864|yousefrezaei1986@gmail.com|
21260706|NCT01392183|UT MD Anderson Cancer Center|Amado J. .Zurita-Saavedra, MD/ Associate Professor, Genitourinary Medical Oncology|713- 563-6966|azurita@mdanderson.org|
21260707|NCT00407355|Wilmer Eye Institute|Peter Campocahiro|: 410-955-5106|pcampo@jhmi.edu|
21260708|NCT00963807|Washington University in St. Louis|John P Crandall|(314) 747 - 5561|jcrandall@wustl.edu|
21260709|NCT01587950|GlaxoSmithKline|GSK Response Center|866-435-7343||
21260710|NCT03128957|University of Michigan|Dr. Paul Picton|734 615 9864|ppicton@med.umich.edu|
21260711|NCT00684177|GlaxoSmithKline|GSK Response Center|866-435-7343||
21260712|NCT02093702|Barrie and Community Family Health Team|Dr. Andrew Wozniak|(705) 728-2618|andrew.wozniak@barriefht.ca|
21260713|NCT02224664|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21260714|NCT02108457|University of Pennsylvania|Lilie Lin, MD|215-662-6515|lin@xrt.upenn.edu|
21260715|NCT03551028|University of Virginia|Emma Mitchell|4342433962|emm6z@virginia.edu|
21260716|NCT01024244|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21260717|NCT02811744|Univerisity of Pennsylvania|Erin Schubert|215-573-6569|erin.schubert@pennmedicine.upenn.edu|
21260718|NCT03026803|City of Hope|Jeffrey Longmate, Ph.D.|626-256-4673|jlongmate@coh.org|62478
21260719|NCT00265941|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21303565|NCT01129024|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
21303566|NCT04656899|Washington State University Elson S. Floyd College of Medicine, Analytics and PsychoPharmacology Laboratory (APPL)|Dr. Crystal Smith (backup: Dr. Sterling M. McPherson)|(509) 368-6876|crystal.lederhos@wsu.edu|
21303567|NCT01848782|Assistance publique hopitaux de paris|Isabelle Boutron|+33 1 42 34 78 33|isabelle.boutron@htd.aphp.fr|
21303568|NCT02409914|USherbrooke|Stephen Cunnane|1-819-780-2220|Stephen.Cunnane@USherbrooke.ca|45670
21303569|NCT03513848|University of California, Irvine|Alyson Zalta|949-824-3409|azalta@uci.edu|
21303570|NCT00708201|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
21303571|NCT00761748|Coloplast A/S|Director of Medical Outcome||dkbir@coloplast.com|
21303572|NCT01857310|NICHD|Dr. Enrique Schisterman|3014356893|schistee@mail.nih.gov|
21303573|NCT02554279|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21303574|NCT00812487|Ohio State University|Kathleen Dungan, MD, MPH|614-685-3333|kathleen.dungan@osumc.edu|
21303575|NCT00998764|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21303576|NCT01995045|Emory University|Dr. Timothy Olsen|404-778-4996|tolsen@emory.edu|
21303577|NCT04761627|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21303578|NCT01933789|University of Washington|Dr. J. Randall Curtis|206-744-3356|jrc@uw.edu|
21303579|NCT02757950|GlaxoSmithKline|GSK Clinical Trials|877-379-3718|GSKClinicalSupportHD@gsk.com|
21303580|NCT03398278|Mundipharma(China) Pharmaceutical. Co. Ltd|Rongna. A|86 10 65636885|rongna.a@mundipharma.com.cn|
21303581|NCT00723203|City of Hope National Medical Center|Paul Frankel, Ph.D.|(626)359-8111|pfrankel@coh.org|65265
21303582|NCT00274924|ECOG Statistical Office|Study Statistician|617-632-3012||
21288717|NCT04919161|Gaylord Hospital Inc.|Dr. Henry C. Hrdlicka, Research Coordinator|203-284-2864|hhrdlicka@gaylord.org|
21303583|NCT01055496|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21288718|NCT02489773|Asahi Kasei Pharma Corporation|Takuji Kohzuma PhD|+81-3-3296-3617|kouzuma.tb@om.asahi-kasei.co.jp|
21288719|NCT00712920|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us|
21288720|NCT00584285|University of Iowa|Dr. Christine W. Sindt|319-356-2916|christine-sindt@uiowa.edu|
21288721|NCT02887586|Clinical Cancer Center, Xiyuan Hospital, China Academy of Chinese Medical Sciences|Hebin|13520253895|hebinbj68@163.com|
21288722|NCT01555931|University of North Carolina School of Medicine|Dr. Gretchen Stuart|919-962-4880|gstuart@med.unc.edu|
21303584|NCT01514162|St Jude Medical|Jennifer Johnson|6517566803|jjohnson101@sjm.com|
21303585|NCT01698710|Massachusetts General Hospital|Dr. William Brugge|6173083532|Brugge.William@mgh.harvard.edu|
21303586|NCT03103061|Medical University of South Carolina|Hunter Gray, Program Coordinator|843-876-3185|grayhu@musc.edu|
21303587|NCT02915874|University of Iowa|Jess G Fiedorowicz, MD, PhD|319-384-9267|jess-fiedorowicz@uiowa.edu|
21303588|NCT03102190|Massachusetts Eye and Ear Infirmary|Project Manager, Clinical Trials|617-573-6981|elizabeth_grimm@meei.harvard.edu|
21303589|NCT01325792|W. L. Gore & Associates, Inc., Sponsor|Lori Norton, PhD|800-437-8181|lnorton@wlgore.com|
21303590|NCT03681288|PROVIDENCE VAMC/ BROWN UNIVERSITY|Erica Eaton, Ph.D.|14012737100|erica_eaton@brown.edu|13428
21303591|NCT03734705|Stanford University|Katie Fracalanza, PhD|408-769-0589|kfracalanza@stanford.edu|
21303592|NCT02004288|Sestre milosrdnice University Hospital Center Vinogradska 29, Zagreb, Croatia|Orjena Žaja, MD MSc PhD primarius Ass Prof Pediatrics, Pediatric gastroenterologist|P:+38513787342 M:+3859937872|Orjena Žaja <orjenazf@yahoo.com>|
21303593|NCT02518464|Columbia University Medical Center|Robert Sommer, MD|212-305-7060|rs2463@cumc.columbia.edu|
21303594|NCT00481507|GEORGETOWN UNIVERSITY|Daniel Merenstein, MD|202-687-2745|djm23@georgetown.edu|
21303595|NCT00819793|Abbott|Poornima Sood||psood@sjm.com|
21303596|NCT00266877|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
21288723|NCT05696847|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21303597|NCT02581839|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Paula Silverman|1-800-641-2422|CTUreferral@UHhospitals.org|
21303598|NCT04268823|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21303599|NCT01842633|GlaxoSmithKline|GSK Response Center|866-435-7343||
21303600|NCT00371761|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21303601|NCT00334074|Baylor University Medical Center|Dr. Edward Agura|214-818-8472|Sandyli@baylorhealth.edu|
21303602|NCT05204381|University of North Carollina at Chapel Hill|Zachary Stewart|919-966-9929|zachary_stewart@med.unc.edu|
21303603|NCT01479985|Washington University in St. Louis|Dr. Tessa Madden, MD, MPH|314-747-6495|maddent@wudosis.wustl.edu|
21303604|NCT01117792|Boston Scientific|Tom Stoltz, Clinical Trial Manager|1-800-227-3422|thomas.stoltz@bsci.com|
21303605|NCT01721577|Rush University Medical Center|Crista Brawley|312-563-2312|crista_brawley@rush.edu|
21303606|NCT01673282|UCB Cares|UCB (Study Director)|+1 887 822 9493||
21303607|NCT03935399|Wake Forest Health Sciences|Dr. James Eisenach|3367164182|eisenach@wakehealth.edu|
21303608|NCT02067975|Maryland Psychiatric Research Center|Sam Kane-Gerard|410-402-6120|SGerard@som.umaryland.edu|
21288724|NCT01697579|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21288725|NCT01044498|Hoffmann-La Roche|Medical Communications|800 821-8590||
21288726|NCT05142774|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
21303609|NCT00732940|GlaxoSmithKline|GSK Response Center|866-435-7343||
21303610|NCT03562767|Emory University|Dr. Ambar Kulshreshtha|(404) 686-2410|akulshr@emory.edu|
21303611|NCT01589770|Vanderbilt University Medical Center|Dr. C. M. Stein|615-936-3420|michael.stein@vanderbilt.edu|
21303612|NCT00997113|Minneapolis Medical Reseach Foundation|James Miner|6128738791|miner015@umn.edu|
21303613|NCT00938886|Brown University|Christopher Kahler|401 863-6651|christopher_kahler@brown.edu|
21303614|NCT01120067|VA Boston Healthcare System|John Otis|857-364-5740|john.otis@va.gov|
21303615|NCT03761797|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21303616|NCT04711837|Haisco USA Pharmaceutical Inc.|Yu-Ling Lai Senior Director Clinical Operations|1 732-26-4759|Yuling.lai@Haisco-usa.com|
21303617|NCT01150474|Mayo Clinic|Dr. Kristina A. Butler|480-301-5934|butler.kristina@mayo.edu|
21303618|NCT03021564|Groupe Hospitalier de la Rochelle Ré Aunis|Dr Maxime Leloup|+33 (0)5 46 45 66 09|maxime.leloup@ght-atlantique17.fr|
21303619|NCT00969280|Korea Institute of Oriental Medicine|Tae-Hun Kim, Researcher|82-10-6532-5524|rockandmineral@gmail.com|
21303620|NCT00821327|US Oncology Research, McKesson Specialty Health|Dr. Matthew D. Galsky|212-659-5412|matthew.galsky@mssm.edu|
21303621|NCT00459979|CCCC|Dr. Brian Rini|216-444-9567|rinib2@ccf.org|
21303622|NCT00989573|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21303623|NCT00814801|Janssen Pharm KK Japan|Director|81-3-4411-5717||
21303624|NCT04148872|University of Wisconsin - Madison|Scott Chaiet, MD|608-263-0192|chaiet@surgery.wisc.edu|
21303625|NCT02486718|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21303626|NCT02081248|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
21303627|NCT01037088|UCaliforniaDavis|Dr. Barth Wilsey, MD|916-843-9082|blwilsey@ucdavis.edu|
21303628|NCT03351101|Bausch Health|Study Director|+1 (585) 338-6399|Robert.Steffen@bausch.com|
21303629|NCT02216812|Massachusetts General Hospital|Dr. Neal Chen|617-726-4700|nchen1@mgh.harvard.edu|
21288727|NCT03093844|University of Colorado|Dr. Jonathan Gutman|303-724-9562|JONATHAN.GUTMAN@CUANSCHUTZ.EDU|
21288728|NCT04443452|University of Nottingham|Professor Ana Valdes|0115823114|ana.valdes@nottingham.ac.uk|
21288729|NCT03487445|Viatris Innovation GmbH|Viatris Innovation Clinical Trial Information|+41 58 844 07 44|viatrisinnovationclinicaltrials@viatris.com|
21288730|NCT01963234|University of Wisconsin - Madison|Andrew Quanbeck|6082627385|arquanbe@wisc.edu|
21288731|NCT04132050|Kissei Pharmaceutical Co., Ltd.|Clinical Development Division|Email olly|rinsyousiken@pharm.kissei.co.jp|
21288732|NCT04556097|McLean Hospital|Dr. Brent Forester|617-855-3622|bforester@mclean.harvard.edu|
21288733|NCT05436613|University of East Lonson|Professor Cynthia Fu|020 8223 4119|c.fu@uel.ac.uk|
21288734|NCT06480032|Rehman Medical Institute|Dr.Iftikhar qayum|+92 91 5838 333|iftikhar.qayum@rmi.edu.pk|4708
21288735|NCT05184842|Montefiore Medical Center|Mendel Goldfinger, MD|718-920-4826|mgoldfin@montefiore.org|
21303630|NCT00873873|National Jewish Health|Head, Pediatric Clinical Pharmacology|303-398-1193|szeflers@njhealth.org|
21303631|NCT00527488|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21303632|NCT01958827|AbbVie|Global Medical Information|800-633-9110||
21303633|NCT03036800|University of Leicester|Prof Melanie Davies|0116 258 6481|melanie.davies@uhl-tr.nhs.uk|
21303634|NCT01986933|Chugai Pharmaceutical|Clinical trials information||clinical-trials@chugai-pharm.co.jp|
21303635|NCT01077154|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21303636|NCT04030026|Trevi Therapeutics, Inc.|Thomas Sciascia, MD, Chief Scientific Officer|203-304-2499|info@trevitherapeutics.com|
21303637|NCT02207946|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
21303638|NCT02545543|Seqirus|Seqirus Clinical Trial Disclosure Lead|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
21303639|NCT01278927|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
21303640|NCT00811642|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21303641|NCT00721253|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21303642|NCT02829944|Duke University Medical Center|Emily Barney|9709031869|ezb2@duke.edu|
21303643|NCT05744258|UZ Brussel|prof. dr. Sebastien Kindt|+32 2 477 60 11|sebastien.kindt@uzbrussel.be|
21303644|NCT06372782|Q-Med AB|Clinical Scientist|+46184749000|reception.seupp@galderma.com|
21303645|NCT04675151|Ocuphire Pharma, Inc.|Drey Coleman|8134041993|dcoleman@ocuphire.com|
21303646|NCT01730937|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
21303647|NCT03947684|UT southwestern medical center|Dr. Yasin Dhaher|2146450064|yasin.dhaher@utsouthwestern.edu|
21303648|NCT06432088|Levita Magnetics|Vivian Soto|+56958360507|VSoto@Levita.com|
21303649|NCT03875235|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21303650|NCT07123272|University of Michigan|Anna Kratz|734-647-5982|alkratz@med.umich.edu|
21303651|NCT06447688|Medicalpark Hospital|Sefa SURAL|+90 532 565 0160|sesural@hotmail.com|
21303652|NCT02104739|The University of Texas Health Science Center at Houston|Absalon D Gutierrez, MD|(713) 500-6641|Absalon.D.Gutierrez@uth.tmc.edu|
21260720|NCT01217749|Pharmacyclics, Inc.|Dr. Jutta K. Neuenburg|877-877-3536|medinfo@pcyc.com|
21288736|NCT02555878|Janssen Scientific Affairs, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21288737|NCT00765076|GlaxoSmithKline|GSK Response Center|866-435-7343||
21288738|NCT03884374|University of Florida|Eric Weber|352-273-7802|ebweber@ufl.edu|
21303653|NCT01395784|New York State Psychiatric Institute|Jermaine Jones, PhD|646 774-6113|jonesje@nyspi.columbia.edu|
21303654|NCT05772702|Pulvinar Neuro|Dr. Christopher Walker|8043173403|chris.walker@pulvinarneuro.com|
21303655|NCT04153149|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
21303656|NCT00625742|University of Texas (UT) MD Anderson Cancer Center|Rony Dev, DO/Associate Professor, Palliative Care Med||CR_Study_Registration@mdanderson.org|
21303657|NCT02316548|NRG Oncology|Wendy Seiferheld, M.S.|215-574-3208|seiferheldw@nrgoncology.org|
21303658|NCT01343823|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21303659|NCT03468543|Lyndra|Andrew Bellinger, MD, PhD|857-302-7878|abellinger@lyndra.com|
21303660|NCT01249118|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21303661|NCT00997438|VA Portland Health Care System|Dr. Sonemany Salinthone|5032208262|salintho@ohsu.edu|54394
21303662|NCT00095238|Britol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21260721|NCT00810797|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
21260722|NCT03976401|Akero Therapeutics, Inc.|Brittany de Temple, Senior Director Clinical Operations|(650) 868-7935|brittany@akerotx.com|
21260723|NCT00310310|VA San Diego Healthcare System|Carl J. Stepnowsky,PhD|858-642-1240|Carl.Stepnowsky@va.gov|
21260724|NCT01464697|University of British Columbia|Dr. Jerilynn C. Prior, Professor|6048755927|jerilynn.prior@ubc.ca|
21275935|NCT01312181|ResearchFMH|Dr. Efrat Aharonovich|646-774-7954|efrat.aharonovich@nyspi.columbia.edu|
21275936|NCT02003222|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21260725|NCT02197377|DorkuzEU|Anaesthesiology and Reanimation|0905055252901|ozbilginsule@gmail.com|
21275937|NCT03760003|ABIVAX|Fabio Cataldi|+33 (0) 1 53 83 08 41|clinicaltrials@abivax.com|
21275938|NCT01737619|M.D. Anderson Cancer Center|Pamela Soliman, MD|713-745-2352|psoliman@mdanderson.org|
21275939|NCT01886872|Ohio State University|Jennifer Woyach, MD|614-685-5667|jennifer.woyach@osumc.edu|
21275940|NCT02167594|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
21275941|NCT02033317|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
21275942|NCT03294317|Medtronic CRM Clinical|Nonye Harcourt|6122421785|nonye.o.harcourt@medtronic.com|
21275943|NCT02911935|Washington University School of Medicine.|Dr. Avraham Beigelman|314-454-2694|beigelmana@wustl.edu|
21275944|NCT00603512|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21275945|NCT04979858|Georgia Institute of Technology|Dr. Sundaresan Jayaraman|404.894.2461|sundaresan.jayaraman@gatech.edu|
21275946|NCT04253236|Immunovant, Inc|Central Study Contact|1-800-797-0414|clinicaltrials@immunovant.com|
21275947|NCT02922582|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
21275948|NCT02169336|Recro Pharma, Inc|Randall Mack|484-395-2400|rmack@recropharma.com|
21275949|NCT04718129|Vanderbilt University|Principal Investigator|615-330-5605|jgarber.vanderbilt@gmail.com|
21275950|NCT01598896|Beth Israel Deaconess Medical Center|Dr. Kevin Hill|617-667-1504|khill1@bidmc.harvard.edu|
21275951|NCT00420095|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21275952|NCT00393705|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21275953|NCT03346902|Bonti|Wajdie Ahmad|9493796569|wajdie@bonti.com|9493796569
21275954|NCT01120691|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21275955|NCT00938782|Stanford University|Dr. David R Drover|650-725-0364|ddrover@stanford.edu|
21275956|NCT00178711|University of Texas Health Science Center|Guy L Clifton|2024224824|guy@guyclifton.com|
21275957|NCT01223027|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registry@novartis.com|
21275958|NCT04428645|Oregon Health and Science University|Jessica Castle|503-494-7072|castleje@ohsu.edu|
21275959|NCT01321697|University of Arkansas for Medical Sciences|Sandy Annis|5016868274|amannis@uams.edu|
21275960|NCT02061280|Nemours Children's Specialty Care|Kathryn Blake, Pharm.D.|9046865047|kathryn.blake@nemours.org|904
21275961|NCT01977456|University of Cincinnati|Dr. Opeolu Adeoye|513-558-3117|opeolu.adeoye@uc.edu|
21275962|NCT01195116|University of Rochester|Dr. Suzanne Karan|5852751384|suzanne_karan@urmc.rochester.edu|
21275963|NCT03303417|University of Nottingham|Robin Spiller|0115 823 1090|robin.spiller@nottingham.ac.uk|
21275964|NCT02697617|Indiana University School of Medicine|Dr. Sharon Moe|317 278 2868|smoe@iu.edu|
21275965|NCT02786719|Baylor College of Medicine|Sarah Whittle, MD MS|8328241471|whittle@bcm.edu|
21275966|NCT01578317|NIH|John Tsang|301-496-0304|tsangjs@mail.nih.gov|
21275967|NCT01765270|Duke Clinical Research Institute|L. Kristin Newby, MD, MHS|919-668-8805|kristin.newby@duke.edu|
21275968|NCT00329160|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21275969|NCT02419573|Unviersity of Texas Health Science Center at Houston|Henry E. Wang, MD, MS|713-500-7878|henry.e.wang@uth.tmc.edu|
21275970|NCT00493792|Mayo Clinic, Rochester, MN|Emilee Andersen, M.A., Clinical Research Coordinator|507-266-9807|andersen.emilee@mayo.edu|
21275971|NCT02076776|Cleveland Clinic|Dr. Jay Alberts|216 445-3222|albertj@ccf.org|
21275972|NCT00894933|American Medical Systems|Laura Olson, Clinical Project Manager|952-930-6428|laura.olson2@bsci.com|
21275973|NCT02812771|Bausch Health Americas, Inc|Study Director|510-259-5284|aloncaric@bauschhealth.com|
21275974|NCT04254198|University of New Mexico Health Sciences|Janet Page-Reeves|505-272-1694|JPage-Reeves@salud.unm.edu|
21275975|NCT04968925|Johnson & Johnson Vision Care, Inc. (JJVC)|Ross Franklin, BAppSc-Optom|1-800-843-2020|RFRANKL1@its.jnj.com|
21275976|NCT02046863|Great Lakes NeuroTechnologies Inc|Biomedical Research Manager|2163615410|dheldman@glneurotech.com|
21275977|NCT04443569|Massachusetts General Hospital|Christopher Arkfeld|4029803860|carkfeld@mgh.harvard.edu|
21275978|NCT00996437|Diabetic Retinopathy Clinical Research Network|Adam R. Glassman|813-975-8761|drcrstat4@jaeb.org|
21260726|NCT01057277|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
21260727|NCT00833092|USDA Grand Forks Human Nutrition ResearchCenter|Forrest H Nielsen, PhD|701-790-8455|forrest.nielsen@ars.usda.gov|
21260728|NCT02983604|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21260729|NCT00466505|Vanderbilt-Ingram Cancer center|Jordan Berlin, MD|615-343-4128|jordan.berlin@vanderbilt.edu|
21260730|NCT00605826|Bausch Health|Study Director||susan.harris@bauschhealth.com|
21260731|NCT02351115|Engage Therapeutics, Inc|Chief Medical Officer||studydirector@engagetherapeutics.com|
21260732|NCT01241786|Hackensack University Medical Center|Dr. Anthony Mato|551-996-2000|AMato@hackensackumc.org|
21260733|NCT03182738|Columbia University School of Nursing|Dr. Rebecca Schnall|212-342-6886|rb897@cumc.columbia.edu|
21260734|NCT02886715|Fougera Pharmaceuticals Inc.|Angela C Kaplan|631-659-2256|angela.kaplan@sandoz.com|
21260735|NCT00503399|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21260736|NCT01676961|NYU Clinical Cancer Center|Amitabha Mazumder, MD|(212) 731-5757|Amitabha.Mazumder@nyumc.org|
21260737|NCT01172067|CRT, Global Clinical Affairs, Cardiac Arrhythmias and Heart Failure, Abbott Medical Devices|Clay Cohorn, Program Director|+1 972 309 8087|clay.cohorn@abbott.com|
21260738|NCT03168867|Wayne State University|Deborah Ellis, Ph.D.|313-577-1055|dellis@med.wayne.edu|
21260739|NCT01128387|University of Wisconsin Carbone Cancer Center|Dr. Mark Ritter|608-263-8500|ritter@humonc.wisc.edu|
21288739|NCT04262219|Fox Chase Cancer Center|Dr. Jennifer Reese, Associate Professor|215-214-3223|Jennifer.Reese@fccc.edu|
21288740|NCT00876395|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21288741|NCT02880176|Fox Chase Cancer Center|Dr. Marshall Strother|555-555-5555|m12912988@gmail.com|
21288742|NCT00662259|University of California San Diego|Gregory G. Brown|858-246-0607|gbrown@ucsd.edu|
21288743|NCT00601627|Alliance for Clinical Trials in Oncology|George P. Kim, M.D.|507-284-4918||
21288744|NCT00597675|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director of the UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
21288745|NCT01201863|Craig Hospital|Don Gerber, PsyD|303-789-8478|dgerber@craighospital.org|
21288746|NCT00448357|UNC Lineberger Comprehensive Cancer Center|Dr. Thomas Shea|919-966-7746|tom_shea@med.unc.edu|
21288747|NCT03439514|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21288748|NCT02175758|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21288749|NCT00620542|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21288750|NCT01500083|Lundbeck Canada Inc.|Lundbeck Canada Inc.|+45 36301311|LundbeckClinicalTrials@lundbeck.com|
21288751|NCT00741611|CR Bard|Anne Marie Harcarik|908-277-8051|annemarie.harcarik@crbard.com|
21288752|NCT01385644|The Prince Chalres Hospital|Assoc Professor Daniel Chambers|+61 7 3139 4000|daniel.chambers@health.qld.gov.au|
21288753|NCT01510756|University of California, San Diego|Thomas Kipps, MD|(858) 534-5400|tkipps@ucsd.edu|
21288754|NCT01922011|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21288755|NCT01063907|Kyowa Hakko Kirin Pharma, Inc.|Senior VP Drug Development|609-919-1100|clinical.info@kyowa-kirin-pharma.com|
21288756|NCT02299167|Dammam University|Roshdi R. Al-Metwalli|+966 50 289 3485|rmetwalli@iau.edu.sa|
21288757|NCT00924482|University of California San Francisco|Arthur Wallace, M.D., Ph.D.|415-750-2069|wallacea@anesthesia.ucsf.edu|3732
21260740|NCT01159262|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com|
21288758|NCT03802110|Boston Scientific Cardiac Rhythm Management|Stephen J. Hahn, PhD|1-800-227-3422|stephen.hahn@bsci.com|
21288759|NCT06540170|National Healthcare Group Polyclinics|Senior Wound Nurse Clinician|64966611|julia_zhu@nhgp.com.sg|
21288760|NCT04882800|Sonova US|Principal Investigator|630-821-5000|phonakaudiologyresearch@gmail.com|
21260741|NCT02216136|Washington University School of Medicine|Terence M. Myckatyn, M.D.|314-996-3873|myckatyn@wustl.edu|
21260742|NCT04433117|University of Kentucky|Dr. Mohanad Al-Sabbagh|859-257-3003|malsa2@email.uky.edu|
21260743|NCT02704104|Arch Therapeutics, Inc|Medical/Scientific Affairs|617 431-2313|jprats@archtherapeutics.com|
21260744|NCT00824421|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21260745|NCT02499952|Hoosier Cancer Research Network|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
21260746|NCT05089708|Galderma|Clinical Scientist|+46184749000|reception.seupp@galderma.com|
21260747|NCT02286102|Hospital for Special Surgery|Oheneba Boachie-Adjei, MD|212 606-1723|rosst@hss.edu|
21260748|NCT02120417|Incyte Corporation|Study Director|855 463-3463||
21260749|NCT00927485|University of Puerto Rico Medical Sciences Campus|Dr. Marcia Cruz-Correa|787-758-2525|marcia.cruz1@upr.edu|1722
21260750|NCT01440101|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
21260751|NCT00885079|Otsuka Pharmaceutical Co., Ltd.|Mr. Kyoji Imaoka|-81-6-6943-7722||
21260752|NCT02107755|The Ohio State University Comprehensive Cancer Center|Dr. Jose Bazan|614-688-7040|Jose.Bazan2@osumc.edu|
21260753|NCT03303989|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Jeff Foster|2059966086|pjfoster@uabmc.edu|
21260754|NCT04325503|Unversity of Michigan|Nicolaas Bohnen|734-998-8400|nbohnen@umich.edu|
21260755|NCT00702143|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
21260756|NCT03871491|RTI International|Elizabeth McClure|919-316-3773|mcclure@rti.org|
21260757|NCT05202808|RxSight, Inc.|Director, Clinical Trials|9494215463|dgoffredo@rxsight.com|300
21260758|NCT04996797|Merck Sharp and Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21260759|NCT02793544|National Marrow Donor Program/BeTheMatch|Steve Spellman|763-406-8334|sspellma@nmdp.org|
21303663|NCT04300751|University of Kentucky|Director for the Center on Drug and Alcohol Research|859-257-6485|Sharon.Walsh@uky.edu|
21303664|NCT05033002|Duke University School of Nursing|Michael Relf, Ph.D.|919-684-9219|michael.relf@duke.edu|
21303665|NCT02311582|Washington University School of Medicine|Milan G. Chheda, M.D.|314-747-2712|mchheda@wustl.edu|
21303666|NCT04972630|Medical University of South Carolina|Dr. Suparna Qanungo|(843) 876-1125|qanungo@musc.edu|
21303667|NCT02607514|Massachusetts General Hospital|Maren Nyer|6072796290|mnyer@partners.org|
21303668|NCT03422627|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21303669|NCT05171816|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21303670|NCT02937571|Memorial Sloan Kettering Cancer Center|Dr. Neha Korde, MD|646-608-3708|korden@mskcc.org|
21303671|NCT04214288|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21303672|NCT03675321|Medical College of Wisconsin|Clinical Research Manager|4142666131|ksiegel@mcw.edu|
21303673|NCT00807027|GREEN CROSS CELL|CRA of Clinical Trial|82-2-2101-0665|a1pole@greencrosscell.com|665
21303674|NCT03997383|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
21303675|NCT02278341|Astellas Pharma Europe B.V.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|5473
21303676|NCT05293392|Nemours Children's Health|Thao-Ly Phan, MD, MPH|302-331-7342|thaoly.phan@nemours.org|
21303677|NCT04902326|University of Michigan Medical School|Jeffrey Kullgren|734-845-3613|jkullgre@med.umich.edu|
21303678|NCT02397564|University of Louisville|W. James Tidwell|5025831749|wjamestidwell@gmail.com|
21303679|NCT00934648|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21303680|NCT02361580|Massachusetts Generla Hospital|Taylor Pong, Research Coordinator||tpong1@partners.org|
21303681|NCT02047318|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
21303682|NCT00924781|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21303683|NCT01487577|Children's Hospital of Pittsburgh of UPMC|Randy M. Windreich, MD|412-692-5225|randy.windreich@chp.edu|
21303684|NCT00634270|The Univ of Alabama at Birmingham|Bruce Korf, MD, PhD|205.934.5140|kcole@uab.edu|
21303685|NCT01653782|Karolinska Institute|Dr. Irene Jensen|+46852483218|irene.jensen@ki.se|
21303686|NCT05765227|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21303687|NCT02777749|Columbia University Medical Center|Dr. Matthew Grosso|2123058193|mgrosso13@gmail.com|
21303688|NCT01155479|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21303689|NCT02360605|LSUShreveport|Dr. Connie Arnold|318-675-4324|carnol@lsuhsc.edu|
21303690|NCT00689091|University of Michigan|Dr. George A Mashour|734-936-4280|gmashour@med.umich.edu|
21303691|NCT05867342|Stanford University|Peter H. Hwang, MD|(650) 725-6500|hwangph@stanford.edu|
21303692|NCT04365257|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Chetan Bettegowda|4109558620|cbetteg1@jhmi.edu|
21303693|NCT02129777|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21303694|NCT04391569|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
21303695|NCT02891603|Moffitt Cancer Center|Joseph Pidala, MD, PhD|813-745-2556|Joseph.Pidala@moffitt.org|
21303696|NCT04641221|Butler Hospital|Lisa Uebelacker, PhD|401-455-6381|luebelacker@butler.org|
21303697|NCT01470989|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21303698|NCT02119676|Incyte Corporation|Study Director|855 463-3463||
21303699|NCT00219544|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21303700|NCT05856760|Travere Therapeutics, Inc.|Travere Therapeutics Call Center|1-877-659-5518|medinfo@travere.com|
21303701|NCT04035486|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21303702|NCT01006603|AstraZeneca|Boaz Hirshberg , MSD||ClinicalTrialTransparency@astrazeneca.com|
21303703|NCT06661954|University of Alabama at Birmingham|Rachel Cowan, PhD|205-934-5034|recowan@uabmc.edu|
21303704|NCT02964078|Moffitt Cancer Center|Jad Chahoud MD, MPH|813-745-6926|Jad.Chahoud@moffitt.org|
21303705|NCT00562627|Baerum Hospital|Ulrich Johannes Spreng|004798499184|ulispreng@hotmail.com|
21303706|NCT02935543|Univ. of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
21303707|NCT03387150|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
21303708|NCT04078178|MGH|Kayla McEachern|617-643-5265|kmceachern2@mgh.harvard.edu|
21303709|NCT04006119|Alaunos Therapeutics, Inc|Jaymes Holland, Clinical Consultant|6502732627|jholland@alaunos.com|
21260760|NCT04091217|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21260761|NCT02747004|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21303710|NCT02186301|Clovis Oncology|Vi Nguyen|+1 415 915 9982|vnguyen@clovisoncology.com|
21303711|NCT05048082|OncoNano Medicine, Inc|Vice President, Clinical Operations|(682) 285-1411|trials@onconanomed.com|
21288761|NCT00820534|Novartis Consumer Health|Head of Clinical Research|+4122363311||
21288762|NCT05513950|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
21288763|NCT02903914|Call Center|Incyte Corporation|1-855-463-3463|medinfo@incyte.com|
21288764|NCT02989389|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21288765|NCT00373672|Northwestern University|Herbert Y Meltzer|1 312 503 0309|h-meltzer@northwestern.edu|
21288766|NCT02246777|Alcon, A Novartis Division|Associate, Medical Group 1, Japan|1-888-451-3937|alcon.medinfo@alcon.com|
21288767|NCT01470170|Department of Thoracic Medicine|Dr. Yu-Lun, Lo|+886-3-3281200|loyulun@hotmail.com|5108
21288768|NCT01063114|Massachusetts General, Hospital|Torunn Yock, MD|6177262000|tyock@mgh.harvard.edu|
21288769|NCT03409367|Oregon Health & Science University|Director of Clinical Trials|503-764-8544|michaell@ohsu.edu|
21288770|NCT04164979|Chao Family Comprehensive Cancer Center, University of California, Irvine|Chao Family Comprehensive Cancer Center, University of California, Irvine|1-877-UC-STUDY|ucstudy@uci.edu|
21288771|NCT04046471|University of Kansas Medical Center|Dr. Joseph Donnelly|785-864-1687|jdonnelly2@kumc.edu|
21288772|NCT06239610|Parkview Health System|Jan Powers PhD, RN, CCNS, CCRN, CNRN, NE-BC, FCCM|260-266-7761|jan.powers@parkview.com|
21288773|NCT00462462|Orfagen|Clinical Project Manager|+33 5 34 50 64 62|info@orfagen.com|
21288774|NCT01163617|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21288775|NCT02875080|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21303712|NCT02497976|IC Study LLC|Philip C. Bosch, MD|760 743-3135|pboschmd@gmail.com|
21303713|NCT01410552|LivaNova|Scientific Communication manager|33146013082|Anne.rousseauplasse@sorin.com|
21288776|NCT02394756|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan- PRINCIPAL RESEARCH OPTOMETRIST|1 904 443 3449|CColesb@ITS.JNJ.com|
21288777|NCT01164475|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21288778|NCT02335944|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21288779|NCT02406612|Essential Medical|Sam Nardone|6105571009|sam@essmedclosure.com|
21288780|NCT01744821|Northwestern University|Assistant Professor|312-472-4684|dcarson@nm.org|
21288781|NCT02916771|Dana-Farber Cancer Institute|Dr. Irene Ghobrial|617-632-4198|Irene_Ghobrial@DFCI.Harvard.edu|
21288782|NCT01235377|Veterans Health Administration Pharmacy Benefits Management|Madeline McCarren, PhD|7087867987|madeline.mccarren@va.gov|
21288783|NCT02141113|Rochester Center for Behavioral Medicine|Joel L. Young, MD|2486088800|jyoung@rcbm.net|
21288784|NCT00357565|Masonic Cancer Center|Christen Ebens, MD, MPH|(612) 626-2961|ebens012@umn.edu|
21288785|NCT03043573|Weill Cornell Medicine|Dr. Dimitris Kiosses|914-997-4381|dkiosses@med.cornell.edu|
21288786|NCT02337686|UT MD Anderson Cancer Center|Dr. Vinaykumar Puduvalli, MD-Chair, Neuro-Oncology|(713) 745-2343|vpuduval@mdanderson.org|
21288787|NCT04333498|New York State Psychiatric Institute/ HIV Center|Research Program Manager|646-774-6904|christopher.ferraris@nyspi.columbia.edu|
21288788|NCT05463055|Varian Medical Systems|Sophia Shao|+86-21-23156400|sophia.shao@varian.com|
21288789|NCT00484159|Johns Hopkins|Steven P. Cohen|410-955-1822|scohen40@jhmi.edu|
21288790|NCT04766333|Rutgers University|Shawna V. Hudson|848-932-0215|hudsonsh@rutgers.edu|
21288791|NCT04398134|Assembly Biosciences|Executive Director of Clinical Operations|833-509-4583|Clinicaltrials@assemblybio.com|
21288792|NCT04803279|Oticon Medical|Nicole Amichetti, PhD, MS, Manager of Clinical Affairs|6093660424|nitc@oticonmedical.com|
21288793|NCT02320175|Boston Children's Hospital|Isabella Liss, Patient and Family Centered I-PASS SCORE Study Coordinator|857-218-3229|isabella.liss@childrens.harvard.edu|
21288794|NCT00221104|Translational Research Informatics Center, Kobe, Hyogo|Director of Medical Statistics Division|+81-78-303-9108|kagimura@tri-kobe.org|
21288795|NCT01666652|WRAIR|Robin Nielsen, RN|301-319-9063|trials.clinical@amedd.army.mil|
21288796|NCT01018979|TaiGen Biotechnology Co., Ltd.|Chen-En Tsai, M.D., Ph.D.|+886-2-8177-7072|cetsai@taigenbiotech.com|1211
21288797|NCT03954535|Columbia University School of Social Work|Dr. Traci Schwinn|212-851-2280|tms40@columbia.edu|
21288798|NCT04871074|UW School of Medicine and Public Health|Barbara Bendlin, PhD, MA|(608) 265-2483|bbb@medicine.wisc.edu|
21288799|NCT06011798|Unity Biotechnology, Inc.|Anirvan Ghosh|-|anirvan.ghosh@unitybiotechnology.com|
21288800|NCT03506477|Icahn School of Medicine at Mount Sinai|Ingrid Sanabria-Gonzalez|212-523-3812|ingrid.sanabria@mountsinai.org|
21288801|NCT03462680|Charlie Norwood VAMC|Dr. Chandramohan Wakade|706-733-0188|chandramohan.wakade@va.gov|2379
21288802|NCT01757847|VA San Diego Healthcare System|Niloofar Afari, PhD|858-642-3387|niloofar.afari@va.gov|
21303714|NCT01277081|GlaxoSmithKline|GSK Response Center|866-435-7343||
21303715|NCT00058539|Hoffmann-LaRoche|Medical Communications|: 800-821-8590|genentech@druginfo.com|
21303716|NCT01903525|Scottish Rite for Children|Dr. Shane Miller|469-515-7222|shane.miller@tsrh.org|
21275979|NCT01091103|Medivation, Inc.|Mohammad Hirmand, MD, VP, Clinical Development|415-829-4126|mohammad.hirmand@medivation.com|
21275980|NCT01270620|Stanford University School of Medicine|Dr. Pedro Tanaka|6507244066|ptanaka@stanford.edu|
21275981|NCT03307564|SKCCC @ Johns Hopkins|Amol Narang. MD|410-955-7390|anarang2@jhmi.edu|
21275982|NCT01597479|Hospital de la Santa Creu i Sant Pau|Dra. Mireia Rodriguez Prieto|677896054|mrodriguezpr@santpau.cat|
21275983|NCT01045707|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21275984|NCT00348816|The University of Texas Health Science Center at San Antonio, Department of Radiation Oncology|Gregory P. Swanson, MD|210-450-1103|swansong@uthscsa.edu|
21275985|NCT05552261|Dompé Farmaceutici S.p.A.|Clinical Development & Operations|+39 02 583831|clinicaltrials@dompe.com|
21275986|NCT05383170|Cytovation ASA|CEO|+4747718809|contact@cytovation.com|
21303717|NCT03977454|Yale School of Medicine: Anesthesiology|Jinlei Li, MD, PhD|(203) 785-2802|jinlei.li@yale.edu|
21303718|NCT00963677|The Second Xiangya Hospital of Central South University|Ru-Ping Dai, B.Sc(Med), PhD, Associate Professor|86-731-85295970|Ruping_dai@yahoo.com.cn|
21303719|NCT01112683|University of Colorado School of Medicine|Dr. Alberto Costa|303-724-6007|Alberto.Costa@ucdenver.edu|
21303720|NCT01323920|Dana Farber Cancer Institute|Dr. John Koreth|617-632-2949|John_Koreth@dfci.harvard.edu|
21303721|NCT02301611|Lumabridge, LLC|Marsha Greene|(484) 319-1117|mgreene@lumabridge.com|
21303722|NCT00781508|MetroHealth Medical Center|Robert C. Bahler, MD|216 778-2431|rbahler@metrohealth.org|
21303723|NCT01609478|Novartis Pharmaceuticals|Clinical Disclosure Office|+1(862)778-8300||
21303724|NCT05040971|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21303725|NCT05622604|Pray.com|Breanne Laird, PhD|9095574002|breanne.laird@pray.com|
21303726|NCT01351896|The Ohio State University Comprehensive Cancer Center|Dr. Kerry Rogers|614-293-3873|Kerry.Rogers@osumc.edu|
21303727|NCT04702802|Laboratorios Sophia|Alejandra Sanchez-Ríos M.D.|:+52 (33) 3001 4200|alejandra.sanchez@sophia.com.mx|
21303728|NCT02283177|Arog Pharmaceuticals|Edward McDonald|214-593-0500|emcdonald@arogpharma.com|
21303729|NCT01101191|Purdue Pharma L.P.|Stephen Harris, MD|203-588-7592|Stephen.Harris@Pharma.com|
21303730|NCT01233518|Heartflow, Inc.|Whitney Huey|650.257.6697|whuey@heartflow.com|
21228257|NCT04854642|Dompé farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
21228258|NCT00847171|Johns Hopkins University|Dr. Leisha Emens||emensle@jhmi.edu|
21303731|NCT00645788|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21303732|NCT06165627|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21303733|NCT04231981|MedSIR|Alicia Garcia|+34 611261467|alicia.garcia@medsir.org|
21303734|NCT01233687|University of Pittsburgh|Ahmad Tarhini, MD|(412) 648-6578|tarhiniaa@upmc.edu|
21275987|NCT00979212|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21275988|NCT04269993|Brown University|Elizabeth Aston, PhD|401-863-6668|elizabeth_aston@brown.edu|
21275989|NCT02988882|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com|
21303735|NCT00432601|VA HSRD|Dr. Angela Fagerlin|801-587-1694|angie.fagerlin@hsc.utah.edu|
21303736|NCT02197234|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
21303737|NCT05038904|Johns Hopkins University School of Medicine|Melanie C. Dispenza, MD, PhD|410-550-2301|mdispen1@jhmi.edu|
21303738|NCT01445886|Department of Traditional Chinese Medicine, Chang Gung Memorial Hospital at Keelung, Taiwan|Yin-Ku Lin|886-2-2431-3131|lin1266@adm.cgmh.org.tw|2127
21303739|NCT01163032|Vanda Pharmaceuticals Inc.|Marlene Dressman, Ph.D.|202-734-3462|marlene.dressman@vandapharma.com|
21275990|NCT03287687|University of Iowa|Dr. Warren Bishop, Professor of Pediatrics|319 356 2977|warren-bishop@uiowa.edu|
21303740|NCT02751931|Astellas Pharma Europe B.V.|Clinical Trial Disclosure|+44 (0)20 3379 8000|Astellas.resultsdisclosure@astellas.com|
21275991|NCT04116658|Enterome|Jan Fagerberg|+33175772785|info@enterome.com|
21275992|NCT00177164|UPMC|K.N. Roy Chengappa|412-246-5006|chengappakn@upmc.edu|
21303741|NCT01464723|University of California San Diego Shiley Eye Center|Dr. Stuart Brown|(858) 822-2585858-246-0814|sibrown@ucsd.edu|
21275993|NCT05584553|Zimmer Biomet|Dr Nesma Bayrich|+41793001484|nesma.bayrich@zimmerbiomet.com|
21275994|NCT00965757|Eisai Co., Ltd.|Kota Nagai|+81-3-3817-5238||
21303742|NCT01683825|Brigham and Women's Hospital|Sharmila Dorbala, Director Nuclear Cardiology|617-732-6290|sdorbala@bwh.harvard.edu|
21303743|NCT05700747|MGH Institute of Health Professions|Kathleen Lyons|617-643-5372|klyons2@mghihp.edu|
21303744|NCT03326206|Brigham and Women's Hospital|Dr. Sonya Shin|617-872-0310|sshin@bwh.harvard.edu|
21303745|NCT04090411|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21303746|NCT03615508|Denver Health|Dr. Ifantides|303-602-0156|cristos.ifantides@dhha.org|
21303747|NCT03473548|Washington University|Dr. David Leonard|314-454-6162|dsleonard@wustl.edu|
21303748|NCT02233478|Center for Human Nutrition, Department of Medicine, UCLA David Geffen School of Medicine|Zhaoping Li, Professor|310-206-1987|zli@mednet.ucla.edu|61987
21303749|NCT01947907|Ascendis Pharma A/S|VP Clinical Development|+49 172 155 2596|mb@ascendispharma.com|
21303750|NCT02477696|Acerta Pharma BV|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21303751|NCT03587727|University of Colorado|Yesenia Garcia Reyes|720-777-6984|Yesenia.GarciaReyes@childrenscolorado.org|
21303752|NCT05618782|Levicept|Iwona Bombelka|0000000000|info@levicept.com|
21303753|NCT05443594|Boston Scientific|Thomas Stoltz|651-582-4000|Thomas.Stoltz@bsci.com|
21303754|NCT02003365|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
21303755|NCT04247620|Baylor College of Medicine|Dr. Marisa Hilliard|8328247209|mehillia@bcm.edu|
21303756|NCT05710185|Brigham and Women's Hospital|Director of Clinical Trials, Brigham and Women's Hospital Department of Dermatology|617-732-5500|amostaghimi@mgb.org|
21303757|NCT04948866|University of North Carolina at Chapel Hill|Kathryn Wessell, MPH|919-966-2939|kwessell@email.unc.edu|
21275995|NCT03807440|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21303758|NCT04617795|Insulet Corporation|Dr. Trang Ly|9786007628|tly@insulet.com|
21303759|NCT00472459|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
21303760|NCT04850313|University of Arkansas for Medical Sciences|Dr. David Warner|501-686-5822|DBwarner@uams.edu|
21303761|NCT05313009|Medical University of South Carolina|Alan Brisendine|843-792-9007|brisend@musc.edu|
21303762|NCT04999982|Ann & Robert H. Lurie Children's Hospital of Chicago|Dr. Andrea Spencer|3122273402|aspencer@luriechildrens.org|
21303763|NCT03269552|University of Washington|Dr. Stephen Smith|206-606-6546|ssmith50@seattlecca.org|
21303764|NCT01285947|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
21303765|NCT03505671|Wake Forest Baptist Comprehensive Cancer Center|Nancy Avis, PhD|336-713-5440|navis@wakehealth.edu|
21303766|NCT00586729|Maricopa Integrated Health System|Karen Richey, RN|602-344-5125|karen.richey@mihs.org|
21303767|NCT02038829|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
21303768|NCT00749580|USF Health|Charurut Somboonwit, MD|813 3078067|csomboon@health.usf.edu|
21303769|NCT04393298|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21303770|NCT05381454|University of Texas Southwestern Medical Center|Theodoros Kelesidis|2146488979|Theodoros.Kelesidis@UTSouthwestern.edu|
21303771|NCT03754972|Medical Metrics, Inc|Trevor Grieco|713-850-7500|tgrieco@medicalmetrics.com|247
21303772|NCT05803603|University of Maryland School of Social Work|Jay Unick|410-706-3735|junick@ssw.umaryland.edu|
21303773|NCT03544775|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
21303774|NCT06460493|Verona Pharma|Clinical Development|844-341-9901|clinicaltrials@veronapharma.com|
21228272|NCT05007717|University of Washington|Data Analyst|7347809402|wenwenj@uw.edu|
21228273|NCT04565236|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21275996|NCT02451358|Sanofi Pasteur Inc.|Medical Director|800-633-1610|RegistryContactUs@sanofipasteur.com|1#
21275997|NCT05070754|Medical University of South Carolina|Dr. Lara Wine Lee|(843) 792-3021|winelee@musc.edu|
21303775|NCT05128929|Stanford University School of Medicine|Roham Zamanian, MD|650-725-5495|zamanian@stanford.edu|
21303776|NCT02651714|Vanda Pharmaceuticals Inc.|Vanda Pharmaceuticals Inc.|202-734-3400|clinicaltrials@vandapharma.com|
21275998|NCT01398787|Alcon Research, Ltd.|Sharon Holden Thomas, Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com|
21275999|NCT03414034|Cardiff Oncology|Nancy Sherman, Head of Clinical Operations|858-952-7570|clinops@cardiffoncology.com|
21276000|NCT04010227|Indiana University|Dr. Catherine Mosher|3172746769|cemosher@iupui.edu|
21303777|NCT02987660|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21303778|NCT03707184|Huntsman Cancer Institute, Center for Quantitative Cancer Imaging|Sam Mitchell|8012136110|sam.mitchell@hci.utah.edu|
21303779|NCT04704154|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21303780|NCT04950608|Dana-Farber Cancer Institute|Dr. Yvan Beaussant|617-582-9318|patresearch@dfci.harvard.edu|
21303781|NCT03553836|Merck Sharp & Dohme LLC.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21303782|NCT03220438|University of Maryland Baltimore|Dr Laura Rowland|410-402-6073|lrowland@som.umaryland.edu|
21303783|NCT04190680|Maastricht University|Marla Hahnraths, MSc|433882184|mth.hahnraths@maastrichtuniversity.nl|0031
21303784|NCT03469570|Edwards Lifesciences|Edwards Critical Care Clinical Affairs|(949) 250-7169|afmidestudy@edwards.com|
21303785|NCT05660850|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21303786|NCT05001347|I-Mab Biopharma|VP of Clinical Development|240-745-6330|us.info@imabbio.com|
21303787|NCT01634178|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21303788|NCT00926588|VA HSRD|Dr. Kurt Kroenke|317-988-3476|kkroenke@regenstrief.org|
21303789|NCT02524977|University of Cincinnati Health|VP Research UC Health|513-558-6937|christopher.lindsell@uc.edu|
21303790|NCT02483533|Neothetics|Director of Clinical Trials|8585501900||
21303791|NCT02995369|Montefiore Medical Center|Nuntiya Kakanantadilok|718-405-8057|nkakanan@montefiore.org|
21303792|NCT00879879|SunCoast CCOP Research Base|Dr. Jeffrey Krischer, Principal Investigator|813-396-9245|ccop@epi.usf.edu|
21303793|NCT02387476|FRESCA Medical|Robert Lahaderne|949-542-3535|rlahaderne@frescamed.com|
21303794|NCT00495079|Talon Therapeutics|Chief Medical Officer|650-588-6404|info@talontx.com|
21303795|NCT00327470|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21303796|NCT02581943|Wake Forest Baptist Comprehensive Cancer Center|Assistant Director of Clinical Research Operations|336-713-6913|mebrown@wakehealth.edu|
21303797|NCT03783702|Stanford University School of Medicine|Noel Ayoub|3109407055|nfa@stanford.edu|
21303798|NCT00745615|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21303799|NCT01076075|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21303800|NCT03114059|Dietrich-Bonhoeffer-Klinikum|Ahmed Medra|+49 395 775 13483|a.medra@live.com|
21303801|NCT04466228|University of California, San Francisco|Wan-Yu Hsu|+14153531140|wanyuhsu3@gmail.com|
21303802|NCT03624517|Medical University of South Carolina|Dr. Don Rockey|(843) 792-6982|rockey@musc.edu|
21303803|NCT01615029|Janssen Research & Development, LLC|Senior Director, Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21303804|NCT04155567|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
21303805|NCT03764033|San Francisco VA Health Care System|Shira Maguen, PhD|415-221-4810|Shira.Maguen@va.gov|22511
21303806|NCT01163318|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
21303807|NCT01892722|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21303808|NCT05797974|University of Florida|Dr. Jana Sacco|904-244-7418|Jana.Sacco@jax.ufl.edu|
21303809|NCT02604017|AbbVie|Global Medical Services|800-633-9110||
21303810|NCT04104438|University of California Los Angeles|Dr. Fady Kaldas|310-825-1037|fkaldas@mednet.ucla.edu|
21276001|NCT00702507|GlaxoSmithKline|GSK Response Center|866-435-7343||
21303811|NCT05820997|Mayo Clinic|Dr. John Stauffer|904-953-2000|stauffer.john@mayo.edu|
21303812|NCT01315236|Insmed Incorporated|Kevin Mange (Senior VP, Clinical Development)|908-947-2651|kevin.mange@insmed.com|
21303813|NCT03116347|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21303814|NCT04193410|Maastricht University|Marla Hahnraths, MSc|3882184|mth.hahnraths@maastrichtuniversity.nl|0031
21303815|NCT04973137|Prothena Biosciences Limited|Katelyn Diffin|650-837-8550|AFFIRM-ALClinicalTrials@prothena.com|
21303816|NCT01293799|Dept. of Nephrology, Sahlgrenska University Hospital, Gothenburg, Sweden|Susanne Ljungman prof. emer. Director of the study|+46-(0)31-3421000|susanne.ljungman@vgregion.se|28579
21303817|NCT03964337|Duke University|Michael Harrison, M.D.|919-668-8108|michael.harrison@duke.edu|
21303818|NCT03896659|University of Texas Southwestern Medical Center|Dr. E. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
21303819|NCT03160859|Veterans Administration Greater Los Angeles Healthcare System|Felix W. Leung, M.D, Staff Gastroenterologist|818-891-7711|felix.leung@va.gov|32520
21303820|NCT01302834|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21303821|NCT04779216|Massachusetts General Hospital|Karen Miller, MD|6177263870|kkmiller@mgh.harvard.edu|
21303822|NCT02674854|Aerie Pharmaceuticals, Inc|Theresa GH Heah, MD, MBA|908-947-3844|theah@aeriepharma.com|
21303823|NCT00829985|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21303824|NCT03910387|Emory University|Dr. Olumide Gbolahan|404-778-1900|ogbolah@emory.edu|
21303825|NCT02274038|University of Pennsylvania Perelman School of Medicine|Dr. Sharyn Katz, Principal Investigator|215-662-4000|sharyn.katz@pennmedicine.upenn.edu|
21303826|NCT00570232|University of Alabama at Birmingham|Eben Rosenthal,MD|2059349713|erosenthal@uabmc.edu|
21276002|NCT02308696|Univ. WI Madison|Amy Amessoudji|608-263-2621|amessoudji@surgery.wisc.edu|
21276003|NCT01194908|Emory University School of Medicine|Ruth O'Regan, MD|404-778-4824|roregan@emory.edu|
21276004|NCT00113919|University of Arkansas for Medical Sciences|Nathan Petty|501-837-3894|pettynathanm@uams.edu|
21276005|NCT01742208|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21276006|NCT02340962|TaiGen Biotechnology Co., Ltd.|Li-Wen Chang|+886-2-8177-7020|lwchang@taigenbiotech.com|1227
21303827|NCT06340763|Abbott|Vinuta Rau|(408)845-0864|vinuta.rau@abbott.com|
21303828|NCT04594369|Insmed Incorporated|Insmed Medical Information|1-844-446-7633|medicalinformation@Insmed.com|
21276007|NCT03702816|Cleveland Clinic|Aaron Ritter, MD|17024836000|rittera@ccf.org|
21276008|NCT04194008|Theranica Bio-Electronics Ltd|Dr Dagan Harris. VP Clinical & Regulatory Affairs|0542220121|daganh@theranica.com|
21276009|NCT01785615|University of Florida College of Medicine Jacksonville|Dr. Gladys Velarde|(904)244-2060|Gladys.Velarde@jax.ufl.edu|
21276010|NCT01881737|Stanford University School of Medicine|Antonio Hardan, MD|(650) 736-1235|hardanay@stanford.edu|
21276011|NCT01992874|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21276012|NCT00926367|GlaxoSmithKline|GSK Response Center|866-435-7343||
21276013|NCT01517867|Johns Hopkins University|Deborah Gross|410-614-5311|debgross@jhu.edu|
21276014|NCT03847974|LIB Therapeutics|Evan A Stein MD PhD FACC|18596533141|estein@libtherapeutics.com|
21276015|NCT00645827|Emory University|G. Randy Smith Jr.|404.686.6730|grsmith@emory.edu|
21276016|NCT01685216|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21303829|NCT03375788|Massachusetts General Hospital|Dr. Takara Stanley|617-724-9109|tstanley@mgh.harvard.edu|
21276017|NCT01294449|University of Rochester Heart Research Follow-up Program|Dr. Arthur Moss|585-275-5291|Arthur.Moss@heart.rochester.edu|
21303830|NCT05987709|University of Arizona|Gloria D. Coronado, PhD - Professor, Associate Director Population Sciences, Cancer Center|520-626-0023|gdcoronado@arizona.edu|
21276018|NCT02654015|Icahn School of Medicine at Mount Sinai|Samantha St. Elin|(212) 241-1497|samantha.stelin@mountsinai.org|
21303831|NCT03070444|Folktandvården Gävleborg AB|Anke Krämer|+4625155680|anke.kramer@regiongavleborg.se|
21276019|NCT00462839|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|(312)926-9015|r-mccarthy@northwestern.edu|
21303832|NCT01373489|Medical College of Wisconsin|Jennifer Campbell|4149558829|jacampbell@mcw.edu|
21303833|NCT04285580|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21276020|NCT02466386|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
21228279|NCT00662532|OraPharma|Ms. Bindu Patel, Senior Scientist, Regulatory Affairs and Quality Assurance|215-420-4064|bpatel@orapharma.com|
21276021|NCT05317195|Philip Morris Products S.A.|Christelle Haziza, Global Head Clinical Research and Execution|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
21303834|NCT02582255|FIDEC|Ricardo Rüttimann|+13058540075|rruttimann@fidec-online.org|
21228282|NCT00057681|Washington University in St. Louis|Barbara Geller, M.D.|314-747-3657|gellerb@wustl.edu|
21228283|NCT00442468|GlaxoSmithKline|GSK Response Center|866-435-7343||
21228284|NCT00589784|Memorial Sloan Kettering Cancer Center|Dr. Thomas Kaley|212-639-5122|KaleyT@mskcc.org|
21228285|NCT03127956|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21228286|NCT00287079|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21228287|NCT00470184|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21228291|NCT02195011|Sarah Cannon Development Innovations|Senior Director, Regulatory Science|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
21228292|NCT03418571|Ablynx NV|Medical Monitor|+32 9 262 00 00|clinicaltrials@ablynx.com|
21228293|NCT03170232|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21228294|NCT03882008|University of Washington|Bobby Kwanghoon Han|206-685-9950|hank4@uw.edu|
21228295|NCT05780268|University of Minnesota|Birgit Grund|612- 626-8622|birgit@ccbr.umn.edu|
21228296|NCT01222403|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21228298|NCT02068768|Zimmer Biomet Spine|Clinical Affairs|303-501-8571|tammy.stinson2@zimmerbiomet.com|
21228299|NCT01262352|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21228300|NCT01185834|Alcon Research, Ltd.|Sameena Haque-Khan, PhD, BSc(Hons)Optom, MCOptom, FAAO|1-800-241-7629||
21228301|NCT01401959|Sarah Cannon Development Innovations|Senior Director, Regulatory Science|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
21228302|NCT02051816|LSU School of Medicine New Orleans|David Janz, MD, MSc|504-568-3167|djanz@lsuhsc.edu|
21228303|NCT02694718|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21276022|NCT03259789|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
21228304|NCT02925793|DS Biopharma|Study Director|+35312933590|regulatory.dsbiopharma@dsbiopharma.com|
21228305|NCT00393042|Dept. of Psychiatry, University of Washington|Dr. Mark Stein|206-987-1161|mstein42@uw.edu|
21228306|NCT00824070|Bausch & Lomb Inc|Tuyen Ong, MD|(973) 360-6389|tuyen.ong@bausch.com|
21228308|NCT00322153|Forest Research Institute|Stephen M Graham, PhD|201-427-8156|Stephen.Graham@frx.com|
21276023|NCT02063217|Washington University School of Medicine|Dr. Brendan Lucey|314-362-4342|luceyb@wustl.edu|
21276024|NCT00889252|Vistakon|Brian Pall OD MS FAAO|904-443-1290||
21276025|NCT04291508|Massachsetts General Hospital|PETAL Network Coordinatine Center PI, B. Taylor Thompson, MD|617 872-2882|tthompson1@mgh.harvard.edu|
21303835|NCT04509739|University of Washington|Christina Zhao|206-221-6415|zhaotc@uw.edu|
21303836|NCT01709578|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21228311|NCT04644783|University of Michigan|Mohamad El Zaatari|734-647-2954|mohamade@med.umich.edu|
21303837|NCT04050371|UCSF|Robert Grant|415-323-6658|robert.grant@ucsf.edu|
21303838|NCT01107418|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21276026|NCT02710591|EspeRare Fondation|Florence Porte-Thomé|22 794 4004|porte.florence@esperare.org|+41
21303839|NCT00597701|Essentia Health|Charles E Gessert, MD, MPH|218-786-8176|cgessert@eirh.org|
21303840|NCT04243421|Medical University of Białystok|Małgorzata Pietruska|+48606461092|mpietruska@wp.pl|
21303841|NCT01741012|Wayne State University School of Medicine|Dr. J. Patricia Dhar, MD, Principal Investigator|313-577-6011|pdhar@med.wayne.edu|
21303842|NCT04633460|Hospital of the University of Pennsylvania|Payman Zamani|(215) 662-4000|payman.zamani@pennmedicine.upenn.edu|
21303843|NCT05283928|The University of Texas Health Science Center at Houston|Popi Stylianou, DDS,MS|713-486-4048|Popi.Stylianou@uth.tmc.edu|
21303844|NCT04911426|Texas Christian University Institute of Behavioral Research|Dr.Jennifer Pankow|8172577226|j.pankow@tcu.edu|6475
21303845|NCT01515540|Northwestern University|Javeria Ali Hashmi|3125037991|j-hashmi@northwestern.edu|
21303846|NCT02339376|Beth Israel Deaconess Medical Center|Bernard S. Chang, M.D.|617-632-8930|bchang@bidmc.harvard.edu|
21303847|NCT04626310|University of Massachusetts Amherst|Katherine Dixon-Gordon, PhD|413-545-0226|katiedg@umass.edu|
21303848|NCT03115580|Icahn School of Medicine at Mount Sinai|Annapoorna S. Kini, MD|212-241-4181|annapoorna.kini@mountsinai.org|
21303849|NCT02241889|Oregon Health and Science University|Dr. Jessica Castle|503-494-7072|castleje@ohsu.edu|
21303850|NCT01658813|Western Regional Medical Center|Jessica L. Coats|623-207-3899|jessica.coats@ctca-hope.com|
21303851|NCT04473482|University of Michigan|Jessica Mellinger|734-232-0284|jmelling@umich.edu|
21303852|NCT01602666|Children's Oncology Group|Results Reporting Coordinator|626 447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21303853|NCT05458648|CathVision ApS|Clinical Research Manager|0702097102|kpf@cathvision.com|
21303854|NCT03666676|University of Rochester|Dr. Laurel H. Carney|585-276-3948|Laurel_Carney@URMC.Rochester.edu|
21303855|NCT03610555|University of Texas - Medical Branch|Ajay Israni, MD, MS - Division Chief - Transplant & General Nephrology|409 772 2473|akisrani@utmb.edu|
21303856|NCT02275910|Eisai Co., Ltd.|Eisai Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
21303857|NCT06982937|Jerzy Kukuczka Academy of Physical Education|Katarzyna Sadowska|32 207 5189|komisjabioetyczna@awf.katowice.pl|
21303858|NCT04445792|Duke Clinical Research Institute|Kady-Ann Steen-Burrell, Ph.D.|919-668-8300|kady.ann.steen.burrell@duke.edu|
21303859|NCT05592223|Fred Hutchinson Cancer Center|Dr. Elizabeth Chandler Church|2066676982|cchurch2@fredhutch.org|
21303860|NCT05217927|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21228312|NCT01723696|OHSU|Cindy McEvoy, MD|503-494-0223|mcevoyc@ohsu.edu|
21228313|NCT03523000|University Hospitals Cleveland Medical Center|Dr. Salim Hayek|216-844-2685|salim.hayek@uhhospitals.org|
21228314|NCT00772070|Sanofi Pasteur Inc|Medical Director||RegistryContactUs@sanofipasteur.com|
21228315|NCT01309308|Baskent University|Ayse Parlakgumus|00903224586868|ayseparlakgumus@yahoo.de|2102
21228316|NCT04721067|Indiana University|Dr. Samir K. Gupta|3172747926|sgupta1@iu.edu|
21228317|NCT01307020|Menarini Ricerche S.p.A.|Dr Angela Capriati, Corporate Clinical Research Director|+39 055 5680 9933|acapriati@menarini-ricerche.it|
21228318|NCT00266864|James J. Peters VA Medical Center|William A. Bauman, M.D.|718-584-9000|william.bauman@va.gov|5428
21228319|NCT00727532|Northwestern University|Results Entry Administrator|312-695-1301|croqualityassurance@northwestern.edu|
21228320|NCT00829933|Daiichi Sankyo.,LTD|So Yoshino, Manager|81-90-8024-0742|yoshino.so.ej@daiichisankyo.co.jp|
21228321|NCT04647890|Certa Therapeutics Pty Ltd|Prof Darren Kelly, CEO|+61 3 9657 0700|dkelly@certatherapeutics.com|
21228322|NCT03687970|Washington University|Simon Haroutounian, PhD. Assistant Professor,|314-286-1715|simon.haroutounian@wustl.edu|
21228323|NCT05985980|Istanbul Medeniyet University|Mehmet Agirbasli MD|+902166065200|agirbasli@gmail.com|
21228324|NCT01683019|NeoSync, Inc.|Dr. Bill Phillips|949-333-2906|bill@neosync.com|
21228325|NCT03437512|University of Michigan|Emily O. Garnett, PhD, CCC-SLP|734-232-3371|emilyog@med.umich.edu|
21228326|NCT00543855|Eisai Co., Ltd.|Masaki Nakagawa, Study Director|+81-3-3817-5245||
21228327|NCT02417844|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21228328|NCT01785095|IBSA Institut Biochimique SA|IBSA Clinical Research Manager|+41583601000|rd@ibsa.com|
21276027|NCT04235660|Indiana University School of Medicine|Paul Haste|317-944-5005|phaste@iu.edu|
21228329|NCT00301821|Mayo Clinic|Ivana N. M. Micallef, M.D.|507-284-4642|micallef.ivana@mayo.edu|
21228330|NCT02294773|Midwest Fertility Specialists or St. Vincent Women's Hospital|Dr. Matt Will or Dr. Lauren Messinger|317-415-7528|laurenmessinger@gmail.com|
21228331|NCT01865084|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21228332|NCT05828095|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
21228333|NCT01981759|NYU Langone Health|Principal Investigator|646-754-4843|donald.goff@nyumc.org|
21228334|NCT01994590|UT MD Anderson Cancer Center|Corn,Paul,M.D. Ph.D. / Genitourinary Medical Oncology|713-792-2830|PCorn@mdanderson.org|
21228335|NCT03206073|National Cancer Institute|Dr. Tim F. Greten|240-760-6114|tim.greten@nih.gov|
21228336|NCT00255801|Memorial Sloan Kettering Cancer Center|Dr. David Straus|212-639-8365|strausd@mskcc.org|
21228337|NCT03332771|Lexicon Pharmaceuticals, Inc.|Medical Affairs|510-338-6064|medical-information@lexpharma.com|
21228338|NCT03442764|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21228339|NCT01801072|University of Michigan|Dr. Aditya Pandey, Chair, Department of Neurosurgery|734-936-7010|adityap@umich.edu|
21228340|NCT00719264|Novartis Pharmaceuticals|Study Director|862-778-8300||
21228341|NCT01277042|GlaxoSmithKline|GSK Response Center|866-435-7343||
21276028|NCT01833169|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21276029|NCT03718039|Heron Therapeutics, Inc.|Vice President, Clinical Operations|858-251-7232|svisonneau@herontx.com|
21276030|NCT01183884|Memorial Sloan Kettering Cancer Center|Dr. Brian Kushner, MD|212-639-6793|kushnerb@mskcc.org|
21303861|NCT07086378|Cedars Sinai Medical Center|Dr. Robert Wong|3104231682|Robert.Wong@cshs.org|
21303862|NCT02625389|Guerbet|Jing Hao, MD, Global Head of Medical Affairs & Clinical Development|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
21303863|NCT06785857|Xiamen Tongan District Xiangping Street Community Health Service Center|Miaoqian Huang|15880248915|hmiaoqian@163.com|
21303864|NCT06359314|Northwestern University Feinberg School of Medicine|Elizabeth L. Addington, PhD|3125033808|elizabeth.addington@northwestern.edu|
21303865|NCT03576274|Johns Hopkins School of Nursing|Dr.Nada Lukkahatai,|410-614-5297|nada.lukkahatai@jhu.edu|
21303866|NCT02314364|Massachusetts General Hospital|Henning Willers, MD|617-726-5184|hwillers@mgh.harvard.edu|
21303867|NCT02621398|Cancer Institute of New Jersey|Salma Jabbour, MD|732-235-8675|jabbousk@cinj.rutgers.edu|
21303868|NCT05952401|Washington University School of Medicine|Li-Shiun Chen, M.D., MPH, ScD|314-362-3932|li-shiun@wustl.edu|
21303869|NCT00076024|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21303870|NCT00902161|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21303871|NCT00988325|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21303872|NCT01155219|Laboratoires Thea|Dr Pascale Pouliquen|0473981436|p.pouliquen@laboratoires-thea.fr|
21303873|NCT02670343|Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center|Christina Wang, MDAssociate Director UCLA Clinical and Translational Science Institute|1-310-222-1888|wang@labiomed.org|
21303874|NCT03150485|Johnson & Johnson Vision|Thomas Karkkainen - SR PRINCIPAL RESEARCH OPTOMETRIST|904 443-3402|TKarkkai@its.jnj.com|
21303875|NCT02097537|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group||clinical@santen.co.jp|
21303876|NCT04533880|NYU Langone Health|Larry Chen|(646) 501-7200|Larry.Chen@nyulangone.org|
21303877|NCT02284178|University of Central Florida|Mary Lou Sole|407-823-5496|mary.sole@ucf.edu|
21303878|NCT04123665|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21303879|NCT01680549|Texas Tech University Health Sciences Center|Nancy Swinford|806-743-2569|nancy.swinford@ttuhsc.edu|
21303880|NCT05959200|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21303881|NCT01282203|AbbVie (prior sponsor Abbott)|Global Medical Services|1-800-633-9110||
21303882|NCT00930982|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21303883|NCT00991952|Memorial Sloan-Kettering Cancer Center|Dr. Yelena Janjigian|646-888-4186|janjigiy@mskcc.org|
21303884|NCT00518973|UCSD Eating Disorders Treatment and Research Center|Walter H. Kaye|858-534-3951|wkaye@ucsd.edu|
21228342|NCT03034200|Cleveland Clinic Pediatric and Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Peter Anderson|216-308-2706|andersp@ccf.org|
21228343|NCT01966692|Unversity of Florida|Dr Yuanyuan Jiao|(407) 313-7014|yyjiao@cop.ufl.edu|
21228344|NCT01823510|Icahn School of Medicine at Mount Sinai|Dr. Juan Badimon|212-241-8484|juan.badimon@mssm.edu|
21260762|NCT05087030|Gedeon Richter Plc.|Medical Information Scientific Service|+36 1 505 70 32|medinfo@richter.hu|
21260763|NCT04885257|Birmingham VA Medical Center|Research Compliance Officer|205-933-8101|latanya.higginbottom@va.gov|336885
21228345|NCT02469038|University of Chicago|Melanie Norstrom|773-702-1991|mnorstrom@medicine.bsd.uchicago.edu|
21228346|NCT03435640|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
21228347|NCT00510874|GlaxoSmithKline|GSK Response Center|866-435-7343||
21228348|NCT00636987|St Jude Medical|Sr. Clinical Manager|6517566803|jjohnson101@sjm.com|
21228349|NCT01251146|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21228350|NCT01347307|Mercy Research|Lead Regulatory Coordinator - Investigator Initiated Trials|314-251-8827|michelle.mcfarland@mercy.net|
21228351|NCT02876640|University of Wisconsin - Madison|Lisa Barroilhet, MD, MS|608-264-3204|barroilhet@wisc.edu|
21228352|NCT02239224|aTyR Pharma|Gennyne Walker|858 731 8389|clinicaltrials@atyrpharma.com|
21228353|NCT03183778|NYU Langone Health|David Goldfarb, MD|212-263-0744|David.Goldfarb@nyulangone.org|
21228354|NCT00073073|Georgetown University|Dr. Claudine Isaacs|(202)444-3677|isaacsc@georgetown.edu|
21228355|NCT00737464|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21228356|NCT01885871|Cutera, Inc|Clinical Research Department|1-888-428-8372|gweiss@cutera.com|
21228357|NCT00905827|Department of Veteran Affairs|Kathryn Magruder|843-789-7280|Kathryn.Magruder@va.gov|
21228358|NCT00509392|VNUS Medical Technologies / Covidien (sponsor)|Eppie Chang, MS; Director Clinical Research|408-360-7200|eppie.chang@covidien.com|
21228359|NCT05386823|HighField BioPharmaceuticals Corporation|Dr. Yuhong Xu|+86-571-86961869|yhxu@hf-biopharm.com|
21228360|NCT03007407|NSABP Foundation|Director, Department of Site and Study Management|1-800-270-3165|industrytrials@nsabp.org|
21228361|NCT03228420|Nevro Corp.|Donald Middlebrook|(650) 433-2218|don.middlebrook@nevro.com|
21228362|NCT02266914|The Ohio State University Wexner Medical Center|Tamara McMath, MPH|614-293-8082|tamara.mcmath@osumc.edu|
21260764|NCT04640766|NYU Langone Health|Lenard Adler, MD|212-263-3580|Lenard.Adler@nyulangone.org|
21260765|NCT02597062|Canadian Cancer Trials Group|Bingshu Chen|613-533-6000|bechen@ctg.queensu.ca|77703
21303885|NCT03452527|Iconic Therapeutics|Gabriela Burian, M.D.|6504371000|gburian@iconictherapeutics.com|
21303886|NCT00582816|University of Wisconsin Carbone Cancer Center|Dr. Ken DeSantes|608-263-8563|kbdesantes@pediatrics.wisc.edu|
21228363|NCT03954041|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21260766|NCT00741819|United Therpaeutics Corporation|Inhaled Treprostinil Program Head|919-485-8350|clinicalrecordsmanagment@unither.com|
21260767|NCT02863198|Benha university|dr khalid M Salama|01225861026|dr.khalid_sleem@yahoo.com|
21260768|NCT00609622|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21260769|NCT00686543|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21303887|NCT03239665|Rutgers University Center for Health Outcomes, Policy, & Economics|Laura T. Pizzi, PharmD, MPH|8484456825|laura.pizzi@rutgers.edu|
21303888|NCT01565499|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
21303889|NCT01923168|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21303890|NCT01255787|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21303891|NCT00476047|Fred Hutchinson Cancer Research Ctr|Mazyar Shadman, MD|2066675467|mshadman@fredhutch.org|
21303892|NCT00768469|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
21303893|NCT04966741|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
21303894|NCT03835728|UT Southwestern, Dept of Neurology|Dr. Steven Vernino|214-645-8800|steven.vernino@utsouthwestern.edu|
21303895|NCT00773838|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21303896|NCT02502006|University of Pennsylvania|Katherine N. Theken, PharmD, PhD|2158987470|ktheken@upenn.edu|
21303897|NCT00459056|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
21303898|NCT02522871|TransMedics|Laura Damme|978-552-0910|LDamme@TransMedics.com|
21303899|NCT00509262|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21303900|NCT00725842|Merck Sharp & Dohme|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21303901|NCT01853618|National Cancer Institute|Dr. Tim F. Greten|(301) 451-4723|tim.greten@nih.gov|
21303902|NCT00558571|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21303903|NCT00947505|Lexington International, LLC|David Michaels|561-417-0200|dm@hairmax.com|
21303904|NCT02398227|University of Akron|Dawn M Johnson, Ph.d|3309722505|johnsod@uakron.edu|
21303905|NCT00618839|Stratatech Corporation|Mary Lokuta|608-441-8358|mlokuta@stratatechcorp.com|
21303906|NCT01715129|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21303907|NCT02009384|University of Louisville|Jason Chesney|502-562-3429||
21303908|NCT01146860|ENT practice|Dr. Rainer Jund, Specialist in Otorhinolaryngology|+49 89 804880|RainerJund@gmx.de|
21228364|NCT02090075|Los Angeles Biomedical Research Institute at Harbo|Dr Matthew Budoff|3102224107|mbudoff@labiomed.org|
21228365|NCT03868124|Glaukos|Study Manager|949-481-8076|ldoan@glaukos.com|
21228366|NCT04177355|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
21228367|NCT02519387|Mundipharma Pharmaceuticals Sdn Bhd|Elayne Chan|+60 122162170|Elayne.Chan@mundipharma.com.my|
21228368|NCT01896479|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
21228369|NCT01060345|University of Chicago|Nora Jaskowiak, MD|773-702-2048|njaskowi@surgery.bsd.uchicago.edu|
21228370|NCT03823378|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21228371|NCT01606254|Janssen Pharm KK Japan|Medical Director|81-3-4411||5509
21228372|NCT02131532|University of Edinburgh|Dr Simiao Wu|0044-131-242-6371|simiao.wu@ed.ac.uk|26371
21228373|NCT02093026|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21228374|NCT04499599|L-Nutra, Inc.|Dr. Min Wei|323.791.2426|mwei@l-nutra.com|
21228375|NCT00977808|University of Virginia|Boris Kovatchev, Ph.D./Principal Investigator|434-982-6479|pcm9b@virginia.edu|
21228376|NCT00174291|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21228377|NCT00957593|Lehigh Valley Health Netword|Joanne N. Quinones MD MSCE|6104021221|joanne_n.quinones@lvhn.org|
21228378|NCT01582854|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
21228379|NCT03101267|Astellas Pharma Inc.|Clinical Trial Disclosure|+81-3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
21228380|NCT04068896|NGM Biopharmaceuticals|VP Clinical Operations|(650)243-5555|ngm120@ngmbio.com|
21228381|NCT02953509|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21228382|NCT02128100|University of Louisville|Dr. Neal Dunlap|502-561-2700|neal.dunlap@louisville.edu|
21228383|NCT00913692|National Institute of Allergy and Infectious Diseases, Laboratory of Infectious Diseases|Jeffrey I. Cohen, MD|(301) 496-5265|jcohen@niaid.nih.gov|
21228384|NCT00256282|University of California, Irvine|Dr. John P. Fruehauf|714-456-5153|jfruehau@uci.edu|
21228385|NCT02431247|Janssen Sciences Ireland UC|Clinical Registry Group|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21228386|NCT00667446|AbbVie, (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21228387|NCT00591578|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21228388|NCT02380690|VA ORD|Robert O'Brien|2024435741|Robert.O'Brien2@va.gov|
21228389|NCT02300727|Aurora Health Care - Bay Area Medical Center|Dhimant Patel, MD|920-288-4123|dhimant.patel@aurora.org|
21238606|NCT00803101|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
21238607|NCT01782742|Cleveland Clinic Lou Ruvo Center for Brain Health|Jeffrey Cummings, MD, ScD|702.483.6029|cumminj@ccf.org|
21238608|NCT01529008|Bone Therapeutics|Chief Medical Officer|+32 493 09 73 66|Regulatory@bonetherapeutics.com|
21238609|NCT04170686|University of Pennsylvania|Dr. Melissa G. Hunt|610-529-8055|mhunt@psych.upenn.edu|
21260770|NCT01237951|UT MD Anderson Cancer Center|Dr. Nieto, Yago, M.D./Stem Cell Transplantation|713-792-2466|ynieto@mdanderson.org|
21303909|NCT00722371|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21228390|NCT00523367|University of Florida|Juan Munoz, MD|904-633-0089|juan.munoz@jax.ufl.edu|
21238610|NCT04389333|National Clinical Research Center for Digestive Diseases Department of Gastroenterology|Dr. Zhuan Liao|21-31161004|liaozhuan@smmu.edu.cn|+86
21260771|NCT01708057|AstraZeneca|Carin Jorup||aztrial_results_posting@astrazeneca.com|
21260772|NCT00291343|GlaxoSmithKline|GSK Response Center|866-435-7343||
21303910|NCT01092832|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21228391|NCT01848041|RVL Pharmaceuticals|Sr. Director, Clinical Development|908-809-1423|mvelasco@osmotica.com|
21228392|NCT00356122|Sanofi-Aventis|Trial Transparency Team||Contact-Us@sanofi.com|
21228393|NCT00782795|University of Michigan|Matthew DiMagno||mdimagno@umich.edu|
21228394|NCT04480424|Scientific Innovation Office (SIO) Clinical Program Leader/Director Bioscience Clinical & Pharmacovigilance|Rhonda Griffin|+1 919 316 6693|Rhonda.griffin@grifols.com|
21303911|NCT01075191|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21228395|NCT04461509|Cedars-Sinai Medical Center|Laura Sarmiento|310-423-4295|Laura.sarmiento@cshs.org|
21228396|NCT01094561|Columbia University|Elizabeth Hecht, MD|(212)305-6510|eh2560@cumc.columbia.edu|
21228397|NCT03693170|Pierre Fabre Medicament|Isabelle Klauck, MD|+33149108018|isabelle.klauck@pierre-fabre.com|
21228398|NCT04444895|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21228399|NCT03581786|Shanghai Junshi Bioscience Co., Ltd.|Xiaojun Wang|86-021-50796193|xiaojun_wang@junshipharma.com|
21228400|NCT05523323|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21228401|NCT00920829|Medical University of South Carolina|Dr. Raymond Anton|843-792-1226|antonr@musc.edu|
21228402|NCT05654441|University of North Carolina at Chapel Hill|Keely Muscatell, PhD|919-843-5467|kmuscatell@unc.edu|
21228403|NCT01955980|PARI Pharma|Friedrich Gruber|+4989742846|friedrich.gruber@pari.com|10
21228404|NCT00053365|Gynecologic Oncology Group|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
21228405|NCT01583543|Massachusetts General Hospital|Dr. Edwin Choy|617-724-4000|echoy@mgh.harvard.edu|
21228406|NCT01483690|Therapeutic Advancements of Childhood Leukemia and Lymphoma|Clinical Research Coordinator, Consortia|323-361-5312|rleong@chla.usc.edu|
21228407|NCT03981822|Verrica Pharmaceuticals|Susan Cutler, VP, Medical Affairs|484-773-0898|scutler@verrica.com|
21228408|NCT02742246|Yale University School of Medicine|Dr. Brian Kiluk, Associate Professor of Psychiatry|203-737-1544|Brian.kiluk@yale.edu|
21228409|NCT03489551|University of Iowa|Michelle Weckmann|319-384-7538|michelle-weckmann@uiowa.edu|
21228410|NCT00054717|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21228411|NCT00585559|Vanderbilt University Medical Center|Dr. Matthew Fusco|615-322-1054|matthew.r.fusco@vumc.org|
21228412|NCT01117051|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21228413|NCT00206076|Drexel University College of Medicine|David Reich, MD|215-762-7143|David.Reich@DrexelMed.edu|
21303912|NCT00133978|Clinical Evaluation Research Unit|Dr. Daren Heyland|613-549-6666|dkh2@queensu.ca|4847
21228414|NCT00427960|Astrazeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
21228415|NCT01142128|University of Florida|Phillip Toskes, M.D.|352-273-9493|phillip.toskes@medicine.ufl.edu|
21303913|NCT00718237|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21303914|NCT02635646|University of Guanajuato|Dr. Rodolfo Guardado-Mendoza||guardamen@gmail.com|
21303915|NCT03769376|"University of Colorado Denver | Anschutz"|Kerri Font, DDS, MS|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
21303916|NCT03149848|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21303917|NCT01486810|New York Psychiatric Institute|Dr. John Mariani|646-774-8181|John.mariani@nyspi.columbia.edu|
21303918|NCT00330161|University of Michigan Comprehensive Cancer Center|Erin Sargent|(734) 936-3348|esargent@umich.edu|
21303919|NCT04738318|Vanderbilt University Medical Center|Dr. Jed Maslow|615-936-7846|jed.i.maslow@vumc.org|
21228416|NCT03355664|Mahidol Oxford Tropical Medicine Research Unit (MORU)|Thomas Peto|(+66) 802 187 460|tom@tropmedres.ac|
21228417|NCT01960387|University of Pittsburgh Cancer Institute|Michael Boyiadzis, MD|412-623-0040|boyiadzism@upmc.edu|
21276031|NCT00772148|Veloxis Pharmaceuticals|Christina Sylvest|+45 20553877|csy@veloxis.com|
21276032|NCT01214239|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21276033|NCT01756885|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@pennmedicine.upenn.edu|
21276034|NCT02367872|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21276035|NCT05718648|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21276036|NCT00559637|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21276037|NCT02252445|Keimyung university|Assistant professor|+821028862876|onidori1979@gmail.com|
21276038|NCT04501094|National Cancer Institute|Dr. Andrea B. Apolo|301-480-0536|andrea.apolo@nih.gov|
21276039|NCT00685035|University of Minnesota School of Medicine|Dr. Robert Kempainen|612-873-6413|kempa001@umn.edu|
21276040|NCT00623636|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
21276041|NCT00784979|Tampa General Hospital|Dr. John Leone|813-844-5666|jpleone@tgh.org|
21276042|NCT01114997|Cedars Sinai Medical Center|Dr. Roya Yumul|310-423-1682|Roya.Yumul@cshs.org|
21276043|NCT04241133|Montana State University|Dr. Carmen Byker Shanks|406-994-1952|cbykershanks@montana.edu|
21276044|NCT00468208|Vasculitis Clinical Research Consortium|Carol A Langford, MD MHS|216-445-6056|langfoc@ccf.org|
21276045|NCT00631007|InteKrin Therapeutics|Chief Executive Officer|650-941-5501|Info@intekrin.com|
21276046|NCT00683787|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21276047|NCT00460109|Mayo Clinic|Stephen M. Ansell, M.D., Ph.D.|507/284-4642|ansell.stephen@mayo.edu|
21276048|NCT01235715|Hospital for Special Surgery|Dr. Mark P. Figgie|212-606-1932|figgiem@hss.edu|
21276049|NCT03619876|Columbia University|Laura Geraldino-Pardilla, MD|212-305-4308|lbg2124@cumc.columbia.edu|
21276050|NCT02344745|Keck School of Medicine|Begum Ozel, M.D.|323-226-3416|ozel@usc.edu|
21276051|NCT02788513|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21276052|NCT02943993|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21303920|NCT01226121|Indiana Hand to Shoulder Center|F. Thomas D. Kaplan|3178759105|tdk@hand.md|
21303921|NCT00378079|Friends Research Institute|Dr. Timothy Kinlock|(410) 837-3977|tkinlock@friendsresearch.org|224
21303922|NCT03122301|Northwestern Medicine|David Walega, MD|13129271345|d-walega@northwestern.edu|
21303923|NCT01120834|Weill Cornell Medicine|Peter Martin, MD|646.962.2064|amr2017@med.cornell.edu|
21303924|NCT00453388|Fred Hutchinson Cancer Research Center|Dr. Hans-Peter Kiem|206-667-4425|hkiem@fredhutch.org|
21303925|NCT00586664|ISTA Pharmaceuticals, Inc.|Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com|
21303926|NCT04856865|Alladapt Immunotherapeutics|Chief Medical Officer|650-420-3900|info@alladapt.com|
21303927|NCT00686998|Astrazeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21303928|NCT02361346|Molecular Templates, Inc.|Study Director|512 930-0304|trials@mtem.com|
21303929|NCT03052764|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21303930|NCT01314911|Leidos Biomedical Research, Inc. is support to the National Institute of Allergy and Infectious Diseases (NIAID)|John Beigel, M.D|301-451-9881|jbeigel@niaid.nih.gov|
21303931|NCT00306202|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21228418|NCT03190369|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21228419|NCT04163718|Moffitt Cancer Center|Javier Pinilla, MD, PhD|813-745-8212|javier.pinilla@moffitt.org|
21228420|NCT01289782|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
21228421|NCT03742440|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
21228422|NCT00055224|National Institute of Mental Health|Dr Maryland Pao|(301) 435 5770|paom@mail.nih.gov|
21228423|NCT00121173|Johns Hopkins University|Cornelia L. Trimble, MD|410-502-0512|ctrimbl@jhmi.edu|
21228424|NCT03436810|Mahidol University|Sunee Bovonsunthonchai|024415450|sunee.bov@mahidol.edu|
21228425|NCT01754909|Baltimore VAMC|Dr Eric Cohen|410 605 7000|eric.cohen@va.gov|5/7182
21228426|NCT04081233|The University of Texas Health Science Center at Houston|David E. Meyer, MD, MS, FACS|713-500-7244|David.E.Meyer@uth.tmc.edu|
21228427|NCT04291001|University of Utah|Lori Gawron, MD|801-213-4989|lori.gawron@hsc.utah.edu|
21228428|NCT02313454|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21228429|NCT00450112|Seikagaku Corporation|Clinical Development Dept.|81-3-5220-8950|hiroyuki.hosokawa@seikagaku.co.jp|
21228430|NCT01056380|Romark Laboratories, L.C.|Marc Ayers|813-282-8544|Marc.Ayers@romark.com|
21228431|NCT00586326|Hologic, Inc.|Nancy Chenette, Director, Clinical Affairs|508-263-8770|nancy.chenette@hologic.com|
21228432|NCT03595774|Indiana University Purdue University Indianapolis|Dr. Andrew R. Coggan|3172740656|acoggan@iu.edu|
21228433|NCT04831788|University of Novi Sad, Faculty of Medicine|Prof. Vladimir Petrovic|+381648028800|vladimir.petrovic@izjzv.org.rs|
21228434|NCT04115644|UT Southwestern Medical Center|Dr. Michael Khazzam|214/645-8917|michael.khazzam@utsouthwestern.edu|
21228435|NCT02783469|University of Dundee|Professor Blair H. Smith|01382383795|b.h.smith@dundee.ac.uk|
21228436|NCT00484185|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21228437|NCT00573287|Geisel School of Medicine at Dartmouth|Alan I. Green, M.D.|6036507549|alan.i.green@dartmouth.edu|
21228438|NCT02325791|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
21228439|NCT03442400|Cleveland Clinic|Samir Kapadia, MD|216-444-6735|kapadis@ccf.org|
21228440|NCT00555425|Yale University|Dr. David Fiellin|203-688-2471|david.fiellin@yale.edu|
21228441|NCT03189381|Indiana University (IU)|Dr. Kevin Shiue|317 944 2524|kshiue@iupui.edu|
21228442|NCT01975831|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
21228443|NCT00251004|Novartis Pharmaceuticals|Study Director|862-778-8300||
21228444|NCT03794882|University of Wisconsin-Madison|Dr Kristin Bevil|6082638100|kbevil@wisc.edu|
21228445|NCT02045303|Texas Health Resources Presbyterian Hospital of Dallas|Lisley Viana, Physical Therapist|214-345-4334|lisleyviana@texashealth.org|
21228446|NCT01856023|Clinigen|Head of Medical Affairs|8323263256|nancy.gregory@clinigengroup.com|
21228447|NCT00829283|Yale School of Medicine|Dr. Carlos Grilo|203-785-2792|carlos.grilo@yale.edu|
21276053|NCT04178096|VA Pittsburgh Healthcare System|Dr. Shari Rogal|412 360 6177|shari.rogal@va.gov|
21276054|NCT00646763|Emory University Winship Cancer Institute|Edmund Waller, MD, PhD|1-888-946-7447|ewaller@emory.edu|
21276055|NCT00835796|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21276056|NCT00396630|GlaxoSmithKline|GSK Response Center|866-435-7343||
21276057|NCT00876265|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4000|clinicaltrials@merzaesthetics.com|
21276058|NCT02327325|Health Services Research & Development, Durham VA Healthcare System|Kelli Allen, PhD|919-286-0411|kelli.allen@va.gov|7090
21276059|NCT01507233|University of Miama/Jackson Memorial Hospital|Keith Candiotti, MD|305-585-5332|info@jhsmiami.org|
21276060|NCT00651183|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21276061|NCT01402128|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Soo-Wan Chae, MD|82-63-276-8284|soowan@jbnu.ac.kr|
21276062|NCT02919111|University of California, San Francisco|Dr. Thomas Hope, MD|(415) 221-4810|Thomas.Hope@ucsf.edu|22648
21276063|NCT02014441|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21303932|NCT01394718|Children's Hospital of Philadelphia|Athena Zuppa, MD, MSCE|267-426-7359|zuppa@email.chop.edu|
21303933|NCT00403403|Genentech, Inc.|Medical Communications|800-821-8590||
21303934|NCT00096954|Hoffman-LaRoche|Medical Communications|800-821-8590||
21303935|NCT04478123|Memorial Sloan Kettering Cancer Center|Dr. Michael Scordo, MD|646-608-3771|scordom@mskcc.org|
21228448|NCT03631355|NYU Langone Health Orthopedic Hospital|Dr. Michael J. Alaia|6465017223|michael.alaia@nyulangone.org|
21228449|NCT02810340|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
21228450|NCT01412918|Medical College of Wisconsion|Dr. David Friedland|414-805-|dfriedland@mcw.edu|
21228451|NCT02797054|University of Colorado|Julie A Maertens|303-724-7319|julie.maertens@ucdenver.edu|
21228452|NCT00870233|Memorial Sloan Kettering Cancer Center|Dr. Dennis Chi ME|212-639-5016|chid@mskcc.org|
21228453|NCT00769483|UT MD Anderson Cancer Center|Milind Javle, MD/Professor, GI Medical Oncology|713-792-2828|mjavle@mdanderson.org|
21228454|NCT00939952|Albany College of Pharmacy and Health Sciences|Katie Cardone|518-694-7875|katie.cardone@acphs.edu|
21228455|NCT04811573|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
21228456|NCT05074173|Tulane University School of Medicine|Keith Ferdinand|504-988-5492|kferdina@tulane.edu|
21228457|NCT00495131|National Taiwan University Hospital|Chen-Hua Liu, MD|886223123456|jacque_liu@mail2000.com.tw|63572
21228458|NCT04705363|Mayo Clinic of Jacksonville|Dr. Janice Krieger|904-953-6160|krieger.janice@mayo.edu|
21228459|NCT01616082|Translational Research Institute for Metabolism and Diabetes|Dr. Steven R. Smith|407-303-7115|steven.r.smith.md@flhosp.org|
21228460|NCT00976573|Mayo Clinic|Robert R. McWilliams, MD|507/284-8432|mcwilliams.robert@mayo.edu|
21228461|NCT02117427|Aevi Genomic Medicine|Garry A Neil|610-254-4208|garry.neil@aevigenomics.com|
21228462|NCT02730208|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21228463|NCT00439465|Dartmouth-Hitchcock Medical Center|Kenneth Meehan, MD|603-650-6432|Kenneth.R.Meehan@hitchcock.org|
21228464|NCT01520454|Beth Israel Deaconess Medical Center|Dr. Christos Manztoros|617-667-8630|cmantzor@bidmc.harvard.edu|
21228465|NCT02750215|Massachusetts General Hospital|Rebecca Suk Heist, MD|617-726-8033|RHEIST@PARTNERS.ORG|
21228466|NCT01827358|University of Maryland Medical Center|Karen Kotloff, MD|410-706-5328|kkotloff@medicine.umaryland.edu|
21303936|NCT02395016|Biotech Pharmaceutical Co., Ltd.|Director of Clinical Trials|010-51571020|lucy_he@biotechplc.com|8753
21303937|NCT01547780|National Institute of Mental Health|Robert Innis|+1 301 594 1368|innisr@mail.nih.gov|
21303938|NCT02195414|The General Hospital of Shenyang Military Region|Yaling Han, Study Chair of Clinical Trials|+86-024-28856123|hanyaling@263.net|
21303939|NCT00814879|Yale University School of Medicine: Internal Medicine: Infectious Diseases: AIDS Care Program / Viral Hepatitis Program|Dr. Michael J. Kozal|(203)737-4040|michael.kozal@yale.edu|
21303940|NCT00588952|Yale University|Ismene Petrakis|203-932-5711|Ismene.petrakis@yale.edu|2244
21303941|NCT01461057|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21303942|NCT01288976|Abbott Vascular|Jeffrey T Ellis||jeffrey.ellis@av.abbott.com|
21303943|NCT01490723|U.T. MD Anderson Cancer Center|Issa F. Khouri, M.D., Stem Cell Transplantation|(713) 745-0049|ikhouri@mdanderson.org|
21303944|NCT03560739|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21303945|NCT01362595|Feinstein Institutes for Medical Research|Dr. Adrianna Vlachos|516-562-1504|avlachos@northwell.edu|
21303946|NCT00959374|Covidien|Amy Pollack M.D. Vice President Medical Affairs, STI|203-821-4719|amy.pollack@covidien.com|
21303947|NCT02448680|LFB USA, Inc.|Kerry Biron, Director US Clinical Operations|508-370-5166|kerry.biron@lfb-usa.com|
21303948|NCT01739400|Actelion Pharmaceuticals Ltd.|Clinical Trial Disclosure Desk|+41 61 565 6565|clinical-trials-disclosure@its.jnj.com|
21303949|NCT01736657|Terumo BCT, Inc.|Ray Goodrich, Phd, VP Scientifc and Clinical Affairs|303-205-2680||
21303950|NCT03350984|University of Guanajuato|Dra. Paulina Crespo Morfin|+52 4431300112|pb.crespomorfin@outlook.es|
21303951|NCT04198818|Haihe Biopharma Co., Ltd|Medical Officer|86-(021)-20568888|fugen.li@haihepharma.com|8988
21303952|NCT00642473|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21303953|NCT02547714|Novartis Pharmaceuticals|Study Director|862-778-8300||
21303954|NCT04396496|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|bscanlan@uams.edu|
21303955|NCT01711879|University of Colorado School of Medicine|Rachel Gerle|720-848-2020|rachel.gerle@ucdenver.edu|
21303956|NCT02260531|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-3800|Sara_Tolaney@dfci.harvard.edu|
21303957|NCT00958789|Stryker Orthopaedics|Ellen Axelson, Director, Clinical Operations|201-831-5401|ellen.axelson@stryker.com|
21303958|NCT02464917|Memorial Health Systems|Michael Nageotte, MD|562-933-2748|mnageotte@memorialcare.org|
21303959|NCT00478881|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21303960|NCT01466179|Amgen Inc.|Study Director|866-572-6436||
21303961|NCT03028350|Cumberland Pharmaceuticals|Senior Clinical Scientist|6154257644|bgibson@cumberlandpharma.com|
21303962|NCT01083173|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
21303963|NCT03410823|University of Maryland School of Medicine|Denise Orwig|410-706-2406|dorwig@som.umaryland.edu|
21303964|NCT00792077|UT MD Anderson Cancer Center|Sriram Yennu, MD- Professor, Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
21303965|NCT04062123|University of Pittsburgh|Keith Vogt, MD, PhD|4126473147|vogtkm@upmc.edu|
21303966|NCT04111939|RTI International|Charles Knott|9195416294|cknott@rti.org|
21303967|NCT00740246|Luitpold Pharmaceuticals, Inc.|Mark A Falone|610-650-4200|mfalone@americanregent.com|844
21228467|NCT02338336|Norwarta|Peggy Hagerty|267-240-4010|hagertymws@comcast.net|
21228468|NCT01952470|Alfred Health|Benjamin James Tarrant|+61404455658|b.tarrant@alfred.org.au|
21228469|NCT02355977|Zhejiang University|Dr. Ying Wang|86-571-87217437|wyi1006@sina.com|
21228470|NCT00491556|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
21228471|NCT02418156|Aziyo Biolgics, Inc.|Clinical Director|470-514-4085|clinical@aziyo.com|
21228472|NCT01909453|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21228473|NCT04534465|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
21228474|NCT03718871|Weill Cornell Medicine|Dr. Radhika Sundararajan|(646) 962-4654|ras9199@med.cornell.edu|
21228475|NCT02423109|CooperVision|Myhanh Nguyen, OD|9257306716|mnguyen@coopervision.com|
21303968|NCT01041495|SUNY Upstate MEdical Univ|thomas schwartz|3154643166|schwartt@upstate.edu|
21276064|NCT00951093|Clinica Gastrobese|Carlos AS Madalosso, Director of Department of Metabolic and Bariatric Surgery|+55(54)3045-4070|madalosso@gastrobese.com.br|
21303969|NCT03584373|Montefiore Medical Center|Dr. Kara Watts, Associate Professor, Department of Urology|718-920-4531|kwatts@montefiore.org|
21303970|NCT03535571|KGK Science Inc.|Dr. Mal Evans|519-438-9374|mevans@kgkscience.com|
21303971|NCT03780400|University of North Carolina at Chapel Hill|Kelli D. Allen, PhD|919-966-0558|kdallen@email.unc.edu|
21303972|NCT01850602|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
21303973|NCT00366340|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21303974|NCT00367770|Actelion Pharmaceuticals Ltd.|Loïc Perchenet, Head of Global Post-Approval Studies|+41 61 565 64 57|loic.perchenet@actelion.com|
21303975|NCT01778179|Brazilian Center for Studies in Dermatology|Dr. Doris Hexsel|+55 51 30262633|doris@hexsel.com.br|
21303976|NCT04163822|CHCMU|no sponsor, PI: Yuan Shi|13508320283|shiyuan@hospital.cqmu.edu.cn|
21303977|NCT03282565|University of Michigan|Dr. Riann Palmieri-Smith|734-615-3154|riannp@umich.edu|
21303978|NCT00740051|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21303979|NCT02011893|St. Jude Medical|Roni Diaz, Director Clinical Studies|972-309-8601|RDiaz@sjm.com|
21303980|NCT01931709|University of Washington|Jennifer Specht, MD|206-288-6889|jspecht@uw.edu|
21303981|NCT01001299|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21303982|NCT02793622|University of California, San Francisco|Grant Dorsey, MD|628-206-4680|grant.dorsey@ucsf.edu|
21303983|NCT01244490|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21303984|NCT00400153|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|800-542-6257 Option 4|clintriage.rdg@boehringer-ingelheim.com|
21303985|NCT00971620|National Cancer Institute|Dr. Edward Cowen|301-496-4299|cowene@mail.nih.gov|
21303986|NCT00002975|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21303987|NCT03020446|University of Toledo|Munier Nazzal, MD|419-383-3576|Munier.Nazzal@utoledo.edu|
21303988|NCT01423604|Incyte Corporation|Study Director|1-855-463-3463||
21276065|NCT02576717|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21303989|NCT02829983|Universidade Estadual Paulista Júlio de Mesquita Filho|Mauro Pedrine Santamaria|3947-9033|mauro.santamaria@ict.unesp.br|
21303990|NCT02414139|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
21303991|NCT02290431|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21303992|NCT01115582|Retrophin, Inc.|Retrophin Medical Information|1-877-659|medinfo@retrophin.com|5518
21276066|NCT01363011|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21276067|NCT02457819|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
21228476|NCT03347188|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21276068|NCT03330236|Yale University|Lingzhong Meng, MD|(203) 785-2198|lingzhong.meng@yale.edu|
21276069|NCT00763555|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
21276070|NCT00407745|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21303993|NCT03324581|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21276071|NCT00298740|Johns Hopkins University|Johns Hopkins ClinicalTrials.gov Program|410-550-6484|registerclinicaltrials@jhmi.edu|
21276072|NCT02740920|Canadian Cancer Trials Group|Janet Dancey|613-533-2430|jdancey@ctg.queensu.ca|
21276073|NCT00513617|Rho Federal Systems Division|Karen Kesler, PhD|919-408-8000|karen_kesler@rhoworld.com|244
21303994|NCT00321893|University of Texas MD Anderson|Powel H. Brown, MD, PhD/Professor of Medicine and Cancer Prevention||CR_Study_Registration@mdanderson.org|
21276074|NCT03449199|Teijin America, Inc.|President|1-415-887-9742|clinical-trials-contact@teijinpo.com|
21288803|NCT02516241|AstraZeneca|Medical Science Director|1-877-240-9479|information.center@astrazeneca.com|
21288804|NCT04336943|Fred Hutchinson Cancer Center|Dr. Michael Schweizer|2066066252|mtschwei@fredhutch.org|
21303995|NCT03455764|Dana-Farber Cancer Institute|Dr. Elizabeth Buchbinder|6176325055|elizabeth_buchbinder@dfci.harvard.edu|
21303996|NCT01585584|University of Calgary|Dr. Samuel Lee|403-220-8457|samlee@ucalgary.ca|
21303997|NCT05091567|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21303998|NCT05568615|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml.JP@ml.tanabe-pharma.com|
21228477|NCT00397943|GlaxoSmithKline|GSK Response Center|866-435-7343||
21228478|NCT03139604|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21228479|NCT06053463|The Ohio State University College of Optometry|Jennifer Fogt|614-292-0882|fogt.78@osu.edu|
21288805|NCT01078662|AstraZeneca|Anitra Fielding|+44 1625 517178|aztrial_results_posting@astrazeneca.com|
21288806|NCT00325416|H. Lee Moffitt Cancer Center and Research Institute|Daniel M. Sullivan, M.D.|813-745-3878|dan.sullivan@moffitt.org|
21288807|NCT01683526|Beth Israel Medical center|Michael Silverberg|2124202377|msilverberg2@chpnet.org|
21288808|NCT01260948|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21288809|NCT02830087|Wake Forest University Health Sciences|Maxwell Langfit, MD||mlangfit@wakehealth.edu|
21288810|NCT03424148|Cutera|Margout Doucette|415-656-9612|mdoucette@cutera.com|
21288811|NCT04882709|Sonova Canada Inc.|Dr. Jinyu Qian|6472624826|jinyu.qian@sonova.com|
21288812|NCT06455111|Boston University School of Medicine Endocrinology, Diabetes, Nutrition & Weight Management|Nicole L Spartano, PhD|315-415-2040|spartano@bu.edu|
21288813|NCT05635370|Brigham and Women's Hospital|Rishi J Desai, PhD|617-278-0932|rdesai@bwh.harvard.edu|
21288814|NCT03611946|Johns Hopkins CIR|Dr Anna Durbin|410-955-7283|adurbin1@jhu.edu|
21288815|NCT04950686|innovation Research and Training|Tracy Scull, PhD|9194937700|tscull@irtinc.us|
21303999|NCT00565851|NRG Oncology|Christopher Purdy on behalf of Austin Miller PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
21304000|NCT03291067|Tanabe Pharma America, Inc.|Clinical Trials, Information Desk|Please e-mail|information.US@mb.tanabe-pharma.com|
21304001|NCT05587530|Columbia University|Lisa B. Dixon, MD, MPH|646 774 8420|Lisa.Dixon@nyspi.columbia.edu|
21304002|NCT04369053|Freenome|Director of Clinical Development|(650)446-6630|medicalaffairs@freenome.com|
21304003|NCT05079620|UConn Health|Brandon Oto|18606792000|oto.brandon@gmail.com|3881
21304004|NCT06437626|Pharmasoft|Meshcherskiy Y.E., Medical director|+ 7 (495) 626-47-55|pharmasoft@pharmasoft.ru|140
21304005|NCT01695005|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21304006|NCT02664545|Miach Orthopaedics|Rita Paparazzo|1-800-590-6995 x107|rpaparazzo@miachortho.com|
21304007|NCT00255346|The University of Texas MD Anderson Cancer Center|Hagop Kantarjian, MD/Department Chair|713-792-7026|hkantarjian@mdanderson.org|
21304008|NCT04965181|Georgia State University|Claire Spears|404-413-9335|cspears@gsu.edu|
21304009|NCT04758780|Institut de cancérologie de l'Ouest|Dr Caroline ROUSSEAU|+33 240679900|caroline.rousseau@ico.unicancer.fr|
21304010|NCT04402489|Tanabe Pharma America, Inc.|Clinical Trials, Information Desk|Please E-mail|information.US@mb.tanabe-pharma.com|
21304011|NCT03192891|Brigham and Women's Hospital|Raymond Y. Kwong, MD MPH|8573071960|rykwong@bwh.harvard.edu|
21304012|NCT05223868|Janssen Research and Development, LLC|Global Medical Head Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21304013|NCT03760731|Rocky Mountain Regional VA Medical Center|Lauren Michelle Borges, PhD|303-916-0128|lauren.borges2@va.gov|
21304014|NCT01970358|Dana-Farber Cancer Institute|Patrick Ott, MD PhD|6176325990|patrick_ott@dfci.harvard.edu|
21304015|NCT03395197|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21304016|NCT03869216|Xavier University of Louisiana|Margarita Echeverri, Professor of Social and Behavioral Sciences|504-520-6719|mechever@xula.edu|
21304017|NCT03609944|Oregon Health and Science University|Gregory Cote|503-494-4373|coteg@ohsu.edu|
21304018|NCT03809000|American College of Radiology|Wendy Seiferheld|2155743208|wseiferheld@acr.org|
21304019|NCT05403866|Lumosa Therapeutics Co., Ltd.|Sabrina Yeh|+886 2 26557918|sabrina_yeh@lumosa.com.tw|5735
21304020|NCT05330975|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
21304021|NCT04148911|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21304022|NCT03574363|KBP Biosciences USA, Inc.|Kimberly Miller|4847644862|kimberly.miller@kbpbiosciences.com|
21304023|NCT05454657|Massachusetts General Hospital / Harvard Medical School|Dr. David Eddie|6176439194|deddie@mgh.harvard.edu|
21304024|NCT05267106|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21304025|NCT04165824|Tanabe Pharma America, Inc.|Clinical Trials, Information Desk|Please email|information.US@mb.tanabe-pharma.com|
21304026|NCT04986072|University of Rochester Medical Center|Dr. Paulo Lizano MD, PhD|(201) 776-6708|lizanopl@gmail.com|
21304027|NCT03036930|Northwestern University|Seema A. Khan|312-503-4236|s-khan2@northwestern.edu|
21304028|NCT03199885|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
21304029|NCT06102174|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21304030|NCT04227899|Abbott|Karine Ruster|(408) 845-0764|karine.piard-ruster@abbott.com|
21304031|NCT05151471|Tanabe Pharma America, Inc.|Clinical Trials, Information Desk|908-607-1980|information.US@mb.tanabe-pharma.com|
21304032|NCT03988608|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
21304033|NCT04230174|Massachusetts General Hospital|Caterina Mainero|6177247746|cmainero@mgh.harvard.edu|
21304034|NCT04998136|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21304035|NCT04259632|University of Minnesota|Niki Oldenberg|612-625-8781|olden019@umn.edu|
21304036|NCT05280301|Dartmouth-Hitchcock|Dr Nicholas Daniel|603-650-5000|Nicholas.Daniel@hitchcock.org|
21304037|NCT06011759|VA Ann Arbor Health Care System|Paul Pfeiffer, MD, MS, Corresponding Principal Investigator|N/A|paul.pfeiffer@va.gov|
21304038|NCT03292458|Massachusetts Eye and Ear|Prof. Kristina Simonyan|617-573-6016|kristina_simonyan@meei.harvard.edu|
21304039|NCT04927364|VA Palo Alto Healthcare System|Claudia Padula|650-849-1211|padula@stanford.edu|
21304040|NCT05714644|Massachusetts General Hospital|Jennifer Haas, MD|6176434266|jennifer.haas@mgh.harvard.edu|
21304041|NCT02276885|NYU Langone Health|Naamit Gerber, MD|2127316338|Naamit.Gerber@nyulangone.org|
21304042|NCT05101317|Peking University|Dr. Ruiping Xiao|86-010-62757243|xiaor@pku.edu.cn|
21304043|NCT04569032|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21304044|NCT05908162|Republican center of Hygiene, Epidemiology and Public Health|Head of laboratory Fomina E.G.|+375173740417|feg1@tut.by|
21228480|NCT03436563|M D Anderson Cancer Center|Dr. Van Morris|713-792-2828|vkmorris@mdanderson.org|
21228481|NCT04209426|Medextens SARL|Frederic C Daoud, M.D., M.Sc., Epidemiologist-Biostatistician|+33964281703|fcdaoud@medextens.com|
21228482|NCT02285283|The University of Texas Health Science Center at Houston|Amber U. Luong, MD, PhD|713-486-5000|Amber.U.Luong@uth.tmc.edu|
21228483|NCT02477423|Neonatology, Department of Pediatrics, University of Chicago|Dr. Christina S. Kim|773-702-6210|christinakim13@gmail.com|
21228484|NCT02882074|Cleveland Clinic|Dr. Marta Kelava|2162133218|kelavam@ccf.org|
21228485|NCT03682809|The University of Alabama at Birmingham|Dr. Andrew Pucker|920-579-2900|apucker@uab.edu|
21228486|NCT02661711|Moorfields Eye Hospital|Tumelo Kaminskas|02072533411|moorfields.resadmin@nhs.net|2036
21228487|NCT01337687|Montefiore Medical Center, Albert Einstein College of Medicine|Casara Jean Ferretti|3472499694|cferrett@montefiore.org|
21228488|NCT01751802|Psyadon Pharmaceuticals|President/CEO|301-919-2020|info@psyadonrx.com|
21228489|NCT01617148|Cleveland Clinic Foundation|Dr. Rishi Singh|330-888-4000|singhr@ccf.org|
21304045|NCT03837626|University of Missouri|Camila Manrique, MD|573-882-2554|manriquec@missouri.edu|
21304046|NCT04421625|INSTITUT DE CANCEROLOGIE DE L'OUEST|DR FREDERIC BIGOT|02 41 35 27 00|frederic.bigot@ico.unicancer.fr|+33
21228490|NCT02145507|Haemonetics (trial sponsor)|Adrian Orr, Clinical Research Director|781.356.9647|aorr@haemonetics.com|
21228491|NCT00521001|Mayo Clinic|Svetomir Markovic, MD, PhD|507/284-1370|markovic.svetomir@mayo.edu|
21304047|NCT05764265|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21276075|NCT00684567|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21276076|NCT00848042|Nanospectra Biosciences, Inc.|Robin Dickson|7138422720|rdickson@nanospectra.com|216
21304048|NCT02421198|University of Arizona|Dr. Melanie D Hingle|520-621-3087|hinglem@email.arizona.edu|
21304049|NCT05422638|VA San Diego Healthcare System|Ariel J Lang, PhD, MPH|858-552-8585|ariel.lang@va.gov|5953
21276077|NCT02744755|Hexal AG/Sandoz Inc.|Sandoz Biopharma Clinical Development - Strategic Planning|0049(0)80244760|biopharma.clinicaltrials@sandoz.com|
21276078|NCT00809965|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|Development Head Cardiovascular/Urology|1 215 628-5257||
21276079|NCT02046317|The University of Texas Health Science Center at Houston|Carlos J Roldan, MD|713-745-7246|Carlos.J.Roldan@uth.tmc.edu|
21276080|NCT01628549|Allergan|Thearpeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
21276081|NCT06128525|USC/Norris Comprehensive Cancer Center|Tali Homsey|(323) 865-0451|tali.homsey@med.usc.edu|
21304050|NCT04777331|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21304051|NCT04684485|Sun Pharmaceutical Industries Limited|Head Regulatory Affairs|2266455645|Clinical.Trial@sunpharma.com|5689
21276082|NCT00960414|UCSF Osher Center for Integrative Medicine|Rick Hecht, MD|4153739743|rick.hecht@ucsf.edu|
21304052|NCT01827956|Institut Bergonié|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33556333333|s.mathoulin@bordeaux.unicancer.fr|
21276083|NCT00974350|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
21228492|NCT02821910|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21276084|NCT01214980|University South Florida|Dr. Lisa Gould|(410) 736-4646|lgould44@hotmail.com|
21304053|NCT03993379|CytomX Therapeutics|Lawrence Lu|(650) 515-3185|clinicaltrials@cytomx.com|
21304054|NCT05029687|Rutgers University|Sara Heinert, PhD, MPH|732-235-7872|sara.heinert@rutgers.edu|
21304055|NCT03345420|Huntsman Cancer Institute/University of Utah|Clinicaltrials.gov/CTRP Specialist|8012136215|IITDataManagement@hci.utah.edu|
21304056|NCT04230304|Mayo Clinic|Sikander Ailawadhi|904-953-2000|Ailawadhi.Sikander@mayo.edu|
21304057|NCT05740371|Tanabe Pharma GmbH|Clinical Trials, Information Desk|Please email|regulatorycontact.DE@mb.tanabe-pharma.com|
21228493|NCT04218123|Department of Otolaryngology - Head and Neck Surgery, Medical University of South Carolina|Habib Rizk, MD, MSc|8438760112|rizkh@musc.edu|
21228494|NCT00423670|Merck, Sharp and Dohme|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21228495|NCT00900601|Oslo University Hospital|Thomas Kibsgård|99030831|kibsgard@gmail.com|+47
21228496|NCT01654861|Eastern Regional Medical Center|Eiko Klimant, MD|215-537-7400|eiko.klimant@ctca-hope.com|
21228497|NCT01082640|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21228498|NCT03727373|Department of Radiation Oncology, University of Lübeck, Germany|Prof. Dr. med. Dirk Rades|0049 451 500|dirk.rades@uksh.de|45401
21228499|NCT00413478|University of Texas (UT) MD Anderson Cancer Center|Zeev Estrov, MD/Professor, Leukemia|713-794-1675|CR_Study_Registration@mdanderson.org|
21228500|NCT03577171|Assembly Biosciences|Linda Baher, Sr. Director, Clinical Operations|415-521-3808|clinicaltrials@assemblybio.com|
21228501|NCT01056328|St. Jude Medical|Nicole Glowacki, Clinical Project Manager|651-756-3432|NGlowacki@sjm.com|
21228502|NCT01082380|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21228503|NCT01770652|ApoPharma Inc.|Fernando Tricta, MD|Phone: 416-401-7332|ftricta@apopharma.com|
21228504|NCT04543409|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21228505|NCT01052844|Faculdade de Medicina do ABC|Felipe Melo Cruz|+55+11+27595914|felipemcruz@yahoo.com.br|
21228506|NCT01677312|Center for Interventional Endoscopy, Florida Hospital|Dr. Shyam Varadarajulu, MD|407-303-2570|svaradarajulu@yahoo.com|
21228507|NCT03519386|Glaukos|Study Manager|949-481-8076|ldoan@glaukos.com|
21228508|NCT05078138|USARIEM|Dr. Lee Margolis|508-206-2335|lee.m.margolis.civ@health.mil|
21228509|NCT01298193|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
21228510|NCT00107952|Theravance Biopharma Antibiotics, Inc.|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
21228511|NCT03475875|Johnson & Johnson Vision|John Buch - Senior Principal Research Optometrist|904-443-1707|JBUCH@its.jnj.com|
21228512|NCT01642407|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21228513|NCT00424255|GlaxoSmithKline|GSK Response Center|866-435-7343||
21228514|NCT03004248|Revance Therapeutics, Inc.|Todd Gross, PhD, VP Data Science, Interim Head of Clinical Development|510-742-3400|tgross@revance.com|
21228515|NCT02632838|School of Nursing, Rutgers, the State University of New Jersey|Dr. Peijia Zha|7327637412|peijiaz@sn.rutgers.edu|
21228516|NCT03945175|NYU Langone Health|Terry Leon|646 754 4837|terry.leon@nyulangone.org|
21228517|NCT01369485|Ethicon Surgical Care|John Lombard, Manager Clinical Research|908 218 2877|Jlombar8@its.jnj.com|
21228518|NCT03221764|University of Louisville|Dr. Victor van Berkel|502-588-7600|victor.vanberkel@ulp.org|
21228519|NCT02721979|University of Washington|Dr. Michael Schweizer|(206) 606-6252|schweize@uw.edu|
21228520|NCT01306877|Covidien|Tam LaFleur, Clinical Project Manager|203-821-4744|tam.lafleur@covidien.com|
21228521|NCT00006389|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
21228522|NCT01781169|Shenzhen Center for Chronic Disease Control|Dr. Ji-Chang Zhou|86-755-25503842|jichangzhou@gmail.com|
21276085|NCT01344018|EORTC (European Organisation for Research and Treatment of Cancer)|EORTC HEADQUARTERS|+32 2 774 16 11|eortc@eortc.be|
21276086|NCT02725645|Universidade Fernando Pessoa|Sandra Beatriz Pereira Rodrigues||sandrar@ufp.edu.pt|
21260773|NCT00924703|BioMarin Pharmaceutical Inc.|Debra Lounsbury/Sr Principle Scientist, Clinical Sciences|415-506-6348|Dlounsbury@bmrn.com|
21304058|NCT05112809|Mayo Clinic|Michael Cevette, Ph.D.|480-301-4380|mcevette@mayo.edu|
21304059|NCT06374394|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21260774|NCT00666562|University of Wisconsin|Howard H. Bailey|608-263-8624|hhbailey@wisc.edu|
21260775|NCT04906707|Emory University|Dr. Nadine Matthie|404-712-8449|nadine.matthie@emory.edu|
21260776|NCT01976806|Beth Israel Deaconess Medical Center|Dr. Kenneth Mukamal|617-754-1401|kmukamal@bidmc.harvard.edu|
21260777|NCT01106040|Navidea Biopharmaceuticals|Dr. Frederick Cope|614-793-7500|fcope@navidea.com|140
21260778|NCT03929250|Oregon Health & Science University|Dr. Amala Soumyanath|503-494-6878|soumyana@ohsu.edu|
21260779|NCT01041248|Childrens Hospital of Eastern Ontario|Dr Johannes Roth|6137377600|jroth@cheo.on.ca|1015
21260780|NCT01946516|SWOG Statistics and Data Management Center|Cancer Care Delivery Committee Statistician|2066674623|karnold@fredhutch.org|
21260781|NCT04429022|University at Buffalo|Dr Sarah Andres, PI|7163230631|seandres@buffalo.edu|
21260782|NCT05262764|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
21260783|NCT00075881|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
21260784|NCT00371267|San Francisco VA Medical Center|Timothy P. Carmody, Ph.D.|415-221-4810|Timothy.Carmody@va.gov|6344
21304060|NCT04151667|Moffitt Cancer Center|Dr. Rachid Baz|813-745-3163|Rachid.Baz@moffitt.org|
21260785|NCT02109029|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21304061|NCT05673005|Mass General Brigham Department of Urology|Martin Kathrins, MD|617-732-6227|mkathrins@bwh.harvard.edu|
21260786|NCT03195894|KontigoCare AB|Markku Hämäläinen, Research Director|0769 47 31 32|markku.hamalainen@kontigocare.com|
21260787|NCT01575912|Centre Hospitalier Esquirol|Dr Murielle Girard|0033555431028|murielle.girard@ch-esquirol-limoges.fr|
21260788|NCT00686205|Abbott Diagnostics Division|Peggy Moreno|847-937-2044|Peggy.Moreno@abbott.com|
21260789|NCT01217606|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21260790|NCT03424109|NYU Langone Health|Allison Cuthel|212-263-8631|Allison.Cuthel@nyulangone.org|
21260791|NCT02966314|University of Wisconsin - Madison|Ravi Viswanathan|(608) 263-1081|rviswanathan@medicine.wisc.edu|
21304062|NCT06475729|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21304063|NCT05494632|Washington University School of Medicine|Jill B Firszt, PhD|314-362-4760|firsztj@wustl.edu|
21304064|NCT00006436|National Cancer Institute|Dr. Max Gordon|240-858-7151|max.gordon@nih.gov|
21304065|NCT02837237|KBP Biosciences Co., Ltd.|Vincent J. Benn|2677996545|vince.benn@kbpbiosciences.com|
21304066|NCT04091945|Lumosa Therapeutics Co., Ltd.|Sabrina Yeh|+886 2 26557918|sabrina_yeh@lumosa.com.tw|5735
21304067|NCT06588530|Rutgers University|Dr. Robert Laumbach|1-848-445-6084|laumbach@eohsi.rutgers.edu|
21304068|NCT06013176|Abramson Cancer Center|Dr. Samuel Takvorian|267-438-8269|Samuel.takvorian@pennmedicine.upenn.edu|
21304069|NCT05126225|University of California Los Angeles, Joe. C Wen School of Nursing|Dr. Wei-Ti Chen|310-206-8539|wchen@sonnet.ucla.edu|
21304070|NCT04569084|Tanabe Pharma America, Inc.|Clinical Trials, Information Desk|908-607-1980|information.US@mb.tanabe-pharma.com|
21304071|NCT05321784|OHSU Knight Cancer Institute|Khoa Nguyen|503-418-9314|nguyekho@ohsu.edu|
21304072|NCT02483429|Johns Hopkins University|David E. Newman-Toker|443-287-9593|toker@jhu.edu|
21304073|NCT04577404|Tanabe Pharma America, Inc.|Clinical Trials, Information Desk|908-607-1980|information.US@mb.tanabe-pharma.com|
21304074|NCT05468320|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21304075|NCT03921554|Children's Hospital of Philadelphia|Dr. Adeline Vanderver|215-590-1719|vandervera@chop.edu|
21304076|NCT04440592|Tanabe Pharma America, Inc.|Clinical Trials, Information Desk|Please email|information.US@mb.tanabe-pharma.com|
21304077|NCT04090957|Estetra SRL|Clinical Study Leader|+3243254451|clinical.trials@estetra.com|
21304078|NCT06173063|Rockfield Medical Devices Ltd.|Edel Keaveney, Senior Research Manager|(+353) (0)91 763 000|edel@rockfieldmd.com|
21304079|NCT03820947|Medtronic|Wendy Moeyersons, Clinical Research Specialist|+32486313172|wendy.moeyersons@medtronic.com|
21304080|NCT02860000|Mayo Clinic|Dr Tufia C Haddad|507-284-2511|Haddad.Tufia@mayo.edu|
21304081|NCT02578095|Viking Therapeutics, Inc|Scott Stubbe, Vice President Clinical Operations|8587044685|sstubbe@vikingtherapeutics.com|
21304082|NCT05161689|Mahidol University Faculty of Social Sciences and Humanities|Chair of the Institutional Review Board|+662-441-9180|mussirb310@gmail.com|
21228523|NCT01057901|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
21276087|NCT01332968|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21276088|NCT02351167|Washington University School of Medicine|Li-Shiun Chen, M.D.|314-362-3932|li-shiun@wustl.edu|
21276089|NCT00194792|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
21276090|NCT02448563|Boston Medical Center|Ashley McCarthy, Clinical Research Manager|617-638-5906|ashley.mccarthy@bmc.org|
21276091|NCT02339038|NIH Clinical Center|Masur, Henry|+1 301 496 9320|HMasur@cc.nih.gov|
21276092|NCT00722436|The Childrens Hospital of Pittsburgh of UPMC|Franklyn Cladis|412-692-5260|cladfp@upmc.edu|
21276093|NCT02092857|University of Alberta|Dr. Tom Clandinin|7804925188|tclandin@ualberta.ca|
21276094|NCT01292837|UCB|UCB Clinical Trial Call Center|++1 877 822 9493||
21228524|NCT04812080|University of California Davis|Dr. Moon Chen|916-734-1191|mschenjr@ucdavis.edu|
21228525|NCT00999921|Medical College and Hospital Kolkata|Md Tanveer Adil|0091-9830154566|tanveer.cmc@gmail.com|
21228526|NCT02096575|U of New Mexico - Dept of OBGYN/Family Planning|Michel Paves, HS Research Specialist|505-272-9703|MDaliva@salud.unm.edu|
21228527|NCT02376283|The Royal Wolverhampton NHS Trust|Prof James Cotton|01902307999|jamescotton@nhs.net|
21228528|NCT02495103|National Cancer Institute|Dr. Ramaprasad Srinivasan|240-760-6251|ramasrin@mail.nih.gov|
21228529|NCT00633867|NHS Grampian|W Brampton||william.brampton@nhs.net|
21238611|NCT04425902|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21238612|NCT01191840|Duke University Health System|Vance Fowler|919-668-8044|fowle003@mc.duke.edu|
21238613|NCT04669600|Sanofi aventis recherche & développement|Trial Transparency Team|8006331610|Contact-US@sanofi.com|6#
21238614|NCT01544998|Mayo Clinic|Horng Chen, MD, Professor of Medicine|507-284-8846|chen.horng@mayo.edu|
21238615|NCT00691808|Lexicon Pharmaceuticals, Inc.|Joel P. Freiman, MD, MPH - Medical Director, Drug safety|281-863-3000||
21238616|NCT01861574|Medical University of South Carolina|JEFFREY J BORCKARDT|(843)792-3295|borckard@musc.edu|
21238617|NCT00331344|Oakland Medical Center|Andrea Harzstark, M.D.|510-752-6789|andrea.l.harzstark@kp.org|
21238618|NCT04538144|Institute for Exercise and Environmental Medicine|Dr. Craig Crandall|214-345-4623|craigcrandall@texashealth.org|
21260792|NCT02725788|3M|Laura Rutledge|651-733-5394|lfrutledge1@mmm.com|
21288816|NCT07021443|UZ Brussel|Prof. dr. Hendrik Reynaert|+32 2 477 68 11|hendrik.reynaert@uzbrussel.be|
21288817|NCT03496129|University of Louisville|Dr. Martha Bickford|502-852-3527|martha.bickford@louisville.edu|
21288818|NCT06717399|Saint Joseph's University|Nabila Enam|2155967348|nenam@sju.edu|
21288819|NCT05291975|Erchonia Corporation|Clinical Affairs Manager|8882420571|tsammons@erchonia.com|
21288820|NCT02266576|Stanford University|Jan J. Vasquez|408-858-4457|jan.vasquez@stanford.edu|
21288821|NCT01440920|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21288822|NCT02626611|Stanford|Dr. Kari Nadeau|650-867-4592|knadeau@stanford.edu|
21288823|NCT00479232|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21288824|NCT05399771|Atrium Health Wake Forest Baptist|Nicole Levi|336-716-4171|nlevi@wakehealth.edu|
21288825|NCT01692015|Imperial College London|professor Claire Shovlin|+44 (0)20 7589 5111|c.shovlin@imperial.ac.uk|
21288826|NCT02906618|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21288827|NCT01680172|Mayo Clinic|Robert Bright, MD|480-301-4853|bright.robert@mayo.edu|
21288828|NCT01312129|The Mind Research Network|Kent Hutchison, Ph.D.|720-663-0745|khutchison@mrn.org|
21288829|NCT01239680|Truman Medical Center|Charles W. Van Way, III, M.D.|816.235.2553|vanwayc@umkc.edu|
21288830|NCT02734667|Stanford University|Dr. Korey Hood|6504976899|kkhood@stanford.edu|
21288831|NCT05177094|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
21288832|NCT02260986|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
21288833|NCT01111370|Dexcom, Inc|Andy Balo/Sr. VP|8582000203|abalo@dexcom.com|
21288834|NCT00313170|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
21288835|NCT02827708|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21288836|NCT02199574|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
21288837|NCT00898807|Johns Hopkins|Anne Casper|410-955-8183|ashankl1@jhu.edu|
21288838|NCT00407511|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21288839|NCT00529035|Dana-Farber Cancer Institute|John Koreth, MBBS, D.Phil|(617) 632-2949|jkoreth@partners.org|
21288840|NCT01521364|University of Groningen, University Medical Center Groningen|Dr. J.W.C. Alffenaar|+31-50-3614070|j.w.c.alffenaar@umcg.nl|40378
21288841|NCT02636283|University of Minnesota|Otto Sanchez|615-833-9867'|sanc0050@umn.edu|
21288842|NCT03418675|University of Chicago|Dr. Jon E. Grant|7738341325|jgrant4@bsd.uchicago.edu|
21288843|NCT01879852|University of Florida|Dr. Terese Chmielewski|(352)273-6104|tchm@ufl.edu|
21288844|NCT02115386|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
21288845|NCT02409901|University of Illinois Chicago|Shyreen Kamal, Director of Clinical Research|2068830173|shyreen@uic.edu|
21288846|NCT02493855|AbbVie|Global Medical Services|800-633-9110||
21288847|NCT02111980|UC San Diego School of Medicine|Dr. Ulrika Birgersdotter-Green|858-657-5310|ubgreen@ucsd.edu|
21288848|NCT00753142|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
21288849|NCT05059080|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21288850|NCT01047501|Amarin Pharma, Inc.|Alex Giaquinto|+1 908 326 1324|alex.giaquinto@amarincorp.com|
21288851|NCT03562507|University of Michigan Rogel Cancer Center|ClinicalTrials.gov Cancer Center Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
21288852|NCT03600428|Vanderbilt University Medical Center|C. Buddy Creech, MD, MPH|6153430332|buddy.creech@vumc.org|
21288853|NCT00770484|Vanderbilt University|Italo Biaggioni, MD., Professor of Medicine and Pharmacology|(615) 936-3420|italo.biaggioni@vanderbilt.edu|
21288854|NCT00063622|Virginia Commonwealth University|Arun J. Sanyal||asanyal@mcvh-vcu.edu|
21288855|NCT00088153|Massachusetts General Hospital|Anne Klibanski|617-726-3870|aklibanski@partners.org|
21288856|NCT01695746|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21288857|NCT02580604|University of Colorado Anschutz Medical Campus|Dr. Sarah Wherry|303-724-1927|sarah.wherry@cuanschutz.edu|
21288858|NCT02324153|Johns Hopkins University School of Medicine|Karin Neufeld MD MPH: PI of Trial|410-550-0197|kneufel2@jhmi.edu|
21288859|NCT01563081|GlaxoSmithKline|GSK Response Center|866-435-7343||
21288860|NCT03279458|University of Mississippi Medical Center|Dr. Madhankumar Sathyamoorthy, Principal Investigator|6018157066|msathyamoorthy@umc.edu|
21228530|NCT01654796|Massachusetts General Hospital|Dr. Maurizio Fava|617-724-2513|MFAVA@mgh.harvard.edu|
21260793|NCT00828464|GlaxoSmithKline|GSK Response Center|866-435-7343||
21260794|NCT00474240|Aegerion Pharmaceuticals|Chief Medical Officer|617-500-7867||
21260795|NCT00608140|Duke University|Mary Ann Sellers|919-668-8544|maryann.sellers@duke.edu|
21260796|NCT03812510|Aclaris Therapeutics, Inc.|Aclaris Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
21260797|NCT03075839|Yale University|Krysten Bold|203-974-7603|Krysten.bold@yale.edu|
21260798|NCT00594399|Durham VA Medical Center (GRECC/HSRD)|Miriam C. Morey, Ph.D.|919-286-0411|miriam.morey@va.gov|6776
21260799|NCT00659438|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21260800|NCT00410891|Stanford|Professor|6504984791|cta@stanford.edu|
21260801|NCT02469246|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21260802|NCT00046566|Tulane University|Jiang He, MD, PhD, Chair of Epidemiology|5049885165|jhe@tulane.edu|504
21260803|NCT00922935|Straumann|Kristina Espemar Holst, Senior Clinical Trial Manager|+41 61 965 11 11|info@straumann.com|
21260804|NCT01491945|Endologix|Sripad Bellary, Director of Clinical Affairs|9257011628|sbellary@endologix.com|
21260805|NCT02201940|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21260806|NCT02700451|HospitalSS|Catherine Himo Gang|917-260-4603|gangh@HSS.EDU|
21260807|NCT01578902|Sunnybrook Research Institute|Dr Andrew Loblaw, Director GU Radiation Trials|4164804806|andrew.loblaw@sunnybrook.ca|
21260808|NCT00404092|University of Cologne|Oliver A. Cornely|+49 221 478 6494|Oliver.Cornely@zks-koeln.de|
21276095|NCT00216060|Hoosier Oncology Group|Christopher Sweeney, M.B., B.S.|(617) 632 4524|christopher_sweeney@dfci.harvard.edu|
21276096|NCT02174276|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21276097|NCT02522780|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21276098|NCT04106817|WCCT Global|Associate Director of Regulatory Affairs|7207713080|erin.flynn@wcct.com|
21276099|NCT02260635|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21276100|NCT03310619|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21238619|NCT02228967|San Diego State University Research Foundation|Mark B. Reed/Professor and Interim Associate Dean|619-594-6664|mreed@sdsu.edu|
21276101|NCT01812473|Universitaire Ziekenhuizen Leuven|Kim Vanstraelen, PharmD|0032 16 342339|kim_vanstraelen@hotmail.com|
21238620|NCT01264380|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21288861|NCT01937299|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
21288862|NCT00700635|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21288863|NCT01428245|University of Virginia|Clinical Research Coordinator|434-243-6911|pcos@virginia.edu|
21288864|NCT00768053|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21288865|NCT03018938|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21288866|NCT01202591|Astrazeneca|Richard Mather|+44 1763 263593|ClinicalTrialTransparency@astrazeneca.com|
21288867|NCT01769586|VA Connecticut Healthcare System|Dr. Loren Laine|203-932-5711|loren.laine@yale.edu|
21288868|NCT00191100|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21288869|NCT02872714|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21228531|NCT00473746|Janssen R&D US|Sr. Director, Clinical Research|(310)914-2917||
21228532|NCT01017575|Bristol-Myers Squibb International Corporation|BristolMyers Squibb Study Director||clinical.trials@bms.com|
21228533|NCT00586196|BIDMC|Edward R Marcantonio|617-754-1405|emarcant@bidmc.harvard.edu|
21228534|NCT01962922|Veloxis Pharmaceutical|Leslie Callahan|732-321-3221|lca@veloxis.com|
21228535|NCT00744471|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21228536|NCT03224546|University of Kentucky|William W. Stoops|859-257-5383|william.stoops@uky.edu|
21228537|NCT04706416|Valley Baptist Medical Center|Dr. Ameer Hassan|973-303-8146|ameerehassan@gmail.com|
21228538|NCT00970736|University of Florida|Karen Hegland|352 359-1830|kwheeler@ufl.edu|
21228539|NCT01280955|Duke University Medical Center|Mitchell Horwitz, MD|919-668-1045|mitchel.horwitz@duke.edu|
21228540|NCT00596362|Memorial Sloan Kettering Cancer Center|Dr. David Abramson|212-639-7232|abramsod@mskcc.org|
21228541|NCT00817479|The University of Chicago, Department of Medicine|Dr. Gini Fleming, MD|(773) 702-6149|gfleming@medicine.bsd.uchicago.edu|
21228542|NCT02793128|UroGen Pharma Ltd.|Madlen Malinowski|6467689533|madlen.malinowski@urogen.com|
21228543|NCT02359851|Vanderbilt-Ingram Cancer Center|Principal Investigator|615-936-7423|douglas.b.johnson@vanderbilt.edu|
21228544|NCT00055471|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21228545|NCT01854944|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21228546|NCT05419999|University of Texas Health Science Center at San Antonio|Casey Straud|210-562-6700|straud@uthscsa.edu|
21228547|NCT00282347|Genentech, Inc.|Medical Communications|800-821-8590||
21228548|NCT02782923|NYU Langone Madison Avenue Orthopaedics|Yong H. Kim, MD|212-427-3986|Yong.Kim@nyulangone.org|
21228549|NCT01659658|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21228550|NCT01897714|Oncopeptides AB|Eva Nordström|+4686152040|trials@oncopeptides.com|
21228551|NCT00775944|University of Nottingham|Graeme Docherty|01158321380|graeme.docherty@nottingham.ac.uk|
21228552|NCT03875118|National Taipei University of Nursing Health and Sciences|Director of Nursing Department|886-2-28227101|tsaejyy@ntunhs.edu.tw|3118
21228553|NCT02237911|University of Pittsburgh|Dr. Sara Piva|(412) 383-6712|spiva@pitt.edu|
21228554|NCT00721123|Hoffmann-La Roche|Medical Communications|800 821-8590||
21228555|NCT00872027|University of Minnesota|Craig Weinert MD|612-624-0999|weine006@umn.edu|
21228556|NCT02428608|Evolus, Inc|Rui L. Avelar, MD|(805)689-8668|rui@evolusinc.com|
21228557|NCT02840240|Cleveland Clinic|Fabio Rodriguez|216444-9950|rodrigf3@ccf.org|
21228558|NCT01143207|FHI 360|Vera Halpern, MD|919-54-7040|vhalpern@fhi360.org|11390
21228559|NCT01466595|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21228560|NCT02376829|Align Technology Inc|Sherri Wilson-Lopes|408-470-1032|swilson@aligntech.com|
21228561|NCT00057954|ECOG Statistical Office|Study Statistician|617-632-3012||
21228562|NCT00559754|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21228563|NCT01264016|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
21228564|NCT01629706|Alcon Research, Ltd.|Alan Landers, Project Head, Vision Care R&D|1-888-451-3937|alcon.medinfo@alcon.com|
21228565|NCT02117414|Medtronic, Inc|Evera MRI Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|62813
21228566|NCT01439347|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@appirx.com|
21228567|NCT02537574|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
21228568|NCT02663687|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21228569|NCT00417482|New York State Psychiatric Institute|Davangere P. Devanand, MD|212-543-5612|dpd3@columbia.edu|
21228570|NCT01593722|Laboratory of Parasitic Diseases, NIAID, NIH|Dr. Amy Klion|301-435-8903|aklion@niaid.nih.gov|
21228571|NCT03343067|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21228572|NCT00116168|MedImmune|Don Raible, MD|301-398-0000|raibleD@medimmune.com|
21228573|NCT00048061|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21228574|NCT03583073|Brown U|Anthony Spirito|4013692435|anthony_spirito@brown.edu|
21228575|NCT05014490|"PrJSC Pharmaceutical Firm Darnytsia"|Andrii Doroshenko, PhD, MD|+38 044 207 73 53|a.doroshenko@darnytsia.ua|
21228576|NCT01569464|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493||
21238621|NCT01860586|Mid-Atlantic Retina|Dr. Jason Hsu, Principal Investigator|215-928-3092|jshu@midatlanticretina.com|
21228577|NCT01376557|Lexicon Pharmaceuticals, Inc.|Dr. Paul Strumph|(281) 863-3302|pstrumph@lexpharma.com|
21228578|NCT03063203|Washington University School of Medicine|John Welch, M.D., Ph.D.|314-362-2626|jwelch@wustl.edu|
21228579|NCT04025710|BIOTRONIK SE & Co.KG|Senior Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
21288870|NCT05061888|Pennington Biomedical Research Center|Corby Martin|225-763-2585|corby.martin@pbrc.edu|
21228580|NCT00755911|University of Michigan|Darnell Kaigler|734-998-1468|dkaigler@umich.edu|
21228581|NCT00245583|Icahn School of Medicine at Mount Sinai|Dr. Heather Berlin|212-241-4761|heather.berlin@mssm.edu|
21228582|NCT04718103|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21228583|NCT01309893|Bausch & Lomb|Dr. Robert Steffen|585 338-6399|robert.steffen@bausch.com|
21228584|NCT01343901|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21228585|NCT01484938|Alcon Research, Ltd.|Jami Kern, Ph.D., Global Medical Affairs|800-862-5266||
21228586|NCT02942576|Contact for Clinical Trial Information|Daiichi Sankyo|1-908-992-6400|CTRinfo@dsi.com|
21228587|NCT01958112|Dana-Farber Cancer Institute|Dr. Ursula Matulonis|617-632-2334|ursula_matulonis@dfci.harvard.edu|
21228588|NCT01085500|Mayo Clinic|Benjamin Zendejas, MD|507-538-5413|zendejas.benjamin@mayo.edu|
21228589|NCT01388920|Theratechnologies|Senior Medical Advisor|514-336-7800|jmamputu@theratech.com|
21228590|NCT02034422|Salt Lake City VAMC|Joel Trinity, PhD|801-582-1565|joel.trinity@va.gov|1794
21228591|NCT03014492|Cincinanti Childrens Hospital|Kim Foss|5136365971|kim.foss@cchmc.org|
21228592|NCT01484054|Johnson & Johnson Vision Care|Michael Mayers, OD, FAAO|904-443-3252|mmayers@its.jnj.com|
21228593|NCT05281601|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21228594|NCT01860573|Women & Infants Hospital|Dr. Joseph Bliss|4012741100|jbliss@wihri.org|
21228595|NCT04490239|University of Mississippi|Dr. Joshua Sharp|662-915-1758|jsharp@olemiss.edu|
21276102|NCT04307849|NYU Langone Health|Marie Brault, PhD|210-276-9012|Marie.Brault@nyulangone.org|
21276103|NCT02846233|University of California San Francisco, Fresno Medical Education Program|SOE NAING|5593239236|snaing@fresno.ucsf.edu|
21276104|NCT02418754|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21276105|NCT01896505|Karyopharm Therapeutics Inc|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
21276106|NCT02387762|Acerta Pharma|Ahmed Hamdy, MD, VP of Early Development|650-591-2800|a.hamdy@acerta-pharma.com|145
21276107|NCT04203667|Interscope, Inc.|Alexis James, Global Director of Clinical Affairs|508-847-9478|alexis.james@interscopemed.com|
21276108|NCT00593827|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21276109|NCT01160640|University of Pittsburgh|Dr. Harold Wiesenfeld|412-641-1403|wieshc@mail.magee.edu|
21276110|NCT02212457|GlaxoSmithKline|GSK Response Center|866-435-7343||
21276111|NCT00681473|Massachusetts General Hospital|Helen A. Shih, MD|617-724-9627|HSHIH@Partners.org|
21276112|NCT00642811|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21276113|NCT04553406|SperoTherapeutics|Dr. Jon Bruss|(+1) 269-352-3766|jbruss@sperotherapeutics.com|
21276114|NCT03168906|Tufts Medical Center|Jaime Chisholm|617-636-5409|jchisholm1@tuftsmedicalcenter.org|
21276115|NCT00243152|Boston Children's Hospital|Dr. David Borsook|617-281-7135|david.borsook@childrens.harvard.edu|
21276116|NCT04814459|Oakland University|Dr. Sara Arena|2483648682|arena@oakland.edu|
21276117|NCT01841060|Institut Bergonie|Pr Simone Mathoulin-Pélissier|33556333333|s.mathoulin@bordeaux.unicancer.fr|
21276118|NCT01848210|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
21276119|NCT04592419|Kodiak Sciences Inc.|Pablo Velazquez-Martin, MD|1 (650) 281-0850|ClinOps@kodiak.com|
21276120|NCT05838456|The University of Texas Health Science Center at Houston|Sunil A. Sheth, MD|713-500-7897|Sunil.A.Sheth@uth.tmc.edu|
21276121|NCT01118026|Alliance for Clinical Trials in Oncology|Ann S. LaCasce, MD|617-632-5959|alacasce@partners.org|
21276122|NCT06217796|Eyenovia|Greg M. Bennett, VP, Clinical Program Strategy and Development|833-393-6684|gbennett@eyenovia.com|5
21276123|NCT01191476|Abbott|Global Medical Services|800-633-9110||
21276124|NCT01901848|Durham Veterans Health Care System|Eric Dedert, Ph.D.|919-384-8582|eric.dedert@va.gov|4055
21276125|NCT01729026|South Texas Veterans Health Care System; University of Texas Health Science Center at San Antonio|Dr. Stephen Stern|210-887-3754|stephen.stern@va.gov; sterns@uthscsa.edu|
21276126|NCT00493064|PaloAltoMF|Renee Kaneshiro, study coordinator|650-853-4744|kaneshr@pamf.org|
21276127|NCT00108082|GlaxoSmithKline|GSK Response Center|866-435-7343||
21276128|NCT02419924|Mayo Clinic|Dr. Amy Foxx-Orenstein|480-301-6990|foxx-orenstein.amy@mayo.edu|
21276129|NCT00955552|Eurofarma Laboratórios|Eurofarma Laboratórios|08007043876||
21276130|NCT02940730|University of Colorado|Dr. Tyree Kiser|3037242883|ty.kiser@ucdenver.edu|
21276131|NCT01064531|Smith & Nephew, Inc|Tracey Brengola, MS|978-749-1491|Tracey.brengola@smith-nephew.com|
21276132|NCT01201759|UNIVERSITY OF MIAMI- The Miami Project to Cure Paralysis|Dr. Mark S. Nash|(305) 243-3628|MNash@med.miami.edu|
21276133|NCT00906373|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21276134|NCT02780167|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21276135|NCT01470196|Dana-Farber Cancer Institute|Steven P. Treon, MD, PhD|617-632-2681|steven_treon@dfci.harvard.edu|
21276136|NCT02315066|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21276137|NCT02916693|Johns Hopkins University|Dr. Arthur L. Burnett|410-614-3986|aburnet1@jhmi.edu|
21276138|NCT01190930|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21276139|NCT00035555|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21276140|NCT00337428|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21276141|NCT02618382|Dignity Health Research Institute|Lisa Arnold, Clinical Research Operations Manager|602-406-9593|lisa.arnold@arrowneuro.org|
21276142|NCT05932810|Medical University of South Carolina|Dr. Jennifer Dahne|843-876-2280|dahne@musc.edu|
21276143|NCT04886063|Athira Pharma|Dr. Javier San Martin, CMO|1-866-725-0930|clinicaltrials@athira.com|
21276144|NCT02914457|Medtronic Bakken Research Center|Richard Cornelussen|+31433566651|richard.cornelussen@medtronic.com|
21276145|NCT01769222|Stanford University Medical Center|George Albert Fisher, MD|650-725-9057|georgeaf@stanford.edu|
21228596|NCT00413166|The University of Texas (UT) MD Anderson Cancer Center|Dr. Farhad Ravandi-Kashani, Professor, Leukemia|7137927734|fravandi@mdanderson.org|
21276146|NCT00721955|Alexza Pharmaceuticals, Inc|Chief Scientific Officer|650.944.7777|:jcassella@alexza.com|
21238622|NCT04207840|Amphastar Pharmaceuticals, Inc.|Amphastar Pharmaceuticals, Inc.|(909) 980-9484|info@amphastar.com|
21276147|NCT01206439|University of Cincinnati|Jack Rubinstein|513-558-3062|rubinsjk@ucmail.uc.edu|
21276148|NCT03417739|Dana Farber Cancer Institute|Elizabeth Buchbinder, MD|617-632-5055|Elizabeth_buchbinder@dfci.harvard.edu|
21276149|NCT01055886|VA Medical Center|Angela Kirby|919-286-0411|angela.kirby@va.gov|5526
21276150|NCT00781079|Pittsburgh VA|Matthew Chinman|412 360-2438|matthew.chinman@va.gov|
21276151|NCT04254809|Southeast Louisiana Veterans Health Care System|Joseph Boffa, PhD|504-507-2000|joseph.boffa@va.gov|67372
21276152|NCT01928615|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21276153|NCT01362192|Main Line Center for Laser Surgery|Eric F. Bernstein, M.D., M.S.E.|610-645-5551|dermguy@dermguy.com|
21276154|NCT03937791|National Cancer Institute|Scott Norberg, D.O.|301-275-9668|scott.norberg@mail.nih.gov|
21228597|NCT00995865|GE Healthcare- Life Sciences|Amanda Culliton|1-508-683-2232|Amanda.Culliton@ge.com|
21228598|NCT00048893|National Cancer Institute (NCI), National Institutes of Health (NIH)|Claude Sportes, M.D.|301-435-5280|csportes@mail.nih.gov|
21276155|NCT02180230|Nobel Biocare|Head of Clinical Trial Management|+41 43 211 42 00|isabelle.arrighi@nobelbiocare.com|
21276156|NCT01819064|Women and Children's Hospital of Buffalo, State University of New York at Buffalo|Dr. Jerrold Lerman|7168787701|jlerman@buffalo.edu|
21276157|NCT00434837|Rhode Island Hospital|Dr. Braden C. Fleming|401-316-4737|braden_fleming@brown.edu|
21276158|NCT01077258|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21276159|NCT00726895|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21276160|NCT01562132|Yale University|Dr. Ana-Claire Meyer|203-737-8372|ana-claire.meyer@yale.edu|
21276161|NCT02102932|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
21276162|NCT02608476|Cassiopea, SPA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
21276163|NCT05862844|School of Medicine, Virginia Commonwealth University|Asmaa Namoos|804-628-4754|Asmaa.Namoos@vcuhealth.org|
21276164|NCT00218335|Johns Hopkins Bloomberg School of Public Health|Carl Latkin, PhD||clatkin@jhsph.edu|
21276165|NCT04660032|University of Michigan|Dr. Jourdan Triebwasser|734-764-1406|jtriebwa@med.umich.edu|
21276166|NCT02767947|Bausch Health Americas, Inc|Director of Clinical Operations||aloncaric@bauschhealth.com|
21276167|NCT01266603|U T MD Anderson Cancer Center|Dr. Michael A Davies, BA,MD,PHD/Melanoma Medical Oncology|713-792-3454|MDavies@mdanderson.org|
21276168|NCT02725411|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21276169|NCT00819767|Novartis Pharmaceuticals|Study Director|862 778-8300||
21276170|NCT00756717|Loyola University Medical Center|Dr. Kathy Albain|708-327-3102|KALBAIN@lumc.edu|
21276171|NCT02762994|BIOCAD|Nikiforova Aleksandra|+7(812) 380 49 33|nikiforovaan@biocad.ru|6254
21276172|NCT01139294|Vanderbilt University Medical Center|Thomas Abramo, MD||tjabramo@uams.edu|
21276173|NCT00176930|Masonic Cancer Center, University of Minnesota|Dr. Daniel J.Weisdorf, M.D|612 624-3101|weisd001@umn.edu|
21276174|NCT01104090|The University of Texas Health Science Center at Houston|Davide Cattano, MD, PhD|(713) 500-6200|Davide.Cattano@uth.tmc.edu|
21276175|NCT02539368|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21276176|NCT00398073|Memorial Sloan Kettering Cancer Center|Jedd Wolchok, MD, Chief Attending|+1646-888-2315|wolchokj@MSKCC.ORG|
21276177|NCT01263561|Department of Ophthalmology and Vision Sciences, University of Toronto|Dr Yvonne Buys|416-603-5682|y.buys@utoronto.ca|
21276178|NCT00879684|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21276179|NCT02132650|Malcom Randall VA Medical Center|Dr. David Clark|352-376-1611|davidclark@ufl.edu|105244
21276180|NCT04084990|Washington University in St. Louis|Alexander Hincker, Associate Professor of Anesthesiology|3143231312|hinckera@wustl.edu|
21276181|NCT03185741|Northwestern University|Dr. Michael Wolf|(312) 503-5592|mswolf@northwestern.edu|
21276182|NCT00749658|University of Minnesota|Marc Mooney PhD||moon0078@umn.edu|
21276183|NCT01525628|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21276184|NCT03573336|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
21276185|NCT00239005|Novartis Pharmaceuticals|Study Director|862-778-8300||
21276186|NCT02614898|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|475-230-2596|clinicaltrials@alexion.com|
21276187|NCT00787605|Novartis Pharmaceuticals|Study Director|862-778-8300||
21276188|NCT03108820|University of Wisconsin School of Medicine and Public Health|Dr. Ben Zarzaur|(608) 265-9574|zarzaur@surgery.wisc.edu|
21276189|NCT03298880|University of Exeter, Royal Devon and Exeter Hospital|Dr Andrew Appelboam, Isabel FitzGerald|07515688294|andy.appelboam@nhs.net ; if223@exeter.ac.uk|
21276190|NCT02299869|CooperVision|Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
21276191|NCT01488448|Children's Hospital at Montefiore/Albert Einstein College of Medicine|Dr. Alyssa Silver|718-741-2304|alysilve@montefiore.org|
21276192|NCT00654641|West Viginia University|Michael L. Stitely, MD|304-293-1566|mstitely@hsc.wvu.edu|
21276193|NCT01992094|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21276194|NCT01834027|Penn State Milton S. Hershey Medical Center|Sonia Vaida|7175318433|svaida@hmc.psu.edu|
21276195|NCT00434590|Novartis Pharmaceuticals|Study Director|862-778-8300||
21276196|NCT02625298|Faculty of Dentistry, University of Belgrade|Dr. Dejan Markovic, professor at Clinic for Pediatric and Preventive Dentistry|+381600203041|dejan.markovic@stomf.bg.ac.rs|
21228599|NCT02101112|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21228600|NCT04340063|Edward Hines Jr. VA|Dr. Keith Gordon|(312) 503-3339|keith.gordon2@va.gov|
21228601|NCT01030783|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|617-588-1960|Clinical@aveooncology.com|
21228602|NCT03368118|Abivax|Vice President Clinical Operations|01 53 83 08 41|paul.gineste@abivax.com|
21228603|NCT01445626|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21228604|NCT00993044|Children's Hospital Los Angeles|Rajkumar Venkatramani|3233615504|rvenkatramani@chla.usc.edu|
21276197|NCT00965731|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21276198|NCT02710240|University of Pennsylvania|Marie Kerr, Project Manager|215-829-6720|marie.kerr@pennmedicine.upenn.edu|
21276199|NCT03429049|Centrexion Therapeutics, Inc.|Director of Clinical Operations|617-837-6911|info@centrexion.com|
21276200|NCT04703855|Abbott|Carlo Gazzola|+3227746811|carlo.gazzola@abbott.com|
21276201|NCT00571194|Arkansas Children's Hospital|Dr. Eileen Ellis|501-364-1847|elliseileenn@uams.edu|
21276202|NCT05258630|Hennepin Healthcare Research Institute|Katherine Diaz Vickery|612-873-6852|katherine.vickery@hcmed.org|
21276203|NCT03431337|Albany Medical College|Dr. Paul Sorum|518-262-7500|sorump@amc.edu|
21276204|NCT00401245|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21276205|NCT01560819|Helen DeVos Children's Hospital of Spectrum Health Hospitals|Dr. Sachin Kunde|616-267-2100|sachin.kunde@helendevoschildrens.org|
21276206|NCT00357955|Providence VA Medical Center|Wen-Chih Wu, MD; Principal Investigator|4012737100|wen-chih.wu@va.gov|6237
21276207|NCT03388502|Rush University Medical Center|Dr Philip Louie|2539069256|louie.philip@gmail.com|
21276208|NCT00399893|Duke University Medical Center|Michael Freemark, MD|919-684-5091|andrea.haqq@albertahealthservices.ca|
21276209|NCT04412057|Avalo Therapeutics, Inc.|Scott White, MD|484-763-3080|swhite@avalotx.com|
21276210|NCT00114231|Memorial Sloan Kettering Cancer Center|Julio Garcia-Aguilar, MD|212-639-5506|garciaaj@mskcc.org|
21276211|NCT02156154|Cleveland Clinic|Alparslan Turan, MD|216-445-0998|turana@ccf.org|
21276212|NCT02051595|University of Florida|Dr. Ettore Crimi|617-697-2861|ettorecrimi@gmail.com|
21276213|NCT01625507|University of Alberta|Dr. Catherine Chan|780-492-9939|cbchan@ualberta.ca|
21276214|NCT01961882|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21276215|NCT00368316|PDMI, NICHD, NIH|Dr. Rachel Schneerson, Co-Director|301-469-0850|schneerr@mail.nih.gov|
21276216|NCT00928226|Stanford University|Scott Soltys, Associate Professor of Radiation Oncology|65072441569|sgsoltys@stanford.edu|
21276217|NCT03765996|Dr. İsmail Atabek Physiotherapy and Rehabilitation Center|Ertan Şahinoğlu|+90 532 647 86 53|ertan.sahinoglu@hotmail.com|
21276218|NCT02970552|University of North Carolina at Chapel Hill|Joan Price, MD, MPH|919-962-4717|joni@email.unc.edu|
21276219|NCT02668822|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21276220|NCT01522950|University of Minnesota|Jay N. Cohn, M.D., Professor of Medicine|612.625.5646|cohnx001@umn.edu|
21276221|NCT01795079|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526158|fregni.felipe@mhg.harvard.edu|
21276222|NCT03036839|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21276223|NCT03519282|CooperVision|Myhanh Nguyen, Sr. Optometrist|925-730-6716|MNguyen@coopervision.com|
21276224|NCT03136406|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
21276225|NCT02285634|Mayo Clinic|Dr. Tobias Kummer|507 255 4732|vanmeter.derek@mayo.edu|
21276226|NCT04317599|Pierre Fabre|Project leader|+33(0)1 49 10 81 84|farida.beghdad@pierre-fabre.com|
21276227|NCT04364737|NYU Langone Health|Mila B. Ortigoza, MD, PhD|646-634-7803|Mila.Ortigoza@nyulangone.org|
21276228|NCT00112294|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21276229|NCT05181800|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
21276230|NCT02958319|Servicio de Reumatología del Hospital Universitario|David Vega-Morales MD|52 81 80485210|drdavidvega@yahoo.com.mx|
21276231|NCT03843125|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21276232|NCT05889039|LECOM|Dr. Santiago Lorenzo|941-782-5974|slorenzo@lecom.edu|
21276233|NCT02661022|Stemline Therapeutics, Inc.|Ira Gupta, MD, Senior Vice President, Clinical Development & Medical Affairs - Hematology|877-332-7967|clinicaltrials@menarinistemline.com|
21276234|NCT02972515|University of Arizona|Judith Gordon|520-626-4970|judithg@email.arizona.edu|
21276235|NCT00609154|Albert Einstein College of Medicine|Dr. Daniel Stein|718-430-2237|daniel.stein@einsteinmed.edu|
21276236|NCT04531527|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21276237|NCT01272076|TLC Eyecare and Laser Centers|Carmelina Gordon, MD|(517) 7821213|shellie.fuentes@tlcmi.com|
21276238|NCT00569660|The University of Texas M. D. Anderson Cancer Center|Srdan Verstovsek M.D./Associate Professor|713-792-7305|eharriso@mdanderson.org|
21276239|NCT04155840|University of Washington|Dr. Ryan Lynch|206-606-1739|rclynch@uw.edu|
21276240|NCT00142116|Dana Farber Cancer Institute|Steven P. Treon MD, PhD|617-632-2681|steven_treon@dfci.harvard.edu|
21276241|NCT04079452|Hospital de Bellvitge|Clinical Project Manager|+34675335888|anavarroa@bellvitgehospital.cat|
21276242|NCT00345033|Massachusetts General Hospital|David C. Henderson|(617) 912-7800|dchenderson@partners.org|
21276243|NCT01450800|Duke University Medical Center|Dr. Alexis Dieter|919-401-1006|alexis.dieter@duke.edu|
21276244|NCT03496298|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21276245|NCT01658995|Mayo Clinic|Petra M. Casey, M.D.|507-266-9873|Casey.Petra@mayo.edu|
21276246|NCT01186562|University of Minnesota|Melena D. Bellin|612-624-5409|bell0130@umn.edu|
21276247|NCT03316976|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21276248|NCT03224520|University of Massachusetts Medical School|Rajani Sadasivam|508-856-8923|rajani.sadasivam@umassmed.edu|
21238623|NCT03243422|University of North Carolina, Chapel Hill|Lisa Gravens-Mueller, Biostatistician/Supervisor|919 962-3098|lgravens@email.unc.edu|
21276249|NCT01041209|Hospital General de Niños Pedro de Elizalde|Dr. Fernando Torres|+54 11 43070140|slaip@intramed.net|
21276250|NCT00761176|Regenesis Biomedical, Inc.|VP of Clinical Research and Regulatory|602-309-2118|mark.davis@regenesisbio.com|
21276251|NCT02020967|Ipsen|Ipsen Medical Director|see email|clinical.trials@ipsen.com|
21276252|NCT03507686|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21276253|NCT00585312|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21276254|NCT00129116|GlaxoSmithKline|GSK Response Center|866-435-7343||
21276255|NCT02203578|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu|
21238624|NCT02173054|Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University|Papapit Tuchinda|+662-419-4333|papapitt@gmail.com|
21238625|NCT01330316|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21238626|NCT00817999|Creighton University|Tammy Burns, PharmD|402-280-4292|TammyBurns@creighton.edu|
21238627|NCT01337986|Washington Univerisity St. Louis|Robert Naismith, MD|314-747-5576|naismithr@wustl.edu|
21238628|NCT00141739|Blood and Marrow Transplant Program, University of Michigan|Dr. John E. Levine|734-936-8456|jelevine@med.umich.edu|
21238629|NCT01520402|Mount Sinai School of Medicine|Dr. Daniella Kadian-Dodov|(212) 241-9454|daniella.kadian-dodov@mssm.edu|
21238630|NCT02287584|Sumitomo Dainippon Pharmaceutical|Clinical Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
21238631|NCT02269371|Mike O'Callaghan Federal Medical Center|Jill M. Clark, MBA/HCM|7026533298|jill.clark.3.ctr@us.af.mil|
21238632|NCT04711356|London School of Hygiene & Tropical Medicine|Dr Daniela Manno, clinical trial coordinator and responsible physician|+44 20 7927|daniela.manno@lshtm.ac.uk|2092
21238633|NCT03430063|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21238634|NCT03124199|Hospital Universitario de la Princesa|Mercedes Ramas|913093911|mercedesramas@gmail.com|
21238635|NCT03086018|Bernafon AG|Julie Tantau|+41 31 998 1646|juta@bernafon.com|
21238636|NCT01892345|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
21238637|NCT02080195|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Javier Bolaños Meade, MD|410-614-6398|fbolano2@jhmi.edu|
21238638|NCT04219618|The University of Texas Health Science Center at Houston|Igor D. Gregoric, MD|713-486-6714|Igor.D.Gregoric@uth.tmc.edu|
21238639|NCT00621543|University of Rochester|Sarah Betstadt, MD, MPH|585-276-5368|sarah_betstadt@urmc.rochester.edu|
21238640|NCT02192970|University of Wisconsin - Madison|Michael M Altaweel, MD|(608) 263-7290|mmaltaweel@wisc.edu|
21238641|NCT03745222|Celgene Corporation|Anne McClain|908-673-9100|ClinicalTrialDisclosure@Celgene.com|
21238642|NCT00792103|NuPathe Inc.|Mark Pierce, MD PhD|484-567-0130|mpierce@nupathe.com|
21238643|NCT04711603|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email olly|rinsyousiken@pharm.kissei.co.jp|
21238644|NCT05479604|Mayo Clinic|Amar Miglani, M.D.|4803422929|miglani.amar@mayo.edu|
21238645|NCT01591382|Brigham and Women's Hospital|Dr. Srdjan S. Nedeljkovic||snedeljkovic@partners.org|
21238646|NCT03643224|Medtronic CAS|Josman Suri|7635050262|josman.suri@medtronic.com|
21238647|NCT04252742|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21238648|NCT06289192|Johns Hopkins University|Alejandra Ellison-Barnes|n/a|aelliso6@jhmi.edu|
21238649|NCT00227617|UCSF Helen Diller Family Comprehensive Cancer Center|Dr. Emily Bergsland|415-885-7810|Emily.Bergsland@ucsf.edu|
21238650|NCT01542957|Universitat de Barcelona|Prof. Guillem Feixas|0034 933125100|gfeixas@ub.edu|
21238651|NCT02068495|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21238652|NCT03034018|Brigham and Women's Hospital|Hadine Joffe, MD MSc|617-732-4906|hjoffe@bwh.harvard.edu|
21238653|NCT01666808|Emory University|Dr. Ashesh Jani|404-778-3827|abjani@emory.edu|
21238654|NCT00944047|University of Kansas Cancer Center|Dr. Qamar Khan|(913) 588-6029|ctnursenav@kumc.edu|
21238655|NCT04859660|University of Arizona|Martina Gabra|520-626-6636|mgabra2@gmail.com|
21238656|NCT02220894|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21238657|NCT03217747|M D Anderson Cancer Center|Aung Naing|713-563-1930|anaing@mdanderson.org|
21238658|NCT03996291|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21276256|NCT00708682|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com|
21276257|NCT04728620|Vanderbilt University Medical Center|William Martinez, MD|(615) 936-1010|william.martinez@vumc.org|
21288871|NCT04633447|Janssen Research & Development, LLC|Manager Clinical Science Translational|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21288872|NCT01565694|Astellas Pharma Europe B.V.|Clinical Trial Disclosure|310715455050|astellas.resultsdisclosure@astellas.com|
21288873|NCT00541229|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21288874|NCT03807843|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21288875|NCT00104234|BioMarin Pharmaceutical Inc.|Medical Information Services|8009834587|medinfo@bmrn.com|
21288876|NCT01033942|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
21288877|NCT02737618|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
21288878|NCT01115231|Ralph H. Johnson VA Medical Center, Division of Research, Charleston, SC, USA|Baerbel Rohrer, PhD; VA Research Scientist|843-792-5086|rohrer@musc.edu|
21288879|NCT03014362|Walter Reed National Military Medical Center|Christopher E Hines, MD|301-319-8122|christopher.e.hines.civ@mail.mil|
21288880|NCT03071744|UCSD|Eric Roeland, MD|(858) 534-7079|eroeland@ucsd.edu|
21288881|NCT01143792|The Ohio State University|Natasha Slesnick|614 247-8469|slesnick.5@osu.edu|
21228605|NCT04894916|Vanderbilt University Medical Center|William Martinez, MD|(615) 936-1010|william.martinez@vumc.org|
21228606|NCT00734747|Medigus Ltd|Aviel Roy-Shapira, MD|+972 8646 6880|avrish@gmail.com|
21228607|NCT05824741|Penn State College of Medicine|Ian Paul|(717) 531-8006|ipaul@pennstatehealth.psu.edu|
21228608|NCT03642327|University of Maryland School of Medicine|Howard Dubowitz, MD, Professor of Pediatrics|4107066144|hdubowitz@som.umaryland.edu|
21228609|NCT05063318|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar's Oncology, Business Unit|0034918466000|clinicaltrials@pharmamar.com|
21228610|NCT03287635|Toyos Clinic|Dr.|9137064408|mtoyos@toyosclinic.com|
21228611|NCT00396032|Genentech, Inc.|Medical Communications|800-821-8590||
21228612|NCT00323869|Stanford University Medical Center|Heather A Wakelee, MD, Associate Professor of Medicine (Oncology)|650-498-6000|hwakelee@stanford.edu|
21228613|NCT03172910|Apollo Investment Management|Scientific Advisor|+352 2088 1301|rchari@kaiperheathcare.com|
21228614|NCT01847001|Columbia University Medical Center|Dr. Kevin Kalinsky|212-305-1925|cancerclinicaltrials@cumc.columbia.edu|
21228615|NCT04233034|Jaeb Center for Health Research|Colleen Bauza|813-975-8690|cbauza@jaeb.org|
21228616|NCT00572897|Univeristy of Illinois Hospital & Health Sciences System|Dr. Damiano Rondelli|312-996-6179|drond@uic.edu|
21228617|NCT00606944|Seoul National University Bundang Hospital|Sung-Bum Kang|+82-31-787-7093|kangsb@snubh.org|
21228618|NCT03468985|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21228619|NCT02806973|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21228620|NCT04060862|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21228621|NCT01229397|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
21228622|NCT01278303|Johns Hopkins Hospital|Dr. Richard E. Ringel|410-614-6745|rringel@jhmi.edu|
21228623|NCT01869725|University of Iowa|M. Sue O'Dorisio, MD, PhD|319-335-7234|sue-odorisio@uiowa.edu|
21228624|NCT03416374|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21228625|NCT01813110|Pennsylvania State University|Dr. Penny Kris-Etherton|814-863-2923|pmk3@psu.edu|
21228626|NCT03463031|Glenmark Pharmaceuticals Ltd|Study Director|201-684 8000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
21228627|NCT01241240|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21228628|NCT01025154|The University of Texas MD Anderson Cancer Center|Stefan Faderl, MD / Associate Professor|713-745-4613|eharriso@mdanderson.org|
21228629|NCT01810432|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21228630|NCT01251744|GlaxoSmithKline|GSK Response Center|866-435-7343||
21228631|NCT02147184|Baylor College of Medicine|Dr. Chadi Calarge|832-824-4764|chadi.calarge@bcm.edu|
21228632|NCT00701376|Cleveland Clinic|Brian Parker, MD|216-444-9950|parkerb1@ccf.org|
21228633|NCT01151098|Purdue Pharma L.P.|Clinical Leader, Executive Medical Director|800-733-1333 OR 800-745-7445||
21228634|NCT00542451|Dana Farber Cancer Institute|SARA TOLANEY, MD, MPH|617-632-3800|Sara_Tolaney@dfci.harvard.edu|
21228635|NCT03739840|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
21228636|NCT00992927|Seoul National University Hospital|Sun Gun Chung/Professer|+82-2-2072-3954|suncg@snu.ac.kr|
21228637|NCT01058265|Mayo Clinic in Arizona|Larry Bergstrom, MD|480-301-7108|bergstrom.larry@mayo.edu|
21228638|NCT01243671|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21228639|NCT02869438|AstraZeneca|Ubaldo Martin, Global Clinical Lead Benralizumab|+1 301 398 0163|Ubaldo.Martin@astrazeneca.com|
21228640|NCT02962765|Octapharma|Sigurd Knaub, Senior VP CR&D Haematology|01554512141|Sigurd.Knaub@octapharma.com|
21228641|NCT01601431|Baylor College of Medicine|Mohamed Othman, M.D.|713 798 0947|mohamed.othman@bcm.edu|
21228642|NCT02169284|University of Wisconsin Carbone Cancer Center|Dr. Tracy Downs|608-263-9534|downs@urology.wisc.edu|
21228643|NCT02340715|Medical College of Wisconsin|Ergun Ahunbay|4148057898|eahunbay@mcw.edu|
21228644|NCT02764190|Seattle Children's Research Institute|Cari McCarty|206-884-8243|Carolyn.McCarty@seattlechildrens.org|
21228645|NCT00236951|Luitpold Pharmaceuticals|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|844
21228646|NCT00708071|Baxter Innovations, GmbH|Edith Hantak, DVM, Dir, Global Therapeutic Area, BioSurgery||edith_hantak@baxter.com|
21228647|NCT02140775|New York State Psychiatric Institute|Dr. Martin McElhiney|646.774.8035|mcelhin@nyspi.columbia.edu|
21228648|NCT03696927|Abilitech Medical|Director of Clinical and Product Management|833.225.3123|info@abilitechmedical.com|
21228649|NCT00945854|Federico II University|Riccardi Gabriele|+390817462117|riccardi@unina.it|
21228650|NCT00938964|Duke University Health System|Joseph Mathew, M.D|919-681-6646|joseph.mathew@duke.edu|
21228651|NCT01858636|St. Jude Medical|Andrew Campbell|+1.651.756.5538|acampbell2@sjm.com|
21228652|NCT04697381|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21228653|NCT01227564|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21228654|NCT06309407|Oregon Health and Science University|Dr. Sandy Christiansen|2038092318|chrissan@ohsu.edu|
21228655|NCT04650854|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21228656|NCT01987401|Department of Veterans Affairs, Office of Research and Development|Dr. Nicholas L. Smith, Director of Seattle Cooperative Studies Program|2067642773|nicholas.smith@va.gov|
21228657|NCT02378025|Veterans Affairs Palo Alto Healthcare System|Dr. Peter Bayley|650 493-5000|peter.bayley@va.gov|
21228658|NCT00194675|VA Puget Sound Health Care System|Alvin M. Matsumoto, MD|(206) 764-2760|alvin.matsumoto@med.va.gov|
21228659|NCT00704808|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21228660|NCT00667420|MassGH|David P. Ryan|617-724-0245|dpryan@partners.org|
21276258|NCT04547036|Dept. Ophthalmology at Paracelsus Medical University Salzburg|PD Dr. Markus Lenzhofer PhD FEBO|+43 57255|m.lenzhofer@salk.at|24201
21276259|NCT00810602|University of Michigan Comprehensive Cancer Center|Dr. Sung Choi|734-764-8630|sungchoi@med.umich.edu|
21276260|NCT03840382|Rhode Island Hospital|Dr. Larry Brown|+1 (401) 793-8808|lkbrown@lifespan.org|
21276261|NCT02625974|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
21276262|NCT01142661|Eisai Inc.|Prash Gopalakrishna|888-422-4743||
21276263|NCT04773600|Arcutis|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
21276264|NCT01923311|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21276265|NCT02304406|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21276266|NCT04231409|Boston Scientific|Roshini Jain, Sr. Director Clinical Sciences|16619494350|roshini.jain@bsci.com|
21276267|NCT03180528|Stanford University|Kavita Yang Sarin|(650) 723-6316|ksarin@stanford.edu|
21276268|NCT02839798|Butler Hospital|Dr. Linda Carpenter|401-455-6349|Linda_Carpenter_MD@brown.edu|
21228661|NCT03500679|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21276269|NCT04129944|Unity Biotechnology, Inc.|Chief Medical Officer|650-416-1192|Clinicaltrials@unitybiotechnology.com|
21276270|NCT03710590|Virginia Commonwealth University|Dr. Alison Breland|804 628 2300|abbrelan@vcu.edu|
21276271|NCT02488824|VAORD|Dr John Handrakis|(718) 584-9000|John.Handrakis@va.gov|5439
21276272|NCT01185028|NIAID/NIH|Dr. Shyam Kottilil|301-435-0936|skottilil@niaid.nih.gov|
21276273|NCT00412737|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21228662|NCT04186481|Smith+Nephew, Inc.|Alison Walker, Regional Operation Manager ANZ|+61 466 322 200|Alison.walker@smith-nephew.com|
21228663|NCT04223232|MedDay Pharmaceuticals|Dr Frédéric SEDEL, Chief Scientific Officer and Co-founder|+33 1 80 40 14 40|frederic.sedel@medday-pharma.com|
21228664|NCT00586846|Memorial Sloan Kettering Cancer Center|Dr. Paul Meyers|212-639-5952|meyersp@mskcc.org|
21228665|NCT00410202|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21228666|NCT00144027|Central Arkansas Veterans Healthcare System|Jeff Pyne|501-257-1083|jeffrey.pyne@va.gov|
21228667|NCT00937391|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21228668|NCT00245219|Carnegie Mellon University|Michael F. Scheier, PhD|412-268-3791|Scheier@cmu.edu|
21276274|NCT04057248|Diabetes and Endocrinology Consultants of Pennsylvania, LLC (Decpa LLC)|Dr. Alan Schorr|2157501691|abs@sugardoc.com|
21276275|NCT02695719|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21276276|NCT00483548|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21276277|NCT02667821|Canadian Memorial Chiropractic College|Dr. Nicholas Moser|416-482-2340|nmoser@cmcc.ca|319
21276278|NCT01220609|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
21276279|NCT04735068|University of Pennsylvania|Melissa Volpe|215-220-9703|melissa.volpe@Pennmedicine.upenn.edu|
21276280|NCT00868296|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21276281|NCT03440424|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
21228669|NCT00723931|Merck Sharp and Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21228670|NCT01232205|Dept Obstetrics Gynecology Indonesia University|Yuditiya Purwosunu|+44 753 870 6897|yudi@med.showa-u.ac.jp|
21228671|NCT02945787|Moffitt Cancer Center|Thomas H. Brandon PhD|813 745-1750|Thomas.Brandon@moffitt.org|
21228672|NCT02021656|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21228673|NCT00510952|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21228674|NCT03119701|Faron Pharmaceuticals Ltd|Chief Medical Officer|+3584005529411|medical@faron.com|
21228675|NCT02691962|Becton Dickinson and Company|Dawn Heimer|+1-401-825-8681|Dawn.Heimer@bd.com|
21228676|NCT02043379|UAB Pediatric Cardiac Critical Care Medicine|Jeffrey Alten, MD|(205) 975-3123|jalten@peds.uab.edu|
21228677|NCT02125604|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21228678|NCT00911742|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
21228679|NCT04088656|University of Washingtion|Carmen Hazim|4042451459|chazim@uw.edu|
21228680|NCT00122278|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|(718)920-6266|befriedm@montefiore.org|
21228681|NCT01002482|CH Chartres|Dr. Pierre Kalfon|003323730303073|pkalfon@ch-chartres.fr|
21228682|NCT02247531|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21228683|NCT04879225|Wake Forest University School of Medicine|Emily Harwood|8284067599|eaharwoo@wakehealth.edu|
21228684|NCT00090051|Hoffmann-La Roche|Medical Communications||global.clinical_trial_registry@roche.com|
21228685|NCT01298531|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21228686|NCT00736957|Neuroscience Department, Clinical Science Division, R&D, JANSSEN PHARMACEUTICAL. K.K. 5-2, Nishi-kanda 3-chome, Cyiyoda-ku, Tokyo 101-0065 JAPAN|Medical Director|+81-3-4411-5509||
21228687|NCT04521777|UT MD Anderson Cancer Center|An T Ngo-Huang, Assistant Professor, Rehabilitation Medicine|(713) 745-2327|ango2@mdanderson.org|
21228688|NCT00608543|UT Southwestern Medical Center|Dr.Prabha Sunderajan|214-648-0156|prabha.sunderajan@utsouthwestern.edu|
21228689|NCT00842764|Department of Otolaryngology/UCI|Brian J Wong, MD, PhD|7144565753|bjwong@uci.edu|
21228690|NCT03051646|Columbia University Medical Center|Victoria M. Leavitt|212 342 1351|vl2337@cumc.columbia.edu|
21228691|NCT04457973|University of Arizona|Dr. Hyochol Ahn|520-626-1769|hbrian@arizona.edu|
21228692|NCT02960997|Stanford University|Joyce Teng, MD, PhD|(650) 724-9627|jteng3@stanford.edu|
21228693|NCT04824365|Emphycorp/Cellular Sciences, inc.|Dr. Alain Martin|9082371561|dr.martin@erols.com|
21238659|NCT05390970|University of Iowa Healthcare|Dr. Annah J. Vollstedt|712-253-1627|annah-vollstedt@uiowa.edu|
21238660|NCT04098250|Mayo Clinic|Todd Schwedt, M.D.|480-301-9721|Schwedt.Todd@mayo.edu|
21260809|NCT01511445|Amedica Corporation|Sonny Bal, MD|(573) 808-4512|SBal@amedica.com|
21260810|NCT02658461|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21276282|NCT03346850|The University of Texas Health Science Center at Houston|Raymond Parlar-Chun, MD|713-500-5666|Raymond.L.Chun@uth.tmc.edu|
21260811|NCT02344576|University of Colorado School of Medicine|Dr. Larry Allen, Principal Investigator|303-724-4713|larry.allen@ucdenver.edu|
21260812|NCT01271686|University of California, San Diego|Dr. John Liu|858 534-7056|joliu@ucsd.edu|
21260813|NCT02337387|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21276283|NCT02407171|Yale School of Medicine|Allison Campbell, MD/PhD: Assistant Professor of Clinical Therapeutic Radiology|(203) 863-3700|allison.campbell@yale.edu|
21276284|NCT00115869|Fred Hutchinson Cancer Research Center|Arthur V. Peterson, Jr. PhD|206-667-5131|avpeters@fhcrc.org|
21276285|NCT04205162|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
21276286|NCT01999894|Forest Research Institute|Ephraim Katz, PhD / Associate Director|201-427-8000|Ephraim.Katz@frx.com|8169
21238661|NCT00394355|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21238662|NCT04278625|Nationwide Children's Hospital|Dr. Peter Winch|614-722-5936|peter.winch@nationwidechildrens.org|
21260814|NCT02853760|University of Innsbruck, Department of Sport Science|Martin Niedermeier||martin.niedermeier@uibk.ac.at|
21260815|NCT01624142|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21260816|NCT04826900|Chang Gung Memorial Hospital-Kaohsiung Medical Center, Kaohsiung, Taiwan|Jen-Wen Hung, MD|+886975056689|hung0702@cgmh.org.tw|
21260817|NCT03372941|Washington University School of Medicine|Stephen Liang|3017470750|syliang@wustl.edu|
21260818|NCT01053429|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21260819|NCT00752986|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21260820|NCT01697345|Creighton University|Dr. Melissa A Dahir|402-657-2847|melissadahir@creighton.edu|
21260821|NCT02382133|Barnes-Jewish Hospital|Dr. Marilyn Schallom|314-286-0835|marilyn.schallom@bjc.org|
21260822|NCT01245647|University of Florida|Dr. Bob Cook|352-273-5869|cookrl@ufl.edu|
21260823|NCT03971721|The Ohio State University|Dr. Ulysses Magalang|(614) 293-4925|Ulysses.Magalang@osumc.edu|
21260824|NCT03972488|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
21260825|NCT00000479|Brigham and Women's Hospital|Julie E. Buring|617 732 4965|jburing@rics.bwh.harvard.edu|
21260826|NCT04984889|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21260827|NCT00045032|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
21260828|NCT02582658|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21260829|NCT02581995|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
21276287|NCT01077817|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21276288|NCT00372996|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21276289|NCT01186016|University of Nebraska Medical Center|Julia F Houfek|402-660-4046|jhoufek@unmc.edu|
21276290|NCT00890916|Louis Stokes Cleveland VAMC|Dr. Kevin Kilgore|216-9573657|klk4@case.edu|
21276291|NCT03750695|Duke University|Dr. William Todd Cade|919-660-9825|todd.cade@duke.edu|
21276292|NCT01386125|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21228694|NCT01068652|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21228695|NCT05153473|CHU de Poitiers|Dr Louis Etienne GAYET|+33(0)5.49.44.44.92|Louis-Etienne.GAYET@chu-poitiers.fr|
21228696|NCT02788474|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21228697|NCT03555435|National Center for PTSD|Eve Carlson|6504935000|eve.carlson@va.gov|24058
21228698|NCT01828515|UT Southwestern Medical Center|Dr. E. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
21228699|NCT01323946|GlaxoSmithKline|GSK Response Center|866-435-7343||
21228700|NCT02964507|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21260830|NCT01841632|University Hospital Regensburg|Prof. Dr. Marc-H. Dahlke, Ph. D.|+49941944|marc.dahlke@ukr.de|6809
21260831|NCT03277196|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21288882|NCT01178411|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21288883|NCT02453048|ILIAD Biotechnologies|Ken Solovay|9543360777|ken@iliadbio.com|
21228701|NCT04341662|University of Birmingham|Dr Adam Devall|+447971823452|a.j.devall@bham.ac.uk|
21228702|NCT03953183|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
21228703|NCT00645710|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
21228704|NCT02273739|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
21228705|NCT01562873|Dana-Farber Cancer Institute|Nancy Lin, MD|617.632.2335|Nancy_Lin@dfci.harvard.edu|
21228706|NCT02398409|VHA|Dr. Virginia (Daggett) Wilder|307-675-3659|virginia.wilder@va.gov|
21228707|NCT03370289|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21228708|NCT00922701|University G. D'Annunzio|Mario Bonomini, M.D.|+39 0871 540120|m.bonomini@nephro.unich.it|
21228709|NCT00873860|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com|
21228710|NCT02139800|Children's Hospital of Philadelphia (CHOP)|Dr. Haresh Kirpalani|215-590-2455|kirpalanih@email.chop.edu|
21228711|NCT01172275|Yale University|Dr. Michael H. Bloch|203-737-4809|michael.bloch@yale.edu|
21228712|NCT01765803|University of New Mexico|Stuart Winter, MD|505-272-4461|SWinter@salud.unm.edu|
21228713|NCT04859114|Medical College of Wisconsin|Mir A Basir|4142666820|mbasir@mcw.edu|
21228714|NCT05308290|Stanford University|Charles Brown, MD PhD|6504983512|chbrown@stanford.edu|
21228715|NCT01285960|InSightec|Nadir Alikacem|214-630-2000|nadira@insightec.com|
21228716|NCT00832390|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21228717|NCT04867434|Raziel Therapeutics|Dr. Racheli Gueta, Director of Clinical Trials|97289124670|racheli@raziel-therapy.com|
21228718|NCT04437368|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21228719|NCT00095628|London Regional Cancer Centre|Dr. Eric Winquist|519-685-8600|eric.winquist@lhsc.on.ca|53243
21228720|NCT04271280|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21228721|NCT00364130|Children's Hospital of Philadelphia|Mary Leonard, MD, MSCE|215-590-0874|leonard@email.chop.edu|
21228722|NCT02239627|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
21228723|NCT01352468|Cincinnati Children's Hospital Medical Center|Dr. Jeff Epstein|5136368296|jeff.epstein@cchmc.org|
21228724|NCT01178073|GlaxoSmithKline|GSK Response Center|866-435-7343||
21228725|NCT01674634|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
21228726|NCT05080660|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
21228727|NCT04533685|UCLA|Principal Investigator|310-206-6328|pszilagyi@mednet.ucla.edu|
21228728|NCT03496571|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
21228729|NCT01226043|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21228730|NCT05223335|Mayo Clinic|Mandeep Singh, M.D.|507-255-2398|Singh.Mandeep@mayo.edu|
21228731|NCT04638673|Medical University of South Carolina|Dr. Mark S. George|843-876-5142|georgem@musc.edu|
21238663|NCT05096156|The Ohio State University College of Optometry|Dr. Jennifer Fogt, OD MS, Principal Investigator|16142928858|OPT-EyeStudies@osu.edu|
21288884|NCT01482221|AstraZeneca|Sanjeev Pathak||ClinicalTrialTransparency@astrazeneca.com|
21288885|NCT04900272|Northwestern University Feinberg School of Medicine|Katherine O'Brien|314-747-5361|obrien.k@wustl.edu|
21288886|NCT03086343|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21288887|NCT01716195|University of California Davis|Dr. Megan Daly|916-734-5428|medaly@ucdavis.edu|
21288888|NCT01625182|Novartis Pharmaceuticals|Study Director|862-778-8300||
21288889|NCT00263562|Baylor College of Medicine|Andrea T. Cruz, MD, MPh|832-824-5582|acruz@bcm.edu|
21288890|NCT02447029|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
21288891|NCT01257542|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21288892|NCT01566162|Sunovion|Medical Director CNS Clinical Trials|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
21288893|NCT00693303|Shenandoah University|Deborah Marr ScD, OTR/L|540-678-4312|dmarr@su.edu|
21288894|NCT00243061|Juravinski Cancer Centre|Dr. Elaine McWhirter|905-387-9495|elaine.mcwhirter@hrcc.on.ca|67559
21288895|NCT02132468|Mateon Therapeutics|Clinical Operations|6506357000|ca@mateon.com|
21288896|NCT00549328|GlaxoSmithKline|GSK Response Center|866-435-7343||
21288897|NCT00153920|Dana-Farber Cancer Institute|Paul G. Richardson|617.632.2104|Paul_Richardson@dfci.harvard.edu|
21288898|NCT05630755|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21288899|NCT04868682|VA Greater Los Angeles Healthcare System|Dr. Cathy Alessi|818 891-7711|cathy.alessi@va.gov|39311
21288900|NCT03384966|Viatris Innovation GmbH|Viatris Innovation Clinical Trial Information|+41 58 844 07 44|viatrisinnovationclinicaltrials@viatris.com|
21288901|NCT03880565|University of Minnesota|Demetri Yannopoulos, MD|612-626-2935|yanno001@umn.edu|
21288902|NCT02202616|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21288903|NCT00367458|National Cancer Institute|Frank Maldarelli|301-435-8019|fmalli@mail.nih.gov|
21288904|NCT05221866|University of Nebraska Medical Center|Karsten Bartels|402-559-4081|anesthesiology.research@unmc.edu|
21288905|NCT04470427|ModernaTX, Inc|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
21288906|NCT04598828|Atrium Health Wake Forest Baptist|Project Manager|336-713-8793|richarlette.hightower@advocatehealth.org|
21288907|NCT04818112|University of Arizona|Dr. Aleeca Bell|5206260575|aleecab@arizona.edu|
21288908|NCT01913353|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
21288909|NCT00385840|GlaxoSmithKline|GSK Response Center|866-435-7343||
21288910|NCT04017962|Memorial Sloan Kettering Cancer Center|Dr. Genovefa Papanicolaou, MD|212-639-6483|papanicg@mskcc.org|
21276293|NCT01098539|GlaxoSmithKline|GSK Response Center|866-435-7343||
21276294|NCT03173560|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21276295|NCT02359864|William Beaumont Hospital|Dr. James Fontanesi, Professor of Neurosurgery, Director of Radiation Oncology|947-521-8121|james.fontanesi@beaumont.org|
21276296|NCT00725764|GlaxoSmithKline|GSK Response Center|866-435-7343||
21276297|NCT04480307|GeNeuro SA|David Leppert, Study director|225524800|dl@geneuro.com|+41
21276298|NCT01889797|ECOG-ACRIN Biostatistics Center|PrECOG Statistician|617-632-3627|jmanola@jimmy.harvard.edu|
21228732|NCT01977937|OHSU|Dr Elizabeth Pedigo|5039705211|pedigo@ohsu.edu|
21228733|NCT00392821|Sarah Cannon Research Institute|John D Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
21228734|NCT03004443|Emory University|Andrew H. Miller, MD|404-727-8260|amill02@emory.edu|
21228735|NCT01782833|KoreaOtsukaPharma|Jeong, Hyo-Won||jhw0159@otsuka.co.kr|
21228736|NCT00406718|UT_SanAntonio UTHSCSA|Dr. Dawn Velligan|210-567-5508|velligand@uthscsa.edu|
21228737|NCT01604109|ThammasatU|Thanya Sitthisettapong|6629869213|thanyasang@yahoo.com|7150
21276299|NCT01589601|Duke University Medical Center|Joseph G. Rogers, MD|919-681-1370|joseph.rogers@duke.edu|
21288911|NCT00632359|The University of Texas (UT) MD Anderson Cancer Center|Alessandra Ferrajoli, Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
21228738|NCT01888003|University of Alabama at Birmingham Department of Anesthesiology and Perioperative Medicine|Dr. Thomas Vetter|205.934.6501|tvetter@uab.edu|
21228739|NCT03187756|Perlmutter Cancer Center, NYU Langone Health|David Kaminetzky, MD|212-731-5855|David.Kaminetzky@nyulangone.org|
21238664|NCT02612064|GlaxoSmithKline|GSK Response Center|866-435-7343||
21288912|NCT06904404|Wolfe Eye Clinic|Edward Hu|(319) 362-8032|ehu@wolfe.com|
21288913|NCT03580928|Dana-Farber Cancer Institute|Matthew Davids, MD|617-632-6331|matthew_davids@dfci.harvard.edu|
21288914|NCT01127061|University of Michigan School of Medicine|Dr. Sara Saberi, MD, MS|734-764-4500|saberis@med.umich.edu|
21288915|NCT00962598|Icahn School of Medicine at Mount Sinai|Dr. Vilma Gabbay|212-659-1661|vilma.gabbay@mssm.edu|
21288916|NCT03921541|Immedica Pharma AB|Vice President, Head of Global Integrated Evidence / Global Head of Genetic and Metabolic Diseases|+46 8 533 39 500|Clinical@immedica.com|
21288917|NCT02798952|GlaxoSmithKline|GSK Response Center|866-435-7343|eg763112@gsk.com|
21288918|NCT00420407|University of Texas Health Science Center at San Antonio|Stephen Cohn, M.D.|210-567-5724|mccarthyj@uthscsa.edu|
21288919|NCT03641924|Corporal Michael J. Crescenz VAMC|Dr. James Cobb Scott|2158235800|James.Scott2de50a@va.gov|207138
21288920|NCT05416203|Department of Veteran Affairs|Dr. Nicholas Allan|8502740567|nicholas.allan@va.gov|
21288921|NCT01373229|Duke University Medical Center|Danielle Brander, MD|919-286-6897|danielle.brander@duke.edu|
21288922|NCT03720847|University of North Carolina at Chapel Hill|Tory Eisenlohr-Moul|859-317-0503|moul@med.unc.edu|
21288923|NCT00990288|Hospital for Special Surgery|Mark P. Figgie MD|212-606-1932|figgiem@hss.edu|
21288924|NCT03033901|James A. Haley Veterans' Hospital|Risa Richardson, PhD|813-972-2000|Risa.Richardson@va.gov|5309
21276300|NCT00515216|Washington University School of Medicine|A. Craig Lockhart, M.D.|314-362-5740|alockhar@dom.wustl.edu|
21276301|NCT03023137|Hospital Federal dos Servidores do Estado|Dr. Silvia Hoirisch-Clapauch|5521999737500|sclapauch@gmail.com|
21276302|NCT02250651|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21276303|NCT02907073|Mayo Clinic|Dr. Timothy R. DeGrado|507-293-3793|DeGrado.Timothy@mayo.edu|
21288925|NCT00924651|University of Rochester Medical Center|Karen M. Mustian, PhD, MPH, Associate Professor|585-273-1796|Karen_Mustian@urmc.rochester.edu|
21276304|NCT00732160|Vanderbilt University Medical Center|James M. Luther|(615) 936-3420|James.Luther@Vanderbilt.edu|
21276305|NCT00676494|Pathway Medical Technologies, Inc.|Kevin Peters/Director of Clinical Affairs|425-636-4053|petersk@pathwaymedical.com|
21276306|NCT02795676|Protalix Ltd.|Sari Alon, MSc|+972-4-9028100|sari@protalix.com|215
21288926|NCT01797185|Sun Pharma Advanced Research Company Limited|SPARC|+912266455645|Clinical.Trials@Sparcmail.com|
21288927|NCT01847209|Brigham and Women's Hospital|Dr. Raphael Bueno|617-732-8148|rbueno@partners.org|
21288928|NCT00729586|NRG Oncology|Angela Kuras on behalf of Virginia Filiaci|716-845-5702|kurasa@nrgoncology.org|
21288929|NCT01858948|University of Cincinnati|Dr. Robert McNamara|513-558-5601|robert.mcnamara@uc.edu|
21288930|NCT02513199|Icahn School of Medicine at Mount Sinai|Michael Buckstein|212-241-7502|michael.buckstein@mountsinai.org|
21288931|NCT03235414|Cincinnati Children's Hospital Medical Center; Department of Radiology|Dr. Andrew Trout|513-803-3004|andrew.trout@cchmc.org|
21288932|NCT02397837|Brigham and Women's Hospital|Dr. Katherine Burdick|617-732-5789|kburdick1@bwh.harvard.edu|
21288933|NCT04764604|University College London Hospitals NHS Foundation Trust|Brian Saccente-Kennedy, Speech and Language Therapist|+44 20 3456 5180|brian.saccente-kennedy@nhs.net|
21288934|NCT04772547|University of Florida|Dr. Carolina B. Maciel|(352) 273-5550|carolina.maciel@ufl.edu|
21288935|NCT00138294|Baylor College of Medicine|Pedro A Piedra, MD|713-798-5240|ppiedra@bcm.edu|
21288936|NCT04119336|Massachusetts General Hospital|Andrew Yee, MD|617-724-4000|AYEE1@mgh.harvard.edu|
21288937|NCT02536794|Northwestern University|Ami Shah, MD|312 503 5488|amishah@northwestern.edu|
21288938|NCT05276804|Atrium Health|Gregory T. Scarola|704 355-5379|gregory.scarola@advocatehealth.org|
21288939|NCT00607594|Cross Cancer Institute|Dr. Heather-Jane Au|780-432-8500|heathera@cancerboard.ab.ca|
21288940|NCT01410604|Hospital Regional de Alta Especialidad del Bajio|M.D. Maria L. Evia-Viscarra|+52 (477) 267-2000|evialola@hotmail.com|1405
21288941|NCT01733888|DMG Dental Material Gesellschaft|Manager Clinical Research|+494084006|clinicalresearch@mtcompanies.com|0
21288942|NCT03928327|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
21288943|NCT04602000|Celltrion, Inc|Yun Ju Bae / Head of Clinical Planning 1 Department|+82 32 850 4160|YunJu.Bae@celltrion.com|
21288944|NCT05607043|Rutgers School of Dental Medicine, Newark, New Jersey, United States|Gayathri Subramanian, PhD, DMD|732 824 7241|subramga@sdm.rutgers.edu|
21288945|NCT01846871|Massachusetts General Hospital|Dr. Elizabeth Gerstner|617-724-8770|EGERSTNER@mgh.harvard.edu|
21276307|NCT02058160|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21276308|NCT01203917|AstraZeneca|Haiyi Jiang|+86 21 60302408|aztrial_results_posting@astrazeneca.com|
21276309|NCT00152516|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
21276310|NCT03604549|Penn State Health Milton S. Hershey Medical Center|Richard S. Legro, M.D., Principal Investigator|717-531-6210|rsl1@psu.edu|
21288946|NCT00478036|University of Colorado, Dept. of Ophthalmology|Malik Kahook, MD|720-848-2501|Malik.kahook@ucdenver.edu|
21238665|NCT03284112|Columbia University|Dr. James M. Noble|212-342-4126|jn2054@columbia.edu|
21238666|NCT00249249|Kowa Research Europe, Ltd.|Dr Neil Hounslow|+44 118 922 9004|nhounslow@kowa.co.uk|
21238667|NCT00284141|Sanofi|Trial Transparency Team||Contact-Us@Sanofi.com|
21238668|NCT06369779|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
21238669|NCT01995539|Medtronic Minimed|Suiying Huang, Statistician|8184763319|suiying.huang@medtronic.com|
21276311|NCT00090753|Hoffmann-La Roche|Medical Communications|800-821-8590||
21276312|NCT01160445|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
21276313|NCT01086969|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21276314|NCT01514513|Tec Laboratories, Inc.|Wendy Langley|5419264577|wendy@teclabsinc.com|338
21228740|NCT05032859|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
21228741|NCT04070144|Injeq|Chief Scientific Officer|+358405805944‬|info@injeq.com|
21228742|NCT01927341|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21228743|NCT00451451|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
21228744|NCT03861611|Montefiore Medical Center|Eddie Irizarry, MD|718-904-2104|eddiriza@montefiore.org|
21228745|NCT03402659|EIP Pharma|Jennifer Conway, Associate Director of Clinical Development|(617) 744-4400|jconway@eippharma.com|
21288947|NCT00731198|Changhai Hospital, Second Military Medical University, Shanghai, China|Zhaoshen Li M.D.|86-21-81873271|zhaoshenlismmu@gmail.com|
21288948|NCT05427916|Icahn School of Medicine at Mount Sinai|John C Lantis II|(212) 523-4797|John.Lantis@mountsinai.org|
21288949|NCT04757584|Weill Cornell Medicine|Maryam Hyder|646-962-5904|mah4022@med.cornell.edu|
21288950|NCT00429299|GlaxoSmithKline|GSK Response Center|866-435-7343||
21288951|NCT04871113|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21288952|NCT01565551|University of California, San Francisco|Geoffrey Manley, MD, PhD|415-206-8300|manleyg@neurosurg.ucsf.edu|
21288953|NCT00315822|Cleveland Clinic|Daniel Sessler, MD|216-444-4900|sessled@ccf.org|
21288954|NCT00081458|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21288955|NCT02162433|Massachusetts Eye and Ear|Dr. Makara Cayer|617-573-3380|makara_cayer@meei.harvard.edu|
21228746|NCT00695578|Wake Forest University Health Sciences|Steve Feldman MD|336-716-3775|sfeldman@wakehealth.edu|
21228747|NCT01442038|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21228748|NCT00089284|Northwestern University|Clinical Research Office Administrator|312-695-1301|cancertrials@northwestern.edu|
21228749|NCT03646643|University of Pennsylvania|Dr. Saman Nazarian|215-615-5220|Saman.Nazarian@pennmedicine.upenn.edu|
21228750|NCT05314478|Liverpool University Hospitals NHS Foundation Trust|Dr Tristan Payne|01517064553|tristan.payne@liverpoolft.nhs.uk|
21228751|NCT03583164|F2G Ltd|Daniela Zinzi|43 664 3582281|dzinzi@f2g.com|
21228752|NCT00214500|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
21228753|NCT01880047|Weill Cornell Medicine|Sujit Sheth|2126463400|shethsu@med.cornell.edu|
21228754|NCT01287078|National Heart Lung and Blood Institute|Dr Richard Childs|301-451-7128|childsr@nhlbi.nih.gov|
21228755|NCT02343081|FLENI- mrc (FLENI Multi-specialty Research Center)|Dr. Alejandro Muggeri (Principal Investigator)|54-11-5777 3200|alemuggeri@hotmail.com.ar|2020
21228756|NCT02675231|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21228757|NCT05323656|Calliditas Therapeutics AB|Head of Clinical Operations|+4684113005|info@calliditas.com|
21228758|NCT02495233|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
21228759|NCT03880461|Kaiser Permanente Northern California|Monique Hedderson, Ph.D.|925-520-0785|monique.m.hedderson@kp.org|
21276315|NCT01466036|Dana-Farber Cancer Institute|Dr. Jennifer Chan|617-632-6315|jang@partners.org|
21276316|NCT03401918|Stanford University|Ruth Bunker Lathi|(650) 498-7911|clinicaltrials-gov@stanford.edu|
21276317|NCT01609582|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21276318|NCT03222037|Johnson & Johnson Vision Care, INC.|Chantal Coles-Brennan -PRINCIPAL RESEARCH OPTOMETRIST|1-904-443-3449|CColesb@its.jnj.com|
21276319|NCT00250705|The University of Iowa|An Open Label Trial of Aripiprazole in the Treatment of Conduct Disorder in Adolescents.|319-356-1482|Samuel-Kuperman@uiowa.edu|
21276320|NCT04784637|University of Virginia|Sue Brown|434-982-0602|sab2f@virginia.edu|
21276321|NCT05103657|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21276322|NCT04974736|Massachusetts General Hospital|Jonathan P. WInickoff|(617) 726-2728|jwinickoff@mgh.harvard.edu|
21276323|NCT01621906|Memorial Sloan Kettering Cancer Center|Dr. Andrew Seidman, MD|646-888-4559|seidmana@MSKCC.ORG|
21276324|NCT04100096|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Medical Affairs|800 562-3974|clinicaltransparency@otsuka-us.com|
21276325|NCT02137382|Abbott|Suntje Sander - Struckmeier|+49 (0) 511 6750 3254|suntje.sander-struckmeier@abbott.com|
21276326|NCT00991510|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21276327|NCT01976728|Ferring Pharmaceuticals|Clinical Development Support|+1 833-548-1402|DK0-Disclosure@ferring.com|
21276328|NCT02356211|TVHS GRECC, Nashville TN|James S. Powers MD, Clinical Associate Director, GRECC|615-873-8032|james.powers2@va.gov|
21276329|NCT01563237|InnFocus, Inc.|Sharon Herbert, Associate Director of Clinical Operations|(415) 268-9059|sharon.herbert@santen.com|
21276330|NCT01119807|Mecklenburg EMS Agency|Jonathan R Studnek PhD|7049436046|jonst@medic911.com|
21276331|NCT01124695|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21276332|NCT02960438|Eisai Co., Ltd.|Inquiry Service||eisai-chiken_hotline@hhc.eisai.co.jp|
21276333|NCT01922219|NYSPI|Jeffrey Miller, M.D.|646-774-7613|jm2233@cumc.columbia.edu|
21276334|NCT01701037|Vanderbilt-Ingram Cancer Center|Mark C. Kelley|615-936-7423|mark.kelley@vanderbilt.edu|
21228760|NCT04847622|Research Organisation King's Cross (KC) Ltd.|Toni Sobande, Clinical Project Manager|447494 795 982|toni.sobande@rokcservices.com|
21276335|NCT00271739|Columbia University|Walter Palmas, M.D.|212-305-3163|wp56@columbia.edu|
21276336|NCT03170388|Bausch Health Americas, Inc|Study Director|5102595284|aloncaric@bauschhealth.com|
21276337|NCT00556491|St Louis University|Tarek El-Achkar|317 278 6822|telachka@iu.edu|
21276338|NCT01652729|AstraZeneca|ClinicalTrialTransparency@astrazeneca.com||ClinicalTrialTransparency@astrazeneca.com|
21276339|NCT04523324|Centers for Disease Control and Prevention|Dr. Ashley Fowlkes|4046394830|afowlkes@cdc.gov|
21276340|NCT03180801|SEEK|Dr Olga Pleguezuelos|+44 020 7153 6601|olga.pleguezuelos@seekacure.com|
21276341|NCT03173170|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21276342|NCT01142908|Veterans Administration HSRD, Durham COIN|Hayden B. Bosworth, PhD, Assoc Dir, Durham HSR&D COIN|919-286-0411|hayden.bosworth@va.gov|6936
21276343|NCT00367016|University of California-Davis, Department of Dermatology|Fu-Tong Liu, M.D., Ph.D.|916-734-6556|fliu@ucdavis.edu|
21276344|NCT04090879|Brown University|Jennifer W. Tidey|4018636418|jennifer_tidey@brown.edu|
21276345|NCT01148524|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21276346|NCT00529217|Columbia University Department of Psychiatry, City University of New York|Dr. Antonio Mantovani|212-650-5417|AMantovani@med.cuny.edu|
21276347|NCT01546519|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21276348|NCT01519947|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21276349|NCT00452543|Massachusetts General Hospital|Dr. Janet Witte|617-726-5104|jwitte@partners.org|
21276350|NCT02525263|CTI|Dr William S Aronstein|5135989290|baronstein@ctifacts.com|
21276351|NCT03460899|Medical University of Graz|Assoc.-Prof. Harald Sourij, MD|0043 316 385|ha.sourij@medunigraz.at|81310
21276352|NCT01264835|Ethicon Endo-Surgery|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
21276353|NCT00680524|VA Puget Sound Health Care System|Bradford Felker, MD|(206)277-1191|Bradford.Felker@VA.GOV|
21228761|NCT00672204|University of Minnesota|Bernhard J. Hering, M.D.|612-626-5735|bhering@umn.edu|
21228762|NCT02652767|GenSight Biologics|Magali Taiel CMO|1 76 21 72 26|mtaiel@gensight-biologics.com|0033
21228763|NCT03839082|University of California Los Angeles|Monica Tincopa|310 825-2631|mtincopa@mednet.ucla.edu|
21228764|NCT03367247|Dana-Farber Cancer Institute|Dr. Alexi Wright|617-632-2334|alexi_wright@dfci.harard.edu|
21228765|NCT00887744|Medtronic Spinal & Biologics Europe and Central Asia|E. Wülfert, Medical Affairs & Clinical Operations Director||inca.studyregistration@medtronic.com|
21228766|NCT01115803|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21228767|NCT03533686|University of Miami|Dr. Hillary Snapp|305-243-4611|hsnapp@med.miami.edu|
21228768|NCT01879540|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21228769|NCT02862600|Heart Metabolics, Ltd.|Mark G. Midei, MD, Executive Director and Head of Cardiology|4103715357|markgmidei@gmail.com|410
21228770|NCT01490788|Tonix Pharmaceuticals, Inc.|Greg Sullivan, MD||greg.sullivan@tonixpharma.com|
21228771|NCT01525173|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21228772|NCT02961218|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21276354|NCT00108550|VA San Diego Healthcare System|J. H. Atkinson MD|858-642-3775|joseph.atkinson@va.gov|
21276355|NCT01115933|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
21276356|NCT02427399|Fenway Health|Dr. Jennifer Potter|617-416-0986|jpotter@bidmc.harvard.edu|
21228773|NCT04616027|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21276357|NCT00605176|Graceway Pharmaceuticals LLC|Sharon F. Levy, MD|267-948-0400|sharon.levy@gracewaypharma.com|
21228774|NCT01462227|Yale University|Robert Stanley Sherwin, MD|203 737 1932|robert.sherwin@yale.edu|
21228775|NCT01158703|BROOKE ARMY MEDICAL CENTER|AHMAD M. SLIM, MD, LTC, MC|210-916-4717|AHMAD.SLIM@US.ARMY.MIL|
21228776|NCT01234207|UCaliforniaBerkeley|Andrew D. Graham|510-643-9252|agraham@berkeley.edu|
21228777|NCT00901927|The University of Texas (UT) MD Anderson Cancer Center|Nathan Fowler/Clinical Professor, Lymphoma-Myeloma|(832) 671-3018|nfowler@mdanderson.org|
21228778|NCT03737851|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21228779|NCT01702571|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21228780|NCT00828854|Syndax Pharmaceuticals, Inc.|Michael Meyers, MD, PhD, Chief Medical Officer|+1-646-690-7620|mmeyers@syndax.com|
21228781|NCT04221230|Neumora Therapeutics, Inc.|Study Contact|+1- (857) 760-0900|clinicaltrials@neumoratx.com|
21228782|NCT00915356|AstraZeneca|Gerard Lynch||clinicalTrialTransparency@astrazeneca.com|
21228783|NCT03425019|The University of Texas Health Science Center at Houston|Hyochol Ahn|(713) 500-2179|hahn@fsu.edu|
21228784|NCT00191646|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21228785|NCT00322101|Fred Hutchinson Cancer Research Center|Bart Lee Scott|206-667-1990|bscott@fhcrc.org|
21228786|NCT04350606|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21228787|NCT01753739|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
21228788|NCT05211284|Zydus Therapeutics Inc.|Dr Deven Parmar|7324050886|dparmar@zydustherapeutics.com|
21228789|NCT02595996|Columbia University Irving Medical Center|June K. Wu, MD|212-342-3704|jw92@cumc.columbia.edu|
21228790|NCT03194490|Loma Linda University|Dr. Everett Lohman III|(909) 558-4632|elohman@llu.edu|83171
21228791|NCT01505647|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21228792|NCT01574079|University of Mississippi Medical Center|Principle investigator|601-984-6369|lbarnes@umc.edu|
21228793|NCT00285467|Indiana University School of Medicine|Sharon Moe, MD|317-278-2868|smoe@iupui.edu|
21228794|NCT04808999|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MSCCR, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
21228795|NCT03640559|Pharmasyntez|Mikhail Shurygin|+7 3952 550 355|m.shurygin@pharmasyntez.com|189
21228796|NCT01436162|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21228797|NCT02153710|University of Washington|Diane Kendall|2066160537|dkendall@uw.edu|
21228798|NCT02750943|GlaxoSmithKline|GSK Response Center|866-435-7343||
21276358|NCT00685750|GlaxoSmithKline|GSK Response Center|866-435-7343||
21276359|NCT04974580|Ohio State University College of Public Health|Dr. Elizabeth G. Klein|614-292-5424|klein.232@osu.edu|
21276360|NCT00587431|Memorial Sloan-Kettering Cancer Center|Dr. Dana Rathkopf|646-422-4379|rathkopd@mskcc.org|
21276361|NCT05467982|Dartmouth-Hitchcock|Sarah Pratt, PhD-Contact PI|603-496-2665|sarah.i.pratt@dartmouth.edu|
21276362|NCT00260689|NHLBI, NIH|Danielle Townsley MD|301-402-3477|townsleydm@nhlbi.nih.gov|
21276363|NCT02997722|University of Mississippi Medical Center|Allen Richert, MD|(601) 984-4820|arichert@umc.edu|
21276364|NCT01493596|Catalyst Pharmaceutical Partners, Inc.|Douglas Winship, Vice President of Regulatory Operations|305 529-2522|dwinship@catalystpharma.com|12
21276365|NCT04381481|University of North Carolina at Chapel Hill|Marissa Hall, PhD|919-962-5907|mghall@unc.edu|
21276366|NCT00220727|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
21276367|NCT02221817|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
21276368|NCT02508116|University of Pennsylvania School of Medicine|Sony Tuteja, PharmD, MS|215-573-7834|sonyt@pennmedicine.upenn.edu|
21276369|NCT00109850|SWOG Statistical Center|Study Statistician|206-667-4623||
21276370|NCT04234464|Avillion LLP|Chief Medical Officer|+44 (0)203 764 9530|avillion@avillionllp.com|
21276371|NCT00983528|UC San Diego|MCC Clinical Trials Office|(858) 534-5417|tkipps@ucsd.edu|
21276372|NCT00476593|Department of Ophthalmology, St. Olavs Hospital, Trondheim Norway|Dr Alexandra Wexler|99716763|a.wexler@online.no|0074
21276373|NCT04763278|Point Designs|Director of Clinical Research|7206004753|research@pointdesigns.com|
21276374|NCT03430011|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
21276375|NCT03604432|Corewell Health|Dr. Charles Willekes|616-459-7258|Charles.Willekes@corewellhealth.org|
21276376|NCT02578745|Washington University|Methodius Tuuli|6785582874|methodiustuuli@yahoo.com|
21276377|NCT00330460|Amgen Inc.|Study Director|866-572-6436||
21276378|NCT03712124|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
21228799|NCT04597918|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21276379|NCT01332721|TRACON Pharmaceuticals|Dr Charles Theuer|8585500780|ctheuer@traconpharma.com|233
21276380|NCT00388037|Cancer Centre of Southeastern Ontario at Kingston|Dr. James Biagi|(613) 544-2630|jim.biagi@krcc.on.ca|
21276381|NCT00602537|University of Pennsylvania|Dr. Jay Amsterdam|(215) 662-3462|jamsterd@mail.med.upenn.edu|
21276382|NCT01290237|Boston Children's Hospital|Dr. Alicia Demirjian||alicia.demirjian@post.harvard.edu|
21228800|NCT05140382|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21228801|NCT06120777|Masimo Corporation|Ahmed Alghazi|949-297-7000|studies@masimo.com|
21228802|NCT05419908|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
21260832|NCT06119191|CooperVision, Inc.|Cameron Postnikoff|925-730-6734|postnikoff@coopervision.com|
21276383|NCT02941523|Noxopharm Limited|Clinical Manager|+61 499005049|marinella.messina@noxopharm.com|
21228803|NCT03670836|Columbia University Medical center|Rachana Gavara|914-356-2730|rg2460@cumc.columbia.edu|
21228804|NCT01711372|CogCubed|Dr Monika Roots, Chief Medical Officer|6173082009|monika@cogcubed.com|
21276384|NCT04330157|University hospital Osijek|Nenad Neskovic|+385996787250|nneskov@gmail.com|
21228805|NCT01397201|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21228806|NCT00683085|Research Hospital, The Institute of Medical Science, The University of Tokyo|Hitomi Nagayama, M.D., Ph.D. / Project Lecturer|+81-3-3443-8111|zephyrus@ims.u-tokyo.ac.jp|
21228807|NCT00851630|Duke University Medical Center|Dr. Nathan Thielman|919-6687174|n.thielman@duke.edu|
21228808|NCT00401531|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21228809|NCT01948310|Duke Medical Center|Leslie Willis|9196606782|leslie.willis@duke.edu|
21228810|NCT01614600|Alcon Research, Ltd.|Jami Kern, MBA, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
21228811|NCT02437513|Protip Medical|Linda Nicolini CEO|0033388103068|l.nicolini@protipmedical.com|
21228812|NCT03092024|Lady Davis Institute|Dr. Brett Thombs|514-340-8222|brett.thombs@mcgill.ca|25112
21228813|NCT03956056|Washington University School of Medicine|William Gillanders, M.D.|314-747-0072|gillandersw@wustl.edu|
21228814|NCT03403374|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21228815|NCT02128828|University of Hawaii|Dr. Cecilia Shikuma|808 692-1328|shikuma@hawaii.edu|
21228816|NCT03257696|Groupe Hospitalier de la Rochelle Ré Aunis|Dr. Camille Bonnin|+0546455050|camille.bonnin@ght-atlantique17.fr|
21228817|NCT01092507|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21228818|NCT04882501|InovaHCS|Principal Investigator Inova Fair Oaks Hospital|703 391-4892|Laura.McNicholl@inova.org|
21228819|NCT04629508|1-855-463-3463|Study Director|1-855-463-3463|medinfo@incyte.com|
21228820|NCT04073368|Axcella Health, Inc|Margaret Koziel, MD|8573202200|clinicaltrials@axcellahealth.com|
21228821|NCT01742936|Nationwide Children's Hospital|Vidya Raman, MD|614-722-4200|Vidya.Raman@nationwidechildrens.org|
21228822|NCT00736879|Clinical Trial Transparency|AstraZeneca||Clinical.Trial.Transparency@astrazeneca.com|
21228823|NCT00735254|Arizona Dermatology and Cosmetic|Edward Galiczynski, MD|(602) 277-1449|egaliczynski@arizonaderm.com|
21228824|NCT01031381|UPMC Cancer Centers|Rita Johnson, Associate Director of Clinical Research Services|412-647-8571|johnsonr1@upmc.edu|
21228825|NCT00147251|MedStar Research Institute|Barbara V Howard|301-560-7305|barbara.v.howard@medstar.net|
21228826|NCT06400979|University of California, Davis Medical Center|Carolyn Mofidi, RN-BC, BSN, MS-L|(916) 734-3333|cmofidi@ucdavis.edu|
21228827|NCT02694523|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21228828|NCT04489732|University of Wisconsin Carbone Cancer Center|Randy Kimple, MD, PhD, FASTRO|608-263-5361|rkimple@humonc.wisc.edu|
21228829|NCT06207435|University of Pennsylvania|Dr. Farouk Dako|2673091241|farouk.dako@pennmedicine.upenn.edu|
21228830|NCT01367119|Mayo Clinic|Dr. Keith G. Rassmussen|507-284-2933|rasmussen.keith@mayo.edu|
21228831|NCT01257802|University of Michigan|W Joseph McCune MD Professor of Rheuntic Diseases University of Michigan|734 936 5560|jmccune@med.umich.edu|
21228832|NCT02808871|Baylor College of Medicine|Ivan O. Rosas, MD|617-510-9910|Ivan.Rosas@bcm.edu|
21228833|NCT01028378|Clinical Research Consultants, Inc.|Barbara S. Fant, Pharm.D.|513-961-8200|bsfant@crc-regulatory.com|
21228834|NCT00064298|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
21228835|NCT02017171|Joslin Diabetes Center|Dr. Alessandro Doria (Sponsor and PI of the study)|617-319-0970|alessandro.doria@joslin.harvard.edu|
21228836|NCT02220998|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21228837|NCT03309046|MemphisVAMC|Dr. Linda Olivia Nichols|901 523-8990|linda.nichols@va.gov|5082
21228838|NCT01194427|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|4432876489|vstearn1@jhmi.edu|
21228839|NCT02280473|Allergan plc|Michael Robinson|1-714-246-6415|Robinson_Michael@Allergan.com|
21228840|NCT01539317|Oregon Health and Science University|Dr. Martha Goetsch|503-494-3666|whru@ohsu.edu|
21228841|NCT02393690|Academic and Community Cancer Research United (ACCRU)|Alan Ho, M.D.|212-639-7202|hoa@mskcc.org|
21228842|NCT00591266|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21228843|NCT05298306|Lateral Pharma|Dr Stuart Mudge|+61424588904|sm@lateral-pharma.com|
21228844|NCT03497676|Family Health International (FHI 360)|IMPAACT ClinicalTrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
21228845|NCT00237185|Novartis|Study Director|862-778-8300||
21228846|NCT00484718|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21228847|NCT00910988|Washington University|Julie Schweiger/Michael Yingling|3143623153/5735791412|schweigj@psychiatry.wustl.edu/yinglinm@psychiatry.wustl.edu|
21228848|NCT00252629|Northport, VAMC|Mohammad M. Amin, MD|6312614400|mohammad.amin2@va.gov|2469
21228849|NCT00972088|bikur holim hospital|samuel n adler md, director of clinical trial|972 2 6464206|nasnadler@gmail.com|
21228850|NCT03911843|Azienda Ospedaliero-Universitaria di Novara, Italy|Dr. Francesco Cadario, Head of the Pediatric Diabetology service|+39 347 226 6507|francesco.cadario@gmail.com|
21228851|NCT02819518|Merck Sharp & Dohme LLC.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21228852|NCT00880165|Philadelphia VA Medical Center|Samuel T. Kuna, MD|215-823-4400|Samuel.Kuna@va.gov|
21228853|NCT01758289|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21228854|NCT02865343|Harvard Medical School|Dr J. Andrew Taylor|6177585503|jandrew_taylor@hms.harvard.edu|
21228855|NCT01594385|St. Luke's University Health Network|Stanislaw P. Stawicki, M.D.|484-526-4426|stanislaw.stawicki@sluhn.org|
21260833|NCT02101437|taipei city hospital|chen yueh-chung|88627093600|chenyuehchung.tw@yahoo.com.tw|3741
21228856|NCT00395538|Rho, Inc|Robert James|(919) 595-6468|robert_james@rhoworld.com|
21228857|NCT00990938|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
21228858|NCT04669535|UMass Chan Medical School|Dr. Terence Flotte|508-856-8992|terry.flotte@umassmed.edu|
21288956|NCT01946802|Seoul National University Hospital|Pf. Gil Joon Suh|82-2-2072-2196|suhgil@snu.ac.kr|
21288957|NCT03097315|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
21288958|NCT00195429|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21288959|NCT02556788|Galderma S.A.|Anne Fulton|+1 817-961-5203|anne.fulton@galderma.com|
21288960|NCT04502524|Fred Hutchinson Cancer Center|Jaimee Heffner, Ph.D., Associate Professor|206.667.7314|jheffner@fredhutch.org|
21288961|NCT01334515|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
21288962|NCT04327271|University of Washington|Caryl Feldacker|+1-314-600-6743|cfeld@uw.edu|
21288963|NCT04339972|Medical University of South Carolina|Dr. Mark George or Dr. Bashar Badran|843-792-6076|georgem@musc.edu|
21288964|NCT03683901|MetroHealth Rehabilitation Institute|Dr. Victoria Whitehair|216-778-4414|vwhitehair@metrohealth.org|
21288965|NCT03780387|University of North Carolina at Chapel Hill|Michelle Hernandez, MD|919-843-5383|michelle_hernandez@med.unc.edu|
21288966|NCT00776997|Torax Medical|Amy Derosier, VP of Clinical Affairs|651-361-8900|aderosier@toraxmedical.com|
21288967|NCT01716156|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21288968|NCT04837521|Duke University|Dr. Andrada Neacsiu|+1 919 684 6714|andrada.neacsiu@duke.edu|
21288969|NCT04057365|Massachusetts General Hospital|Joseph Franses, MD, PhD|617-724-4000|JFRANSES@MGH.HARVARD.EDU|
21288970|NCT04738487|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21228859|NCT01298544|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21228860|NCT05169567|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21228861|NCT02211638|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21228862|NCT01510457|Rehabilitation Institute of Chicago Center for Pain Studies|Dr. R. Norman Harden|312.238.5654|centerforpainstudies@ric.org|
21228863|NCT04041700|Cochlear|Johan Blechert|+46766498632|jblechert@cochlear.com|
21228864|NCT02775903|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21228865|NCT03173534|Cleveland Clinic|Samir Kapadia, MD Chairman Cardiovascular Medicine|216 444-6735|KAPADIS@ccf.org|
21228866|NCT00458536|Beth Israel Deaconess Medical Center|David Avigan, MD|617-667-9920|davigan@bidmc.harvard.edu|
21228867|NCT03237871|Johns Hopkins Bloomberg School of Public Health|Principal Investigator|410-955-3537|ljennin6@jhu.edu|
21228868|NCT02658097|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Nathan Pennell|1-866-223 8100|TaussigResearch@ccf.org|
21228869|NCT03120624|Mayo Clinic|Jamie N Bakkum-Gamez MD|507-284-2511|bakkum.jamie@mayo.edu|
21228870|NCT00309738|Kowa Research Institute|Bill Arana|919 433 1600|barana@kowaus.com|
21228871|NCT00970073|Cleveland Clinic|Bijan Eghtesad|2164029954|eghtesb@ccf.org|
21228872|NCT04382391|Allegheny Health Network (AHN)|Tariq Cheema, MD, Vice President and Medical Director AHN Research Institute|412-321-3344|tariq.cheema@ahn.org|
21228873|NCT00215683|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
21228874|NCT02171065|Lund University|Principal Investigator: David Erlinge, MD, PhD|+46-733746165|david.erlinge@gmail.com|
21228875|NCT00674973|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21228876|NCT00763048|Colgate Palmolive Co.|William Devizio|732-878-7901|William_Devizio@colpal.com|
21228877|NCT00084838|Dana-Farber Cancer Institute|Mark Kieran|(617) 632-4907|mark_kieran@dfci.harvard.edu|
21228878|NCT00518687|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21228879|NCT01557894|Babes-Bolyai University|Bogdan Tudor Tulbure|+40745753061|btulbure@gmail.com|
21228880|NCT02231918|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21228881|NCT02395666|Beat Childhood Cancer|Dr. Giselle Sholler|704-381-9900|Giselle.Saulniersholler@atriumhealth.org|
21228882|NCT03288454|Apollo Investment Management|Scientific Advisor|+352 2088 1301|rchari@kaiperheathcare.com|
21228883|NCT00145600|St. Jude Children's Research Hospital|Jamie Flerlage, MD|1-866-278-5833|info@stjude.org|
21228884|NCT04087213|DEKA Research|Clinical Research Manager|(603) 669-5139|clinical@dekaresearch.com|
21228885|NCT03090412|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-6269|Chong.Wang@roswellpark.org|
21228886|NCT00718302|Boston Medical Center|Paul Tornetta, III, MD|617-414-6295|tornetta@bu.edu|
21228887|NCT02751788|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
21228888|NCT01684020|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
21228889|NCT01952600|Arbor Research Collaborative for Health|Dr. Francesca Tentori|7346654108|francesca.tentori@arborresearch.org|
21228890|NCT04865640|"Medical Products Group | Analog Devices Inc."|Tony Akl|781-937-1665|tony.akl@analog.com|
21238670|NCT00530803|Montefiore Medical Center|Associate Professor, Dept of Pediatrics|718-741-2460|cskae@montefiore.org|
21238671|NCT03474107|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
21238672|NCT00229957|McMaster University|Dr. Julie Richardson|905-525-9140|jrichard@mcmaster.ca|27811
21238673|NCT01222195|The University of Texas M. D. Anderson Cancer Center|Gautam Borthakur, MBBS / Assistant Professor|713-792-7305|eharriso@mdanderson.org|
21238674|NCT00659984|NANT Consortium|NANT Operations Center|323-361-5687|nantops@chla.usc.edu|
21238675|NCT02487810|Fostering Improvement in End-of-Life Decision Science (FIELDS) Program|Beth Cooney, Assistant Director of FIELDS Program|215-573-9461|elcooney@exchange.upenn.edu|
21228891|NCT01272661|UHospitalsCleveland; Rainbow Babies and CHildren's Hospital|Lydia Furman MD, PI|216-844-8260|Lydia.Furman@uhhospitals.org|
21228892|NCT00750880|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21228893|NCT00573248|University of California, Irvine|Jean Gehricke, Ph.D.|949-824-1834|jgehrick@uci.edu|
21228894|NCT04505540|University of Vermont|Dr. Scott Mackey, PhD|8028478767|msmackey@uvm.edu|
21228895|NCT00805948|Medtronic, Inc|Michael McGuffey, Clinical Research Director|707-591-7126|michael.mcguffey@medtronic.com|
21228896|NCT02057393|Penn State Hershey Medical Center|Colette Pameijer, Associate Professor of Surgery|717-531-5272|cpameijer@pennstatehealth.psu.edu|
21228897|NCT03180684|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
21228898|NCT03660488|University of Southern California|Jeffrey D Klausner MD MPH, Clinical Professor of Population and Public Health Sciences|4158768901|jdklausner@med.usc.edu|
21228899|NCT01130103|Research Foundation for Mental Hygiene|Franklin Schneier MD|212-543-5368|frs1@columbia.edu|
21228900|NCT03614975|University of Pittsburgh, Department of Family Medicine|Richard Zimmerman, MD|412-383-2354|zimmrk@upmc.edu|
21228901|NCT01336296|UCincinnati|Research Associate Professor|5135852145|adele.rike@uc.edu|
21228902|NCT01390220|Proximagen, LLC|David Sequeira|952-658-7438|dsequeira@proximagen.com|
21228903|NCT00249288|Schizophrenia Program, Massachusetts General Hospital|Michelle Hill|617-912-7846|michelehill1@gmail.com|
21228904|NCT03059446|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21228905|NCT00136604|GlaxoSmithKline|GSK Response Center|866-435-7343||
21228906|NCT03091777|Gage Development Company|Gage Development Company|1-847-999-0600|clinicalinfo@capstonedevservices.com|
21228907|NCT02536833|Samumed|Christopher Swearingen, PhD, VP of Clinical Outcomes and Analytics|858.926.2952|chris@samumed.com|
21228908|NCT02354482|University of Kentucky|Jessica Clouser|8593230284|jess.clouser@uky.edu|
21228909|NCT00089674|Amgen Inc.|Study Director|866-572-6436||
21228910|NCT03963401|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21228911|NCT01982331|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
21228912|NCT03488927|University of Nebraska-Lincoln|Katie Edwards|402-472-2223|katie.edwards@unl.edu|
21228913|NCT01482351|George Mason University|Dr. Kathy C. Richards|(703) 946-3725|kricha11@gmu.edu|
21238676|NCT03607825|Minnetronix Neuro|Director of Clinical Trials|651-917-4060|info@cerevention.com|
21238677|NCT01287611|DrLutfi|Dr. Cem Turan|00905323513423|cemturan@gmail.com|
21238678|NCT00763958|University of Alabama at Birmingham|Dr. Karen Cropsey|205-917-3786|kcropsey@uab.edu|205
21238679|NCT04074590|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
21238680|NCT02489110|Photozig, Inc.|Bruno Kajiyama|6506947595|info@photozig.com|
21238681|NCT01281202|National Institute on Drug Abuse|David McCann, Ph.D.|301-443-2999|dmccann@nida.nih.gov|
21228914|NCT02204007|Cleveland Clinic Foundation|Dr. Carlos A Higuera, MD|2166361136|higuerc@ccf.org|
21228915|NCT02766465|The Emmes Company, LLC|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
21238682|NCT04581200|Duke University|Christopher Cox|9196817232|christopher.cox@duke.edu|
21260834|NCT00745030|Northwestern University|Angelica Marconi|312-503-1999|a-marconi@northwestern.edu|
21228916|NCT01907100|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21228917|NCT00667602|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21228918|NCT04192370|Brigham and Women's Hospital|Joji Suzuki, MD|617-455-7981|Jsuzuki2@bwh.harvard.edu|
21228919|NCT02301988|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21228920|NCT02745210|Loma LInda University Medical Center|Brenda Bartnik Olson|1-909-558-4000|BBartnik@llu.edu|85216
21228921|NCT02891161|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
21228922|NCT01535664|Acorda Therapeutics, Inc.|Gustavo Suarez, MD|(914) 326-5394|gsuarez@acorda.com|
21228923|NCT01931202|New York State Psychiatric Institute|Bret R. Rutherford|6467748660|bret.rutherford@nyspi.columbia.edu|
21228924|NCT01074047|Celgene|Anne McClain, Senior Manager Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
21228925|NCT01876810|Centre for Addiction and Mental Health|Bernard LeFoll|416-535-8501|bernard.lefoll@camh.ca|34772
21228926|NCT01069185|Pablo Tobon Uribe Hospital|Dr.Jorge Donado Research Unit Chief|+574459753|jdonado@hptu.org.co|
21228927|NCT01857583|Daiichi Sankyo.,LTD|Masayuki Fukuzawa, Associate Director|81-90-5584-2197|fukuzawa.masayuki.gn@daiichisankyo.co.jp|
21228928|NCT04382755|UZ Gent|Anja Delporte|+3293320228|anja.delporte@uzgent.be|
21228929|NCT04571515|MEDA Pharma GmbH & Co. KG (A Viatris Company)|Susanne Vogt|+49 (0) 172 19 20 321|susanne.vogt@viatris.com|
21228930|NCT00729924|Vanderbilt University|David W. Haas, MD|615-936-8594|david.w.haas@vanderbilt.edu|
21228931|NCT01104701|Clinical Trial Transparency|AstraZeneca||ClinicalTrialTrasparency@astrazeneca.com|
21228932|NCT00423722|UT MD Anderson Cancer Center|Dr. Eduardo Bruera, MD / Professor|713-792-6085|ebruera@mdanderson.org|
21228933|NCT02598960|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21228934|NCT00931879|Eastern Virginia Medical School|Dr. Henri Parson|(757)446-7976|parsonhk@evms.edu|
21228935|NCT00595465|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|1175
21228936|NCT00107783|NHGRI|William Gahl, MD/Clinical Director|301-402-2739|gahlw@mail.nih.gov|
21228937|NCT00422097|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21228938|NCT02360995|Loma Linda University School of Dentistry|Yiming Li, DDS|909-558-8069|yli@llu.edu|
21228939|NCT03714620|Trinity Health, Loyola University Medical Center, Stritch School of Medicine|Shannon Lovett, MD, Associate Professor of Emergency Medicine|7082168705|slovett@lumc.edu|
21228940|NCT00547196|City of Hope|Dr. Anna Pawlowska, MD|626-359-8111|apawlowska@coh.org|
21228941|NCT00331864|Novartis Pharmaceuticals|Study Director|862-778-8300||
21228942|NCT00137631|Department of Human Development, State University of New York at Binghamton|Leo Wilton, PhD|607-777-9215|lwilton@binghamton.edu|
21260835|NCT01232946|Indiana University|Kieren J. Mather MD|317-278-7826|kmather@iu.edu|
21260836|NCT00374556|Johns Hopkins University School of Medicine|Michael Smith, PhD, Associate Professor of Psychiatry, Director of Behavioral Medicine|410-550-7000|msmith62@jhmi.edu|
21288971|NCT02717611|Acerta Pharma|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21288972|NCT02676973|RTI International|Marie Gantz|919-541-5110|mgantz@rti.org|
21288973|NCT05172570|Indiana Univeristy School of Medicine|Randomized prospective study comparing variable Gabapentin dosages for postoperative analgesia follo|317-274-0275|yyeap@iupui.edu|
21288974|NCT02013427|Northwestern University|Apkar Vania Apkarian|+1 312 503 0404|a-apkarian@northwestern.edu|
21288975|NCT04298853|Indiana University School of Medicine|Anna Thomas, MD|317-944-9392|aeschwar@iu.edu|
21288976|NCT04050605|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
21288977|NCT06170827|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@GSK.com|
21288978|NCT01192698|Carolinas Medical Center|Dr. Mark W. Russo|704-355-6649|mark.russo@carolinashealthcare.org|
21288979|NCT00182637|UC Irvine|Dr. Lauren Pinter-Brown|(714) 456-5153|lpinterb@uci.edu|
21288980|NCT04941898|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21288981|NCT00003456|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
21288982|NCT04928339|University of Wisconsin - Madison|Jeremy Sullivan|6082639976|jasullivan@wisc.edu|
21288983|NCT00587457|MedImmune, LLC.|Mark C Lanasa|301-398-0000|clinicaltrialenquiries@medimmune.com|
21288984|NCT03234881|VA Connecticut Healthcare System|Robin Masheb, PhD|203-932-5711|Robin.Masheb@va.gov|3954
21288985|NCT03128086|HOSPITAL UNIVERSITARIO GENERAL DE CASTELLÓN, SPAIN. CONSELLERIA SANITAT|DR. ALBERTO BELENGUER-MUNCHARAZ|964 72 50 00|belengueralberto8@gmail.com|
21288986|NCT04529980|Children's Health Children's Medical Center|Dr. Mayra Garcia, DNP, APRN, PCNS-BC, EBP-C|12144567990|Mayra.Garcia@childrens.com|
21288987|NCT01500096|Johns Hokpins University|Adriana Andrade|410-955-7287|aandrade@jhmi.edu|
21288988|NCT00639379|Vistakon|Kurt Moody, OD|904-443-3088||
21288989|NCT00723944|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
21288990|NCT01724190|Nationwide Childrens Hospital|Kathryn Obrynba|6147224425|kathryn.obrynba@nationwidechidrens.org|
21288991|NCT02506036|Johns Hopkins University School of Medicine|Dr. Argye Hillis|410-614-2381|argye@jhmi.edu|
21288992|NCT02383173|Birmingham VA Medical Center|Kathryn L. Burgio, PhD|205-558-7064|kburgio@uabmc.edu|
21288993|NCT00800540|Alcon Research, Ltd.|Director, Global Medical Affairs|1-888-451-3937||
21288994|NCT01239745|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21288995|NCT00726557|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21260837|NCT00473694|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21228943|NCT00994929|The University of Pittsburgh|Margaret V. Ragni, MD, MPH|412-209-7288|ragni@pitt.edu|
21228944|NCT00351000|Massachusetts General Hospital Schizophrenia Research Program|Dr. David Henderson|(617) 912-7800|dchenderson@partners.org|
21228945|NCT00085709|SWOG Statistical Office|SWOG Leukemia Statistician|206-667-4408||
21228946|NCT01409434|University of Florida|Dr. Rhonda Cooper-DeHoff|352-273-6184|dehoff@cop.ufl.edu|
21228947|NCT00293215|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
21228948|NCT01229371|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
21228949|NCT02213042|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21228950|NCT04622735|Unither Pharmaceuticals|Non Clinical & Clinical Project Manager|+33 (0)1 44 63 51 78|clinicaltrials@unither-pharma.com|
21228951|NCT05015530|BG ClinicalS|Dr Bernard Gout|+33 (0)561 531 944|b.gout@bgclinicals.com|
21228952|NCT02007512|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21228953|NCT03126370|University of Colorado Anschutz Medical Campus|Jennifer Kiser, PharmD, PhD|3037246131|jennifer.kiser@cuanschutz.edu|
21228954|NCT00994318|Vifor Pharma|Medical Information|41 58 851 8222|medinfo@viforpharma.com|
21260838|NCT03285529|Cleveland Clinic|Viktor Krebs|216-444-2600|krebsv@ccf.org|
21260839|NCT03874234|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21276385|NCT00337987|Yale University School of Medicine|Francine Foss, MD|203-737-5312|francine.foss@yale.edu|
21228955|NCT04157621|MUSC|Vanessa Hinson|843-876-0829|hinsonvk@musc.edu|
21228956|NCT03960554|Columbia University Irving Medical Center|Thomas L. Nickolas MD|212-305-5020|tln2001@cumc.columbia.edu|
21228957|NCT00920231|Baltimore VA MC|Dr Cha-Min Tang|410 706-2347|ctang@som.umaryland.edu|
21228958|NCT02545075|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21228959|NCT00093782|Princess Margaret Cancer Centre|Dr. Lillian Siu|416-946-2911|lillian.siu@uhn.ca|
21228960|NCT02563990|University of Miami|Andres Missair|3055857037|amissair@miami.edu|
21228961|NCT02180165|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21228962|NCT00267189|Novartis Pharmaceuticals|Study Director|862-778-8300||
21228963|NCT00751621|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
21228964|NCT01272284|Coloplast Corp|Clinical Trials Manager|612-302-4990|usdibe@coloplast.com|
21228965|NCT01086423|GlaxoSmithKline|GSK Response Center|866-435-7343||
21228966|NCT01417936|Symphogen A/S|Chief Scientific Officer|+45 8838 2600|info@symphogen.com|
21228967|NCT00925990|Conatus Pharmaceuticals Inc.|Vice President, Clinical Development|858-457-7227|mhuyghe@conatuspharma.com|
21228968|NCT05619523|University of Maryland, College Park|Dr. Melanie Killen|(301) 405-3176|mkillen@umd.edu|
21228969|NCT05342532|Icahn School of Medicine at Mount Sinai|Gres Karim|212-241-2499|gres.karim@mountsinai.org|
21228970|NCT03862040|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
21228971|NCT04508140|Highlight Therapeutics S.L.|Marisol Quintero|+34 961 10 99 55|mquintero@highlighttherapeutics.com|
21228972|NCT00450385|University of Miami|Izidore Lossos MD|305-243-4785|ilossos@med.miami.edu|
21228973|NCT02314143|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21228974|NCT01528215|DENTSPLY Implants|Manager Global Clinical Affairs|+46313763500|ClinicalResearchMolndal@dentsplysirona.com|
21228975|NCT01476644|Wills Eye Hospital, Glaucoma Research Center|George L. Spaeth, MD|215-928-3123|gspaeth@willseye.org|
21228976|NCT00586066|Massachusetts General Hospital|Andrew Nierenberg, Principal Investigator|6177240837|anierenberg@partners.org|
21228977|NCT01016561|University of Pennsylvania|Lilie Lin, MD|215-662-6515|lin@xrt.upenn.edu|
21228978|NCT02676466|University of Florida|ENRGISE Coordinating Center Project Manager|352-294-5800|ENGISEACC@aging.ufl.edu|
21228979|NCT01302379|University of San Diego, California|Ruth Patterson|8585349235|repatterson@ucsd.edu|
21228980|NCT04181320|Mölnlycke|Vice President Corporate Clinical & Medical Affairs CMO & RQA|+46317223045|jane.clark@molnlycke.com|
21228981|NCT01090973|H. Lee Moffitt Cancer Center and Research Institute|Celeste Bello, M.D.|813-745-8623|celeste.bello@moffitt.org|
21228982|NCT00445978|BioMarin Pharmaceutical Inc.|Joshua Lilienstein/Medical Director, Global Medical Affairs|651.523.0310|MEDINFO@bmrn.com|
21228983|NCT00843726|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|7168451300|adrienne.groman@roswellpark.org|
21228984|NCT02325856|Department of Nephrology, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan|Lim Paik-Seong|886-4-26581919|jamespslim@gmail.com|
21228985|NCT03374631|The University of Texas at Dallas|Dr. Amy Pinkham|(972) 883-4462|amy.pinkham@utdallas.edu|
21228986|NCT02443519|Yeshiva University & Albert Einstein College of Medicine|Dr. Elizabeth Seng|646-592-4368|elizabeth.seng@yu.edu|
21228987|NCT06352060|Kansas City Heart Rhythm Institute|Dhanunjaya Lakkireddy|913-934-4300|dlakkireddy@gmail.com|
21228988|NCT00760084|Eisai Inc.|Yufang Lu, MD, PhD|888-422-4743||
21228989|NCT02567552|IVI Barcelona|Evelin Lara Molina|+34 93 531 63 00|Evelin.Lara@ivi.es|27503
21228990|NCT03309150|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21228991|NCT00171054|Novartis Pharmaceuticals|Study Director|862-778-8300||
21228992|NCT03861702|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
21228993|NCT02900560|Translational Research In Oncology (TRIO)|Director, Project Management|33 158 10 09 09|026@trioncology.org|
21260840|NCT01587963|Rutgers RWJMS|Vincente Gracias|732-235-7920|graciavh@rwjms.rutgers.edu|
21228994|NCT00859027|University of Connecticut Health Center|Pamela Taxel MD|860-679-4743|taxel@nso.uchc.edu|
21228995|NCT02037607|Indiana University|Heather Cero, Research Nurse Manager|317-396-1298|hcero@iupui.edu|
21276386|NCT00869440|PAION UK Ltd|Trial Information||reg_paion@paion.com|
21228996|NCT04468321|Yale University|Joseph Ross, MD, MHS|2037852987|joseph.ross@yale.edu|
21228997|NCT00285207|TigrisPharmaceuticals|Chief Medical Officer||info@tigrispharma.com|
21228998|NCT03552965|University of Arkansas for Medical Sciences|Rashad Perry|501-686-8274|Rperry3@uams.edu|
21228999|NCT02981940|Dana-Farber Cancer Institute|Eudocia Q Lee, MD MPH|617.632.2166|eudocia_lee@dfci.harvard.edu|
21229000|NCT00814788|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu|
21229001|NCT02160782|Mirum Pharmaceuticals|Mirum Clinical Trials|1 650-667-4085|medinfo@mirumpharma.com|
21229002|NCT00413400|Massachusetts General Hospital|Steven K. Grinspoon|617-724-9109|sgrinspoon@partners.org|
21229003|NCT00414271|Johns Hopkins Singapore|Prof Alex Chang|+65 68802220|alexchang@imc.jhmi.edu|
21229004|NCT01846104|Department of Clinical Research Division of Medicine USAMRIID|Matthew Chambers, MD|301-619-6731|matthew.s.chambers@mail.mil|
21229005|NCT00398411|University of Cologne|Prof. Dr. Oliver A. Cornely|+49 221 478 88794|oliver.cornely@zks-koeln.de|
21229006|NCT01956435|University of Texas at Austin Medical School and Seton Family of Hospitals|Ammar Ahmed, MD|512-504-0855|amahmed@seton.org|
21229007|NCT03061097|Microbiome Health Research Institute|Majdi Osman, MD, MPH|617-575-2201|majdi@openbiome.org|
21229008|NCT01043146|Corimmun, GmbH|Gary Peters, MD, Managing Director|001-215 628-5257|gpeters7@its.jnj.com|
21229009|NCT02611960|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21229010|NCT04839146|Radboudumc|Benjamin Mordmüller (Principal investigator)|+31 (0)24 3619499|benjamin.mordmueller@radboudumc.nl|
21229011|NCT04131556|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21229012|NCT04735536|Cogntion Therapeutics Inc|Chief Medical Officer, Head of R&D|914-221-6730|acaggiano@cogrx.com|
21229013|NCT03026088|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21229014|NCT00761579|Clinical Research Team, Medical Affairs Korea|Senior Clinical Research Associate|82-2094-4804||
21229015|NCT03611010|Cumberland Pharmaceuticals Inc.|Senior Manager, Clinical Development|6155642188|imaciasperez@cumberlandpharma.com|
21229016|NCT00504985|UT MD Anderson Cancer Center|Xin Shelley Wang, MD, MPH / Associate Professor|713-745-3504||
21229017|NCT00950911|Amgen Inc.|Study Director|866-572-6436||
21229018|NCT02600351|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21229019|NCT02063880|University of Washington|Grace John-Stewart|206 5434278|gjohn@uw.edu|
21229020|NCT02106910|University of North Carolina at Chapel Hill|Nicholas J. Shaheen, MD|919-966-7655|nicholas_shaheen@med.unc.edu|
21229021|NCT02521766|Alcon Research, LLC|Sr. Clinical Trial Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21229022|NCT00567593|University of Pennsylvania|James D. Lewis, MD, MSCE|215-573-5137|lewisjd@mail.med.upenn.edu|
21229023|NCT02476422|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21229024|NCT01859143|MedImmune, LLC|Raburn Mallory, MD/Senior Director, Clinical Development|301-398-0000|malloryr@medimmune.com|
21229025|NCT00438451|Interdisciplinary Center for Clinical Trials (IZKS Mainz)|C. Ruckes|+49 (0) 6131 17|ruckes@izks-mainz.de|9919
21229026|NCT02413372|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21229027|NCT01288027|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21229028|NCT01550471|Allegheny Health Network|Deborah Gentile, Principal Investigator|412-359-4099|dgentile@wpahs.org|
21229029|NCT00760214|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21229030|NCT00700570|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21229031|NCT01134315|AbbVie|Global Medical Services|800-633-9110||
21229032|NCT04587271|University of Kentucky|Dr. Suzanna Attia|859-323-6211|suzanna.attia@uky.edu|
21229033|NCT02360111|Memorial Sloan Kettering Cancer Center|Dr. Ann Jakubowski, Ph.D., MD|212-639-5013|jakubowa@mskcc.org|
21229034|NCT01933217|Children's Hospital Medical Center, Cincinnati|Brad Kurowski, MD, MS|513-803-3655|brad.kurowski@cchmc.org|
21229035|NCT01669096|GlaxoSmithKline|GSK Response Center|866-435-7343||
21229036|NCT02861131|Oregon Health & Science University|Brandon Togioka|5034944572|togioka@ohsu.edu|
21229037|NCT03923738|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21229038|NCT05246397|University of Washington|Andrew Bowdle MD, PhD, FASE|206-979-0477|bowdle@u.washington.edu|
21229039|NCT03875768|Duke University|Gary G. Bennett, PhD|919-684-4510|gary.bennett@duke.edu|
21229040|NCT01925274|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21229041|NCT00922233|FHI360|Dr. Vera Halpern|9195447040|vhalpern@fhi360.org|
21229042|NCT04327674|Department of Respiratory Diseases and Allergy. Aarhus University Hospital. Denmark.|Søren Helbo Skaarup|28911869|soeska@rm.dk|
21229043|NCT00315146|Wake Forest Universtiy Baptist Medical Center|Stephen Kritchevsky|336-713-8548|skritche@wakehealth.edu|
21229044|NCT00723398|Milton S. Hershey Medical Center|Dr. Andrea Manni|717-531-8395|amanni@pennstatehealth.psu.edu|
21229045|NCT03153956|NYU Langone Health|Dennis A. Cardone, DO|+1 646 501 7223|Dennis.Cardone@nyulangone.org|
21260841|NCT00430040|State University of NY at Buffalo|Paresh Dandona|7165351852|dandona@buffalo.edu|
21260842|NCT04101890|Children's Research Institute|Elena Gibson|(202) 476-6877|egibson@cnmc.org|
21229046|NCT04396665|University of Oviedo|Vicerrectorado de investigación|+34985104190|viceinvestigacion@uniovi.es|
21229047|NCT05402020|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21229048|NCT01225887|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|lgedeon@gogstats.org|
21260843|NCT01896232|Amgen Inc.|Study Director|866-572-6436||
21229049|NCT03686514|Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
21229050|NCT01400815|22nd Century Group, Inc.|Karen Delaney|716-270-1523|kdelaney@xxiicentury.com|
21229051|NCT01123850|Zimmer|Laura Herdrich|952-830-6224|laura.herdrich@zimmer.com|
21229052|NCT04007198|Equillium|Clinical Operations|8582401200|clinicaltrials@equilliumbio.com|
21229053|NCT06138145|University of Pennsylvania|Dr. Kevin B. Johnson|215-573-5885|Kevin.Johnson1@Pennmedicine.upenn.edu|
21229054|NCT01822678|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
21229055|NCT01200862|Mereo BioPharma|Dr. Jackie Parkin|+44 333 0237300|enquiries@mereobiopharma.com|
21276387|NCT04314843|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
21276388|NCT01899326|Albert Einstein College of Medicine|Dr. Amit Verma|718-430-4091|amit.verma@einsteinmed.edu|
21276389|NCT03558139|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21276390|NCT00373425|Astellas Pharma Global Development, Inc.|Senior Medical Director, Medical Oncology||clinicaltrial.disclosure@us.astellas.com|
21276391|NCT02808819|AstraZeneca|AstraZeneca Information Center|+1 8002369933|information.center@astrazeneca.com|
21276392|NCT02752802|Osprey Medical, Inc|Michele Shepard, Vice President of Clinical Affairs|952-955-8236|mshepard@ospreymed.com|
21276393|NCT00251316|NIDDK, NIH|Dr. Monica Skarulis|301-496-6087|monicas@intra.niddk.nih.gov|
21276394|NCT01237080|Department of Anaesthesiology, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark|Mogens Ydemann|+4531155995|clinicaltrials@ydemann.dk|
21276395|NCT00569777|Vistakon|Brian Pall OD MS FAAO|904-443-1290||
21276396|NCT01839695|Medtronic Vascular|Taryn Dellaripa, Principal Clinical Research Specialist|541-301-3181|taryn.dellaripa@medtronic.com|
21276397|NCT02030535|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21276398|NCT04511208|CCF|Daniel Sessler, MD|216-444-4900|sseslerd@ccf.org|
21276399|NCT00576303|F. Hoffmann-La Roche AG|Name/Official Title:Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21276400|NCT00858013|Ajou University|Kwan Woo Lee|82-31-219-4526|lkw65@ajou.ac.kr|
21276401|NCT02447887|Fox Chase Cancer Center|Dr. Daniel M. Geynisman|215-728-3889|daniel.geynisman@fccc.edu|
21276402|NCT03941834|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21276403|NCT02688387|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21276404|NCT00418522|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21276405|NCT01163084|UT MD Anderson Cancer Center|Logothetis, Christopher, M.D. / Genitourinary Medical Oncology|7137922830|clogothe@mdanderson.org|
21276406|NCT01049412|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21276407|NCT05966090|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21276408|NCT00804141|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
21229056|NCT00337350|Massachusetts General Hospital Schizophrenia Research Program|Dr. David Henderson|(617) 912-7800|dchenderson@partners.org|
21229057|NCT01437878|Actelion Pharmaceutical Ltd|Maziar Assadi Gehr|+41 61 565 5525|maziar.assadi-gehr@actelion.com|
21229058|NCT04105543|University of Wisconsin Carbone Cancer Center|Justine Bruce, MD|(608) 262-4961|jybruce@medicine.wisc.edu|
21229059|NCT01369615|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
21229060|NCT04263454|University of Alabama at Birmingham|Jarred Younger|205-975-5821|youngerlab@uab.edu|
21229061|NCT00986479|AstraZeneca|Clinical Trial Transparency||ClinicalTrialTransparency@astrazeneca.com|
21229062|NCT01721070|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
21229063|NCT02035475|OhioHealth|Dr. Ronney Abaza|614-544-8104|ronney.abaza@ohiohealth.com|
21229064|NCT01460368|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21229065|NCT02322021|Eisai Medical Information|Eisai Ltd.|+1-888-274-2378|esi_medinfo@eisai.com|
21229066|NCT02047227|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21229067|NCT01721473|VA San Diego Healthcare System|Arthur Brody|8585528585|arthur.brody@va.gov|
21229068|NCT02001181|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21229069|NCT01842815|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
21229070|NCT00706810|Huntsman Cancer Institute|Dr. Randy Jensen|801-581-6908|randy.jensen@hci.utah.edu|
21229071|NCT05466448|Raziel Therapeutics|Racheli Gueta|97289126941|racheli@raziel-therapy.com|
21229072|NCT02435069|Nemours Children's Clinic|Kimberly S. Jarczyk, PhD, C-PNP|9044611730|jarczykks@gmail.com|
21229073|NCT03112590|Moffitt Cancer Center|Hyo S. Han, MD|813-745-4933|Hyo.Han@moffitt.org|
21229074|NCT00590889|St.Jude Medical|Heidi Hinrichs, VP of Clinical Study Management, St. Jude Medical||hhinrichs@sjm.com|
21229075|NCT02059005|Treatment Research Institute|Adam Brooks, PhD|215-399-0980|abrooks@tresearch.org|128
21276409|NCT01601691|Oulu University Hospital|Dr. Markku Vaarala|+3588315|markku.h.vaarala@ppshp.fi|2840
21229076|NCT02103218|UNC Greensboro|Lisa Goble Director Office of Research Integrity|336-256-1173|lagoble@uncg.edu|
21229077|NCT00739596|Novartis Pharmaceuticals|Study Director|862-778-8300||
21229078|NCT00908011|St. Paul's Hospital/University of B.C.|Dr. Greg Bondy|604-806-8192|gbondy@providencehealth.bc.ca|
21229079|NCT02520661|UW School of Medicine and Public Health|Manish N. Shah, MD, MPH|608-263-6690|mnshah@medicine.wisc.edu|
21229080|NCT02176343|Alcon Research, Ltd.|Clinical Project Lead, GCRA, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21229081|NCT00891462|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
21229082|NCT01083485|Mundipharma Research|Maggie Wilson|+ 4401223 424444||2303
21229083|NCT05108922|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21229084|NCT05036369|VibrantGastro|Clinical trials manager|+972 046663322|service@vibrantgastro.com|
21229085|NCT02260440|UPMC Hillman Cancer Center|Anuradha Krishnamurthy, MD|412-623-3283|krishnamurthya2@upmc.edu|
21229086|NCT02095223|University of Miami|Christopher Kuenze|5174325018|kuenzech@msu.edu|
21229087|NCT01397162|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21229088|NCT01564914|TRACON Pharmaceuticals|Medical Monitor|8585500780|ctheuer@traconpharma.com|
21229089|NCT02793921|University of Pittsburgh|Dr. Catherine Bender, Principal Investigator|412-624-3594|cbe100@pitt.edu|
21229090|NCT01507298|Imperial College London|Dr. Richard Mark Kwasnicki|07851759471|rmk107@ic.ac.uk|
21229091|NCT03906461|Abbott|Clinical Research Scientist|16517563101|laura.zitellaverbick@abbott.com|
21229092|NCT01920555|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|MFAVA@mgh.harvard.edu|
21229093|NCT04925271|Thomas Jefferson University|Anand Kumar, Associate Professor of Medicine|215-955-8900|anand.kumar@jefferson.edu|
21229094|NCT01795638|University of Cincinnati Medical Center|Barbara Isemann|513-584-5060|barbara.isemann@uchealth.com|
21229095|NCT00611533|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu|
21229096|NCT00745940|Lakehead University|Dr. Michel Bédard|807-343-8630|mbedard@lakeheadu.ca|
21229097|NCT00559936|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana|617-573-3313|cornea_research@meei.harvard.edu|
21229098|NCT01954342|Pennington Biomedical Research Center|Dr. Leanne Redman|2257630947|Leanne.Redman@pbrc.edu|
21229099|NCT00835159|NYU Langone Medical Center|ALEXANDER ZASLAVSKY|212-263-5569|michael.haile@nyumc.org|
21229100|NCT00984568|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21229101|NCT02148107|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21229102|NCT00277446|Northwestern University|Lewis J. Smith|312-503-0501|ljsmith@northwestern.edu|
21229103|NCT01680887|Perelman School of Medicine|Kyle Kampman|215 746 2764|kampman@pennmedicine.upenn.edu|
21229104|NCT02310321|Astellas Pharma Inc.|Clinical Transparency|800-888-7704|astellas.resultsdisclosure@astellas.com|
21229105|NCT04950166|OncoNano Medicine, Inc|Vice President, Clinical Operations|(682) 285-1411|trials@onconanomed.com|
21229106|NCT05896748|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21229107|NCT03207555|The University of Texas MD Anderson|Jan Burger, MD/Professor|713-563-1487|jaburger@mdanderson.org|
21276410|NCT02418455|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
21276411|NCT02445287|Carestream Health, Inc.|Susan Pate, RN, MS, RAC|585-627-6557|susan.pate@carestream.com|
21276412|NCT03235479|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
21229108|NCT01729247|Aerocrine, Inc.|Nancy Herje, BSN, RN, MBA|919-449-8873|Nancy.Herje@aerocrine.com|
21276413|NCT02001051|National Cancer Institute|Dr. Dhaval Patel|301-827-4989|pateldt@nih.gov|
21276414|NCT00779402|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@Dendreon.com|
21229109|NCT00857415|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
21229110|NCT00764504|DJO Surgical|Manager of Clinical Affairs|512-832-9500|jane.jacob@djosurgical.com|6323
21229111|NCT02456103|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
21229112|NCT04795622|Merz Aesthetics|Public Disclosure Manager|+49 69 1503|Aesthetic.Trials@merz.com|1
21229113|NCT01070043|Novartis Pharmaceuticals|Study Director|862 - 778- 8300||
21229114|NCT01610271|Baylor College of Medicine|Rabih Darouiche, MD|713.799.5088|sdself@gmail.com|
21229115|NCT01638819|Sutter Health|Michael Chez, MD|(916) 773-8711|ChezM@sutterhealth.org|
21229116|NCT00979069|Atlanta VAMC|Dr. Joe Nocera|404 321 6111|joe.nocera2@va.gov|6354
21229117|NCT00471146|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21229118|NCT01267656|Bausch Health|Study Director||susan.harris@bauschhealth.com|
21229119|NCT00467610|Rush university medical center|Jamile shammo|312-942-5157|jamile_shammo@rush.edu|
21229120|NCT01385371|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21229121|NCT04398316|Hennepin County Medical Center, Department of Emergency Medicine|Elliott Chinn, DO|612-873-3508|elliott.chinn@hcmed.org|
21229122|NCT02436681|Miromatrix|Head of Clinical Affairs|952.942-6000|mmacenski@miromatrix.com|
21229123|NCT01498601|Fraser Health|Trudy Robertson RN, MSN, CNN(c)|604-520-4715|Trudy.Robertson@fraserhealth.ca|
21229124|NCT02030938|Sofregen|Clinical Project Manager|4029991564|fjawed@sofregen.com|
21229125|NCT01599832|University of Chicago Comprehensive Cancer Center|Walter Stadler|(773) 702-4150|wstadler@medicine.bsd.uchicago.edu|
21229126|NCT05430022|University of Southern California|Dr. Jessica Schwartzman, Assistant Professor|3232075910|jstrendlab@gmail.com|
21229127|NCT05521906|University of Nebraska-Lincoln, Department of Educational Psychology/Interpersonal Violence Research Laboratory|Katie M Edwards, PhD|402-472-2448|katie.edwards@unl.edu|
21229128|NCT05595382|Rutgers University Associate Professor|Dr. Lauren Daniel|856-225-6535|lauren.daniel@rutgers.edu|
21229129|NCT02422940|Acorda Therapeutics|Holy Roberts, Executive Medical Director - Medical Affairs|914-326-5224|hroberts@acorda.com|
21229130|NCT03722173|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21229131|NCT04128579|Equillium, Inc.|Clinical Trial Manager|8582401200|clinicaltrials@equilliumbio.com|
21229132|NCT06624449|University of Cincinnati|Fahad Alanezi|5138845844|alanezfz@mail.uc.edu|
21229133|NCT01828320|University of California, Berkeley|Professor of Clinical Psychology|5104736490|aharvey@berkeley.edu|
21229134|NCT04493333|University of Arkansas for Medical Sciences|I-Shin Wen|5016868274|iwen@uams.edu|24024
21229135|NCT00704912|Penn State College of Medicine, Penn State Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-8478|rsl1@psu.edu|
21229136|NCT02349061|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21229137|NCT02053051|Imperial College London|Prof Nick Oliver|02075941862|nick.oliver@imerial.ac.uk|
21229138|NCT01854658|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
21229139|NCT00426231|Johns Hopkins University|Dhananjay Vaidya|410-6142307|dvaidya1@jhmi.edu|
21229140|NCT02367131|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21229141|NCT02572388|University of Oxford|Adrian V Hill, DPhil FRCP|+44 1865 617610|adrian.hill@ndm.ox.ac.uk|
21229142|NCT01051466|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21229143|NCT02570074|University of Illinois at Chicago|Keith A. Rodvold, PharmD, FCCP, FIDSA|312-996-3341|kar@uic.edu|
21229144|NCT00841971|University of Pittsburgh|Dr Nina Singh|412 360-1688|nis5@pitt.edu|
21229145|NCT05061966|University of Pensylvania|Dr. Jose Bauermeister|215-898-9993|bjose@upenn.edu|
21229146|NCT02923427|DorkuzEU|Anaesthesiology and Intensive Care, Sule Ozbilgin|905055252901|ozbilginsule@gmail.com|
21229147|NCT01325623|Cyberonics Europe BVBA|Wim Van Grunderbeek, Clinical Operations Manager Cyberonics Europe|+32 2 720 95 93|wim.vangrunderbeek@cyberonics.com|312
21229148|NCT01420653|AFT Pharmaceuticals Ltd.|Jennifer Zhang|+ 64 9 488 0232|jenniferz@aftpharm.com|710
21238683|NCT03131960|MicroTransponder Inc.|Study Director|8556289375|studies@microtransponder.com|
21229149|NCT04465162|UT MD Anderson Cancer Center|Dr. Bouthaina S Dabaja, MD-Professor, Radiation Oncology Department|(713) 563-2406|bdabaja@mdanderson.org|
21229150|NCT01539642|AcelRx Pharmaceuticals, Inc|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
21276415|NCT03068949|University of Rochester|Dr. Angela Branche|5852750526|angela_branche@urmc.rochester.edu|
21229151|NCT00598702|Mallinckrodt Pharmaceuticals|Lawrence Hill, VP Clinical Development|908-238-6370|lawrence.hill@mallinckrodt.com|
21229152|NCT02556203|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
21229153|NCT00739999|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21229154|NCT01431131|University of Louisville|Dr. Henry Greenwell, Principal Investigator|502-852-6928|henry.greenwell@louisville.edu|
21229155|NCT01146275|Q-Med AB|Head of Medical Affairs|+46 (0) 18 4749000|reception.SEUPP@galderma.com|
21229156|NCT01359007|University of Oklahoma|Ingrid Block - CTO Directo|405-271-8777|ingrid-block@ouhsc.edu|
21276416|NCT00693225|Mayo Clinic|Dr. Yvonne Romero|507-266-9156|romero.yvonne@mayo.edu|
21229157|NCT02943460|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21229158|NCT04171765|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21229159|NCT03584100|Stanford University|Jeffrey Yao|650-723-5643|jyao@stanford.edu|
21229160|NCT02540226|Hospital for Special Surgery|Dr. Kethy Jules-Elysee|212-606-1206|JulesElyseeK@HSS.EDU|
21229161|NCT00809354|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21229162|NCT03028103|Epizyme|Kemly Calixte|617-500-0608|kcalixte@epizyme.com|
21229163|NCT00783965|ChildrensHRCOakland|Raj Prasad|510-450-7602|rprasad@chori.org|7602
21229164|NCT02781779|Kansas City Heart Rhythm Institute|Donita Atkins|816-651-1969|donita.atkins@hcahealthcare.com|
21229165|NCT04137224|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
21229166|NCT00566501|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
21229167|NCT00749515|St. Jude Children's Research Hospital|Ellis Neufeld, MD, PhD|901-595-7509|ellis.neufeld@stjude.org|
21229168|NCT01368432|Johns Hopkins University & school of Medicine|Vani Rao|410-550-2288|vrao@jhmi.edu|
21229169|NCT01270542|Doheny Eye Institute/USC/University of Iowa|Dr. Elliott Sohn|319-356-3185|elliott-sohn@uiowa.edu|
21229170|NCT00437320|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
21229171|NCT02791594|Abramson Cancer Center|Dr. Michael Farwell|215-662-7750|michael.farwell@pennmedicine.upenn.edu|
21229172|NCT02234986|CASI Pharmaceuticals, Inc.|Dr. Alexander Zukiwski|+1 240 864 2888|alexz@casipharmaceuticals.com|
21229173|NCT01698905|Novartis|Study Director|862-778-8300|novartis.email@novartis.com|
21229174|NCT02448810|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21229175|NCT05708586|University of Michigan|Dr. Noelle Whyte|734 936-5780|whyteno@umich.edu|
21229176|NCT00470847|Dana-Farber Cancer Institute|Nancy Lin, MD|617-632-2335|nlin@partners.org|
21229177|NCT03194503|The Children's Hospital of Philadelphia|Dr. Akira Nishisaki|267-426-0665|NISHISAKI@email.chop.edu|
21229178|NCT04231318|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
21229179|NCT00568685|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21229180|NCT01231230|University of Miami|Adam Wanner, MD|(305)243-2568|awanner@med.miami.edu|
21229181|NCT00542971|The University of MD Anderson Cancer Center|Farhad Ravandi-Kashani, M.D./Associate Professor|713-745-0394|fravandi@mdanderson.org|
21229182|NCT00923936|National Cancer Institute|Dr. Robert Yarchoan|301-496-0328|yarchoanr@pop.nci.nih.gov|
21229183|NCT03538431|Massachusetts General Hospital|Dr. Joseph Biederman|6177261743|biederman@helix.mgh.harvard.edu|
21229184|NCT05394350|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21229185|NCT03530800|University of Chicago|Dr. Jon E. Grant|7738341325|jgrant4@bsd.uchicago.edu|
21229186|NCT01231347|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
21229187|NCT01212107|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21229188|NCT01626495|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
21229189|NCT01945112|Stanford Department of Emergency Medicine|Grant Lipman|415-290-9286|gslipman@stanford.edu|
21229190|NCT01483807|VA SALT LAKE CITY HEALTHCARE SYSTEM|Dr. Julie Wambaugh|8015821565|julie.wambaugh@health.utah.eduj|1363
21229191|NCT02979197|Kitov Pharma Ltd.|J. Paul Waymack, M.D., Chief Medical Officer|(202) 965-2215|paul@kitovpharma.com|
21229192|NCT03643159|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
21229193|NCT03438383|Department of Vascular Surgery, Korgialeneio-Benakeio Hellenic Red Cross Hospital, Athens, Greece|Dr. Konstantinos Roditis, Study Chair|+306976686951|roditis.k@gmail.com|
21229194|NCT01528033|Witten/Herdecke University|Dörthe Seidel|00492219895731|Doerthe.Seidel@uni-wh.de|
21229195|NCT03954132|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
21229196|NCT03170856|Boston Children's Hospital|Dr. William Meehan|781-216-1328|william.meehan@childrens.harvard.edu|
21229197|NCT01414608|NRG Oncology|Linda Gedeon for Wei Deng|716-845-1169|gedeonl@nrgoncology.org|
21229198|NCT05156073|Johns Hopkins University School of Medicine|Dr. Ariel Green|(410) 550-6733|ariel@jhmi.edu|
21229199|NCT00973349|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com|
21229200|NCT03635788|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
21229201|NCT03029702|University of Pittsburgh|Maisa Feghali|412 641 1000|feghalim@upmc.edu|
21229202|NCT02452697|Duke University|Cristina Gasparetto, MD|919-668-1000|cristina.gasparetto@duke.edu|
21260844|NCT02983058|New York State Psychiatric Institute|Marlene Carlson, MPH|646-774-8436|marlene.carlson@nyspi.columbia.edu|
21276417|NCT01315028|University of Glasgow|Professor Andrew Gumley|0044 141 211 3927|andrew.gumley@glasgow.ac.uk|
21260845|NCT00852644|Boston Medical Center|Minh Tam Truong|617-638-7070|minh-tam.truong@bmc.org|
21229203|NCT05098938|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21229204|NCT03803683|Columbia University|Rebecca Schnall, PhD, MPH, RN-BC, FAAN, FACMI|212-342-6886|rb897@cumc.columbia.edu|
21229205|NCT00492050|UT MD Anderson Cancer Center|Sheeba Thomas, MD-Professor, Lymphoma-Myeloma|(713) 792-2860|sthomas@mdanderson.org|
21229206|NCT02791399|VA Portland Health Care System|Benjamin Morasco, PhD|5032208262|benjamin.morasco@va.gov|
21229207|NCT02206048|UT MD Anderson Cancer Center|Dr. Kathleen M. Schmeler, MD|713-745-3518|kschmele@mdanderson.org|
21229208|NCT02925923|University of Alabama at Birmingham|Leah Pogwizd|(205) 996-4410|leahpogwizd@uabmc.edu|
21229209|NCT01262131|Pico-Tesla Magnetic Therapies, LLC|Allen S. Braswell CEO|303 795-3222|abraswell@pico-tesla.com|
21229210|NCT00866788|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21229211|NCT02339285|University of North Carolina at Chapel Hill|Dr. Flavio Frohlich|(919) 966-4584|flavio_frohlich@med.unc.edu|
21229212|NCT00282412|Northwestern University|Dr Richard Burt|312-695-4960|rburt@northwestern.edu|
21229213|NCT03911713|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21229214|NCT00509041|University of Minnesota Masonic Cancer Center|Arkadiusz Dudek, MD, PhD||dudek002@umn.edu|
21229215|NCT00108433|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21229216|NCT02203071|University of Missouri|Research Project Analyst|573-882-7583|jonesvicki@health.missouri.edu|
21229217|NCT01193660|CHA Bundang Medical Center, CHA University|Minyoung Kim, MD, PhD|82-31-780-1872|kmin@cha.ac.kr|
21229218|NCT00195273|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21229219|NCT02595970|Novartis Pharmaceuticals|Study Director|+1(862)778-8300|Novartis.email@novartis.com|
21229220|NCT01886716|Miami University|Dr. Elise Clerkin|513-529-2483|clerkiem@miamioh.edu|
21229221|NCT01012167|Maryland Psychiatric Research Center|William Carpenter, Jr.|410-402-7101|wcarpent@mprc.umaryland.edu|
21229222|NCT00161473|VA Puget Sound Healthcare System|Lucy Y. Wang, M.D.|206-277-5089|wanglucy@u.washington.edu|
21229223|NCT02841189|Indiana University|Nicole Horn MD|317-944-9981|nhorn@iupui.edu|
21229224|NCT00810108|University of California San Diego|Dr. Brookie M. Best, Associate Professor|858-822-5550|brookie@ucsd.edu|
21229225|NCT03326726|Medline Industries|Sr. Regulatory Affairs Specialist|847-643-3515|aminarcik@medline.com|
21229226|NCT02754557|Emory University|Negar Fani, PhD|404-712-0354|nfani@emory.edu|
21229227|NCT00942448|IBSA Institut Biochimique|Barbara Gugliotta|+41 58 360 1000|barbara.gugliotta@ibsa.ch|
21229228|NCT03793556|Sofar Spa|Dr Francesca Baldan|0039 02 909362|francesca.baldan@sofarfarm.it|1
21229229|NCT04416633|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21229230|NCT00785928|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21229231|NCT04066647|Cedars Sinai Medical Center|Kacey Haptonstall|424-315-4489|kacey.haptonstall@cshs.org|
21229232|NCT05021081|Johnson & Johnson Vision Care, Inc. (JJVC)|John R. Buch, O.D., M.S., F.A.A.O.|1-800-843-2020|jbuch@its.jnj.com|
21229233|NCT01461980|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21229234|NCT00122109|VA Pacific Islands Healthcare System|Leslie A. Morland, PsyD, Principal Investigator|(808) 566-1934|leslie.morland@va.gov|
21229235|NCT00100178|Barbara Davis Center for Childhood Diabetes, Health Sciences Center, University of Colorado|Peter Gottleib, MD|303-724-6714|Peter.Gottleib@uchsc.edu|
21229236|NCT01480089|Loyola University|Elizabeth Mueller, M.D.|708-216-2180|emuelle@lumc.edu|
21229237|NCT01439568|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21229238|NCT00149734|University of Colorado Denver|Director, Clinical Research Administration|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
21229239|NCT03161093|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21229240|NCT02657538|Department of Preventive, Restorative and Pediatric Dentistry, University of Bern|PD Dr. Klaus Neuhaus|+41 (0)31 632 49 74|klaus.neuhaus@zmk.unibe.ch|
21229241|NCT02439879|Universidad Popular Autonoma del Estado de Puebla|Dr. Hector Garcia Alcala|+522222299400|hector.garcia@upaep.mx|7466
21229242|NCT02437383|University of North Carolina at Chapel Hill|Dr. Inna E. Tchivileva|1 919 537 3291|inna_tchivileva@unc.edu|
21229243|NCT02409810|The Ohio State University|Judy Opalek Director, Research Administration|6147789696|judy.opalek@osumc.edu|
21229244|NCT00762216|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21229245|NCT01649804|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21229246|NCT03719586|NIAID/NIH|Dr. Richard T. Davey, Jr., M.D., U.S. study PI|301-496-8029|rdavey@niaid.nih.gov|
21229247|NCT01199731|ViiV Healthcare|GSK Response Center|866-435-7343||
21229248|NCT01465191|Columbia University|Richard Smiley, MD|212-342-2742|rms7@cumc.columbia.edu|
21229249|NCT00943124|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21229250|NCT02992132|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
21229251|NCT01289457|The University of Texas M D Anderson Cancer Center|Jabbour,Elias Joseph, M.D./Associate Professor|713-792-4764|CR_Study_Registration@mdanderson.org|
21229252|NCT01687036|Medical University Innsbruck, Department of Internal Medicine III, Cardiology|Markus Stühlinger, MD|+43 512 504|markus.stuehlinger@uki.at|81 320
21229253|NCT00179127|Vanderbilt University Medical Center|Sheila McMorrow|615-343-8332||
21229254|NCT00457366|USC|Dr George Simpson|7604687106|gsimpson@usc.edu|
21229255|NCT01810588|Weill Cornell Medicine|Alexandra Gomez Arteaga, MD|646-962-7950|alg9117@med.cornell.edu|
21229256|NCT00381381|Eisai Korea Inc.|Jihee Mun, Pharmacist, Medical team manager|+82-2-3451-5531|jihee_mun@eisaikorea.com|
21229257|NCT01916967|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21229258|NCT00846287|UMass Medical School|Dr. Mitchell Albert|(807) 684-7270|albertmi@tbh.net|
21229259|NCT03799211|NYU Langone Health|Mia Minen, MD, MPH|212-263-7744|Mia.Minen@nyulangone.org|
21229260|NCT00764491|Spineology|Rose Griffith, Sr. Director, Clinical Affairs|651-256-8503|Rgriffith@spineology.com|
21260846|NCT03109951|International St. Mary's Hospital, Catholic Kwandong University|Myong Ki Baeg|82-10-6391-9010|baegmk@gmail.com|
21260847|NCT00486902|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu|
21276418|NCT01992016|University of Colorado Cancer Center|Elaine Lam, MD|7208480273|elaine.lam@ucdenver.edu|
21229261|NCT00620464|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21229262|NCT02027376|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
21229263|NCT02856698|Hospital Universitario de Canarias|Alberto Dominguez Rodriguez. MD, PhD, FESC|+34 922678000|adrvdg@hotmail.com|
21229264|NCT00932737|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21229265|NCT02949700|Baylor College of Medicine|Dr. Vlad Sandulache|713-798-7218|Vlad.Sandulache@bcm.edu|
21229266|NCT02780609|Moffitt Cancer Center|Taiga Nishihori, MD|813-745-1856|Taiga.Nishihori@moffitt.org|
21229267|NCT02898116|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21229268|NCT03763318|Equillium|Clinical Operations|858-240-1200|clinicaltrials@equilliumbio.com|
21229269|NCT05597020|Idorsia Pharmaceuticals Ltd|Idorsia Clinical Trial Information|+1 856 661 3721|idorsiaclinicaltrials@idorsia.com|
21229270|NCT01015131|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21229271|NCT00560885|AtriCure, Inc.|Jim Lucky|1-513-755-4101|jlucky@atricure.com|
21229272|NCT02887859|Humacyte Inc.|Dr. Shamik Parikh, MD, CMO|919-313-9633|sparikh@humacyte.com|
21260848|NCT02677779|AOU Careggi|Dr. Matteo Monami, Director Diabetic Foot Unit|00390557946563|matteo.monami@unifi.it|
21260849|NCT04178590|Department of Periodontology and Oral Medicine, School of Dental Medicine, University of Belgrade|Dr Mila Vuckovic|+381637060694|jovanovic.dr.mila@gmail.com|
21229273|NCT01554397|UCSD Moores Cancer Center|Dr. Loren Mell|858-246-4071|lmell@health.ucsd.edu|
21229274|NCT03148275|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
21260850|NCT04723537|RedHill Biopharma Ltd.|Gilead Raday, COO|+972-(0)3-541-3131|info@redhillbio.com|
21260851|NCT02432807|Eyevance Pharmaceuticals|Mark Jasek|817-677-6127|mjasek@eyevance.com|
21260852|NCT00089128|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
21260853|NCT02210780|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
21260854|NCT00942409|University of California, San Diego|Januario E Castro, MD|(858) 822-6600|jecastro@ucsd.edu|
21260855|NCT02872103|Generon|Jianmin Chen|7327100262|jianmin_chen@generonbiomed.com|
21260856|NCT01697215|Cleveland Clinic Foundation|Adriano Tonelli, MD|216-444-0812|tonella@ccf.org|
21260857|NCT01929083|Indiana University|Dr. James E Tisdale|317-880-5418|jtisdale@purdue.edu|
21260858|NCT02599402|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
21260859|NCT02945657|Medimetriks Pharmaceuticals, Inc.|Director of Clinical Development|973-882-7512|clinicaltrials.gov_inquiries@medimetriks.com|524
21260860|NCT01591005|University Hospital Ostrava|Prof. David Skoloudik, MD, Ph.D.|+420597375613|skoloudik@hotmail.com|
21260861|NCT01075087|Northwestern University|Gildasio De Oliveira MD,MS|312-472-3573|g-jr@northwestern.edu|
21260862|NCT00087438|Radition Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@gmail.com|
21260863|NCT01486264|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
21260864|NCT00283387|Mayo Clinic|Dr. Dawn S. Milliner|507-284-7431|milliner.dawn@mayo.edu|
21260865|NCT03431012|KCL|Dr D D'Antoni||donatella.d'antoni@kcl.ac.uk|
21260866|NCT05340504|Medical University of South Carolina|James J. Prisciandaro, Ph.D.|843-792-1433|priscian@musc.edu|
21229275|NCT00257608|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21260867|NCT03068715|Stanford University|Dr. Nolan Williams|(650)800-6920|nolanw@stanford.edu|
21229276|NCT03673046|Massachusetts General Hospital, Department of Psychiatry|Director, Center for OCD and Related Disorders|617-724-6146|swilhelm@mgh.harvard.edu|
21260868|NCT03584009|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21229277|NCT03817879|Ambu A/S|Anna Charlotte Lundgaard|+4529643748|aclu@ambu.com|
21229278|NCT03693300|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21229279|NCT00537238|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21260869|NCT00768560|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21229280|NCT00697073|Santhera|Dr Thomas Meier|+41 61 906 8964|thomas.meier@santhera.com|
21229281|NCT03538678|University of Pittsburgh|Kar-Hai Chu|412-692-2578|chuk@pitt.edu|
21229282|NCT00145704|Upstate Orthopedics|Timothy A. Damron|315-464-8602|damront@upstate.edu|
21229283|NCT03265665|University of Illinois at Chicago|Dr. Sharmilee Nyenhuis|3124131655|snyenhui@uic.edu|
21229284|NCT03150160|Novartis Pharmaceuticals|Study Director|1-862-778-8300|novartis.email@novartis.com|
21229285|NCT01845818|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21229286|NCT01680965|Moffitt Cancer Center|Joseph Pidala, M.D., PhD|813-745-2069|Joseph.Pidala@moffitt.org|
21229287|NCT01006369|Rutgers Cancer Institute of New Jersey|Elizabeth Poplin MD|732-235-7620|poplinea@cinj.rutgers.edu|
21276419|NCT01303068|University of New Mexico|Hengameh Raissy|5052725484|hraissy@salud.unm.edu|
21260870|NCT00117312|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
21260871|NCT01021111|Stanford University|Professor Thomas P. Andriacchi|6507238024|tandriac@stanford.edu|
21260872|NCT01535235|Medical College of Wisconsin|Dr. Leslie Cockerham|414-805-0738|lcockerham@mcw.edu|
21229288|NCT00082342|NINDS, NIH|Mark Hallett, MD, Chief|301-496-9526|hallettm@ninds.nih.gov|
21229289|NCT04806503|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21229290|NCT03589469|ADC Therapeutics SA|Clinical Trials Information|954-903-7994|clinical.trials@adctherapeutics.com|954
21229291|NCT02219438|UCSD|Dr Brian Ilfeld|(619) 543-5560|bilfeld@ucsd.edu|
21229292|NCT02006888|IconBioscience|Howard Franklin|2153961332|hfranklin@iconbioscience.com|215
21229293|NCT03089320|Yale University|Dr. David Fiellin|203-737-3347|david.fiellin@yale.edu|
21229294|NCT00231842|Montefiore Medical Center|Mark Einstein, MD, MS|718-405-8082|meinstei@montefiore.org|
21229295|NCT02422303|University of Texas Health Science Center San Antonio|Bonnie Gillis|210-567-4500|gillis@uthscsa.edu|
21229296|NCT00850343|Astellas Pharma Inc.|Medical Director, Global Medical Sciences||ClinicalTrials.Disclosure@astellas.com|
21229297|NCT00639678|GlaxoSmithKline|GSK Response Center|866-435-7343||
21229298|NCT01973569|Contact for Clinical Trial Information|Daiichi Sanyko|+81 362251111 (M-F 9-5 JST)|dsclinicaltrial@daiichisankyo.co.jp|
21229299|NCT00371826|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21229300|NCT02436304|Alcon, A Novartis Division|Clinical Scientific Director, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
21229301|NCT01237821|Penn State Hershey Medical Center|Diane Thiboutot|717-531-1513|dthiboutot@pennstatehealth.psu.edu|
21229302|NCT02710396|Columbia University Herbert Irving Comprehensive Cancer Center|Catherine Shu|212 305 3997|cas2145@cumc.columbia.edu|
21229303|NCT05027464|Veterans Affairs San Francisco HCS|Nicole McCamish|415-221-4810|nicole.mccamish@va.gov|24284
21229304|NCT03764007|University of California, San Francisco|Dr. Thomas A. Hope, MD|(415) 221-4810|Thomas.Hope@ucsf.edu|
21229305|NCT01675427|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21229306|NCT01924988|Georgetown University Medical Center|James B. Spies MD MPH|202-444-3450|spiesj@gunet.georgetown.edu|
21229307|NCT01967433|University of Oklahoma Health Sciences Center and VAMC, Oklahoma City|Salman Nusrat|4052715428|salman-nusrat@ouhsc.edu|
21229308|NCT00369122|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
21229309|NCT01072669|Cleveland Clinic|Dr. Soumya Chatterjee|216-444-9945|chattes@ccf.org|
21229310|NCT00408629|Abbott|Global Medical Services|800-633-9110||
21229311|NCT03633617|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21229312|NCT02477839|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21229313|NCT01578330|Novartis|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21229314|NCT01050543|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21229315|NCT03053271|Millendo Therapeutics|Clinical Trial Information|+1 734 845-9000|millendo@millendo.com|
21229316|NCT00580970|Virginia Commonwealth University/Massey Cancer Center|Mitchell S. Anscher, M.D. Professor and chairman|804-828-7238|mitchell.anscher@vcuhealth.org|
21229317|NCT02654314|Yale Center for Analytical Sciences|Jesse S Reynolds|(203) 785-5445|jesse.reynolds@yale.edu|
21229318|NCT00570765|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
21229319|NCT01669928|Imperial College London|Professor Neil Poulter|+44 20 7594 3446|n.poulter@imperial.ac.uk|
21229320|NCT01631110|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
21229321|NCT00057876|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
21229322|NCT02758171|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21229323|NCT01649609|Columbia University Medical Center|Sumit Mohan, MD|2123053273|sm2206@cumc.columbia.edu|
21229324|NCT02315989|Linkou Chang Gung Memorial Hospital|Hong, Ji-Hong M.D.|03-3281200|jihong@cgmh.org.tw|2600
21229325|NCT04137627|Universitas Indonesia|Dr. dr. Diani Kartini, Sp.B-K(Onk)|+628122684919|d.kartini@gmail.com|
21229326|NCT05085730|UT Southwestern|Research Coordinator|214-645-8907|jennifer.barillas@utsouthwestern.edu|
21229327|NCT05447897|General Internal Medicine, University of Colorado School of|Dr. Gina Kruse, PI|303-724-4811|gina.kruse@cuanschutz.edu|
21229328|NCT04010539|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21229329|NCT02038452|Keele University|Dr Edward Roddy|01782 734715|e.roddy@keele.ac.uk|
21229330|NCT03139279|Department of Anesthesiology, SUNY Downstate Medical Center|Dennis Dimaculangan, MD|718-270-3765|dennis.dimaculangan@downstate.edu|
21229331|NCT02080637|Duke University|Kevin Hill, M.D.|919-668-8305|kevin.hill@duke.edu|
21229332|NCT01565642|University of North Carolina at Chapel Hill|Laura C. Hanson, MD, MPH|919-843-4096|lhanson@med.unc.edu|
21229333|NCT01934972|The Ohio State University|Nicholas Breitborde, PhD|614-685-6052|nicholas.breitborde@osumc.edu|
21229334|NCT01278160|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21229335|NCT03171051|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
21229336|NCT00304239|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
21229337|NCT01631812|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
21229338|NCT02401022|National Institute on Drug Abuse|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov|
21229339|NCT02718300|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21229340|NCT01858376|The Ohio State University|Chandan K. Sen|6142477786|chandan.sen@osumc.edu|
21229341|NCT01854242|University of Florida|David A. Weinstein, MD, MMSc|3522650855|weinsda@peds.ufl.edu|
21229342|NCT02910362|Arizona Eye Consultants|Sean McCafferty, MD|(520) 791-7401|sjmccafferty66@hotmail.com|
21229343|NCT03894046|Entasis Therapeutics|Dr. David Altarac - Chief Medical Officer|+1 781 810 0120|david.altarac@entasistx.com|
21229344|NCT00809848|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21229345|NCT02202837|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21229346|NCT01601860|University of São Paulo|Dra. Alessandra Cristina Marcolin|+55(16)36022813|dralemar@uol.com.br|
21229347|NCT01137396|Yale University|Peter Morgan|203-974-7560|peter.morgan@yale.edu|
21229348|NCT01890746|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
21229349|NCT02059902|Health Partners|Dr. William J Mohr|(651)454-5304|William.J.Mohr@healthpartners.com|
21229350|NCT03257371|University of Missouri|Dr. James Cook|573-882-7189|cookjl@health.missouri.edu|
21229351|NCT00365144|UCaliforniaSF|Andrew Ko, MD|415-353-9888|andrewko@medicine.ucsf.edu|
21229352|NCT01031706|University of North Carolina at Chapel Hill|Dr. Scott H. Donaldson|919-966-9198|scott_donaldson@med.unc.edu|
21229353|NCT02124161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21229354|NCT02517866|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21229355|NCT03114488|University of Minnesota|Elias Boroda|763-498-4176|borod002@umn.edu|
21229356|NCT01436006|Università di Palermo|Sergio Salerno|00390916552315|sergio.salerno@unipa.it|2315
21229357|NCT03711266|Michigan Medicine|Rebecca Sripada|734-222-7432|rekaufma@med.umich.edu|
21229358|NCT03387683|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
21229359|NCT01646073|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21229360|NCT04558281|University of California San Diego|Brian Ilfeld, MD, MS|(858) 822-0776|bilfeld@health.ucsd.edu|
21229361|NCT01393301|Massachusetts General Hospital|Dr. Conall O'Cleirigh, PI|(617) 643-0385|cocleirigh@mgh.harvard.edu|
21229362|NCT00853073|Wills Eye Hospital|Marlene R. Moster, MD|215-928-3123|marlenemoster@gmail.com|
21229363|NCT01999114|Purdue Pharma L.P.|Clinical Leader|800-733-1333|stephen.harris@pharma.com|
21229364|NCT03342963|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21229365|NCT01008150|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|judy.langer@nsabp.org|
21229366|NCT01309165|Sunnybrook Research Institute|Dr. Sara McEwen|4162266780|sara.mcewen@sunnybrook.ca|7957
21229367|NCT01497275|Duke University Medical Center|Anne Beaven, MD|919-668-1211|anne.beaven@duke.edu|
21229368|NCT01950169|Department of Geriatric Medicine, Karolinska University Hospital, Stockholm, Sweden|Dr. Lena Flodin|Mobile: 0701910300|lena.flodin@sll.se|
21229369|NCT01938573|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
21229370|NCT03420625|Karolinska University Hospital|Dr. Paul Ackermann|+46 8 517 700 00|paul.ackermann@sll.se|717 34
21229371|NCT02617888|Ft. Belvoir Community Hospital|Michael K. Cheezum, MD|571-231-2159|Michael.k.cheezum.mil@mail.mil|
21229372|NCT01739309|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21229373|NCT04553679|University of Southern California|Marika Demers, PhD, OT, post-doctoral research fellow|13234421196|demers@pt.usc.edu|
21260873|NCT01588821|Massachusetts General Hospital|Rebecca Suk Heist, MD|617-724-4000|rheist@partners.org|
21229374|NCT00178633|University of Texas Medical School at Houston|Heinrich Taegtmeyer, MD, DPhil, Principal Investigator|713 500-6569|heinrich.taegtmeyer@uth.tmc.edu|
21229375|NCT03845543|iD3 Medical|Clinical Research Professional|+32 (0)52252745|office@iD3medical.com|
21288996|NCT02810327|Medical University of South Carolina|Kimberly Brown Foil|843-792-6474|foilk@musc.edu|
21288997|NCT02143778|Exalenz Bisocience|Clinical Trial Manager|97289737500|avrahamh@exalenz.com|
21229376|NCT04242173|Moffitt Cancer Center|Christine Chung|1-813-745-5061|Christine.Chung@moffitt.org|
21229377|NCT03649867|NHS Tayside - Dundee Adult Psychological Therapies Service|Dr Lucie Bartoskova|00441382346556|lucie.bartoskova@nhs.net|
21229378|NCT02028871|University of Illinois at Chicago|Dr. Ajna Hamidovic|312-355-1713|ahamidov@uic.edu|
21229379|NCT02907268|ICLS|Shantel Demay|905-842-2262|s.demay@icls.ca|
21229380|NCT02633501|Guerbet|Jing Hao, MD, Global Head of Medical Affairs & Clinical Development|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
21229381|NCT02759354|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21229382|NCT01104155|Eisai Inc.|Eisai Medical Information|1-888-422-4743|esi_oncmedinfo@eisai.com|
21229383|NCT00975637|Valeant Pharmaceuticals|Director of Clinical Trials|908|binu.alexander@valeant.com|
21229384|NCT01484132|New England Research Institutes|Felicia Trachtenberg, Principal Research Scientist|617-972-3120|ftrachtenberg@neriscience.com|
21229385|NCT01912963|Dana-Farber Cancer Institute|Rachel Freeman MD|617.632.3000|Rachel_Freedman@dfci.harvard.edu|
21229386|NCT00390234|Princess Margaret Hospital|Dr. Amit Oza|416-946-2818|amit.oza@uhn.ca|
21229387|NCT02787551|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21229388|NCT01336569|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Medical Affairs Leader, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
21288998|NCT03637374|Johns Hopkins University|Dr. James H. Black, III|(410) 955-5165|jhblack@jhmi.edu|
21288999|NCT03759184|National Cancer Institute|Dr. Kevin Conlon|240-858-3570|conlonkc@mail.nih.gov|
21289000|NCT00565864|Oregon Health & Science University|Dr. Mary Samuels|5034945242|samuelsm@ohsu.edu|
21289001|NCT02403271|Pharmacyclics LLC, An AbbVie Company|Thorsten Graef|(408) 215-3127|tgraef@pcyc.com|
21289002|NCT05561140|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21289003|NCT05955378|Shirley Ryan AbilityLab|Arun Jayaraman|312-238-6875|ajayaraman@sralab.org|
21289004|NCT01188447|Ottawa Hospital Research Institute|Dr. Christian Vaillancourt|613-798-5555|cvaillancourt@ohri.ca|17012
21289005|NCT03301714|Kornber School of Dentistry|Dr. Marisol Tellez Merchan|2177071773|marisol@temple.edu|
21289006|NCT02522845|Imperial College London|Mr Roshan Bootun|+442033117335|r.bootun@imperial.ac.uk|
21289007|NCT02112552|Albert Einstein College of Medicine - Montefiore Medical center|Dr. Jessica Atrio, Professor, Department of Obstetrics & Gynecology and Women's Health|917-721-6155|jatrio@montefiore.org|
21289008|NCT04285411|Vital USA Inc.|Mark H Khachaturian, PhD|+1(561)282-6074|mark.khachaturian@vvvital.com|
21289009|NCT00825175|University of Michigan|Julia Looper|253 534 8499|jlooper@umich.edu|
21289010|NCT04822194|Rice University|Bryan Denny|713-348-8257|bryan.denny@rice.edu|
21289011|NCT00248547|Oregon Health & Science University, Knight Cancer Institute|Joseph Bubalo, PharmD|503-494-1054|bubaloj@ohsu.edu|
21289012|NCT00118287|Fred Hutchinson Cancer Research Center|Bart Scott|206-667-1990|bscott@fredhutch.org|
21289013|NCT03976375|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21289014|NCT03091439|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21289015|NCT03122106|Washington University School of Medicine|William Gillanders, M.D.|314-747-0072|gillandersw@wustl.edu|
21289016|NCT00640289|Children's Hospital of Orange County|Clinical Trial Coordinator||KBirschbach@choc.org|
21289017|NCT03550209|Nationwide Children's Hospital|Dr. Sarah Keim|1-800-792-8401|sarah.keim@nationwidechildrens.org|52849
21289018|NCT01590875|Medical College of Wisconsin|Marcie Berger, MD|414-955-6806|mgberger@mcw.edu|
21289019|NCT02347787|University of Pennsylvania School of Medicine|Lindsey Norton|215-573-9961|lindsey.turr@uphs.upenn.edu|
21289020|NCT00306488|National Eye Institute|Wai Wong, MD, PhD|301-496-7566|wongw@mail.nih.gov|
21289021|NCT03244189|Duke University|Charles D. Scales Jr, MD MSHS FACS|919-684-1999|chuck.scales@duke.edu|
21289022|NCT04253626|Stanford University|Deirdre J. Lyell, MD|(650) 498-4069|dlyell@stanford.edu|
21289023|NCT03599713|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21289024|NCT06400914|CooperVision, Inc.|Jose A. Vega, OD, MSc, FAAO|925-621-3761|javega@coopervision.com|
21289025|NCT06937346|Karaganda Medical University|Amirbekova Mariyam Sayatovna|+77472224951|Amirbekova31081998@gmail.com|
21289026|NCT02850406|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21229389|NCT02963935|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21289027|NCT05578872|Anaveon AG|Medical Director, MD|+41615218383|anaveonclinicaltrials@anaveon.com|
21289028|NCT00363168|Johns Hopkins University|Neil M. Bressler|410-955-8342|nbressler@jhmi.edu|
21289029|NCT04795323|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
21289030|NCT01479530|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
21289031|NCT02836769|Sunnybrook Research Institute|Dr. Sara McEwen|416-226-6780|sara.mcewen@sunnybrook.ca|7957
21289032|NCT01119222|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21289033|NCT00585650|Wake Forest Baptist Health, Department of Dermatology|Steven Feldman, MD, PhD|336-716-3775|sfeldman@wakehealth.edu|
21229390|NCT02337738|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21229391|NCT03911154|University of Pennsylvania|Dr. David Dinges|215-898-9665|dinges@pennmedicine.upenn.edu|
21229392|NCT00406354|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21229393|NCT05055453|Sonova|Jean Anne Schnittker, Research Audiologist|+41 58 928 01 01|jeananne.schnittker@sonova.com|
21289034|NCT03142750|Children's Hospital Colorado|Pediatric Surgery Research Fellow|720-777-5371|youngmeeyoungmee@gmail.com|
21289035|NCT02120079|Tufts Medical Center|Dr. Pedram Hamrah|617-636-5321|phamrah@tuftsmedicalcenter.org|
21289036|NCT00303628|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
21289037|NCT04925934|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21289038|NCT03158688|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21229394|NCT01224665|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|ctangen@fredhutch.org|
21229395|NCT00725504|Stanford University|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@pain.stanford.edu|
21229396|NCT00292318|Greater Los Angeles VA Medical Center|Felix W. Leung, MD|818-891-7711|felix.leung@va.gov|9403
21229397|NCT01822496|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21229398|NCT01881373|University of Hawaii|Rachel Novotny|808-956-3848|novotny@hawaii.edu|
21289039|NCT03144635|Kyushu University Hospital|Dr. Eiichi Ogawa / Assistant Professor|81926425909|eogawa@gim.med.kyushu-u.ac.jp|
21289040|NCT00933166|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
21289041|NCT06069609|Bausch & Lomb|Jeffery Schafer, OD, MS Director, Clinical Research|585-338-5664|jeffery.schafer@bausch.com|
21289042|NCT02948400|University of Alabama at Birmingham|David Schwebel|205-934-8745|schwebel@uab.edu|
21289043|NCT03925220|Tufts University|Dr. Margie Skeer|8579191262|margie.skeer@tufts.edu|
21289044|NCT05774977|University of Pennsylvania Perelman School of Medicine|Dr. Mathias Basner, MD, PhD, MScEpi|215-573-5866|basner@pennmedicine.upenn.edu|
21289045|NCT02317549|Leading BioSciences|Tom Hallam, PhD, MBA|631-739-3088|tom.hallam@leadingbiosciences.com|
21289046|NCT03349515|Medical University of South Carolina|Dr. Michelle Rovner|843-792-2322|rovner@musc.edu|
21289047|NCT04055519|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21289048|NCT01403584|Universitätsklinik, Essen|Prof. Helmut Teschler|0201 433 4001|teschlerh@t-online.de|
21289049|NCT02503865|Republican Scientific Center for Emergency care at Nazarbayev University|Dr. Kuat Oshakbayev|+77013999141|okp.kuat@mail.ru|
21229399|NCT00772304|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21229400|NCT02906332|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
21229401|NCT02046902|Saint Luke's Mid America Heart Institute|Carole Decker|(816) 932-5440|c1decker@saint-lukes.org|
21229402|NCT03945266|Pennsylvania State University|Dr. Abigail Pauley|814-863-7354|amp34@psu.edu|
21229403|NCT01532973|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21229404|NCT03242824|Mayo Clinic|Nadia N. Laack, MD, MS|507/284-2511|Laack.Nadia@mayo.edu|
21229405|NCT06033521|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21229406|NCT02130024|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21229407|NCT02024555|Vanderbilt University Medical Center|Wonder Drake, MD|(615) 322-2035|wonder.drake@vumc.org|
21238684|NCT04708223|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
21238685|NCT01849263|Washington University School of Medicine|Nancy L. Bartlett, M.D.||nbartlet@dom.wustl.edu|
21276420|NCT03585959|Medtronic|Katie Bayliss|(763) 647-5547|katie.j.bayliss@medtronic.com|
21238686|NCT04359784|Fred Hutchinson Cancer Center|Jordan Gauthier|206-667-2713|jgauthier@fredhutch.org|
21238687|NCT04130802|Oculis SA|Chief Development Officer|0041 21 711 39 70|info@oculis.com|
21276421|NCT02531594|Cincinnati Children's Hospital Medical Center|Dr. Melinda Mahabee-Gittens|513-636-7966|melinda.mahabee-gittens@cchmc.org|
21276422|NCT03636386|Universidad Andrés Bello|Professor Hernán Andrés de la Barra Ortiz|+56984706322|quiropraxiayequilibrio@gmail.com|
21276423|NCT01201486|StavangerUH|Torbjørn Moe Eggebø, phd|004792699433|tme@lyse.net|
21276424|NCT01903564|University of Wisconsin-Madison|Ronald Wakai, Ph.D.|6082654988|rtwakai@wisc.edu|
21276425|NCT03904550|UT Southwestern Medical Center|Tiffany Moon, MD|(214) 648-6400|tiffany.moon@utsouthwestern.edu|
21276426|NCT01557920|Massachusetts General Hospital|Dr. Matthias Eikermann|6176434408|meikermann@partners.org|
21276427|NCT00981227|Bial-Portela & Cª, S.A.|Head of Clinical Research Section|+351 22 986 6100|clinical.trials@bial.com|
21276428|NCT01808248|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21276429|NCT02690935|ECSOR|Dr. Stephane Heijmans|3267444093|Jacques.Bruhwyler@ecsor.com|
21276430|NCT02994290|Yale University|Dr. Sangini Sheth|203-785-5545|Sangini.Sheth@yale.edu|
21276431|NCT00496262|CSL Behring|Program Director, Clinical R&D|Use email contact.|clinicaltrials@cslbehring.com|
21276432|NCT01216410|Duke University Medical Center|Ashraf Habib|919 668 6266|habib001@dm.duke.edu|
21276433|NCT01334957|Cumberland Pharmaceuticals Inc.|Dr. Amy Rock|615-255-0068|arock@cumberlandpharma.com|
21276434|NCT00559364|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
21276435|NCT04126343|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21276436|NCT00136760|Brown University|Jennifer Tidey, Ph.D.|401-863-6418|Jennifer_Tidey@brown.edu|
21276437|NCT01857973|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
21276438|NCT00908882|Eastern Colorado Health Care System|Catherine Battaglia PhD RN|720-857-5099|catherine.battaglia@va.gov|
21276439|NCT01701973|Vanderbilt University Medical Center|Dr. Jessica Devin|6159361665|jessica.devin@vanderbilt.edu|
21276440|NCT04458467|UC San Diego|John Finneran|(619) 543-2202|jfinneran@health.ucsd.edu|
21276441|NCT00597428|Sucampo Pharma Americas, LLC|VP, Clinical Development|301-961-3400|info@sucampo.com|
21276442|NCT02412722|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21276443|NCT03073811|Durham VA Health Care System|Kathryn Starr, PhD, RD; Research Health Scientist|919-660-7571|kathryn.starr2@va.gov|
21276444|NCT00551616|HRA Pharma|Henri Mathé|+33140331130|medical2914@hra-pharma.com|
21276445|NCT02692482|Istituto Ortopedico Rizzoli|Cristiana Forni|0516366694|cristiana.forni@ior.it|0039
21276446|NCT00105157|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21276447|NCT03689894|Dartmouth Hitchcock Medical Center|Director of Clinical Research|2167129120|sean.hobson@hitchcock.org|
21276448|NCT00709306|Fox Chase Cancer Center|Carolyn Heckman, PhD|215-214-3962|carolyn.heckman@fccc.edu|
21276449|NCT01610063|Mayo Clinic|Dr. Daniel K. Hall-Flavin|507-255-4151|flavin.daniel@mayo.edu|
21276450|NCT01393457|The University of Texas Health Science Center at Houston|Charles Green, PhD|713-500-6402|charles.green@uth.tmc.edu|
21276451|NCT04405739|Ridgeback Biotherapeutics|Wendy Painter, MD, MPH|786-687-2495|EIDD2801@ridgebackbio.com|
21276452|NCT01378962|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21276453|NCT02056652|University of Pennsylvania|Bridget Nolan|2156623324|bridget.nolan@uphs.upenn.edu|
21276454|NCT02248662|Dana-Farber Cancer Institute|Rinaa Punglia, MD|617-582-8759|rinaa_punglia@dfci.harvard.edu|
21276455|NCT01835548|Neos Tx|Carolyn Sikes, PhD|972-408-1300|csikes@neostx.com|1255
21276456|NCT01634854|Vanderbilt University Medical Center|Angela Wilson-Liverman CNM||angela.wilson-liverman@vanderbilt.edu|
21276457|NCT00987831|Oklahoma Medical Research Foundation|Joan T Merrill, M.D|405-271-7805|JTMmail@aol.com|
21276458|NCT03253094|SCYNEXIS|Dr. David Angulo|(201) 884 - 5471|david.angulo@scynexis.com|
21276459|NCT02219308|University of California, San Diego|Dr. Sheila Mody|858-249-1205|smody@ucsd.edu|
21276460|NCT00824369|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21276461|NCT00442546|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21276462|NCT00392782|Masonic Cancer Center, University of Minnesota|Daniel Weisdorf, M.D.|612-624-0123|weisd001@umn.edu|
21276463|NCT00101413|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21276464|NCT01557582|VentriPoint, Inc.|Jim bodtke, Vice President Clinical Affairs and Development|206-283-0221|jbodtke@ventripoint.com|
21276465|NCT02843659|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21276466|NCT03203642|Kadmon, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
21289050|NCT05073315|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21238688|NCT02063828|Wake Forest NCORP Research Base|Emily Dressler, PhD|336 716-0891|ncorp@wakehealth.edu|
21289051|NCT01529268|Johns Hopkins Data Coordinating Center|Laura Wilson|410-955-0719|lwilson9@jhu.edu|
21276467|NCT02413294|University of Michigan|Dr. Amanda Leggett|734-232-0538|leggetta@med.umich.edu|
21276468|NCT00548431|Rigshospitalet, Juliane Marie Centret|Thomas Frandsen|+45 35458364|thomas.leth.frandsen@rh.regionh.dk|
21276469|NCT03169816|New York State Psychiatric Institute|Frances R Levin, MD|6467746137|frl2@columbia.edu|
21276470|NCT04149535|Boston Scientific|Sarah Zanon - Director Clinical Trials, Interventional Cardiology|+41798407006|sarah.zanon@bsci.com|
21276471|NCT02175368|Ivoclar Vivadent AG|Dr. Erik Braziulis||erik.braziulis@ivoclarvivadent.com|
21276472|NCT02875028|Medical University of Vienna|Bernd Jilma|+4314040029910|bernd.jilma@meduniwien.ac.at|
21276473|NCT05068284|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21276474|NCT00109837|SWOG Statistical Office|SWOG Leukemia Statistician|206-667-4408||
21276475|NCT02717078|University of Minnesota|Anne Bantle|612-625-8673|endofixer@umn.edu|
21229408|NCT05736224|Yale University Department of Dermatology|Kacie Carlson, Physician Assistant|203 785 7432|Kacie.carlson@yale.edu|
21276476|NCT02012452|VA Boston healthcare system|Sandra Japuntich|6082398018|sjjapuntich@gmail.com|
21276477|NCT02190279|National Cancer Institute|Dr. Maria Liza Lindenberg|240-760-6109|liza.lindenberg@nih.gov|
21276478|NCT04403399|U of Michigan|Dr. Cathie Spino, Research Professor of Biostatistics|7346155469|spino@umich.edu|
21276479|NCT00802178|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21276480|NCT01606228|Janssen China|Medical Affairs Director, CNS, Asia Pacific|8610 5821 8766||
21229409|NCT04526509|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21229410|NCT03806491|University of Missouri|Dr. Mary Beth Miller|573-882-1813|millmary@health.missouri.edu|
21229411|NCT03950791|Stanford University School of Medicine|Maisa Ziadni, PhD|(650) 724-9143|mzaidni@stanford.edu|
21229412|NCT01896050|University of Michigan Comprehensive Cancer Center|Norah Lynn Henry, MD|734-936-4991|norahh@med.umich.edu|
21229413|NCT02614092|VISN 21 MIRECC, VA Palo Alto Health Care System|Dr. Kaci Fairchild|6504935000|jenniferkaci.fairchild@va.gov|63432
21229414|NCT00392015|United States Military Malaria Vaccine Program Naval Medical Research Center|Dr. Judith Epstein|301-252-9026|judith.epstein@med.navy.mil|
21229415|NCT02742441|Therapeutics, Inc.|Clinical Research, Therapeutics, Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com|
21229416|NCT01182610|Accelerated Community Oncology Research Network, Inc.|Vice Presidnet of Scientific Affairs||mwalker@acorncro.com|
21229417|NCT01824342|Amgen Inc.|Study Director|866-572-6436||
21229418|NCT02160990|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
21229419|NCT04195906|Sanifit Therapeutics S. A.|Peter Szecsödy|+41588529079|clinicaltrials@cslbehring.com|
21229420|NCT02486302|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21229421|NCT01871142|Colorado State University|Christopher Bell, Ph.D.|(970) 491-7522|christopher.bell@colostate.edu|
21229422|NCT03485391|Ralph H. Johnson VA Health Care System|Stephanie Hart|843-577-5011|Stephanie.Hart4@va.gov|205103
21229423|NCT00734474|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21229424|NCT02104752|VA Greater Los Angeles Healthcare System/UCLA|Jonathan K. Wynn, Ph.D.|(310) 478-3711|jkwynn@ucla.edu|44957
21229425|NCT02899299|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
21229426|NCT03481907|George Washington University|Dr. Adam Friedman|214 235 7381|ajfriedman@mfa.gwu.edu|
21229427|NCT00313300|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21229428|NCT00428792|Novartis Pharmaceuticals|Study Director|862 778-8300||
21229429|NCT04612790|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21229430|NCT04644003|STALICLA SA|Eric Painbeni, PhD - Head of Clinical Operations|+41 (0)79 918 33 16|clinical@stalicla.com|
21229431|NCT03615326|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21229432|NCT01348607|SunCoast CCOP Research Base|Cristina Burroughs, Clinical Research Administrator|(813) 396-9237|Cristina.Burroughs@epi.usf.edu|
21229433|NCT03572244|University of Iowa|Dr. Chris Barwacz|3193843002|chris-barwacz@uiowa.edu|
21229434|NCT02239354|ViaCyte|Corporate Communications|858-207-0500|info@viacyte.com|
21229435|NCT01892267|Johns Hopkins Hospital|Dr. Mouen Khashab|443-287-1960|mkhasha1@jhmi.edu|
21229436|NCT04172623|Yale School of Medicine|Krysten Bold, PhD|2039747603|krysten.bold@yale.edu|
21229437|NCT02651467|GlaxoSmithKline|GSK Response Center|866-435-7343||
21229438|NCT00004635|National Cancer Institute, National Institutes of Health|William L. Dahut, M.D.|301-435-8183|dahutw@mail.nih.gov|
21229439|NCT00191906|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21229440|NCT00573937|Mayo Clinic|Donald Northfelt, MD|480-301-8335|northfelt.donald@mayo.edu|
21229441|NCT00333801|Tuscaloosa VA Medical Center|Lori Davis, MD|205-554-3819|lori.davis@va.gov|
21229442|NCT00777205|Veterans Affairs Healthcare System|Marcia Valenstein, MD|734-845-3649|marcia.valenstein@va.gov|
21229443|NCT02268955|Maricopa Integrated Health System|Dan Quan, DO|602-344-5058|dany_quan@dmgaz.org|
21229444|NCT00631696|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21238689|NCT02753595|Eisai, Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21238690|NCT02453581|Qeensland Institute of Medical Research|Dr James McCarthy|+61 7 3845 3796|James.McCarthy@qimr.edu.au|
21238691|NCT01064297|GlaxoSmithKline|GSK Response Center|866-435-7343||
21238692|NCT01091948|Cleveland Clinic Foundation|Dr. Basem Abdelmalak|216-444-3746|abdelmb@ccf.org|
21276481|NCT00831233|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
21289052|NCT00303953|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623|mleblanc@fhcrc.org|
21238693|NCT00504426|Headwuarters of New Product Evaluation and Development, Otsuka Pharmaceutical Co., Ltd.|IMAOKA, Kyoji, Operatin Officer, Gemeral Manager|+81-3-6361-7366||
21276482|NCT00784134|Johns Hopkins University Division of Brain Injury Outcomes|Dr. Daniel F. Hanley|4106146996|dhanley@jhmi.edu|
21289053|NCT00021255|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21276483|NCT03785145|Medytox Inc.|Young Ryu|+82-2-6901-5424|aab005@medytox.com|
21276484|NCT02211014|Acerta Pharma B.V.|Acerta Clinical Trials|1-888-292-9613|acertamc@dlss.com|
21276485|NCT00097786|Novartis Pharmaceuticals|Study Director|862 778-8300||
21276486|NCT02265341|Mayo Clinic|Mitesh J. Borad, MD|480/301-8335|Borad.Mitesh@mayo.edu|
21276487|NCT02443324|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21276488|NCT01647711|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21276489|NCT01316419|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21276490|NCT05918822|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21276491|NCT02451150|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
21276492|NCT03404401|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
21276493|NCT02948257|Cardiva Medical|Terry Alverson, Director of Regulatory and Clinical|408-470-7119|Terry_Alverson@cardivamedical.com|
21276494|NCT00988208|Celgene Corporation|Senior Manager , Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21276495|NCT01796964|Alcon Research, Ltd.|Clinical Project Group Lead, GCRA, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
21229445|NCT01134731|UAB|Dr. Richard Shelton|205-934-2484|rshelton@uab.edu|
21229446|NCT05095454|Mayo Clinic|Tyson Scrabeck|507-538-1016|scrabeck.tyson@mayo.edu|
21229447|NCT00679055|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21229448|NCT00629772|Innovaderm Research|Annie Levesque|514 521 4285|alevesque@innovaderm.ca|222
21229449|NCT03840174|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21229450|NCT02410551|UT MD Anderson Cancer Center|Popat,Uday,M.D. / Stem Cell Transplantation|713-792-8750|upopat@mdanderson.org|
21229451|NCT05012657|Point Designs|Director of Clinical Research|7206004753|research@pointdesigns.com|
21229452|NCT03789214|The Johns Hopkins University School of Medicine|Andrew S. Huhn, Ph.D.|410-550-1971|ahuhn1@jhu.edu|
21229453|NCT01349231|Yale University, Connecticut Mental Health Center|Dr. Michael Bloch, MD, MS|203-737-4809|michael.bloch@yale.edu|
21229454|NCT00590460|BAYLOR|Malcolm Brenner, MD|832-824-4663|mbrenner@bcm.edu|
21229455|NCT03139318|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|bscanlan@uams.edu|
21229456|NCT01069627|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21229457|NCT04209348|The University of Tennessee, Knoxville|Dr. Samantha Ehrlich|510 299 8747|sehrlic1@utk.edu|
21229458|NCT02396251|Galderma|Reception|+46184749000|reception.seupp@galderma.com|
21229459|NCT00240227|VA Puget Sound Health Care System|Andrew J. Saxon, M.D.|206-764-2782|andrew.saxon@va.gov|
21229460|NCT02617784|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21229461|NCT02149875|Shanghai Sixth People's Hospital|Dr. Hao Chen|02164369181|chenhao_316@aliyun.com|8405
21276496|NCT04025684|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21229462|NCT04102956|Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.|Xiaoyun Liu PhD|+8613191887318|audrey-l@163.com|
21229463|NCT01209923|University of Southern California|Edward Schroeder|323-442-2498|eschroed@usc.edu|
21229464|NCT02955797|Sanofi Pasteur Inc.|Medical Director|800-633-1610|Contact-US@sanofi.com|1#
21229465|NCT03131453|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21229466|NCT02081183|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21229467|NCT00543543|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21229468|NCT04308304|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21229469|NCT00945555|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21229470|NCT00834678|The Ohio State University Comprehensive Cancer Center|Rachel Layman, MD|614-366-8541|Rachel.Layman@osumc.edu|
21229471|NCT04502979|University of North Carolina at Chapel Hill|Eric A Hodges, PhD, FNC-BC, FAAN|919-966-0534|eahodges@email.unc.edu|
21229472|NCT03318900|M D Anderson Cancer Center|Amir A. Jazaeri, MD|713-792-2921|aajazaeri@mdanderson.org|
21229473|NCT00165984|Emory University|Paul Kirshbom|404-785-6330|pkirshb@emory.edu|
21229474|NCT01686828|University of Washington|Dr. Katya Rubinow|206-7543-3470|rubinow@uw.edu|
21229475|NCT01736124|James J. Peters Veterans Affairs Medical Center|Dr. Jeremy Silverman|718-584-9000|jeremy.silverman@va.gov; jeremy.silverman@mssm.edu|1700
21229476|NCT02734433|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21229477|NCT03698331|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
21229478|NCT04432272|Beaumont Hospitals|Matthew Sims, MD|248-551-0027|matthew.sims@beaumont.org|
21229479|NCT03772678|Arch Biopartners Inc.|Richard Muruve|(647) 428-7031|info@archbiopartners.com|
21229480|NCT03448653|Centre Hospitalier Départemental Vendée|Dr. Vincent MACE|0251446572|vincent.mace@ght85.fr|+33
21229481|NCT02719327|Madison Veterans Affairs Geriatrics Research, Education & Clinical Center (GRECC)|Cynthia Carlsson, MD, MS; Professor of Medicine (Geriatrics)|608-280-7000|cynthia.carlsson@va.gov|
21229482|NCT02875132|The Chinese University of Hong Kong|Dr. Herbert Ho Fung LOONG|35052166|h_loong@clo.cuhk.edu.hk|
21229483|NCT04176497|UNC Lineberger Comprehensive Cancer Center|Melahat Canter|919-966-4432|Melahat_Canter@med.unc.edu|
21229484|NCT04063384|University of Texas at Austin|Dr. Elizabeth Lippard|512-495-5216|elizabeth.lippard@austin.utexas.edu|
21229485|NCT03789396|University of Colorado|Adit Ginde, MD, MPH|720-848-6777|ADIT.GINDE@CUANSCHUTZ.EDU|
21229486|NCT02022020|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21229487|NCT01926015|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21229488|NCT01364649|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21229489|NCT01191333|Director, VISN21 MIRECC, Department of Veterans Affairs|Jerome Yesavage, MD|650-852-3287|Jerome.Yesavage@va.gov|
21229490|NCT02468232|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
21229491|NCT01826604|Saint Louis University|Dr. Katherine M. Scolari Childress|314-977-2090|scolarik@slu.edu|
21229492|NCT03423641|Kaiser Permanente|Elizabeth McGlynn, Ph.D.|6265643807|Elizabeth.A.Mcglynn@kp.org|
21229493|NCT04540497|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21229494|NCT05274815|AstraZeneca|Global Clinical Lead|8772409479|information.center@astrazeneca.com|
21229495|NCT06132659|University of Michigan|Dr. Stefanie Russman Block|734-232-0373|srblo@umich.edu|
21229496|NCT03914326|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21229497|NCT04798781|Cedars-Sinai Medical Center|Andrew Hendifar, MD, MPH|3104232217|andrew.hendifar@cshs.org|
21229498|NCT04046055|University of Iowa|Dr. Craig D. Workman|319-467-0746|craig-workman@uiowa.edu|
21229499|NCT02607930|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21229500|NCT01784848|HCor|Dr Carlos Schiavon|1130536611|schiavon.ca@gmail.com|8201
21229501|NCT03198078|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21229502|NCT01676727|Medtronic Bakken Research Center|Maarten Hollander|+31620534428|Maarten.Hollander@medtronic.com|
21229503|NCT03140254|Becton Dickinson|Erin Zook|201-847-5351|erin.zook@bd.com|
21229504|NCT00722423|VA San Diego Healthcare System|Dr. Samuel B. Ho|8586423280|Samuel.Ho2@va.gov|
21229505|NCT04040244|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-716-4760|jkettler@wakehealth.edu|
21229506|NCT05143541|Kantonsspital St. Gallen|Dr. André E. Dutly|071 494 9944|andre.dutly@kssg.ch|
21229507|NCT00737438|Memorial Sloan Kettering Cancer Center|Dr. David Ilson|646-888-4183|ilsond@mskcc.org|
21229508|NCT05469113|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21229509|NCT04926077|Philips|Bill Hardy|412-874-2710|bill.hardy@philips.com|
21229510|NCT03755791|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
21229511|NCT01986140|Baylor College of Medicine|Tao Wang|7137985388|taow@bcm.edu|
21229512|NCT03616171|Emory University|Ashley Coombe, PhD|404-712-9313|ashley.coombe@emory.edu|
21229513|NCT01833546|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21229514|NCT00464269|UCB|Clinical Trial Call Center|+1 877 822 9493||
21229515|NCT05055128|Cinclus Pharma Holding AB|Kajsa Larsson, MD, PhD|+46 70 675 01 28|kajsa.larsson@cincluspharma.com|
21229516|NCT00273910|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
21229517|NCT00747461|CSA Medical|Ann Murphy Legg, Director of Clinical Research|781-538-4732|alegg@csamedical.com|
21229518|NCT03648827|PTC Therapeutics, Inc.|Medical Information|1-866-562-4620|medinfo@ptcbio.com|
21229519|NCT04176705|Wake Forest University Health Sciences|John Bailey, MD|(336) 716-8002|jkbailey@wakehealth.edu|
21289054|NCT01163656|The Children's Hospital of Philadelphia|John Fiadjoe, MD|215-590-3916|fiadjoej@email.chop.edu|
21289055|NCT01132755|Memorial Sloan Kettering Cancer Center|Dr. Peter Kingham MD|212-639-5260|kinghamt@mskcc.org|
21276497|NCT04894084|Coloplast A/S|Medical Affairs Project Manager|+4549111341|dkteaa@coloplast.com|
21276498|NCT03122587|University of North Carolina at Chapel Hill|Stacey Daughters, PhD|9199629924|daughter@unc.edu|
21276499|NCT01613378|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21276500|NCT02000531|HoffmannLa Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21276501|NCT00794417|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
21276502|NCT00317642|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
21229520|NCT03882788|Research Office|Clinical Trials Manager|650-724-1720|clinicaltrials-gov@stanford.edu|
21229521|NCT04916769|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21229522|NCT03659916|Albireo, An Ipsen Company|Medical Director|see email|clinical.trials@ipsen.com|
21229523|NCT03805646|University of California Los Angeles|Dr. Catherine Juillard|310-267-9609|cjuillard@mednet.ucla.edu|
21229524|NCT02682420|BD Peripheral Intervention|Courtney Rothwell, Clinical Project Manager|602-830-5544|courtney.rothwell@bd.com|
21229525|NCT04686786|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21229526|NCT05628103|Otsuka Pharmaceutical Development & Commercialization, Inc.|Clinical Transparency|1-800-441-6763|smb_clinicaltranspa@otsuka-us.com|
21229527|NCT04840888|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21229528|NCT04191187|Moffitt Cancer Center|Dr. Nelli Bejanyan|813-745-6008|Nelli.Bejanyan@moffitt.org|
21229529|NCT04340193|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21229530|NCT03924869|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21229531|NCT03708770|Becton Dickinson (BPV)|Courtney Rothwell|480.350.6037|courtney.rothwell@bd.com|
21229532|NCT04905082|City of Hope|Stacy W. Gray, MD. AM.|626-715-4425|stagray@coh.org|
21229533|NCT04026711|University of Vermont|Anne Dixon, Professor of Medicine|802 847 0000|anne.dixon@uvmhealth.org|
21229534|NCT04823650|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21229535|NCT06350474|Seattle Children's|Margaret Kloster|206-884-7862|margaret.kloster@seattlechildrens.org|
21229536|NCT04246372|Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz|Joaquin Espinosa|303-724-7389|joaquin.espinosa@cuanschutz.edu|
21229537|NCT04339140|Beth Israel Deaconess Medical Center|Dr. Rushad Patell|617-667-7000|rpatell@bidmc.harvard.edu|
21229538|NCT01314703|CareFusion|Jennifer Raeder-Devens|847-454-4939|jennifer.raeder-devens@carefusion.com|
21229539|NCT01743131|Boston Children's Hospital|Dr. Leslie Kean|404-376-0187|leslie.kean@childrens.harvard.edu|
21229540|NCT02281773|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21229541|NCT00546104|Duke University Health System|Kimberly Blackwell, MD|919-668-1478|kimberly.blackwell@duke.edu|
21229542|NCT00385762|Weill Cornell Medical College|Peter N Schlegel, MD|2127465491|pnschleg@med.cornell.edu|
21229543|NCT01126801|Brigham & Women's Hospital|Dr. Hadine Joffe|617-732-4906|hjoffe@partners.org|
21229544|NCT00726375|University of Michigan Comprehensive Cancer Center|Dr. Sung Choi|734-615-5707|sungchoi@umich.edu|
21229545|NCT03323502|Indiana University School of Nursing|Dr. Susan Hickman|317-274-0032|hickman@iu.edu|
21229546|NCT03794583|United Therapeutics|United Therapeutics Global Medical Information|1-240-821-1881|305PerfectOLEStudy@lungbiotechnology.com|
21229547|NCT03708562|Becton Dickinson (BPV)|Courtney Rothwell|480-350-6037|courtney.rothwell@bd.com|
21229548|NCT02497612|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21229549|NCT02699697|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|3367135440|Doris.R.Brown@advocatehealth.org|
21229550|NCT00902668|Virginia Commonwealth University|Laurie W. Cuttino, MD|804-828-7232|LCuttino@mcvh-vcu.edu|
21229551|NCT00615108|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21229552|NCT01914757|AstraZeneca|Mitchell Goldman, Medical Science Director|+1 301 398 0323|Mitchell.Goldman@astrazeneca.com|
21229553|NCT02476201|Abbott Medical|Pilar Santamaria|+34 917 278 964|pilar.santamaria@abbott.com|
21229554|NCT02175628|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|9199664997|rad_research@med.unc.edu|
21229555|NCT03534362|Saint Louis University|Joe D Brunworth, MD|314-577-8884|joe.brunworth@health.slu.edu|
21229556|NCT01954160|Duke Clinical Research Institute|Kathy Moore|919-668-8065|kathy.moore@dm.duke.edu|
21289056|NCT02232698|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993 863164|joe.bugler@abbott.com|
21289057|NCT02393755|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
21229557|NCT02480920|Department of Cardiology, Afyonkarahisar State Hospital, Afyonkarahisar, Turkey|Volkan Emren||vemren@hotmail.com|
21229558|NCT00303901|Barbara Ann Karmanos Cancer Institute|Peter Littrup, M.D.|313-576-8758|littrupp@karmanos.org|
21229559|NCT00694707|Allergan|Willie R. Earley, MD Associate Vice President Clinical Development-CNS|714-246-4500|IR-CTRegistration@allergan.com|
21229560|NCT01076231|University of Pennsylvania|Dr. Jacob Shabason|215-662-3998|susan.mazzoni@uphs.upenn.edu|
21229561|NCT02664610|University of Michigan|Lesli Skolarus|734-936-9075|lerusche@umich.edu|
21229562|NCT04810481|Medtronic|Keith Holloman|6126707136|keith.holloman@medtronic.com|
21276503|NCT00255151|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
21229563|NCT01318642|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|866-572-6436|Bobby.Reddy@Immunitybio.com|
21229564|NCT00369707|Northwestern University|Leo Gordon, MD|312-695-4520|l-gordon@northwestern.edu|
21229565|NCT04429243|WL Gore|Charee Robe|9288644048|crobe@wlgore.com|
21229566|NCT04102098|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21229567|NCT06448078|Ege University|Gizem Kececi Ozgur|+90 506 678 71 28|gizem.kececi.1991@gmail.com|
21276504|NCT01602471|Certus International, Inc.|Edward M. Aten, M.D.|603.627.1212|eaten@certusintl.com|
21229568|NCT00799812|BD|Erin Zook|847-362-9047|erin.zook@bd.com|
21229569|NCT03599635|University of Minnesota|Jason Habeck|612-624-9990|habe0073@umn.edu|
21229570|NCT02394548|Massachusetts General Hospital|Dr. Henning Willers|617-726-5184|hwillers@mgh.harvard.edu|
21229571|NCT04562792|Children's Mercy|Dr. Alan Gamis|816-302-6808|agamis@cmh.edu|
21229572|NCT01254292|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21229573|NCT02083081|Mayo Clinic|Christi Patten PhD|507-538-7370|patten.christi@mayo.edu|
21229574|NCT02263131|The Catholic University of Korea, Seoul St. Mary's Hospital|Dr. Kang Jin Han|+82-10-4251-8375|kjhan@catholic.ac.kr|
21229575|NCT01230710|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21229576|NCT02905149|Instituto de Investigación Sanitaria La Fe|Maria Cortell|961246611|investigacion_clinica@iislafe.es|
21229577|NCT03277690|Cortendo AB|Xeris Medical Director|+1 610-254-9200|LOGICS@cortendo.com|
21229578|NCT00747812|Boston Scientific|Lyn Pimentel, Clinical Project Manager|(661) 949-4174|Lyn.Pimentel@bsci.com|
21229579|NCT03109847|Thomas Jefferson University|Joseph Curry, MD|215-503-6828|joseph.curry@jefferson.edu|
21229580|NCT00299182|University of Texas (UT) MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor, Sarcoma Medical Oncology|713-792-7966|CR_Study_Registration@mdanderson.org|
21229581|NCT00771316|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21229582|NCT01783054|Medical University of South Carolina|Eric Kimchi, MD|842-792-4271|kimchi@musc.edu|
21229583|NCT02497300|University of Alabama at Birmingham|Eric Judd|205 934-9509|ejudd@uab.edu|
21229584|NCT04068610|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
21229585|NCT05535972|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21229586|NCT01366417|CareFusion|Jennifer Raeder-Devens|847-454-4939|jennifer.raeder-devens@carefusion.com|
21229587|NCT02649894|Becton Dickinson|Dawn Heimer|2018476800|dawn.heimer@bd.com|
21229588|NCT04590963|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21229589|NCT03750461|Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH Geisel School of Medicine, Hanover, NH|Matthew Z. Wilson, MD MSc FACS FASCRS|(603) 650-8113|Matthew.Z.Wilson@hitchcock.org|
21229590|NCT04430738|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21229591|NCT06007664|University of Michigan|Noah J. Webster|734-936-3075|njwebs@umich.edu|
21229592|NCT02628769|Imperial College London|Louise Donnelly|+44 02075947895|l.donnelly@imperial.ac.uk|
21229593|NCT01467583|Harper University Hospital|Krista Wahby, Critical Care Pharmacist in the Medical ICU|313-745-2711|kwahby@dmc.org|
21229594|NCT03727425|Auris Health, Inc.|Scott Rehage|9256832590|scott.rehage@aurishealth.com|
21229595|NCT00309985|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
21229596|NCT04941456|Gaylord Hospital, Inc.|Dr. Henry Hrdlicka|203-284-2864|hhrdlicka@gaylord.org|
21229597|NCT02296684|Washington University School of Medicine|Douglas R. Adkins, M.D.|314-362-4471|dadkins@wustl.edu|
21229598|NCT05171777|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21229599|NCT02364713|Mayo Clinic|Evanthia Galanis|507-266-0584|galanis.evanthia@mayo.edu|
21229600|NCT02475031|Indiana University School of Medicine - Anesthesia Division|Dr. Yar Yeap|317-274-0275|yyeap@iupui.edu|
21229601|NCT05741528|Otsuka Pharmaceutical Development & Commercialization, Inc.|Clinical Transparency|1-800-441-6763|SMB_ClinicalTranspa@otsuka-us.com|
21229602|NCT03401489|San Francisco VA Medical Center|Bruce Ovbiagele|415-750-2047|bruce.ovbiagele@va.gov|
21229603|NCT05938920|InSilico Medicine Hong Kong Limited|Yujin Tian|+86-21-50831718|Insilico-Clinicaltrial@insilico.ai|
21229604|NCT01251861|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21238694|NCT00755040|Vanderbilt Ingram Cancer Center|Madan Jagasia, M.D.|(615) 936-8422|madan.jagasia@vanderbilt.edu|
21238695|NCT03248375|Icahn School of Medicine at Mount Sinai|Dr. Edward Kim|(212) 241-7409|Edward.Kim@mountsinai.org|
21238696|NCT01089231|Leibniz Universität Hannover|M. Sc. Simone Schmidt|+49 (511) 762 5931|Schmidt@nutrition.uni-hannover.de|
21238697|NCT00633464|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21238698|NCT00717860|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21238699|NCT03538015|University of Utah|Dr. Owen Chan|801-581-7755|ochan@u2m2.utah.edu|
21276505|NCT01734694|Augusta University|Jose Vazquez|(706) 723-0105|JVAZQUEZ@augusta.edu|
21238700|NCT00698646|Novartis Pharmaceuticals|Study Director|862-778-8300||
21276506|NCT02255487|Irrimax Corporation|Chevy Brown, Clinical Trials Manager|770-807-3355|chevy.brown@irrisept.com|15
21229605|NCT05439941|Evelo Biosciences, Inc|Duncan McHale, MBBS, MRCP, PhD|+447500128938|duncan@evelobio.com|
21229606|NCT00573183|Univerity of Washington Alcohol & Drug Abuse Institute|Dr. Dennis Donovan|206-543-0937|ddonovan@u.washington.edu|
21229607|NCT02362035|Acerta Pharma|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21229608|NCT02765269|Xinhua Translational Institute for Cancer Pain, Shanghai|Gang Ding|021-69691540||
21229609|NCT01797731|Hospital for Special Surgery|David Mayman|2127742024|maymand@hss.edu|
21229610|NCT03711318|NYS Psychiatric Institute|Dr. Adam Bisaga, study PI|646-774-6155|adam.bisaga@nyspi.columbia.edu|
21229611|NCT03656107|University of Leicester|Dr Lucy Beishon|0116252|lb330@le.ac.uk|3134
21229612|NCT04517500|Mayo Clinic|Roberto P. Benzo, M.D.|507-284-0561|Benzo.Roberto@mayo.edu|
21229613|NCT01189604|Astrazeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21229614|NCT00986830|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
21229615|NCT01495975|MGH Diabetes Center|Nancy Wei, MD|617-724-7597|ncwei@mgh.partners.org|
21229616|NCT00808483|University of Oslo|Professor Anne Marit Mengshoel|004790036933|a.m.mengshoel@medisin.uio.no|
21229617|NCT02038881|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
21229618|NCT00333840|Novartis Pharmaceuticals|Study Director|862-778-8300||
21229619|NCT02357979|University of California at San Francisco|Dr. Peter Rechmann|415 514 3225|Peter.Rechmann@ucsf.edu|
21229620|NCT03945214|University of California San Francisco|Dr. Rachel Radin|845-641-9569|rachel.radin@ucsf.edu|
21229621|NCT01955564|Newron Pharmaceuticals S.p.A.|Dr. Ravi Anand|+39 026103461|ravi@anand.ch|
21229622|NCT04081324|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21229623|NCT03449901|Washington University School of Medicine|Mia Weiss, M.D.|314-362-5737|m.c.weiss@wustl.edu|
21229624|NCT03150173|Montefiore Medical Center|Dr. Aaron D. Fox, Professor, General Internal Medicine|718-920-7173|adfox@montefiore.org|
21229625|NCT03594435|University of California Los Angeles|Dr. Lara Ray|310-206-6756|lararay@psych.ucla.edu|
21229626|NCT01191411|University of Texas Southwestern Medical Center|Keith E. Argenbright, MD|817-288-9898|keith.argenbright@utsouthwestern.edu|
21229627|NCT04041375|Michael E. DeBakey VAMC|Dr. Natalie E. Hundt|713-791-1414|natalie.hundt@va.gov|10315
21229628|NCT01967342|University of Alabama|Beverly E. Thorn, Ph.D.|(205) 348-8024|bthorn@ua.edu|
21229629|NCT01986946|Duke University Hospital|Dr. Erin Manning|919-681-3551|erin.manning@duke.edu|
21229630|NCT02404220|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21229631|NCT01259596|Wake Forest School of Medicine|Gretchen A. Brenes, Ph.D.|336-716-4551|gbrenes@wakehealth.edu|
21229632|NCT01708161|Novartis Pharmaceuticals|Study Director|1-888-669-6682|Novartis.email@novartis.com|
21229633|NCT05835323|Johnson & Johnson MedTech Surgery|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
21229634|NCT04048122|Washington University School of Medicine|Dr. Erin Foster|314-286-1638|erfoster@wustl.edu|
21229635|NCT01672736|University Health Network - Princess Margaret Cancer Centre|Dr. Suzanne Trudel|416-946-4501|Suzanne.Trudel@uhn.ca|4566
21229636|NCT01697358|Medtronic Restorative Therapies Group - Pain Stim|Restorative Therapies Group Clinical Trials||medtronicneurotrials@medtronic.com|
21229637|NCT02853344|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|18006726372|ClinicalTrialsDisclosure@merck.com|
21229638|NCT04251273|Truth Initiative|Amanda L. Graham, PhD, Principal Investigator|(202) 525-6473‬|vapestudy@truthinitiative.org|
21229639|NCT00810693|Bayer|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21229640|NCT03860597|University of California, San Diego|Neal Swerdlow, M.D., Ph.D.|(619) 543-6270|nswerdlow@ucsd.edu|
21229641|NCT00936611|Dana-Farber Cancer Institute|Irene Ghobrial|6176324101|irene_ghobrial@dfci.harvard.edu|
21276507|NCT02684396|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
21229642|NCT03467048|Cleveland Clinic|Dr. Kurt Ruetzler|216-445-8105|ruetzlk@ccf.org|
21229643|NCT02282358|Memorial Sloan Kettering Cancer Center|Dr. Andrew Zelenetz, MD, PhD|646-608-3728|zeleneta@mskcc.org|
21260874|NCT00509106|Cerexa, Inc.|Vice President, Clinical Sciences|(510) 285-9200|clinicaltrials@cerexa.com|
21229644|NCT01898208|Mayo Clinic|Ritu Banerjee, M.D., Ph.D.|507-284-6904|banerjee.ritu@mayo.edu|
21229645|NCT02155881|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21229646|NCT00961649|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21229647|NCT04043728|Rush University Medical Center|Dr. Amanda Mathew|13125631273|amanda_mathew@rush.edu|
21229648|NCT03841448|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
21229649|NCT00586625|ISTA Pharmaceuticals, Inc.|Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com|
21229650|NCT03594994|Washington University|Joseph Beals|314-362-8199|bealsjw@wustl.edu|
21229651|NCT02717273|University of Virginia|Robert Sawyer|4349821632|rws2k@virginia.edu|
21229652|NCT04452344|Rutgers University School of Dental Medicine|Cecile A. Feldman, DMD|973-972-4634|feldman@rutgers.edu|
21229653|NCT04294277|EAU Research Foundation|Dr. Wim Witjes|31263890677|w.witjes@uroweb.org|
21229654|NCT03350620|Vyluma, Inc|VP of Clinical Development|9083677400|info@vyluma.com|
21229655|NCT01470859|Department of Neurology, Huashan Hospital affiliated to Fudan University.|Dr. Jian Wang|+86-13321934789|wangjian336@hotmail.com|
21276508|NCT05633082|CooperVision Inc.|José A. Vega OD, MSc, FAAO|+19256213761|jvega2@coopervision.com|
21229656|NCT03001882|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21276509|NCT03170869|University of Colorado|Dr. Thor Johnson|720-848-1765|thor.johnson@ucdenver.edu|
21276510|NCT02913131|University of California, San Francisco|Dr. Rahul Aggarwal, MD|(415) 353-9278|Rahul.Aggarwal@ucsf.edu|
21276511|NCT02010996|changhai hospital|Bi-Hongda|86-13918233009|bihongda0411@yahoo.com.cn|
21276512|NCT01175473|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21276513|NCT02630316|United Therapeutics|United Therapeutics Global Medical Information|919-485-8350|clinicaltrials@unither.com|
21276514|NCT03635983|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21276515|NCT01235442|Amgen Inc.|Study Director|866-572-6436||
21276516|NCT02663882|Yeshiva University|Dr. Andrea Weinberger|(646) 592-4474|andrea.weinberger@yu.edu|
21276517|NCT05070390|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21276518|NCT04449341|Carl R Darnall Army Medical Center|Matthew Perdue|(254) 553-4653|matthewperdue94@gmail.com|
21276519|NCT00931996|Ullinois|Dr. Jeffrey Bishop|312-413-3495|jbishop@uic.edu|
21276520|NCT01020526|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21276521|NCT03546647|University of Houston|Kathryn Richdale OD, PhD|713-743-1974|richdale@central.uh.edu|
21276522|NCT00124462|Boston Univeristy|ClinicalTrials.gov Administrator|617 638 8862|damusk@bu.edu|617
21276523|NCT03297294|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21276524|NCT01396421|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
21276525|NCT03314662|Seqirus|Seqirus Clinical Trial Disclosure Manager|Phone: 1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
21276526|NCT00925301|Amicus Therapeutics|Medical Affairs|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
21276527|NCT05766787|Alcon Research, LLC|Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21276528|NCT00438659|Mayo Clinic|Robert C. Miller, M.D.||miller.robert@mayo.edu|
21276529|NCT01867606|Mayo Clinic|Aminah Jatoi, M.D.|(507) 284-4918|jatoi.aminah@mayo.edu|
21229657|NCT03507400|Practice for Neurology and Ludwigs-Maximilians-Universitiy Munich|Dr. Monika Empl|+4989500598710|dr.empl@dr-empl-neurologie.de|
21276530|NCT01588548|AstraZeneca|Karen Keating|+1 781 839 4182|karen.keating@astrazeneca.com|
21276531|NCT01169038|Vanderbilt University|Wonder Drake|615-322-2035|wonder.drake@vanderbilt.edu|
21276532|NCT02490800|Basilea Pharmaceutica International Ltd, Allschwil|Thomas Kaindl, MD|+41 61 567 15 24|thomas.kaindl@basilea.com|
21276533|NCT03257254|Boston Scientific|Timothy Keo|425-599-3814|Timothy.Keo@bsci.com|
21276534|NCT03365791|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21276535|NCT00739973|Novartis Pharmaceuticals|Study Director|862 778-8300||
21229658|NCT01555983|UC Davis (currently at UC San Diego)|Barth Wilsey MD|916-402-2270|bwilsey@ucsd.edu|
21276536|NCT01989676|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21276537|NCT02938442|University of Arkansas for Medical Sciences|Sorena Lo|5016868274|SBLo@uams.edu|
21229659|NCT02353754|Pacira Pharmaceuticals Inc.|James B. Jones, MD, PharmD|(973) 254-3560|jim.jones@pacira.com|
21276538|NCT01115855|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21276539|NCT00480324|GlaxoSmithKline|GSK Response Center|866-435-7343||
21276540|NCT00966381|UNC Greensboro|Cheryl Lovelady|336 256-0310|cheryl_lovelady@uncg.edu|
21260875|NCT03932240|Emory University|Laura Downey, MD|404-785-6670|laura.ansley.downey@emory.edu|
21276541|NCT01915940|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21276542|NCT03686150|University of Arkansas for Medical Sciences|Songthip Ounpraseuth|501-686-7233|stounpraseuth@uams.edu|
21276543|NCT01344616|PHCC LP|James G. Christian|7195468633|jim@phcclp.com|
21276544|NCT01844531|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21276545|NCT02548312|BMJ|Dr Sara Schroter|02073836744|sschroter@bmj.com|
21276546|NCT01573533|Mayo Clinic|Fernando C. Fervenza, M.D., Ph.D.|507-266-1045|Fervenza.Fernando@mayo.edu|
21276547|NCT02551679|Hemostemix|Dr. Fraser Henderson|2022978858|fhenderson@hemostemix.com|
21276548|NCT02956616|Montefiore Medical Center|Peter S. Bernstein, MD, MPH|718-904-2767|pbernste@montefiore.org|
21276549|NCT03764735|Mitotech S.A.|Chief Operating Officer|+352621692785|info@mitotechpharma.com|
21276550|NCT01345318|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21276551|NCT00450983|Fred Hutchinson Cancer Research Center|Ann Woolfrey, MD|206-667-4453|awoolfre@fredhutch.org|
21276552|NCT00792623|GlaxoSmithKline|GSK Response Center|866-435-7343||
21276553|NCT01685073|Johns Hopkins University|Ryan Vandrey, PhD|410-550-4036|rvandrey@jhmi.edu|
21276554|NCT00934596|Cardiothoracic Surgery, Skåne University Hospital Lund|Dr. Bansi Koul MD, PhD, Principal Investigator|+46 46 171649|bansi.koul@skane.se|
21276555|NCT00880087|University of Utah|Dr. Rich Holubkov, Professor of Pediatrics|807-587-3326|richard.holubkov@hsc.utah.edu|
21276556|NCT00743509|University of Michigan|Scott Schuetze|734-647-8925|scotschu@umich.edu|
21276557|NCT01239472|Hospital e Maternidade Marieta Konder Bornhausen|Dr Andre Barreto Pereira|+55 47 984482826|andrebarper@yahoo.com.br|
21276558|NCT03662308|SPINAL CORD DAMAGE RESEARCH CENTER|Dr. John Handrakis|718.584.9000|john.handrakis@va.gov|3129
21276559|NCT01005329|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@gmail.com|
21276560|NCT02504723|Kaohsiung Veterans General Hospital|Dr. Wen-Chi Chen|886-7-3422121|wcchen@vghks.gov.tw|2139
21276561|NCT01280617|Lahey Hospital & Medical Ctr|Mary Ann Simpson, Ph.D|781-744-2500|Mary.a.Simpson@Lahey.org|
21276562|NCT00573170|GlaxoSmithKline|GSK Response Center|866-435-7343||
21276563|NCT00232479|UMiami|Judith Hurley|305-243-6698|jhurley@miami.edu|
21276564|NCT03110380|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21276565|NCT02147587|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21276566|NCT01714739|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email:|Clinical.Trials@bms.com|
21276567|NCT01028911|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21276568|NCT00707434|UT MD Anderson Cancer Center|Clinical Research Operations, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org|
21276569|NCT01011556|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21276570|NCT00614822|Christiana Care Health System|Dr. Michael Guarino|302 366 1200|mguarino@cbg.org|
21276571|NCT03649412|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21276572|NCT00530348|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21276573|NCT04364763|Renibus Therapeutics|Stacey Ruiz|682-285-1711|sruiz@renibus.com|
21276574|NCT00448227|Novartis Pharmaceuticals|Study Director|862-778-8300||
21276575|NCT01256060|Holland Bloorview Kids Rehabilitation Hospital|Dr. Evdokia Anagnostou|416-753-6005|eanagnostou@hollandbloorview.ca|
21238701|NCT00995072|ECIR|Benjamin Epstein, PharmD|904-854-1354|benjamin.epstein@eastcoastresearch.net|
21238702|NCT01345721|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21238703|NCT00511875|University of Michigan|Dr. Thomas W. Gardner|734 232-8404|tomwgard@med.umich.edu|
21238704|NCT01349920|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21238705|NCT02686034|electroCore INC|Clinical Affairs|+1 973 355 6683|clinical@electrocore.com|
21238706|NCT00459342|The University of Texas (UT) MD Anderson Cancer Center|Faye Johnson, MD / Associate Professor|713-792-7734|fmjohns@mdanderson.org|
21238707|NCT00542880|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
21238708|NCT00696384|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21238709|NCT01678131|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21238710|NCT00558064|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21238711|NCT04552743|Stanford Medicine at Stanford University|Khanh Nguyen|650-721-2372|khanhpn@stanford.edu|
21238712|NCT02027402|Seoul St Mary's hospital|Teaho Hong|821052065266|gshth@catholic.ac.kr|
21238713|NCT03152084|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21238714|NCT03513757|Medical College of Wisconsin|Susan Taylor MD|414-266-3560|sutaylor@mcw.edu|
21276576|NCT00838981|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
21276577|NCT00089076|Mayo Clinic|Dr. Stephen Ansell|507-284-0923|ansell.stephen@mayo.edu|
21276578|NCT00808509|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21276579|NCT00931463|The Kirby Institute|Prof Sean Emery|+61293850900|semery@kirby.unsw.edu.au|
21276580|NCT04936594|University of Kentucky|Dr. Gopalkumar Rakesh|859-562-2348|gopalkumar.rakesh@uky.edu|
21276581|NCT02438540|Nanjing university of TCM|Dr. Amir Firouzjaei|+989125397047|amirfi@yahoo.com|
21276582|NCT00084799|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21276583|NCT04499482|Pennington Biomedical Research Center|Dr. Candida Rebello|2252882411|Candida.Rebello@pbrc.edu|
21276584|NCT02487082|Stony Brook Medicine Dept. of Neurology|Ruth A. Reinsel Ph.D., Clinical Research Associate II|(631) 638-2087|ruth.reinsel@stonybrookmedicine.edu|
21276585|NCT02898103|University California San Diego|Brian Ilfeld, MD, MS|858-822-0776|bilfeld@ucsd.edu|
21276586|NCT05022563|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21276587|NCT04569786|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21276588|NCT01684878|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21276589|NCT00810888|Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center|Dr Jane Khoury, Professor of Pediatrics|513-636-2690|jane.khoury@cchmc.org|
21276590|NCT01435031|Abbott Vascular|Jennifer M Jones-McMeans, PhD (Associate Director Clinical Research)|408-845-1459|jennifer.jones@av.abbott.com|
21276591|NCT01841216|Sport & Spine Rehab Clinical Research Foundation|Jena Etnoyer, Clinical Research Coordinator|240-766-0300|jetnoyer@ssrehab.com|838
21276592|NCT03942211|Janssen Cilag International NV|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21276593|NCT00127166|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21276594|NCT00133679|University of California, San Francisco|Roberta Keller, MD|(415) 476-1888|roberta.keller@ucsf.edu|
21276595|NCT01148225|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21276596|NCT00611325|Duke University Medical Center|Dr. Katherine B. Peters|(919) 684-6173|katherine.peters@duke.edu|
21276597|NCT00104247|BioMarin Pharmaceutical Inc.|Medical Information Services|1-800-983-4587|medinfo@bmrn.com|
21276598|NCT00925756|UCSD|Sheldon Morris|6195438080|shmorris@ucsd.edu|
21276599|NCT03496987|Yale University School of Medicine|Jonathan Puchalski, MD|2037375699|jonathan.puchalski@yale.edu|
21276600|NCT00605917|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21276601|NCT01506908|GlaxoSmithKline|GSK Response Center|866-435-7343||
21276602|NCT01818518|Mednax. Inc|Kimberly Maurel|714-593-9171|kimberly_maurel@mednax.com|
21276603|NCT02919826|Queen's University|Dr. Muhammad Ayub|613-549-7944|ma84@queensu.ca|
21276604|NCT03043560|Icahn School of Medicine at Mount Sinai|Dr, James Murrough|212-585-4640|james.murrough@mssm.edu|
21276605|NCT01117766|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21276606|NCT03718117|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21276607|NCT00206102|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
21276608|NCT01917968|Boston Scientific Corporation|Director, Clinical Operations|952-930-6000|teresa.takle-flach@bsci.com|
21276609|NCT03623035|Wake Forest Baptist Health|Christopher Edwards|3367168222|chedward@wakehealth.edu|
21276610|NCT01435928|Sunovion|Medical Director, CNS|1-866-503-6351||
21276611|NCT03922139|UW School of Medicine and Public Health|Michael Suer, MD|608-265-3207|suer@rehab.wisc.edu|
21276612|NCT00834236|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
21276613|NCT00292227|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
21276614|NCT01114581|Reckitt Benckiser Inc.|Gail Solomon, Director, Clinical Development|973-404-2752|gail.solomon@rb.com|
21276615|NCT00537017|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21276616|NCT00948792|University of Oklahoma Health Sciences Center|Doug Dannaway|4052715215|douglas-dannaway@ouhsc.edu|42048
21276617|NCT02329431|UNC Chapel Hill|Kathleen Thomas|919-966-3387|kathleen_thomas@unc.edu|
21276618|NCT04947150|Drexel University|Dr. Meghan Butryn|215-553-7108|mlb34@drexel.edu|
21276619|NCT03581188|The University of Sydney, Australia|Associate Professor Katy Bell|+61 415 764 321|katy.bell@sydney.edu.au|
21276620|NCT00760526|Jaeb Center for Health Research|Katrina Ruedy|813-975-8690|direcnet@jaeb.org|
21276621|NCT01619579|VA Medical Center & UCSD Center for Pain Medicine|Tobias Moeller-Bertram, MD|858-552-8585|tmoellerbertram@ucsd.edu|3123
21276622|NCT03907241|CRMG|Mikaela Raymond|866-337-1868|ctgov@clinicalresearchmgt.com|
21276623|NCT01684215|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21276624|NCT02234752|George Washington University, Washington, DC|Maju Koola|678-200-8613|majumkoola@gmail.com|
21229660|NCT00289718|GlaxoSmithKline|GSK Response Center|866-435-7343||
21229661|NCT04102189|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21229662|NCT01950390|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21229663|NCT06462014|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
21229664|NCT03319173|Bristlecone Health, Inc.|Dr. Kelly J. Gibas|763-913-4600|kelly-gibas@bethel.edu|
21229665|NCT03428932|Nemours Children's Health|Nelly Mauras, MD|904-697-3674|Nelly.Mauras@nemours.org|
21229666|NCT00717093|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21229667|NCT00721500|Vistakon|Kurt Moody OD FAOO / Director|904-443-3088||
21229668|NCT01543698|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21229669|NCT00217620|SWOG Statistical Center|Study Statistician|206-667-4623||
21229670|NCT03948698|Elizabeth Glaser Pediatric AIDS Foundation|Shirin Kakayeva|2404377929|skakayeva@pedaids.org|
21229671|NCT00418015|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|3129269015|r-mccarthy@northwestern.edu|
21276625|NCT00455962|Massachusetts General Hospital|Janet E. Hall, MD|617-877-1112|jehall@partners.org|
21229672|NCT00089414|Behavioral Endocrinology Branch/National Institute of Mental Health/NIH|Pedro E. Martinez, M.D., Principal Investigator|301-402-0615|martinep@mail.nih.gov|
21229673|NCT01805440|Department of Psychiatry|Douglas Kondo, MD|801-583-2500|doug.kondo@hsc.utah.edu|
21229674|NCT02903355|Southern Illinois University School of Medicine|Gary Fifer, MSHI|217-545-7823|gfifer@siumed.edu|
21229675|NCT01517074|National Institutes of Health|H. Nida Sen, MD, MHSc, Principal Investigator, NEI|301-402-3254|senh@nei.nih.gov|
21229676|NCT01863953|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21229677|NCT02495831|CROSS REsearch SA|Dr. Milko Radicioni|+41.91.63.00|clinic@croalliance.com|510
21229678|NCT02008318|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21229679|NCT04021771|Thomas Jefferson University|Dr. Kristin Rising|215-503-5507|Kristin.Rising@jefferson.edu|
21229680|NCT02336373|Baylor College of Medicine|Vivien Sheehan, MD, PhD|(832) 824-4459|vxsheeha@txch.org|
21229681|NCT03095885|Allena Pharmaceuticals, Inc|Allena Medical Affairs|6174674577|AllenaMedInfo@allenapharma.com|
21229682|NCT02160535|University of Washington|Dr. Sylvia Lucas, MD, PhD|206-598-9260|lucass@uw.edu|
21229683|NCT03270644|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21229684|NCT00333177|University of California, Los Angeles|Keith H. Nuechterlein, Ph.D., Principal Investigator|(310) 825-0036|keithn@ucla.edu|
21229685|NCT00354614|ResMed|VP Medical Affairs|858 836 6782|ResmedScienceCenter@resmed.com.au|
21229686|NCT03650556|Abbott Medical|Amber Miller|(612) 413-7236|amber.miller@abbott.com|
21229687|NCT00463580|Emory University|Andrew H. Miller, MD|404-727-8260|amill02@emory.edu|
21229688|NCT01788046|Amgen Inc.|Study Director|866-572-6436||
21229689|NCT01188421|Johns Hopkins University, School of Medicine|Eric C. Strain, MD|410-550-1191|estrain1@jhmi.edu|
21229690|NCT01147640|Cubist Pharmaceuticals, Inc.|Dr. Obi Umeh, Vice President Global Medical Sciences|781-860-8415|obiamiwe.umeh@cubist.com|
21229691|NCT01604408|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21229692|NCT00917501|University of Cincinnati|Dr. Robert McNamara|513-558-5601|robert.mcnamara@uc.edu|
21229693|NCT02509481|Colorado State University|Dr. Brian D. Foy, Professor|970-491-3470|Brian.Foy@colostate.edu|
21229694|NCT01453725|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21229695|NCT01436396|Sanofi Pasteur|Director||Contact-US@sanofi.com|
21229696|NCT01102270|Brigham and Women's Hospital|Atul Malhotra|6177326488|amalhotra1@partners.org|
21229697|NCT00875979|Hoffmann-La Roche|Medical Communications|800 821-8590||
21229698|NCT00843531|University of California, San Francisco|Emily Bergsland, MD|(415) 514-6520|Emily.Bergsland@ucsf.edu|
21229699|NCT00216476|Janssen Cilag European Medical Affairs|EMEA Medical Affairs Director Psychiatry|+34 91 7228043||
21229700|NCT01573260|McGill University|Dr.Ronald B Postuma|514-934-8026|ron.postuma@mcgill.ca|
21229701|NCT02191137|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21229702|NCT00538291|City of Hope National Medical Center|Paul Frankel, Ph.D.|(626)359-8111|pfrankel@coh.org|65265
21229703|NCT02640716|Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China|Dr. Yi Tang|+86 10 83199456|tangyi@xwhosp.org|
21229704|NCT01904058|Mirum|Study Physician|1-650-667-4085|medinfo@mirumpharma.com|
21229705|NCT03096483|GE Healthcare|Beth Heckel|2623127269|beth.heckel@ge.com|
21229706|NCT03417804|Centro Hospitalar do Porto|Dr. Simão Esteves|+351222077549|simao.esteves@me.com|
21229707|NCT02556736|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
21229708|NCT02046733|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki-Voser|+41 31 511 94 18|STIMULI@etop-eu.org|
21229709|NCT03605212|Menarini Group|Angela Capriati, MD PhD - Corporate Director Clinical Sciences|+39 055 5680|acapriati@menarini-ricerche.it|9990
21229710|NCT01756053|Center for Interdisciplinary Research on Nicotine Addiction|Benjamin Albelda (Project Manager)|2157467173|albeldab@mail.med.upenn.edu|
21276626|NCT04039919|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21276627|NCT02760264|ReveraGen Biopharma Inc.|Dr. Eric P. Hoffman|240-672-0295|ericphoffman@gmail.com|
21276628|NCT00983918|Baylor College of Medicine|Jaime Ortiz, MD|713-873-2860|jaimeo@bcm.edu|
21276629|NCT03244475|VA San Diego Health System|Dr. Mingxiong Huang|858-534-1254|mingxiong.huang@va.gov|
21276630|NCT03250299|Basilea Pharmaceutica International Ltd (Basilea)|Thomas Kaindl, MD, Global Medical Director|+41615671505|thomas.kaindl@basilea.com|
21229711|NCT00285818|Stanford University|Dr. Hugh Brent Solvason|650 776 4793|solvason@stanford.edu|
21229712|NCT04674644|Suleyman Demirel University|Dr Esra Oz|05326788040|esrakaraagac@sdu.edu.tr|
21229713|NCT05280782|Washington University School of Medicine|Dr. Pamela K. Woodard|314-362-7100|woodardp@wustl.edu|
21229714|NCT01024231|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21229715|NCT01268150|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
21229716|NCT00395733|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21238715|NCT00982930|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21238716|NCT00941798|Novartis Pharmaceuticals|Study Director|862-778-8300||
21238717|NCT04251884|Ospedale Regionale di Lugano|Dr. Francesco Mongelli|+41764706297|francesco.mongelli@mail.com|
21238718|NCT04179721|Northwell Health|Dr. Liron Sinvani, Principal Investigator|646-766-7169|ldanay@northwell.edu|
21238719|NCT04225988|Cedars Sinai Medical Center|Dr. Edmund Huang, MD|310-423-2641|edmund.huang@cshs.org|
21238720|NCT00404495|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21238721|NCT03904043|Washington University School of Medicine|Dr. Michael Waters|314-747-7236|m.r.waters@wustl.edu|
21238722|NCT06615544|Ivoclar Vivadent AG|Head of Department Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
21238723|NCT04839354|Emory University|Claudia Morris, MD|404-785-7141|claudia.r.morris@emory.edu|
21276631|NCT01546922|University Medical Center Groningen|A. P. van Beek, MD PhD|00315036110388|a.p.van.beek@umcg.nl|
21238724|NCT07069764|National Institute of Laser Enhanced Sciences (NILES), Cairo University|DR.hala shaaban attiyah|01012894478|std.halashaaban@niles.edu.eg|
21238725|NCT04716413|Montefiore Medical Center|Dr. Naum Shaparin|718-920-4316|nshapari@montefiore.org|
21238726|NCT01493960|Index Pharmaceuticals|Dr Thomas Knittel|0046 8 508 847 31|thomas.knittel@indexpharma.com|
21238727|NCT03935217|Lupin Pharmaceuticals|Director of Clinical Operations|443-301-3146|jackieshaw@lupin.com|
21238728|NCT02412501|Medtronic Coronary/Structural Heart|Beth Moe, Clinical Study Manager|763-526-1184|beth.moe@medtronic.com|
21238729|NCT01160484|Oncotherapeutics|Director, Clinical Operations|323-623-1200|lthulin@oncotherapeutics.com|
21238730|NCT00332332|Amgen Inc.|Study Director|866-572-6436||
21238731|NCT03921346|University Hospitals of Geneva|Dr Johan N. Siebert|+41795534072|Johan.Siebert@hcuge.ch|
21238732|NCT00939731|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21238733|NCT02128646|University of Kansas Medical Center|Michael Moncure, MD|913-588-1240|mmoncure@kumc.edu|
21260876|NCT01051739|Iowa City Veterans Administration Medical Center|Michael Wall, M.D.|319-3380581|michael-wall@uiowa.edu|
21260877|NCT03830281|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21260878|NCT00201851|International Breast Cancer Research Foundation|Richard R. Love|608-698-7881|richardibcrf@gmail.com|
21276632|NCT03325972|NYU Langone Health|Lisa Doan, MD|212.201.1004|Lisa.Doan@nyulangone.org|
21276633|NCT04086641|University of Washington|Conrad Slater|5409318478|conslate13@gmail.com|
21276634|NCT01322971|Stanford University|Ruth Lathi||rlathi@stanford.edu|
21276635|NCT00126126|Miami VAHS & University of Miami, Department of PT|Robert Gailey, PhD, PT|305-284-4535|rgailey@miami.edu|
21276636|NCT01534078|Massachusetts General Hospital|Jeremy Abramson, MD|617-724-4000|JABRAMSON@mgh.harvard.edu|
21276637|NCT04975321|University of Washington|Mariella Garcia|2065431740|mgarciaf@uw.edu|
21276638|NCT00986570|Biolab Sanus Farmacêutica Ltda.|Priscilla Padilha, MD|55(11)35736335|ppadilha@biolabfarma.com.br|
21229717|NCT03557853|MSD Pharmaceuticals LLC|Vladimir Achikyan|+74959167100|vladimir.achikyan@merck.com|
21276639|NCT02225665|Sangamo Therapeutics|Medical Monitor|510-970-6000|clinicaltrials@sangamo.com|
21276640|NCT01311557|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21276641|NCT00608517|Vanderbilt-Ingram Cancer Center|Brian Engelhardt, M.D.|615-936-1803||
21276642|NCT00572039|Thomas Jefferson University|Barry W. Rovner, MD|2155031254|Barry.Rovner@jefferson.edu|
21276643|NCT03852524|Ohio State University|Shelby Miracle|614-366-1648|shelby.miracle@osumc.edu|
21229718|NCT01147172|Anika Therapeutics|Adrian Orr, Director Clinical Affairs|781.457.9000|aorr@anikatherapeutics.com|
21229719|NCT02927262|Astellas Pharma Global Development, Inc|Clinical trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
21229720|NCT02387710|Brigham and women's Hospital|Andrew Wellman, MD, PhD||awellman@rics.bwh.harvard.edu|
21229721|NCT04836312|University of Pennsylvania|Alexander Fanaroff, MD|215-615-7674|alexander.fanaroff@pennmedicine.upenn.edu|
21229722|NCT01498978|OHSU Knight Cancer Institute|Kristi Eilers|503-494-2897|eilersk@ohsu.edu|
21229723|NCT04357782|Central Virginia VA Health Care System|Dr. Brian Davis|804-675-5000|Brian.Davis5@va.gov|
21229724|NCT01786148|Emory University|Marcia McDonnell Holstad|404-727-1307|nurmmcd@emory.edu|
21229725|NCT00675259|The Ohio State University|Ewa Mrozek, MD|614-293-0066|Ewa.mrozek@osumc.edu|
21229726|NCT00072176|Princess Margaret Hospital, Toronto, Canada|Dr. Amit M. Oza|416 946 4501|amit.oza@uhn.ca|2818
21229727|NCT02000180|St. Michael's|Dr. Samir C. Grover|4168645628|samir.grover@utoronto.ca|
21229728|NCT04128371|National Institute of Allergy and Infectious Diseases|Dr. Paneez Khoury|+1 301 402 3673|paneez.khoury@nih.gov|
21229729|NCT01706822|Covidien|Julie Doyle|781-839-1729|Julie.Doyle@Covidien.com|
21229730|NCT02840721|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21229731|NCT01739361|LSU Health Sciences Center New Orleans|Dr. David R Janz, MD, MSc, Assistant Professor of Medicine|504-568-3167|djanz@lsuhsc.edu|
21229732|NCT05274165|Sonova USCS|Senior Research Audiologist|630-821-5000|phonakaudiologyresearch@gmail.com|
21229733|NCT02127723|Q-Med AB|Q-Med AB|+46 18 474 9000|medicalinfo.q-med@alderma.com|
21229734|NCT03672643|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21260879|NCT01119040|University Hospitals Case Medical Center|Jeffrey Marks, MD/Principal Investigator|216-983-4930|jeffrey.marks@UHhospitals.org|
21260880|NCT00074958|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
21260881|NCT03124069|Fisher & Paykel Healthcare|Hanie Yee|+64 9 574 0123|Hanie.Yee@fphcare.co.nz|7909
21276644|NCT01470417|University of Florida|Thomas J. George, Jr., MD|(352) 273-8008|thom.george@medicine.ufl.edu|
21238734|NCT00755222|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
21229735|NCT05985395|University of Nebraska Medical Center|Windy Alonso|814-577-2941|windy.alonso@unmc.edu|
21229736|NCT03774082|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novatis.email@novartis.com|
21229737|NCT02027883|Wellmont CVA Heart Institute|Terrie Walker, Director of Clinical Research|423-230-5643|twalker@mycva.com|
21229738|NCT00150709|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21229739|NCT00316719|GlaxoSmithKline|GSK Response Center|866-435-7343||
21229740|NCT02975336|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21229741|NCT04667481|University of Washington|Dr. Kerryn Reding, Study Principal Investigator|206-221-1571|kreding@uw.edu|
21229742|NCT03509883|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21229743|NCT02024529|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
21229744|NCT02642029|McLean Hospital|Ann Shinn, MD|617-855-3053|akshinn@partners.org|
21229745|NCT02585843|Columbia University|A. Reshad Garan|(917) 374-3346|arg2024@cumc.columbia.edu|
21229746|NCT00691301|Gynecologic Oncology Group|Linda Gedeon for Mark Brady, PhD|716-845-1169|lgedeon@gogstats.org|
21229747|NCT01823146|University of Florida|Dr. Natalie Ebner|203 691 0371|natalie.ebner@ufl.edu|
21229748|NCT00736944|Washington University School of Medicine|Dr. Douglas R. Adkins|314-362-5654|dadkins@dom.wustl.edu|
21229749|NCT01426438|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21229750|NCT00091442|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Director Medical Leader|908 218 7361||
21229751|NCT00845858|Evoke Pharma|Marilyn R. Carlson|858-345-1494|mcarlson@evokepharma.com|
21229752|NCT00392860|Human Engineering Research Laboratories|Michael L Boninger|412-822-3700|boninger@upmc.edu|
21229753|NCT02391701|Hospital Clínico Universitario de Santiago|Dr. María del Mar Calvo Malvar|34 981950395|mariadelmar.calvo.malvar@sergas.es|
21229754|NCT03725852|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
21229755|NCT04981392|UMass Chan Medical School|Kimberly Fisher, MD|5088561975|kimberly.fisher2@umassmed.edu|
21229756|NCT04856891|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
21229757|NCT02808650|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21260882|NCT03352245|Yale University|Dr. Brett Bade|203 785 6670|Brett.bade@yale.edu|
21229758|NCT03072732|ZOLL|Project Manager|14127216444|moszm@yahoo.com|
21229759|NCT01419639|NYU Langone Medical Center|Matthias A. Karajannis|212 263 9959|matthias.karajannis@nyumc.org|
21229760|NCT02484287|University of Oklahoma Health Science Center|Blair Apple|4052714658|Blair-Apple@ouhsc.edu|1
21229761|NCT00669396|University of Utah|David Turok, MD|801-581-7647|david.turok@hsc.utah.edu|
21229762|NCT01262573|Brigham and Women's Hospital|Dr. Jon Einarsson|617-525-8582|jeinarsson@partners.org|
21229763|NCT04402060|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
21229764|NCT00331422|Masonic Cancer Center, University of Minnesota|Melissa Geller, MD|612-626-3111|gelle005@umn.edu|
21260883|NCT02690701|Novartis Pharmaceuticals|Study Director|+1 (800) 778-8300|Novartis.email@novartis.com|
21229765|NCT02345226|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21229766|NCT01848704|Assistance publique hopitaux de paris|Isabelle Boutron|+33 1 42 34 78 33|isabelle.boutron@htd.aphp.fr|
21229767|NCT01033851|Massachusetts General Hospital|Dr. Elizabeth Hoge|6177240859|ehoge@partners.org|
21229768|NCT00066729|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21229769|NCT00968890|GlaxoSmithKline|GSK Response Center|866-435-7343||
21229770|NCT02349542|OrthoCarolina Research Institute|Senior Research Scientist|704-323-2260|susan.odum@orthocarolina.com|
21229771|NCT02215096|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21229772|NCT01011738|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21229773|NCT00200161|Memorial Sloan Kettering Cancer Center|Dr. Lisa Deangelis|212-639-7997|deangell@mskcc.org|
21229774|NCT03896165|Ohio State University College of Nursing|Assistant Professor|614-292-5684|thrane.2@osu.edu|
21229775|NCT03181893|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21276645|NCT03488030|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21276646|NCT02973321|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|
21276647|NCT05045469|CGMH|Dr. HuanHsuan Hsu|0978839349|10356017a@cgmh.org.tw|
21276648|NCT03460158|University of Pennsylvania|Ivona Percec, MD, PhD|215-662-7300|ivona.percec@pennmedicine.upenn.edu|
21276649|NCT01845116|Atrium Health Levine Children's Hospital|Ricardo A. Caicedo, MD|704-381-8840|ricardo.caicedo@atriumhealth.org|
21276650|NCT01098110|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21276651|NCT01355302|Eisai Inc.|Eisai Medical Services|888-422-4743||
21276652|NCT00263887|Talecris Biotherapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
21276653|NCT02274948|Faculty of Medicine, University of Colombo|Prof V Pujitha Wickramasinghe|+94112688748|pujithaw@yahoo.com|170
21276654|NCT03476317|Children's Hospital of Philadelphia|Lindsey Albenberg, DO|267-426-0139|albenbergl@chop.edu|
21276655|NCT00865514|University of Florida|Dr. Peter W. Stacpoole|(352) 273-9023|pws@ufl.edu|
21276656|NCT02865395|George Washington University|Dr. Patrick Mufarrij|2027154000|pmufarrij@gmail.com|
21229776|NCT02158975|University of Michigan Comprehensive Cancer Center|Dr. Ryan Wilcox, M.D.|734-615-1482|rywilcox@umich.edu|
21229777|NCT03329508|Pharma 2B LTD|Pninit Litman study director|+972 8 9472672|pninit@pharma2b.com|
21276657|NCT03920280|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21229778|NCT04815031|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21276658|NCT01839838|Hospital of the University of Pennsylvania|Gary Freedman, MD|215-615-6767|Gary.freedman@pennmedicine.upenn.edu|
21276659|NCT00985231|Bausch & Lomb Incorporated|William Reindel, OD, MS|(585) 338-8129|william.t.reindel@bausch.com|
21276660|NCT03420768|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21229779|NCT03021304|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21229780|NCT02308189|Ohio University|Brian Clark, PhD|740-593-2354|clarkb2@ohio.edu|
21229781|NCT03022435|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker.|650-724-4437|cdekker@stanford.edu|
21229782|NCT00423514|Memorial Sloan Kettering Cancer Center|Dr. Farid Boulad, MD|1-833-MSK-KIDS|bouladf@MSKCC.ORG|
21229783|NCT01361568|Cara Therapeutics|Frédérique Menzaghi, PhD; Vice President, Research & Development|203-567-1502|fmenzaghi@caratherapeutics.com|
21229784|NCT02728596|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|karnold@fredhutch.org|
21276661|NCT00983476|VA Greater Los Angeles Healthcare System, Los Angeles, CA|Dr. Alexander S. Young|310-794-7219|alexander.young@va.gov|
21229785|NCT03439657|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21276662|NCT01997723|UIllinois|Bharati Prasad|3129968433|bpradsad@uic.edu|
21229786|NCT03353246|Duke University Medical Center|Michael Haglund, M.D., Ph.D.|919-684-6936|haglu001@mc.duke.edu|
21229787|NCT00561457|Bard Peripheral Vascular|Director of Clinical Affairs|480-303-2644|John.Reviere@crbard.com|
21229788|NCT00667875|Medical University of South Carolina|Raymond F. Anton, MD|843-792-1226|antonr@musc.edu|
21229789|NCT03553927|Imperial College London|Channa Jayasena|02083833242|c.jayasena@imperial.ac.uk|
21229790|NCT01441180|NIAID/NIH|Dr. Shyam Kottilil|301-435-0936|skottilil@niaid.nih.gov|
21276663|NCT02681406|University of Pennsylvania|James McKay|215-746-7704|jimrache@upenn.edu|
21276664|NCT00575380|Inspire|Mike Schiewe|919-941-9777|mschiewe@inspirepharm.com|
21276665|NCT04019054|UCLA Psychiatry|Dr. Michael K. Leuchter|3108906943|mkleuchter@mednet.ucla.edu|
21276666|NCT01040793|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21229791|NCT01558739|Novartis Pharmaceuticals|Study Director|862-778-8300||
21229792|NCT01771952|University of Virginia, Kinesiology|Joe Hart|4349246187|jmh3zf@virginia.edu|
21229793|NCT00142298|Novartis Pharmaceuticals|Study Director|862-778-8300||
21229794|NCT03630042|Oxford University Hospital NHS Trust|Jaimal Kothari|NA|Jaimal.Kothari@ouh.nhs.uk|
21229795|NCT02423772|Queen's University of Belfast|Kevin Vowles|+44 (0)28 9097 5445|k.vowles@qub.ac.uk|
21229796|NCT01386008|Clinical Research Center (CRC) UC Berkeley School of Optometry|Meng Lin, OD, PhD|(510) 642-9731||
21229797|NCT04449861|Jilin Cancer Hospital|Ying Cheng, MD|NA|jl.cheng@163.com|
21229798|NCT05268055|UMass Chan Medical School|Melissa L. Anderson, PhD|508-856-5820|melissa.anderson@umassmed.edu|
21229799|NCT00531934|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21229800|NCT01816074|Dept of Psychiatry, University of Washington|Dr. Mark Stein|206-987-1161|mstein42@uw.edu|
21229801|NCT03355365|Tisch MS Research Center of New York|Saud Sadiq|212-265-8070|ssadiq@tischms.org|
21229802|NCT04075279|Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health|Dr. Tyler Quinn|412-386-4450|yhh7@cdc.gov|
21229803|NCT00608972|Rutgers Cancer Institute of New Jersey|Deborah L Toppmeyer, M.D.|732-235-6789|toppmede@cinj.rutgers.edu|
21229804|NCT00320931|University of Maryland, Baltimore|Vasken Dilsizian, MD|410-328-6890|vdilsizian@umm.edu|
21229805|NCT00752102|Joslin Diabetes Center|Dr. Sylvia Rosas|617-309-2477|sylvia.rosas@joslin.harvard.edu|
21229806|NCT01303861|Duke University Medical Center - Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@dm.duke.edu|
21229807|NCT02056639|University of Pennsylvania|Bridget Nolan|2156623324|bridget.nolan@uphs.upenn.edu|
21229808|NCT00676338|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21229809|NCT02122458|VA Pittsburgh Healthcare System|Sheila R. Pratt, Ph.D.|412-979-3157|Sheila.Pratt@va.gov|
21229810|NCT00412542|UT MD Anderson Cancer Center|Vinay Puduvalli, MD / Associate Professor|713-745-5769|kuhunter@mdanderson.org|
21229811|NCT02833350|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21229812|NCT01500031|Boston Scientific|Director Clinical Trials|708-771-4737|Pamela.Grady@bsci.com|
21229813|NCT02927327|GE Healthcare|John Strohmeyer|609-865-7423|john.strohmeyer@ge.com|
21229814|NCT01856907|Woman's Hospital|Dr Karen Elkind-Hirsch|225-231-5278|karen.elkind-hirsch@womans.org|
21229815|NCT00075218|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21238735|NCT03168295|University of Texas Health San Antonio|Carolina Solis-Herrera|(210) 567-6691|solisherrera@uthscsa.edu|
21276667|NCT00003531|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
21276668|NCT00346164|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordintator@childrensoncologygroup.org|
21276669|NCT03139240|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
21276670|NCT01955044|NorthShore University HealthSystem|Brandy L Frost|847-570-2033|bfrost@northshore.org|
21276671|NCT02376257|Boston UCRC|Michael Otto, PhD|617-353-9610|mwotto@bu.edu|
21276672|NCT02260258|BIDMC|Mike Donnino|6177542882|mdonnino@bidmc.harvard.edu|
21276673|NCT00862537|Pico-Tesla Magnetic Therapies, LLC|Allen S. Braswell CEO|303 795-3222|abraswell@pico-tesla.com|
21276674|NCT04232540|UNC Chapel Hill|Amanda Poliseno|919-962-5344|amanda_poliseno@unc.edu|
21276675|NCT02105701|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21276676|NCT03234608|Portland State University|Dr. Christina Nicolaidis|503-725-9603|nicol22@pdx.edu|
21276677|NCT01362296|GlaxoSmithKline|GSK Response Center|866-435-7343||
21229816|NCT03643575|Reckitt Benckiser, Inc|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
21229817|NCT00850070|The Children's Health Council|Glen R. Elliott, Ph.D., M.D.|650.688.3649|gelliott@chconline.org|
21229818|NCT01522248|Johns Hopkins University|Kawsar Talaat|410-502-9627|ktalaat@jhu.edu|
21229819|NCT01332331|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21229820|NCT01696695|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21229821|NCT01464996|University of North Carolina at Chapel Hill School of Dentistry|Dr. Andre Ritter, Professor and Chair|919-537-3987|andre_ritter@unc.edu|
21229822|NCT00739050|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21229823|NCT01296360|Valneva Austria GmbH|Senior Manager Clinical Research|+43 1 206 20|katrin.dubischar-kastner@valneva.com|1175
21229824|NCT01479127|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
21229825|NCT00515177|University of Minnesota|Cynthia Gross PhD|612-624-8676|gross002@umn.edu|
21229826|NCT04515394|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21229827|NCT00199875|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
21229828|NCT02737397|Clinilabs, Inc|Magdy Shenouda, MD|201-417-7765|Jackie@sen-jam.com|
21229829|NCT03469934|AnaptysBio, Inc|Clinical Project Leader|858-362-6295|info@anaptysbio.com|
21229830|NCT03569033|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21229831|NCT01013350|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21229832|NCT00624234|Vanderbilt University|Dr. Laurie Cutting|615-875-1054|Laurie.Cutting@Vanderbilt.Edu|
21229833|NCT02913612|Duke Clinical Research Institute|Kanecia Zimmerman, MD, PhD, MPH|919-668-8651|kanecia.zimmerman@duke.edu|
21229834|NCT02507973|The R Adams Cowley Shock Trauma Center|Dr Deborah Stein|410-328-3495|dstein@umm.edu|
21229835|NCT04141046|University of North Carolina at Chapel Hill|Saira Sheikh, MD|919-966-0545|szsheikh@email.unc.edu|
21229836|NCT01927627|Case Comprehensive Cancer Cent|Jorge Garcia MD|216-444-7774|garciaj4@ccf.org|
21229837|NCT01710046|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21229838|NCT02503410|Spaulding Rehabilitation Hospital|Paolo Bonato|617-952-6319|pbonato@partners.org|
21229839|NCT00989157|NRIFargo|Dr. James Roerig|701 365 4919|jroerig@nrifargo.com|
21229840|NCT03386474|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21238736|NCT01610154|Fuwai Hospital|Dr. Hui Wang|86-010-88396587|wh_endo@163.com|
21260884|NCT01856114|UT MD Anderson Cancer Center|Dr. David Hui, MD, Associate Professor, Palliative Care Medicine|713-792-6258|dhui@mdanderson.org|
21276678|NCT03693950|BIOCAD|Yulia Linkova Medical Director|+7 (495) 992 66 28 ext. 930|linkova@biocad.ru|
21276679|NCT04230876|Amptify|Chris Cardinal|3143999940|Chris@amptify.com|
21276680|NCT02774850|Children's Hospital of Philadelphia|Dr. Richard Aplenc|267-426-7252|aplenc@email.chop.edu|
21276681|NCT01662362|Abbott|Barbara Kaesdorf, Associate Director Clinical Affairs|847-937-8702|barbara.kaesdorf@abbott.com|
21276682|NCT04350008|BIOTRONIK SE & Co.KG|Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
21276683|NCT00545688|Hoffmannb-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21276684|NCT02339090|Aravive, Inc.|Chief Operating Officer|(936) 355-1910|clinicaltrials@aravive.com|
21276685|NCT01168687|Ernest Gallo Clinic and Research Center, UCSF|Jennifer Mitchell, Clinical Project Director|510-985-3100|jmitchell@gallo.ucsf.edu|
21276686|NCT04243096|Boston University|Deepak Kumar, PT, PhD|617-358-3037|kumard@bu.edu|
21276687|NCT00248170|Novartis|Study Director|862-778-8300||
21276688|NCT02521181|Cleveland Clinic Foundation|Jennifer J. Gassman, PhD|(216) 444-9938|gassmaj@ccf.org|
21276689|NCT01598545|Emory University|Dr. Grant Lynde|404-778-3900|glynde@emory.edu|
21276690|NCT02449473|AstraZeneca|Global Clinical Lead|+1 301-398-0582|ClinicalTrialTransparency@astrazeneca.com|
21276691|NCT03346070|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21276692|NCT00977548|H. Lee Moffitt Cancer Center and Research Institute|Rami Komrokji, Principal Investigator|813-745-4692|rami.komrokji@moffitt.org|
21276693|NCT03008837|VAORD|Dr. Anna Woodbury|404-321-6111|anna.woodbury@va.gov|
21238737|NCT01147822|Novartis Pharmaceuticals|Study Director|1-862-778-8300|Novartis.email@Novartis.com|
21276694|NCT02070757|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21276695|NCT01546142|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
21276696|NCT01213836|Astra Zeneca|Gerard Lynch||ClinicalTrailTransparency@astrazeneca.com|
21276697|NCT00521989|Zalicus|Margaret Lee, PhD|617-301-7142|mlee@zalicus.com|
21276698|NCT00706095|Eisai Call Center|Eisai Inc.|888-422-4743||
21276699|NCT01332578|GlaxoSmithKline|GSK Response Center|866-435-7343||
21276700|NCT02429375|Memorial Sloan Kettering Cancer Center|Dr. Alison Moskowitz, MD|\646-608-3726|moskowia@mskcc.org|
21276701|NCT01002794|Oslo University Hospital|Professor May Arna Risberg|+4741312776|marisb@ous-hf.no|
21276702|NCT00892281|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
21276703|NCT02423317|Govt. Medical College, Haldwani.|Dr. Bikramjit Das|8937963828|bikramjit.anesth@gmail.com|
21276704|NCT04220775|M D Anderson Cancer Center|Dr. Renata Ferrarotto|(713) 745-6774|rferrarotto@mdanderson.org|
21276705|NCT00436917|Mayo Clinic Jacksonville|Stephanie L. Hines, M.D.|507-266-0800|hines.stephanie@mayo.edu|
21276706|NCT02169791|Northside Hospital|Scott R. Solomon, MD|404-255-1930|ssolomon@bmtga.com|
21276707|NCT01321437|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
21276708|NCT01009515|University of New Mexico|Montaser Shaheen, MD, PhD|505-925-0404|MoShaheen@salud.unm.edu|
21276709|NCT01966809|Medical College of Wisconsin|Dr. Harry T. Whelan|414-266-7516|hwhelan@mcw.edu|
21229841|NCT01021306|Palmer Center for Chiropractic Research, Palmer College of Chiropractic|Dr. James DeVocht|563.884.5150|james.devocht@palmer.edu|
21276710|NCT01501110|Hospital de Clínicas de Porto Alegre|Josi Vidart|+55 51 98472520|josividart@gmail.com|
21276711|NCT02075606|Ipsen|Medical Director|00441753627777|clinical.trials@ipsen.com|
21229842|NCT02711345|Novartis Pharma AG|Study Director|862 778-8300|Novartis.email@novartis.com|
21229843|NCT03780543|Assembly BioSciences Inc.|Chief Development Officer|415-855-3006|manderson@assemblybio.com|
21229844|NCT03488355|Memorial University of Newfoundland|Dr. Peter Daley|7097772089|pkd336@mun.ca|
21276712|NCT02969876|Massachusetts General Hospital|Dr. Andrew Nierenberg|6175122641|anierenberg@mgh.harvard.edu|
21276713|NCT01439724|Instituto Nacional de Cancer|Dr. Heliton Spindola Antunes|55 21 32076597|hspindola@inca.gov.br|
21276714|NCT01857206|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21276715|NCT01679054|The Chinese University of Hong Kong|Vivian Lee|+85239438012|vivianlee@cuhk.edu.hk|
21276716|NCT01483625|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21276717|NCT00574067|Friends Research Institute|Dr. Michael Gordon|410-837-3977|mgordon@friendsresearch.org|251
21276718|NCT01261624|Italfarmaco S.p.A.|Clinical R&D Director|026443|p.bettica@italfarmaco.com|2584
21276719|NCT00271024|University of Chicago|Dr. Andrea King|7737026181|aking@bsdad.uchicago.edu|
21276720|NCT00807209|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
21276721|NCT02094261|AstraZeneca|Senior Medical Director, Tagrisso||ClinicalTrialTransparency@astrazeneca.com|
21276722|NCT00703976|University of Pittsburgh|Julie Bauman, MD|412-623-7833|baumanje@upmc.edu|
21276723|NCT00843830|University of Michigan Comprehensive Cancer Center|Mark Zalupski, M.D.|734-615-3969|zalupski@umich.edu|
21276724|NCT01143649|Laboratory of Neuromodulation and Center of Clinical Research Training. Spaulding Rehabilitation Hospital.|Dr. Felipe Fregni|617.952.6153|info@neuromodulationlab.org|
21276725|NCT01083680|AbbVie|Global Medical Information|800-633-9110||
21276726|NCT03877926|Emergent BioSolutions Inc.|Bojan Drobic, Director, Clinical Research|204 275 4196|bdrobic@ebsi.com|
21276727|NCT02400476|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|1-424-248-6500|clinicaltrials@pumabiotechnology.com|
21276728|NCT00588731|Yale University|Mohini Ranganathan, M.D.|203-932-5711|mohini.ranganathan@yale.edu|2546
21276729|NCT02621463|University of Utah|Dr. Kai Kuck, PhD|8012051010|kai.kuck@hsc.utah.edu|
21276730|NCT00467831|NHGRI/NIH|Dr. Thomas Markello|301-451-1305|markellot@mail.nih.gov|
21276731|NCT01832402|UT MD Anderson Cancer Center|David Hui, MD/ Associate Professor, Palliative Care Medicine|713-792-6258|dhui@mdanderson.org|
21276732|NCT01198873|Sanofi|Trial Transparency Team||Contact_US@sanofi.com|
21276733|NCT00860743|Wayne State University and John D. Dingell VA Medical Center|Jason H. Mateika|313-576-4481|jmateika@med.wayne.edu|
21276734|NCT02776553|University of Arkansas for Medical Sciences|Arny A. Ferrando, Ph.D.|501-526-5711|aferrando@uams.edu|
21276735|NCT02927834|Loma Linda University|Dr. Kristin Seiberling|9095582002|kseiberling@llu.edu|
21276736|NCT00479388|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21276737|NCT01644149|PharmaJet, Inc.|Marilyn Dysart, Clinical Affairs Manager|720-214-9399|marilyn.dysart@pharmajet.com|
21276738|NCT01886937|New York State Psychiatric Institute|Dr. Laurel Mayer|646-774-8067|lsm16@cumc.columbia.edu|646
21276739|NCT04798482|Boston Children's Hospital|Keira Mason MD|617-355-5775|keira.mason@childrens.harvard.edu|
21276740|NCT00690482|AstraZeneca|Alison Holt||ClinicalTrialTransparency@astrazeneca.com|
21276741|NCT00890552|Stanford University School of Medicine|Brenda Hann, RN, MBA, CCRC|650-723-0966|bhann@stanford.edu|
21276742|NCT03770078|Coloplast|Head of Medical Writing and Biostatistics|49113143|dkpen@coloplast.com|+45
21276743|NCT01246713|BIDMC|Michael Ganetsky, MD|6177542323|mganetsk@bidmc.harvard.edu|
21276744|NCT02244424|Michigan State University, College of Nursing|Dr. Mildred A. Horodynski|(517) 355-6744|millie@msu.edu; silkk@msu.edu|
21276745|NCT04117945|Mayo Clinic|Daniel H. Ahn, D.O.|(480) 342-4800|Ahn.Daniel@mayo.edu|
21276746|NCT02568007|Medical College of Wisconsin|Praveen Goday|4142663690|pgoday@mcw.edu|
21276747|NCT00562120|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21276748|NCT02148445|Department of Preventive Medicine & Public Health|Edward F. Ellerbeck, MD, MPH, Chair|913-588-2829|eellerbe@kumc.edu|
21276749|NCT02093923|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21276750|NCT03438006|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21276751|NCT02737592|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
21276752|NCT02792218|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21276753|NCT03123783|Pyxis Oncology, Inc.|Pyxis Oncology Clinical Operations|(339) 545 8252|clinicaltrials@pyxisoncology.com|
21276754|NCT05427045|UArkansas|Dr. Santos-Horta|507-250-5880|ESantoshorta@uams.edu|
21276755|NCT00955721|University of Miami|Peter J. Hosein MD|3052433462|phosein@miami.edu|
21276756|NCT02408445|University of Colorado|Dr. Shanlee Davis|720-777-6073|shanlee.davis@childrenscolorado.org|
21276757|NCT01631682|Massachusetts General Hospital|Scott P. Orr, Ph.D.|617-643-7269|scott_orr@hms.harvard.edu|
21276758|NCT03512002|Atrium Wake Forest Baptist Health School of Medicine|Charles Tegeler, MD|336-716-9447|BBRP@wakehealth.edu|
21276759|NCT01253317|Boston Children's Hospital|Walter E. Kaufmann, MD|617-355-5230|rettresearch@childrens.harvard.edu|
21289058|NCT00728923|New York State Psychiatric Institute|Dr. Carolyn Rodriguez|212-543-5637|cr2163@columbia.edu|
21289059|NCT01131585|Novartis Pharmaceuticals|Study Director|41 61 324 1111||
21229845|NCT00338104|Northwestern University|Mark E. Molitch, M.D.|312 503-4130|molitch@northwestern.edu|
21276760|NCT00503113|Hoffman-LaRoche|Medical Communications|800-821-8590||
21289060|NCT00812097|Mentor|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
21276761|NCT02280226|University of Bonn|Dr. Jonas Doerner|017632817006|jonas.doerner@ukb.uni-bonn.de|
21276762|NCT00749411|GlaxoSmithKline|GSK Response Center|866-435-7343||
21276763|NCT04052698|Octapharma|Dr. Sigurd Knaub, Senior VP CR&D Haematology|01554512141|Sigurd.Knaub@octapharma.com|
21276764|NCT06442410|Medtronic|Thanh Tran|7278082652|thanh.tran2@medtronic.com|
21276765|NCT01507090|Children's Mercy Hospital|Principal Investigator|816-234-3059|srahman@cmh.edu|
21276766|NCT02966184|Norton Healthcare|Tristan Murray, PharmD|5026295571|tristan.murray@nortonhealthcare.org|
21276767|NCT02928536|Istituto di Ricerche Farmacologiche Mario Negri|Silvano Gallus, head of the Laboratory of Lifestyle Epidemiology|0039023901|silvano.gallus@marionegri.it|4657
21276768|NCT04815850|University of Leicester|Dr Matthew Graham-Brown|01162588043|mgb23@le.ac.uk|
21276769|NCT02284347|Medtronic Xomed|Director of Clinical Trials|904-296-9600|dl.nuventstudy@medtronic.com|
21276770|NCT01301482|Mike O'Callaghan Military Medical Center|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
21276771|NCT01682642|Fertility Center AZ Jan Palfijn|dr. Wim Decleer, PI|0032 9 325 92 20|wim.decleer@janpalfijngent.be|09/2248851
21276772|NCT03694808|University Hospitals Cleveland Medical Center|Dr. David Canaday|216-368-5537|dxc44@case.edu|
21276773|NCT03326986|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21276774|NCT02999984|Orchard Therapeutics (Europe) Ltd|Orchard Medical Information|+44 (0) 203 808 8286|medinfo@orchard-tx.com|
21276775|NCT02631837|Imelda ziekenhuis Bonheiden|Dr Jan Baekelandt|+ 32 15 505208|jan.baekelandt@imelda.be|
21276776|NCT00754013|Eisai inc.|Eisai Medical Services|1-888-422-4743||
21276777|NCT03614494|The University of Hong Kong|Dr Raymond Li|+852 22554517|raymondli@hku.hk|
21276778|NCT03756883|Teva Pharmaceuticals, USA|Director, PD/CE Studies|1-888-483-8279|usmedinfo@tevapharm.com|
21276779|NCT00619359|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21276780|NCT02136238|University of South Florida|Jason Highsmith|813-974-3806|mhighsmi@health.usf.edu|
21276781|NCT05212883|Duke University|Saira Siddiqui, M.P.H.|919-688-8464|saira.siddiqui@duke.edu|
21276782|NCT02502734|GlaxoSmithKline|GSK Response Center|866-435-7343||
21276783|NCT01430819|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21276784|NCT01218984|Alkermes, Inc.|Bernard L. Silverman, VP, Clinical Development|781-609-6000|bernard.silverman@alkermes.com|
21276785|NCT03095118|Mayo Clinic|Dr. Fernando C. Fervenza|507-266-1045|Fervenza.Fernando@mayo.edu|
21276786|NCT03767062|Ataturk University|Mustafa Ceylan|+905062773216|drmuson16@hotmail.com|
21276787|NCT02363439|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
21276788|NCT01913795|Boston Children's Hospital|Dr. Wanda Phipatanakul|617-355-6117|Wanda.Phipatanakul@childrens.harvard.edu|
21260885|NCT01642212|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21276789|NCT03573817|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
21276790|NCT00707447|FIDAM|Norbert Hermanns|0049 7931 594|hermanns@diabetes-zentrum.de|553
21276791|NCT01719562|Wake Forest University|Project Manager|+1(336) 758-3728|jvolpini@wakehealth.edu|
21276792|NCT00508027|Children's Hospital & Research Center Oakland|Dr. Carolyn Hoppe, Principal Investigator|(510)428-3193|choppe@mail.cho.org|
21276793|NCT04155073|Medical University of South Carolina|Dr. Jennifer Dahne|843-876-2280|dahne@musc.edu|
21276794|NCT02013531|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21276795|NCT02240186|Mayo Clinic|Dr. Kenton Kaufman, Principal Investigator|507-284-2262|kaufman.kenton@mayo.edu|
21276796|NCT03554317|Johns Hopkins Sidney Kimmel Comprehensive Cancer Center|Dr. Mark Markowski|410-614-0567|mmarko12@jhmi.edu|
21276797|NCT04061577|UCLA|Dr. Mersedeh Bahr Hosseini|3107941195|MBahrHosseini@mednet.ucla.edu|
21276798|NCT01352182|Cincinnati Children's Hospital Medical Center|Jennifer Kaplan|513-636-4259|jennifer.kaplan@cchmc.org|
21260886|NCT03430310|The University of Alabama at Birmingham|Barbara Gower, PhD|205-934-4087|bgower@uab.edu|
21276799|NCT00939627|Vanderbilt Ingram Cancer Center|Jill Gilbert, M.D.|615-343-4677|jill.gilbert@vanderbilt.edu|
21276800|NCT03396874|University of Michigan|Morand Piert|734-936-5385|mpiert@med.umich.edu|
21276801|NCT00444821|Medtronic|Kristel Wittebols|707-591-3275|kristel.wittebols@medtronic.com|
21276802|NCT00537199|UT MD Anderson Cancer Center|Mark Chambers, MS, DMD / Professor|713-792-6510||
21276803|NCT02740179|Massachusetts General Hospital|Dr. Steven K. Grinspoon|617-724-9109|sgrinspoon@mgh.harvard.edu|
21276804|NCT02326363|Medical University of South Carolina|Nathaniel L Baker|843-792-5028|bakern@musc.edu|
21276805|NCT00612677|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D., via Moffitt Cancer Center|813-745-3050|alberto.chiappori@moffitt.org|
21276806|NCT01491633|Dana-Farber Cancer Institute|Dr. Peter Hammerman|617-632-3000|phammerman@partners.org|
21276807|NCT03417830|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21276808|NCT00823199|Bronx Psychiatric Center|Nigel Bark MD|7188625429|Nigel.Bark@omh.ny.gov|
21260887|NCT01446809|University of Washington|Dr Darin Davidson|206-543-3690|djdavi@uw.edu|
21276809|NCT00467987|State University of NY at Buffalo|Paresh Dandona|17165351852|dandona@buffalo.edu|
21276810|NCT00941720|CCCC|Dr. Ronald Sobecks|216-444-6833|sobeckr@ccf.org|
21276811|NCT01748955|New York State Psychiatric Institute|Michael F. Grunebaum, MD|6467747573|mgruneb@nyspi.columbia.edu|646
21276812|NCT01998243|Hospital severo ochoa|Dr Luis Ramon Rabago Torre|34914818000|lrabagot@gmail.com|8326
21276813|NCT01566526|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21276814|NCT05197829|University of Massachusetts Chan Medical School|Mark O'Connor|508-334-1000|mark.oconnor2@umassmed.edu|
21276815|NCT00268892|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
21276816|NCT01640184|Peking University International Hospital|Dr. Zhang Dongliang|+86-10-69006561|zhangdongliang@pkuih.edu.cn|
21276817|NCT02087176|SCRI Development Innovations|Charles H. Davis|+615-524-4341|charles.davis2@scri-innovations.com|
21276818|NCT02492841|UNIVERSIDAD DE LOS ANDES|Dra. CLAUDIA BRIZUELA CORDERO|562226181166|clau@cibrizuela.com|
21276819|NCT04925713|Morphogenesis, Inc|James Bianco, MD - Chief Executive Officer|8138756600|jbianco@morphogenesis-inc.com|104
21276820|NCT03812991|UMissouri - Missouri Orthopaedic Institute|Vicki L Jones|573-882-7583|jonesvicki@health.missouri.edu|
21276821|NCT01876368|Novartis Pharmaceuticals|Study Director|862-778-8300||
21276822|NCT02563769|Temple University Episcopal Hospital|Yaminah Carter Research Coordinator|2678097602|yaminah.carter@tuhs.temple.edu|
21276823|NCT02210052|Mayo Clinic|Dr. Tim J. Lamer, M.D.|507 778-8760|lamer.tim@mayo.edu|
21276824|NCT01411488|Cleveland Clinic|Nancy Albert|216-444-7028|albertn@ccf.org|
21276825|NCT01192399|Alexion Pharmaceuticals, Inc|Alexion Pharmaceuticals, Inc||clinicaltrials@alexion.com|
21276826|NCT01930175|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21276827|NCT02820740|Monteris Medical|Clinical Program Manager|763-401-1727|medicalaffairs@monteris.com|
21276828|NCT03060759|Massachusetts General Hospital|Farrah J. Mateen, MD, PhD, Associate Professor of Neurology|617-724-8653|fmateen@mgh.harvard.edu|
21276829|NCT03903159|University of Minnesota|Amy Krentzman|612-625-2312|akrentzm@umn.edu|
21276830|NCT00724373|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21276831|NCT02732691|JenaValve Technologies Inc.|Vinny Podichetty, Vice President: Clinical & Med Affairs|949-767-2110|podichetty@jenavalve.com|1050
21229846|NCT02362269|University of Wisconsin|Dr. Corinne D. Engleman|(608) 265-5491|cengelman@wisc.edu|
21276832|NCT03450629|Sun Pharma Advanced Research Company Limited|Head, Clinical Developmnt|912266455645|clinical.trials@sparcmail.com|
21276833|NCT03366194|Esthetic Education LLC|Study Coordinator|(480) 656-2251|Support@skinstylus.com|
21229847|NCT01163266|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21229848|NCT02586064|Providence VA Medical Center|Dr. Tracie Shea|401-273-7100|MaryTracie.Shea@va.gov|6248
21229849|NCT02919696|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|ClinicalTrials.gov@lilly.com|
21229850|NCT00397215|GlaxoSmithKline|GSK Response Center|866-435-7343||
21229851|NCT00484094|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21229852|NCT04032652|NorthShore University HealthSystem|Asst Director Research Compliance|2243647975|rpulido@northshore.org|
21229853|NCT00193258|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21229854|NCT00761631|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21229855|NCT01999868|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21229856|NCT00502944|Massachusetts General Hospital|Rochelle P. Walensky, MD, MPH|(617) 724-8445|rwalensky@partners.org|
21229857|NCT00310401|Vanderbilt University|Lorraine B. Ware M.D.|615 322 8614|lorraine.ware@vanderbilt.edu|
21229858|NCT00289016|Amgen, Inc.|Study Director|866-572-6436||
21229859|NCT00319501|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21229860|NCT02612129|Zevra Denmark A/S|Medical Affairs|+1-888-289-5607|medicalaffairs@zevra.com|
21229861|NCT02557295|Celltrion Inc|JiWoong Lim|82-32-850-5702|jiwoong.lim@celltrion.com|
21229862|NCT01066000|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21229863|NCT01067976|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21229864|NCT00566111|Yale University Department of Psychiatry|Dr. Gerard Sanacora|(203) 974-7535|gerard.sanacora@yale.edu|
21229865|NCT00976677|ECOG Statistical Office|Study Statistician|617-632-3012||
21229866|NCT04092582|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21229867|NCT03689114|Istituto di Ricerche Farmacologiche Mario Negri IRCCS|Giorgia Giussani|0239014604|giorgia.giussani@marionegri.it|
21276834|NCT01181531|Amgen Inc.|Study Director|866-572-6436||
21276835|NCT00096122|UT MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-745-5783|eharrison@mdanderson.org|
21276836|NCT00932282|University of North Carolina at Chapel Hill|Edwin Kim, Director UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
21276837|NCT02953678|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21229868|NCT01313858|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21229869|NCT02609204|Wills Eye Hospital, Glaucoma Research Center|Dr. L. Jay Katz|215-928-3123|ljkatz@willseye.org|
21260888|NCT01331161|Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
21260889|NCT02730546|Mayo Clinic|Harry H Yoon MD MHS|507-284-2511|yoon.harry@mayo.edu|
21276838|NCT04678817|University of Utah|Lori Gawron, MD|801-213-4989|lori.gawron@hsc.utah.edu|
21276839|NCT05368012|Hospital for Special Surgery|MIDCAB (Mid-Calf Block) for foot surgery: A pilot study|646-797-8948|popovicm@hss.edu|
21276840|NCT02121041|UNC Chapel Hill|Dr. Anthony Viera|984-974-4636|viera@med.unc.edu|
21229870|NCT03689530|University of Michigan|Michele Heisler|(734) 845-3504|mheisler@med.umich.edu|
21229871|NCT01392443|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21229872|NCT01977794|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21229873|NCT03019575|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21229874|NCT01925677|University of Maryland, Baltimore|Dr. Rolf Barth|4103286020|rnbarth@som.umaryland.edu|4103286020
21229875|NCT00491075|U.T. MD Anderson Cancer Center|Quality Assurance Specialist|713-792-2830|guclinicaltrials@mdanderson.org|
21229876|NCT01603355|Oregon Health & Science University|Dr. Eric Suhler|503-494-5023|suhlere@ohsu.edu|
21229877|NCT03792191|Mansoura University|Dr. Mohamed Mohamed Tawfik|1001183400|m2tawfik@mans.edu.eg|0020
21229878|NCT00246753|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
21229879|NCT05203289|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21229880|NCT02234570|University of Iowa|Patricia Winokur, MD|319-384-1735|patricia-winokur@uiowa.edu|
21229881|NCT00659360|Cross Cancer Institute|Dr. Margaret Von Mehren|215-214-1663|margaret.vonmehren@fccc.edu|
21276841|NCT02124902|Washington University School of Medicine|Foluso Ademuyiwa, M.D., MPH|314-362-7201|bisiademuyiwa@wustl.edu|
21276842|NCT00546910|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21276843|NCT03185182|Lund University|Professor Håkan Axelson|+46 046 2226434|hakan.axelson@med.lu.se|
21276844|NCT01730040|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com|
21276845|NCT03407612|Jameson Crane Sports Medicine Institute|Maria Munsch|614-293-3600|maria.munsch@osumc.edu|
21276846|NCT00544817|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
21276847|NCT01552369|University of Pittsburgh - Medicine - Infectious Diseases|Nina Singh, MD|412-360-1688|nis5@pitt.edu|
21276848|NCT00614926|Columbia University|Judith Rabkin, PhD|212 543 5762|jgr1@columbia.edu|
21276849|NCT02322788|AstraZeneca R&D Gothenburg, SE-431 83 Mölndal, Sweden|Göran Eckerwall, MD, PhD|+46 708467664|goran.eckerwall@astrazeneca.com|
21276850|NCT02310789|Stanford University|Jeff Wine, PhD|650-725-2462|wine@stanford.edu|
21276851|NCT01197417|Medical College of Wisconsin|David Brousseau MD, MS|414-266-2625|dbrousse@mcw.edu|
21289061|NCT00927082|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21289062|NCT00729807|University of Maryland Greenebaum Cancer Center|Edward A. Sausville, M.D., Ph.D.|410-328-7394|esausville@umm.edu|
21289063|NCT01786109|Mayo Clinic|Dr. Michael Camilleri|507-266-2306|camilleri.michael@mayo.edu|
21289064|NCT02723331|University of Colorado Hospital|Wells Messersmith, MD|303-724-0747|wells.messersmith@cuanschutz.edu|
21229882|NCT01868503|Stanford University|Dr. Kathleen Horst|6507360921|kateh@stanford.edu|
21289065|NCT02641834|Department of Experimental and Clinical Medicine, University of Florence, Italy|Prof. Francesco Sofi|+390557949429|francescosofi@gmail.com|
21289066|NCT00781950|St. Boniface Hospital Research Centre|Dr. Grant Pierce|(204) 235-3414|GPierce@sbrc.ca|
21289067|NCT02949934|University of Colorado School of Medicine|Joseph P. Schacht, Ph.D.|(303) 724-3773|joseph.schacht@cuanschutz.edu|
21289068|NCT01684592|Battelle|Dr. Victoria Coleman-Cowger|4103722748|colemancowger@battelle.org|
21289069|NCT00657605|University of Miami|Richard Bookman|305-243-0494|y.p.davis@med.miami.edu|
21229883|NCT00398918|Boston University|Ofra Sarid-Segal, MD|617-414-1990|ofra.segal@bmc.org|
21229884|NCT00723580|Child Psychopharmacology Institute|Bill J. Duke, Ph.D.|701-241-9281|bduke@ChildPsychopharmacologyInstitute.org|2
21289070|NCT04069520|Emory University|Dr. Kim Barber Foss|404-544-1306|kim.barberfoss@emory.edu|
21229885|NCT03917459|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21289071|NCT00849472|GlaxoSmithKline|GSK Response Center|866-435-7343||
21229886|NCT00567307|Wake Forest School of Medicine, Winston Salem, NC|Dr. Elsayed Z Soliman, Director of the Epidemiological Cardiology Research Center|336-716-8632|esoliman@wakehealth.edu|
21289072|NCT06086340|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21289073|NCT01767415|Weill Cornell Medicine|Anita Ou|646-962-8188|ano2014@med.cornell.edu|
21289074|NCT03998462|North Florida/South Georgia VA Healthcare System|Dr. Dawn Schiehser, Ph.D.|352-376-1611|Dawn.Schiehser@va.gov|107538
21289075|NCT05710224|Instituto Butantan|Fernanda Castro Boulos - Diretoria Médica, Centro de Ensaios Clínicos e Farmacovigilância|+55 11 3723-6797|fernanda.boulos@fundacaobutantan.org.br|
21289076|NCT05893823|IRCCS Istituto Ortopedico Rizzoli|Francesco Castagnini|0516366418|francescocastagnini@hotmail.it|+39
21289077|NCT03369223|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21229887|NCT00131508|St Jude Children's Research Hospital|Winfred Wang|1-866-278-5833|info@stjude.org|
21289078|NCT04057768|Venus Concept|Clinical Research Manager|888-907-0115|rmays@venusconcept.com|
21229888|NCT01360593|UPMC Hillman Cancer Center|Barbara Stadterman, Regulatory Supervisor, MPH, CCRP|412-647-5554|stadtermanbm@upmc.edu|
21289079|NCT04615507|Johnson & Johns Vision Care Inc.|Thomas Karkkainen- Sr. Research Principal Optometrist|1-800-843-2020|tkarkkai@its.jnj.com|
21289080|NCT01257438|Bard Peripheral Vascular|Josh Smale, Associate Director Clinical Affairs|(480) 603-8140|Josh.Smale@crbard.com|
21289081|NCT00308685|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
21229889|NCT03441269|Maimonides Medical Center|Sergey Motov, MD|718-283-8693|alikourezos@maimonidesmed.org|
21289082|NCT04937387|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21289083|NCT03439839|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21289084|NCT05124184|W. L. Gore & Associates|Austin Phillips|+1 928 864 3641|agphilli@wlgore.com|
21229890|NCT02390908|Hunter College|Dr. Tyrel J. Starks|212-772-5550|tstarks@hunter.cuny.edu|
21289085|NCT03096353|National Center for Complementary and Integrative Health|Catherine Bushnell|+1 301 496 2222|mary.bushnell@nih.gov|
21289086|NCT03712852|Università degli studi G. D'ANNUNZIO|Prof. Michele Paolantonio|3395204073|mpaolantonio@unich.it|
21289087|NCT03298061|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21289088|NCT01956942|Ophthalmology Department The George Washington University|Dr. David Belyea|2027412800|dbelyea@mfa.gwu.edu|
21289089|NCT04307394|Butler Hospital|Brandon Gaudiano, Ph.D.|401-455-6457|brandon_gaudiano@brown.edu|
21289090|NCT00818272|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21229891|NCT01869439|WoundVision LLC|Dr. James G. Spahn, M.D.|(317) 775-6080|brett@woundvision.com|
21229892|NCT01691898|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21289091|NCT00416949|SKCCC|George Sgouros|4106140116|gsgouros@jhmi.edu|
21289092|NCT03228914|The University of Texas Health Science Center at Houston|William C. Yao, MD|713-500-5410|william.c.yao@uth.tmc.edu|
21289093|NCT00714272|eXcorLab GmbH|Dr. Horst-Dieter Lemke|+49-6022-812648|horstdieter.lemke@excorlab.de|
21289094|NCT02985710|Massachusetts General Hospital|PI|6177260580|akaraa@mgh.harvard.edu|
21229893|NCT02019277|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21238738|NCT02337517|HCI Research Compliance Office|Data Manager|8015850601|compliance@hci.utah.edu|
21238739|NCT01751230|Pennington Biomedical Research Center|Dr. Leanne Redman|2257630947|leanne.redman@pbrc.edu|
21229894|NCT04738734|Pulse Biosciences, Inc.|William A. Knape, VP Clinical, Regulatory, and Quality Affairs|510-906-4649|bknape@pulsebiosciences.com|
21229895|NCT04093414|Beaumont Hospitals|Diedre Brunk|248-898-5580|Diedre.Brunk@beaumont.org|
21229896|NCT04889222|Masimo Corporation|Ahmed Alghazi|949-297-7437|aalghazi@masimo.com|
21229897|NCT02639546|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21229898|NCT00113087|New England Research Institute|Lynn Sleeper|617-972-3235|lsleeper@neriscience.com|
21229899|NCT03452228|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21229900|NCT03998566|Boston Scientific|Jeya Satheesh|6124490870|jeya.satheesh@bsci.com|
21229901|NCT02572609|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21229902|NCT04295772|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21229903|NCT00968864|PRA Health Sciences|Dr. Andrew Gilman|704-615-2744|gilmanandy@prahs.com|
21229904|NCT01967173|Penn State University|David Mauger|717-531-7178|dmauger@psu.edu|
21229905|NCT02096679|AstraZeneca|Dr Mireille Cantarini||ClinicalTrialTransparency@astrazeneca.com|
21229906|NCT03666624|University of Washington|Karen Fredriksen Goldsen|206-543-5722|fredrikk@uw.edu|
21229907|NCT03225599|Northwell Health|Administrative Director, Clinical Research|(516) 881-7064|dcannone1@northwell.edu|
21229908|NCT01254630|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21276852|NCT01202071|Eisai Co., Ltd.|Masaharu Yokoyama, Director|+81-3-3817-3908|m-yokoyama@hhc.eisai.co.jp|
21276853|NCT02813421|Children's Hospital Los Angeles|Dr. Jessica Ferris|323-361-4606|jeferris@chla.usc.edu|
21276854|NCT00441350|Menarini Group|Angela Capriati, MD PhD - Global Director Clinical Sciences|+39 055 5680|acapriati@menarini-ricerche.it|9990
21276855|NCT01679197|University of Michigan|Dr. Elif Oral|7346157271|eliforal@med.umich.edu|
21276856|NCT04213209|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21276857|NCT00385788|UT MD Anderson Cancer Center|Clinical Research Operations Team, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org|
21276858|NCT03050697|Alcon Research, LLC|Sr. Clinical Trial Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21276859|NCT02597582|Taichung Veterans General Hospital|Shih-An Liu|+886-4-23592525|saliu@vghtc.gov.tw|5409
21276860|NCT00423683|North Shore LIJ Health System|Valerie Blake|516-562-0100|vblake@nshs.edu|
21276861|NCT01680783|University of Chicago|John P. Kress|7737026790|jkress@medicine.bsd.uchicago.edu|
21276862|NCT02129647|NYU Langone|Theodore Nicolaides|212-263-9959|Theodore.Nicolaides@nyualangone.org|
21276863|NCT04862156|OrganOx|Katerina de Metz|19713442167|katerina.demetz@organox.com|
21276864|NCT01570283|Center for Cell and Gene Therapy|Dr. Helen Heslop|832-824-4662|heheslop@txch.org|
21276865|NCT00256776|EBMT|Clinical Study Unit|+31(0)715265005|ebmtcsu@lumc.nl|
21276866|NCT00685802|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21276867|NCT01333072|MUSouthCarolina|C. Lindsay DeVane, Pharm.D.|8432701818|devaneL@musc.edu|
21276868|NCT03233958|University of Toronto|Barna Konkoly-Thege|+1 (705) 549 3181|konkoly.thege.barna@gmail.com|2614
21276869|NCT03093272|Dana-Farber Cancer Institute|Lauren Harshman, MD|617-632-2429|laurenc_harshman@dfci.harvard.edu|
21276870|NCT00103038|Oregon Health and Science University|Gerda Teglassy, MD|5034945626|tothg@ohsu.edu|
21276871|NCT01463982|HanmiPharma|Director of clinical research team|8224109038|jajung@hanmi.co.kr|
21276872|NCT01265667|Can-Fite BioPharma Ltd|Zivit Harpaz|972-3-9241114|zivit@canfite.co.il|
21276873|NCT02462486|Allergan, Inc|Clinical Trials Registry Team|1-800-347-4500|IR-CTRegistration@allergan.com|
21276874|NCT01118845|Symbio Pharmaceuticals|Toshihiko Nagase|81-3-5472-1127|tnagase.331@symbiopharma.com|
21276875|NCT01731886|Columbia University|Suzanne Lentzsch, MD, PhD, Professor of Medicine|646-317-4840|sl3440@cumc.columbia.edu|
21276876|NCT02280187|Medtronic Spinal and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
21276877|NCT04668274|Marshall A. Hayward, Ph.D., Jupiter Orphan Therapeutics Inc.|David Wyatt|305-547-5857|david.wyatt@syneoshealth.com|
21276878|NCT02127073|Montefiore Medical Center|Dr. Sheldon Feldman, Chief Breast Surgery and Breast Surgery Oncology|929-246-6300|sfeldman@montefiore.org|
21276879|NCT02039063|EA Pharma Co., Ltd|Corporate Communication Dept.|+81-(0)3-6280-9600|contact_ea@eapharma.co.jp|
21276880|NCT00171340|Novartis Pharmaceuticals|Study Director|862- 778 8300||
21276881|NCT03827018|Kiniksa Pharmaceuticals (UK), Ltd. c/o Kiniksa Pharmaceuticals Corp.|Clinical Operations Study Director|1-781-431-9100|studyinfo@kiniksa.com|
21276882|NCT01067716|Abbott Medical Optics|Amelia Saliba|408-273-4158|amelia.saliba@amo.abbott.com|
21276883|NCT02646917|Crown Laboratories, Inc.|Thomas Hitchcock, PhD|8883723982|THitchcock@crownlaboratories.com|
21276884|NCT00680186|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21276885|NCT01351350|Takeda|Medical Director, Clinical Science|+1-866-835-2233|trialdisclosures@takeda.com|
21276886|NCT04647383|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
21276887|NCT03746002|University of Maryland School of Pharmacy|Brent Reed|410-706-1452|breed@rx.umaryland.edu|
21276888|NCT00304707|University of Massachusetts Medical School|David Kalman, PhD|9785782371|kalmand@comcast.net|
21238740|NCT04382924|Algernon Pharmaceuticals|Dr. Christopher Bryan|2045572308|cbryan@algernonpharmaceuticals.com|
21276889|NCT00613730|Amgen Inc.|Study Director|866-572-6436||
21276890|NCT00777855|UCSF|Leslie Benet|(415) 476-3853|leslie.benet@ucsf.edu|
21229909|NCT02959983|Allergan, Inc|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
21229910|NCT03221270|University of North Carolina at Chapel Hill|Rachel Force, PhD|984-974-6239|rachel_force@med.unc.edu|
21229911|NCT03308786|Case Western Reserve University|Michael M. Lederman MD|2168448786|MXL6@CASE.EDU|
21229912|NCT03572972|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21229913|NCT04266769|LightForce Orthodontics|Kelsey Fafara|7329775646|kelsey@lightforceortho.com|
21229914|NCT01193842|AIDS Malignancy Consortium|AMC Statistical Center|501-526-6712|jylee@uams.edu|
21229915|NCT00894127|bioAffinity|Maria Zannes|505-400-9747|mz@bioaffinitytech.com|
21276891|NCT01043926|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21238741|NCT02659787|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
21238742|NCT00261495|Janssen Pharmaceutica NV|EMEA Medical Affairs Director Analgesia|+49 4107 312356|kpappert@its.jnj.com|
21238743|NCT01932697|Mayo Clinic|Daniel J. Ma, M.D.|507/284-3261|Ma.Daniel@mayo.edu|
21238744|NCT01083654|University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|608-262-7563|sss@ctri.wisc.edu|
21238745|NCT05582304|Johnson & Johnson Vision Care, Inc. (JJVC)|John R Buch|1-800-843-2020|jbuch@its.jnj.com|
21238746|NCT01916655|VA San Diego Healthcare System|Carl J. Stepnowsky, PhD|858-642-1240|Carl.Stepnowsky@va.gov|
21238747|NCT02401464|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21238748|NCT00215540|Discovery Laboratories, Inc.|Dr. Robert Segal|215-488-9300|rsegal@discoverylabs.com|
21238749|NCT03010462|Nexstim Plc|Vice President, Medical Affairs|+358927271710|jarmo.laine@nexstim.com|
21238750|NCT01492686|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21238751|NCT02313909|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
21276892|NCT00789113|University of Minnesota College of Pharmacy|Dr. Rory P. Remmel|6126240472|remme001@umn.edu|
21276893|NCT04965389|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
21276894|NCT01436643|Novartis Pharmaceuticals|Study Director|862-778-8300||
21276895|NCT00842530|Sanofi Pasteur|Medical Director||Contact-US@sanofi.com|
21276896|NCT01382251|Department of Anesthesiology, The Ottawa Hospital|Dr. Gregory L Bryson|613.761.4169|glbryson@ottawahospital.on.ca|
21276897|NCT01117987|Novartis Pharmaceuticals|Study Director|862-778-8300|Trialandresults.registries@novartis.com|
21276898|NCT02377063|UCLA Center for Human Nutrition|Zhaoping Li, MD, PhD - Principal Investigator|310-206-1987|zli@mednet.ucla.edu|
21276899|NCT01524913|Emory University|Gary Bouloux, MD, DDS|404-778-4500|gfboulo@emory.edu|
21276900|NCT00702208|CUNY School of Public Health, Hunter College|Heidi Jones|212-396-7750|hjon@hunter.cuny.edu|
21276901|NCT03391115|University of Colorado, College of Nursing|Heather Coats, PhD, APRN-BC, PI|303-724-3740|heather.coats@cuanschutz.edu|
21276902|NCT02664987|Mundipharma Pte Ltd|Valerie Leck|+65 6511 1165|info.rma@mundipharma.com.sg|
21276903|NCT03183141|Seres Therapeutics|Lisa von Moltke, MD, Chief Medical Officer|617-945-9626|clinicalstudies@serestherapeutics.com|
21276904|NCT04034355|Egetis Therapeutics AB|Kristina Sjoblom Nygren|+46 732344698|kristina.sjoblom@egetis.com|
21276905|NCT03535857|University of Pittsburgh|Dr, Gnankang Sarah Napoe|412-641-7850|napoegs@upmc.edu|
21276906|NCT00380757|Ottawa Hospital Research Institute|Manya Charette|613-798-5555|mancharette@ohri.ca|17758
21276907|NCT01937351|Avinger|Thomas Lawson|650.241.7030|tlawson@avinger.com|
21276908|NCT01961687|Becton Dickinson|Dawn Heimer / Sr. Director Medical Affairs|401-479-1253|dawn.heimer@bd.com|
21276909|NCT03632135|Cordgenics|Pier Paolo Claudio, MD, Chief Scientific Officer|6064657226|claudio@cordgenics.com|
21276910|NCT01467479|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21276911|NCT03815240|Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergology Charité - Universitätsmedizin Berlin|Dr. Jan Kottner|+49 30 450 518218|jan.kottner@charite.de|
21276912|NCT02065713|Instituto Medicina Molecular|Elsa Vieira-Sousa|00351 217999544|elsa-sousa@hotmail.com|47221
21276913|NCT00655850|University of Alabama at Birmingham|Francisco Robert, MD|205-934-5077|pacorobertuab@cs.com|
21276914|NCT02459665|University of Liverpool|Prof. Janneke van de Wijgert, Chief Investigator|+447557195108|j.vandewijgert@liverpool.ac.uk|
21276915|NCT01117337|Moulana Hospital|Mohamed Ismail, Chief Consultant, Moulana Hospital, Perianthalmanna|0091-9447128511|drgargpankaj@yahoo.com, mdismail13@gmail.com|
21276916|NCT01045993|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21276917|NCT01004042|Brazilian Center for Studies in Dermatology|Dr. Doris Hexsel|+55 51 30262633|cientifico@cbed.org.br|
21276918|NCT00474851|Boston Children's Hospital|Dr. Amy D. DiVasta|617-355-3792|Amy.DiVasta@childrens.harvard.edu|
21276919|NCT01833533|AbbVie|Global Medical Information|800-633-9110||
21276920|NCT02017860|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21276921|NCT03738020|LG Chem|Study Leader|82-2-6987-4148|sodam@lgchem.com|
21289095|NCT01471574|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21289096|NCT03380572|Imperial College London|Mr R Aggarwal|02033126840|r.aggarwal@ic.ac.uk|
21229916|NCT02484690|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21229917|NCT01757535|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinica.Trials@bms.com|
21229918|NCT00589290|National Institutes of Health (NIH), National Cancer Institute (NCI)|Arun Rajan, M.D.|301-594-5322|rajana@mail.nih.gov|
21229919|NCT00485433|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
21229920|NCT03487549|Verrica Pharmaceuticals|Susan Cutler, VP, Medical Affairs|484-773-0898|scutler@verrica.com|
21229921|NCT02637622|Johns Hopkins Bloomberg School of Public Health|John FP Bridges|614-685-2543|john.bridges@osumc.edu|
21229922|NCT04638400|Division of Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo, 462 Grider St, Buffalo, NY 14215, USA|Dr. Paresh Dandona|7169574325|pdandona@kaleidahealth.org|
21289097|NCT00447278|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21229923|NCT03366012|Columbia University|Julian Abrams, MD, MPH|212-305-1909|ja660@cumc.columbia.edu|
21229924|NCT02323113|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21289098|NCT00357162|Washington University|Amanda Cashen, M.D.||acashen@im.wustl.edu|
21289099|NCT03927157|AstraZeneca|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
21229925|NCT00690274|University of Texas Southwestern Medical Center|Carol A. Tamminga, MD|214-645-2789|carol.tamminga@utsouthwestern.edu|
21229926|NCT02280304|Michael E. DeBakey VA Medical Center|Dr. Mary Newsome|713-791-1414|mary.newsome@va.gov|25947
21289100|NCT06262607|Clexio Biosciences Ltd|Regulatory Affairs Lead|972-733318704|myriam.belahcen@clexio.com|
21289101|NCT02249793|Upenn|Dr. Carsten Skarke|215-573-0673|cskarke@pennmedicine.upenn.edu|
21289102|NCT05950906|Calibr-Skaggs|Director of Clinical Operations|(858) 242-1000|abrooks@scripps.edu|
21289103|NCT01692756|Univerisity of Kentucky|Cale Jacobs, ATC, PhD|8592183065|Kycartilagedoc@gmail.com|
21289104|NCT02969018|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21289105|NCT04790201|University of North Carolina at Chapel Hill|Bradley Gaynes, MD, MPH|(919) 445-0214|bradley_gaynes@med.unc.edu|
21289106|NCT01365611|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|828
21289107|NCT00376506|James Madison University|Christy L. Ludlow, PhD|540-568-3876|ludlowcx@jmu.edu|
21289108|NCT02942407|Duke Universitey|Christopher Granger, MD|919-668-8900|christopher.granger@duke.edu|
21289109|NCT00374868|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21289110|NCT03188185|Alkermes|Eva Stroynowski|781-609-7000|eva.stroynowski@alkermes.com|
21289111|NCT00774748|UNC Chapel Hill School of Medicine Dept. Hematology|Clinical Research Coordinator|919-966-2359|catherine_soriano@med.unc.edu|
21289112|NCT02965456|Bausch Health Americas, Inc.|Clinical Operations Director|1-510-259-5284|aloncaric@bauschhealth.com|
21289113|NCT04465955|NGM Biopharmaceuticals|VP, Clinical Operations|(650)243-5555|ngm282@ngmbio.com|
21229927|NCT00928395|Uroplasty, Inc|Clinical Study Manager|952-426-6153|megan.otoole@uroplasty.com|
21276922|NCT02772562|Medical University of South Carolina|Dr. Michael Lilly|843-792-4271|lillym@musc.edu|
21276923|NCT04578886|University of Alabama at Birmingham, Department of Anesthesiology and Perioperative Medicine|Dr. Andrew B. Barker, MD|205-934-6007|abbarker@uabmc.edu|
21276924|NCT03478865|National Institutes of Health|Emily Chew, MD, Principal Investigator, NEI|3014966583|emily.chew@nih.gov|
21276925|NCT01048502|UPenn|Muredach Reilly|215-573-1214|muredach@mail.med.upenn.edu|
21276926|NCT03336242|Radius Pharmaceuticals, Inc.|Tarek El Akkad, Head of Clinical Development|6175514000|telakkad@radiuspharm.com|
21276927|NCT04136951|Columbia University|Maxim Topaz, PhD, Elizabeth Standish Gill Associate Professor of Nursing|6462760460|mt3315@cumc.columbia.edu|
21276928|NCT02457611|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21276929|NCT00384293|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21276930|NCT03005067|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21276931|NCT00296491|GlaxoSmithKline|GSK Response Center|866-435-7343||
21276932|NCT02560779|TRACON Pharmaceuticals Inc.|Charles Theuer|(858) 550-0780|ctheuer@traconpharma.com|
21276933|NCT02296853|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21276934|NCT01835379|Smith & Nephew, Inc.|Vice President, Medical & Clinical Affairs|817-302-3914|jaime.dickerson@smith-nephew.com|
21289114|NCT01327703|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
21289115|NCT05324371|Boston Scientific|Nilou Zilinek|508-683-6127|nilou.zilinek@bsci.com|
21289116|NCT00317369|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21289117|NCT03491917|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
21289118|NCT01068912|MediVector, Inc., managing member MDVI, LLC|Dr. Carol Epstein, Chief Medical Officer|617-439-4500|cepstein@medivector.com|
21289119|NCT02965833|Alcon, A Novartis Division|Head, CDMA Vision Care Franchise|1-888-451-3937|alcon.medinfo@alcon.com|
21289120|NCT03370302|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21289121|NCT03407482|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21276935|NCT05575063|Johnson & Johnson Surgical Vision|Brian Pall, Dr.|+1 904 6292289|bpall@its.jnj.com|
21289122|NCT00627978|Weill Cornell Medicine|Linda Vahdat, MD|646-962-9888|ltv2001@med.cornell.edu|
21289123|NCT03442569|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
21289124|NCT03290768|Savvysherpa, LLC|Jared Jones|763-549-3540|JaredJones@savvysherpa.com|8116
21276936|NCT00493454|The University of Texas (UT) MD Anderson Cancer Center|Felipe Samaniego, MD / Associate Professor||CR_Study_Registration@mdanderson.org|
21276937|NCT02593396|UNIVERSITY MALAYA|Dr. Anne Yee|+60379492068|annyee17@um.edu.my|
21276938|NCT01740791|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21276939|NCT00277524|Medtronic Cardiac Rhythm Disease Management|Melinda Hoey, Clinical Research Specialist|763-526-2831|Melinda.hoey@medtronic.com|
21276940|NCT02310763|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21276941|NCT02010255|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21289125|NCT02239289|Université du Québec à Trois-Rivières|Martin Descarreaux|1-819-376-5011|martin.descarreaux@uqtr.ca|3791
21289126|NCT03010501|Laboratory for the Study of Human Ingestive Behavior, The Pennsylvania State University|Dr. Barbara J. Rolls|814-863-8481|bjr4@psu.edu|
21289127|NCT04507321|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21276942|NCT04625062|New York University|Dr. Tara McAllister|212-992-9445|tkm214@nyu.edu|
21276943|NCT00396331|Genzyme|Medical Monitor||medinfo@genzyme.com|
21276944|NCT01931527|Washington University School of Medicine|Elisa Fabbrini, MD, PhD|314-362-8156|efabbrini@dom.wustl.edu|
21276945|NCT04072315|Pliant Therapeutics, Inc.|Éric Lefebvre, M.D., Chief Medical Officer|1-650-481-6779|ELefebvre@pliantrx.com|
21276946|NCT02470091|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21276947|NCT02598895|University of Washington/Fred Hutchinson Cancer Center|Dr. Heather Cheng|206-606-7416|hhcheng@uw.edu|
21229928|NCT03642457|Icahn School of Medicine at Mount Sinai|Poonam Pai|347-569-4816|poonam.paibantwalhebbalasankatte@mountsinai.org|
21229929|NCT01895062|5i Sciences|Dr. Richard Rose|858-759-2205|rrose@5isciences.com|
21276948|NCT02389101|Turku Univesrity Hospital, Turku, Finland|Heikki Minn, MD|+35823130000|heikki.minn@utu.fi|30149
21276949|NCT01298778|Wake Forest School of Medicine|Dr. Jessica Booth|336-718-8278|jbooth@wakehealth.edu|
21276950|NCT02540447|Mansoura Faculty of Medicine|Amr Mohamed Yassen Ali Badawy|+201001497044|amryassen@hotmail.com|
21276951|NCT00604201|National Heart Lung and Blood Institute|Childs, William|+1 301 451 7128|childsr@nhlbi.nih.gov|
21276952|NCT00536484|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21276953|NCT01770431|Huazhong University of Science and Technology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong Wuhan, Hubei, China|Xiaoping Chen, Professor|+86 27 83663400|chenxp@medmail.com.cn|
21276954|NCT02549573|US WorldMeds|Regulatory Affairs Specialist||regulatoryaffairs@usworldmeds.com|
21276955|NCT02083926|Yale University|Dr. Michael H. Bloch|2037374539|michael.bloch@yale.edu|
21276956|NCT02919813|Oregon Health & Science University|OB/Gyn Regulatory Specialist|503-494-3666|whru@ohsu.edu|
21276957|NCT02939950|Bausch Health Americas, Inc.|Director of Clinical Operations|(585) 338-5306|Daniel.Donatello@bausch.com|
21276958|NCT02409329|Vanderbilt University Medical Center|Lindsay S. Mayberry, PhD, MS|615-875-5821|lindsay.mayberry@vumc.org|
21276959|NCT03200535|Kaiser Permanente Colorado|Dr. Emily Schroeder|303-636-2478|emily.b.schroeder@kp.org|
21276960|NCT03291041|Vanda Pharmaceuticals|Vanda Pharmaceuticals|2027343400|clinicaltrials@vandapharma.com|
21276961|NCT01447225|Merrimack Pharmaceuticals, Inc.|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
21276962|NCT01451996|University of Chicago|Anup Malani, J.D., Ph.D|773-702-9602|amalani@uchicago.edu|
21276963|NCT00784524|Masonic Cancer Center, University of Minnesota|Dr. Douglas Yee|612-626-8487|yeexx006@umn.edu|
21276964|NCT00156715|Dartmouth Medical School|Christopher OKeefe, M.A|603-271-5287|chris.okeefe@hitchcock.org|
21276965|NCT00865098|Merck Serono Co., Ltd, Tokyo, Japan|Masataka Ota|+81 0 3 6853 8611||
21276966|NCT01014624|Daiichi Sankyo, Inc.|Brian Baker|973-944-2712|bbaker@dsi.com|
21276967|NCT01715896|MedImmune, LLC|Marius Albulescu, Associate Medical Director|301-398-0000|albulescum@medimmune.com|
21276968|NCT02834806|Medinol|Dina Kofler, VP Clinical Affairs|+97237679032|dinak@medinol.com|
21289128|NCT01917773|Riley Hospital for Children, Indiana University|Joseph Croffie|317-944-3774|jcroffie@iupui.edu|
21289129|NCT02260622|Ottawa Hospital Research Institute|Penny Phillips|613-737-8899|pphillips@ohri.ca|
21289130|NCT00544882|Teva Branded Pharmaceutical Products R&D|Director of Clinical Research|610-786-7047|clinicaltrialsdisclosure@tevapharm.com|
21289131|NCT02583269|Wake Forest University Health Sciences|Study Nurse|336-713-7748|saverill@wakehealth.edu|
21289132|NCT03579771|Robert H. Lurie Comprehensive Cancer Center of Northwestern University Clinical Cancer Center|Shishir Maithel, MD|312-908-5250|shishir.maithel@nm.org|
21289133|NCT02369458|Washington University School of Medicine|Peter Oppelt, M.D.|636-916-9922|poppelt@wustl.edu|
21289134|NCT06048068|Columbia University Irving Medical Center|Dr. Sachin Agarwal, MD MPH|212-305-7236|sa2512@cumc.columbia.edu|
21289135|NCT03853798|Agios Pharmaceuticals, Inc.|Agios Medical Affairs|833-228-8474|medinfo@agios.com|
21289136|NCT02743494|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21289137|NCT02207608|University of Rome Tor Vergata|Prof. Enrico Finazzi Agro|+393296152920|efinazzi@tin.it|
21289138|NCT05800145|Wake Forest University Health Sciences|Deepak Palakshappa, MD|3367161795|dpalaksh@wakehealth.edu|
21289139|NCT05643794|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21289140|NCT02813447|Duke University Medical Center|Neil MacIntyre|919 681 2720|macin001@mc.duke.edu|
21289141|NCT04167670|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|Please email|medicalinformation@phathompharma.com|
21289142|NCT04827446|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
21289143|NCT05399485|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21289144|NCT02955394|University of Colorado Hospital|Anthony Elias|720-848-0300|anthony.elias@cuasnchutz.edi|
21276969|NCT01659736|The Institute of Living|Gretchen J. Diefenbach, Ph.D|860-545-7685|Gretchen.Diefenbach@hhchealth.org|
21276970|NCT05444556|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21276971|NCT01746264|Mayo Clinic|Dr. Seema Kumar|507-538-2724|Kumar.Seema@mayo.edu|
21276972|NCT02791893|Mount Sinai Beth Israel, New York, NY|Dr. Benjamin Natelson|212-844-6768|Benjamin.Natelson@mountsinai.org|
21276973|NCT04051463|Cornea Research Foundation of America|Marianne Price|317-814-2990|mprice@cornea.org|
21289145|NCT01363076|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|
21229930|NCT00533897|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21289146|NCT04706403|UMass Chan Medical School|Dr. Kimberly Fisher|(508)8561975|Kimberly.Fisher@umassmemorial.org|
21229931|NCT02515825|AUM Cardiovascular|Marie Johnson, PhD|612.799.2511|mariej@aumcv.com|
21289147|NCT02642679|Brigham and Women's Hospital|Indranil Sinha, MD|617-732-5282|isinha@bwh.harvard.edu|
21289148|NCT03735498|Massachusetts General Hospital|Dr. Deborah Forst|617-724-8770|dforst@partners.org|
21229932|NCT01134276|Seoul National University College of Medicine|Sun-Whe Kim|+82-2-2072-2315|sunkim@plaza.snu.ac.kr|
21289149|NCT01653262|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
21289150|NCT00371631|Michael E. DeBakey Veterans Affairs|Dr. Barbara Trautner, MD, PhD|713-440-4438|barbara.trautner@va.gov|
21289151|NCT01112267|Janssen Korea/ Seoul|Therapeutic area Scientist|+82-2-2094-4802||
21289152|NCT00160615|Cares|UCB|+1844 599||2273
21289153|NCT02014103|University of Cincinnati|Rita Alloway|513.558.1568|rita.alloway@uc.edu|
21289154|NCT05638737|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21289155|NCT02068794|Mayo Clinic|Evanthia Galanis MD|(507) 284-2511|galanis.evanthia@mayo.edu|
21289156|NCT03690544|Mayo Clinic|Alison J. Bruce, M.B., Ch.B.|904-953-6402|Bruce.Alison@mayo.edu|
21289157|NCT02787291|Abbott CAHF CRM|Dr. Adam Cline- Clinical Scientist|818-493-2025|adam.cline@abbott.com|
21276974|NCT04943159|CLINUVEL PHARMACEUTICALS LTD|Clinical Operations Manager||mail@clinuvel.com|
21276975|NCT03316573|Dana-Farber Cancer Institute|Eric Jacobsen, MD|617-632-6633|edjacobsen@partners.org|
21229933|NCT01935791|Imperial College London|Dr Chioma Izzi-Engbeaya|02075942454|c.izzi@imperial.ac.uk|
21229934|NCT01546207|Icahn School of Medicine at Mount Sinai|Dr. Vivek Y. Reddy|212-241-7114|vivek.reddy@mountsinai.org|
21229935|NCT01626456|Alkermes, Inc.|ARISTADA Medical Information|866-274-7823|usmedinfo@alkermes.com|
21229936|NCT00713323|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
21229937|NCT00506662|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21229938|NCT03921073|Moffitt Cancer Center|Dr. John Mullinax|813-745-1867|John.Mullinax@moffitt.org|
21229939|NCT03643796|University of Arkansas for Medical Sciences|Mohamed Abdeldayem|2244279747|Maabdeldayem@uams.edu|
21229940|NCT00270790|University of Maryland School of Medicine|Mohan Suntharalingam|410-328-2328|msuntha@umm.edu|
21229941|NCT03019185|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21229942|NCT02764333|Memorial Sloan Kettering Cancer Center|Dr. Jason Konner, MD|848-225-6530|konnerj@MSKCC.ORG|
21229943|NCT03626168|The University of Alabama|Dr. Amy Ellis, principal investigator|205-348-8128|aellis@ches.ua.edu|
21289158|NCT04439175|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21229944|NCT01772160|GlaxoSmithKline|GSK Response Center|866-435-7343||
21238752|NCT02798211|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
21289159|NCT01022580|University of California, San Francisco|Roberta A Ballard, MD|415-476-4193|roberta.ballard@ucsf.edu|
21289160|NCT00835978|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21289161|NCT01105130|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
21276976|NCT04075890|UCLA|Reza Tadayon Nejad|3102066389|rtadayonnejad@mednet.ucla.edu|
21276977|NCT01396382|Vanderbilt-Ingram Cancer Center|Dr. Ronald Walker|615-343-8516|ronald.walker@vanderbilt.edu|
21276978|NCT00775528|Solvay Pharmaceuticals|Sven Voet - Global Communication|+32 (0)2 509 69 77|sven.voet@solvay.com|
21276979|NCT01099631|Masonic Cancer Center, University of Minnesota|Daniel Saltzman|612 626 4214|saltz002@umn.edu|
21289162|NCT00943904|University of California, Riverside|Dr. Karen Noblett|(951) 827-7581|karen.noblett@ucr.edu|
21276980|NCT00873119|Topotarget A/S|PRS Administrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com|
21276981|NCT03648879|National Cancer Institute|Dr. Jeremy L. Davis|240-760-6229|jeremy.davis@nih.gov|
21289163|NCT02927145|University of Oxford|Dr Angela Minassian|0044 01865611425|angela.minassian@ndm.ox.ac.uk|
21229945|NCT00071396|The University of Texas M. D. Anderson Cancer Center|Alessandra Ferrajoli, MD, BS / Assistant Professor|713-745-4613|eharriso@mdanderson.org|
21229946|NCT01032174|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21229947|NCT00386607|Novartis Pharmaceuticals|Study Director|862-778-8300||
21229948|NCT02761733|Felton Institute & Palo Alto University|Joyce Chu (Principal Investigator)|650-814-8376|jchu@paloaltou.edu|
21289164|NCT02582632|AbbVie|Global Medical Services|800-633-9110||
21289165|NCT05027282|Bausch Health Americas, Inc|Study Director|19083009920|susan.harris@bauschhealth.com|
21289166|NCT00580398|Massachusetts General Hospital|Elyse Park, Ph.D., MPH|617-724-6836|epark@partners.org|
21229949|NCT02713204|Regeneron Pharmaceuticals|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
21229950|NCT01222884|Pharmacosmos A/S|Vice President Research & Development Department|+45 59485959|llt@pharmacosmos.com|
21289167|NCT00327171|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
21238753|NCT01782872|Hospital for Special Surgery|Dr. Jacques YaDeau|212774224|yadeauj@hss.edu|
21289168|NCT02346916|Bassett Healthcare Network Research Institute|Melissa B Scribani|6075477635|melissa.scribani@bassett.org|
21289169|NCT03677401|Menlo Therapeutics, Inc.|Iain Stuart|1-800-775-7936|Iain.Stuart@foamix.com|
21289170|NCT02421211|Janssen Research & Development|Trial Physician, Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
21289171|NCT01177410|Salix Pharmaceuticals, Inc.|Vice President of Clinical Operations|919-862-1000|enoch.bortey@salix.com|
21289172|NCT00886236|Medical University of South Carolina|Larry Field|843-876-5744|field@musc.edu|
21289173|NCT00471354|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21289174|NCT05558410|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21289175|NCT04368910|Medicines for Malaria Venture|Stephan Duparc, MD|+41 22 555 0300|duparcs@mmv.org|
21289176|NCT02265744|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21289177|NCT00574951|NRG Oncology|Angela Kuras on behalf of Mike Sill, PhD|716-845-5702|kurasa@nrgoncology.org|
21289178|NCT00923702|International Agency for Research on Cancer|Dr Partha Basu|+3347273|basup@iarc.fr|8167
21289179|NCT05161936|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
21289180|NCT01086475|Christian Sarkine Autism Treatment Center|Dr. Minshawi|317-944-8162|nminshaw@iupui.edu|
21289181|NCT02541903|UAB|Dr. Lisle Nabell, MD, Professor|(205) 934-3061|lnabell@uabmc.edu|
21289182|NCT02448043|Department of Ophthalmology, Northwestern University Feinberg School of Medicine|Dr. David J. Palmer|3126958150|dpalmermd@comcast.net|
21289183|NCT01017497|Duke University Medical Center|John Kirkpatrick MD|919 6687342|john.kirkpatrick@dm.duke.edu|
21289184|NCT00827242|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21289185|NCT05762679|Johns Hopkins school of medicine|Dr. Preeti Raghavan|9174889626|praghavan@jhmi.edu|
21289186|NCT01431846|Eastern Colorado Health Care System|Dr. Michael Ho|720-857-5115|michael.ho@va.gov|
21289187|NCT01186406|Duke University Medical Center|Annick Desjardins, MD, FRCPC|9196846173|annick.desjardins@duke.edu|
21289188|NCT01944774|TaiGen Biotechnology Co., Ltd.|Chen-En Tsai, M.D., Ph.D.|+886-2-8177-7072|cetsai@taigenbiotech.com|1211
21289189|NCT02635035|NYU Langone Health|Terry Leon|1 646 754 4841|Terry.Leon@nyulangone.org|
21289190|NCT04913636|Procter & Gamble|Clinical Trial Manager|513-622-4601|conde.e.1@pg.com|
21289191|NCT05399355|University of California San Diego|Brian Ilfeld, MD, MS|(858) 220-5714|baabdullah@health.ucsd.edu|
21289192|NCT02337946|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21276982|NCT03851588|University of Cape Town|Prof Gary Maartens|214066008|gary.maartens@uct.ac.za|+27
21289193|NCT02513563|Moffitt Cancer Center|Jhanelle E. Gray, MD|813-745-2677|Jhanelle.Gray@moffitt.org|
21289194|NCT01648959|Toronto Western Hospital/UHN|Emad Al Azazi|416-603-8500|emad.alazazi@uhnresearch.ca|6237
21289195|NCT01059851|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21289196|NCT03770455|Tulane University School of Medicine|Jodi L. Layton, MD|504-988-6121|jlayton@tulane.edu|
21289197|NCT01121575|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21289198|NCT00153842|Dartmouth-Hitchcock Medical Center|James Rigas, MD|603-650-6344|Cancer.Research.Nurse@Dartmouth.edu|
21289199|NCT06059066|Houston Methodist Hospital|Julu Benoy|(713) 441-6455|jbenoy@houstonmethodist.org|
21289200|NCT05417113|Icahn School of Medicine at Mount Sinai|Dr. Christina Jeng|212-241-4743|christina.jeng@Mountsinai.org|
21276983|NCT01884688|University of Arkansas for Medical Sciences|Frits van Rhee|501-526-6990|vanrheefrits@uams.edu|
21289201|NCT00134719|GlaxoSmithKline|GSK Response Center|866-435-7343||
21276984|NCT02938013|Johns Hopkins University School of Medicine|Dr. Mark Sulkowski|443-997-1900|msulkowski@jhmi.edu|
21276985|NCT04099641|OncXerna Therapeutics, Inc.|CDO, OncXerna Therapeutics, Inc.|(781) 907-7810|medical@oncxerna.com|
21276986|NCT00895037|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21276987|NCT00738361|Ohio State University Comprehensive Cancer Center|Thomas Olencki, D.O.|614-293-2886|Thomas.Olencki@osumc.edu|
21276988|NCT01103479|Northwestern University|Kenzie A. Cameron|312-503-3910|k-cameron@northwestern.edu|
21276989|NCT00834899|University of North Carolina at Chapel Hill|Kenneth I. Ataga, MD|919-966-0178|kataga@med.unc.edu|
21229951|NCT02256072|Northwestern University Feinberg School of Medicine|Dr. Lee A. Lindquist|312-503-3916|LAL425@md.northwestern.edu|
21276990|NCT00161382|The University of Texas Health Science Center at Houston (UTHealth) School of Public Health|Dr. Susan R. Tortolero|713-500-9634|Susan.Tortolero@uth.tmc.edu|
21276991|NCT02610816|Cincinnati Childrens Hospital Medical Center|Marc E. Rothenberg, MD, PhD|513-636-7177|Marc.Rothenberg@cchmc.org|
21276992|NCT00384176|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
21276993|NCT00402025|Amgen, Inc.|Study Director|866-572-6436||
21276994|NCT02767934|University of Washington|Dr. Ryan Cassaday|206-606-1202|cassaday@seattlecca.org|
21276995|NCT04290494|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21276996|NCT02369354|Duke University School of Medicine|Dr. L. Ebony Boulware|919-613-2099|ebony.boulware@duke.edu|
21276997|NCT03078478|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21276998|NCT04184999|SR Cornea Consultants|Dr. Sanjay Rao|8476685498|sanjaynraomd@gmail.com|
21276999|NCT02642237|Radboud university medical centre|Matthijs Kox|+31243653881|matthijs.kox@radboudumc.nl|
21277000|NCT02756637|Abramson Cancer Center of the University of Pennsylvania|John Christodouleus|215-662-2428|John.Christodouleas@uphs.upenn.edu|
21277001|NCT03182751|Mayo Clinic|Dr. Brandon Yuan|507-255-6112|Yuan.Brandon@mayo.edu|
21277002|NCT03064438|Accuitis, Inc.|Chief Science Officer|678-812-1492|info@accuitis.com|
21277003|NCT01314118|Janssen Services, LLC|Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21277004|NCT04266301|Novartis Pharmaceuticals|Study Director|862-778-3000|novartis.email@novartis.com|
21277005|NCT04079712|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
21277006|NCT01432574|H. Lee Moffitt Cancer Center and Research Institute|Anna Giuliano, Ph.D.|813-745-6820|anna.giuliano@moffitt.org|
21277007|NCT04373551|University of Alabama at Birmingham|Dr. Mirjam-Colette Kempf|205-934-9333|MKempf@uab.edu|
21277008|NCT01042535|H. Lee Moffitt Cancer Center and Research Institute|Hatem Soliman, M.D.|813-745-4933|hatem.soliman@moffitt.org|
21277009|NCT00682617|Oregon Health & Science University|Dr. Nels Carlson|(503) 494-6420|carlsonn@ohsu.edu|
21277010|NCT00107042|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
21277011|NCT03919448|Laboratorios Richmond|Regulatory Affairs Department|(+54 11) 5555 - 1600|info@richmondlab.com|
21277012|NCT03341546|NHS Tayside|Mark Worrall|01382632177|markworrall@nhs.net|
21277013|NCT01221090|Scott & White Hospital|Dr. Samuel N. Forjuoh|(254) 771-7695|SFORJUOH@sw.org|
21277014|NCT03438539|University of Kentucky|Craig Rush, Ph.D.|859-257-5388|crush2@uky.edu|
21277015|NCT04507126|MGH|Research Operations Director|617-724-1992|jgerber2@mgh.harvard.edu|
21277016|NCT01440010|Medical Faculty Mannheim, Heidelberg University|PD Dr. med. Elena Sperk|+496213838624|elena.sperk@medma.uni-heidelberg.de|
21277017|NCT00440466|J&J PRD|Peter Bowers|908-927-2116||
21277018|NCT02997657|Brown University School of Public Health|Christopher Kahler|401 863-6651|christopher_kahler@brown.edu|
21277019|NCT00140413|Children's Hospital Los Angeles|Dr. Mark Borchert|323-361-6219|mborchert@chla.usc.edu|
21277020|NCT02062801|Sharp HealthCare|Dr. David R. Gambling|858-395-5668|david.gambling@sharp.com|
21277021|NCT01223235|Memorial Sloan Kettering Cancer Center|Dr. Paul Sabbatini, MD|212-639-4016|sabbatip@mskcc.org|
21277022|NCT01057381|Baylor College of Medicine|Olutoyin A. Olutoye, M.D., M.Sc.|(832) 824-5800|oao@bcm.edu|
21277023|NCT02596321|Abbott|Therapeutic Area Clinical Director|+31294477008|dmitri.kazei@abbott.com|
21277024|NCT01231750|University of Cincinnati|Dr. Faisal Khan|513-558-4272|faisal.khan@uc.edu|
21277025|NCT03998436|Novalead Pharma Pvt. Ltd.|Supreet K. Deshpande|7066233033|supreet@novaleadpharma.com|
21277026|NCT04976621|Corporal Michael J. Crescenz VA Medical Center|Helene Moriarty, PhD, RN|610-519-5735|helene.moriarty@va.gov|
21277027|NCT03851796|Virginia Commonwealth University|Dr. Melanie K Bean|804-527-4756|melanie.bean@vcuhealth.org|
21277028|NCT05363683|University of Nebraska Medical Center|Elizabeth Wellsandt|402-559-4309|elizabeth.wellsandt@unmc.edu|
21277029|NCT05560763|Inari Medical|Ashleigh Willson|925-330-3446|ashleigh.willson@inarimedical.com|
21277030|NCT03347838|Rocky Mountain Regional VA Medical Center / University of Colorado School of Medicine|Robert Keith, MD|720-857-5120|robert.keith@cuanschutz.edu|
21289202|NCT01807520|Novartis Pharmaceuticals|Study Director|862-778-8300||
21277031|NCT03422198|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
21277032|NCT00949988|UCSD Moores Cancer Center|Kimberly Aguilar, Clinical Trials Manager|858-534-5201|k1aguilar@ucsd.edu|
21277033|NCT01929395|Dartmouth Hitchcock Medical Center|Dr Richard J. Barth Jr.|(603) 650-9479|Richard.J.Barth.Jr@hitchcock.org|
21277034|NCT01980342|Johns Hopkins University School of Medicine|Jenny Robinson, MD MP FACOG|4105500337|mailto:jrobin87@jhmi.edu|
21277035|NCT03604341|Oregon Health & Science University|OB/Gyn Regulatory Specialist|503-494-3666|whru@ohsu.edu|
21277036|NCT00484419|Daiichi Sankyo Inc.|John Raia, Director, Professional Affairs|973-630-2683|jraia@dsus.com|
21277037|NCT01829113|Sarah Cannon Development Innovations|Senior Director, Regulatory Science|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
21277038|NCT00845975|McDonald hearing Aid Centers|Louis A Looper, MA, CCC-A|916-218-4100|llooper@hearingmed.com|
21277039|NCT00355472|Kyowa Hakko Kirin|Project Management Department, Development Division||clinical.info@kyowa-kirin.co.jp|
21277040|NCT05445843|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
21277041|NCT03453840|University of California San Francisco|Liusheng Huang (Co-Investigator and Drug Research Unit Co-Director)|415-502-2594|liusheng.huang@ucsf.edu|
21277042|NCT05307679|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21277043|NCT03581214|Washington University in St Louis|Nandini Raghuraman|3144548181|nraghuraman@wustl.edu|
21277044|NCT06279871|Arcturus Therapeutics, Inc.|Arcturus Therapeutics, Inc.|858-900-2660|clinicaltrials@arcturusrx.com|
21277045|NCT02674386|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21277046|NCT04706507|Fred Hutch Cancer Center|Dr. Michael J. Boeckh|2066676706|mboeckh@fredhutch.org|
21277047|NCT00606138|Rush University Medical Center|Mathew MacCumber, MD, PhD|312-563-4032|denise_voskuil-marre@rush.edu|
21277048|NCT02080507|Emory University|Dr. William McDonald|404-712-6945|wmcdona@emory.edu|
21277049|NCT00285584|NYU School of Medicine|Michael Marmor, Ph.D.|212-263-6667|michael.marmor@nyumc.org|
21277050|NCT00712244|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21277051|NCT02063087|Mayo Clinic|Dr. Erik Hess|507-255-6501|hess.erik@mayo.edu|
21277052|NCT00303667|Masonic Cancer Center|Sarah Cooley, M.D.|612-626-4024|cool0023@umn.edu|
21277053|NCT01029392|William Beaumont Hospital|Dr. Peter Gerrits|248-551-0487|peter.gerrits@beaumont.org|
21277054|NCT01534637|Comprehensive Cancer Center of Wake Forest University|James Lovato, MS|336-713-4172|jlovato@wakehealth.edu|
21277055|NCT01523587|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21277056|NCT02709486|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21277057|NCT00489281|Johns Hopkins University|F Javier Bolanos Meade, MD|4106146398|fbolano2@jhmi.edu|
21277058|NCT00737737|National Institutes of Health Clinical Center|Andrew Mannes, M.D.|301-594-3427|Andrew.Mannes@nih.gov|
21277059|NCT00706355|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21277060|NCT02463799|Johns Hopkins University|Emmanuel Antonarakis, MD|410-502-8341|eantona1@jhmi.edu|
21277061|NCT02691741|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21277062|NCT02139124|Purdue Pharma|Dr Lance Payne|1-800-384-5349|Lance.Payne@purdue.ca|
21277063|NCT02697773|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21277064|NCT02243293|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21277065|NCT03069417|Massachusetts General Hospital|Dr. Christina Psaros|617.726.7458|cpsaros@mgh.harvard.edu|
21277066|NCT00440115|Department of Preventive Medicine & Public Health|Edward F. Ellerbeck, MD, MPH, Chair|913-588-2829|eellerbe@kumc.edu|
21277067|NCT01769274|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21277068|NCT01172821|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21277069|NCT02985879|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21277070|NCT04266041|Dartmouth-Hitchcock Medical Center|Dr. Yinchen Song|603-650-5104|yinchen.song@hitchcock.org|
21277071|NCT02723773|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21277072|NCT05168774|Children's Hospital of Philadelphia|Dr. David Lynch|215-590-2242|lynch@chop.edu|
21277073|NCT03940703|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21277074|NCT03310957|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
21277075|NCT01794572|Institut de Cancérologie de l'Ouest|Pr Stéphane SUPIOT|(+33) 2406799 00|stephane.supiot@ico.unicancer.fr|
21277076|NCT02658487|Vanderbilt University Medical Center|Stephen Strickland, MD|(615) 936-8422|stephen.strickland@vumc.org|
21277077|NCT03707041|Medicines for Malaria Venture|Andrew Slade|+41 22 555 0415|sladea@mmv.org|
21277078|NCT02277704|Tonix Pharmaceuticals|Gregory M. Sullivan, Chief Medical Officer|862-904-0355|greg.sullivan@tonixpharma.com|
21277079|NCT02473783|Tri-Service General Hospital, National Defense Medical center|Dr. Chin-bin Yeh|886-2-87923311|chinbinyeh@gmail.com|17387
21277080|NCT01891305|Viamet Pharmaceuticals Inc|Neil Moore||nmoore@viamet.com|
21277081|NCT03768726|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21277082|NCT01286558|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21277083|NCT00362817|The Ohio State University Medical Center and James Cancer Hospital & Solove Research Inst.|Herbert Newton,|614-293-4448|newton.12@osu.edu|
21277084|NCT01787279|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21277085|NCT00836719|LSU Health Sciences Center-New Orleans|Jesus Lovera MD|5045686700|jlover@lsuhsc.edu|
21277086|NCT01567826|Icahn School of Medicine at Mount Sinai|Dr. Pedro R. Moreno||pedro.moreno@mountsinai.org|
21277087|NCT01612884|Indiana University School of Medicine|Rolf Kreutz, MD|3179620500|rkreutz@iu.edu|
21277088|NCT01360866|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|609 524 6788|clinicaltransparency@otsuka-us.com|
21277089|NCT03647046|University of Rochester|Study Coordinator|(585) 276-6922|keratoconusstudy@gmail.com|
21277090|NCT00918463|Weill Cornell Medicine|Dr. Peter Martin||pem9019@med.cornell.edu|
21277091|NCT01784666|Massachusetts General Hospital, Center for Quantitative Health|Dr. Roy Perlis|617-643-6310|rperlis@partners.org|
21277092|NCT03465748|Illinois College of Optometry|Dr. Yi Pang|3129497287|YPang@ico.edu|
21277093|NCT00276549|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Robert Dreicer|216-445-4623|dreicer@ccf.org|
21277094|NCT04939519|Huntsman Cancer Institute at University of Utah|Dr. David Wetter|801-213-6178|david.wetter@hci.utah.edu|
21277095|NCT04060719|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21277096|NCT04319159|Biofrontera Bioscience GmbH|Clinical Trial Department|+49 214 876 32|ameluz@biofrontera.com|66
21277097|NCT00971737|Johns Hopkins University|Leisha Emens, MD, PhD||emensle@jhmi.edu|
21277098|NCT00754442|University of Maryland School of Medicine|Elizabeth A Streeten, MD|410-328-6219|estreete@medicine.umaryland.edu|
21277099|NCT01557842|Biosense Webster, Inc.|Karen Cropper, Manager, Clinical Operations|(800) 729-9010|Kcropper@its.jnj.com|8607
21277100|NCT06972251|Health Systems Research Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT)|Allison Lewinski, PhD, MPH, RN, FAAN|919-286-0411|allison.lewinski@va.gov|
21277101|NCT01453413|Taking Control of Your Diabetes|Dr. Steven Edelman, MD|858-755-5683|svedelman@vapop.ucsd.edu|
21277102|NCT05224544|Coloplast, Clinical strategies|Malene Hornbak Landauro, Medical writer of Clinical strategies|+4549112057|dkmhla@coloplast.com|
21229952|NCT01297920|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21229953|NCT03212690|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21229954|NCT00474760|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21229955|NCT03608254|The University of Alabama|Dr. Amy Ellis|2053488128|aellis@ches.ua.edu|
21229956|NCT03476278|Derince Eğitim Ve Araştırma Hastanesi|Dr. Hande Aytuluk|5336515650|handegrbz@gmail.com|
21229957|NCT03000569|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21277103|NCT04625673|University of Pennsylvania|Regulatory Lead|215.573.7101|psom-ind-ide@pobox.upenn.edu|
21277104|NCT04744155|Children's Mercy Kansas City|Melissa K. Miller MD|8162343430|mmiller@cmh.edu|
21277105|NCT00351351|IU Health Methodist Hospital|James Lingeman, MD|317-962-0870|lrawlings@iuhealth.org|
21277106|NCT01341587|University of Maryland Baltimore|*Administrator, Division of Gerontology|4107062406|cquinn@som.umaryland.edu|
21277107|NCT03208673|Allergan|Medical Director|714-246-4500|CTRegistration@allergan.com|
21277108|NCT03891329|BIOTRONIK SE & Co.KG|Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
21277109|NCT03176784|University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|608-262-7563|sss@ctri.wisc.edu|
21277110|NCT02990806|Nichi-Iko Pharmaceutical Co., Ltd|Hiroshi Anekawa|+81-3-6262-1564|hiroshi-anekawa@nichiiko.co.jp|
21277111|NCT02654587|OSE Immunotherapeutics|Chief Medical Officer Immuno-Oncology|+33 2 28 29 10 10|contact@ose-immuno.com|
21277112|NCT01825837|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
21277113|NCT02269631|Emory Unioversity|Hartman, Terry Professor, SPH Epidemiology|404-727-8713|terryl.johnson.hartman@emory.edu|
21277114|NCT00904748|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21277115|NCT01682148|Ipsen|Medical Director, Neurology|clinicaltrials@ipsen.com|clinicaltrials@ipsen.com|
21277116|NCT01056640|Mayo Clinic|Dr. Paul Takahashi|507-284-2511|takahashi.paul@mayo.edu|
21277117|NCT01803269|University of Chicago|Theodore Karrison, PhD|773-702-9326|tkarrison@health.bsd.uchicago.edu|
21277118|NCT01202877|The University of Texas (UT) MD Anderson Cancer Center|Jorge Cortes, MD/Professor, Leukemia|1-877-632-6789|CR_Study_Registration@mdanderson.org|
21277119|NCT04403763|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21277120|NCT01376310|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21277121|NCT04844021|Northwestern University|Dr. Rinad Beidas|312-503-0546|rinad.beidas@northwestern.edu|
21277122|NCT02339740|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21277123|NCT01807117|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Raj Paspulati|1-800-641-2422|Raj.Paspulati@UHhospitals.org|
21277124|NCT00572117|Stanford University School of Medicine|Michael J. Ostacher, MD, MPH, MMSc|650-493-5000|ostacher@stanford.edu|
21277125|NCT00606502|Allos Therapeutics, Inc|Medical Monitor|303-426-6262|gweems@allos.com|
21277126|NCT01615887|SUNY University at Buffalo|Ralph Benedict|716-323-0556|benedict@buffalo.edu|
21277127|NCT02443545|Chiesi Canada Corp.|Fernando Tricta, MD|1-800-854-3534|f.tricta@chiesi.com|7049
21277128|NCT04179019|Brigham and Women's Hospital|Anand Vaidya|6177325666|anandvaidya@bwh.harvard.edu|
21277129|NCT01855048|Organization:Institute of iNtRON Biotechnology|Jun SooYoun, Ph.D. / Executive Director/ Principal researcher|+82-31-739-5332|jsy@intron.co.kr|
21277130|NCT03465436|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21277131|NCT01813071|PATH|Jennifer O'Reilly|202-540-4510|joreilly@path.org|
21289203|NCT01631188|Rutgers University|Enrique Pantin, MD|7328900640|pantinej@rwmjs.rutgers.edu|
21289204|NCT01870596|Sidney Kimmel Comprehensive Cancer Center|B. Douglas Smith|(410) 287-2935|bdsmith@JHMI.edu|
21289205|NCT04575324|Chestnut Health Systems|Dr. Dennis Watson|312-274-5316|dpwatson@chestnut.org|
21289206|NCT01363440|Regeneron|Clinical Trial Management|914 847 7000|clinicaltrials@regeneron.com|
21289207|NCT01771913|Faculdade de Medicina - Universidade de Sao Paulo|Dr. Luiz Alexandre Lorico Tissiani|55-11-981798707|latissiani@gmail.com|
21289208|NCT00992836|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|919-405-1429|mallen@fhi360.org|
21289209|NCT03695094|Cares|UCB|+1844 599|clinicaltrials@ucb.com|2273
21238754|NCT03505476|University of Iowa|Dr. Jennifer Hrabe Clinical Associate Professor|319-384-7359|jennifer-hrabe@uiowa.edu|
21238755|NCT02748694|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21238756|NCT01005303|Belfast Health and Social Care Trust|Dr Nick McKeag|02895048487|nick.mckeag@belfasttrust.hscni.net|
21238757|NCT04026165|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21238758|NCT01257880|Swedish Medical Center|Jill T. Jesurum, Ph.D.|206-683-1505|jill.jesurum@swedish.org|
21238759|NCT01059630|Genentech|Medical Communications|800-821-8590|genentech@druginfo.com|
21238760|NCT03170375|VA Ann Arbor Health System|Scott Hummel|734-845-5283|scott.hummel@va.gov|
21238761|NCT00441701|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21238762|NCT00077064|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
21238763|NCT05028426|Groupe Hospitalier de la Rochelle Ré Aunis|Dr. Vivien Fontaine|+33546455050|recherche.clinique@ght-atlantique17.fr|
21238764|NCT02206217|School of Optometry, The Hong Kong Polytechnic University|Prof. Carly Sin Yin Lam|2766 6091|carly.lam@polyu.edu.hk|
21238765|NCT02007434|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
21238766|NCT01321541|Institut de Recherches Internationales Servier|Anton Egorov, Associate Project Director Clinical Development|+33 1 55 72 31 94|anton.egorov@servier.com|
21238767|NCT06097676|Azurity Pharmaceuticals, Inc.|David Sequeira|(913) 389-7961|david.sequeira@azurity.com|
21238768|NCT00828308|BrUOG|Anthony Mega, MD|4018633000|BrUOG@brown.edu|
21238769|NCT03299686|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21277132|NCT05486065|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21277133|NCT01425528|University of utah|Kathryn Swoboda MD|801-585-9717|Swoboda@genetics.utah.edu|
21277134|NCT00307931|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
21277135|NCT00854373|University of California, San Francisco|Mitchell P. Rosen, MD|415-353-7475|rosenm@obgyn.ucsf.edu|
21277136|NCT00613834|The Ohio State University|Dr. Michelle Isley|614-293-4203|Michelle.Isley@osumc.edu|
21277137|NCT03360539|Harvard University|Dr. Margaret McConnell|6174321232|mmcconne@hsph.harvard.edu|
21277138|NCT03377023|Moffitt Cancer Center|Dr. Jhanelle E. Gray|813-745-7282|jhanelle.gray@moffitt.org|
21238770|NCT02709005|University of Iowa Hospitals and Clinics|Patricia Winokur, MD|319-384-4590|patricia-winokur@uiowa.edu|
21277139|NCT04121091|Unit of Biological and Precision Psychiatry|Dr Daniel Lindqvist|+4646173885|daniel.lindqvist@med.lu.se|
21238771|NCT02348684|Medical College of Wisconsin|Dr. Carmen Bergom|414-805-4365|cbergom@mcw.edu|
21238772|NCT03532308|Yale University School of Medicine|Michael S. Leapman, MD|(203) 785-2815|michael.leapman@yale.edu|
21238773|NCT03720938|Abant Izzet Baysal University|Dr. Halil Ibrahim Atasoy|90 532 599 89 53|halilibrahimatasoy@gmail.com|
21238774|NCT02535364|Juno Therapeutics|Dr. Nikolaus Trede|206-566-5886|Nick.Trede@junotherapeutics.com|
21277140|NCT05529511|University Hospitals of Derby and Burton NHS Foundation Trust|Hayley Carter|01332254631|hayley.carter1@nhs.net|
21277141|NCT03740113|Univeristy of Virginia|Dr. Jamie Zoellner|434-962-4488|jz9q@virginia.edu|
21277142|NCT03028948|Rutgers Cancer Institute of New Jersey|Dr. Sharon Manne|7322356759|mannesl@cinj.rutgers.edu|
21277143|NCT00118378|New York State Psychiatric Institute|Dr. Judith Rabkin|212.543.5762|jgr1@columbia.edu|
21289210|NCT02323334|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21289211|NCT00266812|Merck, Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21289212|NCT01617967|Alnylam Pharmaceuticals, Inc.|Chief Medical Officer|1-877-256-9526|medinfo@alnylam.com|
21289213|NCT00530075|Nippon Kayaku Co., Ltd.|Pharmaceuticals Group|+81-3-6731-5200||
21289214|NCT04764539|iTherapy, LLC|Lois Brady, CEO|9258120037|lois@itherapyllc.com|
21289215|NCT01166945|University of Wisconsin School of Medicine and Public Health|Ellen Wald, MD|608-263-8558|erwald@pediatrics.wisc.edu|
21289216|NCT00977184|Department of Neurology, Centre Hospitalier Universitaire Vaudois|David H. Benninger, MD||David.Benninger@chuv.ch|
21289217|NCT03520569|University of Virginia|Eugene Barrett|434-924-1263|EJB8X@VIRGINIA.EDU|
21289218|NCT00784927|Mayo Clinic Arizona|Craig B. Reeder, MD||Reeder.Craig@mayo.edu|
21289219|NCT01779362|George Washington University Biostatistics Center|Sharon Edelstein, Lead Research Scientist|301-881-9260|sharone@bsc.gwu.edu|
21277144|NCT02516410|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21277145|NCT01252719|Melinta Therapeutics, LLC|Medical Information|1-844-633-6568|medinfo@melinta.com|
21277146|NCT04051684|Montefiore Medical Center|Dr. Karina Gritsenko|718-920-7246|kgritsen@montefiore.org|
21238775|NCT02252432|Cedars Sinai Medical Center|Ofelia Loani Elvir Lazo, MD|310-423-1682|Loani.Elvir-Lazo@cshs.org|
21277147|NCT01475253|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21277148|NCT03135899|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21238776|NCT00560612|Durham VA Medical Center|Christine Marx, MD|919 286-0411|marx0001@mc.duke.edu|7426
21229958|NCT01346969|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21229959|NCT02002832|Sumitomo Pharma (Suzhou) Co., Ltd.|Chief Medical Officer|+86-10-57322070|luo@dsmpharm.com.cn|
21229960|NCT03540030|OrthoCarolina Research Institute|Susan Odum|7049457710|susan.odum@orthocarolina.com|
21229961|NCT04122534|Montana State University|Dr. Kelly E. Knight|303-819-6997|kelly.knight3@montana.edu|
21229962|NCT00644189|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu|
21229963|NCT00579878|University of Nebraska Medical Center|James O'Dell|402 559-7288|jrodell@unmc.edu|
21229964|NCT02128932|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
21229965|NCT01433731|TetraLogic Pharmaceuticals|Vice President, Clinical Research|610-889-9900|jeffrey.skolnik@tetralogicpharma.com|
21229966|NCT03685123|University of Virginia|Damon Swift|(434) 924-1436|dls3s@virginia.edu|
21229967|NCT02020577|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21229968|NCT01893203|Helsinki university hospital|Noora Neittaanmäki-Perttu|+358407190362|noora.neittaanmaki@fimnet.fi|
21229969|NCT02925117|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21229970|NCT02663908|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
21229971|NCT00370071|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21229972|NCT02004522|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
21229973|NCT03175978|IGF Oncology, LLC|Hugh McTavish|651-207-8270|hmctavish@igfoncology.com|
21229974|NCT01787331|University of California, San Francisco|Rahul Aggarwal, MD|877-827-3222|cancertrials@ucsf.edu|
21229975|NCT00450255|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
21229976|NCT01892865|Michael E. DeBakey VAMC|Panos Kougias MD MSc|713.794.7700|panagiotis.kougias@va.gov|
21229977|NCT01402011|University of British Columbia Department of family practice|Dr. Helene Bertrand, M.D., CCFP, LM|604-985-5381|dr.hbertrand@gmail.com|
21229978|NCT00394147|University of Maryland|Dr. Ranee Mehra|410-328-7904|rmehra@umd.edu|
21229979|NCT01759511|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21229980|NCT02569671|Institut Straumann|Mustapha El Amrani|0041619651741|mustapha.elamrani@straumann.com|
21229981|NCT01484041|Georgetown University|Dr. Claudine Isaacs|2024443677|isaacsc@georgetown.edu|
21229982|NCT02675114|Edwards Lifesciences|Research Director|949-250-2500|THV_CT.gov@Edwards.com|
21229983|NCT03423082|University of Pittsburgh|Nghi C. Nguyen, MD, PhD|412-647-0104|nguyennc@upmc.edu|
21229984|NCT00545766|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21229985|NCT05154578|MinervaX|Cornelia Oostvogels/Chief Medical Officer (CMO)|00491515092821|lio@minervax.com|
21229986|NCT03930680|University of Arkansas for Medical Sciences|Hui-Ming Chang, MD, MPH|501-686-7575|hchang@uams.edu|
21229987|NCT04622306|Sagami|Mr Grant R Burt|+33 607 54 52 41|grantburt@sagami-europe.com|
21229988|NCT01200524|AstraZeneca|Heather Bryson||clinicaltrialtransparency@astrazeneca.com|
21229989|NCT02758132|University of Hawaii Cancer Center|Stacy Mercado|8084404561|smercado@cc.hawaii.edu|
21229990|NCT00491764|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21229991|NCT00894166|Duke University Medical Center|Jed E. Rose, Ph.D.|919-668-5055|jed.rose@duke.edu|
21229992|NCT05350410|Alzheimer's Disease Cooperative Study|Sara Moukarzel, PhD, Program Manager|(858) 432-8828|smoukarzel@health.ucsd.edu|
21229993|NCT01601132|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21229994|NCT00354887|UT MD Anderson Cancer Center|Robert Wolff, MD / Professor|713-792-2828|mjlim@mdanderson.org|
21229995|NCT02110238|Seikagaku|Junko Takamura||junko.takamura@seikagaku.co.jp|
21229996|NCT02050841|Octapharma|Michael Eppolito|2016041155|michael.eppolito@octapharma.com|
21229997|NCT03273543|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
21229998|NCT01479478|Stanford University|Dr. Natali Aziz, MD|650-725-5720|mfmresearch@stanford.edu|
21229999|NCT00815698|Herlev Hospital, dept. of Surgery|Jacob Rosenberg|+45 26237323|jacob.rosenberg@regionh.dk|
21230000|NCT00142935|The Miriam Hospital/Brown University|Josiah D. Rich, MD, MPH|401-793-4770|jrich@lifespan.org|
21230001|NCT01330030|Stanford University|Dr Joel D Killen|650-723-5895|jkillen@stanford.edu|
21230002|NCT05047770|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21230003|NCT01952145|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
21230004|NCT04138810|University of Pennsylvania, Department of Urogynecology|Dr. Lily Arya|215-662-4147|larya@pennmedicine.upenn.edu|
21230005|NCT05294640|Moyes Eye Center|Meleha Ahmad|401-523-5911|meleha.ahmad@gmail.com|
21230006|NCT05981391|The University of Texas Health Science Center at San Antonio|Dr. John Moring|210-562-6716|moringj@uthscsa.edu|
21230007|NCT05224141|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21230008|NCT02956070|Universidade Federal Fluminense|Dr. Luiz Augusto Poubel|55 21 981113344|luizpoubel@id.uff.br|
21230009|NCT03225573|AIn Shams University|Professor Ali Gamal Zohni|+2 01004931448|zohniali@gmail.com|
21230010|NCT03881670|IU School of Optometry|Pete Kollbaum|812-856-0108|kollbaum@iu.edu|
21230011|NCT04545060|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
21230012|NCT00619177|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21277149|NCT04146363|Eli Lilly and Company|Chief Medical officer|800-549-5929|ClinicalTrials.gov@lilly.com|
21230013|NCT00914485|Southeast Louisiana Veterans Health Care System|P. Adam Kelly, PhD, MBA|504-988-6630|peter.kelly@va.gov|
21230014|NCT02435147|HealthEast Care System|Amy Fehrer|651-232-5363|afehrer@healtheast.org|
21230015|NCT02939079|Isfahan University of Medical Sciences|Dr. Vahid Shaygannejad|+98 913 313 3550|shaygannejad@med.mui.ac.ir|
21277150|NCT03660241|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21230016|NCT01609231|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21230017|NCT01180647|NYU School of Medicine|Joshua D. Lee|212-263-4242|joshua.lee@nyumc.org|
21277151|NCT06141824|Pfizer|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21230018|NCT04873700|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21230019|NCT01044706|Kremers Urban Development Company|Bang Qian Xu, Ph.D., Director of Biopharmaceutics|812-523-5453|Bang.xu@ucb.com|
21277152|NCT02914236|Aerin Medical, Inc.|Scott Wolf, M.D., Chief Medical Officer|650-597-0111|swolf@aerinmedical.com|
21277153|NCT00380692|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21277154|NCT02676284|Zambon S.A.U.|Antonio Esteras, MD|+34 93 544 64 00|antonio.esteras@zambongroup.com|
21277155|NCT00735917|University of Colorado Cancer Center|Wells A. Messersmith, M.D.||wells.messersmith@ucdenver.edu|
21277156|NCT00708708|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21230020|NCT01485393|MGH|Dr. Johnson-Akeju|6177247200|ojohnsonakeju@partners.org|
21277157|NCT04776746|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261|medicalinformation@acadia-pharm.com|2897
21277158|NCT05017974|University of California, San Francisco|Dr. Jennifer Felder|415-476-7014|jennifer.felder@ucsf.edu|
21277159|NCT00856830|Univeristy of Alabama at Birmingham|Francisco Robert, MD, Department of Medicine, Division of Hematology and Oncology|205-934-5077|pacorobertuab@cs.com|
21277160|NCT02148913|Corewell Health|Esther Peariso|616-486-0358|esther.peariso@corewellhealth.org|
21230021|NCT01561378|Montefiore Medical Center|Daniel Ceusters|718-920-2956|dceuster@montefiore.org|
21277161|NCT01191242|Intermountain Heart Institute|John Carlquist, PhD|8014081028|john.carlquist@imail.org|74707
21277162|NCT01287039|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21277163|NCT02694549|CaveoMed GmbH|Albertus M. Scheule, MD, PhD, MBA|+49(0)7071-53982-10|albertus.scheule@caveomed.com|
21277164|NCT01005706|Medical University of South Carolina|Charles F. Bratton, MD|843-792-4003|brattocf@musc.edu|
21289220|NCT01137812|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
21289221|NCT04425018|Dana-Farber Cancer Institute|Adrienne G. Waks, MD|617-632-3800|adrienne_waks@dfci.harvard.edu|
21230022|NCT04545554|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21230023|NCT02478372|Golden Jubilee National Hospital|David McDonald|07914861078|david.mcdonald@nhs.net|
21230024|NCT00116428|Biosense Webster|Melissa Schultz, Project Manager, Regulatory Affairs|800-729-9010|mschult1@its.jnj.com|8787
21230025|NCT02350569|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21230026|NCT00788073|Seaside Therapeutics|Dr. Paul Wang, Vice President of Clinical and Medical Affairs|617-374-9009|pwang@seasidetherapeutics.com|1015
21230027|NCT00910273|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21230028|NCT00660673|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21230029|NCT01713608|Medicines for Malaria Venture|Dr Fiona Macintyre|+41 22 799 4078|macintyref@mmv.org|
21230030|NCT00579098|Mayo Clinic|Paul A. Friedman, MD|507-255-2398|friedman.paul@mayo.edu|
21230031|NCT03505190|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21230032|NCT01254331|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21230033|NCT00633750|Vanderbilt-Ingram Cancer Center|Carlos Arteaga, M.D.|(615) 936-1919||
21230034|NCT01903031|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21230035|NCT05213481|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21230036|NCT00569270|Arthur F Gelb MD|Arthur F Gelb MD Principal Investigator|562-633-2204|afgelb@msn.com|
21230037|NCT01811680|Tan Tock Seng Hospital|Dr Karen Chua|65 68894580|karen_chua@ttsh.com.sg|
21230038|NCT00447005|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21230039|NCT00492531|Professor of Medicine: Chief, Pulmonary, Allergy and Critical Care Medicine: Director, Hemostasis and Vascular Biology Research Institute; University of Pittsburgh School of Medicine|Mark Gladwin|412-692-2117|gladwinmt@upmc.edu|
21230040|NCT01469234|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21230041|NCT03451578|Duke Eye Center|Dr. Sharon Fekrat|919-681-3937|sharon.fekrat@duke.edu|
21230042|NCT00400764|Hoffman-LaRoche|Medical Communications|800-821-8590||
21230043|NCT04584970|University of North Carolina at Chapel Hill|Jacob Nelson|704-677-3801|jacob14@live.unc.edu|
21230044|NCT03113071|Fox Chase Cancer Center|Dr. Henry Fung|215-728-2674|Henry.Fung@tuhs.temple.edu|
21230045|NCT02764697|Tampa Bay Uveitis Center, LLC|Dr. Grace Levy Clarke|855 798 8393|grace@tampabayuveitis.com|
21230046|NCT00302107|Tuscaloosa VA Medical Center|Lori Davis, MD|205-554-2000|lori.davis@va.gov|
21230047|NCT00437983|Sourazky Tel-Aviv Medical Center|Prof. A. Korczyn|972-3-6974229|amosk@tasmc.health.gov.il|
21230048|NCT00621959|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
21230049|NCT01790932|Dana-Farber Cancer Institute|Nancy Lin, MD|617.632.2335|nlin@partners.org|
21230050|NCT04721171|Medical College of Wisconsin|Thangam Venkatesan|262-226-9632|tvenkate22@gmail.com|
21230051|NCT03360747|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
21289222|NCT04740567|Vanderbilt University Medical Center|Jin H. Han|615-936-0253|jin.h.han@vumc.org|
21289223|NCT06204887|Recep Tayyip Erdogan University|Dr. Ahter Şanal Çıkman|05069293341|ahter.sanalcikman@erdogan.edu.tr|
21289224|NCT02762604|Albert Einstein College of Medicine|Dr. Helena Blumen|7184303810|helena.blumen@einsteinmed.edu|
21289225|NCT05128942|Spruce BioSciences Inc.|Spruce CMO, MD|415-655-4169|clinicaltrials@sprucebio.com|
21230052|NCT03569618|University of California, San Francisco|Riley Bove, MD MSc|415.502.7209|riley.bove@ucsf.edu|
21230053|NCT06238362|SleepRes|Bernard Hete|+1 615-921-2406|bhete@sleepres.com|
21230054|NCT03730012|Astellas Pharma Global Development, Inc|Clinical trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
21230055|NCT01798004|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21230056|NCT03320057|University of California San Francisco|Shelly Kaller|510-986-8945|shelly.kaller@ucsf.edu|
21277165|NCT03623620|Massachusetts General Hospital, Center for Women's Mental Health|Lee Cohen, MD|617-724-8020|lcohen2@mgh.harvard.edu|
21277166|NCT03265288|Laurent Pharmaceuticals Inc.|Dr Jean-Marie Houle, VP Clinical Development|514-941-2313|jmhoule@laurentpharma.com|
21277167|NCT02790034|Newron Pharmaceuticals S.p.A.|Ravi Anand MD, Chief Medical Officer|+41 793741364|regulatoryaffairs@newron.com|
21277168|NCT00099268|Novartis Pharmaceuticals|Study Director|862 778-8300||
21277169|NCT03702049|University of California, Irvine, Sue & Bill Gross School of Nursing|Adeline M Nyamathi|(949) 824-8932|anyamath@hs.uci.edu|
21277170|NCT05016622|Montefiore Medical Center|Dr. Balazs Halmos|718-405-8404|bahalmos@montefiore.org|
21277171|NCT02678442|Mayo Clinic|Dr. Michael B. Wallace|904-953-2222|wallace.michael@mayo.edu|
21277172|NCT00836017|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21277173|NCT02164734|Albany Medical Center|Joaquim Pinheiro, MD, MPH|518-262-5421|pinheij@amc.edu|
21277174|NCT03301532|University of Texas Southwestern Medical Center|Dr. Juan Pascual|214-648-3550|juan.pascual@utsouthwestern.edu|
21277175|NCT01011075|University of Pittsburgh Cancer Institute|Julie E. Bauman, MD|412-648-6507|baumanje@upmc.edu|
21277176|NCT00171301|Novartis Pharmaceuticals|Study Director|862-778-8300||
21277177|NCT00894517|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21277178|NCT02370914|Stanford University|Dr. Paul Auerbach|(650) 725-9445|auerbach@stanford.edu|
21277179|NCT00251225|University of Pittsburgh Cancer Institute|Leonard J. Appleman, MD, PhD|412-648-6507|applemanlj@upmc.edu|
21277180|NCT00252174|McLean Hospital at time of study|John H. Halpern, M.D.|6179065063|jhalpern@recoverycoa.com|
21277181|NCT04323098|BioMarin Pharmaceutical Inc.|Tara M Robinson, MD, PhD, Senior Medical Director, Late-Stage Clinical Development|415-455-7931|tara.robinson@bmrn.com|
21277182|NCT04440449|University of Texas Health San Antonio|Rozmin Jiwani|210-450-8498|jiwani@uthscsa.edu|
21230057|NCT06956170|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21277183|NCT01134627|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21277184|NCT04776954|University of Minnesota|Michael Todd|6126264551|mmtodd@umn.edu|
21230058|NCT01516437|GlaxoSmithKline|GSK Response Center|866-435-7343||
21230059|NCT00403234|Purdue Pharma L.P.|Clinical Leader, Director of Clinical Research|800-733-1333||
21230060|NCT00825682|Sheba Medical Center|Dr Dorit Gamus|+972-3-5303956|dorit.gamus@sheba.health.gov.il|
21230061|NCT01696084|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency|2158709177|tom.chmielewski@jazzpharma.com|
21230062|NCT01925534|Tufts Medical Center|Dr. Nicholas Hill|(617) 636-6377|nhill@tuftsmedicalcenter.org|
21230063|NCT04805541|Akdeniz University|Prof.Dr. Ahmet Burak Bilgin|5465473336|gozdrburakbilgin@gmail.com|
21230064|NCT03695250|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
21230065|NCT04015336|National Cancer Institute|Dr. Scott Norberg, D.O.|301-275-9668|scott.norberg@nih.gov|
21230066|NCT03228433|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21230067|NCT00689078|ORA|Paul Gomes|9786858900|pgomes@oraclinical.com|
21230068|NCT03055156|Stanford University|Dr. Seiji Nishino|650-725-8602|nishino@stanford.edu|
21230069|NCT00304746|McLean Hospital|Harrison G Pope Jr., M.D.|617-855-2911|hpope@mcLean.harvard.edu|
21230070|NCT00129272|The University of Tennessee|Uma Rao, MD|615-794-3351|urao@utk.edu|
21230071|NCT03473171|The University of Texas Health Science Center at Houston|James M. Stark, MD|713-500-5650|James.M.Stark@uth.tmc.edu|
21230072|NCT01550731|Veterans Administration|Dr. Rebecca Sudore|(415) 221-4810|Rebecca.Sudore@va.gov|23475
21230073|NCT02601027|Stanford University|Gordon Kwanlyp Lee, Professor of Surgery (Plastic and Reconstructive Surgery)|650-723-5824|glee@stanford.edu|
21230074|NCT03289858|University of Massachusetts, Worcester|Eric Swart|503-880-7125|eric.swart@umassmemorial.org|
21230075|NCT01419626|Johnson & Johnson Consumer and Personal Products Worldwide|DIRECTOR ORAL HEALTH, MEDICAL AFFAIR & CLINICAL RESEARCH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21230076|NCT01365052|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21230077|NCT01146912|Columbia University|Melissa Stockwell, MD MPH|212-342-5372|mss2112@columbia.edu|
21230078|NCT02980783|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21230079|NCT00880542|University of Calicornia Los Angeles (UCLA)|William Tap, MD|888-798-0719|wtap@mednet.ucla.edu|
21230080|NCT00074984|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
21230081|NCT04289623|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
21230082|NCT03758443|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
21230083|NCT03080454|Feinstein Institute for Medical Research at Northwell Health|Bruce Volpe|516-562-3384|bvolpe1@northwell.edu|
21277185|NCT00466726|GIMEMA|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it|
21277186|NCT00350402|University of Florida|Dr. Dawn Bowers|(352) 392-3450|dawnbowers@phhp.ufl.edu|
21260890|NCT04068103|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
21260891|NCT04909463|CommonSpiritHealth|Trenton Bradbury|7193730213|trenton_b1@yahoo.com|
21260892|NCT01491958|The Ohio State University Comprehensive Cancer Center|Yvonne Efebera, M.D|614-293-3196|Yvonne.Efebera@osumc.edu|
21260893|NCT01695369|University of Houston, College of Optometry, TERTC|Jan Bergmanson, OD,PhD|713-743-1950|jbergmanson@uh.edu|
21277187|NCT00645944|Yale University|Cenk Tek, M.D.|203-974-7484|cenk.tek@yale.edu|
21277188|NCT00176631|Rutgers Cancer Institute of New Jersey|Dr. Robert DiPaola, MD|732-235-8675|dipaolrs@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
21277189|NCT04070287|Saint Louis University|Dr. Juliet Iwelunmor|2405280123|juliet.iwelunmor@slu.edu|
21277190|NCT02377921|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
21277191|NCT03399318|University of Rochester|Professor Gretchen L. Birbeck|+ 1(517) 505-0283|gretchen_birbeck@urmc.rochester.edu|
21277192|NCT04209335|University of Salford|ISOMETRIC CORE MUSCLE ENDURANCE IN HEALTHY ACTIVE AND NON-ACTIVE WORKING AGE POPULATIONS|07488550768|H.Holmberg@edu.salford.ac.uk|
21277193|NCT00703508|Virginia Commonwealth University|Dr. Kai Cheang|(804) 828-2257|kicheang@vcu.edu|
21277194|NCT05307887|Imperial College NHS Foundation Trust|Dr Thomas Sewell|02033122152|thomas.sewell2@nhs.net|
21277195|NCT00560937|Durham Veterans Affairs Medical Center|Christine E. Marx, MD, MA|919 286-0411|marx0001@mc.duke.edu|7426
21277196|NCT03919162|Vivoryon Therapeutics N.V.|Study Director|0049 34555599|clinics@vivoryon.com|00
21277197|NCT03471143|Washington University School of Medicine|Dr. Patricia Dickson|314-273-2943|pdickson@wustl.edu|
21277198|NCT01688726|Alcon Research, Ltd.|Abayomi Ogundele, Global Brand Medical Affairs Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21277199|NCT04553913|Atrium Health Wake Forest Baptist|Seiha Kim, DO|336-716-4498|sekim@wakehealth.edu|
21289226|NCT04544267|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21289227|NCT04536038|Hospital of the University of Pennsylvania|Alexander C. Fanaroff, MD, MHS|2156157674|alexander.fanaroff@pennmedicine.upenn.edu|
21289228|NCT05182125|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
21289229|NCT02085551|Penumbra, Inc.|Michaella Corso|+1 510-995-2079|mcorso@penumbrainc.com|
21289230|NCT05887401|University of North Carolina at Chapel Hill|Dr. Erin Coffman|9195254677|erin.coffman@advocatehealth.org|
21289231|NCT04530526|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
21289232|NCT05179603|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21289233|NCT05937373|Wake Forest University Health Sciences|Susan R. Vishneski, MD|336-306-0778|svishnes@wakehealth.edu|
21289234|NCT05942040|Rutgers University|Dr. Elizabeth Luth, Principal Investigator|6465120670|eluth@rwjms.rutgers.edu|
21289235|NCT06061952|University Hospitals Cleveland Medical Center|Martha Sajatovic, MD|216-844-2808|martha.sajatovic@UHHospitals.org|
21289236|NCT06142383|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21289237|NCT02943213|Cycle Pharmaceuticals Ltd|James Price|+44 1223 803638|james.price@cyclepharma.com|
21260894|NCT01195025|University Hospital Linköping|Dr. Joachim Zdolsek|+46101030000|joachim.zdolsek@lio.se|
21277200|NCT01481324|Shriners Hospital for Children|Dr. Todd Milbrandt|859-266-2101|tmilbrandt@shrinenet.org|
21277201|NCT06400745|Alcon Research, LLC|Director Clinical Trial Management, Surgical IOL|1-888-451-3937|alcon.medinfo@alcon.com|
21277202|NCT00656968|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|886-7-3422121|pihsu@isca.vghks.gov.tw|8233
21277203|NCT01885182|Mundipharma (China) Pharmaceutical Co. LTD|Clinical study manager|0086-10-65636800|Wei.Zhu@mundipharma.com.cn|6900
21277204|NCT00811434|Riley Hospital|Girish Subbarao|317-944-3774|gsrao@iupui.edu|
21277205|NCT03923699|Washington University School of Medicine|Thomas Kannampallil|(314) 273-7801|thomas.k@wustl.edu|
21277206|NCT03575871|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21277207|NCT05506358|The University of British Columbia|Pranav Shrestha|6507893270|pranav.shrestha@alumni.ubc.ca|
21277208|NCT00391079|GW Pharmaceuticals|Richard Potts Clinical Operations Director|+44 1223 266800|rp@gwpharm.com|
21277209|NCT03438396|Genmab A/S|Ibrahima Soumaoro|+1 609 430 2481|clinicaltrials@genmab.com|
21277210|NCT00262041|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21277211|NCT00834652|Washington University School of Medicine|Patrick J. Lustman, Ph.D.|3142861320|lustmanp@psychiatry.wustl.edu|
21277212|NCT03578237|University of California San Diego|Program Manager|(858) 220-5714|baabdullah@health.ucsd.edu|
21277213|NCT01173471|AstraZeneca|Stuart McIntosh||ClinicalTrialTransparency@astrazeneca.com|
21277214|NCT04132336|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21277215|NCT02488330|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21277216|NCT00584844|USAMRIID|Mark Goldberg, MD|301-619-4562|mark.goldberg@amedd.mil|
21277217|NCT00946348|Geisel School of Medicine at Dartmouth|Alan I. Green, M.D.|603-650-7549|alan.i.green@dartmouth.edu|
21277218|NCT03050203|Istituto Ortopedico Rizzoli|Cristiana Forni|0039516366|cristiana.forni@ior.it|694
21277219|NCT02384941|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21277220|NCT02493777|Ironshore Pharmaceuticals and Development, Inc.|Chief Scientific Officer|13457498174|bev@ironshorepharma.com|
21277221|NCT00468728|Optimer Pharmaceuticals, Inc.|Chief Scientific Officer|1-855-343-4243|medinfo@optimerpharma.com|
21277222|NCT01705236|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21277223|NCT06005597|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
21277224|NCT02100319|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21277225|NCT02224573|Greenwich Biosciences|Medical Enquiries|1-833-424-6724|medinfo@greenwichbiosciences.com|
21277226|NCT02546362|CEFALY Technology|Clinical Trials Department director|+32 4 367 67 22|info@cefaly.com|
21277227|NCT01138826|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21277228|NCT02566993|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|0034 918466000|clinicaltrials@pharmamar.com|
21277229|NCT05206448|University of Iowa|Rachel Mejia, DO|319-356-3143|rachel-mejia@uiowa.edu|
21277230|NCT03360916|University of Kansas Medical Center|John P. Thyfault|913-588-1790|jthyfault@kumc.edu|
21277231|NCT02589522|Johns Hopkins University|Grants Administrative Manager|4439273568|JHCCCRO@jhmi.edu|
21277232|NCT01478828|The SKCCC at Johns Hopkins|Dr. Phuoc Tran|410-614-6477|tranp@jhmi.edu|
21277233|NCT05611996|Massachusetts General Hospital|Dr. Jin Hui Joo|6177245317|jhjoo@mgh.harvard.edu|
21277234|NCT03053583|Anesthesiology|Jerrold Lerman MD|716-323-6570|jlerman@buffalo.edu|
21277235|NCT04479475|Johns Hopkins University|Haneefa Saleem, PhD, MPH|443-287-5130|haneefa.saleem@jhu.edu|
21277236|NCT02025010|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-7221|mtaplin@partners.org|
21277237|NCT01122316|University of California Los Angeles|Tamara Horwich, MD, MS|310-825-8816|thorwich@mednet.ucla.edu|
21277238|NCT04572243|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
21277239|NCT01661881|Dana-Farber Cancer Institute|Philippe Armand MD, PhD|617.632.2305|Philippe_Armand@dfci.harvard.edu|
21277240|NCT03451006|Mayo Clinic|Mandeep Singh, M.D.|507-255-2398|Singh.Mandeep@mayo.edu|
21277241|NCT01359748|Aguiflai Iberica, SL|Angel Pons Ferré|+34 93 7540370|calidad@keito.com|
21277242|NCT02278718|MediWound|Keren David Zarbiv|972-77-9714103|kerend@mediwound.com|
21277243|NCT02547766|University of Utah|Associate Director of Clinical Trials|801-581-5318|heather.thiesset@hsc.utah.edu|
21277244|NCT04317313|Second Affiliated Hospital, School of Medicine, Zhejiang University|Dr. Xiaohui Zhang|+86-571-87767188|zhanghui4127@zju.edu.cn|
21277245|NCT00767338|University of Michigan|Gregory Christman, MD|734-764-8142|growthh@umich.edu|
21277246|NCT03253744|National Cancer Institute|Dr. Deborah E. Citrin|240-760-6206|citrind@mail.nih.gov|
21277247|NCT03847194|Seattle Children's Research Institute|Joyce Yi-Frazier|2068841456|joyce.yi-frazier@seattlechildrens.org|
21277248|NCT01010750|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21277249|NCT00654654|CBR International Corp.|Kevin Hennegan|(720)746-1190|khennegan@cbrintl.com|
21277250|NCT02442271|AbbVie|Global Medical Services|800 633-9110||
21277251|NCT01560507|Duke University Medical Center|Dr. Jed Rose|919-668-5055|jed.rose@duke.edu|
21277252|NCT03545191|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 58 844 00 00|clinical-trials-disclosure@idorsia.com|
21277253|NCT03179163|Penn State|Lacy M. Alexander, Ph.D.|8148671781|lma191@psu.edu|
21277254|NCT00195013|Weill Cornell Medicine|Linda Vahdat, MD|646-962-9888|ltv2001@med.cornell.edu|
21277255|NCT04400760|The University of the West Indies, St. Augustine|Dr. Naveen Seecheran|18687537686|nseecheran@gmail.com|
21277256|NCT02746627|Vanderbilt University Medical Center|Sarah Jaser, PhD|615-343-6775|sarah.jaser@vanderbilt.edu|
21277257|NCT02858726|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
21277258|NCT00754468|University of Miami|Dr. Alfonso Ribeiro|305-243-4000|Aribeiro@med.miami.edu|
21277259|NCT01972035|University of Minnesota|Henry Balfour, MD|612-625-3998|balfo001@umn.edu|
21277260|NCT00233987|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623||
21277261|NCT02508259|University of California, San Diego School of Medicine|Dr. Robert K. Naviaux, MD, PhD|619-543-2904|naviaux@ucsd.edu|
21277262|NCT01699763|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com|
21277263|NCT00710749|Astra Tech AB|Head of Clinical Research Area Health Care|+46317763000||
21277264|NCT00965055|UCSD|Ori Ben-Yehuda|9179697273|obenyehuda@ucsd.edu|
21277265|NCT05478252|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21277266|NCT04846881|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21277267|NCT04560998|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21277268|NCT04862949|CHA Bundang Medical Center|Hong Jae Chon|82-31-780-3928|minidoctor@cha.ac.kr|
21277269|NCT02332980|Mayo Clinic|Wei Ding|5072845096|Ding.Wei@mayo.edu|
21277270|NCT07106489|Universidad Nacional de Colombia|Leidy Tatiana Reyes Vega|+573016971711|ltreyesv@unal.edu.co|
21277271|NCT03821272|University of Arkansas for Medical Sciences|Mayumi Nakagawa, M.D., Ph.D.|(501) 686-8635|MNakagawa@uams.edu|
21277272|NCT05904769|Mayo Clinic|Guru Kowlgi M.B.B.S., M.S.|507-422-0549|Kowlgi.NarayanGurukripa@mayo.edu|
21277273|NCT04141696|National Institute of Nursing Research (NINR)|Dr. Leorey Saligan, PhD.|+1 301 451 1685|saliganl@mail.nih.gov|
21277274|NCT05626803|Vaxart|Melanie Drayton|650-392-3109|ClinicalTrials@Vaxart.com|
21277275|NCT04583163|Hackensack Meridian Health|Tania Zielonka|5519964452|tania.zielonka@hmhn.org|
21277276|NCT03943537|McLean Hospital|Virginie-Anne Chouinard|617-855-3034|vchouinard@mclean.harvard.edu|
21277277|NCT04974619|Moffitt Cancer Center|Dr. Shannon Christy|813-745-8840|Shannon.Christy@moffitt.org|
21277278|NCT03860207|Y-mAbs Therapeutics|Joris Wilms|+45 7026 1414|clinicaltrials@ymabs.com|
21277279|NCT05599269|Ivoclar Vivadent AG|Dr. med. dent. Ronny Watzke|+423 235 3401|Ronny.Watzke@ivoclar.com|
21277280|NCT03959527|GARDP|Dr Alison Luckey|+41 22 559 05 39|aluckey@gardp.org|
21277281|NCT01688466|National Cancer Institute|Dr. Najla El Jurdi|240-992-4033|najla.eljurdi@nih.gov|
21277282|NCT06357286|Cornell University|Heather Schofield|6172334775|hws44@cornell.edu|
21277283|NCT01000610|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21277284|NCT01010126|Mayo Clinic|Henry Pitot, M.D.|(507) 284-2511|pitot.henry@mayo.edu|
21277285|NCT00635830|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21277286|NCT00493246|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
21277287|NCT05218109|University of Florida|Sarah Bottari, M.S.|(352) 273-6455|sbottari@ufl.edu|
21277288|NCT00595335|Mayo Clinic|Dr. Rebecca S. Bahn|507-284-2462|bahn.rebecca@mayo.edu|
21277289|NCT01959490|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Paula Silverman|1-800-641-2422|CTUreferral@UHhospitals.org|
21277290|NCT04859699|University of Washington|Linda K. Ko|+1 206 707-5624|lindako@uw.edu|
21277291|NCT04718545|Goteborg University|Dr Olivier Carcuac|317863124|olivier.carcuac@gu.se|+46
21277292|NCT04843566|Weill Cornell Medicine|Jim Hu|2127463418|jch9011@med.cornell.edu|
21277293|NCT04963569|NHS Lothian/University of Edinburgh|Dr John (Jack) Cafferkey|0|j.cafferkey@ed.ac.uk|
21277294|NCT00493779|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21277295|NCT01647958|EndoGastric Solutions|Adrian Lobontiu|650-474-9259|alobontiu@endogastricsolutions.com|
21277296|NCT01131299|NIH NHLBI|Dr. Marcelo Amar|301-402-0521|mamar@mail.nih.gov|
21277297|NCT01300624|Brain Rehabilitation Research Center, Malcom Randall VA, Gainesville, FL|Lisa Edmonds, PhD|352.262.4465|lisa.annamarie.edmonds@gmail.com|
21277298|NCT01398059|University of Prince Edward Island|Dr. Travis Saunders|902-566-0641|trsaunders@upei.ca|
21277299|NCT01207440|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21277300|NCT03341000|MCRA, LLC|Nicole Harris|202-552-5800|nharris@mcra.com|5823
21277301|NCT01592721|UTexas_SanAntonio|Anand B. Karnad, MD|2104501365|regulatoryaffairs@uthscsa.edu|
21277302|NCT00821873|RTI Biologics|Robin Waite, Director, Clinical Projects|386-418-8888|rwaite@rtix.com|4172
21277303|NCT02698865|DePuy Synthes|FRANCHISE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21277304|NCT03861481|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
21277305|NCT00773734|Celgene Corporation|Anne McClain|888-243-1360|clinicaltrialdisclosure@celgene.com|
21277306|NCT03715998|Quantum Genomics|Dr Bruno Besse|+33 1 85 34 77 73|bruno.besse@quantum-genomics.com|
21277307|NCT01660191|University of Kansas Medical Center|Julie-Ann Dutton|913-588-4064|JDUTTON@kumc.edu|
21277308|NCT01220297|Stanford Univesity|Laura Johnston, MD|650-723-0822|laura.johnston@stanford.edu|
21277309|NCT03111914|Duke University|Dr. Daniele Marin|919-684-7366|daniele.marin@duke.edu|
21277310|NCT02119286|GlaxoSmithKline|GSK Response Center|866-435-7343||
21277311|NCT04109313|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21277312|NCT01272921|Northwestern University|Mark Kendall, M.D.|312-695-2528|m-kendall@northwestern.edu|
21277313|NCT01132664|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registry@novartis.com|
21277314|NCT00882206|University of Minnesota, Pediatric Hematology Dept.|Dr. Michael Burke, MD|612.672.7422||
21277315|NCT01996332|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21277316|NCT02113189|University of Texas Southwestern Medical Center|Karen McCain, PT, DPT, NCS|2146481559|karen.mccain@utsouthwestern.edu|
21277317|NCT02954159|Medical College Of Wisconsin|Andres Yarur, MD; Principal Investigator|414-955-6858|ayarur@mcw.edu|
21277318|NCT01744093|Weill Cornell Medicine|Mei Wang, BS, CCRP|646-962-2672|mew2001@med.cornell.edu|
21277319|NCT02006628|GW Research Ltd|Medical Enquires|+44 01223 238170; 18778862810|medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
21277320|NCT01642914|Forest Research Institute|Steven Shiff, Executive Director, Clinical Development|201-427-8000|Steven.Shiff@actavis.com|8077
21277321|NCT03028740|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21277322|NCT01231373|BTG International Inc.|David Wright MBBS|610-278-1660|david.wright@btgplc.com|
21277323|NCT01790113|Arthrex|Clinical Affairs Manager|2392161894|melissa.hirschberg@arthrex.com|
21277324|NCT00775606|Rush University Medical Center|Allan R. Tenorio|312-942-3665|allan_s_tenorio@rush.edu|
21277325|NCT00768118|Barbara Ann Karmanos Cancer Institute|Fazlul Sarkar, Ph.D.|(313) 576-8327|sarkarf@karmanos.org|
21277326|NCT01144403|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21277327|NCT05472116|University of Minnesota|Jonathan Strutt|(314) 578-8045|strutt@umn.edu|
21277328|NCT04740931|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21277329|NCT04588688|University of Michigan|Tobias Else|734-936-1319|telse@med.umich.edu|
21277330|NCT01481740|Department of Women's & Obstetric Anesthesia, IWK Health Centre|Dr. Ronald B George|902-470-6627|rbgeorge@dal.ca|
21277331|NCT02510014|Indivior, Inc.|Global Director, Clinical Development|804-379-1090|Robert.Bauer@Indivior.com|
21277332|NCT01343095|Wake Forest Baptist Health|Matthew C. Miles|336-716-7765|mmiles@wakehealth.edu|
21277333|NCT01020799|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
21277334|NCT05012865|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21277335|NCT01949116|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21277336|NCT02972502|OhioHealth Research Institute|Chelsea Blessing, PhD|(513) 461-1772|chelsea.blessing@ohiohealth.com|
21277337|NCT03832738|Akros Pharma Inc.|Kazuhiro Okamiya|609-919-6123|okamiya@akrospharma.com|
21277338|NCT03852459|Aponia Labs|Kenneth Corroon|917-574-5335|kcorroon@aponialabs.com|
21277339|NCT00049842|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21277340|NCT00831623|LomaLindaU|Dr. Jason Slater|909-558-4243|jaslater@llu.edu|
21277341|NCT00408564|Medical University of South Carolina|Kate Anderton, MPH, CCRP|843-792-2708|anderton@musc.edu|
21277342|NCT00486018|Genentech, Inc.|Medical Communications|800-821-8590||
21277343|NCT00631852|Southern Illinois University School of Medicine|Director of Oncology Clinical Trials|217-545-8000|krobinson@siumed.edu|
21277344|NCT02080832|VCU|F. Gerard Moeller, M.D.|804-828-4134|frederick.moeller@vcuhealth.org|
21277345|NCT02416011|Moffitt Cancer Center|Dr. Thomas Bradon|(813) 745-1750|Thomas.Brandon@moffitt.org|
21277346|NCT01138111|Piramal Imaging|Juergen Hirschfeld, Senior Director Regulatory Affairs|+49 30 461 1246 15|juergen.hirschfeld@piramal.com|
21230084|NCT02202980|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21277347|NCT01118117|Terumo Medical Corporation|Adam Thompson, Clinical Program Manager|201-398-3283|adam.thompson@terumomedical.com|
21277348|NCT01660022|Medicines for Malaria Venture|Fiona Macintyre|0041 22 555 0319|macintyref@mmv.org|
21277349|NCT01448356|Singapore Eye Research Institute|Dr Andrea Petznick|+65 6322|andrea.petznick@seri.com.sg|4512
21277350|NCT00306163|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21277351|NCT01277718|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21277352|NCT00653991|Annenberg School for Communication and Journalism, University of Southern California|Professor Lynn Carol Miller|310-874-3402|lmiller@usc.edu|
21277353|NCT02149121|Celltrion, Inc.|SungYoung Lee|+82 32 850 6532|SungYoung.Lee@celltrion.com|
21277354|NCT00515034|Johnson and Johnson Pharmaceutical Research and Development L.L.C.|Senior Director of Clinical Development|510 248-2310||
21277355|NCT02655016|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21230085|NCT01216761|University of Michigan Health System|Laraine Washer, MD|734-936-5205|laraine@med.umich.edu|
21230086|NCT00696800|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21230087|NCT01540838|University of Helsinki, Children´s Hospital, Helsinki University Hospital|Dr. Okko Savonius, PhD candidate|+358456731185|okko.savonius@helsinki.fi|
21230088|NCT02130570|Brigham and Women's Hospital|Dr. Jeffrey L Schnipper, MD, MPH, FHM|617-732-7063|jschnipper@partners.org|
21230089|NCT03779711|Mayo Clinic|Clint Hagen|(507) 577-1764|hagen.clint@mayo.edu|
21230090|NCT04460937|The Ohio State University Comprehensive Cancer Center|Dr. Eric Miller|614-293-8595|eric.miller@osumc.edu|
21230091|NCT01457573|Houston Methodist Hosptial System|Timothy Boone, MD, PhD, Principal Investigator|713-441-6455|tboone3@houstonmethodist.org|
21230092|NCT00413244|Icahn School of Medicine at Mount Sinai|Dr. Mary Ann McLaughlin|(212) 241-3340|maryann.mclaughlin@mountsinai.org|
21230093|NCT02653872|AstraZeneca AB|AZD7986 Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
21230094|NCT01058655|Dana-Farber Cancer Institute|Brian M. Wolpin|617.632.6942||
21230095|NCT04569253|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
21230096|NCT04206800|Boston IVF|Kristin Rooney|781-434-6470|krooney@bostonivf.com|
21277356|NCT00603291|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
21277357|NCT06029959|University of Washington|Sandeep Khot, MD|206-744-3251|skhot@uw.edu|
21277358|NCT04495283|Nevakar, Inc.|Eric Lang, MD|(908) 367-7400|Clinicaltrials@nevakar.com|
21277359|NCT02287909|University of Florida|Dominick J. Angiolillo, MD, PhD|9042443378|dominick.angiolillo@jax.ufl.edu|
21277360|NCT04718194|Yale|Dr. Dani Chiaramonte|3479310195|danielle.chiaramonte@yale.edu|
21277361|NCT01215513|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21277362|NCT00134043|The Ohio State University Comprehensive Cancer Center|Manisha Shah, MD|614-293-8629|manisha.shah@osumc.edu|
21277363|NCT00522171|Ethicon Endo-Surgery|Sheryl Helsinger|513-337-3079|SHelsing@its.jnj.com|
21277364|NCT00289757|GlaxoSmithKline|GSK Response Center|866-435-7343||
21277365|NCT01304693|Alcon Research, Ltd.|Georges Weissgerber, Executive Director, Novartis Pharma AG|1-888-451-3937|alcon.medinfo@alcon.com|
21277366|NCT01237353|University of California San Francisco|Dr. Leslie Benet|415-476-3853|leslie.benet@ucsf.edu|
21277367|NCT02581163|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21277368|NCT03394755|Cellphire Therapeutics, Inc.|Mike Fitzpatrick, PhD|240-268-2470|mfitzpatrick@cellphire.com|
21277369|NCT03533374|Aarhus University Hospital|Professor Sandor Beniczky|+4526981536|sbz@filadelfia.dk|
21277370|NCT00158756|GlaxoSmithKline|GSK Response Center|866-435-7343||
21277371|NCT01206816|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21277372|NCT01939496|Janssen Scientific Affairs, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
21277373|NCT00140621|Sanofi|Trial Transparency Team||Contact-US@Sanofi.com|
21277374|NCT01300052|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21277375|NCT03212794|Brigham and Women's Hospital|Joji Suzuki, MD|617-732-5752|Jsuzuki2@bwh.harvard.edu|
21277376|NCT02312713|University of North Carolina at Chapel HIll|Kelli Allen|919-966-0558|kdallen@email.unc.edu|
21277377|NCT00897949|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21277378|NCT01763918|Amgen Inc.|Study Director|866-572-6436||
21277379|NCT01553747|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21277380|NCT00102687|Celgene Corporation|CL Beach||CLBeach@celgene.com|
21277381|NCT01490931|Univeristy of Pennsylvania School of Dental Medicine|Elliot V Hersh DMD, MS, PhD Professor of Pharmacology|215-898-9686|evhersh@pobox.upenn.edu|
21277382|NCT05444543|University Hospitals Cleveland Medical Center|Dr. Thomas Sferra|(216)844-1765|Thomas.Sferra@UHhospitals.org|
21277383|NCT02408120|Emory University|Dr. Priyathama Vellanki|404-251-8957|priyathama.vellanki@emory.edu|
21277384|NCT00754494|University of California, Irvine|Dr. Timothy R. Morgan|562-826-5756|timothy.morgan@va.gov|
21277385|NCT00977431|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21277386|NCT05528861|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
21277387|NCT01652976|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
21277388|NCT01602172|VA Pittsburgh Healthcare System|Lauren M. Broyles, PhD, RN|412-360-2269|Lauren.Broyles@va.gov|
21277389|NCT03739138|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21277390|NCT03069677|University of Pennsylvania|Veena Graff MD, MS|(215) 662-8244|veena.graff@uphs.upenn.edu|
21277391|NCT00518882|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21277392|NCT02696031|Novartis Pharma AG|Study Director|1-888-669-6682|novartis.email@novartis.com|
21277393|NCT00597116|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21277394|NCT02096588|SKCCC SOM Onc Breast and Ovarian Cancer|Dr. Karen Smith ; Clinical Associate|2026606500|ksmith60@jhmi.edu|
21277395|NCT01258101|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21277396|NCT02903238|Northwestern University Medical School|Dr. Apkar Vania Apkarian|(312) 503-0404|a-apkarian@northwestern.edu|
21277397|NCT02743728|University of Minnesota|Dr. Bernadette Gillick|612-626-5898|gillick@umn.edu|
21277398|NCT01606852|University of Minnesota|Craig Weinert MD|612-624-0999|weine006@umn.edu|
21277399|NCT04632706|MedinCell S.A.|Joel Richard - Chief Development Officer|00336984590|joel.richard@medincell.com|99
21277400|NCT01510652|Institute of Cardiology, Univ. of Bologna, Bologna, Italy|Prof. Giuseppe Boriani||giuseppe.boriani@unibo.it|
21277401|NCT02556307|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
21277402|NCT03438227|Brown University|Dr. Methodius Tuuli|401-430-1575|MTuuli@wihri.org|
21277403|NCT04079127|Zimmer Biomet|Emilie Rohmer, Clinical Operations Manager|+41 58 85 48210|Emilie.Rohmer@zimmerbiomet.com|
21277404|NCT02994355|University of Washington|Dr. R. Scott McClelland|+206-543-4278|mcclell@uw.edu|
21277405|NCT03050918|Vanderbilt University Medical Center|Maame Yaa Yiadom|615-936-0087|maya.yiadom@vumc.org|
21277406|NCT00578071|Duke University Medical Center Radiation Oncology|Dr Brian Czito|668-7336|brian.czito@duke.edu|
21277407|NCT01251978|New England Retina Associates|Leslie Hurst- study coordinator|203-288-2020|lhurst@retinamd.com|
21277408|NCT03657108|Icahn School of Medicine at Mount Sinai|Ketan Badani|(212) 241-3919|ketan.badani@mountsinai.org|
21277409|NCT00706992|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
21277410|NCT04464993|Arizona State University|Matthew P Buman, PhD, Director & Professor|602-496-8617|mbuman@asu.edu|
21277411|NCT01244061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21277412|NCT03166124|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21277413|NCT00787020|Duke University Medical Center|DaiWai M Olson|9196683751|Olson006@mc.duke.edu|
21277414|NCT01862419|Yale University School of Medicine|Francis Perry Wilson, MD MSCE|2037371704|francis.p.wilson@yale.edu|
21289238|NCT00942851|Office of the Clinical Director, NINDS, NIH|Codrin Lungu, MD|301-496-5295|lunguci@ninds.nih.gov|
21289239|NCT01685437|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
21289240|NCT03656133|Moffitt Cancer Center|Jimmy Caudell, MD, PhD|813-745-8226|jimmy.caudell@moffitt.org|
21230097|NCT02635776|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
21277415|NCT03487848|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21277416|NCT01036490|Hines VA Hospiral|David J. Leehey, M.D.|(708)2022589|david.leehey@va.gov|
21230098|NCT03208127|Massachusetts General Hospital|Raymond Chung, MD|617-724-7562|chung.raymond@mgh.harvard.edu|
21277417|NCT03714555|HonorHealth|Gayle Jameson, MSN, ACNP-BC, AOCN|480-323-1364|clinicaltrials@honorhealth.com|
21230099|NCT01811225|University of Minnesota|Dr. Sharon Allen|612-624-2446|allen001@umn.edu|
21230100|NCT00287365|University of North Carolina at Chapel Hill|David B. Peden, MD, MS|919-966-0768|dpeden@med.unc.edu|
21277418|NCT03755336|University of Nebraska Omaha|Nathaniel Hunt|402-554-4195|nhunt@unomaha.edu|
21230101|NCT02298023|, Seoul National University Hospital|Dr. Sun G. Chung|+82-2-2072-2560|chung60611@gmail.com|
21230102|NCT01749631|AbbVie|Global Medical Information|800-633-9110||
21230103|NCT01612858|Tufts Medical Center|Rakhi Kohli MD MS|617-636-4709|rkohli@tuftsmedicalcenter.org|
21230104|NCT03113916|Kaiser Permanente Center for Health Research|Nangel Lindberg|503 528 3961|Nangel.M.Lindberg@kpchr.org|
21230105|NCT00737243|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21230106|NCT01758523|University of Connecticut School of Medicine|Dr. Jonathan Covault|860-679-7560|jocovault@uchc.edu|
21230107|NCT00722800|MGH|Alexandra B. Kimball, MD|617-726-5066|harvardskinstudies@partners.org|
21230108|NCT04729621|Teva Pharmaceuticals|US Medical Affairs|1-888-483-8279|usmedinfo@tevapharm.com|
21230109|NCT01449539|University of Arkansas for Medical Science-MIRT|Sarah Waheed, MD|501-686-8230|mirt@uams.edu|
21230110|NCT01387789|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21260895|NCT01614457|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21277419|NCT02246439|RedHill Biopharma Ltd.|Dr. Terry Plasse|+972-(0)3-541-3131|terry@redhillbio.com|
21277420|NCT05713552|Johnson & Johnson Vision Care, Inc. (JJVC)|Benjamin Straker|1-800-843-2020|bstraker@its.jnj.com|
21277421|NCT03439852|University of Hawaii at Manoa, Office of Research Studies|Sharleen Andreshak|808 356 5762|sfa2@hawaii.edu|
21277422|NCT04271735|National Heart Lung and Blood Institute (NHLBI)|Michael Sack, M.D. Principal Investigator, NIH, NHLBI|301.402.9259|sackm@nhlbi.nih.gov|
21277423|NCT00922272|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21277424|NCT03197558|Tusker Medical|Laura England, PhD|(650) 223-6909|lengland@tuskermed.com|
21277425|NCT00353652|University of Texas Southwestern Medical Center|Wanpen Vongpatanasin|2146458000|wanpen.vongpatanasin@utsouthwestern.edu|
21277426|NCT02466230|Weill Cornell Medical College|Marc Dubin, M.D.|(212) 746-5817|mrd9035@med.cornell.edu|
21277427|NCT00430495|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21277428|NCT03656874|HealthPartners Institute|Dr. D. Brad Rindal|952.967.5026|D.Brad.Rindal@HealthPartners.com|
21277429|NCT00723645|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21289241|NCT03393013|Kezar Life Sciences, Inc|Regulatory Affairs|650-822-5600|clinicaltrials@kezarbio.com|
21289242|NCT03860584|Ohio State University|Richard Bruno|8603358494|bruno.27@osu.edu|
21289243|NCT03686488|Moffitt Cancer Center|Dae Won Kim, MD|813-745-1277|daewon.kim@moffitt.org|
21289244|NCT01312519|Vidacare Corporation|Senior Director of Science and Clinical|210-375-8500|thomas.philbeck@vidacare.com|
21289245|NCT03971422|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21289246|NCT01658878|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21289247|NCT05905250|The George Washington University|Carla Berg|202-994-0168|carlaberg@gwu.edu|
21277430|NCT04475250|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|joseph.tobias@nationwidechildrens.org|
21289248|NCT05225727|The University of Texas Health Science Center at Houston|Melissa Peskin, PhD|713-500-9759|melissa.f.peskin@uth.tmc.edu|
21289249|NCT02405208|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
21289250|NCT03928704|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21289251|NCT05416515|Mayo Clinic|Peter Amadio, M.D.|507-538-1296|pamadio@mayo.edu|
21289252|NCT05141357|HUYABIO International|Chief Medical Officer|(858) 798-8800|Glee@huyabio.com|
21289253|NCT05887908|Clinical Development Department|Meiji Seika Pharma Clinical Trial Administrator|(+81) 3-3273-3745|clinical-trials@meiji.com|
21289254|NCT06413797|University of North Carolina at Chapel Hill, School of Medicine, Department of Family Medicine, and Lineberger Comprehensive Cancer Center|Leah Ranney, PhD, MA, Research Professor and Director of the Tobacco Prevention and Evaluation Progr|984-974-4888|leah_ranney@unc.edu|
21289255|NCT03928743|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21289256|NCT03576846|Karolinska Institutet|Ass professor Iben Axén|+46704400618|iben.axen@ki.se|
21289257|NCT06132386|Johns Hopkins University|Grant Principal Investigator|410-375-4418|chendrix@jhmi.edu|
21289258|NCT03833167|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21289259|NCT03003962|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21289260|NCT06461455|Alcon Research, LLC|Sr. Principal, Clinical Project Management, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21289261|NCT05838664|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
21289262|NCT06991803|Recep Tayyip Erdoğan University, Faculty of Dentistry, Department of Endodontics|Medine Çiçek|5442745525|medinecicekk@hotmail.com|+90
21238777|NCT02889133|Columbia University Medical Center|Dr. Eldad Hod|212-305-4109|eh2217@cumc.columbia.edu|
21289263|NCT03734809|The Chinese University of Hong Kong|Dr. Edwin Pun HUI|3505 2145|p_hui@clo.cuhk.edu.hk|
21277431|NCT00253981|William Beaumont Army Medical Center|COL Richard Petri, Chief Integrative Pain Management|915-742-3245|richard.petri@amedd.army.mil|
21277432|NCT00063882|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21277433|NCT00700817|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21277434|NCT00767520|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21277435|NCT02777918|Bournemouth University|Prof. Katherine Appleton|+441202965985|k.appleton@bournemouth.ac.uk|
21277436|NCT00589849|Creighton University|Dr. Aryan Mooss|402-280-4566|aryanmooss@creighton.edu|
21277437|NCT00058214|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
21277438|NCT02854059|Hansa Biopharma AB|Elisabeth Sonesson (Director Clinical Operations)|+46 (0)708 54 86 46|elisabeth.sonesson@hansabiopharma.com|
21238778|NCT01375205|Oregon Health & Science University|Eric Simpson, MD, MCR|503-494-3968|simpsone@ohsu.edu|
21238779|NCT01148862|Medtronic|Thomas P Troub|818-576-3142|thomas.troub@medtronic.com|
21230111|NCT05004077|University of Kentucky|Dr. Kevin Hatton|859-218-0365|kevin.hatton@uky.edu|
21230112|NCT00913380|Seoul National University Bundang Hospital|Kyoung Ho Lee|82-31-787-7607|kholeemail@gmail.com|
21230113|NCT01788228|GlaxoSmithKline|GSK Response Center|866-435-7343||
21230114|NCT02187744|Pfizer, Inc.|Pfizer CT.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21230115|NCT00601198|University of Cincinnati|Alison Kastl, Director of Clinical Trials|813-584-0436|kastla@ucmail.uc.edu|
21230116|NCT00828412|Promius Pharma|Joanne Fraser|908 429-4504|joannefraser@promiuspharma.com|
21230117|NCT01602120|Hoffmann-La Roche|Medical Communications|800 821 - 8590|genentech@druginfo.com|
21230118|NCT01435603|Northwestern University|Research Project Manager|312-503-3359|emily.anderson1@northwestern.edu|
21230119|NCT00775346|Covidien|Manager, Clinical Affairs|303 305 2591|Norma.Prince@Covidien.com|
21230120|NCT01682954|Ohio State University|Dr. Carla Miller|614-292-1391|miller.4453@osu.edu|
21230121|NCT02012283|Center for Human Nutrition, Department of Medicine, UCLA David Geffen School of Medicine|Zhaoping Li, Professor|310-206-1987|zli@mednet.ucla.edu|
21230122|NCT00579137|Baylor|Robert Krance, MD|832-824-4661|rkrance@bcm.edu|
21230123|NCT01187433|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21230124|NCT00144391|Charles R. Drew University of Medicine and Science|Dr. Theodore Friedman|310-668-5197|theodorefriedman@cdrewu.edu|
21230125|NCT04223973|Medtrum France|Mrs Melanie MARMOUNIER-WILHLEM- Commercial DIrector|+33620591224|melanie.marmounier@medtrum.com|
21230126|NCT01267045|VA Puget Sound Health Care System|David J. Kearney, MD|206-277-1445|David.Kearney@VA.gov|
21230127|NCT00594659|Geisel School of Medicine at Dartmouth College|Alan J. Budney, PhD Principal Investigator|855-290-2822|Alan.J.Budney@dartmouth.edu|
21230128|NCT03105479|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk|0041615656565|clinical-trials-disclosure@its.jnj.com|
21230129|NCT04439201|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21230130|NCT05136690|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21230131|NCT04508335|Reia, LLC|Chief Medical Officer|603 715-7017|paul@reiahealth.com|
21230132|NCT01995825|U of Maryland|James Polli|410-706-8292|jpolli@rx.umaryland.edu|
21230133|NCT01367002|Yale School of Medicine|Alessandro Santin, MD|(203) 200-4176|alessandro.santin@yale.edu|
21230134|NCT03811028|Sobi|Global Communication|+4686972000|info@sobi.com|
21230135|NCT00560105|VA WNY Health Care System|Dr. S. Sethy|716-862-7875|ssethi@buffalo.edu|
21230136|NCT02400333|AstraZeneca AB|Brilinta Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
21230137|NCT00956020|NYEEI Department of Otolaryngology|Anthony Sclafani, MD|212-979-4200|asclafani@nyee.edu|
21230138|NCT03281577|Takeda|Medical Director|+1-877-825-3327|takedadisclosures@takeda.com|
21230139|NCT01332500|GlaxoSmithKline|GSK Response Center|866-435-7343||
21230140|NCT01687998|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21230141|NCT00443261|University of Kansas Cancer Center|Dr. Stephen Williamson|9139455059|swilliam@kumc.edu|
21260896|NCT03518840|Loyola University Chicago|Colleen Fitzgerald, M.D., M.S.|708-216-3380|CFITZGERALD@lumc.edu|
21230142|NCT01550289|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21230143|NCT00739674|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21230144|NCT00354744|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21230145|NCT01519271|University of Pennsylvania|Daniel Weintraub, MD|215-349-8207|Daniel.Weintraub@UPHS.UPENN.EDU|
21289264|NCT03600350|University of Wisconsin Carbone Cancer Center|Douglas McNeel, MD, PhD|(608) 263-4198|dm3@medicine.wisc.edu|
21289265|NCT03083379|University of Virginia Health System|Daniel D. Rowley, MSc, RRT-ACCS, FAARC|434-465-7235|ddr8a@virginia.edu|
21289266|NCT02400736|Tuscaloosa VA Medical Center|Lori L. Davis, M.D.|205-554-2000|Lori.Davis@va.gov|1-3819
21289267|NCT01002105|Shaar Menashe Mental Health Center|Prof. Alexander Grinshpoon|+972-4-6278719|alexander.grinshpoon@sm.health.gov.il|
21230146|NCT00814970|Medtronic Aortic and Peripheral Vascular|Arslan Malik - Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com|
21230147|NCT00541931|Stanford University|Dr. Anne Chang, MD|(650)721-7151|alschang@stanford.edu|
21230148|NCT00064337|SWOG Statistical Center|Study Statistician|206-667-4623||
21289268|NCT03573700|St. Jude Children's Research Hospital|Aimee Talleur, MD|8662785833|referralinfo@stjude.org|
21289269|NCT03674411|University of Minnesota, Masonic Cancer Center|Dr. Margaret MacMillan|(612) 626-5654|macmi002@umn.edu|
21289270|NCT02227199|University of Washington|Dr. Ajay Gopal|26-606-2037|agopal@uw.edu|
21289271|NCT03573882|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21289272|NCT02691572|Department of Anesthesia and Surgical Intensive Care, Mansoura University Hospitals, Mansoura, Egypt.|Dr. Mohamed Mohamed Tawfik|1001183400|m2tawfik@mans.edu.eg|0020
21289273|NCT03159195|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21289274|NCT01750073|University of Nebraska Medical Center|Amulya C Yellala|402-559-5388|amulya.yellala@unmc.edu|
21289275|NCT04337021|Cprl. Michael J. Crescenz VA Medical Center|Dr. Amy Helstrom|215-823-4164|amy.helstrom@va.gov|
21289276|NCT01405911|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21289277|NCT06375655|University Hospitals Cleveland Medical Center|Dr. Furman|216-844-3971|Lydia.Furman@UHhospitals.org|
21289278|NCT01276652|University of Iowa|Brian Gehlbach, MD|319-356-3603|brian-gehlbach@uiowa.edu|
21289279|NCT02530242|UCSF Benioff's Children's Hospital Oakland|Ashutosh Lal, MD||Ashutosh.Lal@ucsf.edu|
21289280|NCT00283959|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
21289281|NCT03837938|Dompé Farmaceutici SpA|Mauro P Ferrari, Pharm D|+39 02 583831|clinical.trials@dompe.com|
21289282|NCT06875115|Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation|Ying-Hsu Juan, M.D. Principal Investigator|+886-5-2648000|ddjjaa@tcts.seed.net.tw|
21289283|NCT01853215|Vidacare Corporation|Larry J. Miller, MD|210-375-8500|larry.miller@vidacare.com|
21289284|NCT03514017|Moffitt Cancer Center|Julio Chavez, MD, MS|813-745-4294|julio.c.chavez@moffitt.org|
21289285|NCT06394323|University of North Carolina at Chapel Hill|Lauren Hill, PhD|919-966-5771|hilllm@ad.unc.edu|
21289286|NCT06901544|Ain Shams University, Faculty of Medicine|Osama Khalil|01010000903|Osama.Ahmed.Ahmed.Salem.Khalil@med.asu.edu.eg|
21289287|NCT02313597|Services Institute of Medical Sciences|Dr, Shabbar Hussain Changazi|923059700111|shabbarchangazi246@gmail.com|
21289288|NCT01263379|Abeona Therapeutics|Chief Medical Officer|(216) 282-8150|clinicalresults@abeonatherapeutics.com|
21289289|NCT00552058|UCB|Study Director|+1 877 822 9493||
21289290|NCT00422461|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21289291|NCT02357485|UCLA Medical Center|Peter Fodor, MD|3102039818|pbfodor@centurysurgery.com|
21289292|NCT01795937|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21289293|NCT01028053|GE Healthcare|Paul Sherwin M.D.|16095146820|Paul.Sherwin@ge.com|
21289294|NCT00845182|UTexas_SanAntonio|Devjit Tripathy|2105676691|tripathy@uthscsa.edu|
21289295|NCT04621760|University of California, San-Francisco|Dr. Dominika Seidman|(415) 353-2119|Dominika.Seidman@ucsf.edu|
21289296|NCT00743262|Netherlands Cancer Institute|Prof. Dr. F.J.M. Hilgers|+31-20-5252550|f.hilgers@nki.nl|
21289297|NCT02965716|SWOG Data Management Center|Melanoma Committee Statistician|206-667-4623|jmoon@fredhutch.org|
21289298|NCT01336972|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21289299|NCT02313272|Moffitt Cancer Center|Peter Forsyth, MD|813-745-3063|peter.forsyth@moffitt.org|
21289300|NCT02441114|Seoul National University Hospital|Clinical Pharmacology and Therapeutics|82-2-2072-4081|rheesjin@gmail.com|
21289301|NCT00593645|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
21289302|NCT03446573|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21289303|NCT01793909|University of Colorado|Dr. Judy Regensteiner|303-724-2247|judy.regensteiner@ucdenver.edu|
21289304|NCT01279187|University of Michigan|Jill Bashutski||jillbashutski@gmail.com|
21289305|NCT00875329|Tampa VAMC|Rodney Vanderploeg, Ph.D|(813) 972-2000|Rodney.Vanderploeg@va.gov|6728
21230149|NCT03260881|University of Miami Miller School of Medicine|Dr Gianluca Iacobellis MD PhD Professor of Medicine|3052433636|giacobellis@med.miami.edu|
21230150|NCT00617851|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com|
21230151|NCT00944671|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
21277439|NCT00411398|SUNY Upstate|Thomas Schwartz|3154643166|schwartt@upstate.edu|
21277440|NCT02480582|University of Leeds|Dr Graham Finlayson|0113 343 7601|g.s.finlayson@leeds.ac.uk|
21277441|NCT00958126|Seqirus|Clinical Trials Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
21277442|NCT00720226|Johns Hopkins University School of Medicine|Robert A. Wise|410 550 0545|rwise@jhmi.edu|
21230152|NCT03750955|University of Washington|Dr. Diane Daubert|206-685-3766|ddaubert@uw.edu|
21230153|NCT01024335|NYS Psychiatric Institute|Adam Bisaga|646-774-6155|amb107@columbia.edu|
21230154|NCT00697788|Mass General Hospital for Children|Erik Shank, MD|6177242250|eshank@partners.org|
21230155|NCT02432742|Q-Med AB|Clinical Project Manager|+46184749000|reception.seupp@galderma.com|
21277443|NCT00733369|DePuy Ortho Joint US|Kimberly Dwyer, PhD, CCRA||kdwyer2@its.jnj.com|
21230156|NCT01180985|Johnson & Johnson Vision Care|John Buch, OD, MS, FAAO|1 904 443-1707|jbuch@its.jnj.com|
21230157|NCT00705289|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21277444|NCT03401073|BIDMC|Christopher Gibbons MD|617-632-8454|cgibbons@bidmc.harvard.edu|
21277445|NCT01470612|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21277446|NCT03078582|Ra Pharmaceuticals, Inc|Sponsor Ra Pharmaceuticals, Inc.|+1 617 401 4060|trials@rapharma.com|
21277447|NCT02039414|Western Kentucky University|Dr. Rachel Tinius, Assistant Professor|2707455026|rachel.tinius@wku.edu|
21277448|NCT01347866|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21277449|NCT00430950|Daiichi Sankyo|Global Clinical Leader|908-992-6400|DataSharing@dsi.com|
21277450|NCT02537873|Virginia Commonwealth University|F. Gerard Moeller, M.D.|804-628-7788|lmbobb@vcu.edu|
21277451|NCT02429934|University of California at Los Angeles|Dr. Bevra Hahn|8184869745|bhahn@mednet.ucla.edu|8184869745
21277452|NCT00869024|University of Minnesota|Dr. Ganesh Raveendran|612-626-4283|ravee001@umn.edu|
21277453|NCT00293202|University of California, Davis|George Kaysen MD PhD|916-734-3774|gakaysen@ucdavis.edu|
21277454|NCT01064323|Johns Hopkins University School of Medicine|Harry Silber, M.D., Ph.D. Assistant Professor of Medicine, Division of Cardiology|410-550-5717|hsilber@jhmi.edu|
21277455|NCT01564459|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21277456|NCT00106938|Abbott Vascular|Jennifer M Jones-McMeans, PhD (Associate Director Clinical Research)|408-845-1459|jennifer.jones@av.abbott.com|
21277457|NCT00775684|University of Pennsylvania|Professor of Medicine, Director of Translational Research Program|215 746-0025|rickels@pennmedicine.upenn.edu|
21277458|NCT02728752|CRMG|Mikaela Raymond|866-337-1868|ctgov@clinicalresearchmgt.com|
21277459|NCT02025751|Evoke Pharma|Chief Medical Officer|8589457189|mcarlson@evokepharma.com|
21277460|NCT02181296|University of Pennsylvania|Dr. Nabil M Elkassabany|(215) 662-3793|Nabil.Elkassabany@uphs.upenn.edu|
21277461|NCT03864042|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21277462|NCT04527328|Alkahest, Inc.|Head of Communications|(650) 801-0474|sm-Trials-alkahest@grifols.com|
21277463|NCT00766831|Medical Affairs|Clinical Research Associate|82-2-2094-4835||
21277464|NCT01398839|Topcon Medical Systems|Bob Gibson|(201) 599-5121|RGIBSON@TOPCON.COM|
21277465|NCT00788593|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
21277466|NCT01392326|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
21277467|NCT00518622|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21277468|NCT03499119|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21277469|NCT02333487|H. LUndbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
21277470|NCT00123955|Wake Forest Baptist Health|Dr. Dalane Kitzman|336-716-3274|dkitzman@wakehealth.edu|
21277471|NCT01558297|Yale Medical School|Dr. Rachel Barnes|2037856395|rachel.barnes@yale.edu|
21277472|NCT00094094|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21277473|NCT04143243|Baylor College of Medicine|Lilian Dindo|713-440-4637|lilian.dindo@bcm.edu|
21277474|NCT02218307|University of Miami|Dr. Roy Casiano|305-243-1870|rcasiano@miami.edu|
21277475|NCT04459715|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21277476|NCT02427984|Medical technology laboratory, Rizzoli Orthopaedic Institute|Susanna Stea|00390516366861|stea@tecno.ior.it|
21277477|NCT03692312|AMO Pharma Ltd.|Dr. Mike Snape, Chief Scientific Officer|+44 (0) 7775915639|mike.snape@amo-pharma.com|
21277479|NCT05506930|Medical University of South Carolina|Natalie Barnett|(843) 792-5454|barnettn@musc.edu|
21277480|NCT02631876|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
21277481|NCT02786277|Yale University|F. Perry Wilson|203-737-1704|francis.p.wilson@yale.edu|
21277482|NCT01013649|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
21277483|NCT04285567|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21277484|NCT01408563|Massachusetts General Hospital|Dr. Zachariah DeFilipp|617-643-3944|ZDEFILIPP@mgh.harvard.edu|
21277485|NCT00996931|Sutter Institute for Medical Research|Carol Parise, PhD|916-733-4413|PariseC@sutterhealth.org|
21277486|NCT00997139|Northwestern University Department of Dermatology|Clinical Trials Unit Coordinator|312-695-6829|mandybrowning2015@u.northwestern.edu|
21277487|NCT00313443|Unité de Recherches Thérapeutiques. Service de Médecine Interne A. Hôpital Lariboisière. Paris, France|Dr Carmelo Lafuente-Lafuente|+33 1 49 95 63 37|c.lafuente@nodo3.net|
21277488|NCT00931268|Q-Med AB|Head of Clinical Development|+46 (0)18 4749000|reception.SEUPP@galderma.com|
21277489|NCT02072148|Icahn School of Medicine at Mount Sinai|Dr. Raymond L Chai|(212) 844-8775|Raymond.Chai@mountsinai.org|
21277490|NCT01421342|VA Cooperative Studies Program Coordinating Center, West Haven, CT|Gary R. Johnson, MS|(203) 932-5711|gary.johnson4@va.gov|3774
21277491|NCT03633448|Reckitt Benckiser Inc.|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
21277492|NCT02528123|London Vision Clinic|Prof Dan Z Reinstein|02072214005|dzr@londonvisionclinic.com|
21277493|NCT02274844|University of Wisconsin-Madison|Susan Andreae|608-265-8195|sandreae@wisc.edu|
21277494|NCT04539886|Pulse Biosciences, Inc.|William A. Knape, VP Clinical, Regulatory and Quality Affairs|510-906-4649|bknape@pulsebiosciences.com|
21277495|NCT03463993|University of Zimbabwe|Dr Chipo Gwanzura|+263774718381|chipo.gwanzura@gmail.com|
21277496|NCT04355663|Third Faculty of Medicine, Charles University|PhDr. Kamila Řasová, Ph.D.|+420604511416|kamila.rasova@gmail.com|
21277497|NCT05420012|University of Utah|Josef Stehlik|801-585-9797|josef.stehlik@hsc.utah.edu|
21277498|NCT03808740|Vanderbilt University Medical Center|Dr Cyndya Shibao|6159364584|cyndya.shibao@vumc.org|
21277499|NCT00867048|University of Minnesota|Birgit Grund|612-624-8076|birgit@umn.edu|
21277500|NCT00942331|Memorial Sloan-Kettering Cancer Center|Jonathan Rosenberg, MD|646-422-4461|rosenbj1@mskcc.org|
21277501|NCT01397617|Nobel Biocare Services AG|Head Clinical Trial Management|+41 43 211 42 00|isabelle.arrighi@nobelbiocare.com|
21277502|NCT00567476|Novartis Pharmaceuticals|Study Director|862 778-8300||
21277503|NCT01829919|Noven Therapeutics, LLC|Sailaja Bhaskar, Executive Director, Clinical Research|(212) 287-0798|sbhaskar@noven.com|
21277504|NCT01553201|National Institute of Neurological Disorders & Stroke|Barbara Karp, MD|301-496-0150|karpb@ninds.nih.gov|
21277505|NCT00594620|The University of Kansas|Jeffrey Holzbeierlein, MD, FACS|913-945-8239|jholzbeierlein@kumc.edu|
21277506|NCT01338987|National Cancer Institute|Dr. Christopher Kanakry|240-760-6171|christopher.kanakry@nih.gov|
21277507|NCT00757848|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21277508|NCT02071953|University of Pennslyvania|Ricardo Walter|215-898-9164|walterr@dental.upenn.edu|
21277509|NCT00279955|Medtronic CRDM Clinical Research|CRDM Core Clinical|800-328-2518|medtroniccrmtrials@medtronic.com|
21260897|NCT00920309|Yale University School of Medicine|Dr. Neera Dahl|203-785-4184|neera.dahl@yale.edu|
21277510|NCT03856593|University of Southern California|Jason Doctor|213.821.8142|jdoctor@usc.edu|
21277511|NCT01901874|W. L. Gore & Associates|Bryan Randall|928-864-4832|BRandall@WLGore.com|
21277512|NCT01602016|University of Arkansas for Medical Sciences|Tracy Gatlin|501-686-6803|tlgatlin@uams.edu|
21277513|NCT02689063|AFT Pharmaceuticals|Jennifer Zhang -Project Manager|+ 64 9 488 0232|jenniferz@aftpharm.com|710
21277514|NCT04017754|Aalborg University Hospital, Gynecologic and Obstetric department|Caroline Nørgaard-Pedersen|+45 41120267|carolinenp94@gmail.com|
21277515|NCT03977701|San Diego State University|Dr Jessica Barlow, Principal Investigator|6195943807|jbarlow@sdsu.edu|
21277516|NCT02447926|Northwestern University|Dr. Josh Levitsky|312-695-4837|j-levitsky@northwestern.edu|
21277517|NCT02519621|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
21277518|NCT03676751|UCSF FI Proctor|Pr Thomas Lietman|(415) 476-1442|tom.lietman@ucsf.edu|
21277519|NCT03345394|Federal University of Sao Paulo|Dr. André Miguel|+55 11 965884111|aqcmiguel@gmail.com|
21277520|NCT02687360|Columbia Univeristy|Diana Martinez|646-774-6160|dm437@cumc.columbia.edu|
21277521|NCT04722601|University of Chicago|Dr. Sonali Smith|855-702-8222|smsmith@bsd.uchicago.edu|
21277522|NCT02939014|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21277523|NCT01568866|Amgen Inc.|Study Director|866-572-6436||
21277524|NCT01698775|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21277525|NCT01019707|University of California Los Angeles|Edythe D London|310 825 0606|elondon@mednet.ucla.edu|
21277526|NCT01869478|Mayo Clinic|Kevin M. Barrett, MD|904-953-9740|Barrett.Kevin@mayo.edu|
21277527|NCT02143583|ANERGIS SA|G. DELLA CORTE Clinical Development Director|+41 21 651 92 30|gilles.dellacorte@anergis.ch|
21277528|NCT03020719|Seattle Children's Hospital|Arthur Baines|2068841431|Arthur.Baines@seattlechildrens.org|
21277529|NCT02340221|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21277530|NCT01583218|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
21277531|NCT03168321|Bausch Health Americas, Inc|Study Director|510-259-5284|aloncaric@bauschhealth.com|
21277532|NCT00952276|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21260898|NCT02468193|Novartis PharmaCeuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21260899|NCT00742781|Pennsylvania State University|Dr. Margherita Cantorna|814-863-2819|mxc69@psu.edu|
21260900|NCT01416181|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21277533|NCT02091141|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
21277534|NCT04551911|OPKO Health Inc|OPKO Health Inc|305-575-4100|contact@opko.com|
21277535|NCT01383421|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
21277536|NCT00666848|Vanderbilt University School of Medicine|Nancy J. Brown, M.D.|615-343-8701|nancy.j.brown@vanderbilt.edu|
21277537|NCT02177136|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
21277538|NCT02054130|MedImmune, LLC|Fred Reid|+44 (0) 203 749 6512|information.center@astrazeneca.com|
21277539|NCT01386684|AbbVie|Global Medical Services|800-633-9110||
21277540|NCT00364949|Northwestern University|Dr. Andrea Dunaif|312-503-2902|a-dunaif@northwestern.edu|
21230158|NCT01030536|MedImmune LLC, Milstein Building, Granta Park, Cambridge, CB21 6GH, United Kingdom|Edward Bradley, MD|+44 (0)1223 895997||
21230159|NCT01431989|GlaxoSmithKline|GSK Response Center|866-435-7343||
21230160|NCT02763462|INA-RESPOND|Publication Division|+62214208693|inapublikasi@ina-respond.net|
21230161|NCT00675948|GW Pharma LTD.|Mr Richard Potts, Clinical Operations Director|00 44 1223 266 800|rp@gwpharm.com|
21230162|NCT04269707|American Regent, Inc.|Mark A. Falone, MD|631.772.3544|mfalone@americanregent.com|
21230163|NCT02100514|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21230164|NCT02577549|Wake Forest University|Dr. Stephen Messier|336-758-5849|messier@wfu.edu|
21230165|NCT02248701|North Florida/South Georgia Veterans Health System|Joshua Yarrow, MS, PhD|(352) 548-6477|Joshua.Yarrow@va.gov|
21277541|NCT00094458|Centocor Ortho Biotech Services, L.L.C.|Study Director|215 325-7405||
21277542|NCT02130583|Alpert Brown Medical School|Shirley Yen, Ph.D., Principal Investigator|4014441915|Shirley_Yen_PhD@Brown.edu|
21277543|NCT02149290|ZOLL LifeVest|VP of Medical Affairs|412-968-3333|stevens@zoll.com|14400
21277544|NCT00131378|Massachusetts General Hospital|Dr. Karen K. Miller|617-726-3870|kkmiller@partners.org|
21277545|NCT01995266|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|clinical.trials@bms.com|
21277546|NCT03247517|Supernus|Joseph Hull, PhD, Associate Director Clinical Research|240-403-5324|jhull@supernus.com|
21277547|NCT00619112|UCSF|Nicholas Butowski|4153532966|Butowski@neurosurg.ucsf.edu|
21277548|NCT00729248|Northwestern University|Lorenzo Gallon, MD - Study Principal Investigator|312-695-4457|l-gallon@northwestern.edu|
21277549|NCT01996943|University of California, San Francisco|Dr. Gregory Marcus|(415) 353-2554|Greg.Marcus@ucsf.edu|
21230166|NCT02218320|University of North Carolina at Chapel Hill|Dr. Angela Kashuba|919 966-9998|akashuba@unc.edu|
21230167|NCT00319553|Sanofi Pasteur Inc.|Medical Director||RegistryContactUS@sanofipasteur.com|
21230168|NCT01896102|bluebird bio, Inc|Study Medical Director|339-499-9300|medinfo@bluebirdbio.com|
21230169|NCT02673138|Yale Pediatric Diabetes|Neha S. Patel, DO|203-764-6747|neha.patel@yale.edu|
21230170|NCT03719612|Lantheus Medical Imaging, Inc|Istvan Molnar|978-671-8686|istvan.molnar@lantheus.com|
21230171|NCT00762385|Vistakon|Kurt Moody, OD FAAO|904-443-3088||
21230172|NCT01101880|University of Washington|Pamela Becker, MD, PhD|206-288-7273|pbecker@uw.edu|
21230173|NCT00591344|Northwestern University|Daniel Corcos, PhD|708-214-5454|daniel.corcos@northwestern.edu|
21230174|NCT03863197|KU Leuven|Dr. Britta Hanssen|+3216341295|britta.hanssen@kuleuven.be|
21230175|NCT01065597|Department of Psychiatry, University of Maryland School of Medicine|William T. Regenold, MDCM|410-328-6511|wregenol@psych.umaryland.edu|
21230176|NCT01781975|University of South Florida|Melissa Parker|8133969378|MELISSA.PARKER@EPI.USF.EDU|
21230177|NCT01622231|GlaxoSmithKline|GSK Response Center|866-435-7343||
21230178|NCT02329080|International Extranodal Lymphoma Study Group (IELSG)|Scientific and Medical Director|+41 58 666|ielsg@ior.usi.ch|7321
21230179|NCT02509767|Planned Parenthood Federation of America|Julia Kohn|2122614636|julia.kohn@ppfa.org|
21277550|NCT03573505|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21277551|NCT04268316|Stanford University|Margot Paul|415-625-3127|mdpaul@stanford.edu|
21230180|NCT00973674|University of Washington|Scott Emerson, PhD|206-616-6678|semerson@uw.edu|
21230181|NCT02100579|Northwestern University, Feinberg School of Medicine|Antoun Nader|312-695-3045|a-nader2@northwestern.edu|
21277552|NCT00746018|Memorial Sloan Kettering Cancer Center|Nadeem Abu-Rustum, M.D.|212-639-7051|abu-rusn@mskcc.org|
21277553|NCT02040779|Teva Branded Pharmaceutical Products R&D|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21230182|NCT01440452|Johns Hopkins Hospital|Daniel Becker|4108284629|db@inirehab.com|
21230183|NCT03082261|Abbott|Robyn Capobianco|+15129343941|robyn.capobianco@abbott.com|
21230184|NCT00839852|Allergan|Willie R. Earley, MD Associate Vice President Clinical Development-CNS|714-246-4500|IR-CTRegistration@allergan.com|
21277554|NCT02132637|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21277555|NCT01030653|University of Michigan|Manjuanth Pai|7346470006|amitpai@med.umich.edu|
21277556|NCT00003224|University of Virginia|Craig Slingluff|434-924-1730|cls8h@virginia.edu|
21277557|NCT00866658|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21230185|NCT02068027|BDSI|Vice President Clinical Operations|919-582-0294|twarneke@bdsi.com|
21230186|NCT01704521|University of Cincinnati|Kenneth E. Sherman, MD. PhD|513-558-3918|kenneth.sherman@uc.edu|
21230187|NCT00494299|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21230188|NCT03783975|University of Maryland Baltimore|Dr. Amber Beitelshees|410-706-0118|abeitels@som.umaryland.edu|
21230189|NCT01281137|International Breast Cancer Study Group (IBCSG)|Head Trial Activities and Deputy Director: Dr. Heidi Roschitzki-Voser|+41 31 511 94 00|heidi.roschitzki@ibcsg.org|
21230190|NCT01581710|CHA UNIVERSITY|Dr. HAN, MAN YONG|82-31-780-6262|drmesh@gmail.com|
21230191|NCT02846324|Global Blood Therapeutics|Nick Vlahakis|1 650 8228756|nvlahakis@gbt.com|
21230192|NCT00098956|The Ottawa Hospital|Dr. Glenwood Goss|613-737-7700|ggoss@ottawahospital.on.ca|56708
21230193|NCT04010695|PATH|Pooja Bansil|206 302 4920|pbansil@path.org|
21230194|NCT03273270|Medical University of South Carolina|Gonzalo Revuelta|7927262|revuelta@musc.edu|
21230195|NCT03822182|AHNI Orthopedics|Brian Badman|3178328800|bbadman@gmail.com|
21230196|NCT00810355|Richard L. Roudebush VA Medical Center|Dr. Paul Lysaker|317-988-2546|paul.lysaker@va.gov|
21230197|NCT02850601|BWH|Dr. Herve Sroussi|617 5256864|hsroussi@bwh.harvard.edu|
21230198|NCT01533077|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21230199|NCT02130297|Icahn School of Medicine at Mount Sinai|Dr. Hooman Khorasani|347-574-8500|hooman.khorasani@mountsinai.org|
21230200|NCT02564497|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
21230201|NCT01219673|University of Texas (UT) MD Anderson Cancer Center|Dr. David Rosenthal Professor, Radiation Oncology Department|713-792-7734|CR_Study_Registration@mdanderson.org|
21230202|NCT00347360|GlaxoSmithKline|GSK Response Center|866-435-7343||
21230203|NCT00134030|MRC Clinical Trials Unit at UCL|Prof Matt Sydes||mrcctu.euramos@ucl.ac.uk|
21230204|NCT01972568|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21230205|NCT02358681|Columbia University|Daniel Tsze MD MPH|212-317-0997|dst2141@cumc.columbia.edu|
21230206|NCT02059408|University of California, San Francisco|Carmen Peralta, Professor of Medicine|415-221-4810|carmenalicia.peralta@ucsf.edu|23678
21230207|NCT00508755|Malcom Randall VA Medical Center, Gainesville Florida|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center of Excellence|(352) 376-1611|janis.daly@neurology.ufl.edu|5223
21230208|NCT00957580|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21230209|NCT00945893|MedImmune, LLC|Raburn Mallory, MD Senior Director Clinical Development|301-398-0000|malloryr@medimmune.com|
21230210|NCT04502433|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
21230211|NCT00795145|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21230212|NCT01999179|Versiti|Dr Lisa Baumann Kreuziger|414-937-6826|lisakreuziger@versiti.org|
21230213|NCT00880997|Baylor College of Medicine|Thomas Kosten, MD|713-794-7032|kosten@bcm.edu|
21230214|NCT00300274|Novartis Pharmaceuticals|Study Director|862-778-8300||
21230215|NCT00242216|The University of Texas Health Science Center at Houston|Dr. Roberto C. Arduino, Professor of Medicine|713-500-6731|roberto.c.arduino@uth.tmc.edu|
21230216|NCT01663532|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21230217|NCT02785432|UT Southwestern|Jason Zafereo|146481002|jason.zafereo@utsouthwestern.edu|146481002
21230218|NCT02432729|Philip Morris Products S.A.|Christelle Haziza, Director Health Science and Biostatistics|+41 58 242 11 11|christelle.haziza@pmi.com|
21230219|NCT03663816|University of Florica|Sharareh Sharififar|352-273-7410|sharareh75@phhp.ufl.edu|
21230220|NCT00871260|The University of Chicago|Dr. Amit Patel|773-702-9461|apatel2@medicine.bsd.uchicago.edu|
21230221|NCT03539081|University of Iowa|Marshall Holland, MD|205-934-2654|mtholland@uabmc.edu|
21230222|NCT02025621|Duke Clinical Research Institute|Rajendra Mehta, MD Study Principal Investigator|919-668-8971|raj.mehta@dm.duke.edu|
21230223|NCT02373852|Gardia Medical Ltd|Dr Vardit Segal|972-52-4579178|vardit@gardiamedical.com|
21230224|NCT03243071|NYU Langoen Health|Girardin Jean-Louis, PhD|646-501-3431|Girardin.Jean-Louis@nyulangone.org|
21230225|NCT01897454|NYU Langone|Dr. Jennifer Chuy|646-501-0194|jennifer.chuy@nyulangone.org|
21230226|NCT00990236|Oregon Health & Science University|Samantha Underwood, Research Manager|503-494-8481|traumare@ohsu.edu|
21230227|NCT01560403|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21230228|NCT00539656|Johns Hopkins University School of Medicine|Allen Chen, MD,PhD,MHS|410-614-4434|chenal@jhmi.edu|
21230229|NCT00983437|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21230230|NCT00094172|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21230231|NCT01020981|VHA HSR&D|Marcia Valenstein, MD|7349453649|marcia.valenstein@va.gov|
21230232|NCT01337700|Montefiore Medical Center, Albert Eins|Eric Hollander, MD|7189204287|eholland@montefiore.org|
21230233|NCT00993200|University of Utah|Robert Pendleton|801 581 7818|robert.pendleton@hsc.utah.edu|
21230234|NCT00289133|DePuy Orthopaedics, Inc.|Clinical Portfolio Leader|574-372-7231|shimden@its.jnj.com|
21230235|NCT01691339|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21230236|NCT03372096|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
21230237|NCT01397890|AstraZeneca|Nongluk Yimsuan|66 2 7397400|ClinicalTrialTransparency@astrazeneca.com|429
21230238|NCT03094169|Formation Biologics|Sandra Sinclair|8326221699|sandra@forbius.com|
21230239|NCT04645953|Alexza Pharmaceuticals Inc.|Dan Myers, PhD, VP Product & R&D|(650) 210-6164|dmyers@alexza.com|
21230240|NCT04613375|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21230241|NCT00434954|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21230242|NCT01145625|Johnson & Johnson Healthcare Products Division of MCNEIL-PPC, Inc.|Study Director|(973) 385-3203||
21230243|NCT01751178|GlaxoSmithKline|GSK Response Center|866-435-7343||
21289306|NCT02639559|Washington University School of Medicine|Geoffrey Uy, M.D.|314-454-8304|guy@wustl.edu|
21289307|NCT04999020|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
21289308|NCT05706701|Yale University|Stephen R Baldassarri, M.D.|203-785-3627|stephen.baldassarri@yale.edu|
21289309|NCT04022694|University of Pennsylvania|Deputy Director of PEACH Lab|2158987093|thepeachlab@gmail.com|
21289310|NCT02609633|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21289311|NCT02320292|Mayo Clinic|Dr. Thomas E Witzig|507-266-4994|witzig.thomas@mayo.edu|
21289312|NCT01197898|Healthpoint, Ltd.|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|817-302-3914|jaime.dickerson@healthpoint.com|
21289313|NCT02691663|Campbell University|Snezana Petrovic, MD, PhD, FASN|(910) 893-1751|spetrovic@campbell.edu|
21289314|NCT04268979|Moffitt Cancer Center|Margaret Byrne, Ph.D.|813-745-5569|Margaret.Byrne@moffitt.org|
21289315|NCT00471107|NIH/NINDS|Eric Wassermann|301-496-0151|wassermanne@ninds.nih.gov|
21260901|NCT01583647|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21289316|NCT03914703|Zimmer Biomet|Jarrod Hunnicutt, Clinical Affairs Manager|574-453-7834|jarrod.hunnicutt@zimmerbiomet.com|
21289317|NCT04828486|Mayo Clinic|Nguyen H Tran MD MPH|507-284-2511|Tran.Nguyen@mayo.edu|
21289318|NCT03325439|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21289319|NCT00837447|Ewha Womans University School of Medicine|Young-Hoo Kim, MD|822-26505900|younghookim@ewha.ac.kr|
21289320|NCT00896233|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21289321|NCT00387127|GlaxoSmithKline|GSK Response Center|866-435-7343||
21289322|NCT04056468|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21289323|NCT02991521|Medical City Arlington, 3301 Matlock Rd, Arlington, TX 76015|Danielle A Pigneri, MD, FACS|(502) 387-3117|dpigneri@gmail.com|
21289324|NCT03296345|Valley Children's Hospital|Jonathan Bryan Cooper-Sood, MD|559-353-3000|coopersoodj@usacs.com|
21289325|NCT02487485|Yale School of Medicine|Chadi Abdallah|347-987-0717|chadi.abdallah@yale.edu|
21289326|NCT02068599|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21289327|NCT01263028|Kaiser Permanente|John J. Sim, MD||john.j.sim@kp.org|
21289328|NCT06042855|Duke University|Susanna Naggie, MD|919-684-2584|susanna.naggie@duke.edu|
21289329|NCT06428591|Tandem Diabetes Care|Manager, Clinical Affairs|8583666900|clinicalaffairs@tandemdiabetes.com|
21289330|NCT06038643|McGill University|Maiya R. Geddes|514-398-8751|maiya.geddes@mcgill.ca|
21289331|NCT00294398|CHOP|Esther Sampayo MD MPH|215-590-1944|sampayo@email.chop.edu|
21289332|NCT01769365|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@isca.vghks.gov.tw|8233
21289333|NCT01428128|The University of Texas Health Science Center at San Antonio, Department of Radiation Oncology|Chul S. Ha, MD, Professor and Chair|210-450-1109|hac@uthscsa.edu|
21289334|NCT00250718|University of New Mexico|Dulcinea Quintana, MD|505-272-4661|dcandelaria@salud.unm.edu|
21289335|NCT04136366|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
21289336|NCT06100250|University of Michigan|Dr. Akshay Sharma|734-647-0151|akshaydr@umich.edu|
21289337|NCT03677206|University of Arizona|Dr. Mohab Ibrahim|(520) 626-7221|mohab@arizona.edu|
21289338|NCT00424008|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21289339|NCT01181479|Agile Therapeutics|Joseph Chiodo III, Senior Medical Director|609-683-1880|jachiodo@agiletherapeutics.com|
21289340|NCT03233217|Sanofi Pasteur|Medical Director|800-633-1610|Contact-US@sanofi.com|1#
21289341|NCT02114684|CAPRISA|Mrs Nonhlanhla Yende-Zuma|0027312604392|Nonhlanhla.Yende@caprisa.org|
21289342|NCT03969420|Sumitomo Pharma Oncology, Inc|Reyna Bishop|512-363-8755|reyna.bishop@oncology.Sumitomo-Pharma.com|
21289343|NCT00500890|UT MD Anderson Cancer Center|Dr. Richard Gorlick, MD/Division Head, Pediatrics Administration|713- 563-2516|rgorlick@mdanderson.org|
21289344|NCT01397747|Exact Sciences|Director of Clinical Operations|608-284-5700|tvaughn@exactsciences.com|
21289345|NCT03828383|University of California, Berkeley|Robert W. Levenson|510-643-8952|boblev@berkeley.edu|
21289346|NCT02643199|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
21289347|NCT00504309|Penn State University|Ann Skulas-Ray|814-863-0856|aus164@psu.edu|
21289348|NCT02665455|Abbott Diabetes Care|Jolyon Bugler, Snr Director Clinical Development & Regulatory Affairs|+44 1993 863094|joe.bugler@abbott.com|
21289349|NCT00223821|Birmingham VA Medical Center|Kathryn L. Burgio, PhD|205-558-7064|kburgio@uabmc.edu|
21289350|NCT06818708|University of California San Diego|Baharin Abdullah|+1 858-220-5714|baabdullah@health.ucsd.edu|
21289351|NCT01039675|GlaxoSmithKline|GSK Response Center|866-435-7343||
21289352|NCT02564978|National Institutes of Health|Tiarnan Keenan, MD, PhD, Principal Investigator, NEI|301-451-6330|tiarnan.keenan@nih.gov|
21289353|NCT03554473|National Cancer Institute|Dr. Anish Thomas|2407607343|anish.thomas@nih.gov|
21289354|NCT05206604|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21289355|NCT00567580|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21289356|NCT01258855|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
21289357|NCT04289298|Weill Cornell Medical College|Dr. Patricia Marino, PhD|914-997-8691|pam2029@med.cornell.edu|
21289358|NCT01778985|University of Texas Southwestern Medical Center|David D. Rahn, M.D.|214-648-6430|david.rahn@utsouthwestern.edu|
21289359|NCT01292265|UCB, Inc.|Study Director|+1 887 822 9493||
21289360|NCT00504231|University of Washington|Ru-Chien Chi B.S., M.D., M.S.|206 768-5217|rchi@u.washington.edu|
21289361|NCT01629563|PregLem|Dr Pablo Arriagada|0041228840355|info@preglem.com|
21289362|NCT04229381|The Ohio State University Comprehensive Cancer Center|Dr. Carolyn Presley|614-293-9424|Carolyn.Presley@osumc.edu|
21230244|NCT00885846|Bastyr University|Guan-Cheng Sun, PhD|425-602-3389|gsun@bastyr.edu|
21230245|NCT05091047|Erchonia Corporation|Clinical Affairs Manager|888.242.0571|tsammons@erchonia.com|
21230246|NCT01496248|Krea University College of Medicine|Young-Hoon Ko|+82-31-412-5140|korean@chol.com|
21230247|NCT02747875|Children's National Hospital|Dr. Andrew Waberski, Assistant Professor|2024762025|awabersk@childrensnational.org|
21230248|NCT04424888|Pendulum Therapeutics|James Bullard, PhD, Chief Technical Officer|(844) 912-2256|james.bullard@pendulum.co|
21230249|NCT00493025|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Rosalyn Juergens, MD.|410-908-7829|rjuerge1@jhmi.edu|
21230250|NCT03285984|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21230251|NCT01986907|Novartis Pharmaceuticals|Study Director|+41613241111|trialandresults.registries@novartis.com|
21230252|NCT01961362|National Jewish Health|Dr. Jeffrey J. Swigris|303-398-1621|swigrisj@njhealth.org|
21230253|NCT03800173|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
21230254|NCT01313312|Ipsen Innovation|Medical Director, Neurology.||clinical.trials@ipsen.com|
21230255|NCT01761175|CHU de Québec, Département d'Anesthésie-Réanimation de l'Hôpital de l'Enfant-Jésus|Dre Marie-Josée Nadeau|418 649-5807|marie-josee.nadeau@fmed.ulaval.ca|
21230256|NCT00784641|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
21230257|NCT02716805|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
21230258|NCT00066365|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21230259|NCT04288752|J3 Bioscience, Inc|R. Tyler McCabe, Ph.D.|801-550-9956|tmccabe@j3bio.com|
21230260|NCT00467857|Kimberly-Clark Health Care|Dr. Shu-Ping Yang|770-587-7267|Shu-Ping.Yang@kcc.com|
21230261|NCT00787761|Blood and Marrow Transplant Group of Georgia|Asad Bashey, MD, PhD, Principal Investigator|404-255-1930|abashey@bmtga.com|
21230262|NCT01252147|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21230263|NCT03638622|Massachusetts General Hospital, Boston|Tayyaba Hasan|617-726-6996|thasan@mgh.harvard.edu|
21230264|NCT00516074|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21230265|NCT01589978|Boston Scientific|Peter Maurer, Director Clinical Trials|508-683-6678|Peter.Maurer@bsci.com|
21230266|NCT00369824|GlaxoSmithKline|GSK Response Center|866-435-7343||
21230267|NCT01216631|University of Leeds|Professor Philip Conaghan|+44 113 3924884|p.conaghan@leeds.ac.uk|
21230268|NCT01484275|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21230269|NCT00003487|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
21238780|NCT04270747|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21238781|NCT00947661|Sun Pharma Advanced Research Company|Dr Shravanti Bhowmik||shravanti.bhowmik@sparcmail.com|
21238782|NCT00586170|Biomet|Manager of Research|973-299-9300|hallie.murray@zimmerbiomet.com|3415
21238783|NCT05597722|University of Pittsburgh|Dr. Eva Szigethy|412-667-0416|szigethye@upmc.edu|
21238784|NCT04108000|Emory University|Professor Mi-Kyung Song, PhD, RN|404-727-3134|mi-kyung.song@emory.edu|
21238785|NCT05361655|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21238786|NCT04411849|Ohio State University|Dr. Paul Reiter|614-292-4803|reiter.36@osu.edu|
21238787|NCT05559866|Mayo Clinic|Dr. Omar Ghanem|507-284-2095|ghanem.omar@mayo.edu|
21277558|NCT01936519|Penn State Milton S Hershey Medical Center|Dr Zakiyah Kadry|717 531 5921|zkadry@pennstatehealth.psu.edu|
21238788|NCT03750006|VA Kansas City Healthcare System|Bruce Troen|913-574-4896|bruce.troen@va.gov|
21238789|NCT05619003|Coloplast|Senior Scientific Manager|+45 49112880|dkcpov@coloplast.com|
21238790|NCT03538951|Vidac Pharma|Max Herzberg|0544257381|maxherzberg@gmail.com|
21238791|NCT06238999|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
21238792|NCT00811382|BIOTRONIK|Mathias Freudigmann|+49(0)30 68905 - 1248|mathias.freudigmann@biotronik.com|
21238793|NCT07018999|Department of Anaesthesiology & Perioperative Medicine, Hong Kong Children's Hospital|Dr. Vansie Kwok, Consultant|+852-96737367|kv314@ha.org.hk|
21238794|NCT03444376|Clinical Development|• Project Lead|+82-2-6098-2756|yoonjeong.choi@genexine.com|
21238795|NCT04081220|UT HEALTH MAYS CANCER CENTER|Dr Zohra Nooruddin|2013362409|nooruddinz@uthscsa.edu|
21238796|NCT00856167|University of Arizona|Dr. Cheryl Ritenbaugh, Principal Investigator|520-822-6710|ritenbau@email.arizona.edu|
21238797|NCT03237858|Boston Scientific|Joe Hobbs, Clinical Trial Manager|612-206-4703|JOE.HOBBS@BSCI.COM|
21238798|NCT02623816|MetroHealth Medical Center|Nisheet Waghray|2167785736|nwaghray@metrohealth.org|
21238799|NCT02026232|Washington University School of Medicine|Dr. Janet McGill|314-273-3929|jmcgill@wustl.edu|
21230270|NCT02197273|OhioHealth|Deborah Napier|614-566-5575|Deborah.Napier@ohiohealth.com|
21238800|NCT01108458|Stanford University Medical Center|George Albert Fisher, MD|650-725-9057|georgeaf@stanford.edu|
21238801|NCT01382602|Cook MyoSite Incorporated|Ron Jankowski, PhD|412-963-7380|Ron.Jankowski@CookMyosite.com|
21238802|NCT03091673|Xeris Pharmaceuticals, Inc.|Martin J. Cummins, VP, Clinical Development|806-282-2120|mcummins@xerispharma.com|
21238803|NCT01686165|University of Arizona Cancer Center|Daniel Persky, M.D.|520-626-8908|dpersky@uacc.arizona.edu|
21238804|NCT05056870|Johnson & Johnson Vision Care, Inc.|Benjamin Straker-Principal Research Optometrist|1-800-843-2020|bstraker@its.jnj.com|
21238805|NCT01887470|Cumberland Pharmaceuticals, Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
21238806|NCT00582946|EarLens Corporation|Sunil Puria|650-366-9000|spuria@earlenscorp.com|
21277559|NCT00652028|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com|
21230271|NCT04154930|Galderma|Clinical Project Manager|817-961-5655|aestheticclinicaltrials@galderma.com|
21230272|NCT00657358|UAB|Dr. Michael Froelich|205-975-0145|froelich@uab.edu|
21238807|NCT01114204|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
21238808|NCT03155932|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
21230273|NCT00515411|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian, MD|646-888-4186|janjigiy@mskcc.org|
21230274|NCT03558087|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
21230275|NCT03943160|Cardiovascular Systems Inc.|Clinical Trials Manager|651.259.2500|clinicaltrials_csi@csi360.com|
21230276|NCT03104543|Fred Hutchinson Cancer Center|Dr. Eric Chow|206-667-7724|ericchow@uw.edu|
21230277|NCT04203797|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21230278|NCT00678080|UT Health|Dr. Jerrie Refuerzo, M.D.|713-500-6416|jerrie.s.refuerzo@uth.tmc.edu|
21230279|NCT01453361|Gradalis, Inc.|Director of Clinical Trials|2144428124|info@gradalisinc.com|
21230280|NCT01752985|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
21230281|NCT02823431|Duke Biomedical Engineering|Warren Grill PhD|(919) 660-5276|warren.grill@duke.edu|
21230282|NCT00544466|City of Hope Medical Center|Dr. Jeffrey Wong, MD|6263598111|JWong@coh.org|
21230283|NCT01385566|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21230284|NCT00967668|VA Center for Clinical Management Research|Laura Damschroder|734-845-3603|laura.damschroder@va.gov|
21230285|NCT01542125|Alberta Health Services|Research Coordinator|780-492-2398|manu.saraswat@albertahealthservices.ca|
21230286|NCT02468674|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21230287|NCT01650844|University of Rochester|Dr. Jill Halterman|585-275-5798|jill_halterman@urmc.rochester.edu|
21230288|NCT01644565|Enteric Diseases Department, Naval Medical Research Center|Ramiro L. Gutierrez, MD, MPH|301-319-3193|ramiro.gutierrez@med.navy.mil|
21230289|NCT03542474|Northwestern University|Dr. Daniel Corcos|312-908-6792|daniel.corcos@northwestern.edu|
21230290|NCT02958293|TriHealth Inc.|Dr. Rachel Pauls|513-463-4300|Rachel_Pauls@trihealth.com|
21230291|NCT02195583|GlaxoSmithKline|GSK Response Center|866-435-7343||
21230292|NCT01112358|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
21230293|NCT00040365|National Cancer Institute (NCI), National Institutes of Health (NIH)|Kevin A. Camphausen|301-496-5457|camphauk@mail.nih.gov|
21230294|NCT00680017|AstraZeneca|Gerard Lynch|+44 1509 645 895|aztrial_results_posting@astrazeneca.com|
21230295|NCT02840097|University of California, Davis|Daniel Nishijima, Study Co-PI|916.734.3884|dnishijima@ucdavis.edu|
21230296|NCT02555683|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21230297|NCT03513328|University of Florida|Biljana Horn, MD|352-273-9121|biljana.horn@ufl.edu|
21230298|NCT01947582|University of Texas Southwestern Medical Center|Karen McCain, PT, DPT, NCS, Principal Investigator|214-648-1559|karen.mccain@utsouthwestern.edu|
21230299|NCT02279420|USGI Medical|Senior Director of Clinical Research|9493693890|samlung@usgimedical.com|
21230300|NCT00612040|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21230301|NCT02835820|University of Alabama at Birmingham|Shannon Morrison|12059967841|samorris@uab.edu|
21230302|NCT03554746|National Yang Ming University|Dr. Yi-Fen Shih|+886-2-28267340|yfshih@ym.edu.tw|
21230303|NCT01548651|Baylor College of Medicine|Mandeep Bajaj|713-798-1712|bajaj@bcm.edu|
21230304|NCT02911857|Novartis Pharmaceuticals|Study Director|862-778-1873|Novartis.email@novartis.com|
21230305|NCT00899574|NYU Cancer Institute|Sylvia Adams, MD|212-263-6485|sylvia.adams@nyumc.org|
21230306|NCT02924571|NYU Langone Health|Themistocles Protopsaltis|646-501-7200|themistocles.protopsaltis@nyulangone.org|
21277560|NCT01385306|electroCore LLC|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
21230307|NCT03783949|UZLeuven|Ellen Reynders, SC|+3216342996|ellen.reynders@uzleuven.be|
21230308|NCT00002651|SWOG Statistical Center|Study Statistician|206-667-4623||
21230309|NCT01705730|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21230310|NCT01773733|"FEDERAL STATE BUDGETARY INSTITUTION ENDOCRINOLOGY RESEARCH CENTRE MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION"|Prof. Ivan I . Dedov, Director of the Endocrinology Research Centre|+7 499 124 4300|dedov@endocrincentr.ru|
21230311|NCT04755790|Point Designs|Director of Clinical Research|7206004753|research@pointdesignsllc.com|
21230312|NCT03345914|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
21230313|NCT02096731|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21230314|NCT01833988|Massachusetts General Hospital Diabetes Research Center|Dr. Steven J. Russell|617.726.1848|sjrussell@partners.org|
21230315|NCT00120523|MEDA Pharma GmbH & Co. KG|Clinical Research|+49 6172 888|clinical.research@medapharma.de|01
21230316|NCT02640573|Baylor College of Medicine|Vivien Sheehan|832 824 4459|vsheehan@bcm.edu|
21230317|NCT02605304|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21230318|NCT03576495|Brigham and Women's Hospital|Dr. Douglas S. Smink|617-983-7260|dsmink@bwh.harvard.edu|
21230319|NCT02867150|Optimal Health and Weight Center|Dr. Ellyn Levine M.D.|(619) 567-6914|dr.levine@teamtsfl.com|
21230320|NCT01216748|University of Miami|Matthias Salathe, MD|(305)243-2568|msalathe@med.miami.edu|
21230321|NCT02628938|Riyadh Colleges of Dentistry and Pharmacy|Dr. Mohammad Rayyan|00966508821318|mohammadrayyan1979@gmail.com|
21230322|NCT02058693|Collaborative Behavioral Health|Michael Topel PsyD|847-922-3253|michaeltopel@gmail.com|
21230323|NCT00843856|Imperial College NHS Trust|Dr Megan Griffith|02083835272|megan.griffith1@nhs.net|
21230324|NCT03855228|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21230325|NCT02993757|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21230326|NCT03351933|Grifols Therapeutics LLC|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
21230327|NCT01468675|Brigham and Women's Hospital|Jennifer Haas, M.D.|617-525-6652|jhaas@partners.org|
21238809|NCT02255357|new york psychiatric institute|wilfrid raby, m.d.|2129233031|wilfrid.raby@nyspi.columbia.edu|
21238810|NCT01856712|University of Wisconsin|Randall Brown|6082636558|rtbrown@wisc.edu|
21277561|NCT02751359|University of California Los Angeles|Dr. Ziva Cooper, Principal Investigator|310-206-9942|zcooper@mednet.ucla.edu|
21277562|NCT02400671|University of Washington|Dr. Keshet Ronen|206-685-4363|keshet@uw.edu|
21277563|NCT03949244|Icahn School of Medicine at Mount Sinai|Harriet Lloyd|212-979-4672|hlloyd@nyee.edu|
21277564|NCT02145026|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21277565|NCT00127036|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-2069|jonathan.strosberg@moffitt.org|
21277566|NCT01280409|University of Texas Health Science Center at Houston|Dr Jerrie Refuerzo|713.500.7780|Jerrie.S.Refuerzo@uth.tmc.edu|
21277567|NCT03275766|University of Bern, University Hospital of Psychiatry, Bern|Prof. Sebastian Walther|+41 632 8979|sebastian.walther@upd.unibe.ch|
21277568|NCT01797835|RAND|Dr. Elizabeth D'Amico|3103930411|damico@rand.org|6487
21277569|NCT01403064|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
21277570|NCT00973765|Washington Hospital Center|Gillian Schmitz, MD|919-724-9185|gillianmd@gmail.com|
21277571|NCT04920916|University of Virginia Health System|William Petri|434-305-9633|wap3g@virginia.edu|
21277572|NCT02011113|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
21277573|NCT01338649|Massachusetts General Hospital|Aleksandar Videnovic|855-644-6387|avidenovic@mgh.harvard.edu|
21277574|NCT02669940|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21277575|NCT01892657|Galderma Laboratories, L.P.|Elizabeth M. Nieman, Medical Information Specialist|817-961-5130|elizabeth.nieman@galderma.com|
21277576|NCT05065983|Emergent BioSolutions|Dr. Sufia Muhammad|346-732-7331|muhammads@ebsi.com|
21277577|NCT00986180|Janssen Pharmaceuticals|Vice President, Medical Affairs, Internal Medicine|1 908 218-7250||
21277578|NCT03261960|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
21277579|NCT03251963|University of Utah|Christopher Pannucci|801 581 2121|christopher.pannucci@hsc.utah.edu|
21277580|NCT04505293|Duke University|Anthony 'Tony' T. Fuller, MD, MScGH|919-613-1813|anthony.fuller@duke.edu|
21277581|NCT00506129|University of Texas (UT) MD Anderson Cancer Center|Chitra M. Hosing, Professor, Stem Cell Transplantation|1-877-MDA-6789|CR_Study_Registration@mdanderson.org|
21277582|NCT04295135|Indiana University|Dr. Christopher A. Harle|317 278 3245|charle@iu.edu|
21277583|NCT02923674|Wake Forest School of Medicine|Barbara Nicklas, MD|336-713-8569|bnicklas@wakehealth.edu|
21277584|NCT02712333|Fudan University|Dr. Haidong Kan|86-21-54237908|kanh@fudan.edu.cn|
21289363|NCT00088881|ECOG Statistical Office|Study Statistician|617-632-3012||
21289364|NCT01129284|Columbia University Medical Center|Dr. Andrew S. Bomback, MD, MPH|212-305-0320|asb68@columbia.edu|
21289365|NCT02082483|Kidney Transplant Research|Dr. John Gill|6046822344|jgill@providencehealth.bc.ca|64706
21289366|NCT01404260|Shanghai Chest Hospital|Shun LU|86-2162821990|shun_lu11@163.com|
21289367|NCT01028560|Jacobi Medical Center / Albert Einstein College of Medicine|Gabriele de Vos, M.D.|7184152809|gabriele.de-vos@einstein.yu.edu|
21289368|NCT01060111|Medical Affairs / Janssen-Cil Korea|Clinical Research Associate|82-2-2094-4837||
21289369|NCT05278065|Brown University|Alexander Sokolovsky|401-863-6629|alexander_sokolovsky@brown.edu|
21289370|NCT04149353|North Carolina State University|David Lalush|919-513-7671|dslalush@ncsu.edu|
21289371|NCT01871727|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21289372|NCT03019588|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21289373|NCT03838874|Mayo Clinic|Dr. Matthew Abdel|507-538-1296|Abdel.Matthew@mayo.edu|
21289374|NCT00366535|Symptoms Biology Unit, DIR, NINR, NIH|Leorey Saligan, Chief|301-451-1685|saliganl@mail.nih.gov|
21289375|NCT00106535|Hoffmann-La Roche|Medical Communications|800-821-8590||
21289376|NCT02958527|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21289377|NCT05901467|Massachusetts General Hospital|Stephanie Seminara|617-726-1309|MGHKisspeptinResearch@partners.org|
21289378|NCT00699751|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21289379|NCT01947933|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21289380|NCT02475837|Stanford University|Ken Mahaffey MD|650.723.3096|kmahaf@stanford.edu|
21289381|NCT00371449|Mountain Home VA Medical Center|Sherri L. Smith|423.926.1171|sherri.smith@va.gov|7569
21289382|NCT05259033|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21289383|NCT04185246|Trust Biosonics, Inc.|Charly Kang|+886-3-668-4965|charlykang@trust-biosonics.com|211
21289384|NCT02593864|Stanford University|Constance Chu, MD|650-723-5643|chucr@stanford.edu|
21289385|NCT02213575|University of Florida|Dr. Carl J. Pepine|(352) 339-0696|carl.pepine@medicine.ufl.edu|
21289386|NCT04249778|Emory University|Dr. Guillermo E. Umpierrez|(404) 778-1663|geumpie@emory.edu|
21289387|NCT01346683|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
21289388|NCT01789775|Galderma R&D|Galderma CPM|00 33 4 93 95 70 70|clinicaltrials@galderma.com|
21289389|NCT03345095|EORTC|Dr. Thierry Gorlia|+32 2 7741652|thierry.gorlia@eortc.org|
21289390|NCT05865886|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21289391|NCT01671059|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21289392|NCT07085845|Medical College of Wisconsin|Alan Nyitray, PhD|414-955-7701|anyitray@mcw.edu|
21289393|NCT06922760|University of Michigan|Njira Lugogo|734-647-6477|nlugogo@med.umich.edu|
21289394|NCT05136430|Brown University|Cara M. Murphy, Ph.D.|4018636519|murphybrownlab@brown.edu|
21289395|NCT01501513|Braintree Laboratories, Inc.|Head of R&D, GI|781-843-2202|studydirector@sebelapharma.com|
21289396|NCT04971837|Colorado State University|Dr. Christopher Bell, Director, Laboratory of Integrative Physiology|(970) 491-7522|Christopher.Bell@colostate.edu|
21289397|NCT02740582|University of California, San Franciso|Jennifer Mitchell, PhD|510-985-3522|jennifer.mitchell@ucsf.edu|
21289398|NCT05675020|Florida State University|Rachel Sharp|850-865-4443|rls14c@fsu.edu|
21230328|NCT00190671|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21230329|NCT02699593|Johnson & Johnson Vision Care Inc.|Brian Pall, OD, MS, FAAO -Sr. Principal Research Optometrist|904 443-1290|BPALL@its.jnj.com|
21230330|NCT01681472|Isofol Medical|Anders Rabbe|+46 (0)707 64 65 00|anders.rabbe@isofolmedical.com|
21230331|NCT02369016|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21230332|NCT02229383|AstraZeneca|Global Clinical Leader|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
21230333|NCT00672932|UCSF|Richard W. Price, M.D.|415-206-4487|rwprice@sfgh.ucsf.edu|
21230334|NCT02556554|Regents of the University of Colorado|Sarit Polsky, MD, MPH|3037248575|sarit.polsky@ucdenver.edu|
21230335|NCT01696071|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21230336|NCT01234831|Massachusetts General Hospital|Dr. Erica S. Shenoy|617-726-2036|eshenoy@partners.org|
21230337|NCT00074269|UCSD|Dr. Edward Ball, Director BMT Program|858-822-6600|tball@ucsd.edu|
21230338|NCT03763175|MAST Program|Director of Clinical Trials|(310) 423-0617|GroupMedicineMAST@cshs.org|
21230339|NCT00672646|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21230340|NCT00289783|GlaxoSmithKline|GSK Response Center|866-435-7343||
21230341|NCT02403986|Q-Med AB|Cecilia Skoglund, Manager Study strategy and publications|46 18 474 9000|cecilia.skoglund@galderma.com|
21230342|NCT01960400|Université de Sherbrooke|Dr Yannick Tousignant-Laflamme|819-821-8000|Yannick.Tousignant-Laflamme@USherbrooke.ca|72912
21230343|NCT04547712|Medtronic Neuromodulation|Helen Berrier|763-526-8178|helen.berrier@medtronic.com|
21230344|NCT03298867|Horizon Pharma USA, Inc.|Suzy Hammel|866-479-6742|clinicaltrials@horizontherapeutics.com|
21230345|NCT01594281|Novartis Pharmaceuticals|Study Director|1-862-778-8300|Novartis.email@novartis.com|
21230346|NCT01871532|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21230347|NCT00283400|Baylor College of Medicine|Jose I Suarez, MD, Professor of Neurology|713-798-8472|jisuarez@bcm.edu|
21230348|NCT00289471|Durham VAMC|John W. Williams|919-286-6963|jw.williams@duke.edu|
21230349|NCT01673867|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21230350|NCT02048891|Rambam health Care campus|Shahar Kol Director IVF Unit|97247773232|skol@rambam.health.gov.il|
21230351|NCT02550106|Novartis Pharmaceuticals|Study Director|(862) 778-8300||
21230352|NCT04019288|M.D. Anderson Cancer Center|Amir A Jazaeri|713-745-1613|aajazaeri@mdanderson.org|
21230353|NCT03166735|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21230354|NCT01543958|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21230355|NCT04538430|University of Utah|Shellie Cunningham|801-587-5488|shellie.cunningham@hsc.utah.edu|
21230356|NCT01292746|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com|
21230357|NCT01259128|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
21230358|NCT00926328|Colgate Palmolive|William De Vizio, DMD|732-878-7901|William_Devizio@colpal.com|
21230359|NCT02577978|Northwestern Medicine|David W Manning|3124726023|David.Manning@nm.org|
21230360|NCT03486223|Vanderbilt University Medical Center|Dr. James M Luther|6153223353|james.luther@vumc.org|
21230361|NCT01819831|Loma Linda University Health|Gary Yang, Professor, Chair of Radiation Medicine|909 558 4444|gyang@llu.edu|
21230362|NCT01948947|VA San Diego Healthcare System|Valerie Metzger Smith, Study Coordinator|858-750-0274|valerie.metzgersmith@va.gov|
21230363|NCT03535844|National University of Singapore|Dr. Kim Jung Eun|+6565161136|fstkje@nus.edu.sg|
21230364|NCT01803204|USP|Cristina Sousa|+5511996017972|crissousa@usp.br|
21230365|NCT01153347|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21230366|NCT00297830|Columbia University|Dr. Elizabeth Shane|2123056289|es54@columbia.edu|
21230367|NCT01539694|Bausch Health|Study Director||robert.steffen@bausch.com|
21230368|NCT00003473|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
21230369|NCT04401423|Columbia University Irving Medical Center|Dr. Jeanine D'Armiento / Principal Investigator|212-305-3745|jmd12@cumc.columbia.edu|
21230370|NCT00827502|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21230371|NCT05096221|Sarepta Therapeutics Inc.|Sarepta Therapeutics Inc.|1-888-727-3782|SareptAlly@sarepta.com|
21230372|NCT02061774|TTUHSC CRI|Cathy Lovett|806-743-4222|cathy.lovett@ttuhsc.edu|
21230373|NCT00779701|Temple University Hospital|Dr. Nina Gentile|215-707-2000|ngentile@temple.edu|8402
21230374|NCT02478632|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21230375|NCT01086033|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21230376|NCT02614586|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21230377|NCT02193867|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
21230378|NCT00187200|St. Jude Medical|Ashish Oza|(818) 493-3648|aoza@sjm.com|
21230379|NCT03741062|University of Manitoba|Dr. Brian Wiens|613-809-4501|wiensb3@myumanitoba.ca|
21230380|NCT01315665|Riley Hospital for Children|James Chmiel|317-948-7180|jfchmiel@iu.edu|
21230381|NCT03417219|VA Palo Alto Health Care System|Dr. Blake Scanlon|6504935000|blake.scanlon@va.gov|65316
21230382|NCT03992014|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21230383|NCT00762229|Bronx VA Medical Center|Dr. Lawrence Baruch|718-584-9000|lawrence.baruch@va.gov|6776
21230384|NCT02609828|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21230385|NCT01281865|Memorial Sloan-Kettering Cancer Center|Dr. Mary Keohan|646-888-4160|keohanm@mskcc.org|
21230386|NCT03478657|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21230387|NCT01517711|University of Cincinnati College of Medicine|Dr. Thomas Geracioti, Principle Investigator|513-748-9825|thomas.geracioti@uc.edu|
21230388|NCT03733470|University of Iowa|Eric Hoffman, PhD|319-365-1381|eric-hoffman@uiowa.edu|
21230389|NCT02983825|University of Pennsylvania|Nicolas Bamat, MD MSCE|2155904010|bamatn@email.chop.edu|
21230390|NCT01786668|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21289399|NCT03787212|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan, OD - Principal Research Optometrist|904 443 3449|CColesb@its.jnj.com|
21230391|NCT03019783|Brigham and Women's Hospital|Dr. Joshua Beckman|617-732-5500|joshua.a.beckman@vanderbilt.edu|
21230392|NCT01979445|The Medicines Company|Global Health Science Center, The Medicines Company|1-888-977-6326|medical.information@themedco.com|
21230393|NCT01776840|Janssen Research & Development, LLC|EXECUTIVE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21230394|NCT03641339|National Institutes of Health|Matthew J. Memoli, MD, MS|301-443-5971|memolim@niaid.nih.gov|
21230395|NCT02989545|Shaare Zedek Medical Center|Dr. Dan Livovsky|+972525622398|danlivo@szmc.org.il|
21230396|NCT05338216|Northeastern University|Dr. Erin Meier|1 (617) 373-7438|e.meier@northeastern.edu|
21289400|NCT00142597|University of Michigan|Richard E. Harris|734-998-6996|reharris@med.umich.edu|
21289401|NCT02169401|Abbott|Robyn Capobianco|512-286-4274|robyn.capobianco@abbott.com|
21230397|NCT04457336|Spruce Biosciences|Dina Ayala-Jones, Associate Director, Clinical Development Operations|424.558.1211|djones@sprucebio.com|
21230398|NCT05379231|National Centre for Audiology|Dr. Susan Scollie|519 661-2111|scollie@nca.uwo.ca|88948
21230399|NCT01554683|Beth Israel Deaconess Medical Center|Dr. Daniel Press|617-667-4074|dpress@bidmc.harvard.edu|
21230400|NCT02693119|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-(617) 600-6888|jim.carr@stealthbt.com|
21230401|NCT01719783|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
21230402|NCT02319837|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21230403|NCT00753766|VA Boston Healthcare System|Paul R. Conlin, M.D.|8572035111|paul.conlin@va.gov|
21230404|NCT00147212|MGH Cancer Center|M. Dror Michaelson, MD PhD|6177261594|dmichaelson1@partners.org|
21230405|NCT01206166|CERU Queen's University|Dr.Daren Heyland|403-915-5573|dkh2@queensu.ca|
21230406|NCT00932126|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21230407|NCT02127710|AstraZeneca|Senior Medical Director, Savolitinib||ClinicalTrialTransparency@astrazeneca.com|
21230408|NCT05306977|University of Pennsylvania|Nicholas Balderston|2157463058|nicholas.balderston@pennmedicine.upenn.edu|
21230409|NCT00415168|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21230410|NCT00241358|Washington University School of Medicine|John F. DiPersio, M.D., Ph.D.|314-454-8603|jdipersi@wustl.edu|
21230411|NCT01611155|Mayo Clinic|Charles L. Loprinzi, MD|507-284-3731|cloprinzi@mayo.edu|
21230412|NCT01540266|University Hospital Basel|Dr. med. Roland Bingisser|+41 61 265 58 30|roland.bingisser@usb.ch|
21230413|NCT00087607|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21230414|NCT02015754|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
21230415|NCT03704467|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21230416|NCT05544734|Weill Cornell Medicine|Dr Shari Lipner|6469623376|shl9032@med.cornell.edu|
21230417|NCT02989714|University of Michigan Rogel Cancer Center|Ajjai Alva, MD|734-936-0091|ajjai@umich.edu|
21230418|NCT02963649|Medtronic|Giulia Gatta, Clinical Study Manager|+310629467793|giulia.gatta@medtronic.com|
21230419|NCT05263895|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21230420|NCT05764408|Prisma Health|Dr. Melissa Wise|8644551600|melissa.wise2@prismahealth.org|
21230421|NCT06934993|Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine|Dr. Abdulgani Orhun YENİGÜN|+90 05346214600|orhunyenigun@gmail.com|
21230422|NCT03749447|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21230423|NCT04096963|Boston Scientific Corperation|Associate Clinical Trial Manager|+861085742971|yifan.zhao@bsci.com|
21230424|NCT00259649|University of Pittsburgh|Dawn marcus|412-953-4797|marcusd@upmc.edu|
21230425|NCT00745823|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1- 800-672-6372|ClinicalTrialsDisclosure@merck.com|
21230426|NCT00787891|Janssen R&D US|PORTFOLIO/CDT LEADER|1 609 730-2548||
21230427|NCT01431170|NJMS, Rutgers University|Suqin Guo, MD|973-972-2031|guos1@njms.rutgers.edu|
21230428|NCT04218695|BIDMC|Dr. Zachary Fricker|6176321070|zfricker@bidmc.harvard.edu|
21230429|NCT01890473|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21230430|NCT01945281|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21230431|NCT00934089|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21230432|NCT00799383|Baylor College of Medicine|Chadi Calarge, MD|832-824-4764|chadi.calarge@bcm.edu|
21230433|NCT00726986|Case Comprehensive Cancer Center|Afshin Dowlati MD|216-844-1228|afshin.dowlati@uhhospitals.org|
21230434|NCT00681083|Fisher & Paykel Healthcare|Hansinie Laing|+64 9 574 0123|CPAP.TRIAL@fphcare.co.nz|8601
21230435|NCT02767843|California Center for Sleep Disorders|Jerrold Kram, MD|510.263.3300|info@californiasleepcenters.com|
21230436|NCT01513343|Baylor College of Medicine|Dr. Sheryl O. Hughes, Associate Professor|713-798-7017|shughes@bcm.edu|
21230437|NCT01434667|Brigham and Women's Hospital|Kurt Christensen, PhD|(617) 264-5883|kchristensen@bwh.harvard.edu|
21230438|NCT02417831|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21230439|NCT02647203|University of Talca|Dr. Rodrigo Giacaman|+56712201546|giacaman@utalca.cl|2654
21230440|NCT02034110|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21289402|NCT00884949|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|800-983-4587|medinfo@bmrn.com|
21289403|NCT03022630|Vanderbilt University Medical Center|Dr. Cheryl Gatto|6153432252|cheryl.l.gatto.1@vumc.org|
21230441|NCT02587234|University of Kentucky|Lumy Sawaki, MD, PhD||lumy.sawaki@uky.edu|
21230442|NCT02165215|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21230443|NCT05074667|Stanford University|Sejal Shah, MD|650-498-7351|sshah2@stanford.edu|
21230444|NCT04678661|University of Pittsburgh|Dr. Linda Siminerio|412-559-0359|similx@upmc.edu|
21230445|NCT01867424|National Cancer Institute|Dr. Ismail Baris Turkbey|301-443-2315|turkbey@nih.gov|
21230446|NCT00864721|Ocala Oncology, Ocala, FL, USA|Dr. Craig Reynolds|352-732-4032|Craig.Reynolds@USOncology.com|
21230447|NCT01921387|Seattle Cancer Care Alliance|Ajay Kumar Gopal, MD, Director of Clinical Research|(206) 606-2037|agopal@uw.edu.org|
21230448|NCT00261807|U. of Maryland Medical Systems, R Adams Cowley Shock Trauma Center|Dr. Manjari Joshi|410-328-3656|mjoshi@som.umaryland.edu|
21230449|NCT01706146|Northwestern University|Adin-Cristian Andrei, Ph.D.|312-694-0509|Adin-Cristian.Andrei@nm.org|
21230450|NCT02582983|Hoffmann-La Roche|Medical Communications|800-821-8590||
21230451|NCT02527161|Stryker SP|David Fulker|+61 2 9467 1072|david.fulker@stryker.com|
21230452|NCT03416946|Orthopaedic Innovation Centre|Trevor Gascoyne|204-926-1235|tgascoyne@orthoinno.com|
21230453|NCT02021331|University of Michigan|Dr. Robert Eber|734-647-4023|reber@umich.edu|
21230454|NCT01439633|Massachusetts General Hospital|Gary Tearney, PI|617-724-2979|gtearney@partners.org|
21230455|NCT01081678|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21230456|NCT01004705|Ferrer Internacional S.A.|Natalia Oudovenko|+34 93 509 32 82|noudovenko-research@ferrergrupo.com|
21230457|NCT02589405|Galderma R&D|Stephanie Leclerc|492386706|stephanie.leclerc@galderma.com|+33
21230458|NCT04208997|Vanderbilt University Medical Center|Dr Giovanni Davogustto|6159361720|giovanni.e.davogustto@vumc.org|
21230459|NCT00446251|University of Washington|Dr. Connie L. Davis|206-598-6079|cdavis@u.washington.edu|
21230460|NCT02581787|Stanford University|Maximilian Diehn, MD, PhD|(650) 721-1550|diehn@stanford.edu|
21277585|NCT01825889|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21230461|NCT02149719|Imperial College London|Dr Paul Turner|+44 20 3312 7754|p.turner@imperial.ac.uk|
21230462|NCT04718961|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
21230463|NCT02727842|Cochlear Americas|Kimberly Nix, Clinical Project Manager|303-264-2340|knix@cochlear.com|
21230464|NCT00939640|University of Michigan|Dr. Scott Hummel|734-998-7991|scothumm@med.umich.edu|
21230465|NCT03407625|University of Texas Southwestern Medical Center|Emily Adhikari, MD|214-648-7825|emily.adhikari@utsouthwestern.edu|
21230466|NCT00590135|Cleveland Clinic|Brian Griffin MD|216-444-6812|Griffib@ccf.org|
21230467|NCT03698409|SUNY Upstate medical University|Assistant Profressor|3154644243|zidan@upstate.edu|
21230468|NCT00306189|Amgen Inc.|Study Director|866-572-6436||
21230469|NCT05248867|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21230470|NCT03128411|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21230471|NCT04659928|The University of Texas Health Science Center at Houston|Claudia Ruiz Brisuela, DDS|713-486-4138|Claudia.RuizBrisuela@uth.tmc.edu|
21230472|NCT05147428|UMass Chan Medical School|Jerry H. Gurwitz, MD|508-856-3085|jerry.gurwitz@umassmed.edu|
21230473|NCT03128047|Hackensack Meridian Health|Jeanette Haugh|5519963457|Jeanette.haugh@hmhn.org|
21230474|NCT00688753|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
21230475|NCT04147221|Center for Anti Infective Research and Development|Dr. Joseph L. Kuti|860-972-3612|joseph.kuti@hhchealth.org|
21230476|NCT05996718|Georgia State University|Candace L. Kemp|404-413-5216|ckemp@gsu.edu|
21230477|NCT01218113|GlaxoSmithKline|GSK Response Center|866-435-7343||
21230478|NCT01713686|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
21230479|NCT03187197|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21230480|NCT02385045|Imperial College London|Professor Julian Teare|02033126666|j.teare@ic.ac.uk|
21230481|NCT00115739|University of Michigan Comprehensive Cancer Center|Frances Worden, M.D.|(734) 615-6633|fworden@umich.edu|
21230482|NCT01637935|Takeda|Head, Pharmacoepidemiology|+1-877-825-3327|trialdisclosures@takeda.com|
21230483|NCT00595530|Connecticut Children's Medical Center|Dr. William T. Zempsky|860-837-5207|wzempsk@ConnecticutChildrens.org|
21230484|NCT01337739|Northwestern University|Paul Fitzgerald|312-472-3539|p-fitzgerald2@northwestern.edu|
21230485|NCT00651794|University of Texas HSC-Houston|Dr. Eric Thomas|713-500-7958|Eric.Thomas@uth.tmc.edu|
21230486|NCT01633853|Peking University Internetional Hospital|Dr. Zhang Dongliang|+86-10-69006561|zhangdongliang@pkuih.edu.cn|
21230487|NCT00300391|UPittsburgh|Barb Early, RN, BSN, CCRC|(412) 647-9745|earlybj@upmc.edu|
21230488|NCT02955602|CymaBay Therapeutics, Inc.|Elaine Watkins, DO, MSPH, Vice President of Clinical Development|510-293-8800|medinfo@cymabay.com|
21230489|NCT01258582|Massachusetts General Hospital|Rochelle P. Walensky, MD, MPH|(617) 724-8445|rwalensky@partners.org|
21260902|NCT03816995|The Cleveland Clinic|Rita Brienza|216-399-9186|brienzr@ccf.org|
21260903|NCT00541307|W. L. Gore & Associates, Inc.|Chad Badorek|928/437-8181|cbadorek@wlgore.com|
21230490|NCT02980601|Wake Forest Baptist Health|Joseph Molnar|336-716-4171|jmolnar@wakehealth.edu|
21230491|NCT01575769|Hoffmann-LaRoche or Genentech, Inc|Medical Communications|800 821-8590|genentech@druginfo.com|
21230492|NCT01709513|Regeneron Pharmaceuticals, Inc|Clinical Trial Administrator||clinicaltrials@regeneron.com|
21230493|NCT01034631|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
21277586|NCT01884064|University of Minnesota|Dr. Teresa Jacobson Kimberley|612-626-4096|tjk@umn.edu|
21230494|NCT01193530|The University of Texas (UT) MD Anderson Cancer Center|Rony Dev, DO/Associate Professor, Palliative Care Medicine|713-792-6085|rdev@mdanderson.org|
21260904|NCT02513940|Indiana University|Dr. James E Tisdale|317-880-5418|jtisdale@iu.edu|
21277587|NCT01546649|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21277588|NCT01570348|FHCRC|Dr. George Georges|(206) 667-6886|ggeorges@fredhutch.org|
21277589|NCT01621191|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21230495|NCT03119831|Department of Periodontology, School of Dentistry, National and Kapodistrian University of Athens, Greece|Dr. Anastasios M. Gkatzonis|6976486314|gkatzonis.tasos@gmail.com|0030
21230496|NCT01227434|University of California San Francisco|Michael Prados, MD|4154767217|pradosm@neurosurg.ucsf.edu|
21277590|NCT02494817|University of Hawaii|Jason W. Mitchell, PhD, MPH|8082196729|jasonmit@hawaii.edu|
21277591|NCT02660528|Brigham and Women's Hospital|Dr. Jessica Harder|617-525-7919|jaharder@bwh.harvard.edu|
21277592|NCT00706381|NIDDK|Kong Chen, Ph.D.|301-451-1636|chenkong@niddk.nih.gov|
21277593|NCT01026181|Royal Alexandra Hospital|Xinzhe Shi|7807356735|xinzhe.shi@ahs.ca|
21277594|NCT03529461|Bristol Hospital|Makram Gedeon, MD|8605853339|mgedeon@bristolhospital.org|
21277595|NCT02003911|Mount Sinai Kravis Children's Hospital|Dr. Lindsey Douglas|2122416500|lindsey.douglas@mssm.edu|
21277596|NCT01782482|Alcon Research, Ltd.|Sharon Thomas, O.D., Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com|
21277597|NCT00511992|University of Oklahoma|Ingrid Block, CTO Director|405 271-8001|ingrid-block@ouhsc.edu|
21277598|NCT03395639|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21277599|NCT02994251|Yale University|Dr. Todd Schlachter|203-785-5885|todd.schlachter@yale.edu|
21277600|NCT01155778|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21277601|NCT01045031|Health and Prevention Center, Sanatorium Hera, Vienna, Austria|Dr. Robert Winker|0043(1)-31350|robert.winker@hera.co.at|45666
21277602|NCT01825122|Invion, Inc.|Mitchell Glass, M.D., EVP of R&D|+61 7 3295 0500|mitchell.glass@inviongroup.com|
21277603|NCT02046525|Washington University in St. Louis|Kimberly Reske, MPH|3147474041|kreske@wustl.edu|
21277604|NCT01933464|UCSD Dermatology Clincal Trials|Dermatology Clinical Trial Manager|(858)657-8390|dermstudies@ucsd.edu|
21277605|NCT03508687|University of Michigan|Dr. Elif Oral|734-615-7271|eliforal@med.umich.edu|
21277606|NCT01641133|GlaxoSmithKline|GSK Response Center|866-435-7343||
21277607|NCT02220725|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
21277608|NCT04189445|Taiho Oncology, Inc|Taiho Oncology, Inc|609-250-7336|clinicaltrialinfo@taihooncology.com|
21277609|NCT00003138|ECOG Statistical Office|Study Statistician|617-632-3012||
21277610|NCT00102518|Otsuka Pharmaceutical Development & Commercialization, Inc.|Margaretta Nyilas|609-452-5673|Margaretta.nyilas@otsuka-us.com|
21277611|NCT02960893|Biohaven Pharmaceuticals|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
21277612|NCT01045421|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21277613|NCT00856973|Sunovion|CNS Medical Director|866-503-6357||
21277614|NCT04556552|Emory University|Dr. J. Douglas Bremner|404-712-9569|doug.bremner@emory.edu|
21277615|NCT01553279|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21277616|NCT00605865|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21277617|NCT03955471|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21277618|NCT03012672|University of Washington|Anna Halpern, MD|206-606-1978|halpern2@uw.edu|
21277619|NCT01030341|Johns Hopkins Data Coordinating Center|Mark Van Natta|410-614-1362|mvannat1@jhu.edu|
21277620|NCT01884311|Bio Products Laboratory Ltd|European Medical Affairs Lead|+44 (0)20 8957 2200|medinfo@bpl.co.uk|
21277621|NCT03805100|Xbrane Biopharma AB|Clinical Affairs|+46 85-590 56 00|xbregistry@xbrane.com|
21277622|NCT01461226|University of Antwerp/Antwerp University Hospital|dr. Luc bruyndonckx|003238213000|luc.bruyndonckx@uza.be|
21230497|NCT01023620|UT Southwestern Medical Center|Dr. Michael Limerick|214-590-0611|Michael.Limerick@UTSouthwestern.edu|
21230498|NCT01877265|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21230499|NCT01738321|Nationwide Children's Hospital|Senthil Krishna, MD|614-722-4200|Senthil.Krishna@nationwidechildrens.org|
21230500|NCT01468012|New York State Psychiatric Institute|Adam Bisaga|646-774-6155|bisagaa@nyspi.columbia.edu|
21230501|NCT00528788|Duke University Medical Center|Jula Inrig, MD|919-660-6882|Jula.Inrig@duke.edu|
21230502|NCT03039283|Cochlear|Nicole Neben|+4951154277220|nneben@cochlear.com|
21230503|NCT02114216|Seoul National University Hospital|Dr. Jinjoo Kim|82-10-6261-6483|jjkim0727@gmail.com|
21230504|NCT00469274|Vanderbilt University Medical Center|Dr. Thomas R. Talbot|615-322-2789|tom.talbot@vanderbilt.edu|
21230505|NCT00727636|Children's Hospital Boston|Dr. Athos Bousvaros|617-355-2962|athos.bousvaros@childrens.harvard.edu|
21230506|NCT00900237|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21230507|NCT01619423|PledPharma AB|Stefan Carlsson, MD, PhD, Chief Medical Officer|+46 8 679 72 10|stefan.carlsson@pledpharma.se|
21251459|NCT02804399|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|001800781021|ClinicalTrials.gov_Inquiries@pfizer.com|
21277623|NCT03310411|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21251460|NCT01174264|University of Chicago|Theodore Karrison|773-702-9326|tkarrison@health.bsd.uchicago.edu|
21230508|NCT01610570|National Cancer Institute|Dr. Brigitte Widemann|301-496-7387|widemanb@mail.nih.gov|
21230509|NCT04159571|Wake Forest University School of Medicine|Merideth Addicott, PhD|336-716-7792|maddicot@wakehealth.edu|
21230510|NCT05673889|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21230511|NCT02590003|Yale University|Rogerio C. Lilenbaum, MD, Professor of Medicine (Medical Oncology); Chief Medical Officer of Smilow|(203) 200-5864|rogerio.lilenbaum@yale.edu|
21230512|NCT02264639|Apellis Pharmaceuticals, Inc.|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
21230513|NCT00381550|Sidney Kimmel Comprehensive Cancer Center|Michael McDevitt, MD PhD|410-955-9175|mmcdev1@jhmi.edu|
21230514|NCT01416272|Bausch & Lomb / Valeant Pharmaceuticals|Robert Steffen, OD, MS|585-338-6399|robert.steffen@bausch.com|
21230515|NCT01350492|William S. Middleton Memorial Veterans Hospital|Aaron J. Stegner, Ph.D.|608-262-1290|aaron.stegner@va.gov|
21230516|NCT00702689|National Institute of Arthritis and Musculoskeletal and Skin Diseases|Edward Cowen, M.D.|301-827-2328|cowene@mail.nih.gov|
21230517|NCT03993132|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
21230518|NCT02805972|University of California San Francisco|Ashley Mason, PhD|415 514 6820|ashley.mason@ucsf.edu|
21230519|NCT00644657|University of Oklahoma Health Sciences Center|Eliot Schechter, MD|405-456-5378|eliot-schechter@ouhsc.edu|
21230520|NCT00239590|Imperial College London|Dr Carolyn Webb|03301288860|c.webb@imperial.ac.uk|
21230521|NCT02121522|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21230522|NCT01202565|AbbVie|Global Medical Services|800-633-9110||
21230523|NCT02169479|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21230524|NCT00892047|University of Pittsburgh|Charles F. Reynolds III, MD|412-246-6414|reynoldscf@upmc.edu|
21230525|NCT01443078|Memorial Sloan Kettering Cancer Center|Chaft, Jamie, MD|646-888-4545|ChaftJ@mskcc.org|
21230526|NCT01809106|Mario Negri Institution|Dr. Oscar Corli|+390239014564|oscar.corli@marionegri.it|
21230527|NCT01706978|The Ottawa Hospital Research Institute|Dr. Peter Lapner|613-737-8899|plapner@toh.ca|78377
21230528|NCT02106975|Virginia Commonwealth University School of Medicine|Alpha A Fowler, III, MD|804-828-9071|alpha.fowler@vcuhealth.org|
21230529|NCT03546062|"Università degli studi della Campania luigi Vanvitelli"|Raffaele Marfella|+390815665110|raffaele.marfella@unicampania.it|
21230530|NCT00806351|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21230531|NCT00259610|University of Alabama at Birmingham|Dr. Jeffrey R. Curtis,|205-934-7733|jcurtis@uab.edu|
21230532|NCT02028754|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21230533|NCT02718157|GenePOC|Dr Keith Chiasson, PhD|418-650-3535|keith.chiasson@genepoc.ca|322
21230534|NCT01201785|University of Florida-Jacksonville|Dominick J. Angiolillo, MD, PhD|904-244-3933|dominick.angiolillo@jax.ufl.edu|
21230535|NCT02151110|MedImmune LLC|David Howe, MBChB, MD, MRCOG|+44 (0) 1223 895980|information.center@astrazenea.com|
21230536|NCT01064310|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
21230537|NCT00001880|National Heart Lung and Blood Institute (NHLBI)|Richard Childs, M.D. Principal Investigator, NIH, NHLBI|301.451.7128|childsr@nhlbi.nih.gov|
21230538|NCT02639065|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
21230539|NCT00873015|University of Virginia Medical Center|Dr. Edward Oldfield|(434) 982-0059|EHO4U@hscmail.mcc.virginia.edu|
21230540|NCT00345839|Amgen Inc.|Study Director|866-572-6436||
21230541|NCT03928353|SFJ Pharmaceuticals, Inc.|Michele LaRussa SVP, Chief Regulatory Officer|925-223-6233|Bentracimab.General@SFJ-Pharma.com|
21230542|NCT00660699|Washington University School of Medicine|Benjamin Tan, M.D.|314-362-5740|btan@dom.wustl.edu|
21230543|NCT05166824|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
21230544|NCT00599924|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21230545|NCT01806298|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21230546|NCT00592384|University of Washington|Dr. Jesse R. Fann|206 6854280|fann@uw.edu|
21230547|NCT01144286|Privatni gynekologicka ambulance|Vladimir Dvorak|+420 542 221 661|ssgcr@ti.cz|
21230548|NCT00590720|MedImmune|Joseph Parker, MD|301-398-0000|parkerj@medimmune.com|
21230549|NCT00905151|Tufts Medical Center|Associate Professor|617-636-2569|linker@tuftsmedicalcenter.org|
21230550|NCT01966159|Shenyang Northern Hospital (The General Hospital of Shenyang Military Region)|Dr. Hanyaling|024-28897310|hanyl@medmail.com.cn|
21230551|NCT00867568|NMTRC|Giselle Sholler, MD|6162670335|giselle.sholler@helendevoschildrens.org|
21230552|NCT01056653|University of Calgary, Faculty of Nursing|Dr. Karen Benzies|403-220-2294|benzies@ucalgary.ca|
21230553|NCT03639935|University of Michigan Rogel Cancer Center|ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
21230554|NCT02683161|Johns Hopkins University|Kelly Dunn|410-550-2254|kdunn9@jhmi.edu|
21230555|NCT06333613|Johnson & Johnson Vision Care|Johnson & Johnson Vision Care Study Contact|1-800-843-2020|osova@its.jnj.com|
21230556|NCT01847274|GSK|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21230557|NCT03727230|Guangzhou Blood Center|Director of Clinical Trials|+86-20 83595049|fuyongshui1969@yahoo.com|
21230558|NCT00541593|Baystate Medical Center|Dr. John R. Romanelli|(413) 794-3175|john.romanelli@bhs.org|
21230559|NCT02124083|National Institute of Child Health and Human Development|Porter, Forbes|+1 301 435 4432|fdporter@mail.nih.gov|
21230560|NCT02059395|The Ottawa Hospital|Dr. Sylvain Boet|6137985555|sboet@toh.on.ca|14775
21230561|NCT05209360|The University of Iowa|Jason M Wilken, PT, PhD|319-335-6857|jason-wilken@uiowa.edu|
21230562|NCT00134082|Johns Hopkins University|Richard Ambinder, MD|4109558839|rambind1@jhmi.edu|
21230563|NCT02569658|Rush University Medical Center|Yale Fillingham|3095310220|yale.fillingham@gmail.com|
21230564|NCT00724932|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21230565|NCT02849678|University of Pittsburgh Medical Center Department of Anesthesiology|Jacques E. Chelly, MD, PhD, MBA|412-623-6382|chelje@anes.upmc.edu|
21230566|NCT00695409|City of Hope National Medical Center|Dr. Amrita Krishnan|626-256-4673|AKrishnan@coh.org|82405
21230567|NCT00289991|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21230568|NCT00961233|University of North Carolina School of Medicine|Evan S. Dellon, MD MPH|919-966-2511|edellon@med.unc.edu|
21230569|NCT02340975|MedImmune, LLC|Shahram Rahimian|+1-800-236-9933|information.center@astrazeneca.com|
21230570|NCT01007812|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
21230571|NCT01091974|University of Rochester Medical Center|Joseph A. Roscoe Ph.D.|(585) 275-9962|Joseph_Roscoe@URMC.Rochester.edu|
21230572|NCT04891978|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21230573|NCT03948581|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21230574|NCT03068455|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
21230575|NCT00692341|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|ClinicalTrials.gov_Inquiries@pfizer.com|
21230576|NCT04600375|University of Arkansas for Medical Sciences|Dr. Vivian Shi|5015266994|VYShi@uams.edu|
21230577|NCT03330288|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21289404|NCT00382070|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
21230578|NCT00408460|University of Washington|Renato G Martins, MD|206-288-2048|rgmart@uw.edu|
21230579|NCT02506465|Medi-Tate / Olympus|Sivan Baker|+97247701839|sivan.baker@olympus.com|
21230580|NCT01172522|ConnecticutSC|Edward M. Lane|2033720009|EMLMD@msn.com|
21230581|NCT02713373|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-1300|Chong.Wang@RoswellPark.org|
21230582|NCT04789499|Washington University in Saint Louis|Research Statistician|3143621077|kallogjerid@wustl.edu|
21230583|NCT01235689|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
21230584|NCT00578383|McLean Hospital|Dr. Michael Rohan|617-855-3127|mrohan@mclean.harvard.edu|
21230585|NCT02217878|Collegium Medicum, Nicolaus Copernicus University|Prof. Jacek Kubica|+485854023|jkubica@cm.umk.pl|
21230586|NCT01390649|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
21230587|NCT00389597|LDR Spine|Noah Bartsch, VP, Clinical,Regulatory,Quality|512-344-3319|noah.bartsch@ldrspine.com|
21230588|NCT00005044|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21230589|NCT00181155|Johns Hopkins University|Robert G. Weiss, MD|410-955-1703|rweiss@jhmi.edu|
21230590|NCT02572401|University of Pennsylvania|Dr. John B. Jemmott III|215-573-9366|jjemmott@asc.upenn.edu|
21230591|NCT01548287|AstraZeneca Pharmaceuticals LP, Neuroscience iMed|Joel Posener, MD||clinicaltrialtransparency@astrazeneca.net|
21230592|NCT01957930|Karolinska Institutet Södersjukhuset|Thomas Nyström|+46704325214|thomas.nystrom@sodersjukhuset.se|
21230593|NCT00353795|NIH|David Bluemke|301 402 1854|bluemked@nih.gov|
21230594|NCT01768286|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21230595|NCT02083965|Bioverativ|Bioverativ Study Medical Director||clinicaltrials@bioverativ.com|
21230596|NCT00929383|Stryker Neurovascular|David Hess, Manager Clinical Affairs|1-510-413-2642|david.hess@stryker.com|
21230597|NCT00868608|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21230598|NCT02516046|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
21230599|NCT00674362|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
21230600|NCT02653183|Universitair Ziekenhuis Gent|Prof. Dr. Hilde Beele|+32 9 332 21 11|Hilde.Beele@uzgent.be|
21230601|NCT00939770|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21230602|NCT04066023|Zosano Pharma Corporation|Don Kellerman, Sr. VP, Clinical Development and Medical Affairs|+1 (510) 745-4004|dkellerman@zosanopharma.com|
21230603|NCT04665856|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21230604|NCT03386448|The Taub Group|Neal Taub MD|7044429805|nealtaub@gmail.com|
21230605|NCT03338010|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21289405|NCT01734928|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21289406|NCT00620035|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21289407|NCT04290676|EyePoint Pharmaceuticals|Dario Paggiarino, MD|(617) 610-3411|dpaggiarino@eyepointpharma.com|
21289408|NCT03684057|Brown University|Dr. Judson Brewer|401-863-2826|judson.brewer@brown.edu|
21289409|NCT03017261|Think Surgical|Valentina Campanelli|510-249-2314|vcampanelli@thinksurgical.com|
21289410|NCT00456612|Beth Israel Deaconess Medical Center|Anand Mahadevan, MD|617-667-2345|amahadev@bidmc.harvard.edu|
21289411|NCT02316613|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21289412|NCT00442689|Northwestern University|Dr. Laura Torchen|312-227-6492|ltorchen@luriechildrens.org|
21289413|NCT01952678|GE Healthcare|Jose M Zubeldia, M.D.|011-44-1494-543137|jose.zubeldia@ge.com|
21289414|NCT03202550|Johns Hopkins University|Katrina Thaler|410-550-8506|kstouff3@jhmi.edu|
21289415|NCT00358579|Singapore General Hospital|A/Prof Marcus Ong Eng Hock|+6563213590|marcus.ong.e.h@sgh.com.sg|
21230606|NCT01146665|University of Alberta|Dr. Amanda Newton|780-248-5581|an6@ualberta.ca|
21230607|NCT00981370|Childrens Hospital Los Angeles|Thomas Coates, MD|323-361-2352|tcoates@chla.usc.edu|
21230608|NCT02538029|Cleveland Clinic|Dr. Jay Alberts|216 445-3222|albertj@ccf.org|
21289416|NCT03422718|University of Michigan|Principal Investigator|734-615-2766|mdome@umich.edu|
21230609|NCT02929667|University of Iowa|Dr. Rup Sainju|319-356-4337|rup-sainju@uiowa.edu|
21260905|NCT01485614|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21289417|NCT03309605|Eloxx Pharmaceuticals|Executive Director Clinical Trials|1-781-577-5300|CTI@eloxxpharma.com|
21230610|NCT00072566|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
21230611|NCT00481078|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
21230612|NCT01289080|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21230613|NCT02914119|Herlev Hospital, research unit, anesthesia|Dr. JLD Thomsen|004538633863|prs@demants.dk|
21230614|NCT03483740|University of Toronto|Andrew Eaton|4169788895|andrew.eaton@utoronto.ca|
21230615|NCT02342327|University of Minnesota|Michael Kotlyar|612-625-1160|kotly001@umn.edu|
21230616|NCT01700725|University of Wisconsin - Madison|David Rabago, MD|608-843-0850|david.rabago@fammed.wisc.edu|
21230617|NCT00666029|University Hospital Southampton|Professor Christopher Byrne|+44 238120 5006|cdtb@soton.ac.uk|
21230618|NCT03192462|Baylor College of Medicine|Dr. Benjamin Musher|(713)798-3750|blmusher@bcm.edu|
21230619|NCT00809276|SKCCC|Leo Luznik, MD|410-502-7732|lluznik2@jhmi.edu|
21230620|NCT02885012|Medical University of South Carolina|John Terrill Huggins|(843) 792-2296|hugginjt@musc.edu|
21230621|NCT02200211|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
21230622|NCT00381485|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@spcorp.com|
21230623|NCT01235351|TIMI Study Group|Jessica L. Mega, MD, MPH|6172780145|jmega@partners.org|
21230624|NCT01206660|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914-345-9001|natalie.yantovskiy@taro.com|
21230625|NCT00126191|DFCI|Ann LaCasce, MD|617-632-5959|ALACASCE@PARTNERS.ORG|
21230626|NCT00307294|University of Pittsburgh|Rita Johnson RN BSN CCRC|412-647-8571|johnsonr1@upmc.edu|
21230627|NCT02519036|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
21230628|NCT01661621|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|Dr. Hann-Chorng Kuo|886-3-8561825|hck@tzuchi.com.tw|2113
21230629|NCT01433991|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21230630|NCT01619982|Stanford University|Chandra Ramamoothy|650-723-5728|chandrar@stanford.edu|
21230631|NCT00290888|Pan Am Clinic|Dr. Peter MacDonald|204-925-7480|pmacdonald@panamclinic.com|
21230632|NCT02551757|University of Washington|Dr. Sandeep Khot|206-744-3251|skhot@uw.edu|
21230633|NCT01473836|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21230634|NCT01335191|Thymon LLC|Dr. Gideon Goldstein|(973) 467-9558|gidgold@gmail.com|
21230635|NCT03068130|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21230636|NCT01001377|Amgen Inc.|Study Director|866-572-6436||
21230637|NCT02643381|UT-Southwestern Medical Center|Gerald Matchett|214-648-6400|gerald.matchett@utsouthwestern.edu|
21230638|NCT00964860|Procter and Gamble|Holly Eynon|513-622-2920|eynon.ha@pg.com|
21230639|NCT00332163|Amgen Inc.|Study Director|866-572-6436||
21230640|NCT03570697|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21230641|NCT01849783|University of Iowa|Margarida Magalhaes-Silverman, MD|319-384-9156|margarida-silverman@uiowa.edu|
21230642|NCT02000583|University of Kansas Medical Center|Jeffrey M. Burns MD|913-588-0555|jburns2@kumc.edu|
21230643|NCT01876420|Medtronic|Terry Noel|763-526-0309||
21230644|NCT03173313|ZOLL Circulation, Inc.|Vice President of Clinical Affairs|(408) 541-2140|jcreech@zoll.com|
21230645|NCT04461210|University at Buffalo|Director of the Clinical and Translational Science Institute|7168884850|vmbarnab@buffalo.edu|
21230646|NCT02498132|University of Kansas|Professor Carl Lejuez|240-535-0467|clejuez@ku.edu|
21230647|NCT03095612|University of Texas Southwestern Medical Center|Dr. David Gerber|214-648-4180|david.gerber@utsouthwestern.edu|
21230648|NCT04447794|University of Alaska Anchorage|Dr. Patrick Dulin|(907) 786-1653|pldulin@alaska.edu|
21230649|NCT01042678|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21230650|NCT01117948|JSW-Lifesciences|Director of Clinical Trials|0043316 258111|office@jsw-lifesciences.com|310
21230651|NCT02284516|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21230652|NCT00205881|Advanced Bionics, LLC|Kenneth Ripley|(661) 362-4572|Kenneth.Ripley@advancedbionics.com|
21230653|NCT03463512|Abbott|Suntje Sander|+495116750|suntje.sander@abbott.com|3254
21230654|NCT04203498|Jazz Pharmaceuticals Inc.|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
21230655|NCT00781274|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21230656|NCT00223262|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD|2146456950|sherwood.brown@utsouthwestern.edu|
21230657|NCT02762578|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21230658|NCT01090492|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21230659|NCT00282984|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21230660|NCT00911547|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21230661|NCT00457301|Lung transplant program, University of Alberta Hospital|Maria Jose Santana|780-441-1661|msantana@ualberta.ca|
21230662|NCT00191269|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21230663|NCT00941005|University of Wisconsin - Madison|Jeffrey Larson, MD|(608) 417-6175|larsonjef@surgery.wisc.edu|
21230664|NCT02774954|USCalifornia|Ricky Bluthenthal|3234428236|rbluthen@usc.edu|
21230665|NCT03344796|Northwestern Univ|Dr. June Robinson|312-503-5941|june-robinson@northwestern.edu|
21230666|NCT01199965|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
21230667|NCT00758836|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21230668|NCT02564796|UC San Diego|Dr. David Werho|(858) 966-5855|dwerho@rchsd.org|
21230669|NCT00293033|Meda Pharmaceuticals Inc.|Larry Gever, PharmD, Director, Medical Affairs|732-564-2400|larry.gever@meda.us|
21260906|NCT00733902|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21260907|NCT03537664|University of Sao Paulo|Dr. Ericka Pinheiro|551126488293|erickapinheiro@usp.br|
21260908|NCT03617926|Oystershell Laboratories|Frank Eertmans|+3293772485|fe@oystershell.be|
21277624|NCT04029311|Tohoku University|Dr. Yasue Tanaka|+81227178396|yasue.tanaka.b3@tohoku.ac.jp|
21277625|NCT03623386|Yale School of Medicine|Sule Tinaz, MD, PhD: Associate Professor of Neurology|(877) 925-3637|sule.tinaz@yale.edu|
21277626|NCT03052322|Fresenius Kabi Swiss BioSim GmbH|Eugenia Kunina, senior clinical development manager|+41791093376|clinical.development@fresenius-kabi.com|
21277627|NCT01507155|Genomind|Dr. Rachel Scott|267-989-3435|rscott@genomind.com|
21277628|NCT03840616|Mycovia Pharmaceuticals Inc|Clinical Trial Administration|919-467-8539|adminops@mycovia.com|
21277629|NCT03949803|Universidad de Murcia|Prof. Marta Garaulet Aza|+34868889478|garaulet@um.es|
21277630|NCT00003875|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
21277631|NCT01070771|University Hospital Southampton NHS Foundation Trust|Professor Nick Curzen|+44 023 80777222|nick.curzen@uhs.nhs.uk|
21277632|NCT05080426|Purdue University|Dr. Ellen Ernst Kossek|(765) 494-6852|ekossek@purdue.edu|
21277633|NCT03835325|Eurofarma Laboratórios S.A|Sandra Rodrigues|1150908600|sandra.rodrigues@eurofarma.com.br|8417
21277634|NCT01370213|Masonic Cancer Center, University of Minnesota|Dr. Jeffrey Miller|612-626-4024|mille011@umn.edu|
21277635|NCT01227655|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21260909|NCT01503021|Rockwell Medical, Inc|Senior Director, Clinical Research|248-960-9009|rd@rockwellmed.com|
21230670|NCT03583697|BioMarin Pharmaceutical Inc.|Alice Huntsman Labed|+44 792-756-5104|alice.huntsmanlabed@bmrn.com|
21230671|NCT00453063|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21230672|NCT01586065|Nemours Children's Health|Larry A Fox, MD|9046973600|larry.fox@nemours.org|
21230673|NCT00114530|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21230674|NCT01577108|China Medical University Hospital|Ming Ho, MD|886422052121|mi.ho@msa.hinet.net|2063
21230675|NCT00365508|University of Pennsylvania|Robert Schnoll|215-746-7143|schnoll@mail.med.upenn.edu|
21230676|NCT03724032|University of Michigan|Jacqueline Dobson|734-763-8469|contactHOPE@umich.edu|
21230677|NCT02450591|Memorial Sloan Kettering Cancer Center|Dr. Helena Yu, MD|646-888-4274|YuH@mskcc.org|
21230678|NCT00404235|Mayo Clinic|Svetomir N. Markovic, MD, Ph.D|(507) 284-1370|markovic.svetomir@mayo.edu|
21230679|NCT00743483|Swedish Orphan Biovitrum|Maria Öhman, TA Clinical Head Neonatology|+46 70 694 81 61|maria.ohman@sobi.com|
21230680|NCT00873912|MedImmune, LLC|Elissa Malkin, DO|301-398-0000|malkine@medimmune.com|
21230681|NCT03100500|Novartis Pharmaceuticals|Director|862-778-8300|novartis.email@novartis.com|
21230682|NCT02352974|4Pharma AB|Åsa Carlsheimer|+4672244516|asa.carlsheimer@4pharma.com|
21230683|NCT01785069|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21230684|NCT01213329|Northwestern University|Dr. Lorenzo Gallon|312-695-8900|l-gallon@northwestern.edu|
21230685|NCT01088997|Children's Hospital of Philadelphia|Haresh Kirpalani, MD, MSc|215-590-2455|kirpalanih@email.chop.edu|
21230686|NCT02383498|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
21230687|NCT01703039|Brigham and Women's Hospital|Dr. Jessica Harder|617-525-7919|jaharder@bwh.harvard.edu|
21230688|NCT05570500|Ain Shams University|Dr. Omar Alaa Taqa|01001454416|o.a.taqa@hotmail.com|
21230689|NCT01095731|Columbia University Irving Medical Center|E. Sander Connolly Jr., MD|212-305-0376|esc5@cumc.columbia.edu|
21230690|NCT00147446|Northwestern University|David C. Mohr|312-503-3128|m.lisetteluistro@northwestern.edu|
21230691|NCT02302807|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21230692|NCT03261973|Massachusetts General Hospital|Grace Ha|617-643-1697|gha2@mgh.harvard.edu|
21230693|NCT03000283|Allina Health|Dr. Jesse Corry|651-241-6550|Jesse.Corry@allina.com|
21230694|NCT04840615|National Cancer Institute|Dr. Raffit Hassan|240760-6232|rh276q@nih.gov|
21230695|NCT00842608|Regenstrief Institute, Inc.|Dr. Malaz Boustani|(317) 274-9235|mboustan@iu.edu|
21230696|NCT01749137|Rhythm Pharmaceuticals, Inc|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
21230697|NCT01270516|University of Kentucky|Emily Bradford, Clinical Trial Compliance Administrator|859) 323-2973|emily.bradford@uky.edu|
21230698|NCT00621985|Children's Hospital Boston|Joseph Majzoub|617-355-7476|joseph.majzoub@childrens.harvard.edu|
21230699|NCT01244724|Weill Cornell Medical College|James H. Kocsis, M.D.|212-746-5913|jhk2002@med.cornell.edu|
21230700|NCT03229278|Cancer Institute of New Jersey Rutgers|Dr. Biren Saraiya - Associate Professor of Medicine Medical Director, Office of Human Research Servi|732-235-5773|saraiybi@cinj.rutgers.edu|
21230701|NCT00980057|Medtronic, Inc|Adaptive CRT Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|
21230702|NCT01874132|University of Trás-os-Montes e Alto Douro|Professor Nelson Sousa|259350756|nelsons@utad.pt|+351
21230703|NCT00691015|Barbara Ann Karmanos Institute|Zaid Al-Kadhimi, M. D.|(404) 778-1900|zalkadh@emory.edu|
21230704|NCT02139228|Novartis Vaccines and Diagnostics Srl|Posting Director||RegistryContactVaccinesUS@novartis.com|
21230705|NCT04160195|National Cancer Institute|Dr. James N. Kochenderfer|240-760-6062|kochendj@mail.nih.gov|
21230706|NCT00706823|University of Texas Medical School at Houston|Carin A. Hagberg, MD|713-500-6222|carin.a.hagberg@uth.tmc.edu|
21230707|NCT03766581|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21230708|NCT02732119|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
21230709|NCT05275400|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21230710|NCT02585960|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21230711|NCT04566302|Massachusetts General Hospital|Guillermo Tearney, MD, PhD|617-724-2979|gtearney@mgb.org|
21230712|NCT01651039|Icahn School of Medicine at Mount Sinai|Dr. Ajai Chari|212-241-7873|ajai.chari@mountsinai.org|
21230713|NCT01373242|University of North Carolina at Chapel Hill|Edwin Kim, MD; Director UNC Food Allergy Initiative|919-537-3193|edwinkim@email.unc.edu|
21230714|NCT04377620|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21230715|NCT04930965|Tulane University|Erin Peacock|504-988-1075|epeacoc@tulane.edu|
21230716|NCT00288054|SWOG Statistical Center|Lung Committee Statistician|206-667-4623||
21230717|NCT01529502|Massachusetts General Hospital|Dr. Lorenzo Berra|617 724 1901|LBERRA@MGH.HARVARD.EDU|
21230718|NCT01158157|Cangene Corporation|Christine Hall, Ph.D. Director Clinical|204-275-4248|chall@ebsi.com|
21230719|NCT00444912|Genzyme|Medical Information||medinfo@genzyme.com|
21230720|NCT01606007|AstraZeneca Pharmaceuticals|Boaz Hirshberg||ClinicalTrialTransparency@astrazeneca.com|
21230721|NCT03758066|Dimagi, Inc.|Y. Xian Ho|617-649-2214|yho@dimagi.com|63
21230722|NCT03675477|ReistoneBiopharma|Roger Liu, Medical Director|+8613917512446|roger.liu@reistonebio.com|
21230723|NCT00730405|GlaxoSmithKline|GSK Response Center|866-435-7343||
21230724|NCT01496807|H. Lee Moffitt Cancer Center and Research Institute|Dr. Andrew Brohl|813-745-3242|andrew.brohl@moffitt.org|
21230725|NCT00959764|Tarsa Theapeutics, Inc.|Dr. David Krause, Chief Medical Officer|1-267-273-7940|dkrause@tarsatherapeutics.com|
21230726|NCT00000371|Freedom Clinic Trail, Massachusetts General Hospital|Dr. Donald Goff|617-921-7899|goff@psych.mgh.harvard.edu|
21230727|NCT00963937|GlaxoSmithKline|GSK Response Center|866-435-7343||
21230728|NCT00334958|Eisai Medical Services|Eisai Inc.|1-888-422-4743|esi_medinfo@eisai.com|
21230729|NCT03988088|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21230730|NCT00113022|Experimental Therapeutics and Pathophysiology Branch, NIMH|Dr. Carlos Zarate|301-451-0861|zaratec@mail.nih.gov|
21230731|NCT02935842|University Hospital Basel|Prof. Peter Fuhr|0041 61 265|peter.fuhr@usb.ch|41 66
21260910|NCT03941548|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
21230732|NCT01745133|DermResearch PLLC|leon kircik|5023965310|wedoderm@yahoo.com|
21277636|NCT00472797|EMD Serono, INc.|Fernando Dangond, MD|781 681 2348|fernando.dangond@emdserono.com|
21230733|NCT02168361|Center for Hepatitis C|Dr. Brian Pearlman|4042651044|brianpearlman3@hotmail.com|
21230734|NCT01804465|University of California, San Francisco|Dr. Lawrence Fong, MD|(415) 514-3160|Lawrence.Fong@ucsf.edu|
21230735|NCT00727220|IndianaU|Linda A DiMeglio|317-944-3889|dimeglio@iu.edu|
21230736|NCT00923156|Novartis Pharmaceuticals|Study Director|862-778-8300||
21230737|NCT01899261|Montefiore Medical Center and Albert Einstein College of Medicine|Dr. Nitin Ohri|718-920-7750|nohri@montefiore.org|
21230738|NCT00084383|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Daniel Laheru|410-955-8974|laherda@jhmi.edu|
21238811|NCT00509236|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21238812|NCT01355458|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
21238813|NCT00927355|Emory|Dr. George Beck|404-686-1000|gbeck@emory.edu|
21238814|NCT01572389|Department of Veteran Affairs|Aanand, Naik, MD|713-794-8541|anaik@bcm.edu|
21238815|NCT00499863|Noven Pharmaceuticals, Inc.|Amaury Sanchez, Sr. Manager, Regulatory Affairs||asanchez@noven.com|
21238816|NCT00571701|Northwell Health (previously known as NorthShore-LIJ Health System)|Dr. Bettie Steinberg|516-562-1159|bsteinbe@northwell.edu|
21238817|NCT01247428|Micell Technologies|Dennis Donohoe, MD, Chief Medical Advisor|919-313-2102|ddonohoeconsult@gmail.com|
21238818|NCT01112228|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
21238819|NCT00691132|University of Minnesota|Dr. Dorothy Hatsukami|612-626-2121|hatsu001@umn.edu|
21238820|NCT04766086|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21238821|NCT02660801|UQTR|Pr Martin Descarreaux|819-376-5011|martin.descarreaux@uqtr.ca|3791
21238822|NCT01959347|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
21238823|NCT03541044|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21238824|NCT01282801|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21238825|NCT01060553|Veteran Affairs New Jersey Health Care System|Thomas W. Findley, MD, PhD|973-676-1000|thomas.findley@va.gov|2713
21238826|NCT00312702|Walter Reed Army Institute of Research|James F. Cummings, MD|301-319-9312|james.cummings@us.army.mil|
21238827|NCT02918500|University of Ottawa Heart Institute|Dr. Andrew Pipe|613-696-7000|apipe@ottawaheart.ca|
21238828|NCT01462162|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21238829|NCT03485911|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
21238830|NCT01215357|Psyadon Pharmaceuticals|Dr. Richard Chipkin|301-919-2020|rchipkin@psyadonrx.com|
21238831|NCT03333928|HighTide Therapeutics|Dr. Adrian Di Bisceglie, CMO|314-791-0593|adibisceglie@hightidetx.com|
21238832|NCT02881008|MYR GmbH|Dr. med. Alexander Alexandrov|+491777168259|alexandrov@myr-pharma.com|
21238833|NCT04037436|University of Waterloo|The MoveStrong program for promoting balance and functional strength training and adequate protein i|519-888-4567|lmgiangr@uwaterloo.ca|46357
21238834|NCT01674621|Radius Health Inc.|Program Director|(617) 551-4700|info@radiuspharm.com|
21238835|NCT01859793|Medical College of Wisconsin|Michael E. Widlansky|414-955-6806|mwidlans@mcw.edu|
21238836|NCT04543188|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21238837|NCT03815019|University of Kansas Medical Center|Ann Davis, PhD, MPH, ABPP, Director, Center for Children's Healthy Lifestyles & Nutrition|(913) 588-1227|adavis6@kumc.edu|
21238838|NCT06199934|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21238839|NCT01220869|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21238840|NCT05960097|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21238841|NCT01784068|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21238842|NCT01856530|Boston University|Dr. Stefan G. Hofmann|617-353-9233|shofmann@bu.edu|
21238843|NCT03899753|Montefiore Medical Center|Konrad Gruson, MD|3475774412|kgruson@montefiore.org|
21238844|NCT00462280|University of California, Irvine|Dr. Kenneth G. Linden|714-456-3719|kglinden@uci.edu|
21238845|NCT03210155|Texas A&M University Corpus Christi|Dr. Christina Murphey|316.825.3747|christina.murphey@tamucc.edu|
21238846|NCT00438880|Mayo Clinic Cancer Center|Thomas E. Witzig, M.D.||witzig.thomas@mayo.edu|
21238847|NCT01802086|SormlandCC|Beatrice Olsson Duse|0704948359|bod257@hotmail.com|
21238848|NCT03125005|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
21238849|NCT02080780|Ventrus Biosciences|Ventrus|646-706-5208|VEN307@ventrusbio.com|
21238850|NCT01489189|Jaeb Center for Health Research|Adam Glassman|813-975-8690|drcrnet@jaeb.org|
21238851|NCT00112580|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21238852|NCT06027619|Cleveland Clinic, Dermatology and Plastic Surgery Institute, Case Comprehensive Cancer Center|Edward V Maytin|(216) 445-6676|maytine@ccf.org|
21238853|NCT03075501|University of Illinois at Chicago|Emma Childs|312-355-2726|echilds@uic.edu|
21238854|NCT01486615|B. P. Koirala Institute of Health Sciences|Dr Krishna Pokharel|0977-9841986321|drkrishnapokharel@gmail.com|
21238855|NCT01886963|Carolinas HealthCare System|Dr. Todd Heniford|7043551813|todd.heniford@carolinashealthcare.org|
21238856|NCT03610737|Vertos Medical|Angie Lee|949-349-0008|alee@vertosmed.com|
21238857|NCT01392300|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
21238858|NCT02207725|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
21260911|NCT01012661|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4041|clinicaltrials@merzaesthetics.com|
21230739|NCT01201850|Children's Hospital Colorado|Margaret Macy, MD|720-777-5877|margaret.macy@childrenscolorado.org|
21238859|NCT03145766|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21238860|NCT01391325|Ardea Biosciences, Inc.|Vice President, Clinical Research and Development|858.652.6587|sbaumgartner@ardeabio.com|
21238861|NCT03395808|Avenue Therapeutics|Micheal Ryan, VP Clinical|781-652-4514|mryan@avenuetx.com|
21230740|NCT03137537|Dana Farber Cancer Institute|Dr. Anju Nohria|6175257052|anohria@partners.org|
21230741|NCT01552694|Washington University School of Medicine|Kevin Yarasheski, PhD|3143628173|key@wustl.edu|
21230742|NCT00672243|The Preston Robert Tisch Brain Tumor Center at Duke|David A. Reardon, MD|(919) 668-1409|reard003@mc.duke.edu|
21230743|NCT00191139|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21230744|NCT01211730|Northwestern University Feinberg School of Medicine|Mark E. Molitch, M.D.|312 503-4130|molitch@northwestern.edu|
21230745|NCT00816595|Mayo Clinic|Tait Shanafelt, M.D.||shanafelt.tait@mayo.edu|
21230746|NCT00751933|Haukeland University Hospital|Gunnar Nysæter or Solomon Tefera or Jan Hatlebakk|+47 55972900|jhat@helse-bergen.no|
21230747|NCT01817530|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21230748|NCT03846804|Indiana University School of Medicine|James Wood, MD|317-944-7260|woodjb@iu.edu|
21230749|NCT00566995|National Cancer Institute|Dr. W. Marston Linehan|301-496-6353|linehanm@mail.nih.gov|
21230750|NCT00679432|Santarus, Inc.|Michael Huang, MD, Senior Medical Director, Clinical Research|8583145700|mhuang@santarus.com|
21230751|NCT00824720|Vistakon|Brian Schwam MD/Director Clinical Affairs & Ocular Sciences|904-443-1482||
21289418|NCT05788328|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21289419|NCT02181621|Smith & Nephew, Inc.|Matthew Christensen|+1-303-249-5812|Matthew.Christensen@smith-nephew.com|
21289420|NCT00145327|Novartis Pharmaceuticals|Study Director|862-778-8300||
21277637|NCT01550744|Janssen Biotech, Inc|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
21277638|NCT01610453|Stavanger UH|Professor Torbjørn Moe Eggebø|+4792699433|tme@lyse.net|
21277639|NCT02787408|Edwards Lifesciences|Ted Feldman, MD|949-250-2500|Feldman_Info@edwards.com|
21277640|NCT00995085|Alcobra Inc|Jonathan Rubin, MD, MBA|610-504-7814|jrubin@alcobra-pharma.com|
21260912|NCT01242111|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|800-983-4587|medinfo@bmrn.com|
21260913|NCT00870688|Desitin|Lohmueller|0049(0)40-59101|lohmueller@desitin.de|373
21277641|NCT01194973|Alexion Pharmaceuticals Inc|Alexion Pharmaceuticals Inc||clinicaltrials@alexion.com|
21277642|NCT03844789|University of Virginia Center for Diabetes Technology|Marc Breton|434-982-6484|mb6nt@virginia.edu|
21277643|NCT02595008|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
21277644|NCT03407118|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
21277645|NCT01797484|University Heart Centre Hamburg Eppendorf|Dr. Tjark F. Schwemer|+49 40 7410|t.schwemer@uke.de|56800
21277646|NCT01491035|H. Lundbeck A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com|
21277647|NCT03351231|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email|Clinical.Trials@bms.com|
21277648|NCT03052972|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
21277649|NCT01673698|ReShape Medical|Director of Clinical Operations|94429-6680|lfong@reshapemedical.com|
21277650|NCT01297322|Daniel & Daniel Consulting, LLC|Michael A. Daniel, Consulting VP Regulatory Affairs|7753922970|madaniel@clinregconsult.com|
21277651|NCT01111019|Merck Healthcare, a business of Merck KGaA|Merck KGaA Communication Center|+49 6151 72 5200|service@merckgroup.com|
21277652|NCT02013375|University of Illinois at Chicago|Dr Damiano Rondelli|312-996-6179|drond@uic.edu|
21277653|NCT00712985|Milton S. Hershey Medical Center|Allan Lipton, MD|717-531-5960|alipton@hmc.psu.edu|
21277654|NCT02674061|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21277655|NCT03182582|Stanford University|Geoffrey C. Gurtner, MD|650-736-2776|ggurtner@stanford.edu|
21277656|NCT03334721|Medical University of South Carolina|James J. Prisciandaro, Ph.D.|843-792-1433|priscian@musc.edu|
21277657|NCT01663727|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
21277658|NCT01902628|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21277659|NCT01232491|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21277660|NCT02646449|University of Pittsburgh|Jack R. Cornelius, M.D., M.P.H.|412-246-5149|corneliusjr@upmc.edu|
21277661|NCT02932228|VA Palo Alto Health Care System|Dr Donna Zulman|650-493-5000|Donna.Zulman@va.gov|29113
21277662|NCT03340064|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21277663|NCT02522403|Universidad Autonoma de Nuevo Leon|Carlos Acosta-Olivo|528183467798|dr.carlosacosta@gmail.com|
21277664|NCT05142566|Essential Medical LLC (a subsidary of Teleflex, Inc.)|Darra Bigelow, Sr. Manager, Clinical Operations|610-331-7299|darra.bigelow@teleflex.com|
21277665|NCT01108666|University of Pennsylvania|Dr. Abigail Berman|215-615-3659|Abigail.Berman@uphs.upenn.edu|
21277666|NCT02664363|Duke University Medical Center|Principal Investigator|9196845301|dukebrain1@duke.edu|
21277667|NCT00515541|Invitrox, Inc|Dr. Don A. Gabriel|(919) 485-4600|dgabriel@invitrox.com|
21277668|NCT02588950|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21277669|NCT02072824|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21277670|NCT01248013|Mind-Body Digestive Center|Charles D. Gerson, M.D.|212 496 6161|cgerson@yahoo.com|
21277671|NCT00725530|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21277672|NCT00782821|University of Cincinnati|E. Steve Woodle, MD|513-558-6001|woodlees@ucmail.uc.edu|
21277673|NCT02667288|Aclaris Therapeutics|Judy Schnyder, Sr. Director Clinical Operations|484-329-2144|jschnyder@aclaristx.com|
21230752|NCT01558271|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21277674|NCT01196078|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21277675|NCT03921151|Virginia Commonwealth University|Liangsuo Ma, PhD|(804) 828-2871|liangsuo.ma@vcuhealth.org|
21230753|NCT02339584|Enter Alcon, A Novartis Division|Clinical Scientific Associate Director, GCRA, GDD|1-888-451-3937|alcon.medinfo@alcon.com|
21277676|NCT01207648|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21277677|NCT00857792|The University of Chicago Medical Center|Victor Mor-Avi|773-702-7780|vmoravi@bsd.uchicago.edu|
21277678|NCT01387581|MelaSciences|Mrinalini Roy|800-729-8849|mishti@melasciences.com|
21277679|NCT03001219|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21277680|NCT01598350|University of Puget Sound|Julia Looper, PT PhD|253 879 2895|jlooper@pugetsound.edu|
21277681|NCT03760250|University of Pennsylvania|Jenny Wei|2153165151|jenny.wei@pennmedicine.upenn.edu|
21277682|NCT03733210|Stanford Medicine at Stanford University|Yu-Jin Lee, MD, MS|650-725-4711|yujinlee@stanford.edu|
21277683|NCT03728634|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
21277684|NCT00929331|GlaxoSmithKline|GSK Response Center|866-435-7343||
21277685|NCT04421586|Duke University|Lavanya Vasudevan, Ph.D.|919-613-1423|lavanya.vasudevan@duke.edu|
21277686|NCT02963441|IDx LLC|IDx President, Dr. Michael Abramoff|319-248-5620|info@eyediagnosis.net|
21277687|NCT04688931|UroGen Pharma|Head of Clinical Development|+1 855-987-6436|info@urogen.com|
21277688|NCT00361335|Centocor, Inc.|Senior Director Clinical Research|1-800-457-6399||
21277689|NCT01765582|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21277690|NCT04493320|New York State Psychiatric Institute|Dr. Bret Rutherford|646 774 8660|bret.rutherford@nyspi.columbia.edu|
21277691|NCT00616941|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21277692|NCT04408599|NextCure, Inc|Chief Medical Officer|(240) 399-4900|NCClin@nextcure.com|
21289421|NCT00908388|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com|
21289422|NCT00864513|Georgetown University|Dr. Jimmy Hwang|202-444-2198|jh96@gunet.georgetown.edu|
21289423|NCT00762788|Vistakon|Kathy Osborn, OD, MS, FAAO, FBCLA Senior Principal Research Optometrist|1 904 443-1032|kosborn@its.jnj.com|
21289424|NCT02197104|Rush University Medical Center|Dr. Deborah A Hall|312-563-2900|Movementdisorder@rush.edu|
21289425|NCT03073109|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21289426|NCT05938010|Scripps Optometric Group|Dr Jay Mashouf|1-858-530-2800|jaymashouf@gmail.com|
21289427|NCT00666978|University of Kansas Medical Center|Lisa Sanderson Cox|913-588-2643|lcox@kumc.edu|
21289428|NCT00727337|Department of Veterans Affairs|Rachel McArdle|727-398-6661|Rachel.mcardle@va.gov|17479
21289429|NCT01901588|NYU School of Medicine|Assistant Professor, Department of Anesthesiology, Perioperative Care, and Pain Medicine|212.263.5072|wanda.chin@nyumc.org|
21289430|NCT01158404|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21289431|NCT01004393|Seirei Hamamatsu General Hospital|Masanori Mori, MD|81-53-474-2222|Masanori.Mori@sis.seirei.or.jp|
21289432|NCT03281538|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
21289433|NCT02029443|Acerta Pharma BV|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21289434|NCT03270241|Johns Hopkins Medicine Dermatology Cutaneous Translational Research Program|Ruizhi Wang|4105027546|rwang@jhmi.edu|
21289435|NCT02070991|Actelion Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 61 565 6565|clinical-trials-disclosure@its.jnj.com|
21289436|NCT04018001|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21289437|NCT03670628|University of Miami, Miller School of Medicine - Desai Sethi Urology Institute|Ranjith Ramasamy, MD|305-243-4562|ramasamy@miami.edu|
21289438|NCT03123588|Incyte Corporation|Call Center|1.855.463.3463|medinfo@incyte.com|
21289439|NCT00393380|The EMMES Corporation|Adam Mendizabal, Statistician|301-251-1161|amendizabal@emmes.com|221
21289440|NCT00997126|MinneapolisMRF|James Miner|6128732493|miner015@umn.edu|
21289441|NCT02822287|GlaxoSmithKline|GSK Response Center|866-435-7343||
21277693|NCT00714493|Centocor Ortho Biotech, Inc.|Sr. Director, Clinical Research - Medical Affairs|215-325-6811|Ddeckto2@its.jnj.com|
21277694|NCT00076804|Johns Hopkins University Center for TB Research|Richard E. Chaisson|4109551755|rchaiss@jhmi.edu|
21289442|NCT01769443|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21277695|NCT00354341|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21277696|NCT00251719|Takeda Global Research & Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
21277697|NCT00334061|Penumbra Inc|Siu Po Sit, PhD Study Coordinator|510 748 3200|siupo.sit@penumbrainc.com|221
21277698|NCT01732874|Nationwide Childrens Hospital|Dr. Christina J. Valentine MD,MS,RD|(614) 722-2000|Christina.Valentine@nationwidechildrens.org|
21277699|NCT00688376|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
21277700|NCT00557076|Edward Hines, Jr VA Hospital|Dr. Theresa Pape|708-202-4953|Theresa.Pape@va.gov|
21277701|NCT01517659|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
21277702|NCT02792959|Institute Bergonie|Dr. Anne Laure Cazeau, Coordinating Investigator|0556337860|A.Cazeau@bordeaux.unicancer.fr|
21277703|NCT03041324|Sangamo Therapeutics, Inc.|Medical Monitor|(510) 307-7266|clinicaltrials@sangamo.com|
21277704|NCT03484117|Massachusetts General Hospital|Dr. Julie Levison, PI|617-724-4698|jlevison@partners.org|
21277705|NCT01780987|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_inquiries@pfizer.com|
21277706|NCT02303041|Stanford University|Anne Lynn S. Chang/ Associate Professor of Dermatology|650-723-6316|alschang@stanford.edu|
21277707|NCT00886288|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21277708|NCT02335983|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21230754|NCT02610725|Massachusetts General Hospital|Louisa G. Sylvia, Ph.D.|617-643-4804|lsylvia2@mgh.harvard.edu|
21230755|NCT04094883|University of North Carolina at Chapel Hill|Joseph Duncan, MD, PhD|919-966-2536|joseph_duncan@med.unc.edu|
21230756|NCT01084083|ECOG-ACRIN Statistical Office|ECOG-ACRIN statistician|617-632-3012||
21230757|NCT00228384|W. L. Gore & Associates, Inc.|Chad Badorek|800/437-8181|cbadorek@wlgore.com|
21230758|NCT01072331|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21230759|NCT01466153|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazenca.com|
21230760|NCT05695209|Indiana University|Principal Investigator|317-278-3154|mmatthia@iu.edu|
21230761|NCT03802227|Nektar Therapeutics|Study Director|415-482-5416|medicalaffairs@nektar.com|
21230762|NCT04362072|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21230763|NCT01133522|Amgen Inc.|Study Director|866-572-6436||
21230764|NCT03835780|Centre for Musculoskeletal Research|Maya H Buch|+441613066000|maya.buch@manchester.ac.uk|
21230765|NCT04731363|Cleveland Clinic Foundation|Dr. Stanley Hazen, MD|216-444-9426|hazens@ccf.org|
21230766|NCT01055171|Medical University of South Carolina|Dr. Michael Saladin|843-792-5306|saladinm@musc.edu|
21230767|NCT01918774|Richard L. Roudebush VA Medical Center|Marina Kukla|317-988-3330|marina.kukla2@va.gov|
21230768|NCT01606800|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21230769|NCT01511315|UCSF Psoriasis Center|Mio Nakamura, MD|4154764701|mio.nakamura@ucsf.edu|
21230770|NCT01182675|UCSF|Christopher C. Dvorak, MD|415-476-2188|dvorakc@peds.ucsf.edu|
21230771|NCT01135420|Department of Veterans Afairs|Christine Timko|650-493-5000|Christine.Timko@va.gov|
21230772|NCT00717197|University of Florida|Erin M. Dunbar, MD|(352) 273-9000|edunbar@neurosurgery.ufl.edu|
21230773|NCT00982137|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21230774|NCT01811654|NYU Langone Health|Dennis Cardone, DO|212-460-0176|ariel.aponte@nyumc.org|
21230775|NCT01898806|Columbia University|Grace Ulerio|212-305-6953|gu2102@cumc.columbia.edu|
21230776|NCT03003390|Yale University|Dr. E. Vincent S Faustino|203-785-4651|vince.faustino@yale.edu|
21230777|NCT01340885|Oregon Health & Science University|Diana Dimitrova|503-494-7269|dimitrov@ohsu.edu|
21230778|NCT00940225|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
21230779|NCT02140372|NYU School of Medicine|Binita Shah|212-263-4235|binita.shah@nyumc.org|
21230780|NCT03576976|New York State Psychiatric Institute|Dr. Alice Medalia|646-774-8482|am2938@cumc.columbia.edu|
21277709|NCT00289874|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21230781|NCT03000439|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21230782|NCT02370160|Masonic Cancer Center at University of Minnesota|Dr. Veronika Bachanova|612-625-8287|pham0179@umn.edu|
21230783|NCT01308060|Q-Med AB|Clinical Project Manager|+46184749000|reception.seupp@galderma.com|
21230784|NCT02501473|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21230785|NCT01581931|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21230786|NCT02734940|Virginia Commonwealth University|Dr. Jessica Potter|(804) 828-2755|jessica.potter@vcuhealth.org|
21230787|NCT04666051|Menoufia Univeristy|M. Ashraf BAlbaa|+20482224216|mohamed.balbaa@med.menofia.edu.eg|
21230788|NCT02954237|Abbott|Jordan Anderson, Clinical Scientist|651-756-3360|ClinicalTrials.gov_SH_Inquiries@abbott.com|
21230789|NCT00674700|Stallergenes|Michel Roux, Medical Director|+33 1 55 59 2970|mroux@stallergenes.com|
21230790|NCT00395304|Penn State Hershey College of Medicine|Vernon M. Chinchilli|717-531-4262|vchinchi@psu.edu|
21230791|NCT03130257|Kaiser Permanente Washington Health Research Institute|Beverly B. Green, MD, MPH|206-287-2997|Bev.B.Green@kp.org|
21230792|NCT03600818|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21230793|NCT02837328|University of Minnesota|Pamela Lutsey, PhD MPH|612-624-5812|lutsey@umn.edu|
21230794|NCT01488370|Loma Linda University Department of Anesthesiology|Elizabeth Ghazal, MD|909-558-4475|EGhazal@llu.edu|
21230795|NCT03355820|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21230796|NCT04189081|Procter & Gamble|Clinical Trial Manager|5136225362|combs.cs@pg.com|
21230797|NCT00044083|Office of the Clinical Director-NIMH-NIH-HHS|Jose A. Apud|3015946561|apudj@mail.nih.gov|
21230798|NCT01112865|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21230799|NCT02249585|Seoul National University Hospital|Dr Kook Hyun Lee, MD, PhD|82-2-2072-2467|leekh@snu.ac.kr|
21230800|NCT00977860|UPMC Hillman Cancer Center|Barbara M Stadterman, MPH, MCCR|412-647-5554|stadtermanbm@upmc.edu|
21230801|NCT00851747|Loyola Medical Center|Rebecca Tung, MD|(708) 216-4962|rtung@loyolamedical.org|
21230802|NCT04003012|CAMC Institute of Academic Medicine|Dr. Stephanie Thompson|304-388-9911|stethompson@camc.org|
21230803|NCT04353271|University of South Alabama|Office of Research Complaince|2514607573|swhite@southalabama.edu|
21230804|NCT02499783|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21230805|NCT02228460|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21230806|NCT01243892|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21230807|NCT00119106|CDC|Dr. Michael Martin|662 580 0669|ZND9@CDC.GOV|
21230808|NCT01866293|Memorial Sloan Kettering Cancer Center|Sergio Giralt, MD|212-639-6009|GiraltS@mskcc.org|
21230809|NCT01010061|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21230810|NCT03066804|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21230811|NCT00790985|Primus Pharmaceuticals|Robert Levy, MD., Director of Clinical Development|480-483-1410|Rlevy@primusrx.com|
21230812|NCT03050554|UC San Diego Moores Cancer Center|Dr. Andrew Sharabi|858-534-4808|ansharabi@health.ucsd.edu|
21230813|NCT03470441|Faraday Pharmaceuticals, Inc|Clinical Trials Manager|206-492-5310|info@faradaypharma.com|
21230814|NCT03982368|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
21230815|NCT00518284|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21230816|NCT03768414|SWOG Statistics and Data Management Center|Gastrointestinal Committee Statistician|2066674623|scolby@fredhutch.org|
21230817|NCT01152697|University Hospitals of Cleveland|Martha Sajatovic, Professor of Psychiatry|2168442808|martha.sajatovic@uhhospitals.org|
21230818|NCT02571777|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21230819|NCT03706079|AstraZeneca|Global Clinical Head|+1 302 885 1180|information.center@astrazeneca.com|
21230820|NCT00329238|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21230821|NCT00801632|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21230822|NCT03652012|University of Arizona|Dr Ying-hui Chou|5206217447|yinghuichou@arizona.edu|
21277710|NCT03127644|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
21277711|NCT04972123|University of Wisconsin - Madison Cardiovascular Medicine|Mohamed H. Hamdan, MD, MBA|608-263-4856|mhamdan@medicine.wisc.edu|
21277712|NCT05070546|Janssen Vaccines & Prevention B.V.|Director Biomarkers Viral Vaccines|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21277713|NCT00136318|Kliniken Essen-Mitte, Department of Psychiatry|Professor Dr. Martin Schaefer|+49201-17430001|m.schaefer@kliniken-essen-mitte.de|
21277714|NCT04982874|Pharma Metric Labs, Indonesia|Pharma Metric Labs|+62 21 4265310|nabila.sutanto@pharmametriclabs.com|
21277715|NCT00436904|Mayo Clinic|Dr. Clive Zent|507-284-5362|zent.clive@mayo.edu|
21277716|NCT02684201|University of Pittsburgh|Dr. Lee Fisher, PhD|412-383-1077|lef44@pitt.edu|
21277717|NCT00038649|University of Texas (UT) MD Anderson Cancer Center|Jorge Cortes, MD/Professor, Leukemia Department|713-794-5783|CR_Study_Registration@mdanderson.org|
21277718|NCT03736928|QMedAB|Clinical Project Manager|(817) 961-5000|aestheticclinicaltrials@galderma.com|
21277719|NCT03096847|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21277720|NCT00359632|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21277721|NCT03978091|ARLG - Albany College of Pharmacy and Health Sciences|Thomas Lodise, PharmD, PhD|1 (518) 694-7292|Thomas.Lodise@acphs.edu|
21277722|NCT02324673|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
21277723|NCT02477774|University of California, San Francisco|Rahul Seth, MD|415-353-9500|Rahul.Seth@ucsf.edu|
21230823|NCT01288235|Massachusetts General, Hospital|Torunn I. Yock, MD|6177262000|tyock@mgh.harvard.edu|
21230824|NCT00764738|Retina Macula Institute|Dr. Ron Gallemore||rongallemoremd@gmail.com|
21277724|NCT02214420|Scripps Clinic|Dr. Paul Pockros|(858) 554-8879|Pockros.paul@scrippshealth.org|
21277725|NCT01401257|Hôpital La Timone, Marseille|Pr Shahram ATTARIAN|04 91 38 65|shahram.attarian@ap-hm.fr|79
21277726|NCT02999477|Dana-Farber Cancer Institute|Adrienne Waks, MD|617-632-3800|adrienne_waks@dfci.harvard.edu|
21277727|NCT01846273|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21277728|NCT00891839|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21277729|NCT03431974|Syntrix Pharmaceuticals|Aaron Schuler|253-833-8009|aschuler@syntrixbio.com|21
21277730|NCT03303625|Janssen Vaccines and Prevention B.V.|Trial Physician|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21277731|NCT05392907|INAIL|Ing. Emanuele Gruppioni|+39 051 6936 609|e.gruppioni@inail.it|
21277732|NCT02221037|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21277733|NCT02307266|Galderma|Gaëlle Charier|+33 4 93 95 70 68|gaelle.charier@galderma.com|
21277734|NCT03474432|Jesse Brown VAMC|Dr. Mladen Vidovich, study PI|312-996-6730|miv@uic.edu|
21277735|NCT02856880|GlaxoSmithKline|GSK Response Center|866-435-7343||
21277736|NCT00793780|Yale University|Erin Sullivan|+1 (203) 974-7317|erin.reutenauer@yale.edu|
21277737|NCT02858492|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21277738|NCT02944383|NeuroBo Pharmaceuticals|Vice President Clinical Operations|+1 (857) 702-9600|info@neurobopharma.com|
21277739|NCT00915928|Odense University Hospital, Odense, Denmark|Frantz Rom Poulsen, Professor, consultant|0045 65413600|frantz.r.poulsen@rsyd.dk|
21277740|NCT01032018|Columbia University Medical Center|Karina W Davidson, PhD|212-342-4493|kd2124@cumc.columbia.edu|
21289443|NCT00634972|University of South Alabama|Fabien Eyal, MD|251-415-1055|feyal@health.southalabama.edu|
21289444|NCT00866320|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Brian Rini|216-444-9567|rinib2@ccf.org|
21289445|NCT02063724|H. Lee Moffitt Cancer Center and Research Institute|Dr. Brian Czerniecki|813-745-7575|brian.czerniecki@moffitt.org|
21289446|NCT02315625|National Cancer Institute|Dr. Naris Nilubol|240-760-6154|niluboln@nih.gov|
21289447|NCT02697422|VA Puget Sound Health Care System|Dr. Karin Nelson|(206)277-4507|karin.nelson@va.gov|
21289448|NCT02939781|Great Ormond Street Hospital NHS Trust|Dr Samiran Ray|4420274059200|samiran.ray@gosh.nhs.uk|8213
21289449|NCT03753542|Institute of Nursing Dow University of Health Sciences, Karachi/Sindh Nurses Examination Board, Karachi|Nomi Waqas Gul, Student MSN DUHS ION and Asst. Controller Sindh Nurses Examination Board, Karachi|0345-2506790|nomiwg@gmail.com|
21289450|NCT01068249|UT MD Anderson Cancer Center|Dr. Pamela Soliman,Professor, Gyn Onc & Reproductive Med|(713) 745-2352|psoliman@mdanderson.org|
21289451|NCT05537571|Silence Therapeutics plc|Global Regulatory|+442034576900|global-regulatory@silence-therapeutics.com|
21289452|NCT05866367|HealthPartners Institute Neuroscience Research|Clinical Research Coordinator|651-495-6363|ClinicalTrials@HealthPartners.com|
21289453|NCT04439123|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21230825|NCT00915278|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21230826|NCT01702961|Baylor College of Medicine|George Carrum, MD||GCarrum@houstonmethodist.org|
21230827|NCT02465515|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21230828|NCT01273597|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21230829|NCT01594762|Dipexium Pharmaceuticals, Inc|Robert J DeLuccia|+19145226503|delucciarj@gmail.com|
21230830|NCT02151383|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21230831|NCT03288129|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
21277741|NCT01453894|Northwestern University Feinberg School of Medicine|David W. Baker, MD, MPH|312-503-6400|dbaker1@nmff.org|
21277742|NCT00256984|Ethicon Endo-Surgery|Susan Knippenberg, Clinical Scientist|513 337-3452|sknippen@its.jnj.com|
21277743|NCT00858143|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21277744|NCT00937378|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
21277745|NCT04425538|Neely Center for Clinical Research, Tufts Medical Center|Director of Clinical Trials|617-636-5000|ncccr@tuftsmedicalcenter.org|3264
21277746|NCT03853148|Medical University of South Carolina|Teresa Kelechi, Associate Dean for Research and PhD Studies|843-792-4602|kelechtj@musc.edu|
21277747|NCT00281671|Ann & Robert H. Lurie Children's Hospital of Chicago|John M. Costello, MD MPH|312 227 1551|jmcostello@luriechildrens.org|
21277748|NCT02802449|Charles Drew University of Medicine and Science|Dr. David Martins|323-568-3353|davidmartins@cdrewu.edu|
21277749|NCT00599521|Galderma|Michael Graeber MD/ Head of Global Clinical Project Management|609-860-8201|michael.graeber@galderma.com|
21277750|NCT03882528|Walter Reed Army Institute of Research|Dr. James Moon, Principal Investigator|301-319-9176|James.e.moon.mil@mail.mil|
21277751|NCT01293539|Johns Hopkins|Monica Pearl, M.D.|410-955-8525|msmit135@jhmi.edu|
21277752|NCT00418301|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
21277753|NCT05855616|Marques de Valdecilla University Hospital|Raquel Pelayo Alonso, Head Nurse of Nephrology, RN|+34 649443488|raquel.pelayo@scsalud.es|
21277754|NCT01796912|Imperiwal College London|Dudley Pennell|+44 (0)20 3811 6871|d.pennell@imperial.ac.uk|
21277755|NCT00841906|Sleep Center of Greater Pittsburgh|Sukhdev Grover MD|412-681-7771|Info@SleepCenterOfGreaterPittsburgh.com|
21277756|NCT02163486|DorkuzEU|Bahar Kuvaki|902324122836|ozbilginsule@gmail.com|
21277757|NCT01449279|Stanford Cancer Institute|Dr. Susan J Knox|650-725-2720|sknox@stanford.edu|
21277758|NCT02737332|SPARC|Head, Clinical Development|912266455645|clinical.trials@sparcmail.com|
21277759|NCT03201250|Vanderbilt University Medical Center|Muhamed Baljevic, MD|615-936-8422|muhamed.baljevic@vumc.org|
21277760|NCT03551496|Boston Scientific|Dana Hromyak|1 216-526-8534|Dana.Hromyak@bsci.com|
21277761|NCT01551888|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
21277762|NCT04700280|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
21289454|NCT00002874|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21260914|NCT02015819|City of Hope Medical Center|Dr. Jana Portnow|6262189200|jportnow@coh.org|
21230832|NCT02777333|University of Oxford|Mr P Garfjeld Roberts|01865 227374|patrick.garfjeldroberts@ndorms.ox.ac.uk|
21230833|NCT01980940|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21230834|NCT00837811|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21230835|NCT04543838|UPMC|Parthasarathy Thirumala, MD|412-648-4208|thirumalapd@upmc.edu|
21230836|NCT02761252|Menarini International Operations Luxembourg SA|Medical Director|+352 2649761|aconte@menarini.lu|
21230837|NCT03128424|Endologix|Mohamed Moawad|949-595-7244|mmoawad@endologix.com|
21230838|NCT01648101|GlaxoSmithKline|GSK Response Center|866-435-7343||
21230839|NCT02469298|GlaxoSmithKline|GSK Response Center|866-435-7343||
21230840|NCT00872534|PLx Pharma|Ronald Zimmerman, CEO & President|1-713-842-1249|ron.zimmerman@plxpharma.com|205
21230841|NCT02957305|Dep. of Obstetrics and Gynecology, Universidade Federal do Rio Grande do Sul, Porto Alegre - RS - Brazil|Ricardo Francalacci Savaris|+5551997781966|rsavaris@hpca.edu.br|
21230842|NCT03797014|Institute of Human Virology, University of Maryland Baltimore|Dr. Joel Chua|14107065704|jchua@ihv.umaryland.edu|
21230843|NCT03903874|University of Alabama at Birmingham|Dr. Dori Pekmezi|205-975-8061|dpekmezi@uab.edu|
21230844|NCT02356575|Memorial Sloan Kettering Cancer Center|Dr. Jun Mao, MD, MSCE|646-888-0866|maoj@mskcc.org|
21230845|NCT03305575|Tufts Medical Center|Alaa Basura, MD|6176365000|abasura@tuftsmedicalcenter.org|6208
21230846|NCT01389817|Medical College of Wisconsin|Harry T. Whelan M.D.|414-266-3466|hwhelan@mcw.edu|
21230847|NCT00105469|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21230848|NCT04980040|Takeda|Medical Director|+1 877-825-3327|trialdisclosures@takeda.com|
21230849|NCT01408485|St. Jude Medical|Nancy Ouch, Senior Clinical Project Manager|949-769-5000|NOuch@sjm.com|
21230850|NCT01508650|Wake Forest School of Medicine|Dr. Dalane Kitzman|336-716-2227|dkitzman@wakehealth.edu|
21230851|NCT02064894|CHU Ste-Justine Hospital|Dr. Sylvie Le May|514-343-6384|sylvie.lemay@umontreal.ca|
21230852|NCT03095066|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21230853|NCT00160693|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
21230854|NCT03716024|Paratek Pharmaceuticals, Inc.|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
21230855|NCT04343261|Saint Francis Hospital and Medical Center|Latha Dulipsingh, MD|860-714-4402|Latha.Dulipsingh@trinityhealthofne.org|
21230856|NCT05988619|Pomona College|Dr. Benjamin Rosenberg|408-458-5375|benjamin.rosenberg@pomona.edu|
21230857|NCT04538261|AdventHealth Orlando|D. Ashley Hill, MD|407-303-1444|Ashley.Hill.MD@AdventHealth.com|
21230858|NCT00587054|Memorial Sloan-Kettering Cancer Center|Dr. Ann Jakubowski|212-639-5013|jakubowa@mskcc.org|
21230859|NCT05873257|Coloplast A/S|Clinical Strategy Project Manager: Johanne Louise Gotfredsen|004549113350|dkjoat@coloplast.com|
21230860|NCT00726232|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21230861|NCT00709761|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
21230862|NCT03478930|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21230863|NCT04950998|University of Southern California|Dr. Stacey Schepens Niemiec|3234422069|schepens@usc.edu|
21230864|NCT00553644|Veterans Affairs Medical Center/University of Minnesota|Vicki Morrison, M.D.||morri002@umn.edu|
21230865|NCT00705484|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21230866|NCT02197247|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
21230867|NCT02621060|Institute of Experimental and Clinical Therapeutics|Dra. Esperanza Martínez Abundis|+52-33-10-58-52-00|esperanzamartnezabundi@yahoo.com|34211
21230868|NCT00740831|PregLem SA|Dr Elke Bestel|+41 22 884 03 40|medical@preglem.com|
21230869|NCT03851705|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21230870|NCT04431453|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21230871|NCT00622401|Beth Israel Deaconess Medical Center|David Avigan, MD|617-667-9920|davigan@bidmc.harvard.edu|
21230872|NCT01194466|Mount Mercy University/The University of Iowa|Dr. Jen Lee|3193231623|jlee@mtmercy.edu|
21230873|NCT02933606|Bionomics Limited|VP Clinical Development|+61 8 8150 7400|BNC210clinicalstudies@bionomics.com.au|
21230874|NCT03087643|University of Verona|Dr. Massimo Venturelli|00390458415114|massimo.venturelli@univr.it|
21230875|NCT02083783|Tris Pharma, Inc.|Antonio Pardo MD|732-823-4755|apardo@trispharma.com|
21230876|NCT01323959|GlaxoSmithKline|GSK Response Center|866-435-7343||
21230877|NCT03834441|MGH|Margaret Samuels-Kalow|617-726-8340|msamuels-kalow@partners.org|
21230878|NCT02021773|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21238862|NCT02799472|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21238863|NCT01966003|Amgen Inc.|Study Director|866-572-6436||
21238864|NCT02801669|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21238865|NCT00674570|San Francisco VA Health Care System|Sabra Inslicht, Ph.D.|415-221-4810|sabra.inslicht@ucsf.edu|23341
21238866|NCT00571961|Yale University AIDS Program|R. Douglas Bruce, MD, MA, MSc|(203) 737-6133|robert.bruce@yale.edu|
21277763|NCT01843348|Novartis Pharmaceuticals|Study Director|862-779-8300||
21277764|NCT00251641|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21238867|NCT02569437|Icahn School of Medicine at Mount Sinai|Dr. Benjamin Malkin||Benjamin.D.Malkin@kp.org|
21238868|NCT00985985|GlaxoSmithKline|GSK Response Center|866-435-7343||
21289455|NCT00990769|Duke University Medical Center|Dr. Heather Frederick|919-812-6204|heather.frederick@duke.edu|
21289456|NCT03812328|Tetherex Pharmaceuticals|Jonathan Stocker, Ph.D.|855-222-0722|jstocker@tetherex.com|
21289457|NCT06923033|Moffitt Cancer Center|Dr. Christine Vinci, Ph.D.|813-745-5421|Christine.Vinci@Moffitt.org|
21289458|NCT01729091|The University of Texas MD Anderson Cancer Center|Samer Srour, MD / Stem Cell Transplantation|713-794-4354|SSrour@mdanderson.org|
21289459|NCT03166631|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21289460|NCT01552889|Washington University School of Medicine|Dr. Robert Carney|314-286-1313|carneyr@wustl.edu|
21289461|NCT03761914|Sellas Life Sciences|Dr Dragan Cicic, Chief Development Officer|646-200-5278|info@sellaslife.com|
21289462|NCT01309880|Bausch & Lomb|Dr. Robert Steffen|585 338 6399|robert.steffen@bausch.com|
21289463|NCT02370394|Butler Hospital/Women and Infants Hospital|Caron Zlotnick, Ph.D.|(401) 455-6529|CZlotnick@Butler.org|
21289464|NCT01834261|Stony Brook University|Lilianne Mujica Parodi, PhD / Study Principal Investigator|631-632-1008|lilianne.strey@stonybrook.edu|
21238869|NCT02343003|Halyard Health|David Curd|470-448-5178|david.curd@hyh.com|
21289465|NCT01108796|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21289466|NCT00758043|Vertex Pharmaceuticals Incorporated|Robert Kauffman, MD, PhD|617-444-6158|Robert_Kauffman@vrtx.com|
21289467|NCT04132466|Kestra Medical Technologies, Inc.|Laura Gustavson|14255264759|laura.gustavson@kestramedical.com|
21289468|NCT05890586|Duke University|Susanna Naggie, MD, MHS, FIDSA|919-684-2584|susanna.naggie@duke.edu|
21289469|NCT03989570|Minia university|Dr. Hassan Elshorbagy|1204427271|Hassan.Hetta@mu.edu.eg|0020
21289470|NCT02545127|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
21289471|NCT03197935|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21289472|NCT04027946|National Cancer Institute|Dr. Azam Ghafoor|240-858-3289|azam.ghafoor@nih.gov|
21289473|NCT00985192|UCLA GI Oncology Program, David Geffen School of Medicine at UCLA|Dr. Zev Wainberg|310 794-6500|zwainberg@mednet.ucla.edu|
21289474|NCT02083263|Karolinska University Hospital|Maria Cecilia Rodriguez Hortal|0046709558699|cecilia.rodriguez-hortal@karolinska.se|
21289475|NCT00069329|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Goldbach-Mansky, Raphaela|+1 301 435 6243|goldbacr@mail.nih.gov|
21289476|NCT02707744|Imperial College|Yura Mareev|+79166364410|mareev84@gmail.com|
21289477|NCT02331407|Columbia University|Dr. Tomoko Kitago|212-305-8389|tk2229@columbia.edu|
21289478|NCT01286324|University of Michigan|Suzanna M Zick|734-998-9553|szick@umich.edu|
21289479|NCT01875237|UT MD Anderson Cancer Center|Champlin,Richard,M.D. / Stem Cell Transplantation|713-792-8750|rchampli@mdanderson.org|
21289480|NCT00983957|Bristol-Myers Squibb International Corporation|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
21289481|NCT03055195|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21289482|NCT00986232|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21289483|NCT02568423|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21289484|NCT00790933|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21289485|NCT03395990|Duke University Medical Center|Jeff Gadsden|919-681-6437|jeff.gadsden@duke.edu|
21289486|NCT00720083|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.com|
21289487|NCT04017910|Sonavex|Katy Feeny|443-862-2024|kfeeny@sonavex.com|
21289488|NCT01913470|Emory University|Miriam Vos, MD, MSPH|404-727-9930|mvos@emory.edu|
21289489|NCT04565288|Brown University|Dr. Robert Miranda Jr.|401-863-6658|Robert_Miranda_Jr@brown.edu|
21289490|NCT00245570|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21289491|NCT00412451|ThromboGenics NV|Petra Kozma-Wiebe, MD|+32 16751310|petra.kozma@thrombogenics.com|
21289492|NCT01829165|Stanford University|Amit Etkin, MD, PhD|(650) 725-5736|aetkin@stanford.edu|
21289493|NCT02573467|Novartis Pharmaceuticals|Study Director|862-778-8300||
21289494|NCT04285684|Ketamine Research Foundation|Philip E Wolfson, MD|415-550-1700|ketamine.research@gmail.com|
21289495|NCT00710970|Baylor College of Medicine|Seth P. Lerner, M.D., F. A. C. S.|713-798-6841|slerner@bcm.edu|
21277765|NCT02093221|Grifols Therapeutics LLC|Kimberly Steinmann, MD|919-308-5444|kimberly.steinmann@grifols.com|
21277766|NCT00725621|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21277767|NCT01189500|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21277768|NCT01635062|Brigham and Women's Hospital|Dr. Anand Vaidya (Asst Professor of Medicine)|6175258285|avaidya1@partners.org|617
21277769|NCT00851643|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21277770|NCT00359788|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21277771|NCT00673933|Dermatology Institute|Dr Ashish Bhatia|630-942-5040|acbhatia@gmail.com|
21277772|NCT04932941|MetrioPharm Deutschland GmbH|Clinical Disclosure Officer|+49303384395|info@metriopharm.com|36
21277773|NCT05069155|University of Pennsylvania|Clinical research coordinator|7574471579|aileen.oon@pennmedicine.upenn.edu|
21277774|NCT02206620|Oregon Health & Science University|Dr. Martina Mancini|5034182602|mancinim@ohsu.edu|
21277775|NCT01929031|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21277776|NCT05816200|Federal University of Rio Grande do Norte|PhD Cristianne Kalinne Santos Medeiros|+55(84)3342-2341|cristiannekalinne@gmail.com|
21277777|NCT01366443|University of Utah Medical Center, Dept. of OB/GYN|Dr. Michael Draper, MD University of Utah Medical Center, Dept. of OB/GYN|801-581-7647|mike.draper@hsc.utah.edu|
21277778|NCT02394730|University of New South Wales|Sean Emery, Chief Principal Investigator|+61 2 9385 0897|s.emery@unsw.edu.au|
21277779|NCT00731549|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
21277780|NCT00588640|Memorial Sloan Kettering Cancer Center|Dr. Natalia Moryl|646-888-2681|moryln@mskcc.org|
21277781|NCT00103402|University of Pennsylvania|J. Richard Landis, PhD|215-573-4922|hultman@upenn.edu|
21277782|NCT01393730|Dana-Farber Cancer Institute|Dr. Mary-Ellen Taplin|617-582-7221|mary_taplin@dfci.harvard.edu|
21277783|NCT00507546|VAPAHCS|Dr. Jamie Zeitzer|6504935000|jzeitzer@stanford.edu|62410
21277784|NCT02384850|GSO Global Clinical Research B.V., EBC Amsterdam, Keizersgracht 62-64, 1015 CS Amsterdam|Dr. Anne L. Kranich|+49 40 44 19 54 60|kranich@gsoglobal.com|
21277785|NCT01524302|Michigan State University|Dr. Gary E. Stein|517-353-5126|steing@msu.edu|
21277786|NCT00986453|Medtronic Surgical Technologies|Robert Swain, PhD|+1 (603) 294-5428|robert.e.swain@medtronic.com|
21277787|NCT01856361|Weill Cornell Medical College|Peter N Schlegel, MD|2127465491|pnschleg@med.cornell.edu|
21277788|NCT03510182|University of Michigan|Carol Persad|734-615-8112|cpersad@umich.edu|
21277789|NCT01418482|Uppsala Akademiska Hospital, Dept. of Plastic Surgery|Fredrik Huss|+46 771 405 405|Fredrik.Huss@surgsci.uu.se|
21277790|NCT00375492|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21277792|NCT04062448|Janssen Pharmaceutical K.K.|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21277793|NCT04385277|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21277794|NCT04905290|Medtronic|James Burrell, Senior Statistician|18006338766|burrej3@medtronic.com|
21277795|NCT03295318|Serum Institute of India Pvt. Ltd.|Abhijeet Dharmadhikari|+91-20-26602855|abhijeet.dharmadhikari@seruminstitute.com|2855
21277796|NCT03747601|BIDMC|Daniel Press, MD Chief of Cognitive Neurology Unit|617-667-4074|dpress@bidmc.harvard.edu|
21277797|NCT05140954|Departments of Global Health and Epidemiology, University of Washington|Kenneth K. Mugwanya, MBChB, MS, PhD|+1 206 520-3800|mugwanya@uw.edu|
21277798|NCT04319718|University of Pittsburgh|Dr. Leslie Meyn, Research Assistant Professor|412-641-4233|meynla@mwri.magee.edu|
21277799|NCT00321828|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600||
21230879|NCT00530946|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21230880|NCT01534962|Menarini Ricerche S.p.A|Angela Capriati MD PhD, Head of Corporate Clinical Research|00390555680|acapriati@menarini-ricerche.it|9933
21230881|NCT02243696|BIOTRONIK, Inc.|Clinical Studies Engineer Manager|1-800-547-0394|crystal.miller@biotronik.com|
21230882|NCT00622284|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21230883|NCT04545385|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
21230884|NCT01919606|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
21230885|NCT02412618|VCU Medical Center|Dr. Frances Casey|804-828-7877|frances.casey@vcuhealth.org|
21230886|NCT01086761|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21260915|NCT00987415|Duke University|Kevin Anstrom|919-668-8902|kevin.anstrom@dm.duke.edu|
21260916|NCT03723447|Cedars-Sinai|Dr Karen Zaghiyan|(310) 289-9224|kzaghiyan@yahoo.com|
21260917|NCT02904226|Jounce Therapeutics, Inc.|Stew Kroll, Chief Development Officer|(650) 576-9679|skroll@jouncetx.com|
21230887|NCT02094677|Coopervision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|jvega@coopervision.com|
21230888|NCT03408483|UAB|Adam Sturdivant|205-934-4042|Adamsturdivant@uabmc.edu|
21230889|NCT05399641|Scynexis|David Angulo|201-884-5471|david.angulo@scynexis.com|
21230890|NCT00478231|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21230891|NCT04338074|University of Alabama at Birmingham|Dr. Timothy J Ness|205-975-9643|tness@uabmc.edu|
21230892|NCT00602797|University of Nebraska Medical Center|Apar Ganti|402-559-5622|aganti@unmc.edu|
21230893|NCT00834171|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
21230894|NCT00629707|University of California, Davis|Dr. Nicole Glaser|916-734-7098|nsglaser@ucdavis.edu|
21230895|NCT02657369|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21230896|NCT02605824|UCSF Airway Clinical Research Center|Fahy Research Manager|415-514-1539|ariana.baum@ucsf.edu|
21230897|NCT04875195|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@msd.com|
21230898|NCT02389361|ASTES|Dr. DEFLANDRE Eric|0032477764241|eric.deflandre@gmail.com|
21230899|NCT00826943|Vanderbilt University|Douglas Tzanetos|615-942-7971|dtzanetos@hotmail.com|
21230900|NCT03715530|University of Iowa|Dr. Mark Santillan|319-356-3180|mark-santillan@uiowa.edu|
21230901|NCT03547583|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
21230902|NCT01744197|Evergreen Hematology and Oncology|Melanie Matson, RN, BSN|5094642873|mmatson@evergreen4cure.com|
21230903|NCT04706091|Massachusetts General Hospital|John W Winkelman, MD PhD|617-724-7426|jwwinkelman@mgh.harvard.edu|
21230904|NCT03329573|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21230905|NCT00650260|University of South Florida Dept of Surgery/Anesthesiology|Enrico Camporesi MD|813-844-7170|ecampore@health.usf.edu|
21277800|NCT00573157|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21277801|NCT00090610|Duke University Medical Center|Angeles Alvarez Secord, Director of Gynecologic Oncology Clinical Trials|919-684-3765|secor002@mc.duke.edu|
21277802|NCT00609518|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21277803|NCT04032158|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@merckgroup.com|
21277804|NCT00059787|Montefiore Medical Center - New York Cancer Consortium|NYCC Regulatory Coordinator|718-379-6862|sforde@montefiore.org|
21277805|NCT01859130|Zimmer Biomet|Clinical Research Specialist|5745497606|tim.swanson@zimmerbiomet.com|
21277806|NCT01388166|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21277807|NCT04325204|Emory University|Fayron Epps, PhD, RN|404-727-6936|fepps@emory.edu|
21277808|NCT00903448|The Procter & Gamble Company|John Mcrorie, PhD, FACG, AGAF|513-622-1423|mcrorie.jw@pg.com|
21277809|NCT00820443|MicroPort Orthepedics|Matt C. Paul, Project Manager|(901) 867-4350|mpaul@ortho.microport.com|
21277810|NCT04710979|University of Minnesota|Dr. Daheia J. Barr-Anderson|240-475-2806|barra027@umn.edu|
21277811|NCT04397445|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.Strauss@fda.hhs.gov|
21277812|NCT01429051|Takeda|Medical Director|+1-800-778-2860|clinicaltrialregistry@tpna.com|
21277813|NCT00891371|Ipsen|Medical Director, Gastroenterology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21289496|NCT01033227|Children's Hospital Los Angeles|Dr. Thomas Coates|323 361 3841|TCoates@chla.usc.edu|
21289497|NCT01960842|AbbVie|Global Medical Information|1-800-633-9110||
21238870|NCT01923805|Cleveland Clinic|Alison Klika; Research Program Manager, Adult Reconstruction|216-444-4954|klikaa@ccf.org|
21238871|NCT01153269|Abbott|Global Medical Services|1-800-633-9110||
21277814|NCT00307034|GlaxoSmithKline|GSK Response Center|866-435-7343||
21277815|NCT02034058|Stryker Neurovascular|Alice Lin, Clinical Program Manager|510 413 2673|alice.lin@stryker.com|
21277816|NCT02044796|Fred Hutchinson Cancer Research Center|Roland B. Walter|1-206-667-3599|rwalter@fredhutch.org|
21277817|NCT03709823|Achieve Life Sciences|Daniel Cain, Vice President, Clinical Research|425.686.1546|dcain@achievelifesciences.com|
21289498|NCT02296801|NSABP Foundation Inc|Director, Department of Site and Study Management|1-800-270-3165|industrytrials@nsabp.org|
21277818|NCT00846521|Yale University School of Medicine|Tania Burgurt, MD|203-785-7152|tania.burgurt@yale.edu|
21277819|NCT04392583|Smith+Nephew, Inc|Judith Horner|+44 1482 673251|judith.horner@smith-nephew.com|
21277820|NCT02397408|University of California, Los Angeles|Albert J. Chang, MD, PhD|(310) 82509771|ajchang@mednet.ucla.edu|
21289499|NCT02056288|Baylor College of Medicine|Chris D. Glover, MD, MBA, Principal Investigator|832-824-5800|cdglover@texaschildrens.org|
21289500|NCT00505362|Stanford University|Anna Girsen, Manager of Research Operations|6507250499|agirsen@stanford.edu|
21230906|NCT02166905|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-2300|chong.wang@roswellpark.org|
21230907|NCT03432897|Brown Oncology Research Group|BrUOG|4018633000|BrUOG@Brown.edu|
21230908|NCT05243641|M D Anderson Cancer Center|Rachel M. Layman, MD|713) 745-8401|rlayman@mdanderson.org|
21230909|NCT00895232|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|844
21289501|NCT02384460|Amicus Therapeutics, Inc.|Patient Advocacy|+1-609-662-2000|clinicaltrials@amicusrx.com|
21230910|NCT05372419|Chief Medical Officer|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
21230911|NCT04997304|University of Michigan|Njira Lugogo|734-647-6477|nlugogo@med.umich.edu|
21289502|NCT02400580|University of Pittsburgh Medical Center|Dr. Noah Rindos|(412) 641-8769|rindosnb@upmc.edu|
21289503|NCT04233580|University of Texas Southwestern Medical Center|Tara Kristof|214-648-8602|tara.kristof@utsouthwestern.edu|
21289504|NCT00625378|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
21230912|NCT04249583|Galderma Research & Development|Galderma Research & Development|8179615000|clinical.studies@galderma.com|
21230913|NCT03311724|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21230914|NCT00634166|Mylan Pharmaceuticals Inc.|Eric Davis, M.D.|304.554.6503|eric.davis@mylan.com|
21230915|NCT01970397|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21230916|NCT02536040|Advantage Silver Dental Arrest, LLC|Peter Milgrom|2062516831|drmilgrom@silverarrest.com|
21230917|NCT02123121|University of Florida|Dr. Stephen Anton|(352) 273-7514|santon@ufl.edu|
21230918|NCT01471171|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
21230919|NCT00407797|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21230920|NCT01812174|Artivion, INC|Erica Troup , Clinical Project Manager|706-409-5974|erica.troup@artivion.com|
21230921|NCT00555971|Cleveland Clinic|David M. Lang|216-444-6933|langd@ccf.org|
21230922|NCT05469178|BerGenBio ASA|BerGenBio Clinical Team|+47 559 61 159|registry.postings@bergenbio.com|
21230923|NCT05393895|Orasis Pharmaceuticals, Ltd.|Head of Regulatory Affairs|+972-9-8877745|iris.meisner@orasis-pharma.com|
21230924|NCT01521546|The Ohio State University|Subha V. Raman, MD|(614)293-8963|raman.1@osu.edu|
21230925|NCT02158273|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
21230926|NCT01203098|Daiichi Sankyo.,LTD|Masayuki Fukuzawa, Associate Director|81-90-5584-2197|fukuzawa.masayuki.gn@daiichisankyo.co.jp|
21230927|NCT02650856|Universidad Autonoma de Nuevo Leon|FELIX VILCHEZ CAVAZOS|8183476698|vilchez.doctor@gmail.com|
21230928|NCT00244010|St. Jude Children's Research Hospital|Kimberly Kasow, DO|901-595-3300|kimberly_kasow@med.unc.edu|
21230929|NCT02478775|University of Colorado School of Medicine|Dr. Alex Polotsky|303-704-8221|ALEX.POLOTSKY@CUANSCHUTZ.EDU|
21230930|NCT00621582|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21260918|NCT00728416|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21230931|NCT03617185|University of Michigan|Brian Callaghan, MD|7349367183|Bcallagh@med.umich.edu|
21260919|NCT04112914|Seattle Children's Research Institute|Dr. Emily Kroshus|206-884-5326|Emily.Kroshus@seattlechildrens.org|
21260920|NCT01120626|Stanford University|Allan Reiss, MD|650-498-4538|reiss@stanford.edu|
21260921|NCT02635204|Dr. Reddy's Lab, Inc|Srinivas Sidgiddi, MD|609-375-9900|srinivassidgiddi@drreddys.com|
21260922|NCT03102411|TriHealth Inc.|Rachel Pauls MD|513-463-4300|Rachel_Pauls@trihealth.com|
21277821|NCT03056157|VA Boston Healthcare System|Dr. Brett Litz|(617)5849314|brett.litz@va.gov, litzb@bu.edu|
21277822|NCT00140426|University of Colorado School of Medicine, Childrens Hospital Colorado|Jennifer Hagman MD|720-777-2539|jennifer.hagman@childrenscolorado.org|
21277823|NCT00950963|Denver Health|Raymond Estaico, MD|303-860-9900|Ray.Estacio@cpcmed.org|
21277824|NCT04168190|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21277825|NCT01675661|Medical University of South Carolina|Kevin Gray, MD|843-792-6330|graykm@musc.edu|
21277826|NCT04765384|Janssen Vaccines & Prevention B.V.|Vice President Medical Affairs IDV|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21277827|NCT02992418|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21277828|NCT00629265|Boston Medical Center|Dr. Susan Langmore, PhD, Director of Speech Language Pathology|617-414-1753|langmore@bu.edu|
21289505|NCT04676646|AstraZeneca|Global Clinical Lead|18772409479|information.center@astrazeneca.com|
21277829|NCT01006135|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21277830|NCT01732484|Medical University of Vienna|Prof. Dr. R. Menapace|+43 699 19660272|rupert.menapace@meduniwien.ac.at|
21277831|NCT01087489|Miami Veterans Affairs Medical Center|Dr. Ninel Gregori, MD|305-575-7000|ngregori@med.miami.edu|3081
21277832|NCT01708590|Bausch Health|Study Director|510-259-5284||
21277833|NCT02032706|Advanced Brain Monitoring, Inc.|Daniel Levendowski|760 720 0099|dan@b-alert.com|x6040
21277834|NCT00893737|Clinvest|Rebecca Browning|(417) 841-3664|rbrowning@clinvest.com|
21277835|NCT00928707|Italfarmaco SpA|Carlo Bianchini, MD|+39 02 6443 2540|c.bianchini@italfarmaco.com|
21277836|NCT00132028|SWOG Statistical Center|Study Statistician|206-667-4623||
21277837|NCT02140411|Novartis Pharmaceuticals|Study Director|862-778-1873||
21277838|NCT03584724|Eye Pharma|Elena Meloni|7862187339|elena.meloni@eyepharma.com|
21277839|NCT03981419|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
21277840|NCT03562559|Vancouver General Hospital|Marcus Tholin|604-875-4111|marcus.tholin@vch.ca|
21277841|NCT02337959|Carestream Health, Inc.|Susan Pate, RN, MS, RAC|585-627-6557|susan.pate@carestream.com|
21277842|NCT01330459|Oregon Health and Science University|Alison Edelman, MD, Assistant Professor|(503) 494-3666|edelmana@ohsu.edu|
21277843|NCT01231399|City of Hope|Paul Frankel, Ph.D.|(626) 218-5265|pfrankel@coh.org|
21277844|NCT01437943|Brigham and Women's Hospital|Anil Chandraker, MD|617-732-7412|achandraker@partners.org|
21277845|NCT02697240|Children's National Medical Center|Suvankar Majumdar|2024763800|smajumdar@childrensnational.org|
21289506|NCT04270760|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21289507|NCT01814332|San Francisco VA Medical Center|Jennifer Hlavin|415-221-4810|jennifer.hlavin@va.gov|26624
21277846|NCT04988152|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
21277847|NCT02005887|International Breast Cancer Study Group|Meredith M. Regan|+1 617-632-3012|mregan@jimmy.harvard.edu|
21277848|NCT01615263|Institut universitaire de cardiologie et de pneumologie de Québec, Laval University|Dr Jean S. Bussières, anesthesiologist, director of research|418 656-4870|jbuss@criucpq.ulaval.ca|
21277849|NCT00160641|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
21277850|NCT01321008|University of Texas MD Anderson Cancer Center|Bouthaina Dabaja, MD / Associate Professor, Radiation Oncology|713-563-2300|CR_Study_Registration@mdanderson.org|
21277851|NCT02931045|1st Chair and Department of Cardiology, Medical University of Warsaw|Aleksandra Gasecka, MD, PhD|+48225991951|alesandra.gasecka@wum.edu.pl|
21289508|NCT00668564|Masonic Cancer Center, University of Minnesota|Paul Orchard, M.D.|612-626-2313|orcha001@umn.edu|
21260923|NCT02700529|Eiger BioPharmaceuticals, Inc.|Senior VP, Clinical Development|1-650-618-1621|info@eigerbio.com|
21260924|NCT03502746|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 921-2050|fsharmin@hoosiercancer.org|
21260925|NCT05421754|Northwestern University|Shuai Xu|312-695-8106|stevexu@northwestern.edu|
21260926|NCT03527043|Weill Cornell Medicine|Jonathan Gal|646-962-4811|jog4018@med.cornell.edu|
21260927|NCT01697332|Brigham and Women's Hospital|Samuel Patz|6172780616|patz@bwh.harvard.edu|
21260928|NCT02039947|Novartis Pharmaceutical|Study Director|862-778-8300|novartis.email@novartis.com|
21260929|NCT01772134|GlaxoSmithKline|GSK Response Center|866-435-7343||
21260930|NCT00636818|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21260931|NCT04898166|Jinnah postgraduate medical centre|Syeda Mahanum Ali|03033901112|mahanumsyed8@gmail.com|
21260932|NCT01023789|Abbott Vascular International BVBA|Susan Veldhof|+31653428610|susan.veldhof@av.abbott.com|
21260933|NCT01852084|Bausch Health|Study Director||susan.harris@bauschhealth.com|
21260934|NCT02533089|Li Ka Shing knowledge institute|Dr. L M Puchalski Ritchie|416 864 6060|lisa.puchalskiritchie@utoronto.ca|
21260935|NCT00095563|Princess Margaret Cancer Centre|Dr. Lillian Siu|416-946-2911|lillian.siu@uhn.ca|
21260936|NCT02115308|Cardiovascular Imaging Technologies, LLC|Joseph Soltys, PhD|816-531-2842|jsoltys@cvit.com|103
21260937|NCT03322358|University of Pennsylvania|Heather Schofield|617-233-4775|hschof@wharton.upenn.edu|
21260938|NCT02335502|St. Jude Medical|Roni Diaz|+19723098601|RDiaz@sjm.com|
21260939|NCT01442181|UF Healthcare|Dr. Thomas Beaver|352-273-5503|thomas.beaver@surgery.ufl.edu|
21260940|NCT00749203|Icahn School of Medicine at Mount Sinai|Dr. Adriana Feder|212-241-1563|adriana.feder@mssm.edu|
21260941|NCT02034123|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21260942|NCT00246259|Janssen Inc., Toronto, ON, Canada|Director Medical Affairs - CNS|+1-416-382-5094||
21260943|NCT03133767|University of Iowa|Nicholas Mohr|319-384-8285|nicholas-mohr@uiowa.edu|
21260944|NCT04233424|PolyPid|Clinical Development Manager|+972-74-7195700|olga.b@polypid.com|
21260945|NCT02698189|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21260946|NCT02240706|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21260947|NCT03301857|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21260948|NCT03664726|University at Buffalo|Leonard H. Epstein|716-829-3400|lhenet@buffalo.edu|
21260949|NCT02319369|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21260950|NCT05502289|Johnson & Johnson Vision Care, Inc. (JJVC) 7500 Centurion|Benjamin Straker|1-800-843-2020|bstraker@its.jnj.com|
21260951|NCT04454411|University of Pennsylvania|James Loughead, Ph.D.|215-205-1876|loughead@pennmedicine.upenn.edu|
21260952|NCT03119649|Galapagos NV|Evelyn Fox|0032 15 34 29 00|evelyn.fox@glpg.com|
21260953|NCT01564784|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21260954|NCT05300087|Intech Biopharm Ltd.|Sabina Chien|+886-2-7721-8877|sabina.i198@intechbiopharm.com|631
21260955|NCT01126580|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21260956|NCT04109599|play2PREVENT Lab, Yale Center for Health and Learning Games, Department of Internal Medicine|Tyra Pendergrass Boomer, Deputy Director of Programs and Partnerships|+1 (203) 737-6101|tyra.pendergrass@yale.edu|
21260957|NCT01731002|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director of Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
21260958|NCT00803114|University of Toronto|Dr. Alison Macarthur|416 586 4800|alison.macarthur@uhn.on.ca|6632
21289509|NCT04996264|Ophirex, Inc.|Tim Platts-Mills, Chief Medical Officer|5592406073|tim@ophirex.com|
21260959|NCT00947349|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21260960|NCT00538681|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21260961|NCT05198713|Sonova US Corporate Services, LLC|Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
21238872|NCT03315936|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21238873|NCT02635724|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
21238874|NCT04048863|B. Braun Medical Inc.|Dr. Diana Valencia|610-596-2875|diana.valencia@bbraunusa.com|
21238875|NCT02424591|NYU School of Medicine|John Ard, MD|212.263.5072|john.ard@nyumc.org|
21238876|NCT00770432|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21238877|NCT01453348|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21238878|NCT01673893|Cardiovascular Institute of the South Clinical Research Corporation|Deanna K. Benoit, LPN, CCRC|985-876-0300|deanna.benoit@cardio.com|5613
21238879|NCT03160287|University of Washington|Oleg Zaslavsky|2066163242|ozasl@uw.edu|
21238880|NCT01498822|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
21238881|NCT01991821|Acacia Pharma|Dr Gabriel Fox|01223875130|GabrielFox@acaciapharma.com|149
21238882|NCT00632281|University of Florida|Bridget Fitzgerald, Clinical Research Coordinator|352-265-0680|fitzgb@shands.ufl.edu|87829
21238883|NCT03592277|Saint Francis Hospital and Medical Center|David Shapiro, MD, MHCM, FACS, FCCM CMO of Saint Francis Hospital and Medical Center|860-833-5673|dshapiro@trinityhealthofne.org|
21238884|NCT01781390|Mesoblast, Inc.|Kenneth Borow, MD (Lead, Global Cardiovascular Development)|(212) 880-2060|Ken.Borow@Mesoblast.com|7951
21238885|NCT04707196|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21238886|NCT01625923|University of Michigan|Allen Lee|734-936-9454|allenlee@umich.edu|
21238887|NCT01862796|National Institute of Diabetes Digestive and Kidney Diseases/NIH|Dr. Marci E. Gluck|602-200-5317|gmarci@mail.nih.gov|
21238888|NCT04404478|Ohio State University|Dr. Holly Jones|760-415-6147|jones.7935@osu.edu|
21238889|NCT02192775|University of Arkansas for Medical Sciences|Brittany Lehman|501-686-8274|blehman@uams.edu|
21238890|NCT01973036|Geisinger|Dr. A. Dhanya Mackeen|570-714-1099|admackeen@geisinger.edu|
21238891|NCT02255032|Clearside Biomedical, Inc.|Thomas Ciulla, MD|(678) 392-2318|thomas.ciulla@clearsidebio.com|
21238892|NCT02037438|Stanford University|Dr. Clete Kushida|650-721-7560|clete@stanford.edu|
21277852|NCT00770692|Eisai Co., Ltd.|Atsushi Kamijo, Study Director|+81-3-3817-5245|a-kamijo@hhc.eisai.co.jp|
21238893|NCT06131294|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
21238894|NCT03056534|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
21238895|NCT00125593|Clinical Trial Service Unit & Epidemiological Studies Unit, University of Oxford|Professor Colin Baigent|+44 1865 743743|colin.baigent@ctsu.ox.ac.uk|
21238896|NCT04146896|Aptinyx|Aptinyx Clinical Development|847-871-0377|clinicalstudies@aptinyx.com|1
21238897|NCT01597505|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21238898|NCT02675465|Amicus Therapeutics, Inc.|MedInfo|001 609-662-2000|MedInfoUSA@amicusrx.com|
21238899|NCT05031078|Emory University|Dr. Erin Scherer|404-712-6904|erin.margaret.scherer@emory.edu|
21238900|NCT02583763|Region Östergötland / University of Linköping|Olov Änghagen PhD student|+461047246|olov.anghagen@regionostergotland.se|
21238901|NCT05398796|Vaccine Research Center Clinical Trials Program, NIAID|Lesia K. Dropulic, M.D./Principal Investigator; Laura Novik, R.N., M.A./Study Coordinator|301-451-8717|lesia.dropulic@nih.gov; laura.novik@nih.gov|
21238902|NCT05004688|Mass General|Kayla McEachern|617 643 5265|kmceachern2@mgh.harvard.edu|
21238903|NCT00728962|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
21238904|NCT04954586|McMaster University|Dr. Lisa Carlesso|9055259140|carlesl@mcmaster.ca|23811
21238905|NCT00532155|Sanofi-aventis|Trial Transparency Team||Contact-Us@sanofi.com|
21238906|NCT03483038|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
21238907|NCT02134925|University of Pittsburgh|Robert E. Schoen, M.D., M.P.H|412-864-7078|rschoen@pitt.edu|
21238908|NCT04027348|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-2300|Kris.Attwood@roswellpark.org|
21238909|NCT02158884|Major Extremity Trauma and Rehabilitation Consortium|Susan Collins (Study Manager)|410 502 8966|scolli21@jhu.edu|
21238910|NCT02487472|GlaxoSmithKline|GSK Response Center|866-435-7343|lzr30020@gsk.com|
21238911|NCT01313286|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21238912|NCT04843930|Weill Cornell Medicine|Lindsay Victoria, PhD|646-962-3973|liv3002@med.cornell.edu|
21238913|NCT05158296|Sepul Bio|Zuhal Butuner - Chief Medical Officer|(905) 599-7887|contact@sepulbio.com|
21238914|NCT02552238|Bracco Diagnostics Inc.|Melda S. Dolan, MD, FACC, FASE, Head, Medical Affairs and Cardiac Ultrasound|1-609-514-2506|Melda.Dolan@diag.bracco.com|
21277853|NCT01230892|Emory University|Dr. Habib Samady|404-778-5299|hsamady@emory.edu|
21277854|NCT00679913|Seoul National University Hospital|Sun-Whe Kim, M.D., Ph.D., FACS|82-2-2072-2310|sunkim@plaza.snu.ac.kr|
21277855|NCT01000493|GlaxoSmithKline|GSK Response Center|866-435-7343||
21277856|NCT00062751|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21277857|NCT03629028|Principal investigator of the research|Şafak Yılmaz Baran, MD|+903224586868|safakyilmazbaran@gmail.com|
21277858|NCT00534794|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||clinicaltrialsdisclosure@merck.com|
21277859|NCT03323723|Rinovum Subsidiary 2, LLC.|Clinical Development Manager|7242418932|hwhitelam@rinovum.com|
21277860|NCT03097588|Department of Pharmacy Services, Oregon health & Science University Hospital|Joseph Bubalo, PharmD (Oncology Clinical Pharmacy Specialist)|5034948007|bubaloj@ohsu.edu|
21277861|NCT01144364|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21277862|NCT03828448|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
21277863|NCT02037165|Boehringer Ingelheim pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21277864|NCT00695435|Alcon Research, LTD|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21277865|NCT02192164|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21277866|NCT02150759|Inje University, Haeundae paik hospital|Ki Hwa Lee|82-51-797-0421|tedy3333@naver.com|
21277867|NCT00321594|Department of Clinical Oncology, The Chinese University of Hong Kong|Professor Winnie Yeo|852-2632|winnieyeo@cuhk.edu.hk|2118
21277868|NCT03554603|Memorial University|Peter Daley MD MSc|7097772089|pkd336@mun.ca|
21277869|NCT00609466|Grunenthal|René Allard|49 241 569 3223|Clinical-Trials@grunenthal.com|
21277870|NCT03512262|Radius Health, Inc.|Clinical Operations|617-551-4000|info@radiuspharm.com|
21277871|NCT01299805|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21277872|NCT03218163|SKCCC|Dr. Philip Imus|4109558873|pimus1@jhmi.edu|
21277873|NCT02935686|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21277874|NCT01183221|Icahn School of Medicine at Mount Sinai|Dr. Alexander Kolevzon|(212) 659-8762|alexander.kolevzon@mssm.edu|
21277875|NCT03535675|Johns Hopkins University|Channing Paller; M.D.|4109558239|cpaller1@jhmi.edu|
21277876|NCT03426137|University of Maryland School of Nursing|Research Coordinator|410-706-5975|NRSCollocaLab@umaryland.edu|
21277877|NCT00103311|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
21277878|NCT00912093|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21277879|NCT03687658|Stanford University|Russell Poldrack, PhD|(650) 497-8488|poldrack@stanford.edu|
21277880|NCT00166036|Emory University|Arshed A Quyyumi, MD|404 712 2741|aquyyum@emory.edu|
21277881|NCT03827564|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
21277882|NCT02070302|Arizona Arthritis & Rheumatology Research, PLLC|Amanda Santimaw|4806266653|amanda.santimaw@azarthritis.com|
21277883|NCT03667014|UCSF|Tina Bhutani|4153537800|tina.bhutani@ucsf.edu|
21277884|NCT02621034|Zahedan university of medical sciences|Seyed Roholla Havaei|+989215257093|marty_zl@yahoo.com|
21277885|NCT00026221|The Ohio State University Comprehensive Cancer Center|William E. Carson III, MD|614-293-6306|William.Carson@osumc.edu|
21277886|NCT02372071|Hadassah Hospital located in Jerusalem, Israel|PROF. BAR-OZ BENJAMIN|02-6774919|baroz@hadassah.org.il|
21277887|NCT01968694|Brigham & Women's Hospital|Dr. Antje M Barreveld|617-243-6298|abarreveld@partners.org|
21277888|NCT02836496|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21277889|NCT01400919|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
21277890|NCT03347422|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21277891|NCT02252718|Medical University of Warsaw|Katarzyna Wojtyniak|(+48) 223179536|wojtyniakkasia@gmail.com|
21277892|NCT01246011|Massachusetts General Hospital|Anne Philip, Data Manager|617 726 0423|alphilip@partners.org|
21277893|NCT00063635|Columbia University Medical Center|Joel E. Lavine, MD, PhD||jl3553@columbia.edu|
21277894|NCT01663935|University of Wisconsin, Madison|Dr Michael Struck|608 263-6429|mcstruck@wisc.edu|
21277895|NCT02075671|The George Washington University, Medical Faculty Associates|Dermatology Research Fellow|202-741-2632|knelson@mfa.gwu.edu|
21277896|NCT03300544|M D Anderson Cancer Center|Arvind Dasari|(713) 792-2828|adasari@mdanderson.org|
21277897|NCT03914950|Medical University of Graz, Department of Radiology, Division of Nuclear Medicine|Dr. Susanne Stanzel|+43-316-385-81789|susanne.stanzel@medunigraz.at|
21277898|NCT00119067|CDC|Jennifer G Wright||jgwright@cdc.gov|
21277899|NCT00894738|Washington University School of Medicine|Dr. Ginger Nicol|(314) 362-2461|nicolg@psychiatry.wustl.edu|
21277900|NCT02575911|Alcon, A Novartis Division|Global Brand Med Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21230932|NCT04672993|Coloplast|Senior Scientific Manager Marianne Raff Dambæk|004549112562|dkmr@coloplast.com|
21230933|NCT01387932|Merit Medical Systems, Inc.|Vicky Brunk RN, Vice President, Medical Affairs, Merit Medical|+1 (717) 873-3309|vicky.brunk@merit.com|
21230934|NCT01964430|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21230935|NCT02591290|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21230936|NCT02571075|Womack Army Medical Center|Anthony Plunkett|910-643-2324|anthony.r.plunkett.civ@mail.mil|
21230937|NCT04092439|Pennington Biomedical Research Center|Tim Allerton, Ph.D.|225-763-2940|timothy.allerton@pbrc.edu|
21230938|NCT00864383|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|(212) 227-7540|Dan.Everitt@tballiance.org|
21230939|NCT02197520|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21230940|NCT00913497|Corewell Health|Esther Peariso|6164860358|esther.peariso@corewellhealth.org|
21230941|NCT01306942|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
21230942|NCT03190915|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21230943|NCT03385564|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21230944|NCT01146834|Weill Cornell Medicine|Ruben Niesvizky, MD|646-962-9376|run9001@med.cornell.edu|
21230945|NCT00183677|Massachusetts General Hospital|Dan Iosifescu, MD, MSc||diosifescu@partners.org|
21230946|NCT01546883|University of Utah|Clinical Research Manager|8015873889|christina.pacchia@hsc.utah.edu|
21230947|NCT02256631|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
21230948|NCT01427972|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21230949|NCT01481376|Surgical Department of the Protestant Hospital|Docteur Dieter BIRK|06332 422120||
21230950|NCT03965039|Procter and Gamble|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
21230951|NCT02771093|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21230952|NCT01128842|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
21230953|NCT03322631|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21230954|NCT01646762|Mayo Clinic|Dr. Rafael Fonseca|480-301-4280|fonseca.rafael@mayo.edu|
21230955|NCT02378961|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21230956|NCT04528732|Washington University in St. Louis|Dr. Proscovia Nabunya|3149359087|nabunyap@wustl.edu|
21230957|NCT01253408|Mayo Clinic|Dr. Michael Camilleri|507-266-2306|camilleri.michael@mayo.edu|
21230958|NCT01300650|Virginia Commonwealth University|Benjamin Van Tassell|8049820997|bvantassell@vcu.edu|
21230959|NCT02557555|Rutgers New Jersey Medical School|Assistant Professor|4133869415|ajantoni@gmail.com|
21230960|NCT01996852|Case Comprehensive Cancer Center|Dr. Amy Zhang|+1 216-368-0968|amy.zhang@case.edu|
21230961|NCT02494297|Center for Epidemiology and Health Research, Germany|Dr. Klaas Heinemann|0049 (0) 30 945 101 20|k.heinemann@zeg-berlin.de|
21230962|NCT02784431|Cerus Endovascular|Lori E Adels, Ph.D.|510-651-4000|lori.adels@cerusendo.com|109
21230963|NCT00361569|Duramed Research|Duramed Research Protocol Chair|215-293-7279|medicalaffairs@barrlabs.com|
21230964|NCT00074152|International Breast Cancer Study Goup|Barbara Ruepp|+4131 3899222|barbara.ruepp@ibcsg.org|
21230965|NCT01446289|Novartis vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
21230966|NCT03307967|Yale University|Christina Lazar, Project Director|203-932-5711|christina.lazar@yale.edu|4833
21230967|NCT02915016|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
21230968|NCT02578316|Eisai Inc.|Eisai Medical Services|888-||
21230969|NCT02617628|University of Pennsylvania Office of Research Services|W. Stuart Watson|215-573-6707|wswatson@upenn.edu|
21230970|NCT02065375|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21230971|NCT03278873|MeiraGTx|Program Manager|0044 (0)20 3866 4320|ocularinfo@meiragtx.com|
21230972|NCT04785677|Florida State University|Stephen Tripodi|850-645-1572|stripodi@fsu.edu|
21230973|NCT05169437|Tempus AI, Inc|Virginia Rhodes, MD|(800) 976-5448|support@tempus.com|
21230974|NCT05405309|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
21230975|NCT01886794|University of Texas Medical Branch|Kathleen L. Vincent, M.D.|409-772-2610|klvincen@utmb.edu|
21230976|NCT05670236|Cleveland Clinic Foundation|Dr. Patrick Corrigan|216-618-9932|corrigd4@ccf.org|
21230977|NCT04518306|George Medicines Pty Limited|Anthony Rodgers (Principal Investigator)|+44 7983 578 290|arodgers@georgeinstitute.org|
21289510|NCT00685698|TaiGen Biotechnology Co., Ltd.|Chen-En Tsai, M.D., Ph.D.|+886-2-8177-7072|cetsai@taigenbiotech.com|1211
21230978|NCT03268954|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21230979|NCT02159560|Beth Israel Deaconess Medical Center|Philip Hess|6176673112|phess@bidmc.harvard.edu|
21230980|NCT05358444|Johns Hopkins University Schoo of Medicine|Maya Venkataramani MD, MPH|4109559869|mvenkat2@jh.edu|
21230981|NCT02801331|University of Pittsburgh School of Medicine|Elisabeth B Salisbury, PhD|14122465378|salisburye2@upmc.edu|
21230982|NCT02443987|Gloucestershire Hospitals NHS Foundation Trust|Dr Sharan Athwal|0300 422 2222|sharan.athwal@glos.nhs.uk|
21230983|NCT00946478|UCSD Dermatology|Dr. Tissa Hata|858-657-8390|ucsddermstudies@gmail.com|
21230984|NCT05438888|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21230985|NCT00887653|THE MIRIAM HOSPITAL|Aadia Rana|4017934680|arana@lifespan.org|
21277901|NCT01249365|GlaxoSmithKline|GSK Response Center|866-435-7343||
21277902|NCT03579966|Catalyst Pharmaceuticals, Inc.|Gary Ingenito, MD, Chief Medical Officer|3054203200|gingenito@catalystpharma.com|
21277903|NCT02620150|University of Pennsylvania|Chelsea Voytek|215-746-3711|chelseav@pennmedicine.upenn.edu|
21277904|NCT02408068|Simbec Research Ltd|Dr G Sharma|0800 691995|contact@simbec.com|
21230986|NCT04698187|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21230987|NCT03820986|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21230988|NCT03069378|Memorial Sloan Kettering Cancer Center|Dr. Ciara Kelly, MD|646-888-4312|Kellyc1@mskcc.org|
21230989|NCT02993146|Johns Hopkins University|Grants Administrative Manager|4439273568|JHCCCRO@jhmi.edu|
21230990|NCT01397708|Alaunos Therapeutics, Inc|Jaymes Holland Clinical Consultant|6502732627|jholland@alaunos.com|
21230991|NCT02284126|Columbia University Irving Medical Center|Dr. E. Sander Connolly Jr.|2123054118|esc5@cumc.columbia.edu|
21230992|NCT04524689|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21230993|NCT00607815|Cincinnati VA Medical Center|Dr. Kathleen M. Chard|859-572-6741|Kathleen.Chard@va.gov|
21230994|NCT04487730|Weill Cornell Medicine|Dr. Nili Solomonov|212-746-5886|nis2051@med.cornell.edu|
21230995|NCT00907777|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21230996|NCT03875885|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-713-0677|radellin@wakehealth.edu|
21230997|NCT03364023|Medtronic Neurovascular Clinical Affairs|Medtronic Neurovascular Clinical Affairs|9498373700|rs.nvclinicalprospr-sea@medtronic.com|
21230998|NCT00903396|Mayo Clinic|Michele Halyard, M.D.|4803014567|mhalyard@mayo.edu|
21230999|NCT03444961|Cleveland Clinic|Dr. Aleksandra Rachitskaya|216-445-9519|rachita@ccf.org|
21231000|NCT01304316|University of Pennsylvania|Dr. Elliot V. Hersh|215-898-9686|evhersh@pobox.upenn.edu|
21289511|NCT02030418|Abbott Cardiac Rhythm Management|Nicole Harbert, Director Clinical Research|972-526-4841|nicole.harbert@abbott.com|
21289512|NCT03034928|Alcon, A Novartis Division|Sr CDMA Project Lead, GCRA - Vision Care|1-888-451-3937|Alcon.medinfo@alcon.com|
21289513|NCT01835756|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com|
21231001|NCT02820753|Northwestern University|Stephanie Batio|312-503-4684|stephanie.batio@northwestern.edu|
21231002|NCT01397084|AstraZeneca|James Armbrust||aztrial_results_posting@astrazeneca.com|
21231003|NCT04617509|Gesynta Pharma AB|Charlotte Edenius|+46733864246|charlotte.edenius@gesynta.se|
21231004|NCT02155608|University of California, Los Angeles|James McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu|
21231005|NCT00684593|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21231006|NCT01751867|Janssen R&D US|SR DIR COMPD DEV TM LDR|1 908 704-5197||
21231007|NCT04932096|Oregon Health & Science University|Dr. Cydni Williams|5034945522|willicyd@ohsu.edu|
21231008|NCT01396148|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21231009|NCT01089062|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
21231010|NCT00224042|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
21231011|NCT00840450|NYU Cancer Institute|Franco Muggia, MD|212-263-6485|franco.muggia@nyumc.org|
21231012|NCT02577510|CF|Gaurav Gupta|6139451601|gaurav00gupta@gmail.com|
21231013|NCT03052725|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21231014|NCT04592874|Alector|Alector Medical Information|650-826-2454|medinfo@alector.com|
21231015|NCT01976338|Novartis|Study Director|862-778-8300||
21231016|NCT04213079|Icahn School of Medicine at Mount Sinai|Sergei Yakushin|212-241-9349|sergei.yakushin@mssm.edu|
21231017|NCT00844714|University of California, San Francisco|Priscilla Hsue, MD|415-206-8257|phsue@medsfgh.ucsf.edu|
21231018|NCT00520936|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21231019|NCT00975650|Acerus Pharmaceuticals Corporation|Dr. Nathan Bryson, Vice President, Scientific Affairs|1-416-679-0776|nbryson@aceruspharma.com|
21231020|NCT02010840|The Hog Kong Polytechnic University|Vivian Ngai|2766|vivian.ngai@polyu.edu.hk|6775
21231021|NCT01061177|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registry@novartis.com|
21231022|NCT03984994|University of Maryland|Dr. Steven J. Prior|301-405-2483|sprior@umd.edu|
21231023|NCT03010176|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21231024|NCT04220866|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21231025|NCT01903187|St. Jude Medical, Inc.|Steven Madej|651-756-2230|smadej@sjm.com|
21231026|NCT03739593|Aerie Pharmaceuticals, Inc|Kevin Kerr, Director of Clinical Development|(949) 526-8701|kkerr@aeriepharma.com|
21231027|NCT03897465|Lohmann & Rauscher GmbH & Co. KG|Dr Daria Trofimenko, Senior Manager Clinical Regulatory Affairs|+49 (0) 2631 99 6385|Daria.Trofimenko@de.LRMed.com|
21231028|NCT00521014|Memorial Sloan Kettering Cancer Center|Dr. Craig Moskowitz|212-639-7992|moskowic@mskcc.org|
21231029|NCT02864498|DS Biopharma|Study Director|+353 1 2933590|regulatory.dsbiopharma@DSBiopharma.com|
21231030|NCT02019693|National Cancer Institute|Dr. Ramaprasad Srinivasan|240-760-6251|ramasrin@mail.nih.gov|
21231031|NCT03132220|University of Colorado School of Medicine|Dr. Meredith Mealer|303-724-6857|Meredith.Mealer@cuanschutz.edu|
21231032|NCT00601458|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21231033|NCT00370032|GlaxoSmithKline|GSK Response Center|866-435-7343||
21231034|NCT00518986|Cephalon, Inc.|Medical monitor|1-800-896-5855||
21231035|NCT00968513|Stanford University|Judith Prochaska|6507243608|jodi.prochaska@stanford.edu|
21231036|NCT01328431|Yale University|Steven L. Bernstein, MD|203-737-3574|steven.bernstein@yale.edu|
21231037|NCT00018031|NIAID/NIH|Dr. Shyam Kottilil|301-435-036|skottilil@niaid.nih.gov|
21231038|NCT03292562|The University of Texas Health Science Center at Houston|Amir Khan, MD|713-500-5519|Amir.M.Khan@uth.tmc.edu|
21231039|NCT05466682|NYU Langone Health|Mia T Minen, MD|212-263-7744|mia.minen@nyulangone.org|
21231040|NCT02801396|Johnson & Johnson Vision|Meredith Bishop, OD, MS, FAAO|904-443-1396|MBishop4@its.jnj.com|
21231041|NCT03208244|Massachusetts General Hospital|Raymond Chung, MD|617-724-7562|Chung.Raymond@mgh.harvard.edu|
21277905|NCT01340768|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21277906|NCT02878486|University of Kansas|Amber Watts, PhD|785-864-2604|amberwatts@ku.edu|
21277907|NCT03052959|Unity Health Toronto|Dr. Aisha Lofters|4163236400|aisha.lofters@utoronto.ca|3832
21277908|NCT01524679|IZKS of the University Medical Center of the Johannes Gutenberg University Mainz|Christian Ruckes|+49 6131 17|ruckes@izks-mainz.de|9919
21277909|NCT03801265|University of Pittsburgh|Sharad Khetarpal, MD|4126235020|khetarpalsk@upmc.edu|
21277910|NCT03321630|NYU Langone Health|Paul Oberstein|2127316120|paul.oberstein@nyulangone.org|
21277911|NCT02149108|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21277912|NCT02325518|Alcon, A Novartis Division|Novartis Pharma KK|1-888-451-3937|alcon.medinfo@alcon.com|
21277913|NCT00987389|McMaster University, Hamilton, Ontario|Dr. Michael Walsh|905-522-1155|lastwalsh1975@gmail.com|34055
21277914|NCT01342107|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
21277915|NCT00289536|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21277916|NCT01830205|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21277917|NCT03246126|NYU Langone Health|Thomas Maldonado|212-263-7311|Thomas.Maldonado@nyulangone.org|
21277918|NCT02468570|BioMarin Pharmaceutical Inc.|Karen Gu/Director, BioStatistics|650-829-4017|kgu@bmrn.com|
21277919|NCT04465630|SIght Sciences, Inc|Kavita Dhamdhere, MD|877-266-1144|kdhamdhere@sightsciences.com|
21277920|NCT02356003|University of Calgary|Frank MacMaster|403-955-2784|fmacmast@ucalgary.ca|
21277921|NCT01912274|Helsinn HealthcareSA|Edwin de Wit - Head of Clinical development|+ 41 919852121|info-HHC@helsinn.com|
21277922|NCT01684436|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21231042|NCT01805154|Abbott|Clay Cohorn, Clinical Program Director|972-309-8087|clay.cohorn@abbott.com|
21277923|NCT05297578|Vaxcyte|Vice President of Clinical Development|650-585-0029|clinicaltrialsgov@vaxcyte.com|
21231043|NCT00255125|Kansas City VA Medical Center|Dr. Peter Van Veldhuizen|816-861-4700|peter.vanveldhuizen@va.gov|
21231044|NCT02051686|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu|
21231045|NCT00335478|OHSU Knight Cancer Institute|Joseph Bubalo, PharmD, BCPS, BCOP|503-494-1080|bubaloj@ohsu.edu|
21231046|NCT04967443|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21231047|NCT02405780|Fujifilm Kyowa Kirin Biologics Co., Ltd., EU Branch|Clinical Trial Information|0044 1896 668 173|Clinical-Trials@fk-b.com|
21231048|NCT01654536|Sunovion|Respiratory Medical Director|1-866-503-6351||
21231049|NCT00668707|The Centre for Health Innovation|Mark Legacy, Clinical Trial Coordinator|613-792-1222|mlegacy@thechi.ca|1
21231050|NCT04502693|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
21231051|NCT03943147|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21231052|NCT00418457|Cleveland Clinic|Daniel Sessler, MD|216-444-4900|sessled@ccf.org|
21231053|NCT00968201|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21231054|NCT00363883|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
21231055|NCT01382212|AbbVie|Global Medical Information|800-633-9110||
21231056|NCT02657915|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
21231057|NCT00701675|Ralp H. Johnson VA Medical Center|Olga Brawman-Mintzer, MD|8437242302|mintzero@musc.edu|2834
21231058|NCT05853185|Liaquat University of Medical and Health Sciences|Dr. Sarang Suresh|03154044802|hotchandanisarang@gmail.com|
21231059|NCT01949506|Froedtert and the Medical college of Wisconsin|Meena Bedi, MD|414-805-4400|mbedi@mcw.edu|
21231060|NCT02513394|Dana-Farber Cancer Institute|Erica L. Mayer, MD, MPH|617-632-3800|emayer@partners.org|
21231061|NCT05231954|Indiana University|Katrina Coppedge|317-278-1602|kcoppedg@iu.edu|
21231062|NCT05947643|Washington University, Department of Otolaryngology - Head and Neck Surgery|Dorina Kallogjeri, Assoc.Professor of Otolaryngology|314-362-1077|kallgjerid@wustl.edu|
21231063|NCT01354977|Albert Einstein College of Medicine|Dr. Meredith Hawkins|7184302903|meredith.hawkins@einstein.yu.edu|2903
21231064|NCT00612690|University of Illinois at Chicago|Marc S. Atkins, Ph.D.|312-413-1048|atkins@uic.edu|
21231065|NCT01664533|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21277924|NCT01169532|Fox Chase Cancer Center|Elizabeth Plimack|215-728-3889|Elizabeth.Plimack@fccc.edu|
21277925|NCT01775865|University of Iowa|Gary Pierce|319-335-9487|gary-pierce@uiowa.edu|
21277926|NCT01156142|Mayo Clinic|Robert C. Miller, M.D.|507/266-6247|Miller.Robert@mayo.edu|
21277927|NCT02643355|Hennepin Healthcare|Dr. Marc Martel|612-873-7448|Edresearch@hcmed.org|
21277928|NCT02666352|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21277929|NCT02701413|Northwestern University|Dr. Christina Lewicky-Gaupp|312-472-3874|christina.lewickygaupp@nm.org|
21277930|NCT00985712|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21277931|NCT01875471|Johnson & Johnson Vision Care|Daria Wicks|1 904 443-1391|RA-VISUS-ClnclStds@its.jnj.com|
21277932|NCT00257920|Abbott|Medical Information Specialist|1-800-633-9110||
21277933|NCT00888459|Mayo Clinic|Jon O. Ebbert|507-266-1944|ebbert.jon@mayo.edu|
21277934|NCT04764630|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.Strauss@fda.hhs.gov|
21277935|NCT01346774|University of Michigan|Betsy Foxman, Hunein F. and Hilda Maassab Professor of Epidemiology|734-764-5487|bfoxman@umich.edu|
21277936|NCT03322384|University of California, Davis|Analyst|9167348053|nlogihara@ucdavis.edu|
21277937|NCT03736213|New York University|Dr. Tara McAllister|212-992-9445|tkm214@nyu.edu|
21277938|NCT00448136|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21277939|NCT02287493|University Medical Center Hamburg-Eppendorf|Dr. Christina König|+49 040 7410 -0|ch.koenig@uke.de|
21277940|NCT03407430|University of North Carolina Medical Center|Dr. Benyam Muluneh|919-966-3213|benyam.muluneh@unchealth.unc.edu|
21277941|NCT00922987|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21277942|NCT01319773|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21277943|NCT05882279|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21277944|NCT01334710|Emory University|Dr. Bassel El-Rayes|404-778-1900|belraye@emory.edu|
21277945|NCT03083821|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21277946|NCT00586482|Mayo Clinic|David O. Warner, MD|507-255-4288|warner.david@mayo.edu|
21277947|NCT02470390|Depomed|Clinical Operations|510-744-8000|clinicaltrials@depomed.com|
21277948|NCT02766374|Rutgers - Robert Wood Johnson Medical School|Paul M. Lehrer, PhD|(732) 235-4413|lehrer@rutgers.edu|
21277949|NCT02440022|Becton Dickinson (BD)|Heidi Ronhovde|480-597-8579|Heidi.Ronhovde@bd.com|
21277950|NCT03758404|MeiraGTx|Program Manager|020 3866 4320|CNGA3@meiragtx.com|
21277951|NCT00678041|University of Pittsburgh, UPP13 WH Uro Gynecology - Cor|Gary Sutkin, MD|412--641-1440|gsutkin@mail.magee.edu|
21277952|NCT02358343|Center for Biomedical Statistics, University of Washington|Tessa Rue, Biostatistician|206-543-4246|ruet@uw.edu|
21277953|NCT00577395|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
21277954|NCT03716076|BC Women's Hospital|Dr. Anthony Chau|604-875-2158|anton.chau@ubc.ca|
21277955|NCT02135653|University of Pennsylvania|Dr. Neha Vapiwala|(215) 662-2337|Neha.Vapiwala@pennmedicine.upenn.edu|
21277956|NCT01276301|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21277957|NCT01700049|Mayo Clinic|Dr. Scott Fosko|904-953-2303|fosko.scott@mayo.edu|
21277958|NCT01404078|St John's Research Institute|Dr. Alben Sigamani|+918049467080|alben@sjri.res.in|
21277959|NCT03084367|Philips (Volcano)|Becky Inderbitzen, Global Director, Clinical Development|+1.858.764.1336|becky.inderbitzen@philips.com|
21277960|NCT01206101|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21277961|NCT00569530|University of California, San Francisco|Roberta R. Keller, MD|415-514-3192|roberta.keller@ucsf.edu|
21277962|NCT02358135|Keck School of Medicine of University of Southern California|April W. Armstrong, MD, MPH; Associate Dean of Clinical Research|323-865-3871|april.armstrong@med.usc.edu|
21277963|NCT00971841|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21277964|NCT03537274|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21277965|NCT00967044|University of Texas MD Anderson Cancer Center|Yasuhiro Oki, MD / Assistant Professor, Lymphoma/Myeloma|713-792-2860|CR_Study_Registration@mdanderson.org|
21277966|NCT00450619|National Cancer Institute, National Institutes of Health|Dr. James Gulley, M.D.|301-435-2956|gulleyj@mail.nih.gov|
21277967|NCT03254602|Guided Therapy Systems|Rich Amodei, RDMS|480-649-8587|r.amodei@guidedtherapy.com|
21277968|NCT03309007|UNewMexico|MArk Burge|5052724658|mburge@salud.unm.edu|
21277969|NCT02963311|The Medicines Company|Frank Bosley, Vice-President, Regulatory Operaions|9732906016|frank.bosley@themedco.com|
21277970|NCT01691820|GlaxoSmithKline|GSK Response Center|866-435-7343|biliana.v.nestorova@gsk.com|
21277971|NCT03426566|Wroclaw Medical University|Dr Sutkowska Edyta|0048503077016|edytasutkowska@yahoo.com|
21277972|NCT04442490|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21289514|NCT02122952|AveXis, Inc.|Doug Feltner, MD|833-828-3947|medinfo@avexis.com|
21238915|NCT01986101|Sumitomo Dainippon Pharmaceutical|Clinical Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
21277973|NCT01284296|University of California, San Francisco|Ronald D. Miller|415 476-9034|millerr@anesthesia.ucsf.edu|
21289515|NCT02508207|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21277974|NCT05227300|Indiana University School of Dentistry|Dr. Kenneth Spolnik|317-274-7280|kspolnik@iu.edu|
21289516|NCT01659541|MetroHealth Medical Center|Anthony F. DiMarco, MD|216-778-3906|afd3@case.edu|
21289517|NCT03983109|Flat Medical Co., Ltd|LI YU LIN|+886 25672959|liyulin@flatmedical.com|16
21277975|NCT03161964|University of Utah|Dr. Anu Sharma|(801) 581-7761|Anu.Sharma@hsc.utah.edu|
21277976|NCT02038907|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
21277977|NCT02618408|Supernus|Gianpiera Ceresoli-Borroni, PhD, Director of Clinical Research|301-838-2521|gceresoliborroni@supernus.com|
21277978|NCT01155024|The Ohio Willow Wood Company|Applied Research Engineer|740-869-3377|mariag@owwco.com|
21277979|NCT02713386|NRG Oncology|Christopher Purdy on behalf of Michael Sill, PhD|716-845-1300|purdyc@nrgoncology.org|2296
21277980|NCT02122406|University of Pavia|Vittorio Grosso MD|+393332605945|vittorio.grosso@gmail.com|
21277981|NCT00415194|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21277982|NCT01297465|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21277983|NCT00969540|Hologenix, LLC|Seth Casden|310-600-3673|seth.casden@celiant.com|
21277984|NCT01646138|National Institute of Allergy and Infectious Diseases|Matthew J. Memoli|+1 301 443 5971|memolim@niaid.nih.gov|
21277985|NCT01683838|Acorda Therapeutics, Inc.|Chief Scientific Officer|914-347-4300|ablight@acorda.com|5102
21277986|NCT04049617|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21277987|NCT00801099|Swiss Tropical Institute|Franziska Saxer, MD||franziskabrenneke@yahoo.com|
21277988|NCT04078126|AstraZeneca AB|AstraZeneca AB|877-240-9479|information.center@astrazeneca.com|1
21289518|NCT00887588|Novartis Pharmaceuticals|Study Director|862-778-8300||
21277989|NCT02455050|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21277990|NCT03402750|University of Miami|Brian McCabe|305-248-1530|bmccabe@miami.edu|
21231066|NCT04869644|Northwell Health|Joan Duer-Hefele, RN, MA|646-766-7153|jduerhefele@northwell.edu|
21231067|NCT00844831|University of Louisville|John M. Wo, MD|502-852-6991|johnwogi@gmail.com|
21231068|NCT05255068|The University of Iowa|Wen Liu|3193557104|wen-liu-1@uiowa.edu|
21231069|NCT00680862|VHA|Henry Anaya|310-478-3711|henry.anaya@va.gov|48488
21231070|NCT03156543|University of Michigan Medical School|Bethany Ruffino|734 615-0768|bruffino@med.umich.edu|
21231071|NCT02674529|University of Pittsburgh|Project Research Coordinator|412-376-3913|neppacham@upmc.edu|
21231072|NCT02891850|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21231073|NCT01651195|Helsinki University Central Hospital|Prof. Anne Pitkäranta|+358406430511|anne.pitkaranta@hus.fi|
21231074|NCT02129725|Vanderbilt University Medical Center|Nancy J. Brown, M.D.|615-343-8701|nancy.j.brown@vanderbilt.edu|
21231075|NCT02543437|Stryker Japan|Yasuyuki Inatsugu, Associate manager of clinical affairs|81 3 6894 8394|yasuyuki.inatsugu@stryker.com|
21231076|NCT02397278|Stanford University|Michael Fadell II|3037241111|mfadell@stanford.edu|
21277991|NCT02981303|HiberCell|Chief Medical Officer|651.675.0300|CMO@hibercell.com|
21277992|NCT01831765|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
21289519|NCT00762177|Colgate Palmolive Co.|William De Vizio|732-878-7901|William_Devizio@colpal.com|
21231077|NCT01758432|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
21231078|NCT02871297|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
21231079|NCT01509950|Stanford University|Research Operations Manager|6507255720|agirsen@stanford.edu|
21231080|NCT02966028|Sanifit|SVP Clinical Development Operations|18582815976|Claire.Padgett@sanifit.com|
21231081|NCT04115839|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21231082|NCT03808545|University of Alabama at Birmingham|Brooks Wingo, Associate Professor|2059345982|bcwingo@uab.edu|
21231083|NCT02161731|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21231084|NCT02381288|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21231085|NCT00790023|Sunovion|Respiratory Medical Director|1-866-503-6351||
21231086|NCT00573469|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
21231087|NCT01338792|USC Norris Comprehensive Cancer Center|Jacek Pinski, MD|323-865-3900|pinski_j@ccnt.usc.edu|
21231088|NCT00004978|Division of Biostatistics, University of Minnesota|James Neaton, PhD|612-626-9040|jim@ccbr.umn.edu|
21231089|NCT01044862|Yale University|Heping Zhang, PhD|203-785-5185|heping.zhang@yale.edu|
21231090|NCT01652703|Amgen Inc.|Study Director|866-572-6436||
21231091|NCT03719885|Penn Medicine|Research Coordinator|215-662-9393|jonathan.lilley@pennmedicine.upenn.edu|
21231092|NCT00062374|Memorial Sloan-Kettering Cancer Center|Dr. David P. Kelsen|646-888-4179|kelsend@mskcc.org|
21231093|NCT02151591|YALE UNIVERSITY SCHOOL OF MEDICINE|Dr. Lisa Fucito|203-200-1470|Lisa.fucito@yale.edu|
21231094|NCT03644212|Maimonides Medical Center|Sara Meeder|7182837253|smeeder@maimonidesmed.org|
21231095|NCT03555591|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21231096|NCT03633695|AcuFocus, Inc.|Magda Michna, PhD., Chief Global Clinical, Medical and Regulatory Affairs Officer|(949) 585-9511|mmichna@acufocus.com|
21231097|NCT01532414|Repros Therapeutics Inc.|Jennifer L Wike, Director of Regulatory Affairs|281-719-3402|jwike@reprosrx.com|
21231098|NCT00869349|Brigham and Women's Hospital|Nancy A. Shadick|617-732-5266|nshadick@partners.org|
21231099|NCT02728050|University of Washington|Anna Halpern, MD|206-606-1978|halpern2@uw.edu|
21231100|NCT02380677|NewLink Genetics Corporation|Manager, Clinical Operations|515-598-5020|csmith@linkp.com|2624
21231101|NCT05426902|Duke University|Amanda Eudy, MSPH, Ph.D.|919-681-1811|amanda.eudy@duke.edu|
21231102|NCT02584673|The Cooper Health System|Irwin Gratz|856-968-8527|gratz-irwin@cooperhealth.edu|
21231103|NCT02599129|Icahn School of Medicine at Mount Sinai|Dr. Mark Lebwohl|2122413288|giselle.singer@mssm.edu|
21231104|NCT00617773|Recepta Biopharma|Dr. Oren Smaletz, M.D., Medical Director|55 11 3709-2140|oren.smaletz@receptabiopharma.com.br|
21231105|NCT01029795|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21231106|NCT01342796|Novartis Vaccines and Diagnostics|Posting Director||Novartis.email@novartis.com|
21231107|NCT03217175|MGH Diabetes Research Center|Courtney Balliro, BS, RN, CDE|617-726-1242|cballiro@partners.org|
21231108|NCT01223001|The Rehabilitation Hospital of Indiana|Dr. Lance Trexler|(317)879-8940|lance.trexler@rhin.com|
21231109|NCT01896544|Massachusetts General hospital|Tiffany M.N. Otero|4074950753|totero@partners.org|
21231110|NCT00036738|Fred Hutchinson Cancer Research Center|Dr. George Georges|206-667-6886|ggeorges@fredhutch.org|
21231111|NCT05526716|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClincalTrialsDisclosure@msd.com|
21231112|NCT03487276|InflaRx N.V.|Dr. Korinna Pilz, MD, MSc|+49 89 414 189 78 00|Korinna.Pilz@InflaRx.de|
21231113|NCT01354990|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21231114|NCT04182763|Oregon Health & Science University|Allison Gregory, MS CGC, Project Manager|503-494-4344|gregorya@ohsu.edu|
21231115|NCT03616600|Hong Kong Polytechnic University|Dr. Henry Chan|+85227667937|henryhl.chan@polyu.edu.hk|
21231116|NCT03210376|UT MD Anderson Cancer Center|Dr. Wendell H. Williams III / Anesthesiology & Perioperative Medicine|713-563-0034|WHWilliams@mdanderson.org|
21231117|NCT03858309|Oregon Health & Science University (OHSU)|Selda Yildiz, PhD|(503) 494-7219|yildiz@ohsu.edu|
21231118|NCT02535312|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
21231119|NCT00730132|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21231120|NCT02423993|Endocrinology Research Centre, Moscow|Dr. Lyudmila Ibragimova|+7 9266180811|doc_mila@mail.ru|
21231121|NCT02002091|Algiers' university -1- Benyoucef Benkhedda, Faculty of Medicine Meherzi, Algiers.|Dr Wafia- Nadia Nibouche-Hattab|+213771810932|wani16000@yahoo.fr|
21231122|NCT02856035|Department of Veterans Affairs, N Fl/S Georgia VA Medical Center|Dr. Janis J Daly|216 402 8940|jjd17@case.edu|
21231123|NCT02846714|Huntsman Cancer Institute University of Utah|Dr. Yelena Wu|8012135653|yelena.wu@utah.edu|
21231124|NCT02467075|University of Michigan, Department of Radiology|Matthew Davenport, MD|734-232-2095|matdaven@med.umich.edu|
21231125|NCT03685968|The University of Texas Health Science Center at Houston (UTHealth)|Elizabeth M. Gendel|+1 (713) 500-3587|Elizabeth.M.Gendel@uth.tmc.edu|
21231126|NCT00390468|UT MD Anderson Cancer Center|Quality Assurance Specialist|713-792-2830|caperez@mdanderson.org|
21231127|NCT02267083|Gem Pharmaceuticals, LLC|Elizabeth Moore, Regulatory Affairs Agent|8583532019|elizabethmoore109@comcast.net|
21231128|NCT03736447|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
21231129|NCT02619175|Loewenstein Rehabilitation Hospital|Mrs. Shirley Handelzalts|972-9-7709010|peregshir@gmail.com|
21231130|NCT01434030|University of Virginia|Boris P Kovatchev, Ph.D.|434-924-5592|bpk2u@virginia.edu|
21231131|NCT02695329|Zimmer Biomet G.K.|Clinical Affairs Senior Manager|+81-6402-6777|takahito.nakai@zimmerbiomet.com|
21231132|NCT00393029|National Cancer Institute (NCI), National Institutes of Health (NIH)|Steven Rosenberg, M.D., Ph.D.|301-496-4164|Steven.Rosenberg@nih.gov|
21231133|NCT00382252|Institut Bergonie|Dr Françoise Bonichon||F.Bonichon@bordeaux.unicancer.fr|
21231134|NCT01600638|Zeltiq Aesthetics|Kerrie Jiang, Executive Director Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
21231135|NCT03338998|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21231136|NCT00039130|Duke University Medical Center|David Rizzieri, M.D.||rizzi003@dm.duke.edu|
21231137|NCT02612727|Minnesota Medical Research Foundation (now Hennepin Healthcare) and University of Minnesota|Tina M. Slusher|612-624-4586|tslusher@umn.edu|
21231138|NCT01063868|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
21231139|NCT03199274|Thomas Jefferson University|John Eisenbrey, PhD|(215) 503-5188|john.eisenbrey@jefferson.edu|
21231140|NCT05766423|Northwestern University|Research Assistant Professor|312-503-0274|allison.pack@northwestern.edu|
21231141|NCT00540514|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21231142|NCT00638378|Incyte Corporation|Study Director|1-855-463-3463||
21231143|NCT03291808|Johns Hopkins University|Gem Roy|4432875796|groy2@jhu.edu|
21231144|NCT02417974|Boston Medical Center and BU School of Medicine|Alan Moss, MD, PhD|617-638-6116|alan.moss@bmc.org|
21231145|NCT01892293|Adaptimmune|Clinical Trials Management||clinicaltrials@adaptimmune.com|
21231146|NCT04988646|Pharma Metric Labs, Indonesia|Pharma Metric Labs|+62 21 4265310|nabila.sutanto@pharmametriclabs.com|
21231147|NCT03602482|Pennsylvania State University College of Medicine|Dr. Amanda J. Miller|7175317676|aross1@pennstatehealth.psu.edu|
21231148|NCT02114814|The Ohio State University|Dr. Jie Hu|6146880394|hu.1348@osu.edu|
21231149|NCT02601469|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
21231150|NCT00618072|New York Medical College|Harriette R. Mogul MD MPH|914-594-2278|Harriette_Mogul@NYMC.edu|
21231151|NCT02552199|Botanix Pharmaceuticals|Anthony Robinson MS CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
21231152|NCT05035550|Michigan State University|Dr. Jason Moser|517-355-2159|jmoser@msu.edu|
21277993|NCT01772758|Augusta University|Ryan Harris, Ph.D.|706-721-5998|ryharris@augusta.edu|
21277994|NCT04561375|Cleveland Clinic|Dr. Daniel Sessler|2168702620|ds@ccf.org|
21277995|NCT00706511|University of Chicago|Eve Van Cauter, PhD|773-702-0169|evcauter@bsd.uchicago.edu|
21277996|NCT01025271|University of Pittsburgh|Karin Byers, MD|412-648-6553|dlp5@pitt.edu|
21289520|NCT05877586|Duke University|Cristina C. Hendrix, DNS, GNP, FAAN|919-684-9358|cristina.hendrix@duke.edu|
21289521|NCT04210375|Salubris Biotherapeutics, Inc|SVP, Clinical Development|16176459160|amanda.mcewen@salubrisbio.com|
21289522|NCT05752487|Biosense Webster, Inc.|Director Medical Affairs|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21289523|NCT03585543|Medical University of South Carolina College of Nursing|Shannon Phillips, PhD, RN, Associate Professor|843-792-9379|phillipss@musc.edu|
21289524|NCT04124965|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21231153|NCT00429273|University of California, Los Angeles|James T. McCracken, M.D.|310-825-0470|jmccracken@mednet.ucla.edu|
21231154|NCT01438957|Pfizer|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21289525|NCT02184156|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
21231155|NCT00144963|Talon Therapeutics|VP, Regulatory Affairs|650-228-5066|ttarlow@talontx.com|
21231156|NCT00617123|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21231157|NCT00461045|Triphase Accelerator|Associate Director of Clinical and Regulatory Operations|858-295-4337|jennifer.ki@triphaseco.com|
21231158|NCT03809117|George Washington University|Dr. Andrew Meltzer|202-741-2952|ameltzer@mfa.gwu.edu|
21231159|NCT00777608|Merck Sharp and Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21231160|NCT01448486|St. Vincent's Hospital, Sydney|Prof. Bruce Brew|61 2 8382 1111|b.brew@unsw.edu.au|4100
21231161|NCT02853604|Advaxis, Inc.|Surya Vangala|609-423-2528|vangala@advaxis.com|
21231162|NCT00727025|Dartmouth-Hitchcock|Dr. Carolyn Kerrigan|603 650-5148|carolyn.l.kerrigan@hitchcock.org|
21231163|NCT04251169|SOLTI|Sara Cano|34 664 449 862|info@gruposolti.org|
21231164|NCT01539538|AcelRx|Pamela Palmer|650-216-3500|ppalmer@acelrx.com|
21231165|NCT00847379|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
21231166|NCT00378378|Merck, Sharp & Dohme Corp.|Senior Vice Presiden, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21231167|NCT02713347|VA|Dr. David Bekelman|7207236388|david.bekelman@va.gov|
21231168|NCT03250845|UZ Leuven|Datamanager|+3216346880|jonas.vanham@uzleuven.be|
21231169|NCT03822078|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21231170|NCT05973981|RAND|William Shadel|412-683-2300|shadel@rand.org|4489
21231171|NCT00982878|Imperial College London|Professor Alan Winston|+44 (0)20 3312 1603|a.winston@imperial.ac.uk|
21231172|NCT01854710|Alexza Pharmaceuticals, Inc|Chief Scientific Officer|650.944.7777|jcassella@alexza.com|
21231173|NCT03722966|The University of Oklahoma Health Sciences Center|Dr. Darla Kendzor|(405) 271-8001|Darla-Kendzor@ouhsc.edu|
21277997|NCT04645264|Rush University Medical Center|Kern Singh, MD|(312) 432-2435|kern.singh@rushortho.com|
21277998|NCT02116608|University of Colorado Denver|Jeremy Prager, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
21277999|NCT00988442|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 6283313|ACTGCT.Gov@s-3.com|
21278000|NCT02623348|University of California, San Francisco|Anoop Sheshadri|415-221-4810|anoop.sheshadri@ucsf.edu|22576
21278001|NCT04620135|Aerie Pharmaceuticals Inc.|Michelle Senchyna, PhD. VP, Clinical Development and Medical Affairs|+1 908-947-3551|msenchyna@aeriepharma.com|
21278002|NCT04740320|Imperial College London|Clinical Project Manager|+442083831284|polly.fox@imperial.ac.uk|
21278003|NCT02272634|Yungjin Pharm. Co., Ltd.|Director of Clinical Trials|82-2-2041-8318|mhlee2017@yungjin.co.kr|
21278004|NCT04647721|Merz Aesthetics|Public Disclosure Manager|+49 69 1503 1|Aesthetic.Trials@merz.com|
21278005|NCT04380090|Cleveland Clinic Lutheran Hospital|Kathleen Gonzalez|2162174226|gonzalk2@ccf.org|
21278006|NCT01974440|Janssen Research & Development, LLC|Executive Medial Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21278007|NCT00762437|AbbVie|Sally Hallas, RN|209-294-5571|sally.hallas@abbvie.com|
21231174|NCT01336764|National Center for PTSD|Steven H. Woodward, PhD|650-493-5000|steve.woodward@va.gov|22111
21231175|NCT01626391|TauRx Therapeutics Ltd|Dr. Jiri Hardlund|+44 (0)1224438550|JHH@taurx.com|
21289526|NCT00759096|Alcon Research, Ltd.|Benny Li, PhD|+86 21 6375 8762|Benny.Li@Alconlabs.com|
21278008|NCT04771403|Oregon Health and Science University|Jessica Castle|503-494-7072|castleje@ohsu.edu|
21278009|NCT00857259|Novartis Pharmaceuticals|Study Director|862-778-8300||
21278010|NCT02138136|Mallinckrodt Pharmaceuticals|Clinical Team Leader|800-556-3314|clinicaltrials@mnk.com|
21278011|NCT00535587|Oregon Health & Science University|Kim Dupree Jones|503 494 3837|joneskim@ohsu.edu|
21278012|NCT01660334|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21278013|NCT00988065|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21278014|NCT00725751|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21278015|NCT01640873|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21278016|NCT02749292|Massachusetts General Hospital- Vasculitis and Glomerulonephritis Center|John L Niles|617-726-4132|JLNILES@mgh.harvard.edu|
21278017|NCT02458092|US Army Medical Research Unit - Kenya|Nekoye Otsyula|254-722-239-828|notsyula@wrp-ksm.org|
21278018|NCT00876018|GlaxoSmithKline|GSK Response Center|866-435-7343||
21278019|NCT00016718|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
21278020|NCT00456495|The New York Eye Cancer Center|Clinic Coordinator|212-832-8170|kchin@eyecancer.com|
21278021|NCT01301508|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21278022|NCT01300923|Cincinnati Childrens Hospital|Craig Erickson|5136366265|craig.erickson@cchmc.org|
21278023|NCT03329079|University of Nebraska Medical Center|Kevin Kupzyk|402-552-7262|kkupzyk@unmc.edu|
21278024|NCT02707861|TaiMed Biologics USA Corp.|Manager - Clinical Operations|713-478-2927|bbell@taimedbio.com|
21278025|NCT01940497|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21278026|NCT03123861|University of North Carolina at Chapel Hill|Jennifer Wu, MD, MPH, Professor of OBGYN|919-966-0014|jennifer_wu@med.unc.edu|
21278027|NCT02494102|Penn State Health Milton S. Hershey Medical Center|Zyad J. Carr, M.D., FASA|717-531-8521|zcarr@pennstatehealth.psu.edu|
21278028|NCT00369382|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21278029|NCT03110601|Stimgenics|VP of Clinical Affairs|309-662-4321|clinicalSG@stimgenics.com|217
21278030|NCT01565616|Emory University|Lakshmanan Krishnamurti, MD||lakshmanan.krishnamurti@emory.edu|
21278031|NCT05742347|Medline Industries, LP|Julie J. Finley|(800) 33-5463|jjfinely@medline.com|
21278032|NCT04221789|IECS|Dr Fernando Rubinstein|01147778767|frubinstein@iecs.org.ar|
21278033|NCT01670487|Cleveland Clinic|Dr. Sharon Mace|216-445-4598|maces@ccf.org|
21278034|NCT04018664|Trevi Therapeutics|Thomas Sciascia, MD|203-304-2499|thomas.sciascia@trevitherapeutics.com|
21278035|NCT06218823|University of Wisconsin Center for Tobacco Research and Intervention|Associate Director of Research|6082628673|demccarthy@ctri.wisc.edu|
21278036|NCT06077487|University of California, San Francisco|Dr. Brian Anderson|(415) 476-1000|Brian.Anderson@ucsf.edu|
21278037|NCT05101486|Janssen Vaccines & Prevention B.V.|Director Biomarkers Viral Vaccines|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21278038|NCT02788045|Janssen Vaccines & Prevention B.V|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21278039|NCT04394351|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21278040|NCT00144781|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
21278041|NCT02068092|Houston Methodist Neal Cancer Center|Jenny Chang|713.790.3333|ccresearch@houstonmethodist.org|
21278042|NCT03696953|Marquette University, College of Nursing|Dr. Lisa Hanson|1-414-288-3841|lisa.hanson@marquette.edu|
21278043|NCT03502707|Janssen Vaccines & Prevention B.V.|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21278044|NCT00461253|Center for Epidemiology and Health Research, Germany|Dr. Jürgen Dinger|0049 (0) 30 945 101 20|dinger@zeg-berlin.de|
21278045|NCT01933113|Allegheny Health Network|Donald Whiting, MD|412-359-6200|donald.whiting@ahn.org|
21278046|NCT02297438|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21278047|NCT03107026|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
21278048|NCT00062010|ECOG Statistical Office|Study Statistician|617-632-3012||
21278049|NCT00852969|Tufts Medical Center|Mark Sarnak, MD|617 636-1182|msarnak@tuftsmedicalcenter.org|
21278050|NCT00807248|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
21278051|NCT00679926|Oklahoma State University Center for Health Sciences|Johnny Stephens|918-382-3527|johnny.stephens@okstate.edu|
21231176|NCT05683249|Neurocentria Inc.|Clinical Development|925-954-4868|info@neurocentria.com|
21231177|NCT01930123|Duke University|Brian J. Soher, Ph.D.|919-684-7350|brian.soher@duke.edu|
21231178|NCT02446483|GlaxoSmithKline|GSK Response Center|866-435-7343||
21231179|NCT02899793|Yale University School of Medicine|Dr. Alessandro Santin|203-737-4450|alessandro.santin@yale.edu|
21231180|NCT03310021|Portola Pharmaceuticals|Head of Clinical Development|6502767153|ClinicalTrials@Portola.com|
21289527|NCT01214720|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21289528|NCT05591755|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
21289529|NCT03694652|University of New Mexico|Dr. Tracie Collins|505-272-4979|tccollins@salud.unm.edu|
21289530|NCT03158311|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21289531|NCT00314106|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
21289532|NCT01033071|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21289533|NCT03651609|Institute of Clinical Neurophysiology, Division of Neurology, University Medical Centre Ljubljana, Slovenia|Gregor|+38631226546|gregor.omejec@kclj.si|
21289534|NCT03315689|Aclaris Therapeutics, Inc.|Marco Cardillo, Clinical Trial Manager|484-540-6299|mcardillo@aclaristx.com|
21289535|NCT01348698|National Cancer Institute|Dr. Naris Nilubol|301-451-2355|niluboln@nih.gov|
21289536|NCT01297244|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|857-400-0101|Clinical@aveooncology.com|
21289537|NCT02595749|USC Dept. of Preventive Medicine|Matthew Kirkpatrick|3234428221|mgkirkpa@usc.edu|
21289538|NCT00669331|Pharmaxis Ltd|Dr Brett Charlton, Medical Director|+61 2 94547210|brett.charlton@pharmaxis.com.au|
21278052|NCT03576183|Valneva Austria GmbH|Head Global Medical Affairs|20620|info@valneva.com|0
21278053|NCT02518919|Children's Hospital of Michigan|Dr. Nirupama Kannikeswaran, Associate Professor of Pediatrics and Emergency Medicine|313-745-5260|nkannike@dmc.org|
21278054|NCT04498403|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21278055|NCT01951885|Case Comprehensive Cancer Center|Betty Hamilton MD|866-223-8100|TaussigResearch@ccf.org|
21289539|NCT01454063|Omeros Corporation|Chief Medical Officer|(206) 676-5000|swhitaker@omeros.com|
21289540|NCT01562444|GlaxoSmithKline|GSK Response Center|866-435-7343||
21289541|NCT00546273|UTE. Fund. Inst. Germans Trias i Pujol|Cristina Vilaplana, MD|+34 93 497 86 81|cvilaplana@gmail.com|
21289542|NCT03387046|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21289543|NCT03558672|Tactile Medical|Director of Clinical Research|612.540.5267|astone@tactilemedical.com|
21289544|NCT00509600|UT MD Anderson Cancer Center|Robert J. Wells, MD / Professor|713-792-6620||
21289545|NCT01908842|University of Virginia|Dr. Erik Gunderson, MD, FASAM|(434) 202-8612|EWG2N@hscmail.mcc.virginia.edu|
21289546|NCT00038610|The University of Texas (UT) MD Anderson Cancer Center|Naval Daver, MD/Leukemia||CR_Study_Registration@mdanderson.org|
21278056|NCT03062228|Global Innovations for Reproductive Health & Life|Dr. Allan Kember, Director of Programs|+1-902-580-8385|allan.kember@mail.utoronto.ca|
21289547|NCT02550210|Dartmouth Hitchcock Medical Center|Dr. Richard J. Barth Jr.|(603) 650-9479|Richard.J.Barth.Jr@hitchcock.org|
21289548|NCT03794544|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21289549|NCT01027416|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21289550|NCT00421733|Abbott|Global Medical Services|800-633-9110||
21289551|NCT00875667|Celgene Corporationi|Anne McClain, Senior Manager, Clinical Trial Disclosure|8882601599|ClinicalTrialDisclosure@Celgene.com|
21289552|NCT00894647|Graceway Pharmaceuticals|Vice President Medical Affairs|267-948-0400|Sharon.levy@gracewaypharma.com|
21289553|NCT01967277|Capillus LLC|Patricia Schnoor|7868881874|pschnoor@capillus.com|
21289554|NCT03050489|First State Pavlov Medical University|Nikolay Bunenkov|+7-950-028-17-40|bunenkov2006@gmail.com|
21289555|NCT01676350|WellSpan York Hospital|Brent Becker|717-851-2223|bbecker2@wellspan.org|
21289556|NCT01524705|University of Washington|Jeffrey L Probstfield, MD|206-616-0292|jeffprob@uw.edu|
21289557|NCT00103506|Janssen R&D UK|Project Physician||ClinicalTrialDisclosure@its.jnj.com|
21289558|NCT00585585|University of Cincinnati|Erik Nelson, MD|513-558-5115|erik.nelson@uc.edu|
21289559|NCT03300336|HSRD ADAPT|S. Nicole Hastings|919-286-6936|susan.hastings@va.gov|
21289560|NCT02153827|University of St. Augustine|Eric Chaconas|904-826-0084|echaconas@usa.edu|1275
21289561|NCT01567020|VA Portland Health Care System|Dr. Frederick Gallun|5032208262|Frederick.Gallun@va.gov|57472
21289562|NCT00397930|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
21289563|NCT03676725|AlkaliDx|Lynn Feldman|16178791670|lynn@alkalidx.com|
21289564|NCT01579305|Allergan, Inc.|Medical Monitor|805 961 5000|devicetrials@allergan.com|
21289565|NCT00965094|Novartis Pharmaceuticals|Study Director|862-778-8300||
21278057|NCT02910674|Barbara Davis Center for Childhood Diabetes|Dr. Satish K. Garg|303.724.6713|satish.garg@ucdenver.edu|
21278058|NCT01687478|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21278059|NCT03188718|University of Colorado Denver|Michelle Sobremonte-King, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
21278060|NCT04322149|Eledon Pharmaceuticals|Laura Batterman|949-874-3487|lbatterman@eledon.com|
21278061|NCT03402555|Danone Asia Pacific Holdings|Digital Project Manager|82281172|jill.wong@danone.com|
21289566|NCT01433978|Eisai Call Center|Eisai Inc.|888-422-4743||
21289567|NCT01773889|The Cancer and Therapy Center at The University of Texas Health Science Center San Antonio|Tyler Curiel, MD|210-562-5287|CURIELT@UTHSCSA.EDU|
21289568|NCT03954938|University of Kentucky|William W. Stoops|8592575388|william.stoops@uky.edu|
21289569|NCT02565186|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21278062|NCT05339334|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21278063|NCT00368979|GlaxoSmithKline|GSK Response center|866-435-7343||
21278064|NCT00394524|Emory University|Guillermo Umpierrez, MD|404-778-1665|geumpie@emory.edu|
21278065|NCT01462318|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21278066|NCT02238626|MediciNova, Inc.|Director, Scientific Affairs|8583444535|makhay@medicinova.com|
21278067|NCT00270257|Fred Hutchinson Cancer Research Center|Senior Statistical Analyst|206-667-6167|geetha@scharp.org|
21278068|NCT00197392|Codman & Shurtleff, Inc|J. Thomas Megerian, MD|508.880.8274|jmegeri1@its.jnj.com|
21278069|NCT01195103|Mayo Clinic|John B Leslie MD|480-301-8000|leslie.john@mayo.edu|
21278070|NCT02920918|Virginia Commonwealth University|Salvatore Carbone|804 628 3980|scarbone@vcu.edu|
21278071|NCT01969448|Washington University School of Medicine|Marissa J. Tenebaum, M.D.|314-996-8800|tenenbaumm@wustl.edu|
21278072|NCT00974974|Impax Laboratories, Inc.|Michelle Landolfi, Director, Regulatory Affairs|510-240-6402|mlandolfi@impaxlabs.com|
21278073|NCT01959035|H. Lundbeck A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com|
21278074|NCT01911897|Vascular Dynamics|Director, Clinical Operations|9492317602|lgreen@vasculardynamics.com|
21278075|NCT00333879|Atlanta VA Rehab R&D Center|David Ross|404-321-6111|rosss0128@bellsouth.net|6817
21278076|NCT02227147|Dompé|Flavio Mantelli, MD, PhD|02 583831|info@dompe.com|
21278077|NCT00158600|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
21278078|NCT02181426|Medical University of South Carolina, Department of Anesthesia and Perioperative Medicine|Research Coordinator for Anesthesia and Perioperative Medicine|843-792-2322|joneswr@musc.edu|
21278079|NCT00622466|The University of Texas Southwestern Medical Center|Dr. Barbara Haley|214-648-4180|barbara.haley@utsouthwestern.edu|
21278080|NCT05183217|University of Wisconsin - Madison|Heidi Brown|619-695-4714|heidi.w.brown@kp.org|
21278081|NCT01593696|National Cancer Institute|Dr. Nirali N. Shah|240-760-6199|shahnn@nih.gov|
21278082|NCT01936623|Friends Research Institute|Robert Schwartz, M.D.|410-837-3977|rschwartz@friendsresearch.org|276
21278083|NCT00242619|Stanford University|Dr. Natalie Rasgon|(650) 724-6689|natalie.rasgon@stanford.edu|
21278084|NCT04941521|The University of Texas Health Science at Houston|Joy M Schmitz, PhD|713-486-2867|Joy.M.Schmitz@uth.tmc.edu|
21278085|NCT00369655|Mayo Clinic|Dr. Timothy Hobday|507-284-1159|hobday.timothy@mayo.edu|
21278086|NCT02669758|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
21278087|NCT00631449|University of California, San Francisco|Steven Deeks, MD|415-476-4082|Steven.Deeks@ucsf.edu|404
21278088|NCT03393806|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21278089|NCT02534844|Mandos, LLC|Executive Vice President, Regulatory Affairs|619-905-0489|jspinella@mandoshealth.com|
21278090|NCT00507130|MedImmune|Don Raible, MD|301-398-0000|raibleD@medimmune.com|
21278091|NCT01775852|Baylor College of Medicine|Lilian Dindo, PhD|713-791-1414|lilian.dindo@bcm.edu|10296
21278092|NCT00080938|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
21278093|NCT00117325|GlaxoSmithKline|GSK Response Center|866-435-7343||
21278094|NCT01359644|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Trials@bms.com|
21278095|NCT04795908|West Virginia University|Jessica Frey|304-598-6127|jessica.frey@hsc.wvu.edu|
21278096|NCT00311311|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21278097|NCT00546572|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21278098|NCT03979820|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21278099|NCT00536263|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21278100|NCT00548171|GlaxoSmithKline|GSK Response Center|866-435-7343||
21278101|NCT02327741|shiraz university of medical sciences|Professor|009836250352|kojurij@yahoo.com|
21278102|NCT02257541|Memorial Sloan Kettering Cancer Center|Dr. William Tap, MD|646-888-4163|tapw@mskcc.org|
21278103|NCT00621049|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21278104|NCT00686582|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
21278105|NCT00899470|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
21278106|NCT02989168|Global Blood Therapeutics|Nick Vlahakis|16508228756|nvlahakis@gbt.com|
21278107|NCT03456960|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21278108|NCT00532935|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21278109|NCT00502801|Janssen Scientific Affairs, LLC|Vice President, Data Generation|908 927-2943||
21278110|NCT02811263|University of California, San Francisco|Yvonne W. Wu, MD, MPH|(415) 353-2400|Yvonne.Wu@ucsf.edu|
21278111|NCT03935464|University of California San Francisco|Dr. Monica Gandhi|415 260 6709|monica.gandhi@ucsf.edu|
21278112|NCT05011123|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext: 6#|Contact-US@sanofi.com|
21278113|NCT03653507|Astellas Pharma Global Development, Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
21278114|NCT01288053|Northwestern University|Dr Richard Burt|312-695-4960|rburt@northwestern.edu|
21278115|NCT03188666|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21278116|NCT04092894|Beth Israel Deaconess Medical Center|Balachundhar Subramaniam|7814750572|bsubrama@bidmc.harvard.edu|
21289570|NCT00617903|Bayer|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21289571|NCT00976391|GlaxoSmithKline|GSK Response Center|866-435-7343||
21278117|NCT01106014|Actelion Pharmaceuticals Ltd|Clinical trial disclosure desk||clinical-trials-disclosure@actelion.com|
21278118|NCT05071313|Janssen Vaccines & Prevention B.V.|Director Biomarkers Viral Vaccines|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21278119|NCT03596151|Antiviral Research Center, University of California, San Diego|Sheldon Morris, MD, MPH|619-543-4761|shmorris@ucsd.edu|
21278120|NCT01700036|University of Michigan Cancer Center|Dr. Pavan Reddy, MD|734-936-8785|reddypr@umich.edu|
21278121|NCT02444793|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21278122|NCT01685411|Masonic Cancer Center, University of Minnesota|Margaret L. MacMillan, M.D.|612-626-2778|macmi002@umn.edu|
21278123|NCT03996148|Cooper University Hospital|Ludmil Mitrev|(800) 826-6737|mitrev-ludmil@cooperhealth.edu|
21278124|NCT02504671|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21278125|NCT00210249|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Pr Simone Mathoulin-Pélissier|+33 (0)5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
21289572|NCT01371565|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
21289573|NCT02217982|Rocky Mountain MS Research Group|Tammy Hoyt|8014085711|thoyt@rmmsc.com|
21289574|NCT05156125|Oppilan Pharma Ltd|Clinical Trial Contact|+1(888)-411-5176|clinicaltrials@ventyxbio.com|108
21289575|NCT02993302|Dr. Cipto Mangunkusumo Hospital|Dyah Purnamasari|62213907703|dyah_p_irawan@yahoo.com|
21289576|NCT01623752|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21289577|NCT01755637|GlaxoSmithKline|GSK Response Center|866-435-7343||
21289578|NCT04389671|Windtree Therapeutics, Inc.|Executive Director of Biostatistics & Data Management|215-488-9300|psimmons@windtreetx.com|
21289579|NCT03338023|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21289580|NCT03412890|Myovant Sciences GmbH|Clinical Trials at Myovant|+1 650 238 0250|clinicaltrials@myovant.com|
21289581|NCT01853085|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21289582|NCT02583477|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
21289583|NCT05507450|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21289584|NCT02904356|Baylor College of Medicine|Sameer Sheth, MD, PhD|713-798-4696|sasheth@bcm.edu|
21289585|NCT05436288|Kiora Pharmaceuticals, Inc.|Eric Daniels|858-353-0469|edaniels@kiorapharma.com|
21289586|NCT03948386|Thomas Jefferson University|Eric S Schwenk, MD|215-955-6161|eric.schwenk@jefferson.edu|
21289587|NCT00464464|Rutgers- Robert Wood Johnson Medical School|Dr. Roseanne Dobkin|732-235-4051|dobkinro@rutgers.edu|
21289588|NCT03767894|Columbia University|Dr. Joel Stein|(212) 305-4818|js1165@columbia.edu|
21289589|NCT01222351|Columbia University|Yaakov Stern|212-342-1350|ys11@columbia.edu|
21289590|NCT01436500|Cumberland Pharmaceuticals Inc|Jerry Fox, DVM|615-255-0068|jfox@cumberlandpharma.com|
21289591|NCT05610267|Integra LifeSciences|Dr. Dennis Adam Young|443 766 2569|dennis.young@integralife.com|
21289592|NCT03055507|University of Washington, Department of Otolaryngology - Head & Neck Surgery|Dr. Greg Davis, Director of Rhinology and Skull Base|(206) 598-4022|GEDavis@uw.edu|B
21278126|NCT00671918|Navidea Biopharmaceuticals|Dr. Frederick Cope|614-793-7500|fcope@navidea.com|140
21289593|NCT04625972|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21289594|NCT00433290|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21289595|NCT02547935|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
21289596|NCT00086307|NIMH|Dr. Carlos A. Zarate|301-451-0861|zaratec@mail.nih.gov|
21289597|NCT01018953|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21278127|NCT03182244|Astellas Pharma Inc|Clinical Transparency|+81 3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
21278128|NCT02049450|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21278129|NCT02492880|Boston Scientific|Director of Clincial Sciences|855-213-9890|BSNClinicalTrials@bsci.com|
21278130|NCT02381626|Memorial Sloan Kettering Cancer Center|Dr. Jennifer Leng, MD, MPH|646-888-8057|lengj@mskcc.org|
21278131|NCT00292188|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21278132|NCT00824616|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21278133|NCT01200992|Prometic Biosciences Inc.|Aline Hagerimana, MD, Senior Director Clinical Affairs|(514) 781-0115|a.hagerimana@prometic.com|
21278134|NCT00792935|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21289598|NCT00724503|Sirtex Medical|Janet Bell, M.B.A.|+ 888-474-7839|jbell@sirtex.com|710
21289599|NCT05067270|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21289600|NCT03630354|Oregon Health & Science University|Dr. Kerri Winters-Stone|503-494-0813|wintersk@ohsu.edu|
21289601|NCT01560416|Dana-Farber Cancer Institute|Nancy Lin|617-632-2335|Nancy_Lin@dfci.harvard.edu|
21289602|NCT01695772|Hoffmann-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21289603|NCT00254072|UC Irvine Medical Center|Ninh T. Nguyen, M.D.|714-456-8580|ninhn@uci.edu|
21289604|NCT00727064|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21289605|NCT04073407|Axcella Health, Inc|Margaret Koziel, MD|8573202200|clinicaltrials@axcellahealth.com|
21278135|NCT03186781|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD|301-451-8715|martin.gaudinski@nih.gov|
21278136|NCT04709835|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21278137|NCT01289665|AdventHealth|Dr. Ashley Hill|407-303-1444|Ashley.Hill.MD@adventhealth.com|
21278138|NCT04870138|University of North Carolina at Chapel Hill|Marcia M. Hobbs, PhD|919-843-6893|mmhobbs@med.unc.edu|
21278139|NCT01383135|Stanford University|Andrei Iagaru, MD|6507362859|aiagaru@stanford.edu|
21278140|NCT03167723|Atrium Health Wake Forest|Bradley Thomas MD|704-355-3176|bradley.thomas@atriumhealth.org|
21278141|NCT03397771|Ixaltis|Chief Development Officer|33457260076|svanberg@ixaltis.com|
21278142|NCT04040322|CiVi Biopharma, Inc.|Chief Executive Officer|301-968-2390|sj@civibio.com|
21231181|NCT04087096|Massachusetts General Hospital|Dr. Elaine Yu|617-643-6353|EWYU@mgh.harvard.edu|
21278143|NCT01259115|Purdue Pharma L.P.|Executive Medical Director, Clinical Pharmacology|800-733-1333||
21278144|NCT01971970|Erasmus University Medical Centre - Sophia Childrens Hospital|Professor J.C. Escher|+31107036076|j.escher@erasmusmc.nl|
21278145|NCT00848107|United Therapeutics Corporation|Rex Mauthe, Assoc VP, Regulatory Affairs|(919) 485-8350|RMauthe@unither.com|
21278146|NCT02524730|Stryker|Britta von den Brincken, Sr. Clinical Study Manager|+491638999202|britta.vondenbrincken@stryker.com|
21278147|NCT00859586|NIH NHLBI|Dr. Minoo Battiwalla|301-827-0939|battiwam@nhlbi.nih.gov|
21231182|NCT00702923|University of Wisconsin Carbone Cancer Center|Douglas McNeel, M.D., Ph.D.|(608) 263-4198|dm3@medicine.wisc.edu|
21278148|NCT02605993|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1-855-752-2356|clinicaltrials@alexion.com|
21278149|NCT00121472|Thoratec Corporation|Poornima Sood, MD, MBA, Sr. Director, Clinical Affairs|(781) 852-8334|psood@thoratec.com|
21278150|NCT03272464|Massachusetts General Hospital|David M. Miller, MD, PhD|617-726-2667|dmiller4@mgh.harvard.edu|
21278151|NCT03468075|University of Iowa, Holden Comprehensive Cancer Center|Clinical Assistant Professor|319-384-9497|varun-monga@uiowa.edu|
21278152|NCT00759187|Colgate Palmolive|William DeVizio- DMD|732-878-7901|William_Devizio@colpal.com|
21278153|NCT01468818|National Cancer Institute|Dr. Steven A. Rosenberg|301-496-4164|sar@mail.nih.gov|
21278154|NCT02266134|Kaiser Permanente Washington Health Research Institute|Dr. Cara C. Lewis|206-422-4076|Cara.C.Lewis@kp.org|
21278155|NCT01442688|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21278156|NCT00302081|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21278157|NCT02685202|University of North Carolina at Chapel Hill|Anne E. Sanders, PhD|919-537-3275|anne_sanders@unc.edu|
21278158|NCT01229735|UCB Pharma|UCB Clinical Trial Call Center|+1877 822||9493
21278159|NCT02130882|National Institute of Allergy and Infectious Diseases, NIH|Dr. Amy Klion|301-435-8903|aklion@nih.gov|
21278160|NCT00520286|National Institutes of Health|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov|
21278161|NCT01715064|University of Guelph-Humber|Dr. Daniel Santa Mina|416-798-1331|daniel.santamina@guelphhumber.ca|6065
21278162|NCT00826449|University of Texas (UT) MD Anderson Cancer Center|Faye Johnson, Associate Professor, Thoracic/Head & Neck Med Oncology||CR_Study_Registration@mdanderson.org|
21278163|NCT02331368|University of Michigan Comprehensive Cancer Center|Dr. Attaphol Pawarode, M.D.|734-936-8785|pawarode@umich.edu|
21231183|NCT01233258|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21278164|NCT03670264|Children's Hospital of Philadelphia|Dr. Brian Jenssen|215-554-4390|jenssenb@chop.edu|
21231184|NCT03889444|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21278165|NCT02365870|Johns Hopkins University School of Medicine|Dr. Gregory Pontone|(410) 502 - 0477|gpontone@jhmi.edu|
21231185|NCT02644135|UHCMC|Dr. Robert Salata|2168443293|robert.salata@uhhospitals.org|
21278166|NCT02302859|The University of Texas (UT) MD Anderson Cancer Center|Dr. Lorna McNeill, MPH,PHD/ Chair, Health Disparities Research|713- 563-1103|lmcneill@mdanderson.org|
21278167|NCT03003949|University of North Carolina at Chapel Hill|Susan Girdler, PhD|919-590-0813|rachel_kozik@med.unc.edu|
21278168|NCT02205983|University of Chicago|Dr. Harriet de Wit|773-702-3560|dewitlab@yoda.bsd.uchicago.edu|
21278169|NCT04453202|Janssen Vaccines & Prevention B.V.|CLINICAL FRANCHISE LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21278170|NCT02615171|University of Connecticut|Dr. Sherry Pagoto|8604868979|Sherry.Pagoto@uconn.edu|
21231186|NCT02795832|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21231187|NCT00779285|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21231188|NCT00256750|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21278171|NCT02581007|Northside Hospital|Dr. Melhem Solh|404-255-1930|msolh@bmtga.com|
21278172|NCT00741936|Hong Kong Baptist University|Prof. Zhao-xiang Bian|(852) 3411 2905|bzxiang@hkbu.edu.hk|
21231189|NCT01348165|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21278173|NCT03176459|Pacira Pharmaceuticals|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
21278174|NCT00446199|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21278175|NCT01822574|Mayo Clinic|Robert T. Trousdale, M.D.|507-284-6586|trousdale.robert@mayo.edu|
21278176|NCT03071094|Transgene|Associate Medical Director|+ 33 (0)3 88 27 91 00|clinical.trials@transgene.fr|
21278177|NCT01079832|Case Comprehensive Cancer Center|Dr. Charles Kunos|330-375-4485|kunosc@summahealth.org|
21278178|NCT04969861|Nektar Therapeutics|Study Director|415-482-5300|StudyInquiry@nektar.com|
21278179|NCT00290251|NICHD, NIH|Lynnette Nieman MD|301-496-8935|NiemanL@nih.gov|
21278180|NCT05205772|University of North Carolina at Chapel Hill|Miriam Sklerov, MD, MS|984-974-4401|miri@email.unc.edu|
21278181|NCT02799095|Mural Oncology, Inc.|Study Director|+1 (781) 614-0100|clinicaltrials@muraloncology.com|
21278182|NCT04791969|University of California San Francisco|Glenn-Milo Santos|(415) 476-1435|glenn-milo.santos@ucsf.edu|
21278183|NCT04002063|VHAPTH|Judith A. Callan PhD, RN|412-628-1534|judith.callan@va.gov|
21278184|NCT02579161|Northwell Health|Dr. Zeph Okeke|516-734-8500|zokeke@northwell.edu|
21278185|NCT02327117|Isfahan University of Medical Sciences|Amin Nemati|00989131009918|nemati@med.mui.ac.ir|
21278186|NCT02128217|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21278187|NCT00541970|GlaxoSmithKline|GSK Response Center|866-435-7343||
21278188|NCT04280705|Organization:NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
21278189|NCT03222583|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21278190|NCT03986138|Guerbet|Frantz Hebert, Global Head of Clinical Development|+33 (0)6 80 24 93 34|frantz.hebert@guerbet.com|
21278191|NCT02031458|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21278192|NCT00721630|Memorial Sloan Kettering Cancer Center|Dr. Tiffany Traina|646-888-5209|trainat@mskcc.org|
21278193|NCT01812681|Dr. Sami Ulus Children's Hospital|Dr. Serdar Beken|00903123056449|serbeken@gmail.com|
21278194|NCT00667810|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21278195|NCT02369900|Beth Israel Deaconess Medical Center|Michael N. Cocchi MD|617-754-2388|mcocchi@bidmc.harvard.edu|
21278196|NCT00673153|Fred Hutch Cancer Research Center|Roland B. Walter, MD, PhD, MS|(206) 667-3599||
21278197|NCT01916590|UColorado|Colleen Dingmann R.N. Ph.D.|303-724-7494|colleen.dingmann@ucdenver.edu|
21278198|NCT01659866|Northwestern University|Dr. Anthony Schaeffer|312-908-1615|ajschaeffer@northwestern.edu|
21278199|NCT03365752|Hospital for Special Surgery|Marla Sharp, MPH, MA|646-797-8419|sharpm@hss.edu|
21278200|NCT03412396|The University of Texas MD Anderson Cancer Center|Dr. John Davis|(713) 792-3250|johndavis@mdanderson.org|
21289606|NCT00126737|Edward Hines, Jr. VA Hospital|Elly Budiman-Mak, MS MPH MD|708-202-2414|elly.mak@va.gov|
21289608|NCT00771602|UT MD Anderson Cancer Center|Stefan Faderl, MD / Professor|713-745-4613||
21278201|NCT02633488|University of Virginia|Eugene J. Barrett MD PhD|434-924-1263|ejb8x@virginia.edu|
21278202|NCT01383213|IRCCS Fondazione Cà Granda Policlinico Milano|Dr Roberto Cosentini|+390255033618|r.cosentini@gmail.com|3618
21278203|NCT03493386|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21278204|NCT04146116|University of Wisconsin, Madison|Dr. Marin Schweizer|6082631545|mschweizer@medicine.wisc.edu|
21278205|NCT00271154|Medtronic CRDM|CRDM Core Clinical|800-328-2518|medtroniccrmtrials@medtronic.com|
21278206|NCT04536935|University of Washington|Morgan Johnson|715-416-1493|mjohn23@uw.edu|
21278207|NCT03456583|Hologic|Muhammad Waqas|5088267183|Muhammad.Waqas@hologic.com|
21278208|NCT00328016|National Institute on Aging|Jessica McNeeley, Research Fellow|410-558-8110|mcneeleyj@mail.nih.gov|
21278209|NCT01434186|AstraZeneca AB, S-151 85 Södertälje, Sweden|Eva Johnsson, Clinical Science Lead, GLOBAL_MEDICINES_DEV|+46 31 7762484|Eva.Johnsson@astrazeneca.com|762 484
21278210|NCT00831766|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jeffrey Lancet|813-745-1387|jeffrey.lancet@moffitt.org|
21278211|NCT01447420|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21278212|NCT02731326|Columbia University|Suzanne Bakken, PhD, RN|212-305-1278|sbh22@columbia.edu|
21278213|NCT05472662|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
21278214|NCT03362112|Nanjing First Hospital|Ma Jianhua|8625-52887092|majianhua196503@126.com|
21278215|NCT01119716|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21278216|NCT04480710|Hepion Pharmaceuticals Inc|Clinical Operations|732-902-4016|jgreytok@hepionpharma.com|
21278217|NCT04480021|University of Washington|Dr. Amritha Bhat|206-543-3117|amritha@uw.edu|
21278218|NCT05084963|Revolo Biotherapeutics|Chief Medical Officer|(888) 599-7431|clinicaltrials@revolobio.com|
21278219|NCT03569228|Department of Veterans Affairs|Candice Quinn, Principal Investigator|919-922-8046|candice.quinn@va.gov|
21278220|NCT03819049|Janssen Research & Development, LLC|Trial Physician|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21278221|NCT01986010|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21278222|NCT00115297|UMass|Craig M. Lilly, MD|508-868-5106|craig.lilly@umassmed.edu|
21278223|NCT01335997|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21278224|NCT01103466|Coloplast A/S|Dr. Lis Hentze Poulsen|4549111111|dklhp@coloplast.com|
21231190|NCT04659161|Karuna Therapeutics, Inc.|Inder Kaul, VP Clinical Development|1-888-783-0380|medinfo@karunatx.com|
21231191|NCT01003288|University of Bergen|Professor Rebecca Cox|+4755974668|rebecca.cox@uib.no|
21231192|NCT01929343|UT Southwestern Medical Center|Josh Becker|2146485277|joshua.becker@utsouthwestern.edu|
21231193|NCT00901316|Texas Children's Hospital|Sheldon L. Kaplan, MD|832-824-4330|skaplan@bcm.edu|
21231194|NCT02197130|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21231195|NCT00565045|MetroHealth Medical Center|Dr. Jayme Knutson|216-778-8364|jsk12@case.edu|
21231196|NCT03648983|Montefiore Medical Center|Lisa Wiechmann||lwiechma@montefiore.org|
21231197|NCT03129178|University of Portsmouth|Dr Anthony Shepherd|02392 84|ant.shepherd@port.ac.uk|5289
21231198|NCT01269463|Rhodes Pharmaceuticals L.P.|Inder Chaudhary, PhD|401-262-9272|inder.chaudhary@rhodespharma.com|
21231199|NCT00456014|Stony Brook University School of Medicine|Ramin V. Parsey, MD, PhD|631-444-3084|Ramin.Parsey@stonybrookmedicine.edu|
21231200|NCT04404361|CTI BioPharma Corp.|John Volpone|206-351-7663|jvolpone@ctibiopharma.com|
21238916|NCT04241094|Center for Care Delivery & Outcomes Research|Laura Meis, PhD|651-467-4516|laura.meis@va.gov|
21278225|NCT01019928|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|
21278226|NCT02994940|UC Davis Anesthesiology & Pain Medicine|Richard L. Applegate II MD|916-734-5028|rapplegate@ucdavis.edu|
21278227|NCT04300010|UW School of Medicine and Public Health|Eric Cotter, MD|920.362.9221|ecotter@uwhealth.org|
21289609|NCT01629862|University of Pittsburgh|Sanjay Patel|412-692-2035|patelsr2@upmc.edu|
21231201|NCT00558558|UT MD Anderson Cancer Center|Ying Guo, MD - Associate Professor|713-745-2327|jaallo@mdanderson.org|
21231202|NCT01125605|Pascoe pharmazeutische Praeparate GmbH|Director of Clinical Trials|0049 641 7960100|klinische.forschung@pascoe.de|
21231203|NCT02549937|HUTCHMED Limited|Martin Benes|+1.973.306|martinb@hutch-med.com|4490
21231204|NCT00217594|NHLBI, NIH|Chris Hourigan MD|301-451-0257|hourigancs@mail.nih.gov|
21231205|NCT01352546|Plastic Surgery Professional Association|Peter T. Pacik, MD, FACS|603 387 7735|ptpacik@verizon.net|
21231206|NCT05330702|University of Iowa|Shaoping Zhang|(319) 335-7386|shaoping-zhang@uiowa.edu|
21231207|NCT05276401|Lakewood Amedex|Dr. Adam Ruskin|941-225-2514|ARuskin@LakewoodAmedex.com|
21231208|NCT01411774|Baylor College of Medicine|Dr. Eric Storch|727-767-8230|eric.storch@bcm.edu|
21231209|NCT00056316|University of Missouri-St. Louis|Ann M. Steffen, PhD, Associate Professor|314-516-5382|ann_steffen@umsl.edu|
21231210|NCT00583778|MetroHealth Medical Center|Dr. Rita Cydulka|216-778-7800|rcydulka@gmail.com|
21231211|NCT01315678|Insmed Incorporated|Kevin Mange (Senior VP, Clinical Development and Medical Affairs)|908-947-2651|kevin.mange@insmed.com|
21231212|NCT02471430|Massachusetts General Hospital|Mathias Lichterfeld|617-726-2000|mlichterfeld@mgh.harvard.edu|
21231213|NCT00441883|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
21278228|NCT02853370|U.O.C. Haematology - A.O.U. Policlinico Paolo Giaccone, Palermo (Italy)|Dr. Emilio Iannitto|+39 091 6554415|emilio.iannitto@gmail.com|
21231214|NCT00331682|Memorial Sloan-Kettering Cancer Center|Dr. Eileen O'Reilly|646-888-4182|oreillye@mskcc.org|
21231215|NCT02468414|Aevi Genomic Medicine|Garry A. Neil, MD|610-254-4208|garry.neil@aevigenomics.com|
21231216|NCT03292588|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21231217|NCT00187486|University of California San Francisco|Michael Prados, MD|415 353 2076|PradosM@neurosurg.ucsf.edu|
21231218|NCT00543140|Ethicon Endo-Surgery|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
21231219|NCT02483520|University of Kansas School of Nursing|Kristine Williams, RN, PhD, FNP-BC, FGSA, FAAN, E. Jean Hill Professor|913 588-1673|Kwilliams1@kumc.edu|
21231220|NCT02515058|UT Health Science Center at San Antonio|Dr. Brian Mealey|210-567-3567|mealey@uthscsa.edu|
21231221|NCT03808493|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21231222|NCT01104493|MedImmune, LLC|Dr. Robert Gasser|301-398-0000|gasserr@medimmune.com|
21231223|NCT02511184|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21231224|NCT00846430|Corewell Health|Dr. Albert Cornelius|616-391-2086|albert.cornelius@helendevoschildrens.org|
21231225|NCT01148940|Albert Einstein College of Medicine|Dr. Henny Billett|718-430-2186|hbillett@montefiore.org|
21231226|NCT00133952|Chromaderm|info@chroma-derm.com||info@chroma-derm.com|
21231227|NCT03143894|Johns Hopkins University|Tracy Vannorsdall, PhD|410-502-3701|TVannor1@jhmi.edu|
21231228|NCT02170298|UC Davis|Julie B Schweitzer|916-703-0294|jschweitzer@UCDAVIS.EDU|
21231229|NCT00426855|Kantonsspital Aarau|Dr. Peter Moosmann|+41 62 838 60 51|peter.moosmann@ksa.ch|
21231230|NCT03680105|Reven Pharmaceuticals|Head, Global Clinical Affairs|13036691336|kristina.cabala@reven.com|
21231231|NCT01312272|VISN 22 Mental Illness Research, Education, and Clinical Center|Dr. Michael C. Davis|3104783711|mcdavis@mednet.ucla.edu|49234
21231232|NCT00003499|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
21231233|NCT01744574|University of Minnesota|Dr. Sharon Allen|612-624-0446|allen001@umn.edu|
21231234|NCT01256008|Wenzhou Medical University|Director of Clinical Trials|+86 0577 55579363|hjc@wmu.edu.cn|
21231235|NCT02256189|Lund University|Professor Bo Ahrén|+46462220758|Bo.Ahren@med.lu.se|
21231236|NCT01402492|UCLA Integrated Substance Abuse Programs|Walter Ling, MD|310-267-5888|lwalter@ucla.edu|
21231237|NCT04866225|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21231238|NCT02227758|St Jude Medical/Abbott|Clinical Study Director||rdiaz@sjm.com|
21238917|NCT01669798|Duke University Medical Center|Angeles Alvarez Secord|919-684-3765|secor002@mc.duke.edu|
21238918|NCT05918978|argenx BVBA|Regulatory Manager|+32 93103400|regulatory@argenx.com|
21278229|NCT02642575|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
21278230|NCT01520532|Medtronic AF Solutions|Jay Kelley, Director of Clinical Research|+1.760.827.0076|jay.l.kelley@medtronic.com|
21278231|NCT00643565|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21278232|NCT02317614|Western Michigan University|Dr. Anthony DeFulio|269-387-4459|anthony.defulio@wmich.edu|
21278233|NCT03283761|Hoosier Cancer Research Network|Clinical Data Analyst|3179212050|amajumdar@hoosiercancer.org|
21231239|NCT02573311|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21231240|NCT00603889|Albert B. Sabin Vaccine Institute|Dr. David Diemert, Director of Clinical Trials|202-842-5025|david.diemert@sabin.org|
21231241|NCT04862585|Ohio State University|Mike Berger, PharmD|614-366-0556|michael.berger@osumc.edu|
21231242|NCT04124757|LUMC|Martijn Boon MD PhD|003171522301|m.boon@lumc.nl|
21289610|NCT00960856|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clincialtrials@urlmutual.com|
21289611|NCT03593629|Jomo Kenyatta University of Agriculture and Technology and University of Washington|Kenneth Ngure|+254722362219|kngure@uw.edu|
21289612|NCT01428713|Baylor College of Medicine/TCH|Dr. Lakshmi Srivaths|832-822-1514|lvsrivat@txch.org|
21289613|NCT02979054|Laboratoires Théa|Clinical Development Director|+33(0)473981414|Corentin.LECAMUS@theapharma.com|
21289614|NCT00120250|Massachusetts General Hospital|Dr. Mark Pollack|312-942-5372|mark_pollack@rush.edu|
21289615|NCT00585169|Yale Unviersity|Marc N. Potenza, M.D., Ph.D.|203-737-3553|marc.potenza@yale.edu|
21289616|NCT03055221|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
21289617|NCT01964560|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21289618|NCT02391584|Entellus Medical|Clinical Affairs Manager|7634631595|rschacherer@entellusmedical.com|
21289619|NCT02002208|Atopix Therapeutics Limited|Chief Medical Officer|+44 1235 841 522|atopix@atopixtherapeutics.co.uk|
21231243|NCT05537883|Wake Forest University Health Sciences|Selwan Barbat, MD|704-355-2000|Selwan.Barbat@atriumhealth.org|
21289620|NCT01030575|RTI International|Dr. Abhik Das|301-770-8214|adas@rti.org|
21289621|NCT05696158|Mahana Therapeutics|Kathryn Jenkins|17742666693|kathryn@mahanatherapeutics.com|
21289622|NCT00489268|Mayo Clinic, Arizona|David E. Fleischer, M.D.|(480) 301-4461|fleischer.david@mayo.edu|
21289623|NCT01441414|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21289624|NCT03992482|University of Illinois Chicago|Dr. Sandeep Jain|312-996-4476|jains@uic.edu|
21289625|NCT01368185|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21231244|NCT00769392|Lahey Clinic|Gregory Blaha, MD|781-744-2580|christine.gould@lahey.org|
21231245|NCT02296320|MedImmune, LLC|Hasan S. Jafri|301-398-4431|information.center@astrazeneca.com|
21231246|NCT03282682|Comenius University in Bratislava|Doc. Mgr. Milan Sedliak, PhD.|+421918340671|milan.sedliak@uniba.sk|
21231247|NCT05229406|Center for Healthy Minds, University of Wisconsin - Madison|Simon B. Goldberg, PhD|608-265-8986|sbgoldberg@wisc.edu|
21231248|NCT00040664|GlaxoSmithKline|GSK Response Center|866-435-7343||
21231249|NCT01709162|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21289626|NCT01507103|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21289627|NCT04863807|Imperial College Healthcare NHS Trust|Dr Alex Wickham|+4420233121248|alex.wickham@nhs.net|
21289628|NCT03611062|University of Massachusetts Lowell|Dr. Jiabin Shen|978-934-3965|jiabin_shen@uml.edu|
21289629|NCT01058005|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
21289630|NCT01717859|UCLA|Veena K. Ranganath|310-825-4321|vranganath@mednet.ucla.edu|
21289631|NCT02933476|Stanford School of Medicine|Raumin Neuville|6507236709|raumin@stanford.edu|
21289632|NCT02287025|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21289633|NCT00899847|Stanford University School of Med|Wen-Kai Weng, MD; Associate Professor of Medicine|650-723-7689|wkweng@stanford.edu|
21231250|NCT02334358|LG Chem|Study Leader|82-2-6987-4148|sodam@lgchem.com|
21238919|NCT00622180|UT Southwestern Medical Center at Dallas|Amit Pandya, M.D.|214-645-8300|amit.pandya@utsouthwestern.edu|
21289634|NCT05987540|Scion NeuroStim, Inc|Robert Black|919-260-5528|bacllc@earthlink.net|
21289635|NCT01421134|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
21289636|NCT02959892|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21289637|NCT04433975|University of Michigan Medical School|Dr. Mark Ilgen|734-845-3646|marki@med.umich.edu|
21289638|NCT02734147|Christiana Care Health Services|Jamie Rosini, Pharm D|302-733-6364|jrosini@christianacare.org|
21289639|NCT03896217|UCL Institute of Neurology|Prof. Richard Nicholas|0208 383 0675|richard.nicholas3@nhs.net|
21289640|NCT04392635|Stanford University|Study Team|650-723-6189|smeyer27@stanford.edu|
21289641|NCT02213107|University of Rochester|Chunkit Fung, MD|585 - 275 - 5823|chunkit_fung@urmc.rochester.edu|
21289642|NCT00724893|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21289643|NCT01810952|Baylor College of Medicine|Professor of Medicine|713-660-9902|glennc@bcm.edu|
21289644|NCT01290731|Janssen Pharmaceutical K.K., Japan|Manager|81 3 44115639||
21289645|NCT04308694|Duke University|William John, Ph.D.|919-681-7291|william.john@duke.edu|
21289646|NCT01179516|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21289647|NCT01968317|Obstetrics and Gynecology Hospital of Fudan University|Xiaojun Chen|33189900|xiaojunchen2013@sina.com|
21289648|NCT02216851|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
21289649|NCT00888849|Ethicon Endo Surgery, Inc|Sheryl Helsinger/Clinical Affairs Director|513-337-3079|shelsing@its.jnj.com|
21231251|NCT03953820|Aquestive Therapeutics|Denis Scheper, Director of Portfolio Management and Clinical Operations|(908)941-1887|denis.scheper@aquestive.com|
21231252|NCT01049308|VA Loma Linda Healthcare System|Dr Helme Silvet|9095836097|helme.silvet@va.gov|
21231253|NCT03845985|UMass Chan Medical School|Melissa L. Anderson, Associate Professor of Psychiatry|508-856-5820|melissa.anderson@umassmed.edu|
21231254|NCT01318993|GlaxoSmithKline|GSK Response Center|866-435-7343||
21231255|NCT03334539|Hanall Biopharma|Project Manager|82-222041763|parksm@hanall.co.kr|
21231256|NCT02457260|University of Pittsburgh|Daniel E. Forman - Chief of a section of Geriatrics Cardiology|412-864-2507|formand@pitt.edu|
21231257|NCT04974697|Johnson & Johnson Vision Care (JJVC)|Ross Franklin, BAppSc-Optom|1-800-843-2020|RFRANKL1@its.jnj.com|
21231258|NCT03706456|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21231259|NCT00496808|UT MD Anderson Cancer Center|Raphael E Pollock,PHD/Professor Emeritus, Surgical Oncology|(713) 792-6928|CR_Study_Registration@mdanderson.org|
21231260|NCT01845831|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
21231261|NCT00221403|Ohio State Medical Center/Nationwide Children's Hospital|Robert Kowatch, MD, PhD|(614) 355-2872|Robert.Kowatch@nationwidechildrens.org|
21231262|NCT00592943|Massachusetts General Hospital; Harvard Medical School|Thomas J. Spencer, MD|(617) 726-1731|tspencer@partners.org|
21289650|NCT05064800|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21289651|NCT00629239|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21289652|NCT01851369|National Cancer Institute|Dr. Alice P.Chen|2407813320|chenali@mail.nih.gov|
21289653|NCT00183391|Icahn School of Medicine at Mount Sinai|Dr. Jeffrey H Newcorn|212-659-8705|jeffrey.newcorn@mssm.edu|
21289654|NCT00395512|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21289655|NCT03712618|National Institutes of Health, Clinical Center (NIH CC)|Dr. Willy Flegel|+1 301 594 7401|bill.flegel@nih.gov|
21289656|NCT02618187|Seres Therapeutics|Dr. Michele Trucksis, Chief Medical Officer|617-945-9626|mtrucksis@serestherapeutics.com|
21289657|NCT04584554|Duke University School of Nursing|Tolu Oyesanya, PI of study|919-684-5292|tolu.oyesanya@duke.edu|
21289658|NCT01254877|JohnHopkinsU|Mary E McCaul|410-955-9526|mmccaul1@jhmi.edu|
21289659|NCT01483651|Legacy Health System|Kenneth Ward|971-570-2632|kenward503@msn.com|
21289660|NCT01799278|Weill Cornell Medical College|Dr. Himisha Beltran|(646) 962-2072|GUONC@med.cornell.edu|
21289661|NCT01184118|UW Madison|Mihaela Teodorescu, MD|608-256-1901|mt3@medicine.wisc.edu|
21289662|NCT01186419|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21289663|NCT04115228|Nine Continents Medical, Inc.|Peter Jacobson|6128105810|PETERJACOBSON777@YAHOO.COM|
21289664|NCT01928771|AstraZeneca|Mitchell Goldman , Medical Science Director|+1 301 398 0323|Mitchell.Goldman@astrazeneca.com|
21289665|NCT01937117|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Jenna Canzoniero, MD|410-955-8983|jcanzon1@jhmi.edu|
21289666|NCT01455519|Rehabilitation Institute of Chicago|Center for Pain Studies|312.238.5654|centerforpainstudies@ric.org|
21289667|NCT01407367|University of Maryland Baltimore|Jeffrey C. Fink MD, MS; Principal Investigator|410-382-4822|jfink@som.umaryland.edu|
21289668|NCT01271855|Northwestern University|Kimberly Kenton MD, MS|312-472-3874|kkenton@nm.org|
21289669|NCT02269488|MedImmune, LLC, a wholly-owned subsidiary of AstraZeneca PLC|Raburn Mallory|+1 301-398-5799|malloryr@medimmune.com|
21289670|NCT02186171|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21289671|NCT01245062|GlaxoSmithKline|GSK Response Center|866-435-7343||
21289672|NCT00574353|Memorial Sloan Kettering Cancer Center|Dr. John Humm, PhD|212-639-7367|hummj@MSKCC.ORG|
21289673|NCT05762744|University of Maryland School of Medicine|Simeon Taylor, MD, PhD (Professor of Medicine0|4107066439|staylor2@som.umaryland.edu|
21289674|NCT03018730|Protalix Ltd.|Sari Alon|+972-4-9028100|sari@protalix.com|215
21289675|NCT00004859|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
21289676|NCT03882801|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21289677|NCT01793129|RTI International|Dr. Abhik Das|301-770-8214|adas@rti.org|
21289678|NCT04128215|University of Florida|Dr. Demetra Christou|3522941715|ddchristou@ufl.edu|
21289679|NCT04193176|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21289680|NCT00944645|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21289681|NCT02011464|Maimonides Medical Center|Dr. Piyush M Gupta|7182837189|pgupta@maimonidesmed.org|
21289682|NCT04535362|Yale School of Medicine|Mehmet Sofuoglu, MD, PhD: Professor of Psychiatry; Director of VA New England Mental Illness Researc|(203) 937-4809|mehmet.sofuoglu@yale.edu|
21289683|NCT03791060|Beth Israel Deaconess Medical Center|Co-Director Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS)|6176675834|mporter3@bidmc.harvard.edu|
21289684|NCT02018887|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21289685|NCT04053452|Duke University|Natalia Gonzalez, MD|919-684-5422|natalia.gonzalez@duke.edu|
21289686|NCT00122187|VAHSRD|Linda Humphrey|503-220-8262|linda.humphrey@va.gov|57176
21289687|NCT00580294|Icahn School of Medicine at Mount Sinai|Marco Pappagallo, MD|212-241-7749|dionne.bobb@mountsinai.org|
21289688|NCT03099863|MetroHealth Medical Center|Dr. Jeffrey Mangel|2167784444|jmangel@metrohealth.org|
21289689|NCT02061592|Johnson & Johnson Vision Care, Inc|Brian Pall, OD, MS, FAAO - Senior Principal Research Optometrist|904-443-3500|BPALL@its.jnj.com|1290
21289690|NCT04402957|Arch Biopartners Inc.|Richard Muruve|647-428-7031|rm@archbiopartners.com|
21289691|NCT01584388|MGH Rheumatology|John H Stone|617-726-7938|jhstone@partners.org|
21289692|NCT03362957|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
21289693|NCT04246476|Washington University in St. LOuis|Gammon Earhart|3142861407|earhartg@wustl.edu|
21289694|NCT01279200|University of Michigan|Senait Fisseha, MD, JD|734-763-4323|sfisseha@med.umich.edu|
21289695|NCT01399099|Neodyne Biosciences|Sr. Director of R&D|510-456-4128|jjackson@neodynebio.com|128
21289696|NCT02181738|Bristol Myers Squibb|Bristol Myers Squibb Study Director|855-907-3286|Clinical.Trials@bms.com|
21289697|NCT01668537|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
21289698|NCT01149538|University of Minnesota|Jeffrey R. Wozniak, Ph.D.|612-273-9741|jwozniak@umn.edu|
21289699|NCT05254210|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
21289700|NCT00625729|Masonic Cancer Center, University of Minnesota|Veronika Bachanova, M.D.|612-625-5469|bach0173@umn.edu|
21289701|NCT00567112|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21289702|NCT04689009|EMOLED SRL|Dr. Rossi Degl'Innocenti Duccio, Clinical Affairs Manager|+390550751960|d.rossi@emoled.com|
21289703|NCT00985790|GlaxoSmithKline|GSK Response Center|866-435-7343||
21289704|NCT01666314|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
21289705|NCT04501445|Rush University Medical Center|Jared A Greenberg|312-942-6744|jared_greenberg@rush.edu|
21289706|NCT02512445|UCSD|Dr. Sonya Norman|858-518-8266|snorman@ucsd.edu|
21289707|NCT02082288|al-azhar university|wael mohamed hamed|002-01001556162|wael79hamed@yahoo.com|
21289708|NCT04514458|Yale University|Tariq Ahmad|203-843-1667|tariq.ahmad@yale.edu|
21289709|NCT05089357|Q-Med AB|Clinical Scientist|+46184749000|reception.seupp@galderma.com|
21289710|NCT02021318|Astellas Pharma Europe B.V.|Clinical Trial Disclosure|+44 (0)20 3379 8000|Astellas.resultsdisclosure@astellas.com|
21289711|NCT00689052|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21289712|NCT04180696|Medtronic, Bakken Research Center B.V.|Lidwien Vainer|+31610419653|lidwien.vainer@medtronic.com|
21289713|NCT01740427|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21289714|NCT04906421|Sagimet Biosciences, Inc.|Study Director|650-561-8675|sitecontact@sagimet.com|
21289715|NCT04796207|University of Arizona|Floyd H. Chilton|520-621-5327|fchilton@arizona.edu|
21289716|NCT00963508|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914 -345-9001|natalie.yantovskiy@taro.com|
21289717|NCT01860989|Novartis Pharmaceuticals|Study Director|862-778-8300||
21231263|NCT00680706|Baystate Medical Center|Howard Smithline|413-794-3433|howard.smithline@baystatehealth.org|
21231264|NCT00750815|H. Lee Moffitt Cancer Center and Research Institute|Melissa Alsina, M.D.|813-745-6886|melissa.alsina@moffitt.org|
21231265|NCT00279305|Type 1 Diabetes TrialNet|Carla Greenbaum, MD||cjgreen@benaroyaresearch.org|
21278234|NCT02654860|Sintetica SA|Dr.Elisabetta Donati, Corporate Director Scientific Affairs|+41.91.640.42.50|edonati@sintetica.com|
21278235|NCT00001586|National Cancer Institute, National Institutes of Health|Wyndham H. Wilson, M.D.|301-435-2415|wilsonw@mail.nih.gov|
21278236|NCT01355159|Ottawa Hospital Research Institute|Dr. Mark Walker|6137378899|mwalker@ohri.ca|76655
21278237|NCT03276221|Massachusetts General Hospital|Randi M. Schuster, PhD|617-643-6673|rschuster@mgh.harvard.edu|
21278238|NCT00681590|University of Miami|Dr. Silvina Levis|305-575-3388|slevis@miami.edu|
21278239|NCT02912650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21278240|NCT02562482|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr. Grace Chen, Deputy Chief, Clinical Trials Program, Vaccine Research Center|240-669-2809|grace.chen@nih.gov|
21278241|NCT00916136|Vanderbilt|William Obremskey MD MPH|615-936-0112|william.obremskey@vanderbilt.edu|
21278242|NCT00975286|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21278243|NCT01674647|Bayer HealthCare AG|Bayer HealthCare AG||clinical-trials-contact@bayerhealthcare.com|
21278244|NCT01941940|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21278245|NCT04135196|Worcester Polytechnic Institute|Dr. Karen Troy|1-(508)-831-5000|ktroy@wpi.edu|6093
21278246|NCT02523196|University of Colorado Denver|Dr. Amanda Wieland|720-848-2291|amanda.wieland@cuanschutz.edu|
21278247|NCT01733147|Mayo Clinic|Dr. Prasad Iyer|507-293-7911|iyer.Prasad@mayo.edu|
21278248|NCT03212521|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21278249|NCT00444457|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21278250|NCT01401049|NYU School of Medicine|Mitchell Lee, MD|212.263.5071|mitchell.lee@nyumc.org|
21278251|NCT00914459|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21231266|NCT02521870|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-665-0414|rjanssen@dynavax.com|
21278252|NCT01661179|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21238920|NCT00279201|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21238921|NCT02624739|ResMed|Paul Phillips|01 906 8861|paul.phillips@resmed.com|
21238922|NCT03466918|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@edwards.com|
21278253|NCT01083810|Abbott|Global Medical Services|1-800-633-9110||
21278254|NCT01602965|Istituto Ortopedico Rizzoli|Mariela Terrafino|0516366694|cristiana.forni@ior.it|0039
21289718|NCT02759458|Rush University Medical Center|Nikhil Verma, MD|(312) 563-2214|nikhil.verma@rushortho.com|
21289719|NCT04739709|AimMax Therapeutics Inc.|Chief Medical Officer|919-797-1146|admin@aimmaxrx.com|
21289720|NCT03003468|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
21289721|NCT00421993|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
21289722|NCT02405962|The Hong Kong Polytechnic University|Dr. Yim Wah Mak|(852) 2766-6421|yw.mak@polyu.edu.hk|
21289723|NCT01980888|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21231267|NCT04334902|Heuron|Yoomi Kim_Clinical Research Team Leader|01035173212|yoomi_kim@iheuron.com|
21289724|NCT02193152|Washington University School of Medicine|Daniel Morgensztern, M.D.|314-362-5737|danielmorgensztern@wustl.edu|
21289725|NCT00165698|Eisai Co., Ltd.|Takao Ishii, Asia regulatory affaires|81-3-3817-3914||
21289726|NCT02641353|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21289727|NCT01398475|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21289728|NCT01767285|Duke University|Dr. Beverly Gray|919-684-8111|beverly.gray@dm.duke.edu|
21289729|NCT03888274|Tivic Health Systems|Blake Gurfein|5615737652|blake.gurfein@tivichealth.com|
21289730|NCT01727154|Dendreon|Shabnam Vaziri|206.455.2323|svaziri@Dendreon.com|
21289731|NCT00003474|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
21289732|NCT03020888|Endomag|Dr Matthew Womack|+44 7851 247439|mwomack@endomag.com|
21289733|NCT03927716|Novan|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
21289734|NCT03461861|Medical College of Wisconsin|Dr. Yang Wang|4149555473|yangwang@mcw.edu|
21289735|NCT01198548|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21289736|NCT02015104|National Cancer Institute|Dr. Raju Chelluri|240-858-3700|raju.chelluri@nih.gov|
21289737|NCT06025695|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21231268|NCT03480646|Constellation, Inc.|Clinical Program Lead|1-844-667-1992|medinfo@morphosys.com|
21231269|NCT01638546|Memorial Sloan Kettering Cancer Center|Dr. Charles Rudin|646-888-4527|rudinc@mskcc.org|
21231270|NCT03396367|Hunter College|Dr. Tyrel Starks|212-772-5550|tstarks@hunter.cuny.edu|
21231271|NCT04292743|Lombardi Comprehensive Cancer Center|Marcus Noel|202-444-2223|Marcus.S.Noel@gunet.georgetown.edu|
21231272|NCT02881554|University of Washington|Dr. Smith Apisarnthanarax, Principal Investigator|+1 206 598-4100|apisarn@uw.edu|
21231273|NCT00684307|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21231274|NCT00759031|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
21231275|NCT04532164|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21231276|NCT04492618|Mayo Clinic|Aaron R. Mangold, M.D.|480-301-4256|Mangold.Aaron@mayo.edu|
21231277|NCT03489720|Vanderbilt University Medical Center|Dr. Uma Shastri|615-936-3198|uma.shastri@vumc.org|
21231278|NCT01806545|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21231279|NCT02111772|University of Virginia|Dr. Peter W. Heymann|434-242-8209|pwh5a@virginia.edu|
21231280|NCT00884312|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21231281|NCT03902574|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21231282|NCT00314093|University of Texas Southwestern Medical Center|Dr. Ellen Vitetta|214-648-1200|ELLEN.VITETTA@UTSouthwestern.edu|
21231283|NCT02442869|University of Nevada, Reno|Dr. Jacqueline Pistorello|775-784-4648|pistorel@unr.edu|
21231284|NCT03521934|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
21231285|NCT05048784|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21231286|NCT01603056|ALK-Abelló A/S|Vivian Wang, Sr. Medical Affairs Manager|86 - 10 5166 8198|Vivian.Wang@alk.net|
21231287|NCT02101060|Salem VA Medical Center|Dr. Krisann Oursler|540-982-2463|krisann.oursler@va.gov|4981
21231288|NCT02269241|Exeltis|Dr. Enrico Colli, Chief Scientific Officer|+34917711500|enrico.colli@exeltis.com|
21231289|NCT03020160|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21231290|NCT02270957|Oklahoma Medical Research Foundation|Joan T. Merrill, M.D.|405 822 2336|joan-merrill@omrf.org|
21231291|NCT03291054|Northwell|Richard Carvajal, MD|516-734-8900|rcarvajal2@northwell.edu|
21231292|NCT01246401|Yale University|Dr. Sandra Springer||sandra.springer@yale.edu|
21231293|NCT00284050|Novartis Pharmaceuticals|Study Director|862 778-8300||
21231294|NCT01391559|Dartmouth-Hitchcock|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org|
21231295|NCT00038857|MDAnderson Cancer Center|Dr. Richard E. Champlin|713-792-8750|celsaenz@mdanderson.org|
21231296|NCT00166114|University of Miami School of Medicine|Dominique Musselman, MD, MSCR|404-723-8361|dmusselman@med.miami.edu|
21231297|NCT02335294|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
21231298|NCT00545168|ParaPRO LLC|Director, Quality and Regulatory|317-810-6205|kerrym@parapro.com|
21231299|NCT01218204|GlaxoSmithKline|GSK Response Center|866-435-7343||
21231300|NCT03508921|Vanderbilt Medical Center|Melissa Kaufman, MD, PhD Professor of Urology|615-322-3807|melissa.kaufman@vumc.org|
21289738|NCT01452347|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21289739|NCT01030900|National Cancer Institute|Dr. Wyndham Wilson|(240) 760-6092|wilsonw@mail.nih.gov|
21289740|NCT00441896|Marinus Pharmaceuticals, Inc.|Marinus|484-801-4670|clinicaltrials@marinuspharma.com|
21289741|NCT01301092|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21289742|NCT03334175|UCSF|Meghana Gadgil|4153537922|meghana.gadgil@ucsf.edu|
21289743|NCT01350973|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21289744|NCT02507284|Azevan Pharmaceuticals, Inc.|Neal Simon, PhD|(610) 419-1057|ngsimon@azevan.com|
21289745|NCT00853047|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD||plapuerta@lexpharma.com|
21289746|NCT02638493|University of North Carolina at Chapel Hill|Julie B. Dumond, PharmD, MS, BCPS, AAHIVP|919-966-5017|jdumond@unc.edu|
21289747|NCT01567085|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc. (Sponsor)||clinicaltrials@alexion.com|
21289748|NCT03150797|UCSF|Dr. Amy Gelfand|415-502-1914|amy.gelfand@ucsf.edu|
21289749|NCT00324857|VA|Said A. Ibrahim, MD, MPH|215 823 5800|Said.Ibrahim2@va.gov|7163
21238923|NCT02272725|Stanford University School of Medicine|Dr. Grant Lipman|415-290-9286|gslipman@stanford.edu|
21238924|NCT00140205|BIDMC|Dr. Christos mantzoros|6176671656|cmantzor@bidmc.harvard.edu|
21289750|NCT05715346|Levation Pharma|Houman Hemmati, M.D., Ph.D.|424 274 2642|info@levationpharma.com|
21289751|NCT03537729|Grand Valley State University|Dr. Rebecca Davis|616.331.3079|davirebe@gvsu.edu|
21289752|NCT03404167|DynPort Vaccine Company LLC, a GDIT Company|George A. Saviolakis, MD, PhD, Medical Director|1-240-651-8116|George.Saviolakis@gdit.com|
21289753|NCT01148420|Harbor - UCLA Medical Center|Anita Nelson|310-222-3871|anitanelsonwhc@earthlink.net|
21238925|NCT02584725|Columbia University Irving Medical Center|Robert Maniker, MD|212-305-9876|rm3046@cumc.columbia.edu|
21238926|NCT01816763|VA Palo Alto|Karl Lorenz MD MSHS, Principal Investigator|6504935000|kalorenz@stanford.edu|
21238927|NCT01746043|UT MD Anderson Cancer Center|Lin,Steven H,M.D. Ph.D. / Radiation Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
21238928|NCT03171480|The Ohio State University|Kara Rood, MD|440-321-0264|kara.rood@osumc.edu|
21289754|NCT03403517|Rigshospitalet|Kristin steinthorsdottir|004531666112|kjs@dadlnet.dk|
21289755|NCT00284934|Novartis Pharmaceuticals|Study Director|862-778-8300||
21289756|NCT00454142|National Cancer Centre Singapore|Dr. Wan Teck LIM|65-64368174|dmolwt@nccs.com.sg|
21289757|NCT01389284|Bayer HealthCare LLC, Consumer Care|Head Medical Affairs||clinical-trials-contact@bayerhealthcare.com|
21238929|NCT01373931|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21289758|NCT01245751|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21238930|NCT00742079|Massachusetts General Hospital|Jennifer Gottlieb, PhD|617-912-7800|jgottlieb2@partners.org|
21238931|NCT00991341|New England Research Institutes|Susan Assmann, PhD|617-972-3048|sassmann@neriscience.com|
21289759|NCT02504775|GlaxoSmithKline|GSK Response Center|866-435-7343||
21289760|NCT01783015|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21289761|NCT00504556|Daiichi Sankyo Inc.|William Maxwell, Assoc. Director|732-590-5000|wmaxwell@dsi.com|
21231301|NCT04390191|Icahn School of Medicine at Mount Sinai|Dr. Neomi Shah|212-241-6286|neomi.shah@mssm.edu|
21278255|NCT02312063|Kansai Electric Power Medical Research Institute|Dr. Daisuke Yabe|+81-6-6458-5821|ydaisuke-kyoto@umin.ac.jp|
21278256|NCT01412372|University of Utah|Dr. Ashok Tuteja|801-581-5679|Ashok.Tuteja@hsc.utah.edu|
21278257|NCT02876575|Medtronic|Melody LaBeau, Director of Clinical Operations|7635262931|melody.a.labeau@medtronic.com|
21278258|NCT01769339|Janssen Philippines|Medical Affairs Manager|+6328248935||
21278259|NCT01195272|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21278260|NCT03544879|UC San Diego|Dr. Erik Groessl|858-642-6347|egroessl@ucsd.edu|
21278261|NCT03548064|University of Maryland|Wilbur H. Chen, MD, MS|410-706-1188|wchen@som.umaryland.edu|
21278262|NCT05730556|Mayo Clinic|Amaal Starling, M.D.|715-537-1345|Starling.Amaal@mayo.edu|
21278263|NCT04941729|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
21278264|NCT06262191|Northern Arizona University|PI|928-523-1787|zachary.lerner@nau.edu|
21278265|NCT03299088|U of California Davis|Leslie Garcia|916-734-0156|lesgarcia@ucdavis.edu|
21278266|NCT00759902|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com|
21278267|NCT04305587|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21278268|NCT01523457|Yale University|Jill Lacy|+1 (203) 737-1600|jill.lacy@yale.edu|
21278269|NCT02752906|Sanofi Pasteur Inc.|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21278270|NCT05984186|Vapotherm|Katherine Gerich|5854696753|kgerich@vtherm.com|
21278271|NCT01404923|Laboratoires Mayoly Spindler|Clinical trials Manager|33 134805555|contact_essais_cliniques@mayoly-spindler.fr|
21278272|NCT03398070|Massachusetts General Hospital|David Perez|6177262000|dlperez@partners.org|
21278273|NCT04711902|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21278274|NCT03786718|Vanderbilt University Medical Center|William Martinez, MD|(615) 936-1010|william.martinez@vumc.org|
21278275|NCT03190213|Huntsman Cancer Institute Research Compliance Office|Data Manager|8015850601|compliance@hci.utah.edu|
21278276|NCT03244644|Rebiotix inc, a Ferring Company|Clinical Development|651-705-8778|US8-StudyInfo@ferring.com|
21278277|NCT01781481|Children's HOspital of Eastern Ontario|Dr. Janice Cohen|613-737-7600|cohen@cheo.on.ca|2497
21231302|NCT03978832|Indivior Inc|PERSERIS Medicines Development Lead and Head Global Clinical Operations and Development|804 379-1090|regan.fong@indivior.com|
21231303|NCT02244606|SCYNEXIS|Dr. David Angulo|(201) 884 - 5471|david.angulo@scynexis.com|
21231304|NCT02248103|Faculty of Oral and Dental Medicine Cairo University|Ass. Prof. Dr. Noha Ghallab|+201005263365|noha.ghallab@dentistry.cu.edu.eg|
21231305|NCT03647033|National University Hospital|Dr. David Chen|+6594550281|david_chen@nuhs.edu.sg|
21231306|NCT04605484|AlloVir, Inc.|Richard Riese|617-433-2605|rriese@allovir.com|
21231307|NCT04171531|RTI International|Marie Gantz|919-541-5110|mgantz@rti.org|
21231308|NCT00265798|University of Chicago|Dr. Hedy L. Kindler|773-702-0360|hkindler@medicine.bsd.uchicago.edu|
21231309|NCT03366337|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21231310|NCT05288062|Mayo Clinic|Wilson I. Gonsalves, MD|507-266-5947|Gonsalves.Wilson@mayo.edu|
21231311|NCT02099708|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21231312|NCT04026308|UAMS|Michael Wilson|501-686-8729|MPWilson@uams.edu|
21231313|NCT04171050|University of California, Los Angeles|Tamara Grisales, MD|310-983-1023|tgrisales@mednet.ucla.edu|
21231314|NCT04518293|George Medicines Pty Limited|Anthony Rogers (Principal Investigator)|+44-7983 578 290|arodgers@georgeinstitute.org|
21231315|NCT01658072|Hospital for Special Surgery|Kethy Jules-Elysee, MD|2126061206|juleselyseek@hss.edu|
21231316|NCT05451225|Columbia University|Dr. Michael Compton|646-774-8476|mtc2176@cumc.columbia.edu|
21231317|NCT04746963|AsclepiX Therapeutics|Dr A Shojaei|800-572-3545|info@asclepix.com|
21231318|NCT00799422|Alcon Research, Ltd.|Head, Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
21231319|NCT00880009|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21231320|NCT04456959|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21231321|NCT04584645|Evidation Health|Director, Enterprise Research Design|650-389-9550|results@evidation.com|
21231322|NCT00545662|Columbia University|Dr. William Friedewald|212-305-3017|wtf1@columbia.edu|
21231323|NCT01146418|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21231324|NCT03789474|ALL INDIA INSTITUTE OF MEDICAL SCIENCES,RISHIKESH,UTTARAKHAND,INDIA.|Dr M KESARI|7093005219|kesyellow@yahoo.com|
21231325|NCT03708328|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21231326|NCT04523220|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21231327|NCT02010775|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21231328|NCT02006719|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
21231329|NCT03123913|University of Rochester Medical Center|Chad Heatwole, MD, MS-CI|585-275-7867|dystrophy_registry@urmc.rochester.edu|
21231330|NCT02439138|Dana-Farber Cancer Institute|Jorge J. Castillo|617-632-6045|jorgej_castillo@dfci.harvard.edu|
21231331|NCT02517567|Alcon, A Novartis Division|Sr Global Brand Medical Affairs Lead, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
21231332|NCT02615145|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21231333|NCT00006237|SWOG statistical office|SWOG Melanoma Statistician|206-667-4408||
21231334|NCT03727347|Aerin Medical, Inc.|Anais Laborde|(650) 518-9624|alaborde@aerinmedical.com|
21231335|NCT02320669|Seattle Childrens hospital|Michael A Portman|206-987-1014|michael.portman@seattlechildrens.org|
21231336|NCT01257087|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
21231337|NCT01846416|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21231338|NCT01893632|NYSPI|john mariani, md|646-774-6140|john.mariani@nyspi.columbia.edu|
21231339|NCT02144012|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21231340|NCT00317356|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21231341|NCT00598832|Galderma|Michael Graeber MD/ Head of Global Clinical Project Management|609-860-8201|michael.graeber@galderma.com|
21231342|NCT02142959|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21231343|NCT02136810|Yale School of Medicine|Dr. Robert Schonberger, PI|203-785-2802|robert.schonberger@yale.edu|
21231344|NCT05284656|Al-Azhar University|Amira Reda Muhammad|0106 822 0389|amira.reda89@hotmail.com|
21231345|NCT02016560|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
21231346|NCT01943292|Verastem|Lou Vaickus, MD, FACP/Chief Medical Officer|781-292-4200|lvaickus@verastem.com|
21231347|NCT00911820|Dana-Farber Cancer Insitute|Peter Enzinger, MD|617-632-6855|Peter_Enzinger@dfci.harvard.edu|
21231348|NCT00996216|GlaxoSmithKline|GSK Response Center|866-435-7343||
21231349|NCT05519540|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21231350|NCT02804932|University of Iowa|Dr. Darren Casey|13193841009|darren-casey@uiowa.edu|
21231351|NCT03825315|Revance Therapeutics, Inc.|Todd Gross, PhD, VP, Clinical Development & Data Science|510-742-3400|tgross@revance.com|
21231352|NCT00963547|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21231353|NCT00279591|University of Arkansas for Medical Sciences|Dr. Michael Stroud|501-364-1861|StroudMichaelH@uams.edu|
21289762|NCT03607695|University of Washington|Valerie E. Kelly, PT, PhD|206-598-5350|vekelly@uw.edu|
21289763|NCT02741193|NYU Langone Health|Anli Liu|9294552340|Anli.Liu@nyulangone.org|
21289764|NCT02320825|Memorial Sloan Kettering Cancer Center|Dr. Ilya Laufer, MD|212-639-2368|lauferi@mskcc.org|
21289765|NCT02502383|University of New Mexico Health Sciences|Alberta Kong|505-272-5551|AKong@salud.unm.edu|
21289766|NCT00289978|Novartis Pharmaceuticals|Study Director|862 778-8300||
21289767|NCT00903344|University of Kansas Medical Center|Dr. Leigh Eck|913-588-6022|leck2@kumc.edu|
21289768|NCT00382928|Atlanta Research and Education Foundation|Dr. A. Maziar Zafari|404-321-6111|azafari@emory.edu|4019
21289769|NCT01243424|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21289770|NCT01034527|Mayo Clinic|Dr. Timothy Hewett|513-636-5971|hewett.timothy@mayo.edu|
21289771|NCT00299221|Newark Beth Israel Medical Center|David Baran MD|973-926-7205|dbaran@barnabashealth.org|
21289772|NCT02164721|University of Rochester|Valentina Kutyifa MD, PhD|585-275-2676|valentina.kutyifa@heart.rochester.edu|
21289773|NCT02016885|Dermira Inc.|Eugene A. Bauer, MD, Chief Medical Officer|650-421-7202|eugene.bauer@dermira.com|
21289774|NCT01215240|University of Alberta|Dr. Lindsay Ryerson|780 407 3396|ryerson@ualberta.ca|780
21289775|NCT03926598|Research Scientist|Jiten Chhabra|4048942000|jiten@imtc.gatech.edu|
21289776|NCT01093885|University of Pennsylvania Health System|Dr. Chris Derk|215-662-2792|chris.derk@uphs.upenn.edu|
21289777|NCT01301001|University of Tennessee Health Science Center|Dr. Candace Brown|9014124341|CSBROWN@TENNESSEE.EDU|
21289778|NCT01560988|Brigham and Women's Hospital|Dr. Joshua Boyce|617-525-1261|jboyce@partners.org|
21289779|NCT01160744|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21289780|NCT04366583|Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan|Dr. Huay-Min Wang|+886-7-3422121|hmwang@vghks.gov.tw|2075
21289781|NCT01282138|Alcon Research|Head, Global Medical Affairs|1-800-862-5266|medinfo@alconlabs.com|
21289782|NCT02301429|Medtronic Regional Clinical Center|Clinical Study manager|0039(0)22 241371|laura.manotta@medtronic.com|
21289783|NCT01502072|UT MD Anderson Cancer Center|Roy F. Chemaly, MD,MPH- Professor, Infectious Diseases|(713) 745-1116|rfchemaly@mdanderson.org|
21289784|NCT00500110|MD Anderson Cancer Center|Quality Assurance Specialist|713-563-1602|caperez@mdanderson.org|
21289785|NCT00605657|NIAID|V. Koneti Rao, MD|301-496-6502|korao@niaid.nih.gov|
21238932|NCT00864708|NF/SG VA Medical Center, Gainesville Florida|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center of Excellence|(352) 376-1611|janis.daly@neurology.ufl.edu|5223
21238933|NCT04461795|Clinvest Research|Jim Sly|417-841-3673|jsly@clinvest.com|
21238934|NCT00615264|CBR International|Dr. Jeanne Novak|7207461190|jnovak@cbrintl.com|
21238935|NCT00058422|Memorial Sloan Kettering Cancer Center|Paul A. Hamlin, M.D.|646-608-1667|hamlinp@mskcc.org|
21238936|NCT00185640|Stanford University|Robert Lowsky|650-723-0822|rlowsky@stanford.edu|
21238937|NCT01134601|National Cancer Institute|Dr. Deborah E. Citrin|301-496-5457|citind@mail.nih.gov|
21238938|NCT01817374|UAB Radiology Research|Marianne Vetrano|205-934-4080|mvetrano@uabmc.edu|
21238939|NCT03154281|Avera Cancer Institute|Dr. Casey Williams|6053223588|Casey.Williams@avera.org|
21238940|NCT03863522|Johns Hopkins University|Dr. Sara Sukumar|4106142479|saras@jhmi.edu|
21238941|NCT02884414|Stanford University|Jennifer Hledik|650-493-5000|jerhart@stanford.edu|62388
21238942|NCT02396537|University of Alabama at Birmingham|Dr. Christopher Pruitt|2056389587|cpruitt@peds.uab.edu|
21238943|NCT01982435|Cleveland Clinic Foundation|Dr. Justis Ehlers|216-636-0183|Ehlersj@ccf.org|
21238944|NCT00871403|GlaxoSmithKline|GSK Response Center|866-435-7343||
21238945|NCT00304512|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
21238946|NCT00708435|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
21238947|NCT01691521|GlaxoSmithKline|GSK Response Center|866-435-7343||
21238948|NCT03954743|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21238949|NCT02281760|National Human Genome Research Institute|Gahl, William|+1 301 402 2739|gahlw@mail.nih.gov|
21238950|NCT00860067|MedImmune LLC, an affiliate of AstraZeneca AB|Judith Falloon, MD/ Sr. Dir. Clinical Development|301-398-0000|falloonj@medimmune.com|
21289786|NCT04821245|Benaroya Research Institute|Joseph M. Neal, MD|206-223-6980|Joseph.Neal@virginiamason.org|
21289787|NCT02284854|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21289788|NCT03646188|Medicus Pharma|Dr. Huma Qamar, MD., Chief Scientific Officer|610- 540-7515|hqamar@medicuspharma.com|106
21289789|NCT00397046|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
21289790|NCT03636269|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
21289791|NCT04250363|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21289792|NCT01291160|Ogenix|S.Sarangapani|7817026732|ssarangapani@ogenix.com|
21289793|NCT01975285|Department of Anesthesiology at Cedars-Sinai Medical Center in Los Angeles|Roya Yumul, M.D., Ph.D.|310-423-5841|(Roya.Yumul@cshs.org)|
21289794|NCT02852434|Stanford University Division of Family Planning Services and Research|Stanford University, Department of OB/GYN|6507211562|familyplanningresearch@stanford.edu|
21289795|NCT05075772|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21289796|NCT03203512|University of Reading|Professor Parveen Yaqoob|+443787113|p.yaqoob@reading.ac.uk|
21289797|NCT01145222|PAION UK Ltd|Trial Information||reg_paion@paion.com|
21238951|NCT00100932|Eisai|Dr. Peter Tarassoff|888-422-4743||
21238952|NCT01159743|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21238953|NCT00829686|Wilford Hall Medical Center|Gillian Schmitz, MD|919-724-9185|gillianmd@gmail.com|
21289798|NCT00604383|Chromaderm|info@chroma-derm.com||info@chroma-derm.com|
21289799|NCT01698008|University of Nebraska Medical Center|Whitney Goldner|402-559-3579|wgoldner@unmc.edu|
21289800|NCT00508300|lausanne university hospital|martin hübner|+41795561506|martin.hubner@chuv.ch|
21289801|NCT01011283|Eisai Inc.|Erhan Berrack, M.D.|888-422-4743||
21289802|NCT00943202|Division of Infectious Diseases and Immunology, Saint Louis University Medical School|Sharon E. Frey, M.D.|314-977-5500|freyse@slu.edu|
21289803|NCT02619812|Mayo Clinic|Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
21289804|NCT00191152|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21289805|NCT04219774|Duke University|David Hasan, MD, MSc|919-684-7777|david.hasan@duke.edu|
21289806|NCT00114777|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21289807|NCT02371252|Mahidol University|Dr. Aasis Unnanuntana|+66836871159|uaasis@gmail.com|
21289808|NCT02636322|University of Texas M D Anderson Cancer Center|Dr. Jason Westin|(713) 792-3750|jwestin@mdanderson.org|
21289809|NCT02280499|Smith & Nephew|Evita Leiber, Clinical Study Manager|+41 41 766 2205|evita.leiber@smith-nephew.com|
21289810|NCT02826551|Cedars-Sinai|Josh Page|3104233198|josh.page@cshs.org|
21289811|NCT01109381|Synergy Pharmaceuticals Pte Ltd|Medical Director|+64 9 522 4278|damian@pethica.net|
21289812|NCT02018809|University of Pennsylvania|Dr. Peter P. Reese|215-898-6086|peter.reese@uphs.upenn.edu|
21289813|NCT03511066|Celltrion|Clinical Planning Department Leader|82328505000|contact@celltrion.com|
21289814|NCT01270867|Concentric Medical / Stryker Neurovascular Inc|Paula Schmidt, Clinical Project Manager|510-413-2271|paula.schmidt@stryker.com|
21289815|NCT04560309|Nationcal Cardiovascular Center Harapan Kita|I Made Adi Parmana, M.D.|+62 812-4601-212|adiparmana13@gmail.com|
21289816|NCT05085405|University of Michigan|Dr. Jacob E Kurlander, MD, MS|734-647-9252|jkurland@umich.edu|
21289817|NCT04146909|Yale School of Medicine|Renata Belfort De Aguiar, MD, PhD|(203) 785-5331|renata.aguiar@yale.edu|
21289818|NCT01860404|Children's Hospital of Philadelphia|Dr. Daniel Corwin|215-327-2306|corwind@chop.edu|
21289819|NCT01106950|Masonic Cancer Center, University of Minnesota|Jeffrey S. Miller, M.D.|612-625-7409|mille011@umn.edu|
21289820|NCT00356421|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21289821|NCT00663351|Smith & Nephew, Inc.|Rachael Winter, Director, Global Clinical Operations|+44 1482 673475|rachael.winter@smith-nephew.com|
21289822|NCT03336866|InterveXion Therapeutics|Chief Operating Officer|5015542377|misty.stevens@intervexion.com|
21289823|NCT03462563|Ethicon SARL|Richard Kocharian|+1 609 6423787|rkochar1@its.jnj.com|
21289824|NCT04203056|University of California, Los Angeles|Kenneth Subotnik, PhD|3108250334|ksubotnik@mednet.ucla.edu|
21289825|NCT03011372|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21289826|NCT03738215|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21289827|NCT03277274|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
21289828|NCT05894564|Duke University|Susanna Naggie, MD, MHS, FIDSA|919-684-2584|susanna.naggie@duke.edu|
21289829|NCT02724644|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquires@endo.com|
21289830|NCT01045265|Maple Leaf Research|Tony Antoniou|4164657936|tantoniou@smh.toronto.on.ca|
21289831|NCT00676052|GlaxoSmithKline|GSK Response Center|866-435-7343||
21260962|NCT02770807|Quince Therapeutics (former Erydel SpA)|Irene Maccabruni, M.Sc.|+39 02 36504470|imaccabruni@quincetx.com|
21260963|NCT04907045|Kaiser Permanente Washington Health Research Institute|Joseph E Glass, PhD|206-287-4266|joseph.e.glass@kp.org|
21289832|NCT02930941|University of California, Davis Medical Center|Aimee Moulin, MD|916-703-6110|akmoulin@ucdavis.edu|
21289833|NCT03794323|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21238954|NCT02387996|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21238955|NCT00818363|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
21238956|NCT00633919|ALK-Abelló S.A.|Santiago Martín - Trial Manager|+34 913276127|santiago.martin@alk-abello.com|
21238957|NCT02756832|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21238958|NCT00622713|Novartis Pharmaceuticals|Study Director|862-778-8300||
21238959|NCT03564782|Istari Oncology|W. Garrett Nichols, MD MS|919-245-7662|info@istarioncology.com|
21289834|NCT01084759|SKCCC at Johns Hopkins|Dr. Samuel Denmeade|410-955-8875|denmesa@jhmi.edu|
21289835|NCT00527748|University of Missouri|Dr. Saul G Trevino|573/884-8840|trevinos@health.missouri.edu|
21238960|NCT02786264|Yale School of Medicine|Dr. Robert Schonberger|2037852802|robert.schonberger@yale.edu|
21238961|NCT00993824|International Diabetes Center|Roger Mazze PhD|952-993-3796|rmazze@aol.com|
21238962|NCT05414318|W.L. Gore & Associates|Charee Robe|928-864-4048|crobe@wlgore.com|
21238963|NCT03434457|Douglas Mental Health University Institute|Dr Patricia Pelufo Silveira|1514-761-6131|patricia.silveira@mcgill.ca|3928
21238964|NCT02413463|Faculty of Medicine, Cairo University|Ahmed Awadein, MD|201223911743|ahmedawadein@yahoo.com|
21238965|NCT03728972|Memorial Sloan Kettering Cancer Center|Dr. Malin Hultcrantz MD, PhD|646-608-3714|hultcram@mskcc.org|
21238966|NCT04203537|Concentric Analgesics|Nancy Wu|(415) 484-7921|nancy@concentricanalgesics.com|
21289836|NCT00710554|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
21289837|NCT01346709|European Society of anaesthesiology|Brigitte Leva, Research Team Leader|+3222109414|research@esahq.org|
21238967|NCT00895622|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21238968|NCT01081041|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21238969|NCT03635489|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21238970|NCT02010632|Khon Kaen University|Miss Nontaya Nakkam|66862642540|nonna_na@hotmail.com|
21238971|NCT01547299|Medivation, Inc.|William Novotny, MD, Sr. Director, Clinical Development|415- 983-3066|william.novotny@medivation.com|
21238972|NCT01987817|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
21289838|NCT01990352|George Washington Cancer Center|Dr. Pavani Chalasani|(202)-741-2277|pavani.chalasani@email.gwu.edu|
21289839|NCT00949078|Johns Hopkins University School of Medicine|Professor Robert Wood, M.D.|rwood@jhmi.edu|rwood@jhmi.edu|
21289840|NCT02194088|Brigham and Women's Hospital|Edwards Robert|617-732-9486|rredwards@partners.org|
21289841|NCT03737032|University of Pittsburgh Medical Center, Department of Psychiatry|Dr. Erika Forbes|412-383-5438|forbese@upmc.edu|
21289842|NCT01531803|Kedrion S.p.A|Dr. Mirella Calcinai, MD, Clinical Research Director|+393486559761|m.calcinai@kedrion.com|
21289843|NCT02773537|Medical University of South Carolina|Dr. Eric Bolin|843-792-2322|bolin@musc.edu|
21289844|NCT00383565|MD Anderson Cancer Center|Dr. Luis E. Fayad / Associate Professor|713-792-2860|jmdennison@mdanderson.org|
21231354|NCT02038023|AUERBACH HEMATOLOGY ONCOLOGY ASSOC|Dr Michael AUERBACH|410-780-4050|MAUERBACHMD@ABHEMONC.COM|
21231355|NCT03761277|Medtronic Neuromodulation Clinical Research|Pain Therapies Clinical Research Director|763-514-4000|rs.embracetdd@medtronic.com|
21289845|NCT02421510|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21231356|NCT00903695|UOklahoma Health Sciences Center|Marilee Monnot, PhD|405-456-5773|marilee-monnot@ouhsc.edu|5773
21231357|NCT04882540|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21231358|NCT02430311|Astrazeneca|Gershon Locker|+1 773 868 0184|Gershon.Locker@astrazeneca.com|
21231359|NCT00578812|NuVasive, Inc|Julie Pairamore, Sr. Manager, Clinical Affairs|858-320-5258|jpairamore@nuvasive.com|
21231360|NCT01804296|Mayo Clinic|Paul E. Croarkin, D.O., M.S.|507-293-2557|Croarkin.Paul@mayo.edu|
21289846|NCT02053584|Wolfson Medical Center|Dr. Julio Weinstein|972-3-5028371|vainstein@wolfson.health.gov.il|
21289847|NCT02203786|Centre for Addiction and Mental Health|Dr. Daniela Lobo, Qualified Investigator for Study, Clinician-Scientist|416-535-8501|Daniela.Lobo@camh.ca|36568
21289848|NCT02264821|CHU Brugmann|Dr Madeleine Wilwerth|003224773996|madeleine.wilwerth@chu-brugmann.be|
21289849|NCT00619242|The University of Chicago|Ezra Cohen, MD|773/702-4137|ecohen@medicine.bsd.uchicago.edu|
21289850|NCT03142334|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21289851|NCT05574764|Duke University|Emily M. D'Agostino, DPH, MS, MEd, MA|646-853-1223|emily.m.dagostino@duke.edu|
21289852|NCT03528577|SPIL|Clinical Trials|912266455645|clinical.trials@sparcmail.com|
21289853|NCT04882215|University of Glasgow|Professor Jonathan Evans|0141 330 3299|Jonathan.Evans@glasgow.ac.uk|
21289854|NCT03911687|Columbia University|Sarah Collins Rossetti, PhD|2123056605|sac2125@cumc.columbia.edu|
21289855|NCT04098302|UConn Health|Jonathan Covault Study PI|860-679-7560|jocovault@uchc.edu|
21289856|NCT05061706|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646 440-9333|ITCIClinicalTrials@itci-inc.com|
21289857|NCT02043847|University of Illinois at Chicago|Dr. Rondelli|312-996-6179|drond@uic.edu|
21289858|NCT00601107|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21289859|NCT03892915|RAND Corporation|Glenn Wagner|310-393-0411|gwagner@rand.org|7695
21289860|NCT01181128|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21289861|NCT04477486|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21289862|NCT02502071|University of Colorado School of Medicine|Dr. Petter Bjornstad, Assistant Professor|7207774659|petter.bjornstad@childrenscolorado.org|
21289863|NCT02336503|Botanix Pharmaceuticals|Vice President, Head of Development|+1 (445) 300-3403|trials@botanixpharma.com|
21289864|NCT01543503|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21289865|NCT02460380|Maimonides Medical Center|Mohamad Irani|3472862167|mohamad.irani@hotmail.com|
21289866|NCT02201628|King's College Hospital NHS Foundation Trust|Dr Emily Haberman|07890549924|emilysaffer@gmail.com|
21289867|NCT02957123|Institute of Fundamental and Clinical Immunology|Alexander A Ostanin, MD, PhD|+7 (383) 236-03-29|ostanin62@mail.ru|
21289868|NCT01478087|Mayo Clinic|Jeffrey Lawrence Winters, MD|507-538-1707|winters.jeffrey@mayo.edu|
21289869|NCT03095976|Indiana University School of Dentistry|Dr. Yusuke Hamada|317-274-5121|yuhamada@iupui.edu|
21289870|NCT03566550|University of Nottingham|Professor Alan Smyth|01158230612|alan.smyth@nottingham.ac.uk|
21289871|NCT02614768|Medical University of Graz|Mader, Julia, Assoz. Dr.med.univ.|0043316385|julia.mader@medunigraz.at|12383
21289872|NCT04576949|Achieve Life Sciences|Daniel Cain, Vice President, Clinical Research|425.686.1546|dcain@achievelifesciences.com|
21260964|NCT00222105|University of Kansas Medical Center|Cancer Center Clinical Trials Office|(913) 945-5059|SWILLIAM@kumc.edu|
21260965|NCT00853632|Edwards Lifesciences|Director of Clinical Affairs|949-250-2500|Aya_Westbrook@edwards.com|
21260966|NCT01385696|Almirall S.A.|Clinical Project Leader and Trial Manager|+34 93 291 3200||
21289873|NCT04957082|Michigan State University|Dr. Todd Lucas|810-600-5629|lucastod@msu.edu|
21289874|NCT00052715|North American Brain Tumor Consortium|Michael Prados, MD|410-955-8837|jfisher@jhmi.edu|
21289875|NCT01936974|CTCA|Jessica Coats, RN|6232073899|jessica.coats@ctca-hope.com|
21289876|NCT00986583|Cleveland Clinic|Alparslan Turan, M.D.|216-444-4000|turana@ccf.org|9857
21289877|NCT00063999|NRG Oncology|Linda Gedeon for Virginia Filiaci, PhD.|716-545-8321|lgedeon@gogstats.org|
21289878|NCT03335267|Weill Cornell Medical College|Dr. Ellen K. Ritchie|646-962-2700|ritchie@med.cornell.edu|
21289879|NCT05938816|Oregon Health and Science University|Josh Kaplan, PhD|503) 494-8311|kaplajos@ohsu.edu|
21289880|NCT01078545|Abbott|Global Medical Services|1-800-633-9110||
21289881|NCT02497755|University of Washington|Dr. Amy Bauer|206.221.8385|abauer1@uw.edu|
21289882|NCT02864914|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
21231361|NCT00309387|University of Parma|Giovanni Maraini, MD|+39 0521 238527|maraini@unipr.it|
21260967|NCT03528681|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21278278|NCT00372411|Dept. of Veterans Affairs, Cooperative Studies Program, West Haven, CT|Peter Guarino, MPH, PhD, Director, WH-CSPCC|203-932-5711|peter.guarino@va.gov|3780
21278279|NCT01398514|Massachusetts General Hospital|Dr. Naomi Simon|617-726-7913|nsimon@partners.org|
21278280|NCT04208958|Vedanta Biosciences|Jeffrey Silber|(857) 706-1427|ConsortiumIO-ctinquiries@vedantabio.com|
21278281|NCT02622113|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21278282|NCT02326337|AOTI Ltd.|Dr. Mike Griffiths (Medical Director)|+1(760) 431 4700|mike.griffiths@aotinc.net|
21278283|NCT01570686|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21278284|NCT02244918|University of Kansas Medical Center|Dr. Nicole Nollen|913-588-3784|nnollen@kumc.edu|
21278285|NCT00505375|Benaroya Research Institute|Carla Greenbaum||cjgreen@benaroyaresearch.org|
21278286|NCT01345175|Memorial Sloan Kettering Cancer Center|Dr. Philip Paty, MD|212-639-6703|patyp@MSKCC.ORG|
21278287|NCT03688282|TheraNova|Vice President of Research and Development|415-926-8616|clinicalstudy@theranova.com|
21278288|NCT01561430|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21278289|NCT04112173|University of Delaware|Jeremy Crenshaw, Ph.D.|302-831-4795|crenshaw@udel.edu|
21278290|NCT01055132|Johnson & Johnson Vision Care|Ross Franklin|1-904-443-1379|RFrankl1@its.jnj.com|
21278291|NCT02746471|Medtronic|Erika Pouliot|17635261270|erika.pouliot@medtronic.com|
21278292|NCT02551432|Seoul National University Hospital|Bhumsuk Keam|82+10-3231-2208|bhumsuk@snu.ac.kr|
21278293|NCT01007942|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21278294|NCT04492020|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21278295|NCT03614897|Transcend Medical Group|Alicia Harbison|5708874882|aliciajeanbrown@gmail.com|
21278296|NCT00556400|NICHD|Dr. Pamela Stratton|301 496-9079|strattop@mail.nih.gov|
21278297|NCT04645966|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21278298|NCT00470067|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21278299|NCT01460901|Children's Mercy Hospitals and Clinics|Dr. Gary Douglas Myers|8163026817|gdmyers@cmh.edu|7-6817
21278300|NCT01992523|Careggi Hospital|Guido Parodi|00390557947732|parodiguido@gmail.com|
21278301|NCT00296231|University of Iowa|Tarah Colaizy||tarah-colaizy@uiowa.edu|
21278302|NCT00895947|Amarillo Biosciences, Inc.|Martin J. Cummins|806-376-1741|mcummins@amarbio.com|14
21278303|NCT02176408|NYU Langone Health|Kristin Szuhany|6467545161|kristin.szuhany@nyulangone.org|
21278304|NCT01243112|Scott & White Healthcare|James Collins, MD|254-724-7508|jbcollins@swmail.sw.org|0612
21278305|NCT00375830|Stanford University|Andrei Iagaru, Professor of Radiology (Nuclear Medicine)|650-725-4711|aiagaru@stanford.edu|
21278306|NCT03756506|Prevent-Plus|Jeff Elbl|314-606-5046|jeff.elbl@prevent-plus.com|
21278307|NCT01059344|The Role of Centralized Reading of Endoscopy in a Randomized Controlled Trial of Mesalamine for Ulcertive Colitis|Brian G. Feagan et al|Gastroenterology 2013; 145:||149-157
21289883|NCT01774370|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21289884|NCT01118091|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
21289885|NCT00514917|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
21289886|NCT01895647|Mackay Memorial Hospital|Dr. Kuang-Hua Cheng|886-975837711|jeff01@mmh.org.tw|
21289887|NCT04243837|PureTech Health, Inc|Director of Clinical Trials|6034982261|ckorth@puretechhealth.com|
21289888|NCT01708525|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
21289889|NCT02555098|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
21289890|NCT03501277|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
21289891|NCT01482286|Pennington Biomedical Research Center|Dr. Joshua R. Sparks|2257632928|joshua.sparks@pbrc.edu|
21289892|NCT01873833|USC Norris Comprehensive Cancer Center|Victoria Soto, Regulatory Administrator|323-865-0432|Victoria.Soto@med.usc.edu|
21289893|NCT03193307|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21289894|NCT00137280|Greater Los Angeles Veterans Healthcare Center|Dr. Alexander S. Young|310-268-3416|alexander.young@va.gov|
21289895|NCT05001165|VA Greater Los Angeles|Boback Ziaeian|310-478-3711|boback.ziaeian@va.gov|
21289896|NCT04193527|GE Healthcare Ltd.|Yongqing Tang, MD, PhD|21 38774044|Yongqing.Tang@ge.com|+86
21289897|NCT03808909|University of New Mexico, Health Sciences Center|Pilar Sanjuan|505/272-7055|psanjuan@salud.unm.edu|
21289898|NCT00632970|Medical Faculty Associates|Gary Simon|202 741-2234|Gsimon@mfa.gwu.edu|
21289899|NCT01487161|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
21289900|NCT03113136|OhioSUCCC|Dr. Theodore L. Wagener|614-366-4265|Theodore.Wagener@osumc.edu|
21289901|NCT03677180|Henry Ford Hospital|Dr. Mir Babar Basir|313-916-2896|mbasir1@hfhs.org|
21289902|NCT00977561|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21289903|NCT02187055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21289904|NCT04159480|University of Colorado, Anschutz Medical Campus|Lisa Brenner|7208481980|lisa.2.brenner@cuanschutz.edu|
21289905|NCT01751685|University of California, San Francisco|Wendy Katzman, PT|415-353-7598|Wendy.Katzman@ucsf.edu|
21289906|NCT01107457|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21289907|NCT00694161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21289908|NCT03601052|Viridian Therapeutics (formerly miRagen Therapeutics)|Regulatory Affairs|720-722-5917|clinicaltrials@viridiantherapeutics.com|
21289909|NCT01179399|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21289910|NCT03572218|Perelman School of Medicine at the University of Pennsylvania|Dr. Rebecca Pearl|215-746-5129|rpearl@pennmedicine.upenn.edu|
21289911|NCT04634903|Stony Brook University|Dr. Jessica Schleider|917-439-1872|jessica.schleider@stonybrook.edu|
21289912|NCT00476788|Greenville Hospital System|Elaine Moreland MD|8644545661|emoreland@ghs.org|
21289913|NCT00520572|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21289914|NCT03532490|Johns Hopkins University|Gem Roy|4432875796|groy2@jhu.edu|
21289915|NCT03548415|Ionis Pharmaceuticals, Inc|Ionis Pharmaceuticals, Inc|800-679-4747|patients@ionisph.com|
21289916|NCT01723839|John Theurer Cancer Center at Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
21289917|NCT04605588|Rutgers, The State University of New Jersey|Jeffrey L Carson, MD|732-235-7122|Jeffrey.Carson@Rutgers.edu|
21289918|NCT01230814|University of Arkansas for Medical Sciences|Shelly Lensing, MS|501-686-8203|sylensing@uams.edu|
21231362|NCT00208091|Clinical Motor Physiology Laboratory|Dr. Seth Pullman|212-305-3808|sp31@columbia.edu|
21289919|NCT02527265|MannKind Corporation|Clinical Development|844.323.7399|mapp@mannkindcorp.com|
21289920|NCT01803737|University of Arizona|David O. Garcia, PhD|520-626-4641|davidogarcia@email.arizona.edu|
21289921|NCT01748552|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21278308|NCT01739348|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21278309|NCT02695537|University of Alabama at Birmingham|Dr. Martina Bebin, MD|205-934-3866|ebebin@uab.edu|
21278310|NCT02792699|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21278311|NCT00997204|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21278312|NCT02440568|University of Illinois at Chicago|Dr. John Quigley|312-413-1300|seanq@uic.edu|
21278313|NCT02987959|Fox Chase Cancer Center|Protocol Developer|215-728-4097|ryan.romasko@fccc.edu|
21278314|NCT01011179|The Hospital for Sick Children|Dr. Jennifer Stinson|416-813-7654|jennifer.stinson@sickkids.ca|304514
21278315|NCT03285308|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21278316|NCT02283983|Centre Hospitalier Départemental Vendée|Dr. Frank PRIOU|0251446161|frank.priou@ght85.fr|+33
21278317|NCT03055650|Alcon Research, LLC|Senior CDMA Project Lead, CDMA Ocular Health|1-888-451-3937|alcon.medinfo@alcon.com|
21278318|NCT05308368|NC State University|Nitin Sharma|9195130787|nsharm23@ncsu.edu|
21278319|NCT00168311|Monash Alfred Psychiatry Research Centre|Professor Paul Fitzgerald|+61 3 9076 6564|p.fitzgerald@alfred.org.au|
21278320|NCT00669071|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
21278321|NCT00424775|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21278322|NCT01270724|Nationwide Children's Hospital|Megan Blue|614-722-3686|megan.blue@nationwidechildrens.org|
21278323|NCT02876926|Brown University School of Public Health|Dr. Tyler Wray|401-863-6659|tyler_wray@brown.edu|
21278324|NCT00944749|National Heart Lung and Blood Institute|Dr Danielle Townsley|301-402-3477|townsleydm@nhlbi.nih.gov|
21231363|NCT03684811|Forma Therapeutics, Inc.|Medical Affairs|(617) 679-1970|medicalinformation@formatherapeutics.com|
21231364|NCT01599234|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
21231365|NCT02033694|Infraredx, A Nipro Company|Priti Shah|781-345-9646|pshah@infraredx.com|646
21231366|NCT00786682|Cancer Institute of New Jersey|Dr. Mark Stein|732-235-8675|steinmn@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
21231367|NCT02041286|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
21231368|NCT01824901|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
21231369|NCT02950025|Washington University School of Medicine|Michael C. Roach, M.D.|314-747-1786|roachm@wustl.edu|
21231370|NCT01349790|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201 604-1155|michael.eppolito@octapharma.com|
21231371|NCT02495168|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
21231372|NCT02376361|Albany Medical College|Loay Salman, MD|518-262-5176|SalmanL@amc.edu|
21231373|NCT04166435|Yale University|Dr. Michael Cecchini|(203) 737-3472|michael.cecchini@yale.edu|
21231374|NCT03462082|University of Rochester|Karlo J Lizarraga, MD, MS / Assistant Professor of Neurology|585-341-7500|karlo.lizarraga@gmail.com|
21231375|NCT00919724|Indiana University School of Medicine|Samir K. Gupta, MD, MS|317-274-7926|sgupta1@iu.edu|
21231376|NCT00960778|Medical University of South Carolina|Dr. Karen Hartwell|843-792-8174|hartwelk@musc.edu|
21231377|NCT00127660|University of Minnesota|Lisa Harnack, DrPH|612-626-9398|harna001@umn.edu|
21231378|NCT01833520|UT MD Anderson Cancer Center|Vivek Subbiah,Associate Professor, Invest. Cancer Therapeutics|(713) 563-0393|vsubbiah@mdanderson.org|
21231379|NCT00859053|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21231380|NCT00489541|Boston Scientific|Andrey Nersesov, Clinical Project Manager|508-683-4988|andrey.nersesov@bsci.com|
21231381|NCT05131646|Clearside Biomedical, Inc.|Susan Coultas, PhD|678.270.3639|susan.coultas@clearsidebio.com|
21231382|NCT04028700|University of North Carollina at Chapel Hill|Matthew S. Karafin MD MS|984-974-1583|matthew.karafin@unchealth.unc.edu|
21231383|NCT01898611|University of Pennsylvania|Anne Cappola, MD|215-573-5359|acappola@mail.med.upenn.edu|
21231384|NCT03784729|Guang'anmen Hospital, China Academy Chinese Medical Sciences|Zhishun Liu|+86 010 88002331|liuzhishun@aliyun.com|
21231385|NCT00003479|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
21231386|NCT03348956|Dartmouth Hitchcock Medical Center|Victoria Lawson|(603) 650-5104|victoria.h.lawson@hitchcock.org|
21231387|NCT02128113|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21231388|NCT00299104|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
21231389|NCT03814356|Massachusetts General Hospital|Brian L. Edlow, M.D.|617-724-6352|bedlow@mgh.harvard.edu|
21231390|NCT02969369|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltraildisclosure@sunovion.com|
21231391|NCT04394286|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
21231392|NCT00187369|Sunnybrook Health Sciences Center|Dr Jon Barrett||jon.barrett@sunnybrook.ca|
21231393|NCT01774604|Penn State Hershey Medical Center/Dartmouth-Hitchcock Medical Center|John M. Levenick|603-667-1332|jlevenick@hmc.psu.edu|
21231394|NCT01484197|Novartis Pharmaceuticals|Study Director|862-778-8300||
21231395|NCT01727297|Medtronic, Inc.|Medtronic Cardiac Rhythm and Heart Failure clinical trial manager|763-505-6000|medtronicCRMtrials@medtronic.com|
21231396|NCT02042183|Mallinckrodt Pharmaceuticals|Clinical Team Leader|800-844-2830|clinicaltrials@mnk.com|5
21231397|NCT01192516|Veterans Affairs--Ann Arbor Health Care System|Research Health Science Specialist|734-936-2123|sumurphy@umich.edu|
21231398|NCT02254252|Mashhad University of Medical Sciences|Pouya Nezafati|00989151578421|nezafatip871@mums.ac.ir|
21231399|NCT02348606|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
21278325|NCT01490866|SCRI Development Innovations|Charles H. Davis, RAC|615 524-4341|charles.davis2@scri-innovations.com|
21231400|NCT02321800|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
21231401|NCT01051323|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21231402|NCT01193868|The University of Texas MD Anderson Cancer Center|George Blumenschein, MD / Professor|713-792-2734|CR_Study_Registration@mdanderson.org|
21231403|NCT03926169|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21231404|NCT03302234|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21231405|NCT04112784|Masimo Corporation|Ahmed Alghazi|949-297-7000|aalghazi@masimo.com|
21231406|NCT03936985|University of Utah|Gerald (Jerry) Cochran, PhD|801-213-0654|jerry.cochran@hsc.utah.edu|
21231407|NCT02030041|PGIMER|Anil Bhansali|01722756583|ashuendo@gmail.com|
21231408|NCT00833794|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
21231409|NCT00787852|BrUOG|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
21231410|NCT01372462|Clinical Research Consulting|Richard J. Morishige, MS, RRT|510-606-0375|rjmorishige@gmail.com|
21231411|NCT01866930|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|clinical.trials@bms.com|
21231412|NCT02288897|Provectus Biopharmaceuticals, Inc.|Eric Wachter, Chief Technology Officer|865-769-4011|wachter@pvct.com|23
21231413|NCT00519831|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
21231414|NCT02854631|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21231415|NCT02862171|International Partnership for Microbicides|Dr John Steytler|+27 21 8602300|jsteytler@ipmglobal.org|
21278326|NCT03082664|University of Chicago|Dr. Maritza G. Gonzalez|7737026118|mggonzalez@bsd.uchicago.edu|
21278327|NCT03201211|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21231416|NCT03930797|Fox Chase Cancer Center|Dr. Jennifer Reese, Associate Professor|215-214-3223|Jennifer.Reese@fccc.edu|
21278328|NCT01970865|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21278329|NCT04048343|AstraZeneca|Global Clinical Head|+1 302 885 1180|information.center@astrazeneca.com|
21278330|NCT02041091|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21278331|NCT03118570|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
21278332|NCT01531738|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
21278333|NCT01573169|Stroke Unit and Division of Internal and Cardiovascular Medicine University of Perugia, Santa Maria della Misericordia Hospital|Dr. Maurizio Paciaroni|+390755786424|maurizio.paciaroni@unipg.it|
21278334|NCT00321737|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
21231417|NCT00662012|Uniformed Services University of Health Sciences (USUHS)|Naomi Aronson, MD|(301) 295-3621|naomi.e.aronson.civ@mail.mil|
21289922|NCT01260324|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21289923|NCT00292370|Ralph H. Johnson VA Medical Center|Mark Hamner, MD|843-789-7799|Mark.Hamner@va.gov|
21289924|NCT02799290|Tampere University Hospital|Ilkka Kaartinen|505687096|ilkka.kaartinen@pshp.fi|
21289925|NCT02365064|Sleep and Human Health Institute|Dr. Barry Krakow|(505) 9987204|bkrakow@sleeptreatment.com|
21289926|NCT00662038|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21289927|NCT01840163|University of Michigan|Dr. Sarah Hawley|734-936-8816|sarahawl@med.umich.edu|
21289928|NCT03774810|University of Pennsylvania|Michael L. Perlis, PHD|215-746-3577|mperlis@upenn.edu|
21231418|NCT00753415|Merck Sharpe & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21289929|NCT02212977|Duke University Medical Center|Dr. Charles Kim|9196847424|charles.kim@duke.edu|
21289930|NCT00927186|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21289931|NCT03994120|National Institutes of Health/NINDS|Dr. Eric Wasserman|301-495-0151|wassermanne@ninds.nih.gov|
21289932|NCT04914000|Moffitt Cancer Center|Dr. Ursula Martinez|813-745-1754|Ursula.Martinez@moffitt.org|
21289933|NCT04641975|Astellas Pharma Global Development Inc|Clinical Trial Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
21289934|NCT04299425|Vanderbilt University Medical Center|Dr. Carmen C Solorzano|615-343-2735|carmen.solorzano@vumc.org|
21289935|NCT02350998|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
21289936|NCT01259024|Washington University|Patricia Nieters, RN, BSN, Clinical Research Specialist|314-362-3371|nietersp@wustl.edu|
21289937|NCT00756444|Amgen Inc.|Study Director|866-572-6436||
21289938|NCT00564070|Behavioral Medicine Service, Massachusetts General Hospital|Dr. Steven Safren|(305) 284-2818|ssafren@miami.edu|
21289939|NCT02346370|Halozyme, Inc.|Halozyme Study Information|1-844-855-4256|medinfo@halozyme.com|
21289940|NCT01217047|Kennedy Krieger Institute|Daniel Becker, M.D.|888-923-9222|dbecke13@jhu.edu|
21289941|NCT04865978|Inova Schar Heart and Vascular|Dr. Palak Shah|703-776-2213|palak.shah@inova.org|
21289942|NCT05587998|AstraZeneca|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
21289943|NCT03835117|Autism Discovery & Treatment Foundation|Richard E Frye|844-ADTF-Research|DrFrye@AutismDiscovery.org|1
21289944|NCT04263532|Philips|Chuck Cain|412-657-1814|chuck.cain@philips.com|
21289945|NCT06083493|University of Michigan|Zirui Huang|734-615-2875|huangzu@med.umich.edu|
21289946|NCT04072432|Renibus Therapeutics|Stacey Ruiz, PhD / VP, Drug Development|424-209-2734|sruiz@renibus.com|
21289947|NCT03225989|Lokon Pharma|Angelica Loskog CEO|+46 18-50 74 44|angelica.loskog@lokonpharma.com|
21289948|NCT03093870|ASLAN Pharmaceuticals|Study Director|+65 6222 4235|contact@aslanpharma.com|
21289949|NCT02318277|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
21289950|NCT03364686|University of Pittsburgh|Darrell J. Triulzi, MD|412-209-7304|triudj@upmc.edu|
21289951|NCT00483509|Molmed S.p.A|Clinical Operations|003902212771|clinical.operations@molmed.com|
21289952|NCT00682838|VA San Diego Healthcare System|Carl J. Stepnowsky, PhD|858-642-1240|Carl.Stepnowsky@va.gov|
21289953|NCT01986751|University of Alabama Birmingham|Dr. Promil Kukreja|205-996-7025|pkukreja@uabmc.edu|
21289954|NCT04097223|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21289955|NCT01968785|Medstar Health Research Institute|Megan Rowland|2028772959|megan.e.rowland@medstar.net|
21289956|NCT00098293|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21289957|NCT02829957|Indiana University|Dr. Jeffrey Kline|317-880-3869|jefkline@iu.edu|
21289958|NCT00676689|Edwards Lifesciences|Sharanjeet Dhanjal|949-250-2083|sharanjeet_dhanjal@edwards.com|
21289959|NCT01827943|Institut Bergonie|Dr Nadine Houede, oncologist|05.56.33.33.33|nadine.HOUEDE@chu-nimes.fr|
21289960|NCT00501085|Apollo Endosurgery, Inc.|Laura Eaton, R.N., BSN, CCRN-R|949-468-9301|laura.eaton@apolloendo.com|
21289961|NCT04786600|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
21289962|NCT02362412|Astellas Pharma Inc.|Vice-President, Japan-Asia Clinical Development Administration||Astellas.resultsdisclosure@astellas.com|
21289963|NCT00545948|Duke University Medical Center|Neal Ready, PhD, MD|919-681-6932|neal.ready@duke.edu|
21289964|NCT03467945|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21289965|NCT01509807|University of South Florida|Jorge Marcet, MD|813-844-4545|jmarcet@health.usf.edu|
21289966|NCT02821793|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
21289967|NCT02975700|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21289968|NCT01064284|"Centro Emofilia e Trombosi Angelo Bianchi Bonomi, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico di Milano"|Prof. Flora Peyvandi|0039 0255035414|flora.peyvandi@unimi.it|
21289969|NCT01541254|MicroVention, Inc.|Mary Schmitz|714-247-8025|mary.schmitz@microvention.com|
21289970|NCT05737745|Virginia Tech Carilion Clinic|Shannon Armbruster MD, MPH|540-581-0160|sdarmbruster@carilionclinic.org|
21289971|NCT02569242|Ono Pharmaceutical Co. Ltd|Medical Information Center|ー|clinical_trial@ono.co.jp|
21289972|NCT03651336|Implandata Ophthalmic Products|Clinical Study Manager|+49 (0) 511 - 2204 2580|clinical@implandata.com|
21289973|NCT03378336|University of Pennsylvania|Dr. Alexis Ogdie-Beatty|215-614-2454|alexis.ogdie@pennmedicine.upenn.edu|
21289974|NCT01125748|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21289975|NCT01028391|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372||
21289976|NCT00837330|Southeast Retina Center, P.C.|Dr. Dennis M Marcus Principal Investigator|706-650-0061|dmarcus@southeastretina.com|
21289977|NCT01227395|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21289978|NCT01940146|SPARC|Shravanti Bhowmik, MD||shravanti.bhowmik@sparcmail.com|
21289979|NCT00694122|Massachusetts General Hospital|David M. Nathan, MD|617-726-1848|dnathan@partners.org|
21278335|NCT02283294|University of South Florida|David Rose, MD|813-259-8577|drose1@usf.edu|
21278336|NCT00594646|Fenway Health|Dr. Kenneth Mayer|617-927-6400|kmayer@fenwayhealth.org|
21278337|NCT03845296|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
21278338|NCT05091307|Janssen Vaccines & Prevention B.V.|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21278339|NCT05104073|Penn State College of Medicine|Ian Paul, MD|7175318006|ipaul@pennstatehealth.psu.edu|
21231419|NCT04936256|Gainesville Eye Associates|Clayton Blehm, MD|7705324444|claytonblehm@gmail.com|
21231420|NCT02959307|Massachusetts General Hospital|Dr. Paolo Cassano|617-643-9622|pcassano@mgh.harvard.edu|
21278340|NCT04732221|MSD|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21231421|NCT02700815|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21231422|NCT00806390|UMaryland|Stephen Gottlieb|410-328-8788|sgottlie@medicine.umaryland.edu|
21278341|NCT04616430|Atossagenetics|Dr. Steven Quay|206.419.4873|steven.quay@atossainc.com|
21278342|NCT02700386|University of Colorado, Denver|Christine Fisher, MD, MPH|720-848-0154|christine.fisher@cuanschutz.edu|
21278343|NCT00379340|Childrens's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21278344|NCT05538065|Brigham and Women's Hospital|Niteesh Choudhry|617-278-0930|nkchoudhry@bwh.harvard.edu|
21278345|NCT05327816|Janssen Vaccines & Prevention B.V.|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21278346|NCT01972919|Medical College of Wisconsin|Beth Erickson, MD|414-805-4462|BErickson@mcw.edu|
21278347|NCT05367336|Corewell Health Lakeland|Rachelle Pichot; Clinical Research Specialist|240-389-7340|rachelle.pichot@corewellhealth.org|
21278348|NCT04763564|University of North Carolina at Chapel Hill|Hans Herfarth, MD, PhD|9199666806|hherf@med.unc.edu|
21278349|NCT00658658|Amgen Inc.|Study Director|866-572-6436||
21278350|NCT01367665|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21278351|NCT03283319|BARDA|Silvija Tresnjak-Smith|202-557-1993|Silvija.Tresnjak-Smith@hhs.gov|
21278352|NCT04820530|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21278353|NCT03954834|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21278354|NCT01997216|Alcon Research, Ltd.|Joachim Nick, Dipl.-Ing. (FH), Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21278355|NCT00754650|Hoffmann-La Roche|Medical Communications|800 821-8590||
21278356|NCT01076686|Pacira Pharmaceuticals|Executive Medical Director|203-837-6500|erolo@pacira.com|
21278357|NCT03514641|Theracos Sub, LLC|Albert Collinson|(508) 688-4221|acollinson@theracos.com|
21278358|NCT00642694|UT Southwestern Medical Center|Dr.Prabha Sunderajan- Assistant Professor|214-645-6964|psunderajan@utsouthwestern.edu|
21278359|NCT02906930|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21278360|NCT01736241|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21289980|NCT00105508|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|496151725200|service@merckgroup.com|
21231423|NCT04567225|The Cleveland Clinic Foundation|Dr. Mohammed Al-Jaghbeer|216-476-7983|ALJAGHM@ccf.org|
21231424|NCT00345345|National Heart Lung and Blood Institute|Stefan F Cordes, Principal Investigator, M.D., Ph.D.|+1 240 383 6460|stefan.cordes@nih.gov|
21231425|NCT02324569|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21231426|NCT01693653|NYU Langone Medical Center, Center for Musculoskeletal Care|Yusuf Yazici|646-501-7400|yusuf.yazici@nyumc.org|
21231427|NCT00869206|Christiana Care Health System|Andrew L. Himelstein, MD|(302) 366-1200|ahimelstein@cbg.org|
21231428|NCT00085631|Duke University Medical Center|Dr Mark Dewhirst|919 6683726|joan.cahill@dm.duke.edu|
21231429|NCT01513473|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21231430|NCT03729960|Danone Asia Pacific Holdings|Digital Project Manager|82281172|jill.wong@danone.com|
21231431|NCT00799604|The Medicines Company|Jason Campagna. MD, PhD|973-290-6199|jason.campagna@themedco.com|
21231432|NCT00743340|Gilead Sciences|Clinical Trial Disclosures & Data Transparency|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21231433|NCT01425281|Abbott Vascular International BVBA|Susan Veldhof|+31653428610|susan.veldhof@av.abbott.com|
21231434|NCT03266107|Relievant Medsystems Inc.|VP Clinical Affairs|(650) 368-1000|dsahr@relievant.com|280
21231435|NCT02548650|University of Florida College of Medicine - Jacksonville|Dominick J Angiolillo|9042443933|dominick.angiolillo@jax.ufl.edu|
21231436|NCT01191801|Sunesis Pharmaceuticals, Inc|Judy Fox, Chief Scientific Officer|(650) 266-3736|jfox@sunesis.com|
21231437|NCT00814164|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21231438|NCT01980992|Icahn School of Medicine at Mount Sinai|Dr. Hugh A. Sampson|212-659-9426|hugh.sampson@mssm.edu|
21231439|NCT03012165|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
21231440|NCT01238471|Rambam Medical Center|Professor Imad Makhoul|972-4-8542219|makhoul@rambam.health.gov.il|
21231441|NCT04380116|Yale University|Dr. Frank Buono|2037795799|frank.buono@yale.edu|
21231442|NCT01169493|Duke University Medical Center|Brett D. Atwater, MD|9196848111|brett.atwater@duke.edu|
21231443|NCT05228132|Becton Dickinson|Joshua Black, Clinical Project Manager|520-599-6124|joshua.black@bd.com|
21231444|NCT03284398|Fresenius Kabi Deutschland, GmbH|Prof. Dr. med. Martin Westphal|+49 6172 686-7348|martin.westphal@fresenius-kabi.com|
21231445|NCT02627144|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21231446|NCT05883449|Affimed GmbH|Clinical Operations|+49 621 560030|trials@affimed.com|
21231447|NCT01044771|Metropolis Medical|Dr. Fritz Bredeek|415 292 5477|fritz@doctor.com|
21231448|NCT02651922|PASCOE Pharmazeutische Präparate GmbH|Dr. Inga Trompetter and Jennifer Lebert|0049-(0)641-7960-955|Jennifer.lebert@pascoe.de|
21231449|NCT05820685|The University of Texas Health Science Center at Houston|John Harvin, MD, FACS|713-500-7244|John.Harvin@uth.tmc.edu|
21231450|NCT03018704|Department of Veteran Affairs|David Oslin|215-823-5894|dave.oslin@va.gov|
21231451|NCT00642460|Hoffman-LaRoche|Medical Communications|800-821-8590||
21231452|NCT04448171|Mayo Clinic|John Occhino, M.D., M.S.|507-538-5883|Occhino.John@mayo.edu|
21231453|NCT01115101|University of Rostock|Dr. Max Dieterich|+493814401|max.dieterich@uni-rostock.de|4500
21231454|NCT02454296|University of Hawaii|Reni Soon, MD|808-203-6548|rsoon@hawaii.edu|
21231455|NCT01401582|Geman Centr for Neurodegenerative Diseases (DZN)|PD Dr. JR Thyrian|+49383486|rene.thyrian@dzne.de|7592
21231456|NCT01667029|Massachusetts General Hospital|Dr. Brian Wainger|617-726-8810|Brian.Wainger@mgh.harvard.edu|
21231457|NCT01025752|VA Connecticut Healthcare System|Dr. Alicia Heapy|203-932-5711|alicia.heapy@va.gov|2299
21231458|NCT00211809|Icahn School of Medicine at Mount Sinai|Dr. Andrea Allen|212-241-3176|andrea.allen@mssm.edu|
21231459|NCT00023764|Memorial Sloan-Kettering Cancer Center|Dr. John Gerecitano|212-639-3748|gerecitj@mskcc.org|
21231460|NCT01537393|CaseWestern|Dr. Jonathan Lass|2168448368|Jonathan.Lass@UHhospitals.org|
21231461|NCT01191398|University of Texas Southwestern Dallas Medical Center|Craig J. Huang, MD|214-456-6371|craig.huang@utsouthwestern.edu|
21231462|NCT01697566|M.D. Anderson Cancer Center|Karen H. Lu, MD|713-745-8902|khlu@mdanderson.org|
21231463|NCT01619774|University of Texas (UT) MD Anderson Cancer Center|Michael Davies, Associate Professor, Melanoma Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
21231464|NCT00459953|Stanford University|Joel D Killen|(650) 723-5895|jkillen@stanford.edu|
21231465|NCT01447433|Changhai Hospital|Prof. Donglian Cai|86 21 81873168|nutrition1226@126.com|
21231466|NCT00036270|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21231467|NCT00496470|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
21231468|NCT02516163|Stryker SP|Holly Solomon|+61 2 9467 1072|Holly.Solomon@stryker.com|
21231469|NCT01217814|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21231470|NCT01370356|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21231471|NCT03170401|University of Washingtion|Dr. Grant E O'Keefe|206-744-8016|gokeefe@uw.edu|
21231472|NCT00729651|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21231473|NCT01874054|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
21231474|NCT01525563|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
21231475|NCT04891874|Shanghai Eastern Hepatobiliary Surgery Hospital|Dr. SHI Changying|+86-021-81887735|nona-peach@hotmail.com|
21231476|NCT01844518|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21231477|NCT01217801|Par Pharmaceutical|Medical Affairs|800-828-9393|DrugInfo@strativapharma.com|
21231478|NCT00291577|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21231479|NCT00830362|Medical University of South Carolina|Dr. Michael Saladin|843-792-5306|saladinm@musc.edu|
21231480|NCT01197560|Celgene|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21238973|NCT02402296|Al-Azhar University- Faculty of dental medicine (Girls branch)|Professor Hala Helmi Hazzaa|00201014129297|hala.hazzaa@yahoo.com|
21238974|NCT01576718|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21238975|NCT01874145|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21238976|NCT04631705|Institute of Virology|Prof. Florian Klein|49221478|florian.klein@uk-koeln.de|85800
21238977|NCT05741385|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21238978|NCT01742364|PATH|Courtney Jarrahian|206-285-3500|cjarrahian@path.org|
21238979|NCT02280239|Providence Health Care|Vininder Kour Bains|604-682-2344|VBains@providencehealth.bc.ca|62207
21238980|NCT06387472|Mayo Clinic|Matthew Hall, M.D.|904-953-6412|Hall.Matthew@mayo.edu|
21238981|NCT04182880|Cali Biosciences|Chief Medical Officer|12038376500|e.onel@calibiosciences.com|
21238982|NCT02036645|AstraZeneca Pharmaceuticals|Michael Pomfret, Project Director, IMED Neuroscience||Clinicaltrialstransparency@astrazeneca.net|
21238983|NCT03522077|Aurora Health Care|Dr. Muhammad Fuad Jan|414-649-3491|fuad.jan@aah.org|
21238984|NCT02439749|Medtronic|Pamela McKenna, Sr. Principal Clinical Research Specialist|(773) 597-5241|pamela.m.mckenna@medtronic.com|
21238985|NCT02332590|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21238986|NCT00916032|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21238987|NCT01995487|Medinol|Dina Kofler, VP Clinical Affairs|+97237679032|dinak@medinol.com|
21238988|NCT02498834|University of North Carolina at Chapel Hill|Betsy Sleath, PhD|(919) 962-0079|betsy_sleath@unc.edu|
21238989|NCT01806584|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21238990|NCT04204200|Centre Hospitalier de Ham|Dr. Jean-Francois Cazeneuve, Surgeon|06 62 29 24 51|jfc.laon@gmail.com|0033
21238991|NCT01949779|Stryker Neurovascular|Cheryl Fontana, Sr. Manager, Clinical Services|510-413-2948|cheryl.fontana1@stryker.com|
21238992|NCT03995784|Catalyst Biosciences|Howard Levy, Chief Medical Officer|+1.650.266.6871|hlevy@catbio.com|
21238993|NCT04226365|Penn Medicine / Lancaster General Hospital|Halle Becker, MPH, Research Project Manager|7175441777|Halle.Becker@pennmedicine.upenn.edu|
21238994|NCT06412146|Children's Mercy Research Institute|Sophie MacColl|8166011485|risingT1DE@cmh.edu|
21238995|NCT04739761|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21238996|NCT03881696|DAIT/NIAID|Director, Clinical Research Operations Program|202-604-9855|DAITClinicalTrialsGov@niaid.nih.gov|
21238997|NCT05690776|Zimmer Biomet|Julie Nicoux|+33672613502|julie.nicoux@zimmerbiomet.com|
21238998|NCT01061333|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21238999|NCT02241720|Huntsman Cancer Institute|Kimberlee Taylor|801-213-5673|Kimberlee.Taylor@hci.utah.edu|
21239000|NCT02783820|Medicines for Malaria Venture|Dr Cristina Donini|+41 22 555 0312|doninic@mmv.org|
21239001|NCT01186328|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
21239002|NCT02202434|Boston Scientific|Amy Maurer|508-683-6647|amy.maurer@bsci.com|
21239003|NCT04858802|Medtronic plc|Xiaomin Deng|707-566-1311|Xiaomin.deng@medtronic.com|
21239004|NCT02357290|Massachusetts General Hospital|Dr. Janet Wozniak|617-724-5600|jwozniak@partners.org|
21239005|NCT02714868|Department of Occupational Therapy, Boston University|Dr. Jessica Kramer, Assistant Professor, PI|617-353-2702|kramerj@bu.edu|
21239006|NCT00970216|Chang Gung Memorial Hospital|Chau-Ting Yeh|88633281200|chautingy@gmail.com|8121
21239007|NCT02938169|Department of Rehabilitation Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine|Dr. Juseok Ryu|+82-10-4382-2328|jseok337@snu.ac.kr|
21239008|NCT00710606|Columbia University|Carolyn Westhoff|212-305-4805|clw3@columbia.edu|
21239009|NCT01213043|Grifols Therapeutics Inc.|Benjamin King, PhD||ben.king@grifols.com|
21239010|NCT02670538|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21239011|NCT05648357|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21239013|NCT00674323|Novartis Pharmaceuticals|Study Director|862-778-8300||
21239014|NCT01678443|Fred Hutchinson Cancer Research Center|Ajay K. Gopal, MD|206-288-2037|agopal@u.washington.edu|
21239015|NCT02243202|Janssen Research & Development, LLC|Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
21239016|NCT01175148|Mary Babb Randolph Cancer Center|Pam Bunner, Clinical Research Specialist|304-598-4511|bunnerp@wvuhealthcare.com|
21239017|NCT02013388|Nivalis Therapeutics, Inc.|Nivalis Therapeutics, Inc. (Formerly N30 Pharma)|720-945-7700|steven.shoemaker@nivalis.com|
21239018|NCT01676532|St.Michael's Hospital|Sloane Freeman|416-864-6060|freemansl@smh.ca|77042
21239019|NCT03036384|Centre Hospitalier Universitaire Saint Pierre|Panayota Kapessidou|+32.2.535|pkapessi@ulb.ac.be|3750
21239020|NCT03645967|Medline Industries, LP|Keri Jorgenson|2243014670|kajorgenson@medline.com|
21239021|NCT01105702|Perlmutter Cancer Center at NYU Langone|Michael Gruber, MD|212-731-5577|michael.gruber@nyumc.org|
21239022|NCT01187914|Arrhythmia Research Center, University of Utah|Dr. Kavitha Damal, Clinical research Manager|8012133775|kavitha.damal@carma.utah.edu|
21239023|NCT02110732|Helsinki University Hospital|Anne Pitkäranta|+358406430511|anne.pitkaranta@hus.fi|
21239024|NCT00633932|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21239025|NCT04836858|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21239026|NCT00539643|Memorial Sloan Kettering Cancer Center|Dr. Anne Covey, MD|212-639-6746|coveya@MSKCC.ORG|
21239027|NCT02228395|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
21231481|NCT00585247|University of Ccalifornia, Irvine. Beckman Laser Institute|Dr. Kristen Kelly|949.824.7997|kmkelly@uci.edu|
21231482|NCT03844646|Stanford University|Sun H. Kim, MD, MS|650-723-8284|sunhkim@stanford.edu|
21231483|NCT00621153|AstraZeneca|Gerard Lynch|+44 1509 64589|aztrial_results_posting@astrazeneca.com|4589
21231484|NCT04212650|Steadman Philippon Research Institute|Suzanne Liv Page, JD|970-401-8770|spage@sprivail.org|
21289981|NCT00683384|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21289982|NCT00120874|NYU Langone Medical Center|Barry Reisberg|121-263-8550|barry.reisberg@nyumc.org|
21289983|NCT00845000|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21289984|NCT00809146|University of Michigan|Robert Silbergleit MD, Principal Investigator|734-232-2142|robie@umich.edu|
21289985|NCT00300495|Houston Methodist Hospital|Min Kim|7134415177|mpkim@houstonmethodist.org|
21289986|NCT01348490|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21289987|NCT03632720|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21289988|NCT01049828|Washington University in St. Louis|Dr. Andre Wineland|314-362-5296|winelanda@ent.wustl.edu|
21289989|NCT06765889|A*STAR|Alessandro Sparacio|80728247|Alessandro_Sparacio@sics.a-star.edu.sg|
21289990|NCT03004183|Houston Methodist Cancer Center|Jenny C Chang, MD|713-441-0629|ccresearch@houstonmethodist.org|
21289991|NCT03885206|Landsforeningen for hjerte- og lungesyke|Senior Consultant|0047 95706313|irene.steinsvik@lhl.no|
21289992|NCT03312114|University of Texas Southwestern Medical Center|Phase II trial of Concurrent Anti-PD-L1 and SAbR for Patients with Persistent or Recurrent Epithelia|(214) 645-7296|kevin.albuquerque@utsouthwestern.edu|
21289993|NCT06358144|Wake Forest University Health Sciences|Beth Reboussin, PhD|336-713-5213|brebouss@wakehealth.edu|
21231485|NCT01179568|Columbia School of Social Work|M. Katherine Shear, MD|212-851-2176|ks2394@columbia.edu|
21231486|NCT00357968|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21231487|NCT02970422|McGill University|Emilie Michalovic, Ph.D. Candidate|514-941-6450|emilie.michalovic@mail.mcgill.ca|
21231488|NCT00679302|Southern Illinois University, School of Medicine|Dr. Myto Duong, Pediatric Emergency Medicine Director|217-545-7409|myto_duong@yahoo.com|
21231489|NCT03547687|Oregon Health Science University|Dr. Julia Durrant|503-494-0353|durrantj@ohsu.edu|
21231490|NCT02812160|Spatz FGIA Inc.|Jeffrey Brooks MD|1-516-303-0613|jeff@spatzmedical.net|
21231491|NCT04656691|UnitedHealth Group/Optum Labs|Tracy Ziolek , Vice President, Human Research Affairs|215-868-3114|tracy_ziolek@uhg.com|
21231492|NCT03779724|Aksaray University Training and Research Hospital|The principal investigator|905555289493|mlk.aykut@gmail.com|
21231493|NCT02846779|Brigham and Women's Hospital|Niteesh K. Choudhry, MD, PhD|617-278-0930|nkchoudhry@bwh.harvard.edu|
21231494|NCT00590005|Emory University Department of Pediatrics|Dr. Anne Fitzpatrick, Director, Emory Asthma Clinical Research Program|404-727-9112|anne.fitzpatrick@emory.edu|
21231495|NCT01753856|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21231496|NCT00887978|United Therapeutics Corporation|Kevin Laliberte, PharmD|919-425-8350|klaliberte@unither.com|
21231497|NCT05980182|Virginia Commonwealth University|Dr. Maria Thomson|804-628-2640|mthomson2@vcu.edu|
21231498|NCT01955733|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21231499|NCT02267811|Biolux Research, Ltd.|Dr. Peter Brawn|6046690674|p.brawn@bioluxresearch.com|
21231500|NCT02239978|Salt Lake City VA|Dr. Daniel Peterson|6028242279|daniel.peterson1@asu.edu|
21231501|NCT00602953|UT Southwestern Medical Center, Dallas, TX|Dr. ILDIKO LINGVAY|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
21231502|NCT01850550|Penn State Hershey Medical Center|Jennifer Kraschnewski|717-531-8161|jkraschnewski@hmc.psu.edu|
21231503|NCT01852110|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21231504|NCT03758274|University of Rochester|Kenneth R. Conner|585-275-1211|kenneth_conner@urmc.rochester.edu|
21231505|NCT02566083|Johnson & Johnson Surgical Vision|Devi Priya Janakiraman, OD, FAAO|+1 714 247- 8628|djanaki1@its.jnj.com|
21231506|NCT01204853|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21231507|NCT01549860|VP Medical Affairs|Pamela Unger|(952) 224-8755|punger@celleration.com|
21231508|NCT01366521|GlaxoSmithKline|GSK Response Center|866-435-7343||
21239028|NCT01446796|Duke University Medical Center|Michel Khouri, MD|919 684 8111|michel.khouri@duke.edu|
21239029|NCT00988221|Hoffman-La Roche|Medical Communications|800 821-8590||
21239030|NCT00954733|Northwestern University|Gildaasio De Oliveira, M.D.|312-472-3573|gjr@northwestern.edu|
21239031|NCT03579290|Yale University|Theresa Babuscio Data Manager|203-737-5430|theresa.babuscio@yale.edu|
21239032|NCT01566630|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21239033|NCT01108757|Cleveland Clinic|Lynn Borzi|2164453158|borzil@ccf.org|
21239034|NCT00861601|GlaxoSmithKline|GSK Response Center|866-435-7343||
21239035|NCT02299258|The First People's Hospital of Yuhang District|Dr.Ding Shi|+8657189369162|shidingyuhang@163.com|
21239036|NCT02712398|Becton Dickinson|Dawn Heimer / Sr. Director Medical Affairs|401-479-1253|dawn.heimer@bd.com|
21239037|NCT00699140|Instituto Grifols, S.A|Marta Carretero, PhD, Clinical Project Leader|+ 34 93 571 22 00|marta.carretero@grifols.com|
21239038|NCT01725386|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21231509|NCT02899988|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21231510|NCT03848650|Columbia University|Manish Parikh, MD|212-326-8532|map2224@cumc.columbia.edu|
21231511|NCT02485301|GlaxoSmithKline|GSK Response Center|866-435-7343||
21231512|NCT01059825|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21231513|NCT00105482|Yale School of Medicine, Department of Psychiatry|Stephanie Samples O'Malley PhD, Director, Division of Substance Abuse Research|(203) 974-7590|stephanie.omalley@yale.edu|
21231514|NCT02708121|Department of Health Education and Behavior, College of Health and Human Performance, University of Florida|Dr. Megan McVay|(352)294-7029|megan.mcvay@ufl.edu|
21231515|NCT01929460|Kaiser Permanente, Los Angeles Medical Center|Karl Kwok, MD|800-954-8000|regional-research-committee@kp.org|
21231516|NCT01749514|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21231517|NCT02551731|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
21231518|NCT01750242|Medtronic Neuromodulation|Stephanie Salisbury|763-526-8096|stephanie.salisbury@medtronic.com|
21231519|NCT04677374|University of North Carolina at Chapel Hill|Mitch Matoga, MD, MS|00265 1 755056|mmatoga@email.unc.edu|
21231520|NCT03765918|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21231521|NCT04202965|Protagonist Therapeutics, Inc|Clinical Study Director|1-888-899-1543|ptgxclintrials@ptgx-inc.com|
21231522|NCT00586001|Boston University Charles River Campus|Todd Farchione|(617) 353-9610|tfarchio@bu.edu|
21231523|NCT00299975|Hong Kong Baptist University|Prof. Zhao-xiang Bian|(852) 3411 2905|bzxiang@hkbu.edu.hk|
21231524|NCT01746745|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21231525|NCT03167411|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
21231526|NCT01578187|Syneron Beauty|Doran Rozen, Director of Clinical Affairs|+972-54-7800260|Doran.Rozen@syneron.com|
21231527|NCT01218243|Guang'an Men Hospotal Affiliated to China Academy of Chinese Medical Sciences|Zhishun Liu, Director of the study|8610-010-88001124|liuzhishun@yahoo.com.cn|
21231528|NCT00823095|Loma Linda University Medical Center|Deborah Dodge|(909) 558-4000|ddodge@llu.edu|48500
21231529|NCT01637272|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21231530|NCT01496612|NIH/NINDS|Dr. William Theodore|301-496-1505|theodorw@ninds.nih.gov|
21231531|NCT03473977|Cincinnati Children's Hospital Medical Center|Marc E. Rothenberg, MD, PhD|513-636-7177|marc.rothenberg@cchmc.org|
21231532|NCT03725098|Biom'up|William Spotnitz, MD, MBA|351-514-5009|w.spotnitz@biomup.com|
21231533|NCT03129100|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21231534|NCT01587001|National Jewish Health|Nabeel Hamzeh|303-270-2613|hamzehn@njhealth.org|
21231535|NCT02756013|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Peter Rose|+1 216-444-6601|ROSEP@ccf.org|
21231536|NCT00571948|Research Institute of Child Nutrition|Dortmund Intervention Trial for Optimization of Infant Nutrition|0049 231 7922100|kersting@fke-do.de|
21231537|NCT01032837|Hoffman-LaRoche|Medical Communications|800-821-8590||
21231538|NCT00843024|GlaxoSmithKline|GSK Response Center|866-435-7343||
21231539|NCT05201703|University of Florida - Jacksonville|Dr. Katherine Zarroli|3025615456|katherine.zarroli@jax.ufl.edu|
21231540|NCT01487200|Flexion Therapeutics|Scott Kelley, Chief Medical Officer|781-305-7142|skelley@flexiontherapeutics.com|
21231541|NCT00663169|Novartis Pharmaceuticals|Study Director|862-778-8300||
21231542|NCT02984709|Vanderbilt University Medical Center|Sarah Jaser|615-343-6775|sarah.jaser@vanderblit.edu|
21231543|NCT00496054|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21231544|NCT01737697|ZS Pharma, Inc.|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21231545|NCT01362205|Denver Health Medical Center|Katie Overdier RN|303 602 1479|Katie.Overdier@dhha.org|
21231546|NCT02207244|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
21231547|NCT00080470|Boston Scientific|Director of Clinical Operations|866-360-4747|Valerie.Lucero-Cimmarust@bsci.com|
21231548|NCT01950741|Pusan National University Hospital|Ji Eun Lee, Assoicated professor|+82-51-240-7957|jlee@pusan.ac.kr|
21231549|NCT00508716|Griffin Hospital|Dr. Dorothea Wild|203 7327327|dwild@griffinhealth.org|
21231550|NCT02579239|aTyr Pharma|Study Director|858 731 8389|clinicaltrials@atyrpharma.com|
21231551|NCT00471328|Novartis Pharmaceuticals|Study Director|862-778-8300||
21231552|NCT04051008|SUNY Buffalo|Stephanie Anzman-Frasca|17168296692|safrasca@buffalo.edu|
21231553|NCT02233647|University of Kentucky|William W. Stoops, Ph.D.|859-257-5388|william.stoops@uky.edu|
21231554|NCT04774328|Concentric Analgesics|Carrie Khouri, Associate Director of Clinical Operations|1-415-484-7921|ckhouri@concentricanalgesics.com|
21231555|NCT00458211|Bronx Psychiatric Center|Nigel Bark MD|718 862 5429|Nigel.Bark@omh.ny.gov|
21260968|NCT00597558|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director|919-843-9087|edwinkim@email.unc.edu|
21289994|NCT02469961|Maimonides Medical Center|Piyush Gupta, Director of clinical affairs|718-283-7189|pgupta@maimonidesmed.org|
21289995|NCT03254147|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21289996|NCT01386645|VA Puget Sound Hlthcare System|Kristina Utzschneider|206-277-3568|kutzschn@uw.edu|6-3568
21289997|NCT01530256|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
21289998|NCT04621786|University of New Mexico|Dr. Chris Abbott|5052720406|cabbott@salud.unm.edu|
21289999|NCT02533674|Pharma Mar, S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|+34 918466000|clinicaltrials@pharmamar.com|
21290000|NCT03021005|Johns Hopkins University|Dr. Yu-Hsiang Hsieh|410-735-6413|yhsieh1@jhmi.edu|
21290001|NCT03188705|University of Maryland School of Medicine|Joshua P. Lewis, PhD|410-706-5087|jlewis2@som.umaryland.edu|
21231556|NCT04342897|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21231557|NCT00176228|Uillinois|Dr. Mani Pavuluri|312 4130064|mpavuluri@psych.uic.edu|
21231558|NCT01900704|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
21231559|NCT01414010|Beth Israel Deaconess Medical Center|Ciaran Kelly, MD|617-667-1272|ckelly2@bidmc.harvard.edu|
21231560|NCT01112241|Azienda Ospedaliera Universitaria San Martino, Genova, Italy|Dr. Giovanni Barisione, MD|+39 010 5553367|giovanni.barisione@hsanmartino.it|
21231561|NCT04600921|Department of Internal Medicine, Division of Cardiology, Medical University of Graz|Dr. Dirk von Lewinski|+4331638580684|dirk.von-lewinski@medunigraz.at|
21231562|NCT03734055|University of Rochester|Dr. Edith Williams|5856020802|edith_williams@urmc.rochester.edu|
21231563|NCT00858130|University of North Carolina at Chapel Hill|Dr. Stephan Moll, Professor of Hemology/Oncology|919-966-3311|stephan_moll@med.unc.edu|
21231564|NCT05425745|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
21231565|NCT00524368|Tibotec Pharmaceuticals, Ireland|Medical Leader|+32 015 461 497||
21231566|NCT04023526|OncoVerity|Clay Smith, MD Chief Medical Officer|7204981136|csmith@oncoverity.com|
21231567|NCT00998660|Medtronic, Inc.|Todd Weaver, PhD|763-526-8130|todd.weaver@medtronic.com|
21231568|NCT03631472|Gala Therapeutics|James Stambaugh SVP of Clinical Affairs|4087186834|jstambaugh@galatherapeutics.com|
21231569|NCT00040937|SWOG|Robert Z. Orlowski, MD,PhD|(713) 792-2860|rorlowsk@mdanderson.org|
21231570|NCT02470234|Rhodes Pharmaceuticals L.P.|Dr. Akwete Adjei|401-262-9408|akwete.adjei@rhodespharma.com|
21231571|NCT00793403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21231572|NCT00218465|Center for Addiction Medicine|Sara Carlini|617-643-1990|scarlini@partners.org|
21231573|NCT00842712|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21231574|NCT00410046|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21231575|NCT02715076|Department of outcomes research Cleveland Ohio|Dr. Daniel I. Sessler||ds@or.org|
21231576|NCT02066740|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
21231577|NCT02141282|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21231578|NCT03312933|Brigham and Women's Hospital|Dr. Jeremy T. Smith|(617) 983-7295|jsmith42@bwh.harvard.edu|
21231579|NCT00875212|Federal University of Paraiba|Fabio Correia Sampaio (research leader)|+55 83 3216 7795|fabios@ccs.ufpb.br|
21231580|NCT01752907|Amgen Inc.|Study Director|866-572-6436||
21231581|NCT03098550|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
21231582|NCT01384760|ChineseUHK|Dr Susanna S Ng|(852) 98075787|drsssng123@yahoo.com.hk|
21231583|NCT00630396|Georgia Health Sciences University|David Hess, MD|706-721-1691|dhess@georgiahealth.edu|
21231584|NCT01479517|Rock Dental Clinic|Christina Sletten, DDS|719-599-9700||
21231585|NCT02990910|the Children's Hospital of Fudan University|Dr.Wang Xuan|18017591058|744734170@qq.com|
21231586|NCT01206608|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
21231587|NCT02893514|NYU Langone Health|Jennifer McNeely, MD, MS|(646) 501-3551|Jennifer.McNeely@nyulangone.org|
21231588|NCT00719134|Beth Israel Deacxoness Medical Center|Rami Burstein|617 735 2832|rburstei@bidmc.harvard.edu|
21231589|NCT00760578|Metabolic Solutions Development Company|Jerry Colca, PhD|269-343-6732|jcolca@msdrx.com|
21231590|NCT02989194|Visterra|Chief Medical Officer|617-498-1070|clinicaltrials@visterrainc.com|
21231591|NCT00482612|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21231592|NCT03506815|The Ottawa Hospital|Dr. Marc Carrier|613-737-8899|mcarrier@toh.ca|73034
21231593|NCT04160091|Flexion Therapeutics, Inc.|David Golod, Vice President, Clinical Operations|(781) 305-7572|dgolod@flexiontherapeutics.com|
21231594|NCT01011634|UCSF|Karen Meckstroth, MD|415 206-8713|meckstrothk@obgyn.ucsf.edu|
21231595|NCT04159025|Washington University School of Medicine|Alexander Chen, M.D.|314-454-8764|chenac@wustl.edu|
21231596|NCT00381095|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21231597|NCT02113592|Kaiser Permanente Washington Health Research Institute|Lynn DeBar, PhD, MPH, Principal Investigator|206-287-2900|lynn.debar@kp.org|
21231598|NCT02000973|First Hospital of China Medical University|Jun Wang|8602483283100|wjun2000@hotmail.com|
21231599|NCT00856284|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21231600|NCT01635101|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
21231601|NCT02569723|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
21231602|NCT01327885|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21231603|NCT03232801|University of Pittsburgh|Holly Thomas|412-586-9836|thomashn@upmc.edu|
21231604|NCT04271605|National Taiwan University BioMedical Park Hospital Chu-Tung Campus|Chirn-Bin Chang|0972654906|G03776@hch.gov.tw|
21231605|NCT03991715|University of North Carolina at Chapel Hill|Kelly Evenson, PhD|(919) 966-1967|kelly_evenson@unc.edu|
21231606|NCT03138889|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
21231607|NCT00411645|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21231608|NCT04016285|University of Kentucky Department of Orthopaedic Surgery & Sports Medicine|Dr. Stephen Duncan|859-218-3084|stephen.duncan@uky.edu|
21278361|NCT04234984|Department of Anaesthesiology & Pain Medicine, Maastricht University Medical Centre, Postbus 5800, 6202 AZ Maastricht, The Netherlands.|Prof. Dr. Jan Van Zundert|(+32) 475687657|jan.van.zundert@mumc.nl|
21278362|NCT04796779|University of Virginia|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
21278363|NCT02570113|Ablative Solutions Inc|Kate Rumrill|+1 (650) 688-9743|krumrill@ablativesolutions.com|
21278364|NCT02564211|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21231609|NCT01987505|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21231610|NCT04648631|University of Miami|Hadar Lev-Tov, MD|305-689-2646|hlevtov@med.miami.edu|
21231611|NCT03042533|harborview medical center|julie agel|206.744.4113|bagel@uw.edu|
21231612|NCT02221947|Neurotrope BioScience, Inc|Vice President, Regulatory Affairs|973-826-5109|dcrockford@neurotropebioscience.com|
21231613|NCT02794883|Northwestern University, Feinberg School of Medicine|Karan Dixit, MD|312-503-4724|karan.dixit@northwestern.edu|
21231614|NCT05374434|Lumendo|Mark Bispinghoff|+41 44 589 68 02|mark.bispinghoff@lumendo.ch|
21231615|NCT01366209|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21231616|NCT01053221|University of Wisconsin-Madison|William Burlingham, PhD|6082630119|burlingham@surgery.wisc.edu|
21231617|NCT02266225|University of Waterloo|Dr. Lora Giangregorio|519-888-4567|lora.giangregorio@uwaterloo.ca|36357
21231618|NCT00420927|Abbott|Global Medical Services|1-800-633-9110||
21231619|NCT00320411|GlaxoSmithKline|GSK Response Center|866-435-7343||
21231620|NCT01110434|Brown University|Dr. Robert Miranda|401.863.6658|Robert_Miranda_Jr@brown.edu|
21231621|NCT02088047|University of Arkansas for Medical Sciences|Betholyn Gentry|(501) 603-1010|bfgenry@uams.edu|
21231622|NCT01417234|KCI|VP, Global Clinical Development|12102555595|jane.hart@acelity.com|
21231623|NCT01369758|Hologic, Inc|Christina Mastandrea|508-263-8772|Christina.Mastandrea@Hologic.com|
21231624|NCT02268084|Wave Neuroscience|Meagan Kovacs, Clinical and Regulatory Affairs Manager|9492292869|meagan@waveneuro.com|
21231625|NCT05227027|University of California, San Francisco|Dr. Justin White, Associate Professor|415-476-8045|justin.white@ucsf.edu|
21231626|NCT00855920|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
21231627|NCT00211510|Medtronic, Inc|John Shin, PhD, MBA|818 576 4019|john.shin@medtronic.com|
21231628|NCT02216591|Duke University School of Medicine|Dr. Sheri Towe|919-668-4030|sheri.towe@duke.edu|
21231629|NCT03791489|Stryker ENT|Pr. Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
21231630|NCT02837783|Ironwood Pharmaceuticals, Inc.|Lara Lane|(617) 621-7722|llane@ironwoodpharma.com|
21231631|NCT01962896|University of Texas Southwestern Medical Center|Theodore Laetsch, MD|214-648-5475|ted.laetsch@utsouthwestern.edu|
21231632|NCT03200860|University Medical Center Groningen - Department of Cardiology|Prof. dr. A.A. Voors|0031503616161|a.a.voors@umcg.nl|
21231633|NCT00844896|Massachusetts General Hospital|Frederick J. Stoddard Jr., M.D.,|(617) 371-4762|fstoddard@partners.org|
21231634|NCT02634320|Alkermes, Inc.|ARISTADA Medical Information|866-204-7823|usmedinfo@alkermes.com|
21231635|NCT00838578|KYOWA KIRIN PHARMA|Project Leader|6099191100|clinical.info@kyowa-kirin-pharma.com|
21231636|NCT03919799|Kadmon (A Sanofi Company)|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
21231637|NCT01593215|RegionSkane|Anders Rosengren|+4640391169|anders.rosengren@med.lu.se|
21231638|NCT00646776|Bristol-Myers Squibb|BMS Study Director||ClinicalTrials@bms.com|
21231639|NCT03305653|Children's Hospital Colorado|Dr. Calies Menard-Katcher|720-777-2318|calies.menard-katcher@childrenscolorado.org|
21231640|NCT00439244|Novartis Pharmaceuticals|Study Director|862-778-8300||
21231641|NCT02762266|Stanford University|Erqi Pollom, MD|(650) 498-0484|erqiliu@stanford.edu|
21231642|NCT01113983|Edwards Lifesciences|Shin Sakai, PhD||shin_sakai@edwards.com|
21231643|NCT02422511|Baylor College of Medicine|Jill Robinson|7137985848|jill.robinson@bcm.edu|
21231644|NCT02961751|University of California, Los Angeles|Jeffrey D. Klausner, MD, MPH|310-267-0409|jdklausner@mednet.ucla.edu|
21231645|NCT02298803|Diabetes Centre, Royal Prince Alfred Hospital|Dr Ted Wu|61295155888|ted.wu@sswahs.nsw.gov.au|
21231646|NCT02373202|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21231647|NCT03010254|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21231648|NCT02144233|University of Santiago de Compostela. A Coruña. SPAIN|Professor Urbano Santana Penín|+34647344093|urbano.santana@usc.es|
21231649|NCT02299479|Boston Children's Hospital|Garry Steil, PhD|617 355-6000|Garry.Steil@childrens.harvard.edu|
21231650|NCT03909295|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21231651|NCT02785354|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21231652|NCT00848081|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21231653|NCT02310568|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21231654|NCT02255604|Aarhus Universitets Hospital|Hans Jürgen Hoffmann|7845000|Hans.Jurgen.Hoffmann@ki.au.dk|
21231655|NCT00113217|University of Texas (UT) MD Anderson Cancer Center|Eric Jonasch, MD / Associate Professor|713-563-7232|ejonasch@mdanderson.org|
21231656|NCT00187876|University of Florida|Peter Indelicato, MD|352-273-7017|wernegs@ortho.ufl.edu|
21231657|NCT02064868|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21231658|NCT00616200|UNC Center for Functional GI & Motility Disorders|Stephan R. Weinland, Ph.D.|9198437828|stephan_weinland@med.unc.edu|
21231659|NCT03975790|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21278365|NCT00858962|Yale University AIDS Program|R. Douglas Bruce, MD, MA|(203) 737-6133|robert.bruce@yale.edu|
21231660|NCT01577329|University of Michigan|Roxane Raffin Chan|7344780170|roxchan@comcast.net|734
21231661|NCT00106392|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
21231662|NCT00844051|Children's Hospital Los Angeles|Pia Pannaraj, MD, MPH|323-361-2509|ppannaraj@chla.usc.edu|
21231663|NCT03342690|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21231664|NCT02289690|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21231665|NCT01170754|Temple University|Frank Friedenberg, MD|215-707-9900|frank.friedenberg@temple.edu|
21231666|NCT02573350|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21231667|NCT02743520|University of Miami, Miller School of Medicine|Alberto Ramos, MD, MSPH, FAASM|305-243-8393|a.ramos1@med.miami.edu|
21231668|NCT03247530|Supernus|Joseph Hull, PhD, Associate Director Clinical Research|240-403-5324|jhull@supernus.com|
21231669|NCT00936585|National Institute of Allergy and Infectious Diseases|Michael Yao, MD|301-594-0593|yaomic@niaid.nih.gov|
21231670|NCT02509156|University of Texas-Houston School of Public Health|Shelly Sayre, M.P.H. Project Manager|713-500-9529|Shelly.L.Sayre@uth.tmc.edu|
21231671|NCT01573572|Bausch Health|Study Manager|908-242-8287|sandra.narain@bauschhealth.com|
21231672|NCT02547649|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21231673|NCT03454997|Johns Hopkins University School of Medicine|Gail Daumit MD, MHS|410-614-6460|gdaumit@jhmi.edu|
21231674|NCT00571987|UAMS|Dr. Suzanne Klimberg|501-686-6504|klimbergsuzanne@uams.edu|
21231675|NCT02461563|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21231676|NCT01111149|University of Minnesota|Dr. S. Hossein Fatemi|612-626-3633|fatem002@umn.edu|
21231677|NCT03857243|UTSW|Timea Hodics, M.D.|(240)-423-2741|Timea.Hodics@UTSouthwestern.edu|
21231678|NCT00006903|NRG Oncology, Statistics and Data Management Center, Buffalo Office|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
21239039|NCT04750655|University of California, San Francisco|Ying Han|(415) 353-2020|ying.han@ucsf.edu|
21239040|NCT00879996|SUNY Buffalo|Dr. Richard Blondell|716-898-4971|blondell@buffalo.edu|
21239041|NCT00094211|Stanford University|Dr. Abby C. King|650-725-5394|king@stanford.edu|
21239042|NCT02914314|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
21239043|NCT04772053|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21239044|NCT03107377|Evofem|Chief Medical Officer|858-550-1900|kculwell@evofem.com|
21239045|NCT03787680|University of Michigan Rogel Cancer Center|Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
21239046|NCT05652036|Houston Methodist Hospital Department of Urology|Dr. Rose Khavari|713-441-6455|rkhavari@houstonmethodist.or|
21239047|NCT05454410|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|novartis.email@novartis.com|
21239048|NCT02227316|UCLA Department of Radiological Sciences|Director of Clinical Research|310-794-8995|schaabane@mednet.ucla.edu|
21239049|NCT01368900|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
21239050|NCT01786902|Asan Medical Center|Dr. Hanwook Yoo|82-2-3010-3374|hwyoo@amc.seoul.kr|
21239051|NCT02492854|Boston Medical Center|Jeffrey Siracuse, MD|617-638-8488|Jeffrey.Siracuse@bmc.org|
21239052|NCT02034708|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical|+33 (0) 1 45 91 51 84|corinne.dubourdieu@guerbet-group.com|
21239053|NCT00654901|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21239054|NCT00724464|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@Merck.com|
21239055|NCT00335257|Center for Epidemiology and Health Research, Germany|Juergen Dinger, MD, PhD|0049(0)30 945 10120|dinger@zeg-berlin.de|
21239056|NCT00652938|GlaxoSmithKline|GSK Response Center|866-435-7343||
21239057|NCT03020225|BGU|Prof. Iris Shai|+972 52-579-3040|irish@bgu.ac.il|
21239058|NCT00782496|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
21239059|NCT00584935|UAB Department of Dermatology|Wendy Cantrell, CRNP|205-502-9960|wcantrell@uabmc.edu|
21239060|NCT00117156|Dana-Farber Cancer Institute|Jennifer R. Brown, MD, PhD|(617) 632-3316|Jennifer_Brown@dfci.harvard.edu|
21239061|NCT00584402|University of Califonia, Davis|John McGahan, M.D.|(916)734-0519|john.mcgahan@ucdmc.ucdavis.edu|
21239062|NCT02070484|OhioHealth|Josepha Shehadi, MD|614-220-5648|joseph@drshehadi.com|
21239063|NCT01521884|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21239064|NCT02821819|Instituto Bernabeu|Dr. Juan Carlos Castillo|+34650562634|jcastillo@institutobernabeu.com|
21239065|NCT00975221|Amgen Inc.|Study Director|866-572-6436||
21239066|NCT03289481|Clinical Research|Caroline Knight|2079218959|CKnight@pbmc.org|
21239067|NCT01862991|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
21239068|NCT02075021|NYU Clinical Cancer Center|Amitabha Mazumder, MD|(212) 731-5757|Amitabha.Mazumder@nyumc.org|
21239069|NCT02970032|University of Utah Health|Corinne Bertolaccini, PharmD|801-581-2167|Corinne.Bertolaccini@hsc.utah.edu|
21239070|NCT02796274|Santhera Pharmaceuticals|Vanessa Dos Reis Ferreira|+41 61 906 89 50|office@santhera.com|
21239071|NCT00857805|Loma Linda University Health|David Bush, MD, Professor Radiation Medicine|909 558 1000|DBush@llu.edu|88056
21239072|NCT01289041|Novartis Pharmaceuticals|Study Director|862-778-8300||
21239073|NCT01129531|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21239074|NCT05044325|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21278366|NCT00910091|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21278367|NCT01908816|Novartis Pharmaceuticals|Study Director|862-778-8300||
21278368|NCT04594707|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21278369|NCT04585789|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21239075|NCT03941015|Department of Anesthesiology, Beijing Anzhen Hospital, Capital Medical University|Dr. Jun Ma|13370103671|18710168703@163.com|
21239076|NCT01250119|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21231679|NCT01909674|Weill Cornell Medical College|Dr. Matthew Ebben|6469629318|mae2001@med.cornell.edu|
21231680|NCT00811798|GlaxoSmithKline|GSK Response Center|866-435-7343||
21239077|NCT01155830|University of Utah|Dr. Christian Yost|801/581-7052|christian.yost@hmbg.utah.edu|
21239078|NCT00805493|Emotion and Development Branch, NIMH-IRP|Kenneth Towbin, M.D., Chief Clinical Child and Adolescent Psychiatry|301-402-4403|Kenneth.Towbin@nih.gov|
21278370|NCT01175811|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21278371|NCT02109419|Pennington Biomedical Research Center|Dr. Corby K. Martin|225-763-2585|corby.martin@pbrc.edu|
21278372|NCT02628743|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21278373|NCT00655876|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21278374|NCT00326963|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21278375|NCT04257552|University of Pittsburgh, Magee Womens Research Institute|Dr. Katherine Himes|(412) 641-1805|himekp@upmc.edu|
21278376|NCT00552578|SUNY Buffalo|R Blondell|716-898-4971|blondell@buffalo.edu|
21278377|NCT01714232|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
21278378|NCT04091659|University of Pennsylvania|Nicholas A. Giordano, PhD RN|(215) 898-8281|ngio@upen.edu|
21278379|NCT03678285|University of Wyoming|Dr. Evan Johnson|307-766-5282|ejohns54@uwyo.edu|
21278380|NCT00123474|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21278381|NCT00616629|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21231681|NCT02602496|University of Nebraska Lincoln|Dr. Devin Rose|402-472-2802|drose3@unl.edu|
21231682|NCT01906008|UT MD Anderson Cancer Center|Dr. James Yao, MD, Director of GI Medical Oncology|(713) 792-2828|jyao@mdanderson.org|
21231683|NCT01465997|Cares|UCB|+1844 599||2273
21231684|NCT00660309|Novartis Pharmaceuticals|Study Director|862-778-8300||
21231685|NCT00589563|City of Hope Medical Center|Dr. Ryotaro Nakamura|626-256-4673|rnakamura@coh.org|65285
21231686|NCT01891695|University of Virginia|Paul Read, MD|434-924-5191|pwr3u@hscmail.mcc.virginia.edu|
21231687|NCT02701400|Emory University|Dr. Taofeek Owonikoko|404-778-5575|TOWONIK@emory.edu|
21231688|NCT01666782|Rochester General Hospital|Saad Jamshed, MD|585-922-4020|Saad.Jamshed@rochesterregional.org|
21231689|NCT04786990|Supernus Pharmaceuticals|Joseph T. Hull, PhD|240-403-5324|jhull@supernus.com|
21231690|NCT02007109|Baylor College of Medicine|Dr. Mary Felberg|832-824-5800|mafelber@texaschildrens.org|
21231691|NCT00687323|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21231692|NCT02465216|IDRI|Dr. Corey Casper|2063810883|corey.casper@idri.org|
21231693|NCT03031678|MED-EL Corporation|Allison Racey|1-888-633-3524|research.us@medel.com|
21231694|NCT04557371|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21231695|NCT01154764|Asan Medical Center|Hyeong-Seok Lim MD, Ph.D|+82 2 3010 4613|mdihs@amc.seoul.kr|
21231696|NCT01482884|AstraZeneca|Mark Berner Hansen|+46 31 776 4794|Mark.Berner.Hansen@astrazeneca.com|
21231697|NCT03898362|VA Pittsburgh Healthcare System|Dr. Brad Dicianno|412-822-3700|brad.dicianno@va.gov|
21231698|NCT05542576|Amydis, Inc.|Matthew Lehman|6463317899|matt.lehman@amydis.com|
21231699|NCT02299297|Columbia University Department of Dermatology Clinical Research Unit|Grace Ulerio, CCRC|212-305-6593|gu2102@cumc.columbia.edu|
21231700|NCT05353985|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21231701|NCT04419714|Wesper/Tatch|Amir Reuvent|5754482824|amir@wesper.co|
21231702|NCT02057406|Duke University Medical Center|Dr. Wei Jiang|919-668-0762|jiang001@mc.duke.edu|
21231703|NCT02692716|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21231704|NCT03709771|Vanderbilt University Medical Center|Emily Shardelow|615-875-8949|emily.m.shardelow@vumc.org|
21231705|NCT03562481|University of North Carolina at Chapel Hill|Jessica Lee, DDS, MPH, PhD|9195373955|jessica_lee@unc.edu|
21231706|NCT02056782|Cantex|CBertrand|954-315-3660|cbertrand@cantex.com|
21231707|NCT03654651|The Pennsylvania State University|Dr. Penny Kris-Etherton|814-863-2923|pmk3@psu.edu|
21231708|NCT01401283|Hamburg Eppendorf University Hospital|Daniel A. Reuter, MD|+49-40-7410-0|dreuter@uke.de|
21231709|NCT02433483|St. Jude Children's Research Hospital|Jeffrey E. Rubnitz, MD, PhD|901-595-2388|jeffrey.rubnitz@stjude.org|
21231710|NCT03824912|Encube Ethicals Pvt Ltd|Dr. Lalatendu Panigrahi, Chief Scientific Officer|+91-22-6264-7002|lalatendu.p@encubeethicals.com|
21231711|NCT03454581|Federal University of Rio Grande do Sul|PhD Manoela Domingues Martins|55-51-33085011|manomartins@gmail.com|
21231712|NCT03836612|St Thomas' Hospital, London|Dr Peter Irving|020 7188 7188|peter.irving@gstt.nhs.uk|
21231713|NCT01414114|Amgen, Inc|Study Director|866-572-6436||
21231714|NCT01737944|Antares Pharma|Jonathan Jaffe, MD; Vice President Clinical Development|1-609-359-3020|jjaffe@antarespharma.com|324
21231715|NCT05620563|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21231716|NCT01781403|Asan Medical Center|Dr. Tae Won Kim|+82-2-3010-3910|twkimmd@amc.seoul.kr|
21231717|NCT00597545|Columbia University|Eric J Heyer|212-305-9072|ejh3@cumc.columbia.edu|
21231718|NCT02085785|Department of Veterans Affairs|Dr. Alyson Littman, Research Health Scientist|206-277-4182|alyson.littman@va.gov|
21231719|NCT00779467|Wake Forest School of Medicine|Peter H. Pan, MD, MSEE|336-718-8278|ppan@wakehealth.edu|
21231720|NCT00644995|Group Health Cooperative|Jennifer McClure, PhD|206-287-2737|mcclure.j@ghc.org|
21231721|NCT01427504|University of Colorado|Dr. Jennifer Kiser|303-724-6131|jennifer.kiser@ucdenver.edu|
21231722|NCT00865124|Brigham and Women's Hospital|Gail K. Adler|617-732-5661|gadler@partners.org|
21231723|NCT03950167|UFUK UNIVERSITY|DR MÜGE KESKİN|+905333522090|mugekeskin1@hotmail.com|
21231724|NCT02309489|King's College London, UK|Dr Marina Daniele|020 7836 5454|marina.daniele@kcl.ac.uk|
21231725|NCT02368431|VA Connecticut Healthcare System West Haven Campus, West Haven, CT|Dr Albert Arias|804-828-5793|albert.arias@vcuhealth.org|
21231726|NCT00484874|Dana-Farber Cancer Institute|Heather Jacene, MD|617-632-3767|hjacene@partners.org|
21231727|NCT01678911|Rehabilitation Institute of Chicago|Director of the Center for Pain Studies|312.238.5654|centerforpainstudies@ric.org|
21231728|NCT04649060|Oncopeptides AB|VP Chief Operating Officer|+46 8 615 20 40|trials@oncopeptides.com|
21231729|NCT02117648|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21231730|NCT01815515|Johns Hopkins University|Steven Rowe, M.D, Ph.D|4105021520|srowe8@jhmi.edu|
21231731|NCT00171730|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21231732|NCT05025241|Neuren Pharmaceuticals|Chief Medical Officer|+61 (3) 9092 0480|MedicalInformation@neurenpharma.com|
21231733|NCT02670837|University of Minnesota, Masonic Cancer Center|Dr. Christen Ebens|(612) 626-5654|ebens012@umn.edu|
21231734|NCT01985867|The Medical University of Warsaw|Katarzyna Wojtyniak|+48 22 317 94 21|wojtyniakkasia@gmail.com|
21231735|NCT02220205|Beth Israel Deaconess Medical Center|Siripanth Nippita|617-667-4165|snippita@bidmc.harvard.edu|
21231736|NCT02397785|Cleveland Clinic Foundation|Erica Magelky, Principal Investigator|713-628-5357|magelke@ccf.org|
21231737|NCT02557646|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21231738|NCT00137046|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21231739|NCT02532972|Massachusetts Eye & Ear Infirmary|Dr. Daniel Lee|6175736981|Daniel_Lee@meei.harvard.edu|
21231740|NCT03223246|Massachusetts General Hospital|Dr. Margaret Samuels-Kalow|6177262000|msamuels-kalow@mgh.harvard.edu|
21231741|NCT03552198|KCL|Dr D D'Antoni|NA|donatella.d'antoni@kcl.ac.uk|
21231742|NCT02925494|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21231743|NCT02845453|Boston Medical Center|Amy Yule, MD|617-414-1936|amy.yule@bmc.org|
21239079|NCT01010477|Rutgers-Robert Wood Johnson Medical School|Jill Williams, MD, Principal Investigator|7322354341|Jill.williams@rutgers.edu|
21231744|NCT02911753|University of Arizona|David O. Garcia, PhD, FACSM|520-626-4641|davidogarcia@email.arizona.edu|
21231745|NCT03334448|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
21239080|NCT00548132|Washington University School of Medicine|Bernard C. Camins, MD|3144548351|bcamins@dom.wustl.edu|
21239081|NCT04887948|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21231746|NCT06149247|Soligenix, Inc.|Richard Straube, MD/Chief Medical Officer|609-538-8200|rstraube@soligenix.com|
21231747|NCT03735433|The Ohio State University|Kara Rood, MD|614-293-8515|Kara.Rood@osumc.edu|
21231748|NCT01767155|Aeterna Zentaris|Dr. Nicola Ammer|+496942602|nammer@aezsinc.com|3472
21231749|NCT02518750|St. Jude Children's Research Hospital|Sima Jeha, MD|901-595-3901|sima.jeha@stjude.org|
21231750|NCT01365910|Vanderbilt-Ingram Cancer Center|Dr. Jordan Berlin|615-343-4128|jordan.berlin@vanderbilt.edu|
21231751|NCT00371137|Jazz Pharmaceuticals, Inc.|Grace Wang, MD, Medical Monitor & Director of Clinical Development|650-496-3777||
21231752|NCT02013791|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21239082|NCT02948959|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21231753|NCT03809052|Galecto BIotech|Dr Bertil Lindmark, Chief Medical Officer|+45 70 70 52 10|info@galecto.com|
21231754|NCT00923247|National Cancer Institute|Dr. Ravi Madan|301-480-7168|madanr@mail.nih.gov|
21231755|NCT01782222|UCB|UCB Cares|+1 877 822 9493||
21231756|NCT02071914|Celltrion|Head of Clinical Planning Department|82328505000|contact@celltrion.com|
21231757|NCT01756898|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21231758|NCT01500694|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21231759|NCT01691781|Brigham and Women's Hospital|Anand Vaidya|6175258285|avaidya1@partners.org|
21231760|NCT03978520|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21231761|NCT02818569|Massachusetts General Hospital|Dr. Oluwaseun Johnson-Akeju|617-724-7200|ojohnsonakeju@partners.org|
21231762|NCT01918085|Coloplast|Henrik Sigaard Knoth|+ 45 4911 3469|dkhsk@coloplast.com|
21231763|NCT02154243|HSS|Dr. Haskins|(212) 606-1000|HaskinsS@hss.edu|
21231764|NCT03158116|UCSF Benioff Children's Hospital Oakland|Rachna Wadia, MD|844-724-4140|rawadia@mail.cho.org|
21231765|NCT01118221|MVAHS|Robert M Jackson, MD|305-575-3548|robert.jackson4@va.gov|
21231766|NCT02132130|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
21231767|NCT02760069|Brooke Army Medical Center|Dr. Michael D. April|210-916-0808|Michael.D.April.mil@mail.mil|
21231768|NCT04748120|Cleveland Clinic Foundation|Dr. Clayton Petro|216-444-3501|petroc@ccf.org|
21231769|NCT01550302|University of Washington|Srdjan Jelacic|(206) 598-3777|sjelacic@uw.edu|
21231770|NCT00600483|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
21231771|NCT02343627|Taro Pharmaceuticals U.S.A. Inc|Senior Director, Clinical|+1 914-345-900|Natalie.Yantovskiy@Taro.com|
21231772|NCT00705653|Progen Industries|Michael Fitzgerald|919-803-9988|michaelf@progen-pharma.com|
21231773|NCT04208698|CinDome Pharma, Inc.|Director of Clinical Trials|844-531-1834|info@cinrx.com|
21231774|NCT02547454|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21231775|NCT01684007|Alcon Research, Ltd.|Magda Michna, Expert Clinical Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21278382|NCT00790335|Washington University in St. Louis|Dr. Suresh Vedantham, Principal Investigator|3143622900|vedanthams@mir.wustl.edu|314
21278383|NCT01085201|BloodCenter of Wisconsin|Dr. Joshua J. Field|414-937-3848|joshua.field@bcw.edu|
21278384|NCT00528411|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21278385|NCT03893565|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21278386|NCT05005312|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21278387|NCT01283035|DFCI|Joyce Liu, MD, MPH|617-632-5269|joyce_liu@dfci.harvard.edu|
21278388|NCT00851318|Astellas Pharma Inc.|Medical Director, Global Medical Sciences||ClinicalTrials.Disclosure@astellas.com|
21278389|NCT02421224|University of California, San Francisco|Dr. Justin S. White|415-476-8045|justin.white@ucsf.edu|
21278390|NCT01715571|Johns Hopkins University School of Medicine|Arthur Burnett, MD|410-614-3986|aburnet1@jhmi.edu|
21278391|NCT01687972|Johns Hopkins Univesity School of Medicine|Janice Henderson, MD Assistant Professor|443-287-2783|jhender7@jhmi.edu|
21231776|NCT03655691|Eirion Therapeutics|Chief Executive Officer|(781) 935-1216|info@eirionthera.com|
21231777|NCT03159624|University of Alabama at Birmingham|Dr. Brad Woodworth|205-801-7858|bwoodworth@uabmc.edu|
21231778|NCT03694821|UConn Health|Director of Outcomes, Research & Quality|860-679-4932|mcote@uchc.edu|
21231779|NCT04221009|James A Haley Veterans' Hospital|Dr. Marc A Silva|813-972-2000|marc.silva1@va.gov|5613
21231780|NCT00793598|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
21278392|NCT01708629|Bausch Health|Study Director|510-259-5284||
21278393|NCT03870477|Zimmer Biomet|Ryan Boylan, Clinical Affairs Manager|574-371-9784|ryan.boylan@zimmerbiomet.com|
21278394|NCT04558918|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21278395|NCT02849938|Billings Clinic|Patricia M Notario, MD|406-238-2143|pnotario@billingsclinic.org|
21278396|NCT02256436|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21278397|NCT05961215|Cedars-Sinai Medical Center|Robert Vescio, MD|3104231825|robert.vescio@cshs.org|
21278398|NCT05779943|Emory University|Dr. David Schuster|4047781900|dschust@emory.edu|
21231781|NCT02154490|SWOG Statistics & Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
21231782|NCT01404325|Novartis Pharmaceuticals|Study Director|8627788300||
21231783|NCT01075204|Abbott|Esther Oppermann, Clinical Trial Manager|49 511 6750 3954|esther.oppermann@abbott.com|
21231784|NCT00945139|University of Vermont CC|Dr. Claire Verschraegen|802-656-5487|claire.verschraegen@vtmednet.org|
21231785|NCT00660023|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21231786|NCT00603993|Abbott|Global Medical Services|1-800-633-9110||
21231787|NCT04180488|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
21231788|NCT00471068|Alcon Labs|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21231789|NCT04113304|Wayne State University|"Dr. Kathleen Lucy McGoron"|313.664.2500|Lucy.K.McGoron@wayne.edu|
21231790|NCT01393704|Brigham and Women's Hospital|Dr. Jon Einarsson|617-525-8582|jeinarsson@partners.org|
21231791|NCT00464087|Medstar Health Research Institute|Ron Waksman, MD|202-877-2812|ron.waksman@medstar.net|
21231792|NCT00088985|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@UNC.med.edu|
21231793|NCT00418314|St. Jude Medical|Sr. Director Clinical Studies|(408) 522-6410|tshipman@sjm.com|
21231794|NCT01224431|Phoenix Children's Hospital|Angelique Ferayorni|602-546-1910|aferayorni@phoenixchildrens.com|
21231795|NCT02557698|Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergology Charité - Universitätsmedizin Berlin|Dr. Jan Kottner|+49 30 450 518218|jan.kottner@charite.de|
21231796|NCT00549302|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21231797|NCT03585504|Medical University of South Carolina|Dr. Angela Dempsey|843-762-4500|dempsear@musc.edu|
21231798|NCT03590041|University of Colorado Anschutz medical Campus|Dr. Bethany Kwan|303-724-5153|bethany.kwan@cuanschutz.edu|
21231799|NCT02692703|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21231800|NCT04626297|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21231801|NCT04118166|Stanford Medicine at Stanford University|Maria Ahern|650-725-6413|mahern@stanford.edu|
21231802|NCT03434275|Baudax Bio, Inc.|Development|484-395-2440|info@baudaxbio.com|
21231803|NCT02533427|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21231804|NCT03303079|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21231805|NCT01829191|Vistakon, USA|XU CHENG, PRINCIPAL CLINICAL SCIENTIST|1 904 443-1245|xcheng6@its.jnj.com|
21231806|NCT01276353|Clinical Development. JAC PCU. Eisai Co., Ltd.|Naoki Kubota|+81-3-3817-5245||
21231807|NCT03546192|Sanofi Pasteur Inc.|Medical Director|800-633-1610 ext 1#|RegistryContactUs@sanofipasteur.com|
21231808|NCT01200602|Mayo Clinic|Vilmarie Rodriguez, MD|507-284-2695|rodriguez.vilmarie@mayo.edu|
21231809|NCT02205814|MENARINI Group|Angela Capriati, MD PhD - Corporate Director Clinical Research|+39 055 5680|acapriati@menarini-ricerche.it|9990
21231810|NCT01426373|Kythera Biopharmaceuticals, Inc.|Clinical Trial Disclosure||clinical_trials@kythera.com|
21231811|NCT02246660|Northwestern University|Dr. Mary McDermott|312-503-6419|mdm608@northwestern.edu|
21231812|NCT00726661|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21231813|NCT02756689|UAB|Lorie Harper, MD|205-934-5611|lmharper@uabmc.edu|
21231814|NCT00587639|Mayo Clinic|Dr. Christopher Wall|5072843352|wall.chris@mayo.edu|
21231815|NCT01574326|Genzyme Corporation|Trial Transparency Team||Contact-US@sanofi.com|
21231816|NCT03856164|University of Texas Southwestern|Dr. Olutoyosi Ogunkua|2145578873|olutoyosi.ogunkua@utsouthwestern.edu|
21231817|NCT02695498|Atrium Health Wake Forest Baptist|Rebecca Wells, MD, MPH|336-716-2357|rewells@wakehealth.edu|
21231818|NCT00911053|Oregon Health and Science University|OHSU IRB|5034948849|irb@ohsu.edu|
21231819|NCT00005937|NIH National Heart, Lung and Blood Institute|Neal S. Young MD|301-402-1806|youngns@nhlbi.nih.gov|
21231820|NCT01288469|Sanofi|Trial Transparency Team||Contact --US@sanofi.com|
21231821|NCT03782272|PATH|Gwen Ambler, Clinical Research Officer|+1-206-285-3500|gambler@path.org|
21231822|NCT05860647|HealthPartners Institute Neuroscience Research Center|Bhavani Kashyap, MBBS, PhD|651-495-6565|bhavani.x.kashyap@healthpartners.com|
21231823|NCT00582166|University of Wisconsin Carbone Cancer Center|Lymphoma/Myeloma Disease Oriented Team|608-265-3794|barnstable@wisc.edu|
21231824|NCT04488068|VA San Diego Healthcare System|Mahadevan Rajasekaran, Ph.D.|8585528585|Mahadevan.Rajasekaran@VA.gov|7114
21231825|NCT01606436|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21231826|NCT02859454|National Cancer Institute|Scott Norberg, DO|301-275-9668|scott.norberg@nih.gov|
21231827|NCT04294472|Vera Therapeutics Inc.|Isabel Gorham, Director of Clinical Operations|(910)200-0532|isabel.gorham@veratx.com|
21231828|NCT00110149|BIDMC|Robin Joyce, MD|617-667-9920|rjoyce@bidmc.harvard.edu|
21231829|NCT02452398|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
21231830|NCT04216017|University of Washington|Dr. Jonah Hebert-Davies|2067443466|jdavies2@uw.edu|
21231831|NCT03944954|University of Kentucky|Dr. Michael J Wesley|8593230579|michael.wesley@uky.edu|
21231832|NCT00748033|Wellspect Health Care|Head of Medical Affairs|+46313763000|mace@wellspect.com|
21231833|NCT01018186|GlaxoSmithKline|GSK Response Center|866-435-7343||
21231834|NCT02603419|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21231835|NCT02421315|New York State Psychiatric Institute|Dr. Rachel Marsh|646-774-5774|rachel.marsh@nyspi.columbia.edu|
21231836|NCT01317030|Bausch & Lomb Incorporated|Robert Steffen, O.D., M.S.|585-338-6399|Robert.Steffen@bausch.com|
21231837|NCT04102020|ABBVIE CALL CENTER|AbbVie|844-663-3742|abbvieclinicaltrials@abbvie.com|
21231838|NCT05109442|Affimed GmbH|Clinical Operations|+49 621 56003-0|trials@affimed.com|
21231839|NCT04216329|National Cancer Institute|Dr. Kevin A. Camphausen|240-760-6205|camphauk@mail.nih.gov|
21231840|NCT04853225|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21231841|NCT03918447|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21290002|NCT03074643|Wake Forest University School of Medicine|Dr. Denise Houston|336-713-8558|dhouston@wakehealth.edu|
21290003|NCT01174459|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21290004|NCT00290758|NorthwesternU|Seema Khan, MD|312-695-0288|skhan@nmh.org|
21290005|NCT01556100|Chang Gung Memorial Hospital|Dr. kun-Ju Lin|033281200|lin4857@adm.cgmh.org.tw|2632
21231842|NCT03278613|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
21290006|NCT00474968|CytoCore, Inc.|Richard Domanik, Ph.D.|312-222-9550|rdomanik@cytocoreinc.com|
21290007|NCT01111292|Northwestern University|Dr. Seema Khan|(312) 503-4236|SKhan@nm.org|
21290008|NCT00215553|Discovery Laboratories, Inc.|Robert Segal, MD|215-488-9300|rsegal@discoverylabs.com|
21290009|NCT01429623|Bar Ilan University|Jonathan Rabinowitz, PhD|+972544643889|Jonathan.Rabinowitz@biu.ac.il|
21290010|NCT00981175|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21290011|NCT01096186|Impax Laboratories, Inc.|Daven Mody, PharmD, MBA, Director, Regulatory Affairs|510-240-6073|dmody@impaxlabs.com|
21290012|NCT02728726|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|Renew.J@mayo.edu|
21290013|NCT00793611|University of New Mexico Health Sciences Center and CTSC|Yuko Komesu MD|505-925-4395|ykomesu@salud.unm.edu|
21290014|NCT03156621|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844 734 6643|clinicaltrials@regeneron.com|
21231843|NCT01405456|Massachusetts General Hospital|Dr. Steven K. Grinspoon|6177249109|sgrinspoon@mgh.harvard.edu|
21290015|NCT00799864|Janssen R&D BE|Director 1 Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21290016|NCT00079781|NeuroPace, Inc.|Dr. Martha Morrell, Chief Medical Officer|650-237-2776|mmorrell@neuropace.com|
21290017|NCT00225758|Dartmouth-Hitchcock Medical Center|Gary N. Schwartz, MD|(603) 653-6181|gary.n.schwartz@hitchcock.org|
21290018|NCT00576407|Duke University Medical Center|M. Louise Markert, MD, PhD Professor of Pediatrics and Immunology|919-684-6263|marke001@mc.duke.edu|
21290019|NCT00621322|GlaxoSmithKline|GSK Response Center|866-435-7343||
21290020|NCT01431573|NYSPI|David Hellerstein|646-774-8069|david.hellerstein@nyspi.columbia.edu|
21290021|NCT01657500|Case Western Reserve Univ and University Hospitals Case Medical Center|Jonathan Lass MD|2168445893|jonathan.lass@uhhospitals.org|
21290022|NCT00063362|University Hospitals Case Medical Center|Dr. Keming Gao|216-844-2865|keming.gao@UHhospitals.org|
21290023|NCT00087672|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes, M.D./ Professor|713-794-5783|eharriso@mdanderson.org|
21290024|NCT00552279|GlaxoSmithKline|GSK Response Center|866-435-7343||
21290025|NCT02453191|University of Iowa, Holden Comprehensive Cancer Cente|Varun Monga, MD|319-384-9497|varun-monga@uiowa.edu|
21290026|NCT01520714|The Heart Hospital Baylor Plano|Research Manager|469-814-4712|natalie.settele@baylorhealth.edu|
21290027|NCT00185900|Stanford University|Dr. Anna Girsen|(650) 725-5720|agirsen@stanford.edu|
21290028|NCT01210443|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21290029|NCT02719366|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
21290030|NCT02807181|Sirtex|Director, Clinical Research Operations|+1-888-474-7839|info-us@sirtex.com|
21290031|NCT01489358|Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr Julie E Ledgerwood||ledgerwood@mail.nih.gov|
21290032|NCT03518203|Cincinnati Children's Hospital Medical Center|Sonata Jodele, MD|(513) 636-5917|Sonata.Jodele@cchmc.org|
21290033|NCT01457430|MGH Allergy Associates|Dr. Aleena Banerji|617-726-3850|abanerji@mgh.harvard.edu|
21290034|NCT01266083|Sellas Life Sciences|Dragan Cicic|646-200-5278|info@sellaslife.com|
21290035|NCT02675452|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21290036|NCT04595370|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21290037|NCT03520387|VA Puget Sound Health Care System Seattle Division, Seattle, WA|Pradeep Suri, MD|206-764-2673|Pradeep.Suri@va.gov|
21290038|NCT00541775|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21290039|NCT01945242|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21231844|NCT05475236|Veterans Health Administration|Dr. Clayton Swanson|3523761611|clayton.swanson@va.gov|107583
21290040|NCT04913675|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
21290041|NCT05660538|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21290042|NCT04518410|ACTG Network Coordinating Center, DLH|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
21290043|NCT02218268|University of Florida|Michael Haller|352-265-0111|hallemj@peds.ufl.edu|
21290044|NCT01341990|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
21290045|NCT03259308|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
21290046|NCT00290238|RS Medical|Clinical Research Manager|360-891-7299||
21290047|NCT03834883|Purdue University|James E. Tisdale, PharmD|317-880-5418|jtisdale@purdue.edu|
21290048|NCT04826731|Ankara Sanatoryum Training and Research Hospital|Dr. Kerem Ensarioğlu|905426142727|kerem.ensarioglu@gmail.com|
21290049|NCT01569763|Minerva Surgical, Inc.|Dr. Eugene Skalnyi, VP Medical Affairs|(1) 650-284-3500|Eugenes@minervasurgical.com|
21239083|NCT00787319|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21239084|NCT02312856|CERENOVUS|Christopher Hendricks|415-656-6565|chendric@its.jnj.com|
21239085|NCT01932294|University of Alabama at Birmingham|RongBing Xie|205-975-3624|rongbingxie@uabmc.edu|
21239086|NCT04415151|Yale School of Medicine|Hyung Chun, MD, FAHA|(203) 785-6012|hyung.chun@yale.edu|
21239087|NCT00409786|University of Pittsburgh|Kathleen McTigue|412-692-2940|mctiguekm@upmc.edu|
21239088|NCT00638235|Eastern Virginia Medical School|Dr. James C Lukban, Professor & Director Division of urogynecology|7574467900|lukbanjc@evms.edu|
21239089|NCT02211534|Regenesis Biomedical|Heather Vander Ploeg|602-4287041|Heather.VanderPloeg@regenesisbio.com|
21239090|NCT02608905|Baylor College of Medicine|Mandeep Bajaj|713-798-1712|bajaj@bcm.edu|
21239091|NCT00597714|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
21278399|NCT02944071|BSC International Medical Trading (Shanghai) Co., Ltd|Junyang Bai|+13671646036|junyang.bai@bsci.com|
21278400|NCT01394952|Eli Lilly and Company|Chief Medical Officer|800-545-5979|www.ClinicalTrials.gov@lilly.com|
21278401|NCT04740814|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21278402|NCT00085423|Dartmouth-Hitchcock|Dr. Marc Ernstoff|603 650 5534|marc.s.ernstoff@hitchcock.org|
21278403|NCT01948986|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21278404|NCT01031953|Oregon Health & Science University|Dr. Joseph Bubalo|503-494-8007|bubaloj@ohsu.edu|
21278405|NCT01763684|Zimmer Biomet|Linda Meijer, Clinical Operations Manager|+31786292935|linda.meijer@zimmerbiomet.com|
21278406|NCT00673244|Department of Anesthesiology and Critical Care Medicine, George Washington University|Lakhmir S. Chawla|202-994-7903|minkchawla@gmail.com|
21290050|NCT01926509|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21231845|NCT01774968|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21231846|NCT02044393|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21231847|NCT05355805|Acelyrin|Donald Betah|(805) 419-3805|Donald.Betah@acelyrin.com|
21231848|NCT00534430|Department of Hematology, City of Hope|Anthony Stein, MD, Clinical Professor|626-537-5748|astein@coh.org|
21231849|NCT04847557|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21231850|NCT01325584|Midwestern Regional Medical Center|Director of Clinical Trials|847-731-1648|Bruce.Steinert@CTCA-Hope.com|
21231851|NCT02389088|University of California, San Diego|Dr. R. Jeffrey Chang|858-534-8930|rjchang@ucsd.edu|
21231852|NCT01986855|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21231853|NCT04317066|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21231854|NCT00333814|Allergan, Inc|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
21231855|NCT02825992|Acutus Medical, Inc.|Steve McQuillan, Sr. Vice President Regulatory, Clinical, & Quality Assurance|763-331-4344|steven.mcquillan@acutus.com|
21231856|NCT01780636|UC Irvine|Karen Noblett|714-456-6807|knoblett@uci.edu|
21231857|NCT00711711|HECVSanté|Pr. Claude Pichonnaz|++41213168126|claude.pichonnaz@hesav.ch|
21231858|NCT02279173|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21231859|NCT01129609|Medtronic|Rianna Rapson|763-526-2170|rianna.k.rapson@medtronic.com|
21231860|NCT01164956|Dana-Farber Cancer Institute|Christina K. Ullrich, MD, MPH|617.632.4997|Christina_Ullrich@dfci.harvard.edu|
21231861|NCT00609492|GlaxoSmithKline|GSK Response Center|866-435-7343||
21231862|NCT00720434|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21231863|NCT02425046|Center for Children's Healthy Lifestyles & Nutrition - Children's Mercy Hospital|Dr. Helena Laroche|(816) 234-9251|hhlaroche@cmh.edu|
21231864|NCT02782780|San Francisco VA Health Care System|Dr. Linda Chao|415-221-4810|linda.chao@va.gov|24386
21231865|NCT01413191|UT MD Anderson Cancer Center|Dr. Sapna Patel, MD - Associate Professor, Melanoma Medical Oncology|713-792-2921|SPPatel@mdanderson.org|
21231866|NCT02904512|Veterans Affairs Medical Center|Dr. Ilias (Elias) Spanakis|(617) 319-9731|ispanakis@som.umaryland.edu|
21231867|NCT04493281|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp|
21231868|NCT03828357|Abbott|Grant Kim, Director Clinical Programs|8184933147|grant.kim1@abbott.com|
21231869|NCT03219294|Maine Medical Center|Research Coordinator|2076622862|richaj3@mmc.org|
21231870|NCT02634684|UC San Diego|Neal Swerdlow, M.D., Ph.D.|619-543-6270|nswerdlow@health.ucsd.edu|
21231871|NCT03395886|Zhongshan Hospital, Fundan university|Mr Zhe Luo|64041990|ec@zs-hospital.sh.cn|
21231872|NCT01963403|UC Davis|Dr. Mitchell Creinin|916-734-6670|mdcreinin@ucdavis.edu|
21231873|NCT00589914|Johnson & Johnson Pharmaceutical Research & Development LLC|Clinical Leader Psychiatry|1 609 730-2324||
21231874|NCT03519932|CooperVision Inc.|Jose A.Vega OD, MSc., FAAO|9256213761|javega@coopervision.com|
21231875|NCT01979016|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
21231876|NCT01442493|Friends Research Institute|Robert Schwartz, M.D.|410-837-3977|rschwartz@friendsresearch.org|276
21231877|NCT01354951|Memorial Sloan Kettering Cancer Center|Dr. Michael Zelefsky, MD|212-639-6802|zelefskm@mskcc.org|
21231878|NCT04326231|Cognoa|Senior Director of Clinical Research|4082076659|minda.seal@cognoa.com|
21231879|NCT00759954|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com|
21231880|NCT03124875|LimFlow Inc.|Cecilia Petrella|(888) 478-7705|cpetrella@limflow.com|101
21231881|NCT00372112|GlaxoSmithKline|GSK Response Center|866-435-7343||
21239092|NCT01488708|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21239093|NCT00750282|Piramal Imaging|Dr. Juergen Hirschfeld|49 30 461 1246 15|juergen.hirschfeld@piramal.com|
21239094|NCT03802864|Weill Cornell Medicine|Russell Hayden|2127465566|rph9002@med.cornell.edu|
21239095|NCT01641926|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21239096|NCT03673462|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
21239097|NCT01737684|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21239098|NCT02924324|Memorial Sloan Kettering Cancer Center|Dr. Ellen Basu, MD, PhD|212-639-5204|BasuE@mskcc.org|
21239099|NCT01480596|GlaxoSmithKline|GSK Response Center|866-435-7343||
21239100|NCT02387216|Elevation oncology|VP, Clinical Operations|+1-716 371 1125|clinical@elevationoncology.com|
21239101|NCT04559282|Cochlear|Therese Agat|+46766498562|tagat@cochlear.com|
21239102|NCT02917265|Oklahoma Medical Research Foundation|Aikaterini Thanou, MD|405-271-7805|aikaterini-thanou@omrf.org|
21239103|NCT02481375|University of British Columbia|Crystal Karakochuk|604 822 0421|crystal.karakochuk@ubc.ca|
21239104|NCT03982043|University of Pittsburgh|Tina R. Goldstein, Ph.D.|4122465604|goldtr@upmc.edu|
21239105|NCT05436912|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21239106|NCT00979602|GlaxoSmithKline|GSK Response Center|866-435-7343||
21239107|NCT03885011|Orasis|Head of Regulatory Affairs|+972-9-8877745|iris.meisner@orasis-pharma.com|
21239108|NCT01216163|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21239109|NCT03597035|University Hospitals Cleveland Medical Center|Sanjay Rajagopalan|216-844-5125|Sanjay.Rajagopalan@UHhospitals.org|
21239110|NCT02002182|Baylor College of Medicine|Dr. Andrew Sikora|7137983909|Andrew.Sikora@bcm.edu|
21239111|NCT02914379|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21239112|NCT05261191|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
21239113|NCT03879408|Johnson & Johnson Consumer, Inc.|ASSOCIATE DIRECTOR CLINICAL RESEARCH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21239114|NCT01320943|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21239115|NCT01490125|Novartis|Study director|41 61 324 1111||
21239116|NCT04616014|Oramed, Ltd.|Chief Scientific Officer|972-2-566-0001|miriam@oramed.com|
21239117|NCT05458024|University of North Carolina at Chapel Hill|Sam McLean, MD, MPH|+1 (919) 843-5931|samuel_mclean@med.unc.edu|
21239118|NCT04522180|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionisph.com|
21239119|NCT05807919|University of Mihcigan|Prashant Singh|734-647-9252|singhpr@med.umich.edu|
21239120|NCT06334042|Hacettepe University Department of Anesthesiology and Intensive Care|Oguzhan Kahveci, MD|+903123051207|kahveci.oguz@hotmail.com|
21239121|NCT04571099|Philips Clinical & Medical Affairs Global|Marijke van Vlimmeren|+31 6 31042408|marijke.van.vlimmeren@philips.com|
21239122|NCT00361439|University of Chicago|Jayant Pinto, MD|773-702-6727|jpinto@surgery.bsd.uchicago.edu|
21239123|NCT01931735|VA Palo Alto Research|Jessica Asay|650-493-5000|asay@stanford.edu|65971
21239124|NCT02719990|Aravive, Inc.|Chief Operating Officer|(936) 355-1910|clinicaltrials@aravive.com|
21239125|NCT02404389|Novartis Pharmaceuticals|Study Director|862-778-8300||
21239126|NCT03324880|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21239127|NCT01412801|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21239128|NCT01769170|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
21239129|NCT01472874|Yale|Dr. Schilsky|203-785-2565|michael.schilsky@yale.edu|
21239130|NCT00717314|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21239131|NCT05076149|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21239132|NCT05096208|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21239133|NCT02087501|Endospan|Jessica Kleine||j.Kleine@endospan.com|
21239134|NCT00094328|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
21239135|NCT01481545|National Cancer Institute of Naples|Dr. Antonio Avallone|+39 081 5903629|a.avallone@istitutotumori.na.it|
21239136|NCT01483937|BalanceSense LLC|Karen L. Atkins PhD PT|407 625 9680|atkins.balancesense@gmail.com|
21239137|NCT01919970|Baylor College of Medicine|Dr. Eric Storch|727-767-8230|eric.storch@bcm.edu|
21239138|NCT02213328|Desmond Tutu HIV Foundation|Dr Katherine Gill|+2721 785 3121|katherine.gill@hiv-research.org.za|
21239139|NCT00990340|Teva Neuroscience|Thomas Smith, MD, VP, Medical Affairs|816-508-5000|tom.smith@tevapharm.com|
21239140|NCT04615182|TransMedics Inc.|Laura Damme, VP Clinical Affairs|9785520900|ldamme@transmedics.com|
21239141|NCT01126060|Samsung medical center|Dr. Man Ki Chung|82-2-3410-1845|manki.chung@samsung.com|
21239142|NCT00402337|Ironwood Pharmaceuticals|Doug Levine, MD|617.374.3906|dlevine@ironwoodpharma.com|
21239143|NCT03565068|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21239144|NCT00658138|University of Bologna, Italy|Professor Giovanni Dondi dall'Orologio|+39 051-2088132|gdondi@alma.unibo.it|
21239145|NCT02239380|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|001-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21239146|NCT03857230|IVFarma LLC|General Manager|+7(499)6455342|info@ivfarma.ru|1
21239147|NCT02707692|UC San Diego|David (Davey) Smith|619-300-9638|d13smith@health.ucsd.edu|
21278407|NCT04305496|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21239148|NCT02764775|Fort Worth Independent School district|Dr. Julie Brown|214-725-8232|jbrown18@twu.edu|
21239149|NCT00429494|The University of Texas (UT) MD Anderson Cancer Center|Dr. Naoto T. Ueno, MD, PhD / Professor||CR_Study_Registration@mdanderson.org|
21239150|NCT04684641|Yale University|Dr. Jonathan Koff|475-224-8167|jon.koff@yale.edu|
21239151|NCT00976703|Metrohealth Medical Center|Kelly S Gibson, MD|216-778-5498|kgibson@metrohealth.org|
21239152|NCT03549234|University of California San Diego|Matthew Swisher, MD|415-314-4099|matthew.swisher@gmail.com|
21239153|NCT02243631|Zablocki VA Medical Center|Dr. Ann Rosenthal , MD ACOS/Research|414-384-2000|ann.rosenthal@va.gov|41430
21239154|NCT01959945|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
21239155|NCT01992549|Octapharma|Sylvia Werner|415 260-9577|sylvia.werner@octapharma.com|
21239156|NCT01495221|Vitreous Retina Macula Consulatants of New York|Jason S. Slakter, MD|212-861-9797|mail@vrmny.com|
21239157|NCT00840996|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
21239158|NCT04022889|Cerus Corporation|Carol Moore|9258766819|cmoore@cerus.com|
21239159|NCT00856934|CHUV - CPR|Dr. Wassim Raffoul|+41 21 314 25 05|Wassim.Raffoul@chuv.ch|
21239160|NCT01900054|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21239161|NCT03047174|Department of Radiation Oncology, University of Lübeck, Germany|Prof. Dr. med. Dirk Rades|0049 451 500|dirk.rades@uksh.de|45401
21239162|NCT02762981|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
21239163|NCT00957931|University of California, San Francisco|Dr. Sandhya Kharbanda, MD||Sandhya.Kharbanda@ucsf.edu|
21239164|NCT02169895|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21239165|NCT00605319|Weill Cornell Medical College|Dr. Alexis Te|646-962-4811|aet2005@med.cornell.edu|
21239166|NCT02419547|Brigham and Women's Hospital|Douglas Shook, MD, Chief, Divison of Cardiac Anesthesia|617-732-8219|dshook@bwh.harvard.edu|
21239167|NCT02991482|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki|+41 31 511 94 00|Heidi.Roschitzki@etop-eu.org|
21239168|NCT02887989|Cedars-Sinai Health System|Garth Fuller|3236003890|garth.fuller@cshs.org|
21239169|NCT02045433|UT Southwestern/Simmons Cancer Center-Dallas|Dr.Kevin Albuquerque|2146458499|Kevin.Albuquerque@UTSouthwestern.edu|
21239170|NCT01559454|University at Buffalo|Dr. Ricahrd Blondell|716-816-7237|blondell@buffalo.edu|
21239171|NCT00431184|McLean Hospital|Beth Murphy MD|617-855-2297|BMurphy5@partners.org|
21260969|NCT03063385|University of Pennsylvania School of Nursing|Dr. Antonia M. Villarruel|2158988283|amvillar@nursing.upenn.edu|
21239172|NCT03270514|University of Pittsburgh Medical Center Department of Anesthesiology and Perioperative Medicine|Kathirvel Subramaniam, MD, MPH, FASE|724-799-5852|subramaniamk@upmc.edu|
21239173|NCT00462670|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7314||
21239174|NCT00482274|Oregon Health & Science University Knight Cancer Institute|Study Coordinator|503 494-2897|eilersk@ohsu.edu|
21239175|NCT03215901|Boston University|Jacob Bor, Assistant Professor|617-358-2176|jbor@bu.edu|
21239176|NCT01778946|Vanderbilt University Medical Center|Dr. Paul Newhouse|6159360928|paul.newhouse@vanderbilt.edu|
21239177|NCT02150837|Medifast|Chris Coleman|410-504-8161|ccoleman@choosemedifast.com|
21239178|NCT03075904|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
21239179|NCT01588990|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21239180|NCT01287520|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21239181|NCT03587142|Temple University|Dr. Henry Parkman|(215) 707-7579|henry.parkman@temple.edu|
21239182|NCT01800201|University of Pennsylvania|Noora Marcus|215-746-4429|noora.marcus@uphs.upenn.edu|
21239183|NCT02352363|Acorda Therapeutics|Charles Oh|914-326-5455|coh@acorda.com|
21260970|NCT04442581|University of Washington|Madeline Jacoby|2026068246|mjacoby@seattlecca.org|
21239184|NCT04503096|Medical University of South Carolina|Andreana Benitez PhD|(843) 876-8479|benitez@musc.edu|
21239185|NCT01576367|Novartis Pharmaceuticals|Study Director|862-778-8300||
21260971|NCT02017444|University of Birmingham|Professor Alex Sinclair|+44 121 415 9125|a.b.sinclair@bham.ac.uk|
21260972|NCT01756976|Haemonetics|Clinical Project Manager|781-356-9595|michael.dioguardi@haemonetics.com|
21260973|NCT02342171|Institute of Tropical Medicine|Prof. Dr. Johan van Griensven|+3232476426|jvangriensven@itg.be|
21260974|NCT02062177|Università Vita-Salute San Raffaele|Professor Testoni Pier Alberto|+390226432756|testoni.pieralberto@hsr.it|
21260975|NCT01612793|electroCore LLC|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
21260976|NCT00886821|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21260977|NCT04645797|Apros Therapeutics|Tom Wu, PhD|+1-858-284-8839|tom_wu@aprostx.com|
21260978|NCT03596164|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21260979|NCT00389207|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21260980|NCT05614011|QuantuMDx|Alice Toomey-Smith|4408708031234|alice.toomey-smith@quantumdx.com|
21260981|NCT01740362|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21260982|NCT02500550|Kiadis Pharma Netherlands B.V.|Andrew Sandler, MD / Chief Medical Officer|+1 206 779 9213|a.sandler@kiadis.com|
21260983|NCT03293680|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
21260984|NCT01894672|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman MD|646-888-4162|chapmanp@MSKCC.ORG|
21260985|NCT02604264|Fresenius Medical Care North America|Jeffrey L. Hymes, MD|615-567-4821|Jeffrey.HymesMD@fmc-na.com|
21260986|NCT03192904|Ruijin Hospital Shanghai JiaoTong University School of Medicine|Prof. Hecheng Li, Chair of Thoracic Surgery|(86)13917113402|lihecheng2000@hotmail.com|
21260987|NCT00424398|ISTA Pharmaceuticals, Inc.|Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com|
21260988|NCT01523821|Fred Hutchinson Cancer Research Center|H. Joachim Deeg, MD|206-667-5985|jdeeg@fredhutch.org|
21260989|NCT01309737|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21260990|NCT00709202|Nathan Kline Institute for Psychiatric Research|Dr. Robert C Principal Investigator. Smith,|845-398-6531|robert.smith@nki.rfmh.org|
21260991|NCT00855439|University of Michigan|Rodica Pop-Busui, MD, PhD|734 647-9809|rpbusui@med.umich.edu|
21260992|NCT00477087|Stanford University Medical Center|Sandy Srinivas, MD; Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu|
21260993|NCT01397851|independent|Richard Sedlmayr|6468412169|richard.sedlmayr@gmail.com|
21260994|NCT02272790|AstraZeneca|Pejvack Motlagh, MD|+44 (0) 7384 799 850|pejvack.motlagh@astrazeneca.com|
21260995|NCT01076179|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
21260996|NCT03459040|Icahn School of Medicine at Mount Sinai|Dr. John Levine|212-241-6021|john.levine@mssm.edu|
21260997|NCT00986349|GI Dynamics, Inc.|Clinical Affairs Manager|781.357.3261|pkeating@gidynamics.com|
21260998|NCT02299934|University of Colorado, Denver|Dr. Samuel Chang|720-848-1875|SAMUEL.CHANG@UCDENVER.EDU|
21260999|NCT01273818|S.B.Ankara Diskapi Yildirim Beyazit Education and Teaching Hospital|Dr.Gaye Seker|+905323360618|gayeebru@superonline.com|
21261000|NCT03815175|Abbott|Lijuan Jenn Wang|01-408-8453133|Lijuan.wang1@abbott.com|
21261001|NCT03577990|The University of North Carolina at Charlotte|Willie M. Abel, Associate Professor of Nursing|704-687-7949|wmabel@uncc.edu|
21261002|NCT00463437|GlaxoSmithKline|GSK Response Center|866-435-7343||
21261003|NCT03934684|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21261004|NCT00488631|Janssen Research & Development|Senior Director|215-793-7540||
21261005|NCT01073943|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21261006|NCT00551707|Zalicus|Margaret Lee, PhD|617-301-7142|mlee@zalicus.com|
21261007|NCT00761215|Cubist Pharmaceuticals, Inc.|Philippe Prokocimer, MD|858-452-0370|philippe.prokocimer@cubist.com|241
21261008|NCT05662332|Eli Lilly and Company|Chief Medical Officer|08004595979|ClinicalTrials.gov@lilly.com|
21261009|NCT00667277|Icahn School of Medicine at Mount Sinai|Dr. Ronald Hoffman|(212) 241-2297|ronald.hoffman@mssm.edu|
21290051|NCT02730169|Mereo BioPharma Group|Jackie Parkin|+44 (0) 333 023 7300|enquiries@mereobiopharma.com|
21290052|NCT03681093|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21261010|NCT03248128|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21261011|NCT01914679|University of Michigan|Daniel Clauw, MD|734-998-6901|dclauw@med.umich.edu|
21290053|NCT03076164|Memorial Sloan Kettering Cancer Center|Dr. Helene Yu, MD|646-608-3912|YuH@mskcc.org|
21261012|NCT01696357|University of Rochester Medical Center|Hyekyun Rhee|5852763775|hyekyun_rhee@urmc.rochester.edu|
21290054|NCT01213251|Medtronic plc|PRomPT Clinical Team|+1 800-328-2518|MedtronicCRMtrials@medtronic.com|
21231882|NCT02706691|University of Chicago Comprehensive Cancer Center|Technical Director|773-702-0819|pccc_regulatory@bsd.uchicago.edu|
21231883|NCT02927431|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21231884|NCT01830972|Ultragenyx Pharmaceutical Inc|Kim Mooney, Associate Director, Patient Advocacy Medical Services|408-981-3526|kmooney@ultragenyx.com|
21231885|NCT00553514|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21231886|NCT02648178|The Koop Institute at Dartmouth, Geisel School of Medicine|Dr James Sargent|603-653-9025|James.D.Sargent@dartmouth.edu|
21231887|NCT00143403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21231888|NCT01860651|Hvidovre University Hospital|Dr. Katrine Carlsen|26180513|katrinec@gmail.com|0045
21231889|NCT02245308|Durham VA Health Care System|Angela Kirby|919-286-0411|angela.kirby@va.gov|175526
21231890|NCT03798483|Oxford University hospital foundation trust|Colin Forde|+441865221540|Colin.Forde@ouh.nhs.uk|
21231891|NCT02289417|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
21231892|NCT02725710|Duke University|Jeremy M. Weber|919-681-4561|jeremy.m.weber@duke.edu|
21231893|NCT01462097|University of Maryland School of Medicine|Stephen Seliger, MD MS|410-605-7000|sseliger@som.umaryland.edu|x55231
21231894|NCT01858389|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021||
21231895|NCT03572062|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21231896|NCT01605877|Alcon Japan, Ltd.|Hiroshi Kodama, Group Manager|81-3-6899-5000||
21231897|NCT01580618|Kaiser Permanente|Hyo-Chun Yoon, MD, PHD|8084327342|Hyo-Chun.Yoon@nsmtp.kp.org|
21231898|NCT03501069|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21231899|NCT00580606|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsgov@niaid.nih.gov|
21231900|NCT00240162|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
21231901|NCT03064451|Johnson and Johnson Medical NV/SA|Nathalie Macours / Clinical Research Director|+32 2 746 35 27|nmacours1@its.jnj.com|
21231902|NCT00064844|Yale University School of Medicine|Ned Cooney, PhD|860-594-6339|ned.cooney@yale.edu|
21231903|NCT00750204|Johns Hopkins University School of Medicine|Roy Brower, M.D.|1 (410) 614-6292|rbrower@jhmi.edu|
21231904|NCT01428453|GlaxoSmithKline|GSK Response Center|866-435-7343||
21231905|NCT01996709|Alcon Research, Ltd.|Jessie Lemp, DrPH, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21231906|NCT00477971|Mayo Clinic|Dr. Morie Gertz||gertz.morie@mayo.edu|
21231907|NCT02167893|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21231908|NCT01730833|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
21231909|NCT01438424|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21231910|NCT02927080|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21231911|NCT01411228|Target Health Inc.|Glen Park|212-681-2100|gpark@targethealth.com|
21231912|NCT00664742|Novartis Pharmaceuticals|Study Director|862-778-8300||
21231913|NCT02670083|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21231914|NCT01938378|Octapharma|Michael Eppolito|201-604-1155|michael.eppolito@octapharma.com|
21231915|NCT01571427|Oregon Health & Science University|Dr. Hiroko Dodge|(503) 494-6695|dodgeh@ohsu.edu|
21231916|NCT03045328|Stanford University|Steven Edward Coutre, Professor of Medicine (Hematology)|650-498-6000|coutre@stanford.edu|
21231917|NCT02564042|GlaxoSmithKline|GSK Response Center|866-435-7343||
21231918|NCT01356966|Emory University|Dr. Jeanie Park|404-727-1386|jeanie.park@emory.edu|
21231919|NCT02743806|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21231920|NCT00660530|University of Illinois College of Pharmacy|Dr. Alan Lau|(312) 996-0894|alanlau@uic.edu|
21261013|NCT01363050|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|828
21231921|NCT00849381|GlaxoSmithKline|GSK Response Center|866-435-7343||
21231922|NCT01622699|Isala|Dr J Bekhof|0384247492|j.bekhof@isala.nl|+31
21278408|NCT02357342|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com|
21278409|NCT02582866|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21278410|NCT00771745|University of Cincinnati|Dr. Rita Alloway|513-558-1568|Rita.Alloway@uc.edu|
21231923|NCT02461355|Burke Neurological Institute|Tomoko Kitago, MD|914-368-3169|tok7002@med.cornell.edu|
21278411|NCT01666197|Novartis Consumer Health SA|Clinical Project Leader|41223635293||
21278412|NCT00786994|Center for Dermatooncology, Department of Dermatology, University Hospital Tübingen, Tübingen, Germany|Dr Annette Pflugfelder||annette.pflugfelder@med.uni-tuebingen.de|
21278413|NCT02011386|Rigshospitalet, Denmark|Professor Mikkel Østergaard, MD, PhD, DMSc|+45 38633014|mo@dadlnet.dk|
21278414|NCT01193127|Omeros Corporation|Chief Medical Officer|(206) 676-5000|swhitaker@omeros.com|
21278415|NCT00578669|UT Austin School of Nursing|Dr. Richard A. Brown|512-471-8584|brown2@utmail.utexas.edu|
21278416|NCT04625426|Tan Tock Seng Hospital|George Glass, Nurse Researcher|+65 6903-5440|glass_george_frederick@ttsh.com.sg|
21278417|NCT02569112|Venus Concept Ltd.|Dr. Yoni Iger|8889070115|yoni@venusconcept.com|
21278418|NCT02352779|University of Rochester Medical Center|Luke J. Peppone, PhD, MPH. Assistant Professor|585-275-7827|Luke_Peppone@urmc.rochester.edu|
21278419|NCT00006721|SWOG Statistical Center|Study Statistician|206-667-4623||
21278420|NCT05424042|Wake Forest University School of Medicine|Cynthia Stowe|336-716-0686|cynthia.stowe@advocatehealth.org|
21278421|NCT03611543|Hologic, Inc.|Muhammad Waqas, Director of Global Clinical Affairs, BSH|(508) 263-8935|ClinicalResearch@Hologic.com|
21278422|NCT03047473|Clinique Neuro-Outaouais|Dr Francois Jacques|819-777-2500|francois.jacques@neuro-outaouais.ca|217
21278423|NCT01167257|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|Dr. Hann-Chorng Kuo|886-3-8561825|hck@tzuchi.com.tw|2113
21278424|NCT01480843|Joslin Diabetes Center|Medha Munshi, MD|617-309-4683|medha.munshi@joslin.harvard.edu|
21278425|NCT02213510|UC San Diego School of Medicine|Ulrika Birgersdotter-Green, MD|858-657-5310|ubgreen@ucsd.edu|
21278426|NCT04773301|Complejo Asistencial Universitario de Salamanca - Instituto de Investigación Biomédica de Salamanca (IBSAL)|Dr. Agustín Díaz Álvarez|0034 923291353|adiazal@saludcastillayleon.es|
21278427|NCT00945100|Jaeb Center for Health Research|Ray Kraker, M.S.P.H., Director of PEDIG Coordinating Center|(813) 975-8690|rkraker@jaeb.org|
21278428|NCT03047629|Enterin|Dr. Richard Larson, Chief Medical Officer|5054692670|l.larson@enterininc.com|
21231924|NCT04429061|University of Alabama at Birmingham|Dr Carolyn Bolton|966841034|Carolyn.Bolton@cidrz.org|
21278429|NCT04590040|UT Health San Antonio|Bennett Amaechi BDS, MD, PhD|210 567 3185|amaechi@uthscsa.edu|
21290055|NCT02698787|Cochlear|Naomi Croghan|+13032642131|ncroghan@cochlear.com|
21290056|NCT00594308|Indiana University School of Medicine|Robert Nelson, MD|317-278-6871|ronelson@iupui.edu|
21290057|NCT00295503|UT Southwestern|Jonathan Dowell|214-648-4180|jonathan.dowell@utsouthwestern.edu|
21290058|NCT01882829|Icahn School of Medicine at Mount Sinai|Dr. James W Murrough|212-241-7574|james.murrough@mssm.edu|
21290059|NCT03453515|North Carolina State University|Dr. Laura Widman|919-513-2546|lmwidman@ncsu.edu|
21290060|NCT00800345|Vector Oncology|Vice President of Scientific Affairs|901.435.5570|mwalker@vectoroncology.com|1759
21290061|NCT04668599|The MetroHealth|Vidya Krishnan|2167784527|vkrishnan@metrohealth.org|
21290062|NCT02935036|Taro Pharmaceuticals U.S.A., Inc.|Manager, Clinical Research|9143459001|Businessdevelopment@taro.com|
21290063|NCT00326495|National Cancer Institute|Dr. Alice Chen|240-276-6565|chenali@mail.nih.gov|
21290064|NCT02802865|University of Iowa|Dr. Rachel Mejia|319-356-3143|rachel-mejia@uiowa.edu|
21290065|NCT01862029|National Institute of Health, NHLBI, Laboratory of Obesity and Aging Research|Jay H. Chung, Ph.D, MD|301-496-3075|chungj@nhlbi.nih.gov|
21290066|NCT03931785|Ironwood Pharmaceuticals, Inc.|Wilmin Bartolini, Ph.D.|617.621.8314|wbartolini@ironwoodpharma.com|
21290067|NCT03211858|Trial Transparency Team|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21290068|NCT04630626|NuVasive, Inc.|Nicole Czaplewski, Manager Clinical Affairs|308-660-2021|nczaplewski@nuvasive.com|
21290069|NCT01529112|Eisai Call Center|Eisai Inc.|888-422-4743||
21290070|NCT00678574|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu|
21290071|NCT00548691|Luitpold Pharmaceuticals, Inc.|Mark Falone, MD|610-650-4200|mfalone@luitpold.com|
21290072|NCT02123511|Mayo Clinic|Michele Halyard, M.D.; Robert Foote, M.D.|480-301-4567|mhalyard@mayo.edu; foote.robert@mayo.edu|
21290073|NCT01423084|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
21290074|NCT02551809|United Neuroscience|Responsible Medical Officer|+(353) 1 524 0397|info@unitedneuroscience.com|
21290075|NCT01133977|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
21290076|NCT02462057|Kaiser Permanente Northern California Division of Research|Anjali Gopalan|510-891-3458|Anjali.Gopalan@kp.org|
21290077|NCT03606213|University of California, San Francisco (UCSF)|Professor of Medicine|14154761000|Steven.Deeks@ucsf.edu|
21290078|NCT04315961|Johns Hopkins University School of Medicine|Dustin Lee|410-550-4035|dlee214@jhmi.edu|
21290079|NCT01749293|University of Illinois|Dr. Pritesh Patel|312-996-5762|prpatel8@uic.edu|
21290080|NCT01908699|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director|301-608-9292|info@lungbiotechnology.com|
21239186|NCT00595270|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar.kastner@intercell.com|0
21239187|NCT04359771|faculty of medicine, Cairo University|Dr. Ahmed Abdelbaki|00201066642728|a.abdelbaki@kasralainy.edu.eg|
21239188|NCT00517075|New York State Psychiatric Institute|Linda Sherman|(646) 774-7158|lsherma@nyspi.columbia.edu|
21239189|NCT00909480|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21239190|NCT01962025|Ottawa HRI|Dr. Deborah Zimmerman|613-722-7000|dzimmerman@toh.ca|
21239191|NCT03528174|Oregon Health and Science University|Jessica Castle MD|503-494-7072|castleje@ohsu.edu|
21239192|NCT01616576|Advanced Bionics, LLC|Cedric Navarro, Vice President of Regulatory/Clinical Affairs and Quality|(661) 362-1963|Clinical.Research@advancedbionics.com|
21239193|NCT02904902|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21239194|NCT01719237|University of New Mexico|Dr. Nicholas Lam|505-272-2610|nlam@salud.unm.edu|
21239195|NCT03338621|TB Alliance|Morounfolu Olugbosi|1 212 227 7540|morounfolu.olugbosi@tballiance.org|
21239196|NCT00989586|The Ohio State University Comprehensive Cancer Center|Beth Christian|614-293-8858|beth.christian@osumc.edu|
21239197|NCT01821417|University of Alabama at Birmingham|Nicolaas C. Geurs, DDS MS|2059344506|ngeurs@uab.edu|
21239198|NCT02118337|MedImmune, LLC|Farzana Walcott|+1 301-398-3063|information.center@astrazeneca.com|
21239199|NCT02835846|Loyola University Chicago|Alan J Wolfe|7082165814|awolfe@luc.edu|
21239200|NCT00453102|University of Miami|Izidore S. Lossos|305-243-4785|ilossos@med.miami.edu|
21239201|NCT03154944|Coloplast|Head of Medical Writing and Biostatistics|49113143|dkpen@coloplast.com|+45
21239202|NCT04249219|University of Massachusetts Chan Medical School|Elise Stevens|(774) 455-6684|elise.stevens@umassmed.edu|56684
21239203|NCT05400746|University of Oxford|Dr. Angela M Minassian|01865611424|angela.minassian@bioch.ox.ac.uk|
21239204|NCT05375955|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21239205|NCT03724396|University of California San Diego|Dr. Dawn Eichen|858-249-1123|deichen@ucsd.edu|
21239206|NCT03489057|University of North Carolina Lineberger Comprehensive Cancer Center|Xianming Tan, PhD|+1 919-966-8450|xianming@email.unc.edu|
21239207|NCT02247336|William S Middleton Memorial Veterans Hospital|Corrine Voils, PhD|608-256-1901|corrine.voils@va.gov|12208
21239208|NCT00943306|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|857-242-5142|alison.long@aegerion.com|
21239209|NCT00733980|GlaxoSmithKline|GSK Response Center|866-435-7343||
21278430|NCT01531439|Children's Mercy Hospital|Dr Ben Pieters|816-234-3464|bjpieters@cmh.edu|
21278431|NCT00000378|New York State Psychiatric Institute|Steven Roose MD|646-774-8661|spr2@columbia.edu|
21278432|NCT02813265|Kala Pharmaceuticals, Inc|VP, Clinical Development|(781) 996-5252|Results006@kalarx.com|
21278433|NCT01284361|Hollister Incorporated|Malford Cullum PhD/Sr Clin Res Scientist|847-918-3975|malford.cullum@hollister.com|
21278434|NCT00805675|Novartis Pharmaceuticals|Study Director|862-778-8300||
21278435|NCT02198183|Hospital for Special Surgery, Anesthesiology|Dr Jacques Yadeau|2126061036|Yadeauj@hss.edu|
21278436|NCT02026687|Dept of anaesthesia, Linköping University Hospital, Sweden|Dr Lena Nilsson|0046101030000|lena.nilsson@regionostergotland.se|
21278437|NCT01957397|Coloplast A/S|Birte Petersen Jakobsen, MD|+45 4911 1395|dkbir@coloplast.com|
21278438|NCT00540293|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21278439|NCT01823497|Medical College of Wisconsin|Keri R. Hainsworth|414-266-6306|khainswo@mcw.edu|
21278440|NCT00325195|Savient Pharmaceuticals, Inc.|Medical Director|732-418-9300||
21278441|NCT04715932|Montreal Heart Institute|Dr Jocelyn Dupuis (Principal Investigator)|514 376-3330|jocelyn.dupuis@icm-mhi.org|3477
21278442|NCT03560986|Grünenthal GmbH|Director Clinical Trials|+49 241 569|Clinical-Trials@grunenthal.com|3223
21278443|NCT01059539|Allergan|Willie R. Earley, MD Associate Vice President Clinical Development-CNS|714-246-4500|IR-CTRegistration@allergan.com|
21278444|NCT01110135|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org|
21278445|NCT01265433|Sellas Life Sciences|Dr. Dragan Cicic|646-200-5278|info@sellaslife.com|
21278446|NCT02971735|Linkou Chang Gung Memorial Hospital|Dr. Li-Ang Lee|886 33281200|5738@cgmh.org.tw|3972
21278447|NCT00626392|Abbott|Medical Information Specialist|800-633-9110||
21278448|NCT00338455|Scios R&D, Inc.|Sr. Director Clinical Leader|650 564-5084||
21278449|NCT01517373|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21278450|NCT01085734|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com|
21278451|NCT01963143|Bio Products Laboratory|Head of Medical Information|+44 (0)20 8957 2200|medinfo@bpl.co.uk|
21278452|NCT05594264|University of Delaware|Dr. Yendelela Cuffee|(302) 831-1302|ylcuffee@udel.edu|
21278453|NCT02699060|IMSechenovMMA|MD, PhD Ivashkin Vladimir Trofimovich|+79252667987|motility_2013@mail.ru|
21239210|NCT02739347|Baylor College of Medicine|Raymond Cho|7137987781|Raymond.Cho@bcm.edu|
21278454|NCT01045135|Akershus University Hospital|Dr.Jette Stær-Jensen, Dr. Franziska Siafarikas|+47-6796000|jett@ahus.no|
21290081|NCT02105012|Pearl Therapeutics Inc.|Paul Dorinsky, MD, FCCP|650-305-2600|pdorinsky@pearltherapeutics.com|
21239211|NCT00920023|Massachusetts General Hospital|Ralph Weissleder|6177268226|RWEISSLEDER@MGH.HARVARD.EDU|
21239212|NCT01235403|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
21239213|NCT03682705|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21239214|NCT00265330|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21239215|NCT04043962|Seattle Children's Hospital|Tonya Palermo, Professor, Anesthesiology and Pain Medicine, Seattle Children's Hospital|206-884-4208|tonya.palermo@seattlechildrens.org|
21239216|NCT02658630|VA Pittsburgh Healthcare System|George F. Wittenberg|412-648-4178|GeoWitt@Pitt.edu|
21239217|NCT02613221|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21239218|NCT03879603|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Julie E. Ledgerwood, DO (Study Chair)|301-594-8502|ledgerwood@mail.nih.gov|
21239219|NCT04366726|Radius Health, Inc.|Associate Director, Clinical Operations|(617) 551-4000|info@radiuspharm.com|
21239220|NCT01786330|University of Kansas School of Medicine - Wichita|Zachary Kuhlmann, DO|316-685-7234|zkuhlmann@kumc.edu|
21239221|NCT02914132|ExThera Medical Corporation|Sr. Director of Regulatory and Clinical Affairs|9258392079|erdie@extheramedical.com|
21239222|NCT02053077|MUG|Thomas Pieber|004331638512383|thomas.pieber@medunigraz.at|
21239223|NCT04834817|University of California, Irvine|Dr. Kristen Kelly, Professor and Chair, Dept. of Dermatology|949-824-5515|kmkelly@hs.uci.edu|
21239224|NCT00311155|Daiichi Sankyo Pharma Development|Sr. Director, Regulatory Operations|732-590-5032|hmkessler@dsi.com|
21239225|NCT00552786|National Taiwan University|Dr. Yue-Liang Guo|+886-2-33228216|leonguo@ntu.edu.tw|
21239226|NCT01265030|Maine Medical Center|Dr. Aaron Weiss, Principal Investigator|2073967565|Aaron.Weiss@mainehealth.org|
21239227|NCT03117517|Khyber Medical University|Dr. Mohsin Shah (Associate Professor)|3429620074|mohsin.ibms@kmu.edu.pk|+92
21239228|NCT01590771|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21239229|NCT02019563|The Hospital for Sick Children|Trang Nguyen|6473300825|trang.nguyen@easternhealth.ca|
21239230|NCT01785628|China Medical University Hospital|The chief, Department of Neurology|8864-22052121|d8079@mail.cmuh.org.tw|5035
21239231|NCT02209636|Rocky Mountain VA Medical Center|Anna Jovanovich, MD|303-724-8677|anna.jovanovich@va.gov|
21239232|NCT00767104|Wake Forest University Health Sciences|Alan Fleischer, Jr. MD|336-716-3775|Afleisch@wfubmc.edu|
21239233|NCT01108835|The Chinese University of Hong Kong|Fanny Ko|85226323133|fannyko@cuhk.edu.hk|
21239234|NCT03285295|Abbott Laboratories|George Chen (Associate Director Clinical Affairs)|224-668-9185|george.chen@abbott.com|
21239235|NCT03015116|Landstuhl Regional Medical Center|Dr. Ann Kobiela Ketz|8022656263|annketz@gmail.com|
21239236|NCT01015807|Univerisity of Washington|Dr. Laurent Bollag|+12063277328|bollag@uw.edu|
21239237|NCT02200939|Smith+Nephew, Inc.|Laura England, Sr. Director Global Clinical Strategy|+1 650 223 6941|Laura.England@smith-nephew.com|
21239238|NCT04567693|Montefiore Medical Center|Dr. Jonathan Ross|718-920-7064|joross@montefiore.org|
21239239|NCT04867785|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21239240|NCT01403441|Stanford University|Dr. Hugh Brent Solvason|650 776 4793|solvason@stanford.edu|
21261014|NCT03040154|Children's Hospital Los Angeles|Joyce R. Javier, MD, MPH, MS|(323)669-2113|jojavier@chla.usc.edu|
21261015|NCT03072602|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Dr. Pankaj Arora|12059754720|parora@uabmc.edu|
21261016|NCT03912584|Optos|Michael Sinai, PhD|+1 800 854 3039|MSinai@optos.com|1495
21261017|NCT04321343|POXEL|Director, Medical Operations|+33 (0)4 37 37 20 10|carole.thang@poxelpharma.com|
21261018|NCT01682044|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21261019|NCT00843986|Astellas Pharma Global Development|Medical Director||clinicaltrials@us.astellas.com|
21261020|NCT01903148|Hospital de Bellvitge|Dr. Alberto Martínez Castelao|610 459 262|albertomcastelao@gmail.com|
21261021|NCT01075347|Natinal Taiwan University Hospital|We-Li Chen , MD|886-2-2356|chenweili@ntu.edu.tw|5206
21278455|NCT04916444|University of Florida Norman Fixel Institute for Neurological Diseases|Dr. Jun Yu|352-294-5400|jun.yu@neurology.ufl.edu|
21261022|NCT01167712|NRG Oncology|Linda Gedeon for Mark Brady, PhD.|716-845-1169|lgedeon@gogstats.org|
21261023|NCT01084252|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
21261024|NCT04364854|Medical University of South Carolina|Principal Investigator|843-876-8311|bonilha@musc.edu|
21278456|NCT04005352|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21278457|NCT06017479|Department of Urology, Faculty of Medicine University of Indonesia - Cipto Mangunkusumo General Hospital|Prof. dr. Harrina Erlianti Rahardjo, Sp.U(K), PhD|+62 816-825-226|harrinaerlianti@gmail.com|
21278458|NCT04420273|Northwestern University Feinberg School of Medicine|Dr. June Robinson|3129433703|june-robinson@northwestern.edu|
21278459|NCT02737748|Transwell Biotech Co., Ltd.|Dr. Bin-Ru She|+886-3-5670399|binru.she@tw-bio.com|207
21278460|NCT00077857|Hoffman-LaRoche|Medical Communications|800-821-8590||
21278461|NCT01096368|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21278462|NCT06187909|Department of Anesthesia, Intensive Care, and Pain Management, Faculty of Medicine, Ain Shams University, Cairo, Egypt|Yasser Mohamed Reyad Ahmed El-Mansoury|01000286206|yassermoahmed0102107@med.asu.edu.eg|
21278463|NCT06354998|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
21278464|NCT05442866|MedStar Health Research Institute|Dr. Hunter Groninger|202-877-7445|hunter.groninger@medstar.net|
21278465|NCT05407714|BSC International Medical Trading (Shanghai) Co., Ltd|Associate Clinical Trial Manager|+13671646036|junyang.bai@bsci.com|
21278466|NCT02800213|San Antonio Uniformed Services Health Education Consortium|Dr. Michael D. April|2109160808|Michael.D.April@post.harvard.edu|210
21278467|NCT00475150|University of Wisconsin Comprehensive Cancer Center|Mark B. Juckett, MD||mbj@medicine.wisc.edu|
21278468|NCT04126213|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21239241|NCT03926065|Laboratory for the Study of Human Ingestive Behavior, The Pennsylvania State University|Dr. Barbara J. Rolls|814-863-8481|bjr4@psu.edu|
21239242|NCT03463915|University of Louisville|Sean Francis|502-561-7260|Sean.francis@louisville.edu|
21239243|NCT01334944|Cumberland Pharmaceutical Inc.|Dr. Amy Rock|615-255-0068|arock@cumberlandpharma.com|
21239244|NCT02687412|SichuanCHRI|Dr Cui Ling|+8618181422637|cuiling1985@qq.com|
21239245|NCT00553202|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21239246|NCT00369681|Johns Hopkins University|Dr. Yvette Kasamon|410-955-8839|ykasamon@jhmi.edu|
21239247|NCT00981474|Northwestern University|Paul C. Fitzgerald RN, BSN, MS|312-695-1064|p-fitzgerald2@northwestern.edu|
21239248|NCT00612222|National Cancer Institute (NCI), National Institutes of Health (NIH)|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
21239249|NCT02966002|University of Michigan|Adam Lubert|734-764-5177|luberta@med.umich.edu|
21239250|NCT01350141|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21239251|NCT02367716|Cardiac Rhythm Management, Abbott Medical Devices|Clay Cohorn, Clinical Program Director|+19723098087|clay.cohorn@abbott.com|
21239252|NCT01473381|Forest Research Institute|Suresh Durgam, MD Clinical Asset Lead for Vilazodone - Senior Director - Clinical Development|201 427-8000|suresh.durgam@frx.com|8172
21239253|NCT04343586|Northwestern University|Dermatology CTU|312-503-5944|NUderm-research@northwestern.edu|
21239254|NCT02648971|Wake Forest University|Dr. John Hubbard|336-998-1297|jhubbard@wakehealth.edu|
21239255|NCT00500240|UT MD Anderson Cancer Center|Khanh D Vu, MD/ Associated Professor|713-745-4516|eharriso@mdanderson.org|
21239256|NCT02508532|Blueprint Medicines|Medical Information|1-888-258-7768|medinfo@blueprintmedicines.com|
21239257|NCT02768662|Otonomy, Inc.|Otonomy Medical information Center|1-844-686-4636|medinfo@otonomy.com|
21239258|NCT01422369|Kowa Research Institute, Inc|Roger Morgan, MD FACS|919-433-1600|RMorgan@kowaus.com|
21239259|NCT04041440|Customized Learning Exercises for Aural Rehabilitation|Chief Operating Officer|314 399-9943|chris@amptify.com|
21239260|NCT02306265|GE Healthcare|Sara Lam|1-262-548-2369|Sara.J.Lam@ge.com|
21239261|NCT01346514|VA Puget Sound|Carol Malte|206.277.3780|carol.malte@va.gov|
21239262|NCT05737433|Hepion Pharmaceuticals Inc|Jill Greytok|732-902-4000|jgreytok@hepionpharma.com|
21239263|NCT03002038|Isfahan University of Medical Sciences|Dr. Vahid Shaygannejad|+98 913 313 3550|shaygannejad@med.mui.ac.ir|
21239264|NCT04251065|SC Ematologia - Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) - Trieste|Prof. Francesco Zaja|+ 39 040 3992015|francesco.zaja@asugi.sanita.fvg.it|
21239265|NCT04296890|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
21239266|NCT01782963|Massachusetts General Hospital|Noopur Raje, MD|617-724-4000|NRAJE@mgh.harvard.edu|
21239267|NCT02237508|Zambon SpA|Isabella Salerio, PhD|+39 02665241|clinicaltrials@zambongroup.com|
21239268|NCT01650519|Cumberland Pharmaceutical Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
21239269|NCT04986085|Grupo Español de Tumores Neuroendocrinos y Endocrinos|A responsible Person Designated by the Sponsor|0034934344412|investigacion@mfar.net|
21239270|NCT00747123|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21239271|NCT03267680|University of Southern California|Tali Homsey|3238650430|tali.homsey@med.usc.edu|
21239272|NCT02277743|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
21239273|NCT00674466|ConjuChem Biotechnologies Inc.|Associate Director of Regulatory Affairs|310-405-7549|Aleece.Nolasco@nantbio.com|
21239274|NCT01224158|Johnson & Johnson Consumer and Personal Products Worldwide|Director Oral Health, Medical Affair & Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21239275|NCT01622010|St. Boniface Hospital|Kelly Codispodi BMR PT|204-237-2138|kcodispodi@sbgh.mb.ca|
21239276|NCT02055157|BioMarin Pharmaceutical Inc.|Alice Hunstman-Labed|+44 207 4203392|alice.huntsmanlabed@bmrn.com|
21239277|NCT03976466|ISSEMyM Instituto de Seguridad Social del Estado de Mexico y Municipios|Julio Carlos Vélez de Lachica, Head of the orthopedics department at Regional Hospital Tlalnepantla|5526269200|activeknee@gmail.com|2100
21239278|NCT01557322|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21239279|NCT00733499|DePuy Ortho Joint US|Tamiko Magee-Rodgers, PhD||TMageeRo@its.jnj.com|
21239280|NCT00576732|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Clinical Leader|609 730 2317||
21239281|NCT02978443|Georgetown University|Suthee Rapisuwon|202-877-6583|Suthee.Rapisuwon@medstar.net|
21239282|NCT02296190|Milestone Pharmaceuticals|Francis Plat _MD_Chief Medical Officer|514-336-0444|fplat@milestonepharma.com|225
21239283|NCT00280826|National Eye Institute|Robert Nussenblatt, MD, MPH|301-496-3123|drbob@intra.nei.nih.gov|
21239284|NCT00682643|GlaxoSmithKline|GSK Response Center|866-435-7343||
21239285|NCT01875185|Johns Hopkins University School of Medicine|RhondaLyn McLean|(215) 662-4949|rhondalyn.mclean@uphs.upenn.edu|
21239286|NCT00263328|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21239287|NCT01199926|Purdue University|Dr. Dorothy Teegarden|765-494-8791|teegarden@purdue.edu|
21239288|NCT01226914|Medical University of South Carolina - Department of Otolaryngology - Head and Neck Surgery|Shaun A. Nguyen, MD, FAPCR|8437921356|nguyensh@musc.edu|
21239289|NCT01301274|Intensive Care Unit - Hospital Pedro de Elizalde|Dr Facundo Jorro Barón|00541143632100|jorrobox@yahoo.com.ar|2035
21239290|NCT02917941|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21239291|NCT01893827|NYU Langone Health|Mia Malone|646-501-3577|mia.malone@nyulangone.org|
21239292|NCT00399763|Denver Health|Christian Thurstone, M.D.|303-436-6006|christian.thurstone@dhha.org|
21239293|NCT04064242|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
21239294|NCT03389477|Washington University School of Medicine|Douglas Adkins, M.D.|(314) 362-4471|dadkins@wustl.edu|
21239295|NCT03403426|Reflow Medical|Isa Rizk|9494810399|info@reflowmedical.com|
21239296|NCT00626366|University of Nebraska Medical Center|Erin K O'Brien|402-559-6463|irbora@unmc.edu|
21231925|NCT02310464|OBI Pharma, Inc.|Chen-En Tsai, MD, PhD|886 2 27866589|chenentsai@obipharma.com|215
21231926|NCT02618434|Supernus Pharmaceuticals|Gianpiera Ceresoli-Borroni Director Clinical Research|3018382521|gceresoliborroni@supernus.com|
21231927|NCT02106728|Toronto General Hospital|Dr. Gina Dimitropoulos|416-340-3749|gdimit@ucalgary.ca|
21231928|NCT01967121|Michigan State University|Tracey Covassin|517-353-2010|covassin@msu.edu|
21231929|NCT02289898|Mereo BioPharma Group Plc.|John, Lewicki, Chief Scientific Officer|+44333023300|John.Lewicki@mereobiopharma.com|
21231930|NCT00885105|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21231931|NCT02254486|Norgine Ltd|Lucy Clayton|+44-1895-826669|lclayton@norgine.com|
21231932|NCT01350414|Boston Scientific|Narinder Shargill|408-635-3907|Narinder.Shargill@bsci.com|
21231933|NCT01493570|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21231934|NCT00267046|UT MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor|713-792-7966|xzhou@mdanderson.org|
21231935|NCT00460408|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21231936|NCT00103142|Duke University Medical Center|Dr. Michael Morse|919-684-5705|michael.morse@dm.duke.edu|
21231937|NCT01077856|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21231938|NCT04983264|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21231939|NCT00938639|Seqirus|Clinical Trial Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
21231940|NCT01830699|Keesler Medical Center|Matthew B. Carroll, MD|228-376-3629|matthew.carroll.1@us.af.mil|
21231941|NCT01313936|UCSF Dept of Pediatrics|Steven DuBois, MD|415-476-3831|duboiss@peds.ucsf.ed|
21231942|NCT00010374|Synapse Biomedical, Inc.|Anthony Ignagni|440-774-2488|aignagni@synapsebiomedical.com|110
21231943|NCT00449046|GlaxoSmithKline|GSK Response Center|866-435-7343||
21231944|NCT06185374|NYU Langone Health|Peter Liang, MD|(212) 686-7500|peter.liang@nyulangone.org|5745
21261025|NCT04933812|Duke University|Dr. Sarahn Wheeler|919-668-5462|sarahn.wheeler@duke.edu|
21231945|NCT00982592|Perlmutter Cancer Center at NYU Langone|Deirdre Cohen, MD|212-731-5656|deirdre.cohen@nyumc.org|
21231946|NCT01741701|University of Kansas Medical Center|Dr. Rajesh Pahwa|913-588-6782|rpahwa@kumc.edu|
21231947|NCT01669915|Brigham and Women's Hospital;181 Longwood Ave; Boston, MA 02115|Jae Hee Kang|617-525-2022|nhjhk@channing.harvard.edu|
21231948|NCT04247581|Apple|Health Tech Clinical Operations|866-905-5303|htclinicalquestions@apple.com|
21231949|NCT03033394|Imperial College London|Richard Wilson|02033132732|richard.wilson@imperial.ac.uk|
21231950|NCT00356369|GlaxoSmithKline|GSK Response Center|866-435-7343||
21231951|NCT03545165|Weill Cornell Medicine|Scott Tagawa MD, Principal Investigator|646-962-2072|guonc@med.cornell.edu|
21231952|NCT02408315|Indiana University School of Medicine|Dr. David M. Haas|317-880-3949|dahaas@iu.edu|
21231953|NCT00673465|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21231954|NCT04952402|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
21231955|NCT03327649|University of Oklahoma Health Sciences Center|Dr. Stavros Stavrakis|14052714742|stavros-stavrakis@ouhsc.edu|
21231956|NCT01919723|University of Alabama at Birmingham|Mehak Goel ,PhD|205-975-4021|mehakgoel@uabmc.edu|
21261026|NCT04493619|Opna Bio|Kerry Inokuchi|650-204-4065|info@opnabio.com|
21261027|NCT01419171|Peter Maurer, Director Clinical Trials|Peter Maurer, Director Clinical Trials|508-683-6678|Peter.Maurer@bsci.com|
21261028|NCT03368859|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21239297|NCT03520400|VA Palo Alto Health Care System|Dr. Jonathan Myers|6504503440|Drj993@aol.com|
21239298|NCT00859651|Columbia University|Katherine Crew, MD|212-305-1732|kd59@cumc.columbia.edu|
21261029|NCT02559505|University Of Rochester|Dr. Jennifer Nayak|5852767404|Jennifer_Nayak@URMC.Rochester.edu|
21261030|NCT03523585|Daiichi Sankyo|Contact for Clinical Trial Information|1-908-992-6400|CTRinfo@dsi.com|
21261031|NCT00698516|GlaxoSmithKline|GSK Response Center|866-435-7343||
21278469|NCT00392236|Feinstein Institute for Medical Research|Delbert Robinson, M.D.|718 470-8195|drobinso@nshs.edu|
21278470|NCT02196701|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21278471|NCT03275064|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21278472|NCT02829294|Eosera Inc|Joseph Griffin PhD|8447327929|info@eosera.com|
21278473|NCT00620555|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21278474|NCT03796039|University of New Brunswick|Dr. Danielle Bouchard|(506) 443-3908|dboucha1@unb.ca|
21239299|NCT00445679|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21261032|NCT05882890|Rahbek FYS|Cathrine Rahbek|0045 30645390|cathrinerahbek@outlook.dk|
21290082|NCT00493285|MedImmune, LLC|Elissa Malkin, DO, MPH|301-398-0000|malkine@medimmune.com|
21290083|NCT05345405|University of Washington|Principal Investigator|206-503-3287|edworkin@uw.edu|
21290084|NCT01834651|Cedars-Sinai Medical Center|Dr. Edwin Posadas|310-423-7600|Edwin.Posadas@cshs.org|
21290085|NCT01750281|AstraZeneca|Dr Gabriella Mariani|+44 (0)207 6048000|ClinicalTrialTransparency@astrazeneca.com|
21290086|NCT04189588|TerSera Therapeutics Inc.|Executive Director Clinical Development|888 600 8116|jnorth@tersera.com|
21290087|NCT00673114|Duke University Medical Center|Dr. Joanne Kurtzberg|919-668-1100|kurtz001@mc.duke.edu|
21290088|NCT00948935|Abramson Cancer Center|Bruce Giantonio|(215) 615-5858|bruce.giantonio@uphs.upenn.edu|
21290089|NCT01433081|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu|
21290090|NCT00271570|University of California, San Diego|Jane Burns, MD, Professor|858-246-0155|jcburns@ucsd.edu|
21290091|NCT00201773|The Ohio State University Comprehensive Cancer Center|Steven Provoski, MD|614-293-8700|Stephen.Povoski@osumc.edu|
21290092|NCT01658735|University of Utah School of Medicine|Matthew A Hughes, MD, MPH|8015814800|matthew.hughes@hsc.utah.edu|
21290093|NCT04032327|Walter Reed National Military Medical Center|Katherine L Dengler, MD|301-400-2468|katherine.l.dengler.mil@mail.mil|
21290094|NCT03302936|Icahn School of Medicine at Mount Sinai|Annacecilia Peacher-Holderied|2104887216|apeacher4@gmail.com|
21290095|NCT01379937|GlaxoSmithKline|GSK Response Center|866-435-7343||
21290096|NCT01122680|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21290097|NCT04985682|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21290098|NCT01694186|Eyepoint Pharmacueticals|Clinical Affairs|6179726204|fleonin@eyepointpharma.com|
21290099|NCT00501943|UCSF|Dr Emmanuelle Waubant, MD|415- 514 2468|Emmanuelle.Waubant@ucsf.edu|
21290100|NCT03760640|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21290101|NCT03016403|Latino Research and Policy Center, University of Colorado Denver|Evelinn Borrayo, Associate Director|303-724-0884|Evelinn.Borrayo@cuanschutz.edu|
21290102|NCT05463705|Brigham and Women's Hospital|Nancy Haff, MD, MPH|857-307-3826|nhaff@mgb.org|
21290103|NCT01655069|Astellas Pharma Europe B.V.|Medical Director|+31 (0) 71 5455 050|Astellas.resultsdisclosure@astellas.com|
21290104|NCT01530997|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
21290105|NCT00428077|University of Utah Huntsman Cancer Institute|Michael Deininger, MD, PhD|801-585-3229|michael.deininger@hci.utah.edu|
21290106|NCT02298491|UMaryland|Horea Rus|410-706-3170|hrus@som.umaryland.edu|
21290107|NCT01309100|Bausch & Lomb|Dr. Robert Steffen|585 338 6399|robert.steffen@bausch.com|
21290108|NCT03063164|Stanford University School of Medicine|Edward E. Manche|6507255765|edward.manche@stanford.edu|
21231957|NCT04502589|Virginia Commonwealth University|Albert Arias, M.D.|(804) 828-5793|albert.arias@vcuhealth.org|
21290109|NCT00407030|Merz Pharmaceuticals GmbH|Angelika Hanschmann|++49-69-1503|angelika.hanschmann@merz.de|538
21231958|NCT01574612|Meda Pharmaceutical|David Ginsberg, DO|732 564 2200|ginsberg.david@gmail.com|
21290110|NCT01452789|Thomas Jefferson University|Walter Kraft|215 955 9077|walter.kraft@jefferson.edu|
21290111|NCT00066170|Jazz Pharmaceuticals, Inc|Grace Wang, MD Director of Clinical Development & Medical Monitor|650-496-3777||
21290112|NCT03722030|University of Wisconsin - Madison|Dr. Lisa Cadmus-Bertram|608-262-1167|lisa.bertram@wisc.edu|
21231959|NCT01683383|Stanford University School of Medicine|Krisa P. Van Meurs, M.D.|+1 650 723 5711|vanmeurs@stanford.edu|
21231960|NCT02496611|University of Minnesota|Aaron Kelly PhD|6126253492|kelly105@umn.edu|
21231961|NCT02850965|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21231962|NCT00536198|Yale University School of Medicine|Kimberly A. Yonkers, M.D.|203-764-5914|Kimberly.Yonkers@yale.edu|
21231963|NCT02643082|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|650-305-2600|creisner@pearltherapeutics.com|
21231964|NCT00276744|SKCCC|Dr. Daniel Laheru|410-955-8974|laherda@jhmi.edu|
21231965|NCT02860169|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21231966|NCT04973826|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21231967|NCT00165776|Eisai Co., Ltd.|Hiroki Shimizu, Study Director|+81-3-3817-5245||
21231968|NCT00492583|Georgetown University|Daniel J Merenstein, MD|202-687-2745|djm23@georgetown.edu|
21231969|NCT01307007|Luitpold Pharmaceuticals, Inc.|Sumita Chowdhury, MD, MPH, FACC, MBA|610-650-4200|SChowdhury@lpicrd.com|
21231970|NCT00387023|UT MD Anderson Cancer Center|Bita Esmaeli, MD / Professor||CR_Study_Registration@mdanderson.org|
21231971|NCT03310775|Kyunghee university hospital, Seoul, South Korea|Dr. Miae Oh|82-10-8929-5048|miae612@naver.com|
21231972|NCT02066233|Mayo Clinic|Dr. Prasad G. Iyer|507-284-6469|Iyer.Prasad@mayo.edu|
21231973|NCT02772081|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
21231974|NCT03267186|Stanford University|Andrew R. Rezvani, MD|650-725-4077|arezvani@stanford.edu|
21231975|NCT01214356|MUSC|Vanessa Diaz, MD MSCR|8438762923|diazva@musc.edu|
21231976|NCT02598076|Yale Comprehensive Epilepsy Center, Department of Neurology, Yale Univseristy School of Medicine|Benjamin Tolchin, MD, MS|347-721-8491|benjamin.tolchin@yale.edu|
21231977|NCT01828281|Chinese University of Hong Kong|Prof David SC Hui|2632 3134|dschui@cuhk.edu.hk|
21239300|NCT01654601|The Catholic university of Korea|Won-myung Bahk. M.D. PhD.|82-2-3779-1051|wmbahk@catholic.ac.kr|
21239301|NCT02636270|Cincinnati Childrens Hospital Medical Center|Philippe Backeljauw|513-636-8444|philippe.backeljauw@cchmc.org|
21261033|NCT02939300|Massachusetts General Hospital|Priscilla Brastianos, MD|617-724-8770|pbrastianos@partners.org|
21231978|NCT01124422|GlaxoSmithKline|GSK Response Center|866-435-7343||
21239302|NCT01833143|Memorial Sloan Kettering Cancer Center|Gregory Riely, MD, PhD|646-608-3913|rielyg@mskcc.org|
21261034|NCT01495988|The Emmes Corporation|Damon Collie|301-251-1161|dcollie@emmes.com|
21261035|NCT00753636|Northwestern University|Dr. Tanya Simuni, MD|312-503-2970|tsimuni@nmff.org|
21278475|NCT01140503|Stanford University Department of Dermatology|David Fiorentino|650-721-7160|fiorentino@stanford.edu|
21278476|NCT04314414|Boston Medical Center|Sabrina A Assoumou, MD MPH|(617) 414-5282|sabrina.assoumou@bmc.org|
21278477|NCT01157897|WRAIR|Donna Tosh|301-319-9332|donna.m.tosh.ctr@mail.mil|
21278478|NCT03734666|Moffitt Cancer Center|Christine Vinci|813-745-5421|Christine.Vinci@moffitt.org|
21278479|NCT01910389|New England Research Institutes|Brian Harty|617-972-3224|bhartY@neriscience.com|
21278480|NCT01943110|PATH|Courtney Jarrahian|206-285-3500|cjarrahian@path.org|
21278481|NCT01898650|Washington University School of Medicine|Gary Skolnick|13144544005|gskolnic@wustl.edu|
21278482|NCT00753220|Prostate Institute of America|Dr. Duke K. Bahn|888-234-0004|DKBahn@CMHhospital.org|
21239303|NCT00909428|Loyola University Chicago|Mary P FitzGerald|708-216-2170|mfitzg8@lumc.edu|
21278483|NCT01795105|KoreaOtsukaPharma|Jeong, Hyo-Won||jhw0159@otsuka.co.kr|
21239304|NCT03021668|Johns Hopkins Hospital|Dr. Matthew J. Weiss|4106143368|mweiss5@jhmi.edu|
21261036|NCT00702624|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21261037|NCT04331899|Stanford University|Dr. Prasanna Jagannathan, MD|1-650-724-5343|prasj@stanford.edu|
21278484|NCT01791153|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21278485|NCT00939120|Research institute at Deaconess Clinic|Dr. Paul Siami|812-426-9548|paul.siami@deaconess.com|
21231979|NCT02606604|Stony Brook University|Lori Hochman|631-444-1193|lori.hochman@stonybrook.edu|
21231980|NCT05081011|Stanford University|Ashwin K Nayak, MD|(650) 725-5071|aknayak@stanford.edu|
21231981|NCT02709785|Saint Louis University|D. Douglas Miley|314-977-8381|ddouglas.miley@health.slu.edu|
21231982|NCT01961323|Icahn School of Medicine at Mount Sinai|Dr. Partho Sengupta|212-659-8847|partho.sengupta@mountsinai.org|
21231983|NCT03315208|Massachusetts General Hospital/Harvard Medical School|Dr. Kate Bentley|617-724-7741|kbentley@mgh.harvard.edu|
21231984|NCT03472469|The University of Texas Health Science Center at Houston|John A. Harvin, MD|(713) 500-7244|John.Harvin@uth.tmc.edu|
21231985|NCT02875860|Baylor College of Medicine|Dr. Michael Belfort|832-826-7375|belfort@bcm.edu|
21231986|NCT05259696|Palleon Pharmaceuticals|Palleon Clinical Development|857-285-5900|clinical@palleonpharma.com|
21231987|NCT02320149|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21231988|NCT00473642|Retina Specialists of Michigan|Scott Westhouse, DO|616-954-2020|s.westhouse@gmail.com|
21231989|NCT01156311|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21231990|NCT06133348|University of Alabama at Birmingham Cancer Center|Gabrielle Rocque, MD, MSPH|205-996-9281|grocque@uabmc.edu|
21231991|NCT01285310|Celgene Corporation|Anne McClain|888-260-1599|clinicaltrialdisclosure@celgene.com|
21231992|NCT01996982|Ascension Seton|Research Enterprise Staff|512-3247991|ra@seton.org|
21231993|NCT03530098|Stanford University|Safwan S Halabi, MD|(650) 721-2850|safwan.halabi@stanford.edu|
21231994|NCT02278250|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21231995|NCT01195415|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski, M.D.|734-615-3969|zalupski@umich.edu|
21231996|NCT00533845|Maimonides Medical center|Danny A Sherwinter|7182837952|dsherwinter@maimonidesmed.org|
21231997|NCT01370174|University of Maryland|Dr. Vicki Gray Principal Investigator|4107063778|vicki.gray@som.umaryland.edu|
21231998|NCT01442675|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21231999|NCT00555321|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21232000|NCT00160251|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21232001|NCT01250834|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21232002|NCT00563381|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21232003|NCT01911689|Sichuan Key Laboratory of Medical Imaging, Department of Radiology, Affiliated Hospital of North Sichuan Medical College|Dr.XiaoMing Zhang|+86 817 2262218|cjr.zhxm@vip.163.com|
21232004|NCT02407704|University of Pittsburgh|Dr. Kirk Erickson|412-624-4533|kiericks@pitt.edu|
21232005|NCT01957644|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21232006|NCT01957553|Coloplast|Dr. Birte P.Jakobsen|+45 4911 1395|dkbir@coloplast.com|
21232007|NCT04044716|Atrium Health Wake Forest Baptist|Dr. Carolyn Huffman|336.713.4018|cshuffma@wakehealth.edu|
21232008|NCT02532933|University Of Denver|Kevin Shelburne|3039021249|kevin.shelburne@du.edu|
21232009|NCT03235154|Community Research Initiative of New England|Amy E. Colson, MD|6175021700|acolson@crine.org|
21232010|NCT03636061|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
21232011|NCT01922089|Novartis Pharmaceuticals|Study Director|862-778-8300||
21232012|NCT02988843|Masonic Cancer Center, University of Minnesota|Dr. Shilpa Gupta|612 624 0123|guptash@umn.edu|
21278486|NCT05896202|University of Miami|Marlon L. Wong|3052842670|mwong2@miami.edu|
21232013|NCT02326025|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21232014|NCT00881712|University of Florida Proton Therapy Institute|Bradford Hoppe, M.D.|904-588-1800|bhoppe@floridaproton.org|
21232015|NCT01324999|University of North Carolina at Chapel Hill|H. James Ford, MD|(919) 966-2531|hjford@med.unc.edu|
21232016|NCT02784275|NovMetaPharma Co., Ltd|Peter Lee|+82 (0)2 538 1893|Peter@NovMeta.com|
21232017|NCT02505867|The Ohio State Unveristy|Rami Khayat|6142477717|rami.khayat@osumc.edu|
21232018|NCT03681405|Wake Forest Baptist Comprehensive Cancer Center|Meg O'Mara|336-716-9055|megreen@wakehealth.edu|
21232019|NCT03178903|Butler Hospital|Ana M. Abrantes, Ph.D.|4014556440|Ana_Abrantes@Brown.edu|
21232020|NCT00060008|Children's Hospital of Philadelphia|Dr. Michael Fisher|215 590 2800|fisherm@email.chop.edu|
21232021|NCT01307397|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21232022|NCT00560859|University of Pennsylvania|Dr. Susan S. Ellenberg|215-573-3904|sellenbe@upenn.edu|
21232023|NCT02503735|Massachusetts General Hospital|Dr. Meghan Sise|617-726-5050|MSise@partners.org|
21232024|NCT01714635|Abbott Medical Optics|Kendra Hileman, Ph.D., Director, Clinical Research & Development|714-247-8613|kendra.hileman@amo.abbott.com|
21232025|NCT01129960|BIAL - Portela & Cª, S.A.|Director R&D|351-22-9866100|clinical.trials@bial.com|
21232026|NCT00230607|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21232027|NCT01835587|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
21232028|NCT01209260|University of California San Diego|Jonathan Hsu, MD, MAS|415-476-5706|jonathan.hsu@ucsd.edu|
21232029|NCT00126568|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Panayiotis Savvides|216-844-5946|Panayiotis.Savvides@uhhospitals.org|
21232030|NCT03358290|Akros Pharma Inc.|Kazuhiro Okamiya|609-919-6123|okamiya@akrospharma.com|
21232031|NCT00203996|The University of Chicago|David A. Ehrmann, MD|(773) 702-6138|dehrmann@medicine.bsd.uchicago.edu|
21232032|NCT00897104|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21232033|NCT00434330|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
21232034|NCT01217840|Stanford University|Sejal Shah MD|6507211811|sshah2@stanford.edu|
21232035|NCT03789318|Concentric Analgesics|Head of Clinical Operations|14154847921|nancy@concentricanalgesics.com|
21232036|NCT00850564|Massachusetts General Hospital|Steven Grinspoon, MD|617-724-9109|sgrinspoon@partners.org|
21232037|NCT01937559|Hawkins Foundation|Kyle Adams, Research Coordinator|864-454-7458|kyle.adams@hawkinsfoundation.com|
21232038|NCT01804075|Eastern Maine Medical Center|Dr. Mark Brown|207-973-9503|mbrown@emh.org|
21232039|NCT00531232|Genzyme, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21232040|NCT00397982|University of Virginia|Craig Slingluff|434 924 1730|cls8h@virginia.edu|
21232041|NCT04232124|Vanderbilt University Medical Center|David G. Harrison|6158753049|david.g.harrison@vumc.org|
21232042|NCT02423577|President and Chief Scientific Officer|Russell Wilson, PhD|504-896-2789|rbw@autoimmune.com|
21232043|NCT02345850|The Emmes Company|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
21232044|NCT02392247|Virginia Commonwealth University|Dr.Bruce Spiess, Principal Investigator|804-828-2267|bruce.spiess@vcuhealth.org|
21232045|NCT01991067|Medical University of Vienna, Department of Medicine I, Division of Infectious Diseases|Assoc. Prof. Dr. Christina Bahrs|+4314040044400|christina.a.forstner@meduniwien.ac.at|
21232046|NCT03134989|Cochlear|Ruth English|0386633105|REnglish@cochlear.com|
21232047|NCT00224055|Watson Pharmaceuticals, Inc|Naomi Dahl, PharmD Director, Clinical Affairs||Naomi.dahl@watson.com|
21232048|NCT02771990|Providence Veterans Affairs Medical Center|Benjamin Greenberg|4012737100|benjamin.greenberg@va.gov|
21232049|NCT00407563|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
21232050|NCT02014597|Baylor College of Medicine|Dr. Benjamin Frankfort|713-798-3453|benjamin.frankfort@bcm.edu|
21232051|NCT00754624|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
21239305|NCT04236258|Brigham and Women's Hospital|Dr. Elizabeth Yoselevsky|314-413-1254|eyoselevsky@bwh.harvard.edu|
21239306|NCT02417532|The Chris Moody Centre|Nick Birch|+44 1604 215440|nickbirch@doctors.org.uk|
21239307|NCT02134210|Coherus BioSciences, Inc|Barbara K. Finck, MD Chief Medical Officer|650-649-3529|Bfinck@coherus.com|
21278487|NCT02435836|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21278488|NCT01946191|University of Utah|Dr. Molly Conroy|801-581-8310|Molly.Conroy@hsc.utah.edu|
21278489|NCT01855074|Janssen. Pharmaceutical Companies of Johnson and Johnson|Medical Manager Neurosciences|+507-3989740|dmuschet@its.jnj.com|
21278490|NCT02991430|Scion NeuroStim, LLC|Dr. Robert Black|(919) 260-5528|rblack@scionneurostim.com|
21239308|NCT01486758|Washington University in St. Louis|Dr. Avraham Beigelman (PI)|314-454-2694|beigelman_a@kids.wustl.edu|
21278491|NCT01150890|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21278492|NCT03970837|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21278493|NCT02304991|University of North Carolina School of Medicine|Edwin Kim, MD, MS|919-962-4960|edwinkim@email.unc.edu|
21278494|NCT03801382|Philips Research|Clinical product lead|+31646802217|daisy.van.minde@philips.com|
21278495|NCT03567382|University of North Carolina at Chapel Hill|Peyton Thompson, MD, MSCR|919-445-0854|peyton_thompson@med.unc.edu|
21278496|NCT04555720|Duke University Medical Center|Kyle Mitchell, MD|919-668-2879|kyle.mitchell@duke.edu|
21278497|NCT00719849|Fred Hutchinson Cancer Research Center|Dr. Colleen Delaney|2066671385|cdelaney@fredhutch.org|
21278498|NCT06219278|Candela|Katherine Coleman|508-358-7400|katherinec@candelamedical.com|28533
21278499|NCT01745211|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
21278500|NCT01749995|General Hospital Groeninge, Kortrijk, Belgium|Dr. Philip Debruyne|+32 056 63 39 00|philip.debruyne@azgroeninge.be|
21278501|NCT01868893|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21278502|NCT01783548|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21278503|NCT03825341|St. Jude Children's Research Hospital|Jeremie Estepp, MD|(901) 595-5703|jeremie.estepp@stjude.org|
21232052|NCT04067544|University of Utah College of Nursing|Lisa Taylor-Swanson|801.585.5486|lisa.taylor-swanson@nurs.utah.edu|
21278504|NCT00110136|Wake Forest CCOP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
21278505|NCT00459121|Barbara Ann Karmanos Cancer Institute|Shirish Gadgeel, M.D.|313-576-8753|sgadgeel@med.umich.edu|
21278506|NCT04283500|NYU Langone Health|Ryan McCormack|2122632862|Ryan.McCormack@nyulangone.org|
21278507|NCT03599271|Intersect ENT|Andrew Campbell PhD, MPH Clinical Affairs Director|6506412100|acampbell@intersectent.com|
21278508|NCT01043653|VISN 5 MIRECC|Dr. Amy Drapalski|410-637-1855|amy.drapalski@va.gov|
21278509|NCT04540406|Notitia Biotechnologies|Clinical Research Associate|732-230-3175|ciarra.williams@notitiabio.com|
21278510|NCT03875859|Stanford University|Kavita Yang Sarin|650-804-2899|ksarin@stanford.edu|
21278511|NCT04053465|University at Buffalo|Dr. Riana Pryor|7168295456|rpryor@buffalo.edu|
21232053|NCT00967798|Emory University|Arlene Stecenko, MD|404-712-2657|astecen@emory.edu|
21232054|NCT00536601|Roswell Park Cancer Institute|Theresa Hahn, PhD|716-845-5819|theresa.hahn@roswellpark.org|
21232055|NCT02070692|Oregon Health & Science University|Dr. Katharine Simmons|404-718-6619|simmonka@ohsu.edu|
21261038|NCT00101361|James J. Peters VA Medical Center|William A. Bauman, M.D.|718-584-9000|william.bauman@va.gov|
21261039|NCT01062399|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21261040|NCT02424539|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21261041|NCT00719810|Melinta Therapeutics|Eugene Sun, M.D.|203.624.5606|esun@melinta.com|
21261042|NCT03453060|Aronora, Inc.|Norah G. Verbout, Senior Scientist and Project Manager|503-964-0250|norah.verbout@aronorabio.com|
21261043|NCT04106492|Shasqi Inc|Jose M. Mejia Oneto, MD, PhD|415-800-1376|clinicalstudies@shasqi.com|
21261044|NCT00450463|National Cancer Institute|Dr. Ravi Madan|301-480-7168|ravi_madan@nih.gov|
21261045|NCT04893265|University of California San Francisco|Janice Tsoh, PhD, Professor/ Principal Investigator|4155028438|janice.tsoh@ucsf.edu|
21261046|NCT02465034|Emory University|Dr. Michael Borich|404-712-0612|michael.borich@emory.edu|
21261047|NCT00573131|Boston Scientific Corporation|Jessie Stockwell|1-612-618-1136|jessie.stockwell@bsci.com|
21261048|NCT03033108|Kubota Vision Inc.|Clinical Trials Helpdesk|(206) 805-8310|clinicaltrials@kubotavision.com|
21261049|NCT01959204|PPSI|Study Director|8139279302|mgoodhead@pharmaprojectsolutions.com|
21232056|NCT04615923|Healey Center for ALS at Massachusetts General Hospital|Healey Center for ALS Project Management|833-425-8257 (HALT ALS)|healeyalsplatform@mgh.harvard.edu|
21232057|NCT00592839|Duramed Research|Duramed Research Protocol Chair|215-293-7279|medicalaffairs@barrlabs.com|
21278512|NCT02085135|Alkermes|Eva Stroynowski|781-609-7000|eva.stroynowski@alkermes.com|
21278513|NCT01212588|IndianaU|Dr. Alan Breier|317-880-8495|abreier@iupui.edu|
21278514|NCT02885181|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21232058|NCT02282020|AstraZeneca AB|Global Clinical Leader|1-877-240-9479|ClinicalTrialTransparency@astrazeneca.com|
21278515|NCT03317834|Smith+Nephew, Inc.|Helena Kyriakou|+1 8186995700|Helena.Kyriakou@smith-nephew.com|
21278516|NCT04228783|Janssen Vaccines & Prevention B.V.|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21278517|NCT00996775|Center for Mental Healthcare and Outcomes Research, Central Arkansas Veterans Healthcare System|Michael A. Cucciare, Ph.D.|501-257-1068|michael.cucciare@va.gov|
21278518|NCT03002571|Bausch Health Americas, Inc|Study Director|19083009920|susan.harris@bauschhealth.com|
21278519|NCT03151811|Oncopeptides AB|Chief Operating Officer|+46 8 615 20 40|trials@oncopeptides.com|
21232059|NCT01500629|Johnson & Johnson Consumer and Personal Products Worldwide|Daniel Qi, MD, PhD, Director, Clinical Research|973 385-2260|dqi6@its.jnj.com|
21278520|NCT00054665|National Cancer Institute, National Institues of Health|Wyndham Wilson, M.D.|301-435-2415|wilsonw@mail.nih.gov|
21278521|NCT01234922|Wake Forest Baptist Health|William J. Petty, MD|336-716-3313|wpetty@wakehealth.edu|
21278522|NCT01081834|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
21278523|NCT02651259|Family Health International (FHI 360|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
21278524|NCT00742924|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
21278525|NCT00660400|H. Lee Moffitt Cancer Center and Research Institute|Teresa Field, M.D., Ph.D.|813-745-7202|teresa.field@moffitt.org|
21278526|NCT01161407|Purdue University|Kathleen M. Hill Gallant|765-494-0101|hillgallant@purdue.edu|
21278527|NCT01777620|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21278528|NCT04562155|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21278529|NCT02701270|Danisco Sweeteners Oy|Kirsti Tiihonen|+358 10 431 050|kirsti.tiihonen@dupont.com|
21278530|NCT03149445|Saniona A/S|Janus Schreiber Larsen|+457070 5225|janus.larsen@saniona.com|
21278531|NCT00849186|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21278532|NCT03303196|Children's Hospital of Philadelphia|Lauren Mitteer|267-426-9915|MitteerL@email.chop.edu|
21278533|NCT00936897|Amgen Inc.|Study Director|866-572-6436||
21278534|NCT00417170|Novartis Pharmaceuticals|Study Director|862-778-8300||
21278535|NCT01756079|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21232060|NCT00249444|Columbia University|Dr Wilfrid Raby|212-923-3031|rabywil@nyspi.columbia.edu|
21232061|NCT01499667|Novartis Pharnaceuticals|Study Director|862-778-8300||
21232062|NCT02959944|Pharmacyclics, LLC|Justin Wahlstrom MD|669-215-7210|jwahlstrom@pcyc.com|
21232063|NCT02051608|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21232064|NCT00142584|Viatris Inc|M. Rachel Kirker, PhD, Director, Clinical Oversight & Inspection Readiness|724-485-6170|rachel.kirker@viatris.com|
21232065|NCT03070782|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
21232066|NCT02288559|Hoffmann-La Roche|Medical Communications|(+41) 616878333|global.trial_information@roche.com|
21232067|NCT00558025|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21232068|NCT00449540|Neuralieve|Cynthia Merrell|408-245-6400|cmerrell@neuralieve.com|
21232069|NCT01881776|StLukeNY|Dr.Admir Hadzic|212-665-1400|admir@nysora.com|
21232070|NCT00022633|Cleveland Clinic|Dr. Derek Raghavan|216-445-6888|raghavd@cc.ccf.org|
21232071|NCT01025791|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21232072|NCT02036294|Johns Hopkins University|Principle Investigator|410-637-7152|habouma1@jhmi.edu|
21232073|NCT02393547|Mayo Clinic|Ryan T. Hurt, MD|507-266-1944|nicotineresearch@mayo.edu|
21232074|NCT00514540|University of Texas MD Anderson Cancer Center|Lisa Pruitt, Quality Assurance Specialist|713-792-0411|LPruitt@mdanderson.org|
21232075|NCT04468204|Department of Otolaryngology - Head and Neck Surgery|Director of Clinical Research|(843)792-1356|nguyensh@musc.edu|
21232076|NCT02237950|Starpharma|Dr Jeremy Paull||jeremy.paull@starpharma.com|
21232077|NCT03483051|University of Pennsylvania|Dr. Julio Chirinos|215-200-7779|juliochi@pennmedicine.upenn.edu|
21232078|NCT00345254|Edith Wolf son Medical Cemter|Samuel Lurie|+972-35028329|drslurie@hotmail.com|
21232079|NCT06316973|Clear Scientific|Piercen Oliver|617-621-8500|poliver@clearsci.com|
21232080|NCT03078647|Candela Corporation|Director of Clinical Marketing|(949) 599-7646|doranr@candelamedical.com|
21232081|NCT00752232|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21232082|NCT05989815|Federal University of São Carlos (UFSCar)|Italo Amaral de Oliveira, Principal Investigator|+55 19 99719-0361|italoao@estudante.ufscar.br|
21232083|NCT04583891|University of Virginia|Philip Chow|9146453458|pic2u@virginia.edu|
21232084|NCT02788357|University of Kentucky|Dr. Lumy Sawaki||lsawa2@uky.edu|
21232085|NCT02170051|Professor of Psychiatry, UC San Diego|Elizabeth W Twamley, PhD|858-642-3848|etwamley@health.ucsd.edu|
21232086|NCT01294267|Icahn School of Medicine at Mount Sinai, Helmsley Electrophysiology Center|Vivek Y. Reddy, MD|212-241-7114|vivek.reddy@mountsinai.org|
21232087|NCT01932112|Seoul St Mary's hospital|Y. Oh, director of clinical trial|82-2-2258-1141|oys@catholic.ac.kr|
21239309|NCT01062763|Dept. of Endocrinology, Odense University Hospital|Dr. Ib A. Jacobsen|+45 27203135|ib.abildgaard@rsyd.dk|
21239310|NCT02392611|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21278536|NCT04015908|University of Utah|Dr. Jeffrey D. Swenson|801-581-6393|jeff.swenson@hsc.utah.edu|
21239311|NCT03260127|VA San Diego Healthcare System|Laura Crocker|8586426484|laura.crocker@va.gov|
21232088|NCT03672747|Boys Town National Research Hospital|Tony Wilson|531-355-8909|tony.w.wilson@gmail.com|
21232089|NCT00824512|Ipsen|Medical Director, Primary Care|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21239312|NCT03800979|Institute of Dermatology|Dr. Chinmanat Lekhavat (My old last name is Tangjaturonrusamee.)|+660847607474|chinmanat@hotmail.com|
21239313|NCT03239873|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21278537|NCT03464630|Georgia State University|Dr. Kathleen Baggett|404-413-1571|kbaggett@gsu.edu|
21278538|NCT02865460|Miami VA Healthcare System|Nancy Klimas, MD|305-575-7000|nancy.klimas@va.gov|1-4800
21278539|NCT00901576|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21278540|NCT02922738|University of Vermont|Marianne Burke|802-236-0075|marianne.burke@uvm.edu|
21278541|NCT01696279|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21278542|NCT00171951|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21278543|NCT06077149|University of Rochester|Ann Falsey, MD|585-922-4339|Ann_Falsey@URMC.Rochester.edu|
21278544|NCT04658095|Sight Sciences, Inc.|VP, Medical and Clinical Affairs|877-266-1144|jdickerson@sightsciences.com|
21278545|NCT05788289|Memorial Sloan Kettering Cancer Center|Dr. Anita Kumar, MD|646-608-3780|kumara2@mskcc.org|
21278546|NCT02143973|Trevi Therapeutics|Thomas Sciascia, MD|203-304-2499|thomas.sciascia@trevitherapeutics.com|
21278547|NCT04823975|Huntsman Cancer Institute|Anne Kirchhoff|801-587-4084|Anne.Kirchhoff@hci.utah.edu|
21278548|NCT02970318|Astrazeneca Clinical Trial|Study Director|1-888-292-9613|information.center@astrazeneca.com|
21278549|NCT03384654|Janssen-Cilag International NV|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21278550|NCT01568320|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
21278551|NCT01616953|University of Michigan|Dr. Darnell Kaigler|734-615-4023|dkaigler@umich.edu|
21278552|NCT00762931|electroCore LLC|Clinical Affairs electroCore LLC|+1 973 355 6683|clinical@electrocorellc.com|
21278553|NCT00816361|MedImmune LLC|Susan Perez MD, MSc|+1 301-398-2827|information.center@astrazeneca.com|
21278554|NCT01222286|Innate Pharma|Dr Renaud Buffet|33 4 30 30 30 32|renaud.buffet@innate-pharma.fr|
21278555|NCT02500641|A. Menarini Industrie Farmaceutiche Riunite SrL|Post-Registration Clinical Trial Responsible|+39 055 5680459|pfabrizzi@menarini.it|
21278556|NCT03233230|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21278557|NCT01584843|GlaxoSmithKline|GSK Response Center|866-435-7343||
21278558|NCT03923530|NF South Ga VAMC|Dr. Anthony Bavry|352-548-4726|anthony.bavry@va.gov|
21278559|NCT04154150|University of Pittsburgh|Dr. Rebecca Price|412-383-2150|pricerb@upmc.edu|
21278560|NCT01181271|Mass General Hospital|Yi-Bin Chen, MD|617-726-5765|ychen6@partners.org|
21278561|NCT01408628|University of Kansas Medical Center|Virginia Lewis|913-588-2097|vlewis@kumc.edu|
21278562|NCT04156620|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21278563|NCT01753336|Ipsen Biopharmaceuticals, Inc.|Medical Director||clinical.trials@ipsen.com|
21278564|NCT01121666|Five Office Ltd|Dr. Melanie Ruf|+41 44 9324132|clin@five.ch|
21278565|NCT01576874|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
21232090|NCT01897402|JN-International Medical Corporation|Regulatory Affairs Director|4028843477|dr_orten@jn-vaccines.org|
21232091|NCT01161862|Department of Biomedical Engineering, Boston University, Boston, Massachusetts.|Edward R. Damiano|(617) 353-9493|edamiano@bu.edu|
21232092|NCT00071513|Univeristy of Washington|Elizabeth McCauley, PHD, Principal Investigator|206-987-2579|eliz@uw.edu|
21232093|NCT01648205|University of Rochester|Wojciech Zareba, MD, PhD|5852755391|wojciech_zareba@urmc.rochester.edu|
21232094|NCT01958008|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
21232095|NCT01634360|Eisai Call Center|Eisai Inc.|888-422-4743||
21232096|NCT03667924|University of Minnesota|Joseph Gaugler, PhD|612-626-2485|gaug0015@umn.edu|
21232097|NCT02402127|Alcon Research, Ltd.|Global Medical Affairs Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21232098|NCT02260921|Myoscience|Director of Clinical|5109331541||
21232099|NCT01244425|BAXTER INNOVATIONS GmbH|Ildiko Szabo, MD, MBA Medical Director, Biosurgery||ildiko_szabo@baxter.com|
21232100|NCT02743871|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21232101|NCT02999854|Kiadis Pharma Netherlands B.V|Klaudia Traudtner, MD. Head of Safety and Pharmacovigilance.|+31 (0)20 240 52 50|k.traudtner@kiadis.com|
21232102|NCT03032705|Tufts University School of Dental Medicine|Dr Gerard Kugel|(617) 636-0870|Gerard.Kugel@tufts.edu|
21232103|NCT03482440|University of Iowa|Anna Stanhewicz|3194671732|anna-stanhewicz@uiowa.edu|
21232104|NCT04818840|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
21232105|NCT00973739|New York University Langone Medical Center|Matthias Karajannis, MD|212-263-8400|matthias.karajannis@nyumc.org|
21232106|NCT00733408|University of Washington|Jennifer Specht, MD, Associate Professor|(206) 606-1000|jspecht@uw.edu|
21232107|NCT04346537|Boston Scientific|Gena Kantor|1-800-227-3422|gena.kantor@bsci.com|
21232108|NCT01134783|University of North Carolina, Chapel Hill|Dr. Leslie A. Lytle|919-843-8171|llytle@email.unc.edu|
21232109|NCT01148745|Dialysis Clinic, Inc.|Dr. Toros Kapoian, M.D., F.A.C.P.|732-940-8368|Toros.Kapoian@dciinc.org|
21232110|NCT02152696|Yale University|Heping Zhang, PhD|203-785-5185|heping.zhang@yale.edu|
21232111|NCT04812964|VA Greater Los Angeles Healthcare System|Dr. Jonathan Jacobs|310-478-3711|jonathan.jacobs2@va.gov|
21232112|NCT02329730|Shanghai Public Health Clinical Center|Shuihua Lu|021-37990333|tubercle@gmail.com|2582
21232113|NCT00264641|Hypoglycaemia Research Group|Prof. Birger Thorsteinsson|+4548294829|Birger.Thorsteinsson@regionh.dk|
21278566|NCT01629966|Forest Research Institute, Inc|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
21278567|NCT01672970|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21278568|NCT02132754|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21278569|NCT04430855|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21278570|NCT01770392|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21278571|NCT03401450|NYU Langone|Dr. Prianka Desai|212-263-5072|prianka.desai@nyulangone.org|
21278572|NCT02642536|VA|Dr. Gina Evans|713-440-4459|gina.evans@va.gov|
21278573|NCT00390221|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21278574|NCT04682730|University of Pittsburgh|Dr. Deborah Polk, PhD|14126488656|dpolk@pitt.edu|
21278575|NCT00761865|University of Rochester|Benedict DiGiovanni|5852731611|benedict_digiovanni@urmc.rochester.edu|
21278576|NCT03867097|CiVi Biopharma, Inc.|Chief Executive Officer|301-968-2390|sj@civibio.com|
21278577|NCT01372774|Mayo Clinic|Paul D. Brown, M.D.|(713) 563-2415|brown.paul@mayo.edu|
21278578|NCT00389831|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
21278579|NCT02201290|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
21278580|NCT01398943|Augusta University|Ryan Harris, Ph.D.|706-721-5998|ryharris@augusta.edu|
21278581|NCT01580813|University of Colorado Denver|Irene Schauer, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
21278582|NCT03190330|Johnson & Johnson Private Limited|Sr. Medical Advisor|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21278583|NCT02081209|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
21278584|NCT02370329|Mayo Clinic Arizona|Jeanne M. Palmer, MD|480/342-8000|palmer.jeanne@mayo.edu|
21278585|NCT00633243|Yale University|R. Douglas Bruce|(203) 737-6133|robert.bruce@yale.edu|
21278586|NCT02022748|AstraZeneca Pharmaceuticals LP|Naeem Khan, MD|+1 302-885-8976|Naeem.Khan@astrazeneca.com|
21278587|NCT06378749|Pro-Change Behavior Systems, Inc.|Kerry E. Evers|4013602985|kevers@prochange.com|
21278588|NCT04347122|KUMC|Kyle Sweeney, MD|913886100|ksweeney2@kumc.edu|
21278589|NCT03510598|Zeltiq Aesthetics|Lori Brandt, Director Clinical Trial Management|925 621-7460|lori.brandt@abbvie.com|
21278590|NCT04994483|Cassava Sciences, Inc.|Study Director|737-910-1045|ClinicalTrials.gov@cassavasciences.com|
21278591|NCT03589768|University of Maryland School of Medicine|Kathleen M. Neuzil, MD, MPH|410-706-5328|kneuzil@medicine.umaryland.edu|
21278592|NCT00112866|Adult Brain Tumor Consortium (ABTC)|Mark Gilbert, MD|410-955-8837|jfisher@jhmi.edu|
21278593|NCT01539135|Tulane University Hospital and Clinics|Dr. Sabrina Bent|5049887137|sabrina.bent@hcahealthcare.com|
21278594|NCT04663295|Medtronic MiniMed|Senior Statistician|+18185764034|dz.dai@medtronic.com|
21278595|NCT00554190|Carbylan BioSurgery Inc.|Marcee Maroney, VP Clinical Affairs|650 855 6774|mmaroney@carbylan.com|
21278596|NCT00191113|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21278597|NCT01502410|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
21278598|NCT02903030|Nisonger Center|Dr. L. Eugene Arnold, MD, MED. Professor Emeritus College of Medicine|614-685-6701|l.arnold@osumc.edu|
21278599|NCT05958888|University of North Carolina at Chapel Hill|Marissa Hall, PhD|(919) 445-1310|mghall@unc.edu|
21278600|NCT03700385|FARAPULSE, Inc.|Christopher (Kit) Schneider Sr. Director of Clinical & Pre-Clinical Engineering|617-686-7661|kschneider@farapulse.com|
21278601|NCT00699283|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
21278602|NCT02684630|Terumo BCT, Inc.|Heather Pidcoke, MD, PhD|(303) 231-4805|Heather.Pidcoke@terumobct.com|
21278603|NCT03376061|Population Health Research Institute|Research assistant|19055212100|Austin.Browne@phri.ca|40582
21278604|NCT04247100|Virginia Commonwealth University|Gisela Chelimsky, MD|804-628-4859|gisela.chelimsky@vcuhealth.org|
21278605|NCT01806571|Mayo Clinic|Aref Al-Kali, M.D.|(507) 538-0591|alkali.aref@mayo.edu|
21278606|NCT02771795|Samsung Bioepis Co., Ltd.|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
21278607|NCT03537599|The Ohio State University Comprehensive Cancer Center|Dr. Sumithira Vasu|614-293-9869|Sumithira.Vasu@osumc.edu|
21278608|NCT05083585|Janssen Vaccines & Prevention B.V.|Director Biomarkers Viral Vaccines|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21278609|NCT00114166|NRG Oncology, Statistics and Data Management Center - Buffalo Office|Jessalyn Reboy|716-845-7738|ReboyJ@nrgoncology.org|
21278610|NCT03469336|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21278611|NCT01090921|BVARI|Nikhil C. Munshi, M.D.|857-203-6172|nikhil_munshi@dfci.harvard.edu|
21278612|NCT02740699|National Heart, Lung, and Blood Institute at the National Institutes of Health|Dr. Marcus Chen|301.496.0077|chenmy@nhlbi.nih.gov|
21278613|NCT01108406|Sonitus Medical, Inc.|Lily Woodby, AuD|8668162076|lily@sonitusmedical.com|
21278614|NCT02393248|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21278615|NCT02585934|Axovant Sciences, Inc.|Ilise Lombardo, MD|646-822-8626|ilise.lombardo@axovant.com|
21278616|NCT04713553|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
21278617|NCT03544424|University of Manchester|Dr Joanne Taylor|0161 306 6000|joanne.taylor-2@manchester.ac.uk|
21278618|NCT02958982|Rhizen Pharmaceuticals S.A.|Dr. Prajak Barde|+41 32 580 0113|pjb@rhizen.com|
21278619|NCT02603393|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21278620|NCT00699374|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21278621|NCT02067468|Universidad de Antioquia|Dr Gloria I Sanchez|+57 (4) 219 6062|sanchezg@une.net.co|
21278622|NCT01359969|Pharming Technologies BV|Anurag Relan, MD, VP Clinical Research & Medical Affairs|+31 715247400|a.relan@pharming.com|
21278623|NCT02174419|Trevi Therapeutics|Thomas Sciascia, MD|203-304-2499|thomas.sciascia@trevitherapeutics.com|
21278624|NCT00593736|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21278625|NCT01857271|Albert Einstein Cancer Center|Dr. Haiying Cheng|718-405-8404|hcheng@montefiore.org|
21278626|NCT01853930|Jesse Brown VA Medical Center|Dr. Janet P. Szlyk, PhD|312-997-3644|janet.szlyk@va.gov|
21278627|NCT03682224|Southern Illinois University School of Medicine|Sowmy Thuppal, Research Assistant Professor|217-545-2320|sthuppal83@siumed.edu|
21278628|NCT04729309|Hoffmann - LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21278629|NCT00735306|Duke University|Dr. Brian Czito|919-668-7336|brian.czito@duke.edu|
21278630|NCT00176423|Maryland Psychiatric Research Center|Robert W. Buchanan, M.D.|410-402-7876|rbuchanan@som.umaryland.edu|
21278631|NCT00462124|BioProtect|Galit Itzhaki|+972-9-7731929|galit@bioprotect.co.il|
21278632|NCT03597529|Director, Child and Adolescent Headache Program, UCSF Benioff Children's Hospitals|Dr. Amy A. Gelfand|415-502-1914|Amy.Gelfand@ucsf.edu|
21278633|NCT03769714|Maimonides Medical Center|Pedram Bral, MD|7182836000|pbral@maimonidesmed.org|
21278634|NCT04623086|University of Washington|Arthi Thirumalai|206-221-0521|arthidoc@uw.edu|
21278635|NCT03007238|City of Hope Medical Center|Dr. Amandeep Salhotra|626-359-8111|asalhotra@coh.org|
21278636|NCT03196635|GE Healthcare|Sara Lam|262-548-2369|sara.j.lam@ge.com|
21278637|NCT00555152|University of Texas (UT) MD Anderson Cancer Center|Powel H. Brown, MD/Chair, Clinical Cancer Prevention||CR_Study_Registration@mdanderson.org|
21278638|NCT03490344|Memorial Sloan Kettering Cancer Center|Dr. Sham Mailankody, MBBS|646-608-3712|mailanks@mskcc.org|
21278639|NCT04154631|Department of Psychology, University of California, Berkeley|Professor of Clinical Psychology|5104736490|aharvey@berkeley.edu|
21278640|NCT01441947|Massachusetts General Hospital|Steven Isakoff, MD, PhD|617-643-5415|sisakoff@partners.org|
21278641|NCT02238795|Jena University Hospital, Center for Clinical Studies|Prof. Dr. Frank M. Brunkhorst|+49 3641 939|frank.brunkhorst@med.uni-jena.de|6687
21278642|NCT02174432|Trevi Therapeutics|Thomas Sciascia, MD|203-304-2499|thomas.sciascia@trevitherapeutics.com|
21278643|NCT05187013|George Washington University|Ramin Asgary|(202) 994-6803|raminasgary1@gwu.edu|
21278644|NCT02387983|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21278645|NCT04159935|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
21278646|NCT01341782|Abbvie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21278647|NCT02472223|Washington University School of Medicine|Mae Gordon|3143623716|gordon.mae@wustl.edu|
21278648|NCT00724048|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21278649|NCT01676415|NORTHWESTERN UNIVERSITY|BRUCE TAN|3126958182|CPRICE2@NM.ORG|
21278650|NCT00587990|EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@emmes.com|221
21278651|NCT03541980|Newark Beth Israel Medical Center|Dr Cena Tejani|973 926 7337|ctejani5@gmail.com|
21278652|NCT00206323|Baylor College of Medicine|Dr. Joseph Jankovic|713-798-6556|josephj@bcm.edu|
21278653|NCT03334617|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
21278654|NCT02329847|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21278655|NCT03657342|Zambon SpA|Enrica Bucchioni, MD, PhD, Global Clinical Development Senior Director|+3902665241|clinicaltrials@zambongroup.com|
21278656|NCT00407758|NRG Oncology|Angela Kuras on behalf of Mike Sill, PhD|716-845-5702|kurasa@nrgoncology.org|
21278657|NCT00750308|Vanderbilt University|Dr. Nancy J. Brown|615-343-8701|nancy.j.brown@vanderbilt.edu|
21278658|NCT02980874|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
21278659|NCT04271020|NeoTract, Inc.|Emily Friedland, Director, Global Clinical Affairs|1-610-331-7299|emily.friedland@teleflex.com|
21278660|NCT00193427|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net|
21278661|NCT02683265|Rhodes Pharmaceuticals L.P.|Inder Chaudhary|401-262-9272|inder.chaudhary@rhodespharma.com|
21232114|NCT02758899|Washington University|Wilson Z. Ray|314-747-6145|rayz@wustl.edu|
21278662|NCT00030992|National Cancer Institute, National Institutes of Health|Tito Fojo, M.D.|301-496-2631|FojoT@mail.nih.gov|
21278663|NCT01233921|Fred Hutchinson Cancer Research Cetner|Dr. Paul J. Martin|206-667-4798|pmartin@fhcrc.org|
21278664|NCT03258853|Massachusetts General Hospital|Dr. Melissa Putman|617-726-1847|msputman@mgh.harvard.edu|
21278665|NCT01709838|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21278666|NCT00968799|Cantonal Hospital St.Gallen|Sascha Müller, MD|+41 71 494 1317|ulrich.beutner@kssg.ch|
21278667|NCT01540773|Pennington Biomedical Research Center|Dr. Frank Greenway, Chief of Outpatient Clinic|225-763-2578|Frank.Greenway@pbrc.edu|
21278668|NCT03907462|University of California, San Diego|Dr. Job Godino|6195152344|jobg@fhcsd.org|2344
21278669|NCT04639713|Novoxel Ltd|Ifat Klein|972-52-6009860|ifat@novoxel.com|
21278670|NCT02087995|Dexcom, Inc|Andrew Balo/ EVP|8582000203|abalo@dexcom.com|
21278671|NCT01811316|Sunstar Americas, Inc.|Akane Takemura|+1-847-794-4276|akane.takemura@us.sunstar.com|
21278672|NCT04086407|Sleep Systems|Director of Operations|978-835-7036|e.lyons@sleepsystems-llc.com|
21232115|NCT00463346|Yale University School Of Medicine Department of Psychiatry|Elizabeth Ralevski|2039325711|elizabeth.ralevski@yale.edu|4282
21232116|NCT01909154|Hospital Universitario Puerta de Hierro Majadahonda, Madrid|Dr. Vaquero Crespo|91 191 7760|jesus.vaquero@salud.madrid.org|
21278673|NCT00658515|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
21278674|NCT01555671|Prof.Dr.Cemil Tascioglu City Hospital|Orhan SAHIN|+90 532 240 00 12|drorhansahin@gmail.com|
21278675|NCT03047330|Brigham and Women's Hospital|Hadine Joffe, MD MSc|617-732-4906|hjoffe@bwh.harvard.edu|
21278676|NCT03929757|Janssen Vaccines & Prevention B.V.|Medical Lead|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21278677|NCT01154816|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21278678|NCT00806286|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21278679|NCT00686075|MedImmune, LLC.|Filip Dubovsky, Vice President, Clinical Development|301-398-0000|dubovskyf@medimmune.com|
21278680|NCT01682863|Novartis Pharmaceuticals|Study Director|862-778-8300||
21278681|NCT00918138|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
21278682|NCT00977379|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21278683|NCT03972163|UMass Chan Medical School|Dr. Jennifer Tjia, Principal Investigator|774-455-3538|jennifer.tjia@umassmed.edu|
21278684|NCT02006693|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21278685|NCT01119508|UT MD Anderson Cancer Center|Dr. Sapna P. Patel, Assistant Professor, Melanoma Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
21278686|NCT00265395|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21278687|NCT01955837|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.||toiawase@taiho.co.jp|
21278688|NCT02563106|Synthetic Biologics|Michael Kaleko, MD|(240) 238-3862|mkaleko@syntheticbiologics.com|
21261050|NCT02401256|Indiana University School of Medicine|Dr. Zeruesenay Desta|3172742823|zdesta@iu.edu|
21278689|NCT02338193|Woman's Hospital|Dr Karen Elkind-Hirsch, Director of Research|225 231-5278|karen.elkind-hirsch@womans.org|
21278690|NCT04689867|University of Michigan|Lindsay Bornheimer|(734) 615-2915|bornheim@umich.edu|
21278691|NCT01136967|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
21278692|NCT02240030|Acorda Therapeutics|Charles Oh|914-326-5455|coh@acorda.com|
21278693|NCT01735955|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21278694|NCT05084716|RAND|Laura Bogart|3103930411|lbogart@rand.org|
21278695|NCT03839823|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21278696|NCT01716715|NRG Oncology|Linda Gedeon on behalf of Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org|
21278697|NCT03327792|Yale University|Dr. Suchitra Krishnan-Sarin|203-974-7595|suchitra.krishnan-sarin@yale.edu|
21278698|NCT01740726|Emory University School of Medicine|Research Coordinator|404-727-4799|sean.carey@emory.edu|
21278699|NCT00952211|UCSD|Dr. Joel Dimsdale||jdimsdale@ucsd.edu|
21278700|NCT01025453|Memorial Sloan Kettering Cancer Center|Dr. Eric Sherman, MD|646-888-4234|shermane@mskcc.org|
21278701|NCT03490760|Miami Cancer Institute at Baptist Health, Inc.|Michael Chuong, M.D.|(786) 596-2000|michaelchu@baptisthealth.net|
21278702|NCT03511326|Galderma R&D SNC|CTA Coordinator|+33 0493 95 70 85|cta.coordinator@galderma.com|
21278703|NCT01392625|ISCI / University of Miami Miller School of Medicine|Joshua M. Hare, MD|305-243-5579|JHare@med.miami.edu|
21278704|NCT04058067|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21278705|NCT02955758|Stanford University|Dr. Joel W. Neal|(650) 498-6000|jwneal@stanford.edu|
21278706|NCT00867503|University Of Arizona|Dr. Setsuko K Chambers|520/626-0950|schambers@azcc.arizona.edu|
21278707|NCT01839318|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21278708|NCT02287818|TWi Biotechnology Inc.|JingYi Lee|886-2-26571788|jingyi.lee@twibiotech.com|201
21278709|NCT01001988|Sanofi Pasteur|Medical Director|800-633-1610|RegistryContactUS@sanofi.com|
21278710|NCT01844856|La Jolla Pharmaceutical Company|Chief Development Officer|+1.617.715.3600|ljpcregulatory@ljpc.com|
21278711|NCT03340207|VA Western NY Healthcare System|Dr. Nader D. Nader|716-862-8707|nnader@buffalo.edu|
21278712|NCT00927394|Novartis Pharmaceuticals|Study Directors|862-778-8300||
21278713|NCT01221363|Research Centre for Prevention and Health|Mette Aadahl|+45 38663359|mette.aadahl@regionh.dk|
21278714|NCT04628793|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21278715|NCT02315430|NRG Oncology|Linda Gedeon on behalf of William Brady, PhD|716-845-1169|lgedeon@gogstats.org|
21278716|NCT00613886|University of California, Irvine|Chris Nishi Clinical Trials Coordinator|949-824-3238|cnishi@uci.edu|
21261051|NCT03090191|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21261052|NCT01251575|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fredhutch.org|
21261053|NCT00893789|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21261054|NCT02024464|Alcon Research, LLC|Director, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21261055|NCT01479725|Beaumont Hospital, Royal Oak|Dr. Kenneth Peters|248-551-0387|Kenneth.Peters@Beaumont.edu|
21261056|NCT03818815|Novus Therapeutics|Clinical Director|949-679-1110|study006@novustherapeutics.com|
21261057|NCT01845025|Novartis Pharmaceuticals|Study Director|862-778-8300||
21261058|NCT01552876|Johnson & Johnson Vision Care|Katherine Osborn OD, MS FAAO|1 904 443-1032|kosborn@its.jnj.com|
21261059|NCT03767738|Regeneron Pharmaceuticals, Inc|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
21261060|NCT03047005|Yale University|Dr. Carlos Grilo|203 785 7210|carlos.grilo@yale.edu|
21278717|NCT05502081|Mansoura University Hospital|Dr. Ahmed Hosny|+2001554658010|ahmedony26@gmail.com|+200115584
21278718|NCT01329549|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21278719|NCT01090752|University Hospital Geneva and Lausanne, Switzerland|Zanchi Anne, MD|0041213140775|azanchidel@hotmail.com|
21261061|NCT01315574|Massachusetts Eye and Ear Infirmary|Dr. Pedram Hamrah|617-573-6060|ophthalmologyclinicalresearch@meei.harvard.edu|
21278720|NCT01755767|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21278721|NCT00191165|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21278722|NCT00715624|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21278723|NCT03200912|Teva Pharmaceuticals Inc. USA|Senior Director, CE Studies|1-888-483-8259|USMedInfo@tevapharm.com|
21278724|NCT00735618|UT MD Anderson Cancer Center|Ying Guo, MD, MS/Associate Professor||jaallo@mdanderson.org|
21278725|NCT00229723|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
21278726|NCT01316315|N30 Pharmaceuticals Inc.|Janice M. Troha|720-945-7714|janice.troha@n30pharma.com|
21278727|NCT00998309|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21278728|NCT03769207|Stanford University|Marco Perez, Associate Professor of Medicine|(650) 723-9363|mvperez@stanford.edu|
21278729|NCT00735397|Eisai Inc.|Eisai Call Center|888-422-4743||
21278730|NCT02677714|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21278731|NCT03421730|Vectura Limited|Gary Burgess, MD|+44 (0)1249 667700|clinical.enquiries@vectura.com|
21278732|NCT00513682|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
21278733|NCT02450526|Ipsen|Medical Director||clinical.trials@ipsen.com|
21278734|NCT02722148|University of North Carolina at Chapel Hill|Dr. Evan S. Dellon|(919) 966-2513|evan_dellon@med.unc.edu|
21278735|NCT00911807|EBEWE Pharma|Dr. Philipp Novak|01143-7665-8123|philipp.novak@ebewe.com|733
21278736|NCT05161806|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21278737|NCT00855803|University of Texas Southwestern Medical Center|Dr. Robert Timmerman|214/645-7637|robert.timmerman@utsouthwestern.edu|
21278738|NCT01174082|UT MD Anderson Cancer Center|Qazilbash,Muzaffar,M.D. / Stem Cell Transplantation|713-792-7734|CR_Study_Registration@mdanderson.org|
21278739|NCT04568031|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21278740|NCT02304458|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21278741|NCT00186043|Bipolar and Depression Research Program, Stanford University, School of Medicine, VA Palo Alto Health Care System|Trisha Suppes MD, PhD|6504962567|tsuppes@stanford.edu|
21278742|NCT04874636|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21278743|NCT01362127|Karolinska Institutet|Fredrik Klevebro|+46858580000|fredrik.klevebro@ki.se|11111
21278744|NCT04188301|Washington University in St. Louis|Dr. Gary Weil|3144547787|gary.j.weil@wustl.edu|
21278745|NCT00228423|University Of Ottawa Heart Institute|Dr. Marc Ruel||mruel@ottawaheart.ca|
21278746|NCT02351544|The Ohio State University|Dr. Jeffrey Janis|(614) 293-8566|jeffrey.janis@osumc.edu|
21278747|NCT02175576|Zimmer Biomet|Hillary Overholser|574-933-4180|hillary.overholser@zimmerbiomet.com|
21278748|NCT00620659|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21278749|NCT03564444|MedImmune, LLC|Raburn Mallory|+1-301-398-5799|information.center@astrazeneca.com|
21278750|NCT03246646|CMC VA Medical Center|Steven L. Sayers|(215) 823-5196|steven.sayers@va.gov|
21278751|NCT00529282|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Clincal Team Lead|908 927-3785||
21261062|NCT01931865|Yale University School of Medicine|Bahman Jabbari M.D.|203-737-2464|bahman.jabbari@yale.edu|
21278752|NCT04241315|On Target Laboratories, Inc.|Tommy Lee|214-289-6422|tlee@ontargetlabs.com|
21278753|NCT00663026|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21278754|NCT03964649|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21278755|NCT03783039|ETHICON, Inc|Patricia Schleckser|01 908 218 2244|PSchleck@its.jnj.com|
21278756|NCT00837473|Medtronic Spine and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
21278757|NCT03400943|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
21278758|NCT00537303|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21278759|NCT02201212|Dana Farber Cancer Institute|Dr. David Kwiatkowski|8573070781|dk@rics.bwh.harvard.edu|
21278760|NCT01273896|Memorial Sloan Kettering Cancer Center|Modi, Shanu/Medicine (Assistant Attending)|+1646-888-4564|modis@mskcc.org|
21278761|NCT04524364|Biosense Webster, Inc.|Associate Director - Medical Affairs|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21278762|NCT00670202|Brigham and Women's Hospital|Anju Nohria|617-525-7052|anohria@partners.org|617
21278763|NCT00380744|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21278764|NCT01006018|Emory University|Mary Rhee, M.D.|404-778-1666|mrhee@emory.edu|
21278765|NCT01497808|University of Pennsylvania|Dr. Amit Maity|(215) 615-6767|maity@uphs.upenn.edu|
21278766|NCT01338870|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21278767|NCT00258128|Joslin Diabetes Center|Allison B. Goldfine, MD|617-309-2400|allison.goldfine@joslin.harvard.edu|
21278768|NCT02467478|GW MFA|Sabyasachi Sen|3014616676|ssen1@gwu.edu|
21278769|NCT01955083|Chang Gung Memorial Hospital|Dr. Hsueh-Yu Li|886-3-3281200|hyli38@adm.cgmh.org.tw|3967
21278770|NCT02763826|Medical University or SC|Scott Hutchison, Manager of COBRE Research Operations|843-792-2712|hutchis@musc.edu|
21278771|NCT01559389|Loyola University Medical Center|Elizabeth Mueller, MD|708-216-2180|emuelle@lumc.edu|
21278772|NCT02871492|AiCuris Anti-infective Cures GmbH|Information Desk|+4920231763|info@aicuris.com|0
21261063|NCT01121406|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21278773|NCT04546724|Valn|Clinical Strategy Manager|+43 1 206 20|office@valneva.com|0
21278774|NCT03583086|Vanderbilt-Ingram Cancer Center|Teresa Melton|6159367423|teresa.melton@vumc.org|
21261064|NCT00504257|H. Lee Moffitt Cancer Center and Research Institute|Robert Wenham, Principal Investigator|813-745-8478|robert.wenham@moffitt.org|
21278775|NCT04113785|University of Tennessee|Richard Komistek, Principal Investigator|8659742093|rkomiste@utk.edu|
21232117|NCT03641651|Zurich University of applied sciences|Prof. Dr. Markus Wirz|+41 58 934|markus.wirz@zhaw.ch|6321
21261065|NCT02750410|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21261066|NCT00759577|New York University|Dr. Victor Nitti|646 825 6300|Victor.Nitti@NYUMC.org|
21261067|NCT03494647|Children's Hospital Colorado|Emily Sweeney, MD|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
21278776|NCT00396812|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21278777|NCT00435812|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-848-5100||
21278778|NCT01881984|University of Pittsburgh|Dr. Gerard Vockley|412-692-7746|gerard.vockley@chp.edu|
21278779|NCT03201445|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
21278780|NCT01228019|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21278781|NCT02914210|Duke Clinical Research Institute|Janet Bettger, ScD|919-613-0379|janet.bettger@duke.edu|
21278782|NCT01346293|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21278783|NCT02687217|Lady Hardinge Medical College and associated Hospitals|Dr. Swati Sattavan|9891777424|swatisattavan@gmail.com|91
21278784|NCT01844505|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21278785|NCT00128830|Tibotec Pharmaceuticals|Trial Physician|+32-14-607-767||
21278786|NCT02730351|GlaxoSmithKline|GSK Response Center|866-435-7343|sarah.l.west@gsk.com|
21278787|NCT00311402|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21278788|NCT02640053|Mayo Clinic|Charles L. Loprinzi, M.D.|507/284-6026|cloprinzi@mayo.edu|
21278789|NCT02036775|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21278790|NCT01268501|Alcon Research, Ltd.|Director of Alcon Clinical|1-800-241-7629||
21278791|NCT04058249|Stanford University|Protocol Director|650-800-6920|brainstimulationstudy@stanford.edu|
21278792|NCT02927366|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21278793|NCT04181723|Acadia Pharmaceuticals Inc.|Study Director|844-422-2342|medicalinformation@acadia-pharm.com|
21278794|NCT02910063|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21278795|NCT03496610|Duke University|Hector F. Martinez-Wilson, MD, PhD|919-681-6437|hector.martinez-wilson@duke.edu|
21278796|NCT03750292|University of Rochester|Daniel Croft|(585) 275-4861|daniel_croft@urmc.rochester.edu|
21278797|NCT00048737|UT MD Anderson Cancer Center|Issa Khouri, MD / Professor||rvalverde@mdanderson.org|
21278798|NCT02774642|San Diego VA Healthcare System|Dr. Peter Colvonen|858-552-8585|peter.colvonen@va.gov|2468
21278799|NCT00827632|Columbia University|Carolyn Westhoff|212-305-4805|clw3@columbia.edu|
21278800|NCT00511095|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-848-5100||
21278801|NCT06281171|dfusion Inc.|Lane Edwards, MPH, Project Director|8314402192|Lane.edwards@dfusioninc.com|
21278802|NCT03347006|Queen Mary University of London|Professor Jesmond Dalli|+442078828263|j.dalli@qmul.ac.uk|
21278803|NCT01158573|University of Michigan|Michael Coffey M.D.|734-936-6267|coffeym@umich.edu|
21278804|NCT04669691|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
21278805|NCT01222390|Northwestern University|John Y.S. Kim, MD|312-695-0208|jokim@nmh.org|
21278806|NCT01822275|University of Maryland Medical Center|Caitlin Eggleston|4103287586|caitlineggleston@umm.edu|
21278807|NCT05034276|University of Utah|Eric Garland|801-581-3826|eric.garland@socwk.utah.edu|
21278808|NCT00073021|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
21278809|NCT00809159|Novartis|Study Director|862-778-8300||
21278810|NCT02103270|The Sean N. Parker Center for Allergy Research at Stanford|Dr Andres Alvarez Pinzon, Director of Regulatory Affairs and Translational Medicine|9544465645|andresap@stanford.edu|
21290113|NCT02540434|Weill Cornell Medicine|Michele Steinkamp|2127462953|mls9004@med.cornell.edu|
21261068|NCT00215930|Karmanos Cancer Institute (formerly at Moffitt Cancer Center)|Gerald Bepler, M.D., via Moffitt Cancer Center|813-745-4398|beplerg@karmanos.org|
21290114|NCT03343886|Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Madrid, Spain.|José Luis Ayuso Mateos||joseluis.ayuso@uam.es|
21290115|NCT00754559|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21290116|NCT00345592|S. Anna Hospital|Giovanni Luca Botto|0315851|gluca.botto@gmail.com|+39
21232118|NCT01430091|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21232119|NCT00951665|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21232120|NCT02068443|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21232121|NCT00127712|Purdue University|James E. Tisdale|317-613-2315|jtisdale@iupui.edu|306
21232122|NCT02801942|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21232123|NCT02450903|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21232124|NCT05126901|Shield TX (UK) Ltd.|Clinical Operations, Shield TX (UK) Ltd.|+44 (0) 191 511 8500|info@shieldtherapeutics.com|
21232125|NCT01320085|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21239314|NCT01671839|Merz Pharmaceuticals|Public Disclosure Manager|+49 69 1503 0|clinicaltrials@merz.com|
21239315|NCT01567943|Washington State University|Michael McDonell|509 368-6967|mmcdonell@wsu.edu|
21239316|NCT02291432|Cook MyoSite Incorporated|Ron Jankowski, PhD|412-963-7380|Ron.Jankowski@CookMyosite.com|
21239317|NCT02596022|NYSPI|Linda Sherman|6467747158|lsherma@nyspi.columbia.edu|
21239318|NCT02145078|Barbara Ann Karmanos Cancer Institute|Gerold Bepler|(313)576-8670|beplerg@karmanos.org|
21239319|NCT00519896|University of Washington|Renato G Martins|206-288-2048|rgmart@uw.edu|
21239320|NCT00810082|Dartmouth College|Dr. Jon D. Lurie, MD, MS|603-653-3575|Jonathan D. Lurie <Jonathan.D.Lurie@hitchcock.org>|
21239321|NCT03327402|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21239322|NCT02134119|University of Georgia|Jamie Cooper|7065424903|jamie.cooper@uga.edu|
21239323|NCT01454830|The Pennsylvania State University|Amy M. Sawyer, PhD|814-863-1020|ams24@psu.edu|
21239324|NCT00584805|USAMRIID Medical Division|Anthony Cardile, D.O.|301-619-8833|anthony.cardile.mil@mail.mil|
21239325|NCT01077362|Janssen Research & Development, LLC|Senior Director, Clinical Research|1-800-526-7736||
21239326|NCT00301080|Northwestern University|Clinical Research Office|312-695-1301|cancertrials@northwestern.edu|
21239327|NCT03097861|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
21239328|NCT03502616|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21239329|NCT01581840|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
21239330|NCT01785563|University of Iowa|Tarah T. Colaizy|3193255640|tarah-colaizy@uiowa.edu|
21239331|NCT00628901|Boston Scientific|Ana Becker / Sr. Clinical Program Manager|651-581-4605|Ana.Becker@bsci.com|
21239332|NCT01616771|Seoul National University Hospital|Jin-Tae Kim|82-10-6260-8490|jintae73@gmail.com|
21239333|NCT00744328|Northwestern University|Research Study Coordinator|312-695-8441|emily.pinheiro@northwestern.edu|
21239334|NCT00815035|University of North Carolina at Chapel Hill|Edwin Kim, Director UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
21239335|NCT04399356|Tufts Medical Center|Dorothy Dulko, PhD - Research Project Director|(617) 636-5009|ddulko@Tuftsmedicalcenter.org|
21239336|NCT02091739|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
21239337|NCT01187329|Cleveland Clinic|Andra E. Duncan, M.D|216-445-2372|DUNCANA@ccf.org|
21239338|NCT01805882|National Institute of Allergy and Infectious Diseases|Shyam Kottilil MD|+1 410 706 4872|Skottilil@ihv.umaryland.edu|
21239339|NCT00910520|Allergan, Inc|Therapeutic Area Head,|714-246-4500 ext:|clinicaltrials@allergan.com|
21239340|NCT00130793|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21239341|NCT00211237|Medtronic Spine and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
21261069|NCT01531725|ZNA Middelheim Department Interventional Cardiology, Antwerpen, Belgium|Paul Vermeersch, MD, PhD|+32 3 280 3211|paul.vermeersch@zna.be|
21232126|NCT01409564|Seoul National University Hospital|Prof. Jung Seok Choi|82-2-870-3461|choijs@neuroimage.snu.ac.kr|
21232127|NCT05040386|University of Alabama at Birmingham|Anand Iyer, MD, MSPH|2059341968|aiyer@uabmc.edu|
21278811|NCT03316378|University of Iowa, Department of Physical Therapy & Rehabilitation Science|Ruth Chimenti, Assistant Professor|319-335-9791|ruth-chimenti@uiowa.edu|
21278812|NCT03918109|Otonomy, Inc.|Otonomy Medical Information Center|1-844-686-4636|medinfo@otonomy.com|
21278813|NCT01045174|University Hospitals Cleveland Medical Center|Dr. Jerri Rose|216-844-7147|jerri.rose@uhhospitals.org|
21278814|NCT01997229|Alexion Pharmaceuticals, Inc.|Jing-Jing Wang, MD|+1 (475) 230-2596|JingJing.Wang@alexion.com|
21278815|NCT00477295|Eisai Call Center|Eisai Inc.|888-422-4743||
21278816|NCT03039179|Istituto Ortopedico Rizzoli|Head of the Research Nursing Unit|0516366694|cristiana.forni@ior.it|0039
21278817|NCT03276780|University of Alabama at Birmingham, Department of Psychiatry and Behavioral Neurobiology|Dr. Karen Cropsey|205-975-4204|kcropsey@uabmc.edu|
21278818|NCT00510289|Duke University Medical Center|David Rizzieri, MD|919-668-1014|David.Rizzieri@duke.edu|
21278819|NCT01425723|Bioverativ Therapeutics Inc.|Bioverativ Study Medical Director|781-6631801|clinicaltrials@bioverativ.com|
21278820|NCT00861198|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu|
21278821|NCT02288182|gwd consult · contract research|Dr. Manfred Klasser|+49 (6108) 8256520|manfred.klasser@gwd-consult.de|
21278822|NCT01088802|Johns Hopkins Medicine|Harry Quon, MD|410-502-3877|hquon2@jhmi.edu|
21278823|NCT04619992|Hollister Incorporated|Director of Global Clinical Affairs|+1 224-206-2857|sara.wegener@hollister.com|
21278824|NCT01197755|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
21278825|NCT03365011|Washington University School of Medicine in St. Louis|Jay F. Piccirillo, MD, FACS|(314) 362-8641|piccirij@wustl.edu|
21278826|NCT03582826|MEBO Research|Maria De la Torre, Executive Director|786 228-6880|maria.delatorre@meboresearch.org|
21278827|NCT01413516|Stanford University|Judith Prochaska|6507243608|jodi.prochaska@stanford.edu|
21278828|NCT00804713|USUHS|James Mancuso|301-295-3734|james.mancuso@usuhs.edu|
21278829|NCT00758680|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21278830|NCT00319982|Brigham and Women's Hospital|Carolyn Ho, MD|617-732-5685|cho@partners.org|
21278831|NCT03480386|Mayo Clinic|Roberto P. Benzo, MD|507-284-0561|Benzo.Roberto@mayo.edu|
21278832|NCT00574912|University of Maryland, Baltimore|Dr. Stephen N. Davis|4103282488|sdavis@medicine.umaryland.edu|
21278833|NCT01282723|Reproductive Research Technologies, LP|Jack McCrary|7136800200|jmc@innovalp.com|
21278834|NCT03753763|Zambon S.p.A.|Director of Clinical Trial - Charlotte Keywood, MD|+39 02 665241|charlotte.keywood@zambongroup.com|
21278835|NCT01104779|Allergan|Medical Director|877-277-8566|IR-CTRegistration@Allergan.com|
21278836|NCT00810576|UT MD Anderson Cancer Center|Barbara Pro, MD|713-792-2933||
21278837|NCT04036799|Hospital for Sick Children|Seema Mital, Staff Cardiologist|416-813-7418|seema.mital@sickkids.ca|
21278838|NCT04240392|Yale School of Medicine|Ariadna Forray, MD|203-785-2618|ariadna.forray@yale.edu|
21278839|NCT02155543|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21278840|NCT03665441|Erytech Pharma Inc|Anu Gupta, Senior Study Team Lead|7327424937|anu.gupta@erytech.com|
21278841|NCT05307510|The University of Toledo|Laura Schmelzer|419-530-5068|laura.schmelzer@utoledo.edu|
21278842|NCT04345601|Baylor College of Medicine|Dr. Laquisa Hill|713-441-1450|LaQuisa.Hill@bcm.edu|
21278843|NCT03610516|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
21278844|NCT00631657|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21278845|NCT03035929|Vanderbilt University Medical Center|Grace Henderson, Study Coordinator|615-936-5356|grace.henderson@vumc.org|
21278846|NCT03796598|Richmond VA Medical center|Jasmohan Bajaj|8046755802|jasmohan.bajaj@va.gov|
21278847|NCT05773794|North Carolina A&T State University|Dr. Shengmin Sang|7042505710|ssang@ncat.edu|
21278848|NCT00661895|Creighton Cardiac Center|Tammy Burns, PharmD, Research Manager|402-280-4292|TammyBurns@creighton.edu|
21278849|NCT00362466|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21290117|NCT00400205|Emory University Winship Cancer Institute|Nabil Saba, MD|1-888-946-7447|nfsaba@emory.edu|
21232128|NCT01702454|GlaxoSmithKline|GSK Response Center|866-435-7343||
21232129|NCT00710710|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21261070|NCT03215277|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21261071|NCT01854177|Dartmouth-Hitchcock|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org|
21290118|NCT01663987|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21278850|NCT02487303|Medical University of South Carolina|Sylvia Wilson|8437921414|wilsosh@musc.edu|
21278851|NCT04003896|Penn State Health|Dr. Nelson Yee|7175310003|nyee@pennstatehealth.psu.edu|280677
21278852|NCT01199471|Abbott|Global Medical Services|800-633-9110||
21278853|NCT03151408|Helsinn Healthcare SA|Francesco Scarci|+41 (0)91 985 1946|francesco.scarci@helsinn.com|
21278854|NCT01996449|UT Southwestern Medical Center|Wanpen Vongpatanasin|2146458000|Wanpen.Vongpatanasin@UTSouthwestern.edu|
21278855|NCT02315196|Cancer Institute of New Jersey|Deborah L Toppmeyer, MD|732-235-6789|toppmede@cinj.rutgers.edu|
21278856|NCT04576923|Indiana University|Samer Gawrieh, MD|317-278-9326|sgawrieh@iu.edu|
21278857|NCT01475097|GE Healthcare|Debra Mansfield|609-514-6329|dabra.mansfield@ge.com|
21278858|NCT02383810|Helsinn Healthcare SA|Director of Clinical Division|+41 91 9852121|info@helsinn.com|
21290119|NCT01829503|University of Pittsburgh Cancer Institute|Dr. Annie P. Im|412-623-2393|imap@upmc.edu|
21290120|NCT01783236|Weill Cornell Medicine|Hugh Hemmings, MD, PhD|212-746-2953|hchemmi@med.cornell.edu|
21278859|NCT02105558|The University of Texas Health Science Center at Houston|Madhumani Rupasinghe, MD|(713) 500-6200|Madhumani.Rupasinghe@uth.tmc.edu|
21278860|NCT01635283|Jonsson Comprehensieve Cancer Center|Dr. Robert Prins|310-825-7647|rprins@mednet.ucla.edu|
21278861|NCT04516759|St George Street Capital|Mike Johnson, Managing Director|+447768335460|mike@sgscapital.org|
21278862|NCT01305044|Huntsman Cancer Institute|Anita Kinney, PhD, RN|801-585-1151|anita.kinney@hci.utah.edu|
21278863|NCT02309138|University of Pittsburgh|Director of Center for Research on Health Care Data Center|412-692-2023|dcenter@pitt.edu|
21278864|NCT03904264|Department of Veterans Affairs|Tara Zaugg, AuD / CRH REC Consultant, VISN 20 and REC ICC Clinical Lead, VISN 20|208-422-1000|tara.zaugg@va.gov|
21278865|NCT03369197|The Johns Hopkins University|Dr. Laeben Lester|410-955-7519|llester4@jhmi.edu|
21278866|NCT00118534|VA Puget Sound (Seattle)|Dr. Miles McFall|(206) 764-2177|Miles.McFall@va.gov|
21278867|NCT01661062|University of Michigan Comprehensive Cancer Center|Avraham Eisbruch, M.D.|734-936-4302|eisbruch@umich.edu|
21278868|NCT00873457|Duke University Medical Center|Daphne Friedman, MD|919-684-9220|daphne.friedman@dm.duke.edu|
21278869|NCT00838435|BioMarin Pharmaceutical Inc.|Joshua Lilienstein/Medical Director, Global Medical Affairs|651.523.0310|MEDINFO@bmrn.com|
21278870|NCT01135186|Stanford University|Dr. Linda Anh B. Nguyen|650-736-5555|nguyenlb@stanford.edu|
21278871|NCT02754856|University of Texas M D Anderson Cancer Center|Dr. Michael Overman|(713) 792-2828|moverman@mdanderson.org|
21278872|NCT04874155|Noctrix Health, Inc.|Jonathan Charlesworth, PhD|804-683-4279|jcharlesworth@noctrixhealth.com|
21278873|NCT03735316|Mayo Clinic|James A. Nelson, M.B.B.S.|480-342-1800|Nelson.James1@mayo.edu|
21278874|NCT00530218|City of Hope National Medical Center|Ricardo Spielberger, MD|626-359-8111|RSpielberger@coh.org|65298
21278875|NCT01798316|Northwell|Director of Clinical Research, Department of Anesthesiology|718-470-7630|odowling@northwell.edu|
21278876|NCT00678886|GlaxoSmithKline|GSK Response Center|866-435-7343||
21278877|NCT03477903|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21278878|NCT01147107|University of Hawaii at Manoa John A Burns School of Medicine|Dr. Cecilia Shikuma|8086921328|shikuma@hawaii.edu|
21278879|NCT04435184|Johns Hopkins University - Baltimore, MD|Dr. Charles Lowenstein|4105020391|clowens1@jhmi.edu|
21290121|NCT04000724|Friends Research Institute, Inc.|Cathy Reback|3234631601|reback@friendsresearch.org|
21261072|NCT00500071|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21261073|NCT01043640|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|612-626-2313|orcha001@umn.edu|
21261074|NCT01667848|LudwigBoltzmannIOL|Dr. Bettina Klugsberger|+43 732 7806 2133|Bettina.Klugsberger@akh.linz.at|
21261075|NCT00356915|GlaxoSmithKline|GSK Response Center|866-435-7343||
21261076|NCT03348514|University of Kansas Medical Center|Dr. John A Taylor III|913-588-8170|Jtaylor27@kumc.edu|
21261077|NCT02580058|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21261078|NCT02333227|Baylor College of Medicine, Department of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine|Dr. Kjersti Aagaard|7137988467|aagaardt@bcm.edu|
21261079|NCT00397150|Centre for International Health, University of Bergen, Norway|Prof Thorkild Tylleskar|+47 55588562|Thorkild.Tylleskar@cih.uib.no|
21261080|NCT04375878|First Wave BioPharma Inc.|Chief Medical Officer|(561) 589 7020|info@firstwavebio.com|
21261081|NCT03022461|Abbott|Poornima Sood|+17818528334|poornima.sood@abbott.com|
21261082|NCT01982630|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21290122|NCT00455455|CCLR|Dr Craig A Woods|519 888 4567|cawoods@uwaterloo.ca|36547
21290123|NCT01370538|AstraZeneca|Gerard Lynch|1625 518062|aztrial_results_posting@astrazeneca.com|+44
21290124|NCT01084135|Duke University Medical Center|Jane Ann Baker,MS, CGC|919-668-4576|janeann.mckillop@duke.edu|
21290125|NCT02366130|UT MD Anderson Cancer Center|Dr. Naoto T Ueno, Professor, Breast Medical Oncology|(713) 792-8754|nueno@mdanderson.org|
21290126|NCT01065766|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-888-577-8839|ClinicalTrialsDisclosure@merck.com|
21290127|NCT00712075|VA San Diego Healthcare System, San Diego|Eric Granholm, PhD|858-552-8585|egranholm@ucsd.edu|7768
21290128|NCT04217057|Washington University School of Medicine|Dr. Farrokh Dehdashti|314-362-1474|dehdashtif@wustl.edu|
21290129|NCT02945046|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21290130|NCT03907579|Dartmouth-Hitchcock Norris Cotton Cancer Center|Director of Community Education and Prevention|603-653-9960|nccc.community.outreach@dartmouth.edu|
21290131|NCT01608308|The University of Texas Health Science Center at Houston|Davide Cattano|(713) 500-6200|Davide.Cattano@uth.tmc.edu|
21290132|NCT03587857|UCSF|Dr. Parya Saberi|415-502-1000 ext. 17171|parya.saberi@ucsf.edu|
21290134|NCT06171399|Wake Forest University School of Medicine|Dr. Beth Reboussin|336-713-5213|brebouss@wakehealth.edu|
21290135|NCT00032487|Hines CSPCC|Project Manager|708-202-5785|tamara.paine@va.gov|
21290136|NCT04267328|HealthPartners Institute - Neuroscience|Clinical Research Coodinator|651-495-6360|clincialtrials@HealthPartners.com|
21290137|NCT01807104|VOA Research Foundation|Dr. William P. Barrett, MD|425-656-5060|wpbarrett@comcast.net|3063
21290138|NCT00908687|Valneva Austria GmbH|Head Clinical Development|0043120620|info@valneva.com|0
21290139|NCT03389750|New York State Psychiatric Institute|Jermaine Jones|646 774-6113|jermaine.jones@nyspi.columbia.edu|
21290140|NCT01117350|sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21278880|NCT04693416|University of Tennessee Health Science Center|Karen Derefinko, PhD|901-448-2526|kderefin@uthsc.edu|
21278881|NCT00474266|GlaxoSmithKline|GSK Response Center|866-435-7343||
21278882|NCT01695863|Aurora Gastroenterology, West Allis WI|Maqsood Khan MD FACG|414-328-8750|mkhangi@yahoo.com|
21232130|NCT03510884|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21232131|NCT00715078|Dendreon|Shabnam Vaziri|206-455-2323|Svaziri@Dendreon.com|
21232132|NCT01313767|Clinical Development Team of Medytox Inc.|Medytox Inc.|82-70-8666-6911|hgpark@medytox.com|
21232133|NCT00157950|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21232134|NCT02673489|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
21232135|NCT00759863|Photozig, Inc.|Bruno Kajiyama|650-694-7496|lifezig@photozig.com|3
21232136|NCT02781051|UT Southwestern Medical Center|Chad Rethorst, Associate Professor|2146480153|chad.rethorst@utsouthwestern.edu|
21232137|NCT01988103|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
21232138|NCT02506153|SWOG Statistics and Data Management Center|Melanoma Committee Statistician|2066674623|jmoon@fredhutch.org|
21232139|NCT01141907|Johns Hopkins University|Dr. Cheryl Dennison|443-287-4174|cdennis4@jhu.edu|
21232140|NCT00311623|Duke University|Andrew Armstrong, MD ScM FACP|(919) 668-8797|andrew.armstrong@duke.edu|
21232141|NCT03103919|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21232142|NCT03998189|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-713-4550|aohlmans@wakehealth.edu|
21232143|NCT01402544|Univeristy of California, San Diego|Dr. Henry Ferreyra|858-822-7982|hferreyra@ucsd.edu|
21232144|NCT02775162|OrganOx Ltd|Robert Bovy, VP of Regulatory Affairs, North America|608-556-4429|robert.bovy@organox.com|
21232145|NCT04876274|School of Pharmacy, Taipei Medical University|Professor Hsiang-Yin Chen|(02)2736-1661|shawn@tmu.edu.tw|6175
21232146|NCT03454893|AVROBIO, Inc|AVROBIO MedInfo|617-914-8419|medinfo@avrobio.com|
21232147|NCT01986985|GE Healthcare|Terri Hanlon, Clinical Affairs Project Manager|609-578-0173|terri.hanlon@GE.com|
21232148|NCT01083576|US Army Medical Materiel Development Activity (USAMMDA)|Director, Division of Regulated Activites and Compliance|301-619-0197|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil|
21232149|NCT03527966|Virtua Health Inc.|Jillian Hoopes|856-761-3904|jhoopes@virtua.org|
21232150|NCT01948050|Beth Israel Medical Center|Helena Knotkova, PhD|212-844-8541|hknotkov@chpnet.org|
21232151|NCT02005445|VA Boston Healthcare System|Dr. Daniel Gottlieb|857-203-6375|daniel.gottlieb@va.gov|
21232152|NCT02135146|University of Colorado|Nick Naughton, Professional Research Assistant|3037200833|nick.naughton@cuanschutz.edu|
21232153|NCT00333866|Organization: Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21232154|NCT06073119|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
21232155|NCT05185089|NeRRe Therapeutics Ltd|CMO|+44 (0)1438 906960|info@nerretherapeutics.com|
21232156|NCT04997161|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21232157|NCT00667368|University of Alabama at Birmingham|Dr. Jane Schwebke|205-975-5665|schwebke@uab.edu|
21232158|NCT02730455|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
21232159|NCT02733367|Diurnal|Information Line|+44 (0) 2920 682069|info@diurnal.co.uk|
21232160|NCT01348347|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21232161|NCT05564429|National Institute of Mental Health (NIMH)|Dr Robert Innis|301-594-1368|robert.innis@nih.gov|
21232162|NCT02480439|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
21232163|NCT03049280|Intuitive Surgical|Intuitive Surgical Clinical Affairs|408-523-2100|sylvie.akiel-fu@intusurg.com|
21232164|NCT00996307|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21232165|NCT00001723|National Institute of Child Health and Human Development, NIH|Jack A. Yanovski, MD, PhD, Chief SGO, PDEGEN|301-496-4686|yanovskj@mail.nih.gov|
21232166|NCT01867021|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21232167|NCT00640601|AstraZeneca|Gerard Lynch|441625 518062|aztrial_results_posting@astrazeneca.com|
21232168|NCT01862874|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21232169|NCT03198234|Stanford|Rajni Agarwal, MD|650-725-9250|rajnia@stanford.edu|
21232170|NCT04285879|Connecticut Children's|Adam P. Weaver, PT, DPT|860-284-0246|Aweaver@connecticutchildrens.org|
21232171|NCT01064713|University of Texas (UT) MD Anderson Cancer Center|Agop Y. Bedikian, MD/Professor||CR_Study_Registration@mdanderson.org|
21232172|NCT03228537|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|jmoon@fredhutch.org|
21232173|NCT01927367|QEII Health Sciences Centre, Halifax, Nova Scotia|Dr. Jafna L Cox|(902) 473-7811|jafna.cox@dal.ca|
21232174|NCT02622321|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21232175|NCT00886899|BridgePoint Medical|VP, Clinical Affairs|763-225-8500|jschultz@bridgepointmedical.com|
21232176|NCT00790855|The University of MD Anderson Cancer Center|Hagop M. Kantarjian, M.D.|713-792-7026|eharriso@mdanderson.org|
21232177|NCT00241280|Johnson & Johnson Vision Care, Inc.|David C. Turner, Ph.D. GLOBAL PLATFORM SR DIRECTOR, R&D|904-443-3500|DTURNER2@its.jnj.com|3479
21232178|NCT00965718|Yonsei university|Moonjae Chung, MD|82-2-2228-2274|MJCHUNG@yuhs.ac|
21232179|NCT00138203|University of Wisconsin Carbone Cancer Center|Dr. Anne Traynor|(608) 262-8158|amt@medicine.wisc.edu|
21232180|NCT01414855|Genentech, Inc.|Medical Communications|800-821-8590|genetech@druginfo.com|
21232181|NCT00360828|H. Lee Moffitt Cancer Center and Research Institute|Edward Pan, M.D.|813-745-3871|edward.pan@moffitt.org|
21232182|NCT01346839|Michael E. DeBakey VA Medical Center and Baylor College of Medicine|Dr. Hardeep Singh|713-794-8515|hardeeps@bcm.edu|
21232183|NCT01694641|Kaali Inst. IVF Center|Dr Peter Kovacs|36-1-202-2802|peterkovacs1970@hotmail.com|
21232184|NCT00289315|Pennington Biomedical Research Center|Lori Steib|(225) 252-5030|Lori.Steib@pbrc.edu|
21232185|NCT01572909|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
21232186|NCT04779489|UT Southwestern Medical Center|Dr. Solomon Woldu|214-648-9558|solomon.woldu@utsouthwestern.edu|
21239342|NCT01121172|4th Department of Pediatrics, School of Medicine, Aristotle University of Thessaloniki|Assimina Galli-Tsinopoulou, As.Professor of Pediatric Endocrinology|00302310991537|agalli@auth.gr|
21239343|NCT01003639|University of Iowa Hospitals and Clinics|Dr. Michael Wall|319-353-3942|michael-wall@uiowa.edu|
21239344|NCT02954458|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
21239345|NCT04000594|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21239346|NCT01552954|Department of Internal Medicine, Seoul National University Bundang Hospital|Ho Jun Chin|+82-10-7360-7025|mednep@snubh.org|
21239347|NCT00779779|GlaxoSmithKline|GSK Response Center|866-435-7343||
21239348|NCT01395823|Dialysis Clinic Inc|Karen Majchrzak|615-342-0483|karen.majchrzak@dciinc.org|
21261083|NCT00561353|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
21278883|NCT05330468|Abbott|Director, Clinical Programs Structural Interventions & Cardiac Surgery|(651)-202-8362|ryan.palmer@abbott.com|
21278884|NCT00369317|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordintator@childrensoncologygroup.org|
21278885|NCT02365558|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21278886|NCT00420459|Cincinnati Childrens Hospital|Craig Erickson|5136366265|craig.erickson@cchmc.org|
21278887|NCT01687244|FKD Therapies Oy|David Sawutz, PhD|416-607-9515|david.sawutz@fkdtherapies.com|
21278888|NCT01330420|Massachusetts General Hospital|Kathleen Miller, RN|781-485-6176|kmiller16@partners.org|
21278889|NCT02819050|Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center|Virender Rehan|3102221965|vrehan@labiomed.org|
21261084|NCT00256295|University of California, Irvine|Nicole Macaranas|714-456-6550|nicole.macaranas@uci.edu|
21261085|NCT01696461|National Marrow Donor Program/BeTheMatch|Dr. Steven Devine|7634068239|sdevine2@nmdp.org|
21261086|NCT05369806|University of Washington|Keshet Ronen|2065854363|keshet@uw.edu|
21278890|NCT00426361|GlaxoSmithKline|GSK Response Center|866-435-7343||
21261087|NCT00628355|Ribeirao Preto Medical School - University of Sao Paulo|Omero Benedicto Poli Neto|551636023183|polineto@fmrp.usp.br|
21261088|NCT00140855|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21261089|NCT01815957|UNewMexico|Bina Ahmed|505-272-7028|hkhawaja@salud.unm.edu|
21261090|NCT03542682|Yale School of Medicine|Laura Marie Nally, MD|(877) 925-3637|laura.nally@yale.edu|
21261091|NCT01236391|Pharmacyclics, Inc.|Dr. Darrin Beaupre|855-427-8846|medinfo@pcyc.com|
21261092|NCT00765765|Cancer Institute of New Jersey|Dr. Vassiliki Karantza|732-235-8675|karantva@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
21290141|NCT04902144|University of Washington|Dr. Marianne Dubard-Gault|206-606-6990|mdg2019@uw.edu|
21290142|NCT03361072|Helsinki University Hospital|Dr Paula Kauppi|+358504286802|paula.kauppi@hus.fi|
21290143|NCT06173648|State Univeristy of Paulista Júlio de Mesquita Filho, School of Dentistry at Araraquara|Dr. Renato de Toledo Leonardo|+55-16-3301-6391|rleonard@foar.unesp.br|
21290144|NCT02487199|AbbVie|Global Medical Services|800-633-9110||
21290145|NCT03181009|The Sean N. Parker Center for Allergy and Asthma Research at Stanford University|Dr Andres Alvarez Pinzon, Director of Regulatory Affairs and Translational Medicine|650 - 521 - 7237|andresap@stanford.edu|
21290146|NCT00394472|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21290147|NCT01654250|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21290148|NCT02004275|Levine Cancer Institute|Peter Voorhees|980-442-5219|peter.voorhees@carolinashealthcare.org|
21290149|NCT00458705|Memorial Sloan Kettering Cancer Center|Dr. Heather Landau|212-639-8808|landauh@mskcc.org|
21290150|NCT03777176|Zealand Pharma|Sune Birch|+45 5060 3864|SBirch@zealandpharma.com|
21290151|NCT00378560|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21290152|NCT02070380|Bracco Diagnostics, Inc.|Gianpaolo Pirovano, MD|609-514-2226|gianpaolo.pirovano@diag.bracco.com|
21290153|NCT03850431|Center to Improve Veteran Involvement in Care (CIVIC), HSR&D Center of Innovation, VA Portland Health Care System|Dr. Alan Teo|5032208262|alan.teo@va.gov|52461
21290154|NCT01682603|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|Dr. Hann-Chorng Kuo|886-3-8561825|hck@tzuchi.com.tw|2113
21290155|NCT01791205|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21239349|NCT01778556|NIDDK|Dr. Rebecca Brown|301-594-0609|brownrebecca@mail.nih.gov|
21239350|NCT00070135|The Ohio State University|Steven Devine, MD||steven.devine@osumc.edu|
21239351|NCT03300570|Fox Chase Cancer Center|David Weinberg, M.D., M.Sc.|215-214-1424|david.weinberg@fccc.edu|
21239352|NCT00116272|Amgen Inc.|Study Director|866-572-6436||
21239353|NCT03188120|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21239354|NCT03571737|Brody School of Medicine @ East Carolina University|Dr. Jennifer Stahl|2527442570|stahlj@ecu.edu|
21239355|NCT02139358|H. Lee Moffitt Cancer Center and Research Institute|Dr. Hatem Soliman|813-745-4933|hatem.soliman@moffitt.org|
21239356|NCT04485130|University of California, San Francisco|Dr. Sulggi Lee|415-735-5127|sulggi.lee@ucsf.edu|
21239357|NCT02178566|Inova Health Systems|Christopher King, MD|7037763067|christopher.king@inova.org|
21239358|NCT05778526|The Hong Kong Polytechnic University.|Dr. Ka Po Wong|64860214|portia.wong@polyu.edu.hk|
21239359|NCT00085202|St. Jude Children's Research Hospital|Amar Gajjar, MD|866-278-5833|info@stjude.org|
21239360|NCT03238300|Medical University of South Carolina|Lindsay M. Squeglia, PhD|843-792-5451|squegli@musc.edu|
21239361|NCT02081950|Chemi SpA (Part of Italfarmaco Group)|Paolo Bettica, MD|+39 02 64431|p.bettica@italfarmaco.com|
21239362|NCT00818961|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD|404-255-1930|ssolomon@bmtga.com|
21239363|NCT01286441|Santalis Pharmaceuticals|Dr. Paul Castella Ph.D.|210-399-2316|paulc@santalispharma.com|101
21239364|NCT00524225|University of Pittsburgh|Dr. Margaret Ragni, Professor of Medicine|412-209-7288|ragni@dom.pitt.edu|
21239365|NCT01436201|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21239366|NCT00110890|Amgen Inc.|Study Director|866-572-6436||
21239367|NCT01686581|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21239368|NCT01975220|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21239369|NCT02839343|Mayo Clinic|Frank Sinicrope|5072664338|Sinicrope.Frank@mayo.edu|
21239370|NCT01870388|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21239371|NCT01852058|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21239372|NCT03619590|GlaxoSmithKline|GSK Response Center|866-435-7343|sk994601@gsk.com|
21239373|NCT01279343|Washington University School of Medicine|Jeanine Carbone MD|314-362-8523|jfcarbone@hotmail.com|
21239374|NCT03287414|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
21239375|NCT03536546|Department of Veterans Affairs|Paul N Pfeiffer, MD MS|(734) 769-1000|Paul.Pfeiffer@va.gov|
21239376|NCT01119898|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
21239377|NCT02217280|Missouri Orthopaedic Institute|Dr. Christina Goldstein|573-884-9022|goldsteincl@health.missouri.edu|
21239378|NCT01015976|University of North Dakota - Neuropsychiatric Research Institute|James L. Roerig PharmD, BCPP|701 365 4919|jroerig@nrifargo.com|
21239379|NCT00116844|GlaxoSmithKline|GSK Response Center|866-435-7343||
21239380|NCT01933880|Xi'an Janssen Pharmaceutical Ltd.|Director - CNS & Pain, CDMA, China R&D and SA|+86 10 5821-8307||
21239381|NCT02907814|Rutgers New Jersey Medical School|Dr. Elliot Crane|973-972-2020|cranees@njms.rutgers.edu|
21239382|NCT01125722|Ethicon Endo-Surgery|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
21239383|NCT00045435|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|206-667-4961|bsandmai@fhcrc.org|
21239384|NCT00051168|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21239385|NCT00709059|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21239386|NCT02172625|Georgia State University|Dr. Gerald S. Zavorsky|404-413-1271|zavorsky@gsu.edu|
21239387|NCT02944656|Emory University|Tiffany Hailstorks, MD, MPH|404-778-1385|tiffany.p.hailstorks@emory.edu|
21278891|NCT02828241|Dr. Reddy's Laboratories|Katherine D'Angelo|609-282-1400|kdangelo@drreddys.com|
21239388|NCT01596283|Memorial Sloan Kettering Cancer Center|Dr. Mary Fischer MD|212-639-6745|fischerm@mskcc.org|
21239389|NCT03722264|Virginia Commonwealth University|Eser Tufekci, DDS, PhD|804-828-9326|etufekci@vcu.edu|
21278892|NCT02373189|Rush University Medical Center|John Burns|13129420379|john_burns@rush.edu|
21278893|NCT02151877|Advocate Health Care|Chawki Elzein, MD, FACS|7086843029|chawki.elzein@advocatehealth.com|
21278894|NCT02012348|UCSD Dermatology Clinical Trials|UCSD Dermatology Clinical Trials Manager|(585)-657-8390|dermstudies@ucsd.edu|
21278895|NCT03095638|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21278896|NCT03050060|University of Washington|Dr. Ramesh Rengan, Department Chair|206-598-4100|rengan@uw.edu|
21239390|NCT02494921|University of California, San Francisco|Dr. Rahul Aggarwal, MD|(415) 353-9278|Rahul.Aggarwal@ucsf.edu|
21278897|NCT03835221|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
21239391|NCT04105972|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21290156|NCT03939494|Cincinnati Children's Hospital|Mary Banks|513-636-2147|mary.banks@cchmc.org|
21290157|NCT03615534|Al-Kindy College of Medicine, ////university of Baghdad|Lewai Sharki Abdulaziz|750 659 0024|lewaisharki@kmc.uobaghdad.edu.iq|+964
21290158|NCT05688657|CooperVision|Jose A. Vega, OD, MSc, FAAO|925-621-3761|jvega2@coopervision.com|
21290159|NCT04046952|Long Beach VA Healthcare System|Dr. Arnold Seto|562-826-8000|arnold.seto@va.gov|12876
21290160|NCT03071965|Neurotech Pharmaceuticals, LLC|CMO|401-333-3880|neurotech@neurotechusa.com|
21290161|NCT04829214|Otonomy, Inc.|Medical Information|+1 844-686-4636|medinfo@otonomy.com|
21290162|NCT06399471|Georgia Institute of Technology|Kinsey Herrin, MSPO, C/LPO, FAAOP, Senior Research Scientist|470-578-7600|kinsey.herrin@gatech.edu|
21290163|NCT04034056|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21290164|NCT04635280|Air Liquide|Marie-Danielle MILCENT / Clinical Project Manager|+33 (0)1 84 76 42 39|fralsi-ctpublication@airliquide.com|
21290165|NCT04135352|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21290166|NCT00609973|University of North Carolina|Hans Herfarth|9199666806|hherf@med.unc.edu|
21232187|NCT03879655|Mandos, LLC|Executive Vice President, Regulatory Affairs|619-905-0489|jspinella@mandoshealth.com|
21232188|NCT02723084|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21232189|NCT02290509|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
21278898|NCT00499174|Canadian Cancer Trials Group|Keyue Ding, Biostatistician|613-533-6430|kding@ctg.queensu.ca|
21232190|NCT05024058|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
21290167|NCT01362270|Oregon Health & Science University|Samantha Underwood, Research Manager|503-494-8481|underwos@ohsu.edu|
21290168|NCT02046200|UCLA Department of Psychology|Dr. Lara Ray|310-794-5383|lararay@psych.ucla.edu|
21290169|NCT01691482|GlaxoSmithKline|GSK Response Center|866-435-7343||
21290170|NCT01392495|Novartis Pharmaceuticals|Study Director|862-778-8300||
21290171|NCT02571244|Federal University of Juiz de Fora/Brazil|Dr. Erica Cruvinel|55-32-99174-8855|ericacruvinel@gmail.com|
21290172|NCT01696214|University of California San Diego|Dr. Joe Ramsdell|619-543-7241|jramsdell@ucsd.edu|
21290173|NCT02134028|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21290174|NCT00449007|Perelman School of Medicine, University of Pennsylvania|Maria A. Oquendo, M.D., Ph.D.|215-662-2818|moquendo@pennmedicine.upenn.edu|
21290175|NCT02777190|Penn State Milton S. Hershey Medical Center|Dr. Jaimey Pauli|717-531-8142|jpauli@pennstatehealth.psu.edu|5
21290176|NCT01370642|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21290177|NCT01928576|Johns Hopkins|Amber Michalik|667-306-8336|amichal2@jhmi.edu|
21290178|NCT00987935|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21290179|NCT01089543|Eisai Inc.|Yoshiumi Okubo, Study Director|+81-3-3817-3908|y4-okubo@hhc.eisai.co.jp|
21290180|NCT00309244|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
21290181|NCT03438656|University of Washington|Assistant Professor|414-331-4871|jennessj@uw.edu|
21290182|NCT03335566|GE Healthcare|Francois Tranquart, M.D, PhD|011-44-1494-543037|francois.tranquart@ge.com|
21290183|NCT04223687|University of North Carolina at Chapel Hill|Marissa Hall, PhD|(919) 445-1310|mghall@unc.edu|
21290184|NCT02468700|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com|
21290185|NCT03319654|Antwerp University Hospital, Belgium|Dr. Alessa Sugihara|00328213684|alessa.sugihara@uza.be|
21290186|NCT04128228|Department of Psychiatry, Yale University School of Medicine|Dongju Seo|475-441-3457|dongju.seo@yale.edu|
21290187|NCT03163264|VA New York Harbor Manhattan|Dr. Melanie Jay|212-686-7500|melanie.jay@va.gov|5097
21290188|NCT04648241|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21290189|NCT02057666|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21290190|NCT05661734|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21261093|NCT02871479|Santalis Pharmaceuticals|Dr. Paul Castella|2103992316|paulc@satalispharma.com|101
21278899|NCT01214915|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21278900|NCT00871741|GlaxoSmithKline|GSK Response Center|866-435-7343||
21278901|NCT05323123|Columbia University|Corina Lelutiu-Weinberger, PhD|(212) 342-1502|cl4265@cumc.columbia.edu|
21278902|NCT05529472|Abbott Vascular|Ikuko Kishimoto, Principal Clinical Scientist|651.756.4878|ikuko.kishimoto@abbott.com|
21278903|NCT04975191|Rutgers University|Dr. Danielle Dick|732-235-5607|Danielle.M.Dick@rutgers.edu|
21278904|NCT00761657|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441||
21278905|NCT03593538|Perelman School of Medicine at the University of Pennsylvania|Dr. Rebecca Ashare|2157465789|rlashare@pennmedicine.upenn.edu|
21278906|NCT00359801|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21278907|NCT01564537|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
21278908|NCT02932306|Bausch Health Americas, Inc.|Clinical Operations Director|1-510-259-5284|aloncaric@bauschhealth.com|
21278909|NCT05776862|University of Miami|Mark Nash, PhD|305-243-3628|mnash@med.miami.edu|
21278910|NCT02448706|Northwestern University|Pamela Souza|8474912433|p-souza@northwestern.edu|
21232191|NCT00139399|Imperial College London|Dr Carolyn Webb|03301288860|c.webb@imperial.ac.uk|
21232192|NCT00714389|University of Rochester|Gunhilde Buchsbaum, MD|585-273-3232|gunhilde_buchsbaum@urmc.rochester.edu|
21232193|NCT03055260|University of Minenesota|Russel Giveans|5042314007|russell.giveans@gmail.com|
21232194|NCT00931762|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21232195|NCT01432886|Eisai Co., Ltd.|Tadashi Nakanishi|81-3-3817-5252||5252
21232196|NCT00225251|NY State Psychiatric Institute|David Hellerstein MD|6467748000|hellers@nyspi.columbia.edu|
21232197|NCT02664441|Seattle Children's Hospital|Christian L. Roth, MD|206-987-5428|christian.roth@seattlechildrens.org|
21232198|NCT02560584|Regional Hospitals & Family Health Centers|Dr. J. Stephen Jones|+1-216-442-5060|joness7@cff.org|
21232199|NCT01531374|Medtronic, Inc.|Hatice Bilgic Lim||rs.medtroniccardiovascularclinicaltrials@medtronic.com|
21232200|NCT01529346|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21232201|NCT02892760|The University of Texas Health Science Center at Houston|Gerard Francisco, MD|713-797-7636|Gerard.E.Francisco@uth.tmc.edu|
21232202|NCT00258882|Sanofi Pasteur Inc|Medical Drector||RegistryContactus@sanofipasteur.com|
21232203|NCT04867850|Abramson Cancer Center|Dr. Samuel Takvorian|267-438-8269|Samuel.takvorian@pennmedicine.upenn.edu|
21232204|NCT00386776|Beth Israel Deaconess Medical Center|Dr. Warner V. slack|617 278 8155|wslack@bidmc.harvard.edu|
21232205|NCT00588848|MetroHealth Medical Center|Dr. Dennis Auckley|216-778-7212|dauckley@metrohealth.org|
21232206|NCT00082355|NIHCC|Dr Richard Chang|301-402-0256|rchang@cc.nih.gov|
21232207|NCT02335489|St. Jude Medical|Roni Diaz|+1 972 309 8601|rdiaz@sjm.com|
21232208|NCT01207765|Tufts Medical Center|Andreas Klein, MD|617-636-8884|aklein2@tuftsmedicalcenter.org|
21232209|NCT01969240|Mayo Clinic|Dr. Erik Hess|507-284-7221|hess.erik@mayo.edu|
21232210|NCT02653391|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
21232211|NCT00412854|GlaxoSmithKline|GSK Response Center|866-435-7343||
21232212|NCT02452346|Weill Cornell Medicine|Dr. Sangmin Lee, MD|646-962-2700|sal9053@med.cornell.edu|
21232213|NCT00531050|Novartis Pharmaceuticals|Study Director|862-778-8300||
21232214|NCT01411696|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21232215|NCT02233309|University of Nebraska Children's Hospital & Medical Center|Jessica K. Goeller, DO|(402) 955-4303|JGoeller@childrensOmaha.org|
21232216|NCT01067456|MGH|Dr. Udo Hoffmann|617-726-1255|uhoffmann@partners.org|
21232217|NCT02328755|University of Michigan|John Magenau|734 936-8785|johnmage@med.umich.edu|
21239392|NCT00584701|UCSF|Robert Hendren, DO|415-476-7198|robert.hendren@ucsf.edu|
21278911|NCT02065700|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
21278912|NCT01635218|Hospital Juárez de México|Dr. Emma del Carmen Macías-Cortés|+52 55 5747 7605|ecmc2008@hotmail.es|
21278913|NCT03559400|University of California, San Francisco|David Shearer, MD, MPH, Associate Professor|628-206-8812|david.shearer@ucsf.edu|
21278914|NCT02784444|Cirius Therapeutics Inc.|Jules Lee|8583336274|jlee@ciriustx.com|514
21278915|NCT03262038|University of Michigan|Elizabeth Putnam|734-763-2435|eread@umich.edu|
21278916|NCT04933968|AlloVir, Inc.|Senior Vice President|+1 617-433-2605|rriese@allovir.com|
21278917|NCT01724489|Massachusetts General Hospital|Dr. Karen K. Miller|617-726-3870|kkmiller@mgh.harvard.edu|
21278918|NCT05119348|Desmond Tutu Health Foundation|Dr. Philip Smith|+27216501895|Philip.Smith@hiv-research.org.za|
21278919|NCT01664130|Case Comprehensive Cancer Center|Kevin Stephans MD|216-445-8285|stephak@ccf.org|
21278920|NCT03323437|Weill Cornell Medicine|Dr. Dikoma C. Shungu|212-746-2481|dcs7001@med.cornell.edu|
21278921|NCT00843479|Laboratory of Investigation on Metabolism and Diabetes - LIMED / State University of Campinas - Brazil|Dr. Bruno Geloneze|+55 19 35218589|bgeloneze@terra.com.br|
21278922|NCT01473524|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
21278923|NCT01544179|AstraZeneca|Haiyi Jiang/Asia Medical Director|+86 21 60302408|haiyi.jiang@astrazeneca.com|
21278924|NCT02045147|University of Nebraska Medical Center|Lani Zimmerman|402-472-3847|lzimmerm@unmc.edu|
21278925|NCT04839692|Massachusetts General Hospital|Dr. Dieter Manstein|617-726-4893|dmanstein@mgh.harvard.edu|
21278926|NCT01386983|GlaxoSmithKline|GSK Response Center|866-435-7343||
21278927|NCT03146962|Weill Cornell Medicine|Dr. Manish Shah, Sponsor-Investigator|646-962-6200|mas9313@med.cornell.edu|
21278928|NCT00049530|ECOG Statistical Office|Study Statistician|617-632-3012||
21278929|NCT04314648|RAND|Dr. Allison Ober|3103930411|ober@rand.org|6639
21278930|NCT00492024|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21278931|NCT03247816|Shield TX (UK) Limited|Jackie Mitchell MA DPhil|+44 (0) 191 511 8515|jmitchell@shieldtx.com|
21278932|NCT03416829|Massachusetts General Hospital|Jarrad H Van Stan|617-643-8410|jvanstan@mghihp.edu|
21278933|NCT01837524|Kaiser Center for Clinical and Outcomes Research|Kristina Lewis|404-364-7150|khlewis@wakehealth.edu|
21278934|NCT02861014|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21278935|NCT00926783|Biosense Webster EMEA|Ellen Harris, Sr. Clinical Research Associate, Clinical Operations|(800) 729-9010|eharris@its.jnj.com|
21278936|NCT02351271|Ziemer Ophthalmic Systems AG|Sarah Moyle|970 308 9199|sarah.moyle@ziemergroup.com|
21278937|NCT00696787|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21278938|NCT02704403|GENFIT|Carol Addy, MD MMSc|+01 6179536469|clinicaltrial@genfit.com|
21278939|NCT03857750|Rigshospitalet|Dr. Matias Vested|+4524464955|matiasvested@gmail.com|
21232218|NCT00799487|Ortho-McNeil Janssen Scientific Affairs, LLC|VP Medical Affairs, CNS|609-730-2136||
21278940|NCT01377987|Brigham and Women's Hospital|Dr. Scott Sands|617 278 0911|sasands@bwh.harvard.edu|
21278941|NCT00469144|University of Texas (UT) MD Anderson Cancer Center|Richard E. Champlin, MD/Chair, Stem Cell Transplantation|713-792-3618|rchampli@mdanderson.org|
21278942|NCT01994291|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21278943|NCT01775189|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21278944|NCT00451048|Princess Margaret Hospital|Dr. Karen Yee|416-946-4495|karen.yee2@uhn.on.ca|
21232219|NCT00232817|Columbia University|Dr. Pamela Flood|201-370-3933|pamelaflood181@gmail.com|
21232220|NCT01484873|Vanderbilt University|Ashley Shoemaker|615-343-8116|ashley.h.shoemaker@vanderbilt.edu|
21232221|NCT01549392|London Health Sciences Hospital|Barbara Fisher|519-685-8650|barbara.fisher@lhsc.on.ca|
21232222|NCT00227903|Yale University|Dr. Kimberly Yonkers|1-203-764-6621|Kimberly.Yonkers@yale.edu|
21232223|NCT04273217|AbViro LLC|Urban Ramstedt|617-818-8112|urban.ramstedt@abviro.com|
21232224|NCT01843751|University of Wisconsin|Randall Brown|608-263-6558|rtbrown@wisc.edu|
21232225|NCT04309656|TB Alliance|Erica Egizi|917-696-4984|erica.egizi@tballiance.org|
21232226|NCT03720470|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21232227|NCT00460031|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@ccf.org|
21232228|NCT04532099|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21232229|NCT01194479|Department of Internal Medicine and Endocrinology, Yale University School of Medicine, New Haven, CT|Robert Sherwin, MD|(203) 785-3482|robert.sherwin@yale.edu|
21232230|NCT05492942|Boston Medical Center, Internal Medicine|Emily Hurstak, MD MPH|(617) 414 5951|emily.hurstak@bmc.org|
21232231|NCT01907815|The University of Texas MD Anderson Cancer Center|Nitin Jain, MD, Assistant Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
21232232|NCT02663232|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21232233|NCT00759811|Instituto de Cardiologia do Rio Grande do Sul|Daniel Medeiros Moreira, MD. MSc.|55 (51) 3219-2802|danielmedeirosmoreira@gmail.com|
21232234|NCT01712490|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21232235|NCT02423876|University of Wisconsin Carbone Cancer Center|Cancer Connect|800-622-8922|clinicaltrials@cancer.wisc.edu|
21232236|NCT03748758|Novus Therapeutics|Clinical Director|949-679-1110|study002@novustherapeutics.com|
21232237|NCT02056340|Beth Israel Deaconess Medical Center|Dr Maureeen Chase, Assistant professor of Emergency Medicine|6177542298|mchase1@bidmc.harvard.edu|
21232238|NCT01782495|AbbVie|Global Medical Services|800-633-9110||
21278945|NCT02227446|METRC|Susan Collins|4105028966|scolli21@jhu.edu|
21232239|NCT01973166|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
21232240|NCT02848651|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21232241|NCT00667004|Bausch Health|Study Director||susan.harris@bauschhealth.com|
21232242|NCT03194698|Mayo Clinic|Joanne F. Shen, M.D.|480-301-8085|Shen.Joanne@mayo.edu|
21232243|NCT02480114|Vanderbilt University Medical Center|Derek Smith, DDS, PhD|6159367423|derek.k.smith@vumc.org|
21232244|NCT01535053|NRG Oncology|Linda Gedeon for Virginia Filiaci, PhD.|716-845-1169|lgedeon@gogstats.org|
21232245|NCT01031069|GlaxoSmithKline|GSK Response Center|866-435-7343||
21232246|NCT00512707|Brigham and Women's Hospital|Dr. Shalender Bhasin|617-525-9150|sbhasin@partners.org|
21232247|NCT01317160|Karolinska university Hospital|Dr. Paul W. Ackermann|+46851770000|paul.ackermann@karolinska.se|
21232248|NCT05286281|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21232249|NCT04405037|Cleveland Clinic Foundation|Dr. Scott Steele|216-444-4715|steeles3@ccf.org|
21232250|NCT01705288|Masonic Cancer Center at University of Minnesota|Dr. Peter Argenta|612-626-6283|argenta@umn.edu|
21232251|NCT02835274|Boston Scientific|Director of Clinical Sciences|6619494350|roshini.jain@bsci.com|
21232252|NCT01182493|CHU Caen|Prof. Yves Reznik|+33231064585|reznik-y@chu-caen.fr|
21232253|NCT01853826|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21232254|NCT03653637|James J. Peters VA Medical Center|Dr. Marianne Goodman|6462457071|mggoodman2001@yahoo.com|
21232255|NCT05661942|Advocate Health|Michael Cirone, MD|7086841710|michael.cirone@aah.org|
21232256|NCT04202354|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|1 (626) 304-3400|info@arrowheadpharma.com|
21232257|NCT01287897|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21232258|NCT02902965|Pharmacyclics Switzerland GmbH|Dr. Bernhard Hauns, Medical Monitor|+41 52 556 0800|bhauns@pcyc.com|
21232259|NCT03263442|University of North Carolina - Chapel Hill|Zev Nakamura|984-974-3829|zev_nakamura@med.unc.edu|
21232260|NCT02436889|University of California, San Francisco|Alison Huang, MD|415-514-8697|alison.huang@ucsf.edu|
21232261|NCT01084174|Johns Hopkins University|Robert A. Wood, MD|410-955-5883|rwood@jhmi.edu|
21232262|NCT00708643|Vistakon|Kurt Moody, O.D. FAOO|904-443-3088||
21232263|NCT00176826|University of Minnesota|Dr. Angela Smith|612-626-2778|smith719@umn.edu|
21278946|NCT02121392|University of Chicago Medical Center|Dr. Hue Luu|773-702-6937|hluu@bsd.uchicago.edu|
21232264|NCT01946425|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21232265|NCT02451839|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21232266|NCT04585022|Copenhagen University Hospital Hvidovre, Orthopaedic Department|MD Peter Nyby Hersnaes|+45 40104845|pnhersnaes@gmail.com|
21232267|NCT05682326|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21278947|NCT01352416|William Beaumont Hospital|Ilana Kutinsky, DO|248-267-5050|ikutinsky@beaumont.edu|
21278948|NCT00819637|Henry Ford Health System, Detroit, Michigan|Richard M Nowak MD|313 881 0023|rnowak1@hfhs.staff|
21278949|NCT01054404|Northwestern University|Dr. John F. Bebawy, Assistant Professor of Anesthesiology & Neurological Surgery|312-695-0061|j-bebawy@northwestern.edu|
21278950|NCT02876757|ICES Western|Blayne Welk|5196466000|blayne.welk@sjhc.london.on.ca|
21232268|NCT03414424|Bronx VA Medical Center|Noam Y. Harel|718-584-9000|Noam.harel@va.gov|1742
21232269|NCT00877877|GlaxoSmithKline|GSK Response Center|866-435-7343||
21278951|NCT00961402|University of Minnesota|Beth Lewis|612-625-0756|blewis@umn.edu|
21278952|NCT03016975|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
21278953|NCT02901548|Moffitt Cancer Center|Jingsong Zhang, MD, PhD|813-745-6926|Jingsong.Zhang@moffitt.org|
21232270|NCT02734238|Pennington Biomedical Research Center|Jennifer C. Rood|225-763-2524|jennifer.rood@pbrc.edu|
21239393|NCT01449240|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21239394|NCT00708526|University of Utah|Dwayne Westenskow, PhD|801-581-2478|Dwayne.Westenskow@hsc.utah.edu|
21290191|NCT02489045|Thomas Jefferson University|Flemming Forsberg, PhD|215-955-4870|flemming.forsberg@jefferson.edu|
21290192|NCT02970812|Family Medicine Clinic, Pusan National University Yangsan Hospital|Sang Yeoup Lee|3601442|saylee@pnu.edu|55
21290193|NCT05181657|University of California, San Diego|Dr. Steffanie Strathdee|858-822-1952|sstrathdee@health.ucsd.edu|
21290194|NCT00066937|Johns Hopkins University|Jennifer Haythornthwaite|410-550-7985|jhaytho1@jhmi.edu|
21290195|NCT01108055|Stanford University|Sandy Srinivas, MD|650 498 6000|sandysri@stanford.edu|
21290196|NCT03339453|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21290197|NCT00063232|National Institute of Diabetes and Digestive and Kidney Diseases|Jay Hoofnagle, M.D.|3014961333|hoofnaglej@extra.niddk.nih.gov|
21290198|NCT02903381|Dana-Farber Cancer Institute|Dr. Irene Ghobrial|617-632-4198|irene_ghobrial@dfci.harvard.edu|
21290199|NCT04002557|Imperial College London|Ms Ann-Eneli Allas|07508775892|anastassija@hotmail.com|
21239395|NCT00768430|Baylor College of Medicine|Dr. Sanjay Mathew|7137911414|sjmathew@bcm.edu|5439
21239396|NCT01478113|Massachusetts General Hospital|Maren Nyer|617-643-4897|mnyer@partners.org|
21239397|NCT02949921|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
21239398|NCT01703702|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
21239399|NCT03355755|Ekso Bionics|Leslie Van Hiel|4042268017|leslie.vanhiel@gmail.com|
21239400|NCT03585296|Aclaris Therapeutics|Executive Director Clinical Operations|4843242144|jschnyder@aclaristx.com|
21239401|NCT00041756|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com|
21239402|NCT03980184|Yale University|Rajita Sinha, PhD, Study PI|203-737-5805|rajita.sinha@yale.edu|
21239403|NCT02002884|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
21239404|NCT01662531|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
21239405|NCT02341456|AstraZeneca|Lone Ottesen|1-877-240-9479|ClinicalTrialTransparency@astrazeneca.com|
21239406|NCT00509002|The University of Texas (UT) MD Anderson Cancer Center|George R Blumenschein Jr, MD, Professor, Thoracic/Head & Neck Med. Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
21239407|NCT00247624|August Health University|Vaughn McCall|706-721-3141|wmccall@augusta.edu|
21239408|NCT01111838|Memorial Sloan Kettering Cancer Center|Dr. Andrea Cercek|646-888-4189|CercekA@mskcc.org|
21239409|NCT02294630|Wayne State University|Beena G. Sood, MD, MS|313-745-5638|bsood@med.wayne.edu|
21239410|NCT02567825|UPMC Children's Hospital of Pittsburgh|Alejandro Hoberman, MD|412-999-3277|hobermana@upmc.edu|
21239411|NCT02444663|University of Oxford|Thomas Hamilton, Clinical Research Fellow|01865227696|thomas.hamilton@ndorms.ox.ac.uk|
21239412|NCT03195465|Loma Linda University School of Allied Health Professions|Amy Sadek, PhD Rehabilitation Science|951-212-2104|asadek@llu.edu|
21239413|NCT03921190|University of Jordan|Dr. Ahmad El-Ma'aita|+9625355000|a.maaita@ju.edu.jo|
21239414|NCT05061537|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21239415|NCT00553098|Fred Hutch Cancer Research|Dr. Lauri Burroughs|206-667-2396|lburroug@fredhutch.org|
21239416|NCT01767935|Wake Forest University Health Sciences|Dr. David Childs|336-716-2471|dchilds@wakehealth.edu|
21239417|NCT02247804|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21239418|NCT01834222|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|001-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21239419|NCT01054573|Janssen Research & Development, LLC|Medical Leader|1 609 730-3174||
21239420|NCT03812536|Ohio State University|Dr. Syed Husain|6142938772|syed.husain@osumc.edu|
21239421|NCT00152009|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21239422|NCT01306201|Covidien|Ulf Borg, Director of Clinical Affairs|303-305-2400|ulf.borg@covidien.com|
21239423|NCT00393523|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21239424|NCT02207439|University of Pennsylvania|Alexander Lin, MD|215-662-3198|alexander.lin2@pennmedicine.upenn.edu|
21239425|NCT03148236|Virginia Commonwealth University|Cory Trankle, MD|804-213-2679|cory.trankle@vcuhealth.org|
21239426|NCT03452176|Massachusetts General Hospital|Dr. Michael Levy|617-726-0412|mlevy11@mgh.harvard.edu|
21239427|NCT04145037|AVROBIO, Inc|AVROBIO MedInfo|617-914-8419|medinfo@avrobio.com|
21239428|NCT01756560|University of Chicago|TARIQ MALIK|773-8342643|tmalik@dacc.uchicago.edu|
21239429|NCT02235701|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
21239430|NCT00525265|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7314||
21239431|NCT01916941|University of New Mexico|Dr. Claire Wilcox|505-272-2333|cewilcox@salud.unm.edu|
21239432|NCT00098254|National Cancer Institute|Giuseppe Giaccone, M.D., PH.D.|301-496-4916|giacconeg@mail.nih.gov|
21239433|NCT00744263|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21239434|NCT03500640|University of Pittsburgh School of Medicine|Elizabeth M. Venditti PhD, Associate Professor of Psychiatry and Epidemiology|4123025228|vendittiem@upmc.edu|
21239435|NCT03557086|Massachusetts General Hospital|Dr. Nneka Ufere|617-643-3408|nneka.ufere@mgh.harvard.edu|
21239436|NCT03245255|Thomas Jefferson University|Jaydev Dave|2158684795|dave.jaydev@mayo.edu|
21239437|NCT01087996|The EMMES Corporation|Adam Mendizabal|301 251 1161|amendizabal@emmes.com|221
21239438|NCT00661661|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21239439|NCT04512066|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21239440|NCT00971750|Gundersen Lutheran Health System|Dr. Shanu Kothari|608-775-2331|snkothar@gundluth.org|
21239441|NCT01657266|Laboratorios Sophia S.A. de C.V.|Leopoldo M Baiza-Duran MD, Clinical trials Director|52+ (33) 30 01 42 00|leopoldo.baiza@sophia.com.mx|
21239442|NCT01316770|NIDCR/NIH|Ilias Alevizos|3014966207|alevizosi@mail.nih.gov|
21239443|NCT01353222|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@dendreon.com|
21239444|NCT02260401|University of Washington|Dr. Janna Friedly|206-744-3000|friedlyj@uw.edu|
21239445|NCT03474549|Rapid-Medical|Dr. Walid Haddad- Chief Clinical Officer|+972 72 2503331|walid@rapid-medical.com|
21239446|NCT01861522|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21239447|NCT00834808|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
21239448|NCT03573908|Ironwood Pharmaceuticals, Inc.|Vanessa Chong|(617) 374-3923|vchong@ironwoodpharma.com|
21278954|NCT02348723|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21239449|NCT04006925|Stanford University|Emmanuel During|212-844-8888|Emmanuel.During@mountsinai.org|
21239450|NCT00583622|The University of Texas MD Anderson Cancer|Yago Nieto, MD, PhD / Professor||celsaenz@mdanderson.org|
21239451|NCT01755143|Medtronic Cardiac Rhythm and Heart Failure|5076MRI Clinical Team|1-800-328-2518|MedtronicCRMtrials@medtronic.com|
21278955|NCT01404832|Dallas VAMC|Stuart Spechler|214-374-7799|sjspechler@aol.com|
21239452|NCT04466215|The Scripps Research Institute|Dr. Barbara J.. Mason, Ph.D.|(858) 784-7324|mason@scripps.edu|
21232271|NCT02935088|Abbott Vascular|Tarn Teraphongphom, Sr. Clinical Scientist|408-9310504|tarn.teraphongphom@abbott.com|
21232272|NCT01506479|University of Pittsburgh|Dr. Charity G. Moore|412-383-6630|cgp22@pitt.edu|
21232273|NCT01846507|Nationwide Children's Hospital|Sarah O'Brien, MD|614-722-3070|sarah.obrien@nationwidechildrens.org|
21232274|NCT01314443|Ohio State University|Richard Bruno, PhD, RD|614-292-5522|bruno.27@osu.edu|
21232275|NCT01980914|Gerontology Research Unit|Boris Feldman|6048755115|boris.feldman@vch.ca|
21232276|NCT04545866|University of Alabama at Birmingham|Namasivayam Ambalavanan MD|2059344680|nambalav@uabmc.edu|
21232277|NCT05247866|Children's Hospital of Philadelphia|Jonathan Spergel|2155902549|spergel@chop.edu|
21232278|NCT02311933|Alliance for Clinical Trials in Oncology|Matthew P. Goetz, MD|: 507-284-2511|goetz.matthew@mayo.edu|
21232279|NCT04994522|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21232280|NCT04463719|University of Florida|Naykky Singh Ospina|(352) 273-8655|naykky.singhospina@medicine.ufl.edu|
21232281|NCT04577118|iotaMotion, Inc|Laura Chenier|442-325-4171|lchenier@iotamotion.com|
21232282|NCT00810407|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21232283|NCT02746874|Northwestern University|David Walega, MD|312-695-0061|d-walega@northwestern.edu|
21232284|NCT00487747|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21261094|NCT01097044|Clinuvel Pharmaceuticals Limited|Dr. Dennis Wright, Acting Chief Scientific Officer|646 527 7310|Dennis.Wright@clinuvel.com|
21232285|NCT00276159|Masonic Cancer Center, University of Minnesota|Sarah Cooley, MD|612-625-8474|cool0023@umn.edu|
21232286|NCT04356690|Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center|John Mark Sloan, MD|617-638-7002|mark.sloan@bmc.org|
21232287|NCT01359449|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21232288|NCT00456547|Northwestern University Feinberg School of Medicine|Dr. Robert J McCarthy, Pharm D|312-926-9015|r-mccarthy@northwestern.edu|
21232289|NCT00330564|UT MD Anderson Cancer Center|Quality Assurance Specialist|713-563-1602|caperez@mdanderson.org|
21232290|NCT02536196|Keystone Heart|Pauliina Margolis - CMO|813.530.8200|pauliina.margolis@keystoneheart.com|
21232291|NCT02979522|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21261095|NCT01212445|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21232292|NCT01485770|Jazz Pharmaceuticals|Director, Disclosure & Transparency|(215) 970-7145|ClinicalTrialDisclosure@JazzPharma.com|
21232293|NCT02485574|Chung-Ang University hospital|Kwang-Sup Song|+82-1037616503|ksong70@cau.ac.kr|
21261096|NCT04865731|University of Texas Health Science Center at San Antonio|Dr. Shraddha Dalwadi|210-567-1203|dalwadi@uthscsa.edu|
21290200|NCT02278237|University of Chicago|Valerie G. Press, MD, MPH|773-702-5170|vpress@medicine.bsd.uchicago.edu|
21290201|NCT00236197|Eisai Medical Research Inc.|Yufang Lu, MD, PhD, Study Director|201-403-2500||
21290202|NCT01300065|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
21232294|NCT01408914|Harvard Medical School|Carole Mitnick|617-432-6018|Carole_Mitnick@hms.harvard.edu|
21232295|NCT01958320|University of California San Francisco|Ronald Clyman, MD PI|415-443-9305|clymanr@peds.ucsf.edu|
21232296|NCT00191789|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21232297|NCT05582889|University of New Mexico|Dr. Cindy Blair|5059257907|CiBlair@salud.unm.edu|
21232298|NCT06112756|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21232299|NCT04551092|Quantum Applied Science & Research, QUASAR Inc.|Gayle Guy|858 412 1839|gayle@quasarusa.com|
21232300|NCT01966900|Imperial College London|Dr Tom Cole|+44(0)2033136198|t.cole@imperial.ac.uk|
21232301|NCT03060629|Janssen Vaccines & Prevention B.V|CLINICAL FRANCHISE LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21232302|NCT05740644|Zynex Monitoring Solutions|Clinical Team|888-386-4185|clinical@zynexmonitoring.com|
21232303|NCT02032810|H. Lee Moffitt Cancer Center and Research Institute|Dr. Nikhil I. Khushalani|813-745-3437|nikhil.khushalani@moffitt.org|
21232304|NCT03498300|Faculty of Medicine Siriraj Hospital, Mahidol University|Dr. Nalat Sompagdee|+6687-008-7100|pear_nalat@hotmail.com|
21232305|NCT00867009|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21232306|NCT03266094|Medtronic|Melody LaBeau, Director of Clinical Operations|763.526.2931|melody.a.labeau@medtronic.com|
21232307|NCT00147199|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
21232308|NCT01563003|University of South Florida|Eric Storch, Ph.D.|727-767-8230|estorch@health.usf.edu|
21232309|NCT03057431|Inselspital, Bern University Hospital, Bern, Switzerland|Prof. Daniel Fuster|++41316323144|daniel.fuster@insel.ch|
21290203|NCT03760666|Clear Creek Bio, Inc.|Vice President, Clinical Operations|(617) 765-2252|clinical@clearcreekbio.com|
21232310|NCT04140292|Cleveland Clinic Foundation|Maytin, Edward, V|1-866-223-8100|taussigresearch@ccf.org|
21232311|NCT00396591|sanofi-aventis|Trial Transparency Team||Contact-Us@sanofi.com|
21232312|NCT00848367|Ottawa Hospital Research Institute|Dr. Giorgio Tasca|1-613-737-8085|gtasca@toh.on.ca|
21290204|NCT02129556|International Breast Cancer Study Group (IBCSG)|Heidi Roschitzki-Voser|+41 31 511 94 18|heidi.roschitzki@ibcsg.org|
21278956|NCT01671332|University of Wisconsin|Anne Traynor|608-262-5092|amt@medicine.wisc.edu|
21278957|NCT00635232|Ligand Pharmaceuticals|Director of Project Management|858-550-7892|hzientek@ligand.com|
21278958|NCT04572893|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
21278959|NCT00612430|Duke University Medical Center|David Reardon, MD|919-668-2329|David_Reardon@DFCI.harvard.edu|
21278960|NCT02269163|Prometic Biotherapeutics Inc|Director, External Biologics|438-802-3497|clinical@prometic.com|
21278961|NCT01208220|LSUShreveport|Dr. Stanley McCallon|318-813-2996|smccal@lsushc.edu|
21232313|NCT04049123|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@llilly.com|
21232314|NCT03036072|Maine Medical Center|Alexa Craig, MD|207-396-6920|craiga@mmc.org|
21232315|NCT00680043|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
21232316|NCT02484729|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
21232317|NCT00662363|Rehabilitation Institute of Chicago|Christina Marciniak|312-238-1000|cmarciniak@ric.org|
21232318|NCT05119569|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21232319|NCT03334903|Brigham and Women's Hospital|Dr. Wolfgang Fitz|6177325500|wfitz@bwh.harvard.edu|
21232320|NCT02960776|Columbia University Irving Medical Center|Marie-Pierre St-Onge|212-305-9379|ms2554@cumc.columbia.edu|
21232321|NCT02081690|Actelion Pharmaeuticals Ltd.|Clinical Trial Disclosure Manager||clinical-trials-disclosure@actelion.com|
21232322|NCT01711177|Université de Montreal|Pierre Forcier|514-343-7468|pierre.forcier@umontreal.ca|
21232323|NCT01463878|Eastern Virginia Medical School|Dr Paul Marik|757-446-8910|marikpe@evms.edu|
21232324|NCT01034462|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
21232325|NCT01594125|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21232326|NCT05584176|MP Biomedicals|Dana Hummel|8008540530|Dana.Hummel@mpbio.com|7019
21232327|NCT01475331|Milton S. Hershey Medical Center|Dr. Matthew T. Moyer|717-531-3694|mmoyer@pennstatehealth.psu.edu|
21232328|NCT00462761|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21232329|NCT02877082|Emory University/Winship Cancer Institute|Zaid Al-Kadhimi, MD|404-778-1900|zalkadh@emory.edu|
21232330|NCT01949051|GlaxoSmithKline|GSK Response Center|866-435-7343||
21232331|NCT01782859|Hospital for Special Surgery|Kethy Jules-Elysee, MD|2126061206|juleselyseek@hss.edu|
21232332|NCT02436356|Vanderbilt University Medical Center|Jeffry S. Nyman, Ph.D.|615-936-6296|jeffry.s.nyman@vumc.org|
21232333|NCT04483011|Bioenergy Life Science, Inc.|Alex Xue, Chief Technology Officer|763-746-0032|alex.xue@bioenergyls.com|3924
21232334|NCT01660698|Clinical Development Unit / Metabolic Unit|Dr Maurice Beaumont, Principal Investigator|+41217858054|maurice.beaumont@rdls.nestle.com|
21232335|NCT00429104|University of Texas MD Anderson Cancer Center|Naoto Ueno, MD.PhD./Professor|713-792-8754|CR_Study_Registration@mdanderson.org|
21232336|NCT02493621|MUSC|Sylvia Wilson|8437922322|wilsosh@musc.edu|
21232337|NCT01896531|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21232338|NCT02956486|Eisai Ltd.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
21232339|NCT00680745|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
21232340|NCT02151253|Duke University Health System|Andrew D. Krystal, MD, MS|919-971-4355|andrew.krystal@duke.edu|
21232341|NCT01214811|Molnlycke Health Care|Viktoria Ahlenius Körner|0046 31 7223000|viktoria.ahleniuskorner@molnlycke.com|
21232342|NCT00446290|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
21232343|NCT04851314|UC Irvine Health|Dr. Robert Ryan Field|7145065703|fieldr@uci.edu|
21232344|NCT03171415|Raziel Therapeutics|Racheli Gueta - Clinical Trials Manager|972-8-9126941|racheli@raziel-therapy.com|
21232345|NCT01339429|Brigham and Women's Hospital|Dr. Gita Mody|617-921-8221|gmody@partners.org|
21232346|NCT01085591|Cubist Pharmaceuticals, Inc.|Vice President, Clinical Research|1.781.860.8660||
21232347|NCT03457129|University of Arizona, College of Medicine Phoenix|Stephanie Marsh, MPH, CCRC|602-255-7552|slmarsh@arizona.edu|
21232348|NCT00459667|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21232349|NCT01013701|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
21232350|NCT03241342|Oncternal|Mary Breitmeyer|858-434-1113|MBreitmeyer@oncternal.com|
21232351|NCT01267812|City of Hope|Dr. Matthew Mei|626-359-8111|mamei@coh.org|
21232352|NCT00556712|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21232353|NCT01537029|TTUHSC|Ronald Hall|2143589009|ronald.hall@ttuhsc.edu|
21232354|NCT00849810|University of Mississippi Medical Center|Professor of Medicine|601-984-5600|DMinor@umc.edu|
21232355|NCT01846611|Janssen Research & Development, LLC|Senior Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21232356|NCT00541034|Memorial Sloan Kettering Cancer Center|Dr. Renier Brentjens|1212-639-7053|brentjer@mskcc.org|
21232357|NCT01988857|GlaxoSmithKline|GSK Response Center|866-435-7343||
21232358|NCT00847704|Oregon Health & Science University|Paul J. Cordo|503-418-2520|cordop@ohsu.edu|
21290205|NCT01800058|Hospital Universitario de La Princesa|Almudena Zapatero, MD PhD|+34 91 520 23 15|almudena.zapatero@salud.madrid.org|
21232359|NCT01962207|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21232360|NCT02289079|University of MInnesota|Dr. Jacob Hutchins|6126249990|hutc0079@umn.edu|
21232361|NCT02671422|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21232362|NCT02111850|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|sar@mail.nih.gov|
21232363|NCT03061331|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21232364|NCT02625259|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21232365|NCT01980875|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21232366|NCT00513474|Massachusetts General Hospital|Bimalangshu R. Dey, MD, PhD||bdey@mgh.harvard.edu|
21232367|NCT00195676|Abbott|Global Medical Services|800-633-9110||
21239453|NCT00738101|Baylor College of Medicine|Dr. Muralidhar H Premkumar|8328267980|premkuma@bcm.edu|
21239454|NCT00926003|Michigan State University|Dr. Michael J. Boivin|5174324204|Michael.Boivin@hc.msu.edu|
21239455|NCT01396317|Hospital for Special Surgery|Dr. Robert Spiera|212-774-2048|spierar@hss.edu|
21239456|NCT01620567|Tufts University|Elizabeth J. Johnson, PhD|617.556.3204|elizabeth.johnson@tufts.edu|
21239457|NCT00524030|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21239458|NCT03315130|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
21239459|NCT04398537|University of Alabama at Birmingham|Stefanie Woodard|205-996-4132|swoodard@uabmc.edu|
21239460|NCT03535337|Florida State University|Sylvie Naar, PhD; Distinguished Endowed Professor|18506442334|sylvie.naar@med.fsu.edu|
21239461|NCT00186498|Stanford University|Dr. Hugh Brent Solvason|650 776 4793|solvason@stanford.edu|
21239462|NCT00386308|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21239463|NCT03518658|CRHF Clinical|Keith Holloman|763-526-1545|keith.holloman@medtronic.com|
21239464|NCT00649389|Daiichi Sankyo|Howard Kessler|732-590-5032|hmkessler@dsi.com|
21239465|NCT04662671|EmitBio, Inc.|Chief Scientific Officer|(919) 321-1734|nstasko@emitbio.com|
21239466|NCT02746575|Washington University|Principal Investigator|7737022544||
21239467|NCT00976482|ospedale S Orsola- Malpighi, Bologna, Italy|dr Mauro Biffi|+393337661449|mauro.biffi@aosp.bo.it|
21239468|NCT02959671|University of Minnesota|Thorsten Gruenheid, DDS, PhD|612-625-3903|tgruenhe@umn.edu|
21239469|NCT03366220|The University of Texas Health Science Center at Houston|Dr. Lillian S Kao|(713) 500-6280|Lillian.S.Kao@uth.tmc.edu|
21239470|NCT02608489|Soonchunhyang University Hospital|Dr. JinKwon Chung|82-2-709-9354|schcornea@schmc.ac.kr|
21239471|NCT00708721|Huntsman Cancer Institute|Dr. Paul Shami|801-585-0100|paul.shami@hci.utah.edu|
21239472|NCT02341287|Weill Cornell Medicine|Matthew R. Ebben, Ph.D.|646-962-9313|mae2001@med.cornell.edu|
21239473|NCT02254408|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21239474|NCT00917267|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21239475|NCT03728153|Massachusetts General Hospital|Farrah Mateen|16177248653|fmateen@mgh.harvard.edu|
21239476|NCT00252590|VA San Diego Healthcare/University of California, San Diego|Dr. Susan Tate|619-426-9402|srtate@ucsd.edu|
21239477|NCT00802659|Washington University School of Medicine|Jeffrey Bradley, M.D.|314-362-8525|jbradley@radonc.wustl.edu|
21239478|NCT00289770|GlaxoSmithKline|GSK Response Center|866-435-7343||
21239479|NCT00423293|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
21239480|NCT00674115|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21278962|NCT00469911|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-0183|groplerr@mir.wustl.edu|
21278963|NCT02062294|Hoffmann-LaRoche|Clinical Operations Department|800-821-8590|switzerland.clinical-research@roche.com|
21232368|NCT01189812|Columbia Northwest Pharmaceuticals|Director of Clinical Operations|425.453.0404|jhobus@nwcrc.net|
21239481|NCT04042285|Hull University Teaching Hospitals NHS Trust|Louise Hitchman|01482 311925|l.hitchman@nhs.net|
21239482|NCT00067990|University_of_Minnesota|Hassan N. Ibrahim, MD|(612) 624-9444|ibrah007@umn.edu|
21232369|NCT01905657|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21239483|NCT01200030|The Hong Kong Polytechnic University|Dr. Shamay Ng|(852) 2766-4889|Shamay.Ng@polyu.edu.hk|
21239484|NCT01749501|William Beaumont Hospital|Dr. Martin Espinosa|248-898-0633|Martin.espinosa@beaumont.edu|
21261097|NCT02656472|Advocate Children's Hospital|Andrew VanBergen|7086848758|andrew.vanbergen@advocatehealth.com|
21261098|NCT00875420|Radius Health, Inc.|Program Director|(617) 551-4700|info@radiuspharm.com|
21261099|NCT00914628|AGC Biologics S.p.A|Anna Stornaiuolo|00390221277440|astornaiuolo@agcbio.com|
21261100|NCT03716726|Boston Medical Center|Patricia Kavanagh, MD|617-414-3573|Patricia.Kavanagh@bmc.org|
21261101|NCT02579603|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21261102|NCT00942162|GlaxoSmithKline|GSK Response Center|866-435-7343||
21261103|NCT02833311|Case Western Reserve University|Matthew Plow, Ph.D.|216-368-8969|map208@case.edu|
21261104|NCT01006356|Medical department / Korea|Medical Director|+82-2-2094-4518||
21261105|NCT01670201|Harborview Medical Center / Seattle, Washington|Dr Nicole Gibran|206-744-3140|nicoleg@uw.edu|
21261106|NCT02189382|Procter and Gamble|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
21261107|NCT01756157|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21261108|NCT01623466|Agile Therapeutics|Lisa Flood|609-683-1880|lflood@agiletherapeutics.com|
21261109|NCT02799381|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21261110|NCT02698410|Ipsen|Ipsen Medical Director|see email|clinical.trials@ipsen.com|
21261111|NCT03952130|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21261112|NCT01713348|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993863164|joe.bugler@abbott.com|
21261113|NCT02638012|St. Michael's Hospital|Dr. John Lee|416-864-5306|John.Lee@unityhealth.to|
21232370|NCT02123745|ivWatch, LLC|Garret T. Bonnema|1.855.489.2824|garret.bonnema@ivwatch.com|7018
21232371|NCT04080297|Chief Exceutive Officer|Rob Crombie|+61 3 9657 0731|rcrombie@queoncology.com|
21232372|NCT02059057|Boston Scientific|Kristi Winterfeldt|+1 763-494-1165|kristi.winterfeldt@bsci.com|
21232373|NCT05838742|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21232374|NCT06092710|CAndreRenard|CEDRIC GARCION|+33661817274|cedric.garcion.osteo@gmail.com|
21232375|NCT03909178|Massachusetts General Hospital|Dr. Scott Martin|(617) 726-7500|sdmartin@partners.org|
21232376|NCT02623439|University of California, San Diego|Michelle Padilla|(858) 822-5354|CancerCTO@health.ucsd.edu|
21232377|NCT01754623|Florida Hospital Orlando (Formerly at Moffitt Cancer Center)|Ravi Shridhar, M.D., Ph.D.|407-303-5857|ravi.shridhar.md@flhosp.org|
21232378|NCT01880840|Meda Pharmaceutical|Dr.Nancy Ruiz Chief Medical Officer|732 564 2200|nancy.ruiz@meda.us|2390
21232379|NCT02200445|Brigham and Women's Hospital|Dr. Jessica Allegretti|617-732-5500|jallegretti@bwh.harvard.edu|
21232380|NCT04484142|Daiichi Sanyko, Inc|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21232381|NCT03700671|University of Central Lancashire|Stefan Birkett Lecturer in Exercise Science|01772 893325|sbirkett4@uclan.ac.uk|
21232382|NCT05371509|Mayo Clinic|Umesh Goswami, M.B.B.S., M.D.|480-342-1137|goswami.umesh@mayo.edu|
21232383|NCT01083368|Case Comprehensive Cancer Center|Jorge Garcia MD|216-444-7774|garciaj4@ccf.org|
21232384|NCT06253806|Washington University, Department of Otolaryngology - Head and Neck Surgery|Nyssa Farrell, MD|314-273-2490|nyssafarrell@wustl.edu|
21232385|NCT03851302|Bronx Veterans Medical Research Foundation|Principal Investigator|718-584-9000 x1742|NOAM.HAREL@VA.GOV|
21232386|NCT03578367|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
21232387|NCT00587561|VA Connecticut Healthcare System|Dr. Joanna Fiszdon|2039325711|joanna.fiszdon@va.gov|2231
21232388|NCT00982488|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21232389|NCT04244786|New York State Psychiatric Institute|Jeffrey Miller|646-774-7613|jeffrey.miller@nyspi.columbia.edu|
21232390|NCT01199289|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21232391|NCT02635828|The Ohio State Universtiy Wexner Medical Center|Director of Neuroanesthesia|6142933559|sergio.bergese@osumc.edu|
21232392|NCT00415909|University of Texas MD Anderson Cancer Center|Jorge Cortes, MD / Professor, Leukemia|713-794-5783|CR_Study_Registration@mdanderson.org|
21232393|NCT02734810|Anthera Pharmaceuticals|Monica Gangal|510-856-5600|info@anthera.com|
21232394|NCT00528398|City of Hope National Medical Center|Anthony Stein, M.D.|626-256-4673|AStein@coh.org|82405
21232395|NCT02507505|University of Pennsylvania Perelman School of Medicine|Mark D. Neuman, MD, MSc (Principal Investigator)|215-746-7468|mark.neuman@uphs.upenn.edu|
21232396|NCT00254540|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21232397|NCT00293254|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21232398|NCT00503308|UCSF, San Francisco General Hospital|Deborah Cohan, MD|415 206 3658|cohand@obgyn.ucsf.edu|
21232399|NCT04481750|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please e-mail|cti-inq-ml@ml.mt-pharma.co.jp|
21232400|NCT00475176|National Institute of Diabetes and Digestive and Kidney Diseases, National In|Jay H. Hoofnagle, M.D.|301-496-1333|hoofnaglej@mail.nih.gov|
21261114|NCT01498991|AMES Technology Inc.|Paul Cordo|15039706129|pcordo@amesdevices.com|
21261115|NCT00621023|Duke University Medical Center|Dr. Carlos de Castro|919-684-8964|decas003@mc.duke.edu|
21278964|NCT04730349|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21278965|NCT02629354|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21278966|NCT00638027|University of Rochester|Cynthia Irish, RN, MSCN|585-275-6120|cindy_irish@urmc.rochester.edu|
21278967|NCT03613727|Virginia Commonwealth University|BMT- CIT Team|804-628-6430|masseybmt@vcu.edu|
21278968|NCT01246063|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@wustl.edu|
21278969|NCT03558061|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
21261116|NCT01712360|Merz North America, Inc.|Ashlee Duncan|984-222-6040|Ashlee.Duncan@merz.com|
21261117|NCT04425850|Eurnekian Public Hospital|Dr. Héctor Carvallo|54144800949|hymcarvallo@hotmail.com|
21278970|NCT03982199|Janssen Vaccines & Prevention B.V.|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21232401|NCT02493608|Texas Tech Health Sciences Center|Chadley Copeland|8067434752|chadley.copeland@ttuhsc.edu|
21232402|NCT01113801|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21232403|NCT03287804|Autolus Ltd|Clinical Project Manager|+44 1483 920748|clinicaltrials@autolus.com|
21232404|NCT00003644|NRG Oncology|Linda Gedeon, Christopher Purdy on behalf of Mark Brady, PhD|(716) 845-1169|lgedeon@gogstats.org|
21232405|NCT01454947|University of Southern California|Jason N. Doctor|213.821.8142|jdoctor@usc.edu|
21232406|NCT03178773|University of Southern California|Elizabeth Burner|3234096667|eburner@usc.edu|
21232407|NCT00770289|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21232408|NCT02733991|Medtronic Diabetes EMEA|Ohad Cohen M.D., Medical Affairs Director|+972 54 321 1108|ohad.cohen@medtronic.com|
21232409|NCT02545101|Otsuka Pharmaceutical Europe Ltd.|Medical Department|+44(0)2037475000||
21232410|NCT01905384|Vanderbilt University Medical Center|Sharee Burkeen, Research Program Manager|(615) 875-7515|sharee.k.burkeen@vumc.org|
21232411|NCT00862745|University of California, San Francisco|Dr. Jeanette Brown|415-353-9751|brownj@obgyn.ucsf.edu|
21232412|NCT02617511|University of Manitoba|Dr. Stephen Cornish|204-474-9981|Stephen.Cornish@umanitoba.ca|
21232413|NCT00255047|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21232414|NCT00811473|AstraZeneca|Gerard Lynch||aztrail_results_posting@astrazeneca.com|
21232415|NCT04127331|Nationwide Children's Hospital|Dr. Alok Moharir|614-722-4200|alok.moharir@nationwidechildrens.org|
21232416|NCT02704975|United States Army|Rob Halle|910-689-8887|robhalle@gmail.com|
21232417|NCT02403154|Indiana University|Krista Brown, Clinical Research Coordinator|317-963-1944|brownkm@indiana.edu|
21232418|NCT01585194|MD Anderson Cancer Center|Dr. Sapna P. Patel/Associate Professor, Melanoma Medical Oncology|713-792-2921|sppatel@mdanderson.org|
21232419|NCT01119131|VA Portland Health Care System|Amie Hiller, MD|503.721.1091|peterami@ohsu.edu|
21232420|NCT00732615|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21232421|NCT00993291|Vanderbilt University|Fenna Phibbs M.D.|615-936-2025|fenna.phibbs@vanderbilt.edu|
21232422|NCT00003492|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
21232423|NCT01333059|Cook Children's Medical Center|Javier Gelvez, MD||Javier.Gelvez@cookchildrens.org|
21232424|NCT03566823|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
21232425|NCT04446377|AI Therapeutics|Peter R. Young/Chief Scientific Officer|203-458-7100|pyoung@ai-thera.com|
21232426|NCT01733407|Massachusetts General Hospital|Dr. Florian Eichler|617-643-3799|Feichler@partners.org|
21261118|NCT03199911|University of California, San Francisco|Davin Ashraf MD|415-353-2800|davin.ashraf@ucsf.edu|
21232427|NCT04152603|Seattle Children's Research Institute|Professor Stephanie Kraft|20688471022068841191|stephanie.kraft@seattlechildrens.org|
21232428|NCT02455531|Carelon Research|Dr. Felicia Trachtenberg|Felicia.Trachtenberg@carelon.c|Felicia.Trachtenberg@carelon.com|
21232429|NCT01414075|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441||
21232430|NCT03847233|Boston Scientific Japan K.K.|Yoko Takizawa/Clinical Project Manager|+81-3-6853-7500|Yoko.Takizawa@bsci.com|
21232431|NCT01590238|New York Eye & Ear Infirmary|Anthony P Sclafani, MD|212-979-4200|asclafani@nyee.edu|
21232432|NCT01187043|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com|
21232433|NCT04903626|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21232434|NCT00573534|Columbia University/New York State Psychiatric Instittue|Stephen J. Donovan MD|646 774 8078|sd45@columbia.edu|
21232435|NCT03035409|UT MD Anderson Cancer Center|Dr. Sriram Yennu, Professor, Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
21232436|NCT02642952|Ramón y Cajal University Hospital|Dr. Andrés Reyes Valdivia|0034 629586239|cauzaza@hotmail.com|
21232437|NCT00923598|University of California San Diego|Dr. Brian Ilfeld, Professor of Anesthesiology, In Residence|(858) 444-5949|bilfeld@ucsd.edu|
21232438|NCT00927784|Mount Sinai School of Medicine|Deborah Ascheim, MD, Principal Investigator, Data Coordinating Center|212-659-9567|deborah.ascheim@mssm.edu|
21232439|NCT02457910|Vanderbilt University Medical Center|Vandana Abramson, MD|(615)936-8422|vandana.abramson@vumc.org|
21261119|NCT02907944|Yale School of Medicine|David Fiellin, MD|(203) 688-5555|david.fiellin@yale.edu|
21261120|NCT02523586|Oregon Health and Science University|Jeffrey Kirsch|503-494-9000|kirschje@ohsu.edu|
21261121|NCT03102736|Icahn School of Medicine at Mount Sinai|Dr. James Murrough|212-585-1640|james.murrough@mssm.edu|
21261122|NCT01324830|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21261123|NCT01973283|New York State Psychiatric Institute|Patrick J Brown|646-774-8666|patrick.brown@nyspi.columbia.edu|
21261124|NCT00817414|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21261125|NCT00886938|Washington University|Dr. Jay F Piccirillo|(314) 362-8641|piccirilloj@ent.wustl.edu|
21261126|NCT02081963|Department of Respiratory Medicine, Qilu Hospital of Shandong University|Dr.Yu Li|13791122770|qlliyu@163.com|
21261127|NCT03669133|Indiana University|Regina Weber|317-278-3584|reginaw@iu.edu|
21261128|NCT03872180|Emory University Hospital/Winship Cancer Institute|Dr. Jonathon Cohen|4047781900|jonathon.cohen@emory.edu|
21261129|NCT00947154|Stanford Medical Center, Department of Psychiatry|Matthew White, M.D., clinical assistant professor|650 725-5598|mpwhite@stanford.edu|
21261130|NCT00644592|University of Florida|Reginald F. Frye, PhD, Associate Professor|3522735453|fryerf@ufl.edu|
21261131|NCT00900796|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21278971|NCT01565850|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21278972|NCT05065567|SpectrumLakeland|Research Specialist|(240)389-7340|rachelle.pichot@corewellhealth.org|
21278973|NCT03395405|Northwestern University Feinberg School of Medicine|Michael G Ison|3126954186|mgison@northwestern.edu|
21278974|NCT00213135|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21232440|NCT00467259|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
21261132|NCT03981029|Ottawa Hospital Research Institute|Alysha Harvey|613-737-8899|alyharvey@ohri.ca|73838
21261133|NCT01049776|Illinois CancerCare, P.C.|Sachdev Thomas, M.D.|309-243-3000|sthomas@illinoiscancercare.com|
21290206|NCT06868667|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21290207|NCT01537367|Division of HIV/AIDS (Epidemiology Branch), National Center for HIV/Hepatitis/STD/Tuberculosis Prevention, Centers for Disease Control and Prevention|Lytt I. Gardner, Ph.D., CDC Project Officer|(404) 639-6163|lig0@cdc.gov|
21290208|NCT00286455|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21290209|NCT05033561|FIDEC Corporation|Ricardo Rüttimann|+5491161188536|rruttimann@fidec-online.org|
21290210|NCT02562040|Brigham and Women's Hospital|Dr. Susan Redline|(617) 732-5500|sredline@bwh.harvard.edu|
21290211|NCT03435107|Academic Research Office, Clinical Trial Center, Asan Medical Center|Project manager|82-2-3010-7187|jiyun.an@amc.seoul.kr|
21290212|NCT04566510|UCSF|Dr. Grant Dorsey|628-206-4680|grant.dorsey@ucsf.edu|
21232441|NCT01516346|University of Pennsylvania|Julio Chirinos, MD, PhD|215-573-6606|julio.chirinos@pennmedicine.upenn.edu|
21232442|NCT06079320|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21232443|NCT01405742|University of Pittsburgh|Margaret V. Ragni, MD, MPH|412-209-7288|ragni@pitt.edu|
21232444|NCT04900220|West Virginia University|Dr. Shafic Sraj - Associate Professor|304-293-3007|shafic.sraj@hsc.wvu.edu|
21232445|NCT02196558|Eisai Co., Ltd.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
21232446|NCT03428360|Aquestive Therapeutics|Clinical Project Manager|9089411896|cbuan@aquestive.com|
21232447|NCT00830596|Palmer College of Chiropractic|Christine Goertz, DC, PhD, Principal Investigator|(563) 884-5150|christine.goertz@palmer.edu|
21232448|NCT02107482|Tufts Medical Center|Nicole Dumont|617 636 7462|ndonovan1@tuftsmedicalcenter.org|
21232449|NCT04474704|The Ohio State University|Maged Costantine, MD|614-293-2222|Maged.Costantine@osumc.edu|
21232450|NCT00576927|Emory University Division of General Medicine and Geriatrics|Dr. Patricia Griffiths|404-321-6111|pcgriff@emory.edu|7138
21232451|NCT03128892|Masimo Corporation|Chelsea Frank|949-297-7000|studies@masimo.com|
21232452|NCT04570150|UCSD|Dr. Rodney Gabriel|6194710670|ragabriel@health.ucsd.edu|
21232453|NCT01850524|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21232454|NCT00368355|Baylor College of Medicine|Dr. Robert A. Krance|832-824-4661|rakrance@txch.org|
21232455|NCT02727751|Ardelyx|Chief Development Officer|5107451752|drosenbaum@ardelyx.com|
21232456|NCT04899921|Dana-Farber Cancer Institute|Senior Physician|6176326836|ann_silk@dfci.harvard.edu|
21232457|NCT04061915|New York University|S. Raquel Ramos|212-992-5994|TheHOTIEStudy@gmail.com|
21232458|NCT01322360|Roxane Laboratories, Inc|Anton (Tony) Amann, PhD, Executive Director, Drug Regulatory and Medical Affairs|614-272-4785|Tony.Amann@boehringer-ingelheim.com|
21232459|NCT01457521|Gynuity Health Projects|Elizabeth Raymond|2124481230|eraymond@gynuity.org|
21239485|NCT02265224|Zambon S.p.A.|Isabella Salerio, PhD|+3902665241|clinicaltrials@zambongroup.com|
21239486|NCT03810313|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21239487|NCT00872430|Hospital de Clínicas de Porto Alegre|Dr. Paulo Dornelles Picon|55 xx 51 21018752|paulopicon@gmail.com|
21239488|NCT04048759|University of Kansas Medical Center|Dr. Lauren Ptomey|913-588-7983|lptomey@kumc.edu|
21239489|NCT01299090|Moy, Fincher, Chipps Medical Group|Lisa Chipps, MD|(310) 274-5372|lchipps@ucla.com|
21239490|NCT01872910|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21239491|NCT01540565|NRG Oncology|Christopher Purdy on behalf of Mike Sill|(716)845-1300|purdyc@nrgoncology.org|2296
21239492|NCT00154310|Novartis Pharmaceuticals|Study Director|862-778-8300||
21239493|NCT03469349|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21239494|NCT03771157|University of Rochester|Michael Brady|585-276-3203|michael_brady@urmc.rochester.edu|
21239495|NCT02086162|Dartmouth-Hitchcock|Dr. Mary F. Brunette|603-229-5419|mary.f.brunette@hitchcock.org|
21239496|NCT03447730|Synlogic|Andrew Marsh, Head Clinical Operations|617-401-9975|andrew.marsh@synlogictx.com|9135
21239497|NCT03349268|University of Michigan|Keith Kaye|732 235-9312|kk1116@rwjms.rutgers.edu|
21239498|NCT01350505|VA Palo Alto Health Care System|Dr. Jamie Zeitzer|650-493-5000|jamie.zeitzer@va.gov|62410
21239499|NCT00868699|Sunovion|Medical Director, CNS|1-866-503-6351||
21278975|NCT04648696|Wake Forest University Health Sciences|John Williamson, PhD|336.713.3431|johnwill@wakehealth.edu|
21278976|NCT02886624|Hôpital Saint Antoine|Prof. Karine Lacombe|+33 1 49 28 24 38|karine.lacombe2@aphp.fr|
21278977|NCT02420912|The University of Texas MD Anderson Cancer Center|Nitin Jain, MD/Associate Professor|713-745-6080|njain@mdanderson.org|
21278978|NCT01392963|Seton Family of Hospitals|Katherine Sebastian|512-324-9999|krsebastian@seton.org|89612
21278979|NCT01689779|Massachusetts General Hospital|Sadeq A. Quraishi, MD|617-726-3030|squraishi@mgh.harvard.edu|
21278980|NCT00450801|University of Miami|Izidore Lossos MD|305-243-4785|ilossos@med.miami.edu|
21278981|NCT00324649|Gilead Sciences|Pedro Ferrer|+34 91 771 2478|pedro.ferrer@gilead.com|
21278982|NCT04684238|Sedana Medical AB|Ida Sverud|+46 8 124 052 00|medinfo@sedanamedical.com|
21278983|NCT01396512|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21278984|NCT02711878|Emory university|Dr. Eun Ok IM|404-712-9805|eun.ok.im@emory.edu|
21278985|NCT02618759|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
21278986|NCT02152605|GlaxoSmithKline|GSK Response Center|866-435-7343||
21278987|NCT00470392|Louis Stokes VA Medical Center and University Hospitals Case Medical Center|Kevin D. Cooper MD|216 844 3111|kevin.cooper@uhhospitals.org|
21278988|NCT02657928|Mayo Clinic|Gerardo Colon-Otero, MD|904/953-2000|gcolonotero@mayo.edu|
21278989|NCT01988129|Brigham and Women's Hospital|Steven W. Lockley PhD|16177324977|slockley@hms.harvard.edu|
21278990|NCT02500043|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
21278991|NCT00580788|University of Pittsburgh|Mara J Horwitz, MD|4126922848|horwitz@pitt.edu|
21278992|NCT00573378|University of Michigan Rogel Cancer Center|Dale L. Bixby, MD|734-936-4991|dbixby@med.umich.edu|
21278993|NCT01701011|UMCU|Henrietta Ockhuijsen 1,*, Agnes van den Hoogen, Marinus Eijkemans , Nick Macklon, Jacky Boivin|+31307553628|h.d.l.ockhuysen@umcutrecht.nl|
21278994|NCT04732624|University of Washington/Nepal cleft and burn center|Dr. Raslina Shrestha|+977 9849978888|raslinas@uw.edu|
21278995|NCT02740114|UT MD Anderson Cancer Center|Pedro Ramirez, MD /Professor, Gyn Onc & Reproductive Med|713-745-5498|peramire@mdanderson.org|
21278996|NCT01551030|Memorial Sloan Kettering Cancer Center|Dean Bajorin, MD|646-888-4700|bajorind@MSKCC.ORG|
21278997|NCT01439009|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Research and Development|+81-3-6361-7366||
21239500|NCT04702568|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
21239501|NCT01735396|Tisch Cancer Center, Icahn School of Medicine at Mount Sinai|Dr. Matthew David Galsky|212-689-5412|matthew.galsky@mssm.edu|
21278998|NCT02278055|Memorial Sloan Kettering Cancer Center|Dr. Michael Morris, MD|646-422-4469|morrism@MSKCC.ORG|
21232460|NCT03473808|Medical University of South Carolina|Amanda Vatinno|8437924840|vatinno@musc.edu|
21232461|NCT01706081|Memorial Sloan Kettering Cancer Center|Dr. Ting Bao MD|646-888-0865|baot@mskcc.org|
21232462|NCT04059094|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21232463|NCT02994979|The New Jewish Home|Dr. Kenneth Boockvar|212-870-5062|kenneth.boockvar@mssm.edu|
21232464|NCT03649750|Reckitt Benckiser Inc.|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
21290213|NCT00368849|The University of Iowa|Leigh J. Beglinger, Ph.D.|319-335-8765|leigh-beglinger@uiowa.edu|
21290214|NCT04804709|Columbia University Irving Medical Center|Cheng-Chia Wu, MD, PhD|646-317-3033|cw2666@cumc.columbia.edu|
21290215|NCT01902303|Beech Tree Labs, Inc.|Dr. John McMichael|518-872-1144||
21232465|NCT00883116|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21232466|NCT00118365|University of California, Irvine|Dr. Frank Meyskens, Jr.|714-456-6310|flmeyske@uci.edu|
21232467|NCT01059799|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21232468|NCT00671502|Meda Pharma US|David Ginsberg, MD Sr Medical Director|732 564 2364|david.ginsberg@meda.us|
21232469|NCT04772755|Duke University|Emmanuel B Walter, MD, MPH|919-620-5346|chip.walter@duke.edu|
21232470|NCT00959842|Professor|Dr. Greg Shearer|814-867-3040|gcs13@psu.edu|
21232471|NCT03204981|Icahn School of Medicine at Mount Sinai|Sam Cammack|212-824-8931|sam.cammack@mountsinai.org|
21232472|NCT04203238|Pennington Biomedical Research Center|Dr. Candida Rebello|2257633159|Candida.Rebello@pbrc.edu|
21232473|NCT01662908|Daiichi Sankyo, Inc.|Senior Director, CVM TA Development|732-590-5000||
21232474|NCT00001596|National Human Genome Research Institute|Dr. William A. Gahl|301-402-2739|gahlw@mail.nih.gov|
21232475|NCT03274687|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21232476|NCT01024296|Stanford University|Bilal M Shafi, MD|(215) 738-0400|bmshafi@stanford.edu|
21232477|NCT03867981|The Miriam Hospital|Principal Investigator|401-793-8966|junick@lifespan.org|
21232478|NCT00180414|Boston Scientific|Jens Goetzke|+32 2 41|jens.goetzke@bsci.com|67011
21232479|NCT02703909|University of Missouri - Columbia|Terri G. Monk, MD, Principal Investigator|(573)-882-2568|monkt@health.missouri.edu|
21232480|NCT00613938|Johnson & Johnson Pharmaceutical Research & Development|Senior Director, Clinical Leader|609-730-4537||
21232481|NCT00623727|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21232482|NCT02636868|Windtree Therapeutics, Inc.|Executive Director of Biostatistics & Data Management|215-488-9477|psimmons@windtreetx.com|
21232483|NCT03220217|Ipsen|Ipsen Medical Director|See email|clinical.trials@ipsen.com|
21232484|NCT03025542|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21232485|NCT03745937|MedImmune, LLC|Lars Hansen|+1 301 398 4563|information.center@astrazeneca.com|
21232486|NCT00501293|Shire Pharmaceutical|Timothy Whitaker, MD||twhitaker@shire.com|
21232487|NCT00488345|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21232488|NCT03626714|Auritec|Sarjan Shah|9092109715|sshah@auritecpharma.com|
21232489|NCT02127567|Assistance publique hopitaux de paris|Isabelle Boutron|+33 1 42 34 78 33|isabelle.boutron@htd.aphp.fr|
21232490|NCT00903617|GlaxoSmithKline|GSK Response Center|866-435-7343||
21232491|NCT01104636|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21232492|NCT01706003|UT Southwestern Medical Center|Deborah I. Friedman, MD, MPH, Professor of Neurology and Neurotherapeutics and Ophthalmology|2146483517|Deborah.Friedman@utsouthwestern.edu|
21232493|NCT04538066|Synaptogenix, Inc.|Chief Medical Officer|973 242-0005|atuchman@synaptogen.com|
21232494|NCT03182829|DOASENSE GmbH|Harenberg, Job Prof Dr.|+496221825|j.harenberg@doasense.de|9785
21232495|NCT03316131|AstraZeneca RD, Gothenburg|Fredrik Erlandsson|1-877-240-9479|information.center@astrazeneca.com|
21232496|NCT05608005|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21232497|NCT02366845|University of Colorado|Dr. Marc Moss|303-724-6080|marc.moss@cuanschutz.edu|
21232498|NCT00786487|University of Minnesota|Dr. Lisa Chow|612-625-8934|chow0007@umn.edu|
21232499|NCT02259582|OncoMed Pharmaceuticals, Inc.|Manager, Regulatory Affairs|6509958322|imran.chaudhry@oncomed.com|
21232500|NCT03518073|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21232501|NCT03045081|University of Washington|Dale J. Langford, PhD; Research Assistant Professor|2066160158|dalejwl@uw.edu|
21232502|NCT01853046|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21232503|NCT03804879|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21290216|NCT01699685|Novartis Pharmaceuticals|Study Director|862-778-8300||
21290217|NCT03635996|Milestone Pharmaceuticals Inc.|Cameron Szakacs _PhD_VP Drug Development|1 704-594-4102|cszakacs@milestonepharma.com|
21232504|NCT00708162|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21232505|NCT00911495|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21232506|NCT02699554|University of Washington|Katherine Steele|206-685-2390|kmsteele@uw.edu|
21232507|NCT00788151|Sanofi Pasteur SA|Director||Contact-US@sanofi.com|
21232508|NCT00503009|GlaxoSmithKline|GSK Response Center|866-435-7343||
21232509|NCT01985581|Center for Pediatric Excellence|Dr. Judy van Stralen|613-726-7355|judyvanstralen@bellnet.ca|
21232510|NCT02169739|University of California Los Angeles|Latisha Sharma, MD|310-794-6379|lali@mednet.ucla.edu|
21232511|NCT03635957|Horizon Therapeutics Ireland DAC|Paul Peloso, MD|866-479-6742|clinicaltrials@horizontherapeutics.com|
21232512|NCT01710033|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21232513|NCT00100815|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21232514|NCT04396990|Vance Thompson Vision|Keeley Boever|6053613937|keeley.boever@vancethompsonvision.com|
21232515|NCT02880189|Mayo Clinic|Dr. Barham K. Abu Dayyeh|507-284-1825|AbuDayyeh.Barham@mayo.edu|
21261134|NCT01602731|VA Loma Linda Healthcare System|Dr. Helme Silvet, cardiologist|9095836097|helme.silvet@va.gov|
21261135|NCT02586805|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21261136|NCT01859403|VA San Diego Health Sciences|Amir Zarrinpar, MD, PhD, Assistant Professor of Gastroenterology|858-246-1665|azarrinpar@health.ucsd.edu|
21261137|NCT01157117|Ichan School of Medicine at Mount Sinai|Dr. Hugh A. Sampson|212-659-9426|hugh.sampson@mssm.edu|
21261138|NCT00811252|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
21261139|NCT03014648|UPMC Hillman Cancer Center|Barbara M Stadterman, Regulatory Supervisor, Clinical Research Services|412-647-5554|stadtermanbm@upmc.edu|
21261140|NCT00813748|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21261141|NCT00749606|SUNY Upstate Medical University|Ruth S. Weinstock MD PhD|315-464-5740|weinstor@upstate.edu|
21261142|NCT01829048|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21290218|NCT03137407|Revance Therapeutics, Inc.|Todd Gross, PhD, VP, Clinical Development & Data Science|510-742-3400|tgross@revance.com|
21290219|NCT00004228|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21261143|NCT00892437|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21261144|NCT01961531|BrUOG- Brown University Oncology Research Group|Jaroslaw Hepel, MD|401-863-3000|BrUOG@brown.edu|
21261145|NCT03185130|University Medical Center of Southern Nevada|Tony Zitek, MD|7023837885|zitek10@gmail.com|4
21261146|NCT02286960|NYU Langone Health|Milan Amin|646-754-1206|Milan.Amin@nyulangone.org|
21261147|NCT00716443|Galderma Laboratories, L.P.|Ron W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
21261148|NCT02504541|Antares Pharma, Inc.|Jonathan Jaffe, MD|609-359-3020|jjaffe@antarespharma.com|
21261149|NCT01860170|Spectrum Health|A. Samer A;-Homsi|616-486-5933|a.samer.al-homsi@spectrumhealth.org|
21261150|NCT04249882|University of California Los Angeles|Dr. Lara Ray|310-206-6756|lararay@psych.ucla.edu|
21261151|NCT00327392|Eisai Inc|Eisai Medical Services|1-888-422-4743||
21261152|NCT02176486|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21261153|NCT00651040|Rheumatology Institute Prague|Rheumatology Institute Prague|+420234075111|vencovsky@revma.cz|
21261154|NCT01882725|Arizona Institute of Footcare Physicians|Kerry Zang, DPM|480-834-8804|kerryzang@aol.com|
21261155|NCT02317510|Lutfiye NBGH|Dr. Turgut Donmez|00905347400967|surgeont73@hotmail.com|
21261156|NCT00472303|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|Clinical-Trials@grunenthal.com|
21261157|NCT01122927|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21261158|NCT02389881|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21261159|NCT03427073|Almac Discovery|Professor Richard Kennedy, Medical Director|+44 28 3833 2200|richard.kennedy@almacgroup.com|
21261160|NCT01244737|Children's Hospital of Philadelphia|Dr. Frederick Grant|267-600-1542|grantf@chop.edu|
21261161|NCT02955329|University of California, San Francisco|Dr. Gideon St. Helen|628-206-2687|gideon.sthelen@ucsf.edu|
21261162|NCT00759603|The University of Texas (UT) MD Anderson Cancer Center|Alessandra Ferrajoli, MD/Professor, Leukemia||CR_Study_Registration@mdanderson.org|
21261163|NCT02835495|Wake Forest School of Medicine|Mara Z. Vitolins, DrPH, MPH, RDN|(336) 716-2886|mvitolinn@wakehealth.edu|
21261164|NCT01225354|DeNova Research|Jack Arkins, Data Manager|312-335-2070|jack@drdayan.com|
21261165|NCT02371629|Novartis Pharmaceuticals|Study Director|862-778-8300||
21261166|NCT03486314|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21290220|NCT01161121|St. Louis University|Dr. Michael Lim|314-268-7992|limmj@slu.edu|
21261167|NCT01015443|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21290221|NCT01267136|Children's Hospitals and Clinics of Minnesota|Andrea Postier/Clinical Research Program Manager|612-813-6409|andrea.postier@childrensmn.org|
21290222|NCT01013870|Baylor College of Medicine|Claudia Robertson, MD|713-873-2792|claudiar@bcm.edu|
21261168|NCT03652454|IzmirKCU|dr.dt.mücahid faik şahin|+902323254040|m.faiksahin@hotmail.com|
21290223|NCT00090402|Oregon Health & Science University|Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu|
21239502|NCT00779558|Stanford University|Alan Schroeder|408 885-5260|alan.schroeder@hhs.sccgov.org|
21239503|NCT00423852|Memorial Sloan Kettering Cancer Center|Dr. Darren Feldman, Assistant Attending|+1646-422-4491|Feldmand@mskcc.org|
21239504|NCT00980005|GlaxoSmithKline|GSK Response Center|866-435-7343||
21239505|NCT00572624|Washington University School of Medicine|Dr. Linda Peterson, M.D.|314-362-4577|lpeterso@dom.wustl.edu|
21239506|NCT00817804|Respironics California|Adam Seiver|760-703-6993|adam.seiver@philips.com|
21239507|NCT05288023|University of California San Francisco|Kieran O'Brien|(415) 476-1442|kieran.obrien@ucsf.edu|
21239508|NCT04078035|University of Pittsburgh|Dr. Anna Marsland|14123705622|marsland@pitt.edu|
21239509|NCT03758118|IRCCS Fondazione Bietti|Dr, Vincenzo Parisi|+390686356727|vmparisi@gmail.com|
21239510|NCT01737281|VA NY Harbor Healthcare System|Dr. Scott Sherman|212-686-7500|scott.sherman@va.gov|7386
21239511|NCT01905046|City of Hope|Victoria Seewaldt, M.D.|6262564674|vseewaldt@coh.org|67321
21239512|NCT01970787|Laser Surgery Care|Stephen E Goldstone|212-242-6500|segmd@prodigy.net|
21239513|NCT03501043|MossRehab|Stella Lee|215-663-6665|leest@einstein.edu|6665
21239514|NCT01905254|Universitiy Clinic Hamburg eppendorf|PD Dr. Ulrike Denzer|040741055380|u.denzer@uke.de|
21239515|NCT00612534|AcelRx|Pamela Palmer, MD PhD|650-216-3500|ppalmer@acelrx.com|
21239516|NCT03482505|Masimo|Cristina Johnson|949-297-7000|clinicalresearchdept@masimo.com|
21239517|NCT02117934|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-848-5100||
21239518|NCT01985828|Advocate Health|Geraldine Lara|8477238239|geraldine.lara@aah.org|
21239519|NCT01435655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21239520|NCT04534114|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21239521|NCT02223754|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, O.D., M.S., F.A.A.O., Sr. Principal Research Optemtrist|904-443-3500|TKarkkai@its.jnj.com|3402
21239522|NCT01960530|Diurnal Limited|Dr John Porter|02920 682069|info@diurnal.com|
21239523|NCT01008475|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21239524|NCT02668016|Imperial College London|Professor Darrel Francis|0207 594 9647|d.francis@imperial.ac.uk|
21239525|NCT01044576|Imperial College London|Professor Paolo Muraro|02075946670|p.muraro@imperial.ac.uk|
21239526|NCT01122381|Vetarans Administration Pittsburgh Healthcare System|Kathy Gardner MD|(412) 360-6185|kathy.gardner@va.gov|
21239527|NCT02395133|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
21239528|NCT00510458|Stryker Orthopaedics|Director, Clinical Operations|201-831-5401|ellen.axelson@stryker.com|
21239529|NCT02569710|Alios BioPharma, Inc|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21239530|NCT00432835|University of Mississippi Medical Center|Thomas L. Abell, MD, Professor of Medicine|6019844540|tabell@umc.edu|
21239531|NCT02430818|Washington University School of Medicine|Evan Schwarz|3147473690|schwarze@wustl.edu|
21239532|NCT01827254|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21239533|NCT01560260|Sarcoma Alliance for Research through Collaboration (SARC)|Kristen Nuyen, Research Project Manager|734-930-7600|sarc@sarctrials.org|
21239534|NCT01458990|Hunter Holmes McGuire VA Medical Center|Jasmohan Bajaj|804 675 5802|jasmohan.bajaj@va.gov|
21239535|NCT00308737|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
21239536|NCT01225822|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21239537|NCT01290822|Columbia University|Henry M. Spotnitz, MD|(212) 305-6191|hms2@columbia.edu|
21239538|NCT01515189|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21239539|NCT02100722|Stanford University|William Fearon, MD|650-725-2621|wfearon@stanford.edu|
21239540|NCT02541383|Intergroupe Francophone du Myélome|Chief Executive Officier|+33 1 40 21 24 02|ifmclinicaltrials@myelome.fr|
21239541|NCT05644353|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21239542|NCT04986982|BIAL - Portela & Ca, SA|Responsible of Clinical Operations|+351229866100|clinical.trials@bial.com|
21239543|NCT05796518|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-713-0031|mnjenkin@wakehealth.edu|
21239544|NCT01535274|University of Michigan|Dr. Paul Picton|734-936-4280|ppicton@umich.edu|
21239545|NCT05777174|MediBeacon, Inc.|Richard B Dorshow, PhD|314-735-0967|rbdorshow@medibeacon.com|
21239546|NCT02690077|Advocate Aurora Health|Jessica J F Kram, MPH|414-219-5594|jessica.kram@aah.org|
21239547|NCT01845974|Advocate Medical Group Cardiology|Scott M. Miller MD|847-698-5500|scott.miller@advocatehealth.com|
21239548|NCT02667886|X4 Pharmaceuticals|Chief Medical Officer|(857) 529-8300|patientinfo@x4pharma.com|
21239549|NCT00594217|University of Virginia Center for Research in Reproduction|Dr. Christopher R. McCartney|4342436911|cm2hq@virginia.edu|
21239550|NCT05672680|Icahn School of Medicine at Mount Sinai|Celia Divino|(212) 241-3348|celia.divino@mountsinai.org|
21239551|NCT04186403|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21239552|NCT01447849|TexasTech|Dr. Jerzy Sarosiek, Director, Mol. Medicine Research|915-215-5255|jerzy.sarosiek@ttuhsc.edu|
21239553|NCT03929562|University of Michigan|Anne C. Fernandez|734-232-0521|acfernan@med.umich.edu|
21239554|NCT02201056|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21239555|NCT01407354|University Maryland Rehabilitation and Orthopaedic Institute|Paula Richley Geigle PT PhD|410 448 6773|pgeigle@umm.edu|
21239556|NCT01036022|GlaxoSmithKline|GSK Response Center|866-435-7343||
21261169|NCT00542828|Genzyme Corporation|Genzyme MedInfo|800-745-4447|medinfo@genzyme.com|
21278999|NCT01934335|Holden Comprehensive Cancer Center|Ronald Weigel, MD, PhD|319-353-7474|ronald-weigel@uiowa.edu|
21290224|NCT04250675|Purdue University|Bruno Roseguini|7654906284|brosegui@purdue.edu|
21239557|NCT02778399|Clinical Operations|Medical Responsible|+41 (0)22 552 1560|clinicaltrials@obseva.ch|
21239558|NCT00578721|UC Irvine Health - Chao Family Comprehensive Cancer Center|Jason Zell, DO, MPH, MS|714-456-5153|jzell@hs.uci.edu|
21261170|NCT01364467|Virginia Commonwealth University|Kelley M. Dodson, MD, FACS|804-828-3965|kelley.dodson@vcuhealth.org|
21261171|NCT01634243|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
21261172|NCT04283461|Kaiser Permanente Washington|Lisa Jackson, MD, MPH|206-442-5216|lisa.a.jackson@kp.org|
21232516|NCT00826020|University of Nebraska Medical Center|David Mercer|402-559-6955|dmercer@unmc.edu|
21232517|NCT02338960|AMAG Pharmaceuticals|Medical Information|1-877-411-2510||
21232518|NCT01525550|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21232519|NCT02261714|Targovax ASA|Chief Medical Officer|004721398810|contact@targovax.com|
21232520|NCT02522286|Palo Alto Medical Foundation Research Institute|Dr. Ming Tai-Seale|650-853-4779|Tai-SealeM@pamfri.org|
21232521|NCT01244906|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD|404-255-1930|ssolomon@bmtga.com|
21232522|NCT03889158|University of Illinois at Chicago|Dr. Elizabeth Lefferts|312-996-9607|eschro7@uic.edu|
21232523|NCT03480750|National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University|Dr. Yu-Fang Huang|886 6 2353535|yufangh@mail.ncku.edu.tw|5221
21232524|NCT00723892|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800--672-6372|ClinicalTrialsDisclosure@merck.com|
21232525|NCT02411292|Division of Plastic Surgery, University of Utah|Dr. Christopher J. Pannucci, M.D., M.S.|801-581-7719|christopher.pannucci@hsc.utah.edu|
21232526|NCT03060447|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21232527|NCT02232425|Ixchelsis Limited|Chief Medical Officer|44(0)1227-832760|ian.osterloh@ixchelsis.com|
21232528|NCT00705081|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21232529|NCT01601626|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21232530|NCT00498602|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21232531|NCT02632552|U.S. Department of Veterans Affairs, Center for Healthcare Organization and Implementation Research (CHOIR)|Timothy P. Hogan, PhD,|508-244-2303|Timothy.Hogan@VA.gov|
21232532|NCT02611778|bioeq GmbH|Head of Clinical Development|+498024463330|columbus@bioeq.com|
21232533|NCT03108027|Novartis Pharmaceutical|Study Director|862-778-8300|novartis.email@novartis.com|
21232534|NCT02426892|UT MD Anderson Cancer Center|Dr. Renata Ferrarotto,MD, Associate Professor, Thoracic-Head & Neck Med Onc|(713) 745-6774|rferrarotto@mdanderson.org|
21232535|NCT03402386|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608 Japanese only|cti-inq-ml@ml.mt-pharma.co.jp|
21232536|NCT00268996|GlaxoSmithKline|GSK Response Center|866-435-7343||
21232537|NCT03325075|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
21232538|NCT02744391|New York State Psychiatric Institute|Dr. Bret R. Rutherford|646-774-8660|brr8@cumc.columbia.edu|
21232539|NCT02607033|Baltimore VA Hosptial|Odessa Addison|4106057000|odessa.addison@va.gov|55393
21232540|NCT04434092|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21232541|NCT02554812|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21232542|NCT02879305|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21232543|NCT00429507|University of Texas (UT) MD Anderson Cancer Center|Nato Ueno, MD, PhD/Professor, Breast Medical Oncology||CR_Study_Registration@mdanderson.org|
21232544|NCT01188694|University of Washington|Lori Zoellner|206 685-3617|zoellner@u.washington.edu|
21232545|NCT00478569|Takeda|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
21232546|NCT00936910|Children's Hospital of Pittburgh|Dr. William McGhee, Clinical Pharmacy Specialist, Transplant|412-692-5733|william.mcghee@chp.edu|
21232547|NCT05022784|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21232548|NCT03020407|Department of Emergency Medicine, Faculty of Medicine, Chulalongkorn University|Dr. Khrongwong Musikatavorn|+6626494000|kmusikatavorn@yahoo.com|83058
21232549|NCT01585428|National Cancer Institute|D. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
21232550|NCT02057198|Duke University Medical Center|Daniel Sexton, M.D.|919-684-4596|sexto002@mc.duke.edu|
21232551|NCT00065507|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21232552|NCT00350636|Watson Laboratories, Inc|Gary Hoel, PhD, Executive Director|801-808-8866|gary.hoel@watson.com|
21232553|NCT01214161|Columbia University|Anne Davis, MD|212-305-4951|ard4@cumc.columbia.edu|
21232554|NCT01647282|UNMC College of Dentistry|Dr. Amy C. Killeen|402-202-7848|akilleen@unmc.edu|
21232555|NCT01042236|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21232556|NCT02345811|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
21232557|NCT03040466|UCSF|Dr. Thomas Chi|415-476-1611|tom.chi@ucsf.edu;manint.usawachintachit@ucsf.edu|
21232558|NCT05584644|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21232559|NCT03683758|Mountain Health and Performance|Dr. Matthew Wentzell|6043566986|drwentzell@mountainhp.ca|
21232560|NCT00453921|Dartmouth Hitchcock Medical Center|Dr. Laura Flashman|6036505824|Laura.A.Flashman@hitchcock.org|
21232561|NCT00303498|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21232562|NCT00174915|Takeda Global Research & Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21232563|NCT03045887|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21232564|NCT02132767|Icahn School of Medicine at Mount Sinai|Annetine C. Gelijns, PhD|212-659-9568|annetine.gelijns@mssm.edu|
21232565|NCT04155632|Medical University of South Carolina|Dr. Xiaolong Peng|8437928642|pengxi@musc.edu|
21232566|NCT00546637|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21232567|NCT02140788|Duke University Health System|Joseph P. McEvoy|919-819-9295|JMCEVOY@gru.edu|
21232568|NCT02968563|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21232569|NCT03742154|MUSC|Lisa Coles Program Coordinator|843-876-2291|colesl@musc.edu|
21232570|NCT04008030|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
21232571|NCT04249310|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21232572|NCT02574247|University of Illinois at Urbana-Champaign|Dr. Ian Mertes|217-300-4756|imertes@illinois.edu|
21232573|NCT01382446|SJHMC|Tracy L. Thomas MSN RN CCRN ACNS-BC|602-406-2567|Tracy.Thomas007@dignityhealth.org|
21279000|NCT01111825|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
21279001|NCT02137486|cardiovascular section|taipei city hospital Ren-Ai branch|0088627093600|chenyuehchung.tw@yahoo.com.tw|3741
21279002|NCT00599053|University of Alabama at Birmingham|Dr. David Randolph|205-934-4680|drandolph@peds.uab.edu|
21279003|NCT00276861|Dept. of Oncology Johns Hopkins Singapore Intl Medical Center|Gilberto Lopes MD|656-880-2240|glopes@imc.jhmi.edu|
21279004|NCT02087189|BIOTRONIK SE & Co. KG|Mathias Freudigmann, Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|1248
21279005|NCT00589329|MetroHealth Medical CEnter|Larraine Presley|216-778-8927|lpresley@metrohealth.org|
21279006|NCT01458106|Bioverativ|Bioverativ Study Medical Director||clinicaltrials@bioverativ.com|
21279007|NCT03375294|Palo Alto Veterans Affairs|Dr. Carolyn Rodriguez|650-723-6158|cr2163@stanford.edu|
21279008|NCT01436799|Gachon University Gil Medical Center|Dr.HJ Kwak|82-32-460-3400|hyun615@gilhospital.com|
21279009|NCT04428333|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21232574|NCT04458909|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21232575|NCT00632411|University of Tennessee Health Science Center|Dr. Robert Klesges|901-448-3174|lcolvin1@uthsc.edu|
21232576|NCT00422591|UT MD Anderson Cancer Center|Farhad Ravandi-Kashani, MD|713-792-7734|CR_Study_Registration@mdanderson.org|
21232577|NCT00913003|Northwestern University|Paul Fitzgerald|312-695- 1064|p-fitzgerald2@northwestern.edu|
21232578|NCT04210310|NYU Langone Health - Preston Robert Tisch Center for Men's Health|Lawrence Newman, MD|646-754-2000|Lawrence.Newman@nyulangone.org|
21232579|NCT00495170|UT MD Anderson Cancer Center|Dr. Joe Chang / Professor, Radiation Oncology Department|713-563-2337|jychang@mdanderson.org|
21232580|NCT04191499|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21232581|NCT01928329|C.N.H. Long Professor of Immunobiology and of Medicine (Endocrinology)|Kevan Herold, MD|(203) 785-6507|kevan.herold@yale.edu|
21232582|NCT00330616|GlaxoSmithKline|GSK Response Center|866-435-7343||
21232583|NCT00697203|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
21232584|NCT02141997|AbbVie|Global Medical Information|1-800-633-9110||
21232585|NCT03063476|Vanderbilt University Medical Center|Dr. Jane Ferguson|6158759896|jane.f.ferguson@vanderbilt.edu|
21232586|NCT06273124|Tandem Diabetes Care|Supervisor, Clinical Operations|(858) 366-6900|clinicalaffairs@tandemdiabetes.com|
21232587|NCT03336853|AOUCareggi|Dr. Riccardo Pace|+390557945608|riccardo.pace@unifi.it|
21232588|NCT00530764|GW Pharma Ltd.|Matthew Hersch, Senior Clinical Project Manager|+44 1353 616600|mhersch@gwpham.com|
21232589|NCT03557151|Nemours Children's Hospital, Delaware|Melissa A. Alderfer, Ph.D., Center Director & Principal Research Scientist|302-651-6522|melissa.alderfer@nemours.org|
21232590|NCT00840294|University of Chicago|Scott Eggener|(773) 702-5195|seggener@surgery.bsd.uchicago.edu|
21232591|NCT03383198|Prisma Health|Dr. William R. Hand|864.522.3707|William.Hand@prismahealth.org|
21232592|NCT05392998|Clínica Rementería|Dr. Inés Contreras|34913083838|contreras@clinicarementeria.es|
21232593|NCT00828347|Department of Nephrology, Kumamoto University Graduate School of Medical Sciences|A study of maintenance therapy after intravenous maxacalcitol for secondary hyperparathyroidism|+81-96-373-5164|m-adachi@gpo.kumamoto-u.ac.jp|
21232594|NCT02947997|Massachusetts General Hospital|Gary Tearney, MD|617-724-2979|gtearney@partners.org|
21232595|NCT02028065|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21232596|NCT04868890|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|17204376500|clinicaltrials@ampiopharma.com|
21232597|NCT02418026|Groupe Hospitalier de la Rochelle Ré Aunis|Mrs Sandrine Delavaux|+33 5 46 45 50 50|saniade@msn.com|
21232598|NCT02669433|Axovant Sciences, Inc.|Ilise Lombardo, MD|646-822-8626|ilise.lombardo@axovant.com|
21232599|NCT00379574|Asan Medical Center, Ulsan University College of Medicine|Dr. Cheolwon Suh|+82-2-3010-3209|csuh@amc.seoul.kr|
21232600|NCT02157298|AstraZeneca K.K.|Yuji Ageishi|+81-3-6268-2740|Yuji.Ageishi@astrazeneca.com|
21232601|NCT03445650|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
21232602|NCT00818662|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21232603|NCT01722071|University of Michigan|Tiffany Love, PhD|734-219-3674|tiflove@umich.edu|
21232604|NCT03021265|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21232605|NCT01338493|Medtronic Spinal & Biologics|Cristina Faria|+41 (0)21 802 70 00|cristina.faria@medtronic.com|
21232606|NCT01698801|Celgene Corporation|Senior Manager, Clinical Trials Disclosure|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
21232607|NCT01614067|University of California, San Francisco|Mitchell Rosen, MD|415-353-7475||
21290225|NCT02743312|San Francisco State University|Dr. Diane Allen|4153386837|ddallen@sfsu.edu|
21290226|NCT00862277|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21290227|NCT02168439|Children's Hospital of Pittsburgh of UPMC|Desiree Neville|4126927692|desiree.neville@chp.edu|
21290228|NCT01292473|Genentech, Inc|Medical Communications|800 821-8590||
21290229|NCT04432298|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1346|jcharpentier@fibrogen.com|
21290230|NCT02451007|Pharma Mar, S.A.|Clinical Development Department of PharmaMar's Oncology Business Unit|+34 91 846 60 00|clinicaltrials@pharmamar.com|
21290231|NCT01716559|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21290232|NCT00348374|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21290233|NCT02062008|University of California San Francisco|miguel hernandez pampaloni|4153531886|miguel.pampaloni@ucsf.edu|
21290234|NCT01631929|HOSPITAL GENERAL DE NIÑOS PEDRO DE ELIZALDE|Ferreira Juan Pablo MD|+5491136085959|ferreirajuanpablo@hotmail.com|
21290235|NCT00782379|Blood and Marrow Transplant Group of Georgia|Dr. Scott Solomon|404-255-1930|ssolomon@bmtga.com|
21290236|NCT04334681|Principal investigator|Dr. Alpaslan Şahin|0332310500|drasahin@gmail.com|50510
21290237|NCT02327143|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21290238|NCT02180672|The Children's Hospital of Philadelphia|Ignacio Tapia, MD, Principal Investigator, Associate Professor|(267) 426-5842|tapia@chop.edu|
21290239|NCT03023683|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
21290241|NCT03008213|UCSD|Eric Roeland, MD|858- 534-7079|eroeland@ucsd.edu|
21290242|NCT01697501|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21290243|NCT02242903|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21290244|NCT03917901|University of Houston|Brooke Kauffman|(713) 743-8056|bkauffma@central.uh.edu|
21290245|NCT04498273|University of Pittsburgh|Dr. Frank Sciurba|412-648-6494|sciurbafc@upmc.edu|
21290246|NCT00779909|Boston University School of Dental Medicine|Raul I Garcia, DMD|617-638-6385|rig@bu.edu|
21290247|NCT00337194|The Ohio State University|Dr. Kristie Blum||kristie.blum@osumc.edu|
21290248|NCT01896986|MCRI|Dr. Nigel Crawford|9345 4772|nigel.crawford@rch.org.au|
21232608|NCT02062879|UC Health University of Cincinnati Medical Center|Sheila Takieddine|513-585-6195|Sheila.Takieddine@UCHealth.com|
21232609|NCT00775645|SWOG Statistical Center|Study Statistician|206-667-4623||
21232610|NCT00665847|Tibotec Pharmaceuticals, Ireland|Senior Director|32 14 641 265|gdsmedt1@its.jnj.com|
21232611|NCT02192814|UCB Pharma|UCB Clinical Trial Call Center|+1877 822||9493
21232612|NCT02530554|Evic Romania|Dr. R Olsavszky|40 21 335 70 91|evicromania@evic.ro|
21232613|NCT00511667|Merck Sharp & Dohme|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21232614|NCT00616655|Sunovion|Eszopiclone Medical Director|866-503-7813|clinicaltrialdisclosure@sunovion.com|
21232615|NCT03761147|Hebrew Univeristy|Anna Shaphir|+972 50 716 7309|shaphira@hadassah.org.il|
21232616|NCT00309842|Masonic Cancer Center, University of Minnesota|Dr.Claudio G. Brunstein MD, PhD|612-625-3918|bruns072@umn.edu|
21232617|NCT03564145|Sol-Gel Technologies, Ltd.|Sol-Gel|972-8-9313433|info@sol-gel.com|
21232618|NCT02045797|GlaxoSmithKline|GSK Response Center|866-435-7343||
21232619|NCT00670800|University of Michigan|Yolanda Smith|(734) 936-7401|ysmith@umich.edu|
21232620|NCT03878745|Becton Dickinson|Michael Gibney|201-847-6170|Michael.gibney@bd.com|
21232621|NCT02355691|UNC Orthopaedics|Scott Eskildsen, MD|(919) 966-9166|seskilds@unch.unc.edu|
21232622|NCT00594997|Brigham and Women's Hospital|Nancy Shadick|617-732-5266|nshadick@partners.org|
21232623|NCT00583804|MetroHealth Medical Center|Principal Investigator|2169573683|ue.fes.clinicaltrials@gmail.com|
21232624|NCT01290640|The University of Tennessee|Dr. Richard Komistek, Professor|865-974-4159|rkomiste@utk.edu|
21232625|NCT01623323|OptiNose|Jennifer Carothers|908-432-3061|jennifer.carothers@optinose.com|
21232626|NCT02074631|University of Minnesota, Masonic Cancer Center|Dr. Kyriakie Sarafoglou|(612) 624-5965|saraf010@umn.edu|
21232627|NCT00778700|Incyte Organization|Study Director|1-855-463-3463|medinfo@incyte.com|
21232628|NCT03227029|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
21232629|NCT03274440|Columbia University/New York State Psychiatric Institute|Dr. Reilly Kayser|6467748118|reilly.kayser@nyspi.columbia.edu|
21232630|NCT01291173|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21232631|NCT00450450|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21232632|NCT04984993|Futura Medical Development Ltd.|Andrew Graham, Senior Clinical Project Manager|+44 1483 685682|Andy.Graham@futuramedical.com|
21232633|NCT01110707|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21232634|NCT03318315|University of Maryland School of Medicine|Kathleen M. Neuzil, MD, MPH|410-706-5328|kneuzil@som.umaryland.edu|
21232635|NCT02350881|Casa di Cura VIlla Berica|Dr Stefano Fieschi||stefanofieschi@gmail.com|
21232636|NCT00159250|Imperial College London|Francesco Muntoni|+44 02075941872|f.muntoni@ucl.ac.uk|
21232637|NCT01930747|az sint jan brugge|jan mulier|0032486729203|jan.mulier@azsintjan.be|
21232638|NCT00385996|Weill Cornell Medical College|Nasser Altorki, MD|212-746-5156|nkaltork@med.cornell.edu|
21232639|NCT03179995|Fox Chase Cancer Center|Protocol Development Coordinator|215-728-4097|ryan.romasko@fccc.edu|
21232640|NCT00674661|Avedro, Inc.|Vineeta Belanger, VP of Clinical Affairs|781-768-3459|vbelanger@avedro.com|
21232641|NCT00614315|Bard Peripheral Vascular, Inc.|John Reviere, Director, Clinical Affairs|480-303-2644|John.Reviere@crbard.com|
21232642|NCT00003901|Memorial Sloan Kettering Cancer Center|Valerie Rusch, MD|212-639-5873|ruschv@mskcc.org|
21232643|NCT00765375|DeNova Research|Jack Arkins, Data Manager|312-335-2070|jack@drdayan.com|
21232644|NCT02049307|Hennepin Healthcare Research Institute|Jason Baker|612-873-2705|baker@umn.edu|
21232645|NCT02659631|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21232646|NCT02377466|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21232647|NCT03035708|National Institute on Alcohol Abuse and Alcoholism|Health Scientist Administrator|301-443-0788|falkde@mail.nih.gov|
21232648|NCT01496313|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
21232649|NCT05167734|Mayo Clinic|Matthew Warner, M.D.|507-422-1714|Warner.Matthew@mayo.edu|
21232650|NCT01510379|The Ohio State University|Kyle A. Perry, MD|614-293-5815|kyle.perry@osumc.edu|
21232651|NCT00451321|GlaxoSmithKline|GSK Response Center|866-435-7343||
21232652|NCT00598663|University Children's Hospital Vrazov trg 1 SI-1525 Ljubljana, Slovenia|Tadej Battelino|+386 1 522 50 50|tadej.battelino@mf.uni-lj.si|
21232653|NCT00597766|MetroHealth Medical Center|Dr. Richard Wilson|216-957-3529|rwilson@metrohealth.org|
21232654|NCT00676455|Lahey Clinic|Christopher Wald, MD|781-744-8710|Christopher.Wald@lahey.org|
21232655|NCT01528254|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21279010|NCT04853992|LEO Pharma A/S|Clinical disclosure|+45 4494 5888|disclosure@leo-pharma.com|
21232656|NCT01166763|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-588-4523|bkimler@kumc.edu|
21232657|NCT01909479|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
21232658|NCT02049957|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21232659|NCT02810392|Wake Forest School of Medicine|Cheryl Bushnell, MD|336-713-2983|cbushnel@wakehealth.edu|
21232660|NCT01190878|InSite Vision|Senior Manager, Clinical Sciences||manjiri.desai@sparcmail.com|
21232661|NCT03715764|Region Västra Götaland, Närhälsan|PhD-student, Chan-Mei Ho-Henriksson|+46709892821|chan-mei.ho@vgregion.se|
21232662|NCT01551082|Alliance of Cardiac Vascular and Thoracic Surgeons|Jeremy Smith RN|4236245200|jsmith@actvsurgeons.com|
21232663|NCT01361464|H. Lee Moffitt Cancer Center and Research Institute|Jeffrey Lancet, M.D.|813-745-6841|jeffrey.lancet@moffitt.org|
21232664|NCT01106898|University of Nebraska Medical Center|Elizabeth Reed|402-559-5166|ereed@unmc.edu|
21232665|NCT01705652|The University of Texas Health Science Center at San Antonio Department of Radiation Oncology|Gregory P. Swanson, MD|210-450-1109|swansong@uthscsa.edu|
21232666|NCT00656474|Glycotex|Dr. Reinhard Koenig, CEO|301-670-2825|Reinhard.Koenig@glycotexinc.com|
21290249|NCT02944461|Skin Sciences, PLLC|M. McAllister|5024519000|mmdermresearch@yahoo.com|
21290250|NCT02193347|Duke University|Katy Peters, M.D., Ph.D.|919-684-6173|katherine.peters@duke.edu|
21290251|NCT03757715|UAB|Dr. Jessica W. Grayson|205-801-7801|jgrayson@uabmc.edu|
21290252|NCT00281580|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21290253|NCT04045145|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
21290254|NCT03374956|Mayo Clinic|Andres Acosta|507-266-6931|acosta.andres@mayo.edu|
21290255|NCT00276380|Ipsen|Medical Director||clinical.trials@ipsen.com|
21290256|NCT01018056|Johns Hopkins University|Dr. Harvey S. Singer|410-955-7212|hsinger@jhmi.edu|
21290257|NCT00983801|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21290258|NCT01651208|University of Miami|Ana M. Palacio|3052439754|apalacio2@med.miami.edu|
21290259|NCT02067156|University of California, San Diego Moores Cancer Center|Dr. David Piccioni|858-657-7000|dpiccioni@ucsd.edu|
21290260|NCT03596983|NYU Langone Health|Susan Malone, PhD, RN|212 992-7047|Susan.Malone@nyulangone.org|
21290261|NCT00736476|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21290262|NCT03733483|University of Colorado, Anschutz Medical Campus|Christine Swanson, MD, MCR, Assistant Professor|(303)724-0073|christine.swanson@cuanschutz.edu|
21290263|NCT01796470|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21290264|NCT00147537|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21290265|NCT01927861|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21290266|NCT00452530|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21290267|NCT02222181|Unesp|Fernanda Mariana de Oliveira|+551636640217|femoliveira12@gmail.com|
21290268|NCT03124602|Masimo|Tala Harake|9492977459|studies@masimo.com|
21290269|NCT00468546|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21290270|NCT02006654|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
21290271|NCT01933425|Herlev Hospital, University of Copenhagen, Department of Anesthesiology|Dr. Matias Vested Madsen|+4538689058|matias.vested.madsen@regionh.dk|
21290272|NCT01905267|University of Illinois at Chicago|Rachel Jacobs|3124139178|rjacobs@psych.uic.edu|312
21290273|NCT02294019|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21290274|NCT00846482|Montefiore Medical Center|Dr. Sanjay Goel|718-405-8404|sgoel@montefiore.org|
21290275|NCT01189227|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600||
21290276|NCT00684554|New York State Psychiatric Institute|Dr. Frances Levin|646-774-6137|frl2@columbia.edu|
21290277|NCT02991859|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21290278|NCT01016015|Memorial Sloan Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org|
21290279|NCT02774278|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21290280|NCT01312675|B. Braun Medical Inc.|Dr. Diana Velencia, Associate Director of Clinical Affairs|610-596-2875|diana.valencia@bbraunusa.com|
21290281|NCT03782103|Zurex Pharma|Andrew Morgan Exec. VP RA/QA Clinical|16082175239|amorgan1@charter.net|
21290282|NCT00930176|Bio Products Laboratory|Head of Medical Affairs|+44 20 8957 2200|medinfo@bpl.co.uk|
21290283|NCT00362609|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21290284|NCT05330429|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21290285|NCT06097273|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
21290286|NCT03020082|Ascletis Pharmaceticals Co., Ltd|Clinical Trial Disclosures|86057187707910|xin.li@ascletis.com|
21290287|NCT04857281|Mayo Clinic Arizona|Dr. Jay Pasricha|(480)301-4279|pasricha.jay@mayo.edu|
21290288|NCT01251965|The University of Texas (UT) MD Anderson Cancer Center|Srdan Verstovsek, Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
21290289|NCT01027754|Albert Einstein College of Medicine/Montefiore Medical Center|Dr. Shadi Nahvi|718 920 5379|SNAHVI@montefiore.org|
21290290|NCT02529488|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21290291|NCT01557244|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21232667|NCT03195088|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21290292|NCT01313676|GlaxoSmithKline|GSK Response Center|866-435-7343||
21279011|NCT02351960|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21290293|NCT02821000|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21290294|NCT05058456|Shockwave Medical|Kavita Arjungi|1-510-279-4262|karjungi@shockwavemedical.com|
21290295|NCT02933151|Dialysis Clinic, Inc. /Tufts Medical Center|Dr. Daniel Weiner|6176365070|dweiner@tuftsmedicalcenter.org|
21290296|NCT01832038|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21232668|NCT02998840|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
21279012|NCT01094886|Janssen Scientific Affairs, LLC|VP Medical Affairs, Internal Medicine|1 908 218-7250||
21279013|NCT03866902|University of Miami|Hudson Santos|3052845812|hsantos@miami.edu|
21279014|NCT02519738|University of Michigan|Ron Hirschl|734 764-6482|rhirschl@med.umich.edu|
21279015|NCT04180163|Takeda|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
21279016|NCT02092467|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21279017|NCT00371397|Ohio State University Institute for Behavioral Medicine Research|Janice Kiecolt-Glaser, PhD|614-292-0033|Kiecolt-Glaser.1@osu.edu|
21279018|NCT01284621|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21279019|NCT02392351|Boston Scientific|Clinical Trial Manager|970-294-4082|nicole.kilburn@bsci.com|
21279020|NCT02377427|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21279021|NCT02342639|University of Kansas Medical Center|Dr. Jason Stubbs|9135886074|jstubbs@kumc.edu|
21279022|NCT02293863|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21279023|NCT00704847|Nordic Bioscience A/S|Bente Juel Riis, Medical Director|+45 22901317|bjr@nordicbioscience.com|
21279024|NCT00416884|Center for Hematologic Malignancies|Center for Hematologic Malignancies|503-494-1551||
21279025|NCT03483363|The University of Texas Health Science Center at Houston|Nagi Demian, MDDS|(713) 500-5082|Nagi.Demian@uth.tmc.edu|
21279026|NCT03433755|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21279027|NCT03936101|Columbia University|Jessica L Giordano, CGC|516-521-5604|jlg2197@cumc.columbia.edu|
21279028|NCT06913153|Tianjin Medical University|Zhenqiang Song, M.S., Associate Professor and Master's Supervisor|8622-18602276218|Zsong@tmu.edu.cn|
21279029|NCT03785600|VA Portland Health Care System|Jonathan Elliott|503-220-8262|jonathan.elliott@va.gov|53874
21279030|NCT02185690|Princess Margaret Cancer Centre, University Health Network|Dr. Natasha Leighl, Sponsor-Investigator, Division of Medical Oncology|416-946-4645|natasha.leighl@uhn.ca|
21279031|NCT01143766|Indiana University|Gregory A. Cote|317-944-2740|gcote@iupui.edu|
21279032|NCT01328379|Acorda Therapeutics|Vice President - Clinical Development & Medical Affairs|(914) 347- 4300|hhenney@acorda.com|5138
21279033|NCT05264129|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21279034|NCT00998868|Seoul National University Hospital|Tai Ryoon Han, MD, PhD./Professor|+82-2-2072-3218|tairyoon@snu.ac.kr|
21279035|NCT01027195|The Cleveland Clinic|Wael K Barsoum, MD|216-444-7515|barsouw@ccf.org|
21232669|NCT01686633|GlaxoSmithKline|GSK Response Center|866-435-7343||
21239559|NCT00405639|Mayo Clinic|Dr. Horng H. Chen|507-538-2354|chen.horng@mayo.edu|
21290297|NCT02596893|Celgene Corporation|Anne Mcclain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
21290298|NCT03280615|Institute of Nutrition and Food Technology University of Chile|Dr. Francisco Perez Bravo, Director|+5629781411|fperez@inta.uchile.cl|
21290299|NCT03052257|Durham VA Medical Center, Durham, NC|Dr. Kelly Muir|919-286-0411|Kelly.Muir@va.gov|174035
21290300|NCT01934231|GlaxoSmithKline|GSK Response Center|866-435-7343||
21290301|NCT02457546|Ethicon, Inc.|Richard Kocharian, MD, PhD|1-908-218-2013|rkochar1@its.jnj.com|
21290302|NCT01489826|e-Therapeutics plc|Clinical Operations Manager|+44 1993 880000|contact@etherapeutics.co.uk|
21290303|NCT01755156|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21290304|NCT01052428|University of Alabama at Birmingham|Louis J. Dell'Italia, M.D.|205-934-0850|loudell@uab.edu|
21290305|NCT00871000|GlaxoSmithKline|GSK Response Center|866-435-7343||
21290306|NCT02695771|Corewell Health|Dr. Brian Lane|616-267-7333|brian.lane@corewellhealth.org|
21290307|NCT01061710|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21290308|NCT01234714|University of Zurich|Dr Dimitri Aristotle Raptis, Principal Investigator|+41442553300|dimitri.raptis@usz.ch|
21279036|NCT00826007|William Beaumont Hospital|Tamra Dukatz, CRNA, MSN|2489924741|tdukatz@beaumont.edu|
21290309|NCT02197065|Hospital for Special Surgery|Anne R. Bass, MD|212-774-7043|bassa@hss.edu|
21290310|NCT02771145|Alcon, A Novartis Division|Sr. Clinical Project Lead, GCRA, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21290311|NCT01391299|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21290312|NCT03473301|Duke University|Jesse D. Troy, PhD, MPH|919-668-1102|cordbloodtherapyinfo@dm.duke.edu|
21290313|NCT05287685|Florida International University|Shayl Griffith, PhD|305-348-9891|shagriff@fiu.edu|
21290314|NCT05529173|Rutgers - NJ Medical School|Dr. Dennis Grech|973 972-5007|grechde@njms.rutgers.edu|
21290315|NCT05965323|University of Washington|Linda K Ko, PhD, Principal Investigator|2062568261|lindako@uw.edu|
21290316|NCT00835549|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21290317|NCT03492385|SFJ Pharmaceuticals, Inc.|Michele LaRussa SVP, Chief Regulatory Officer|925-223-6233|Bentracimab.General@SFJ-Pharma.com|
21290318|NCT03760081|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
21290319|NCT00986102|Jan-Cil Singapore|VP MEDICAL AFFAIRS ASIA PACIFIC|+65 6827 6753||
21290320|NCT04008069|Stanford University, School of Medicine, Immunology & Rheumatology|Dr. Matthew C. Baker, Principal Investigator|650- 498-4528|mbake13@stanford.edu|
21290321|NCT04601493|University of Minnesota|Ezra Golberstein|612-626-2572|egolber@umn.edu|
21290322|NCT00965991|University of New Mexico|Lisa Moore|5052727028|hkhawaja@salud.unm.edu|
21290323|NCT02314247|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
21290324|NCT01953354|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21290325|NCT01570192|University of Florida, Department of Medicine|Dr. George L. Drusano|407-313-7060|gdrusano@ufl.edu|
21290326|NCT02965976|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-2300|Kris.Attwood@roswellpark.org|
21290327|NCT00806026|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21261173|NCT05490771|ECOG-ACRIN Cancer Research Group|Study Statistician|16176323012|eatrials@jimmy.harvard.edu|
21261174|NCT01472276|Queen's University, Belfast|Michelle McKinley, Professor|02890978936|m.mckinley@qub.ac.uk|
21261175|NCT00816036|Department of Veterans Affairs|David Katz, MD, MSc|319-338-0581|david-katz@uiowa.edu|7598
21261176|NCT00004980|Yale University School of Medicine|Ralph Hoffman|203-688-9734|ralph.hoffman@yale.edu|
21290328|NCT00819832|UT MD Anderson Cancer Center|Dawid Schellingerhout, MD/Asst. Professor||CR_Study_Registration@mdanderson.org|
21290329|NCT00930787|LifeCell|Dr Michael Franz|908094701100|mfranz@lifecell.com|
21290330|NCT02261532|Taiho Pharmaceutical co., ltd.|Clinical Trial Registration Contact|+81-3-3293-2113|toiawase@taiho.co.jp|
21290331|NCT01063881|Janssen Research & Development, LLC|Sr. Director CDTL, RA CVM Urology|1 908 704-4648||
21290332|NCT01340170|Dentsply Sirona Implants|Manager of Global Clinical Reseach|+46313763500|clinicalresearchmolndal@dentsplysirona.com|
21290333|NCT01248468|Novartis Consumer Health|Clinical Project Leader|973-503-8000||
21290334|NCT02191397|GlaxoSmithKline|GSK Response Center|866-435-7343||
21232670|NCT00056407|GlaxoSmithKline|GSK Response Center|866-435-7343||
21232671|NCT03605303|Johnson & Johnson Vision Care Inc.|Brian Pall OD, MS, FAAO - Director of Clinical Sciences|9044431290|BPALL@its.jnj.com|
21232672|NCT01026792|BC Cancer Agency, Vancouver Clinic, Vancouver, BC, Canada|Dr. Anna Tinker|604 877 6217|atinker@bccancer.bc.ca|
21232673|NCT01364207|Massachusetts Eye and Ear Infirmary|Dr. Louis R. Pasquale|617-573-4240|aliya_jiwani@meei.harvard.edu|4240
21232674|NCT03143569|WASHINGTON UNIVERSITY|Thomas J Graetz|3147474155|graetzt@wustl.edu|
21232675|NCT01472081|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21232676|NCT04702997|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21232677|NCT02811445|Tufts University HNRCA|Michael Lustgarten|617-556-3399|Michael.Lustgarten@tufts.edu|
21232678|NCT01386554|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
21232679|NCT00353262|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21232680|NCT05286307|NYU Langone Health|Eric J Strauss, MD|646 501-7223|Eric.Strauss@nyulangone.org|
21232681|NCT02759471|CooperVision|Senior Manager Global Medical Scientific Affairs|1-925-621-3761|javega@coopervision.com|
21232682|NCT06029673|Stanford University|Research Team|(650) 497-5175|gynresearch@stanford.edu|
21232683|NCT01103284|CBR International|Dr. Jeanne Novak|7207461190|jnovak@cbrintl.com|
21232684|NCT03730948|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
21232685|NCT01786629|Braintree Laboratories, Inc.|John McGowan, Director Clinical Research|781-843-2202|jmcgowan@braintreelabs.com|
21232686|NCT00410761|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21232687|NCT03694171|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
21232688|NCT02659709|Wills Eye Hospital, Glaucoma Service|Dr. Jonathan S. Myers|215-928-3197|jmyers@willseye.org|
21232689|NCT00312494|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21232690|NCT02642614|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21232691|NCT03540147|University of Texas at Austin|Hirofumi Tanaka|5122324801|htanaka@austin.utexas.edu|
21232692|NCT01349803|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
21232693|NCT03232281|Ipsen Pharma|Medical Director|see email|clinical.trials@ipsen.com|
21232694|NCT01403246|GIMEMA|Alfonso Piciocchi|+393203671224|a.piciocchi@gimema.it|
21232695|NCT03633487|Reckitt Benckiser, Inc|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
21232696|NCT00605813|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21232697|NCT01172847|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21232698|NCT01163279|Baycrest Health Sciences|Dr. Deirdre Dawson|416-785-2500|ddawson@research.baycrest.org|2136
21232699|NCT00183092|UCaliforniaSF|Michael Geschwind, MD, PhD|415-476-2901|mgeschwind@memory.ucsf.edu|
21232700|NCT00665353|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21232701|NCT00573755|Mayo Clinic|Dr. Vivek Roy|507-284-1159|roy.vivek@mayo.edu|
21232702|NCT03724812|Abbott|Angelic Roach|+1 651 756 3379|angelic.roach@abbott.com|
21232703|NCT00870363|University of California Davis Medical Center|David M Asmuth|(916) 734-8695|dasmuth@ucdavis.edu|
21232704|NCT01870583|Stony Brook Medicine|Dr David Garry|631-444-7650|david.garry@stonybrookmedicine.edu|
21232705|NCT00390858|Novartis Pharmaceuticals|Study Director|862-778-8300||
21232706|NCT00587483|Mayo Clinic|Dr. William Mauermann|507-255-4240|mauermann.william@mayo.edu|
21232707|NCT01230801|BioMarin Pharmaceutical Inc.|Manager, Clinical Operations|415-455-7448|Slava.Titov@bmrn.com|
21232708|NCT02865187|Wright State University|Steven R Lindheim|858-740-1083|doclalalindheim@gmail.com|
21232709|NCT04267133|University of Rochester|Jean-Philippe Couderc, PhD|585-275-1096|heartjpc@heart.rochester.edu|
21232710|NCT02369341|GlaxoSmithKline|GSK Response Center|866-435-7343||
21232711|NCT02972554|University of North Carolina at Chapel Hill|Dr. Keely A. Muscatell|919-843-9113|kmuscatell@unc.edu|
21232712|NCT03756688|Mayo Clinic|Dr. Landon Trost|507-202-1995|landontrost@gmail.com|
21232713|NCT05319795|University Health Network|Professor Catriona Steele|4165973422|catriona.steele@uhn.ca|7802
21232714|NCT00857220|Sunovion|CNS Medical Director|866-503-6357||
21232715|NCT02612428|Vital Therapies, Inc.|Robert Ashley, Chief Technical Officer|001 858-673-6840|rashley@vitaltherapies.com|
21232716|NCT00742001|Terumo BCT|Marty Huntington / Sr Mgr Global Clinical Affairs|+1 (303) 231-4849|Marty.Huntington@terumobct.com|
21232717|NCT00137423|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21232718|NCT03611790|BioMDg, CRO for VITAL Study|Sigi Caron, President and CEO at BioMDg|(831) 346-6970|sigi@biomdg.com|
21232719|NCT03187262|Dana-Farber Cancer Institute|Dr. Jorge Castillo|617-632-2681|jorgej_castillo@dfci.harvard.edu|
21232720|NCT03254927|Celldex Therapeutics|Chief Medical Officer|844-723-9363|info@celldex.com|
21232721|NCT01341964|Population Health Reseach Institute, Hamilton, ON, Canada|Lynda Hill|905-297-3479|Lynda.Hill@phri.ca|40323
21232722|NCT00909389|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21232723|NCT01516424|Shang Hai Mental health center|Dr.HuafangLi|13641625395|lhlh_5@163.com|
21232724|NCT01608659|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21232725|NCT00737282|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
21232726|NCT02763189|Wake Forest School of Medicine|Dr. Michael A. Olympio|3369182132|molympio@wakehealth.edu|
21232727|NCT03626623|Integra LifeSciences|Allison Matthews|(443) 766-3869|allison.matthews@integralife.com|
21290335|NCT00318136|Genentech, Inc.|Medical Communications|800-821-8590||
21232728|NCT00416078|VAGLAHS at West Los Angeles|Dr. Theodore Hahn|3102684108|thahn@ucla.edu|
21232729|NCT00989014|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
21232730|NCT03439670|ReveraGen BioPharma Inc.|Dr. Eric Hoffman|301-762-7980|ericphoffman@gmail.com|
21232731|NCT03388294|University of North Carolina at Chapel Hill|Linda R. Watson, EdD|919-966-1007|lwatson@med.unc.edu|
21232732|NCT01710254|University of Utah, Dept. of Radiology Research|Edward DiBella, Ph.D.|801-585-5543|edward.dibella@hsc.utah.edu|
21232733|NCT02626520|Essentia Health|Dr. Bret Friday|218-786-3625|bret.friday@essentiahealth.org|
21232734|NCT00492115|UCSD|Dr. Sonia Ancoli-Israel|858 822 7710|sancoliisrael@ucsd.edu|
21232735|NCT00319644|University of California, San Francisco|Julin Tang, MD|415-206-5274|tangj@anesthesia.ucsf.edu|
21232736|NCT03915496|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21232737|NCT02472795|Viatris Innovation GmbH|Viatris Innovation Clinical Trial Information|+1 908 435 2675|viatrisinnovationclinicaltrials@viatris.com|
21232738|NCT04166513|Medical College of Wisconsin|Sara Pillay|414-955-4482|Sapillay@mcw.edu|
21232739|NCT04616547|Markey Cancer Center|Dr. Zin Myint|866-340-4488|zin.myint@uky.edu|
21232740|NCT04219891|Alcon Research, LLC|Clinical Projects Director, Surgical|8884513937|alcon.medinfo@alcon.com|
21232741|NCT00597012|The Brigham and Women's Hospital|Jeffrey N. Katz, MD, MSc|617-732-5338|jnkatz@bwh.harvard.edu|
21232742|NCT05636098|Masimo Corporation|Ahmed Alghazi|949-297-7000|studies@masimo.com|
21232743|NCT00696696|NYU Cancer Institute|Deirdre Cohen, MD|212-731-5656|deirdre.cohen@nyumc.org|
21232744|NCT01485640|Sunovion|Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
21232745|NCT05359666|Irrimax Corporation|Director of Clinical Trials|770-807-3355|cs@irrisept.com|
21232746|NCT00119392|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org|
21232747|NCT01851720|Johns Hopkins School of Medicine|Alex Coon|410-955-2438|acoon2@jhmi.edu|
21232748|NCT01394523|Nationwide Children's Hospital|Tarun Bhalla, MD|6147224200|Tarun.Bhalla@nationwidechildrens.org|
21232749|NCT02389998|Boston Children's Hospital|Dr Samuel Nurko|6173556055|samuel.nurko@childrens.harvard.edu|
21232750|NCT03525574|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21232751|NCT00905554|Valduce Hospital - Como - Italy|Vittorio Terruzzi, MD|+39031324009|vterruzzi@valduce.it|
21232752|NCT04741074|Geisinger|Alexander Chang|570-271-8026|achang@geisinger.edu|
21232753|NCT01770379|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
21232754|NCT01516957|Bausch Health|Director of Clinical Trials|310-770-7750|anya.loncaric@bauschhealth.com|
21232755|NCT02929823|PPD|Joseph Pollard|+1 910 558 4428|joseph.pollard@ppdi.com|
21232756|NCT05855005|Northwestern University|Kendra Marks|2069991423|kendra.marks@northwestern.edu|
21232757|NCT06119529|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21232758|NCT01074450|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21232759|NCT03226392|Novartis pharmaceutical|Study Director|862-778-8300|Novartis.email@novartis.com|
21232760|NCT02728895|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21232761|NCT02769247|Walter Reed National Military Medical Center|Dr. Shana Miles|318 456 6389|shana.m.miles2.mil@mail.mil|
21232762|NCT04788953|Brigham and Women's Hospital|Dr. Kirsi-Marja Zitting|617-525-8339|kzitting@bwh.harvard.edu|
21232763|NCT00937157|Buffalo Neuroimaging Analysis Center|Robert Zivadinov, MD, PhD|716-859-7040|rzivadinov@bnac.net|
21232764|NCT00469092|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21232765|NCT02402309|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
21232766|NCT02621242|University of Washington|Dr. Joanne Stekler|206-744-8312|jstekler@uw.edu|
21232767|NCT04344314|Becton, Dickinson and Company|Christopher Rini, Associate Director Translational and Clinical Sciences Center of Excellence|+1 984 389 1186|christopher.rini@bd.com|
21232768|NCT01998737|Bone Index Finland Ltd.|CTO|+358 45 896 2650|janne.karjalainen@boneindex.fi|
21232769|NCT02092662|University of Haifa|Sharon Israely|972-523-755-091|sharonis@mh.org.il|
21232770|NCT02268864|Janssen Research and Developement, Belgium|Trial Physician||ClinicalTrialDisclosure@its.jnj.com|
21232771|NCT05407675|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21232772|NCT01050257|Hoffman-LaRoche|Medical Communications|800-821-8590||
21232773|NCT00171223|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21232774|NCT00584558|University of Oklahoma Health Sciences Center|Karen Beckman, MD|405-271-9696|karen-beckman@ouhsc.edu|37536
21232775|NCT00278109|Indiana University School of Medicine|Richard Zellars MD|3179444505|rzellars@iu.edu|
21232776|NCT02064166|Brigham & Women's Hospital|Peter Novak, MD PhD|617-732-8896|pnovak2@bwh.harvard.edu|
21232777|NCT04339296|Health Systems Evaluation & Evidence - Alberta Health Services|Research and Evaluation Coordinator|4036489255|armghan.ahmad@albertahealthservices.ca|
21232778|NCT00278655|Northwestern University|Dr Richard Burt|312-908-0059|rburt@northwestern.edu|
21232779|NCT00310791|Children's Hospital Boston|Dr. Catherine Gordon|401-444-4712|cgordon1@lifespan.org|
21232780|NCT00383149|Organization: Bristol-Myers Squibb|Name/Official Title: BMS Study Director||Clinical.Trials@bms.com|
21232781|NCT01166724|Cleveland Clinic|Dr. Stuart Flechner|216 445-5772|FLECHNS@ccf.org|
21232782|NCT03721276|Yale University|Dr. John Pachankis|6463444060|john.pachankis@yale.edu|
21232783|NCT01150981|University of Massachusetts Medical School|Samir Malkani, MD|5088563800|samir.malkani@umassmemorial.org|
21232784|NCT01340898|GlaxoSmithKline|GSK Response Center|866-435-7343||
21239560|NCT02081456|Cayuga Medical Center|Dr. Michael Costello, PT, DSc, OCS, MTC|607-252-3500|mcostellopt@gmail.com|
21232785|NCT02375113|The University of Texas at San Antonio|Dr. Meizi He|2104585416|meizi.he@utsa.edu|
21232786|NCT00734903|VA BOSTON|Lisa Najavits, PhD|617-299-1620|lisa.najavits@va.gov; najavits@bu.edu|
21232787|NCT00969150|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
21232788|NCT01879332|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21232789|NCT00461682|GlaxoSmithKline|GSK Response Center|866-435-7343||
21232790|NCT03305822|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
21232791|NCT03087760|University of Pennsylvania|Ching Lai|267-250-9244|ching.lai@pennmedicine.upenn.edu|
21232792|NCT02573857|Medicines for Malaria Venture|Dr Joerg Moehrle|+41 22 555 0330|moehrlej@mmv.org|
21232793|NCT04128267|Vanderbilt-Ingram Cancer Center|Teresa Melton|(615) 936-7423|teresa.melton@vumc.org|
21232794|NCT05020990|CooperVision Inc.|Director Global Clinical Affairs|+19256213761|jvega2@coopervision.com|
21232795|NCT04501666|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
21232796|NCT00642941|F. Hoffmann-La Roche AG|Study Director|+41 616878333|global.trial_information@roche.com|
21232797|NCT01183897|Memorial Sloan Kettering Cancer Center|Brian Kushner MD|212-639-6793|kushnerb@mskcc.org|
21232798|NCT03051607|Acorda Therapeutics|Christopher Kenney, Senior Vice President - Medical Affairs|9143265775|ckenney@acorda.com|
21232799|NCT01505868|UT MD Anderson Cancer Center|Paul Corn, MD PHD- Chair Ad Interim, Genitourinary Medical Oncology|(713) 563-7208|pcorn@mdanderson.org|
21232800|NCT01196923|CardioFocus, Inc.|Burke Barrett, VP, Regulatory & Clinical Affairs|508 658-7200|bbarrett@cardiofocus.com|
21232801|NCT00553150|Mayo Clinic|Jann N. Sarkaria, M.D.|507/284-3559|sarkaria.jann@mayo.edu|
21232802|NCT00706407|Weill Cornell Medical College|Dr. Alexis Te|646-962-4811|aet2005@med.cornell.edu|
21232803|NCT03251079|Senseonics, Incorporated|Katherine Tweden, PhD|651.335.2205|Katherine.Tweden@senseonics.com|
21232804|NCT02658357|Braeburn|Christine Kampf|6104678728|ckampf@braeburnrx.com|
21232805|NCT00951808|New England Research Institutes|Hae-Young Kim|617-972-3251|hkim@nerisicence.com|
21232806|NCT03204305|Johns Hopkins School of Medicine|Dr. Elise M. Weerts, PhD, Professor|443-550-2781|eweerts@jhmi.edu|
21232807|NCT01865539|Canandaigua VA Medical Center|Dr. Paul Dougherty, PI|585-463-2673|paul.dougherty@va.gov|
21232808|NCT01603459|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
21232809|NCT00196716|Genzyme Corporation|Genzyme MedInfo|800-745-4447|medinfo@genzyme.com|
21232810|NCT00399360|Massachusetts General Hospital|Dr. Steven Grinspoon, Principal Investigator|617-726-3890|sgrinspoon@partners.org|
21232811|NCT00535223|Atlanta VA Medical Center|David J. Ready,Ph.D.|(404) 321-6111|David.Ready@va.gov|7082
21232812|NCT00631566|Infectious Disease Clinical Research Program, USUHS and HJF|Dr. Brian Agan, Deputy Science Director|301-816-8446|bagan@idcrp.org|
21232813|NCT01367158|Novartis Vaccines|Posting Director||RegistryContactVaccineUS@novartis.com|
21232814|NCT01765153|University of Alberta|Dr. Jaynie Yang|780-492-2894|jaynie.yang@ualberta.ca|
21232815|NCT02663674|Duke Clinical Vaccine Unit|Emmanuel Walter, M.D., M.P.H.|919-620-5346|walte002@mc.duke.edu|
21232816|NCT02893878|GlaxoSmithKline|GSK Response Center|866-435-7343||
21232817|NCT03712904|Thomas Jefferson University|Wenyin Shi, MD, PhD|(215) 955-6702|wenyin.shi@jefferson.edu|
21232818|NCT01852942|University of Minnesota|Timothy Schacker, MD|612-626-6577|olso7966@umn.edu|
21232819|NCT04693507|Antev Ltd|Carol MacLean|+447525177617|cmaclean@antev.co.uk|
21232820|NCT01277354|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu|
21232821|NCT01829516|University of California, San Francisco|Jennifer Mitchell, PhD|510-985-3921|jennifer.mitchell@ucsf.edu|
21232822|NCT04708886|Northwestern University Feinberg School of Medicine|Thomas Schnitzer|3125032315|tjs@northwestern.edu|
21232823|NCT01729754|Sun Pharma Advanced Research Company Limited|Head-Clinical Development|912266455645|clinical.trials@sparcmail.com|
21232824|NCT00602576|University of Pennsylvania|Dr. Ravi Amaravadi|2157965159|ravi.amaravadi@pennmedicine.upenn.edu|
21232825|NCT00772772|The Rockefeller University|Dr. Mansih Ponda|212-327-7631|mponda@rockefeller.edu|
21232826|NCT00861146|Yale University School of Medicine|Ned L. Cooney, PhD|860-594-6339|ned.cooney@yale.edu|
21232827|NCT02489344|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21232828|NCT01132482|National Jewish Health|Jennifer Taylor-Cousar, Principal Investigator|3032702764|Taylor-CousarJ@NJHealth.org|
21239561|NCT02101918|UT MD Anderson Cancer Center|Dr. Daniel M. Halperin/ GI Medical Oncology|713-792-2828|DMHalperin@mdanderson.org|
21239562|NCT01508013|East Tennessee State University|Dr. Joel Hillhouse|423-439-4332|hillhous@etsu.edu|
21279037|NCT02245412|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
21279038|NCT01056289|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21279039|NCT01917916|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21279040|NCT01650584|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
21279041|NCT01794455|Vanderbilt University|Dr. Warren Taylor|615-936-3555|warren.d.taylor@vanderbilt.edu|
21279042|NCT00270855|Penn State Hershey Medical Center|Dr. David Gater|7175314263|dgater@hmc.psu.edu|
21279043|NCT05424679|Johns Hopkins Center for Indigenous Health|Dr. Emily Haroz|(410) 449-0051|eharoz1@jhu.edu|
21279044|NCT03301649|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
21279045|NCT00674739|Graceway Pharmaceuticals|Robert Babilon, Vice President, Product Development|267-948-0400|robert.babilon@gracewaypharma.com|20428
21279046|NCT00887289|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21279047|NCT03134248|CooperVision|Jose A.Vega OD MSc., FAAO|9256213761|javega@coopervision.com|
21279048|NCT03022084|VA RR&D National Center for Rehabilitative Auditory Research|Dr. James Henry|503-220-8262|James.Henry@va.gov|
21279049|NCT04176406|Duke University|Dr. Lawrence G. Appelbaum|919-613-7664|greg@duke.edu|
21232829|NCT05333900|University of Minnesota|Alexander Khoruts|612-624-2101|khoru001@umn.edu|
21232830|NCT02024867|University at Buffalo|Dr. Lucy Holmes|716-878-7277|LHolmes@upa.chob.edu|
21232831|NCT02150954|Duke University Medical Center|Chad Grotegut , MD||chad.grotegut@dm.duke.edu|
21232832|NCT03642210|Medicines360|Emily Morris|415.951.8700|emorris@medicines360.org|
21232833|NCT04473937|Massachusetts General Hospital|Chirayu Patel, MD|617-724-9627|CPATEL@MGH.HARVARD.EDU|
21232834|NCT01086540|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21232835|NCT03777007|Stanford University|Derek F. Amanatullah|(650) 723-2257|dfa@stanford.edu|
21232836|NCT00227305|AstraZeneca|Seroquel Medical Science Director, MD||AZTrial_Results_Posting@astrazeneca.com|
21232837|NCT00870896|University of South Florida|Thomas Truncale|813 974 8952|ttruncal@health.usf.edu|
21232838|NCT02707991|Johns Hopkins University|Laura Starbird|9787587909|Lstarbi1@jhu.edu|
21232839|NCT00527943|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21232840|NCT00535990|UCSD|Dr. Jonathan Li|6618603471|jzl023@health.ucsd.edu|
21232841|NCT01770483|SIMS|Prof. Faisal Masud|00923004260213|faisalmasud@hotmail.com|
21232842|NCT02580357|Institute of Science and Technology of São José dos Campos (Unesp)|Dr. Mauro P. Santamaria|+55 (16) 981937777|mauro.santamaria@ict.unesp.br|
21232843|NCT03706053|UVA Health|Dr. Alex Kadl|434-243-4851|AK5SC@uvahealth.org|
21232844|NCT02315170|Raj K M|Raj K Maturi MD|3178171414|maturi.md@midwesteye.com|
21232845|NCT00619801|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
21232846|NCT00450333|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21232847|NCT02172742|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|francisco.rocha@bial.com|
21232848|NCT01471106|M D Anderson Cancer Center|Dr. Arun K. Banu|(713) 792-2817|barun@mdanderson.org|
21232849|NCT01689701|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Sang-Wook Kim, MD|82-63-276-8284|clickm@jbnu.ac.kr|
21232850|NCT02417701|Memorial Sloan Kettering Cancer Center|Dr. Paul Paik, MD|646-608-3759|paikp@mskcc.org|
21232851|NCT01214629|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21232852|NCT03107754|University of Hawaii|Dr. Reni Soon|808-983-6000|rsoon@hawaii.edu|
21232853|NCT00877383|Novartis Pharmaceuticals|Study Director|862 778-8300||
21232854|NCT00459108|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
21232855|NCT01857232|Acacia Pharma Ltd|Dr Gabriel Fox|+44-(0)1223-875149|GabrielFox@acaciapharma.com|149
21232856|NCT01829230|Vistakon USA|XU CHENG, PRINCIPAL CLINICAL SCIENTIST|1 904 443-1245|xcheng6@its.jnj.com|
21232857|NCT00233103|Icahn School of Medicine at Mount Sinai|Wayne A Gordon, PhD|212-659-9372|wayne.gordon@mssm.edu|
21232858|NCT02733588|Joslin Diabetes Center|Mary-Elizabeth Patti, MD|617-309-2665|mary.elizabeth.patti@joslin.harvard.edu|
21232859|NCT03855280|Medexus Pharma|Julissa Leon|3125483125|julissa.leon@medexus.com|
21232860|NCT03676218|Institut Bergonié, Bordeaux Comprehensive Cancer Center|Carine Bellera, PhD|+33 5 56 33 04 95|c.bellera@bordeaux.unicancer.fr|
21232861|NCT05027438|VA Pittsburgh Healthcare System|Adam Bramoweth, PhD (Principal Investigator)|(412) 360-2806|adam.bramoweth@va.gov|
21232862|NCT00555750|Brigham and Women's Hospital|Dr. John Winkelman, MD, PhD|617-278-0061|jwwinkelman@partners.org|
21232863|NCT04568590|Wake Forest University School of Medicine|Elizabeth Halvorson, MD, MS|336-716-4999|ehalvors@wakehealth.edu|
21232864|NCT02315755|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21232865|NCT01190254|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21232866|NCT00773292|Imperial College London|Graham P Taylor|0207 594 3910|g.p.taylor@imperial.ac.uk|
21232867|NCT04105998|Wake Forest University School of Medicine|Dr. James Eisenach|336-716-4182|jimeisenach@gmail.com|
21232868|NCT02604212|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
21232869|NCT04232670|Oregon Health and Science University|Gregory Cote|503-494-4373|coteg@ohsu.edu|
21232870|NCT03742037|Viatris Innovation GmbH|Viatris Innovation Clinical Trial Information|+1 908 435 2675|viatrisinnovationclinicaltrials@viatris.com|
21232871|NCT04447755|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21232872|NCT00071760|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21232873|NCT02073279|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21232874|NCT01994629|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21232875|NCT05074693|University of Houston|Michael Zvolensky, Ph.D.|713-743-8056|mjzvolen@Central.UH.EDU|
21232876|NCT03338062|IndianaU|Dr. Ryan Rhome|(317) 944-1367|rrhome@iu.edu|
21232877|NCT04600414|University of Washington|John Fortney, Professor|2066856955|fortneyj@uw.edu|
21232878|NCT01092559|GeNO, LLC|Director of Clinical Development|321-785-2613|matthew.rush@genollc.com|
21232879|NCT01270711|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21232880|NCT03424265|University of Arkansas for Medical Sciences|Scott Schutzler, R.N.|501-526-5734|seschutzler@uams.edu|
21232881|NCT01422772|Helixmith Co., Ltd.|Jinsub Lee PhD|+82-10-8256-0439|jinsub.lee@helixmith.com|
21232882|NCT00453544|UC San Diego|Dr. Barton Palmer|858-246-0765|bpalmer@ucsd.edu|
21232883|NCT01558752|The Ottawa Hospital Research Institute|Dr Paul Beaule|613-737-8899|pbeaule@toh.ca|73265
21239563|NCT01336621|GlaxoSmithKline|GSK Response Center|866-435-7343||
21239564|NCT02487095|National Cancer Institute|Dr. Anish Thomas|240-760-7343|thomasa6@nih.gov|
21239565|NCT02934620|Ohio State University, College of Public Health|Maria Gallo|16146882145|gallo.86@osu.edu|
21232884|NCT01980355|Spectrum Health|G. Paul Wright, MD|6162678540|paul.wright@spectrumhealth.org|
21232885|NCT04340362|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21232886|NCT01601782|University of Michigan|Jon Jacobson, MD|734-936-4365|jjacobsn@umich.edu|
21232887|NCT01347008|Federal University of Sao Paulo|Fernando Villela Andrigueti, MD|+55 11 55764239|fernando.andrigueti@usp.br|
21232888|NCT00391274|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21232889|NCT00894322|Clinical Trial Transparency|AstraZeneca||Clinical.Trial.Transparency@astrazeneca.com|
21232890|NCT00531817|Hoffmann-La Roche|Medical Communications|800-821-8590||
21232891|NCT03338855|AstraZeneca|Global Clinical Lead|+1 877-240-9479|information.center@astrazeneca.com|
21279050|NCT02679235|University of Sherbrooke|Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
21279051|NCT03634475|Panoptes Pharma|Study Director|+43 664 851 5865|ssperl@kiorapharma.com|
21279052|NCT00554606|Novartis|Study Director|+41613241111|Novartis.email@novartis.com|
21279053|NCT00923273|National Cancer Institute|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov|
21279054|NCT00605540|HC/FMB-Unesp|Renata Ferrari|55 14 38116213|renataferrarifisio@gmail.com|
21279055|NCT00509366|Duke University|Neal Ready, MD, PhD|919-681-6932|neal.ready@duke.edu|
21279056|NCT01235195|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21279057|NCT02119819|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21279058|NCT01171118|University of Rochester|Dr. Suzanne Karan|585-275-5161|suzanne_karan@urmc.rochester.edu|
21279059|NCT00282919|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21279060|NCT01327508|Smith & Nephew, Inc.|Cathy Newbill|800-821-5700|cathy.newbill@smith-nephew.com|
21279061|NCT01438996|Novartis Vaccines Institute for Global Health|Dr. Audino Podda|+39 0577 243496|audino.podda@novartis.com|
21279062|NCT04505956|Vanderbilt University Medical Center - Department of Urology|Nicole Miller, M.D.|(615) 322-3807|nicole.miller@vumc.org|
21279063|NCT01631071|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
21279064|NCT04497948|AstraZeneca|Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21232892|NCT03965533|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21279065|NCT02246114|The Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-6210|rsl1@psu.edu|
21232893|NCT00112593|Fred Hutchinson Cancer Research Center|Ann Woolfrey, MD|206-667-4453|awoolfre@fredhutch.org|
21232894|NCT00975481|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21232895|NCT01895855|Emergent BioSolutions Canada Inc.|David Cassie, Scientist, Clinical Research|204-275-4589|dcassie@ebsi.com|
21232896|NCT03559257|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21232897|NCT02738450|AC Immune|Olivier Sol|+41 21 345 91 21|clinicaltrials@acimmune.com|
21232898|NCT03630120|Moffitt Cancer Center|Christine Chung, MD|813-745-5061|Christine.Chung@moffitt.org|
21232899|NCT01519960|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|61 6878333|global.trial_information@roche.com|
21232900|NCT01387347|ReGenTree, LLC|Won S. Yang, President & CEO|609-734-4328|wonsyang@regentreellc.com|
21232901|NCT01169610|Mayo Clinic|Mark A. Frye, MD|507-255-9391|mfrye@mayo.edu|
21232902|NCT02654483|Stanford University|Irene Bailey, CRC|650-721-7149|baileyhi@stanford.edu|
21232903|NCT00561080|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21232904|NCT01165554|GE Healthcare|Dr. Paul Sherwin|1-609-514-6820|paulsherwin@ge.com|
21232905|NCT02014844|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
21232906|NCT02953314|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21232907|NCT02335099|University of Virginia|Emaad Abdel-Rahman, MD|434-924-5820|ea6n@virginia.edu|
21232908|NCT01288287|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
21232909|NCT03194555|Allodynic Therapeutics, Inc.|Dr. Annette Toledano, Sponsor-Investigator|+13058956808|annette.toledano@allodynic.com|
21232910|NCT01831154|James A Haley Veterans Hosptial|Dr. Sierra Gower|(813) 972-2000|sierra.gower@va.gov|5946
21232911|NCT01641692|GlaxoSmithKline|GSK Response Center|866-435-7343||
21232912|NCT03831347|Butler Hospital|Dr. Lisa Uebelacker|401-455-6200|LUebelacker@butler.org|
21232913|NCT01685996|Johns Hopkins University School of Medicine|Dr. Annie Umbricht, M.D.|410-550-1917|annieumbricht@jhu.edu|
21232914|NCT00841087|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21232915|NCT04948450|National Geriatric Hospital|Dr Nguyen Xuan Thanh|0983277646|xuanthanhbmlk@hmu.edu.vn|
21232916|NCT00735787|Abbott Laboratories|Global Medical Services|1-800-633-9110||
21279066|NCT01917214|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21232917|NCT03251508|UNC Food Allergy Initiative|Edwin Kim, MD, MS|919-537-3193|edwinkim@email.unc.edu|
21232918|NCT00101907|Amgen Inc.|Study Director|866-572-6436||
21232919|NCT00624052|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21232920|NCT03930446|University of Chicago|Dr. Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
21232921|NCT03658538|Johns Hopkins University|Dr. Nadia Hansel|410-955-3841|nhansel1@jhmi.edu|
21232922|NCT02710890|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21232923|NCT00202644|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21232924|NCT02750592|Novartis Pharmaceuticals|Study Director|1-888-669-6682|novartis.email@novartis.com|
21232925|NCT02981342|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21232926|NCT01372501|GI Dynamics, Inc.|Clinical Affairs Manager|781.357.3261|pkeating@gidynamics.com|
21279067|NCT01957761|Ann & Robert H. Lurie Children's Hospital of Chicago|Larry Kociolek, MD, MSCI|312-227-4080|lkociolek@luriechildrens.org|
21232927|NCT01277523|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21279068|NCT03257865|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21279069|NCT01504958|Beth Israel Deaconess Medical Center|Alvaro Pascual-Leone, M.D., Ph.D.|617-667-0203|apleone@bidmc.harvard.edu|
21279070|NCT01421511|Cubist Pharmaceuticals, Inc.|Philippe Prokocimer, MD|858-452-0370|philippe.prokocimer@cubist.com|241
21279071|NCT05384171|VA Boston Healthcare system|Dr. Dawne Vogt|857-364-5976|dawne.vogt@va.gov|
21279072|NCT04040192|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21279073|NCT04074616|The University of Texas Health Science Center at Houston|Argyrios Stampas, MD|713-797-5938|argyrios.stampas@uth.tmc.edu|
21279074|NCT00875797|UMCLjubljana|Lidija Kompan, principal Investigator|0038651301781|lidija.kompan@gmail.com|
21279075|NCT03150407|J3 Bioscience, Inc|R. Tyler McCabe, Ph.D.|801-550-9956|tmccabe@j3bio.com|
21279076|NCT04893018|Cancer Immunotherapy Trials Network|Clinical Trial Manager|206-667-2541|citn.core.reg@hvtn.org|
21279077|NCT01739699|Northshore University Healthsystem, Evanston Hospital|Dr. Steven Greenberg|8475702760|sbgreenb@gmail.com|
21279078|NCT04482387|Cambridge University Hospitals NHS Foundation Trust|Stephen Kelleher|01223217418|research@addenbrookes.nhs.uk|
21279079|NCT01708967|Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea|Dr. Ki Tae Suk|+82-33-240-5826|ktsuk@hallym.ac.kr|
21279080|NCT00195338|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21279081|NCT01085357|Transcend Medical, Inc.|Vice President of Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
21279082|NCT00314951|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21279083|NCT02910011|University of Florida|Dr. Anna DeBenedetto|352 594 1500|adebenedetto@dermatology.ufl.edu|
21279084|NCT05084924|University of North Carolina at Chapel Hill|Justin Riddle, PhD|850-644-9869|justin_riddle@med.unc.edu|
21279085|NCT00717041|University of Rochester|Manish N. Shah, MD MPH|585-275-1198|manish.shah@rochester.edu|
21232928|NCT00302042|Northwestern University|Dr. Ronald T. Ackermann|3126036400|r.ackermann@northwestern.edu|
21232929|NCT01859494|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
21232930|NCT02432846|Immunicum Aktiebolag (AB)|Chief Medical Officer|+46 (0)8 732 84 00|info@immunicum.com|
21290336|NCT01950039|Joslin Diabetes Center|Mary Elizabeth Patti MD|617 309 2635|mary.elizabeth.patti@joslin.harvard.edu|
21239566|NCT04557826|EmitBio|Director of Clinical Trials|919-321-1734|info@emitbio.com|
21239567|NCT01474213|Department of Anaesthetics, Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Tong University, School of Medicine|Dr. Jiang Hong|86-21-13512122883|hr310@vip.sina.com.cn|
21239568|NCT02130284|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
21279086|NCT00182325|Department of Family Medicine, McMaster University|Dr. Heather Waters|(905) 575-6782|watersh@mcmaster.ca|
21279087|NCT01420965|Georgetown University|Dr. Samir Khleif|(202) 687-0100|snk48@georgetown.edu|
21279088|NCT02015065|National Cancer Institute|Dr. Brigitte Widemann|240-760-6203|widemanb@nih.gov|
21279089|NCT01120704|UWisconsin|Stevens Smith|608-262-7563|sss@ctri.medicine.wisc.edu|
21279090|NCT01292226|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21279091|NCT04106661|Husson University|William Lindblad, Director of Research and Scholarship|20-7992-1958|lindbladw@husson.edu|
21279092|NCT06154200|SCCO at MBKU|Dr. Jerry Paugh, Professor Emeritus|7144497487|jpaugh@ketchum.edu|
21279093|NCT03065218|MedStar Health Research Institute|Dr. Douglas Van Nostrand|202-877-0300|douglasvannostrand@gmail.com|
21279094|NCT01210612|University of Toledo Health Science Campus|Phillip Gribble|(419) 530-2691|pgribbl@UTNet.UToledo.Edu|
21279095|NCT02143648|Trevi Therapeutics|Thomas Sciascia, MD|203-304-2499|thomas.sciascia@trevitherapeutics.com|
21279096|NCT00813800|Mayo Clinic|Mark Frye, MD|507-255-9391|mfrye@mayo.edu|
21279097|NCT01860677|McLean Imaging Center, McLean Hospital|Scott E. Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu|
21290337|NCT05370209|Circius Pharma AB|Maria Carlsson|+46 (0) 31-81 84 00|RAQA@circiuspharma.com|
21290338|NCT00472641|Stanford University School of Medicine|Dr. Po W. Wang|650-723-2483|wangp0@stanford.edu|
21290339|NCT03888482|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21290340|NCT00567229|Memorial Sloan Kettering Cancer Center|Dr. Hani Hassoun|212-639-3228|hassounh@mskcc.org|
21290341|NCT02882178|Institut Bergonié|Pr Simone Mathoulin-Pélissier|0556333333|s.mathoulin@bordeaux.unicancer.fr|
21290342|NCT05652140|Department of Physical Education and Sport Sciences, National Taiwan Normal University|Dr. Yu-Kai Chang|+886277493223|yukaichangnew@gmail.com|
21290343|NCT03375164|Sarepta Therapeutics, Inc.|Medical Director|888-727-3782|SareptAlly@sarepta.com|
21290344|NCT02402036|Levine Cancer Institute-Concord|Mohamed Salem, MD|704-403-1370|mohamed.salem@lcic.edu|
21290345|NCT00968968|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21290346|NCT04401293|System Director - Anticoagulation and Clinical Thrombosis Services Northwell Health at Lenox Hill Hospital Affiliation: Northwell Health|Alex Spyropoulos, MD|(212) 434-6776|aspyropoul@northwell.edu|
21290347|NCT03679884|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 58 844 00 00|clinical-trials-disclosure@idorsia.com|
21290348|NCT01026038|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21290349|NCT01083472|LifeCell|Sandra VanGuldener|310612504695|svanguldener@lifecell.com|
21290350|NCT00964444|Pinnacle Health|David B. Peisner MD|717-231-8472|dpeisner@pinnaclehealth.org|
21290351|NCT00480025|GlaxoSmithKline|GSK Response Center|866-435-7343||
21290352|NCT00682435|Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-7464|achang@montefiore.org|
21290353|NCT03721367|Baylor College of Medicine|Dr. Lindsay Burrage|832-822-4280|burrage@bcm.edu|
21290354|NCT01064622|University of Chicago|Hedy Kindler, MD|773-702-0360|hkindler@medicine.bsd.uchicago.edu|
21290355|NCT03772340|Vanda Pharmaceuticals Inc.|Vanda Pharmaceuticals Inc.|2027343400|clinicaltrials@vandapharma.com|
21290356|NCT01395537|Case Comprehensive Cancer Center|David Adelstein MD|216-444-9310|adelstd@ccf.org|
21290357|NCT04359680|Romark, L.C.|Sr. Director, Research Operations|8132828544|jessica.fulgencio@romark.com|
21290358|NCT03810365|School of Nursing, University at Buffalo|Dr Suzanne S. Dickerson|716-829-3254|sdickers@buffalo.edu|
21290359|NCT02255279|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
21290360|NCT00107614|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|pettynathanm@uams.edu|2461
21290361|NCT02722330|ENT Department, Royal Hallamshire Hospital, Sheffield|Professor Jaydip Ray|+44 (0)114 271 1900|jaydip.Ray@sth.nhs.uk|
21290362|NCT04392362|University of Pretoria|Dr. Amanda Makhubela|0722746091|neurosurgeon76@gmail.com|
21290363|NCT01897896|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21290364|NCT00432991|Weill Cornell Medicine, Department of Anesthesiology|Michele Steinkamp, Research Nurse Specialist|212-746-2953|mls9004@med.cornell.edu|
21290365|NCT00363467|H. Lee Moffitt Cancer Center|Jeffrey Lancet MD|813-745-6841|Jeffrey.Lancet@moffitt.org|
21290366|NCT05069415|Carolina Eyecare Physicians, LLC|Director of Clinical Trials|8438813937|hps@cepmd.com|
21290367|NCT02918630|The University of Texas Health Science Center at Houston|Jin Ho Yoon, PhD|(713) 486-2796|Jin.Ho.Yoon@uth.tmc.edu|
21290368|NCT00101400|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21290369|NCT03160573|University Health Resources Group|Sushma Nachnani, MS, PhD|(310) 645-8576|sushnach@yahoo.com|
21290370|NCT01620047|Gulf-to-Bay Anesthesiology Associates LLC|Director of Research|813-844-4413|rkarlnoski@fgtba.com|
21290371|NCT02389738|Johns Hopkins/NIH|Principal Investigator|4109558837|sjacks78@jhmi.edu|
21290372|NCT00382863|Paracor Medical, Inc.|Michael Kolber, General Manager, VP of Regulatory Affairs|408-734-6000|info@paracor.com|
21290373|NCT03400787|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
21290374|NCT03912805|Clinical Research Management Group|Patrick Murphy|(866) 337-1868|p.murphy@crmg-usa.com|
21290375|NCT03408808|NHS Grampian|Miss Katharine Hamlin|0845 456 6000|katharine.hamlin@nhs.scot|56755
21290376|NCT00449787|Montefiore Medical Center|Benjamin Friedman|718-920-6626|bwfriedmanmd@gmail.com|
21290377|NCT01585207|Icahn School of Medicine at Mount Sinai|Dr. Barbara J. Coffey|212-659-1663|Barbara.coffey@mssm.edu|
21290378|NCT02595437|Rockwell Medical, Inc|Clinical Project Manager|248-960-9009|sgrimberg@rockwellmed.com|
21290379|NCT02925143|Herlev Hospital|Dr. Jakob Thomsen|004538683868|dr.j@demants.dk|
21290380|NCT03574389|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21290381|NCT02923167|Spaulding Rehabilitation Hospital|Paolo Bonato|617-952-6319|pbonato@mgh.harvard.edu|
21290382|NCT05084885|Centre for Addiction and Mental Health|Dr. Nigel Turner|416-535-8501|nigel.turner@camh.ca|36063
21290383|NCT02094885|Ethicon, Inc|Jonathan Batiller, Senior Clinical Director|+1 908 218-2492|JBatill2@its.jnj.com|
21290384|NCT02003898|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
21232931|NCT01912287|NYU Langone Health|Naomi Simon|646-754-4507|Naomi.Simon@nyulangone.org|
21232932|NCT02631850|University of Massachusetts Lowell|Lynne Gauthier|9789345383|lynne_gauthier@uml.edu|
21232933|NCT01462084|Stanford Sleep Medicine|Michelle Cao, DO, FAASM|(650) 723-6601|michellecao2007@gmail.com|
21232934|NCT02278263|Ko Awatea|Dr Marinus Stowers|+64 276 0044|msto062@aucklanduni.ac.nz|2219
21232935|NCT04631029|Johns Hopkins University|Grants Administrative Manager|4439273568|JHCCCRO@jhmi.edu|
21232936|NCT01463644|McMaster University|Dr. Parameswaran Nair|905-522-1155|parames@mcmaster.ca|34934
21232937|NCT00326950|Eisai Call Center|Eisai Inc.|888-422-4743||
21290385|NCT05166902|CooperVision|Jose A Vega, OD, MSc, FAAO|9256213761|javega2@coopervision.com|
21232938|NCT01514760|University of Arkansas for Medical Sciences|Dr. Tamara T. Perry|501-364-3264|perrytamarat@uams.edu|43264
21232939|NCT00519818|Diurnal Ltd|Richard JM Ross|0044 114 2712386|r.j.ross@sheffield.ac.uk|
21279098|NCT00118131|Cancer Institute of New Jersey|Dr. Joseph Aisner|732-235-8675|aisnerjo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
21279099|NCT00418821|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21279100|NCT02823652|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21279101|NCT03155945|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
21279102|NCT02013674|ISCI / University of Miami Miller School of Medicine|Marietsy pujol / Senior Regulatory Specialist|305-243-7273|mpujol@med.miami.edu|
21279103|NCT04324073|Hopital Hotel-Dieu (AP-HP)|Dr Raphael Porcher|+33(0)1.42.34.89.87|raphael.porcher@aphp.fr|
21279104|NCT03722589|Centers for Disease Control and Prevention|Fatimah Dawood, Medical Officer|404-639-0431|hgj0@cdc.gov|
21279105|NCT01200069|Rutgers/New Jersey Medical School|Vasanti Tilak, MD|974 972-5254|tilakva@njms.rutgers.edu|
21279106|NCT04998851|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21279107|NCT00070499|SWOG Statistical Office|SWOG Leukemia Statistician|206-667-4408||
21279108|NCT00805467|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
21279109|NCT04308226|Division of General Internal Medicine, Massachusetts General Hospital|Travis Baggett, MD, MPH|617-643-9314|tbaggett@mgh.harvard.edu|
21279110|NCT01908907|Sanford Health|Lora Black, Senior Director of Clinical Research|605-328-1368|lora.black@sanfordhealth.org|
21279111|NCT00660907|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
21279112|NCT00618332|University of Chicago|Dr. Robert Naclerio|773-702-0080|rnacleri@surgery.bsd.uchicago.edu|
21279113|NCT00478244|Masonic Cancer Center, University of Minnesota|John E. Wagner, M.D.|612-626-2961|wagne002@umn.edu|
21279114|NCT02929056|Prisma Health|Dr. Thomas Oliver|864-454-8272|Tom.Oliver@prismahealth.org|
21279115|NCT00459043|DFCI|Robert Haddad|6176326725|robert_haddad@dfci.harvard.edu|
21279116|NCT05048329|NorthShore university HealthSystem|Nirav S Shah|847-570-3542|nshah@northshore.org|
21279117|NCT01403051|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21279118|NCT00591773|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21279119|NCT02135614|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21279120|NCT01433549|Alcon Research, Ltd.|R. Alan Landers, O.D., M.S., F.A.A.O.|1-888-451-3937|alcon.medinfo@alcon.com|
21279121|NCT02656069|Xeris Pharamaceuticals, Inc.|Martin J. Cummins, VP, Clinical Development|806-282-2120|mcummins@xerispharma.com|
21279122|NCT02549027|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21279123|NCT00127218|The Johns Hopkins Hospital, Department of Medicine, Division of Cardiology|Dr. Joao AC Lima|410-614-1284|jlima@jhmi.edu|
21279124|NCT02242045|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21279125|NCT00749892|UT MD Anderson Cancer Center|Dr. Arlene O. Siefker-Radtke,Professor, Genitourinary Medical Oncology|(713) 792-2830|asiefker@mdanderson.org|
21279126|NCT04581369|Indiana University|Eric Orman|317-278-1630|esorman@iu.edu|
21279127|NCT00780910|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21279128|NCT00089024|University of Nebraska Medical Center|Jean L Grem|402-552-3233|jgrem@unmc.edu|
21279129|NCT00106964|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
21279130|NCT03207243|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21279131|NCT03196219|Armata Pharmaceuticals, Inc.|Clinical Operations|3106652928|info@armatapharma.com|
21279132|NCT00168818|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21279133|NCT01056315|Grünenthal|Study Director|+49 (0)-241-569-3223|clinical-trials@grunenthal.com|
21279134|NCT00603837|University of Oklahoma Health Sciences Center|Doug Dannaway, MD|405-271-5215|douglas-dannaway@ouhsc.edu|42048
21279135|NCT04867174|University of Southern California|Professor Mireille Jacobson|(213) 740-5156|mireillj@usc.edu|
21279136|NCT00856375|Nektar Therapeutics|Study Director||medicalaffairs@nektar.com|
21279137|NCT02538965|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosur|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
21279138|NCT00627861|The Rogosin Institute|Warren Bobb, N.P.|212-746-9114|wab9006@nyp.org|
21279139|NCT00811928|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21279140|NCT04411914|Temple University|Mary Morrison, MD, MS|215=707=4037|mary.morrison@temple.edu|
21279141|NCT01504997|Shizuoka Cancer Center|Doctor Masanori Tokunaga|81-55098908777|m.tokunaga@scchr.jp|
21279142|NCT00233402|Photocure|Yngvil Kloster Thomas|+1 2167732505|ykt@photocure.no|
21279143|NCT03280381|PATH|Dr. Patricia S. Coffey|206-302-4704|pcoffey@path.org|
21279144|NCT03503864|Sun Yat-sen Memorial Hospital|Dr Yang Li|02081332045|drliyang@126.com|
21279145|NCT00423319|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21279146|NCT02639052|Lewis Katz School of Medicine at Temple University|Susan G. Fisher, M.S., Ph.D., Associate Dean and Director, Temple Clinical Research Institute|215-707-3577|susan.fisher@tuhs.temple.edu|
21279147|NCT00895414|Masonic Cancer Center, University of Minnesota|Dr. Anne Blaes|612-626-8138|blaes004@umn.edu|
21279148|NCT00478426|University Health Network - Princess Margaret Cancer Centre|Dr. Amit Oza|416-946-2082|amit.oza@uhn.ca|
21290386|NCT03436420|Emory University|Miriam Vos, MD|404-727-9930|mvos@emory.edu|
21290387|NCT01903720|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21290388|NCT00159874|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21290389|NCT01104870|United Therapeutics, Corp.|Kevin Laliberte, PharmD|919-425-8176|KLaliberte@unither.com|
21290390|NCT02150863|Massachusetts General Hospital|Elizabeth Morehouse, Clinical Research Coordinator|617-724-2168|emorehouse@partners.org|
21290391|NCT01853280|Massachusetts General Hospital|Dr. Craig Surman|617-726-8422|csurman@partners.org|
21290392|NCT00104884|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
21290393|NCT03654326|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21290394|NCT00835042|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21290395|NCT02662582|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
21290396|NCT04543786|University of Pittsburgh|Lee Fisher|412-383-1329|lef44@pitt.edu|
21290397|NCT00511199|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21290398|NCT00489359|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21290399|NCT03180138|Johns Hopkins University|Sanjay K Jain|4105028241|sjain5@jhmi.edu|
21290400|NCT01775410|Avinger, Inc.|Director of Clinical Trials|650 241 7030|tlawson@avinger.com|
21290401|NCT01260311|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21290402|NCT01903733|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21290403|NCT01714063|Department of Pediatrics UAMS/COM|Ariel Perlinkski MT||berlinskiariel@uams.edu|
21290404|NCT02633527|Supernus|Joseph Hull, PhD, Director Clinical Research|240-403-5324|jhull@supernus.com|
21290405|NCT03721107|4D pharma plc|Programme Development Director|+4401138950130|clinicaltrials@4dpharmaplc.com|
21290406|NCT00979615|Alcon Research, Ltd.|Maria J. Tort, PhD|(817) 302-5968|Maria.Tort@alconlabs.com|
21290407|NCT04818086|Virginia Commonwealth University|Dr. Frederick Gerald Moeller|804-828-4134|fgmoeller@vcu.edu|
21290408|NCT03377127|Beaumont Health|Dr. Alexandra Halalau|2485513481|alexandra.halalau@beaumont.org|
21290409|NCT01835431|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21290410|NCT02978508|Mayne Pharma LLC|Associate Director, Clinical Operations|919 573 7948|phoevos.hughes@maynepharma.com|
21290411|NCT02427672|Nanyang Technological University|Dr. Olivia Choy|(65)65921522|oliviachoy@ntu.edu.sg|
21290412|NCT02687165|New York State Psychiatric Institute|Alla Landa PhD|6467746717|AL2898@cumc.columbia.edu|
21290413|NCT02792257|Johns Hopkins University|Dr. Paul Rosenberg|4105509883|prosenb9@jhmi.edu|
21290414|NCT02946996|Medical University of South Carolina|Tricia Bentz CTO Administrative Director|8437921415|adraleta@musc.edu|
21290415|NCT04967417|Samsung Medical Center|Myung-Ju Ahn|+82-2-3410-3438|silkahn@skku.edu|
21290416|NCT02151604|Oxford University Hospitals NHS Foundation Trust|Avianna Laws, Clinical Research Operations Manager|01865 (2)26221|avianna.laws@ouh.nhs.uk|
21290417|NCT02568254|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan BSc, OD, FAAOPrincipal Research Optometrist|904 443 3449|CColesb@ITS.JNJ.com|
21290418|NCT00655746|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21290419|NCT02931539|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
21290420|NCT02059642|Alcobra|Dr. Jonathan Rubin|610-940-1631|jrubin@alcobra-pharma.com|
21290421|NCT03178942|Encube Ethicals Pvt ltd|GM-Strategy & Commercial|+91-22-6228-8000|Pratik.K@EncubeEthicals.com|8003
21290422|NCT03645681|W. L. Gore & Associates|Bre Lester|480-698-6670|blester@wlgore.com|
21290423|NCT00684138|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21290424|NCT03508440|University of Missouri|Rebecca Schneider, Assistant Director of Research|573-882-2549|schneiderri@health.missouri.edu|
21290425|NCT01197300|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21290426|NCT02113878|Dana Farber Cancer Institute|Glenn J. Hanna, MD|617.632.6799|GJHanna@partners.org|
21290427|NCT01428635|The University of Texas MD Anderson Cancer Center|Gautam Borthakur MD./Professor|713-563-1586|GBorthak@mdanderson.org|
21290428|NCT02257138|The University of Texas MD Anderson Cancer Center|Dr. Farhad Ravandi-Kashani|713-745-0394|fravandi@mdanderson.org|
21290429|NCT00530257|The Children's Hospital of Philadelphia|Dr. Nathan Blum|215-590-6336|blum@email.chop.edu|
21290430|NCT00385515|Mucosal Therapeutics, LLC|Eward G. Fey, PhD|857-228-1100||
21290431|NCT03676270|Institut Bergonié|Pr Antoine Italiano|335 56333333|a.italiano@bordeaux.unicancer.fr|
21290432|NCT05130281|Weill Cornell Medicine|Maddy Schier|(646) 289-5271|mas4019@med.cornell.edu|720
21290433|NCT06844812|mazhar osman mental and nervous diseases hospital|Dr. Enes Faruk ALTUNKILIÇ|+905077362191|enesfarukaltunkilic@gmail.com|
21290434|NCT02006836|Huazhong University of Science and Technology|Dr.Yu|862783662883|xfyu188@163.com|
21232940|NCT01053819|University of Alabama at Birmingham|Boni Elewski, MD|205-502-9960|beelewski@gmail.com|
21232941|NCT01266460|NRG Oncology|Christopher Purdy on behalf of Austin Miller PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
21232942|NCT01132547|SunCoast CCOP Research Base at the University of South Florida|Angelina Fink, Research Base Administrator|813-396-9245|angelina.fink@epi.usf.edu|
21232943|NCT05811234|Almirall S.A|Head of Global Clinical Development|+34932913000|gco@almirall.com|
21232944|NCT02710045|University of Tasmania|Katie Flanagan|+61 3 6777 4081|katie.flanagan@ths.tas.gov.au|
21261177|NCT01299025|Region Örebro County|Dr Anette Forsberg|+46-19-6025788|anette.forsberg@regionorebrolan.se|
21232945|NCT01275833|Boston Scientific|Elke Sommerijns|+32479767156|elke.sommerijns@bsci.com|
21232946|NCT03019107|Liberate Medical|Angus Mclachlan|+1 (833) 203-4663|info@liberatemedical.com|
21232947|NCT00644280|University of California San Francisco|Shan C. Lin, MD|415-353-2608|lins@vision.ucsf.edu|
21232948|NCT01192282|Groote Schurr Hospital / University of Cape Town|Dr Shahila Tayib|0060195773376|syarq@yahoo.com|
21232949|NCT02118012|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Christopher Koh, M.D.|(301) 443-9402|kohchris@mail.nih.gov|
21239569|NCT03108157|ProcreaTec|Dr. Alexandra Izquierdo, Medical and Scientific Director at ProcreaTec|0034651879266|endoscratchtrial@gmail.com|
21239570|NCT04395183|University of Utah|Brent Kious, MD, PhD|801-585-1418|brent.kious@hsc.utah.edu|
21239571|NCT04472377|Hygeia Touch Inc.|Lance Yang|+886-3-6675616|cyyang@hygeiatouch.com|
21239572|NCT01022073|San Francisco VA Medical Center|William J. Marks, Jr., M.D.|415-750-2100|William.Marks@va.gov|
21239573|NCT05093049|Apyx Medical|Senior Director of Clinical Affairs|801-244-0058|kari.larson@apyxmedical.com|
21239574|NCT04999644|Johns Hopkins University School of Medicine|Justin Strickland|4105501975|jstric14@jhmi.edu|
21239575|NCT01807650|Amryt Pharma|Head of Clinical Development|+353 1 518 0200|medinfo@amrytpharma.com|
21239576|NCT00736489|AstraZeneca|Carin Jorup, MSD||ClinicalTrialTransparency@astrazeneca.com|
21239577|NCT02205801|The University of Chicago Medicine & Biological Sciences|Dr. Raymond H. Grogan|773-702-7125|rgrogan@surgery.bsd.uchicago.edu|
21239578|NCT02946918|UT Southwestern Medical Center|Dr. Alex Tessnow-ASSOC PROFESSOR|214/648-3685|Alex.Tessnow@UTSouthwestern.edu|
21239579|NCT00069784|sanofi|Trial Transparency Team||Contact_US@sanofi.com|
21239580|NCT02654990|pharmaand GmbH|Medical Information Department|+43/1/3560006|medinfo@pharmaand.com|
21239581|NCT02669095|Johnson & Johnson Vision Care Inc.|Kristy Canavan, O.D., FAAO Principal Research Optometrist|904 443-1474|KCANAVA2@its.jnj.com|
21239582|NCT00674622|University of Pittsburgh School of Medicine Department of Psychiatry|Ronald Glick, MD|412-623-3023|glickrm@upmc.edu|
21239583|NCT01292070|Tunitas Therapeutics|Nolan Sigal, MD, PhD, CEO, Tunitas Therapeutics|(650) 887-4747|nsigal@tunitastherapeutics.com|
21239584|NCT01555164|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21239585|NCT03203694|University of Missouri|Jaume Padilla|(573) 882-7056|padillaja@missouri.edu|
21239586|NCT03443713|Oregon Health and Science University|Jessica Castle MD|503-494-7072|castleje@ohsu.edu|
21239587|NCT04686279|Johns Hopkins University|Dr. Craig Hendrix|410-955-9707|chendrix@jhmi.edu|
21239588|NCT00855010|UT Southwestern Medical Center|Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
21239589|NCT04255342|University of Iowa|Chris Barwacz|(319) 384-3002|chris-barwacz@uiowa.edu|
21239590|NCT01672853|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21239591|NCT02969525|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21239592|NCT03445065|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21239593|NCT01158378|HyperBranch Medical Technology, Inc|Michael Carnahan, PhD|919-433-3329|michaelc@hyperbranch.com|
21239594|NCT03017235|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DKO-Disclosure@ferring.com|
21239595|NCT02326844|National Cancer Institute|Dr. Jung-Min Lee|301-443-7735|leej6@mail.nih.gov|
21239596|NCT04602494|Massachusetts General Hospital|A. Eden Evins, MD, MPH|6176434679|aeevins@mgh.harvard.edu|
21239597|NCT00453310|Memorial Sloan Kettering Cancer Center|Dr. Robert Motzer|646-422-4312|motzerr@mskcc.org|
21239598|NCT01806740|Guerbet|Corinne Dubourdieu, Head of Clinical Projects|+33145915000|corinne.dubourdieu@guerbet.com|
21239599|NCT04666922|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21239600|NCT02444988|Vanderbilt University Medical Center|Matthew W. Semler, MD, MSc|(615) 322-3412|matthew.w.semler@vumc.org|
21239601|NCT01382940|Hoffmann-La Roche|Medical Communications|800 821-8590||
21239602|NCT04551196|Washington University School of Medicine|David Leonard, MD, Principal Investigator|314-454-2136|dsleonard@wustl.edu|
21239603|NCT00244374|University of California, San Francisco|Dr. Paula J. Lum|415-476-4082|plum@php.ucsf.edu|411
21239604|NCT01517243|Dartmouth College|Lionel Lewis|1-603-650-8685|lionel.d.lewis@dartmouth.edu|
21279149|NCT01189487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21279150|NCT04630158|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21279151|NCT05162014|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21239605|NCT02105636|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21239606|NCT00720902|Columbia University|Pamela Freda, MD|212-305-3725|puf1@columbia.edu|
21239607|NCT00291655|UCB Pharma|UCB Clinical trial call center|+1 877 822 9493||
21239608|NCT03462706|Indiana University|Clinical Research Specialist|317-948-0724|rlahr@iu.edu|
21239609|NCT01411501|Guang'an Men Hospital Affiliated to China Academy of Chinese Medical Sciences|Liu Zhishun|8610-010-88001124|liuzhishun@aliyun.com|
21239610|NCT01097395|University of Colorado|Jennifer Kiser|3037246131|jennifer.kiser@cuanschutz.edu|
21261178|NCT01624194|Stanford University|Antonio Y. Hardan, MD|(650) 736-1235|hardanay@stanford.edu|
21239611|NCT02010697|UCSD|Principal Investigator|8583001056|szhu@ucsd.edu|
21239612|NCT00474929|Mayo Clinic|Thomas E. Witzig, M.D.||witzig.thomas@mayo.edu|
21261179|NCT03212261|Massachusetts General Hospital/Harvard Medical School|Dr. Giselle K. Perez|617-724-0765|gperez@mgh.harvard.edu|
21261180|NCT05480514|Johnson & Johnson Vision Care, Inc. (JJVC)|Brian Pall|1-800-843-2020|bpall@its.jnj.com|
21239613|NCT00819403|Univ Maryland|Dr Michael Miller|410 328-6299|mmiller@medicine.umaryland.edu|
21232950|NCT00483379|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
21232951|NCT04318990|Baylor Scott and White Resarch Institute|Sarah Hale|469-814-4845|sarah.hale@bswhealth.org|
21232952|NCT00536107|AstraZeneca|Sharon Chang||aztrial_results_posting@astrazeneca.com|
21232953|NCT00391989|GIMEMA|Dr. Paola Fazy; Dr. Marco Vignetti|+39 06.70390521|gimema@gimema.it|
21232954|NCT01304966|Queen Sirikit Nation Institute of Thailand|Dr.Pavinee Intakorn|06623548333|pintakorn@yahoo.com|2301
21232955|NCT00641862|Harvard T.H. Chan School of Public Health|Dr. Christopher Duggan|617-355-7612|christopher.duggan@childrens.harvard.edu|
21232956|NCT04519645|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
21232957|NCT03033511|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21232958|NCT01953120|UCLA|Dr. Suphamai Bunnapradist|3107948516|bunnapradist@mednet.ucla.edu|
21232959|NCT01519414|The Ohio State University Comprehensive Cancer Center|Paul Monk, MD|(614) 293-6196|Paul.Monk@osumc.edu|
21232960|NCT04387435|University of California, Los Angeles|Olujimi Ajijola, MD, Phd|310-206-2235|oajijola@mednet.ucla.edu|
21232961|NCT02422745|Brigham and Women's Hospital; 900 Commonwealth Ave, 3rd fl.; Boston, MA 02215|COSMOS Study Director|1-800-633-6913|cosmostrial@partners.org|
21232962|NCT01899300|Asian Institute of Gastroenterology|Rajesh Gupta, MD|+91 4023378888|drrajeshgupta98@gmail.com|
21232963|NCT01991457|University of Alabama at Birmingham|Dr. Omer Jamy|2059349294|omerjamy@uabmc.edu|
21232964|NCT03447990|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21232965|NCT00423150|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21232966|NCT02951156|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21232967|NCT03519347|NYU Langone Health|David M Charytan, MD, MSc|646-501-9086|david.charytan@nyulangone.org|
21232968|NCT01092182|National Cancer Institute|Dr. Mark J. Roschewski|240-760-6183|roschewskimj@nih.gov|
21232969|NCT02515045|Carolina Eyecare Physicians, LLC|Helga P. Sandoval, MD, MSCR. Director of Research|8438813937|helga.sandoval@carolinaeyecare.com|
21232970|NCT00471848|European Group for Blood and Marrow Transplantation|Prof. Judith Marsh|+31 (0)71 5265005|a.j.barrois@lumc.nl|
21232971|NCT01997515|Rhode Island Hospital|Director of Research|401-444-4933|mark.kendall@lifesapn.org|
21232972|NCT01474876|AbbVie|Global Medical Information|800-633-9110||
21232973|NCT02291055|Advaxis, Inc.|Surya Vangala|609-423-2528|vangala@advaxis.com|
21232974|NCT01762631|Pennington Biomedical Research Center|Leanne Redman, PhD|2257630947|leanne.redman@pbrc.edu|
21232975|NCT01523886|Herlev Hospital|Mona R Gätke, MD, PH.D.|004538662420|mona.gatke@regionh.dk|
21232976|NCT00657241|SUNYBuffalo|Joseph L. Izzo Jr. M.D.|716-898-5625|jizzo@buffalo.edu|
21232977|NCT04262232|Fred Hutchinson Cancer Center|Megan Shen|206-667-4172|mshen2@fredhutch.org|
21232978|NCT03333044|NYU Langone Health|Shinu Mammen|646-501-3484|shinu.mammen@nyulangone.org|
21232979|NCT02921776|The Ohio State University|Mary Beth Happ, PhD, RN|614-292-8336|happ.3@osu.edu|
21232980|NCT05247229|Department of Medicine, Division of Occupational, Environmental, and Climate Medicine, University of California|Matthew O. Gribble|‭(949) 350-6134‬|matt.gribble@ucsf.edu|
21232981|NCT04537234|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21232982|NCT02070744|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21232983|NCT07114198|Inonu|Assistant Professor Merve Bilmez Selen|5457673089|merve.selen@inonu.edu.tr|
21232984|NCT01698463|University of Waterloo|Dr. Lora Giangregorio|(519) 888-4567|lmgiangr@uwaterloo.ca|36357
21232985|NCT04318080|BeiGene|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
21232986|NCT06308822|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21232987|NCT02926924|University of Michigan|Rakesh Patel|734 615-2002|rakeshpa@med.umich.edu|
21232988|NCT04916600|Wayne State University School of Medicine|Dr. Mark Greenwald, Professor|3139933965|mgreen@med.wayne.edu|
21232989|NCT00708942|Photocure|Bjørn Klem, Project Director|+47 22 06 22 10|bk@photocure.no|
21232990|NCT03055000|National Institute of Allergy and Infectious Diseases|Memoli, Matthew|+1 301 443 5971|mm982v@nih.gov|
21232991|NCT04734652|CAPRISA|Dr Anushka Naidoo|031 655 0668|anushka.naidoo@caprisa.org|0669
21232992|NCT01921179|San Francisco VA HCS|Dr Tatjana Novakovic-Agopian|415-753-3888|tatjana.novakovic-agopian@va.gov|
21232993|NCT02356783|Hospital for Special Surgery|Robert Griffin, MD, PhD|212-774-2944|griffinr@hss.edu|
21232994|NCT02603809|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 58 844 19 77|clinical-trials-disclosure@idorsia.com|
21232995|NCT04146545|University of Chicago|Emily Abramsohn|7738344832|eabramsohn@bsd.uchicago.edu|
21232996|NCT00112502|The University of Texas (UT) MD Anderson Cancer Center|John F de Groot, Chair Ad Interim, Neuro-Oncology|713-745-3072|jdegroot@mdanderson.org|
21232997|NCT00265343|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21232998|NCT02994732|Biomed Valley Discoveries|Associate Director of Translational Sciences|636-887-6429|Dknoerzer@biomed-valley.com|
21232999|NCT02807350|Jaeb Center for Health Research|Raymond Kraker, Coordinating Center Director|(813)-975-8690|rkraker@jaeb.org|
21233000|NCT03662542|Janssen Research & Development, LLC|Head of Gastroenterology Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21261181|NCT05738486|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21261182|NCT03395210|Sanofi aventis recherche & développement|Trial Transparency Team|8006331610|Contact-US@sanofi.com|6#
21261183|NCT01672892|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21261184|NCT00468715|Memorial Sloan Kettering Cancer Center|Dr. Tiffany Traina|646-888-4558|trainat@mskcc.org|
21261185|NCT00934895|Rutgers Cancer Institute of New Jersey|Deborah L Toppmeyer, M.D.|732-235-6789|toppmede@cinj.rutgers.edu|
21261186|NCT02128490|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21233001|NCT01854905|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21261187|NCT02243176|ASTRAZENECA INVESTMENT (CHINA) CO., LTD.|Xia, Zhang|+86 21 6030 2288|Xia.Zhang@astrazeneca.com|2035
21290435|NCT01866150|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
21290436|NCT00600704|Larissa University Hospital Dept. of Anesthesiology|Dr Athina Kleitsaki|00306948481865|theoath1@gmail.com|
21290437|NCT02683954|Ain Shams Maternity hospital|amr ahmed mahmoud riad|01005347179|amr.riad@med.asu.edu.eg|+2
21290438|NCT04565353|Behavior Change for Good initiative|Dr. Joseph Kay|2157466609|jskay@wharton.upenn.edu|
21290439|NCT03142451|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
21290440|NCT05333965|CooperVision|Jose A. Vega, OD, MSc, FAAO|9256213761|jvega2@coopervision.com|
21290441|NCT03048019|Sinai Center for Thrombosis Research|Director of Clinical Trials|443-244-1497|kbliden@lifebridgehealth.org|
21290442|NCT01730729|Northwestern University|Cesar Santa-Maria, MD|312-695-6180|cancertrials@northwestern.edu|
21290443|NCT01889563|Federal university of Sao Carlos|Audrey Borghi e Silva|+55 163351-8952|audrey@ufscar.br|
21290444|NCT00203242|Thomas Jefferson University/Jefferson Headache Center|Stephen D. Silberstein-Principal Investigator|215-955-9477|Stephen.Silberstein@jefferson.edu|
21290445|NCT02685436|Manicure university children hospital|Dr.Ahmed Zaki|0201008335567|drahmedmd17@yahoo.com|
21290446|NCT02837952|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21290447|NCT01517178|Bispebjerg Hospital|Tonny Karlsmark||tkar0002@bbh.regionh.dk|
21290448|NCT01959919|Pfizer Clinical Trial.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrails.gov_Inquiries@Pfizer.com|
21290449|NCT03439072|Xeris Pharmaceuticals, Inc.|Martin J. Cummins|312-736-1624|mcummins@xerispharma.com|
21290450|NCT03627468|Botanix Pharmaceuticals|Anthony Robinson, MS, MBA, CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
21233002|NCT01217060|UT MD Anderson Cancer Center|Steven H. Lin, Associate Professor, Radiation Oncology Department|(713) 563-8490|shlin@mdanderson.org|
21233003|NCT01959542|Brigham and Women's Hospital/Dana-farber Cancer Institute|Dr. Fiona Fennessy|617 632 4891|ffennessy@bwh.harvard.edu|
21233004|NCT03050619|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21233005|NCT03202264|McMaster University|Dr. Dee Mangin|905-525-9140|mangind@mcmaster.ca|21219
21233006|NCT02996864|Klein Buendel|Valerie Myers, PhD|3035654343|vmyers@kleinbuendel.com|
21233007|NCT01879228|University of Pennsylvannia|Paola Alvarado|215-746-2081|paola.alvarado@pennmedicine.upenn.edu|
21233008|NCT01716013|OptMed|Associate Director of Quality Assurance|(908) 720-2372|nyajnik@optmed.com|
21233009|NCT02312726|University of New Mexico - Family Planning Research Division|Michel Paves, Research Specialist|505-272-9703|mdaliva@salud.unm.edu|
21233010|NCT01998633|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
21233011|NCT00413192|Eisai Ltd. Mosquito Way, Hatfield, Hertfordshire, AL 10 9SN|Gitta Irmer Associate Director, Data Quality & Standards Global Regulatory Operations|+44 (0) 845 676 1618||
21233012|NCT03814746|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21233013|NCT05089682|Mayo Clinic|Dr. Gregory A. Worrell|507-538-4880|Worrell.Gregory@mayo.edu|
21233014|NCT03992781|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21233015|NCT01996826|Mass. Eye and Ear|Reza Dana, M.D., M. Sc, MPH|6175734331|Reza_Dana@meei.harvard.edu|
21233016|NCT00695396|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Head of Hematology and Nephrology||pbowers@its.jnj.com|
21233017|NCT02734979|Stanford University|Dr. Stanley G Rockson, Allan and Tina Neill Professor of Lymphatic Research and Medicine|650-725-7571|rockson@stanford.edu|
21233018|NCT00518323|Johnson & Johnson Pharmaceutical Research & Development|Compound Development Team Leader (CDTL)|609-730-4530||
21233019|NCT01312818|University of Minnesota, Pediatric Hematology Dept.|Dr. Michael Burke, MD|612-672-7422||
21233020|NCT03164928|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21233021|NCT00772707|Alcon Global Medical Affairs|Jami Kern, Ph.D.|1-888-451-3937||
21233022|NCT04499781|NYU Langone Health|Ann-Margaret Navarra, PhD, CPNP-PC|631-638-0859|amd363@nyu.edu|
21233023|NCT00371254|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21233024|NCT03329690|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21233025|NCT01817725|Chang Gung Memorial Hospital, Linkou Branch|Dr. Ming-Wei Lai|886-3-3281200|a22141@adm.cgmh.org.tw|8969
21233026|NCT02290106|Massachusetts General Hospital|Takara Stanley, MD|6177249109|tstanley@mgh.harvard.edu|
21233027|NCT02337907|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21233028|NCT01679002|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21233029|NCT03971188|Washington University in St. Louis|Dr. Charles Goldfarb|(314) 362-3768|goldfarbc@wustl.edu|
21233030|NCT02409459|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610.650.4200|mfalone@luitpold.com|844
21290451|NCT02134808|University of Utah|Dr. Douglas Kondo|(801) 587-1549|doug.kondo@hsc.utah.edu|
21233031|NCT00545155|University of Rochester|Manish N. Shah|585-463-2920|manish.shah@rochester.edu|
21233032|NCT00525733|Aaron Diamond AIDS Research Center|Martin Markowitz MD|212-448-5020|mmarkowitz@adarc.org|
21233033|NCT00613015|MUSC|Dr. McRae-Clark|843-792-5216|mcraeal@musc.edu|
21233034|NCT03632655|Weill Cornell Medicine|Dr. Jim C. Hu|(646) 962-9600|jch9011@med.cornell.edu|
21233035|NCT04327388|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21233036|NCT04829318|Janssen-Cilag Limited|Director Global Medical Affairs Lead|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21233037|NCT00728130|Simmons Cancer Institute at Southern Illinois University School of Medicine|Director of Clinical Trials|217-545-1946|krobinson@siumed.edu|
21233038|NCT02730299|Gamida Cell|Associate Director, Clinical Operations|+972-073-2064774|aurelie@gamida-cell.com|
21233039|NCT04053023|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21233040|NCT02014363|e-Therapeutics plc|Clinical Operations Manager|+44 1993 880000|contact@etherapeutics.co.uk|
21233041|NCT00455429|Janssen Research and Development, 3210 Merryfield Row San Diego, CA 92121|William Barchuk, M.D.|858-784-3111||
21233042|NCT01412021|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21233043|NCT00238121|University of Chicago Comprehensive Cancer Center|Dr. Gini Fleming|773-702-6712|gfleming@medicine.bsd.uchicago.edu|
21233044|NCT03255382|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21233045|NCT01166178|Novartis|Study Director|41 61 324 1111||
21233046|NCT00484939|Hoffmann-La Roche|Medical Communications|800 821-8590||
21233047|NCT02466555|University Hospitals Connor Integrative Health Network|Samuel Rodgers-Melnick, MT-BC, music therapist|216-844-7727|Samuel.RodgersMelnick@UHhospitals.org|
21233048|NCT04640519|Columbia University|Imama Naqvi, MD|646-426-3876|ian2108@cumc.columbia.edu|
21233049|NCT03141281|Florida State University|Dr. Neil Charness|850-644-6686|charness@psy.fsu.edu|
21233050|NCT02113956|Center for Innovative Public Health Research|Dr. Michele Ybarra|877-302-5858|michele@innovativepublichealth.org|801
21233051|NCT02467465|Universidad Complutense de Madrid|Miguel Suárez Varela|+34913941518|misuarezvarela@gmail.com|
21233052|NCT01499563|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinialTrials@itci-inc.com|
21233053|NCT01239368|National Cancer Institute|Dr. Steven Pavletic|301-402-4899|steven_pavletic@nih.gov|
21233054|NCT02145039|University of Minnesota Cancer Center|Dr. Claudio Brunstein|612-625-8942|bruns072@umn.edu|
21233055|NCT03181399|Weill Cornell Medicine|Dr. Juan Pascual|(212) 746-3278|jup9003@med.cornell.edu|
21233056|NCT01536379|GlaxoSmithKline|GSK Response Center|866-435-7343||
21233057|NCT02064907|Takeda Study Registration Call Center|Takeda|+1-877-825-3327|medicalinformation@tpna.com|
21233058|NCT00939809|Gynecologic Oncology Group Statistical and Data Center|Jessalyn Reboy|716-845-7738|reboyj@nrgoncology.org|
21233059|NCT00380978|Department of Anesthesiology; Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu|
21233060|NCT04729127|University of Pennsylvania|Melanie Pellecchia|215-746-1950|melanie.pellecchia@pennmedicine.upenn.edu|
21233061|NCT01245270|University of Aberdeen Rowett Institute of Nutrition and Health|Dr Nigel Hoggard|[+44] (0) 1224 438700|N.Hoggard@abdn.ac.uk|
21233062|NCT02608268|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21233063|NCT04014075|Daiichi Sankyo|Contact for Clinical Trial Information|1-908-992-6400|CTRinfo@dsi.com|
21233064|NCT02584504|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21233065|NCT03839511|Pennington Biomedical Research Center|Dr. David McDougal|2257630278|DAVID.MCDOUGAL@PBRC.EDU|
21233066|NCT01203046|Dr. Silvia M. Pinango L|Dr. Silvia M. Pinango L.|+584169267988|pinangosilvia@yahoo.com|
21233067|NCT05172544|Najít Technologies, Inc.|Dr. Ian Amanna|9717273569|iamanna@najittech.com|
21233068|NCT00612924|Terumo|Amanda Isula, Clinical Research Coordinator|800-262-3304|amanda.isula@terumomedical.com|5549
21233069|NCT03141242|University of Colorado|Hillary Lum, MD, PhD|3037241911|hillary.lum@cuanschutz.edu|
21233070|NCT01179477|Abbott|Clay Cohorn, Clinical Program Director|972-309-8087|clay.cohorn@abbott.com|
21290452|NCT01550965|AbbVie|Global Medical Information|800-633-9110||
21290453|NCT02317042|University of Western Australia|Prof Nigel McArdle & Prof Peter Eastwood|+61 8 9346 1706|peter.eastwood@health.wa.gov.au|
21290454|NCT03093246|São Paulo State University - Unesp|Dr Mauro Pedrine Santamaria|+5516981937777|mauro.santamaria@unesp.br|
21290455|NCT02570425|Sydney Medical School, University of Sydney & Woolcock Institute of Medical Research|Assoc Prof Sinthia Bosnic-Anticevich|+61 2 9114 0040|sinthia.bosnic-anticevich@sydney.edu.au|
21290456|NCT01347086|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21290457|NCT02624687|University of Pittsburgh|Bethany Barone Gibbs|4123834002|bbarone@pitt.edu|412
21290458|NCT03111108|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21290459|NCT01514357|Mayo Clinic|Dr. John C. Burnett|507-284-7932|burnett.john@mayo.edu|
21290460|NCT04893811|Pfizer Inc.|PfizerClinicalTrials.gov Call Center|1-8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21290461|NCT02739828|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21290462|NCT01722734|Harvard School of Public Health|Dr Günther Fink|6174327389|gfink@hsph.harvard.edu|
21290463|NCT01837550|Sodra Alvsborg, Hearing Organisation|Milijana Malmberg, PhD student|0046 703 80 36 63|milijana.lundberg.malmberg@vgregion.se|
21290464|NCT01307618|University of Chicago Comprehensive Cancer Center|Tomas Gajewski|773-702-4601|tgajewsk@medicine.bsd.uchicago.edu|
21290465|NCT04191733|DePuy Orthopaedics|FRANCHISE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21233071|NCT00189228|University of New Mexico Health Sciences Center|Dr. Mark Schuyler|5059254197|mschuyler@salud.unm.edu|
21233072|NCT02448654|Yale University|Elise E. DeVito, Ph.D./ Associate Research Scientist|203-737-4882|elise.devito@yale.edu|
21290466|NCT02202577|Virginia Commonwealth University Health System|Edward H Springel, MD|804-828-8468|edward.springel@vcuhealth.org|
21290467|NCT03878602|Ospedale Buon Consiglio Fatebenefratelli|Dr.Giuseppe De Bernardo|3357441303|pinodebtin@gmail.com|+39
21290468|NCT02100644|GlaxoSmithKline|GSK Response Center|866-435-7343||
21233073|NCT02221284|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21233074|NCT01556581|Madigan Army Medical Center|Dr. Dan Rhon|253-968-0780|daniel.i.rhon.ctr@mail.mil|
21233075|NCT00529542|Milton S. Hershey Medical Center|Richard S. Legro|717-531-8478|rsl1@psu.edu|
21233076|NCT01566461|Medtronic Endovascular Therapies|Arslan Malik, Sr. Clinical Research Manager||arslan.malik@medtronic.com|
21233077|NCT01467947|CSL Behring|Program Director, Clinical R&D|Use email contact|clinicaltrials@cslbehring.com|
21233078|NCT04035161|Becton Dickinson|Erin Zook, PhD|224-358-5019|erin.zook@bd.com|
21233079|NCT03616899|Kala Pharmaceuticals, Inc|VP, Clinical Development|(781) 996-5252|Results011@kalarx.com|
21233080|NCT03839212|University of Miami|Daniel E. Jimenez, Ph.D., Associate Professor|3052432776|dej18@miami.edu|
21233081|NCT03448185|University of Texas Southwestern Medical Center|Eriko Iwatate|214-648-3680|Eriko.Iwatate@UTSouthwestern.edu|
21233082|NCT00679263|Medicinova Inc|Kazuko Matsuda, MD, Vice President Clinical Development|858-373-1500|matsuda@medicinova.com|132
21233083|NCT00862446|Vanderbilt University Medical Center|William Walsh|615-322-3476|bill.walsh@vumc.org|
21233084|NCT05104567|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
21233085|NCT03479307|Faes Farma|Nieves Fernández, MD, PhD|+34 94 481 83 00|nfernandez@faes.es|
21233086|NCT01464346|Medtronic Diabetes Clinical Research|Pamela Haworth||pamela.c.haworth@medtronic.com|
21233087|NCT00733746|Alliance for Clinical Trials in Oncology|Peter Pisters, MD||ppisters@mdanderson.org|
21233088|NCT02295995|Durham VA HCS|Dr. Katherine S. Hall|919-286-0411|katherine.hall@duke.edu|6734
21233089|NCT01173718|W. L. Gore & Associates|Debby Pfile, Clinical Research Associate|623-234-5226|dpfile@wlgore.com|
21233090|NCT02124863|vrije universiteit brussel|filip van ginderdeuren|+3224763916|filip.vanginderdeuren@telenet.be|
21233091|NCT01498458|University Hospital Heidelberg|Dr. Andreas Schneeweiss|+49 (0)6221 56 36051|andreas.schneeweiss@med.uni-heidelberg.de|
21233092|NCT02226003|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21233093|NCT05734443|Virginia Tech|Michael Madigan|5402313543|mlm@vt.edu|
21233094|NCT03578081|University of Alabama at Birmingham|Dr Rudolph M. Navari|205-975-2833|rnavari@uabmc.edu|
21233095|NCT00496756|University of Nebraska Medical Center|Ralph Hauke, MD|402-354-8124|rhauke@nebraskacancer.com|
21233096|NCT03279692|Massachusetts General Hospital|Priscilla Brastianos, MD|617-724-8770|pbrastianos@partners.org|
21233097|NCT05986019|Medical University of South Carolina|Dr. Bashar Badran|843-792-6076|badran@musc.edu|
21233098|NCT05198843|University of Texas M D Anderson Cancer Center|Dr. Rachel Layman|(713) 745-8401|RLayman@mdanderson.org|
21233099|NCT02446990|Institut de Recherches Internationales Servier (I.R.I.S.)|Therapeutic Innovation Pole|+33155724366|clinicaltrials@servier.com|
21233100|NCT01064401|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21233101|NCT03158051|University of Wisconsin School of Medicine and Public Health|Kara Hoppe, DO|608-417-4224|khoppe2@wisc.edu|
21233102|NCT02588833|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
21233103|NCT02005250|Odense Universitetshospital, afd.M|Prof. Steen Bonnema|+4527339180|steen.bonnema@rsyd.dk|
21233104|NCT02738151|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21233105|NCT01975909|Beth Israel Deaconess Medical Center|Brad Manor, Ph.D.|617-971-5332|bmanor@bidmc.harvard.edu|
21279152|NCT00390559|Virginia Commonwealth University|Thomas Eissenberg|804.827.4617|teissenb@vcu.edu|
21279153|NCT00575887|Marmara University|Ufuk Abacioglu|902123853100|ufuk@abacioglu.com|
21279154|NCT02752087|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21279155|NCT02458287|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21279156|NCT00843635|University of Miami|Donald T. Weed MD FACS|305-243-9095|dweed@miami.edu|
21279157|NCT02290223|Kaiser NCAL Division of Research|Monique Does, Project Manager|510-891-3612|monique.does@kp.org|
21279158|NCT05293639|Johnson & Johnson MedTech|Reecha Sharma|949.789.3919|rshar120@its.jnj.com|
21279159|NCT01943994|Sheppard Pratt|Dr. Matthew W. Johnson|443 862 0461|mjohnson3@sheppardpratt.org|
21279160|NCT03322930|Retina Foundation of the Southwest|Dr. David Birch|214-363-3911|dbirch@retinafoundation.org|105
21279161|NCT00090363|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21279162|NCT01758588|Weill Cornell Medicine|Assistant Director of Leukemia and BMT Clinical Trials|646-962-9305|ell2028@med.cornell.edu|
21279163|NCT05038800|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21279164|NCT00121134|DFCI|Dr Harold J. Burstein|617-632-3800|hal_burstein@dfci.harvard.edu|
21279165|NCT04080544|The University of Texas at Dallas|Dr. Joseph Hennessee|408-813-4488|joseph.hennessee@utdallas.edu|
21279166|NCT04967508|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
21279167|NCT00857584|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21279168|NCT02533375|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21279169|NCT00673387|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21279170|NCT01102374|University of Colorado School of Medicine|Adit Ginde, MD, MPH, Professor of Emergency Medicine|720-848-6777|adit.ginde@ucdenver.edu|
21279171|NCT03040323|Indiana University Department of Radiology|Jordan Swensson ,MD|317-944-1831|jswensso@iupui.edu|
21279172|NCT02067273|Stanford University School of Medicine|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu|
21233106|NCT02047747|University of California, San Diego|David Piccioni M.D., Ph.D.|(858) 822-6346|dpiccioni@ucsd.edu|
21233107|NCT04709341|Medical University of South Carolina|Samuel Bidwell- Research Manager|843-792-2305|bidwells@musc.edu|
21233108|NCT03649711|University of Arkansas for Medical Sciences|Dr. Nishank Jain, Associate Professor of Medicine|5016865295|njain2@uams.edu|
21233109|NCT01892371|The University of Texas MD Anderson Cancer Center|Yesid Alvarado MD./Associate Professor|713-794-4364|yalvarado@mdanderson.org|
21233110|NCT04007094|The Ohio State University|Shelby Miracle|614-366-1648|shelby.miracle@osumc.edu|
21233111|NCT02653560|UT Southwestern Medical Center|Dr Wanpen Vongpatanasin|2146489078|wanpen.vongpatanasin@utsouthwestern.edu|
21233112|NCT03628703|Cincinnati Children's Hospital Medical Center|Steve W. Wu, M.D.|513-636-4222|steve.wu@cchmc.org|
21233113|NCT01928524|Odense University Hospital|Per Pfeiffer|+45-26283844|per.pfeiffer@rsyd.dk|
21279173|NCT02952898|Gage Development Company|Gage Development Company|1-847-999-0600|clinicalinfo@capstonedevservices.com|
21233115|NCT04350788|UNC-CH School of Nursing|Biostatistician|919-966-7181|peiran@live.unc.edu|
21233116|NCT01581307|H. Lee Moffitt Cancer Center and Research Institute|Dr. Sarah Hoffe|813-745-4380|sarah.hoffe@moffitt.org|
21233117|NCT04994444|Brown University|Dr. Patricia Cioe|4018636638|patricia_cioe@brown.edu|
21233118|NCT02117999|Studio Italiano di Oftalmologia|Marco Lombardo|+39 331 34 38 300|mlombardo@visioeng.it|
21233119|NCT00378209|Dana-Farber Cancer Institute|Dr. Paul Richardson|617-632-2104|Paul_Richardson@dfci.harvard.edu|
21233120|NCT01894581|University of Colorado Denver|Dr. Alex Polotsky|303-724-2001|alex.polotsky@ucdenver.edu|
21233121|NCT03084081|Cleveland Clinic|Miriam Cremer, M.D.|216-213-6460|cremerm@ccf.org|
21233122|NCT03795298|Boston Scientific|Anne Cornaille|+1-800-227-3422|anne.cornaille@bsci.com|
21233123|NCT01252940|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21233124|NCT04199117|University of Wisconsin School of Medicine and Public Health|Danielle McCarthy, Ph.D.|6082655949|demccarthy@ctri.wisc.edu|
21233125|NCT04383743|University of Washington|Dr. Petros Grivas|2066061943|pgrivas@uw.edu|
21233126|NCT05230693|Medical University of South Carolina|Ennis James, MD|843-792-3769|jamesw@musc.edu|
21233127|NCT03939897|Washington University in St. Louis School of Medicine|Cynthia X. Ma, M.D., Ph.D.|314-362-9383|cynthiaxma@wustl.edu|
21233128|NCT03482791|Washington University School of Medicine|Gregory Vlacich, M.D., Ph.D.|314-362-8610|gvlacich@wustl.edu|
21233129|NCT00296374|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21233130|NCT01721330|Massachusetts General Hospital|Leah Feinberg|617-726-4651|lkfeinberg@mgh.harvard.edu|
21233131|NCT04709575|Regeneron Pharmaceuticals, Inc|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
21233132|NCT00542919|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21233133|NCT02385266|Northwestern University|Camila Bonin Pinto, PhD|3125033971|camila.pinto@northwestern.edu|
21233134|NCT03684512|University of Kansas Medical Center|Dr. Lauren Ptomey|913-588-7983|lptomey@kumc.edu|
21233135|NCT03927612|Indiana University School of Medicine|Clinical Research Specialist|317-274-8670|vrlab@iupui.edu|
21233136|NCT03492099|Johns Hopkins University School of Medicine|Dr. Sophie Lanzkron|4105028642|slanzkr@jhmi.edu|
21233137|NCT01948739|Rice University|Marcia K. O'Malley, PhD|(713) 348-3545|omalley@rice.edu|
21233138|NCT02082210|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21233139|NCT04762680|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21233140|NCT03388138|Johnson & Johnson Vision Care, Inc.|Brian Pall O.D, MS, FAAO|1-800-843-2020|bpall@its.jnj.com|
21233141|NCT01528072|Zimmer Biomet Spine|Clinical Affairs|303-501-8571|spinemedinfo@zimmerbiomet.com|
21233142|NCT01268111|Mayo Clinic|A J Vinaya Simha|5072664321|simha.aj@mayo.edu|
21233143|NCT03001258|BRAC|Anita Sharif Chowdhury/Research Fellow of BRAC Research and Evaluation Division|+88029846448|anita.sc@brac.net|3719
21233144|NCT03493828|New York Methodist Hospital|Dr Joel Yarmush|(718) 780-3279|joelyarmush@gmail.com|
21239614|NCT03661996|Centrexion Therapeutics Corporation|Clinical Operations|617-837-6911|info@centrexion.com|
21239615|NCT03321513|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|mhuggins@jaeb.org|
21239616|NCT01976364|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21239617|NCT02757521|Washington University|Ben J Palanca, MD PhD MSC|314-286-0132|palancab@wustl.edu|
21239618|NCT01161472|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21239619|NCT00003511|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
21239620|NCT02914184|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21239621|NCT00462722|University of Colorado Anschutz Medical Campus|Catherine Jankowski|303-724-7383|catherine.jankowski@ucdenver.edu|
21239622|NCT00798174|Washington University in St. Louis|Dr. Timothy W. Smith|314-286-1501|tsmith@wustl.edu|
21239623|NCT01395043|Aalborg Hospital|Dr Nils Bjerregaard|004522860649|niheb@rn.dk|
21239624|NCT02342314|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21239625|NCT01683994|National Cancer Institute|Dr. William Dahut|240-760-6070|william_dahut@nih.gov|
21239626|NCT00999661|Ethicon Endo-Surgery, Inc.|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
21279174|NCT02802631|Melinta Therapeutics, LLC|Medical Information|1-844-633-6568|medinfo@melinta.com|
21279175|NCT02212379|Inserm, Sorbonne Universite, IPLESP|Dr Lambert Assoumou|0142164280|lambert.assoumou@iplesp.upmc.fr|
21279176|NCT02105974|GlaxoSmithKline|GSK Response Center|866-435-7343||
21279177|NCT02968849|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
21233145|NCT02094716|Mylan Pharmaceuticals Pvt Ltd|Clinical Sciences Program Lead||prasannac.ganapathi@mylan.in|
21233146|NCT02430337|Georgia State University|Shannon Self Brown, PhD|404-413-1283|sselfbrown@gsu.edu|
21239627|NCT00312858|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21239628|NCT03638635|Inova Health System|Erica Emery|703-776-7615|erica.emery@inova.org|
21290469|NCT00478140|The University of Texas (UT) MD Anderson Cancer Center|Dr. Ahmed Kaseb / Associate Professor|713-792-2828|akaseb@mdanderson.org|
21290470|NCT03856177|University of New Mexico|Dr. James F. Cavanagh|4158670303|jcavanagh@unm.edu|
21290471|NCT01898091|Medical University of South Carolina|Susan G. Reed, DDS, MPH, DrPH|843 792-1577|reedsg@musc.edu|
21290472|NCT00563316|Amgen Inc.|Study Director|866-572-6436||
21290473|NCT02268305|MOMH|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
21290474|NCT00908908|Eisai Call Center|Eisai Inc.|888-422-4743||
21290475|NCT01378273|University of Washington|Sandra Juul MD, PhD|2062216814|sjuul@uw.edu|
21290476|NCT05094102|University of Wisconsin School of Medicine and Public Health|Heather Neuman, MD, MS|(608) 262-2025|neuman@surgery.wisc.edu|
21290477|NCT02598973|Crescenz VA Medical Center|James Morley|215-823-5934|james.morley@va.gov|
21290478|NCT02844075|Yonsei University|Byoung Chul Cho|+82 2 2228 4190|cbc1971@yuhs.ac|
21290479|NCT06048705|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21290480|NCT02614066|Kite, A Gilead Company|Medical Information|844-454-5483(1-844-454-KITE)|medinfo@kitepharma.com|
21233147|NCT00862186|Seattle Children's Hospital|Catherine Fiona Macpherson, PhD|206-987-2032|catherine.macpherson@seattlechildrens.org|
21233148|NCT01810666|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21233149|NCT02436759|RVL Pharmaceuticals, Inc.|Senior Director of Clinical Operations|9088091423|mvelasco@osmotica.com|
21233150|NCT02381418|Abbott|Global Clinical Director|+31294477184|serge.vandewitte@abbott.com|
21233151|NCT01290666|University of California, Irvine|Michael J Stamos, MD|888-532-4123||
21233152|NCT00775931|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|612-626-2313|orcha001@umn.edu|
21233153|NCT01652664|Alcon Research, Ltd.|Subha Venkataraman, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21233154|NCT00297037|University of Utah|Dr. Christopher Hull|801-581-6465|christopher.hull@hsc.utah.edu|
21233155|NCT00581776|University of Wisconsin- Madison|Brad S Kahl|608-263-1836|bsk@medicine.wisc.edu|
21233156|NCT02357901|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
21233157|NCT04259762|University of New Mexico Health Sciences Center|Dr. Shiraz Mishra|505-925-6085|smishra@unm.edu|
21233158|NCT03453684|"University of Colorado Denver | Anschutz"|Melissa Brooks-Peterson, MD|30372411111|clinicalresearchsupportcenter@ucdenver.edu|
21233159|NCT02063516|tianjinMUGH|Dr. Haiyun Wang|008613752211206|wanghy819@hotmail.com|
21233160|NCT00491387|University of Cincinnati|Myron Gerson MD|5135583974|myron.gerson@uc.edu|
21233161|NCT02293655|Cincinnati Children's Hospital Medical Center|Tanya Froehlich, MD|5136361154|tanya.froehlich@cchmc.org|
21233162|NCT04098107|Children's Hospital of Philadelphia|Elliot Greenberg|215-590-1527|GREENBERGE@chop.edu|
21290481|NCT04565756|Exonate|Loic Lhuillier|+44 (0)1223 734716|loic.lhuillier@exonate.com|
21239629|NCT01603420|The Proton Collaborative Group|Corey Woods|630-836-8668|cwoods@pcgresearch.org|
21239630|NCT02318719|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21239631|NCT03093428|Dana Farber Cancer Institute|Atish Choudhury|617-632-6328|achoudhury@partners.org|
21239632|NCT01014975|Grifols Therapeutics, Inc.|Henry Li, PhD|800-520-2807|henry.li@grifols.com|
21239633|NCT01336634|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21239634|NCT02176421|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
21239635|NCT02406885|The Johns Hopkins University School of Medicine|Dr. Brent Petty|410-955-8181|bpg@jhmi.edu|
21239636|NCT01971580|UT Southwestern|Ari Cedars|3149224788|acedars97@gmail.com|
21239637|NCT02632786|Prothena|Wendy Curlin|650 837 8550|clinicaltrials@prothena.com|
21239638|NCT01355419|CHU St Pierre|Dr Marie Bruyneel|00325354219|Marie_BRUYNEEL@stpierre-bru.be|
21239639|NCT02951351|Mayo Clinic|Margaret M. Reynolds, MD|507-284-2733|margaretmmreynolds@gmail.com|
21239640|NCT05266963|Vanderbilt University Medical Center|Dan Moore, M.D., Ph.D.|615-322-7247|daniel.moore@vumc.org|
21239641|NCT02912468|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1
21290482|NCT04274218|US Department of Veterans Affairs|Matthew Major|3125035731|matthew.major2@va.gov|
21290483|NCT04679818|Cleveland Clinic|Kurt Ruetzler|216 636-0561|ruetzlk@ccf.org|
21233163|NCT00706979|Medical University of South Carolina'|Matthew J. Carpenter|843-792-3974|carpente@musc.edu|
21233164|NCT01628601|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21233165|NCT00151320|Weill Cornell Medicine|John Leonard, MD|646.962.2064|amr2017@med.cornell.edu|
21233166|NCT01199744|GlaxoSmithKline|GSK Response Center|866-435-7343||
21233167|NCT02418468|Novartis Pharmaceuticals|Study Director|862-778-8300||
21233168|NCT00909779|Sunovion|Respiratory Medical Director|1-866-503-6351||
21233169|NCT01592344|Bioness|Charlene Myers, Contractor|9499101655|cahanderson@msn.com|
21233170|NCT00099437|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21233171|NCT00949325|Johns Hopkins University|David M. Loeb, M.D., Ph.D.|410-502-7247|loebda@jhmi.edu|
21233172|NCT02809677|UT Southwestern Medical Center|Dr. E. Sherwood Brown|24-645-6950|sherwood.brown@utsouthwestern.edu|
21233173|NCT00730912|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21233174|NCT03311659|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21233175|NCT02205333|MedImmune, LLC|Victoria Chiou|301-398-4330|chiouv@MedImmune.com|
21233176|NCT01176266|Alexion Pharmaceuticals, Inc.|Director of Clinical Trials|475-230-2596|ClinicalTrials@alexion.com|
21233177|NCT01335581|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
21233178|NCT04351087|The Ohio State University|Dr. Michael Baria|614-293-8196|michael.baria@osumc.edu|
21233179|NCT05517382|Yale University|Claudia-Santi Fernandes|203-785-2885|Claudiasanti.fernandes@yale.edu|
21233180|NCT03525210|KU Leuven / UZ Leuven|Head of Leuven University Vaccinology Center|+32 16 321 078|luvac@kuleuven.be|
21233181|NCT01374087|Ipsen|Medical Director|use email|clinical.trials@ipsen.com|
21233182|NCT02461225|Regulatory Insight, Inc.|Elvira Cawthon|6154475150|elvira@reginsight.com|
21233183|NCT00271947|Northwestern University|Dr Richard Burt|312-908-0059|rburt@northwestern.edu|
21233184|NCT01786954|Duke Eye Center|Dr Paul Hahn|919-684-5631|paul.s.hahn@duke.edu|
21233185|NCT01522365|Dentsply Sirona Implants|Director Center of Clinical Research, AnnaKarin Lundgren|+46 (0)31 376 30 00|clinicalresearchmolndal@dentsplysirona.com|
21233186|NCT00651755|University of Texas MD Anderson Cancer Center|Saroj Vadhan-Raj, MD / Professor||xzhou@mdanderson.org|
21233187|NCT01120756|VA Northern California|Anthony Chen, MD|925-372-2000|anthony.chen@va.gov|
21233188|NCT00698581|UCB|UCB Cares|+1 877 822 9493||
21233189|NCT03760146|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21233190|NCT00449644|Janssen Infectious Diseases - Diagnostics BVBA|Medical Leader|1 609 730-7768||
21233191|NCT01918761|Cecog|MD Christiane Thallinger|+43 1 409 77 25|office@cecog.at|
21233192|NCT01816893|Brigham and Women's Hospital|Dr. Gail Kurr Adler|(617) 732-8742|gadler@bwh.harvard.edu|
21233193|NCT02410382|University of Arizona|Dr. Sun K. Yi|(520) 694-7236|sunkyi@email.arizona.edu|
21233194|NCT00265473|Schulze Diabetes Institute, University of Minnesota|Melena D. Bellin, MD|612-625-4686|bell0130@umn.edu|
21233195|NCT06063603|Mayo Clinic|Andrea L. Cheville, MD|507-284-2511|cheville.andrea@mayo.edu|
21233196|NCT01002755|The University of Texas M D Anderson Cancer Center|Ferrajoli,Alessandra M.D.|713-792-2063|aferrajo@mdanderson.org|
21233197|NCT00858442|coaniquem|M Beatriz Quezada.MD|56-2-28734077|investigacion@coaniquem.cl|
21233198|NCT01280552|ImmunoCellular Therapeutics Ltd.|Anthony Gringeri, Ph.D. Senior Vice President Strategic Resources|818 264 2300|anthony.gringeri@imuc.com|
21233199|NCT02016625|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21233200|NCT02155738|University of Pittsburgh|Halina Zyczynski|412-641-1440|hzyczynski@mail.magee.edu|
21233201|NCT03303404|University of Texas at Austin|Brandon Fico|512-471-8594|bfico@utexas.edu|
21233202|NCT06145542|Zhejiang University|Dr. Xiao Tan|18651218270|xiao.tan@zju.edu.cn|
21233203|NCT02953990|Virginia Commonwealth University School of Nursing|Patricia Kinser, PI|804-828-0724|kinserpa@vcu.edu|
21233204|NCT01254227|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21233205|NCT03970733|Valneva Austria GmbH|Director Clinical Strategy|+43120620|office@valneva.com|0
21233206|NCT02341807|Spark Therapeutics|Clinical Director|1-866-647-7275|clinicaltrials@sparktx.com|
21233207|NCT02189473|Department of Radiation Oncology, University of Lübeck, Germany|Prof. Dr. Dirk Rades|0049 451 500|dirk.rades@uksh.de|45401
21233208|NCT02784821|University of Florida|Dr. Josef Neu|352-733-0111|neuj@peds.ufl.edu|
21239642|NCT04091360|Verona Pharma|Medical Science Director|6464130307|margot.macdonald-berko@veronapharma.com|
21239643|NCT01107743|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21239644|NCT02224482|Fox Chase Cancer Center|Dr. Suzanne Miller|215-728-4069|Suzanne.Miller@fccc.edu|
21239645|NCT01913639|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian, MD|646-888-4186|janjigiy@mskcc.org|
21239646|NCT02300285|Boston Children's Hospital|Michael SD Agus, MD|617 355-5849|michael.agus@childrens.harvard..edu|
21239647|NCT01583101|Indiana University School of Medicine|Aaron E. Carroll, MD, MS|3172789616|aaecarro@iu.edu|
21239648|NCT00962247|SUNY Buffalo|Leonard H. Epstein|716-829-3400|lhenet@buffalo.edu|
21239649|NCT01536184|Child Development Clinic SSCY Centre|Dr. Ana Hanlon-Dearman|204-258-6628|ahdearman@hsc.mb.ca|
21239650|NCT01974700|Indiana University|Dr. Aaron Cohen-Gadol|317-396-1300|ACohen@goodmancampbell.com|
21239651|NCT03621202|Saranas, Inc.|Zaffer Syed|833-375-9273|zaffer@saranas.com|
21239652|NCT00402194|Indiana University|Dr. Kieren Mather|317-278-7826|kmather@iu.edu|
21290484|NCT03315559|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21290485|NCT03378635|Zealand Pharma A/S|Dr Kim Mark Knudsen|+4550603780|KMKnudsen@zealandpharma.com|
21290486|NCT02413346|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21290487|NCT02205359|CRM|Janelle van Wel|+3166 273 886 62|janelle.van.wel@medtronic.com|
21290488|NCT02189629|Galderma S.A.|Anne Fulton|+1 817-961-5203|anne.fulton@galderma.com|
21290489|NCT02766478|Emory University|Dr. Jessica Alvarez|404-727-1390|jessica.alvarez@emory.edu|
21290490|NCT00089583|ViiV Healthcare|GSK Response Center|866-435-7343||
21290491|NCT01412983|Bausch & Lomb|Dr. Robert Steffen|1 585 338 6399|robbert.steffen@bausch.com|
21290492|NCT01623154|Otsuka America Pharmaceutical, Inc|Tao Wang, PhD|240-683-3213|Tao.Wang@otsuka-us.com|
21290493|NCT04349098|Karyopharm Therapeutics Inc|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
21290494|NCT00800384|Population Health Research Institute, McMaster University|Dr. Jeff Healey|001 905 330 6760|jeff.healey@phri.ca|
21290495|NCT04921800|Northwestern University|Shuai Xu|312-695-3721|stevexu@northwestern.edu|
21290496|NCT01245049|GlaxoSmithKline|GSK Response Center|866-435-7343||
21290497|NCT00450749|University of Texas MD Anderson Phase I/II Prevention Consortium|Powel H Brown, MD, PhD/Professor of Medicine and Cancer Prevention|713-792-2830|PHBrown@mdanderson.org|
21290498|NCT00537082|Novartis Pharmaceuticals|Study Director|862-778-8300||
21290499|NCT04495478|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21290500|NCT06896734|Eminence Clinical Research, Inc.|Nick Leppo|719-400-7464|nleppo@ecr-inc.com|
21290501|NCT03061214|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21290502|NCT01879826|University of California San Francisco|Cynthia Kim|(415)353-1328|cynthia.kim@ucsf.edu|
21290503|NCT03992872|Bavarian Nordic|Medical Information|1-844-422-8274|medical.information_NA@bavarian-nordic.com|
21290504|NCT01537432|Novartis Pharmaceuticals|Study Director|862-778-8300||
21290505|NCT03446690|University of Alabama at Birmingham|Chung How Kau|205-934-1289|ckau@uab.edu|
21290506|NCT00889005|New York Langone Medical Center Department of Psychiatry|Arieh Y. Shalev, M.D.|6467544782|arieh.shalev@nyumc.org|
21290507|NCT01998477|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21290508|NCT00129974|Tufts Medical Center|Research Administration||mcoughlin@tuftsmedicalcenter.org|
21290509|NCT00128492|Gilead Sciences, Inc.|Mark Bresnik, Director of Clinical Research|650-522-5934|Mark.Bresnik@gilead.com|
21290510|NCT00612768|SmartPractice|Kathy Shannon|602-225-0595|kshannon@smarthealth.com|7208
21290511|NCT01132690|Protalix Biotherapeutics|Senior VP Development|+972-4-902-8100|einat@protalix.com|
21290512|NCT04629157|Alder Hey Children's NHS Foundation Trust|Miss Rachel Harwood|0151 228 4811|rachel.harwood@alderhey.nhs.uk|
21290513|NCT00867334|George Mason University|Emanuel Petricoin|571-830-4166|epetrico@gmu.edu|
21290514|NCT00601731|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21290515|NCT00347269|University of Washington|Peter Roy-Byrne MD Professor of Psychiatry|206-313-8504|roybyrne@u.washington.edu|
21290516|NCT06091956|Mayo Clinic|Aaron Mangold, M.D.|480-301-6169|Mangold.Aaron@mayo.edu|
21290517|NCT00742157|University of Nebraska Medical Center|Fedja Rochling, MD|402-559-3652|frochling@unmc.edu|
21290518|NCT02176525|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21290519|NCT00728182|NoNO Inc.|Roberta Anderson, Vice President of Clinical Development|613 833-1020|randerson@nonoinc.ca|
21239653|NCT00697190|Vistakon|John Buch OD|904-443-1707||
21233209|NCT01139450|Fougera Pharmaceuticals Inc.|Angela C. Kaplan|631-659-2256|angela.kaplan@sandoz.com|
21233210|NCT02794103|Université de Montréal|Dr. Sylvie Le May, Professor & Researcher|514 345-4931|sylvie.lemay@umontreal.ca|4938
21233211|NCT04608500|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
21233212|NCT01010906|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21233213|NCT01881230|Celgene|Anne McClain, Senior Manager Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
21233214|NCT05123222|Center for Immunization Research|Anna Durbin|667-306-9772|adurbin1@jhu.edu|
21233215|NCT00834210|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
21233216|NCT00914810|Minneapolis VA Health Care System|Ken Kunisaki, M.D.|612-467-4400|kunis001@umn.edu|
21233217|NCT02747420|NYU Langone Health|Dr. Benjamin Brucker|+1 646 825 6300|Benjamin.Brucker@nyulangone.org|
21233218|NCT04782856|Uconn Health|Francesco S. Celi, MD, MHSc.|860-679-2715|celi@uchs.edu|
21233219|NCT02535741|Stryker European Operations BV|Doug McGurty|+44(0)1635 500690|doug.mcgurty@stryker.com|
21233220|NCT01030523|Dentsply Sirona Implants|Manager of Global Clinical Research|+46313763500|ClinicalResearchMolndal@dentsplysirona.com|
21233221|NCT00426283|Cincinnati Children's Hospital Medical Center|Marc E Rothenberg|513-636-7177|rothenberg@cchmc.org|
21233222|NCT00798369|Novartis Pharmaceuticals|Study Director|862-778-8300||
21233223|NCT04475588|Biocon Biologics India Limited|Dr. Subramanian Loganathan|0802808|subramanian.l101@biocon.com|5466
21233224|NCT03020823|Syncore|Dr. Lin|0227603688|JWLin@syncorebio.com|
21233225|NCT00588822|Mayo Clinic|Dr. Benn E. Smith|480-301-6711|bsmith@mayo.edu|
21233226|NCT00470574|Memorial Sloan Kettering Cancer Center|Teresa Gilewski, MD|(212) 639-2000|gilewskt@mskcc.org|
21233227|NCT01701115|HSS|Dr. Daniel Maalouf|(212) 606-1000|MaaloufD@HSS.EDU|
21233228|NCT01413360|Seoul National University Hospital|Jung-Hwan Yoon|+82-2-2072-2228|yoonjh@snu.ac.kr|
21233229|NCT00862810|Duke University Health System|Emmanuel Walter MD, MPH|919-620-5346|walte002@mc.duke.edu|
21233230|NCT02246673|Study Information Center AstraZeneca|Jesse Hall, MD|+1 877-240-9479|information.center@astrazeneca.com|
21233231|NCT02914769|UFRN|Draulio Barros de Araujo|+5584991225987|draulio@neuro.ufrn.br|
21233232|NCT02410954|University of California, San Francisco|Andrew Krystal, MD|(415) 476-7702|andrew.krystal@ucsf.edu|
21233233|NCT02738333|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21279178|NCT00815360|Retina Associates of Florida, P.A.|Dr. Ivan J. Suner|813-875-6373|ivansuner@gmail.com|
21279179|NCT00704730|Exelixis, Inc|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
21279180|NCT03120325|Stanford University|Linda Nguyen|650-736-0431|nguyenlb@stanford.edu|
21279181|NCT00402116|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21279182|NCT02899195|PrECOG|Dr. Zhuoxin Sun|617-632-3012|zhuoxin@jimmy.harvard.edu|
21279183|NCT03758716|Oneness Biotech Co., Ltd.|NienYi Chen PhD|+886 2 2655 8687|nienyichen@onenessbio.com.tw|613
21279184|NCT04778904|Barinthus Biotherapeutics|Chief Medical Officer|+44 (0) 1865 818 808|clinicaltrials@barinthusbio.com|
21279185|NCT03156504|Mayo Clinic|Dr. Jennifer Vande Voort|507-255-6782|VandeVoort.Jennifer@mayo.edu|
21279186|NCT03452137|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21279187|NCT02856802|Upsher-Smith Laboratories, LLC|Clinical Operations|(763) 315-2000|uslinfo@upsher-smith.com|
21279188|NCT03772717|Emory University|Sumit Verma, MD|404-785-9893|sumit.verma@emory.edu|
21279189|NCT04138043|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21279190|NCT00587860|Mayo Clinic|Yuri A. Saito Loftus, M.D., M.P.H.|507-284-5010|saito.yuri@mayo.edu|
21279191|NCT01659125|Institute of Living|Gretchen J. Diefenbach|860-545-7685|gretchen.diefenbach@hhchealth.org|
21279192|NCT02755649|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
21279193|NCT01286753|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21279194|NCT02089659|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21279195|NCT02126826|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21279196|NCT01371747|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
21279197|NCT03092219|Teoxane SA|Clinical Project Manager|+41(0) 22 344 96 36|m.chenet@teoxane.com|
21279198|NCT03278626|NYU Langone Health - Perlmutter Cancer Center|Jennifer Wu, MD|212-263-3809|Jennifer.Wu@nyulangone.org|
21279199|NCT05013008|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
21279200|NCT02928055|MetroHealth Medical Center|Richard Wilson, MD|216-778-4414|rwilson@metrohealth.org|
21279201|NCT02856555|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21279202|NCT03333941|AVITA Medical|VP Clinical Research|661-367-9710|clinicaltrial@avitamedical.com|
21279203|NCT04971187|M D Anderson Cancer Center|Dr. Xiuning Le|(713) 792-6980|xle1@mdanderson.org|
21279204|NCT00411411|Gentofte University Hospital|Dr. Kasper Aaboe|+4522170200|kasper@dadlnet.dk|
21279205|NCT00547586|Bausch Health|Study Director||susan.harris@bauschhealth.com|
21279206|NCT01368653|Rutgers, The State University of New Jersey|Danielle E. McCarthy, Ph.D.|608-265-5949|demccarthy@wisc.edu|
21279207|NCT01207583|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21279208|NCT05177718|Vumc|Natalizumab and chronic Blood Brain Barrier Breakdown|6159360060|francesca.r.bagnato@VUMC.ORG|
21233234|NCT05413369|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21233235|NCT03165110|Ascensia Diabetes|Jane Wallace|(574) 850-1467|jane.wallace@ascensia.com|
21233236|NCT01335230|University of Cincinnati, Associate Prof., PI.|Mohamed Tarek M. shata|(513) 558-6110|mohamed.shata@uc.edu|
21279209|NCT01696058|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21233237|NCT04147455|Emory University|Dr. Kathryn Yount|404-727-8511|kyount@emory.edu|
21233238|NCT00454987|GlaxoSmithKline|GSK Response Center|866-435-7343||
21233239|NCT04311424|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21233240|NCT02642432|AbbVie|Global Medical Services|800-633-9110||
21233241|NCT03999892|Johns Hopkins|Gail Daumit|410 614 6460|gduamit@jhmi.edu|
21233242|NCT01848756|Esanex Inc|Eric Orlemans, Chief Scientific Officer|919-338-2019|eorlemans@esanexpharma.com|
21233243|NCT03245008|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp|
21233244|NCT02075658|UCI Health Department of Urology|Clinical Research Coordinator|714-456-8176|yoonrh@uci.edu|
21233245|NCT01286012|Rockwell Medical|Raymond Pratt, MD CMO|248 960 9009|rd@rockwellmed.com|
21233246|NCT00827983|IBSA Institut biochimique|Clinical trial manager|+41583601000|barbara.cometti@ibsa.ch|
21233247|NCT04056195|Oscotec Inc.|Sungsil Lee/Team Leader of Clinical Development|+82316287624|sslee@oscotec.com|
21233248|NCT02406651|Generon/Evive Biotech|Christina Tay|1-908-540-0816|christina.tay@evivebiotech.com|
21233249|NCT01395329|University of Colorado|Dr. Christopher DeSouza|303-492-2988|desouzac@colorado.edu|
21233250|NCT00718328|Johns Hopkins University SOM (former employer during the study)|Neeraj Naval|9042026290|neerajnaval@gmail.com|
21233251|NCT02865915|Millendo Therapeutics US, Inc.|Director of Clinical Operations|734-845-9000|millendo@millendo.com|
21233252|NCT00663052|Wyeth, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21233253|NCT01876485|Department of Veterans Affairs|Dr. LeChauncy Woodard|(713) 440-4441|woodard.lechauncy@va.gov|
21233254|NCT01602380|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21233255|NCT06002958|University of North Carolina at Chapel Hill|Kelsey Ludwig, PhD|(919) 962-1401|kelsey_ludwig@med.unc.edu|
21233256|NCT05760300|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21233257|NCT03313804|University of Kentucky|Dr. John Villano|8593234405|jlvillano@uky.edu|
21233258|NCT01502423|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21233259|NCT00567892|Washington University|Dr. Jay F. Piccirillo|314.362.8641|piccirilloj@ent.wustl.edu|
21233260|NCT04814433|NYU Langone Health|Thomas Calahan|929-455-5826|Thomas.Calahan@nyulangone.org|
21233261|NCT01331148|Carolinas Healthcare System|Ifeyinwa Osunkwo, MD, MPH, Principal Investigator|980 442 5001|ify.osunkwo@carolinashealthcare.org|
21233262|NCT01545817|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21233263|NCT04439253|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21233264|NCT03971695|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21233265|NCT04447417|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21233266|NCT00702403|Fred Hutchinson Cancer Research Center|Dr. Paul A. Carpenter|(206) 667-5191|pcarpent@fredhutch.org|
21233267|NCT01341600|University of Maryland School of Medicine|Richard Horenstein M.D., Associate Professor of Medicine|410-706-0154|rhorenst@medicine.umaryland.edu|
21233268|NCT01230931|The University of Texas Health Science Center at Houston|Catherine G. Ambrose, PhD||Catherine.G.Ambrose@uth.tmc.edu|
21233269|NCT00887354|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21233270|NCT00824044|Massachusetts General Hospital|Dr. Amy Farabaugh|617-726-1629|afarabaugh@partners.org|
21233271|NCT01466348|GlaxoSmithKline|GSK Response Center|866-435-7343||
21233272|NCT01291056|University of Utah Department of Obstetrics & Gynecology|Dr. Jessica Pittman|801-339-4103|jessica.pittman@hsc.utah.edu|
21233273|NCT00192504|MedImmune, LLC|Genevieve A. Losonsky, MD/VP Clinical Development|301-398-0000|losonskyG@medimmune.com|
21233274|NCT03989440|ReNetX Bio, Inc.|George D. Maynard, Ph.D., Study Director|2032088925|info@renetx.com|
21233275|NCT02974296|Columbia University|DR. Marta Moreno-Ortega|9142187311|mm4355@cumc.columbia.edu|
21233276|NCT01955161|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
21233277|NCT03928847|University of California at San Francisco|Harold A. Chapman, M.D.|415-514-1210|hal.chapman@ucsf.edu|
21233278|NCT05129488|Bausch & Lomb|Study Director|15853386399|robert.steffen@bausch.com|
21233279|NCT01925404|RAND|Deborah Cohen|310 3930411|dcohen@rand.org|
21233280|NCT00706641|Hoosier Cancer Research Network, Inc.|Noah Hahn, MD|317-921-2050|jsmith@hoosiercancer.org|
21233281|NCT01327300|University of Florida|Dr. Baharak Moshiree|(352)273-8393|bmoshiree@med.miami.edu|
21233282|NCT03739112|Medicago|Medical Director|+1 418-658-9393|clinicaltrialinquiries@medicago.com|
21233283|NCT03340337|Universidad Maimónides - Universidad Nacional Arturo Jauretche - Instituto Universitario de Ciencias de la Salud Fundación H.A. Barceló|Oscar Ronzio|+54-11-4905-1140|ronzio.oscar@maimonides.edu|
21233284|NCT04307446|Tufts University|Nancy Baker|617 627 5562|nancy.baker@tufts.edu|
21233285|NCT01063764|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
21233286|NCT03054857|King Chulalongkorn Memorial Hospital|Dr.Yada Thongsuk|+66817738629|thongsuk.y@hotmail.com|
21233287|NCT01727141|Novartis Pharmaceuticals|Study Director|862-778-8300||
21233288|NCT02529137|Philips Digital Pathology Solutions|Mischa Nelis, Clinical Study Director||dpsclinicaltrials@philips.com|
21233289|NCT04855643|The University of Texas Health Science Center at Houston|Antonio L. Teixeira, MD, PhD, MSc|713-486-2555|Antonio.L.Teixeira@uth.tmc.edu|
21233290|NCT01660711|NorthShore University/University of Chicago|Dr Robert Marsh|847-5702112|rmarsh@northshore.org|
21233291|NCT00952341|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21233292|NCT01686841|Zeltiq Aesthetics|Lori Brandt, Director Clinical Trial Management|(925) 621-7460|lori.brandt@abbvie.com|
21233293|NCT02066467|Boston Scientific|Caroline Beaudoint|+32479904163|Caroline.Beaudoint@bsci.com|
21233294|NCT01442363|Braintree Laboratories, Inc.|Head of R&D, GI|7818432202|studydirector@sebelapharma.com|
21233295|NCT01319812|BIOTRONIK|Amy Culley, Director of Vascular Intervention|503-451-8034|amy.culley@biotronik.com|
21233296|NCT02759120|Weill Cornell Medicine|Elizabeth Peters|646-962-2742|elp2018@med.cornell.edu|
21233297|NCT04461015|Mayo Clinic|Adrian Vella|507-255-6515|vella.adrian@mayo.edu|
21233298|NCT01633892|University of Pittsburgh|J. Peter Rubin|412-624-9703|rubipj@upmc.edu|
21233299|NCT03538158|Weill Cornell Medicine|Chelsie Burchett|212-746-1417|cob2014@med.cornell.edu|
21233300|NCT02631954|INHA UNIVERSITY HOSPITAL|Sang-Heon Cho, Ph.D.|82-32-890-1122|shcho123@inha.ac.kr|
21233301|NCT01229423|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
21233302|NCT04356963|University of Maryland School of Medicine|Dr. Nicholas Morris|410-328-4515|nicholas.morris@som.umaryland.edu|
21233303|NCT00629499|Sarah Cannon Research Institute|Director, Breast Cancer Research|615-329-7274|asksarah@scresearch.net|
21233304|NCT00791518|GlaxoSmithKline|GSK Response Center|866-435-7343||
21233305|NCT02658136|Rigshospitalet|Dr Kiran Mirza|004535451442|KMIR0003@regionh.dk|
21233306|NCT00006101|University of California, Irvine|Dr. Thomas Ahlering|(714) 456-6068|tahlerin@uci.edu|
21233307|NCT01748643|Ziekenhuis Oost-Limburg|Dr. Pascal Vanelderen|+3289325298|pascal.vanelderen@gmail.com|
21233308|NCT02447133|Topcon|Charles Reisman|201-599-5283|CREISMAN@topcon.com|
21233309|NCT04256785|Universidad de Granada|Dr. Elena Pita Calandre|+34 958246291|epita@ugr.es|
21233310|NCT01172184|Kaohsiung veterans general hospital|Dr. Shih-Hung Hsiao|886-7-3422121|irb@vghks.gov.tw|1518
21233311|NCT00271609|National Cancer Institute, National Institutes of Health|Teri Kreisl, M.D.|301-402-3423|kreislt@mail.nih.gov|
21233312|NCT03341533|Mayo Clinic|Dr. Tatnai Burnett|507-538-5783|burnett.tatnai@mayo.edu|
21233313|NCT00643682|Boston Medical Center|Brian Jacobson, MD, Principal Investigator|6176386563|brian.jacobson@bmc.org|
21233314|NCT02084147|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Philipp Frank Graner|+1 216-844-8275|philipp.graner@uhhospitals.org|
21233315|NCT03755414|Washington University School of Medicine|Dr. Ramzi Abboud|314-454-8304|rabboud@wustl.edu|
21233316|NCT02153112|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21233317|NCT02155647|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21233318|NCT01675128|National Cancer Institute|Dr.Tim Greten|301-451-4723|gretentf@mail.nih.gov|
21233319|NCT00967993|Keryx Biopharmaceuticals Inc|Medical Information|1-844-44-KERYX (1-844-445-379|medicalinfo@keryx.com|
21233320|NCT04418999|Illinois College of Optometry|Jennifer Harthan|3129497249|JHarthan@ico.edu|
21233321|NCT03011307|Wake Forest University School of Medicine|Dr. James Eisenach|336-716-4182|eisenach@wakehealth.edu|
21233322|NCT03526458|University of Wisconsin, School of Medicine and Public Health, Department of Urology|Shuang Li|6082638336|lis@urology.wisc.edu|
21233323|NCT01782664|GlaxoSmithKline|GSK Response Center|866-435-7343||
21233324|NCT02404285|Next Science|Matt Myntti PHD, President|9046474161|mmyntti@nextscience.org|
21279210|NCT03781037|Florida International University|Dr. Jeremy Pettit|305-348-1671|jpettit@fiu.edu|
21233325|NCT04170348|CUIMC|Dr. Margaret T. Lee, Professor of Pediatric|212-305-6290|ml653@cumc.columbia.edu|
21233326|NCT04026048|Memorial University of Newfoundland|Dr. Sheila Garland|(709) 864-4897|sheila.garland@mun.ca|
21233327|NCT00506155|University of Texas (UT) MD Anderson Cancer Center|Arlene Siefker-Radtke, MD/Associate Professor, Genitourinary Medical Oncology||CR_Study_Registration@mdanderson.org|
21233328|NCT01082965|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21233329|NCT03642717|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21233330|NCT02587065|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
21233331|NCT01559012|Città della Salute e della Scienza Ospedale Sant'Anna. Servizio di Medicina Interna|Dr. Aldo Maina M.D. Obstetric Medicine|0039011313|amaina@cittadellasalute.to.it|5735
21233332|NCT04665050|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21233333|NCT00302458|Massachusetts General Hospital|Dr. Thomas Spencer|617-726-1731|spencer@helix.mgh.harvard.edu|
21233334|NCT00946712|SWOG Statistics & Data Management Center|Lung Committee Statistican|2066675712|jmiao@fredhutch.org|
21233335|NCT03022292|Stein Eye Institute of UCLA|Dr. David Sarraf|310-825-7836|DSarraf@ucla.edu|
21233336|NCT02967692|Novartis Pharmaceuticals|Study Director|862 778 8300|Novartis.email@Novartis.com|
21279211|NCT02186834|H. Lee Moffitt Cancer Center and Research Institute|Dr. Rachid Baz|813-745-8212|rachid.baz@moffitt.org|
21279212|NCT01053000|Roger H. Stewart MD PA|Barry Galitzer MD|954-491-0510|barry@galitzer.com|
21279213|NCT04746794|University of Washington|Faith Beers|206-543-1733|fabeers@uw.edu|
21233337|NCT05477875|University of Florida Oaks Eye Center|Yujia Zhou|3522652020|yzhou1996@ufl.edu|
21233338|NCT00613028|Preston Robert Tisch Brain Tumor Center at Duke|David A. Reardon, MD|919-668-1409|reard003@mc.duke.edu|
21233339|NCT05394025|Center to Improve Veteran Involvement in Care (CIVIC), VA Portland Health Care System|Project Manager|503-220-8262|Holly.McCready2@va.gov|51856
21233340|NCT02731729|Parker Institute for Cancer Immunotherapy|Ute Dugan|203-379-6757|udugan@parkerici.org|
21233341|NCT01344447|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21233342|NCT03460587|UCLA|Steven C. Cramer, MD|424-522-7273|sccramer@mednet.ucla.edu|
21233343|NCT04322396|Gentofte Hospital|Prof. Jens-Ulrik Stæhr Jensen, MD PHD|+4538673057|jens.ulrik.jensen@regionh.dk|
21233344|NCT04302389|University of Connecticut|Dr. Sherry Pagoto|860-486-8979|sherry.pagoto@uconn.edu|
21233345|NCT02004028|Verastem Oncology|Clinical Trials|+1-781-292-4204|clinicaltrials@verastem.com|
21233346|NCT02063854|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21233347|NCT03240679|Mayo Clinic|Dr. Kenneth K. Wang|507-284-2691|wang.kenneth@mayo.edu|
21233348|NCT02419742|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21233349|NCT02829463|Third Xiangya Hospital of Central South University|Dr. Jinshen He|8613517470997|jinshen.he@hotmail.com|
21233350|NCT02255981|Escuela Neijing|Researcher|5744211000|lhgut2001@gmail.com|
21279214|NCT01422187|Target Health Inc.|Glen Park|212-681-2100|gpark@targethealth.com|
21290520|NCT02236767|Hartford Hospital|Gretchen Diefenbach|860-545-7396|gretchen.diefenbach@hhchealth.org|
21290521|NCT04792970|Duke University Medical Center|Scott Shofer|(919) 668-2402|scott.shofer@duke.edu|
21290522|NCT02369159|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
21233351|NCT00912990|Rady Children's Hospital San Diego|Dr. Sandeep Khanna|858-966-5863||
21233352|NCT03425331|Dana-Farber Cancer Institute|Mark Awad, MD, PhD|(617) 632-3468|mark_awad@dfci.harvard.edu|
21233353|NCT01232920|Proctor Foundation, University of California San Francisco|Nisha Acharya|415-476-8131|nisha.acharya@ucsf.edu|
21233354|NCT01454570|James J Peters VA Medical Center|Dr. Ann Spungen - PI|718-584-9000|ann.spungen@va.gov|5420
21279215|NCT03578549|Univeristy of Michigan|Dr. Darya Dabiri|4198821017|daryad@umich.edu|
21279216|NCT04611529|Montefiore Medical Center|Dr. Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
21279217|NCT04414345|Healey Center for ALS at Massachusetts General Hospital|Healey Center for ALS Project Management|833-425-8257 (HALT ALS)|healeyalsplatform@mgh.harvard.edu|
21279218|NCT03138590|University of Texas at Dallas|Dr. Sven Vanneste, Principal Investigator|972-883-7277|sven.vanneste@utdallas.edu|
21279219|NCT00425373|Novartis Pharmaceuticals|Study Director|862 778-8300||
21279220|NCT00242684|Central Arkansas Veterans Healthcare System|Melinda Bopp, Project Coordinator|501-257-2045|melinda.bopp@va.gov|
21279221|NCT02960490|Eisai Co., Ltd.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
21279222|NCT02667067|NuVasive, Inc.|Nicole Czaplewski|308-660-2021|nczaplewski@nuvasive.com|
21279223|NCT01590797|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21279224|NCT03106987|AstraZeneca Clinical Study Information Center|Global Clinical Head|1-877-240-94 79|information.center@astrazeneca.com|
21279225|NCT03336528|Emory University|Dr. Guillermo E. Umpierrez|(404) 778-1663|geumpie@emory.edu|
21279226|NCT03100123|Ottawa Hospital Research Institute|Dr. Leslie Skeith|403-944-5246|laskeith@ucalgary.ca|
21279227|NCT02460679|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
21279228|NCT00920790|Kyowa Hakko Kirin|Project Management Department, Development Division||clinical.info@kyowa-kirin.co.jp|
21279229|NCT01992185|Physicians Institute|Sharon Keene, MD|(520) 290-5555|monican@appliedbiology.com|
21279230|NCT03225001|Edwards Lifesciences|Edwards THV Clinical Affairs|(949) 250-2500|THV_CT.gov@Edwards.com|
21279231|NCT00468650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21279232|NCT02655666|Medtronic Minimed|Willam Lv|86-21-20325454|william.lv@medtronic.com|
21279233|NCT03203564|Isofol Medical AB|Chief Medical Officer|+46 (0)707646500|karin.ganlov@isofolmedical.com|
21279234|NCT00789737|Daiichi Sankyo Pharma Development|Director Metabolic Clinical Development|732-590-5000||
21279235|NCT03136965|University of Wisconsin School of Medicine and Public Health|Kenneth Lee, MD, MBA|(608) 263-9387|klee2@uwhealth.org|
21279236|NCT02785952|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
21279237|NCT00642278|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
21290523|NCT02214628|Ophthotech Corp.|Keith Westby|732-824-7474|keith.westby@ophthotech.com|
21233355|NCT01852812|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21290524|NCT03000751|University of California San Francisco|Rebecca Smith-Bindman, MD|415-353-4946|rebecca.smith-bindman@ucsf.edu|
21290525|NCT03888287|Hackensack Meridian Health|Hooman Azmi, MD|201-342-2550|hooman.azmi@hmhn.org|
21290526|NCT00425854|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21290527|NCT01514422|Mood and Anxiety Disorders Program, Icahn School of Medicine at Mount Sinai|Dr. Dan V. Iosifescu|212-241-4480|dan.iosifescu@mssm.edu|
21290528|NCT01630811|Sutter Medical Group, Neurology|Michael Chez, MD|(916) 454-6667|ChezM@sutterhealth.org|
21290529|NCT01217411|University of Texas (UT) MD Anderson Cancer Center|Morris D. Groves, MD / Professor|713-792-2573|mgroves@mdanderson.org|
21290530|NCT01725308|Astellas Pharma Inc.|Head of Clinical Development Administration||Astellas.resultsdisclosure@astellas.com|
21290531|NCT03511209|VA Greater Los Angeles Healthcare System|Constance H. Fung, MD, MSHS|818-891-7711|Constance.Fung@va.gov|39311
21290532|NCT02592655|Marcus Migura|Marcus Migura|(619) 436-7323|mwmigura@gmail.com|
21290533|NCT02628145|University of Rhode Island|Matthew Delmonico|4018745440|delmonico@uri.edu|
21290534|NCT04409418|William Beaumont Hospitals|Dr. Amit Bahl|248 898-9111|amit.bahl@corewellhealth.org|
21233356|NCT02876900|Noven Pharmaceuticals|George Harb, MD, MPH - Executive Director, Clinical Development|1-551-233-2656|gharb@noven.com|
21261188|NCT00918723|Fred Hutchinson Cancer Research Center|Dr. Mazyar Shadman|2066675467|mshadman@fredhutch.org|206
21261189|NCT03311126|University of Wisconsin Carbone Cancer Center|Julie Chang, MD|(608) 263-9823|jc2@medicine.wisc.edu|
21261190|NCT03113500|City of Hope Medical Center|Dr. Alex Herrera|626-359-8111|aherrera@coh.org|
21261191|NCT06470087|Adichunchanagiri Institute of Medical Sciences, BG Nagara|Dr Naveen N|9980023372|drnaveenn@bgsaims.edu.in|+91
21261192|NCT02517515|AbbVie|Global Medical Services|800-633-9110||
21261193|NCT00469079|University of Minnesota|Dorothy Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu|
21261194|NCT02981472|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21261195|NCT03638011|Maimonides Medical Center|Dr Dennis Feierman|718-283-6000|dfeierman@maimonidesmed.org|7703
21261196|NCT02396147|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21233357|NCT02285907|Purdue University|Dr. Heather Leidy|765-496-0184|hleidy@purdue.edu|
21233358|NCT00117559|VA Boston Healthcare System|Amy Silberbogen, Ph.D.|857-364-4797|amy.silberbogen@va.gov|
21233359|NCT02488681|Medtronic|Micra CA Study Manager|800-328-2518|rs.micracontinuedaccess@medtronic.com|
21233360|NCT00720057|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21233361|NCT04949165|University of Minnesota|Protocol Manager for BLIS|(612)590-2697|telke001@umn.edu|
21233362|NCT04969224|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21233363|NCT01498952|MedImmune LLC|Mohammed Dar|+301-398-0000|information.center@astrazeneca.com|
21233364|NCT05533632|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21233365|NCT02726074|Eisai Inc.|Eisai Korea Inc. Medical department|+82-2-3451-5539|h3-park@eisaikorea.com|
21233366|NCT00579826|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-588-4523|bkimler@kumc.edu|
21233367|NCT02701647|The Hong Kong Polytechnic University|Chloe Chung|2766|chloe.lh.chung@connect.polyu.hk|7092
21233368|NCT03054870|Cyclomedica Australia Pty Ltd|James McBrayer|+61 2 9541 0411|clinicaltrials@cyclomedica.com|
21233369|NCT02009046|PHI|Norman A. Constantine, Ph.D.|925-284-8118|nconstantine@berkeley.edu|
21233370|NCT01096810|Mount Sinai|Dr. Sundar Jagannath|2122417873|sundar.jagannath@mountsinai.org|
21233371|NCT01807897|VA Boston Healthcare System|Dr. Daniel Gottlieb|857-203-6175|daniel.gottlieb@va.gov|
21233372|NCT00973479|Centocor, Inc.|Director Clinical Research|1-800-457-6399||
21233373|NCT05075850|Monteris Medical|Christa Seligman|(952) 463-7747|cseligman@monteris.com|
21233374|NCT01154218|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21233375|NCT01265849|CEL-SCI Corporation|John Cipriano, Senior VP Regulatory Affairs, Eyal Talor Chief Scientific Officer|(205) 586-6947|jcipriano@cel-sci.com|
21233376|NCT00362115|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21233377|NCT01170091|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21233378|NCT03194321|Cedars Sinai Medical Center|Dr. Stanley C. Jordan, MD|310-423-2641|sjordan@cshs.org|
21233379|NCT02188589|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
21233380|NCT01547000|University of South Florida|Tanya K. Murphy, MD, MS|813-974-2201|tmurphy@health.usf.edu|
21233381|NCT03168308|University of Texas Southwestern|Tiffany Moon, MD|4694195790|Tiffany.Moon@UTSouthwestern.edu|
21233382|NCT04039412|Zagazig University-Faculty of Human Medicine|Dr. Ayman Fathy Elsayed|+201125020593|aymanf28@yahoo.com|
21233383|NCT00003641|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
21233384|NCT00944450|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21233385|NCT02154581|UT Health San Antonio|Research Compliance Coordinator-Senior|210-567-8554|NijlandK@uthscsa.edu|
21233386|NCT02591147|University of Iowa College of Dentistry|Dr. Justine Kolker|(319) 335-7583|justine-kolker@uiowa.edu|
21233387|NCT03886220|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21233388|NCT02664909|UConn Health|Vincent Williams, M.D.|(860) 679-8384|vwilliams@uchc.edu|
21233389|NCT03082599|Carolina Eyecare Physicians, LLC|Dr. Helga P Sandoval, Director of Research|8438813937|helga.sandoval@carolinaeyecare.com|
21233390|NCT01340144|Colorado Joint Replacement|Raymond Kim, MD|720-524-1367|raymondkim@ccentura.org|
21233391|NCT00832585|Rush University Medical Center - Department of Dermatology|Dr. Michael D. Tharp|312-563-4001|derm@rush.edu|
21233392|NCT04404855|UT Health San Antonio|Michael Liss, MD|210-567-5676|liss@uthscsa.edu|
21233393|NCT03098173|Tokyo University|Dr. Ryota Niikura|+81-3-3815-5411|niikura-dky@umin.ac.jp|
21233394|NCT00853723|UPittsburgh|Mara J Horwitz|4126922848|horwitz@pitt.edu|
21233395|NCT02517996|Johns Hopkins University School of Medicine|Dr. Tola Fashokun|410-464-6641|bunmi_omo@hotmail.com|
21233396|NCT04248933|University of Maryland, College Park|Dr. Jessica Magidson|301-405-5095|jmagidso@umd.edu|
21233397|NCT00445965|Memorial Sloan Kettering Cancer Center|Dr. Kim Kramer MD|212-639-6410|kramerk@MSKCC.ORG|
21233398|NCT02447081|Abbott|Ryan Gage, Senior Scientist|651 756 3334|Ryan.Gage@abbott.com|
21233399|NCT05778786|Johnson & Johnson Vision Care, Inc. (JJVC)|Benjamin Straker|1-800-843-2020|bstraker@its.jnj.com|
21233400|NCT01787175|University of Utah Health Care System|Dr. Jonathan Nebeker|801-582-1565|Jonathan.Nebeker@hsc.utah.edu|2458
21233401|NCT04595513|Cincinnati Children's Hospital Medical Center|Darcy A. Krueger, MD., PhD|513-636-4222|krueger_darcy@cchmc.org|
21233402|NCT05497284|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
21233403|NCT00066066|The Forsyth Institute|Ricardo P Teles, DDS, DMSc|617 892-8556|rteles@forsyth.org|
21233404|NCT03752307|University of New Mexico|Corey Ford, M.D., Ph.D.|505-925-4124|cford@salud.unm.edu|
21233405|NCT02515942|Alcon, A Novartis Division|WW Brand Medical Director Ophtha, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com|
21233406|NCT00697515|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21233407|NCT02603432|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21233408|NCT00666757|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21233409|NCT05954052|University of Chicago|Karam Radwan, MD|7738346686|radwan@uchicago.edu|
21233410|NCT01957462|Coloplast|Daniel Carter|+45 49222523|dkdac@coloplast.com|
21239654|NCT00886639|Schön Klinik BGL|Dr. Klaus Kenn|0865293|iheinzelmann@schoen-kliniken.de|1540
21233411|NCT02130063|Pharmacosmos|Chief Medical Officer|+45 5948 5959|llt@pharmacosmos.com|
21233412|NCT01723163|Durham Veterans Affairs Medical Center|Dr. Patrick Calhoun|919-286-0411|patrick.calhoun2@va.gov|7970
21233413|NCT02510794|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21279238|NCT03713619|Novarts Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
21233414|NCT01649375|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21290535|NCT02971137|VA Connecticut Healthcare System|Dr. Lori A. Bastian|203-932-5711|lori.bastian@va.gov|2655
21233415|NCT04939727|HealthPartners Institute|Dr. Rebecca Rossom|952-883-5466|Rebecca.C.Rossom@HealthPartners.com|
21233416|NCT01856790|Yale University School of Medicine|Dr. Jennifer Sherr|203-785-5831|jennifer.sherr@yale.edu|
21233417|NCT04091646|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
21233418|NCT01921829|University of Pittsburgh|Dr. Kelly Liang|507-269-7812|liangk@upmc.edu|
21233419|NCT03102918|Beth Israel Deaconess Medical Center|Dr. Kevin Hill|617-667-1504|khill1@bidmc.harvard.edu|
21233420|NCT00539838|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21233421|NCT02681549|Harvey and Kate Cushing Professor of Medicine (Oncology) and of Dermatology; Director, Yale SPORE in Skin Cancer, Yale Cancer Center|Harriet Kluger, MD|(203) 200-6622|harriet.kluger@yale.edu|
21233422|NCT01660893|University of Maryland|Dr. Sharon M. Gordon|410-706-1656|sgordon@dental.umaryland.edu|
21233423|NCT02658890|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
21233424|NCT02474199|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21233425|NCT03090100|Janssen Research & Development, LLC|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21233426|NCT02752191|UCLA|J. Paul Finn|(310) 825-5344|ohrpp@research.ucla.edu|
21233427|NCT04765358|Jaeb Center for Health Research|Robin Gal|813-975-8690|rgal@jaeb.org|
21233428|NCT00159588|St. Olavs Hospital|Professor Knut Hagen|+47 95401579|knut.hagen@stolav.no|
21233429|NCT03446040|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21233430|NCT00456521|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|Medinfo@Orexigen.com|
21233431|NCT01316276|Insmed Incorporated|Kevin Mange (Senior VP, Clinical Development)|908-947-2651|kevin.mange@insmed.com|
21233432|NCT00605475|Novartis Pharmaceuticals|Study Director|862 778 8300||
21233433|NCT02596854|GE Healthcare|John Strohmeyer|609-865-7423|john.strohmeyer@ge.com|
21233434|NCT05853250|Cleveland Clinic|Nancy M. Albert, PhD, Associate Chief Nursing Officer|216-444-7028|albertn@ccf.org|47028
21233435|NCT05469100|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21233436|NCT00464568|GlaxoSmithKline|GSK Response Center|866-435-7343||
21233437|NCT00507442|Millennium Pharmaceuticals, Inc|Dixie-Lee Esseltine, MD|(617) 679-7000||
21233438|NCT04236804|University of Pittsburgh|Brian O'Connell|3023997506|oconnellb2@upmc.edu|
21233439|NCT03506373|Mayo Clinic Jacksonville|Asher Chanan-Khan, MD|904-953-2708|chanan-khan.asher@mayo.edu|
21233440|NCT00107198|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21233441|NCT03002012|University of Minnesota|David Boulware|612-624-1966|boulw001@umn.edu|
21233442|NCT04649164|Rush University Medical Center|Dr. Jori Fleisher|3125632900|jori_fleisher@rush.edu|
21233443|NCT00304356|VA Houston|Daniel Musher|713-794-7386|daniel.musher@va.gov|
21233444|NCT04120974|Becton, Dickinson and Company|Sandra van Guldener, Director OUS Clinical Affairs|+31646900840|sandra.vanguldener@bd.com|
21233445|NCT02951338|University Health Network|Avril Mansfield|416-597-3422|avril.mansfield@uhn.ca|7831
21233446|NCT03019939|The University of Texas MD Anderson Cancer Center|Prithviraj Bose MD/Associate Porfessor|713-792-7747|PBose@mdanderson.org|
21233447|NCT00741039|Memorial Sloan Kettering Cancer Center|Dr. Susan Seo|212-639-3151|seos@mskcc.org|
21233448|NCT00768300|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21233449|NCT02068222|AbbVie|Global Medical Information|800-633-9110||
21233450|NCT00735878|Dartmouth-Hitchcock Medical Center (DHMC)|Konstantin H. Dragnev, MD|(603) 650-6344|konstantin.h.dragnev@hitchcock.org|
21233451|NCT02867709|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21233452|NCT00877058|Göteborg University|Professor Synneve Dahlin-Ivanoff (Research leader)|+46317865733|synneve.dahlin-ivanoff@gu.se|
21233453|NCT01722240|Division of Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo, 462 Grider St, Buffalo, NY 14215, USA|Dr. Paresh Dandona|7169574325|pdandona@kaleidahealth.org|
21233454|NCT03188094|NYU Langone Health|Jennifer Zanowiak|212 263 0485|Jennifer.Zanowiak@nyulangone.org|
21233455|NCT02946047|Mayo Clinic|Dr. Nathan Cummins|507-284-3747|Cummins.Nathan@mayo.edu|
21233456|NCT03615105|Memorial Sloan Kettering Cancer Center|Dr. Brian Shaffer, MD|646-608-3737|shaffeb1@mskcc.org|
21233457|NCT05041322|Spaulding Hospital Cambridge|Jason Hamner|6177585501|jhamner@mgb.org|
21233458|NCT02556333|National Institutes of Health, National Institute of Allergy and Infectious Diseases|Alice Pau, Pharm.D., Staff Scientist (Clinical)|301-451-3740|apau@niaid.nih.gov|
21233459|NCT04690751|SK Life Science, Inc.|Executive Director and Head, Clinical Pharmacology|862-271-2645|vvashi@sklsi.com|
21233460|NCT01344161|Tehran University of Medical Sciences|Dr.Farzad Shidfar|09123082922|f-shidfar@tums.ac.ir|
21233461|NCT04364620|Alethia Biotherapeutics ULC|Dr. Julie Laurin, Vice-President, Drug Development|514-581-8125|julie.laurin@alethiabio.com|
21290536|NCT00215657|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
21290537|NCT01331330|Abbott Medical Devices|Devyani Nanduri|+1 510-561-4328|devyani.nanduri@abbott.com|
21290538|NCT01887600|Astellas Pharma Europe B.V. (APEB)|Clinical Trial Disclosure|31 (0) 715455050|astellas.resultsdisclosure@astellas.com|
21290539|NCT03688139|Weill Medical College of Cornell University|Dr. Jennifer N. Bress|914-997-8683|jeb2061@med.cornell.edu|
21290540|NCT01185366|UT MD Anderson Cancer Center|Amado Zurita-Saavedra,Associate Professor, Genitourinary Medical Oncology|(713) 563-6966|azurita@mdanderson.org|
21290541|NCT03274661|Miami Cancer Institute at Baptist Health, Inc.|Dr. John Diaz, Principal Investigator|(786) 527-8284|johnpd@baptisthealth.net|
21290542|NCT00308282|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21290543|NCT01783938|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
21290544|NCT00498485|Rutgers|Dr Benjamin Natelson|973-2236370|bnatelson@chpnet.org|
21290545|NCT00907088|The Hospital for Sick Children|Dr. Patricia Parkin|416-813-7654|patricia.parkin@sickkids.ca|301544
21290546|NCT00452400|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21290547|NCT01292538|Regulatory Insight, Inc.|Elvira Walls|615-712-9743|elvira@reginsight.com|
21290548|NCT01712074|Pfizer|Pfizer|1-8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21290549|NCT03478787|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21290550|NCT02539394|HospitalSS|Catherine Himo Gang|917-260-4603|gangh@hss.edu|
21290551|NCT02403778|Univesity Colorado Ansshutz Medical Campus|Martin McCarter|303-724-2728|martin.mccarter@ucdenver.edu|
21290552|NCT01044693|Vanderbilt University|Italo Biaggioni MD|615-936-3420|italo.biaggioni@vanderbilt.edu|
21290553|NCT02301793|Johns Hopkins Medical Institutions|Elliott R Haut M.D, PhD, Associate Professor of Surgery, Anesthesiology &Critical Care Medicine|410-502-3122|ehaut1@jhmi.edu|
21290554|NCT01316900|GlaxoSmithKline|GSK Response Center|866-435-7343||
21290555|NCT00562861|Tufts Medical Center|Nassir Ghaemi|6176365735|nghaemi@tuftsmedicalcenter.org|
21290556|NCT00655356|CBR International Corp.|Kevin Hennegan|720-746-1190|khennegan@cbrintl.com|
21290557|NCT01684033|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21290558|NCT00667589|Northwestern University|Hae Bae|312-695-6829|j-bae@northwestern.edu|
21290559|NCT05626686|Coloplast|Zenia Størling, Senior Director of Clinical Strategies|+4549111869|dkzenst@coloplast.com|
21290560|NCT01093573|Case Comprehensive Cancer Center|Brenda Cooper MD|(216) 844-3213|Brenda.cooper@uhhospitals.org|
21290561|NCT02496156|Nemours Children's Health System|Vicky Funanage, PhD, Operational Vice President for Research|302-651-6819|vfunanag@nemours.org|
21290562|NCT00289900|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21290563|NCT01703221|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21290564|NCT05177328|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21290565|NCT03927846|Wake Forest Health Sciences|Dennis Ang, Primary Investigator|336-705-8701|dang@wakehealth.edu|
21290566|NCT00176254|University of Kentucky|Dr. Emily Van Meter/Assistant Professor, Division of Cancer Biostatistics|859-323-3076|emily.vanmeter@uky.edu|
21290567|NCT02318979|Denver Research Institute|Judith Jung, DRI Executive Director|303-501-0540|Judith.Jung@dri-va.org|
21290568|NCT00992394|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21290569|NCT00561821|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21290570|NCT05670756|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|joseph.tobias@nationwidechildrens.org|
21290571|NCT04681885|Sunstar Americas, Inc.|Toru Saito|1-847-794-4271|toru.saito@us.sunstar.com|
21290572|NCT04744831|Daiichi Sanyko, Inc|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21290573|NCT02376010|Lundquist Institute|Matthew Budoff|3102224107|mbudoff@lundquist.org|
21290574|NCT05401409|Westmead Hospital and Westmead Institute for Medical Research|Prof Gopala Rangan|8627 3000|g.rangan@sydney.edu.au|
21239655|NCT01871558|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
21239656|NCT01709305|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21239657|NCT02281526|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21239658|NCT00118898|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21239659|NCT05473000|The University of British Columbia|Dr. Michael Koehle|604-822-3838|michael.koehle@ubc.ca|
21239660|NCT01338012|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@dendreon.com|
21239661|NCT02714205|University of California, San Francisco|Mike Schembri, Data Systems Analyst|415-353-7161|michael.schembri@ucsf.edu|
21239662|NCT05879198|Henry Ford Health|Dr. Julia Felton|313-598-0841|jfelton4@hfhs.org|
21239663|NCT02089230|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani MD/Professor|713-745-0394|fravandi@mdanderson.org|
21239664|NCT01598298|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|2066674623|amoseley@fredhutch.org|
21239665|NCT02073097|Cleveland Clinic Foundation, Case Comprehensive Cancer Center|Dr. Brian T. Hill|1-866-223 8100|TaussigResearch@ccf.org|
21239666|NCT03813147|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21239667|NCT01693692|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
21261197|NCT02874794|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21261198|NCT01473004|Thomas Jefferson University|Takami Sato, MD|215-955-8874|Takami.Sato@jefferson.edu|
21290575|NCT02290574|Samsung Medical Center|Professor|82-2-3410-2612|hee.ro.park@gmail.com|
21290576|NCT02410200|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21290577|NCT02144337|University of Nottingham (UK)|Helen Quirk|01157484325|ntxhq1@nottingham.ac.uk|
21290578|NCT02402907|Icahn School of Medicine at Mount Sinai|Dr. Joanne Stone|212-241-5681|joanne.stone@mssm.edu|
21290579|NCT03701074|University of South Alabama|Ramachandra Bhat|2514151055|rbhat@health.southalabama.edu; rambhat79@gmail.com|
21290580|NCT01644331|Duke Clinical Research Institute|G. Michael Felker, MD|919-668-8919|Michael.Felker@duke.edu|
21290581|NCT01339091|Durata Therapeutics|Michael Zelasky|203-871-4616|mzelasky@duratatherapeutics.com|
21290582|NCT01500135|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21290583|NCT01661595|University of Texas Medical Branch|Melinda Sheffield-Moore|409-772-8707|melmoore@utmb.edu|
21290584|NCT00661687|Bausch & Lomb Incorporated|Gerard Cairns|(585)338 - 5170|gerard.cairns@bausch.com|
21290585|NCT00912509|Cornea Research Foundation of America|Marianne O. Price, PhD|317-814-2990|mprice@cornea.org|
21290586|NCT02593630|University of New England|Peter S. Millard, MD, Phd|2072992131|pmillard@mac.com|207
21290587|NCT01362530|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21290588|NCT01034657|Novartis|Study Director|862-778-8300||
21239668|NCT02805595|Beth Israel Deaconess Medical Center|Martina Porter - Associate Directory of Dermatology Research|6176675834|mporter3@bidmc.harvard.edu|
21290589|NCT02715856|UT MD Anderson Cancer Center|Dr. Robert Satcher, Associate Professor, Orthopaedic Oncology|(713) 794-5242|rlsatcher@mdanderson.org|
21290590|NCT01557569|UAMS|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu|
21290591|NCT01050218|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21290592|NCT02790736|NY State Psychiatric Institute|Franklin Schneier MD|6467748041|fschneier@nyspi.columbia.edu|
21290593|NCT03682367|UC Davis Health|Arnaud Bewley|9167342704|abewley@ucdavis.edu|
21290594|NCT00756314|IMIP - Instituto Materno Infantil Prof. Fernando Figueira|Ana Laura Carneiro Gomes Ferreira - MD|+558121224779|analaura@imip.org.br|
21290595|NCT02872142|Grifols Bioscience Industrial Group|Michael Woodward|+34 938008784|michael.woodward@grifols.com|
21290596|NCT00309946|The University of Chicago|Dr. Hedy Kindler|(773) 702-0360|hkindler@medicine.bsd.uchicago.edu|
21290597|NCT02244957|UCSD|Dillon Gilbertson|8582452155|dcgilbertson@health.ucsd.edu|
21239669|NCT02906683|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.|+81-3-3293-2455|toiawase@taiho.co.jp|
21239670|NCT04934137|University of Texas Medical Branch|Dr. Melissa Morrow|409-266-0344|memorrow@utmb.edu|
21239671|NCT01167179|Radboud University Nijmegen Medical Center|Jacqueline de Leeuw MSc|+31243614925|j.deleeuw@kno.umcn.nl|
21239672|NCT00663117|Pennsylvania State University, College of Medicine Hershey, PA 17033|Jill P Smith, MD Professor of Medicine, Gastroenterology Division|717-531-3694|jsmith2@psu.edu|
21239673|NCT02769065|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
21239674|NCT02531295|University of California, San Francisco|Sulggi Lee, MD PhD|415-735-5127|sulggi.lee@ucsf.edu|
21239675|NCT05197257|University of Colorado|Dr. Bennett Chin|720-848-0000|Bennett.Chin@cuanschutz.edu|
21239676|NCT01923896|Emory University|William G. Sharp Ph.D.|404-419-5162|wgsharp@emory.edu|
21239677|NCT03545113|Wake Forest University Health Sciences|Mariana Murea, MD|336-716-5777|mmurea@wakehealth.edu|
21239678|NCT03029247|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|1
21239679|NCT02593305|University of Iowa|Dr. Darren P. Casey|3193841009|darren-casey@uiowa.edu|
21239680|NCT01993017|Center for Behavioral Cardiovascular Health|Ian Kronish, MD, MPH, Principal Investigator|212-342-1335|ik2293@columbia.edu|
21239681|NCT00068380|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
21239682|NCT01190215|GlaxoSmithKline|GSK Response Center|866-435-7343||
21239683|NCT03472287|Castle Creek Pharmaceuticals, LLC|Dr. Mary Spellman/Chief Medical Officer|862 286 0400|mspellman@castlecreekpharma.com|
21239684|NCT02960763|Washington University in St. Louis|Dr. Eric Lenze|314-362-5154|lenzee@wustl.edu|
21239685|NCT00335725|IBSA instutut Biochimique SA|IBSA Clinical Research Manager|+41 58 360 1000|sd@ibsa.ch|
21239686|NCT02250521|The University of Texas Health Science Center at Houston|Carin A. Hagberg, MD|713-500-6200|Carin.A.Hagberg@uth.tmc.edu|
21239687|NCT00525135|University of California San Francisco|UCSF PRS Administrator|415-502-3212|Elaine.Cooperstein@ucsf.edu|
21239688|NCT05340751|Hospital for Special Surgery|Dr. Friedrich Boettner|2127742127|BoettnerF@hss.edu|
21239689|NCT04502056|JPAL North America|Tristan Loisel|6307476739|tloisel@povertyactionlab.org|
21239690|NCT00936481|Vanderbilt Universit|Kanika Bagai, MD, Assistant Professor|6153220283|kanika.bagai@vanderbilt.edu|
21239691|NCT01973491|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21239692|NCT01863043|University of Florida|Dr. Leslie Parker|352 215 9360|parkela@ufl.edu|
21239693|NCT01987596|Barbara Ann Karmanos Cancer Institute|Dr. Maxim Yankelevich|313-745-5515|myankele@med.wayne.edu|
21239694|NCT00854295|Zimmer Biomet|Erin Osborn|574-371-9884|erin.osborn@zimmerbiomet.com|
21239695|NCT00709592|Virginia Commonwealth University|Amir A Toor, MD|804-828-4360|atoor@mcvh-vcu.edu|
21239696|NCT01231841|Cleveland Clinic Foundation|Jaroslaw Maciejewski, MD PhD, Principal Investigator|216-445-5962|maciejj@ccf.org|
21239697|NCT02674490|Johns Hopkins University School of Medicine|Dr. Argye Hillis, MD|4109552228|argye@jhmi.edu|
21239698|NCT02440594|University of Pennsylvania|Shahrzad Mavandadi|215-823-5211|shahrzad.mavandadi@va.gov|
21239699|NCT04250337|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21239700|NCT01129336|Novartis Pharmaceuticals|Study Director|862-778-8300||
21239701|NCT00152763|University Health Network, Toronto General Hospital|Dr. Jane Irvine|(416) 736-5115|jirvine@yorku.ca|22444
21239702|NCT00569803|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21239703|NCT04668989|Coopervision|Jose A. Vega, O.D., MSc, FAAO|9256213761|jvega2@coopervision.com|
21290598|NCT02811419|University of California San Francisco|Trilokesh Kidambi|909-973-0629|tkgastromd@gmail.com|
21290599|NCT04691115|AnaMar AB|Chief Medical Officer|+46 (0)46-275 60 00|info@anamar.com|
21290600|NCT01514279|School of Medicine, Case Western Reserve University|Dr. Elaine Borawski, PhD|216)368-1024|exb11@case.edu|
21290601|NCT00830336|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21290602|NCT01437189|ZhejiangU|Bo Wang|87784711|wangke1121@163.com|
21290603|NCT03032484|University of Texas Health San Antonio|Andrew Brenner, MD|210-562-4090|brennera@uthscsa.edu|
21290604|NCT01689649|Janssen-Cilag Taiwan|Medical Director|886 2 23762155||
21290605|NCT00677040|Essentia Health|Ken Dornfeld|218 786-1311|kenneth.dornfeld@essentiahealth.org|
21290606|NCT05201495|Element Science, Inc.|Chief Medical Officer|(415) 872-6500|zubin@elementsci.com|
21290607|NCT01725282|Astellas Pharma Inc.|Vice President, Clinical Development Administration||clinicaltrials@us.astellas.com|
21290608|NCT04581629|Calcilytix Therapeutics, Inc., a BridgeBio company|Medical Information|650.600.3610|MedInfo@bridgebio.com|
21290609|NCT03719300|Anchiano Therapeutics, Israel Ltd.1 Kendall Square, Building 1400, Suite 105 Cambridge, MA 02139|David Kerstein, M.D.,Chief Medical Officer|857-259-4626|David.Kerstein@anchiano.com|
21290610|NCT04130425|Mayo Clinic|Stephanie Kannas, OTR/L, OTD, CHT|507-284-8841|kannas.stephanie@mayo.edu|
21290611|NCT02349477|Medical University of South Carolina|Dr. Michaela Hoffman|8437927758|HoffmaMi@musc.edu|
21290612|NCT01646216|Kennedy Krieger Institute|Anthony Gonzalez|4439080074|gonzalezan@kennedykrieger.org|
21290613|NCT00113373|NRG Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
21290614|NCT02395627|University of California, San Francisco|Dr. Pamela Munster, MD|(415) 502-3598|Pamela.Munster@ucsf.edu|
21290615|NCT04135443|dfusion, Inc|Tamara Kuhn, Vice President and Research Scientist|831-222-5003|tamara.kuhn@dfusioninc.com|
21290616|NCT02757963|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21290617|NCT00911157|GlaxoSmithKline|GSK Response Center|866-435-7343||
21290618|NCT01217515|S.L.A. Pharma UK Ltd|Dr C Jordan, Head of Clinical Operations|44 01923 681001|cjordan@slapharma.com|
21290619|NCT03769467|Atara Biotherapeutics|Study Director|650-278-8930|clinicalstudies@atarabio.com|1
21233462|NCT01124604|Neuroscience Department, Clinical Science Department, R&D in Janssen Japan Chiyodaku, Tokyo 101-0065 Japan|Manager|+81-3-4411-5509||
21233463|NCT00076011|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21233464|NCT06134817|NYU Langone Health|Bedros Taslakian, MD|332-237-9866|Bedros.Taslakian@nyulangone.org|
21233465|NCT05230082|HealthPartners Institute Neuroscience Research Center|Amanda Herrmann, PhD|651-495-6363|Amanda.A.Herrmann@HealthPartners.com|
21233466|NCT03406858|Wayne State University/Karmanos Cancer Institute|Dr. Abhinav Deol|313-576-8093|deola@karmanos.org|
21233467|NCT00405587|Plexxikon Inc.|Dr. Henry Hsu|510-647-4000|hhsu@plexxikon.com|
21233468|NCT06027866|Queen's University Belfast/Western Health & Social Care Trust|Carla McClintock|07706482050|cmcclintock02@qub.ac.uk|
21233469|NCT00390325|The Ohio State University Comprehensive Cancer Center|Manisha Shah, MD|614-293-8629|Manisha.Shah@osumc.edu|
21233470|NCT00930579|Columbia University|Dawn Hershman, MD|212-305-1945|dlh23@cumc.columbia.edu|
21233471|NCT02672423|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21233472|NCT04335279|Lady Davis Institute|Dr. Brett Thombs|514-340-8222|brett.thombs@mcgill.ca|25112
21233473|NCT01794806|University of Iowa|Gustavo Avila-Ortiz|3193357241|gustavo-avila@uiowa.edu|
21233474|NCT01046682|UHospitalsCleveland|Grace McComsey, MC|216-844-3607|mccomsey.grace@clevelandactu.org|
21233475|NCT05071183|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21233476|NCT02046148|GlaxoSmithKline|GSK Response Center|866-435-7343||
21233477|NCT02808130|Ondokuz Mayıs University Dentalfaculty Periodontology Dep.|Assoc Prof Muge Lutfioglu|+905063073738|mugelutfioglu@hotmail.com|
21233478|NCT06002347|Boise State University|Dr. Aida Midgett|2084261219|aidamidgett@boisestate.edu|
21233479|NCT00885755|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21233480|NCT04196140|Insulet Corporation|Dr. Trang Ly|9786007628|tly@insulet.com|
21233481|NCT02492269|Nationwide Children's Hosp.|Dr. Aymen Naguib|614-722-4200|Aymen.Naguib@nationwidechildrens.org|
21233482|NCT04493060|Mayo Clinic|Dr. Robert R McWilliams|507-284-2511|mcwilliams.robert@mayo.edu|
21233483|NCT02939560|Medical University of South Carolina|McLeod F. Gwynette, MD|843-792-9162|gwynette@musc.edu|
21233484|NCT00755131|University of Naples Federico II|Prof. Carlo Vigorito, Director Cardiac Rehabilitation Unit, Federico II University|+39081746|vigorito@unina.it|2639
21233485|NCT03340025|University of Alabama at Birmingham|Benjamin Greene, MD|205-801-7855|bjgreene@uabmc.edu|
21233486|NCT02420691|UT MD Anderson Cancer Center|Arvind Dasari,MBBS|713-792-2828|adasari@mdanderson.org|
21233487|NCT00325754|Harbo-UCLA Research and Education Institute|Richard Casaburi|310-22-8249|casaburi@ucla.edu|
21233488|NCT01334723|GlaxoSmithKline|GSK Response Center|866-435-7343||
21233489|NCT03836963|Edward Hines Jr. VA Hospital|Sandra Kletzel|708-202-5735|sandra.kletzel@va.gov|
21233490|NCT00177970|UPittsburgh|Dr. George Arnold|4126212334|arnoldgl@upmc.edu|
21233491|NCT02916563|Barbara Davis Center for Childhood Diabetes|Dr. Satish K. Garg|3037246713|satish.garg@ucdenver.edu|
21233492|NCT02149173|University of Washington|Hannah M Linden|206-606-2053|hmlinden@uw.edu|
21233493|NCT01752855|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21233494|NCT02625090|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
21233495|NCT02250443|Novartis Pharmaceutical|Study Director|862-778-8300||
21233496|NCT03168464|Weill Cornell Medicine|Sharanya Chandrasekhar|646-962-3110|shc2043@med.cornell.edu|
21290620|NCT05226884|Clinical Research Coordinator|Diana Hill|713-526-1600|diana.hill@berkeleyeye.com|
21233497|NCT01969812|Atrium Health|Bradley Hurst, M.D.|704-355-3153|brad.hurst@atriumhealth.org|
21233498|NCT01549964|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21233499|NCT00634088|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21233500|NCT04916795|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21233501|NCT02290821|Novartis Consumer Health|Clinical Research Director Pain, CH Clinical Research & Development Lead|+41225672574||
21233502|NCT00499096|Department of Veterans Affairs|Dr. Amy M. Kilbourne, PhD, MPH|734-845-3502|Amy.Kilbourne@va.gov|
21233503|NCT01110421|Janssen R&D US|Therapeutic Areas Director||ClinicalTrialDisclosure@its.jnj.com|
21233504|NCT02439320|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
21233505|NCT02245841|Cleveland Clinic|Anthony Fernandez, MD, PhD|216-445-8776|fernana6@ccf.org|
21233506|NCT02449174|University of Texas School of Public Health|Dr. Herbert DuPont|713 500 9366|herbert.l.dupont@uth.tmc.edu|
21233507|NCT02653456|Ra Medical Systems, Inc.|Vice President of Regulatory Affairs and Quality Assurance|877-635-1800|vchester@ramed.com|207
21233508|NCT01520363|Hugo W. Moser Research Institute at Kennedy Krieger , Inc.|Dr. Sakkubai Naidu|443 923 2778|naidu@kennedykrieger.org|
21233509|NCT00178841|Vanderbilt University Dermatology|John Zic, MD|615-322-6485|john.zic@vanderbilt.edu|
21233510|NCT02735551|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
21233511|NCT04191382|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21233512|NCT00620828|Duke UMC|Michael Bolognesi, MD|919-668-4732|bolog002@mc.duke.edu|2
21233513|NCT00731770|Penn State University|Erin Banta|717-531-6525|ebanta@hmc.psu.edu|1
21233514|NCT00878709|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
21233515|NCT02225743|Medical University of South Carolina|Sylvia Wilson, MD|843-792-2322|wilsosh@musc.edu|
21233516|NCT01347541|University of Washington School of Medicine|Dr, Douglas Zatzick|206-744-6701|dzatzick@uw.edu|
21261199|NCT03549520|Children's Hospital of Philadelphia|Misun Hwang|267-425-7129|hwangm@chop.edu|
21233517|NCT00322842|Genzyme Corporation|Genzyme Medical Information||medinfo@genzyme.com|
21233518|NCT00323492|Gilead Sciences|Camille Aubron-Olivier|+33(0)1 42 737130|camille.aubron-olivier@gilead.com|
21233519|NCT02486042|UC San Diego Health|Sarah Lazar, clinical research manager|(858) 249-1711|slazar@health.ucsd.edu|
21233520|NCT03706794|Albert Einstein College of Medicine|Dr. Elizabeth Seng|646-592-4368|Elizabeth.Seng@einsteinmed.edu|
21233521|NCT02530450|UT Health Science Center in San Antonio|Dr. Maria Rayas, Assistant Professor in Pediatric Endocrinology and Diabetes|210-567-5283|rayas@uthscsa.edu|
21233522|NCT01724060|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
21233523|NCT01057017|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org|
21233524|NCT00281684|GlaxoSmithKline|GSK Response Center|866-435-7343||
21233525|NCT03979638|Bellus Health Inc|Senior Director Clinical Development|833-703-0708|lharvey@bellushealth.com|
21233526|NCT03745092|Xuanwu Hospital, Capital Medical University|Pro. Ran Meng|+86-10-83199280|ranmeng2011@pku.org.cn|
21233527|NCT00578942|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
21233528|NCT03200899|The University of Texas at Austin|Dr. Alexa Stuifbergen|+1 (512) 471-4100|astuifbergen@mail.utexas.edu|
21233529|NCT01001442|Biotest AG|Iris Bobenhausen|+49 6103 801|iris.bobenhausen@biotest.com|4832
21233530|NCT01400516|Brigham and Women's Hospital|Daniel H Solomon, MD, MPH||dsolomon@partners.org|
21233531|NCT00549562|Indiana University School of Medicine|David D. Dunn MD|317-944-8164|ddunn@iupui.edu|
21233532|NCT02485912|University of Oxford|Adrian V Hill, DPhil FRCP||vaccinetrials@ndm.ox.ac.uk|
21233533|NCT00947297|Hyperion Therapeutics|Craig James|650-745 7840|craig.james@hyperiontx.com|
21233534|NCT00699972|Eisai Call Center|Eisai Inc.|888-422-4743||
21233535|NCT02059928|Health Partners|Dr. Ralph J Frascone|6512545304|ralph.j.frascone@healthpartners.com|
21233536|NCT00571259|Satellite Healthcare, Inc.|Veronica Legg, MS: Director of Research Business|360-607-6892|leggv@satellitehealth.com|
21233537|NCT00476021|University of Pittsburgh|Principal Investigator|412-641-5496|chenba@upmc.edu|
21233538|NCT03181828|Children's National|Dr. Nicholas Ah Mew|2025452513|nahmew@childrensnational.org|
21233539|NCT05447156|Masonic Cancer Center|Dana Mowls Carroll, Ph.D., M.P.H.|612-624-4511|dcarroll@umn.edu|
21233540|NCT01541969|University of Nottingham|Professor Deborah Hall, Professor of Hearing Sciences|+44 (0) 115 823 2600|deborah.hall@nottingham.ac.uk|
21233541|NCT01365507|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21233542|NCT00525174|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-875-8690|pedig@jaeb.org|
21261200|NCT03815292|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
21279239|NCT03344861|on behalf of Concordia Laboratories Inc.|Kim McDonald-Taylor|647-267-2942|kmcdonald-taylor@rogers.com|
21279240|NCT04642365|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21279241|NCT01144715|Kinetic Muscles|James Koeneman, PhD|602-677-5256|jimkoeneman509@gmail.com|
21279242|NCT03553576|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.edu|
21279243|NCT02552212|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21279244|NCT02728843|Chiesi Canada Corp.|Caroline Fradette, PhD|1-800-854-3534|c.fradette@chiesi.com|7014
21279245|NCT02478320|M D Anderson Cancer Center|Dr. David Hong|(713) 563-5844|dshong@mdanderson.org|
21279246|NCT02575976|Federal University of Minas Gerais|Professor Raquel Britto|+55 31 99970-4527|r3britto@gmail.com|
21279247|NCT00197496|University of Waterloo|Dr. Lora Giangregorio|5198884567|lmgiangr@uwaterloo.ca|36357
21279248|NCT00960115|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21279249|NCT01175031|Shanghai Jiao Tong University School of Medicine|Quing Yun Li, MD, PhD|86-21-64314162|liqingyun68@hotmail.com|
21279250|NCT03014180|Microport CRM|Director of Scientific Communication|0677164209|anne.rousseauplasse@crm.microport.com|
21279251|NCT02906566|Stanford University|Dr. Anne L. Chang|650-721-7195|alschang@stanford.edu|
21279252|NCT02099682|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21279253|NCT03383523|Drugs for Neglected Diseases Initiative|Jean Yves Gillon|+41229069232|jygillon@dndi.org|
21279254|NCT03408639|CinnaGen Co.|Dr. Nassim Anjidani|00989125477964|Anjidani.N@orchidpharmed.com|
21279255|NCT01784055|NeoChord, Inc.|Lori E Adels, PhD|1-952-698-7804|ladels@neochord.com|
21239704|NCT01993823|Laboratorios SALVAT|Enrique Jimenez, Medical Director|+39933946470|ejimenezv@salvatbiotech.com|
21239705|NCT02006420|University of Michigan|Dinesh Khanna|734-763-7182|khannad@umich.edu|
21239706|NCT01622348|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
21239707|NCT03765762|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
21239708|NCT00791921|Professor, Department of Allergy and Rheumatology, Division of Internal Medicine, Graduate School of Medicine, University of Tokyo|Dr. Kazuhiko Yamamoto, Medical Advisor of the Clinical Trial|+81 3 5800 8825|yamamoto-tky@umin.ac.jp|
21239709|NCT02392767|Dr. Loges + Co. GmbH|Dr. Birgit Goyvaerts|0049-4171-707182|goyvaerts@loges.de|
21239710|NCT00389974|Princess Margaret Hospital, Toronto, Canada|Dr. Helen Mackay|(416) 946-2253|helen.mackay@uhn.ca|
21239711|NCT00422799|Dana-Farber Cancer Institute|Irene M. Ghobrial|(617) 632-4218|Irene_Ghobrial@DFCI.HARVARD.EDU|
21239712|NCT01965158|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|1454
21239713|NCT00474175|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21239714|NCT00467142|Institut Bergonié|Pr Yves Becouran||y.becouarn@bordeaux.unicancer.fr|
21239715|NCT01619787|SUNYBuffalo|Leonard H. Epstein|716-829-3400|ckk@buffalo.edu|
21239716|NCT04537897|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21239717|NCT01034579|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21239718|NCT00453479|GlaxoSmithKline|GSK Response Center|866-435-7343||
21239719|NCT01532817|electroCore LLC|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
21239720|NCT03029780|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21239721|NCT00197028|GlaxoSmithKline|GSK Response Center|866-435-7343||
21239722|NCT00178256|University of Rochester|Yuhchyau Chen MD, PhD|585-275-5575|yuhchyau_chen@urmc.rochester.edu|
21239723|NCT03066622|Regions Hospital|Meghan O'Brien|651-254-5303|meghan.e.obrien@healthpartners.com|
21261201|NCT00613314|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21233543|NCT02255500|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
21261202|NCT01584024|University of Michigan|Dr. Mathilde Peters (PI)|734-925-2750|mcpete@umich.edu|
21261203|NCT01568944|Dental College of Georgia|chairman|706-7212442|chcutler@augusta.edu|
21261204|NCT04419506|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21233544|NCT01012622|Janssen Korea MAF, Korea|Clinical Research Associate|82-2-2094-4837||
21233545|NCT01074164|Northwestern University Department of Dermatology|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu|
21261205|NCT00345605|Baylor College of Medicine|Dr. Sandesh Nagamani||nagamani@bcm.edu|
21261206|NCT04586712|University of Florida|Dr. Paul Borsa|352-294-1726|pborsa@ufl.edu|
21233546|NCT04254978|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21233547|NCT03257631|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21261207|NCT03806452|THERAVIA|Clinical Operation Manager|+330149709583|laura.thomas-bourgneuf@theravia.com|
21233548|NCT02310919|UCSF Center for Reproductive Health|Dr. Yanett Anaya, Assistant Professor|832-654-8361|Yanett.anaya2@ucsf.edu|
21261208|NCT01126619|Abbott|Global Medical Services|800-633-9110||
21233549|NCT03244865|UF Health Department of Anesthesiology|Dr. Tammy Euliano|352-514-7460|teuliano@anest.ufl.edu|
21233550|NCT03509675|University of Washington|Stuart Taylor|206-221-3772|stuartt@uw.edu|
21261209|NCT04876391|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
21233551|NCT00902564|H. Lundbeck A/S|Study Director|Email contact via|LundbeckClinicalTrials@lundbeck.com|Lundbeck
21233552|NCT00277212|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21233553|NCT03898349|VA|Vera Yakovchenko|7816873374|vera.yakovchenko@va.gov|
21233554|NCT03336216|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21261210|NCT03293030|University of California San Francisco|Wilson Liao|415-476-8364|wilson.liao@ucsf.edu|
21233555|NCT05620576|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21233556|NCT05005390|The University of Texas Health Science Center at Houston|Travis Markham, MD|713-500-6200|Travis.H.Markham@uth.tmc.edu|
21233557|NCT00922766|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21279256|NCT01924754|University of California, San Francisco|Dr. Joel Palefsky, MD|(415) 476-8885|Joel.Palefsy@ucsf.edu|
21233558|NCT02622828|University of Manitoba|Dr. Jacquie Ripat|204-789-3303|jacquie.ripat@umanitoba.ca|
21233559|NCT00843713|University of California, San Francisco|Priscilla Hsue, MD|415-206-8257|Priscilla.Hsue@ucsf.edu|
21233560|NCT02666183|Case Western Reserve University|Sara L. Douglas, PhD, RN, Professor FPB School of Nursing|216-368-0702|sld4@case.edu|
21233561|NCT01231581|GlaxoSmithKline|GSK Response Center|866-435-7343||
21233562|NCT03616912|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
21233563|NCT01859507|Cairo University. Department of Obstetrics and Gynecology|Abdelmaguid Ramzy|+201008606060|amramzy@gmail.com|
21233564|NCT03483935|University of Dundee|Prof Charlotte Proby|+44 1382 383289|c.proby@dundee.ac.uk|
21233565|NCT01762943|University of North Carolina at Chapel Hill|Dr. Crystal Schiller|9199664810|crystal_schiller@med.unc.edu|
21233566|NCT02404311|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
21233567|NCT04061694|Folktandvården Skåne AB|Björn Gjelvold|+46709467870|bjorn.gjelvold@gmail.com|
21233568|NCT02826681|American Regent, Inc.|Mark Falone|631.772.3544|mfalone@americanregent.com|244
21233569|NCT01797328|UHLinkopeing|Fredrik H Nystrom|+46101037749|fredrik.h.nystrom@liu.se|
21233570|NCT04296006|University of Kentucky|Joshua Lile, Ph.D.|859-323-6034|jalile2@uky.edu|
21239724|NCT04741802|Duke University|Nia S. Mitchell, MD, MPH|919-668-7202|nia.s.mitchell@duke.edu|
21239725|NCT03101241|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-870-9177|ClinicalTrialDisclosure@JazzPharma.com|
21239726|NCT00692406|DukeUMC|Dr. F. Joseph McClernon|919-668-3987|mccle011@mc.duke.edu|
21239727|NCT02597933|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21239728|NCT04205929|Oregon Health & Science University|Dr. Alison Edelman|503-494-3666|edelmana@ohsu.edu|
21239729|NCT01617005|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21239730|NCT01097915|University of Cagliari|Iole Tomassini Barbarossa, Associate Professor|+390706754144|tomassin@unica.it|
21239731|NCT01320735|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21239732|NCT04599101|William Beaumont Hospitals|Christine Batchelder, Research Nurse Manager|2488981075|christine.batchelder@corewellhealth.org|
21239733|NCT02307513|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21239734|NCT05952297|University of Utah|Dr. Kelly Baron|8015857588|kelly.baron@utah.edu|
21239735|NCT03501693|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
21290621|NCT05259722|LEO Pharma|Clinical Disclosure|+4544945888|disclosure@leo-pharma.com|
21239736|NCT00284089|Novartis Pharmaceuticals|Study Director|862 778-8300||
21239737|NCT03961009|Kedrion S.p.A|Dr. Mirella Calcinai, MD, Clinical Research Director|+393486559761|m.calcinai@kedrion.com|
21239738|NCT02759185|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corporation|Berra Yazar-Klosinski, PhD / Chief Scientific Officer|(831) 429-6362|trialdata@mapsbcorp.com|
21239739|NCT02234063|Icahn School of Medicine at Mount Sinai|Dr. Carol R. Horowitz|212-659-9564|carol.horowitz@mssm.edu|
21239740|NCT04591977|Pennsylvania State University College of Medicine|Jennifer L. Moss, PhD|7175310003|jmoss1@pennstatehealth.psu.edu|323429
21239741|NCT03469284|UT MD Anderson Cancer Center|Dr. Carlos Roldan, Associate Professor, Pain Medicine|(713) 563-7402|croldan@mdanderson.org|
21239742|NCT02781506|UT Southwestern Medical Center|Dr. Raquibul Hannan|214-645-8525|Raquibul.Hannan@UTSouthwestern.edu|
21239743|NCT00437125|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21239744|NCT02248961|R-Pharm|Boris Berezhanskiy, Medical Advisor|0074959567937|berezhanskiy@rpharm.ru|2468
21239745|NCT02835443|Enspire DBS Therapy, Inc.|Director of Clinical Trials|123-456-7890|info@enspiredbs.com|
21239746|NCT00983489|Deen Dayal Upadhaya Hospital, New Delhi|Dr Kanchan Sharma|919417938224|psaiims@yahoo.co.in|
21239747|NCT00871819|Boston Scientific|Nitzan Mekel-Bobrov, Ph.D.|(661) 949-4537|Nitzan.Mekel-Bobrov@bsci.com|
21239748|NCT02802319|UT Health Science Center at San Antonio|Dr. Brian Mealey|210-567-3567|mealey@uthscsa.edu|
21239749|NCT04651114|University of Michigan|Dr. Claire Kalpakjian|734-763-0153|clairez@umich.edu|
21239750|NCT01966796|Far Eastern Memorial hospital|Dr. Ping-huai Wang|886-2-89667000|pinghuaiwang@gmail.com|2816
21239751|NCT00235443|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
21239752|NCT01045122|University of Rochester Medical Center|Dr. Suzanne Karan|585-275-5161|Suzanne_Karan@urmc.rochester.edu|
21239753|NCT00136812|Stanord University|Judith Prochaska, PhD, MPH; Associate Professor|650-724-3608|JPro@stanford.edu|
21239754|NCT01763788|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21290622|NCT00962650|Ethicon Endo-Surgery, Inc.|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
21290623|NCT00420056|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21290624|NCT00298155|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
21290625|NCT00291226|Yale University School of Medicine|Scott W. Woods, MD|203-974-7038|scott.woods@yale.edu|
21290626|NCT00127933|Hoffman-LaRoche|Medical Communications|800-821-8590||
21290627|NCT01339013|Region Skane, Lund University Hospital, Lund, Sweden|Dr Louise Walther Sturesson|+46 46 171953|louise.waltersturesson@skane.se|
21290628|NCT03111732|National Cancer Institute|Dr. Tim F. Greten|240-760-6114|tim.greten@nih.gov|
21290629|NCT03406975|Mayo Clinic|Dr. Barham Abu Dayyeh|507-266-4347|AbuDayyeh.Barham@mayo.edu|
21290630|NCT03072875|Evidence-Based Practice Institute|Linda Dimeff, PhD|206-455-7934|research@ebpi.org|83
21290631|NCT00401830|UCB Clinical Trial Call Center|Study Director|+1 877 822 9493||
21290632|NCT01943825|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21290633|NCT01472835|Johns Hopkins|Steven Cohen|410-955-1818|scohen40@jhmi.edu|
21290634|NCT01098578|Ottawa Hospital Research Institute|Dr. Shaun Kilty|613-798-5555|skilty@ottawahospital.on.ca|18514
21290635|NCT03425188|Respicardia, Inc.|Tim Meyer, VP Clinical Affairs|952-540-4479|tmeyer@respicardia.com|
21290636|NCT01044459|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
21290637|NCT05346640|Cionic|Rebecca Webster, Clinical Operations Manager|9257886649|rebecca@cionic.com|
21290638|NCT04634331|Cleveland Clinic|Dr. Jay Alberts|216 445-3222|albertj@ccf.org|
21290639|NCT03726879|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21290640|NCT00761137|NeuroHealing Pharmaceuticals|Daniel Katzman|617-965-0872|info@neurohealing.com|
21290641|NCT00553475|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21290642|NCT00890097|Alcon Research, Ltd.|Dana Sager, Clinical Manager Group Leader|1-888-451-3937|alcon.medinfo@alcon.com|
21290643|NCT01152385|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|
21290644|NCT02656173|Astellas Pharma Inc.|Medical Director|+81-3-3244-0512|astellas.resultsdisclosure@astellas.com|
21290645|NCT04132427|Arizona State University|James B. Adams|480 965-3316|jim.adams@asu.edu|
21290646|NCT00834587|Teva Pharmaceuticals USA|Manger, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21290647|NCT03810495|Go Medical Industries, Pty Ltd|Director of Operations|61(8) 9388 1700|ctc@gomedical.com.au|
21290648|NCT03289741|Memorial Sloan Kettering Cancer Center|Dr. Nitya Raj, MD|646-888-4849|rajn@mskcc.org|
21290649|NCT03449147|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|18006726372|ClinicalTrialsDisclosure@merck.com|
21233571|NCT03314584|VAORD|Dr. Albert Leung|858-552-8585|ayleung@health.ucsd.edu|3331
21239755|NCT03321006|NYP Institute|Dr. Katharine Brewster|646 774 6380|Katharine.Brewster@nyspi.columbia.edu|
21239756|NCT03303469|The University of Alabama at Birmingham|Janis O'Malley|205-934-6504|jomalley@uabmc.edu|
21239757|NCT00749125|University of Pennsylvania|Yvette Sheline|215-573-0082|sheline@pennmedicine.upenn.edu|
21239758|NCT03560258|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
21239759|NCT01460160|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
21239760|NCT03893825|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21239761|NCT01316341|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage@boehringer-ingelheim.com|
21239762|NCT02006121|Britannia Pharmaceuticals|Medical Director|+44 1189209500|reception@britannia-pharm.com|
21290650|NCT04028960|HealthPartners Institute dba International Diabetes Center|Anders Carlson, MD|952-993-1927|Anders.L.Carlson@HealthPartners.Com|
21233572|NCT04434131|University of New Mexico Health Sciences Center|Dr. Michelle Harkins|5052724751|mharkins@salud.unm.edu|
21233573|NCT02864251|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21233574|NCT01820416|Dept. of Communication Sciences & Disorders, University of Iowa|Shawn S Goodman|319-335-8700|shawn-goodman@uiowa.edu|
21233575|NCT04773158|Indiana University School of Medicine, Pediatrics|William E Bennett, MD|317-944-3774|webjr@iu.edu|
21233576|NCT01480076|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21233577|NCT00704535|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21233578|NCT02503332|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
21233579|NCT04053101|Institut Bergonié|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33556333333|s.mathoulin@bordeaux.unicancer.fr|
21233580|NCT05694546|University of Maryland Baltimore|Cassidy Claassen|316-727-6185|cclaassen@ihv.umaryland.edu|
21233581|NCT02120950|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21233582|NCT02424383|Becton Dickinson|Sharon Christensen|612-757-0750|Sharon.Christensen@bd.com|
21233583|NCT03559179|HealthPartners Institute|Dr. Rebecca C Rossom|952-883-5466|Rebecca.C.Rossom@HealthPartners.com|
21233584|NCT02438722|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|jmiao@fredhutch.org|
21239763|NCT02354859|University of Washington|Christopher H. Goss, Professor of Medicine and Pediatrics|206-543-3166|goss@uw.edu|
21290651|NCT02043860|UIC Cancer Center Clinical Trials Office|Annette Kinsella, RN, CCRC, QA Education Specialist|312-996-5931|annettek@uic.edu|
21290652|NCT00954538|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21239764|NCT02357043|Remington-Davis Inc.|Dr. Ian Baird|6144872560|hbaird@remdavis.com|
21239765|NCT04498247|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21239766|NCT00669903|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21239767|NCT02979626|University of Colorado Denver|Dr. Suchitra Rao|7207771234|suchitra.rao@childrenscolorado.org|
21239768|NCT01336959|Mereo BioPharma|Dr. Ian Hodgson|+44 333 0237300|enquiries@mereobiopharma.com|
21239769|NCT04488003|Biomed Valley Discoveries|Caroline Emery, PhD|816-960-4615|cemery@biomed-valley.com|
21239770|NCT01737996|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21239771|NCT00058019|University of Chicago Medical Center|Dr. Sonali M. Smith|773-834-2895|smsmith@medicine.bsd.uchicago.edu|
21239772|NCT01248962|Memorial Sloan Kettering Cancer Center|Dr. Roisin O'Cearbhaill, MD|646-888-4227|ocearbhr@mskcc.org|
21239773|NCT00985543|St Stephens Centre, Chelsea and Westminster Hospital|Dr Marta Boffito|+44 2088 466 507|marta.boffito@chelwest.nhs.uk|
21239774|NCT00245856|University of Oklahoma Health Sciences Center|Suman Rathbun MD|4052714742|suman-rathbun@ouhsc.edu|44773
21290653|NCT01657942|Insightec|Nadir Alikacem|214-630-9900|nadira@insightec.com|
21290654|NCT04526925|Rush University|Jie Li|3125634643|jie_li@rush.edu|
21290655|NCT04280783|Emory University|Dr. Jacob Kariuki|4047272353|jacob.kariuki@emory.edu|
21290656|NCT05170061|SUNYBuffalo|Joseph Izzo MD|7168985625|jizzo@buffalo.edu|
21290657|NCT03443401|USouthDakota|Kory Zimney, PhD|6056586373|kory.zimney@usd.edu|
21290658|NCT02363283|UT MD Anderson Cancer Center|Dr. Sapna Pradyuman Patel,MD/ Melanoma Medical Oncology|713-792-2921|SPPatel@mdanderson.org|
21290659|NCT01394185|Johns Hopkins University|Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
21290660|NCT04110145|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21290661|NCT02371889|University of Pennsylvania Perelman School of Medicine|Henry R. Kranzler, M.D.|215-746-1943|kranzler@pennmedicine.upenn.edu|
21290662|NCT05520333|RTI International|Nisha Gottfredson O'Shea|9192481826|nishaoshea@rti.org|
21290663|NCT05538728|Galderma Research and Development, LLC|Clinical Project Manager|817-961-5000|aestheticclinicaltrials@galderma.com|
21290664|NCT02254460|GlaxoSmithKline|GSK Response Center|866-435-7343||
21290665|NCT02336555|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21290666|NCT01772693|Insightec|Nadir Alikacem, Ph.D., VP Clinical Research|214-630-2000|nadira@insightec.com|
21290667|NCT00781898|University Of Pennsylvania|Charle P. O'Brien|215-222-3200|obrien@mail.med.upenn.edu|
21290668|NCT01633112|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21290669|NCT01630109|Genesys Regional Medical Center Office of Research|Dr. Steven Brooks|8106067722|Steven.Brooks@genesys.org|
21290670|NCT01085903|University of Arkansas for Medical Sciences|Mark Mennemeier, PhD|501 526 7773|msmennemeier@uams.edu|
21290671|NCT03704922|University of North Carolina at Chapel Hill|Matthew S. Karafin MD MS|984-974-1583|matthew.Karafin@unchealth.unc.edu|
21290672|NCT02605967|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21290673|NCT01079390|Mass General Hospital|Jian Kong|617-726-7893|kongj@nmr.mgh.harvard.edu|
21290674|NCT04019704|Axsome Therapeutics, Inc.|Caroline Streicher, Senior Director, Clinical Operations|212-332-5061|cstreicher@axsome.com|
21290675|NCT05122143|Altamira Medica Ltd.|Thomas Meyer|0041 61 201 13|ra@altamiramedica.com|50
21290676|NCT01475825|Kastle Therapeutics, LLC|Medical Information|1-800-745-4447|medinfo@genzyme.com|
21290677|NCT00160563|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
21290678|NCT04157738|Emory University|Dr. Eric Felner|404-727-7651|efelner@emory.edu|
21290679|NCT02118831|California Retina Consultants|Director of Research|8059631648|gabe@californiaretina.com|3034
21290680|NCT02579057|Johns Hopkins Hospital|Stuart Russell MD|4109555708|srusse14@jhmi.edu|
21290681|NCT03232892|University of California, San Francisco|Dr. Collin Blakely, MD PhD.|(415) 502-6959|Collin.Blakely@ucsf.edu|
21290682|NCT00395447|BIOTRONIK, Inc|Crystal Miller, Clinical Studies Engineer|503-451-8051|crystal.miller@biotronik.com|
21290683|NCT03766906|Oregon Research Behavioral Intervention Strategies, Inc. dba Behavioral Influents Innovations|Jessie Marquez|541-484-2123|jessie.marquez@influentsin.com|
21290684|NCT02090894|Indiana University School of Medicine|Dr. Ally-Khan Somani|317-944-7744|somania@iupui.edu|
21290685|NCT01220687|OUHSC College of Medicine, Pediatrics, Neonatal-Perinatal Medicine|Krishnamurhty Sekar, MD, Professor of Pediatrics|405-271-5215|kris-sekar@ouhsc.edu|
21290686|NCT04250207|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
21290687|NCT02772302|Massachusetts General Hospital|Brian Edlow|6177246352|bedlow@mgh.harvard.edu|
21290688|NCT04526158|Minneapolis VAMC|Dr. Diana Burgess|612-567-1591|diana.burgess@va.gov|
21290689|NCT04064567|University of Arkansas for Medical Sciences|Director, Research Programs|501-686-6427|hkhorton@uams.edu|
21290690|NCT03464461|University of Missouri|Dr. Matthew Robinson|573 884-4400|robinsonmt@health.missouri.edu|
21290691|NCT05524948|HALEON|Haleon Response Center|+447880182593|ww.clinical-trial-register@haleon.com|
21290692|NCT05463952|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21290693|NCT03255200|Mainstay Medical|Director, Clinical Affairs|877 702-8488|clinical@mainstaymedical.com|
21290694|NCT01586897|Massachusetts General Hospital|Steven J. Atlas, Director of Massachusetts General Primary Care Practice Based Research Network|617-724-4736|satlas@partners.org|
21290695|NCT04629521|Alcon Research, LLC|Director, Clinical Projects - CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21290696|NCT03163667|Calithera Biosciences, Inc|Study Director|650-870-1000|clinicaltrials@calithera.com|
21290697|NCT01335685|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21290698|NCT02542280|Ain Shams Maternity Hospital|Ahmed Bahaa|+20 1111700556|abahaa0503@yahoo.com|
21290699|NCT02554474|University of British Columbia|Dr. Linda Li|604-207-4020|lli@arthritisresearch.ca|
21290700|NCT03211832|Prevention Research Center, Brown School, Washington University in St. Louis|Ross Brownson|3149350121|rbrownson@wustl.edu|
21290701|NCT00855166|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
21290702|NCT02770365|Perrigo|Associate Director|718-960-9900|jonathan.schwartz@perrigo.com|
21290703|NCT03777020|University of Maryland School of Nursing|Dr. Erika Friedmann|410 706 0659|friedmann@umaryland.edu|
21290704|NCT00489476|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
21290705|NCT02913326|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21290706|NCT01421459|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21290707|NCT01422382|Kowa Research Institute, Inc|Roger Morgan, MD FACS|919-433-1600|RMorgan@kowaus.com|
21290708|NCT03138382|UCSD|Dr Paul McGeoch|858-232-3312|pdmcgeoch@ucsd.edu|
21290709|NCT03189433|Eagle Pharmaceuticals, Inc.|Chief Medical Officer|201-326-5300|medinfo@eagleus.com|
21290710|NCT04743206|University of Florida|Silvia Delgado Villalta|7185684198|silviadelgado@ufl.edu|
21239775|NCT01003184|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21290711|NCT03000166|University of Wisconsin-Milwaukee|Jeanne M. Erickson, PhD, RN|414-229-6920|ericksoj@uwm.edu|
21290712|NCT00231465|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-2158|alberto.chiappori@moffitt.org|
21290713|NCT03624036|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
21290714|NCT02470377|University of Minnesota|Yoon-Hee Cha|612-301-2738|ycha@umn.edu|
21290715|NCT01390584|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21290716|NCT01539525|Yale University School of Medicine|Kimberly A Yonkers|203-764-6621|kimberly.yonkers@yale.edu|
21290717|NCT02268851|Dana-Farber Cancer Institute|Matthew Davids, MD, MMSc|617-632-6331|matthew_davids@dfci.harvard.edu|
21290718|NCT02474901|University of Colorado|Adriana Weinberg, MD|3037244480|adriana.weinberg@ucdenver.edu|
21290719|NCT01694771|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21290720|NCT00879619|University of California, Irvine|Nicole Macaranas, Clinical Research Specialist|714-456-6550|nicole.macaranas@uci.edu|
21290721|NCT02536339|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
21290722|NCT01905683|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
21290723|NCT01157429|Tulane University|Dr. Michael Scheeringa|5049882167|mscheer@tulane.edu|
21290724|NCT02037984|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21290725|NCT03404375|UTMB Galveston|Antonio Saad|4097721571|afsaad@utmb.edu|
21290726|NCT03338686|University of Alabama at Birmingham|Ramzi Abou-Arraj|2059344506|rva@uab.edu|
21290727|NCT00974233|University of Wisconsin|Julie E. Chang, MD|608-262-3970|jc2@medicine.wisc.edu|
21290728|NCT01691092|Yale University - Psychiatry Department|Irina Esterlis, Ph.D.|(203)737-6820|irina.esterlis@yale.edu|
21290729|NCT00088699|National Institute of Mental Health|Zarate, Carlos|+1 301 451 0861|zaratec@mail.nih.gov|
21290730|NCT00581100|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21290731|NCT04129398|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21290732|NCT00590317|Emory University|Dr. Daniel Wu|(404) 251-8875|dtwu@emory.edu|
21290733|NCT02904265|Mayo Clinic|Dr. Katherine Nickels|5072660774|nickels.katherine@mayo.edu|
21290734|NCT01509404|Medical University of South Carolina|James Fleming|843-792-0312|fleminj@musc.edu|
21290735|NCT00185614|Stanford University School of Medicine|Wen-Kai Weng, MD; Associate Professor of Medicine|650-723-7689|wkweng@stanford.edu|
21290736|NCT02735642|Yale University School of Nursing|Ann Kurth|N/A|ann.kurth@yale.edu|
21239776|NCT00557622|GlaxoSmithKline|GSK Response Center|866-435-7343||
21290737|NCT04255381|Yale University|Dr. Stuart Weinzimer|203-785-5831|stuart.weinzimer@yale.edu|
21239777|NCT01468922|National Cancer Institute|Dr. Alice Chen|240-781-3274|chenali@mail.nih.gov|
21290738|NCT00963638|William Beaumont Hospitals|Catherine Coleman, RN, BSN|248-655-5865|cjcoleman@beaumont.edu|
21290739|NCT01254214|University of Minnesota|Cynthia Gross PhD|612-624-8676|gross002@umn.edu|
21290740|NCT06151418|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21290741|NCT03829514|Medical University of South Carolina|Misti Leyva|endo office|leyva@musc.edu|
21290742|NCT00866775|Sunovion Phamaceuticals Inc.|Eslicarbazepine acetate Medical Director|866-503-7813|clinicaltrialsdisclosure@sunovion.com|
21290743|NCT00003907|ECOG Statistical Office|Study Statistician|617-632-3012||
21290744|NCT02553473|Sørlandet hospital HF|Anne Marit Solheim, MD|0047 38 07 39 10|anne.marit.solheim@sshf.no|
21290745|NCT00993473|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi.com|
21290746|NCT04556006|Kilis 7 Aralık University|Dr. Uğur Doğan|+903488139301|63ugurdogan@gmail.com|
21239778|NCT01923389|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21290747|NCT00770679|Johns Hopkins University School of Medicine|Harry Silber, M.D., Ph.D. Assistant Professor of Medicine, Division of Cardiology|4105505717|hsilber@jhmi.edu|
21239779|NCT04848662|Avillion LLP|Chief Medical Officer|+44 (0)203 764 9530|avillion@avillionllp.com|
21239780|NCT02551744|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
21239781|NCT02991144|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
21239782|NCT01989598|Princess Margaret Cancer Centre|Dr. Suzanna Trudel|4169464501|Suzanne.Trudel@uhn.ca|4566
21239783|NCT03237013|San Diego State University|Dr. Aaron Blashill|619-594-2245|ajblashill@sdsu.edu|
21239784|NCT01466764|Stanford University|Gary Peltz|650-721-2487|gpeltz@stanford.edu|
21239785|NCT00007475|National Institute of Diabetes & Digestive & Kidney Diseases|Jeffrey B. Kopp, MD|+1 (301) 594-3403|jbkopp@nih.gov|
21239786|NCT01719224|Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital|Matthias Eikermann, MD, PhD|617-643-7735|meikermann@partners.org|
21239787|NCT00258440|Oregon Health and Science Univeristy|Joseph Bubalo|503-494-8007|bubaloj@ohsu.edu|
21239788|NCT00737061|Hologic, Inc.|Edward Evantash, MD, Medical Director, Vice President Medical Affairs|508-263-8475|edward.evantash@hologic.com|
21239789|NCT03000673|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21239790|NCT01472562|Weill Cornell Medicine|Jia Ruan M.D, Ph.D|646.962.2064|amr2017@med.cornell.edu|
21239791|NCT01512745|Fudan University Shanghai Cancer Center, Shanghai; PLA Cancer Centre, The 81 Hospital of PLA, Nangjing|Co-Director of Clinical Trials|021-64433755|fudanlijin@163.com,qinsk@csco.org.cn|
21239792|NCT02357810|Northwestern University|Mary Mulcahy, MD|312-695-0990|Mary.Mulcahy@nm.org|
21239793|NCT00562978|City of Hope National Medical Center|Dr. Auayporn Nademanee|626-256-4673|ANademanee@coh.org|82405
21239794|NCT00258180|Johns Hopkins School of Medicine|Maria Oliva-Hemker MD|410-955-8769|moliva@jhmi.edu|
21239795|NCT00152971|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21239796|NCT00675506|Massachusetts General Hospital|Steven K. Grinspoon MD|617-726-3890|sgrinspoon@partners.org|
21239797|NCT00936221|AstraZeneca|Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com|
21239798|NCT06173570|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21239799|NCT03820323|University of Washington|Rena C. Patel|206-520-3800|rcpatel@uw.edu|
21239800|NCT03151395|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21239801|NCT00366301|Brigham and Women's Hospital|Aruna Pradhan|617-732-8777|apradhan@partners.org|
21239802|NCT01348776|Syneron Beauty|Doran Rozen, Director of Clinical Affairs|+972-54-7800260|Doran.Rozen@syneron.com|
21239803|NCT04785326|Dong-A ST|Clinical Research Manager|02-920-1111|imspring@donga.co.kr|
21239804|NCT01372605|University of North Carolina-Chapel Hill|Dr. Brian Pence|9199667446|bpence@unc.edu|
21239805|NCT01108510|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21239806|NCT00210119|Institut Bergonie|Dr Gabriel Etienne||g.etienne@bordeaux.unicancer.fr|
21239807|NCT00951509|Human Engineering Research Labs|Rory Cooper, PhD|412-822-3700|rcooper@pitt.edu|
21239808|NCT02641249|University of California|Dr. Kalpashri Kesavan|3108256304|KKesavan@mednet.ucla.edu|
21239809|NCT03125941|rigshospitalet|kristin steinthorsdottir, md|31666112|kjs@dadlnet.dk|
21239810|NCT00089895|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21239811|NCT01298921|Geisinger Health System|Office of Research Compliance|570-214-9628|orc@geisinger.edu|
21239812|NCT01103960|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21239813|NCT01017120|GlaxoSmithKline|GSK Response Center|866-435-7343||
21239814|NCT01087723|The Medicines Company|Global Health Science Center|800-388-1183||
21239815|NCT00806624|Daiichi Sankyo.,LTD|Atsushi Nonogaki, Manager|81-80-3029-7553|nonogaki.atsushi.zz@daiichisankyo.co.jp|
21239816|NCT01912222|Takeda|Medical Director|+1-866-835-2233|GlobalOncologyMedinfo@takeda.com|
21239817|NCT00603265|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
21239818|NCT04399551|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21239819|NCT00010439|Medical University of South Carolina|Deborah A Bowlby, M.D., Assistant Professor, Pediatric Endocrinology|843-792-6807|bowlbyd@musc.edu|
21239820|NCT02122341|USC Intitute of Urology|Dr. Matthew Dunn|323-865-3700|mdunn@med.usc.edu|
21239821|NCT01118455|Cyberonics, Inc.|Mark Bunker, PharmD, Sr. Director, Global Medical Affairs|281-228-7223|Mark.Bunker@cyberonics.com|
21290748|NCT03956082|Mercy Hospital St. Louis|David Levine, MD|314-251-7650|DAVID.LEVINE@MERCY.NET|
21239822|NCT00636792|Millennium Pharmaceutical Inc|Carol Satler|(617) 551-3729||
21239823|NCT01414413|Liverpool School of Tropical Medicine|Dr Peter MacPherson|0044151 705 3100|p.macpherson@liv.ac.uk|
21239824|NCT01928225|University of Colorado|Cynthia Frinhaber|720-848-0000|cynthia.firnhaber@cuanschutz.edu|
21239825|NCT03223272|UAB|Physician|4346545260|dacalhou@sentara.com|
21290749|NCT00836901|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21239826|NCT00451217|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21239827|NCT03154359|Children's Mercy Hospital|James Steven Leeder, PharmD, PhD|816-731-7116|sleeder@cmh.edu|
21239828|NCT03664739|Bausch Health Americas, Inc|Study Director|19083009920|susan.harris@bauschhealth.com|
21239829|NCT01582880|Massachusetts Eye and Ear Infirmary|Dr. Joseph Ciolino, MD|617-573-4437|joseph_ciolino@meei.harvard.edu|
21239830|NCT00574990|Salt Lake City VA HSRD IDEAS 2.0 Center of Innovation|Dr. Charlene Weir|801-582-1565|charlene.weir@utah.edu|5114
21261211|NCT04899271|Dompé Farmaceutici SpA|Clinical Development and Operations|+39 (0) 583831|clinical.trials@dompe.com|
21261212|NCT02233842|National Cancer Institute (NCI)|Dr. Stephanie Land|240-276-6946|stephanie.land@nih.gov|
21233585|NCT03343483|University of Rochester Medical Center|Dr. Kim Van Orden (PI)|585-275-5176|kimberly_vanorden@urmc.rochester.edu|
21233586|NCT01835743|Coughlin Foot and Ankle Clinic|Michael Coughlin, MD|208-367-3330|thefootmd@gmail.com|
21233587|NCT01488097|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|475-230-2596|clinicaltrials@alexion.com|
21233588|NCT01577758|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21233589|NCT01293240|Alcon Research|Peter Bergenske|1-800-241-7629||
21233590|NCT03394768|Changi General Hospital|Serene Yeow, Senior Executive, Clinical Trials and Research Unit|+6581258267|serene_yeow@cgh.com.sg|+656426781
21233591|NCT03342742|"University of Colorado Denver | Anschutz"|Kristen Nowak|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
21233592|NCT00751348|GlaxoSmithKline|GSK Response Center|866-435-7343||
21233593|NCT04383210|Elevation Oncology|Medical Information|+1-716-371-1125|medinfo@elevationoncology.com|
21233594|NCT03095456|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
21261213|NCT02318602|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
21233595|NCT02404350|Novartis Pharmaceuticals|Clinical Disclosure Office|+1 (862) 778-8300|Novartis.email@novartis.com|
21233596|NCT05389657|University of California, San Francisco|Erin Accurso|415-476-5139|erin.accurso@ucsf.edu|
21261214|NCT00095303|University of Miami Miller School of Medicine|Viviana E. Horigian, MD|305-243-4305|vhorigian@med.miami.edu|
21233597|NCT04503564|Capillary BioMedical, Inc.|Director of Clinical Affairs|949-317-1711|alayne.lehman@capillarybio.com|
21233598|NCT05237206|Alloplex Biotherapeutics|Dr. Sharron Gargosky, Chief Development Offier|+1 503-915-1400|sgargosky@alloplexbio.com|
21261215|NCT01773395|Dana-Farber Cancer Institute|Dr. Vincent Ho|617-632-5938|Vincent_Ho@dfci.harvard.edu|
21261216|NCT03228186|Rogel Cancer Center|Gregory Kalemkerian, MD|734-647-8921|kalemker@med.umich.edu|
21233599|NCT03261947|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21233600|NCT03969992|Aerogen Pharma|David Durand, MD|510-928-2111|ddurand@aerogenpharma.com|
21233601|NCT01476696|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21233602|NCT03038815|Institute for Biomechanics ETH Zürich|Silvio Lorenzetti|078 608 14 84|sl@ethz.ch|
21233603|NCT02918851|Stony Brook Medicine|Dr. Elliott Bennett-Guerrero|6314442979|elliott.bennett-guerrero@stonybrookmedicine.edu|
21261217|NCT04312997|Pulmotect, Inc.|Dr. Brenton Scott, President & COO|713-579-9226|bscott@pulmotect.com|
21233604|NCT05365750|Kaiser Permanente Colorado|Ingrid A Binswanger, MD, MPH|720-416-7104|ingrid.a.binswanger@kp.org|
21261218|NCT03953118|University of California San Francisco CA|Julie Schallhorn, MD|415-514-1922|julie.schallhorn@ucsf.edu|
21261219|NCT00258154|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
21261220|NCT02481505|Sintetica SA, via Penate 5 Mendrisio|Elisabetta Donati Clinical Project Leader|+41.91.640.42.50|edonati@sintetica.com|
21261221|NCT03842137|Butler Hospital|Ana M. Abrantes, Ph.D.|401-455-6440|aabrantes@carene.org|
21261222|NCT05139030|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
21233605|NCT03965962|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21233606|NCT02590939|CEFALY Technology|Clinical Trials Department director|+32 4 367 67 22|info@cefaly.com|
21261223|NCT03655444|Washington University School of Medicine|Douglas R. Adkins, M.D.|314-747-8475|dadkins@wustl.edu|
21239831|NCT05033743|Indiana University School of Medicine|Chemen M. Neal, Associate Professor|3172789639|chmtate@iupui.edu|
21239832|NCT01592695|University of Iowa|Mark Vander Weg, PhD|319-338-0581|mark-vanderweg@uiowa.edu|7717
21239833|NCT04542226|NPO Petrovax Pharm, LLC|Nikolay Dodonov, Head of medical department|Phone: +7(495) 730-75-45 ext.|DodonovNS@petrovax.ru|125
21239834|NCT00641719|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21239835|NCT00885352|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21239836|NCT01381874|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21239837|NCT02765490|Janssen Research & Development, LLC|Trial Physician, Medical Department|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21239838|NCT03662997|Molnlycke Health Care|David Pham|678-231-9655|david.pham@molnlycke.com|
21239839|NCT01361620|George Washington University|Dr. Timothy McCaffrey|(202) 994-8919|mcc@email.gwu.edu|
21239840|NCT00706784|MGH|Alexandra B. Kimball, MD|617-726-5066|akimball@partners.org|
21239841|NCT01830881|Oregon Health and Science University|Lisa Bayer, MD|503-494-3666|whru@gmail.com|
21261224|NCT02814721|Henry Ford Hospital|Dr. Lalathaksha Kumbar|3136271761|lkumbar1@hfhs.org|
21239842|NCT00734214|McMaster University|Dr. Karen Choong|905-5212100|choongk@mcmaster.ca|75617
21239843|NCT03487718|University of Kentucky|Ridge Preservation with Leukocyte Platelet Rich Fibrin: A Clinical, Radiographic, and Histomorphomet|8593236193|firasayafi@uky.edu|
21261225|NCT02502864|H. Lee Moffitt Cancer Center and Research Institute|Christine M. Walko, Pharm.D., BCOP|813-745-1519|christine.walko@moffitt.org|
21261226|NCT03772327|Weill Cornell Medicine|Dr. Grant Ellsworth|212-746-7204|gre9006@med.cornell.edu|
21261227|NCT01175369|University of Rochester|Dr. Jill Halterman|5852755798|jill_halterman@urmc.rochester.edu|
21261228|NCT00931164|University of Utah|Dr. Kathryn Swoboda|801-585-9717|taran@genetics.utah.edu|
21261229|NCT00613626|Hoosier Cancer Research Network|Georgia Gould|317-921-2050|ggould@hoosiercancer.org|
21261230|NCT01416129|University of South Florida|Jason Highsmith|813-974-3806|mhighsmi@health.usf.edu|
21261231|NCT01233726|Intensive Care Unit, Hospital Clínico Universitario|Alfonso Mesejo|961 97 35 00|mesejo_alf@gva.es|
21261232|NCT00820040|Medtronic|Heather McManus|2038213323|heather.mcmanus@medtronic.com|
21261233|NCT02256358|Haeundae Paik Hospital, Inje University|Kihwa Lee|82-51-797-0426|tedy333@paik.ac.kr|
21261234|NCT03195140|Tandem Diabetes Care, Inc|Jordan Pinsker, MD|858-366-6900|clinicalaffairs@tandemdiabetes.com|
21239844|NCT04362137|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21239845|NCT00771875|University of Cincinnati|E. Steve Woodle, MD|513-558-6001|woodlees@ucmail.uc.edu|
21239846|NCT04475848|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21239847|NCT02494206|Memorial Sloan Kettering Cancer Center|Dr. Babak Mehrara MD|212-639-3099|mehrarab@mskcc.org|
21239848|NCT01013792|HCA Retreat Hospital, Institute of Plastic and Reconstructive Surgery|Joseph V. Boykin, Jr., MD|804-353-8100|joseph.boykin@HCAhealthcare.com|
21239849|NCT04394845|Hoffmann-La Roche|Medical Communications|800 821-8590|global-roche-genentech-trials@gene.com|
21239850|NCT01121484|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21261235|NCT01259466|Yale University School of Medicine|Dr. Marney A. White|203-785-4349|marney.white@yale.edu|
21279257|NCT03132155|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
21279258|NCT04320823|Haemonetics Corporation|Jan Hartmann, MD, Vice President of Medical Affairs and Clinical Development|(781) 348 7396|Jan.Hartmann@haemonetics.com|
21279259|NCT02925403|University of Oxford|Adrian V Hill, DPhil FRCP|+44 1865 617610|vaccinetrials@ndm.ox.ac.uk|
21279260|NCT00261443|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21279261|NCT05289869|The Ohio State University|Heather Frey, MD, MSCI|614-688-6798|Heather.Frey@osumc.edu|
21233607|NCT00368654|Kaiser Permanente (Current), UC Davis (Previous)|Chai Sue Lee||lam.nguyen@ucdmc.ucdavis.edu|
21233608|NCT04962009|Mati Therapeutics Inc.|Deepank Utkhede|778-991-3301|dutkhede@matitherapeutics.com|
21233609|NCT03722017|Tennessee Valley Healthcare System Nashville Campus|Amanda Mixon, MD MSPH MS|(615) 936-3710|amanda.mixon@va.gov|
21233610|NCT00156533|University of Rochester|Wilfred Pigeon|585 275-3374|wilfred_pigeon@urmc.rochester.edu|
21233611|NCT01263301|Mennonite Christian Hospital|Ling-Chih Wu MD|88638241234|lingchihwu@yahoo.com|1810
21233612|NCT03265249|Duke University|Alisha Mavis, M.D.|919-684-5068|alisha.mavis@duke.edu|
21233613|NCT01614990|Geriatric Research, Education and Clinical Center, VA Puget Sound Health Care System|Jose Garcia, MD, PhD|(206) 764-2984|jg77@uw.edu|
21233614|NCT05630274|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21233615|NCT06076694|Clinical Study Center of the First Hospital of Jilin University|TenNor|0512-86861979|info@tennorx.com|
21290750|NCT01148771|Center for Anti-Infective Research and Development, Hartford Hospital|Joseph L. Kuti, Pharm.D. / Associate Director, Clinical and Economic Studies|860-545-3612|jkuti@harthosp.org|
21239851|NCT03679767|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21239852|NCT03915951|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21239853|NCT05408468|University Hospitals Cleveland Medical Center|Dr. Grant Pignatiello|216-368-4480|gap54@case.edu|
21239854|NCT02130453|The University of Texas MD Anderson Cancer Center|Nicolas Palaskas, MD|(713) 745-1942|nlpalaskas@mdanderson.org|
21239855|NCT01960075|Medical University of South Carolina|Jordan Elm, PhD Biostatistician|843-876-1605|elmj@musc.edu|
21239856|NCT02204579|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21239857|NCT01396395|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21239858|NCT01370005|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21239859|NCT03691948|Medical University of South Carolina|Jenna L. McCauley, PhD, Assistant Professor of Psychiatry|8437923922|mccaule@musc.edu|
21239860|NCT03428126|MD Anderson Cancer Center|Dr. Michael Overman|(713) 792-2828|moverman@mdanderson.org|
21239861|NCT03916744|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
21239862|NCT00884754|London Health Sciences Centre|Philip Jones|519-685-8500|philip.jones@lhsc.on.ca|36306
21239863|NCT04765735|Medtronic|Janelle Blum|262-289-8419|janelle.blum@medtronic.com|
21239864|NCT03556358|Tanvex|Study Director|19494838507|jennifer.lai@tanvex.com|
21239865|NCT00315588|University of Miami Miller School of Medicine Miami Fl|Dr. Rodolfo Alejandro|305 243 5324|ralejand@med.miami.edu|
21239866|NCT00525603|The University of MD Anderson Cancer Center|William G. Wierda, MD/Associate Professor|713-745-0428|eharriso@mdanderson.org|
21239867|NCT00515437|Solstice Neurosciences, Inc|Regulatory Affairs Specialist||regulatoryaffairs@usworldmeds.com|
21239868|NCT02066896|Federal University of Sao Paulo|Tania Sales de Alencar Fidelix|11991346992|fidelixtania@gmail.com|11
21239869|NCT00180713|Imperial College London|Professor Martin R Wilkins|+44 (0)20 8383 2049|m.wilkins@imperial.ac.uk|
21239870|NCT00513786|The Ohio State University Comprehensive Cancer Center|Dr. David O'Malley|614-293-3873|David.O'Malley@osumc.edu|
21239871|NCT05067933|Vaxart|Melanie Drayton|650-392-3109|ClinicalTrials@Vaxart.com|
21239872|NCT01065350|Mayo Clinic|Nathan J. Smischney, MD|507-255-6032|smischney.nathan@mayo.edu|
21239873|NCT01373450|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21239874|NCT02716038|Columbia University Irving Medical Center|Catherine A. Shu, MD|212-305-3997|cas2145@cumc.columbia.edu|
21239875|NCT01986361|Reckitt Benckiser Inc.|Gail Solomon, Director, Clinical Development|973-404-2752|gail.solomon@rb.com|
21239876|NCT02875834|AstraZeneca|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
21239877|NCT00267696|The Ohio State University Comprehensive Cancer Center|Larry Copeland, MD|614-293-8697|Larry.Copeland@osumc.edu|
21239878|NCT03697980|Medtronic Cardiac Rhythm and Heart Failure|CRM/MCS Clinical Team|800-328-2518|MedtronicCRMtrials@medtronic.com|
21239879|NCT05200936|Mind Medicine Inc|Medical Affairs|1-332-245-4732|MedAffairs@mindmed.co|
21239880|NCT00539279|VA San Diego Healthcare System|Steven R. Thorp, Ph.D., ABPP|(858) 552-8585|Steven.Thorp@va.gov|2468
21239881|NCT03221660|Ivoclar Vivadent AG|Dr. med. dent. Lukas Enggist, Dentist internal clinic (Principal Investigator)|+423 235 34 46|lukas.enggist@ivoclarvivadent.com|
21239882|NCT00405353|UCLA|Dr. Rhonda Voskuhl|(310) 206-4636|rvoskuhl@mednet.ucla.edu|
21239883|NCT01340482|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
21239884|NCT02593539|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21239885|NCT01282476|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu|
21239886|NCT01542541|BIDMC|Dr Alan Moss|6176673197|amoss@bidmc.harvard.edu|
21239887|NCT01288781|UWalesBangor|Mr Justin Stevan Lawley|00441248382810|pepa16@bangor.ac.uk|
21239888|NCT00670462|University of Minnesota|Robert W. Jeffery PhD|612-626-8580|jeffe001@umn.edu|
21239889|NCT01811563|Duke University Medical Center|Samuel Wellman, MD|919-681-4055|samuel.wellman@duke.edu|
21239890|NCT01060020|Washington University School of Medicine|Brian R. Lindman, MD, Assistant Professor of Medicine|314-747-3617|brlindman@wustl.edu|
21239891|NCT04424290|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21239892|NCT01946243|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
21239893|NCT02936037|MedDay Pharmaceuticals|Dr Frédéric SEDEL, Chief Scientific Officer and Co-founder|+33180401440|frederic.sedel@medday-pharma.com|
21239894|NCT01267825|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|718-920-6266|befriedm@montefiore.org|
21239895|NCT04249336|Dow University of Health Sciences|Syed Jaffar Abbas Zaidi|00923412481371|jaffar.zaidi@duhs.edu.pk|
21239896|NCT01242176|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21239897|NCT00871351|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21239898|NCT02791490|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21239899|NCT01189890|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21239900|NCT00077636|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21239901|NCT00592319|Trustee of Boston Univ. Medical Campus|Dr. Zhi Wang|617-414-1590|zwang@bu.edu|
21239902|NCT02410967|Florida International University|Dr. Jeremy Pettit|305-348-1671|jpettit@fiu.edu|
21239903|NCT02032173|Novartis Pharmaceuticals|Study Director|862-778-1873||
21239904|NCT05082142|Northwestern University|Nicholas Dean (current fellow)|7806906285|nicholas.dean@northwestern.edu|
21290751|NCT01047540|AiCuris Anti-infective Cures GmbH|Information Desk|+4920231763|info@aicuris.com|0
21239905|NCT01642602|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21239906|NCT01112514|Massachusetts General Hospital|Andrew T. Chan|617 726 3212|achan@partners.org|
21239907|NCT02961881|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21239908|NCT00543400|Momenta Pharmaceuticals|Jim Roach, MD Chief Medical Officer|617-491-9700|jroach@momentpharma.com|
21239909|NCT02721641|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
21239910|NCT01235975|GlaxoSmithKline|GSK Response Center|866-435-7343||
21239911|NCT01047475|Microbio / Sophie Chang|Director of Clinical Trials|886-2-2570-5596|sophie_chang@fountainmab.com|556
21239912|NCT01580098|Landeskrankenanstalten-Betriebsgesellschaft|Dr. Hannes Steinberger|+4346355212 50303|hannes.steinberger@kabeg.at|
21239913|NCT03308058|University of Nebraska Medical Center|Jane Meza|402-559-6825|jmeza@unmc.edu|
21239914|NCT01622543|The Ottawa Hospital - Cancer Centre|Dr. Derek Jonker|613-737-7700|djonker@ottawahospital.on.ca|70170
21239915|NCT00345384|Baylor Research Institute|President Baylor Research Institute|214-820-3296|researchclinicaltrials@baylorhealth.edu|
21239916|NCT00365378|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21239917|NCT04229030|Raziel Therapeutics|Racheli Gueta, Director of Clinical trials|97289126941|racheli@raziel-therapy.com|
21239918|NCT03354325|University of Utah|Eric Coon|801-662-3645|Eric.Coon@hsc.utah.edu|
21239919|NCT01421589|Massachusetts General Hospital|Hideo Makimura, MD, PhD|617-726-8277|hmakimura@partners.org|
21239920|NCT00251927|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21239921|NCT01678820|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21239922|NCT00658697|DFCI|Rana R. McKay, MD|6176323237|rana_yehia@dfci.harvard.edu|
21239923|NCT01170884|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
21239924|NCT00452413|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21239925|NCT00773955|Washington University|Maria Q. Baggstrom, M.D.||Mbaggstr@im.wustl.edu|
21239926|NCT03119610|UT Health San Antonio|Sara Espinoza, MD|210-617-5197|espinozas2@uthscsa.edu|
21239927|NCT00535743|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21239928|NCT00114634|NICHD, NIH|Forbes D Porter|301-435-4432|fdporter@mail.nih.gov|
21239929|NCT00684762|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21239930|NCT05150587|Alfasigma|Nicola Gargano - Senior Clinical Scientist|0039 (0)6 91395072|nicola.gargano@alfasigma.com|
21239931|NCT00332605|University of Chicago|Jon E. Grant|773-834-1325|jongrant@uchicago.edu|
21239932|NCT01539863|Karolinska Institutet|Ass professor Iben Axén|+46704400618|iben.axen@ki.se|
21239933|NCT02693834|Baylor Institute for Rehabilitation|Priya Karakkattil, PT PhD|469-888-5172|Pjke7991@gmail.com|
21239934|NCT00759772|Massachusetts General Hospital|Pouneh K. Fazeli, MD|617-726-3870|pkfazeli@partners.org|
21239935|NCT01568827|The Ohio State University|Dr. Joseph Kitzmiller|6142928438|joseph.kitzmiller@osumc.edu|
21261236|NCT01341912|Octapharma|VP of Clinical Research and Development|+41 554512141|sigurd.knaub@octapharma.com|
21279262|NCT02094417|Kyowa Kirin Korea Co. Ltd.,|Clinical Development Team, Clinical Development Department|82221912918|kyungmo.lee.m6@kyowakirin.com|
21279263|NCT01443728|Columbia University|Gary Brittenham, MD|212-305-7005|gmb31@cumc.columbia.edu|
21279264|NCT02794597|Denver Health & Hospital Authority|Deborah Rinehart|303-602-2743|deborah.rinehart@dhha.org|
21279265|NCT02156167|Cochlear|Christiane D'hondt, Clinical Research Specialist|+32 15 76 55 14|cdhondt@cochlear.com|
21279266|NCT00741286|Department of Neurology, Sanggye Paik Hospital, Inje University College of Medicine|Sang Won Han|82-2-950-8864|swhan@paik.ac.kr|
21279267|NCT02597127|The Medicine's Company|Global Health Science Center|1-888-997-6326|Medical.Information@themedco.com|
21279268|NCT00253448|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Research Investigator|937-395-8646|douglas.einstein@khnetwork.org|
21279269|NCT01342757|Emory University School of Medicine|Jeffrey J. Olson, MD|404-778-3091|jolson@emory.edu|
21279270|NCT02564887|University of Pittsburgh|Christine Harrison, Clinical Research Coordinator|412-647-9665|harrisonta@upmc.edu|
21279271|NCT00000620|Wake Forest School of Medicine|Tim Craven / Senior Biostatistician|336-716-6109|tcraven@wakehealth.edu|
21279272|NCT02648932|University of Chicago|Hongtao Liu|773-834-0589|hliu2@medicine.bsd.uchicago.edu|
21279273|NCT01199016|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21279274|NCT00561418|The Ohio State University Comprehensive Cancer Center|Craig Hofmeister, MD|614-293-9869|craig.hofmeister@osumc.edu|
21279275|NCT01900561|Department of Veterans Affairs|Dr. Sarah Hawley|734-936-8816|sarahawl@umich.edu|
21279276|NCT02368314|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
21279277|NCT01266031|National Cancer Institute|Dr. Mark Gilbert|301-402-6383|gilbertmr@mail.nih.gov|
21279278|NCT01307111|University of New Mexico|Eve Espey, MD, MPH, Principle Investigator|505-272-6372|eespey@salud.unm.edu|
21279279|NCT00569855|University of Arkansas, Arkansas Children's Hospital, Dept. of Pediatrics|Research Program Manager, Cardiovascular Surgery, Dept. of Pediatrics|501-364-1100|althagekarena@uams.edu|5859
21279280|NCT02842073|University of North Carolina at Chapel Hill|James C Garbutt, MD|984-974-2201|jc_garbutt@med.unc.edu|
21279281|NCT00385008|GlaxoSmithKline|GSK Response Center|866-435-7343||
21279282|NCT01333397|Ipsen|Medical Director|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21279283|NCT00706485|Massachusetts General Hospital|Thomas F. DeLaney, M.D.|617-726-6876|tdelaney@mgh.harvard.edu|
21279284|NCT03366207|Iterum Therapeutics|Senior Director, Clinical Development|18606614035|saronin@iterumtx.com|
21279285|NCT01651793|University of Georgia|Dr. Patrick J. O'Connor|706-542-4382|poconnor@uga.edu|
21279286|NCT02130622|Dartmouth-Hitchcock|Gastroenterology Research Team Lead|603-653-9033|Jessica.I.Chevalier@hitchcock.org|
21279287|NCT02010645|The University of Texas MD Anderson Cancer Center|Courtney DiNardo, MD/Associate Professor|713-794-1141|CDiNardo@mdanderson.org|
21290752|NCT03268499|The Chinese University of Hong Kong|Simon Chun Ho Yu|+852 35051035|simonyu@cuhk.edu.hk|
21239936|NCT04071470|Vanderbilt University Medical Center|Carolyn Audet|615-343-2418|carolyn.m.audet@vanderbilt.edu|
21239937|NCT03306043|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21239938|NCT01544491|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21239939|NCT04112940|University Health Network|Director, Swallowing Rehabilitation Research Laboratory|4165973422|tri-swallowinglab@uhn.ca|7802
21239940|NCT05229653|NYU Langone Health|Kathy Huang, MD|(212) 545-5400|Kathy.Huang@nyulangone.org|
21239941|NCT05295732|LEO Pharma A/S|Clinical Disclosure|+4544945888|disclosure@leo-pharma.com|
21239942|NCT00550550|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21239943|NCT02459093|Stony Brook Medicine|Dr David Garry|631-444-7650|david.garry@stonybrookmedicine.edu|
21239944|NCT00591864|Mayo Clinic|Amy Lynn Conners MD|(507) 284-2511|MBI@mayo.edu|
21239945|NCT03519243|BIOCAD|Linkova Iuliia|+7 (495) 992 66 28|linkova@biocad.ru|930
21239946|NCT00118092|Karmanos Cancer Institute at Wayne State University|Elisabeth Iljas Heath, M.D.||heathe@karmanos.org|
21239947|NCT03331185|University of Manitoba|Dr. Jonathan Bouwer|204 898 1132|jfbouwer@gmail.com|
21239948|NCT03396432|Children Hospital of Philadelphia|Dr. John Fiadjoe, PI|267-426-2961|fiadjoej@email.chop.edu|
21239949|NCT03311230|University of Pennsylvania|Joseph Harrison|2157461249|joseph.harrison@uphs.upenn.edu|
21239950|NCT01302938|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21239951|NCT03342053|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21239952|NCT02294474|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21239953|NCT01586312|Instituto de Biología y Genética Molecular (IBGM)|Professor Javier Garcia-Sancho|34 983 423 084|jgsancho@ibgm.uva.es|
21239954|NCT02415998|University of Iowa|Kenichi Ueda|319-356-2633|kenichi-ueda@uiowa.edu|
21239955|NCT03104647|Shaare Zedek Medical Center|Dr. Yair Barzilay, PI|+972-2-6555166|barzilay@szmc.org.il|
21239956|NCT04235582|Aurora Health Care|Mindy Waite, Behavioral Health Research Scientist|414-773-4323|mindy.waite@aah.org|
21239957|NCT04921969|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21239958|NCT04287868|National Cancer Institute|Dr. Charalampos Floudas|240-858-3032|charalampos.floudas@nih.gov|
21239959|NCT00398398|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
21239960|NCT02291289|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21239961|NCT02949674|Instituto Mexicano del Seguro Social|Dr. Juan Lopez|+5257473500|juanlopez110@hotmail.com|25538
21239962|NCT01868035|GlaxoSmithKline|GSK Response Center|866-435-7343||
21239963|NCT02550132|Université du Québec à Trois-Rivières|Dr Martin Descarreaux DC, PhD|18193765011|martin.descarreaux@uqtr.ca|3791
21239964|NCT01617083|University of South Florida Rothman Center|Study Coordinator|7277678393|ebrenna1@health.usf.edu|
21239965|NCT04995497|University of Iowa Healthcare|Archit Sharma, M.D.|(319) 384-7911|archit-sharma@uiowa.edu|
21239966|NCT00154063|Eisai Call Center|Eisai Inc.|888-422-4743||
21239967|NCT01432535|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21239968|NCT01912781|Alcon Research, Ltd.|Clinical Project Lead, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
21239969|NCT03377790|Verrica Pharmaceuticals|Susan Cutler, VP, Medical Affairs|484-773-0898|scutler@verrica.com|
21239970|NCT00919893|Clinic for urology and pediatric urology, JL-University, Giessen, Germany|Dr. F.M.E. Wagenlehner|0049 641 9944518|wagenlehner@AOL.com|
21239971|NCT03278886|Boston Medical Center|Dr. Jeffrey Samet|617-414-7444|jsamet@bu.edu|
21239972|NCT00101660|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21239973|NCT00708305|GlaxoSmithKline|GSK Response Center|866-435-7343||
21239974|NCT04711460|University of MN|Joan D. Lund|612-273-9115|Lund1687@umn.edu|
21239975|NCT03283696|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21239976|NCT02223065|AstraZeneca AB, S-151 85 Södertälje, Sweden|Eva Johnsson, Clinical Science Lead, GLOBAL_MEDICINES_DEV|+46 31 7762484|Eva.Johnsson@astrazeneca.com|762 484
21239977|NCT02104830|Biocad|Roman Ivanov, Director of Clinical Trials|+7 (812) 380 49 33|ivanov@biocad.ru|950
21239978|NCT02572817|National Institute of Allergy and Infectious Diseases (NIAID)|John Beigel, M.D.|301-451-9881|jbeigel@niaid.nih.gov|
21239979|NCT01614847|Northeastern State University Oklahoma College of Optometry|Thomas O. Salmon, OD, PhD, Professor|918-444-4011|salmonto@nsuok.edu|
21239980|NCT01165840|Texas Tech University HSC|Ronald Hall|214-358-9009|ronald.hall@ttuhsc.edu|
21239981|NCT00249496|Johns Hopkins School of Medicine: Department of Psychiatry|Dr. Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
21239982|NCT02310126|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, O.D., M.S., F.A.A.O., Sr. Principal Research Optometrist|904-443-3500|TKarkkai@its.jnj.com|3402
21239983|NCT00000143|Johns Hopkins School of Public Health|Curtis Meinert, PhD|410-955-8198|cmeinert@jhsph.edu|
21239984|NCT02111213|Stanford University|Principal Investigator|6507232880|desparza@stanford.edu|
21239985|NCT04548531|Massachusetts General Hospital|Karen Sepucha|6177243350|ksepucha@mgh.harvard.edu|
21261237|NCT03679494|Taipei MU|MS. Po-Yao Chiu|+886-2-27361661|m437106006@tmu.edu.tw|6311
21261238|NCT02527304|Montefiore Medical Center|Dr. Madhur Garg, Clinical Director, Department of Radiation Oncology|718-920-4361|mgarg@montefiore.org|
21261239|NCT01824602|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
21261240|NCT00184054|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist, Clinical Investigations Support Office|323-226-6384|victoria.soto@med.usc.edu|
21290753|NCT05071027|Montefiore Medical Center|Dr. David Altschul, Department of Neurosurgery|718-920-7498|daltschu@montefiore.org|
21290754|NCT04576481|Children's Hospital of Philadelphia|James Guevara, MD MPH|215-590-1130|guevara@chop.edu|
21290755|NCT05263791|MacKay Memorial Hospital|Chien-Chung Huang|02-25433535|titanh@gmail.com|3009
21239986|NCT00439179|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org|
21290756|NCT03689179|University of Utah|Rebecca Utz|801 699 5685|rebecca.utz@utah.edu|
21290757|NCT03168529|Wayne State University|Phillip Levy, MD|3135771214|plevy@med.wayne.edu|
21290758|NCT04463914|Medical University of South Carolina|Dr. Jennifer Dahne|843-876-2280|dahne@musc.edu|
21290759|NCT05155085|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
21290760|NCT00595075|Sentara Neurology Specialists|Daniel Cohen|757-388-6323|dacohen@sentara.com|
21290761|NCT03329131|University of Texas Health Science Center in San Antonio|Virginia Kaklamani, MD|210-450-3838|kaklamani@uthscsa.edu|
21290762|NCT01397591|OHSU Knight Investigational Cancer Services|Jeff Donovan|503-494-7702|mastersj@ohsu.edu|
21290763|NCT05261490|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21290764|NCT01244412|University of Rochester|David Kleinman, MD||david_kleinman@urmc.rochester.edu|
21290765|NCT01971593|UT Southwestern|Ari Cedars|3149224788|acedars97@gmail.com|
21290766|NCT01682720|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21290767|NCT01687595|Agenus Inc.|Agenus, Inc. Clinical Trial Information|781-674-4265|clinicaltrialinfo@Agenusbio.com|
21290768|NCT04204902|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21290769|NCT05451329|VivaVision Biotech, Inc.|Xiao-Yan (Joanne) Li, M.D.|(858) 692-9752|joanne.li@vivavisionbio.com|
21261241|NCT02296840|Emory University|Roy Rajan, MD|404-778-2400|royrajan@yahoo.com|
21261242|NCT02485717|ParaPRO, LLC|Kerry W. Mettert, MBA, MT(ASCP)|317-810-6205|kerrym@parapro.com|
21261243|NCT02827877|City of Hope Medical Center|Dr. Joanne Mortimer|626-359-8111|jmortimer@coh.org|
21261244|NCT00729430|Brigham and Women's Hospital|Dr. Raymond Y. Kwong, Director of Cardiac Magnetic Resonance Imaging|857-307-1960|rykwong@partners.org|
21233616|NCT02155335|Merck Sharp & Dohme|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21233617|NCT04171414|Celltrion Inc.|JiWoong Lim|032-850-5806|jiwoong.lim@celltrion.com|
21233618|NCT01742338|Rutgers Robert Wood Johnson Medical School|Dr. Jeffrey L. Carson|732-235-7122|jeffrey.carson@rutgers.edu|
21233619|NCT02586493|GlaxoSmithKline|GSK Response Center|866-435-7343||
21233620|NCT03249779|Mayo Clinic|Melissa C. Lipford, M.D.|507-255-9230|Lipford.Melissa@mayo.edu|
21233621|NCT04345614|CalciMedica, Inc.|Sudarshan Hebbar, MD|8168387105|sudarshan@calcimedica.com|
21233622|NCT04133168|Boston Scientific|Stephanie Roelke, Clinical Trial Manager|651-582-4000|Stephanie.Roelke@bsci.com|
21233623|NCT02855437|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Jeff Foster|205-996-6086|pjfoster@uabmc.edu|
21233624|NCT01378221|Heart and Diabetes Center North Rhine-Westphalia, Germany|Dr. Armin Zittermann|+49 5731 97|azittermann@hdz-nrw.de|1912
21233625|NCT03970590|VA Bedford Healthcare System Center for Health Organization and Implementation Research|Sarah Cutrona, MD|781-687-2861|sarah.cutrona@va.gov|
21233626|NCT04343521|Emory University|Gonzalo Vazquez-Prokopec, PhD|404-727-4217|gmvazqu@emory.edu|
21233627|NCT02836600|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21233628|NCT02532647|PAION UK Ltd|Trial Information||reg_paion@paion.com|
21233629|NCT04415281|University of Florida|Eric Weber|3522737802|ebweber@ufl.edu|
21233630|NCT01052207|CHOA/Emory|Dr. Kiran Hebbar|404-785-6135|khebbar@emory.edu|
21233631|NCT01505608|NMTRC|Giselle Sholler, MD|6162670335|genevieve.bergendahl@helendevoschildrens.org|
21233632|NCT01272830|Clinic Orthopaedic Center|Thomas Bear, MD|330-375-3906|kovacikm@summahealth.org|
21233633|NCT01251380|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21233634|NCT00600756|AstraZeneca|Gerard Lynch||clinicaltrialtransparency@astrazeneca.com|
21233635|NCT00768144|Dana-Farber Cancer Institute|Susana M. Campos, MD, MPH|617-632-5269|susana_campos@dfci.harvard.edu|
21233636|NCT01712854|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
21233637|NCT01150123|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
21233638|NCT02171260|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
21233639|NCT05821842|Sound Health Systems, Inc.|Paramesh Gopi|313-509-8237|pgopi@soundhealth.life|
21233640|NCT01466387|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21233641|NCT01319877|Hoffmann-La Roche|Medical Communications|800-821-8590||
21233642|NCT00566150|Yale University|Dr. Zubin Bhagwagar|203-974-7560|zubin.bhagwagar@yale.edu|
21233643|NCT02347189|Medtronic|Megan Mueller, Clinical Research Manager|612-916-4771|megan.d.mueller@medtronic.com|
21233644|NCT02677987|Northwestern University Feinberg School of Medicine|Lisa M. Wu, Ph.D.|(312) 503-7722|lisa.wu1@northwestern.edu|
21233645|NCT00091273|University of Virginia|Craig L. Slingluff, MD|434-924-1730|cls8h@virginia.edu|
21261245|NCT00814710|GlaxoSmithKline|GSK Response Center|866-435-7343||
21233646|NCT03320564|Wake Forest Baptist Health|Katie Holbrook Bingman|336-713-7765|krholbro@wakehealth.edu|
21233647|NCT00673179|UT MD Anderson Cancer Center|Peter M. Anderson, MD, PHD / Professor||CR_Study_Registration@mdanderson.org|
21261246|NCT03885284|Georgetown University|Benjamin Weinberg, MD|202-444-2223|baw12@gunet.georgetown.edu|
21290770|NCT00069953|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
21239987|NCT02761629|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21239988|NCT04957732|University of Florida Shands Emergency Department|Richard Petrik, MD, Clinical Assistant Professor|352-265-5911||
21239989|NCT03767634|Imperial College London|Dr Chris Gale|+44 (0)20 3315 3519|christopher.gale@imperial.ac.uk|
21239990|NCT02378402|Department of Radiology, Chang Gung Memorial Hospital|Gigin Lin, MD, PhD|886-3-3281200|giginlin@cgmh.org.tw|2575
21239991|NCT01035333|Albany College of Pharmacy and Health Sciences|Dr Margaret Malone|518 694 7275|margaret.malone@acphs.edu|
21239992|NCT01844115|Forest Research Institute, Inc|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
21239993|NCT00545363|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21239994|NCT01258660|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21239995|NCT00582491|Yale University School of Medicine|Peter Morgan, MD, PhD|203-974-7515|Peter.Morgan@yale.edu|
21239996|NCT02136498|Group Health Research Institute|Principle Investigator|206-287-2737|mcclure.j@ghc.org|
21239997|NCT04192630|Bausch + Lomb Incorporated|Anya Loncaric, Executive Director, Global Clinical Operations|(310) 770-7750|Anya.Loncaric@bauschcloud.com|
21239998|NCT01193582|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21239999|NCT01425632|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21240000|NCT00350701|University at Buffalo|Dr. Paresh Dandona|7165351850|dandona@buffalo.edu|
21240001|NCT02459080|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
21240002|NCT01448421|keystoneheart|Karen Jaffe, VP RA./QA/CA|97246158005|karen.jaffe@keystoneheart.com|8005
21240003|NCT00406419|F. Hoffmann-La Roche Ltd|Medical Communications|+41 616878333|global.trial_information@roche.com|
21240004|NCT01775930|UT MD Anderson Cancer Center|Dr. Eric Jonasch, MD / Professor, Genitourinary Medical Oncology|713- 563-7232|ejonasch@mdanderson.org|
21240005|NCT01208415|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Affairs|765-463-7537|Scott.Snyder@CookMedical.com|
21240006|NCT01115491|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21240007|NCT03856996|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
21240008|NCT03959592|Duke University|Alessandro Jammal, M.D., Ph.D.|919-684-0202|alessandro.jammal@duke.edu|
21240009|NCT02340520|UConn Health|Nausherwan Burki, MD||nburki@uchc.edu|
21240010|NCT01840319|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21240011|NCT01586338|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21240012|NCT01868074|University of Iowa|Neil Segal, M.D., M.S.|3193560737|segal-research@uiowa.edu|
21240013|NCT00896454|Amgen Inc.|Study Director|866-572-6436||
21240014|NCT01461993|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21240015|NCT00680056|UNIFESP|Danilo Berton|55-11-55718384|dcberton@gmail.com|
21240016|NCT01821898|Baylor College of Medicine/Texas Children's Hospital|Carla M. Davis, MD|832-824-1319|carlad@bcm.edu|
21240017|NCT05064735|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21240018|NCT00930943|MedVadis Research Corporation|Egilius L.H. Spierings, M.D., Ph.D.|781-588-5430|Spierings@MedVadis.com|
21240019|NCT01018563|Eisai Medical Information|Eisai Medical Information|888 422 4743|esi_medinfo@eisai.com|
21240020|NCT00798486|Ascensia Diabetes Care|Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
21240021|NCT00589550|The Ohio State University Comprehensive Cancer Center|Thomas Olencki, DO|614-293-2886|Thomas.Olencki@osumc.edu|
21240022|NCT04844970|Lahey Hospital & Medical Center|Julia Roache, Manger, Research Programs|7817443055|julia.roache@lahey.org|
21240023|NCT00447954|Neurotech Pharmaceuticals, LLC|CMO|401-333-3880|neurotech@neurotechusa.com|
21240024|NCT00856661|H. Lundbeck A/S|study director||LundbeckClinicalTrials@Lundbeck.com|
21240025|NCT02120664|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
21240026|NCT03176238|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
21240027|NCT04524598|Limbix Health|Janel Shelton-DeMagnus, Research Operations Manager|8885462495|janel@limbix.com|709
21240028|NCT00977769|Oslo University Hospital|Professor Leiv Arne Rosseland|+4723070000|lrossela@ous-hf.no|
21240029|NCT02736968|University of California, San Diego|Sharon Reed, MD|858-822-2808|slreed@ucsd.edu|
21240030|NCT00548041|Temple University Hospital|Dr. Ellen Tedaldi|215-707-2000|ellen.tedaldi@tuhs.temple.edu|
21240031|NCT01804673|Clinic for Anaesthesiology, Intensive Care Unit and Pain Therapy at the Westfälische Wilhelms-Universität Münster, Albert-Schweitzer-Str. 33, 48149 Munster.|Head|+49 251 / 83 - 4 72 52||
21240032|NCT03483077|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21240033|NCT01857934|St. Jude Children's Research Hospital|Sara M. Federico, MD|866-278-5833|referralinfo@stjude.org|
21240034|NCT01024959|Gen-Probe, Incorporated|Jennifer Reid, Director of Clinical Affairs|858-731-5985|jennifer.reid@hologic.com|
21240035|NCT00313911|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21240036|NCT03384953|Osher Center for Integrative Medicine|Dr. Lindsey C. McKernan|615-320-7770|lindsey.mckernan@vumc.org|
21240037|NCT04161807|Theranica Bio-Electronics Ltd|Dr Dagan Harris. VP Clinical @Regulatory Affairs|0542220121|daganh@theranica.com|
21240038|NCT01798186|Johns Hopkins University|Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
21240039|NCT00282815|University of Michigan|Devin Brown, MD|734-936-9075|devinb@umich.edu|
21240040|NCT00192023|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21240041|NCT02524054|Beth Israel Deaconess Medical Center|Robert Banzett, PhD|6176670572|rbanzett@bidmc.harvard.edu|
21240042|NCT02441946|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21261247|NCT04333966|University of North Texas Health Science Center|Dr. Dana Litt|817-735-5453|dana.litt@unthsc.edu|
21240043|NCT01232465|North Shore|Dennis Marchesi|516-562-1761|dmarches@nshs.edu|
21240044|NCT00758160|Janssen Pharmaceutical, Taiwan|Medical Affairs Director|+886-2-23762155||
21240045|NCT02153359|Johns Hopkins University|Dr. Sonali Bose|410-550-2708|kladson1@jhmi.edu|
21240046|NCT02289989|Rutgers Robert Wood Johnson Medical School|Amy Pappert, MD|732-235-7765|papperas@rwjms.rutgers.edu|
21240047|NCT02201446|Department of Burn Surgery, Changhai Hospital, The Second Military Medical University, Shanghai, People's Republic of China|Guo-sheng Wu|+86 18019359841|drwuguosheng@sina.cn|
21240048|NCT01234649|Woman's Hospital|Dr Karen Elkind-Hirsch|225 231-5275|karen.elkind-hirsch@womans.org|2
21240049|NCT00566943|Synovis Surgical Innovations|Lesa Hobright-Turner, Director Clinical Affairs|651-796-7506|lesa.hobrightturner@synovissurgical.com|
21240050|NCT00580229|University of South Florida|John D. Carter, M.D.|813-974-2681|jocarter@health.usf.edu|
21240051|NCT01304082|Massachusetts General Hospital|Brian Wainger|617-726-8810|bwainger@partners.org|
21240052|NCT02733042|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21240053|NCT02838628|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
21240054|NCT02667444|Novan, Inc.|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
21240055|NCT04719013|InMode|Maria Shusterman|9057076787|Maria.Shusterman@inmodemd.com|
21240056|NCT05415124|NYU Langone Health|Melissa Debordeaux, MD|(212) 263-7300|Melissa.Debordeaux@nyulangone.org|
21240057|NCT04175912|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21240058|NCT04654468|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21240059|NCT06390826|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21240060|NCT02009696|Biotronik, Inc.|Clinical Studies Engineer|503-927-7230|justin.michalski@biotronik.com|
21240061|NCT02344537|New York State Psychiatric Institute|Brian Fallon, MD|6467748052|brian.fallon@nyspi.columbia.edu|
21240062|NCT05490329|Florida State University|Lisa Hightow-Weidman, MD, MPH|8506443296|lhightowweidman@fsu.edu|
21240063|NCT02460263|Outset Medical, Inc|Clinical Operations|(669) 231-8200|clinical@outsetmedical.com|
21240064|NCT02306122|Brown University|Joanne Michaud|401-863-9317|joanne_michaud@brown.edu|
21240065|NCT01642082|NRG Oncology|Linda Gedeon, BA, CCRP Clinical Research Coordinator|716-845-1169|lgedeon@gogstats.org|
21240066|NCT01351025|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|301-628-3313|ACTGCT.Gov@s-3.com|
21240067|NCT00479089|The University of Texas (UT) MD Anderson Cancer Center|Arlene Siefker-Radtke, MD/Associate Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org|
21240068|NCT04152343|Dartmouth-Hitchcock Medical Center|Dr. Eric Hoffer, Director of Interventional Radiology|603 650 7417|hoffer@hitchcock.org|
21240069|NCT02090634|UCSD HIV Neurobehavioral Research Program (HNRP)|Dr. David J Moore, Professor of Psychiatry|619-543-5093|djmoore@ucsd.edu|
21240070|NCT01965938|Vanderbilt University School of Medicine|Dr. Bret Alvis, MD|615-343-6268|bret.d.alvis@vanderbilt.edu|
21240071|NCT03757234|Paratek Pharmaceuticals, Inc.|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
21240072|NCT00610701|University of Missouri|Brett D. Crist, MD|5738826562|cristb@health.missouri.edu|
21240073|NCT01152294|Massachusetts General Hospital|Karen Sepucha, Ph.D.|617-724-3350|ksepucha@partners.org|
21240074|NCT00171873|KKS Marburg|Carmen Schade-Brittinger|0049-6421-2866458|carmen.brittinger@kks.uni-marburg.de|
21240075|NCT02041923|University of Illinois at Chicago|Rosemary White-Traut|312-996-7935|rwt@uic.edu|
21240076|NCT02061696|Borgess Heart Institute|Frank Saltiel, MD|269-381-3963||
21240077|NCT02780622|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21240078|NCT00309608|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21240079|NCT04613882|Coopervision|Jose A. Vega, OD, MSc, FAAO|9256213761|javega@coopervision.com|
21240080|NCT00621296|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21240081|NCT00127413|VA Boston Healthcare System|John D. Otis|8573645740|john.otis@va.gov|
21240082|NCT01283321|University of Maryland|Dr. Kenichi Tanaka|412-328-0205|ktanaka@anes.umm.edu|
21240083|NCT02274649|Shepherd Center|Michael Jones, PhD, Director Research|4043507595|mike_jones@shepherd.org|
21240084|NCT01051063|GlaxoSmithKline|GSK Response Center|866-435-7343||
21240085|NCT01928680|Chinese Academy of Medical Science|Dr. Qiao Li|86-18500027849|liqiaopumc@qq.com|
21240086|NCT02023879|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21240087|NCT03713021|Washington University School of Medicine|Ryan Jackson, M.D.|314-362-0365|jackson.ryan@wustl.edu|
21240088|NCT00874432|University of Wisconsin - Madison|Dr. Arjang Djamali|(608) 262-9306|axd@medicine.wisc.edu|
21240089|NCT01076283|Brown University|Lorenzo Leggio, MD|401-863-1000|lorenzoleggio@gmail.com|
21240090|NCT02708433|University of North Carolina at Chapel Hill|Raymond P. White, Jr. DDS, PhD|919-537-3944|ray_white@unc.edu|
21240091|NCT00384059|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21240092|NCT01774071|Memorial Sloan Kettering Cancer Center|Dr. Steven Larson, MD|646-888-2212|LarsonS@MSKCC.ORG|
21240093|NCT00381641|University of Chicago|Dr. Tanguy Seiwert|(773) 702-2452|tseiwert@medicine.bsd.uchicago.edu|
21240094|NCT03864926|University of Wisconsin Hospital and Clinics|Sandesh Parajuli, MD, MBBS|(608) 265-0152|sparajuli@medicine.wisc.edu|
21240095|NCT00445601|SWOG Statistics and Data Management Center|Catherine Tangen, Genitourinary Committee Statistician|206-667-2933|ctangen@fredhutch.org|
21240096|NCT01091428|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21240097|NCT00214903|Center for Epidemiology and Health Research, Germany|Juergen Dinger, MD, PhD|+49 (0) 30 945 101 20|dinger@zeg-berlin.de|
21240098|NCT02543723|East Carolina University|Essie Torres|252-328-1818|torrese@ecu.edu|
21240099|NCT04213989|Laser Lipo and Vein Center|Thomas Wright, MD|636-397-4012|info@laserlipoandveins.com|
21240100|NCT00440180|University of Utah|Marie Gibson|801-213-2845|marie.gibson@hsc.utah.edu|
21279288|NCT01994850|University of Pennsylvania Abramson Cancer Center|Jakub Svoboda, MD|855-216-0098|PennCancerTrials@emergingmed.com|
21290771|NCT02800785|University of Washington|Erin Fannon|206-685-9770|ecarney@uw.edu|
21240101|NCT03918239|Shire|Study Director|+1 866-842-5335|ClinicalTransparency@takeda.com|
21240102|NCT00963989|Penumbra, Inc.|Director of Clinical Affairs|+1 510 995 2183|blawson@penumbrainc.com|
21240103|NCT00358215|Amgen Inc.|Study Director|866-572-6436||
21240104|NCT00744237|Forest Laboratories, Inc|Noah Rosenberg , MD, Exec. Dir, Clin Dev, Cardiovascular and Metabolism|2014278000|noah.rosenberg@frx.com|2133
21240105|NCT06017999|Xgene Pharmaceutical|Director of Clinical Trials|+886-2-2528-0580|emily.chen@xgenepharm.com|
21240106|NCT03076359|Vanderbilt University|Carolyn Audet|615-343-2418|carolyn.m.audet@vanderbilt.edu|
21240107|NCT02040792|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
21240108|NCT01089556|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21240109|NCT01757665|Edwards Lifesciences, LLC|Aya Westbrook, PhD, Director of Clinical Program Management|949-250-2500|aya_westbrook@edwards.com|4035
21240110|NCT01702428|GlaxoSmithKline|GSK Response Center|866-435-7343||
21240111|NCT02091869|University of Arkansas for Medical Sciences|Dr. Tamara T. Perry|501-364-1538|perrytamarat@uams.edu|41538
21240112|NCT02165904|Hospital Universitario Puerta de Hierro Majadahonda, Madrid|Dr. Vaquero Crespo|91 191 7760|jesus.vaquero@salud.madrid.org|
21240113|NCT01533714|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
21240114|NCT00956540|Hospital Virgen de la Salud|Dr. Gonzalo Hernández|0034629625428|ghernandezm@telefonica.net|
21240115|NCT02564055|GlaxoSmithKline|GSK Response Center|866-435-7343||
21240116|NCT01375959|Albert Einstein College of Medicine|Dr. Jill Crandall|718-430-3765|jill.crandall@einstein.yu.edu|
21240117|NCT02771210|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
21240118|NCT01576055|W.L. Gore & Associates|Thomas Sabin|928-864-3153|tsabin@wlgore.com|
21240119|NCT01930435|UCSF|Dr. Sue Yom|415-353-7175|yoms@radonc.ucsf.edu|
21261248|NCT00002850|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
21240120|NCT01560377|Novadaq Technologies, Inc.|Alicia Wilton|1.905.629.3822|awilton@novadaq.com|209
21240121|NCT04012814|Venus Concept|Director of Clinical Affairs|1-888-907-0115|mgronski@venusconcept.com|
21240122|NCT04397523|Institute for Transfusion Medicine of RNM|Assoc. Prof. Dr. Rada M. Grubovic Rastvorceva, MD MSci PhD, CMO|+38923226923|drgrubovic@gmail.com|
21240123|NCT04789577|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21240124|NCT01275196|Novartis Pharmaceuticals|Study Director|862-778-8300||
21240125|NCT01027364|Bioverativ|Bioverativ Study Medical Director||clinicaltrials@bioverativ.com|
21240126|NCT01394250|The Chidren's Hospital of Philadelphia|Deb Potts|215-590-7098|pottsd@email.chop.edu|
21240127|NCT02226172|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21240128|NCT00267111|Mount Sinai Hospital|Dr. Vibhuti Shah|416-586-4816|vshah@mtsinai.on.ca|
21240129|NCT00779584|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21240130|NCT03632434|University of East London|Professor Cynthia Fu|07563 240193|c.fu@uel.ac.uk|
21240131|NCT02590068|The Rockefeller University|Dr. Aileen O'Connell, Laboratory Manager|212-327-7047|aoconnell@rockefeller.edu|
21240132|NCT01182727|Maryland Psychiatric Research Center|Dr. Robert Buchanan, M.D.|410-402-7876|rwbuchanan@mprc.umaryland.edu|
21240133|NCT04297241|Cincinnati Children's Hospital|Mary Banks|513-636-2147|mary.banks@cchmc.org|
21240134|NCT00886262|Medical University of South Carolina|Dr. Scott Reeves|843-792-5699|reevess@musc.edu|
21240135|NCT04038346|University of Pittsburgh Children's Hospital of Pittsburgh|Desiree Neville|412-692-7692|desiree.neville@chp.edu|
21240136|NCT01844193|OrthoIndy|Dr. Frank Kolisek|3178845160|fkolisek@orthoindy.com|
21240137|NCT00786474|Duke University Medical Center|Thomas Ortel, MD, PhD, Principal Investigator|919-684-5350|thomas.ortel@duke.edu|3
21240138|NCT01799720|Universidad Miguel Hernández|Dr. Elena García García|965222025|egarcia@umh.es|2025
21240139|NCT01644396|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21240140|NCT04131959|CytoSorbents|CytoSorbents|732-329-8885|info@cytosorbents.com|
21240141|NCT02228525|Memorial Sloan Kettering Cancer Center|Dr. Eytan Stein, MD|646-608-3749|steine@mskcc.org|
21290772|NCT03253627|New York University Meyers College of Nursing|John Merriman, PhD, RN|212-998-5375|john.merriman@nyu.edu|
21290773|NCT03829683|Virginia Commonwealth University|Arun J Sanyal, MD|804-828-4060|arun.sanyal@vcuhealth.org|
21290774|NCT04710303|Immunitybio|Lennie Sender, Chief Operating Officer|855-797-9277|lennie.sender@immunitybio.com|
21290775|NCT04717479|University of Michigan|Sarah Yon|734-763-0412|shlim@umich.edu|
21290776|NCT03460704|Zambon S.p.A.|Michela Meroni - Clinical Trial Manager|+39 02 665241|clinicaltrials@zambongroup.com|
21290777|NCT01767857|Janssen Research & Development, LLC|Product Development Portfolio Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21290778|NCT02899754|Philadelphia VA Medical Center (CMCVAMC), Philadelphia, PA|Dr. Marilyn M Schapira, Senior Investigator, Center for Health Equity Research & Promotion (CHERP)|215 898 2022|mschap@pennmedicine.upenn.edu|
21290779|NCT04082364|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
21290780|NCT02364271|Chinese University of Hong Kong|Professor Timothy Rainer|00 852 2632 1034|thrainer@cuhk.edu.hk|
21290781|NCT01512251|University of California, San Francisco|Alain Algazi|(415) 353-7552|alain.algazi@ucsf.edu|
21290782|NCT02514746|PATH|Jorge Flores, MD|(202) 822-0033|jeflores@path.org|
21240142|NCT03688711|Zealand Pharma A/S|Dr Kim Mark Knudsen|+4550603780|KMKnudsen@zealandpharma.com|
21240143|NCT01088529|Janssen R&D US|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
21261249|NCT01450540|Philips|Senior Data Scientist|+14125423651||
21240144|NCT03056859|University of New Mexico Anesthesiology Department|Research Officer|505-272-2610|HSC-Anesthesiology@salud.unm.edu|
21240145|NCT04193293|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
21240146|NCT01155661|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21261250|NCT02452359|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
21261251|NCT04884243|Cloudbreak Therapeutics LLC|Dr. Rong Yang|9496798408|rong_yang@cloudbreaktherapeutics.com|
21261252|NCT01887210|Rhode Island Hospital|Dr. Larry Brown|401-793-8808|lkbrown@lifespan.org|
21261253|NCT00840463|UT Southwestern|Kelly Chin|214-645-1825|kelly.chin@utsouthwestern.edu|
21261254|NCT03414359|UAMS|Nadir El Sharawi|5016866114|nelsharawi@uams.edu|
21261255|NCT00770861|Forest Laboratories|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|1-201-427-8259|John.Whalen@frx.com|
21261256|NCT02985801|Mayo Clinic|Dr. Massimo Raimondo|904-953-6982|Raimondo.Massimo@mayo.edu|
21261257|NCT03439345|Nuffield Department of Population Health, University of Oxford|Associate Professor David Preiss|01865 743 743|lens@ndph.ox.ac.uk|
21261258|NCT05405166|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
21261259|NCT01386385|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|jmiao@fredhutch.org|
21290783|NCT04003142|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
21261260|NCT05768789|University of Pittsburgh, UPMC|Harikesh Subramanian, MBBS, MS, D.ABA, ABPM-CI|412-647-9085|subramanianh4@upmc.edu|
21261261|NCT03746080|Stanford University|Lawrence Recht, MD|(650) 725-8630|lrecht@stanford.edu|
21261262|NCT03665155|Memorial Sloan Kettering Cancer Center|Jason Lewis, PhD|314-276-1830|lewisj2@mskcc.org|
21261263|NCT01348919|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21261264|NCT04745832|MEI Pharma|Richard Ghalie, MD CMO|858.898-0956|rghalie@meipharma.om|
21261265|NCT06400238|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21261266|NCT04191668|Ectosense|Frederik Massie|+1 786 305 8547|frederik.massie@ectosense.com|
21261267|NCT03440112|University of Michigan|Stiven Roytman|7349988424|stivenr@med.umich.edu|
21261268|NCT01009463|GlaxoSmithKline|GSK Response Center|866-435-7343||
21261269|NCT03187379|Cleveland Clinic Foundation|Dr. Matthew Kroh|12164457410|krohm@ccf.org|
21261270|NCT04430348|NightHawk Biosciences Inc.|Vice President, Clinical Development|9197948950|info@nighthawkbio.com|
21261271|NCT00728507|Johns Hopkins University|Susan Dorman|410-955-1755|dsusan1@jhmi.edu|
21261272|NCT03451825|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21261273|NCT03839524|TRANSGENE|Director of Medical Affairs|+ 33 3 88 27 91 00|clinical.trials@transgene.fr|
21261274|NCT04902885|Jiangsu Simcere Pharmaceutical Co., Ltd.|Study Director|86-025-85566666|simcere@simcere.com|
21261275|NCT01142323|University of Miami|Dr. Cynthia Levy|305-243-2147|clevy@med.miami.edu|
21261276|NCT04329949|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
21261277|NCT02037919|Family Planning Associates Medical Group , Ltd.|Allison A. Cowett, MD MPH|312-707-8988|aacowett@gmail.com|
21261278|NCT02494141|"University of Colorado Denver | Anschutz"|Kristen Nowak, Ph.D.|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
21261279|NCT00917384|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21261280|NCT01521845|Shaheed Beheshti Medical University|Dr.Jamshid Salamzadeh|00982188662334|j.salamzadeh@yahoo.com|
21261281|NCT03717922|UCLA Psychiatry & Biobehavioral Sciences|Dr. Taylor P. Kuhn, PhD|‭(310) 829-5968‬|tkuhn@mednet.ucla.edu|
21261282|NCT01458340|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
21261283|NCT03126227|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
21261284|NCT02417415|Vanderbilt University Medical Center|Italo Biaggioni|(615) 322-2318|italo.biaggioni@vumc.org|
21261285|NCT01021007|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
21261286|NCT01575548|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21261287|NCT00736229|Saint Luke's Health System|Steven P. Marso, MD|816-932-5773|smarso@saint-lukes.org|
21261288|NCT00693706|GlaxoSmithKline|GSK Response Center|866-435-7343||
21261289|NCT02095561|INSTITUTO NACIONAL DEL CÁNCER, ARGENTINA|Silvina Arrossi, Phd|541152390562|silviarrossi2020@gmail.com|
21261290|NCT04871815|Emphycorp/Cellular Sciences, inc.|Dr. Alain Martin|9082371561|dr.martin@erols.com|
21261291|NCT00730236|Aegerion Pharmaceuticals|Mark Sumeray, MD, Chief Medical Officer|617-500-7867|msumeray@aegerion.com|
21261292|NCT00462423|Northern California Medical Center|Lynn E. Spitler, MD|415-435-9861|lynn@drspitler.com|
21261293|NCT00465569|Johns Hopkins University|Robert A. Wood, MD|410-955-5883|rwood@jhmi.edu|
21261294|NCT02388776|Weill Cornell Medicine|Christine Lennon, M.D.|212-746-2621|chl9083@med.cornell.edu|
21261295|NCT03826914|University of Manitoba|Dr. Semone Myrie|(204) 474-7290|semone.myrie@umanitoba.ca|
21261296|NCT00843180|UCSF|Dr. Wolf Mehling, MD|415-353 9506|mehlingw@ocim.ucsf.edu|
21261297|NCT00104871|UT MD Anderson Cancer Center|Steven Sherman, MD / Professor|713-792-2841|sisherma@mdanderson.org|
21261298|NCT05036785|Royal Devon and Exeter NHS Trust|Dr Ellen Richards|01392 411611|ellen.richards6@nhs.net|
21261299|NCT00519532|UCB|UCB Clinical Trial Call Center|+18778229493||
21290784|NCT03657407|University of Maryland Medical Center|Anna Reinert, MD|6029089960|anna.reinert@gmail.com|
21290785|NCT03973489|VA Portland Health Care System|William Hoffman|503-220-8262|hoffmanw@ohsu.edu|56491
21261300|NCT03429075|Imperial College London|Dr Robin Carhart-Harris|02075947992|r.carhart-harris@imperial.ac.uk|
21240147|NCT01263106|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21261301|NCT00484354|Wake Forest School of Medicine|Michael Rocco, MD|3367164650|mrocco@wakehealth.edu|
21261302|NCT02932267|Galderma|Rajeev Chavda|0033|rajeev.chavda@galderma.com|492382928
21261303|NCT04090164|Mansoura University|Osama Hussein|00201099815110|osamahussein@mans.edu.eg|
21261304|NCT02625402|Massachusetts General Hospital|Karen Sepucha|6177243350|ksepucha@partners.org|
21233648|NCT00352846|The University of Texas (UT) MD Anderson Cancer Center|Fredrick Hagemeister, MD/Professor||psanjorjo@mdanderson.org|
21233649|NCT01527682|ASST Spedali Civili di Brescia|Prof. Luciano Quaranta|+39 030 3995|luciano.quaranta@unibs.it|847
21233650|NCT01531387|St. Jude Children's Research Hospital|James M. Boyett, PhD|901-595-4986|james.boyett@stjude.org|
21233651|NCT02586896|NYU School of Medicine|Michael Bogenschutz|646-501-4026|michael.bogenschutz@nyulangone.org|
21233652|NCT00600938|Novartis Pharnaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21233653|NCT04220411|Arjil Pharmaceuticals LLC.|YEH B, WU|+886-3-573-3608|ybw333@arjilbio.com|
21233654|NCT02680639|Philips|Senior Clinical Development Scientist|(724) 733-5835|chuck.cain@philips.com|
21233655|NCT02678676|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21233656|NCT04646499|University of California San Francisco|Dr. Theodore Zanto|415-502-7322|theodore.zanto@ucsf.edu|
21233657|NCT00302133|University of Miami Miller School of Medicine|Ihsan Salloum, MD, MPH|305 243-7931|isalloum@med.miami.edu|
21233658|NCT02753699|Debiopharm International, S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
21233659|NCT01412866|DArtmouth-Hitchcock|Mary F. Brunette|603-27105747|mary.f.brunette@dartmouth.edu|
21233660|NCT00128921|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|pettynathanm@uams.edu|2461
21233661|NCT02496533|Midwestern Regional Medical Center, Inc.|Jessica Kapustin, RN-C||Jessica.Kapustin@CTCA-Hope.com|
21233662|NCT05756790|University of California San Francisco|Dr. Amy Conroy|303-522-9439|amy.conroy@ucsf.edu|
21233663|NCT00610532|The Ohio State University|Dr. Jim McAuley|614-292-9713|mcauley.5@osu.edu|
21233664|NCT02327429|University of Alberta|Catherine Chan|780-492-9939|cbchan@ualberta.ca|
21233665|NCT03256552|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
21233666|NCT01713868|Boston University|Michael Corwin, MD||mjcorwin@bu.edu|
21233667|NCT02268409|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21233668|NCT00427635|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21233669|NCT02376946|TuftsU|Dr. Archana Viswanath|617-636-3578|Archana.Viswanath@tufts.edu|
21233670|NCT00838201|Amgen Inc.|Study Director|866-572-6436||
21233671|NCT00489853|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21233672|NCT05083442|Mayo Clinic Rochester|Dr. Ivana Croghan|507 284-2511|gimresearchstudies@mayo.edu|
21233673|NCT03878316|National Institute on Alcohol Abuse and Alcoholism|Dr. Daniel Falk|301-443-0788|falkde@mail.nih.gov|
21233674|NCT03961100|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21233675|NCT03873987|Melinta Therapeutics, Inc.|Vice President Clinical Operations|9086171319|kfusaro@melinta.com|
21233676|NCT00004888|Eastern Cooperative Oncology Group Statistical Office|Study Statistician|617-632-3012||
21233677|NCT00136084|St. Jude Children's Research Hospital|Jeffrey Rubnitz, M.D|1-866-278-5833|info@stjude.org|
21233678|NCT02579265|Fresenius Kabi Deutschland GmbH|Dr. Jean-Marc Lohse, Director Clinical Operations PN NAM & ELAMA|+49 6172 686|Jean-Marc.Lohse@fresenius-kabi.com|4911
21233679|NCT02174848|Chiesi Canada Corp.|Fernando Tricta, MD|416--558-6342|f.tricta@chiesi.com|
21233680|NCT02229318|The Children's Hospital of Philadelphia|Dr Christina Bergqvist, M.D., Study Principal Investigator|+1 215 590 1719|Bergqvist@Email.CHoP.Edu|
21233681|NCT02520011|Sumitomo Dainippon Pharma Oncology, Inc.|Susan Smith|+1-210-414-7702|Susan.smith@sdponcology.com|
21233682|NCT00644969|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21233683|NCT02449239|Sesen Bio, Inc.|Dr. Rachelle Dillon|204-296-6579|rachelle.dillon@sesenbio.com|
21233684|NCT03239470|DAIT/NIAID|Director, Clinical Research Operations Program|240-669-5064|DAITClinicalTrialsGov@niaid.nih.gov|
21233685|NCT01023581|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21233686|NCT03856437|University of Maryland, College Park|Xiaoli Nan|301-405-0640|nan@umd.edu|
21233687|NCT01176292|Anderson Orthopaedic Research Institute|Dr. William Hamilton|703-619-4411|research@aori.org|
21233688|NCT00997503|Boston Scientific Corporation|Peter Maurer, Director of Clinical Trials|1-508-683-6678|Peter.Maurer@bsci.com|
21233689|NCT00380393|GlaxoSmithKline|GSK Response Center|866-435-7343||
21233690|NCT01933048|Uniformed Services University of the Health Sciences|Eugene V. Millar, PhD|301-816-8451|emillar@idcrp.org|
21233691|NCT02780804|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21233692|NCT02476968|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21233693|NCT04896658|University of Maryland, Baltimore|Ashraf Badros, MD|410-328-1230|abadros@umm.edu|
21233694|NCT00076687|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21233695|NCT00826800|Memorial Sloan Kettering Cancer Center|Dr. Leonard Saltz|646-888-4286|saltzl@mskcc.org|
21233696|NCT03897179|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
21233697|NCT03167879|RAND Corporation|Dr. Glenn Wagner|310-393-0411|gwagner@rand.org|7698
21233698|NCT01085097|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21233699|NCT03615807|Balgrist University Hospital|Professor Ilker UCKAY|+41 44 386 37 05|ilker.uckay@balgrist.ch|
21233700|NCT01737047|Imperial College London|Alan Winston|02033121603|a.winston@imperial.ac.uk|1603
21233701|NCT06049043|KDHRC|Andrew Simkus, Research Analyst|7046073567|asimkus@kdhrc.com|
21233702|NCT03089606|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat G. Canter MD MS ACRP-CP, Clinical Trial Analyst|(919) 962-0000|Melahat_Canter@med.unc.edu|
21233703|NCT00335972|Cleveland Clinic|Rafi Avitsian, M.D|(216)-444-9735|avitsir@ccf.org|
21233704|NCT00922883|NHLBI|Cynthia E Dunbar|301-496-5093|dunbarc@nhlbi.nih.gov|
21290786|NCT03247673|Celltrion|Clinical Planning Department Leader|82328505000|contact@celltrion.com|
21290787|NCT00622843|Infectious Disease Clinical Research Program, Uniformed Services University and HJF|Dr. Brian Agan, Deputy Science Director|240-694-2946|bagan@idcrp.org|
21290788|NCT04754399|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
21290789|NCT01691313|Laguna Pharmaceuticals, Inc.|Howard C. Dittrich|858-405-1429|HDittrich@lagunarx.com|
21290790|NCT03109769|Riyadh Colleges of Dentistry and Pharmacy|Omar Alkadhi|966505154754|omar.alkadhi@riyadh.edu.sa|
21290791|NCT04105725|Medical University of South Carolina|Dr. Kathryn Gex|(843) 876-2084|soltisk@musc.edu|
21290792|NCT00912873|University California San Diego|Brian Ilfeld, MD, MS|(858) 822-0776|bilfeld@health.ucsd.edu|
21290793|NCT04691492|University at Buffalo|Jennifer Read, PhD.|(716) 645-0193|jpread@buffalo.edu|
21290794|NCT02691494|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21290795|NCT02916433|Western Connecticut Health Network|Joann Petrini|203-739-6882|Joann.Petrini@wchn.org|
21290796|NCT01941628|Dept. of Anaesthesiology and Intensive Medicine, General University Hospital in Prague|Assoc. Prof. Jan Blaha, MD, PhD|+420 224962243|jan.blaha@lf1.cuni.cz|
21290797|NCT01426555|VA Boston Healthcare System|Dr. Antonio Lazzari|857-364-6381|antonio.lazzari@va.gov|
21290798|NCT04616196|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
21290799|NCT02943499|Brown University|Dr. Judson Brewer|401-863-2826|judson_brewer@brown.edu|
21290800|NCT01904279|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21290801|NCT00839930|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21290802|NCT02500836|STATKING Clinical Services|Lori Christman, PhD|513-858-2989|lori@statkingclinical.com|317
21290803|NCT02267447|Ottawa Hospital Research Institute|Dr. Doug Manuel|613-798-5555|dmanuel@ohri.ca|19108
21290804|NCT03283241|AddBio AB|Ulf Sewerin, CEO|+46708797988|ulf.sewerin@addbio.se|
21290805|NCT02439957|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
21290806|NCT00586157|Massachusetts General Hospital|Timothy Wilens, MD|617-726-1731|twilens@partners.org|
21233705|NCT00369512|University of Alabama at Birmingham|Eben Rosenthal, MD Department of Surgery Department|(205) 934-9714|erosenthal@uabmc.edu|
21233706|NCT02140567|Imperial College Healthcare NHS Trust in London, United Kingdom|Dr. Phang Boon Lim|+44|p.b.lim@imperial.ac.uk|(0)20 3313
21233707|NCT01209442|University of Colorado|Douglas Ney, M.D.|303-724-2184|Douglas.Ney@ucdenver.edu|
21233708|NCT02802592|Johns Hopkins University School of Medicine|Dr. Kenneth Horvath|301-896-3100||
21233709|NCT02882854|Vanderbilt University Medical Center|Stephen Harvey, MD|(615) 936-3198|stephen.harvey@vumc.org|
21233710|NCT00788892|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency|215-832-3750||
21233711|NCT01358357|Sunovion Pharmaceuticlas Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
21233712|NCT01826487|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
21233713|NCT00729183|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21233714|NCT02742987|Campus Bio-Medico University|Dr. Fabio Mangiacapra|003906225411612|f.mangiacapra@unicampus.it|
21233715|NCT01359254|The University of Chicago Medicine|Andrew Artz, MD, MS|(773) 834-8980|aartz@medicine.bsd.uchicago.edu|
21233716|NCT01308450|BioBDx|Calvin R. Sumner, MD, CMO, Sr. VP for Clinical Development|978-431-5103|calvin_sumner@biobdx.com|
21233717|NCT00699556|Yale University|Sherry McKee|(203) 737-3529|sherry.mckee@yale.edu|
21233718|NCT01457885|University of Michigan Comprehensive Cancer Center|Dr. John Magenau, M.D.|734-936-8785|johnmage@umich.edu|
21233719|NCT04668950|Washington University in St. Louis|Dr. Eric Lenze|314-362-5154|lenzee@wustl.edu|
21233720|NCT04993287|NorthShore University HealthSystem|Dr. Nirav Shah|847-657-5959|nshah2@northshore.org|
21233721|NCT01124643|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21233722|NCT02028988|Dana-Farber Cancer Institute|Glenn Bubley MD|617-735-2062|gbubley@bidmc.harvard.edu|
21233723|NCT02803307|Taiwan Liposome Company|Dr. Carl Brown|886-2-2655-7377|carlb@tlcbio.com|
21233724|NCT01342510|University of Wisconsin School of Medicine and Public Health, Department of Anesthesiology|Kristopher Schroeder, MD|608-263-8100|kmschro1@wisc.edu|
21233725|NCT00323115|Dartmouth-Hitchcock Medical Center|Dr. Camilo Fadul|603-653-6312|camilo.e.fadul@hitchcock.org|
21233726|NCT04365556|Cincinnati Children's Hospital Medical Center|Rachelle Ramsey|513-803-0415|rachelle.ramsey@cchmc.org|
21233727|NCT04439318|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21233728|NCT02558790|Massachusetts General Hospital|Craig Surman, MD|617-726-8422|csurman@partners.org|
21233729|NCT01554891|Geisel School of Medicine at Dartmouth|Laura A. Flashman, Ph.D.|6036505824|flashman@dartmouth.edu|
21233730|NCT04476030|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21233731|NCT02042924|Masonic Cancer Center, University of Minnesota|Dr. Susanta Hui|626-218-0556|shui@coh.org|
21233732|NCT01536496|Denver Health Medical Center|Ernest E. Moore|303.602.1817|Ernest.Moore@dhha.org|
21233733|NCT00526058|B. Braun Medical Inc.|Kevin Minnich, Manager Clinical Affairs/Safety Officer|610-596-2358|kevin.minnich@bbraun.com|
21261305|NCT01200433|Clevland Clinic Foundation|Ehab Farag, MD|216-444-9950|farage@ccf.org|
21290807|NCT00062764|National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health|Jay H. Hoofnagle, MD|3014961333|hoofnaglej@extra.niddk.nih.gov|
21290808|NCT01225952|Bausch & Lomb Incorporated|Omid Khodai, OD,RAC|(949) 521-7894|omid.khodai@bausch.com|
21290809|NCT00831389|Medtronic Diabetes|Harry Clark|818-576-5653|bud.clark@medtronic.com|
21290810|NCT01377402|Stavanger University Hospital|Dennis WT Nilsen, MD, phd, professor|+4795777735|dnilsen1@getmail.no|
21290811|NCT00278161|Johns Hopkins University|Lode Swinnen, MD|4106146398|lswinne1@jhmi.edu|
21290812|NCT01817777|GlaxoSmithKline|GSK Response Center|866-435-7343||
21290813|NCT01935947|Johns Hopkins University|Gary Rosner|410-955-4884|grosner1@jhmi.edu|
21290814|NCT00692237|Sapienza University of Rome|Dr Andrea Isidori|+39 0649970540|andrea.isidori@uniroma1.it|
21290815|NCT00752219|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21290816|NCT05898178|Maribor University Medical Centr|Borut Kovačič||Borut.KOVACIC@ukc-mb.si|0038631211
21261306|NCT02043574|South Texas Veterans Health Care System|Monica Serra|210-617-5300|monica.serra@va.gov|15313
21290817|NCT01683812|Boston Children's Hospital|Michele DeGrazia PhD, RN, NNP-BC, FAAN|617-919-1222|Michele.DeGrazia@childrens.harvard.edu|
21290818|NCT04889950|Novoxel Ltd|Ifat Klein|972-6009860|ifat@novoxel.com|
21290819|NCT05702047|Florida State University|Director, Cardiovascular and Applied Physiology Laboratory|8506441828|jwatso@fsu.edu|
21290820|NCT02360085|Toronto Western Hospital/UHN|Emad Al Azazi|416-603-8500|emad.alazazi@uhnresearch.ca|6237
21290821|NCT02758626|NYU Langone Health, Comprehensive Epilepsy Center|Orrin Devinsky, MD|6465580803|Orrin.Devinsky@nyulangone.org|
21290822|NCT02732145|Ginekološka poliklinika Dr. Vesna Harni|Dr. Vesna Harni|0038512923648|vesnaharni@gmail.com|
21290823|NCT04103814|Rush University Medical cEnter|Dr E Bailey Terhune|8018249805|bailey.terhune@rushortho.com|
21290824|NCT03876808|University of Missouri - Columbia|Dr. Boris Mraovic, Professor of Clinical Anesthesiology|573-882-2568|mraovicb@health.missouri.edu|
21290825|NCT00456365|PKD Research Group, University of Colorado Anschutz Medical Campus|Melissa Cadnapaphornchai, MD|3037241690|pkd@ucdenver.edu|
21290826|NCT00967486|Vascular center of excellence (CAMC medical staff-with admitting privileges)|Ali Fawazi AbuRahma MD|304-388-9973||
21290827|NCT01469156|Southeast Retina Center|Dr. Dennis Marcus|706-650-0061|dmarcus@southeastretina.com|
21290828|NCT01813227|Hackensack Meridian Health|Joshua Zenreich|5519964248|joshua.zenreich@hmhn.org|
21290829|NCT00803049|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21290830|NCT04126174|Gainesville Eye Associates|Clayton Blehm, MD|7705324444|claytonblehm@gmail.com|
21290831|NCT05181085|NorthSea Therapeutics BV|Michelle Yokley|31 035760 65 05|info@northseatherapeutics.com|
21290832|NCT01272219|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21290833|NCT03131479|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21290834|NCT05305651|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21290835|NCT00214526|Boston Scientific Corporation|Mark G. Grubb|412-749-1423|Mark.Grubb@bsci.com|
21290836|NCT01491919|Duke Clinical Research Institute|Uptal Patel, MD|919-668-4601|uptal.patel@duke.edu|
21290837|NCT02100826|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21290838|NCT00967499|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
21290839|NCT04003389|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|8008887704|astellas.resultsdisclosure@astellas.com|
21290840|NCT04818229|Connect Biopharma|Dr. Chin Lee, MD Chief Medial Officer|+1 650 676 9617|clee@connectpharm.com|
21290841|NCT03186378|Verrica Pharmaceuticals|Susan Cutler, VP, Medical Affairs|484-773-0898|scutler@verrica.com|
21290842|NCT03769116|Sarepta Therapeutics, Inc.|Medical Director|888-727-3782|SareptAlly@sarepta.com|
21290843|NCT03382873|Indiana University|Dr. Carla Miller (current affiliation)|812-855-1608|ckm1@iu.edu|
21290844|NCT00890656|The University of Texas M. D. Anderson Cancer Center|Stefan Fader, M.D./Associate Professor|713/745-4613|eharriso@mdanderson.org|
21290845|NCT05021224|University of Pennsylvania|Dr. Courtney Wolk|215-746-6099|courtney.wolk@pennmedicine.upenn.edu|
21290846|NCT03996395|Baylor College of Medicine|Nancy E. Moran, PhD|713-798-0520|nancy.moran@bcm.edu|
21290847|NCT01924065|Akdeniz Sifa Konyaalti Medical Center|Mehmet Ozaydin|905533354243|mehmetozaydin@hotmail.com|
21290848|NCT03213405|Pontificia Universidad Católica de Chile|Dr. Alexis Kalergis|+56223541924|akalergis@bio.puc.cl|
21290849|NCT05375929|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21290850|NCT03301415|The University of Alabama at Birmingham|David W. Kimberlin, MD|205-934-5316|dkimberlin@peds.uab.edu|
21290851|NCT00392288|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21290852|NCT01444924|University of Wisconsin Hospitals and Clinics|Dr. David Kushner|608-263-0796|dmkushner@facstaff.wisc.edu|
21290853|NCT04755231|Alcon Research, LLC|Director, Clinical Projects, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21290854|NCT02069184|Montefiore Medical Center|Jeffrey Bernstein|718-920-4317|JBernste@montefiore.org|
21290855|NCT00025233|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
21290856|NCT01720602|University of Washington|Hannah Linden, MD|206-288-6989|hmlinden@u.washington.edu|
21290857|NCT02184442|Edwards Life Sciences|Tenley Koepnick|949-250-6504|Tenley_Koepnick@Edwards.com|
21290858|NCT00787800|Mayo Clinic|Paul A. Friedman, MD, Professor of Medicine|507-284-7661|friedman.paul@mayo.edu|
21290859|NCT00966446|Perelman School of Medicine, University of Pennsylvania|Ebbing Lautenbach, MD, MPH, MSCE|215-898-6977|ebbing@mail.med.upenn.edu|
21290860|NCT00507507|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21290861|NCT03878069|Chiesi Canada Corp.|Anna Rozova, MD, Clinical Program Leader|1-800-854-3534|a.rozova@chiesi.com|7038
21290862|NCT01258985|Tufts Medical Center|chenchen wang|617-636-3251|cwang2@tuftsmedicalcenter.org|
21240148|NCT03662360|Clinica Luganese Moncucco|Dr. Med. Pio Fontana|0041919608712|pioeugenio.fontana@moncucco.ch|
21240149|NCT00715741|University of Utah|Harriet Hopf, MD|801-205-1013|Harriet.Hopf@hsc.utah.edu|
21240150|NCT01356667|UCLA, Integrated Substance Abuse Programs|Dr. Daniel Dickerson|562-277-0310|daniel.dickerson@ucla.edu|
21240151|NCT01468532|Barbara Ann Karmanos Cancer Institute|Ulka N. Vaishampayan|313-576-8718|vaishamu@karmanos.org|
21240152|NCT03169881|University of Utah|Robin K Ohls, MD|801-581-7052|robin.ohls@hsc.utah.edu|
21240153|NCT03936777|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21240154|NCT02301156|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
21240155|NCT02638623|West Virginia University Department of Orthopaedics|Matthew J. Dietz, MD|304-285-7445|mdietz@hsc.wvu.edu|
21240156|NCT06536465|Recursion Pharmaceuticals, Inc.|Recursion Pharmaceuticals|385-374-1724|clinicaltrials@recursionpharma.com|
21240157|NCT03797326|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21240158|NCT03012061|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21240159|NCT01741454|University of Wisconsin School of Medicine & Public Health|Shuang Li (Linda)|608.263.8336|lis@urology.wisc.edu|
21240160|NCT03599986|DataClin|Medical Writer|(+2) 01001566602|mariam.abdalla@dataclin.com|
21240161|NCT01744860|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21240162|NCT02401308|St. Joseph's Hospital and Medical Center|Lisa Arnold - Operations Manager Neurosurgery Clinical Research|602-406-9593|lisa.arnold@dignityhealth.org|
21240163|NCT02578914|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
21240164|NCT00147225|University of Texas MD Anderson Cancer Center|Dr. Saroj Vadhan-Raj|713-792-7966|svadhanr@mdanderson.org|
21240165|NCT01032044|Mayo Clinic, Jacksonville, Florida, USA|Dr Michael B. Wallace|904 953-7630|wallace.michael@mayo.edu|
21240166|NCT02998021|University of Pittsburgh|Alicia Koontz, PhD|4128223700|akoontz@pitt.edu|
21240167|NCT02961374|Cancer Prevention Network (CPN) - Mayo Clinic College of Medicine|Paul J. Limburg, M.D., M.P.H.|507-284-2511|limburg.paul@mayo.edu|
21240168|NCT01439087|Massachusetts General Hospital|Gary Tearney, MD, PhD|617-724-2979|GTEARNEY@PARTNERS.ORG|
21240169|NCT03390036|Anika|Carol Pekar, VP Clinical Affairs|781-457-9218|cpekar@anikatherapeutics.com|
21240170|NCT01984424|Amgen Inc.|Study Director|866-572-6436||
21240171|NCT01807221|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21240172|NCT00373295|New York State Psychiatric Institute|Dr. Margaret Haney|646-774-6129|reslabsurc@gmail.com|
21240173|NCT04267614|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21240174|NCT02707523|UAB|Dr. Michele Kong, PI|205-6389387|mkong@peds.uab.edu|
21240175|NCT00988351|Malcom Randall VA|Dr. Richard B. Berry|3522621575|Richard.Berry@medicine.ufl.edu|
21240176|NCT01597388|AstraZeneca|Julie Charlton|+ 01625-582828|ClinicalTrialTransparancy@astrazeneca.com|
21240177|NCT04396535|Mayo Clinic|Dr. Konstantinos Leventakos|507-284-2511|leventakos.konstantinos@mayo.edu|
21240178|NCT02303626|BioCryst Pharmaceuticals, Inc|VP Clinical Development|(+1) 919 859 1302|clinicaltrials@biocryst.com|
21240179|NCT05832437|Columbia University School of Nursing|Maureen George|212-305-1175|mg3656@cumc.columbia.edu|
21240180|NCT05376371|University or Wisconsin-Madison|Ryan Westergaard|6082657927|rpw@medicine.wisc.edu|
21240181|NCT04159415|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21240182|NCT05407311|Clarity Pharmaceuticals|Dr. Othon Gervasio, Chief Medical Officer|+61 (0)2 9209 4037|info@claritypharmaceuticals.com|
21240183|NCT02400437|Dana-Farber Cancer Institute|Jorge Castillo|617-632-2681|jorgej_castillo@dfci.harvard.edu|
21240184|NCT00337662|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21240185|NCT02088632|Jefferson Headache Center|Clinical research manager|2159552680|mary.hopkins@jefferson.edu|
21240186|NCT01265823|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21240187|NCT03777865|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21240188|NCT04694482|ASST Monza|Dr. Alice Caldiroli|+3495009941|a.caldiroli@asst-monza.it|
21240189|NCT05525286|SOTIO Biotech a.s.|Richard Kapsa|(+420) 2241 74448|kapsa@sotio.com|
21240190|NCT00960752|UT MD Anderson Cancer Center|Michael Davis, PHD., Chair, Melanoma Medical Oncology|713-792-3454|mdavies@mdanderson.org|
21240191|NCT05259774|Relife Srl|Lia Fabbri|05556809528|lfabbri@relifecompany.it|
21240192|NCT05027074|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21240193|NCT04195880|Providence VAMC|Vincent Mor, Principal Investigator|4012737100|vincent_mor@brown.edu|6259
21240194|NCT01811940|NYSPI|Frances R. Levin, M.D.|646-774-6137|Frances.levin@nyspi.columbia.edu|
21240195|NCT03734991|SCYNEXIS|Dr. David Angulo|(201) 884-5471|david.angulo@scynexis.com|
21240196|NCT00735449|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
21240197|NCT02322814|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21240198|NCT01164228|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21240199|NCT04908449|Medical College of Wisconsin|Dr. Anne L. Castro|(414) 805-8700|anncastro@mcw.edu|
21240200|NCT04536571|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
21240201|NCT01567865|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
21261307|NCT00662155|University of Pennsylvania|Michael Perlis|(215) 746-3577|mperlis@upenn.edu|
21261308|NCT00957372|Bial - Portela & Cª, S.A.|Head of Clinical Research Section|+ 351 22 986 61 00|clinical.trials@bial.com|
21279289|NCT03774407|Texas Tech|Dr Mirla Avila|8322448072|mirla.avila@ttuhsc.edu|
21240202|NCT05256381|SOTIO Biotech a.s.|Richard Kapsa|(+420) 2241 74448|kapsa@sotio.com|
21240203|NCT05569954|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21290863|NCT06790303|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21290864|NCT03413995|Johns Hopkins University|Mark Markowski, MD|410-614-0567|mmarko12@jhmi.edu|
21290865|NCT05796245|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21290866|NCT03026777|LSUHSC New Orleans|Dr. David Janz|504-913-5006|djanz@lsuhsc.edu|
21290867|NCT02579759|Pharnext|Susanne Dorn|+33 (0)1 41 09 22 30|contact@pharnext.com|
21290868|NCT04622267|Icahn School of Medicine at Mount Sinai|Nicola Tavella|212-241-3888|nicola.tavella@mssm.edu|
21290869|NCT00833703|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi-aventis.com|
21290870|NCT03895476|University of Alabama at Birmingham|Hussein Basma, DDS, MS|2059344506|basma86@uab.edu|
21290871|NCT00353119|Innovaderm Research Inc|Annie Levesque|514-521-4285|alevesque@innovaderm.ca|222
21290872|NCT02310269|Recordati AG|Mario Maldonado|+41798030344|maldonado.m@recordati.com|
21290873|NCT01356940|MS Center at Evergreenhealth|Theodore R. Brown, MD|425-899-5350|trbrown@evergreenhealth.com|
21290874|NCT02971839|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21290875|NCT03412591|Penn State College of Medicine|Dr. Scott Bunce|2155108295|sbunce@pennstatehealth.psu.edu|
21290876|NCT02272985|University Medical Center Groningen|Dr. C.F.M. Franssen|+0031(0)50 3616161|c.f.m.franssen@umcg.nl|
21290877|NCT00685295|Harvard/MGH|Stephen Thomas|6177267622|sthomasmd@gmail.com|
21290878|NCT00505687|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
21290879|NCT01382108|Centre for Contact Lens Research|Kathy Dumbleton|519-888-4567|kdumble@uwaterloo.ca|32694
21290880|NCT00666263|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21290881|NCT03242434|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21290882|NCT00414609|Novartis Pharmaceuticals|Study Director|862-778-8300||
21290883|NCT00266032|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21290884|NCT03318393|UT Southwestern Medical Center|Lakshmi Raman|214-456-6222|lakshmi.raman@utsw.edu|
21240204|NCT04885530|Duke University|Susanna Naggie, MD, MHS, FIDSA|919-684-2584|susanna.naggie@duke.edu|
21240205|NCT01518946|Shire|Study Director|+1 866-842-5335|ClinicalTransparency@shire.com|
21261309|NCT04278573|Mayo Clinic|Dr. Stephen P. Merry|507-284-5180|merry.stephen@mayo.edu|
21290885|NCT00814983|Duke University Medical Center|Mitchell Horwitz, MD|919-668-1045|Mitchell.Horwitz@duke.edu|
21233734|NCT04920123|University of Massachusetts Amherst|Juhyeon Lee|413-404-4732|juhyeonlee@cs.umass.edu|
21233735|NCT02984384|University of Maryland School of Medicine|Robert O'Toole|410-328-6280|rotoole@som.umaryland.edu|
21233736|NCT01117727|University of Michigan|Jane Huggins|734-936-7177|janeh@umich.edu|
21233737|NCT00278954|Bio Products Laboratory|Margaret Stratford Bobbitt|+44 20 8258 2288|Margaret.Stratford-Bobbitt@bpl.co.uk|
21233738|NCT02098161|The University of Texas MD Anderson Cancer Center|Naveen Pemmaraju MD/ Associate Professor|713-792-4956|NPemmaraju@mdanderson.org|
21233739|NCT03760796|Johns Hopkins University School of Medicine|Dr. Seth Martin|(610) 331 - 3842|smart100@jhmi.edu|
21233740|NCT02211131|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21233741|NCT05664490|University of California, San Francisco|Dr. Jennifer Velloza|9173923561|Jennifer.Velloza@ucsf.edu|
21233742|NCT02269280|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Mnaero|713-745-3428|ggarciam@mdanderson.org|
21233743|NCT01589445|Ministry of Science and Technology, Government of the People's Republic of Bangladesh|Dr. Masuma Parvin|88 01819141258|acmasuma@gmail.com|
21233744|NCT01990495|VA Palo Alto Health Care System|Dr. Jonathan Myers|6504503440|Drj993@aol.com|
21233745|NCT03412084|University of Wisconsin - Madison|Dr. Kelli F Koltyn|608-263-6746|kelli.koltyn@wisc.edu|
21233746|NCT01420289|Calvary Hospital|Oscar M. Alvarez PhD, Director Center for Curative and Palliative Wound Care|718-518-2577|oalvarez@calvaryhospital.org|
21233747|NCT03869450|Q-Med AB|Clinical Project Manager|+4618 474 9000|reception.seupp@galderma.com|
21233748|NCT01928862|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21233749|NCT01478321|Northwestern University|Karan Dixit, MD|312-695-1301|karan.dixit@northwestern.edu|
21233750|NCT00703885|UCSD|Murray B. Stein MD, MPH|858-534-6451|mstein@ucsd.edu|
21233751|NCT01100242|University of New Mexico|Richard Lauer, MD|5052725837|rlauer@salud.unm.edu|
21233752|NCT00181207|Johns Hopkins University|Gregory Diette|410-955-3497|gdiette@jhmi.edu|
21233753|NCT00314574|Hoffman-LaRoche|Medical Communications|800-821-8590||
21233754|NCT02418195|University of Alabama at Birmingham|Samantha White/ Clinical Trials Manager|12059349189|swwhite@uabmc.edu|
21233755|NCT02053753|Amgen Inc.|Study Director|866-572-6436||
21233756|NCT00449956|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21233757|NCT02882321|The University of Texas MD Anderson Cancer Center|Marina Konopleva MD./Professor|713-794-1628|mkonople@mdanderson.org|
21233758|NCT01565330|Avid Radiopharmaceuticals|Chief Medical Officer|215-290-0700|clinicaloperations@avidrp.com|
21233759|NCT02972632|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21233760|NCT01828034|Memorial Sloan Kettering Cancer Center|Dr. Ghassan Abou-Alfa, MD|646-888-4184|abou-alg@mskcc.org|
21233761|NCT02023151|Johns Hopkins University|Sarbjit Saini|4105502191|ssaini@jhmi.edu|
21233762|NCT04064294|Portland VA Health Care System|Dr. Kathryn Chung|(503) 721 -1091|Kathryn.Chung@va.gov|
21233763|NCT03450707|BIDMC|Dr. Michael Donnino|6177542882|mdonnino@bidmc.harvard.edu|
21233764|NCT01988571|Wake Forest NCI Community Oncology Research Program Research Base|Lead Biostatistician|336-716-0891|NCORP@wakehealth.edu|
21233765|NCT02719158|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
21233766|NCT00481195|Cephalon, Inc.|Medical Monitor|1-800-896-5855||
21233767|NCT03137693|Moffitt Cancer Center|Michael Montejo, MD|813-745-8424|Michael.Montejo@moffitt.org|
21233768|NCT01451775|boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21290886|NCT01229111|Case Comprehensive Cancer Center|Dr. Smitha Krishnamurthi|216-844-5234|smitha.krishnamurhti@uhhospitals.org|
21290887|NCT04102514|University of Kansas Medical Center|Lauren Ptomey|913-588-7983|lptomey@kumc.edu|
21240206|NCT03857841|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
21240207|NCT04635059|Medical College of Wisconsin|Deepak Kilari, MD|414-805-4600|dkilari@mcw.edu|
21240208|NCT04386746|Johns Hopkins Sidney Kimmel Comprehensive Cancer Center|Max Kates, MD|4105028130|mkates@jhmi.edu|
21240209|NCT04435795|Research Institute of the McGill University Health Center|Dr Nicole EZER|514-934-1934|nicole.ezer@mcgill.ca|76192
21240210|NCT01625910|University of Minnesota, Department of Family Medicine and Community Health|Steven D. Stovitz, MD, MS|612-310-2344|sstovitz@umphysicians.umn.edu|
21240211|NCT02391038|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21240212|NCT02959138|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21240213|NCT02873286|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
21240214|NCT01327547|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21240215|NCT00329719|Mayo Clinic|Kurt A. Jaeckle, M.D.|5072842511|jaeckle.kurt@mayo.edu|
21240216|NCT01086605|Mayo Clinic|Alvaro Moreno-Asptia, M.D.|507/284-1159|morenoaspitia.alvaro@mayo.edu|
21240217|NCT02240589|Indiana University School of Medicine|Flora Hammond, MD|317-329-2106|flora.hammond@rhin.com|
21240218|NCT01681368|National Cancer Institute|Dr. Christina Annunziata|301-402-7189|annunzic@mail.nih.gov|
21240219|NCT01026909|Seattle Children's Hospital|Dr Klane White|206-987-5678|klane.white@seattlechildrens.org|
21261310|NCT01444391|Acclarent|Director Clinical|650-687-5888|lenglan1@its.jnj.com|
21261311|NCT00630032|Unicancer|Deputy Director R&D|(+33)1 44 23 04 19|b-juzyna@unicancer.fr|
21261312|NCT02332915|University of Utah|Julie Wambaugh|8015846164|julie.wambaugh@health.utah.edu|
21261313|NCT01901328|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
21261314|NCT02462889|Ophthalmic Consultants of Boston|Jeffrey S. Heier, MD|617-314-2694|jsheier@eyeboston.com|
21261315|NCT01497171|Mayo Clinic|Dr. Emanuel C. Trabuco|507-284-7519|trabuco.emanuel@mayo.edu|
21261316|NCT03232073|Actelion Pharmaceuticals Ltd|Associate Director Clinical Sciences Neuro|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21261317|NCT02032875|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21261318|NCT04060277|City of Hope Medical Center|Dr. Ryotaro Nakamura|6263598111|rnakamura@coh.org|
21261319|NCT01093612|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
21261320|NCT03191786|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21261321|NCT05847881|Back & Pain Center Clinical Research|Afton L. Hassett, PsyD|734-763-5226|afton@med.umich.edu|
21261322|NCT00430781|GlaxoSmithKline|GSK Response Center|866-435-7343||
21261323|NCT05408858|Massey University|Dr. Ilana Seager van Dyk|+64 4 979 3625|i.seagervandyk@massey.ac.nz|
21261324|NCT03851744|USARIEM|Dr. Lee Margolis|508-206-2335|lee.m.margolis.civ@mail.mil|
21261325|NCT01475955|DUSA Pharmaceuticals, Inc|Manager of Clinical Studies||houlihana@dusapharma.com|
21261326|NCT01451515|St. Jude Children's Research Hospital|Hiroto Inaba, MD, PhD|(901) 595-3144|hiroto.inaba@stjude.org|
21261327|NCT01532453|Galderma Spirig|Dr. Francine Santoro|+41 62 387 87 87|Francine.santoro@galderma.com|87 20
21261328|NCT00427661|University of Pittsburgh-Department of Pediatrics|Nancy Harter-Administrative Director of Research|412-692-7487|harterne@upmc.edu|
21261329|NCT04281537|Amicus Therapeutics, Inc.|Patient Advocacy|001 6096622000|clinicaltrials@amicusrx.com|
21261330|NCT03230097|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21261331|NCT05980416|Elevation Oncology|Medical Information|+1-716-371-1125|medinfo@elevationoncology.com|
21261332|NCT01702805|Emeritus Professor U Pennsylvania at CHOP and Emeritus Professor McMaster University, Dept Pediatrics|Haresh Kirpalani|267-844-3233|kirpalan@mcmaster.ca|
21261333|NCT00635102|Yale University School of Medicine|Dr John Krystal|203-785-6396|john.krystal@yale.edu|
21261334|NCT01241539|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21261335|NCT00440401|Medical Scientific Strategy|Medical Responsible|+45 4677 1111|clinicaltrials@nycomed.com|
21261336|NCT01925703|University of Maryland School of Pharmacy, Department of Pharmacy Practice and Science|Dr. Brent N. Reed||breed@rx.umaryland.edu|
21261337|NCT00058370|Memorial Sloan Kettering Cancer Center|Dr. Ira Dunkel, MD|212-639-2153|dunkeli@mskcc.org|
21261338|NCT01238120|University of Rochester Medical Center|Michelle C. Janelsins, PhD, MPH|(585) 276-4656|Michelle_Janelsins@urmc.rochester.edu|
21261339|NCT00881205|Novartis Pharmaceuticals|Study Director|862-778-8300||
21261340|NCT02888626|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
21261341|NCT01415960|Grand Strand Urology Carolina Urology Reseearch Centre|Dr. Neal Shore MD|+1 843 839 1679|nshore@grandstrandurology.com|
21261342|NCT02498652|Study Information Center AstraZeneca|Jesse Hall, MD|(877) 240-9479|information.center@astrazeneca.com|
21261343|NCT01193335|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21261344|NCT01733329|Hospital Universitario José Eleuterio González, Universidad Autónoma de Nuevo León|Dr. Flavio Hernández Castro|8112776459|flaviohernandezc@yahoo.com|
21261345|NCT01078753|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21261346|NCT01576471|Coronado Biosciences|Vice President, Clinical Operations|7816524516|nsilver@coronadobio.com|
21261347|NCT02362373|Columbia University|Anne Davis, MD|212-305-4951|ard4@cumc.columbia.edu|
21261348|NCT01985321|Benu BioPharma, Inc.|Dr. Eric M. Morrel|5082085634|emorrel@benubio.com|
21261349|NCT00482001|Sunnybrook Health Sciences Centre|Dr. Mark Rapoport|416-480-4085|Mark.Rapoport@sunnybrook.ca|
21261350|NCT04786210|NYU Langone Health|Nayoung Lee, MD|212-263-7019|nayoung.lee@nyulangone.org|
21279290|NCT02895100|Protagonist Therapeutics, Inc|Director Clinical Development|(+1) 888-899-1543|ptgxclintrials@ptgx-inc.com|
21261351|NCT02379858|Medical College of Wisconsin|Matthew Goldblatt, MD|414-955-5751|mgoldbla@mcw.edu|
21261352|NCT04334148|Duke University|Dr. Susanna Naggie|919-684-2584|susanna.naggie@duke.edu|
21240220|NCT02354924|Mackay Memorial Hospital_Taipei|Dr. Huey-Chuan Cheng|886-2-25433535|hccheng@ms2.mmh.org.tw|
21240221|NCT00900627|Astrazeneca|Dr Serban Ghiorghiu||ClinicalTrialTransparency@astrazeneca.com|
21240222|NCT01649596|Genesys Regional Medical Center|Surgeon|810-606-6500|twasfie@gmail.com|
21240223|NCT02821832|National Institute of Allergy and Infectious Diseases|Dr. Clif E. Barry 3rd|301-693-4665|cbarry@niaid.nih.gov|
21240224|NCT00594906|University of Rochester|Dr. J. Edward Puzas|(585) 275-3664|edward_puzas@urmc.rochester.edu|
21240225|NCT03685708|National Institutes of Health (NIH) / The National Heart, Lung, and Blood Institute (NHLBI)|Christopher Pleyer, M.D. Principal Investigator, NIH, NHLBI|510.709.6649|christopher.pleyer@nih.gov|
21240226|NCT02682498|UC Irvine Health|Joseph Rinehart|714-456-5059|jrinehar@uci.edu|
21240227|NCT01311362|University of Heidelberg|Prof. Dr. med. Gerd Mikus|4966215639197|gerd.mikus@med.uni-heidelberg.de|
21240228|NCT00227760|Princess Margaret Cancer Centre - University Health Network|Dr. Srikala Sridhar|416-946-2249|srikala.sridhar@uhn.ca|
21240229|NCT00832338|Emory University|Jane Meisel, MD|404-778-1900|jane.l.meisel@emory.edu|
21240230|NCT05462652|Big Health, Inc.|Jessica Lake|(510) 244-3753‬|research@bighealth.com|
21240231|NCT02222896|Microbac|Dr. Bashir|703-925-9366|muhammad.bashir@microbac.com|
21240232|NCT01744496|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
21240233|NCT00601718|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org|
21240234|NCT04241575|The Chinese University of Hong Kong|Dr Vincent Wong|+85235054205|wongv@cuhk.edu.hk|
21240235|NCT01865617|Fred Hutchinson Cancer Research Center|Dr. Jordan Gauthier|206-667-2713|jgauthier@fredhutch.org|
21240236|NCT00600743|St. Luke's/Roosevelt Hospital|Harry R. Kissileff|212-523-4200|hrk2@columbia.edu|
21240237|NCT02500979|AstraZeneca|Dr. Peter Ohman|+1 (301) 398-0120|Peter.Ohman@astrazeneca.com|
21240238|NCT03772314|Emory University|Dr. Lynn Marie Trotti|404-712-7240|lbecke2@emory.edu|
21261353|NCT00498173|Lurie Center for Autism, Massachusetts General Hospital|Christopher John McDougle, M.D.|7818601721|cmcdougle@mgh.harvard.edu|
21290888|NCT04169009|University of Colorado Anschutz Medical Campus|Adriana Weinberg MD|303-724-4480|adriana.weinberg@cuanschutz.edu|
21290889|NCT05418426|Daré Bioscience, Inc.|Jessica Hatheway, VP of Clinical Operations|858-926-7655|jhatheway@darebioscience.com|
21290890|NCT00607477|University of Chicago|Michael Maitland, MD, PhD|773-702-4400|mmaitlan@medicine.bsd.uchicago.edu|
21290891|NCT00928720|University of Virginia School of Nursing|Ann Gill Taylor, Professor Nursing|434-924-0113|agt@virginia.edu|
21290892|NCT02096354|EpicentRx, Inc|Study Director: Bryan Oronsky, Chief Medical Officer|858-229-1062|boronsky@epicentrx.com|
21290893|NCT02951819|Janssen Scientific Affairs|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21290894|NCT03715829|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21240239|NCT01613027|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21233769|NCT02932904|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21233770|NCT03999411|University of Miami|Dr. Taghrid Asfar|305-243-3826|tasfar@med.miami.edu|
21261354|NCT04246047|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21261355|NCT04689828|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21261356|NCT04322708|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
21290895|NCT05273437|University of California San Diego|Dr. Eric Hekler|8584299370|ehekler@health.ucsd.edu|
21290896|NCT03647137|Department of Veteran Affairs|Dr. Nicolaas Bohnen|7347697100|nicolaas.bohnen@va.gov|
21290897|NCT03566732|University of Bergen|Professor Dagny F. Haugen|+4747606633|dagny.haugen@uib.no|
21290898|NCT03579719|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21290899|NCT01443026|University of Illinois at Chicago|Dr. Peter Gann|312-355-3723|pgann@uic.edu|
21290900|NCT00829868|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21290901|NCT01548885|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
21290902|NCT02799043|Abbott|Anne Sarver, PhD|1-651-756-3813|anne.sarver@abbott.com|
21290903|NCT02412982|UC Health - University of Cincinnati Medical Center|Molly Droege, PharmD|513-584-2126|molly.droege@uchealth.com|
21290904|NCT02852005|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
21290905|NCT01922895|U.T. Southwestern Medical Center|Mack C. Mitchell, MD|2146485036|mack.mitchell@utsouthwestern.edu|
21290906|NCT01916226|GlaxoSmithKline|GSK Response Center|866-435-7343||
21290907|NCT00979407|GlaxoSmithKline|GSK Response Center|866-435-7343||
21290908|NCT01166646|Therapeutics, Inc.|Clinical Research, Therapeutics Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com|
21290909|NCT02420314|University of Iowa|Dr. Muhammad Furqan|319-356-1616|muhammad-furqan@uiowa.edu|
21290910|NCT05430919|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21290911|NCT04379271|Immunic AG|Silke Kropp, Specialist Regulatory Operations & Systems|+49|Silke.Kropp@imux.com|1626774453
21290912|NCT04439903|University of Virginia Center for Diabetes Technology|Patricio Colmegna, PhD|434-924-5592|pc2jx@virginia.edu|
21290913|NCT01854762|Fundação Bahiana de Infectologia / Universidade Federal da Bahia|Dr. Carlos Brites|5571992329552|crbrites@gmail.com|
21290914|NCT03784300|Cassava Sciences|Michael R Marsman, PharmD|5125822173|mmarsman@cassavasciences.com|
21290915|NCT02181413|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21290916|NCT00257933|The Children's Hospital of Philadelphia|Joseph Zorc, MD|215-590-1944|zorc@email.chop.edu|
21261357|NCT01161225|University of Rochester Medical Center|Hyekyun Rhee|5852763775|hyekyun_rhee@urmc.rochester.edu|
21261358|NCT04332419|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|Dr. Ram Gurajala, MD|1-866-223-8100|TaussigResearch@ccf.org|
21261359|NCT02493751|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21261360|NCT00519623|Altea Therapeutics|Pei-Ling Roerig, Sr. Manager Clinical Research, Altea Therapeutics|404-835-6415|proerig@alteatherapeutics.com|
21261361|NCT02513446|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21261362|NCT03819140|University of California, San Francisco|Heather Huddleston|(415) 353-7475|Heather.Huddleston@ucsf.edu|
21261363|NCT02192359|City of Hope Medical Center|Dr. Jana Portnow|626-546-8293|JPortnow@coh.org|
21261364|NCT00457639|UT Southwestern Medical Center|Zahid Ahmad, M.D.|214-648-2377|zahid.ahmad@utsouthwestern.edu|
21261365|NCT02117687|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21261366|NCT01477450|University of Cincinnati|Richard Branson||bransord@uc.edu|
21261367|NCT04002167|Stanford University|Hadi Hosseini|6507235798|hosseiny@stanford.edu|
21261368|NCT01586091|University of Charité Berlin; Dpt. of Dermatology and Allergy|Professor Marcus Maurer|+49 30 450 518 043|marcus.maurer@charite.de|
21261369|NCT00590161|Cleveland Clinic Lerner College of Medicine of Case Western Reserve University|Claudia O. Zein, MD, MSc|216-444-0421|zeinc@ccf.org|
21261370|NCT01687673|University of California, San Francisco|Dr. R. Katie Kelley, MD|(415) 353-9888|Katie.Kelley@ucsf.edu|
21261371|NCT02234622|Roudebush VA Medical Center|Louanne Davis Psy.D.|317-710-1338|louannedavis52@gmail.com|
21261372|NCT03476239|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21261373|NCT00618956|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Robert Palmer, MD|201-427-8218|robert.palmer@frx.com|
21261374|NCT03598777|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
21261375|NCT02006576|University of Nebraska Medical Center|Amy Nelson|402-559-5536|amyjnelson@unmc.edu|
21261376|NCT00785577|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21290917|NCT04806373|Memorial Healthcare System|Mark Block, Chief, Division of Thoracic Surgery|9542651125|mblock@mhs.net|
21290918|NCT05810597|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21240240|NCT00299195|Memorial Sloan Kettering Cancer Center|Dr. Jay Boyle, MD|212-639-2906|boylej@mskcc.org|
21290919|NCT01450631|KCI USA, Inc.|Jill Twardowski, Director of Clinical Operations|210-515-4166|jill.twardowski@kci1.com|
21290920|NCT02170519|Duke University Medical Center|Neil MacIntyre, MD|919-681-2720|neil.macintyre@dm.duke.edu|
21290921|NCT02214212|University of Washington|Jeanne Hoffman|2062216511|jeanneh@u.washington.edu|
21290922|NCT03926247|University of New Mexico|Dr. Jessica Goodkind|505-277-2501|jgoodkin@unm.edu|
21290923|NCT00373360|United Therapeutics Corporation|Rex Mauthe; Senior Director, Regulatory Affairs|919-485-8350|rmauthe@unither.com|
21290924|NCT02481141|SBI Pharmaceuticals Co, Ltd.|Dr. Riyadh Rehani, President of MENA Region|+973 66394100|rrehani@sbigroup.co.jp|
21290925|NCT03249558|Massachusetts General Hospital|Dr. Jianren Mao|617-724-6102|mghpainresearch@partners.org|
21290926|NCT00527878|NIAID, NIH|Alexandra Freeman MD, Staff Clinician, Lead Associate Investigator for Protocol|301-594-9045|freemaal@mail.nih.gov|
21290927|NCT02657356|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21290928|NCT03379870|The Children's Cochlear Implant Center at UNC|Lisa Park, AuD|919-419-1449|lisa_park@med.unc.edu|
21290929|NCT03058952|VA Puget Sound|Dr. Tracy Simpson|(206) 277-3337|Tracy.Simpson@va.gov|
21290930|NCT00107575|Brown University|Christopher Kahler|(401) 863-6651|Christopher_Kahler@brown.edu|
21290931|NCT03768336|Massachusetts General Hospital/Harvard Medical Schoool|Dr. Giselle K. Perez|617-724-0765|gperez@mgh.harvard.edu|
21290932|NCT05654181|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21290933|NCT04101331|Affimed GmbH|Clinical Operations|+49 621 560030|trials@affimed.com|
21290934|NCT01444781|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21290935|NCT02254291|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
21290936|NCT02078869|TCART|Robert F Casper, PI|416-972-0777|casper@lunenfeld.ca|
21290937|NCT03033784|The University of Toledo|Elissar Andari, PhD|419-383-5227|elissar.andari@Utoledo.edu|
21290938|NCT03562156|Mycovia Pharmaceuticals Inc|Clinical Trial Administration|919-467-8539|adminops@mycovia.com|
21290939|NCT03257657|University of Colorado|Darcy Thompson, Associate Professor|303 724 7471|darcy.thompson@ucdenver.edu|
21290940|NCT02801578|The University of Texas MD Anderson Cancer Center|Prithviraj Bose, MD./Associate Professor|713-792-7747|PBose@mdanderson.org|
21290941|NCT00137449|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21290942|NCT02296099|TriHealth|Clinical Research Specialist|513-862-2341|ganga_devaiah@trihealth.com|
21290943|NCT00668642|Northshore University Healthsystem|Dr. Daniel Shevrin|847-570-2515|Dshevrin@northshore.org|
21290944|NCT00690339|Allergan, Inc.|Medical Monitor|714-246-4500|clinicaltrials@allergan.com|
21290945|NCT03707821|Johnson & Johnson VIsion|John Buch OD, MS, FAAO Sr. Principal Research Optometrist|9044431707|JBUCH@its.jnj.com|
21290946|NCT01432444|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21290947|NCT02014467|GlaxoSmithKline|GSK Response Center|866-435-7343||
21290948|NCT04642976|University of Pennsylvania|Timothy Markman|215-615-4332|timothy.markman@pennmedicine.upenn.edu|
21290949|NCT00443456|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21290950|NCT00557440|Novartis Pharmaceuticals|Study Director|862-778-8300||
21290951|NCT02157610|Moffitt Cancer Center|Jennifer Vidrine, PhD, MS|813-745-8764|jennifer.vidrine@moffitt.org|
21290952|NCT00944021|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|212 227 7540|Dan.Everitt@tballiance.org|
21290953|NCT00124657|St. Jude Children's Research Hospital|Alberto Broniscer, MD|866-966-5934|info@stjude.org|
21290954|NCT03680521|Mirati Therapeutics|Sr. Clinical Operations Trial Manager|858-332-3540|hallinm@mirati.com|
21290955|NCT03177798|Vanderbilt University Medical Center|Dr. Jorge L. Gamboa|615-343-4176|jorge.gamboa@vumc.org|
21290956|NCT00619918|Children's Hospital Los Angeles|Susan Wu|323-361-6177|suwu@chla.usc.edu|
21290957|NCT03533491|Oregon Research Behavioral Intervention Strategies, Inc.|Dana Smith|541-484-2123|dana.smith@influentsin.com|
21290958|NCT02517918|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
21290959|NCT01969409|University of Alabama at Birmingham|Steven R. Duncan, MD|(205) 934-5017|duncsr19@uab.edu|
21290960|NCT01603368|University of Linköping|Thomas Abrahamsson, MD PhD|+46.10.1030000|thomas.abrahamsson@liu.se|
21290961|NCT01554904|University of Florida|Richard B Berry, M.D. Principal Investigator|3522621575|Richard.Berry@medicine.ufl.edu|
21290962|NCT02951481|Fundación de investigación Hospital Universitario 12 de Octubre|MD, PhD José María Aguado García|913908000|jaguadog1@gmail.com|4632
21290963|NCT01051661|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21290964|NCT01681849|Emory University|Dr. J. Douglas Bremner|404-712-9569|doug.bremner@emory.edu|
21290965|NCT03813121|Wake Forest University School of Medicine|Dr. Merideth Addicott|336-716-7792|maddicot@wakehealth.edu|
21290966|NCT05007639|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Pr Simone Mathoulin-Pélissier|+33 (0)5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
21290967|NCT04525183|Dana-Farber Cancer Institute|Dr. Alexi Wright|617-362-2334|alexi_wright@dfci.harvard.edu|
21290968|NCT01257750|Massachusetts Eye and Ear Infirmary|Reza Dana, MD, MPH, MSc|617-573-3313|Cornea_Research@meei.harvard.edu|
21290969|NCT05142306|Emergent BioSolutions Canada Inc|Mila Mirceta, PhD, Senior Scientist, Clinical Research|204-275-4074|mircetam@ebsi.com|
21290970|NCT02614248|Genesis Medical Center|Michelle Martin, RN|562-421-7743|MartinMi@genesishealth.com|
21290971|NCT01375140|The University of Texas MD Anderson Cancer Center|Srdan Verstovsek, MD/Professor|713-745-3429|sverstov@mdanderson.org|
21290972|NCT03285893|University of Minnesota|Joni Jensen|612-624-5178|jense010@umn.edu|
21290973|NCT04042311|Hull University Teaching Hospitals NHS Trust|Dr Sean Pymer|01482 674643|s.pymer@nhs.net|
21290974|NCT03518060|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21290975|NCT05078112|Duke University|Sujay Kansagra, MD|919-668-0477|sujay.kansagra@duke.edu|
21261377|NCT00499915|University of Rochester|Dr. Jill Halterman|585-275-5798|jill_halterman@urmc.rochester.edu|
21261378|NCT05175170|Ann & Robert H. Lurie Children's Hospital of Chicago|Dr. Diane Chen|312-227-2939|DiChen@luriechildrens.org|
21233771|NCT03144180|Texas Tech University Health Sciences Center at El Paso|Associate Director of Ob/Gyn Research|9152155103|christina.bracamontes@ttuhsc.edu|
21261379|NCT01650805|ARIAD Pharmaceuticals, Inc.|Maureen Conlan, Senior Medical Director|1-617-621-2316|Maureen.Conlan@ariad.com|
21261380|NCT02515669|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21261381|NCT03750838|University of North Texas Health Science Center|Dr. Dana Litt|817-735-5453|dana.litt@unthsc.edu|
21261382|NCT02798523|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|Dr. Luis Franco|+1 240 220 4366|luis.franco@nih.gov|
21261383|NCT01909492|Providence Health & Services|Director of PBSI /WC Clinical Research Program|(503) 216-1012|Chiayi.Chen@providence.org|
21261384|NCT04070378|The Feinstein Institutes for Medical Research|Marc L Gordon, MD|(516) 562-3492|mlgordon@northwell.edu|
21261385|NCT06046560|Mass General Brigham|Alexander Blood, MD|617-732-7144|ablood3@mgb.org|
21261386|NCT04067661|University of Michigan|Kristi Gamarel|7346473178|kgamarel@umich.edu|
21279291|NCT04581330|UT Southwestern Medical Center|Dr. Heather Goff|2146484229|heather.goff@utsouthwestern.edu|
21279292|NCT00345943|New York State Psychiatric Institute|Dr. Rachel Marsh|6467745774|rachel.marsh@nyspi.columbia.edu|
21279293|NCT00912925|Genzyme Corporation|Genzyme Medical Information||medinfo@genzyme.com|
21279294|NCT03485365|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21279295|NCT03661697|University of Miami|Lisa D Grunebaum MD|3052433223|lgrunebaum@med.miami.edu|
21279296|NCT00763061|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21279297|NCT01275430|Bard Access Systems, Inc.|Sharon Molotsky|856-266-1327|sharon.molotsky@crbard.com|
21279298|NCT04988087|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
21279299|NCT02613182|Prothena|Wendy Curlin|650 837 8550|clinicaltrials@prothena.com|
21279300|NCT00863772|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21279301|NCT03020589|University of North Carolina at Chapel Hill|Robert Dupuis, PharmD|919-966-6194|re_dupuis@unc.edu|
21279302|NCT05278650|Duke University|Eleanor McConnell, Ph.D.|919-684-9229|eleanor.mcconnell@duke.edu|
21279303|NCT01595386|University of Alabama at Birmingham, Pediatric Cardiac Critical Care|Jeffrey Alten, M.D., Director of Clinical and Translational Research Department|205-975-3123|jalten@peds.uab.edu|
21279304|NCT00373698|VA Medical Center, White River Junction, VT|Dr. Paula Schnurr and Dr. Mathew Friedman|802-296-5132|Paula.Schnurr@va.gov; Matthew.Friedman@va.gov|
21279305|NCT03862755|Shanghai Pulmonary Hospital|Dr. Lei Shen|86-21-65115006|sh_leisen@126.com|2054
21279306|NCT02297698|LumaBridge|Dr. George Peoples|210 557 4291|gpeoples@lumabridge.com|
21279307|NCT04844762|OhioSUCCC|Dr. Theodore L. Wagener|614-366-4265|Theodore.Wagener@osumc.edu|
21279308|NCT00399880|Vanderbilt University Medical Center|Kathryn Goggins, Research Coordinator|6159364819|Kathryn.m.goggins@vanderbilt.edu|
21279309|NCT04400682|Farmagen|Aydin Erenmemisoglu|+90 532 551 0082|a.erenmemisoglu@farmagenarge.com|
21290976|NCT04903093|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21290977|NCT03204812|UT MD Anderson Cancer Center|Dr. Sumit Subudhi, PhD-Associate Professor, Genitourinary Medical Oncology|(713) 792-2830|sksubudhi@mdanderson.org|
21290978|NCT02412436|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21290979|NCT02544763|GW Research Ltd|Medical Enquiries|+1 833 424 6724|medinfo@gwpharm.com; medinfo@greenwichbiosciences.com|
21290980|NCT02528305|University of Striling|Dr Niels Vollaard|+441786466488|n.vollaard@stir.ac.uk|
21290981|NCT01852214|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu|
21290982|NCT00421408|Yale University|Dr. Karl Insogna|203-737-2871|Karl.insogna@yale.edu|
21290983|NCT02370693|Northwestern University|Manu Jain, MD|312-503-4242|m-jain@northwestern.edu|
21290984|NCT01270555|Massachusetts General Hospital|Timothy Wilens, MD|617-503-1053|twilens@partners.org|
21290985|NCT00773461|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21290986|NCT00913835|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21290987|NCT01827306|Sport & Spine Rehab Clinical Research Foundation|Jena Slaski|7179915595|jslaski@ssrehab.com|
21290988|NCT03345550|University of Michigan|Frederick Korley|734 647-0261|korley@med.umich.edu|
21290989|NCT00889330|Johnson & Johnson Vision Care, Inc.|Arthur Shedden, MD|904-443-1557|ashedden@its.jnj.com|
21290990|NCT02085980|The Christ Hospital - Cincinnati, OH|Dr. Mickey Karram|(513) 463-2500|mickey.karram@thechristhospital.com|
21290991|NCT01149460|Teva Pharmaceuticals USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21290992|NCT03014089|ModernaTX, Inc|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
21290993|NCT00321932|Masonic Cancer Center, University of Minnesota|Linda Burns, M.D.|612-624-8144|burns023@umn.edu|
21290994|NCT02378480|Paratek Pharmaceuticals, Inc.|Dr. Paul McGovern; Vice President, Clinical Affairs|484-751-4935|Paul.Mcgovern@paratekpharma.com|
21290995|NCT01217892|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
21290996|NCT02069847|Mayo Clinic|Michael B. Wallace|507-953-2221|wallace.michael@mayo.edu|
21290997|NCT00480532|University of Hawaii (UH)|Bliss Kaneshiro|808-203-6500|bkaneshiro@ucera.org|
21290998|NCT01592747|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21290999|NCT02367885|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21291000|NCT01602484|Brigham and Women's Hospital|Dr. Eric Bluman|6179837363|ebluman@partners.org|
21240241|NCT01290536|University of California San Francisco|Nicholas Fidelman, MD|1-415-353-1300|Nicholas.Fidelman@ucsf.edu|
21240242|NCT00119262|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
21240243|NCT03141528|Inselspital|Dr. Tina Pedersen|+4522125797|tinaheidipedersen@yahoo.dk|
21240244|NCT02917577|UCalgary|Heinrike Schmeling|4039553194|schmelingresearch@albertahealthservices.ca|
21240245|NCT04485546|Dompé Farmaceutici S.p.A|Sarah Wilting, OD MS|833-366-7387|usmedinfo@dompe.com|
21240246|NCT00882921|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21240247|NCT02302066|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21240248|NCT01722318|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020||
21233772|NCT00337103|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21233773|NCT01142310|UT Southwestern Medical Center|Dr. E. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
21233774|NCT02016482|AbbVie|Global Medical Services|800-633-9110||
21233775|NCT03387813|Abbott|Fei San Lee, PhD, Sr Clinical Research Scientist|925-694-2109|feisan.lee@abbott.com|
21233776|NCT01289847|Bio Products Laboratory|Head of Medical Affairs|+44 20 8957 2200|medinfo@bpl.co.uk|
21233777|NCT03441633|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21233778|NCT05876273|Center for Diabetes Technology, University of Virginia School of Medicine|Boris Kovatchev, PhD|434-924-5592|boris@virginia.edu|
21233779|NCT03583996|HepQuant LLC|Elyse Handley|3037480524|elyse.handley@hepquant.com|
21233780|NCT02063737|Carolinas HealthCare System|Dr. Daniel Patterson|704-446-0433|Daniel.Patterson@carolinas.org|
21233781|NCT02457403|The Ohio State University|A James Hanje|614 293 6255|james.hanje@osumc.edu|
21233782|NCT00439556|UT MD Anderson Cancer Center|Dr. Khouri,Issa,M.D. / Stem Cell Transplantation|713-792-8750|ikhouri@mdanderson.org|
21233783|NCT03818516|Emory University|David R. Goldsmith, MD|404-727-3735|drgolds@emory.edu|
21233784|NCT01642238|Icahn School of Medicine at Mount Sinai|Dr. Juan J. Badimon|(212) 241-8484|Juan.Badimon@mssm.edu|
21233785|NCT04372602|Washington University School of Medicine|John DiPersio, M.D., Ph.D.|314-454-8491|jdipersi@wustl.edu|
21233786|NCT01324388|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21233787|NCT01405963|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21233788|NCT00176592|Rutgers New Jersey Medical School|Stuart Cook, MD|973-972-2550|cooksd@njms.rutgers.edu|
21233789|NCT03742141|Icahn School of Medicine at Mount Sinai|Dr. David Steinmetz|646-831-5950|dsteinmetz0@gmail.com|
21233790|NCT01498640|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
21233791|NCT03023085|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
21233792|NCT00850395|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21233793|NCT00129129|GlaxoSmithKline|GSK Response Center|866-435-7343||
21233794|NCT04017936|Virginia Commonwealth University|Dr. Jordana Kron, MD|804-828-7565|jordana.kron@vcuhealth.org|
21233795|NCT03774433|Dartmouth College|Dr. Lisa Marsch|603-646-7092|Lisa.A.Marsch@dartmouth.edu|
21233796|NCT00108160|VA Ann Arbor Healthcare System|Suzanne F. Bradley, M.D.|734-845-5820|sbradley@umich.edu|55826
21233797|NCT01062555|University of Minenesota|Arthur Matas|612-625-5151|matas001@umn.edu|
21233798|NCT04837131|Mayo Clinic|Michael Pham, M.D.|480-301-8318|Pham.Michael@mayo.edu|
21233799|NCT00403273|minneapolis VAMC|jasvinder singh|205-504-9559||
21233800|NCT00589108|Mayo Clinic|Dr. Robert T. Trousdale|507-284-3663|trousdale.robert@mayo.edu|
21233801|NCT01398566|The Ohio State University|Lise Worthen-Chaudhari|614-304-1421|liseworthen@gmail.com|
21233802|NCT03026257|Alcon, A Novartis Division|Senior Clinical Project Lead, GCRA - Clin Dev Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21233803|NCT02181556|FFCD|Mrs Karine Le Malicot, Head of biostatistics|+33 3 80 39.34.79|karine.le-malicot@u-bourgogne.fr|
21233804|NCT04380857|Cleveland Eye Clinic|Kathleen Jee, MD|440-526-1974|kjee@midwestvision.com|
21233805|NCT04865354|Alcon Research, LLC|Sr. Project Lead, CDMA Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21233806|NCT01465022|University of New Mexico|Eve Espey MD, MPH, Principal Investigator|505 272 6372|eespey@salud.unm.edu|
21233807|NCT02256891|Health Partners|Michael Walsh|(952) 831-8742|michael.walsh@tria.com|
21233808|NCT03865329|Mayo Clinic|Dr. Roberto Benzo|(507) 284-0561|Benzo.Roberto@mayo.edu|
21233809|NCT01746784|N30 Pharmaceuticals|Dr. Steven Shoemaker|720-945-7700|steven.shoemaker@n30pharma.com|
21233810|NCT02487394|UTMB|William Calhoun, M.D.|409-772-1176|wjcalhou@utmb.edu|
21233811|NCT01018420|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21233812|NCT00265616|CHUV Lausanne|Dr Andrea O. Rossetti|+41 21 314 1190|andrea.rosseti@chuv.ch|
21233813|NCT03893799|Renibus Therapeutics|Donald J Keyser, Chief Operating Officer|18178756991|jkeyser@renibus.com|
21233814|NCT00218296|University of Minnesota|Dorothy Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu|
21233815|NCT02623803|Mayo Clinic|Dr. Elird Bojaxhi|904-956-3327|bojaxhi.elrid@mayo.edu|
21233816|NCT04693585|University of California San Francisco|Nadia Diamond-Smith|415-353-4545|nadia.diamond-smith@ucsf.edu|
21233817|NCT03221595|Denver Health Medical Center|Research Coordinator|303-602-6213|Kiara.Leasia@dhha.org|
21233818|NCT02212587|Hospital of Sick Children|Dr. Valerie Waters|416-813-1500|valerie.waters@sickkids.ca|
21233819|NCT00134381|UMDNJ-Robert Wood Johnson Medical School|Dr M Magliocco||maglioma@yahoo.com|
21233820|NCT04066426|Tekirdag Namik Kemal University|Dr. Volkan Kaplan|+90282250000|dr.volkankaplan61@gmail.com|6307
21233821|NCT02711800|Duke University|Nancy Zucker|9196680075|zucke001@mc.duke.edu|
21233822|NCT04452331|University of Illinois Chicago|Dr. Alan Schwartz|3129962070|alansz@uic.edu|
21233823|NCT01295515|National Cancer Institute|Dr. Frank Maldarelli|301- 846-5611|frank_maldarelli@nih.gov|
21233824|NCT05442554|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21233825|NCT04938232|Dana-Farber Cancer Institute|Reid Merryman|6176326844|reid_merryman@dfci.harvard.edu|
21233826|NCT01446965|University of California, San Francisco|Jeffrey Olgin, MD|415-476-1000|jeffrey.olgin@ucsf.edu|
21233827|NCT00004412|Boston University School of Medicine|Douglas V. Faller, Ph.D., M.D., Susan P. Perrine, M.D.|(617) 638-5639|sperrine@bu.edu|
21233828|NCT00006478|University of Nebraska Medical Center Division of Oncology/Hematology|Bryan Ludwig, Regulatory Coordinator|402-559-8071|bmludwig@unmc.edu|
21233829|NCT04534764|Johnson & Johnson Vision Care|Meredith Bishop, OD, MS, FAAO-Sr. Principal Research Optometrist|904-443-1783|mbishop4@its.jnj.com|
21233830|NCT02151448|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS|412-647-5554|stadtermanbm@upmc.edu|
21233831|NCT04227236|dFusion, Inc.|Regina Firpo-Triplett|831-222-5094|regina.firpo@dfusioninc.com|
21233832|NCT00914862|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21233833|NCT02039674|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21233834|NCT01408030|Cure HHT|James R. Gossage, MD, Medical Director of Cure HHT|706-721-6789|jgossage@augusta.edu|
21233835|NCT05265260|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
21233836|NCT05045144|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21233837|NCT02965703|Northwestern University|Dr. Seema A. Khan|312-503-4236|s-khan2@northwestern.edu|
21233838|NCT02081079|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21233839|NCT01035944|HemCon Medical Technolgoies|Dr. Jody Oyama|503.245.0459|jody.oyama@hemcon.com|
21233840|NCT00363779|National Cancer Institute (NCI), National Institutes of Health (NIH)|Thomas Waldmann, M.D.|301-496-6653|Thomas_Waldmann@nih.gov|
21233841|NCT02968979|CHUGAI PHARMA FRANCE|Dr Luz BOBADILLA, Medical Affairs Director|+33 1 56 37 05 28|bobadilla@chugai-pharm.fr|
21233842|NCT01471379|UNC Chapel Hill|Dr. Spencer Dorn Associate Professor|919-966-0141|sdorn@med.unc.edu|
21233843|NCT00788827|Imperial College London|Professor Charles Pusey|+44 3313 2308|c.pusey@imperial.ac.uk|
21233844|NCT01218555|Emory University|Taofeek K. Owonikoko, MD, PhD, MSCR|404-778-1900|towonik@emory.edu|
21233845|NCT01200797|Vanderbilt-Ingram Cancer Center|Marta A. Crispens, M.D.|615-322-8072|marta.crispens@Vanderbilt.Edu|
21233846|NCT03608774|University of Washington|Julia C. Dombrowski, MD, MPH|206-744-5640|jdombrow@uw.edu|
21233847|NCT02531321|University of Southern California|Dr. Nicole Bender|3234093416|nicole.bender@med.usc.edu|
21233848|NCT00851799|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21233849|NCT01976442|University of Rochester Medical Center|Neil Blumberg MD|(585) 275-3189|neil_blumberg@urmc.rochester.edu|
21233850|NCT01538862|Vanderbilt University|Haydar Frangoul, MD, MS|615-342-7339|Haydar.Frangoul@hcahealthcare.com|
21233851|NCT02818218|Cleveland Clinic Foundation|YanYan Han|216-444-2250|HANY3@ccf.org|
21240249|NCT00459303|National Taiwan University Hospital|Fung-Rong Hu|+886223123456|fungronghu@ntuh.gov.tw|2131
21240250|NCT00461292|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21240251|NCT02180438|University of Washington|Dr. Geoffrey S Gottlieb. MD PhD (PI)|1-206-616-2631|gottlieb@uw.edu|
21240252|NCT02058290|Pacira Pharmaceuticals, Inc.|Erol Onel, MD|858-625-2424|erol.onel@pacira.com|
21240253|NCT01238549|VAORD|Dr. Ann Spungen|718-584-9000|ann.spungen@va.gov|5814
21240254|NCT00785707|MED-EL Corporation|Sr. Clinical Research Associate||clinicaltrials@medelus.com|
21240255|NCT03295266|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21240256|NCT00105586|Washington University in St. Louis|Eric Lenze|314-362-1671|lenzee@wustl.edu|
21240257|NCT00675415|Cleveland Clinic|Dr. John Vargo|(216) 445-5012|vargoj@ccf.org|
21240258|NCT02262260|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21240259|NCT01794117|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|Dr. Edward W. Cowen|301-827-2328|cowene@mail.nih.gov|
21240260|NCT00405704|UNC Chapel Hill|Dr. Myra Carpenter, Senior Investigator|919-962-3245|myra_carpenter@unc.edu|
21240261|NCT04150029|Novartis Pharmaceuticals|Study Director|862-778-3000|novartis.email@novartis.com|
21240262|NCT02696902|MedImmune, LLC|Mark Esser|+1 301 3986849|information.center@astrazeneca.com|
21240263|NCT01719900|University of Calgary|Dr. Raylene Reimer|14032208218|reimer@ucalgary.ca|
21240264|NCT01233609|Foundation Fighting Blindness Clinical Research Institute|Chief Drug Development Officer|410 423 0581|pzilliox@blindness.org|
21240265|NCT00735644|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21240266|NCT01861457|Medical University of South Carolina|Shaun A. Nguyen, MD, Associate Professor- Director of Clinical Research|8437921356|nguyensh@musc.edu|
21240267|NCT06385483|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21240268|NCT00799643|Joslin Diabetes Center|Allison B.Goldfine|617-309-2400|allison.goldfine@joslin.harvard.edu|
21240269|NCT00654940|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21240270|NCT00802737|GlaxoSmithKline|GSK Response Center|866-435-7343||
21240271|NCT03677128|Duke University|Kristin Schroeder, MD MPH|919-668-6288|kristin.schroeder@duke.edu|
21240272|NCT00619476|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
21240273|NCT01155388|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
21240274|NCT03884231|Abbott|Tucker Tomlinson|+1/ 972 526 9646|tucker.tomlinson@abbott.com|
21240275|NCT00830947|OrthoAccel Technologies, Inc.|Zaffer Syed, Director of Clinical & Regulatory Affairs|(832) 803-0339|zsyed@orthoaccel.com|
21240276|NCT04176133|Mayo Clinic|Robert J. Pignolo, MD, PhD|507-255-8716|Pignolo.Robert@mayo.edu|
21240277|NCT05719285|Cleveland Clinic Foundation|Dr. Lauren Gleich|701-330-1669|LAURENGLEICHDO@GMAIL.COM|
21240278|NCT03875495|Genenta Science|Chief Medical Officer|+39 02 2643 3982|info-trial@genenta.com|
21240279|NCT04800757|The University of Texas Health Science Center at Houston|Maria Eugenia Fernandez-Esquer|(713) 500-9657|Maria.E.Fernandez-Esquer@uth.tmc.edu|
21240280|NCT00654329|Children's National Medical Center|Julia C. Finkel, MD|202-476-4867|jfinkel@cnmc.org|4867
21240281|NCT00502996|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21240282|NCT01729728|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|Clinical-Trials@grunenthal.com|
21240283|NCT02132533|UT Southwestern Medical Center|Chet Edward Wells, MD|214-648-2316|dawn.wilson@utsouthwestern.edu|
21240284|NCT00672958|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21240285|NCT01964521|The Norfolk & Norwich University Hospitals NHS Foundation Trust|Dr Ketan Dhatariya|+44 1603 286286|ketan.dhatariya@nnuh.nhs.uk|
21240286|NCT00579982|GlaxoSmithKline|GSK Response Center|866-435-7343||
21240287|NCT00183456|Johns Hopkins Bloomberg School of Public Health|Carl Latkin, PhD||clatkin@jhsph.edu|
21240288|NCT01927718|UT MD Anderson Cancer Center|Qaiser Bashir, MD/Associate Professor, Stem Cell Transplantation|713-792-7734|QBashir@mdanderson.org|
21240289|NCT00240526|GlaxoSmithKline|GSK Response Center|866-435-7343||
21261387|NCT05781542|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
21233852|NCT04476537|Columbia University|Gulam Manji, MD|212-342-5162|gam2140@cumc.columbia.edu|
21233853|NCT02280941|University of Ottawa Heart Institute|Dr. Terrence Ruddy|6136967000|truddy@ottawaheart.ca|7267
21233854|NCT00483223|Massachusetts General Hospital|Steven Isakoff, MD, PhD|617-726-4920|SISAKOFF@mgh.harvard.edu|
21233855|NCT04328207|University of Alabama at Birmingham|Cynthia Owsley|2053258635|cynthiaowsley@uabmc.edu|
21233856|NCT00322335|GlaxoSmithKline|GSK Response Center|866-435-7343||
21233857|NCT00983281|University of Miami|Kenneth Proctor, PhD|305-243-4694|kproctor@med.miami.edu|
21233858|NCT00502697|Vanderbilt University|Melanie Lutenbacher, PhD, MSN, FAAN|615-343-3314|melanie.lutenbacher@vanderbilt.edu|
21233859|NCT00864474|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21233860|NCT04076644|University of Missouri|Matt Schmidt|573-882-5688|schmidtmw@health.missouri.edu|
21233861|NCT02283814|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21233862|NCT01364090|Viral Hepatits Clinical Research Program - The Kirby Institute - UNSW Sydney|Dr. Jason Grebely|+61 2938 50957|Jgrebely@kirby.unsw.edu.au|
21233863|NCT04033003|University of Michigan, School of Nursing|Jody R. Lori PhD, Associate Dean for Global Affairs, Director, PAHO/WHO Collaborating Center|734-763-0097|jrlori@med.umich.edu|
21233864|NCT01604343|Janssen Research & Development, LLC|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
21240290|NCT01896115|Boston Scientific|Stephen Carcieri, PhD|661-949-4756|Stephen.Carcieri@bsci.com|
21240291|NCT02649322|Orlando Health|Daryl C. Osbahr, MD|321.843.4800|Daryl.Osbahr@orlandohealth.com|
21240292|NCT01752413|Memorial Blood Centers|Jed B Gorlin MD, MBA|651-332-7284|Jed.Gorlin@innovativeblood.org|
21279310|NCT00477633|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
21279311|NCT02777073|State University of NY at Buffalo|Paresh Dandona|7165351850|dandona@buffalo.edu|
21279312|NCT02091466|Faculdade de Ciências Médicas da Santa Casa de São Paulo|Dr. Ricardo Caio Gracco De Bernardis|55-11-21767280|rcaiog@yahoo.com.br|
21279313|NCT01191827|Denver VA Medical Center|Research Biologist|303-724-6232|jason.tregellas@va.gov|
21279314|NCT02542605|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21233865|NCT03754959|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21279315|NCT01178528|IRCCS San Raffaele|G Rosano|0652252309|giuseppe.rosano@sanraffaele.it|
21233866|NCT03552575|University of Glasgow|Professor John McMurray|0141 330 2627|john.mcmurray@glasgow.ac.uk|
21279316|NCT05833139|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21233867|NCT03161483|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21233868|NCT02767427|Columbia University|Dr. Kiehyun Daniel Riew, Professor of Orthopedic Surgery|212-932-4410|kr2637@cumc.columbia.edu|
21233869|NCT04128683|University of California San Diego|Dr. Guido Frank|858-246-2053|gfrank@health.ucsd.edu|
21233870|NCT03007394|National Institute on Drug Abuse|David McCann, Ph.D.|301-827-5934|dmccann@nida.nih.gov|
21233871|NCT00743652|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21233872|NCT00805766|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21233873|NCT01841151|KIND, KBH, Karolinska Institutet|Prof. Sven Bölte|0046703170105|sven.bolte@ki.se|
21233874|NCT00228917|GlaxoSmithKline|GSK Response Center|866-435-7343||
21233875|NCT00409617|Abbott|Global Medical Services|800-633-9110||
21233876|NCT00591942|University of Iowa|Dr. Clark Stanford|319-335-7381|Clark-Stanford@uiowa.edu|
21233877|NCT00149747|Stanford Prevention Research Center|Abby C. King|6507252826|king@stanford.edu|
21233878|NCT03373383|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21233879|NCT02159521|EKOS Corporation|David Hahn|4254153100|David.Hahn@btgplc.com|
21233880|NCT04649775|Duke University|Loretta Que, M.D.|919-681-8551|loretta.que@duke.edu|
21233881|NCT04753164|Idorsia Pharmaceuticals Ltd|Idorsia Clinical Trial Information|+18566613721|idorsiaclinicaltrials@idorsia.com|
21233882|NCT00694369|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21233883|NCT00907374|Charles R. Drew University|Mayer B. Davidson, MD|323 357-3439|mayerdavidson@cdrewu.edu|
21233884|NCT02871739|Massachusetts General Hospital Health Decision Sciences Center|Karen Sepucha|617-724-3350|ksepucha@partners.org|
21233885|NCT02508571|Department of Pediatrics, Seoul National University College of Medicine|Dr. Ee-Kyung Kim|82-2-2072-3628|kimek@snu.ac.kr|
21233886|NCT02180412|University of Texas Medical Branch, Galveston|Dr. Karl Anderson, MD|409-772-9092|kanderso@utmb.edu|
21233887|NCT01354496|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21233888|NCT00651573|Cleveland Clinic Foundation|Daniel Sessler, MD|216-4444900|ds@or.org|
21233889|NCT01524692|University of Virginia|Dr. Patrick Dillon|4349821495|pmd5b@virginia.edu|
21233890|NCT03190889|The Ohio State University Wexner Medical Center|Nathaniel A. Bates|614-293-9013|nathaniel.bates@osumc.edu|
21233891|NCT01709695|Icahn School of Medicine at Mount Sinai|Department of Psychiatry|212-241-6623||
21233892|NCT04007523|Michigan Medicine|Dr. Phillip Vlisides|734-936-4280|pvliside@med.umich.edu|
21233893|NCT00867451|Cincinnati Children's Hospital Medical Center|Richard Gilman, Ph.D.|513-636-8172|richard.gilman@cchmc.org|
21233894|NCT01278485|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21233895|NCT02136576|Tufts University School of Dental Medicine|Dr. Britta Magnuson|617-636-3878|britta.magnuson@tufts.edu|
21233896|NCT00537381|Janssen Research & Development, L.L.C.|Senior Director|908-927-2116||
21233897|NCT00680901|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21233898|NCT05544786|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21233899|NCT03717480|Dana-Farber Cancer Institute|Dr. Vincent Ho|617-632-6256|vincent_ho@dfci.harvard.edu|
21233900|NCT01708174|Novartis Pharmaceuticals|Study Director|862-778-8300||
21233901|NCT01894152|Abbott Vascular|Roy Leong|+65 (6277) 3202|roy.leong@abbott.com|
21233902|NCT02741700|VA ORD: Birmingham VA Medical Center|Dr. Jasvinder Singh|205-934-3235|jasvinder.md@gmail.com|
21233903|NCT00923559|Dept of Women's and Children's Health, Karolinska Institutet|Björn Salomonsson|+46851777206|bjorn.salomonsson@ki.se|
21233904|NCT01774786|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21233905|NCT02268812|Eisai Europe Ltd.|Eisai Medical Services|+44 (0)20 8600 1400||
21233906|NCT00075582|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21233907|NCT02385084|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21233908|NCT04544293|Savara Inc.|Raymond D Pratt, MD FACP|512 614 1848|ray.pratt@savarapharma.com|
21233909|NCT04903249|Dartmouth-Hitchcock Medical Center|Courtney J. Stevens, PhD, Principal Investigator|603-650-9643|courtney.j.stevens@dartmouth.edu|
21233910|NCT03556579|Johnson & Johnson Vision Care Inc.|John Buch, O.D. F.A.A.O - Senior Principal Research Optometrist|904-443-1707|JBUCH@its.jnj.com|
21233911|NCT01144442|Masonic Cancer Center|Peter Argenta, MD|612-626-3111|argenta@umn.edu|
21233912|NCT01951157|Pharma Mar S.A.|Pharma Mar S.A.|00 34 91846 60 00|clinicaltrials@pharmamar.com|
21233913|NCT00744627|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21233914|NCT02268786|Illumina|Tasha Kalista|858-202-4500|tkalista@illumina.com|
21233915|NCT01625455|VANDERBILT UNIVERSITY MEDICAL CENTER|Nancy J. Brown, M.D., Principal Investigator|6153438701|nancy.j.brown@vanderbilt.edu|
21233916|NCT04809220|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21233917|NCT02535845|The University of Chicago|Dr. Jasmin Tiro|773-834-4384|jtiro@bsd.uchicago.edu|
21240293|NCT01551303|Massachusetts General Hospital|Dr. Elizabeth Hoge|617-724-0859|ehoge@partners.org|
21240294|NCT02512510|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
21240295|NCT02141659|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21240296|NCT04110366|Imperial College London|Dr Ryan Thwaites|(0044) 0203 3125730|r.thwaites@imperial.ac.uk|
21240297|NCT02471404|AstraZeneca|Eva Johnsson, MD, PhD|+46 (0)31776 24 84|ClinicalTrialTransparency@astrazeneca.com|
21240298|NCT01927731|The University of Texas MD Anderson Cancer Center|Uday Popat, M.D. / Stem Cell Transplantation|713-792-8750|upopat@mdanderson.org|
21240299|NCT00981825|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
21240300|NCT01812005|The Ohio State University James Comprehensive Cancer Center|Kristie Blum, MD|614-293-7807|Kristie.Blum@osumc.edu|
21240301|NCT00305864|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
21240302|NCT01450787|Coa Research Foundation|Kenneth A Beckman, MD|614-506-4720|kenbeckman22@aol.com|
21240303|NCT02836613|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
21240304|NCT01464255|Clinical Research Center, University of California, Berkeley, School of Optometry|Thao N Yeh, O.D.|(510) 642-9649|thaoyeh@berkeley.edu|
21240305|NCT03881059|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21240306|NCT02065570|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21240307|NCT02743793|DAIT/NIAID|Director, Clinical Research Operations Program|13015947669|DAITClinicalTrialsGov@niaid.nih.gov|
21240308|NCT02697006|Fresenius MCD|Dr. Anja Derlet-Savoia|+49 6172 608 2801|Anja.Derlet@fmc-ag.com|
21240309|NCT04276090|University of Kentucky|Dr. Michael Cavnar|859-323-8920|michael.cavnar@uky.edu|
21240310|NCT04642469|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21240311|NCT00787722|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
21240312|NCT02874066|National Taiwan University Hospital|Chen-Hua Liu|+886-972651880|jacque_liu@mail2000.com.tw|
21240313|NCT03912220|Johns Hopkins University|Dr. Ahmet Hoke|410-955-2227|ahoke1@jh.edu|
21240314|NCT02066532|Columbia University Irving Medical Center|Dawn Hershman, MD|212-305-5098|dlh23@cumc.columbia.edu|
21240315|NCT05033080|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21240316|NCT03560245|Neurotropebioscience, Inc|Alan J. Tuchman, MD, Acting Chief Medical Officer|973-242-0005|atuchman@neurotrope.com|
21240317|NCT01381952|Karolinska University Hospital|Dr. Söderman|+46851774037|michael.soderman@karolinska.se|
21240318|NCT02913521|Egeen|Kalev Kask|16504690600|kalev.kask@egeeninc.com|
21240319|NCT01850082|VA Boston Healthcare System|Marco Zenati, M.D.|857-203-6815|Marco.Zenati@va.gov|
21240320|NCT01680458|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21240321|NCT02138747|Astellas Pharma US, Inc.|Clinical Trial Disclosure||Astellas.resultsdisclosure@astellas.com|
21240322|NCT00183443|Stanford University|Dr. Patricia Suppes|6504935000|tsuppes@Stanford.edu|62567
21240323|NCT01378520|Dartmouth-Hitchcock|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org|
21240324|NCT00547105|UT Southwestern Medical Center|Director of Clinical Trial||ClinicalTrials@utsouthwestern.edu|
21240325|NCT00220961|University of Texas Health Science Center at San Antonio|Ralph DeFronzo, MD|210-567-6691|defronzo@uthscsa.edu|
21240326|NCT03406702|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
21240327|NCT00601003|Beat Childhood Cancer|Giselle Sholler, MD|704-381-9900|Giselle.Saulniersholler@atriumhealth.org|
21240328|NCT04858295|University of Pennsylvania|Dr. Sarah Schrauben|267-324-7588|sarahsch@upenn.edu|
21240329|NCT06211296|Pi-Cardia|Hadas Givon, VP CA/RA|+972-8-9484800|hadas@pi-cardia.net|
21240330|NCT01040780|Cancer Hospital, Chinese Academy of Medical Sciences|Yan Sun, M.D.|0086-010-87788519|zhangheping@csco.org.cn|
21240331|NCT03681639|Zimmer Biomet|Esther Foo|+41792894930|esther.foo@zimmerbiomet.com|
21240332|NCT01432015|Gynecologic Oncology Associates|John P. Micha, M.D.|949-642-5165|Research@gynoncology.com|
21240333|NCT01004250|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21240334|NCT03268590|Case Western Reserve University|Michael John Decker, PhD|216-368-2467|mjd6@case.edu|
21240335|NCT02173535|Johnson & Johnson Vision Care Inc.|Charis Lau, Pharm.D., O.D., FAAO|(904) 443-1293|MLau87@ITS.JNJ.com|
21240336|NCT04204772|University of Minnesota, Department of Medicine|Armin Rashidi, MD, PhD|612-624-0123|arashidi@umn.edu|
21240337|NCT02694640|University of South Carolina|Dr. Bernardine Pinto|8037779272|pintob@mailbox.sc.edu|
21240338|NCT04076020|University of Pittsburgh|Dr. Jared Magnani|(412)383-0611|magnanij@pitt.edu|
21240339|NCT03410914|Sunnybrook Health Sciences Centre|Dr. Paul Karanicolas|4164806100|paul.karanicolas@sunnybrook.ca|4774
21240340|NCT00855868|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
21240341|NCT00859508|Synthes USA HQ, Inc.|Heidi Hausner, Clinical Research Manager|610-719-5707|hausner.heidi@synthes.com|
21240342|NCT03537261|Massachusetts General Hospital Lurie Center|Lisa Nowinski, PhD|781-860-1700|lnowinski@mgh.harvard.edu|
21240343|NCT00479037|Nycomed|Clinical Trial Operations|+45 4677 1111|clinicaltrials@nycomed.com|
21240344|NCT01316692|Vanderbilt-Ingram Cancer Center|Jeff Sosman, MD|615-875-8359|jeff.sosman@vanderbilt.edu|
21240345|NCT02001974|Dompé Farmaceutici|Pieradelchi Ruffini, MD|+39 (0)2 583831|info@dompe.it|
21279317|NCT03996447|Guerbet|Jing Hao, MD, Global Head of Medical Affairs & Clinical Development|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
21279318|NCT02896712|The University of Texas Health Science Center at Houston|Joy Schmitz, PhD|713-486-2867|joy.m.schmitz@uth.tmc.edu|
21279319|NCT01810302|University of Florida|Dr. Spiros Blackburn|(352) 273-9000|spiros.blackburn@neurosurgery.ufl.edu|
21279320|NCT01613768|University of Washington|Research Manager|206-606-7445|smasters@seattlecca.org|
21279321|NCT04981717|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
21279322|NCT02207634|Amgen Inc.|Study Director|866-572-6436||
21240346|NCT00993317|Korea Otsuka Pharmaceutical|Eun Young Cho, Clinical Trial Manager|+82-2-3287-9233|hyerim@otsuka.co.kr|
21240347|NCT01380990|UCL Institute of Child Health|Dr Claire Booth|+44207 905 2198|C.Booth@ucl.ac.uk|
21240348|NCT02354963|IIS La Fe|Dr Cesar Diaz-Garcia|961 24 67 00|cesar.diaz@ivirma.com|
21240349|NCT04422639|University of Arkansas for Medical Sciences|Assistant Director of Cancer Clinical Trials|501-686-8274|bscanlan@uams.edu|
21240350|NCT03121534|The University of Texas MD Anderson Cancer Center|Philip Thompson MD.|713-745-5732|PAThompson2@mdanderson.org|
21240351|NCT02374593|Riley Hospital for Children|Dr. Erica Eugster|317 944-3889|eeugster@iu.edu|
21240352|NCT01284140|University of Iowa|Brian K. Gehlbach, MD|319-356-3603|brian-gehlbach@uiowa.edu|
21240353|NCT01463293|Fonterra Research Centre|Dr James Dekker|+64 6 350 6323|james.dekker@fonterra.com|
21240354|NCT02796963|UNC Project-China|Dr. Weiming Tang|+86-21-83755824|weimingtangscience@gmail.com|
21240355|NCT03192215|Columbia University|Mitchell S.V. Elkind, MD, MS, FAHA/ Randolph S. Marshall, MD, MS (trial investigators)|212-305-1710/ 212-305-8389|mse13@cumc.columbia.edu, rsm2@cumc.columbia.edu|
21240356|NCT02593032|University of Pennsylvania|Dr. Nalaka Gooneratne|215 573 2048|ngoonera@pennmedicine.upenn.edu|
21240357|NCT02038764|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21240358|NCT03853317|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
21240359|NCT01306175|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21240360|NCT04844918|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21240361|NCT00110513|GTC Biotherapeutics|Denise Tilton, RN, MHA, Director Clinical Affairs|508-370-5257|denise.tilton@gtc-bio.com|
21240362|NCT01990820|NorthShore University HealthSystem|Dr. Mark Gerber|847-504-3300|mgerber@northshore.org|
21240363|NCT01009047|Janssen Research & Development, LLC|Senior Director, Clinical Leader|+1-609-730-2436||
21240364|NCT02731313|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21240365|NCT04716881|Go Medical Industries, Pty Ltd|Director of Operations|61(8) 9388 1700|ctc@gomedical.com.au|
21240366|NCT01716208|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
21240367|NCT02029040|UT Southwestern Medical Center|Mohamed Badawy, MD|2144567106|Mohamed.Badawy@UTsouthwestern.edu|
21240368|NCT01630590|UT MD Anderson Cancer Center|Dr. Paul Corn, Chair Ad Interim, Genitourinary Medical Oncology|(713) 563-7208|pcorn@mdanderson.org|
21240369|NCT01017653|Preston Robert Tisch Brain Tumor Center|Annick Desjardins||annick.desjardins@dm.duke.edu|
21240370|NCT02366936|Duke University Health System|Dr. William Malcolm|919-681-4913|william.malcolm@duke.edu|
21240371|NCT01751113|GlaxoSmithKline|GSK Response Center|866-435-7343||
21240372|NCT02878213|EPD Solutions|Chen Sagy Bross|+972-50-5560073|chensb@epd-medical.com|
21240373|NCT00363896|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
21240374|NCT01558674|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21240375|NCT00785538|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21240376|NCT00322374|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21240377|NCT03897205|Hansa Biopharma AB|Vice President Research and Development|+4646165670|info@hansabiopharma.com|
21240378|NCT01272882|ChristianaCHS|Gerard Fulda|302-733-4260|gfulda@christianacare.org|
21240379|NCT01000376|Eisai|Dr. Peter Tarassoff|888-422-4743||
21240380|NCT02269943|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
21240381|NCT01952301|Perio Health Professionals, PLLC|Dr. Michael K. McGuire|713-783-5442|mkmperio@swbell.net|
21240382|NCT04285229|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21240383|NCT04793464|University of Oregon|Dr. Leslie Leve|541-346-9528|leve@uoregon.edu|
21240384|NCT00762021|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21240385|NCT00845871|Novartis pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21240386|NCT03729024|RxSight|Jeffrey Ha, Senior Director of Clinical Research|949-521-7870|jha@rxsight.com|
21240387|NCT04394247|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21240388|NCT04318093|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21240389|NCT02559609|UConn Health|Sheia Alessi|860-679-1849|salessi@uchc.edu|
21240390|NCT00655551|UCB, Inc|UCB Clinical Trial Call Center|+1 877 822 9493||
21240391|NCT01734434|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21240392|NCT02855164|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
21240393|NCT00876460|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21240394|NCT02956434|VA Boston Healthcare System|Dr. Johanna Thompson-Hollands|857-364-2311|johanna.thompson-hollands@va.gov|
21240395|NCT02049710|Carnegie Mellon University, Social and Decision Sciences|Mandy Lanyon, Research Associate II|4122683249|mandy@cmu.edu|
21240396|NCT00003458|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
21240397|NCT01216293|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21240398|NCT03391960|3M|Helen Han|651-737-9234|mhan3@mmm.com|
21240399|NCT05819619|Hackensack Meridian Health|Melissa M. Figueroa, MD, MPH, FACOG|551-996-8400|melissa.figueroa@hmhn.org|
21240400|NCT00581113|Virginia Commonwealth University|Martha D. Wellons|804-628-1939|mwellons@vcu.edu|
21240401|NCT01818141|Hartford Hospital|Dr. David P. Nicolau, PharmD, FCCP, FIDSA|860-972-3941|david.nicolau@hhchealth.org|
21291001|NCT01378195|Photozig, Inc.|Bruno Kajiyama|650-694-7496|info@photozig.com|
21240402|NCT01222832|SEMC|Peter catalano|617-789-5004|peter.catalano@steward.org|
21240403|NCT01554982|Keryx|Lisa Loram|919-434-6195|lisa.loram@keryx.com|
21240404|NCT00678444|UPittsburgh|Dr. Jerry Lowder|314-747-1402|lowderj@wudosis.wustl.edu|
21291002|NCT00425555|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21291003|NCT03787615|The Pennsylvania State University|Dr. David Conroy|814-863-3451|conroy@psu.edu|
21291004|NCT00492544|GlaxoSmithKline|GSK Response Center|866-435-7343||
21291005|NCT04661839|Emergent BioSolutions Canada Inc.|Clinical Development Representative|204-275-4074|ctgov@ebsi.com|
21291006|NCT01946880|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21291007|NCT02609503|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
21291008|NCT02034565|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21291009|NCT01531335|Pontificia Universidad Javeriana|Dr Saul Rugeles|5715946161|rujeles@javeriana.edu.co|2240
21291010|NCT00802503|Geneva University Hospitals, Division of Intensive Care,Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14/Switzerland|Dr CP Heidegger|+41223827440|claudia-paula.heidegger@hcuge.ch|
21291011|NCT00721110|Cleveland Clinic|Daniel Sessler, MD|216-444-4200|sesslerd@ccf.org|
21291012|NCT01833078|University of Pennsylvania|Dr. Anne Cappola, PI|215-573-5359|acappola@mail.med.upenn.edu|
21291013|NCT05781685|UT Southwestern Medical Center|Chance Ryan Strenth|337-274-7647|chance.strenth@utsouthwestern.edu|
21291014|NCT02871440|University of New South Wales|Dr Jacqueline Tan|+61 (02) 9385 6551|jacqueline.tan@unsw.edu.au|
21291015|NCT04079920|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21291016|NCT03760068|Sr. Director Global Clinical Operations, General Medicine|Keri L. Vaughan|+1 267.980.5015|keri.vaughan@mylan.com|
21291017|NCT01618708|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21291018|NCT02915601|University of Colorado Anschutz Medical Campus|Dr. Jessica Kendrick|3037244837|Jessica.Kendrick@cuanschutz.edu|
21291019|NCT05014919|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
21261388|NCT04974307|National Institute of Child Health and Human Development (NICHD)|Dr. An Ngoc Dang Do|301-496-8849|an.dangdo@nih.gov|
21291020|NCT00680914|GlaxoSmithKline|GSK Response Center|866-435-7343||
21291021|NCT01848457|The Children's Hospital of Philadelphia|Frank Balis, MD|2674265414|balisf@email.chop.edu|
21291022|NCT02940223|UT MD Anderson Cancer Center|Sriram Yennu,Professor, MD- Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
21261389|NCT05110300|Gaylord Specialty Healthcare|John Corbett|2032943224|jcorbett@gaylord.org|
21261390|NCT01843374|AstraZeneca|Paul Stockman, MD, PhD|+44 162-523-1815|Paul.Stockman@astrazeneca.com|
21261391|NCT01826214|Novartis Pharmaceuticals|Study Director|82-778-8300|trialandresults.registries@novartis.com|
21261392|NCT00955110|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
21261393|NCT01332435|GlaxoSmithKline|GSK Response Center|866-435-7343||
21261394|NCT03704051|California Polytechnic State University|Dr. Alison Ventura|(805) 756-5693|akventur@calpoly.edu|
21261395|NCT01382186|Center of Innovation on Disability and Rehabilitation Research|Dr. Jolie Haun|813-558-7622|jolie.haun@va.gov|
21261396|NCT03348683|Icahn School of Medicine at Mount Sinai|Dr. Catherine A Bigelow|651-206-9069|cassie.bigelow@gmail.com|
21261397|NCT04573777|UCaliforniaLA|David Liebeskind|‭(310) 963-5539‬|dliebeskind@mednet.ucla.edu|
21261398|NCT00678496|University of Sheffield|Daniel Hind, Assistant Director, Sheffield CTRU|+441142220707|d.hind@sheffield.ac.uk|
21233918|NCT04681482|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21233919|NCT00642668|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21233920|NCT01586819|Loyola University Chicago|Rebecca Tung, M.D.|708-216-8000|rtung@lumc.edu|
21233921|NCT00896337|Boston Scientific|Angela Schutt|763-494-2166|schutta@bsci.com|
21233922|NCT00265512|VA Center for Innovation to Implementation|Todd Wagner|6504935000|todd.wagner@va.gov|22048
21233923|NCT04222712|Tarsier Pharma|COO|+972508371319|zohar@tarsierpharma.com|
21233924|NCT00868712|Walter Reed Army Medical Center, Cardiology Service|Todd C. Villines, MD|301-295-7839|todd.villines@us.army.mil|
21233925|NCT00828191|IBSA Institut Biochimique SA|IBSA U.S. Agent|805 376 00 78|cejtwsxx@verizon.net|
21233926|NCT02204748|The University of Tennessee|Adrija Sharma, Ph. D.|8659742093|asharma1@utk.edu|
21233927|NCT01132495|St. Jude Medical|Sr. Director, Global Clinical Affairs|651-756-5586|jmifek@sjm.com|
21233928|NCT03007758|Prisma Health|Abby Birrell, Study Coordinator|8645222117|abby.birrell@prismahealth.org|
21233929|NCT01796197|Dana-Farber Cancer Institute|Beth Overmoyer, MD, FACP|617.632.3800|beth_overmoyer@dfci.harvard.edu|
21233930|NCT00244712|GlaxoSmithKline|GSK Response Center|866-435-7343||
21233931|NCT01519882|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
21233932|NCT01077804|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21233933|NCT02776917|University of California, San Diego|Barbara Parker, MD|(858) 657-6100|baparker@health.ucsd.edu|
21233934|NCT04041869|University of Iowa|Lucas Carr|319-353-5432|lucas-carr@uiowa.edu|
21233935|NCT00574405|Arkansas Children's Hospital Research Institute|Kathryn Thrailkill, MD|501-364-1430|thrailkillkathrynm@uams.edu|
21261399|NCT02927223|Vanderbilt University Medical Center|Dr. Prince Kannankeril|615-322-7447|prince.kannankeril@vumc.org|
21279323|NCT02052011|Yale School of Medicine|Dr. Basmah Safdar|2037853453|basmah.safdar@yale.edu|
21279324|NCT03551821|Aclaris Therapeutics|Executive Director Clinical Operations|4843247933|jschnyder@aclaristx.com|
21233936|NCT01336738|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21233937|NCT01083433|Rainbow Babies and Children's Hospital|Sarah A. MacLeish, DO|216-844-3661|sarah.macleish2@uhhospitals.org|
21279325|NCT01851330|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21279326|NCT02318303|Glenmark Pharmaceuticals Ltd|Cathy Tyrrell|91 2267720000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
21279327|NCT00242632|Stanford University|Dr. Natalie Rasgon|(650) 724-6689|natalie.rasgon@stanford.edu|
21279328|NCT03300843|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|steven-rosenberg@nih.gov|
21240405|NCT02169830|Saint Louis University|Dr. Anthony A Mikulec|314-977-8884|anthony.mikulec@health.slu.edu|
21240406|NCT03204695|Coherex Medical, Inc.|Senior Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21240407|NCT04834362|National Institute of Neurosciences and Hospital, Dhaka|Dr. Mashfiqul Hasan|+8801816268746|mashfiqul.hasan@nins.gov.bd|
21291023|NCT00143845|University of Michigan Comprehensive Cancer Center|Dr. John Levine, M.D.|734-936-8456|jelevine@umich.edu|
21291024|NCT00521352|Columbia University Department of Psychiatry, City University of New York|Dr. Antonio Mantovani|212-650-5417|AMantovani@med.cuny.edu|
21291025|NCT03773562|Mayo Clinic|Dr. Todd Schwedt|480-342-2695|schwedt.todd@mayo.edu|
21291026|NCT03555994|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21291027|NCT01111552|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21291028|NCT02097225|Massachusetts General Hospital|Ryan Sullivan, MD|617-643-3614|RSULLIVAN7@PARTNERS.ORG|
21291029|NCT05135754|Coloplast A/S|Senior Clinical Strategy Project Manager|+4549111341|dkteaa@coloplast.com|
21291030|NCT01027351|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21291031|NCT04650893|University of Nebraska Medical Center|Peter Danielson|402-559-1703|peter.danielson@unmc.edu|
21291032|NCT04091438|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21291033|NCT04309500|University of Michigan|Annalise M. Rahman-Filipiak|734-763-9259|rahmanam@med.umich.edu|
21291034|NCT00637156|Medtronic Spine and biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
21233938|NCT02383667|The University of Toledo|Saima Karim, DO|419-383-3697|Saima.Karim@utoledo.edu|
21233939|NCT01332149|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21233940|NCT04982029|Brigham and Women's Hospital|Dr. Joji Suzuki|617-455-7981|jsuzuki2@bwh.harvard.edu|
21233941|NCT04615949|CardiolRx|Andrea B. Parker, MSc. PhD, Senior Director Clinical Operations|+1 289 9100862|andrea.parker@cardiolRx.com|
21233942|NCT03036566|University of Michigan|Dennis J. Fasbinder, DDS|7346474450|djfas@umich.edu|
21233943|NCT05458856|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
21233944|NCT04320940|Hikma Pharmaceuticals|Amy Schutte|440-201-5010|aschutte@Hikma.com|
21233945|NCT00110812|University of Minnesota|Deborah Wentworth|612-726-9005|wentw001@umn.edu|
21233946|NCT01344369|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21233947|NCT01886833|CIDRZ|Dr. Roma Chilengi|+2609173724935|Roma.Chilengi@cidrz.org|
21233948|NCT01454726|Xuan Wu Hospital of Capital Medical University|Dr. Jianping JIA|0086-10-83198899|jiajp@vip.sina.com|8650
21233949|NCT01661712|2Guy's and St Thomas' NHS Foundation Trust, Lane Fox Respiratory Unit/Sleep Disorders Centre, London, UK|Dr Joerg Steier|020 7188 3430|joerg.steier@gstt.nhs.uk|
21233950|NCT02919670|DFCI|Kelly Masone|6176324167|kmasone@partners.org|
21233951|NCT01714310|University of California, Los Angeles|James J. McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu|
21233952|NCT01641367|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21233953|NCT00826267|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21233954|NCT02146482|Stanford University|Grant Ognibene|9518343465|grantog@stanford.edu|
21233955|NCT01675882|DBV Technologies|Chief Medical Officer|33-1-55-42-78-78|clinicaltrials@dbv-technologies.com|
21233956|NCT00850200|University of Florida Proton Therapy Institute|Bradford Hoppe, MD, MPH|904-588-1800|bhoppe@floridaproton.org|
21233957|NCT00112242|Department of Oncology, Division of Medical Oncology University Hospital Lausanne|Prof Olivier Michielin|+41 21 314 01 85|Olivier.Michielin@chuv.ch|
21233958|NCT02129803|Virginia Commonwealth University|Bruce K. Rubin MEngr, MD, MBA, FRCPC|804 828 9604|bruce.rubin@vcuhealth.org|
21233959|NCT03917420|UNC Chapel Hill|Amanda Poliseno|919-962-5344|amanda_poliseno@unc.edu|
21233960|NCT02319005|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
21233961|NCT02689258|Heron Therapeutics, Inc.|Clinical Operations|1-800-767-0524|cquaratino-baker@herontx.com|
21233962|NCT03317431|Department of Anesthesia,Xinhua hospital affiliated to Shanghai Jiaotong University School of Medicine|Dr.Lai Jiang|021-25078999|jianglaimz@sina.com|
21233963|NCT00594464|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
21233964|NCT00785486|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlmutual.com|
21233965|NCT00706836|University of California San Diego|Murray B. Stein MD, MPH|858-534-6400|mstein@ucsd.edu|
21233966|NCT00544076|City of Hope|Laura Crocitto, M.D.|626-218-3708|lcrocitto@coh.org|
21233967|NCT02907359|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
21233968|NCT03131440|Northwestern University|Siobhan Phillips|312-503-4235|smphillips@northwestern.edu|
21233969|NCT03892460|University of Vermont College of Medicine|Michael Toth|802-656-7989|michael.toth@med.uvm.edu|
21233970|NCT00746941|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
21233971|NCT01805024|Santhera Pharmaceuticals|Roxana Drake|+41 61 906 89 29|roxana.drake@santhera.com|
21233972|NCT01113632|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21233973|NCT04654117|Department of Psychology, Michigan State University|Dr. Brooke Ingersoll, Professor|517-432-8412|ingers19@msu.edu|
21233974|NCT01821534|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21233975|NCT02197806|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21233976|NCT03352323|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
21233977|NCT03065244|Dept. of Pediatrics UCSD School of Medicine|Dr. Jane Burns|858-246-0155|jcburns@health.ucsd.edu|
21233978|NCT00500292|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21233979|NCT05218018|University of Washington|Angela Hanson|206-897-5393|hansonaj@uw.edu|
21233980|NCT03035955|WakeForest|Director of Clinical Trials|336-716-3775||
21291035|NCT00461812|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
21291036|NCT02679274|University of Texas Medical Branch|Dr. Edgar L. Dillon|409 772 8701|eldillon@utmb.edu|
21291037|NCT01308788|Indiana University|Alon Harris|3170278-0177|alharris@indiana.edu|
21291038|NCT00322218|Spectrum Pharmaceuticals,Inc.|Gajanan Bhat|949-743-9219|gajanan.bhat@sppirx.com|
21291039|NCT04548219|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21291040|NCT04976855|Indivior Inc.|Global Director Clinical Development|(804) 594-4488|trialdisclosure@indivior.com|
21291041|NCT05487378|APR Applied Pharma Research s.a.|Chief Scientific Officer|+41.91.6957020|giorgio.reiner@apr.ch|
21291042|NCT04603560|Brigham and Women's Hospital|Nancy Haff, MD, MPH|617-278-0930|nhaff@mgb.org|
21291043|NCT04778709|NYU College of Dentistry|Aikaterini Georgantza|212-998-9986|ag4222@nyu.edu|
21291044|NCT04136288|Mayo Clinic|Chandler Chapman, DHSc, MPH, Senior Clinical Research Coordinator|9049538681|Chapman.Chandler@mayo.edu|
21291045|NCT03053362|Brain and Cognition Discovery Foundation|Dr. Roger McIntyre|(416) 943-6284|rogermcintyre28@gmail.com|
21291046|NCT06003829|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21291047|NCT02842242|MyoKardia Inc.|Dr. Amy Sehnert|650-741-7798|asehnert@myokardia.com|
21291048|NCT02397720|The University of Texas MD Anderson Cancer Center|Naval Daver MD./Professor|713-794-4392|NDaver@mdanderson.org|
21291049|NCT00908141|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Robert Dreicer MD|216-445-4623|dreicer@ccf.org|
21291050|NCT00003645|UT MD Anderson Cancer Center|Dr. Curtis A. Pettaway, M.D.- Professor, Urology|713-792-7734|cpettawa@mdanderson.org|
21291051|NCT00834574|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21291052|NCT01397253|University of Pittsburgh|Kenneth J Smith, MD, MS|4126474794|smithkj2@upmc.edu|
21291053|NCT02947984|Massachusetts General Hospital|Nina Sanford, MD||NSANFORD@PARTNERS.ORG|
21291054|NCT00980044|University of Kentucky College of Medicine|Michelle Lofwall, MD, Associate Professor|8593239321|michelle.lofwall@uky.edu|
21291055|NCT04378153|Seattle Children's|Margaret Kloster|206-884-7862|margaret.kloster@seattlechildrens.org|
21291056|NCT00500331|GlaxoSmithKline|GSK Response Center|866-435-7343||
21291057|NCT00734032|GlaxoSmithKline|GSK Response Center|866-435-7343||
21291058|NCT02489279|Think Now, Inc.|Dr. Gregory V. Simpson|4156016522|greg@think-now.com|
21291059|NCT02263547|University of South Florida, COM Neurology|Assistant Director of Research|8139746378|aaungst@health.usf.edu|
21291060|NCT00856557|Jesse Brown VA Medical Center|Dr. Saul J. Weiner|3125192697|Saul.Weiner@va.gov|
21291061|NCT02301897|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21291062|NCT03673176|Stanford University|Joseph Shrager, MD|(650) 721-2086|shrager@stanford.edu|
21291063|NCT00337168|SWOG Statistical Office|SWOG Leukemia Statistician|206-667-4623||
21291064|NCT01189760|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21291065|NCT01230060|Bausch & Lomb Incorporated|Jon Hayashida|(949) 521-7876|jon.hayashida@bausch.com|
21291066|NCT03802916|Chiesi Canada Corp.|Fernando Tricta, MD|1-416-558-6342|ftricta@chiesi.com|
21240408|NCT01868789|Orthopedic Foot and Ankle Center|Dr. Gregory Berlet|6148958747|ofacresearch@orthofootankle.com|
21240409|NCT02555371|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21240410|NCT03095599|IVAC|Le Van Be|(+84 90) 3501529|ivaclevabe@dng.vnn.vn|
21240411|NCT00299689|James Graham Brown Cancer Center, University of Louisville|Dr. Jason Chesney|502/852-3679|jaches03@exchange.louisville.edu|
21240412|NCT00968838|The University of Texas M D Anderson Cancer Center|Dr. Emil J. Freireich MD/Professor|713-792-2660|eharriso@mdanderson.org|
21240413|NCT00742885|GlaxoSmithKline|GSK Response Center|866-435-7343||
21240414|NCT04781647|Assembly BioSciences Inc.|Director of Clinical Operations|415-366-5172|psalstrand@assemblybio.com|
21261400|NCT01981187|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21291067|NCT01285102|Fox Chase Cancer Center|Dr. Efrat Dotan|215-214-4283|Efrat.Dotan@fccc.edu|
21291068|NCT04189484|U.S. Food and Drug Administration|David Strauss, MD, PhD|3017966323|David.Strauss@fda.hhs.gov|
21291069|NCT03524157|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
21291070|NCT04507763|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21291071|NCT03322566|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
21291073|NCT05763381|The Geneva Foundation|Elizabeth Metzger, Scientific Program Manager|253-383-1398|emetzger@genevausa.org|
21291074|NCT00841815|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21291075|NCT03729609|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21291076|NCT04805593|Alcon Research, LLC|Clinical Projects Director, Surgical|18884513937|alcon.medinfo@alcon.com|
21291077|NCT02997085|Baylor Scott & White Research Institute|Dr. Mark Powers|2148652409|Mark.Powers1@bswhealth.org|
21291078|NCT01661283|SARC|SARC|(734) 930-7600|sarc@sarctrials.org|
21240415|NCT00777803|Merz Pharmaceuticals GmbH|Matthias Zerm|+49 69 1503|matthias.zerm@merz.de|865
21261401|NCT01362322|GlaxoSmithKline|GSK Response Center|866-435-7343||
21291079|NCT02327169|Takeda|Takeda Study Registration Call Center|+1-866-835-2233|GlobalOncologyMedinfo@takeda.com|
21291080|NCT01847014|Actelion Pharmaceuticals US, Inc.|Scott Tsurutani|6508086586|scott.tsurutani@actelion.com|
21291081|NCT01704157|Pacira Bioscience, Inc.|Pacira MedInfo|1-855-793-9729|MedInfo@Pacira.com|
21240416|NCT01755689|GlaxoSmithKline|GSK Response Center|866-435-7343||
21291082|NCT06582732|Glaukos Corporation|Study Director|714-478-2287|ldoan@glaukos.com|
21291083|NCT03931330|Medical College of Wisconsin|Gisela Chelimsky, MD|414-266-3690|gchelimsky@mcw.edu|
21291084|NCT03412929|Medline Industries, Inc|Stephanie Martynenko|2242163822|smartynenko@medline.com|
21291085|NCT04897568|University of Colorado|Dan Mattlock|(303)724-9941|daniel.matlock@cuanschutz.edu|
21291086|NCT06301815|University of Winchester|Amelia Shaw|01962 717478|a.shaw2.18@unimail.winchester.ac.uk|
21291087|NCT04481685|University of Kansas Medical Center|Gregory Gan, MD PhD|913 588 5881|ggan@kumc.edu|
21291088|NCT00581919|University of Wisconsin Hospital and Clinics|Dr. Natalie Callander|608-265-8690|nsc@medicine.wisc.edu|
21291089|NCT03900650|Arizona State University|Kelly Cue Davis|602-496-3217|Kelly.Cue.Davis@asu.edu|
21291090|NCT00823797|University of Washington|Maciej Mrugala, MD, PhD, MPH|206-543-4069|mmrugala@uw.edu|
21291091|NCT02014376|Amicus Therapeutics, Inc.|Patient Advocacy|+1-609-662-2000|clinicaltrials@amicusrx.com|
21291092|NCT01202162|Northwestern University|Gildasio De Oliveira, M.D.|312-926-8371|g-jr@northwestern.edu|
21291093|NCT02298946|National Cancer Institute|Dr. Tim F. Greten|301-451-4723|gretentf@mail.nih.gov|
21291094|NCT04197583|Boston Scientific|Director, Clinical Operations|5133058628|teresa.takle-flach@bsci.com|
21291095|NCT03193437|Georgetown University|Chul Kim, MD|(202) 444-2223|Chul.Kim@gunet.georgetown.edu|
21291096|NCT01385995|Brigham and Women's Hospital|Dr. Susan Redline|857-307-0352|sredline1@rics.bwh.harvard.edu|
21291097|NCT02414841|Proteon Therapeutics, Inc|Steven Burke, MD|781-890-0102|Clinical@ProteonTx.com|
21291098|NCT00112385|Brigham and Women's Hospital|A Pilot Study of Etanercept in Dermatomyositis|617-732-8046|aamato@partners.org|
21291099|NCT05697380|University of Chicago|Dr. Emily Rogalski|855-824-7887|emily.rogalski@bsd.uchicago.edu|
21291100|NCT05293314|Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, School of Medicine, Tongji University，Shanghai, China|Jin-Fu Xu|008621 65115006|jfxu@tongji.edu.cn|
21297126|NCT01107665|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
21297127|NCT02566590|University of Utah|Micah Drummond|8015877764|micah.drummond@hsc.utah.edu|
21297128|NCT01115673|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
21297129|NCT03043391|Istari Oncology|W. Garret Nichols, MD MS|919-245-7662|info@istarioncology.com|
21297130|NCT03047031|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21297131|NCT03304119|Hôpital Privé Antony|V Chassaing|+33 1 46 74 37 00|vchassaing92@gmail.com|
21297132|NCT00666224|Teva Pharmaceutical Industries, Ltd.|Yossi Gilgun, PhD, Global Clinical Leader|972-9-863-1491|yossi.gilgun@teva.co.il|
21297133|NCT03521141|Vanderbilt University Medical Center|Stephen King|615-875-9394|stephen.king@vumc.org|
21297134|NCT01350232|Thomas Jefferson University|Joanne Filicko-O'Hara, MD|215-955-8874|jef001@jefferson.edu|
21297135|NCT00491491|Chaim Sheba Medical Center|Dr Avichai Shimoni|972 3 530 5303|ashimoni@sheba.health.gov.il|
21297136|NCT00610311|National Cancer Institute, National Institues of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
21297137|NCT01721226|George Washington University|Dr. Irene Kuo|202-994-0367|ikuo@gwu.edu|
21297138|NCT00705367|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21297139|NCT02277925|University of North Carolina at Chapel Hill|Jennifer Wu, MD, MPH|919-966-0014|jennifer_wu@med.unc.edu|
21297140|NCT00303485|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21297141|NCT01959139|SWOG Statistical Center|SWOG Statistician|2066674623|mduong@fredhutch.org|
21297142|NCT02133781|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
21297143|NCT01193114|The Ohio State University|Dr. Natasha Slesnick|614 247-8469|slesnick.5@osu.edu|
21297144|NCT01378325|AUBMC|Sahar Siddik-Sayyid|9611350000|ss01@aub.edu.lb|6380
21297145|NCT01559675|Cedars Sinai Medical Center|Dr. Phillip Fleshner|310-289-9224|pfleshner@aol.com|
21297146|NCT01496469|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21297147|NCT00635167|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Edouard Trabulsi|215-955-1000|edouard.trabulsi@jefferson.edu|
21297148|NCT01963845|University of California, San Diego|Rohit Loomba, MD professor of Medicine|858-543-2230|roloomba@ucsd.edu|
21297149|NCT00193180|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
21297150|NCT03274414|Memorial Sloan Kettering Cancer Center|Dr. Marc Cohen, MD|212-639-3769|cohenm2@mskcc.org|
21297151|NCT00891228|NICHD|H. Trent MacKay, MD, MPH|301-435-6988|mackayt@mail.nih.gov|
21297152|NCT00118742|Hoffmann-La Roche|Medical Communications|800-821-8590||
21297153|NCT02381015|Wake Forest University Health Sciences|Dr. Aubrey R. Turner|336-918-3585|aubreyturner@gmail.com|
21297154|NCT00904488|UNC Eshelman School of Pharmacy|Dr. Jo Ellen Rodgers|(919) 962-2249|jerodgers@unc.edu|
21297155|NCT02688985|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
21297156|NCT02445326|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com|
21297157|NCT00930553|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21297158|NCT01964963|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21233981|NCT03560531|Zeno Alpha Inc.|Head of Regulatory Affairs|(858) 263-4333|RegLeads@zentalis.com|
21297159|NCT01235234|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il|
21240417|NCT04448236|Haven of Hope hospital, Hospital Authority|Dr. Lau Chung Wai|27038888|lcw431@ha.org.hk|
21240418|NCT02930122|University of Kentucky|Dr. Cale Jacobs|859-218-3065|cale.jacobs@uky.edu|
21240419|NCT01995357|Coloplast A/S|MD, Medical Director|+45 4911 1395|dkbir@coloplast.com|
21240420|NCT02609659|AbbVie|Global Medical Services|800-633-9110||
21240421|NCT03943589|Hansa Biopharma AB|Vice President Research and Development|+4646165670|info@hansabiopharma.com|
21240422|NCT04329104|National Institute of Allergy and Infectious Diseases (NIAID)|Dr. Peter Crompton|301-761-5042|pcrompton@niaid.nih.gov|
21240423|NCT00225420|Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
21240424|NCT02802020|Boston Scientific Corporation|Brian Vatcher|+1-508-683-5274|brian.vatcher@bsci.com|
21240425|NCT01474512|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21240426|NCT01238575|Emory University|Lawrence Scahill, MSN, PhD||lawrence.scahill@emory.edu|
21240427|NCT02516579|Addmedica|Medical director|+33172690186|corinne.duguet@addmedica.com|
21240428|NCT04764929|Columbia University|Patrick Wilson, MD|212-305-8458|ptw2107@cumc.columbia.edu|
21240429|NCT02338713|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21240430|NCT00883103|Baystate Medical Center|Oz Harmanli, MD|4137945608|oz.harmanli@baystatehealth.org|
21240431|NCT05584657|Iterum Therapeutics|Senior Vice President and Head of Clinical Development|8606614035|saronin@iterumtx.com|
21240432|NCT02254421|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21240433|NCT00867490|Novartis Pharmaceuticals|Study Director|862 778-8300||
21240434|NCT00358150|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21240435|NCT00531011|Abbott Vascular, Italy|Maria Jose' M. Lopera|+39-02-516251|mariajose.lopera@av.abbott.com|
21240436|NCT02823964|Anthera Pharmaceuticals|Nicole Ramza|510-856-5600|info@anthera.com|
21240437|NCT01177813|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21240438|NCT02368002|University of Minnesota|Nancy Sherwood|612-625-4567|sherw005@umn.edu|
21240439|NCT04011384|University of Pennsylvania|Dr. Laura Gibson|215-898-7093|gibla@pennmedicine.upenn.edu|
21240440|NCT01598428|Shandong University|Dr.Yang Gao|0086-543-89268587|pinkapples@126.com|
21240441|NCT00924469|Janssen Research & Development, LLC 10990 Wilshire Blvd, Suite 1200 Los Angeles, CA 90024|Senior Director, Clinical Research|(310) 914-2917||
21240442|NCT00656916|UT MD Anderson Cancer Center|Lara Bashoura, MD / Assistant Professor||CR_Study_Registration@mdanderson.org|
21240443|NCT04147260|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21240444|NCT00630058|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21240445|NCT01651936|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinialTrialsDisclosure@merck.com|
21240446|NCT03044353|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21240447|NCT01079143|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21240448|NCT02162992|H. Germans Trias i Pujol|Dr. Roger Villuendas|+34 4978398|rogervilluendas@hotmail.com|
21240449|NCT01555021|Massachusetts General Hospital, Boston, MA|John D. Matthews, M.D., M.Sc.|617-643-9095|jmatthews@partners.org|
21240450|NCT02204293|Helios Fachklinik Vogelsang-Gommern GmbH, Germany|Prof. Dr Eugen Feist|+49 30 450 513 192|eugen.feist@charite.de|
21240451|NCT01225835|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21240452|NCT03119571|University of Minnesota|Demetri Yannopoulos, MD|6126261382|yanno001@umn.edu|
21291101|NCT02185183|ENZO|Dr. Elazar Rabbani|2125830100|erabbani@enzo.com|
21240453|NCT02589392|Galderma|Stéphanie Leclerc|+33492386706|stephanie.leclerc@galderma.com|
21240454|NCT01266993|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21240455|NCT03051659|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|(877) 442-3324|Sara_Tolaney@dfci.harvard.edu|
21240456|NCT02293837|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21240457|NCT04779242|Paratek Pharmaceuticals Inc|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
21240458|NCT03285113|China Medical University Hospital (in Taiwan)|Dr. Yeong-Ray Wen (Department of Anaesthesia)|+886 4 2205-2121|yray.wen@gmail.com|
21240459|NCT02965144|Rigshospitalet|Karin Piil|0045612078067|Karin.Piil@regionh.dk|
21240460|NCT01076088|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21240461|NCT01757067|University of Maryland Medical Center|Dr. Timm-Michael Dickfeld|410-328-7801|Tdickfel@som.umaryland.edu|
21240462|NCT03053492|Medical University of South Carolina|Michelle Woodbury|843-792-1671|woodbuml@musc.edu|
21240463|NCT02643979|Icahn School of Medicine at Mount Sinai|Dr. Daniel Katz|212-241-7475|daniel.katz@mountsinai.org|
21240464|NCT00849680|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||clinicaltrialsdisclosure@merck.com|
21240465|NCT04267575|Jerome Canady Research Institute for Advanced Biological and Technological Sciences|Jerome Canady, M.D.|301-270-0147|drjcanady@gwu.edu|
21240466|NCT03382600|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21240467|NCT00401102|Iona College|Dr. Colleen Jacobsonn|646-207-3563|cjacobson@iona.edu|
21240468|NCT02452866|Symbiomix Therapeutics|VP Clinical Operations|609-722-7250|nadetoro@symbiomix.com|112
21240469|NCT01414426|UChicago|Dr. Alexander Pearson|855-702-8222|apearson5@medicine.bsd.uchicago.edu|
21261402|NCT01943539|Akili Interactive Labs|SVP of Medical Devices|617-456-0984|skellogg@akiliinteractive.com|
21261403|NCT02123329|Qatar University College of Pharmacy|Dr. Maguy El Hajj|0097444035577|maguyh@qu.edu.qa|
21240470|NCT01857622|Daiichi Sankyo.,LTD|Kenichi Sakakura, Manager|81-90-1885-0271|sakakura.kenichi.ef@daiichisankyo.co.jp|
21240471|NCT03380780|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21240472|NCT01374802|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21291102|NCT01373281|Sanofi Pasteur Inc.|Medical Director||Contact-US@sanofi.com|
21291103|NCT02296476|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21291104|NCT03369158|Medacta International|Clinical Data Manager|+41 91 696 60 60|bonacina@medacta.ch|
21291105|NCT00775658|Vanderbilt Medical Center|John Fahrenholz, M.D.|615-936-2727|john.m.fahrenholz@vanderbilt.edu|
21291106|NCT03502681|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-921-2050|jsmith@hoosiercancer.org|
21291107|NCT00442702|Hoffman-LaRoche|Medical Communications|800-821-8590||
21291108|NCT00313560|Sidney Kimmel Comprehensive Cancer Center|Dr. Amol Narang|410-502-3823|anarang2@jhmi.edu|
21291109|NCT04717258|University of York|Sarah Cockaiyne|01904321736|sarah.cockayne@york.ac.uk|
21291110|NCT03436732|National Cancer Institute|Dr. Raffit Hassan|240-760-6322|rh276q@nih.gov|
21291111|NCT00267488|GlaxoSmithKline|GSK Response Center|866-435-7343||
21291112|NCT02093520|Vertos Medical|VP of Clinical Affairs|9493490008|kdavis@vertosmed.com|
21291113|NCT00851084|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
21291114|NCT03468998|University of Alabama at Birmingham|Ramzi Abou-Arraj|2059341125|rva@uab.edu|
21291115|NCT01892189|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21291116|NCT01467557|Vistakon|Jurandir Araujo|+1 904 443-1379|jaraujo7@its.jnj.com|
21291117|NCT01599286|Children's National Hospital|Robert McCarter|202-476-3140|RMcCarte@childrensnational.org|
21291118|NCT03440411|Fondazione EMN Italy Onlus|Fondazione EMN Italy Onlus|+39 011 0243236|clinicaltrialoffice@emnitaly.org|
21291119|NCT03226691|National Heart Lung and Blood Institute|John Tisdale|+1 301 402 6497|johntis@nhlbi.nih.gov|
21291120|NCT01052779|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
21291121|NCT03663582|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21291122|NCT03427619|University of Iowa|Dr. Richard Smith|319-356-2177|richard-smith@uiowa.edu|
21291123|NCT02853136|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21291124|NCT00605189|KCI, an Acelity Company|Senior Director, Global Clinical Development|210-255-5595|jane.hart@kci1.com|
21291125|NCT02697448|Medical University of South Carolina|George Guldan|(843) 792-2322|guldan@musc.edu|
21291126|NCT05498870|Medical University of South Carolina|Carey Brewbaker|843-792-2322|brewbake@musc.edu|
21291127|NCT06045273|Johns Hopkins Center for Indigenous Health|Dr. Victoria O'Keefe|410-955-6931|vokeefe3@jhu.edu|
21291128|NCT04989218|The University of Alabama at Birmingham|Dr. Mehmet Akce, Associate Professor|2059342992|makce@uabmc.edu|
21291129|NCT02919618|Washington University|Dr. Phillip Cuculich|314-454-7698|pcuculic@wustl.edu|
21291130|NCT02947048|Yamo Pharmaceuticals|Tracy Fischer|8596855862|tfischer@yamopharma.com|
21291131|NCT03658304|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
21291132|NCT01674062|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21291133|NCT03895372|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21291134|NCT03685149|University of Rochester|Dr. Wojciech Zareba|585-275-5391|wojciech_zareba@urmc.rochester.edu|
21291135|NCT01881932|University of Maryland Baltimore Greenebaum Cancer Center|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu|
21291136|NCT02655601|BioMimetix JV, LLC|Sara Penchev|610-308-6640|sara.penchev@bmxpharma.com|
21291137|NCT00356187|Denver Health and Hospital Authority|Elizabeth Kingsley, Senior Grants Analyst|3036027061|elizabeth.kingsley@dhha.org|
21291138|NCT04642079|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21291139|NCT02226653|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21291140|NCT04011241|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21291141|NCT00759395|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21291142|NCT00086515|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21291143|NCT01435356|EAU Research Foundation|Wim P.J. Witjes, MD, PhD Scientific and Clinical Research Director|+31 26 389 0677|w.witjes@uroweb.org|
21291144|NCT02796651|AstraZeneca AB|Global Clinical Leader|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
21291145|NCT04248153|Bracco Diagnostics Inc.|Giordana Marioni, Clinical Trial Assistant|609-514-2282|giordana.marioni@diag.bracco.com|
21291146|NCT02251041|UZLeuven|Diethard Monbaliu|+32 16 348727|diethard.monbaliu@uzleuven.be|
21291147|NCT01046669|Spectral Diagnostics Inc.|Debra Foster, VP Clinical Development|4166263233|dfoster@spectraldx.com|2001
21291148|NCT02971163|Mount Sinai Medical Center|Dr. Marc A. Probst|212-824-8094|marc.probst@mssm.edu|
21291149|NCT00526799|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
21291150|NCT05070819|Petrovsky NRCS|Dr. Artem Gubko|+79684241490|gubko@artvig.ru|
21291151|NCT02871219|The University of Texas MD Anderson Cancer Center|Jason Westin, MD|(713) 792-3750|jwestin@mdanderson.org|
21291152|NCT03975660|Stanford University School of Medicine|Dr. Brendan Carvalho|(650) 861-8607|bcarvalho@stanford.edu|
21291153|NCT03034044|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21291154|NCT04134936|MorphoSys|Medical Information|+1 844 667-1992|medinfo@morphosys.com|
21291155|NCT04629196|NYU Langone Health|David Hudesman, MD|646-501-9327|David.Hudesman@nyulangone.org|
21240473|NCT01291225|Center for Injury Research and Policy|Dr. Gary Smith|614-355-5850|Gary.Smith@Nationwidechildrens.org|
21291156|NCT03792737|Johnson & Johnson Medical Shanghai Ltd.|Xiaolei, Wang|+86 21 33378749|xwang183@its.jnj.com|
21291157|NCT00323622|GlaxoSmithKline|GSK Response Center|866-435-7343||
21291158|NCT03630679|Danone Asia Pacific Holdings|Digital Project Manager|82281172|jill.wong@danone.com|
21291159|NCT02061085|MedSIR|Alicia Garcia|+34 611261467|alicia.garcia@medsir.org|
21233982|NCT03745144|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49 6151-72-5200|service@emdgroup.com|
21233983|NCT01177540|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
21233984|NCT04448210|innovation Research & Training|Dr. Alison Parker|919-493-7700|aparker@irtinc.us|
21233985|NCT04662801|Yale School of Medicine|Dr Valentina Ivezaj, Assistant Professor of Psychiatry|+1 (203) 785-7807|valentina.ivezaj@yale.edu|
21233986|NCT02323854|Medtronic|Dr. Jaime Kean|303-882-6759|Jaime.m.Kean@medtronic.com|
21233987|NCT02818777|University of Colorado|Dr. Maureen Anne Leehey|303-724-2194|maureen.leehey@ucdenver.edu|
21233988|NCT00589316|Fred Hutchinson Cancer Center|Johnnie Orozco, MD, PhD|(206) 667-4102|jorozco@fredhutch.org|
21233989|NCT01883427|Umeå University|MD, PhD Krister Tano|0046705569043|krister.tano@umu.se|
21233990|NCT04697693|New York State Psychiatric Institute|Dr. Bret Rutherford|646-774-8660|bret.rutherford@nyspi.columbia.edu|
21233991|NCT00747435|MED-EL Corporation|Sr. Clinical Research Associate||clinicaltrials@medelus.com|
21233992|NCT01324349|Covidien|Vice President, Medical Affairs|203-500-4256|amy.pollack@covidien.com|
21233993|NCT00748215|University of Texas (UT) MD Anderson Cancer Center|Bryan Kee, MD/Assistant Professor, GI Medical Oncology|713-792-2828|bkkee@mdanderson.org|
21233994|NCT02013167|Amgen Inc.|Study Director|866-572-6436||
21233995|NCT02138461|MDbackline, LLC|John A. Hovanesian, MD|949 951 9248|jhovanesian@mdbackline.com|
21233996|NCT01951339|University of Colorado|Dr. Judy Regensteiner|303-724-2247|judy.regensteiner@ucdenver.edu|
21233997|NCT01113879|The Ohio State University|Stacy Harnish|614-688-1471|harnish.18@osu.edu|
21233998|NCT04151290|Cognoa|Senior Director Clinical Research|4082076659|minda.seal@cognoa.com|
21233999|NCT01449526|Bausch & Lomb Incorporated|Robert Steffen, OD, MS|585-338-6399|robert.steffen@bausch.com|
21234000|NCT00082433|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21234001|NCT01633320|Edouard Herriot hôspital Anaesthesia and intensive care|Dr Emmanuel Boselli|+334711689|emmanuel.boselli@chu-lyon.fr|
21234002|NCT02276612|Gilead Sciences|Clinical Trial Disclosures & Data Transparency|1-833-445-3230|GileadClinicalTrials@gilead.com|
21234003|NCT04097821|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21234004|NCT03003520|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21234005|NCT03264404|Columbia University|Ruth White, MD, PhD|212-342-5162|raw2168@cumc.columbia.edu|
21291160|NCT03538808|University of Alabama at Birmingham|Samantha Schiavon|9515509388|sschiavon@uabmc.edu|
21240474|NCT02768558|RTOG Foundation|Wendy Seiferheld|215-574-3208|wseiferheld@acr.org|
21291161|NCT03709472|University of Miami|Victoria Mitrani|3052849139|vmitrani@miami.edu|
21291162|NCT03506360|Mayo Clinic|Yi Lin|5072845096|Lin.Yi@mayo.edu|
21291163|NCT00723632|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21291164|NCT02085720|Chinese University of Hong Kong|Dr Susanna Ng SS|85226322211|drsssng123@yahoo.com.hk|
21291165|NCT02038036|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21291166|NCT05472870|Shanghai Jiaotong University School of Medicine Xinhua Hospital|Fei Li|18930830950|feili@shsmu.edu.cn|
21291167|NCT00934180|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21291168|NCT03549507|Children's Hospital of Philadelphia|Misun Hwang|267-425-7129|hwangm@chop.edu|
21291169|NCT02613507|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21291170|NCT03048682|Wake Forest Baptist Health|Dr. Catherine Matthews|336-716-4131|camatthe@wakehealth.edu|
21291171|NCT03918031|University of Houston|Brooke Kauffman|(713) 743-8056|byredmond@central.uh.edu|
21291172|NCT04732468|Immunitybio|Lennie Sender, Chief Operating Officer|855-797-9277|lennie.sender@immunitybio.com|
21291173|NCT03514134|University of Michigan|Brittany Ross|(734) 764-2368|rossbrit@umich.edu|
21291174|NCT02471144|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21291175|NCT00710944|DENTSPLY Implants|Senior Manager Global Clinical Research|+46313763500|clinicalresearchmolndal@dentsply.com|
21291176|NCT00791648|Vanderbilt University|Frederic Billings|615-343-6268|frederic.t.billings@vanderbilt.edu|
21291177|NCT00462826|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
21291178|NCT03977155|Boston Pharmaceuticals, Inc.|Craig Basson|(617) 655-9681|clinicaltrials@bostonpharmaceuticals.com|
21291179|NCT00936936|University of Texas MD Anderson Cancer Center|Dr. Yago Nieto, PhD. / Stem Cell Transplantation Department|713-792-8750|ynieto@mdanderson.org|
21291180|NCT00499447|Comprehensive Cancer Center of Wake Forest University|Dr. James Urbanic|336-713-3600|jurbanic@wakehealth.edu|
21291181|NCT02278003|Memorial Sloan Kettering Cancer Center|Dr. Eric Kelhoffer, MD|212-639-8781|kelhoffe@mskcc.org|
21291182|NCT04073056|Icahn School of Medicine at Mount Sinai|Dr. Ali Shariat|212-523-2500|AliNima.Shariat@mountsinai.org|
21291183|NCT03744637|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21291184|NCT04123704|Baylor College of Medicine, Dan L Duncan Comprehensive Cancer Center|Dr. C. Kent Osborne|713-798-1640|kosborne@bcm.edu|
21291185|NCT03440385|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21291186|NCT00488293|Department of Veterans Affairs|John D. Whited, MD, MHS|919-286-6926|john.whited@va.gov|
21291187|NCT00939185|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21291188|NCT02374255|Icahn School of Medicine at Mount Sinai|Radhi Yagnik|212-659-5933|radhi.yagnik@mountsinai.org|
21291189|NCT01798225|Medical University of South Carolina|Renata Leite|843-792-3908|leiter@musc.edu|
21291190|NCT03360344|Loma Linda University|Donnamarie Krause|7347642243|donnamarie.krause@gmail.com|
21291191|NCT00133705|University of Rochester|Dr. Kevin Fiscella|585-271-1206|kevin_fiscella@urmc.rochester.edu|205
21291192|NCT00959049|Seqirus|Clinical Program Director||Seqirus.ClinicalTrials@Seqirus.com|
21291193|NCT03840967|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
21291194|NCT01765400|University of Nebraska Medical Center|Paul P Dobesh|402-559-3982|pdobesh@unmc.edu|
21291195|NCT04881058|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
21291196|NCT01342666|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (INCMNSZ)|Favorable effect of tomato consumption on HDL-c serum levels|525555133891|shiverqks@hotmail.com|
21291197|NCT04033640|PATH|Pooja Bansil|206 302 4920|pbansil@path.org|
21291198|NCT00836706|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21291199|NCT01992757|University of Pennsylvania Hospital|Rupa Chowdary|215-615-4105|rupa.chowdary@uphs.upenn.edu|
21291200|NCT02682056|Emory University|Eric Felner MD|404-727-7651|efelner@emory.edu|
21291201|NCT01943227|UC Davis Medical Center|Neal Fleming, MD, PhD|916-734-5046|nwfleming@ucdavis.edu|
21291202|NCT02332928|Virginia Commonwealth University Massey Cancer Center|Massey Cancer Center Cancer Prevention & Control Team|877-462-7739|masseycpc@vcu.edu|
21291203|NCT01497197|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21291204|NCT04484857|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG4592-096Study@fibrogen.com|
21291205|NCT01425814|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
21291206|NCT00565747|Origio A/S|Chief Scientific Officer|+45 46790200|sbendz@origio.com|
21291207|NCT02684461|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat Canter|(919) 962-0000|gmelahat@med.unc.edu|
21291208|NCT04507204|Purdue Pharma L.P.|Jaromir Mikl, PhD MSPH|800-745-7445|jaromir.mikl@pharma.com|7277
21291209|NCT03580044|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21291210|NCT00498628|NIAAA|Dr. Raye Litten|301-443-0636||
21291211|NCT00863304|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21291212|NCT00478257|UCSD|Dr. Sonia Ancoli-Israel|858 642-7710|sancoliisrael@ucsd.edu|
21291213|NCT01182350|Dana-Farber Cancer Institute|Karen Wright|617.632.6740|KarenD_Wright@dfci.harvard.edu|
21234006|NCT01558700|Northwestern University|Apkar Vania Apkarian|(312) 503-0404|a-apkarian@northwestern.edu|
21261404|NCT04260607|Naval Medical Center Camp Lejeune|Naval Medical Center Camp Lejeune|317-691-1718|nathan.butler@usmc.mil|
21291214|NCT04330859|University of Virginia Children's Hospital|Santina Zanelli|4349242697|sz5d@virginia.edu|
21291215|NCT00361712|Rabin Medical Center|Dr Leonid Edilman|972-9376850|leidelman@clalit.org.il|
21291216|NCT02592863|University of Missouri|Assistant Director of Research|573-882-2549|schneiderri@health.missouri.edu|
21291217|NCT02743221|Institut de Recherches Internationales Servier (I.R.I.S.)|Dr Patrick Therasse|+33 1 55 72 43 47|patrick.therasse@servier.com|
21291218|NCT04547556|UMC Utrecht|Dr Cristina Prat Aymerich|+31631118128|c.prataymerich-2@umcutrecht.nl|
21291219|NCT03411044|Zimmer Biomet|Esther Foo|+41787183202|esther.foo@zimmerbiomet.com|
21291220|NCT02527512|Boston Children's Hospital|Lauren Hutchinson, Clinical Research Manager|6179191632|lauren.hutchinson@childrens.harvard.edu|
21291221|NCT00189475|Allegheny Singer Research Institute, WPAHS|David Skoner, MD|4123594099|dskoner@wpahs.org|
21291222|NCT00815633|Icahn School of Medicine at Mount Sinai|Dr. Joshua Zeichner||joshzeichner@gmail.com|
21291223|NCT01969214|Analyze & Realize|Felix Alt|+49 30 4000 8194|FAlt@a-r.com|
21291224|NCT03485157|MIMEDX|Chief Medical Officer|(770) 651-9100|CTInquiries@mimedx.com|
21261405|NCT02158533|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
21291225|NCT01849276|Northwestern University|Dr. Jessica Altman|312-503-1761|J-altman@northwestern.edu|
21291226|NCT04104477|University of Florida|Jennifer Nichols, Ph.D.|352-294-8803|jnichols@ufl.edu|
21234007|NCT04625803|The First Affiliated Hospital, Zhejiang University School of Medicine|Weijia Fang|+86 87235147|weijiafang@zju.edu.cn|
21291227|NCT04910165|Saint Luke's University Health Network|Dr. Chinenye Nwachuku|6096101054|chinenye.nwachuku@sluhn.org|
21291228|NCT01441492|Baylor College of Medicine|Amy McElhany, Clinical Research Manager|7137981016|pancreas@bcm.edu|
21291229|NCT03135067|University of Pennsylvania|Dr. Harsha Thirumurthy|215-746-0410|hthirumu@upenn.edu|
21291230|NCT05081843|University of Pittsburgh School of Public Health|Dr. Jaime Sidani|412-383-0733|jes107@pitt.edu|
21291231|NCT02365688|Duke University Medical Center, Department of Anesthesiology|Timothy Miller MB ChB, FRCA|(+1) 919 6819660|timothy.miller2@duke.edu|
21291232|NCT00050011|Novartis Pharmaceuticals|Study Director|862-778-8300||
21291233|NCT00835354|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21291234|NCT05572567|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21291235|NCT00821821|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21291236|NCT02605616|University of Virginia|Dr. Rita Basu|434-924-5183|rb4vd@virginia.edu|
21291237|NCT01415453|Columbia University Medical Center|Dr Ronald Silverman|2123055484|rs3072@columbia.edu|
21291238|NCT05528445|Neurosteer|Nathan Intrator, Prof.|+1 (401) 837-0351|nathan@neurosteer.com|
21291239|NCT03648372|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21291240|NCT05964166|Nationwide Children's Hospital|Dr. Joseph Tobias|6147224200|Joseph.Tobias@nationwidechildrens.org|
21291241|NCT04976777|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21291242|NCT00363298|Stanford University Medical Center, Department of Psychiatry|Lorrin M. Koran, M.D.|650 498-5035|lkoran@stanford.edu|
21291243|NCT02956473|Dana-Farber/Brigham Cancer Center|Dr. Tari King|617-582-8292|tking7@bwh.harvard.edu|
21291244|NCT03134209|NYU Langone Health|Ran Schwarzkopf, MD|646-356-9405|Ran.Schwarzkopf@nyulangone.org|
21234008|NCT05087875|University of Kentucky|Carolyn Lauckner|8595623335|carolyn.lauckner@uky.edu|
21234009|NCT01852292|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21234010|NCT01914666|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21234011|NCT01195467|St Stephen's AIDS Trust|Dr Mark Nelson|02033|mark.nelson@chelwest.nhs.uk|155610
21234012|NCT01088646|Givenimaging|Hilla Debby/Director of clinical affairs|97249097774|hila.debby@givenimaging.com|7774
21234013|NCT01572038|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21234014|NCT03711162|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
21234015|NCT02431754|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21234016|NCT01275066|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|(800) 983-4587|medinfo@bmrn.com|
21234017|NCT02281851|University of Birmingham|Mathew Soden|07800549318|matthewsoden33@gmail.com|
21234018|NCT00394212|Davol Inc., Subsidiary of C.R. Bard|Dawn Heimer, Clinical Research|401-825-8681|Dawn.Heimer@crbard.com|
21234019|NCT00588445|Memorial Sloan Kettering Cancer Center|Dr. Charles Rudin|646-888-4527|rudinc@mskcc.org|
21234020|NCT03240133|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
21234021|NCT00554671|Providence VA Medical Center|Wen-Chih Wu, MD|4012737100|wen-chih.wu@va.gov|6237
21234022|NCT00116831|GlaxoSmithKline|GSK Response Center|866-435-7343||
21234023|NCT02945410|Technical University of Munich|Dr. Karsten Koehler|+49 89 289 24488|karsten.koehler@tum.de|
21234024|NCT04904185|National Center for Cancer Immune Therapy (CCIT-DK)|MD, PhD Tine Juul Monberg|38682983|tine.monberg@regionh.dk|
21234025|NCT02061969|Emory University|Saumeth Cardona MD|404-616-4827|scardon@emory.edu|
21234026|NCT03567850|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-2300|Kristopher.Attwood@roswellpark.org|
21234027|NCT01127503|Valeant Pharmaceuticals|Johnson Varughese|9089271400||
21234028|NCT04200248|Ribomic, Inc.|Dr. Yoshikazu Nakamura|81-3-3440-3303|yoshi@ribomic.com|
21234029|NCT00254995|Sanofi Pasteur Inc|Medical Drector||RegistryContactus@sanofipasteur.com|
21234030|NCT02342704|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21234031|NCT00302003|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21234032|NCT01218516|Morphotek (subsidiary of Eisai)|Morphotek (subsidiary of Eisai)|1-888-422-4743|esi_medinfo@eisai.com|
21234033|NCT01539226|International Partnership for Microbicides|Dr John Steytler||jsteytler@ipmglobal.org|
21234034|NCT01632891|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21234035|NCT00935428|OHSU|Dr. John Mayberry|503-494-5300|mayberrj@ohsu.edu|
21234036|NCT04070833|Brigham and Women's Hospital|Pamela M. Rist|617-278-0835|prist@bwh.harvard.edu|
21291245|NCT01198691|TriHealth|Donna Lambers, MD|513-862-2828|donna_lambers@trihealth.com|
21291246|NCT03332056|University of Washington|Jonathan Harper|2065988279|jdharper@uw.edu|
21291247|NCT00730327|Apollo Endosurgery|Laura Eaton, Study Director, RN, BSN, CCRN-R,|949-468-9301|laura.eaton@apolloendo.com|
21291248|NCT01145183|Baylor College of Medicine|Thomas Kosten, MD|713 798 8628|kosten@bcm.edu|
21291249|NCT05012579|Cala Health|Alex Kent|267-973-4180|alex.kent@calahealth.com|
21291250|NCT02989857|Servier Pharmaceuticals LLC|Medical Affairs|888-788-1735|clinical.trial.management@servier.com|
21291251|NCT00688740|sanofi-aventis|International Clinical Development Study Director||Contact-us@sanofi-aventis.com|
21291252|NCT01697709|NYSPI|john mariani. MD|212-923-3031|John.mariani@nyspi.columbia.edu|
21291253|NCT01905540|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21291254|NCT02743962|University of Bradford|Hilary Pape|01274 236228|hpape@bradford.ac.uk|
21291255|NCT00725985|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21291256|NCT01381679|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21291257|NCT05473715|Bayer AG|Therapeutic Area Head|30 300139003|clinical-trials-contact@bayer.com|
21240475|NCT00514046|National Cancer Institute|Dr. Brigitte Widemann|240-760-6203|widemanb@nih.gov|
21240476|NCT00591123|UCLA GI Oncology Program, David Geffen School of Medicine at UCLA|Zev Wainberg, MD|310-829-5471|zwainberg@mednet.ucla.edu|
21240477|NCT01163747|Hoffman-LaRoche|Medical Communications|800-821-8590||
21240478|NCT01404611|Laboratorios SALVAT|Enrique Jimenez, Medical Director|+34933946470|ejimenezv@salvatbiotech.com|
21240479|NCT02044458|Aurora Health Care, Inc.|Jessica J F Kram, MPH|414-219-5594|jessica.kram@aurora.org|
21240480|NCT01682538|Swedish Orphan Biovitrum|Medical Director|+4686972000|erik.brouwer@sobi.com|
21240481|NCT01853254|Hoffmann-La Roche|Medical Communications|800 821-8590||
21240482|NCT02462083|Bausch Health Americas, Inc.|Director of Clinical Operations|1-510-259-5284|aloncaric@bauschhealth.com|
21240483|NCT01642186|Memorial Sloan Kettering Cancer Center|Dr. Ghassan Abou-Alfa, MD|646-824-6566|abou-alg@mskcc.org|
21240484|NCT00163215|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21240485|NCT00739583|Johns Hopkins University|Simon C Mears|410-550-0101|smears1@jhmi.edu|
21240486|NCT01668147|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
21240487|NCT01809210|AstraZeneca|Dr Gabriella Mariani , MD|+44 (0)207 6048000|ClinicalTrialTransparency@astrazeneca.com|
21240488|NCT00315627|University of Miami Miller School of Medicine|Dr. Rodolfo Alejandro|305 243-5324|ralejand@med.miami.edu|
21240489|NCT02662244|UCSD|Dr. Arisa Ortiz|858-657-1697|dermstudies@ucsd.edu|
21240490|NCT01115998|University of Oklahoma Health Sciences Cetner|Director of Sponsored Programs|405-271--2090|mary-cotter@ouhsc.edu|
21240491|NCT00224133|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
21240492|NCT00827944|Derriford Hospital, Department of Surgery|Pr. Andrew KINGSNORTH|+44 175 276 3017|Andrew.Kingsnorth@phnt.swest.nhs.uk|
21240493|NCT03888885|The Chinese University of Hong Kong|Dr. Sum Kim Wai Raymond|+852 39436091|kwsum@cuhk.edu.hk|
21240494|NCT01938664|Baylor College of Medicine|Thomas Kosten, MD|713-794-7032|kosten@bcm.edu|
21240495|NCT01118962|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
21240496|NCT00593554|IndianaU|Dr. Sherif Farag|317-278-0460|ssfarag@iu.edu|
21240497|NCT03796689|University of California, San Fransico|Dr. Mark Pletcher, Professor|415-514-8008|mark.pletcher@ucsf.edu|
21240498|NCT00795132|University of Utah|Dr. Michael Pulsipher|801-588-2680|michael.pulsipher@hsc.utah.edu|
21291258|NCT03528902|Vanderbilt University Medical Center|Research Programs Manager|615-322-4703|ph_research@vumc.org|
21240499|NCT00962585|Ausio Pharmaceuticals, LLC|Rick Schwen, PhD, DABT, RAC / Vice President of Regulatory Affairs|513-731-0222|rick@ausiopharma.com|
21240500|NCT00262743|Mayo Clinic|Dr. Tait Shanafelt||shanafelt.tait@mayo.edu|
21240501|NCT05454449|National Yang-Ming Chiao-Tung University|Yi-Fen Shih, Ph.D Department of Physical Therapy and Assistive Technology|+886-2-28267340|yfshih@nycu.edu.tw|
21240502|NCT03092960|Stanford University|Lisa Goldman Rosas|(650) 721-8415|lgrosas@stanford.edu|
21240503|NCT02722941|Moffitt Cancer Center|Taiga Nishihori, MD|813-745-8156|Taiga.Nishihori@moffitt.org|
21240504|NCT04430335|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-716-9055|megreen@wakehealth.edu|
21240505|NCT01080196|University of Utah|Dr Paul LaStayo|8019719298|paul.lastayo@health.utah.edu|
21240506|NCT00179010|Vanderbilt University|Italo Biaggioni, MD., Professor of Medicine and Pharmacology|(615) 936-3420|italo.biaggioni@vanderbilt.edu|
21240507|NCT03988374|Church & Dwight Co., Inc|Dr. Annahita Ghassemi, PhD|6098061200|annhita.ghassemi@churchdwight.com|
21240508|NCT03748979|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
21240509|NCT01335308|University of Michigan|Ken Resnicow|734 647 0212|kresnic@umich.edu|
21240510|NCT03249376|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinicalTrials@itci-inc.com|
21240511|NCT00627042|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21240512|NCT04747275|Children's Mercy|Max Feldt|816-960-8892|mmfeldt@cmh.edu|
21240513|NCT02360774|Beth Israel Deaconess Medical Center|Jody Dushay|6176671996|jdushay@bidmc.harvard.edu|
21240514|NCT04254679|McGill University|Dr. Julio F. Fiore Jr|514 934-1934|julio.fiorejunior@mcgill.ca|35655
21240515|NCT00178620|The University of Texas Health Science Center at Houston|Dr. Richard W. Smalling|713-500-6559|richard.w.smalling@uth.tmc.edu|
21240516|NCT02708238|"Department of Translational Medical Sciences, Section of Pediatrics, University of Naples Federico II"|Annamaria Staiano|00390817462679|staiano@unina.it|
21291259|NCT04770285|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21291260|NCT04620668|University of New Brunswick|Luke MacNeill|506-648-5500|luke.macneill@unb.ca|
21240517|NCT01388530|David Geffen School of Medicine at UCLA|James McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu|
21291261|NCT03559530|Unversidade de Sao Paulo|Dr Priscila Rosalba Domingos de Oliveira|551126616900|priscila.rosalba@hc.fm.usp.br|
21240518|NCT05284019|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
21240519|NCT01990300|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21240520|NCT02420327|University of Maryland School of Medicine|Dr. Britta Hahn|410-402-6112|bhahn@som.umaryland.edu|
21291262|NCT04047355|New York State Institute for Basic Research|J. Helen Yoo, Ph.D.|718-494-5295|jhelen.yoo@opwdd.ny.gov|
21291263|NCT01472185|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21291264|NCT05468918|Sonova USCS|Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
21291265|NCT03232567|Altimmune|Stephanie Holland, Clinical Project Manager|240-654-1450|sholland@altimmune.com|40
21291266|NCT05837481|Massachusetts General Hospital|Chien Yi Maximilian Png, MD|617-726-5308|cypng@mgh.harvard.edu|
21291267|NCT00427700|Hospital de Clínicas de Porto Alege|Dr. Ricardo Francalacci Savaris|51 33598405|rsavaris@hcpa.edu.br|
21291268|NCT04581395|IU school of Medicine, Department of Anesthesiology|Dr. Leighan Bye, Assistant Professor of Clinical Anesthesia|317-274-0275|lbye@iu.edu|
21291269|NCT00103844|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21291270|NCT01362790|National Cancer Institute|Dr. Raffit Hassan|301-451-8742|raffit_hassan@nih.gov|
21291271|NCT02457065|Dartmouth-Hitchcock Medical Center|Michael S Chapman, MD|(603) 650-5000|Michael.Shane.Chapman@hitchcock.org|
21291272|NCT03038087|SENSE Diagnostics, Inc.|Joe Korfhagen|844-373-6730|jkorfhagen@senseneuro.com|
21291273|NCT00654355|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-3885|sfeldman@wfubmc.edu|
21291274|NCT00635050|UAB|John Carpenter, M.D.|205-910-8886 or 205-934-2084|jtc4321@bellsouth.net|
21291275|NCT00811850|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
21291276|NCT02011542|University of Utah, Dept. of Gastroenterology|Dr. Ashok Tuteja|801-581-5679|ashok.tuteja@hsc.utah.edu|
21291277|NCT00663260|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
21291278|NCT01813357|Monash University and Alfred Health|Dr Janine Trevillyan|03 90762000|janine.trevillyan@monash.edu|
21291279|NCT01799135|Dana Farber Cancer Institute|Raymond H. Mak|617.632.3591|RMAK@PARTNERS.ORG|
21291280|NCT02678377|Northwestern University|Dr. Kimberly Kenton|3124723874|kkenton@nm.org|
21291281|NCT01979185|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21291282|NCT00980798|Janssen-Cilag Ireland|EMEA Medical Affairs Director Analgesia|0035 878 339174||
21291283|NCT00522379|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
21291284|NCT03863574|Zydus Therapeutics Inc.|Dr Deven Parmar|7324050886|dparmar@zydustherapeutics.com|
21240521|NCT00614198|Center for Autisme|Lennart Pedersen|44982355|lpe@centerforautisme.dk|
21291285|NCT04554836|Evangelisches Krankenhaus Hamm Werler Str. 110, 59063 Hamm|Prof. Dr. Alexander Baraniskin|+49 (0) 2381 / 589 1863|Alexander.Baraniskin@ruhr-uni-bochum.de|
21291286|NCT02607722|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
21291287|NCT04347538|Vanderbilt University Medical Center|Justin H. Turner, MD, PhD|615-343-8848|justin.h.turner@vumc.org|
21291288|NCT02135133|Dana-Farber Cancer Institute|Jennifer R. Brown, MD, PhD|(877) 442-3324|Jennifer_Brown@dfci.harvard.edu|
21291289|NCT02259231|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21291290|NCT03607500|University of Michigan|Abhijit Naik|734-763-0990|abhinaik@med.umich.edu|
21291291|NCT03312543|Johnson & Johnson Consumer Inc.|Sidney Hornby|908-874-2756|SHornby@its.jnj.com|
21291292|NCT04507269|Brii Biosciences Limited|Clinical Research|86 10 6299 8808|clinicaltrials@briibio.com|
21291293|NCT05852340|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21291294|NCT02402647|VA San Diego|Catherine Ayers|858-220-4041|catherine.ayers1@va.gov|
21291295|NCT02120261|The University of Texas Health Science Center at Houston|Carlos J. Roldan, MD||Carlos.J.Roldan@uth.tmc.edu|
21291296|NCT00375713|UCB Pharma|UCB Clinical Trial Call Center|+ 1 877 822 9493||
21291297|NCT03637348|Cornea Research Foundation of America|Marianne Price, PhD|3178142990|mprice@cornea.org|
21291298|NCT03211416|Roswell Park Comprehensive Cancer Center|Kris Attwood|8772757724|Kris.Attwood@roswellpark.org|
21291299|NCT01950520|NIDDK|Kong Chen, PhD, MSCI|301-451-1636|chenkong@niddk.nih.gov|
21291300|NCT03559556|University of Texas Southwestern Medical Center|Dr. Robert Timmerman|214-645-7637|robert.timmerman@utsouthwestern.edu|
21291301|NCT02620865|Karmanos Cancer Institute|Dr. Anthony Shields|313-576-8735|shieldsa@karmanos.org|
21291302|NCT04632030|RAND|William G. Shadel|412-683-2300|shadel@rand.org|4489
21291303|NCT00793520|Forest Research Institute|Allan Spera|201-427-8399|allan.spera@frx.com|
21291304|NCT00095576|Merck, Sharp & Dohme|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21291305|NCT01344356|Mercy Research|Mercy Research Manager - Regulatory Operations|314-251-8827|michelle.bryant@mercy.net|
21291306|NCT01332981|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21291307|NCT02390076|Minneapolis VA Health Care System|Seth Disner|3105605990|disne014@umn.edu|
21291308|NCT01206517|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21291309|NCT00895921|Veterans Medical Research Foundation|Jonathan M. Meyer, MD|858-964-0777|jmmeyer@ucsd.edu|
21291310|NCT01822925|NeuroBo Pharmaceuticals, Inc.|Vice President Clinical Operations|617-313-7331|nikki.shannon@neurobopharma.com|
21291311|NCT01731782|Cleveland Clinic Florida Region|Dr. Conor Delaney|954-659-6001|DELANEC@ccf.org|
21291312|NCT02314923|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21291313|NCT04476784|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21291314|NCT06034340|Emory University|Dr. Eric Felner -Professor of Pediatrics|404-785-0935|efelner@emory.edu|
21291315|NCT04700800|Mayo Clinic|Lori Roust|(602) 543-4254|Roust.Lori@mayo.edu|
21240522|NCT01146574|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
21291316|NCT01055028|Stanford University Medical Center|Kristen Ganjoo, MD|650-725-6413|kganjoo@stanford.edu|
21291317|NCT00645658|VA Palo Alto Health Care System|Jonathan Myers|6504503440|drj993@aol.com|
21291318|NCT04258631|Mayo Clinic|Sean C. Dowdy, M.D.|507-266-0225|Dowdy.Sean@mayo.edu|
21291319|NCT03093415|Oregon Health and Sciences University|Andrew Seaman, MD|1 (971) 271 - 6102|seaman@ohsu.edu|
21291320|NCT03896633|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
21291321|NCT01767987|Kettering Health Network|Suzanne Coleman, PhD|937-395-8390|suzanne.coleman@khnetwork.org|
21291322|NCT01153516|University of Texas Southwestern at Dallas|Dr. Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
21291323|NCT05112640|University of Texas Medical Branch|Brett Goldman|9542632359|brettryangoldman@gmail.com|
21291324|NCT01840072|Tulane University|Dr. Jiang He|5049885165|jhe@tulane.edu|
21291325|NCT01251757|Kaiser Permanente Center for Health Research|William M Vollmer, PhD|503-335-2400|william.vollmer@kpchr.org|
21291326|NCT05807945|ABC Medical Center|Angel Cruz Miranda|5516647121|cruz.angel@aol.com|
21291327|NCT01648322|Generon (shanghai) corporation|Chief Medical Officer|8621-61760866|tangt@generonbiomed.com|
21291328|NCT03817580|Eurofins EVIC|Commercial Manager|40 213357090|luciachirita@eurofins.com|
21291329|NCT00209131|Emory University|Dr. Kenneth Ogan|404-778-4898|kogan@emory.edu|
21291330|NCT05360784|Bausch and Lomb|Johnson Varughese|908-927-1162|johnson.varughese@bausch.com|
21291331|NCT00437073|GlaxoSmithKline|GSK Response Center|866-435-7343||
21291332|NCT04875533|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_lnquiries@pfizer.com|
21291333|NCT04918771|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
21291334|NCT00539500|University of Texas MD Anderson Cancer Center|Laura L. Worth, MD / Professor, Pediatrics|713-792-6620|CR_Study_Registration@mdanderson.org|
21291335|NCT02702999|The University of Texas Health Science Center at Houston|Olaide Azizat Ashimi Balogun, MD|(713) 500-6412|Olaide.A.Ashimi@uth.tmc.edu|
21291336|NCT02657343|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|(877) 442-3324|Sara_Tolaney@dfci.harvard.edu|
21291337|NCT01287208|Massachusetts General Hospital|Anne Thorndike, MD, MPH|617-724-4608|athorndike@partners.org|
21291338|NCT01299961|UCLA|Veena K. Ranganath, MD, MS Assistant Clinical Professor|310-825-3061|vranganath@mednet.ucla.edu|
21291339|NCT02904096|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
21291340|NCT03988205|Froedtert and the Medical college of Wisconsin|Laura Michaelis, MD|414-805-6700|lmichaelis@mcw.edu|
21291341|NCT03238196|Vanderbilt-Ingram Cancer Center|Brent Rexer, MD, PhD, Assistant Professor|615-322-4967|brent.rexer@vumc.org|
21291342|NCT04562090|Astellas Pharma China, Inc.|Clinical Transparency|+86-(0)10-85216666|astellas.resultsdisclosure@astellas.com|
21291343|NCT00847730|KCI|VP, Global Clinical Affairs|2102555595|jane.hart@kci1.com|
21291344|NCT04341012|Mayo Clinic|Tushar Patel|9049532000|patel.tushar@mayo.edu|
21291345|NCT04938427|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21291346|NCT03408262|Imperial College London|Research Integrity Officer|020 7594 1872|rgit@imperial.ac.uk|
21291347|NCT03633058|Vanderbilt University Medical Center|Jeffrey L. Neul, MD, PhD, Principal Investigator|615-322-8242|jeffrey.l.neul@vumc.org|
21291348|NCT00553969|University of Minnesota Medical School|Jay N. Cohn, M.D.|612.625.5646|cohnx001@umn.edu|
21291349|NCT05216380|UMass Chan Medical School|Jamie Faro|7744553744|Jamie.faro@umassmed.edu|
21291350|NCT04906512|Ruijin Hospital|Dr. Hongping Qu|021-64370045|rjhcrc@126.com|
21291351|NCT01969058|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21291352|NCT00057577|Vanderbilt University|Dr. Steven D. Hollon|615-322-3369|steven.d.hollon@vanderbilt.edu|
21291353|NCT04090749|Johns Hopkins University School of Nursing|Martha Abshire Saylor|4433406201|mabshir1@jhu.edu|
21291354|NCT03510715|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21291355|NCT03207347|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
21291356|NCT00689884|Dartmouth-Hitchcock Medical Center|John M. Hill, MD - Principal Investigator|603-650-4628|john.m.hill@hitchcock.org|
21291357|NCT04983979|Queen Mary University of London|Emily Kirkpatrick|02078825673|cvctu@qmul.ac.uk|
21291358|NCT04144517|Mural Oncology, Inc.|Study Director|+1 (781) 614-0100|clinicaltrials@muraloncology.com|
21291359|NCT00391716|The Scripps Research Institute|Dr. Barbara J. Mason|858-784-7324|mason@scripps.edu|
21240523|NCT03299062|University of Arkansas for Medical Sciences|Rohit Dhall, MD|6025033193|rdhall@uams.edu|
21240524|NCT00683449|MediciNova, Inc.|Kazuko Matsuda, MD PhD MPH, Vice President, Clinical Development|858-373-1500|matsuda@medicinova.com|132
21240525|NCT00925782|University of Kansas Medical Center|Omar Aljitawi, M.D., Assistant Professor of Medicine|913-588-6029|oaljitawi@kumc.edu|
21240526|NCT01448044|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21240527|NCT00507026|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21240528|NCT00681187|Ipsen|Medical Director, Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21240529|NCT04230980|Weill Cornell Medical College|Grace Tan, Clinical Research Coordinator|212-746-3208|grt2008@med.cornell.edu|
21240530|NCT01600950|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21240531|NCT02372058|Albert Einstein Medical Center located in Philadelphia, Pennsylvania, USA|Dr. David L. Schutzman|215-456-6698|schutzmand@einstein.edu|
21240532|NCT00658736|Cleveland Clinic|Dr. Tyler Stevens|216 445-1996|stevent@ccf.org|
21240533|NCT00318149|GlaxoSmithKline|GSK Response Center|866-435-7343||
21240534|NCT03541642|Temple University|Dr. Sarah Bass|215-204-5110|sbass@temple.edu|
21240535|NCT03523871|NYU Langone Health|Luis Angel, MD|646-501-0119|Luis.Angel@nyulangone.org|
21291360|NCT05251805|UZ Brussel|Head of the anesthesiology department|024776001|anesthesiology.clinicaltrials@uzbrussel.be|+32
21291361|NCT02457793|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21240536|NCT00219141|Novartis Pharmaceuticals|Study Director|862 778-8300||
21240537|NCT00972179|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21240538|NCT03055832|TearFilm Innovations, Inc.|Rob Thornhill|844-458-9776|rthornhill@tearfilm.com|
21240539|NCT01994720|AstraZeneca R&D|Brilinta Global Clinical Lead|+46 31 776 10 00||
21240540|NCT03619174|Viveve|Vice President, Clinical & Medical Affairs|720-696-8173|clinicalaffairs@viveve.com|
21240541|NCT02216422|AbbVie|Global Medical Services|800-633-9110||
21240542|NCT00792428|Beth Israel Deaconess Medical Center|Gottfried Schlaug, MD, PhD|617-632-8917|gschlaug@bidmc.harvard.edu|
21240543|NCT01012973|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21240544|NCT02061761|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21240545|NCT00967018|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
21240546|NCT03216902|Santen Inc|R&D Quality Manager|+1 415 268 9199|clinicaltrials@santen.com|
21240547|NCT02969031|Dana-Farber Cancer Institute|Julie Goldman|617-632-5563|Julie_Goldman@dfci.harvard.edu|
21240548|NCT01872949|CHF Solutions, Inc.|Audrey Singh|952-345-4217|audrey.singh@chf-solutions.com|
21240549|NCT04170296|Endo Pharmaceuticals|David Hernandez, MD|800-462-3636|clinicaltrials@endo.com|
21240550|NCT02468934|SPR Therapeautics|Clinical Affairs|216-378-9108|support@SPRTherapeutics.com|
21240551|NCT00383240|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21240552|NCT01234766|Dartmouth-Hitchcock Medical Center|Frederick Lansigan, MD|603-650-4628|Frederick.Lansigan@hitchcock.org|
21240553|NCT01370603|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21240554|NCT00518713|Lundbeck LLC|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
21240555|NCT02133924|Icahn School of Medicine at Mount Sinai|Dr. John Levine|212-241-3429|john.levine@mssm.edu|
21240556|NCT00050089|VAMC Bronx|Dr. Sheldon Brown|(718) 584-9000|sheldon.brown@va.gov|6666
21240557|NCT01097460|Merrimack Pharmaceuticals|Dr. Victor Moyo|1-617-441-1094|vmoyo@merrimackpharma.com|
21240558|NCT01919996|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21240559|NCT02924389|Emory University|Cecile Lahiri, MD|404-616-6306|cdelill@emory.edu|
21240560|NCT04714216|Emory University|Dr. Francisco J. Pasquel|404-778-1695|fpasque@emory.edu|
21240561|NCT01349829|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
21240562|NCT00528190|Ottawa Hospital Research Institute|Shawn Aaron|613-737-8259|saaron@ohri.ca|
21240563|NCT00377741|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21240564|NCT04006795|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21240565|NCT01852162|University of Florida|Dominick Angiolillo, MD, PhD|904-244-3933|dominick.angiolillo@jax.ufl.edu|
21240566|NCT01500226|Tesaro|Martin Huber, M.D., Senior Vice President and Chief Medical Officer|781-257-2536|mhuber@tesarobio.com|
21240567|NCT02955277|Assuta Hospital Systems|Dr. Zvi Buckman|+97237462520|Bukman_tz@mac.org.il|
21240568|NCT04212169|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21240569|NCT02176928|University of Miami|Shirin Shafazand, MD, MS|305-243-7888|sshafazand@med.miami.edu|
21240570|NCT02018861|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21240571|NCT02748564|Cancer Institute of New Jersey|Adam Berger, MD|215-235-8079|ab2047@cinj.rutgers.edu|
21240572|NCT02819479|Norton Neuroscience Institute|Shervin R. Dashti, MD, PhD, Principal Investigator|502-394-6390|shervin.dashti@nortonhealthcare.org|
21240573|NCT00504348|Tokyo Medical and Dental University|Kazuki Takada, M.D.|81-3-3813-6111|takada.rheu@tmd.ac.jp|
21240574|NCT00709891|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21240575|NCT02968940|NYU Langone Health - Perlmutter Cancer Center|Sylvia Kurz, MD, PhD|212-731-6267|Sylvia.Kurz@nyulangone.org|
21240576|NCT02718417|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21240577|NCT01305356|Wright Medical|Justin Moss|615-236-4984|Justin.Moss@wright.com|
21240578|NCT01023308|Novartis Pharmaceuticals|Study Director|862-778-8300||
21240579|NCT00551213|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21240580|NCT01890967|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21240581|NCT01861301|University of Chicago|Hedy Kindler, MD|773-702-0360|hkindler@medicine.bsd.uchicago.edu|
21240582|NCT03905811|University of Iowa|Jordan Schultz|3193849388|jordan-schultz@uiowa.edu|
21240583|NCT01383993|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21240584|NCT02137538|Stanford University|E Kirk Neely|650-723-5791|neely@stanford.edu|
21240585|NCT02701582|NYU School of Medicine|Marc Bloom, MD, PHD|305 689-2388|mbloom@miami.edu|
21240586|NCT02766673|Children's Hospital of Philadelphia|Natalie Napolitano, MPH, RRT-NPS, FAARC|215-590-1708|napolitanon@email.chop.edu|
21240587|NCT02774343|The University of Texas Health Science Center at Houston|Joy M. Schmitz, PhD|713-486-2867|Joy.M.Schmitz@uth.tmc.edu|
21240588|NCT01154036|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21240589|NCT02264574|Pharmacyclics LLC, An AbbVie Company|Lori Styles|(408) 215-3770|lstyles@pcyc.com|
21240590|NCT03954158|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21240591|NCT00794820|University of Texas (UT) MD Anderson Cancer Center|Susan O'Brien, MD/ Leukemia|1-877-632-6789|CR_Study_Registration@mdanderson.org|
21240592|NCT04496414|Integra LifeSciences (Shanghai) Co., Ltd.|Dr. Hua Tang|0086 21 63179772|hua.tang@integralife.com|
21240593|NCT05022602|Seno Medical, Inc.|Shaan Schaeffer|6106983259|sschaeffer@senomedical.com|
21240594|NCT03230864|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
21240595|NCT01930643|Mackay Memorial Hospital|Dr. Kuang-Hua Cheng|+886-975837711|jeff01@mmh.org.tw|
21240596|NCT00432679|GlaxoSmithKline|GSK Response Center|866-435-7343||
21291362|NCT04316143|BIAL - Portela & Ca, SA|Responsible of Clinical Research & Operations|+351229866100|clinical.trials@bial.com|
21291363|NCT00835172|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21291364|NCT03941093|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1337|lapis@fibrogen.com|
21291365|NCT01195597|University of Catania|Prof Riccardo Polosa|0957436413|polosa@unict.it, p.caponnetto@unict.it|0039
21291366|NCT03243084|UNC Chapel Hill|Julianna Prim|919-962-5271|jhprim@email.unc.edu|
21291367|NCT05870345|University of CHicago|Alisa Brennan, Pediatric Emergency Medicine Fellow, Physician, Co-PI|9787585263|Brennanak@gmail.com|
21291368|NCT00376558|nyspi|Diana Martinez|212-543-6628|dm437@columbia.edu|
21291369|NCT00553254|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21291370|NCT02546323|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
21291371|NCT00952692|Duke University|Dr. Michael Morse|919-681-3480|morse004@mc.duke.edu|
21240597|NCT04102540|University of Colorado College of Nursing|Dr. Samantha Stonbraker|3037248281|Samantha.Stonbraker@CUAnschutz.edu|
21240598|NCT00280293|UT Southwestern Medical Center|Dr. E. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
21240599|NCT01861756|Aristotle University Thessaloniki|Dr. Apostolos Tsapas||atsapas@auth.gr|
21240600|NCT00581256|University of Michigan Cancer Center|Dr. Lori Pierce, M.D.|734-764-9922|ljpierce@umich.edu|
21240601|NCT00610675|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21240602|NCT01458249|Eisai Co., Ltd.|Sun Asami|+81-3-3817-5252||5252
21240603|NCT01824082|University of California San Diego|Brian M. Ilfeld|858-822-0776|bilfled@health.ucsd.edu|
21240604|NCT02056119|Rush University Medical Center|David Vines, PhD, RRT|3129424408|david_vines@rush.edu|
21240605|NCT03220737|Emergent BioSolutions Canada Inc.|David Cassie, Scientist, Clinical Research|204-275-4589|dcassie@ebsi.com|
21240606|NCT00684983|Mayo Clinic|Paul Haluska Jr MD PhD|507-284-1159|haluska.paul@mayo.edu|
21240607|NCT00176865|Masonic Cancer Center, University of Minnesota|Dr. Angela Smith|612-626-2778|smith719@umn.edu|
21240608|NCT04524104|Univeristy of Illinois, Chicago|Nan Lv, PhD, Research Scientist|312-802-1072|lvn2017@uic.edu|
21240609|NCT01686932|Novartis|Study Director|862-778-8300||
21240610|NCT03657264|Guerbet|Jing Hao, MD|+33145915000|jing.hao@guerbet.com|
21240611|NCT01313923|UC Irvine Dermatology Research Center|Sergei A. Grando, MD, PhD, DSc|9498242713|sgrando@uci.edu|
21240612|NCT03358329|Intersect ENT, Inc.|James Stambaugh, Vice President of Clinical & Medical Affairs|650-641-2103|jstambaugh@intersectent.com|
21240613|NCT02982720|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317.921.2050|jsmith@hoosiercancer.org|
21240614|NCT03875911|UCLA Jules Stein Eye Institute|Dr. Joseph Caprioli|310-825-6323|caprioli@jsei.ucla.edu|
21240615|NCT01231503|GlaxoSmithKline|GSK Response Center|866-435-7343||
21240616|NCT00287469|Armed Forces Research Institute of Medical Services|Mrigendra P. Shrestha MD|662-644-4888|shrestham@afrims.org|
21240617|NCT05515679|Hopeful Aging|Michael Skrajner|4404777881|info@hopefulaging.com|
21240618|NCT02207374|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
21240619|NCT02087150|Acclarent|Patricia Chen|949-453-6408|pchen126@its.jnj.com|
21240620|NCT02571439|Maimonides Medical Center|Dr Kalpana Tyagaraj|7182836000|KTyagaraj@maimonidesmed.org|
21240621|NCT02501135|Nationwide Children's Hospital|Clinical Research Coordinator|6147222997|heather.dellinger@nationwidechildrens.org|
21240622|NCT00393094|National Cancer Institute, National Institutes of Health|Howard A. Fine, M.D.|301-402-6383|hfine@mail.nih.gov|
21240623|NCT02019602|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21240624|NCT00780442|Medical University of South Carolina|Dr. Kimber L. Price|843-792-4847|pricekl@musc.edu|
21240625|NCT03653416|Icahn School of Medicine at Mount Sinai|Poonam Pai B. H|347-569-4816|poonam.paibantwalhebbalasankatte@mountsinai.org|
21240626|NCT02788006|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
21240627|NCT02341144|Johns Hopkins All Children's Hospital|Nicole Chandler|7277674170|nicole.chandler@jhmi.edu|727
21240628|NCT01435798|Translational Pain Research, Brigham and Women's Hospital|Christine N. Sang, MD, MPH|617-525-7246|paintrials@partners.org|
21240629|NCT03228017|NYU Langone|Dr. Michael Garshick|212-263-0855|michael.garshick@nyulangone.org|
21240630|NCT01556763|EnVivo Pharmaceuticals, Inc.|Maria Gawryl, Ph.D., Vice President, Regulatory Affairs & Drug Development|617-225-4264|mgawryl@envivopharma.com|
21240631|NCT02258464|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21240632|NCT00776100|Mayo Clinic|Steven E. Schild, M.D.|507-538-1760|sschild@mayo.edu|
21240633|NCT03567993|UMass Chan Medical School|Dr. Rajani Sadasivam|508-456-8923|rajani.sadasivam@umassmed.edu|
21240634|NCT00903786|Eisai Inc.|Eisai Medical Services Inc.|1-888-422-4743|esi_medinfo@eisai.com|
21240635|NCT02285595|Sonendo, Inc.|Director of Clinical Research|9496678036|clinical@sonendo.com|
21240636|NCT01960790|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21240637|NCT00064025|Gynecologic Oncology Group Statistical and Data Center|Jessalyn Reboy|716-845-7738|reboyj@norgoncology.org|
21240638|NCT01644474|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21261406|NCT00384956|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
21261407|NCT00290472|University of Chicago Comprehensive Cancer Center|Dr. Sonali M. Smith|7738342895|smsmith@medicine.bsd.uchicago.edu|
21261408|NCT00174941|Takeda Global Research & Development Center, Inc.|Sr VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21291372|NCT04023487|University of Southern California|Beth Pyatak|323-442-2615|beth.pyatak@chan.usc.edu|
21240639|NCT02435511|University of Chicago|Dr. Stacy Lindau|7738348986|slindau@bsd.uchicago.edu|
21240640|NCT02711995|Weill Cornell Medicine|Katerina Andreadis|646-962-9883|kaa2055@med.cornell.edu|
21240641|NCT00322868|Case Western Reserve University|Michael W Konstan, MD|2168443267|michael.konstan@case.edu|
21240642|NCT03615482|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21240643|NCT03248570|University of California, San Francisco|Dr. David Oh, MD|(415) 476-1000|David.Oh@ucsf.edu|
21240644|NCT04404257|William Beaumont Hospitals|Dr. Simon Dixon, MD|248-898-4198|simon.dixon@beaumont.edu|
21240645|NCT00360555|Sprout Pharmaceuticals|Scientific Program Director|9198820850|clinicaltrials@sproutpharma.com|
21240646|NCT01603940|Hospital Universitario Pedro Ernesto (UERJ)|Ronaldo Altenburg Gismondi, MD, PhD|+5521996092383|ronaldogismondi@gmail.com|
21240647|NCT03367962|Stanford University|Dr. Robert Negrin|6507230822|negrs@stanford.edu|
21240648|NCT03114995|Cardiovascular Center, Seoul National University Bundang Hospital|Dr. Tae-Jin Youn|+82-31-787-7031|ytjmd@snubh.org|
21240649|NCT04223154|Wake Forest University School of medicine|Colleen A. Hanlon, Ph.D.|336-716-5465|chanlon@wakehealth.edu|
21240650|NCT02466126|Department of Veterans Affairs, Micheal E. DeBakey VAMC|Dr. Jeffrey Cully|713-794-8526|Jeffrey.Cully@va.gov|
21240651|NCT00590980|University of Illinois at Chicago|Sepideh Amin-Hanjani, MD|312-996-4842|hanjani@uic.edu|
21240652|NCT00506285|Psychiatry Research Clinic|Barrie K. Marchant|801 585-6663|barriemarchant@aol.com|
21240653|NCT04975789|University of Wisconsin - Madison, School of Nursing|Maichou Lor, PhD, RN|608-265-4248|mlor2@wisc.edu|
21240654|NCT01646320|AstraZeneca Pharmaceuticals|Eva Johnsson, Clinical Science Lead|+46 31 7762484|Eva.Johnsson@astrazeneca.com|762 484
21240655|NCT01489020|Roxall Medicina España S.A.|Dr. M Cruz Gómez project manager of Roxall Medicina España S.A.|+34 944438000|maricruz.gomez@roxall.es|
21240656|NCT02892409|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21240657|NCT03685747|Thomas Jefferson University|Walter Kraft|2159559077|walter.kraft@jefferson.edu|
21240658|NCT02451930|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21240659|NCT00415493|ASTHMA Inc.|Principal Investigator|(510) 620-5714|dennis.shusterman@cdph.ca.gov|
21240660|NCT02485353|IndianaU|Hamid Sayar, MD|317-948-7576|ssayar@iu.edu|
21240661|NCT05258747|Sandoz|Sandoz Disclosure Office|+49 8024 / 908 0|sandoz.disclosure@sandoz.com|
21240662|NCT04411940|Cycle Pharmaceuticals|Head of Global Regulatory Affairs & Clinical Development|+441223803635|claudia.percivalle@cyclepharma.com|
21240663|NCT01033773|MedStar Health Research Institute|Dr Michelle Magee|2028772383|michelle.f.magee@medstar.net|
21240664|NCT01406860|University of Iowa Hospitals and Clinics|Brett Faine|3193108067|brett-faine@uiowa.edu|
21240665|NCT01950273|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21240666|NCT00472186|Dupage Chidlren's ENT & Allergy|Manali Amin, MD|630-785-0367|manali.amin@gmail.com|
21240667|NCT01254565|Amgen, Inc|Study Director|866-572-6436||
21240668|NCT02367014|Stealth BioTherapeutics Inc.|Jim Carr PharmD Chief Clinical Development Officer|617-600-6888|jim.carr@stealthbt.com|
21240669|NCT03354637|Aclaris Therapeutics, Inc.|Marco Cardillo, Clinical Trial Manager|484-540-6299|mcardillo@aclaristx.com|
21240670|NCT02726399|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian, MD|646-888-4186|janjigiy@mskcc.org|
21240671|NCT04006366|Perelman School of Medicine at the University of Pennsylvania|Kelly C. Allison, PhD|2158982823|kca@pennmedicine.upenn.edu|
21240672|NCT03123263|TTUHSC-El Paso|Sumit Gaur|9152155200|sumit.gaur@ttuhsc.edu|
21240673|NCT02971891|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
21240674|NCT00997243|Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center|Alison Walker, MD|614-293-3196|Alison.Walker@osumc.edu|
21240675|NCT02900781|Texas Tech University Health Sciences Center|Nancy Swinford CCRC|8067432569|nancy.swinford@ttuhsc.edu|
21240676|NCT02086552|Mayo Clinic|Francis K Buadi, MD|507/284-2511|Kumar.Shaji@mayo.edu|
21240677|NCT02206152|University of Minenesota|Elizabeth Seaquist, MD|612-624-9176|chape044@umn.edu|
21240678|NCT00478608|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21240679|NCT02080520|Atherosclerosis Research Unit, University of Southern California|Howard N. Hodis, M.D.|323-442-1478|athero@usc.edu|
21240680|NCT00390455|Dana-Farber Cancer Institue|Harold Burstein, M.D.||hburstein@partners.org|
21240681|NCT05641077|Cleveland Clinic|Lannah Lua-Mailland|216-314-2163|lual@ccf.org|
21240682|NCT02406261|Eli Lilly and Company|Chief Medical Officer|800-545-5079||
21240683|NCT03039543|Seoul National University Bundang Hospital|Dr. Junghee Ryu, Associate Professor|82-31-787-7497|jinaryu74@gmail.com|
21240684|NCT00634322|BTG International (Protherics)|VP Clinical Development, BTG International|610-943-3632|janet.rush@btgplc.com|
21240685|NCT01591460|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21240686|NCT03679013|Inova Fairfax Hospital|Ramesh Singh, MD|(703)776-8025|ramesh.singh@inova.org|
21240687|NCT00906503|Barbara Ann Karmanos Cancer Institute|Barbara Ann Karmanos Cancer Institute|313-576-9370|davisv@karmanos.org|
21240688|NCT01567163|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21240689|NCT02339389|Brigham and Women's Hospital|Bhavani Kodali|6175258449|bkodali@partners.org|
21240690|NCT03405662|University of California, San Francisco & San Francisco VA Health Care System|Dr. Linda Chao|415-221-4810|linda.chao@ucsf.edu|24386
21240691|NCT01348854|Abbott Medical Optics|Carrie Garufis|714-247-8200|carrie.garufis@amo.abbott.com|
21261409|NCT05740813|Healey Center for ALS at Massachusetts General Hospital|Healey Center for ALS Project Management|833-425-8257 (HALT ALS)|healeyalsplatform@mgh.harvard.edu|
21261410|NCT00981435|Stanford University|Clinical Research Coordinator|6507236995|mnunez1@stanford.edu|
21291373|NCT03898180|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21291374|NCT02507934|Dompé farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
21291375|NCT04503616|NYU Langone Health|Kelli Cole, NP|646-501-4848|Kelli.Cole@NYULangone.org|
21291376|NCT03766399|AstraZeneca Clinical Study Information Center|Global Clinical Head|+1-877-240-94 79|information.center@astrazeneca.com|
21291377|NCT05030766|University of Miami|Dr. Taghrid Asfar|+1 (901) 371-7229|tasfar@miami.edu|
21291378|NCT01722643|Dartmouth-Hitchcock|Dr. Catherine Stanger|603-646-7023|catherine.stanger@dartmouth.edu|
21291379|NCT01559935|Weill Cornell Medicine|Ruben Niesvizky, MD|6469626500|run9001@med.cornell.edu|
21291380|NCT05078437|University of Kentucky|Daniela Moga, Associate Professor|8593239682|daniela.moga@uky.edu|
21291381|NCT05889468|Duke University Medical Center|Brenna L. Hughes, MD, MSc|919-684-8111|brenna.hughes@duke.edu|
21291382|NCT02958865|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21291383|NCT01309230|Gradalis, Inc.|Clinical and Regulatory Operations|214-442-8100|info@gradalisinc.com|
21291384|NCT02661815|Dana-Farber Cancer Insitute|Dr. Joyce Liu|617-632-5269|joyce_liu@dfci.harvard.edu|
21291385|NCT02474498|Piracicaba Dental School - University of Campinas|Prof.Dr. Enilson Antonio Sallum|+55 19 2106-5301|easallum@fop.unicamp.br|
21291386|NCT00244985|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21291387|NCT05022719|Medtronic|Melanie Crystal|774-245-8756|melanie.crystal@medtronic.com|
21261411|NCT00609271|Tulane University|Dr. Lydia Bazzano|5049887323|lbazzano@tulane.edu|
21261412|NCT02439775|Medtronic|Elishea Argent, Sr. Clinical Research Specialist|(763)505-9584|elishea.n.argent@medtronic.com|
21291388|NCT01605097|BC Cancer|Dr Juanita Crook|250 712 3958|jcrook@bccancer.bc.ca|
21291389|NCT05006495|Seoul National University Hospital|Researcher of Clinical Trials|+821049051485|junhiya@snu.ac.kr|
21240692|NCT01720797|University of Florida|Calogero Dolce, DDS, PhD|352-273-5700|cdolce@dental.ufl.edu|
21240693|NCT00983619|MedImmune, LLC|Shahram Rahimian|800-236-9933|information.center@astrazeneca.com|
21240694|NCT00724061|Northwestern University|Dr. Timothy Kuzel|312-695-6180|cancertrials@northwestern.edu|
21240695|NCT02379117|UNottingham|Dr Gordon Moran|44 [0]115 9249924|Gordon.Moran@nottingham.ac.uk|70608
21240696|NCT04827134|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21240697|NCT01048606|Université de Sherbrooke|Pr Isabelle Dionne, Ph.D., vice-dean to research and graduate studies|1-819-821-8000|isabelle.dionne@usherbrooke.ca|63327
21240698|NCT00688259|VA Greater Los Angeles Healthcare System at West Los Angeles|Shirley M. Glynn, Ph.D.|3102683939|shirley.glynn@va.gov|
21240699|NCT02443103|IndianaU|Dr. Kathy Miller|317-948-3855|kathmill@iu.edu|
21240700|NCT01448525|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21240701|NCT02144519|University of South Carolina|Michael W Beets|8037773003|beets@mailbox.sc.edu|
21240702|NCT02343575|Stanford University|Yelizaveta Sher, MD|650-736-0459|ysher@stanford.edu|
21240703|NCT03207711|University of California, San Francisco|Frederick Hecht, MD|(415) 353-9743|rick.hecht@ucsf.edu|
21240704|NCT00549822|Massachusetts General Hospital|Dr. Paul Goss|617-724-3118|pgoss@mgh.harvard.edu|
21240705|NCT02682563|AmsterdamUMC|Erik van Bommel|+31 20 444 2264|e.vanbommel@amsterdamumc.nl|
21240706|NCT01083160|Abbott|Global Medical Services|1-800-633-9110||
21240707|NCT02076074|Washington University School of Medicine|Imran Zoberi, M.D.|314-362-8610|izoberi@wustl.edu|
21240708|NCT01267253|NRG Oncology|Linda Gedeon for Wei Deng,PhD|716-845-1169|lgedeon@gogstats.org|
21240709|NCT01515345|Kaiser Franz Josef Hospital|Univ.Prof. Dr Günter Christ|+43160191|guenter.christ@wienkav.at|2508
21240710|NCT00547911|National Institutes of Health|Dr. David Goldstein|301-496-1115|goldsteind@ninds.nih.gov|
21240711|NCT02413190|Kennedy Krieger Institute|Dr. Kathryn Wagner|443-923-9525|wagnerk@kennedykrieger.org|
21240712|NCT04129580|Penn State Milton S. Hershey Medical Center|Dr Sarah Kawasaki|7175311000|skawasaki@pennstatehealth.psu.edu|
21240713|NCT03699124|Bavarian Nordic A/S|Bavarian Nordic Call Center|1-844-422-8274|medical.information_us@bavarian-nordic.com|
21240714|NCT03595683|University of Chicago|Dr. Randy Sweis|773-834-3094|rsweis@uchicago.edu|
21240715|NCT02561455|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
21240716|NCT03294213|Ambu A/S|Anna Lundgaard|+4529643748|aclu@ambu.com|
21240717|NCT04758403|BIDMC|Adnan Majid|617-632-8386|tsipresearchstaff@bidmc.harvard.edu|
21240718|NCT02774265|University of Maryland Medical Center|Dr. Bryce Haac|410-328-3495|bhaac@som.umaryland.edu|
21240719|NCT01951092|Alpert Medical School of Brown University/The Miriam Hospital|Aadia Rana, MD|401-793-4680|arana@lifespan.org|
21240720|NCT00136916|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21240721|NCT01991197|Clinical Research Centre, St Vincent's University Hospital, Dublin, Ireland|Dr Maeve Lynch||maeve.lynch2@hse.ie|
21240722|NCT01010217|UT MD Anderson Cancer Center|Dr. Stefan O Ciurea, Associate Profeddor of Stem Cell Transplantation|713-745-0146|sciurea@mdanderson.org|
21240723|NCT00955903|Wake Forest School of Medicine|Jamy Ard, MD|3367169837|jard@wakehealth.edu|
21240724|NCT03020095|Ascletis Pharmaceticals Co., Ltd|Clinical Trial Disclosures|86057187707910|xin.li@ascletis.com|
21240725|NCT04033991|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21240726|NCT02410161|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
21240727|NCT00577720|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
21240728|NCT03246672|William S Middleton Memorial Veterans Hospital|Dr. Corrine Voils|608-262-9636|corrine.voils@va.gov|
21240729|NCT03260504|University of Washington|Scott Tykodi, MD, PhD|206-606-7763|stykodi@fredhutch.org|
21240730|NCT01932996|University of Minnesota|Rebekah Pratt|612-625-1196|rjpratt@umn.edu|
21240731|NCT02923895|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21240732|NCT00846742|St. Jude Children's Research Hospital|Matt Ehrhardt, MD, MS|(901) 595-5913|matt.ehrhardt@stjude.org|
21240733|NCT03542175|Memorial Sloan Kettering Cancer Center|Dr. Atif Khan, MD|848-225-6334|khana7@mskcc.org|
21240734|NCT05868954|Wake Forest University Health Sciences|Julio Mateus Nino, MD, PhD|704-355-8248|julio.mateusnino@advocatehealth.org|
21240735|NCT03051997|Medcial University of South Carolina|Professor|843-876-1840|cunninpb@musc.edu|
21240736|NCT01586000|Premier Research|Kimberly Myer, Sr. Program Director, NIH|984-238-1297|Kimberly.Myer@premier-research.com|
21240737|NCT03257995|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21240738|NCT02275533|University of Chicago|Theodore Karrison|708-925-6771|tkarrison@health.bsd.uchicago.edu|
21240739|NCT01570868|The University of Texas (UT) MD Anderson Cancer Center|Jorge Cortes, MD/Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
21240740|NCT04936308|Janssen Research & Development, LLC|Senior Medical Leader PEDIATRICS IMM|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21240741|NCT01168674|Tufts Medical Center|Dr. Nassir Ghaemi|6176365735|nghaemi@tuftsmedicalcenter.org|
21240742|NCT00932646|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21240743|NCT00653263|UArkansas|Michael J Mancino|501-526-8442|mjmancino@uams.edu|
21240744|NCT02611830|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21240745|NCT03687450|Brigham and Women's Hospital|Julia Loewenthal, MD|6177325500|jloewenthal@bwh.harvard.edu|
21240746|NCT05480722|University of Delaware|William B Farquhar|302-831-6168|wbf@udel.edu|
21261413|NCT01330446|University of Texas M D Anderson Cancer Center|Dr. Gary B. Gunn|(713) 563-2562|gbgunn@mdanderson.org|
21240747|NCT04759885|NTC srl|Alessandro Colombo|+390243850490|alessandro.colombo@ntcpharma.com|
21240748|NCT00195715|Abbott|Global Medical Services|1-800-633-9110||
21240749|NCT03844321|Massachusetts General Hospital|Andrew Nierenberg|617-512-2641|anierenberg@mgh.harvard.edu|
21291390|NCT04380142|AbbVie|Global Medical Services|1-800-633-9110|abbvieclinicaltrials@abbvie.com|
21291391|NCT02908178|Yale University|Shi-Yi Wang, MD, PhD|2037852886|shiyi.wang@yale.edu|
21291392|NCT01506726|Duke University Medical Center|Harvey J. Cohen, MD|919-660-7502|harvey.cohen@dm.duke.edu|
21291393|NCT04079738|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
21291394|NCT05552859|Sanofi|Trial Transparency email recommended (Toll free for US & Canada)|800-633-1610|Contact-us@sanofi.com|Option 6
21291395|NCT01380080|ACTG Network Coordinating Center, Social & Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21291396|NCT00210132|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
21291397|NCT00432965|Acelity|Sr Director, Global Clinical Development|210-255-5595|jane.hart@kci1.com|
21240750|NCT03421496|Radius Health|Bruce Mitlak, MD; Head of Discovery Science and Chief Medical Officer|617-444-1943|bmitlak@radiuspharm.com|
21240751|NCT05822921|Virginia Tech|Dr. Angela Scarpa|540-231-2615|ascarpa@vt.edu|
21240752|NCT00544544|McLean Hospital|Brian P. Brennan, M.D.|617-855-2911|bbrennan@partners.org|
21291398|NCT02784587|Maine Medical Center|Research coordinator|2076622862|richaj3@mmc.org|
21240753|NCT03277378|Abbott|Robyn Capobianco, PhD|+1 512 286 4274|robyn.capobianco@abbott.com|
21240754|NCT02397265|Imperial College London|Nick Oliver|020 7594 2460|nick.oliver@imperial.ac.uk|
21291399|NCT00071032|Rutgers Robert Wood Johnsom Medical School|Jeffrey L Carson, MD|732-235-7122|Jeffrey.Carson@rutgers.edu|
21291400|NCT01889251|Alcon Japan, Ltd.|Group Manager, Clinical Development|+81368995277||
21291401|NCT04261985|UCLA DGSOM|Dr. Alma Guerrero|3102672789|aguerrero@mednet.ucla.edu|
21291402|NCT01722669|Beth Israel Deaconess Medical Center, Harvard Medical School|Jeffrey Zwicker, Division of Thrombosis and Haemostasis, Division of Hematology and Oncology|617-667-9299|jzwicker@bidmc.harvard.edu|
21291403|NCT01350479|VA Maryland Healthcare System|Mary-Claire Roghmann|410-706-0062|mroghman@epi.umaryland.edu|
21291404|NCT02927964|Stanford University|Dr. Ronald Levy|(650) 725-6452|levy@stanford.edu|
21240755|NCT02036515|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21240756|NCT01823614|Central Research Institute for Epidemiology|Dmitry Kireev|+74959749646|dmitry.kireev@pcr.ru|2227
21240757|NCT01671748|Cardiff and Vale University Health Board|Dr Judith White|02920744771|judith.white3@wales.nhs.uk|
21240758|NCT04145349|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21240759|NCT00513019|University of Minnesota|Jon E. Grant|612-273-9800|grant045@umn.edu|
21240761|NCT04569058|Massachusetts General Hospital|T. Atilla Ceranoglu, MD|617-726-1291|aceranoglu@mgh.harvard.edu|
21240762|NCT05675709|Oregon Health & Science University|Susan Flocke|503 494 4404|fmresrch@ohsu.edu|
21240763|NCT01300559|Duke University Medical Center|Steven E. Hill, M.D.|681-6614|hill0012@mc.duke.edu|
21261414|NCT01588197|Medical University of South Carolina|Dr. Jeffrey J. Borckardt|8437923295|borckard@musc.edu|
21261415|NCT04168203|BWH|Physician|6177326984|gpiazza@bwh.harvard.edu|
21261416|NCT00315302|Jaeb Center for Health Research|Raymond Kraker|813-975-8690|pedig@jaeb.org|
21240764|NCT05876351|European Clinical Trial Information|Alexion Pharmaceuticals Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
21240765|NCT00447330|Duke University Medical Center|Brant Hamel|919-668-1861|brant.hamel@duke.edu|
21240766|NCT04168385|Mirum Pharmaceuticals, Inc.|Mirum Clinical Trials|16506674085|medinfo@mirumpharma.com|
21240767|NCT02748512|Axiom|Kelley Collins-Winters, RTR, BS, MBA|469-667-6655|kelleyc@axiom.cc|
21240768|NCT01754779|UT Southwestern Medical Center|Dr. Naim Maalouf|214/648-2954|naim.maalouf@utsouthwestern.edu|
21240769|NCT03415022|New York State Psychiatric Institue|Dr. Franklin Schneier|646-774-8041|Franklin.Schneier@nyspi.columbia.edu|
21261417|NCT01938625|Janssen Research & Development|Medical Leader||ClinicalTrialDisclosure@its.jnj.com|
21279329|NCT02114385|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21261418|NCT01937312|Alcon Research, Ltd.|Global Brand Leader, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
21261419|NCT00091793|Amgen Inc.|Study Director|866-572-6436||
21261420|NCT05309083|Washington University School of Medicine|Dr. Kerri Rawson|813-468-8900|rawson@wustl.edu|
21261421|NCT01748227|Richard L. Roudebush VAMC HSR&D|Dr. Marianne Matthias|317-988-4514|marianne.matthias@va.gov|
21261422|NCT01184989|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21261423|NCT04207710|Henry Ford Health|Director of Research, Department of Anesthesiology|313-771-7128|knowak2@hfhs.org|
21261424|NCT01754688|Minnesota Medical Research Foundation and University of Minnesota|Tina M. Slusher, MD|612-624-4586|tslusher@umn.edu|
21261425|NCT05370157|University of Pittsburgh|Dr. Elizabeth McGuier|412-246-5895|millerea3@upmc.edu|
21261426|NCT01508676|Massachusetts General Hospital|Dr. Jianren Mao|6177246102|mghpainresearch@partners.org|
21261427|NCT00609128|University of Wisconsin-Madison|Jim Stahl, PhD|608-263-6177|jlstahl@wisc.edu|
21261428|NCT06129487|University of Connecticut|Zexin Ma, Ph.D.|(860) 486-6871|zexin.ma@uconn.edu|
21261429|NCT03643692|Imperial College London|Nick Oliver|02033111093|nick.oliver@imperial.ac.uk|
21261430|NCT06105138|Colorado State University|Dr. Hollis Karoly|970-491-3677|hollis.karoly@colostate.edu|
21261431|NCT04378426|Palo Alto VA|Carolyn Rodriguez, MD, PhD|650-493-5000|carolyn.rodriguez@va.gov|60067
21261432|NCT00587223|Organogenesis Inc.|Director of Clinical Operations||kgiovino@organo.com|
21261433|NCT00195351|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21261434|NCT02111369|Emory University|Dr. Michael Johns|323-865-9839||
21261435|NCT03959189|Expansion Therapeutics, Inc.|Chief Medical Officer|858-764-4290|info@expansionrx.com|
21261436|NCT06081283|University of North Carollina at Chapel Hill|Meitra Kazemi|919-914-9579|meitra_kazemi@med.unc.edu|
21261437|NCT00828451|Washington University|Aaron Hamvas, MD|314-454-6148|hamvas@kids.wustl.edu|
21261438|NCT03721328|Nor Consult, LLC|Nor Consult|206-607-6861|regulatory@nor-consult.com|
21261439|NCT03872427|The University of Texas MD Anderson Cancer Center|Dr. Funda Meric-Bernstam|(713) 794-1226|fmeric@mdanderson.org|
21261440|NCT00095121|Gilead Sciences|John Flaherty, PharmD, Director, Clinical Research|650-522-5592|John.Flaherty@gilead.com|
21261441|NCT02258412|3M Health Care Business|Clinical Research Specialist|651-736-1578|mdavid@mmm.com|
21261442|NCT02928289|Sight Sciences, Inc.|VP, Medical and Clinical Affairs|877-266-1144|jdickerson@sightsciences.com|
21261443|NCT04358458|Genmab|CLINICAL TRIAL INFORMATION|+45 7020 2728|clinicaltrials@genmab.com|
21261444|NCT04636177|Stanford University School of Medicine|Laura E Simons|(650) 736-0838|lesimons@stanford.edu|
21261445|NCT07215806|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21261446|NCT02495077|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21261447|NCT02742649|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21261448|NCT01709799|University of Florida|Dr. Dawn Bowers|(352) 392-3450|dawnbowers@phhp.ufl.edu|
21261449|NCT03167619|Duke Clinical Research Institute|Senior Biostatistician|919-668-8052|lilin.she@duke.edu|
21261450|NCT00812110|Akron Children's Hospital|P. Cooper White, M.D.|330-543-8530|CWhite@chmca.org|
21261451|NCT02082184|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993 863164|joe.bugler@abbott.com|
21261452|NCT04352660|UCSD Shiley Eye Institute|Dr. Jiun Do|8585346290|jiundo@ucsd.edu|
21261453|NCT02413398|Global Clinical Leader-Dapagliflozin AstraZeneca|Anna Maria Langkilde, MD PhD|Tel: + 46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
21261454|NCT03847337|Vanderbilt University Medical Center|Zachary Warren|615-875-3085|zachary.e.warren@vumc.org|
21261455|NCT00537940|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21279330|NCT04204057|Rhizen Pharmaceuticals|Prajak Barde MD|+41325800175|pjb@rhizen.com|
21279331|NCT01256944|Taipei Medical University - WanFang Hospital|Dr. Ming-I Hsu|886-2-2930-7930|hsumigni@yahoo.com.tw|2508
21279332|NCT02047734|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
21279333|NCT01174043|IndianaU|Dr. Hamid Sayar|(317)278-6871|ssayar@iu.edu|
21279334|NCT02441660|UT Health San Antonio|Michelle Trbovich|210-617-5300|TrbovichM@uthscsa.edu|18192
21279335|NCT00582010|University of Alabama at Birmingham|Rakesh Patel|205-934-3411|rakeshp@uab.edu|
21279336|NCT04082338|Center for Asian Health, Lewis Katz School of Medicine, Temple University|Dr. Grace X. Ma|215-707-6493|grace.ma@temple.edu|
21279337|NCT04797221|Veterans Health Administration|Joseph Simonetti|7207236491|joseph.simonetti@va.gov|
21279338|NCT02029196|Fontem Ventures|Dr Ana Cravo|+441173322528|AnaMaria.Cravo@fontemventures.com|
21279339|NCT01853332|Beth Israel Deaconess Medical Center|Dr. Christos Mantzoros|6176678630|cmantzor@bidmc.harvard.edu|
21279340|NCT00486031|Valeant Pharmaceuticals|Johnson Varughese|9089271400||
21240770|NCT04963764|Ann & Robert H. Lurie Children's Hospital of Chicago|Dr. Todd Florin|312-227-6080|edpneumoniaresearch@luriechildrens.org|
21279341|NCT03495921|Gradalis, Inc.|Clinical and Regulatory Operations|(214) 442-8100|info@gradalisinc.com|
21234037|NCT02227485|Shiraz University of Medical Sciences|Dr. Mahsa Rostami-Chijan|+989111960300|mahsa_59_2007@yahoo.com|
21279342|NCT05320887|Wake Forest School of Medicine|Darcy Lockhart, Project Manager I|3367166182|alaverdi@wakehealth.edu|
21279343|NCT04520009|Dartmouth Geisel School of Medicine|Tor D. Tosteson, ScD|603 646-5724|tor.d.tosteson@dartmouth.edu|
21279344|NCT02289456|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@celgene.com|
21279345|NCT02463357|University of Colorado Denver|Robert Roach||clinicalresearchsupportcenter@ucdenver.edu|
21279346|NCT03509857|Montefiore MC|Dr. Aravind Pothula|9178015577|apothula@montefiore.org|
21279347|NCT01371539|Alcon Research, Ltd.|Stacie Cummings, O.D.|1-800-241-7629||
21279348|NCT02279108|CHU Saint-Etienne|Pr Céline CHAULEUR|04 77 82 86 11|celine.chauleur@chu-st-etienne.fr|+33
21279349|NCT01721317|GlaxoSmithKline|GSK Response Center|866-435-7343||
21279350|NCT01072617|BIDMC|Alvaro Pascual-Leone|617-667-0203|apleone@bidmc.harvard.edu|
21279351|NCT03168334|Bausch Health Americas, Inc|Study Director|510-259-5284|aloncaric@bauschhealth.com|
21279352|NCT00958893|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
21279353|NCT03907657|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat Canter|9199620000|melahat.garipagaoglu@gmail.com|
21279354|NCT00378573|sanofi-aventis|Medical Affairs study director||publicregistryUSMA@sanofi-aventis.com|
21279355|NCT01654315|The Ohio State University|Dr. Stephen Page|614-292-5490|STEPHEN.PAGE@OSUMC.EDU|614
21279356|NCT03094637|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Manero MD/Professor|713-745-3428|ggarciam@mdanderson.org|
21279357|NCT00711880|GW Pharma Ltd|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
21279358|NCT00704132|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21279359|NCT00442962|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21279360|NCT03348163|The University of Texas Health Science Center at Houston|Jordan Elizabeth Lake, MD, Associate Professor|(713) 500-6759|Jordan.E.Lake@uth.tmc.edu|
21279361|NCT00339144|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21279362|NCT02181790|Icahn School of Medicine at Mount Sinai|Dr Mark Lebwohl|2122413288|giselle.singer@mssm.edu|
21279363|NCT05147324|University of North Carolina at Chapel Hill|Angelica Cristello Sarteau|919-445-1191|angcri@live.unc.edu|
21279364|NCT01727726|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development||DT-inquiry@otsuka.jp|
21279365|NCT02714426|University of Florida|Michael Marsiske, Ph.D.|352.273.5097|marsiske@phhp.ufl.edu|
21279366|NCT00896480|GlaxoSmithKline|GSK Response Center|866-435-7343||
21279367|NCT03565679|Medline Industries, Inc|Kara Cassady|847-643-3809|kcassady@medline.com|
21279368|NCT00401986|Boston Scientific Corp.|G Mark Grubb, RN, CCRA|(412) 716-0717|grubbm@bsci.com|
21279369|NCT03185013|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
21279370|NCT01024686|U.S. Military Malaria Vaccine Program (USMMVP)|Dr. Michele Spring|301-319-9307||
21279371|NCT01881113|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
21279372|NCT01104792|Allergan|Willie R. Earley, MD Associate Vice President Clinical Development-CNS|714-246-4500|IR-CTRegistration@allergan.com,|
21279373|NCT01432379|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21279374|NCT02071849|Biostable Science and Engineering, Inc.|John Wheeler|512-386-1996|John.wheeler@biostable-s-e.com|
21279375|NCT03255655|Guided Therapy Systems|Rich Amodei, RDMS|480-649-8587|r.amodei@guidedtherapy.com|
21279376|NCT00658021|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21279377|NCT01806506|Department of General, Transplant and Liver Surgery, Medical University of Warsaw|Piotr Kalinowski|0048 22 599 2546|kalip@o2.pl|
21279378|NCT00725205|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21279379|NCT01680497|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21279380|NCT01119794|Brown University Oncology Research Group (BrUOG)|Eric Winer, MD|4018633000|kayla_rosati@brown.edu|
21279381|NCT05819203|Pharmndev Experts|Dr Bernard Gout|+41798659000|bgout@pharmndev.ch|
21279382|NCT01243775|Chonnam National University Hwasun Hospital|Dr. Young-Chul Kim|82-61-379-7614|kyc0923@jnu.ac.kr|
21279383|NCT01177059|Janssen-Cilag Pty Ltd, Australia|Executive Director Medical & Scientific|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21279384|NCT04051619|Brown University|Carolina Haass-Koffler, PharmD, PhD (PI)|4155191385|carolina_haass-koffler@brown.edu|
21279385|NCT03956355|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
21279386|NCT00974922|UCHC|Dr. William White|860-679-2104|wwhite@uchc.edu|
21279387|NCT00287586|Brigham and Women's Hospital|Shalendar Bhasin, MD||Sbhasin@partners.org|
21279388|NCT03831711|Stanford University|Dr. Andrei Iagaru, MD|650-725-4711|aiagaru@stanford.edu|
21279389|NCT01762800|GlaxoSmithKline|GSK Response Center|866-435-7343||
21279390|NCT02640482|AbbVie|Global Medical Services|800-633-9110||
21279391|NCT00517881|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21279392|NCT00113763|Amgen Inc.|Study Director|866-572-6436||
21279393|NCT03743415|University of Arizona College of Nursing|Terry Badger, PhD|520-626-6058|tbadger@arizona.edu|
21279394|NCT02847260|United Therapeutics Corporation|Leigh Peterson, Director, Product Development, Product Development & Global Clinical Operations|919-425-8165|lpeterson@unither.com|
21279395|NCT02968602|Maryland Psychiatric Research Center|Heidi J Wehring|410-402-6854|hwehring@som.umaryland.edu|
21279396|NCT00094861|Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com|
21279397|NCT00264550|Centocor Research & Development, Inc.|Director Clinical Research|1-800-457-6399||
21234038|NCT02118428|Terumo BCT Biotechnologies, LLC|Ray Goodrich, PhD|(303) 231-4832|ray.goodrich@terumobct.com|
21279398|NCT00129389|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
21291405|NCT02496000|Orange County Research Center|Joel M. Neutel, M. D.|714-541-5591|jmneutel@aol.com|
21291406|NCT02255656|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21291407|NCT03909971|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21291408|NCT03734536|Smith+Nephew|Samantha Andrews|9789718990|samantha.andrews@smith-nephew.com|
21291409|NCT01877278|University of Messina|Gianfilippo Bagnato|00390902212502|gianbagnato@gmail.com|
21291410|NCT03140969|Sepul Bio|Zuhal Butuner - Chief Medical Officer|(905) 599 7887|contact@sepulbio.com|
21291411|NCT04727151|Triumvira Immunologics|Maria Apostolopoulou, Clinical Scientist|518-892-8426|mapostolopoulou@triumvira.com|
21291412|NCT00642759|Massachusetts General Hospital|Dr. Rebecca Heist|6177244000|rheist@partners.org|
21291413|NCT03546439|Saint Luke's Hospital of Kansas City|Sanjaya Gupta, MD|8169311883|sgupta@saint-lukes.org|
21291414|NCT02476448|Cleveland Clinic Florida|Dr. Eric Hurtado|954-659-5559|hurtade@ccf.org|
21291415|NCT04262479|NTNU|Ingrid K Hals|+47 73412207|ingrid.hals@ntnu.no|
21291416|NCT05185453|University of Pittsburgh|Dr. Alison Culyba|412-692-6056|alison.culyba@chp.edu|
21291417|NCT02516813|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21291418|NCT01972659|Kocaeli University Medical Faculty|Assistant Professor Dr Z Ipek ARSLAN AYDIN|00905325011339|zehraipek48@gmail.com|
21291419|NCT02399228|University of Texas Health Science Center at San Antonio|Dr. Ying Li, M.D., Ph.D.|210-450-1719|liy8@uthscsa.edu|
21291420|NCT04652765|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Cathy Handy Marshall|4109550231|chm@jhmi.edu|
21291421|NCT03664544|Mitsubishi Tanabe Pharma Europe Ltd|General Information|Please e-mail|regulatory@mt-pharma-eu.com|
21291422|NCT03814044|Smith + Nephew, Inc.|Judith Horner|+44 1482 673251|Judith.Horner@smith-nephew.com|
21291423|NCT02757768|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
21291424|NCT05218434|Simbec Orion|Dr Annelize Koch|01443694313|gabrielle.brill@simbecorion.com|
21291425|NCT00835367|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21291426|NCT05929326|Hung Vuong Hospital|Dr. Huan N Pham|+84906884435|huanpmd@gmail.com|
21291427|NCT05700422|Scheie Eye Institute|Ophthalmology Clinical Research|215-662-8038|ophth.clinicalresearch@pennmedicine.upenn.edu|
21291428|NCT04093453|Imperial College London|Dr. Edward Chambers|+44 20 7594 0959|e.chambers@imperial.ac.uk|
21240771|NCT03226457|University of Dundee|Dr Natalie Mordi (Principle Investigator)|+ 44 (0) 1382 383 667|n.a.mordi@dundee.ac.uk|
21240772|NCT03583541|Washington University in St. Louis|Fred Ssewamala|3149358521|fms1@wustl.edu|
21291430|NCT02495883|UCSD|Fatta Nahab, MD|858-822-5871|fnahab@health.ucsd.edu|
21291431|NCT03557502|University of Oregon|Dr. Christopher Minson|541-953-2231|minson@uoregon.edu|
21291432|NCT00964678|Virginia Commonwealth University Health System|Dan Grinnan, MD|804-828-9000|daniel.grinnan@vcuhealth.org|
21291433|NCT03359395|Wake Forest Health Science|T. Quinn McCutchen, MD|336.716.4498|tmccutch@wakehealth.edu|
21291434|NCT05339659|Kaiser Permanente|Dr. Jennifer McClure|206-287-2737|jennifer.b.mcclure@kp.org|
21291435|NCT03164356|University of Washington|Daniel Ballesteros|206-221-5873|danieb25@uw.edu|
21291436|NCT00543127|Department of Medical Oncology, Hospital Universitario Gregorio Marañón|Dr. Miguel Martin||miguel.martin@salud.madrid.org|
21291437|NCT04494971|Pennington Biomedical Research Center|Dr. Hanim Ecem Diktas|(225) 763-2832|hanim.diktas@pbrc.edu|
21291438|NCT03396445|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21291439|NCT02964377|UC Davis Health|Dr. Craig McDonald, Professor and Chair|(916) 734-4293|cmmcdonald@ucdavis.edu|
21291440|NCT03552029|Daiichi Sankyo|Contact for Clinical Trial Disclosure Information|908-992-6400|CTRinfo@dsi.com|
21291441|NCT01882816|Memorial Sloan Kettering Cancer Center|Dr. Nancy Lee, MD|212-639-3341|leen2@mskcc.org|
21291442|NCT02541591|ZOL Genk|Koen Ameloot|0485685969|koen.ameloot@zol.be|
21291443|NCT01212900|National Heart Lung and Blood Institute|Mehta, Nehal|+1 301 827 0483|mehtann@mail.nih.gov|
21291444|NCT05157360|Department of Surgery, University of Kansas School of Medicine-Wichita|Dr. Thomas Resch|316-268-5990|tresch@wsspa.com|
21291445|NCT00876447|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21291446|NCT00567502|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21291447|NCT02297516|Q-Med AB|Head of Development|+ 46 (0) 18 474 90 00|reception.seupp@galderma.com|
21291448|NCT00710593|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
21291449|NCT04490278|Washington University|Chris Palmer|314-215-7384|cmpalmer@wustl.edu|
21291450|NCT02965781|Squarex LLC|Hugh McTavish|6512078270|hmctavish@squarex-pharma.com|
21291451|NCT00366457|Massachusetts General Hospital|Lawrence S. Blaszkowsky, MD|6172191230|LBLASZKOWSKY@mgh.harvard.edu|
21291452|NCT02538614|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21291453|NCT01098747|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21291454|NCT03835078|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
21291455|NCT01638507|Medtronic, Coronary Clinical Affairs|Lisa Bousquette, Clinical Research Director|(707) 591-2967|lisa.r.bousquette@medtronic.com|
21240773|NCT00884286|Pharma Mar, S.A.|Clinical Development Department of PharmaMar´s Oncology,Business Unit.,|+34 918466000|clinicaltrials@pharmamar.com|
21261456|NCT03215914|University of Pennsylvania|Cornelia V. Dalton Bakes|215-746-2085|corneliv@pennmedicine.upenn.edu|
21291456|NCT01999530|Centre for Addiction and Mental Health|Bernard Le Foll|416-535-8501|bernard.lefoll@camh.ca|34772
21291457|NCT03359161|St. Elizabeth's Medical Center|Dr. Lana Tsao|617-789-3036|lana.tsao@steward.org|
21291458|NCT00183248|University of Miami|George W. Burke III, M.D.|(305) 355-5060|Gburke@med.miami.edu|
21261457|NCT03715465|University of Michigan|Leslie Swanson|734-764-2242|lmswan@med.umich.edu|
21291459|NCT04734210|Surface Ophthalmics, Inc.|VP, Clinical Operations|(925) 494-3660|cbaenziger@surfaceophthalmics.com|18
21291460|NCT01358734|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
21291461|NCT03641287|University of Washington Medical Center|Kathryn Pennington, MD|206-598-8300|katypenn@uw.edu|
21291462|NCT00600340|CECOG|MD. Christiane Thallinger|+43 1 409 77 25|office@cecog.at|
21291463|NCT00127439|University of Louisville|Andrea L. Behrman, PhD, PT|502-582-7451|andreabehrman@catholichealth.net|
21291464|NCT03847519|Advaxis, Inc.|Sumitra Sheeri|609-423-2528|sheeri@advaxis.com|
21291465|NCT02095106|Orthopaedic Institute for Children|Dr. Mauricio Silva|213-742-1109|msilva@mednet.ucla.edu|
21291466|NCT04023045|Orthocare Innovations, LLC|Sarah Chang|425-771-0797|schang@orthocareinnovations.com|1007
21291467|NCT03373435|Eiger BioPharmaceuticals, Inc.|Senior VP, Clinical Development|1-650-272-6138|info@eigerbio.com|
21291468|NCT00189137|University of Michigan Comprehensive Cancer Center|Dr. Scott Schuetze, M.D., Ph.D.|1-800-865-1125|scotschu@umich.edu|
21291469|NCT00023595|Duke University Health System|Dr. Eric Velazquez|919-668-8700|velaz002@mc.duke.edu|
21291470|NCT02284893|AstraZeneca|Katarina Fridman|+46(31)7762040|katarina.fridman@astrazeneca.com|62040
21291471|NCT04116684|Cleveland Clinic|Venu Menon, M. D.|216-445-5390|menonv@ccf.org|
21291472|NCT03078868|University of Chicago|Shirley Rodriguez|773-834-4337|srodrigu@surgery.bsd.uchicago.edu|
21291473|NCT01983111|Mundipharma Korea Ltd.|PhD. Miyoung Song||miyoung.song@mundipharma.co.kr|
21291474|NCT03038620|UT Southwestern Medical Center|Dr. Parag Joshi|2146458000|parag.joshi@utsouthwestern.edu|
21291475|NCT00105066|National Institute On Aging|Dr. James Strait|4105588084|straitj@mail.nih.gov|
21291476|NCT02733757|Universidade federal de Minas Gerais|Dr Renato Gomez|553134099760|renatogomez2000@yahoo.com.br|
21291477|NCT01483560|University of Glasgow|Prof John Petrie|+44 141 330|John.Petrie@glasgow.ac.uk|3325
21291478|NCT03261505|Massachusetts General Hospital|Prof. Jian Kong|16179620978|kongj@nmr.mgh.harvard.edu|
21291479|NCT01890031|University of Rochester|Robert Block, MD, MPH; Clinical Trial Director|585-275-3356|robert_block@urmc.rochester.edu|
21291480|NCT02231580|Ipsen|Vice President Early Development & Clinical Pharmacology||clinical.trials@ipsen.com|
21291481|NCT02711202|Institute for Clinical and Experimental Medicine|Prof. Ondřej Viklický, M.D., Ph.D.|+420 2 6136 4110|ondrej.viklicky@ikem.cz|
21291482|NCT05852470|Alcon Research, LLC|Clinical Project Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21291483|NCT01903863|Duke University Hospital|Dr. Caroline Ozment|919-681-2554||
21291484|NCT01107496|Supernus Pharmaceuticals, Inc.|Jonathan Rubin, MD, Senior Vice President and Chief Medical Officer|240-403-5710|jrubin@supernus.com|
21291485|NCT03448393|National Cancer Institute|Dr. Nirali N. Shah|240-760-6970|shahnn@mail.nih.gov|
21291486|NCT01587196|University of Pennsylvania|Daniel Langleben, MD|215-760-7067|langlebe@pennmedicine.upenn.edu|
21234039|NCT02378844|electroCore INC|Clinical Affairs|+1 973 355 6683|clinical@electrocore.com|
21291487|NCT03826472|California Health Sciences University College of Osteopathic Medicine|Emily Johnston|9737685888|eajohnst@gmail.com|
21291488|NCT02096107|Medical University of South Carolina|David Taber|843-792-3368|taberd@musc.edu|
21291489|NCT03612570|Pulse Biosciences, Inc.|William A. Knape|(510) 906-4649|bill.knape@pulsebiosciences.com|
21291490|NCT05318287|Oregon Research Behavior Intervention Strategies, Inc. dba Influents Innovations|David Smith|541-484-2123|david.smith@influetnsin.com|
21291491|NCT00937105|University Hospitals Eye Institute|Loretta Szczotka-Flynn OD, PhD|216-844-3609|loretta.szczotka@uhhospitals.org|
21291492|NCT03537508|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21291493|NCT04308512|Baylor College of Medicine|Dr. Bijan Najafi|(424) 467-7127|najafi.bijan@gmail.com|
21291494|NCT03176173|Stanford University|Clinical Associate Professor, Radiation Oncology - Radiation Therapy|(650) 723-6171|mgens@stanford.edu|
21261458|NCT05134974|Ocuphire|Drey Coleman, VP of Clinical Operations|813-404-1993|dcoleman@ocuphire.com|
21291495|NCT02513641|Pennington Biomedical Research Center|Dr. Eric Ravussin|225-763-3186|eric.ravussin@pbrc.edu|
21291496|NCT00131885|University of Utah|Patricia Murphy, DrPH|801-793-5729|patricia.murphy@nurs.utah.edu|
21291497|NCT02520154|University of Texas M D Anderson Cancer Center|Dr. Amir Jazaeri MD|(713) 745-1613|aajazaeri@mdanderson.org|
21291498|NCT06022107|Yale University|Li Yan McCurdy, PhD|2037372912|liyan.mccurdy@yale.edu|
21291499|NCT02333799|Global Alliance for TB Drug Development|Eugene Sun, MD|212-227-7540|eugene.sun@tballiance.org|
21291500|NCT03716830|Massachusetts General Hospital|Jian Kong, PI of the clinical trial|6177267893|kongj@nmr.mgh.harvard.edu|
21291501|NCT05484895|Emory University|Dr. Don Operario|404-727-0503|don.operario@emory.edu|
21291502|NCT04795531|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21291503|NCT04887831|G1 Therapeutics, Inc.|Clinical Trial Info.|919-213-9835|clinicalinfo@g1therapeutics.com|
21291504|NCT02552225|Boson Medical Center|Pieter Noordzij, MD|(617) 414-1756|pieter.noordzij@bmc.org|
21291505|NCT03122184|Massachusetts General Hospital|Dr. Jeff Huffman|617-724-2910|JHUFFMAN@mgh.harvard.edu|
21291506|NCT00633126|Cerexa, Inc.|David Friedland, MD|510-285-9200|clinicaltrials@cerexa.com|
21291507|NCT01168596|University of Florida Center for Movement Disorders and Neurorestoration|Irene A. Malaty, MD|352-273-5550|Irene.Malaty@neurology.ufl.edu|
21291508|NCT00123630|University of Utah|Dr. John Fang|801-581-7802|john.fang@hsc.utah.edu|
21291509|NCT02829996|Inotek Pharmaceuticals Corp.|Roni Cohen|781-676-2100|rcohen@inotekpharma.com|
21291510|NCT02323048|University of Chicago|Dr. Harriet de Wit|773-702-3560|dewitlab@yoda.bsd.uchicago.edu|
21291511|NCT00189423|Advanced Circulatory Systems, Inc.|Director of Clinical Trials|651-403-5600|csetum@advancedcirculatory.com|
21291512|NCT03901430|University of New Mexico|Julia Hess|5052724462|jmhess@unm.edu|
21291513|NCT01385579|Northwestern University|Dr. Muriel Jean-Jacques, Assistant professor|312-503-9642|mjean@nmff.org|
21291514|NCT01681147|Joslin Diabetes Center|Dr. Florence Brown|617-309-2675|Florence.Brown@joslin.harvard.edu|
21291515|NCT03594500|VA NY Harbor Healthcare System|Dr. Joshua Chodosh|212-686-7500|joshua.chodosh@va.gov|5043
21291516|NCT05296824|SacEP Research|Arash Aryana, MD, PhD|916-453-2684|a_aryana@outlook.com|
21291517|NCT02134184|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
21291518|NCT00806585|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDevelopment@merck.com|
21291519|NCT00304161|University of Pennsylvania|Dr. Daniel Weintraub|215-349-8207|daniel.weintraub@uphs.upenn.edu|
21291520|NCT04618276|University Hospital Zurich|PD Dr. med. Yvonne Achermann|+41 44 396 74 18|yvonne.achermann@usz.ch|
21291521|NCT02038647|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21291522|NCT04462471|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho, MD, PhD|646-608-3774|hoa@mskcc.org|
21291523|NCT04486677|VA San Diego|Dr. Emily Treichler|6192288075|emily.treichler@va.gov|
21291524|NCT00855335|Janssen Scientific Affairs, LLC|Medical Leader, Medical Department||ClinicalTrialDisclosure@its.jnj.com|
21291525|NCT05126303|Guard Therapeutics|Sara Thuresson, Head of Clinical Operations|+46733319438|sara.thuresson@guardtherapeutics.com|
21291526|NCT02526290|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21291527|NCT02082977|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21291528|NCT00737360|The University of Texas M.D, Anderson Cancer Center|Dr. Anne Tsao, Principal Investigator|713-792-6363||
21291529|NCT05036343|Mayo Clinic|Ana L. Creo, M.D.|507-284-3300|Creo.Ana@mayo.edu|
21291530|NCT02106832|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21291531|NCT02878785|University of Maryland Greenebaum Cancer Center|Maria Baer, M.D.|410-328-8708|mbaer@umm.edu|
21291532|NCT02706392|Fred Hutchinson Cancer Center|Dr. David Maloney|2066675616|dmaloney@fredhutch.org|
21291533|NCT00619866|AbbVie|Global Medical Services|800-633-9110||
21291534|NCT06203717|Butler Hospital|Mascha van 't Wout-Frank|401-680-4198|mascha_vant_wout@brown.edu|
21291535|NCT00265122|Centocor Research & Development, Inc.|Sr. Dir. Clinical Research|1-800-457-6399||
21291536|NCT04716894|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
21291537|NCT00608062|University of Colorado Anschutz Medical Campus|Dr. Kerrie Moreau. PI|303-724-1914|kerrie.moreau@cuanschutz.edu|
21291538|NCT05205616|University of Califronia, San Francisco|Sepehr Hashemi, DMD|4133674736|sepehr.hashemi@ucsf.edu|
21291539|NCT04992065|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21291540|NCT01275300|Upenn|Wenliang Song, MD|215-662-4652.|wenliangsong@gmail.com|
21291541|NCT03648892|NIH|Dr. Kevin Hall|301-402-8248|kevinh@niddk.nih.gov|
21291542|NCT01467466|MAVERIC, VA Boston|Christopher Donnelly, Chief of Data Management|857-364-2332|christopher.donnelly2@va.gov|
21291543|NCT02268656|Gil hospital|Dr. Hyun Jeong Kwak|82324603636|hyun615@gilhospital.com|
21291544|NCT03338920|Currax Pharmaceuticals LLC|Dr. Michael Kyle|708.834.8254|mkyle@curraxpharma.com|
21291545|NCT01772654|Mayo Clinic|Cheolsu Shin, M.D.|507-284-4961|shin@mayo.edu|
21261459|NCT03618641|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR; CRS Regulatory Supervisor|412-647-5554|stadtermanbm@upmc.edu|
21261460|NCT01518530|Hillel Yaffe Medical Center|Dr. Yaron River|972-523-756-446|yaronr@hy.health.gov.il|
21234040|NCT01010282|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21234041|NCT03341052|Mayo Clinic|Andres Acosta|15072666931|acosta.andres@mayo.edu|
21234042|NCT00735371|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21234043|NCT03405142|Stanford Medicine at Stanford University|Roan Courtney Raymundo|650-721-4071|rcraymun@stanford.edu|
21234044|NCT00436748|Amgen Inc.|Study Director|866-572-6436||
21234045|NCT01610791|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21234046|NCT01105247|Pharmacyclics|Danelle James|855-427-8846|medinfo@pcyc.com|
21234047|NCT04627064|Dana-Farber Cancer Institute|Toni Choueiri, M.D|617-6325456|toni_choueiri@dfci.harvard.edu|
21234048|NCT00097721|Eisai Inc|Eisai Call Center|888-422-4743||
21234049|NCT01067768|Hospital Pablo Tobón Uribe|Dr. María Victoria Restrepo|57-4-4459315|mrestrepo@hptu.org.co|
21234050|NCT02126969|University of Kentucky|Dr. Susanne Arnold|8592579568|smarno0@uky.edu|
21234051|NCT05583903|Department of Surgery, Houston Methodist Hospital|Dr. Hina Faisal|713-714-4973|hfaisal@houstonmethodist.org|
21234052|NCT01533246|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@ccf.org|
21234053|NCT00354172|Masonic Cancer Center, University of Minnesota|Jeffrey Miller, M.D.|612-625-7409|mille011@umn.edu|
21234054|NCT01052545|Michael E. DeBakey VA Medical Center|Barbara Trautner, MD, PhD|713-440-4438|barbar.trautner@va.gov|
21234055|NCT03792672|Takeda|Medical Director|1-877-825-3327|medicalinformation@tpna.com|
21234056|NCT00453999|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|919-859-1302||
21234057|NCT00983216|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21234058|NCT04238728|University of Rochester Medical Center|Julie Ryan, MD|585-276-3862|Julie_Ryan@URMC.Rochester.edu|
21234059|NCT02901951|GlaxoSmithKline|GSK Response Center|866-435-7343|sk994601@gsk.com|
21234060|NCT00594061|University of Iowa|Bruce Gantz|319-353-8776|bruce-gantz@uiowa.edu|
21234061|NCT00829296|University of Chicago|Dr. George Bakris|773-702-7936|gbakris@medicine.bsd.uchicago.edu|
21234062|NCT00537446|Columbia University Irving Medical Center|Robert Basner, MD||rcb42@cumc.columbia.edu|
21234063|NCT04960228|Lady Davis Institute for Medical Research|Ben Haward, Research Assistant|514-340-8222|ben.haward@ladydavis.ca|23978
21234064|NCT01987427|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
21234065|NCT04630093|University of Florida|Dr. Julio Duarte|352-273-8132|juliod@cop.ufl.edu|
21234066|NCT01073865|AstraZeneca|Global Clinical Lead|+44 1509 645895|clinicaltrialtransparency@astrazeneca.com|
21234067|NCT04590547|GeneOne Life Science|Senior Clinical Operations Associate|6106576351|dkane@genels.us|
21234068|NCT02547129|Mayo Clinic|Dr. Michael J. Taunton|507-284-7692|Taunton.Michael@mayo.edu|
21234069|NCT03925324|Medstar Health Research Institute|Megan Rowland|202-877-2959|megan.e.rowland@medstar.net|
21234070|NCT03799484|The University of Texas Health Science Center at Houston|Karina Richani-Reverol, MD|(713) 559-5200|Karina.RichaniReverol@uth.tmc.edu|
21234071|NCT00794196|Parc Sanitari Sant Joan de Déu|Dr. Antoni Serrano Blanco|+34936406350|aserrano@pssjd.org|12215
21234072|NCT04414553|University of Colorado|Lisa Ross DeCamp|3037246499|lisa.decamp@cuanschutz.edu|
21234073|NCT00259090|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21234074|NCT02319031|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
21234075|NCT01015586|Medical University of South Carolina|Bryan K. Tolliver, MD PhD|843-792-4869|tollive@musc.edu|
21234076|NCT00358462|University of Washington|Lisa E. Manhart, PhD - PI|206-744-3646|lmanhart@uw.edu|
21234077|NCT04371380|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21234078|NCT02244580|Biontech Diagnostics GmbH|Dr. Michael Oed|+49 6131/ 6358030|michael.oed@theracode.de|
21234079|NCT00446147|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
21234080|NCT02910167|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21234081|NCT01418937|GlaxoSmithKline|GSK Response Center|866-435-7343||
21234082|NCT00656630|The Scripps Research Institute|Barbara J. Mason, Ph.D.-Principal Investigator|858784-7328|mason@scripps.edu|
21234083|NCT04052542|University of Pittsburgh School of Medicine|Timothy D Girard, MD, MSCI|(412) 383-0582|timothy.girard@pitt.edu|
21234084|NCT01667978|Montefiore|Jessica Atrio|718 405 82 60|jatrio@montefiore.org|
21234085|NCT00856908|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21234086|NCT01063595|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201 604-1155|michael.eppolito@octapharma.com|
21234087|NCT06021951|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
21234088|NCT04059146|University of Iowa|Dr. Ruth Chimenti|319-335-9802|ruth-chimenti@uiowa.edu|
21234089|NCT01623596|Novartis Pharmaceuticals|Study Director|(862) 778-8300||
21234090|NCT01070316|Cincinnati Children's Hospital Medical Center|Elizabeth Hoskins|(513) 803-7263|elizabeth.hoskins@cchmc.org|
21234091|NCT00026793|National Cancer Institute|Dr. Robert Yarchoan|240-760-6075|robert.yarchoan@nih.gov|
21234092|NCT04243538|Weill Cornell Medicine|Dr. Veerawat Phongtankuel|212-746-7000|vep9012@med.cornell.edu|
21234093|NCT00655564|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-3775|sfeldman@wakehealth.edu|
21234094|NCT04536727|University of Illinois at Chicago|Dr. David Marquez|(312) 996-1209|marquezd@uic.edu|
21234095|NCT02214277|Claret Medical|Director of Clinical Research|707-528-9300|info@claretmedical.com|
21234096|NCT00500370|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21234097|NCT05627518|Cinclus Pharma AB|Kristofer Katkits Nilsson, Global Trial Manager|+46 7064955|kristofer.katkits@cincluspharma.com|
21234098|NCT02904057|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
21240774|NCT01196104|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
21240775|NCT00409240|Providence VAMC|Wen-Chih Wu, MD|401-273-7100|wen-chih.wu@va.gov|6237
21240776|NCT04655313|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
21240777|NCT03781960|University of Pennsylvania Hospital|Thomas Karasic, MD|215-614-1858|thomas.karasic@pennmedicine.upenn.edu|
21240778|NCT01094171|GlaxoSmithKline|GSK Response Center|866-435-7343||
21240779|NCT00594932|Oklahoma Medical Research Foundation|Joan T Merrill M.D.|405 271 7805|joan-merrill@omrf.org|
21240780|NCT01536145|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21240781|NCT02444234|University of Southern California|Paul M Beringer, Pharm.D.|323-442-1402|beringer@usc.edu|
21240782|NCT01183650|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21240783|NCT00088205|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21240784|NCT05199233|Mayo Clinic Rochester|Dr. Ivana T. Croghan|507 284-2511|gimresearchstudies@mayo.edu|
21240785|NCT00736073|DUMC|Dr. Martin Poleski|9196841817|martin.poleski@dm.duke.edu|
21240786|NCT02563834|Indiana University|Dr. Kieren J Mather|317-278-7826|kmather@iu.edu|
21240787|NCT02491892|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21240788|NCT01734850|CSL Behring|Trial Registration Coordinator|484-878-4000|clinicaltrials@cslbehring.com|
21240789|NCT03824938|Columbia University Irving Medical Center|Victoria M. Leavitt, MD|212-342-1351|vl3227@cumc.columbia.edu|
21240790|NCT05126459|Loma Linda University Health|Dr. Jung-Wei Chen|909 558 1000|JWChen@llu.edu|
21240791|NCT00065468|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21240792|NCT04496167|Endo Pharmaceuticals|Clinical Operations|800-462-3636|clinicaltrials@endo.com|
21240793|NCT01058863|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21240794|NCT00570258|University of Arkansas for Medical Sciences|Beth Scanlan|501-686-8274|bscanlan@uams.edu|
21240795|NCT03088137|IVFarma LLC|Mikhail Polzikov (PhD)|+74996455342|mikhail.polzikov@ivfarma.ru|1
21240796|NCT03050398|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
21240797|NCT05108649|University of Pennsylvania|Valentina Goren, MRA Project Manager|215-746-3602|vsoup@pennmedicine.upenn.edu|
21240798|NCT04612049|University of Montreal|Dr Danielle Levac|5148639108|danielle.levac@umontreal.ca|
21240799|NCT00918749|Warner Chilcott|Grexan Wulff, Manager, Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
21240800|NCT01712789|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
21240801|NCT03018106|Emory University|Gina Northington, MD|(404) 778-5770|gina.northington@emory.edu|
21279399|NCT00451204|University of California Los Angeles|Dr. Rhonda Voskuhl|310-206-4636|rvoskuhl@mednet.ucla.edu|
21240802|NCT03553940|Saint Louis University|Daniel F. Hoft, MD, PhD|314-977-5500|daniel.hoft@health.slu.edu|
21240803|NCT02213055|The Deirdre Imus Environmental Health Center at HackensackUMC|Project Manager, Environmental Research|551-996-8071|dimuscenter@hackensackumc.org|
21240804|NCT03190083|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Nidhi Sharma|+1 216-444-9014|sharman2@ccf.org|
21240805|NCT02025205|Pulmonx|Narinder Shargill, Vice President, Global Medical and Clinical Affairs|650-216-0108|nshargill@pulmonx.com|
21240806|NCT04675242|Nicox Ophthalmics, Inc.|Doug Hubatsch|832-360-3022|hubatsch@nicox.com|
21240807|NCT02448719|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21240808|NCT01024751|Bausch & Lomb Incorporated|William Reindel, OD, MS|(585) 338-8129|william.reindel@bausch.com|
21240809|NCT03786094|Spexis AG|Christian Zwingelstein|+41 61 567 16 00|info@spexisbio.com|
21240810|NCT02218203|Translational Pain Research, Brigham and Women's Hospital|Christine N. Sang, MD, MPH|617-525-7246|paintrials@partners.org|
21240811|NCT02601937|Epizyme, Inc.|Medical Lead or Designee|(855) 500-1011|clinicaltrials@epizyme.com|
21240812|NCT03038672|Mayo Clinic|Stephen Ansell|(507)284-5096|ansell.stephen@mayo.edu|
21240813|NCT04423393|Vir Biotechnology, Inc.|Study Inquiry|(415) 906-4324|clinicaltrials@vir.bio|
21240814|NCT05220501|Sunnybrook Health Sciences Centre|Dr. Laurence Klotz|+1. 416 480 4673|Laurence.Klotz@sunnybrook.ca|
21240815|NCT01929993|Fundação Oswaldo Cruz|Dr Fábio Russomano|55 21 25541815|fabiorussomano@gmail.com|
21240816|NCT03985098|University of Houston|Susan Abughosh|832-842-8395|smabughosh@uh.edu|
21240817|NCT02307916|Massachusetts Eye and Ear|Dr. Brad Welling|617-573-4075|brad_welling@meei.harvard.edu|
21240818|NCT01440049|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21240819|NCT02268552|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21240820|NCT01969162|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21240821|NCT04463615|City of Hope Medical Center|Dr. Christiane Querfeld|6263598111|cquerfeld@coh.org|
21240822|NCT00661258|Boston University Center for Global Health and Development|Dr. Lora Sabin|617-414-1272|lsabin@bu.edu|
21240823|NCT01708187|Orthopedic Foot and Ankle Center|Gregory Berlet, MD|614-895-8747|ofacresearch@orthofootankle.com|
21240824|NCT04242875|Carolina Eyecare Physicians|Director of Research|8438813937|hsandoval@cepmd.com|
21240825|NCT02501759|OHSU Knight Cancer Institute|Fegus Coakley|503-494-2333|coakleyf@ohsu.edu|
21240826|NCT02408549|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21279400|NCT03760185|Denver Health and Hospital Authority|Dr Cristos Ifantides|303-436-4949|Cristos.Ifantides@dhha.org|
21261461|NCT01389128|University of São Paulo|Dr. Silvana Maria Quintana|+55(16)36022813|quintana@fmrp.usp.br|
21279401|NCT00866879|Northwestern University|Lorenzo Gallon, MD|3126954457|l-gallon@northwestern.edu|
21279402|NCT02495259|Emory University|Dr. Igor Zhukov|404-268-1404|izhukov@live.com|
21279403|NCT00976911|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21240827|NCT00231894|Nathan Kline Institute ofr Psychiatric research|Robert C. Smith MD|845-398-6531|rsmith@nki.rfmh.org|
21279404|NCT01191944|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21240828|NCT01833117|Alcon Research, Ltd.|Michela Montecchi-Palmer, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21240829|NCT01232556|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21240830|NCT01628510|Washington University|Roberta Pineda|314-286-1304|pineda_r@kids.wustl.edu|
21240831|NCT04707391|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21240832|NCT04374565|University of Virginia|Dr. Jeffrey Sturek|434-284-1776|JMS3HK@hscmail.mcc.virginia.edu|
21240833|NCT03983993|Emory University|Olatunji Alese|404-778-6639|olatunji.alese@emory.edu|
21240834|NCT02500316|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
21240835|NCT01406717|SPIL|Clinical Trials|912266455645|clinical.trials@sparcmail.com|
21240836|NCT02040090|Kamada|Eran Schenker, VP Medical Director|+972-8-9406472|Erans@kamada.com|
21240837|NCT02554435|California State Polytechnic University, Pomona|Dr. Zakkoyya Lewis|5628819950|drkoyyalewis@gmail.com|
21240838|NCT03370276|Moffitt Cancer Center|Christine Chung, MD|813-745-5061|Christine.Chung@moffitt.org|
21240839|NCT01614574|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21240840|NCT02875561|University of Colorado|Dr. Saketh Guntupalli|303-724-2024|saketh.guntupalli@cuanschutz.edu|
21240841|NCT02584855|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21240842|NCT02337478|Wake Forest University Health Sciences|Timothy Pardee, MD, Ph.D.|336-716-5440|tpardee@wakehealth.edu|
21240843|NCT00895843|University of Manchester|Mr Sin L Yong|01612756806|sin.l.yong@manchester.ac.uk|
21240844|NCT02329600|Faculty of Oral and Dental Medicine Cairo University|Dr. Noha Ayman Ghallab|+201005263365|noha.ghallab@dentistry.cu.edu.eg|
21240845|NCT04963062|University of Wisconsin School of Medicine and Public Health|Shuang Li|608.263.8336|lis@urology.wisc.edu|
21240846|NCT03171168|Montefiore Medical Center|Matthew Bartels|(914) 597-2332|MBARTELS@montefiore.org|
21240847|NCT03500172|Johns Hopkins Bloomberg School of Public Health|Dr. Stefan Baral|4105028975|sbaral@jhu.edu|
21240848|NCT00996580|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21240849|NCT02218489|Kala Pharmaceuticals, Inc|VP, Clinical Development|781-996-5252|Results003@kalarx.com|
21240850|NCT01778062|Novartis Pharmaceuticals|Study Director|862-778-8300||
21240851|NCT03958630|National Institute of Mental Health|Innis, Robert|+1 301 594 1368|robert.innis@nih.gov|
21240852|NCT01815736|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21240853|NCT04039503|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21240854|NCT02413684|Duke Asthma, Airway and Allergy Center|Njira Lugogo|919-613-5707|njira.lugogo@duke.edu|
21240855|NCT03387514|UW School of Medicine and Public Health|Steve Cho, MD|608-263-5585|cho85@wisc.edu|
21240856|NCT04436796|Sansum Diabetes Research Institute|Jordan Pinsker|805-682-7640|jpinsker@sansum.org|
21240857|NCT04701593|Virginia Tech|Dr Vishak John|(540) 855-5100|vishakjohn@vt.edu|
21240858|NCT00462644|Wake Forest University, Department of Surgery|Amy N. Hildreth, MD||ahildret@gmail.com|
21240859|NCT04157686|Medytox Inc.|Young Ryu|+82-2-6901-5424|aab005@medytox.com|
21240860|NCT02018315|University of Texas Southwestern Medical Center|Juan Pascual, M.D., Ph.D.|214-648-3550|juan.pascual@utsouthwestern.edu|
21240861|NCT00107744|Tulane University|Jiang He, MD, PhD, Chair of Epidemiology|504-988-5165|jhe@tulane.edu|
21240862|NCT01388543|"University of Colorado | Skaggs School of Pharmacy and Pharmaceutical Sciences"|Dr. Peter Anderson|3037246128|peter.anderson@cuanschutz.edu|
21240863|NCT01556243|Mayo Clinic|Judy Boughey|507-266-9997|Boughey.Judy@mayo.edu|
21240864|NCT04684914|Altimmune|Randy Brown|3179003335|rbrown@altimmune.com|
21240865|NCT04471792|Kansas State University|Dr. Judy Delp|3522269535|mullerdelp@vet.k-state.edu|
21240866|NCT03872388|MD Anderson Cancer Center|Carlos Barcenas, MD|(713) 794-5098|chbarcenas@mdanderson.org|
21240867|NCT03997851|University of Miami|Leigh Nattkemper|3055889734|Lxn202@med.miami.edu|
21240868|NCT05089656|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21240869|NCT04191135|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21240870|NCT05160025|Rutgers University|Dr. John Palmieri, Study Coordinator|9733562378|john.palmieri@rutgers.edu|
21240871|NCT00107380|SWOG Statistical Center|Study Statistician|206-667-4623||
21240872|NCT03673098|Massachusetts General Hospital|Dr. Christina Psaros|617-726-7458|cpsaros@mgh.harvard.edu|
21240873|NCT01268059|MedImmune, LLC|Mohammed Dar, MD, Vice President & Head, Clinical Development, Oncology|+1 301-398-0000|information.center@astrazeneca.com|
21240874|NCT03660943|Centrexion Therapeutics, Inc.|Director of Clinical Operations|617-837-6911|info@centrexion.com|
21240875|NCT01021878|Pontifícia Universidade Católica do Paraná|Dr. Roberto Pecoits-Filho and Dr. Thyago P. Moraes|554132713150|r.pecoits@pucpr.br|
21240876|NCT01155726|Alcon Research|Director of Clinical Trials|1-800-241-7629||
21240877|NCT02054247|Eskisehir Osmangazi University|Dr. Onur Armagan|00902222392979|dronurarmagan@hotmail.com|
21240878|NCT01330043|Stanford University|Dr. Sean P. David|401-265-2275|spdavid@stanford.edu|
21240879|NCT04990687|UAB|Samantha White|205-934-1989|swwhite@uabmc.edu|
21240880|NCT02472314|Wayne State University School of Medicine and Cleveland Clinic Florida|Vani J. Sabesan, MD|131375138489|sabes001@gmail.com|
21240881|NCT05794997|Brigham and Women's Hospital|Rishi J Desai, PhD|6172780932|rdesai@bwh.harvard.edu|
21240882|NCT02096081|Merz North America, Inc.|Michelle Widmann|919-582-8238|Michelle.Widmann@merz.com|
21291546|NCT01262105|Nimbic Systems|Sean Self|281-565-5700|self@nimbicsystems.com|
21240883|NCT00109928|SWOG Statistical Center|Study Statistician|206-667-4623||
21291547|NCT00330733|Phoenix VA Health Care System|Peter Reaven|602 277 5551|Peter.Reaven@va.gov|5817
21240884|NCT01041508|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
21240885|NCT02411591|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21240886|NCT01405794|University of Utah|Dr. Mark Munger|801-581-6165|mmunger@hsc.utah.edu|
21240887|NCT00598481|Fondazione Telethon|Fondazione Telethon||cvezzali@telethon.it|
21240888|NCT01439711|Duke University Medical Center|E. Shelley Hwang MD MPH|919-684-6849|shelley.hwang@duke.edu|
21240889|NCT01603121|Eastern Virginia Medical School|Dr. David Lieb, Principal Investigator|7574465910|liebdc@evms.edu|
21240890|NCT00738530|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21240891|NCT04179461|Cincinnati Children's Hospital Medical Center|Theresa Guilbert, MD, MS|(513) 636-6771|Theresa.Guilbert@cchmc.org|
21240892|NCT03785340|Ocugen|Vijay Tammara, VP, Strategic regulatory Operations|484-328-4751|Vijay.tammara@ocugen.com|
21240893|NCT01848834|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21240894|NCT01342029|Cedars-Sinai Medical Center|C.Noel Bairey Merz, MD|310-423-9680|merz@cshs.org|
21240895|NCT04374500|Umeå University, Umeå, Sweden|Stefan Söderberg|+46 70 319 38 03|stefan.soderberg@umu.se|
21240896|NCT01607411|GlaxoSmithKline|GSK Response Center|866-435-7343||
21240897|NCT00670982|Dana-Farber Cancer Institute|Harold J. Burstein, MD|617-632-2335|hal_burstein@dfci.harvard.edu|
21240898|NCT02683993|Boston Scientific|Teri Bird|6123221189|teri.bird@bsci.com|
21240899|NCT03749460|University of Washington|Cristina Rodriguez|2066066748|rodrigcr@uw.edu|
21240900|NCT01513967|Regenera Pharma Ltd|Dr Konstatin Adamsky|+972 8 9316306|kostia@Regenerapharma.com|
21240901|NCT02906202|bluebird bio, Inc|Study Medical Director|339-499-9300|medinfo@bluebirdbio.com|
21240902|NCT01987830|Massachusetts General Hospital|Dr. Elizabeth Gerstner|(617) 726-2000|EGERSTNER@mgh.harvard.edu|
21240903|NCT01706965|New York State Psychiatric Insititute|Marlene Carlson|646-774-8436|marlene.carlson@nyspi.columbia.edu|
21291548|NCT00982280|Grünenthal GmbH|Dr. Ilona Steigerwald|+49 241 569 0|Clinical-Trials@grunenthal.com|
21291549|NCT04724837|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-94|information.center@astrazeneca.com|79
21291550|NCT03213509|Ariadne Labs|Dr. Katherine Semrau|617-384-6555|betterbirth@ariadnelabs.org|
21291551|NCT06071104|Alcon Research LLC|Sr. Principal Clinical Project Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21291552|NCT00085839|Astellas Pharma Global Development|Medical Monitor||clinicaltrials@us.astellas.com|
21291553|NCT04312022|University of Nebraska at Omaha|Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
21291554|NCT01344226|Discover Vision Centers|Melissa Morrison Toyos|8164781230|mtoyos@discovervision.com|
21291555|NCT05677347|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21291556|NCT04118764|Columbia University|Elisa Konofagou, PhD, Robert and Margaret Hariri Professor in Biomedical Engineering and Radiology|212-342-0863|ek2191@columbia.edu|
21291557|NCT02420717|The University of Texas MD Anderson Cancer Center|Dr. Nitin Jain MD./Associate Professor|713-745-6080|njain@mdanderson.org|
21291558|NCT03781570|Dartmouth College|Tor D Wager, PhD|(603)-646-2196|Tor.D.Wager@Dartmouth.edu|
21291559|NCT03229057|University of Pennsylvania|Dr Anuja Dokras|215-615-0085|adokras@pennmedicine.upenn.edu|
21291560|NCT03636022|Minnesota HealthSolutions|Sara Seifert|6128036998|sara@minnhealth.com|
21291561|NCT01346592|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21291562|NCT04604431|Northwestern University Feinberg School of Medicine|Lucy Bilaver, Associate Professor of Pediatrics, iREACH Co-Investigator|312-503-5618|l-bilavere@northwestern.edu|
21291563|NCT04890509|BerGenBio ASA|BerGenBio Clinical Team|+ 47 559 61 159|cmo@bergenbio.com|
21291564|NCT02625428|Mayo Clinic|J. Scott Kriegshauser|480-342-5664|skriegshauser@mayo.edu|
21291565|NCT05943990|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21291566|NCT02776735|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21291567|NCT05847686|University of Washington|Anthony Back MD|2066194367|tonyback@uw.edu|
21291568|NCT00525421|University of California San Francisco|Nita Chainani-Wu|415-476-2045|nita.wu@ucsf.edu|
21291569|NCT03302767|Institut Bergonié|Véronique GERAT-MULLER|0556337839|v.gerat-muller@bordeaux.unicancer.fr|
21291570|NCT04617860|Wave Life Sciences|Medical Director|855-215-4687|clinicaltrials@wavelifesci.com|
21291571|NCT02836249|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21291572|NCT04752566|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
21291573|NCT03331354|VA North Texas Health Care System|James LePage|214-857-0240|james.lepage@va.gov|
21240904|NCT01563978|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44-1625-512415|dave.goldstraw@astrazeneca.com|
21240905|NCT05764239|Synlogic|Clinical Operations|(617) 401-9975|info@synlogictx.com|
21240906|NCT03698864|Processa Pharmaceuticals|Mary G. Nyberg, VP Clinical Operations|443-776-3133|mnyberg@processapharmaceuticals.com|
21240907|NCT00057811|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21240908|NCT00556374|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21240909|NCT04131907|Laborie Medical Technologies|Jill Moland|800-522-6743|jmoland@laborie.com|
21291574|NCT01646827|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
21291575|NCT05134649|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21291576|NCT00928668|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21291577|NCT04392154|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21291578|NCT01838226|Durham VAHCS HSR&D|Dr. David Edelman|919-286-6936|david.edelman@va.gov|
21240910|NCT05294419|Genomics Ltd|Seamus Harrison|+44 1865 981600|seamus.harrison@genomics.com|
21240911|NCT00847301|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21291579|NCT03057548|SacEP Research|Arash Aryana, MD, PhD|916-453-2684|a_aryana@outlook.com|
21240912|NCT05708846|vitalera (FollowHealth SL)|Data Scientist of vitalera|+34644499760|dheart@humanitcare.com|
21240913|NCT03621982|ADC Therapeutics|Yvan LeBruchec|+41799110551|Yvan.LeBruchec@adctherapeutics.com|
21240914|NCT00238420|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21240915|NCT00859131|Medical University of South Carolina|Kenneth Chavin, MD, PhD|843-792-3368|chavinkd@musc.edu|
21240916|NCT00641186|Baylor College of Medicine|Christine Hunter|713-798-3951|chunter@bcm.edu|
21240917|NCT00442286|CVRx|Vice President of Clinical Research|763-416-2876|lgalle@cvrx.com|
21240918|NCT02922985|University of Texas Medical Branch|Emily Hadley|4022028626|ehadley15@gmail.com|
21240919|NCT03428815|University of Pittsburgh|Dr. Goeran Fiedler|14126246475|gfiedler@pitt.edu|
21240920|NCT05221749|Alexandria University|Nour Ammar|4868066|nour.ammar@alexu.edu.eg|201
21240921|NCT02404493|Johnson & Johnson Consumer, Inc|Amisha Parikh-Das, PhD/Study Director|973-255-8701 USA EST|AParikh1@its.jnj.com|
21240922|NCT01053637|BAYLOR COLLEGE OF MEDICINE|Corrie E. Chumpitazi|832 824-1353|corriec@bcm.edu|
21240923|NCT04140890|Wayne State University|Dr. Yi-Ling Hu|3142039991|ha1124@wayne.edu|
21240924|NCT01700348|Philips Oral Healthcare, Inc|Marcia Delaurenti, Clinical Project Manager|425-908-1212|marcia.delaurenti@philips.com|
21240925|NCT02102464|TearScience, Inc.|VP Clinical and Regulatory Affairs|919-467-4007|regulatory@tearscience.com|
21240926|NCT00915902|Nemours Alfred I. duPont Hospital for Children|Research Coordinator|302-651-6686|cprosper@nemours.org|
21240927|NCT00950937|Hospital de Clínicas de Porto Alegre|Pedro Dall'Ago|555133038751|pdallago@pq.cnpq.br|
21240928|NCT03796013|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21240929|NCT01736358|Montefiore Medical Center|Dr.David Hoenig||dhoenig@montefiore.org|
21240930|NCT01824472|University of Pennsylvania|Dr. Nalaka Gooneratne|215 573 2048|ngoonera@upenn.edu|
21240931|NCT03040687|Johns Hopkins University|Kawsar Talaat|410-502-9627|ktalaat@jhu.edu|
21240932|NCT03317379|New York State Psychiatric Institute|Lisa Ranzenhofer, PhD|240 671 9040|lr2840@cumc.columbia.edu|
21240933|NCT02846558|Johns Hopkins Department of Neurology|Dr. Ellen Mowry, M.D., M.C.R.|410-502-0675|emowry1@jhmi.edu|
21240934|NCT04445155|University of South Florida|Dr. Ukamaka Oruche|813-396-2524|orucheu@usf.edu|
21240935|NCT01875861|Central Arkansas Veterans Healthcare System|Dr. Richard Owen|(501) 257-1710|Richard.Owen2@va.gov|
21240936|NCT00810641|KONOS|Treatment of apogeotropic HC BPPV|82 10 5538 6565|ohsun@jbnu.ac.kr|
21240937|NCT03703206|University of Pennsylvania|Nabil Elkassbany, MD|2158236700|nabil.elkassabany@uphs.upenn.edu|
21240938|NCT02325713|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21240939|NCT03363659|Advocate Aurora Health|Manager of Oncology research|414 778 4345|karen.cheek@aah.org|
21240940|NCT02359019|Barbara Ann Karmanos Cancer Institute|Dr. Ammar Sukari|313-576-8778|sukaria@karamanos.org|
21240941|NCT01213173|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|
21240942|NCT02253316|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8323|rvij@wustl.edu|
21240943|NCT02353832|University of Texas Southwestern|Michael Folkert, M.D., Ph.D.|214-645-8525|Michael.Folkert@utsouthwestern.edu|
21240944|NCT00904150|Centre for Neuroscience and Trauma, Queen Mary, University of London|Professor Anne MacGregor|+44 7774 868628|e.macgregor@qmul.ac.uk|
21261462|NCT00756002|Takeda Global Research & Development Center, Inc.|Sr VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21261463|NCT04329923|UPenn|Amelia Anderson|215-509-5690|amelia.anderson@pennmedicine.upenn.edu|
21261464|NCT03334214|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
21261465|NCT03695276|UCSF|Rachel Willard-Grace|415-476-5248|Rachel.Willard@ucsf.edu|
21261466|NCT00003820|Stanford University|Ranjana Advani, MD, Professor of Lymphoma|650-725-6456|radvani@stanford.edu|
21261467|NCT01720251|ANERGIS SA|Dr Gilles DELLA CORTE Clinical Development Director|+41 21 651 92 30|gilles.dellacorte@anergis.ch|
21261468|NCT00550238|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
21261469|NCT01660815|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
21261470|NCT01486238|Valley Retina Institute, PA|Victor Gonzalez, MD|956-631-8875|research@vritx.com|
21261471|NCT01050062|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21261472|NCT01330290|UCB|UCB Clinical Trials Call Center|+1 877 822 9493||
21261473|NCT01570491|Cleveland Clinic|Daniel Sessler, MD|2164444900|sessled@ccf.org|
21261474|NCT02495779|University of Pittsburgh, Graduate School of Public Health|James Egan|4126242255|jee48@pitt.edu|
21261475|NCT00780403|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21261476|NCT00754390|United States Department of Agriculture (USDA) Grand Forks Human Nutrition Research Center|Brenda Ling|701-795-8300|brenda.ling@ars.usda.gov|
21261477|NCT00847613|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21261478|NCT00845429|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21261479|NCT00213239|The Hospital for Sick Children, Department of Anesthesia and Pain Medicine|Dr. Jason Hayes|416-813-7654|jason.hayes@sickkids.ca|208963
21261480|NCT01480180|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21261481|NCT04222725|Tarsier Pharma|Zohar Milman|+972-50-8371319|Zohar Milman <zohar@Tarsierpharma.com>|
21261482|NCT00658333|Novartis Pharmaceuticals|Study Director|862-778-8300||
21261483|NCT03519178|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21261484|NCT04323488|Stanford University|Jason Yeatman, PhD|(650) 321-7553|jyeatman@stanford.edu|
21279405|NCT05204082|Mayo Clinic|Michael E. Nemergut, M.D., Ph.D.|507-255-7976|Nemergut.Michael@mayo.edu|
21279406|NCT02954991|Mirati Therapeutics|Clinical Operations Director|858-381-5289|LatvenL@Mirati.com|
21240945|NCT02692235|AWFiS|Robert Olek|+48 58 5547392|robol@awf.gda.pl|
21291580|NCT04198012|DEKA Research|Regulatory Affairs Manager|603-669-6491|psmolenski@dekaresearch.com|
21261485|NCT03256539|University of California, San Francisco|Dr. Yue Leng|415 502 2949|yue.leng@ucsf.edu|
21261486|NCT04045912|University of California, San Francisco|Dr. Jenny Liu|1-415-502-5200|Jenny.Liu2@ucsf.edu|
21261487|NCT05755438|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21261488|NCT01885689|City of Hope|Dr. Monzi M.Al Malki, MD|626-359-8111|malmalki@coh.org|
21261489|NCT03914300|The Ohio State University Comprehensive Cancer Center|Dr. Bhavana Konda|614-293-9779|bhavana.konda@osumc.edu|
21234099|NCT00749463|J&J Consumer and Personal Products Worldwide|Joyce Hauze, Sr Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
21261490|NCT02280811|National Cancer Institute|Dr. Christian Hinrichs|301-435-3027|hinrichs@nih.gov|
21261491|NCT06027593|Children's Hospital of Philadelphia|Kathleen Chiotos|267-426-7729|chiotosk@chop.edu|
21261492|NCT00513344|Clinical Development Unit / Metabolic Unit|Dr Maurice Beaumont, Principal Investigator|+41217858054|maurice.beaumont@rdls.nestle.com|
21261493|NCT00624338|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21261494|NCT01548638|University of Pennsylvania Perelman School of Medicine|Dr. Rebecca Ashare|2157465789|rlashare@mail.med.upenn.edu|
21261495|NCT05917288|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21234100|NCT01381861|TRACON Pharmaceuticals|Charles Theuer, Medical Monitor|8585500780|ctheuer@traconpharma.com|
21234101|NCT00782210|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21234102|NCT00820612|University of Michigan|B. Joseph Elmunzer, MD.|735 615 6652|badihe@umich.edu|
21234103|NCT05358821|Sage Therapeutics|Amy Bullock|617-949-5151|amy.bullock@sagerx.com|
21261496|NCT03476850|Medical University of South Carolina|Eric Bolin, MD|8437921869|bolin@musc.edu|
21261497|NCT01476787|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21261498|NCT01591330|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21261499|NCT02912364|Stanford University|Kimford Meador|650-725-6648|kmeador@stanford.edu|
21261500|NCT03291379|Biocompatibles UK Ltd|Sarah Cooper|07805354224|Sarah-Jane.Cooper@bsci.com|
21261501|NCT01039207|NRG Oncology|Angela Kuras on behalf of Mike Sill, PhD|716-845-5702|kurasa@nrgoncology.org|
21261502|NCT00938548|Department of Anaesthesiology and Pain Medicine and Anaesthesia and Pain Research Institute, Department of surgery, Yonsei University College of Medicine|Dr. So Yeon Kim|82-2-2227-3642|kimsy326@hanmail.net|
21261503|NCT04037085|UPMC|Grace Lim, MD, MSc|412-641-1110|limkg2@upmc.edu|
21261504|NCT01294228|Alere San Diego|Director of Clinical Affairs|1-858-805-4808|william.arnold@alere.com|
21261505|NCT01919411|Massachusetts Eye & Ear Infirmary|Dr. Eric Holbrook|617-573-3209|Eric_Holbrook@meei.harvard.edu|
21261506|NCT00144300|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21261507|NCT03294304|Masonic Cancer Center, University of Minnesota|Dr. Konety Badrinath|612-625-1655|brkonety@umn.edu|
21261508|NCT02403206|Alcon, A Novartis Division|Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21261509|NCT01676116|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21261510|NCT01877655|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
21261511|NCT02628223|Temple University Hospital|Dr. Jeffrey Henderer|267-418-9126|Jeffrey.Henderer@tuhs.temple.edu|
21261512|NCT01821677|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|720-437-6500|clinicaltrials@ampiopharma.com|
21261513|NCT00538733|Weill Cornell Medical College|Jennifer Hess|6469629440|jmh2004@med.cornell.edu|
21261514|NCT02677740|University of Minnesota|Silvia Mangia, Associate Professor|6126254920|mangia@umn.edu|
21261515|NCT03497689|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
21261516|NCT03567187|University of Kansas Medical Center|Neil Segal, MD|9135740961|segal-research@kumc.edu|
21261517|NCT01225068|Northwestern University Feinberg School of Medicine|Thomas J Schnitzer|3125032315|tjs@northwestern.edu|
21279407|NCT00576316|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21279408|NCT02691143|Sport and Spine Rehab Clinical Research Foundation|Jena Slaski|240-766-0300|jslaski@ssrehab.com|838
21279409|NCT01830790|Duke University|Sharon Fekrat: Associate Professor of Ophthalmology|(919) 681-0341|Sharon.Fekrat@dm.duke.edu|
21279410|NCT02814890|Huashan Hospital, Fudan University, Shanghai|Dr. Jun Zhang|0086-021-52887694|snapzhang@aliyun.com|
21279411|NCT02794246|Univ. of Pennsylvania|Emerging Med|855-216-0098|penncancertrials@emergingmed.com|
21234104|NCT02704364|NGM Biopharmaceuticals, Inc|Clinical Trial Information and Disclosure|650-243-5555|ngm282@ngmbio.com|
21234105|NCT04609020|AbbVie|ABBVIE CALL CENTER|844-663-3742|abbvieclinicaltrials@abbvie.com|
21234106|NCT00779103|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|ClinicalTrials@Endo.com|
21234107|NCT02086110|University of California, Davis Health System|Dr. Kathleen Angkustsiri|916-703-0278|kangkustsiri@ucdavis.edu|
21234108|NCT01869192|University of Colorado|Anthony Elias, MD|17208480347|anthony.elias@ucdenver.edu|
21234109|NCT02462967|Galectin Therapeutics|Vice President of Regulatory Affairs|678-620-3186|horton@galectintherapeutics.com|
21234110|NCT01203072|Daiichi Sankyo.,LTD|Kei Ibusuki, Associate Director|81-90-2732-9505|ibusuki.kei.tx@daiichisankyo.co.jp|
21234111|NCT00577512|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|pettynathanm@uams.edu|2461
21234112|NCT02272413|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21234113|NCT02153944|National Institute of Mental Health (NIMH)|Dr Maryland Pao|301-435-5770|paom@mail.nih.gov|
21234114|NCT02286193|Group Health Research Institute|Clarissa Hsu, PhD|206-287-4276|hsu.c@ghc.org|
21279412|NCT04602546|Medtronic|Keith Holloman|6126707136|keith.holloman@medtronic.com|
21234115|NCT00423891|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21240946|NCT00802841|Novartis|Study Director|862-778-1873||
21240947|NCT00432159|Depuy Synthes|Lynn Wilson|508-880-8109|lwilso45@its.jnj.com|
21240948|NCT05516342|Hopeful Aging|Michael Skrajner|4404777881|mike@hopefulaging.com|
21240949|NCT01866475|Teleflex|Tatiana Puga|2104451794|tatiana.puga@teleflex.com|
21240950|NCT03850444|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21240951|NCT01518257|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21240952|NCT02107274|Ministry of Health of Malaysia|Dr. Albert Iruthiaraj L. Anthony|+60174633410|albert5409@yahoo.com|
21240953|NCT02708641|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS|412-647-5554|stadtermanbm@upmc.edu|
21240954|NCT03251144|University of California Los Angeles|Theodoros Kelesidis|3108257875|tkelesidis@mednet.ucla.edu|
21240955|NCT03158948|INOTREM SA|Executive VP Research and Medical Sciences|30 62 86 51|jjg@inotrem.com|+33 (0)6
21240956|NCT05305040|AlloVir, Inc.|Kevin Anderson|617-433-2605|kanderson@allovir.com|
21240957|NCT01195675|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21240958|NCT02424344|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
21240959|NCT04730947|Mayo Clinic|Dr. Barry A. Borlaug|507-293-2762|borlaug.barry@mayo.edu|
21240960|NCT01174550|Duke University Medical Center|Dr. Pamela Douglas|919-668-8700|pamela.douglas@duke.edu|
21240961|NCT02123966|Dana-Farber Cancer Institute|Nathaniel S. Treister, DMD, DMSc|617-632-2806|ntreister@partners.org|
21240962|NCT01536262|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21240963|NCT00412516|PATH|Anthony A Marfin, Director Japanese Encephalitis Vaccine Introduction and Sustainability Project|2062853500|aamarfin@path.org|
21240964|NCT01460381|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21240965|NCT01097655|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
21240966|NCT05257837|The Ohio State University|Dr. Brad Bushman|614-688-8779|bushman.20@osu.edu|
21240967|NCT01033643|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21240968|NCT03639675|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
21240969|NCT02459587|Veterans Health Administration|Dr. Mark Ilgen|7349366266|mark.ilgen@va.gov|
21240970|NCT03861728|University of Miami|Wendy Lee|305-326-6434|wlee@miami.edu|
21240971|NCT01021332|Astellas Pharma Europe B.V.|Medical Director, Global Medical Science||astellas.resultsdisclosure@astellas.com|
21240972|NCT04731714|Washington University School of Medicine|Kevin J. Black, M.D.|314-362-5041|kevin@wustl.edu|
21240973|NCT05559047|Bleep, LLC|Stuart Heatherington|919-619-7170|stuart@bleepsleep.com|
21240974|NCT05343455|Journey Medical Corporation|Dr. Srinivas Sidgiddi|9084585362|ssidgiddi@jmcderm.com|
21240975|NCT00839917|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21240976|NCT03468426|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21240977|NCT02139982|The Second Affiliated Hospital & Yuying Children hospital of Wenzhou Medical University|Dr. Ting Li|008613587876896|liting1021@aliyun.com|
21240978|NCT00787943|Northwestern University|Amy Paller, MD|312-695-3721|apaller@northwestern.edu|
21240979|NCT02033993|Canadian Cancer Trials Group|Dr. Wendy Parulekar|613-533-6430|wparulekar@ctg.queenus.ca|
21240980|NCT00765661|Veloxis|Christina Sylvest, Sr VP Global Clinical Development & Operations|45 20553877|csy@veloxis.com|
21240981|NCT01600703|University Health Network|Dr. Gary Lewis|416-340-4270|gary.lewis@uhn.ca|
21240982|NCT02633891|BVAMC|Dr. Lindsay Zilliox|410-328-3100|lzilliox@som.umaryland.edu|
21240983|NCT00108524|Durham VAMC|William S Yancy, Jr. MD, MHSc|919-286-0411|william.yancy2@va.gov|7770
21240984|NCT04466618|Mayo Clinic|Dr Adrian Vella|5072843754|vella.adrian@mayo.edu|
21240985|NCT01349907|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21240986|NCT05818540|Bleep, LLC|Stuart Heathington|919-619-7170|stuart@bleepsleep.com|
21240987|NCT02800928|Yale School of Medicine|Sherry McKee PhD|203-737-3529|sherry.mckee@yale.edu|
21240988|NCT02886728|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21240989|NCT00839982|FCHRC|Elihu Estey, MD, Director of AML Program|206-288-7176|eestey@seattlecca.org|
21240990|NCT01364727|Stanford University Medical Center|Heather A Wakelee, MD|650-736-7221|hwakelee@stanford.edu|
21240991|NCT01676220|Sanofi|Trial Transparency Team||Contact --US@sanofi.com|
21240992|NCT04227340|St. Jude Children's Research Hospital|Belinda Mandrell, PhD, RN|(901) 595-4209|belinda.mandrell@stjude.org|
21240993|NCT00445263|SAMU 93|Pr Frédéric Lapostolle|0033148964454|frederic.lapostolle@avc.aphp.fr|
21240994|NCT00750893|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21240995|NCT00305682|Masonic Cancer Center, University of Minnesota|Dr.Claudio G. Brunstein MD, PhD|612-625-3918|bruns072@umn.edu|
21240996|NCT01628874|Children's Hospital Colorado|Dr. Ryan Caltagirone|303-521-8563|ryan.caltagirone@childrenscolorado.org|
21240997|NCT00788255|Stanford University School of Medicine|Dr. Alexander Butwick|(650) 736-8513|ajbut@stanford.edu|
21240998|NCT01152554|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21240999|NCT02397460|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21241000|NCT02511561|Otonomy|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
21241001|NCT01767129|Avanir Pharmaceuticals|Avanir Medical Information|855-572-2722|medinfo@avanir.com|
21241002|NCT01473420|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21241003|NCT04172987|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21241004|NCT01656759|Rush University|Sean Kearns|708-236-2664|sean_m_kearns@rush.edu|
21241005|NCT07083843|OmanMOH|Amal Salim AlSahi|96103040|amalalsahi@gmail.com|968
21241006|NCT04007796|San Francisco VA Health Care System|Dr. Liz Goldstein|415-694-3443|lizabeth.goldstein2@va.gov|
21241007|NCT04988477|Hennepin Healthcare Research Institute|Dr. Sandra Japuntich|6128736856|sandra.japuntich@hcmed.org|
21241008|NCT05567952|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21241009|NCT02385721|Boryung Pharmaceutical Co., Ltd|Myung Sook Hong|82-2-708-8238|mshong@boryung.co.kr|
21279413|NCT00682357|University of Kansas Medical Center|Dr. Herbert Lindsley|(913) 588-3402|HLINDSLE@kumc.edu|
21279414|NCT00005957|Juravinski Cancer Centre at Hamilton Health Sciences|Dr. Timothy J. Whelan|1(905) 387-9495|twhelan@HHSC.CA|
21279415|NCT01609023|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21279416|NCT03904108|Stony Brook University|Dr. Roger Keresztes|631-638-1000|roger.keresztes@stonybrookmedicine.edu|
21279417|NCT02646761|University of Pittsburgh|Dr. James J. Irrgang|(412) 383-9865|jirrgang@pitt.edu|
21279418|NCT04172597|Assertio Holdings|Howard Franklin, MD|224 419 7106|Hfranklin@assertiotx.com|
21279419|NCT03717012|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21279420|NCT00789035|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21279421|NCT01520870|MFAR Clinical Research|Pau Doñate||investigacion@mfar.net|
21279422|NCT00687830|Cleveland Clinic Florida|Dr. Shibu Varughese and Dr. Anand Kumar|305-310-1238|akuma003@fiu.edu|
21279423|NCT02797171|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
21279424|NCT02585778|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21279425|NCT04841577|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21279426|NCT02054338|Institut de Recherche Pierre Fabre|Karim Keddad|+33 5 34 50 61 69|karim.keddad@pierre-fabre.com|
21279427|NCT02281422|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21279428|NCT05211726|University of Delaware|Christopher Martens|302-831-7270|cmartens@udel.edu|
21279429|NCT03898908|Grupo Español Multidisciplinar en Melanoma (GEM)|GEM Technical Secretary|0034934344412|secretaria@groupgem.es|
21279430|NCT01267994|North Shore-LIJ Health System|Andrea Vambutas, MD, FACS|718-470-7748|vambutas@nshs.edu|
21279431|NCT02950818|University of Michigan School of Public Health|Cathleen Connell|734-647-3189|cathleen@umich.edu|
21279432|NCT03276078|AstraZeneca PLC|Dr Sami Daoud|1-877-240-9479|Information.centre@astrazeneca.com|
21279433|NCT03332979|Marie Curie Palliative Care Research Department, Division of Psychiatry, University College London|Dr Kirsten Moore|020 7679 9488|kirsten.moore@ucl.ac.uk|
21279434|NCT03968978|AstraZeneca|Global Clinical Head|+1 877-240-9479|information.center@astrazeneca.com|
21279435|NCT00086281|Jazz Pharmaceuticals, Inc.|Grace Wang, MD Director Clinical Development & Medical Monitor|650-496-3777||
21279436|NCT03149757|University of Minnesota|Keith Horvath|619-594-3346|khorvath@sdsu.edu|
21279437|NCT00205803|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21279438|NCT00351533|University of Vermont|Renee Stapleton, MD PhD|802-656-7975|renee.stapleton@uvm.edu|
21279439|NCT02056392|AstraZeneca|Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com|
21279440|NCT00555360|Ann Arbor VA Healthcare System|Dr. John Piette, PhD|734-845-3626|jpiette@umich.edu|
21279441|NCT00103610|Genzyme Corporation|Genzyme MedInfo||medinfo@genzyme.com|
21279442|NCT02494180|Kwong Wah Hospital|Dr SF Lai|85223322311|lsf087@ha.org.hk|
21279443|NCT00563576|Columiba University|Carolyn Westhoff|212-305-4805|clw3@columbia.edu|
21279444|NCT00315731|GlaxoSmithKline|GSK Response Center|866-435-7343||
21279445|NCT04784533|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
21279446|NCT00963560|Alcon Research, Ltd.|Director of Alcon Clinical|888-451-3937; 817-568-6725|medinfo@alconlabs.com|
21279447|NCT01462773|The Ohio State University Comprehensive Cancer Center|William Carson|614-293-6306|william.carson@osumc.edu|
21279448|NCT04123561|Taiwan Liposome Company|Dr. Tien-Tzu Tai|+886 2 2655 7377|tttai@tlcbio.com|801
21279449|NCT02454127|Tufts Medical Center|Michael Dansinger, MD|617-636-5000|mdansinger@tuftsmedicalcenter.org|
21279450|NCT02203331|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21279451|NCT03844386|University of North Carolina at Chapel Hill|Cynthia Gay, MD, MPH|919-843-2726|cynthia_gay@med.unc.edu|
21279452|NCT03597464|Aurinia Pharmaceuticals|Clinical Trials Information|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
21279453|NCT04328961|University of Washington|Ruanne Barnabas|206 520 3800|rbarnaba@uw.edu|
21279454|NCT02682927|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21279455|NCT01621477|St. Jude Children's Research Hospital|Brandon M. Triplett, MD|901-595-2766|brandon.triplett@stjude.org|
21279456|NCT02125721|NYU Langone Health|David Goldfarb|212 263 0744|David.Goldfarb@nyulangone.org|
21279457|NCT03316547|Washington University|Roberta Pineda|314-286-1304|bobbi.pineda@chan.usc.edu|
21279458|NCT00278889|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
21279459|NCT03462459|University of Wisconsin-Madison|Nasia Safdar, Professor|608-265-1545|ns2@medicine.wisc.edu|
21279460|NCT05292183|Dartmouth-Hitchcock Medical Center|Dr. Krzysztof Bujarski|603 650 5104|krzysztof.a.bujarski@hitchcock.org|
21279461|NCT03128060|University of Southern California|Susan Enguidanos|(213) 740-9822|enguidan@usc.edu|
21279462|NCT05849454|Center for Behavioral Cardiovascular Health|Nadia Liyanage-Don|917-280-3776|nal2151@cumc.columbia.edu|
21279463|NCT00369486|Jaeb Center for Health Research, Diabetic Retinopathy Clinical Research Network|Adam R. Glassman, M.S., Director|(813) 975-8690|drcrnet@jaeb.org|
21279464|NCT03888066|Vifor Pharma, Inc.|DIAMOND Clinical Study Team|+41 588 518 000|Diamond_Information@viforpharma.com|
21279465|NCT02077140|Medtronic Spine and Biologics|Clinical Affairs|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
21279466|NCT00836407|The Sidney Kimmel Comprehensive Cancer Center at Johns|Dr. Dung Le||dle@jhmi.edu|
21279467|NCT03104400|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21291581|NCT03057704|Wake Forest University School of Medcine|Timothy N. Harwood MD|3367164498|tharwood@wakehealth.edu|
21291582|NCT02329587|Butler Hospital|Sarah Garnaat|401-455-6659|sgarnaat@butler.og|
21291583|NCT00455702|Massachusetts General Hopsital|Donald C Goff|617-912-7899|goff@psych.mgh.harvard.edu|
21291584|NCT03815344|Maimonides Medical Center|Pedram Bral, MD|7182836000|pbral@maimonidesmed.org|
21291585|NCT03290027|Dr. Reddys Laboratories Inc.|Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
21291586|NCT03861338|New York State Psychiatric Institute|John Mariani MD|6467748181|john.mariani@nyspi.columbia.edu|
21291587|NCT03620981|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|06-6943-7722|CL_OPCJ_RDA_Team@otsuka.jp|
21291588|NCT05705375|University of Texas at Arlington|Ziyad Ben Taleb|817-272-8297|ziyad.bentaleb@uta.edu|
21291589|NCT04251533|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
21291590|NCT05634538|Corindus|Alison Lord|617-943-5472|alison.lord@siemens-healthineers.com|
21291591|NCT02303821|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21291592|NCT05196776|Temple University Hospital|Ryan Gibbons|2157075522|ryan.gibbons@tuhs.temple.edu|
21234116|NCT02871375|Alcon, A Novartis Division|Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21291593|NCT04716725|University of California, San Francisco|Dr. Ivan de Kouchkovsky, MD|(415) 221-4810|ivan.dekouchkovsky@ucsf.edu|2129
21291594|NCT04116489|UMass Chan Medical School; Tan Chingfen Graduate School of Nursing|Donna Perry, PhD, RN|508-856-3621|DonnaJ.Perry@umassmed.edu|
21291595|NCT03138564|Emory University|Mi-Kyung Song, PhD, RN|404-727-3134|mi-kyung.song@emory.edu|
21291596|NCT06517394|Center for Health Outcomes and Interdisciplinary Research, Massachusetts General Hospital|Principal investigator|6177267913|apresciutti@mgh.harvard.edu|
21291597|NCT05177354|Medtronic Neuromodulation|Nancy McClelland|1-800-633-8766|nancy.l.mcclelland@medtronic.com|
21291598|NCT06028464|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21291599|NCT02876172|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
21291600|NCT03330847|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21291601|NCT03532256|University of Pennsylvania|Mucio Delgado, MD, Principal Investigator|215-746-8256|mucio.delgado@pennmedicine.upenn.edu|
21291602|NCT02769481|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
21234117|NCT03592121|Applied Biology, Inc.|Dr. Andy Goren|(949) 387-4526|andyg@appliedbiology.com|
21234118|NCT02963493|Oncopeptides|Global Clinical Project Lead|866-596-6626|info@oncopeptides.com|
21234119|NCT03663283|Mayo Clinic|Steven J. Hattrup, M.D.|480-301-8519|hattrup.steven@mayo.edu|
21234120|NCT00579111|Baylor|Rammurti Kamble, MD|713-394-6252|rtkamble@tmhs.org|
21234121|NCT04327999|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
21234122|NCT02667483|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21234123|NCT00422032|The University of Texas M. D. Anderson Cancer Center|Hagop Kantarjian, MD / Professor|713-792-7026|eharriso@mdanderson.org|
21234124|NCT02872116|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21234125|NCT02346136|MGH Biostatistics|Eric Macklin, PhD|617-724-9828|emacklin@mgh.harvard.edu|
21234126|NCT00980395|University of Arizona|Amy Selegue, NCTN Program Coordinator|520-626-0301|aselegue@email.arizona.edu|
21234127|NCT01112293|AbramsonCC|James Robinson|215-662-8758|jamesrobinson2@pennmedicine.upenn.edu|
21234128|NCT01094548|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21234129|NCT01734551|University of Kentucky|Dr. Henrietta S. Bada, Professor and Vice Chair, Academic Affairs|859-323-1019|hbada2@uky.edu|
21234130|NCT00606892|Yale University|Mehmet Sofuoglu, M.D., Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
21234131|NCT03608488|SultanAbdulhamid|Tugba OZsoy-Unubol|+905074583382|tugbaozsoyy@gmail.com|
21234132|NCT02127632|DorkuzEU|Anaesthesiology and Reanimation|90.505.525.29.01|ozbilginsule@gmail.com|
21234133|NCT01971853|"University of Colorado Denver | Anschutz"|Director, Clinical Research Administration||clinicalresearchsupportcenter@ucdenver.edu|
21234134|NCT04225923|Nobelpharma Co. Ltd.|Research & Development Divion|81-3-6670-3800|watanabe.tatsuya@nobelpharma.co.jp|
21234135|NCT00855309|Comprehensive Cancer Center of Wake Forest University|LeAnne Kenndy, PharmD|336-713-3416|lakenned@wakehealth.edu|
21234136|NCT04964453|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21234137|NCT01907828|Abbott|Rebecca Maslow, MA, Clinical Project Manager|+1 651-756-5564|rebecca.maslow@abbott.com|
21234138|NCT01193907|Novartis Vaccines Institute for Global Health|Dr. Audino Podda|+39 0577 243496|audino.podda@novartis.com|
21234139|NCT01364428|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21234140|NCT01585766|MedImmune|Armando Flor, MD, Director, Clinical Development|301-398-1955|information.center@astrazeneca.com|
21234141|NCT00582933|Memorial Sloan Kettering Cancer Center|Dr. Farid Boulad|212-639-2429|bouladf@mskcc.org|
21234142|NCT04120610|Medtronic|Janki Shah|732-266-2503|janki.shah@medtronic.com|
21234143|NCT02356692|CooperVision|Donald Siegel, OD|602 485 3414|dsiegel@coopervision.com|
21234144|NCT02508636|University of California, San Francisco|Dr. Hao Nguyen|(415) 514-5541|Hao.Nguyen@ucsf.edu|
21234145|NCT01371656|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
21234146|NCT03712410|University of Pennsylvania|George Demiris|2158988559|gdemiris@upenn.edu|
21234147|NCT00696137|BDSI|Tim Warneke|919-582-0294|twarneke@bdsi.com|
21234148|NCT01874262|AstraZeneca|Susanna Jerström|+46 8 553 260 00||
21234149|NCT00314236|Piramal Healthcare (Canada) Limited|Alberto Restrepo, MD, Director of Medical and Clinical Affairs|450-686-2437|alberto.restrepo@piramal.com|315
21234150|NCT00966238|VaxInnate|Dr. David N. Taylor|609-860-2260|david.taylor@vaxinnate.com|
21241010|NCT03280563|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21291603|NCT00643279|Medtronic|Dana Wigert|763-526-2802|dana.wigert@medtronic.com|
21291604|NCT06272383|University of Manitoba|Dr Alex Aregbesola|2047893957|Alex.Aregbesola@umanitoba.ca|
21291605|NCT05715827|Medtronic|Yewon Lee|1031132023|yewon.lee@medtronic.com|
21291606|NCT04846868|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21291607|NCT05212168|Vaxart|Maria Apkarian|+1 (650) 779-4560|mapkarian@vaxart.com|
21234151|NCT03621878|imam abdulrahman bin faisal university|Mohammed Alghamdi|+966556852888|mohdg.ios@gmail.com|
21234152|NCT04334460|Blade Therapeutics|SVP, Global Regulatory Affairs, Quality, and Safety|(650) 278 4291|dmody@blademed.com|
21234153|NCT01465464|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.||toiawase@taiho.co.jp|
21234154|NCT03458130|Eidos Therapeutics|Mark McGovern, Vice President of Clinical Operations|415-887-1471|medinfo@eidostx.com|
21234155|NCT03395314|Yale School of Medicine|Sarah Fineberg, MD, PhD|(203) 974-7265|sarah.fineberg@yale.edu|
21234156|NCT00775437|AbbVie|Global Medical Information|800-633-9110||
21234157|NCT01183975|Ethicon, Inc.|Birgit Temiz|+49 (0) 40 5297 3144|btemiz@its.jnj.com|
21234158|NCT03316885|Alcon Research, LLC|Director, Clinical Projects - CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21234159|NCT01820754|Duke University Medical Center|Neal Ready, MD|919 681-6932|neal.ready@duke.edu|
21234160|NCT01845792|University of Colorado Cancer Center|Elaine Lam, MD|7208480273|elaine.lam@ucdenver.edu|
21234161|NCT01566448|West Virginia University Hospitals|Aaron Cumpston|304-598-4000|cumpstona@wvumedicine.org|73350
21234162|NCT01102413|Pharmacosmos A/S|Vice President Research & Development Department|+45 59485959|llt@pharmacosmos.com|
21234163|NCT00262509|Atlanta VA Rehabilitation R&D Center of Excellence|David A. Ross|404-321-6111|ross0128@bellsouth.net|6817
21234164|NCT04964128|Medtronic|Roseline Re|+33684520425|roseline.re@medtronic.com|
21234165|NCT02120794|Medtronic Minimed|Suiying Huang, Statistician|8184763319|suiying.huang@medtronic.com|
21234166|NCT00827255|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
21234167|NCT01048723|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Zager, M.D.|813-745-1085|jonathan.zager@moffitt.org|
21234168|NCT00994240|University of Wisconsin-Madison|Clinical Research Administrator|608-287-2640|dbock@dermatology.wisc.edu|
21234169|NCT01148511|Novartis Pharmaceuticals|Study Director|862 778-8300||
21234170|NCT01025427|University of California, San Francisco|Hiroyu Hatano|415-476-4082|hhatano@php.ucsf.edu|122
21234171|NCT04258605|Zimmer Biomet|Carina Hafner|+41797073093|carina.hafner@zimmerbiomet.com|
21234172|NCT00543764|BIDMC|Bernard Lee|617-632-7835|blee3@bidmc.harvard.edu|
21234173|NCT05300295|University of Minnesota|Lindsey Weiler, PhD|612-301-9345|lmweiler@umn.edu|
21234174|NCT00842348|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21234175|NCT03274986|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21234176|NCT03200925|Kettering Health Network|Catherine Caponero, DO|937-723-4124|catherine.caponero@ketteringhealth.org|
21234177|NCT02196324|Menlo Therapeutics Inc. (formerly Tigercat Pharma, Inc.)|Iain Stuart, PhD.|1- 800-775-7936|Iain.Stuart@foamix.com|
21234178|NCT02620046|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21234179|NCT04866771|University Of Illinois At Chicago|PRS Training Lead|(312) 996-4995|awards@uic.edu|
21234180|NCT02970968|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
21234181|NCT02565381|Massachusetts General Hospital|Travis P. Baggett, MD, MPH (Principal Investigator)|617-643-9314|tbaggett@mgh.harvard.edu|
21234182|NCT03369717|Montefiore Medical Center|Nadeem Akbar MD|7189204646|nakbar@montefiore.org|
21234183|NCT05308901|Providence Portland Medical Center|Dr. Matthew Taylor|503-215-1979|canrsrchstudies@providence.org|
21234184|NCT02388737|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
21234185|NCT03252522|Oregon Health & Science University|Jeanette Johnstone, PhD|5034943700|jojeanet@ohsu.edu|
21234186|NCT03018392|Bone and Joint Clinic of Baton Rouge|Research Projects Director|2254218207|aobrien@bjcbr.com|
21234187|NCT03299842|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21234188|NCT00071812|GlaxoSmithKline|GSK Response Center|866-435-7343||
21234189|NCT03661814|Icahn School of Medicine at Mount Sinai|Dr. Joel Bauer|914-715-4242|jjb.msh@gmail.com|
21234190|NCT01816139|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21234191|NCT01940120|Abbott Vascular Structural Heart (formerly Evalve, Inc.)|Chithra Sangli|650-430-1329|chithra.sangli@av.abbott.com|
21234192|NCT01888497|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21234193|NCT04152447|Massachusetts General Hospital|Dr. Marilyn Heng|617-643-0149|mheng@mgh.harvard.edu|
21234194|NCT04013191|Cares|UCB|+1844 599|clinicaltrials@ucb.com|2273
21234195|NCT03662100|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21234196|NCT02159547|Akdeniz University|Cenker EKEN|00905321593948|cenkereken@akdeniz.edu.tr|
21234197|NCT04718870|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21234198|NCT04127786|Sanofi Pasteur|Trial Transparency Team|8006331610|Contact-US@sanofi.com|6#
21234199|NCT03034954|University of Michigan|Dr. Annalise Rahman-Filipiak|734-763-9259|rahmanam@med.umich.edu|
21234200|NCT02400723|VA Palo Alto Health Care System|Christine Gould, PhD|650-493-5000|Christine.gould@va.gov|68899
21234201|NCT02340299|Charité - Universitätsmedizin Berlin|PD Dr. Christoph Czernik, principal investigator|+49 30 450|christoph.czernik@charite.de|566122
21234202|NCT03568942|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21234203|NCT00358527|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21234204|NCT04144166|North Shore University Hospital|Director of Clinical Research for Emergency Medicine|(516) 562-1513|TLi2@northwell.edu|
21234205|NCT02809430|University of Washington|Dr. Sandeep Khot|206-744-3251|skhot@uw.edu|
21234206|NCT00913744|ThromboGenics NV|Dr. Petra Kozma-Wiebe|+32 16 751 310|Petra.kozma@thrombogenics.com|
21234207|NCT00805935|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21241011|NCT02065245|University of Miami, Miller School of Medicine - Interdisciplinary Stem Cell Institute (ISCI)|Joshua M Hare, MD|305-243-5579|JHare@med.miami.edu|
21241012|NCT03531905|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
21241013|NCT03961256|Mayo Clinic|Mark D. Stegall, M.D.|507-266-2812|Stegall.Mark@mayo.edu|
21241014|NCT05153174|University of Rochester Medical Center|Dr Thu H. Le, MD, FAHA - Chief of Nephrology|585-273-4259|thu_le@urmc.rochester.edu|
21241015|NCT03303105|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21241016|NCT02023944|Bedford Veterans Hospital|Maureen K. O'Connor|781-687-2830|maureen.oconnor@va.gov|
21241017|NCT03527277|University of California, Davis|Kimber Stanhope|5302190914|klstanhope@ucdavis.edu|
21241018|NCT01781611|Oklahoma Medical Research Foundation|Joan T. Merrill, M.D.|405-822-2336|joan-merrill@omrf.org|
21241019|NCT01333943|Hospital for Special Surgery|David H. Kim, MD|(212) 606-1206|KimD@HSS.EDU|
21241020|NCT01421771|University of New Mexico Health Sciences Center|Samiha Mateen|505-272-6057|smateen@salud.unm.edu|
21241021|NCT02091063|Columbia University|Jennifer Amengual, MD|212-305-0591|jea2149@cumc.columbia.edu|
21241022|NCT02652130|Mesoblast, Inc.|Christopher James, VP, Head of Clinical Operations|212-880-2060|Christopher.James@Mesoblast.com|7925
21241023|NCT02028884|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21241024|NCT00354029|Baerum Hospital|Ulrich J Spreng|004798499184|ulispreng@hotmail.com|
21241025|NCT00826280|Astellas Pharma Global Development|Senior Medical Director||clinicaltrials@us.astellas.com|
21241026|NCT05205941|MMV|Benoit Bestgen|+41797651868|bestgenb@mmv.org|
21241027|NCT00412867|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21241028|NCT00344370|Kowa Research Institute|Bill Arana|919 433-1600|barana@kowaus.com|
21241029|NCT01477749|Dendreon Pharmaceuticals, Inc.|Lynn Ngo|206-274-6763|lngo@dendreon.com|
21241030|NCT01853163|Navitas Life Sciences GmbH|Managing Director|+49 (0) 69-66 80 30-0|marty.boom@navitaslifesciences.com|
21241031|NCT04004208|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21241032|NCT00939796|Acclarent|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
21241033|NCT01310868|University College London|GALA-5 Trial Coorinator|0207 679 9898|ctc.sponsor@ucl.ac.uk|
21241034|NCT00873093|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21241035|NCT01008722|University of California, San Diego|Dr. Sanjiv Narayan (Professor of Medicine, Principal Investigator)|(650) 498-8161|sanjiv1@stanford.edu|
21241036|NCT00146640|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
21241037|NCT02117544|Alcon Research, Ltd|Clinical Project Lead, Vision Care, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
21241038|NCT02059161|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21241039|NCT03486899|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
21241040|NCT01723826|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21241041|NCT01146808|Columbia University Medical Center|Robert S. Brown Jr., MD, MPH|(212) 305-3839|tt2103@columbia.edu|
21241042|NCT02225275|The University of Texas MD Anderson Cancer Center|Dr. Alessandra Ferrajoli MD/ Professor|173-792-2063|aferrajo@mdanderson.org|
21241043|NCT00597870|Lundquist Institute of BioMedical Studies|Rodney A. White, MD|3109635230|rawhite@ucla.edu|
21241044|NCT02308501|Ora|Caitlin Pearson|978-685-8900|cpearson@oraclinical.com|
21241045|NCT02186938|MUSC|Dr Hand|843-792-5442|handw@musc.edu|
21241046|NCT03862482|Université de Montréal|Dr. Aldo Joseph Camarda|514-343-7124|aj.camarda@umontreal.ca|
21241047|NCT03100838|USFDA|Dr. Minori Kinjo|240-40269118|minori.kinjo@fda.hhs.gov|
21241048|NCT01347645|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
21241049|NCT02760862|Ain-Shams University Hospitals|Dr. Ibrahim Mamdouh Esmat|01001241928|ibrahim_mamdouh@med.asu.edu.eg|
21241050|NCT01141660|Eastern Virginia Medical School|Cristina Baldassari|7576689853|baldassc@yahoo.com|
21241051|NCT01438229|St. Jude Medical|Steven Madej|651-756-2230|smadej@sjm.com|
21241052|NCT00209027|Emory University|Erica Duncan|404-321-6111|erica.duncan@va.gov|7532
21241053|NCT02335268|GMIHO Gesellschaft für Medizinische Innovation - Hämatologie und Onkologie mbH|Dr. Carsta Köhler|+49 351 25933|info@gmiho.de|100
21241054|NCT02859597|Montefiore Medical Center|Dr.Jay Berger|7189204316|jberger@montefiore.org|
21241055|NCT05049616|The University of Texas Health Science Center at Houston|Michal Fishel Bartal, MD|(713) 500-6421|michal.f.bartal@uth.tmc.edu|
21241056|NCT02916862|Florida International University|Cristina Palacios|3053483235|crpalaci@fiu.edu|
21241057|NCT03160079|University of California, San Diego, Moores Cancer Center|Dr. James Mangan|858-822-6600|jmangan@health.ucsd.edu|
21241058|NCT01107730|Attikon Hospital|Ioannis K. Toumpoulis|00306977243942|toumpoul@otenet.gr|
21241059|NCT04648891|Mayo Clinic|David G. Lott, M.D.|480-342-2983|Lott.David@mayo.edu|
21241060|NCT01112696|Medtronic|Scott Lee M.D.|818-576-4204|scott.w.lee@medtronic.com|
21241061|NCT01923428|Ardelyx|Chief Development Officer|510 745 1752|drosenbaum@ardelyx.com|
21241062|NCT03262701|Loma Linda University School of Dentistry|Yoon Jeong Kim|(909) 558-4610|yjkim02d2@llu.edu|
21241063|NCT00946647|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21241064|NCT01368211|Transfusion Service Rigshospitalet - Dept of Immunology, Copenhagen Denmark|Dr. Pär Johansson|+45 35452030|per.johansson@rh.regionh.dk|
21241065|NCT03990363|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21241066|NCT01500746|Northwestern University|Dr. Elliot Hirsch|312-695-6022|elliot-hirsch@md.northwestern.edu|
21241067|NCT01349660|Sarah Cannon Development Innovations|Charles Davis, RAC||Charles.Davis2@scri-innovations.com|
21241068|NCT04630756|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21241069|NCT02388074|bioAffinity Technologies Inc.|Bijal Karia, PhD Director of Research|2107485287|bk@bioaffinitytech.com|
21241070|NCT04069221|Medicines for Malaria Venture|Dr Myriam El Gaaloul, PharmD|+41 22 555 0377|elgaaloulm@mmv.org|
21241071|NCT00920374|GlaxoSmithKline|GSK Response Center|866-435-7343||
21291608|NCT03274466|"KCI | 3M"|Director of Clinical Research|(210) 515-4060|actate@mmm.com|
21291609|NCT02371187|Colorado State University|Manager of Research Operations|9704912242|Laurie.Biela@colostate.edu|
21291610|NCT00618787|Tyco Healthcare Group|Tonya Eggleston, RN, MPH, Study Director|(508) 261-8420|Tonya.Eggleston@Covidien.com|
21291611|NCT01107886|AstraZeneca LP|Boaz Hirshberg MD, MBA|1 302 885 4997|ClinicalTrialTransparency@astrazeneca.com|
21291612|NCT05819398|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21291613|NCT02953457|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-1300|Chong.Wang@Roswellpark.org|
21291614|NCT01649869|University of Alabama at Birmingham|David Kimberlin, MD|(205) 638-2530|DKimberlin@peds.uab.edu|
21291615|NCT05395338|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
21291616|NCT01139515|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21291617|NCT01323192|Janssen Pharm KK Japan|Medical Director|+81-3-4411-5509||
21291618|NCT03698279|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21291619|NCT02276040|OrthoCarolina Research Institute|Senior Research Scientist|704-323-2260|susan.odum@orthocarolina.com|
21291620|NCT02835690|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21291621|NCT00582907|Shaare Zedek Medical Center/Cleveland Clinic|Philip Hashkes, MD, MSc|972-2-6555307|hashkesp@szmc.org.il|
21291622|NCT04622592|Medicago|Medical Director|+1 418-658-9393|clinicaltrialinquiries@medicago.com|
21291623|NCT03309202|Pfizer,Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21291624|NCT00415636|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21291625|NCT02138825|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21291626|NCT03014635|Revance Therapeutics, Inc.|Todd Gross, PhD, VP Data Science, Interim Head of Clinical Development|510-742-3400|tgross@revance.com|
21291627|NCT01702298|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21291628|NCT00400686|Cleveland Clinic|Beth Faiman, MSN,CNP, AOCN|216-445-3738|faimanb@ccf.org|
21291629|NCT01752049|St. Michael's Hospital|Dr. Marie Faughnan|416-864-6060|marie.faughnan@unityhealth.to|5412
21291630|NCT05093621|Yale School of Medicine|Jeffrey Testani, MD, MTR Associate Professor of Medicine|(203) 785-7191|jeffrey.testani@yale.edu|
21291631|NCT01664624|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21291632|NCT00560508|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21291633|NCT03493958|Clinical Center|Wallen, Gwenyth|+1 301 496 0596|gwallen@cc.nih.gov|
21291634|NCT02367456|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21291635|NCT02300545|Washington University School of Medicine|Brian A. Van Tine, M.D., Ph.D.|314-747-8475|bvantine@wustl.edu|
21291636|NCT01645176|Stanford University School of Medicine|Mark C. Genovese|650-498-4528|genovese@stanford.edu|
21291637|NCT04987372|UZ Ghent|dr. Harlinde Peperstraete|+3293325185|harlinde.peperstraete@uzgent.be|
21291638|NCT04903288|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
21241072|NCT01939158|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21241073|NCT05310084|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21291639|NCT00573768|Novartis Consumer Health|Sandy Hamelsky|+19735037258|sandy.hamelsky@novartis.com|
21241074|NCT05373901|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21291640|NCT00904371|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21291641|NCT04252014|Georgetown University|Darren Mays|2026878937|dmm239@georgetown.edu|
21241075|NCT00924664|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21241076|NCT01598987|Novartis Pharmaceuticals|Study Director|862-778-8300||
21234208|NCT02433834|Pearl Therapeutics, Inc.|Paul Dorinsky, MD, FCCP|650-305-2600|pdorinsky@pearltherapeutics.com|
21234209|NCT00614913|Radiation Medicine - Loma Linda University Medical Center|David Bush MD|909-558-4280|dbush@dominion.llumc.edu|
21234210|NCT00283439|Amgen Inc.|Study Director|866-572-6436||
21234211|NCT00333229|Novartis Pharmaceuticals|Study Director|862-778-8300||
21234212|NCT02129075|Fred Hutchinson Cancer Research Center|Dr. Martin A. Cheever|206-667-4141|mcheever@fredhutch.org|
21234213|NCT00348556|Mayo Clinic|Dr. Horng Chen|507-284-8846|chen.horng@mayo.edu|
21234214|NCT01466270|Wake Forest School of Medicine|Dr. Doug Case|336-716-1048|dcase@wakehealth.edu|
21234215|NCT01944059|University Cincinnati Physicians Company|Vincent Martin, MD|513-558-7581|vincent.martin@uc.edu|
21234216|NCT02821962|University of Ottawa Heart Institute|Dr. Robert Reid|613-696-7393|breid@ottawaheart.ca|
21234217|NCT02111252|Takeda|Medical Director, Clinical Science|800-778-2860|trialdisclosures@takeda.com|
21234218|NCT00430092|Sirion Therapeutics, Inc.|Jeremy Brace|813-496-7325|jbrace@siriontherapeutics.com|343
21234219|NCT00654381|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21234220|NCT04883632|Croma Pharma|Clinical Development - Head of Clinical Operations|+432262684680|clinical.studies@croma.at|
21234221|NCT00651482|Stanford University Medical Center|Associate Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu|
21234222|NCT01978314|University of Alabama, Birmingham|Dana Victor Rizk, M.D.||drizk@uab.edu|
21234223|NCT00645333|University of Michigan|Anne F. Schott, MD|1-800-865-1125|canceranswerline@umich.edu|
21234224|NCT00048542|Abbott|Global Medical Services|800-633-9110||
21234225|NCT05847153|Massachusetts General Hospital|Dr. Christine Ritchie|4156721780|csritchie@mgh.harvard.edu|
21234226|NCT02121483|Boehringer Ingelheim (BI)|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21234227|NCT02107599|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
21234228|NCT00006489|University of Pennsylvania|Dr. Edna Foa|215-746-3327|foa@mail.med.upenn.edu|
21234229|NCT00578175|GlaxoSmithKline|GSK Response Center|866-435-7343||
21234230|NCT02308735|University of Oklahoma Health Sciences Center|Douglas Dannaway|405-271-5215|douglas-dannaway@ouhsc.edu|42048
21234231|NCT00802412|VA San Diego|Neal Doran, PhD|8585528585|neal.doran@va.gov|2421
21234232|NCT01632202|Weill Cornell Medicine|Sr. Research Compliance Specialist|646-962-4065|lao2003@med.cornell.edu|
21234233|NCT06431061|CooperVision Inc.|Jose A Vega, OD,MSc,PhD|925-621-3761|JVega2@coopervision.com|
21234234|NCT01417481|Instituto Nacional de Enfermedades Respiratorias|Dr. Mario H. Vargas|(+55)54871771|mhvargasb@yahoo.com.mx|
21234235|NCT03029624|Valencia Technologies|Stacy Chambliss, Chief of Clinical Trials|661-775-1414|schambliss@valenciatechnologies.com|1002
21234236|NCT02376166|Icahn School of Medicine at Mount Sinai|Dr. Matthew D. Galsky|(212) 659-5599|matthew.galsky@mssm.edu|
21234237|NCT04180020|Yale School of Medicine|Sandra Springer, MD|877-554-3578|sandra.springer@yale.edu|
21234238|NCT01425879|The Ohio State University|Tanios Bekaii-Saab, MD|614-293-9863|tanios.bekaii-saab@osumc.edu|
21234239|NCT01640366|Smith & Nephew Inc|Rachael Winter, Director of Clinical Operations|+44 1482 673475|rachael.winter@smith-nephew.com|
21234240|NCT02045511|Johns Hopkins University School of Medicine Dept. Otolaryngology-HNS|Carrie Nieman|3025368362|cnieman1@jhmi.edu|
21234241|NCT00738972|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21234242|NCT02739269|The University of Hong Kong|Dr. Raymond Li|+852 22554517|raymondli@hku.hk|
21234243|NCT01519453|Johns Hopkins School of Medicine|Dr. Michelle Eakin|410-550-0487|meakin1@jhmi.edu|
21234244|NCT03554291|University of Washington|Peter Leary|206-685-2484|learyp@uw.edu|
21234245|NCT01228747|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
21234246|NCT02074995|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21234247|NCT00847288|Medtronic Cardiac Rhythm Disease Management|OptiVol Care Pathway Clinical Team|1-800-328-2518|medtronicCRMtrials@medtronic.com|
21234248|NCT04251221|Yale University|Dr. Ansel Hillmer|203-737-6400|ansel.hillmer@yale.edu|
21234249|NCT01165138|GlaxoSmithKline|GSK Response Center|866-435-7343||
21234250|NCT02641379|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21234251|NCT01398956|UCB Cares|UCB (Study Director)|+1887822||9493
21234252|NCT00181961|Massachusetts General Hospital|Dr. Christina Dording|6177249457|cdording@mgh.harvard.edu|
21234253|NCT00962104|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21234254|NCT02554656|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21234255|NCT03240575|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21234256|NCT02488785|Joslin Diabetes Center|Sylvia Rosas|6173092486|sylvia.rosas@joslin.harvard.edu|
21234257|NCT01140477|Bausch & Lomb, a division of Valeant Corporation|Johnson Varughese|908-541-2179|Johnson.Varughese@valeant.com|
21234258|NCT04482179|Clinical Research Coordinator|Daniela Sacchetti, MS|215-573-4336|danielas@pennmedicine.upenn.edu|
21234259|NCT02674412|Cleveland Clinic|Scott Gabbard, MD|216 444-6523|gabbars@ccf.org|
21234260|NCT01481116|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21234261|NCT01232296|Novartis Pharmaceuticals|Study Director|862-778-8300||
21234262|NCT02108821|Children's Mercy Hospital, Kansas City|Alka Goyal MD|816-302-3069|agoyal4@stanford.edu|
21234263|NCT00559962|Aegerion Pharmaceuticals|Mark Sumeray, MD, Chief Medical Officer|617-500-7867||
21234264|NCT00404352|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21234265|NCT00699010|Acura Pharma|Dr. Ron Spivey|847-705-7709|rspivey@acurapharm.com|
21234266|NCT01479621|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000||
21241077|NCT01824446|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21241078|NCT02783482|Green Cross Corporation|Clinical Project Manager|82 31 260 9472|sungsil.lee@gccorp.com|
21241079|NCT02537444|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
21241080|NCT01341080|Rush University Medical Center|Deborah A Hall MD PhD|312-563-2900|Deborah_A_Hall@rush.edu|
21241081|NCT01330355|Valeant Pharmaceuticals|Johnson Varughese|908-541-2179|Johnson.Varughese@valeant.com|
21241082|NCT02724020|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21241083|NCT00425503|Baylor College of Medicine|Dr. Teresa Hayes - Associate Professor|713-794-7368|thayes@bcm.edu|
21241084|NCT01925170|Mayo Clinic|Dr. Deborah Rhodes|507-284-7971|rhodes.deborah@mayo.edu|
21241085|NCT00628628|The University of Texas (UT) MD Anderson Cancer Center|Saroj Vadhan-Raj, MD / Professor||CR_Study_Registration@mdanderson.org|
21241086|NCT02839681|National Cancer Institute|Dr. Raffit Hassan|240-760-6232|raffit_hassan@nih.gov|
21241087|NCT01653847|Northwestern University|Lorenzo Gallon, MD|312-695-4457|l-gallon@northwestern.edu|
21241088|NCT02165124|Johns Hopkins Univesity|Dr. Clifford Weiss|4106141046|cweiss@jhmi.edu|
21241089|NCT00768599|AmDerma Pharmaceuticals|Candis Edwards|631-974-7949|cedwards@amderma.com|
21241090|NCT00801242|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21241091|NCT02554513|VASLCHCS|Dr. Shannon Mauszycki|801-582-1565|shannon.mauszycki@utah.edu|
21279468|NCT03112642|RutgersSUNJ|William R Grubb MD|7327426528|wrgrubb@aol.com|
21241092|NCT00184028|USC/Norris Comrpehensive Cancer Center|Barbara Gitlitz, MD|323-865-3906|Gitlitz@usc.edu|
21241093|NCT00388362|Stanford University|Laura Johnston, MD|650-723-0822|janices1@stanford.edu|
21241094|NCT00813111|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
21241095|NCT03259373|Harvard Pilgrim Health Care|Richard Platt, MD|(617) 867-4912|Richard_Platt@harvardpilgrim.org|
21241096|NCT05893797|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21241097|NCT04770220|Alzheon|Aidan Power|(508) 861-7709|aidan.power@alzheon.com|
21241098|NCT05087095|Virginia Commonwealth University|Ashlee Loughan, PhD, LCP|804-828-9815|ashlee.loughan@vcuhealth.org|
21279469|NCT02540850|BioChain (Beijing) Science and Technology, Inc.|Dr. Lele Song|86-10-63401580|songlele@biochainbj.com|
21279470|NCT02462291|University of Verona|Massimo Venturelli - PI|+39 02503 14648|massimo.venturelli@univr.it|
21279471|NCT02129608|Mayo Clinic|Ivana Croghan|507-266-1944|domcro@mayo.edu|
21279472|NCT02473523|St. Jude Children's Research Hospital|Kirsten Ness, PT, PhD|901-595-5157|kiri.ness@stjude.org|
21279473|NCT02552303|University of Pennsylvania|Michael Perlis|(215) 746-3577|mperlis@upenn.edu|
21279474|NCT04141930|University of Washington|Research Coordinator|2066165859|jheimo@uw.edu|
21279475|NCT01831258|SleepMed of South Carolina|Dr Richard Bogan|8777537633|rbogan@sleepmedinc.com|
21279476|NCT01753557|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21279477|NCT03834142|University of Pittsburgh|Amy Monroe|412-623-6382|monroeal@upmc.edu|
21279478|NCT01753297|Ipsen Pharma SAS|Medical Director|see email|clinical.trials@ipsen.com|
21279479|NCT01275729|University of Chicago|Dr. Jay L Koyner|773-702-4842|jkoyner@uchicago.edu|
21279480|NCT02533180|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21279481|NCT00447876|Ipsen|Medical Director||clinical.trials@ipsen.com|
21279482|NCT03751007|Precigen Actobio T1D, LLC|Sven Blomme|+3292771177|sblomme@actobio.com|
21279483|NCT02640690|Atlanta VA Health Care System|Dr. Ursula Kelly|4047272715|ukelly@emory.edu|
21279484|NCT01118975|University of Maryland|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu|
21279485|NCT01645787|Columbia University|Claudia A. Chiriboga, MD, MPH|(212) 305-8549|cac3@columbia.edu|
21279486|NCT02620579|University of Florida|Dr. Samuel S. Wu|3522945910|samwu@biostat.ufl.edu|
21279487|NCT02892149|Akebia Therapeutics, Inc.|Clinical Trial Information Desk|+1 617-844-6128|trials@akebia.com|
21279488|NCT00626808|MedImmune, LLC|Chris Ambrose|301-398-0000|ambrosec@medimmune.com|
21279489|NCT01098474|GlaxoSmithKline|GSK Response Center|866-435-7343||
21279490|NCT02165735|University of Rochester|Dr. Kevin Fiscella, PI|5853244563|kevin_fiscella@urmc.rochester.edu|
21279491|NCT03066258|Regenxbio Inc.|Sherri Van Everen, PharmD/ Vice President of Clinical Development|240.552.8181|svaneveren@regenxbio.com|
21279492|NCT02784795|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21279493|NCT00101283|ECOG Statistical Office|Study Statistician|617-632-3012||
21279494|NCT00595309|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|1175
21279495|NCT04238650|mAbxience|Susana Millan|+34917711500|susana.millan@mabxience.com|
21279496|NCT02756208|Institute of Human Virology|Dr. Mohammad Sajadi|410-7061779|msajadi@ihv.umaryland.edu|
21279497|NCT03617783|Maryland Psychiatric Research Center|Dr. Robert Buchanan|410-402-7876|rwbuchanan@som.umaryland.edu|
21279498|NCT00356525|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21279499|NCT00652340|Tragara Pharmaceuticals|Tracy Parrott|858-350-6919|tparrott@tragarapharma.com|
21279500|NCT03682107|Cincinnati Children's Hospital|Dr. Grant Paulsen|513-636-4578|Grant.Paulsen@cchmc.org|
21279501|NCT02614924|UHCW NHS Trust|Dr Ratidzo Danha|02476 964000|Ratidzo.Danha@uhcw.nhs.uk|25871
21241099|NCT04894903|Vanderbilt University Medical Center|William Martinez, MD, MS|615-936-1010|william.martinez@vumc.org|
21279502|NCT00214383|University of Wisconsin - Madison|Alice Pulvermacher|(608) 262-8448|alice.pulvermacher@chess.wisc.edu|
21279503|NCT04152291|Wihuri Research Institute|Professor Katariina Öörni|+358 40 7023711|kati.oorni@wri.fi|
21291642|NCT01668004|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21241100|NCT01822353|Helsinki University Hospital, Helsinki, Finland|Paula Kauppi, Chief Specialist|+358504286802|paula.kauppi@hus.fi|
21279504|NCT03597295|Incyte|Incyte Corporation Call Center (US)|1.855.463.3463|medinfo@incyte.com|
21291643|NCT01190527|University of Michigan Comprehensive Cancer Center|Dr. Shruti Jolly, M.D.|734-936-4300|shrutij@umich.edu|
21291644|NCT03130569|Memorial Sloan Kettering Cancer Center|Dr. Jennifer Hay|646-888-0039|hayj@mskcc.org|
21291645|NCT02008617|Northwestern University, Feinberg School of Medicine|Rohit Rahangdale, M.D.|312-695-4814|rrahangd@nmff.org|
21291646|NCT01500317|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
21291647|NCT00976456|Krankenhaus Martha-Maria Halle-Doelau gGmbH|Prof. Dr. Wolfgang Schuette|+49 345 5591440|wolfgang.schuette@martha-maria.de|
21291648|NCT00335829|Johns Hopkins, Interventional Radiology|Jeff Geschwind, MD|410-614-6597|jfg@jhmi.edu|
21291649|NCT01137890|Johns Hopkins University|Dr. Annie Umbricht|410-550-1917|annieumbricht@jhu.edu|
21291650|NCT02090764|Ferrer Internacional, S.A.|Clinical Research Manager|+34 93 509 32 75|nalbareda@ferrer.com|
21291651|NCT01394159|Center for Interventional Endoscopy, Florida Hospital|Dr Shyam Varadarajulu|407-303-2570|svaradarajulu@yahoo.com|
21291652|NCT00427037|Emory University School of Medicine|Vin Tangpricha|404-727-7254|vin.tangpricha@emory.edu|
21291653|NCT03229538|Duke University|Kevin Hill, MD|919-681-6846|kevin.hill@duke.edu|
21291654|NCT02621892|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
21291655|NCT01864434|University of Tennessee|Adrija Sharma, Ph. D.|8659742093|asharma1@utk.edu|
21291656|NCT00673920|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21291657|NCT01650402|UConn Health|William White, MD|860-679-4556|wwhite@uchc.edu|
21291658|NCT00998010|University of California at Los Angeles|Mark Glover|(310) 794-8742|mglover@mednet.ucla.edu|
21291659|NCT02300233|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
21291660|NCT00833690|The Parkinson Study Group|Michael A. Schwarzschild, MD, PhD|617-724-9611|mschwarzschild@partners.org|
21291661|NCT04773665|VBI Vaccines Inc|Francisco Diaz-Mitoma, MD, PhD|613-749-4200|fdiazmitoma@vbivaccines.com|
21291662|NCT05448950|Phraxis, Inc.|Cindy Setum, PhD|16128016730|csetum@phraxis.com|
21291663|NCT03605693|Center for Behavioral Cardiovascular Health, Columbia University Irving Medical Center|Dr. Ian Kronish|212-342-1335|ik2293@columbia.edu|
21291664|NCT04562116|Galderma|Clinical Operations|08179615000|Clinical.Studies@galderma.com|1
21291665|NCT01014871|Galderma|Florence Paliargues / CPM|+33492952957|florence.paliargues@galderma.com|
21291666|NCT02757430|Abbott|Clinical Research Scientist|6517562885|amber.miller@abbott.com|
21291667|NCT03502200|OhioSUCCC|Dr. Theodore L. Wagener|614-366-4265|Theodore.Wagener@osumc.edu|
21241101|NCT04320615|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21241102|NCT00850720|Children's Healthcare of Atlanta|Kiran Hebbar, MBBS|404-785-1600|kiran.hebbar@choa.org|
21241103|NCT01857323|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
21241104|NCT03873246|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
21241105|NCT02107443|University of Rochester, Medical Center|Dr. Supriya Mohile, Professor of Medicine|585-275-0394|URCC_COACH@URMC.Rochester.edu|
21241106|NCT00885495|University of Cincinnati College of Medicine|Dr. Carl J. Fichtenbaum|513-584-6361|carl.fichtenbaum@uc.edu|
21241107|NCT01400893|CytoPherx, Inc|H. David Humes|734-997-7055|dhumes@cytopherx.com|302
21241108|NCT00519636|GlaxoSmithKline|GSK Response Center|866-435-7343||
21241109|NCT04504916|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21241110|NCT04387162|Atlanta VA Medical Center|Amy Rodriguez|404-321-6111|amy.rodriguez@va.gov|
21241111|NCT03057834|Wake Forest University School of Medicine|Candace Parker-Autry, MD|336-716-3779|candace.parkerautry@wfusm.edu|
21241112|NCT00003509|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
21241113|NCT01133860|IRCCS Policlinico San Matteo Foundation|Prof. Carlo Balduini|0039.0382.502580|c.balduini@smatteo.pv.it|
21241114|NCT02406209|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
21241115|NCT02334527|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
21241116|NCT01591161|Bausch Health|Study Director||susan.harris@bauschhealth.com|
21241117|NCT04178551|VA Connecticut Healthcare System|William C. Becker, MD|203-932-5711|william.becker4@va.gov|2427
21241118|NCT05593211|Anthem Biotechnologies|Jeremy D. Ollerenshaw, Ph.D.|770.337.2390|ollerenj@anthembiotech.com|
21241119|NCT04343222|University of Wisconsin - Madison|Maxwell Wingelaar|231-233-6051|mwingelaar@uwhealth.org|
21241120|NCT03077620|Washington University in St Louis School of Medicine|Dr. Brendan Lucey|314-747-3805|luceyb@wustl.edu|
21241121|NCT03225846|Wave Life Sciences|Medical Director|855-215-4687|clinicaltrials@wavelifesci.com|
21241122|NCT04248465|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
21241123|NCT01254890|University of Texas (UT) MD Anderson Cancer Center|Farhad Ravandi-Kashani, Professor, Leukemia Department||CR_Study_Registration@mdanderson.org|
21241124|NCT01159535|University of Washington|Dr. Sarah Bowen|(206) 543-3452|swbowen@uw.edu|
21241125|NCT00245011|Sidney Kimmel Comprehensive Cancer Center|David M. Loeb, M.D., Ph.D., Director, Musculoskeletal Tumor Program|410.502.7247|loebda@jhmi.edu|
21241126|NCT00550173|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21241127|NCT01728805|Kyowa Kirin Inc|Fiona Herr, Associate Director, Medical Communications|1 (908) 234-1096|medinfo-US@kyowakirin.com|
21241128|NCT02419755|St. Jude Children's Research Hospital|Tanja A. Gruber, MD, PhD|901-595-2252|tanja.gruber@stjude.org|
21241129|NCT02841267|Hugo W. Moser Research Institute at Kennedy Krieger Inc.|Dr. Kathryn R. Wagner|443-923-9525|wagnerk@kennedykrieger.org|
21241130|NCT06403605|ETS Wound Care, LLC|Donald Buck, MD|410-490-5998|dbuck@etswoundcare.com|
21241131|NCT02699190|The Children's Hospital of Philadelphia|Dr. Adeline Vanderver|215-590-1719|vandervera@chop.edu|
21291668|NCT00731484|TearLab, Inc.|Dr. Benjamin Sullivan|855-832-7522|bdsulliv@TearLab.com|
21291669|NCT03097289|Terumo BCT, Inc.|Ned Cosgriff, MD|+1 303-239-2316|ned.cosgriff@TerumoBCT.com|
21241132|NCT04213846|University of Washington|Christine Lee, Ph.D.|206-543-6574|leecm@uw.edu|
21241133|NCT05737550|Kontigo Care AB|Markku Hämälainen, CSO|+46 (0)76 947 3132|markku.hamalainen@kontigocare.com|
21241134|NCT03374072|Boston University|Dr. Gael Orsmond|(617)353-2703|gorsmond@bu.edu|
21241135|NCT01672983|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
21241136|NCT02174198|Columbia University|Nurit Bittner, DDS, MS, Dip.ABP|212-342-2763|nb2203@cumc.columbia.edu|
21241137|NCT02823990|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
21241138|NCT04096365|AtaCor Medical, Inc.|Alan Marcovecchio, Vice President, Clinical Affairs|949 391 2252|alan@atacor.com|
21241139|NCT02401529|King Fahd General Hospital|Dr Faris Ahmed Bahammam|00966554699544|dr_farisbahammam@yahoo.com|
21241140|NCT01414036|Boston Medical Center|Karen E. Lasser|617-414-6688|karen.lasser@bmc.org|
21241141|NCT02491411|SKCCC at JHU|Samuel Denmeade|410-955-8875|denmesa@jhmi.edu|
21241142|NCT02941146|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
21241143|NCT01036087|UT MD Anderson Cancer Center|Dr. Naoto Ueno, Professor, Breast Medical Oncology|(713) 792-8754|nueno@mdanderson.org|
21241144|NCT02651103|Nationwide Children's Hospital|Clinical Research Coordinator|6147222997|heather.dellinger@nationwidechildrens.org|
21241145|NCT02206685|Baylor College of Medicine|Kim P. Nguyen, MD, Principal Investigator|832-824-5907|kpnguyen@texaschildrens.org|
21241146|NCT01616563|Metabolic Syndrome Canada|Rupinder Dhaliwal|613 484 3830|rupinder.dhaliwal@metsc.ca|
21241147|NCT00072475|University of Minnesota|Pankaj Gupta, M.D.||gupta013@umn.edu|
21241148|NCT02331940|University of Crete|Director of Clinical Trials|2810394824|izolthi@gmail.com|0030
21241149|NCT01450943|VA Northern California Health Care System|Sara Dahle, D.P.M., M.P.H.|916-843-7151|Sara.dahle@va.gov|
21241150|NCT01385280|University of Arizona Cancer Center|Program Coordinator|520-626-0301|aselegue@email.arizona.edu|
21241151|NCT04822298|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21241152|NCT00465361|Children's Mercy Hospitals and Clinics|Sarah S. Nyp|816-234-3000|ssnyp@cmh.edu|
21241153|NCT04351750|National Cheng Kung University|Dr. Kuan-Yin Lin|+88662353535|10802003@gs.ncku.edu.tw|5931
21241154|NCT01625338|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21241155|NCT01789203|Methodist Hospital|Samir Patel|267-808-0577|spatel2@houstonmethodist.org|
21241156|NCT00951561|Another Way Products|Charles Tepper|917-538-6894|charles_tepper@yahoo.com|
21241157|NCT05176353|University of Michigan|Owen Albin, MD|734.232.1871|oalbin@med.umich.edu|
21241158|NCT02403674|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21241159|NCT01447914|University of Texas (UT) MD Anderson Cancer Center|Robert Orlowski, MD, PhD / Professor, Department of Lymphoma/Myeloma|713-792-2860|ROrlowski@mdanderson.org|
21241160|NCT03487666|Georgetown University|Candace Mainor, MD|202-444-2223|Candace.Mainor@gunet.georgetown.edu|
21241161|NCT03201757|Alkermes|Global Clinical Services|888-253-8008|clinicaltrials@alkermes.com|
21241162|NCT01254305|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
21241163|NCT02297503|Galderma|Maria Norberg|+46184891267|maria.norberg@galderma.com|
21241164|NCT00765362|DJO Surgical|Manager of Clinical Affairs|512-832-9500|jane.jacob@djosurgical.com|1323
21241165|NCT03930186|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21241166|NCT04569240|Cleveland Clinc|Andrea Parianos|216-445-8354|debsa@ccf.org|
21241167|NCT04365413|University of Oklahoma Health Sciences Center, Stephenson Cancer Center|Lacey McNally|405-325-0789|lacey-mcnally@ouhsc.edu|
21241168|NCT02037061|Cleveland Clinic|Dr. Cecile Unger|216-444-0542|ungerc@ccf.org|
21241169|NCT03019458|Sunshine Care Foundation|Dr. Patrick Acuna|+63 947 959-1851|patrick_acuna@hotmail.com|
21241170|NCT00557505|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21241171|NCT00031447|Collaborative Antiviral Study Group|Penelope M Jester|205-934-2424|pjester@peds.uab.edu|
21241172|NCT01161160|GlaxoSmithKline|GSK Response Center|866-435-7343||
21241173|NCT02521259|Seoul National University Bundang Hospital|Dr. YEA JI LEE|+821086307701|ladydaisy82@naver.com|
21241174|NCT00519779|The Ohio State University|Dr. Janice Kiecolt-Glaser|614-293-3499|Janice.Kiecolt-Glaser@osumc.edu|
21241175|NCT01561079|Johns Hopkins University School of Medicine|Dr. Lauren M Jansson|410-550-5438|ljansson@jhmi.edu|
21241176|NCT02062905|Ocular Therapeutix, Inc.|Director, Clinical Affairs|781-357-4000|dmulani@ocutx.com|
21241177|NCT01123161|Cedars-Sinai Medical Center|Dr. Patrick Lyden|310-423-5166|lydenp@cshs.org|
21241178|NCT00664521|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21241179|NCT01323660|GlaxoSmithKline|GSK Response Center|866-435-7343||
21241180|NCT01207934|Washington University School of Medicine|Samuel Klein, MD|3143628708|sklein@wustl.edu|
21241181|NCT00751790|Debiopharm S.A.|Eija Lundström|+41 21 3210111|elundstrom@debiopharm.com|
21241182|NCT01276535|Westlake Dermatology|Gregory A. Nikolaidis, MD|512-328-3376|karen@westlakedermatology.com|
21241183|NCT00707863|Indiana Uiniveristy|Amit Anand MD|3172747422|aanand@iupui.edu|
21241184|NCT01106976|VAAAHS|Nicolaas Bohnen|7349988400|Nicolaas.Bohnen@va.gov|
21241185|NCT02949518|Hospital for Special Surgery|Dr. Ellen Soffin|212-606-1206|soffine@hss.edu|
21241186|NCT03560141|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21241187|NCT05570747|Bleep, LLC|Stuart Heatherington, Founder and Executive Chairman of Bleep|(919) 619-7170|stuart@bleepsleep.com|
21241188|NCT05677867|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21241189|NCT01521949|University of Colorado Cancer Center|Elaine Lam, MD|7208480273|elaine.lam@ucdenver.edu|
21241190|NCT02029703|Cleveland Clinic|M. Elaine Husni, MD, MPH|216-445-1853|HUSNIE@CCF.ORG|
21241191|NCT02988375|Henry Ford Health|Dr. Christopher Drake|(248) 344-6672|cdrake1@hfhs.org|
21241192|NCT00180687|Imperial College London|Dr. Nawar Alkhamesi|442033121110|n.alkhamesi@imperial.ac.uk|
21241193|NCT00051311|National Cancer Institute|Dr. Ronald Gress|240-760-6167|Ronald_Gress@nih.gov|
21241194|NCT04990440|Janssen Research & Development, LLC|Director Clinical Research Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21241195|NCT04170023|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
21241196|NCT03712098|SUNY Buffalo|Rebecca Ashare|7168296273|rlashare@buffalo.edu|
21241197|NCT03566680|The University of Alabama at Birmingham|Dr. Andrew Pucker|920-579-2900|apucker@uab.edu|
21241198|NCT04830514|University of Arkansas for Medical Sciences|David D. Church, Ph.D., Assistant Professor|5015265709|dchurch@uams.edu|
21241199|NCT03836664|University of Kansas Medical Center|Dr Dipika Aggarwal, Clinical Assistant Professor|9139459926|daggarwal@kumc.edu|
21241200|NCT01275053|Beth Israel Deaconess Medical Center|Dr. Christos Mantzoros|6176678633|cmantzor@bidmc.harvard.edu|
21241201|NCT02550873|Promedior Inc.|Renu Gupta, MD, Chief Medical Officer|856-722-9824|rgupta@promedior.com|
21241202|NCT00118144|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
21241203|NCT00852137|LEO Pharma|Dr. Torsten Skov|+4520736294|torsten.skov@leo-pharma.com|
21241204|NCT02684903|University of Oregon|Dr. Elizabeth Skowron|541-346-9329|eskowron@uoregon.edu|
21241205|NCT03824535|Stanford University|Dr. Carina Mari Aparici|650-497 9280|drmari@stanford.edu|
21241206|NCT00394095|University of Cincinnati|Melissa DelBello, MD|513-558-4489|melissa.delbello@uc.edu|
21241207|NCT01106287|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21241208|NCT01893320|The University of Texas MD Anderson Cancer Center|Naval Daver MD, Associate Professor|713-794-4392|NDaver@mdanderson.org|
21241209|NCT05406791|University of Illinois at Chicago|Colleen Stiles-Shields, PhD|312-413-1128|ecss@uic.edu|
21241210|NCT00515086|Novartis Pharmaceuticals|Study Director|862-778-8300||
21241211|NCT01636362|Molnlycke Health Care AB|Joan Wilson|706 504 8997|joan.wilson@molnlycke.com|
21241212|NCT03330119|Main Line Health System|Dr. Norman Brest|484-476-2325|brestn@mlhs.org|
21241213|NCT03748264|Philips|Jeff Jasko|4125423651|Jeff.Jasko@philips.com|
21241214|NCT00550732|Merck Sharp & Dohme Corp.|Senior Vice President, Globalo Clinical Development||ClinicalTrialsDisclosure@merck.com|
21241215|NCT02435901|Northwell Health System Cohen Children's Medical Center of NY|Indira Sahdev, MD|7184703460|isahdev@northwell.edu|
21241216|NCT00926393|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
21241217|NCT03311854|Sobi AG|Veronica Asnaghi, MD|+41 61 201 13 20|veronica.asnaghi@sobi.com|
21241218|NCT01403987|Boston Medical Center|Brian Jacobson, MD, Principal Investigator|617-6386563|brian.jacobson@bmc.org|
21241219|NCT02307123|Tampere University Hospital|Toni Pakkanen, MD|358408227209|toni.pakkanen@icloud.com|
21241220|NCT00180674|Imperial College London|Prof Mark Thursz|+44 (0)20 3312 1903|m.thursz@imperial.ac.uk|
21241221|NCT03302910|Indiana University School of Medicine|Peter S. Pang|317-880-3900|ppang@iu.edu|
21241222|NCT02223689|Medline Industries, Inc.|Lori Rotolo|8476434640|lrotolo@medline.com|
21241223|NCT00953160|Cutera Inc.|Ayse Turley, Clinical Development Researcher|415-657-5665|aturley@cutera.com|
21241224|NCT02179918|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21241225|NCT00276250|Emory University|Nicole Turgeon, MD|404-727-3257|nturgeo@emory.edu|
21241226|NCT03189134|Boston Children's Hospital|Aditya K. Kaza, MD|617-355-7932|aditya.kaza@cardio.chboston.org|
21241227|NCT02118714|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21241228|NCT02954575|Octapharma AG|Cristina Solomon|+41 (0)55 451 21 89|Cristina.Solomon@octapharma.com|
21241229|NCT00229619|NIH National Heart, Lung and Blood Institute|Adrian Wiestner MD, NHLBI|301-594-6855|wiestnera@nhlbi.nih.gov|
21241230|NCT00570661|Italfarmaco SpA|Maurizio Caserini, MD|+39 0264431|m.caserini@italfarmaco.com|
21241231|NCT01066156|Cambridge Health Alliance|Igor Elman|(617) 665-1000|ielman@challiance.org|
21241232|NCT01700673|Johns Hopkins University School of Medicine, Division of Hematologic Malignancies|Jonathan Webster, MD|4106149106|jwebst17@jhmi.edu|
21241233|NCT01734382|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21241234|NCT03890120|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21241235|NCT04537949|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
21241236|NCT04003974|Fulcrum Therapeutics|Call Center|617-651-8853|clinicaltrials@fulcrumtx.com|
21241237|NCT02400307|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21241238|NCT03248440|Senju USA, Inc.|Takahiro Ogawa, PhD|+1 818 719 7190|ogawataka@senju-usa.com|
21241239|NCT01052662|University of Massachusetts Medical School|Gerardo Gonzalez, MD|508 856 6480|gerardo.gonzalez@umassmed.edu|
21241240|NCT00401817|Weill Cornell Medicine|John Leonard, MD|646.962.2064|amr2017@med.cornell.edu|
21241241|NCT04081298|Fred Hutchinson Cancer Center|Heather Greenlee|206-667-4502|hgreenlee@fredhutch.org|
21241242|NCT00479674|Duke University Medical Center|Dr. Kimberly Blackwell|919-668-1748|black034@duke.edu|
21241243|NCT01054911|University of Alabama in Birmingham, Comprehensive Cancer Center|Dr. James Posey, MD|205-934-0916|jposey@uabmc.edu|
21241244|NCT02478359|Kaiser Permanente|Huong Q2 Nguyen, Research Scientist|626-564-3935|huong.q2.nguyen@kp.org|
21241245|NCT02071095|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu|
21241246|NCT00905060|University of California, Davis|Dr. Orin Bloch, MD||obloch@ucdavis.edu|
21241247|NCT03293485|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21241248|NCT03023332|Case Western Reserve University|Jaclene Zauszniewski, PhD|216.368.3612|jaz@case.edu|
21241249|NCT02013687|Fraunhofer USA Center for Molecular Biotechnology|Dr. Jessica Chichester, Senior Scientist Immunology|302-369-3635|jessica.chichester@fhcmb.org|
21241250|NCT01782326|Novartis Pharmaceuticals|Study Director|862-778-8300||
21241251|NCT03633903|Laureate Institute for Brain Research|Namik Kirlic, PhD|918-502-5747|nkirlic@laureateinstitute.org|
21241252|NCT05968482|Amzell BV|Chief Executive Officer|+31235560460|amzell-disclosure@amzell.com|
21241253|NCT02559817|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21241254|NCT01657682|Arog Pharmaceuticals|Edward McDonald|214-593-0500|emcdonald@arogpharma.com|
21241255|NCT03389893|DAIT/NIAID|Director, Clinical Research Operations Program|240-669-5064|DAITClinicalTrialsGov@niaid.nih.gov|
21241256|NCT00525057|UT MD Anderson Cancer Center|Patrick Lin, MD/Professor, Orthopaedic Oncology|(713) 745-0088|plin@mdanderson.org|
21241257|NCT02150044|Acclarent, Inc.|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
21241258|NCT01719861|Stanford University Medical Center|Joel Neal, MD, PhD; Assistant Professor of Medicine|650-725-3081|jwneal@stanford.edu|
21241259|NCT04305236|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
21241260|NCT04183192|U.S. Food and Drug Administration|David Strauss, MD, PhD|3017966323|David.Strauss@fda.hhs.gov|
21241261|NCT02034435|Vanderbilt University Medical Center|Dr. James M. Luther, MD|(615) 936-3420|james.luther@vumc.org|
21241262|NCT00772928|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21241263|NCT04653051|Zimmer Biomet|Georgia Tsapara|+41 79 94 54936|georgia.tsapara@zimmerbiomet.com|
21241264|NCT02874846|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director of Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
21241265|NCT00429702|SunCoast CCOP Research Base|SunCoast CCOP Research Base Lead Biostatistician|18009091242|ccop@epi.usf.edu|
21241266|NCT04955626|BioNTech clinical trials patient information|BioNTech SE|+49 6131 90840|patients@biontech.de|
21241267|NCT05194735|Alaunos Therapeutics, Inc.|Jaymes Holland|6502732627|jholland@alaunos.com|
21241268|NCT00731042|3M Company|Chou Eyberg|651-737-0934|cieyberg1@mmm.com|
21241269|NCT01256476|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@KowaUS.com|
21241270|NCT02600429|clinical operation|Director of clinical operation||swkang@regentreellc.com|
21241271|NCT04034238|National cancer Institute|Dr. Christine C. Alewine|240-760-6146|christine.alewine@nih.gov|
21241272|NCT01345292|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
21241273|NCT02967016|Rutgers SUNJ|Dr. Antonio Gonzalez|4133869415|ajantoni@gmail.com|
21241274|NCT05967442|Advocate Christ Medical Center|Marc McDowell|708684800|marc.mcdowell@aah.org|
21241275|NCT01244763|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441||
21241276|NCT02271594|BD|Dr. Ken Strauss|32475380454|kenneth.strauss@bd.com|
21241277|NCT01528124|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21241278|NCT01328587|National Heart Lung and Blood Institute|Dunbar, Cynthia|+1 301 827 1164|dunbarc@nhlbi.nih.gov|
21241279|NCT03413605|Center for Asian Health, Lewis Katz School of Medicine, TempleUniversity|Dr. Grace X. Ma|215-707-6493|grace.ma@temple.edu|
21241280|NCT02015663|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
21241281|NCT01818700|Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University school of medicine, Seoul Korea|Dr. Whan Eoh|82-2-3410-3491|w.eoh@samsung.com|
21241282|NCT02412761|The University of Texas Health Science Center at Houston|Joyce P. Samuel, MD, MS|(713) 500-5670|Joyce.P.Samuel@uth.tmc.edu|
21241283|NCT01852955|Northwestern University|Gildasio De Oliveira, M.D.|312-695-4858|gjr@northwestern.edu|
21241284|NCT01627340|GlaxoSmithKline|GSK Response Center|866-435-7343||
21241285|NCT01272011|Malcom Randall VAMC|Dr. Nicole Tester|352-376-1611|ntester@phhp.ufl.edu|7507
21241286|NCT06096181|Cedars-Sinai Medical Center|Glenn Tan, MD|310-423-5841|Glenn.Tan@cshs.org|
21241287|NCT02240680|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21241288|NCT01657032|The Medical University of Warsaw|Hanna Szajewska, Malgorzata Pieścik-Lech|+48-22-45-23-309|hania@ipgate.pl|
21241289|NCT02987829|Tracon Pharmaceuticals Inc.|Charles Theuer, MD PhD|8585500780|ctheuer@traconpharma.com|
21241290|NCT01911221|Novartis Vaccines and Diagnostics|Posting Director||RegistryCpontactVaccinesUS@novartis.com|
21241291|NCT00958009|EMD Serono, Inc.|Fernando Dangond, MD|781-681-2348|Fernando.dangond@emdserono.com|
21241292|NCT00087490|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21241293|NCT00761774|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21241294|NCT01077024|University of Cincinnati Addiction Sciences Division|Dr. Theresa Winhusen|513-585-8227|winhust@ucmail.uc.edu|
21241295|NCT03379233|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21241296|NCT02300311|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
21241297|NCT02687919|University of Iowa|Amanda Irish||amanda.k.irish@gmail.com|
21241298|NCT00848211|Thymon LLC|Gideon Goldstein, MD, PhD|(973) 467-9558|gidgold@gmail.com|
21241299|NCT00419003|Baylor College of Medicine|Dr. Sanjay Mathew|7137985439|sjmathew@bcm.edu|
21241300|NCT02531438|Paratek Pharmaceuticals, Inc.|Dr. Paul McGovern; Vice President, Clinical Affairs|484-751-4935|Paul.Mcgovern@paratekpharma.com|
21241301|NCT01653743|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21241302|NCT01845636|New York State Psychiatric Institute|Dr. Davangere Devanand|646-774-8658|dpd3@cumc.columbia.edu|
21241303|NCT03748771|University of California San Diego|Dr. Rakesh Bhattacharjee|858-966-5846|rlbhattacharjee@ucsd.edu|
21241304|NCT01318811|Vanderbilt_Univeristy MC|Dr. Thomas Golper|615-322-5914|thomas.golper@vumc.org|
21241305|NCT00811187|Montefiore Medical Center|Research Program Administrator|718-405-8526|fheitor@montefiore.org|
21241306|NCT00131911|Mayo Clinic Cancer Center|Timothy J. Hobday M.D.||Hobday.timothy@mayo.edu|
21241307|NCT02825043|University of Oklahoma Health Sciences Center Dept. of Medicine|Clinical Trials Manager|(405)271-6651|research@ouhsc.edu|
21241308|NCT00329303|Cares|UCB|+1844599|UCBCares@ucb.com|2273
21241309|NCT00083174|Canadian Cancer Trials Group|Senior Biostatistician|613-533-6430|dtu@ctg.queensu.ca|
21241310|NCT03582137|University of Colorado|Maureen Leehey, MD|3037248288|maureen.leehey@cuanschutz.edu|
21241311|NCT02402764|H. Lee Moffitt Cancer Center and Research Institute|Dr. Hyo Sook Han|813-745-8960|hyo.han@moffitt.org|
21241312|NCT03704298|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
21241313|NCT00558753|Rush University Medical Center|Asokumar Buvanendran, M.D.|(312) 942-3685|asokumar@aol.com|
21241314|NCT04992442|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21241315|NCT04515797|Massachusetts General Hospital|Dr. Raymond Chung|6177247562|Chung.Raymond@mgh.harvard.edu|
21241316|NCT02774213|Tools4Patient|Stephanie Alvarez|+32 71 14|stephanie.alvarez@tools4patient.com|02 00
21241317|NCT05768945|Brigham and Women's Hospital|Rishi J Desai, PhD|617-278-0932|rdesai@bwh.harvard.edu|
21241318|NCT01670500|DFCI|Project Manager|617-632-2257|CTOPM@dfci.harvard.edu|
21241319|NCT03864133|Wake Forest University Health Sciences|Keith Walter, MD|336-716-3937|kwalter@wakehealth.edu|
21241320|NCT03658811|Toyos Clinic|Dillon O'Brien|6153274015|dobrien@toyosclinic.com|6
21241321|NCT03888365|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director|301-608-9292|info@lungbiotechnology.com|
21241322|NCT04951479|UPMC|Anish Ghodadra, MD|4126470104|ghodadraa@upmc.edu|
21241323|NCT04209790|Geisinger|Regulatory Project Manager|570-214-2462|khassanzadeh@geisinger.edu|
21241324|NCT01638468|Boston Scientific|Angela Schutt|763-494-2166|angela.schutt@bsci.com|
21241325|NCT04060680|Medtronic|Drew Turk, Clinical Research Specialist|7633580375|drew.turk@medtronic.com|
21241326|NCT05617040|Barinthus Biotherapeutics|Chief Medical Officer|+44 1865 818808|enquiries@barinthusbio.com|
21241327|NCT02711826|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21241328|NCT00729690|Rush University|Asokumar Buvanendran|(312) 942-3685|asokumar@aol.com|
21241329|NCT02169219|Massachusetts General Hospital, Division of Rheumatology|Dr. John Stone|617-643-2140|adfernandes@mgh.harvard.edu|
21241330|NCT02044419|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|857-242-5142|alison.long@aegerion.com|
21241331|NCT02507219|Laureate Institute for Brain Research|Dr. Martin Paulus|918-502-5120|mpaulus@laureateinstitute.org|
21241332|NCT02886936|University of Pennsylvania|Jessica Kenia, Research Coordinator|215-893-2678|jessica.kenia@pennmedicine.upenn.edu|
21241333|NCT04562779|Denver Health & Hospital Authority|Dr. Dale Terasaki|303-602-6922|dale.terasaki@dhha.org|
21241334|NCT02320721|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21241335|NCT03173248|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33155726000|scientificinformation@servier.com|
21241336|NCT01544582|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21241337|NCT00075803|NHLBI|Nancy DiFronzo, PhD|301-435-0065|difronozon@nhlbi.nih.gov|
21279505|NCT00879411|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21241338|NCT02624778|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21241339|NCT05296629|Journey Medical Corporation|Dr. Srinivas Sidgiddi|9084585362|ssidgiddi@jmcderm.com|
21241340|NCT00231179|Children's Hospital of Philadelphia|Jerilynn Radcliffe, PhD|215-590-7446|Radcliffe@email.chop.edu|
21241341|NCT01955382|NIAID/NIH|Dr. Rick M. Fairhurst, Principal Investigator|301-761-5077|rfairhurst@niaid.nih.gov|
21241342|NCT04610684|Hoosier Cancer Research Network|Clinical Data Analyst|3179212050|amajumdar@hoosiercancer.org|
21241343|NCT04672460|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_inquires@pfizer.com|
21241344|NCT02949271|Duke University|Ashraf Habib, M.D.|919-681-4544|ashraf.habib@duke.edu|
21241345|NCT05336123|Brown University|Dr. Lauren Weinstock|401-455-6304|Lauren_Weinstock@brown.edu|
21241346|NCT02373813|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21241347|NCT02068729|Stryker Spine|Marissa Conrad, Senior Director of Clinical and Medical Affairs|201-749-8162|marissa.conrad@stryker.com|
21241348|NCT01511536|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21241349|NCT02357758|London Health Sciences Centre|Dr. Sumit Dave|519.685.8439|Sumit.Dave@lhsc.on.ca|
21241350|NCT01764386|Orexigen Therapeutics, Inc.|Executive Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com|
21241351|NCT02021461|BIAL - Portela & Cª, S.A.|Director R&D|351-22-9866100|clinical.trials@bial.com|
21241352|NCT02703532|Emory University|Sarah Blanton, PT, DPT, NCS, FNAP|404-712-2222|sblanto@emory.edu|
21241353|NCT03738241|Baylor College of Medicine|Hana El Sahly, MD, FIDSA|713-798-2058|hana.elsahly@bcm.edu|
21241354|NCT03169361|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21241355|NCT02788656|Brigham and Women's Hospital|Akshay Desai|617-732-7046|adesai@bwh.harvard.edu|
21241356|NCT04446975|UNMC|Dr. Karsten Bartels|(402) 559-4081|anesthesiology.research@unmc.edu|
21241357|NCT00495469|GlaxoSmithKline|GSK Response Center|866-435-7343||
21241358|NCT01819415|Maisonneuve-Rosemont Hospital|Dr. Flavio Rezende|514-867-2990|frezendef@hotmail.com|
21241359|NCT03929302|UT Southwestern Medical center|Namrata Das|2146082836|Namrata.Das@utsouthwestern.edu|
21241360|NCT03815916|Clene Nanomedicine|Jeremy Evan, PA-C|5419086335|jeremy@clene.com|
21241361|NCT02459964|UT MD Anderson Cancer Center|Sai-Ching J. Yeung, MD, Professor, Emergency Medicine|(713) 745-9911|syeung@mdanderson.org|
21279506|NCT05124691|Instituto de Salud Global de Barcelona - ISGLOBAL|Jose Muñoz|+34608774071|jose.munoz@isglobal.org|
21279507|NCT01890434|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21279508|NCT00428116|University of Washington|Grace John-Stewart|206 543 4278|gjohn@uw.edu|
21279509|NCT01038297|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21241362|NCT00715390|The Children's Hospital of Philadelphia|Ronald Litman, DO|215-590-5091|litmanr@email.chop.edu|
21241363|NCT03835546|Fundació Lluita contra la SIDA|Jose A. Muñoz-Moreno|+34 93 497 84 14|jmunoz@flsida.org|
21241364|NCT02664220|McGovern Medical School, University of Texas Health Sciences Center at Houston|Dr. Kuojen Tsao|713-500-7300|Kuojen.Tsao@uth.tmc.edu|
21279510|NCT01044264|Perrigo Company|Manager|718-960-0119|jonathan.schwartz@perrigo.com|
21241365|NCT00106431|Celgene Corporation|Elizabeth Faust, PhD, Vice President, Clinical Research Services|617/583-1300|EFaust@Celgene.com|
21241366|NCT02256969|Massachusetts Eye and Ear Infirmary|Assistant Professor of Ophthalmology|617-573-6060|ophthalmologyclinicalresearch@meei.harvard.edu|6060
21241367|NCT01902901|Kaiser Permanente Center for Health Research|Katrina Goddard|503-335-6353|katrina.ab.goddard@kpchr.org|
21261518|NCT03596645|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21261519|NCT01123889|Loma Linda University Orthopaedic Surgery|Liz Clarke|909-558-5592|eaclarke@llu.edu|
21241368|NCT00402883|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21241369|NCT01427907|Fresenius Medical Care, North America|Mayuri Thakuria MD (MBBS), MPH|781-699-4645|mayuri.thakuria@fmc-na.com|
21241370|NCT00755755|PregLem S.A.|Dr Elke Bestel|+41 22 884 03 40|medical@preglem.com|
21241371|NCT01813422|Amgen Inc.|Study Director|866-572-6436||
21241372|NCT02015195|Division of Emergency Medicine, Department of Surgery, Stanford University School of Medicine|Paul Auerbach, MD|650.725.9445|auerbach@stanford.edu|
21241373|NCT02444143|University of Illinois at Chicago|Dr. Patricia West-Thielke|312-996-5695|pwest@uic.edu|
21241374|NCT00483262|Dana-Farber Cancer Institute|Irene Ghobrial, MD|617-632-4198|irene_ghobrial@dfci.harvard.edu|
21241375|NCT00487721|University of Colorado, Denver|Dr. Thomas Flaig|(720) 848 0655|Thomas.Flaig@ucdenver.edu|
21241376|NCT00832260|Hospital Universitari i politecnic La Fe|Dr. José Olagüe|+34 961 24 40 00|jolague@terra.com|
21241377|NCT02303574|AstraZeneca|Bengt Larsson|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
21241378|NCT01359410|Washington University School of Medicine|William Hawkins, M.D.|314-362-7046|hawkinsw@wustl.edu|
21241379|NCT05590910|UT Health San Antonio-Faculty; Texas Woman's University-Student|Jorgie Ann Contreras|2107235319|contrerasj6@uthscsa.edu|
21241380|NCT00994279|Wake Forest NCI NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
21241381|NCT01606189|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
21241382|NCT00859014|University of Texas Health Science Center|Dr. Sean I. Savitz, Professor and Director of Stroke|713.500.7083|sean.i.savitz@uth.tmc.edu|
21241383|NCT00162942|Otsuka America Pharmaceutical, Inc|Tao Wang|240-683-3213|tao.wang@otsuka-us.com|
21241384|NCT01354938|Abbott|Esther Oppermann, Clinical Trial Manager|49 511 6750 3954||
21241385|NCT01167023|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21241386|NCT00410384|GlaxoSmithKline|GSK Response Center|866-435-7343||
21241387|NCT03453385|Medical University of South Carolina (MUSC)|Dr. Matthew Carpenter|843-876-2436|carpente@musc.edu|
21241388|NCT00577629|Duke University Medical Center|Anne Beaven, MD|919-684-8964|anne.beaven@duke.edu|
21241389|NCT01027871|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21241390|NCT03782727|Cardiff and Vale University Health Board|Dr Rachel Abbott|02920743181|rachel.abbott@wales.nhs.uk|
21241391|NCT02405390|Nicklaus Children's Hospital|Jose M. Vargas Loayza, M.D.|786-624-3588|jose.vargas-loayza@mch.com|
21241392|NCT04887285|Northwestern University|Steven P. Cohen|312-695-2500|steven.cohen@northwestern.edu|
21241393|NCT04640571|University of Maryland, Baltimore|James Polli|410-465-3466|jpolli@rx.umaryland.edu|
21241394|NCT02820051|UANL|Dr. Julio E. González-Aguirre|82204444|jeglza111@gmail.com|229
21241395|NCT02338609|Novartis Pharmaceuticals|Study Director|+1 862-778-8300|novartis.email@novartis.com|
21241396|NCT00832780|University of New Mexico Comprehensive Cancer Center|Ben Liem, MD|505-272-0086|BLiem@salud.unm.edu|
21241397|NCT02655653|Montefiore Medical Centr|Dr. Jonathan Leff|7189205409|jleff@montefiore.org|
21241398|NCT05705167|Pharma Mar, S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|+34 918466000|clinicaltrials@pharmamar.com|
21241399|NCT04736056|Duke University|Hannah Fisher, PhD|919-416-3471|hannah.fisher@duke.edu|
21241400|NCT04529538|PATH|Chris Gast, Ph.D.|206-285-3500|cgast@path.org|
21241401|NCT02668432|University of Texas Health San Antonio|Bethany Kalich, PharmD|210-883-1177|kalich@uiwtx.edu|
21241402|NCT00114959|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21241403|NCT03706690|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21241404|NCT03803774|National Cancer Institute|Dr. Vassiliki Saloura|240-760-6352|vassiliki.saloura@nih.gov|
21241405|NCT02538679|Cedars Sinai Medical center|Dr. Karen Zaghiyan|310-289-9224|karen.zaghiyan@cshs.org|
21241406|NCT04482855|University of Pennsylvania School of Nursing|Dr. Jie Deng|2155734729|jiedeng@nursing.upenn.edu|
21241407|NCT04019561|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21241408|NCT05781490|Lument AB|Dr Jan Marsal|+46709822008|jan.marsal@med.lu.se|
21241409|NCT03212365|University of Utah|Christopher Pannucci, MD|801 581 2121|christopher.pannucci@hsc.utah.edu|
21241410|NCT00665561|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21241411|NCT02337361|Public Health Institute/Alcohol Research Group|Madhabika B. Nayak|510-898-5849|mnayak@arg.org|
21241412|NCT01786343|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani MD/Professor|713-745-0394|fravandi@mdanderson.org|
21241413|NCT00701311|William Beaumont Hospital|Kenneth M. Peters, MD|248-551-0387|kmpeters@beaumont.edu|
21241414|NCT05397470|Fulcrum Therapeutics|Call Center|617-651-8853|clinicaltrials@fulcrumtx.com|
21241415|NCT02153788|Duke University Medical Center|Andrew Krystal, MD|919-681-8742|andrew.krystal@duke.edu|
21241416|NCT03575962|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21241417|NCT04940390|Satsuma Pharmaceuticals, Inc.|Vice President of Regulatory Affairs and Quality|650-837-0799|clin.inquiries@satsumarx.com|
21241418|NCT01207908|Cincinnati Children's Hospital Medical Center|Dr. Meilan Rutter|513-636-4744|meilan.rutter@cchmc.org|
21261520|NCT00443560|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy, PharmD|312-926-9015|r-mccarthy@northwestern.edu|
21261521|NCT02333331|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
21241419|NCT05458102|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21241420|NCT02092987|Columbia University Medical Center|Jose Luchsinger|212-305-4730|jal94@cumc.columbia.edu|
21241421|NCT03239210|NYU Langone Health|Nicolette Recchia|845-398-6563|nicolette.recchia@nyulangone.org|
21241422|NCT01575860|Abramson Cancer Center of the University of Pennsylvania|Jakub Svoboda, MD. Study Principal Investigator|855-216-0098|PennCancerTrials@emergingmed.com|
21241423|NCT00305760|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Daniel Laheru|410-955-8974|laherda@jhmi.edu|
21241424|NCT00278564|Northwestern University|Dr. Richard Burt|312-695-4960|rburt@northwestern.edu|
21241425|NCT01094743|Johnson & Johnson Vision Care|Huan Sheng, MD, PhD|1-904-443-3440|HSheng2@its.jnj.com|
21241426|NCT02851511|University of Florida|Adam Woods, Ph.D.|352-294-5842|ajwoods@phhp.ufl.edu|
21241427|NCT00372567|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21241428|NCT03825393|Tokat State Hospital|Dr.Sevil Okan|5308211797|doctorsevil@yahoo.com|
21241429|NCT01169519|Duke University Medical Center|Dr. Kevin Hill|919-668-8305|kevin.hill@duke.edu|
21241430|NCT03278028|Aclaris Therapeutics|Executive Director, Clinical Operations|+1(484) 329-2144|jschnyder@aclaristx.com|
21241431|NCT02724787|James A. Haley Veterans' Hospital|Dr. Shannon Miles|813-972-2000|shannon.miles@va.gov|6728
21241432|NCT00372528|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21241433|NCT01417000|Aduro Biotech, Inc.|Corporate Communications|510-848-4400||
21241434|NCT00562965|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21241435|NCT02284464|Hospital Regional Universitario de Málaga|Dr. Domingo Hernandez|951291174|domingohernandez@gmail.com|
21241436|NCT00965484|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21241437|NCT01124617|Neuroscience department, clinical science department, R&D in Janssen Japan, Chiyodaku, Tokyo 101-0065 Japan|Manager|+81-3-4411-5509||
21241438|NCT00945477|Illinois CancerCare, P.C.|James Knost, M.D.|309-243-3000|jknost@illinoiscancercare.com|
21241439|NCT04582045|HealthPartners Institute|Linda M. Loes|952-967-7862|linda.m.loes@healthpartners.com|
21241440|NCT04796935|Elevate Clinical Consulting|Keri Urwin|919-247-8845|kurwin@elevateclinicalconsulting.com|
21241441|NCT01253200|Boston Scientific|Timothy Meyer; Director of Clinical Trials|651 581 3425|Timothy.meyer@bsci.com|
21241442|NCT02049437|University Hospitals Cleveland Medical Center|Marijke Frederix, PhD|(216) 844-0383|marijke.frederix@UHhospitals.org|
21241443|NCT00783718|Millennium Pharmaceuticals Inc|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
21241444|NCT02706626|Criterium, Inc.|Tom Stinchcombe|9196819509|Thomas.stinchcombe@duke.edu|
21241445|NCT01055782|Specialist Doctors Rolighedsvej|Lene Hendel MD|+4545819090|lene@hendel.dk|
21241446|NCT01163149|Alexion Pharmaceuticals, Inc.|Director of Clinical Trials|475-230-2596|ClinicalTrials@alexion.com|
21241447|NCT01192295|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
21241448|NCT00630539|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
21241449|NCT01253980|Poisons Information Centre, Red Cross War Memorial Children's Hospital and University of Cape Town|Dr Kate Balme|+27 21 658 5308|kate.balme@uct.ac.za|
21241450|NCT01700530|University of Missouri|John P. Thyfault, PhD|573-874-9728|thyfaultj@missouri.edu|
21241451|NCT00696293|University of Pittsburgh|Jordan F. Karp, MD|412-246-6048|karpjf@upmc.edu|
21241452|NCT01688102|The Rockefeller University|Dr. Manish Ponda|212-327-7631|mponda@rockefeller.edu|
21241453|NCT04159896|Karmanos Cancer Institute|Dr. Elisabeth Heath|313.576.8734|heathe@karmanos.org|
21241454|NCT01449721|Christiana Care Health System|Ryan Arnold, MD, Director of Research, Emergency Medicine|302-733-5108|ryarnold@christianacare.org|
21241455|NCT01577732|GlaxoSmithKline|GSK Response Center|866-435-7343||
21241456|NCT01342887|Fred Hutch Cancer Research Center|Roland B. Walter, MD, PhD, MS||rwalter@fredhutch.org|
21241457|NCT01125774|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21241458|NCT02698436|JNJWorldwide|Lisa Fitzgerald|+1 908-904-6235|lfitzge6@its.jnj.com|
21241459|NCT03323151|ECOG-ACRIN Statistical Center|Opeyemi Jegede, Statistician|617-582-7613|ojegede@ds.dfci.harvard.edu|
21241460|NCT00097370|GlaxoSmithKline|GSK Response Center|866-435-7343||
21241461|NCT01394991|Johnson and Johnson PRD|Clinical Development Team Lead|1 908 218 6097||
21241462|NCT01031043|Georgia Regents University|Gregory N. Postma MD|706-721-6100|gpostmat@gru.edu|
21241463|NCT03073005|Northwestern University|Dr. Jeffrey H Barsuk|312-926-5924|jbarsuk@nm.org|
21241464|NCT01734811|Inmunotek|Medical Director|916 510 010|mcasanovas@inmunotek.com|
21241465|NCT02427646|LHSC|Dr. Mandar Jog|519-685-8500|mandar.jog@lhsc.on.ca|76708
21241466|NCT03824236|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21241467|NCT01290094|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21241468|NCT01101542|GlaxoSmithKline|GSK Response Center|866-435-7343||
21241469|NCT01974687|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21241470|NCT00814489|GlaxoSmithKline|GSK Response Center|866-435-7343||
21241471|NCT04880161|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|17204376500|clinicaltrials@ampiopharma.com|
21241472|NCT01354106|cyberDERM|Dr. Gary Grove|610-325-0112|GGrove@cyberderm-inc.com|
21241473|NCT00901485|Royal Brompton Hospital|Miss Julia Kelly|+44 2073528121|j.kelly@rbht.nhs.uk|4183
21241474|NCT01871285|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
21241475|NCT03015740|M D Anderson Cancer Center|Dr. Pavlos Msaouel|713-563-4585|PMsaouel@mdanderson.org|
21241476|NCT03253653|San Diego State University Research Foundation|Dr. Nada Kassem|619-370-7488|Nkassem@sdsu.edu|
21241477|NCT00929305|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
21291670|NCT00509288|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
21291671|NCT00049543|NCIC Clinical Trials Group|Dr. Keyue Ding|1-613-533-6000|king@ctg.queensu.ca|77705
21291672|NCT02421094|Galectin Therapeutics|Vice President of Regulatory Affairs|678-620-3186|horton@galectintherapeutics.com|
21291673|NCT01656161|Debiopharm International|Eija Lundstrom, Medical Director|+41 21 321 06 03|eija.lundstrom@debiopharm.com|
21291674|NCT00963872|University of Minnesota|Dr. Claudio Brunstein|612-625-3918|bruns072@umn.edu|
21291675|NCT01138514|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
21234267|NCT01271868|Aptevo Therapeutics|Dr. David Schaaf|206-859-6655|schaafd@apvo.com|
21234268|NCT03216850|University Hospital Hradec Kralove|Dr. David Astapenko|+420495833218|astapenko.d@seznam.cz|
21234269|NCT00405548|Mayo Clinic|Dr. Horng H. Chen|507-538-2354|chen.horng@mayo.edu|
21234270|NCT01116232|Barbara Ann Karmanos Cancer Institute|Zaid Al-Kadhimi, M.D.|404-778-5984|zalkadh@emory.edu|
21234271|NCT00811577|Capstone Therapeutics Corp.|Denise Lamon|602-286-5206|dlamon@capstonethx.com|
21234272|NCT01068509|PrimaBioMed, Ltd.|Marc Voigt|49 173 6771602|marc.voigt@primabiomed.com.au|
21234273|NCT01429272|Laureate Institute for Brain Research|Jonathan Savitz; Principal Investigator|918 502 5104|jsavitz@laureateinstitute.org|
21234274|NCT00329407|Boston University|Ofra sarid-Segal, MD|617-414-1990|ofra.segal@bmc.org|
21234275|NCT02357940|Johnson & Johnson Consumer Inc.|Amisha Parikh-Das, PhD/Study Director|973-255-8701 USA EST|AParikh1@its.jnj.com|
21234276|NCT02442778|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21234277|NCT02482025|VA Greater Los Angeles Healthcare System|Steven R. Simon, MD|310.268.3132|steven.simon2@va.gov|
21234278|NCT01751386|National Institute on Alcohol Abuse and Alcoholism|Lorenzo Leggio|+1 301 435 9398|lorenzo.leggio@mail.nih.gov|
21234279|NCT01644175|Sanofi|Trial Transparency Team||Contact -US@sanofi.com|
21234280|NCT01017237|University of North Carolina School of Dentistry|Jay Anderson, DDS, MD|919-966-1126|janderson@aims.unc.edu|
21234281|NCT03483675|FHCRC|Kate Chilson|206-667-6069|kchilson@fredhutch.org|
21234282|NCT00799578|Columbia University|Dr. Joel Lavine|212 304 5533|jl3553@columbia.edu|
21234283|NCT01162382|Washington University School of Medicine|Kathy Pierce|314-362-5626|jenkerson_m@wustl.edu|
21234284|NCT00451035|Novartis pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21234285|NCT01886807|UTSouthwestern Medical Center|Dr. Jeffrey Steiner, PI|214-456-0606|jeffrey.steiner@utsouthwestern.edu|
21234286|NCT01965288|CooperVision|Jose A. Vega Sr. Mgr. Global Medical Scientific Affairs|(925) 621-3761|jvega2@coopervision.com|
21234287|NCT01712256|Bionor Pharma ASA|Maja Sommerfelt|+4723010960|ms@bionorpharma.com|
21234288|NCT04944901|Scioto Biosciences|Phoevos Hughes, VP Clinical Operations|866-672-4686|phoevos@sciotobiosciences.com|700
21234289|NCT05516082|CooperVision, Inc.|José A. Vega OD, MSc, FAAO|19256213761|javega@coopervision.com|
21234290|NCT00603746|GlaxoSmithKline|GSK Response Center|866-435-7343||
21234291|NCT05233566|Washington University School of Medicine|Dr. Bradley Fritz|3142733453|bafritz@wustl.edu|
21234292|NCT03664752|Bausch Health Americas, Inc|Study Director|19083009920|susan.harris@bauschhealth.com|
21234293|NCT01524627|UPenn|Teresa R. Franklin, Ph.D.|215-746-1883|teresafr@mail.med.upenn.edu|
21234294|NCT03323658|UT MD Anderson Cancer Center|Priya Thomas,MD-Associate Professor, Clinical Cancer Prevention|(713) 745-1075|psthomas@mdanderson.org|
21234295|NCT03913091|NYU Langone Health|Uchenna O. Umeh, MD|(212) 598-6085|Uchenna.Umeh@nyulangone.org|
21234296|NCT00969553|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21234297|NCT00615056|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21234298|NCT01726738|University of North Carolina Lineberger Comprehensive Cancer Center|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
21234299|NCT01076504|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21234300|NCT03639766|University of Central Florida|Dr. David Weinstein|(407)266-4900|david.weinstein@ucf.edu|
21234301|NCT01380184|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21234302|NCT04248816|University of Pennsylvania|Dr. Shivan Mehta|215-898-6027|shivan.mehta@pennmedicine.upenn.edu|
21234303|NCT03350503|Alcon Research|Expert Clinical Project Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21234304|NCT04010266|AppliedVR|Vice President of Research|13108901584|tmaddox@appliedvr.io|
21234305|NCT00262067|Genentech, Inc.|Medical Communications|800 821-8590||
21234306|NCT03829046|Icahn School of Medicine at Mount Sinai|Dr. Qinzhong Chen|212-659-8864|qinzhong.chen@mssm.edu|
21234307|NCT00816101|Sheftel Associates Dermatology, LLC|Scott Sheftel, MD|520-293-5757|ssheftel@sheftelderm.com|7106
21234308|NCT02679911|Galderma|Farzaneh SIDOU Clinical Project Manager|0493957051|farzaneh.sidou@galderma.com|33
21234309|NCT01399593|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alexion.com|
21234310|NCT02131402|Optics Department, University of Valencia 46100 Valencia, Spain|Dr. Robert Montés-Mico O.D., MPhil, PhD|34-9635-44764|robert.montes@uv.es|
21234311|NCT00344773|Astrazeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
21234312|NCT00249470|Johns Hopkins School of Medicine: Department of Psychiatry|Dr. Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
21234313|NCT04859868|Mayo Clinic|Gaurav N. Pradhan, Ph.D.|480-301-5351|Pradhan.Gaurav@mayo.edu|
21234314|NCT02766244|Texas Tech University Health Sciences Center|Dr. Sharmila Dissanaike|8067435609|sharmila.dissanaike@ttuhsc.edu|
21234315|NCT02849548|Howard University|Ihori Kobayashi|202-865-7185|ihori.kobayashi@gmail.com|
21234316|NCT00714259|UAB|William Vaughan, MD|20-934-0066|liwilliams@uabmc.edu|
21234317|NCT00638885|Atlanta VAMC|J Douglas Bremner MD|404-712-9569|jdbremn@emory.edu|
21234318|NCT04804813|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21234319|NCT05965349|University of Washington|Dr. Linda Ko|2066854978|lindako@uw.edu|
21291676|NCT03510273|PATH|Dr. Silvia de Sanjose|2062853500|sdesanjose@path.org|
21291677|NCT00862940|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
21234320|NCT00560950|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21234321|NCT01581593|Kedrion S.p.A|Dr. Mirella Calcinai, MD, Clinical Research Director|+393486559761|m.calcinai@kedrion.com|
21234322|NCT02586012|University of Pittsburgh|Craig Seaman, MD|412-209-7308|seamanc@upmc.edu|
21234323|NCT03277846|University of Pennsylvania|Michael Perlis|215-746-3577|mperlis@upenn.edu|
21234324|NCT05168475|Cambridge University Hospitals NHS Foundation Trust|Professor David Jayne|01223 336816|dj106@cam.ac.uk|
21234325|NCT01589822|Ethicon|Director of Clinical Development|1 908 218-2492|JBatill2@its.jnj.com|
21234326|NCT01302964|Massachusetts General Hospital|Christopher J. McDougle, MD|781-860-1783|cmcdougle@mgh.harvard.edu|
21234327|NCT05543928|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
21234328|NCT01904604|DAIT/NIAID|Director, Clinical Research Program|(301) 594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21234329|NCT05124665|Yale School of Public Health|Dr. J. Lucian Davis|203-785-3665|lucian.davis@yale.edu|
21234330|NCT01945489|Allergan, Inc|Vice President Medical Affairs|1-877-277-8566|IR-CTRegistration@allergan.com|
21234331|NCT04147442|Bernafon AG|Dr Barbara Simon|+41 31 998 1515|bsim@bernafon.com|1684
21234332|NCT00697346|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21234333|NCT03569371|Incyte Corporation|Incyte Corporation Call Center, Study Director|1-855-463-3463|medinfo@incyte.com|
21234334|NCT03643562|Mandos, LLC|Executive Vice President, Regulatory Affairs|619-905-0489|jspinella@mandoshealth.com|
21234335|NCT04145895|Beaumont Hospitals|Diane Studzinski|2485512570|diane.studzinski@corewellhealth.org|
21234336|NCT01236755|The Hong Kong Polytechnic University|Prof Pauline Cho|+852 2766-6100|pauline.cho@polyu.edu.hk|
21234337|NCT03848845|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21234338|NCT02547662|Mayo Clinic|Shaji Kumar MD|507 284 2511|Kumar.Shaji@mayo.edu|
21234339|NCT01200875|Stanford University|Jason Dragoo, Associate Professor|(650) 721-3430|jdragoo@stanford.edu|
21234340|NCT00596011|H. Lee Moffitt Cancer Center and Research Institute|Nagi Kumar, Ph.D.|813-745-6885|nagi.kumar@moffitt.org|
21234341|NCT00934544|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
21234342|NCT02643251|BDSI|Tim Warneke|919-582-0294|twarneke@bdsi.com|
21241478|NCT05927480|HealthPartners Institute|Sandy Vang, Director of Research Administration at Regions Hospital|1-651-254-6961|sandy.x.vang@healthpartners.com|
21241479|NCT01796665|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
21241480|NCT02395185|Shriners Hospital for Children|Rebecca Davis|859-268-5705|rfdavis@shrinenet.org|
21241481|NCT02263885|InSightec|Nadir Alikacem, PhD|214-630-2000|nadira@insightec.com|
21241482|NCT01598025|Memorial Sloan Kettering Cancer Center|Dr. Richard O'Reilly, MD|646-888-2157|oreillyr@mskcc.org|
21241483|NCT04531540|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21241484|NCT00003377|Gynecologic Oncology Group Statistical & Data Center|Melissa Leventhal|(716)845-5702|mleventhal@gogstats.org|
21241485|NCT01873287|Children's Hospital of Eastern Ontario|Dr. Roger Zemek|613-737-7600|rzemek@cheo.on.ca|
21241486|NCT00582790|University of Wisconsin Carbone Cancer Center|Study coordinator|(608) 263-7107|uwcccgu@medicine.wisc.edu|
21241487|NCT03570255|Masimo|Vikram Ramakanth|949-297-7416|clinicalresearchdept@masimo.com|
21241488|NCT00790062|University of Alabama at Birmingham|Alan T. N. Tita, MD|(205) 934-9616|atit@uab.edu|
21241489|NCT00480441|Treatment Research Center|Dr. Marina Goldman, Principle Study Investigator|215 222 3200|marinag@mail.med.upenn.edu|104
21241490|NCT02374957|Wake Forest University Health Sciences|Dr. Matthew Edwards|336-716-9343|medwards@wakehealth.edu|
21241491|NCT00748969|LA Biomed at Harbor-UCLA Medical Center|Dr. Lynda Polgreen|310-222-1972|lpolgreen@labiomed.org|
21241492|NCT03532178|UCaliforniaSF|Dr. Chanhung Lee|4154762131|chanhung.lee@ucsf.edu|
21241493|NCT01608971|Heart and Diabetes Center NRW|Andreas Koster|0043 5731 3284|akoster@hdz-nrw.de|
21241494|NCT00674492|Center for Healthcare Organization and Implementation Research|Jack A. Clark, PhD|781.687.2937|Jack.Clark@va.gov|
21241495|NCT01113463|University of Texas MD Anderson Cancer Center|Charles A. Conrad, MD / Professor, Neuro Oncology|713-792-2883|CR_Study_Registration@mdanderson.org|
21241496|NCT02726178|Sainte Justine university hospital center|Dr. Anne Monique Nuyt|514 3454931|anne-monique.nuyt@recherche-ste-justine.qc.ca|3971
21241497|NCT02953548|GW Research Ltd|Medical Enquires|+44 01223 238170; 1877886281|medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
21241498|NCT00578227|GlaxoSmithKline|GSK Response Center|866-435-7343||
21241499|NCT01023178|Stanford University|Sejal Shah MD|6507235791|sshah2@stanford.edu|
21241500|NCT03610633|Medical University of South Carolina|Laura Lohnes|843-792-7709|lohnes@musc.edu|
21241501|NCT00310362|MInneapolis VA Health Care System|Dr. Joan Griffin|507-538-1490|griffin.joan@mayo.edu|
21241502|NCT00916006|LEO Pharma|Dr. Torsten Skov|+4520736294|tosdk@leo-pharma.com|
21241503|NCT01051778|Cairo university|Usama .M .Fouda|+20123595106|umfrfouda@yahoo.com|
21241504|NCT03419780|University of Pennsylvania|Dr Rebecca Hamm|215-662-6913|rebecca.feldmanhamm@pennmedicine.upenn.edu|
21241505|NCT01605136|Clinuvel Inc.|Dr. Dennis Wright|646 527 7310|Dennis.Wright@clinuvel.com|170
21241506|NCT01072929|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21241507|NCT02929108|Washington University School of Medicine|Debra Oliver, Ph.D.|314-747-5361|oliverd@wustl.edu|
21241508|NCT00052962|National Cancer Institute, National Institutes of Health|Marybeth Hughes, M.D.|301-594-9341|hughesm@mail.nih.gov|
21241509|NCT01414166|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21234343|NCT00240071|University of Alabama at Birmingham|Carla I Falkson|205-975-2691|cfalkson@uab.edu|
21241510|NCT02806336|Baltimore VA Geriatric Research Education and Clinical Center|Dr. Leslie Katzel|4106057248|leslie.katzel@va.gov|
21291678|NCT04537650|KITE Research Institute - University Health Network|Catriona M. Steele, PhD|14165973422|catriona.steele@uhn.ca|7802
21241511|NCT03682536|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21241512|NCT05489224|CELLTRION, Inc.|Head of Clinical Planning Department 3|+82-32-850-4167|jeehye.suh@celltrion.com|
21241513|NCT04794062|Good Samaritan Hospital, TriHealth|Leonid Khokhlov, MD|5138858974|leonkhokhlov@gmail.com|
21241514|NCT03643965|Calliditas Therapeutics|Clinical Program Leader|0737456451|kristin.onnestam@calliditas.com|
21241515|NCT06268301|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21241516|NCT04536025|University of Colorado|Dr. Chelsey Anderson|12069926861|chelsey.anderson@cuanschutz.edu|
21241517|NCT03008122|Saint Louis University|Sarah George, MD|314-977-9035|sarah.george@health.slu.edu|
21241518|NCT00610883|Memorial Sloan Kettering Cancer Center|Dr. Tanya Trippett|212-639-8267|trippet1@mskcc.org|
21241519|NCT01222247|The George Washington University Biostatistics Center|Elizabeth Thom, Ph.D.|301-881-9260|e_thom@bsc.gwu.edu|
21241520|NCT02084082|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21241521|NCT03298113|3M Healthcare Business Group|Nancy Klinger, Clinical Manager|651 736|nmklinger@mmm.com|5825
21241522|NCT04883346|Section on Growth and Obesity, NICHD, NIH|Jack A. Yanovski, MD, PhD|301-496-0858|yanovskj@mail.nih.gov|
21241523|NCT03669042|Artivion, Inc.|Karen Sylvester|7704193355|karen.sylvester@artivion.com|
21241524|NCT02223182|DBV Technologies|Pharis Mohideen, MD Chief Medical Officer|908-679-5200|clinicaltrials@dbv-technologies.com|
21241525|NCT05302791|University of Montana|Dustin Slivka|406-243-2389|dustin.slivka@umontana.edu|
21241526|NCT03552978|San Francisco Veterans Affairs Medical Center|Ellen Herbst, MD|415-221-4810|Ellen.Herbst@va.gov|24926
21241527|NCT03663712|Duke University|Dan G. Blazer III, MD|919-668-1861|trey.blazer@duke.edu|
21241528|NCT04956692|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21241529|NCT03541603|Tenax Therapeutics, Inc.|Stuart Rich, MD; Chief Medical Officer|919 855 2100|s.rich@tenaxthera.com|
21241530|NCT03437668|UCaliforniaLA|Stephen R Marder|3102670221|smarder@mednet.ucla.edu|
21241531|NCT02099539|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
21241532|NCT05812794|The University of Texas Health Science Center at Houston|Stuart Mason Fraser, MD|713-500-7142|Stuart.M.Fraser@uth.tmc.edu|
21241533|NCT03473756|Bayer AG|Bayer Clinical Trials Contact|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21241534|NCT03714022|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21241535|NCT05121675|Perelman School of Medicine|Dr. Heather Nuske|2153495537|Heather.Nuske@Pennmedicine.upenn.edu|
21241536|NCT02148718|AbbVie|Global Medical Services|800-633-9110||
21241537|NCT04447820|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
21241538|NCT02487446|Novartis Pharmaceuticals|Study Director|862-778-1873||
21241539|NCT02234310|Bioverativ, a Sanofi company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6
21241540|NCT03289455|Autolus Ltd|Clinical Project Manager|+44 1483 920748|clinicaltrials@autolus.com|
21241541|NCT01822821|Cleveland Clinic|Nicole Zimmerman|216-636-9449|zimmern2@ccf.org|
21241542|NCT00333788|UCB, Inc|UCB Clinical Trial Call Center|+1 877 822 9493||
21241543|NCT03251378|HUTCHMED International|William Schelman, MD, PhD|973-306-4490|albertof@hutch-med.com|+1
21241544|NCT04996069|Tufts University School of Dental Medicine|Mabi Singh|6176363931|mabi_l.singh@tufts.edu|
21241545|NCT00935792|Mayo Clinic|Timothy Call, M.D.|5076682050|Call.Timothy@mayo.edu|
21241546|NCT02956967|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21241547|NCT02322775|AstraZeneca Research and Development|Mitchell Goldman, Global Clinical Leader Benralizumab|301 398 0323|Mitchell.Goldman@astrazeneca.com|+1
21241548|NCT04739423|CuraSen Therapeutics, Inc|Clinical Trial Information Desk|+1 650 475 2842|clinicaltrials@curasen.com|
21241549|NCT01007552|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|groman@appliedstats.com|847
21241550|NCT02451423|University of California, San Francsico|Dr. Lawrence Fong, MD|(415) 514-3160|lawrence.fong@ucsf.edu|
21241551|NCT01939938|Weill Cornell Medical College|Dr. Matthew Ebben|6469629318|mae2001@med.cornell.edu|
21241552|NCT00764868|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21241553|NCT00308061|University of Bamako Faculty of Medicine, Mali|Mahamadou A. Thera, MD MPH|223-222-1809|mthera@mrtcbko.org|
21241554|NCT01521143|Prima BioMed, Ltd.|Marc Voigt|49 173 6771602|marc.voigt@primabiomed.com.au|
21241555|NCT00741273|Repros Therapeutics|Jennifer Wike|2817193402|jwike@reprosrx.com|
21241556|NCT03713645|Temple University Hospital, Inc.|Adam Diamond, PharmD, BCPS, FAST|215-280-8041|adam.diamond@tuhs.temple.edu|
21241557|NCT00333138|Novartis pharmaceuticals|Study director|862-778-8300||
21241558|NCT03005288|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21241559|NCT04438785|Grupo Hospitalario Quironsalud|Francisco Jesus Gonzalez|0034645014593|fgonzasan@gmail.com|
21241560|NCT04011033|BeijingYouan Hospital|Lu Jun|+86-010-83997153|lujun98@ccmu.edu.cn|
21241561|NCT02027935|University of Texas MD Anderson Cancer Center|Dr. Adi Diab|(713) 745-7336|adiab@mdanderson.org|
21241562|NCT04873817|Abbott|Devyani Nanduri, Sr. Director, Clinical and Regulatory Affairs|+16698329450|Devyani.Nanduri@abbott.com|
21241563|NCT00216320|Innovative Neurotronics|Director of Clinical Research|512-721-1922|hrogers@ininc.us|
21279511|NCT04052334|Moffitt Cancer Center|John E. Mullinax, MD, FACS|813-745-4673|John.Mullinax@moffitt.org|
21279512|NCT05831774|Houston Methodist Hospital|Haley Goble|713-441-3930|hmgoble@houstonmethodist.org|
21279513|NCT01898221|Houston Methodist Hospital, Dept of Cardiology|Miguel Valderrabano, MD|713 441 5231|MValderrabano@houstonmethodist.org|
21279514|NCT03985852|University of Utah|Dr. Kimberly Kaphingst|801-213-5724|kim.kaphingst@hci.utah.edu|
21279515|NCT00252239|University of Virginia Health System|Dr. E. Clarke Haley, Jr.|434-924-8041|ech@virginia.edu|
21241564|NCT00924560|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21234344|NCT01818804|Aalborg University hospital|Salome Kristensen, MD. PhD|+45 97664015|sakr@rn.dk|
21234345|NCT02633956|Intercept Pharmaceuticals, Inc|Medical Information|844-782-4278|medinfo@interceptpharma.com|
21241565|NCT00593320|Washington University School of Medicine|Jeffrey Bradley, M.D.|314-362-8502|jbradley@radonc.wustl.edu|
21241566|NCT00663962|Queen's University|Pregabalin and Post-thoracotomy pain|(613) 548-7827|zamoraj@kgh.kari.net|
21241567|NCT01114620|GlaxoSmithKline|GSK Response Center|866-435-7343||
21241568|NCT01489176|University of Nebraska Medical Center|Thomas R Porter|402-559-5156|trporter@unmc.edu|
21241569|NCT05541497|Yale School of Medicine|Lisa Fucito, PhD: Associate Professor of Psychiatry; Director, Tobacco Treatment Service, Psychiatry|(203) 688-1878|lisa.fucito@yale.edu|
21241570|NCT04091672|AVITA Medical|SVP Global Clinical Research|1-833-462-8482|ekirshner@avitamedical.com|
21241571|NCT00359619|GlaxoSmithKline|GSK Response Center|866-435-7343||
21241572|NCT02655692|Yale University|John Krystal|203.785.6396|john.krystal@yale.edu|
21241573|NCT00716079|The George Institute for Global Health|Professor Craig Anderson|+612 9993 4521|canderson@georgeinstitute.org.au|
21241574|NCT01251614|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
21241575|NCT01032850|University of New Mexico Cancer Center|Dr. Yehuda Patt, MD|505-925-0405|yzpatt@salud.unm.edu|
21241576|NCT01876043|Institut Bergonié|Dr Antoine ITALIANO|+33556333333|a.italiano@bordeaux.unicancer.fr|
21241577|NCT00049517|ECOG Statistical Office|Statistician|617-632-3012||
21241578|NCT00079937|Novartis Pharmaceuticals|Study Director|862-778-8300||
21241579|NCT02857283|UNC Center for Environmental Medicine, Asthma and Lung Biology|Michelle Hernandez, MD|919-843-5383|michelle_hernandez@med.unc.edu|
21241580|NCT00093795|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org|
21241581|NCT00940017|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21241582|NCT00613301|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21241583|NCT00569946|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21279516|NCT04791514|Insmed Incorporated|Insmed Medical Information|1-844-446-7633|medicalinformation@insmed.com|
21234346|NCT02224872|Johns Hopkins University|Amy DeZern|4105027208|Adezern1@jhmi.edu|
21234347|NCT04118010|Emory University|Dr. Vin Tangpricha|404-727-7254|vtangpr@emory.edu|
21234348|NCT04206293|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21234349|NCT03863210|University of Split School of Medicine|Dr. Slavica Jurić Petričević||slavica.juric01@gmail.com|
21234350|NCT05028374|Karmanos Cancer Institute|Dr. Jeffery Zonder|313-576-8732|zonderj@karmanos.org|
21234351|NCT01956110|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
21234352|NCT01166594|Sunnybrook Health Sciences Centre|Dr Catherine Birt|416 480-5882|catherine.birt@sunnybrook.ca|
21234353|NCT00742313|Duke University Medical Center|Terry Ainsworth, Director, Clinical Research Operations, Education & Training|919-681-7084|terry.ainsworth@duke.edu|
21234354|NCT03325166|Oregon Health and Science University|Gerda Teglassy, MD|503-494-4526|tothg@ohsu.edu|
21234355|NCT02299050|University of Texas Health San Antonio|Mariam Alatrach|210-358-7220|alatrach@uthscsa.edu|
21234356|NCT00706966|University of California San Francisco|Mack Roach, MD|415-353-9855|tdiep@radonc.ucsf.edu|
21234357|NCT02822508|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
21234358|NCT01631474|Cassiopea, SpA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
21234359|NCT01467076|Wayne State University|Beena Sood, M.D.|313-745-5638|bsood@med.wayne.edu|
21234360|NCT03354429|Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
21234361|NCT03100825|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21234362|NCT00542750|Medical University of South Carolina|Kevin M. Gray, M.D.|8437920135|graykm@musc.edu|
21234363|NCT00994448|UCLA|Keith Heinzerling MD|310-794-0619|KHeinzerling@mednet.ucla.edu|
21234364|NCT02981381|VA Providence|Noah S. Philip MD|401-273-7100|noah.philip@va.gov|12369
21234365|NCT05923229|Washington University School of Medicine|Kerri Rawson|314-273-1053|rawson@wustl.edu|
21234366|NCT04164901|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33 1 55 72 60 00|scientificinformation@servier.com|
21234367|NCT04098458|Medical University of South Carolina|Evan M. Graboyes, MD, MPH (principal investigator)|843-792-0719|graboyes@musc.edu|
21234368|NCT01800916|Coloplast A/S|Marian Sinvani|+45 49112356|dkmards@coloplast.com|
21234369|NCT01461096|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21234370|NCT04889625|Johnson & Johnson Vision Care, Inc.|Thomas R. Karkkainen, OD, MS, FAAO|1-904-254-0152|TKarkkai@its.jnj.com|
21234371|NCT05052190|UCLA|Principal Investigator|310-206-6328|pszilagyi@mednet.ucla.edu|
21234372|NCT04152226|Dermbiont, Inc|Emma Taylor, MD (Chief Medical Officer)|510-607-8155|emma@dermbiont.com|
21234373|NCT03047135|Johns Hopkins University|Catherine Handy Marshall, MD|410-955-0231|chm@jhmi.edu|
21234374|NCT01256593|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21234375|NCT05619692|Sage Therapeutics|Amy Bullock|617-949-5151|amy.bullock@sagerx.com|
21234376|NCT00915798|UC Irvine|Dr. Jean Gehricke|949-267-0404|jgehrick@uci.edu|
21279517|NCT02257385|GlaxoSmithKline|GSK Response Center|866-435-7343||
21279518|NCT01316302|The Medical Research Network, LLC|Michael R. Liebowitz, M.D.|(212) 595-5012|MLiebowitz@MedicalResearchNetwork.com|
21279519|NCT02288156|UZ Leuven|Prof. Dr. Hellings|016336340|nkogh@uzleuven.be|
21279520|NCT03287843|Ege University Hospital|Erhan Akgun,MD, Proffessor|+902323905050|z.erhan.akgun@ege.edu.tr|
21234377|NCT00167934|Washington University School of Medicine|Michael Yingling|573-579-1412|yinglingm@wustl.edu|
21234378|NCT02036502|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21241584|NCT00961805|Federal University of Sao Paulo|Andreia S Baptista, PT|551155764239|deiasalvador1@yahoo.com.br|
21241585|NCT01684046|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21241586|NCT01306331|Evofem|Clinical Operations|858-550-1900|clinicaloperations@evofem.com|
21241587|NCT05642000|University of California San Diego|Rebecca Fielding-Miller|8583810603|rfieldingmiller@health.ucsd.edu|
21241588|NCT03614130|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21291679|NCT00879398|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21291680|NCT02347410|Spineology|Rose Griffith, Sr. Director, Clinical Affairs|6512568503|Rgriffith@spineology.com|
21291681|NCT04222673|Pittsburgh VA|Matthew Chinman|8184813909|chinman@rand.org|
21291682|NCT04398706|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21291683|NCT04116853|Advocate Aurora Research Institute|Kathryn Ross, PhD MPH|414-647-6312|Kathryn.Ross@aah.org|
21291684|NCT06899100|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
21291685|NCT01346176|University of Pennsylvania School of Medicine|Scott D. Halpern|215.573.9461|elcooney@exchange.upenn.edu|
21291686|NCT01994876|Coloplast A/S|Director of Clinical Affairs|+45 4911 25 23|dkdac@coloplast.com|
21291687|NCT04522973|Virginia Commonwealth University|Michelle Peace, PhD|804-828-8240|mrpeace@vcu.edu|
21291688|NCT04630769|Masonic Cancer Center, University of Minnesota|Melissa Geller, MD|612-626-3111|gelle005@umn.edu|
21291689|NCT02445911|Kaneq Bioscience Limited|Dr. Gosse Bruinsma|1-613-800-0955|gosse.bruinsma@kaneqbioscience.ca|
21291690|NCT02581930|University of North Carolina at Chapel Hill|Dr. Stergios Moschos|919-843-7713|stergios_moschos@med.unc.edu|
21291691|NCT05395936|Atrium Health Wake Forest Baptist Comprehensive Cancer Center|Adam Katz|336-716-4171|akatz@wakehealth.edu|
21291692|NCT03021486|UT MD Anderson Cancer Center|David Hui, MD- Associate Professor, Palliative Care Medicine|(713) 792-6258|dhui@mdanderson.org|
21291693|NCT04043286|Loma Linda University, School of Dentistry|Dr. Sasiya Bhumpattarachai|6267565156|sbhumpattarachai@llu.edu|
21291694|NCT03326245|National Institute on Alcohol Abuse and Alcoholism (NIAAA)|Dr. Dardo Tomasi|+1 301 496 1589|tomasidg@mail.nih.gov|
21291695|NCT02180828|Peking University|Shangrong Fan|860755-83923333|fanshangrong@163.com|5502
21291696|NCT01276704|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-205-6382|bkimler@kumc.edu|
21291697|NCT03728933|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21291698|NCT03674281|University of Virginia|Sue Brown, MD|434-982-0602|sab2f@virginia.edu|
21291699|NCT01441960|Mass General Hospital|Ala Nozari|978-318-3933|anozari@partners.org|
21291700|NCT02004158|Massachusetts General Hospital|Jeff Huffman|617-724-2910|jhuffman@partners.org|
21291701|NCT00276419|Mayo Clinic|Dr. Robin L. Smith|507-284-1210|smith.robin@mayo.edu|
21291702|NCT03186638|University of Rochester Medical Center, Dept of Surgery, Supportive Care in Cancer|Michelle Janelsins, PhD, MPH|585-276-4656|michelle_janelsins@urmc.rochester.edu|
21291703|NCT03801525|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
21291704|NCT01263119|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21291705|NCT01690273|Universidade Sao Paulo|Andrea Lopes Gallinaro; Researcher|55112601|algallinaro@gmail.com|8022
21291706|NCT05201807|Johnson & Johnson Vision Care, Inc.|John R. Buch-Senior Principal Research Optometrist|1-800-843-2020|jbuch@its.jnj.com|
21291707|NCT05077969|Leidos, Inc.|Tilly Lawrence|703-578-7034|tilly.lawrence@leidos.com|
21291708|NCT01029535|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21291709|NCT02862574|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21291710|NCT01383005|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21291711|NCT02458235|University of California, San Francisco|Dr. Christopher Dvorak, MD|(415) 476-0554|Christopher.Dvorak@ucsf.edu|
21291712|NCT00845702|Guerbet|Pierre Desche, MD, Head of Clinical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
21291713|NCT00030264|Children's Hospital of Philadelphia|Ratnakar Patti|267-426-5503||
21291714|NCT03136055|University of California, San Francisco|Dr. Emily Bergsland|(415) 353-9888|Emily.Bergsland@ucsf.edu|
21291715|NCT00284180|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
21291716|NCT02369536|IRCCS Neuromed|Dr. Chiara Cerletti, operative responsible of the trial and corresponding author of the data public|0865915246|chiara.cerletti@moli-sani.org|
21291717|NCT00822094|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency|(215) 832-3750||
21291718|NCT02243358|Henry Ford Cancer Institute|Dr. Gazala Khan, MD|313-598-2860|gkhan1@hfhs.org|
21291719|NCT01870869|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21291720|NCT02569853|Dr. Reddy's|Director, Clinical Development|609-375-9900|ebrandschieber@drreddys.com|
21291721|NCT00402987|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21291722|NCT00419744|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21291723|NCT00583219|Mayo Clinic|Dr. Steven P. Petrou|904-953-7330|petrou.steven@mayo.edu|
21291724|NCT02037529|Mayo Clinic|Minetta Liu|5072930526|Liu.Minetta@mayo.edu|
21291725|NCT02131766|UVA|Sue Brown, MD|434-982-0602|sab2f@virginia.edu|
21291726|NCT00754572|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21291727|NCT02384421|Stanford University|Dr. Helen Bronte-Stewart, MD, MSE|650-723-6709|bronte-stewart-lab@stanford.edu|
21261522|NCT01494038|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
21261523|NCT05665335|Apyx Medical|Kari Larson, Sr. Director of Clinical Affairs|8012440058|kari.larson@apyxmedical.com|
21291728|NCT00718315|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21261524|NCT00623012|Yale University|Dr. Stuart Seropian|203-737-2477|Stuart.Seropian@yale.edu|
21291729|NCT01874392|Sansum Diabetes Research Institute|Director of Research and Innovation|8056827640|dkerr@sansum.org|
21241589|NCT05805059|Coopervision|Jose A. Vega,OD,MSc,FAAO, PhD|925-621-3761|jvega2@coopervision.com|
21241590|NCT00172185|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21241591|NCT04048135|89bio, Inc.|Clinical Director|1-858-261-8838|bio89-100-002@89bio.com|
21241592|NCT04188288|Yale University|Kathleen Garrison, PhD|203-737-6232|kathleen.garrison@yale.edu|
21241593|NCT02790606|C.R. Bard|Talar Saber, Clinical Project Manager|480-379-2839|talar.saber@crbard.com|
21241594|NCT02735915|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21241595|NCT05328973|M.D. Anderson Cancer Center|Neil Bailard, MD|713-597-1687|nbailard@mdanderson.org|
21241596|NCT04669249|PRO Health Group|Dr. Steven Proctor|305-814-7762|sproctor@prohealthgroup.net|
21241597|NCT03127358|Albert Einstein College of Medicine|Julia Arnsten, MD|718-920-6641|jarnsten@montefiore.org|
21241598|NCT00852475|Baltimore VAMC and University of Maryland Medical Center|Michael Miller, MD|4103286299|mmiller@medicine.umaryland.edu|
21241599|NCT00409708|Novartis Pharmaceuticals|Study Director|862 778-8300||
21241600|NCT00946114|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21241601|NCT01175707|Cubist Pharmaceuticals|Vice President, Clinical Research|781-860-8318||
21241602|NCT00350532|Wake Forest University School of Medicine|Dr. James Eisenach|336-716-4498|jimeisenach@gmail.com|
21241603|NCT03085017|Loma Linda University Health Care|David G. Rabkin, MD FACS|909-558-4354|drabkin@llu.edu|
21241604|NCT00058058|American College of Radiology Imaging Network|Senior Director of Protocol Management||Donna Hartfeil <dhartfeil@acr.org>|
21241605|NCT04337489|Imperial College London|Fahad Iqbal|020 3312 6666|f.iqbal@imperial.ac.uk|
21241606|NCT01579578|AstraZeneca|Dr Serban Ghiorghiu||ClinicalTrialTransparency@astrazeneca.com|
21241607|NCT00335153|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21261525|NCT03952546|Northwell Health System|Nancy Dengler, RN, MS Clinical Research Nurse|516-496-2637|ndengler@northwell.edu|
21261526|NCT00249379|Virginia Commonwealth University|Michael Weaver, MD|804-828-1283|mweaver@mcvh-vcu.edu|
21261527|NCT00685178|Johns Hopkins University|Dr. Annie Umbricht|410-550-1917|annieumbricht@jhu.edu|
21261528|NCT00416351|Memorial Sloan Kettering Cancer Center|Dr. Steven Horowitz MD|646-608-2680|horwitzs@mskcc.org|
21261529|NCT00077623|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21261530|NCT01334125|University of Massachusetts Medical School|Benjamin U. Nwosu, MD|5083347872|Benjamin.Nwosu@umassmemorial.org|
21261531|NCT02412644|Psoriasis Treatment Center of Central New Jersey|Jerry Bagel Director of Clinical Trials|6094434500|dreamacres1@aol.com|
21261532|NCT02836886|Columbia University|Larisa Geskin, MD|2123055550|ljg2145@cumc.columbia.edu|
21261533|NCT02138110|InVivo Therapeutics Corporation|Dr. Rich Toselli|(617) 863-5540|rtoselli@invivotherapeutics.com|
21261534|NCT00844298|Asan Medical Center, University of Ulsan College of Medicine|Dr. Dae-Young Kim|82230105930|dani@amc.seoul.kr|
21261535|NCT00882713|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21261536|NCT04901026|Faculty of Medicine, Prince of Songkla University|Dr Pittayapon Pitathawatchai|+6674451390|pittayapon.p@psu.ac.th|
21261537|NCT00401973|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21261538|NCT03019055|Froedtert Hospital and the Medical College of Wisconsin|Dr. Nirav Shah, MD|414-805-8900|cccto@mcw.edu|
21261539|NCT01092442|CryoLife, Inc.|Scott B. Capps, MS|800-438-8285|clinicaltrialregistration@cryolife.com|
21261540|NCT00708877|University of Utah|Dr. Jason Schwarz|8015852708|jason.schwartz@hsc.utah.edu|
21261541|NCT03159754|University of Michigan|Steven Bruch, MD|7349368464|sbruch@umich.edu|
21261542|NCT00320671|Northwell|Delbert Robinson MD|718.470.8195|drobinson@nshs.edu|
21261543|NCT01335971|Johns Hopkins University School of Medicine|Alexis Rea|(443) 287-8496|area5@jhu.edu|
21261544|NCT05299892|Hearts For Hearing|Sara Neumann, AuD|405-548-4300|sara.neumann@heartsforhearing.org|
21261545|NCT01059812|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21261546|NCT00467844|GTx Inc.|Senior Director, Clinical Operations|901-523-9700|mdesordi@gtxinc.com|
21261547|NCT00149214|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21261548|NCT01538615|University of Minnesota School of Nursing|Dr. Jayne A. Fulkerson|612-624-4823|fulke001@umn.edu|
21261549|NCT01260181|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21261550|NCT03968965|Hospital for Special Surgery|Celeste Abjornson|2127742126|AbjornsonC@HSS.edu|
21261551|NCT02088034|Northwestern University|Matthew J. O'Brien, MD|312-503-5046|matthew.obrien1@northwestern.edu|
21261552|NCT03794986|Yale University, School of Medicine|Dr. Joan Cook|203-856-2782|joan.cook@yale.edu|
21261553|NCT03133481|University of Alabama at Birmingham|Adam Sturdivant|205-934-4042|Adamsturdivant@uabmc.edu|
21261554|NCT02273115|University of Massachusetts - Baystate|Dr. Corina Schoen|4137543470|Corina.SchoenMD@baystatehealth.org|413
21261555|NCT00637728|Endo Pharmaceuticals Inc.|M. Todd Kirby, PhD|(484) 216-6491|kirby.todd@endo.com|
21261556|NCT01873950|U.S. Food and Drug Administration|David G Strauss, MD, PhD|301-796-6323|david.strauss@fda.hhs.gov|
21261557|NCT03894540|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
21261558|NCT03000452|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
21261559|NCT03043365|National Heart Lung and Blood Institute (NHLBI)|Marcelo J. Amar, M.D. Principal Investigator, NIH, NHLBI|301-402-0521|mamar@nhlbi.nih.gov|
21241608|NCT04038099|UT Southwestern Medical Center|Christina Hicks, MS, APRN, WHNP-BC, FAUNA|2146453848|christy.hicks@utsouthwestern.edu|
21241609|NCT03688542|Community Pharmacy, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Switzerland|Dr Anne Niquille|+41213144845|anne.niquille@unisante.ch|
21241610|NCT01034111|Merck, Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21261560|NCT00593112|Massachusetts General Hospital|Paul Hammerness, M.D.|617-503-1040|phammerness@partners.org|
21234379|NCT04652479|Stanford University|Marilyn Tan, MD, FACE|(650) 721-1300|mjtan@stanford.edu|
21234380|NCT00056563|Center for Management of Complex Chronic Care|Frances M. Weaver, Ph.D, Study Investigator|(708) 202-2414|Frances.Weaver@va.gov|
21234381|NCT00978068|University of California, San Francisco|Tamara Clark|415-206-8790|tamara.clark@ucsf.edu|
21279521|NCT01449370|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21279522|NCT00710866|British Columbia Centre for Disease Control|Danuta M Skowronski, MD|604-660-6067|danuta.skowronski@bccdc.ca|
21279523|NCT01357148|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21234382|NCT02469116|Washington University School of Medicine|David G. Mutch, M.D.|314-362-3181|mutchd@wustl.edu|
21234383|NCT01251588|Vericel Corporation|Ann Remmers, Senior Director, Clinical Science|734-428-4526|aremmers@vcel.com|
21234384|NCT04492891|Baylor College of Medicine|Michelle Almarez: Clinical Research Manager|713-798-3680|malmarez@bcm.edu|
21234385|NCT02357147|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21234386|NCT03962543|SpringWorks Therapeutics, Inc.|Head of Clinical Operations|8772794870|clinical@springworkstx.com|
21234387|NCT05535777|UCLA|Principal Investigator|310-206-6328|pszilagyi@mednet.ucla.edu|
21234388|NCT01101841|Noven Therapeutics, LLC|Sailaja Bhaskar, Executive Director, Clinical Research|(212) 287-0798|sbhaskar@noven.com|
21234389|NCT02381392|Harbor-UCLA Medical Center|Kelly D. Young, MD|310-222-3506|kyoung@emedharbor.edu|
21234390|NCT00653224|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
21234391|NCT03756558|Terumo Medical Corporation|Director of Clinical Operations|9085146154|charis.sugden@terumomedical.com|
21234392|NCT02582840|AstraZeneca K.K.|Yu Shimizuishi|81 6 7711 4669|Yu.Shimizuishi@astrazeneca.com|
21234393|NCT00773175|Halozyme Therapeutics|Dimitrios Chondros, M.D., Chief Medical Officer|858-794-8889|dchondros@halozyme.com|
21234394|NCT00503841|Barbara Ann Karmanos Cancer Institute|Dr. Elaina Gartner|313-576-8724|egartner@seagen.com|
21234395|NCT01076985|Abbott|Global Medical Services|800-633-9110||
21234396|NCT03641378|Massachusetts General Hospital|Areej El-Jawahri|617-724-4000|ael-jawahri@mgb.org|
21234397|NCT01982253|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@takeda.com|
21234398|NCT01489969|Neurim Pharmaceuticals (1991) LTD|Amnon Katz|972-3-768-4906|amnonk@neurim.com|
21234399|NCT02789176|University of Michigan|Stephanie Rau|734-232-8474|shatchew@med.umich.edu|
21234400|NCT02223767|Universitätsklinikum Würzburg|Prof. Dr. M Herrmann|093120176650|Herrmann_m@ukw.de|
21234401|NCT02347527|University of Colorado School of Medicine|Dr. Kristina Legget|3037245809|kristina.legget@cuanschutz.edu|
21234402|NCT00192075|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21234403|NCT01857258|The Ohio State University|Richard Bruno, PhD, RD|6142925522|bruno.27@osu.edu|
21279524|NCT00908310|GE Healthcare|Debra Mansfield|609-514-6329|debra.mansfield@ge.com|
21279525|NCT02391987|Mayo Clinic|Charles J. Bruce|904-953-7227|bruce.charles@mayo.edu|
21291730|NCT02271880|Florida International University|Dr. William Pelham|305-348-0477|wpelham@fiu.edu|
21291731|NCT01959685|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
21291732|NCT00474903|Mayo Clinic Rochester|Paul J. Limburg, M.D., M.P.H.||limburg.paul@mayo.edu|
21291733|NCT02735200|Dammam University|Dr Dalal Bubshait|+966505848281|dbubshait@ud.edu.sa|
21291734|NCT01416025|JohnHopkinsU|Dr. Darin Ostrander|(443) 287-6217|dostrander@jhu.edu|
21291735|NCT04856527|University of Cincinnati|Sarah Schwab|5135587477|schwabsr@mail.uc.edu|
21291736|NCT02115321|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21291737|NCT02468583|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
21291738|NCT01463527|Yale University|Dr. Melissa Langhan|203-737-7413|melissa.langhan@yale.edu|
21291739|NCT01493414|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
21291740|NCT04403919|NYU Langone Health|Ran Schwarzkopf, MD|646-501-7070|Ran.Schwarzkopf@nyulangone.org|
21241611|NCT00372970|Temple University|Frank Friedenberg|215-707-9900|frank.friedenberg@temple.edu|
21241612|NCT04880070|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
21241613|NCT00530777|University of Washington|Dr. Carey Farquhar|206-543-4278|cfarq@uw.edu|
21241614|NCT02359058|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21241615|NCT01582243|Novartis Pharmaceuticals|Study Director|862-778-8300||
21241616|NCT01805323|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21241617|NCT02408965|UCSF|Jennifer Kerns|4152068715|Jennifer.kerns@ucsf.edu|
21241618|NCT02096003|Icahn School of Medicine at Mount Sinai|Dr. Yaakov Beilin|212-241-7467|yaakov.beilin@mountsinai.org|
21241619|NCT00980278|University of Michigan School of Dentistry|Dr. William Giannobile, Chair Department of Periodontics and Oral Medicine|734-763-2105|wgiannob@umich.edu|
21241620|NCT01008748|UT MD Anderson Cancer Center - Clinical Research Operations|Dr. Sharon Giordano, MD/Chair, Health Svcs Research-Clinical|713-563-0020|sgiordan@mdanderson.org|
21241621|NCT04833855|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21241622|NCT04654351|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21241623|NCT04824131|HPTN Statistical & Data Management Center|HPTN Statistical Manager|1206-667-4004|HPTN-Data-Access@scharp.org|
21241624|NCT03686384|Laboratorios Salvat, S.A|Medical Director|+34933946400|ejimenez@svt.com|
21241625|NCT03298815|University of Utah|Catherine Lee, MD|206-667-4922|Catherine.Lee@hci.utah.edu|
21241626|NCT00615433|Sunovion Pharmacetuicals Inc.|Josephine Cucchiaro, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
21241627|NCT00783692|Millennium Pharmaceuticals Inc|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
21241628|NCT03750656|University of Kansas Medical Center|Dr. David Duchene|(913) 588-8721|dduchene@kumc.edu|
21241629|NCT03050294|Wake Forest Baptist Health|Steven R. Feldman|336-716-7740|sfeldman@wakehealth.edu|
21241630|NCT00819234|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21241631|NCT01823341|Jaeb Center for Health Research|Judy Sibayan, MPH, CCRP|813-975-8690|jsibayan@jaeb.org|
21241632|NCT03507309|Imperial College Healthcare NHS Trust|Dr Amit Kaura|020 3312 6666|amit.kaura@nhs.net|
21241633|NCT00689104|Astellas Pharma Europe B.V.|Director Medical Science||ClinicalTrials.Disclosure@us.astellas.com|
21241634|NCT01925781|Creighton University|Director of Clinical Trials|402-280-4961|sandrabyers@creighton.edu|
21241635|NCT01155999|Laboratoires Thea|Pascale Pouliquen (Medical director)|0473963614|p.pouliquen@laboratoires-thea.fr|
21241636|NCT00209274|Abbott Vascular Structural Heart (formerly Evalve, Inc.)|Chithra Sangli|650-421-6994|chithra.sangli@av.abbott.com|
21241637|NCT03658629|Novavax Inc.|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
21241638|NCT00604786|Johns Hopkins University|Sarbjit S. Saini|410-550-2129|ssaini@jhmi.edu|
21241639|NCT02081365|Maurice H. Kornberg School of Dentistry, Temple University|Marisol Tellez M. BDS, MPH, Ph.D|215-707-1773|marisol@temple.edu|
21241640|NCT02230579|Medicines for Malaria Venture|Dr Cristina Donini - Associate Director|00 41 22 555 03 12|doninic@mmv.org|
21241641|NCT00062868|Baylor College of Medicine|Dr. Helen E. Heslop|832-824-4662|hheslop@bcm.edu|
21241642|NCT01641861|Khon Kaen University|Dr. Kemporn Kitsahawong|66-910-566-996|kkempo@kku.ac.th|
21241643|NCT03230006|Center for Anxiety and Related Disorders, Boston University|Dr. Todd Farchione|6173539610|tfarchio@bu.edu|
21279526|NCT00246324|LSU Health Sciences Center in Shreveport Department of Neurology|Alireza Minagar, MD|318-813-1481|aminag@lsuhsc.edu|
21279527|NCT03456453|University of Kentucky|Michele Staton|859-312-8245|mstaton@uky.edu|
21279528|NCT00088621|Sunovion|Josephine Cucchiaro, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
21279529|NCT01613313|GerutZ|Dr. Zachary E.Gerut|516 295-2100|Drgerut@drgerut.com|
21279530|NCT03739645|Johns Hopkins University|Fred Lenz|443.287.1609|flenz1@jhmi.edu|
21279531|NCT02551666|Virginia Tech|Professor Michael L. Madigan, PhD|540-231-3543|mlm@vt.edu|
21279532|NCT05573763|Fisher & Paykel Healthcare Ltd|Kelly Tay|+64 9-282-9734|kelly.tay@fphcare.co.nz|5634
21279533|NCT04582149|Emory University|Ofer Sadan, MD, PhD|470-480-6956|ofer.sadan@emory.edu|
21279534|NCT02017015|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
21279535|NCT03102606|BeyondSpring Pharmaceuticals|Ramon Mohanlal|6468491102|rmohanlal@beyondspringpharma.com|
21279536|NCT01277601|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21279537|NCT04021238|UNC Chapel Hill|Director, Clinical Research, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
21291741|NCT03746015|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21241644|NCT01712685|National Cancer Institute|Dr. Adam Metwalli|301-435-6237|metwallia@mail.nih.gov|
21241645|NCT01515319|Imperial College London|Dr Tricia Tan|020 838 38038|t.tan@imperial.ac.uk|
21241646|NCT01449929|GlaxoSmithKline|GSK Response Center|866-435-7343||
21279538|NCT02260570|Department of Veterans Affairs|Andrew Kayser, MD PhD|925-372-2000|Andrew.Kayser@va.gov|
21291742|NCT03648385|Brown University Health, Center for Advanced Lung Care|Corey Ventetuolo, MD|401-444-2733|corey_ventetuolo@brown.edu|
21241647|NCT01919619|M D Anderson Cancer Center|Issa Khouri, MD / Stem Cell Transplantation Department|713-792-8750|ikhouri@mdanderson.org|
21241648|NCT04207255|Medical University of South Carolina|Alan Brisendine|(843) 792-9007|brisend@musc.edu|
21241649|NCT02268396|Pearl Therapeutics Inc|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
21241650|NCT01565538|Sun Yat-sen University Cancer Center|Dr. Si-Yu Wang|020-87343439|wsysums@163.net|
21241651|NCT01304706|Alimera Sciences, Inc.|Kathleen Billman, Senior Director, Scientific Affairs|678-527-1302|kathleen.billman@alimerasciences.com|
21241652|NCT04978363|University of Iowa|Molly Pacha|319-290-7596|molly-pacha@uiowa.edu|
21241653|NCT05080192|University of Pennsylvania|Seavmeiyin Kun|215-917-0115|seavmeiyin.kun@pennmedicine.upenn.edu|
21241654|NCT04094064|University of Virginia Center for Diabetes Technology|Dr. Meaghan Stumpf|(434) 982-4351|MMS5CF@hscmail.mcc.virginia.edu|
21241655|NCT03371108|Gan & Lee Pharmaceuticals USA Corp.|Jia Lu, MD, PhD Executive Director of US Clinical Sciences|+1 888-288-5395|Jia.Lu@ganlee.us|
21241656|NCT00723294|Weill Cornell Medicine|Rache M. Simmons, MD|(212) 821-0870|rms2002@med.cornell.edu|
21241657|NCT01211665|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
21241658|NCT02685293|Pearl Therapeutics Inc.|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
21241659|NCT00498186|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
21241660|NCT04454567|Assembly Biosciences|Executive Director of Clinical Operations|833-509-4583|Clinicaltrials@assemblybio.com|
21241661|NCT02757885|Emory University|Professor of Pediatrics, Dr. Suhag H. Parikh|4047853240|suhag.parikh@emory.edu|
21241662|NCT01456780|Massachusetts Eye and Ear|Dr. Reza Dana|617-573-4431|Reza_Dana@meei.harvard.edu|4431
21241663|NCT00112723|The Ohio State University Comprehensive Cancer Center|Jeffrey Jones, MD|614-293-3507|Jeffrey.Jones@osumc.edu|
21241664|NCT04170764|TriHealth|Dr. Emily Aldrich|513-463-4300|Emily_Aldrich@trihealth.com|
21241665|NCT02688621|University of Vermont|Doris Ogden|802-656-1960|doris.ogden@uvm.edu|
21241666|NCT01501929|University of Texas Southwestern|Wanpen Vongpatanasin|2146482103|Wanpen.Vongpatanasin@UTSouthwestern.edu|
21241667|NCT02359838|Dana-Farber Cancer Institute|Gregory A. Abel|617-632-2304|gregory_abel@dfci.harvard.edu|
21241668|NCT04565249|Pliant Therapeutics, Inc.|Éric Lefebvre, M.D., Chief Medical Officer|1-650-481-6779|ELefebvre@pliantrx.com|
21241669|NCT01996644|Washington University|Cheri Levinson|5023456483|cherialevinson@wustl.edu|
21241670|NCT04760444|University of Michigan School of Social Work|Dr. Jaclynn Hawkins|(734) 647-4072|jachawk@umich.edu|
21241671|NCT05349864|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21241672|NCT02333630|Nationwide Children's Hospital|David Stukus, MD|614 722-4808|david.stukus@nationwidechildrens.org|
21241673|NCT00984282|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21261561|NCT02723630|Eisai Inc.|Eisai Medical Services|1-888-247-2378|esi-medinfo@eisai.com|
21241674|NCT02223793|University of Oslo|Karianne Svendsen|+4795026445|karianne.svendsen@medisin.uio.no|
21241675|NCT00315055|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21241676|NCT01515956|BioMarin Pharmaceutical Inc.|Peter Slasor/Sr Director, Biostatistics, Global Clinical Sciences|415-506-6765|PSlasor@bmrn.com|
21241677|NCT02321540|UT MD Anderson Cancer Center|Dr. John V. Heymach, Chair, Thoracic-Head & Neck Med Onc|(713) 792-6363|jheymach@mdanderson.org|
21241678|NCT03606460|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21241679|NCT00427973|Massachusetts General Hospital Cancer Center|Andrew X. Zhu, MD|617-643-3415|azhu@partners.org|
21241680|NCT05142228|University of Maryland, School of Dentistry|Dr. Marcela Romero Reyes|4107067168|mromero@umaryland.edu|
21241681|NCT04541186|89bio, Inc.|Entrigue Study Team|1-415-432-9270|Ct.gov_SHTG@89bio.com|
21241682|NCT02347943|Acclarent, Inc|Patricia Chen|949-453-6408|pchen126@its.jnj.com|
21241683|NCT01079598|Medtronic|Stephanie Brucato, Principal Clinical Research Specialist|508-261-8000|stephanie.m.brucato@medtronic.com|
21241684|NCT00303303|Carolinas Medical Center|William Kerns II MD Program Directorm Medical Toxicology|704-355-5297|rkerns@carolinas.org|
21241685|NCT00691028|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21241686|NCT00451698|Medical College of Wisconsin|Dr. Steven Zangwill|414-266-2380|szangwill@chw.org|
21241687|NCT01492309|UPenn|Deborah Kim, MD|6107261020|drkim@upenn.edu|
21241688|NCT02596906|Center for BrainHealth, The university of Texas at Dallas|Dr. Namrata Das|9728833266|Namrata.Das@utdallas.edu|
21241689|NCT02680756|Shield Therapeutics|Jackie Mitchell MA DPhil|0044 752 565 6885|jmitchell@shieldtx.com|
21241690|NCT03681691|Wake Forest University Health Science|Christina Hugenschmidt, PhD|336.713.4190|chugensc@wakehealth.edu|
21241691|NCT02334306|MedImmune, LLC|Gabor Illei|+1 240 558 0038 118|information.center@astrazenea.com|
21241692|NCT01687270|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21241693|NCT00465985|Novartis Pharmaceuticals|Study Director|862-778-8300||
21241694|NCT03302156|UW School of Medicine and Public Health|Elizabeth Sadowski, MD|608-263-9028|esadowski@uwhealth.org|
21241695|NCT02390557|Massachusetts General Hospital, Mongan Institute for Health Policy|Lisa I. Iezzoni, MD, MSc|6176430657|liezzoni@mgh.harvard.edu|
21241696|NCT01711918|University of Iowa|Dr. Ron Schey|3193849756|ron-schey@uiowa.edu|
21279539|NCT04034927|NRG Oncology|Christopher Purdy on behalf of Danielle Enserro, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
21241697|NCT03635112|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
21241698|NCT00507208|University of Alabama at Birmingham|William Carroll, MD|205-934-9713|wcarroll@uabmc.edu|
21241699|NCT02002819|UCLA Mary S. Easton Center for Alzheimer's Disease Research|Dr. Keith Vossel|310-794-3665,|neuroeaston@mednet.ucla.edu|
21261562|NCT00537745|PIRE|Patricia Hokanson|505-765-2325|info@bhrcs.org|
21279540|NCT05676814|Wake Forest University Health Sciences|Scott Coleman, DO|336-716-2712|srcolema@wakehealth.edu|
21291743|NCT02303262|SARC|SARC|(734) 930-7600|sarc@sarctrials.org|
21261563|NCT01823653|Solta Medical|Director of Clinical Programs|510-259-5284|aloncaric@solta.com|
21279541|NCT00230178|Sanofi-aventis|International Clinical Development, Clinical Study Director||GV-Contact-us@sanofi-aventis.com|
21234404|NCT00910715|UMC Ljubljana, Department of Infectious Diseases|Dr.Dasa Stupica|+386 1 522 2110|cerar.dasa@gmail.com|
21279542|NCT02652611|U Maryland|Haley Demyanovich|4107063935|hdemyanovich@som.umaryland.edu|
21279543|NCT03577301|Florida State University|Sylvie Naar, PhD; Distinguished Endowed Professor|18506442334|sylvie.naar@med.fsu.edu|
21279544|NCT02252406|University of Florida, Jacksonville|Gladys Velarde, MD|904-244-2060|gladys.velarde@jax.ufl.edu|
21279545|NCT03545893|University of Pennsylvania|Arden McAllister, Research Program Manager|215-662-3532|arden.mcallister@pennmedicine.upenn.edu|
21279546|NCT00794339|ACR|Donna Hartfeil|215-717-2765|dhartfeil@acr.org|
21279547|NCT01109147|Hopital Sainte Marguerite - APHM - Service du Pr. Azorin|Dr. Eric Fakra||eric.fakra@ap-hm.fr|
21279548|NCT02934191|Children's Hospital of Philadelphia|Dr. John Germiller|215-590-3440|germiller@email.chop.edu|
21279549|NCT02952586|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21279550|NCT01931878|Yale University School of Medicine|Bahman Jabbari M.D.|203-737-2464|bahman.jabbari@yale.edu|
21279551|NCT00492778|NRG Oncology|Linda Gedeon for Danielle Enserro, PhD.|7168451169|gedeonl@nrgoncology.org|
21279552|NCT00841828|Department of Medical Oncology, Hospital Universitario Virgen de la Victoria|Dr. Emilio Alba||emilioalbac@gmail.com|
21279553|NCT00362336|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21279554|NCT04974749|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21279555|NCT04414618|RedHill Biopharma Ltd.|Vered Katz Ben-Yair|+13474144462|vered@redhillbio.com|
21279556|NCT00658879|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21279557|NCT01399658|Dana-Farber Cancer Institute|Martin King, MD|617-732-4332|Martin_King@dfci.harvard.edu|
21279558|NCT01277159|HSS|Dr. Yadeau|212.606.1206|YadeauJ@hss.edu|
21279559|NCT00796107|Hoffmann-La Roche, Ltd.|Study Director|888-662-6728 (U.S.)|global-roche-genentech-trials@gene.com|
21279560|NCT04902014|Colorado State University|Dr. Kayla Nuss|9705814824|kayla.nuss@colostate.edu|
21279561|NCT01783912|Center for Tobacco Research and Intervention|Bruce Christiansen|608-262-4087|bc1@ctri.wisc.edu|
21279562|NCT02681510|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|6082627563|sss@ctri.wisc.edu|
21279563|NCT01545518|Emory University|Dr. Charles M. Epstein|404-778-3633|cepstei@emory.edu|
21279564|NCT04315506|Duke University|Devon Noonan|919-684-3786|devon.noonan@duke.edu|
21234405|NCT02412631|Mayo Clinic|Dr. Ryan Hurt|(507) 284-2511|gimresearchstudies@mayo.edu|
21234406|NCT02884089|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21234407|NCT00386256|VA Greater Los Angeles Healthcare System|Nancy Harada, PhD|310-268-3632|Nancy.Harada@va.gov|
21234408|NCT01691027|Kansas City VA Medical center|Health Scientist|816-861-4700|George.Timberlake@va.gov|52755
21234409|NCT05288556|Cleveland Clinic|Eric Yudelevich Blumrosen, MD|216 445-6914|YUDELEE@ccf.org|56914
21234410|NCT02465528|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
21234411|NCT02638298|Medical University of South Carolina|Dr. Leddy|843-876-1119|leddyl@musc.edu|
21234412|NCT01241903|University of Kentucky|Dr. Susan S. Smyth|(859) 323-2274|ssmyt2@uky.edu|
21234413|NCT05040152|The Ohio State University Comprehensive Cancer Center|Xiaochen Zhang|614-293-9600|xiaochen.zhang@osumc.edu|
21234414|NCT03400332|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21234415|NCT01188577|Amphastar Pharmaceuticals, Inc.|Stephen A. Campbell, Esq.|(909) 980-9484|stephenc@amphastar.com|2016
21234416|NCT06138756|Theranica|Dr Dagan Harris|+972-73-3703649|daganh@theranica.com|
21234417|NCT03795610|University of California, San Diego|Dr. Assuntina Sacco|(858) 822-6100|agsacco@health.ucsd.edu|
21234418|NCT02775344|Queen Mary Hospital|Dr Manwa Lui|22554647|ellenlui@hku.hk|
21234419|NCT00235872|Abbott|Global Medical Services|800-633-9110||
21279565|NCT02559180|Cleveland Clinic Foundation|Rishi P Singh|772-223-5945|singhr@ccf.org|13014
21279566|NCT00900822|Institut Straumann AG|Clinial Trial Manager|+41 61 965 11 11|info@straumann.com|
21279567|NCT02661217|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21279568|NCT01778634|University of Maryland|Rose Marie Viscardi, M.D.|410-706-1913|rviscard@som.umaryland.edu|
21234420|NCT02027844|Department of Anesthesiology and Pain medicine, Yeungnam University School of Medicine, Deagu, Repulic of Korea|Sun Mee Jung, M.D.|+82-53-620-3368|applejsm@gmail.com|
21234421|NCT00378014|Novartis Pharmaceuticals|Study Director|862-778-8300||
21234422|NCT00654069|Acura Pharma|Dr. Ron Spivey|847-705-7709|rspivey@acurapharm.com|
21234423|NCT00414661|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21234424|NCT02852265|University of California, Davis|Dr. Melissa Chen|916-734-6670|mejchen@ucdavis.edu|
21234425|NCT02432716|HealthPartners Neuroscience Research|Clinical Trial Manager|651-495-6363|maria.x.pyle@healthpartners.com|
21234426|NCT01054703|Acclarent|Laura England, Manager-Clinical Research|650-687-4466|lenglan1@its.jnj.com|
21234427|NCT00534235|Paradigm Spine|Fran Magee, DVM|212-367-7274|fran.magee@paradigmspine.com|
21234428|NCT00151814|Daiichi Sankyo|Howard Kessler|732-590-5032|hmkessler@dsi.com|
21234429|NCT04370691|Abbott|Vinuta Rau|+ 1 408-834-0621|vinuta.rau@abbott.com|
21234430|NCT03013543|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
21234431|NCT00323414|Cleveland Clinic Foundation|Srinivasan Dasarathy MD|216-444-2766|dasaras@ccf.org|
21234432|NCT02552316|University of Pennsylvania|Junko Takeshita|215-349-5551|Junko.Takeshita@pennmedicine.upenn.edu|
21234433|NCT02614547|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
21234434|NCT04116710|NightHawk Biosciences Inc.|Vice President, Clinical Development|9197948950|barana@nighthawkbio.com|203
21234435|NCT04296396|George Washington University Biostatistics Center|MFMU Principal Investigator|301-881-9260|mfmudatasets@bsc.gwu.edu|
21234436|NCT01246791|Nobelpharma|Department director of clinical development department 1|+81-3-5651-1177|murakami@nobelpharma.co.jp|
21234437|NCT04049760|Amicus Therapeutics, Inc.|Patient Advocacy|001 609-662-2000|clinicaltrials@amicusrx.com|
21234438|NCT00974571|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21234439|NCT02927457|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21234440|NCT00748956|Icahn School of Medicine at Mount Sinai|Dr. Adriana Feder|212-659-9145|adriana.feder@mssm.edu|
21234441|NCT03778931|Stemline Therapeutics, Inc.|Carlos A. Garay, MD, Senior Vice President, Clinical Development & Medical Affairs - Solid Tumors|+1-877-332-7967|clinicaltrials@menarinistemline.com|
21234442|NCT02130765|Abbott|Senior Clinical Research Scientist|6517562885|amber.miller@abbott.com|
21234443|NCT01764607|University of Florida|Priya K Gopalan|352-273-8699|gopalpk@ufl.edu|
21234444|NCT04514991|University of Pennsylvania- Endodontic Department|Dr. Bekir Karabucak|2158984927|bekirk@upenn.edu|
21234445|NCT01495585|National Insitute of DIabetes and Digestive and Kidney Diseases|Dr. Theo Heller|301-402-7147|hellert@mail.nih.gov|
21234446|NCT02603835|TherOx, Inc.|Jeffrey L. Creech, Ph.D.|(949) 225-6587|jcreech@therox.com|
21234447|NCT00717769|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21234448|NCT00692770|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21234449|NCT04327986|National Cancer Institute|Dr. Udo Rudloff|240-760-6238|udo.rudloff@nih.gov|
21234450|NCT02769702|Washington University School of Medicine|Richard Brasington MD|314-454-7255|rbrasing@wustl.edu|
21234451|NCT02917031|AstraZeneca R&D|AstraZeneca R&D|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
21234452|NCT02453113|UC Irvine|Kristen Kelly|949 824 5515|kmkelly@uci.edu|
21234453|NCT02896400|Yale School of Medicine|Steven L. Bernstein, MD|203-737-3574|steven.bernstein@yale.edu|
21234454|NCT02984020|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21234455|NCT01700179|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
21234456|NCT01896895|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
21234457|NCT01207778|University of Utah|Dr. Robin Ohls|505-400-7644|robin.ohls@hsc.utah.edu|
21234458|NCT04015219|BioTissue|Medical Affairs|8882968858|medicalaffairs@biotissue.com|
21234459|NCT00646204|Baylor College of Medicine/Houston Methodist|William G. Ondo, MD|713-363-8930|wondo@houstonmethodist.org|
21234460|NCT05194020|Midwest Evaluation and Research|Dr. Matthew Shepherd|833-643-9377|matt.shepherd@midwestevaluation.com|
21234461|NCT00779675|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21234462|NCT03237234|Shepherd Center|Dr. Edelle C. Field-Fote|404-603-4274|edee.field-fote@shepherd.org|
21234463|NCT01569529|University of Illinois at Chicago, Institute for Health Research and Policy|Dr. Robin Mermelstein|312 996-1469|robinm@uic.edu|
21234464|NCT03427658|Bournemouth University|Dr Katherine Appleton|+441202965985|k.appleton@bournemouth.ac.uk|
21234465|NCT01163604|jinling hospital|xinfeng Liu|025-84801861|xfliu2@vip.163.com|
21234466|NCT04587934|Sharp Healthcare|Dr. Anup Katheria|858-939-4170|Anup.Katheria@sharp.com|
21234467|NCT03097653|Istituto di Ricerche Farmacologiche Mario Negri IRCCS|Dr. Paola Mosconi and Dr. Anna Roberto|+390239014503|donnainformata-mammografia@marionegri.it; paola.mosconi@marionegri.it|
21234468|NCT01633944|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
21234469|NCT01436279|Boston Medical Center|Olivera Vragovic|617 414 7304|Olivera.Vragovic@bmc.org|
21234470|NCT02096458|Takeda Development Center Americas, Inc.|Takeda Study Registration Call Center|800-778-2860|medicalinformation@tpna.com|
21234471|NCT00463060|Good Samaritan Hospital Medical Center|Dr. Johnny Kao|(631) 376-4444|johhny.kao@chsli.org|
21234472|NCT01400841|Biostable Science and Engineering, Inc.|John Wheeler|512-386-1996|John.wheeler@biostable-s-e.com|
21234473|NCT00701129|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21234474|NCT03913078|Milton S. Hershey Medical Center|Christopher Sciamanna, MD, MPH|717-531-4417|csciamanna@pennstatehealth.psu.edu|
21234475|NCT00770120|SWOG Statistical Center|Lung Committee Statistician|206-667-6197|jmoon@fredhutch.org|
21234476|NCT04304001|Florida A&M University|Dr. Tanise Jackson, Director of Animal Welfare Research Integrity|850-599-3214|tanise.jackson@famu.edu|
21234477|NCT03752619|MetroHealth Medical Center|Dr. Richard Wilson|216-957-3623|rwilson@metrohealth.org|
21241700|NCT00463151|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21241701|NCT05349084|Washington University School of Medicine|Dr. Pamela K. Woodard|314-362-7100|woodardp@wustl.edu|
21234478|NCT03907683|The Pennsylvania State University|Dr David E Conroy|814-863-3451|conroy@psu.edu|
21234479|NCT00727714|Telemark Hospital|Dr. Anne Kristin M. Fell, MD, PhD|+4735003106|annfel@sthf.no|
21234480|NCT01265446|Novartis Consumer Health, Nyon, Switzerland|Clinical Project Leader|+41223633279|Rowland.Furcha@novartis.com|
21241702|NCT00972543|Merck Serono S.A., a division of Merck KGaA|Medical Responsible|+49-6151-75-5200|service@merckgroup.com|
21241703|NCT00688688|Astellas Pharma Global Development, Inc.|Medical Director, Global Medical Sciences||ClinicalTrials.Disclosure@us.astellas.com|
21241704|NCT01950260|Mayo Clinic|Dr. Marius N. Stan|507-284-2463|stan.marius@mayo.edu|
21241705|NCT01882062|Inserm U1127|Dr Fanny MOCHEL|+33 (0)1 5727 46 78|fanny.mochel@upmc.fr|
21241706|NCT03283553|Johns Hopkins University|Research Program Manager|410-614-7910|dechava1@jhu.edu|
21241707|NCT03686683|Dendreon Corporation|Director, Clinical Operations|206-455-2476|clinical@dendreon.com|
21241708|NCT04296942|National Cancer Institute|Dr. Fatima H. Karzai|301-480-7174|fatima.karzai@nih.gov|
21241709|NCT03255941|FHI 360|Mario Chen|919 544 7040|mchen@fhi360.org|11399
21241710|NCT02865434|Navidea Biopharmaceuticals|Bonnie Abbruzzzese|6147937500|babbruzzese@navidea.com|
21241711|NCT01770860|Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc.|Associate Director, Clinical Research|973-385-7984||
21241712|NCT05124899|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
21241713|NCT00438971|Rush University|Dr. Mark Pollack|312-942-5372|mark_pollack@rush.edu|
21241714|NCT04034121|Elixir Medical|Candace Elek, Executive Vice President, Clinical Research|408-636-2020|celek@elixirmedical.com|
21241715|NCT00714233|University of Rochester|Kathleen M Hoeger MD MPH|5852757891|Kathy_hoeger@urmc.rochester.edu|
21241716|NCT03432533|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21241717|NCT01648283|Washington University School of Medicine|Evan D. Kharasch, MD, PhD|314-362-8796|kharasch@wustl.edu|
21241718|NCT00821236|Durrie Vision|Brigette Ellis|913-491-3330|bellis@durrievision.com|7255
21241719|NCT03587194|Psoriasis Treatment Center of Central New Jersey|Ashley Reed|6094434500|ashley.reed@schweigerderm.com|
21241720|NCT03163992|Samsung Medical Center|Jeeyun Lee|8223410-1779|jyunlee@skku.edu|
21241721|NCT01104103|The University of Texas Health Science Center at Houston|Dr. Richard Bradley|713-500-7878|Richard.N.Bradley@uth.tmc.edu|
21241722|NCT03382821|University of Utah, Department of Physical Medicine and Rehabilitation|Dr. Zachary McCormick|801-587-5432|PMR.Research@hsc.utah.edu|
21241723|NCT00797225|AbbVie|Global Medical Services|800-633-9110||
21241724|NCT05174065|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21241725|NCT01419717|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21241726|NCT00587288|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21241727|NCT00797862|Novartis Pharmaceuticals|Study Director|862- 778- 8300||
21241728|NCT01743729|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21241729|NCT05074498|Truebinding, Inc|Dongxu Sun|650-847-1117|info@truebinding.com|
21241730|NCT01257503|University of Washington|James A Taylor|206-616-1206|uncjat@uw.edu|
21234481|NCT00486265|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21234482|NCT01452412|Albert Einstein College of Medicine|Michal Melamed, MD|718-430-2496|michal.melamed@einstein.yu.edu|
21234483|NCT05132127|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21234484|NCT04087122|Valley Health|Rebekah Smith, RN, BSN|540-536-5547|rsmith3@valleyhealthlink.com|
21234485|NCT02659020|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21234486|NCT04382911|University of North Carolina at Chapel Hill|Director, Clinical Research, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
21234487|NCT04521166|Northwestern University|Varsha Rallapalli|847-467-0897|varsha8904@gmail.com|
21234488|NCT00577083|Indiana University|Douglas K Rex, MD|317-948-8741|drex@iu.edu|
21234489|NCT01120210|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director Translational Medicine|858.320.3408|wradzisz@its.jnj.com|
21234490|NCT06219915|University of Michigan|Principle Investigator|734-998-8400|pchatkae@umich.edu|
21234491|NCT05320029|Fengh Medical Co., Ltd.|Jiao Liu|13815132106|jiao.liu@fulbrightmed.com|
21234492|NCT06105528|ProMIS Neurosciences, Inc.|Wendy Luca|617-250-0365|promisclinical@promisneurosciences.com|
21234493|NCT01589302|The Ohio State University Comprehensive Cancer Center|Kami Maddocks, MD|614-293-3507|Kami.Maddocks@osumc.edu|
21279569|NCT02075515|GlaxoSmithKline|GSK Response Center|866-435-7343||
21279570|NCT01297985|Center on Mental Health Services Research and Policy, University of Illinois at Chicago, Department of Psychiatry|Dr. Judith A. Cook, Director|312-355-3921|jcook@uic.edu|
21279571|NCT00377832|Weill Cornell Medical College|Daniel W. Skupski, MD|718-670-1495|dwskupsk@med.cornell.edu|
21279572|NCT02032680|VA, University of Pittsburgh|Dr. Armando Rotondi|412-360-2494|ArmandoRotondi1@gmail.com|
21279573|NCT03086486|TB Alliance|Morounfolu Olugbosi|1 212 227 7540|morounfolu.olugbosi@tballiance.org|
21234494|NCT02703636|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
21234495|NCT02561130|McMaster University|Natalia McInnes|905-521-2100|natalia.mcinnes@mcmaster.ca|
21279574|NCT03593395|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
21291744|NCT00934921|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21291745|NCT01143402|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646 888 4162|chapmanp@mskcc.org|
21291746|NCT01734525|Federal University of Rio de Janeiro|Marcio Nucci|5521-39382463|mnucci@hucff.ufrj.br|
21291747|NCT04442893|National Yang Ming University|Chiu-Yueh Yang, Professor|886-2-28267388|cyyang3@ym.edu.tw|8862282673
21291748|NCT02481557|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
21291749|NCT00397540|Seoul National University Hospital Boramae Medical Center|Won Kim|82 2 870 2233|wonshiri@yahoo.com|
21261564|NCT01515072|Rutgers-New Jersey Medical School|Baburao Koneru, MD, MPH|(973) 972-9599|koneruba@njms.rutgers.edu|
21291750|NCT01098422|UC San Diego|Dr. Tony Reid|8583531942|treid@ucsd.edu|
21291751|NCT01968980|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21291752|NCT00776230|Valneva Austria GmbH|Katrin Dubischar-Kastner|+43120620|info@valneva.com|0
21291753|NCT01215851|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|(212) 227-7540|dan.everitt@tballiance.org|
21291754|NCT03949517|Stanford University|Dr. Andrei Iagaru, MD|650-725-4711|aiagaru@stanford.edu|
21291755|NCT01474109|Actelion Pharmaceuticals Ltd|Angelina Marr|+41 61 565 63 69|angelina.marr@actelion.com|
21291756|NCT02589938|Wake Forest NCORP Research Base|Lead Biostatistician (Dr. Emily Dressler)|336-716-0891|NCORP@wakehealth.edu|
21291757|NCT01276106|TWi Biotechnology, Inc.|Medical Director|+886-2-26573350|Carl.Brown@twipharma.com|368
21291758|NCT03078452|Emory University|Dr. Ajay Nooka|404-778-1900|anooka@emory.edu|
21291759|NCT01242514|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
21291760|NCT01082939|The University of Texas MD Anderson Cancer Center|William G. Wierda, MD, PhD, BS / Associate Professor|713-745-0428|eharriso@mdanderson.org|
21291761|NCT00787150|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21291762|NCT01957384|Coloplast A/S|Marian Dyreborg Sinvani, Clinical Manager|+45 4911 2356|dkmards@coloplast.com|
21291763|NCT01121757|Duke University Health Center|Anne Beaven, MD, Associate Professor|9196848964|anne.beaven@duke.edu|
21291764|NCT03773484|University of Southern California|Dr. Jason Doctor|213-821-8142|jdoctor@usc.edu|
21291765|NCT03112902|University of Colorado|Brice McConnell|303-724-3897|brice.mcconnell@cuanschutz.edu|
21291766|NCT02274571|Pennington Biomedical Research Center|Dr. Eric Ravussin|2252844345|eric.ravussin@pbrc.edu|
21291767|NCT05901636|Janssen Research & Development, LLC|Medical Lead|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21291768|NCT05211596|National Center for Deaf Health Research|Steven Barnett, PhD|585-506-9484|steven_barnett@urmc.rochester.edu|
21291769|NCT04532749|Janssen Research & Development, LLC|Executive Director CDTL Neuro|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21291770|NCT04696146|Cedars-Sinai Medical Center|Noriko Ammerman|3102488186|noriko.ammerman@cshs.org|
21291771|NCT01576783|Nationwide Children's Hospital|Dr. Sarah Keim|614-722-3177|Sarah.Keim@nationwidechildrens.org|
21291772|NCT05489328|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21291773|NCT01083602|Novartis Pharmaceuticals|Study Director|862-778-8300||
21291774|NCT01359956|NCI Naples|Paolo A Ascierto, M.D., Ph.D|+39 081 5903431|p.ascierto@istitutotumori.na.it|
21291775|NCT01784029|Children's Hospital at Montefiore|Hina Talib|718-920-6781|htalib@montefiore.org|
21291776|NCT03226418|University of Nebraska Medical Center|Vijaya Bhatt|402-559-5520|IITOffice@unmc.edu|
21291777|NCT02481414|University of Arkansas for Medical Sciences|Matthew Kovak, Director of Clinical Trials|501-686-8274|MRKovak@uams.edu|
21291778|NCT01766102|Massachusetts General Hospital|Michelle Specht, MD|617-726-0340|MSPECHT@mgh.harvard.edu|
21291779|NCT01209767|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
21291780|NCT01161771|Allergan, Inc.|Vice President, Global Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
21291781|NCT00687076|Baylor College of Medicine|Gerd Brunner, PhD|713-790-5800|gbrunner@bcm.edu|
21291782|NCT02410772|Centers for Disease Control and Prevention|Dr. Ekaterina Kurbatova, MD, PhD, MPH|4046392017|ies3@cdc.gov|
21291783|NCT04573972|Carnegie Mellon University|Gretchen Chapman, PhD|4122687380|gchapman@andrew.cmu.edu|
21291784|NCT01517984|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21291785|NCT05067335|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21291786|NCT02724839|Cincinnati Children's Hospital Medical Center|Dr.Kristen Copeland|5136361687|kristen.copeland@cchmc.org|
21291787|NCT01636284|Sillajen Biotherapeutics Inc.|Kyoung Soo Ha, Head of Clinical Development|+1-415-281-8886|ksha@kr.sillajen.com|
21291788|NCT00949533|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21291789|NCT03807089|Massachusetts General Hospital|Dr. Norman Nishioka|617-726-4422|nnishioka@partners.org|
21291790|NCT01948427|Horizon Therapeutics, LLC|Horizon Therapeutics, LLC|866-479-6742|clinicaltrials@horizontherapeutics.com|
21291791|NCT02434081|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki-Voser|+41 31 511 94 18|NICOLAS@etop-eu.org|
21291792|NCT02668666|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
21291793|NCT05528770|Center for Diabetes Technology|Manager of Clinical Research|434-982-0602|mc7m@uvahealth.org|
21291794|NCT03462745|American University of Beirut Medical Center|Dr. Roland Kaddoum|01350000|rk16@aub.edu.lb|6704
21291795|NCT01117779|Boston Scientific|Chantal Laframboise, Clinical Research Manager|613-882-0876|chantal.laframboise@bsci.com|
21291796|NCT02448381|Soligenix, Inc.|Richard Straube, MD/Chief Medical Officer|609-538-8200|rstraube@soligenix.com|
21291797|NCT02519842|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21261565|NCT03700892|University of North Carolina at Chapel Hill, Center for Environmental Medicine Asthma and Lung Biology|Assistant Director of Clinical Research|919 966-5638|robinet@med.unc.edu|
21291798|NCT00744861|Bioventus LLC|Manager Clinical Affairs|1-800-396-4325||
21241731|NCT00367237|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21241732|NCT02359435|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
21241733|NCT02584790|Pamela Youde Nethersole Eastern Hospital|Dr Wong Kai Chuen|(852) 64600771|wkc568@ha.org.hk|
21241734|NCT04878172|Cynosure|Jamie Trimper|9788776342|jamie.trimper@cynosure.com|
21241735|NCT01528709|Lynn Heart and Vascular Institute, Boca Raton Regional Hospital|Dr. Alexander Kulik|5619556300|alex_kulik@yahoo.com|
21241736|NCT01237678|ImmunoGen Inc.|Dr. Richard Bates, Sr. Manager, Publications|781 895 0196|Richard.Bates@immunogen.com|
21241737|NCT03398356|Wroclaw Medical University|Dr Edyta Sutkowska|+48/503077016|edytasutkowska@yahoo.com|
21241738|NCT01982760|Case School of Medicine|Dr. Bahman Guyuron|440-461-7999|bguyuron@guyuron.com|
21241739|NCT00282438|Northwestern University|Dr Richard Burt, Chief, Division of Immunotherapy, Department of Medicine|312-695-4960|rburt@northwestern.edu|
21241740|NCT02397889|Icahn School of Medicine at Mount Sinai|Adriana Feder|212-659-9279|adriana.feder@mssm.edu|
21241741|NCT00875641|GlaxoSmithKline|GSK Response Center|866-435-7343||
21241742|NCT04500821|Johnson & Johnson Surgical Vision|Luis Vargas, MD|714-247-8200|LVarga17@ITS.JNJ.com|
21241743|NCT02954055|ETOP IBCSG Partners Foundation|Dr. Heidi Roschitzki, PhD|+41 31 511 94 00|heidi.roschitzki@etop.ibcsg.org|
21241744|NCT00587132|Mayo Clinic|Dr. Naoki Takahashi|507-284-7249|takahashi.naoki@mayo.edu|
21241745|NCT01119703|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21241746|NCT01511250|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21241747|NCT01763047|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, OD., M.S., F.A.A.O- Senior Principal Research Optometrist|904-443-3500|TKarkkai@its.jnj.com|3402
21241748|NCT01112735|Baxter Healthcare Corporation|Clinical Trials Disclosure Group|734-646-8214|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
21241749|NCT02148809|HospitalSS|Dr. Friedrich Boettner|2127742127|boettnerf@HSS.edu|
21241750|NCT01366196|Hss|Dr. Michael Urban|(212) 606-1000|UrbanM@hss.edu|
21241751|NCT01941316|Cancer Research and Biostatistics|Director of Quality and Regulatory Compliance|206-839-1782|lisau@crab.org|
21241752|NCT02775435|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21241753|NCT02282527|Grifols Therapeutics Inc.|Henry Li|1-919-316-6042|henry.li@grifols.com|
21241754|NCT00941031|Novartis Pharmaceuticals|Study Director|862-778-8300||
21241755|NCT00100659|Johns Hopkins University School of Medicine|Kathleen B. Schwarz, M.D.|410-955-8769|kschwarz@jhmi.edu|
21241756|NCT04555044|Organization: Baxter Healthcare|Name/Official Title: Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
21241757|NCT01675830|Boston Children's Hospital|Karen Sakakeeny|617-355-6369|Karen.Sakakeeny@childrens.harvard.edu|
21241758|NCT00631917|Novartis Pharmaceuticals|Study Director|862-778-8300||
21241759|NCT02783950|University of Michigan|Todd Morgan, MD|734-647-8902|tomorgan@med.umich.edu|
21241760|NCT01767909|Wake Forest School of Medicine|Suzanne Craft, PhD, Project Director for Clinical Trial|(336) 713-8830|suzcraft@wakehealth.edu|
21241761|NCT04348370|Texas A&M University College of Medicine|Jeffrey D. Cirillo|979-436-0343|jdcirillo@tamu.edu|
21241762|NCT03163511|Vertex Pharmaceuticals, Inc|Gautham Marigowda|617-961-0568|gautham_marigowda@vrtx.com|
21241763|NCT04001114|University of Maryland|Britta Hahn, Ph.D.|410-402-6112|bhahn@som.umaryland.edu|
21261566|NCT00849212|Eisai Call Center|Eisai Inc.|888-422-4743||
21279575|NCT02806024|University of Washington|Mallory Kremer|206.616.5258|mkremer@uw.edu|
21279576|NCT00295061|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
21279577|NCT00626561|University of Texas MD Anderson Cancer Center|Michael M. Frumovitz, MD / Professor, Gynecologic Oncology|713-792-9599|CR_Study_Registration@mdanderson.org|
21279578|NCT01598194|UT MD Anderson Cancer Center|Weston,Brian,MD / Gastroenterology Hepatology & Nutrition|713-792-7734|BWESTON@MDANDERSON.ORG|
21279579|NCT01372748|University of Washington, Resuscitation Outcomes Consortium|Dr. Susanne May|206-685-1302|rochelp@uwctc.org|
21279580|NCT00134901|New York State Psychiatric Institute|Dr Adam Bisaga|(646) 774-6155|bisagaa@nyspi.columbia.edu|
21279581|NCT00606632|Heidelberg Pharma AG (former Wilex AG)|Head of R&D||info@hdpharma.com|
21279582|NCT03908437|University of Pennsylvania, Dpt of Psychiatry, Perelman School of Medicine|Dr. David Metzger, Research Professor, Director of HIV Prevention Research Unit|215-746-7355|dsm@pennmedicine.upenn.edu|
21279583|NCT03633825|Harvard University|Principal Investigator|617-496-4484|jaroszewski@fas.harvard.edu|
21279584|NCT05246670|Geisinger Medical Center|Mellar P. Davis, MD, FCCP, FAAHPM|570-271-7383|mdavis2@geisinger.edu|
21279585|NCT03837743|DURECT Corporation|Executive Director of Regulatory Affairs|408-777-1829|jill.burns@durect.com|
21279586|NCT01822366|University of Washington|Dr. Shannon Dorsey|(206) 543-4527|dorsey2@uw.edu|
21234496|NCT04688164|Relmada Therapeutics|Marco Pappagallo, MD|786-638-7384|info@relmada.com|
21234497|NCT03985813|University of Pittsburgh|Oliver Lindhiem|4122465909|lindhiemoj@upmc.edu|
21234498|NCT03463889|University of California, San Francisco|Dr. Robert Flavell, MD PhD|877-827-3222|Robert.Flavell@ucsf.edu|
21234499|NCT02151526|bluebird bio, Inc.|Study Medical Director|339-499-9300|medinfo@bluebirdbio.com|
21234500|NCT00627679|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|(650) 386-3100|dkellerman@mappharma.com|
21234501|NCT00409292|Dana-Farber Cancer Institute|Brian Wolpin, MD|617-632-3000|brian_wolpin@dfci.harvard.edu|
21234502|NCT04865432|Boston University Chobanian & Avedisian School of Medicine|Michael F. Holick PhD, MD|617-358-6139|mfholick@bu.edu|
21234503|NCT01554618|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21234504|NCT00477672|ACADIA Pharmaceuticals Inc.|Roger Mills, MD|858-202-7563|rmills@acadia-pharm.com|
21234505|NCT02275481|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
21234506|NCT01215227|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21291799|NCT02493764|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21234507|NCT01393405|University of North Carolina, Chapel Hill, NC|Dr. Hans Herfarth|9199666806|hherf@med.unc.edu|
21234508|NCT00739752|Indiana University|Dr. Gregory Zimet|317-274-8812|gzimet@iu.edu|
21241764|NCT03057132|Cancer Treatment Centers of America|Joseph Rudolph, BSN, RN, CWOCN, DWC|(215) 537-4678|Joe.Rudolph@ctca-hope.com|
21241765|NCT04436029|Cartesian Therapeutics|Chief Medical Officer|(301) 348-8698|trials@cartesiantx.com|
21241766|NCT02696785|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21241767|NCT03486197|University of Washington/Fred Hutch Cancer Center Proton Therapy|Dr. Jing Zeng|2065984110|jzeng13@uw.edu|
21241768|NCT01016353|KCI|Senior Director, Global Clinical Development|(210) 255-5595|jane.hart@kci1.com|
21241769|NCT04863898|RTI International|Laura Nyblade, Fellow|202-728-1961|lnyblade@rti.org|
21241770|NCT00614744|Brown University, Women & Infants Hospital of Rhode Island|Abbot Laptook|401-274-1122|alaptook@wihri.org|47421
21241771|NCT02431533|Pharmabiotix, Inc|Mark Cobb|214-327-4712|cobbcoinc@aol.com|
21241772|NCT02303743|Hospital Germans Trias i Pujol|Dr. Vicente Lorenzo-Zúñiga García|+34-934978866|vlorenzo.germanstrias@gencat.cat|8443
21241773|NCT00235495|University of Miami|Dr. Myron D. Ginsberg|305-243-6103|MGinsberg@med.miami.edu|
21241774|NCT02320253|MGH Diabetes Center|Dr. Deborah J. Wexler|617-726-8767|dwexler@mgh.harvard.edu|
21241775|NCT05051540|University of Miami|Hadar Lev-Tov, MD|305-243-1953|hlevtov@med.miami.edu|
21241776|NCT05780047|Million Marker Wellness, Inc.|Carol Kwiatkowski, VP of Research|510-305-5690|carol@millionmarker.com|
21241777|NCT03109015|Duke University|Michael Harrison, MD|919-668-8108|michael.harrison@duke.edu|
21241778|NCT03194776|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21241779|NCT02963597|Albert Einstein Healthcare Network|Dr Sunil Sharma|2154566950|sharmasu@einstein.edu|
21241780|NCT00336232|Tufts University|Sarah Booth, PhD|617-556-3231|sarah.booth@tufts.edu|
21241781|NCT04783415|City of Hope Medical Center|Dr. Alexey Danilov|626-359-8111|adanilov@coh.org|
21241782|NCT03115346|VA Hospital|Dr. Mark Eid|502-295-8961|mark.a.eid01@gmail.com|
21241783|NCT04816526|Cartesian Therapeutics|Dr. Milos Miljkovic, Chief Medical Officer|4436335855|milos@cartesiantx.com|
21241784|NCT01737268|Astellas Pharma Inc.|Vice-President, Japan-Asia Clinical Development Administration|+81-3-3244-0512|Astellas.resultsdisclosure@astellas.com|
21241785|NCT02753530|Zevra Denmark A/S|Medical Affairs|+1-888-289-5607|medicalaffairs@zevra.com|
21241786|NCT01221181|Columbia University Medical Center|Andrew Bomback, MD, MPH|212-305-0320|asb68@cumc.columbia.edu|
21241787|NCT03369951|Northwestern University of Feinberg School of Medicine|Richard G. Wunderink, MD|312-695-1878|r-wunderink@northwestern.edu|
21241788|NCT02141581|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
21241789|NCT05579886|CooperVision Inc.|José A. Vega OD, MSc, FAAO, PhD|19256213761|javega@coopervision.com|
21241790|NCT04580407|Director|Study|+1-877-825-3327|TrialDisclosures@takeda.com|
21241791|NCT04949399|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21241792|NCT00670540|University Hospital Grenoble|Jean-Luc Bosson|33 4 76 76 50 40|jean-luc.bosson@imag.fr|
21241793|NCT01866917|Montefiore Medical Center|Ja Hyun Shin|718-920-5157|JASHIN@montefiore.org|
21241794|NCT01245413|Lægehuset, Skodsborg Strandvej 125A, 2942 Skodsborg, Denmark|Dr. Claus Hyldahl|4545801331|hyldahl@info.dk|
21241795|NCT02530151|Northwestern University|Michael Terry, MD|312-472-6488|mterry@nm.org|
21241796|NCT01374490|Bausch Health|Study Director||susan.harris@bauschhealth.com|
21241797|NCT01311648|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
21241798|NCT01645111|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|Joseph.Tobias@nationwidechildrens.org|
21241799|NCT05526911|TB Alliance|Antonio Lombardi|917.601.0024|antonio.lombardi-consultant@tballiance.org|
21241800|NCT05025449|Emory University|Laura Oh, MD|404-778-1709|laura.oh@emory.edu|
21241801|NCT02165605|UT Southwestern Medical Center|Sarmistha Sen|214-645-1477|Sarmistha.Sen@UTSouthwestern.edu|
21241802|NCT00762463|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21241803|NCT00531479|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21241804|NCT01240356|The University of Texas Health Science Center at Houston|James C. Grotta, MD|+1 (713) 500-7088|james.c.grotta@uth.tmc.edu|
21241805|NCT01677936|Louisville Metabolic and Atherosclerosis Research Center|Kathy Schmitz RN|502.515.5672|kschmitz@lmarc.com|
21234509|NCT02281552|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21234510|NCT01224639|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21234511|NCT04656132|NYU Rory Meyers College of Nursing|Margaret M. McCarthy, PhD, RN, FNP-BC|212-992-5796|mmm529@nyu.edu|
21234512|NCT04365699|NYU Langone Health|Stuart Katz, MD|212-263-3946|Stuart.Katz@nyulangone.org|
21234513|NCT03761732|University of Washington|Lori Zoellner|206 685 3617|ContactUWCATS@uw.edu|
21234514|NCT03925727|Mimetogen Pharmaceuticals|VP Clinical Development|514 924 7484|karen.meerovitch@mimetogen.com|
21234515|NCT02581384|Dana-Farber Cancer Institute|Karen Marcus MD|16177328783|karen_marcus@dfci.harvard.edu|
21234516|NCT02321462|Ipsen Pharma|Medical Director||clinical.trials@ipsen.com|
21234517|NCT04425746|CLINUVEL PHARMACEUTICALS LTD|Clinical Operations Manager||mail@clinuvel.com|
21234518|NCT01183169|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
21234519|NCT01514396|Medline Industries, Inc.|Ed Drower|847-643-3874|edrower@medline.com|
21234520|NCT03044197|UTexasGalveston|Lori Simon|409-772-1978|lasimon@utmb.edu|
21234521|NCT00834912|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
21234522|NCT00624806|Center of Innovation for Complex Chronic Health Care|Marylou Guihan, PhD|708-202-2414|marylou.guihan@va.gov|
21241806|NCT00887640|Duke University Medical Center|Dr. Andrew Armstrong|919-668-8108|andrew.armstrong@dm.duke.edu|
21241807|NCT03379740|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
21241808|NCT03837028|bakirkoy dr sadi konuk training and research hospital|Ismail Alay|+905462375638|dr_ismailalay@hotmail.com|
21241809|NCT00157014|Astellas Pharma Canada, Inc|Associate Director, Scientific Affairs||clinicaltrials@us.astellas.com|
21241810|NCT01362491|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21241811|NCT04867902|Massachusetts General Hospital|Dr. Emily Feig|617-724-9140|efeig@mgh.harvard.edu|
21241812|NCT02213900|Indiana University|Babar Khan, MD|317-274-9132|bakhan@iu.edu|
21241813|NCT00088465|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21241814|NCT00448864|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
21241815|NCT01390857|GlaxoSmithKline|GSK Response Center|866-435-7343||
21241816|NCT02485964|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|bscanlan@uams.edu|
21241817|NCT01474538|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21241818|NCT02501629|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21241819|NCT02004613|Cleveland Clinic Foundation|Dr. Alparslan Turan|216-445-9857|turana@ccf.org|
21241820|NCT03120676|Memorial Sloan Kettering Cancer Center|Dr. Anas Younes, MD|212-639-5059|younesa@mskcc.org|
21241821|NCT02933320|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
21241822|NCT00886613|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21241823|NCT00496379|Dana-Farber Cancer Institute|Dr. Nancy Lin|617-632-2335|nlin@partners.org|
21241824|NCT00623506|Durham VA Medical Center|Christine E. Marx, MD|919 286-0411|marx0001@mc.duke.edu|7426
21279587|NCT05199090|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21241825|NCT01289119|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21241826|NCT01704846|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21241827|NCT02912195|Alameda Health System|Andrew Herring|510 437-8356|aherring@alamedahealthsystem.org|
21241828|NCT00530335|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21241829|NCT01244984|GlaxoSmithKline|GSK Response Center|866-435-7343||
21241830|NCT03647475|Medtronic Coronary/Renal Denervation (C/RDN)|Cecile Mahoney, Sr. Clinical Research Specialist|763-505-1057|cecile.c.mahoney@medtronic.com|
21241831|NCT04577183|RedDress Medical|Clinical Trial Manager|1-800-674-9615|alon@reddress.co.il|
21241832|NCT00672256|Duke University Medical Center|Joseph McClernon|919-668-3987|mccle011@mc.duke.edu|
21241833|NCT02321748|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
21241834|NCT01360840|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21241835|NCT02446223|Cosmetic Laser Dermatology/West Dermatology Research|Clinical Research Coordinator|858 657 1004|IGuiha@CLderm.com|
21241836|NCT00920686|NeurAxon, Inc|Thomas Lategan, PhD|417 673 6697|tlategan@neuraxon.com|
21241837|NCT03006341|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21241838|NCT00293462|University of California, San Francisco|Marylin J. Dodd, RN, PhD, FAAN|415-476-2191|Marylin.dodd@ucsf.edu|
21241839|NCT02950545|University of Virginia|Principal Investigator|434-924-8021|djc4f@virginia.edu|
21241840|NCT00372060|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21241841|NCT01004263|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21241842|NCT02341534|BIOTRONIK SE & Co. KG|Sascha Mrosk, Senior Clinical Project Manager|15168901308|sascha.mrosk@biotronik.com|0049
21241843|NCT01258387|Acorda Therapeutics, Inc.|Anthony Caggiano, MD, PhD|914-347-4300|tcaggiano@acorda.com|5150
21241844|NCT05064761|Galderma Research and Development, LLC (GLLC)|Clinical Project Manager|+1 817-961-5000|aestheticclinicaltrials@galderma.com|
21241845|NCT01516892|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21241846|NCT04794179|University of Utah Healthcare|Richard Gurgel MD, PI|801-585-1626|Richard.Gurgel@hsc.utah.edu|
21279588|NCT03489109|Clinical Center|Hadigan, Colleen|+1 301 594 5754|hadiganc@nih.gov|
21279589|NCT00767624|STANFORD UNIVERSITY|Rachel Manber, PhD|6504981266|rmanber@stanford.edu|
21279590|NCT04868968|Novartis Pharmaceuticals|Study Director|+1 862-778-8300|novartis.email@novartis.com|
21279591|NCT00384930|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21279592|NCT03431493|Johns Hopkins University|Ann Parker, MD, PhD|443-287-2616|aparke36@jhu.edu|
21279593|NCT02552732|Fisher and Paykel Healthcare|Dr Stanislav Tatkov|09 5740100|stanislav.tatkov@fphcare.co.nz|
21279594|NCT02686138|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
21279595|NCT01547130|Wyckoff Heights Medical Center|Dr Vijaypal Arya|718-326-0400|varyamd@yahoo.com|
21279596|NCT01178216|Cedars-Sinai Medical Center|Noriko Ammerman, PharmD|3102488186|noriko.ammerman@cshs.org|
21279597|NCT00025259|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21279598|NCT01685840|Duke University Health System|G. Michael Felker, M.D.|919-668-8919|michael.felker@duke.edu|
21279599|NCT01004003|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21279600|NCT01462812|OptiNose|Sr. Director of Clinical Development|(267) 364-3620|jennifer.carothers@optinose.com|
21279601|NCT02521376|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21279602|NCT00676780|LSUShreveport|Dr. Jerry W. McLarty, Ph.D.|(318)813-1446|jmclar@lsuhsc.edu|
21279603|NCT01374269|Grupo Rehabilitacion en Salud|Dr. Fabio Salinas Duran|5742196475|fabios@une.net.co|
21279604|NCT01987479|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21279605|NCT01954745|Massachusetts General Hospital Cancer Center|Dr. Lipika Goyal|617-724-4000|Lgoyal@partners.org|
21241847|NCT01096056|GlaxoSmithKline|GSK Response Center|866-435-7343||
21241848|NCT03568162|Ichnos Sciences SA|Ichnos Sciences Clinical Trials Administrator|315-583-1249|clinicaltrials@ichnossciences.com|
21241849|NCT01110174|PI has left the institution, all efforts to locate PI have been exhausted.|PI has left the institution, all efforts to locate PI have been exhausted.||steve.martinez@ucdmc.ucdavis.edu|
21241850|NCT00768066|The EMMES Corporation|Adam Mendizabal, Biostatistician|301-251-1161|amendizabal@emmes.com|221
21241851|NCT04831775|The University of Texas at Austin|Dr. Heather Cuevas|5124226059|hcuevas@mail.nur.utexas.edu|
21241852|NCT00337818|GlaxoSmithKline|GSK Response Center|866-435-7343||
21241853|NCT03590743|Mayo Clinic|Robert D. McBane, II M.D.|507-266-3964|mcbane.robert@mayo.edu|
21241854|NCT02696226|Cleveland Clinic|Dr. Douglas Johnston|216-444-5613|JOHNSTD3@ccf.org|
21241855|NCT01190176|GlaxoSmithKline|GSK Response Center|866-435-7343|pr266560@gsk.com|
21241856|NCT02909101|Duke University School of Medicine|Dr. Sheri Towe|919-668-4030|sheri.towe@duke.edu|
21241857|NCT02189863|Alcon Research, Ltd.|Global Brand Lead, Global Medical Affairs, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21241858|NCT03697460|Mayo Clinic|Aaron R. Mangold, M.D.|480-301-6479|Mangold.Aaron@mayo.edu|
21241859|NCT00429793|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
21241860|NCT00365417|NSABP Foundation, Inc.|Diana Gosik|412-339-5333|diana.gosik@nsabp.org|
21241861|NCT01324882|UConn Health Center|Joseph Anderson|8022959362|joseph.anderson@dartmouth.edu|6003
21241862|NCT02414828|Aeras|Ann Ginsberg, Chief Medical Officer|301-547-2912|aginsberg@aeras.org|
21241863|NCT02376933|University of Arizona Cancer Center|Program Coordinator|520-626-0301|aselegue@email.arizona.edu|
21241864|NCT01779375|George Washington University Biostatistics Center|Sharon Edelstein|3018819260|sharone@bsc.gwu.edu|
21241865|NCT00389519|King Pharmaceuticals, Inc.|Professional Information Services|1-800-776-3637||
21241866|NCT01140347|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21241867|NCT01959880|Mentor|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
21241868|NCT04155424|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
21241869|NCT05968079|Masimo|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
21241870|NCT01721564|Royal Prince Alfred Hospital, Sydney, Australia|Prof David Celermajer|+61 2 9515 6519|david.celermajer@email.cs.nsw.gov.au|
21241871|NCT01801930|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21241872|NCT02072226|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21241873|NCT00360126|GlaxoSmithKline|GSK Response Center|866-435-7343||
21241874|NCT03255018|National Cancer Institute|Dr. Mark J. Roschewski|240-760-6183|mark.roschewski@nih.gov|
21241875|NCT00810303|Department of Clinical Pharmacology|Danilo Wegner|+4903834865640|dwegner@uni-greifswald.de|
21241876|NCT01720043|Huntsman Cancer Institute|Kimberlee Taylor|8012135673|Kimberlee.Taylor@hci.utah.edu|
21241877|NCT01688973|City of Hope National Medical Center|Przemyslaw W. Twardowski, MD|626-256-4673|ptwardowski@coh.org|68218
21241878|NCT01124162|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21241879|NCT02022462|University of Southern California|Dr. John Brekke|213-740-0297|brekke@usc.edu|
21241880|NCT01702896|Western Regional Medical Center|Jessica L. Coats|623-207-3899|jessica.coats@ctca-hope.com|
21241881|NCT04371536|Baylor College of Medicine|Dr. Jacquelyn Powers|832-824-7330|jmpowers@txch.org|
21241882|NCT03613129|Bateman Horne Center|Lucinda Bateman, MD|(801) 359-7400|LBateman@batemanhornecenter.org|
21241883|NCT02534896|SPARC|Dr Mudgal Kothekar|912266455645|clinical.trials@sparcmail.com|
21241884|NCT02796092|GITMI (University of Zaragoza)|Prof. Alicia Laborda|0034 976 76 15 49|alaborda@unizar.es|
21241885|NCT00711646|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
21241886|NCT03441360|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
21241887|NCT00269399|Bausch Health Americas, Inc.|Director of Clinical Operations|908-927-0873|lindsey.mathew@bauschhealth.com|
21241888|NCT03439124|Basilea Pharmaceutica International Ltd.|Project Physician|+41 79 701 0551|marc.engelhardt@basilea.com|
21241889|NCT04353037|UnitedHealth Group R&D / Optum Labs|Mike Lahm, Director Data Science|302-379-0209|MichaelLahm@uhg.com|
21241890|NCT02749045|University of Pittsburgh Medical Center|Prem Soman, MD, PhD|412 647 3435|somanp@upmc.edu|
21241891|NCT03101592|David Geffen School of Medicine at UCLA|Dr. Risa Hoffman, MD, MPH; Director of GHP; Associate Professor of Clinical Medicine|310 825-7225|rhoffman@mednet.ucla.edu|
21241892|NCT00647348|University of London|Professor Jeremy Chataway, Chief Investigator|07974752295|j.chataway@ucl.ac.uk|
21241893|NCT01125202|New York University School of Medicine|Mary Ann Sevick, ScD|6465012621|mary.sevick@nyumc.org|646
21241894|NCT02775617|London School of Hygiene and Tropical Medicine|Dr Michael Marks|02079272566|michael.marks@lshtm.ac.uk|
21241895|NCT03404609|Stanford University|Dr. Carolyn Rodriguez|650-723-6158|cr2163@stanford.edu|
21241896|NCT02219490|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21241897|NCT01454362|Queen Mary University of London|Dr Hayden McRobbie|0207 882 7260|researchamendments@bartsandthelondon.nhs.uk|
21241898|NCT02419521|Medtronic Coronary Structual Heart|Beth Moe, Clinical Study Manager||beth.moe@medtronic.com|
21241899|NCT01928940|GlaxoSmithKline|GSK Response Center|866-435-7343||
21261567|NCT04407507|Investigacion Biomedica para el Desarrollo de Fármacos S.A. de C.V|Carmen de la Rocha|523320028697|carmen.delarocha@investigacionbiomedica.com.mx|306
21291800|NCT01561976|GlaxoSmithKline|GSK Response Center|866-435-7343||
21291801|NCT02610634|Newcastle University|Professor Lynn Rochester|0191 208 1291|lynn.rochester@ncl.ac.uk|
21291802|NCT03443635|Tulane University Goldring Center for Culinary Medicine|Principal Investigator|3373290724|dominique.monlezun@gmail.com|
21241900|NCT01363479|Helsinn Healthcare SA|Marco Palmas MD, Head of Clinical Development|+41919852121|marco.palmas@helsinn.com|
21241901|NCT01352507|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21279606|NCT03764618|Rigel Pharmaceuticals, Inc.|Executive Director, Global Clinical Operations|(650) 624-1100|clinicaltrials@rigel.com|
21279607|NCT03654599|Arizona State University|Dr. Sunny Kim|602-496-6789|Sunny.Kim@asu.edu|
21291803|NCT01072526|University of Missouri|Lenworth Johnson, MD|573-882-8473|JohnsonLN@health.missouri.edu|
21291804|NCT01977222|Boston Children's Hospital|Dr. Fred Wu|6173556508|fred.wu@cardio.chboston.org|
21291806|NCT04319809|Minnesota HealthSolutions|Sara Seifert, President|6128036998|sara@minnhealth.com|
21291807|NCT01605669|Naval Medical Center San Deigo|LCDR William Bennett MD FACC|619-532-7400|william.bennett5@med.navy.mil|
21291808|NCT04846231|Cleveland Clinic|Luke Laffin, MD|216-372-4315|Laffinl@ccf.org|
21291809|NCT02980107|University of Split School of Medicine|Ivan Buljan|+385989027209|ibuljan@mefst.hr|
21291810|NCT02412670|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21291811|NCT03781479|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|3054203200|gingenito@catalystpharma.com|
21291812|NCT01728246|Janssen Pharmaceutica|Medical Affairs Manager|+632-8247901||
21291813|NCT05805150|CooperVision|Jose Vega|925-621-3761|jvega2@coopervision.com|
21291814|NCT03139721|Medtronic|Jessica Halverson, Clinical Research Director|763-514-9756|rs.CSHHAMMOCKPAS@medtronic.com|
21291815|NCT00538850|Insys Therapeutics, Inc.|Larry Dillaha, M.D., Chief Medical Officer|602 910-2617|ldillaha@insysrx.com|
21291816|NCT04138056|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21234523|NCT01574352|USouthernDenmark|professor Lars Bo Andersen|+45 60114380|lars.bo.andersen@hvl.no|
21234524|NCT06425458|Unity Health Toronto|Dr. Naomi Thulien|(416) 864-6060|naomi.thulien@unityhealth.to|77476
21241902|NCT03178201|Columbia University|Ana Ignat|212-305-3612|ai2111@cumc.columbia.edu|
21241903|NCT04668144|University of Florida College of Medicine Jacksonville|Francesco Franchi, MD|904244206|francesco.franchi@jax.ufl.edu|
21241904|NCT03999944|FRESCA Medical|Vice President, RA/CA/QA|949-542-3535|mlmooney@frescamed.com|
21241905|NCT00884611|Stanford University|Dr. Bruce Buckingham, MD||buckingham@stanford.edu|
21241906|NCT02095158|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21241907|NCT00320489|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21241908|NCT05457842|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|8008887704|astellas.resultsdisclosure@astellas.com|
21241909|NCT01872611|Alcon Research, Ltd.|Therapeutic Unit Head, Cornea and Inflammation|1-888-451-3937|alcon.medinfo@alcon.com|
21241910|NCT03441984|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21241911|NCT02280655|Emory University|Dr. John D. Roback|404-712-1774|jroback@emory.edu|
21241912|NCT00883350|Pennington Biomedical Research Center|Corby Martin|763-2585|corby.martin@pbrc.edu|
21241913|NCT03537651|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21241914|NCT01835899|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21261568|NCT01499576|Konyang University Hospital|Dr. Kyung Ho SONG, Assistnat Professor of Konyang University||postit2@daum.net, postit@kyuh.ac.kr|
21261569|NCT02334267|Frenova Renal Research|Brigid Flanagan, MS, RN, CCRC|781-699-2970|Brigid.Flanagan@frenovarenalresearch.com|
21261570|NCT03396471|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
21261571|NCT00923091|Daiichi Sankyo Europe, GmbH|Bettina Ammentorp|00498978080|bettina.ammentorp@daiichi-sankyo.eu|
21261572|NCT02796144|University of North Carolina at Chapel Hill|Lars Fredrik Jarskog, MD|919-843-7683|lars_jarskog@med.unc.edu|
21261573|NCT03237845|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
21261574|NCT01221233|University of Delaware, Department of Physical Therapy|Dr. Jaclyn Megan Sions, PhD, DPT, PT|302-831-7231|megsions@udel.edu|
21261575|NCT01889810|Queen's University, Belfast|Professor Michelle McKinley|02890978936|m.mckinley@qub.ac.uk|
21261576|NCT01819922|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21261577|NCT02460822|University of Michigan|Dr. Lawrence C. An|734-763-6099|lcan@med.umich.edu|
21279608|NCT03975491|Pennington Biomedical Research Center|Dr. Justin Brown|2257632715|Justin.Brown@pbrc.edu|
21279609|NCT03922529|University of Pittsburgh|Daniel Forman, MD|412-360-2411|formand@pitt.edu|
21241915|NCT01859195|The Miriam Hospital|Principal Investigator|401-793-4775 or 401-793-8180|scu-uvin@lifespan.org; kate.guthrie@lifespan.org|
21241916|NCT04939428|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21241917|NCT04319094|Mass General Hospital|Dr. Jin hui Joo|410-724-5317|jhjoo@mgh.harvard.edu|
21241918|NCT00877851|Queen's University, Belfast|Prof Michelle McKinley|+44(0)2890632685|m.mckinley@qub.ac.uk|
21241919|NCT03285711|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21241920|NCT03424239|Massachusetts General Hospital|Dr. Elaine Yu|617-643-6353|ewyu@mgh.harvard.edu|
21241921|NCT00770211|Merz Pharmaceuticals GmbH|Dr. Matthias Zerm|0049-69-1503|matthias.zerm@merz.de|865
21241922|NCT02982928|Nationwide Children's Hospital|Ahsan Syed, MD|614-722-4200|Ahsan.Syed@nationwidechildrens.org|
21241923|NCT00318656|GlaxoSmithKline|GSK Response Center|866-435-7343||
21241924|NCT01446003|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21241925|NCT03905135|National Cancer Institute|Dr. Kevin C. Conlon|240-858-3570|conlonkc@mail.nih.gov|
21241926|NCT01740557|M D Anderson Cancer Center|Dr. Rodabe Amaria M.D.|(713) 792-2921|rnamaria@mdanderson.org|
21241927|NCT00490555|University of Washington|Dr. Stephanie Page|2066160483|page@u.washington.edu|
21241928|NCT02042443|SWOG Statistics & Data Management Center|SWOG Statistician|206-667-4408||
21241929|NCT02735187|Philips Light & Health|Dr. Joerg Liebmann|+ 49-(0)1733715907|joerg.liebmann@philips.com|
21241930|NCT01007149|Novartis Pharmaceuticals|Study Director|862-778-8300||
21241931|NCT02784704|La Jolla Pharmaceutical Company|Chief Development Officer|617-715-3600|ljpcregulatory@ljpc.com|
21241932|NCT01913340|University of California San Francisco|Yvonne Wu, MD MPH||wuy@ucsf.edu|
21241933|NCT00603538|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21241934|NCT05010304|University of Texas Southwestern|Dr Timothy Chow|2144569093|timothy.chow@utsouthwestern.edu|
21241935|NCT05750745|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
21241936|NCT00938340|Penn State University|Penny Kris-Etherton||pmk3@psu.edu|
21241937|NCT02178436|Karmanos Cancer Institute|Mohammed Najeeb Al Hallak M.D.|313-576-8718|alhallakm@karmanos.org|
21241938|NCT03677375|Masimo|Tala Harake|9492977000|studies@masimo.com|
21241939|NCT00725010|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21241940|NCT03425539|Idorsia Pharmaceuticals Ltd|Idorsia Clinical Trial Information|+1 856 661 3721|idorsiaclinicaltrials@idorsia.com|
21241941|NCT01080131|Novartis Pharmaceuticals|Study Director|862 778-8300||
21241942|NCT00299702|Ortho-McNeil, Inc. N America Pharm CNS/IM|Therapeutic Area Lead|609-730-3693||
21241943|NCT01560949|UT MD Anderson Cancer Center|Dr. Gauri R Varadhachary,Professor, GI Medical Oncology|(713) 792-2828|gvaradha@mdanderson.org|
21241944|NCT00751036|Novartis Pharmaceuticals|Study Director|862-778-8300||
21241945|NCT03921528|Scholar Rock|Clinical Trials Coordinator|833-724-7625|clinicaltrials@scholarrock.com|
21241946|NCT03896230|Hackensack Meridian Health|Gabrielle L. Procopio, Pharm.D., BCPS|551-996-4368|Gabrielle.Procopio@hmhn.org|
21241947|NCT02613897|University of Texas Health San Antonio|Yuejuan Qin|210-617-5300|qiny@uthscsa.edu|
21241948|NCT02738840|Abbott|Robyn A Capobianco|+1 512 934 3941|robyn.capobianco@abbott.com|
21291817|NCT02135484|UT MD Anderson Cancer Center|John C. Araujo, Associate Professor, Genitourinary Medical Oncology|(713) 792-2830|johna@mdanderson.org|
21291818|NCT01959932|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
21291819|NCT01606150|Georgetown University NICU|Judith Palafoutas, Research Director|202 444 8756|jxp11@gunet.georgetown.edu|
21291820|NCT00485173|Medtronic Spinal|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
21291821|NCT00829244|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21291822|NCT02297412|Mayo Clinic|Charles L. Loprinzi, M.D.|507/284-6026|cloprinzi@mayo.edu|
21291823|NCT05047627|Dartmouth College|Nicholas Jacobson|(603) 646-7037|Nicholas.C.Jacobson@dartmouth.edu|
21291824|NCT03374306|HK Polytechnic University|Prof. Henry Chan|+85227667937|henryhl.chan@polyu.edu.hk|
21241949|NCT01801449|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Montealegre, Gina|+1 301 761 7747|montealegrega@mail.nih.gov|
21241950|NCT02162446|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
21241951|NCT03618095|Boston Scientific|Amy Maurer|800-876-9960|amy.maurer@bsci.com|
21241952|NCT00256308|University of California, Irvine|Chao Family Comprehensive Cancer Center|(877) 827-8839|UCstudy@uci.edu|
21241953|NCT01537133|Penn State University|David Mauger|717-531-7178|dtm5@psu.edu|
21241954|NCT03766438|Mayo Clnic|Mark Wieland, MD, MPH|507-284-1195|wieland.mark@mayo.edu|
21241955|NCT02466516|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21241956|NCT04358549|FUJIFILM Pharmaceuticals U.S.A., Inc.|Clinical Research Manager|No phone at site|fphucontact@fujifilm.com|
21241957|NCT03712930|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21241958|NCT02909439|Stony Brook Medicine|Ramon Abola, Clinical Associate Professor|631-444-2975|ramon.abola@stonybrookmedicine.edu|
21241959|NCT00785772|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21241960|NCT01062126|Abbott (Previously St Jude Medical)|Grant Kim|818-493-3147|grant.kim1@abbott.com|
21241961|NCT00646451|Baylor College of Medicine|Dr. Joseph Jankovic|713-798-6556|josephj@bcm.edu|
21241962|NCT03784963|The University of Chicago|Dr. Ann Nguyen, MD|773-702-9396|anguyen3@medicine.bsd.uchicago.edu|
21241963|NCT05355116|University of Winchester|Dr James Belsey|(+44) 07799040556|KneeResearch@pm.me|
21241964|NCT00868231|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
21241965|NCT01260662|MinneapolisMRF|James Miner|612-873-3000|miner015@umn.edu|
21241966|NCT01168401|Medical Director|Takeda|+1-877-825-3327|trialdisclosures@takeda.com|
21241967|NCT03049111|University of North Carolina at Chapel Hill|Michelle Hernandez, MD|919-843-5383|michelle_hernandez@med.unc.edu|
21241968|NCT00908947|BD/Bard|Talar Saber, Senior Project Manager, Clinical Affairs|1.480.379.2839|Talar.Saber@crbard.com|
21291825|NCT06378008|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
21234525|NCT05711927|Columbia University Irving Medical Center|Toni Iurcotta, MD|646-532-8196|ti2241@cumc.columbia.edu|
21234526|NCT04399928|Smith & Nephew|Fleur Derdeyn, Clinical Study Manager|+32497602032|fleur.derdeyn@smith-nephew.com|
21234527|NCT01340976|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21234528|NCT02953821|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
21234529|NCT01067352|Merck Serono S.p.A., Italy, an affiliate of Merck KGaA, Darmstadt, Germany|Medical Responsible|+49-6151-72-5200|service@merckgroup.com|
21234530|NCT02566759|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
21234531|NCT01096784|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21234532|NCT00976898|Massachusetts General Hospital|Theodore Sunki Hong, MD|617-724-1159|tshong1@mgh.harvard.edu|
21234533|NCT05107128|Sage Therapeutics|Amy Bullock, PhD|617-949-5151|amy.bullock@sagerx.com|
21234534|NCT03761628|Gedea Biotech AB|Annette Säfholm, CEO|0046 708 91 86 81|annette.safholm@gedeabiotech.com|
21234535|NCT01740596|CHF Solutions|Audrey Singh|9523454217|audrey.singh@chf-solutions.com|
21234536|NCT05459129|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21234537|NCT03064126|Boston Scientific|Cynthia Peterson|763-955-8233|Cynthia.Peterson@bsci.com|
21234538|NCT04508725|Stanford University|Dr. Alice Fan|(650) 498-6000|afan@stanford.edu|
21234539|NCT03307759|Peter MacCallum Cancer Centre|Clinical Research Development and Operations|+61 3 8559 5000|crdo@petermac.org|
21234540|NCT04649151|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
21234541|NCT04476017|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
21234542|NCT04063761|Attune Medical|Clinical Research Coordinator|888.534.4873|info@attune-medical.com|
21234543|NCT03817320|TACL|TACL|3233615429|TACL@chla.usc.edu|
21234544|NCT04664998|University of Washington|Dr. Renee Heffron|2065203817|rheffron@uw.edu|
21234545|NCT03909165|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21234546|NCT06034496|Center for Applied Brain and Cognitive Sciences|Research Assistant Professor|617-627-1059|kana.okano@tufts.edu|
21234547|NCT02018458|Baylor Scott and White Health|Dr. Joyce O'Shaughnessy|214-818-8472|joyce.oshaughnessy@usoncology.com|
21234548|NCT02845752|The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center|Dr. Harry Rossiter|3102228200|hrossiter@lundquist.org|
21234549|NCT01428193|University of Virginia|Clinical Research Coordinator|434-243-6911|pcos@virginia.edu|
21234550|NCT03523117|American Regent, Inc.|Mark A. Falone, MD|631.772.3544|mfalone@americanregent.com|
21234551|NCT03909009|Izmir Katip Çelebi University, Faculty of Medicine|Doç.Dr. Ayhan AŞKIN|00902322444444|ayhanaskin@hotmail.com|1529
21234552|NCT03277261|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
21234553|NCT03762083|Gedea Biotech AB|Annette Säfholm, CEO|0046 708 91 86 81|annette.safholm@gedeabiotech.com|
21241969|NCT02712099|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
21291826|NCT05322408|Masonic Cancer Center|Melissa Geller, MD, MS|612-626-3111|gelle005@umn.edu|
21291827|NCT04583618|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext: 6#|Contact-US@sanofi.com|
21291828|NCT03584490|Northwestern University|James W. Griffith, PhD|3125035345|j-griffith@northwestern.edu|
21291829|NCT02302222|Acelity|Sr Director, Global Clinical Development|2102555595|jane.hart@acelity.com|
21291830|NCT04212442|University of Pennsylvania|Dr. Rebecca Brown|215-573-2021|rebecca.brown@pennmedicine.upenn.edu|
21291831|NCT02293551|Chief Medical Officer|Eli Lilly and Company|800-545-5979||
21291832|NCT02936323|Tarveda Therapeutics, Inc.|Tarveda Clinical Information Center|(617) 923-4100|clinical.information@tarvedatx.com|
21261578|NCT00971321|GlaxoSmithKline|GSK Response Center|866-435-7343||
21291833|NCT05239221|Amolyt Pharma|Senior VP of Clinical Development and Regulatory Affairs|+33 428 01 21 54|contact@amolyt.com|
21291834|NCT01400412|ACTG Network Coordinating Center, Social and Scientific Systems|ACTG Clinicaltrials.gov Coordinator|301-628-3313|ACTGCT.Gov@s-3.com|
21234554|NCT03491150|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21234555|NCT00117143|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21234556|NCT00548860|Luitpold Pharmaceuticals, Inc.|Mark Falone, MD|610-650-4200|mfalone@luitpold.com|
21234557|NCT01103934|University of Chicago|Robert M Naclerio, MD|(773) 702-0080|rnacleri@surgery.bsd.uchicago.edu|
21234558|NCT00937547|Instituto de Oncología Dr. Luis Razetti, Caracas Venezuela|Dr. Jorge Sánchez-Lander Corresponding Author|582129870165|animamotrix@live.com|
21234559|NCT00325234|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21234560|NCT01234467|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
21234561|NCT02315768|UCSD|Dr. Thomas Kipps|858-534-5400|tkipps@ucsd.edu|
21234562|NCT02402452|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21234563|NCT02644967|Idera Pharmaceuticals, Inc|Head of Clinical Operations|484-348-1605|lcolfer@iderapharma.com|
21234564|NCT02287896|LFB Biotechnologies|Clinical trial Information desk|33169825656|supportqcm@lfb.fr|
21234565|NCT05179421|Wake Forest University School of Medicine|Professor James C. Eisenach, MD|336-716-4182|jimeisenach@gmail.com|
21234566|NCT00792610|National Taiwan University Hospital|Jan, Chyi-Feng|886-2-23562147|jcf036@ntu.edu.tw|
21234567|NCT03746522|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
21234568|NCT01639040|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
21234569|NCT04135703|The Oho State University|Natasha Slesnick|6142478469|slesnick.5@osu.edu|
21234570|NCT05422053|Tandem Diabetes Care|Supervisor, Clinical Operations|(858) 366-6900|clinicalaffairs@tandemdiabetes.com|
21234571|NCT01077960|EMD Serono|EMD Serono Medical Information|1-888-ASK-SERO (275-7376)||
21234572|NCT02457598|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21234573|NCT03837899|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21234574|NCT00868621|Cleveland Clinic Florida|Gamal M. Ghoniem, MD, FACS|954-659-5188|ghonieg@ccf.org|
21234575|NCT00393939|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21234576|NCT01494610|GlaxoSmithKline|GSK Response Center|866-435-7343||
21234577|NCT02385799|UC Davis MIND Institute|Dr. Randi Hagerman|916-703-0247|rjhagerman@ucdavis.edu|
21234578|NCT00087633|Hoffmann-La Roche|Medical Communications|800-821-8590||
21234579|NCT04707534|University of Oklahoma Health Sciences Center|Manager of Clinical Trials|405-271-6173|Dianne-Belshe@ouhsc.edu|
21234580|NCT01110915|Medtronic, Inc|Advisa MRI Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|62813
21234581|NCT02948842|University of South Florida|Lucas Wiegand, MD|813-844-5972|lwiegand@usf.edu|
21234582|NCT01537783|Brigham and Women's Hospital|Scott Weiner, MD, MPH|617-732-5640|sweiner@bwh.harvard.edu|
21234583|NCT02350309|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
21234584|NCT01205165|GlaxoSmithKline|GSK Response Center|866-435-7343||
21234585|NCT04352140|Mayo Clinic|J. Ross Renew, M.D.|904-956-3325|Renew.J@mayo.edu|
21234586|NCT01736696|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21234587|NCT04011410|University of Kentucky College of Medicine|Patrick Hensley|859-562-3223|patrick.hensley@uky.edu|
21234588|NCT01455012|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
21234589|NCT00704028|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
21234590|NCT04155008|Montefiore Medical Center|Dr. Justin Tang|718-920-4094|jtang@montefiore.org|
21234591|NCT01434290|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21234592|NCT03945981|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21234593|NCT03750903|Department of Veterans Affairs|Dr. Joe Nocera, PI|404 321 6111|joe.nocera2@va.gov|121662
21234594|NCT00256698|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21234595|NCT00705107|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21234596|NCT02777125|University of Tennessee Health Sciences College of Medicine/Le Bonheur Children's Hospital|Mark Snider DO, Principal Investigator|9012875986|marksnider02@hotmail.com|
21234597|NCT04036500|Medical College of Wisconsin|Jenna Sarvaideo, DO|414-955-7069|jsarvaideo@mcw.edu|7069
21234598|NCT00634647|National Cancer Institute, National Institutes of Health|Dr. William Dahut|301-435-8183|dahutw@mail.nih.gov|
21234599|NCT00667342|St. Jude Children's Research Hospital|Michael Bishop, MD|866-278-5833|referralinfo@stjude.org|
21234600|NCT01433263|Novartis Pharmaceuticals|Study Director|862-778-8300||
21234601|NCT04016324|Medtronic|Rianna Rapson (Prin. Clinical Research Specialist)|763-526-2170|rianna.k.rapson@medtronic.com|
21234602|NCT04709237|Coopervision|Paul Chamberlain|925-251-6682|PChamberlain@coopervision.com|
21234603|NCT02610192|Zimmer Biomet|Mr. Cahit Akbas|+31622981737|Cahit.Akbas@zimmerbiomet.com|
21234604|NCT04048460|University of South Florida Department of Communication Sciences & Disorders|Michelle Arnold, AuD, PhD, CCC-A Assistant Professor|(813) 974-1262|mlarnold@usf.edu|
21279610|NCT04514679|Dartmouth Geisel School of Medicine|Tor D. Tosteson, ScD|603 646-5274|tor.d.tosteson@dartmouth.edu|
21279611|NCT03355469|Rutgers University|Dr. Steven Malin|848-932-705|steven.malin@rutgers.edu|
21279612|NCT02731638|University of California, San Francisco|Dr. Jennifer Rose-Nussbaumer|+1 415 502 2666|jennifer.rose-nussbaumer@ucsf.edu|
21279613|NCT04158245|Tulane University|Brian Lewis|504-988-6300|blewis@tulane.edu|
21279614|NCT02291510|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com|
21279615|NCT02454608|Massachusetts Eye and Ear Infirmary|Benjamin Bleier|(617) 573-6966|Benjamin_Bleier@MEEI.HARVARD.EDU|
21279616|NCT02465398|Zimmer Biomet|Elliott Goff|+41 79 222 23 08|elliott.goff@zimmerbiomet.com|
21279617|NCT02906358|The University of Texas Health Science Center at San Antonio|Barbara J Turner|210-562-5551|turner@uthscsa.edu|
21279618|NCT02699684|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
21234605|NCT03285373|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21234606|NCT05723770|Bausch & Lomb|Megan Cavet|5852849474|Megan.Cavet@bausch.com|
21234607|NCT00145509|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21234608|NCT01359592|SWOG Statistics and Data Management Center|Lymphoma Committee Statistician|206-667-4623|lymph@crab.org|
21234609|NCT02881996|Children's Mercy Hospital|Shawn St. Peter|816-234-3000|sspeter@cmh.edu|3575
21234610|NCT01433107|Novartis|Clinical Project leader|+41223633111||
21234611|NCT00326612|DIvision of Pediatric Emergency Medicine|Maija Holsti, MD, MPH|801-587-7450|maija.holsti@hsc.utah.edu|
21234612|NCT00419562|Benaroya Research Institute|Carla Greenbaum||cjgreen@benaroyaresearch.org|
21234613|NCT01276314|Chang Gung Memorial Hospital, Linko|Drug Hypersensitivity Clinical and Research Center, Laboratory of Dr. Wen-Hung Chung,|886-3-328-1200|kiruamairo@gmail.com|8494
21234614|NCT02365636|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21234615|NCT00355238|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21234616|NCT01454934|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21234617|NCT00749775|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21234618|NCT05044234|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21234619|NCT00480636|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21234620|NCT03912233|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21234621|NCT00933491|University of Michigan|Tae-Ju Oh|734-647-3320|taejuoh@umich.edu|
21234622|NCT02583256|Seqirus|Seqirus Clinical Trial Disclosure Manager|Phone: 1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
21234623|NCT02530294|Dermira, Inc.|Eugene A. Bauer, MD, Chief Medical Officer|650-421-7202|eugene.bauer@dermira.com|
21234624|NCT01948375|Guang'an Men Hospotal Affiliated to China Academy of Chinese Medical Sciences|Zhishun Liu, Director of the study|8610-010-88001124|liuzhishun@aliyun.com.cn|
21234625|NCT03004534|Translational Research In Oncology (TRIO)|Director, Project Management|33 158 10 09 09|030@trioncology.org|
21234626|NCT02177266|Mayo Clinic|Dr. Jae K. Oh|507-284-6055|oh.jae@mayo.edu|
21234627|NCT01023659|Centre for Addiction and Mental Heatlh|Dr. Peter Selby|416-535-8501|peter.selby@camh.ca|74946
21234628|NCT01873989|Yale University|Dr. Declan Barry|203-285-2708|declan.barry@yale.edu|
21234629|NCT04537806|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
21234630|NCT03019627|Dompé|Valeria Motta, PhD|02583831|info@dompe.it|
21234631|NCT03364049|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|18006726372|ClinicalTrialsDisclosure@merck.com|
21234632|NCT00546715|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21234633|NCT00418691|UT MD Anderson Cancer Center|Jeffrey Wefel, PHD/ Associate Professor, Neuropsychology|713-563-0514|jwefel@mdanderson.org|
21234634|NCT01369875|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
21234635|NCT02477020|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21234636|NCT01802775|Daiichi Sankyo Development Inc.|Clinical Trial Information|+44 1753482800|info@dsd-eu.com|
21234637|NCT01236196|San Francisco VA Medical Center|Dr. Timothy Carmody|415-221-4810|Timothy.Carmody@va.gov|6344
21234638|NCT00519649|GlaxoSmithKline|GSK Response Center|866-435-7343||
21234639|NCT01465802|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21234640|NCT03852316|University of California, San Diego|Sheldon Morris, MD, MPH|619-543-4761|shmorris@ucsd.edu|
21234641|NCT03219333|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
21234642|NCT02975934|pharmaand GmbH|Medical Information Department|+43/1/3560006|medinfo@pharmaand.com|
21234643|NCT02102256|University of Southern California|Dr. Laurie Eisenberg|213-764-2826|laurie.eisenberg@med.usc.edu|
21234644|NCT02075840|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21234645|NCT03032796|University of California San Francisco|"Joaquin A. Anguera, Associate Professor, Neuroscape | UCSF"|415-502-7322|joaquin.anguera@ucsf.edu|
21234646|NCT05429203|Stanford University|Subhas Banerjee, MD|(650) 736-5555|subhas.banerjee@stanford.edu|
21234647|NCT00433654|Medtronic, Inc|EnRhythm MRI Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|62813
21234648|NCT02650986|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kris.Attwood@roswellpark.org|
21234649|NCT04033159|Dynacure|Dynacure|+33 3 74 95 20 50|info@dynacure.com|
21241970|NCT03396835|Masimo Corporation|Tala Harake|949-297-7137|studies@masimo.com|
21279619|NCT01549405|Ministry of health Diskapi Yıldirim Beyazit Training and Research Hospital|Dr Derya Özkan|00903125962553|derya_z@yahoo.com|
21279620|NCT02111603|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
21291835|NCT00285779|Stanford University Department of Dermatology|David Fiorentino|650-723-6316|fiorentino@stanford.edu|
21241971|NCT01451814|Brown University School of Public Health|Dr. Christopher Kahler|401 863-6651|Christopher_Kahler@brown.edu|
21241972|NCT02049866|Columbia University|Mariana Bucovsky|212-305-7225|mb3523@cumc.columbia.edu|
21241973|NCT02467491|University of Florida|Dr. Vincenzo Valiani|352-2835906|vincio86@gmail.com; v.valiani@ufl.edu|
21241974|NCT03710564|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21241975|NCT02993471|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21241976|NCT00619151|Sorin Group USA, Inc.|Barbara Mathews Director Clinical and Medical Affairs|512-435-3602|Barbara.mathews@sorin.com|
21241977|NCT04088188|MD Anderson|Shubham Pant|832-803-5306|spant@mdanderson.org|
21241978|NCT02524288|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21241979|NCT03360422|Northeastern University|Robert Leeman|6173736501|r.leeman@northeastern.edu|
21241980|NCT02616263|Washington University in St. Louis, School of Medicine, Program in Physical Therapy|Dr. Mary Hastings, Professor|3142107108|hastingsmk@wustl.edu|
21241981|NCT04807517|Massachusetts General Hospital Lurie Center for Autism|Lurie Center Research Manager|781-860-1711|luriecenterresearch@mgh.org|
21241982|NCT03569813|Emory University|Aaron Siegler, PhD|404-712-9733|asiegle@emory.edu|
21241983|NCT02939183|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21241984|NCT05015478|Icahn School Of Medicine at Mount Sinai|Mariana Figueiro PhD|212-241-6500|Mariana.Figueiro@mountsinai.org|
21241985|NCT05096117|National Institute on Alcohol Abuse and Alcoholism|Dr. Daniel Falk|3014430788|falkde@mail.nih.gov|
21241986|NCT04927975|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21241987|NCT03781804|OptiNose|John Messina, PharmD, SVP of Clinical Research & Medical Affairs|267-521-0565|John.Messina@optinose.com|
21241988|NCT03717194|Seoul National University Bundang Hospital|Soo Lim|+82-31-787-7035|limsoo@snu.ac.kr|
21241989|NCT02266329|VA Puget Sound Health Care System|Hollie Holmes|206-277-6207|Hollie.Holmes@va.gov|
21241990|NCT03499600|George Mason University|Dr. Amanda Sanchez|703-993-1354|asanch49@gmu.edu|
21241991|NCT00561574|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21241992|NCT03971357|Price Vision Group|Marianne Price|317-814-2990|mprice@cornea.org|
21241993|NCT00445692|Fred Hutch Cancer Research Center|Leona A. Holmberg, MD, PhD|206-667-6447|lholmber@fredhutch.org|
21241994|NCT01796977|Halyard Health, Inc.|Director of Clinical Affairs|470-448-5352|david.curd@hyh.com|
21241995|NCT03860077|Brown University|Dr. Rachel Cassidy|4018636621|rachel_cassidy@brown.edu|
21241996|NCT02147990|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
21241997|NCT00630864|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21241998|NCT00430677|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21241999|NCT01555762|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21242000|NCT00819910|Brooke Army Medical Center|Ahmad Slim, MD|2109164717|ahmad.slim@us.army.mil|
21242001|NCT00112112|MedImmune, LLC|Raburn Mallory|301-398-0000|malloryr@medimmune.com|
21242002|NCT02639429|The University of Texas Health Science Center at Houston|Mesk Alrais, MD|(713) 566-5735|Mesk.A.Alrais@uth.tmc.edu|
21242003|NCT02040844|Circassia Ltd|VP Clinical Operations|+44 1865 405560|info@circassia.com|
21242004|NCT00946192|Massachusetts General Hospital and Harvard Medical School|Madhu Misra, MD; Chief, Pediatric Endocrine|6177245602|mmisra@mgh.harvard.edu|
21242005|NCT03032159|Seattle Children's|Tumaini R. Coker, MD, MBA|206-884-0559|Tumaini.Coker@seattlechildrens.org|
21242006|NCT05460663|University of New Mexico, College of Nursing|Stephen H. A. Hernandez, PhD, RN, FAAN|505-272-0756|shhernandez@salud.unm.edu|
21242007|NCT02068885|Boston Children's Hospital|Cara Ebbeling, PhD, Co-Director, New Balance Foundation Obesity Prevention Center|617-919-3457|Cara.Ebbeling@childrens.harvard.edu|
21242008|NCT00681811|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21242009|NCT00828919|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21242010|NCT01562743|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-6361-7366||
21242011|NCT05567159|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
21242012|NCT03719677|Wayne State University|Heather Fritz|313-664-2627|Heather.fritz@wayne.edu|
21242013|NCT03059992|SCYNEXIS, Inc.|Dr. David Angulo, SCYNEXIS CEO|201-884-5471|david.angulo@scynexis.com|
21242014|NCT02449044|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21242015|NCT01171924|Curis, Inc.|Associate Director of Regulatory Affairs|(617) 503-6548|lsaunders@curis.com|
21242016|NCT00349908|Codman & Shurtleff|J. Thomas Megerian, MD|508.828.8274|jmegerian1@its.jnj.com|
21242017|NCT00248612|Center for Anxiety and Related Disorders at Boston University|Todd J. Farchione, PhD|617 353 9610|tfarchio@bu.edu|
21242018|NCT03106025|Loma Linda University Medical Center|Dr. Stephanie Tseeng|9095584000|ttseeng@llu.edu|
21242019|NCT03557385|Duke Clinical Research Institute|Marjan Cobbaert|9196995638|mr157@duke.edu|
21242020|NCT04381494|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21242021|NCT04310579|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.Strauss@fda.hhs.gov|
21242022|NCT03467724|Venus Concept|Director of Clinical Affairs|1-888-907-0115|mgronski@venusconcept.com|
21291836|NCT04164277|Michigan State University|Jiying Ling|5173538591|lingjiyi@msu.edu|
21242023|NCT01325870|Advanced Circulatory|Clinical Research Associate|651-403-5606|nburkhart@advancedcirculatory.com|
21242024|NCT02236559|McGovern Medical School at The University of Texas Health Science Center at Houston|Dr. Pratik Doshi, MD||pratik.b.doshi@uth.tmc.edu|
21242025|NCT03721016|Medytox Inc.|Young Ryu|+82-2-6901-5424|aab005@medytox.com|
21291837|NCT00529633|University of California, Davis|George Kaysen MD PhD, Principal Investigator|916-734-3774|gakaysen@ucdavis.edu|
21242026|NCT03700658|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21242027|NCT01149681|Pharma Mar, S.A.|Clinical Development Department of PharmaMar´s Oncology,Business Unit.,|+34 918466000|clinicaltrials@pharmamar.com|
21242028|NCT03107611|Mylan Pharmaceuticals Pvt Ltd|Prasanna C Ganapathi, Clinical Sciences Program Lead|+91 9148448200|PrasannaC.Ganapathi@mylan.in|
21242029|NCT01020838|Piramal Imaging|Dr. Juergen Hirschfeld|49 30 461 1246 15|juergen.hirschfeld@piramal.com|
21242030|NCT02243007|Massachusetts General Hospital|David P. Ryan, MD|6177240245|dpryan@mgh.harvard.edu|
21242031|NCT04969822|Vitrolife A/S|Mr. Jørgen Berntsen|+4551542005|jberntsen@vitrolife.com|
21242032|NCT00763282|Center of Innovation for Complex Chronic Health Care|Marylou Guihan, PhD|708-202-2414|marylou.guihan@va.gov|
21242033|NCT00742274|W.L. Gore and Associates|Jennifer Gorman|928-864-3381|jgorman@wlgore.com|
21242034|NCT02060279|Nemours Children's Specialty Care|Dr. Amanda Lochrie|904-697-3698|alochrie@nemours.org|
21242035|NCT01970943|Massachusetts General Hospital|Dr David Borsook, study PI|6172817135|david.borsook@childrens.harvard.edu|
21242036|NCT00335556|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21242037|NCT02365298|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan|904-443-3449|CColesb@ITS.JNJ.com|
21242038|NCT02347917|Sumitomo Dainippon Pharmaceutical|Clinical Research (Oncology)|e-mail only|cc@ds-pharma.co.jp|
21242039|NCT03124108|Genfit SA|Clinical Head|+33320164000|clinicaltrial@genfit.com|
21242040|NCT02266810|Intersect ENT|James Stambaugh (VP, Clinical Affairs)|650-641-2103|jstambaugh@intersectent.com|
21242041|NCT00578617|Mayo Clinic|Kristi Monahan|507-255-6676|CABANA@mayo.edu|
21242042|NCT01670019|Duke University|John Beyer, M.D.|919-668-0209|john.beyer@dm.duke.edu|
21242043|NCT05487703|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21242044|NCT02403323|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21242045|NCT03582956|Yale University|Michelle Van Name|2037855831|michelle.vanname@yale.edu|
21242046|NCT00197236|GlaxoSmithKline|GSK Response Center|866-435-7343||
21242047|NCT03885596|Concentric Analgesics|Head of Clinical Operations|14154847921|nancy@concentricanalgesics.com|
21242048|NCT00746330|Novartis Pharmaceuticals|Study Director|862-778-8300||
21242049|NCT01076335|The University of Texas (UT) MD Anderson Cancer Center|Lance Pagliaro, MD|1-877-632-6789|CR_Study_Registration@mdanderson.org|
21242050|NCT01129778|Stanford University|W. Ray Kim, MD, Chief of Gastroenterology and Hepatology|650-725-6511|wrkim@stanford.edu|
21242051|NCT00517933|Duke Clinical Research Institute|Kevin J Anstrom, PhD|919-668-8902|kevin.anstrom@duke.edu|
21242052|NCT04081545|Virginia Mason Medical Center|Christine Oryhan|206-223-6980|christine.oryhan@virginiamason.org|
21242053|NCT04639947|Duke Eye Center|Dr. Sanjay Asrani|+1 919 684 8656|sanjay.asrani@duke.edu|
21242054|NCT01018511|Astellas Pharma Europe B.V.|Medical Director, Global Medical Science||Astellas.resultsdisclosure@astellas.com|
21242055|NCT00654238|Abramson Cancer Center at the University of Pennsylvania|Dr. Marcia Brose|215-746-6344|brosem@mail.med.upenn.edu|
21242056|NCT00658411|Dana-Farber Cancer Institute|Philippe Armand, MD, PhD|617-632-2305|parmand@partners.org|
21242057|NCT04523181|Golden Biotechnology Corporation|Dr. Howard Cheng|+886228086006|howard@goldenbiotech.com|826
21242058|NCT01481935|University of Maryland School of Medicine|Anthony D. Harris, MD MPH|410-706-0064|aharris@epi.umaryland.edu|
21242059|NCT02806895|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
21242060|NCT01559090|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21242061|NCT00126113|National Center for Rehabilitative Auditory Research|Gabrielle Saunder Ph.D.|503-220-8262|gabrielle.saunders@va.gov|56210
21242062|NCT01729871|Janssen Scientific Affairs, LLC|Senior Director Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
21242063|NCT01143077|Sunovion Pharmaceuticals|Medical Director, CNS|1-866-503-6351||
21242064|NCT00836810|University of Bristol|Professor John Kirwan|+44 117 342 2904|John.Kirwan@Bristol.ac.uk|
21242065|NCT01912495|Erasmus MC|B.J.A.Rijnders|0031107034529|b.rijnders@erasmusmc.nl|
21242066|NCT01772719|University of Louisville, James Graham Brown Cancer Center|James Graham Brown Cancer Center, Clinical Trials|502-562-3429|ctobcc@louisville.edu|
21242067|NCT03663101|Ipsen Innovation SAS|Medical Director|see email|clinical.trials@ipsen.com|
21242068|NCT02014558|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
21242069|NCT03181724|Massachusetts General Hospital|Dr. Neal Chen|617-726-4700|nchen1@mgh.harvard.edu|
21242070|NCT02931396|University of Pittsburgh|Alicia Koontz|4128223700|akoontz@pitt.edu|
21242071|NCT05273801|Shirley Ryan AbilityLab|Dr. Miriam Rafferty|3122387233|mrafferty@sralab.org|
21242072|NCT04159506|VA Connecticut Healthcare System|Steve Martino, Ph.D.|203-932-5718|Steve.Martino@va.gov|7418
21242073|NCT03227757|Abbott|Karine Miquel|+32 479 600 107|karine.miquel@abbott.com|
21242074|NCT01144468|University Health Network|Dr. Angela Cheung|416-340-4841|jscher@uhnresearch.ca|
21242075|NCT02960659|NIDDK|Dr. Stephanie Chung|301-402-2122|stephanie.chung@nih.gov|
21242076|NCT04476472|Insulet Corporation|Dr. Trang Ly|9786007628|tly@insulet.com|
21242077|NCT00821184|Lahey Clinic|John T. Stoffel, MD|781-744-5481|John.T.Stoffel@lahey.org|
21242078|NCT04199728|Penn State College of Medicine|Dr. Scott Bunce|215-510-8295|sbunce@pennstatehealth.psu.edu|
21242079|NCT03068468|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
21242080|NCT02555449|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21242081|NCT03181958|Children's Hospital of Chongqing Medical University|Dr.Yuan Shi|+86 23 68757731|shiyuan@hospital.cqmu.edu.cn|
21261579|NCT02782715|University of Wisconsin School of Medicine and Public Health|Michael Bassetti, MD, PhD|608-263-8500|bassetti@humonc.wisc.edu|
21242082|NCT03079375|OdenseUH|Lene V. Ravn-Nielsen clinical pharmacist|+4523467925|lene.ravn-nielsen@rsyd.dk|
21242083|NCT01335789|Medical University of South Carolina|Aimee McRae-Clark, Pharm.D., BCPP|843-792-5216|mcraeal@musc.edu|
21242084|NCT01268891|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
21242085|NCT03783533|University of Washington|Dr. Jessica Jenness|206-616-7967|jennessj@uw.edu|
21242086|NCT00991276|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21242087|NCT03615001|Laborie|Stephanie Gallone, Clinical Research Manager|9056121170|sgallone@laborie.com|1755
21242088|NCT01107626|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21242089|NCT02488317|Arbor Research Collaborative for Health|Dr. Francesca Tentori|7346654108|francesca.tentori@arborresearch.org|
21242090|NCT00817635|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21242091|NCT00918957|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
21242092|NCT02753413|GlaxoSmithKline|GSK Response Center|866-435-7343||
21242093|NCT01720446|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
21242094|NCT01167426|Teva Pharmaceuticals Medical Affairs|Thomas Smith, MD|816-508-5128|tom.smith@tevapharm.com|
21242095|NCT01908634|Illinois Institute of Techology|Britt Burton-Freeman|708-341-0178|bburton@iit.edu|
21242096|NCT01524536|National Institute of Allergy and Infectious Diseases|Paneez Khoury|+1 301 402 3773|khouryp@niaid.nih.gov|
21242097|NCT04176458|Northwestern University|Daniel Ganger, MD|3126954496|daniel.ganger@nm.org|
21242098|NCT02131324|Dr. Reddy's Lab, Inc|Srinivas Sidgiddi, MD|609-375-9900|srinivassidgiddi@drreddys.com|
21242099|NCT00891618|University of Texas MD Anderson Cancer|Michael Wang, MD / Professor, Lymphoma/Myeloma|713-792-2860|CR_Study_Registration@mdanderson.org|
21242100|NCT03533036|UCLA|Dr. Aparna Sridhar, Associate Clinical Professor|3107947274|asridhar@mednet.ucla.edu|
21242101|NCT04582877|Zurich Medical|Charles Chan|(612) 889-9412|cchan@zurichmed.com|
21242102|NCT00003656|Weill Cornell Medical College|Sharon Singh|(646) 962-9340|shs4011@med.cornell.edu|
21242103|NCT01522339|Cincinnati Children's Hospital Medical Center|Jean Tkach|513-636-7166|jean.tkach@cchmc.org|
21242104|NCT01248221|Mayo Clinic|Dr. Adil E. Bharucha|507-284-2687|bharucha.adil@mayo.edu|
21242105|NCT01268566|MedImmune, LLC, an affiliate of AstraZeneca|A Phase 2 Study of MEDI-575 in Adult Subjects with Recurrent Glioblastoma Multiforme|1-877-240-9479|information.center@astrazeneca.com|
21242106|NCT00601965|Veterans Medical Research Foundation|Dr. Julie Wetherell|858-552-8585|jwetherell@ucsd.edu|2752
21242107|NCT01649427|Novartis Pharmaceuticals|Study Director|(862) 778-8300||
21242108|NCT02138916|AstraZeneca|Ulbaldo Martin|1.301.398.0163|ulbaldo.martin@astrazeneca.com|
21242109|NCT02387749|Cairo university, faculty of medicine|Dina Mohammed Riad Ebrahim Abdelmagid|+201112052600|drdina_m@hotmail.com|
21242110|NCT05096884|Hackensack Meridian Health|Jana Tancredi|5519962353|Jana.Tancredi@hmhn.org|
21242111|NCT01113515|NovaLead Pharma Pvt. Ltd.|Supreet Deshpande|+91-866-965-6660|supreet@novaleadpharma.com|12
21242112|NCT02482233|Royal Columbian Hospital / University of British Columbia|Dr. Susan Ming Lee|604-520-4253|susanlee.anesthesia@gmail.com|
21242113|NCT04888585|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21242114|NCT02237079|Tulane University|Dr. Franck Mauvais-Jarvis|504-988-5990|fmauvais@tulane.edu|
21242115|NCT02929069|Yale University|John Pachankis, PhD|(203) 785-3710|john.pachankis@yale.edu|
21242116|NCT02708862|HHRI|Audrey Hendrickson|6128737448|audrey.hendrickson@hcmed.org|
21242117|NCT04678830|CytoDyn Inc.|Bernie Cunningham, PhD|(360) 980-8524|bcunningham@cytodyn.com|
21242118|NCT05550337|Teva Pharmaceuticals, Inc.|Director, PD/CE Studies|1-888-483-8279|usmedinfo@tevapharm.com|
21242119|NCT06044948|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|8884513937|alcon.medinfo@alcon.com|
21242120|NCT03788291|University of Rochester|Paul Barr, MD|585-273-3258|paul_barr@urmc.rochester.edu|
21242121|NCT01836458|Novartis Pharmaceuticals|Study Director|862-778-8300||
21242122|NCT02081391|Grünenthal GmbH|Clinical Trial Helpdesk|+49 241 569|Clinical-Trials@grunenthal.com|3223
21242123|NCT03184428|Eyestylianides ophthalmology center|Christoforos Stylianides|0035725320244|Info@eyestylianides.com|
21242124|NCT00813488|Cephalon, Inc.|Sponsor's Medical Expert, Clinical Research|1-800-896-5855||
21242125|NCT02926937|Lexicon Pharmaceuticals, Inc,|Medical Affairs|338-6064|medical-information@lexpharma.com|(510)
21242126|NCT04985383|Alkahest, Inc.|Head of Communications|(650) 801-0474|sm-Trials-alkahest@grifols.com|
21242127|NCT01333514|Rush University Medical Center|Chung-Kay Koh|8475305230|chungkay@gmail.com|
21242128|NCT00477412|UT MD Anderson Cancer Center|Michael Wang, Professor, Lymphoma-Myeloma|(713) 792-2860|miwang@mdanderson.org|
21242129|NCT00147043|Imperial College London|Professor Nagy Habib|+442033138574|nagy.habib@imperial.ac.uk|
21242130|NCT02501811|University of Texas-Houston School of Public Health|Shelly Sayre, M.P.H. Project Manager|713-500-9529|Shelly.L.Sayre@uth.tmc.edu|
21242131|NCT00662909|Astellas Pharma Global Development, Inc.|Medical Director, Medical Sciences||ClinicalTrials.Disclosure@us.astellas.com|
21242132|NCT04257058|Emory University|Dr. Jordan Marchak|404-727-2293|jgillel@emory.edu|
21242133|NCT03297112|Sidney Kimmel Cancer Center at Thomas Jefferson University|Flemming Forsberg, PhD|215-955-4870|flemming.forsberg@jefferson.edu|
21261580|NCT04170621|FARAPULSE|Christopher (Kit) Schneider|6176867661|christopher.schneider@bsci.com|
21279621|NCT01582152|The University of Texas (UT) MD Anderson Cancer Center|Dr. Alfred Yung, Clinical Professor, Neuro-Oncology|713-792-7734|wyung@mdanderson.org|
21279622|NCT02437903|Baumann Cosmetic and Research Institute|Leslie Baumann, MD|(305) 531-5788|studies@derm.net|
21279623|NCT02229474|Northumbria Healthcare NHS Foundation Trust|Professor Richard Walker|+441912932709|richard.walker@nhct.nhs.uk|
21279624|NCT01611857|Sarah Cannon Research Institute|Charles H. Davis|615-524-4341|charles.davis2@scri-innovations.com|
21279625|NCT02439970|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
21279626|NCT00637494|Corcept Therapeutics|Thaddeus S. Block, MD|(650) 688-8816|tblock@corcept.com|
21242134|NCT02703714|University of California, San Francisco|Dr. R. Katie Kelley, MD|(415) 353-9888|katie.kelley@ucsf.edu|
21242135|NCT04057196|Duke University|Katherine Ramos, Ph.D.|919-416-3434|Katherine.Ramos@duke.edu|
21242136|NCT03895034|RxSight|Jeffrey Ha, Senior Director of Clinical Research|949-521-7870|jha@rxsight.com|
21242137|NCT02085356|University of Miami Miller School of Medicine|Violeta Rodriguez|3052432188|vjrodriguez@med.miami.edu|
21242138|NCT01118377|Hoffmann-La Roche|Medical Communications|800 821-8590||
21242139|NCT00739102|Cordis Corporation, a Johnson & Johnson company|Patricia Schleckser, Director Medical Affairs|908-541-4564|pschleck@its.jnj.com|
21242140|NCT05365633|University of Oklahoma|Dr. Julia McQuoid|405-271-8001|julia-mcquoid@ouhsc.edu|1
21242141|NCT01331824|Icahn School of Medicine at Mount Sinai|Dr. Matthew D. Galsky|212-241-6756|matthew.galsky@mssm.edu|
21242142|NCT01606124|Mayo Clinic|Frank A. Sinicrope, M.D.|507-284-2511|sinicrope.frank@mayo.edu|
21242143|NCT01091454|Mayo Clinic|Alvaro Moreno-Aspitia MD|507-284-1159|morenoaspitia.alvaro@mayo.edu|
21242144|NCT01510912|Iroko Pharmaceuticals, LLC|Daniel Solorio, Executive Director of Clinical Operations|267-546-3150|dsolorio@iroko.com|
21242145|NCT02695290|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21242146|NCT01144949|Watson Laboratories, Inc.|Gary Hoel, RPh PhD, VP Global Brands Clinical Research|801 588-6641|gary.hoel@watson.com|
21242147|NCT02008292|Yale University|Dr. Kelly Cosgrove|203-737-6969|kelly.cosgrove@yale.edu|
21242148|NCT02891629|EyeFree Assisting Communication|Or Retzkin, CEO|+972526490093|or@eyecontrol.co.il|
21242149|NCT02734056|Brigham|Bhavani Kodali|6175258449|kodali@zeus.bwh.harvard.edu|
21242150|NCT04866407|Rutgers RWJMS|Dr Sydney Asselstine|6469403587|sydneyasselstine@gmail.com|
21242151|NCT02001623|Genmab A/S|Clinical Trial Information|70202728|clinicaltrials@genmab.com|
21242152|NCT03669354|Southern California University Of Health Sciences|Anupama Kizhakkeveettil|(562) 475-5158|anu@scuhs.edu|
21242153|NCT00959920|Loyola University Medical Center|Dr. Sarita Massey|708-354-9250|smassey@lumc.edu|
21242154|NCT00109967|Mayo Clinic|Stephen M. Ansell, M.D., Ph.D.||ansell.stephen@mayo.edu|
21242155|NCT02628093|Weill Cornell Medicine|Koianka Trencheva|646-9622342|kivanova@med.cornell.edu|
21242156|NCT02786771|Partners Connected Health Innovation|Odeta Dyrmishi - Acting Project Manager|6177243605|odyrmishi@partners.org|
21242157|NCT01063036|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21242158|NCT02702921|Ethicon Endo Surgery|Jason Waggoner, PhD|+1 513.337.8310|jwaggon1@its.jnj.com|
21242159|NCT01977612|Washington University School of Medicine|Lindsay Kuroki, M.D.|314-362-2368|kurokil@wustl.edu|
21242160|NCT01760291|Boston Scientific|Director of Clinical Trials|18002273422|peter.maurer@bsci.com|
21242161|NCT02715258|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
21242162|NCT02052648|Lumos Pharma Corporation|Lumos Pharma, Inc.|515-598-2921|clinical.trials@lumos-pharma.com|
21242163|NCT04208243|Children's Hospital Colorado|Dr. Jennifer Raybin|720-777-3407|jennifer.raybin@childrenscolorado.org|
21242164|NCT02263508|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21242165|NCT01117480|AbbVie|Global Medical Information|800-633-9110||
21242166|NCT01280591|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21242167|NCT02955069|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
21242168|NCT00943605|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
21242169|NCT04148937|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21242170|NCT03999554|FluGen|Pamuk Bilsel, CSO|6084426562|pbilsel@flugen.com|
21242171|NCT02082158|National Center for Occupational Health and Infection Control|Aaron Eagan|352-376-1611|aaron.eagan@va.gov|4973
21242172|NCT04012853|WJB Dorn VA Medical Center|Dr. X. Michelle Androulakis Chief of Neurology|803-776-4000|xiao.androulakis@va.gov|4077
21242173|NCT04304534|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21242174|NCT01695317|St. olavs Hospital|Dr. knut Hagen|95401579|knut.hagen@stolav.no|
21242175|NCT00464672|Novartis Vaccines and Diagnostics|Novartis Vaccines and Diagnostics||RegContactVacUS.nvdit@Novartis.com|
21242176|NCT03055767|"University of California, Irvine | Dept. of Anesthesiology & Perioperative Care"|Shalini Shah, MD|(949) 824-7246|ssshah1@hs.uci.edu|
21242177|NCT02759731|National Cancer Institute|Dr. Steven Pavletic|240-760-6174|pavletis@mail.nih.gov|
21242178|NCT01101165|Purdue Pharma L.P.|Stephen Harris, MD|203-588-7592|Stephen.Harris@Pharma.com|
21242179|NCT00073957|Beth Israel Deaconess Medical Center|Robin Joyce, MD|617-667-9920|rjoyce@bidmc.harvard.edu|
21242180|NCT02047461|Origin Biosciences (affiliate of BridgeBio)|Business Development and Operations|650-391-9740|info@bridgebio.com|
21242181|NCT00015457|National Institutes of Health|Barbara I Karp, MD|301-496-0150|karpb@ninds.nih.gov|
21242182|NCT04974489|University of North Carolina, Chapel Hill|M. Justin Byron, PhD|(919)966-3292|jbyron@unc.edu|
21242183|NCT01456936|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21242184|NCT02317705|On Target Laboratories|Tommy Lee, MSHS, Vice President, Clinical Operations|765-588-4547|Tlee@ontargetlabs.com|
21242185|NCT03095508|Sandoz|Study Director|+41613241111|Sandoz.email@sandoz.com|
21242186|NCT01674569|Tyrogenex, Inc|Sr Vice President, Development|240-403-7153|Dan@tyrogenex.com|
21242187|NCT01599325|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
21242188|NCT05674370|Mayo Clinic|Dr. Matthew Binicker|507-284-3697|binnicker.matthew@mayo.edu|
21242189|NCT01710514|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21242190|NCT02020018|Mayo Clinic|Dr. Hartzell V. Schaff|507-255-7066|schaff.hartzell@mayo.edu|
21279627|NCT00741338|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21279628|NCT01141205|Statens Serum Institut|Dr Anders Fomsgaard|+45-32683460|afo@ssi.dk|
21279629|NCT03423186|Swedish Orphan Biovitrum AB|Anders Bröijersén, Medical Director|+46 8 697 20 00|anders.broijersen@sobi.com|
21291838|NCT01334918|Astellas Scientific and Medical Affairs, Inc. / Astellas Pharma Global Development, Inc.|Senior Medical Director, Medical Affairs||ClinicalTrials.Disclosure@us.astellas.com|
21291839|NCT01270529|University of California, San Francisco|Dr. Kirsten Johansen|415-221-4810|kirsten.johansen@ucsf.edu|23598
21291840|NCT04096417|Mayo Clinic|Tanios Bekaii-Saab M.D.|480-342-2000|Bekaii-Saab.Tanios@mayo.edu|
21291841|NCT01227785|Guidant, a Boston Scientific Company|Paji Vitoff, Senior Clinical Manager|651-582-5415|paji.vitoff@bsci.com|
21291842|NCT01657370|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21291843|NCT02777086|Texas Christian University|Wayne E.K. Lehman, Ph.D.|18172577226|w.lehman@tcu.edu|
21291844|NCT01133665|The University of Chicago|Dr. Everett Vokes|773-702-9306|evokes@medicine.bsd.uchicago.edu|
21291845|NCT01819272|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com|
21291846|NCT01732536|Intersect ENT, Inc.|James Stambaugh, Vice President of Clinical & Medical Affairs|650-641-2103|jstambaugh@intersectent.com|
21291847|NCT00805389|GlaxoSmithKline|GSK Response Center|866-435-7343||
21291848|NCT01409096|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD|2146466948|sherwood.brown@utsouthwestern.edu|
21291849|NCT02359006|Yale University|Dr. Mehmet Sofuoglu|203-932-5711|mehmet.sofuoglu@yale.edu|4809
21291850|NCT02336815|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
21291851|NCT00370292|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21291852|NCT00069641|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21291853|NCT02704208|San Diego State University|Keith J. Horvath|619-594-3346|khorvath@sdsu.edu|
21291854|NCT03545672|Renji Hospital, Shanghai Jiaotong University School of Medicine|Dr. Meng Jiang|+86 13788912766|jiangmeng0919@163.com|
21291855|NCT02673944|Laborie|Clinical Researcher|905-612-1170|sbitzos@laborie.com|1755
21291856|NCT02649920|Centre Hospitalier Départemental Vendée|Dr. Guillaume DUCARME|02 51 44 61 61|guillaume.ducarme@ght85.fr|
21291857|NCT02234362|MGH Center for Women's Mental Health|Dr. Marlene Freeman|617-723-6403|mfreeman@partners.org|
21291858|NCT01959529|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
21291859|NCT00560417|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21291860|NCT02164864|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21291861|NCT00320606|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsgov@niaid.nih.gov|
21291862|NCT03984825|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21291863|NCT00261833|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
21291864|NCT00622726|University of Texas Health Science Center-Houston|Helen Mintz-Hittner, M.D.|713-559-5277|Helen.A.Mintz-Hittner@uth.tmc.edu|
21291865|NCT04358406|BioAegis Therapeutics Inc.|Mark J. DiNubile, MD|609-706-5866|mdinubile@bioaegistx.com|
21291866|NCT00854360|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21291867|NCT02006927|William Beaumont Hospitals|Deborah Hasenau, RN|248 551-0804|deborah.hasenau@beaumont.org|
21291868|NCT01295710|Neovii|Anne Kuan|781 966 3832|anne.kuan@neovii.com|
21291869|NCT00859833|Univesity of Utah|Sheldon Litwin|801-581-7715|sheldon.litwin@hsc.utah.edu|
21291870|NCT02943473|Icahn School of Medicine at Mount Sinai|Dr. Ajai Chari|(212) 241-7873|ajai.chari@mountsinai.org|
21291871|NCT00431964|Seattle Children's Hospital|Nicole Hamblett|206-987-5725|tdncc@seattlechildrens.org|
21291872|NCT00758563|Colgate Palmolive|William DeVizio - DMD|732-878-7901|William_DeVizio@colpal.com|
21291873|NCT02625181|Vanderbilt University Medical Center|Jonathan Wanderer|615-536-5194|jon.wanderer@vanderbilt.edu|
21291874|NCT03199079|Advanced Tactile Imaging, Inc.|Egorov Vladimir, Principal Investigator|609 883-0100|egorov@tactile-imaging.com|
21291875|NCT01280942|Washington Univ Sch of Medicine|Thomas C. Bailey, MD|314-454-8293|tbailey@dom.wustl.edu|
21291876|NCT00016354|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Antonio Wolff|410-614-4192|awolff@jhmi.edu|
21291877|NCT03193801|Edwards Lifesciences|Director of Research|949-250-2500|THV_ct.gov@edwards.com|
21291878|NCT03110562|Karyopharm Therapeutics Inc.|Karyopharm Medical Information|(888) 209-9326|clinicaltrials@karyopharm.com|
21291879|NCT01561469|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21291880|NCT02274675|Universiti Teknologi Malaysia|Project Leader||cfyeong@utm.my|
21291881|NCT02160808|Dartmouth-Hitchcock Medical Center|Timothy B. Gardner MD MS|603-650-6472|timothy.b.gardner@hitchcock.org|
21291882|NCT03189719|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21291883|NCT03012880|Mayo Clinic|Shaji Kumar|507-284-5096|Kumar.Shaji@mayo.edu|
21291884|NCT01355627|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21291885|NCT02781558|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21291886|NCT01230411|Thomas Jefferson University- Jefferson Headache Center|Dr. Hsiangkuo Yuan|2159552243|Hsiangkuo.Yuan@jefferson.edu|
21291887|NCT02106429|NYU Langone Health|Jeffrey Berger, MD|212-263-4004|jeffrey.berger@nyulangone.org|
21291888|NCT04756531|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21242191|NCT03404843|Colorado State University|Frank Dinenno|970-491-3203|frank.dinenno@colostate.edu|
21242192|NCT04044664|Aptinyx|Aptinyx Clinical Development|847-871-0377|clinicalstudies@aptinyx.com|1
21242193|NCT00728845|Cancer Institute of New Jersey|Dr. Joseph Aisner|732-235-8675|aisnerjo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
21242194|NCT01219855|OPKO Health, Inc.|Douglass Laidlaw, PhD, Vice President, Medical Affairs|305-575-4172|dlaidlaw@opko.com|
21242195|NCT01639443|West Los Angeles VA / Cedars-Sinai Medical Center|Jennifer Talley Soares|(310) 478-3711|jennifer.soares@va.gov|83240
21291889|NCT02257528|NRG Oncology|Linda Gedeon for Wei Deng|716-845-1169|linda.gedeon@roswellpark.org|
21261581|NCT01065428|Department of Critical Care Medicine, Nanjing Zhong-Da Hospital, Southeast University School of Medicine, China|Dr. Haibo Qiu; Dr. Christer Sinderby|008613951965301|haiboq2000@yahoo.com.cn|
21261582|NCT01662999|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
21261583|NCT01031095|Bursa Postgraduate Hospital|Dr.Hasan ARI|00902243605050|hasanari03@yahoo.com|1739
21261584|NCT01933672|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21261585|NCT04125745|University of California San Francisco|Marc Simon, MD, Director of Pulmonary Vascular Disease and Pulmonary Hypertension Comprehensive Care|415-476-1325|Marc.Simon@ucsf.edu|
21261586|NCT00833859|H. Lee Moffitt Cancer Center and Research Institute|Gregory Springett, M.D., Ph.D., via Moffitt Cancer Center|813-745-6898|gregory.springett@moffitt.org|
21261587|NCT03661541|Squarex LLC|Hugh McTavish|6512078270|hmctavish@squarex-pharma.com|
21261588|NCT04095416|Henry Ford Hospital|Raef Ali Fadel|3139321347|rfadel2@hfhs.org|
21261589|NCT03590457|Rush University|Dr. Brady Scott|3129426389|jonathan_b_scott@rush.edu|
21261590|NCT05165394|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
21261591|NCT04957498|Stanford University School of Medicine|Dr. James Lock|(650) 723-6643|jimlock@stanford.edu|
21261592|NCT00001259|National Institute of Mental Health|Schmidt, Peter|+1 301 496 6120|peterschmidt@mail.nih.gov|
21261593|NCT03705494|The University of Hong Kong|Dr Kris LOK|39176690|krislok@hku.hk|
21261594|NCT01582282|Procter and Gamble|John McRorie, PhD|513-622-1423|mcrorie.jw@pg.com|
21261595|NCT00492622|University Louisville|Nancy Alsip|502-852-2905|nancy.alsip@louisville.edu|
21261596|NCT03937986|University of Kentucky|William W. Stoops|859-257-5388|william.stoops@uky.edu|
21261597|NCT02770287|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
21261598|NCT02839746|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21261599|NCT02089737|Takeda|Medical Director, Clinical Science|800-778-2860|trialdisclosures@takeda.com|
21242196|NCT02809911|Regenesis Biomedical|Heather Vander Ploeg|602-4287041|Heather.VanderPloeg@regenesisbio.com|
21242197|NCT03822351|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21242198|NCT01458275|Sunovion|Respiratory Medical Director|1-866-503-6351||
21242199|NCT00871429|Northwestern University|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu|
21242200|NCT03102242|Mayo Clinic|Helen J. Ross, MD|4803018000|Ross.Helen@mayo.edu|
21242201|NCT01875250|National Cancer Institute|Dr. Ravi A. Madan|301-480-7168|m480i@nih.gov|
21242202|NCT02749968|University of Cincinnati|Michael Goodman|5135585661|michael.goodman@uc.edu|
21242203|NCT00661778|Hoffmann-La Roche|Medical Communications|800 821-8590||
21242204|NCT05298111|Universiti Sultan Zainal Abidin|Ms Ong Ying Qian|+60142186195|oyq0109@gmail.com|
21242205|NCT02232178|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
21242206|NCT01259102|Purdue Pharma L.P.|Executive Medical Director, Clinical Pharmacology|800-733-1333||
21242207|NCT00913913|Dartmouth-Hitchcock Medical Center|Dr. Marc Ernstoff|603-650-5534|marc.s.ernstoff@hitchcock.org|
21242208|NCT00686517|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21242209|NCT01803646|Auris Medical Inc.|Thomas Meyer, CEO|+1 312 396 4150|hear@aurismedical.com|
21242210|NCT02175212|Hospital Universitario de la Princesa; Health Research Institute IIS from Hospital Universitario de la Princesa|Dr. Almudena Zapatero|+34 91 520 23 15|almudena.zapatero@salud.madrid.org|
21242211|NCT01072357|Massachusetts Eye and Ear|Dr. Reza Dana|617-573-4431|Reza_Dana@meei.harvard.edu|4431
21242212|NCT01876511|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dung Le, MD|443-287-0002|dle@jhmi.edu|
21242213|NCT01048788|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
21242214|NCT02145182|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alexion.com|
21242215|NCT01196988|GlaxoSmithKline|GSK Response Center|866-435-7343||
21242216|NCT01233050|Penn Medicine|Dr. Najjia Mahmoud, MD, Cheif of Colorectal Surgery|(215) 662-2078|najjia.mahmoud@uphs.upenn.edu|
21242217|NCT01771666|Stanford University|Dr. Irene Wapnir|650-724-1953|Wapnir@stanford.edu|
21242218|NCT00601848|University of Pennsylvania|Keith A Cengel, MD, PhD|(215) 615-5312|cengel@pennmedicine.upenn.edu|
21242219|NCT01466881|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623|hongli@fredhutch.org|
21242220|NCT00957229|Children's Hospital of Oakland Research Institute, Oakland|Ervin H Epstein Jr., MD|510-450-5688|eepstein@chori.org|
21242221|NCT00606580|US Army Medical Materiel Development Activity (USAMMDA)|Division of Regulated Activies and Compliance|301-619-0317|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil|
21242222|NCT04580303|Endo Pharmaceuticals|Clinical Operations|1-800-462-3636|ClinicalTrials@Endo.com|
21242223|NCT01444287|Vistakon|Noel Brennan|1 904 4433494|nbrenna2@its.jnj.com|
21242224|NCT01833065|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21242225|NCT00434278|Genentech, Inc.|Medical Communications|800-821-8590||
21242226|NCT00927823|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21242227|NCT00828672|UZ Leuven|Prof. Dr. Eric Van Cutsem|+32 16 34 42 18|Eric.VanCutsem@uzleuven.be|
21242228|NCT00601640|University of Arizona/Arizona Cancer Center|Joanne Jeter, MD|520.626.9295|jjeter@azcc.arizona.edu|
21242229|NCT02427737|Hypnalgesics, LLC d/b/a Comfort Talk|Elvira V. Lang, MD (PI of SBIR grant sponsoring site-PIs); CEO|617 734 9087|drevlang@ComfortTalk.com|
21242230|NCT01134575|The University of Texas MD Anderson Cancer Center|Hagop M. Kantarnian, MD/Chair|713-792-7026|hkantarjian@mdanderson.org|
21242231|NCT01878890|Institut Bergonié|Dr Guilhem Roubaud|33 5 56 33 33 33|g.roubaud@bordeaux.unicancer.fr|
21242232|NCT02005666|Cadila Healthcare Limited|Mr Anuj K Saini|02717623666|Anuj.Saini@zyduscadila.com|314
21261600|NCT01330381|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21291890|NCT01356147|Stanford University School of Medicine/Division of Neonatology|Dr. Melissa Scala|650-724-9653|mscala@stanford.edu|
21291891|NCT04237584|MANA RBM|Penelope Manasco, CEO|9195566456|pmanasco@manarbm.com|
21291892|NCT02114177|Janssen Infectious Diseases BVBA|Associate Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
21291893|NCT01897493|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21291894|NCT01658059|Hadassah Medical Organization|Moti Moskovitz||motim@ekmd.huji.ac.il|
21261601|NCT01197573|Cleveland Clinic|Bijan Eghtesad, MD|216 444-9898|eghtesb@ccf.org|
21261602|NCT03163342|Altimmune|Stephanie Holland, Clinical Project Manager|240|Sholland@altimmune.com|40
21234650|NCT02377089|UCLA Semel Insititute|Andrew F. Leuchter|310-825-0207|afl@ucla.edu|
21234651|NCT00116558|University of Kentucky|Edward J. Kasarskis, M.D., Ph.D.|859-218-5061|ejkas@uky.edu|
21234652|NCT00357370|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
21234653|NCT01143090|Sunovion Pharmaceuticals Inc|Medical Director, CNS|1-866-503-6351||
21234654|NCT00499603|The University of Texas MD Anderson Cancer Center|Clinical Research Operations, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org|
21234655|NCT02662387|Loma Linda University Children's Hospital|Dr. Janeth Ejike|9095584000|jejike@llu.edu|44250
21234656|NCT05220397|Mayo Clinic|Mark Stegall, M.D.|507-266-2812|stegall.mark@mayo.edu|
21234657|NCT02052739|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
21234658|NCT02043015|Emory University|Patrick S Sullivan PhD/DVM|404-727-2038|pssulli@emory.edu|
21234659|NCT01403974|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21234660|NCT01526889|Novartis Pharmaceuticals|Study Director|+1 862-778-8300|Novartis.email@novartis.com|
21234661|NCT01990677|Wills Eye|Mitchell Fineman,MD|215-928-3092|research@midatlanticretina.com|
21234662|NCT03995953|Implenomics|Sujha Subramanian|(302) 200 8310|sujha.subramanian@implenomics.com|
21234663|NCT00006184|National Cancer Institute, National Institutes of Health|Dr, Claude Sportes, M.D.|301-435-5280|csportes@mail.nih.gov|
21234664|NCT02161718|Alkermes|Director, Corporate and R&D Communications|781-609-7000|Gretchen.Murphy@alkermes.com|
21234665|NCT00283933|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
21234666|NCT05124873|Liberating Technologies, Inc.|Brianna Rozell|774-233-0876|brianna.rozell@liberatingtech.com|
21234667|NCT00207142|Bristol-Myers Squibb|Study Director||clinical.trials@bms.com|
21234668|NCT01857063|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21234669|NCT04958109|Massachusetts General Hospital|Margaret Lippincott|6177268434|mlippincott@mgh.harvard.edu|
21234670|NCT01256710|Abbott Medical Devices, Structure Heart Valves|Yunlong (Phil) Zhang, MD, MS, Clinical Consultant|669-203-9308|phil.yl.zhang@abbott.com|
21234671|NCT00058825|Baylor College of Medicine|George Carrum, MD||GCarrum@houstonmethodist.org|
21234672|NCT03023488|Marmara University, School of Medicine, Department of Urology|Dr. Tarik Emre Sener|+905337620712|dr.emresener@gmail.com|
21234673|NCT02681302|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
21234674|NCT00838565|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21234675|NCT00458484|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Mitchell Machtay MD|216-844-2530|mitchell.machtay@uhhospitals.org|
21234676|NCT01838642|National Cancer Institute|Dr. James Gulley|301-496-4916|gulleyj@mail.nih.gov|
21234677|NCT01557400|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
21234678|NCT01153581|Yale School of Medicine|Nina Stachenfeld|203-562-9901|nina.stachenfeld@yale.edu|219
21234679|NCT00245765|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21234680|NCT04976530|CytoSorbents Corp|Weihong Fan|732-329-8885|wfan@cytosorbents.com|
21234681|NCT04477304|University of Southern California|Jason Doctor|(213) 821-8142|jdoctor@usc.edu|
21234682|NCT05677425|Haukeland University Hospital|Øyvind Ulvik|+47 97 50 00|doc.ulvik@online.no|
21234683|NCT03548584|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21234684|NCT00293384|Barbara Ann Karmanos Cancer Institute|Muneer Abidi, M.D.|(313) 576-8713|abidim@karmanos.org|
21234685|NCT00640510|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21234686|NCT01440322|Alcon Research, Ltd.|Sharon Holden Thomas, Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com|
21234687|NCT02267629|Stanford University|Dr. Carolyn Rodriguez, Assistant Professor, Director of Rodriguez Translational Therapeutics Lab|650-723-6158|cr2163@stanford.edu|
21234688|NCT02619409|Medical University of South Carolina|Dr. Eric Bolin|8437922322|bolin@musc.edu|
21234689|NCT02995915|Duke University Medical Center|Angela Kirby, MS|(919) 824-7729|angela.kirby@duke.edu|
21234690|NCT02624284|University of Pennsylvania|Mary Falcone, Ph.D.|215-746-3782|mfalc@pennmedicine.upenn.edu|
21234691|NCT01782313|Northwestern University|Mark Agulnik, MD|312 695 6182|magulnik@nm.org|
21234692|NCT00958776|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|919-859-1302||
21234693|NCT00326911|ImClone LLC|Chief Medical Officer||ClinicalTrials@ImClone.com|
21234694|NCT04027218|University|Ms. Leticia Carmen Simón López|+34 680721340|leticia.simon25@gmail.com|
21234695|NCT02506816|Medica Scientia Innovation Research (MedSIR)|Director of Operations|0034 932 214 135|alicia.garcia@medsir.org|
21234696|NCT02744846|Harvard Pilgrim Health Care Institute|Dr. Jason Block|6178674841|jblock1@partners.org|
21234697|NCT01288534|University of Michigan Comprehensive Cancer Center|Dr. Daniel Spratt, M.D.|734-936-9630|sprattda@med.umich.edu|
21234698|NCT00494494|University of North Carolina at Chapel Hill|Kennth L. Cohen, MD|919 843-0292|klc@med.unc.edu|
21234699|NCT02103478|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
21234700|NCT00723606|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21291895|NCT03198871|University of Pittsburgh School of Medicine / UPMC|Dr. Kathirvel Subramaniam MD MPH FASE|7247995852|subramaniamk@upmc.edu|
21242233|NCT00478556|UAB Hospital Radiology|Lisa Nelson|205-934-4015|lnelson@uabmc.edu|
21242234|NCT00831792|UT MD Anderson Cancer Center|Corn,Paul,M.D. Ph.D. / Genitourinary Medical Oncology|713-792-7734|PCORN@MDANDERSON.ORG|
21242235|NCT03736785|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21242236|NCT01982643|UCLA Integrated Substance Abuse Programs|Walter Ling, MD|310-267-5888|lwalter@ucla.edu|
21242237|NCT02974010|NeuroRx|Martin Brecher|+1 484 254 6134|mbrecher@neurorxpharma.com|
21242238|NCT01078233|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21242239|NCT00996372|Sprout Pharmaceuticals|VP, Clinical Development|9198820850|clinicaltrials@sproutpharma.com|
21242240|NCT04490148|Penn State College of Medicine|Dr. Andrew Geronimo|717 531 0003|ageronimo@pennstatehealth.psu.edu|282576
21242241|NCT02595398|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
21242242|NCT00502593|GlaxoSmithKline|GSK Response Center|866-435-7343||
21242243|NCT00880906|Vanderbilt University|Michael Vaezi, MD, PhD|615-322-3739|michael.vaezi@vanderbilt.edu|
21242244|NCT00544440|Clinical Research, Janssen R&D, 10990 Wilshire Blvd, Suite 1200, Los Angeles, CA 90024|Senior Director|310-943-8040||2917
21242245|NCT03601507|University of Arizona Cancer Center|Ricklie Julian, MD|520-694-2873|rickliej@arizona.edu|
21242246|NCT05650333|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Centre|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21242247|NCT03061513|Weill Cornell Medical College|Claire Henchcliffe|2127462584|clh2007@med.cornell.edu|
21242248|NCT01460342|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21242249|NCT00683410|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21242250|NCT02107014|University of Alabama at Birmingham|Dr. Jarred Younger|2059755821|younger@uab.edu|
21242251|NCT00591838|Washington University School of Medicine|Clifford Robinson, M.D.|314-362-4633|clifford.robinson@wustl.edu|
21242252|NCT03586167|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21242253|NCT03761784|Sol-Gel Technologies, Ltd.|Sol-Gel|972-8-9313433|info@sol-gel.com|
21242254|NCT03058783|Bausch Health Americas, Inc|Study Director|19083009920|susan.harris@bauschhealth.com|
21242255|NCT00586339|GlaxoSmithKline|GSK Response Center|866-435-7343||
21242256|NCT02001714|Beaumont Health|Ananias C. Diokno, MD||ananias.diokno@beaumont.edu|
21242257|NCT04163458|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
21242258|NCT00295867|UCSF Helen Diller Family Comprehensive Cancer Center|Hope S. Rugo|415-353-7618|hrugo@medicine.ucsf.edu|
21242259|NCT03852433|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21242260|NCT01981850|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21242261|NCT01467700|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
21242262|NCT03168438|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21242263|NCT01103973|Boston IVF|Alice D. Domar, PhD|781-434-6500|domar@domarcenter.com|
21242264|NCT04109118|Boston Medical Center and BU School of Medicine|Tae Woo Park, MD|617-414-1906|taewoo.park@bmc.org|
21279630|NCT00337181|Thai Ministry of Public Health|Supachai Rerks-Ngarm|6629659571|supachai@health.moph.go.th|
21279631|NCT02495623|Synthetic Biologics Inc|Michael Kaleko|(240) 238-3862|mkaleko@syntheticbiologics.com|
21279632|NCT04252092|Eksen Sağlık ve Rehabilitasyon|PT,Cansu Hayıroğlu|+905378405948|cansu5309@gmail.com|
21279633|NCT00534404|University of Michigan|Larry An, MD|734-763-6099|lcan@med.umich.edu|
21279634|NCT02996487|Beaumont Hospitals|Maureen Cooney|248 551-0099|maureen.cooney@corewellhealth.org|
21279635|NCT02027428|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
21279636|NCT01307748|Oregon Health & Science University|Irina Chamine|503.577.6211|fonareva@ohsu.edu|
21279637|NCT01128543|GlaxoSmithKline|GSK Response Center|866-435-7343||
21279638|NCT04487067|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21279639|NCT00299130|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21279640|NCT03516513|University of Washington|Michael Pullmann|6158304563|pullmann@uw.edu|
21279641|NCT02881840|Acacia Pharma Ltd|Dr Gabriel Fox|+44-(0)1223-919764|GabrielFox@acaciapharma.com|
21279642|NCT01098487|GlaxoSmithKline|GSK Response Center|866-435-7343||
21279643|NCT00345631|Cordis Corporation, a Johnson&Johnson company|Hans-Peter Stoll, M.D.|908-541-4770|hpstoll@its.jnj.com|
21279644|NCT00517556|The Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-6210|rsl1@psu.edu|
21234701|NCT01470469|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21234702|NCT03362502|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21234703|NCT02509065|Massachusetts General Hospital|Courtney A Balliro|617-726-1242|cballiro@partners.org|
21234704|NCT02471521|Seoul National University Hospital|Jin-Tae Kim|82-2-2072-3661|jintae73@gmail.com|
21234705|NCT02016963|Human Genome Sciences Inc.|GSK Response Center|866-435-7343||
21234706|NCT02388997|University of Virginia|Peter W. Heymann|434-982-3654|pwh5a@virginia.edu|
21234707|NCT00384813|Emory University School of Medicine|Marianne Celano, PhD, ABPP|404-778-1536|mcelano@emory.edu|
21234708|NCT00715793|University of Pittsburgh|Hussein Tawbi, MD, PhD|713-792-6111|HTawbi@mdanderson.org|
21234709|NCT02346240|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21234710|NCT01573624|GlaxoSmithKline|GSK Response Center|866-435-7343||
21234711|NCT02942017|Sage Therapeutics|Medical Monitor|617-299-8380|info@sagerx.com|
21234712|NCT04399161|JSS Dental College & Hospital, JSS Academy of Higher Education & Research|Dr. Krupa NC|8105064056|kripa_555@yahoo.com|+91
21234713|NCT03417141|Mayo Clinic|Jason C. Sluzevich, M.D.|904-953-6192|Sluzevich.Jason@mayo.edu|
21234714|NCT02722928|The Ohio State University Wexner Medical Center|Juan Fiorda-Diaz Postdoctoral Researcher|6142933559|juan.fiorda@osumc.edu|
21279645|NCT02064985|Pharmaceutical Product Development, LLC.|Rong Fu|86-021-80135112|rong.fu@ppdi.com|
21261603|NCT01272180|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
21261604|NCT03351244|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21261605|NCT01120639|Stanford University|Dr. Scott Soltys (Associate Professor of Radiation Oncology)|650-724-1569|sgsoltys@stanford.edu|
21279646|NCT01326923|LSU Health Shreveport|J.K. Miller|318 8131406|jmil12@lsuhsc.edu|
21279647|NCT01589497|ACTG Network Coordinating Center, Social & Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21234715|NCT03571516|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21234716|NCT04552587|Medical University of South Carolina|Katherine R. Sterba, PhD, MPH|843- 876-2419|sterba@musc.edu|
21234717|NCT01822132|Oregon Health & Science University|Dr. Todd Korthuis|503-494-8044|korthuis@ohsu.edu|
21234718|NCT01467999|NYSPI|daniel brooks|6467746171|daniel.brooks@nyspi.columbia.edu|
21234719|NCT00291668|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21234720|NCT00313612|Montefiore Medical Center|Lisa Escobar-Peralta|718-379-6866|lescobar@montefiore.org|
21234721|NCT02540954|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21234722|NCT00213148|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21234723|NCT01723228|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21234724|NCT02434770|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
21234725|NCT03080961|CLJI WORLDWIDE|Ty Cross, President & CEO|305-397-8880|tycross@cljiworldwide.com|
21234726|NCT00660348|Sidney Kimmel Comprehensive Cancer Center|Michael Erdek, MD|410-502-7388|merdek1@jhmi.edu|
21234727|NCT01617603|Medical School, Michael White Diabetes Centre, 220-236, Anlaby Road,|Prof. Stephen Atkin, Principal Investigator|+44(0)1482 675312|Stephen.Atkin@hyms.ac.uk|
21234728|NCT04174313|Hospital El Cruce|Nestor Pistillo|054 1142109000|npistillo@yahoo.com.ar|5636
21234729|NCT01282424|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21234730|NCT02741115|Mezzion Pharmaceuticals, Inc|Director of Clinical Trials|5734342579|kelly.williams@mezzion.com|
21234731|NCT04602624|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
21234732|NCT00445328|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21234733|NCT00316199|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21234734|NCT03316872|Princess Margaret Cancer Centre|Dr. Jennifer J Knox|+1-416-946-2399|jennifer.knox@uhn.ca|
21234735|NCT02285504|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
21234736|NCT02742103|CSL Behring|Trial Registration Coordinator|6108784000|clinicaltrials@cslbehring.com|
21234737|NCT04346615|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21234738|NCT02449356|Xiangya Hospital|Jiali Shao|+8684327413|zwyfeng@163.com|
21234739|NCT00533949|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21234740|NCT00727194|Alexion Pharmaceuticals|Alexion Pharmaceuticals|855-752-2356|clinicaltrials@alexion.com|
21234741|NCT05226104|UT Southwestern|Research Coordinator|214-645-8907|jennifer.barillas@utsouthwestern.edu|
21234742|NCT01516268|Tehran University of Medical Sciences|Dr. Laleh Eslamian|0098218490|leslamian@tums.ac.ir|2415
21234743|NCT01595516|University of Colorado|Dr. Christopher DeSouza|303-492-2988|desouzac@colorado.edu|
21234744|NCT01677195|University of Texas Health Science Center at San Antonio / University of California, Davis* current|Dr. Bradley H. Pollock, PI|(530) 752-7250|pbollock@ucdavis.edu|
21234745|NCT04368429|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21234746|NCT03633396|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
21234747|NCT01012817|Mayo Clinic|Andrea Wahner Hendrickson MD|507-293-0553|WahnerHendrickson.Andrea@mayo.edu|
21234748|NCT00023673|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org|
21234749|NCT02472756|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21234750|NCT00110266|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21234751|NCT04031885|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21234752|NCT01344057|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21234753|NCT02871128|Chung Shan Medical University|Dr. You-Cheng Shen|+886-4-24730022|youcheng@csmu.edu.tw|12107
21234754|NCT03854916|Klein Buendel, Inc.|Dr. David Buller|3035654321|dbuller@kleinbuendel.com|
21234755|NCT00548808|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21234756|NCT04300296|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21234757|NCT01962558|MicroTransponder|VP Clinical Affairs|512-371-4160|studies@microtransponder.com|
21234758|NCT00279708|The National Institutes of Health/ The National Heart, Lung, and Blood Institute|Joseph Fontana, MD|301-451-7740|fontanaj@nhlbi.nih.gov|
21234759|NCT02896127|Novartis PharmaAG|Study Lead|+41613241111|novartis.email@novartis.com|
21234760|NCT02940691|Kirby Institute|Professor Jason Grebely|+61 2 9385 0957|jgrebely@kirby.unsw.edu.au|
21234761|NCT00622427|University of Alabama at Birmingham|Rachel Fargason|205-934-5151|mfargason@uab.edu|
21234762|NCT03592641|Duke University Medical Center|John Strickler, MD|919-668-1861|john.strickler@duke.edu|
21234763|NCT01403090|BiO2 medical|Luis Angel, MD|2102139778|langel@bio2medical.com|
21234764|NCT01049919|Zimmer Biomet|Hillary Overholser|574-373-2042|hillary.overholser@zimmerbiomet.com|
21234765|NCT01126541|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21234766|NCT02984995|Daiichi Sankyo Co., Ltd.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21234767|NCT04354831|Medical College of Wisconsin|Mary Beth Graham, MD|414-955-0500|mbgraham@mcw.edu|
21291896|NCT01246960|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21234768|NCT06285981|Orthofix|Clinical Program Manager|0456719077|danielacangiano@orthofix.it|
21242265|NCT03235349|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21242266|NCT03394027|National Cancer Institute|Dr. Stanley Lipkowitz|240-760-6129|lipkowis@navmed.nci.nih.gov|
21242267|NCT04432974|Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia|Dr. Massimiliano Paltenghi|(+39) 3487046844|massimiliano.paltenghi@spedalicivili.brescia.it|
21242268|NCT05191797|University of Washington|Rafael Santana-Davila|2066062190|rafaelsd@uw.edu|
21242269|NCT05887323|Abbott|Director of Clinical Research|9725269673|kwangdeok.lee@abbott.com|
21242270|NCT04305912|CooperVision, Inc|Jose Vega, OD, MSc, FAAO|9256213761|JVega2@coopervision.com|
21261606|NCT01844076|Fox Chase Cancer Center|Crystal Denlinger MD, FACP|215-214-1676|Crystal.Denlinger@fccc.edu|
21261607|NCT05483127|Alcon Research, LLC|Associate Director, CRD Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21261608|NCT02951273|Rigshospitalet|Niels D. Olesen|004520262459|niels.damkjaer.olesen.01@regionh.dk|
21261609|NCT00121225|Princess Margaret Cancer Centre|Dr. David Hogg|416-946-4501|david.hogg@uhn.ca|4521
21261610|NCT00217438|Fred Hutchinson Cancer Research Center|Dr. William Bensinger|206-667-4933|wbensing@fhcrc.org|
21261611|NCT02437669|Columbia University College of Physicians and Surgeons|Daniel S. Tsze, MD, MPH|212-305-9825|dst2141@columbia.edu|
21261612|NCT00308620|University of Minnesota|David Boulware|6126269546|boulw001@umn.edu|
21261613|NCT05780281|University of Minnesota|Greg Grandits|651-528-9491|greg-g@ccbr.umn.edu|
21261614|NCT03002506|Texas Tech UHSC|Ronald Hall, PharmD, MSCS|214-358-9009|ronald.hall@ttuhsc.edu|
21261615|NCT01025336|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21261616|NCT01165229|GlaxoSmithKline|GSK Response Center|866-435-7343||
21261617|NCT00474253|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21261618|NCT02255838|University of Louisville|Rainer Lenhardt|5028523122|rainer.lenhardt@louisville.edu|
21261619|NCT01512368|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|Dr. Daniel Cuevas-Ramos|525554870900|shiverqks@hotmail.com|2407
21261620|NCT02532543|University of North Carolina at Chapel Hill|Gidgetta Kang|919-537-3968|gidgetta_jenkins@unc.edu|
21261621|NCT05207436|VA San Diego Healthcare System|Leslie Morland|858-226-5765|leslie.morland@va.gov|
21261622|NCT00906789|Georgetown University Medical Center|Matthew T. Freedman|4105429680|MTFreedman@verizon.net|
21261623|NCT01319929|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21261624|NCT04355117|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21261625|NCT01645280|Janssen Pharmaceuticals|Senior Director Clin Development||ClinicalTrialDisclosure@its.jnj.com|
21261626|NCT02228499|The George Washington University|Dr. Seema Agrawal|202 699 1648|seema300@yahoo.com|
21261627|NCT04429932|Nerudia Ltd|Paul Morris|+44 7508 708 917|paul.morris@nerudia.com|
21261628|NCT02049502|Emory University|Dr. Shaffer|404-778-5033|virginia.o.shaffer@emory.edu|
21261629|NCT05439928|Columbia University|Magdalena Bogun, MD|2128515494|mmb2263@cumc.columbia.edu|
21261630|NCT03368404|Bausch + Lomb|Associate Director, Global Clinical Operations|+49 30 330 93|natasa.orlic-pleyer@bausch.com|318
21261631|NCT02514070|National Heart Lung and Blood Institute (NHLBI)|Marcelo J. Amar, M.D. Principal Investigator, NIH, NHLBI|301-402-0521|mamar@nhlbi.nih.gov|
21261632|NCT00153166|Brigham and Women's Hospital|Mark Creager|617-732-5267|mcreager@partners.org|
21261633|NCT01751646|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
21261634|NCT02190591|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
21261635|NCT00857246|Perlmutter Cancer Center|Theresa Ryan, MD|212-731-5430|theresa.ryan@nyumc.org|
21261636|NCT02426086|Geron Corp.|Study Director|650-473-7700|myf2001-info@geron.com|
21261637|NCT04542291|Washington University School of Medicine|Kian-Huat Lim, M.D.|314-362-6157|kian-huat.lim@wustl.edu|
21261638|NCT00524303|GlaxoSmithKline|GSK Response Center|866-435-7343||
21261639|NCT03478683|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21261640|NCT01134510|Cedars-Sinai Medical Center|Stanely Jordan, MD|310-428-8186|stan.jordan@cshs.org|
21261641|NCT03037905|Cleveland Clinic|Christian N. Burchill, PhD, RN, CEN|216-445-9317|burchic@ccf.org|
21261642|NCT01607892|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
21261643|NCT03983941|Nationwide Children's Hospital|Julie Rice-Weimer, RN|614-355-3142|julie.rice-weimer@nationwidechildren.org|
21261644|NCT03022422|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
21261645|NCT01287117|Genentech, Inc.|Medical Communications|800 821-8590||
21261646|NCT01274897|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21261647|NCT02042131|The University of Utah|Craig Bryan|801-587-7978|craig.bryan@utah.edu|
21261648|NCT01769404|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21261649|NCT02768129|Butler Hospital|Benjamin Greenberg|(401) 455-6200|bgreenberg@butler.org|
21261650|NCT03461965|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Margaret Mann, MD|1-800-641-2422|CTUReferral@uhhospitals.org|
21261651|NCT02862912|Columbia University|Dr. Allison Lee|212-305-6494|al3196@cumc.columbia.edu|
21261652|NCT03572634|Sr. Director Drug Development/Clinical Operations|Susan Smith|210-414-7702|s.smith@toleropharma.com|
21261653|NCT02293954|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
21261654|NCT00538642|University of Texas Health Science Center at San Antonio|Dr. Alexander Miller|210-567-5508|millera@uthscsa.edu|
21261655|NCT02277444|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21261656|NCT05278104|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21261657|NCT05635838|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21261658|NCT03412630|ECOG-ACRIN Statistical Office|Study Statistician|4018639181|ecog-acrin@stat.brown.edu|
21261659|NCT02031146|University of Washington|Christina Marra, MD|206-744-3251|cmarra@uw.edu|
21261660|NCT02629393|Origin Biosciences (affiliate of BridgeBio)|Business Development and Operations|650-391-9740|info@bridgebio.com|
21242271|NCT00928200|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
21242272|NCT01348087|Novartis Pharmaceuticals|Study Director|862-778-8300||
21242273|NCT00555581|Hospital for Special Surgery|Robert F. Spiera|212-774-2048|spierar@hss.edu|
21242274|NCT01210820|AMO Development, LLC|Carrie Garufis|714-566-3728|carrie.garufis@amo.abbott.com|
21242275|NCT00538213|GlaxoSmithKline|GSK Response Center|866-435-7343||
21242276|NCT03140176|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21242277|NCT03196167|Yale University|Amit Bardia|2038436469|amit.bardia@yale.edu|
21242278|NCT02234128|Lung Bioengineering Inc.|Michael Roberts, Director Regulatory Affairs|2406502261|mroberts@lungbioengineering.com|
21242279|NCT03179787|Otsuka Pharmaceutical Co., Ltd.|Section Chief of Pharmacovigilance|+81-3-6717-1400|Sugimoto.Yuna@otsuka.jp|
21242280|NCT02030028|University of Pittsburgh|Dr. Dana Ascherman (Principal Investigator)|14123838123|DAscher@pitt.edu|
21242281|NCT00149630|Baylor College of Medicine|Thomas R. Kosten, M.D.|(713) 794-7032|kosten@bcm.edu|
21242282|NCT00427557|MD Anderson Cancer Center|Dr. Partow Kebriaei|713-563-5174|celsaenz@mdanderson.org|
21242283|NCT03667547|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21242284|NCT03223883|University of Iowa Carver College of Medicine|Dr. Diana Jalal|319-356-3500|diana-jalal@uiowa.edu|
21242285|NCT02657629|HackensackUMC|Nicole Spillane MD|917-446-6656|nspillane@hackensackumc.org|
21242286|NCT00516503|Mayo Clinic|Debra Barton, R.N., Ph.D.||Barton.debra@mayo.edu|
21242287|NCT03357341|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21242288|NCT02162667|Celltrion|Head of Clinical Planning Department|82328505000|contact@celltrion.com|
21242289|NCT01956669|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21242290|NCT01570751|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21242291|NCT00930813|Lutonix Inc. a subsidiary of C.R. Bard|Chris Barry|763-445-2352|LutonixResearch@crbard.com|
21242292|NCT00315120|University of North Texas Health Science Center-The Osteopathic Research Center|John C. Licciardone, DO, MS, MBA|817-735-2028|john.licciardone@unthsc.edu|
21242293|NCT05790408|Northwestern University|Angelo P. Tanna|3129088152|atanna@northwestern.edu|
21242294|NCT01693614|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21242295|NCT01131494|University Federal of Bahia|Natalie Argolo Ponte|55 31 3274 5579|natyargolo@hotmail.com|
21242296|NCT05419557|Inova Health System|Dr. Elyssa Wood|5714728649|elyssa.wood@inova.org|
21242297|NCT00016913|Department of Medicine, Memorial Sloan-Kettering Cancer Center|Wm. Kevin Kelly, DO||kellyw@mskcc.org|
21242298|NCT00588666|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org|
21242299|NCT02281318|GlaxoSmithKline|GSK Response Center|866-435-7343||
21242300|NCT05257798|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21242301|NCT00812877|Oregon Health & Science University|Dr. Thomas J. Hilton|503.494.8672|hiltont@ohsu.edu|
21242302|NCT00703911|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21242303|NCT01064817|Promedior, Inc.|Elizabeth G. Trehu, MD|781-538-4203|btrehu@promedior.com|
21279648|NCT02803229|New York State Psychiatric Institute|Frances R Levin, MD|6467746137|frl2@cumc.columbia.edu|
21279649|NCT03390426|Duke University Medical Center|William Michael Bullock, MD, PhD|919-681-6437|william.bullock@duke.edu|
21279650|NCT02593682|University of California, San Francisco|Dr. Andrew Goddard|(317) 274-3960|agoddard@fresno.ucsf.edu|
21279651|NCT02906241|Wayne State University/Karmanos Cancer Institute|Susan Eggly, PhD|313-576-8260|egglys@karmanos.org|
21279652|NCT00259272|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21279653|NCT01325181|Seoul National University Hospital|Jang Won Heo|82220720836|hjw68@snu.ac.kr|
21279654|NCT03301623|Cedars-Sinai Medical Center|Brennan Spiegel|310-423-6467|brennan.spiegel@cshs.org|
21279655|NCT01203020|WV Cancer Institute|Abraham Kanate|3049065228|tlr0011@hsc.wvu.edu|
21279656|NCT01653912|Novartis Pharma AG|Study Director|+41 613241111||
21279657|NCT00708227|Nemours Children's Specialty Care|Kathryn Blake|9046973806|kathryn.blake@nemours.org|
21279658|NCT04007991|Emalex Biosciences, Inc.|Clinical contact|7150562|dkim@emalexbiosciences.com|1847
21279659|NCT05314816|Medical College of Wisconsin|Dr. Kelly Graff|414-266-4123|kegraff@mcw.edu|
21279660|NCT01290302|Luitpold Pharmaceutical, Inc|Marsha Simon|631-772-3507|msimon@lpicrd.com|61807
21279661|NCT05938621|Vanderbilt University Medical Center|Dr. Carolyn Audet|615-343-2418|carolyn.m.audet@vanderbilt.edu|
21279662|NCT00678210|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21279663|NCT04825912|Duke University|Katherine Ramos, Ph.D.|919-416-3434|Katherine.Ramos@duke.edu|
21279664|NCT00459355|Bedford VA Medical Center|Dr. Kathy Horvath|781-687-2006|Kathy.Horvath@va.gov|
21279665|NCT01808547|InSite Vision|Senior Manager, Clinical Sciences||manjiri.desai@sparcmail.com|
21279666|NCT00618371|University of Pittsburgh|Deborah McMahon|412-383-1675|mcmahond@pitt.edu|
21279667|NCT03965689|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
21279668|NCT00478062|Johns Hopkins Sidney Kimmel Cancer Center|Yvette Kasamon|4109135018|ykasamon@jhmi.edu|
21279669|NCT01173120|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21279670|NCT02037425|Clinvest/A Division of Banyan Group Inc.|Dr. Roger Cay, M.D.|417-883-7889|rcady@banyangroupinc.com|
21242304|NCT03102710|Massachusetts General Hospital, Harvard Medical School|Jian Kong, Principal Investigator|617-726-7893|jkong2@mgh.harvard.edu|
21242305|NCT01368406|Programa de Esquizofrenia PROESQ UNIFESP|Cecilia Attux|551155733599|cattux@gmail.com|
21279671|NCT03870880|Laboratorios Farmacéuticos Rovi, S.A.|Director of Medical Department|91 375 62 30|departamento.medico@rovi.es|
21279672|NCT01383707|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21242306|NCT02228408|New York University Medical Center|David Charytan|(646) 501-9086|david.charytan@nyulangone.org|
21242307|NCT00618540|University of Minnesota, Pediatric BMT|Dr. Angela Smith, MD|612-626-2778|smith719@umn.edu|
21242308|NCT00130780|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris, Attending|+1646-888-4205|krism@mskcc.org|
21242309|NCT02299635|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21242310|NCT00543725|Janssen Infectious Diseases BVBA|Medical Leader|32 14 641418||
21242311|NCT00906698|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21242312|NCT01250002|Northwestern University|Gildasio De Oliveira, MD|312-926-8373|g-jr@northwestern.edu|
21242313|NCT02430181|Eiger BioPharmaceuticals, Inc|Senior VP, Clinical Development|1-650-618-1621|info@eigerbio.com|
21242314|NCT03879642|Nemours Children's Health-Jacksonville|Dr. Susana Patton|904-697-2000|susana.patton@nemours.org|
21242315|NCT04054661|PATH|Pooja Bansil|206 302 4920|pbansil@path.org|
21242316|NCT00578214|Mayo Clinic|Dr. Clark C. Otley|507-284-3579|otley.clark@mayo.edu|
21242317|NCT00567164|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21242318|NCT00001575|National Cancer Institute|Thomas Waldmann M.D.|301-496-6653|waldmann@nih.hhs.gov|
21242319|NCT03256344|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21242320|NCT00404079|Oslo University Hospital Ullevaal|Project Manager: Philip Wilkens|004723016140|philip.wilkens@medisin.uio.no|
21242321|NCT00853827|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21242322|NCT01879371|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21242323|NCT02606734|Osprey Medical|Michele Shepard|952-955-5236|mshepard@ospreymed.com|
21242324|NCT01506362|BioLineRx LTD|Dr. Arnon Aharon|972-2-548-9100|arnona@biolinerx.com|135
21242325|NCT01636206|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21242326|NCT00580801|Janssen Research & Development, LLC, Titusville, NJ|Clinical Leader|609-730-3174||
21242327|NCT01664104|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21242328|NCT00559949|UNC Lineberger Comprehensive Cancer Center|Dr. David Neil Hayes|919-966-3786|hayes@med.unc.edu|
21242329|NCT02512042|Teva Pharmaceuticals USA, Inc.|Director, CE Studies|1-888-483-8279|USMedinfo@tevapharm.com|
21242330|NCT01335932|FHCRC|Dr.Michael Boeckh|206 667-6706|mboeckh@fredhutch.org|
21242331|NCT03320096|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
21242332|NCT00952718|ChangGungMH|Dr. Liaw MY|+8867317123|myliaw1@yahoo.com.tw|8199
21242333|NCT01194258|Halozyme Therapeutics|Vice President, Endocrinology Clinical Development|858-794-8889||
21242334|NCT01078246|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21242335|NCT00121199|SWOG Statistical Center|Study Statistician|206-667-4623||
21242336|NCT01830842|University of Arkansas for Medical Sciences|Merideth Addicott|501-526-8436|MAddicott@uams.edu|501
21242337|NCT01560143|University of Michigan|Manjunath Pai|7346473466|amitpai@med.umich.edu|
21242338|NCT02824432|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21242339|NCT05822440|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21242340|NCT05365386|Novoxel Ltd|Dr. Ifat Klein|+972.52-6009860|ifat@novoxel.com|
21242341|NCT00117988|UT MD Anderson Cancer Center|Dr. Anas Younes, MD / Professor||etubbs@mdanderson.org|
21242342|NCT03563053|Quince Therapeutics (former Erydel SpA)|Irene Maccabruni, M.Sc.|+39 02 36504470|imaccabruni@quincetx.com|
21242343|NCT00124982|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21242344|NCT01137292|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21242345|NCT04549051|Albert Einstein College of Medicine|Sayed Wahezi, M.D.|718-920-7246|swahezi@montefiore.org|
21242346|NCT01311713|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21242347|NCT00731211|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21242348|NCT03598790|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21242349|NCT05570006|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21242350|NCT03888144|Cleveland Clinic foundation|Dr Sriharan Sivalingam|2162130159|SIVALIS@ccf.org|
21242351|NCT03919955|Brigham and Women's Hospital|Scott Sands|8579280341|scottysands@gmail.com|
21242352|NCT05333263|Mayo Clinic|Kenton Kaufman, Ph.D|507-284-2262|Kaufman.Kenton@mayo.edu|
21242353|NCT03410992|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21242354|NCT04804605|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
21242355|NCT05323630|West End Plastic Surgery|Paul G. Ruff, MD|202-785-4187|drruff@westendplasticsurgery.com|
21242356|NCT04018066|Rutgers, The State University of New Jersey|Dr. Diana Roopchand, Study Investigator|8489320248|roopchand@sebs.rutgers.edu|
21242357|NCT03568318|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21242358|NCT05245669|Alkem Laboratories Limited|Dr. Akhilesh Sharma|+91- 9701346369|akhilesh.sharma@alkem.com|
21242359|NCT04988295|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21242360|NCT05546515|Johns Hopkins School if Medicine|Jennifer Ellis|4105506346|jellis36@jhmi.edu|
21242361|NCT04083976|Janssen Research & Development, LLC|Executive Medical Director Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21242362|NCT04618471|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
21242363|NCT04936035|Alnylam Pharmaceuticals|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
21242364|NCT01313182|New York University School of Medicine|Dr. Michael Phillips|212 263 4316|michael.phillips@nyumc.org|
21242365|NCT03673124|The GOG Foundation, Inc.|Brian Slomovitz, MD|1-215-854-0770|bslomovitz@gog.org|
21279673|NCT00180661|Imperial College London|Professor Fan Chung|00442075947954|f.chung@imperial.ac.uk|
21242366|NCT03745794|UT MD Anderson Cancer Center|Dr. Ching-Wei D. Tzeng, MD/Associate Professor, Surgical Oncology|(713) 792-0386|cdtzeng@mdanderson.org|
21242367|NCT05827926|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
21242368|NCT05197049|Janssen-Cilag International NV|Senior Medical Leader IMM|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21242369|NCT04889118|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21242370|NCT04131933|Ottawa Hospital Research Institute|Dr. Mark Clemons|+1-613-737-7700|mclemons@toh.ca|70170
21242371|NCT02846415|School of Nursing, The Hong Kong Polytechnic University|Dr Daphne Cheung|+852 27664534|cheungdaphne@polyu.edu.hk|
21242372|NCT05576051|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21242373|NCT04154943|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21242374|NCT04930822|Gaylord Hospital|Dr. Henry Hrdlicka|2032842864|hhrdlicka@gaylord.org|
21242375|NCT03381274|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21242376|NCT05916170|Wake Forest University Health Sciences|Dr. Erin Sutfin|336-713-5282|erin.sutfin@wfusm.edu|
21291897|NCT05111145|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21242377|NCT03412747|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21242378|NCT04075266|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21242379|NCT05905302|Cleveland Clinic|Jay Alberts, PhD|216-445-3222|albertj@ccf.org|
21242380|NCT03473743|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21242381|NCT03610698|Northwestern University|Project Manager|3125035247|amanda.summers@northwestern.edu|
21242382|NCT02864992|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21242383|NCT04982575|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21242384|NCT05483933|Shattuck Labs|VP, Clinical Operations|919-864-2700|clinicaltrials@shattucklabs.com|
21242385|NCT04948333|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
21242386|NCT03038022|Madrigal Pharmaceuticals, Inc.|Thomas Hare|267-268-7800|thare@madrigalpharma.com|
21242387|NCT03887936|Michael E. DeBakey VA Medical Center|Dr, Reina Villareal|314-313-4550|reina.villareal@bcm.edu|
21242388|NCT00539591|St. Jude Children's Research Hospital|Alberto Pappo, MD|901-595-2322|info@stjude.org|
21242389|NCT06269367|University of Michigan|Chandramouli Krishnan|(734) 936-4031|mouli@umich.edu|
21242390|NCT03331250|Massachusetts General Hospital|Gregory Cote, MD, PhD|617-726-8748|GCOTE@mgh.harvard.edu|
21242391|NCT01615809|Fundaciò per la Recerca i la Docencia sant Joan de Deu|Rosa Maria morales Palau|936009751|rmorales@fsjd.org|
21242392|NCT06078774|Virginia Commonwealth University|Sarah Farthing|804-527-4756|sarah.malone@vcuhealth.org|
21242393|NCT02137850|Novo Nordisk A/S|Clinical Reporting Office (2834)|866-867-7178|clinicaltrials@novonordisk.com|(+1)
21242394|NCT02912260|Madrigal Pharmaceuticals, Inc.|Thomas Hare|267-268-7800|thare@madrigalpharma.com|
21242395|NCT05005429|Fundación GECP|Eva Pereira|+34 934302006|gecp@gecp.org|
21242396|NCT00980538|Janssen Research & Development, LLC|DIRECTOR CLINICAL LEADER EST PRODUCTS|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21242397|NCT03878446|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21242398|NCT05663866|Janssen Research & Development LLC|Senior Medical Director Global Medical Affair Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21242399|NCT01467427|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21242400|NCT03805295|Massachusetts General Hospital|Dr. Rachel Whooten|6176434585|rwhooten@mgh.harvard.edu|
21242401|NCT04925752|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21242402|NCT04269200|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21242403|NCT04181827|Janssen Research & Development, LLC|Executive Medical Director Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21242404|NCT04538664|Janssen Research & Development|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21242405|NCT03681678|William Beaumont Hospital|Jennifer Giordano|248-551-3517|jennifer.giordano@corewellhealth.org|
21242406|NCT03431350|Janssen Research & Development, LLC|Executive Medical Director Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21242407|NCT04540822|CHD Vendée|Stéphanie BREHU|06 88 39 85 17|stephanie.brehu@ght85.fr|+33
21242408|NCT02141074|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21242409|NCT03536884|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21242410|NCT03301220|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21242411|NCT04845620|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
21242412|NCT05803720|RAND|Dr. Lu Dong|3103930411|ldong@rand.org|7494
21242413|NCT03370133|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21242414|NCT06688370|Pierre Fabre Médicament|Aurore Puglisi Mouton|+335679463982|aurore.puglisi.mouton@pierre-fabre.com|
21242415|NCT04540835|Baskent University|Leyla Kerimova Köse|+905378986689|lkerimova@baskent.edu.tr|
21242416|NCT04487080|Janssen Research & Development|Global Medical Head Onc|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21242417|NCT03105336|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
21242418|NCT03451851|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21242419|NCT05150210|Intuitive|Anna Virk|1 480-676-3938|SP.Thoracic@intusurg.com|
21242420|NCT07214922|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21234769|NCT02942979|VA Bedford Medical Center|David Smelson|781-687-2845|david.smelson@va.gov|
21234770|NCT02504372|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21234771|NCT03323099|University of California San Francisco|Dr. Greg Marcus|4154763393|greg.marcus@ucsf.edu|
21234772|NCT00767676|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
21234773|NCT02082717|Baptist Health South Florida|Diana D'Orazio-Garcia|786-594-9737|DianaDO@baptisthealth.net|
21234774|NCT01502644|Brigham and Women's Hospital|Ajay D. Wasan, M.D., M.Sc.||awasan@partners.org|
21234775|NCT01409291|Creighton University|Kathleen Packard, PharmD, MS, BCPS (AQ Cardiology)|402-481-3915|kathleenpackard@creighton.edu|
21234776|NCT00547703|Cleveland Clinic Florida|Fernando Castro|954-659-5646|castrof@ccf.org|
21234777|NCT00531843|UCSF/SF General Hospital|M. Margaret Knudson, MD|415.205.4623|pknudson@sfghsurg.ucsf.edu|
21234778|NCT03078946|Ain-Shams University Hospitals|Dr. Ibrahim Mamdouh Esmat|01001241928|ibrahim_mamdouh@med.asu.edu.eg|
21234779|NCT03120013|University of Brescia|Prof. Barbara Borroni|+39 0303995631|bborroni@inwind.it|
21234780|NCT05059600|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
21234781|NCT06259331|Supernus|Charlene A. Tucker|(301) 838-2500|ctucker@supernus.com|
21234782|NCT02800148|Perrigo|Associate Director|718-960-9900|jonathan.schwartz@perrigo.com|
21234783|NCT02940327|University of Leicester|Clinical Trials Co-ordinator|0116 250 2427|ha200@le.ac.uk|
21234784|NCT04907032|UAB|Russell Stanley|325-829-8315|russellstanley74@gmail.com|
21234785|NCT02253810|Hospital for Special Surgery|Dr. Ernest Sink|2126061279|Sinke@hss.edu|
21234786|NCT03900299|Alexandria university|DR. mostafa elsayed|560566541|m_elsayed2009@yahoo.com|+966
21234787|NCT03465878|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21234788|NCT04019041|Janssen Research & Development, LLC|Director Clinical Research Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21234789|NCT01393743|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
21234790|NCT05409235|Chief Development Officer|D. Scott Edwards, Ph.D.|(339) 234-1333|sedwards@ocuterratx.com|
21234791|NCT01458327|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corp.|Berra Yazar-Klosinski, PhD / Chief Scientific Officer|(831) 429-6362|trialdata@mapsbcorp.com|
21234792|NCT01831232|Fred Hutchinson Cancer Research Ctr|Dr, Mazyar Shadman|206-667-5467|mshadman@fredhutch.org|
21234793|NCT01524770|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21234794|NCT01431703|Shanghai Jiaotong university|Dr Ge zhi zheng|86021-34506250|shenyufeng303@gmail.com|
21234795|NCT01864291|Massachusetts Eye & Ear Infirmary|Dr. Daniel Lee|6175736391|Daniel_Lee@meei.harvard.edu|
21234796|NCT01806896|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21234797|NCT01282216|Johns Hopkins University|Rich Ambinder, MD|4109558839|rambind1@jhmi.edu|
21234798|NCT02448875|Alcon Research|Senior Clinical Project Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21234799|NCT05093426|Closed Loop Medicine Ltd.|Nihal Noori|07443603405|nihal.noori@closedloopmedicine.com|
21234800|NCT00590954|Memorial Sloan Kettering Cancer Center|Thomas Kaley, MD|212-639-5122|kaleyt@mskcc.org|
21234801|NCT02283788|BIAL - Portela & Cª, S.A.|Head of Clinical Research|+351 22 9866100|francisco.rocha@bial.com|
21234802|NCT02533921|University of Colorado|Benzi Kluger, MD, MS, Principal Investigator|303-724-2194|Benzi.kluger@ucdenver.edu|
21234803|NCT02215070|Duke University|Anthony Sung|919-668-1000|anthony.sung@duke.edu|
21234804|NCT02595567|Washington University School of Medicine|Alexander Chen, Director of Interventional Pulmonology|314-454-8764|achen@dom.wustl.edu|
21234805|NCT03853707|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
21234806|NCT04269161|University of Missouri|Roger Fales|5738841564|falesr@missouri.edu|
21234807|NCT02096835|Huashan Hospital Fudan University Shanghai, China|Dr.Xiaoyu Yang|086-021-52889999|yangxiaoyu@huashan.org.cn|7693
21234808|NCT03940508|New York University|Dr. Michael A. Lindsey|212-998-5959|michael.lindsey@nyu.edu|
21234809|NCT00218062|The University of Texas Health Science Center at Houston|Dr Joy M. Schmitz|(713) 486-2867|Joy.M.Schmitz@uth.tmc.edu|
21234810|NCT03366077|BioGaia AB|Jenny Palming Clinical research Director|+46 738299900|jp@biogaia.se|
21234811|NCT03107988|New Approaches to Neuroblastoma Therapy|NANT Medical Director|3233615687|nantops@chla.usc.edu|
21234812|NCT01018264|University of South Florida|Theresa Zesiewicz, MD, Professor of Neurology|813-974-5909|tzesiewi@health.usf.edu|
21234813|NCT00812929|GlaxoSmithKline|GSK Response Center|866-435-7343||
21234814|NCT04027686|UCLA Periodontics and Implant Surgery|Dr Perry Klokkevold|3108251927|pklokkevold@dentistry.ucla.edu|
21234815|NCT00079274|North Central Cancer Treatment Group|Dr. Steven Alberts|507-284-8432|alberts.steven@mayo.edu|
21234816|NCT01696032|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
21234817|NCT02188576|Boston Childrens Hospital|Dr. Susan Goobie, PI|6173557737|susan.goobie@childrens.harvard.edu|
21234818|NCT00376168|Protalix Ltd.|Einat Almon|972-4-9889488|einata@protalix.com|137
21234819|NCT01020019|New York State Psychiatric Institute|Daniel Brooks|646-774-6171|brooksd@nyspi.columbia.edu|
21234820|NCT02375672|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 634-5842|fsharmin@hoosiercancer.org|75
21234821|NCT04115358|Marmara University|Prof. Dr. Ali Mentes|+90 2164140545|alimentes@gmail.com|
21234822|NCT05435885|Department of Rehabilitation Medicine, Pusan National University Hospital|Dr. Sanghun Kim|82-51-240-7485|kel5504@gmail.com|
21234823|NCT02152995|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho, MD, PhD|646-608-3774|hoa@mskcc.org|
21234824|NCT02098109|Washington University School of Medicine|Camille Abboud, M.D.|314-454-8304|cabboud@wustl.edu|
21234825|NCT01565291|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
21234826|NCT02353247|University of Louisville|Professor Andrew Scott LaJoie, PhD, statistician on project|502-852-1879|lajoie@louisville.edu|
21234827|NCT06561217|Emory University School of Medicine|Ravi B. Parikh, MD, MPP|(352) 422-4285|ravi.bharat.parikh@emory.edu|
21234828|NCT02219815|St. Boniface Hospital|Dr. Rakesh Arora|2042581078|rarora@sbgh.mb.ca|
21234829|NCT03508219|European Cardiovascular Research Institute (ECRI-10)|Ernest Spitzer, MD|0031102062828|e.spitzer@ecri-trials.com|
21234830|NCT04466891|Jazz Pharmaceuticals Inc.|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
21234831|NCT05114005|The Ohio State University Comprehensive Cancer Center|Dr. Lise Worthen-Chaudhari|614-293-6281|wort08@osumc.edu|
21234832|NCT04413929|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
21234833|NCT02782949|Mayo Clinic|Dr Paul J. Limburg|507-284-2511|limburg.paul@mayo.edu|
21234834|NCT01966926|University of Minnesota|Dr. Jennifer Linde|612-624-0065|linde074@umn.edu|
21234835|NCT01168024|Osprey Medical|VP Of Clinial Affairs|952-955-8230|mshepard@ospreymed.com|
21234836|NCT02239536|Seoul ST. Mary's hospital|Bo-In Lee|821083671055|gidoc4u@gmail.com|
21234837|NCT04074317|Xeris Pharmaceuticals Inc.|Dawn Harper, VP Clinical Devlopment|(215) 704-7290|dharper@xerispharma.com|
21234838|NCT03091192|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21234839|NCT01038778|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|7168451300|adrienne.groman@roswellpark.org|
21234840|NCT06023394|Children's Mercy Kansas City|Dr. Emily Weisberg, pediatric anesthesiologist|9136605813|eweisberg@cmh.edu|
21234841|NCT05645432|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
21234842|NCT03195478|Bristol-Myers Squibb|Bristol-Myers Squibb Study Directo|1-855-907-3286|Clinical.Trials@bms.com|
21234843|NCT01706952|McGill University Health Centre|Marc A. Tewfik|+15147976673|marc.tewfik@mcgill.ca|
21234844|NCT02143414|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|2066674623|amoseley@fredhutch.org|
21234845|NCT01532362|Jonsson Comprehensive Cancer Center: University of California at Los Angeles|Dr. Jay Moon Lee|(310) 794-7333|jaymoonlee@mednet.ucla.edu|
21234846|NCT02307552|UC Irvine|Thomas Ahlering, MD|714 456-6068|tahlerin@uci.edu|
21234847|NCT00978731|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21234848|NCT02492451|Zeynep Kamil Research and Teaching Hospital|Selcuk Selcuk|+905321630488|md_sel@hotmail.com|
21234849|NCT01221441|TissueGene, Inc|R. Ogden Copeland|(301) 921-6000|ocopeland@tissuegene.com|122
21234850|NCT02649972|Memorial Sloan Kettering Cancer Center|Dr. Eli Diamond, MD|212-610-0243|diamone1@mskcc.org|
21234851|NCT01663272|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski, M.D.|734-647-8902|zalupski@med.umich.edu|
21234852|NCT00721526|NYU Grossman School of Medicine|Michael Bogenschutz|505-999-9325|Michael.Bogenschutz@nyulangone.org|
21234853|NCT00501540|University of Wisconsin Carbone Cancer Center|Dr. Noelle LoConte|608-265-5883|ns3@medicine.wisc.edu|
21234854|NCT02331446|Federal Universisty of Pelotas|Msc. Matheus Pintanel Freitas||matheus.pintanel@hotmail.com|
21234855|NCT04879745|University of Pittsburgh Medical Center|Dr. Mehret Birru Talabi|412-383-8000|birrums@upmc.edu|
21234856|NCT00120042|The University of Western Australia|Dr Jan Dickinson|61-8-93401330|Jan.Dickinson@uwa.edu.au|
21234857|NCT01860417|CITOSPIN|Dr. Javier García-Sancho,|0034 983184827|jgsancho@uva.es|
21234858|NCT04532112|University of Pennsylvania|Dr. Michael Kohanski|2153495766|michael.kohanski@pennmedicine.upenn.edu|
21234859|NCT00529386|Dept of Urology, Queen's University|J C Nickel|613 548 2497|jcn@queensu.ca|
21234860|NCT02939404|Obesity & Diabetes Clinical Research Section, NIDDK|Douglas C. Chang, MD|602.200.5312|Douglas.Chang@nih.gov|
21234861|NCT04182100|PharmaEssentia Japan KK|Hiroaki Kawase|+81-3-6910-5103|hiroaki_kawase@pharmaessentia.com|
21234862|NCT02100007|MEI Pharma Inc|Richard Ghalie, MD, Sr Vice President Clinical Development|858 369-7116|rghalie@meipharma.com|
21234863|NCT03912753|Columbia University|Corina Lelutiu-Weinberger, PhD|212-342-1502|cl4265@cumc.columbia.edu|
21234864|NCT05773287|Duke University|Katherine Collins-Bennett, Ph.D.|919-479-2368|katherine.collins-bennett@duke.edu|
21234865|NCT01468896|The Ohio State University Comprehensive Cancer Center|William Carson, MD|614-293-6306|William.Carson@osumc.edu|
21234866|NCT04439240|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21234867|NCT02867605|Cleveland Clinic Foundation|Dr. Carol De la Motte|216 444-5374|delamoc@ccf.org|
21234868|NCT00813124|University of Texas (UT) MD Anderson Cancer Center|Richard E. Champlin, MD/Chair, Stem Cell Transplantation|713-792-3618|rchampli@mdanderson.org|
21234869|NCT02097992|University of Miami|Adam Wanner|(305)243-3045|awanner@med.miami.edu|
21234870|NCT01830140|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21234871|NCT00617240|The University of North Carolina at Chapel Hill|Linmarie Sikich, MD|(919) 972-7500|lsikich@med.unc.edu|
21234872|NCT01611259|AGMT|Public contact Daniela Wolkersdorfer|00436626404411|d.wolkersdorfer@agmt.at|
21234873|NCT04936685|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21234874|NCT00280566|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21234875|NCT01302392|Amgen, Inc.|Study Director|866-572-6436||
21234876|NCT01702233|Biologische Heilmittel Heel|Dr Istvan Zatik|+497221501(0)|istvan.zatik@heel.com|3192
21234877|NCT03604692|Syndax Pharmaceuticals|Syndax Pharmaceuticals|781-419-1400|clinicaltrials@syndax.com|
21234878|NCT00637195|GlaxoSmithKline|GSK Response Center|866-435-7343||
21234879|NCT00203203|Texas Heart Institute|Emerson C. Perin, M.D., Ph.D.|832-355-9405|eperin@texasheart.org|
21234880|NCT05035017|CooperVision Inc.|Lee Hall BSc PhD MCOptom, FBCLA|925-251-6884|lhall@coopervision.com|
21234881|NCT05091528|Silverback Therapeutics, Inc.|Chief Scientific Officer|206-456-2900|info@silverbacktx.com|
21234882|NCT02214121|AstraZeneca|Brilinta Global Clinical Lead|+46 31 776 1000|kontakt@astrazeneca.com|
21234883|NCT02203591|3M|Joan Paulson|651-736-6583|jepaulson@mmm.com|
21234884|NCT00835497|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21234885|NCT03306264|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
21234886|NCT02114879|Washington University|Emily Lenard|314-747-5706|lenarde@wustl.edu|
21291898|NCT03376516|Octapharma AG|Sylvia Werner|604-1149|sylvia.werner@octapharma.com|+1 (201)
21291899|NCT01581684|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21291900|NCT03235050|AstraZeneca|AstraZenenca Information Center|1-877-240-9479|information.center@astrazeneca.com|
21291901|NCT02986074|Abbott|Yagna Pathak|+1-469-243-0088|yagna.pathak@abbott.com|
21291902|NCT01444911|University of Wisconsin Carbone Cancer Center|Dr. David Kushner|608-263-1210|dmkushner@facstaff.wisc.edu|
21291903|NCT02239926|Mayo Clinic|Dr. Yuri Saito Loftus|507-255-3680|saito.yuri@mayo.edu|
21291904|NCT04099277|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21291905|NCT00598650|Eisai Co., Ltd.|Masaki Nakagawa|+81-3-3817-5245||5245
21234887|NCT00330551|University of California, Los Angeles|Keith Nuechterlein, PhD|(310) 825-0036|keithn@ucla.edu|
21234888|NCT03697811|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
21234889|NCT02600637|VA Northern California|Juliana Baldo|925-372-4649|juliana.baldo@va.gov|
21234890|NCT02519712|Memorial Sloan Kettering Cancer Center|Brian Shaffer, MD|212-639-2212|shaffeb1@mskcc.org|
21234891|NCT00613509|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21234892|NCT04847674|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
21234893|NCT00677807|Novartis Pharmaceuticals|Study Director|862-778-8300||
21234894|NCT01420081|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21234895|NCT02469610|CarmelMC|Dr LEVY FABER Dan|97248250289|DANLf@clalit.org.il|
21234896|NCT04590495|West Virginia University|Toni Marie Rudisill, MS, PhD|304-293-0687|trudisill@hsc.wvu.edu|
21234897|NCT00414388|Oncology Specialists, S.C.|Sigrun Hallmeyer, MD (Director of Research); Chadi Nabhan, MD (PI)|847-268-8200|shallmeyer@oncmed.net|
21234898|NCT03467425|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21234899|NCT00411619|Cincinnati Children's Hospital Medical Center|Dr. David Franz|513-636-4222|david.franz@cchmc.org|
21234900|NCT00025883|National Institute of DIabetes and Digestive and Kidney Dseases, National Institutes of Health|Dr. Phillip Gorden|301-402-7340|phillipg@mail.nih.gov|
21234901|NCT00678561|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21234902|NCT00218543|COLUMBIA UNIVERSITY|Frances R Levin, MD|212-543-5896|FRL2@COLUMBIA.EDU|
21234903|NCT02920983|CooperVision Inc.|Jose Vega, O.D., MSc., FAAO|9256213761|jvega2@coopervision.com|
21234904|NCT01451424|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
21234905|NCT00712296|Icahn School of Medicine at Mount Sinai|Xiu-Min Li, MD|212-241-1755|Xiu-min.li@mssm.edu|
21234906|NCT01387607|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21234907|NCT02084628|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21234908|NCT02908529|Brigham and women's Hospital|Luigi Taranto Montemurro, MD|6177326541|ltarantomontemurro@bwh.harvard.edu|
21234909|NCT00689481|GlaxoSmithKline|GSK Response Center|866-435-7343||
21234910|NCT00528528|Janssen Research & Development, LLC Titusville, NJ|Clinical Leader|609-730-3174||
21234911|NCT00466960|Seattle Cancer Care Alliance|Barbara Goff|206-543-3668|bgoff@u.washington.edu|
21234912|NCT04973488|"University of Medicine and Pharmacy Victor Babes Timisoara"|Dr. Novacescu Alexandru|+40745064844|novacescu_alex@yahoo.com|
21234913|NCT03238911|Pharmacosmos A/S|Clinical trial disclosure desk|+45 5948 5935|trial@pharmacosmos.com|
21234914|NCT00368940|Weill Cornell Medicine|Dimitris N. Kiosses, Ph.D.|914-997-4381|dkiosses@med.cornell.edu|
21234915|NCT01507493|Huazhong University of Science&Technology|Xianwei Zhang|13037154560|znpain@sina.com|
21234916|NCT01379963|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21234917|NCT02097134|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21234918|NCT01845155|Deutsches Zentrum für Musiktherapieforschung (Viktor Dulger Institut) DZM e.V. - German Center for Music Therapy Research|Dr. Heike Argstatter|+49-6221-7963960|heike.argstatter@dzm-heidelberg.de|
21234919|NCT02665481|Washington University in St. Louis|Dr. Eric Lenze|314-362-5154|lenzee@wustl.edu|
21234920|NCT03285646|Regeneron Pharmaceuticals, Inc.|Study Director|844-734-6643|clinicaltrials@regeneron.com|
21234921|NCT02684591|UCSD|Rohit Loomba, MD, MHSc|858-246-2201|roloomba@ucsd.edu|
21234922|NCT00424372|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21234923|NCT02652624|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21234924|NCT01993108|University of Michigan|Chandra Sripada|734 232 0281|sripada@umich.edu|
21234925|NCT00796861|Penn State Health|Dr. Leah Cream|717-531-8870|lcream@pennstatehealth.psu.edu|
21234926|NCT01663259|University of Michigan Rogel Cancer Center|Michelle Mierzwa|734-936-7810|mmierzwa@umich.edu|
21234927|NCT04589559|Columbia University Irving Medical Center|Dr. Jeffrey Birk|212-342-5503|jlb2287@cumc.columbia.edu|
21234928|NCT02664038|VA Connecticut Healthcare System|Morris Bell, Ph.D., Senior Research Career Scientist|203-932-5711|morris.bell@va.gov|2281
21234929|NCT03226652|Imperial College London|Professor M Cowie|+44 (0)207 3518856|m.cowie@imperial.ac.uk|
21234930|NCT03758040|University of Nebraska Omaha|Nathaniel Hunt|402-554-4195|nhunt@unomaha.edu|
21234931|NCT05446909|Arizona State University|Yi-Yuan Tang|4807903577|yiyuan@asu.edu|
21234932|NCT03738826|Duke University|Kai Sun, M.D.|919-681-7417|kai.sun@duke.edu|
21234933|NCT05560932|Yale University|Amy C Justice, MD, PhD|203-932-5711|amy.justice2@va.gov|3541
21234934|NCT04875520|Nationwide Children's Hospital|Jason G. Newland, MD|614-722-3416|Jason.Newland@nationwidechildrens.org|
21291906|NCT01628913|Novartis Pharmaceuticals|Study Director|862-778-8300||
21234935|NCT04456699|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21291907|NCT00508521|Malcom Randall VA Medical Center, Gainesville Florida|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center|(352) 376-1611|janis.daly@neurology.ufl.edu|6603
21291908|NCT01622296|UCSF School of Dentistry|Dr. Susan Parveen Tavana|415-476-1891|susan.tavana@ucsf.edu|
21291909|NCT02415556|Beth Israel Deaconess Medical Center (BIDMC)|Dr. Vera Novak, Principal Investigator|6176328680|vnovak@bidmc.harvard.edu|
21291910|NCT00105534|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21234936|NCT02915029|University of New Mexico|Dr Vallabh Shah|505-272-9615|vshah@salud.unm.edu|
21242421|NCT03944512|The Ohio State University|Maged M. Costantine, MD|614-293-9036|maged.costantine@osumc.edu|
21242422|NCT00567879|Novartis|Study Director|862-778-8300||
21242423|NCT00151996|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21242424|NCT02156687|Cleveland Clinic|Cecile Ferrando, M.D.|216-444-0642|ferranc2@ccf.org|
21242425|NCT01281813|Janssen Research & Development, LLC|Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21242426|NCT02274493|UT MD Anderson Cancer Center|Dr. Jesse C Selber / Professor, Plastic Surgery|713-794-1297|jcselber@mdanderson.org|
21242427|NCT03131206|Dana-Farber Cancer Institute|Mark Awad, MD, PhD|6176323468|mark_awad@dfci.harvard.edu|
21242428|NCT00286741|Durham VA Medical Center|David Edelman|919-286-6936|dedelman@duke.edu|
21242429|NCT00667693|Cleveland Clinic Foundation|Daniel I Sessler, MD|216-445-8396|sesslerd@ccf.org|
21242430|NCT01744691|Pharmacyclics, Inc.|Dr. Alvina Chu|855-427-8846|medinfo@pcyc.com|
21242431|NCT02086708|Massachusetts General Hospital|Dr. Uzma Shah|617-726-1450|USHAH@mgh.harvard.edu|
21242432|NCT02701361|Duke University Health System|Christopher Cox|9196817232|christopher.cox@duke.edu|
21242433|NCT04588480|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
21242434|NCT01242085|VA Palo Alto HCS|Steven T Woolson, MD|650-493-5000|steven.woolson@va.gov|66101
21242435|NCT01178762|National Taiwan University Hospital|Yan-Ming Chen / Yu-Chih Hou|886-2-2312-3456|louice1070@gmail.com|62131
21242436|NCT02410291|Sunnybrook Health Sciences Centre|Krista Dawdy, Clinical Educator|416 480 6104|krista.dawdy@sunnybrook.ca|
21242437|NCT02322216|Alcon, a Novartis Company|Clinical Project Lead, GCRA-Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
21242438|NCT00097253|The Ohio State University, Department of Psychiatry|Janice K. Kiecolt-Glaser, PhD|614-292-0033|Kiecolt-Glaser.1@osu.edu|
21242439|NCT02430532|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21242440|NCT01190150|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21242441|NCT04469218|Lineus Medical|CEO|844-546-3728|vance@lineusmed.com|
21242442|NCT02121418|University of Washington|Dr. Pamela Becker|206-606-7273|pbecker@u.washington.edu|
21242443|NCT01320072|Montefiore Medical Center|Dr. Elina Jerschow, attending physician|9173625291|ejerscho@montefiore.org|
21242444|NCT01534910|Los Angeles Biomedical Research Institute|Dr Matthew Budoff|310-222-4107|mbudoff@labiomed.org|
21242445|NCT01549652|Stanford University School of Medicine Department of Anesthesiology|Dr. Larry F. Chu|6507236632|lchu@stanford.edu|
21242446|NCT03068611|Brown University|Christopher Kahler|401 863-6651|christopher_kahler@brown.edu|
21242447|NCT03861169|Sight Sciences|Tommie Rodriguez, Senior Clinical Research Manager|818-687-3310|trodriguez@sightsciences.com|
21242448|NCT01992354|GE Healthcare|John Strohmeyer|+1 609 865 7423|john.strohmeyer@ge.com|
21242449|NCT02526680|Wills Eye Hospital Glaucoma Research Center|Dr. L. Jay Katz|215-928-3123|ljkatz@willseye.org|
21242450|NCT02873754|Duke University School of Medicine|Angela Kirby|919-286-0411|angela.kirby@duke.edu|5526
21242451|NCT03523962|University of Maryland, Baltimore|Research Administrator|410-706-6823|ahowe@som.umaryland.edu|
21242452|NCT03727854|Seoul National University Hospital|Professor|82-2-2072-2217|ymchomd@snu.ac.kr|
21242453|NCT00917865|Emory University|David Schuster, MD|404-712-4859|dschust@emory.edu|
21242454|NCT01081145|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21242455|NCT04210024|University of Kentucky|Dr. Brittany Smalls|859-323-4916|brittany.smalls@uky.edu|
21242456|NCT01582945|Massachusetts General Hospital|Dr. Cristina Cusin|6177266421|ccusin@mgh.harvard.edu|
21242457|NCT01726023|AstraZeneca|David Wilson, Statistical Team Leader - Infection|+44 1625 517830|David.Wilson2@astrazeneca.com|
21242458|NCT00816829|Solvay Pharmaceuticals|Sven Voet, Global Communication|+32 (0) 2 509 69 77|sven.voet@solvay.com|
21242459|NCT03643211|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21242460|NCT04858425|First Wave BioPharma|VP, Regulatory, QA & Compliance|19194491484|AChandler@FirstWaveBio.com|
21242461|NCT05457491|Mayo Clinic|Saranya P. Wyles, M.D., Ph.D.|507-284-5475|Wyles.Saranya@mayo.edu|
21242462|NCT04536077|Washington University School of Medicine|Roheena Z. Panni, M.D.|314-362-7046|roheenazpanni@wustl.edu|
21242463|NCT04798521|Oregon Health & Science University|Dr. P. Todd Korthuis|503-494-8044|korthuis@ohsu.edu|
21242464|NCT02443792|U of Cape Town|Dr. Justin Shenje|0027788938497|justintshenje@gmail.com|
21242465|NCT02908620|University of Pennsylvania, School of Dental Medicine|Elliot V Hersh, DMD, Ph.D., Director Clinical Pharmacology Research|215-898-9686|evhersh@pobox.upenn.edu|
21242466|NCT04548622|Yale University Department of Psychiatry|Dr. Philip R. Corlett PhD|(203) 974-7866|philip.corlett@yale.edu|
21242467|NCT01155869|Providence VA Medical Center|Peter Friedmann|401-273-7100|peter.friedmann@va.gov|6240
21242468|NCT01843465|Clinique Pasteur, Toulouse, France|Dr Serge Boveda|(33) 5 62 21 16 45|sboveda@clinique-pasteur.com|8819
21242469|NCT00881335|Shanghai Tenth People's Hospital, Tongji University|Zhang Xiangyu|86-21-66307174|xiangyu62@126.com|
21234937|NCT04452188|The University of Michigan Health System|Dr. Nathaniel Sznycer-Taub|734-936-8993|nsznycer@umich.edu|
21234938|NCT02665728|Braintree Laboratories, Inc.|Vice President, Clinical Affairs|781-843-2202|john.mcgowan@sebelapharma.com|
21234939|NCT01147653|Duke University School of Medicine, Division of Pediatric Blood and Marrow Transplantation|Jesse Troy, PhD||cordbloodtherapyinfo@dm.duke.edu|
21234940|NCT00670228|sanofi-aventis|Trial Transparency Team||GV-contact-us@sanofi-aventis.com|
21234941|NCT05267054|BeiGene|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
21234942|NCT00858390|The University of Texas Health Science Center at Houston|G Hergenroeder, Principal Investigator|7135006130|Georgene.W.Hergenroeder@uth.tmc.edu|
21234943|NCT04646616|Drexel University School of Public Health|Dr. Mariana Lazo|2673596058|ml3629@drexel.edu|
21234944|NCT01813019|Novartis Pharmaceuticals|Study Director|862-778-8300||
21234945|NCT01193556|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
21234946|NCT00554749|Centre for Child and Adolescent Mental Health, Eastern and Southern Norway|Dr. Hanne Kristensen|+4722586000|hanne.kristensen@r-bup.no|
21234947|NCT00457197|The University of Texas Southwestern Medical Center|E. Sherwood Brown, M.D., Ph.D., Professor|214-645-6950|sherwood.brown@utsouthwestern.edu|
21234948|NCT02165111|Johns Hopkins University|Dr. Ricardo J. Bello|4109557566|rbello@jhmi.edu|
21234949|NCT03921411|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
21234950|NCT01541826|University of Wisconsin-Madison, Department of Food Science|Dr. Bradley Bolling|608-890-0212|bwbolling@wisc.edu|
21234951|NCT01365273|Monlycke Health Care|Joan Wilson, MSN, MHA, RN|706 504 8997|joan.wilson@molnlycke.com|
21234952|NCT04043312|Hospital of the University of Pennsylvania|Dr. Timothy Markman|267-593-0103|timothy.markman@uphs.upenn.edu|
21234953|NCT03072134|Northwestern University|Christina Amidei, PhD|13126959124|christina.amidei@nm.org|
21234954|NCT02445027|Massachusetts General Hospital|Anna Gao RN.|617-643-6092|tearneylabtrials@partners.org|
21234955|NCT03037528|University of Michigan|Laura Saslow|(734) 764-7836|saslowl@umich.edu|
21234956|NCT02705820|Bank Of Cyprus Oncology Centre|Dr. Harris Charalambous|+35722847300|haris.charalambous@bococ.org.cy|450
21234957|NCT06017089|University of Virginia Center for Diabetes Technology|Marc Breton, PhD|434-982-6484|marc.breton@virginia.edu|
21234958|NCT02702401|Merck Sharp & Dohme LLC.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21234959|NCT01833403|University of Minnesota|Lisa Chow MD|612-625-8934|chow0007@umn.edu|
21234960|NCT01228968|Washington University School of Medicine|Gary Skolnick|3143625292|gskolnic@wustl.edu|
21234961|NCT00247728|Progen Pharmaceuticals Ltd|Director of Regulatory Affairs and Clinical Development|+61 (0)7 38423333|darrynb@progen-pharma.com|
21234962|NCT01462357|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21234963|NCT01106456|The University of Kansas Medical Center|Dr. Won S. Choi|(913) 588-4742|wchoi@kumc.edu|
21234964|NCT01188603|Sprout Pharmaceuticals|Sprout Pharmaceuticals|1-919-882-0850|clinicaltrials@sproutpharma.com|
21234965|NCT01924169|The University of Texas MD Anderson Cancer Center|Alessandra Ferrajoli, MD/Professor|713-792-7734|CR_Study_Registration@mdanderson.org|
21234966|NCT01686646|GlaxoSmithKline|GSK Response Center|866-435-7343||
21234967|NCT02694315|Ain Shams Maternity hospital|amr ahmed mahmoud riad|01005347179|amr.riad@med.asu.edu.eg|+2
21234968|NCT04292730|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21234969|NCT01527292|University of Louisville, James Graham Brown Cancer Center|Dr. Shiao Woo|502-561-2700|sywoo001@exchange.louisville.edu|
21234970|NCT02549508|Fisher & Paykel Healthcare|Clinical Research Scientist|+64 09 574 0100|CPAPtrial@fphcare.co.nz|7044
21234971|NCT00314366|Texas Heart Institute|Emerson C. Perin, M.D., Ph.D.|832-355-9405|eperin@texasheart.org|
21234972|NCT03400033|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21234973|NCT00006916|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
21234974|NCT00558103|GlaxoSmithKline|GSK Response Center|866-435-7343||
21234975|NCT02457325|University of Sao Paulo / Bauru School of Dentistry|Carlos Ferreira Santos|+551432358200|cfsantos@fob.usp.br|
21234976|NCT01574703|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21234977|NCT00749931|Dune Medical Devices|Clinical Research Manager|+97246178000|shiri@dunemedical.com|
21234978|NCT03993938|Henry Ford Health System|Trevor Szymanski MD|(313) 622-4168|tszyman1@hfhs.org|
21234979|NCT02967367|CHU Saint-pierre|Pr. Marie Bruyneel|00325354219|marie_bruyneel@stpierre-bru.be|
21234980|NCT02751983|Rocky Mountain Mental Illness Research, Education, and Clinical Center|Sean Barnes|720-723-6560|Sean.Barnes2@va.gov|
21234981|NCT00989833|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
21234982|NCT00308711|Cytokine PharmaSciences, Inc.|Barbara L. Powers|610-687-1776|bpowers@cytokinepharmasciences.com|214
21234983|NCT02318693|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21234984|NCT04497987|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21234985|NCT04099524|Stanford University|Feng Vankee Lin, PI|6082156005|vankee_lin@stanford.edu|
21234986|NCT04733157|University of Zimbabwe|Dr. Chipo Gwanzura|+263774718381|chipo.gwanzura@gmail.com|
21234987|NCT00352612|Johns Hopkins University|Aaron Chen|4109556143|achen33@jhmi.edu|
21234988|NCT02056171|Weill Cornell Medicine|Chani Traube|212-746-3056|chr9008@med.cornell.edu|
21234989|NCT03337724|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21234990|NCT00773097|University Pittsburgh|Robert E. Schoen ME|412-648-9115|rschoen@pitt.edu|
21279674|NCT02013817|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21234991|NCT00991302|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21234992|NCT01707004|UW Carbone Cancer Center|Aric Hall|608-262-1604|achall@medicine.wisc.edu|
21234993|NCT04318210|Centers for Disease Control and Prevention|Dr. Allan Taylor|404-639-6120|avt0@cdc.gov|
21234994|NCT03085927|Indiana University School of Nursing|Dr. Sheri Robb, MT-BC|317-274-3152|shrobb@iu.edu|
21234995|NCT05063734|Oxurion|Clinical Department|+32 16 75 13 10|info@oxurion.com|
21234996|NCT02573324|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21234997|NCT02349711|Food Science and Human Nutrition Department, University of Florida|Dr. Bobbi Langkamp-Henken|352-294-3721|henken@ufl.edu|
21234998|NCT00941733|Medtronic - CardioVascular|Clinical Research Director|+31433566580|kristel.wittebols@medtronic.com|
21279675|NCT05992623|Inova Schar Heart and Vascular|Brett D. Atwater MD|9192390127|brett.atwater@inova.org|
21279676|NCT03624920|Theranexus|Chief Medical Officer|+33680026779|werner.rein@theranexus.fr|
21291911|NCT04102007|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21291912|NCT05173974|HALEON|Haleon Response Center|+447880182593|ww.clinical-trial-register@haleon.com|
21291913|NCT03289143|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21291914|NCT00730756|GlaxoSmithKline|GSK Response Center|866-435-7343||
21291915|NCT00948688|Massachusetts General Hospital|Lawrence S. Blaszkowsky, M.D.|617-219-1230|lblaszkowsky@mgh.harvard.edu|
21291916|NCT04388826|Veru|Gary Barnette PhD CSO|9194263611|gbarnette@verupharma.com|
21291917|NCT03564886|University of Missouri, Department of Orthopaedics|Lasun Oladeji, MD|573-884-7796|OladejiL@health.missouri.edu|
21291918|NCT01146613|NIAAA|Megan Ryan, M.B.A.|301-443-4225|mryan1@mail.nih.gov|
21234999|NCT00194012|Johns Hopkins University School of Medicine|Robert Findling, MD, MBA, Director, Child and Adolescent Psychiatry|410-614-3225|rfindli1@jhmi.edu|
21235000|NCT05036642|Stanford University|Allison Okamura|(650) 723-3148|aokamura@stanford.edu|
21235001|NCT01965067|Department of Anesthesiology and Pain Medicine, Hanyang University Hospital|Kyo Sang Kim, MD, PhD|+82-2-2290-8680|kimks@hanyang.ac.kr|
21235002|NCT01105533|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21235003|NCT01610700|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
21235004|NCT02717949|UT Southwestern Medical Center|Mamta K.Jain, MD|214-648-9914|mamta.jain@utsouthwestern.edu|
21235005|NCT02033005|Imperial College London|Dr Chris Gale|+44 (0) 2033153519|christopher.gale@imperial.ac.uk|
21235006|NCT01639001|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21235007|NCT02453594|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21235008|NCT02610868|Solstice Neurosciences|Regulatory Affairs Specialist|502-815-8148|regulatoryaffairs@usworldmeds.com|
21235009|NCT00679341|Genentech, Inc.|Medical Communications|800 821-8590||
21235010|NCT02660359|Ipsen|Medical Director|See email|clinical.trials@ipsen.com|
21235011|NCT00306592|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
21235012|NCT04101526|Moffitt Cancer Center|Dr. Brian Gonzalez|813-745-3219|Brian.Gonzalez@moffitt.org|
21235013|NCT00739336|SUNY Upstate Medical University|Clinical Trials Officer|315-464-5476|Rudesj@upstate.edu|
21235014|NCT00953329|DukeUMC|Shirley Blalock|919-668-0999|shirley.blalock@duke.edu|
21235015|NCT01434823|University of Pennsylvania|Dr. Meeta P. Kerlin|215.614.0627|meeta.prasad@uphs.upenn.edu|
21235016|NCT01299077|Eisai China Inc.|Haibo Song|0086-21-24192864|songhaibo@eisai.com.cn|
21235017|NCT03670810|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
21235018|NCT00678691|SUNY Upstate Medical University|Thomas Schwartz|3154643166|schwartt@upstate.edu|
21235019|NCT01150838|University of Virginia|George Politis MD|434-924-2283|GDP8A@hscmail.mcc.virginia.edu|
21235020|NCT02214147|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21235021|NCT03204942|National Cancer Institute|Director of Ethical Committee|+201224276580|drsherryfanous@yahoo.com|
21235022|NCT01194297|University of Rochester|Dr. Carl D'Angio|585-275-2972|carl_dangio@urmc.rochester.edu|
21235023|NCT02606136|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG3019-079DMDStudy@fibrogen.com|
21235024|NCT06640829|The University of Kansas Medical Center|Holly Hull|9135881000|hhull@kumc.edu|
21235025|NCT01350128|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
21235026|NCT01252290|University of Kansas Medical Center|Carol J. Fabian, MD; Professor|913-588-7791|cfabian@kumc.edu|
21235027|NCT05944250|Stanford University|Dr. Yuri Ikeda|650-647-3485|yurikeda@stanford.edu|
21235028|NCT02075437|Duke University|Dr. Nancy Zucker|919-668-0075|nancy.zucker@duke.edu|
21235029|NCT01632800|Weinberg Medical Physics LLC|Irving Weinberg MD PhD|3013467944|inweinberg@gmail.com|
21235030|NCT00673452|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21235031|NCT02003625|Massachusetts General Hospital|Bimalangshu Dey, MD, PhD|617-724-1124|BDEY@mgh.harvard.edu|
21235032|NCT00075335|NHLBI NIH|Dr. Richard Childs|301-594-8008|childsr@nhlbi.nih.gov|
21235033|NCT02410811|Cincinnati Children's Hospital Medical Center|Dr. Charles T. Quinn|5138033086|charles.quinn@cchmc.org|
21235034|NCT00353366|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21235035|NCT00259857|Medical University of South Carolina|Deborah A Bowlby, MD, Asst.Professor, Pedeiatric Endocrinology|843-792-6807|bowlbyd@musc.edu|
21235036|NCT00780572|VA SLC HCS|Director HSR&D|801-582-1565|IDEAS@va.gov|
21235037|NCT01552226|St. Joseph Mercy Hospital Ann Arbor|Dr. Robert Cleary|7347128150|Robert.Cleary@trinity-health.org|
21235038|NCT00727857|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21235039|NCT01469065|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21235040|NCT04542070|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21235041|NCT02985736|Psoriasis Treatment Center of Central New Jersey|Jerry Bagel Director of Clinical Trials|6094434500|dreamacres1@aol.com|
21235042|NCT03049813|University of Michigan|Brittany Ross|(734) 764-2368|rossbrit@umich.edu|
21235043|NCT02144675|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu|
21235044|NCT02164396|Johnson & Johnson Vision Care Inc.|Brian Pall, O.D., M.S.- Senior Principal Research Optometrist|904-443-3500|BPALL@its.jnj.com|190
21235045|NCT03025828|Icahn School of Medicine at Mount Sinai|Dr. Kirk Campbell|212-241-6271|kirk.campbell@mssm.edu|
21235046|NCT00094653|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21235047|NCT03029689|Fundació Lluita Contra les Infeccions|Dr. Roger Paredes|(+34) 93 465 7897|rparedes@lluita.org|8209
21235048|NCT00854581|University of Miami|Juan Carlos Ramos MD|305-243-4909|jramos2@med.miami.edu|
21235049|NCT02149342|Helsinki university central hospital|Md, PhD Noora Neittaanmäki-Perttu|+358407190362|noora.neittaanmaki@fimnet.fi|
21291919|NCT05878067|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21261661|NCT00744055|Yale University School Of Medicine Department of Psychiatry|Elizabeth Ralevski|2039325711|elizabeth.ralevski@yale.edu|4282
21261662|NCT01466751|Stanford University|Amit Etkin|650-725-5736|amitetkin@stanford.edu|
21261663|NCT02413255|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21235050|NCT03181542|Penn State Hershey Medical Center|Dr Priti Dalal|717-531-6597|pdalal@pennstatehealth.psu.edu|
21261664|NCT01878006|National Institute on Alcohol Abuse and Alcoholism|Ramchandani, Vijay|+1 301 402 8527|vijayr@mail.nih.gov|
21261665|NCT02760602|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
21261666|NCT03056287|Medical University of South Carolina|Chris Gregory|8437921078|gregoryc@musc.edu|
21261667|NCT02757547|Philips|Pat Olsen|(303) 475-3417|pat.olsen@philips.com|
21261668|NCT02424149|Hartford Hospital|Katie Propst, MD|860-972-4338|katie.propst@hhchealth.org|
21261669|NCT03063255|Department of Anesthesiology, NF/SG Veterans Health System|Dr. Jose R. Soberon, Jr.|352-413-2317|jsoberon@anest.ufl.edu|
21261670|NCT02162979|Loma Linda University|Tonya Hamilton, reszearch Compliance Auditor|909-558-4908|thamilton@llu.edu|
21261671|NCT01357239|Novartis Pharmaceuticals|Study Director|862-778-8300||
21261672|NCT01542372|Massachusetts|Dr. Devon Hinton|617-620-4522|DHINTON1@mgh.harvard.edu|
21261673|NCT02102230|VA Palo Alto Health Care System|Kimberly Babson, PhD|831-325-1540|kimberly.babson@gmail.com|
21261674|NCT00325572|Milton S. Hershey Medical Center|Jeanette C. Ramer MD|717 531-8414|jramer2@hmc.psu.edu|
21261675|NCT00852930|Vanderbilt University School of Nursing|Sheila H, Ridner, PHD|615-322-0831|Sheila.Ridner@Vanderbilt.edu|
21235051|NCT04138615|University of Texas Southwestern Medical Center|Dr Craig Crandall|2143454623|craigcrandall@texashealth.org|
21235052|NCT00556842|The Centre for Evidence-Based Orthopaedics|Paula McKay|905-521-2100|mckayp@mcmaster.ca|44131
21235053|NCT01032135|University of Pennsylvania|James McKay, PhD|215-746-7704|jimrache@mail.med.upenn.edu|
21235054|NCT00806546|NuPathe Inc.|Mark Pierce, MD, PhD|484-567-0130|mpierce@nupathe.com|
21235055|NCT01247090|Columbia University Medical Center|Anjali Ganda, MD|617-835-3789|ag355@columbia.edu|
21235056|NCT01226719|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21235057|NCT01922024|Curetis USA, Inc.|Clinical Operations|800-659-1221|neil.mucci@curetis.com|
21235058|NCT02353091|UCL Ear Institute|Mr Georgios Stavrinos|07856067517|georgios.stavrinos.13@ucl.ac.uk|
21235059|NCT02367599|UCSD|Sheldon Morris|6195438080|shmorris@ucsd.edu|
21235060|NCT02665975|Anglia Ruskin Univeristy|Eldre Beukes|01223698847|eldre.beukes@anglia.ac.uk|2847
21235061|NCT03385239|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
21235062|NCT01556204|Cleveland Clinic|Tommaso Falcone, M.D.|216-444-1752|falcont@ccf.org|
21235063|NCT02167256|Yale University|Stephen Strittmatter|2037854878|stephen.strittmatter@yale.edu|
21235064|NCT03139916|Massachusetts General Hospital|Elizabeth R. Gerstner, MD|617-724-8770|egerstner@mgh.harvard.edu|
21235065|NCT01957475|Coloplast|Daniel Carter|+45 49112523|dkdac@coloplast.com|
21235066|NCT03591575|Chiesi Canada Corp.|Caroline Fradette, PhD|1-(800) 854-3534|c.fradette@chiesi.com|7014
21235067|NCT02915744|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
21235068|NCT00813358|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|alan.saunders@cookmedical.com|321204
21235069|NCT00700011|Texas Oncology - Amarillo|Dr. Seah Lim|806-358-8654|seah.lim@usoncology.com|
21235070|NCT00004031|SWOG Statistics and Data Management Center|Study Statistician|2066674623||
21235071|NCT02553421|ivWatch, LLC|Jason Naramore|855-485-2824|jason.naramore@ivwatch.com|7019
21235072|NCT00501891|The Preston Robert Tisch Brain Tumor Center at Duke|Annick Desjardins, MD|919-684-6173|annick.desjardins@duke.edu|
21235073|NCT02026115|University of Florida|Diana J. Wilkie, PhD, RN, FAAN, Professor, Prairieview Trust - Earl and Margo Powers Endowed Profess|352-273-6401|diwilkie@ufl.edu|
21235074|NCT04084769|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21235075|NCT04579679|HUTCHMED International Corporation|Nick Lawn|+44 7826 422448|nickl@hutch-med.com|
21235076|NCT06893809|Başakşehir Çam and Sakura City Hospital|Dr. Emine Ozcan|05301592856|dr.emine3419@gmail.com|
21235077|NCT02851108|Heidelberg University|Prof. Dr. Olaf Müller|+49 6221 56 4904|olaf.mueller@urz.uni-heidelberg.de|
21235078|NCT01709318|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21235079|NCT02383758|Emory University|Dr. Nathan Call||nathan.call@choa.org|
21235080|NCT03892889|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21235081|NCT02066298|Penn State University|David Mauger|717-531-7178|dmauger@psu.edu|
21235082|NCT04260191|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21235083|NCT02284828|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21235084|NCT01519518|Liverpool Heart and Chest Hospital|Dr Rod Stables|01512281616|rod.stables@lhch.nhs.uk|1489
21235085|NCT02517580|Lebanese American University|Dr. Sola Aoun Bahous|+961-1-200-800|sola.bahous@lau.edu.lb|
21235086|NCT00598689|Georgia Regents University|David D. Bogorad, MD, FACS|706-721-1160|dbogorad@gru.edu|
21235087|NCT02873923|Institut Bergonié|Dr Carine Bellera|33 5 56 33 04 95|c.bellera@brodeaux.unicancer.fr|
21235088|NCT00298896|Sunesis Pharmaceuticals, Inc.|Mike Johnston, Senior Director Regulatory Affairs|(650) 266-3727|mjohnston@sunesis.com|
21235089|NCT02506114|University of California, San Francisco|Dr. Lawrence Fong, MD|(415) 514-3160|Lawrence.Fong@ucsf.edu|
21235090|NCT00348205|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
21235091|NCT02488629|Syncore|Dr. Lin|0227603688|JWLin@syncorebio.com|
21261676|NCT00779038|Janssen-Cilag Belgium|Study Responsible Physician|003214649584||
21261677|NCT05372315|Iworks Laser and Vision Center|Dr. Patrick L. Spencer|937-226-7870|iworkeye@gmail.com|
21235092|NCT00654628|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21261678|NCT00328198|Genzyme Corporation|Genzyme Medical Information|1-800-745-4447||
21242470|NCT05824351|Duke University|Amy Barto, MD|919-684-1817|amy.barto@duke.edu|
21242471|NCT03722446|University of Michigan - Department of Anesthesiology|Dr. Carlo Pancaro|617-435-5403|cpancaro@med.umich.edu|
21242472|NCT04460898|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21242473|NCT00470626|Cook|Scott Snyder|765-463-7537|ssnyder@medinst.com|
21242474|NCT03720990|University of Nebraska Medical Center|William Rizzo|402-559-2560|wrizzo@unmc.edu|
21242475|NCT01249092|Cleveland Clinic|Claudia O. Zein, MD|216-444-0421|zeinc@ccf.org|
21242476|NCT02380742|Loyola University|Brendan Martin, Biostatistician|708-216-8051|bmartin5@luc.edu|
21242477|NCT00802919|Nathan Kline Institute for Psychiatric Research|Robert C. Smith MD|845-398-6531|rsmith@nki.rfmh.org|
21242478|NCT03518112|The University of Texas MD Anderson Cancer Center|Dr. Elias Joseph Jabbour MD/Professor|713-792-4764|ejabbour@mdanderson.org|
21242479|NCT01546155|Massachusetts General Hospital|Dr. Jian Kong|617-726-7893|JKONG2@mgh.harvard.edu|
21242480|NCT02930343|JIPMER|Dr Pooja Belani|8940482248|drpoojabelani@gmail.com|
21242481|NCT02899000|Galderma Laboratories, LP|Dr. Jean Philippe York, Medical Affairs Manager|1-817-961-5468|jp.york@galderma.com|
21242482|NCT02220478|Zimmer Biomet|Hillary Overholser|574-933-4180|hillary.overholser@zimmerbiomet.com|
21242483|NCT01729819|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21242484|NCT01025843|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21242485|NCT01649791|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21242486|NCT00364286|The University of Texas MD Anderson Cancer Center|Susan O'Brien, MD/ Professor|713-792-7543|eharriso@mdanderson.org|
21242487|NCT02814643|AstraZeneca|Mitchell Goldman MD, PhD|+1 610 457 5585|Mitchell.Goldman@astrazeneca.com|
21242488|NCT03284411|Medtronic|SCS Dosing Clinical Research Study Team|800-633-8766|rs.scsdosing@medtronic.com|
21242489|NCT01541358|David Geffen School of Medicine at UCLA|Andrew Quon, MD|310-983-1419|AQuon@mednet.ucla.edu|
21242490|NCT01227278|MedImmune, LLC.|Rene van der Merwe, MBChB/Senior Director, Clinical Development|301-398-0000|vandermerwer@medimmune.com|
21242491|NCT00420316|GlaxoSmithKline|GSK Response Center|866-435-7343||
21242492|NCT04020718|Massachusetts General Hospital|Dr. Gina Kruse|6177243157|gkruse@mgh.harvard.edu|
21261679|NCT00650585|PIRE|Heddy Clark|919-265-2643|hclark@pire.org|
21261680|NCT02640612|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21261681|NCT02048878|University of Chicago|Eve Van Cauter, PhD|773-702-0169|evcauter@bsd.uchicago.edu|
21261682|NCT03583424|The Ohio State University Comprehensive Cancer Center|Dr. Kami Maddocks|614-293-9165|Kami.Maddocks@osumc.edu|
21261683|NCT01144637|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
21261684|NCT03756012|Ohio Pain Clinic|Dr. Amol Soin|937-434-2226|drsoin@ohiopainclinic.com|
21261685|NCT01731691|Institute for Human Genetics and Biochemistry|Dr. Cynthia L. Bristow|631-444-6238|cynthia.bristow@stonybrook.edu|
21261686|NCT04109443|Boston University School of Public Health|Kimberly M Nelson, PhD|617-358-1482|knel@bu.edu|
21261687|NCT02984878|Prollenium Medical Technologies, Inc.|Ario Khoshbin, President|866-353-3015||
21235093|NCT00912405|Intersect ENT|James Stambaugh|650-641-2103|jstambaugh@intersectent.com|
21235094|NCT01797536|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21235095|NCT00754247|University of Miami|Dr. Robert Kirsner|305-243-4472|RKirsner@med.miami.edu|
21235096|NCT00844545|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals Inc||clinicaltrials@alxn.com|
21235097|NCT01540370|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21235098|NCT03058796|The MetroHealth System|Dr. Jayme Knutson|216-957-3557|jsk12@case.edu|
21235099|NCT01532687|OHSU Knight Cancer Institute|Dr. Christopher Ryan|503-494-9000|ryanc@ohsu.edu|
21235100|NCT00403455|Department of Veterans Affairs|Dr. Zhewu Wang|(843) 789-7949|Zhewu.Wang@va.gov|
21235101|NCT03160703|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21235102|NCT04805983|Associate Director of the Yale Alzheimer's Disease Research Unit|Adam Mecca, MD, PhD|(203) 785-4736|adam.mecca@yale.edu|
21235103|NCT01358981|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21235104|NCT02738775|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
21235105|NCT01060384|University of Nebraska Medical Center|Julie M. Vose|402-559-3848|jmvose@unmc.edu|
21235106|NCT01401530|Eisai Inc.|Eisai Medical Services Inc.|1-888-422-4743|esi_medinfo@eisai.com|
21235107|NCT02247349|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|855-907-3286|Clinical.Trials@bms.com|
21235108|NCT03969212|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21235109|NCT03511560|Columbia University|Amanda Alonso|212-342-0261|aa2974@cumc.columbia.edu|
21235110|NCT03487913|Centessa Pharmaceuticals|Milena Kanova, MD, Vice President, Clinical Operations|+44 7780 430583|Milena.Kanova@centessa.com|
21235111|NCT00382733|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
21235112|NCT03075644|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21235113|NCT00439140|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21235114|NCT00427804|Emory University|Vin Tangpricha, M.D., Ph.D.|404-727-7254|vin.tangpricha@emory.edu|
21235115|NCT01458171|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
21235116|NCT02270060|University Hospitals Connor Integrative Health Network|Samuel Rodgers-Melnick, MT-BC, music therapist|216-844-7727|Samuel.RodgersMelnick@UHhospitals.org|
21235117|NCT01072682|SeaStar Medical, Inc|Eric Schlorff|8444278100|eric@seastarmed.com|
21261688|NCT03865407|Virginia Commonwealth University|Cristin Kaspar, MD|804-628-3866|cristin.kaspar@vcuhealth.org|
21242493|NCT03546907|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21242494|NCT00332644|University of Wisconsin|Piper, Megan E|608-265-5472|mep@ctri.medicine.wisc.edu|
21242495|NCT03720210|Mayo Clinic|Marius N. Stan, M.D.|507-266-3769|Stan.Marius@mayo.edu|
21242496|NCT04033432|Northwestern University|Maha Hussain, MD|312-908-5487|mhussain@northwestern.edu|
21242497|NCT01551056|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
21242498|NCT03110458|Sensorion|Director of Regulatory Affairs|+33 4 67 20 77 30|contact@sensorion-pharma.com|
21242499|NCT00558363|GlaxoSmithKline|GSK Response Center|866-435-7343||
21242500|NCT02174562|Thomas Jefferson University|Barry Rovner, MD|215-503-1243|Barry.Rovner@Jefferson.edu|
21242501|NCT03201809|UC Davis|Dr. Granger Wong, Chief and Professor of Plastic Surgery|(916) 734-7289|gwong@ucdavis.edu|
21242502|NCT03608670|Medtronic Cardiac Rhythm Management|CRM Clinical Research|+1 800 328 2518|rs.medtronicCRMtrials@medtronic.com|
21242503|NCT03636451|University of California, San Diego|Sheila Mody|8583294464|smody@health.ucsd.edu|
21242504|NCT01651949|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21242505|NCT02155829|USUHS|Dr. David M. Benedek|(301) 295-3294|david.benedek@usuhs.edu|
21242506|NCT00771849|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21242507|NCT03058991|Boston University Charles River Campus|Dr. Michael Otto|617-353-9610|mwotto@bu.edu|
21242508|NCT01689519|Hoffmann-La Roche|Medical Communications|800 821-8590||
21242509|NCT01787240|MGH|Dr. Cristina Cusin|617 726 6421|ccusin@partners.org|
21242510|NCT01161563|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com|
21242511|NCT02982213|Northwestern University|Feyce Peralta, MD|312-472-3585|feyce.peralta@northwestern.edu|
21242512|NCT03237936|Santen Inc|R&D Quality Manager|4152689199|evelyn.chikere@santen.com|
21242513|NCT01669148|Massachusetts General Hospital|Thomas J. Brady, MD|6177268294|tbrady@mgh.harvard.edu|
21242514|NCT02596035|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email|Clinical.Trials@bms.com|
21242515|NCT01559506|Nimbic Systems|Sean Self|281-565-5715|self@nimbicsystems.com|
21242516|NCT00835380|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21242517|NCT03247543|Supernus|Joseph Hull, PhD, Associate Director Clinical Research|240-403-5324|jhull@supernus.com|
21242518|NCT01097343|St. Vincent Medical Group|Dr. Joseph S. Rossi|765 482 0656|jrossi@thecaregroup.com|
21242519|NCT03495713|Abramson Cancer Center at Penn Medicine|John P. Plastaras, MD, PhD|855-216-0098|PennCancerTrials@emergingmed.com|
21242520|NCT00964119|University of Wisconsin - Madison|Dermatology Clinical Trials Administrator|608-287-2640|dbock@dermatology.wisc.edu|
21242521|NCT02979899|TRACON Pharmaceuticals Inc|Charles Theuer, Medical Monitor|8585500780|ctheuer@traconpharma.com|
21242522|NCT02059980|University of Wisconsin-Milwaukee|Dr. Han Joo Lee|414-229-5858|leehj@uwm.edu|
21242523|NCT01321606|William S. Middleton Memorial Veterans Affairs Medical Center|Dr. Nasia Sardar|608-256-1901|nasia.safdar@va.gov|17800
21242524|NCT01253226|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21242525|NCT04979988|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21242526|NCT00414206|CoMentis, Inc.|Carl Grove|650-869-7600|cgrove@comentis.com|
21242527|NCT04550039|Shirley Ryan AbilityLab|Katherine Enzler, Physical Therapist|312-238-2941|kenzler@sralab.org|
21242528|NCT00967369|UT MD Anderson Cancer Center|Dr. Michelle A Fanale / Associate Professor, Lymphoma/Myeloma|713-792-2860|MFANALE@MDANDERSON.ORG|
21242529|NCT00554801|Portland VA Medical Center|Marjorie R. Leek|503-220-8262|Marjorie.Leek@va.gov|54525
21242530|NCT05196737|Medical University of South Carolina|Gretchen Seif, PT, DPT, MHS, OCS, FAAOMPT|(843) 792-9345|seif@musc.edu|
21242531|NCT00331162|Wake Forest University Health Sciences|Dr. Alan Farney|336-716-6510|afarney@wakehealth.edu|
21242532|NCT00828945|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21242533|NCT04222959|San Diego State University Research Foundation|Elizabeth Reed|508-212-1517|ereed@sdsu.edu|
21242534|NCT04164563|Brigham and Women's Hospital|Dr. Jeremy T. Smith|6177325322|jsmith42@bwh.harvard.edu|
21242535|NCT00635817|Abbott|Global Medical Services|800-633-9110||
21242536|NCT03981549|The Emmes Company, LLC|Principal Investigator of the TRUST Data Coordinating Center|301-251-1161|trust@emmes.com|
21242537|NCT05012644|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21242538|NCT00603447|Amgen, Inc.|Study Director|866-572-6436||
21242539|NCT04341298|Avulux|Dr. Charles Posternack, President|833-288-5890|cposternack@avulux.com|
21242540|NCT04133363|University of Alabama at Birmingham|Nicolaas C. Geurs, DDS, MS, Interim Dean, Principal Investigator|205-9344506|ngeurs@uab.edu|
21242541|NCT03523702|Albert Einstein College of Medicine|Dr. Nitin Ohri|718-920-7750|nitin.ohri@einsteinmed.edu|
21242542|NCT04969991|Ophirex, Inc.|Tim Platts-Mills, Chief Medical Officer|5592406073|tim@ophirex.com|
21242543|NCT03645031|University of Florida|Dr. Barbara K. Smith|352-294-5315|bksmith@ufl.edu|
21242544|NCT00482729|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21242546|NCT04622527|Mayo Clinic|Dr. Ivana Croghan|507-284-2511|gimresearchstudies@mayo.edu|
21242547|NCT01090024|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21242548|NCT00771667|Janssen Research and Development, US|Director, Clinical Research|610-651-6554||
21242549|NCT01897233|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21261689|NCT02117050|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21261690|NCT03291197|Physical Medicine and Rehabilitation Ottawa Resident|Dr. Marc Monsour|6137377350|mmonsour051@gmail.com|
21261691|NCT02723162|Medical University of South Carolina|Dr. Kevin Gray|843-792-9162|graykm@musc.edu|
21261692|NCT00546819|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21291920|NCT01198587|Boston Children's Hospital|Michelle Niescierenko MD MPH|617-919-4121|michelle.niescierenko@childrens.harvard.edu|
21291921|NCT01493089|Norgine Ltd|Dr. Richard Ng Kwet Shing|+441895453584|RNg@Norgine.com|
21291922|NCT01440764|Beth Israel Deaconess Medical Center|Robert Banzett, PhD|(617)667-0572|rbanzett@bidmc.harvard.edu|
21291923|NCT00652834|UCLA Kidney Transplant Research Program|Dr. Bunnapradist|310-794-8516|bunnapradist@mednet.ucla.edu|
21291924|NCT01528592|Northwestern University|Darren Gitelman, MD|312-908-8266|d-gitelman@northwestern.edu|
21291925|NCT00399529|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Leisha Emens|412-623-3239|emensla@upmc.edu|
21291926|NCT01170663|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21291927|NCT02746809|Medtronic|Phuong-Uyen Le|763-526-0989|phuong-uyen.n.le@medtronic.com|
21291928|NCT01093014|University of Iowa / Iowa City VA Medical Center|Richard K. Shields PhD, PT|319-335-9791|richard-shields@uiowa.edu|
21291929|NCT00742625|Massachusetts General Hospital Cancer Center|Eyal Attar, MD|617-724-1124|eattar@partners.org|
21291930|NCT01164007|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21291931|NCT00894387|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21291932|NCT01076010|AVEO Pharmaceuticals, Inc.|Cheif Medical officer|857-400-0101|Clinical@aveooncology.com|
21291933|NCT01612676|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21291934|NCT01204788|University of Texas (UT) MD Anderson Cancer Center|Emil Freireich, MD, Professor, Department of Medical Education|713-745-2723|CR_Study_Registration@mdanderson.org|
21261693|NCT03849560|NPO Petrovax Pharm, LLC|Nikolay Dodonov, Head of medical department|+7(495) 730-75-45|DodonovNS@petrovax.ru|125
21291935|NCT02976181|Medtronic|Carina Leone, Latam CVG Trial Leader|+5411 5789 8521|carina.leone@medtronic.com|
21291936|NCT04661033|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
21291937|NCT05200845|Virginia Tech|Alexandra DiFeliceantonio|540-526-2285|dife@vt.edu|
21291938|NCT02622191|Wills Eye Hospital, Glaucoma Research Center|Dr. L. Jay Katz|215-928-3123|ljkatz@willseye.org|
21291939|NCT00565409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21291940|NCT04064905|ModernaTX, Inc|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
21291941|NCT02814656|AstraZeneca|Ioannis Psallidas||ClinicalTrialTransparency@astrazeneca.com|
21291942|NCT01465841|Penumbra, Inc.|Michaella Corso|415-815-8904|mcorso@penumbrainc.com|
21291943|NCT03961308|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21291944|NCT00867139|FHCRC|Michael Boeckh MD|206 667 6706|mboeckh@fhcrc.org|
21291945|NCT03050710|CROMA - PHARMA|Head of Clinical Operations|+43 0226268468|clinical.studies@croma.at|
21291946|NCT05643495|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21291947|NCT01729039|James H Quillen VAMC|Dr. Courtney Hall|423-926-1171|courtney.hall@va.gov|7518
21291948|NCT03449576|Rehabilitation Research & Development|Dr. Shirley Groer (Scientific Program Manager)|202-553-9899|shirley.groer@va.gov|
21291949|NCT00698841|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21291950|NCT00789555|Alcon Research|Terri Pasquine, Sr. Clinical Lead|817-551-4760|terri.pasquine@alconlabs.com|
21291951|NCT00404248|Adult Brain Tumor Consortium Central Office - Johns Hopkins|Director of Adult Brain Tumor Consortum|410-955-3657|jfisher@jhmi.edu|
21297160|NCT01726582|Froedtert and the Medical College of Wisconsin|Susan Tsai, MD|414-955-1412|stsai@mcw.edu|
21235118|NCT00578565|Mayo Clinic|Eric. L. Matteson, M.D.|507-284-8450||
21235119|NCT03022617|University of Alabama at Birmingham|Dr. Boni Elewski|205-502-9960|dermresearch@uabmc.edu|
21235120|NCT02143843|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21235121|NCT00480779|University of Pittsburgh|M. Kaye Kramer|4123831286|mkk3@pitt.edu|
21235122|NCT00005669|National Institute of Child Health and Human Development, NIH|Jack A. Yanovski, MD, PhD, Chief, Unit on Growth and Obesity|301-496-0858|yanovskj@mail.nih.gov|
21235123|NCT01339390|Clement J. Zablocki VA Medical Center|Dr. Jeff Whittle|(414) 384-2000|jeffrey.whittle@va.gov|46444
21235124|NCT01446731|Center for Cancer ImmuneTherapy|Per Kongsted, M.D.|+45 38689255|per.kongsted@regionh.dk|
21235125|NCT00378703|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
21235126|NCT01930058|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21235127|NCT03012386|Vanderbilt University Medical Center|Cyndya Shibao MD|6159364584|cyndya.shibao@vumc.org|
21235128|NCT01482767|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21235129|NCT01346267|Wake Forest University School of Medicine|Thomas W. McLean, MD|336-716-4085|tmclean@wfubmc.edu|
21235130|NCT01868633|University of Iowa|Dr. Unyime Ituk|3193562633|unyime-ituk@uiowa.edu|
21235131|NCT01541930|Galderma K.K.|Clinical Project Manager|+81 3 5937 3850|GaldermaKK.ClinDev@galderma.com|
21235132|NCT01466192|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21235133|NCT00862784|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21235134|NCT03665038|Sage Therapeutics|Medical Monitor|(617) 299-8380|medinfo@sagerx.com|
21235135|NCT03013491|CytomX Therapeutics, Inc.|Head of Clinical Operations|(650) 515-3185|clinicaltrials@cytomx.com|
21235136|NCT05445128|Ensoma|Ensoma head of regulatory or head of clinical research & development|6127191200|ddietz@ensoma.com|
21235137|NCT04740034|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21235138|NCT05559320|University of Connecticut Department of Kinesiology|Dr. Sudha Srinivasan|(860)-486-6192|sudha.srinivasan@uconn.edu|
21235139|NCT05648565|The University of Texas Health Science Center at Houston|David Z. Allen|713-500-5427|David.Allen@uth.tmc.edu|
21235140|NCT05346406|Medical College of Wisconsin|Alina G Burek MD|414-337-7050|aburek@mcw.edu|
21235141|NCT03890367|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21291952|NCT00253422|Institute of Cancer Research, Clinical Trials and Statistics Unit (ICR-CTSU)|Professor Judith Bliss (Director of ICR-CTSU)|+44 0208 722|aude.espinasse@icr.ac.uk|4349
21291953|NCT04646005|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21291954|NCT02918942|Grace Medical, Inc.|Robert Stroup|901-386-0990|robert.stroup@gracemedical.com|
21291955|NCT02661672|Icahn School of Medicine at Mount Sinai|Sydney Edwards|212-241-2524|sydney.edwards@mountsinai.org|
21291956|NCT01621178|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21291957|NCT02935192|Institute of Virology, Vaccines and Sera, Torlak|Katarina Ilic|+381 11 3953 700|kilic@torlak.rs|214
21291958|NCT02465931|RTI International|Dr. Don Bailey|(919) 541-6488|dbailey@rti.org|
21242550|NCT02076919|Alcon Research, Ltd.|Principal Clinical Scientist, CA CSI ID|1-888-451-3937|alcon.medinfo@alcon.com|
21291959|NCT01561833|Yale University School of Medicine|Francine Foss MD|2037375312|francine.foss@yale.edu|
21242551|NCT00628862|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21291960|NCT00492557|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21291961|NCT01574144|Medtronic, Inc|Amy Lautenbach|7633609163|amy.a.lautenbach@medtronic.com@medtronic.com|
21242552|NCT01883492|Zimmer Biomet G.K.|Senior Manager of Clinical Affairs|+81-3-6402-6610|takahito.nakai@zimmerbiomet.com|
21242553|NCT03265210|Weill Cornell Medicine|Dimitris Kiosses, PhD|914-997-4381|dkiosses@med.cornell.edu|
21291962|NCT00372957|GlaxoSmithKline|GSK Response Center|866-435-7343||
21235142|NCT02373124|New York State Psychiatric Institute|Elias Dakwar, MD|6467748728|elias.dakwar@nyspi.columbia.edu|
21242554|NCT00796068|Fred Hutchinson Cancer Center|Dr. Filippo Milano|206-667-5925|fmilano@fredhutch.org|
21291963|NCT04778592|Eliem Therapeutics|Clinical Operations|+1-888-506-2573|studyinfo@eliemtx.com|
21291964|NCT03423121|Johns Hopkins University School of Medicine|Dr. Pavan Bhargava|410-614-1522|pbharga2@jhmi.edu|
21291965|NCT01354223|Foresight Regulatory Strategies, Inc.|William J. Gleason, O.D.|978-658-6888||151
21291966|NCT03246087|MOMH|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
21291967|NCT04790786|UPMC|Erin McCreary|4845159589|mccrearye3@upmc.edu|
21242555|NCT03768856|Cleveland Clinic, Case Comprehensive Cancer Center|Dr Shlomo Koyfman|1-800-223-2273|TaussigResearch@ccf.org|
21242556|NCT00549848|St. Jude Children's Research Hospital|Sima Jeha, MD|(901) 595-3901|sima.jeha@stjude.org|
21242557|NCT00868192|Washington University School of Medicine|David G. Mutch, M.D.|314-362-2181|mutchd@wudosis.wustl.edu|
21242558|NCT04008836|Ascensia Diabetes Care|Jane Wallace|5748501467|jane.wallace@ascensia.com|
21242559|NCT03336450|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21242560|NCT00798096|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
21242561|NCT03670602|University at Buffalo|Leonard H. Epstein|716-829-3400|lhenet@buffalo.edu|
21242562|NCT03383887|Brigham and Women's Hospital|Luigi Taranto Montemurro, MD|6177326541|ltarantomontemurro@bwh.harvard.edu|
21242563|NCT00300456|Abbott|Medical Information Specialist|800-633-9110||
21242564|NCT00975806|Celgene Corporation|Anne McClain,Senior Manager|1-888-260-1599|clinicaltrialsdisclosure@celgene.com|
21242565|NCT00246012|Centocor, Inc.|Senior Director|908-927-2116||
21242566|NCT02377362|GLWL Research Inc|Study Director||choruspharma@lists.lilly.com|
21242567|NCT02718118|Galderma Laboratories|Jay Mashburn||jay.mashburn@galderma.com|
21242568|NCT01806714|University of Rochester|Dr. Cynthia Rand|585 275-9316|cynthia_rand@urmc.rochester.edu|
21242569|NCT01585038|Indiana University School of Medicine|Samir K Gupta, Md, MS|317-274-7926|sgupta1@iu.edu|
21242570|NCT00678795|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
21242571|NCT01919697|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020||
21242572|NCT04107805|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21291968|NCT01152307|Massachusetts General Hospital|Dr. Karen Sepucha|617-724-3350|ksepucha@partners.org|
21235143|NCT02556710|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
21235144|NCT04524403|Corcept Therapeutics Incorporated|Medical Director|650-327-3270|info@corcept.com|
21235145|NCT03370341|The University of Texas at Dallas|Dr. Amy Pinkham|(972) 883-4462|amy.pinkham@utdallas.edu|
21235146|NCT00273364|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
21235147|NCT02805647|Department of Pediatric Orthopedics and Traumatology Medical University of Bialystok|MichałKarpiński|692224714|gufkarp@gmail.com|+48
21235148|NCT02258152|Acorda Therapeutics|Christopher Kenney, Senior Vice President - Medical Affairs|914-326-5775|ckenney@acorda.com|
21235149|NCT02616250|GALDERMA|Fabien AUDIBERT, Sr CPM|+33 (0) 4 9238 3034|fabien.audibert@galderma.com|
21235150|NCT00646958|Melinta Therapeutics|Eugene Sun, M.D.|203.624.5606|esun@melinta.com|
21235151|NCT01607905|Karyopharm Therapeutics Inc|Jatin Shah|(617) 658-0600|jshah@karyopharm.com|
21235152|NCT01310413|GlaxoSmithKline|GSK Response Center|866-435-7343||
21235153|NCT02564471|SUNY Upstate Medical University|Dr. Timothy Endy|3154647692|endyt@upstate.edu|
21235154|NCT02448303|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
21235155|NCT00630877|Abbott|Medical Information Specialist|800-633-9110||
21235156|NCT01643473|NYU School of Medicine|Antoinette Schoenthaler|212-263-4205|antoinette.schoenthaler@nyumc.org|
21235157|NCT02033889|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21235158|NCT02343458|Pearl Therapeutics Inc.|Pearl Therapeutics Inc.|650-305-2600|creisner@pearltherapeutics.com|
21242573|NCT02750709|Cycle Pharmaceuticals Ltd|James Price|+44 1223 803638|james.price@cyclepharma.com|
21242574|NCT00588965|MetroHealth Medical Center|Dr. Elizabeth Kaufman|216-778-2349|ekaufman@metrohealth.org|
21291969|NCT00524121|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21242575|NCT00422201|HRA Pharma|Head of Clinical Research|0033140331130|s.durand@hra-pharma.com|
21242576|NCT01120275|SWOG Statistical Center|Melanoma Committee Statistician|2066674623|jmoon@fredhutch.org|
21242577|NCT01234532|University of Maryland, Baltimore|Katherine Tkaczuk, M.D.|410-328-2565|ktkaczuk@umm.edu|
21242578|NCT01191086|Upsher-Smith Laboratories, Inc.|Bob Anders, Sr. Director of Clinical Operations|763-315-2000|bob.anders@upsher-smith.com|
21242579|NCT01859312|National Institute of Child Health and Human Development (NICHD)|Deborah P. Merke, MD, MS|301-496-0718|DMerke@cc.nih.gov|
21242580|NCT00290732|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|4432876489|vstearn1@jhmi.edu|
21291970|NCT04047446|Hospital for Special Surgery|Dr. David H. Kim|212-606-1036|kimd@hss.edu|
21242581|NCT02736799|Vibrant LTD|Tal Malina / Clinical trials manager|+972 046663322|tal.m@vibrantgastro.com|
21242582|NCT01833832|National Cancer Institute|Dr. Jeremy Davis|240-760-6229|jeremy.davis@nih.gov|
21242583|NCT01156116|University of Chicago|Esra Tasali|773-702-1497|etasali@medicine.bsd.uchicago.edu|
21242584|NCT00843193|GlaxoSmithKline|GSK Response Center|866-435-7343||
21242585|NCT02057718|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
21242586|NCT00542386|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21242587|NCT00197015|GlaxoSmithKline|GSK Response Center|866-435-7343||
21242588|NCT00614406|Oregon Health and Sciences University|Allison Edelman, MD, MPH|503-494-5949|edelmana@ohsu.edu|
21242589|NCT04511650|EyePoint Pharmaceuticals, Inc.|Dario Paggiarino, MD|8589670016|dpaggiarino@eyepointpharma.com|
21242590|NCT00434018|VACO|Dr. Shirley Groer|202-553-9899|Shirley.Groer@va.gov|
21242591|NCT04059237|Stanford University|Catherine Benedict, PhD|650-498-9111|cbenedict@stanford.edu|
21242592|NCT00608907|Johnson & Johnson Pharmaceutical Research & Development|Helgi van de Velde, MD, PhD||HVDVELDE@ITS.JNJ.COM|
21242593|NCT02050308|The University of Kansas Medical Center|Dr. Won S. Choi|(913) 588-4742|wchoi@kumc.edu|
21242594|NCT01186848|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
21242595|NCT01104415|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD||plapuerta@lexpharma.com|
21242596|NCT03098966|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
21242597|NCT03593070|Rush University College of Nursing|Dr. Olimpia Paun|3129426996|olimpia_paun@rush.edu|
21242598|NCT03612804|VA Puget Sound Health Care System|Steven B Zeliadt|206-277-4175|Steven.Zeliadt@va.gov|
21242599|NCT02104765|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21242600|NCT04771273|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21242601|NCT02357784|Northwestern University|Dr. Margaret Mueller|13124723874|mgmueller@nm.org|
21242602|NCT00995709|Novartis Pharmaceuticals|Study Director|862-778-8300||
21242603|NCT03328949|Shockwave Medical, Inc.|Beaux Alexander, Vice President of Clinical Affairs|510-279-4262 ext. 145|balexander@shockwavemedical.com|
21242604|NCT00392678|Joslin Diabetes Center|Allison B. Goldfine, MD co-investigator|617-309-2643|allison.goldfine@joslin.harvard.edu|
21242605|NCT01670110|Mayo Clinic|Marie C. Hogan, M.D., Ph.D.|507-284-3479|Hogan.Marie@mayo.edu|
21242606|NCT03395353|Shionogi|Corporate Communications Department|+81-6-6209-7885|shionogiclintrials-admin@shionogi.co.jp|
21242607|NCT02685033|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21242608|NCT00708097|GlaxoSmithKline|GSK Response Center|866-435-7343||
21242609|NCT03425643|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
21242610|NCT01838200|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
21242611|NCT04415333|North Carolina A&T State University|Marc Cook, PhD|336-285-3547|mdcook@ncat.edu|
21242612|NCT03354390|National Heart Lung and Blood Institute (NHLBI)|Richard Childs, M.D. Principal Investigator|301-451-7128|childsr@nhlbi.nih.gov|
21242613|NCT02743078|RTOG Foundation|Wendy Seiferheld|215-574-3208|wseiferheld@acr.org|
21242614|NCT02126878|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
21242615|NCT00777556|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21242616|NCT02689349|Envoy Medical Corp.|Elizabeth Anderson, Ph.D.|(1) 651-788-3017|landerson@envoymedical.com|
21242617|NCT01549314|Massachusetts General Hospital Endocrine Unit|Dr. Melissa Putman|857-218-5017|msputman@partners.org|
21242618|NCT02425449|The University of Toledo|Shashi Bhatt, MD|419-383-3556|Shashi.Bhatt@utoledo.edu|
21242619|NCT00486759|Hoffmann-La Roche|Medical Communications|800 821-8590||
21242620|NCT01185522|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21242621|NCT02987543|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21242622|NCT03224299|Becton Dickinson|Erin Zook|224-358-5019|erin.zook@bd.com|
21242623|NCT03646669|Icahn School of Medicine at Mount Sinai|Maria Peralta|212-274-7571|Maria.peralta@mountsinai.org|
21242624|NCT00377455|Georgetown University|Dr. Virginia Steen|202-444-6200|steenv@georgetown.edu|
21242625|NCT00309452|Yale University|Vinod H. Srihari|2039747816|vinod.srihari@yale.edu|
21242626|NCT02962674|seleon gmbh|Annegret Genger|+49 175 934 91 83|Annegret.Genger@seleon.de|
21242627|NCT00669461|University of Arkansas for Medical Sciences|Muhannad Heif, MD|5016500215|mmheif@gmail.com|
21291971|NCT01840943|Xian Janssen Pharmaceutical LTD|Senior Director Clin Development||ClinicalTrialDisclosure@its.jnj.com|
21291972|NCT00329420|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
21242628|NCT02504619|Gamida Cell|Kelly Myers|026595631|kelly@gamida-cell.com|
21242629|NCT05193318|Metrohealth Hospital System (formerly employee of Medical University of South Carolina)|Eric Dobson, MD (principal nvestigator)|513-504-2091|edobson@metrohealth.org|
21242630|NCT02046616|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21242631|NCT04420195|NYU Langone Health|Tyler C Lewis|646-501-4222|Tyler.lewis@nyulangone.org|
21291973|NCT01446874|Washington University School of Medicine|Varun Puri, M.D.|314-362-4191|varunpuri@wustl.edu|
21242632|NCT01183533|University of Texas Health Science Center at Houston|Sean I. Savitz, MD|713-500-7083|sean.i.savitz@uth.tmc.edu|
21242633|NCT00344019|BIDMC|Director of Clinical Trials|6176678800|dcutlip@bidmc.harvard.edu|
21242634|NCT02503202|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21242635|NCT00906035|Upenn|Emile Mohler, MD|215-573-6606|Emile.Mohler@uphs.upenn.edu|
21242636|NCT00139737|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21242637|NCT00942149|Duke University Medical Center|Brian Smith|9196688951|brian.smith@duke.edu|
21242638|NCT02925195|University of Washington|Dr. Ian de Boer|206-616-5403|IDeBoer@Nephrology.washington.edu|
21242639|NCT05252871|Western University of Health Sciences|Frank Spors|9097063883|fspors@westernu.edu|
21242640|NCT01245439|Hoffmannb-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21242641|NCT00217672|University of California, Los Angeles|Sara Hurvitz, M.D.|310-829-5471|shurvitz@mednet.ucla.edu|
21242642|NCT01591616|Virginia Commonwealth University, School of Dentistry|Tegwyn H. Brickhouse, DDS, PhD|(804) 827-2699|thbrickhouse@vcu.edu|
21242643|NCT03525119|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21242644|NCT03781336|National Institutes of Health|Psychologist|3014027360|amelir@mail.nih.gov|
21242645|NCT00932022|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21242646|NCT00982033|Wake Forest School of Medicine|Dalane W. Kitzman, M.D.|336-716-3274|dkitzman@wakehealth.edu|
21291974|NCT01135992|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21242647|NCT00158054|Columbia University Medical Center|Karina W Davidson, PhD|212-342-4493|kd2124@cumc.columbia.edu|
21242648|NCT00414648|Division of Pulmonary, Critical Care and Sleep Medicine, University of Cincinnati|Francis X. McCormack, MD|513-558-4831|mccormfx@ucmail.uc.edu|
21242649|NCT00988637|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Dierctor|817-961-5358|ron.gottschalk@galderma.com|
21242650|NCT01544062|University of Washington|Srdjan Jelacic, MD|(206) 598-3777|sjelacic@uw.edu|
21242651|NCT03098030|United Therapeutics Corporation|Program Manager, Oncology|919-485-8350|kmaher@unither.com|
21242652|NCT05484726|Fatima Memorial Hospital Shadman Lahore|Assistant Professor Dr Rafia Gul|00923064620027|docrafiagul@gmail.com|
21242653|NCT04391309|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21242654|NCT03028363|Eli Lilly and Company.|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21242655|NCT00768651|Faculty of Medicine and Dentistry, University of Alberta|Peter Senior, MD, PhD - Professor of Medicine, Medical Director-Clinical Islet Transplant Program,|780-407-1480|peters@islet.ca|
21242656|NCT00462943|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21242657|NCT01697319|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|800-983-4587|medinfo@bmrn.com|
21242658|NCT01421654|ResMed|Amy Blase/Clinical Research Manager|858-836-6715|amy.blase@resmed.com|
21242659|NCT02698241|Medtronic CRHF Clinical Research|Joe Hobbs Clinical Research Specialist|800-633-8766|joe.hobbs@medtronic.com|
21242660|NCT01944319|Peking University Third Hospital|Dr. Qingtao ZHOU|86-10-82265562|zhouqingtaobysy@sina.com|
21242661|NCT04026620|University of North Carolina at Chapel Hill|Julie Hasken, PhD|704-250-5000|julie_hasken@unc.edu|
21242662|NCT01543685|Iroko Pharmaceuticals, LLC|Daniel Solorio|267-546-3150|dsolorio@iroko.com|
21242663|NCT00604721|UNC Lineberger Comprehensive Cancer Center|Bert. H. O'Neil, Associate Professor, Clinical Research|919-966-4431|bert_oneil@med.unc.edu|
21242664|NCT04776213|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21242665|NCT03392532|Alcon, A Novartis Division|CDMA Project Lead, CDMA Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21242666|NCT00556543|Oregon Health & Science University|John Mayberry, MD|503-494-5300|mayberrj@ohsu.edu|
21242667|NCT01838551|Strongbridge Biopharma|Chief Medical Officer|14845890392|f.cohen@strongbridgebio.com|
21242668|NCT00906282|SCRI Development Innovations|Charles Davis, RAC|615-524-4341|charles.davis2@scri-innovations.com|
21242669|NCT02908464|Beth Israel Deaconess Medical Center|Brian O'Gara, MD, MPH|617-754-3189|bpogara@bidmc.harvard.edu|
21242670|NCT01391013|Jan-Cil Italy|Therapeutic Area Medical Manager|39 02 2510589||
21242671|NCT01286402|University of Texas Health Science Center at Houston|Angela Stotts, PhD, PI|713-500-7590|Angela.L.Stotts@uth.tmc.edu|
21242672|NCT02163915|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21242673|NCT01751724|University of Miami|Eduardo Bancalari M.D., Director Division of Neonatology|3055856408|ebancalari@miami.edu|
21242674|NCT02013037|Cedars Sinai Smidt Heart Institute|Dr. Jignesh Patel|310-248-8300|jignesh.patel@cshs.org|
21242675|NCT01278862|3M HCBG Clinical Operations|Rolf Halvorson|651-733-3384|rhhalvorson@mmm.com|
21242676|NCT05208359|Loyola University Chicago|Sungha Kang|7735082712|skang@luc.edu|
21242677|NCT04670822|State University of New York at Buffalo|Dr. Xiaozhong Wen|7168296811|xiaozhon@buffalo.edu|
21242678|NCT04411082|Imara, Inc.|Rahul Ballal|617-206-2020|rballal@imaratx.com|
21242679|NCT00589667|Memorial Sloan-Kettering Cancer Center|David Pfister, MD|646-888-4232|pfisterd@mskcc.org|
21242680|NCT02804594|University of California San Francisco|Emmanuelle Waubant, MD|415 514 2468|Emmanuelle.Waubant@ucsf.edu|
21242681|NCT03538041|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21242682|NCT01049503|Bauru Dental School/University of São Paulo|Dr. Marília Buzalaf|+55 14 32358346|mbuzalaf@fob.usp.br|
21242683|NCT00726596|Rutgers Cancer Institute of New Jersey|Mark Stein, MD|732-235-5773|steinmn@cinj.rutgers.edu|
21242684|NCT00580073|University of Wisconsin-Madison|CRA|608-265-4347|smccarthy@medicine.wisc.edu|
21242685|NCT00954707|Cordis Corporation, a Johnson & Johnson company|Amy Orlick, Associate Director|908-541-4347|aorlick@its.jnj.com|
21242686|NCT02195713|Theranova, LLC|Devyani Nanduri|415-926-8616|dnanduri@theranova.com|
21242687|NCT03686813|Duke University|Richard Moon, M.D.|919-684-8762|richard.moon@duke.edu|
21235159|NCT01312909|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21235160|NCT03894449|University of Veterinary & Animal Sciences, Lahore, Pakistan|Dr. Waqas Ahmed|0092-42-99211449|waqas.niaz@uvas.edu.pk|296
21235161|NCT01913041|Peking Union Medical College Hospital, Anesthesia Department|Dr. Jie Yi|+86 10 69152025|neyil@pumch.cn|
21261694|NCT04276558|Recordati Rare Diseases Sarl|Beatrice Martin, Clinical study Manager|+33 1 47 73 64 58|martin.be@recordati.com|
21279677|NCT01125371|Johns Hopkins University|Dr. Geetanjali Chander|443-287-2030|gchande1@jhmi.edu|
21279678|NCT01434810|Minnesota Medical Research Foundation and University of Minnesota|Tina M. Slusher|612-624-4586|tslusher@umn.edu|
21279679|NCT04036838|ARJ Medical, Inc.|President|813-855-1557|info@gulfcoastscientific.com|
21279680|NCT02237092|Tver Regional Perinatal Center|Dr. Alexandr Ronenson|011-7-4822-776213|ronensonam@gmail.com|
21235162|NCT01513317|Janssen Research & Development|DIRECTOR CLINICAL RESEARCH||ClinicalTrialDisclosure@its.jnj.com|
21235163|NCT00182689|SWOG Statistical Center|Study Statistician|206-667-4623||
21235164|NCT02564198|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21235165|NCT01640301|Fred Hutchinson Cancer Research Center|Dr. Aude Chapuis|2066674369|achapuis@fredhutch.org|
21235166|NCT02842060|University of Pennsylvania|Dr. Jose Bauermeister|215-898-9993|bjose@upenn.edu|
21235167|NCT02200042|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21235168|NCT01969838|Sierra Oncology, a GlaxoSmithKline company|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21235169|NCT00408993|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21235170|NCT02880371|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21235171|NCT00854087|SCTI Research Foundation|Dr. Tarek Hassanein|6195220330|thassanein@livercenters.com|
21235172|NCT01777997|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21235173|NCT01694706|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21235174|NCT01923181|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21235175|NCT02944578|Emory University|Dr. Lisa Flowers|404-251-8931|flowe2@emory.edu|
21235176|NCT01257204|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21235177|NCT01878604|Central South University|Shuiping Zhao|86-731-85295806|zhaosp@medmail.com.cn|
21235178|NCT03394391|Babcock University|Dr. Olumide ABIODUN|07038569725|olumiabiodun@gmail.com|7038569725
21235179|NCT02932891|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
21235180|NCT04622254|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
21235181|NCT03511521|Northwestern University Feinberg School of Medicine|Dr. Mark Molitch, Principal Investigator|3125034130|molitch@northwestern.edu|
21235182|NCT01560624|United Therapeutics|Louis Holdstock|919-425-8866|lholdstock@unither.com|
21235183|NCT00451282|Children's Hospital of Philadelphia|Nancy Kassam-Adams|215-590-3118|nlkaphd@mail.med.upenn.edu|
21235184|NCT00098839|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21235185|NCT00577122|IndianaU|Kathy Miller, MD||kathmill@iupui.edu|
21235186|NCT01733368|Hospital Clinico Universitario Virgen de la Victoria|Dr. Javier Alzueta Rodríguez|951 03 20 00|jalzueta@telefonica.net|
21235187|NCT00323739|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21235188|NCT00456092|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21235189|NCT03228680|Ferring Pharmaceuticals|Clinical Development Support|-|DK0-Disclosure@ferring.com|
21235190|NCT02099721|Medtronic CRHF|Katy Muckala, Sr. Clinical Research Specialist|(763) 526-1767|katy.a.muckala@medtronic.com|
21235191|NCT04904510|UCLA|Dr. Noah Kojima|(310) 319-4377|nkojima@ucla.edu|
21235192|NCT02039427|Department of Anesthesiology and Pain medicine, Yeungnam University School of Medicine, Daegu, Republic of Korea|Sung Mee Jung, M.D|+82-53-620-3368|applejsm@gmail.com|
21235193|NCT05165121|MDHearing|Dr. Sandra Porps|7346572209|slp@mdhearingaid.com|
21235194|NCT00087568|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21235195|NCT00226941|Stanford Cancer Institute, Stanford University|George Albert Fisher, Jr, MD, PhD; Colleen Haas Chair, School of Medicine|650-723-2990|georgeaf@stanford.edu|
21235196|NCT01513291|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21235197|NCT03732638|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
21235198|NCT00058240|The Ohio State University Comprehensive Cancer Center|John Byrd, MD|614-293-3196|John.Byrd@osumc.edu|
21235199|NCT03728582|Johns Hopkins University|Dr. Argye Hillis|(443) 287-4610|argye@jhmi.edu|
21235200|NCT02992899|Emory University|Dr. Douglas Bremner|404-712-9569|doug.bremner@emory.edu|
21235201|NCT02002767|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21235202|NCT01332305|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
21235203|NCT02476565|Vanderbilt University Medical Center|Antonio Hernandez, MD|615 322-4650|antonio.hernandez@vanderbilt.edu|
21235204|NCT01600040|Massachusetts General Hospital|Andrea Russo, MD|617-726-7941|alrusso@mgh.harvard.edu|
21235205|NCT01263873|University Hospitals of Cleveland|Brian Radesic|3309725175|radesic@uakron.edu|
21235206|NCT00672438|Stanford University|Dr. Martin Angst, Professor of Anesthesia|650-498-5109|ang@stanford.edu|
21235207|NCT03915548|MGH Institute of Health Professions|Dr. Kathleen Lyons|617-643-5372|klyons2@mghihp.edu|
21235208|NCT00642304|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21235209|NCT01646671|Novartis Pharmaceuticals|Study Director|+1-862-778-8300||
21235210|NCT02074735|UT Southwestern Medical Center|E. Sherwood Brown, MD, PhD|214-645-6950|sherwood.brown@utsouthwestern.edu|
21279681|NCT00799825|GlaxoSmithKline|GSK Response Center|866-435-7343||
21242688|NCT00531518|Maine Medical Center Research Institute|William R McFarlane, M.D.|207-662-4348|mcfarw@mmc.org|
21242689|NCT00357396|Memorial Sloan Kettering Cancer Center|Dr. Susan Prockop|212-639-6715|prockops@mskcc.org|
21242690|NCT04002973|Masimo|Chelsea Frank|(949) 297-7000|studies@masimo.com|
21242691|NCT00487578|Clinvest|M.E. Beach|(417) 841-3618|mbeach@clinvest.com|
21242692|NCT02378714|Northwestern University|Dr. Brian Hitsman|312-504-5834|b-hitsman@northwestern.edu|
21242693|NCT00726999|Medical College of Wisconsin|Lynn Rusy, MD|414-266-2555|lrusy@chw.org|
21242694|NCT02488980|Penn State Hershey Infectious Diseases|Jose Stoute, MD|800-243-1455|noemail@no.com|
21242695|NCT02620761|Medical College of Wisconsin|Jeffrey Segar|14143377702|jsegar@mcw.edu|
21242696|NCT00565110|USC Suzanne Dworak-Peck School of Social Work|Kathleen Ell, DSW, Principle Investigator|760-399-0263|ell@usc.edu|
21242697|NCT02614560|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
21242698|NCT02192606|Brigham and Women's Hospital|Jon I. Einarsson|617-732-5500|jeinarsson@partners.org|
21242699|NCT00738699|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
21242700|NCT01213706|University of Miami|Adam Wanner, MD|(305) 243-2568|awanner@med.miami.edu|
21242701|NCT05174013|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21242702|NCT02034916|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21242703|NCT00753012|Massachusetts General Hospital|Dr. Paul Hammerness|(503)617-1040|phammerness@partners.org|
21242704|NCT00864682|Virginia Mason Medical Center|Joseph M. Neal, MD|206-223-6980|anejmn@vmmc.org|
21242705|NCT00957658|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@stryker.com|
21242706|NCT04889664|Icahn School of Medicine at Mount Sinai|Dr. Adriana Feder|212-585-4661|adriana.feder@mssm.edu|
21242707|NCT03408860|University of Kentucky|Shannon Sauer-Zavala|858-218-4082|ssz@uky.edu|
21242708|NCT02087306|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
21242709|NCT00130637|National Eye Institute, NIH|H. Nida Sen, MD, MHS|301-435-5139|senh@nei.nih.gov|
21242710|NCT01972152|Xeris Pharmaceuticals, Inc.|Martin J. Cummins, VP, Drug Development|512-498-2675|mcummins@xerispharma.com|
21242711|NCT01959412|Novartis Pharmaceuticals|Study Director|862-778-8300||
21242712|NCT04379713|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21242713|NCT04567888|Twill|Eliane M. Boucher, PhD (Sr Director of Research Strategy)|(800) 264-6428|eliane@twill.health|
21242714|NCT00509769|Genentech, Inc.|Medical Communications|800 821-8590||
21242715|NCT02371746|Envisia Therapeutics, Inc.|Kristin Blackwell, Consultant, Regulatory Affairs & Quality Assurance|919-219-6448|kristin.blackwell@envtx.com|
21261695|NCT01254344|Merck Sharp & Dohme (China) Ltd.|Naimi Missoum|+8621 2211 8546|naimi_missoum@merck.com|
21261696|NCT00467649|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21261697|NCT01633060|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21261698|NCT00807664|Coloplast|Dr Birte Petersen Jacobsen|004549110000|DKBIR@coloplast.com|1395
21261699|NCT03233048|Mayo Clinic|Dr. Imad Absah|507-266-0114|absah.imad@mayo.edu|
21261700|NCT00491530|Abbott|Medical Information Specialist|800-633-9110||
21261701|NCT01856673|CISALVA, Universidad del Valle|Maria Isabel Gutierrez|+57-2-5577206|maria.gutierrez@correounivalle.edu.co|103
21261702|NCT03240081|OHSU|Dr. Martha Goetsch|503-494-3666|goetsch@ohsu.edu|
21261703|NCT00883753|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21261704|NCT02859415|National Cancer Institute|Dr. David S. Schrump|240-858-7000|schrumpd@mail.nih.gov|
21261705|NCT00691574|Oregon Health & Science University|Alfred Lewy, MD, PhD|(503) 494-7746|lewy@ohsu.edu|
21261706|NCT01396525|AbbottVascular|David R Rutledge|408-845-3820|david.rutledge@av.abbott.com|
21261707|NCT03114969|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21261708|NCT02282332|MedStar Health Research Institute|Scientific Center Adminstrator|(301) 560-7300|Research@medstar.net|
21261709|NCT02278146|Skyline Urology|Fredrick Wolk, MD|+1 310.602.5005|fred.wolk@skyuro.com|
21261710|NCT02436239|Allergan|Armin Szegedi, MD, PhD, Vice President CNS Clinical Development|714-246-4500|IR-CTRegistration@allergan.com|
21261711|NCT02168946|Rempex Pharmaceuticals, A Wholly Owned Subsidiary of Melinta Therapeutics, Inc.|Global Health Science Center|1-844-633-6568|medinfo@melinta.com|
21261712|NCT04634162|Division of Cardiology University of Florida College of Medicine - Jacksonville|Francesco Franchi, MD|1-904-244-2060|francesco.franchi@jax.ufl.edu|
21261713|NCT02457897|NIDDK|Dr. Rebecca Brown|301-594-0609|Rebecca.Brown@NIH.gov|
21261714|NCT01852344|University of Michigan|Dr. Chandra Sripada, MD PhD||csripada@umich.edu|
21261715|NCT01450137|Department of Rheumatology, Immunology and Allergology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland|Prof Peter M Villiger||peter.villiger@insel.ch|
21261716|NCT01926886|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21279682|NCT01121562|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21279683|NCT03713632|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
21279684|NCT04237272|Medical University of South Carolina|Dr. Tracy Smith|843 792 5164|smithtra@musc.edu|
21279685|NCT03971474|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
21279686|NCT01375946|Agile Therapeutics|Joseph Chiodo III, Senior Medical Director|609-683-1880|jachiodo@agiletherapeutics.com|
21279687|NCT02370238|Dompé Farmaceutici SpA|Dr Pier Adelchi Ruffini, MD|+39 02 583831|info@dompe.it|
21279688|NCT01153425|University of Pennsylvania, Perelman School of Medicine|Felix W. Wehrli, Ph.D.|215-662-7951|wehrli@mail.med.upenn.edu|
21242716|NCT00754936|Weill Cornell Medicine|George S Alexopoulos|914-997-5767|gsalexop@med.cornell.edu|
21242717|NCT00619645|University of California Davis|Data Manager|916-734-8381|nmahaffey@ucdavis.edu|
21242718|NCT01157182|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21242719|NCT01490580|NICU, CHI Créteil|Dr Xavier Durrmeyer|+33145175433|xavier.durrmeyer@chicreteil.fr|
21242720|NCT00878722|Topotarget A/S|PRS Admnistrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com|
21242721|NCT00383188|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21242722|NCT00117663|Group Health Research Institute|Diana Buist PhD, Principal Investigator|206-287-2931|buist.d@ghc.org|
21242723|NCT05325853|American Genomics, LLC|Dr. Martin Uram|973-885-3447|aschupp@cmcturnkey.com|
21242724|NCT01839877|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
21242725|NCT00597519|Memorial Sloan Kettering Cancer Center|Dr. Juliet Barker|212-639-3468|barkerj@mskcc.org|
21242726|NCT02781584|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21242727|NCT03396913|Lumenis|Yair Manor, Clinical Director|+972-52-3763416|yair.manor@lumenis.com|
21242728|NCT05826431|UW Medicine Multiple Sclerosis Center|Dr. Kevin Alschuler, Director of Rehabilitation Research|206-668-8413|kalschul@uw.edu|
21242729|NCT00782639|Bracco Diagnostics, Inc|Usha Halemane|609-514-2578|usha.halemane@diag.bracco.com|
21242730|NCT01624168|Appalachian State University|Dr. Karen Caldwell, Professor|828-262-6045|caldwellkaren@appstate.edu|
21242731|NCT02987335|Albert Einstein College of Medicine|Dr Meredith Hawkins|718.430.3186|meredith.hawkins@einsteinmed.org|
21242732|NCT01981356|Center for Innovation to Implementation, VA Palo Alto HCS|Matthew Boden, Ph.d.|650-493-5000|Matthew.Boden@va.gov|27529
21242733|NCT02317016|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
21242734|NCT02555631|Albert Einstein College of Medicine|Dr. Elizabeth Walker|718-430-3242|elizabeth.walker@einstein.yu.edu|
21242735|NCT02251613|Alcon Japan, Ltd.|Hironari Sakaguchi, Phase IV Clinical & Regulatory Affairs, Japan|+81 3 6899 5054|Hironari.Sakaguchi@alcon.com|
21242736|NCT02465359|University of South Florida|Tuan H. Vu, MD|813-974-9413|tvu6@usf.edu|
21242737|NCT02952261|Shanghai Pulmonary Hospital affiliated to Tongji university|Dr. Chang Chen|+86 13816869003|chenthoracic@163.com|
21242738|NCT00798265|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|hoyoung.maeng@nih.gov|
21242739|NCT03141788|3M|Elaine Egging|651-737-0263|eegging@mmm.com|
21242740|NCT02729701|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-205-6382|bkimler@kumc.edu|
21242741|NCT02810080|ZOLL|Nathan Burkhart|763.367.0462|nburkhart@zoll.com|
21242742|NCT03597100|Cala Health|Sr. Director of Clinical Operations|6506515296|vivien@calahealth.com|
21242743|NCT00816751|UC San Diego Health|Jessica M. Kingston, MD|858-249-1204|jkingston@ucsd.edu|
21242744|NCT01772420|Albert Einstein College of Medicine|Dr. Amit K. Verma|718-430-8761|amit.verma@einsteinmed.edu|
21242745|NCT03557333|Impel NeuroPharma|Karen Craig, PhD (Medical Writer)|206-568-1466|kcraig@impelnp.com|
21242746|NCT05097573|Venus Concept|Director of Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
21242747|NCT00742573|New York State Psychiatric Institute|Mark Olfson, MD, MPH|646-774-6413|mark.olfson@nyspi.columbia.edu|
21242748|NCT00657280|Stanford Hospital and clinics|Dr. Michael Fowler Director of the Heart Failure|650-721-5540|mfowler@stanford.edu|
21242749|NCT00094809|Amgen Inc.|Study Director|866-572-6436||
21242750|NCT04181632|Nemours Children's Health System (North Florida/JAX)|Jennifer Pfieffer|904 383 0414|jennifer.pfieffer@nemours.org|
21242751|NCT02699970|Philips Digital Pathology Solutions|Mischa Nelis, Clinical Study Director||dpsclinicaltrials@philips.com|
21242752|NCT02469064|Universidad del Valle|Dr Lina Marcela Sandoval Moreno|316 478 0808|linamarce48@gmail.com|
21242753|NCT02506257|AMC Amsterdam|Dr. IJE van Der Muelen|020 - 566 9111|TtT@amc.uva.nl|
21242754|NCT00964366|GlaxoSmithKline|GSK Response Center|888-435-7343||
21242755|NCT05372094|Sonova US|Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
21242756|NCT03760419|Vanderbilt University Medical Center|Derek J. Williams, MD, MPH|615-322-2744|derek.williams@vumc.org|
21242757|NCT02957539|VA Puget Sound Health Care System|Paul Hebert|2062774165|paul.hebert2@va.gov|
21242758|NCT02242773|University of Miami|Sanoj Punnen, MD|+1 (305) 2436596|s.punnen@med.miami.edu|
21242759|NCT04842604|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21242760|NCT03036735|Steward Health Care|Dr Peter Catalano|617-789-5004|peter.catalano@steward.org|5004
21242761|NCT01193153|Janssen Scientific Affairs, LLC, Titusville, NJ|Director of Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
21242762|NCT01678196|Minneapolis VA Healthcare Service Center|Christopher Erbes, PhD|612-725-2000|christopher.erbes@va.gov|2125
21242763|NCT01563354|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21242764|NCT01377623|UMDNJ-New Jersey Medical School|Alex Bekker|973-972-5007|alex.bekker@nyumc.org|
21242765|NCT04897737|UCLA|Dr. Dvora Joseph Davey, PI|310-701-1526|dvoradavey@ucla.edu|
21242766|NCT05334758|BioTeke USA|Chang Turkmani|202-679-2112|chang@themegaco.com|
21279689|NCT01482312|Alcon Research|Director of Alcon Clinical|1-800-241-7629||
21242767|NCT00478335|University of Colorado Denver|Melissa Cadnapaphornchai, MD|720776263|melissa.cadnapaphornchai@ucdenver.edu|
21242768|NCT01740817|University of Texas Health Science Center at San Antonio|Dr. Nicolas Musi|200-562-6152|musi@uthscsa.edu|
21261717|NCT03368898|bakirkoy dr sadi konuk training and research hospital|İsmail Alay|+905462375638|dr_ismailalay@hotmail.com|
21279690|NCT03154125|FHI 360|Vera Halpern, M.D., Director of Clinical Development|+1 (919) 321-3331|VHalpern@fhi360.org|3117
21279691|NCT01295320|GlaxoSmithKline|GSK Response Center|866-435-7343||
21279692|NCT00462904|University of Texas Southwestern Medical Center|Joseph Minei|214-648-3917|joseph.minei@utsouthwestern.edu|
21279693|NCT01569295|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|ClinicalTrialDisclosures@gilead.com|
21279694|NCT02125877|Novartis|Study Director|862-778-8300||
21279695|NCT01973595|University of Florida|Dr. Bobbi Langkamp- Henken|352-392-1991|henken@ufl.edu|205
21279696|NCT06101264|University of Connecticut School of Medicine|Prabhath Mannam|8607092371|pmannam@uchc.edu|
21242769|NCT01986686|Stony Brook Medicine|Roberto Bergamaschi, MD, PhD|631-638-2215|roberto.bergamaschi@stonybrookmedicine.edu|
21291975|NCT01977898|Northwestern University|Feyce Peralta, MD|312-472-3585|f-peralta@northwestern.edu|
21291976|NCT05130593|Pennington Biomedical Research Center|Jennifer C Rood, PhD|225-763-2524|jennifer.rood@pbrc.edu|
21242770|NCT01852019|The Medicines Company|Jayne Prats, PhD - VP, Global Knowledge Management|888-779-MDCO|jayne.prats@themedco.com|1510
21242771|NCT00208507|DePuy Orthopaedics, Inc|Dave Whalen|574-372-7028|DWhalen@its.jnj.com|
21242772|NCT03888755|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21242773|NCT01872819|University of Washington|Dr. Pamela Becker|206-288-7273|pbecker@u.washington.edu|
21242774|NCT03038399|ReveraGen BioPharma Inc.|Dr. Eric Hoffman|301-762-7980|ericphoffman@gmail.com|
21242775|NCT01595854|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21242776|NCT04365400|Afimmune|Study Director|+3532946380|info@afimmune.com|
21242777|NCT00079183|Fred Hutchinson Cancer Research Center|Dr. Paul A. Carpenter|(206) 667-5191|pcarpent@fredhutch.org|
21242778|NCT00770965|Novartis|Study Director|862-778-8300||
21242779|NCT02613364|University of Rochester Medical Center|Dr. Karen Mustian, Study PI|585-275-0557|karen_mustian@urmc.rochester.edu|
21242780|NCT01235949|GlaxoSmithKline|GSK Response Center|866-435-7343||
21242781|NCT00371566|GlaxoSmithKline|GSK Response Center|866-435-7343||
21242782|NCT02534350|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21242783|NCT00410124|Novartis Pharmaceuticals|Novartis Pharmaceuticals|862-778-8300||
21242784|NCT00319436|Yale University School of Medicine, Department of Psychiatry and Yale Child Study Center|Nancy Suchman, Ph.D., Associate Professor|203-937-3486|nancy.suchman@yale.edu|7430
21242785|NCT01147380|University of Miami|Dr. Seigo Nishida|305-355-5760|snishida@med.miami.edu|
21242786|NCT04286529|Mayo Clinic|Rajiv Kumar, MD|507-284-0020|rkumar@mayo.edu|
21242787|NCT02341625|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
21242788|NCT01161498|Amgen, Inc.|Study Director|866-572-6436||
21242789|NCT02509585|Cardinal Health|LaTosha Eligon|913-661-3896|latosha.eligon@cardinalhealth.com|
21242790|NCT01224678|University of Vermont|Marie E. Wood, M.D|802-656-5452|marie.wood@uvm.edu|
21242791|NCT03310983|University of Kansas Medical Center|Dr. Holly Hull|9135881000|hhull@kumc.edu|
21242792|NCT03368001|Vanderbilt University Medical Center|Blythe Corbett, Ph.D.|615-936-0280|blythe.corbett@vumc.org|
21242793|NCT01656304|Barbara Ann Karmanos Cancer Institute|Ulka Vaishampayan, M.D.|(313) 576-8718|vaishamu@karmanos.org|
21242794|NCT01093534|Astellas Pharma Europe Ltd.|Director Medical Affairs - Urology||clinicaltrials@us.astellas.com|
21242795|NCT04436120|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21242796|NCT00281918|Hoffmann-LaRoche|Medical Communications|800-821-8590||
21242797|NCT02124460|Massachusetts General Hospital|Dr. Elsie Taveras|617-726-8555|elsie.taveras@mgh.harard.edu|
21242798|NCT01673113|Massachusetts General Hospital|Dr. Lilit Garibyan|617-726-6168|lgaribyan@partners.org|
21242799|NCT01769391|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21242800|NCT01975467|Sonoma Orthopedics|Rick Epstein|8479872516|repstein@sonomaorthopedics.com|
21242802|NCT00038103|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21242803|NCT01144182|VA New York Harbor Healthcare System|Sundar Natarajan, MD, M.Sc.|212-951-3395|sundar.natarajan@va.gov|
21242804|NCT03772964|University of Pittsburgh|Dr. Brian Zuckerbraun|(412) 647-3065|zuckerbraunbs@upmc.edu|
21242805|NCT03254394|Washington University in St Louis|Simon Haroutounian, PhD. Associate Professor|3132861715|sharout@wustl.edu|
21242806|NCT03545984|Cleveland Clinic|Dr. Maged Argalious|+12164452064|ARGALIM@ccf.org|
21242807|NCT00387465|SKCCC|John Wrangle, MD|843-792-7789|wrangle@musc.edu|
21242808|NCT00907218|MassGH|Dr. Timothy Wilens|617-724-5226|twilens@partners.org|
21242809|NCT01768676|Vivus|Wesley D Day, PhD|650-934-5200||
21242810|NCT03693742|BC Cancer - Vancouver|Study Manager|(604) 877-6000,|hsaprunoff@bccancer.bc.ca|
21242811|NCT02023125|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21242812|NCT01867580|KCI, an Acelity Company|Anthony Tate, RN, BSN|210-515-4060|anthony.tate@kci1.com|
21242813|NCT01304147|Icahn School of Medicine at Mount Sinai|Dr. James W. Murrough|212-241-7574|james.murrough@mssm.edu|
21242814|NCT01244828|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21242815|NCT04520165|CHU-Uliege|Dr Florence Schleich|003243667881|fschleich@chuliege.be|
21242816|NCT05233085|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
21242817|NCT01942707|Universidade Federal de São Paulo|Dr. Heraldo Carlos Borges Inforzato|55-13-997112644|heraldo@litoral.com.br|
21242818|NCT02812966|Advocate Aurora Research Institute|Director, Clinical Trials Research Cardiovascular and Multiple Specialties|708-860-7792|laura.wrona@aah.org|
21242819|NCT01066923|University of Pittsburgh|Clifton Callaway|412-647-3078|callawaycw@upmc.edu|
21291977|NCT04563767|HealthPartners Neurology|Michael Rosenbloom, MD|651-495-6363|michael.h.rosenbloom@healthpartners.com|
21291978|NCT00548886|Emory University|Dr. Peter Seth Fischbach|404-256-2593|pfischb@emory.edu|
21291979|NCT03386773|Colorado School of Public Health|Susan L. Moore, PhD, MSPH|303-724-8858|susan.l.moore@cuanschutz.edu|
21242820|NCT02577523|NeuroDerm Ltd.|Laurence Salin, MD, Senior Medical Director||laurence@neuroderm.com|
21242821|NCT02525796|Brigham and Women's Hospital|Anand Vaidya|16177325666|anandvaidya@bwh.harvard.edu|
21242822|NCT01199783|Herz- und Diabeteszentrum NRW|PD Dr. Bernd Stratmann|+495731973768|bstratmann@hdz-nrw.de|
21242823|NCT00955825|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
21242824|NCT01198275|Department of Experimental and Applied Medicine-Section of Cardiovascular Diseases|Dr. Savina Nodari|00390303996|nodari@med.unibs.it|587
21242825|NCT00391846|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21242826|NCT03624413|Emory University|Brian C. Zanoni, MD|404-727-0284|brian.christopher.zanoni@emory.edu|
21242827|NCT02385669|University of Virginia|Craig L. Slingluff, Jr. MD|434-924-9311|cls8h@virginia.edu|
21242828|NCT02477670|Avanir Pharmaceuticals, Inc.|Sanjay Dubé, M.D.|949-389-6700|SDube@avanir.com|
21242829|NCT00970307|GlaxoSmithKline|GSK Response Center|866-435-7343||
21242830|NCT02937831|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21242831|NCT00831272|University of Pennsylvania|David Oslin|215 823 5894|oslin@upenn.edu|
21242832|NCT02507336|University of Miami|Izidore Lossos MD|+1 (305) 2434785|ilossos@med.miami.edu|
21242833|NCT01596751|University of California, San Francisco|Dr. Hope Rugo, MD|(415) 353-7070|Hope.Rugo@ucsf.edu|
21242834|NCT03748433|Imperial College London|Professor Nick Oliver|+44 (0)20 7594 1796|nick.oliver@imperial.ac.uk|
21242835|NCT01370694|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21242836|NCT01119950|Novartis Pharmaceuticals|Study Director|41 61 324 1111||
21242837|NCT01988233|University of Illinois Chicago|Dr. David X. Marquez|3129961209|marquezd@uic.edu|
21242838|NCT03264248|University of Pittsburgh|Dr. Jonathan Pearlman|412-822-3685|jlp46@pitt.edu|
21242839|NCT03621761|University of Michigan|Tiffany Braley|734-232-1147|tbraley@med.umich.edu|
21242840|NCT00470106|VA Greater Los Angeles|Michael F. Green, PhD|(310)2693376|michael.green6@va.gov|
21242841|NCT01191788|RAND Corporation|Katherine Watkins|(310) 393-0411|kwatkins@rand.org|6509
21242842|NCT02178540|Novartis Pharmaceuticals|Study Director|862-778-8300||
21242843|NCT01050569|University of Minnesota|Dorothy Hatsukami|612 626-2121|hatsu001@umn.edu|
21242844|NCT03673943|RadioMedix Inc|Ebrahim Delpassand|7134999733|edelpassand@radiomedix.com|
21242845|NCT03939819|Emory University|Dr. Elizabeth Hechenbleikner|404-778-3712|elizabeth.hechenbleikner@emory.edu|
21242846|NCT00001304|National Institute of Child Health and Human Development|WINER, Karen|+1 301 435 6877|winerk@mail.nih.gov|
21242847|NCT04089488|Statistical and Data Analysis Center, AIDS Malignancy Consortium|Deukwoo Kwon|(713) 500-7964|deukwoo.kwon@mountsinai.org|
21242848|NCT02148133|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21242849|NCT03808883|Case Western Reserve University|Sarah Fulton, MA, RA, Begun Center, Jack, Joseph and Morton Mandel School of Applied Social Science|216-368-0429|sarah.fulton@case.edu|
21242850|NCT01909336|HIMFG|Claudia Montserrat Flores Robles|(52) 5566756686|montseflores@hotmail.com|
21242851|NCT00436644|Mayo Clinic|Dr. Paul Haluska|507-266-2123|haluska.paul@mayo.edu|
21242852|NCT01114945|Department of Anesthesiology at Cedars-Sinai Medical Center in Los Angeles|Roya Yumul, M.D., Ph.D.|310-423-5841|(Roya.Yumul@cshs.org)|
21242853|NCT04364269|Vifor Pharma, Inc.|CSL Vifor|+41 588 518 000|VIT2763-THAL-201.study@viforpharma.com|
21242854|NCT04173572|University of North Carolina at Chapel Hill|Tonya Elliott|919-966-3915|tonya_elliott@med.unc.edu|
21242855|NCT04615299|John Dingell VA Medical Center|Dr Padmavathi Patel|313-576 2731|Padmavathi.Patel@va.gov|
21242856|NCT02026258|UConn Health|Flavio Uribe|8606793656|furibe@uchc.edu|
21242857|NCT04246762|R-Pharm|Marina Beloukhova, Scientific advisor|0074959567937|beloukhova@rpharm.ru|2129
21242858|NCT02914522|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21242859|NCT00177216|University of Pittsburgh|Jean Miewald|412-246-6406|miewaldjm@upmc.edu|
21242860|NCT03399370|The Medicines Company|Vice-President, Regulatory Operations|973-985-0597|frank.bosley@novartis.com|
21242861|NCT00639002|Incyte Corporation|Study Director|855 463-3463||
21242862|NCT00739765|New York State Psychiatric Institute|John C. Markowitz, M.D.|646 774-8098|jcm42@cumc.columbia.edu|
21242863|NCT01323777|Alcon Japan, Ltd.|Group Manager, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21242864|NCT02807493|University of Minnesota|James Gambucci|612-625-7448|gambu001@umn.edu|
21242865|NCT01227707|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21242866|NCT05819190|Pharmndev Experts|Dr Bernard Gout Organization|+41798659000|Email:bgout@pharmndev.ch|
21242867|NCT04495634|University of North Carolina at Chapel Hill|Doreen Steed, R.T. (R)(M)|919-966-0188|doreen_steed@med.unc.edu|
21242868|NCT03105128|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21242869|NCT03468920|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
21242870|NCT00823979|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21242871|NCT03523091|William Beaumont Hospital|Jennifer Giordano|248-551-3517|jennifer.giordano@beaumont.org|
21242872|NCT00741988|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21242873|NCT00811057|University of Mississippi Medical Center|Dr. Rick Martin|601-815-7035|rmartin@umc.edu|
21242874|NCT01199237|University of California, San Francisco|Rachel Eshima McKay|415-502-1715|eshimar@anesthesia.ucsf.edu|
21242875|NCT03008915|Columbia University|Dr. Carrie Pistenmaa|212-342-4162|"cp2346@atcumc.columbia.edu"|
21242876|NCT04318444|Columbia University|Jon T. Giles, MD|212-305-6327|jtg2122@cumc.columbia.edu|
21242877|NCT00712166|Gilead Sciences, Inc.|Mark Bresnik, MD, Director, Clinical Research|(650) 522-5934|mark.bresnik@gilead.com|
21279697|NCT00794508|University of California Los Angeles|Dr. Donald B. Kohn|310-794-1964|dkohn1@mednet.ucla.edu|
21279698|NCT03138655|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21279699|NCT04759768|Opiant Pharmaceuticals|Clinical Director|18043791090|PatientSafetyNA@Indivior.com|
21279700|NCT04868500|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
21279701|NCT02859142|University of Chicago|Andrea King, Ph.D.|7737026181|aking@yoda.bsd.uchicago.edu|
21279702|NCT02676765|Virginia Commonwealth University|Dr. Brant Ward|804-828-1941|brant.ward@vcuhealth.org|
21242878|NCT01773122|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21242879|NCT04173962|Icahn School of Medicine at Mount Sinai|Dr. James Murrough|212-585-4640|james.murrough@mssm.edu|
21242880|NCT02289560|Insightec|Nadir Alikacem, SVP Global Regulated Clinical Affairs|214-630-9900|nadira@insightec.com|
21242881|NCT02540213|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21242882|NCT01264718|Medica Research Institute|Dr. Glenn Flores, Distinguished Chair of Health Policy Research|952-992-3367|Glenn.Flores@medica.com|
21242883|NCT03386929|Worldwide Innovative Network (WIN) Association|Fanny Wunder, Project Manager|0033604090029|fanny.wunder@winconsortium.org|
21242884|NCT00536380|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21242885|NCT03418324|Cedars-Sinai Medical Center|Edwin Posadas, MD|310-423-7600|Edwin.Posadas@cshs.org|
21242886|NCT03906968|MUSC|Dr. Zachary M. Soler|(843) 792-3531|solerz@musc.edu|
21242887|NCT03121950|The Ohio State University|Deb Kegelmeyer|614-293-0214|kegelmeyer.1@osu.edu|
21242888|NCT04181307|NYU Langone Health|Andrea B. Troxel, ScD|646-501-3654|andrea.troxel@nyulangone.org|
21242889|NCT04248829|Yuhan Corporation|Dongmin Kim|+82-2-828-0523|clinicaltrials@yuhan.co.kr|
21242890|NCT02132702|Clinic for Spinal Cord Injuries, Rigshospitalet, University of Copenhagen|Carsten Bach Baunsgaard|1111111111|carsten.bach.baunsgaard@regionh.dk|
21242891|NCT02299336|Retina Consultants of Houston|Dr. Charles C. Wykoff|7135243434|ccwmd@houstonretina.com|
21242892|NCT01910636|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21242893|NCT01212757|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21242894|NCT00573833|Memorial Sloan Kettering Cancer Center|Dr. Josh Yoshiya Yamada, Assistant Attending|+1212-639-2950|yamadaj@mskcc.org|
21242895|NCT05052983|Galderma Research & Development|Sponsor|(817) 961-5000|clinical.studies@galderma.com|
21242896|NCT01070888|Boston Children's Hospital|Wanda Phipatanakul|857-218-5336|wanda.phipatanakul@childrens.harvard.edu|
21242897|NCT02631148|Brigham and Women's Hosptial|Dr. Ciaran McMullan|617 732 5500|mcmullcj@gmail.com|
21242898|NCT02787694|University of Alabama at Birmingham|David A. Brown, PT, PhD|205-975-2788|dbrownpt@uab.edu|
21242899|NCT00150176|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21242900|NCT04035668|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21242901|NCT00004124|SWOG Statistics and Data Management Center|Catherine Tangen, Genitourinary Committee Statistician|(206) 667-4623|ctangen@fredhutch.org|
21242902|NCT02630719|Truman Medical Center|Sean Gratton MD|816-404-5275|sean.gratton@tmemed.org|
21242903|NCT03426228|Fakih IVF|Dr. Ayla Coussa|+971501403866|A.coussa@warwick.ac.uk|
21242904|NCT02224924|Memorial Sloan Kettering Cancer Center|Dr. Amgad Moussa MD|212-639-3690|moussaa@mskcc.org|
21242905|NCT01458210|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21242906|NCT03923491|Brown University School of Public Health|Dr. Alison Tovar|401-863-7327|alison_tovar@brown.edu|
21242907|NCT00355914|Pain Management Center of Paducah, Paducah, KY|Laxmaiah Manchikanti, MD|2705548373|drlm@thepainmd.com|100
21242908|NCT02633358|China Medical University Hospital, Taichung, Taiwan|Dr. Da-Long Chen, director of cardiac intensive care unit|0952122027|my686chen@gmail.com|
21242909|NCT03823300|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21242910|NCT03622580|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21242911|NCT00354640|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|4432876489|vstearn1@jhmi.edu|
21242912|NCT01169311|Covidien|Tam LaFleur|203-821-4744|tam.lafleur@covidien.com|
21242913|NCT00590707|Johns Hopkins|frederick Sieber|410-550-0942|fsieber1@jhmi.edu|
21279703|NCT03340974|Galera Therapeutics|Judy Schnyder, Sr. Vice President Clinical Operations and Data Management|484-870-9625|jschnyder@galeratx.com|
21279704|NCT04642404|University of Texas Health Science Center at San Antonio|Vanessa Chrepa, DDS|210-459-3601|vanessa.chrepa@rutgers.edu|
21279705|NCT02374346|Attikon Hospital|P. Matsota|00302105831000|matsota@yahoo.gr|
21279706|NCT00706589|Kiho Moon|Medical Director|+82-2-3287-9009|khmoon@otsuka.co.kr|
21279707|NCT03473015|Oxford Heart Centre, Oxford University Hospitals, Oxford, United Kingdom|Professor Adrian Banning|1865 228934|adrian.banning@ouh.nhs.uk|+44
21279708|NCT00396565|Janssen Pharmaceutical K.K.|Director of Clinical R&D Dept. 3|81-3-4411-5652||10118
21279709|NCT03010683|2nd Cardiology Department, National and Kapodistrian University of Athens, Attikon Hospital|Dr Ignatios Ikonomidis|+30 6944805732|ignoik@gmail.com|
21279710|NCT01252277|University of Kansas Medical Center|Carol J. Fabian, M.D.|913-588-7791|cfabian@kumc.edu|
21279711|NCT04324021|Swedish Orphan Biovitrum|Henrick Andersson, Director of Statistical Science|+46760011816|henrik.andersson@sobi.com|
21279712|NCT04877457|Yale University|Erin Longbrake, MD|203-287-6100|erin.longbrake@yale.edu|
21279713|NCT02211417|Dignity Sciences Ltd|Study Director|+353 1 2933590|dsbiopharma.regulatory@dsbiopharma.com|
21279714|NCT01198132|Merck KGaA|Title: Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21279715|NCT00490841|Abbott Vascular|Ellen Travis|408-845-1512|Ellen.Travis@av.abbott.com|
21242914|NCT01930045|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21291980|NCT03983421|Department of Psychiatry and Behavioral Sciences, Health Sciences Center, University of New Mexico|Annette Crisanti, PhD|5052726238|acrisanti@salud.unm.edu|
21242915|NCT00241644|GlaxoSmithKline|GSK Response Center|866-435-7343||
21242916|NCT03959241|The Emmes Company, LLC|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
21242917|NCT03951649|UAB|Rachel Sinkey|(205) 934-5611|rsinkey@uabmc.edu|
21242918|NCT01256034|Chiba University Graduate School of Medicine|Dr. Katsunori Furukawa|+81-43-226-2269|k-furukawa@umin.ac.jp|
21242919|NCT01713530|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21242920|NCT00758602|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21242921|NCT05046132|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
21242922|NCT02441036|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
21242923|NCT02903836|Wockhardt|Dr Manishkumar D Shah|02226534444|manish.shah@wockhardt.com|6893
21242924|NCT01183780|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21242925|NCT04628572|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21242926|NCT00855465|Bayer|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21242927|NCT02470949|University of Florida|Michelle Cardel, PhD, RD|(352) 273-9703|mcardel@ufl.edu|
21242928|NCT03743246|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21242929|NCT01596504|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21242930|NCT00395018|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21242931|NCT04439799|University of Miami, Miller School of Medicine - Desai Sethi Urology Institute|Ranjith Ramasamy, MD|305-243-6596|Ramasamy@miami.edu|
21242932|NCT05565391|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21242933|NCT00530842|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21242934|NCT00128193|Colorado State University, Department of Microbiology, Immunology and Pathology|Patrick J. Brennan, Ph.D.|970-491-6700|patrick.brennan@colostate.edu|
21242935|NCT00972504|GlaxoSmithKline|GSK Response Center|866-435-7343||
21242936|NCT00761930|Colgate Palmolive Co.|William Devizio|732-878-7901|William_Devizio@colpal.com|
21242937|NCT03478696|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21242938|NCT03257813|Laboratorios Sophia|Dr. Ricardo Llamas (clinical safety pharmacologist)|3001 4200|ricardo.llamas@sophia.com.mx|1059
21242939|NCT02878330|MedImmune, LLC|M. Pamela Griffin|+1 301-398-4059|information.center@astrazeneca.com|
21242940|NCT04673851|University of North Carolina at Chapel Hill|Bryan Stiles, MA|919-590-5811|stilesb@unc.edu|
21242941|NCT03615924|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21242942|NCT00716144|GlaxoSmithKline|GSK Response Center|866-435-7343||
21242943|NCT03280836|Penn State University|Dr. Kathleen Sturgeon|7175314530|kms99@psu.edu|284676
21242944|NCT01891968|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Manero, MD|713-745-3428|CR_Study_Registration@mdanderson.org|
21242945|NCT00880048|GlaxoSmithKline|GSK Response Center|866-435-7343||
21242946|NCT01069341|The University of Medicine and Dentistry of New Jersey|Dr. Neelakshi Bhagat|973-972-2032|bhagatne@umdnj.edu|
21242947|NCT02476890|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21242948|NCT02861937|Krishnadevaraya college of dental sciences|Dr. Rudrakshi C|080-28467083|drrudrakshi@rediffmail.com|
21242949|NCT00790790|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21242950|NCT03253913|University of Cincinnati|Nishant Gupta, MD|5135584831|nishant.gupta@uc.edu|
21242951|NCT02808338|Philips|Clinical Operations Manager|14125423669|jeremy.powers@philips.com|
21242952|NCT02053363|Rady Children's Hospital|Michael P Kelly|858-576-1700|mkelly5@rchsd.org|223750
21242953|NCT00756730|Community Research initiavte|Dr. Daniel Skiest|413 794 5376|Daniel.Skiest@baystatehealth.org|
21242954|NCT00166166|Emory University|Dr. Arshed Quyyumi|404-727-3655|aquyyum@emory.edu|
21242955|NCT04349150|Massachusetts General Hospital|Daniel C. Chung, MD|6177263544|chung.daniel@mgh.harvard.edu|
21242956|NCT05382104|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21242957|NCT02336438|Bassett Healthcare Network|Dr. Amy Freeth|607-547-3273|amy.freeth@bassett.org|
21242958|NCT01493778|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21242959|NCT04210180|Rose Research Center|Jed E. Rose, Ph.D.|9193282345|jed.rose@roseresearchcenter.com|
21242960|NCT05190419|UNION therapeutics A/S|UNION therapeutics A/S|+4561777435|clinicaltrials@uniontherapeutics.com|
21242961|NCT03538054|The University of Alabama at Birmingham|Dr. Jarred Younger|2059755821|younger@uab.edu|
21242962|NCT00208767|Emory University School of Medicine|Dr. Arshed Quyyumi|404-727-3655|aquyyum@emory.edu|
21242963|NCT02754479|DuPage Medical Group|Kelly Stankiewicz, MD FAAD|(630) 547-5040|kjstanki@gmail.com|
21242964|NCT03183518|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21242965|NCT01303835|Duke University Medical Center, The Preston Robert Tisch Brain Tumor Center|Katherine B. Peters, MD, PhD|(919) 684-6173|katherine.peters@duke.edu|
21242966|NCT04493242|Direct Biologics, LLC|Dr. Amy Lightner|512-354-7124|alightner@directbiologics.com|
21242967|NCT00849147|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
21242968|NCT01613118|Travere Therapeutics, Inc.|Jula Inrig, MD|1-445-529-6312|Jula.Inrig@travere.com|
21242969|NCT03544515|Columbia University College of Dental Medicine|Philip Y. Kang, DDS|212-342-5244|pyk2104@cumc.columbia.edu|
21242970|NCT03169244|University of North Carolina at Chapel Hill|James C. Garbutt, MD|919-445-0205|jc_garbutt@med.unc.edu|
21242971|NCT00178399|University of Rochester|Michael Milano|585-273-4096|michael_milano@urmc.rochester.edu|
21242972|NCT02027558|VA Greater Los Angeles Healthcare System|Cathy Alessi, MD|818-891-7711|Cathy.Alessi@va.gov|39311
21242973|NCT00114244|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
21242974|NCT00393848|UAMS|Arny Ferrando|501-526-5711|aferrando@uams.edu|
21242975|NCT02107339|NorthShore University HealthSystem|Glenn Murphy|847-570-2760|dgmurphy2@yahoo.com|
21242976|NCT02200523|Cleveland Medical Devices|Sarah Weimer|216-791-6720|sweimer@clevemed.com|
21242977|NCT03245580|Parkview Mirro Research Center|Christina Zelt RN|2602664153|christina.zelt@parkview.com|
21242978|NCT02694978|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
21242979|NCT01613716|Cleveland Clinic Foundation|Sunil K. Srivastava, MD|216-636-2286|srivass2@ccf.org|
21242980|NCT02550197|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21242981|NCT04763044|Procter & Gamble|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
21242982|NCT03848910|Hearing CRC Melbourne|Professor Robert Cowan|+61 3 9035 5347|r.cowan@unimelb.edu.au|
21242983|NCT01376089|GE Healthcare|Lauren Lim, PharmD|1-626-356-1937|lauren.lim@ge.com|
21242984|NCT03854253|Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Science, Tomsk, Russia|Dr. Stanislav Sapozhnikov|+79091919191|stas_ss@bk.ru|
21242985|NCT00419094|UCB, Inc.|Study Director|+1 877 822 9493||
21242986|NCT01811706|University of Florida|Dr. Guangbin Xia, Assistant Professor|352-273-5550|guangbin.xia@neurology.ufl.edu|
21242987|NCT02452918|Melinta Therapeutics|Study Director|1-844-633-6568|medinfo@melinta.com|
21242988|NCT00989937|UCSD|David Feifel||dfeifel@kadimanp.com|
21242989|NCT02567656|Rhizen Pharmaceuticals S.A.|Prajak Barde MD|+41 32 580 0113|pjb@rhizen.com|
21242990|NCT00203216|Thomas Jefferson University/Jefferson Headache Center|Dr. William Young, Principal Investigator|215-955-2243|William.B.Young@Jefferson.Edu|
21242991|NCT03287622|University of Michigan|Dr. Terri Voepel-Lewis|734-646-6803|terriv@umich.edu|
21242992|NCT05882812|Medical Pain Consultants|Dr. Ralph Ortiz|607-844-9979|rodoc@cnymail.com|
21242993|NCT01616654|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
21242994|NCT00610688|Cincinnati Children's Hospital Medical Center|Dr. Adekunle Dawodu|513-636-1966|Adekunle.Dawodu@cchmc.org|
21242995|NCT02057692|Mirum|Study Physician|1 650-667-4085|medinfo@mirumpharma.com|
21242996|NCT00943735|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21242997|NCT00486330|Yale University AIDS Program|R. Douglas Bruce|2037374040|robert.bruce@yale.edu|
21242998|NCT01027286|The Cleveland Clinic|Wael K Barsoum, MD|216-444-7515|barsouw@ccf.org|
21242999|NCT03804918|Imperial College London|Dr Gehan Soosaipillai|+44 20 3312 6666|gsoosaip@ic.ac.uk|7651
21243000|NCT00545844|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21243001|NCT01087762|Cares|UCB|+1887822||9493
21243002|NCT01329328|University of Verona|Prof. Carlo Zancanaro|+390458027155|carlo.zancanaro@univr.it|
21243003|NCT01565928|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21243004|NCT05340244|GE Healthcare|Tracy Grzendzielewski|414-218-6167|tracy.grzendzielewski@ge.com|
21243005|NCT00612586|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21243006|NCT00762606|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21243007|NCT04296227|Vital USA Inc.|Mark H Khachaturian, PhD|+1(561)282-6074|mark.khachaturian@vvvital.com|
21243008|NCT00949975|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21243009|NCT01568918|Mayo Clinic|Michelle Clarke, M.D.|(507) 284-5317|Clarke.Michelle@mayo.edu|
21243010|NCT04301986|UNC Center for Esophageal Diseases & Swallowing|Ariel E. Watts, Assistant Director of Clinical Trial Operations|919-962-7316|ariel_watts@med.unc.edu|
21243011|NCT01989910|Taipei Veterans General Hospital|Dr. WEN-WEI KU|+886228751997|stephaneku@gmail.com|
21243012|NCT04141917|University of Washington|Dr. Helen Chu|206-685-8702|helenchu@uw.edu|
21243013|NCT02954848|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21243014|NCT01802632|AstraZeneca|Senior Medical Director, Tagrisso||ClinicalTrialTransparency@astrazeneca.com|
21243015|NCT03299816|Johns Hopkins University School of Medicine|Deidra C. Crews, MD, ScM|410-502-0518|dcrews1@jhmi.edu|
21243016|NCT00082810|Montefiore Medical Center - New York|NYCC Regulatory Coordinator|718-379-6862|sforde@montefiore.org|
21243017|NCT00373269|Temple University|Dr. Nina T. Gentile|215-707-8402|ngentile@temple.edu|
21243018|NCT01184508|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21243019|NCT01269736|Yale University|Professor Marjorie Funk, PhD, RN|(203) 737-2346|marjorie.funk@yale.edu|
21243020|NCT02194933|Otsuka Data Transparency Organization|Global Clinical Development||DT-inquiry@otsuka.jp|
21243021|NCT03210402|Medtronic Inc|Mike Bennett, Clinical Study Manger|262-362-1956|mike.s.bennett@medtronic.com|
21243022|NCT04470193|University of Utah|Flory Nkoy, MD, MS, MPH|801-662-3660|flory.nkoy@hsc.utah.edu|
21261718|NCT04458857|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
21261719|NCT02986373|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21261720|NCT04800315|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21261721|NCT00753922|Ethicon Endo-Surgery|Michael L. Schwiers|513-337-1172|mschwier@its.jnj.com|
21261722|NCT00196937|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21261723|NCT01322815|Ruesch Center at Georgetown Lombardi|John L Marshall|202.444.7064|marshalj@georgetown.edu|
21261724|NCT00968344|University of Texas Medical Branch|Douglas Paddon-Jones, Professor|409-772-3073|djpaddon@utmb.edu|
21261725|NCT01526356|The University of Texas Health Science Center at Houston|Mary Kay Koenig, MD|713-500-7142|mary.k.koenig@uth.tmc.edu|
21261726|NCT02983292|Senior Specialist-Clinical Study Management|Dr. Manvendra Saxena|+61 455 870 175|manvendra.saxena@smith-nephew.com|
21261727|NCT04725682|FDA/CDER/OGD|Wei-Jhe Sun, Ph.D.|301-796-6176|ORSHSR@fda.hhs.gov|
21261728|NCT00964795|Regeneron|Clinical Trials Administrator|9148475385|clinicaltrials@regeneron.com|
21261729|NCT03949673|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21261730|NCT01328873|Northside Hospital|H. Kent Holland, MD|404-255-1930|kholland@bmtga.com|
21261731|NCT02453841|Nationwide Children's Hospital|Richard Cartabuke, MD|614-722-4200|Richard.Cartabuke@nationwidechildrens.org|
21261732|NCT00586690|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
21261733|NCT00098059|Novartis Pharmaceuticals|Study Director|862-778-8300||
21261734|NCT01151137|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi.com|
21261735|NCT00072189|California Cancer Consortium|DCC Project Administrator|: 626-256-4673|CCCP@coh.org|60094
21261736|NCT02973815|School of Nursing, University of Minnesota|Dr. Jayne A. Fulkerson|612-624-4823|fulke001@umn.edu|
21261737|NCT01684826|Philips|Frank Everaerts|+31630728782|frank.everaerts@philips.com|
21261738|NCT02273973|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21261739|NCT02680301|Seton Family of Hospitals/Ascension|Katherine Sebastian|801-598-2484|krsebastian@ascension.org|
21261740|NCT02378753|Centers for Disease Control and Prevention|Dr. Barbara Mahon|404-718-1157|bdm3@cdc.gov|
21261741|NCT00756977|Braintree Laboratories|John McGowan|781-843-2202|jmcgowan@braintreelabs.com|
21261742|NCT02606877|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21261743|NCT00778999|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21261744|NCT02032524|Sanofi-Aventis Recherche & Developpement|Trial Transparency Team|800-633-1610|contact-us@sanofi.com|6#
21261745|NCT04513158|Norton Healthcare|Joseph M. Flynn, DO, MPH|502-272-5001|joseph.flynn@nortonhealthcare.org|
21261746|NCT02858193|Dompé farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
21261747|NCT01894516|Galapagos N.V.|Clinical Trial Information Desk|+32 (0)15 342 900|rd@glpg.com|
21261748|NCT05652660|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21261749|NCT00266110|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
21261750|NCT01438710|Veloxis Pharmaceuticals|Christina Sylvest|+4520553877|csy@veloxis.com|
21261751|NCT02452970|EpicentRx, Inc.|Study Director: Bryan Oronsky, Chief Medical Officer|408-569-3202|boronsky@epicentrx.com|
21261752|NCT01266148|Novartis Pharmaceuticals|Study director|862-778-8300||
21261753|NCT00345371|National Institute on Drug Abuse|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov|
21261754|NCT01853228|Janssen Research & Development, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21261755|NCT02340104|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21261756|NCT01269125|Dept. of Ob/Gyn, Patra University School of Medicine, Greece|Apostolos Kaponis, M.D.|+30-2610999569|kaponisapostolos@hotmail.com|
21261757|NCT01040832|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21261758|NCT01300286|Duke University Medical Center|Dr. Ian Welsby|919-668-2699|ian.welsby@duke.edu|
21261759|NCT03635190|Cardio Flow, Inc.|Michael J Kallok, PhD|16512531754|mjkallok@cardioflow.net|
21261760|NCT00970203|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|7168451300|adrienne.groman@roswellpark.org|
21261761|NCT02767570|Stanford University|Julie Kolesar, PhD|614-561-1563|julie14@stanford.edu|
21261762|NCT00417612|Yale University School of Medicine|Dr. Thomas O. Carpenter|203-785-6526|thomas.carpenter@yale.edu|
21261763|NCT03774745|University of California, Davis|Dr. Mitchell Creinin|916-734-6670|mdcreinin@ucdavis.edu|
21261764|NCT01712438|Octapharma|Sylvia Werner|415 260-9577|sylvia.werner@octapharma.com|
21261765|NCT04426630|Yale University School of Medicine|Dr. Jeremy Schwartz|2036801598|jeremy.schwartz@yale.edu|
21261766|NCT02786537|UF Hepatology Research at CTRB|Lauren Morelli|352-273-9508|lauren.morelli@medicine.ufl.edu|
21261767|NCT03216265|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21261768|NCT01306058|Principal Investigator|Dr. Tim Greten|301-451-4723|tim.greten@nih.hhs.gov|
21261769|NCT01539837|Imperial College London|David Dexter|+44 (0)20 7594 6665|d.dexter@imperial.ac.uk|
21261770|NCT00849693|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21261771|NCT01978912|Teijin America, Inc.|President|+1-212-308-8744|clinical-trials-safety@teijinpo.com|
21291981|NCT03639610|Oncopeptides AB|VP Chief Operating Officer|+46 8 615 20 40|trials@oncopeptides.com|
21261772|NCT00224107|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
21261773|NCT01408537|Department of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University, Thailand|Dr. Pornthep Chanthavanich|6623549161|tmpct@mahidol.ac.th|
21291982|NCT02660229|Mundipharma Korea Ltd.|Mrs Suyoun Yang/CR head|82-2-527-9219|suyoun.yang@mundipharma.co.kr|
21243023|NCT04663802|University of Pennsylvania|Dr. Meeta Prasad Kerlin (PI)|215-746-0446|prasadm@pennmedicine.upenn.edu|
21243024|NCT02517307|Oregon Health & Science University|Melanie Gillingham, PhD|503-494-1682|gillingm@ohsu.edu|
21243025|NCT02885311|Northwell Health|Dr. Jonathan Morgenstern|(516) 837-1694|jmorgenste@northwell.edu|
21243026|NCT01001078|Maisonneuve-Rosemont Hospital|Nikola Joly, M.D.|+1 514 252 3426|nikola.joly@umontreal.ca|
21279716|NCT01277211|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21243027|NCT03863834|Inmode Ltd|Maria Shusterman, Clinical Director|9057070975|maria.shusterman@inmodemd.com|
21243028|NCT02685488|University of Arizona|Dr. John J.B. Allen|(520) 621-7448|john.jb.allen@arizona.edu|
21243029|NCT00667745|Bipolar Clinic and Research Program at|Dr. Andrew Nierenberg, Director of the Bipolar Trials Network|617-724-0837|ANIERENBERG@PARTNERS.ORG|
21243030|NCT02351180|Washington University in St. Louis|Ramsey Hachem, MD|3144548766|rhachem@wustl.edu|
21243031|NCT02930590|Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergology Charité - Universitätsmedizin Berlin|Dr. Jan Kottner|+49 30 450 518218|jan.kottner@charite.de|
21243032|NCT00605033|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
21243033|NCT00939991|Duke University Medical Center|Katherine Peters, MD, PhD|919-684-3914|katherine.peters@dm.duke.edu|
21243034|NCT03768206|University of South Carolina|Christine Pellegrini|803-777-0911|pellegca@mailbox.sc.edu|
21243035|NCT05328297|Janssen Research & Development|Senior Director Clinical Sciences Neuroscience|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21243036|NCT05147233|OCULIS Operations SàrI|Sharon Klier, M.D., M.S., M.P.H, Chief Development Officer|+41 21 711 3970|info@oculis.com|
21243037|NCT04513522|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21243038|NCT03284957|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21243039|NCT04517864|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21243040|NCT04541303|Univ of Mo|Brianna Castillo MD|813-765-1619|briannacastillo.md@gmail.com|
21243041|NCT04722003|Emory University Vaccine and Treatment Evaluation Unit (VTEU)|Varun K. Phadke, MD|404-712-9046|varun.phadke@emory.edu|
21243042|NCT04860258|CureVac AG|Clinical Trial Information|0049 6976805870|clinicaltrials@curevac.com|
21243043|NCT01124188|UPMC Late Life Depression|Jordan F. Karp, MD|412-246-6048|karpjf@upmc.edu|
21243044|NCT00028769|SWOG Statistical Center|Study Statistician|206-667-4623||
21243045|NCT01645098|Nationwide Children's Hospital|Marco Corridore, MD|614-722-4200|Marco.Corridore@nationwidechildrens.org|
21243046|NCT02496702|Technical University of Denmark, Center for Playware|Jari Due Jessen|+45 45 25 39 29|jdje@elektro.dtu.dk|
21243047|NCT01324453|Minneapolis Heart Institute Foundation|Jane Fox|6128636289|jane.fox@allina.com|
21243048|NCT01499134|Thomas Jefferson University|Danielle Duffy MD|215 955 5050|Danielle.Duffy@jefferson.edu|
21243049|NCT00708032|Johnson & Johnson Vision Care, Inc.|Kathy Osborn, OD|+1 904 443-1032|clinicalstudies@its.jnj.com|
21243050|NCT01904071|Maimonides Medical Center|Dr. Eitan Dickman, Director of EM Ultrasound|718-283-6057|edickman@maimonidesmed.org|
21243051|NCT01012388|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4041|clinicaltrials@merzaesthetics.com|
21243052|NCT00446550|Patient Advocacy|Amicus Therapeutics|+1-609-662-2000|Clinicaltrials@amicusrx.com|
21243053|NCT01759264|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
21243054|NCT03557008|Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
21243055|NCT00701896|Ohio State University|Dr. Philip Diaz|6142934925|diaz.3@osu.edu|
21243056|NCT03020745|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21243057|NCT00743444|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
21243058|NCT00186186|Stanford University|Dr. Terence Ketter, Chief Bipolar Disorder Clinic|650-723-2515|tketter@stanford.edu|
21243059|NCT00807144|Imperial College Healthcare NHS Trust|Adam McLean|+44 020 8383 5164|adammclean@nhs.net|
21243060|NCT02680457|Instituto de Terapéutica Experimental y Clínica, Universidad de Guadalajara|Dr. Manuel González Ortiz|+52 3310585200|uiec@prodigy.net.mx|34212
21243061|NCT01192542|Johnson and Johnson Vision Care|Brian Pall, O.D., M.S. F.A.A.O. Principal Research Optometrist|1 904 443-1290|bpall@its.jnj.com|
21243062|NCT02513238|Rigshospitalet|Principal Investigator, Mesrix|26276374|c.gronhoj@gmail.com|
21243063|NCT00813904|ZymoGenetics, a Bristol-Myers Squibb company|John Pribble, Vice President, Medical Affairs; Scot Maxon, Scientific Information|(206) 428-2756; (206) 434-3365|John.Pribble@bms.com; Scot.Maxon@bms.com|
21243064|NCT01405924|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21243065|NCT02393716|Medtronic|Kristel Wittebols Sr. Clinical Research Director|31 (0)43-3566566|kristel.wittebols@medtronic.com|
21243066|NCT01924767|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21243067|NCT01648140|GlaxoSmithKline|GSK Response Center|866-435-7343||
21243068|NCT03987451|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21243069|NCT03192046|UtexasSouthwestern|Staci Shearin|214-648-6564|staci.shearin@utsouthwestern.edu|
21279717|NCT03452943|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21279718|NCT02252354|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21279719|NCT03307226|Washington University in St. Louis|Dr. Fred Ssewamala|3149358521|fms1@wustl.edu|
21279720|NCT04697069|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
21279721|NCT05180227|James J Peters VA Medical Center|Dr. Jill Maria Wecht|(718) 584-9000|JM.Wecht@va.gov|3122
21279722|NCT02520297|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
21279723|NCT01130597|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
21261774|NCT05523362|University Hospitals Cleveland Medical Center|Dr. Ian Neeland|(216)844-5965|Ian.Neeland@UHhospitals.org|
21261775|NCT05099991|Stanford University|Research Team|(650) 497-5175|gynresearch@stanford.edu|
21261776|NCT01183858|Hoffmann-La Roche|Medical Communications|800-821-8590|genetech@druginfo.com|
21261777|NCT00098345|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21261778|NCT03707977|Harvard T.H. Chan School of Public Health|Molly Pretorius Holme|617-432-4377|mpretori@hsph.harvard.edu|
21261779|NCT03842709|University of New Mexico-Dept of Neurosciences|ERIN MILLIGAN,|505-272-4411|EMilligan@salud.unm.edu|
21261780|NCT00641147|Johns Hopkins University|Study Coordinator|410-955-3817|lhylind1@jhmi.edu|
21261781|NCT00791128|GI Dynamics, Inc.|Project Manager, Clinical and Regulatory|781.357.3263|kwoessner@gidynamics.com|
21261782|NCT00984659|GlaxoSmithKline|GSK Response Center|866-435-7343||
21261783|NCT01505062|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21261784|NCT01720667|University of California San Diego, School of Medicine|Dr. Richard Haas|(858) 822-6700|rhaas@ucsd.edu|
21261785|NCT03472534|Castle Creek Pharmaceuticals|Dr. Mary Spellman/Chief Medical Officer|862-286-0400|mspellman@castlecreekpharma.com|
21261786|NCT02614794|Seattle Genetics, Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
21261787|NCT00234104|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7314||
21261788|NCT00175006|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21261789|NCT02052960|Glycotope GmbH|Senior Director Clinical Department|0049309489|contact@glycotope.com|2600
21261790|NCT04045613|Basilea Pharmaceutica International Ltd, Allschwil|Study Director|+41 76 302 53 10|manuel.haeckl@basilea.com|
21261791|NCT00748657|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
21261792|NCT01243593|Sick Kids Hospital|Dr. Jason Hayes|416-813-7445|jason.hayes@sickkids.ca|
21261793|NCT04460027|Stanford Prevention Research Center, Department of Medicine, Stanford University|Judith J. Prochaska, PhD|650-724-3608|jpro@stanford.edu|
21261794|NCT01057121|AIDS Malignancy Consortium|AMC Statistical Center|501-526-6712|jylee@uams.edu|
21261795|NCT03633331|City of Hope Comprehensive Cancer Center|Mina S. Sedrak MD, MS|626-218-4173|msedrak@coh.org|
21261796|NCT00949650|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21261797|NCT03322657|Cleveland Clinic Foundation|Dr. Ehab Farag|216 444-7550|FARAGE@ccf.org|
21261798|NCT03671369|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21261799|NCT03134963|University of Leicester|Dr Lucy Beishon|0116252|lb330@le.ac.uk|3134
21261800|NCT01743027|Alcon Research, Ltd.|James Wheeler, Unit Head, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
21261801|NCT00450866|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|David Peereboom, MD|216-445-6068|peerebd@ccf.org|
21261802|NCT01753518|Mayo Clinic|Dr. Margaret Dow|507-266-8008|dow.margaret@mayo.edu|
21261803|NCT01971476|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21279724|NCT03371459|Pearl Therapeutics, Inc, a Member of the AstraZeneca Group|Colin Reisner, MD FCCP, FAAAAI|9739750321|Colin.Reisner@astrazeneca.com|
21279725|NCT01906515|Cairo University School Of Medicine|Dr Wael N Awada|00201006481958|waoool@hotmail.com|
21279726|NCT01885195|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21279727|NCT02516553|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21279728|NCT04614246|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
21279729|NCT02185053|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21279730|NCT03006302|SKCCC Johns Hopkins Medical Institution|Dung Le, MD|443-287-0002|Dle@jhmi.edu|
21291983|NCT01453166|Instituto de Ensino e Pesquisa do Hospital do Coração|Dr. Otavio Berwanger|+ 55 11 30536677|oberwanger@hcor.com.br|8201
21291984|NCT01049373|PASCOE pharmazeutische Präparate GmbH|Dr. Gabriele Weiss|0049/641/7960-0|klinischeforschung@pascoe.de|
21291985|NCT03610048|Alkermes|Director, Corporate and R&D Communications|781-609-7000|Gretchen.Murphy@alkermes.com|
21291986|NCT01155050|PenningtonBRC|Ronald Horswell|225-763-2931|Ronald.Horswell@pbrc.edu|
21291987|NCT02136914|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com|
21291988|NCT04136145|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21291989|NCT00557193|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21291990|NCT03421886|University of Alabama at Birmingham|Chung How Kau, chair and professor|(205) 934-2782|ckau@uab.edu|
21291991|NCT01156844|Novartis Pharmaceuticals|Study Director|862-778-8300||
21291992|NCT03892317|Imperial College Healthcare Trust|Goodall Dawn|+44 (0)20 7589 5111|dawn.goodall1@nhs.net|
21291993|NCT01130337|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21291994|NCT03886493|Johns Hopkins University School of Medicine|Kenneth Pienta, M.D.|410-502-3137|kpienta1@jhmi.edu|
21291995|NCT04067011|Emergent Biosolutions|Clinical Development Representative|+1 (204) 275-4196|ctgov@ebsi.com|
21291996|NCT00584857|UAB|J. Michael Straughn, MD|205-934-4986|Michael.straughn@ccc.uab.edu|
21291997|NCT03767881|Boston Scientific|Evelyne Ho, Clinical Project Manager|1-978-483-8856|Evelyne.ho@bsci.com|
21291998|NCT00534001|Roswell Park Cancer Institute|Martin Mahoney|716-845-2300|martin.mahoney@roswellpark.org|
21291999|NCT02958345|Tulane University|Dr. Luis Balart|504-988-3047|lbalart@tulane.edu|
21292000|NCT00760552|Iowa City VA Health Care System|Dr. Gary Rosenthal|319-338-0581|gary-rosenthal@uiowa.edu|
21292001|NCT01038323|Wake Forest|dennis ang|336-716-4209|dang@wakehealth.edu|
21292002|NCT01918189|VA Boston Healthcare System|Diana M. Higgins, PhD|857-364-2221|diana.higgins2@va.gov|
21292003|NCT04211363|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844)692-6729|medinfo@arcutis.com|
21292004|NCT01736917|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
21243070|NCT01194154|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21243071|NCT01505881|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21243072|NCT01147341|michael schiff|Michael schiff|303 773 8429|michael.schiff@me.com|
21243073|NCT01901276|Columbia University Medical Center|Daniel Freedberg, MD, MS|212-305-1021|def2004@cumc.columbia.edu|
21243074|NCT02314117|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21292005|NCT01734902|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21292006|NCT00060944|Janssen R&D US|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
21292007|NCT01126957|University of Missouri-Columbia|Dr. David Henry|573/884-2582|henryda@missouri.edu|
21292008|NCT02092181|Evergreenhealth|Gowri Rajendran|425-899-5370|grajendran@evergreenhealth.com|
21292009|NCT00956293|Novartis Pharmaceuticals|Study Director|+1 (862) 778-1873||
21292010|NCT02536664|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21292011|NCT03383666|Cerenovus|Michael Liao|510-770-5376|mliao7@its.jnj.com|
21292012|NCT01497756|uNewMexico|Mark Hauswald MD|505-269-6699|markhauswald@gmail.com|
21292013|NCT00659425|MedImmune, LLC|Mark Lanasa, MD Associate Director, Clinical Development, Oncology|301-398-0000|information.center@AstraZeneca.com|
21292014|NCT03358030|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
21292015|NCT03342560|Massachusetts General Hospital|Anthony E. Samir|6176432009|asamir@mgh.harvard.edu|
21292016|NCT03770286|Children's Hospital Los Angeles|Alexander Alcaraz|323-361-2130|aalcaraz@chla.usc.edu|
21292017|NCT02505425|The University of Alabama at Birmingham, School of Nursing|Marie A. Bakitas, DNSc, NP-C, FAAN|(205) 934-5277|mbakitas@uab.edu|
21292018|NCT02579811|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Moshe Ornstein|1-866-223-8100|TaussigResearch@ccf.org|
21292019|NCT04951193|MUSC|Dr. Jennifer Dahne|843-876-2280|dahne@musc.edu|
21292020|NCT04066829|University of Michigan|Kao-Ping Chua|(734) 615-8169|chuak@med.umich.edu|
21292021|NCT00775671|Vanderbilt University|Nancy J Brown|615-343-8701|nancy.j.brown@vanderbilt.edu|
21243075|NCT03368937|University of Virginia|Sue Brown|434-982-0206|sab2f@virginia.edu|
21243076|NCT01271452|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
21243077|NCT02950558|University of Cincinnati|Jun-Ming Zhang, MD, MSc|5135582427|jun-ming.zhang@uc.edu|
21243078|NCT03383146|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21243079|NCT01317420|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21243080|NCT02533167|Wake Forest Health Sciences|Ashley Tonidandel, MD|336-718-8278|atonidan@wakehealth.edu|
21261804|NCT00138151|Rutgers Cancer Institute of New Jersey|Lorna Rodriguez, MD, PhD|732-235-8675|rodriglo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
21261805|NCT02624700|Virginia Commonwealth University Massey Cancer Center|Andrew Poklepovic, MD|(804) 828-0450|AskMassey@vcu.edu|
21261806|NCT04925570|Stanford Prevention Research Center, Department of Medicine, Stanford|Judith J. Prochaska, PhD, MPH|650-724-3608|jpro@stanford.edu|
21261807|NCT02675517|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21261808|NCT01950078|Huazhong University of Science and Technology|Dr. Xianwei Zhang|027 83663173|znpin@sina.cn|
21261809|NCT03249350|Oregon Social Learning Center|Dr. Mike McCart|541-485-2711|MikeM@oslc.org|
21292022|NCT00163293|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21292023|NCT04133415|Washington University School of Medicine|Matthew Spraker, M.D., Ph.D.|314-362-8567|mspraker@wustl.edu|
21292024|NCT03549338|Symphogen A/S|Vice President, Global Oncology|+45 8838 2600|info@symphogen.com|
21243081|NCT03586544|The Ohio State University|Dharini Bhammar|614-866-9467|dharini.bhammar@osumc.edu|
21243082|NCT01832506|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21243083|NCT02020616|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21243084|NCT05019729|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
21243085|NCT00299741|Massachusetts General Hospital|Dr. Dror Michaelson|617-726-1594|dmichaelson1@partners.org|
21243086|NCT02770248|Alcon, A Novartis Division|Field Medical, Ophthalmology|1-888-451-3937|alcon.medinfo@alcon.com|
21243087|NCT01579916|MedImmune, LLC|Raburn Mallory, MD/Senior Director Clinical Development|301-398-0000|malloryr@medimmune.com|
21243088|NCT01597128|University of Kentucky Medical Center|J. Scott Roth, M.D.|859-323-6346|arockich@uky.edu|246
21243089|NCT01359371|VA Center for Clinical Management Research Health Services|Sonia A. Duffy, Ph.D., R.N., FAAN|734.395.0613|Sonia.Duffy@va.gov|
21243090|NCT02355158|BDSI|Tim Warneke|919-582-0294|twarneke@bdsi.com|
21243091|NCT02878850|Duke University|Miriam Treggiari|9196819933|miriam.treggiari@duke.edu|
21243092|NCT03351075|KU Leuven|Prof. An De Groef|+32 16 342 171|an.degroef@kuleuven.be|
21243093|NCT01072006|VANCHCS|Juliana Baldo|925-372-4649|juliana.baldo@va.gov|
21243094|NCT05219253|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21243095|NCT03086369|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21243096|NCT05011396|Vistagen Therapeutics, Inc.|Ester Salman, MPH|650-577-3693|clinicalstudies@vistagen.com|
21261810|NCT02111811|Crescenz VA Medical Center|David Oslin, MD|215-823-8594|dave.oslin@va.gov|
21243097|NCT04668339|Arcturus Therapeutics, Inc.|Arcturus Therapeutics, Inc.|858-900-2660|clinicaltrials@arcturusrx.com|
21243098|NCT02986178|Istari Oncology|Head of Clinical Operations|919-245-7662|info@istarioncology.com|
21243099|NCT03253848|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21243100|NCT02694835|Alcon, A Novartis Division|Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21243101|NCT00941655|National Cancer Institute, National Institutes of Health|Dr. Udo Rudloff|301-496-3098|Udo.Rudloff@nih.gov|
21243102|NCT02860286|Epizyme|Kemly Calixte|617-500-0608|kcalixte@epizyme.com|
21243103|NCT02698891|Dana-Farber Cancer Institute|Dr. Nancy Lin|617-632-3800|nlin@partners.org|
21243104|NCT04218110|Eurofins EVIC|Commercial Manager|+40 213357090|luciachirita@eurofins.com|
21243105|NCT00516386|Massachusetts General Hospital|Madhu Misra, MD|617-724-5602|mmisra@partners.org|
21292025|NCT01492426|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21292026|NCT00269113|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21292027|NCT01770743|Emergent BioSolutions|Dr. Gurdyal Kalsi|301-216-9927|kalsig@ebsi.com|
21292028|NCT01714323|Massachusetts General Hospital|Nancy Rigotti, MD|617-724-4709|nrigotti@partners.org|
21292029|NCT00716820|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21292030|NCT02122380|Vanderbilt University Medical Center|Dr. Jessica Devin|970-875-2708|jessica.devin@vumc.org|
21292031|NCT01126190|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
21292032|NCT00892008|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21292033|NCT01466491|Oregon Health & Science University|Dr. Paula Bednarek|503-494-3666|whru@ohsu.edu|
21243106|NCT04238429|Sun Yat-sen University|Dr. Hongchun Liu|86-13826189071|hongchun_liu@vip.sina.com|
21243107|NCT03262935|Byondis B.V.|Clinical Development|0031246795101|clinicaltrials@byondis.com|
21243108|NCT03176654|Loma Linda University Health|Everett Lohman, PhD. Professor||elohman@llu.edu|83171
21261811|NCT02772783|Boston Children's Hospital|Belinda Lennerz|617 355 7476|belinda.lennerz@childrens.harvard.edu|
21261812|NCT03443024|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21261813|NCT00149825|Stanford University, School of Medicine|Rachel Manber, PhD|650-724-2377|Rmanber@stanford.edu|
21279731|NCT00340678|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Dr. Robert Nelson|(602) 200-5205|rnelson@phx.niddk.nih.gov|
21279732|NCT03532373|Stanford University|Robin Kamal|650-721-7629|rnkamal@stanford.edu|
21279733|NCT00754546|Dartmouth-Hitchcock Medical Center|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org|
21279734|NCT00996892|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21279735|NCT02759692|Johnson & Johnson Vision Care Inc.|Brian Pall, OD, MS, FAAO|904 443-1290|BPALL@its.jnj.com|
21279736|NCT03245827|Saint Louis University|Sandeep Dhindsa|716-977-4911|sandeep.dhindsa@health.slu.edu|
21279737|NCT00553735|Massachusetts Eye and Ear Infirmary|Reza Dana, MD, MPH, MSc|617-573-3313|Cornea_Research@MEEI.Harvard.edu|
21279738|NCT04042376|Janssen Research & Development, LLC|Executive Medical Director Onc|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21279739|NCT01059786|National Cancer Institute|Dr. Robert J. Kreitman|301-480-6187|kreitmar@mail.nih.gov|
21279740|NCT04205812|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21279741|NCT04559347|The Guthrie Clinic|Poovendran Saththasivam MD|5708874882|Poovendran.Saththasivam@guthrie.org|
21279742|NCT00371033|University of Pennsylvania|J. Richard Landis, PhD|215-573-4922|hultman@upenn.edu|
21279743|NCT02905240|Zimmer Biomet|Jennifer Woodell-May, Research Associate Director|5742651885|jennifer.woodell-may@zimmerbiomet.com|
21279744|NCT05789576|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
21292034|NCT01496287|Acclarent, Inc.|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
21292035|NCT00329030|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
21243109|NCT00831415|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21292036|NCT03036852|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21292037|NCT00991809|Johns Hopkins University, School of Medicine|Dr. D. Andrew Tompkins|410-550-5953|dtompki1@jhmi.edu|
21292038|NCT02250417|The Ohio State University|Ulysses J. Magalang|614-292-6563|magalang.1@osu.edu|
21243110|NCT01290224|Mayo Clinic|Dr. Charles L. Loprinzi|507-284-2511|cloprinzi@mayo.edu|
21292039|NCT02196922|Northwell Health|Renee Pekmezaris, Ph.D., Vice President Community Health & Health Services Research|516 465-3161|rpekmeza@northwell.edu|
21292040|NCT01999192|Biotest AG|Xuefei Zhou Manager Strategy & Development|+496103801|xuefei_zhou@biotest.de|1229
21292041|NCT03338400|Cleveland Clinic Florida|Dr. David Ossin|954-659-5559|ossind@ccf.org|
21292042|NCT02468830|CHU de Quebec-Universite Laval|Dr Stephane Bolduc||Stephane.Bolduc@fmed.ulaval.ca|
21292043|NCT02639390|Department of Veterans Affairs|Peter Lum|12023195181|lum@cua.edu|
21292044|NCT03019887|Okada hospital|Dr. Ryota Ataniya|+81-4-7124-6151|ryotaataniya@pbt.nir.jp|
21292045|NCT00680628|Indiana University School of Medicine|Jeffrey Kline|3172873004|jefkline@iupui.edu|
21292046|NCT01531998|University of Texas (UT) MD Anderson Cancer Center|Jatin J. Shah, MD/Associate Professor, Lymphoma/Myeloma|713-792-2860|CR_Study_Registration@mdanderson.org|
21292047|NCT02581891|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21292048|NCT02927795|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21292049|NCT03259295|University of Florida|Juan Carlos Roig|352-273-8985|roigjc@peds.ufl.edu|
21292050|NCT05525910|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21292051|NCT02831660|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21292052|NCT00181844|Massachusetts General Hospital|Janet Wozniak, MD|617-503-1038|jwozniak@partners.org|
21292053|NCT02918669|Paradigm Spine|Fran Magee, DVM|212-367-7274|fran.magee@paradigmspine.com|
21292054|NCT00107276|SWOG|Study statistician|206-667-4623||
21292055|NCT05209386|University of Pittsburgh|Taylor Abel|412-692-9631|abeltj@upmc.edu|
21292056|NCT03179761|Vanderbilt-Ingram Cancer Center|Natasha Halasa, MD, MPH|800-811-8480|natasha.halasa@vumc.org|
21292057|NCT01484652|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
21292058|NCT03440008|VA Puget Sound Health Care System|Dr. Joseph Iaquinto|206-277-1738|Joseph.Iaquinto@va.gov|
21292059|NCT02170064|BIAL - Portela & Cª, SA|Head of Clinical Research|+351-22 9866100|clinical.trials@bial.com|
21292060|NCT02359903|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
21292061|NCT03381989|National Heart Lung and Blood Institute|Lederman, Robert|+1 301 402 6769|lederman@nih.gov|
21292062|NCT00790673|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il|
21292063|NCT02972996|Stratton V.A. Medical Center|Margaret M. Wilson MS, RD, LD/N, CD/N, CNSC, CDE|518 626-6889|margaret.wilson2@va.gov|
21292064|NCT03507127|Brown University|Dr. Jennifer Tidey|4018636418|jennifer_tidey@brown.edu|
21292065|NCT01240863|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21292066|NCT01800786|Brigham and Women's Hospital|Ina Djonlagic|617 667 5129|idjonlag@bidmc.harvard.edu|
21292067|NCT00746811|Biofortis Research (formerly Provident)|John Marshall, General Manager|630-748-5339|john.marshall@mxns.com|
21292068|NCT02604511|Dana-Farber Cancer Institute|Dr. Steven Treon|617-632-2681|steven_treon@dfci.harvard.edu|
21292069|NCT01370551|Medinova|Doerthe Bassfeld|+41 44 306 1371|bassfeld.doerthe@medinova.ch|
21292070|NCT00833521|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21292071|NCT02666560|University College London|Joanne Lindop|07909116145|joanne.lindop.12@ucl.ac.uk|
21292072|NCT00545779|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21292073|NCT01405196|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21292074|NCT01542788|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21292075|NCT03802396|Duke University|Miles Berger, MD, PhD|919-684-8679|miles.berger@duke.edu|
21243111|NCT05694065|Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China|Dr. Fenghua Ding|+00 86 21 64370045|ruijindfh@126.com|
21243112|NCT00424762|University of Texas Southwestern Medical Center at Dallas|Dr. Darren K. McGuire|214 645 7520|darren.mcguire@utsouthwestern.edu|
21243113|NCT02311972|Duke University|Dr. Robin B. Dail|919-684-3786|robin.dail@duke.edu|
21243114|NCT01122901|Adult Brain Tumor Consortium|David Peereboom, MD|410-955-8837|jfisher@jhmi.edu|
21243115|NCT03557658|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
21243116|NCT02716324|The Children's Hospital of Philadelphia|James Guevara, MD MPH|2155901130|guevara@email.chop.edu|
21243117|NCT00888979|UConn Health|Cheryl Oncken|860-679-3425|oncken@uchc.edu|
21243118|NCT04347954|Stanford University|Jayakar Nayak, MD, PhD|(650) 723-5281|jnayak@stanford.edu|
21243119|NCT05641311|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
21243120|NCT00922207|HoffmannLa Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21243121|NCT00367991|New York University School of Medicine|Stuart Katz, MD|212-263-3946|stuart.katz@nyumc.org|
21292077|NCT02561962|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21292078|NCT03586973|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
21243122|NCT03515304|Johns Hopkins University - Baltimore, MD|Dr. Thorsten Leucker|4105020469|tleucke1@jhmi.edu|
21243123|NCT03684265|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21243124|NCT02570295|Swiss Federal Institute of Sport Magglingen SFISM|Dr. Thomas Wyss|+41 58 467 64 16|thomas.wyss@baspo.admin.ch|
21243125|NCT02969863|MGH|Courtney Balliro, BS RN CDE|617-726-1242|cballiro@partners.org|
21243126|NCT02705586|VA Portland Health Care System|Dr. Amie Hiller|503 721 1091|peterami@ohsu.edu|
21243127|NCT02045836|GlaxoSmithKline|GSK Response Center|866-435-7343||
21243128|NCT00057837|ECOG Statistical Office|Study Statistician|617-632-3012||
21243129|NCT02000817|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21243130|NCT05686421|Wills Eye Hospital|Joel Schuman, MD FACS|215-928-3197|JSchuman@willseye.org|
21243131|NCT00367055|GlaxoSmithKline|GSK Response Center|866-435-7343||
21243132|NCT00539292|The Hospital for Sick Children|Dr Jacob C Langer|416-813-7340|jacob.langer@sickkids.ca|
21243133|NCT02165761|W.L. Gore and Associates, Inc.|Suzy Palmer, CCRP|928-864-3670|supalmer@wlgore.com|
21243134|NCT00176839|University of Minnesota Masonic Cancer Center|Margaret MacMillan, M.D.|612-626-2778|macmi002@umn.edu|
21243135|NCT00145041|Talon Therapeutics|Chief Medical Officer|650-588-6404|info@talontx.com|
21243136|NCT02885350|Helsinki University Central hospital/Women's hospital/anaesthesia|Dr Antti Vaananen|358504271850|antti.vaananen@hus.fi|
21243137|NCT00324038|Napp Pharmaceutical Ltd|Dr Paul Schofield, Medical Director|01223424444|info@contact-clinical-trials.com|
21243138|NCT01378065|Coloplast Corp|Cathy Bartz|612-834-3127|uscmba@coloplast.com|
21243139|NCT00361283|University of Florida|Reginald F. Frye, PhD, Associate Professor|3522735453|fryerf@ufl.edu|
21243140|NCT01837641|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21243141|NCT03264456|University of Alabama at Birmingham|Samuel Galgano|2059341388|samuelgalgano@uabmc.edu|
21243142|NCT01123083|GlaxoSmithKline|GSK Response Center|866-435-7343||
21243143|NCT00961636|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21243144|NCT04884737|UCLA School of Nursing|Barbara Bates-Jensen, PhD, RN, FAAN|626-437-8543|batesjen@sonnet.ucla.edu|
21243145|NCT00290706|Northwestern University|Leo Gordon|312-695-4520|l-gordon@northwestern.edu|
21243146|NCT04066738|Oxford University Hospitals NHS Foundation Trust|Prof. Tim Betts|01865 220256|ep.doctors@ouh.nhs.uk|
21243147|NCT01196429|NRG Oncology Statistics and Data Management Center - Buffalo|Linda Gedeon for William Brady PhD|716-845-5702|lgedeon@nrgoncology.org|
21243148|NCT00688519|GlaxoSmithKline|GSK Response Center|866-435-7343||
21243149|NCT02486588|Kaiser Permanente Northern California Division of Research|Anjali Gopalan|510-891-3458|Anjali.Gopalan@kp.org|
21243150|NCT00329732|Thomas Jefferson University|Kathleen Bradley|215-955-2025|Kathleen.Bradley@jefferson.edu|
21243151|NCT02551055|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21243152|NCT00430300|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21243153|NCT02666742|Kansas City Heart Rhythm Institute|Donita Atkins|913-253-3064|Donita.Atkins@hcahealthcare.com|
21243154|NCT02205307|Novadaq Technologies|Alicia Wilton|416-949-4992|alicia.wilton@stryker.com|
21243155|NCT01063517|AstraZeneca|Anitra Fielding|+44 1625 517178|aztrial_results_posting@astrazeneca.com|
21243156|NCT02041104|Mlinotest d. d.|Ana Velikonja|0038651321785|anaa.velikonja@gmail.com|
21243157|NCT02106442|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21243158|NCT03215927|University of Pittsburgh|Rohit Aggarwal|4123838123|aggarwalr@upmc.edu|
21243159|NCT02945332|Texas Tech University|Dr. Nikhil Dhurandhar|806 834-6446|nikhil.dhurandhar@ttu.edu|
21243160|NCT04001829|ECOG-ACRIN Biostatistics Center|Study statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21243161|NCT03175172|Aduro Biotech, Inc.|Medical Affairs|510.809.2452|MedicalAffairs@aduro.com|
21243162|NCT02974634|University of Pennsylvania|Dr. Robert Krouse|215-615-4573|robert.krouse@pennmedicine.upenn.edu|
21243163|NCT01393119|Oncternal Therapeutics|Mary Breitmeyer|8582092082|mbreitmeyer@oncternal.com|208
21243164|NCT01266265|United Therapeutics Corporation|Nicole Leedom|919-425-5870|nleedom@unither.com|
21243165|NCT01580293|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21243166|NCT01400776|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21243167|NCT02064959|The University of Texas Health Science Center at Houston|Georgene W. Hergenroeder, Ph.D., Associate Professor|713-500-6230|lisa.h.schmitt@uth.tmc.edu|
21243168|NCT00534937|Allegheny General Hospital|Dr. Satish Muluk|(412) 359-3714|muluk@usa.net|
21243169|NCT02711839|Taipei Medical University|Dr. Sing-Chung Li|886-2-27361661|sinchung@tmu.edu.tw|6560
21243170|NCT03290248|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
21243171|NCT01815008|Johns Hopkins School of Medicine|Rehan Qayyum|410-955-7781|rqayyum@jhmi.edu|
21243172|NCT05674136|Masimo Corporation|Ahmed Alghazi|949-297-7000|studies@masimo.com|
21243173|NCT02983617|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21243174|NCT00002842|City of Hope|Jeffrey Longmate, Ph.D.|626-256-4673|jlongmate@coh.org|
21243175|NCT02383472|Boston Children's Hospital|Dr. William Meehan|781-216-1328|William.Meehan@childrens.harvard.edu|
21243176|NCT02013830|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21243177|NCT01111526|H. Lee Moffitt Cancer Center and Research Institute|Dr. Lia Perez|813-745-3665|lia.perez@moffitt.org|
21243178|NCT01171625|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
21243179|NCT01867216|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21279745|NCT03367572|University of Rochester Medical Center|Luke J. Peppone, PhD, MPH|585-275-7827|Luke_Peppone@urmc.rochester.edu|
21279746|NCT05929651|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext: 6#|Contact-US@sanofi.com|
21279747|NCT05026177|Cassava Sciences, Inc.|Study Director|737-910-1045|ClinicalTrials.gov@cassavasciences.com|
21279748|NCT06831760|Adichunchanagiri Institute of Medical Sciences|Dr Naveen N|+91-9980023372|naveen_uno1@yahoo.co.in|
21279749|NCT03816878|Johns Hopkins University Center for Immunization Research|Kawsar Talaat|410-336-9164|ktalaat1@jhu.edu|
21243180|NCT01112670|University of Colorado|Christina Aquilante, Pharm.D.|303-724-6126|christina.aquilante@ucdenver.edu|
21261814|NCT05897853|Hospital of Ludwig Maximilians University, Munich|Prof. Dr. Michael Strupp|+49 894400|Michael.Strupp@med.uni-muenchen.de|76980
21261815|NCT03851510|Philips|Chuck Cain|412-657-1814|chuck.cain@philips.com|
21261816|NCT01145391|University of Colorado Denver School of Medicine|Amy Huebschmann|303-724-2268|amy.huebschmann@ucdenver.edu|
21261817|NCT00970294|University of Kansas Medical Center|Patricia Kluding PT PhD|913-588-6918|pkluding@kumc.edu|
21261818|NCT01333189|University of Colorado, Denver|Cory L Christiansen, PT, PhD|303-724-9101|cory.christiansen@ucdenver.edu|
21261819|NCT01739595|Repros Therapeutics Inc|Jennifer Wike|2817193402|jwike@reprosrx.com|
21261820|NCT02104180|Mylan Medical SAS|Benoit LA ROCHE|+33 1 46 25 86 76|benoit.la-roche@mylan.com|
21261821|NCT00793585|1st Affiliated Hospital, Sun Yat-Sen University|Xueqing Yu , M.D. & Ph.D.|8620-87766335|yuxq@mail.sysu.edu.cn|
21261822|NCT00035815|Mayo Clinic|Eric J. Sorenson, MD|507 538-1037|sorenson.eric@mayo.edu|
21261823|NCT00003270|Roswell Park Comprehensive Cancer Center|Dr. Theresa Hahn|716-845-5819|theresa.hahn@roswellpark.org|
21261824|NCT04952389|Mayo Clinic|Janalee K. Stokken, M.D.|507-284-1482|Stokken.Janalee@mayo.edu|
21261825|NCT01928030|Stanford University|Dr. Mark Pegram, Susy Yuan-Huey Hung Professor|650-723-5801|mpegram@stanford.edu|
21261826|NCT02420652|Rutgers Cancer Institute of New Jersey|Biren Saraiya, MD|732-235-3360|saraiybi@cinj.rutgers.edu|
21261827|NCT02605863|University of Rochester|Edward Messing, ND|585-275-0998|edward_messing@urmc.rochester.edu|
21261828|NCT00435539|ThromboGenics|Petra Kozma-Wiebe, MD|+32 16751310|petra.kozma@thrombogenics.com|
21261829|NCT01322607|Baltimore VA Medical Center (VAHMCS)|Research Specilist|410-605-7156|alyssa.stookey@va.gov|
21261830|NCT04075604|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21261831|NCT00950352|The Brain Institute of the University of Utah|Perry Renshaw, MD, PhD, MBA|801-587-1216|perry.renshaw@hsc.utah.edu|
21261832|NCT01048125|University of Missouri-Columbia|Dr. Anand Chockalingam|573/882-2296|chockalingama@health.missouri.edu|
21261833|NCT01419249|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21261834|NCT00353977|Hematology Branch, NHLBI|Minoo Battiwalla, MD|301 827 0939|battiwam@nhlbi.nih.gov|
21261835|NCT01673061|Albert Einstein Medical Center|Kamran Mohiuddin, Director Clinical Research Emergency Medicine|2154562313|mohiuddk@einstein.edu|
21261836|NCT01745055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21261837|NCT02717546|Zimmer Biomet|Ryan Boylan, Clinical Affairs Manager|574.527.7934|ryan.boylan@zimmerbiomet.com|
21261838|NCT01009294|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
21261839|NCT01678846|London School of Hygiene and Tropical Medicine|Dr Karen Devries|0207958 8164|Karen.Devries@lshtm.ac.uk|8164
21261840|NCT00414440|Novartis|Study Director|+1 (862) 778-8300||
21261841|NCT04382651|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21261842|NCT01507545|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21261843|NCT03739983|University of Wisconsin Carbone Cancer Center|Ryan Spencer, MD, MS|608-265-1700|rjspencer2@wisc.edu|
21261844|NCT00790296|University of Connecticut Health Center|Andrew Winokur MD PhD|860-679-6775|awinokur@uchc.edu|
21261845|NCT02612077|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21261846|NCT00940342|The University of Texas MD Anderson Cancer Center|Alessandra Ferrajoli, MD/Professor|713-792-7734|CR_Study_Registration@mdanderson.org|
21261847|NCT04901507|Virginia Commonwealth University School of Dentistry|Dr. Caroline Carrico|804-828-8328|ckcarrico@vcu.edu|
21261848|NCT01716169|Stanford School of Medicine|Dr. Alfred Lane|650 721 7166|atlane@stanford.edu|
21261849|NCT00553787|Vivus, Inc|Wesley W Day PhD|650-934-5200|day@vivus.com|
21261850|NCT01088412|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21261851|NCT00793104|RI Biologics|Robin Waite , Clinical Projects Director|386-418-8888|rwaite@rtix.com|
21261852|NCT00466752|University of Washington / Seattle Cancer Care Alliance|Evan Yu|206-288-1152|evanyu@u.washington.edu|
21261853|NCT05121103|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
21261854|NCT00754767|HealthPartnersInstitute|Dr. Alice Shapiro|952-993-1704|shapia@parknicollet.com|
21261855|NCT03494725|DuPont Nutrition and Biosciences|Elaine Patterson, Ph. D.|+358-40-4827-626|elaine.patterson@dupont.com|
21261856|NCT02619253|IndianaU|Dr. Nabil Adra|317-278-7728|nadra@iu.edu|
21261857|NCT00514449|Western Psychiatric Institute and Clinic|Dr. Konasale Prasad|412-586-9014|prasadkm@upmc.edu|
21261858|NCT04083144|Centre for Addiction and Mental Health|Dr. Bernard Le Foll|4165358501|bernard.lefoll@camh.ca|33111
21261859|NCT02101008|Huntsman Cancer Institute|Kenneth Grossmann|801-587-4289|kenneth.grossmann@hci.utah.edu|
21261860|NCT02830165|University of California at Los Angeles, David Geffin School of Medicine, Radiation Oncology|Nicholas Nickols, MD|310 825-8278|nnickols@mednet.ucla.edu|50472
21261861|NCT01363843|BrUOG|William Sikov, MD and Kimberly Perez, MD|4018633000|kayla_rosati@brown.edu|
21261862|NCT02694029|UT Southwestern Medical Center|Asal Rahimi, MD|214/645-8556|Asal.Rahimi@UTSouthwestern.edu|
21261863|NCT00301067|Northwestern University|Clinical Trials Office|312-695-1301||
21261864|NCT01359982|EpicentRx, Inc|Study Director: Bryan Oronsky, Chief Medical Officer|8582291062|boronsky@epicentrx.com|
21261865|NCT05593432|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21261866|NCT03529214|Ariadne Labs|Dr. Amber Weiseth|206-786-0282|aweiseth@ariadnelabs.org|
21261867|NCT03246074|SKCCC at Johns Hopkins|Stephanie Gaillard, MD PhD|410-955-3774|stephanie.gaillard@jhmi.edu|
21261868|NCT02609399|Johns Hopkins University|Dr. Richard Rothman|410-735-6428|rrothma1@jhmi.edu|
21261869|NCT00069121|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21261870|NCT00306891|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21261871|NCT01811030|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
21261872|NCT00206518|Baylor College of Medicine|Tao Wang|7137985388|taow@bcm.edu|
21261873|NCT02335450|Oakland University|Beth Black|248-364-8694|bblack@oakland.edu|
21292079|NCT01005290|Ferrer Internacional S.A.|Natalia Oudovenko|+34 93 509 32 82|noudovenko-research@ferrergrupo.com|
21292080|NCT02051426|Herzog Hospital|Uriel Heresco-Levy, M.D.|+972-2-5316906|urielh@ekmd.huji.ac.il|
21292081|NCT01150357|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
21292082|NCT00652743|GlaxoSmithKline|GSK Response Center|866-435-7343||
21292083|NCT03233828|Nova Scotia Health|Principal Investigator|9024736177|carman.giacomantonio@nshealth.ca|
21292084|NCT02495285|B. Braun Melsungen|Study Manager|05661/71|studies@bbraun.com|0
21292085|NCT01585025|Imperial College London|Prof Julian Walters|+442033132361|julian.walters@imperial.ac.uk|
21292086|NCT00503984|University of Miami|Rakesh Singal MD|305-243-9544|rsingal@med.miami.edu|
21292087|NCT03430349|University of Antwerp|Pierre Van Damme, MD, PhD|+32 3 265 21 30|pierre.vandamme@uantwerpen.be|
21292088|NCT00952705|MedImmune, LLC|JA Sliman, MD, MPH, Director, Clinical Development|301-398-0000|SlimanJ@medimmune.com|
21292089|NCT00140140|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21292090|NCT00639457|Washington Univ Med Sch|Kevin Yarasheski, PhD|3143628173|key@wustl.edu|
21292091|NCT04606927|University Medical Center Groningen|Dr. Jozine ter Maaten|0503616161|j.m.ter.maaten@umcg.nl|
21292092|NCT02727322|University of Pittsburgh|Halina Zyczynski|421-641-1440|hzyczynski@upmc.edu|
21243181|NCT01337635|Medical College of Wisconsin|Yvonne Chiu, MD|414-955-2818|ychiu@mcw.edu|
21292093|NCT00399035|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
21292094|NCT01987414|University of Minnesota|Chih-Huang Yu|6126262443|yuxxx648@umn.edu|
21292095|NCT02949011|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
21292096|NCT01541371|CDMA, Beijing|Therapeutic Area Manager|00861058218352||
21292097|NCT02441218|Institut de Recherches Internationales Servier (I.R.I.S.)|Therapeutic Innovation Pole|+33155724366|clinicaltrials@servier.com|
21292098|NCT01131052|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
21292099|NCT00163189|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21292100|NCT03435380|Duke University|Kevin Oeffinger, MD|919-668-2122|kevin.oeffinger@duke.edu|
21292101|NCT02431325|Massachusetts General Hospital|Janet Lo, M.D., M.MSc.|617-724-3425|jlo@mgh.harvard.edu|
21292102|NCT01917318|University of Colorado|Michael H. Allen, M.D.|(303) 724-3300|Michael.Allen@ucdenver.edu|
21292103|NCT01008618|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387||
21292104|NCT01128569|GlaxoSmithKline|GSK Response Center|866-435-7343||
21292105|NCT02941614|Kaiser Permanente Southern California Department of Research and Evaluation|Erin Hahn|626-564-3505|Erin.E.Hahn@kp.org|
21292106|NCT00487981|Boston Scientific|Lyn M. Pimentel, M.B.A.|(661) 949-4174|Lyn.Pimentel@bsci.com|
21292107|NCT01865487|Aeras|Dr. Dereck Tait|27214424991|dtait@aeras.org|
21292108|NCT02319486|Zhongshan Ophthalmic Center, Sun Yat-sen University|Huasheng Yang|+862087331539|yanghs64@126.com|
21292109|NCT00129285|University of Pennsylvania Treatment Research Center|Kyle Kampman|215-746-2764|kampman@mail.med.upenn.edu|
21292110|NCT01627691|Boston Scientific|Anne Cornaille|+33608863659|anne.cornaille@bsci.com|
21292111|NCT01908140|AstraZeneca|Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21292112|NCT01307449|Emory University|Rouphael, Nadine|404-712-1435|nroupha@emory.edu|
21292113|NCT03218917|Insmed Incorporated|Insmed Medical Information|1-844-446-7633|medicalinformation@Insmed.com|
21292114|NCT00427193|Duke University Medical Center|William E. Kraus, Director of Clinical Research, Duke Center for Living|919-681-6733|william.kraus@duke.edu|
21243182|NCT01113931|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
21243183|NCT02568644|Universidade Federal de Minas Gerias|Dr. Antonio Lucio Teixeira||altexr@gmail.com|
21292115|NCT00698828|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21292116|NCT02013609|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21292117|NCT01816295|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21292118|NCT01119287|Alcon Research|Head, Alcon Clinical|1-888-451-3937||
21292119|NCT01175343|Princess Margaret Cancer Centre|Dr. Amit M. Oza|416-946-2818|amit.oza@uhn.ca|
21292120|NCT00383071|SAIC/National Institute of Allergy and Infectious Diseases|John Beigel, M.D.|+1 301 451 9881|jbeigel@niaid.nih.gov|
21292121|NCT02604459|University of Missouri|Dr. Quinn Johnson|573-882-2568|johnsonql@health.missouri.edu|
21292122|NCT01138475|William Beaumont Hospital|Kerstyn Zalesin|248-655-5900|Kerstyn.zalesin@beaumont.edu|
21292123|NCT01534481|University of Iowa|Dr. Tarah Colaizy|319-356-3508|tarah-colaizy@uiowa.edu|
21292124|NCT00945659|Nemours Foundation: Dept. of Biomedical Research|Tim Wysocki, PhD|904-697-3483|twysocki@nemours.org|
21292125|NCT04700423|Swiss TPH|Prof. Dr. Jennifer Keiser|+41612848218|jennifer.keiser@swisstph.ch|
21292126|NCT02287779|Mirum|Study Physician|1 650-667-4085|medinfo@mirumpharma.com|
21292127|NCT00476645|Stanford University Medical Center|Associate Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu|
21292128|NCT03498716|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21292129|NCT02284191|NHS Lothian|Prof Alasdair Gray Chief Investigator|0131 242 1284|alasdair.gray@ed.ac.uk|
21292130|NCT04849897|University of Southern California|Steven Richeimer|323-442-6202|steven.richeimer@med.usc.edu|
21292131|NCT02257684|Jazz Pharmaceuticals|Head of Clinical Development|650-496-3777||
21243184|NCT03387319|Emory University|Kimberly R Jacob Arriola, PhD, MPH|404-727-2600|kjacoba@emory.edu|
21243185|NCT00842257|Massachusetts General Hospital|Dr. David Patrick Ryan, Chief, Hem/Onc|617-974-4545|DPRYAN@mgh.harvard.edu|
21292132|NCT00265850|Alliance for Clinical Trials in Oncology|Alan Venook, M.D.||Venook@cc.ucsf.edu|
21292133|NCT01448616|University of Washington|Rachel Bender Ignacio, MD MPH|2065204340|rbi13@uw.edu|
21243186|NCT00909363|Weill Cornell Medicine|Dr james B Bussel|917-291-5091|jbussel@med.cornell.edu|
21292134|NCT01570387|Boston Medical Center|Vaishali Sanchorawala|617-638-7017|vaishali.sanchorawala@bmc.org|
21292135|NCT01987557|WilfridLU|Matthew Lasswell|9056992087|lass3260@mylaurier.ca|
21292136|NCT03323164|Wills Eye Hospital|Dr. Daniel Lee|12159283197|daniellee@willseye.org|
21292137|NCT00461708|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21292138|NCT02394561|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21292139|NCT05788991|Medinova|Dr. Anahí Hurtado|+41443061396|hurtado.anahi@medinova.ch|
21292140|NCT04712669|Sumitomo Pharma America|Ravi Grewal|+1 (508) 481-6700|ravi.grewal@us.sumitomo-pharma.com|
21292141|NCT04464473|Florida State University|Dr. Derek Nee|8506441963|dnee@fsu.edu|
21292142|NCT01114737|BioMarin Pharmaceutical Inc.|Medical Information Services|1-800-983-4587|medinfo@bmrn.com|
21292143|NCT01123148|University of Michigan|Jane Huggins, PhD|734-936-7177|janeh@umich.edu|
21292144|NCT01693367|AO Foundation|Clinical Operations Manager of Clinical Investigation and Documentation|0041 44 200 24 67|andreas.faeh@aofoundation.org|
21292145|NCT00325143|GlaxoSmithKline|GSK Response Center|866-435-7343||
21292146|NCT02286895|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
21292147|NCT00256126|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21292148|NCT02652221|Cincinnati Children's Hospital Medical Center|Andrew T. Trout, MD|513-803-3004|andrew.trout@cchmc.org|
21292149|NCT04108273|NYU Langone Health|Francisco Castellanos, MD|6467545194|Francisco.Castellanos@nyulangone.org|
21292150|NCT02764996|Mike O'Callaghan Miltary Medical Center|Jill Clark, Senior Research Associate/Research Manager|(702) 653-3298|Jill.M.Clark15.ctr@mail.mil|
21292151|NCT02154061|Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
21292152|NCT00506142|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@appirx.com|
21292153|NCT01103414|Mstabolic Solutions Company. LLC|Dr. Jerry Colca, President & CSO|269.343.6732|jcolca@msdrx.com|
21292154|NCT01936831|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
21292155|NCT00454116|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21292156|NCT03085680|University of Florida|Dr. Robert Mankowski|+1 (352) 294-5055|r.mankowski@ufl.edu|
21292157|NCT02261961|Central Arkansas Veterans Healthcare System|Richard Dennis|501-257-5583|richard.dennis2@va.gov|
21292158|NCT03500211|Oregon Health & Science University|OB/Gyn Regulatory Specialist|503-494-3666|whru@ohsu.edu|
21292159|NCT04460183|Thirty Respiratory Ltd|Alison Bracchi, MSc|+447763882519|alison.bracchi@30.technology|
21292160|NCT01213082|University of California Davis|Susanna Park, MD|9167346074|sscpark@ucdavis.edu|
21292161|NCT03758261|University of Pittsburgh Medical Center|Dr. Charles Luke|4127485589|lukecb@upmc.edu|
21292162|NCT01365793|University of California, Davis (UC Davis Health)|Nathan Kuppermann|916-734-1535|nkuppermann@ucdavis.edu|
21243187|NCT02326649|UCSD|Christopher Davis|8589665855|cdavis@rchsd.org|5668
21292163|NCT01469039|Alkermes, Inc.|ARISTADA Medical Information|866-274-7823||
21292164|NCT03139448|Vanderbilt University Medical Center|Koffi Kla, MD|615-343-9419|koffi.m.kla@vumc.org|
21292165|NCT03398330|Mundipharma(China) Pharmaceutical. Co. Ltd|Rongna. A|86 10 65636885|rongna.a@mundipharma.com.cn|
21292166|NCT03261830|UMissouri|Vicki Jones|573-882-7583|jonesvicki@health.missouri.edu|
21292167|NCT02108288|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Research and Development|+81-3-6361-7366||
21292168|NCT01832727|Amgen, Inc|Study Director|866-572-6436|medinfo@amgen.com|
21292169|NCT01991860|Acacia Pharma Ltd|Dr Gabriel Fox|44-(0)1223-919764|Gabrielfox@acaciapharma.com|
21292170|NCT00501644|UT MD Anderson Cancer Center|Michael E. Garcia, RN, BSN||mgarcia@mdanderson.org|
21292171|NCT02553629|Leiden University Medical Center|Prof. Dr. A. Dahan|+31 71 526 2301|a.dahan@lumc.nl|
21292172|NCT03434834|Duke University|Dr. Adam Wax|919-660-5143|a.wax@duke.edu|
21292173|NCT01306292|Bracco Diagnostics Inc.|Dr. Maria Luigia Storto|609-514-2262|marialuigia.storto@diag.bracco.com|
21292174|NCT01823289|Department of Respiratory Medicine, SHANGHAI First People's Hospital Affiliated to SHANGHAI JiaoTong University|Director of Respiratory Department|86-21-63071428|xzhou53@163.com|
21292175|NCT02797821|Alexion Pharmaceuticals|Alexion Pharmaceuticals|475-230-2596|ClinicalTrials@Alexion.com|
21292176|NCT01812057|Duke University Medical Center|Dr Terrence K Allen|9196682024|terrence.allen@duke.edu|
21243188|NCT02311907|Mayo Clinic|Charles L. Loprinzi M.D.|507/284-1623|cloprinzi@mayo.edu|
21243189|NCT01733238|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21243190|NCT03608839|State University of Campinas (UNICAMP)|Dr Rodrigo Pessoa Cavalcanti Lira|551935217396|alayf@hotmail.com|7396
21243191|NCT03320434|Ora, Inc|Caitlin Pearson|978-685-8900|cpearson@oraclinical.com|
21243192|NCT03506880|The Pennsylvania State University|Dr. Rob Turrisi|814-865-7808|rturrisi@psu.edu|
21243193|NCT02547922|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21279750|NCT05612685|UCLA|Kristen Choi, Associate Professor|3107947493|krchoi@ucla.edu|
21243194|NCT00468052|UMDNJ|Anuradha Patel, MD|973 972-5254|patelan@umdnj.edu|
21243195|NCT00857649|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
21279751|NCT03659929|Azurity Pharmaceuticals, Inc.|Vice President of Clinical Development|1-800-461-7449|david.sequeira@azurity.com|
21279752|NCT04856930|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
21279753|NCT00916643|B. Braun Medical, Inc.|Kevin Minnich|610 596 2358|kevin.minnich@bbraun.com|
21279754|NCT01433055|Maryland Psychiatric Research Center|Deanna L. Kelly, Pharm.D., BCPP|410-402-6861|dkelly@mprc.umaryland.edu|
21279755|NCT04721808|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21279756|NCT01728844|Sunstar Americas, Inc.|Akane Takemura|8477944276|akane.takemura@us.sunstar.com|
21279757|NCT00733005|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21279758|NCT01068548|VANTHCS|Eric Mortensen, MD|214-857-1588|ericm.mortensen@va.gov|
21292177|NCT02148588|Washington University School of Medicine|Simon Haroutounian|3142861715|simon.haroutounian@wustl.edu|314
21292178|NCT01911260|Federal University of Sao Paulo|Ana Paula Poblacion|+55 11 55391783|anapoblacion@yahoo.com.br|
21243196|NCT04707313|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21243197|NCT00940992|Solgel|Ofra Levy-Hacham, Ph.D, VP of Quality Assurance|972-8-9313433|ofra.levy-hacham@sol-gel.com|3802
21243198|NCT04221438|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21243199|NCT05673720|Florida State University|Geraldine Martorella, Hyochol Ahn|850-645-9758|gmartorella@fsu.edu|
21243200|NCT02248480|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21243201|NCT00147277|Medtronic Italia S.p.A.|Laura Manotta|003902241371|laura.manotta@medtronic.com|
21243202|NCT00839540|Michigan State University|Dr. Gary E.Stein, Pharm.D.|517-353-5126|steing@msu.edu|
21243203|NCT01215695|University Louisville|Rainer Lenhardt, MD|502-228-7517|rainer.lenhardt@louisville.edu|
21243204|NCT03360396|Boston Scientific Corporation|Jessica Stockwell|612-618-1136|Jessie.Stockwell@bsci.com|
21243205|NCT00546871|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21243206|NCT01713946|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
21243207|NCT03516942|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21243208|NCT03779048|University of Pennsylvania|Dr. Jena Tronieri|2157465045|jena.tronieri@pennmedicine.upenn.edu|
21243209|NCT01286272|Alliance for Clinical Trials in Oncology|Kristie A. Blum, MD|614-293-8858|kristie.blum@osumc.edu|
21243210|NCT04496960|National Institute of Dental and Craniofacial Research|Dr. Blake Warner|+1 301 500 8063|blake.warner@nih.gov|
21243211|NCT02932410|Actelion Pharmaceuticals Ltd|Executive Medical Director CP|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21243212|NCT00550394|University of Cincinnati|Melissa DelBello, MD, MS|513-558-2989|delbelmp@uc.edu|
21243213|NCT06331403|Massachusetts General Hospital|Lucy Finkelstein-Fox, PhD|617-726-6300|lfinkelsteinfox@mgh.harvard.edu|
21243214|NCT05758415|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21243215|NCT03622593|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21243216|NCT01037530|Hull University Teaching Hospitals NHS Trust|Judith Long|01482 311918|judith.long3@nhs.net|
21243217|NCT01134562|Amgen, Inc|Study Director|866-572-6436||
21243218|NCT00423098|Novartis Pharmaceuticals|Study Director|862-778-8300||
21243219|NCT02284555|Destiny Pharma|Director of Projects|+44 (0)1273 704440|medinfo@destinypharma.com|
21243220|NCT00711958|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com|
21243221|NCT02015546|Duke University Medical Center|Dr. Ashwin Patkar|919-681-0613|ashwin.patkar@duke.edu|
21243222|NCT04424641|Genmab|Clinical Trial Information|+45 7020 2728|clinicaltrials@genmab.com|
21243223|NCT00597038|UCSF Helen Diller Family Comprehensive Cancer Center|Adil Daud, Director, Melanoma Clinical Research|415-353-7392|adaud@medicine.ucsf.edu|
21243224|NCT05855655|Brown University|Shufang Sun|401-863-5735|shufang_sun@brown.edu|
21243225|NCT01426269|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5130|elizabeth.nieman@galderma.com|
21243226|NCT04580160|Vesper Medical|Joseph C. Griffin, III|4848926340|Jgriffin@vespermedical.com|
21243227|NCT03675581|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21243228|NCT02296424|Novartis Pharmaceuticals|Clinical Disclosure Office|+1 (862) 778-8300|Novartis.email@novartis.com|
21243229|NCT00854906|University of Arkansas for Medical Sciences|Richard Harper|501 526-6000|harperricharda@uams.edu|2616
21243230|NCT04147897|University of Washington|Dror Ben-Zeev, Professor|206-685-9655|dbenzeev@uw.edu|
21243231|NCT00114101|Roswell Park Cancer Institute|Philip McCarthy, MD||philip.mccarthy@roswellpark.org|
21243232|NCT00814346|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21243233|NCT03941912|Regulatory Insight, Inc.|Elvira Cawthon|6154475150|elvira@reginsight.com|
21243234|NCT05136443|Cornea Research Foundation of America|Marianne Price|317-814-2990|mprice@cornea.org|
21243235|NCT00326924|Ottawa Hospital Research Institute|Dean Fergusson, Senior Scientist|613-737-8480|dafergusson@ohri.ca|
21243236|NCT00507689|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21243237|NCT01188499|TetraLogic Pharmaceuticals|Vice President, Clinical Research|610-889-9900|Jeffrey.Skolnik@tetralogicpharma.com|141
21243238|NCT01145885|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21243239|NCT05299606|ETHICON|Erin Meyers|937-681-0322|eprifog1@its.jnj.com|
21243240|NCT00596167|Indiana University School of Medicine|Brian Decker MD, PharmD|317-278-2868|bsdecker@iupui.edu|
21243241|NCT02203630|Vanderbilt University Medical Center|Raj Keriwala|615-322-3412||
21243242|NCT03946670|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21243243|NCT00717626|The Hospital for Sick Children|Dr. Brian Feldman|416-813-5828|brian.feldman@sickkids.ca|
21243244|NCT02806869|University of Michigan|Dr. Duxin Sun|734-615-8740|duxins@med.umich.edu|
21243245|NCT01135511|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21292179|NCT01259011|Emory University|Dr. Mi-Kyung Song|404-727-3134|mi-kyung.song@emory.edu|
21243246|NCT04001517|EIP Pharma|Dr. John Alam|6176698426|johnjalam@gmail.com|
21243247|NCT02537522|Johnson & Johnson Vision Care Inc.|Andrea Le, OD -Manager Global Medical Affairs|904 4431866|ale3@ITS.JNJ.com|
21292180|NCT02633735|HealthPartners Institute|Elyse Kharbanda|952-967-5038|elyse.o.kharbanda@healthpartners.com|
21243248|NCT01794936|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
21243249|NCT03920215|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
21243250|NCT05575375|The Miriam Hospital|Emily Gathright|4017938271|emily.gathright@brownhealth.org|
21243251|NCT02425111|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21243252|NCT00585533|Huntsman Cancer Institute/University of Utah|Wallace Akerley, MD|801-585-5986|wallace.akerley@hci.utah.edu|
21243253|NCT02798835|Department of Anesthesia and Perioperative Care, Vancouver General Hospital, Vancouver, BC, Canada.|Dr. Steven Lee|6048754111|steven.lee2@vch.ca|61534
21243254|NCT03024606|Saint Louis University|Research Nurse|314-977-2090|jathompson@slu.edu|
21243255|NCT01576523|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
21243256|NCT01867632|MUHC|Dr. Mirko Gilardino|514.934.1934|Mirko.Gilardino@muhc.mcgill.ca|
21243257|NCT01996917|Columbia University|Christine Rohde, MD|212-342-3707|chr2111@cumc.columbia.edu|
21243258|NCT00739141|Memorial Sloan Kettering Cancer Center|Juliet Barker, MBBS|646-608-3756|barkerj@mskcc.org|
21243259|NCT03482011|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21243260|NCT02709655|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
21243261|NCT00102063|Otsuka Pharmaceutical Development & Commercialization, Inc.|Margaretta Nyilas|609-452-5673|Margaretta.nyilas@otsuka-us.com|
21243262|NCT02498769|Duke University Health System|Dr. Joseph P Mathew Professor of Anesthesiology and Chairman Department of Anesthesiology|919-681-6646|joseph.mathew@duke.edu|
21243263|NCT03687892|Stanford University|Principal Investigator|650-736-2233|nbassano@stanford.edu|
21243264|NCT00630786|Amgen Inc.|Study Director|866-572-6436||
21243265|NCT02031471|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21243266|NCT03070483|Loyola University Chicago|Dr. Holly Kramer|7083279039|hkramer@lumc.edu|
21243267|NCT06269640|National Heart Lung and Blood Institute|Robert Lederman, M.D.|301.402.6769|lederman@nih.gov|
21243268|NCT03172624|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho, MD, PhD|646-888-4235|hoa@mskcc.org|
21243269|NCT03723616|Duke University|Isaac Lipkus Reiner, Ph.D.|919-668-2348|isaac.lipkus@duke.edu|
21243270|NCT03979365|Mayo Clinic|Mark Stegall, M.D.|507-266-4505|stegall.mark@mayo.edu|
21243271|NCT03142841|North Florida South Georgia Veterans Health System|Dr. Ivette Magaly Freytes|352-376-1611|ivette.freytes@va.gov|102012
21243272|NCT06001177|Kanyos Bio, Inc.|Study Director|+1-857-320-6607|clinicaltrials@anokion.com|
21243273|NCT04396860|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
21243274|NCT00799396|University of Maryland School of Medicine|Alan R Shuldiner, MD|410-706-1623|ashuldin@medicine.umaryland.edu|
21243275|NCT03593876|University of Pittsburgh|Dr. Elizabeth Skidmore|(412) 383-6617|skidmore@pitt.edu|
21243276|NCT00432458|Mayo Clinic|Dr. Thomas Witzig||witzig@mayo.edu|
21243277|NCT06119113|Başakşehir Çam Ve Sakura Şehir Hastanesi|Dr.Ayşenur Çalış Özbayram|+905549707052|draysenurcalis@gmail.com|
21243278|NCT05309668|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21243279|NCT02696707|Ottawa Hospital Research Institute|Dr. John Hilton|613-737-7700|jfhilton@toh.ca|70170
21243280|NCT00071799|Celgene Corporation|CL Beach||CLBeach@celgene.com|
21243281|NCT05526248|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21243282|NCT04527549|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21243283|NCT05764161|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21243284|NCT01241435|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21243285|NCT02221219|University of Kentucky|Research Protocol Manager/Clinical/UKHC|(859) 257-1000|hong.huang@uky.edu|
21243286|NCT03460756|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
21243287|NCT04333758|Tan Tock Seng Hospital Pte Ltd|Ms Lim Chien Joo|9035249|Chien_Joo_LIM@ttsh.com.sg|
21243288|NCT00723450|GlaxoSmithKline|GSK Response Center|866-435-7343||
21243289|NCT02459899|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21243290|NCT01118338|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
21243291|NCT02739035|Mayo Clinic|Gabriel Schouten - Clinical Research Coordinator|5072665895|schouten.gabriel@mayo.edu|
21243292|NCT00833365|University of Utah|Dr. Gary Chan|801-587-7508|gary.chan@hsc.utah.edu|
21243293|NCT01591733|Massachusetts General Hospital|Dr. Theodore Hong|617-726-6050|TSHONG1@mgh.harvard.edu|
21243294|NCT03165175|Naval Health Research Center|Suzanne Hurtado|619-553-7806|suzanne.l.hurtado.civ@mail.mil|
21243295|NCT06315907|Pennington Biomedical Research Center|Professor|+1 (225) 763-2585|corby.martin@pbrc.edu|
21243296|NCT05019144|Medical University of South Carolina|Dr. Aaron P. Lesher|843-408-6782|leshera@musc.edu|
21243297|NCT05241691|Orthofix srl|Clinical Program Manager|0456719000|danielacangiano@orthofix.it|
21243298|NCT04177394|Abbott|Melody Dong|4086434617|melody.dong@abbott.com|
21243299|NCT00843882|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21243300|NCT01582269|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21243301|NCT06218251|ABBVIE CALL CENTER|AbbVie|844-663-3742|abbvieclinicaltrials@abbvie.com|
21243302|NCT05076266|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21243303|NCT00997386|University of Arizona Cancer Center|Program Coordinator|52-626-0301|aselegue@email.arizona.edu|
21243304|NCT05797155|Oregon Research Behavioral Intervention Strategies Inc.|Dr. Dana Smith|541-484-2123|danas@ori.org|
21243305|NCT00617201|University of Kentucky|Dr. Sharon Walsh|859-257-2684|sharon.walsh@uky.edu|
21292181|NCT00654732|UT MD Anderson Cancer Center|Dr. Hun Ju Lee, Associate Professor, Lymphoma/Myeloma|713 794-1829|hunlee@mdanderson.org|
21243306|NCT01350804|Novartis|Study Director|862-778-8300||
21243307|NCT04036058|Wm. S. Middleton Memorial VA Hospital|Linda McKinley|608-256-1901|linda.mckinley2@va.gov|
21292182|NCT01951391|UCSD Dermatology Clinical Trials|UCSD Dermatology Clinical Trials Manager|(858)657-8390|dermstudies@ucsd.edu|
21292183|NCT01180127|Columbia University Medical Center, Division of Behavioral Medicine in Psychiatry|Richard Sloan|646-774-8940|rps7@cumc.columbia.edu|
21292184|NCT01133847|University of Texas Health Science Center Houston|Dr. Carolyn Denton|713-500-3891|carolyn.a.denton@uth.tmc.edu|
21235211|NCT03217136|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21292185|NCT04436744|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21292186|NCT01880957|Stony Brook University|Dr. Christine DeLorenzo|(631) 638-1523|Christine.Delorenzo@stonybrookmedicine.edu|
21292187|NCT01378117|EUSOM|Guillermo Umpierrez, MD|4047781665|geumpie@emory.edu|
21292188|NCT01463033|Children's National Medical Center|Dr. Pavel Klein, P.I.|301-704-4925|kleinp@epilepsydc.com|
21292189|NCT01854528|AbbVie|Global Medical Information|800-633-9110||
21292190|NCT03060902|University of Oregon|Maureen Zalewski|541-346-7073|zalewski@uoregon.edu|
21292191|NCT04655157|UPMC Hillman Cancer Center|Barbara M. Stadterman, MPH, MCCR|412-647-5554|stadtermanbm@upmc.edu|
21292192|NCT01419119|Umea University, Umeå, Sweden|Dr Margareta Norberg|+46702618614|margareta.norberg@umu.se|
21292193|NCT03710889|Radius Health, Inc.|Associate Director, Clinical Operations|(617) 551-4000|info@radiuspharm.com|
21292194|NCT01111162|University of Pennsylvania|Pablo Tebas|2153498092|pablo.tebas@uphs.upenn.edu|
21292195|NCT02850978|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21292196|NCT00421148|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21292197|NCT04881760|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21292198|NCT01538199|Massachusetts General Hospital|Dr. Paolo Cassano|617-643-9622|pcassano@mgh.harvard.edu|
21292199|NCT02081586|University of Pittsburgh School of Nursing|Dr. Judith A. Callan PhD, RN|412-383-5321|callanja@pitt.edu|
21292200|NCT01832610|Medtronic|Thomas Vassiliades, MD - VP MCS Clinical/Medical Affairs|+15085321956|thomas.a.vassiliades@medtronic.com|
21292201|NCT03722810|BIHAM, University of Bern|Prof. Michael Harris|+44 1761 241366|michael.harris@biham.unibe.ch|
21292202|NCT03708367|Johnson & Johnson Surgical Vision|Sanjeev Kasthurirangan, PhD|+1 408 5335282|skasthur@ITS.JNJ.com|
21292203|NCT01147302|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21292204|NCT00636181|Stanford Sleep Medicine Center|Clete A. Kushida, MD, PhD|(650) 721-7560|clete@stanford.edu|
21292205|NCT02371356|Kaiser Permanente Division of Research|De-Kun Li, MD, PhD|510.891.3749|De-Kun.Li@kp.org|
21261874|NCT02613572|Scheie Eye Institute; Perelman School of Medicine; University of Pennsylvania|Benjamin J. Kim, MD|215-662-8675|benjamin.kim@uphs.upenn.edu|
21292206|NCT04549454|Loyola Marymount University|Dr. Bradley Trager, Research Scientist|3103385238|bradley.trager@lmu.edu|
21292207|NCT04336826|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
21235212|NCT03192150|Sun Pharma Global FZE|Head, Clinical development|91 2266455645|Clinical.Trials@sparcmail.com|
21235213|NCT01824303|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21235214|NCT01333488|Memorial Healthcare System|Dr Greg Zorman|954 265 1840|csareli@mhs.net|
21235215|NCT01859715|University of Colorado|Andrew A Monte, MD||andrew.monte@ucdenver.edu|
21235216|NCT00086580|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
21235217|NCT01495481|University of Pittsburgh|Dr. Gaurav Arora|412-692-6054|gaurav.arora@chp.edu|
21235218|NCT03296163|mAbxience Research SL|Susana Millan|+34917711500|susana.millan@mabxience.com|
21235219|NCT01000051|MD Anderson Cancer Center|Dr. Popat, Uday / Professor, Stem Cell Transplantation|713-745-3055|upopat@mdanderson.org|
21235220|NCT01271543|Penn State Milton S. Hershey Medical Center|Sonia Vaida|7175318433|svaida@hmc.psu.edu|
21235221|NCT03773757|Indiana University|Dr. Greg Sachs|317-278-5570|sachsg@iu.edu|
21235222|NCT00550836|Mayo Clinic|Steven R. Alberts, M.D.||alberts.steven@mayo.edu|
21235223|NCT00179413|BIDMC|Dr. Nezam Afdhal|617632118|nafdhal@bidmc.harvard.edu|
21235224|NCT01192152|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
21235225|NCT00827372|IndianaU|Kathy Miller, MD|317-944-0920|kathmill@iupui.edu|
21235226|NCT00659646|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
21235227|NCT00158379|Charite Campus Vichow Klinikum|Prof. Dr. Jalid Sehouli|+49 30-450564052|jalid.sehouli@charite.de|
21235228|NCT03843502|University of Florida|Robyn Nelson|3522945563|r.nelson@ufl.edu|
21292208|NCT05437419|Teijin America, Inc.|President|+1 (415) 887-9742|clinical-trials-contact@teijinpo.com|
21292209|NCT05175014|Epicentre|Dr Matthew E Coldiron|+33 1 40 21 55 55|matthew.coldiron@epicentre.msf.org|
21292210|NCT03801993|Seattle Children's Hospital|Dr. Christopher H. Goss M.D., M.Sc.|(206) 987-5725|cgoss@uw.edu|
21292211|NCT05270863|Visus Therapeutics, Inc.|Visus Therapeutics|800-281-4536|trials.info@visustx.com|
21292212|NCT03384875|Cytosorbents|Darlene Lambert-Christie/ Director, Clinical Operations|732.822.3332|DLambert-Christie@cytosorbents.com|
21292213|NCT02735421|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
21292214|NCT02006108|Stanford University, Department of Radiology|Dr. Heike E. Daldrup-Link|650-497-8601|emisquez@stanford.edu|
21292215|NCT01978145|GlaxoSmithKline|GSK Response Center|866-435-7343||
21292216|NCT00322049|U.S. Army Medical Component Armed Forces Research Institute of Medical Services|Wipa Chawachalasai|662-696-2700|wipac@afrims.org|4351
21292217|NCT01250054|CIBA VISION|Joe Rappon, OD, MS, FAAO / Head, Clinical Trial Management|1-678-415-3343|Joseph.Rappon@cibavision.com|
21292218|NCT03372161|Scilex Pharmaceuticals, Inc.|Associate Director Clinical Operations|(650) 386-6709|cambrose@scilexpharma.com|
21292219|NCT00755807|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21292220|NCT00939107|Back and Rehabilitation Center Copenhagen|Tom Petersen|+45 35304974|tom.petersen@suf.kk.dk|
21292221|NCT02094118|Mayo Clinic|Dr. Daryl Kor|507-255-6051|kor.daryl@mayo.edu|
21292222|NCT00427011|Eisai Call Center|Eisai Inc.|888-422-4743||
21292223|NCT02921789|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
21292224|NCT01192126|Bausch & Lomb Incorporated|Dr. Robert Steffen OD|585-338-6399|robert.steffen@bausch.com|
21292225|NCT01248793|Janssen Research & Development|Associate Director, Clinical Research|610-500-3369||
21292226|NCT00517699|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21292227|NCT02332187|University of Kentucky|Gerald Supinski, MD, Professor|859-494-3480|gsupi2@email.uky.edu|
21292228|NCT02580877|Benaroya Research Institute|Carla Greenbaum, MD|1-800-425-8631|cjgreen@benaroyaresearch.org|
21292229|NCT00355030|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21292230|NCT00339040|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
21292231|NCT01462929|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
21243308|NCT01307267|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21243309|NCT04956575|ModernaTX, Inc|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
21243310|NCT01786564|Northwestern University|Kristen Knutson|312-503-1526|kristen.knutson@northwestern.edu|
21243311|NCT03034915|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21243312|NCT02138006|Karolinska Institutet Södersjukhuset|Thomas Nyström|+46704325214|thomas.nystrom@sodersjukhuset.se|
21243313|NCT03861767|UPMC|Matthew D. Neal, MD FACS|412-647-1158|nealm2@upmc.edu|
21243314|NCT00346333|Harvard Medical School|Eliot L. Berson, M.D.|617-573-3600|marilyn_sullivan@meei.harvard.edu|
21243315|NCT00117286|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
21243316|NCT00189202|University of Michigan|Dr. Akinlolu Ojo, Professor of Medicine|734 9364890|aojo@umich.edu|
21243317|NCT03466788|Centre François Baclesse|Jean-Michel Grellard|0231455002|jm.grellard@baclesse.unicancer.fr|
21243318|NCT04446117|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
21243319|NCT03654768|SWOG Statistics and Data Management Center|Leukemia Committe Statistician|2066674623|amoseley@fredhutch.org|
21243320|NCT00588770|ECOG-ACRIN Cancer Reserch Group Statistical Office|Study statistician|6176323012|eatrials@jimmy.harvard.edu|
21243321|NCT04697628|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21243322|NCT02819752|The Royal Marsden NHS Foundation Trust|PEACH Senior Trial Manager|(+44) 02089156666|peach.trial@rmh.nhs.uk|
21243323|NCT03388632|National Cancer Institute|Dr. Jiran Ahmed|240-781-4042|jibran.ahmed@nih.gov|
21243324|NCT04108208|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21243325|NCT02115282|ECOG-ACRIN Cancer Research Group|Study Statistician|6176323012|eatrials@jimmy.harvard.edu|
21243326|NCT02950896|Washington University School of Medicine|Heather McKenzie|3142862628|heather.mckenzie@wustl.edu|
21243327|NCT04795752|Sight Sciences, Inc|VP, Medical and Clinical Affairs|1-877-266-1144|jdickerson@sightsciences.com|
21243328|NCT06129045|Black Hills State University|Ashley Pfeiffer|6053815370|ashley.pfeiffer@bhsu.edu|
21243329|NCT05455476|VA Center of Excellence for Suicide Prevention|Lisham Ashrafioun|585-430-2026|Lisham.ashrafioun@va.gov|
21243330|NCT00800605|Alachua Government Services, Inc.|Angie Kimbler|386-418-8751|angie.kimbler@resilience.com|
21243331|NCT03617263|Zydus Therapeutics Inc.|Dr Deven Parmar|7324050886|dparmar@zydustherapeutics.com|
21243332|NCT03492177|Actelion Pharmaceuticals Ltd|Clinical Scientist|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21243333|NCT04789330|University of California, San Francisco|Matthieu LEGRAND MD, PhD|415-885-7388|matthieu.legrand@ucsf.edu|
21243334|NCT05959655|Bright Uro|Brittany Carter|9492025689|brittany@brighturo.com|
21243335|NCT05555082|University of Linkoping, Department of Health, Medicine and Care|Peter Johansson|460700896548|peter.b.johansson@liu.se|
21243336|NCT05314634|National Taiwan Normal University|Ruei-Hong Li|+886988163220|rueihongli@gmail.com|
21243337|NCT02320123|UT Southwestern Medical Center|Dr. Ramona Rhodes|214-648-9012|ramona.rhodes@utsouthwestern.edu|
21243338|NCT03573518|Botanix Pharmaceuticals|Head of Development|+1 445 300 3403|trials@botanixpharma.com|
21243339|NCT01765543|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21243340|NCT03718767|National Cancer Institute|Dr. Jing Wu|240-760-6036|jing.wu3@nih.gov|
21292232|NCT02499887|UBMD Emergency Medicine|Heather Lindstrom|716-898-4564|hlindstrom@ecmc.edu|
21292233|NCT02808897|Montreal Heart Institute|Philippe Demers|5143763330|philippe.demers@icm-mhi.org|
21292234|NCT00030147|National Institute of Mental Health|Schmidt, Peter|+1 301 496 6120|peterschmidt@mail.nih.gov|
21292235|NCT02217618|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21292236|NCT02133573|Children's Hospital of Philadelphia|Dr. J. William Gaynor|215-590-5806|gaynor@chop.edu|
21292237|NCT02213250|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|(001)8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21292238|NCT00099021|Masonic Cancer Center, University of Minnesota|Frank G. Ondrey, M.D.|612-625-3200|ondre002@umn.edu|
21292239|NCT02808429|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21292240|NCT03500289|Johns Hopkins University|Dr. Bardia Nourbakhsh|4106141522|bnourba1@jhmi.edu|
21292241|NCT02609425|Henry Ford Health System|Sarah Meehan|313-916-9387|smeehan1@hfhs.org|
21292242|NCT01788943|University of Pennsylvania|Jacob Dubroff,M.D., Ph.D., Assistant Professor of Radiology|215-662-3041|jacob.dubroff@uphs.upenn.edu|
21292243|NCT01976871|Massachusetts General Hospital|Dr. John W. Winkelman|617-643-9101|jwwinkelman@partners.org|
21292244|NCT01580410|Wake Forest University Health Sciences|Dr. Edward Levine|336-716-2763|elevine@wakehealth.edu|
21292245|NCT02347605|University of Minnesota|Michael Kotlyar|612-251-8780|kotly001@umn.edu|
21235229|NCT02348489|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
21235230|NCT02866682|University of California, Los Angeles (UCLA)|Dr. Suphamai Bunnapradist|310-794-8516|bunnapradist@mednet.ucla.edu|
21243341|NCT01241292|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21243342|NCT03145480|Northwell Health|Jacqueline Barrientos, MD|516-470-4050|jbarrientos@northwell.edu|
21243343|NCT01190007|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21292246|NCT04031729|Massachusetts General Hospital|Dr. Tracey Simon|617-724-2401|tgsimon@partners.org|
21292247|NCT01567722|AMC Statistical Center|Madhu Mazumdar|(212) 659-9558|madhu.mazumdar@mountsinai.org|
21235231|NCT00201006|University of Florida|Michael G. Perri, PhD|352 273-6214|mperri@ufl.edu|
21235232|NCT02837744|Axio Biosolutions Pvt. Ltd.|Shailee Mehta, Clinical Research Manager|9879009940|shailee.m@axiobio.com|
21235233|NCT01750268|San Francisco VA Health Care System/University of California, San Francisco|Steven L. Batki, MD|415-221-4810|steven.batki@ucsf.edu|23671
21235234|NCT00509197|Hôpital du Sacré-Coeur de Montréal|Dr Catherine Lemiere|514 338 2796|catherine.lemiere@umontreal.ca|
21235235|NCT03738904|Cedars-Sinai Medical Center|Dr. Karen Zaghiyan|310-289-9224|karen.zaghiyan@cshs.org|
21235236|NCT02086591|University of Rochester|Carla Casulo|585-273-3258|carla_casulo@urmc.rochester.edu|
21235237|NCT01529645|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
21235238|NCT01326780|Valeant|Johnson Varughese|908 927-1162|johnson.varughese@bauschhealth.com|
21235239|NCT00274716|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21235240|NCT04193202|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21235241|NCT00723801|Brigham and Women's Hospital|Mark Creager|617-732-5267|mcreager@partners.org|
21235242|NCT02167035|Cornerstone Healthcare|Michael Tepedino, MD|336-802-2255|mtepedino@wakehealth.edu|
21235243|NCT02148003|Cleveland Clinic|Nagy Mekhail, MD|216 444-9114|mekhain@ccf.org|
21235244|NCT02489981|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21235245|NCT01174030|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
21235246|NCT05022810|HALEON|Marc Renard|+44 7880 182593|marc.m.renard@haleon.com|
21235247|NCT01565993|Hospital Universitario Severo Ochoa|Dra Elvira Quintanilla|34 914818000|elviramquintanilla@hotmail.com|8326
21235248|NCT02732847|Memorial University|Reza Tabrizchi|706-864-3381|rtabrizc@mun.ca|
21235249|NCT02370888|Univeristy of Florida Health Cancer Center|Archana Narasanna, Project Manager|(352) 273-6772|PMO@cancer.ufl.edu|
21235250|NCT01034397|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21235251|NCT04574362|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21235252|NCT01785524|Victoria University|Jason D. Allen, PhD|61 3 9919 4264|jason.allen@vu.edu.au|
21235253|NCT02104557|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21235254|NCT02579616|Eisai Co.,Ltd.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
21235255|NCT02178475|Amgen Inc.|Study Director|866-572-6436||
21235256|NCT01430585|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21235257|NCT00482391|Memorial Sloan Kettering Cancer Center|Dr. Chau Dang|914-367-7181|dangc@mskcc.org|
21235258|NCT01448850|MedImmune, LLC.|Rene van der Merwe, MBChB/Senior Director, Clinical Development|301-398-0000|vandermerwer@medimmune.com|
21235259|NCT00779766|GlaxoSmithKline|GSK Response Center|866-435-7343||
21235260|NCT03054909|University of Minnesota, Masonic Cancer Center|Dr. Melissa Geller|+1 612-626-3111|gelle005@umn.edu|
21235261|NCT01132144|University of Sao Paulo|Dr. Wellington P Martins|55162231|wpmartins@gmail.com|
21235262|NCT01412424|Cedars-Sinai Medical Center|Shlomo Melmed, MD|310 423-4691|melmed@csmc.edu|
21235263|NCT01274637|Ottawa Hospital Research Institute|Dr. Marc Rodger|6137388899|mrodger@ohri.ca|
21235264|NCT02722668|University of Minnesota, Masonic Cancer Center|Dr. Margaret MacMillan|612-626-2961|macmi002@umn.edu|
21235265|NCT05421078|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
21235266|NCT03296696|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21235267|NCT04694131|National Institutes of Health|Dr. Eric Wassermann|301-496-0151|wassermanne@nih.gov|
21235268|NCT00261716|VAGLAHS at West Los Angeles|Shirley M. Glynn. Ph.D.|310-268-3939|sglynn@ucla.edu|
21235269|NCT00128180|UNewMexico|Gregory Mertz, MD|5059808601|gmertz@salud.unm.edu|
21235270|NCT02047110|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21235271|NCT00705575|Novartis Pharmaceuticals|Study Director|862 778-8300||
21243344|NCT03193619|Becton, Dickinson, and Company|Anna Lovas|952-239-0548|anna.lovas@bd.com|
21243345|NCT01254019|GlaxoSmithKline|GSK Response Center|866-435-7343||
21243346|NCT03963583|Johns Hopkins University School of Nursing|Martha Abshire Saylor|4433406201|mabshir1@jhu.edu|
21279759|NCT02185339|Department of Anesthesiology and Pain Medicine, The Catholic University of Korea College of Medicine, Seoul St. Mary's Hospital|Dr. Sanghyun Hong|82-2-2258-2236|shhong7272@gmail.com|
21279760|NCT00599248|TissueGene, Inc|R. Ogden Copeland|(301) 921-6000|ocopeland@tissuegene.com|122
21279761|NCT01216735|University of Miami|Adam Wanner, MD|(305) 243-2568|awanner@med.miami.edu|
21279762|NCT01009814|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21279763|NCT02923232|Pacific University|Dr. Shun-nan Yang|5033522852|shunnan.yang@pacificu.edu|
21279764|NCT01977417|University of Iowa|Gary Pierce, PhD|319-335-9487|gary-pierce@uiowa.edu|
21279765|NCT01145508|ECOG Statistical Office|Study Statistician|617-632-3012||
21279766|NCT03055624|UCSD|Andrew Picel MD|619-543-3436|apicel@stanford.edu|
21279767|NCT01495702|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21279768|NCT04152863|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21279769|NCT00919126|University Hospital Schleswig-Holstein|Prof. Dr. Med Berthold BEIN|+49(0)431-5973 739|bein@anasthesie.uni-kiel.de|
21279770|NCT01644617|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21279771|NCT00719615|University of Nebraska Medical Center|Whitney S Goldner, MD|402-559-6205|wgoldner@unmc.edu|
21279772|NCT01524978|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21279773|NCT02995408|Massachusetts General Hospital|Karen Kuhlthau, PhD Researcher|6177242842|kkuhlthau@partners.org|
21279774|NCT05560386|Icahn School of Medicine at Mount Sinai|Nita Vangeepuram|917-478-2106|nita.vangeepuram@mssm.edu|
21279775|NCT02540083|GE Healthcare|Sara Lam|1-262-548-2369|Sara.J.Lam@ge.com|
21279776|NCT00185588|Stanford University|George Albert Fisher, Associate Professor of Medicine, Stanford University|650-725-9057|georgeaf@stanford.edu|
21279777|NCT02604407|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21279778|NCT00398866|Hospital for Special Surgery|Dr. Lisa Mandl|2127742754|MandlL@hss.edu|
21279779|NCT02268877|Denver Health and Hospital Authority|Dr. John Kendall|(303)602-5187|John.Kendall@dhha.org|
21279780|NCT02481869|University of Missouri|Dr. James Cook|5738827615|cookjl@health.missouri.edu|
21279781|NCT02779166|Northwestern Univeristy Department of Orthopaedic Surgery|Dr. Michael Terry|312-926-4444||
21279782|NCT02292940|Northern California Kaiser Permanente, Division of Research|Mary Reed, DrPH|510-891-3808|Mary.E.Reed@kp.org|
21279783|NCT05445492|Analog Devices, Inc.|Emily Wycallis|9784351644|emily.wycallis@analog.com|
21279784|NCT03474874|NeXtGen Biologics Inc|Dayna Healy|352-215-9961|Dhealy@nextgenbiologics.com|
21279785|NCT04289363|NYU Langone Health|Ryan McCormack|2122632862|Ryan.McCormack@nyulangone.org|
21279786|NCT03277066|Noven Pharmaceuticals, Inc.|Gunnar Klauss, MD|1-551-233-2656|gklauss@noven.com|
21279787|NCT03790657|Malcom Randall VA Medical Center|David Clark|3523761611|david.clark1@va.gov|105244
21279788|NCT03126435|SynCore Biotechnology Co., Ltd.|Albert Lin, Ph.D./Special Assistant to GM|+886-2-2760-3688|JWLin@syncorebio.com|2308
21279789|NCT01807065|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
21279790|NCT03450473|Washington University School of Medicine in St. Louis|Dr. Grant Bochicchio|314-362-9347|gbochicchio@wustl.edu|
21279791|NCT01937871|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21279792|NCT01699815|Duke University School of Nursing|Virginia C. Muckler|919-684-9307|chris.muckler@duke.edu|
21279793|NCT00810511|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
21279794|NCT02652949|Medtronic|Rianna Rapson - Clinical Study Manager|763-526-2170|rianna.k.rapson@medtronic.com|
21279795|NCT00911300|GlaxoSmithKline|GSK Response Center|866-435-7343||
21235272|NCT00354224|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
21235273|NCT02170727|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21235274|NCT00821626|Infectious Disease Service, and Travel Clinic, University Hospital of Lausanne, Switzerland|Dr Serge de Vallière|+41 79 556 43 12|serge.de-valliere@unisante.ch|
21235275|NCT01959581|University of Delaware|Michele A. Lobo|302-831-8526|malobo@udel.edu|
21235276|NCT00057746|NRG Onoclogy|Wendy Seiferheld||seiferheldw@nrg.oncology.org|
21235277|NCT00395044|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
21235278|NCT04378933|Mayo Clinic|R. Robert Auger, M.D.|507-266-1066|Auger.Raymond1@mayo.edu|
21235279|NCT01660412|UAMS|James A Ntambi|5015265062|jantambi@uams.edu|
21235280|NCT03551210|R-Pharm|Aleksandr Chernavin, Regional Medical Director|0074959567937|chernavin@rpharm.ru|
21235281|NCT03265119|Aevi Genomic Medicine|Garry A. Neil, MD|610-254-4208|garry.neil@aevigenomics.com|
21235282|NCT04953442|Baylor College of Medicine|Erica Soltero, PhD|4029100832|soltero@bcm.edu|
21235283|NCT02139644|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21235284|NCT04011475|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21235285|NCT01010984|University of Louisville|Robert Martin, MD, PhD|502-629-3355|robert.martin@louisville.edu|
21235286|NCT00600821|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21235287|NCT02192684|Stanford Universtiy|Dr. Gerald Reaven|650-724-3416|greaven@stanford.edu|
21235288|NCT02602288|Temple University|Dr. Stephen Lepore|215-204-9422|slepore@temple.edu|
21235289|NCT03189914|Rexahn|Doug Swirsky/ Chief Executive Officer|12402685300|swirskyd@rexahn.com|
21235290|NCT01621373|UZ Leuven, NICU|Liesbeth Thewissen, MD, PhD|003216343211|liesbeth.thewissen@uzleuven.be|
21292248|NCT02259114|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21292249|NCT03937479|Verona Pharma Plc|Nancy Herje|+1 646-951-0961|nancy.herje@veronapharma.com|
21243347|NCT00792948|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|(206) 667-4623||
21243348|NCT04345913|Washington University in St. Louis School of Medicine|Nusayba Bagegni|3142733022|nbagegni@wustl.edu|
21243349|NCT00762619|Colgate Palmolive Co.|William De Vizio|732-878-7901|William_Devizio@colpal.com|
21243350|NCT01390402|University of Texas (UT) MD Anderson Cancer Center|Richard E. Champlin, MD/Chair, Stem Cell Transplantation||CR_Study_Registration@mdanderson.org|
21243351|NCT02445391|ECOG-ACRIN Cancer Research Group|Study Statistician|16176323012|eatrials@jimmy.harvard.edu|
21243352|NCT02611037|Moffit Cancer Center|Bela Kis, MD, PhD|813-745-8425|Bela.Kis@Moffitt.org|
21243353|NCT05850520|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21243354|NCT03889925|Andrews Research & Education Foundation|Director of Research|8509168570|jessica.truett@andrewsref.org|
21243355|NCT02188420|University of Minnesota|Kate Frost|612-626-0637||
21243356|NCT03215095|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho, MD, PhD|646-608-3774|hoa@mskcc.org|
21292250|NCT02578901|University of Washington|Dr. Susanne May|206-685-1302|sjmay@uw.edu|
21292251|NCT00940602|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21292252|NCT00740181|Brown Univeristy Oncology Research Group|James Butera|401-863-3000|Kayla_Rosati@brown.edu|
21292253|NCT02961244|Dokuz Eylul University Medicine Faculty, General Surgery Department|Ali Kadir Degirmenci|+902324122901|alikadir@hotmail.com|
21292254|NCT02951780|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21292255|NCT01957865|Massachusetts General Hospital|Jessica Haberer|617 724 0351|jhaberer@partners.org|
21292256|NCT01082614|Loma Linda University|Tonya Hamilton|909-558-9408|thamilton@llu.edu|
21292257|NCT00811720|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
21292258|NCT03783780|Masimo|Tala Harake|1-949-297-7100|studies@masimo.com|
21292259|NCT03768427|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21292260|NCT01937520|Rutgers, The State University of New Jersey|Dennis Grech, MD|973 972-5007|grechde@njms.rutgers.edu|
21292261|NCT02742129|Duke Clinical Research Institute|Adrian Hernandez|919-668-7515|Adrian.Hernandez@duke.edu|
21292262|NCT02874092|NYU Langone|Dr. Jeffrey Berger|212-263-0855|Jeffrey.Berger@nyulangone.org|
21292263|NCT00928772|VAMC|Grigory Chernyak, MD|405-326-1885|grigory.chernyak@va.gov|
21292264|NCT04540367|Houston Methodist Hospital|Bradley Lambert|8326872483|bslambert@houstonmethodist.org|
21292265|NCT00606489|Cumberland Pharmaceuticals|Amy Rock, Doctor of Philosophy (Ph.D.)|6152550068|arock@cumberlandpharma.com|
21292266|NCT01563055|GlaxoSmithKline|GSK Response Center|866-435-7343||
21292267|NCT00165789|Eisai Call Center|Eisai Inc.|888-422-4743||
21292268|NCT02031302|Boston Scientific Corp.|Blessie Concepcion, Director Clinical Trials|408-385-8604|Blessie.Concepcion@bsci.com|
21292269|NCT01816984|University of Chicago Medicine and Biological Sciences|Dr Everett Vokes, MD|855-702-8222|evokes@medicine.bsd.uchicago.edu|
21292270|NCT05899829|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21292271|NCT02121509|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21292272|NCT01061528|University of Texas at Austin|Dr. Richard A. Brown|512-471-8584|brown2@utexas.edu|
21292273|NCT03820011|Board of Trustees at University of Illinois|Dr. Mary Khetani, Associate Professor|312-996-0942|mkhetani@uic.edu|
21292274|NCT00867035|Department of Orofacial Sciences, University of California, San Francisco|Milton Robert Wirthlin, DDS, MS|415-476-1731|m.robert.wirthlin@ucsf.edu; ddsmmr@att.net|
21292275|NCT05076045|Baycrest Academy for Research & Education|Claude Alain|416-785-2500|calain@research.baycrest.org|3523
21292276|NCT01143636|Spaulding Rehabilitation Hospital, Boston, MA.|Dr. Felipe Fregni, Director of the Laboratory of Neuromodulation|617.952.6153|info@neuromodulationlab.org|
21292277|NCT02993263|Cleveland Clinic|Daniel Sessler, MD|216-444-9400|sesslers@ccf.org|
21292278|NCT01347060|GlaxoSmithKline|GSK Response Center|866-435-7343||
21292279|NCT04704193|Massachusetts General Hospital|Daniel Chung, MD|617-726-8687|chung.daniel@mgh.harvard.edu|
21292280|NCT00542178|Wake Forest University School of Medicine|Dr. Walter Ambrosius, PhD|336-716-6281|wambrosi@wakehealth.edu|
21243357|NCT00925899|Bispebjerg Hospital|Lise Pedersen|004535312305|lise.pedersen.01@regionh.dk|
21243358|NCT03648762|VA Pittsburgh Healthcare System|Daniel E. Forman, MD|(412) 360-2917|Daniel.Forman@va.gov|
21243359|NCT02135679|University of Pennsylvania|Ching Lai|267-250-9244|ching.lai@pennmedicine.upenn.edu|
21243360|NCT04480827|Galmed Pharmaceuticals|Dr. Yossi Gilgun-Sherki|972.3.693.8448|yossigs@galmedpharma.com|
21243361|NCT00773370|VA Medical Center, Baltimore Maryland|Mary Stuart, ScD, VA Research Investigator|410-455-2084|stuart@umbc.edu|
21243362|NCT01582100|Northwestern University|Christine Ebert Nelson|3126954513|c-ebert@northwestern.edu|
21243363|NCT00360698|sanofi-aventis|Medical Affairs study director||publicregistryGMA@sanofi-aventis.com|
21243364|NCT01755949|Mayo Clinic|Joseph L. Blackshear, Principal Investigator|904-953-7279|blackshear.joseph@mayo.edu|
21243365|NCT03401112|Imara Inc.|Imara Clinical Operations|617-206-2020|info@imaratx.com|
21243366|NCT01264679|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
21243367|NCT03475316|Albert Einstein College of Medicine|Dr. Joe Verghese|718-430-3877|joe.verghese@einsteinmed.org|
21243368|NCT00424645|UT MD Anderson Cancer Center|Saroj Vadhan, MD||CR_Study_Registration@mdanderson.org|
21243369|NCT01595061|NRG Oncology|Linda Gedeon for Wei Deng|716-845-1169|linda.gedeon@roswellpark.org|
21243370|NCT03189589|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21243371|NCT03194958|Washington University in St. Louis|Matthew Kreuter|314-935-3701|mkreuter@wustl.edu|
21243372|NCT02348658|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21243373|NCT01179334|Bayer|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21243374|NCT00256243|Chao Family Comprehensive Cancer Center|Dr. Rita Mehta|(714) 456-5153|rsmehta@uci.edu|
21243375|NCT01152190|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21243376|NCT01335542|Hospital for Special Surgery|Dr. Jacques YaDeau|2127742224|yadeauj@hss.edu|
21243377|NCT01595321|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Daniel Laheru, MD|410-955-8974|Laherda@jhmi.edu|
21243378|NCT00834834|NYSPI|Barbara Stanley, Ph.D.|6467747582|stanley@nyspi.columbia.edu|
21243379|NCT00373529|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
21243380|NCT00748410|GlaxoSmithKline|GSK Response Center|866-435-7343||
21243381|NCT01585558|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
21243382|NCT04970342|National Advanced Driving Simulator, University of Iowa|Timothy Brown, Ph.D.|3193354785|timothy-l-brown@uiowa.edu|
21243383|NCT02601170|Tri-service general hospital|Dr. Tsung-Ying Li|886-2-87927166|doc31141@gmail.com|
21243384|NCT02763124|Gainesville Eye Associates|Clayton Blehm, MD|7705324444|claytonblehm@gmail.com|
21243385|NCT01123928|Zhongshan Ophthalmic Center|Dr. Nathan Congdon|13925056342|ncongdon1@gmail.com|
21243386|NCT04178941|Children's Hospital of Philadelphia|Chris Bonafide, MD, MSCE|267-426-2901|bonafide@chop.edu|
21292281|NCT00829998|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21292282|NCT02026011|University of California, Los Angeles|Lara Ray|310-794-5383|lararay@psych.ucla.edu|
21292283|NCT05010070|University of Michigan|Laura Saslow, Associate Professor|(734) 764-7836|saslowl@umich.edu|
21292284|NCT00628498|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency|(215) 832-3750||
21292285|NCT00529243|Kaiser Permanente|William Towner, MD|323-783-7855|William.J.Towner@KP.org|
21292286|NCT01783444|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21292287|NCT02896257|VA Puget Sound Health Care System|Dr. David Au|206-764-2504|David.Au@va.gov|
21292288|NCT03793621|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21292289|NCT03759600|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21292290|NCT03257358|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21292291|NCT01669902|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21292292|NCT02903823|Vanderbilt University Medical Center|Peter Konrad, MD PhD - PI|6153439822|peter.konrad@vumc.org|
21292293|NCT02852967|Kadmon Corporation, LLC|Olivier Schueller, Senior Vice President, CMC & Clinical Pharmacology|724-778-6170|olivier.schueller@kadmon.com|
21292294|NCT03886948|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21292295|NCT00887159|ECOG-ACRIN Statistical Office|Study statistician|617-632-6012||
21292296|NCT00688467|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21292297|NCT00690794|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
21292298|NCT03848416|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21292299|NCT00856609|National Institutes of Health|Dr. Jonathan Krakoff|602-200-5217|jkrakoff@mail.nih.gov|
21292300|NCT00783432|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2351|wwheeler@medapharma.us|
21292301|NCT01436110|GlaxoSmithKline|GSK Response Center|866-435-7343||
21292302|NCT03273907|Alcon Research, LLC|CDMA Clinical Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21292303|NCT01088503|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21292304|NCT00110214|Thomas Jefferson University|William Kevin Kelly, DO||wm.kevin.kelly@jefferson.edu|
21292305|NCT01847092|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
21243387|NCT01810263|Seoul National University Bundang Hospital|Nam-Jong Paik|82-031-787-7731|njpaik@snu.ac.kr|
21243388|NCT00026312|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21243389|NCT02322840|Medtronic|Yetunde Ishola (Clinical Study Manager)|734-221-8182|yetunde.a.ishola@medtronic.com|
21243390|NCT05672030|Brigham and Women's Hospital, Allergy and Clinical Immunology|Tanya M. Laidlaw, MD, Associate Professor of Medicine|6177329850|tlaidlaw@partners.org|
21243391|NCT05793112|Massachusetts General Hospital|Dr. Qian Yuan|6172435466|QYUAN@mgh.harvard.edu|
21243392|NCT05841680|Florida International University|Jeremy Pettit|3053481671|jpettit@fiu.edu|
21243393|NCT03602911|West Virginia University|Rusha Patel, MD|4052717559|Rusha-Patel@ouhsc.edu|
21243394|NCT02098343|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
21243395|NCT05515562|Wake Forest University Health Sciences|John Williamson, PharmD|336.713.3431|johnwill@wakehealth.edu|
21243396|NCT02582593|University of Florida|Dawn Bowers, Ph.D.|(352) 273-6617|dawnbowers@phhp.ufl.edu|
21243397|NCT03785782|University of North Carolina at Chapel Hill|Director, Clinical Research, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
21243398|NCT05777785|VIZO Specs|Yael Richter, PhD|972-54-7384809|yaelr@vizo-o.com|
21243399|NCT05644444|Reckitt Benckiser Health Limited|Clinical Study Manager|+44 (0)1482 326151|ClinicalRequests@reckitt.com|
21243400|NCT00493649|US Oncology Research, McKesson Specialty Health|Dr. Stephen E Jones|832-381-7580|steve.jones@usoncology.com|
21243401|NCT02639286|NIDDK|Dr. Rebecca Brown|301-594-0609|rebecca.brown@nih.gov|
21243402|NCT00227994|Washington University School of Medicine|Eric Lenze|314-362-1671|lenzee@wustl.edu|
21243403|NCT01823536|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21243404|NCT00768664|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21243405|NCT02544152|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
21243406|NCT00465816|GlaxoSmithKline|GSK Response Center|866-435-7343||
21243407|NCT02139046|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21261875|NCT02342561|The Orthopaedic Research Unit, Department of Orthopaedic Surgery and Trauma, Odense University Hospital, Denmark|Nikolaj Milandt, Undergraduate researcher|26616611|nikolaj.rongsted.milandt@rsyd.dk|0045
21261876|NCT00231478|Hoffman-LaRoche|Medical Communications|800-821-8590||
21279796|NCT00699816|Seoul National University College of Medicine|Jung-Hwan Yoon, MD, PhD|+82-2-2072-2228|yoonjh@snu.ac.kr|
21279797|NCT01895777|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|8002430127|clintriage.rdg@boehringer-ingelheim.com|
21279798|NCT00717288|The Ohio State University|Kathleen Dungan, MD|614-292-3800|kathleen.dungan@osumc.edu|
21279799|NCT02508935|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
21279800|NCT03203681|University of Miami|Dr. Ranjith Ramasamy|3052433670|ramasamy@miami.edu|
21279801|NCT03901092|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
21279802|NCT04223752|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21279803|NCT04759703|Massachusetts General Hospital|John W. Winkelman, MD, PhD|6176436026|JWWINKELMAN@MGH.HARVARD.EDU|
21279804|NCT03617458|Vanderbilt University Medical Center|Research Programs Manager|615-322-4703|ph_research@vumc.org|
21292306|NCT03623698|Imperial College London|Mrs. Natalia Galaz Souza|07751842851|natalia.galaz-souza16@imperial.ac.uk|
21243408|NCT02207972|Mount Sinai West|Dr Barbara Orlando MD and PI|2125236915|barbara.orlando@mountsinai.org|
21243409|NCT00818454|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21243410|NCT03454529|Karmanos Cancer Institute|Michael Simon,MD|313. 576-8727|simonm@karmanos.org|
21243411|NCT00779870|Imperial College London|Prof Fan Chung|00442075947954|f.chung@imperial.ac.uk|
21243412|NCT01402531|UCSD|Department of Surgery|(858) 657-5291||
21243413|NCT01040689|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21243414|NCT02334436|Evolus, Inc|Rui L. Avelar, MD|(805)689-8668|rui@evolusinc.com|
21243415|NCT01924975|University of Iowa Hopspital & Clinics|Satoshi Hanada/Clinical Assistant Professor|3193561219|satoshi-hanada@uiowa.edu|
21243416|NCT04483856|Relife Srl|Clinical Trials Coordinator|05556809528|lfabbri@relifecompany.it|
21243417|NCT00494442|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
21243418|NCT00604019|RUSH University Medical Center|Gourang Patel, PharmD|312-942-4258|gourang_p_patel@rush.edu|
21261877|NCT00853905|Wills Eye Hospital Glaucoma Research Center|Marlene Moster MD|215-825-4713|jmolineaux@willseye.org|
21279805|NCT01406444|Massachusetts General Hospital|Dr. Karen Klahr Miller|6177263870|kkmiller@mgh.harvard.org|
21279806|NCT02800642|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21279807|NCT01669603|University of Virginia|Ronald Turner||rbt2n@virginia.edu|
21261878|NCT04538950|Mayo Clinic|John P. Bois, M.D.|507 284-4072|Bois.John@mayo.edu|
21261879|NCT00847561|The Johns Hopkins University School of Medicine|Dr. Golda Ginsburg|410-955-1544|gginsbu@jhmi.edu|
21261880|NCT02312986|Washington University in St. Louis|Kimberly Reske, MPH, Research Coordinator|314-747-4041|kreske@wustl.edu|
21261881|NCT00393458|Novartis Pharmaceuticals|Study Director|862 778-8300||
21261882|NCT02509546|City of Hope Medical Center|Dr. Vinod Pullarkat, MD|626-359-8111|vpullarkat@coh.org|
21261883|NCT01535937|NYSPI|Elias Dakwar, MD|646.774.8728|elias.dakwar@nyspi.columbia.edu|
21261884|NCT03165981|Duke University|Dr. Emmanuel B. Walter|919-620-5346|chip.walter@duke.edu|
21261885|NCT01783522|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Beth Faiman|216-444-3705|faimanb@ccf.org|
21261886|NCT02100657|Pharma Mar S.A.|Pharma Mar S.A.|00 34 91846 60 00|clinicaltrials@pharmamar.com|
21261887|NCT00403117|New York State Psychiatric Institute|Margaret Haney, PhD|646-774-6153|mh235@cumc.columbia.edu|
21261888|NCT01543490|Sun Pharma Advanced Research Company Limited|Head-Clinical Development|912266455645|clinical.trials@sparcmail.com|
21261889|NCT04168645|Hartford Hospital|David Tolin|860-545-7685|david.tolin@hhchealth.org|
21261890|NCT01383200|Bascom Palmer Eye Institute|Dr. Sonia Yoo|305-243-2020|syoo@med.miami.edu|
21261891|NCT03692910|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21261892|NCT00151411|Penn State Hershey|Sandy Eyer|717-531-1540|seyer@hmc.psu.edu|
21261893|NCT01283581|Melinta Therapeutics|Dr. Sue Cammarata|312-724-9401|scammarata@melinta.com|
21261894|NCT01259492|Novartis Pharmaceuticals|Study Director|8627788300||
21261895|NCT00089843|Massachusetts General Hospital|Anne Klibanski, M.D.|617-726-3870|aklibanski@partners.org|
21261896|NCT03846947|UNC Chapel Hill|Director, Clinical Research, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
21261897|NCT03060577|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21261898|NCT02889510|Dynamic Science S.L|Anna Royo|+34680603119|a.royo@dynasolutions.com|
21261899|NCT02584634|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21261900|NCT04243369|Philips|T.J. Battisti|(425) 205-3515|t.j.battisti@philips.com|
21261901|NCT01295905|Alcon Research|Director of Alcon Clinical, Atlanta|1-800-241-7629||
21261902|NCT03069690|University of Pittsburgh Medical Center|Dr. Michele Levine|(412) 647-0703|levinem@upmc.edu|
21261903|NCT02564120|The University of North Carolina at Chapel Hill|Dr. Ronald Chen|984-974-0400|ronald_chen@med.unc.edu|
21261904|NCT01629667|MedImmune, LLC|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21261905|NCT00891657|Integra LifeSciences|Director, Medical Affairs|609-275-0500||
21261906|NCT00577590|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
21261907|NCT03455543|Regenesis Biomedical|Heather Vander Ploeg|602-428-7041|heather.vanderploeg@regenesisbio.com|
21261908|NCT00066781|Mayo Clinic|Matthew Goetz, M.D.|(507) 284-2511|goetz.matthew@mayo.edu|
21261909|NCT02648230|Columbia University|Ajay Kirtane, MD, SM|212-305-7060|akirtane@columbia.edu|
21261910|NCT00909090|University of Georgia|Dr. Billy Hammond, Principal Investigator|(706) 54204812|bhammond@uga.edu|
21261911|NCT02004990|University of Minnesota|Robert S. Jones DDS PhD|612-626-2900|rsjones@umn.edu|
21261912|NCT02926573|Washington University School of Medicine|Melanie Townsend, M.D.|314-362-4470|townsendm@wustl.edu|
21261913|NCT03099369|University of North Carolina at Chapel Hill|David Lee, MD|347-882-8010|dave.lee0530@gmail.com|
21261914|NCT00611455|GlaxoSmithKline|GSK Response Center|866-435-7343||
21261915|NCT04601272|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.harvard.edu|
21261916|NCT02235285|The Department of Plastic Surgery, Winners Clinic|Dr. Cheol Hwan Kim|.+82.2.511.9446|winners511@naver.com|
21261917|NCT00942708|UT Southwestern|Kelly Chin|214-645-5989|kelly.chin@utsouthwestern.edu|
21261918|NCT00995371|Coastal Orthopedics & Sports Medicine|Lois A. Davis|941-782-1353|ldavis@coastalorthopedics.com|
21261919|NCT00673673|Yale University|Dr. Jill Lacy|203-737-1600|jill.lacy@yale.edu|
21261920|NCT01462292|GlaxoSmithKline|GSK Response Center|866-435-7343||
21261921|NCT02333045|Emory University|Anandi Sheth, MD|404-616-6240|ansheth@emory.edu|
21279808|NCT00537511|Celgene|Associate Director, Clinical Trial Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21279809|NCT05299528|Vanderbilt University Medical Center|Daniel Larach, MD|(615) 322-6033|daniel.larach@vumc.org|
21261922|NCT00953121|Preston Robert Tisch Brain Tumor Center at Duke University Medical Center|Dr. Annick Desjardins|919-684-1691|annick.desjardins@duke.edu|
21292307|NCT03604497|University of Alabama at Birmingham|Dr David Schwebel|2059348745|schwebel@uab.edu|
21292308|NCT00811954|ACTG Network Coordinating Center, Social & Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21292309|NCT01016067|Medtronic Spinal|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
21292310|NCT02103127|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
21292311|NCT00186628|Stanford University Medical Center|David Miklos, MD, PhD; Associate Professor of Medicine (Blood and Marrow Transplantation)|650-725-4626|dmiklos@stanford.edu|
21292312|NCT01247064|Cincinnati Children's Hospital Medical Center|Todd Florin|513-636-7966|todd.florin@cchmc.org|
21292313|NCT00658541|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21292314|NCT04828707|Theranica Bio-Electronics Ltd|Dr Dagan Harris. VP Clinical & Regulatory Affairs|+972723909755|daganh@theranica.com|
21292315|NCT03134326|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
21292316|NCT01886235|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21292317|NCT04207320|University of Chicago|Dr. John Cunningham|773-702-6808|jcunning@bsd.uchicago.edu|
21292318|NCT01188967|Massachusetts General Hospital|Maurizio Fava M.D.|617-724-2513|mfava@partners.org|
21292319|NCT01876381|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
21292320|NCT00523978|Medtronic AF Solutions|Linda Nelson, RN, BSN, MBA - AF Solutions Clinical Operations Director|(763)526-2891|linda.k.nelson@medtronic.com|
21292321|NCT01464879|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21292322|NCT01657305|Amryt Pharma|Head of Clinical Development|+353 1 669 4606|medinfo@amrytpharma.com|
21292323|NCT00696878|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21292324|NCT04103450|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
21292325|NCT02455167|"University of Colorado Denver | Anschutz"|Amanda Wieland, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
21292326|NCT00814255|NYUmed|Howard Trachtman|646-501-2663|howard.trachtman@nyumc.org|
21292327|NCT02712788|Indiana University|Heather Cero, RN - research cooordinator|317-396-1398|hcero@iupui.edu|
21292328|NCT02411461|Vanderbilt University Medical Center|Ashley Shoemaker, Principal Investigator|6153438116|ashley.h.shoemaker@vanderbilt.edu|
21292329|NCT03789292|Celltrion Inc.|JiWoong Lim|032-850-5806|jiwoong.lim@celltrion.com|
21292330|NCT01696643|Cubist Pharmaceuticals|Vice President, Clinical Research|1.781.860.8660||
21292331|NCT01074125|Keryx Biopharmaceuticals Inc|Medical Information|1-844-44-KERYX (1-844-445-3799|medicalinfo@keryx.com|
21292332|NCT01129206|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii Saab, MD|614-293-6529|Tanio.Saab@osumc.edu|
21292333|NCT00518180|Novartis Vaccine and Diagnostics|Posting Director||RegistryContactVaccinesUS@Novartis.com|
21292334|NCT01368614|Philips|Jeff Jasko|412-542-3651|jeff.jasko@philips.com|
21292335|NCT00508482|Guang'anmen Hospital Affiliated to China Academy of Chinese Medical Sciences|Dr. Zhishun Liu|0086-010-88001124|liuzhishun@aliyun.com|
21292336|NCT00546481|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21292337|NCT01227057|VASDHS|Catherine Ayers|8585528585|catherine.ayers1@va.gov|2976
21292338|NCT00244621|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21292339|NCT00587041|Mayo Clinic|Use of Symbiotics to Reduce Urinary Oxalate Excretion|507-266-7960|lieske.john@mayo.edu|
21292340|NCT01193101|Novartis Pharmaceuticals|Study Director|+1 (862) 778-1873||
21292341|NCT02347085|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
21292342|NCT02271529|Cook Research Incorporated|Scott Snyder, Director, Clinical Affairs|765-463-7537|SSnyder@medinst.com|
21292343|NCT00956761|Novartis Vaccines and Diagnostics S.r.l|Posting Director||RegistryContactVaccinesUS@novartis.com|
21292344|NCT03508050|Institut universitaire de cardiologie et de pneumologie de Québec|Dr Jean S. Bussières|418-656-8711|jbuss@criucpq.ulaval.ca|
21292345|NCT03734822|Nationwide Children's Hospital|Anne May, MD|614-722-4766|Anne.May@nationwidechildrens.org|
21292346|NCT01585402|National Heart, Lung, and Blood Institute (NHLBI)|Alessandra Brofferio, M.D.|301.496.2634|alessandra.brofferio@nih.gov|
21243419|NCT03184558|BerGenBio ASA|BerGenBio Clinical Team|+47 559 61 159|trialsites@bergenbio.com|
21243420|NCT04589689|Stanford University|Jessie Wong, PhD|6507361517|wongjj@stanford.edu|
21243421|NCT03061474|University of California, Irvine|Dr. Joshua Grill|(949) 824-5905|jgrill@uci.edu|
21243422|NCT03109795|University of Iowa|Professor|319-335-9487|gary-pierce@uiowa.edu|
21243423|NCT01391130|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21243424|NCT01665092|Univeristy of Mississippi Medical Center|Alan Jones|601-384-5586|aejones@umc.edu|
21243425|NCT04153435|Aarhus University|Lars W. Andersen|+4551781511|lwandersen@clin.au.dk|
21243426|NCT03520413|Durham Veterans Affairs Medical Center|Matthew Crowley, MD|919-286-0411|matthew.crowley@va.gov|
21243427|NCT00638963|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21243428|NCT00971789|National Cancer Institute, National Institutes of Health|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov|
21243429|NCT00463788|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21243430|NCT04598321|Brown University Oncology Research Group (BrUOG)|Assistant Director|401-863-3000|BrUOG@brown.edu|
21243431|NCT02755116|Icahn School of Medicine at Mount Sinai|Dr. Jaime B. Hyman|212-241-7473|Jaime.hyman@mountsinai.org|
21243432|NCT02200770|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
21243433|NCT01647438|Northwestern University|Dr. Namratha Kandula, Principal Investigator|312-503-6470|nkandula@nm.org|
21243434|NCT04925765|University of Pittsburgh Medical Center|Dr. Katherine Grace Lim|4126411777|limkg2@upmc.edu|
21243435|NCT01214824|Abbott Diabetes Care|Director Global Clinical and EMEA Regulatory Affairs|01993863164|joe.bugler@abbott.com|
21243436|NCT05283395|Alcon Research, LLC|Scientific Advisor, Clinical R&D|1-888-451-3937|alcon.medinfo@alcon.com|
21243437|NCT00634621|GE Healthcare|Emilio Moreno Carretero, M.D.|011-34-9166-30970|Emilio.Morenocarretero@ge.com|
21261923|NCT01748695|Brigham and Women's Hospital|Dr. Christine N. Sang, Director of Translational Pain Research|617-525-7246|csang@partners.org|
21243438|NCT00712335|Inje University|Dr. Chang-Keun Kim|82-2-950-8832|kimck@paik.ac.kr|
21261924|NCT05610969|University of Pennsylvania|Veena Graff MD, MS|(215) 662-8244|veena.graff@pennmedicine.upenn.edu|
21261925|NCT04579393|The National Institutes of Health / The National Heart, Lung, and Blood Institute|Jeffrey Strich, MD|301.496.9320|jeffrey.strich@nih.gov|
21261926|NCT01282814|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21261927|NCT01524289|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21261928|NCT02704429|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21243439|NCT00317226|Luitpold Pharmaceuticals, Inc.|Mark Falone, MD|610-650-4200|mfalone@luitpold.com|
21243440|NCT00356265|University of Michigan|Crystal Gadegbeku||crystal.Gadebeku@tuhs.temple.edu|
21243441|NCT02971488|Hospital Universitario Infanta Leonor|Pablo Ryan|0034616832148|pablo.ryan@salud.madrid.org|
21243442|NCT00818805|Alcon Labs|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21243443|NCT02115139|MFAR Clinical Research|Pau Doñate||investigacion@mfar.net|
21243444|NCT00258895|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21243445|NCT00547118|Maryland Psychiatric Research Center|Dr. Robert W. Buchanan|410-402-7876|rwbuchanan@mprc.umaryland.edu|
21243446|NCT00433199|Abbott|Global Medical Services|800-633-91110||
21243447|NCT03505099|Novartis Gene Therapies EU Limited|EMEA Medical Information|+353 (1) 566-2364|medinfoemea.gtx@novartis.com|
21243448|NCT03603717|Department of Veterans Affairs, Center of Excellence for Suicide Prevention|Wilfred Pigeon, PhD|(585) 393-7918|wilfred.pigeon2@va.gov|
21243449|NCT00732381|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21261929|NCT02519231|University of Washington|Dr. Emily Godfrey|206.685.4895|godfreye@uw.edu|
21261930|NCT03557372|Dana Farber Cancer Institute|Dr. Shyam Tanguturi|617-632-0000|stanguturi@partners.org|
21261931|NCT00104104|Novatis Pharmaceuticals|Study Director|862-778-8300||
21261932|NCT00447421|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21261933|NCT01707147|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21261934|NCT02234011|McLean Hospital, Biological Psychiatry Laboratory|Dr. Brian Brennan, MD|617-855-2911|bbrennan@partners.org|
21261935|NCT02725177|Cleveland Clinic Foundation|Daniel Culver, DO|216-444-6508|culverd@ccf.org|
21279810|NCT03097991|University of South Florida|Dr. James McHale|7278734848|jmchale@usf.edu|
21279811|NCT02006732|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21279812|NCT01755091|University of Illinois at Chicago|David W. Carley, PhD|312-996-3827|dwcarley@uic.edu|
21279813|NCT01199146|University of California, San Francisco|Charles Ryan, MD|415-353-9279|charles.ryan@ucsf.edu|
21279814|NCT01107197|"Department of Clinical Nutrition and Dietetics, Azienda Ospedaliera Maggiore della Carità"|Dr. Federico D'Andrea|+39 0321.373.3275|dietologia@maggioreosp.novara.it|
21279815|NCT03071276|St. Jude Children's Research Hospital|Jeffrey E. Rubnitz, MD, PhD|901-595-2388|jeffrey.rubnitz@stjude.org|
21279816|NCT03052127|Aura Biosciences|Uma Chandrasekaran, Director, Clinical Development Scientist|706-294-3454|UChandrasekaran@aurabiosciences.com|
21279817|NCT03694327|MyDigitalStudy|Alankar Gupta, VP, Medical Affairs & Clinical Development|862-485-9279|agupta@clicktherapeutics.com|
21279818|NCT03131544|Prostate Laser Center, PLLC|Dr. Ara Karamanian, Medical Director of the Prostate Program|(713) 904-4014|drkaramanian@halodx.com|
21279819|NCT04140032|UCLA Fielding School of Public Health|Dr. Burt Cowgill|310-794-3569|bcowgill@ucla.edu|
21279820|NCT05109611|SaNOtize R&D Corp|Chief Science Officer|778-899-0607|chris@sanotize.com|
21279821|NCT05064384|Boston Scientific|Karen Noblett, MD, Chief Medical Officer|559-250-8082|karen.noblett@bsci.com|
21279822|NCT01887171|Republican scientific and practical center for organ and tissue transplantation|Aliaksej Shcherba|+375293330689|aleina@tut.by|
21279823|NCT03203850|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
21279824|NCT02717455|St. Jude Children's Research Hospital|Dr. Arzu Onar-Thomas|901-595-5499|arzu.onar@stjude.org|
21279825|NCT01769456|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
21279826|NCT01602068|Eyegate Pharmaceuticals, Inc.|Lisa Brandano|781-398-3806|lbrandano@eyegatepharma.com|
21279827|NCT05244122|BrighamHospital|Jeremy Wolfe, Principle Investigator|617-851-1166|jwolfe@bwh.harvard.edu|
21279828|NCT00615199|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21279829|NCT02653625|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21279830|NCT03860974|University of California, San Diego|Brian Ilfeld|8582493660|bilfeld@health.ucsd.edu|
21279831|NCT05377749|University of North Carolina Lineberger Comprehensive Cancer Center|Zev Nakamura, MD|(984) 974-3829|zev_nakamura@med.unc.edu|
21279832|NCT02969382|Sunovion Pharmaceuticals, Inc.|CNS Medical Director|1-866-503-6351|CLINICALTRIALDISCLOSURE@SUNOVION.COM|
21279833|NCT02090725|Dartmouth-Hitchcock|Jeffrey A. Cohen, MD|603-650-4211|jeffrey.a.cohen@hitchcock.org|
21279834|NCT00764881|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21279835|NCT01214655|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21279836|NCT04933383|Aquilon Pharmaceuticals SA|Clinical Operations|003242292800|clinops@aquilonpharma.com|
21279837|NCT00221338|University of California San Francisco|Clinical Research Coordinator|4154769489|Christopher.Tang2@ucsf.edu|
21279838|NCT05256134|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21243450|NCT01170026|Department of Psychiatry and Human Behavior, The Alpert Medical School of Brown University|Dr. Anthony Spirito|401-369-2435|anthony_spirito@brown.edu|
21243451|NCT04817670|CSL Behring|Study Director|+1 610-878-4000|clinicaltrials@cslbehring.com|
21243452|NCT00304031|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
21243453|NCT01188655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21243454|NCT00683696|Biotronik, Inc.|Kelly Mohr|800-547-0394|kelly.mohr@biotronik.com|
21243455|NCT00089544|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
21243456|NCT02396316|Bayer|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21243457|NCT05636332|Philips|Tiffani Bowers|724-989-3072|tiffani.bowers@philips.com|
21243458|NCT04112069|Mass. General Hospital|Courtney Balliro, BS, RN, CDE|617-726-1242|cballiro@partners.org|
21243459|NCT01662336|AbbVie (prior Sponsor Abbott)|Global Medical Services|800-633-9110||
21243460|NCT02189252|AstraZeneca AB|Hong Yang, Study Statistician|+46-(0)317762397|hong.yang1@astrazeneca.com|
21243461|NCT00566735|Massachusetts General Hospital|Dr. John Matthews|617-724-0847|jmatthews@partners.org|
21243462|NCT05876949|Alvotech Swiss AG|Clinical Development and Medical Lead|+41 78 659 89 89|alvotech.clinical@alvotech.com|
21243463|NCT00508924|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21243464|NCT02755805|University of Pittsburgh|Elizabeth R. Skidmore, PhD, OTR/L, FAOTA|(412) 383-6617|skidmore@pitt.edu|
21243465|NCT02369484|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki-Voser, Lead Trial Activities|+41 31 511 94 18|Heidi.Roschitzki@etop-eu.org|
21243466|NCT02178241|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
21243467|NCT06258785|Endeavor Health|Dr. Claudia Paya Ten|847-570-4729|claudia.payaten@endeavorhealth.org|
21243468|NCT03593213|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21243469|NCT02658240|UT Southwestern Medical Center|Irina Gasanova|4694191997|Irina.Gasanova@UTSouthwestern.edu|
21243470|NCT01831791|GlaxoSmithKline|GSK Response Center|866-435-7343||
21243471|NCT00494780|GlaxoSmithKline|GSK Response Center|866-435-7343||
21243472|NCT00845832|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21243473|NCT03698708|Nemours Children's Health|Dr. Susana Patton|904-697-2000|susana.patton@nemours.org|
21243474|NCT00869323|Masonic Cancer Center, University of Minnesota|Dr. Anne Blaes|612-626-8138|blaes004@umn.edu|
21243475|NCT00908830|University of Michigan Health System|Linda Stuckey, Pharm.D|734-936-8129|lindastu@med.umich.edu|
21243476|NCT02880241|Medicines for Malaria Venture (MMV)|Dr Stephan Duparc, Chief Medical Officer|+41 22 555 0351|duparcs@mmv.org|
21243477|NCT00846066|Childrens Mercy Hospital|Nasreen Talib MD, MPH.|816-234-3242|ntalib@cmh.edu|
21243478|NCT04303156|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21243479|NCT00588809|The University of Chicago Medicine|Olatoyosi Odenike, MD|(773) 702-6149|todenike@medicine.bsd.uchicago.edu|
21243480|NCT02570711|Acerta Pharma, LLC|Priti Patel, MD, Vice President - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
21243481|NCT01254188|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
21243482|NCT04283552|Washington University School of Medicine|Richard L. Wahl, M.D.|314-362-7100|rwahl@wustl.edu|
21243483|NCT00545077|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
21243484|NCT03260140|VA Puget Sound Health Care Sysem|Margaret P. Collins|206.764.2085|margaret.collins@va.gov|
21243485|NCT00831675|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21243486|NCT01692938|Stanley M. Truhlsen Eye Institute|Quan Nguyen, MD Director of the Stanley M. Truhlsen Eye Institute|402-559-4276|quan.nguyen@unmc.edu|
21243487|NCT01667796|Johns Hopkins|Ellen Mowry|4106141522|vitamindtrialms@jhmi.edu|
21243488|NCT01836133|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21243489|NCT02423291|"Institute of Hematology L. e A. Seràgnoli, AOU Policlinico S.Orsola-Malpighi Via Massarenti, 9 - 40138 Bologna Italy"|MD Vittorio Stefoni|+39 0512143680|vittorio.stefoni2@unibo.it|
21243490|NCT01063972|University of Kansas Medical Center|Sharon Fitzgerald, MPH|913-588-3488|sfitzgerald@kumc.edu|
21243491|NCT00959946|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21243492|NCT00566527|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21243493|NCT01837966|NYU School of Medicine|Associate Professor ; Res Program Dir/Medical Dir Day Surgery; Vice Chair for Education|212.263.5072|michael.wajda@nyumc.org|
21243494|NCT03293498|Novavax Inc.|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
21243495|NCT04975308|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
21243496|NCT01568073|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21243497|NCT00841035|University of Alabama at Birmingham|Research Nurse Supervisor of Clinical trials|(205)975-0450|jhrichardson@uabmc.edu|
21243498|NCT00891176|GlaxoSmithKline|GSK Response Center|866-435-7343||
21243499|NCT00357097|GlaxoSmithKline|GSK Response Center|866-435-7343||
21243500|NCT00658996|Bausch & Lomb Incorporated|Gerard Cairns, PhD, MCOptom|(585) 338-5170|gerard.cairns@bausch.com|
21243501|NCT01625013|University of California, San Francisco|Anthony Luke, MD|4155146120|Anthony.Luke@ucsf.edu|
21243502|NCT02994654|AVITA Medical|VP Clinical Research|661-367-9170|USClinicalTrials@avitamedical.com|
21243503|NCT00385801|Massachusetts General Hospital - Harvard Medical School|A. Eden Evins, MD, MPH. Director of the MGH-Harvard Center for Addiction Medicine|6176434679|a_eden_evins@hms.harvard.edu|
21243504|NCT00605904|NIAAA, NIH|Markus Heilig|301.435.9386|mheilig@mail.nih.gov|
21243505|NCT02247063|University of Michigan|Thiago Nascimento|734-615-9390|Nasci@umich.edu|
21243506|NCT01190566|Seoul National University Hospital|Woo Kyung Moon|82-2-2072-2584|moonwk@snu.ac.kr|
21243507|NCT01121549|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21243508|NCT03995069|Ralph H. Johnson VA Health Care System|Principal Investigator|8434671373|NaJin.Seo@va.gov|
21243509|NCT03619226|Coloplast A/S|Julie Schnipper, Medical Writer|49111257|dkjuls@coloplast.com|
21243510|NCT04250883|Radboud umc|Dr. Michiel Warle|024-3613808|michielwarle@radboudumc.nl|
21243511|NCT04951310|University of Pennsylvania|Dr. Katherine Milkman|215-573-9646|bcfg@wharton.upenn.edu|
21243512|NCT02763319|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21243513|NCT04926181|University of California, San Francisco|Dr. Rahul Aggarwal, MD|(415) 476-1000|Rahul.Aggarwal@ucsf.edu|
21243514|NCT04603924|Robert Homolka|Sr. Vice President Clinical Operations|8572991035|bob.homolka@neurobopharma.com|
21243515|NCT01175317|Maastricht University Medical Center|Kostan Reisinger|0031433881494|k.reisinger@maastrichtuniversity.nl|
21243516|NCT03762668|Alcon Research, LLC|Sr. CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21243517|NCT02164240|DFCI|Suzanne George|617-632-5204|Suzanne_George@dfci.harvard.edu|
21243518|NCT00686855|Dana-Farber Cancer Institute|Nathaniel S. Treister, DMD, DMSc|617-632-2806|ntreister@partners.org|
21243519|NCT01731041|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD-Associate Professor of Medicine Director, Cardiovascular Research|+1-904-244-3005|dominick.angiolillo@jax.ufl.edu|
21243520|NCT02731755|University of Reading|Prof Jeremy Spencer|+44(0) 1183788724|j.p.e.spencer@reading.ac.uk|
21243521|NCT01460446|Hoffmann-La Roche|Medical Communications|800 821-8590||
21243522|NCT00714714|Valeant Pharmaceuticals International, Inc|David Lineberry, Associate Director Clinical Operations|949-973-1153|David.Linberry@valeant.com|
21243523|NCT02616900|eSight Corporation|Rob Hilkes|613 276-4145|rhilkes@eSightcorp.com|
21243524|NCT01296815|Centro de Investigación en. Enfermedades Infecciosas|Gustavo Reyes-Teran|52 55 56667985|gustavo.reyesteran@gmail.com|
21243525|NCT03644849|Saint Louis University|Dr. Ramona Behshad|314-977-9721|ramona.behshad@health.slu.edu|
21243526|NCT02613871|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21243527|NCT00980330|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
21243528|NCT04054635|University of Manitoba|Dr. Robert J. Schroth|204-977-7764|robert.schroth@umanitoba.ca|
21243529|NCT03737240|University of Miami Miller School of Medicine|Dr. Rodolfo Galindo|305-243-7707|Rodolfo.galindo@miami.edu|
21243530|NCT00891930|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|866-572-6436|Bobby.Reddy@Immunitybio.com|
21243531|NCT05001945|Mineralys Therapeutics|David Rodman, MD Chief Medical Officer|1-888-378-6240|drodman@mineralystx.com|
21243532|NCT02448446|South Coast Retina Center|Dr. Julie Gasperini|5629847024|jgasperini@gmail.com|
21243533|NCT00376363|University of North Carolina|Donald Budenz|919-843-0297|donald_budenz@med.unc.edu|
21243534|NCT01059877|QuietMind Foundation|Marvin Berman, PhD|610.940.0488|marvinberman@quietmindfdn.org|
21243535|NCT00640250|Institute of Clinical Research, Department of Dermoto Venerology and Allergy Center|Evy Paulsen, MD|+45 65 41 27 08||
21243536|NCT02957136|Duke University Health System|Christopher Polage|919-668-5008|christopher.polage@duke.edu|
21243537|NCT00439569|Westat|René Gonin, PhD (Math. Stats.)|301-251-1500|renegonin@westat.com|
21243538|NCT02214160|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
21243539|NCT01510717|Alcon Research, Ltd.|Magda Michna, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
21243540|NCT02476409|University of North Carolina at Chapel Hill|Amanda Lee|919-843-9936|akg72@med.unc.edu|
21243541|NCT00275392|James H. Quillen VAMC|Courtney D. Hall, PhD|423-926-1171|courtney.hall@va.gov|7518
21243542|NCT04221828|US Biotest, Inc.|Gere S. diZerega, MD|18055951300|gere.dizerega@usbiotest.com|
21243543|NCT02555215|Biogen|Medical Director, Overall Study Officials|866-633-4636|clinicaltrials@biogen.com|
21243544|NCT00529789|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21243545|NCT01968226|Cleveland Clinic|Dr. Balaji Tamarappoo|216-444-6765|tamarab@ccf.org|
21243546|NCT00886145|James J. Peters VA Medical Center|William A. Bauman|718-584-9000|william.bauman@va.gov|5428
21243547|NCT00857545|NRG Oncology|Linda Gedeon for Wei Deng PhD|716-845-1169|lgedeon@gogstats.org|
21243548|NCT00457743|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21243549|NCT01202955|University of Pennsylvania|Dr. Caryn Lerman|215-746-7141|clerman@mail.med.upenn.edu|
21243550|NCT02928224|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21243551|NCT01278394|Anacor Pharmaceuticals, Inc.|Sheryl Baldwin, RN/Associate Director|650-223-8597|clinicaltrials@anacor.com|
21243552|NCT00468910|Northwestern University|Dr. Seema Khan|312-503- 4236|skhan@nm.org|
21243553|NCT01909778|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21243554|NCT00664430|Abbott|Global Medical Services|800-633-9110||
21243555|NCT05323734|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
21243556|NCT04923724|Washington University School of Medicine|Venessa Riegler|314-362-1721|rieglerv@wustl.edu|
21243557|NCT03072953|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
21243558|NCT00457691|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21243559|NCT01353963|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21243560|NCT01420549|Aché Laboratórios Farmacêuticos S. A.|Antonio Carlos Amedeo Vattimo|+55 11 26088111|antonio.vattimo@ache.com.br|
21243561|NCT04584099|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
21243562|NCT04786457|University of Maryland, Baltimore, Center for Vaccine Development and Global Health|Kirsten E. Lyke, MD|410-706-5328|klyke@som.umaryland.edu|
21243563|NCT03073941|Zimmer Biomet|Chiara Griffoni, Clinical Project Senior Lead|+41 79 560 16 28|chiara.griffoni@zimmerbiomet.com|
21243564|NCT05470868|Laboratorios Sophia|Alejandra Sanchez-Ríos M.D.|:+52 (33) 3001 4200|alejandra.sanchez@sophia.com.mx|
21243565|NCT03936660|Duke Clinical Research Institute|Chris Granger, MD|9196688700|christopher.granger@duke.edu|
21243566|NCT01391832|University of Texas at Dallas|Dr. John Hart, Jr.|972-883-4853|jill.ritter@utdallas.edu|
21243567|NCT00589277|Yale University School of Medicine|Benjamin Toll, Ph.D. Associate Professor of Psychiatry|(203) 974 5767|benjamin.toll@yale.edu|
21243568|NCT00722046|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21243569|NCT00490802|Holland Bloorview Kids Rehabilitation Hospital|Dr. Evdokia Anagnostou|416-753-6005|eanagnostou@hollandbloorview.ca|
21243570|NCT00085436|Dartmouth-Hitchcock Medical Center|Dr. Marc S. Ernstoff|603-650-5534|marc.s.ernstoff@hitchcock.org|
21243571|NCT01668940|The Hospital for Sick Children|Dr Shinya Ito, Principal Investigator|4168135776|shinya.ito@sickkids.ca|205776
21243572|NCT00516321|GlaxoSmithKline|GSK Response Center|866-435-7343||
21243573|NCT01292252|University of California, San Francisco|Shane Burch, MD|415-353-4487|Shane.Burch@ucsf.edu|
21243574|NCT01556724|University of Pittsburgh|Susan Sandusky|412-383-1036|sis127@pitt.edu|
21243575|NCT01599104|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300||
21243576|NCT01925469|University of Pennsylvania|Dr. Emelia Bachman|443-955-9195|emeliacleo@gmail.com|
21243577|NCT02271854|Novartis Consumer Health a GSK Consumer Healthcare company|Director Clinical Research pain category|+413635528||
21243578|NCT03795194|Phoenix Children's|Research Coordinator|6029331858|zhunteman@phoenixchildrens.com|
21243579|NCT01185561|Loyola University|Sue Penckofer, Ph.D.|708-216-9303|spencko@luc.edu|
21243580|NCT01078116|Abbott|Global Medical Services|1-800-633-9110||
21243581|NCT02499159|Inova Health System|Devon Collins|703-776-4096|Devon.Collins@inova.org|
21243582|NCT02242487|Acorda Therapeutics|Dr. Charles Oh, Senior Vice President - Clinical Development|914-326-5455|coh@acorda.com|
21243583|NCT00083551|UAMS Myeloma Institute|Bart Barlogie|501-526-6990|barlogiebart@uams.edu|2420
21243584|NCT02564744|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
21243585|NCT00687856|University of Pittsburgh|John Gorcsan MD|4126476570|gorcsanj@upmc.edu|
21243586|NCT04040296|Yale University|Abinet Aklilu|203-737-1787|abinet.aklilu@yale.edu|
21243587|NCT01956032|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21243588|NCT02252042|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21243589|NCT02593149|Pursuit Vascular, Inc.|Laurie Lynch, PhD|6124249006|llynch@pursuitvascular.com|
21243590|NCT01571557|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21243591|NCT01177670|Hologic, Inc.|Edward Evantash, MD|508-263-8475|edward.evantash@hologic.com|
21243592|NCT00979992|NRG Oncology Statistics and Data Management Center - Buffalo Office|Angela M. Kuras, Associate Director of Administration and Operations|716-845-5702|kurasa@nrgoncology.org|
21243593|NCT00749749|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|Innocoll|484-406-5211|ctucker@innocoll.com|
21243594|NCT02663297|UNC Lineberger Comprehensive Cancer Center|Melahat Canter|919-962-0000|Melahat_Canter@med.unc.edu|
21243595|NCT04532528|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21243596|NCT01636687|Novartis Pharmaceuticals|Study Director|+1-862-778-8300|Novartis.email@novartis.com|
21243597|NCT02771899|Columbia University Medical Center|Dr. Lawrence Lenke|2129324410|ll2989@columbia.edu|
21243598|NCT03835819|Dana-Farber Cancer Institute|Dr. Panagiotis Konstantinopoulos|617-632-5269|Panagiotis_Konstantinopoulos@dfci.harvard.edu|
21243599|NCT01269749|University of Florida|Dr Scott Rivkees|352-273-9001|srivkees@ufl.edu|
21243600|NCT03691428|Yale|Dr. Joan Monin|203785-2895|joan.monin@yale.edu|
21243601|NCT01460290|University Hospitals of Cleveland|Martha Sajatovic, Professor of Psychiatry|2168442808|martha.sajatovic@uhhospitals.org|
21243602|NCT02527148|Stryker South Pacific|David Fulker|+61 2 9467 1072|david.fulker@stryker.com|
21243603|NCT02918279|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21243604|NCT00309907|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
21243605|NCT00869258|Columbia University|Robert Fine, MD|212-305-1168|rlf20@columbia.edu|
21243606|NCT02888080|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21243607|NCT01641198|Université de Montréal|Dr. Aldo-Joseph Camarda|(514) 343-7124|aj.camarda@umontreal.ca|
21243608|NCT01039688|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21243609|NCT00346151|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21243610|NCT03040661|Inova Heart and Vascular Institute|Vineet Kumar|(703) 289-9400|vineet.kumar@inova.org|
21243611|NCT00535145|Ortho-McNeil Janssen Scientific Affairs, LLC|Vice President, Medical Affairs, CNS|609-730-2136||
21243612|NCT04018924|Emoled|Duccio Rossi Degl'Innocenti|+39 0550751981|d.rossi@emoled.com|
21243613|NCT01124734|Penn State Cancer Institute|Joseph Drabick, MD|717 531 5059|jdrabick@pennstatehealth.psu.edu|
21243614|NCT02423798|Medtronic Minimed|Odile O'Sullivan, Clinical Trial Manager|8184763319|odile.osullivan@medtronic.com|
21243615|NCT01224015|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21243616|NCT01430611|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21243617|NCT02204982|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
21243618|NCT00237770|James J Peters VA Medical Center|Dr. Jill M. Wecht, principal Investigator|718 584-9000|jm.wecht@va.gov|3122
21243619|NCT00392054|Population Health Research Institute|Carlos A. Morillo, MD, FRCPC, FACC, FHRS, FESC, FHRS|905-527-4322|Carlos.Morillo@phri.ca|40311
21243620|NCT01943916|Seno Medical Instruments, Inc|Shaan Schaeffer, VP Clinical Operations|2106156501|sschaeffer@senomedical.com|
21243621|NCT00919763|Galderma|Clinical Operations|8179615000|Clinical.Studies@galderma.com|1
21261936|NCT04435769|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21235291|NCT01076400|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21235292|NCT02160873|Florida State University|Dr. Michael J. Ormsbee|(850) 645-5000|mormsbee@fsu.edu|
21235293|NCT02766608|Pearl Therapeutics, a Member of the AstraZeneca Group|Paul M. Dorinsky, MD|650-305-2600|paul.dorinsky1@astrazeneca.com|
21235294|NCT02261818|Johns Hopkins University|Dr Jin Hui Joo|4105502282|jjoo1@jhmi.edu|410
21235295|NCT02080091|Alimera Sciences, Ltd.|Andrew Joyson - Associate Director, Clinical Operations Europe|+44 1252 354 026|Andrew.Joyson@alimerasciences.com|
21235296|NCT03019536|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21235297|NCT03223298|Weill Cornell Medicine|Dr. Gwendolyn S. Reeve|(212) 746-5175|gsr9001@med.cornell.edu|
21235298|NCT01265953|Oregon Health & Science University|Dr.Jackilen Shannon|503-418-9860|shannoja@ohsu.edu|
21235299|NCT03143829|University of Central Floroda|Victoria Loerzel|407-823-0762|victoria.loerzel@ucf.edu|
21235300|NCT01353339|St Paul's Hospital|Dr. John S. Gill|604-806-8970|jgill@providencehealth.bc.ca|
21235301|NCT00423436|UT MD Anderson Cancer Center|Charles S Cleeland, PhD, Professor||asaleeba@mdanderson.org|
21235302|NCT03738865|Xeris Pharmaceuticals, Inc.|Chelsea Boundy|312-517-1466|cboundy@xerispharma.com|
21235303|NCT04086472|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21235304|NCT03348904|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21235305|NCT00048724|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21235306|NCT01743092|Centre for Addiction and Mental Health|Nigel Turner, Ph.D.|416-535-8501|nigel.turner@camh.ca|36063
21235307|NCT03586869|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
21235308|NCT04116229|Washington University School of Medicine|Sarah Eisenstein, Associate Professor in Psychiatry|3143627107|seisens@wustl.edu|
21235309|NCT02595684|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
21235310|NCT02809976|Tufts Medical Center|David Romarin, MD Prinicpal Investigator|617 636 7462|drosmarin@tuftsmedicalcenter.org|
21235311|NCT00883389|University of Maryland, School of Medicine|Dr. Jeffrey C. Fink, Associate Professor, Nephrology|410-328-5720|jfink@medicine.umaryland.edu|
21235312|NCT00211081|Emory University|Dr. Willam Mahle|404-785-6000|wmahle@emory.edu|
21235313|NCT00113516|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21235314|NCT00047463|Vanderbilt University|Beth Malow/Principal Investigator|615-322-0283|beth.malow@vanderbilt.edu|
21235315|NCT00982189|Minneapolis Medical Foundation|Dr. Jason Baker|612-873-2705|baker459@umn.edu|
21235316|NCT03091751|Grifols Therapeutics Inc|Henry Li, PhD|+1 919 316 6042|henry.li@grifols.com|
21235317|NCT01161329|UppsalaU|Karin Hellström|+46184714762|karin.hellstrom@neuro.uu.se|
21235318|NCT00111228|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
21235319|NCT01420302|Department and Laboratory of Intensive Care Medicine KULeuven/UZLeuven|Professor Greet Van den Berghe|003216344017|greet.vandenberghe@kuleuven.be|
21235320|NCT00962429|Oregon Health and Science University|Diana Dimitrova|503-494-7269|dimitrov@ohsu.edu|
21235321|NCT02713321|Icahn School of Medicine at Mount Sinai|Dr. Victoria Mayer|(212) 659-9194|victoria.mayer@mountsinai.org|
21235322|NCT03698773|University of New Mexico Anesthesiology Department|Research Officer|505-272-2610|hsc-anesthesiology@salud.unm.edu|
21235323|NCT03235024|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
21235324|NCT02357576|University of Michigan|Meghan Arnold|734-936-8978|meghanar@umich.edu|
21235325|NCT03495908|The University of Texas Southwestern Medical Center|Dr Pablo F Mora|469-585-0000|pf_mora@yahoo.com|
21235326|NCT00539526|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
21235327|NCT03097068|Vitreo-Retinal Associates, P.C.|Louis C. Glazer, MD|1-616-285-1200|glazerlc@vrapc.com|
21235328|NCT02802345|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21235329|NCT00811564|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
21235330|NCT02075320|UNC School of Medicine Department of Radiology|Dr. Yueh Lee|(919) 537-3730|yueh_lee@med.unc.edu|
21235331|NCT01397695|UCSD|Research Compliance and Integrity|(858) 822-4939|ctgov@ucsd.edu|
21235332|NCT01109316|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21279839|NCT00886015|JohnHopkins U|Sheila West|410-955-2606|shwest@jhmi.edu|
21279840|NCT01692626|West Virginia University|Mohammed Almubarak, MD, Assistant Professor|304-293-4229|malmubarak@hsc.wvu.edu|
21292347|NCT03368066|University of Virginia|Dr. Brian Wentworth|9739436781|bw8xz@hscmail.mcc.virginia.edu|
21243622|NCT04740164|The University of Texas MD Anderson Cancer Center|Dr. Katherine Hagan|(713) 794-5945|khagan@mdanderson.org|
21243623|NCT05216510|Tonix Pharmaceuticals|Herb Harris, MD, PhD|(862) 904-0355|herb.harris@tonixpharma.com|
21243624|NCT00442117|Merck Sharp and Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclcosure@merck.com|
21243625|NCT00206375|Texas Children's Hospital, Baylor College of Medicine|Dr. MJ Redondo (designated by the institution to enter results)|832-822-1019|redondo@bcm.edu|
21243626|NCT04789408|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
21243627|NCT03439891|University of California, San Francisco|Dr. R. Katie Kelley, MD|(415) 353-9888|katie.kelley@ucsf.edu|
21243628|NCT02576574|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21243629|NCT00233090|Icahn School of Medicine at Mount Sinai|Wayne A Gordon, PhD|212-659-9372|wayne.gordon@mssm.edu|
21243630|NCT00840177|SWOG Statistical Center|S0919 Statistician|2066674623|amoseley@fredhutch.org|
21243631|NCT01154985|Mochida Pharmaceutical Company Ltd.|Hironori Sato, Director|+81-3-3225-6331|hnsato@mochida.co.jp|
21243632|NCT03345901|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|drcrnet@jaeb.org|
21243633|NCT00925587|Amgen Inc.|Study Director|866-572-6436||
21243634|NCT00414544|Cosmeta, A Gel-Del Technolgies Company|Dr. David B. Masters|651 209-0707|dmasters@gel-del.com|
21243635|NCT00373386|Research Institute at Nationwide Children's hospital|Robert P. Hoffman MD|614-722-4425|robert.hoffman@nationwidechildrens.org|
21243636|NCT01318382|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21243637|NCT00019747|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
21243638|NCT01308567|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21243639|NCT01571596|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
21243640|NCT03344536|Memorial Sloan Kettering Cancer Center|Dr. Komal Jhaveri MD|646-888-5145|jhaverik@mskcc.org|
21243641|NCT01437605|Moffitt Cancer Center|Dr. Nikhil Khushalani|813-745-3437|Nikhil.Khushalani@Moffitt.org|
21243642|NCT01647581|VA|Linda Feagins|214-587-1603|linda.feagins@austin.utexas.edu|
21243643|NCT01105117|Actelion Pharmaceuticals, US|Wade Benton, PharmD, Director of Medical Affairs|650-808-6562|wade.benton@actelion.com|
21243644|NCT00585052|University of Iowa|Raymond Hohl, MD|319-335-6564|rhohl@pennstatehealth.psu.edu|
21243645|NCT04425863|Eurnekian Public Hospital|Dr. Héctor Carvallo|54144800949|hymcarvallo@hotmail.com|
21243646|NCT03122236|University of Florida|Dr. David Clark|352-376-1611|davidclark@ufl.edu|105244
21243647|NCT00829036|Atlanta VA Rehab R&D Center of Excellence|David A. Ross|404-321-6111|ross0128@bellsouth.net|6817
21243648|NCT00277355|Massachusetts General Hospital|Merit Cudkowicz, MD, MSc|617-726-1873|mcudkowicz@partners.org|
21243649|NCT00808405|University of Washington|Connie Celum, MD, MPH|206-520-3824|ccelum@uw.edu|
21243650|NCT01140048|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21243651|NCT00636207|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21243652|NCT01396837|RedDress|Saron Sirota, Clinical Team Leader|+972-54-5800765|sharon@reddress.co.il|
21243653|NCT00568854|Los Angeles County Department of Public Health|Dr. Alicia Chang|213-745-0846|alchang@ph.lacounty.gov|
21243654|NCT00666276|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21243655|NCT02594735|GWU Myositis Center|Dr. Rodolfo Curiel|202-741-2488|rcuriel@gwu.edu|
21243656|NCT00668863|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21243657|NCT01883908|University of Maryland Baltimore Greenebaum Cancer Center|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu|
21243658|NCT01296191|Bucci Laser Vision|Frank A. Bucci Jr., MD|570-825-5949|buccivision@aol.com|
21243659|NCT04567407|Boston Children's Hospital|Roland Brusseau MD|857-218-4814|roland.brusseau@childrens.harvard.edu|
21243660|NCT03844269|Akili Interactive Labs, Inc.|Minny Suh|857-254-4444|minny@akiliinteractive.com|
21243661|NCT01316263|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21243662|NCT00475319|Dermatologicals & Ophthalmologicals, Otsuka Pharmaceutical Co., Ltd.|Eiji Murakami|+81-6-6231-6067||
21243663|NCT01075217|Bracco Diagnostics Inc|Usha Halemane|609.514.2578|Usha.Halemane@diag.bracco.com|
21243664|NCT03897348|University of California, San Francisco/San Francisco VA Health Care System|Steven L. Batki, MD|415-221-4810|steven.batki@ucsf.edu|23671
21243665|NCT01068743|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
21261937|NCT01326962|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21261938|NCT02053246|University of Florida|Dr. Julio Duarte|352-273-8132|juliod@cop.ufl.edu|
21261939|NCT02707757|Imperial Healthcare NHS Trust|Dr Damien Ashby||d.ashby@imperial.ac.uk|
21261940|NCT01056523|Jewish General Hospital|Dr. Assouline|514-340-8222|sarit.assouline@mcgill.ca|8434
21261941|NCT03429556|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21261942|NCT03425656|Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.|Dr. Reza Safaei, M.D|0098-9124548684|safaiino@sina.tums.ac.ir|
21261943|NCT01596595|Boston Scientific|Paji Vitoff, Manager, Clinical Trials|651-582-5415|Paji.Vitoff@bsci.com|
21261944|NCT04441931|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21261945|NCT01863758|Octapharma|Sylvia Werner|415 260-9577|sylvia.werner@octapharma.com|
21261946|NCT02369510|Icahn School of Medicine at Mount Sinai|Dr. Daniel Katz|212-241-7475|Daniel.Katz@MountSinai.org|
21261947|NCT02029430|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
21261948|NCT02088216|Qilu Hospital of Shandong University|Yu Li|13791122770|qlliyu@163.com|
21292348|NCT00950651|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
21243666|NCT00293293|Moffitt Cancer Center|Patricia L. Judson, M.D.|813-745-1600|Patricia.Judson@moffitt.org|
21243667|NCT03873337|Rutgers Robert Wood Johnson Medical School|Marc L. Steinberg, Ph.D.|732-235-4341|marc.steinberg@rutgers.edu|
21243668|NCT02512965|Canadian Cancer Trials Group|Dr. Keyue Ding|16135336430|kding@ctg.queensu.ca|77705
21243669|NCT00835770|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21243670|NCT02507752|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21243671|NCT01369498|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21243672|NCT02384070|Odessa Heart Institute / Permian Research Foundation|Fernando Boccalandro MD FACC FSCAI|432-3373117|Fboccalandro@echd.org|
21243673|NCT01394510|VA Puget Sound Health Care System|Kristina Utzschneider, MD|206-277-3568|kutzschn@uw.edu|6-3568
21243674|NCT02539108|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21243675|NCT02202499|H. Lee Moffitt Cancer Center and Research Institute|Dr. Thomas Brandon|813-745-1750|thomas.brandon@moffitt.org|
21243676|NCT01852071|Orchard Therapeutics (Europe) Ltd|Orchard Medical Information|+44 (0) 203 808 8286|medinfo@orchard-tx.com|
21243677|NCT01240330|Venous Health Systems, Inc.|Director of Quality Assurance & Operations|(650)646-3327|rlaguna@venoushealth.com|104
21243678|NCT00159783|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21243679|NCT02538107|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21243680|NCT01236560|Children's Oncology Group|Results Reporting Coordinator|626-446-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21243681|NCT02471755|Guang'anmen Hospital of China Academy of Chinese Medical Sciences|Dr.Xiaoxu Liu|+86 10 8800 1124|liuxiaoxu_lxx@163.com|
21243682|NCT01576484|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
21243683|NCT00581854|University of Wisconsin|Brad S Kahl, MD|608-263-1836|bsk@medicine.wisc.edu|
21243684|NCT00958633|University Of British Columbia|Dr. Lakshmi Yatham|604-822-7310|yatham@mail.ubc.ca|
21243685|NCT01243619|Brigham and Women's Hospital / Dana Farber Cancer Institute|Harvey Mamon MD, PhD|617-732-8564|hmamon@lroc.harvard.edu|
21243686|NCT01071993|University of Oklahoma|Mazen Abu-Fadel, MD|405-271-4742|mazen-abufadel@ouhsc.edu|
21243687|NCT01499654|Northwestern University|Edwin Wu, MD|847-535-7270|ed-wu@northwestern.edu|
21243688|NCT01576952|InSite Vision|Senior Manager, Clinical Sciences||manjiri.desai@sparcmail.com|
21243689|NCT00094575|VAMC Minneapolis, MN|Dr. Frank A. Lederle|612-725-2158|Frank.Lederle@va.gov|
21243690|NCT00794118|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21243691|NCT00837616|Nemours Children's Clinic|Dr. Nelly Mauras|(904) 697-3674|nmauras@nemours.org|
21243692|NCT04090190|Mass General Brigham|Vatche Minassian, MD, MPH|(617) 732-4838|vminassian@bwh.harvard.edu|
21243693|NCT00042224|Northshore LIJ Health System|Georgios Petrides, M.D.|718-470-8569|GPetride@NSHS.EDU|
21243694|NCT03512756|Tyme, Inc.|Study Director|617-674-9069|Maria.Loushin@TymeInc.com|
21243695|NCT03312907|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21243696|NCT04688450|Massachusetts General Hospital|Dr. Andrew Tomas Reisner|617-726-2241|areisner@mgh.harvard.edu|
21243697|NCT04498052|University of Utah|Kensaku Kawamoto, MD, PhD, MHS / Associate Chief Medical Information Officer|801-581-4080|kensaku.kawamoto@utah.edu|
21243698|NCT03189524|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21243699|NCT04879524|Queen Mary University of London|P Chaichanavichkij|020 7882 8752|p.chaichanavichkij@qmul.ac.uk|
21243700|NCT01780298|Philip Morris Products S.A.|Julia HOENG, PhD|+41 (58) 242 2214|clinicaltrials.pmi@pmi.com|
21243701|NCT03718065|Medical University of South Carolina|Dr. Constance Guille|843-792-6489|guille@musc.edu|
21243702|NCT05286385|Cochlear Ltd.|PRS Specialist, Clinical Affairs|+61294286555|cltd-prs-admin@cochlear.com|
21243703|NCT03803605|University of North Carolina at Chapel Hill|Cynthia Gay, MD, MPH|919-966-2537|cynthia_gay@med.unc.edu|
21243704|NCT01875848|VACT West Haven HealthCare System|William, Becker M.D|203-932-5711|william.becker4@va.gov|2247
21243705|NCT02407249|Abbott|Clinical Program Director|6517566717|kristin.ruffner@abbott.com|
21243706|NCT01622868|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21243707|NCT04252586|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
21243708|NCT00232180|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21243709|NCT02748317|MedStar Health Research Institute|Inger Ljungberg|202-877-1694|inger.h.ljungberg@medstar.net|
21243710|NCT00687167|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21243711|NCT01149369|Johns Hopkins Data Coordinating Center|Katherine Yates|443-287-0082|kyates1@jhu.edu|
21243712|NCT02767765|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21243713|NCT04723394|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21243714|NCT00774397|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21243715|NCT01599793|University of Chicago|Russell Szmulewitz, MD|773-702-7609|rszmulew@medicine.bsd.uchicago.edu|
21243716|NCT02966275|MGH|Courtney Balliro BS, RN, CDE|617-726-1242|cballiro@partners.org|
21243717|NCT00665444|University of Pittsburgh|Holly Swartz, MD|412-246-5588|swartzha@upmc.edu|
21243718|NCT00101010|UT MD Anderson Cancer Center, Community Clinical Oncology Program Research Base|Alma Rodriguez, MD, Lymphoma||CR_Study_Registration@mdanderson.org|
21243719|NCT01185782|Merck Serono Co., Ltd., Japan, an affiliate of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21243720|NCT00149838|MUSC|Mark S. George, MD, Professor|8438700368|georgem@musc.edu|
21279841|NCT00855894|Genentech, Inc.|Medical Communications|800 821-8590||
21261949|NCT04661813|University of Washington|Dr. Chris Longenecker|2066161159|ctlongen@uw.edu|
21261950|NCT03118843|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21261951|NCT04285723|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21261952|NCT03067311|University of North Carolina at Chapel Hill|David Penn, PhD|(919) 843-7514|dpenn@email.unc.edu|
21261953|NCT02747628|Ain-Shams University Hospitals|Dr. Ibrahim Mamdouh Esmat|01001241928|ibrahim_mamdouh@med.asu.edu.eg|
21261954|NCT01089725|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21261955|NCT06384989|The Ohio State University|Julie Mansfield|614-366-2101|julie.mansfield@osumc.edu|
21261956|NCT05287893|Medicines for Malaria Venture|Joerg Moehrle|+41 22 555 03 00|info@mmv.org|
21261957|NCT01486316|Medtronic, Inc|Rachael Rose, Clinical Research Specialist|763-526-2332|rachael.k.rose@medtronic.com|
21261958|NCT03191396|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21261959|NCT05094154|Vanderbilt University Medical Center|Edward T Qian, MD|615-322-2386|edward.t.qian@vumc.org|
21261960|NCT00945750|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21261961|NCT00893113|Chesapeake Urology Research Associates|Ronald Tutrone, MD|443.471.5742|hthomas@cua.md|
21261962|NCT02133235|NTUH|YJ Cheng|886-2-23123456|chengyj@ntu.edu.tw|62158
21261963|NCT02531035|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21261964|NCT02898207|Dana-Farber Cancer Institute|Dr. Panagiotis Konstantinopoulos|617-632-5269|Panagiotis_Konstantinopoulos@dfci.harvard.edu|
21261965|NCT01240811|University of Pittsburgh|Sharon Achilles, MD, PhD|412-641-1403|achisx@upmc.edu|
21261966|NCT03990766|Washington University School of Medicine|Dr. Jake Lee|3143937248|jakejlee@wustl.edu|
21243721|NCT03740009|UNC School of Medicine|Crystal Schiller, PhD|919-966-4810|crystal_schiller@med.unc.edu|
21261967|NCT03726671|University of North Carolina at Chapel Hill|Julie M. Stegall, MSW|704-250-5048|julie_stegall@unc.edu|
21261968|NCT04192448|Eastern Michigan University|Elizabeth Neilson|734-487-4988|eneilso1@emich.edu|
21261969|NCT01976819|University Medical Center Groningen and University of Groningen|Prof. Dr. Bernard F.A.M. van der Laan, PhD, MD|0031 (50) 361 27 00|b.f.a.m.van.der.laan@umcg.nl|
21261970|NCT02400346|H. Lundbeck A/S|Email contact via||LundbeckClinicalTrials@Lundbeck.com|
21261971|NCT02114203|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21261972|NCT01518699|Dr. Reddy's Laboratories Inc.|Dr Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
21261973|NCT02110108|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
21261974|NCT04510922|University of Cincinnati|Alberto Espay, MD, MSc|5135584050|espayaj@ucmail.uc.edu|
21261975|NCT01997567|Rush University Medical Center Department of Anesthesiology|Sandeep Amin, M.D|312-942-6449|Sandeep_Amin@rush.edu|
21261976|NCT00486226|Codman&Shurtleff|Arnaud Nicolas|+33 0 155 004 543|anicolas@its.jnj.com|
21261977|NCT01856491|Boston Scientific|Anneleen Viville|0032479983495|anneleen.viville@bsci.com|
21261978|NCT01981122|Dendreon|Shabnam Vaziri|206.455.2323|svaziri@Dendreon.com|
21261979|NCT04021472|VA Bedford Healthcare System|Timothy P. Hogan|781-687-3181|timothy.hogan@va.gov|
21243722|NCT00523237|Stanford University|Philip Grant, MD|650-723-2804|pmgrant@stanford.edu|
21243723|NCT01061151|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
21243724|NCT01236001|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
21243725|NCT01691690|Nationwide Children's Hospital|Dr. Arlyne Thung|(614) 722-4200|Arlyne.Thung@NationwideChildrens.org|
21243726|NCT05082935|University of Oregon|Dr. Leslie Leve|541-346-9528|leve@uoregon.edu|
21243727|NCT02122445|Sport and Spine Rehab Clincal Research Foundation|Jena Slaski|301-251-2777|jslaski@ssrehab.com|838
21243728|NCT01937507|CTCA|Jessica L. Coats|6232073899|jessica.coats@ctca-hope.com|
21243729|NCT01444417|Amgen Inc.|Study Director|866-572-6436||
21243730|NCT01047241|Copenhagen University Hospital, Rigshospitalet|Sponsor's contact person Bettina Nygaard Nielsen|+45 35459546|bettina.nygaard.nielsen@regionh.dk|
21243731|NCT03531840|National Cancer Institute|Dr. Raffit Hassan|240-760-6232|raffit_hassan@nih.gov|
21243732|NCT02092116|Bionor Pharma ASA|Maja Sommerfelt|+4723010960|ms@bionorpharma.com|
21243733|NCT00770757|Washington University School of Medicine|John F. DiPersio, M.D., Ph.D.|314-454-8603|jdipersi@dom.wustl.edu|
21243734|NCT01546753|University of Arkansas for Medical Sciences|Dr. Stacie Jones|(501) 364-1060|JonesStacieM@uams.edu|
21243735|NCT00939510|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Robert Dreicer|216-445-4623|dreicer@ccf.org|
21243736|NCT05444244|University of Wisconsin School of Medicine and Public Health|Andrea Gilmore-Bykovskyi|6082623057|algilmore@wisc.edu|
21243737|NCT05061693|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21243738|NCT03823911|Institute of Human Virology, University of Maryland School of Medicine|Dr. Poonam Mathur|410-706-4745|pmathur@ihv.umaryland.edu|
21243739|NCT04009577|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
21243740|NCT01600729|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21243741|NCT03302741|The University of Texas Health Science Center at Houston|Sheng Li, MD, PhD|713-797-7125|sheng.li@uth.tmc.edu|
21243742|NCT03994705|Cartesian Therapeutics|Dr. Vera Sarkodie Medical Director,|617-231-8085|vera.sarkodie@cartesiantx.com|
21243743|NCT00305695|NRG Oncology|Linda Gedeon on behalf of James Kauderer, MA, BS|716-845-1169|linda.gedeon@roswellpark.org|
21261980|NCT00283712|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21261981|NCT03321617|New York State Psychiatric Institute|Ragy Girgis, MD|646-774-5553|ragy.girgis@nyspi.columbia.edu|
21243744|NCT01649180|ECOG-ACRIN Biostatistics Center|PrECOG Statistician|617-632-3633|jmanola@jimmy.harvard.edu|
21243745|NCT00233519|University of Rochester Medical Center|Richard T. Moxley, III MD|585-275-5006|RichardT_Moxley@urmc.rochester.edu|
21279842|NCT03395288|Washington University|Jerry Lowder, MD|314-362-0063|lowderj@wustl.edu|
21243746|NCT04305405|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21243747|NCT05714696|Florida State University College of Medicine|Dr. Mary Gerend|8506451541|mary.gerend@med.fsu.edu|
21243748|NCT02674750|Curis, Inc.|Reinhard von Roemeling, M.D., Senior Vice President, Clinical Development|617-503-6500|rvonroemeling@curis.com|
21243749|NCT00028093|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Combination of Pegylated Interferon and Ribavirin as Therapy for Patients With Chronic Hepatitis C W|3014961333|hoofnaglej@extra.niddk.nih.gov|
21243750|NCT01685606|Brown University Oncology Research Group (BrUOG)|Dr. Peter Quesenberry|4018633000|kayla_rosati@brown.edu|
21243751|NCT00940537|Washington University School of Medicine|Gary Skolnick|314-362-5292|gskolnic@wustl.edu|
21243752|NCT01787760|Vistakon, USA|XU CHENG, PRINCIPAL CLINICAL SCIENTIST|1 904 443-1245|xcheng6@its.jnj.com|
21243753|NCT01597258|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21243754|NCT01212991|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21243755|NCT02531113|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email:|Clinical.Trials@bms.com|
21243756|NCT04120454|The Ohio State University Comprehensive Cancer Center|Dr. Asrar Alahmadi|614-293-6786|Asrar.Alahmadi@osumc.edu|
21243757|NCT04411056|The Guthrie Clinic|Praneet Madabhushi MD|5708874882|praneeth.madabhushi@guthrie.org|
21243758|NCT04623008|Ohio State University College of Nursing|Mei-Wei Chang, PhD|614-247-7211|chang.1572@osu.edu|
21243759|NCT03568422|Canadian Cancer Trials Group|Pierre-Olivier Gaudreau|6135336430|p-ogaudreau@ctg.queensu.ca|
21243760|NCT02631603|LMU/ Haunersches Kinderspital|Prof. Dr. med. Matthias Griese|+498944000|matthias.griese@med.uni-muenchen.de|57870
21243761|NCT03122886|Mayo Clinic|Aminah Jatoi, MD|507/284-2511|Jatoi.Aminah@mayo.edu|
21243762|NCT02460900|NIH|National Heart, Lung and Blood Institute--Josh Fessel|3018275514|josh.fessel@nih.gov|
21243763|NCT04888637|University of Arkansas for Medical Sciences (UAMS)|University of Arkansas for Medical Sciences (UAMS)|501-526-6876|ORRAClinicalTrials-govadmin@uams.edu|
21243764|NCT02279095|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
21243765|NCT05938413|Columbia University|Rebecca Schnall, PhD, MPH, RN|212-342-6886|rb897@cumc.columbia.edu|
21243766|NCT03481777|Aarhus University Hospital|Dr. Rolf Blauenfeldt|0045 78450000|rolfblau@rm.dk|
21243767|NCT04046848|Octapharma|Sigurd Knaub, Senior VP CR&D Haematology|01554512141|Sigurd.Knaub@octapharma.com|
21243768|NCT03190174|Sarcoma Oncology Research Center|Erlinda M. Gordon, MD/Principal Investigator|310-552-9999|egordon@sarcomaoncology.com|
21243769|NCT02879162|Canadian Cancer Trials Group|Dr. Janet Dancey|6135336000|jdancey@ctg.queensu.ca|75606
21243770|NCT03613740|University of Guadalajara|PhD. Karina G. Pérez Rubio|+52 1 3310585200|karina.prubio@academicos.udg.mx|
21243771|NCT03452189|NYU Langone Health|Dr. Jerome Lowenstein|+1 212 263 5635|Jerome.Lowenstein@nyulangone.org|
21243772|NCT02724592|University of Greifswald|Dr. Mohammad Alkilzy|0049-17623399340|alkilzym@uni-greifswald.de|
21243773|NCT00687713|National Institute on Drug Abuse|Ann Anderson, MD|301-827-5916|aanderso@nida.nih.gov|
21243774|NCT02374463|Baltimore VA Medical Center|Leslie Katzel, MD, PhD|410-605-7248|leslie.katzel@va.gov|
21243775|NCT01424397|GlaxoSmithKline|GSK Response Center|866-435-7343||
21243776|NCT01951170|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21243777|NCT01318967|Wake Forest School of Medicine|Michael Rocco, MD|336-716-4650|mrocco@wfubmc.edu|
21243778|NCT04676334|pharmaand GmbH|Medical Information Department|+43/1/3560006|medinfo@pharmaand.com|
21243779|NCT01965665|Duke University Medical Center|Michael Kerzner, DMP|919-613-4449|michael.kerzner@duke.edu|
21243780|NCT00077675|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
21243781|NCT02355275|Sport & Spine Rehab Clinical Research Foundation|Jena Slaski|301-251-2777|jslaski@gmail.com|838
21243782|NCT02601820|University of North Carolina at Chapel Hill|Donna Evon, PhD|919-260-4062|donna_evon@med.unc.edu|
21243783|NCT01972724|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21243784|NCT04530149|Maimonides Medical Center|Research Administration Director|7182836896|alikourezos@maimo.org|
21243785|NCT00538759|Minneapolis Heart Institute Foundation|Lisa Tindell, Director of Clinical Operations|6128633816|Lisa.Tindell@allina.com|
21243786|NCT02652442|James H Quillen VAMC|Research Health Science Specialist|(423) 926-1171|courtney.hall@va.gov|7518
21243787|NCT00244855|Fred Hutchinson Cancer Research Center|Dr. David Maloney|206-667-5616|dmaloney@fredhutch.org|
21243788|NCT01911169|Medical University of South Carolina|Dr. James Oates|843-789-6797|oatesjc@musc.edu|
21243789|NCT00364013|Amgen Inc.|Study Director|866-572-6436||
21243790|NCT01149512|Royal Alexandra Hospital|Xinzhe Shi|7807356735|xinzhe.shi@ahs.ca|
21243791|NCT01574807|Division of Endodontics|Dr. John Nusstein|614-292-3596|nusstein.1@osu.ed|
21243792|NCT04530747|Pennington Biomedical Research Center|Prachi Singh|12257633151|prachi.singh@pbrc.edu|
21243793|NCT03292913|RTI International Institute|Megan Lewis|206-268-3613|melewis@rti.org|
21243794|NCT03950622|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21243795|NCT04056624|East Carolina University, Department of Public Health|Stephanie Jilcott Pitts|252-744-5572|jilcotts@ecu.edu|
21243796|NCT03977935|Changhai Hospital|Investigator of Clinical Trials|15021569528|1372971347@qq.com|
21243797|NCT02267824|Shaughnessy Orthodontics|Dr. Timothy Shaughnessy|770-495-9590|staff@straightteethdoc.com|
21243798|NCT04086966|University of Alabama at Birmingham|April Riddle|(205)934-6504|ariddle@uabmc.edu|
21243799|NCT02933944|Targovax|Chief Medical Officer|+ 47 21398810|contact@targovax.com|
21243800|NCT00995904|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
21243801|NCT01832480|Tulane University School of Public Health and Tropical Medicine|Patricia Kissinger, Ph.D.|504-988-7320|kissing@tulane.edu|
21292349|NCT01205503|Markey Cancer Center Biostatistics Shared Resource Facility|Emily Dressler, PhD|859 323-3076|emilydressler@uky.edu|
21292350|NCT00776789|AIIMS|Dr Anu Thukral|01126594605|dranuthukral@yahoo.com|
21292351|NCT00570713|Morphotek, Inc.|Susan Weil, MD|610-423-6182|sweil@morphotek.com|
21243802|NCT02261467|Allergan, Inc|Tanya Brandstetter|714-246-2567|brandstetter_tanya@Allergan.com|
21243803|NCT00736853|Neuroscience Department, Clinical Science Division, R&D, JANSSEN PHARMACEUTICAL. K.K.|Medical Director|+81-3-4411-5509||
21243804|NCT01764464|University of Rochester|John Markman|585-276-3616|john_markman@urmc.rochester.edu|
21243805|NCT03762213|Arkansas Children's Hospital|Dr. Saumya V Joshi|501-364-4619|svjoshi@uams.edu|
21243806|NCT02918071|AstraZeneca|Ubaldo Martin, Global Clinical Lead Benralizumab|+1 301 398 0163|Ubaldo.Martin@astrazeneca.com|
21243807|NCT03473340|University of Michigan|VIbha Lama|734-936-5010|vlama@med.umich.edu|
21243808|NCT02079844|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
21243809|NCT01401023|Michigan State University|Dr. Gary Stein, Pharm D|517-353-5126|steing@msu.edu|
21243810|NCT03394885|Duke Cancer Center|Dr. Angeles Alvarez Secord|919-684-3765|angeles.secord@duke.edu|
21243811|NCT00203411|Translational Research in Oncology|Dr. Arash Naeim|310 267-6810|anaeim@mednet.ucla.edu|
21243812|NCT04980755|University of Plymouth|Dr Joseph Lanario|01752 764403|joseph.lanario@plymouth.ac.uk|
21243813|NCT03949335|Johnson & Johnson Surgical Vision|Eugenia Thomas, OD|+1 657 2903260|ethoma39@its.jnj.com|
21243814|NCT01351272|Universitätsklinikum Würzburg|Prof. Dr. M. Herrmann|093120176650|Herrmann_m@ukw.de|
21243815|NCT01926977|Sierra Eye Associates|Arshad Khanani M.D., Vitreo-Retinal Diseases and Surgery|775-329-0286|arshad.khanani@gmail.com|
21243816|NCT00632424|Organization: Bristol-Myers Squibb|Name/Official Title: BMS Study Director||Clinical.Trials@bms.com|
21243817|NCT00801983|University of Pittsburgh|Dr. Nancy Baker|412 383-6607|nab36@pitt.edu|
21243818|NCT02270645|University of Miami|Keyvan Nouri|3052433380|knouri@med.miami.edu|
21243819|NCT03149991|Massachusetts General Hospital|Dr. Rebecca Hock|617-872-3711|rhock@mgh.harvard.edu|
21243820|NCT00981630|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21243821|NCT03702842|University of Florida|Emily J Fox, Research Associate Professor|352-273-6085|ejfox@phhp.ufl.edu|
21243822|NCT05985044|Johns Hopkins University School of Nursing|Dr.Binu Koirala|707-225-2166|bkoiral1@jhu.edu|
21243823|NCT04520061|Mass General Hospital|Lisa Morse|617-724-2000|lgmorse@partners.org|
21243824|NCT04163328|UAB|Dr. Kelly K. Nichols|205-975-9935|nicholsk@uab.edu|
21243825|NCT03314753|Medtronic|Study Project Manager (CSM)|00491742122|petra.kremer@medtronic.com|081
21243826|NCT01285999|Cardiovascular Institute and Fu Wai Hospital|Dr. Runlin Gao|+861068314466|gaorunlin@citmd.com|
21243827|NCT04714320|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
21243828|NCT00402896|The University of Texas (UT) MD Anderson Cancer Center|Carlos A. Jimenez, MD/Professor, Pulmonary Medicine||CR_Study_Registration@mdanderson.org|
21243829|NCT04425629|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
21243830|NCT03113617|Stanford Medicine at Stanford University|David G Marcellus|650-723-4547|dmarcel2@stanford.edu|
21243831|NCT04259450|Affimed GmbH|Clinical Operations|+49 62216530770|trials@affimed.com|
21243832|NCT03390296|The University of Texas MD Anderson Cancer Center|Naval Daver MD./Associate Professor|713-794-4392|NDaver@mdanderson.org|
21243833|NCT00542789|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21243834|NCT01714492|The University of Tennessee|Richard Komistek, Ph. D.|8659744159|rkomiste@utk.edu|
21243835|NCT02584829|Fred Hutchinson Cancer Research Center|Dr. Aude Chapuis|2066674369|achapuis@fredhutch.org|
21243836|NCT01950780|Columbia University Dept of Dermatology|Director of Clinical Research Dermatology|2123056953|jc299@cumc.columbia.edu|
21243837|NCT00434304|GlaxoSmithKline|GSK Response Center|866-435-7343||
21243838|NCT05262738|University of Texas at Austin, Dell Medical School|Alexander Saucedo, MD|210-845-7571|alexander.saucedo@ascension.org|
21243839|NCT00639860|University of Michigan School of Dentistry|Dr. William Giannobile, Chair Department of Periodontics and Oral Medicine|734-763-2105|wgiannob@umich.edu|
21292352|NCT03289533|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21243840|NCT03538717|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21243841|NCT01305252|Stanford University School of Medicine|Roham Zamanian, MD, FCCP|650- 725-5495|zamanian@stanford.edu|
21243842|NCT00804648|Vistakon|Arthur Shedden MD|904-443-1557||
21243843|NCT03631433|OSU|Dr. Melissa Drum|6142923596|drum.13@osu.edu|
21243844|NCT00446459|University of Washington|Dr. Connie L. Davis|206-598-7162|cdavis@u.washington.edu|
21243845|NCT00253890|Butler Hospital|Dr. Michael D. Stein, MD|401-455-6646|mstein@butler.org|
21243846|NCT00858117|Northwestern University|Olga Frankfurt, MD|312 695 6180|o-frankfurt@northwestern.edu|
21243847|NCT00371787|Centre for Contact Lens Research|Dr. Craig Woods|1-519-888-4567|cawoods@uwaterloo.ca|36547
21243848|NCT02115828|Johns Hopkins University|Emmanuel Antonarakis, MD|410-502-7528|eantona1@jhmi.edu|
21243849|NCT02765100|Weill Cornell Medicine|James H Kocsis, M.D.|212-746-5913|jhk2002@med.cornell.edu|
21243850|NCT01514149|ConjuChem Biotechnologies Inc.|Associate Director of Regulatory Affairs|310-405-7549|Aleece.Nolasco@nantbio.com|
21243851|NCT02597920|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21243852|NCT04977700|Klein Buendel, Inc.|Julia Berteletti|303-565-4321|jberteletti@kleinbuendel.com|
21243853|NCT02675244|Icahn School of Medicine at Mount Sinai|Annetine Gelijns|212-659-9567|annetine.gelijns@mountsinai.org|
21243854|NCT01900249|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
21243855|NCT01065506|The University of Texas at Austin|Jasper Smits|512-475-8095|smits@utexas.edu|
21243856|NCT00391898|Novartis Pharmaceuticals|Study Director|862 778-8300||
21243857|NCT01035658|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21292353|NCT00539240|Southern Arizona VA Health Care System|Christopher Wendel, MS|520 792 1450|christopher.wendel@va.gov|1824
21292354|NCT00902330|Virginia Commonwealth University|Debra Lyon, RN, PhD, FNP|804-828-7743|delyon@vcu.edu|
21292355|NCT01816048|University of Wisconsin Carbone Cancer Center|Dr. Justine Bruce|608-262-4961|jybruce@medicine.wisc.edu|
21292356|NCT01847443|GlaxoSmithKline|GSK Response Center|866-435-7343||
21292357|NCT03571971|The Ohio State University|Stephanie Di Stasi, Principal Investigator|614-293-4220|stephanie.distasi@osumc.edu|
21292358|NCT04067492|R-Pharm|D.V. Bukhanova, Medical Adviser|0074959567|bukhanova@rpharm.ru|3838
21292359|NCT00956384|University Health Network|Dr. Toni Zhong|4163404800|kbutler@uhnresearch.ca|2343
21292360|NCT03096886|University of Pennsylvania|Dr. Yvette Sheline|(215) 573-0082|sheline@pennmedicine.upenn.edu|
21292361|NCT03950856|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21292362|NCT03111030|Unviersity of British Columbia|Dr. Kathleen Martin Ginis|250-807-9768|Kathleen_martin.ginis@ubc.ca|
21292363|NCT04021290|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21292364|NCT03391882|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
21292365|NCT03092479|Geisinger Clinic|Michelle Lent, PhD|5702141004|mrlent1@geisinger.edu|
21292366|NCT00896012|University at Buffalo|Oleh G. Pankewycz, MD||opankewycz@kaleidahealth.org|
21292367|NCT01173679|Massachusetts General Hospital|Philip C. Amrein, M.D.|6177243456|pamrein@partners.org|
21292368|NCT03531814|National Cancer Institute|Staci M Peron, Ph.D.|240-760-6025|martins@mail.nih.gov|
21292369|NCT01053507|Clinvest/A Division of Banyan Group, Inc.|Dr. Roger K. Cady|417-841-3673|jtarrasch@clinvest.com|
21292370|NCT03247829|Abbott_Medical_Devices|Dr. Marie-Elena Brett, PhD; Principal Scientist Clinical Research|17815283613|marieelena.brett@abbott.com|
21292371|NCT00441272|National Institute of Allergy and Infectious Diseases|Colleen Hadigan, MD, MPH|301-594-5754|hadiganc@niaid.nih.gov|
21292372|NCT00443703|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21292373|NCT01047007|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21292374|NCT03702179|SOGUG|A contact designated by the Sponsor|+34671422325|secretaria@sogug.es|
21292375|NCT03423602|Vivasure Medical Ltd|Dr Chris Martin|+353 91 395 442|chris.martin@vsuremed.com|
21292376|NCT02098304|Clark & Watson Dental Practice|Dr Charles Ormond|+44 (0)1324 623445|charlesormond@nhs.net|
21292377|NCT01047189|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-3775|sfeldman@wfubmc.edu|
21292378|NCT00988156|BIAL - Portela & Cª, S.A.|Director R&D|351-22-9866100|clinical.trials@bial.com|
21292379|NCT02554799|Medicines for Malaria Venture|Dr Cristina Donini|+41 22 555 0312|doninic@mmv.org|
21292380|NCT03046446|Flexion Therapeutics|Scott Kelley, Chief Medical Officer|781-305-7142|skelley@flexiontherapeutics.com|
21292381|NCT02970136|University of Miami|Olveen Carrasquillo|305-243-5505|ocarrasquillo@miami.edu|
21292382|NCT03012334|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21292383|NCT01823107|DSM Biomedical|Forde Hansell|484-713-2152|forde.hansell@dsm.com|
21292384|NCT00305448|Astrazeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
21292385|NCT00002766|Memorial Sloan Kettering Cancer Center|Dr. Peter Maslak|212-639-5518|maslakp@mskcc.org|
21292386|NCT00328172|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21292387|NCT00077974|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21292388|NCT01343888|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21292389|NCT00003816|Roswell Park Comprehensive Cancer Center|Theresa Hahn, PhD|716-845-5819|theresa.hahn@roswellpark.org|
21292390|NCT00558636|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21292391|NCT00387088|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21292392|NCT01990742|University of Rochester|Dr. Helena Temkin-Greener|585-275-8713|Helena_Temkin-Greener@urmc.rochester.edu|
21292393|NCT03443687|University of New Mexico, Dept OBGYN|Dr. Gena Dunivan|5052729712|gdunivan@salud.unm.edu|
21292394|NCT02178800|Fred Hutch Cancer Research Center|Gordon Chau|2066672118|gchau@fredhutch.org|
21292395|NCT02805790|Stealth BioTherapeutics Inc.|Rekha Sathyanarayana, Executive Director, Clinical Operations|617-762-2579|Rekha.Sathyanarayana@stealthbt.com|
21292396|NCT00800735|Hoffmann-La Roche|Medical Communications|800 821-8590||
21292397|NCT03715790|Medtronic Cardiac Rhythm Management|CRM Clinical Research|1-800-328-2518|rs.medtronicCRMtrials@medtronic.com|
21292398|NCT00441766|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21292399|NCT00901303|Weill Cornell Medicine|Dr. Peter Martin||pem9019@med.cornell.edu|
21292400|NCT02071771|Alcon Research, Ltd.|Sr Global Brand Lead, GCRA, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21292401|NCT02078752|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21292402|NCT01144143|University of Kansas Medical Center|Dr. Herbert Lindsley|(913) 588-3402|HLINDSLE@kumc.edu|
21292403|NCT01331681|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21292404|NCT00616642|University of California Los Angeles|Anthony Heaney, M.D. Ph.D|310 267 4980|aheaney@mednet.ucla.edu|
21292405|NCT03856359|Duke University Hospital|Dr. Paul V. Suhocki|919-684-7284|suhoc001@mc.duke.edu|
21292406|NCT01664247|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21292407|NCT00382174|RegeneRx Biopharmaceuticals, Inc.|Nabila Turjman, PhD, Executive Director, Regulatory Affairs|301-280-1992|nturjman@regenerx.com|108
21292408|NCT02160288|Massachusetts General Hospital|Dr Liliana Bordeianou|6176430541|lsavitt@mgh.harvard.edu|
21292409|NCT04577781|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
21292410|NCT03763747|OrbusNeich|Stephen M. Rowland, PhD - Vice-President, Research and Development|954-730-0711|srowland@orbusneich.com|
21235333|NCT01936259|Zimmer Biomet, Inc.|Director of Clinical Operations|800-613-6131|clinicaldirector@zimmerbiomet.com|
21235334|NCT02660918|Christiana Care Health System|Dr. Matthew Hoffman Chair Department of OB/GYN|302 733 3350|mhoffman@christianacare.org|
21235335|NCT00245557|McLean Hospital|Brent Forester MD|617-855-3622|bforester@mclean.harvard.edu|
21235336|NCT01362907|Alcon Research|Joachim Nick, Dipl. Ing. (FH)|+49 6022 240 520|joachim.nick@cibavision.com|
21235337|NCT02978690|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21235338|NCT01826825|Brigham and Women's Hospital|Deborah J. Culley, M.D., Principal Investigator|6177327330|dculley@bwh.harvard.edu|
21235339|NCT00515827|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21235340|NCT00850031|AcuFocus, Inc|Eugenia Thomas, Director Clinical Trials|949/585-9511|nthomas@acufocus.com|129
21235341|NCT03254134|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21235342|NCT00075829|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
21235343|NCT01712984|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21235344|NCT01552772|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21235345|NCT01848990|Halozyme Therapeutics|Dimitrios Chondros, M.D., Chief Medical Officer|858-794-8889|dchondros@halozyme.com|
21279843|NCT01983566|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21279844|NCT02753920|Northwell Health|Marjorie Pilkinton|5166225114|mlpilk@gmail.com|
21279845|NCT00181714|Massachusetts General Hospital|Paul Hammerness, MD|617-503-1063|phammerness@partners.org|
21279846|NCT03437031|Cedars Sinai|Melissa Wong, MD MHDS|310-423-0895|wongmsx@cshs.org|
21279847|NCT02794870|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
21279848|NCT00979199|CNR Institute of Clinical Physiology, Pisa, Italy and Fondazione Toscana G. Monasterio, Pisa, Italy|Dr. Danilo Neglia|+390503152019|dneglia@ifc.cnr.it|2019
21279849|NCT01608061|Functional Neuromodulation|Todd Langevin|7636071214|todd@fxneuromod.com|
21279850|NCT06376682|quantum surgical|MESSNER Laetitia, Chief Clinical officer|+33 (0) 4 48 19 40 50|clinical.department@quantumsurgical.com|
21279851|NCT01625988|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21279852|NCT00616421|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@Novartis.com|
21279853|NCT02301390|Icahn School of Medicine at Mount Sinai|Betsy Ellsworth, Research Program Director|212-824-8902|betsy.ellsworth@mountsinai.org|
21279854|NCT00191191|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21279855|NCT01103492|University Hospitals Case Medical Center|Jeffrey Marks, MD|216-983-4930|Jeffrey.Marks@uhhospitals.org|
21279856|NCT01023035|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21279857|NCT04342819|The University of the West Indies|Naveen Seecheran, Senior Lecturer|18687537686|Naveen.Seecheran@sta.uwi.edu|
21235346|NCT00895180|Sidney Kimmel Comprehensive Cancer Center|Dr. Jaishri Blakely|(410) 955-8893||
21235347|NCT03090256|Alcon Research|Expert Clinical Project Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21235348|NCT02553746|424 Army General Hospital|Georgios Kotsovolis|+306948182743|gskotsos@gmail.com|
21235349|NCT02489227|Coherus BioSciences, Inc.|Barbara K. Finck, MD|650-649-3530|bfinck@coherus.com|
21235350|NCT00512096|UT MD Anderson Cancer Center|Cherie A. Perez||caperez@mdanderson.org|
21235351|NCT03212963|Sun Pharma Advanced Research Company Ltd.|Head, Clinical Development|912266455645|clinical.trials@sparcmail.com|
21235352|NCT01312766|IBSA Institut Biochimique SA|Dr. Barbara Cometti, Senior Clinical Research Manager, IBSA|+41 58 360 10 00|barbara.cometti@ibsa.ch|
21235353|NCT02391948|University of Washington|Sarah Westcott McCoy PT, PhD, FAPTA|206-616-8601|westcs@uw.edu|
21235354|NCT01602315|Novartis Pharmaceuticals|Study Director|862-778-8300||
21235355|NCT00593372|UAMS Medical Center|Gary McCullough|501-852-7886|garyhmccullough@uams.edu|
21235356|NCT02212730|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21235357|NCT05711069|Hacetepe University|Ceyda Sofuoğlu M.Sc.|+905338557742|ceyda_sofuoglu@hotmail.com|
21235358|NCT02691455|The University of Texas Health Science Center at Houston|Robert M. Feldman, MD|(713) 559-5239|Robert.M.Feldman@uth.tmc.edu|
21235359|NCT02057757|National Institute of Allergy and Infectious Diseases (NIAID)|Dr. John Beigel|301-451-9881|jbeigel@niaid.nih.gov|
21235360|NCT00440271|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21235361|NCT02514252|UT MD Anderson Cancer Center|Suresh K. Reddy, MD/Professor, Palliative Care Med|(713) 794-5362|sreddy@mdanderson.org|
21235362|NCT01268644|UT Southwestern Medical Center|Dr. Abhimanyu Garg|2146482895|abhimanyu.garg@utsouthwestern.edu|
21235363|NCT01416194|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21279858|NCT01012336|Samsung Medical Center|Pf Duk-Soo Bae|82-2-3410-3519|huna0@naver.com|
21279859|NCT02664181|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Nathan Pennell|1-866-223-8100|TaussigResearch@ccf.org|
21279860|NCT00560391|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21279861|NCT03607487|Incyte Corporation|Incyte Corporation Call Center|1-855-463-3463|medinfo@incyte.com|
21279862|NCT05061420|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
21279863|NCT01814553|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21279864|NCT04036110|University of North Carolina at Chapel Hill|Jia-Rong Wu, PhD, RN|859-323-4712|jiarong.wu2@uky.edu|
21279865|NCT01941498|Alcon Research, Ltd.|Clinical Project Lead, GCRA, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21279866|NCT01301729|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21279867|NCT05794503|UT Southwestern Medical Center|Tiffany Moon, MD|(214) 648-6400|tiffany.moon@utsouthwestern.edu|
21292411|NCT02478489|Boston University School of Public Health and School of Medicine|Richard Saitz, MD MPH|(617) 358-1343|rsaitz@bu.edu|
21292412|NCT01120405|Population Health Research Institute - Mc Master University, Hamilton CANADA|Yannick LE MANACH, MD, PhD|0012892606840|Yannick.Lemanach@phri.ca|
21292413|NCT00967616|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21292414|NCT00575666|UMass Medical School|Xiaoduo Fan, MD, MPH, MS|508-856-3881|Xiaoduo.Fan@umassmed.edu|
21292415|NCT01374425|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21292416|NCT02289469|SAI Interactive|Dr. Dane Boyington|(423) 521-2309|dane@thinkingmedia.com|
21292417|NCT02750930|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21292418|NCT00553631|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21292419|NCT02761642|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21292420|NCT01044030|Boston Children's Hospital|Louis Vernacchio, MD, MSc|617-919-4283|louis.vernacchio@childrens.harvard.edu|
21292421|NCT04940130|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr. Patrick Duffy|301.761.5089|patrick.duffy@nih.gov|
21292422|NCT02537730|Coopervision Japan|Director Professional Services Organization|81-3-5449-6619|taku.muraoka@jp.coopervision.com|
21243858|NCT02529995|AstraZeneca|Global Clinical Lead, Yuri Rukazenkov|+44 1625 231825|Yuri.Rukazenkov@astrazeneca.com|
21292423|NCT00114127|Massachusetts General Hospital|Dr. Naomi Simon|617-726-7913|nsimon@partners.org|
21292424|NCT00469833|Cincinnati VAMC|David D'Alessio, MD, Section head, Endocrinology, Cincinnati VAMC|513-475-6478|david.d'alessio@va.gov|
21292425|NCT01685684|Collegium Pharmaceutical|Clinical Scientist|+1.781.232.0764|clinicaltrials@collegiumpharma.com|
21292426|NCT04089020|Children's Mercy Kansas City|Jordan Carlson, PhD.|816-234-9240|jacarlson@cmh.edu|
21292427|NCT06158867|Taipei Medical University Hospital|Dr. Leon Tsung-Ju Lee|+886-2-27372181|TJ.LEE.SKIN@GMAIL.COM|8281
21292428|NCT04683913|University of British Columbia|Dr. Michael Hunt|604-827-4721|michael.hunt@ubc.ca|
21292429|NCT04422431|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
21292430|NCT03913130|Sepul Bio|Zuhal Butuner - Chief Medical Officer|(905) 599 7887|contact@sepulbio.com|
21292431|NCT00713193|Ohio State University|Spero R Cataland|6142939441|spero.cataland@osumc.edu|
21292432|NCT01174563|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21292433|NCT03402841|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21292434|NCT00444106|Novartis Pharmaceuticals|Study Director|862-778-8300||
21292435|NCT01349114|University of Alabama at Birmingham|David A. Calhoun, MD|205-934-4633|dcalhoun@uab.edu|
21292436|NCT02317627|Kadmon Corporation, LLC|Associate VP, Clinical Operations|833-900-5366|karin.herrera@kadmon.com|
21292437|NCT00279214|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21292438|NCT01280968|Duke University Medical Center|Alexey G Mukhin, M.D., Ph.D.|Telephone: 919-668-5055|amukhin@duke.edu|
21292439|NCT00038948|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21292440|NCT00834197|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21235364|NCT03358576|Iterum Therapeutics|Senior Director, Clinical Development|18606614035|saronin@iterumtx.com|
21235365|NCT01222494|Washington University|Dr. Ginger Nicol|314-362-2461|nicolg@wustl.edu|
21243859|NCT02988817|Genmab A/S|Clinical Trial Information|+45 7020 2728|clinicaltrials@genmab.com|
21243860|NCT03926039|National Taipei University of Nursing and Health Sciences|Director of Nursing Department|886-2-28712121|tsaejyy@ntunhs.edu.tw|3100
21243861|NCT03036813|Global Blood Therapeutics|Margaret Tonda, PharmD, Sr. Director, Clinical Science|(650) 741-7761|mtonda@gbt.com|
21243862|NCT01102231|IFCT|Communications Officer|+33156811045|contact@ifct.fr|
21243863|NCT00546754|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21243864|NCT01195883|Cleveland Clinic|Daniel I. Sessler, MD|216-444-4900|DS@OR.org|
21243865|NCT04470375|University of South Dakota|Dr. Kory Zimney|16056586373|kory.zimney@usd.edu|
21243866|NCT04762875|Ensoma|Elizabeth Hook|617-766-3917|ehook@ensoma.com|
21243867|NCT02943590|MassGH|Tomas Neilan|617726200|tneilan@partners.org|
21243868|NCT05946551|Emory University|Tiffany Walker, MD Assistant Professor|404-778-1621|tiffany.austin.walker@emory.edu|
21243869|NCT01792830|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
21243870|NCT01390818|Merck Serono, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+496151725200|service@merckgroup.com|
21243871|NCT01943799|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21243872|NCT04594759|Medical University of South Carolina|Dr. Samantha Karlin|(843)- 714-0146|karlin@musc.edu|
21243873|NCT00311363|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
21243874|NCT01691326|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21243875|NCT00396084|Case Western Reserve University, Tuberculosis Research Unit|John L. Johnson, M.D.|(216) 368-1949|jlj@case.edu|
21235366|NCT03779997|University of Washington|Judith I. Tsui|206-744-1835|tsuij@uw.edu|
21235367|NCT02252081|Nashville Campus TVHS|Dr. Adriana Hung|6153274751|adriana.hung@va.goc|6731
21235368|NCT01241734|Hackensack Meridan Health|Joshua Zenreich|5519964248|joshua.zenreich@hmhn.org|
21235369|NCT00436280|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21235370|NCT03603964|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
21235371|NCT00563797|Yale University School Of Medicine Department of Psychiatry|Elizabeth Ralevski|203-932-5711|elizabeth.ralevski@yale.edu|4282
21235372|NCT03755765|Department of Family Medicine, Georgetown University Medical Center|Daniel Merenstein, MD|202-687-2745|djm23@georgetown.edu|
21235373|NCT04455893|Carnegie Mellon University|Gretchen Chapman|412-268-3665|gchapman@andrew.cmu.edu|
21292441|NCT03984188|University of Miami|Trishul Siddharthan|305-243-6388|tsiddhar@miami.edu|
21292442|NCT04254692|University of Wisconsin School of Medicine and Public Health|Venkat Rao, MD, MBA|(608) 263-1223|rao@surgery.wisc.edu|
21292443|NCT01747915|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21292444|NCT03341637|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21292445|NCT02259725|USC / Norris Comprehensive Cancer Center|Victoria Soto|3238653000|soto_v@med.usc.edu|
21243876|NCT03811574|Novo Nordisk A/S|Clinical Transparency Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21243877|NCT01697969|Alcon Research, Ltd.|Danyel Crout Carr, MS, CCRA|1-888-451-3937|alcon.medinfo@alcon.com|
21243878|NCT01542229|Charleston VAMC|Dr. Anouk L. Grubaugh|843-789-5853|grubaugh@musc.edu|
21243879|NCT03639558|University of Nottingham/Psychiatric Hospital of the Cross|Dr. Joseph Dib|07748668553|joseph.elie.dib@gmail.com|
21243880|NCT03144674|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21292446|NCT06164691|University of Pittsburgh|Dr. Matthew Neal|412-647-1158|nealm2@upmc.edu|
21292447|NCT02391311|UAB|Pariya L Fazeli, PhD|205-996-0330|plfazeli@uab.edu|
21292448|NCT03183063|Beaumont Health|Joanne Gondert|248 551-0439|joanne.gondert@beaumont.org|
21243881|NCT01395758|ArQule, Inc.|Brian Schwartz, MD Chief Medical Officer|781-994-0300|ClinicalTrials@arqule.com|
21243882|NCT01759771|Ralph H. Johnson Veterans Affairs Medical Center|Stephen J. Savage, MD, Chief Section of Urology|843 789 7330|savages@musc.edu|
21243883|NCT01514734|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
21243884|NCT00696618|Johns Hopkins School of Medicine|Associate Director, Drug Development Unit|(410)641-8762|ejfuchs@jhmi.edu|
21243885|NCT00933400|American College of Radiology|Communications Director|215-574-3150|nfredericks@acr.org|
21243886|NCT02139943|Janssen Research & Development, LLC|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
21261982|NCT02046564|Otsuka Pharmaceutical Co. Ltd.|Director of Clinical Trials|+81-3-6361-7366||
21261983|NCT02747043|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21261984|NCT03735095|Roswell Park Comprehensive Cancer Center|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
21261985|NCT00553059|University of Texas (UT) MD Anderson Cancer Center|Michael J. Fisch, MD/Department of General Oncology|713-563-9905|mfisch@mdanderson.org|
21261986|NCT00631319|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
21261987|NCT04901897|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
21261988|NCT00670111|Boston Scientific|Elke Sommerijns|+32 479 76 71 56|elke.sommerijns@bsci.com|
21261989|NCT01749735|Spaulding Rehabilitation Hospital|Dr. Paolo Bonato|617-952-6319|pbonato@partners.org|
21261990|NCT01873742|Modum Bad Research Institute|Dr. Terje Tilden|+4732749869|tilden@modum-bad.no|
21261991|NCT02498821|Bard Access Systems, Inc.|Gina Gilbert, BSN, RN|407-489-0835|Gina.Gilbert@crbard.com|
21261992|NCT02708212|Evergreen General Hospital|Dr. Chiliang Cheng|+886-3-4631230|chiliang.cheng@gmail.com|
21261993|NCT01417286|Cancer Institute of New Jersey Rutgers|Dr. Haffty|732-235-8675|hafftybg@cinj.rutgers.edu|
21261994|NCT05341466|University of Colorado, Boulder|Andrew Q. Tan|303-735-0259|andrew.tan@colorado.edu|
21261995|NCT01457339|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21261996|NCT02730247|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR; CRS Regulatory Supervisor|412-647-5554|stadtermanbm@upmc.edu|
21261997|NCT01164501|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21261998|NCT01845077|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21261999|NCT02092415|Oregon Health & Science University|Jonathan Lindner MD|503 595-8750|lindnerj@ohsu.edu|
21262000|NCT00312377|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21262001|NCT05258058|University of Rochester|Dr. Allison Magnuson|585-602-5085|allison_magnuson@urmc.rochester.edu|
21262002|NCT00603044|The University of Chicago Medicine|Fuad Baroody, MD|(773) 702-4790|fbaroody@surgery.bsd.uchicago.edu|
21262003|NCT00408681|Fred Hutchinson Cancer Research Center|Paul J. Martin, M.D.|206-667-4798|pmartin@fredhutch.org|
21262004|NCT01050660|Yale University|Dr. Orly Levit|203-688-2320|orly.levit@yale.edu|
21262005|NCT02209597|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
21262006|NCT01399827|Massachusetts General Hospital|Craig Surman, MD|617-726-8392|csurman@partners.org|
21262007|NCT02262130|CHU de Reims|Pr Manuelle Viguier|00333 26 78 43 43|mviguier@chu-reims.fr|
21262008|NCT01855789|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21262009|NCT02050048|NorthShore Univeristy HealthSystem|Dr. Russell Brown|847-657-1900|rbrown@northshore.org|
21262010|NCT03465735|Mayo Clinic|Waldemar E. Wysokinski, M.D., Ph.D.|507-266-6717|Wysokinski.Waldemar@mayo.edu|
21262011|NCT04224987|UCSF Proctor foundation|Dr Thomas Lietman|4154761442|tom.lietman@ucsf.edu|
21262012|NCT02903511|"University of Colorado Denver | Anschutz"|Godela Brosnahan, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
21262013|NCT02699515|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|+49
21262014|NCT05243550|UroGen Pharma|Head of Clinical Development|+1 855-987-6436|info@urogen.com|
21262015|NCT00112151|Univeristy of Colorado at Denver|Dr. Robert S. Schwartz, Head, Division of Geriatric Medicine|303-724-1919|robert.schwartz@ucdenver.edu|
21262016|NCT01777438|UZ Leuven|Dr Hellings|+32 16 332338|peter.hellings@uzleuven.be|
21262017|NCT01792986|Intermountain Heart Institute|Benjamin D. Horne|8015074708|benjamin.horne@imail.org|
21292449|NCT00925002|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21292450|NCT02163577|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
21292451|NCT01073293|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21292452|NCT01451411|Cumberland Pharmaceuticals Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
21243887|NCT01041417|Emory University School of Medicine|Dr. Arshed Quyyumi|4047273655|aquyyum@emory.edu|
21243888|NCT03276871|Cleveland Clinic|Aldo Fafaj|2162195943|fafaja@ccf.org|
21243889|NCT00700336|CanBas Co., Ltd.|Takumi Kawabe, MD, PhD|81559543666|takumi@canbas.co.jp|
21243890|NCT01616459|GlaxoSmithKline|GSK Response Center|866-435-7343||
21243891|NCT02788773|Canadian Cancer Trials Group|Lesley Seymour|6135336430|lseymour@ctg.queensu.ca|
21243892|NCT04300647|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21243893|NCT05386238|Rush University Medical Center|Melissa Crane|312-563-0269|melissa_m_crane@rush.edu|
21243894|NCT04907474|Eyenovia, Inc.|Michael Rowe|833-393-6684|mmrowe@eyenovia.com|
21243895|NCT05055778|University of Virginia|Kara P. Wiseman, MPH, PhD|434-243-8126|kara.wiseman@virginia.edu|
21243896|NCT01353313|University of New Mexico Health Sciences|Kristi Watterberg|505-272-8609|kwatterberg@salud.unm.edu|
21243897|NCT04755660|National Taipei University of Nursing and Health Sciences|Dr. Tingru Lin|886-2-28227101|tingru@ntunhs.edu.tw|3150
21243898|NCT02824029|Karmanos Cancer Institute|Dr. Dipenkumar Modi, MD|313-576-8782|modid@karmanos.org|
21243899|NCT05672667|Wake Forest University School of Medicine|Dr. James Eisenach|336-716-4182|jimeisenach@gmail.com|
21243900|NCT04524390|Mirum Pharmaceuticals, Inc.|Mirum Clinical Trials|16506674085|medinfo@mirumpharma.com|
21262018|NCT00375934|Xanodyne Pharmaceuticals, Inc.|Steve Boesing|1-877-926-6396|clinical-trials@xanodyne.com|
21243901|NCT03873779|Zeltiq|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
21243902|NCT02581215|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
21243903|NCT05930782|MMV Medicines for Malaria Venture|Dr Anne Claire Marrast|+41 22 555 03 00|marrasta@mmv.org|
21243904|NCT04270526|Mount Auburn Hospital|William Winkelman|617-354-5452|william.winkelman@mah.harvard.edu|
21243905|NCT04928001|Montana State University|Dr. Katey T. Franklin|406-570-6056|katey.franklin@montana.edu|
21243906|NCT01693120|Medtronic AF Solutions|Bob Hokanson, Clinical Research Manager|763.526.2811|robert.hokanson@medtronic.com|
21243907|NCT04153565|Merck Sharp& Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21243908|NCT01741363|Department of Internal Medicine, National Taiwan University Hospita|Han-Mo CHIU|+886-2-23123456|hanmochiu@ntu.edu.tw|63354
21243909|NCT03827304|Sheffield Hallam University|Ivan Phelan|+44 114 225 6955|i.phelan@shu.ac.uk|
21262019|NCT03026504|Mayo Clinic|Matthew Koster, M.D.|507-284-5800|koster.matthew@mayo.edu|
21262020|NCT01289392|Associação Fundo de Incentivo à Pesquisa|Dr Teresa Cristina Barros Schutz|55-21-99868033|schutzferraz@gmail.com|
21262021|NCT02773758|GlaxoSmithKline|GSK Response Center|866-435-7343||
21262022|NCT02123017|Cumberland Pharmaceuticals, Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
21262023|NCT00500149|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21262024|NCT01592851|GlaxoSmithKline|GSK Response Center|866-435-7343||
21262025|NCT01988012|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21262026|NCT00521339|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21262027|NCT01058369|Universitätsklinikum Erlangen, Medizinische Klinik 5|Prof. Dr. med. Stefan Krause||stefan.krause@uk-erlangen.de|
21262028|NCT03314519|Mahidol University|Kasana Raksamanee|66967841010|kasana@gmail.com|
21262029|NCT01819935|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21262030|NCT01157169|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21262031|NCT00117962|Washington University School of Medicine|Dr. Ramaswamy Govindan||rgovinda@dom.wustl.edu|
21262032|NCT00663858|Aeterna Zentaris|Herbert Sindermann|+49 69 42602 3429|HSindermann@aezsinc.com|
21262033|NCT02940886|Pharmacosmos A/S|Clinical trial disclosure desk|+45 5948 5935|trial@pharmacosmos.com|
21262034|NCT03042611|Elevar Therapeutics, Inc|Elevar Clinical Trials|(801) 303-7440|info-clinicalstudy@elevartherapeutics.com|
21262035|NCT00502905|UT MD Anderson Cancer Center|Gabriela Rondon, MD / Assistant Professor|713 745-2294|celsaenz@mdanderson.org|
21262036|NCT01277289|Erydel|Angelo Andriulli, MD|+39 882 410784|aandriulli@operapadrepio.it|
21262037|NCT03454048|Radboud university medical center|Prof. dr. Teun Bousema|+3124 3614306|teun.bousema@radboudumc.nl|
21262038|NCT00084682|Montefiore Medical Center|Lisa Escobar-Peralta|718-379-6866|lescobar@montefiore.org|
21262039|NCT03152136|Cala Health|Paula Chidester|650-273-7436|paula@calahealth.com|
21262040|NCT02988986|Houston Methodist Hospital|Dr. Jenny Chang, Director of Houston Methodist Cancer Center|713-441-0681|jcchang@houstonmethodist.org|
21262041|NCT00474630|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com|
21262042|NCT03088605|Topivert Pharma Ltd|Director of Clinical Trials|+44 203 763 9469|info@topivert.com|
21262043|NCT01954628|Aquinox Pharmaceuticals (Canada) Inc.|Clinical|+1 (604) 629-9223|clinical@aqxpharma.com|
21262044|NCT00352781|Centre for Addiction and Mental Health|Co-Investigator|416-535-8501|laurie_zawertailo@camh.net|7422
21279868|NCT00447993|Neurotech Pharmaceuticals, LLC|CMO|401-333-3880|neurotech@neurotechusa.com|
21279869|NCT02924727|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21279870|NCT02936180|McGill University|Ines Colmegna, MD|514-934-1934|ines.colmegna@mcgill.ca|35639
21279871|NCT01464931|Amgen Inc.|Study Director|866-572-6436||
21279872|NCT01982812|University of Rochester|Gretchen L. Birbeck|585-273-4265|gretchen_birbeck@urmc.rochester.edu|
21279873|NCT03648853|UCalifornia San Francisco|Pekka Talke|415 306 3602|pekka.talke@ucsf.edu|
21279874|NCT00307437|Centocor Research & Development, Inc.|Senior Director, Compound Development Team Leader|1 215 793-7612||
21279875|NCT00338728|UT MD Anderson Cancer Center|Dr. Arun,Banu,M.D. / Breast Medical Oncology|713-792-2817|barun@mdanderson.org|
21279876|NCT03859765|Duke University|Sarah A Kelleher, PhD|919-416-3405|sarah.kelleher@duke.edu|
21279877|NCT04380961|Janssen Research & Development, LLC|Director 1 Study Responsible Physician|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21292453|NCT02897115|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21243910|NCT02300298|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21243911|NCT03285763|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21243912|NCT00610649|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21243913|NCT04987021|Cochlear Limited|PRS Specialist, Clinical Affairs|+612 9428 6555|cltd-prs-admin@cochlear.com|
21243914|NCT01406223|Duke University Medical Center|Principal Investigator|919-668-3987|francis.mcclernon@duke.edu|
21243915|NCT02869334|Nathan Kline Institute|Dr. Daniel Javitt|8453986534|javitt@nki.rfmh.org|
21243916|NCT02379819|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
21243917|NCT01839331|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|720-437-6500|clinicaltrials@ampiopharma.com|
21243918|NCT00548418|Washington University School of Medicine|David G. Mutch, M.D.|314-362-2181|mutchd@wudosis.wustl.edu|
21243919|NCT02283749|Brown University Oncology Research Group (BrUOG)|Kayla Rosati|14018633000|kayla_rosati@brown.edu|
21243920|NCT03029598|University of Washington - Cancer Vaccine Institute|Director of Clinical Operations|2062459258|childj@uw.edu|
21243921|NCT02639910|MorphoSys AG|Peter Kelemen MD, PhD - Director, Clinical Program Leader|+498989927|peter.kelemen@morphosys.com|26856
21243922|NCT03074331|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21243923|NCT00741455|Dartmouth-Hitchcock Medical Center|Darcie Findley|603-650-4595|darcie.l.findley@hitchcock.org|
21243924|NCT00350792|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21243925|NCT03451721|Zhongshan Hospital|Dr Yangang Su|+86 13788905096|suyangang111@163.com|
21243926|NCT00960141|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21243927|NCT05274217|University of Washington|Teresa Evans-Campbell|206-543-6075|tecamp@uw.edu|
21243928|NCT05360901|Brigham and Women's Hospital|Jessica M. Lipschitz|617-732-6548|jlipschitz@bwh.harvard.edu|
21243929|NCT04556981|Gates MRI|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
21243930|NCT03764475|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
21243931|NCT00580866|Vanderbilt|William Obremskey|6159363630|william.obremskey@Vanderbilt.Edu|
21243932|NCT05113771|Denovo Biopharma|Julie Doostzadeh, Executive Director|858-799-1021|jdoostzadeh@denovobiopharma.com|709
21243933|NCT02574455|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21262045|NCT00052429|Memorial Sloan Kettering Cancer Center|Dr. Suzanne Wolden|212-639-5148|woldens@mskcc.org|
21262046|NCT03666143|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
21292454|NCT01424943|Institute for Families in Society, University of South Carolina|Dr. Cheri Shapiro|803-777-8760|cshapiro@mailbox.sc.edu|
21292455|NCT00439335|Baylor College of Medicine|Shital Patel, MD|713-798-3793|shitalp@bcm.tmc.edu|
21292456|NCT01100112|Santarus, Inc.|Michael Huang, MD, Senior Medical Director, Clinical Research|8583145700|contact@santarus.com|
21292457|NCT03723980|Dow University of Health Sciences|Dr. Juzer Shabbir Saifee|92-333-2352134|dr.juzer.shabbir@gmail.com|
21292458|NCT02776683|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21235374|NCT01158222|Case Comprehensive Cancer Center|Dr. Brian Rini|216-444-9567|rinib2@ccf.org|
21292459|NCT01773954|Mid Atlantic Retina|Michele Formoso|215-928-3092|research@midatlanticretina.com|
21292460|NCT01023217|Asan Medical Center|Professor Young-Suk Lim|+82-2-3010-5933|limys@amc.seoul.kr|
21292461|NCT01673646|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
21292462|NCT01000506|GlaxoSmithKline|GSK Response Center|866-435-7343||
21292463|NCT03064074|Baylor|dianne Nguyen|7137986694|diannen@bcm.edu|
21292464|NCT03417466|Medtronic Minimed|Fen Peng, Biostatistician|8185763253|fen.peng@medtronic.com|
21292465|NCT05518461|University of Wisconsin - Madison|Dr. Rachel Gicquelais|(608) 890-1837|gicquelais@wisc.edu|
21292466|NCT00269087|GlaxoSmithKline|GSK Response Center|866-435-7343||
21292467|NCT02304159|Southern California Research Center|Dr. Tarek Hassanein|619-319-3993|thassanein@livercenters.com|
21292468|NCT00332696|Novartis Pharmaceuticals|Study Director|862-778-8300||
21292469|NCT02348203|University of Arizona|Sherry Chow|520-626-3358|schow@azcc.arizona.edu|
21292470|NCT02230189|University of California, San Francisco|PI: Prescott G. Woodruff, MD, MPH|415-514-2061|prescott.woodruff@ucsf.edu|
21292471|NCT03824392|aTyR Pharma|Lisa Carey|858 731 8389|clinicaltrials@atyrpharma.com|
21292472|NCT01847755|Jupiter Medical Center|Dr. Barry Miskin|561-263-5791|clinicaltrials@jupitermed.com|
21292473|NCT00746187|DENTSPLY Implants|Senior Manager Global Clinical Research|+46313763500|clinicalresearchmolndal@dentsply.com|
21292474|NCT01904721|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21292475|NCT03988426|CRMG|Mikaela Raymond|866-337-1868|ctgov@clinicalresearchmgt.com|
21292476|NCT01077063|Sidney Kimmel Comprehensive Cancer Center at JHMI|Daniel Laheru, MD|410-955-8974|laherda@jhmi.edu|
21235375|NCT01490060|University of Texas (UT) MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor, Sarcoma Medical Oncology|(713) 792-7966|CR_Study_Registration@mdanderson.org|
21235376|NCT02464969|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21235377|NCT03759223|VA Center for Integrated Healthcare|Dr. Paul King, Clinical Research Psychologist|716-862-6038|paul.king2@va.gov|
21235378|NCT02409615|Nemours/A I duPont Hospital for Children|Karen Sacks, MSN PNP|302-651-5649|ksacks@nemours.org|
21235379|NCT02399085|MorphoSys AG|Lisa Walz|+49 89 89927 26240|Lisa.Walz@morphosys.com|
21235380|NCT00699699|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21235381|NCT00414050|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1 800 672 6372|ClinicalTrialsDisclosure@merck.com|
21292477|NCT02099084|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
21292478|NCT01490918|The Catholic University of Korea, Seoul St Mary's Hospital|Yoon Hee Choi|82-2-2258-8288|choiyh@catholic.ac.kr|
21292479|NCT03046836|Medical University of South Carolina - Institute of Psychiatry|Stacey Sellers|8437925807|sellersst@musc.edu|
21292480|NCT00648037|Memorial Sloan Kettering Cancer Center|Papadopoulos, Esperanza, MD (Attending)|+1212-639-8276|papadope@mskcc.org|
21292481|NCT02967679|MedDay Pharmaceuticals|Dr Frédéric SEDEL, Chief Scientific Officer and Co-founder|+33 1 80 40 14 40|frederic.sedel@medday-pharma.com|
21292482|NCT01545765|Galderma|Farzaneh Sidou Clinical Project Manager)|00.33.4.93.95.70.70|farzaneh.sidou@galderma.com|
21292483|NCT02379195|Center for Cancer Immune Therapy, Herlev Hospital|Dr. Inge Marie Svane|38683868|inge.marie.svane@regionh.dk|
21292484|NCT02706925|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21292485|NCT01953211|University Reproductive Associates|Michael Cho|(201) 288-6330|michaelcho@nyc.com|
21292486|NCT03188263|Northwestern University|Kristen Knutson|312-503-1526|kristen.knutson@northwestern.edu|
21292487|NCT00699413|USC|Michael Goran|323.442.3027|goran@usc.edu|
21292488|NCT00251693|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
21292489|NCT02779777|Kura Oncology, Inc.|Clinical Operations|+1 617-588-3755|ko-tip-003@kuraoncology.com|
21292490|NCT04005586|RxSight|Jeffrey Ha, Senior Director of Clinical Research|949-521-7870|jha@rxsight.com|
21292491|NCT01030822|GlaxoSmithKline|GSK Response Center|866-435-7343||
21292492|NCT01628523|Washington University in St. Louis|Brian M Fuller|3147475368|fullerb@wusm.wustl.edu|
21292493|NCT01284959|Chonbuk National University Hospital|Prof. Youngchul Chung|+82-63-250-2185|chungyc@chonbuk.ac.kr|
21292494|NCT01055613|Johnson & Johnson Vision Care Inc.|Brian Pall, O.D.- Research Principle Optometrist|904-443-1290|BPALL@its.jnj.com|
21292495|NCT02393339|Hadassah School of Dental Medicine, P.O.Box 12272|Dr. Avia Fux-Noy|+972507410935|fuxavia@gmail.com|
21292496|NCT02765399|Helsinki University and Helsinki University Hospital|Prof. Marja-Riitta Taskinen|+358-9-47171990|marja-riitta.taskinen@helsinki.fi|
21292497|NCT00768261|Washington University|John G. Csernansky, MD|(312) 926-2323|jgc@northwestern.edu|
21243934|NCT02189915|The Brain Institute of the University of Utah|Perry Renshaw, MD, PhD, MBA|801-587-1216|perry.renshaw@hsc.utah.edu|
21243935|NCT06243796|Nakhon Phanom hospital|Dr.Kriengkrai Prasert|+6642199222|gpsiam28@gmail.com|1091
21243936|NCT05510245|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21243937|NCT02414204|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Timmy Lee|205-934-3589|txlee@uab.edu|
21243938|NCT00995150|Medicines360|Emily Morris|415.951.8700|emorris@medicines360.org|
21243939|NCT01415349|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21243940|NCT01429350|Penumbra, Inc.|Michaella Corso|510-995-2079|mcorso@penumbrainc.com|
21243941|NCT00716859|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21243942|NCT00411216|Emory|Susan J Herdman, PT, PhD|4047120612|sherdma@emory.edu|
21243943|NCT04578496|CLINUVEL PHARMACEUTICALS LIMITED|Clinical Operations Manager||mail@clinuvel.com|
21243944|NCT01550549|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
21243945|NCT01029587|Johns Hopkins University|Benjamin Philosophe|443-287-7178|bphilosophe@jhmi.edu|
21243946|NCT00590369|Cleveland Clinic|Nancy M. Albert PhD, RN|216-444-7028|albertn@ccf.org|
21243947|NCT04922021|LEO Pharma A/S|Disclosure Specialist|+4544945888|disclosure@leo-pharma.com|
21243948|NCT03133182|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
21243949|NCT03237481|Heron Therapeutics, Inc.|Vice President, Clinical Operations|858-251-7232|svisonneau@herontx.com|
21243950|NCT02544074|The Ohio State University|Douglas Scharre, MD|614-293-4969|Doug.Scharre@osumc.edu|
21243951|NCT01998984|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
21243952|NCT02476695|Wuxi HISKY Medical Technologies Co., Ltd.|Peng Lu|13816688340|yixuebu@fibrotouch.com|
21243953|NCT04279574|Solventum US LLC|Paula Myhre|6513842714|pemyhre1@solventum.com|
21243954|NCT02541565|University of Washington|Dr. Stephen Smith|206-606-6546|ssmith50@seattlecca.org|
21243955|NCT02566902|University of California - San Diego|Mike Gardiner, MD|8589668036|magardiner@ucsd.edu|
21243956|NCT02411084|ADIENNE S.A|Renata Palmieri|+41.91.210.47.22|renata.palmieri@adienne.com|
21243957|NCT03624972|Fox Chase Cancer Center|Dr. Jennifer Reese, Associate Professor|215-214-3223|Jennifer.Reese@fccc.edu|
21243958|NCT02036424|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com|
21243959|NCT00924807|St. Luke's Roosevelt Hospital Center|Seth Cohen, MD|212-523-7289|secohen@chpnet.org|
21243960|NCT04071756|Dana-Farber Cancer Institute|Nicole LeBoeuf, MD, MPH|617-632-6571|nicole_leboeuf@dfci.harvard.edu|
21243961|NCT03628885|Indiana University|Dr. Gregory Zimet|3172748812|gzimet@iu.edu|
21243962|NCT03567252|University of Kentucky|Ann Koempel|(859) 257-3800|ann.koempel@uky.edu|
21243963|NCT01643616|HELIOS-Kliniken Schwerin, Germany|Dr. Ronald Seidel|0049 385 5204251|ronald.seidel@helios-kliniken.de|
21243964|NCT02647905|Senseonics|Vice President, Clinical Sciences|3015157260|katherine.tweden@senseonics.com|
21243965|NCT05848817|Mann Eye Institute|Phillip Brunson|1-713-580-2500|brunsonphillip@gmail.com|
21243966|NCT00642850|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21243967|NCT03733028|Durham VA Health Care System|Angela Kirby|919-824-7729|angela.kirby@va.gov|
21243968|NCT05489484|Guna S.p.a.|Vincenzo Miranda (Clinical Research Manager); Kamilia Laarej (TSU&CRA)|02 280.18.(358)-(359)|v.miranda@guna.it; k.laarej@guna.it|
21243969|NCT01537419|Center for Family Intervention Science, Drexel University|Guy Diamond, Ph.D.|215-571-3420|gd342@drexel.edu|
21243970|NCT03401190|CalciMedica, Inc.|Sudarshan Hebbar, MD|816-838-7105|sudarshan@calcimedica.com|
21243971|NCT00444600|Jaeb Center for Health Research|Adam R. Glassman, Director DRCR.net Coordinating Center|813-975-8690|drcrnet@jaeb.org|
21243972|NCT05132478|UW School of Medicine and Public Health|Corrine Voils, PhD|(608) 262-9636|voils@surgery.wisc.edu|
21243973|NCT00106080|Department of Veterans Affairs, Health Services Research and Development|David H. Au, MD, MS|206-764-2430|david.au@va.gov|
21243974|NCT03833661|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21243975|NCT01414738|UT Southwestern Medical Center|Dr. Robert Timmerman|214/645-7637|ROBERT.TIMMERMAN@UTSouthwestern.edu|
21243976|NCT01266122|Behavioral Medicine Service, Massachusetts General Hospital|Dr. Steven Safren|617-724-0817|ssafren@partners.org|
21243977|NCT00421889|Topotarget A/S|PRS Administrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com|
21243978|NCT03756571|Seattle Children's Research Institute|Kristie Bjornson, PT, PhD|206-884-2066|Kristie.bjornson@seattlechildrens.org|
21243979|NCT00978042|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21243980|NCT00529516|GlaxoSmithKline|GSK Response Center|866-435-7343||
21243981|NCT03752151|Medtronic, Plc|Dana Wigert, Sr Prin Clinical Research Specialist|+17635262802|dana.wigert@medtronic.com|
21243982|NCT03224390|Duke University|Dr. Eric Green|9196817289|eric.green@duke.edu|
21243983|NCT00703820|St. Jude Children's Research Hospital|Jeffrey E. Rubnitz, MD, PhD|901-595-2388|jeffrey.rubnitz@stjude.org|
21243984|NCT00761605|Clinical Research Team, Medical Affairs Korea|Senior Clinical Research Associate|82-2-2094-4804||
21243985|NCT01007396|Samsung Medical Center|Won-Jung Koh|82-2-3410-3429|wjkoh@skku.edu|
21243986|NCT03689920|Boston Scientific|Director of Clinical Sciences|661-949-4350|roshini.jain@bsci.com|
21243987|NCT03283371|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21243988|NCT01373346|Gangnam severance hospital|Seung Ho Choi, M.D., Ph.D.|82-2-2019-3374|choish@yuhs.ac|
21243989|NCT01198028|MD Anderson Cancer Center|Dr. Bonnie Glisson, MD,Professor, Thoracic-Head & Neck Med Onc|(713) 792-6363|bglisson@mdanderson.org|
21243990|NCT01186198|Abbott Medical Devices|Jessie Coe|224 668 5360|Jessie.coe@abbott.com|
21243991|NCT00970359|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho|646-888-4235|hoa@mskcc.org|
21243992|NCT03631550|Neurolief Ltd.|Michal Kedar-Datel|+972-52-6659806|michal.kedar-datel@neurolief.com|
21243993|NCT03887650|Hartford Hospital|Dr. Kevin Finkel|860-972-1778|Kevin.Finkel@hhchealth.org|
21243994|NCT04515641|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21243995|NCT03942042|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21243996|NCT01499199|GlaxoSmithKline|GSK Response Center|866-435-7343||
21243997|NCT01199705|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
21243998|NCT01692730|University of Rochester|Scott McIntosh|585-275-0511|scott_mcintosh@urmc.rochester.edu|
21243999|NCT01199575|University of California, San Diego|Thomas Kipps, MD PhD|858-534-5400|tkipps@ucsd.edu|
21244000|NCT02047981|UCSF F.I. Proctor Foundation|Ying Lin|4155144709|ying.lin@ucsf.edu|
21244001|NCT00704184|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21244002|NCT02701257|MGH Diabetes Research Center|Courtney Balliro|617-726-1242|cballiro@partners.org|
21244003|NCT02515305|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
21244004|NCT03350542|Boston Scientific|Patricia O'Mara|518-744-0046|patricia.omara@bsci.com|
21244005|NCT01251354|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21244006|NCT03632941|Duke University|Michael Morse, M.D.|919-681-3480|michael.morse@duke.edu|
21244007|NCT02237417|Otsuka|Wilt, Timothy|240.683.3095|timothy.wilt@otsuka-us.com|
21244008|NCT04156581|Hospital for Special Surgery|Dr. Justas Lauzadis|212-774-2946|lauzadisj@hss.edu|
21244009|NCT03602612|National Cancer Institute|Dr. James Kochenderfer|240-760-6062|kochendj@mail.nih.gov|
21244010|NCT06336629|Sun Pharmaceutical Industries Limited|Head-Regulatory Affairs|2266455645|Clinical.Trial@sunpharma.com|5689
21244011|NCT03960463|Baylor College of Medicine|Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
21244012|NCT03422276|University of Washington|Dr. Jeanne Hoffman|(206) 221-6511|jeanneh@uw.edu|
21244013|NCT05194917|University of Wisconsin School of Medicine and Public Health Center for Tobacco Research and Intervention|Dr. Adrienne Johnson|608-262-8673|aljohnson43@ctri.wisc.edu|
21244014|NCT05165485|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
21244015|NCT05786391|The University of Texas Health Science Center at Houston|Randa J Jalloul, MD|713-566-5749|Randa.J.Jalloul@uth.tmc.edu|
21244016|NCT05686408|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 904-0355|greg.sullivan@tonixpharma.com|
21244017|NCT03817684|Tetra Therapeutics|CEO|616-224-0084|info@tetratherapeutics.com|
21244018|NCT04941287|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
21244019|NCT03591770|Boston Medical Center|Sharmeel K. Wasan, MD|(617) 638-6116|sharmeel.wasan@bmc.org|
21244020|NCT02991807|Boston Children's Hospital|Dr. Mustafa Sahin|617-355-8994|Mustafa.Sahin@childrens.harvard.edu|
21244021|NCT05406258|Shirley Ryan AbilityLab|Dr. Megan O'Brien, PhD|312-238-2289|mobrien02@sralab.org|
21244022|NCT01108003|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21244023|NCT00332241|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@BMS.com|
21244024|NCT00802464|GlaxoSmithKline|GSK Response Center|866-435-7343||
21244025|NCT00402246|Medtronic, Inc|CONNECT Clinical Trial Specialist||medtronicCRMtrials@medtronic.com|
21244026|NCT02622568|University of Texas Southwestern|Dr. Nnenna Agim|2144561631|Nnenna.Agim@childrens.com|
21244027|NCT01625104|University of Michigan|Eva Kline-Rogers MS, RN|734 9985909|evakline@med.umich.edu|
21244028|NCT04788641|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21244029|NCT01985334|Novartis Pharmaceuticals|Study Director|862-778-8300||
21244030|NCT03988023|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
21244031|NCT04247074|Galderma Research & Development|Galderma Research & Development|8179615000|clinical.studies@galderma.com|
21244032|NCT00174382|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21235382|NCT05051241|Zhejiang GenFleet Therapeutics Inc.|Yuting Peng|+86 21 6882 1388|ytpeng@genfleet.com|
21235383|NCT00720876|City of Hope|Paul Frankel, Ph.D.|626-812-5265|pfrankel@coh.org|
21235384|NCT00286949|Michael E. DeBakey VA Medical Center|Laura Marsh, M.D., Principal Investigator|713-794-8907|laura.marsh2@va.gov|
21235385|NCT03304379|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21235386|NCT03402243|University of Minnesota|Michael Kotlyar|612-625-1160|kotly001@umn.edu|
21235387|NCT03282955|B. Braun Melsungen|Study Manager|05661/71|studies@bbraun.com|0
21235388|NCT01121211|Massachusetts General Hospital|Dr. Anne Klibanski|6177263870|aklibanski@partners.org|
21235389|NCT01559311|St. Jude Medical (Hong Kong) Ltd|Clinical Project Leader Asia|29967605|lyim@sjm.com|
21235390|NCT01649856|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21235391|NCT00179647|Celgene Corporation|Robert D. Knight, M.D.|908-673-9749|rknight@celgene.com|
21235392|NCT05013905|Prometheus Biosciences, Inc.|Study Director|858-422-4300|mm@prometheusbiosciences.com|
21235393|NCT04942938|Centura Health|Dr. Courtney Ellerbusch|3039058272|courtneyellerbusch@centura.org|
21235394|NCT01849588|Massachusetts General Hospital|Dr. Andrew Zhu|617-724-4000|azhu@partners.org|
21235395|NCT03383588|Montefiore Medical Center|Dr Catherine Igel|718-405-8200|cigel@montefiore.org|
21235396|NCT04524962|Cartesian Therapeutics, Inc.|Hafsa Kamboh|4127585340|hafsa@cartesiantx.com|
21279878|NCT01862484|The University of Texas Health Science Center at San Antonio|Steven R. Pliszka MD|210-567-0136|pliszka@uthscsa.edu|
21279879|NCT00721227|Ethicon Endo Surgery, Inc.|Amy Mahanes, Senior Clinical Research Associate|513-337-8366|amahanes@its.jnj.com|
21279880|NCT05422625|William Beaumont University Hospital|Jennifer Giordano RN BSN/ Clinical Research Manager|248-551-3517|Jennifer.Giordano@corewellhealth.org|
21279881|NCT05351164|University of Michigan|Elif Oral|734-615-7271|eliforal@med.umich.edu|
21279882|NCT06419907|University of Liverpool|Gemma Lewis|01744 646668|gemma.lewis@liverpool.ac.uk|
21279883|NCT01427608|Weill Cornell Medicine|Dr. George S. Alexopoulos|(914) 997-5767|gsalexop@med.cornell.edu|
21279884|NCT01473407|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21279885|NCT02422797|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21279886|NCT04071405|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21279887|NCT01439581|Henry Ford Health System|Robert Behrendt|313-874-9537|Rbehren9@hfhs.org|
21279888|NCT05044195|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
21279889|NCT01027702|PRA Health Sciences|Dr. Andrew Gilman|704-615-2744|gilmanandy@prahs.com|
21279890|NCT00403585|GlaxoSmithKline|GSK Response Center|866-435-7343||
21279891|NCT03514966|Department of Gastroenterology|Changhai Hospital|86-21-31161004|liaozhuan@smmu.edu.cn|86-21-6549
21279892|NCT03001453|American Hip Institute|Dr. Benjamin Domb|630-455-7130|drdomb@americanhipinstitute.org|
21279893|NCT03685344|ADC Therapeutics SA|Clinical Trials Information|954-903-7994|clinical.trials@adctherapeutics.com|
21279894|NCT02969421|Duke University Medical Center|Tashima Lambert, MD|484-201-9332|dr.tlambert@gmail.com|
21279895|NCT02121652|University at Buffalo School of Nursing|Suzanne S. Dickerson|716-829-3254|sdickers@buffalo.edu|
21279896|NCT02276807|VA Center for Integrated Healthcare|Dr. Jennifer Funderburk|315-425-4400|Jennifer.Funderburk@va.gov|54703
21279897|NCT00504751|Weill Cornell Medicine|Richard Furman, MD|646.962.2064|amr2017@med.cornell.edu|
21279898|NCT00261950|Amgen Inc.|Study Director|866-572-6436||
21279899|NCT02819284|Kala Pharmaceuticals, Inc.|VP Clinical Development|(781) 996-5252|Results007@kalarx.com|
21279900|NCT03408171|Geisinger Medical Center|David L. Diehl, MD|570-214-2411|dldiehl@geisinger.edu|
21279901|NCT00247676|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21279902|NCT00668317|Hull and East Yorkshire Hospitals Trust|Clinical trials Manager|01482 624067|c.e.wright@hull.ac.uk|
21279903|NCT03345771|NYU Langone Health|Ran Schwarzkopf MD MSc|(646)-501-7300|ran.schwarzkopf@nyulangone.org|
21279904|NCT02839772|University of Hull|Jill Brooks. PhD student,|01491 839044|jb284@btinternet.com|
21279905|NCT01526655|Department of Obstetrics and Gynaecology, and Department of Clinical and Experimental Medicine, Linköpings universitet (LIU), Sweden|Professor Dr. Preben Kjölhede|+4638231188|preben.kjolhede@liu.se|
21235397|NCT02550652|Genentech|Medical Communications|800-821-8590|genentech@druginfo.com|
21235398|NCT03027466|National Cancer Institute|William Klein|2402766972|kleinwm@mail.nih.gov|
21235399|NCT01706250|GlaxoSmithKline|GSK Response Center|866-435-7343||
21235400|NCT03286140|Imperial College London|Professor Alun Davies|+44 (0)20 3311 7309|a.h.davies@imperial.ac.uk|
21235401|NCT02158039|Mayo Clinic|Dr. Mark Topazian|507-284-7602|topazian.mark@mayo.edu|
21235402|NCT02281136|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Manager of Clinical Research|9147608796|Anna.Houlihan@sunpharma.com|
21235403|NCT02563028|Hospital for Special Surgery|Valeria Rotundo|212-774-7885|rotundov@hss.edu|
21235404|NCT01009099|Edward Hines Jr., VA Hospital|Eileen Collins|708-202-3525|eileen.collins@va.gov|
21235405|NCT01856543|Memorial Sloan Kettering Cancer Center|Dr. Daphna Gelblum|914-367-7273|gelblumd@mskcc.org|
21235406|NCT02188485|University of Rochester|Kim Van Orden, PhD|585-275-5176|kimberly_vanorden@urmc.rochester.edu|
21235407|NCT00799617|University of Pennsylvania, Perelman School of Medicine|Peter J. Snyder, MD|215-898-0208|pjsnyder@upenn.edu|
21235408|NCT04545515|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21235409|NCT00685932|University of Iowa Hospitals and Clinics|Abbey Hardy-Fairbank, MD|319-356-2291|abbey-hardy-fairbanks@uiowa.edu|
21235410|NCT03149237|Vanderbilt University Medical Center|Dr. Carolyn Audet|615-343-2418|carolyn.m.audet@vumc.org|
21235411|NCT04587193|Virginia Commonwealth University|Brian Berman|800-762-6161|brian.berman@vcuhealth.org|
21244033|NCT03903822|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21235412|NCT02501096|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21244034|NCT01796236|Ear Nose Throat, University Medical Center Utrecht, Utrecht|Professor Robert Stokroos|0031 8875 56644|R.J.Stokroos@umcutrecht.nl|
21244035|NCT00785512|Forest Laboratories|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|1-201-427-8259|John.Whalen@frx.com|
21244036|NCT03403413|Loui9s Stokes Cleveland VAMC|Dr. Stephen Selkirk|440-552-0493|stephen.selkirk@va.gov|
21244037|NCT02253537|QIAGEN Sciences|Clinical Study Coordinator|301-944-7094|andrew.schumacher@qiagen.com|
21244038|NCT03231358|American University|Caroline Kuo, DPhil, MPhil|2028857385|ckuo@american.edu|
21244039|NCT03337399|Massachusetts General Hospital/Harvard Medical School|Jennifer Temel|617-724-4000|jtemel@mgh.harvard.edu|
21244040|NCT05609032|Columbia University|Rebecca Schnall, PhD, MPH, RN-BC, FAAN, FACMI|212-342-6886|rb897@cumc.columbia.edu|
21244041|NCT04110743|University of California Davis|Dr. Lorenzo Nardo|916-731-9004|lnardo@ucdavis.edu|
21244042|NCT02477605|Alcon, A Novartis Division|Brand Lead, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
21244043|NCT02665988|Houston Methodist Hospital|Dr. Alok Madan|832-930-1662|amadan@houstonmethodist.org|
21244044|NCT01565148|University of Nebraska|Quan Dong Nguyen|4025592020|quan.nguyen@unmc.edu|
21244045|NCT01388361|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21244046|NCT01763970|SKCCC at Johns Hopkins|Matthew Ladra,MD|(202) 537-4788|mladra@jhmi.edu|
21244047|NCT02528188|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21244048|NCT01061034|Assaf Harofeh medical center|Dr. Keren Doenyas-Barak|972-57-7346651|kerendoenyas@gmail.com|
21244049|NCT05330234|Imperial College London|Mr Gianpaolo Fusari|--|g.fusari@imperial.ac.uk|
21244050|NCT00529659|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21244051|NCT03565315|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD|301-451-8715|martin.gaudinski@nih.gov|
21244052|NCT01170962|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21244053|NCT00440011|Allergan, Inc.|Vice President Medical Affairs|(714)246-4500|clinicaltrials@allergan.com|
21244054|NCT01503749|Seoul National University Hospital|Pf. Jung-Hwan Yoon|82-2-2072-2228|yoonjh@snu.ac.kr|
21244055|NCT01083316|Boston Medical Center|Vaishali Sanchorawala|6176386521|vaishali.sanchorawala@bmc.org|
21244056|NCT02101190|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21244057|NCT02808585|PhaseBio|Dr. John Lee, Chief Medical Officer|6109816500|john.lee@PhaseBio.com|
21244058|NCT00282971|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21244059|NCT01849055|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21244060|NCT00475501|Geriatric Research Education and Clinical Center|Stephen Borst, Ph.D|352-374-6114|stephen.borst@va.gov|5033
21244061|NCT00223795|VA Greater Los Angeles Healthcare System|Meika A. Fang, MD|310-268-4503|meika.fang@va.gov|
21244062|NCT01239316|St. Jude Children's Research Hospital|Tong Lin (Biostatistician)|9015952048|Tong.Lin@stjude.org|
21244063|NCT00513526|AMC|Group Statistician|501-526-6712|jylee@uams.edu|
21244064|NCT01819883|Massachusetts General Hospital|Karen Miller|617-726-3870|KKMiller@MGH.Harvard.edu|
21235413|NCT03878134|NIH Clinical Center|Dr. Elizabeth Jones Chief, Radiology and Imaging Sciences|3012634853|ejones@cc.nih.gov|
21244065|NCT03226899|Ironwood Pharmaceuticals, Inc.|Ironwood Study Chair|(617) 621-7722|Info@ironwoodpharma.com|
21244066|NCT02299375|GlaxoSmithKline|GSK Response Center|866-435-7343||
21244067|NCT03546608|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21244068|NCT06630390|University of Rochester Medical Center|Mark Oldham|585-275-3592|mark_oldham@urmc.rochester.edu|
21244069|NCT05135000|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21244070|NCT00130117|BIDMC|Christos Mantzoros|6176678630|cmantzor@bidmc.harvard.edu|
21244071|NCT04585191|Division of Research, Kaiser Permanente Northern California|Dr. Richard Grant|5108213969|Richard.W.Grant@kp.org|
21244072|NCT05233098|Boston Scientific|Jessie Stockwell, Sr. Clinical Trial Specialist|6126181136|jessie.stockwell@bsci.com|
21244073|NCT04201834|University of Rochester|Ruth Schneider, MD|585-341-7500|Ruth_schneider@urmc.rochester.edu|
21244074|NCT05540535|New York University|Liraz Arie|3478661117|la1816@nyu.edu|
21244075|NCT04104321|Galmed Pharmaceuticals|Dr. Yossi Gilgun-Sherki|0543314054|yossigs@galmedpharma.com|
21244076|NCT03845829|Department of Vascular Surgery, Shanghai Ninth People's Hospital|Kaichuang Ye|+86-021-2327166|ykaichuang@163.com|
21244077|NCT04751526|The University of Texas Health Science Center at Houston|Sheng Li, MD, PhD|713-797-7125|sheng.li@uth.tmc.edu|
21244078|NCT04656925|Washington State University|Abigail Bowen|(425) 736-1354|abigail.bowen@wsu.edu|
21244079|NCT02217904|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21244080|NCT01903811|SWOG Statistical Center|S1304 Statistician|2066674623|rachaels@crab.org|
21292498|NCT00363311|GlaxoSmithKline|GSK Response Center|866-435-7343||
21235414|NCT03851016|University of Houston|Dr. Theresa C. Chrisman|713-447-3334|tkchrisman@comcast.net|
21235415|NCT00853658|Novartis Pharmaceuticals|Study Director|862-778-8300||
21235416|NCT01227512|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21235417|NCT04150224|Nearmedic Plus|Viсtoria Shcherbakova|+7 (495) 741 49 89|Viktoriya.Shcherbakova@nearmedic.ru|3869
21235418|NCT02774681|Northwestern University|Massimo Cristofanilli, MD|312-503-5488|Massimo.cristofanilli@nm.org|
21235419|NCT01069289|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21235420|NCT00298038|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
21235421|NCT02696096|Butler Hospital|Dr. Michael Stein|401-455-6652|michael_stein@brown.edu|
21235422|NCT01940705|VA RR&D National Center for Rehabilitative Auditory Research|Gabrielle Saunders, PhD|503-220-8262|Gabrielle.Saunders@va.gov|56210
21235423|NCT02447991|Mayo Clnic|Jeffrey Staab, MD|507-293-9438|staab.jeffrey@mayo.edu|
21292499|NCT00401843|Janssen R&D UK|Project Physician||ClinicalTrialDisclosure@its.jnj.com|
21292500|NCT03175731|Qilu Hospital of Shandong University|Prof. Gao|+86-531-82169386|gaoyanjing@sdu.edu.cn|
21292501|NCT02651545|UBMD Neurology|Michael Jaworski|716-323-0550|mgjawors@buffalo.edu|
21279906|NCT00280735|UNC Lineberger Comprehensive Cancer|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
21292502|NCT00120627|VA San Diego Healthcare System|Jill E. Bormann, PhD, RN, FAAN|858-552-8585|jill.bormann@va.gov|2378
21292503|NCT01182298|NIAID|Shyam Kottilil||Skottilil@niaid.nih.gov|
21292504|NCT01508910|Baxalta US Inc.|Clinical Trial Registries and Results Disclosure||ClinicalTrialsDisclosure@baxalta.com|
21292505|NCT01595529|Westat|Dr. Elizabeth Rowley|(919) 941-8325|ElizabethRowley@westat.com|
21292506|NCT04016714|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21292507|NCT01677988|Medical University of South Carolina|Paul O'Brien, MD|843-792-4271|obrienpe@musc.edu|
21292508|NCT02525679|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21292509|NCT02629861|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|1-888-483-8279|USMedInfo@Tevapharm.com|
21292510|NCT01822665|GlaxoSmithKline|GSK Response Center|866-435-7343||
21292511|NCT00271544|Medtronic CRDM Clinical Research|Hang Nguyen|800-328-2518|hang.t.nguyen@medtronic.com|62832
21292512|NCT00907621|Department of General practice, University of Oslo|Dr. Holgeir Skjeie|+4722850550|Holgeir.Skjeie@medisin.uio.no|
21292513|NCT00730886|InSightec|Nadir Alikacem|214-630-2000|nadira@insightec.com|
21292514|NCT04290624|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
21292515|NCT00656370|Halozyme Therapeutics|Dimitrios Chondros, M.D., Chief Medical Officer|858-794-8889|dchondros@halozyme.com|
21292516|NCT04050384|Nationwide Children's Hospital|Dr. Lance M. Relland|614-722-5971|lance.relland@nationwidechildrens.org|
21292517|NCT00577278|City of Hope Medical Center|Dr. Matthew Mei|626-359-8111|mamei@coh.org|
21292518|NCT04743011|São Paulo State University (UNESP)|Professor Matheus Bertanha, Ph.D.|+551438801444|matheusbertanha@gmail.com|
21292519|NCT03366454|INA-RESPOND|Publication Division|+62214208693|inapublikasi@ina-respond.net|
21292520|NCT01222117|Grifols Therapeutics|Kimberly Steinmann, MD|919-308-5444|kimberly.steinmann@grifols.com|
21292521|NCT02722408|NeuroBo Pharmaceuticals|Vice President Clinical Operations|+1 (857) 702-9600|info@neurobopharma.com|
21292522|NCT00552071|Cedars-Sinai Medical Center|Vivian Hwe|4224-315-4489|hwev@cshs.org|
21292523|NCT00272792|BioMarin Pharmaceutical Inc.|Medical Information Services|1-800-983-4587|medinfo@bmrn.com|
21292524|NCT01900067|Mölnlycke Health Care AB, Surgical Division|Jenny Höglind|0046 31 722 30 00|Jenny.Hoglind@molnlycke.com|
21292525|NCT01058239|Massachusetts General Hospital|Jeremy Abramson, M.D|617-724-4000|JABRAMSON@mgh.harvard.edu|
21292526|NCT03121144|Masimo Corporation|Vikram Ramakanth|(949) 297-7000|clinicalresearchdept@masimo.com|
21292527|NCT03557125|Medical University of South Carolina|Sylvia Wilson, MD|843-792-2322|wilsonsh@musc.edu|
21292528|NCT00937495|University of Wisconsin|Steven Attia, D.O.||sa2@medicine.wisc.edu|
21292529|NCT01856322|National Cancer Institute|Dr. Marybeth Hughes|301-594-9341|hughesm@mail.nih.gov|
21292530|NCT00288015|Northwestern University|Mark Agulnik, MD|312-695-6182|magulnik@nm.org|
21292531|NCT04552041|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
21292532|NCT04592341|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21292533|NCT01944020|Columbia University|Ari Shechter|2123424487|as4874@cumc.columbia.edu|
21292534|NCT00692003|Eisai Inc|Antonio Laurenza, MD, Executive Director|1 201 949-4157|antonio_laurenza@eisai.com|
21244081|NCT04440176|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21244082|NCT03079024|University of Minnesota|Melissa Fisher|(612) 273-9812|mafisher@umn.edu|
21244083|NCT01631214|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21244084|NCT03575052|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|58-261|medicalinformation@acadia-pharm.com|2897
21244085|NCT04188379|argenx BV|Regulatory Manager|+32 9 310 3400|regulatory@argenx.com|
21244086|NCT03043599|H Lee Moffitt Cancer Center & Research Institute|Bradford Perez, MD|813-745-8234|Bradford.Perez@moffitt.org|
21244087|NCT05288283|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
21244088|NCT03112174|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21279907|NCT04753216|Northwestern University Feinberg School of Medicine|Daniela Matei, MD|312-472-4684|daniela.matei@northwestern.edu|
21279908|NCT02142608|Bracco Diagnostics Inc.|Maria Luigia Storto, MD, Executive Director X-Ray and Ultrasound|609-514-2262|marialuigia.storto@diag.bracco.com|
21279909|NCT01965860|Ghent University|Prof. Dr. Isabelle Van Herzeele|93325108|isabelle.vanherzeele@ugent.be|+32
21279910|NCT00955929|Memorial Sloan Kettering Cancer Center|John Mulhall, MD|646-888-6024|mulhalj1@mskcc.org|
21279911|NCT02064296|University of Michigan|Richard Harris|734-998-6996|reharris@med.umich.edu|
21279912|NCT01894087|University of Michigan|Amy Bohnert|734-845-3638|amybohne@med.umich.edu|
21279913|NCT02526667|Evic Romania|Dr. Olsavszky|40 21 335 70 90|research@evic.ro|
21279914|NCT03606343|Cincinnati Children's Hospital Medical Center|Leanne Tamm, Principal Investigator|513-803-3176|leanne.tamm@cchmc.org|
21279915|NCT00972374|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21279916|NCT04149821|Weill Cornell Medicine|Dr. John Allan, Associate Professor of Medicine|2127463481|joa9069@med.cornell.edu|
21279917|NCT02481206|Zoll|Director of Clinical Affairs|724-968-3333|mosz@zoll.com|
21292535|NCT01535287|University of Iowa|Martin Mueller|3193562633|martin-mueller@uiowa.edu|
21292536|NCT00305877|ECOG Statistical Office|Study Statistician|617-632-3012||
21244089|NCT01164098|University of Miami|George W. Burke, M.D.|3053555315|gburke@med.miami.edu|
21292537|NCT00457392|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21292538|NCT00980148|University of Arkansas for Medical Sciences|Shelly Lensing, Statistician|501-686-8203|sylensing@uams.edu|
21292539|NCT05547412|NovaSignal|Manja Lenkin|8776387251|manja.lenkin@novasignal.com|
21292540|NCT03663855|NYU Langone Health|David Goldfarb, MD|(212) 263-7300|David.Goldfarb@nyulangone.org|
21292541|NCT00812955|AstraZeneca|Gerard Lynch|+44 1509 645 895|aztrial_results_posting@astrazeneca.com|
21292542|NCT01309204|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21292543|NCT01435174|University of Michigan College of Pharmacy|Bruce A. Mueller|7346154578|muellerb@umich.edu|
21292544|NCT00512278|Cleveland Clinic|Nizar Zein|216-444-6126|zeinn@ccf.org|
21292545|NCT04512001|Fresenius Kabi SwissBioSim GmbH|Clinical Development|793075735|clinical.development@fresenius-kabi.com|+41
21292546|NCT03389308|Castle Creek Pharmaceuticals|Mary C. Spellman, MD|312-847-1291|mspellman@castlecreekpharma.com|
21292547|NCT03975153|Oregon Health & Science University|Teri Greiling, MD, PhD, FAAD|503-494-3376|PRPStudy@ohsu.edu|
21292548|NCT00570323|Baylor College of Medicine|Tao Wang|7137985388|taow@bcm.edu|
21292549|NCT04263766|Georgia Institute of Technology|Dr. Dobromir Rahnev|6466378219|rahnev@psych.gatech.edu|
21292550|NCT03350451|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
21292551|NCT04232943|PATH|Rahsan Erdem, MD, Senior Medical Officer|+1 202 540 4546|rerdem@path.org|
21292552|NCT02639247|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21292553|NCT01891396|Anika Therapeutics, Inc.|Carol Pekar, VP Clinical Affairs|781.457.9218|cpekar@anikatherapeutics.com|
21292554|NCT04231097|Massachusetts General Hospital|Christina Luberto, PhD|617-643-9453|cluberto@mgh.harvard.edu|
21292555|NCT02266147|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-665-0414|rjanssen@dynavax.com|
21292556|NCT03391986|Columbia University|Carolyn Westhoff, MD|212-305-4805|clw3@columbia.edu|
21292557|NCT00573391|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|pettynathanm@uams.edu|2461
21292558|NCT01896687|Virginia Commonwealth University|Dr. Angela Starkweather|8048283986|astarkweathe@vcu.edu|
21292559|NCT03896477|PATH|Mark Alderson|+ 206.302.4859|malderson@path.org|
21292560|NCT01102738|Imperial College London|Dr. Kathleen Sim|(+44) (0)20 7594 3695|k.sim@imperial.ac.uk|
21292561|NCT01881009|Stanford University|Bruce Buckingham, M.D.|408-356-0911|buckingham@stanford.edu|
21292562|NCT01718522|Kinder- und Jugendkrankenhaus Auf der Bult|Prof. Dr. Thomas Danne|0511-8115-3331|danne@hka.de|
21292563|NCT01063348|University of Chicago|Dr. Jon Grant|773-834-1325|jongrant@uchicago.edu|
21292564|NCT01118780|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21292565|NCT05018689|Penn State College of Medicine|Dr. Deepa Sekhar|717-531-0003|dsekhar@pennstatehealth.psu.edu|x281334
21235424|NCT01976845|Department of Anesthesiology at Cedars-Sinai Medical Center in Los Angeles|Dr. Ronald H Wender|3104231682|ronald.wender@cshs.org|
21235425|NCT04176796|Carnegie Mellon University|Gretchen Chapman|412-268-3665|gchapman@andrew.cmu.edu|
21235426|NCT03042312|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21235427|NCT01856140|Seoul National University College of Medicine|Dr. Sang Yoon Lee|028702673|rehabilee@gmail.com|
21235428|NCT02293005|UT MD Anderson Cancer Center|Dr. Anne Tsao, MD- VP, Academic Affairs, CAO Office|(713) 792-6363|astsao@mdanderson.org|
21235429|NCT01151553|Emory University|Dr. Heather Bloom|404-321-6111|heather.bloom@emory.edu|6391
21235430|NCT01032694|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21235431|NCT02181530|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21235432|NCT01383681|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21235433|NCT00938431|UCB|Study Director|+1877 822 9493||
21235434|NCT01774903|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-792-7200||
21235435|NCT00127790|Universityy of Rochester|Wilfred Pigeon, PhD|(585) 275-3374|wilfred_pigeon@urmc.rochester.edu|
21235436|NCT00961259|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21235437|NCT01252251|Memorial Sloan Kettering Cancer Center|Dr. Michael Postow, MD|646-888-4589|PostowM@mskcc.org|
21235438|NCT01324024|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu|
21235439|NCT00530023|Director, Program Management, Clinical Research|Harold Torunsky|8185765445|harold.torunsky@medtronic.com|
21235440|NCT02709395|Wellspect HealthCare|Head of Medical Affairs, Markus Wittebo|+46 31 376 40 00|markus.wittebo@wellspect.com|
21235441|NCT00627406|Fertility Clinic Regional Hospital Skive|Dr. Peter Humaidan|+45 78 44 57 60|peter.humaidan@viborg.rm.dk|
21235442|NCT01858194|Icahn School of Medicine at Mo|Betsy Ellsworth, Research Program Director|212 824 8902|betsy.ellsworth@mountsinai.org|
21235443|NCT01196871|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
21235444|NCT01744730|Duke Clinical Research Institute, Duke University School of Medicine|Kevin Watt, MD|919-668-8556|kevin.watt@dm.duke.edu|
21235445|NCT00205712|Washington University School of Medicine|John Newcomer, MD|314-362-3153|newcomerj@wustl.edu|
21235446|NCT00096044|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21235447|NCT02442830|UMass Medical School|Principal Investigator|(774) 442-4098|David.Cave@umassmemorial.org|
21235448|NCT00437034|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
21235449|NCT01910064|Galderma K.K.|Clinical Project Manager|+81 3 5937 3850|GaldermaKK.ClinDev@galderma.com|
21235450|NCT02460224|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21235451|NCT00586469|GlaxoSmithKline|GSK Response Center|866-435-7343||
21235452|NCT04055116|Geisinger|Gayatri Malik, MD|15702716355|gmalik1@geisinger.edu|
21244090|NCT05773313|Mayo Clinic|Nathan Delafield, M.D.|480-574-1920|Delafield.Nathan@mayo.edu|
21292566|NCT02457247|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
21292567|NCT02216526|Charité Universitätsmedizin Berlin, Germany|PD Dr. Jan Kottner|+49 (0)30 450 518 218|jan.kottner@charite.de|
21292568|NCT02750514|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21292569|NCT01882465|Johnson & Johnson Vision Care Inc.|Charis Lau, PharmD, OD, FAAO- Principal Research Optometrist|904-433-3500|charislau@gmail.com|
21292570|NCT03119168|Texas Tech University Health Sciences Center at El Paso|The Effect Of Adding High Dose Simethicone To A Standard Polyethylene Glycol Preparation On Adenoma|915-215-4678|antonio.mendoza-ladd@ttuhsc.edu|
21292571|NCT02524561|Brigham and Women's Hospital|Dr. Rulla Tamimi|617-525-0862|rulla.tamimi@channing.harvard.edu|
21244091|NCT01534494|New York University Grossman School of Medicine|Michael Bogenschutz|5059999325|Michael.Bogenschutz@nyulangone.org|
21244092|NCT05137236|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
21244093|NCT00825630|Sharon Hospital|Dr. Haim Shirin|0097239372231|haims3@clalit.org.il|
21244094|NCT02880137|Mayo Clinic|Dr. Jonathan Johnson|507-255-7013|johnson.jonathan@mayo.edu|
21244095|NCT04512482|Indiana University School of Dentistry, Department of Orthodontics|Kelton T. Stewart, Department Chair|317-278-1087|keltstew@iu.edu|
21244096|NCT01939899|Millennium Pharmaceuticals, Inc.|Medical Director|+1-844-662-8532|globaloncologymedinfo@takeda.com|
21244097|NCT00265200|James Graham Brown Cancer Center, University of Louisville|Goetz H Kloecker, MD|502-562-4358|ghkloe01@louisville.edu|
21244098|NCT03285542|Cleveland Clinic|Viktor Krebs|216-445-3843|krebsv@ccf.org|
21244099|NCT05119855|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21244100|NCT02932579|University of Rochester Eastman Institute for Oral Health|Yanfang Ren, Professor|5852735588|yanfang_ren@urmc.rochester.edu|
21244101|NCT04059042|University of Kansas Medical Center|Dr. Rebecca Lepping|913-588-0287|rlepping@kumc.edu|
21244102|NCT02706717|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21244103|NCT05608564|School Of Dental Medicine, University Of Belgrade, Department of Periodontology and Oral Medicine|Assistant Professor Dr. Iva Milinkovic|+381642041811|iva.milinkovic@gmail.com|
21244104|NCT02549170|Shire|Study Director|+18668425335|ClinicalTransparency@shire.com|
21244105|NCT03051165|Emory University|Raj Dedhia, MD, MS|(404) 778-3381|raj.dedhia@emory.edu|
21235453|NCT01978184|UPMC Hillman Cancer Center|Barbara Stadterman|412-647-5554|stadtermanbm@upmc.edu|
21244106|NCT00818246|RoseLab Skin Optics Laboratory|Dr Daniel Barolet|(514) 343-4444|daniel.barolet@mcgill.ca|
21244107|NCT02121002|Amneal Pharmaceuticals|Candis Edwards|631-974-7949|cedwards@amneal.com|
21244108|NCT00409838|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21244109|NCT01319617|UCSD|Felipe Medeiros|858 82245-92|fmedeiros@glaucoma.ucsd.edu|
21244110|NCT01250769|Philips Healthcare, Office of Medical and Health Affairs|Director of Clinical Operations|425 908-1208|wendy.jenkins@philips.com|
21244111|NCT01290341|Merz Pharmaceuticals, LLC|Stefan Plaum, MD Associate Medical Director|800-334-0514|clinicaltrials@merzusa.com|
21244112|NCT03951805|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21244113|NCT03684044|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21244114|NCT03703336|POLYVAC|Nguyen Thuy Huong, Ph.D, Vice Director|+84 912514309|huong72us@yahoo.com|
21244115|NCT00595413|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21244116|NCT03233633|Connecticut Hospice|Jim Prota, Director of Pharmacy|203-848-0660|jprota@hospice.com|
21244117|NCT02088853|Göteborgs University|Professor Lars Fandriks|+46313424123|lars.fandriks@gastro.gu.se|
21244118|NCT00603954|CHU de Liège|Dr. Frédéric Baron|003243667201|f.baron@ulg.ac.be|
21244119|NCT02708108|Childrens Hospital Los Angeles|Dr Etan Orgel|13233612121|eorgel@chla.usc.edu|
21244120|NCT05368831|NorthSea Therapeutics BV|CLIENT TO PROVIDE|31 035760 65 05|info@northseatherapeutics.com|
21244121|NCT00262730|Adult Brain Tumor Consortium Central Office- Johns Hopkins|Director of Adult Brain Tumor Consortium|410-955-3657|jfisher@jhmi.edu|
21244122|NCT00419341|CSL Behring|Clinical Trial Disclosure Manager|Use email contact.|clinicaltrials@cslbehring.com|
21244123|NCT04200365|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|SCRI.InnovationsMedical@scri.com|
21244124|NCT01701986|University of Texas MD Anderson Cancer Center|Dr. Yago Nieto, MD, PhD/ Stem Cell Transplantation Department|713-792-8750|ynieto@mdanderson.org|
21244125|NCT03783026|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21244126|NCT04814186|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21244127|NCT04917588|CROMA - PHARMA|Head of Clinical Operations|+43 0226268468|clinical.studies@croma.at|
21244128|NCT01853748|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|(877) 442-3324|Sara_Tolaney@dfci.harvard.edu|
21244129|NCT03342027|University of Chicago|Dr. Seth Himelhoch|773-834-4314|seth.himelhoch@bsd.uchicago.edu|
21244130|NCT04043455|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
21244132|NCT05505045|University of Missouri|Anna Boone, PhD|573-882-7023|booneae@umsystem.edu|
21244133|NCT01643070|Asan Medical Center|Dr. Tae Won Kim|+82-2-3010-3910|twkimmd@amc.seoul.kr|
21235454|NCT04409041|Washington University|Dr. Caroline Mann|(314) 996-8010|cmann@wustl.edu|
21235455|NCT01394926|GE Healthcare|Paul Sherwin, M.D.|1-609-514-6820|Paulsherwin@ge.com|
21235456|NCT00236938|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|844
21235457|NCT01815671|Specialists in Gastroenterology, LLC|Leonard Weinstock, MD|314-997-0554|lw@gidoctor.net|102
21235458|NCT02047604|Valeant Pharmaceuticals|VP Clinical Services|9089271162|christine.hnatko@valeant.com|
21235459|NCT01767792|The University of Alabama at Birmingham|Bruce Korf, MD, PhD|205.934.4010|bkorf@uabmc.edu|
21235460|NCT01208233|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21235461|NCT01181895|GlaxoSmithKline|GSK Response Center|866-435-7343||
21292572|NCT00532844|BioMarin Pharmaceutical Inc.|Joshua Lilienstein/Medical Director, Global Medical Affairs|651.523.0310|MEDINFO@bmrn.com|
21292573|NCT03894891|Dana-Farber Cancer Institute|Robert Haddad, MD|617.632.3090|Robert_Haddad@dfci.harvard.edu|
21292574|NCT04389866|Advanced Dermatology|Dr. Amy Forman Taub|8474596400|drtaub@advdermatology.com|
21292575|NCT01730872|Ora|Keith Lane|9786858900|klane@oraclinical.com|
21292576|NCT01186250|Stanford University|Kiran K. Khush, MD|650-721-3241|kiran@stanford.edu|
21292577|NCT01313507|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201 604-1155|michael.eppolito@octapharma.com|
21292578|NCT01644643|AstraZeneca-PPD|Yunxia Lu|910-558-4197|Yunxia.Lu@ppdi.com|
21292579|NCT02756403|MedStar Washington Hospital Center|Principal Investigator|202-877-7479|peggy.ye@medstar.net|
21244134|NCT02975505|University of California, San Francisco Division of Nephrology|Dr. Elaine Ku|415-502-7760|elaine.ku@ucsf.edu|
21244135|NCT04842500|Vanderbilt University|Dr. Joseph Lambert|615-343-0824|joseph.m.lambert@vanderbilt.edu|
21244136|NCT02980276|University of Galway|Professor Fidelma Dunne|+35391492117|fidelma.f.dunne@universityofgalway.ie|
21244137|NCT04354337|University of Washington|Weichao Yuwen|2536924478|wyuwen@uw.edu|
21244138|NCT04139668|Centre for Addiction and Mental Health|Dr. Bernard Le Foll|416-535-8501|bernard.lefoll@camh.ca|33111
21244139|NCT03025789|Drugs for Neglected Diseases initiative (DNDi)|Dr. Olaf Valverde Mordt|+41795431713|ovalverde@dndi.org|
21244140|NCT03554265|University of Texas Medical Branch|Randall Urban, MD|409-772-5476|rurban@utmb.edu|
21244141|NCT02652260|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21244142|NCT02723955|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21244143|NCT03657212|University of California, Irvine|Dr Sara Mednick|8589457904|mednicks@uci.edu|
21244144|NCT04999085|University of North Carolina Lineberger Comprehensive Cancer Center|Christopher E. Jensen, MD, MSCR|+1 984-987-1072|cejensen@med.unc.edu|
21244145|NCT00880425|Thomas Jefferson University|Jessica Ailani, MD/ Headache Fellow|631-807-8194|Jessica.Ailani@gmail.com|
21244146|NCT05056246|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21244147|NCT05057897|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21244148|NCT05857644|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21244149|NCT05096819|Oxford University Hospitals|Dr Elizabeth Orchard|01865 741166|elizabeth.orchard@ouh.nhs.uk|
21244150|NCT03324984|Montefiore Medical Center|Dr. Elilary Montilla Medrano|929-263-3302|emontill@montefiore.org|
21244151|NCT03346538|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp|
21244152|NCT03088813|Ipsen Bioscience, Inc.|Medical Director|see email|clinical.trials@ipsen.com|
21244153|NCT03717415|Deciphera Pharmaceuticals, LLC|Clinical Trials|785-830-2100|clinicaltrials@deciphera.com|
21244154|NCT00003042|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
21244155|NCT03504423|Cornerstone Pharmaceuticals Inc.|Sanjeev Luther|585-978-1351|sanjeev.luther@cornerstonepharma.com|
21244156|NCT01808339|GlaxoSmithKline|GSK Response Center|866-435-7343||
21244157|NCT00324350|University of California, San Francisco|Dr. Ann Schwartz|415-514-8000|aschwartz@psg.ucsf.edu|
21244158|NCT00439413|National Institute on Drug Abuse|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov|
21244159|NCT02168400|University of Minnesota|Jazmin Camchong|(612) 625-3330|camch002@umn.edu|
21244160|NCT00335036|Children's National|Charles Berul, MD|202-476-5710|cberul@childrensnational.org|
21244161|NCT04204993|Imperial College London|Professor Chris Chiu|+44 (0)20 8383 2301|c.chiu@imperial.ac.uk|
21244162|NCT00111813|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21244163|NCT00574834|University of Maryland Baltimore|Stephen N. Davis, MBBS- Principal Investigator|410-328-2488|sdavis@medicine.umaryland.edu|
21244164|NCT01919450|Cardiovascular Imaging Technologies, LLC|Timothy M. Bateman, MD|816-531-2842|tbateman@cvit.com|
21244165|NCT00093015|Amgen Inc.|Study Director|866-572-6436||
21244166|NCT02561702|University of Rochester|David Herrmann|585-275-4568|david_herrmann@urmc.rochester.edu|
21244167|NCT03076515|Theranica Bio-Electronics Ltd|Dagan Harris|+972723909755|daganh@theranica.com|
21244168|NCT02101281|Dompé|Flavio Mantelli, MD, PhD|+39 513138|info@dompe.it|
21244169|NCT00296036|Mayo Clinic|Charles Lawrence Loprinzi, M.D.||cloprinzi@mayo.edu|
21244170|NCT00895531|University Louisville|Nancy Alsip|502-852-2905|nlalsi01@exchange.louisville.edu|
21244171|NCT03501264|University of Pittsburgh, Graduate School of Public Health|James Egan|412-624-2255|jee48@pitt.edu|
21244172|NCT00529100|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21244173|NCT03733119|University of Wisconsin Carbone Cancer Center|Kari Wisinski, MD|608-262-2876|kbwisinski@medicine.wisc.edu|
21244174|NCT00807937|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21244175|NCT00533910|Hunter Holmes McGuire VAMC|Jasmohan Bajaj|804 675 5802|jasmohan@gmail.com|
21244176|NCT04629950|Department of Dermatology, Weill Cornell Medicine|Dr. Richard D. Granstein|(646) 962-7546|rdgranst@med.cornell.edu|
21244177|NCT01198145|Mayo Clinic|Robert C. Miller, M.D., M.S.||miller.robert@mayo.edu|
21244178|NCT03049969|NYU Langone Health|Leigh Charvet, MD|9294555141|Leigh.Charvet@nyulangone.org|
21244179|NCT02568683|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21244180|NCT00891436|Rush University Medical College|James N. Moy, M.D.|312-942-6176|jmoy@rush.edu|
21244181|NCT01561989|Roswell Park Cancer Institute|Dr. Martin Mahoney|716-845-2300|martin.mahoney@roswellpark.org|
21244182|NCT00194896|University of Washington|Jerry P. Palmer, MD|206-764-2495|jpp@u.washington.edu|
21244183|NCT03485950|UT MD Anderson Cancer Center|Issam Raad,MD - Chair, Infectious Diseases|(713) 792-7943|iraad@mdanderson.org|
21292580|NCT01824290|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21244184|NCT03930420|University of Washington|Margaret Hannon, PhD|206-616-7859|peggyh@uw.edu|
21244185|NCT00609336|University of Washington|Andrew Coveler, MD|206-288-7509|acoveler@uw.edu|
21244186|NCT00567489|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
21244187|NCT04661410|The WELL Center|Dr. Adrienne Juarascio|443-801-8093|asj32@drexel.edu|
21244188|NCT00068601|SWOG Statistics and Data Management Center|Cancer Survivorship Committee Statistician|206-667-4623||
21244189|NCT01061671|University of Minnesota|Sarah Lindberg|612-626-9011|sharnden@ccbr.umn.edu|
21244190|NCT02570022|Henry Ford Hospital|Dr. Kelechi Okoroha|8324239895|krokoroha@gmail.com|
21244191|NCT02409667|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21244192|NCT01985542|Helsinki University Hospital|Dr. Sanna Salmi|+358505431421|sanna.salmi@helsinki.fi|
21244193|NCT01205048|Galderma|Clinical Scientist|+46184749000|reception.seupp@galderma.com|
21244194|NCT01255670|Helsinki University Central Hospital|Dr. Karin Blomgren|+358504271579|karin.blomgren@hus.fi|
21244195|NCT00823472|UMC Utrecht|Prof. dr. B.C.J.M. Fauser|+31-88-7557524|b.c.fauser@umcutrecht.nl|
21244196|NCT00903162|Dana-Farber Cancer Institute|Ann Partridge, MD, MPH|617.632.3800|ann_partridge@dfci.harvard.edu|
21244197|NCT03087708|VA Long Beach Health Care System|Dr. Pankaj Gupta|562-826-8000|pankaj.gupta@va.gov|
21244198|NCT01996605|Wake Forest University School of Medicine|Professor James C. Eisenach, MD|336-716-4182|jimeisenach@gmail.com|
21244199|NCT04992390|P1vital Products Ltd|Dr Amy Beckenstrom|+44(0)1865 522 030|abeckenstrom@p1vital.com|
21244200|NCT01827787|Dana-Farber Cancer Institute|Dr. Erica Mayer|617-632-2335|Erica_Mayer@dfci.harvard.edu|
21244201|NCT02769858|University of Michigan|Dr. Leslie Swanson|734-239-2248|LMSwan@med.umich.edu|
21244202|NCT02152137|Mayo Clinic|Robert C. Smallridge, M.D.|904-953-2392|smallridge.robert@mayo.edu|
21244203|NCT04878354|ALK-Abelló A/S|Senior Director, Clinical Data Science|+4545747576|clinicaltrials@alk.net|
21244204|NCT03358875|BeiGene|Study Director|1-877-828-5568|Clinicaltrials@beigene.com|
21244205|NCT03599648|University of Oregon|Dr. Laura Lee McIntyre|541-346-7452|llmcinty@uoregon.edu|
21244206|NCT01563341|Mayo Clinic|Ryan J. Uitti, MD|904-953-2000|uitti.ryan@mayo.edu|
21244207|NCT03363854|LEO Pharma A/S|Disclosure|+45 44 94 58 88|disclosure@leo-pharma.com|
21244208|NCT05307783|Merit Medical|Vicky Brunk|(385) 766-9152|vicky.brunk@merit.com|
21244209|NCT04883645|Medical University of South Carolina|Dr. Angela J. Yoon|8437924496|yoona@musc.edu|
21244210|NCT06382064|The Ohio State University College of Optometry|Dr. Jennifer Fogt|614-292-0882|fogt.78@osu.edu|
21244211|NCT00977691|National Heart Lung and Blood Institute|Courtney Fitzhugh, MD, Investigator|+1 301 402 6496|courtney.fitzhugh@nih.gov|
21244212|NCT03460236|Stanford University|Christine Hoang, Clinical Research Coordinator|650-721-7630|c1hoang@stanford.edu|
21244213|NCT06194214|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21244214|NCT04540913|TEOXANE SA|Clinical Research Scientist|+41(0) 22 344 96 36|clinical@teoxane.com|
21244215|NCT05687903|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21244216|NCT05613205|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21244217|NCT04300231|Indiana University Department of Anesthesiology|Yar Luan Yeap, MD|317-274-0275|yyeap@iupui.edu|
21244218|NCT04431050|Imperial|Joan Nanan|+44 (0)20 7594 9000|j.nanan@imperial.ac.uk|
21244219|NCT03050814|National Cancer Institute|Dr. Julius Y. Strauss|240-858-3999|julius.strauss@nih.gov|
21244220|NCT02014129|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21244221|NCT00431834|Medtronic, Inc.|Kristin Lawman|763-514-9809|kristin.j.lawman@medtronic.com|
21244222|NCT01610297|Novartis|Study Director|862-778-8300||
21244223|NCT00243503|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21244224|NCT00914589|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21244225|NCT00510887|Duke University Medical Center|Dr. David Rizzieri|919-668-1000|rizzi003@mc.duke.edu|
21244226|NCT02346526|Massachusetts General Hospital|Philip Saylor, MD|617-724-5197|psaylor@mgh.harvard.edu|
21244227|NCT01381406|GlaxoSmithKline|GSK Response Center|866-435-7343||
21244228|NCT02238483|AstraZeneca|Ziad Taib|+46 708 46 73 56|ziad.taib@astrazeneca.com|
21279918|NCT00666328|The Medicines Company|Jason Campagna. MD, PhD|973-290-6199|jason.campagna@themedco.com|
21279919|NCT02288325|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21279920|NCT02411916|Queens Hospital Center|Dr. Aleksandr Fuks|718 883-4035|fuksal@nychhc.org|
21279921|NCT01884337|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21279922|NCT02455518|Albany Medical College|Dr. Andrew Chang|2125555555|achang3@yahoo.com|
21279923|NCT01350583|H. Lee Moffitt Cancer Center and Research Institute|Robert J. Gillies, Ph.D. - Principal Investigator|813-745-8355|robert.gillies@moffitt.org|
21279924|NCT04186845|Blue Earth Diagnostics|Head of R&D|+44 (0) 1865 784 186|matthew.miller@blueearthdx.com|
21279925|NCT03151304|Helsinn Healthcare|Francesco Scarci, Clinical Operations Manager|+41 (0)91 985 2121|francesco.scarci@helsinn.com|
21279926|NCT01255137|National Cancer Institute, National Institutes of Health|Dr. Tito Fojo|301-496-2631|FojoT@mail.nih.gov|
21279927|NCT01332292|GlaxoSmithKline|GSK Response Center|866-435-7343||
21279928|NCT03295630|Hull University Teaching Hospitals NHS Trust|Dr. Jayne Anderson|01482 875875|jayne.anderson@hey.nhs.uk|5099
21279929|NCT00098774|University of California, San Francisco|James Rubenstein, MD, PhD||jamesr@medicine.ucsf.edu|
21244229|NCT01172418|University of Miami|George W. Burke, M.D.|305-355-5315|gburke@med.miami.edu|
21244230|NCT00856739|Stanford University, Palo Alto Veterans Hospital|Dr. Thomas P. Andriacchi, Ph.D.|650-723-8024|tandriac@stanford.edu|
21279930|NCT00796757|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21244231|NCT02321514|Abbott|Karine Miquel, PhD|+32 479 600 107|karine.miquel@abbott.com|
21244232|NCT03799783|University Hospital Padova|Angela Amigoni, MD|339 8333765|Angela.amigoni@aopd.veneto.it|++39
21244233|NCT02793154|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21235462|NCT00023452|CDC|Dr Elsa Villarino|404-639-5340|mev1@cdc.gov|
21244234|NCT04426500|Icahn School of Medicine at Mount Sinai|Dr. Reza Mehrazin|(212) 241-4812|reza.mehrazin@mountsinai.org|
21244235|NCT02372253|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Anath Shalev, MD|205-996-4777|shalev@uab.edu|
21244236|NCT00629850|Texas State Respiratory Care Department|Chris Russian, Associate Professor|512-245-3794|cr23@txstate.edu|
21279931|NCT01546454|University of Arizona|Dr. Randy Bogan|520-621-1487|boganr@email.arizona.edu|
21244237|NCT01803555|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21244238|NCT00393484|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21244239|NCT03294499|Imperial College Healthcare NHS Trust|Dr Farai Nyatsanza|n/a|farai.nyatsanza@nhs.net|
21244240|NCT00132964|Hospital for Sick Children|Kathy Boutis|4168138982|kathy.boutis@sickkids.ca|
21244241|NCT00780234|Rocky Mountain Regional VA Medical Center|Robert L. Keith, MD|720-857-5120|robert.keith@ucdenver.edu|
21279932|NCT02716727|University of North Carolina at Chapel Hill|Sumitha Ahmed, DDS|919-537-3946|sumitha_ahmed@unc.edu|
21279933|NCT00174954|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21279934|NCT00839254|GlaxoSmithKline|GSK Response Center|866-435-7343||
21279935|NCT00207883|Children's Healthcare of Atlanta / Emory University|Jana Stockwell, MD|404-785-1600|jana.stockwell@choa.org|
21279936|NCT04842292|University of Kentucky|Brittany Bissell|8593239308|bdbi223@uky.edu|
21279937|NCT02374138|Children's Research Institute|Stephen Teach, MD, MPH|202 476 5134|steach@childrensnational.org|
21292581|NCT00800982|University of California San Francisco|Dr Ethan Levin|4154764019|levine@derm.ucsf.edu|
21235463|NCT02710526|Braeburn Inc|Sonnie Kim|6104678718|sonnie@braeburnrx.com|
21235464|NCT02287415|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21235465|NCT04551105|Virginia Tech|Study Director of Clinical Trials|+1 (301) 820-5225|dcben0@gmail.com|
21235466|NCT00459134|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
21235467|NCT00829621|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu|
21235468|NCT01003418|GlaxoSmithKline|GSK Response Center|866-435-7343||
21235469|NCT02770391|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Moshe Ornstein,|18662238100|taussigresearch@ccf.org|
21235470|NCT00019682|Indiana University Health|Dr Douglas Schwartzentruber|317-948-6873|dschwart@iuhealth.org|
21235471|NCT03333486|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
21235472|NCT03995758|Indiana University School of Medicine|Dr. Marcelino Rivera|3179622485|maeriver@iu.edu|
21235473|NCT02276495|UC Irvine Health Department of Anesthesiology & Perioperative Care|Dr. Joseph Rinehart|714-456-7415|jrinehar@hs.uci.edu|
21235474|NCT01755416|Children's Hospital at Montefiore|Dr. Rubina Heptulla|718-920-7004|rheptull@montefiore.org|
21235475|NCT02927691|Teachers College, Columbia University|Michelle Troche|212-678-3953|mst2139@tc.columbia.edu|
21235476|NCT05419947|Instituto de Investigación Biomédica de Salamanca (IBSAL)|Dr. Luis Muñoz Bellvís|0034 923 29 11 00|luismb@usal.es|
21235477|NCT01157533|The University of Texas (UT) MD Anderson Cancer Center|Ara Vaporciyan, MD, BS/ Professor||CR_Study_Registration@mdanderson.org|
21235478|NCT00441337|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21235479|NCT04356716|Columbia University|Suzanne Daly, RN, BSN|212 305 9535|sd2798@cumc.columbia.edu|
21235480|NCT04258839|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21235481|NCT03328897|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21235482|NCT04331366|Emory University|Jeffery Miller, MD|404-778-7200|jeffrey.miller@emory.edu|
21235483|NCT02277626|Stanford University|Carlos Milla, MD|650-723-5193|cmilla@stanford.edu|
21235484|NCT02648698|Department of Hysteroscopic Centre, Fuxing Hospital, the Eighth Clinical Medical College, Capital Medical University, Beijing, China|Dr. Dongmei Song|13651294056|echosdm@163.com|86
21235485|NCT03574129|University of Washington|Dr. Irene Njuguna|2065191275|irenen@uw.edu|
21235486|NCT00317772|UT MD Anderson Cancer Center|Diane C Bodurka,Chief Education & Training Ofc, Education & Training|(713) 745-3358|dcbodurka@mdanderson.org|
21235487|NCT00966940|Alcon Research, Ltd.|Director of Medical Affairs|1-800-862-5266|medinfo@alconlabs.com|
21235488|NCT03151265|dorsaVi Ltd|Sangeeth Wanasinghage|+61 1800 367 728|support@dorsavi.com|
21235489|NCT01040871|Johnson & Johnson Pharmaceutical Research & Development|Dr. Helgi van de Velde||HVDVELDE@ITS.JNJ.COM|
21244242|NCT02178098|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
21244243|NCT02382744|Department of Anesthesia, St. Paul's Hospital/Providence Health Care|Dr. Stephan Schwarz, Director of Research|(604) 806-8337|stephan.schwarz@ubc.ca|
21244244|NCT01109524|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21244245|NCT01923480|Baxter Healthcare|Aparna Valluru, Clinical Project Manager|224.270.6063|Aparna_Valluru@baxter.com|
21244246|NCT01551355|Icahn School of Medicine at Mount Sinai|Dr. Valentin Fuster|212-241-3852|valentin.fuster@mssm.edu|
21244247|NCT02318134|First Affiliated Hospital of Nanchang University|Dr. Ling Ding|15279196058|2495802456@qq.com|
21244248|NCT01925339|University of Michigan|Dr. Hom-Lay Wang|734-763-3383|homlay@umich.edu|
21244249|NCT03664960|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
21244250|NCT04019444|The Hope Clinic of the Emory Vaccine Center|Varun K. Phadke, MD|404-712-9046|vphadke@emory.edu|
21244251|NCT02960204|Histogen Inc.|Mark Hubka, Executive Director, Medical Affairs|858-526-3109|mhubka@histogen.com|
21244252|NCT00475241|VA Ann Arbor Healthcare System|Dr. Sheila A.M. Rauch|734-845-3545|sherauch@med.umich.edu|
21244253|NCT03997916|University Hospitals Cleveland Medical Center|Eric Yeh, MD|216-844-1867|eric.yeh@uhhospitals.org|
21244254|NCT04220229|City of Hope|Lee Cranmer, MD, PhD|626-256-4673|lcranmer@coh.org|
21292582|NCT00527618|University of Washington, Virology Research Clinic|Tara Perti, MD|(206) 520-4340|tarap@u.washington.edu|
21244255|NCT03807778|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21244256|NCT04242940|Oticon Medical|Manager of Clinical Affairs|609-366-0424|studyinfo@oticonmedical.com|
21244257|NCT05028582|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
21244258|NCT04939246|Miami Cancer Institute at Baptist Health, Inc.|Director, Concept Development & Data Management|(786) 527-9546|mciresearchconceptandprotocoldev@baptisthealth.net|
21262047|NCT01103349|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21262048|NCT01148056|Mass General Hospital Cancer Center|Maria Kempner|508.533.4132|mkempner@partners.org|
21262049|NCT02397655|Xuanwu hospital, Capital medical university|Dr. Yang Hua|86-10-83198923|dryanghua99@163.com|
21262050|NCT01736683|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|800-672-6372|ClinicalTrialsDisclosure@merck.com|
21262051|NCT04978376|University of Illinois Chicago|Kelsey Gabel|312-413-8911|kdipma2@uic.edu|
21262052|NCT00915967|Oregon Health & Science University|Director of Clinical Trials|503-494-4314|nsgclinicalresearch@ohsu.edu|
21262053|NCT01966731|Cincinnati Children's Hospital Medical Center|Russell Ware, MD, PhD|(513) 803-1108|russell.ware@cchmc.org|
21244259|NCT04474314|Imara, Inc.|Rahul Ballal|617-206-2020|rballal@imaratx.com|
21244260|NCT04898023|University of Missouri Healthcare|Ryan Camden|(575) 882-4141|camdenr@health.missouri.edu|
21244261|NCT04337372|University of Florida|Lisa Scott|352-273-2125|lscott@ufl.edu|
21244262|NCT03494504|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
21244263|NCT04869982|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21244264|NCT04608045|University of Kansas Medical Center|Dr. John A Taylor|9135888170|jtaylor27@kumc.edu|
21244265|NCT05833789|Vanderbilt University Medical Center|Michael McGill|615-322-0128|michael.g.mcgill@vumc.org|
21244266|NCT02473250|Columbia University Irving Medical Center|Martin Lan MD PhD|646 774 7610|martin.lan@nyspi.columbia.edu|
21244267|NCT03103321|Mayo Clinic|Jon C. Tilburt, MD|5072661105|tilburt.jon@mayo.edu|
21244268|NCT04847999|University of British Columbia|Dr Jonathan Little|2508786893|jonathan.little@ubc.ca|
21244269|NCT02879448|Abbott Medical|Jordan Anderson, Clinical Scientist|651 756 3360|ClinicalTrials.gov_SH_Inquiries@abbott.com|
21244270|NCT05332340|Biozeus Biopharmaceutical S.A.|Joaquim Herzog de Oliveira Knox|+55 (21) 25239089|joaquim.knox@biozeus.com.br|
21244271|NCT03602014|James J Peters VAMC|Dr. Jill Wecht|718-584-9000|jm.wecht@va.gov|3122
21244272|NCT06629454|University of Pennsylvania|Doraid Jarrar|2156627878|doraid.jarrar@pennmedicine.upenn.edu|
21244273|NCT01704079|OPKO Health, Inc.|Douglass Laidlaw, PhD, Vice President, Medical Affairs|305-575-4172|dlaidlaw@opko.com|
21244274|NCT06023082|Citruslabs|Patrick Renner|(805) 292-0714|hello@citruslabs.com|
21244275|NCT05273723|Northwell Health|Karina Davidson|(516) 562-3467|kdavidson2@northwell.edu|
21244276|NCT03584516|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21262054|NCT03952650|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr. Dave Cook|240.627.3066|david.cook@nih.gov|
21279938|NCT00143247|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21279939|NCT00525798|Nordic Bioscience|Dr. Bente Juul Riis|+45 22901317|bjr@nordicbioscience.com|
21279940|NCT02933255|National Cancer Institute|Dr. James L. Gulley|301-480-716|gulleyj@mail.nih.gov|
21279941|NCT02766283|Bayer|Therapeutic Area Head|+49 30 300139003|clinical-trials-contact@bayer.com|
21279942|NCT00805961|Sarah Cannon Research Institute|John D. Hainsworth, MD.|877-691-7274|ASKSARAH@scresearch.net|
21279943|NCT04803305|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21279944|NCT00993421|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21279945|NCT05410964|Enspectra Health|President|650 480-6022|clinical@enspectrahealth.com|
21279946|NCT01579747|Univeristy of New Mexico|Nicholas Lam|505 272 2610|nlam@salud.unm.edu|
21279947|NCT06360081|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21279948|NCT00352417|Tallikut Pharmaceuticals, Inc.|Brian Cunningham, MD|312-505-0420|brian@baycitycapital.com|
21279949|NCT03207867|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21279950|NCT00912912|The University of Texas (UT) MD Anderson Cancer Center|Lance Pagliaro, MD/Genitourinary Medical Oncology||CR_Study_Registration@mdanderson.org|
21279951|NCT02447744|MGH|Dr. Sara Lazar|617-724-7108|slazar@mgh.harvard.edu|
21279952|NCT00306995|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21279953|NCT03130777|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@edwards.com|
21279954|NCT02586688|Neuronetics|Director of Clinical Operations|16123067393|steve.erickson@neurostar.com|
21279955|NCT04856917|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
21279956|NCT03560037|University of California Davis|Christopher L. Bowlus, MD|916-734-8851|clbowlus@health.ucdavis.edu|
21279957|NCT00233948|City of Hope|Paul Frankel, Ph.D.|626-256-4673|pfrankel@coh.org|65265
21279958|NCT00064987|Massachusetts General Hospital|Dr. William Crowley|617-724-2470|wcrowley@partners.org|
21279959|NCT01567462|Emory University|Dr. Kenneth Ogan|404-778-3038|kogan@emory.edu|
21279960|NCT03182933|University of Wisconsin|Laura Zitur - research program manager|6082638118|lzitur@wisc.edu|
21279961|NCT05223920|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@MSD.com|
21279962|NCT02862730|Oregon Health and Science University|Dr. Jessica Castle|503-494-7072|castleje@ohsu.edu|
21279963|NCT05584189|MP Biomedicals|Dana Hummel|8008540530|Dana.Hummel@mpbio.com|7019
21279964|NCT00445432|Abbott|Global Medical Services|800-633-9110||
21279965|NCT02789137|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21279966|NCT01090414|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21244277|NCT05846646|ImmuneSensor Therapeutics, Inc.|Patrick Widhelm, Senior Director Clinical Operations and Project Management|830-730-8176|pwidhelm@immunesensor.com|
21244278|NCT00670046|UTHSCSA|Ron Rodriguez, MD, PhD|2105675643|rodriguezr32@uthscsa.edu|
21244279|NCT03990649|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21244280|NCT01443845|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21244281|NCT01471691|Thomas Hanscom AMC|Thomas O'Hearn MD|310-829-3303|tohearn@gmail.com|
21244282|NCT02461628|Duke University|Wendy O'Meara, PhD|16099103091|wpo@duke.edu|
21244283|NCT02015520|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
21244284|NCT01854385|University of Washington|Dr. Jeanne Hoffman|(206) 221-6511|jeanneh@uw.edu|
21244285|NCT04759833|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21244286|NCT01929759|Boston Medical Center, Boston University School of Medicine|Dr. Nina Lin|617-414-5242|nina.lin@bmc.org|
21244287|NCT03128359|City of Hope Medical Center|Dr. Monzr M.Al Malki, MD|6263598111|malmalki@coh.org|
21244288|NCT02590432|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21244289|NCT02006758|Abbott|Rebecca Maslow, MA, Clinical Project Manager|+1 651-756-5564|rebecca.maslow@abbott.com|
21244290|NCT03399604|Liquidia Technologies|Chief Medical Offier|919-328-4400|safety@liquidia.com|
21244291|NCT00520546|German Federal Armed Forces Hospital, Ulm|Major Medical Corps Dr. Markus Hartenbach|0049 731 1710 1851|markushartenbach@bundeswehr.org|
21244292|NCT00595790|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|0
21244293|NCT00194714|University of Washington - Cancer Vaccine Institute|Director of Clinical Operations|2062459258|childj@uw.edu|
21244294|NCT02554786|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21244295|NCT05052996|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21244296|NCT00957242|University of Chicago Hospital|Imre Noth, MD, Associate Professor of Medicine|773-834-1832|inoth@medicine.bsd.uchicago.edu|
21244297|NCT05018910|University of New Mexico|Jessie Maxwell, MD, MBA|505-272-3967|JRMaxwell@salud.unm.edu|
21244298|NCT03830866|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21244299|NCT02214550|NorthShore University HealthSystem|Dr. Frank Tu|8475702520|ftu@northshore.org|
21244300|NCT01736215|Janssen Cilag Thailand|Medical Affairs Director|+6627927232||
21244301|NCT01248936|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21244302|NCT03635151|University of Cincinnati College of Nursing|Tamilyn Bakas|513-558-2254|tamilyn.bakas@uc.edu|
21244303|NCT00331136|Medicines for Malaria Venture|Stephan Duparc, MD|+41 22 555 0300|duparcs@mmv.org|
21244304|NCT02692417|University of Michigan|Dr. Tim Bruns|(734) 647-8727|bruns@umich.edu|
21244305|NCT03359889|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21244306|NCT02020252|University of Chicago Medicine|Toni M Cipriano|574-339-0652|tcipriano@uchicago.edu|
21244307|NCT01215344|Vanderbilt-Ingram Cancer Center|Madan Jagasa, M.D.|(6150 936-8422|madan.jagasia@vanderbilt.edu|
21244308|NCT03201562|Presbyopia Therapies, LLC|Jerry Horn, MD|(847)-772-8885|visionxcl@icloud.com|
21244309|NCT01381471|GlaxoSmithKline|GSK Response Center|866-435-7343||
21244310|NCT00212134|Stanford University School of Medicine|Scott R Lambert, MD, Study Chairman|650-498-4242|lambert7@stanford.edu|
21244311|NCT00194610|University of Washington|Claire Yang, MD|206-744-6384|cyang@uw.edu|
21244312|NCT01094184|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21244313|NCT00031694|Montefiore Medical Center-New York cancer Consortium|Joseph Sparano|718-405-8404|jsparano@montefiore.org|
21244314|NCT03892564|MC2 Therapeutics|Birgitte Vestbjerg|+45 2077 2575|bve@mc2therapeutics.com|
21244315|NCT01207492|Dana-Farber Cancer Institute|Andrew Wagner, MD, PhD|617.632.5204|andrew_wagner@dfci.harvard.edu|
21244316|NCT04919590|Truth Initiative|Dr. Amanda Graham|202-525-6473‬|vapestudy@truthinitiative.org|
21244317|NCT04192747|Elixir Medical Corporation|Tina Cordaro, Sr. Director, Clinical Trials|585-360-7270|tcordaro@ElixirMedical.com|
21244318|NCT06546657|University of Stirling|Julie Johnson|07815893076|julie.johnson1@stir.ac.uk|
21244319|NCT04847479|University of Pennsylvania|Robert Gross|215-898-2437|grossr@pennmedicine.upenn.edu|
21244320|NCT04076293|Hanmi Pharmaceutical Co., Ltd.|Jiyeon Kang|8224100377|jiyeon.kang@hanmi.co.kr|
21244321|NCT00212355|Nobelpharama|Department director of clinical development department 1|+81-3-5651-1177|murakami@nobelpharma.co.jp|
21244322|NCT03089125|Massachusetts General Hospital|Joseph A. Greer, Ph.D.|617-643-2143|jgreer2@mgh.harvard.edu|
21244323|NCT04310735|The Pennsylvania State University|Stephen Wilson|8148656219|sjw42@psu.edu|
21244324|NCT03012841|Medtronic|Mary Sauline, Clinical Research Specialist|440-596-3529|mary.k.sauline@medtronic.com|
21244325|NCT00186992|St. Jude Children's Research Hospital|Matthew Krasin, MD|(901) 595-3226|matthew.krasin@stjude.org|
21262055|NCT00592683|Massachusetts General Hospital|Janet Wozniak, MD|617-503-1038|jwozniak@partners.org|
21262056|NCT00201201|University of Connecticut|Patricia J. Neafsey, PhD|860-486-0779|pjneafsey@actualmeds.com|
21244326|NCT05696080|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21279967|NCT01085760|Mayo Clinic|Dr. Jayant A. Talwalkar|507-538--4877|talwalkar.jayant@mayo.edu|
21279968|NCT04080739|University of Alabama at Birmingham|Dr. Anthony Morlandt|205-996-2799|morlandt@uab.edu|
21279969|NCT00799058|International Partnership for Microbicides|Dr John Steytler||jsteytler@ipmglobal.org|
21279970|NCT00629018|UMC Ljubljana|Prof. Dr. Bojan Vrtovec|+3861 522 2844|bvrtovec@stanford.edu|
21279971|NCT03417778|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21279972|NCT02088697|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21279973|NCT03594071|Smith+Nephew, Inc.|Kirsten Wall|720-338-9460|Kirsten.wall@smith-nephew.com|
21292583|NCT02240121|Bausch Health Americas, Inc.|Director of Clinical Operations|908-927-0873|lindsey.mathew@bauschhealth.com|
21292584|NCT00846846|Medtronic Cardiovascular|Lisa Bousquette, Director Clinical Research Coronary and Renal Denervation||lisa.r.bousquette@medtronic.com|
21292585|NCT02404168|University of Maryland|James Polli|410-706-8292|jpolli@rx.umaryland.edu|
21292586|NCT05501639|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21292587|NCT01197547|Boston Scientific|Meaghan Wilk|5086834113|wilkm@bsci.com|
21292588|NCT02103062|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
21292589|NCT01974284|Yale University School of Medicine|Dr. Glenda Callendar|203-737-2036|glenda.callender@yale.edu|
21292590|NCT00959907|CBED|Débora Zechmeister do Prado|55 51 30262633|cbed@cbed.org.br|
21292591|NCT03958331|Cincinnati Children's Hospital Medical Center|Dr. Avani Modi|513-636-4864|avani.modi@cchmc.org|
21292592|NCT01991483|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21292593|NCT04344184|Virginia Commonwealth University|Dr. Alpha Fowler|(804) 519-4369|alpha.fowler@vcuhealth.org|
21292594|NCT02030821|Duke University|Michael Bolognesi, M.D.|919-668-4732|michael.bolognesi@duke.edu|
21292595|NCT01846702|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21292596|NCT01911351|NYCHHC Jacobi Medical Center|Dr. Sandra Cunningham|718 918 5250|sandra.cunningham@nbhn.net|
21292597|NCT01333436|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21292598|NCT01634152|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21292599|NCT03210701|School of Pharmacy, Memorial University|Dr. Debbie Kelly|709 864 7805|dvkelly@mun.ca|
21292600|NCT01900665|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21292601|NCT04046939|Knopp Biosciences|Vice President, Clinical and Translational Medicine|4124881776|calman@knoppbio.com|
21292602|NCT01897532|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21292603|NCT01352286|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21292604|NCT00000134|Johns Hopkins University|Curtis Meinert, PhD|410-955-8198|cmeinert@jhsph.edu|
21292605|NCT03682965|Pharma Initiatives|Mark Shapiro|9193063675|mshapiro@pharmainitiatives.com|
21292606|NCT00953706|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com|
21292607|NCT01861665|Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine.|Dr. Glenn Schattman, Associate Professor|646-962-3836|glschatt@med.cornell.edu|
21292608|NCT02549989|Memorial Sloan Kettering Cancer Center|Dr. Vicky Makker, MD|646-888-4224|makkerv@mskcc.org|
21292609|NCT00298389|Imperial College London|Professor Louise Donnelly|+442075947895|l.donnelly@imperial.ac.uk|
21244327|NCT03954184|University of Wisconsin - Madison|Todd Molfenter, PhD|608-262-1685|todd.molfenter@wisc.edu|
21292610|NCT01713582|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21292611|NCT04776161|Brigham and Women's Hospital|Candace Feldman, MD, MPH, ScD|617-525-1035|CFELDMAN@BWH.HARVARD.EDU|
21292612|NCT00342628|PDMI, NICHD, NIH|Feng-Ying (Kimi) Lin, MD, MPH|301-496-0295|link@mail.nih.gov|
21292613|NCT03846427|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21292614|NCT01334554|Vanderbilt University Medical Center|Cyndya A. Shibao|6159364584|cyndya.shibao@vanderbilt.edu|
21292615|NCT02071901|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Sudipto Mukherjee|1-866-223-8100|TaussigResearch@ccf.org|
21292616|NCT02393859|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21292617|NCT00954447|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21292618|NCT03951610|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
21292619|NCT04971967|University of North Carolina at Chapel Hill Project - China|Ms. Xumeng Yan|+8615330225941|xumeng_yan@seshglobal.org|
21292620|NCT00052910|Yale Cancer Center|Charles S. Fuchs, MD, MPH|(203) 785-4095|charles.fuchs@yale.edu|
21292621|NCT00535769|MGH Curtis|Dr. Alexa B. Kimball|617-726-5066|harvardskinstudies@partners.org|
21292622|NCT00682929|UC Davis Health|Janelle Butters, NP|916-734-6276|jbutters@ucdavis.edu|
21292623|NCT00938912|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
21292624|NCT04103112|Imperial College London|Professor Alun Davies|02033117320|a.h.davies@imperial.ac.uk|
21292625|NCT01772550|Becton, Dickinson and Company|Randall Jones, MD|801 565-2843|randall_jones@bd.com|
21292626|NCT00559104|City of Hope National Medical Center|Dr. Auayporn Nademanee|626-256-4673|anademanee@coh.org|62691
21292627|NCT04723355|Hospital Israelita Albert Einstein|Clinical Trialist|551121515915|karla.santo@einstein.br|
21292628|NCT03374358|Helsinki University Hospital|Dr Jussi Sutinen|+358407480437|jussi.sutinen@hus.fi|
21292629|NCT01127633|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21292630|NCT01805687|Cornerstone Therapeutics, Inc.|W. James Alexander, MD, MPH|919-678-6925|jim.alexander@chiesi.com|
21292631|NCT00399568|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
21292632|NCT01104402|Johns Hopkins University & University of Washington|Dr. Noah Lechtzin & Dr. Christopher Goss|410-502-7044|nlechtz@jhmi.edu|
21292633|NCT01109108|Boston Medical Center|Stephen I Pelton|617-414-5591|spelton@bu.edu|
21292634|NCT03420742|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21244328|NCT03398200|University of Rochester|Omar Aljitawi, MD|(585) 275-4099|Omar_Aljitawi@URMC.Rochester.edu|
21244329|NCT04605198|University of California, Los Angeles|Dr. Dana Rose Garfin, Associate Professor|415-407-9498|dgarfin@ucla.edu|
21292635|NCT00420381|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21292636|NCT01516632|Center for Innovative Public Health Reserch|Dr. Michele Ybarra|(877) 302-6858|michele@innovativepublichealth.org|1-801#
21292637|NCT01291108|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21292638|NCT01482195|King Faisal Specialist Hospital and Research Center|Dr. Fowzan Al Kuraya|+966 11 442 7875|falkuraya@kfshrc.edu.sa|
21292639|NCT00753948|James J. Peters VAMC|Joshua Hobson|(718) 584-9000|joshua.hobson@va.gov|3129
21292640|NCT03432494|National Heart, Lung, and Blood Institute (NHLBI)|Dr. Robert Lederman, Principal Investigator|301.402.6769|ledermar@nhlbi.nih.gov|
21292641|NCT00775268|National Cancer Institute|Dr. Esther Mena|240-760-6111|esther.menagonzalez@nih.gov|
21292642|NCT00592631|Indiana University|Robert Tepper, MD, Ph.D.|317-274-9647|rtepper@iu.edu|
21292643|NCT01244035|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21292644|NCT00374595|University of Nebraska Medical Center|Jennifer Larsen|(402) 559-4837|jlarsen@unmc.edu|
21292645|NCT00410189|University of Texas (UT) MD Anderson Cancer Center|Anne S. Tsao, MD / Associate Professor, Thoracic/Head & Neck Med Oncology|713-792-6363|CR_Study_Registration@mdanderson.org|
21292646|NCT03745768|Washington University School of Medicine St. Louis|Pilar Cristancho M.D.|314 362 2413|cristanchopimiento.l@wustl.edu|
21292647|NCT00443118|FUNDASAMIN-Fundacion para la Salud Materno Infantil|Edgardo Szyld MD, MSc|5491144093095|eszyld@gmail.com|
21292648|NCT01029912|MetroHealth Medical Center|Dr. Jayme Knutson|2167787342|jsk12@case.edu|216
21292649|NCT00581048|Vanderbilt University Medical Center|Ryszard Dworski|615-322-3412|ryszard.dworski@Vanderbilt.Edu|
21292650|NCT01553292|University of Manitoba|Dr Yahya Al Ethawi|0012049634721|yalethawi@hsc.mb.ca|
21292651|NCT01212471|Bausch Health|Study Director||susan.harris@bauschhealth.com|
21292652|NCT00400517|Cleveland Clinic|Dr. Jorge Garcia|2164447774|Garciaj4@ccf.org|
21292653|NCT01106157|University of Florida|Michael J Haller|3522739264|hallemj@peds.ufl.edu|
21292654|NCT01154335|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21292655|NCT02298868|University of Virginia|Dr. Zachary Henry|434-243-2718|zhenry@virginia.edu|
21292656|NCT01194245|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|858-794-8889||
21292657|NCT03962855|University of Massachusetts Medical School|Jeffrey J Rade MD|774-441-6310|jeffrey.rade@umassmed.edu|
21292658|NCT03326063|Brigham and Women's Hospital|Tanya Laidlaw, MD|617-525-1034|tlaidlaw@bwh.harvard.edu|
21292659|NCT01859013|University of Minnesota|Claudia Fox|612-626-6616|lusc0001@umn.edu|
21292660|NCT00881894|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
21292661|NCT01253369|Dana-Farber Cancer Institute|David Jackman, MD|617-632-6049|DJACKMAN@PARTNERS.ORG|
21292662|NCT00761345|Fox Chase Cancer Center|Dr. Steven J. Cohen|215-728-4300|steven.cohen@fccc.edu|
21292663|NCT01932788|Professor of Pediatrics|Carol,Wagner, MD|843-792-8829|wagnercl@musc.edu|
21292664|NCT01646814|PLxPharma|Regulatory Affairs Director|17138421249|regaffairs@plxpharma.com|
21292665|NCT00543985|University of Missouri|Kevin C. Dellsperger, MD, PhD, Professor, Internal Medicine|573-884-2013|dellspergerk@health.missouri.edu|
21292666|NCT04749914|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21292667|NCT01903005|TRY Research|Kent Hoffman, DO|(407) 691-3960|Suboxdoc1@yahoo.com|
21292668|NCT01214837|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21292669|NCT05414175|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21292670|NCT00027560|Memorial Sloan-Kettering Cancer Center|Dr. Hugo Castro-Malaspina|212-639-8197|castro-h@mskcc.org|
21292671|NCT04028648|seca gmbh & co. kg|Kristin Klückmann|040200000232|kristin.klueckmann@seca.com|
21292672|NCT03559270|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21292673|NCT04790279|Prisma Health Upstate|Katelyn Pratt|2176223524|katelyn.pratt@prismahealth.org|
21292674|NCT03930771|Weill Cornell Medicine|Rajiv Magge|212-746-6575|ram9116@med.cornell.edu|
21292675|NCT00810277|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21292676|NCT02836470|Palisade Bio|Mitchell Jones, CMO|858-704-4900|mitchell.jones@palisadebio.com|
21292677|NCT03402932|Western Michigan University|Jing Shen|2693878067|jing.shen@wmich.edu|
21244330|NCT04065048|Case Western Reserve University|Abigail Raffner Basson, Principal Investigator & Study Coordinator|2163276003|axb860@case.edu|
21292678|NCT00678288|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21292679|NCT01415583|Massachusetts Eye and Ear Infirmary|Dr. Christopher Hartnick, Division Director, Pediatric Otolaryngology Director, Pediatric Airway, V|617-573-4206|christopher_hartnick@meei.harvard.edu|
21292680|NCT03611881|Massachusetts General Hospital|Elyse Park, PhD, Professor of Psychiatry and Medicine, Harvard Medical School|617.724.6836|epark@mgh.harvard.edu|
21292681|NCT04472650|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21292682|NCT04011592|The University of Texas Health Science Center at Houston|Sudhakar Selvaraj, MD, PhD, Assistant Professor|713-486-2837|Sudhakar.Selvaraj@uth.tmc.edu|
21292683|NCT02628444|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21244331|NCT03397108|The Hospital for Sick Children|Dr. Shinya Ito|4168135776|shinya.ito@sickkids.ca|
21244332|NCT04832360|University of Georgia|Dr. Michelle vanDellen|706-542-8991|mvd@uga.edu|
21244333|NCT05540002|Brigham and Women's Hospital|Robert Jamison|617-732-9046|rjamison@bwh.harvard.edu|
21244334|NCT02728557|University of Haifa|Prof. Sigal Zilcha-Mano|972-4-8249047|sigalzil@gmail.com|
21244335|NCT01718743|University of Texas M D Anderson Cancer Center|Dr. Krina Patel|(713) 792-6662|kpatel1@mdanderson.org|
21244336|NCT03416010|The Ohio State University|Dr. Bernadette Melnyk|6142924844|melnyk.15@osu.edu|
21244337|NCT03625323|Immutep|Immutep CMO|+ 49 30 88716843|regulatoryaffairs@immutep.com|
21244338|NCT03948763|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21244339|NCT02488863|University o fFlorida|Eric Weber|352-273-7802|ebweber@ufl.edu|
21244340|NCT05986565|Mt. Hope Family Center, University of Rochester|Christie L. M. Petrenko, Ph.D.|5852752991|christie_petrenko@urmc.rochester.edu|
21244341|NCT04500301|Wake Forest|Danielle M Boselli|2017903385|Danielle.Boselli@AtriumHealth.org|
21244342|NCT00448240|Henry Ford Health System|Tiffany Pearce, Director of Clinical Trials|313-575-8046|tpearce1@hfhs.org|
21292684|NCT02224508|Group Health Research Institute|Michael Von Korff, ScD|206-287-2874|vonkorff.m@ghc.org|
21279974|NCT02287922|Ablynx NV|Medical Monitor|+32 (0)9 262 00 00|clinicaltrials@ablynx.com|
21292685|NCT01333722|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21292686|NCT00784368|Global Medical Organization; Janssen R&D|Director, Established Products|(609) 730-7674||
21292687|NCT02079909|FUJIFILM Toyama Chemical|Project Manager|+81-3-6427-6245|fftc-clinicaltrial-info1@fujifilm.com|
21292688|NCT02277249|University of California, Los Angeles|Clinical Instructor - Department of Obstetrics and Gynecology|3107942257|priyabatra@mednet.ucla.edu|
21292689|NCT01784367|University Medical Center Hamburg-Eppendorf, Germany|Prof. Dr. Stefan Kluge|+49-40-7410|skluge@uke.de|57011
21292690|NCT00720356|Northwestern University|Jeffery Raizer, MD|312-503-4724|Jeffrey.Raizer@nm.org|
21292691|NCT01869634|University of California, Davis Health, Department of Internal Medicine|Dr. David Asmuth, Professor of Medicine|916-734-8695|dasmuth@UCDAVIS.EDU|
21292692|NCT02237001|Smith+Nephew, Inc.|Kirsten Wall|720-338-9460|Kirsten.wall@smith-nephew.com|
21292693|NCT01364480|University of Pittsburgh|Debbie Harrington, CCRP, senior research coordinator|4123831355|debbie.harrington@pitt.edu|
21292694|NCT04551898|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21292695|NCT03427814|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21292696|NCT01979614|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
21292697|NCT00488514|GlaxoSmithKline|GSK Response Center|866-435-7343||
21292698|NCT00628446|Carolinas Healthcare System|Dr. Jesse Lieberman|704-355-0649|Jesse.Lieberman@Carolinashealthcare.org|
21292699|NCT00756275|Brown University|Damaris Rohsenow, PhD|401-863-6665|Damaris_Rohsenow@brown.edu|
21292700|NCT03394781|DURECT Corporation|Executive Director, Regulatory Affairs|408-777-1829|jill.burns@durect.com|
21292701|NCT01187095|Aarhus University|Yoon Frederiksen|+4587565871|yoonf@psy.au.dk|
21292702|NCT03181971|Stanford University|Anisha Patel, MD|(650) 497-1181|anipatel@stanford.edu|
21235490|NCT02886572|Duke University Health System|Joan Cahill BNS OCN CCRP|(919) 668-5211|joan.cahill@duke.edu|
21235491|NCT02621606|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21235492|NCT01175824|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21235493|NCT03455855|Boston Scientific|Dr Haotian Zhang|+8617621154031|haotian.zhang@bsci.com|
21235494|NCT00924950|UCSF|Tina Bhutani|4154763396|tinabhutanimd@gmail.com|
21279975|NCT03022370|SAMRC|Dr Andrew Gibbs|+27(0)312034899|andrew.gibbs@mrc.ac.za|
21279976|NCT01565356|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
21279977|NCT03668808|Sansum Diabetes Research Institute|Wendy C Bevier|8056827638|wbevier@sansum.org|207
21279978|NCT02001987|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21279979|NCT01330303|GlaxoSmithKline|GSK Response Center|866-435-7343||
21279980|NCT03714919|Nationwide Children's Hospital|Arlyne Thung, MD|614-722-4200|Arlyne.Thung@nationwidechildrens.org|
21279981|NCT02593110|Northwestern University|Mary McDermott MD|312-503-6419|mdm608@northwestern.edu|
21279982|NCT03548337|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21279983|NCT01061476|Johns Hopkins University|Dr. Susheel Patil|410-550-0574|spatil@jhmi.edu|
21279984|NCT04768686|Hanmi Pharm. Co., Ltd.|Young Su (Bobby) Noh|82-2-410-9277|63forever@hanmi.co.kr|
21279985|NCT04502212|GE Research|Diane Minas|(518)698-3959|minas@ge.com|
21279986|NCT03022916|UAB|Director of Clinical Trials, UAB Dermatology|2055029960|Lmroop@uabmc.edu|
21279987|NCT01911273|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21279988|NCT02350816|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21235495|NCT00009737|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21235496|NCT01734746|MaastrichtUMC|R.F.P.M. Kruitwagen|+31433874767|r.kruitwagen@mumc.nl|
21235497|NCT01163682|Columbia University Irving Medical Center|Dawn Hershman|212-342-5162|dlh23@cumc.columbia.edu|
21235498|NCT01931839|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21235499|NCT03224468|Massachusetts General Hospital|Jodi Gilman, PhD|617-643-7293|jgilman1@mgh.harvard.edu|
21235500|NCT02571452|San Francisco VA Healthcare System|Dr. Shira Maguen|415-221-4810|Shira.Maguen@va.gov|22511
21235501|NCT03161314|Physical Therapy Faculty, Mahidol University|Asst.Prof.Dr. Sunee Bovonsunthonchai|024415450|sunee.bov@mahidol.edu|20804
21235502|NCT02863354|Retina Consultants of Houston|Dr. Charles C. Wykoff|713-524-3434|ccwmd@houstonretina.com|
21235503|NCT01591746|Mayo Clinic|Dr. Valerie Lemaine, MD, MPH|507-284-2736|lemaine.valerie17@gmail.com|
21235504|NCT01611571|Columbia University Medical Center|Marcella Walker MD|212-342-5351|mad2037@columbia.edu|
21235505|NCT00724451|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21235506|NCT04165291|Yale University Child Study Center|Carla Stover|12037853486|carla.stover@yale.edu|
21235507|NCT02248922|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
21235508|NCT01599650|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
21235509|NCT02873104|Cutera|Lourdes Moldre, NP|415-971-5118|lmoldre@cutera.com|
21235510|NCT01298063|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21235511|NCT02737566|The University of Oklahoma Health Sciences Center|Dr. Darla Kendzor|(405) 271-8001|Darla-Kendzor@ouhsc.edu|50478
21235512|NCT05038137|Medical University of South Carolina|Dr. Karanchi|(843) 792-2529|karanchi@musc.edu|
21279989|NCT01070953|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21279990|NCT04700137|St. Luke's Health System|Dr. Anna K. Radin|208/381-8460|radina@slhs.org|
21279991|NCT02503787|Medtronic Implantable Therapies|Helen Berrier|1-800-633-8766|medtronicneurotrials@medtronic.com|
21292703|NCT01475721|GlaxoSmithKline|GSK Response Center|866-435-7343||
21292704|NCT00803738|Perrigo Pharmaceuticals|Jonathan Schwartz|718-960-0119|jonathan.schwartz@perrigo.com|
21292705|NCT01048242|University of Pennsylvania|Nalaka Gooneratne|215 349 5938|ngoonera@mail.med.upenn.edu|
21292706|NCT02364037|Washington University School of Medicine|Rachel Paul|3147478176|paulr@wustl.edu|
21292707|NCT01453036|The Catholic University of Korea|Dr. Jin Il Kim|+82-2-3779-2382|jikim@catholic.ac.kr|
21292708|NCT02291133|Institute of Oncology Ljubljana|Dr Gregor Serša|+38615874343|gsersa@onko-i.si|
21292709|NCT01815424|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21292710|NCT04072835|Milestone Pharmaceuticals Inc.|Cameron Szakacs _PhD_VP Drug Development|1 704-594-4102|cszakacs@milestonepharma.com|
21292711|NCT00856323|Friends Research Institute, Inc.|Dr. Cathy Reback|323-463-1601|reback@friendsresearch.org|
21292712|NCT02189889|UT Southwestern Medical Center|Philip Greilich -PROFESSOR|214/645-8018|PHILIP.GREILICH@UTSouthwestern.edu|
21292713|NCT01244711|Weill Cornell Medical College|james kocsis|212-746-5913|jhk2002@med.cornell.edu|
21292714|NCT01119443|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21292715|NCT02329743|Auven Therapeutics|S Weiss|201 486-0396|sid.weiss@auventx.com|
21292716|NCT01428219|University of Michigan Comprehensive Cancer Center|Dr. David C. Smith, M.D.|734-764-3066|dcsmith@umich.edu|
21292717|NCT00825994|Massachusetts General Hospital|Marlene Freeman, MD|617-643-6403|mfreeman@partners.org|
21292718|NCT02921295|University of Pittsburgh|Dr. Goeran Fiedler|4126246475|gfiedler@pitt.edu|
21292719|NCT00437398|Mayo Clinic|Dr. Yogish Kudva|507-284-3964|kudva.yogish@mayo.edu|
21292720|NCT01162551|CHOP|Susan Rheingold, MD|215-590-2801|cancertrials@email.chop.edu|
21292721|NCT01833494|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
21292722|NCT03068897|Montefiore|Dr. Benjamin W. Friedman|718-920-6626|befriedm@montefiore.org|
21292723|NCT01694433|UCLA|Dr. Jenny Kim|310-825-5420|jekim@mednet.ucla.edu|
21292724|NCT03071861|University of Utah|Tara DuPont|8015814178|tara.dupont@hsc.utah.edu|
21292725|NCT02607124|Cincinnati Childrens Hosptial Medical Center|Renee Doughman|513-636-1699|renee.doughman@cchmc.org|
21292726|NCT03091361|MolecuLight Inc.|Liis Teene|416.542.5530|lteene@moleculight.com|
21292727|NCT04571060|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
21292728|NCT04410159|UNIVERSITI SAINS ISLAM MALAYSIA|NURUL AZMAWATI MOHAMED|+603 42892400|drnurul@usim.edu.my|2417
21235513|NCT02181231|Washington University School of Medicine|Dr. Eric Lenze|314-362-1671|lenzee@wustl.edu|
21235514|NCT02520531|Stryker|Britta von den Brincken, Clinical Study Manager|+491638999202|britta.vondenbrincken@stryker.com|
21244343|NCT03446157|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat Canter|919-445-4208|Melahat_Canter@med.unc.edu|
21235515|NCT00622635|Novartis Pharmaceuticals|Study Director|862 778-8300||
21235516|NCT00835406|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21235517|NCT00281840|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Panayiotis Savvides, MD|216-844-5946|Panayiotis.Savvides@uhhospitals.org|
21235518|NCT00733343|Department of Cardiology, Imperial College London, Dovehouse St., London SW3 6LY, United Kingdom|Martin R. Cowie, MD|+44 (0)20 7589 0|m.cowie@imperial.ac.uk|5111
21244344|NCT02386553|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21244345|NCT06027229|UW School of Medicine and Public Health|Dr. Freddy Caldera, DO, PhD, MS|(608) 263-1995|fcaldera@medicine.wisc.edu|
21244346|NCT04630301|Johns Hopkins University|Dr. Jeffrey Thiboutot|410-502-2533|jthibou1@jhmi.edu|
21244347|NCT06459401|Boston University|Ashlyn Aiello|617-500-3645|ajma@bu.edu|
21244348|NCT00998881|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21244349|NCT01121991|EMD Serono Canada Inc., an affiliate of Merck KGaA, Darmstadt, Germany|Medical Responsible|+1-888-737-6668|david.sciberras@emdserono.com|5248
21244350|NCT01619410|University of Pennsylvania|Michael Z. David/Assistant Professor|215-662-6932|michdav@pennmedicine.upenn.edu|
21244351|NCT02462759|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
21244352|NCT02740231|Bone Therapeutics|Dr Olivier Godeaux Medical Officer|+32 71 12 10 00|jta.koa1@bonetherapeutics.com|
21244353|NCT04110054|Shionogi USA|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
21244354|NCT03693937|Sensus Healthcare|Isabelle Raymond|561-922-5808|iraymond@sensushealthcare.com|
21244355|NCT01261052|Legacy Health System|Dr. W Kenneth Ward|503-413-5171|kenward503@msn.com|
21244356|NCT03655262|UCLA|Michelle Craske, Ph. D|(310) 825 8403|mcraske@mednet.ucla.edu|
21244357|NCT01188369|Aarhus University Hospital|Dr. Peter Juhl-Olsen|+4578451199|peter.juhl-olsen@ki.au.dk|
21244358|NCT01828554|University of Madison Carbone Cancer Center|Kari B. Wisinski|(608) 262-2876|kbwisinski@medicine.wisc.edu|
21244359|NCT01695954|NYU School of Medicine|Carlos Malvestutto, MD, MPH|212-263-3570|carlos.malvestutto@nyumc.org|
21244360|NCT03921866|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21244361|NCT02395978|BioLite, Inc.|Hsien-Ming Wu|+886-6579631|sonnywu@bioliteinc.com|
21244362|NCT02131597|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/ Professor|713-745-3428|ggarciam@mdanderson.org|
21244363|NCT03032406|University of Pennsylvania|Dr Angela DeMichele|2156624000|angela.demichele@pennmedicine.upenn.edu|
21244364|NCT04583423|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21244365|NCT03351699|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21292729|NCT01220401|University of Tulsa|Dr. Noelle Balliett|918-631-3976|noelle-balliett@utulsa.edu|
21292730|NCT00362882|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
21292731|NCT01853462|Aristotle University of Thessaloniki|Lazaros Lazarou||lazarosphysiotherapist@gmail.com|
21292732|NCT03386435|Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea|Jun-Gol Song, MD, PhD|+82-2-3010-3869|jungol.song@amc.seoul.kr|
21292733|NCT04068922|University of Florida|Dr. Emily Bartley|352-273-8934|ebartley@dental.ufl.edu|
21292734|NCT00625586|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
21292735|NCT02246010|American University of Beirut|Dr. Mona Nabulsi|9611350000|mn04@aub.edu.lb|5523
21244366|NCT04704284|Mayo Clinic|Julie Guerin, M.D.|507-293-3698|Guerin.Julie@mayo.edu|
21244367|NCT05644730|Ideal Medical Technologies|Dr. Leon DeJournett/Chief Medical Officer|8283379960|leondej@idealmedtech.com|
21244368|NCT03330795|DAIT/NIAID|Director, Clinical Research Operations Program|240-669-5064|DAITClinicalTrialsGov@niaid.nih.gov|
21244369|NCT05782231|Massachusetts General Hospital|Ana-Maria Vranceanu, PhD|617-724-4977|avranceanu@mgh.harvard.edu|
21244370|NCT05575076|Cassava Sciences|Study Director|737-910-1045|ClinicalTrials.gov@cassavasciences.com|
21244371|NCT01877343|University of Florida|Dr. Curt DeGroff|352-273-7770|degroffc@peds.ufl.edu|
21244372|NCT02538341|University of Alabama at Birmingham|Dr. Jeffrey R. Curtis|205-975-2176|jrcurtis@uabmc.edu|
21244373|NCT01136486|North Shore LIJ|Dr. Rosemarie Basile|718 226-6501|rbasile1@siuh.edu|
21244374|NCT00065260|NIH NHLBI|Dr. Bhavisha Patel|301.402.3477|bhavisha.patel@nih.gov|
21244375|NCT03750968|University of Utah John A. Moran Eye Center|Paul Bernstein, MD, PhD|801-581-4069|Paul.Bernstein@hsc.utah.edu|
21244376|NCT04011631|SMART Clinical Products|Ellie Coumans|+31 (0)6 53 82 70 16|e.coumans@smartclinicalproducts.com|
21244377|NCT01553058|University of Pennsylvania|Suzette Baez VanderBeek, MPH|215-662-3514|suzettev@upenn.edu|
21244378|NCT04766034|NYU Langone Health|Pasquale Rummo, MPH, PhD|914-316-5907|Pasquale.rummo@nyulangone.org|
21244379|NCT01304277|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21244380|NCT03757949|SWOG|Danika Lew|206-667-2272|dlew@fredhutch.org|
21244381|NCT05094141|UT Southwestern Medical Center|Dr. Sarah Rebstock|214-456-8106|sarah.rebstock@utsouthwestern.edu|
21244382|NCT04708509|The Ottawa Hospital|Dr. Andrew Seely|613-737-8899|aseely@toh.ca|74052
21244383|NCT04870645|M D Anderson Cancer Center|Jason Johnson, MD|713-792-8443|jasonjohnson@mdanderson.org|
21244384|NCT02576509|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
21244385|NCT05873062|Autifony Therapeutics Ltd|Head of Clinical Project Management|+447909228562|Alice.Sharman@autifony.com|
21244386|NCT01600014|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
21244387|NCT03481660|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@Novartis.com|
21244388|NCT03398148|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21244389|NCT04278586|Cambridge Health Alliance|Dr. Zev Schuman-Olivier|617-591-6056|zschuman@cha.harvard.edu|
21244390|NCT05769595|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21244391|NCT03661359|University of Toledo|Heather Klepacz, M.D, Principle Investigator|419-383-6754|heather.klepacz@utoledo.edu|
21244392|NCT01536886|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
21244393|NCT04541043|Calliditas Therapeutics|Clinical Program Leader|0737456451|kristin.onnestam@calliditas.com|
21244394|NCT04607044|Stryker|Monica Fleeman|251-465-5969|monica.fleeman@stryker.com|
21292736|NCT03192137|InSite Vision|Senior Manager, Clinical Sciences|+91 9987096080|manjiri.desai@sparcmail.com|
21292737|NCT01176877|Northwestern University, Feinberg School of Medicine, Department of Dermatology|Dr. Steven Nwe, Clinical Research Fellow|312-695-4625|steven.nwe@northwestern.edu|
21235519|NCT02138214|University of Wisconsin, Madison|Dr. Rebecca Sippel|608-263-1387|sippel@surgery.wisc.edu|
21235520|NCT02185768|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
21235521|NCT00832429|M D Anderson Cancer Center|Sara Hull|713-563-4598|sehull@mdanderson.org|
21235522|NCT02486406|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21235523|NCT00333606|Ernst Moritz Arndt University of Greifswald|Taras Usichenko, director of the trial|+493834865828|taras@uni-greifswald.de|
21235524|NCT01079234|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21235525|NCT01037790|University of Pennsylvania|Jennifer Louie, Program Manager|267-414-6179|Jennifer.Louie2@pennmedicine.upenn.edu|
21235526|NCT01485601|Medytox Inc.|Young Ryu|+82-2-6901-5890|young.ryu@medytox.com|
21235527|NCT05402995|UMissouri|Vicki L Jones|573-882-7583|jonesvicki@health.missouri.edu|
21235528|NCT01427296|Valeant Pharmaceuticals|Johnson Varughese|9089271400||
21235529|NCT01071512|University of Chicago|Dr. Adil Javed|773.834.0558|ajaved@neurology.bsd.uchicago.edu|
21235530|NCT00955266|Brigham & Women's Hospital|Michael Nurok|617-899-5961|mnurok@gmail.com|
21235531|NCT02316717|Immuron|Neta Tobis, Clinical Director|+972549277334|neta@immuron.com|2549277334
21235532|NCT00183872|USC/Norris Comprehensive Cancer Center|Victoria Soto - Project Specialist|(323) 865-0454|Victoria.Soto@med.usc.edu|
21235533|NCT02052466|Cleveland Clinic Foundation|Dr. Eric Ricchetti|2164456915|ricchee@ccf.org|
21235534|NCT00508742|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21235535|NCT00594256|Nathan Kline Institute|Joshua Kantrowitz MD|845-398-5503|jkantrowitz@nki.rfmh.org|
21235536|NCT00595582|LSU Health Sciences Center, Shreveport LA|Dr. James Patterson/Professor|318-813-2070|jpatte@lsuhsc.edu|
21235537|NCT02797262|University of California, Los Angeles|Research Scientist|3105917541|statue22@gmail.com|
21235538|NCT01600586|Vanderbilt University|Olena Chorna|850-508-5571|olena.chorna@vanderbilt.edu|
21235539|NCT04160260|Paratek Pharmaceuticals, Inc.|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
21235540|NCT01974050|Columbia University|Melissa S. Stockwell|212-342-5732|mss2112@cumc.columbia.edu|
21235541|NCT03146650|Northwestern University, Feinberg School of Medicine|Young Kwang Chae, MD, MPH, MBA|312-926-4248|YCHAE@nm.org|
21244395|NCT05403801|Dana Farber Cancer Institute|Desiree Azizoddin|(617) 632-3000|desiree_azizoddin@dfci.harvard.edu|
21244396|NCT05075408|Galderma Research & Development, LLC|Sponsor|8179615000|aestheticclinicaltrials@galderma.com|
21292738|NCT02665260|Montefiore Medical center|Dr. Steven Cohen|718-920-8470|dermpharmeinstein@gmail.com|
21244397|NCT03416023|OstomyCure AS|Johan Järte|+46 706 524 532|jjaerte@ostomycure.com|
21244398|NCT04468776|CPMCRI|Dr. Katie Stone|(510) 427-4562|katie.Stone@ucsf.edu|
21244399|NCT03890913|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
21244400|NCT04881162|Silk Road Medical|Heather Smith|763-335-5160|hsmith@silkroadmed.com|
21244401|NCT06146374|DynPort Vaccine Company, a GDIT Company|George A. Saviolakis, MD, PhD|301-835-4101|George.Saviolakis@gdit.com|
21244402|NCT01285635|University of Michigan Cancer Center|Dr. Francis Worden, M.D.|734-936-0453|fworden@umich.edu|
21244403|NCT00505934|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
21244404|NCT01296646|University of North Carolina at Chapel Hill|James C. Garbutt, M.D., Professor of Psychiatry|919-966-4652|jc_garbutt@med.unc.edu|
21244405|NCT05384730|University of Southampton|Dr Samantha Meredith|0238120|s.j.meredith@soton.ac.uk|4656
21279992|NCT04787627|Össur Iceland ehf.|Laurine Roussillon|+354 822 1812|lroussillon@ossur.com|
21244406|NCT01000480|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21244407|NCT00570700|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
21279993|NCT04460560|University of Pennsylvania|K. Rajender Reddy, MD|215-662-4311|ReddyR@pennmedicine.upenn.edu|
21279994|NCT00201409|University of Michigan|Dr. Robert Hyzy|7349365201|rhyzy@umich.edu|
21279995|NCT03017612|Ms.|Tracy Shwaery, Global Clinical Research Manager|9497072740|tshwaery@revisionoptics.com|157
21279996|NCT02517463|The University of Hong Kong|Dr. Raymond Li|+852 22553914|raymondli@hku.hk|
21279997|NCT02430038|Imperial College|Professor Christoph Lees|02083831000|christoph.lees@nhs.net|
21279998|NCT00464438|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
21279999|NCT03020537|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
21280000|NCT00489827|Dept Cardiothoracic Surgery, Linköping University Hospital, SE58185 Linköping, Sweden|Rolf Svedjeholm|+46101034825|rolf.svedjeholm@regionostergotland.se|
21280001|NCT02296931|Rice 360: Institute for Global Health|Dr. Rebecca Richards-Kortum|713-348-3823|rkortum@rice.edu|
21280002|NCT01590277|VA Connecticut Healthcare System|Deepak Cyril D'Souza, MD|203-932-5711|deepak.dsouza@va.gov|2594
21280003|NCT04386616|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
21280004|NCT01377012|Novartis|Study Director|862-778-8300||
21280005|NCT02159079|VANDERBILT UNIVERSITY MEDICAL CENTER|Matthew W. Semler, MD, MSc|(615) 322-3412|matthew.w.semler@vumc.org|
21280006|NCT01319500|Center for Epidemiology and Health Research Berlin|Dr Juergen Dinger|+49 (0)30 945 10145|dinger@zeg-berlin.de|
21280007|NCT03048552|Columbia University/New York State Psychiatric Institute|Dr. Katherine Elkington|16467746965|ke2143@cumc.columbia.edu|
21280008|NCT02448368|Ardea Biosciences, Inc.|Jesse Hall, MD|(858) 652-6672|JHall@ardeabio.com|
21280009|NCT01632280|Beth Israel Deaconess Medical Center|Dr. Miguel Alonso-Alonso|617-667-0240|malonso@bidmc.harvard.edu|
21280010|NCT01958073|Kaiser Permanente San Diego|Dr. Kimberly Ferrante|6199801439|klf0409@gmail.com|
21280011|NCT03086551|University of Waterloo, Waterloo, Ontario, Canada|Sean K Meehan, PhD|5198884567|skmeehan@uwaterloo.ca|39278
21280012|NCT00727597|Georegtown University|Dr. Princy Kumar|2024440086|kumarp@georgetown.edu|
21280013|NCT00451178|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21280014|NCT02215967|National Cancer Institute|Dr. James N. Kochenderfer|240-760-6062|kochendj@mail.nih.gov|
21280015|NCT05680740|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
21244408|NCT02410018|IMBiotechnologies Ltd|President|780-945-6609|mstewart@tbwifi.ca|
21244409|NCT02885636|Mayo Clinic|Dr. Barry Borlaug|507-284-8846|borlaug.barry@mayo.edu|
21280016|NCT06473519|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
21280017|NCT05849259|Massachusetts General Hospital|Dr. Christine S Ritchie|415-672-1780|csritchie@mgh.harvard.edu|
21280018|NCT05626231|Boston College School of Social Work|Dr. Maggi Price, PI|541-556-5016|priceml@bc.edu|
21280019|NCT03765788|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21280020|NCT02487966|Spaulding Rehabilitation Hospital|Dr. Felipe Fregni|6179526158|fregni.felipe@mgh.harvard.edu|
21280021|NCT00573261|Duke University Medical Center|Dr. Wei Jiang|919-668-0762|weijiang@duke.edu|
21280022|NCT00486525|Ohio State University Comprehensive Cancer Center|Janice Kiecolt-Glaser, Principal Investigator|614-293-3499|Janice.Kiecolt-Glaser@osumc.edu|
21280023|NCT03573830|BC Children's Hospital Research Institute|Dr. Mariana Brussoni|(604) 875-3712|mbrussoni@bcchr.ubc.ca|
21280024|NCT01250210|Agile Therapeutics|Joseph Chiodo III, Senior Medical Director|609-683-1880|jachiodo@agiletherapeutics.com|
21280025|NCT05021900|Rhizen Pharmaceuticals AG|Dr. Prajak Barde|+919820503970|pjb@rhizen.com|
21280026|NCT04909853|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21280027|NCT03397589|University of Illinois Chicago|Molly A Martin, MD|312-996-2363|mollyma@uic.edu|
21280028|NCT03071692|Kowa Research Institute, Inc.|Director, Clinical Operations|1 (919) 433-1600|CTGResults@KowaUS.com|
21280029|NCT00444587|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21280030|NCT00196326|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000||
21280031|NCT00582660|University of Alabama at Birmingham|Martin J. Heslin M.D.|205-975-0450|marty.heslin@ccc.uab.edu|
21280032|NCT01720225|The University of Texas MD Anderson Cancer Center|Elias Joseph MD./Professor|713-792-4764|ejabbour@mdanderson.org|
21280033|NCT00369941|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21280034|NCT04019626|Nerudia Ltd|Paul Morris|+44 7508 708 917|paul.morris@nerudia.com|
21280035|NCT02964312|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
21280036|NCT02738138|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21292739|NCT01261975|Bausch & Lomb|Omid Khodai|(949) 521-7894|Omid.Khodai@bausch.com|
21292740|NCT01722929|Northwestern University|Murad Alam, MD|312-695-4761|m-alam@northwestern.edu|
21292741|NCT00716274|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21292742|NCT01171677|NYUMED|John Rotrosen|212 951 3294|john.rotrosen@nyumc.org|
21292743|NCT00601367|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
21292744|NCT02421757|University of Maryland School of Medicine|Dr. Peter Rock|410-328-6933|prock@som.umaryland.edu|
21292745|NCT01600287|Postgraduate Institute of Medical Education and Research|Dr G D Puri|00919914209509|gdpuri007@hotmail.com|
21292746|NCT03198156|The Ohio State University Wexner Medical Center|Dr. Ulysses Magalang|614-292- 4307|Ulysses.Magalang@osumc.edu|
21292747|NCT00553410|International Breast Cancer Study Group (IBCSG)|Meredith M. Regan|+1 617 632 3012|mregan@jimmy.harvard.edu|
21292748|NCT02751814|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
21292749|NCT02015039|National Institutes of Health|Dr. Mark Hallett|301-496-9526|hallettm@ninds.nih.gov|
21292750|NCT03848455|Zhujiang Hospital of Southern Medical University|Xiaoya Gao|18680282869|4356975@qq.com|
21292751|NCT00403130|Stanford University Medical Center|George Albert Fisher, MD, PhD|650-725-9057|georgeaf@stanford.edu|
21292752|NCT01404234|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21292753|NCT02670473|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com|
21292754|NCT00288886|Salem Veterans Affairs Medical Center|Steven Lash, Ph.D.|(540)982-2463|Steven.Lash@va.gov|2593
21292755|NCT00456755|Department of Otorhinolaryngology, Head & Neck Surgery, West China Hospital, Sichuan University, China|Zhao Yu||yutzhao@gmail.com|
21292756|NCT04005391|University of Colorado|Margo Harrison|19176555178|margo.harrison@cuanschutz.edu|
21292757|NCT04343092|College of Medicine-University of Baghdad|Faiq I. Gorial|009647801730696|faiqig@gmail.com|
21292758|NCT03073525|Gradalis, Inc|Clinical and Regulatory Operations|214-442-8100|info@gradalisinc.com|
21292759|NCT02477527|Midtown Medical Center|Edward W Braun, MD|8139353221|Dr.Braun@DrEdwardBraun.com|
21292760|NCT01976299|Osprey Medical, Inc|Michele Shepard, Vice President of Clinical Affairs|9529558236|mshepard@ospreymed.com|
21292761|NCT03692403|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
21292762|NCT04567524|Lyndra Therapeutics|Nayana Nagaraj, Senior Medical Director|3023040091|Nnagaraj@lyndra.com|
21292763|NCT00672594|Duke University|Dr. Daniel George|919-668-4615|daniel.george@duke.edu|
21244410|NCT04328727|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21244411|NCT01363492|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21244412|NCT03794024|Cleveland Clinic|Robert Bolash|216-444-3134|bolashr@ccf.org|
21244413|NCT04149002|Duke University|Sarahn M. Wheeler, MD|(919) 684-6327|sarahn.wheeler@duke.edu|
21244414|NCT02252172|Janssen Research & Development, LLC|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21244415|NCT02290613|Thoraxklinik Heidelberg gGmbH at Heidelberg University Hospital|Prof. Dr. med. E. Grünig|+49 6221 396|ekkehard.gruenig@med.uni-heidelberg.de|8053
21244416|NCT01066026|Brazilian Center for Studies in Dermatology|Dr. Doris Hexsel|55 51 30262633|cientifico@cbed.org.br|
21244417|NCT03447249|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21292764|NCT02848092|Cincinnati Children's Hospital Medical Center|Jeff Epstein, Ph.D.|513-636-8296|jeff.epstein@cchmc.org|
21292765|NCT00290810|Mayo Clinic|Tait Shanafelt, M.D.||shanafelt.tait@mayo.edu|
21292766|NCT01639469|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
21292767|NCT00913510|Wellspect HealthCare|Dikran Shamoun|+46313764000||
21292768|NCT05160363|Medicines for Malaria|Senior Director, Program Leadership and Strategy|+41 22 555 03 26|borghinii@mmv.org|
21292769|NCT01147393|Weill Cornell Medicine|Peter Martin, MD|646.962.2064|amr2017@med.cornell.edu|
21292770|NCT02126319|Fox Chase Cancer Center|Dr. Suzanne M. Miller|215 728-4069|Suzanne.Miller@fccc.edu|
21292771|NCT02462187|Novan, Inc.|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
21292772|NCT00856635|Teva Pharmaceuticals, Medical Affairs|Scott Kolodny, M.D.|440-327-1811|scott.kolodny@tevapharm.com|
21292773|NCT02383862|Regenstrief Institute|Research Coordintor|317-274-9288|tltalib@regenstrief.org|
21292774|NCT01665911|Indiana University School of Dentistry|Frank Lippert|317-274-8822|flippert@iu.edu|
21292775|NCT00506779|University of Texas (UT) MD Anderson Cancer Center|David Gershenson, MD|713-745-2565|DGershen@mdanderson.org|
21292776|NCT03198767|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21292777|NCT02820844|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21292778|NCT02954887|GW Research Ltd|Medical Enquires|+44 01223 238170; 18778862810|medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
21292779|NCT00920556|GlaxoSmithKline|GSK Response Center|866-435-7343||
21292780|NCT03637491|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21292781|NCT03141255|The University of Chicago|Jonathan D. Paul, MD|(773) 702-9461|jpaul@bsd.uchicago.edu|
21292782|NCT01151020|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
21292783|NCT04419467|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
21244418|NCT01426412|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21244419|NCT05021133|UMass Chan Medical School|Mayuko Ito Fukunaga|5088561975|mayuko.itofukunaga@umassmed.edu|
21244420|NCT00988858|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21262057|NCT00545818|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
21292784|NCT03511001|California State University San Marcos|Dr. Kim Pulvers|760 750 4127|kpulvers@csusm.edu|
21292785|NCT02471313|National Institutes of Health Clinical Center|Dr. Elliot Levy, Staff Clinician, Radiology & Imaging Sciences|301-402-5368|levyeb@cc.nih.gov|
21292786|NCT00003631|Memorial Sloan Kettering Cancer Center|Dr. Joachim Yahalom|1212-639-5999|yahalomj@mskcc.org|
21292787|NCT00600067|Vivus, Inc|Wesley W. Day, PhD|650-934-5200|day@vivus.com|
21292788|NCT01684839|The Second Hospital of Tangshan|Dr. Chao Chen|86-13700350471|ts_chenchao@163.com|
21292789|NCT00943631|Center for Vaccine Development, University of Maryland|Karen Kotloff, MD|401-706-5328|kkotloff@medicine.umaryland.edu|
21292790|NCT00530634|City of Hope|Jeff Longmate, Ph.D.|626-256-4673|jlongmat@coh.org|62478
21292791|NCT04615624|University of Hawaii and Hawaii Pacific Health|Melanie Maykin|8089836000|mmaykin@hawaii.edu|
21292792|NCT03301779|Hemanext|William Iselin|7813017446|william.iselin@hemanext.com|
21292793|NCT03139032|Arena Pharmaceuticals, Inc.|Head of Document Operations|858-453-7200|ct.gov@arenapharm.com|
21292794|NCT02073162|The Cleveland Clinic Foundation|Dr. Daniel Sessler|216-444-4900|ds@or.org|
21292795|NCT03943290|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21292796|NCT04819113|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21292797|NCT00437268|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21292798|NCT01569815|Novartis Pharmaceuticals|Study Director|862-778-8300||
21292799|NCT00444925|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21292800|NCT00833027|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21244421|NCT02376790|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21244422|NCT03014453|Shengjing Hospital of China Medical University|Dr. Shucheng Zhang|862496615|zhangshucheng76@126.com|57911
21244423|NCT00390299|Mayo Clinic|Evanthia Galanis, M.D.|+1 (507) 266-0584|Galanis.Evanthia@mayo.edu|
21244424|NCT00593866|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski|734-615-3969|zalupski@umich.edu|
21244425|NCT01070069|Endologix|Elisa Hebb|949-598-4628|ehebb@endologix.com|
21244426|NCT00041938|Columbia University|Dr. J.L.P. (Seamus) Thompson|212-342-1252|jlt12@columbia.edu|
21244427|NCT03101930|Vanderbilt University Medical Center|Dr. James M. Luther, MD MSCI (Principal Investigator)|(615) 936-3420|james.luther@vumc.org|
21244428|NCT00262301|Pharming Technologies BV|Medical Affairs Department|+31715247400|medicalinfo@pharming.com|
21244429|NCT00839241|Astra Tech AB|Head of Clinical Research Area Health Care|+46317761000||
21244430|NCT00536341|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21244431|NCT00533546|University of Rochester|Curtis Benesch, M.D., M.P.H.|585 275-2530|curtis_benesch@urmc.rochester.edu|
21244432|NCT04732338|Hackensack Meridian Health|Alphonsa Thomas, DO|7328364504|Alphonsa.Thomas@hmhn.org|
21244433|NCT00001277|NIDDK|Dr. Smita Jha|301-827-1930|smita.jha@nih.gov|
21244434|NCT03161327|Saint Louis University|Dr. Keith Pereira|314-268-5782|keith.pereira@health.slu.edu|
21244435|NCT00879060|Tufts Medical Center|Martin Maron, MD|(617) 636-8066|mmaron@tuftsmedicalcenter.org|
21244436|NCT04767698|Johns Hopkins University, School of Medicine|Dimitrios Ladakis|410-614-1522|dladaki1@jhmi.edu|
21244437|NCT00088413|National Cancer Institute|Dr. James Gulley|301-480-8870|james_gulley@nih.gov|
21244438|NCT02539225|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21244439|NCT01411592|University of Kiel|Dr. Martin Sasse, D.M.D., Assistant Professor|+494315972874|sekretariat@proth.uni-kiel.de|
21244440|NCT03101371|University of Colorado, Anshcutz Medical Campus|Saketh Guntupalli, MD|303-724-2033|saketh.guntupalli@cuanschutz.edu|
21244441|NCT03988842|Cedars-Sinai Medical Center|Victor Tapson|919-971-6441|Victor.Tapson@cshs.org|
21244442|NCT01976312|Novartis|Study Director|862-778-8300||
21244443|NCT01538719|Boston University School of Medicine|Eric A Stratton, Sr. Clinical Research Manager|6174142507|eas@bu.edu|
21244444|NCT03010631|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
21244445|NCT02556138|Mayo Clinic|Dr. Kymberly Watt|507-266-1686|Watt.Kymberly@mayo.edu|
21244446|NCT03939312|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21244447|NCT04881175|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
21244448|NCT03481816|National Cancer Institute|Dr. Marijo Bilusic|240-760-6064|marijo.bilusic@nih.gov|
21244449|NCT05239182|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
21244450|NCT01216176|University of Miami|Joyce Slingerland MD PhD FCRP(C)|305-243-7265|jslingerland@med.miami.edu|
21244451|NCT02791230|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21244452|NCT06241794|Hitit University faculty of medicine|Guvenc Dogan|06342193000|guvencdogan@gmail.com|
21244453|NCT01489813|Emory University|Omer Kucuk|404-778-4729|okucuk@emory.edu|
21244454|NCT05756075|Radboudumc|Drs. D. de Graaf|+31243613450|debbie.degraaf@radboudumc.nl|
21244455|NCT03433469|University of California, San Francisco|Dr. Collin M. Blakely, MD, PhD|(415) 502-6959|collin.blakely@ucsf.edu|
21244456|NCT03821844|Brown University|Ellen McCreedy, PhD|401-863-7345|Ellen_McCreedy@brown.edu|
21244457|NCT02605837|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21244458|NCT05104697|Emma Pendleton Bradley Hospital|Dr. Kristen Benito|401-432-1054|kbenito@lifespan.org|
21244459|NCT03899961|Oslo University Hospital|Leiv Arne Rosseland|92204274|lrossela@ous-hf.no|+47
21262058|NCT02623361|UCSF|Matthias Behrends, PI|415 476 3761|matthias.behrends@ucsf.edu|
21244460|NCT05307978|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
21244461|NCT03651895|Imperial College|Farne Hugo|+44 (0)20 7589 5111|h.farne@imperial.ac.uk|
21244462|NCT02837510|University of Pennsylvaina|James Loughead PhD|215-746-6827|loughead@pennmedicine.upenn.edu|
21244463|NCT01727518|Ludwig Boltzmann Institute for Lung Health|Dr Robab Breyer-Kohansal|+436505398439|Robab.Breyer-Kohansal@lunghealth.lbg.ac.at|
21244464|NCT05419505|Endo Pharmaceuticals|Clinical Operations|800-462-3636|clinicaltrials@endo.com|
21292801|NCT01939145|MGUH Center for Wound Healing and Hyperbaric Medicine|Paul J. Kim, DPM, Director of Research|202-444-3059|Paul.J.Kim@gunet.georgetown.edu|
21292802|NCT01342094|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
21292803|NCT02806414|UCSD Dermatology|Director of Clinical Trials Unit|8586571697|dermstudies@ucsd.edu|
21292804|NCT02382588|Northwestern Universtiy|Dr. Robert Feder|3126958150|r-feder@northwestern.edu|
21292805|NCT01328743|Brown University|Christopher Kahler|4018636651|christopher_kahler@brown.edu|
21292806|NCT05653700|Wake Forest University Health Sciences|Kevin Lobdell, MD|704.355.1585|kevin.lobdell@atriumhealth.org|
21292807|NCT02878382|University of Sao Paulo Medical School Brazil|Dr Luis Torezan Associate Professor Dermatology|+551138491888|torezanluis@uol.com.br|
21292808|NCT01085214|Massey Cancer Center, Virginia Commonwealth University|Steven Grant, M.D.|804-828-5211|stgrant@vcu.edu|
21292809|NCT01482715|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
21292810|NCT01152437|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21292811|NCT01985022|Emory University|Nathan Call, PhD|404-785-9400|nathan.call@choa.org|
21292812|NCT02199041|St. Jude Children's Research Hospital|Brandon Triplett, MD|901-595-2766|brandon.triplett@stjude.org|
21292813|NCT02481258|Mayo Clinic|Jordan D. Miller, Ph.D.|507-293-0813|Miller.Jordan@mayo.edu|
21292814|NCT00806260|Vivus, Inc.|Wesley W Day, PhD|650-934-5200|day@vivus.com|
21292815|NCT01074931|Abbott|Global Medical Services|1-800-633-9110||
21292816|NCT05223673|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33 1 55 72 60 00|scientificinformation@servier.com|
21292817|NCT01088906|Fundación GECP|Eva Pereira|+34 934302006|epereira@gecp.org|
21292818|NCT00457626|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21235542|NCT02460198|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21292819|NCT03508674|Levita Magnetics|Vivian Soto|+56958360507|VSoto@Levita.com|
21292820|NCT04566731|Clinical Research Coordinator|Daniela Sacchetti, MS|215-573-4336|danielas@pennmedicine.upenn.edu|
21244465|NCT05683392|Tandem Diabetes Care, Inc|Supervisor, Clinical Affairs|(877) 801-6901|clinicalaffairs@tandemdiabetes.com|
21292821|NCT00532129|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21292822|NCT03145064|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21292823|NCT00661830|Interdisciplinary Center for Clinical Trials (IZKS Mainz)|A. Kaiser|++49(0)6131-179921|kaiser@izks-mainz.de|
21292824|NCT02433496|University of Wisconsin - Madison|Andrew Quanbeck|6082627385|arquanbe@wisc.edu|
21292825|NCT00551031|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21292826|NCT03460652|KemPharm|Gerald Orehostky|321-250-3699|gorehostky@kempharm.com|
21292827|NCT00548197|Iran university of medical Sciences|Mehdi Modarres|009888602217|mmodarres51@yahoo.com|
21292828|NCT01650831|Exalenz.Bioscience Ltd.|Avraham Hershkowitz, Clinical Trials Manager|+972-8-9737513|avrahamh@exalenz.com|
21292829|NCT02964273|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
21292830|NCT03358355|Northwestern University|Mary McDermott MD|312-503-6419|mdm608@northwestern.edu|
21292831|NCT01336712|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD (Principal Investigator)|404-255-1930|ssolomon@bmtga.com|
21292832|NCT02469701|Brown University Oncology Research Group|Kristen M. Mitchell, CCRP|4018633000|kristen_mitchell@brown.edu|
21292833|NCT03462758|University of California, San Diego|Dr. Sarah Averbach, MD, MAS|858-329-4464|familyplanningresearch@health.ucsd.edu|
21292834|NCT00413660|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21292835|NCT01791517|Johnson & Johnson Vision Care, Inc.|Chantal Coles-Brennan, PRINCIPAL RESEARCH OPTOMETRIST, Global Med Affairs|904-443-3500|CColesb@ITS.JNJ.com|3449
21292836|NCT00353301|University of Colorado, Denver|Dr. Thomas Flaig|(720) 848-0655|Thomas.Flaig@ucdenver.edu|
21292837|NCT03230318|Basilea Pharmaceutica International Ltd, Allschwil|Dr Manuel Häckl, MD|+41 76 302 53 10|manuel.haeckl@basilea.com|
21292838|NCT02141672|Aurinia Pharmaceuticals|Rashieda Gluck|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
21292839|NCT00075764|SWOG|Breast Committee Statistician|206-667-4623||
21292840|NCT03012191|University of Southern California Department of Dermatology|Dr. David Woodley|(323)442-0084|dwoodley@med.usc.edu|
21292841|NCT02817594|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21292842|NCT02010593|International Partnership for Microbicides|Dr John Steytler||jsteytler@ipmglobal.org|
21292843|NCT01773967|Cincinnati Children's Hospital Medical Center|Dr. David Schnadower|5138035526|david.schnadower@cchmc.org|
21292844|NCT03885154|University of Kentucky|Kimberly Jones, MD|859-218-5011|kimberly.jones@uky.edu|
21292845|NCT00739310|Maimonides, Department of Pulmonary Medicine|Kathryn Fitzgerald, NP|718-283-7339|kfitzgerald@maimonidesmed.org|
21292846|NCT01492088|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21235543|NCT00931307|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
21235544|NCT00965848|Medical Affairs, Janssen-Cilag Ltd.,Thailand|Medical Affairs Director|662-792-7200||
21244466|NCT02780388|Viela Bio|Viela Bio Clinical Operations|+1 240-558-0038|ClinicalTrials@VielaBio.com|
21244467|NCT04527146|UPenn|Rachel Paul, Genetic Counselor|215-490-5816|rachel.paul3@pennmedicine.upenn.edu|
21235545|NCT00813761|Vistakon|Kristy Canavan, OD|1-904-443-1474|kcanava2@its.jnj.com|
21235546|NCT00691210|Columbia University Medical Center|Owen A. O'Connor, MD, Ph.D.|212-326-5720|oo2130@cumc.columbia.edu|
21235547|NCT01130740|Center for Health Services Reserach in Primary Care, Durham VAMC|Kelli D. Allen, PhD|919-286-0411|kelli.allen@va.gov|7090
21244468|NCT05107401|Columbia University|Dr. Alissa Davis|212-851-2224|ad3324@columbia.edu|
21244469|NCT05510232|Hospital for Special Surgery|Dr. Peter Fabricant|(212) 606-1996|fabricantstaff@hss.edu|
21244470|NCT02380612|AVITA Medical|VP Clinical Research|661-367-9170|clinicaltrial@avitamedical.com|
21244471|NCT02721381|Michigan State University|Dr. Brooke Ingersoll|517-930-2275|ingers19@msu.edu|
21244472|NCT05166135|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21244473|NCT03569176|Stanford University|Dr. Dennis P. Wall|650-497-9214|dpwall@stanford.edu|
21244474|NCT05952076|Gates MRI|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
21244475|NCT04143061|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21244476|NCT04970407|Ipsen Innovation|Laurent Pons/Clinical Pharmacology Director|see email|clinical.trials@ipsen.com|
21244477|NCT02960230|University of California, San Francisco|Dr. Sabine Mueller, MD PhD|(415) 502-1600|Sabine.Mueller@ucsf.edu|
21244478|NCT03401853|University of Washington|Stephen Smith, MD|(206) 606-6546|ssmith50@fredhutch.org|
21244479|NCT01898494|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21244480|NCT03289039|Dana-Farber Cancer Institute|Jose Pablo Leone, MD|617-632-3800|josep_leone@dfci.harvard.edu|
21244481|NCT02819843|Memorial Sloan Kettering Cancer Center|Dr. Christopher Barker, MD|212-639-8168|barkerc@mskcc.org|
21244482|NCT04732494|BeiGene, Ltd.|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
21244483|NCT03055858|Abbott Laboratories|Ebony Kargbo|612-209-8185|Ebony.Kargbo@abbott.com|
21244484|NCT04586920|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21244485|NCT04761302|University of Puerto Rico: Department of Orthopedic Surgery|Dr. Hans Hess|787-365-5755|hans.hess1@upr.edu|
21244486|NCT00753987|SickKids|Felix Ratjen|4168137500|felix.ratjen@sickkids.ca|
21244487|NCT05136404|Eli Lilly and Company|Chief Medical Officer|8005955979|ClinicalTrials.gov@lilly.com|
21244488|NCT02553642|Memorial Sloan Kettering Cancer Center|Dr. Samuel Funt, MD|646-888-4718|funts@mskcc.org|
21244489|NCT03755141|Korea university Guro hospital|In Hae Park|+82-2-2626-3172|parkih@korea.ac.kr|
21244490|NCT05271903|University of Utah|Melissa Watt|801-587-2100|melissa.watt@hsc.utah.edu|
21244491|NCT01820260|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
21244492|NCT05444192|University of Central Lancashire|Dr Graham Chapman|01772894949|gchapman2@uclan.ac.uk|
21244493|NCT04522713|Karolinska Institutet|Dr. Erland Axelsson|0706171039|erland.axelsson@ki.se|+46
21244494|NCT04848974|The University of Texas MD Anderson Cancer Center|Tapan Kadia MD/Professor|713-563-3534|tkadia@mdanderson.org|
21244495|NCT04424927|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21244496|NCT03727061|Roswell Park Compressive Cancer Center|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|adrienne.groman@roswellpark.org|
21244497|NCT02134951|New York State Psychiatric Institute|Marlene Carlson|646-774-8436|mc157@columbia.edu|
21244498|NCT00894543|University of Pennsylvania School of Medicine|Dr. Ellen W. Freeman|215-349-5521|freemane@mail.med.upenn.edu|
21244499|NCT04048681|Beth Israel Deaconess Medical Center|Dr. Olivia Farr|6176678636|ofarr@bidmc.harvard.edu|
21244500|NCT03380390|Aclaris Therapeutics|Dr. David Gordon|484-540-6273|dgordon@aclaristx.com|
21244501|NCT02886286|University Hospitals Cleveland Medical Center|Salim M. Hayek, MD, PhD|2168442685|salim.hayek@uhhospitals.org|
21244502|NCT01771731|University of California San Francisco|Donald I. Abrams, MD|415-476-4082|Donald.Abrams@ucsf.edu|444
21244503|NCT00976495|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
21244504|NCT05321069|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
21244505|NCT01241916|Massachusetts General Hospital|Dr. David Ring|617-724-3953|dring@partners.org|
21244506|NCT01044303|East Carolina University|Dr. Paul Bolin|252-744-3773|bolinp@ecu.edu|
21244507|NCT01609218|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21244508|NCT03640949|Aarhus University|Lars W. Andersen|+4551781511|lwandersen@clin.au.dk|
21244509|NCT00774852|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21244510|NCT04428112|UCSF|Dr. Veronica Yank|415-476-9654|veronica.yank@ucsf.edu|
21244511|NCT05158153|University of California, San Francisco|Dr. Ian McCoy|415-476-2172|ian.mccoy@ucsf.edu|
21244512|NCT02807779|University of California, San Francisco|Warren Gasper, MD|415-353-4366|warren.gasper@ucsf.edu|
21244513|NCT03582722|Emory University|Michele Marcus, PhD, MPH|404-727-8010|mmarcus@emory.edu|
21244514|NCT06024174|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21280037|NCT00295893|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
21280038|NCT01995513|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21280039|NCT01232452|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21280040|NCT01037452|Novartis|Head New Therapeutic Opportunities|973-503-8000||
21280041|NCT05219448|University of Washington|Dr. Donald L. Chi|206-616-4332|dchi@uw.edu|
21280042|NCT01750190|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|060study@fibrogen.com|
21280043|NCT05387889|State University of New York at Buffalo School of Nursing|Dr. Tania Von Visger|7168292201|Taniavon@buffalo.edu|
21280044|NCT01311687|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599||
21280045|NCT03571828|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21280046|NCT04020887|Washington University School of Medicine|Thaddeus Budelier|314-273-8646|thaddeus.budelier@wustl.edu|
21280047|NCT03852537|Mayo Clinic|Hemang Yadav, MBBS, MS|507-266-3958|Yadav.Hemang@mayo.edu|
21280048|NCT02040077|Johns Hopkins University School of Medicine|Kelly Dunn|410-550-2254|kdunn9@jhmi.edu|
21280049|NCT02683421|Navidea Biopharmaceuticals|Bonnie C. Abbruzzese, MS, RD|614-822-2327|babbruzzese@navidea.com|
21280050|NCT01253902|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21292847|NCT02803203|Memorial Sloan Kettering Cancer Center|Dr. Helena Yu, MD|646-608-3912|YuH@mskcc.org|
21262059|NCT01625169|USC|LaShonda Spencer|323 226-6437|lspencer@usc.edu|
21244515|NCT01649271|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21292848|NCT00590967|Washington University School of Medicine|Perry Grigsby, M.D.|314-362-8502|grigsby@radonc.wustl.edu|
21292849|NCT01881789|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21292850|NCT01887717|BTG International Inc.|Manager of Clinical Development|613-801-1844|TheraSphereClinical@btgplc.com|
21292851|NCT01299389|Janssen Pharmaceutical K.K|Medical director|+81-3-4411-5509||
21244516|NCT05644002|Rutgers, the State University of New Jersey|Dr. Teresa Leyro|848-445-2090|tml124@psych.rutgers.edu|
21292852|NCT02020590|Bone Therapeutics|Chief Medical Officer|+32 71 12 10 00|regulatory@bonetherapeutics.com|
21244517|NCT06180967|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21244518|NCT04038957|Sumitomo Pharma America Inc|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
21244519|NCT03913195|TaiMed Biologics|Dr. Kuei-Ling Kuo|+886-2-26580058|kkuo@taimedbio.com|118
21244520|NCT04840199|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
21244521|NCT03857620|University of Texas MD Anderson Cancer Center|George J. Chang, MD, MS|713-563-1875|gchang@mdanderson.org|
21244522|NCT03271151|Anesthesiology Critical Care & Pain Management|Dr. Jacques Yadeau|2127742224|Yadeauj@hss.edu|
21244523|NCT05265312|Johns Hopkins University School of Medicine|Dr. Eva Tseng|410-583-2774|etseng3@jhmi.edu|
21244524|NCT02201108|Genzyme, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21244525|NCT04118452|University of California, Los Angeles & Kaiser Permanente School of Medicine|Dr. Paul Chung, Professor and Principal Investigator|626-710-0389|paul.j.chung@kp.org|
21244526|NCT03438188|Perlman School of Medicine, University of Pennsylvania|James Loughead, Ph.D.|215-205-1876|loughead@pennmedicine.upenn.edu|
21244527|NCT05215847|Aardvark Therapeutics|Manasi Jaiman MD, MPH, Chief Medical Officer|(858) 225-7696|MJaiman@aardvarktherapeutics.com|
21244528|NCT03433339|Lindner Center of HOPE/ University of Cincinnati Department of Psychiatry and Behavioral Neurosciences|Dr. Francisco Romo-Nava|513-536-0725|romofo@ucmail.uc.edu|
21244529|NCT03830177|Northwestern University|Lucy Bilaver, PhD|312-503-5618|l-bilaver@northwestern.edu|
21244530|NCT05145257|Citruslabs|Patrick Renner|4242450284|hello@citruslabs.com|
21244531|NCT04995484|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21244532|NCT05178810|Ferrer|Clinical Operations Head|+34 649 442 389|nalbareda@ferrer.com|
21244533|NCT06072404|University of Palermo|Prof. Olga Di Fede|00393294030298|olga.difede@unipa.it|
21244534|NCT02793687|Pharmasoft|Meshcherskiy Y.E., Medical director|+ 7 (495) 626-47- 55|meshcherskiy_y@pharmasoft.ru|140
21244535|NCT05568004|Ege University Faculty of Medicine Sport Medicine Department|Dr. Yunus Emre Meydanal|905068046512|yemremeydanal@gmail.com|
21244536|NCT05968495|Pearl Plastic Surgery|Christopher Nichols, MD|360-878-9300|cnichols@pearlplasticsurgery.com|
21244537|NCT00150813|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21244538|NCT02155010|Haeundae paik hospital, Inje University|Ki Hwa Lee|82-51-797-0421|tedy3333@naver.com|
21244539|NCT02808676|Lawson Health Research Institute|Dr. Manuel Montero-Odasso|519-685-4292|manuel.monteroodasso@sjhc.london.on.ca|42179
21244540|NCT01046136|Reckitt Benckiser|Kim Clark|855.966.5483|ClinicalRequests@rb.com|
21244541|NCT04579250|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
21244542|NCT02919449|Vyriad|Alice Bexon MD Chief Medical Officer|+1-617-417-7300|alice.bexon@bexonclinical.com|
21292853|NCT00889707|Sophiris Bio Corp (formerly Protox Therapeutics)|Chief Medical Officer|858-255-4711|richard@sophiris.com|
21292854|NCT02694601|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
21292855|NCT02185534|AstraZeneca|Brilinta Global Clinical Leader|+46 31 776 1000|ClinicalTrialTransparency@astrazeneca.com|
21292856|NCT01635998|Icahn School of Medicine at Mount Sinai|Sam Cammack|(212) 824-8931|sam.cammack@mountsinai.org|
21292857|NCT00243191|SARC|SARC, Chief Operating Officer|734-930-7600|sarc@sarctrials.org|
21292858|NCT01224236|University of Texas Health Science Center - Houston|Kathleen Kennedy|+1 (713) 500-5651|Kathleen.A.Kennedy@uth.tmc.edu|
21292859|NCT03502915|University of North Carolina at Chapel Hill|Kathleen A. Smith, MD|9199665136|ksmith@aims.unc.edu|
21235548|NCT00983814|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
21235549|NCT01891734|Department of Veterans Affairs San Diego|Kathleen Grubbs|808-383-9757|kathleen.grubbs@va.gov|
21244543|NCT02058108|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21244544|NCT01154192|UC San Diego School of Medicine|Dr. R. Jeffrey Chang|858-534-8930|rjchang@ucsd.edu|
21244545|NCT01376700|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21244546|NCT00727909|VA TVHS|Gene W. Bratt, Ph.D.|615-873-6068|gene.bratt@va.gov|
21235550|NCT00555438|CHU SAINT-ETIENNE|Pr patrick MISMETTI|33(1)477127788|patrick.mismetti@chu-st-etienne.fr|
21235551|NCT02707640|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21235552|NCT02517905|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
21235553|NCT04114058|Cedar Sinai -Kerlan Jobe|Dr. Michael Banffy|(310) 665-7200|Michael.Banffy@cskerlanjobe.org|
21235554|NCT01578044|VA Eastern Colorado Health Care System|P. Michael Ho|720-857-2115|michael.ho@va.gov|
21235555|NCT02758236|INA-RESPOND|Publication Division|+62214208693|inapublikasi@ina-respond.net|
21235556|NCT05789875|UCSF|Dr. Parya Saberi|415-502-1000|parya.saberi@ucsf.edu|17171
21235557|NCT01994395|Rehabilitation Institute of Chicago|Arun Jayaraman, PT, PhD; Director of Max Nader Lab for Rehabilitation Technologies and Outcomes|3122386875|ajayaraman@ricres.org|
21235558|NCT01693601|Icahn School of Medicine at Mount Sinai|John Mascarenhas|212-241-3417|john.mascarenhas@mssm.edu|
21235559|NCT01612546|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
21292860|NCT04179305|Weill Cornell Medicine|Sophia Kakarala|(646) 962-5650|sok4004@med.cornell.edu|
21292861|NCT00326599|Roswell Park Cancer Institute|Alex A. Adjei, M.D., Ph.D.|716-845-4101|alex.adjei@roswellpark.org|
21292862|NCT02358993|University of Pennsylvania|Dr Uduak Andy|215-662-7709|uduak.andy@pennmedicine.upenn.edu|
21292863|NCT00149799|Rhode Island Hospital|Katharine A. Phillips, MD|401-444-1646|katharine_phillips@brown.edu|
21292864|NCT01072136|University of Arkansas for Medical Sciences|Shelly Lensing|501-686-8203|sylensing@uams.edu|
21292865|NCT01591408|NavalMCSD|Julie Onton|619-553-6228|julie.a.onton.ctr@mail.mil|
21292866|NCT02153489|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
21292867|NCT00657267|Dana-Farber Cancer Institute / Brigham & Women's Hospital|Patrick Y. Wen, MD|617-632-2166|pwen@partners.org|
21292868|NCT02737501|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21292869|NCT00405288|The Hospital for Sick Children|Dr. Gideon Koren||gkoren@sickkids.ca|
21292870|NCT01070979|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
21292871|NCT00142792|MetroHealth Medical Center|Richard WIlson, MD|216-957-3559|rwilson@metrohealth.org|
21292872|NCT03069716|Vanderbilt University Medical Center|Dr. Evan L. Brittain|(615) 322-4382|Evan.brittain@vumc.org|
21292873|NCT01673126|Coma Science Group, University of Liège|Aurore Thibaut and Pr Steven Laureys|003243662362|athibaut@ulg.ac.be|
21292874|NCT04421404|UCSF|Dr. Annie Luetkemeyer|415-476-4082|annie.luetkemeyer@ucsf.edu|130
21292875|NCT00237042|University of Washington|Dr. Judith Turner|206-543-3997|jturner@u.washington.edu|
21292876|NCT02965989|Hospital Universitario 12 de Octubre de Madrid|Ph.D. Ignacio Zaragoza-García|913908000|izaragoz@ucm.es|4646
21292877|NCT01913327|University of California San Francisco|Michael Minzenberg|5104122199|MMinzenberg@mednet.ucla.edu|
21292878|NCT03132467|UT MD Anderson Cancer Center|Dr. Jennifer Litton, MD- VP, Clinical Research, Clinical Research|(713) 792-2817|jlitton@mdanderson.org|
21235560|NCT03246529|BioLineRx Ltd|VP Clinical & Medical Affairs|+972-8-6429100|clinicaltrials@biolinerx.com|
21244547|NCT01696773|The Ohio State University|Steven J. Schwartz|614-292-2934|schwartz.177@osu.edu|
21244548|NCT04752163|The University of MD Anderson Cancer Center|Naval Daver MD./Professor|713-794-4392|NDaver@mdanderson.org|
21244549|NCT05623345|Acelyrin Inc.|Clinical Trials Information Desk|+18054564393|clinicaltrials@acelyrin.com|
21244550|NCT00411151|Interdisciplinary Center for Clinical Trials (IZKS Mainz)|M. Kabisch|++49 (0)6131-179922|kabisch@izks-mainz.de|
21244551|NCT02191085|University of Calgary|Dr. Sachin Pendharkar|403-210-8617|sachin.pendharkar@ucalgary.ca|
21244552|NCT05050682|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21244553|NCT03405714|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21244554|NCT03144518|University of Nottingham|Dr Kieran Ayling|+44 1158466908|kieran.ayling@nottingham.ac.uk|
21244555|NCT02374307|OsloMet - Oslo Metropolitan University|Maria Bjerk|+4767236683|maria.bjerk@oslomet.no|
21244556|NCT04452318|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
21244557|NCT02638337|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
21244558|NCT00604669|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
21244559|NCT02376530|SUNYBuffalo|Leonard H. Epstein|716-829-3400|lhenet@buffalo.edu|
21244560|NCT05187442|National Taiwan University|PIAO-YI CHIOU, doctoral|+886-2-23123456|piaoyi@ntu.edu.tw|288427
21244561|NCT03271489|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21244562|NCT06061081|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21292879|NCT05599100|University of Washington School of Public Health, Department of Health Systems and Population Health|Magaly Ramirez, PhD, MS, MS|206-543-9773|maggiera@uw.edu|
21235561|NCT03655236|Sun Pharma Advanced Research Company Limited|Head, Clinical Development|912266455645|clinical.trials@sparcmail.com|
21235562|NCT01818336|AllerQuest|Dr. Franklin Adkinson Jr., MD-Vice President, Chief Medical Officer|410-550-2051|fadkinson@allerquest.com|
21235563|NCT00320281|Craig Hospital|Dr. Gary Maerz|303-789-8220|adannels@craighospital.org|
21235564|NCT00608829|W.L. Gore and Associates|Abe Letter|928 864 3113|aletter@wlgore.com|
21235565|NCT02283528|Emory University|Dr. Gary Francis Bouloux|404-778-4500|gfboulo@emory.edu|
21235566|NCT00672477|Salix|David Sorscher|919-862-1827|david.sorscher@salix.com|
21235567|NCT04175262|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21235568|NCT00982319|Sidney Kimmel Comprehensive Cancer Center|Dr. Kala Visvanathan|410-614-1112|kvisvan1@jhu.edu|
21235569|NCT00975975|IndianaU|Dr. Robert Nelson|317-944-0920|ronelson@iu.edu|
21235570|NCT00843791|OREGON HEALTH & SCIENCE UNIVERSITY|Dr. Jonathan Q Purnell|5034941056|purnellj@ohsu.edu|
21235571|NCT00693992|University of Pittsburgh|Mark A. Socinski, M.D.||socinskima@upmc.edu|
21235572|NCT00856024|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClincialTrialsDisclosure@merck.com|
21235573|NCT02496884|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21235574|NCT00097591|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21235575|NCT00491244|National Taiwan University Hospital|Dr. Chen-Hua Liu|+886-2-23123456|jacque_liu@mail2000.com.tw|63572
21244563|NCT01127373|Memorial Sloan Kettering Cancer Center|Dr. Simon Powell, MD|212-639-3639|powells@mskcc.org|
21244564|NCT05450458|RodillaActiva Medical Center|Dr. Julio Carlos Vélez de Lachica|5215518338063|activeknee@gmail.com|
21244565|NCT03148496|The University of Texas Health Science Center at Houston|Julie Holihan, MD|713-500-7188|Julie.L.Holihan@uth.tmc.edu|
21244566|NCT02965846|Allergan, Inc.|Therapeutic Area Head|877-277-8566|clinicaltrials@allergan.com|
21244567|NCT00539734|Prince of Songkla University|Patama Bhurayanontachai|66-74-451380|tpatama@hotmail.com|
21244568|NCT02814838|Dompé Farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
21244569|NCT00073749|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21292880|NCT00841776|GlaxoSmithKline|GSK Response Center|866-435-7343||
21235576|NCT00807092|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21292881|NCT04245449|Medical University of South Carolina|Michelle Woodbury, PhD|843-792-0651|woodbuml@musc.edu|
21292882|NCT01139411|Weight Control and Diabetes Research Center|Dr. Elissa Jelalian|(401) 793-9716|elissa_jelalian@brown.edu|
21292883|NCT00355368|Medical Intensive care unit, University Hospital Basel|Stephan Marsch|+ 41 61 265 2525|smarsch@uhbs.ch|
21292884|NCT01349673|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
21292885|NCT00641108|University of Pennsylvania|Tyrone Quarterman|215-349-5537|tyroneq@upenn.edu|
21235577|NCT01229228|Iroko Pharmaceuticals, LLC|Steven Jensen|267-546-3003|sjensen@iroko.com|
21235578|NCT03264157|Bio Products Laboratory|Head of Medical Affairs|1-844-4BPLUSA|MedInfo@bpl-us.com|
21235579|NCT02013765|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21235580|NCT02061345|Imperial College, London|Prof Pat Price|02075895111|p.price@imperial.ac.uk|
21235581|NCT03095417|Indiana University|Babar Khan, MD, MS|(317) 274-9132|bakhan@iu.edu|
21235582|NCT02821104|Nationwide Children's Hospi|Robert Hoffman|614-722-4425|robert.hoffman@nationwidechildrens.org|
21235583|NCT03835260|Pivot Health Technologies Inc.|Senior Director of Clinical Affairs and Data Science|650-906-4255|craig@pivot.co|
21235584|NCT01260922|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21235585|NCT01731171|Sheppard Pratt Health System|Dr. Faith Dickerson|410-938-4359|fdickerson@sheppardpratt.org|
21235586|NCT01410110|Yale University School of Medicine|Morris Bell, Ph.D.|203-932-5711|morris.bell@yale.edu|2281
21235587|NCT01416805|University of South Florida|Dr. Eric Storch|727-767-8230|Eric.Storch@bcm.edu|
21235588|NCT03653429|Icahn School of Medicine at Mount Sinai|Poonam Pai B. H|212-523-4000|poonam.paibantwalhebbalasankatte@mountsinai.org|
21235589|NCT02708745|Seattle Children's Hospital|Dr. Doug Opel|206-987-2000|douglas.opel@seattlechildrens.org|
21235590|NCT02604589|William Beaumont Hospital|Rose Callahan|248 551-5147|rose.callahan@beaumont.org|
21235591|NCT01700946|St. Jude Children's Research Hospital|Sima Jeha, MD|(901) 595-3901|sima.jeha@stjude.org|
21235592|NCT01168934|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21235593|NCT01504438|Duke University|James Nunley II, M.D.|919-684-4033|james.nunley@duke.edu|
21235594|NCT02418546|Massachusetts General Hospital|Dr. Anne-Marie Wills|6177265532|awills@mgh.harvard.edu|
21235595|NCT04632940|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG3019-094DMDStudy@fibrogen.com|
21235596|NCT00684424|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21235597|NCT01159067|City of Hope National Medical Center|Dr. Vinod Pullarkat|626-256-4673|vpullarkat@coh.org|82405
21235598|NCT02442700|Ramathibodi Hospital, Mahidol University|Asita Wongprikorn, MD|664236949|wongprikorn@yahoo.com|
21235599|NCT01723904|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
21235600|NCT05580575|The Ohio State University College of Optometry|Dr. Jennifer Fogt, OD, MS|614-292-0882|fogt.78@osu.edu|
21235601|NCT00752908|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
21235602|NCT00059475|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-6375|nciirbadmin@mail.nih.gov|
21235603|NCT02610140|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21235604|NCT00887341|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21244570|NCT04154384|Emory University|Mara L. Schenker|404-778-1550|mara.schenker@emory.edu|
21244571|NCT01136876|Bracco Diagnostics Inc.|Maria Luigia Storto, M.D.|609-514-2262|MariaLuigia.Storto@diag.bracco.com|
21244572|NCT04128319|Xenikos|Eric van Hooren, Chief Development Officer|+31 6 109 345 84|e.vanhooren@xenikos.com|
21244573|NCT04484935|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21244574|NCT04820686|Assembly BioSciences Inc.|Director of Clinical Operations|415-366-5172|psalstrand@assemblybio.com|
21244575|NCT01424670|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
21244576|NCT02759016|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21244577|NCT04377308|The University of Toledo Department of Psychiatry|Cheryl McCullumsmith, M.D., Ph.D.|419-383-5669|cheryl.mccullumsmith@utoledo.edu|
21244578|NCT05123742|Rutgers School of Dental Medicine|Cecile A. Feldman, DMD, MBA|9739724634|feldman@sdm.rutgers.edu|
21244579|NCT00972439|USC/Norris Comprehensive Cancer Center|Celeste Pearce, Ph.D.|323 865 0437|cpearce@usc.edu|
21244580|NCT02891915|Vanderbilt Vaccine Research Program|Dr. C. Buddy Creech|615-343-0332|buddy.creech@vanderbilt.edu|
21244581|NCT01522924|University of Louisville|Dr. Jacqueline Singleton|502-852-2611|jasing02@louisville.edu|
21244582|NCT02150967|QED Therapeutics, Inc.|David van Veenhuyzen, Vice President, Clinical Development|1 650 391-9740|david.vanveenhuyzen@bridgebio.com|103
21244583|NCT04048382|San Diego State University|Dr. Aaron J. Blashill|6195942245|ajblashill@sdsu.edu|
21244584|NCT00490100|National Institute of Allergy and Infectious Diseases|De Ravin, SukSee|+1 301 496 6772|sderavin@mail.nih.gov|
21244585|NCT00709098|Actelion Pharmaceuticals Ltd|Laila Rouault, MD/International Clinical Leader|+ 41 61 565 8128||
21244586|NCT03498196|Baylor College of Medicine|Jennifer M. Taylor, MD, MPH|713-797-7670|Jennifer.Taylor@bcm.edu|
21244587|NCT02119650|Incyte Corporation|Study Director|855 463-3463||
21244588|NCT01967836|Ascension Wisconsin|Dr Maureen Greene|414-447-2716|maureen.greene@ascension.org|
21244589|NCT04994509|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21244590|NCT04402294|University of Pennsylvania|Dr. Desmond Oathes, Principal Investigator|215-573-9390|oathes@pennmedicine.upenn.edu|
21244591|NCT04459416|Memorial Sloan Kettering Cancer Center|Dr. Gary Deng, MD, PhD|646-608-8556|dengg@MSKCC.ORG|
21292886|NCT00347932|Bausch & Lomb Incorporated|Timothy Comstock|(585) 338-6631|timothy.comstock@bausch.com|
21235605|NCT02617589|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21244592|NCT03744312|Columbia University|Patrick J. Lao, PhD|212-305-9079|pjl2133@cumc.columbia.edu|
21292887|NCT01285024|Cleveland Clinic|President and CEO Cleveland Clinic Florida|216-444-7515|barsouw@ccf.org|
21292888|NCT00344175|Kowa Research Institute|Bill Arana|919 433-1600|barana@kowaus.com|
21244593|NCT05134337|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21244594|NCT03725722|LEO Pharma A/S|Clinical disclosure|+45 4494 5888|disclosure@leo-pharma.com|
21244595|NCT04592198|Xiamen LP Pharmaceutical Co.,Ltd|Matthew H Nieder|(415) 516-9498|matthew@lppharma.com|
21244596|NCT01259401|VA Greater Los Angeles Healthcare System|Dr. Jennifer Martin|818 891-7711|Jennifer.Martin@va.gov|9173
21244597|NCT03683069|Brigham and Women's Hospital|Gordon H. Williams, Professor of Medicine|617-223-1611|gwilliams@bwh.harvard.edu|
21244598|NCT05768373|Solventum|Helen Han|6517856568|mhan3@solventum.com|
21244599|NCT05478525|Glyscend Therapeutics|Ashish Nimgaonkar, MD|6175483513|ashish.nimgaonkar@gmail.com|
21244600|NCT04499950|SKCCC|Jennifer Sheng|410-614-0762|jsheng7@jhmi.edu|
21244601|NCT01991977|Mayo Clinic|Nadia N. Laack, MD|507/284-2511|Laack.Nadia@mayo.edu|
21244602|NCT04799197|University of Michigan|Kristi Gamarel|7346473178|kgamarel@umich.edu|
21244603|NCT03845465|Vanderbilt University Medical Center|Sarah Jaser, PhD|6153436775|sarah.jaser@vumc.org|
21244604|NCT04491968|Rutgers Robert Wood Johnson Medical School|Dr. Nina Cooperman, Associate Professor|7322358569|cooperna@rwjms.rutgers.edu|
21244605|NCT05656911|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21244606|NCT03236441|UT Southwestern Medical Center|Oladipupo Olafiranye, MD, MS|2148572923|oladipupo.olafiranye@utsouthwestern.edu|
21244607|NCT03888989|Stanford University|Philip Grant|650-521-3540|pmgrant@stanford.edu|
21244608|NCT02525692|Chimerix, Inc.|Chief Medical Officer|919-806-1074|clinicaltrials@chimerix.com|101
21244609|NCT05794763|Stanford University|Dr. Eric Stice|6507237885|estice@stanford.edu|
21244610|NCT00567398|Vantive|Clinical Trials Disclosure Group|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
21244611|NCT03517553|University of Iowa|Dr Bradley S. Dixon|319-356-1626|bradley-dixon@uiowa.edu|
21244612|NCT03229811|Fresenius Medical Care|Dr. Amaka Eneanya|267-769-5455|amakaeneanya@gmail.com|
21244613|NCT04093362|Taiho Oncology, Inc|Taiho|609-250-7336|clinicaltrialinfo@taihooncology.com|
21244614|NCT04247542|Acurx Pharmaceuticals, Inc.|Robert J DeLuccia|914-949-3898|rjdeluccia@acurxpharma.com|
21244615|NCT02597946|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21244616|NCT03379168|University of New Mexico Health Sciences Center|Dustin Richter, MD; Vice Chair of Research|505-272-4107|DLRichter@salud.unm.edu|
21244617|NCT03743636|Northwestern University|Mary M. McDermott, MD|312-503-6419|mdm608@northwestern.edu|
21244618|NCT01938547|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
21244619|NCT02226341|Columbia University|Anca Askanase MD, MPH|212 305 0856|ada20@cumc.columbia.edu|
21244620|NCT05343390|University of North Carolina at Chapel Hill|Nora E. Rosenberg, PhD|(919) 966-3761|nrosenbe@email.unc.edu|
21244621|NCT03467542|Terumo Neuro|Robert Gash|714-247-8000|robert.gash@microvention.com|
21244622|NCT01673984|Ipsen|Medical Director, Uro-Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21244623|NCT02664558|Eiger BioPharmaceuticals, Inc.|Senior VP, Clinical Development|1-650-618-1621|info@eigerbio.com|
21244624|NCT01881412|Rhode Island Hospital and Brown University|Dr. Aris Garro|401-480-8682|arisgarro1@gmail.com|
21244625|NCT04600752|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21244626|NCT03732820|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21244627|NCT04436107|BeiGene|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
21244628|NCT01095796|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21244629|NCT01989455|ApoPharma Inc.|Caroline Fradette, PhD|416-401-7543|cfradett@apopharma.com|
21244630|NCT00632203|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21244631|NCT02641912|GlaxoSmithKline|GSK Response Center|866-435-7343||
21244632|NCT03928522|Washington University|Venessa Riegler|314-362-1721|rieglerv@wustl.edu|
21244633|NCT00448669|National Institutes of Health|Dr. Michael Thigpen|1-240-669-2877|michael.thigpen@nih.gov|
21244634|NCT04287985|Visterra, Inc.|Mohit Mathur, MD|+1-617-498-1070|mmathur@visterrainc.com|
21244635|NCT05751785|The Geneva Foundation|Ms. Elizabeth Metzger, Senior Scientific Program Manager|253-383-1398|emetzger@genevausa.org|
21244636|NCT01340066|Beech Tree Labs, Inc.|Dr. John McMichael|518-872-1144||
21244637|NCT04349072|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21244638|NCT00011986|Gynecologic Oncology Group Statistical and Data Center|Linda Gedeon, BS, CCRP|716-845-1169|lgedeon@gogstats.org|
21244639|NCT03771352|RxSight|Jeffrey Ha, Senior Director of Clinical Research|949-521-7870|jha@rxsight.com|
21244640|NCT00274469|AstraZeneca|Jasmine Lichfield|07585404954|jasmine.lichfield@astrazeneca.com|
21244641|NCT03338816|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
21244642|NCT00445315|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21244643|NCT02633267|University of Michigan|Dr. Joseph Himle|(734) 615-0611|himlej@umich.edu|
21244644|NCT06647238|Atrium Health|Lyndsi Roland|828-434-5434|lyndsi.roland@advocatehealth.org|
21244645|NCT05494788|Cardiol Therapeutics Inc.|Andrea B. Parker, MSc., PhD, Senior Director of Clinical Operations|+1 289 9100862|andrea.parker@cardiolrx.com|
21244646|NCT00136435|Dana Farber Cancer Institute|Dr. Dan DeAngelo|617-582-8410|Daniel_Deangelo@dfci.harvard.edu|
21262060|NCT02441803|University of Texas MD Anderson Cancer Center|Dr. Richard Champlin, MD/Stem Cell Transplantation|713-792-3618|rchampli@mdanderson.org|
21292889|NCT04105868|University of Pittsburgh|Mary Woody, PhD Assistant Professor of Psychiatry|4123832143|mlw114@pitt.edu|
21244647|NCT01017146|GlaxoSmithKline|GSK Response Center|866-435-7343||
21244648|NCT00087139|ECOG Statistical Office|Study Statistician|617-632-3012||
21244649|NCT00215787|Head and Neck Surgery Associates|Scott Phillips|317-926-1056|sphillips@hnsaonline.com|
21292890|NCT00382265|George Washington University|Andrew Meltzer, MD, MS|202-741-2952|ameltzer@mfa.gwu.edu|
21292891|NCT04091048|Medtronic Cardiovascular|Katie Flor, Clinical Research Manager|262 693 6127|katie.j.flor@medtronic.com|
21292892|NCT00589797|Aesculap Inc.|Associate Director of Medical and Scientific Affairs|800-258-1946|mikhail.chkolnik@aesculap.com|5173
21292893|NCT01692743|University of Maryland School of Medicine|Raymond K. Cross, MD, MS, AGAF|410-706-3387|rcross@som.umaryland.edu|
21292894|NCT01821326|Shanghai Jiaotong University|Dr.Zhizheng GE|86-68383015|tanwei_1987@163.com|
21292895|NCT04011735|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21292896|NCT02831855|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21292897|NCT03368196|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21292898|NCT02688192|Rutgers Cancer Inst. of NJ|Dr. Katie Devine|7322357549|katie.devine@rutgers.edu|
21292899|NCT04345900|BeyondSpring Pharmaceuticals|Ramon Mohanlal|6468491102|rmohanlal@beyondspringpharma.com|
21292900|NCT01459666|University Hospitals Cleveland Medical Center|Dr. Kevin Cooper|216-844-3100|Kevin.Cooper@UHhospitals.org|
21244650|NCT02672033|Jonsson Comprehensieve Cancer Center|Dr. Percy Lee|310 825-9771|percylee@mednet.ucla.edu|
21244651|NCT01748916|University of Hohenheim|Dr. Ralf Schweiggert|0049-711-459-22995|ralf.schweiggert@uni-hohenheim.de|
21244652|NCT02671435|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
21280051|NCT04138823|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21280052|NCT00548470|Nathan Kline Institute for psychaitric Research|Robert C Smith MD|845-398-6531|rsmith@nki.rfmh.org|
21280053|NCT02466685|Northwestern University|Mahdi Arshadi|3123839950|mahdi.arshadi@northwestern.edu|
21280054|NCT02565511|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21280055|NCT00104572|NIA|Josephine M. Egan,MD, clinical director NIA|410-558-8414|eganj@grc.nia.nih.gov|
21280056|NCT02969044|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_inquiries@pfizer.com|
21280057|NCT04650204|Mayo Clinic|William Tatum, D.O.|507 284-2511|Tatum.William@mayo.edu|
21280058|NCT00548093|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21280059|NCT01411527|Rigshospitalet|Anders Juul|+45 3545 5085|Anders.Juul@regionh.dk|
21280060|NCT02359994|Artivion|Priya Patel|678-290-4358|priya.patel@artivion.com|
21280061|NCT04597632|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21280062|NCT01823835|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21280063|NCT00509795|Regeneron Pharmaceuticals|Clinical Trials Administrator||clinicaltrials@regeneron.com|
21280064|NCT01320150|Rush University Medical Center|Dr. Robert McCarthy|(312) 563-0448|Robert_J_McCarthy@rush.edu|
21280065|NCT04895982|BioNTech clinical trials patient information|BioNTech SE|+49 6131 90840|patients@biontech.de|
21280066|NCT00789997|The Ottawa Hospital Research Institute|Dr Shawn Aaron||saaron@ohri.ca|
21280067|NCT00919854|Janssen R&D US|Senior Director R&D|1 609 730-7548||
21280068|NCT02213289|University of Chicago|Daniel Catenacci, MD|2-1000|dcatenac@bsd.uchicago.edu|
21280069|NCT00985491|GI Dynamics, Inc.|Manager of Clinical Affairs|781.357.3261|pkeating@gidynamics.com|
21280070|NCT01893346|AstraZeneca Pharmaceuticals|Paul Newell, MBBS MRCP MFPM|+44 1625 515727|paul.newell@astrazeneca.com|
21280071|NCT02687529|QIAGEN Sciences|Clinical Study Coordinator|301-944-7094|andrew.schumacher@qiagen.com|
21280072|NCT00224289|Principal Investigator|Bruce Shields, MD|203-785-6288|bruce.shields@yale.edu|
21280073|NCT01734161|Weill Cornell Medicine|Klaus Kjaer, MD|(212) 746-2953|klk9001@med.cornell.edu|
21280074|NCT03736031|Texas Tech University Health Sciences Center at El Paso|Associate Director of Ob/Gyn Research|915-215-5103|elp-obgynresearch@ttuhsc.edu|
21280075|NCT05221320|Biomed Valley Discoveries|Deborah Knoerzer, Director Translational Sciences|6368876429|dknoerzer@biomed-valley.com|
21280076|NCT03184571|BerGenBio ASA|BerGenBio Clinical Team|+47 559 61 159|registry.postings@bergenbio.com|
21280077|NCT02514447|G1 Therapeutics, Inc.|Clinical Trial Info.|919-213-9835|clinicalinfo@g1therapeutics.com|
21280078|NCT03620708|Rutgers Robert Wood Johnson Medical School|Marc L. Steinberg, Ph.D.|732-235-4341|marc.steinberg@rutgers.edu|
21280079|NCT02498613|Yale School of Medicine|Joseph Kim, MD|(203) 200-4822|joseph.w.kim@yale.edu|
21280080|NCT05168202|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
21280081|NCT04483583|University of Florida|Dominick J Angiolillo|904-244-2636|dominick.angiolillo@jax.ufl.edu|
21280082|NCT04761926|Oticon Medical|Nicole Amichetti, PhD|6093660424|nitc@oticonmedical.com|
21280083|NCT06389396|Coloplast A/S|Julie Schnipper, Medical Writer|004549111257|dkjuls@coloplast.com|
21280084|NCT01013077|Southern California College of Optometry|William Ridder|714-449-7494|wridder@scco.edu|
21280085|NCT06195930|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21280086|NCT03631199|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
21280087|NCT03999996|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21280088|NCT03690388|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
21280089|NCT00001521|Clinical Center|Merke, Deborah|+1 301 496 0718|dmerke@nih.gov|
21280090|NCT00266630|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21280091|NCT03525886|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
21280092|NCT03284723|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21280093|NCT01499095|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21280094|NCT01130532|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21292901|NCT01404650|Sarah Cannon Research Institute|Johanna Bendell, MD|877-691-7274|asksarah@sarahcannon.com|
21292902|NCT01061385|ReShape Medical|Director of Clinical Operations|949-429-6680|lfong@reshapemedical.com|
21262061|NCT02267577|Rice 360: Institute for Global Health|Dr. Rebecca Richards-Kortum|713-348-3823|rkortum@rice.edu|
21262062|NCT00318708|Penn State Hershey College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu|
21262063|NCT00537823|Washington University School of Medicine|David Linehan, M.D.||David_Linehan@URMC.Rochester.edu|
21235606|NCT02015234|Tonix Pharmaceuticals|Gregory M. Sullivan, Chief Medical Officer|212 980 9155|greg.sullivan@tonixpharma.com|117
21262064|NCT02873221|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21262065|NCT01325493|Children's National Health System|Julia Finkel|2024764867|JFINKEL@childrensnational.org|
21262066|NCT02240628|The University of Texas Health Science Center at Houston|Dr. Samia Khalil|713-500-6242|Samia.N.Khalil@uth.tmc.edu|
21262067|NCT02732912|Oxford Brookes University|Dr Derick Wade|+447818452133|derick.wade@ntlworld.com|
21262068|NCT02285010|Mahidol University|Dr.Taniga Kiatchai|+66-2-419-7990|taniga@gmail.com|
21262069|NCT03511638|Bausch & Lomb|Study Director|510-259-5284|aloncaric@bauschhealth.com|
21262070|NCT01208181|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21262071|NCT01832961|Imperial College|Ada Clarice Gastaldi|55 020 7351 8051|ada@fmrp.usp.br|
21262072|NCT01096667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21262073|NCT01004107|Merz North America|Ashlee Duncan|984-222-6040|ashlee.duncan@merz.com|
21262074|NCT00394914|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21262075|NCT00044044|Sunovion|Josephine Cucchiaro, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
21262076|NCT04286867|Kent State University|William Lechner|8144501093|wlechner@kent.edu|
21262077|NCT02179398|Geneva University Hospital|Dr. Laurence Lacroix|+41223725082|laurence.lacroix@hcuge.ch|
21262078|NCT03896425|University of Minnesota|Rebecca Kazinka|612-626-6772|kazin003@umn.edu|
21262079|NCT03004846|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21262080|NCT00649961|Imperial College London|Dr Nazakat Merchant|00447825881907|nazakat.merchant@kcl.ac.uk|
21262081|NCT01787591|The Ohio State University|Richard S. Bruno, PhD, RD|614-292-1698|bruno.27@osu.edu|
21262082|NCT01435512|BVARI|Dr. Casey Taft|857-364-6261|casey.taft@va.gov|
21262083|NCT02489630|Virginia Tech SOM / Carilion Clinic (prior)|Dr Karen J Bowers, co-PI|678-591-7280|bowerskj@gmail.com|
21262084|NCT00815308|Shandong Cancer Hospital and Institute|Jinming Yu|86-531-87984729|jn7984729@public.jn.sd.cn|
21262085|NCT00377299|UT Southwestern Medical Center at Dallas|Dr. E. Sherwood Brown, M.D., Ph.D.|214-645-6950|sherwood.brown@utsouthwestern.edu|
21262086|NCT04799782|JOHN D DINGELL VA MEDICAL CENTER|Dr. Abdulghani Sankari Principal Investigator|13135761000|abdulghani.sankari@va.gov|63105
21262087|NCT04902950|Reading Hospital|Amir Behnam, MD|610-988-9127|amir.behnam@towerhealth.org|
21262088|NCT01589094|Memorial Sloan Kettering Cancer Center|Dean Bajorin, MD|646-888-4700|bajorind@mskcc.org|
21262089|NCT02975349|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21262090|NCT03551522|CymaBay Therapeutics, Inc.|Barry Crittenden, Vice President of Clinical Development|510-293-8800|medinfo@cymabay.com|
21262091|NCT00969618|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21280095|NCT02762929|Heron Therapeutics, Inc.|Clinical Operations|1-800-767-0524|cquaratino-baker@herontx.com|
21235607|NCT01752933|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
21235608|NCT01591681|Jaeb Center for Health Research|Roy W. Beck, M.D., Ph.D.|813-975-8690|jdrfapp2@jaeb.org|
21235609|NCT03062891|University of Notre Dame|Dan Denis|6178066484|ddenis@nd.edu|
21235610|NCT03678181|University of Pennsylvania|Dr. Jose Bauermeister|215-898-9993|bjose@upenn.edu|
21235611|NCT03509948|Achieve Life Sciences|Daniel Cain, Vice President, Clinical Research|425.686.1546|dcain@achievelifesciences.com|
21235612|NCT03221257|University of California, Los Angeles|Dr. Michael D. Roth|3102067389|mroth@mednet.ucla.edu|
21235613|NCT01331694|GlaxoSmithKline|GSK Response Center|866-435-7343||
21235614|NCT01129141|NCRAR, VA RR&D|James A. Henry, Ph.D.|503.220.8262|james.henry@va.gov|57466
21235615|NCT01334866|Medtronic, Inc.|Kristin Lawman|763-514-9809|kristin.j.lawman@medtronic.com|
21235616|NCT00495716|University of Washington Virology Research Clinic|Clinic Director|206-520-4340|vrc@uw.edu|
21235617|NCT03367312|Duke University School of Medicine|Dr. Sudarshan Rajagopal|919-684-6237|sudarshan.rajagopal@duke.edu|
21235618|NCT05267171|Universidad de Oviedo|Claudia Leirós Díaz|663571819|claudia_leiros@hotmail.com|
21235619|NCT02076412|Rigel|Anne-Marie Duliege, MD|6506241100|clinicaltrials@rigel.com|6506241100
21235620|NCT00958880|Southern Methodist University|Jasper Smits, Ph.D.|214-768-4310|jsmits@smu.edu|
21235621|NCT01971346|University of Michigan|Heather Chubb|734-936-6394|hdchubb@med.umich.edu|
21235622|NCT01122511|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21235623|NCT04187196|Atrium Health|Elijah Beaty, MD, MPH, FACC|704-403-6100|Elijah.Beaty@atriumhealth.org|
21235624|NCT01687166|Boston Scientific|Clinical Trial Manager|617-218-3849|weismanm@bsci.com|
21280096|NCT01383720|Boston Scientific Corporation|Director of Clinical Trials, Valves|408-370-1550||
21280097|NCT00077207|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|Resultsreportingcoordinator@childrensoncologygroup.org|
21280098|NCT02099786|VA RR&D National Center for Rehabilitative Auditory Research|Dr. Dawn Konrad-Martin|503-220-8262|dawn.martin@va.gov|52962
21280099|NCT03052751|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21280100|NCT06184399|Swiss Tropical and Public Health Institute|Prof Jennifer Keiser|+41 61 284 82 18|jennifer.keiser@swisstph.ch|
21280101|NCT01474200|Baxter Healthcare Corporation|Drew Jones, MD, Senior Medical Director|224-270-2659|drew_jones@baxter.com|
21280102|NCT05273411|University of British Columbia|Jonathan Little, PhD|2508079876|jonathan.little@ubc.ca|
21292903|NCT00533429|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21292904|NCT03800030|University of North Carolina at Chapel Hill|Justin Riddle, PhD|6617131602|justin_riddle@med.unc.edu|
21292905|NCT02379052|Regeneron Pharmaceuticals, Inc|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
21292906|NCT00127855|GlaxoSmithKline|GSK Response Center|866-435-7343||
21292907|NCT02343302|Johns Hopkins University|Director of Clinical Trials|410-955-7518|sleung7@jhu.edu|
21292908|NCT02592421|University of Texas Health San Antonio|Ralph DeFronzo|210-567-6691|defronzo@uthscsa.edu|
21292909|NCT02655887|Becton Dickinson (BPV)|Megan Hill|480-350-6468|Megan.Hill@bd.com|
21292910|NCT02834819|Children's Hospital Colorado/University of Colorado|Cortney Braund, MD|4406696880|Cortney.Braund@childrenscolorado.org|
21292911|NCT04245709|Duke University|Dwight Koeberl, MD,PhD|919-681-9919|dwight.koeberl@duke.edu|
21292912|NCT00598819|University of California, Irvine Medical Center|Dr. Jeffrey C. Milliken|714-456-3634|jcmillik@uci.edu|
21292913|NCT01339936|Optometric Technology Group|Dr Michel Guillon|+44 2072224224|mguillon@otg.co.uk|
21292914|NCT02251496|University of Iceland|Dr. Áróra Rós Ingadóttir|8461601|aroraros@landspitali.is|
21292915|NCT03542019|University of Jordan|Dr. Ahmad El-Ma'aita|+9626535 5000|a.maaita@ju.edu.jo|
21292916|NCT02041299|Chiesi Canada Corp.|Fernando Tricta, MD|1-416-558-6342|ftricta@chiesi.com|
21244653|NCT04095104|University of Colorado School of Medicine|Jaime Moore, MD MPH|303-724-8419|jaime.moore@cuanschutz.edu|
21292917|NCT02389465|University of Pennsylvania|Dr. Yvette Sheline, McLure Professor of Radiology, Neurology and Psychiatry|(215) 573-0082|sheline@pennmedicine.upenn.edu|
21292918|NCT01925768|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
21292919|NCT04339413|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21292920|NCT00869167|California Pacific Medical Center|Brandon Lu, M.D., M.S.|415-923-3421|lubs@sutterhealth.org|
21292921|NCT04684576|University of Washington Department of Rehabilitation Medicine|Dr. Heather Feldner, Study PI|2065433721|hfeldner@uw.edu|
21292922|NCT01361217|University of Washington|Nina Isoherranen|206-5432517|ni2@uw.edu|
21292923|NCT00087698|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21292924|NCT00361972|university of utah|kathryn peterson|8015817804|kathryn.peterson@hsc.utah.edu|
21292925|NCT01737762|Smith and Nephew|Dr Innes Cargill|817-302-3913|innes.cargill@smith-nephew.com|
21292926|NCT01964378|Grünenthal GmbH|Study Director|+49 241 569 3223|Clinical-Trials@grunenthal.com|
21292927|NCT03542266|Weill Cornell Medical College|Jia Ruan, MD, PhD|646-962-2064|jruan@med.cornell.edu|
21292928|NCT02272946|University of California, San Francisco|Priscilla Hsue, MD|628-206-5801|Priscilla.hsue@ucsf.edu|
21244654|NCT03547999|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
21244655|NCT05048186|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.havard.edu|
21244656|NCT02412748|Rush University College of Nursing|Dr. Wrenetha Julion, Professor|3129426272|Wrenetha_A_Julion@rush.edu|
21244657|NCT00976937|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21244658|NCT04218266|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21244659|NCT01637246|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21244660|NCT00761189|Clinical Research Team, Medical Affairs Korea|Senior Clinical Research Associate|82-2094-4804||
21244661|NCT01494922|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21244662|NCT00352976|Masonic Cancer Center, University of Minnesota|Margaret L. MacMillan, M.D.|612-626-2961|macmi002@umn.edu|
21244663|NCT01227265|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21244664|NCT02269475|CO RIA TA, R&D|Hideo Negi|+81 6 4803 3533|H.Negi@astrazeneca.com|4716
21244665|NCT01037985|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21244666|NCT01704196|National Institute on Drug Abuse|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov|
21244667|NCT02730871|Alcon, A Novartis Division|WW Brand Medical Director Ophtha, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com|
21244668|NCT05368558|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21292929|NCT03503396|University of Missouri|Dr. Denis McCarthy|573-882-0426|mccarthydm@missouri.edu|
21244669|NCT05928624|Columbia University|Giuseppe Cullaro, MD MAS|8454067438|gc2576@cumc.columbia.edu|
21244670|NCT01303445|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21244671|NCT04923347|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21244672|NCT02428192|DFCI|Dr. Suzanne George|617-632-5204|Suzanne_George@dfci.harvard.edu|
21244673|NCT03547908|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21244674|NCT04955717|USC|Dr. Jeffrey D. Klausner|415-876-8901|jdklausner@med.usc.edu|
21244675|NCT04059354|University of Wisconsin - Madison, Waisman Center|Houri K. Vorperian, PhD, Senior Scientist Emerita|608-213-3257|vorperian@waisman.wisc.edu|
21244676|NCT02396199|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
21244677|NCT02349412|Massachusetts General Hospital Cancer Center|Jennifer Temel, MD|(617) 724-0453|jtemel@partners.org|
21244678|NCT03611153|Mayo Clinic|Dr. Barry A. Borlaug|507-255-2200|borlaug.barry@mayo.edu|
21292930|NCT02012218|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21292931|NCT04417257|Laurent Pharmaceuticals Inc.|Vice president Clinical Development|514-941-2313|jmhoule@laurentpharma.com|
21244679|NCT00979576|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21244680|NCT04855760|Relmada Therapeutics|Marco Pappagallo, MD|786-638-7384|info@relmada.com|
21292932|NCT03870048|University of Iowa|Thorsten Rudroff|17205323701|thorsten-rudroff@uiowa.edu|
21292933|NCT00786422|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21292934|NCT03484429|Central Virginia Veterans Affairs Health Care System|Dr. Denise Lester|804-675-5000|denise.lester@va.gov|
21292935|NCT04466384|Medtronic|Ami Stuart PhD|8017934800|ami.stuart@medtronic.com|
21292936|NCT02881775|University of North Carolina at Chapel Hill|Deborah Givens, PhD|919-843-8660|deborah_givens@med.unc.edu|
21292937|NCT00714948|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org|
21292938|NCT03111316|University of Oklahoma Health Sciences Center|Director of Women's Health Research|4052718001|christy-zornes@ouhsc.edu|48137
21292939|NCT02752490|The University of Texas Health Science Center at Houston|Nana-Ama E Ankumah, MD|713-500-6421|Nana.Ama.E.Ankumah@uth.tmc.edu|
21292940|NCT02454530|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21292941|NCT00326001|Biotronik GmbH&Co. KG, Berlin, Germany|Dejan Danilovic|+49 9131 8924 7832|dejan.danilovic@biotronik.com|
21292942|NCT04267926|Department of Veterans Affairs MS Center of Excellence-West and Portland, Oregon Health & Science University|Vijayshree Yadav MBBS, MCR|503-494-3813|yadavv@ohsu.edu|
21292943|NCT03718325|University of Michigan|Dr. Scott Lempka|734-647-9052|NeuromodulationLab@med.umich.edu|
21292944|NCT04522167|Formycon AG|Public Register Contact|+49 89 864667 100|clinicaltrials@formycon.com|
21292945|NCT03137771|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
21292946|NCT00972023|Barbara Ann Karmanos Cancer Institute|Elaina Gartner|800-527-6266|egartner@seagen.com|
21292947|NCT04150913|Massachusetts General Hospital|Director, Cellular Immunotherapy Program|857-367-1486|mghcancercenter@partners.org|
21292948|NCT03052608|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21292949|NCT02220426|University of North Carolina at Chapel Hill|Rosa Tamara Branca, PhD|9199622229|rtbranca@unc.edu|
21292950|NCT02595879|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
21292951|NCT01396187|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21292952|NCT01898286|CBR International|Dr. Jeanne Novak|7207461190|jnovak@cbrintl.com|
21292953|NCT05554146|Montefiore Medical Center|Dr. Deepika Slawek|718-920-3786|dslawek@montefiore.org|
21292954|NCT00620373|Mayo Clinic|Dr. Deborah J. Rhodes|507-538-1703|rhodes.deborah@mayo.edu|
21292955|NCT01408277|Smith & Nephew Biotherapeutics|Jaime E Dickerson, Jr, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
21292956|NCT00118274|University of Virginia|Dr. Craig Slingluff|4349249311|cls8h@virginia.edu|
21292957|NCT01645735|Cerexa, Inc|Medical Monitor|(510) 285-9200||
21292958|NCT04701411|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21292959|NCT00705874|Progen Pharmaceuticals Pty Ltd|Director of Clinical Trials|+61 7 32739133|darrynb@progen-pharma.com|
21292960|NCT00041470|University of Washington|Julie Gralow, MD|206-288-2053|pink@u.washington.edu|
21292961|NCT00833443|UCLA|Keith Heinzerling MD|323-461-3106|kheinzerling@mednet.ucla.edu|
21292962|NCT03465722|Blueprint Medicines|Medical Information Call Center|1-888-258-7768|medinfo@blueprintmedicines.com|
21292963|NCT04581785|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
21292964|NCT02948582|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
21292965|NCT01107964|Milton S. Hershey Medical Center|Dr. David Liang|717-497-9469|dliang12@yahoo.com|
21292966|NCT01791491|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21292967|NCT04970069|Cleveland Clinic|Dr. Alparslan Turan|2162172312|turana@ccf.org|
21292968|NCT00955474|Massachusetts General Hospital|John D. Matthews, MD|6177249144|jdmatthews@partners.org|
21292969|NCT04342091|Yale University|Brett King|(203) 785-7421|Brett.King@yale.edu|
21292970|NCT02382991|OTTOBOCK FRANCE|Aurélie LACROIX|0033 (0)7 86 29 52 03|market.access@ottobock.fr|
21292971|NCT02568722|Unity Health Toronto|Dr. Ron Wald|(416) 867-3703|ron.wald@unityhealth.to|
21292972|NCT04792190|University of Rochester|Mehmet Aktas, MD|585-275-4775|mehmet_aktas@urmc.rochester.edu|
21244681|NCT03805594|University of California, San Francisco|Dr. Rahul Aggarwal, MD|(415) 353-7171|Rahul.Aggarwal@ucsf.edu|
21244682|NCT03424811|University of Pennsylvania|Tanja Kral|(215) 573-7512|tkral@nursing.upenn.edu|
21244683|NCT05931861|Laboratoires Théa|Clinical Affairs Director|0473981436|Corentin.LECAMUS@theapharma.com|
21244684|NCT03055377|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
21244685|NCT04788537|University of Pennsylvania|Edward S Brodkin, MD|1-215-746-0118|ebrodkin@pennmedicine.upenn.edu|
21244686|NCT03157167|Navidea Biopharmaceuticals|Michael Blue, MD|6145714313|mblue@navidea.com|
21292973|NCT02317692|Marquette University|Dr. Alyson Gerdes|414-288-6145|alyson.gerdes@mu.edu|
21292974|NCT04570384|Asklepion Pharmaceuticals, LLC|Gurdyal Kalsi, MD, MFPM (Hon)|+1 410.736.3750|gurdyal.kalsi@asklepionpharm.com|
21292975|NCT02573948|UMR 1058 (Inserm/University of Montpellier/EFS)|NAGOT NICOLAS|+33 4 34 35 91 09|n-nagot@chu-montpellier.fr|
21292976|NCT01876212|UPMC Hillman Cancer Center|Barbara Stadterman, MPH MCCR|412-647-5554|stadtermanbm@upmc.edu|
21292977|NCT04500457|Florida State University|Jesse Cougle|8506458729|cougle@psy.fsu.edu|
21292978|NCT03654274|Myovant Sciences GmbH|Clinical Trials at Myovant|+1 650 238 0250|clinicaltrials@myovant.com|
21292979|NCT01265992|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21292980|NCT01102491|Joint Reconstruction Center, Seoul National University Bundang Hospital|TK Kim|82-31-787-7196|osktk@snubh.org|
21292981|NCT01837680|Roosevelt Hospital, Mount Sinai Health System|Dr. Kimberly M. Herrera||kimmerher@gmail.com|
21244687|NCT04905407|Syros Pharmaceuticals|Tiffany Crowell|617-674-9069|info@syros.com|
21244688|NCT04899115|University of Michigan|Patricia Bloom, MD|734-647-5944|ppbloom@med.umich.edu|
21244689|NCT03263026|DeNovo Biopharma|Gracielli Hage-Kautz, Associate Director Clinical Operations|858-799-1021|gkautz@denovobiopharma.com|746
21292982|NCT05005273|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@BMS.com|
21292983|NCT03265145|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21292984|NCT04409834|Brigham and Women's Hospital|COVID-PACT Project Manager|(617) 278-0145|covid-pact@bwh.harvard.edu|
21292985|NCT02137070|University of Florida|Dr. Ronald Cohen|352-273-6124|roncohen@ufl.edu|
21292986|NCT02151786|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21292987|NCT02043145|Allergan, Inc|Vice President GSE,|714-246-4500|clinicaltrials@allergan.com|
21292988|NCT02112656|Imunon, Inc.|Chief Medical Officer|(609) 896-9100|clinical@imunon.com|
21292989|NCT03761056|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
21292990|NCT02161536|Motus GI Medical Technologies Ltd.|Ravit Peled -Director of Clinical Trial|+972 526145354|ravit@motusgi.com|
21292991|NCT03670160|University of Tennessee Medical Center|Janet Parkey, Director - Research Compliance|865-305-6194|jparkey@utmck.edu|
21292992|NCT01365455|Novartis Pharmaceuticals|Study Director|862-778-8300||
21292993|NCT03965403|Spaulding Rehabilitation Hospital|Paolo Bonato, PhD|6179526319|pbonato@partners.org|
21292994|NCT03300206|Hologic|Hologic Clinical Research Team|508.263.2900|ClinicalResearch@Hologic.com|
21292995|NCT01897727|University of Alabama at Birmingham|Dr. Eric Judd|205 934-9281|ejudd@uab.edu|
21292996|NCT04312932|Nationwide Children's Hospital|Sarah Keim|614-722-2000|sarah.keim@nationwidechildrens.org|
21292997|NCT01683630|Unversity of Manotiba|Salah Mahmud|204-272-3139|salah.mahmud@umanitoba.ca|
21292998|NCT01273038|Coloplast A/S|Director of Medical Affairs|4549111111|dkbir@coloplast.com|
21292999|NCT02197572|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21293000|NCT01306643|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21293001|NCT01465386|FHCRC|Elihu Estey, MD|206-288-7176|eestey@seattlecca.org|
21293002|NCT02656836|Queen's University Belfast|Augusto Azuara-Blanco|2890976350|a.azuara-blanco@qub.ac.uk|
21293003|NCT02746406|Laborie|Clinical Researcher|9056121170|sbitzos@laborie.com|1755
21293004|NCT02479880|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21293005|NCT01279044|San Francisco Department of Public Health|Dr. Phillip Coffin, Director of Substance Abuse Research Unit|(415) 437 6282|phillip.coffin@sfdph.org|
21293006|NCT02975804|The Hong Kong Polytechnic University|Dr tamis W Pin|85227666751|tamis.pin@polyu.edu.hk|
21293007|NCT02840253|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|Joseph.Tobias@nationwidechildrens.org|
21293008|NCT03346083|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
21244690|NCT04868110|University of Kansas Medical Center|Dr. Holly Hull|9135881000|hhull@kumc.edu|
21244691|NCT05485922|Coloplast, Clinical strategies|Medical Writer|+4549112057|dkmhla@coloplast.com|
21244692|NCT03564600|University of Pittsburgh School of Medicine|Professor Debra K. Weiner, M.D.|4124016811|dweiner@pitt.edu|
21244693|NCT06190678|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
21244694|NCT04178733|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21244695|NCT05126862|University of Virginia School of Nursing|Jessie Gibson, PhD, RN|434-924-0107|js6zn@virginia.edu|
21244696|NCT03655132|VA Bedford Healthcare System|Dr. Erin D. Reilly|781-724-4191|Erin.Reilly@va.gov|
21244697|NCT04119284|Nemours Hospital for Children|Suken Shah, MD, Orthopedics Department Chair|3025472557|suken.shah@nemours.org|
21244698|NCT02651324|Albany medical center|Farzana Afroze|518-262-4300|afrozef@amc.edu|
21244699|NCT05919082|LEO Pharma|Clinical Disclosure|+45 44945888|disclosure@leo-pharma.com|
21244700|NCT02287311|Baylor College of Medicine|Dr. Rayne Rouce|832-824-4647|rouce@bcm.edu|
21244701|NCT03737058|Stanford University School of Medicine|Manali I Patel, MD MPH MS|650-723-4000|manalip@stanford.edu|
21244702|NCT05535257|Mayo Clinic Florida|Suzanne Langley OTR/L|9044724288|langley.suzanne@mayo.edu|
21244703|NCT05653856|Curium|Darcy Denner|314-506-3511|Solar@curiumpharma.com|
21244704|NCT05415410|VectivBio AG|Clinical Trial Information Desk|617.621.7722|ClinicalTrialEnquiries@ironwoodpharma.com|
21244705|NCT02365766|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
21244706|NCT05166811|University of Utah|Dr. Michael D. Johnson|(801) 935-0503|mike.johnson@hsc.utah.edu|
21244707|NCT04058626|Imperial College London/ Imperial College Healthcare NHS Trust|Mr Pasha Normahani|020 3312 6666|p.normahani@imperial.ac.uk|switch
21244708|NCT05272852|BostonScientific|Karin Froidcourt|+0032471636566|Karin.Froidcourt@bsci.com|
21244709|NCT02991534|VA Greater Los Angeles Healthcare System|Dr. Bevanne Bean-Mayberry|818-891-7711|bevanne.bean-mayberry@va.gov|36009
21244710|NCT04791709|University of Miami|Dr. Daniel Jimenez|305-243-2776|dej18@miami.edu|
21244711|NCT02724956|UT MD Anderson Cancer Center|Carin Hagberg, MD/Chief Academic Officer, CAO Office|713-792-5888|chagberg@mdanderson.org|
21244712|NCT00650104|GlaxoSmithKline|GSK Response Center|866-435-7343||
21244713|NCT03385629|Case Western Reserve University|Dr. Suchitra Nelson|216-368-3469|suchitra.nelson@case.edu|
21244714|NCT01532388|Karolinska Institutet|Dr Kristina Sinadinovic|+46812345735|kristina.sinadinovic@socialstyrelsen.se|
21244715|NCT01549899|University of Arizona|Daniel J. Taylor, Ph.D.|5206219289|danieljtaylor@arizona.edu|
21244716|NCT02697136|Abionyx Pharma|Constance Peyrottes|+33673045380|cpeyrottes@abionyx.com|
21244717|NCT03578536|Minneapolis VA Health Care System|Andrew Hansen, PhD|612-467-2910|Andrew.Hansen2@va.gov|
21244718|NCT02538900|Northwestern University|Mary McDermott MD|312-503-6419|mdm608@northwestern.edu|
21244719|NCT00999167|Horizon Therapeutics, Inc.|Julia Egofske||clinicaltrials@horizonpharma.com|
21244720|NCT02789020|University of Florida|David Vaillancourt|3522941770|vcourt@ufl.edu|
21244721|NCT04238247|Ann & Robert H. Lurie Children's Hospital of Chicago|Dr. Michelle Macy|312-227-6676|mmacy@luriechildrens.org|
21293009|NCT03801928|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21293010|NCT03688919|University of Michigan School of Public Health|Professor Alison Miller|7346157459|alimill@umich.edu|
21244722|NCT05512962|Oxular Limited|Friedrich Asmus, MD|'+1 631 292 1207|friedrich.asmus@oxular.com|
21244723|NCT04950127|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21293011|NCT00564733|University of Washington|Keith D. Eaton, MD, PhD|2062886249|kdeaton@uw.edu|
21293012|NCT02621476|Kaiser Permanente Northern California|Julie Schmittdiel, PhD, MA|5108913872|Julie.A.Schmittdiel@kp.org|
21293013|NCT01484496|GlaxoSmithKline|GSK Response Center|866-435-7343||
21293014|NCT01456130|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21293015|NCT02661997|VA Boston Healthcare System|Barbara L. Niles, Ph.D.|857-364-4128|barbara.niles@va.gov|
21293016|NCT03369665|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21293017|NCT02168101|Sarah Cannon Development Innovations, LLC|Sarah Cannon|844-710-6157|CANNDLClinicalScience@HCAHealthcare.com|
21293018|NCT02933879|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
21293019|NCT01135459|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21293020|NCT01531582|University of South Florida, Morsani College of Medicine|Edwin J. Weeber, Ph.D.|(813) 396-9995|eweeber@health.usf.edu|
21293021|NCT02236572|Yale Cancer Center|Lajos Pusztai, MD, DPhil|(203) 200-2328|lajos.pusztai@yale.edu|
21293022|NCT01057693|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21293023|NCT02959463|The University of Texas MD Anderson Cancer Center|Matthew Stephen Ning, MD, MPH|(832) 710-8779|msning@mdanderson.org|
21293024|NCT02413996|IRCCS Istituto Ortopedico Galeazzi, Milano|Davide Tornese|0266214046|davidzai@tin.it|
21293025|NCT00709319|Jaeb Center for Health Research|Adam R. Glassman, Director DRCR.net Coordinating Center|813-975-8690|drcrstat3@jaeb.org|
21293026|NCT03889028|Clinical University Hospital of Valencia|David Navarro|+34961973500|david.navarro@uv.es|
21293027|NCT00579553|University of Oklahoma Health Science Center|Andrew Elimian, MD|19146465194|aelimian@aol.com|
21293028|NCT01672879|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21293029|NCT04860869|University of Texas Medical Branch|Randall Urban|409-772-5476|rurban@utmb.edu|
21293030|NCT05069649|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
21293031|NCT02651116|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21293032|NCT01775553|Icahn School of Medicine at Mount Sinai|Dr. Ajai Chari|212-241-7873|ajai.chari@mountsinai.org|
21293033|NCT00515528|Department of Medicine|Thomas F. Gajewski|773-702-4601|tgajewsk@medicine.bsd.uchicago.edu|
21293034|NCT04834726|University of Pennsylvania|Dr. Shivan Mehta|215-898-6027|shivan.mehta@pennmedicine.upenn.edu|
21293035|NCT03810014|Duke University|Wendy P O'Meara, PhD|919-681-7711|wpo@duke.edu|
21293036|NCT02213068|Northwestern University|Lorenzo Gallon, MD|312-695-4457|l-gallon@northwestern.edu|
21293037|NCT03606486|University of Washington|Dr. Barbara Norquist|206-543-3669|bnorquis@uw.edu|
21293038|NCT00958477|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21293039|NCT00730353|Hoosier Oncology Group|Nasser Hanna, M.D.|317-274-3515|nhanna@iupui.edu|
21293040|NCT00442416|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21293041|NCT03205358|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21293042|NCT00633087|Rutgers Cancer Institute of New Jersey|Dr. Robert DiPaola, MD|732-235-8675|dipaolrs@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
21293043|NCT03579693|University of Washington|Bryan Kestenbaum, MD|206-685-7343|brk@uw.edu|
21293044|NCT02148263|The University of Alabama at Birmingham|Dr. Andrew Pucker|920-579-2900|apucker@uab.edu|
21244724|NCT01711632|Memorial Sloan Kettering Cancer Center|Dr. Jae Park, MD|646-608-3743|parkj6@mskcc.org|
21244725|NCT04315181|University of Kentucky|Director for the Center on Drug and Alcohol Research|859-257-6485|Sharon.Walsh@uky.edu|
21244726|NCT01948661|E.O. Ospedali Galliera|Andrea DeCensi|010563|andrea.decensi@galliera.it|4501
21244727|NCT03517969|Dana Farber Cancer Institute|Dr. Atish D Choudhury|617-6326328|atish_choudhury@dfci.harvard.edu|
21244728|NCT03811535|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21244729|NCT00522951|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21244730|NCT02713126|Mayo Clinic|Dr. Barry Borlaug|507-255-1051|borlaug.barry@mayo.edu|
21244731|NCT02371395|CDC|Alexandre Macedo de Oliveira|404 718 4751|acq7@cdc.gov|
21244732|NCT01101451|NRG Oncology|Helen Huang on behalf of Wei Deng Ph.D.|7168452318|huangh@nrgoncology.org|
21244733|NCT05480943|VA Sierra Nevada Healthcare System|Elisabeth Mates, MD,PhD, Principal investigator|775-786-7200|Elisabeth.Mates@va.gov|5273
21244734|NCT02272816|Centre for Experimental Cancer Medicine, Barts Cancer Institute, QMUL|Project Lead|02078828277|bci-carpet@qmul.ac.uk|
21244735|NCT04999592|MaineHealth Maine Medical Center - Portland|David J. Gagnon, PharmD - Principal Investigator|207-662-0111|dgagnon@mmc.org|
21244736|NCT03638427|Stanford University|Paul Blumenthal, MD|(650) 725-6035|gynresearch@stanford.edu|
21244737|NCT04924062|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21244738|NCT03535727|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dung Le, M.D.|443-287-0002|Dle@jhmi.edu|
21244739|NCT04823611|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21244740|NCT05320432|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
21244741|NCT05038566|Liberating Technologies, Inc.|Dr. Todd Farrell|774-233-0873|todd.farrell@liberatingtech.com|
21244742|NCT05535062|Neuronetics|Neha Goyal|763-528-1599|neha.goyal@neurostar.com|
21244743|NCT03285321|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
21244744|NCT03739996|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|ACTG Network Coordinating Cent|ACTGCT.gov@fstrf.org|
21244745|NCT05141903|Prolacta Bioscience|Dr. David Rechtman VP, Medical Affairs|8887765228|drechtman@prolacta.com|
21235625|NCT02755831|Naval Medical Center San Diego|CAPTAIN Dennis Spence, NC, USN, PhD, CRNA|6199161680|dennis.l.spence.mil@mail.mil|
21235626|NCT02296112|Vanderbilt University Medical Center|Douglas Johnson, MD|(615) 936-8422|douglas.b.johnson@vumc.org|
21235627|NCT00298831|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21235628|NCT01516879|Amgen Inc.|Study Director|866-572-6436||
21280103|NCT00524420|University of Washington|David H. Avery, MD, Professor|206-744-4527|averydh@u.washington.edu|
21235629|NCT01720069|Vectura Limited|Gary Burgess, MD|+44(0)1249 667700|clinical.enquiries@vectura.com|
21235630|NCT04568122|Stanford University BioEngineering|Manu Prakash, PhD|(650) 725-3731|manup@stanford.edu|
21235631|NCT01613339|Orebro county council|Dr. Anette Forsberg|+46-19-602 5788|anette.forsberg@orebroll.se|
21235632|NCT01228929|University of Rochester|Dr. James V. Aquavella|585-275-8944|james_aquavella@urmc.rochester.edu|
21235633|NCT03837496|Massachusetts General Hospital|Jamie Jacobs, PhD|617-643-1777|jjacobs@mgh.harvard.edu|
21235634|NCT03136068|UCSF|Director of Clinical Trials|414-206-8715|abby.sokoloff@ucsf.edu|
21235635|NCT03047447|Bristlecone Health, Inc,|Dr. Kelly Gibas, Director or Clinical Trials|(763) 424-2474|kgibas@bristleconefitness.com|
21235636|NCT00432380|GlaxoSmithKline|GSK Response Center|866-435-7343||
21235637|NCT00734305|Merrimack Pharmaceuticals, Inc.|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
21262092|NCT05136885|Healey Center for ALS at Massachusetts General Hospital|Healey Center for ALS Project Management|833-425-8257|healeyalsplatform@mgh.harvard.edu|(HALT ALS)
21262093|NCT00907738|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21262094|NCT05363293|Alzamend Inc.|Eve Del Rio, MD, PhD|9736993847|Eve@RioPharma.com|
21262095|NCT04773041|HealthPartners Institute|Bhavani Kashyap, MBBS, PhD|651-495-6363|bhavani.x.kashyap@healthpartners.com|
21262096|NCT03270085|Mayo Clinic|Michael Camilleri, MD|507-266-2305|camilleri.michael@mayo.edu|
21262097|NCT03825042|A.Menarini Industrie Farmaceutiche Riunite Srl|Director of Clinical Operations|0039 055 5680459|pfabrizzi@menarini.it|
21262098|NCT02316470|Valneva Austria GmbH|Manager Clinical Research|+43120620|info@valneva.com|0
21262099|NCT00733512|Alcon Research, Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21262100|NCT05085392|Montana State University|Dr. Lauren Davis|8287736328|laure.davis6@montana.edu|
21280104|NCT00577863|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21280105|NCT00897910|Barbara Ann Karmanos Cancer Institute|Zaid S. Al-Kadhimi, M.D.|313-576-8022|alkadhiz@karmanos.org|
21280106|NCT03127514|Amylyx Pharmaceuticals|Amylyx Pharmaceuticals, Head of Clinical R&D|(617) 682-0917|medinfo@amylyx.com|
21280107|NCT02543944|University of Arkansas for Medical Sciences|Dr. Alison H. Oliveto, PhD|501-526-8441|olivetoalison@uams.edu|
21280108|NCT02665221|MS Comprehensive Care Center NYU Langone Health|Shannon Haas|646 501 7504|Shannon.Haas@nyumc.org|
21280109|NCT03639779|University of Central Florida College of Medicine|Dr. David Weinstein|(407)266-4900|david.weinstein@ucf.edu|
21280110|NCT00645970|James A. Haley Veterans' Hospital|Kristin Phillips|813-972-2000|kristin.phillips3@va.gov|6721
21280111|NCT02932462|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
21280112|NCT02413229|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
21280113|NCT04584684|University of North Carolina at Chapel Hill|Laura Jacox, DMD, PhD, MS|847-702-0988|ljacox@live.unc.edu|
21280114|NCT02955212|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21280115|NCT02009722|Mayo Clinic|Dr. Hans Sviggum|507-581-6083|sviggum.hans@mayo.edu|
21280116|NCT02454933|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
21280117|NCT04362670|Ocular Therapeutix|Clinical Project Manager|781-357-4000|clinicalaffairs@ocutx.com|
21280118|NCT02071225|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21280119|NCT05027308|Takeda|Study Director|1-877-825-3327|TrialDisclosures@takeda.com|
21280120|NCT03044028|Cleveland Clinic|Carlos Higuera|954-659-5430|higuerc@ccf.org|
21280121|NCT01275846|Detroit Medical Center, Detroit, MI|Ileana L. Piña, MD, MPH, FAHA, FACC|216-225-7385|ilppina@aol.com|
21280122|NCT02232984|Boston Scientific|Eszter Pais|6515825307|eszter.pais@bsci.com|
21280123|NCT01472692|UCSD|Department of Medicine|(858) 552-8585||
21280124|NCT00769379|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
21280125|NCT05534061|University of Oregon|Anne Marie Mauricio, PhD|602-920-7459|amariem@uoregon.edu|
21280126|NCT01412086|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21280127|NCT01027598|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21280128|NCT04347993|Hackensack Meridian Health|Joshua Zenreich|5519965900|joshua.zenreich@hmhn.org|
21280129|NCT03762239|Barcelona Institute for Global Health (ISGlobal)|Dr. Xavier Basagaña|(+34) 93 214 7306|xavier.basagana@isglobal.org|
21280130|NCT00535405|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21235638|NCT01071395|Rush University of Medical Center|Dr. Christopher G. Goetz|312-942-8016|cgoetz@rush.edu|
21235639|NCT02805257|University of California, San Francisco|Ying Han, MD, PhD|415-476-3321|ying.han@ucsf.edu|
21262101|NCT01158534|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Brian Rini|216-444-9567|rinib2@ccf.org|
21235640|NCT00612066|University of California, Los Angeles|Anthony Heaney, M.D. Ph.D|310 267 4980|aheaney@mednet.ucla.edu|
21235641|NCT01946711|Pari Pharma|Friedrich gruber|+4989742846|friedrich.gruber@pari.com|76
21235642|NCT02669329|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
21235643|NCT01043874|Novartis Pharmaceuticals|Study Director|862-778-8300||
21235644|NCT03422003|Dana-Farber Cancer Institute|Dr. Rinaa Punglia|617-632-3591|rpunglia@mgb.org|
21235645|NCT01337089|GW Pharmaceuticals Ltd.|Medical Enquiries||medinfo.USA@gwpharm.com|
21244746|NCT02278562|VA TN Valley Healthcare System|Alp Ikizler MD|615-322-5000|alp.ikizler@vanderbilt.edu|
21244747|NCT05387447|University of Nebraska Medical Center|Marcia Shade|402-559-6641|marcia.shade@unmc.edu|
21244748|NCT01974245|Federal University of São Paulo|Dr. Lilian Cuppari|+551159048499|lcuppari@uol.com.br|
21244749|NCT03854578|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21244750|NCT05461131|ILiAD Biotechnologies|Chief Medical Officer|800-603-3525|contact@iliadbiotech.com|
21244751|NCT06320964|University of California, San Francisco|Nadia Diamond-Smith, PhD, MS|(415) 502-5800|nadia.diamond-smith@ucsf.edu|
21244752|NCT04469036|UC Davis Health|Raynald Dizon|9167344736|rodizon@ucdavis.edu|
21244753|NCT03606642|HonorHealth Research Institute|Joanne Saczynski, MSN, RN, ACRP-CP|480-323-1046|jsaczynski@honorhealth.com|
21244754|NCT05106257|Rush University Medical Center|Amanda R. Mathew, PhD|(312 563-1273|amanda_mathew@rush.edu|
21244755|NCT05054374|Memorial Sloan Kettering Cancer Center|Dr. Ezra Rosen, MD, PhD|646-888-6955|rosene1@mskcc.org|
21244756|NCT05691309|Children's Hospital of Philadelphia|Dr. Kevin Downes|215-590-4024|downeskj@chop.edu|
21244757|NCT01707030|Department of Veterans Affairs|Dr. Micheal Cucciare|501-257-1068|Michael.Cucciare@va.gov|
21244758|NCT04301778|Sidney Kimmel Cancer Center at Johns Hopkins|Lei Zheng, MD PhD|646-239-3110|Lzheng6@jhmi.edu|
21244759|NCT04437433|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21244760|NCT00792636|GlaxoSmithKline|GSK Response Center|866-435-7343||
21244761|NCT05873751|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21244762|NCT06064916|Berkeley Eye Center|Tetiana Huff|713-620-7640|tetiana.huff@berkeleyeye.com|
21244763|NCT04711135|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
21244764|NCT03295734|UAB|Thomas W. Buford, PhD|205-996-3008|twbuford@gmail.com|
21244765|NCT03926819|Hillhurst Bio|President and CEO|858 232 9495|admin@hillhurstbio.com|
21244766|NCT04431726|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21244767|NCT04004325|FORMA Therapeutics, Inc.|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21244768|NCT01691079|University of California, San Francisco|Mona Luke-Zeitoun, MD||lukezeitounm@peds.ucsf.edu|
21244769|NCT02860130|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
21244770|NCT00100698|Massachusetts General Hospital|Janet Lo|617-724-9109|jlo@partners.org|
21244771|NCT02140645|Boehringer Ingelheim (BI)|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21244772|NCT02794480|GlaxoSmithKline|GSK Response Center|866-435-7343||
21244773|NCT00593489|Lawson Research Institute|Dr. Stewart Harris|519 858-5028|sharris1@uwo.ca|
21244774|NCT01256840|UCLA Department of Psychology|Dr. A. Janet Tomiyama|3102066875|tomiyama@psych.ucla.edu|
21244775|NCT01747486|Abramson Cancer Center of the University of Pennsylvania|Noelle Frey, MD|215-662-6901|noelle.frey@uphs.upenn.edu|
21244776|NCT00632749|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21244777|NCT00611559|GlaxoSmithKline|GSK Response Center|866-435-7343||
21244778|NCT00879333|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21244779|NCT03069313|Cleveland Clinic Florida|Zeina Nahleh, MD (previoulsy PI at Texas Tech university HSC-EP)|9546595840|nahlehz@ccf.org|
21244780|NCT02467166|University of California, San Diego Health System|Gregory K. Feld, MD, Director CCEP|(858) 246-2972|gfeld@health.ucsd.edu|
21244781|NCT01011946|University of Chicago|Dr. Daniel Appelbaum|(773) 834-2012|dappelbaum@radiology.bsd.uchicago.edu|
21244782|NCT02057939|Duke University|Andrew Armstrong, MD ScM|919-668-4615|andrew.armstrong@duke.edu|
21244783|NCT01872078|AstraZeneca Pharmaceuticals LP|Martin L. Scott, MD/PhD|781-472-5130|martin.scott@astrazeneca.com|
21244784|NCT02910713|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21244785|NCT03859869|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21244786|NCT04442126|Numab Therapeutics AG|Josephine Adams|00447712295851|j.adams@numab.com|
21244787|NCT06450405|University of California, San Diego|Antoni Duleba|858-657-7000|aduleba@health.ucsd.edu|
21244788|NCT03767517|University of Alabama at Birmingham|Dr. Ronit Elk|205-996-1702|relk@uabmc.edu|
21244789|NCT06377358|University of Malaga|José Rioja Villodres|(+34) 952 137 278|jose.rioja@uma.es|
21244790|NCT03152786|Wake Forest School of Medicine|Ashok Hemal, MD|336-716-5694|ahemal@wakehealth.edu|
21262102|NCT02435173|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21262103|NCT02392208|University of Michigan|Dr. Bruce A. Mueller|734-763-6629|muellerb@med.umich.edu|
21262104|NCT01666444|Vice President, Clinical Affairs|Kristi Manjarrez|206-689-2256|kmanjarrez@ventirx.com|
21262105|NCT00950690|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21262106|NCT01713036|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21262107|NCT00092547|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21262108|NCT01166659|Transcend Medical, Inc.|Vice President of Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
21262109|NCT02657252|UPECLIN|Dr. Matheus Bertanha|+551438116305|matheus.fameca@ig.com.br|
21262110|NCT02901262|UNIMIB, ASST-MONZA San Gerardo Hospital|Prof. Giuseppe Citerio|0039 039 233 4316|giuseppe.citerio@unimib.it|
21262111|NCT00634543|Janssen Korea / 25F, LS Yongsan Tower, 191 Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702 Korea|Clinical Research Director|82-2-2094-4518||
21262112|NCT04315363|Northeastern University|Meishan Ai|858-265-7288|ai.me@northeastern.edu|
21262113|NCT03515538|EpicentRx, Inc|Bryan Oronsky|858-229-1062|mstirn@epicentrx.com|
21244791|NCT05338086|mAbxience Research S.L.|Susana Millan , PhD|(+34) 917.711.500|Susana.Millan@mabxience.com|
21244792|NCT04112316|University of Pennsylvania|Theresa M Scattergood, MSN|215-898-5664|theresa.scattergood@pennmedicine.upenn.edu|
21262114|NCT03323307|Duke University|Dr. Adam Wax|919-660-5143|a.wax@duke.edu|
21293045|NCT00503425|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21293046|NCT00003869|Mayo Clinic|Dr. Edith A. Perez||perez.edith@mayo.edu|
21244793|NCT03217565|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21244794|NCT06066541|Brigham and Women's Hospital|Niteesh Choudhry, MD, PhD|617-278-0930|nkchoudhry@bwh.harvard.edu|
21244795|NCT04533022|Vicore Pharma AB|Chief medical officer Bertil Lindmark|+46 707661505|info@vicorepharma.com|
21244796|NCT02163447|UCSF|Dr. Grant Dorsey|415-206-4680|grant.dorsey@ucsf.edu|
21244797|NCT01939275|City of Hope|Paul Frankel, Ph.D.|626-812-5265|pfrankel@coh.org|
21244798|NCT03697070|Division of Infectious Diseases, University of California Irvine School of Medicine|Dr. Shruti Gohil, MD, MPH|(714) 456-7890|skgohil@hs.uci.edu|
21244799|NCT05161715|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
21244800|NCT04690673|Helsinki and Uusimaa Hospital District, Pain clinic|Dr Johanna Kujala|+358400780411|johanna.kujala@helsinki.fi|
21244801|NCT05194969|University of North Carolina at Chapel Hill|Christopher J. Sayed, MD|984-974-3900|christopher_sayed@med.unc.edu|
21244802|NCT05996744|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21244803|NCT04850807|Brown University|Ellen McCreedy, PhD|401-863-7345|Ellen_McCreedy@brown.edu|
21244804|NCT04272619|Fox Chase Cancer Center|Kristen Sorice|215-214-1433|kristen.sorice@fccc.edu|
21244805|NCT03636503|Dana-Farber Cancer Institute|Caron Jacobson, MD|617-632-6404|caron_jacobson@dfci.harvard.edu|
21244806|NCT05439603|Ancora Bio, Inc dba EmbarkNeuro|Chief Medical Officer|610 871-4891|info@embarkneuro.com|
21244807|NCT03896516|National Institute on Drug Abuse (NIDA)|Dr Lorenzo Leggio, M.D., Ph.D.|1-667-312-5188|lorenzo.leggio@nih.gov|
21244808|NCT05783219|University of Louisville Medical Center|Rodger Rothenberger|(502) 588-7660|Rodger.rothenberger@louisville.edu|
21244809|NCT03739450|UT Southwestern Medical Center|Dr. Shannon Juengst|8328480674|Shannon.Juengst@UTSouthwestern.edu|
21244810|NCT03984695|KUMCRI|Jaime Caldwell|913-588-1261|spa@kumc.edu|
21244811|NCT04549168|Eisai Co., Ltd.|Eisai Inquiry Service|none|eisai-chiken_hotline@hhc.eisai.co.jp|
21244812|NCT05519228|ZimmerBio|Andrea Singer|(0)79 318 06 55|andrea.singer@zimmerbiomet.com|+41
21244813|NCT05849051|UNC Lineberger Comprehensive Cancer Center|Adam O Goldstein|919-270-6491|AOG@med.unc.edu|
21244814|NCT02323321|TransMedics Inc.|Laura Damme|9785520900|ldamme@transmedics.com|
21244815|NCT04281485|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21244816|NCT02926911|Duke university|Dr. Shelley Hwang|919-668-6688|shelley.hwang@duke.edu|
21244817|NCT04093752|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21244818|NCT01084707|J&J Consumer and Personal Products Worldwide|Joyce Hauze, Sr. Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
21244819|NCT00901901|BAYER|Therapeutic Area Head|(+)1-888-84-22937|clinical-trials-contact@bayer.com|
21244820|NCT00951379|University of Texas (UT) MD Anderson Cancer Center|University of Texas MD Anderson Phase I/II Prevention Consortium||CR_Study_Registration@mdanderson.org|
21244821|NCT02742519|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21244822|NCT00620698|Beth Israel Deaconess Medical Center|Seward Rutkove|617-667-8130|srutkove@bidmc.harvard.edu|
21244823|NCT03432858|WellSpan Health|Clinical Research Associate|(717) 851-7634|cbush@wellspan.org|
21244824|NCT03169894|Avalo Therapeutics, Inc.|Garry Neil, MD|908-720-2691|gneil@avalotx.com|
21244825|NCT03580369|Novartis Pharmaceuticals|Study Director|1 (862) 778-8300|novartis.email@novartis.com|
21244826|NCT03912831|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
21244827|NCT03527160|Cincinnati Children's Hospital Medical Center|Dr. Stuart Goldstein|513-636-2209|stuart.goldstein@cchmc.org|
21244828|NCT00766649|National Eye Institute|Wai T. Wong|(301) 905-7301|wongw@nei.nih.gov|
21244829|NCT01721291|Imperial College London|Dr Omar Usmani|+440(0) 207351 8051|o.usmani@imperial.ac.uk|
21244830|NCT01091168|INSTITUT DE RECHERCHE PIERRE FABRE|Dr Karim Keddad|+33 5 34 50 61 69|karim.keddad@pierre-fabre.com|
21244831|NCT03242148|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0123|CPAP.trial@fphcare.co.nz|7044
21244832|NCT04430634|Nerudia|Paul Morris|+44 7508 708 917|paul.morris@nerudia.com|
21244833|NCT04623775|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
21244834|NCT05511467|Medical University of South Carolina|Principal Investigator|(843) 792-3435|heisek@musc.edu|
21244835|NCT03978637|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21244836|NCT01959698|Roswell Park Comprehensive Cancer Center|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
21244837|NCT04455035|The University of Texas Health Science Center at Houston|Brett Chiquet, DDS, PhD, Associate Professor|7135008220|Brett.T.Chiquet@uth.tmc.edu|
21244838|NCT05415436|The University of Toledo Medical Center|Kristi Baker BSN, RN|4193836223|kristi.baker@utoledo.edu|
21244839|NCT04030130|Medical University of South Carolina|Evan Graboyes, MD, MPH|843-792-0719|graboyes@musc.edu|
21244840|NCT04505774|University of Pittsburgh|Dr. Stephen Wisniewski|412-383-4696|stevewis@pitt.edu|
21244841|NCT05386355|University of Arkansas for Medical Sciences|Songthip Ounpraseuth|501-686-7233|stounpraseuth@uams.edu|
21244842|NCT02643667|Washington University School of Medicine|Dr. Russell K. Pachynski|314-286-2341|rkpachynski@wustl.edu|
21244843|NCT03775109|Imperial College, London|Professor Mark Thursz|+44 (0) 203 3126454|m.thursz@imperial.ac.uk|
21244844|NCT04712994|University of Washington|Anjuli Wagner|9784602331|anjuliw@uw.edu|
21244845|NCT03484702|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21244846|NCT04286282|University of Minnesota|Sarah Lofgren|612-624-9996|Lofg0020@umn.edu|
21293047|NCT03364231|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
21293048|NCT00585637|Dana-Farber Cancer Institute|Kimmie Ng, MD, MPH|617-632-4150|Kimmie_Ng@dfci.harvard.edu|
21244847|NCT01226979|SKCCC at Johns Hopkinis|Amol Narang, MD|(410) 955-7390|anarang2@jhmi.edu|
21293049|NCT01183429|Memorial Sloan Kettering Cancer Center|Brian Kushner, MD|212-639-6793|kushnerb@mskcc.org|
21293050|NCT03662282|University of South Florida|Thao Ho|813-844-3437|tho1@usf.edu|
21293051|NCT02534883|St. Louis University|Donald Gregory Ward, MD|314-781-1505|dgreg.ward@health.slu.edu|1
21293052|NCT00886769|Novartis Pharmaceuticals|Study Director|862-778-8300||
21244848|NCT05806788|UT Health San Antonio|Dr. Lisa Smith Kilpela|210-450-8121|kilpela@uthscsa.edu|
21293053|NCT03328832|Kaohsiung Chang Gung Memorial Hospital|Dr. Wang JW|+886-7-7317123|wangjw@adm.cgmh.org.tw|8003
21293054|NCT00414076|UT MD Anderson Cancer Center|Coleman,Robert,M.D. / Gyn Onc & Reproductive Medicine|7137923203|RColeman@mdanderson.org|
21293055|NCT00873821|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21293056|NCT00778336|Boston Scientific Corporation|DeeAnn Tinjum|763-450-8707|deeann.tinjum@bsci.com|
21293057|NCT00049257|Translational Oncology Research International|Dr. Fairooz Kabbinavar, Chief Medical Officer|310 824 1934|FKabbina@mednet.ucla.edu|
21293058|NCT04721158|Johns Hopkins Medicine|Dr. Risa Wolf|410-955-6463|rwolf@jhu.edu|
21293059|NCT02708680|Syndax Pharmaceuticals, Inc.|Kate Madigan, MD, Chief Medical Officer|858-888-3798|kmadigan@syndax.com|
21293060|NCT04162470|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21293061|NCT04687917|The Ohio State University|Dr. Bryan R. Garner|6142573462|bryan.garner@osumc.edu|
21293062|NCT03929913|National Heart, Lung, and Blood Institute (NHLBI)|Dr. Robert Lederman, Principal Investigator|301.402.6769|ledermar@nhlbi.nih.gov|
21293063|NCT03919929|University of Colorado Anschutz Medical Campus|Melanie Cree, MD, PhD|720-777-5743|melanie.cree@childrenscolorado.org|
21293064|NCT03941483|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
21293065|NCT04749745|Butler Hospital|Dr. Shiwen Yuan|2025783000|shiwen_yuan@brown.edu|
21293066|NCT04541667|University of Nebraska Medical Center|Chinenye Dike|402-955-5700|chinenye.dike@unmc.edu|
21293067|NCT00971282|Galderma|Florence Paliargues|0033 4 92 95 29 57|Florence.Paliargues@Galderma.com|
21293068|NCT03132532|Mayo Clinic|Dr. Steven E. Schild|480-342-4800|sschild@mayo.edu|
21293069|NCT02415244|University of Iowa Hosptials and Clinics|Kenichi Ueda|3193562633|kenichi-ueda@uiowa.edu|
21293070|NCT01234480|Becton Dickinson|Karen Yanson|410-316-4793|karen_a_yanson@bd.com|
21293071|NCT00617084|Medtronic Bakken Research Center B.V.|Miraida Weldam|+ 31 43 356|miraida.weldam@medtronic.com|6652
21293072|NCT03370419|Wayen State University|Heather Fritz|313-577-9499|heather.fritz@wayne.edu|
21293073|NCT03844672|Medical University of South Carolina|Dr. Tracy Smith|8437925164|smithtra@musc.edu|
21293074|NCT01693250|University of California San Francisco|Dr. Jyu-Lin Chen|415-502-6015|jyu-lin.chen@ucsf.edu|
21293075|NCT01147965|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
21293076|NCT02257242|Brown University Oncology Research Group|BrUOG|4018633000|BrUOG@BROWN.EDU|
21293077|NCT01834287|Brown University|Bess Marcus|4018636850|bess_marcus@brown.edu|
21293078|NCT02522429|UCLA|Principal Investigator|3108258546|monti@ucla.edu|
21293079|NCT00600106|Cedars-Sinai Medical Center|C. Noel Bairey Merz|310-423-9680|Noel.BaireyMerz@cshs.org|
21293080|NCT04667949|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21244849|NCT01894061|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. David Peereboom|1-866-223-8100|TaussigResearch@ccf.org|
21244850|NCT00739648|Horizon Pharma USA, Inc.|Jeffery Nieves, PharmD, Senior Director||clinicaltrials@horizonpharma.com|
21244851|NCT05110495|University of Oxford|Dr Simon Lord|01865 227212|simon.lord@oncology.ox.ac.uk|
21244852|NCT04173663|Vanderbilt University Medical Center|Julie Lounds Taylor, PhD, principal investigator|615-343-5659|julie.l.taylor@vumc.org|
21244853|NCT03931291|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
21244854|NCT02840474|Vaccine Research Center, NIAID, NIH|Martin Gaudinski, MD|(301) 451-8715|martin.gaudinski@nih.gov|
21244855|NCT04716634|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21244856|NCT03679611|Department of Anesthesiology and Pain Medicine, Toronto Western Hospital, University Health Network|Dr. Jean Wong, MD, FRCPC.|416-603-5800|tojean.wong@uhn.ca|3635
21244857|NCT03089398|Icahn School of Medicine at Mount Sinai|Dr. Emilia Bagiella|212-659-9580|emilia.bagiella@mountsinai.org|
21244858|NCT00579124|Children's Hospital of Philadelphia|Patricia Hankins|215 590 5168|hankinsp@chop.edu|
21244859|NCT03818191|Mayo Clinic|Victor Karpyak, MD, PhD|(507)284-8891|karpyak.victor@mayo.edu|
21244860|NCT05418296|Mentia|Dr Mandy Salomon|4156326872|mandy@mentia.me|
21244861|NCT03262779|Yale School of Medicine|Scott Gettinger, MD|(203) 200-5864|scott.gettinger@yale.edu|
21293081|NCT00901225|Duke University Medical Center|Mitchell E Horwitz, MD, Principal Investigator|919-668-1045|mitchell.horwitz@duke.edu|
21235646|NCT01404312|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21235647|NCT04419493|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21235648|NCT00524134|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
21235649|NCT03266588|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
21235650|NCT00736242|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21235651|NCT02627677|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21235652|NCT02451748|University of Illinois at Chicago|Shiva Shahrara, PhD|312-413-7529|shahrara@uic.edu|
21235653|NCT03087591|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-716-5772|ptriozzi@wakehealth.edu|
21235654|NCT01176591|UPenn|Dr. Jennifer Plebani|215-222-3200|jplebani@upenn.edu|152
21235655|NCT01073618|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21293082|NCT03783962|University of Vermont Department of Nutrition and Food Sciences|Mattie Alpaugh|8026569526|malpaugh@uvm.edu|
21244862|NCT04419168|University of Pittsburgh|Dr. Charles Jonassaint|412-586-9850|cjonassaint@pitt.edu|
21244863|NCT05595629|Women & Infants Hospital of Rhode Island|Adam Lewkowitz|401-274-1122|alewkowitz@kentri.org|
21244864|NCT04640961|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
21244865|NCT03713086|CureVac|CureVac SE|+49 (0) 697680587-0|clinicaltrials@curevac.com|
21244866|NCT05061095|Lineberger Comprehensive Cancer Center|Dr. Daniel Richardson|(919) 966-4432|daniel_richardson@med.unc.edu|
21244867|NCT04864912|Cochlear|PRS Specialist|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
21244868|NCT03414814|Seoul National University Hospital|Ji-Sook Kim|821025866440|kbj3075814@snu.ac.kr|
21244869|NCT04737772|RVO Health|Helena Berlin|702-620-4965|hberlin@rvohealth.com|
21244870|NCT02549339|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
21244871|NCT02728076|Froedtert and the Medical college of Wisconsin|Adam Currey, MD|414-805-4462|acurrey@mcw.edu|
21244872|NCT04820855|University of New Mexico Health Sciences Center|Dr. Angela Dao|5059678428|angela.dao@gmail.com|
21244873|NCT04838262|The University of Texas at Arlington|Dr. Jody Greaney|8172727891|jody.greaney@uta.edu|
21244874|NCT02927769|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21244875|NCT05956002|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21244876|NCT02307565|James J Peters VAMC|Dr. Jill Wecht|718-584-9000|jm.wecht@va.gov|3122
21244877|NCT05386069|Prisma Health|Manager OBGYN Research|864-455-1510|patti.parker@prismahealth.org|
21244878|NCT04838613|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
21244879|NCT04970654|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21244880|NCT03113422|Dana-Farber Cancer Institute|Mr Opeyemi Jegede|(617) 582-7613|ojegede@jimmy.harvard.edu|
21244881|NCT06207058|Tricore|Medical Director|505-938-8461|michael.crossey@tricore.org|
21244882|NCT06155721|Badalona Serveis Assistencials|Jose Ferrer Costa|+34 937407482|jfcosta@bsa.cat|
21244883|NCT02318901|WRMC|Jessica L. Coats|623-207-3899|jessica.coats@ctca-hope.com|
21244884|NCT00715884|Cordis|Amy Orlick, Associate Director Clinical Research|908-541-4347|AOrlick@its.jnj.com|
21244885|NCT00738023|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
21244886|NCT03448458|Emory University|Mehmet Asim Bilen, MD|404-778-1900|mehmet.a.bilen@emory.edu|
21244887|NCT05239039|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21244888|NCT03690206|Zealand Pharma A/S|Head of clinical operations|+45 8877 3600|info@zealandpharma.com|
21244889|NCT05005221|University of Michigan|Manjunath Pai|734/647-0006|amitpai@med.umich.edu|
21244890|NCT06240091|Woebot Health|Tim Campellone, PhD|(415) 209-5642|research@digitaltherapeutic.io|
21244891|NCT03897686|RCBIOFORM|Julia Melentyeva Commercial Director|+7 (495) 223-70-95|md@bioform.ru|
21244892|NCT04052516|NorthSea Therapeutics BV|Chief Scientific Officer|31 035760 65 05|info@northseatherapeutics.com|
21244893|NCT03264131|UNC Lineberger Comprehensive Cancer Center|Melahat Garipagaoglu Canter|919-962-0000|Melahat_Canter@med.unc.edu|
21244894|NCT06143670|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
21244895|NCT00837369|University of Nebraska Medical Center|Thomas Porter|402-559-5151|trporter@unmc.edu|
21244896|NCT03625882|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21244897|NCT05058391|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21244898|NCT05009251|Geisinger|Gail Rosenbaum|800-275-6401|grosenbaum@geisinger.edu|
21244899|NCT04204278|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
21244900|NCT01582711|CDC|Andrey Borisov, MD, MPH, Study Director|(404) 639-3311|pha5@cdc.gov|
21244901|NCT02784509|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
21244902|NCT02662062|ANZUP|Dr Anthony Uccellini - ANZUP Research fellow|61 2 9046 8954|trials@anzup.org.au|
21244903|NCT04049747|Imperial College London|Ms Puja Jadav|020 7594 7773|p.jadav@imperial.ac.uk|
21244904|NCT05249439|Imperial College London|Professor Tricia Tan|44 207 594 9048|t.tan@imperial.ac.uk|
21244905|NCT00616967|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|443-287-6489|vstearn1@jhmi.edu|
21244906|NCT02910583|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21244907|NCT02249949|Georgetown University|Michael J. Pishvaian, MD, PhD|202-444-2144|pishvaim@georgetown.edu|
21244908|NCT04414644|University of Pennsylvania|Kelly Allison, PhD|215-898-2823|kca@pennmedicine.upenn.edu|
21244909|NCT02097420|Abbott|Vinny Podichetty, Clinical Program Director|+1 779-209-9425|vinny.podichetty@abbott.com|
21244910|NCT05059262|Deciphera Pharmaceuticals, LLC|Clinical Trials|785-830-2100|clinicaltrials@deciphera.com|
21280131|NCT01696760|The Ohio State University Comprehensive Cancer Center|Joel Mayerson, MD|614-293-4420|joel.mayerson@osumc.edu|
21280132|NCT03910673|Duke Vaccine and Trials Unit|Emmanuel Walter, MD, MPH|919-620-5346|chip.walter@duke.edu|
21280133|NCT02290405|National Jewish Health|Bryan Simmons|303-398-1850|SimmonsB@NJHealth.org|
21280134|NCT02016183|Takeda|Medical Director|1-877-825-3327|trialdisclosures@takeda.com|
21280135|NCT03142191|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21280136|NCT00825786|University of North Carolina, Department of Anesthesiology, University of North Carolina|Priya Kumar, MD|(919) 966-5136|pkumar@aims.unc.edu,|
21280137|NCT03168022|Tonix Pharmaceuticals|Gregory Sullivan, MD||greg.sullivan@tonixpharma.com|
21280138|NCT03091179|Stanford University|Vladimir Nekhendzy|650-498-4055|nek@stanford.edu|
21293083|NCT00348946|Thomas Jefferson University|Judith L. Ross, M.D.|215-955-1648|judith.ross@jefferson.edu|
21280139|NCT02171195|BIAL - Portela & Cª, S.A.|Head of Clinical Research|+351 22 9866100|francisco.rocha@bial.com|
21244911|NCT04263311|NYU Langone Health|Jennifer Zanowiak|(646) 501-3502|Jennifer.Zanowiak@nyulangone.org|
21244912|NCT04638829|Sobi,Inc.|Medicine Development Leader|1-781-786-7370|medinfo.us@sobi.com|
21293084|NCT02763059|King Abdulaziz University|Prof. Maha A Bahammam|00966126400000|mbahammam@kau.edu.sa|
21293085|NCT02370368|The University of the West Indies, Mona|Dr. Sharmella Roopchand-Martin|876-927-2235|sharmella.roopchandmartin@uwimona.edu.jm|
21293086|NCT01724216|Spectrum Health|Mark Charles DeLano, M.D., Principal Investigator|616-363-7339|delanom@msu.edu|
21293087|NCT04423939|Duke University Medical Center|Dr. Anthony Sung|919-668-1000|anthony.sung@duke.edu|
21293088|NCT04024436|Taiho Oncology, Inc|Taiho Oncology, Inc|+1 844-878-2446|medicalinformation@taihooncology.com|
21293089|NCT01169337|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21293090|NCT01134614|ECOG Statistical Office|Study Statistician|617-632-3012||
21293091|NCT00540592|GlaxoSmithKline|GSK Response Center|866-435-7343||
21293092|NCT03279237|Massachusetts General Hospital|Dr. Theodore Hong|(617) 726-2000|TSHONG1@mgh.harvard.edu|
21293093|NCT04908683|Janssen Vaccines & Prevention B.V.|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21293094|NCT05507567|Pneumagen Ltd|CEO|+44 7748357352|douglas.thomson@pneumagen.com|
21293095|NCT03569878|Department of Psychiatry, University of Washington School of Medicine|Douglas Zatzick|206 744-6701|dzatzick@uw.edu|
21293096|NCT01722994|University of Mississippi Medical Center|Dr. Robert Brodell|601-815-8000|rbrodell@umc.edu|
21293097|NCT01206140|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
21293098|NCT01803880|Smith & Nephew, Inc|Stephan Mangin, Director, Global Clinical Strategy|M +1 (512) 913-8192|stephan.mangin@smith-nephew.com|
21293099|NCT01766037|Aspire Bariatrics, Inc.|VP Regulatory & Quality|484-200-1031|monica.ferrante@aspirebariatrics.com|
21293100|NCT03703232|University of Washington|Murray Maitland PT, PhD, Associate Professor|425-286-5278|mmaitlan@uw.edu|
21293101|NCT05226598|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21293102|NCT00090779|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21293103|NCT02032758|Mayo Clinic in Arizona|Dr. Charles H. Adler|480-301-8100|cadler@mayo.edu|
21293104|NCT03951766|Massachusetts General Hospital, Psychiatry Department|Dr. Bettina Hoeppner|6176431988|bhoeppner@mgh.harvard.edu|
21293105|NCT02388880|Advanced Circulatory Systems|Clinical Research Associate|651.403.5600|nburkhart@advancedcirculatory.com|
21293106|NCT05089292|Icahn School of Medicine at Mount Sinai|Lina Jandorf|(212) 659-5506|lina.jandorf@mssm.edu|
21293107|NCT04229888|Indiana University School of Optometry|Anna Tichenor|812-855-0520|annatich@iu.edu|
21293108|NCT01841021|H. Lee Moffitt Cancer Center and Research Institute|Dr. Lubomir Sokol|813-745-8212|lubomir.sokol@moffitt.org|
21293109|NCT01162473|The Children's Hospital of Philadelphia|Rushani W. Saltzman MD|215-590-2549|allergyandimmunology@email.chop.edu|
21293110|NCT01144416|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21293111|NCT04373421|Tekirdag Namik Kemal University|Dr. Volkan Kaplan|+90282250000|dr.volkankaplan61@gmail.com|6307
21293112|NCT00132301|VA Puget Sound Health Care System|Dr. Bruce Montgomery|206-277-6878|Robert.Montgomery@va.gov|
21293113|NCT00996658|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21293114|NCT04685213|Baylor College of Medicine|Prof. Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
21293115|NCT02292537|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
21293116|NCT02685826|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21293117|NCT03154476|Mayo Clinic|Dr. Alexander Egbe|507-284-3725|Egbe.Alexander@mayo.edu|
21293118|NCT03368781|Acutus Medical, Inc.|Steve McQuillan|4422326080|steven.mcquillan@acutus.com|
21293119|NCT01444430|AstraZeneca Research and Development|Carin Jorup, Global Clinical Lead (GCL) SYMBICORT|+46 31 7761000|Carin.Jorup@astrazeneca.com|
21293120|NCT05393245|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21293121|NCT03640325|Dana-Farber Cancer Institute|Dr Abby Rosenberg|617.632.5286|abbyr_rosenberg@dfci.harvard.edu|
21293122|NCT03493451|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21293123|NCT03046927|University of Mass Medical|Benjamin U. Nwosu, MD|5083406936|bnwosu1@northwell.edu|
21244913|NCT04539574|M.D. Anderson Cancer Center|Max Wintermark, MD|713-792-0845|mwintermark@mdanderson.org|
21293124|NCT01566149|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21293125|NCT01848977|Seoul National University Hospital|Jin-Tae Kim|82-10-6260-8490|jintae73@gmail.com|
21293126|NCT01032954|Brazilian Center for Studies in Dermatology|Dr Doris Hexsel|555130262633|cientifico@cbed.org.br|
21293127|NCT03687957|Washington University School of Medicine|Dr. Milan Chheda|314-747-2712|mchheda@wustl.edu|
21293128|NCT03276728|Amgen (EUROPE) GmbH|IHQ Medical Info-Clinical Trials|866-572-6436|MedInfoInternational@amgen.com|
21293129|NCT00252512|Minneapolis VA Health Care System|Hildi Hagedorn|612-467-3875|hildi.hagedorn@va.gov|
21293130|NCT02213926|AstraZeneca Clinical -Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21293131|NCT01188551|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|Joseph.Tobias@nationwidechildrens.org|
21293132|NCT01537315|University of Arkansas for Medical Sciences|Dumitru Rotaru, MD, PI|501/526-6919|drotaru@uams.edu|
21244914|NCT03315754|Memorial Sloan Kettering Cancer Center, New York, NY, USA|Jonathan Coleman, MD|+1-646-422-4432|colemanj@mskcc.org|
21244915|NCT02954341|CHU de Lille - Institut Coeur Poumon|Dr Pascal De Groote|33 (0)3 20 44 50 38|Pascal.DEGROOTE@chu-lille.fr|
21244916|NCT05695989|Levita Magnetics|Vivian Soto|+56958360507|VSoto@Levita.com|
21244917|NCT05493787|Geisinger|Gail Rosenbaum|570-243-1199|grosenbaum@geisinger.edu|
21244918|NCT01600222|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
21244919|NCT04179149|Ponce Research Institute, Ponce Health Sciences University|Dr. Idhaliz Flores|787-840-2575|iflores@psm.edu|2206
21244920|NCT02384317|ChemoCentryx|Study Director|650-210-2900|medinfo@amgen.com|
21293133|NCT03323853|University of Arkansas for Medical Sciences|Dr. Michael Wilson|501-686-5515|MPWilson@uams.edu|
21280140|NCT00770328|Vanderbilt University Medical Center|James Muldowney|615-936-1720|james.muldowney@vanderbilt.edu|
21280141|NCT03730207|Medtronic|Jane Zhang|86+18612318110|jane.zhang7@medtronic.com|
21280142|NCT03164616|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21280143|NCT04388553|Tuen Mun Hospital|Anyon Chan|24680000|Ca663@ha.org.hk|+852
21280144|NCT04604795|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21280145|NCT00719186|Yale University|Heping Zhang|203-785-5185|rmn-dcc@panlists.yale.edu|
21280146|NCT02864355|The Medical University of South Carolina|George Guldan, MD|843-876-5744|guldan@musc.edu|
21280147|NCT02254265|Sun Pharma Advanced Research Company Limited|SPARC|+912266455645|Clinical.Trials@Sparcmail.com|
21280148|NCT03023176|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker.|650-724-4437|cdekker@stanford.edu|
21280149|NCT01260701|SWOG Statistical Center|Study Statistician|206-667-4623||
21280150|NCT00289120|Emory University|Kenneth Ogan|404-778-4898|kogan@emory.edu|
21235656|NCT02696850|WashingtonU|Dr. Jay F. Piccirillo, Principal Investigator|(314) 362-8641|piccirij@wustl.edu|
21235657|NCT03041415|Stanford University|Principal Investigator|6507235082|king@stanford.edu|
21235658|NCT00673049|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21235659|NCT03226067|Calliditas Therapeutics|Richard Philipson, MD Chief Medical Officer|Desk: +46 556659-9766|richard.philipson@calliditas.com|
21235660|NCT00875394|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21235661|NCT01933334|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21235662|NCT02039505|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21235663|NCT04265755|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21235664|NCT01531959|Beth Israel Deaconess Medical Center|Matthias Eikermann|6176327034|meikerma@bidmc.harvard.edu|
21235665|NCT01863446|Mass General Hospital|Elizabeth Klerman|617-643-2424|ebklerman@hms.harvard.edu|
21235666|NCT02554773|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21235667|NCT02312310|Columbia University Medical Center|Scott A. Small, MD|212-305-1269|sas68@columbia.edu|
21235668|NCT01794949|Emory University|Henry Liberman, MD|404-686-2503|hliberm@emory.edu|
21235669|NCT00759967|Ottawa Hospital Research Institute|Dr. Deborah Zimmerman|613-738-8400|dzimmerman@ohri.ca|82534
21235670|NCT00618657|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
21235671|NCT00365859|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21235672|NCT04713748|Duke Clinical and Translational Science Institute|Douglas Wixted|919-668-0515|douglas.wixted@duke.edu|
21235673|NCT00995449|KaloBios Pharmaceuticals, Inc.|Nestor A. Molfino, MD., MSc|650-243-3103|nmolfino@kalobios.com|
21235674|NCT00406029|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21235675|NCT00889421|Oregon Health & Science University|Dr. Eric Suhler|503-494-5023|suhlere@ohsu.edu|
21235676|NCT01958918|Novartis Pharma AG|Study Director|+41613241111|Novartis.email@novartis.com|
21235677|NCT01597687|GlaxoSmithKline|GSK Response Center|866-435-7343||
21235678|NCT02114892|Institute of Experimental andl Clinical Therapeutics|Dr. Manuel González Ortiz|+52-33-10-58-52-00|uiec@prodigy.net.mx|34212
21235679|NCT01243450|Cu-Tech, LLC|William J. Cunningham, MD|(973) 331-1620|wcunningham@cu-tech.com|
21235680|NCT04479618|BenskinL|Linda Benskin, PhD, RN, Independent Researcher|+1 (512) 659-0812|lindabenskin@utexas.edu|
21235681|NCT04023695|Vanderbilt University|Brian Drolet, MD|(615) 322-2350|brian.c.drolet@vumc.org|
21235682|NCT01134900|The University of Texas Health Science Center at Houston (UTHealth)|Allison B. McCoy, PhD|713-500-6931|allison.b.mccoy@uth.tmc.edu|
21235683|NCT00659269|University of New Mexico|Zoneddy Dayao, MD|5059250404|zdayao@salud.unm.edu|
21235684|NCT02832674|ThermiGen LLC|Toni Fournier, Sr. VP New Products|214-888-0634|TFournier@Thermi.com|
21235685|NCT00718042|Abbott Laboratories|Associate Director Clincal Affairs|847-937-8702|barbara.kaesdorf@abbott.com|
21280151|NCT03300817|Mayo Clinic|Paul J. Limburg, M.D., M.P.H.|507-284-2511|limburg.paul@mayo.edu|
21280152|NCT01581437|Virginia CU|Kenneth Ellenbogen|804-828-7565|kellenbogen@mcvh-vcu.edu|
21280153|NCT03729596|MacroGenics, Inc.|Stephen L. Eck, MD|301-251-5172|info@macrogenics.com|
21280154|NCT04011722|Abbott|Nels Engblom|3198533946|nels.engblom1@abbott.com|
21280155|NCT05239611|University of Kansas Medical Center|Joel Mermis|913-588-6045|jmermis@kumc.edu|
21280156|NCT00879255|Department of Veterans Affairs|Leslie A. Morland, Clinical Psychologist|(619) 497-8406|leslie.morland@va.gov|
21280157|NCT01368497|University of Pittsburgh|Dr. Steven Belle|412-624-3758|belle@edc.pitt.edu|
21280158|NCT02656303|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
21280159|NCT02871011|SaNOtize Research & Development Corp.|Dr Chris Miller|778-899-0607|chris@sanotize.com|
21280160|NCT03041311|G1 Therapeutics, Inc.|Clinical Trial Info.|919-213-9835|clinicalinfo@g1therapeutics.com|
21280161|NCT00443729|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21280162|NCT01842438|Australian Catholic University|Prof Liz Forbat, PI|+61 475978476|elizabeth.forbat@acu.edu.au|
21280163|NCT01622257|Assistant professor of Obstetrics & Gynecology, Ain-shams faculty of medicine|Dr. Moustafa Ibrahim|00201001955996|mi_monem@yahoo.com|
21280164|NCT00782626|Dana-Farber Cancer Institute|Mark Kieran|(617) 632-4907|mark_kieran@dfci.harvard.edu|
21280165|NCT03718832|MIT Sloan School of Management|Joseph doyle|6174523761|jjdoyle@mit.edu|
21280166|NCT02400996|Sir Ganga Ram Hospital, New Delhi, India|Md Tanveer Adil|0091-9830154566|tanveer.cmc@gmail.com|
21280167|NCT02548156|GlaxoSmithKline|GSK Response Center|866-435-7343||
21280168|NCT03288714|Wave Neuroscience|Meagan Kovacs, Clinical and Regulatory Affairs Manager|9492292869|meagan@waveneuro.com|
21293134|NCT01179984|Bard Peripheral Vascular|Associate Director of Clinical Affairs|480-379-2838|josh.smale@crbard.com|
21293135|NCT01947335|Heart Institute (Incor)|Dr. Pedro A. Lemos|+55 11 2661 5000|pedro.lemos@incor.usp.br|
21293136|NCT03458325|scPharmaceuticals|Sr. Vice President, Clinical Development and Medical Affairs|(855) 727 4276|jmohr@scpharma.com|
21293137|NCT02956746|Synermore Biologics Co., Ltd.|Director of Clinical Trials|+886 2 2659 0988|achuang@synermore.com|
21293138|NCT02630693|Canadian Cancer Trials Group|Dr. Wendy Parulekar|613-533-6430|wparulekar@ctg.queenus.ca|
21293139|NCT00175916|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21293140|NCT00310375|GlaxoSmithKline|GSK Response Center|866-435-7343||
21293141|NCT01816776|Respicardia, Inc.|Linda Nelson, VP Clinical Affairs|952-540-4479|lnelson@respicardia.com|
21293142|NCT01194219|Celgene Corporation|Anne McClain|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
21293143|NCT05338710|OHSU|Allison Lindauer, PhD, APRN|5034944347|lindauer@ohsu.edu|
21293144|NCT01081951|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21293145|NCT03377816|University of Haifa|Johanna Czamanski-Cohen|+97246146234|jczamansk@univ.haifa.ac.il|
21293146|NCT02179424|University of Hong Kong|Professor Lam Tai-Hing|39179287|hrmrlth@hku.hk|
21293147|NCT04930198|Vanderbilt University Medical Center|Dr. Martin Were|(617) 319-6462|martin.c.were@vumc.org|
21293148|NCT05384834|Emory University|Dr. Holly Gooding|404-778-1429|holly.gooding@emory.edu|
21293149|NCT01871545|Icahn School of Medicine at Mount Sinai|Dr. Bachir Taouli|212-824-8475|bachir.taouli@mountsinai.org|
21293150|NCT02623972|Dana-Farber Cancer Institute|Filipa Lynce, MD|617-632-4056|Filipa_Lynce@DFCI.HARVARD.EDU|
21293151|NCT05710640|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21293152|NCT04188509|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21293153|NCT04158375|Mayo Clinic|Dr. Sreekumaran Nair - Principal Investigator|507-284-2511|nair.sree@mayo.edu|
21293154|NCT04847843|University of Utah|Tanya Halliday, PhD, RD|801-213-1364|tanya.halliday@utah.edu|
21293155|NCT02734004|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21293156|NCT04570371|Mayo Clinic|Dr. Andrea Cheville|(507) 284-2747|cheville.andrea@mayo.edu|
21293157|NCT04828135|Duke University|Loretta Que|919-681-8551|loretta.que@duke.edu|
21293158|NCT01282866|Laser & Skin Surgery Medical Group Inc.|Suzanne Kilmer, MD|916-456-0400|Study@skinlasers.com|
21293159|NCT00318929|Virginia Commonwealth University|Alan R. Towne, MD|804-282-9869|atowne@mcvh-vcu.edu|
21293160|NCT01541865|Boston Scientific|Angela Schutt, Clinical Trial Manager|763-494-2166|angela.schutt@bsci.com|
21293161|NCT00049322|University of California Los Angeles|Carolyn Britten, M.D.|310 829 4971|cbritten@mednet.ucla.edu|
21293162|NCT00124072|CTSU, University of Oxford|CTSU Reception|01865 743743|secretary@ctsu.ox.ac.uk|
21293163|NCT03163134|University of Pittsburgh|Benita Valappil|412.864.1744|valappilb2@upmc.edu|
21293164|NCT04872569|University of Michigan|Dr. Claire Kalpakjian|734-763-0153|clairez@umich.edu|
21293165|NCT00742170|McLean Hospital|Scott E. Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu|
21293166|NCT00480740|Children's National Medical Center|Dr. Julia Finkel|202-476-4867|jfinkel@childrensnational.org|
21293167|NCT05110781|University of California, Davis|Principal Investigator|916-734-2790|abewley@UCDAVIS.EDU|
21293168|NCT01890265|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|067study@fibrogen.com|
21293169|NCT04951622|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21293170|NCT05102383|The Ohio State University College of Optometry|Jennifer Fogt, OD MS|16142928858|OPTEyeStudies@osu.edu|
21293171|NCT05119582|Bispebjerg University Hospital|Prof. Joergen Serup|+1 21424888|joergen.vedelskov.serup@regionh.dk|
21293172|NCT03517436|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@Edwards.com|
21293173|NCT04271540|Brigham and Women's Hospital|Brittany Weber, MD, PhD|6177326291|bweber@bwh.harvard.edu|
21293174|NCT02101788|NRG Oncology|Linda Gedeon for Austin Miller, PhD|716-845-1169|linda.gedeon@roswellpark.org|
21293175|NCT04587869|RAND|Laura Bogart|3103930411|lbogart@rand.org|7281
21235686|NCT04327934|John B. Pierce Laboratory/Yale School of Medicine|Nina Stachenfeld|203 562 9901|nina.stachenfeld@yale.edu|219
21235687|NCT02443298|AbbVie|Global Medical Services|1-800-633-9110|abbvieclinicaltrials@abbvie.com|
21235688|NCT01877421|Oral Health Research Institute, Indiana University School of Dentistry|Domenick T. Zero, DDS, MS|240-457-0668|dzero@iu.edu|
21235689|NCT04627727|BIDMC|Judy Nee, mD|617-667-2193|jnee@bidmc.harvard.edu|
21235690|NCT04847050|National Cancer Institute|Dr. James Gulley|301-480-8870|gulleyj@mail.nih.gov|
21235691|NCT00908960|Beth Israel Deaconess Medical Center|Jeffrey Zwicker, MD|617-667-9299|jzwicker@bidmc.harvard.edu|
21235692|NCT01158924|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com|
21235693|NCT03795922|Medytox Inc.|Young Ryu|+82-2-6901-5424|aab005@medytox.com|
21235694|NCT04788147|RefleXion|Debradenise Brooks|16504828435|dbrooks@reflexion.com|
21235695|NCT00293540|International Breast Cancer Research Foundation|Richard R. Love, MD|608-698-7881|richardibcrf@gmail.com|
21235696|NCT00781326|University of Pittsburgh|Ellen Whyte, MD|412 246 5066|whyteem@upmc.edu|
21235697|NCT05101252|Johnson & Johnson Vision Care, Inc. (JJVC)|Thomas R. Karkkainen, OD, MS, FAAO|(904)254-0152|TKarkkai@its.jnj.com|
21235698|NCT03732248|Medical University of South Carolina|Dr. Michael Saladin|843-792-5306|saladinm@musc.edu|
21235699|NCT02266381|The First Affiliated Hospital of Guangzhou Medical University|Dr. Guohua Zeng|0086-20-34294163|gzgyzgh@vip.sina.com|
21235700|NCT01736852|Cook Research Incorporated|Alan Saunders,MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
21293176|NCT02157909|Alcon Research, Ltd.|Head Clinical Development, Vision Care, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
21235701|NCT00403546|Massachusetts General Hospital|Donald C. Goff, MD||Donald.Goff@nyumc.org|
21235702|NCT00793910|Carl R. Darnall Army Medical Center|Matthew Kuhnle, DO|216-965-3518|matthew.kuhnle@us.army.mil|
21297161|NCT02630472|UPenn|Nithin D. Adappa, Principal Investigator|215-662-2360|Nithin.Adappa@uphs.upenn.edu|
21293177|NCT02268383|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21293178|NCT00943761|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21293179|NCT04581811|UAB Hospital|David Page - PI|205-975-7387|dpage1@uabmc.edu|
21293180|NCT01342926|GlaxoSmithKline|GSK Response Center|866-435-7343||
21293181|NCT03382912|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21293182|NCT01402869|Loma Linda University|Dr. Lauren Gutenberg|909-558-4690|lgutenberg@llu.edu|
21293183|NCT01544348|MedImmune|Claire Birrell, Senior Clinical Scientist|301-398-0000|birrellc@medimmune.com|
21293184|NCT00642707|CytoDyn, Inc.|Kush Dhody|301-956-2536|kushd@amarexcro.com|
21293185|NCT02891226|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21293186|NCT01445847|King Saud University Medical City - College of Medicine|Dr. Khalid Al-Faleh, Chairman, Institutional Review Board|966556031222|kfaleh@ksu.edu.sa|
21293187|NCT00707993|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21293188|NCT03008070|Inventiva S.A.|Dr Michael Cooreman, Chief Medical Officer|+33380447616|native.public@inventivapharma.com|
21293189|NCT03960684|Levita Magnetics|Vivian Soto|+56958360507|VSoto@Levita.com|
21293190|NCT03533660|University of Pittsburgh|Andrea DiMartini|14122164550|dimartiniaf@upmc.edu|
21293191|NCT03816176|Astellas Pharma Global Development, Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
21293192|NCT01142388|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
21293193|NCT00802997|Baylis Medical|Meghal Khakhar, Director of Regulatory and Scientific Affairs|9056024875|mkhakhar@baylismedical.com|
21293194|NCT04357730|Denver Health Medical Center|Dr. Ernest Moore, Director of Surgical Research|3036021820|ernest.moore@dhha.org|
21293195|NCT05265728|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21293196|NCT05615220|Emalex Biosciences Inc.|Drug Development and Medical Affairs|773 343 0671|mmiller@emalexbiosciences.com|
21293197|NCT01757301|Richard L. Roudebush VA Medical Center|Erica Evans|317-988-3476|erica.evans2@va.gov|
21293198|NCT00604552|Medtronic Vascular|Angela Parsons|707-591-2293|angela.r.parsons@medtronic.com|
21293199|NCT00703963|Mayo Clinic|Dr. Hartzell V. Schaff|507-255-7068|schaff@mayo.edu|
21293200|NCT01081262|NRG Oncology|Linda Gedeon on behalf of William Brady, PhD|716-845-1169|lgedeon@gogstats.org|
21293201|NCT00415870|UCSD|Project Coordinator|858-534-9329|ldillon@ucsd.edu|
21293202|NCT03994211|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21293203|NCT02528942|Thomas Jefferson University|Yevgeniy Vinogradskiy PhD|2159553605|yevgeniy.vinogradskiy@Jefferson.edu|
21293204|NCT00881530|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21293205|NCT03900728|Columbia University Irving Medical Center|Carolyn Westhoff, MD|2123057070|clw3@cumc.columbia.edu|
21293206|NCT02100930|Memorial Sloan Kettering Cancer Center|Dr. Brian Kushner, MD|212-639-6793|kushnerb@mskcc.org|
21293207|NCT00763256|Colgate Palmolive Co.|William DeVizio, DMD|732-878-7901|william_devizio@colpal.com|
21293208|NCT00517010|University of California Davis|Susanna Park MD PhD|916-734-6074|sscpark@ucdavis.edu|
21293209|NCT00906178|Center for Innovative Public Health Reserch|Dr. Michele Ybarra|877-302-6858|michele@innovativepublichealth.org|1-801#
21293210|NCT01272037|SWOG Statistics and Data Management Center|Breast Committee Statistician|206-667-4623|dlew@fredhutch.org|
21293211|NCT02622295|University of Iowa Department of Physical Therapy and Rehabilitation Science|Dr. Richard K. Shields|319-335-9791|richard-shields@uiowa.edu|
21293212|NCT01393899|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21293213|NCT02503085|Reckitt Benckiser Healthcare (UK) Ltd.|Clinical Research Director|+441482 326151||
21293214|NCT01027559|University of Pennsylvania|Dr. Yvette Sheline|215-573-0082|sheline@pennmedicine.upenn.edu|
21293215|NCT02720523|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21293216|NCT03674970|Penn State College of Medicine|Patricia Sue Grigson|717-531-5772|pgrigsonkennedy@pennstatehealth.psu.edu|
21293217|NCT04585269|Rutgers Cancer Institute|Dr. Katie Devine (PI)|7322357549|katie.devine@rutgers.edu|
21293218|NCT06006078|Cleveland Clinic Foundation|Dr. John Vargo|2164455012|vargoj@ccf.org|
21293219|NCT03670355|San Francisco Department of Public Health|Dr. Albert Liu|4154377408|albert.liu@sfdph.org|
21293220|NCT03307785|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21293221|NCT03146663|NuCana Plc|Medical and Scientific Affairs Department|01313571116|info@nucana.com|
21293222|NCT03666988|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21293223|NCT05111613|Inari Medical|Ashleigh Willson|925-330-3446|ashleigh.willson@stryker.com|
21293224|NCT05441527|University of Iowa|Dr. Robert Bowers|(319) 467-3199|robert-bowers@uiowa.edu|
21293225|NCT05526521|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
21293226|NCT05069012|Beth Israel Deaconess Medical Center|Philip Hess|617-667-3112|phess@bidmc.harvard.edu|
21293227|NCT00125788|Emmaus Medical, Inc.|Yutaka Niihara, MD, MPH|310-214-0065|yniihara@emmausmedical.com|
21235703|NCT01070810|BIDMC|Michael W Donnino|617-754-2295|mdonnino@bidmc.harvard.edu|
21235704|NCT03634579|Emory University|Sherif Nour|404-778-3800|sherif.nour@emoryhealthcare.org|
21235705|NCT02480621|Department of Orthopaedic Surgery, NYU Langone Orthopaedic Hospital|Dr. Adam Driesman|2033315938|Adam.Driesman@nyumc.org|
21235706|NCT00235989|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21235707|NCT04796831|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21293228|NCT00436436|National Cancer Institute|Dr. Mark Gilbert|301-402-6383|gilbertmr@mail.nih.gov|
21235708|NCT00178191|University of Rochester|Michael Flynn|585-273-3232|Michaelk_flynn@urmc.rochester.edu|
21235709|NCT04519658|CinCor Pharma|Yuan-Di Halvorsen|617-675-8126|yhalvorsen@cincor.com|
21293229|NCT00947219|Lexington International, LLC|David Michaels|561-417-0200|dm@hairmax.com|
21293230|NCT00766116|University of California, San Diego|Edward D. Ball, MD|858-822-6600|tball@ucsd.edu|
21244921|NCT04245501|University of Denver|Michelle Rozenman, Ph.D., Director, BRAVE Lab & Associate Professor, Department of Psychology|303-871-6448|michelle.rozenman@du.edu|
21293231|NCT03381287|HighTide Therapeutics|Dr. Adrian Di Bisceglie, CMO|314-791-0593|adibisceglie@hightidetx.com|
21293232|NCT02847169|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com|
21293233|NCT03079531|Stanford University|Anne Lynn Chang, MD|650-723-6316|alschang@stanford.edu|
21293234|NCT00648648|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21293235|NCT00841412|Tennessee Valley Healthcare System, GRECC and Vanderbilt University, School of Medicine, Division of Geriatrics, Center for Quality Aging|Sandra F. Simmons, PhD, Associate Professor of Medicine|615-343-6729|Sandra.Simmons@Vanderbilt.edu|
21293236|NCT00325130|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21293237|NCT02683980|Boston Scientific|Clinical Program Manager|612-322-1189|teri.bird@bsci.com|
21293238|NCT03081689|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
21293239|NCT01671956|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
21293240|NCT03896750|Alliance for Multispecialty Research|William Smith, MD|(865) 305-9100|william.smith@amrllc.com|
21293241|NCT04266912|M.D. Anderson Cancer Center|Timothy A. Yap|713-563-1930|tyap@mdanderson.org|
21293242|NCT04446312|Braintree Laboratories, Inc.|Head of R&D, GI|781-843-2202|studydirector@sebelapharma.com|
21293243|NCT00932035|City of Hope|Carolyn Behrendt, Ph.D.|(626)359-8111|Cbehrendt@coh.org|61148
21293244|NCT02610972|Gynuity Health Projects|Hillary Bracken|2124481230|hbracken@gynuity.org|
21293245|NCT03581292|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21293246|NCT01144624|AstraZeneca|Justin Lindemann||ClinicalTrialTransparency@astrazeneca.com|
21293247|NCT01682356|Washington University School of Medicine|Linda R. Peterson, MD|314-362-4577|lpeterso@wustl.edu|
21293248|NCT07214935|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21293249|NCT05823974|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21293250|NCT02744612|City of Hope Medical Center|Dr. Alex Herrera, MD|6263598111|aherrera@coh.org|
21293251|NCT00316706|GlaxoSmithKline|GSK Response Center|866-435-7343||
21293252|NCT04956731|University of California, San Diego|Office of Clinical Trials Administration|858-822-2940|octa@ucsd.edu|
21293253|NCT00283803|University of Washington|Dr. Celestia Higano, MD|206-606-1187|mjcampbe@seattlecca.org|
21293254|NCT01127607|Florida International University|Dr. James Waxmonsky|717 531 8646|jwaxmons@fiu.edu|
21244922|NCT04140708|Vanderbilt University Medical Center|Dr. Daniel Claassen|615-322-6103|daniel.claassen@vumc.org|
21244923|NCT03526861|LEO Pharma A/S|Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
21244924|NCT01253824|Nobelpharama|Department director of clinical development department 1|+81-23-5651-1177|murakami@nobelpharma.co.jp|
21244925|NCT05524233|Baylor College of Medicine|Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
21244926|NCT03610490|M D Anderson Cancer Center|Amir A Jazaeri, MD|713-792-8578|aajazaeri@mdanderson.org|
21244927|NCT04382898|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
21244928|NCT01772472|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21244929|NCT04391894|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
21244930|NCT01889199|University of California, Los Angeles|Daniel A. Dumesic, MD|310-794-5542|DDumesic@mednet.ucla.edu|
21244931|NCT00446225|Fundación GECP|Eva Pereira|+34934302006|epereira@gecp.org|
21244932|NCT04450342|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
21244933|NCT05633407|argenx BV|Regulatory Manager|+32 93103400|regulatory@argenx.com|
21244934|NCT05741489|Emory University|Dr. Guillermo E. Umpierrez|(404) 778-1663|geumpie@emory.edu|
21244935|NCT02500758|Universidad Complutense de Madrid|Dr. Ricardo Becerro de Bengoa Vallejo|914590409|ribebeva@enf.ucm.es|
21244936|NCT00220740|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
21244937|NCT01057433|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@KowaUS.com|
21244938|NCT02345720|Johnson & Johnson Vision Care Inc.|Tom Karkkainen, OD, MS, FAAO|904-443-3500|TKarkkai@its.jnj.com|3402
21244939|NCT02874534|University of North Carolina at Chapel Hill|Gabriel S. Dichter, PhD|9194450132|dichter@med.unc.edu|
21244940|NCT02923180|Johns Hopkins Sidney Kimmel Comprehensive Cancer Center|Dr. Emmanuel Antonarakis|410-502-8341|eantona1@jhmi.edu|
21244941|NCT05198310|Kiniksa Pharmaceuticals, Ltd.|Clinical Operations Study Director|1-781-431-9100|studyinfo@kiniksa.com|
21244942|NCT04116736|Johnson & Johnson Vision Care (JJVC)|Graeme Young|+44(0) 1252 718719|g.young@visioncare.co.uk|
21244943|NCT00731341|Galil Medical|Joy Benson, CRA|651-287-5112|joy.benson@galilmedical.com|
21244944|NCT03526354|UMass Chan Medical School|Dr. Xiaoduo Fan|5088566463|xiaoduo.fan@umassmed.edu|
21244945|NCT06041139|Berkeley Eye Center|Tetiana Huff|713-620-7640|tetiana.huff@berkeleyeye.com|
21244946|NCT02317783|Huntsman Cancer Institute, Center for Quantitative Cancer Imaging|Sam Mitchell|801-213-6110|sam.mitchell@hci.utah|
21244947|NCT03361748|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
21244948|NCT01762059|Massachusetts General Hospital|Dr. Steven J. Russell|617-726-1848|sjrussell@mgh.harvard.edu|
21244949|NCT04854096|NS Pharma, Inc.|Medical Affairs|+1-201-986-3860|trialinfo@nspharma.com|
21244950|NCT04757610|Opthea Limited|Chief Officer|+61 (0) 3 9826 0399|info@opthea.com|
21244951|NCT03811366|Hospital das clínicas- Faculdade de Medicina da Universidade São Paulo|Dra Joyce Hisae Yamamoto|41988263757|vmsakata@yahoo.com.br|
21244952|NCT04277936|Vanderbilt University Medical Center|Stephan Heckers|6159222665|stephan.heckers@vumc.org|
21293255|NCT02220855|IndianaU|Dr. Patrick Loehrer|317-944-0920|ploehrer@iu.edu|
21293256|NCT03419897|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
21293257|NCT05112679|University of Pittsburgh|Sashwati Roy, PI|412 6240422|sar453@pitt.edu|
21293258|NCT05730725|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21293259|NCT02052661|GlaxoSmithKline|GSK Response Center|866-435-7343||
21293260|NCT01133756|Eisai Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
21293261|NCT02234713|Hospital for Sick Children|Dr. Ann Yeh|416-813-7353|ann.yeh@sickkids.ca|207353
21293262|NCT03574610|Houston Methodist Hospital|Rose Khavari, MD|7134419118|rkhavari@houstonmethodist.org|
21293263|NCT04105738|University of Massachusetts|Arlene Williams|508-856-5584|arlene.williams@umassmed.edu|
21293264|NCT01945216|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21293265|NCT03501992|Mayo Clinic|Robert M Jacobson, MD|507-250-4576|jacobson.robert@mayo.edu|
21293266|NCT03941873|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
21293267|NCT04473950|University of California, San Francisco|David Andrew Tompkins, MD, MHS|628-206-3645|david.tompkins@ucsf.edu|
21293268|NCT01541735|Instituto Mexicano del Seguro Social|PhD. Manuel González Ortiz|33 36176000|uiec@prodigy.net.mx|31494
21293269|NCT01664117|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21293270|NCT02982772|Florida International University|Maria Jose Miguez|561-839-0223|mjmiguez@fiu.edu|
21293271|NCT02974140|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21293272|NCT01905943|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21293273|NCT00626782|Wills Eye Hospital|Prinicipal Investigator|484-434-2700|mpro2020@yahoo.com|
21293274|NCT01238991|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21293275|NCT03573206|Cardiva Medical|Terry Alverson, Director of Regulatory and Clinical|650-207-0563|Terry_Alverson@cardivamedical.com|
21293276|NCT00416494|Duke University Medical Center|Brant Hamel|919-68-1861|brant.hamel@duke.edu|
21293277|NCT02574078|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
21293278|NCT02222688|University of California, San Diego|Thomas Kipps, MD, PhD|858-534-5400|tkipps@ucsd.edu|
21293279|NCT06219967|SUNY Upstate Department of Emergency Medicine|Michael Keenan, MD|315-416-4457|keenanm@upstate.edu|
21293280|NCT05875727|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21293281|NCT02297815|Children's Hospital of Philadelphia|Dr. Jeffrey Gerber|(267) 426-8775|gerberj@email.chop.edu|
21293282|NCT02346903|Bassett Healthcare Network Research Institute|Melissa B Scribani|6075477635|melissa.scribani@bassett.org|
21293283|NCT03440463|Old Dominion University|Dr. Abby Braitman|757-683-3708|abraitma@odu.edu|
21293284|NCT00293813|Amgen Inc.|Study Director|866-572-6436||
21293285|NCT00460655|GlaxoSmithKline|GSK Response Center|866-435-7343||
21293286|NCT03650413|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21293287|NCT02553928|H. Lundbeck A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com|
21293288|NCT00910910|Celgene Corporation|Anne McClain, Senior Manager of Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
21244953|NCT03819686|Emory University|Dr. Kimberly Jacob Arriola|404)-727-2600|kjacoba@emory.edu|
21244954|NCT03747484|Fred Hutchinson Cancer Center|Joshua Veatch|206.667.5108|jveatch@fredhutch.org|
21244955|NCT04563793|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
21244956|NCT02790931|University of Sao Paulo|Isabel de Camargo Neves Sacco|+551130918426|icnsacco@usp.br|
21244957|NCT03833245|University of Utah|Gerald Cochran, PhD|801-213-0799|jerry.cochran@hsc.utah.edu|
21244958|NCT03347383|iD3 Medical|Clinical Research Professional|+32 (0)52252745|office@iD3medical.com|
21244959|NCT04030169|Lykos Therapeutics|Berra Yazar-Klosinski, PhD / Chief Scientific Officer|877-627-7722|trialdata@lykospbc.com|
21244960|NCT05691452|Vanderbilt University School of Nursing|Dr. Chorong Park|6153436075|chorong.park@vanderbilt.edu|
21244961|NCT05549726|UCSF|Tamara Clark|415-517-3444|tamara.clark@ucsf.edu|
21244962|NCT04842643|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21244964|NCT02387853|LEO Pharma A/S|Clinical Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
21244965|NCT02630823|Washington University School of Medicine|Premal Thaker, M.D., MSc.|314-362-1740|thakerp@wustl.edu|
21244966|NCT05993078|Tianjin Medical University General Hospital|Jiayue Ding|18518347837|sjnkzz2@163.com|
21244967|NCT05062265|Atlantic Orthopaedic|Dr. Ashley Suttmiller|7573213300|suttmilera@atlanticortho.com|6283
21244968|NCT04172441|Zealand Pharma A/S|Charlotte Teglman Schiøler|+45 5060 3722|cschioler@zealandpharma.com|
21244969|NCT04236856|Corindus|Clinical Scientist|6173012445|hamid.rai@siemens-healthineers.com|
21244970|NCT04630262|DePuy Synthes|Kelly Francher, Staff Clinical Research Scientist|574-241-6581|kfranche@its.jnj.com|
21244971|NCT05114460|New York State Psychiatric Institute|Jermaine Jones PhD: Research Scientist/Associate Professor|646 774-6113|jermaine.jones@nyspi.columbia.edu|
21244972|NCT04703322|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21244973|NCT04638998|University of Alabama at Birmingham|Dr. Jarred Younger|205-975-5821|youngerlab@uab.edu|
21244974|NCT03988634|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21293289|NCT01973231|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21293290|NCT01485796|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21244975|NCT05374837|Rutgers School of Public Health|Shauna Downs|973-972-7212|sd1081@sph.rutgers.edu|
21293291|NCT04830215|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21293292|NCT02440139|Virginia Tech|Dr. ShihChung Benedict Lo|301-9215754|benlo@vt.edu|
21244976|NCT04600323|University of Colorado Denver|Dr. Jessica Kendrick|3037244837|jessica.kendrick@cuanschutz.edu|
21293293|NCT03754556|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21293294|NCT02509936|"Wuqu' Kawoq | Maya Health Alliance"|Dr Peter Rohloff|6174473034|peter@wuqukawoq.org|
21244977|NCT03841669|AdventHealth Research Institute|Dr. Kirk I. Erickson|4125763724|Kirk.Erickson@adventhealth.com|
21293295|NCT01692496|GEIS|Clinical Trial Coordinating Investigator|912866807|secretaria@grupogeis.org|
21244978|NCT05406921|AMGA|Elizabeth Ciemins, PhD, SVP Research|4062813275|eciemins@amga.org|
21244979|NCT04299009|Pittsburgh VA Healthcare System|Isabella Soreca|412 3606815|Isabella.Soreca@va.gov|
21244980|NCT00676715|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21244981|NCT02829814|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 799-8599|greg.sullivan@tonixpharma.com|
21244982|NCT04356027|Abbott|Tarn Teraphongphom, Principal Clinical Research Scientist|+1 (408) 931-0504|tarn.teraphongphom@abbott.com|
21244983|NCT04831281|Athira Pharma|Dr. Javier San Martin, CMO|1-866-725-0930|clinicaltrials@athira.com|
21244984|NCT03161379|Sidney Kimmel Cancer Center at Johns Hopkins|Daniel Laheru, MD|410-955-8974|laherda@jhmi.edu|
21244985|NCT05449795|Ascensia Diabetes Care|Jane Wallace|5748501467|jane.wallace@ascensia.com|
21244986|NCT03393975|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21244987|NCT05021640|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21244988|NCT02312960|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21244989|NCT02207062|University of Washington|Dr. Ajay Gopal, Professor|206-606-2037|agopal@uw.edu|
21244990|NCT02807636|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21244991|NCT05227209|Sumitomo Pharma America Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@suniovion.com|
21244992|NCT05633953|Recordati AG|Mario Maldonado|+41798030344|maldonado.m@recordati.com|
21244993|NCT04419389|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
21244994|NCT05327101|Abbott Medical Devices|Stephanie Delgado|818-493-3285|stephanie.delgado1@abbott.com|
21244995|NCT04638309|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
21244996|NCT05337748|University of Pretoria|Professor De Wet Swanepoel|+27827824009|dewet.swanepoel@up.ac.za|
21244997|NCT02506959|The University of Texas MD Anderson Cancer Center|Yago Nieto, MD / Stem Cell Transplantation Department|713-792-8750|ynieto@mdanderosn.org|
21244998|NCT04969419|Momentum Data Ltd|Dr Andrew McGovern|+44 7531221970|andy.mcgovern@momentumdata.co.uk|
21244999|NCT03453619|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
21245000|NCT04089371|Stryker|Monica Fleeman|251-465-5969|monica.fleeman@stryker.com|
21245001|NCT05229120|Henry Ford Health|Julia Felton, PhD|704-995-7832|jfelton4@hfhs.org|
21245002|NCT05134350|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21245003|NCT03932682|Seqirus|Clinical Trial Disclosure Manager|+1 855 358 8966|seqirus.clinicaltrials@seqirus.com|
21245004|NCT04950192|Philips IGTD|Rashmi Ram, Director of Clinical Development|719-464-6326|rashmi.ram@philips.com|
21245005|NCT03940963|Axogen|Stacy Arnold, VP of Product Development and Clinical Research|770-833-2570|sarnold@axogeninc.com|
21245006|NCT05323084|Pennington Biomedical Research Institute|Prachi Singh|15072068331|prachi.singh@pbrc.edu|
21245007|NCT01198366|Aeras|Product Director|301-547-2919|blandry@aeras.org|
21245008|NCT04401800|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21245009|NCT05751382|Dentsply Sirona Implants and Consumables|AnnaKarin Lungren Dr.|0046 702 666 492|annakarin.lundgren@dentsplysirona.com|
21245010|NCT05767437|University of Valencia|Jose casaña Granell|677361782|jose.casana@uv.es|
21245011|NCT03941860|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21245012|NCT00084552|Fox Chase Cancer Center|Eric Horwitz|215-728-2995|Eric.Horwitz@fccc.edu|
21245013|NCT03748342|UT Southwestern Medical Center|Dr. Tiffany Moon|469/419-5790|Tiffany.Moon@UTSouthwestern.edu|
21245014|NCT04774380|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21245015|NCT05792423|MGH|Anthony Samir|6176432009|asamir@mgh.harvard.edu|
21245016|NCT04572750|VA Palo Alto Health Care System|Keith Humphreys, PhD|(650) 493-5000|keith.humphreys@va.gov|
21245017|NCT02485834|Weill Medical College of Cornell University|Manish A. Shah MD|646-962-6200|mas9313@med.cornell.edu|
21245018|NCT03604263|Medtronic CRHF|Krestyn Thomas|6123236613|krestyn.j.thomas@medtronic.com|
21245020|NCT05902793|The Second Affiliated Hospital of Zhejiang University School of Medicine|Dr. Zhijun Pan|0571-87783777|zepzj@163.com|
21245021|NCT05121740|PharmaMar, S.A.|Clinical Development Virology Business Unit PharmaMar|91 846 60 00|virologytrials@pharmamar.com; clinicaltrials@pharmamar.com|
21245022|NCT04847544|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
21245023|NCT06391177|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-7428|medicalinformation@phathompharma.com|
21245024|NCT04311996|University of Minnesota|Bonny Donzella|6126244351|donzella@umn.edu|
21245025|NCT03676582|Sheffield Teaching Hospitals NHS Trust|Lise Sproson|07753827428|Lise.Sproson@nihr.ac.uk|
21245026|NCT03744936|Mayo Clinic|Dr. Victor Montori|507-284-1920|montori.victor@gmail.com|
21245027|NCT03328702|University of California, Davis|Dr. Peter Belafsky|8582053366|pcbelafsky@ucdavis.edu|
21293296|NCT00770562|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21245028|NCT04833777|University of Saskatchewan|Dr. David Sauder|306-955-9800|sauderdave@gmail.com|
21245029|NCT04674358|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
21245030|NCT03158805|Lindner Center of HOPE|Susan McElroy|5135360700|susan.mcelroy@lindnercenter.org|
21293297|NCT01643408|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
21262115|NCT02740153|Children's National Medical Center|Dr. Nicholas Ah Mew|202-476-5863|nahmew@childrensnational.org|
21262116|NCT02284399|Mednax. Inc|Kimberly Maurel|714-593-9171|kimberly_maurel@mednax.com|
21262117|NCT00073333|University of Central Florida|Deborah C. Beidel, Ph.D.|407-823-3254|deborah.beidel@ucf.edu|
21262118|NCT00915005|UT MD Anderson Cancer Center|Dr. Zhongxing Liao, MD/Professor, Radiation Oncology Department|(713) 563-2300|zliao@mdanderson.org|
21262119|NCT00471380|Alcon Research, LTD|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21262120|NCT00090285|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21262121|NCT01936649|GE Healthcare|Dr. Jose Zubeldia|011-44-1494-543137|jose.zubeldia@ge.com|
21262122|NCT03904446|University of Iowa|Cynthia A. Wong, MD|13193563868|cynthia-wong@uiowa.edu|
21262123|NCT03090620|UColorado|Dr. George Sam Wang|303-724-9967|george.wang@childrenscolorado.org|
21262124|NCT00631488|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21262125|NCT03648476|Indiana University|Dawn Neumann|3173292188|dmneuman@iupui.edu|
21262126|NCT00103194|"ECOG Statistical Office"|"Study Statistician"|617-632-3012||
21262127|NCT03136705|Northwestern University Feinberg School of Medicine|Doctor|312-503-6921|tamara.isakova@northwestern.edu|
21262128|NCT02855411|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
21262129|NCT01391312|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21262130|NCT01097616|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21262131|NCT01848821|Massachusetts General Hospital|Dr. Daniel Dante Yeh, Assistant Professor of Surgery|617-724-8604|dyeh2@partners.org|
21262132|NCT00591227|Rush University Medical Center|David Baldwin MD|312-942-6163|david_baldwin@rush.edu|
21262133|NCT00130208|Keryx Biopharmaceuticals|Medical Information|1-844-44-KERYX|medicalinfo@keryx.com|
21262134|NCT01215318|University Hospital of Zurich|Irene A Burger|+41 44 255 11 11|irene.burger@usz.ch|
21262135|NCT04655586|Arca biopharma Inc.|Dr. Michael Bristow|720-940-2100|Michael.Bristow@arcabio.com|
21262136|NCT02345369|Bassett Medical Center|clinical research nurse supervisor|6075476965|jennifer.victory@bassett.org|
21262137|NCT03897712|Bausch & Lomb|Johnson Varughese|9089271162|Johnson.Varughese@bauschhealth.com|
21262138|NCT01733069|Gen-Probe Incorporated|Jennifer Reid, Director of Clinical Affairs|858-731-5985|jennifer.reid@hologic.com|
21262139|NCT00117338|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21262140|NCT04734873|Corvus Pharmaceuticals|Study Director|650-900-4520|clinicaltrials@corvuspharma.com|
21262141|NCT00621933|Allergan, Inc|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
21262142|NCT01342640|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21262143|NCT02616029|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21262144|NCT00609609|The University of Texas (UT) MD Anderson Cancer Center|Dr. Amin Majid Alousi, Associate Professor, Stem Cell Transplantation|713-792-7734|CR_Study_Registration@mdanderson.org|
21262145|NCT04084392|Vanderbilt University Medical Center|Dr. Dave Marcovitz|615-936-3555|david.marcovitz@vumc.org|
21262146|NCT03988751|Wake Forest University School of Medicine|Dr. Clancy Clark|335-480-8064|cjclark@wakehealth.edu|
21262147|NCT00844883|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
21262148|NCT01938170|UNC Chapel HIll|Ravi Jhaveri MD|919-962-5136|ravi.jhaveri@unc.edu|
21262149|NCT00824538|University of California San Francisco|Hope S Rugo|877-827-3222|clinicaltrials@ucsf.edu|
21262150|NCT01857986|Hospitech Respiration|Clinical Trials Manager|+972-3-9191648|adir@hospitech.co.il|5
21262151|NCT03065530|The First Affiliated Hospital of Nanjing Medical University|Dr. Shijiang Liu, Dr. Mei Gao|+862568303569|liushijiang1983@hotmail.com|
21262152|NCT03811951|University of Illinois at Chicago - College of Pharmacy|Ajna Hamidovic|312-355-1713|ahamidov@uic.edu|
21262153|NCT00479466|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21262154|NCT02927171|University of Colorado Denver|Dr. Jennifer Stevens-Lapsley|303.724.9170|jennifer.stevens-lapsley@cuanschutz.edu|
21262155|NCT01065480|New York State Psychiatric Institute|Edward V. Nunes, MD|646-774-6122|nunesed@nyspi.columbia.edu|
21262156|NCT02677701|Seattle Children's Hospital|Arthur Baines|2068841431|arthur.baines@seattlechildrens.org|
21262157|NCT04530825|Washington University School of Medicine|Maura Kepper, Ph.D.|314-935-0142|kepperm@wustl.edu|
21262158|NCT03870022|Pivot Health Technologies Inc.|VP of Clinical and Medical Affairs|415-757-7696|marler@pivot.co|
21262159|NCT04101422|Moffitt Cancer Center|Christine Vinci|813-745-5421|Christine.Vinci@moffitt.org|
21262160|NCT00850499|Johnson & Johnson Pharmaceutical Research & Development|Andrew Cakana, MD, FRC Path||[ACAKANA@ITS.JNJ.COM|
21262161|NCT00552305|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
21262162|NCT00718861|Novartis Pharmaceuticals|Study Director|8627788300||
21262163|NCT01703819|Biologische Heilmittel Heel GmbH|Christine Frank, PhD|+49 7221 501 3188|christine.frank@heel.com|
21262164|NCT01302041|Astellas Pharma Global Devlopment, Inc.|Clinical Trial Disclosure||Astellas.resultsdisclosure@astellas.com|
21262165|NCT01241513|USARIEM|Charles S Fulco, PI|508 233-4893|charles.fulco@us.army.mil|
21262166|NCT01834144|University of Manitoba|Dr. Jonathan McGavock|204-480-1359|jmcgavock@chrim.ca|
21293298|NCT03697161|Ovid Therapeutics|Todd F. Baumgartner, M.D., MPH|8027525168|tbaumgartner@ovidrx.com|
21293299|NCT00292045|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
21293300|NCT00606411|Massachusetts General Hospital|Dr. John W. Winkelman|617-643-9101|jwwinkelman@partners.org|
21293301|NCT04503551|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21293302|NCT03726658|Gate Neurosciences, Inc|Chief Medical Officer|203-247-3895|ron.burch@gateneuro.com|
21293303|NCT00412958|ThromboGenics|Petra Kozma-Wiebe, MD|+32 16751310|petra.kozma@thrombogenics.com|
21235710|NCT03704376|The University of Texas Health Science Center at Houston|Lane Bailey, PhD, PT|713-704-6794|lane.bailey@uth.tmc.edu|
21235711|NCT06748040|Duke University|Hrishikesh Chakraborty, PhD|919-668-1238|hrishikesh.chakraborty@duke.edu|
21235712|NCT02562755|SillaJen Biotherapeutics Inc.|Kyoung Soo Ha, Senior Medical Director|+1-415-281-8886|ksha@kr.sillajen.com|
21235713|NCT01577706|McLean Hospital|Dr. J. Eric Jensen|617-855-3366|ejensen@mclean.harvard.edu|
21235714|NCT01782131|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21235715|NCT01627249|Jaeb Center for Health Research|Adam Glassman|813-975-8690|drcrstat2@jaeb.org|
21235716|NCT00796718|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21235717|NCT02744534|Emory University|Baowei Fei, PhD|972-883-7239|bfei@utdallas.edu|
21235718|NCT02391402|Portland VA|Megan Callahan|503-220-8262|megan.callahan@va.gov|50525
21235719|NCT02318329|Five Prime Therapeutics|Medical Lead|415-365-5600|FPA144@fiveprime.com|
21235720|NCT02044510|Lawson Research Institute|Mary McKibbon|5196466367|mary.mckibbon@sjhc.london.on.ca|
21235721|NCT03971617|Stony Brook University Medical Center|Sandra Skinner|631-444-7513|sandra.skinner@stonybrookmedicine.edu|
21235722|NCT02979535|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21235723|NCT02621983|Atlanta VA Medical Center|Dr. Erica Duncan|404-321-6111|erica.duncan@va.gov|207532
21235724|NCT00767000|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21235725|NCT03103282|3-D Matrix Europe SAS|Florian REBECA|+33617587769|frebeca@puramatrix.com|
21235726|NCT01722331|Sun Pharma Advanced Research Company Limited|Head-Clinical Development|912266455645|clinical.trials@sparcmail.com|
21235727|NCT02855060|Atrium Health|Rachel Seymour|74-355-6969|rachel.seymour@atriumhealth.org|
21235728|NCT04088097|Yale University|Dr Janet Lydecker|2037374299|janet.lydecker@yale.edu|
21235729|NCT01126593|Orlando Orthopaedic Center|Dr. Randy Schwartzberg|(407) 254-2500|orlandosportsdoc@yahoo.com|
21235730|NCT03556761|University of Pennsylvania|Dr Lisa Levine|215-662-6913|lisa.levine@pennmedicine.upenn.edu|
21235731|NCT03057119|Florida State University|Katie Kloss|9045716395|katie.kloss@med.fsu.edu|
21235732|NCT00353704|Baerum Hospital|Ulrich J Spreng|004798499184|ulispreng@hotmail.com|
21235733|NCT02525133|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
21235734|NCT01343082|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
21235735|NCT01154166|GlaxoSmithKline|GSK Response Center|866-435-7343||
21235736|NCT01375049|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21235737|NCT03614793|University of Utah Orthopaedic Center/ Physical Medicine & Rehabilitation|Zachary McCormick, MD|801-587-1493|u6014808@umail.utah.edu|
21235738|NCT02082522|At the request of Concordia Laboratories Inc.|Dr. Michelle Depot||michelle.depot@advanzpharma.com|
21235739|NCT01575561|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
21235740|NCT00633984|Boston University|Dr. Stefan G. Hofmann|617 353 9233|shofmann@bu.edu|
21235741|NCT02840877|Boston Medical Center|Karen Jacobson, MD MPH|617-414-5213|karen.jacobson@bmc.org|
21235742|NCT01168999|University of Florida|Dr. Joel Bialosky|352-273-8636|bialosky@phhp.ufl.edu|
21235743|NCT01276327|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21235744|NCT05209191|REAL Prevention LLC|Dr. Michael L. Hecht|18143601893|HECHTPSU@GMAIL.COM|
21235745|NCT03766646|University Hospital Southampton|Dr Patrick Butler|81205662|patrick.butler@uhs.nhs.uk|+44 (0)23
21235746|NCT01037309|Prosensa|Fiona Lawrence|+31(0)713322100|f.lawrence@prosensa.nl|
21235747|NCT02652780|GenSight Biologics|Regulatory Affairs|176217220|ipengue@gensight-biologics.com|0033
21235748|NCT01172938|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|clinicaltrialdisclosure@celgene.com|
21235749|NCT01033747|Novartis Pharmaceuticals|Study Director|862 778-8300||
21235750|NCT00003498|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
21235751|NCT02956629|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21235752|NCT04188041|Kent Hospital|Daria Szkwarko, PI|401-921-7981|szkwarkd@gmail.com|77981
21235753|NCT04177693|Yale University|Dr. Heping Zhang|2037855185|heping.zhang@yale.edu|
21235754|NCT04067141|CooperVision, Inc.|Jose A. Vega, O.D., MSC., FAAO|9256213761|javega@coopervision.com|
21235755|NCT01557946|McLean Hospital, Biological Psychiatry Laboratory|Dr. Brian Brennan, MD|617-855-2911|bbrennan@partners.org|
21235756|NCT01219738|University of Miami|Eliana Mendes|(305) 243-2568|e.mendes@miami.edu|
21235757|NCT01978119|GlaxoSmithKline|GSK Response Center|866-435-7343||
21235758|NCT02639884|Masimo Corporation|Vikram Ramakanth|9492977416|vramakanth@masimo.com|
21235759|NCT00812812|GlaxoSmithKline|GSK Response Center|866-435-7343||
21235760|NCT01047683|Amarin Pharma, Inc.|Alex Giaquinto|+1 908 326 1324|alex.giaquinto@amarincorp.com|
21235761|NCT02822794|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21235762|NCT04408963|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
21235763|NCT05061446|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21235764|NCT05468398|University of California, Irvine|Navid Alem, MD / Principal Investigator|(949) 413-4950|alemn@hs.uci.edu|
21235765|NCT02661828|Emory University|Boadie Dunlop, MD|404-727-8474|vcruz@emory.edu|
21235766|NCT05857527|Medical University of South Carolina|Kelly McGloon|8437926443|mcgloon@musc.edu|
21235767|NCT02543346|Kingston General Hospital|Dr. Anne Ellis|6135482336|ellisa@kgh.kari.net|
21235768|NCT01194674|National Institutes of Health|H. Nida Sen, Principal Investigator, National Eye Institute|301-402-3254|senh@nei.nih.gov|
21245031|NCT02682316|Memorial Sloan Kettering Cancer Center|Dr. Mario Leitao, MD|212-639-3987|leitaom@mskcc.org|
21235769|NCT03074734|TobaccoFree Research Institute Ireland|Professor Luke Clancy|+353868364337|lclancy@tri.ie|
21235770|NCT00006411|JCHR|Roy W. Beck, MD, PhD|813-975-8690|cds@jaeb.org|
21235771|NCT01440946|Bioverativ|Bioverativ Study Medical Director||clinicaltrials@bioverativ.com|
21235772|NCT01975389|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21235773|NCT02127307|GE Healthcare|Jose M Zubeldia, M.D.|011-44-1494-5431347|jose.zubeldia@ge.com|
21235774|NCT01312961|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21235775|NCT03333746|The Ohio State University Comprehensive Cancer Center|Dr. Yvonne Efebera|614-293-7243|Yvonne.Efebera@osumc.edu|1278
21235776|NCT00433992|Case Western Reserve University|Dr. Grace McComsey|216-844-2739|mccomsey.grace@clevelandactu.org|
21235777|NCT01514318|DJO Surgical|Dr. Jane M. Jacob|512-834-6323|jane.jacob@djoglobal.com|
21235778|NCT02002494|Toronto Western Hospital/UHN|Emad Al Azazi|416-603-8500|emad.alazazi@uhnresearch.ca|6237
21235779|NCT04666441|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21235780|NCT00766415|AstraZeneca|Alison Holt||ClinicalTrialTransparency@astrazeneca.com|
21235781|NCT01114516|Northwestern University Feinberg School of Medicine|Dr. Emily Miller|3124724685|emily-miller-1@northwestern.edu|
21235782|NCT00132769|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21235783|NCT01431508|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21235784|NCT02755935|Cochlear Americas|Ginger Grant, AuD|410-375-0883|ggrant@cochlear.com|
21235785|NCT00129259|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21235786|NCT01016834|Zogenix|Judith Myers, Senior Director Clinical Operations|510-550-8300|jmyers@zogenix.com|
21235787|NCT03809182|Pontificia Universidad Católica de Chile|Mauricio Ibacache MD|+56984421425|mibacach@med.puc.cl|
21235788|NCT03794089|VA Center for Integrated Healthcare|Dr. Robyn L. Shepardson|315-425-4400|Robyn.Shepardson@va.gov|53956
21235789|NCT03985423|Sobi|Radmila Kanceva, MD|+4686972000|radmila.kanceva@sobi.com|
21235790|NCT02487563|Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University|Yaqiong Tang|+86 18896588075|tangyaqiong@suda.edu.cn|
21235791|NCT03821376|Indiana University|Jordan Swensson, MD|317-944-1831|jswensso@iu.edu|
21235792|NCT00071487|GlaxoSmithKline|GSK Response Center|866-435-7343||
21235793|NCT00581945|Study Director|Novartis Pharmaceuticals|862-778-8300||
21235794|NCT01519713|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21235795|NCT04820673|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
21235796|NCT01162005|Seoul National University Children's Hospital|Hee Gyung Kang|+82-2-2072-0658|pedneph@snuh.org|
21235797|NCT02032901|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21235798|NCT00982020|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21235799|NCT04317586|Stryker|Kevin Barga|2018315073|kevin.barga@stryker.com|
21235800|NCT03003676|Targovax|Dr. Lone H. Ottesen, Chief Development Officer|+44 7920567911|lone.ottesen@targovax.com|
21235801|NCT02530619|Northwestern University, Feinberg School of Medicine|Brady L. Stein, MD|312-695-6832|bstein@nmff.org|
21235802|NCT01282710|Reproductive Research Technologies, LP|Jack McCrary|7136800200|jmc@innovalp.com|
21235803|NCT00786916|Akron Children's Hospital|Michael D. Reed, Pharm.D.|330-543-3193|MReed@chmca.org|
21235804|NCT03021759|University of Pennsylvania|Rebecca Pepe|215-360-0951|peper@pennmedicine.upenn.edu|
21235805|NCT01854554|UT MD Anderson Cancer Center|Dr. Caroline Chung, MD- VP, Chief Data Officer, Data Impact & Governance|(713) 745-5422|cchung3@mdanderson.org|
21235806|NCT02819726|Archigen Biotech Ltd|Medical Director|+44(0)20 3749 5000|info@archigenbio.com|
21235807|NCT00359762|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21235808|NCT02829034|University of Pennsylvania|Yuchi Han, PI of the study|215-615-3417|yuchi.han@uphs.upenn.edu|
21235809|NCT02613481|Yardley Dermatology Associates, PC|Director of Clinical Trials|2155796155|rfried@yardleyderm.com|
21235810|NCT00701389|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21235811|NCT00803023|Jazz Pharmaceuticals|Director of Clinical Development|650-496-3777||
21235812|NCT02647658|University of Pittsburgh|Dr. Charity Patterson|412-383-4812|cgp22@pitt.edu|4123834812
21235813|NCT01542528|Yale University|Dr. James Leckman|203-785-5880|james.leckman@yale.edu|
21235814|NCT05282004|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21235815|NCT02202135|AstraZeneca-PPD|Yunxia Lu|910-558-4197|Yunxia.Lu@ppdi.com|
21235816|NCT02256111|Duke University|Michael Harrison, MD|919-668-4615|michael.harrison@duke.edu|
21235817|NCT04382326|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21235818|NCT02710630|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21235819|NCT02461589|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
21235820|NCT01038921|Emory University|Dr. Abinav Goyal|404-727-8758|agoyal4@emory.edu|
21235821|NCT04695691|Cutera|Director Clinical Research|415-657-5518|mdoucette@cutera.com|
21235822|NCT00559897|Barbara Ann Karmanos Cancer Institute|Dr. Shirish Gadgeel|313-576-8753|gadgeels@karmanos.org|
21235823|NCT03295201|Marmara University|Dr. Kardelen Gencer Atalay|5324404887|kardelengencer@gmail.com|532
21235824|NCT02519504|Emory University|Judith Fridovich-Keil, PhD|404-727-3924|jfridov@emory.edu|
21235825|NCT00572572|Hoosier Cancer Research Network|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
21235826|NCT01831089|Pharma Mar, S.A.|Clinical Development Department of PharmaMar´s Oncology Business Unit.|+34 91 846 60 00|clinicaltrials@pharmamar.com|
21245032|NCT03101904|Bangor Univeristy|Dr Jamie Hugo Macdonald|+44 1248 38|j.h.macdonald@bangor.ac.uk|3272
21245033|NCT04538417|University of Utah Orthopaedic Center/ Physical Medicine & Rehabilitation|Zachary McCormick, MD|801-587-1493|u6014808@umail.utah.edu|
21293304|NCT01318135|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
21293305|NCT01017042|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21293306|NCT01794312|Laboratoires Théa|Clinical Development Director|+33(0)473981414|Corentin.LECAMUS@theapharma.com|
21293307|NCT01523743|Hopital Raymond poincare|Pref. Emmanuel Chartier-kastler|+33 1 42 17 71 29|emmanuel.chartier-kastler@psl.aphp.fr|
21293308|NCT02569476|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21293309|NCT01071954|Amgen (EUROPE) GmbH|IHQ Medical Info-Clinical Trials||MedInfoInternational@amgen.com|
21293310|NCT01152788|NCIC Clinical Trials Group|Dr. Janet Dancey|1-613-533-6430|jdancey@ctg.queensu.ca|
21293311|NCT00598507|H. Lee Moffitt Cancer Center and Research Institute|Ronald DeConti, M.D., Principal Investigator|813-745-8466|ronald.deconti@moffitt.org|
21293312|NCT01434654|St Vincent's Hospital, Sydney|Prof. Bruce Brew|+61 2 8382 1111|b.brew@unsw.edu.au|4100
21293313|NCT04767061|Weill Cornell Medicine|Princess Osma|646-962-5910|pro4001@med.cornell.edu|
21293314|NCT03782064|Beth Israel Deaconess Medical Center|Emma Logan, Director of Research Nursing|6176675984|eklogan@bidmc.harvard.edu|
21293315|NCT00363142|GlaxoSmithKline|GSK Response Center|866-435-7343||
21293316|NCT02137447|Massachusetts General Hospital|Dr. Daniel Dante Yeh, Assistant Professor of Surgery|6177248604|dyeh2@partners.org|
21293317|NCT02625220|Johnson & Johnson Vision Care Inc.|Benjamin Straker, BAppSc(Optom)(HonS) Principal Research Optometrist|904-443-3500|Bstraker@ITS.JNJ.com|1380
21293318|NCT01140867|Eisai Korea Inc.|Jihee Mun, Pharmacist, Medical Department manager|+82-2-3451-5531|jihee_mun@eisaikorea.com|
21293319|NCT01926444|PCC INC.|Patrick Colin|514-586 9297|PCOLIN@VIDEOTRON.CA|
21293320|NCT03751371|The Ohio State University|Anne Kloos|614-688-5942|kloos.4@osu.edu|
21293321|NCT00995436|ChestyerfieldNDRH|Jonathan Sandler|01246512106|JonSandler57@gmail.com|
21293322|NCT02880228|Mayo Clinic|Shaji K Kumar MD|5072842511|kumar.shaji@mayo.edu|
21293323|NCT03035864|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
21293324|NCT02340169|Taro Pharmaceuticals|Senior Director, Clinical Research|+1 914-345-9001|natalie.yantovskiy@taro.com|
21293325|NCT03129464|Cleveland Clinic Florida|Pamela Frazzini Padilla|9546595559f|frazzip@ccf.org|
21293326|NCT04209387|VA Bedford Healthcare System|Mo Modarres, PhD|2164966169|mmodarres@verizon.net|
21293327|NCT02842086|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21293328|NCT01530178|Children's Hospital at Montefiore|Dr. Rubina Heptulla|718-920-7004|rheptull@montefiore.org|
21293329|NCT05935878|University of Oxford, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences|Professor David W Murray|+44 01865 27457|david.murray@ndorms.ox.ac.uk|
21293330|NCT03980743|Washington University School of Medicine|Dr. Ginger E. Nicol|314-747-1862|nicolg@wustl.edu|
21293331|NCT02709512|Polaris Pharmaceuitcals Inc|Dr. Mirla Langlois|858-452-6688|mlanglois@polarispharma.com|161
21293332|NCT02155101|University of Liverpool|Professor Anna Maria Geretti|+44(0)151 795 9625|Geretti@liverpool.ac.uk|
21293333|NCT05327660|Consumer Wellness Solutions/RVO Health|Dr. Kristina Mullis|765-265-9169|kmullis@rvohealth.com|
21235827|NCT02548962|Pharmacyclics Switzerland GmbH|Dr. Bernhard Hauns, Medical Monitor|+41 52 556 0800|bhauns@pcyc.com|
21235828|NCT04071951|Cedars-Sinai Medical Center|Joshua Pevnick|310.423.4683|pevnickj@cshs.org|
21245034|NCT05693610|Northwestern University|Varsha Rallapalli|847-467-0897|varsha8904@gmail.com|
21245035|NCT06311084|Imperial College London|Dr Martina Di Simplicio|0208 383 4162|m.di-simplicio@imperial.ac.uk|
21245036|NCT04453592|FIFA|Dr Andreas Serner|+41796253899|andreas.serner@fifa.org|
21245037|NCT01331005|Jaeb Center for Health Research|Adam Glassman|813-975-8690|drcrnet@jaeb.org|
21245038|NCT04092387|University of Vermont|Stephen T. Higgins, PhD|802-735-6267|stephen.higgins@uvm.edu|
21245039|NCT03205800|University of Maryland, Baltimore|Se-Lim Oh|4107063708|soh@umaryland.edu|
21245040|NCT02193958|FUJIFILM Pharmaceuticals U.S.A, Inc.|Vice President of Clinical Operations|(617) 945-3763|fphucontact@fujifilm.com|
21245041|NCT04501861|Cleveland Clinic Foundation|Dr. Mariya Geube|216-444-2779|Geubem@ccf.org|
21245042|NCT03131648|LEO Pharma A/S|Disclosure|+45 44945888|disclosure@leo-pharma.com|
21245043|NCT02724878|Dana-Farber Cancer Institute|Toni Choueiri|617-632-5456|toni_choueiri@dfci.harvard.edu|
21245044|NCT02496780|University of Minnesota|Antoinette Moran|612-624-5409|moran001@umn.edu|
21245045|NCT04421378|Karyopharm Therapeutics Inc|Karyopharm Medical Information|(888) 209-9326|clinicaltrials@karyopharm.com|
21245046|NCT04258709|University of Pittsburgh|Dr. Jill Demirci|412-648-9236|JVR5@pitt.edu|
21245047|NCT02592330|Massachusetts Eye and Ear|Michael Cheung, MS, CCRP (Clinical Research Project Manager)|617-573-6981|mcheung0@meei.harvard.edu|
21245048|NCT03090152|Hospital for Special Surgery|Dr. Kethy Jules-Elysee|2126061036|JulesElyseeK@HSS.EDU|
21245049|NCT01566695|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21235829|NCT01485861|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21235830|NCT04111497|Fred Hutchinson Cancer Center|Dr. Stephanie Lee|206-667-6190|sjlee@fredhutch.org|
21235831|NCT03056690|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
21235832|NCT02255110|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21235833|NCT02056301|Baylor College of Medicine|Chris Glover, MD, MBA|832-824-5800|cdglover@bcm.edu|
21235834|NCT02328326|VA Pittsburgh Healthcare System, Center for Health Equity Research and Promotion|Dr. Ann-Marie Rosland|4123602259|Ann-Marie.rosland@va.gov|
21235835|NCT01748994|Pennington Biomedical Research Center|Dr. Eric Ravussin|225-763-3186|eric.ravussin@pbrc.edu|
21262167|NCT02234583|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|1-908-992-6400|CTRinfo@DSI.com|
21293334|NCT00276406|Mayo Clinic|Adil E. Bharucha, MD|507-284-6439|bharucha.adil@mayo.edu|
21293335|NCT04248712|Mayo Clinic|Dawn Francis, M.D.|904-953-2254|Francis.Dawn@mayo.edu|
21293336|NCT00662831|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21293337|NCT00294671|Amyloidosis Center, Boston Medical Center|Dr. John L. Berk|617-638-4494|jberk@bu.edu|
21293338|NCT01966354|Complejo Hospitalario de Navarra|Dr. Mikel Batllori|0034 848422174|mikel.batllori.gaston@cfnavarra.es|
21293339|NCT01061723|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21293340|NCT01734785|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21293341|NCT02397915|GlaxoSmithKline|GSK Response Center|866-435-7343||
21293342|NCT00368745|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21293343|NCT03292874|Cedars Sinai Medical Center|Dr. Hyung L Kim|310-423-4700|kimhl@cshs.org|
21293344|NCT02476032|University of Minnesota|Patricia Lenton Director of Oral Health Research Clinic||lento001@umn.edu|
21245050|NCT05470400|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
21293345|NCT01308814|University of North Carolina at Chapel Hill|Susan S. Girdler, Ph.D.|919-966-2179|susan_girdler@med.unc.edu|
21293346|NCT01961297|Icahn School of Medicine at Mount Sinai|Dr. Kristina Simonyan|212-241-0656|kristina.simonyan@mssm.edu|
21293347|NCT02482298|AstraZeneca|Brilinta Global Clinical Leader|+46 31 776 10 00||
21293348|NCT00960401|Winthrop-University Hospital, Division of Hematology and Oncology|Dr. Alexander Hindenburg|516-663-9500|AHindenburg@winthrop.org|
21293349|NCT01685242|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
21293350|NCT03053440|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21293351|NCT01582009|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21293352|NCT05002985|University of Kentucky|Dawn Brewer|859-257-1661|dawn.brewer@uky.edu|
21293353|NCT02705105|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
21293354|NCT03093207|São Paulo State University - Unesp|Dr Mauro Pedrine Santamaria|+5516981937777|mauro.santamaria@unesp.br|
21293355|NCT00485758|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21293356|NCT04556591|University of Michigan|Dr. Noelle E. Carlozzi|734-764-0644|PMR-CODAlab@med.umich.edu|
21245051|NCT05974046|Clinical Development|Global Director|(804) 594-4488|trialdisclosure@indivior.com|
21245052|NCT04294225|Mayo Clinic|Tufia C Haddad MD|507/284-2511|Haddad.Tufia@mayo.edu|
21245053|NCT02790502|Department of Agriculture, Environmental and Development Economics, Ohio State University|Brian Roe|614-688-5777|roe.30@osu.edu|
21245054|NCT04812535|InflaRx GmbH|Dr. Camilla Chong, CMO|+49 3641-508-180|camilla.chong@inflarx.com|
21245055|NCT03436745|National Cancer Institute|William D. Figg, Pharm.D.|240-760-6179|figgw@mail.nih.gov|
21245056|NCT03661840|University of Colorado Hospital|Elissa Kolva, MD|7208488090|elissa.kolva@va.gov|
21245057|NCT02589275|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 904-0355|greg.sullivan@tonixpharma.com|
21245058|NCT00931710|Novartis Pharmaceuticals|Study Director|862-778-8300||
21245059|NCT04927065|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
21245060|NCT05671029|AiCuris Anti-infective Cures GmbH|Information Desk|+4920231763|info@aicuris.com|0
21245061|NCT03338790|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
21245062|NCT03846505|Medical University of South Carolina - Institute of Psychiatry|Stacey Sellers, Lab Manager|8437925807|sellersst@musc.edu|
21245063|NCT00601900|Memorial Sloan-Kettering Cancer Center|Maura Dickler, M.D.||dicklerm@mskcc.org|
21245064|NCT03924986|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
21245065|NCT04922502|Baylor College of Medicine|Dr. Eric Storch|(713) 798-3579|eric.storch@bcm.edu|
21245066|NCT05147155|University of Thessaly|Research Committee - Special Account for Research Grants University of Thessaly|+306971894688|raniakotsiou@gmail.com|
21245067|NCT05592418|AIM ImmunoTech Inc.|Diane Young|352-448-7797|diane.young@aimimmuno.com|
21245068|NCT03822845|University of Iowa Health Care|Dr. Michael Graham|319-356-4302|michael-graham@uiowa.edu|
21245069|NCT02386371|INSTITUT REGIONAL DU CANCER DE MONTPELLIER Cancer de Montpellier|Mme Aurore Moussion, Director of Direction of Clinical Research and Innovation|0467613102|drci-icm105@icm.unicancer.fr|+33
21245070|NCT01494662|Dana-Farber Cancer Institute|Rachel Freedman, MD|617-632-3800|Rachel_Freedman@dfci.harvard.edu|
21245071|NCT04072822|Indiana University School of Medicine|Samer Gawrieh, MD|(317) 278-9326|sgawrieh@iu.edu|
21245072|NCT05481320|UC Davis|Ladson Hinton, MD|9167343485|lwhinton@ucdavis.edu|
21245073|NCT03526874|Children's Hospital of Philadelphia|Dr. Christina Szperka|12155901719|szperka@chop.edu|
21245074|NCT06365086|University of Texas at Austin|Sara Hussain, PhD|5122322686|sara.hussain@austin.utexas.edu|
21245075|NCT05611073|Berkeley Eye Center|Tetiana Huff|713-620-7640|tetiana.huff@berkeleyeye.com|
21245076|NCT04314895|NanOlogy, LLC|Mark Mitchell|8179004074|mark.mitchell@dfb.com|
21245077|NCT05328648|University of North Carolina at Chapel Hill|Emilia Goland, MMSc|919-966-2017|emilia_goland@unc.edu|
21245078|NCT03930342|Washington State University|Michael McDonell|509 368-6967|mmcdonell@wsu.edu|
21245079|NCT02596126|Centro Nacional de Investigaciones Cardiovasculares Carlos III F.S.P (CNIC)|Antonio J Quesada, PhD|+34 914531200|aquesada@cnic.es|(#1163)
21245080|NCT04774237|Visus Therapeutics, Inc.|Visus Therapeutics|800-281-4536|trials.info@visustx.com|
21245081|NCT01328262|Haukeland University Hospital|Elin Opheim Netland|+4755976050|elin.opheim.netland@helse-bergen.no|
21293357|NCT03332173|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21293358|NCT00211172|Kaiser Permanente Center for Heatlh Research|David H. Smith|503-335-6302|david.h.smith@kpchr.org|
21293359|NCT04474197|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21245082|NCT05529966|Stanford University|Robert T. Chang, MD|650-725-5743|christyr@stanford.edu|
21245083|NCT02520063|UAB|Erica Stringer-Reasor|2059759375|esreasor@uabmc.edu|
21245084|NCT05574426|University of British Columbia|Dr. Jonathan Little|250-807-9876|jonathan.little@ubc.ca|
21245085|NCT04521478|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21245086|NCT04578912|University of Minnesota|Christine Conelea|(612) 261-3127|cconelea@umn.edu|
21245087|NCT02187003|Biossil Inc.|Head of Regulatory|978-245-7397|debora@biossil.ai|
21245088|NCT02379156|James J. Peters VA Medical Center|John P. Handrakis|718-584-9000|John.Handrakis@va.gov|3129
21245089|NCT05159583|University of California, Berekeley|Robert W. Levenson|510-643-8952|boblev@berkeley.edu|
21245090|NCT01525966|City of Hope Medical Center|Dr. Yuan Yuan|626-359-8111|Yuyuan@coh.org|
21245091|NCT03703700|Center for Reproductive Medicine, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University|Dr. Dongzi Yang|8602081332233|yangdz@mail.sysu.edu.cn|
21245092|NCT01195831|Leo Pharma|Malin Jaernkrants|+4544945888|malin.jaernkrants@leo-pharma.com|
21245093|NCT04725240|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
21245094|NCT01140880|Friends Research Institute, Inc.|Dr. Cathy J. Reback|323-463-1601|reback@friendsresearch.org|
21245095|NCT03779204|Unity Health Toronto|Dr. Naomi Thulien|647-460-0781|naomi.thulien@unityhealth.to|
21245096|NCT03958955|LEO Pharma A/S|Clinical Disclosure|+45 4494 5888|disclosure@leo-pharma.com|
21245097|NCT04673929|The Royal Marsden Hospital|Professor Vinidh Paleri|02078082732|vinidh.paleri@rmh.nhs.uk|
21245098|NCT05082909|Imperial College London|Dr Timothy Rawson|07891750151|antibiotic.research@imperial.ac.uk|
21245099|NCT04088630|Wake Forest University School of Medicine|Carol Kittel, Senior Biostatistician|336-399-3832|c.kittel@wakehealth.edu|
21245100|NCT03381261|Weill Cornell Medicine|Dr. Lisa Gfrerer|646.962.4250|lig4013@med.cornell.edu|
21245101|NCT04024813|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21245102|NCT02729311|University of California, San Francisco|Deborah Barnes, PhD|415-221-4810|Deborah.Barnes@ucsf.edu|4221
21245103|NCT02287610|Horizon Pharma Ireland, Ltd.|Mike Marshall, PharmD|224-383-3000|clinicaltrials@horizonpharma.com|
21245104|NCT06074523|Lehigh University|Nancy Carlisle|610-758-5122|nbc415@lehigh.edu|
21245105|NCT06093659|Imperial Brands PLC|Tasnim Abusalem|+44 (0) 117 332 2343|tasnim.abusalem@impbrands.com|
21245106|NCT00512070|VA Puget Sound Health Care System|Amanda Wood, PhD|253-583-1652|amanda.wood@va.gov|
21245107|NCT00961571|Georgetown University, Department of Medicine and Oncology|Dr. Aiwu Ruth He|202-444-8642|arh29@georgetown.edu|
21245108|NCT03070184|The University of Alabama at Birmingham|Nehal Vekariya, MS - Clinical Research Coordinator III|2059347173|nvekariya@uabmc.edu|
21245109|NCT03818659|University of California, San Francisco|Dr. Mark Pletcher|415-514-8008|mark.pletcher@ucsf.edu|
21245110|NCT05862870|UConn Health|Mark D. Litt, PhD|860-679-4680|Litt@uchc.edu|
21245111|NCT04321031|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21245112|NCT02900924|Veryan Medical|Nick Yeo|+441403258984|nick.yeo@veryanmed.com|
21245113|NCT04080531|Emory University|Craig C. Hofmeister, MD, MPH|404-778-0519|craig.hofmeister@emory.edu|
21245114|NCT03143153|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
21245115|NCT04237298|NUMalaysia|Dr Asma Ashari, Orthodontist and Senior Lecturer, Principal Investigator|+60192228440|asmaashari@ukm.edu.my|
21245116|NCT05285618|University of California, Santa Barbara|Michael Beyeler|(805) 893-4321|mbeyeler@ucsb.edu|
21245117|NCT04251299|University of New Mexico|Dr. Cindy Blair|15059257907|CiBlair@salud.unm.edu|
21245118|NCT04556656|Prilenia|Prilenia|+972 775558|info@prilenia.com|
21245119|NCT04541706|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21245120|NCT05536440|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21245121|NCT03094663|Hospital for Special Surgery, Anesthesiology|Dr. David Kim|2126061036|kimd@hss.edu|
21245122|NCT01416831|Earle A. Chiles Research Institute, Providence Cancer Institute|Brendan Curti, M.D.|503-215-6588|brendan.curti@providence.org|
21245123|NCT04784559|PharmaMar|Clinical Development Virology Business Unit|+34 918466000|virologytrials@pharmamar.com|
21245124|NCT05102591|University of Calgary/Alberta Health Services|Dr. Serena Orr|403-955-7728|serena.orr@albertahealthservices.ca|
21245125|NCT04588298|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21245126|NCT04621266|The University of Hong Kong|Dr Kris Lok|39176690|krislok@hku.hk|
21245127|NCT02085421|University of Minnesota|Caroline Demro|(612) 625-3330|schi0599@umn.edu|
21245128|NCT04021602|University of Kansas Medical Center|Lisette T. Jacobson, Ph.D., MPA, M.A., Associate Professor, Obstetrics and Gynecology|316-293-3484|ljacobson@kumc.edu|
21245129|NCT03892616|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21245130|NCT02243709|Brown University|Prof. Carolina Haass-Koffler|4155191385|carolina_haass-koffler@brown.edu|
21245131|NCT03683719|LEO Pharma A/S|Clinical disclosure|+45 4494 5888|disclosure@leo-pharma.com|
21245132|NCT02689284|TerSera Therapeutics LLC|VP, Scientific Communications|1-844-334-4035|tersera@medinfodept.com|
21245133|NCT05569252|Daiichi Sankyo|Contact for Clinical Trial Information|9089926400|CTRinfo_us@daiichisankyo.com|
21245134|NCT03665597|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21245135|NCT05516147|Hopeful Aging|Michael Skrajner|440-477-7881|mike@hopefulaging.com|
21245136|NCT01781468|Mayo Clinic Arizona|Alyx B. Porter Umphrey, M.D.|480-301-4062|Porter.alyx@mayo.edu|
21245137|NCT05371652|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21245138|NCT05256706|Emory University|Dr. Arshed Quyyumi|404-712-2741|aquyyum@emory.edu|
21245139|NCT05009004|Environment and Health Group|Patricia Weitzman|6174555976|pat.weitzman@ehgcambridge.com|
21245140|NCT04410042|St. Jude Children's Research Hospital|Michael D. Neel, MD|901-259-1600|mneel@orthosouth.org|
21293360|NCT00237666|The Medical Research Network, LLC|Dr. Michael Liebowitz|(212) 595-5012|MLiebowitz@MedicalResearchNetwork.com|
21293361|NCT00624468|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21293362|NCT04169529|Medtronic|Andy St. Martin|(952) 220-4009|andy.stmartin@medtronic.com|
21293363|NCT05371054|National Cancer Institute|Dr. Christopher J. Melani|240-760-6057|christopher.melani@nih.gov|
21293364|NCT01103440|Icahn School of Medicine at Mount Sinai|Dr. Annapoorna S Kini|(212) 241-4181|Annapoorna.Kini@mountsinai.org|
21293365|NCT03072043|Moffitt Cancer Center|David Sallman, MD|813-745-6841|David.Sallman@moffitt.org|
21293366|NCT01340664|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1 908 927-5775||
21293367|NCT02923531|X4 Pharmacueticals|Chief Medical Officer|(857) 529-8300|patientinfo@x4pharma.com|
21293368|NCT03232827|UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR|Dr. Theodore Wagener|405-271-4407|theodore-wagener@ouhsc.edu|50486
21293369|NCT01823198|University of Texas MD Anderson Cancer Center|Richard Champlin, MD / Stem Cell Transplantation Department|713-792-3618|rchampli@mdanderson.org|
21293370|NCT01653587|Santa Casa de Marília|Dr. Pedro Beraldo de Andrade|+551434025561|pedroberaldo@gmail.com|
21293371|NCT03786224|Massachusetts General Hospital|Randi Schuster, PhD|617-643-6673|rschuster@mgh.harvard.edu|
21293372|NCT01740258|Duke University|Annick Desjardins, MD, FRCPC|919-681-1691|annick.desjardins@duke.edu|
21293373|NCT00418093|Dana-Farber Cancer Institute|Neil Horowitz, MD|617-732-8843|nhorowitz@partners.org|
21293374|NCT01158820|Department of Anesthesiology & Critical Care|Jeff E Mandel MD MS|2156150553|mandelj@uphs.upenn.edu|
21293375|NCT05588440|Oncternal Therapeutics|Mary Breitmeyer|760-703-2802|mbreitmeyer@oncternal.com|
21293376|NCT00962871|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21293377|NCT00100802|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreporingcoordinator@childrensoncologygroup.org|
21293378|NCT02709720|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
21293379|NCT02132572|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21293380|NCT01941927|University of California, San Francisco|Adil Daud, MD|(415) 353-7392|Adil.Daud@ucsf.edu|
21293381|NCT06590441|CooperVision Inc.|José A. Vega|+1 (925) 621-3761|JVega2@coopervision.com|
21293382|NCT06875284|RTI International|Marni Kan, PhD|919-248-1836|mkan@rti.org|
21293383|NCT06631274|Florida State University|Dr. Lyndsay Jenkins|(850) 644-4592|lnjenkins@fsu.edu|
21293384|NCT00928187|UMI 233 IRD Montpellier|Dr Laura Ciaffi|00237 694926786|lauraciaffi2002@yahoo.fr|
21293385|NCT02524145|University of Texas Southwestern Medical Center|Dr. Satyam Sarma|214-345-7111|SatyamSarma2@texashealth.org|
21293386|NCT00735553|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
21293387|NCT05069597|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21293388|NCT00422448|Medical University of Graz - Austria|Prof. Dr. Iris Zalaudek|+436763328269|iris.zalaudek@gmail.com|
21235836|NCT02141516|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21293389|NCT02707965|University of Maryland, School of Pharmacy|Dr. James Polli|410-706-8292|jpolli@rx.umaryland.edu|
21293390|NCT00131352|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
21293391|NCT01771991|Sanford Health|Dr Chad Spanos MD|605-328-8200||
21293392|NCT01399229|Reproductive Research Technologies, LP|Jack McCrary|7136800200|jmc@innovalp.com|
21293393|NCT03809078|Stanford University|Dr. Andrei Iagaru, MD|650-725-4711|aiagaru@stanford.edu|
21293394|NCT02526212|Montefiore Medical Center-Albert Einstein College of Medicine|Aaron Fox, Principal Investigator|718-920-7173|adfox@montefiore.org|
21293395|NCT03645096|UT Southwestern Medical Center|Dr. Sherwood Brown|214-645-6950|Sherwood.Brown@utsouthwestern.edu|
21293396|NCT02096952|Massachusetts General Hospital|Dr. Gahan Joshi|617-726-8392|joshi.gagan@mgh.harvard.edu|
21293397|NCT02346643|St. Jude Medical|Roni Diaz|+1 972 309 8601|RDiaz@sjm.com|
21293398|NCT00635349|Janssen Korea / 25F, LS Yongsan Tower, 191 Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702 Korea|Clinical Research Director|82-2-2094-4518||
21293399|NCT00253513|OHSU Knight Cancer Institute|Eneida Nemecek, MD|(503) 494-0829|nemeceke@ohsu.edu|
21293400|NCT01313910|UCaliforniaDavis|David Asmuth, MD|9167348695|david.asmuth@ucdmc.ucdavis.edu|
21293401|NCT02446769|Philips|Chuck Cain|412-542-3605|chuck.cain@philips.com|
21293402|NCT04482439|Newsom Eye and Laser Center|T. Hunter Newsom, MD|813-908-2020|hunter@newsomeye.net|
21245141|NCT03302494|Coherex Medical, Inc.|Senior Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21245142|NCT03978871|University of Illinois, Urbana-Champaign|Dr. Karen Rudolph|217-333-8624|krudolph@illinois.edu|
21245143|NCT05710107|Medical University of South Carolina|Ellen Johnson|843-792-2322|hayell@musc.edu|
21245144|NCT04166773|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21245145|NCT05268302|University of Maryland, Baltimore Center for Vaccine Development and Global Health (CVD)|Kirsten E. Lyke, MD|410-706-5328|klyke@som.umaryland.edu|
21245146|NCT02811679|Massachusetts General Hospital|Jeffrey Barnes, MD, PhD|6177244000|JABARNES@mgh.harvard.edu|
21235837|NCT00861341|University of Rochester, Wilmot Cancer Center|Charles Francis, MD|585-275-3761|Charles_Francis@urmc.rochester.edu|
21235838|NCT03291613|Klein Buendel|Valerie Myers, PhD|3035654343|vmyers@kleinbuendel.com|
21235839|NCT01825408|UNC Department of Otolaryngology|Dr. Adam Zanation||adam_zanation@med.unc.edu|
21235840|NCT00658112|Wake Forest University Health Sciences|Steve Feldman MD|336-716-3775|sfeldman@wakehealth.edu|
21235841|NCT00983580|Mayo Clinic|Frank A. Sinicrope, M.D.||sinicrope.frank@mayo.edu|
21235842|NCT03735862|Miromatrix|Head of Clinical Affairs|952.942-6000|mmacenski@miromatrix.com|
21235843|NCT01337297|Federal University of Espírito Santo|Dr. Ester Miyuki Nakamura-Palacios|+55 27 7775-7337|emnpalacios@gmail.com|
21235844|NCT02778204|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
21235845|NCT04122443|Montefiore Medical Center|Dr. Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
21293403|NCT00645840|UT Southwestern Medical Center|Perrin White|214 648 6875|perrin.white@utsouthwestern.edu|
21293404|NCT00402324|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21293405|NCT01277822|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21293406|NCT00997984|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21293407|NCT01232127|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21293408|NCT03506412|Mayo Clinic|Naveen L. Pereira, M.D.|507-284-8612|Pereira.Naveen@mayo.edu|
21293409|NCT01176617|Hospital of the University of Pennsylvania|Dr. Sanjay Dixit|215-615-4337|sanjay.dixit@uphs.upenn.edu|
21293410|NCT03162796|Janssen Research & Development, LLC|Head Rheumatology Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21293411|NCT02727816|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com|
21293412|NCT02725476|Xencor, Inc.|Vice President, Biometrics|858-480-3414|bburington@xencor.com|114
21293413|NCT00289289|Medtronic CRDM Clinical|Jen Lahr||jen.lahr@medtronic.com|
21293414|NCT00407602|Second Sight Medical Products, Inc.|Jessy Dorn, PhD, Director of Clinical and Scientific Affiars|8188335089|jdorn@secondsight.com|
21293415|NCT00577707|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris|646-888-4205|krism@mskcc.org|
21293416|NCT01166347|Medtronic|Thomas Vassiliades|+15085321942|thomas.a.vassiliades@medtronic.com|
21293417|NCT03541499|Vanderbilt Vaccine Research Program|Dr. C Buddy Creech|615-3430332|buddy.creech@vanderbilt.edu|
21293418|NCT01154452|Memorial Sloan Kettering Cancer Center|Dr. Mrinal Gounder|646-888-4167|gounderm@mskcc.org|
21293419|NCT00130039|Asan Medical Center, University of Ulsan|Sun U. Kwon, MD, PhD, Prof|82-2-3010-3960|sukwon@amc.seoul.kr|
21293420|NCT03706430|Masimo|Dr. William C. Wilson, CMO, SVP|949-297-7000|william.wilson@masimo.com|
21293421|NCT00145626|St. Jude Children's Research Hospital|Brandon Triplett, MD|866-278-5833|referralinfo@stjude.org|
21293422|NCT01392573|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
21293423|NCT04704713|CLINUVEL PHARMACEUTICALS LIMITED|Clinical Operations Manager||mail@clinuvel.com|
21293424|NCT01198574|South East Asia Ministers of Education Organization, Regional Center for Food and Nutrition|Dr. Min Kyaw Htet, Township Health Officer, Ministry of Health, Myanmar|+62-857-27262672|kyawhtet@gmail.com|
21293425|NCT00200967|Penn State College of Medicine|Vernon M. Chinchilli|717-531-4262|vchinchi@psu.edu|
21293426|NCT00980460|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21293427|NCT05696444|Medtronic|Michele Masters, Sr. Clinical Research Program Manager|4848948925|michele.masters@medtronic.com|
21293428|NCT05200572|University of Rochester|Lee Kehoe, Ph.D.|(585) 276-7686|leekehoephd@gmail.com|
21293429|NCT03744910|CSL Behring|Study Director|16108784000|clinicaltrials@cslbehring.com|
21293430|NCT03280303|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21293431|NCT00948857|Center for Human Reproduction|Dr. Norbert Gleicher|212-994-4400|ngleicher@thechr.com|
21293432|NCT03430843|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
21293433|NCT03452033|D. Western Therapeutics Institute|Shigenobu Nakazora|+81-52-218-8785|shinakazora@dwti.co.jp|
21293434|NCT05360966|Alcon Research, LLC|Scientific Advisor, Clinical Research and Development|1-888-451-3937|alcon.medinfo@alcon.com|
21293435|NCT05396014|UNC Chapel Hill|Matthew Mauck, MD, PhD|(919) 966-5136|Matt_Mauck@med.unc.edu|
21293436|NCT04439539|Janssen Research & Development, LLC|Senior Director Medical Lead|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21293437|NCT01477710|University of Cincinnati|Richard Branson|513-558-6785|bransonrd@uc.edu|
21293438|NCT05258890|Brigham and Women's Hospital|Amar Dhand, MD, PhD|617-732-7432|adhand@bwh.harvard.edu|
21293439|NCT02351063|Alere, Inc.|William Arnold, PhD|8588053177|william.arnold@alere.com|
21293440|NCT03372434|Johnson & Johnson Surgical Vision|Eugenia Thomas, OD|+1 657 2903260|EThoma39@its.jnj.com|
21293441|NCT05516797|HealthPartners Institute|Holly Willis|952-993-3219|holly.willis@parknicollet.com|
21293442|NCT05959447|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21293443|NCT00332579|University of Minnesota|Jon E. Grant|612-273-9800|grant045@umn.edu|
21293444|NCT03759639|IntraBio Ltd|Taylor Fields, Chief Product Development Officer|+44 8081 641283|tfields@intrabio.com|
21293445|NCT01461499|Shiga University of Medical Science|Steering Committee: Takashi Uzu|81-77-548-2222|takuzu@belle.shiga-med.ac.jp|
21293446|NCT01282242|Massachusetts General Hospital|Lee H. Schwamm, MD|617-724-1597|lschwamm@mgh.harvard.edu|
21293447|NCT02013778|University of Pennsylvania|Gregory Nadolski, MD, Principal Investigator|215-662-7892|gregory.nadolski@pennmedicine.upenn.edu|
21293448|NCT00861757|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21293449|NCT00776594|Dana Farber Cancer Institute|Mary-Ellen Taplin, MD|617-632-6328|Mary_taplin@dfci.harvard.edu|
21245147|NCT05319860|University of Miami|Dr. Debbie Anglade|305-284-2388|d.anglade@miami.edu|
21245148|NCT01361711|Northwestern University|Shuo Ma, MD, PhD|312-908-5250|shuo-ma@northwestern.edu|
21245149|NCT03717506|Gage Development Company|Gage Development Clinical Trials|1-847-999-0600|clinicalinfo@capstonedevservices.com|
21245150|NCT00753090|Zimmer Biomet|Lisette Smid|0623956378|lisette.smid@zimmerbiomet.com|
21245151|NCT05113966|G1 Therapeutics, Inc.|Clinical Trial Info.|919-213-9835|clinicalinfo@g1therapeutics.com|
21245152|NCT02815813|Dartmouth-Hitchcock|Dr. Kelly Aschbrenner|603-440-7722|kelly.a.aschbrenner@dartmouth.edu|
21245153|NCT05816551|Institute for Exercise and Environmental Medicine|Craig Crandall, PhD, Primary Investigator|214-345-4623|craigcrandall@texashealth.org|
21245154|NCT04593472|Johns Hopkins Bloomberg School of Public Heath|Dr. Jennifer Wolff|4105020458|jwolff2@jhu.edu|
21293450|NCT00106119|National Institute of Diabetes and Digestive and Kidney Diseases|Dr. Kong Chen|3014511636|chenkong@niddk.nih.gov|
21293451|NCT02414607|University of Missouri|Dr. David Beversdorf|(573) 882-6081|beversdorfd@health.missouri.edu|
21293452|NCT02998684|Medical University of South Carolina|Dr. Jane Joseph|843-792-7683|josep@musc.edu|
21235846|NCT01072201|Colgate Palmolive Co|William De Vizio, DMD|732-878-7901|William_Devizio@colpal.com|
21293453|NCT00391053|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21293454|NCT02140970|University of Colorado|Dr. Kyle Rove|720 777 5893|kyle.rove@childrenscolorado.org|
21293455|NCT04077424|Vanderbilt University Medical Center|Spyros Kalams, MD|6153222035|Joan.e.eason@vumc.org|
21293456|NCT00603941|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21293457|NCT03592771|Emory University|Ilana Graetz, PhD|404-727-1483|ilana.graetz@emory.edu|
21293458|NCT00135330|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21293459|NCT03024112|University of Colorado, Denver|Dr. Jason Brainard|720-848-3257|Jason.Brainard@ucdenver.edu|
21293460|NCT04381052|Columbia University|David J. Cohen, MD|212-305-3273|djc5@cumc.columbia.edu|
21293461|NCT02253433|Environmental Health, Baylor College of Medicine|Dr. Winifred J. Hamilton|713-798-1052|hamilton@bcm.edu|
21245155|NCT03648840|Indiana University - Indianapolis|Dr. Martin H. Plawecki, MD, PhD|317 944 8164|mplaweck@iu.edu|
21293462|NCT00807586|Minneapolis Heart Institute Foundation|Dr. Daniel Melby|612-863-3900|daniel.melby@allina.com|
21293463|NCT02229825|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21293464|NCT01532921|Medtronic, Bakken Research Center Coronary and Structural Heart Disease Management (CSH), Endepolsdomein 5, 6229 GW Maastricht, The Netherlands|Ber Kleijnen|+3143356 6566|ber.kleijnen@medtronic.com|
21293465|NCT01390298|Wake Forest School of Medicine|James C. Eisenach, M.D.|336-716-4498|jimeisenach@gmail.com|
21245156|NCT05098795|Henry Ford Health|Dr. Julia Felton|313-598-0841|jfelton4@hfhs.org|
21245157|NCT05382936|Stemline|Carlos Garay, M.D.|877-332-7967|clinicaltrials@menarinistemline.com|
21245158|NCT05063994|Diurnal Limited|Clinical Trials Information|+44 (0) 292 068 2069|info@diurnal.co.uk|
21245159|NCT03394846|University of South Carolina|Robert Glenn Weaver|8037775605|weaverrg@mailbox.sc.edu|
21245160|NCT05543746|University of North Carolina at Chapel Hill|Rachel Kozik|919-590-0813|rachel_kozik@med.unc.edu|
21245161|NCT04975880|Quanta Dialysis Technologies|Dr. Paul Komenda|(204) 510-5219|paul.komenda@quantadt.com|
21245162|NCT03692676|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21245163|NCT01180634|Horizon Pharma USA, Inc.|Medical Monitor|1-866-479-6742|medicalinformation@horizontherapeutics.com|
21245164|NCT03692611|University of Pittsburgh|Dr. Jessica Merlin|(412) 383-0617|merlinjs@upmc.edu|
21245165|NCT04868227|University of Edinburgh|Professor Malcolm Dunlop|+44 (0) 131 651 8602|malcolm.dunlop@ed.ac.uk|
21245166|NCT04490915|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
21245167|NCT03149315|Johns Hopkins University School of Medicine|Melanie Dispenza, MD, PhD|410-550-1815|mdispen1@jhmi.edu|
21245168|NCT03222128|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@Edwards.com|
21245169|NCT04234698|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21245170|NCT01007591|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
21245171|NCT04083235|Ipsen Pharma|Medical Director|see email|clinical.trials@ipsen.com|
21245172|NCT03016169|Abbott|Karine Miquel, Associate Director of Project Management|+32 479 600 107|karine.miquel@abbott.com|
21245173|NCT04060355|Emory University, School of Nursing|Kenneth Hepburn, PhD|404-712-9286|khepbur@emory.edu|
21245174|NCT05680675|Huntsman Cancer Institute, Center for Quantitative Cancer Imaging|Sam Mitchell|801-213-6110|sam.mitchell@hci.utah.edu|
21245175|NCT04150718|University of Pennsylvania|Dr. Jennifer Goldschmied|215-573-2774|jrgolds2@pennmedicine.upenn.edu|
21245176|NCT05324124|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
21245177|NCT05034952|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21245178|NCT02111798|Johns Hopkins University School of Medicine|Dr. Kelly Dunn, Ph.D., MBA|410-550-2254|kdunn9@jhmi.edu|
21245179|NCT03761537|LEO Pharma A/S|Disclosure|44 94 58 88|disclosure@leo-pharma.com|+45
21245180|NCT04783935|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21245181|NCT05275842|Medical University of South Carolina|Cristina Lopez|843-792-2945|lopezcm@musc.edu|
21245182|NCT05493423|Hemotek Medical Inc|Chief Scientific Officer|7074942895|patrick@hemotekmedical.com|
21245183|NCT00920621|Brigham and Women's Hospital|Scott T. Weiss, MD, MS|617-525-2278|scott.weiss@channing.harvard.edu|
21245184|NCT01426425|Medtronic|Jo Krueger, Senior Clinical Research Specialist|7635261551|jo.krueger@medtronic.com|
21245185|NCT04882449|Bodyport Inc.|Dorothy Kwok, Head of Clinical Operations|669-240-3077|dorothy@bodyport.com|
21245186|NCT03763708|Medtronic Neuromodulation|SCS Research Study Team|800-633-8766|rs.scsresearch@medtronic.com|
21245187|NCT04382404|University of Pittsburgh|Dr. Catherine Chappell|412-641-1403|chappelca@upmc.edu|
21245188|NCT05687916|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21245189|NCT03332017|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21245190|NCT01261312|Astex Pharmaceuticals, Inc.|Dr. Harold Keer|925-560-2913|harold.keer@astx.com|
21245191|NCT05134636|University of Pennsylvania|Ronac Mamtani|215-662-7606|ronac.mamtani@pennmedicine.upenn.edu|
21245192|NCT03662607|Spectrum Health|Dr. Ryan Madder|6163916660|stephen.orey@corewellhealth.org|
21293466|NCT02443337|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21235847|NCT00360334|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21235848|NCT01916304|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
21235849|NCT01898793|Washington University School of Medicine|Amanda Cashen, M.D.|314-434-8323|acashen@wustl.edu|
21235850|NCT01218997|Alkermes, Inc.|Bernard L. Silverman|781-609-6000|bernard.silverman@alkermes.com|
21235851|NCT01222585|Duke Clinical Research Institute|Michael Cohen-Wolkowiez, MD|919668-8812|michael.cohenwolkowiez@dm.duke.edu|
21235852|NCT01443442|SCCO at MBKU|Jerry R. Paugh, OD, PhD|714-449-7487|jpaugh@ketchum.edu|
21293467|NCT00040742|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
21293468|NCT01569737|HRA Pharma|Christine Adelbrecht, Clinical Trial Coordinator|+33 1 40 33 32 74|c.adelbrecht@hra-pharma.com|
21293469|NCT02997865|Washington University School of Medicine in St. Louis|Kenneth E. Freedland, PhD|314-286-1311|freedlak@wustl.edu|
21293470|NCT01119066|Memorial Sloan Kettering Cancer Center|Richard O'Reilly, MD|646-888-2157|oreillyr@MSKCC.ORG|
21293471|NCT00894699|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
21293472|NCT02626156|Medical University of South Carolina|Teresa J. Kelechi|843-792-4602|kelechtj@musc.edu|
21293473|NCT02243371|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dung Le, MD|443-287-0002|dle@jhmi.edu|
21293474|NCT02441101|University of Iowa|Barry London|319-356-2750|barry-london@uiowa.edu|
21293475|NCT02691416|The Third Central Clinical College of Tianjin Medical University, Tianjin the Third Central Hospital|Dr.Haiyun Wang|13752211206|why819@126.com|
21293476|NCT00271856|UCSF Osher Center for Integrative Medicine|Patricia Moran, PhD|415.353.9745|moranp@ocim.ucsf.edu|
21293477|NCT03012828|Medicines Development Limited|Sally Kinrade, Vice President (Clinical Development)|+613 9629 6111|sally.kinrade@medicinesdevelopment.com|
21293478|NCT04599803|Verily Life Sciences LLC|Gabriel Kowalsky|9709011616|gabekowalsky@verily.com|
21293479|NCT02544750|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
21293480|NCT02366923|Coopervision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|jvega@coopervision.com|
21293481|NCT04677543|Insmed Incorporated|Insmed Medical Information|1-844-446-7633|medicalinformation@insmed.com|
21293482|NCT01539070|Instituto Mexicano del Seguro Social|MPH. Gloria Oliva Martínez Andrade|5556059862|gloria_olivam@hotmail.com|21075
21293483|NCT02520388|Ironshore Pharmaceuticals and Development, Inc.|Chief Scientific Officer|13457498174|bev@ironshorepharma.com|
21293484|NCT01437111|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21293485|NCT02623205|Department of Psychiatry, Renaissance School of Medicine at Stony Brook University|Kathryn Hill|904-252-3449|kathryn.hill@stonybrookmedicine.edu|
21293486|NCT02342288|West Virginia University|Dr. Sanford Emery|304-293-1170|semery@hsc.wvu.edu|
21245193|NCT01809691|SWOG Statistics and Data Management Center|Genitourinary Committee Statistician|2066674623|mplets@fredhutch.org|
21245194|NCT01580488|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
21245195|NCT03336333|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
21245196|NCT01969539|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21245197|NCT02682342|Medical College of Wisconsin|Michael E. Widlansky, MD|414-955-6708|mwidlans@mcw.edu|
21245198|NCT05868772|Cataract & Laser Institute|Dr Justin Spaulding|541-779-2020|justinophtho@gmail.com|
21245199|NCT03406871|NationalCCHE,JAPAN|Dr.Kohei Shitara|+81-4-7133-1111|regonivo_core@east.ncc.go.jp|
21245200|NCT02281955|University of North Carolina at Chapel Hill|Dr. Colette Shen|984-974-0400|cjshen@email.unc.edu|
21245201|NCT04302493|Johns Hopkins School of Medicine|Elisabeth B. Marsh, MD|410-550-8703|ebmarsh@jhmi.edu|
21293487|NCT02371785|Corindus Vascular Robotics|Vice President, Clinical and Regulatory Affairs|260-615-8892|john.vanvleet@corindus.com|
21293488|NCT02375373|University of Florida|Volker Mai, PhD, MPH|352-273-9398|vmai@epi.ufl.edu|
21293489|NCT02749201|maimonides medical center|Danny Sherwinter|7182837952|dsherwinter@maimonidesmed.org|
21293490|NCT01445613|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
21293491|NCT03711370|California Polytechnic State University|Dr. Alison Ventura|(805) 756-5693|akventur@calpoly.edu|
21293492|NCT01169701|Novartis Pharmaceuticals|Study Director|862-778-8300||
21293493|NCT04188834|Georgia Institute of Technology Atlanta|Dr. Annabelle Singer|404.385.4936|annabelle.singer@bme.gatech.edu|
21293494|NCT00553436|Ethicon Endo-Surgery, Inc|Amy Mahanes, Clinical Research Associate II|513-337-8366|amahanes@its.jnj.com|
21293495|NCT02619591|UMASS Memorial Department of Emergency Medicine|Executive Vice Chairman|508-421-1400|Romolo.Gaspari@umassmemorial.org|
21293496|NCT02455336|James J. Peters VA Medical Center|Michael F. La Fountaine, EdD, ATC, FACSM|718-584-9000|michael.lafountaine@va.gov|3121
21293497|NCT00391430|NYU Langone|Marylene Cloitre|2122632471|marylene.cloitre@nyulangone.org|
21293498|NCT03299244|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21293499|NCT05007899|Nationwide Children's Hospital|Chelsea Kebodeaux|(614) 722-2250|Chelsea.Kebodeaux@nationwidechildrens.org|
21293500|NCT01955369|Klinikum der Stadt Ludwigshafen|Dr. Joachim Wolf|0049-621|joachim.wolf@diakonissen.de|4200
21293501|NCT02517398|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49 6151-72-5200|service@emdgroup.com|
21293502|NCT01747343|University of Kansas|Brian D. Greer, Ph.D.|386-852-7171|brian.greer@unmc.edu|
21293503|NCT00958360|Hines VA Blind Center|Joan Stelmack, O.D., M.P.H.|708-202-2124|joan.stelmack@va.gov|
21293504|NCT03015363|CardioVascular Research New Brunswick (CVR-NB)|Sohrab Lutchmedial, MD, FRCP(C)|506-648-6101|sohrab.lutchmedial@horizonnb.ca|
21293505|NCT03107052|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21293506|NCT00500357|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21293507|NCT02263326|Northwestern University|Babafemi Taiwo|312-695-5085|b-taiwo@northwestern.edu|
21293508|NCT00078806|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21293509|NCT02200757|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
21293510|NCT01893411|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
21293511|NCT00566982|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
21293512|NCT00161616|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21293513|NCT02719691|University of Colorado|Jennifer Diamond, MD|303-724-5499|jennifer.diamond@cuanschutz.edu|
21293514|NCT01658709|University of Kentucky|Phillip Gribble|8592180885|phillip.gribble@uky.edu|
21293515|NCT02141633|University of Miami|Dr Adam Wanner Professor of Medicine Division of Pulmonary and Critical Care Medicine|(305) 243-3045|awanner@med.miami.edu|
21293516|NCT02403817|University of California, San Diego|Jeanne Townsend, PhD, Professor of Neurosciences|858-246-1931|jtownsend@ucsd.edu|
21293517|NCT01432145|University of Oxford Clinical Trials & Research Governance|Ms Heather House|01865 572245|heather.house@admin.ox.ac.uk|
21293518|NCT02248766|Optometry Research Group (GIO) University of Valencia|Robert Montes-Mico, O.D., PhD|34-9635-44764|robert.montes@uv.es|
21293519|NCT00473889|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21293520|NCT02440204|Severance|Dr. Jae Chul Koh|82-010-8702-3931|jaykoh82@gmail.com|
21293521|NCT01498692|Boston Scientific|Ruth M. Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com|
21245202|NCT04511286|Karolinska Institutet|Dr. Erland Axelsson|0706171039|erland.axelsson@ki.se|+46
21245203|NCT01748448|UZLeuven|Prof. Dr. M. Garmyn|0032 16 33 79 50|marjan.garmyn@uzleuven.be|
21245204|NCT03699709|University of Washington School of Public Health Department of Epidemiology|Dr. Amanda Fretts|2065431065|amfretts@uw.edu|
21245205|NCT02907099|The University of Texas MD Anderson Cancer Center|Brandon Smaglo, MD|(713) 745-8763|bgsmaglo@mdanderson.org|
21245206|NCT03110315|EvergreenHealth Research|Theodore Brown|4258995385|trbrown@evergreenhealthcare.org|
21245207|NCT02992925|Mitsubishi Tanabe Pharma Corporation / The Research Foundation for Microbial Diseases of Osaka University|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp, clinicaldevelopment@mail.biken.or.jp|
21245208|NCT05150860|San Diego State University|Assistant Vice President for Research Support Services|(619) 594-5938|rgulizia@sdsu.edu|
21245209|NCT03175029|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.|+81-3-3293-2455|toiawase@taiho.co.jp|
21245210|NCT03164980|NOGGO e.V.|Jasmin Yamamoto|+49 30 4036865 32|jasmin.yamamoto@noggo.de|
21245211|NCT05634226|Children's Hospital of Pittsburgh|Dr. Tarek Alsaied|5136521226|tarek.alsaied84@gmail.com|
21245212|NCT03047928|CCIT-DK|Prof. MD, Inge Marie Svane|38683868|inge.marie.svane@regionh.dk|+45
21245213|NCT04034251|National Cancer Institute|Dr. Andrew Blakely|240-760-7647|blakelyam@nih.gov|
21245214|NCT04950660|Children's Mercy Kansas City|Anne Stuedemann MSN, RN, CPNP|8162343693|astuedemann@cmh.edu|
21245215|NCT02437318|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21245216|NCT05086016|Renata Medical|Dali Alarian|8553184988|dali@renatamedical.com|6
21245217|NCT05273749|Tonix Pharmaceuticals|Gregory Sullivan, MD|8629040355|greg.sullivan@tonixpharma.com|
21245218|NCT03281291|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21245219|NCT04956861|University of Colorado|Christopher DeSouza Ph.D.|303-492-2988|desouzac@colorado.edu|
21245220|NCT02530671|University Kiel|Dr. Sonja Sälzer|00494315972810|saelzer@konspar.uni-kiel.de|
21245221|NCT05448651|Upstream Bio|Sumathi Sivapalasingam, Vice President of Clinical Development|917-499-0789|sumathi.sivapalasingam@upstreambio.com|
21245222|NCT02736409|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21245223|NCT01415154|Neuronetics|Director of Clinical Operations|16123067393|steve.erickson@neurostar.com|
21245224|NCT02038569|LEO Pharma A/S|Clinical Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
21245225|NCT03126019|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21245226|NCT02891096|Swiss Paraplegic Research|Dr Gabi Mueller|+41419395563|gabi.mueller@paraplegie.ch|
21245227|NCT05551195|Woebot Health|Kate Martin|(415) 209-5642|kate@woebothealth.com|
21245228|NCT00170573|Charite Campus Vichow Klinikum|Prof. Dr. Jalid Sehouli|+49 30-450564052|jalid.sehouli@charite.de|
21245229|NCT05722704|Gulf Medical University|Dr. Rania Zaarour|+971 6 7431333|dr.rania@gmu.ac.ae|4184
21245230|NCT03972813|University of Michigan|Abram Wagner|7347632330|awag@umich.edu|
21245231|NCT06069713|Wake Forest University Health Sciences|Olivia Horton MSW, MPH|000.000.0000|ohorton@wakehealth.edu|
21245232|NCT06283173|Covalon Technologies Inc.|Director of Regulatory Affairs|888-236-4944|customerservice@covalon.com|
21245233|NCT03498651|University of Virginia Department of Psychology|Dr. Bethany Teachman|434-924-0676|bethanyteachman@gmail.com|
21245234|NCT05563246|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21245235|NCT02167867|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
21245236|NCT02897531|Department of Surgery, Seoul National University College of Medicine, Seoul National University Bundang Hospital|Sung-Bum Kang, MD, PhD|+82-031-787-7093|kangsb@snubh.org|
21245237|NCT03138512|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21245238|NCT05200247|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21245239|NCT03420833|Mayo Clinic|Dr. Yong-Mei Cha|507-255-0774|ycha@mayo.edu|
21245240|NCT05102409|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
21245241|NCT03151616|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
21293522|NCT01947283|Disparities Research Unit, Department of Medicine, Massachusetts General Hospital|Margarita Alegria|617-724-4987|malegria@mgh.harvard.edu|
21245242|NCT04750473|Emory University/Winship Cancer Institute|Dr. David Schuster|404-712-4859|dschust@emory.edu|
21245243|NCT04177823|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21245244|NCT04229992|Vanderbilt University Medical Center|Dr. Martha Shrubsole, Dr. Qi Dai|(615)936-0707|Martha.shrubsole@vanderbilt.edu, qi.dai@vanderbilt.edu|
21245245|NCT04169373|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21245246|NCT04610892|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21245247|NCT05081583|Washington State University|Dr. Mary Paine|5093587759|mary.paine@wsu.edu|
21245248|NCT04760678|Insitute of Tropical Medicine|Carolien Hoof|0470102562|choof@itg.be|
21245249|NCT05523154|Mayo Clinic|Dr. Marina Walther-Antonio|(507) - 284-2282|waltherantonio.marina@mayo.edu|
21245250|NCT03720795|Baylor College of Medicine|Dr. Eric Storch|(713) 798-3579|eric.storch@bcm.edu|
21245251|NCT04322643|Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center|Dr. Moshe Ornstein|866-223-8100|TaussigResearch@ccf.org|
21245252|NCT05386758|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21245253|NCT05486078|Guna S.p.a|Dr. Vincenzo Miranda, Clinical Research & Scientific Service Manager|02 280.18.(358)|v.miranda@guna.it|
21245254|NCT05134233|Fralin Biomedical Research Institute at VTC|Jessica Florig|540-526-2261|jnw@vtc.vt.edu|
21245255|NCT01573442|Mayo Clinic|Charles L. Loprinzi, M.D.|507/284-4565|cloprinzi@mayo.edu|
21245256|NCT03649659|University of Michigan|Dr. Margherita Fontana|734-763-3988|mfontan@umich.edu|
21245257|NCT04510974|James J Peters VA Medical Center|Dr. Caitlyn Peters|9733243588|cpeters@kesslerfoundation.org|
21245258|NCT04763265|Croma Pharma GmbH|Clinical Development - Head of Clinical Operations|+43 2262 684680|clinical.studies@croma.at|
21245259|NCT02908477|Mayo Clinic|Katharine Price M.D.|507-284-6139|Price.Katharine@mayo.edu|
21245260|NCT03095274|MFAR|A responsibility person designate by sponsor|934344412|investigacion@mfar.net|
21245261|NCT04115540|Stanford University|Michael Eisenberg MD|650-723-3391|meisenb@stanford.edu|
21245262|NCT04418466|Delpor, Inc.|Eesha Gupta|415-289-1770|eesha.gupta@delpor.com|
21245263|NCT05305235|University of North Carolina at Chapel Hill|Nicole Short, PhD|702-895-3305|nicole.short@unlv.edu|
21245264|NCT05590312|Düzce University Faculty of Medicine|Assistant Professor Özlem Ersoy Karka|+905337293978|drozlemersoy@gmail.com|
21245265|NCT03269136|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21245266|NCT05326776|UC San Diego|Dr. Laura Case|858-246-4968|lcase@health.ucsd.edu|
21245267|NCT05071807|Penn State University|DCH Lab|8148638056|dchlab@psu.edu|
21245268|NCT04952909|Pi-Cardia|Hadas Givon, VP CA/RA|+972-8-9484800|hadas@pi-cardia.net|
21245269|NCT03729999|Nationwide Children's Hospital|Dr. Alok Moharir|614-722-4200|alok.moharir@nationwidechildrens.org|
21245270|NCT04267172|Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences (NDORMS), University of Oxford.|Professor Jonathan Rees|01865737540|jonathan.rees@ndorms.ox.ac.uk|
21245271|NCT04552223|University of Miami|Jose Lutzky MD|+1 (305) 6896500|jose.lutzky@med.miami.edu|
21245272|NCT04856163|RAND|Dr. Lori Uscher-Pines|703-413-1100|luscherp@rand.org|
21245273|NCT00881621|Georgetown University|Dr. Aiwu Ruth He|202-444-8642|arh29@georgetown.edu|
21245274|NCT03158714|Auburn University|Francesca Adler-Baeder|334-844-4151|adlerfr@auburn.edu|
21245275|NCT04359108|Johns Hopkins Applied Physics Laboratory|Seth Billings|240-228-7462|seth.billings@jhuapl.edu|
21245276|NCT02515773|University of Cincinnati|Casey Moore|513-558-6307|casey.moore@uc.edu|
21245277|NCT04176965|BVI medical|Rebecca McQuaid|+353871212615|RMcQuaid@bvimedical.com|
21245278|NCT03468218|Emory University|Dr. Nabil Saba|404-778-1900|nfsaba@emory.edu|
21245279|NCT03033576|SWOG Statistics and Data Management Center|Melanoma Committee Statistician|2066674623|sbellasea@fredhutch.org|
21245280|NCT01214616|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21293523|NCT04729972|Neurotech Pharmaceuticals, LLC|CMO|401-333-3880|neurotech@neurotechusa.com|
21293524|NCT00430989|Bayside health|Professor Paul Myles|+61390762000|p.myles@alfred.org.au|3176
21293525|NCT03782259|University of Washington|Francis Kim, MD|206-744-8305|fkim@uw.edu|
21293526|NCT00590122|Baylor College of Medicine|Christine Hunter|713-798-6556|chunter@bcm.edu|
21293527|NCT03050450|Johns Hopkins All Children's Hospital (St. Petersburg, FL)|Dr Stacie Stapleton|17274701017|stacie.stapleton@jhmi.edu|
21245281|NCT02949362|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21245282|NCT05565092|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
21245283|NCT02471638|Endologix|Tammy Stiver|5136731452|tstiver@endologix.com|
21245284|NCT04280445|Trent Doctorate in Clinical Psychology Programme, University of Nottingham, UK|Dr Daniell De Boos|+44 (0)115 84 67523|danielle.deboos@nottingham.ac.uk|
21245285|NCT05264376|Stanford University|Dr. Eric Stice|650-723-7885|estice@stanford.edu|
21245286|NCT00667251|Novartis Pharmaceuticals|Clinical Disclosure Office|1-862-778-8300|Novartis.email@novartis.com|
21245287|NCT04927637|Dartmouth Health Orthopaedics|Dr. Ida Leah Gitajn|(603) 650-5133|Ida.Leah.Gitajn@hitchcock.org|
21245288|NCT02754882|Samsung Bioepis Co., Ltd|Director of Clinical Trials|031-8061-1096|sbregistry@samsung.com|
21245289|NCT01212029|National Institute of Child Health and Human Development|Dr. Amir Gandjbakhche|2402742949|gandjbaa@mail.nih.gov|
21245290|NCT03973320|Hospital for Special Surgery, Anesthesiology|Dr. Jiabin Liu|2126061036|liuji@hss.edu|
21245291|NCT02671903|Imperial College London|Dr Zachary I Whinnett|+44 (0)20 7594 5735|z.whinnett@imperial.ac.uk|
21245292|NCT03376321|Janssen Research & Development, LLC|Senior Director Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21245293|NCT02995434|University of British Columbia|Dr. Bernie Garrett|604 822 7443|bernie.garrett@ubc.ca|
21245294|NCT03400059|Chordate Medical AB|Dr Jan Hermansson|+46 8 400 115 86|jan.hermansson@chordate.com|
21245295|NCT05097430|Centre for Addiction and Mental Health (CAMH)|Dr. Paul Shuper|416-535-8501|paul.shuper@camh.ca|34097
21245296|NCT04363515|Hennepin Healthcare Research Institute|Dr. Allyson Hart|612-873-6998|allyson.hart@hcmed.org|
21245297|NCT02543281|Cleveland Clinic, Lerner Research Institute|Larisa Tereshchenko|2164442445|tereshl@ccf.org|
21245298|NCT05247489|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21245299|NCT04390048|University of Miami|Brian Arwari|305-284-5418|b.arwari@umiami.edu|
21245300|NCT04323137|Geisinger Health|Amir Goren, PhD|570-214-4395|agoren@geisinger.edu|
21245301|NCT04179500|TB Alliance|Antonio Lombardi|917-601-0024|Antonio.Lombardi-Consultant@tballiance.org|
21245302|NCT04951492|Fred Hutchinson Cancer Center|Dr. Michael Schweizer|2066066252|mtschwei@fredhutch.org|
21245303|NCT04682106|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
21245304|NCT05165108|IndianaU|Thomas Nowak, MD|3179484272|tvnowak@iu.edu|
21245305|NCT05470517|Johns Hopkins All Children's Hospital|Nicole M. Chandler, MD|727-767-4170|nicole.chandler@jhmi.edu|
21245306|NCT04106583|Penumbra, Inc.|Brooke Lawson|+15109952183|blawson@penumbrainc.com|
21245307|NCT02380885|Bar-Ilan University|Prof. Ilanit Hasson-Ohayon|+972-3-5317673|ilanithasson@gmail.com|
21245308|NCT04768569|Washington University in St. Louis|Dr. Craig Buchman, Lindburg Professor & Chair, Department of Otolaryngology-Head & Neck Surgery|314-362-2914|buchmanc@wustl.edu|
21245309|NCT05473234|UCSF FI Proctor|Dr. Catherine E. Oldenburg|415-502-8843|catherine.oldenburg@ucsf.edu|
21245310|NCT02783300|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21245311|NCT03535272|Centers for Disease Control and Prevention|Kristina Angelo|404-718-4876|kangelo@cdc.gov|
21245312|NCT01744782|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224-383-3000|clinicaltrials@horizonpharma.com|
21245313|NCT00378105|Dana-Farber Cancer Institute|Dr. Richardson|617-632-2104|Paul_Richardson@dfci.harvard.edu|
21245314|NCT03623321|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261|medicalinformation@acadia-pharm.com|2897
21245315|NCT03378570|University of Iowa Hospitals & Clinics|Dr. Nicholas Trapp|(319) 467-8188|nicholas-trapp@uiowa.edu|
21245316|NCT04241068|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21245317|NCT03843151|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21245318|NCT01787383|LEO Pharma A/S|Clinical trial disclosure manager|00 45 44 94 58 88|ctr.disclosure@leopharma.com|
21245319|NCT05391893|SpectrumLakeland|Rachelle Pichot; Clinical Research Specialist|(240)389-7340|rachelle.pichot@corewellhealth.org|
21245320|NCT04492007|University of North Carolina Lineberger Comprehensive Cancer Center|Xianming Tan PhD|919-966-8450|xianming@email.unc.edu|
21245321|NCT05178316|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
21245322|NCT00277394|Leo Pharma|Torsten Skov, Senior Medical Advisor|+45 72263990|tosdk@leo-pharma.com|
21245323|NCT03907397|Icahn School of Medicine at Mount Sinai|Dr. Scott Sicherer|212-241-5548|scott.sicherer@mssm.edu|
21245324|NCT01413100|Fred Hutchinson Cancer Center|Dr. Leona Holmberg|206-667-6447|lholmb@fredhutch.org|
21245325|NCT05369403|Chief Medical Officer|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
21245326|NCT04750525|The University of Texas Health Science Center at Houston|Sheng Li, MD, PhD|713-797-7125|sheng.li@uth.tmc.edu|
21245327|NCT05521308|Sonova|Bilal Sheikh - Research Audiologist|2268083260|bilal.sheikh@sonova.com|
21293528|NCT01642901|MetroHealth Rehabilitation Institute|Christina V Oleson, MD|216-778-4414|coleson@metrohealth.org|
21293529|NCT02978157|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
21245328|NCT05337943|University of Pennsylvania|Dr. Lea Ann Matura|2157468819|matura@nursing.upenn.edu|
21245329|NCT03792256|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21245330|NCT02203552|The Ohio State University Comprehensive Cancer Center|Dr. Bhuvaneswari Ramaswamy|614-293-7484|Bhuvaneswari.Ramaswamy@osumc.edu|
21245331|NCT04606069|University of Maryland Medical Center|Dr. Christine Lau, MD, MBA, Department of Surgery, Surgeon-in-Chief|410-328-8407|CLLau@som.umaryland.edu|
21293530|NCT03286829|Saniona A/S|Dr.Kim Krogsgaard, MD, DMSc, CMO|+45 20 14 83 84|kim.krogsgaard@saniona.com|
21245332|NCT05570175|Chang Gung University of Science and Technology|Su-Hui Chen|886-3-2118999|sophee@mail.cgust.edu.tw|3216
21245333|NCT01458782|University Hospital North Norway|Dr.Ann Kristin Hansen|+4777669763|ann.kristin.hansen@unn.no|
21245334|NCT02226276|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
21245335|NCT03562377|LEO Pharma A/S|Disclosure|+45|disclosure@leo-pharma.com|44945888
21245336|NCT03001414|Northern Therapeutics, Inc.|Duncan Stewart, Clinical Trial Medical Consultant|613-737-8899|djstewart@toh.ca|76686
21245337|NCT04831216|University of Arkansas for Medical Sciences|Krista Langston|479-713-8000|KNLangston@uams.edu|
21245338|NCT03272373|Zimmer Biomet|Director of Clinical Operations|800-613-6131|clinicaloperations@zimmerbiomet.com|
21245339|NCT04663087|University of Alabama at Birmingham|Dr. Jan Jansen|205-975-3030|jjansen@uabmc.edu|
21245340|NCT02913872|University of Leicester|Dr Erol Gaillard|+44116 252 3261|eag15@le.ac.uk|
21245341|NCT03818711|Vanderbilt University Medical Center|Senior ClinicalTrials.gov Administrator|615-322-3581|natalie.dilts@vumc.org|
21245342|NCT04739956|Imperial College Healthcare NHS Trust|Dr Margaret Pikovsky|+447870276373|m.pikovsky@nhs.net|
21245343|NCT02386722|Cantonal Hospital Baselland|Dr. Claudia Gregoriano|+41619253765|claudia.gregoriano@ksbl.ch|
21245344|NCT03519581|University of California, Davis Eye Center|Clinical Research Supervisor|916 734-6303|dcmacias@ucdavis.edu|
21245345|NCT05177848|Fralin Biomedical Research Institute at VTC|Dr. Roberta Freitas-Lemos|(540)526-2106|rflemos@vtc.vt.edu|
21245346|NCT06414213|Appalachian State University|Dr. Jared Skinner|828-262-2512|skinnerjw@appstate.edu|
21245347|NCT05694286|University of Pennsylvania|Ivona Percec, MD, PhD|215-662-7300|ivona.percec@pennmedicine.upenn.edu|
21245348|NCT00450658|Horizon Pharma, Inc.|Amy Grahn, MS Senior Vice President, Clinical Development and Operations|224-383-3012|agrahn@horizonpharma.com|
21245349|NCT03898986|Stanford University|Philip Grant, MD|6507239001|pmgrant@stanford.edu|
21245350|NCT03850678|University of Nebraska-Lincoln|Marc Brennan|4024723132|marc.brennan@unl.edu|
21245351|NCT04640298|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
21245352|NCT05329493|Massachusetts General Hospital|Dr. Dieter Manstein|617-726-4893|dmanstein@mgh.harvard.edu|
21245353|NCT03762915|University of Minnesota|Michelle Arnette|6126243457|marnett@umn.edu|
21245354|NCT03983018|Örebro University|Prof Susanne Bejerot|+46701655102|susanne.bejerot@oru.se|
21245355|NCT04072380|Suven Life Sciences|Ramakrishna Nirogi, PhD|+9140 2319 3956|nvsrk@suven.com|
21293531|NCT00984165|National Cancer Institute|Dr. Ronald E. Gress|301-496-1791|gressr@dc10a.nci.nih.gov|
21245356|NCT04550468|University of British Columbia|Dr. Jonathan Little|250-807-9876|jonathan.little@ubc.ca|
21245357|NCT04015167|Stryker|Monica Fleeman|251-465-5969|monica.fleeman@stryker.com|
21245358|NCT03640312|Washington University in St. Louis|Guhan Iyer|3147479487|guhaniyer@wustl.edu|
21245359|NCT05492318|Italfarmaco SpA|Dr. Paolo Bettica, MD|+39 02 64431 (centralino)|p.bettica@italfarmacogroup.com|
21245360|NCT05008835|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261|medicalinformation@acadia-pharm.com|2897
21245361|NCT03964350|University of Chicago|Dr. Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
21245362|NCT04889755|Boston University|Associate Professor|(617) 358-4296|kalong@bu.edu|
21245363|NCT04222660|Iowa City VA Healthcare System|Dr. Mark Yorek|13193380581|mark.yorek@va.gov|637696
21245364|NCT03992274|Columbia University|Kathrine Meyers, DrPH, MPP, MSc|2123046110|kam2157@cumc.columbia.edu|
21245365|NCT03366649|Emory University|Dr. Robert Guyton|404 686-4499|rguyton@emory.edu|
21245366|NCT06064955|Ohio State University|Karen O. Moss|(614) 688-3100|Moss.391@osu.edu|
21245367|NCT03673111|Imperial College London|Professor Tricia Tan|020 8383 8038|t.tan@imperial.ac.uk|
21245368|NCT03792555|Crinetics Pharmaceuticals Inc.|Crinetics Clinical Trials|+1 858-450-6464|clinicaltrials@crinetics.com|
21245369|NCT04485039|SIGA Technologies|Emily Blum, Director of Clinical Development|541-224-1305|eblum@siga.com|
21245370|NCT05481216|Research Organization (KC) Ltd|HIV COCO Project Manager|+44 (0) 7494 795 982|hivcoco@rokcservices.com|
21245371|NCT04005716|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
21245372|NCT05845398|Dicerna Pharmaceuticals, Inc., a Novo Nordisk company|Clinical Reporting Office (2834)|866-867-7178|clinicaltrials@novonordisk.com|(+1)
21293532|NCT00654836|Loyola University|Shelly S. Lo, M.D.|708-327-3154|shlo@lumc.edu|
21245373|NCT00418886|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21245374|NCT03707951|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
21245375|NCT04347161|University of Pennsylvania|Katharine A Rendle, PhD,MSW,MPH|215-349-5442|Katharine.Rendle@pennmedicine.upenn.edu|
21245376|NCT04294290|Duke University|Joanne Kurtzberg, MD|919-668-1119|joanne.kurtzberg@duke.edu|
21245377|NCT04533347|Fast-Track Drugs and Biologics, LLC|Bernadette Tock|240-401-8634|btock@fasttrackresearch.com|
21245378|NCT05520190|University of Rochester|Aileen Aldalur|(585) 371-6125|aileen_aldalur@urmc.rochester.edu|
21245379|NCT01999075|CHEO Research Institute|Dr. Sherri Katz (Principal Investigator)|613-737-7600|skatz@cheo.on.ca|2956
21245380|NCT04059770|Universidade Federal de Ciências da Saúde de Porto Alegre|Professor Alessandro C. Pasqualotto|5551999951614|pasqualotto@ufcspa.edu.br|
21245381|NCT04406857|University of Kentucky|Dr. Charles Kunos|859-323-6486|Charles.Kunos@uky.edu|
21245382|NCT05948670|Woebot Health|Tim Campellone, PhD|(415) 209-5642|research@digitaltherapeutic.io|
21245383|NCT04562649|Columbia University|Rebecca Schnall, PhD, MPH, RN|212-342-6886|rb897@cumc.columbia.edu|
21245384|NCT05368103|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21245385|NCT04864691|Interventional Neuroradiology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.|Feng Gao|13581936066|gaofengletter@sina.com|
21293533|NCT00700622|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
21293534|NCT00383331|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21245386|NCT03675282|Weill Cornell Medicine|Carly Skudin; Research Program Manager|212-746-2003|cas4010@med.cornell.edu|
21293535|NCT01309997|FHCRC|Stephanie J. Lee MD MPH|206-667-6190|sjlee@fhcrc.org|
21293536|NCT00282087|SARC|Research Project Manager|(734) 930-7600|sarc@sarctrials.org|
21293537|NCT03520920|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21293538|NCT00372619|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|ResultsReportingCoordinator@childrensoncologygroup.org|
21245387|NCT05784662|University at Buffalo, School of Social Work|Patricia Logan-Greene|7166451533|pblogang@buffalo.edu|
21245388|NCT03232138|University of Pittsburgh Cancer Institute|Jian-Min Yuan M.D., Ph.D.|412-864-7889|yuanj@upmc.edu|
21245389|NCT03920111|University of Liverpool|Dr Lance Turtle|01517957554|lance.turtle@liverpool.ac.uk|
21245390|NCT05268393|Children's National Hospital|Dr. Eleanor Mackey|202-476-5307|emackey@childrensnational.org|
21245391|NCT05763823|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21245392|NCT05392192|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
21245393|NCT03778112|Rush University Medical Center|Dian Wang, MD|(708) 660-3476|Dian_Wang@rush.edu|
21245394|NCT01997840|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21245395|NCT03555448|Washington University|R. Delos Santos|3143628351|delossantos@wustl.edu|
21245396|NCT04487145|University of Califronia San Francisco|Liusheng Huang(Co-Investigator and Drug Research Unit Co-Director)|415-502-2594|liusheng.huang@ucsf.edu|
21245397|NCT05308004|University of Maryland School of Nursing|Dr. Joan Carpenter|443-880-1430|joan.carpenter@umaryland.edu|
21245398|NCT04799704|UZ Leuven|Heleen Delbeke, MD|003216342229|heleen.delbeke@uzleuven.be|
21245399|NCT03150810|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21245400|NCT04526704|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21245401|NCT06393088|IR Technology LLC|Consulting Director of Clinical Trials|404 915-5938|andyn@invisaredtech.com|
21245402|NCT03903146|University of Kentucky|Dr. Ana Maria Linares, PI|8593234726|am.linares@uky.edu|
21245403|NCT05434078|Baylor College of Medicine|Dr. Bijan Najafi|+1 (424) 467-7127|bijan.najafi@bcm.edu|
21245404|NCT04918823|BostonSight|Dr. Daniel Brocks|7817267337|dbrocks@bostonsight.org|
21245405|NCT03652688|PIRE|Dr. Brenda A. Miller|5105205889|BMiller@prev.org|
21245406|NCT04406441|Geisinger Health System|Dr. Lisa Bailey-Davis|570-214-9625|ldbaileydavis@geisinger.edu|
21245407|NCT03719443|Parexel International|Principal Investigator|(781) 487-9900|info@parexel.com|
21245408|NCT04924660|Vanderbilt University Medical Center|Sean P. Collins, MD|615-343-8010|vcc@vumc.org|
21245409|NCT00554788|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21245410|NCT03557697|NYU Langone Health|Lu Hu|646 501 3438|lu.hu@nyulangone.org|
21245411|NCT05026320|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21245412|NCT05093478|The University of Texas Health Science Center at Houston|Kunal R Shetty, MD|713-486-5000|Kunal.R.Shetty@uth.tmc.edu|
21245413|NCT05582746|University of Kansas Medical Center|Dr. Jason E Glenn|9135880076|jglenn4@kumc.edu|
21280169|NCT03280264|Kyowa Kirin Co., Ltd.|Research & Development Planning Department, Research & Development Division|+81-3-5205-7200|clinical.info.jp@kyowakirin.com|
21245414|NCT05191472|University of California, San Francisco|Dr. Alfred Chung, MD|(415) 476-1000|Alfred.Chung@ucsf.edu|
21245415|NCT02132936|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
21245416|NCT03197662|Montefiore Medical Center|Dr. Eric Hollander|718-839-7516|eholland@montefiore.org|
21245417|NCT03721952|University of Washington|Dr. Ruth Engelberg|206-744-9523|rengel@uw.edu|
21245418|NCT04495894|Emory University|Viraj Master, MD, PhD|404-778-4898|vmaster@emory.edu|
21245419|NCT03364647|University of Kentucky|Brian Noehren|859-323-1100|b.noehren@uky.edu|
21245420|NCT01000961|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224-383-3000|clinicaltrials@horizonpharma.com|
21245421|NCT05184894|Mayo Clinic|Erin Barreto, PharmD, MS|507-284-2511|barreto.erin@mayo.edu|
21245422|NCT03476460|Hospital Universitario Ramón y Cajal, IRYCIS|Coordinator of Research Support Unit, Internal Medicine Dept.|0034913369082|martin.fabregate@salud.madrid.org|
21245423|NCT05332366|Leo Pharma|Clinical Disclosure|+4544945888|disclosure@leo-pharma.com|
21245424|NCT05746455|Columbia University|Dr. Alice Saperstein|646-774-8464|ams2334@cumc.columbia.edu|
21245425|NCT03447470|Redx Pharma Limited|Craig Tilston|+44 (0)7787 983 638|c.tilston@redxpharma.com|
21245426|NCT05184192|Washington University, Department of Otolaryngology - Head and Neck Surgery|Jay F. Piccirillo|314-362-8641|piccirj@wustl.edu|
21245427|NCT04624633|Dana-Farber Cancer Institute|Jennifer R Brown MD PhD|617-632-4894|Jennifer_Brown@dfci.harvard.edu|
21245428|NCT01902173|SWOG|Melanoma Statistician|2066674623|jmoon@fredhutch.org|
21245429|NCT02649842|Johnson & Johnson Surgical Vision|Devi Priya Janakiraman, OD, FAAO|1+ 714-247-8429|djanaki1@its.jnj.com|
21245430|NCT05480124|University of Michigan|Stephan Taylor|(734) 936-4955|sftaylor@med.umich.edu|
21280170|NCT02574832|Northwerstern University|Paloma Toledo, M.D.|312-472-3585|p-toledo@northwestern.edu|
21280171|NCT01648530|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21280172|NCT02319317|University of Pennsylvania|Catherine McDonald. PhD, RN|2157468355|mcdonalc@nursing.upenn.edu|
21280173|NCT00371436|VA RR&D, NCRAR|James A. Henry, Ph.D.|5032208262|james.henry@va.gov|57466
21280174|NCT05262387|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21280175|NCT01342081|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
21280176|NCT00354913|Duke University Medical Center|Dr. Annick Desjardins|919-681-1691|annick.desjardins@dm.duke.edu|
21280177|NCT03440840|Nova Southeastern University|Raymond L Ownby, MD, PhD|954-262-1481|ro71@nova.edu|
21245431|NCT05733975|Duke Univerisity Medical Center|Dr. Monica Lemmon|919-668-0477|monica.lemmon@duke.edu|
21245432|NCT05455086|OhioSUCCC|Dr. Theodore L. Wagener|614-366-4265|Theodore.Wagener@osumc.edu|
21280178|NCT04720053|Mayo Clinic|Dr. Sanjeev Nanda|507-284-9919|GIMRESEARCHSTUDIES@Mayo.edu|
21293539|NCT00066222|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
21245433|NCT04876118|Zeltiq Aesthetics|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
21245434|NCT05089734|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21245435|NCT05297864|University of Oklahoma Health Sciences Center|James Battiste, MD|405-271-8777|James-Battiste@ouhsc.edu|
21245436|NCT05093829|University of Maryland School of Medicine|Wilbur H. Chen, M.D., M.S., FACP, FIDSA|410-706-5328|wchen@som.umaryland.edu|
21245437|NCT06132867|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21245438|NCT04353661|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21245439|NCT05215314|University of Wisconsin-Madison|Daniel Grupe|608-263-7572|grupe@wisc.edu|
21245440|NCT02651428|CorMedix Inc.|Head of Clinical Operations|908-517-9500|lmasson@cormedix.com|
21245441|NCT01747863|Research Institute of the McGill University Health Center|Dr. Guilherme Sant'Anna|(514) 412-4400|guilherme.santanna@mcgill.ca|23489
21245442|NCT01785719|Cornell University|Marla Lujan, PhD|(607) 255-3153|mel245@cornell.edu|
21245443|NCT03443323|Children's Hospital of Philadelphia|Dr. Thomas J. Power|215-590-7447|power@chop.edu|
21245444|NCT03463824|Virginia Commonwealth University|Dr. James Thomas|740-591-1563|jthomas32@vcu.edu|
21245445|NCT03457142|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-2300|Kris.Attwood@roswellpark.org|
21245446|NCT03770273|National Institute of Allergy and Infectious Diseases|Hirsh Komarow|+1 301 594 2197|komarowh@niaid.nih.gov|
21245447|NCT04060654|Indivior Inc|Sunita Shinde|804 379-1090|sunita.shinde@indivior.com|
21245448|NCT04887129|University of Rochester|John Foxe, Phd|585 - 275 - 2591|John_foxe@urmc.rochester.edu|
21245449|NCT04896476|Sonavex|Katy Feeny, Director of Clinical Affairs|443-862-2024|KFEENY@SONAVEX.COM|
21245450|NCT03476187|ZOLL|Nicole Bianco|4129683333|NBianco@zoll.com|14410
21245451|NCT05817708|Senhwa Biosciences, Inc.|Gina Huang|+886-2-89119856|ginahuang@senhwabio.com|111
21245452|NCT03056040|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
21245453|NCT02921230|Boston Scientific|Andrew Campbell|763-494-2722|Andrew.Campbell@bsci.com|
21245454|NCT05424549|Aldeyra Therapeutics, Inc.|Bill Cavanagh|781-257-3063|bcavanagh@aldeyra.com|
21245455|NCT00845481|LEO Pharma|Torsten Skov, Senior Medical Advisor|+45 20 73 62 94|torsten.skov@leo-pharma.com|
21245456|NCT03662698|University of Colorado Hospital|Jamie Studts|303-724-2284|jamie.studts@cuanschutz.edu|
21245457|NCT04142788|University of Glasgow|Prof John Cleland|0141 330 7774|john.cleland@glasgow.ac.uk|
21293540|NCT00405392|GlaxoSmithKline|GSK Response Center|866-435-7343||
21293541|NCT03125031|Masimo|Tala Harake||studies@masimo.com|
21245458|NCT05260684|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21245459|NCT03064217|University of Maryland, Baltimore|Se-Lim Oh|4107063708|soh@umaryland.edu|
21245460|NCT03992339|Antengene Corporation|Yumei Tang|18301318100|yumei.tang@antengene.com|
21245461|NCT03396926|University of California, San Francisco|Dr.Chloe Atreya, MD, PhD|(415) 353-9888|chloe.atreya@ucsf.edu|
21245462|NCT02035787|University of North Carolina Lineberger Comprehensive Cancer Center|Lauren Higgins|919- 966-4432|lqhiggin@ad.unc.edu|
21245463|NCT01728857|Zeltiq Aesthetics|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
21245464|NCT03853746|Johns Hopkins Universtiy|Bardia Nourbakhsh|410-614-1522|bnourba1@jhmi.edu|
21245465|NCT01396278|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21245466|NCT01083758|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
21245467|NCT01084876|Celltrion|Head of Clinical Planning Department|82328505000|contact@celltrion.com|
21245468|NCT04727554|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21245469|NCT00999804|Baylor College of Medicine|Dr. Mothaffar Rimawi|7137981311|rimawi@bcm.edu|
21245470|NCT05028634|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21245471|NCT05653427|Janssen Research & Development, LLC|Global Medical Head Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21245472|NCT01264406|Pennington Biomedical Research Center|Corby Martin|763-2585|corby.martin@pbrc.edu|
21245473|NCT05311384|University of Alabama at Birmingham|Sarah dos Anjos|205.934.7323|smanjos@uab.edu|
21245474|NCT05079789|University Hospital Tuebingen|Dr. Anja Schork|+49 707129 83172|Anja.Schork@med.uni-tuebingen.de|
21245475|NCT04256941|University of Texas M D Anderson Cancer Center|Dr. Senthil Damodaran|713-792-2817|sdamodaran@mdanderson.org|
21245476|NCT04145466|Department of Health and Sport Sciences, TUM School of Medicine and Health, Technical University of Munich|Christoph Hoechsmann|+49 (89) 289 - 24492|christoph.hoechsmann@tum.de|
21245477|NCT02933970|University at Buffalo|Andrew Talal|7168884737|AHTALAL@BUFFALO.EDU|
21245478|NCT03300648|Michigan State University|Terrie E. Taylor|5178988467|ttmalawi@msu.edu|
21245479|NCT05717907|Mahidol university|Pattamon Leelachaikul|+66863019830|pattamonl@hotmail.com|
21245480|NCT02724631|Children's Hospital of Philadelphia|Sharon Y Irving|215 590-1000|irvings@chop.edu|
21245481|NCT05076708|Perelman School of Medicine, University of Pennsylvania|Janet Audrain-McGovern, Ph.D. Director, Addictions, Department of Psychiatry|(215) 746-7145|audrain@pennmedicine.upenn.edu|
21245482|NCT05590403|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21245483|NCT05908344|The Pennsylvania State University|Dr. Anne-Marie Chang|814-863-5226|amchang@psu.edu|
21245485|NCT04971395|Xentria, Inc.|Tom Matthews, Director of Clinical Research|224.443.4615|tmatthews@xentria.com|
21245486|NCT04717492|UAB Lung Health Center|Mark Dransfield|205-934-5425|mdransfield@uabmc.edu|
21293542|NCT02544035|National Institute of Child Health and Human Development|Dr. Diane Putnick|301-496-6291|putnickd@mail.nih.gov|
21293543|NCT03660865|RxSight|Jeffrey Ha, Senior Director of Clinical Research|949-521-7870|jha@rxsight.com|
21293544|NCT05141708|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21245487|NCT01106209|University of Utah - Pediatrics|Christian Con Yost, MD|801-518-7052|christian.yost@u2m2.utah.edu|
21245488|NCT03766009|University of Wisconsin School of Medicine and Public Health|Heather B. Neuman, MD, MS|608-265-5852|neuman@surgery.wisc.edu|
21245489|NCT02487056|Cardiovascular Academy Society|Dr. Mehdi Zoghi|3904001|mehdi_zoghi@hotmail.com|
21245490|NCT02924272|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21245491|NCT06213194|Ibn Haldun University|Dr. Dilruba Sönmez|905365646640|dilrubasonmez@gmail.com|
21245492|NCT03575897|University of Alabama at Birmingham|Dr. Ariel Salas|205-934-4680|asalas@peds.uab.edu|
21245493|NCT01963793|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
21245494|NCT05087693|UNiversity of BRitish COlumbia|Michael Koehle|8229331|michael.koehle@ubc.ca|
21245495|NCT05369533|University of California, Los Angeles|Steven Cramer|424-522-7874|SCCramer@mednet.ucla.edu|
21245496|NCT05116787|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
21245497|NCT02737436|University of Iowa|Dr Lane Strathearn|2193849464|lane-strathearn@uiowa.edu|
21245498|NCT02919683|Dana-Farber Cancer Institute|Jonathan Schoenfeld, M.D. M.P.H.|617-632-3591|jonathan_schoenfeld@dfci.harvard.edu|
21245499|NCT01552473|The University of Texas at Dallas, Center for BrainHealth|Dr. Daniel Krawczyk, Primary Investigator|214-905-3007|dck061000@utdallas.edu|
21245500|NCT05551637|National Institute of Nutrient|Dr. Nguyen Song Tu|0912322602|nguyensongtu@gmail.com|
21245501|NCT04721912|University of New Mexico|Katrina Nardini, CNM, WHNP-BC, MPH|505-205-4118|hsc-familyplanningresearch@salud.unm.edu|
21245502|NCT05179837|Washington University School of Medicine|Vladimir Kushnir, M.D.|314-362-3685|vkushnir@wustl.edu|
21245503|NCT05051124|NYU Langone Health|Jessica Gjonaj|646-501-3663|Jessica.gjonaj@nyulangone.org|
21245504|NCT04782973|Massachusetts General Hospital|Kaavya Paruchuri, MD|617-726-1843|kparuchuri@mgh.harvard.edu|
21245505|NCT03307343|West Virginia University|Bethany Barone Gibbs|304-581-1779|bethany.gibbs@hsc.wvu.edu|
21245506|NCT01120223|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
21245507|NCT03703492|UW School of Medicine and Public Health|Amy Fowler, MD, PhD|608-262-2122|afowler@uwhealth.org|
21245508|NCT05364671|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
21245509|NCT03536754|ChemoCentryx|Study Director|650-210-2900|clinicaltrials@chemocentryx.com|
21245510|NCT04891224|Advocate Health Care|Ramona Donovan, Research Project Manager|847-723-5792|ramona.donovan@aah.org|
21245511|NCT03382652|Zimmer Biomet|Esther Foo|+41787183202|esther.foo@zimmerbiomet.com|
21245512|NCT04709783|University of Florida|Chiung-ju (CJ) Liu|352-273-6496|c.liu1@phhp.ufl.edu|
21245513|NCT04810650|University of California, San Francisco|Douglas Black|4158063016|douglas.black@ucsf.edu|
21245514|NCT05794243|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21245515|NCT02761057|SWOG Statistics and Data Management Center|Genitourinary Committee Statistician|2066674623|mplets@fredhutch.org|
21245516|NCT05194514|Cedars-Sinai|Fardad Esmailian|310-248-7132|fardad.esmailian@cshs.org|
21245517|NCT02727699|Actinogen Medical Limited|Director of Drug Development & Strategy|+61289647401|info@actinogen.com.au|
21245518|NCT04648033|University of Oxford|Professor Geoff Higgins|01865 617311|geoffrey.higgins@oncology.ox.ac.uk|
21245519|NCT03270956|ProKidney|to be determined|n/a|info@prokidney.com|
21245520|NCT03509116|Guy's & St Thomas' NHS Foundation Trust|Dr Alastair Duncan|02071882010|alastair.duncan@gstt.nhs.uk|
21245521|NCT05228730|Murdoch Children's Research Institute|Ms Kathryn Bright|+61 3 99366656|kathrynbright@mcri.edu.au|
21245522|NCT04806594|Relife Srl|Clinical Trial Coordinator|055 56809345|sdipalma@relifecompany.it|
21245523|NCT04318548|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21262168|NCT01849250|The University of Texas MD Anderson Cancer Center|Powel H. Brown, MD/Chair, Clinical Cancer Prevention|713-792-7734|PHBrown@mdanderson.org|
21280179|NCT01960257|University of California, San Diego|Dr. Sara H. Browne|619 543 8080|shbrowne@health.ucsd.edu|
21280180|NCT01942993|Icahn School of Medicine at Mount Sinai|Dr. Philip A Friedlander|212-824-8584|philip.friedlander@mssm.edu|
21280181|NCT02143128|Dept of Anaesthesia and Intensive Care, Akershus University Hospital, Norway|Dr Vladimir Kuklin|98838024|vkuklin@me.com|0047
21280182|NCT01350271|University of Kelaniya|Dr Balachandran Kumarendran|0094112961140|drbkumaran@gmail.com|
21280183|NCT02906670|Symphogen AS|Medical Director|004545265050|info@symphogen.com|
21280184|NCT01349192|University of North Carolina, Chapel Hill|Marianne S. Muhlebach, PI|(1) 919 966 1055|Marianne_Muhlebach@med.unc.edu|
21280185|NCT03749330|Children's Hospital of Philadelphia|Jennifer Walter, MD, PhD, MS Associate Professor of Pediatrics|215-590-1000|walterj1@chop.edu|
21280186|NCT01973439|MRC Clinical Trials Unit at UCL|Trial manager|02076704825|silvia.forcat@ucl.ac.uk|
21280187|NCT02038010|Northwestern University|William Gradishar, MD|312 695 4541|w-gradishar@northwestern.edu|
21280188|NCT02144714|Samsung Bioepis|Samsung Bioepis|+82 31 8061 4534|sbregistry@samsung.com|
21280189|NCT00918866|Lantheus Medical Imaging|Dana Washburn, M.D.|978-671-8686|dana.washburn@lantheus.com|
21280190|NCT02673775|Rutgers, the State University of New Jersey|Andrew Gow, PhD|848-445-4612|gow@pharmacy.rutgers.edu|
21280191|NCT03519087|The Ohio State University|Dr. Stephanie Di Stasi|614-685-9779|stephanie.distasi@osumc.edu|
21280192|NCT01137071|Recepta Biopharma|Director of Clinical Trials|55 11 3709-2140|recepta@receptabio.com.br|
21280193|NCT04807400|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21280194|NCT01130493|Impax Laboratories, LLC|Kaihong Jiang, Senior Director, Head of Biometrics|(908) 307-2234|Kaihong.Jiang@amneal.com|
21280195|NCT02463773|University of Minnesota|Roy Cho, MD|612-626-2637|choxx548@umn.edu|
21280196|NCT00523939|Duke University Medical Center|Dr. David Rizzieri|919-668-1040|rizzi003@mc.duke.edu|
21280197|NCT02263963|Spectrum Health|Dr. Nezar Jrebi|507-271-8284|jrebi.nezar@hotmail.com|
21280198|NCT04728802|Applied Biology, Inc.|Dr. John McCoy|+1 (949)387-4526|johnm@appliedbiology.com|
21280199|NCT02123446|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21245524|NCT05593510|UT Southwestern Medical Center|Kelseanna Hollis-Hansen|214-645-7676|kelseanna.hollis-hansen@utsouthwestern.edu|
21245525|NCT02120456|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
21245526|NCT05192200|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21245527|NCT04873401|New York State Psychiatric Institute|Dr. Katherine Elkington|16467746965|ke2143@cumc.columbia.edu|
21245528|NCT00390793|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani, MD./ Professor|713-745-0394|fravandi@mdanderson.org|
21245529|NCT04650087|Duke University Medical Center|Dr. Thomas Ortel|919-684-5350|thomas.ortel@duke.edu|3
21245530|NCT03445988|Stanford University|Beth Darnall, PhD|N/A|bdarnall@stanford.edu|
21245531|NCT05065658|Medical University of Graz|Dr. Juergen Prattes|004331638530046|juergen.prattes@medunigraz.at|
21245532|NCT00583349|Columiba University Medical Center|Dr. James McKiernan, John K. Lattimer Professor and Chair of Department of Urology|212-342-3976|jmm23@cumc.columbia.edu|
21245533|NCT04274764|University of Michigan|Paula Anne Newman-Casey|734 763-6967|panewman@med.umich.edu|
21245534|NCT03427580|Bar-Ilan University|Prof. Ilanit Hasson-Ohayon|+972-3-5317673|ilanithasson@gmail.com|
21245535|NCT03210272|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21245536|NCT03611621|Hansa Biopharma AB|Study Director|+46 46 16 56 70|clinicalstudyinfo@hansabiopharma.com|
21245537|NCT02143726|Memorial Sloan-Kettering Cancer Center|Eric J. Sherman, M.D.|646-888-4234|shermane@mskcc.org|
21245538|NCT04764448|Dicerna Pharmaceuticals, Inc., a Novo Nordisk company|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21245539|NCT05229146|Henry Ford Health|Dr. Julia Felton|313-598-0841|jfelton4@hfhs.org|
21245540|NCT02975882|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21245541|NCT03936322|UNIVERSITY OF MIAMI|Rodrigo Ruano MD PhD|(305) 585-5610|rodrigoruano@hotmail.com|
21245542|NCT05275231|Emory University|Dr. Megha K. Shah|404-778-6944|mkshah@emory.edu|
21245543|NCT01160211|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21245544|NCT02734290|Providence Portland Medical Center|Dr. David B. Page|5032156588|david.page2@providence.org|
21245545|NCT01814501|The Ohio State University Comprehensive Cancer Center|Dr. John Hays|614-293-3873|John.Hays@osumc.edu|
21245546|NCT03829410|Cardiff Oncology|Nancy Sherman, Head of Clinical Operations|858-952-7570|clinops@cardiffoncology.com|
21245547|NCT03158129|MD Anderson Cancer Center|Tina Cascone, MD|713-792-6363|tcascone@mdanderson.org|
21245548|NCT06181006|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21245549|NCT06205407|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21245550|NCT06491433|Department of Cardiology at Gangnam Severance hospital|Byoung Kwon Lee|+82-10-2721-8813|CARDIOBK@yuhs.ac|
21245551|NCT04572399|Cedars-Sinai|Melissa Hampton|3104230617|Melissa.Hampton@cshs.org|
21245552|NCT05796583|University of California San Diego|Professor of Anesthesiology|(858) 220-5714|bilfeld@health.ucsd.edu|
21245553|NCT04676022|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
21245554|NCT05746494|University of Texas at Dallas|Dr. Linlin Fan|+(853) 8822 4226|linlin.fan@utdallas.edu; linlinfan@um.edu.mo|
21245555|NCT02235909|Azurity Pharmaceuticals, Inc.|David Sequeira|(913) 389-7961|david.sequeira@azurity.com|
21245556|NCT03547869|UTDallas|Sven Vanneste|n/a|sven.vanneste@utdallas.edu|
21245557|NCT03408340|Emory University|Justin B. Long, MD, Associate Professor|404-785-6670|justin.bradley.long@emory.edu|
21245558|NCT02274662|Sumitomo Pharma America, Inc.|Director Clinical Operations|+1 (508) 481-6700|ravi.grewal@us.sumitomo-pharma.com|
21245559|NCT03194217|BenevolentAI|Administrator|+44 20 3781 9360|LondonAdmin@benevolent.ai|
21245560|NCT03241459|Surmodics|Kimberly Hawkinson|952-500-7563|khawkinson@surmodics.com|
21245561|NCT05805865|Loma Linda University Health|Professor, Director of Student Research|909 558 5118|sorankwon@llu.edu|
21245562|NCT06398886|Istanbul Nisantasi Universitesi|Metin Çınaroğlu|009053247320|metincinaroglu@gmail.com|
21245563|NCT01463423|Stanford University|Maximilian Diehn, MD, PhD|650-725-4783|diehn@stanford.edu|
21245564|NCT03134196|NYU Langone Health|Elisabeth Cohen, MD|9294552412|Elisabeth.Cohen@nyulangone.org|
21245565|NCT00875277|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
21245566|NCT03800108|Cleveland Clinic|Dr. Darlene Floden|216-444-1298|flodend@ccf.org|
21245567|NCT04541147|Duke University|Eileen M. Raynor, MD|919-613-4573|eileen.raynor@duke.edu|
21245568|NCT06469138|BerGenBio ASA|BerGenBio Clinical Team|+47 559 61 159|registry.postings@bergenbio.com|
21245569|NCT04683744|Indiana University|Dr. Peter H. Schwartz|317-278-4037|phschwar@iu.edu|
21245570|NCT04026555|Icahn School of Medicine at Mount Sinai|Dr. Matthew Levin|212-241-8382|matthew.levin@mssm.edu|
21245571|NCT04592549|Resilience Government Services|Angie Kimbler|386-418-8751|angie.kimbler@resilience.com|
21245572|NCT00686335|Horizon Pharma|Senior Vice President, Clinical Development & Operations|224-383-3012|agrahn@horizonpharma.com|
21280200|NCT05934396|University of North Carolina at Chapel Hill|Marisa Marraccini, PhD|919-843-5099|mmarracc@unc.edu|
21245573|NCT03637660|University of Alabama at Birmingham|Edward W. Hook, III|205-932-4204|ehooks@uabmc.edu|
21245574|NCT05603143|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21280201|NCT02096744|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21280202|NCT02972892|GE Healthcare|Research Program Integrator|262-290-6037|meghan.terry@ge.com|
21280203|NCT05022212|University of California, San Francisco|Dr Anke Hemmerling, Co-Investigator|4154765878|anke.hemmerling@ucsf.edu|
21280204|NCT02905032|Mayo Clinci|Peter A. Noseworthy, M.D.|507-255-2446|Noseworthy.Peter@mayo.edu|
21245575|NCT03993509|University of Pennsylvania|Nicholas Balderston|2157463058|nicholas.balderston@pennmedicine.upenn.edu|
21245576|NCT03524612|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21245577|NCT05609760|Universidad de concepción|Rosa Figueroa I, Associate Professor|+56412204247|rosa.figueroa@biomedica.udec.cl|
21245578|NCT04986501|Sunbio|Min-Jung Ahn|+82-31-423-5467|mjahn@sunbio.com|
21245579|NCT03396588|University of Kentucky|Dr. Henrietta Bada|8593231019|henrietta.bada@uky.edu|
21245580|NCT05179395|James A Haley Veterans' Hospital and Clinics|Dr. Jeffrey Heckman|813.972.2000|jeffrey.t.heckman@va.gov|7506
21245581|NCT01388777|UT MD Anderson Cancer Center|Hwang, Rosa, M.D.|713-792-7734|CR_Study_Registration@mdanderson.org|
21245582|NCT00812461|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
21245583|NCT01926496|LEO Pharma A/S|Disclosure|+45 44945888|disclosure@leo-pharma.com|
21245584|NCT03891667|Lyme Research Center New York State Psychiatric Institute, New York, New York, United States, 10032|Dr. Brian A. Fallon|646-774-8052|baf1@cumc.columbia.edu|
21245585|NCT05659537|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21245586|NCT04682587|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21245587|NCT02884011|Rush University Medical Center|Joshua DeMott|312-947-0226|joshua_demott@rush.edu|
21245588|NCT00506519|LEO Pharma A/S|Disclosure|+45 44 94 58 88|disclosure@leo-pharma.com|
21245589|NCT02105766|National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)|Matthew Hsieh M.D.|301.402.7687|matthewhs@nhlbi.nih.gov|
21245590|NCT03867500|Mayo Clinic|Michael D. Jensen, M.D.|507-255-6515|jensen@mayo.edu|
21245591|NCT02577835|Italian Institute of Telemedicine|Stefano Omboni|00390331984176|stefano.omboni@iitelemed.org|
21245592|NCT04749615|Hospital for Special Surgery|Justas Lauzadis, PhD|212-774-2946|lauzadisj@hss.edu|
21245593|NCT03611491|CROMA - PHARMA|Head of Clinical Operations|+43 2262 68468|clinical.studies@croma.at|
21245594|NCT03736720|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kristopher.Attwood@roswellpark.org|
21245595|NCT05119023|MGH-Institute of Health Professions|Sofia Vallila Rohter, Project Principle Investigator|617-724-3824|svallilarohter@mghihp.edu|
21245596|NCT03153410|SKCCC Johns Hopkins Medical Institution|Ana De Jesus-Acosta, MD|443-287-0411|adejesu1@jhmi.edu|
21245597|NCT05409183|Tufts Medical Center|James Udelson, MD|(617) 636-8066|James.Udelson@tuftsmedicine.org|
21245598|NCT02962895|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
21245599|NCT04806451|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
21245600|NCT02936752|Yale School of Medicine|Amer Zeidan, MBBS|(203) 200-4363|amer.zeidan@yale.edu|
21245601|NCT03659734|Stanford University|Dr. Jennifer Hah|650-723-4000|map_pain_study@stanford.edu|
21245602|NCT05894577|Duke University|Susanna Naggie, MD|919-684-2584|susanna.naggie@duke.edu|
21245603|NCT03793972|UAntwerpen|Stefan Morreel|003232658721|stefan.morreel@uantwerpen.be|
21245604|NCT03274310|Columbia University Vagelos College of Physicians and Surgeons|Dr. Melissa Stockwell|2123425732|mss2112@cumc.columbia.edu|
21245605|NCT05292365|University of Wisconsin School of Medicine and Public Health|Dr. Ryan Coller|608-263-9408|rcoller@pediatrics.wisc.edu|
21245606|NCT05282173|University of Maryland, College Park|Dr. Jessica Magidson|301-405-5095|jmagidso@umd.edu|
21245607|NCT05891353|University of Central Florida|Abigail Anderson|4078231026|Abigail.Wilson@ucf.edu|
21245608|NCT03443388|University of Pennsylvania|Michael Gelfand, MD, PhD|215 662 3606|epilepsytrials@pennmedicine.upenn.edu|
21245609|NCT05916664|RSV Opco 5, Inc. (dba Kinto)|Joseph T Chung|(857) 600-2273|joe@kinto.care|
21245610|NCT06165146|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21245611|NCT02023866|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224- 383-3000|clinicaltrials@horizonpharma.com|
21245612|NCT03477968|Diagnostica STAGO S.A.S|Nathalie THUILLIER|+33 146 882 167|nathalie.thuillier@stago.com|
21245613|NCT06190340|TenNor Therapeutics (Suzhou) Limited.|TenNor|0512-86861990|info@tennorx.com|
21245614|NCT02432404|University of Washington|Christine Johnston|206-520-4340|cjohnsto@uw.edu|
21245615|NCT01798498|Croma Pharma|Head of Clinical Operations|+43 2262 68468|clinical.studies@croma.at|
21280205|NCT02729909|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21280206|NCT00739063|UT MD Anderson Cancer Center|Ana Gonzalez-Angulo, MD, MS / Associate Professor||CR_Study_Registration@mdanderson.org|
21280207|NCT02730663|Taewoong Medical Co., Ltd.|JiYoung Ahn/Assistant manager|+82-70-4649-1624|sarahahn@stent.net|628
21280208|NCT00866359|Celgene Corporation|Anne McClain|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
21280209|NCT02163057|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
21280210|NCT01625091|Unversity of Florida|Dr. Robert Cook|352-273-5869|cookrl@ufl.edu|
21280211|NCT03126448|Indiana University Health|Dr. Roman Natoli|713-516-8973|rnatoli@IUHealth.org|
21280212|NCT01547390|University of South Florida|Dr. Anthony Odibo|813-259-0828|aodibo@health.usf.edu|
21280213|NCT04182334|Indiana University|Babar Khan, MD, MS|(317) 274-9132|bakhan@iu.edu|
21280214|NCT02698033|Massachusetts General Hospital|Wayne Shreffler|6177266147|wshreffler@mgh.harvard.edu|
21280215|NCT04917861|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
21280216|NCT01128179|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21280217|NCT01004744|Columbia University|Dr. Katherine Crew|212-305-1732|kd59@cumc.columbia.edu|
21280218|NCT02694328|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
21280219|NCT00134004|Johns Hopkins University|Dr. Ephraim Fuchs|410-419-6479|fuchsep@jhmi.edu|
21280220|NCT00720382|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us|
21280221|NCT05192889|St. Jude Children's Research Hospital|Seth Karol, MD|(901) 595-1716|seth.karol@stjude.org|
21280222|NCT04536376|Mayo Clinic|Dr. Ivana T. Croghan|507-284-2511|GIMRESEARCHSTUDIES@MAYO.EDU|
21280223|NCT06075277|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
21280224|NCT00265759|Baylor College of Medicine|Matthew J. Ellis, MB, BChir, BSc., PhD, FRCP|713 798-1999|Matthew.Ellis@bcm.edu|
21280225|NCT03122730|Aerogen Pharma|David Durand, MD|510-928-2111|ddurand@aerogenpharma.com|
21293545|NCT00988052|Teva Pharmaceutical Industries, Ltd|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21293546|NCT00295646|ABCSG (Austrian Breast & Colorectal Cancer Study Group)|Trial Office Director|+43 1 4089230|info@abcsg.at|
21293547|NCT01736267|Massachusetts Eye & Ear Infirmary|Dr. Daniel Lee|6175736391|Daniel_Lee@meei.harvard.edu|
21293548|NCT01509846|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
21293549|NCT03115411|Stanford University School of Medicine|Dr. Subhas Banerjee, MD|650-723-2623|sbanerje@stanford.edu|
21293550|NCT01637584|UPittsburgh|Dr. Anne Germain|4123832150|germax@upmc.edu|
21293551|NCT04396795|University of Miami, Miller School of Medicine - Desai Sethi Urology Institute|Dr Ranjith Ramasamy|305-243-4562|ramasamy@miami.edu|
21293552|NCT02484443|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21293553|NCT01970241|HCMC|Lisa Fish MD|612-873-2705|lisa.fish@hcmed.org|
21293554|NCT03472495|Virginia Commonwealth University|Tammy Nguyen, PharmD|8046630969|Tammy.Nguyen@vcuhealth.org|
21293555|NCT02595866|HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute|Kathryn Lurain, M.D.|240-858-3257|kathryn.lurain@nih.gov|
21293556|NCT02136004|Weill Cornell Medical College|S. Chiu Wong, MD|212-746-4644|scwong@med.cornell.edu|
21293557|NCT02689206|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21293558|NCT00595881|Children's Hospital of Pittsburgh|Jennifer Marin|412-692-7692|jennifer.marin@chp.edu|
21293559|NCT02131311|Procter & Gamble Company Global Clinical Sciences|Mylissa Trowbridge||trowbridge.mm@pg.com|
21293560|NCT01479764|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
21293561|NCT03082677|Memorial Sloan Kettering Cancer Center|Dr. Doris Ponce, MD|646-608-3739|ponced@mskcc.org|
21293562|NCT01181804|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
21293563|NCT00255723|Memorial Sloan Kettering Cancer Center|Dr. Craig Moskowitz|212-639-7992|moskowic@mskcc.org|
21293564|NCT00431444|Novartis Pharmaceuticals|Study Director|862-778-8300||
21293565|NCT02368093|Taichung Veterans General Hospital|Der-Yuan Chen|884-4-23592525|dychen@vghtc.gov.tw|3354
21293566|NCT01574287|Emory University|Schuster, David|404-712-4859|dschust@emory.edu|
21293567|NCT03497039|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21293568|NCT02781571|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21293569|NCT03554018|Montefiore|Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
21293570|NCT02131662|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21293571|NCT01618240|Massachusetts General Hospital|Hooman Mirzakhani|617-291-9779|hmirzakhani@partners.org|
21293572|NCT01928433|Universityhospital Gießen and Marburg, Germany|Prof. Dr. med. Florian Wagenlehner|+49-641-98544516|Florian.Wagenlehner@chiru.med.uni-giessen.de|
21293573|NCT01740687|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
21293574|NCT01562886|Imperial College London|Dr Borja Mora Peris|020 3312 6789|b.mora-peris@imperial.ac.uk|
21293575|NCT03063606|Yale University|Dr. Carlos Grilo|203-785-7210|carlos.grilo@yale.edu|
21293576|NCT00854724|BPRL, McLean Hospital|David M. Penetar|617-855-2913|dpenetar@mclean.harvard.edu|
21293577|NCT00879034|Dana-Farber Cancer Institute|Dr. Mark Kieran|617-632-4907|mark_kieran@dfci.harvard.edu|
21293578|NCT00933608|NYU School of Medicine|Lidia Glodzik|212.263.5698|Lidia.Glodzik@nyumc.org|
21293579|NCT02331589|Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea|Dr. Ki Tae Suk|+82-33-240-5826|ktsuk@hallym.ac.kr|
21293580|NCT02159898|Merit Medical, Inc|Casey Holland|7816817983|casey.holland@merit.com|
21293581|NCT00336284|Biotronik, Inc.|Justin Michalski, M.S. / Clinical Studies Engineer|503-675-2155|justin.michalski@biotronik.com|
21293582|NCT01498744|Ann and Robert H. Lurie Children's Hospital of Chicago|Katherine A Barsness|3122274210|kbarsness@luriechildrens.org|
21293583|NCT03308968|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21293584|NCT04397939|Mount Sinai Hospital|Annapoorna S Kini, M.D.|(212) 241-4181|annapoorna.kini@mountsinai.org|
21293585|NCT01521923|UCB Cares|UCB (Study Director)|+1 887 822 9493||
21293586|NCT03037476|University of Washington|Jason Kilmer, Ph.D.|206-685-4512|jkilmer@uw.edu|
21293587|NCT01675297|Hanlim Pharma|Clinical Trial Unit|82-2-3489-6297|yrsong@hanlim.com|
21293588|NCT00501592|Intercept Pharmaceuticals, Inc.|Cathi Sciacca, Sr. Director, Clinical Operations|858-652-6800|csciacca@interceptpharma.com|
21293589|NCT04908384|University of Washington|Jennifer Sonney|206-685-2161|jsonney@uw.edu|
21245616|NCT05136417|Mayo Clinic|Dr. Mohamad Alkhouli|507-255-2502|Alkhouli.Mohamad@mayo.edu|
21245617|NCT04150900|University of Maryland, Baltimore|Dr. Ranee Mehra|410-328-4059|umgccregulatory@umm.edu|
21245618|NCT04114877|Yale School of Medicine|Ariadna Forray|2037648620|ariadna.forray@yale.edu|
21245619|NCT04295798|Hebrew SeniorLife|Junhong Zhou|617-971-5346|JunhongZhou@hsl.harvard.edu|
21245620|NCT05538754|STAAR Surgical|Joanne Egamino|626-303-7902|jegamino@staar.com|2905
21245621|NCT03524118|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21280226|NCT03713593|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21280227|NCT05061134|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21280228|NCT03176134|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21280229|NCT03915652|Brigham and Women's Hospital|Dr. Candace Feldman|6175251035|cfeldman@bwh.harvard.edu|
21280230|NCT05736861|Duke University|Susanna Naggie, MD, MHS, FIDSA|919-684-2584|susanna.naggie@duke.edu|
21280231|NCT03410056|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21280232|NCT03242408|Lipocine, INC.|Nachiappan Chidambaram, Vice President, Product Development|8018819495|nc@lipocine.com|
21280233|NCT01996241|London School of Hygiene and Tropical Medicine|Dr Tara Beattie|0044 (0)2079272613|tara.beattie@lshtm.ac.uk|
21293590|NCT00833469|Massachusetts General Hospital|Dr. Marlene Freeman, MD|617-643-6403|mfreeman@partners.org|
21293591|NCT01208324|University of Pennsylvania|C. Neill Epperson, M.D|215-573-8871|cepp@mail.med.upenn.edu|
21293592|NCT02943070|Boston Scientific Corporation|Director, Clinical Operations|952-930-6000|teresa.takle-flach@bsci.com|
21293593|NCT01701362|Pfizer, Inc|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21293594|NCT00570778|Novartis Pharmaceuticals|Study Director|862-778-8300||
21293595|NCT01861704|InSound Medical, Newark, California|Tanya Arbogast, Study Principal Investigator|510-792-4000|Srikant.Mantha@phonak.com|
21293596|NCT00249808|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
21293597|NCT00711594|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21293598|NCT00443872|University of Kansas Medical Center|Dr. Kelly Lyons|9135887159|klyons@kumc.edu|
21293599|NCT02789345|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21293600|NCT01129765|Advanced Pediatrics|Mary Margaret Thorne|703-938-5555|mthorne@pop.powweb.com|
21293601|NCT01475643|Valeant Pharmaceuticals NA|Denise Raimondo|9089721885|denise.raimondo@valeant.com|
21293602|NCT02685566|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
21293603|NCT00694577|Massachusetts General Hospital|Alphonse Taghian|6177261160|ataghian@mgh.harvard.edu|
21293604|NCT01756573|University of Chicago|TARIQ MALIK|773-8342643|tmalik@dacc.uchicago.edu|
21293605|NCT02008942|PLx Pharma|Ronald Zimmerman, President & CEO|713-842-1249|ron.zimmerman@plxpharma.com|205
21293606|NCT02836717|Department of Surgery, Cantonal Hospital St. Gallen|Dr Lukas Marti|+41 71 494 11 11|lukas.marti@kssg.ch|
21293607|NCT03226249|Northwestern University, Feinberg School of Medicine|Jane N. Winter, M.D.|(312) 695-4538|j-winter@northwestern.edu|
21293608|NCT01260688|Princess Margaret Cancer Centre|Dr. Lillian Siu|416-946-2911|lillian.siu@uhn.ca|
21293609|NCT00588237|Memorial Sloan Kettering Cancer Center|Dr. Jason Konner|646-888-4219|konnerj@mskcc.org|
21293610|NCT03938103|University of North Carolina at Chapel Hill|Derek Hales, PhD|919-966-6089|derekh@email.unc.edu|
21293611|NCT00436046|Baylor College of Medicine|Robert Couch, MD|713-798-4474|rcouch@bcm.tmc.edu|
21293612|NCT00392834|University of Arkansas for Medical Sciences|Jeannette Lee, Ph.D.|501-526-6712|jylee@uams.edu|
21293613|NCT02767869|Institute of Experimental andl Clinical Therapeutics|Dr. Manuel González Ortiz|+52-33-10-58-52-00|uiec@prodigy.net.mx|34212
21293614|NCT04301934|Mayo Clinic|Johnny Yi, M.D.|480-342-0612|Yi.Johnny@mayo.edu|
21293615|NCT00441142|Dana-Farber Cancer Institute|Dr. Eudocia Quant Lee|617-632-2166|eqlee@partners.org|
21293616|NCT02888691|Steno Diabetes Center Copenhagen|Dr Signe Schmidt|+4551174785|signe.schmidt@regionh.dk|
21293617|NCT01524224|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21293618|NCT05398159|InMode|Maria Shusterman|9057076787|Maria.Shusterman@inmodemd.com|
21293619|NCT00456625|GlaxoSmithKline|GSK Response Center|866-435-7343||
21293620|NCT04283656|Thomas Jefferson University|Dr. Walter K. Kraft|(215) 955-9077|Walter.Kraft@jefferson.edu|
21293621|NCT00803361|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21293622|NCT04445519|Nicox Ophthalmics, Inc.|Doug Hubatsch/Chief Scientific Officer|984-710-5354|hubatsch@nicox.com|
21293623|NCT00394329|Penn State College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu|
21293624|NCT02858440|GlaxoSmithKline|GSK Response Center|866-435-7343|lrs54533@gsk.com|
21293625|NCT04660552|JelikaLite Corp|Katya Sverdlov, Chief Executive Officer|9175668151|katya@jelikalite.com|
21293626|NCT00470262|Denver VA Medical Center|Dr. Neda Rasouli|303-399-8020|neda.rasouli@ucdenver.edu|4314
21293627|NCT00191945|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21293628|NCT00429182|University of Texas MD Anderson Cancer Center|Naoto Ueno, MD / Professor||CR_Study_Registration@mdanderson.org|
21293629|NCT04201639|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
21293630|NCT01451749|Dongzhimen Hospital,Beijing University of Chinese Medicine|Dr.Jinzhou Tian|86-10-84013380|jztian@hotmail.com|
21293631|NCT00972517|GlaxoSmithKline|GSK Response Center|866-435-7343||
21293632|NCT02311881|GlaxoSmithKline|GSK Response Center|866-435-7343||
21293633|NCT04068948|University of Washington|Travis Nelson|206-543-0980|tmnelson@uw.edu|
21293634|NCT01433042|Given Imaging Ltd.|Director of Clinical affairs|+972-4-9097774|Hila.Debby@givenimaging.com|
21293635|NCT00848237|University of north Carolina|Nicholas Shaheen|(919) 966-7047|nshaheen@med.unc.edu|
21235853|NCT01306617|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21235854|NCT02780349|Gardia Medical|Vardit Segal Ph.D|972-4-6277166|vardit@gardiamedical.com|
21235855|NCT03077165|IlkosTherapeutic Inc.|Monique Champagne|450-680-3381|mchampagne@ilkostherapeutic.com|2910
21235856|NCT04028388|Modra Pharmaceuticals|M. Keessen|+31202050188|info@modrapharmaceuticals.com|
21235857|NCT03362515|Thomas Jefferson University|Dr. Mindy Rabinowitz|215-955-6784|mindy.rabinowitz@jefferson.edu|
21235858|NCT02841644|Atrium Health|Vice Chair of Research|7043552000|Rachel.Seymour@atriumhealth.org|
21235859|NCT02430077|UT Southwestern Medical Center|Abhimanyu Garg|2146482895|Abhimanyu.garg@utsouthwestern.edu|
21235860|NCT01609556|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
21235861|NCT00139997|Yale University|Paul Desan, MD, PhD|203 785 2618|paul.desan@yale.edu|
21235862|NCT01632579|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21235863|NCT02788175|NIAID|Dr. Michael C. Sneller|301-496-0491|MSNELLER@niaid.nih.gov|
21235864|NCT00162136|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21235865|NCT04523129|Novaliq GmbH|Dr. Sonja Kroesser|+49 6221 50259|info@novaliq.com|0
21235866|NCT00898677|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21235867|NCT00234884|Abbott|Global Medical Services|1-800-633-9110||
21293636|NCT00556439|Cleveland Clinic|Carol A Langford, MD MHS|216-445-6056|langfoc@ccf.org|
21245623|NCT03483610|University of Rochester|Research Administrator|585-274-1509|peter_macdowell@urmc.rochester.edu|
21245624|NCT04650269|University of Miami Miller School of Medicine|Hansel Tookes|3056897030|hetookes@miami.edu|
21245625|NCT01437709|Memorial Sloan Kettering Cancer Center|Dr. Paul Hamlin, MD|646-608-1667|hamlinp@mskcc.org|
21245626|NCT04091750|Georgetown University|Geoffrey T. Gibney, MD|202-444-2223|Geoffrey.T.Gibney@gunet.georgetown.edu|
21245627|NCT02319759|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21245628|NCT01959425|Biosense Webster Inc.|Stephanie Lyke|(949) 285-7966|SLyke@its.jnj.com|
21245629|NCT04471038|SAB Biotherapeutics|Senior Director Clinical Operations|8326221699|ssinclair@sab.bio|
21245630|NCT04625283|Vanderbilt University Medical Center|Dr. Britany Martin|+1 (615)322-8476|britany.l.raymond@vumc.org|
21245631|NCT02262728|Janssen Research & Development, a division of Janssen Pharmaceutica NV|Medical Leader Hepatitis C, GCO ED&CP||ClinicalTrialDisclosure@its.jnj.com|
21245632|NCT01824394|Biosense Webster, Inc.|Megan Holden|(949) 923-4700|mholden8@its.jnj.com|
21245633|NCT02619838|Duke University|Mark Easley, M.D.|919-660-5066|mark.e.easley@duke.edu|
21245634|NCT01715285|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21245635|NCT05020249|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21245636|NCT01422434|LEO Pharma A/S|Clinical trial disclosure manager|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com|
21245637|NCT04971681|Indiana University|Dr. Martin H. Plawecki, MD, PhD|3179486550|mplaweck@iu.edu|
21245638|NCT03798093|Sharp Healthcare|Dr. Anup Katheria|8589394170|Anup.Katheria@sharp.com|
21245639|NCT06037369|Chang Gung University, Taiwan|Yen-Fan Chin|032118800|yenfan@mail.cgu.edu.tw|5189
21280234|NCT01811472|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21280235|NCT00128401|National Institute of Mental Health|Cameron, Jennifer Ann|+1 301 402 9356|cameronj@mail.nih.gov|
21280236|NCT04882241|Merck Sharp & Dohme LLC.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicalTrialsDisclosure@msd.com|
21280237|NCT00074308|Abramson Cancer Center of the University of Pennsylvania|Jane Daly|215-662-2812|jane@mail.med.upenn.edu|
21280238|NCT04108299|NYU Langone Health|Lu Hu|646-501-3438|lu.hu@nyulangone.org|
21280239|NCT02091856|West University of Timisoara|Dr. Bogdan Tudor Tulbure|+040745753061|btulbure@gmail.com|
21280240|NCT00780338|RAND|Matthew Chinman|412 683-2300|chinman@rand.org|4287
21280241|NCT02023983|Municipal Hospital Ostrava|dr. Kamil Novobílský|+420 59 619 2660|k.novobilsky@mnof.cz|
21280242|NCT02105467|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21280243|NCT03908125|Senseonics, Inc.|Sr. Director of Clinical Operations|301-407-2946|Kathleen.Davis@senseonics.com|
21280244|NCT02676882|Massachusetts General Hospital Center for Women's Mental Health|Dr. Marlene Freeman|617-643-6403|mfreeman@partners.org|
21280245|NCT00397462|Binghamton University, SUNY|Professor Kenneth McLeod|(607)777-5779|kmcleod@binghamton.edu|
21280246|NCT01071915|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
21280247|NCT01288807|UCSD|Tobias Moeller-Bertram (PI)|7603211315|moellerbertram@yahoo.com|
21280248|NCT00958828|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
21280249|NCT00387335|University of Chicago|Ezra Cohen|773-702-4137|ecohen@medicine.bsd.uchicago.edu|
21280250|NCT03885661|University of Pennsylvania|John Millar, PhD|215-898-0638|jsmillar@pennmedicine.upenn.edu|
21280251|NCT00344448|National Institute of Dental and Craniofacial Research|Gabor G Illei, Md, principal Investigator|301 496-4072|illeig@mail.nih.gov|
21280252|NCT02441686|Dana-Farber Cancer Institute|Emily Benjamin|6176324167|emily_benjamin@dfci.harvard.edu|
21280253|NCT03164538|Massachusetts General Hospital|Dr. Jeff Huffman|617-724-2910|JHUFFMAN@mgh.harvard.edu|
21280254|NCT04194645|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21280255|NCT03656744|HighTide Therapeutics|Chief Medical Officer|314-791-0593|adibisceglie@hightidetx.com|
21280256|NCT03076775|University of North Carolina at Chapel Hill|Ashley Battarbee, MD, MSCR|205-975-2361|anbattarbee@uabmc.edu|
21280257|NCT00940316|Northwestern University|Dr. Al Benson|(312) 695-0184|albenson@nm.org|
21280258|NCT04309617|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21280259|NCT01924559|Lehigh Valley Hospital|Marna Rayl Greenberg, DO, MPH|484-884-7514|Marna.Greenberg@lvh.com|
21280260|NCT00996489|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
21280261|NCT06372210|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21280262|NCT00129545|Boston Scientific|Watchman Trial Manager|1-800-227-3422||
21280263|NCT03112473|Department of Rehabilitation Science, The Hong Kong Polytechnic University|Prof. Shamay Ng|27664889|shamay.ng@polyu.edu.hk|
21280264|NCT03541317|University of Michigan|Amy M Kilbourne|734-845-3452|amykilbo@umich.edu|
21280265|NCT00879086|Eisai Inc.|Eisai Medical Information|888-274-2378|esi_oncmedinfo@eisai.com|+1
21280266|NCT01776632|San Diego State University|Elva Arredondo|(619) 594-3481|earredon@sdsu.edu|
21280267|NCT02286843|Memorial Sloan Kettering Cancer Center|Dr. Gary Ulaner, MD, PhD|212-639-7373|carrasj1@mskcc.org|
21280268|NCT02536846|McLean Hospital|Dr. Dost Öngür|617-855-3922|dongur@partners.org|
21280269|NCT00611624|Yale Comprehensive Cancer Center|Kira F. Pavlik, CCRP Clinical Research Coordinator Therapeutic Radiology|(203) 737-2587|kira.pavlik@yale.edu|
21280270|NCT00111241|Monash University|Prof Susan Davis|+61399030827|susan.davis@monash.edu|
21280271|NCT04912232|Dartmouth Health|Norman A. Paradis|(603) 650-7254|Norman.A.Paradis@hitchcock.org|
21280272|NCT02445963|Walter Reed Army Institute of Research (WRAIR) Clinical Trials Center (CTC)|Christopher Duplessis, MD|301-319-9047|Christopher.a.duplessis.mil@mail.mil|
21280273|NCT00125515|New York Psychiatric Institute|Dr Adam Bisaga|212-543-6542|bisagaa@nyspi.columbia.edu|
21245640|NCT05783102|Case Western Reserve University|Kylie Meyer|216-368-1928|knm77@case.edu|
21245641|NCT04505904|University of Arizona|Brian Arizmendi|9168473623|arizmendi@email.arizona.edu|
21245642|NCT03629990|Medical University of South Carolina|Brian Sherman, Ph.D.|843-792-8174|shermanb@musc.edu|
21245643|NCT04277442|The Ohio State University|Dr. Alice Mims|(614) 293-3196|Alice.Mims@osumc.edu|
21245644|NCT06181760|Island Pharmaceuticals|David Foster, CEO|510-393-6523|dfoster@islandpharmaceuticals.com|
21245645|NCT05838313|University of South Florida Morsani College of Medicine, Department of Obstetrics and Gynecology|Anjali Kaimal, MD, MAS|(813) 259-8680|akaimal@usf.edu|
21245646|NCT04938492|University of Rochester|Dr. Lisham Ashrafioun|585-430-2026|lisham_ashrafioun@urmc.rochester.edu|
21245647|NCT05084508|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21245648|NCT04137289|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21245649|NCT03994653|Imperial College London|Dr James Flanagan|44 2075942127|j.flanagan@imperial.ac.uk|
21245650|NCT02876588|Columbia University|Dr. Jason Adelman|646-317-4803|adelman.jason@columbia.edu|
21245651|NCT03931174|Northwestern University|Sara Becker|312-503-4203|sara.becker@northwestern.edu|
21245652|NCT05386030|Croma Pharma|Clinical Development - Head of Clinical Operations|+432262684680|clinical.studies@croma.at|
21245653|NCT04382664|Ultimovacs ASA|Øivind Foss, Head of Clinical Operation|97008357|oivind.foss@ultimovacs.com|
21245654|NCT03213691|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21245655|NCT05302596|State University of NY at Buffalo|Husam Ghanim|7168818924|ghanim@buffalo.edu|
21245656|NCT05417009|Queen Mary University of London|Professor Gareth Ackland|02035940348|g.ackland@qmul.ac.uk|
21245657|NCT01333969|Hospital for Special Surgery|Dr. Stavros Memtsoudis|646-797-8522|MemtsoudisS@hss.edu|8522
21245658|NCT06020534|Erasmus Medical Center|Drs. Yitian Fang|+31 645680154|y.fang.1@erasmusmc.nl|
21245659|NCT04977947|University of Cincinnati|Cathleen Stough, Ph.D.|513-556-5589|odarcc@ucmail.uc.edu|
21245660|NCT04029688|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21245661|NCT05875142|We The Village, Inc.|Jane Macky, PI/CEO|91768344267|jane@wethevillage.co|
21245662|NCT03436290|Vanderbilt University Medical Center|Myrick Shinall, principal investigator|615-343-5613|ricky.shinall@vumc.org|
21245663|NCT02677298|Croma Pharma|Clinical Development - Head of Clinical Operations|+432262684680|clinical.studies@croma.at|
21245664|NCT04130438|Stanford University|Jennifer A. Tremmel, MD, MS|(650) 723-0180|nocad_study@stanford.edu|
21245665|NCT03499821|STAAR Surgical|Joanne Egamino|626-303-7902|jegamino@staar.com|
21245667|NCT05441579|Nationwide Children's Hospital|Dr. Vanessa Olbrecht|614-722-4200|vanessa.olbrecht@nationwidechildrens.org|
21245668|NCT03338933|VA Portland Health Care System|Dr. William Hoffman|503-220-8262|hoffmaw@ohsu.edu|56214
21245669|NCT04515576|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21245670|NCT03812679|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
21245671|NCT04671446|Queen Mary University of London|Dr Myles Lewis, Dr Paul Pfeffer|+4420 7882 5555|myles.lewis@qmul.ac.uk; p.pfeffer@qmul.ac.uk|
21245672|NCT04622943|University of Alabama at Birmingham|Dr. David Schwebel|205-934-8745|schwebel@uab.edu|
21245673|NCT02140554|bluebird bio, Inc|Study Medical Director|339-499-9300|medinfo@bluebirdbio.com|
21245674|NCT02289209|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
21245675|NCT03953508|University of Oklahoma Health Sciences Center|Amy Cohn, PhD|4052711903|amy-cohn@ouhsc.edu|
21245676|NCT03771417|Louisiana State University|Brian A. Irving, PhD|12255787179|brianairving@lsu.edu|
21245677|NCT04456517|Vanderbilt University Medical Center|Michael McGill|615-322-4643|michael.g.mcgill@vumc.org|
21245678|NCT02100813|LEO Pharma A/S|Clinical Trial Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
21245679|NCT01186367|Memorial Sloan Kettering Cancer Center|Dr. Jessica Scott, PhD|646-888-8093|scottj1@mskcc.org|
21245680|NCT04574024|Rutgers, The State University of New Jersey|Suhayl Dhib-Jalbut|732-235-7335|jalbutsu@rwjms.rutgers.edu|
21245681|NCT04509674|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21245682|NCT00817219|LEO Pharma A/S|Malin Järnkrants|+45 7226 2990|malin.jaernkrants@leo-pharma.com|
21245683|NCT04660201|University of Maryland School of Medicine|James Campbell, MD|410-706-5328|Jcampbel@som.umaryland.edu|
21245684|NCT04064164|University of Kansas School of Nursing|Kristine Williams|7859797879|kwilliams1@kumc.edu|
21245685|NCT02222155|ChemoCentryx|Study Director|650-210-2900||
21245686|NCT05130762|Becton, Dickinson and Company|Stephan Hofmann|+49 160 105 3421|Stephan.Hofmann@bd.com|
21245687|NCT02305277|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21245688|NCT01606215|Imperial College London|Professor Paolo Muraro|02075946670|p.muraro@imperial.ac.uk|
21245689|NCT05851573|University of Central Florida|Dr. Deena Schwen Blackett|407-823-0909|deena.blackett@ucf.edu|
21245690|NCT06429319|RCBIOFORM|Julia Melentyeva Commercial Director|84952237095|md@bioform.ru|
21245691|NCT03916510|University of Oxford|CEDAR Trial Manager, Oncology Clinical Trials Office (OCTO)|01865 617085|octo-CEDAR@oncology.ox.ac.uk|
21245692|NCT04316871|Assiut University|Dr Muhammad Shawqi|01100671067|m.shawqi@med.au.edu.eg|+20
21245693|NCT05087992|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21245694|NCT03123848|Janssen Pharmaceutical K.K.|Director, IDV Department|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21245695|NCT01369355|Janssen Research & Development, LLC|Vice President|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21245696|NCT02436096|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 904-0355|greg.sullivan@tonixpharma.com|
21245697|NCT06424236|Washington University|Administrative Director|(314) 221-8344|DIAN-TUDataRequest@wustl.edu|
21245698|NCT04213872|ASU/PVHMC|Dr. Francisco Munoz|909-753-8391|fmunoz007@verizon.net|
21245699|NCT00227344|Biosense Webster, Inc.|Pat Ticknor, Clinical Operations|909-839-8500|PTicknor@its.jnj.com|
21293637|NCT02100423|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Paolo Caimi|1-800-641-2422|paolo.caimi@uhhospitals.org|
21293638|NCT02949024|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
21293639|NCT02025634|AdventHealth|Brad Homan|407-303-4270|Brad.Homan.MD@AdventHealth.com|
21293640|NCT01527045|Fred Hutchinson Cancer Research Center|Dr. Marco Mielcarek|(206) 667-2827|mmielcar@fredhutch.org|
21293641|NCT00936663|University of Nebraska Medical Center|Vijay Shivaswamy|402-559-6208|vshivaswamy@unmc.edu|
21293642|NCT01014767|Tufts Medical Center|Research Administration|617-636-1142|mcoughlin@tuftsmedicalcenter.org|
21293643|NCT01709110|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21293644|NCT02802293|University of Texas Health -- San Antonio|Felipe S. Salinas, Ph.D.|210-567-8214|salinasf@uthscsa.edu|
21293645|NCT04123093|OhioHealth|Dr. Mitch Silver|614-566-1250|mitch.silver@ohiohealth.com|
21293646|NCT02579421|University of Minnesota|Dr. Sharon Allen|612-624-0446|allen001@umn.edu|
21293647|NCT01164891|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
21293648|NCT00338286|Janssen Research and Development|Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
21293649|NCT01265563|VA- STVHCS|Dr. Shweta Bansal|2105674700|bansals3@uthscsa.edu|
21293650|NCT01703091|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21293651|NCT02029755|Taipei medical university hospital|Dr. Hsiao-Chien Tsai|+886-2-27372181|hctsai.anes@gmail.com|8310
21293652|NCT04904744|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
21293653|NCT04998318|Duke University Medical Center|Megan Huchko, MD, MPH|(919) 684-8111|megan.huchko@duke.edu|
21293654|NCT00022763|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21293655|NCT04908865|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21293656|NCT02550288|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21293657|NCT05312697|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
21293658|NCT05420961|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21293659|NCT00783835|Janssen-Cilag Farmaceutica Ltda|Medical Manager|+55 11 30302738||
21293660|NCT01945996|University of Southern California|Elizabeth Burner|3232266667|eburner@usc.edu|
21293661|NCT03248167|NYU Langone Health|Charles Marmar, MD|646-754-4855|Charles.marmar@nyumc.org|
21293662|NCT02122146|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21293663|NCT02110485|Nationwide Children's Hospital|Beth Fischer|614-355-0338|beth.fischer@nationwidechildrens.org|
21293664|NCT03578926|CooperVision Inc.|Jose A. Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com|
21293665|NCT00992056|University of Miami|Richard A Preston MD MSPH MBA|305 243 5930|rpreston@med.miami.edu|
21293666|NCT00295334|Ben-Gurion University of the Negev|Iris Shai|+972086477443|irish@bgu.ac.il|
21293667|NCT01001767|University Hospitals Case Medical Center|Grace McComsey, MC|216-844-3607|mccomsey.grace@clevelandactu.org|
21293668|NCT02584452|Vanderbilt University Medical Center|Christopher Sobey, MD|615-322-4311|christopher.m.sobey@vumc.org|
21293669|NCT01107392|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21293670|NCT00851552|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21293671|NCT00177294|University of Pittsburgh|Charles F. Reynolds III, MD|412-246-6414|reynoldscf@upmc.edu|
21293672|NCT02998671|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21293673|NCT04560686|UT MD Anderson Cancer Center|Dr. Tina Cascone,MD- Assistant Professor, Thoracic-Head & Neck Med Onc|(713) 792-6363|tcascone@mdanderson.org|
21293674|NCT02038946|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21293675|NCT00652314|Vascular Solutions, Inc.|Lisa Gallatin, RAC|763-656-4399|lgallatin@vasc.com|
21293676|NCT01558596|Minneapolis VA Medical Center|Santiago Garcia, MD|6124673670|santiago.garcia@va.gov|
21293677|NCT02473471|Jordanian University of science and Technology|Dr.Amal Alkebsi|00966552358684|amalkibsi@gmail.com,aalkebsi13@den.just.edu.jo|
21293678|NCT02057640|Cleveland Clinic Taussig Cancer Center|Jason Valent, MD|216-445-7238|valentj3@ccf.org|
21293679|NCT03020004|Ascletis Pharmaceuticals Co., Ltd|Clinical Trial Disclosures|+86057185389732|yicheng.zhao@ascletis.com|
21293680|NCT02846792|University of Washington|Research Manager|206-606-7445|smasters@seattlecca.org|
21293681|NCT02063984|Geisel School of Medicine at Dartmouth Center for Technology and Behavioral Health|Alan J. Budney, Ph.D|603-646-7088|alan.budney@dartmouth.edu|
21293682|NCT04175340|Bausch + Lomb Incorporated|Senior Manager, Clinical Trials|(585) 623-9588|Margaret.Swartzenberg@bausch.com|
21293683|NCT02901249|Universidade Federal do Rio Grande do Sul|D.r. Ana Flávia Barros da Silva Lima|51999185180|afbslima@gmail.com.br|
21293684|NCT01958580|Albert Einstein College of Medicine - Montefiore Medical center|Dr. Jessica Atrio - Professor, Department of Obstetrics & Gynecology and Women's Health|917-721-6155|jatrio@montefiore.org|
21293685|NCT01536561|GlaxoSmithKline|GSK Response Center|866-435-7343||
21293686|NCT01030952|Novartis Pharmaceuticals|Study Director|+1-800-244-7668||
21293687|NCT02467192|Hopitaux Universitaires de Geneve|Dr Jerome Stirnemann|+41223729101|jerome.stirnemann@hcuge.ch|
21293688|NCT00958347|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|ellen.axelson@stryker.com|
21293689|NCT01603043|Alcon Research, Ltd.|Yamini Patel, PhD, Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21293690|NCT01763333|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21245700|NCT05505292|SUNY College of Optometry|Danielle Iacono|2129385936|diacono@sunyopt.edu|
21245701|NCT04863378|Oregon Heatlh & Science University|Raina Croff, PhD Study investigator/ KL2 trainee|503-494-2367|croff@ohsu.edu|
21293691|NCT01625416|University of Washington|Dr. Douglas Zatzick|2067446701|dzatzick@uw.edu|
21245702|NCT04149704|Dana-Farber Cancer Institute|Jennifer Snaman|617632-5548|jennifer_snaman@dfci.harvard.edu|
21245703|NCT03629678|The Ohio State University|Dr Robert Cronin|6146889220|robert.cronin@osumc.edu|
21245704|NCT06215430|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21245705|NCT04376502|Miami Cancer Institute at Baptist Health, Inc.|Director, Research Concept & Protocol Development|(786) 527-9546|MCIResearchConceptAndProtocolDev@baptisthealth.net|
21245706|NCT04632992|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21245707|NCT02677805|Croma Pharma GmbH|Clinical Development - Head of Clinical Operations|+432262684680|clinical.studies@croma.at|
21245708|NCT04111536|University of Pennsylvania|Theresa M Scattergood, MSN|215-898-5664|theresa.scattergood@pennmedicine.upenn.edu|
21245709|NCT04187833|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|James Isaacs, MD|1-866-223-8100|TaussigResearch@ccf.org|
21245710|NCT01898754|University of Washington|Professor Lisa Frenkel|+1 206 987-5140|lfrenkel@uw.edu|
21245711|NCT04547920|Avation Medical|Clinical Operations Project Manager|(614) 591-4201|customercare@avation.com|
21245712|NCT04209465|Black Diamond Therapeutics, Inc.|Medical Monitor|617-401-8444|ClinicalTrials@bdtx.com|
21245713|NCT05647304|REGEnLIFE|Guillaume Blivet|+33434481535|gblivet@regenlife.com|
21245714|NCT04171999|University of Chicago|Emily Abramsohn|7738344832|eabramsohn@bsd.uchicago.edu|
21280274|NCT01957176|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21245715|NCT03092518|National Cancer Institute|Dr. Jeremy Davis|2408583731|jeremy.davis@nih.gov|
21245716|NCT02547987|Baylor College of Medicine|Mothaffar Rimawi, M.D.|713-798-1311|rimawi@bcm.edu|
21245717|NCT01743807|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
21245718|NCT01814813|Mayo Clinic|Ian Parney, MD, PhD|507-284-8167|Parney.Ian@mayo.edu|
21245719|NCT05089019|Eli Lilly and Company|Chief Medical Officer|8005955979|ClinicalTrials.gov@lilly.com|
21245720|NCT05170009|Weill Cornell Medicine|Dr. Mirella Salvatore|(646) 318-8506|mis2053@med.cornell.edu|
21245721|NCT04925986|Yale School of Medicine|Sarah Goldberg, MD, MPH: Associate Professor of Internal Medicine (Medical Oncology)|(203) 200-5864|sarah.goldberg@yale.edu|
21280275|NCT01449812|GlaxoSmithKline|GSK Response Center|866-435-7343||
21280276|NCT03449446|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21280277|NCT03785327|The University of Texas at Dallas|Dr. Noah Sasson|972-883-2541|nsasson@utdallas.edu|
21280278|NCT03180645|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21280279|NCT00625872|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21280280|NCT04208750|Indiana University|Dr. Dawn Meyer|812-855-0559|meyerd@indiana.edu|
21280281|NCT04977479|National Institute of Allergy and Infectious Diseases|Pamela Frischmeyer-Guerrerio|301-402-9782|pamela.guerrerio@nih.gov|
21280282|NCT02201277|University of California, San Francisco, Interventional Radiology|Maureen Kohi, MD|(415) 353-1300|maureen.kohi@ucsf.edu|
21280283|NCT01512160|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21280284|NCT02084160|Exalenz|Avrahm Hershkowitz/ Clinical Trial Manager|972-8-9737500|avrahamh@exalenz.com|
21280285|NCT05101343|Winthrop University|Compliance Coordinator|8033232460|smithmr@winthrop.edu|
21280286|NCT04779879|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
21280287|NCT02854527|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21280288|NCT02603146|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21280289|NCT05355532|Privolzhsky Research Medical University|Ilya Pochinka, MD|+79030561932|pochinka4@yandex.ru|
21280290|NCT03325101|Mayo Clinic|Matthew Block, MD, PhD|507-266-7446|Block.Matthew@mayo.edu|
21280291|NCT01198769|GlaxoSmithKline|GSK Response Center|866-435-7343||
21280292|NCT01783990|New England Research Institutes, Inc|Julie Miller|617-972-3197|JMiller@healthcore.com|
21280293|NCT02366689|Farid Ayad|Dr. Farid Ayad|416-473-1189|ayad.farid@gmail.com|
21280294|NCT03503669|University of California, Los Angeles|Helen Lavretsky, MD|(310) 794-4619|HLavretsky@mednet.ucla.edu|
21280295|NCT04793711|Primus Pharmaceuticals, Inc.|Clinical Project Manager|4802506689|msanstead@primusrx.com|
21280296|NCT01295112|The Emmes Corporation|Traci Clemons|1-301-251-1161|tclemons@emmes.com|10212
21280297|NCT01068262|Merck Sharp and Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21280298|NCT04182490|Lumen Bioscience, Inc.|Senior Medical Director|206-899-1904|trials@lumen.bio|
21280299|NCT00743717|Los Alamitos Orthopaedic Group|Dr. Perry Secor|805-384-2748|vsarin@kinamed.com|
21280300|NCT02229461|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21280301|NCT01221207|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
21280302|NCT00661193|SWOG Statistical Center|Lung Committee Statistician|206-667-6197|jmoon@fredhutch.org|
21280303|NCT01231646|North Shore-LIJ Health System|Connie Lau, MS, CCRC|516-325-7022|clau@nshs.edu|
21280304|NCT00934024|MUSC|Dr. Karen Hartwell|843-792-8174|hartwelk@musc.edu|
21280305|NCT02719184|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
21280306|NCT03105518|Brigham and Women's Hospital/Harvard Medical School|Lawrence Tsen, MD|617.732.8216|ltsen@bwh.harvard.edu|
21280307|NCT05024747|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
21280308|NCT01927575|Fujifilm Medical Systems, U.S.A., Inc.|Robert Uzenoff|(203) 602-3664|ruzenoff@fujifilm.com|
21280309|NCT00662649|Novartis Pharmaceuticals|Study Director|862 778-8300||
21280310|NCT01026194|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21280311|NCT01113723|Department of Anesthesiology, Cedars-Sinai Medical Center|Roya Yumul, M.D., Ph.D.|310-423-5841|(Roya.Yumul@cshs.org)|
21280312|NCT04428034|UT Health San Antonio|Kylie Meyer, PhD|210-450-5386|meyerk1@uthscsa.edu|
21293692|NCT01667250|electroCore LLC|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
21293693|NCT02146131|Medical University of South Carolina|Kate Taylor|843-792-2297|Talykat@musc.edu|
21293694|NCT02567799|Humanetics Corporation|Michael D. Kaytor|952-400-0406|mkaytor@humaneticscorp.com|
21293695|NCT02991898|Masonic Cancer Center, University of Minnesota|Claudio Brunstein|612-625-3918|bruns072@umn.edu|
21293696|NCT00778167|University of Colorado Denver|Dr. David R. Camidge|720-848-0449|ross.camidge@ucdenver.edu|
21293697|NCT00861692|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21293698|NCT01925040|Kulzer GmbH|Global Scientific Affairs Management|+4915116891006|andrea.leyer@kulzer-dental.com|
21293699|NCT02218697|GlaxoSmithKline|GSK Response Center|866-435-7343||
21293700|NCT02142803|Dana Farber Cancer Institute|Christine Sceppa McCluskey|617-632-5394|christine_sceppa@dfci.harvard.edu|
21293701|NCT05111002|University of Washington|Lisa E Manhart|206-744-3646|lmanhart@uw.edu|
21293702|NCT02712996|Vanderbilt University Medical Center|Michael Tramontana,PhD|615-327-7144|michael.tramontana@vumc.org|
21293703|NCT03693144|University of Michigan|Dr. Susan Woolford|734 615-8214|swoolfor@med.umich.edu|
21293704|NCT01016132|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
21293705|NCT02227810|Chang Gung memorial hospital|Dr Huang Chung-Chi|88632118800|yhchen@mail.cgu.edu.tw|5233
21293706|NCT00451958|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21293707|NCT02521974|FIDEC Corporationa|Ricardo Rüttimann|+17863546335|rruttimann@fidec-online.org|
21293708|NCT01027650|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21293709|NCT01082081|GlaxoSmithKline|GSK Response Center|866-435-7343||
21293710|NCT02175277|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21293711|NCT00670930|Novartis Pharmaceuticals|Study Director|862-778-8300||
21293712|NCT01042158|Johns Hopkins University|Paul Hassoun, MD|410-614-5158|phassoun@jhmi.edu|
21293713|NCT02201329|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21293714|NCT01534351|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21293715|NCT02702609|Sunstar Americas, Inc.|Akane Takemura|8477944276|akane.takemura@us.sunstar.com|
21293716|NCT02674464|Johns Hopkins University School of Medicine|Dr. Lisa Cooper, Principal Investigator|4106143659|lisa.cooper@jhmi.edu|
21293717|NCT04153981|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21293718|NCT01262638|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
21293719|NCT01122446|LundU|Helena Elding Larsson, PI|+4640337676|helena.elding_larsson@med.lu.se|
21293720|NCT01369199|University of Pittsburgh|Dr. Steven Belle|412-624-5419|belle@edc.pitt.edu|
21293721|NCT01066104|MGH|Dr. Ellen Dutta|6177248256|edutta@mgh.harvard.edu|
21293722|NCT01667133|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21293723|NCT02548910|Ottawa Hospital Research Institute|Dr. Guillaume Martel|6137378899|gumartel@toh.ca|71053
21293724|NCT01916824|Emory University|Boadie Dunlop, MD|404-727-8969|bdunlop@emory.edu|
21245722|NCT01414400|Stanford University School of Medicine|Subhas Banerjee|650-723-2623|sbanerje@stanford.edu|
21293725|NCT00626886|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
21293726|NCT00771927|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
21293727|NCT03835481|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21293728|NCT01116466|Otto Bock Healthcare Products GmbH|Medical Affairs Manager|004315233786733|Milana.Mileusnic@ottobock.com|
21293729|NCT01267864|Albert Einstein College of Medicine, Montefiore Medical Center|Benjamin Friedman, MD|718-920-6626|befriedm@montefiore.org|
21293730|NCT00581399|University of California, Irvine Medical Center|Dr. Jeffrey C. Milliken|714-456-3634|jcmillik@uci.edu|
21293731|NCT00976716|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21293732|NCT04222699|VA Maryland Healthcare System|Dr. Mary-Claire Roghmann|410 706 0062|mroghmann@som.umaryland.edu|
21293733|NCT01145001|Yale University|Dana Cavallo, Assistant Professor|2039747607|dana.cavallo@yale.edu|
21293734|NCT00617058|The University of North Carolina at Chapel Hill|Linmarie Sikich, M.D.|(919) 972-7499|lsikich@med.unc.edu|
21293735|NCT01576939|Stanford University|Quynh Le|650-725-0203|qle@stanford.edu|
21293736|NCT01814046|National Cancer Institute|Dr. Steven Rosenberg|301-496-4164|steven-rosenberg@nih.gov|
21293737|NCT00564902|James A. Lovell Federal Health Care Center|Dr. Stuart P. Richer|224-610-5440|Stuart.Richer1@va.gov|
21293738|NCT02723916|The Ohio State University, College of Nursing|Dr. Susie Breitenstein|6146884614|breitenstein.5@osu.edu|
21293739|NCT04552288|Memorial Sloan Kettering Cancer Center|Dr. Alina Markova, MD|646-608-2342|markovaa@mskcc.org|
21293740|NCT03089047|Duke University|Ian Welsby, M.D.|919-681-6752|ian.welsby@duke.edu|
21293741|NCT03599518|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21293742|NCT03583359|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|Aesthetic.Trials@merz.com|
21293743|NCT00508105|Ottawa Hospital Research Institute|Peter Lapner|613-737-8899|plapner@toh.ca|74700
21293744|NCT02008149|Department of Veterans Affairs|Dr. Gary S. Beaupre|(650) 493-5000|Gary.Beaupre@va.gov|64272
21293745|NCT02561481|Univ of Massachusetts Medical School|Andrew Zimmerman, MD|4109350488|andrew.zimmerman@umassmemorial.org|
21293746|NCT01831466|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21245723|NCT05457647|Studio Italiano di Oftalmologia|Dr. Marco Lombardo, Study Director|+393313438300|studiolombardo@visioeng.it|
21245724|NCT03115476|LEO Pharma|Clinical Trial Disclosure|+45 4494 5888|disclosure@leo-pharma.com|
21293747|NCT02299141|Washington University School of Medicine|Ramaswamy Govindan|314-362-5654|rgovindan@wustl.edu|
21293748|NCT00434993|Acute Respiratory Distress Syndrome (ARDS) Network|David Schoenfeld, ARDSNet CCC PI|617-726-6111|dschoenfeld@partners.org|
21245725|NCT03865498|Columbia University|Sunmoo Yoon|+1 212 300 7081|sy2102@cumc.columbia.edu|
21245726|NCT01648023|University of Louisville|Robert Martin, MD, PhD|502-629-3355|robert.martin@louisville.edu|
21245727|NCT01623167|National Heart Lung and Blood Institute (NHLBI)|Neal S. Young, M.D, NIH Principal Investigator|301-496-5093|youngns@nhlbi.nih.gov|
21245728|NCT05296525|Gamida Cell|Associate director, Clinical Operations|+972556660324|aurelie@gamida-cell.com|
21245729|NCT04531280|Brigham and Women's Hospital|Dr. David Levine|6177328925|dmlevine@bwh.harvard.edu|
21245730|NCT02547363|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
21245731|NCT05228457|University of Pennsylvania|Walid Makhoul|215-573-2409|walid.makhoul@pennmedicine.upenn.edu|
21245732|NCT04528173|The Children's Hospital of Philadelphia|Tori Nicole Sutherland MD MPH|443-631-5032|sutherlant@chop.edu|
21245733|NCT03161028|VA Portland Medical Center|Dr. Rebecca Spain|503-346-0768|rebecca.spain@va.gov|
21245734|NCT02862210|Brown University|Edward Huey, MD|401-455-6403|edward_huey@brown.edu|
21245735|NCT00736723|University|Prof. Dr. Manfred Weiss|#49 731 500 60226|manfred.weiss@uni-ulm.de|
21245736|NCT03492216|University of California, San Francisco (UCSF)|Dr. Gabriel Chamie|415-476-4082|gabriel.chamie@ucsf.edu|445
21245737|NCT02587403|RTI Surgical|Jennifer Johnson, Senior Clinical Manager|386-418-8888|jljohnson@rtix.com|
21245738|NCT01799265|Bluebird Consulting|Melinda Swanson|6123084500|melinda@bluebirddevice.com|
21245739|NCT03134092|University of Pennsylvania Perelman School of Medicine|Dr. Zachary Meisel|215-746-5618|zfm@pennmedicine.upenn.edu|
21245740|NCT04836195|Pacylex Pharmaceuticals|VP Operations|1 (888) 580-4483|ryan.heit@pacylex.com|
21245741|NCT05351554|Kinevant|Study Director|Please email|kinevant.resolve-heart@kinevant.com|
21245742|NCT05030233|The Ohio State University College of Nursing|Marliese D. Nist|614-247-5781|nist.10@osu.edu|
21245743|NCT04342494|University of Michigan|Amy Bohnert|(734) 936-4280|amybohne@med.umich.edu|
21245744|NCT03676764|University of California, San Francisco FI Proctor Foundation|Dr. Thomas Lietman, Director of the UCSF FI Proctor Foundation|415-476-1442|tom.lietman@ucsf.edu|
21245745|NCT02561585|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
21245746|NCT04461405|Oregon Health & Science University|Dr. Deborah Cohen|503-781-8795|cohendj@ohsu.edu|
21245747|NCT06190691|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
21245748|NCT03016754|ZOLL|Nicole Bianco|4129683333|nbianco@zoll.com|14410
21245749|NCT04019873|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21245750|NCT05467345|Ascensia Diabetes Care|Jane Wallace|5748501467|jane.wallace@ascensia.com|
21245751|NCT04185298|Saint John's Cancer Institute|Dr. Jennifer Bramen|310-525-0865|jennifer.bramen@providence.org|
21245752|NCT03896789|University of Washington|Dr. Monica S. Vavilala|206-744-7235|vavilala@uw.edu|
21245753|NCT01842542|Neuronetics|Director of Clinical Operations|16123067393|steve.erickson@neurostar.com|
21245754|NCT02919306|Janssen Vaccines and Prevention BV|CLINICAL FRANCHISE LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21280313|NCT00245518|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
21245755|NCT04473222|University of Oregon|Ariel Williamson|971-352-4004|arielaw@uoregon.edu|
21245756|NCT04293055|The Miriam Hospital|Dr. Jacqueline Hayes|401-793-8917|jhayes3@lifespan.org|
21245757|NCT03560609|NYU Langone Health|Jamika Singleton-Garvin|(212) 263-2573|jamika.singleton-garvin@nyulangone.org|
21245758|NCT02839161|George Washington University|David J. Diemert, MD|202-994-2909|ddiemert@gwu.edu|
21245759|NCT01098812|Abbott Medical Optics|Kristen Featherstone|714-247-8621|kristen.featherstone@amo.abbott.com|
21245760|NCT06321809|Hacettepe University|Assoc.Prof. Duygu Ayhan Baser|+90-505-664-5210|dr.duyguayhan@gmail.com|
21245761|NCT01987895|Actelion Pharmaceuticals Ltd|Clinical Trial disclosure Desk|0041615656565|clinical-trials-disclosure@its.jnj.com|
21280314|NCT02556801|HAL Allergy|Andrey Larionov, MD, Head of Clinical Development|+31881959189|alarionov@hal-allergy.com|
21280315|NCT02045446|University of Texas Southwestern Medical Center|Dr. Puneeth Iyengar|214/645-7603|puneeth.iyengar@utsouthwestern.edu|
21280316|NCT05274178|Phonak Audiology Research Center|Principle Investigator|630-821-5000|phonakaudiologyresearch@gmail.com|
21280317|NCT02515331|Novartis Pharmaceuticals|Study Director|862-778-8300|novartisemail@novartis.com|
21280318|NCT00124748|Novartis Pharmaceuticals|Study Director|862-778-8300||
21280319|NCT00322712|University of New Mexico|Dr. Fa Chyi Lee|505-925-0405|flee@salud.unm.edu|
21280320|NCT00567008|UPenn|Jennifer Plebani|2152223200|jplebani@mail.med.upenn.edu|152
21280321|NCT04176250|Gates MRI|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
21280322|NCT00758524|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
21280323|NCT01339403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21280324|NCT04090125|University of North Carolina at Chapel Hill|Kelli Allen, PhD|919-966-0558|kdallen@email.unc.edu|
21280325|NCT04747470|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21280326|NCT04688671|Eliem Therapeutics|Clinical Operations|+1-888-506-2573|studyinfo@eliemtx.com|
21280327|NCT01525329|Cleveland Clinic|Dr. Edward Maytin|216-445-6676|maytine@ccf.org|
21280328|NCT02262325|The Ohio State University Comprehensive Cancer Center|Dr. Eric Miller|614-293-8595|eric.miller@osumc.edu|
21280329|NCT02815995|The University of Texas MD Anderson Cancer Center|Dr. Neeta Somaiah|(713) 792-3626|nsomaiah@mdanderson.org|
21280330|NCT01125189|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21280331|NCT00114140|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21245762|NCT01073566|Calibra Medical|Vice President Clinical Affairs|650-298-4750|ddreon@calibra.com|
21245763|NCT01389856|Actelion Pharmaceuticals Ltd|Pegah Nowbakht/Senior Clinical Trial Scientist|+41 61 565 68 41|pegah.nowbakht@actelion.com|
21280332|NCT00110396|Merck Serono SA|Bettina Stubinski/Medical Responsible|+41224143396||
21293749|NCT03335150|VASDHS|Dr. Dawn Schiehser|858-552-8585|Dawn.Schiehser@va.gov|2664
21293750|NCT02122666|Washington University School of Medicine|Samantha Adamson, MD, PhD|314-362-3500|sadamson@wustl.edu|
21293751|NCT03148379|Medacta USA|Rena Mandino, Director of Clinical Research|352-359-3581|rmandino@medacta.us.com|
21293752|NCT02591472|University of Florida|MaryBeth Horodyski, EdD|352-273-7074|horodmb@ortho.ufl.edu|
21245764|NCT03309306|Department of Agricultural, Environmental & Development Economics, Ohio State University|Brian Roe|614-688-5777|roe.30@osu.edu|
21245765|NCT03959696|Massachusetts General Hospital|Karen Sepucha|617-724-3350|ksepucha@mgh.harvard.edu|
21245766|NCT03452579|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|David Peereboom, MD|1-866-223-8100|TaussigResearch@ccf.org|
21245767|NCT05337306|GogyUp|Ned Zimmerman-Bence, Co-Founder|6124605358|ned.zb@gogyup.com|
21245768|NCT04858321|University of Portsmouth|Dr Anthony Shepherd|02392845289|ant.shepherd@port.ac.uk|
21245769|NCT01539083|Janssen R&D|Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
21245770|NCT05533359|University of Utah|Dr. Guilherme Del Fiol|801-581-4080|guilherme.delfiol@utah.edu|
21245771|NCT05006872|Health Research Institute of the Balearic Islands|Dra. Rocío Zamanillo Campos|+34 971175883|rocio.zamanillo@ssib.es|
21245772|NCT05328362|Dartmouth College|Catherine Stanger|603-646-7023|catherine.stanger@dartmouth.edu|
21245773|NCT01753414|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
21245774|NCT03913702|University of Texas Medical Branch Galveston|Dr. Jeremy Somerson|409-747-5701|jesomers@utmb.edu|
21245775|NCT05499377|Virginia Commonwealth University|Augustus Whiet|(804) 828-8892|whiteam25@vcu.edu|
21245776|NCT02573493|Washington University School of Medicine|Douglas R. Adkins, M.D.|314-747-8475|dadkins@wustl.edu|
21245777|NCT04332926|Virginia Commonwealth University|Caroline Cobb, PhD, PI|804-828-8687|cobbco@vcu.edu|
21245778|NCT00528268|University of Utah|Dr. Kathryn Swoboda|801-585-9717|swoboda@genetics.utah.edu|
21245779|NCT02433613|Medtronic GmbH|Dr. Ralf Meyer|01755810431|ralf.meyer@medtronic.com|
21245780|NCT02291302|Boston Children's Hospital|Wanda Phipatanakul, MD. MS.|617-355-6117|wanda.phipatanakul@childrens.harvard.edu|
21245781|NCT04350463|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21245782|NCT04652700|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21245783|NCT03097549|Umeå University|Towe Wadensten|0046907865000|towe.wadensten@umu.se|
21245784|NCT02301910|SuperGene LLC|Markin Sergey|(495) 287-98-07|info@supergene.ru|+7
21245785|NCT01824537|McGill University|Eduardo L Franco|514-398-6032|eduardo.franco@mcgill.ca|
21245786|NCT04282148|Abbott|Ikuko Kishimoto, Principal Research Scientist|480-482-8279|ikuko.kishimoto@abbott.com|
21245787|NCT02146378|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21245788|NCT06215521|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21245789|NCT04096040|ZOLL Medical|Director of Scientific Affairs|4129683333|nbianco@zoll.com|14410
21245790|NCT04973254|Boston Medical Center|Laura Fletcher, LCSW MSW MPH|857-225-5183|laura.fletcher@bmc.org|
21245791|NCT04044768|Adaptimmune|Clinical Trials Management|+1 (215) 825 9260|clinicaltrials@adaptimmune.com|
21245792|NCT03858634|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
21245793|NCT03808818|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21245794|NCT05415722|Terns, Inc.|Study Director|+1 650-525-5535|clinicaltrials@ternspharma.com|101
21245795|NCT04629716|Florida State University|Nicole Ennis, PhD|850-644-2334|nicole.ennis@med.fsu.edu|
21245796|NCT04518917|Washington University in St. LOuis|Gammon Earhart|314-286-1407|earhartg@wustl.edu|
21245797|NCT04537715|Epizyme, Inc.|Medical Lead or Designee|(855) 500-1011|clinicaltrials@epizyme.com|
21245798|NCT03448107|NYU Dentistry|Richard Niederman|917-280-5920|r.niederman@nyu.edu|
21245799|NCT04700163|The Rockefeller University|Marina Caskey|2123277396|mcaskey@rockefeller.edu|
21245800|NCT05590962|University of Pennsylvania|Dr. Ravi Parikh|3524224285|ravi.parikh@pennmedicine.upenn.edu|
21245801|NCT03854214|Kennedy Krieger Institute|Ann S. Choe, Ph.D.|443-923-9500|choea@kennedykrieger.org|
21293753|NCT04380753|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21293754|NCT00809926|Novartis Pharmaceuticals|Study Director|862-778-8300||
21293755|NCT02530476|The University of Texas MD Anderson Cancer Center|Naval Daver, MD/Associate Professor|713-794-4392|NDaver@mdanderson.org|
21293756|NCT02870985|Fuwai Hospital|Prof. Yuejin Yang|008613701151408|yangyjfw@126.com|
21293757|NCT00343564|Cytokinetics,Inc.|Project Manager|650-624-2918||
21245802|NCT02396134|City of Hope|Dr. Ryotaro Nakamura|626-359-8111|rnakamura@coh.org|
21293758|NCT04776720|University of California, San Francisco|Alison Huang, MD, MAS, MPhil|415-353-7900|alison.huang@ucsf.edu|
21293759|NCT03913013|UCLA Semel Institute for Neuroscience and Behavior|David J. Miklowitz, Ph.D., Principal Investigator|(310) 267-2659|dmiklowitz@mednet.ucla.edu|
21293760|NCT05356910|University of California, San Diego|Heather Pines|619-594-2481|hpines@health.ucsd.edu|
21293761|NCT03321071|University of South Carolina|R. Glenn Weaver|803-777-5606|weaverrg@email.edu|
21245803|NCT05543629|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@BMS.com|
21245804|NCT04568603|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21245805|NCT04564742|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21245806|NCT04131686|Boryung|Ji-Yeon Kim|82-2-708-8128|jiyeonkim@boryung.co.kr|
21245807|NCT05869383|Sriwijaya University|Nur Riviati|+6281377671384|eviqodir@yahoo.com|
21245808|NCT01424150|Alfred Health|Professor Paul Myles|61 3 9076 3176|p.myles@alfred.org.au|
21293762|NCT03306433|University of Colorado, SoDM|Clifton Carey|3037241046|clifton.carey@cuanschutz.edu|
21293763|NCT00819156|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21245809|NCT02535338|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
21293764|NCT00790582|Forbes Norris MDA/ALS Center|Giovanna Kushner|415-600-3983|kushneg@cpmcri.org|
21293765|NCT00803595|Daiichi Sankyo Pharma Development|Howard Kessler|732-590-5032|hmkessler@dsi.com|
21293766|NCT02953561|The University of Texas MD Anderson Cancer Center|Naval Daver MD./Associate Professor|713-794-4392|ndaver@mdanderson.org|
21293767|NCT00703846|GlaxoSmithKline|GSK Response Center|866-435-7343||
21293768|NCT04601532|University of Pittsburgh|Eleanor Shirley, MA CCRC|412-383-7712|shirleye@upmc.edu|
21293769|NCT02195700|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21293770|NCT01352221|Shield Therapeutics|Jackie Mitchell MA DPhil|+44 (0) 191 511 8515|jmitchell@shieldtx.com|
21293771|NCT02566785|University of Nebraska Medical Center College of Nursing|Dr. Rita McGuire|402-472-4712|rita.mcguire@unmc.edu|
21293772|NCT01597908|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
21293773|NCT02384044|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
21293774|NCT00281099|Medtronic, Inc.|MVP Clinical Trial Leader||medtroniccrmtrials@medtronic.com|
21293775|NCT00837161|Philips Healthcare|Sarah Baxter|425-487-7665|sarah.baxter@philips.com|
21293776|NCT02931838|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21245810|NCT01986712|St. Luke's University Health Network|Neil Belman|484-503-4673|neil.belman@sluhn.org|
21245811|NCT03084536|Washington University School of Medicine|Ryan C. Guffey, M.D.|314-286-2883|rguffey@wustl.edu|
21245812|NCT05002608|Massachusetts General Hospital|Elyse R. Park|6177246836|epark@mgh.harvard.edu|
21245813|NCT04728347|Arcturus Therapeutics, Inc.|Arcturus Therapeutics, Inc.|858-900-2660|clinicaltrials@arcturusrx.com|
21245814|NCT05835336|VIZO Specs|Yael Richter, PhD|972-54-7384809|yaelr@vizo-o.com|
21245815|NCT04489771|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21245816|NCT05373862|Biosense Webster, Inc.|Senior Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21245817|NCT04059484|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21245818|NCT04719390|Partnership to End Addiction|Dr. Sarah Dauber|212-841-5270|sdauber@toendaddiction.org|
21245819|NCT04292223|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261|medicalinformation@acadia-pharm.com|2897
21245820|NCT00753545|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21245821|NCT05453773|Ohio State University Comprehensive Cancer Center|Marielle Brinkman|614-688-3226|brinkman.224@osu.edu|
21245822|NCT00391365|Center For Limb Loss Prevention and Prosthetic Engineering, VA Puget Sound Health Care System|Alan Wesley, Program Manager|206 277 1079|alan.wesley@va.gov|
21245823|NCT04633122|Zai Lab|Medical Director|+86 4008201022|Medinfo@zailaboratory.com|
21245824|NCT03839940|Mayo Clinic|Dr. Kathryn J. Ruddy|507-293-1732|ruddy.kathryn@mayo.edu|
21245825|NCT04799899|Massachusetts General Hopsital|Dr. Christina Luberto|617-643-9453|CLUBERTO@mgh.harvard.edu|
21245826|NCT02561247|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
21245827|NCT04963270|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21245828|NCT01857245|Prisma Health|Dr. Claire Stam - Director, Addiction Medicine Center|(864) 979-6749|claire.stam@prismahealth.org|
21245829|NCT03122847|Aarhus University Hospital|Dr. Torben Harsløf|+4578455470|torbhars@rm.dk|
21245830|NCT04908722|Janssen Vaccines & Prevention B.V.|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21245831|NCT05403827|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
21245832|NCT05597085|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21245833|NCT02979327|Mayo Clinic|Anna Svatikova, M.D., Ph.D.|507-284-3685|Svatikova.Anna@mayo.edu|
21245834|NCT04098263|Lumen Bioscience|Senior Medical Director|206-899-1904|trials@lumen.bio|
21245835|NCT05780437|University of Minnesota|Greg Grandits|651-528-9491|greg-g@ccbr.umn.edu|
21245836|NCT02100891|Fred Hutchinson Cancer Center|Monica Thakar, MD - Professor of Pediatrics|206-667-5000|isioc@fredhutch.org|
21245837|NCT03916042|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
21245838|NCT03474679|Janssen Pharmaceutical K.K.|EXECUTIVE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21245839|NCT05490459|Element Science, Inc.|Chief Medical Officer|4158726500|zubin@elementsci.com|
21245840|NCT05604508|RAND|William Shadel|4126832300|shadel@rand.org|4489
21245841|NCT03885518|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
21245842|NCT05832996|University of Iowa|Douglas Jin, MD|319-356-3185|Douglas-Jin@uiowa.edu|
21245843|NCT04623671|Capricor, Inc.|Mark Awadalla|858-727-1755|clinicaltrialsgov@capricor.com|
21245844|NCT04025554|National Institutes of Health|Dr. Daniel S. Reich|301-496-1801|reichds@ninds.nih.gov|
21245845|NCT04980248|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
21245846|NCT01802788|Abbott|Vinny Podichetty, Clinical Program Director|779-209-9425|vinny.podichetty@abbott.com|
21245847|NCT05257486|Xoft, Inc.|Robert Burnside|14084931533|rob.burnside@elekta.com|
21245848|NCT03021096|Hospital for Special Surgery, Anesthesiology|Dr Jacques Yadeau|2126061036|Yadeauj@hss.edu|
21245849|NCT03848065|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21245850|NCT05194540|Leo Pharma|Clinical Disclosure|+45 44945888|disclosure@leo-pharma.com|
21245851|NCT03313076|University of North Carolina at Chapel Hill|Matt Mauck, MD, PhD|919-966-5136|matt_mauck@med.unc.edu|
21262169|NCT02367170|University of Florida|PhD in exercise physiology|352 2736105|UFCT-gov@ufl.edu|
21293777|NCT00104728|H. Lee Moffitt Cancer Center and Research Institute|Dr. Eric Haura|813-745-6826|eric.haura@moffitt.org|
21262170|NCT04504032|Gates MRI|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
21293778|NCT01963767|University of South Florida|Dr. Brent Small|813-974-9746|bsmall@usf.edu|
21293779|NCT02709577|GI Dynamics, Inc.|Manager of Clinical Affairs|781.357.3263|kwoessner@gidynamics.com|
21293780|NCT03823287|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21293781|NCT01059864|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21293782|NCT02712983|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21293783|NCT00064259|Montefiore Medical Center - New York|NYCC Regulatory Coordinator|718-405-8404|jsparano@montefiore.org|
21293784|NCT02953093|Albert Einstein College of Medicine|Dr. Nir Barzilai|718-430-3144|nir.barzilai@einsteinmed.edu|
21293785|NCT01132651|Northwestern University|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu|
21293786|NCT01321216|American University of Beirut|Dr Ghassan Dbaibo|961-1-350000|gdbaibo@aub.edu.lb|4819
21293787|NCT03866538|Mayo Clinic|Joseph A. Murray, M.D.|507-284-2631|Murray.Joseph@mayo.edu|
21293788|NCT03054805|Chang Gung Memorial Hospital|Dr. Hsun-Chin Chao|88633281200|chaohero@yahoo.com|8969
21293789|NCT03608371|Neumora Therapeutics|Study Contact|8577600900|clinicaltrials@neumoratx.com|
21293790|NCT03062280|Diurnal Limited|Clinical Trials Information|+44 (0) 292 068 2069|info@diurnal.co.uk|
21293791|NCT00814580|Ortho-McNeil Janssen Scientific Affair, LLC|Senior Director of Clinical Development, Pain|(908)927-5469|GVorsang@its.jnj.com|
21293792|NCT02547038|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
21293793|NCT00516893|Biogen Idec Inc.|Biogen Idec Medical Director||clinicaltrials@biogenidec.com|
21293794|NCT00284557|Emory University|Anne L. Dunlop, MD, MPH|404-712-8520|amlang@emory.edu|
21293795|NCT01340625|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21293796|NCT01519791|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
21293797|NCT00623233|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21293798|NCT00559845|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21293799|NCT00459875|Memorial Sloan Kettering Cancer Center|Dr. Robert Motzer|646-422-4312|motzerr@mskcc.org|
21293800|NCT01525862|Stryker ENT|Principal Clinical Research & Publications Manager|764-463-1598|ellen.omalley@stryker.com|
21293801|NCT00241176|NYU School of Medicine, NYU Child Study Center|Barbara J Coffey, M.D, M.S.|(212)263-3926|barbara.coffey@mssm.edu|
21293802|NCT03206970|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21293803|NCT03654040|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21293804|NCT03645421|AstraZeneca|Global Clinical Lead|+13028851180|ClinicalTrialTransparency@astrazeneca.com|
21293805|NCT03379259|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21245852|NCT04573517|University of Texas Medical Branch|Dr. Marissa Berry|402-772-4099|majberry@utmb.edu|
21245853|NCT05144009|ADC Therapeutics|Contact ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
21280333|NCT02414958|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21280334|NCT01269918|Cleveland Clinic|Daniel Sessler, MD|216-445-6500|sesslerd@ccf.org|
21280335|NCT00815880|CHF Solutions, Inc.|Audrey Singh|952-345-4217|audrey.singh@chf-solutions.com|
21280336|NCT02500589|Durahm VA Health Care System|Jennifer Gierisch|919-286-0411|jennifer.gierisch@va.gov; j.gierisch@duke.edu|176936
21280337|NCT00245466|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
21280338|NCT00856193|Novartis Pharmaceuticals|Study Director|862-778-8300||
21280339|NCT05064397|H. Lundbeck A/S|Email contact via H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@Lundbeck.com|
21280340|NCT02607046|Department of Veterans Affairs|Dr. Steven Prior|410-605-7000|steven.prior@va.gov|54129
21280341|NCT03934541|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
21280342|NCT04408729|Massachusetts General Hospital|Jessica Haberer, MD, MS|617-724-0351|jhaberer@mgb.org|
21280343|NCT05807828|1. Academic Orthopaedic Department, Aristotle University Medical School, General Hospital Papageorgiou 2. Centre of Orthopaedic and Regenerative Medicine (CORE), Center for Interdisciplinary Research and Innovation (CIRI)-AUTh|Eustathios Kenanidis - Assistant Professor of Orthopaedic Surgery & Traumatology|6973693693|ekenanidis@auth.gr|
21280344|NCT04805515|Rutgers Center for Tobacco Studies|Andrea Villanti|732 235 9585|andrea.villanti@rutgers.edu|
21280345|NCT01783886|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21280346|NCT03104855|University of Washington|Dr. Ian de Boer|206-616-5403|IDeBoer@Nephrology.washington.edu|
21280347|NCT02324582|Southern Illinois University School of Medicine|Dr. Krishna Rao|217-545-7969|krao@siumed.edu|
21280348|NCT03624192|AVITA Medical|VP, Clinical Research|661-367-9170|USClinicalTrials@avitamedical.com|
21280349|NCT04660331|Fred Hutchinson Cancer Center|Dr. Parth Shah|2066676120|pshah@fredhutch.org|
21280350|NCT02765256|University of Pennsylvania|Lindsey Albenberg, DO|267-426-0139|albenbergl@email.chop.edu|
21280351|NCT00786409|University of Chicago|Linda Wagner-Weinter, MD|773-702-2245|lww@uchicago.edu|
21280352|NCT00610129|Memorial Sloan Kettering Cancer Center|Dr. Diane Reidy|646-888-4185|ReidyD@mskcc.org|
21280353|NCT02216097|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21280354|NCT00952731|Northwestern University|Dr. Seema Khan|312-503-4236|s-khan2@northwestern.edu|
21280355|NCT01329900|UT MD Anderson Cancer Center|Issa F Khouri, M.D. / Stem Cell Transplantation|713-745-0049|ikhouri@mdanderson.org|
21280356|NCT03649347|Stress, Trauma, and Anxiety Research Clinic (STARC) at Wayne State University|Kathleen Gorski, Research Coordinator|313-577-9202|kathleen.gorski2@med.wayne.edu|
21280357|NCT01866098|Connecticut Mental Health Center|Associate Professor of Psychiatry; Director, Psychosis Program, CMHC|(203) 974-7500|cenk.tek@yale.edu|
21280358|NCT01184079|University of Pittsburgh Department of Family Medicine|Chyongchiou Jeng Lin, PhD|412/383-2360|cjlin@pitt.edu|
21293806|NCT00924001|National Cancer Institute, National Institutes of Health|Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
21293807|NCT03850093|faculty of medicine- Zagazig university|assistant professor Abeer M. Elnakera|00201005720754|nakera35@hotmail.com|
21245854|NCT03270501|Department of Rheumatology, Gent University Hospital|Professor Dirk Elewaut|+32 9 332 22 30|reumatologie@uzgent.be|
21245855|NCT04158804|Massachusetts General Hospital|Michael K. Mansour, MD, Ph.D.|617-726-6726|mkmansour@mgb.org|
21245856|NCT00764751|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
21245857|NCT06264986|Blanquerna Institute - Universitat Ramon Llull|Olivia Coope|+447882461097|oliviacharlottec@blanquerna.url.edu|
21293808|NCT01204905|University of Maryland, Baltimore, IHV|Gregory Brogden|410-706-1660|gbrogden@ihv.umaryland.edu|
21245858|NCT02918890|Columbia University|Dr. Andrew M. Gordon|212.678.3332|ag275@columbia.edu|
21245859|NCT04478643|ASST SPEDALI CIVILI - UNIVERSITY OF BRESCIA|Dr. Magda Mensi|+390303995784|magda.mensi@unibs.it|
21245860|NCT04307355|Baylor College of Medicine|Prof. Bijan Najafi|7137987536|najafi.bijan@gmail.com|
21245861|NCT04065841|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
21245862|NCT03298477|Endologix LLC|Tammy Stiver, Manager, Clinical Affairs|+15136731452|tstiver@endologix.com|
21245863|NCT02690558|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
21245864|NCT01420237|Stryker Orthopaedics|Kevin Barga, Senior Manager, Clinical Affairs|201-831-5000|Kevin.Barga@stryker.com|
21245865|NCT05269667|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21245866|NCT05448105|Vanderbilt University Medical Center|William Martinez, MD, MS|615-936-1010|william.martinez@vumc.org|
21245867|NCT04349371|Columbia University|Anca Askanase, MD|212-305-0856|ada20@cumc.columbia.edu|
21293809|NCT00224120|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
21293810|NCT03415581|New York State Psychiatric Institute|Jermaine Jones PhD|6467746113|jermaine.jones@nyspi.columbia.edu|
21293811|NCT00104416|GlaxoSmithKline|GSK Response Center|866-435-7343||
21293812|NCT00438360|Novartis Pharmaceuticals|Study Director|862-778-8300||
21293813|NCT04918381|Pulse Biosciences, Inc.|William Knape / VP, Clinical, Regulatory and Quality Affairs|919-757-2033|bknape@pulsebiosciences.com|
21245868|NCT05270408|UT Southwestern Medical Center|Dr Christian LoBue|2146485265|Christian.LoBue@utsouthwestern.edu|
21245869|NCT05022329|University Health Network|Kevin Yau|416 480 4592|Kevin.Yau@uhn.ca|
21245870|NCT05331053|Penn State University|Lacy M. Alexander, Ph.D.|8148671781|lma191@psu.edu|
21245871|NCT04338061|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21245872|NCT03374787|Oticon Medical|Director of Clinical Affairs|0046-31-7486100|studyinfo@oticonmedical.com|
21245873|NCT04492722|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21245874|NCT04074759|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21245875|NCT03752203|Children's Hospital Colorado|Dr. Todd Hankinson|7207776100|todd.hankinson@childrenscolorado.org|
21245876|NCT03631784|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21245877|NCT05329220|Bavarian Nordic A/S|Bavarian Nordic Call Center|1-844-422-8274|medical.information_us@bavarian-nordic.com|
21245878|NCT04204265|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
21245879|NCT02465268|University of Florida|Duane Mitchell, MD, PhD|352-273-9000|duane.mitchell@neurosurgery.ufl.edu|
21245880|NCT04364048|Hoosier Cancer Research Network|Andrew Benson|317-921-2050|abenson@hoosiercancer.org|
21245881|NCT03322267|National Taiwan University Hospital|Dr Chih-Hung Hsu|+886-23123456|chihhunghsu@ntu.edu.tw|
21245882|NCT03046251|Jacobs School of Medicine and Biomedical Sciences, University of Buffalo, Buffalo, NY, USA.|Dr. Bianca Weinstock-Guttman|716-829-4415|bw8@buffalo.edu|
21245883|NCT01652196|The Ohio State University Comprehensive Cancer Center|Dr. John Hays|614-293-6529|John.hay@osumc.edu|
21245884|NCT04719832|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
21245885|NCT04324359|Surface Ophthalmics Inc.|VP, Clinical Operations|(925) 494-3660|cbaenziger@surfaceophthalmics.com|18
21245886|NCT05966870|Indiana University|Nana Gletsu Miller|812-8557643|ngletsum@indiana.edu|
21245887|NCT05704543|Indivior Inc.|Global Director Clinical Development|(804) 594-4488|trialdisclosure@indivior.com|
21262171|NCT00771030|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21262172|NCT01174784|Avinger Inc.|Thomas Lawson, PhD|650.241.7900|tlawson@avinger.com|
21262173|NCT04940598|UAB|Gordon Fisher|2059964114|grdnfs@uab.edu|
21280359|NCT03172494|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21280360|NCT04589663|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21280361|NCT00041132|SWOG Statistical Center|Study Statistician|206-667-4623||
21280362|NCT02614274|University of Missouri|James L. Cook, Director of Research|573-884-4689|cookjl@health.missouri.edu|
21280363|NCT01182376|University of Utah|Clinical Research Manager|8015873889|christina.pacchia@hsc.utah.edu|
21280364|NCT04952922|The Royal Marsden NHS Foundation Trust|Dr Grainne Brady|0000000000000|grainne.brady@rmh.nhs.uk|
21280365|NCT04467840|RedHill Biopharma Ltd.|Gilead Raday, COO|+972-(0)3-541-3131|info@redhillbio.com|
21280366|NCT06418529|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21280367|NCT06082843|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21280368|NCT05473182|Grand Valley State Univeristy College of Health Professions|Dr. Lisa K. Kenyon|616-331-5653|kenyonli@gvsu.edu|
21280369|NCT06227052|Queen's Medical Center|Catherine Rault|808-686-4690|crault@hawaii.edu|
21280370|NCT04054765|play4REAL XR Lab at the Yale School of Medicine|Dr. Kimberly Hieftje|2037872402|kimberly.hieftje@yale.edu|
21280371|NCT01038336|VA RR&D National Center for Rehabilitative Auditory Research, Portland VA Medical Center|Gabrielle Saunders Ph.D.|503-220-2862|gabrielle.saunders@va.gov|56210
21280372|NCT01290068|Alcon Research, Ltd.|Brand Lead, Surgical, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
21280373|NCT01907490|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
21293814|NCT02455804|Medinol|Dina Kofler, VP Clinical Affairs|+97237679032|dinak@medinol.com|
21293815|NCT01312805|Indiana University School of Medicine|Aaron E. Carroll, MD, MS|3172789616|aaecarro@iu.edu|
21235868|NCT00836875|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21235869|NCT02969928|São Paulo State University - Unesp|Dr Mauro Pedrine Santamaria|+5516981937777|mauro.santamaria@unesp.br|
21235870|NCT04286594|McLean Hospital|Dr. Staci Gruber|617-855-2762|gruber@mclean.harvard.edu|
21235871|NCT02143518|George Washington University|David J. Diemert, MD|202-994-2909|ddiemert@gwu.edu|
21235872|NCT00452335|Sucampo Pharma Americas, Inc.|VP, Clinical Development|301-961-3400|info@sucampo.com|
21235873|NCT04621500|Medical University of South Carolina|Stephen J. Savage, MD|18437925787|savages@musc.edu|
21235874|NCT01343160|W.L. Gore & Associates|Rizwan Afzal|623-234-5408|rafzal@wlgore.com|
21235875|NCT01539291|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21235876|NCT01543256|Boston Scientific|Evelyne Ho|+1 508-683-4140|Evelyne.Ho@bsci.com|
21235877|NCT00822510|University of Arizona College of Nursing|Terry Badger, PhD, PMHCNS-BC, FAAN|520-626-6058|tbadger@email.arizona.edu|
21235878|NCT03119766|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
21235879|NCT02034578|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21262174|NCT00465738|Merz Pharmaceuticals GmbH|Claus Goebel, MD|+49-69-1503-6461|claus.goebel@merz.de|
21262175|NCT02653092|University of Colorado School of Medicine|Dr. Nanette Santoro|303-724-2041|Nanette.Santoro@uanschutz.edu|
21262176|NCT01318902|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21262177|NCT04003155|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
21280374|NCT04544241|Charles R. Drew University of Medicine & Science|Sharon Cobb|323-568-3329|sharoncobb1@cdrewu.edu|
21280375|NCT00793871|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21280376|NCT01928472|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21280377|NCT00307086|H. Lee Moffitt Cancer Center|Mellisa Alsina, MD|813-745-6886|Melissa.Alsina@moffitt.org|
21280378|NCT00065156|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21280379|NCT04583735|Horizon Pharma USA, Inc.|Medical Monitor|1-866-479-6742|medicalinformation@horizontherapeutics.com|
21280380|NCT01176513|GE Healthcare|Paul Gordon, PhD|011-47-2318-5822|Paul.Gordon@ge.com|
21280381|NCT01197911|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21280382|NCT03282916|Columbia University Irving Medical Center|Dr. Davangere P Devanand|646-774-8658|dpd3@cumc.columbia.edu|
21280383|NCT00838526|Eisai Inc.|Eisai Medical Information, Eisai|+1 888 274 2378|esi_medinfo@eisai.com|
21280384|NCT03354598|Iterum Therapeutics|Senior Director, Clinical Development|18606614035|saronin@iterumtx.com|
21280385|NCT04338022|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21280386|NCT01994785|Cleveland Clinic|John Vargo|216 445-5012|vargoj@ccf.org|
21280387|NCT05724589|Institute of Dermatology, Thailand|Dr. Supawee Phanmamuang|6623545222|dewsupawee@gmail.com|
21235880|NCT01045447|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21235881|NCT00129987|Imperial College London|Martyn R Patridge|+44 (0)20 7594 7959|m.patridge@imperial.ac.uk|
21235882|NCT00116805|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21235883|NCT01760954|AbbVie|Global Medical Services|800-633-9110||
21235884|NCT01159938|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21235885|NCT04837482|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21235886|NCT00587587|Organogenesis Inc.|Director of Clinical Operations|781-575-0775|clinical@organo.com|
21235887|NCT01807585|Medtronic Endovascular|Melissa Hasenbank, Clinical Research Director|707-525-0111|melissa.hasenbank@medtronic.com|
21235888|NCT04279925|Plastic Surgery Division of Surgery Department of Cipto Mangunkusumo Hospital Jakarta / Faculty of Medicine Universitas Indonesia|Prasetyanugraheni Kreshanti, MD|08158732424|pras_md@yahoo.com|
21235889|NCT02504645|ImmuPharma|CEO|+33 6 18 22 16 50|robert.zimmer@immupharma.com|
21235890|NCT04808609|Columbia University|Dr. Rebecca Schnall, RN, MPH, PhD, Professor of Disease Prevention and Health Promotion (in Nursing)|212-342-6886|rb897@cumc.columbia.edu|
21235891|NCT00562159|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21235892|NCT01181921|Jan-Cil Spain|COUNTRY MEDICAL DIRECTOR|+34 91 7228043||
21235893|NCT01762761|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
21235894|NCT01709227|Stanford University|David Kwiatkowski|650-721-3290|david.kwiatkowski@stanford.edu|
21235895|NCT02317575|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21235896|NCT01046110|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21235897|NCT01202773|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21235898|NCT02334800|Pfizer Inc.|Pfizer ClinicalTrail.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21235899|NCT02828111|PellePharm, Inc.|Chief Medical Officer|(510) 502-6144|clinical@pellepharm.com|
21235900|NCT03465540|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21235901|NCT04096560|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21235902|NCT00088218|The University of Texas M. D. Anderson Cancer Center|Stefan Fader, M.D./Associate Professor|713/745-4613|eharriso@mdanderson.org|
21235903|NCT00833924|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Science & Biostatistics|765-463-7537|SSnyder@medinst.com|
21235904|NCT00466323|VA VISN 5 Mental Illness Research, Education and Clinical Center|Amy Drapalski, Ph.D.|410-637-1855|amy.drapalski@va.gov|
21235905|NCT01144338|Astrazaneca Inc.|Peter Ohman|1(301)398-0120|Peter.Ohman@astrazeneca.com|
21293816|NCT03462641|University of Michigan|Stiven Roytman|734 998-8400|stivenr@med.umich.edu|
21293817|NCT01804049|VAORD - Portland VA Health Care System|Dr Robert Klein|503-220-8268|kleinro@ohsu.edu|57496
21293818|NCT00070109|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
21293819|NCT01231334|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21293820|NCT01147250|Sanofi|Trail Transparency Team||Contact-US@sanofi.com|
21293821|NCT03588806|University of Pittsburgh|Dr. Ajay D. Wasan|4126658030|wasanad@upmc.edu|
21293822|NCT02342691|Forsyth|Hatice Hasturk|617-892-8499|hhasturk@forsyth.org|
21293823|NCT03985943|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
21293824|NCT00716482|SuperSonic Imagine|Research Coordinator|+33 442 99 24 24|sharon.bruce@supersonicimagine.fr|
21293825|NCT03248531|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
21293826|NCT01858545|Integra LifeSciences|Manager, Clinical Research|443-766-3869|allison.matthews@integralife.com|
21293827|NCT04075513|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21293828|NCT03249909|Mölnlycke Health Care|Andrea Marie Picchietti|260 2583879|andrea.picchietti@molnlycke.com|
21293829|NCT01959178|Bausch Health|Study Director||robert.steffen@bausch.com|
21293830|NCT05411822|Icahn School of Medicine at Mount Sinai|Mariana Figueiro, PhD|(518) 366-9306|Mariana.Figueiro@mountsinai.org|
21293831|NCT01071252|Novartis Pharmaceuticals|Study Director|862-778-8300||
21293832|NCT02125838|DorkuzEU|Sule Ozbilgin|902324122836|ozbilginsule@gmail.com|
21293833|NCT00787839|Atlanta VA Medical Center|Lawrence S Phillips, MD|404-728-7608|lawrence.phillips@va.gov|
21293834|NCT03902392|University of Bari|Thea TM Magrone, BD|+39 080 5478584|thea.magrone@uniba.it|
21293835|NCT03087604|Wake Forest University Health Sciences|Dr. Sean Dobson|3367168834|sdobson@wakehealth.edu|
21293836|NCT01994746|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21293837|NCT00244725|GlaxoSmithKline|GSK Response Center|866-435-7343||
21245888|NCT02272998|The Ohio State University Comprehensive Cancer Center|Dr. Sameek Roychowdhury|614-685-5842|Sameek.roychowdhury@osumc.edu|
21245889|NCT02938377|University of Alabama at Birmingham|Karen Cropsey, Psy.D|(205) 975-4204|kcropsey@uab.edu|
21245890|NCT04830800|PATH|Dr. Thang Tran Cong, Medical office|84-913301883|thangtran@path.org|
21245891|NCT04285515|Intra-Cellular Therapies, Inc.|Susan Kozauer, MD|646 440-9333|ITCIClinicalTrials@itci-inc.com|
21245892|NCT02618577|Universitätsklinikum Hamburg-Eppendorf|Prof. Dr. Paulus Kirchhof|+49 (0)40 7410-52438|p.kirchhof@uke.de|
21245893|NCT05192109|New York University|Dr. Sudha Arunachalam|212-998-4139|sudha@nyu.edu|
21245894|NCT03450980|Schepens Eye Research Institute of Mass Eye & Ear, Harvard Medical School, Boston, MA, USA|Gang Luo|(617) 573-4177|gang_luo@MEEI.HARVARD.EDU|
21245895|NCT06212804|Visterra, Inc.|Mohit Mathur, MD|+1-617-498-1070|mmathur@visterrainc.com|
21245896|NCT03491969|Zhongshan hospital, Fudan University|Dr. Hanchuan Chen|18459111985|chenhanchuan66@126.com|
21245897|NCT03287817|Autolus Ltd|Clinical Project Manager|+44 1483 920748|clinicaltrials@autolus.com|
21245898|NCT00636077|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
21245899|NCT05251909|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21245900|NCT05044793|Sight Sciences, Inc.|VP, Medical and Clinical Affairs|1-877-266-1144|jdickerson@sightsciences.com|
21245901|NCT01461655|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
21245902|NCT05546749|Albert Einstein College of Medicine|Hector Perez|7189205756|heperez@montefiore.org|
21245903|NCT03869866|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21245904|NCT06181227|Aviceda Therapeutics|David Callanan|817-312-9258|dcallanan@avicedarx.com|
21245905|NCT05543915|NYU Langone Health|Guiseppina Pilloni|646-501-9274|giuseppina.pilloni@nyulangone.org|
21245906|NCT02702102|Columbia University|William Kreisl, MD|212-305-9194|wck2107@cumc.columbia.edu|
21245907|NCT04711447|University of Manitoba|Dr. Trisha Scribbans|(204) 272-1699|trisha.scribbans@umanitoba.ca|
21245908|NCT05292872|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
21245909|NCT03059030|Northwestern University|Riad Salem MD|312-695-6371|rsalem1@nm.org|
21280388|NCT02466321|Zimmer Biomet|Elliott Goff|+41 79 222 23 08|elliott.goff@zimmerbiomet.com|
21280389|NCT00115076|Rockefeller University|James G. Krueger MD, PhD|212-327-7730|kruegej@rockefeller.edu|
21280390|NCT02273388|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21280391|NCT04331808|Hopital Hotel Dieu (AP-HP)|Dr Raphael Porcher|+33 (0)1.42.34.89.87|raphael.porcher@aphp.fr|
21280392|NCT01855828|Yale University|Lajos Pusztai, MD, DPhil|203-737-6858|lajos.pusztai@yale.edu|
21280393|NCT05275920|NYU Langone Health|Amrita Mukhopadhyay, MD|212-263-7751|amrita.mukhopadhyay@nyulangone.org|
21280394|NCT04239027|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21280395|NCT03629080|Hookipa Biotech GmbH|Hookipa Front Desk|+43 1 890 63 60 0|office@hookipapharma.com|
21280396|NCT04233073|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1-855-752-2356|clinicaltrials@alexion.com|
21280397|NCT00243412|Hoffman-LaRoche|Medical Communications|800-821-8590||
21280398|NCT00143390|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21280399|NCT00736632|Washington University in St. Louis|Dr. Carlos Bernal-Mizrachi|314-362-0947|cbernal@wustl.edu|
21293838|NCT00335738|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
21280400|NCT02764151|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21280401|NCT01450683|Stanford University Medical Center|Associate Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu|
21293839|NCT01104545|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21245910|NCT06516705|National Tainan Junior College of Nursing|Mei-Chuan Huang|886-0956646992|mayhuang@ntin.edu.tw|
21245911|NCT05682937|Prince of Songkla University|Anucha Thatrimontrichai|66 74451257|tanucha@medicine.psu.ac.th|
21245912|NCT02485938|Capricor, Inc.|Vice President of Clinical Research and Development Operations|858-727-1755|clinicaltrialsgov@capricor.com|
21245913|NCT03241745|Memorial Sloan Kettering Cancer Center|Dr. Claire Friedman, MD|646-888-4247|friedmac@mskcc.org|
21245914|NCT00470704|Dana-Farber Cancer Institute|Nancy Lin|6176322335|Nancy_Lin@dfci.harvard.edu|
21245915|NCT05210608|University of Colorado-Boulder|Anahi Collado, Assistant Research Professor|3037354140|anco7407@colorado.edu|
21245916|NCT04802967|Dompé Farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
21245917|NCT04636528|Sword Health Inc|Fernando Dias Correia|+1 (646) 379-6751|fcorreia@swordhealth.com|
21245918|NCT03131154|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
21245919|NCT03339713|Janssen Research & Development, LLC|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21245920|NCT02268253|Stemline Therapeutics, Inc.|Ira Gupta, MD|1-877-332-7967|clinicaltrials@menarinistemline.com|
21245921|NCT05714761|Icahn School of Medicine at Mount Sinai|Dr. Grenye O'Malley|212-241-7173|omallg01@mssm.edu|
21245922|NCT05672069|SERF|Sponsor|+33 4.72.05.60.10|clinical@serf.fr|
21245923|NCT03001713|Kaiser Permanente Center for Health Research|Rachel Gold, PhD MPH|503-335-2400|rachel.gold@kpchr.org|
21245924|NCT03544281|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21245925|NCT02547233|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
21245926|NCT05235750|University of Arkansas for Medical Sciences|Dr. Mei Bai|501-603-1900|MBai@uams.edu|
21245927|NCT06019559|Kallyope Inc|Clinical Director|917-336-3279|contactus@kallyope.com|
21245928|NCT05949788|ShenzhenBMCHH|Dr. Jun Luo|015818671195|luojun-78@163.com|
21245929|NCT05213390|Newcastle University|Prof Edward Meinert|191 208 6000|edward.meinert@newcastle.ac.uk|
21245930|NCT05362487|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21245931|NCT05986682|Duke University School of Medicine|Dr. Thomas W. LeBlanc|919-668-2115|thomas.leblanc@duke.edu|
21245932|NCT03333590|Abigail Wexner Research Institute at Nationwide Children's Hospital|Dr. Kevin Flanigan|614-355-2947|kevin.flanigan@nationwidechildrens.org|
21245933|NCT03603600|Bausch & Lomb|Johnson Varughese|9089271162|Johnson.Varughese@bausch.com|
21245934|NCT03344094|University of Chicago|anthony t reder|773-702-6204|areder@neurology.bsd.uchicago.edu|
21245935|NCT01363388|ChemoCentryx|Study Director|650-210-2900||
21245936|NCT06238609|Baylor College of Medicine|Prof. Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
21245937|NCT02191618|Sequent Medical, Inc|Director, Clinical Operations|714-247-8000|anne.hurley@microvention.com|
21245938|NCT04997148|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21245939|NCT03031470|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
21245940|NCT03461276|Araclon Biotech, S.L.|Maria Pascual Lucas|+34976796562|mpascual@araclon.com|
21245941|NCT02724449|North Shore University Hospital|Mary Brennan, Assist Director WOCN|516-562-8252|mbrennan@northwell.edu|
21245942|NCT03435614|MUHC-RIMUHC|Marc Perreault|514-343-6111|marc.perreault@umontreal.ca|3788
21245943|NCT02852330|Cochlear|Bernadette Pickering|+61296115909|bpickering@cochlear.com|
21245944|NCT02683447|Sunnybrook Health Sciences Centre|Dr. Fahad Alam|416-480-4864|fahad.alam@sunnybrook.ca|
21245945|NCT04543357|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21245946|NCT04215146|Oncolytics Biotech Inc.|Chief Medical Officer|(403) 670-7377|info@oncolyticsbiotech.com|
21245947|NCT01943409|Toronto General Hospital|Scientific Associate|4163405159|kschweng@uhnresearch.ca|
21245948|NCT02489903|EpicentRx, Inc|Bryan Oronsky|858-229-1062|mstirn@epicentrx.com|
21245949|NCT04542317|University of California, Davis|Ladson Hinton, MD|9167343485|lwhinton@ucdavis.edu|
21245950|NCT03509402|"University of Campania Luigi Vanvitelli"|Prof. Marco Annunziata|0815665515|marco.annunziata@unicampania.it|0039
21245951|NCT02310646|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
21245952|NCT00670358|Mayo Clinic|Dr. Grzegorz Nowakowski|507-284-5096|Nowakowski.Grzegorz@mayo.edu|
21245953|NCT00613106|Horizon Pharma, Inc.|Amy Grahn, MS Senior Vice President, Clinical Development and Operations|224-383-3012|agrahn@horizonpharma.com|
21245954|NCT03496168|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
21245955|NCT05530603|University of South Dakota|Soonhee Roh|6053571593|Soonhee.Roh@usd.edu|
21245956|NCT02619994|Seoul National University|Dr. Prof. JJ Yim|82-02-1588-5700|yimjj@snu.ac.kr|
21245957|NCT02043678|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
21245958|NCT04473430|University of Miami|Dr. Rodolfo Galindo|305-284-3781|rodolfo.galindo@miami.edu|
21245959|NCT04137367|University of Oslo|Nils Inge Landrø|+4795038479|n.i.landro@psykologi.uio.no|
21245960|NCT01175356|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21245961|NCT05792085|University of Pennsylvania|Lauren Eberly|2676244449|Lauren.Eberly@pennmedicine.upenn.edu|
21245962|NCT05692960|The University of Tennessee, Knoxville|Noël Arring, DNP, PhD, RN|865-974-1988|narring@utk.edu|
21245963|NCT04898673|Cochlear Limited|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
21245964|NCT04797897|Smith+Nephew, Inc|Senior Manager Clinical Compliance|07811407089|datasharing.gcs@smith-nephew.com|
21245965|NCT05778695|University of Michigan|Nicolaas Bohnen, MD, PhD|734-936-1168|nbohnen@umich.edu|
21245966|NCT05540665|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21245967|NCT03462030|Johns Hopkins University|Dr. Robert Wood|410-955-5883|rwood@jhmi.edu|
21245968|NCT03628924|Janssen Research & Development, LLC|Product development portfolio leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21262178|NCT01912872|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
21262179|NCT02778880|Cincinnati Children's Hospital Medical Center|Theresa Frey, MD|513-636-7966|theresa.frey@cchmc.org|
21262180|NCT00935857|Northwestern University|Rajesh N. Keswani|312-695-5620|raj-keswani@northwestern.edu|
21262181|NCT00592358|Massachusetts General Hospital|Janet Wozniak, MD|(617)503-1038|jwozniak@partners.org|
21262182|NCT04011436|Universidad Nacional de Colombia|Pt. Luisa Prieto|+57 3202082723|lfprietog@unal.edu.co|
21262183|NCT04760314|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21262184|NCT02024711|Bausch Health|Study Director||susan.harris@bauschhealth.com|
21262185|NCT02344628|London School of Hygiene and Tropical Medicine|Dr Michael Marks|+447984643424|michael.marks@lshtm.ac.uk|
21262186|NCT06001372|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
21262187|NCT01013883|Darlington Memorial Hospital|Dr Rajender singh|01325380100|drrsdogra@yahoo.com|3444
21262188|NCT01371838|AstraZeneca Pharmaceuticals|Melnick, David A / Exec Dir Med Science|+1 302 886 5627|David.Melnick@astrazeneca.com|
21262189|NCT01509586|Medical University of South Carolina|Dr. Matthew J. Carpenter|843-876-2436|carpente@musc.edu|
21262190|NCT04013737|Health Protection Research Unit in HCAI and AMR, Imperial College London|Head of Operations|020 3313 2732|head.ops@imperial.ac.uk|
21262191|NCT00641043|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21262192|NCT01096771|Indiana University School of Medicine|Dr. William Carlos|3178807819|wcarlos@iu.edu|
21262193|NCT04275310|Virginia Commonwealth University|Eric Benotsch|804-828-0133|ebenotsch@vcu.edu|
21262194|NCT04410783|Washington Univeristy|Brian M Fuller|3147475368|fullerb@wustl.edu|
21262195|NCT02345161|GlaxoSmithKline|GSK Response Center|866-435-7343||
21262196|NCT02225223|Merit Medical|Casey Holland|1 (617) 842-0251|casey.holland@merit.com|
21262197|NCT01650779|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21262198|NCT03567291|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21262199|NCT00958568|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21262200|NCT00972244|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
21280402|NCT00681031|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21280403|NCT02108912|University of Texas Southwestern Medical Center|Karen McCain, PT, DPT, NCS|214-648-1559|karen.mccain@utsouthwestern.edu|
21280404|NCT05329259|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21280405|NCT00619060|University of Arizona|Steve Stratton,PhD Chairman of Scientific Review Comittee|(520) 626-9295|SStratton@uacc.arizona.edu|
21280406|NCT02487225|Mayo Clinic|Dr. Santhi Swaroop Vege|507-284-7474|Vege.Santhi@mayo.edu|
21280407|NCT01523002|Medicines for Malaria Venture (MMV)|Stephan Duparc, MD, Chief Medical Officer|+41 22 555 0300|duparcs@mmv.org|
21280408|NCT01256502|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21280409|NCT00489255|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21280410|NCT03485352|Federal University of Uberlandia|Mrs Cibele Crispim|55 34 3218-2084|cibelecrispim@gmail.com|
21280411|NCT02028676|Medical Research Council|Professor Ann Sarah Walker|+44 20 7670 4726|rmjlasw@ucl.ac.uk|
21280412|NCT00773474|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
21245970|NCT04710498|Stanford University|Dr. Vasu Divi|650-725-5968|vdivi@stanford.edu|
21245971|NCT04406623|Shattuck Labs|VP, Clinical Operations|919-864-2700|clinicaltrials@shattucklabs.com|
21245972|NCT05827094|University of Washington School of Nursing|Associate Professor|2068493301|ozasl@uw.edu|
21245973|NCT03768505|MEI Pharma|Richard Ghalie, MD CMO|858 898 0956|rghalie@meipharma.com|
21245974|NCT04948697|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21245975|NCT02815566|University Health Network|Dr. Sharon Walmsley|416-340-3871|sharon.walmsley@uhn.ca|
21245976|NCT06180954|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21245977|NCT06044090|University of Pittsburgh|Gabriella Alvarez, PhD|412-624-4500|gabyalvarez@pitt.edu|
21245978|NCT02861300|University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. David Bajor|(216) 286-4414|david.bajor@uhhospitals.org|
21245979|NCT04910152|The Ohio State University Comprehensive Cancer Center|Dr. Hannah Choe|614-293-3196|Hannah.choe@osumc.edu|
21245980|NCT05459857|Imperial Brands PLC|Libby Clarke|+44 (0117) 3320221|libby.clarke@impbrands.com|
21245981|NCT04520191|University of New Mexico Health Sciences Center|Vallabh Shah, PhD. Principal Investigator|505-272-9615|VShah@salud.unm.edu|
21245982|NCT03468868|Shepherd Center, Atlanta, GA|Deborah Backus, PT, PhD|404-352-2020|deborah.backus@shepherd.org|
21245983|NCT03482557|Beth Israel Deaconess MEdical Center|Marc Mccall|617-418-9216|mmccall1@bidmc.harvard.edu|
21245984|NCT05399459|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21245985|NCT04992520|PATH|Patricia Njuguna/Senior Medical Officer|+254 20 3877177|pnjuguna@path.org|
21245986|NCT05651308|Weill Cornell Medicine|Lisa M. Kern, MD, MPH|646-962-5889|lmk2003@med.cornell.edu|
21245987|NCT05245682|Emory University|Nicole Schmitt|404-778-0278|nicole.cherie.schmitt@emory.edu|
21245988|NCT00986856|LEO Pharma|Anders Rhod Larsen, Scientific advisor|+45 72262990|anders.larsen@leo-pharma.com|
21245989|NCT01541553|LEO Pharma A/S|Clinical trial disclosure|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com|
21245990|NCT05445427|Mayo Clinic|Dr. Ryan T. Hurt, MD, PhD|507-284-4461|hurt.ryan@mayo.edu|
21245991|NCT03020199|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21245992|NCT04313972|Endeavor Health|Urogynecology Research Coordinator|847-570-4729|JLee5@northshore.org|
21262201|NCT04635735|Memorial Sloan Kettering Cancer Center|Dr. Gunjan Shah, MD|646-608-3734|shahg@mskcc.org|
21262202|NCT00907478|Amgen Inc.|Study Director|866-572-6436||
21235906|NCT00096941|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
21235907|NCT02401672|Medical University of South Carolina|Xingbao Li, MD|843-792-5729|lixi@musc.edu|
21235908|NCT04796610|RAND Corporation|Laura Bogart|3103930411|lbogart@rand.org|7281
21235909|NCT00733824|Washington University School of Medicine|Amanda F. Cashen, M.D.|314-454-8304|acashen@wustl.edu|
21235910|NCT01459796|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
21235911|NCT00701051|Baltimore VA Medical Center|Steven J. Prior, PhD|410-605-7000|steven.prior@va.gov|4129
21235912|NCT01384539|University of Colorado|Dr. Jessica Kendrick|303-602-5012|Jessica.Kendrick@ucdenver.edu|
21235913|NCT01166984|AtoxBio, Ltd.|Wayne M Dankner, MD, Chief Medical Officer|1 919-219-6377|wayned@atoxbio.com|
21235914|NCT02658851|Apyx Medical|Kari Larson|8012440058|kari.larson@apyxmedical.com|
21235915|NCT01243944|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
21235916|NCT01714024|UNC School of Dentistry|Steven Offenbacher, DDS, PhD, MMSc|919-537-3205|steven_offenbacher@unc.edu|
21235917|NCT01814722|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21235918|NCT01385059|City of Hope Medical Center|Dr. Sumanta Kumar Pal|626-359-8111|SPal@coh.org|
21235919|NCT03321019|University of Florida|Dr. Karen Hegland|3522948366|kwheeler@ufl.edu|
21235920|NCT03880578|Klinikum Lüdenscheid|Professor Rolf Larisch, Director|‭+49 2351 46|rolf.larisch@klinikum-luedenscheid.de|3311
21235921|NCT04934670|Xenikos BV (no longer in business)|Ypke van Oosterhout, custodian of Sponsor|+31 611 0177 611|ypke@me.com|
21235922|NCT01993719|National Cancer Institute|Dr. Stephanie L. Goff|240-760-6214|stephanie.goff@nih.gov|
21235923|NCT03895853|UT MD Anderson Cancer Center|Joseph L. Nates, Professor, Critical Care& RespiratoryCare|(713) 792-5040|jlnates@mdanderson.org|
21235924|NCT03473886|Massachusetts General Hospital|Rachel A. Millstein|617-724-2047|RAMILLSTEIN@mgh.harvard.edu|
21235925|NCT02799082|Biofrontera Bioscience GmbH|Dr. Beate Schmitz|+49 214 876 32|b.schmitz@biofrontera.com|41
21235926|NCT01592708|UNC Chapel Hill|Dr. Jay Anderson, PI|919-966-5136|janderson@aims.unc.edu|
21235927|NCT02921412|CooperVision|Jose Vega, O.D., MSc., FAAO|9256213761|JVega2@coopervision.com|
21235928|NCT03433456|University of Alabama at Birmingham|Dr. Gareth Dutton|205.934.6876|gdutton@uabmc.edu|
21235929|NCT03105362|Boston Children's Hospital|Dr. Christopher Duggan|617-355-7612|christopher.duggan@childrens.harvard.edu|
21235930|NCT01198600|Alcon Research|R. Alan Landers, O.D., M.S., F.A.A.O.|1-800-241-7629||
21235931|NCT02749903|Memorial Sloan Kettering Cancer Center|Alan Ho, MD, PhD|646-888-4235|hoa@mskcc.org|
21235932|NCT03299192|Kaiser Permanente|Rene Hawkes, Project Manager|206-287-2073|rene.j.hawkes@kp.org|
21235933|NCT01603875|Queen Saovabha Memorial Institute|Dr. Terapong Tantawichien|66225201614|terapong_tantawichien@hotmail.com|125
21235934|NCT04737538|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
21235935|NCT01652716|AstraZeneca|ClinicalTrialTransparency@astrazeneca.com||ClinicalTrialTransparency@astrazeneca.com|
21235936|NCT05204134|Tandem Diabetes Care|Supervisor Clinical Operations|+18778016901|clinicalaffairs@tandemdiabetes.com|
21235937|NCT01312467|University of California, Irvine|Dr. Frank L. Meyskens, Jr.|714-456-6310|flmeyske@uci.edu|
21280413|NCT00852202|Allergan Sales LLC|Therapeutic Area Head,|877-277-8566|IR-CTRegistration@allergan.com|
21235938|NCT00061048|National Cancer Institute, National Institutes of Health|Thomas A. Waldmann, M.D.|301-496-6653|Thomas.Waldmann2@nih.gov|
21235939|NCT02752048|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.|+81-3-3294-4527|toiawase@taiho.co.jp|
21235940|NCT01092195|National Institutes of Health|Pamela Stratton MD|301-435-4068|strattop@mail.nih.gov|
21235941|NCT03779841|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21235942|NCT00818441|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21235943|NCT04450264|Icahn School of Medicine at Mount Sinai|Dr. Jamilia Sly|212-824-7813|jamilia.sly@mssm.edu|
21235944|NCT00970502|Florida Radiation Oncology Group|Dr. Johnny Kao|813-661-6442|johnnykaomd@gmail.com|
21235945|NCT02707055|National Institute on Drug Abuse (NIDA); National Institute on Alcohol Abuse and Alcoholism (NIAAA)|Dr. Lorenzo Leggio, M.D., PhD|+1 443 740 2801|lorenzo.leggio@nih.gov|
21235946|NCT01880424|AstraZeneca|Peter Zeng|+86 21 6030 1867|peter.zeng@astrazeneca.com|
21235947|NCT02212028|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu|
21235948|NCT02280044|Johns Hopkins Bloomberg School of Public Health|David A Sack|443 287 8795|dsack1@jhu.edu|
21235949|NCT01800877|Centre de Recherche du CHUS|Marie-Hélène Masse|819-346-1110|marie-helene.masse3@usherbrooke.ca|14173
21235950|NCT00466193|Purdue Pharma LP|Clinical Leader|800-733-1333||
21235951|NCT00086346|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21235952|NCT02807948|Abbott|Adam M.Cline, MD, MSc.- Principal Scientist|818-493-2025|adam.cline@abbott.com|
21280414|NCT04359797|Vanderbilt University Medical Center|Dr. Edward T. Qian|615-322-2386|edward.t.qian@vumc.org|
21280415|NCT03691727|University of Iowa|David Hasan|319-384-8669|david-hasan@uiowa.edu|
21280416|NCT00141778|Vanderbilt University School of Medicine|Dr. Mias Pretorius|16153430665|mias.pretorius@vanderbilt.edu|
21280417|NCT00768248|University California San Diego|Brian Ilfeld, MD, MS|858-822-0776|bilfeld@ucsd.edu|
21280418|NCT04927845|Strive Weekly Inc|Dr. Leslie Rith-Najarian, Principal Investigator|3108002143|leslie@striveweekly.com|
21280419|NCT01959295|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
21280420|NCT07112885|Istanbul University, Department of Orthopedics and Traumatology|Mehmet Yağız Yenigün, MD (Principal Investigator)|+905544383142|mehmet.yenigun@istanbul.edu.tr|
21280421|NCT01191450|Eurofarma Laboratórios S.A|Eurofarma Laboratórios S.A|50 11 5090-8415|fernanda.martinez@eurofarma.com.br|
21280422|NCT05954988|Rein Therapeutics, Inc.|Shawna Evans|1 (737) 802-1989|info@reintx.com|
21280423|NCT05287230|University of South Carolina|Dr. Monique Brown|8037775057|brownm68@mailbox.sc.edu|
21245993|NCT00967447|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21245994|NCT04447469|Kiniksa Pharmaceuticals, Ltd.|Clinical Operations Study Director|1-781-431-9100|studyinfo@kiniksa.com|
21245995|NCT05201079|Mikrobiomik Healthcare Company S.L.|Olaia Aurtenetxe Saez|+34 944 540 166|ensayosclinicos@mikrobiomik.net|
21245996|NCT05825755|vitalera (FollowHealth SL)|Data Scientist of vitalera|+34644499760|val-hic@humanitcare.com|
21245997|NCT03569631|Shionogi|Shionogi Clinical Trials Administrator Clinical Support Help Line|1-800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
21245998|NCT05562401|UColima|Fabian Rojas Larios|3121206804|frojas@ucol.mx|
21245999|NCT01210807|University Eye Clinic, Tubingen, Germany|PD Dr. med. Peter Szurman|49-7071-29-84915|peter.szurman@med.uni-tuebingen.de|
21246000|NCT05281562|Prisma Health|J. Benjamin Jackson|803-296-9610|benjamin.jackson@prismahealth.org|
21246001|NCT00324805|ECOG-ACRIN Statistical Center|Study Statistician|617-632-3012||
21246002|NCT02675777|Kaiser Permanente Washington Health Research Institute|Katharine Bradley, MD, MPH|206-948-1933|katharine.a.bradley@kp.org|
21246003|NCT05526430|Icahn School of Medicine at Mount Sinai|Jessica L Ables|(212) 241-2774|jessica.ables@mssm.edu|
21246004|NCT03085810|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21246005|NCT02601313|Kite, A Gilead Company|Medical Information|844-454-5483(1-844-454-KITE)|medinfo@kitepharma.com|
21246006|NCT03800654|VA San Diego Healthcare System|Dr. Matthew Herbert|858-642-1411|Matthew.Herbert2@va.gov|
21246007|NCT03459729|Froedtert and the Medical college of Wisconsin|Stuart Wong, MD|414-805-4600|swong@mcw.edu|
21246008|NCT05476328|Cochlear|PRS Specialist|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
21246009|NCT02626533|Hospital for Special Surgery, Anesthesiology|Dr. Meghan Kirksey|2126061036|KirkseyM@hss.edu|
21246010|NCT03701763|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21246011|NCT05493072|Imperial College NHS Healthcare Trust|Calandra Feather|07977185577|calandra.feather@nhs.net|
21246012|NCT05576155|University of Iowa|Kelsey Schwartz|319-467-3096|kelsey-schwartz@uiowa.edu|
21246013|NCT04515849|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21246014|NCT02975375|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
21246015|NCT04078191|Navidea|Michael Blue, MD|6145714313|mblue@navidea.com|
21246016|NCT04164888|CiVi Biopharma, Inc.|Chief, Clinical Development|484-674-5456|chuck.shear@civibiopharma.com|
21246017|NCT04049643|The University of Iowa|Dr. Yu-Hsiang Wu|319-3359758|yu-hsiang-wu@uiowa.edu|
21246018|NCT04081103|Amber Ophthalmics|Director of Clinical Trials|858-539-3418|clinical@Amberophthalmics.com|
21246019|NCT05123118|State University of New York at Buffalo|Dr. Xiaozhong Wen|7168296811|xiaozhon@buffalo.edu|
21246020|NCT03365882|SWOG Statistics and Data Management Center|Gastrointestinal Committee Statistician|2066674623|scolby@fredhutch.org|
21246021|NCT04437615|Olympus Corporation|Jeremy Bolt, Global GI Lead|5085798495|jeremy.bolt@olympus.com|
21246022|NCT04828005|Opiant Pharmaceuticals|Clinical Director|+1 804 379 1090|PatientSafetyNA@Indivior.com|
21246023|NCT05456360|The University of Texas MD Anderson Cancer Center|Dr. Vijaya Gottumukkala|(713) 794-1398|vgottumukkala@mdanderson.org|
21246024|NCT05579899|Evommune|Eugene Bauer, M.D., Chief Medical Officer|310-721-3364|eugene.bauer@evommune.com|
21246025|NCT03023410|Stryker|Kevin Barga|+12018315073|Kevin.Barga@stryker.com|
21246026|NCT05263037|AppliedVR|Vice President of Research|13108901584|tmaddox@appliedvr.io|
21246027|NCT04321395|Washington University in St. Louis|Assistant Professor|314-362-8708|ssfarabi@wustl.edu|
21246028|NCT04987320|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21246029|NCT00085735|Childrens's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreporingcoordinator@childrensoncologygroup.org|
21246030|NCT01824875|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21246031|NCT02014649|Aviragen Therapeutics, Inc.|Anna Novotney-Barry|678-221-3356|abarry@aviragentherapeutics.com|
21246032|NCT00433329|Actelion Pharmaceuticals, US, Inc.|Rajiv Patni/Medical Officer|(650) 624-6900||
21246033|NCT04195698|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21246034|NCT05459688|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21246035|NCT02675751|Johnson & Johnson Surgical Vision|Sanjeev Kasthurirangan Ph.D.|+1 408-273-4081|skasthur@its.jnj.com|
21246036|NCT03371381|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21246037|NCT05368402|Dompé Farmaceutici SpA|Clinical Development & Operations|+30 902 583831|clinicaltrials@dompe.com|
21246038|NCT01593917|Abbott Medical Devices, Structural Heart Divison|Clinical Scientist, Tissue Heart Valves|+1 651-756-2320|Roland.MaudeGriffin@Abbott.com|
21280424|NCT06146361|The University of Texas Health Science Center at Houston|Maria E. Fernandez-Esquer, PhD|713-500-9657|Maria.E.Fernandez-Esquer@uth.tmc.edu|
21280425|NCT02360215|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21280426|NCT04075487|VA Maryland Health Care System, Geriatric Research, Education, and Clinical Center|Dr. Beth Hogans, M.D., Ph.D., Neurologist|410-605-7000|beth.hogans@va.gov|
21280427|NCT05411991|University Hospital Brussels - Vrije Universiteit Brussel|Prof. Dr. Frederik H. Verbrugge|024749657|frederik.verbrugge@uzbrussel.be|+32
21280428|NCT05016960|VA San Diego Healthcare System|Dr. Erin Almklov|858-552-8585|erin.almklov@va.gov|3907
21280429|NCT05579782|Medical College of Wisconsin|Tracy Wang, MD|414-955-1459|tswang@mcw.edu|
21280430|NCT04408183|GeneOne Life Science|Senior Clinical Operations Associate|6106576351|dkane@genels.us|
21280431|NCT05126693|KU Leuven|Prof. dr. Kaat Desloovere|+32 486 40 13 73|kaat.desloovere@kuleuven.be|
21280432|NCT04479852|Sirtsei Pharmaceuticals|Greg Rigdon, PhD|+1 919-949-6862|grigdon@arrivobio.com|
21280433|NCT04589247|Johns Hopkins University|Ranh Voong, MD|4105506597|kvoong1@jhmi.edu|
21246039|NCT04663737|Senhwa Biosciences, Inc.|Kacy Huang, Director of Clinical Department|+886-2-8911-9856|kacyhuang@senhwabio.com|214
21246040|NCT04016662|Jaeb Center for Health Research|Robert Henderson|(813) 975-8690|Rhenderson@jaeb.org|
21246041|NCT03216057|Hospital Infantil de Mexico Federico Gomez|Blanca Estela Del Rio Navarro|+525552289917|leijamjj@gmail.com|2444
21246042|NCT05126433|Jazz Pharmaceuticals Inc.|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
21246043|NCT02809443|GeneOne Life Science|Senior Clinical Operations Associate|6106576351|dkane@genels.us|
21246044|NCT05246280|Navidea Biopharmaceuticals|Michael Blue, MD|6145714313|mblue@navidea.com|
21246045|NCT04599062|University of Iowa, Holden Comprehensive Cancer Center|Varun Monga, MD|319-384-9497|varun-monga@uiowa.edu|
21246046|NCT04032704|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21246047|NCT05038878|Icahn School of Medicine at Mount Sinai|Dr. Alice C. Levine|(212) 241-3422|alice.levine@mountsinai.org|
21246048|NCT03133546|ETOP IBCSG Partners Foundation|Dr. Heidi Roschitzki, PhD|+41 31 511 94 00|heidi.roschitzki@etop.ibcsg.org|
21246049|NCT05034328|Pharmndev Experts|Dr Bernard Gout|+41798659000|bgout@pharmndev.ch|
21246050|NCT02993159|Northwestern University|Seema A. Khan, MD|312-503-4236|s-khan2@northwestern.edu|
21246051|NCT02231164|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21246052|NCT02969707|Stanford University|Dr. David Spiegel|650-723-6421|dspiegel@stanford.edu|
21246053|NCT05283304|UT Southwestern Medical Center|Madhukar Trivedi|214-648-0188|madhukar.trivedi@utsouthwestern.edu|
21246054|NCT02268461|University of Minnesota|Kate Frost|612-626-4913|jahnke.k.131@gmail.com|
21246055|NCT06074172|Colorado State University Pueblo|Dr. Moussa Diawara|719-549-2813|Moussa.Diawara@csupueblo.edu|
21246056|NCT05583578|University of Florida|Dr. Clayton Swanson|3522735919|clayton.swanson@ufl.edu|
21246057|NCT00248287|Baylor Sammons Cancer Center|Dr. Joyce O'Shaughnessy|(214) 370 -1796|Joyce.OShaughnessy@usoncology.com|
21246058|NCT02714257|Milton S. Hershey Medical Center|Christopher Sciamanna, MD, MPH|717-531-4417|csciamanna@pennstatehealth.psu.edu|
21246059|NCT04103580|Washington University|Kyle Pitzer: Study Statistical Data Analyst|314-747-5361|kyleapitzer@wustl.edu|
21246060|NCT04700176|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
21246061|NCT05808257|Icahn School of Medicine at Mount Sinai|Dr. Mantu Gupta|212-241-1272|mantu.gupta@mountsinai.org|
21246062|NCT04568486|University of Kentucky|Brittany Smalls|859-323-4916|brittany.smalls@uky.edu|
21246063|NCT04042233|Houston Methodist Hospital|Thomas Sullivan|2817254460|tsullivan@houstonmethodist.org|
21246064|NCT03986931|University of Iowa|Dr. Linnea Polgreen|(319) 384-3024|linnea-polgreen@uiowa.edu|
21246065|NCT04752709|Elidah, Inc.|Director of Clinical Trials|978.435.4324|customercare@elitone.com|
21246066|NCT00576979|Department of Hematology and Hematopoietic Cell Transplantation, City of Hope|Anthony Stein, MD, corresponding author|626-256-4673|astein@coh.org|62405
21246067|NCT04248725|University of Washington|Dawn Ehde, PhD|206-591-3780|ehde@uw.edu|
21246068|NCT03697096|Division of Infectious Diseases, University of California Irvine School of Medicine|Dr. Shruti Gohil, MD, MPH|(714) 456-7890|skgohil@hs.uci.edu|
21246069|NCT04436276|Janssen Vaccines & Prevention B.V.|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21246070|NCT05312008|Indiana University|Dr. Ann E.K. Kosobud|3172740087|akosobud@iu.edu|
21246071|NCT05698875|University of Stirling|Julie Johnson|07815893076|julie.johnson1@stir.ac.uk|
21246072|NCT03728790|Columbia University|Dr. Leslie Moroz|646-532-8208|lm3000@cumc.columbia.edu|
21246073|NCT05746299|University of Pennsylvania|Anna Schapiro|215-898-0482|aschapir@sas.upenn.edu|
21246074|NCT05977530|University of Alabama at Birmingham|Dr. David Schwebel|205-934-8745|schwebel@uab.edu|
21246075|NCT04524442|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
21246076|NCT00167674|University of Washington|Grace John-Stewart|206 948 9357|gjohn@uw.edu|
21246077|NCT03819153|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21246078|NCT00691002|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
21246079|NCT03974178|Drugs for Neglected Diseases initiative (DNDi)|Dr. Olaf Valverde Mordt|+41229069239/+41795431713|ovalverde@dndi.org|
21246080|NCT04283149|STAAR Surgical|Joanne Egamino|626-303-7902|jegamino@staar.com|2905
21246081|NCT03982459|University of California, San Francisco|Dr. Sue Yom, MD|415-353-7175|sue.yom@ucsf.edu|
21246082|NCT04880863|NeoTX Therapeutics Ltd.|Dr. Ilana Lorber, VP of Clinical Operations|+972-3-912-5853|ilanal@neotx.com|213
21246083|NCT03899259|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
21246084|NCT04508309|PATH|Niranjan Bhat, MD|206 302 4843|nbhat@path.org|
21246085|NCT03058289|Intensity Therapeutics|Lewis Bender|2032217377|LBender@intensityTherapeutics.com|
21246086|NCT03128021|University of Pittsburgh|Rachel Berta|4128607406|goodra@upmc.edu|
21246087|NCT04731818|Eastern Virginia Medical School|Andrea Thurman MD, Principal Investigator|7574465808|thurmaar@evms.edu|
21246088|NCT05239455|Terumo BCT, Inc|Erin Goodhue, DO, MPH, Director, Clinical Affairs|614-400-4638|Erin.Goodhue@TerumoBCT.com|
21246089|NCT06182033|Crane Center for Early Childhood Research and Policy at The Ohio State University|Dr. Laura Justice|614-247-7488|justice.57@osu.edu|
21246090|NCT05124704|Zhejiang Cancer Hospital|Jiangling Wang|15168373331|wangjl@zjcc.org.cn|
21246091|NCT05487404|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
21246092|NCT05623228|Private practice|Dr. Stavroula Rakitzi|6989766935|srakitzi@gmail.com|
21246093|NCT04752657|Framingham Heart Study, Boston University|Joanne M Murabito, MD ScM|508-935-3461|murabito@bu.edu|
21246094|NCT04581564|Assistant Professor. Speech, Language and Hearing|Dr. Yune Lee|972-883-5639|yune.lee@utdallas.edu|
21246095|NCT01129102|Nobelpharma|Department director of clinical development department 1|+81-5651-1177|murakami@nobelpharma.co.jp|
21293840|NCT04532294|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21293841|NCT00375505|Novartis|Study Director|862-778-8300||
21293842|NCT02798315|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21293843|NCT00005947|Dendreon Corporation|Kathleen Picha|206-274-6762|kpicha@dendreon.com|
21293844|NCT00921115|University of Kansas Cancer Center|Qamar Khan, MD|(913) 588-6029|QKHAN@kumc.edu|
21293845|NCT01575808|Toyko Jikei University Hospital|Dr. Takao Ohki|81-090-2478-8304|takohki@msn.com|
21293846|NCT03159468|Arizona State University|Kelly Cue Davis|602-496-3217|Kelly.Cue.Davis@asu.edu|
21293847|NCT00912782|Emory University|Monnie Wasse MD/MPH / Associate Professor of Medicine|404-727-1598|hwasse@emory.edu|
21293848|NCT02482428|Novartis Pharmaceuticals|Study Director|862-778-8300||
21246096|NCT04475679|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
21246097|NCT03379675|Janssen Research and Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21246098|NCT02817776|Biosense Webster Inc|Kendra McInnis|+1 949 322-8010|kmcinnis@its.jnj.com|
21246099|NCT04502888|Shattuck Labs|VP, Clinical Operations|919-864-2700|clinicaltrials@shattucklabs.com|
21246100|NCT05349500|University of North Carolina at Chapel Hill|Kelli Allen, PhD|919-966-0558|kdallen@email.unc.edu|
21246101|NCT03381196|Janssen Research & Development, LLC|Senior Director Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21246102|NCT04002830|Shaare Zedek Medical Center|Majdolen Istaiti|972526659995|joleenist@szmc.org.il|
21246103|NCT02359890|Biosense Webster|Robert Stagg|(800) 729-9010|RStagg@its.jnj.com|
21246104|NCT05260112|University of Pennsylvania|Lily Arya, MD|267-785-8024|larya@pennmedicine.upenn.edu|
21246105|NCT04341896|New York University|Rhiannon Reed|205-999-3360|rjd1125@uab.edu|
21246106|NCT03032107|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-3800|Sara_Tolaney@dfci.harvard.edu|
21246107|NCT01574274|Dana-Farber Cancer Institute|Dr. Lewis Silverman|16176326191|lewis_silverman@dfci.harvard.edu|
21246108|NCT04881903|Durham VA Health Care System|Angela Kirby|919-824-7729|angela.kirby@va.gov|
21246109|NCT03626766|Columbia University|Dr. Anthony Lin|(917) 628-6522|akl17@cumc.columbia.edu|
21246110|NCT05477095|Vaxxinity, Inc.|Executive Director, Clinical Development|254-244-5739|info@vaxxinity.com|
21246111|NCT03907878|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21246112|NCT04625686|Cincinnati Children's Hospital Medical Center|Rosalie Hemphill LSW|5044940883|rosalie.hemphill@cchmc.org|
21246113|NCT03904147|Abbott|Natalie Richardson, Senior Clinical Project Manager|651-756-3842|natalie.richardson@abbott.com|
21246114|NCT05135650|Fred Hutch/University of Washington Cancer Consortium|Dr. Alpana Waghmare (Study Principal Investigator)|206-667-7329|awaghmar@fredhutch.org|
21246115|NCT03625167|Charité - Universitätsmedizin Berlin|Monira El Genedy-Kalyoncu|+49 30 450 529 434|monira.el-genedy@charite.de|
21246116|NCT06103188|Jordan University Hospital|Dr Omar Ismail|+962791301329|omar.moh.isml@gmail.com|
21246117|NCT05216315|University of Valencia|Dr Juan C Melendez|+34 963983844|melendez@uv.es|
21246118|NCT04145440|HI-Bio, A Biogen Company|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21246119|NCT02749006|University Of British Columbia|Dr. Lakshmi Yatham|604-822-7310|l.yatham@ubc.ca|
21246120|NCT00704262|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
21246121|NCT01710488|Fadoi Foundation|Antonella Valerio|0248005140|antonella.valerio@fadoi.org|
21246122|NCT03852472|Chemocentryx|Study Director|650-210-2900|medinfo@amgen.com|
21246123|NCT01919554|Stallergenes|Michel Roux, Medical Director|+33 (0) 1 55 59 20 00|mroux@stallergenes.com|
21246124|NCT06457802|Vanderbilt University School of Nursing|Dr. Shelagh Mulvaney, PhD|6153221198|shelagh.mulvaney@vanderbilt.edu|
21246125|NCT05496231|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21246126|NCT03896867|University of Minnesota|Benjamin Kloesel|612-301-1245|bkleosel@umn.edu|
21246127|NCT01152450|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21246128|NCT05670587|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21246129|NCT03738852|Yale School of Medicine|Renata Belfort De Aguiar, MD, PhD|(203) 785-5331|renata.aguiar@yale.edu|
21246130|NCT01205828|Georgetown University Medical Center|Dr. Aiwu Ruth He|202-444-8642|arh29@georgetown.edu|
21246131|NCT01544114|Horizon Pharma, Inc.|Julie Ball, Executive Director of Clinical Development & Operations||clinicaltrials@horizonpharma.com|
21246132|NCT04649476|Hospital of Stomatology, Wuhan university|Gang Chen, MD|+86 02787686215|geraldchan@whu.edu.cn|
21246133|NCT04223505|University of Ottawa Heart Institute|Dr. Benjamin Chow|6136966786|bchow@ottawaheart.ca|
21246134|NCT01733316|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224-383-3000|clinicaltrials@horizonpharma.com|
21246135|NCT05482698|MC2 Therapeutics|Chief Medical Officer|+45 2018 1111|info@mc2theraprutics.com|
21246136|NCT03879863|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
21246137|NCT05940194|PATH|Dr. Thang Tran Cong, Medical office|+84913301883|thangtran@path.org|
21246138|NCT04625465|Georgia State University|Dr. Dominic Parrott, Distinguished University Professor of Psychology|+1 (404) 413-6287|parrott@gsu.edu|
21246139|NCT04947397|University of California San Francisco|Daniel Abelson|510 428 3000|daniel.abelson@ucsf.edu|
21246140|NCT04753697|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21246141|NCT02151981|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21246142|NCT05446168|University of Michigan|Nicolaas Bohnen, MD, PhD|734-936-1168|nbohnen@umich.edu|
21246143|NCT03847311|University of Arizona|Dr. Mohab Ibrahim|(520) 626-7221|mohab@arizona.edu|
21246144|NCT00597909|Horizon Pharma plc|Bruce Scharschmidt, MD||bscharschmidt@horizonpharma.com|
21246145|NCT05875467|dfusion Inc|Chief Executive Officer|8312225103|tamara.kuhn@dfusioninc.com|
21246146|NCT03272217|Hoosier Cancer Research Network|Fauzia Sharmin|317-634-5842|fsharmin@hoosiercancer.org|75
21246147|NCT05095779|The University of Oklahoma Health Sciences|Dr. Darla E. Kendzor|(405) 271-7848|Darla-Kendzor@ouhsc.edu|
21293849|NCT04309370|Indiana University|Clinical Research Manager|3178808495|iupdp@iupui.edu|
21293850|NCT00809835|Yale University School of Medicine|Kathleen M. Carroll, Ph.D., Albert E Kent Professor of Psychiatry|203.937.3486|kathleen.carroll@yale.edu|7403
21293851|NCT05160415|Edgewise Therapeutics, Inc.|Joanne Donovan MD PhD, Chief Medical Officer|720-262-7002|studies@edgewisetx.com|
21293852|NCT00576628|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21293853|NCT01289275|UC San Diego, California Smokers' Helpline|Sharon Cummins, Ph.D.|8583001046|scummins@ucsd.edu|
21293854|NCT04136548|University of Texas Southwestern Medical Center|Dr. Craig Crandall|2143454623|craigcrandall@texashealth.org|
21293855|NCT02516982|Imperial College London|Dr Josip Car|+44(0)2075940799|josip.car@imperial.ac.uk|
21293856|NCT02377752|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21293857|NCT01951586|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21293858|NCT01222091|Stanford University School of Medicine|Dr. Larry Chu|(650) 723-6632|lchu@stanford.edu|
21293859|NCT02120781|Castle Creek Biosciences|Head, Research and Development|13128471291|medinfo@castlecreekbio.com|
21293860|NCT03195660|ResMed|Adam Benjafield|+61 466 634 609|adam.benjafield@resmed.com|
21293861|NCT00375427|Novartis Pharmaceuticals|Study Director|862-778-8300||
21235953|NCT02473614|University of California at Irvine|Dr. Kelli Sharp|9495107968|ksharp@uci.edu|
21235954|NCT00440050|Oregon Health and Sciences University/Portland VA Medical Center, Portland, Oregon.|Joseph Quinn, MD|503-494-6976|quinnj@ohsu.edu|
21235955|NCT01075074|Northwestern University|Gildasio De Oliveira, MD|312-926-8373|g-jr@northwestern.edu|
21235956|NCT01054729|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21235957|NCT01576536|Vanderbilt University Medical Center|Dr. C. M. Stein|615-936-3420|mike.stein@vanderbilt.edu|
21235958|NCT02377986|Columbia University|Dr. Carolyn Rodriguez|650-723-6158|cr2163@stanford.edu|
21235959|NCT02162810|UPMC Children's Hospital of Pittsburgh|Karen Kenyon, research coordinator|4126923058|kenyonkl@upmc.edu|
21235960|NCT01465334|Dana-Farber Cancer Institute|Jennifer R. Brown, MD, PhD|(617) 632-3316|Jennifer_Brown@dfci.harvard.edu|
21235961|NCT03326999|Icahn School of Medicine at Mount Sinai|Dr. Christina Jeng|212-241-6426|christina.jeng@mountsinai.org|
21235962|NCT03963895|Aronora, Inc.|Norah Verbout, Ph.D.|503-964-0250|norah.verbout@aronorabio.com|
21246148|NCT04506866|Medtronic|Mylène Champs|612-433-0600|mylene.champs@medtronic.com|
21246149|NCT03854227|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_lnquiries@pfizer.com|
21246150|NCT04676763|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21246151|NCT05082116|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21246152|NCT04119843|Ascelia Pharma AB|Andreas Norlin|+46 735179119|an@ascelia.com|
21246153|NCT04499924|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
21246154|NCT04225273|QMedAB|Clinical Project Manager|18179615000|aestheticclinicaltrials@galderma.com|
21246155|NCT03652389|NYU Langone Health|Antoinette M. Schoenthaler|646-501-3434|Antoinette.Schoenthaler@nyulangone.org|
21246156|NCT04413708|Duke University|Sara LeGrand|919-438-0448|sara.legrand@duke.edu|
21246157|NCT04231149|Coloplast A/S|Medical Affairs Vice President|+45 4911 1111|clinical-studies@coloplast.com|
21246158|NCT03532282|Stanford University|Rachel Manber, PhD|(650) 498-9111|rmanber@stanford.edu|
21246159|NCT01501955|Zimmer Biomet|Linda Meijer|+31786292929|linda.meijer@zimmerbiomet.com|
21246160|NCT05877976|NYU Langone Health|Lita Anglin|212-263-2519|Lita.anglin@nyulangone.org|
21246161|NCT04314713|Pharmaron|Paolo DePetrillo|240-673-0500|paolo.depetrillo@pharmaron.com|1731
21246162|NCT04907851|Redx Pharma Limited|Craig Tilston|+44 (0)7787 983 638|c.tilston@redxpharma.com|
21246163|NCT04111874|University of Pennsylvania|Dr. Andrew Guzick|215-573-3708|andrew.guzick@pennmedicine.upenn.edu|
21246164|NCT04893239|Lumen Bioscience|Senior Medical Director|206-899-1904|trials@lumen.bio|
21246165|NCT05495555|Cataract & Laser Institute|Dr Justin Spaulding|541-779-2020|justinophtho@gmail.com|
21246166|NCT05534789|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21246167|NCT03029884|University of California, San Francisco|Prasad Shirvalkar MD, PhD - Principal Investigator|415-885-7246|Prasad.Shirvalkar@ucsf.edu|
21246168|NCT03656510|Janssen Research & Development, LLC|Senior Director Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21246169|NCT05322044|Imperial College London|Dr Louise Fleming|02073528121|l.fleming@imperial.ac.uk|2938
21246170|NCT05477186|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21246171|NCT01767636|Mayo Clinic|Brian Costello MD|507/284-2511|Costello.Brian@mayo.edu|
21246172|NCT05757453|NXTech|Principal Investigator for Study 31380|7814721140|external+studyinvestigator@nxtech.co|
21246173|NCT04084288|Hospital for Special Surgery|Dr. Stephanie Cheng|212-606-1206|chengs@hss.edu|
21246174|NCT01674140|SWOG Statistics and Data Management Center|Breast Committee Statistician|2066674623|jmiao@fredhutch.org|
21246175|NCT02305888|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
21246176|NCT05139810|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
21246177|NCT05533918|University of Utah|Dr. Guilherme Del Fiol|801-581-4080|guilherme.delfiol@utah.edu|
21246178|NCT04914676|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
21246179|NCT03024437|University at Buffalo|Dr. Roberto Pili|(716) 881-8918|rpili@buffalo.edu|
21246180|NCT03621371|Karolinska Institutet|Dr Benjamin Bohman|701713443|benjamin.bohman@ki.se|+46
21246181|NCT03240016|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
21246182|NCT05200403|Boston University School of Medicine|Kevin Thomas, PhD, MBA|617-358-9787|kipthoma@bu.edu|
21246183|NCT05546411|Dana Farber Cancer Institute|Kimberly Perez, MD|617-632-5370|KIMBERLY_PEREZ@DFCI.HARVARD.EDU|
21246184|NCT02606422|Johns Hopkins University School of Medicine|Kyrana Tsapkini|410-614-2646|tsapkini@jhmi.edu|
21246185|NCT03584633|Cleveland Clinic|Dr. Wei F. Chen|319-333-6166|chenw6@ccf.org|
21293862|NCT00924612|Clarus Therapeutics, Inc.|Robert E. Dudley, PhD, CEO and President|847-562-4300|rdudley@clarustherapeutics.com|
21293863|NCT03286543|SPR Therapeutics|Clinical Affairs|216-378-9106|support@sprtherapeutics.com|
21293864|NCT05332392|Masimo|Ahmed Alghazi|949-297-7437|aalghazi@masimo.com|
21293865|NCT01268046|Massachusetts General Hospital|Janet Hall, MD|617-877-1112|janet.hall@nih.gov|
21293866|NCT03636893|RUIJIN HOSPITAL|Dr BIRENDRA KUMAR SAH|0086-64370045|rjsurgeon@hotmail.com|671302
21293867|NCT02314156|Northwestern University|Seema A. Khan, MD|312-503-4236|s-khan2@northwestern.edu|
21293868|NCT00758069|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21293869|NCT04560816|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
21293870|NCT02277691|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21293871|NCT02846389|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
21293872|NCT04343534|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.havard.edu|
21293873|NCT03818607|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21293874|NCT03560102|Kantonsspital Winterthur|Christoph A Binkert (Sponsor-Investigator)|+41 52 266 2602|christoph.binkert@ksw.ch|
21293875|NCT05286658|University of Wisconsin - Madison|Carrie Niziolek, PhD|(608) 262-7583|cniziolek@wisc.edu|
21293876|NCT00842153|GlaxoSmithKline|GSK Response Center|866-435-7343||
21293877|NCT03517371|Center for Neurorehabilitation, College of Health & Rehabilitation, Sargent College, Boston University|Terry Ellis|617-353-2724|tellis@bu.edu|
21293878|NCT03352141|Zeltiq Aesthetics|Lori Brandt, Director Cinical Trial Management|(925) 621-7460|lori.brandt@abbvie.com|
21293879|NCT01345929|Cubist Pharmaceuticals, Inc.|Dr. Obi Umeh, Vice President Global Medical Sciences|781-860-8415|obiamiwe.umeh@cubist.com|
21293880|NCT02819297|Braintree Laboratories, Inc.|VP, Clinical Affairs|781-843-2202|john.mcgowan@sebelapharma.com|
21293881|NCT01670279|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21293882|NCT01407952|Mayo Clinic|Bernard Bendok, MD|3129269441|bendok.bernard@mayo.edu|
21293883|NCT01901614|Oregon Health & Science University|David Huang, MD, PhD|503-494-3000|huangd@ohsu.edu|
21293884|NCT03629223|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21293885|NCT01555073|Northwestern University, Feinberg School of Medicine|Antoun Nader, MD|312-695-3045|a-nader2@northwestern.edu|
21293886|NCT02027311|Digestive Disease Center and Department of Internal Medicine, Cheju Halla General Hospital|Dr. Byung Hyo Cha, Director of ETOMI-1 study|+82-64-740-8050|drhyo@hotmail.com|
21293887|NCT03928418|University of California San Francisco|Dr. Judy Hahn|415-476-5815|judy.hahn@ucsf.edu|
21293888|NCT03177512|Bridge HIV, San Francisco Department of Public Health|Albert Liu|628-217-7408|albert.liu@sfdph.org|
21293889|NCT00617097|University of California, Davis|Dr. Catherine Cansino|9167346930|Catherine.Cansino@ucdmc.ucdavis.edu|
21293890|NCT04855240|Acadia Pharmaceuticals Inc.|Study Director|844-422-2342|medicalinformation@acadia-pharm.com|
21293891|NCT02812238|NHLBI|Dr. Michael N. Sack|301-402-9259|sackm@nih.gov|
21293892|NCT00286091|Amgen Inc.|Study Director|866-572-6436||
21293893|NCT02936869|World Bank|Dr. Adanna Chukwuma|9173712931|adc785@mail.harvard.edu|
21293894|NCT03799952|University of New Brunswick|Dr. Danielle Bouchard|1 (506) 443-3908|danielle.bouchard@unb.ca|
21293895|NCT02688270|Covis Pharma|Clinical Trial Interest|18773744177|CTInterest@covispharma.com|
21293896|NCT00745290|Pacira Pharmaceuticals Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
21293897|NCT04004221|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21293898|NCT03423238|Wake Forest School of Medicine|Tina Brinkley|336-713-8534|tbrinkle@wakehealth.edu|
21293899|NCT05066750|University of Colorado Colorado Springs|Lori James|7192554172|ljames@uccs.edu|
21293900|NCT02688829|Microport Medical, Shanghai, China|Dr Zhang Haotian|8621-38954600|zhanght@microport.com|8552
21293901|NCT02036580|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21293902|NCT00506454|Sepsicure L.L.C.|Vice President|212-606-4352|bianuale@metromediacompany.com|
21293903|NCT00260832|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
21293904|NCT00902850|Bausch & Lomb Incorporated|Robert Steffen, OD, MS|585-338-6399|Robert.Steffen@bausch.com|
21293905|NCT03745638|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21293906|NCT01356498|Savient Pharmaceuticals, Inc.|Chief Medical Officer|732-418-9300||
21293907|NCT00602225|University of Washington|Pamela Becker, MD, PhD|206-288-7273|pbecker@uw.edu|
21293908|NCT02993822|NeRRe Therapeutics Limited|Dr. Stephen Pawsey|+44 (0)1438906960|steve.pawsey@nerretherapeutics.com|
21293909|NCT01271907|National Cancer Institute, National Institutes of Health|James Yang, M.D.|301-496-1574|jamesyang@mail.nih.gov|
21293910|NCT01221753|Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA02215|Robert Haddad, MD|617-632-3090|robert_haddad@dfci.harvard.edu|
21293911|NCT01854775|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21293912|NCT00295009|DePuy Synthes|Erin Prifogle|508-977-6451|eprifog1@its.jnj.com|
21293913|NCT03135431|Mayo Clinic|Vanessa Torbenson, M.D.|507-266-9873|Torbenson.Vanessa@mayo.edu|
21293914|NCT02597452|Penn Medicine|Dr. Ari D Brooks|215-829-8461|ari.brooks@pennmedicine.upenn.edu|
21293915|NCT01659996|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21293916|NCT02701764|University of Miami|Dr. Anat Galor|305-450-6050|agalor@med.miami.edu|
21293917|NCT00475085|University of Rochester|Dr. Charles Heckler|585 273-1141|checkler@urmc.rochester.edu|
21293918|NCT01170273|Miami VA Medical Center|Silvina Levis MD|305-575-3388|silvina.levis-dusseau@va.gov|
21293919|NCT00875485|GlaxoSmithKline|GSK Response Center|866-435-7343||
21293920|NCT02908685|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21293921|NCT02954406|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21293922|NCT00782171|Institut Straumann AG - Clinical Research|Institut Straumann AG|+41 61 965 11 11|research@straumann.com|
21293923|NCT01691014|Pfizer ClinicalTrials.gov Call Center, Pfizer, Inc.|Pfizer Inc.|001 800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21293924|NCT05244603|Utah State University|Dr. Sarah Yoho Leopold|6145708258|sarah.leopold@usu.edu|
21293925|NCT05897242|Fred Hutchinson Cancer Center|Jaimee Heffner, Associate Professor|2066677314|jheffner@fredhutch.org|
21293926|NCT03522246|pharmaand GmbH|Medical Information Department|1-800-506-8501|medinfo@pharmaand.com|
21293927|NCT02249091|GSO mbH|Dr Anne L. Kranich|+494044195460|kranich@gsoglobal.com|
21293928|NCT02684617|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21293929|NCT02141399|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
21293930|NCT05730335|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21293931|NCT00615719|VCU|John D. Grizzard|804-828-8569|jdgrizzard@vcu.edu|
21293932|NCT02300558|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21293933|NCT01471028|Vital Therapies, Inc.|Robert Ashley|858-673-6840|rashley@vitaltherapies.com|
21293934|NCT02318368|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|(857) 400-0101|Clinical@aveooncology.com|
21293935|NCT00935493|Yale University|Christopher van Dyck|203-764-8100|christopher.vandyck@yale.edu|
21293936|NCT00586716|Loma Linda University Medical Center|Dr. Pedro Baron|909-558-6792|PBaron@llu.edu|
21293937|NCT01781806|UCLA CARE Center|Dr. Raphael J. Landovitz|(310) 825-6689|rlandovitz@mednet.ucla.edu|
21293938|NCT02593903|Medical College of Wisconsin|Clinical Research Coordinator|414-337-3441|ebedjeti@mcw.edu|
21293939|NCT02091362|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21293940|NCT00690430|Novartis Pharmaceuticals|Study Director|862-778-8300||
21293941|NCT02565147|The Medicines Company|Global Health Science Center|1.888.977.6326|medical.information@themedco.com|
21293942|NCT03800537|University of North Carolina at Chapel Hill|Desma Jones|919-843-9463|desma_jones@med.unc.edu|
21293943|NCT01928290|Washington University School of Medicine|Haeseong Park, M.D.|314-747-6268|haeseongpark@wustl.edu|
21293944|NCT03098433|Virginia Commonwealth University|Francesco S. Celi, MD, MHSc.|804-828-9696|francesco.celi@vcuhealth.org|
21293945|NCT04470050|Bioxcel Therapeutics|Vice President Head of Clinical Operations|(475) 355 5177|cgommoll@bioxceltherapeutics.com|
21246186|NCT05566639|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
21246187|NCT05166577|Viracta Therapeutics|Dr. Darrel Cohen|858-400-8470|ClinicalTrials@Viracta.com|
21246188|NCT04054193|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21246189|NCT02966873|Medical University of South Carolina|Stacey Sellers|843-792-5807|sellersst@musc.edu|
21246190|NCT05844137|Duke University|Anastasia Alexopoulos|1 919 684 4005|anastasia.alexopoulos@duke.edu|
21246191|NCT04082143|Virginia Commonwealth University|Lyndon Cooper, Dean|(804) 828-7235|cooperlf@vcu.edu|
21246192|NCT03576885|AdventHealth|Hussnain Mirza MD|9736263952|Hussnain.Mirza.MD@adventhealth.com|
21246193|NCT04053075|Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Healthcare Institute|Dr. Meghan Baker, MD, ScD|617-867-4946|MBAKER1@BWH.HARVARD.EDU|
21246194|NCT03235544|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21246195|NCT00950742|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21246196|NCT06176963|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
21246197|NCT05436262|Johns Hopkins University|Cherie Marvel|410-387-8510|cmarvel1@jhmi.edu|
21246198|NCT01456949|Medtronic|Kirsten Rasmussen|763-526-2833|kirsten.l.rasmussen@medtronic.com|
21246199|NCT01658930|Canadian Cancer Trials Group|Lois E. Shepherd|6135336430|LShepherd@ctg.queensu.ca|
21246200|NCT04200456|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21246201|NCT05495971|Visioneering Technologies, Inc.|Dr. Douglas P. Benoit|6035459507|dbenoit@vtivision.com|
21246202|NCT05002088|Abbott|Karine Miquel|+32 479 600 107|karine.miquel@abbott.com|
21246203|NCT04068181|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21246204|NCT05658224|USouthDakota|Dr. Kory Zimney|6056586373|kory.zimney@usd.edu|
21246205|NCT03785964|SpringWorks Therapeutics|Head of Clinical Operations|877-279-4870|clinical@springworkstx.com|
21246206|NCT05070728|EyePoint Pharmaceuticals, Inc.|Ramiro Ribeiro, MD, PhD|908-440-0979|rribeiro@eyepointpharma.com|
21246207|NCT01922050|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
21246208|NCT04971031|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
21246209|NCT03924635|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21246210|NCT04642820|University of Chicago|Harriet de Wit, Principal Investigator|773-702-1234|hdew@uchicago.edu|
21246211|NCT04568434|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
21246212|NCT05469464|UNION therapeutics A/S|UNION therapeutics A/S|+45 61 77 7435|clinicaltrials@uniontherapeutics.com|
21246213|NCT04421989|Cincinnati Children's Hospital Medical Center|Dr. Claire Aarnio-Peterson|5138037459|claire.aarnio-peterson@cchmc.org|
21246214|NCT05374798|Medical University of South Carolina|Stacey sellers|843-792-5807|sellersst@musc.edu|
21246215|NCT03463044|INOTREM SA|Executive VP Research and Medical Sciences, INOTREM SA|30 62 86 51|jjg@inotrem.com|+33 (0)6
21246216|NCT04471246|Ottawa Hospital Research Institute|Krishan Yadav|613-798-5555|kyadav@toh.ca|19489
21246217|NCT04252573|Endologix|Mohamed Moawad|949-595-7244|mmoawad@endologix.com|
21246218|NCT03404115|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
21246219|NCT04079218|Albert Einstein College of Medicine|Dr. Kerry Murphy|718-839-7885|kerry.murphy@einsteinmed.edu|
21246220|NCT03743532|The University of Oklahoma Health Sciences|Dr. Darla E. Kendzor|(405) 271-7848|Darla-Kendzor@ouhsc.edu|
21246221|NCT04019977|University of Maryland School of Social Work|Dr. Lisa Berlin|410 706 6392|lberlin@ssw.umaryland.edu|
21293946|NCT03640507|Beth Israel Deaconess Medical Center|Cassandra R. Duffy, MD, MPH|617-667-2636|cduffy3@bidmc.harvard.edu|
21293947|NCT01270880|Barbara Ann Karmanos Cancer Institute|Elisabeth I. Heath, M.D.|313-576-8715|heathe@karmanos.org|
21280434|NCT04100018|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21280435|NCT02848001|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
21280436|NCT03283566|Cleveland Clinic Foundation, Department of Endocroine and Metabolism|EMI Research Director|216 445-3757|jenkink@ccf.org|
21280437|NCT04515147|CureVac AG|Clinical Trial Information|0049 6976805870|clinicaltrials@curevac.com|
21280438|NCT01769248|Northwestern University|Srinadh Komanduri|312-695-0484|koman1973@gmail.com|
21280439|NCT03983980|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
21280440|NCT01121250|Memphis VA Medical Center|Dr. Linda Nichols|901 523-8990|linda.nichols@va.gov|5082
21280441|NCT01431079|University of Cincinnati|Dr. Manoj Sharma, PI|513-556-3878|manoj.sharma@uc.edu|
21280442|NCT02790437|Hansa Biopharma AB|Elisabeth Sonesson, Director Clinical Operations|+46 (0)708 54 86 46|elisabeth.sonesson@hansabiopharma.com|
21280443|NCT01202175|Univeristy of California, San Diego|Joachim H. Ix, MD, MAS|858-552-7528|joeix@ucsd.edu|
21280444|NCT03805386|Mayo Clinic Arizona|Principal Investigator, Dr Johnny Yi|14803420612|yi.johnny@mayo.edu|
21280445|NCT01626690|University of Wisconsin School of Medicine and Public Health|Dr. Kristopher Schroeder, MD|608-263-8100|kmschro1@wisc.edu|
21280446|NCT00942357|NRG Oncology|Linda Gedeon on behalf of Virginia Filiaci, PhD. and Helen Huang, MS.|716-845-1169|lgedeon@gogstats.org|
21293948|NCT00940290|ITESM|Carlos A. Cuello-García|+52 (81)88882154|carlos.cuello@gmail.com, carlos.cuello@itesm.mx|
21293949|NCT00395486|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21293950|NCT03657134|NYU Langone Health|Lior Jankelson, MD, PhD|212-263-7149|Lior.Jankelson@nyulangone.org|
21293951|NCT01939977|Hospital Universitari de Bellvitge|Dr. Josep M. Cruzado|0034932607602|jmcruzado@bellvitgehospital.cat|
21293952|NCT02959853|Baylor College of Medicine|Rui Chen|812-239-1855|rui.chen2@bcm.edu|
21293953|NCT03213938|Guang'anmen Hospital, China Academy Chinese Medical Sciences|Zhishun Liu|+86 010 88002331|liuzhishun@aliyun.com|
21293954|NCT03641716|University of Pittsburgh|Dr. Angela Caldwell|412-383-7231|arl78@pitt.edu|
21293955|NCT02443116|NGM Biopharmaceuticals, Inc|VP, Clinical Operations|650-243-5555|ngm282@ngmbio.com|
21293956|NCT01917929|Stryker Orthopaedics|Kevin Barga, Senior Manager, Clinical Affairs|201-831-5000|kevin.barga@stryker.com|
21293957|NCT04295759|PediatricBTC|Catherine Billups|901-595-3370|catherine.billups@stjude.org|
21280447|NCT01690117|University of Leipzig, Medical Faculty, Clinic and Policlinic for Psychiatry and Psychotherapy|Prof. Dr. Hermann-Josef Gertz|0049 (0)341 97 24420|Hermann-Josef.Gertz@medizin.uni-leipzig.de|
21293958|NCT01696981|Early Detection Research Group, NCI, NIH|Paul F. Pinsky, Ph.D.|301-496-8544|pinskyp@mail.nih.gov|
21293959|NCT01962428|General Hospital of Chinese People's Armed Police Forces|huiliang Liu|+8601057976707|lhl518@vip.sina.com|
21293960|NCT00465972|Duke University School of Medicine|Andrew Krystal, MD, MS, Professor of Psychiatry and Behavioral Sciences|919-681-8742|andrew.krystal@duke.edu|
21293961|NCT02097719|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21293962|NCT03292640|Dr. Reddy's Laboratoris, Inc|Srinivas Sidgiddi, Senior Director, Clinical Development|9084585362|srinivassidgiddi@drreddys.com|
21293963|NCT02285023|Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University|Prof. Kanokvalai Kulthanan|(662)419-4333|kanokvalai.kul@mahidol.ac.th|
21293964|NCT01108731|Beth_IsraelMC|Dr Benjamin Natelson|212-844-6747|bnatelson@chpnet.org|
21293965|NCT02091531|Memorial Sloan Kettering Cancer Center|Dr. Dana Rathkopf, MD|646-422-4379|rathkopd@mskcc.org|
21293966|NCT00984594|RTI Biologics|Director, Clinical Projects|386-418-8888|rwaite@rtix.com|4172
21293967|NCT00851890|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21293968|NCT01063062|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21293969|NCT02015481|Bioblast Pharma|Warren Wasiewski|717-368-0780|Warren.wasiewski@bioblastpharma.com|
21280448|NCT01004354|University of Massachusetts Medical School|Benjamin U Nwosu, MD|5083347872|benjamin.nwosu@umassmemorial.org|
21280449|NCT01321879|UT MD Anderson Cancer Center|Dr. Issam I. Raad/ Chair, Infectious Diseases|713- 792-7943|iraad@mdanderson.org|
21280450|NCT02321111|University of Texas Health San Antonio|Laurie Che Kelly|210-617-5300|che@uthscsa.edu|14731
21280451|NCT01518322|Aerocrine, Inc.|Nancy Herje|919-449-8873|Nancy.Herje@aerocrine.com|
21280452|NCT03104192|Dartmouth-Hitchcock|John A. Batsis, MD|603-650-5000|john.batsis@gmail.com|
21280453|NCT00218387|Medical University of SC|Robert Malcolm, MD|843-792-1901|malcomr@musc.edu|
21235963|NCT04831736|NYU Langone Health|Lisa Doan, MD|212-201-1004|Lisa.Doan@nyulangone.org|
21235964|NCT00795600|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21235965|NCT01659021|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21235966|NCT04729803|palo alto university|Dr. Mikael Rubin|650-433-3805|mrubin@paloaltou.edu|
21235967|NCT00652457|University of California, San Diego|Jody Corey-Bloom, MD, PhD|858-249-0574|jcoreybloom@ucsd.edu|
21235968|NCT03551938|University of Michigan|Dr. Rob Stephenson|734-763-1188|rbsteph@med.umich.edu|
21235969|NCT01925183|Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna|Markus Peck-Radosavljevic (Principal Investigator)|+43 1 40400|markus.peck@meduniwien.ac.at|47440
21235970|NCT01114646|Hartford Hostpial|Arben Ademi, CCRP|860-972-3561|arben.ademi@hhcealth.org|
21235971|NCT05734846|CooperVision Inc.|Percy Lazon de la Jara BOptom PhD|+1-925-251-6682|PLazon@coopervision.com|
21235972|NCT01381172|Impulse Dynamics (USA) Inc|Sr. Director, Clinical and Data Operations|8453592389|angelas@impulse-dynamics.com|
21235973|NCT01233817|Department of Physical Medicine and Rehabilitation, School of Medicine, University of Utah|Aga Lewelt MD, Principal Investigator|801-518-4572|aga@genetics.utah.edu|
21235974|NCT00905580|Department of Anaesthesiology and Pain Medicine and Anaesthesia and Pain Research Institute, Department of surgery, Yonsei University College of Medicine|Dr. So Yeon Kim|82-2-2227-3642|kimsy326@hanmail.net|
21235975|NCT02159482|Duke University|Dr. Michael Morse|919-681-3480|morse004@mc.duke.edu|
21246222|NCT03617679|University of Colorado Denver|Bradley Robert Corr, MD|303-724-2066|bradley.corr@cuanschutz.edu|
21246223|NCT05093842|West Virginia University|Bethany Barone Gibbs|304-581-1779|behany.gibbs@hsc.wvu.edu|
21246224|NCT05705518|University of California Berkeley Clinical Research Center|Andrew D. Graham|510-643-9252|agraham@berkeley.edu|
21246225|NCT03910478|Fred Hutchinson Cancer Research Center|Michael Boeckh, MD|206-667-6706|mboeckh@fredhutch.org|
21246226|NCT03953417|Stanford University|Principal Investigator|650-736-2233|nbassano@stanford.edu|
21246227|NCT03478956|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21246228|NCT04567238|Duke University School of Medicine|Angela Kirby|9198247729|angela.kirby@duke.edu|
21246229|NCT04800211|Altria|Jeffery Edmiston, Functional Director Clinical Research|8043352366|Jeffery.S.Edmiston@altria.com|
21246230|NCT03643744|Wright State University|Dr. Jeffrey Travers|(937)-245-7500|Jeffrey.Travers@Wright.edu|
21246231|NCT03125070|Fred Hutchinson Cancer Center|Dr. K. Scott Baker|206-667-5594|ksbaker@fredhutch.org|
21246232|NCT02397954|Ophthotech Corp|Keith Westby||Keith.Westby@ophthotech.com|
21246233|NCT04231331|Asan Medical Center|Professor Duk-Hyun Kang|821030103166|dhkang@amc.seoul.kr|
21246234|NCT04032847|Achilles Therapeutics UK Limited|Dr Matilde Saggese|0786 9814607|matildesaggese@gmail.com|
21246235|NCT03056573|Abbott|Angelic Roach, Clinical Program Director|+16517563379|angelic.roach@abbott.com|
21246236|NCT04500613|Hospital for Special Surgery|Marko Popovic|646-797-8948|popovicm@hss.edu|
21246237|NCT03668236|Rigshospitalet, University of Copenhagen|Prof. Anders Perner|+45 35458333|anders.perner@regionh.dk|
21246238|NCT06132282|Texas Christian University|Danica Knight|817-257-4391|d.knight@tcu.edu|
21246239|NCT03936959|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21246240|NCT03748953|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21246241|NCT04858451|Thirty Respiratory Ltd|Inva Hoti, PhD|+44 (0) 1235 431200|Inva.Hoti@30.technology|
21246242|NCT03314454|Northeastern University|Dr. Robert Leeman|6173736501|r.leeman@northeastern.edu|
21246243|NCT04418232|University of Kansas Medical Center|Jaime Perales Puchalt|913-588-3716|jperales@kumc.edu|
21246244|NCT01037881|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
21246245|NCT02841579|Catalan Institute of Oncology, Institut d'Investigació en Ciències, de la Salut Germans Trias i Pujol|Dr. Rafael Rosell|+34 935 543 050|rrosell@iconcologia.net|
21246246|NCT04563546|Duke University|Julian T. Hertz, MD|919-681-0196|julian.hertz@duke.edu|
21246247|NCT03011333|Heron Therapeutics, Inc.|Vice President, Clinical Operations|858-251-7232|svisonneau@herontx.com|
21246248|NCT04233216|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21246249|NCT02998268|Weill Cornell Medicine|Dr. Manish Shah|646-962-6200|mas9313@med.cornell.edu|
21246250|NCT03252847|MeiraGTx|Program Manager|+44 (0)20 3866 4320|ocularinfo@meiragtx.com|
21246251|NCT02895464|Karolinska Institutet|Dr Elisabeth Rydwik|+46852488818|elisabeth.rydwik@ki.se|
21246252|NCT04298983|University of Alabama at Birmingham (UAB)|Andrew McDonald, MD; Principal Investigator|2059345670|ammcdonald@uabmc.edu|
21262203|NCT04146272|Bernafon AG|Barbara Simon|+41 31 998 15 15|bsim@bernafon.com|1664
21262204|NCT01591018|University Hospital Ostrava|David Skoloudik|00420597375630|skoloudik@hotmail.com|
21262205|NCT02238028|Fudan University|Dr. Haidong Kan|+86-021-54237908|kanh@fudan.edu.cn|
21262206|NCT03554005|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21262207|NCT02834052|AUGUSTA UNIVERSITY MEDICAL CENTER|Dr Asha Nayak|7067216748|anayak@augusta.edu|
21262208|NCT02639182|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
21262209|NCT00907881|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21262210|NCT03864237|Brown University School of Public Health|Kate B. Carey|4018636558|kate_carey@brown.edu|
21262211|NCT02546856|Servicio de Cardiologıa, Hospital Universitario Galdakao-Usansolo, OSI Barrualde-Galdakao-Osakidetza, Servicio Vasco de Salud, Galdakao, Bizkaia, Spain .BIOCRUCES, Instituto de Investigacion Sanitaria, Bizkaia, Spain|Juana Oyanguren, Nursing graduate, Master in Heart Failure, CV Pathology and Thrombosis Specialist|34 656780945|juanaoy@hotmail.com|
21262212|NCT01958606|University of Cincinnati|Pierce Boyne|513-558-7499|Pierce.Boyne@uc.edu|
21262213|NCT03132246|University of Maryland School of Medicine|Dr. Aaron Johnson|410-328-1868|ajohnson1@som.umaryland.edu|
21262214|NCT03268746|Alcon Research|Clinical/Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21262215|NCT00589472|Memorial Sloan Kettering Cancer Center|Dr. Susan Slovin|646-422-4470|slovins@mskcc.org|
21262216|NCT01372878|Given Imaging|"Ravit Peled | Biostatistics and Data Management Manager"|+972 (4) 909-7894|ravit.peled@givenimaging.com|7894
21262217|NCT01380093|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21262218|NCT00546351|UCB Clinical Trial Call Center|UCB (Study Director)|1-887-822-9493||
21262219|NCT03626415|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21262220|NCT01530399|TMC|Peter Villiger|+19732906340|peter.villiger@themedco.com|
21262221|NCT04230486|Wake Forest School of Medicine|Huai Jiang, PhD|336-695-6460|jianghuai.ws@gmail.com|
21262222|NCT01839188|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21262223|NCT04983901|The University of M.D. Anderson Cancer Center|Dr. Issam I Raad|713-792-6237|iraad@mdanderson.org|
21262224|NCT02805907|MurciaSalud|Dr. Rubén Andújar-Espinosa|0034669500052|rubemed@hotmail.com|
21262225|NCT02046135|Cohen Children's Medical Center|Dr. James Schneider|7184703330|jschneide2@northwell.edu|
21262226|NCT01933984|Division of Critical Care Medicine, Department of Medicine, Changhua Christian Hospital|Dr. Shin-Hwar Wu|886-4-7238595|126366@cch.org.tw|3971
21280454|NCT01400477|University of Colorado|Dr. Robert Freedman|393 724 1000|robert.freedman@ucdenver.edu|
21246253|NCT00248807|James J Peters VAMC|Dr. Jill M. Wecht; Principal Investigator|718 584-9000|JM.Wecht@va.gov|3122
21246254|NCT02723591|Astellas Pharma Global Development, Inc. (APGD)|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
21246255|NCT04770402|Atrium Health Levine Cancer|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
21246256|NCT02589795|Imperial College London|Research Integrity Officer|020 7594 1872|rgit@imperial.ac.uk|
21246257|NCT02322203|National Heart Lung and Blood Institute (NHLBI)|Marcelo J. Amar, M.D. Principal Investigator, NIH, NHLBI|301.402.0521|mamar@nhlbi.nih.gov|
21246258|NCT03599661|Wake Forest Baptist Comprehensive Cancer Center|Stephanie Bunch|336-716-5180|sbunch@wakeforest.edu|
21246259|NCT04811040|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21246260|NCT01828099|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@Novartis.com|
21246261|NCT04162665|Washington University School of Medicine|Hyun Kim, M.D.|314-362-8502|kim.hyun@wustl.edu|
21246262|NCT05934942|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21246263|NCT05645757|DynPort Vaccine Company, a GDIT Company|George Saviolakis|301-835-4101|George.Saviolakis@gdit.com|
21246264|NCT03905798|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21246265|NCT04826471|Relife Srl|Clinical Trials Coordinator|05556809528|lfabbri@relifecompany.it|
21246266|NCT05764525|Vivozon, Inc.|Chief Medical Officer|609 269 9140|adminus@vivozon.com|
21246267|NCT03334630|Medtronic|Katie Flor, Principal Clinical Research Specialist|+1 763 526 9651|katie.j.flor@medtronic.com|
21246268|NCT05907174|University of Maryland, College Park|Dr. Jessica Magidson|301-405-5095|jmagidso@umd.edu|
21246269|NCT04498390|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21246270|NCT05205460|Tri-service general hospital|Chia-Ying Lai|87923311|pokerface165@gmail.com|13606
21246271|NCT04533737|LEO Pharma A/S|Clinical Disclosure|+45 44 94 58 88|disclosure@leo-pharma.com|
21246272|NCT04089137|Georgia State University|Dr. Amanda Gilmore|(404) 413-2000|agilmore12@gsu.edu|
21246273|NCT04383496|Minneapolis VA Health Care System|Wei Duan-Porter|6124675845|wei.duanporter@va.gov|
21246274|NCT04032041|University of Iowa|Jason M Wilken, PT, PhD|319-335-9791|jason-wilken@uiowa.edu|
21246275|NCT01275677|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
21246276|NCT00207636|DFCI, Harvard|Jennifer Allen|617-632-2269||
21246277|NCT05590728|DynPort Vaccine Company, a GDIT Company|George A. Saviolakis, MD, PhD|301-835-4101|George.Saviolakis@gdit.com|
21246278|NCT03734679|Surmodics|Thu Huyen Ha|952.500.7261|tha@surmodics.com|
21246279|NCT04339101|City of Hope Medical Center|Dr. Ali Haris|626-359-8111|aharis@coh.org|
21246280|NCT06201559|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21246281|NCT00915759|Warfighter Refractive Eye Surgery Program and Research Center at FT Belvoir|Principal Investigator|571-231-1600|dha.belvoir.fbch.mbx.wresp-research@health.mil|
21246282|NCT02733159|Cancer Research UK Clincial Trials Unit, University of Birmingham|PePS2 Trial Coordinator|0121 414 8040|peps2@trials.bham.ac.uk|
21246283|NCT04901078|Kinoxis Therapeutics Pty Ltd|Director of Clinical Operations|+61434360596|tiina.ahveninen@kinoxistherapeutics.com|
21246284|NCT03088878|Oncternal Therapeutics|Mary Breitmeyer|760-703-2802|mbreitmeyer@oncternal.com|
21246285|NCT04690582|The Ohio State University College of Medicine|Dr. Craig Bryan, PsyD, ABPP|614-814-8612|craig.bryan@osumc.edu|
21246286|NCT05104463|CuraSen Therapeutics, Inc|Clinical Trial Information Desk|+1 650 475 2842|clinicaltrials@curasen.com|
21246287|NCT05267470|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21246288|NCT04428203|University of Kentucky|Dr. Zin Myint|8593233964|zin.myint@uky.edu|
21246289|NCT02823145|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21246290|NCT04741776|Dartmouth-Hitchcock Clinic|Fallon Cluxton-Keller, Ph.D.|603-650-4724|Fallon.P.Cluxton-Keller@dartmouth.edu|
21246291|NCT04622774|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
21246292|NCT00957047|Bial - Portela & Cª, S.A.|Head of Clinical Research Section|+ 351 22 986 61 00|clinical.trials@bial.com|
21246293|NCT02852655|Dana-Farber Cancer Institute|Jose R. McFaline Figueroa, MD, PhD|617-632-2166|jose_mcfalinefigueroa@dfci.harvard.edu|
21280455|NCT00811733|GlaxoSmithKline|GSK Response Center|866-435-7343||
21280456|NCT02777372|The Johns Hopkins University School of Medicine|Liisa Hantsoo, Ph.D.|410-502-2334|LHantso1@jh.edu|
21280457|NCT04542057|Verona Pharma plc|Chief Medical Officer|See email|info@veronapharma.com|
21280458|NCT01903798|SCIRE|Executive Director, Southern California Institute for Research and Education|562-826-8000|Sabry.Eassa@va.gov|5747
21280459|NCT02635984|AU Medical Center / University of Georgia College of Pharmacy|Dr. Amber Clemmons, Clinical Pharmacist - BMT/Hematology & Clinical Associate Professor|706-721-6493|aclemmons@augusta.edu|
21280460|NCT01640249|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21280461|NCT00890617|Barbara Ann Karmanos Cancer Institute|Dr. Frank A. Baciewicz|(313) 993-0580|FBaciewi@dmc.org; baciewic@karmanos.org|
21280462|NCT01870778|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21280463|NCT00312338|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21280464|NCT00100828|SKCCC at Johns Hopkins|Arlene Forastiere|410-955-9818|af@jhmi.edu|
21280465|NCT01215136|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-643-5842|jsmith@hoosiercancer.org|41
21280466|NCT03757819|University of Iowa|Thorsten Rudroff|17205323701|thorsten-rudroff@uiowa.edu|
21280467|NCT01125917|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
21280468|NCT05824754|University of Michigan|Inbal Billie Nahum-Shani|7346609626|inbal@umich.edu|
21293970|NCT05253755|Dermbiont Inc|Joanna Jay|415.819.4816|joanna.j@dermbiont.com|
21293971|NCT00943098|IBSA Institut Biochimique|Barbara Gugliotta, Clincial Research Manager|+41 58 360 10 00|barbara.gugliotta@ibsa.ch|
21293972|NCT03122145|Holy Cross Hospital|Lauren Tabor Gray|954 542 3429|lauren.tabor@holy-cross.com|
21293973|NCT00625391|Texas Tech University Health Sciences Center|Dr. Chwan-Li Shen|(806) 743-2815|Leslie.Shen@ttuhsc.edu|
21293974|NCT02016716|Amgen Inc.|Study Director|866-572-6436||
21293975|NCT00079391|NIH National Heart, Lung and Blood Institute|Minocher Battiwalla|301-402-4170|battiwalla@nhlbi.nih.gov|
21293976|NCT03206918|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21293977|NCT00978419|Vanderbilt University Medical Center|Burn Unit Director|(615) 322-4590||
21293978|NCT03479541|Oregon Health and Science University|Dr. Laurie King|5034182602|kingla@ohsu.edu|
21293979|NCT03108521|Department of Pharmacy, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital|Dr. Xingwei Wu and Professor Enwu Long|+8615928017367|wuxw1988@126.com|
21293980|NCT05629312|UZLeuven|Prof. Maria Cadenas|+3216332017|maria.cadenas@uzleuven.be|
21293981|NCT01059357|Wake Forest University Health Sciences|Dr. Joshua Waltonen|3367169068|jwaltone@wakehealth.edu|
21293982|NCT06899737|KDH Research & Communication|Kristen D. Holtz, PhD|4043958711|kholtz@kdhrc.com|
21293983|NCT01308840|University of Rochester|Aram F Hezel|585-275-5823|aram_hezel@urmc.rochester.edu|
21293984|NCT03110029|UAB|Leslie Roop|2059754917|lmroop@uabmc.edu|
21293985|NCT01088295|University of California, Los Angeles|Jordan E. Lake, M.D., M.Sc.|(310)557-1891|jlake@mednet.ucla.edu|
21293986|NCT03281629|Maryland Psychiatric Research Center, University of Maryland School of Medicine|Dr. Xiaoming Du|410 402 6036|xdu@som.umaryland.edu|
21293987|NCT03974932|Heron Therapeutics, Inc.|Clinical Operations|1-800-767-0524|cquaratino-baker@herontx.com|
21293988|NCT01673854|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21293989|NCT00334737|University of New Mexico|Dr. Robin K Ohls|505-272-6753|rohls@salud.unm.edu|
21293990|NCT02316353|CSL Behring|Michelle Hellstern|6102907515|michelle.hellstern@cslbehring.com|
21293991|NCT00375674|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1800718|ClinicalTrials.gov_Inquiries@pfizer.com|1021
21293992|NCT00258908|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21293993|NCT05455580|Hunter-Bellevue School of Nursing, Hunter College, The City University of New York|Tara Heagele, PhD, RN|212-396-7206|th1591@hunter.cuny.edu|
21293994|NCT03224403|JNJWorldwide|Andrew Myers, MD|(215) 273-8421 USA EST|AMyers3@its.jnj.com|
21235976|NCT02753751|Yale University|Francis P. Wilson|2037376095|francis.p.wilson@yale.edu|
21235977|NCT01248884|GlaxoSmithKline|GSK Response Center|866-435-7343||
21235978|NCT00575588|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21235979|NCT01430130|Neodyne Biosciences|Kristin Prosak|650-543-7129|kprosak@neodynebio.com|126
21235980|NCT03525834|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21235981|NCT02703844|University of Kent|David Wilkinson|+44 (0)1227 824772|d.t.wilkinson@kent.ac.uk|
21235982|NCT00801684|Alkermes, Inc.|Bernard L. Silverman, MD|781-609-6000|bernard.silverman@alkermes.com|
21235983|NCT00840970|Intersect ENT|Chris Lewis, VP Clinical Affairs|423-598-6681|clewis@intersectent.com|
21235984|NCT00534352|Tibotec Therapeutics Clinical Affairs, Division of Centocor Ortho Biotech Services, LLC|Vice President, Tibotec Therapeutics Clinical Affairs|877-732-2488||
21235985|NCT03735420|National University of Natural Medicine|Ryan Bradley, ND, MPH|5035521862|rbradley@nunm.edu|
21235986|NCT02187016|Silverstone Research Group|Pejjmon Amini, DMD|702-901-444||
21235987|NCT02059148|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21235988|NCT03321981|Merus N.V.|Executive Director Clinical Trials|+16174014499|USenquiries@merus.nl|
21235989|NCT00877448|BiondVax Pharmaceuticals Ltd.|Tamar Ben-Yedidia, PhD|972-8-9302529|benyedidia@BiondVax.com|
21235990|NCT04689737|Fundació de Lluita contra la SIDA, les Malalties Infeccioses i la Promoció de la Salut i La Ciència|Dr. Jose Molto Marhuenda|+34 934657897|jmolto@lluita.org|
21235991|NCT03067441|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
21235992|NCT02291718|Duke University Medical Center|Dr. Lynne Koweek|919-684-8111|lynne.koweek@duke.edu|
21235993|NCT04289753|Northwestern University|Stephen D. Persell, MD, MPH, FACP|3125036464|spersell@nm.org|
21235994|NCT02096055|The University of Texas MD Anderson Cancer Center|Hagop Kantarjian, MD/Chair|713-792-7026|hkantarjian@mdanderson.org|
21235995|NCT01242527|AstraZeneca Pharmaceuticals|Torbjörn Lundström, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21235996|NCT03373591|Montefiore Medical Center|Diego Camacho, MD|718-920-4800|dicamach@montefiore.org|
21235997|NCT01785602|Novartis|Study Director|862-778-8300||
21235998|NCT03127228|University of Michigan|Dr. Chin-Wei Wang|734-763-2105|jeffwa@umich.edu|
21235999|NCT02041429|Dana-Farber Cancer Institute|Beth Overmoyer, MD|617.632.380|Beth_Overmoyer@DFCI.HARVARD.EDU|
21236000|NCT03251924|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21236001|NCT00153101|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21236002|NCT03169153|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21236003|NCT00439777|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21236004|NCT00784043|MED-EL Corporation|Jennifer Bulls|1-888-633-3524|research.us@medel.com|
21236005|NCT03424681|Mind Research Network|Dr. Claire Wilcox|5052725028|cwilcox@mrn.org|
21236006|NCT01175226|Aviragen Therapeutics, Inc.|Anna Novotney-Barry|678-221-3356|abarry@aviragentherapeutics.com|
21236007|NCT02678039|Dartmouth-Hitchcock|Mark P. Yeager, MD|603-650-5922|mark.p.yeager@hitchcock.org|
21236008|NCT03791398|BrUOG|Brown University Oncology Research Group|401-863-3000|BrUOG@Brown.edu|
21236009|NCT02207829|GlaxoSmithKline|GSK Response Center|866-435-7343||
21236010|NCT01418209|Brigham and Women's Hospital|Hadine Joffe, MD, MSc|617-732-4906|hjoffe@partners.org|
21293995|NCT01271010|Hoffmann-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21246294|NCT04168580|AdventHealth Translational Research Institute|Paul M. coen, PhD., Associate Investigator|765-426-9743|paul.coen@adventhealth.com|
21246295|NCT00462696|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
21246296|NCT03257410|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
21246297|NCT02598388|Janssen Vaccines & Prevention B.V.|MEDICAL LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21246298|NCT03069924|Medical University of South Carolina|Dr. Benjamin Toll|843-876-1132|toll@musc.edu|
21246299|NCT05256017|Drugs for Neglected Disease initiative (DNDi)|Dr Junior Matanglia|+243 970 756 890|jmatangila@dndi.org|
21246300|NCT04171141|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21246301|NCT03663569|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21246302|NCT04979442|Rain Oncology|Clinical Research|7082323791|clinicalresearch@rainoncology.com|
21246303|NCT04506307|Zeltiq Aesthetics|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
21246304|NCT04005794|Vanderbilt University|Dr. Sohee Park, Professor of Psychology and the principal investigator|615 322 3435|sohee.park@vanderbilt.edu|
21246305|NCT03287336|GW University|Homa K. Ahmadzia|2027412500|homa.khorrami@gmail.com|
21246306|NCT00104676|Unicancer|Deputy Director R&D|(+33)1 44 23 04 19|b-juzyna@unicancer.fr|
21246307|NCT05622812|Q-Med AB|Head of Development|1-817-961-5000|reception.seupp@galderma.com|
21246308|NCT02116530|Indiana University School of Medicine South Bend|Rudolph M. Navari, MD, PhD, FACP|574-252-7225|rmnavari@gmail.com|
21246309|NCT02927236|National Institute on Drug Abuse (NIDA)|Yihong Yang, PhD|443-740-2648|yihong.yang@nih.gov|
21246310|NCT05297565|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
21246311|NCT01959607|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|clinicaltrials.pmi@pmi.com|
21246312|NCT03913442|NYU Langone Health|Michael H Pillinger, MD, FACP|646-501-2722|Michael.Pillinger@nyulangone.org|
21246313|NCT03162783|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
21246314|NCT02433379|Boston Scientific|Paji Vitoff, Manager, Clinical Trials|651-582-5415|Paji.Vitoff@bsci.com|
21246315|NCT03952338|University of Calgary|Dr. Dana Lee Olstad|403-210-8673|dana.olstad@ucalgary.ca|
21246316|NCT03710603|Stichting European Myeloma Network (EMN)|Sarah Lonergan|+31 10 268 70 65|sarah.lonergan@emn.life|
21246317|NCT03691935|Milton S. Hershey Medical Center|Urology Research Operations Manager|717-531-0003|UrologyResearch@pennstatehealth.psu.edu|287502
21246318|NCT05446129|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
21246319|NCT03512327|Scripps Clinic|Dr. Gauree Konijeti|8585548880|konijeti.gauree@scrippshealth.org|
21246320|NCT06258174|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
21246321|NCT01946789|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
21246322|NCT04707625|Wake Forest University Health Sciences|Mark Nelson, MD|336.713.1680|mhnelson@wakehealth.edu|
21246323|NCT00321048|Indiana University|Richard Zellars|3179444505|rzellars@iu.edu|
21246324|NCT06473662|Diabetology Ltd|Roger New|07818068012|rn@diabetology.co.uk|
21246325|NCT02398656|University of Calgary|Dr. Shelagh Coutts|4039444286|scoutts@ucalgary.ca|
21246326|NCT05485779|AQILION AB|Anneli Tinnerholm|+46 730 88 14 15|anneli.tinnerholm@aqilion.com|
21246327|NCT02038777|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21246328|NCT04299464|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21246329|NCT03138603|University of Chicago Medicine|Peter Nagele, MD, MSc|773-795-3544|pnagele@uchicagomedicine.org|
21246330|NCT03030261|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8323|rvij@wustl.edu|
21280469|NCT02015611|Wake Forest University School of Medicine|Dr. Denise Houston|336-713-8217|dhouston@wakehealth.edu|
21280470|NCT04421131|Duke University|Lavanya Vasudevan, Ph.D.|919-613-1423|lavanya.vasudevan@duke.edu|
21280471|NCT02308124|SNUH|Jung-Ick Byun|+8224406254|mr830611@gmail.com|
21280472|NCT00708110|ViiV Healthcare|GSK Response Center|866-435-7343||
21280473|NCT02501928|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21280474|NCT00858494|University of Washington|James A Taylor|206-616-1206|uncjat@uw.edu|
21280475|NCT01526057|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21280476|NCT02553772|Allergan, Inc|Therapeutic Area Head,|1-877-277-8566|IR-CTRegistration@allergan.com|
21280477|NCT02435524|London School of Hygiene & Tropical Medicine|Dr Veronique Filippi|+44 (0)20 7927 2874|veronique.filippi@lshtm.ac.uk|
21280478|NCT02189837|Amgen Inc.|Study Director|866-572-6436||
21280479|NCT02421055|Imperial College London|Dr Nicholas Penney|020 7589 5111|n.penney@imperial.ac.uk|
21280480|NCT03417687|Polarean|Laura Sutton|919-206-7900|lsutton@polarean.com|121
21280481|NCT01808573|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|424-248-6500|clinicaltrials@pumabiotechnology.com|
21280482|NCT03953612|Yale School of Medicine|Verica Milivojevic, PhD|203-737-5201|verica.milivojevic@yale.edu|
21280483|NCT03220854|Virginia Commonwealth University Massey Cancer Center|Alfredo I Urdaneta|(804) 828-0450|MasseyRadOnc@vcu.edu|
21280484|NCT01682811|Medical College of Wisconsin|Harry T. Whelan MD, Bleser Professor of Neurology|414-266-7544|hwhelan@mcw.edu|
21280485|NCT04358081|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
21280486|NCT06379048|Çam and Sakura City Hospital|Dr. Emre Kar|+90 (0212) 909 60 00|emre.kar@sbu.edu.tr|11250
21280487|NCT00696423|GlaxoSmithKline|GSK Response Center|866-435-7343||
21280488|NCT03989102|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Patrick E. Duffy|301.761.5089|patrick.duffy@nih.gov|
21293996|NCT01631747|Northwestern University|Mary J. Kwasny|312-503-2294|m-kwasny@northwestern.edu|
21246331|NCT05299242|University of Oxford|Prof. Sally Hopewell|+441865223458|sally.hopewell@csm.ox.ac.uk|
21246332|NCT04777721|University of Oxford|Professor Helen McShane|01865 617606|helen.mcshane@ndm.ox.ac.uk|
21246333|NCT05293171|BioLineRx Ltd|VP Clinical & Medical Affairs|+972-8-6429100|clinicaltrials@biolinerx.com|
21246334|NCT04066205|University of Washington|Teresa Ward, Professor, Department of Pediatrics|206-884-1439|teresa.ward@seattlechildrens.org|
21246335|NCT02052882|Memorial Sloan Kettering Cancer Center|Dr. Cy Wilkins, MD|646-608-3720|wilkinsc@mskcc.org|
21246336|NCT02641639|Mateon Therapeutics Inc|CEO|(650) 635-7000|ir@oncotelic.com|
21246337|NCT06415292|Sun Pharmaceutical Industries Limited|Head-Regulatory Affairs|2266455645|Clinical.Trial@sunpharma.com|5689
21246338|NCT03987022|Metrohealth System|Dr. Robert Pollard|2167781446|rpollard@metrohealth.org|
21246339|NCT05012683|Point Designs|Director of Clinical Research|7206004753|research@pointdesignsllc.com|
21246340|NCT05170841|A Menarini Industrie Farmaceutiche Riunite SrL|Corporate Medical Affair and Clinical Operation Director|+39 055 5680459|pfabrizzi@menarini.it|
21246341|NCT05233800|MedStar Health Research Institute|Hannah Arem, Scientific Director, Implementation Science|2028932430|hannah.arem@medstar.net|
21246342|NCT05123586|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21246343|NCT04487860|Aché Laboratórios Farmacêuticos S.A|Dr. Fabio Ikedo|55 11 26086933|fabio.ikedo@ache.com.br|
21246344|NCT04036253|Biosidus S.A.U.|Director of Clinical Trials|+541149098044|v.berstein@biosidus.com.ar|
21246345|NCT02432261|Health Decisions|Kimberly Myer|9842381297|Kimberly.Myer@premier-research.com|
21246346|NCT06085547|Michigan State University|Dr. Todd Lucas|810-600-5629|lucastod@msu.edu|
21246347|NCT05546385|Rehaler A/S|Troels Johansen|004540977313|tj@rehaler.com|
21246348|NCT06122194|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21246349|NCT05218096|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
21246350|NCT05841004|Coloplast A/S|Christian Riis Forman, Medical writer|49111756|dkcrif@coloplast.com|
21246351|NCT05193409|Bionomics Limited|SVP Clinical Development|+61 8 8150 7400|BNC210clinicalstudies@bionomics.com.au|
21246352|NCT04726371|The Mongan Institute at Massachusetts General Hospital|Dr. Stephen Bartels|617-726-5213|sjbartels@mgh.harvard.edu|
21246353|NCT05863156|Uskudar Univercity|Tugba YILMAZ ESENCAN|05057084946|tugba.yilmazesencan@uskudar.edu.tr|
21246354|NCT03362476|New York University|Ralph J DiClemente|+1 (212) 992-3709|rjd438@nyu.edu|
21246355|NCT05216406|Nova Southeastern University|Dr. Jose Antonio|(954) 262-8140|Jose.Antonio@nova.edu|
21262227|NCT02544984|The University of Texas Health Science Center at Houston|Ricardo A. Mosquera, MD|(713) 500-5650|Ricardo.A.Mosquera@uth.tmc.edu|
21262228|NCT01022853|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21280489|NCT01321749|XuanWu Hospital, Capital Medical University|Xunming Ji, M.D.,Ph.D.|8683198127|jixm70@hotmail.com , Jixm@ccmu.edu.cn|
21280490|NCT04179838|Northwestern University|Thorsten Kahnt|3125032896|thorsten.kahnt@northwestern.edu|
21280491|NCT03411031|Moffitt Cancer Center|Dr. Melissa Alsina|813-745-7202|Melissa.Alsina@moffitt.org|
21280492|NCT02826486|BioLineRx Ltd|VP Clinical & Medical Affairs|+972-8-642-9100|clinicaltrials@biolinerx.com|
21280493|NCT02760004|UMass Chan Medical School / UMass Memorial Health|Nancy Byatt, Tenured Professor of Psychiatry, ObGyn, and Population & Quantitative Health Sciences|508.856.5812|Nancy.Byatt@umassmemorial.org|
21280494|NCT00970593|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21280495|NCT01561716|University of Rochester|Dr. Isabel D Fernandez|585-275-9554|Diana_Fernandez@URMC.Rochester.edu|
21280496|NCT02439216|Astria Therapeutics, Inc|Andrew Nichols, PhD - Chief Scientific Officer|617-349-1971|anichols@astriatx.com|
21280497|NCT00200902|Laboratory of Brain, Behavior, and Pharmacology at the University of California Los Angeles|Andrew Leuchter, MD|310-825-0207|jpv@brain.ucla.edu|
21280498|NCT00470535|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21236011|NCT00101101|H. Lee Moffitt Cancer Center and Research Institute|Sophie Dessureault, M.D., Ph.D.|813-745-1965|sophie.dessureault@moffitt.org|
21236012|NCT01800903|Coloplast A/S|Trine Møller Senior Clinical Manager|+45 4911 2174|dktrm@coloplast.com|
21236013|NCT04382612|Edwards Lifesciences, LLC|Sabrina Hundt, Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Sabrina_Hundt@edwards.com|
21236014|NCT03390907|Penn State Milton S. Hershey Medical Center|Dr. John Levenick|717-531-3834|jlevenick@pennstatehealth.psu.edu|
21236015|NCT01328002|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21236016|NCT01578551|Johns Hopkins University|David Ettinger, MD|410-955-8847|ettinda@Jhmi.edu|
21236017|NCT00389818|AMC|Ronald Mitsuyasu, MD|310-557-1803|rmitsuya@mednet.ucla.edu|
21236018|NCT03117387|LUMC|Maarten Honing|+31715264038|g.h.m.honing@lumc.nl|
21236019|NCT05955560|Becton, Dickinson & Company|Director of Clinical Affairs|551-225-1164|kirsten.hammitt@bd.com|
21236020|NCT00527566|National Jewish Health|Michael Wechsler|617-285-4987|wechslerm@NJHealth.org|
21236021|NCT00074282|ECOG-ACRIN Statistical Office|Study Statistician|617 632 3012|eatrials@jimmy.harvard.edu|
21236022|NCT00464542|University of Pittsburgh|Thomas Cherpes|412 692 5930|cherpestl@upmc.edu|
21236023|NCT01319396|ResMed|Paul Phillips|+353 1 716 3755|paul.phillips@resmed.com|
21236024|NCT01773226|Zimmer Biomet|Linda Korthout, Scientific Affairs Specialist|+31.610.072.853|Linda.Korthout.external@zimmerbiomet.com|
21236025|NCT02055352|Novartis Pharmaceuticals|Study Director|862-778-8300||
21236026|NCT01763567|Medtronic, Inc.|Julie Sekella|818-576-5000|Julie.Sekella@medtronic.com|
21236027|NCT00272168|VA Central Office|Wendy Tenhula, Ph.D.|202-461-4167|Wendy.Tenhula@va.gov|
21236028|NCT02105116|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu|
21236029|NCT01230593|Icahn School of Medicine at Mount Sinai|Albert Wu MD PhD|2125184524|albert.wu@mssm.edu|
21236030|NCT01138124|GlaxoSmithKline|GSK Response Center|866-435-7343||
21236031|NCT01075321|Mayo Clinic|Craig B. Reeder MD|480.301.8000|Reeder.Craig@mayo.edu|
21246356|NCT03617445|University of Wisconsin-Madison|Dr. Nasia Safdar|608-263-1545|ns2@medicine.wisc.edu|
21246357|NCT04270942|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
21246358|NCT06357169|University of Minnesota|Ronda Farah|(612) 625-8625|rfarah@umn.edu|
21246359|NCT06081309|Wave Neuroscience, Inc.|Bill Phillips|714-883-7890|bill@waveneuro.com|
21246360|NCT04386057|Dana-Farber Cancer Institute|Dr. Kimberly Perez, MD|617-632-5370|Kimberly_Perez@DFCI.HARVARD.EDU|
21246361|NCT01236781|American College of Radiology|Director Clinical Research Administration|215-574-3150|info@acr.org|
21262229|NCT00532883|NHLBI|Harvey Luksenburg|301-435-0050|luksenburgh@mail.nih.gov|
21262230|NCT01985685|Beth Israel Deaconess Medical Center|Dr. Katherine Berg|617-667-5864||
21262231|NCT01214434|Promius Pharma, LLC|Medical Information Center|888 966-8766|product-complaints@promiuspharma.com|
21262232|NCT03100435|Tufts University|Robert Gyurko|6176366531|robert.gyurko@tufts.edu|
21262233|NCT02075255|AstraZeneca|Mitchell Goldman, Global Clinical Lead Benralizumab|+1 301 398 0323|Mitchell.Goldman@astrazeneca.com|
21262234|NCT03792750|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21262235|NCT01651052|Edwards Lifesciences, LLC|Mary Edwards, VP Clinical and Regulatory Affairs, Surgical Structural Heart|949-250-2500|mary_edwards@edwards.com|1536
21262236|NCT03503773|Ablative Solutions Inc|Kate Rumrill, CEO|1 650-688-9743|krumrill@ablativesolutions.com|
21262237|NCT00607828|University of Nebraska Medical Center|Chi Lin|402-552-3844|clin@unmc.edu|
21262238|NCT00425438|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21262239|NCT02902809|AstraZeneca|Global Clinical Lead|+1 301-398-0582|ClinicalTrialTransparency@astrazeneca.com|
21262240|NCT00532259|CureTech Ltd.|Director Clinical Resaerch|+972-8-9324000|talh@curetechbio.com|
21262241|NCT01188798|St. Jude Children's Research Hospital|Asha Pillai, MD|1-866-278-5833|info@stjude.org|
21262242|NCT02795767|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21262243|NCT03964415|Janssen Vaccines & Prevention B.V.|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21262244|NCT01016483|Merck Serono, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+496151725200|service@merckgroup.com|
21262245|NCT01097330|Population Health Research Institute|Dr. Carlos Morillo|905-527-4322|Carlos.Morillo@phri.ca|40311
21262246|NCT04983940|University of Miami, Miller School of Medicine - Desai Sethi Urology Institute|Dr. Ranjth Ramasamy|305-243-6596|Ramasamy@miami.edu|
21262247|NCT05848245|King Abdulaziz University|Dr. Zuhair Natto|9666943899|znatto@kau.edu.sa|
21262248|NCT04156646|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21262249|NCT04963179|Womed|Director of Clinical Affairs|0785225561|pauline@womedtech.com|+33
21262250|NCT05270694|MaineHealth Institute for Research|Dr. Kathleen Fairfield|207-661-7614|kathleen.fairfield@mainehealth.org|
21262251|NCT05047640|University of Miami|Giselle Guerra|3053555803|gguerra@med.miami.edu|
21262252|NCT02383719|Convergent Engineering|Study Coordinator|3523784899|carl@conveng.com|113
21262253|NCT01834326|University of Michigan|Stephen E. Feinberg|734 763 5963|sefein@med.umich.edu|
21262254|NCT02057237|Princess Margaret Cancer Centre|Dr. Anthony Joshua|416-946-4501|anthony.joshua@uhn.ca|2520
21262255|NCT02345434|Columbia University|Adam Sacarny|212 305 7084|ajs2102@columbia.edu|
21262256|NCT02064439|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21262257|NCT02433288|AstraZeneca|Traxler, Barry M|+1 301 398 0657|barry.traxler@astrazeneca.com|
21262258|NCT02615535|Spaulding Rehabilitation Hospital|Dr. Ginger Polich|617 952 5000|ginger.polich@mgh.harvard.edu|
21262259|NCT00858702|Daiichi Sankyo|Howard Kessler|732-590-5032|hmkessler@dsi.com|
21262260|NCT00367640|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
21262261|NCT02417233|University of California San Francisco|Dr. Sheri Lippman|415-476-6319|sheri.lippman@ucsf.edu|
21262262|NCT02409784|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
21262263|NCT01063751|Stryker - Joint Replacement|Filesha Haniff / Clinical Study Manager|1 470.528.9214|filesha.haniff@stryker.com|
21262264|NCT00614666|University of Arizona|Dr. John Galgiani|(520) 626-4968|spherule@email.arizona.edu|
21262265|NCT00062738|UMDNJ - RWJMS|Matthew Menza, MD|732-235-4440|menza@umdnj.edu|
21262266|NCT01842464|Western Galilee MC|Menahem Neuman|+972546444033|mneuman@netvision.net.il|
21262267|NCT01600131|Veterans Health Administration|Constance Uphold|352-548-6000|connie.uphold@va.gov|106893
21262268|NCT00114114|Massachusetts General Hospital|Dr. Ben Leder|617-726-6723|bzleder@partners.org|
21262269|NCT02519244|The University of Texas Health Science Center at Houston|Shuo-Hsiu Chang, PT, PhD|713-799-7016|shuo-hsiu.chang@uth.tmc.edu|
21262270|NCT02487745|Johns Hopkins University School of Medicine|Kenneth Silverman|4105502694|ksilverm@jhmi.edu|
21262271|NCT01671488|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
21280499|NCT02094300|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|765-463-7537|SSnyder@medinst.com|
21280500|NCT01111318|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21280501|NCT04123405|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21280502|NCT01050530|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
21280503|NCT00545714|Hoffmann-La Roche|Medical Communications|800--821--8590|global-roche-genentech-trials@gene.com|
21280504|NCT04004481|University hospital Osijek|Nenad Neskovic|+385996787250|nneskov@gmail.com|
21280505|NCT03889886|SilkTech Biopharmaceuticals|Brian Lawrence|6172720691|brianlawrence@silk-tech.com|
21280506|NCT00276484|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21246362|NCT02709161|University of Pittsburgh|Kymberly Young|4126486179|youngk@pitt.edu|
21262272|NCT02416908|Washington University School of Medicine|Geoffrey Uy, M.D.|314-747-8439|guy@wustl.edu|
21246363|NCT05167864|University of Pennsylvania|Dr. Ivona Percec, PhD, MD|215-662-7300|ivona.percec@pennmedicine.upenn.edu|
21246364|NCT04028284|Sunnybrook Health Sciences Centre|Dr. Fahad Alam|416-480-4864|fahad.alam@sunnybrook.ca|
21246365|NCT04059185|Boston College School of Social Work|Catherine Taylor, PhD, LCSW, MPH|(617) 552-4033|catherine.taylor.2@bc.edu|
21246366|NCT05229822|NJSC KARAGANDA MEDICAL UNIVERSITY|Dr. Yermek Turguov|+77016119655|Turgunov@qmu.kz|
21246367|NCT04707326|ErasmusMC|Dr. Casper Rokx|+310107040704|c.rokx@erasmusmc.nl|
21246368|NCT03526887|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
21246369|NCT03916185|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
21246370|NCT03766685|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21246371|NCT04676165|McGill University|Bettina Habib, Research Project Manager|514-396-1156|bettina.habib@mcgill.ca|
21246372|NCT05593900|University of California Davis|Jennifer Rosenthal|9167344719|rosenthal@ucdavis.edu|
21246373|NCT06214559|Eurofins Dermscan Pharmascan|Project Manager|+33 (0)4 72 82 36 56|manon.laune@cpt.eurofinseu.com|
21246374|NCT02844465|MedtronicNeuro|Clinical Study Manager|(877) 590-7835|rs.slatestudy@medtronic.com|
21246375|NCT04228042|M D Anderson Cancer Center|Mehrad Adibi, MD|713-563-7458|mllozano@mdanderson.org|
21246376|NCT05029622|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
21246377|NCT06232590|CooperVision Inc.|José A. Vega|+1 (925) 621-3761|JVega2@coopervision.com|
21246378|NCT05299723|Columbia University Irving Medical Center|Ari Shechter|212-342-1335|as4874@cumc.columbia.edu|
21246379|NCT02460458|Hematology and Transfusion Medicine, L. Sacco University Hospital, University of Milan, Via G. B. Grassi, 74 20157 Milan, Italy|Prof. Augusto B. Federici|+39-0250319895|augusto.federici@unimi.it|
21246380|NCT05299073|mAbxience Research S.L.U.|Susan Millan PhD|+34 917711500|susana.millan@mabxience.com|
21246381|NCT00592852|Massachusetts General Hospital|Gagan Joshi, MD|617-503-1084|joshi.gagan@mgh.harvard.edu|
21246382|NCT04197310|Dana Farber Cancer Institute|Dr. Kimberly Perez|617-632-5960|Kimberly_Perez@DFCI.HARVARD.EDU|
21246383|NCT03725384|Sunnybrook Health Sciences Centre|Dr. Yulia Lin|4164804042|yulia.lin@sunnybrook.ca|
21246384|NCT02505984|Massachusetts General Hospital|Dr. Sharon Dekel|617-726-1352|sdekel@mgh.harvard.edu|
21246385|NCT03709121|Aldeyra Therapeutics, Inc.|VP, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
21246386|NCT04176601|University of Rochester|Dr. Kim Van Orden|585-275-5176|kimberly_vanorden@urmc.rochester.edu|
21246387|NCT02317887|VegaVect, Inc.|Dr. Rob Lin|412-560-9760|r.lin@avistatx.com|
21246388|NCT03511664|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21246389|NCT03859635|Indiana University Department of Anesthesiology|Yar Luan Yeap, MD|3172740275|yyeap@iu.edu|
21246390|NCT04362254|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
21246391|NCT04076618|Wake Forest University School of Medicine|Kristen Beavers, PhD, MPH, RD|336-758-5855|kbeavers@wakehealth.edu|
21246392|NCT01928394|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21246393|NCT03916276|The University of Queensland|Dr. Melissa Day, Co-Principal Investigator|+61 7 3365 6421|m.day@uq.edu.au|
21280507|NCT03901313|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21246394|NCT03209973|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21246395|NCT03528928|Womens Health|Teresa Brousseau|866-432-4400|tbrousseau@isapin.com|
21246396|NCT03806790|LEO Pharma A/S|Clinical disclosure|+4544945888|disclosure@leo-pharma.com|
21246397|NCT00291525|Artivion|Clinical Project Manager (Yael Goode)|8454800137|Yael.Goode@Artivion.com|
21246398|NCT05987813|Virginia Commonwealth University|Gisela Chelimsky|804-628-5882|gisela.chelimsky@vcuhealth.org|
21246399|NCT02240238|NANO MRNA Co.,Ltd.|NANO MRNA Clinical Info Admin|+81 (0)3-6432-4792|clinical.info@nanomrna.co.jp|
21246400|NCT02657005|Oncternal Therapeutics|Mary Breitmeyer|858-434-1113|clinical@oncternal.com|
21246401|NCT02724969|University of Pittsburgh|Jill R. Demirci, PhD, RN, IBCLC|412-648-9236|jvr5@pitt.edu|
21246402|NCT01346540|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21246403|NCT05679908|Tonix Pharmaceuticals|Gregory Sullivan|(862) 904-0355|greg.sullivan@tonixpharma.com|
21246404|NCT04797195|Massachusetts General Hospital Center for Global Health|Katharine Morley, MD|617-726-2000|kemorley@mgh.harvard.edu|
21246405|NCT03221309|Institute of Human Virology, University of Maryland School of Medicine|Dr. Elana Rosenthal / Associate Professor|2403674157|erosenthal@ihv.umaryland.edu|
21246406|NCT04577963|HUTCHMED International, Inc.|William Schelman, MD, PhD, Senior Vice President, Clinical Development, US/Europe|+1 9733064490|williams@hutch-med.com|
21246407|NCT02112526|Acerta Pharma LLC|Study Director|1-888-292-9613|acertamc@dlss.com|
21280508|NCT01608100|Abbott Diagnostics Division|Karla Grasso, Clinical Research Manager|1 224-667-5602|karla.grasso@abbott.com|
21280509|NCT02423200|EIP Pharma|John Alam|617-945-0794|jalam@eippharma.com|
21280510|NCT04937881|UCLA|Dvora Joseph Davey|3107011526|dvoradavey@ucla.edu|
21280511|NCT04055740|University of Chicago|Dr. Andrew Beaser|(888) 824-0200|abeaser@bsd.uchicago.edu|
21280512|NCT01277783|Medtronic Bakken Research Center B.V.|Mireille van Ginneken, Principal Clinical Research Specialist|+31433566801|mireille.vanginneken@medronic.com|
21280513|NCT03347110|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
21280514|NCT00116779|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
21280515|NCT00707239|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21280516|NCT01778530|National Cancer Institute|Dr. Joohee Sul|301-402-6298|Joohee_Sul@nih.gov|
21280517|NCT03472014|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
21280518|NCT00711087|Baylor College of Medicine|Christopher P. Smith, MD, MBA, MSS|713-798-7498|cps@bcm.edu|
21280519|NCT01958437|VA Ann Arbor Healthcare System; University of Michigan|Dr. Benjamin Hampstead|7347639259|bhampste@med.umich.edu|
21280520|NCT01936844|Virginia Commonwealth University|Benjamin Van Tassell, PharmD|8048284583|bvantassell@vcu.edu|
21246408|NCT00866684|Charité Universitätsmedizin Berlin Augustenburger Platz 1 13353 Berlin|Prof. Dr. Petra Reinke|+49 30 450 653 490|petra.reinke@charite.de|
21246409|NCT05121441|Aardvark Therapeutics, Inc.|Manasi Jaiman MD, MPH, Chief Medical Officer|(858) 225-7696|MJaiman@aardvarktherapeutics.com|
21246410|NCT04862416|Radboud university medical center|Dr. Matthew McCall|+31 24 361 43 56|Matthew.McCall@radboudumc.nl|
21246411|NCT00746096|Nobelpharma|Department director of clinical development department 1|+81-3-5651-1177|murakami@nobelpharma.co.jp|
21246412|NCT05207982|University at Buffalo, Department of Psychiatry|Daniel Antonius|7168582792|danielan@buffalo.edu|
21246413|NCT04295512|San Diego State University|Kelsey Dickson|(619) 594-5380|kdickson@sdsu.edu|q
21246414|NCT03728608|University of Florida|Leslie Parker|352 273 6384|parkela@ufl.edu|
21246415|NCT02329262|The Ohio State University Martha S. Pitzer Center for Women, Children and Youth|Principal Investigator|16142924578|smith.5764@osu.edu|
21246416|NCT05207956|University of Pennsylvania|Dr. David Mandell|(215) 573 7494|david.mandell@pennmedicine.upenn.edu|
21246417|NCT04243070|BIOTRONIK SE & Co. KG|Senior Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
21246418|NCT01009788|Massachusetts General Hospital|Steven Isakoff, MD, PhD|617-835-2285|SISAKOFF@mgh.harvard.edu|
21246419|NCT04587453|Leo Pharma A/S|Clinical Disclosure|+45 4494 5888|disclosure@leo-pharma.com|
21246420|NCT03571581|The Miriam Hospital|Elena Salmoirago-Blotcher|401-793-8325|Elena_Salmoirago_Blotcher@brown.edu|
21246421|NCT02800356|San Raffaele Hospital|Prof. Giuseppe Querques|00390226434004|querques.giuseppe@hsr.it|
21246422|NCT03283722|Medtronic|Jenell Lorenz, Sr. Clinical Research Specialist|651-269-4768|jenell.m.lorenz@medtronic.com|
21246423|NCT04737330|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21246424|NCT04884308|Johns Hopkins University|Noah Lechtzin|410-502-7044|nlechtz@jhmi.edu|4102994561
21246425|NCT03295721|Heron Therapeutics, Inc.|Vice President, Clinical Operations|855-251-7232|svisonneau@herontx.com|
21246426|NCT02795858|Dana-Farber Cancer Institute|Dr. Jennifer Chan, MD|617-632-6315|jennifer_chan@dfci.harvard.edu|
21246427|NCT01651403|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21246428|NCT05090683|University of the Fraser Valley|Dr. Cynthia Thomson|6045047441|cynthia.thomson@ufv.ca|2518
21246429|NCT03325985|NYU Langone Health|Keith Goldfeld|(212) 263-5550|Keith.Goldfeld@nyulangone.org|
21246430|NCT03213665|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21246431|NCT03034356|VA Eastern Colorado Health Care System|Jason Tregellas, PhD|303-724-6232|jason.tregellas@va.gov|
21246432|NCT02684227|MD Anderson Cancer Center|Shannon Westin, MD|713-794-4314|swestin@mdanderson.org|
21246433|NCT04070573|Weill Cornell Medicine|Dr Line Malha|6469622606|lim9120@med.cornell.edu|
21246434|NCT05292391|Kaiser Permanente Washington Health Research Institute|Lisa A. Jackson, MD, MPH|(206)-442-5216|Lisa.A.Jackson@kp.org|
21246435|NCT00636389|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
21246436|NCT03221426|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21246437|NCT05098158|Washington State University|Marian Wilson|509-324-7443|marian.wilson@wsu.edu|
21246438|NCT03711734|Hospital for Special Surgery|Dr. Stephanie Cheng|212-606-1206|chengs@hss.edu|1206
21246439|NCT05671653|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21246440|NCT03812549|West China Hospital, Sichuan University|Prof. You Lu|13398179653|radyoulu@hotmail.com|
21246441|NCT01197378|Horizon Pharma USA, Inc.|Evelyn Olson|224-383-3000|clinicaltrials@horizonpharma.com|
21246442|NCT03828799|Institut régional du Cancer de Montpellier|Representative of sponsor|467612446|aurore.moussion@icm.unicancer.fr|+33
21246443|NCT03744182|Hanmi Pharmaceutical Co., Ltd.|GAEUN PARK|+824108746|gaeun.park@hanmi.co.kr|8746
21246444|NCT03374241|HanmiPharma|khseo@hanmi.co.kr|+82 2 410 9042|khseo@hanmi.co.kr|
21246445|NCT04942613|University of Colorado Denver, Anschutz Medical Campus|Dr. Jennifer Stevens-Lapsley|303.724.9170|jennifer.stevens-lapsley@cuanschutz.edu|
21246446|NCT05274074|University of Rochester|Dr. Benzi M. Kluger|5852754259|benzi_kluger@urmc.rochester.edu|
21246447|NCT04117347|University of Michigan|Dr. Helen Burgess|734-615-8303|bhelen@med.umich.edu|
21246448|NCT03687086|University of California, Los Angeles and VA Greater Los Angeles Healthcare System|Dr. Constance Fung|818 891-7711|Constance.Fung@va.gov|39311
21246449|NCT05194956|University Hospitals of Derby and Burton NHS Trust|Mrs Trishna Patel|01332340131|trishnaanil.patel@nhs.net|83556
21246450|NCT02593773|Horizon Pharma Ireland, Ltd, Dublin Ireland|Julie Ball, Executive Director, Clinical Development & Operations|(224) 383-3000|clinicaltrials@horizonpharma.com|
21246451|NCT04294641|National Cancer Institute|Dr. Steven Z. Pavletic|240-760-6174|sp326h@nih.gov|
21246452|NCT01627574|University of Rhode Island|Dr. Lynda Stein, Ph.D.|401-874-2830|lmurphy@uri.edu|
21246453|NCT03397706|Viracta Therapeutics|Medical Director|858-400-8470|ClinicalTrials@Viracta.com|
21246454|NCT03249090|University of North Carolina at Chapel Hill|Principal Investigator|9194456223|symptom_study@unc.edu|
21246455|NCT04200911|UT Health San Antonio|Mitzi Gonzales, PhD|210-450-9047|Gonzalesm20@uthscsa.edu|
21246456|NCT05163496|University of Washington|Anthony Back MD|2066194367|tonyback@uw.edu|
21246457|NCT04314778|University of Pennsylvania|S. Ryan Greysen, MD (Principal Investigator)|215-614-0095|Ryan.Greysen@pennmedicine.upenn.edu|
21246458|NCT05646355|NYU Langone Health|Aasma Shaukat|6465012906|Aasma.Shaukat@nyulangone.org|
21246459|NCT03523572|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21246460|NCT04685135|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21246461|NCT04134208|The University of Texas M D Anderson Cancer Center|Dr. Gregory Ravizzini|(713) 518-9866|gravizzini@mdanderson.org|
21246462|NCT05061069|Ghent University|Prof. Dr. Leen Maes|093324066|leen.maes@ugent.be|+32
21262273|NCT03799718|Brainstorm Cell therapeutics|Chief Medical Officer|201-488-0460|Clinical.Trial@brainstorm-cell.com|
21293997|NCT01456195|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
21293998|NCT02109432|Pennington Biomedical Research Center|Corby Martin, Associate Professor|225-763-2585|corby.martin@pbrc.edu|
21293999|NCT03304054|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|305-420-3200|gingenito@catalystpharma.com|
21294000|NCT03372551|Coopervision|Myhanh Nguyen, Sr. Optometrist|925-730-6716|mnguyen@coopervision.com|
21294001|NCT04523454|Imperial College London|Dr Rochan Agha-Jaffar|0203 311 3000|Rochan.Agha-Jaffar@nhs.net|21253
21294002|NCT03179982|American University|Caroline Kuo|2028853054|ckuo@american.edu|
21294003|NCT04148482|Massachusetts General Hospital|Sara Cromer|6177247303|scromer@mgh.harvard.edu|
21294004|NCT05926544|University of North Carolina at Chapel Hill|Abby Gamble, MA|828-513-0636|abigail_gamble@email.unc.edu|
21294005|NCT04683029|Janssen Pharmaceutical K.K.|Senior Director Clinical Research MD|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21294006|NCT04299308|University of Kansas Medical Center|Dr. Jill Morris|9139457675|jmorris2@kumc.edu|
21294007|NCT02551094|Montreal Heart Institute|Dr. Jean-Claude Tardif (Principle Investigator)|514-376-3330|jean-claude.tardif@icm-mhi.org|3612
21294008|NCT02920528|Lundquist Institute|David Tanen|310-222-3624|dtanen@emedharbor.edu|
21294009|NCT00066703|ETOP IBCSG Partners Foundation|Dr. Heidi Roschitzki-Voser, PhD Head Trial Activities / Deputy Director|41 31 511 94 00|Heidi.Roschitzki@etop.ibcsg.org|
21294010|NCT05280158|University of California, Los Angeles|Yusaku Michael Shino, MD|(310) 866-6327|MShino@mednet.ucla.edu|
21236032|NCT02646423|University of California, San Francisco|Miriam Kupperman, PhD, MPH|415-502-4089|miriam.kupperman@ucsf.edu|
21294011|NCT05924165|Icahn School of Medicine at Mount Sinai|Dr. Mantu Gupta|(212) 241-1272|Mantu.Gupta@mountsinai.org|
21294012|NCT01681186|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21294013|NCT01375127|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294014|NCT00301262|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21294015|NCT01716039|Alimentiv (Formerly Robarts Clinical Trails)|Dr.Jenny Jeyarajah (Sr. Biostatistician)||jenny.jeyarajah@alimentiv.com|
21294016|NCT03530995|Kadmon Corporation|Olivier Schueller, Senior Vice President, CMC & Clinical Pharmacology|833-900-5366|olivier.schueller@kadmon.com|
21294017|NCT01668628|The Catholic University of Korea|Dr. Hye Eun Yoon|82-32-280-5886|berrynana@catholic.ac.kr|
21294018|NCT02058511|UCSF|Matthias Behrends|415 476 3761|matthias.behrends@ucsf.edu|
21294019|NCT01842035|University of Alabama at Birmingham|Fadi Hage|2059757123|fadihage@uab.edu|
21294020|NCT04308239|Virginia Tech|Michael Madigan|(540) 231-3543|mlm@vt.edu|
21294021|NCT01443364|UCB|UCB Clinical Trial Call Center|+1877 822||9493
21294022|NCT02643615|The Ohio State University Wexner Medical Center|Dr. Sergio Bergese|6142933559|sergio.bergese@osumc.edu|
21294023|NCT00801723|Bausch Health|Study Director||susan.harris@bauschhealth.com|
21294024|NCT01986231|Legacy Health System|Kenneth Ward|971-570-2632|kenward503@msn.com|
21294025|NCT04848220|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21294026|NCT03713398|University of North Carolina at Chapel Hill|Amy Wilson, PhD|919-962-3598|amyblank@email.unc.edu|
21294027|NCT01460875|The Ohio State University Comprehensive Cancer Center|William Carson, MD|614-293-6306|William.Carson@osumc.edu|
21294028|NCT00611442|Carl R Darnall Army Medical Center|Dr. Joel Stengel|2545531804|joel.stengel@us.army.mil|
21294029|NCT01511614|NIH/NIDA|Dr. Amy Janes|667.312.5164|amy.janes@nih.gov|
21294030|NCT02150057|Andrews Institute for Orthopaedics & Sports Medicine|Dr. Roger Ostrander|850-916-3700|rostrander@flboneandjoint.com|3725
21294031|NCT00489424|Novartis Pharmaceuticals|Study Director|862-778-8300||
21294032|NCT05791565|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21294033|NCT01558115|Columbia University|John P. Bilezikian, MD|212-305-6257|jpb2@cumc.columbia.edu|
21294034|NCT01436656|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294035|NCT01696994|Early Detection Research Group, NCI, NIH|Paul F. Pinsky, Ph.D.|301-496-8544|pinskyp@mail.nih.gov|
21294036|NCT00335283|Vanderbilt University Medical Center|Manager, Clinical Trials|615-322-4643|tina.higginbotham@vanderbilt.edu|
21294037|NCT02388165|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294038|NCT00705250|Memorial Sloan Kettering Cancer Center|Craig Moskowitz, MD|(212) 639-7992|moskowic@mskcc.org|
21294039|NCT00880269|Novartis Pharmaceuticals|Study Director|862-778-8300||
21294040|NCT01406938|Novartis Pharmaceutical|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21294041|NCT03230890|Atrium Health Wake Forest Baptist|Charles H. Tegeler, MD|336-716-9447|BBRP@wakehealth.edu|
21294042|NCT02926027|Lundquist Institute|Matthew Budoff|3102224107|mbudoff@lundquist.org|
21294043|NCT03454399|Henry Ford Hospital|Yoshihisa Morita|3059784358|YOSHIHISA.MORITA@JEFFERSON.EDU|
21294044|NCT00962741|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294045|NCT00316225|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21294046|NCT03487588|Aclaris Therapeutics|Executive Director Clinical Operations|4843247933|jschnyder@aclaristx.com|
21294047|NCT01814878|Janssen Korea/25F, LS Yongsan Tower, 191 Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702, Korea|Clinical Research Director|82-2-2094-4518||
21294048|NCT01545934|Cal Poly|Suzanne Phelan|805-756-2087|sphelan@calpoly.edu|
21236033|NCT00003457|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
21236034|NCT04564833|Renibus Therapeutics|Stacey Ruiz, PhD / VP, Drug Development|424-209-2734|sruiz@renibus.com|
21236035|NCT02246998|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21262274|NCT02134314|Cedars-Sinai Medical Center|Noriko Ammerman, PharmD|310-248-8186|noriko.ammerman@cshs.org|
21294049|NCT03654404|Dana-Farber Cancer Institute|Hermioni L. Amonoo, Director of Well-Being and Cancer Research Program|617-525-7472|Hermioni_Amonoo@dfci.harvard.edu|
21246463|NCT04911296|Rani Therapeutics|Sr. Director of Clinical Operations|+1 (408) 457-3700|joshua.myers@ranitherapeutics.com|
21246464|NCT03672916|Zimmer Biomet|Martina Hersberger, Clinical Project Lead|+41 79 535 90 29|martina.hersberger@zimmerbiomet.com|
21246465|NCT05868382|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
21246466|NCT04083170|Fred Hutchinson Cancer Center|Dr. Filippo Milano|206.667.5925|fmilano@fredhutch.org|
21246467|NCT03513302|Indiana University Indianapolis|Dr. Andrew Coggan|3172740656|acoggan@iu.edu|
21246468|NCT05256654|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21246469|NCT02807545|Scottish Rite for Children|Karina Zapata|214-559-7790|karina.zapata@tsrh.org|
21246470|NCT04089059|UCSF School of Medicine|Liviu Klein|415-476-2143|liviu.klein@ucsf.edu|
21246471|NCT01309672|University of Colorado, School of Medicine|Dr. Thomas W. Flaig, MD||Thomas.Flaig@ucdenver.edu|
21246472|NCT03895996|Avotres Inc.|Tuochuan Dong, Director, Business & Operations|7169093370|tuochuan.dong@avotres.com|
21246473|NCT01254864|The University of Texas MD Anderson Cancer Center|Paul Corn, MD|(713) 563-7208|pcorn@mdanderson.org|
21246474|NCT04141891|University of Colorado|Dr. Marian Betz|303-550-5669|marian.betz@cuanschutz.edu|
21246475|NCT06180980|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21246476|NCT01828112|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@Novartis.com|
21246477|NCT04308681|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21246478|NCT02573779|Baylor College of Medicine/Texas Children's Hospital|Dr. Amy B. Hair|832-826-1398|abhair@bcm.tmc.edu|
21246479|NCT03746106|University of California, San Francisco|Dr. Kathleen Giacomini|4155144363|kathy.giacomini@ucsf.edu|
21246480|NCT04571619|University of Pennsylvania|Natalie Kuzla|2155732935|nkuzla@pennmedicine.upenn.edu|
21246481|NCT04750538|The University of Texas Health Science Center at Houston|Sheng Li, MD, PhD|713-797-7125|sheng.li@uth.tmc.edu|
21246482|NCT03298945|Corporal Michael J. Crescenz Department of Veterans Affairs Medical Center|Yu-Xiao Yang, MD, MSCE|215-823-5800|yuxiao.yang@va.gov|
21246483|NCT05309291|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
21246484|NCT05209152|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21246485|NCT03100760|University of New Mexico Health Sciences Center|Justin Baca|505-272-5062|jtbaca@salud.unm.edu|
21246486|NCT02568566|University of Arizona|Sherry Chow, PhD|520-626-3358|schow@azcc.arizona.edu|
21246487|NCT04857723|CooperVision Inc.|Paul Chamberlain|+19257306754|pchamberlain@coopervision.com|
21246488|NCT01002235|Helixmith Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
21280521|NCT02394600|Kingston General Hospital|Dr. Anne Ellis|613-548-2336|ellisa@kgh.kari.net|
21246490|NCT05196919|Xalud Therapeutics, Inc.|Director of Medical Inquiries|212-301-6673|medical.information@xaludthera.com|
21246491|NCT00696111|University of Chicago|Karla Temple, Clinical Research Manager|773-702-3334|katemple@uchicago.edu|
21246492|NCT04850898|SAB Biotherapeutics|Senior Director Clinical Operations|8326221699|ssinclair@sabbio.com|
21246493|NCT04550221|University of Washington|Susan M. Graham|206-351-0414|grahamsm@uw.edu|
21246494|NCT05050149|Palvella Therapeutics, Inc.|Christine Kampf, Vice President of Regulatory Affairs|484-844-0865|christine.kampf@palvellatx.com|
21246495|NCT03676192|Celltrion|Head of Clinical Planning Department|82328505000|contact@celltrion.com|
21246496|NCT04731129|Centre hospitalier universitaire de liège|Dr Olivier Bonhomme|003243239580|obonhomme@chuliege.be|
21246497|NCT03386578|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
21246498|NCT03841773|Tonix Pharmaceuticals|Gregory Sullivan, MD|862-904-0355|greg.sullivan@tonixpharma.com|
21246499|NCT02694822|Agenus, Inc.|Clinical Trial Information|1-781-674-4265|clinicaltrialinfo@Agenusbio.com|
21246500|NCT01868997|Horizon Pharma USA, Inc.|Julie Ball, Executive Director||clinicaltrials@horizonpharma.com|
21246501|NCT05370040|Immunitybio|Lennie Sender, Chief Operating Officer|855-797-9277|lennie.sender@immunitybio.com|
21246502|NCT04971109|SIGA Technologies|Emily Blum, Director of Clinical Development|541-224-1305|eblum@siga.com|
21246503|NCT05133739|TEOXANE SA|Clinical Research Scientist|+41(0) 22 344 96 36|clinical@teoxane.com|
21246504|NCT04778397|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21246505|NCT04870307|University of Oklahoma Tulsa|Dr. Juell Homco|918-660-3038|juell-homco@ouhsc.edu|
21246506|NCT05906784|University of California, San Francisco|Maria Chao, DrPH, MPA, Principal Investigator|415-353-7749|Maria.Chao@ucsf.edu|
21246507|NCT04432506|The University of Texas MD Anderson Cancer Center|Paolo Strati, MD|(713) 745-1776|pstrati@mdanderson.org|
21246508|NCT03664700|Oxford University Hospitals|Dr Vassilis Athanassoglou|01865|vassilis.athanassoglou@ouh.nhs.uk|221590
21246509|NCT04730739|Zimmer Biomet|Octavia Gladden, Clinical Research Speaclist|704.493.0178|octavia.gladden@zimmerbiomet.com|
21246510|NCT03308877|University of Rochester Medical Center|Marc T. Swogger, Associate Professor, Psychiatry and Medicine|585-301-7738|marc_swogger@urmc.rochester.edu|
21246511|NCT05089877|AtriCure|Nfii Ndikintum, VP of Clinical Affairs and Biometerics|5136448192|NNdikintum@atricure.com|
21246512|NCT00957684|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
21246513|NCT02315703|Janssen Vaccines & Prevention B.V.|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21280522|NCT02569801|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21280523|NCT00428246|Indiana University|Rajiv Agarwal|317-988-2241|ragarwal@iupui.edu|
21280524|NCT02200055|General Surgery, Naval Medical Center Porstmouth|Dr. Christopher Oxner|757-953-2495|christopher.r.oxner.mil@mail.mil|
21280525|NCT00776035|Washington University School of Medicine|Linda R. Peterson, MD, Professor of Medicine and Radiology|314-362-4577|lpeterso@wustl.edu|
21280526|NCT03442751|Glaukos|Valerie Smith|9493679600|VSmith@glaukos.com|
21280527|NCT00656656|University of Lübeck|Prof. Dr. Detlef Zillikens|+49-451-500-41500|detlef.zillikens@uksh.de|
21294050|NCT02710981|OB-GYN department, Assiut University, Egypt|Essam R. Othman|+201006607801|essamrash@yahoo.com|
21294051|NCT05096247|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
21294052|NCT01280058|The Ohio State University Comprehensive Cancer Center|Anne Noonan, MD|614-685-6912|Anne.Noonan@osumc.edu|
21294053|NCT02003638|University of Pennsylvania|Dr. Emil deGoma|2156156521|emil.degoma@uphs.upenn.edu|
21294054|NCT00760435|University of California, San Diego|Dr. Adriana H. Tremoulet|858-246-0012|atremoulet@ucsd.edu|
21294055|NCT00654745|Daiichi Sankyo|James McCarthy|732-590-3430|jmccarthy@dsi.com|
21294056|NCT04551963|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21294057|NCT00748618|University of Nebraska Medical Center|Fang Yu|(402) 559-9436|fangyu@unmc.edu|
21294058|NCT00466947|GlaxoSmithKline|GSK Response Center|866-435-7343||
21294059|NCT00878254|University of Miami|Izidore Lossos MD|+1 (305) 2434785|ilossos@med.miami.edu|
21294060|NCT03086408|Stanford University|Vladimir Nekhendzy, M.D., FASA|650-498-4055|nek@stanford.edu|
21294061|NCT05445921|Washington University School of Medicine, Dept. of Otolaryngology - Head and Neck Surgery|Dr. Andrew Peterson, Resident Physician|314-362-5626|pandrew@wustl.edu|
21294062|NCT01977729|Yale University|Dr. Wendy Silverman|(203) 737-7053|wendy.silverman@yale.edu|
21294063|NCT04928885|The University of Illinois at Chicago|Dr. Julie Bobitt, PhD|312.355.0247|jbobitt@uic.edu|
21294064|NCT01380197|Morehouse School of Medicine|Iris Buchanan|404-398-9578|ibuchanan@msm.edu|
21294065|NCT03806556|University of Pittsburgh Medical Center|Meghan McCormick, MD MS|412-692-6938|meghan.mccormick3@chp.edu|
21294066|NCT00606034|Mountain Diabetes and Endocrine Center|Dr. Wendy Lane, Director of Clinical Research|828-258-2404|mountaindiabetes@msn.com|314
21294067|NCT02078180|University of Michigan|Dr. Duxin Sun|734-763-9783|pharmacy.research@umich.edu|
21246514|NCT03625115|Children's Hospital of Philadelphia|Dr. James Guevara|2155901130|guevara@chop.edu|
21294068|NCT00765037|DJO Surgical|Jane M. Jacob - Manager of Clinical Affairs|512-834-6323|jane.jacob@djosurgical.com|
21294069|NCT00964002|Department of Medical Oncology, Institut bergonié|Pr Nadine Houede, oncologist||nadine.HOUEDE@chu-nimes.fr|
21294070|NCT02771574|Stanford University School of Medicine|Cindy Lamendola|650-723-3141|clamendola@stanford.edu|
21294071|NCT04181593|OmegaD LLC|Dr. Gregory Smith, MD|3023833948|SGSmith@omegad.com|
21294072|NCT04500171|American Samoa Community Cancer Coalition|Va'atausili Tofaeono|648-699-0110|vtofaeono@cancercoalition.as|
21294073|NCT05422365|Biopharma Plasma LLC|Igor Rudenko, Clinical Research Physician|+380503300865|i.rudenko@biopharma.ua|
21294074|NCT03596047|Boston Medical Group|Carolina Sandoval - Director Research|+57 3133920816|csandoval@bostonmedical.com.co|
21294075|NCT01696968|Early Detection Research Group, NCI, NIH|Paul F. Pinsky, Ph.D.|301-496-8544|pinskyp@mail.nih.gov|
21294076|NCT03727646|University of Washington|Dr. Kevin Douglas O'Brien|2065984300|cardiac@uw.edu|
21294077|NCT04753658|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294078|NCT06523010|Bitlis Eren University|Asst. Prof. Ömer Dursun|5426088687|fztomrdrsn@gmail.com|+90
21294079|NCT04812028|University of Minnesota|Gwenyth Fischer|612-625-9950|fisch662@umn.edu|
21294080|NCT02582814|AstraZeneca|A clinical pharmacology and long-term safety study|+819039706431|Yu.Shimizuishi@astrazeneca.com|4669
21294081|NCT00306293|GlaxoSmithKline|GSK Response Center|866-435-7343||
21294082|NCT00176488|Cancer Institute of New Jersey|Deborah Toppmeyer, MD|732-235-8675|toppmede@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
21294083|NCT02650804|BPGbio Inc|Head of Clinical Operations|6175880083|clinicaltrials.connect@berghealth.com|
21294084|NCT02222909|Johns Hopkins School of Public Health|Christine Weston|443-287-8039|cweston1@jhu.edu|
21294085|NCT04925076|University of Minnesota|Jeff Boissoneault, PhD|612-624-7357|jboisson@umn.edu|
21294086|NCT00117715|Children's Mercy Hospital|J. Steven Leeder|816-234-3059|sleeder@cmh.edu|
21246515|NCT04197336|Johns Hopkins University|Clifford Weiss, MD|410-614-1046|cweiss@jhmi.edu|
21246516|NCT03268382|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
21246517|NCT03808961|VAORD|Chandramohan Wakade|7067211106|cwakade@augusta.edu|
21246518|NCT06007781|HilleVax, Inc.|Astrid Borkowski, Chief Medical Officer|+1 (617) 213-6562|aborkowski@hillevax.com|
21294087|NCT02557100|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21294088|NCT03289910|Johns Hopkins University|Grants Administrative Manager|4439273568|JHCCCRO@jhmi.edu|
21294089|NCT00510718|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294090|NCT04644276|Philips|Chuck Cain|412-657-1814|chuck.cain@philips.com|
21294091|NCT01576146|Amgen, Inc|Study Director|866-572-6436||
21294092|NCT01558492|Weill Cornell Medicine|Himisha Beltran, MD|646-962-2072|hip9004@med.cornell.edu|
21294093|NCT01811485|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21294094|NCT03299881|Elira Therapeutics, Inc.|Stephanie Amlung, PhD, RN, Vice President, Clinical Affairs|513-236-6799|samlung@elira.com|
21294095|NCT02974855|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294096|NCT01474772|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294097|NCT00633074|GlaxoSmithKline|GSK Response Center|866-435-7343||
21294098|NCT01995526|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21294099|NCT01132846|Duke University|Kevin Anstrom|919-668-8902|kevin.anstrom@dm.duke.edu|
21294100|NCT03367403|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21246519|NCT03852550|McMaster University|Research Coordinator|9055259140|galuppi@mcmaster.ca|27852
21294101|NCT00194077|Johns Hopkins University School of Medicine|Robert Findling, MD,MBA Director, Child and Adolescent Psychiatry|410-614-3225|rfindli1@jhmi.edu|
21246520|NCT05204654|University at Buffalo|No Dr. Alexandria Newton|716-829-2845|amnewton@buffalo.edu|
21294102|NCT03470194|U Mass Memorial|Dr Danielle Taylor|508-334-9840|danielle.taylor@umassmemorial.org|
21294103|NCT01822899|GlaxoSmithKline|GSK Response Center|866-435-7343||
21294104|NCT02628405|Accru|Dr Grzegorz S. Nowakowski|507-422-6553|Nowakowski.Grzegorz@mayo.edu|
21294105|NCT00759876|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
21246521|NCT01221948|Bostons Scientific Neuromodulation|Nic Van Dyck, Director International Clinical Operations|+31 43 3568328|vandyckn@bsci.com|
21246522|NCT03756662|Implandata Ophthalmic Products|Clinical Study Manager|+49 (0) 511 - 2204 2580|clinical@implandata.com|
21246523|NCT03626220|An Nan Hospital, China Medical University, Tainan, Taiwan|Dr. Chien-Chen Huang|886-6-3553111|chenchinh2013@gmail.com|2231
21246524|NCT01188928|Leo Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
21246525|NCT04410328|Rutgers New Jersey Medical School|Dr. Amit Singla|319-512-3558|as3321@njms.rutgers.edu|
21246526|NCT05565820|Alliance Pharmaceuticals|R&D Director|01249 466966|medaffairs@allianceph.com|+44
21294106|NCT02363972|Avenu Medical|Gene Reu EVP and General Manager|9492762483|greu@avenumedical.com|
21294107|NCT01450696|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21294108|NCT01295840|Hospital Universitario Virgen de la Victoria|Dr Javier Alzueta|+34 952 64 15 50|jalzueta@telefonica.net|
21294109|NCT02321319|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
21294110|NCT01334216|Indiana University School of Medicine|Stephen M. Downs, MD, MS|3172780552|stmdowns@iu.edu|317
21294111|NCT02570152|GlaxoSmithKline|GSK Response Center|877-379-3718|GSKClinicalSupport@gsk.com|
21294112|NCT00853242|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21294113|NCT03497975|Trevi Therapeutics, Inc.|Chief Development Officer|203-304-2499|info@trevitherapeutics.com|
21294114|NCT02516098|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21294115|NCT03115827|Vanderbilt University Medical Center|Dr. Katherine McDonell|615-875-7987|katherine.mcdonell@vumc.org|
21294116|NCT01355679|NMTRC at Spectrum Health|Giselle Sholler, MD|616-267-0334|giselle.sholler@helendevoschildrens.org|
21294117|NCT00142168|DFCI|Steven P. Treon MD PhD|617 632 2681|steven_treon@dfci.harvard.edu|
21294118|NCT01780337|Columbia University|William Whang|212-305-8620|ww42@cumc.columbia.edu|
21294119|NCT02466425|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21294120|NCT00582712|University of Wisconsin Carbone Cancer Center|Director of Clinical Research|608-265-0540|clinicalresearch@surgery.wisc.edu|
21294121|NCT03587428|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21294122|NCT05141175|Duke University|Dr. Anthony Viera|919 681 3178|anthony.viera@duke.edu|
21294123|NCT02445014|Mass General Hospital|Gary Tearney, MD|617-724-2979|gtearney@partners.org|
21294124|NCT00787241|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu|
21294125|NCT01032603|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
21294126|NCT01813058|Boston Children's Hospital|susan Goobie, MD, FRCPC|6173667737|susan.goobie@childrens.harvard.edu|
21294127|NCT03585764|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
21246527|NCT05828017|Sonova|Bilal Sheikh - Research Audiologist|2268083260|bilal.sheikh@sonova.com|
21294128|NCT02777203|The Advanced Gyn Surgery Institute|Mary Johnston|6303641112|mjohnston@drcharlesmiller.com|
21246528|NCT05419830|University of Pittsburgh|Shachi Tyagi, MD, MS|4126471274|sht55@pitt.edu|
21246529|NCT05012163|Geisinger|Gail Rosenbaum|800-275-6401|grosenbaum@geisinger.edu|
21246530|NCT04132518|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
21246531|NCT03092453|University of Pennsylvania|Regulatory Lead|215-573-7101|psom-ind-ide@pobox.upenn.edu|
21246532|NCT05425420|Duke University|Kanecia Zimmerman|919-668-8651|kanecia.zimmerman@duke.edu|
21246533|NCT03673501|Deciphera Pharmaceuticals, LLC|INTRIGUE Clinical Team|781-209-6400|clinicaltrials@deciphera.com|
21246534|NCT04599634|National Cancer Institute|Dr. Mark J. Roschewski|240-760-6183|mark.roschewski@nih.gov|
21246535|NCT03714815|Actelion Pharmaceuticals Ltd|Clinical Scientific Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21246536|NCT02946736|Oregon Health & Science University|Dr. Leslie Hammer, PI|503-494-9313|hammerl@ohsu.edu|
21246537|NCT03733925|Johnson & Johnson Private Limited|Medical Advisor Immunology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21246538|NCT01385189|George Washington University|Dr. David J. Diemert, Associate Professor|202.994.2909|ddiemert@gwu.edu|
21246539|NCT02631746|Duke University - Duke Cancer Institute LAO|Christy Arrowood|919-613-6130|christy.arrowood@duke.edu|
21246540|NCT02361216|LEO Pharma A/S|Clinical Trial Disclosure Manager||disclosure@leo-pharma.com|
21246541|NCT00323856|Grifols|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
21246542|NCT04086121|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21246543|NCT03825588|University of Texas Southwestern Medical Center, University of Pittsburgh|Dr. Beth Dohoney Kennard; Dr. David Brent|214.456.4244|beth.kennard@utsouthwestern.edu|
21246544|NCT04167553|Hanmi Pharmaceutical Co., Ltd.|Jiyeon Kang|+8224100377|jiyeon.kang@hanmi.co.kr|
21246545|NCT02828358|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21246546|NCT03702270|VANDERBILT UNIVERSITY MEDICAL CENTER|Dr. Cosby A Stone, Jr.|6153223412|Cosby.a.stone@vumc.org|
21246547|NCT05285137|Cidara Therapeutics, Inc.|Chief Medical Officer|858-888-7868|clinicaltrialinfo@cidara.com|
21246548|NCT04479761|New York University|Prof. Anat Lubetzky|2129989195|anat@nyu.edu|
21246549|NCT06130410|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21246550|NCT05809453|University of Texas at Southwestern|Dr. Craig Crandall|214-345-4623|craigcrandall@texashealth.org|
21246551|NCT05361031|Helixmith, Co., Ltd.|Jinsub Lee, PhD|+82-10-8256-0439|jinsub.lee@helixmith.com|
21294129|NCT01581021|University of Mississippi Medical Center|Dr. Lawrence Haber|601-984-6525|lhaber@umc.edu|
21294130|NCT03604172|University of Pennsylvania|Dr. Ariana Chao|215-746-7183|arichao@upenn.edu|
21246552|NCT04183283|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21294131|NCT02676895|GlaxoSmithKline|GSK Response Center|866-435-7343|antonella.s.scire@gsk.com|
21294132|NCT00054327|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Kenneth Cooke MD|216-844-3345|kenneth.cooke@uhhospitals.org|
21294133|NCT02168062|University of California, San Francisco|Li Zhang, PhD|(415) 476-5339|Li.Zhang@ucsf.edu|
21294134|NCT01642056|National Human Genome Research Institute|Gahl, William|+1 301 402 2739|gahlw@mail.nih.gov|
21294135|NCT03028129|Federal University of Mato Grosso do Sul|Julio Croda|+5567981229959|julio.croda@ufms.br|
21294136|NCT00923351|National Cancer Institute, National Institutes of Health|Dr. John Glod|301-451-0391|john.glod@nih.gov|
21294137|NCT00182078|Massachusetts General Hospital|Dr. Frederick J. Stoddard Jr., M.D.|6173714762|fstoddard@partners.org|
21294138|NCT01076205|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21294139|NCT00361231|Massachusetts General Hospital|Dr. Andrew X. Zhu|617-724-4000|azhu@mgh.harvard.edu|
21294140|NCT01732510|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21294141|NCT01253148|H. Lee Moffitt Cancer Center and Research Institute|Sarah Hoffe, M.D.|813-745-3814|sarah.hoffe@moffitt.org|
21294142|NCT01262560|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21294143|NCT06423456|afyonkarahisar health sciences university hospital|Dr. Betül Ahat|05467240341|drbetula@gmail.com|
21294144|NCT00744380|University of Colorado|Robert MacLaren|303 724-2622|rob.maclaren@ucdenver.edu|
21294145|NCT01932372|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294146|NCT03594747|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
21246553|NCT03397654|Imperial College London|Dr David Pinato|+44 20 7594 2799|david.pinato@imperial.ac.uk|
21294147|NCT00349349|GlaxoSmithKline|GSK Response Center|866-435-7343||
21294148|NCT00136695|Massachusetts General Hospital|Dr. Benjamin Leder|617-726-6723|bzleder@partners.org|
21294149|NCT02374060|Johns Hopkins University|Elizabeth Sugar, PhD|(410) 614-7837|esugar2@jhu.edu|
21294150|NCT02242435|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
21294151|NCT03462927|MC2 Therapeutics|Birgitte Vestbjerg|+45 2077 2575|bve@mc2therapeutics.com|
21294152|NCT01667224|Clinical Trial Center for Functional Food in Chonbuk National University Hospital|Dr. Soo-Wan Chae|82-63-250-2348|soowan@jbnu.ac.kr|
21246554|NCT04909801|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
21246555|NCT04447040|Johnson & Johnson Consumer, Inc.|Assoc Dir Med Sci Leader US Self Care Pain|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21246556|NCT01208662|Dana-Farber Cancer Institute|Ajantha Nithi|857-215-2829|ajantha_nithi@dfci.harvard.edu|
21246557|NCT03208049|VA Palo Alto Health Care System, Palo Alto, CA|Dr. Andrea Goldstein-Piekarski|(650) 493-5000|Andrea.Goldstein2@va.gov|60584
21246558|NCT05147116|University of Portsmouth|Dr Anthony Shepherd|02392845289|ant.shepherd@port.ac.uk|
21294153|NCT02752633|Landspitali - The National University Hospital of Iceland|Vidar Orn Edvardsson|+3545431000|vidare@landspitali.is|3452
21246559|NCT04101357|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
21246560|NCT03655028|Edward Hines Jr., VA Hospital|Eileen Collins|312-3550118|ecollins@uic.edu|
21246561|NCT00179400|Albert Einstein College of Medicine|Prof. Meredith A. Hawkins|718 430 3186|meredith.hawkins@einsteinmed.edu|
21246562|NCT04625725|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21246563|NCT04618315|Northwestern University|Sumitrajit Dhar|847 491 8542|s-dhar@northwestern.edu|
21246564|NCT02945176|Implandata Ophthalmic Products|Clinical Study Manager|+49 (0) 511 - 2204 2580|clinical@implandata.com|
21246565|NCT05244187|MEDIcept Inc|Adelina Paunescu, VP Clinical Affairs|781-526-8152|apaunescu@medicept.com|
21246566|NCT03911141|Hospital of the University of Pennsylvania|Alexander C. Fanaroff, MD, MHS|2156157674|alexander.fanaroff@pennmedicine.upenn.edu|
21246567|NCT05086796|Cedars-Sinai Medical Center|Itai Danovitch, MD|310-423-2600|itai.danovitch@cshs.org|
21246568|NCT02393885|AtriCure, Inc.|Nfii Ndikintum|1-513-755-4100|nndikintum@atricure.com|
21246569|NCT00429364|New England Research Institutes, Inc.|Paul Stark, PhD|617-972-3362|pstark@neriscience.com|
21246570|NCT04871529|SWOG|Melissa Plets|206 667 2707|mplets@fredhutch.org|
21246571|NCT05184452|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
21246572|NCT05586490|University of Michigan|Chatkaew Pongmala, PhD|734-936-1168|pchatkae@umich.edu|
21246573|NCT05873556|University of Washington|Dr. Anne Fairlie|2062215896|afairlie@uw.edu|
21246574|NCT04047602|Indiana University Health|Kevin Shiue, MD|317 944 2524|kshiue@iuhealth.org|
21246575|NCT03606408|Recordati AG|Mario Maldonado|+41798030344|maldonado.m@recordati.com|
21246576|NCT04689256|UMass Chan Medical School/UMass Memorial Health|Dr. Brian Silver|508-334-5989|Brian.Silver@umassmemorial.org|
21246577|NCT03556293|Dartmouth College|Dr. Jeremiah Brown|(603) 646-5409|jeremiah.r.brown@dartmouth.edu|
21246578|NCT04867278|Emory University|Dr. Adam Boissonneault|(404) 616-1000|adam.boissonneault@emory.edu|
21246579|NCT02584647|Columbia University|Gulam A. Manji|212 305 0592|gam2140@cumc.columbia.edu|
21246580|NCT03914742|Johns Hopkins University|Program Manager Adult Brain Tumor Consortium (ABTC) and Brain Cancer Program|410-955-8837|jfisher@jhmi.edu|
21294154|NCT01843673|Virginia Commonwealth University|Joshua Evans, Ph.D.|804-628-0661|jevans2@mcvh-vcu.edu|
21294155|NCT03275246|Zimmer Biomet|Oliver Schaetti|0041588548901|oliver.schaetti@zimmerbiomet.com|
21294156|NCT02292082|Hospital for Special Surgery|George Birch|2127747377|birchg@hss.edu|
21246581|NCT05062330|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
21246582|NCT02567409|City of Hope|Paul Frankel. Ph.D.|626-218-5265|pfrankel@coh.org|
21246583|NCT01130519|National Cancer Institute|Dr. Ramaprasad Srinivasan|240-760-6251|ramasrin@mail.nih.gov|
21294157|NCT00433966|Cardiovascular Research Foundation|Ori Ben-Yehuda, MD, Executive Director, Clinical Trials Center|646-434-4123|obenyehuda@crf.org|
21294158|NCT05059301|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21294159|NCT01491789|Kennedy Krieger Institute|Dr. Alberrt Recio|443-923-9227|recio@kennedykrieger.org|
21294160|NCT04952597|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21294161|NCT01296711|UCB BIOSCIENCES GmbH|Clin Trial Reg & Results Disclosure|001-844-599-2273|clinicaltrials@ucb.com|
21294162|NCT03915574|UAMS|Nadir Sharawi|5016866119|nelsharawi@uams.edu|
21294163|NCT00883168|Meda Pharmaceuticals, Inc.|David Ginsberg,D.O.|732 564-2364|david.ginsberg@meda.us|
21294164|NCT01707654|The Second Hospital of Tangshan|Dr. Chao Chen|86-13700350471|ts_chenchao@163.com|
21294165|NCT00923975|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
21294166|NCT01709422|Prince of Songkhla University|Dr. Nisa Netinatsunton|6674451965|nisasan@yahoo.com|9
21294167|NCT01005316|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21294168|NCT04027803|BIOCAD|Morozova Maria|+7 (495) 992 66 28|morozovama@biocad.ru|8436
21294169|NCT00632827|University of California, San Francisco|Lawrence Kaplan, MD|(415) 353-2661|LKaplan@ucsf.edu|
21294170|NCT01035463|University of Nebraska Medical Center|Julie M Vose|402-559-3848|jmvose@unmc.edu|
21294171|NCT02925078|University of Michigan|Clinical Research Coordinator|7347633346|aliceou@umich.edu|
21294172|NCT01734395|Jan-Cil Korea|Clinical Research Director|82 2 2094||4518
21294173|NCT01092780|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21294174|NCT04026009|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21294175|NCT03374683|University of British Columbia|Dr. Mariana Brussoni|604-875-3712|mbrussoni@bcchr.ubc.ca|
21294176|NCT01059682|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
21294177|NCT02957747|VISN 17 Center of Excellence for Research on Returning War Veterans|Dr. Suzannah Creech, Ph.D.|254-297-3025|Suzannah.Creech@va.gov|
21294178|NCT01177553|University of South Florida|Research Coordinator|813-259-8680|obgynclinicalresearch@health.usf.edu|
21294179|NCT01812213|Navidea Biopharmaceuticals|Chief Medical Officer|6149737555|mblue@navidea.com|
21294180|NCT00610857|University of Pittsburgh Cancer Institute|Ahmad Tarhini, MD|4126486507|tarhiniaa@upmc.edu|
21294181|NCT00888329|Mayo Clinic|Javier Magrina MD|480-301-8000|magrina.javier@mayo.edu|
21294182|NCT00002540|Early Detection Research Group, NCI, NIH|Paul F. Pinsky, Ph.D.|301-496-8544|pinskyp@mail.nih.gov|
21294183|NCT04826094|Henry M Jackson Foundation for the Advancement of Military Medicine|David Fetterer, MS (Programmer Analyst)|301.500.3818|dfetterer@global-id.org|
21294184|NCT02151903|Alopexx Oncology, LLC|Chief Medical Officer||daniel.vlock@alopexx.com|
21294185|NCT00778375|University of Texas (UT) MD Anderson Cancer Center|Farhad Ravandi-Kashani, Professor, Leukemia Department||CR_Study_Registration@mdanderson.org|
21294186|NCT01421303|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294187|NCT06003777|Pfizer Inc.|Name or Official Title: Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294188|NCT05319600|University of Vermont|Amy Hughes Lansing, PhD|(802) 656-3801|amy.hughes.lansing@uvm.edu|
21294189|NCT00904670|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294190|NCT01825512|Consorzio per Valutazioni Biologiche e Farmacologiche|Donato Bonifazi|+393936698076|ceo@cvbf.net|
21294191|NCT00435227|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21294192|NCT02120300|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21294193|NCT05319899|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
21294194|NCT01721486|Beaumont Hsopital|Kaveh Aslani, MD|248-898-1907|kaveh.aslani@beaumont.org|
21294195|NCT00613327|Medical Affairs, Janssen Korea|Clinical Research Associate|+82-2-2094-4935||
21294196|NCT01814397|University of Michigan Comprehensive Cancer Center|Dr. Norah Lynn Henry|734-936-4991|norahh@med.umich.edu|
21294197|NCT00313144|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21246584|NCT04180462|Washington University School of Medicine|Allison King, M.D., Ph.D., MPH|314-454-4291|king_a@wustl.edu|
21294198|NCT00893152|VA HSR&D Center for Mental Healthcare & Outcomes Research|Ellen P. Fischer, PhD|501-257-1711|Ellen.Fischer@va.gov|
21294199|NCT04154293|Timber Pharmaceuticals|Alan Mendelsohn, MD|2673004249|amendelsohn@timberpharma.com|
21294200|NCT04731298|Sobi|Emmanuel Monnet|+41225519156|Emmanuel.Monnet@sobi.com|
21294201|NCT01208961|AstraZeneca Pharmaceuticals|Torbjörn Lundström, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21294202|NCT01849692|Alcon Research, Ltd.|Clinical Project Group Leader, GCRA, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
21294203|NCT03403361|Washington University School of Medicine|Dr. Clifford Robinson|314-362-8567|clifford.robinson@wustl.edu|
21294204|NCT02487654|Imperial College London|Professor Prapa Kanagaratnam|+44 20 3313 1000|p.kanagaratnam@imperial.ac.uk|
21294205|NCT04238481|Astellas Pharma Inc|Clinical Trial Disclosure|+81 3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
21294206|NCT02152371|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21294207|NCT00350870|Yale University School Of Medicine Department of Psychiatry|Dr. Kathleen M. Carroll|203-937-3486|kathleen.carroll@yale.edu|7403
21294208|NCT00349921|Wake Forest University Health Sciences|Regina Curry, RN, CCRC|(336) 716-4294|recurry@wfubmc.edu|
21294209|NCT05352412|Washington University School of Medicine|Dr. Michael J. Durkin, Principal Investigator|314-454-8225|mdurkin@wustl.edu|
21294210|NCT05285644|Alcon Research, LLC|Scientific Advisor, Clinical Research and Development|1-888-451-3937|alcon.medinfo@alcon.com|
21294211|NCT00810771|VA Ann Arbor Healthcare System, Center for Clinical Management Research|Sarah Hawley, Ph.D.|734-936-8816|sarahawl@umich.edu|
21294212|NCT04382586|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21294213|NCT02425956|GE Healthcare|Research Manager|262-521-6819|Sandhya.Parameswaran@med.ge.com|
21294214|NCT05818956|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21294215|NCT02265536|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21294216|NCT03869385|University Hospital of Jena|Prof. Dr. Yasser Sakr|01742191538|yasser.sakr@med.uni-jena.de|0049
21294217|NCT02470585|AbbVie|Global Medical Services|1-800-633-9110|abbvieclinicaltrials@abbvie.com|
21294218|NCT03028415|Ferring Pharmaceuticals|Global Clinical Compliance|-+1 833-548-1402|DK0-Disclosure@ferring.com|
21294219|NCT02907216|GlaxoSmithKline|GSK Response Center|866-435-7343|kap69137@gsk.com|
21294220|NCT05079347|Vanderbilt University Medical Center|Carolyn Audet|615-343-2418|carolyn.m.audet@vumc.org|
21294221|NCT02095873|University of Warwick|Paul J Thornalley|+442476968594|P.J.Thornalley@warwick.ac.uk|
21294222|NCT04818216|University of Texas Health San Antonio|Dr. Subrata Debnath, Assistant Professor|210-450-8333|nath@uthscsa.edu|
21294223|NCT03763656|Nova Laboratories Ltd|Dr Hussain Mulla, Head of Clinical Development|0116 223 0101|hussain.mulla@novalabs.co.uk|
21294224|NCT04912089|UC San Diego|Jessica Bomyea|858-822-1470|jbomyea@health.ucsd.edu|
21294225|NCT00107900|Daiichi Sankyo, Inc.|Victor Fernandez|732-590-5000|vfernandez@dsi.com|
21294226|NCT02640625|Oslo University Hospital|Dr. Dag Henrik Reikvam|+4722119881|dagrei@ous-hf.no|
21294227|NCT00197145|ViiV Healthcare|GSK Response Center|866-435-7343||
21294228|NCT02370537|AstraZeneca AB|Stefan Carlsson||Stefan.C.Carlsson@astrazeneca.com|
21294229|NCT04178993|University of Kentucky|Dr. Craig Rush, Ph.D.|8592575388|crush2@uky.edu|
21294230|NCT03045406|FadoiFoundation|Giorgio Vescovo|00390685355188|irenezaratti@fadoi.org|
21294231|NCT03100539|Richard L Roudebush VA Medical Center|Dr. Matthew Bair, Director of Center for Health Information and Communication|317-988-2058|Matthew.Bair@va.gov|
21294232|NCT03804021|Adverum Biotechnology, Inc.|Chief Development Officer|650-649-1413|sseyedkazemi@adverum.com|
21294233|NCT05659719|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294234|NCT02290691|PharmaJet, Inc|Tara Miller, MS, Clinical Affairs Manager|888-900-4321|tara.miller@pharmajet.com|4163
21294235|NCT04324541|University of North Texas Health Science Center|Leigh Johnson, PhD|817-735-2938|Thanhtruc.Truong@unthsc.edu|
21294236|NCT05081167|Relmada Therapeutics|Marco Pappagallo, MD|786-638-7384|info@relmada.com|
21294237|NCT00185380|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21294238|NCT00978380|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
21294239|NCT02199314|Cincinnati Children's Hospital Medical Center|John J McAuliffe, MD|1513-636-4408|john.mcauliffe@cchmc.org|
21294240|NCT02450383|University of Iowa|Gustavo Avila-Ortiz|3193357241|gustavo-avila@uiowa.edu|
21294241|NCT01981863|Stanford University Medical Center|Peter van der Starre|6507236412|pieterva@stanford.edu|
21236036|NCT04495374|Universidade Federal de Alfenas|Profa. Dra. Larissa Helena Lobos Torres Pacheco|3537011805|larissa.torres@unifal-mg.edu.br|55
21294242|NCT01110330|Jan-Cil Switzerland|Director Infectious Diseases|41 41 7673477||
21294243|NCT00814697|The NY Memory and Healthy Aging Services|Dr. Gayatri Devi|212-517-6881|gd@nymemory.org|
21294244|NCT03990415|University of Missouri|Dr. Dana Duren|(573) 884-7023|durendl@health.missouri.edu|
21294245|NCT03258281|Sinai Center for Thrombosis Research|Director of Clinical Trials|443-244-1497|kpbliden@gmail.com|
21294246|NCT01089413|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21294247|NCT02513485|Emory University|Dr. Jennifer Felger|404-727-3987|jfelger@emory.edu|
21294248|NCT03811847|Massachusetts General Hospital|Steven Arnold, MD|617-643-5607|searnold@mgh.harvard.edu|
21294249|NCT02034175|Somnarus Inc|Maria Merchant|4087610884|somnarus@gmail.com|
21294250|NCT00394251|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21294251|NCT03350035|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
21294252|NCT01610557|National Eye Institute (NEI) at National Institutes of Health (NIH)|Henry E Wiley, MD, Principal Investigator|(301) 451-4260|wileyhe@mail.nih.gov|
21294253|NCT01942668|TherapeuticsMD|Sebastian Mirkin, MD, Chief Medical Officer|561-961-1900|smirkin@therapeuticsmd.com|1952
21294254|NCT03215758|Novartis Pharmaceutical|Study Director|862-778-8300|Novartis.email@novartis.com|
21294255|NCT04115748|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21294256|NCT00713349|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
21294257|NCT01200407|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294258|NCT00365105|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
21294259|NCT06004895|Aston University|Professor James S Wolffsohn|07833049245|j.s.w.wolffsohn@aston.ac.uk|
21294260|NCT00425698|Saarland University Medical Centre|Prof. Dr. Danilo Fliser|(49) 6841|indfli@uks.eu|1623526
21294261|NCT01328535|Mayo Clinic|Roxana S. Dronca, M.D.|507/284-2511|Dronca.Roxana@mayo.edu|
21294262|NCT01257230|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21294263|NCT02652208|Massachusetts General Hospital|Dr. Karen Sepucha|617-724-3350|ksepucha@partners.org|
21236037|NCT03727750|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21236038|NCT02203019|Texas Tech University|Dr Kenneth Nugent|18067436847|kenneth.nugent@ttuhsc.edu|
21236039|NCT00844194|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21236040|NCT00659165|Univ NM|Mark Burge|505-272-4658|mburge@salud.unm.edu|
21236041|NCT04450823|Global Surgery Amsterdam|Dr Matthijs Botman|0031648073683|matthijsbotman@gmail.com|
21236042|NCT01614210|Huntsman Cancer Institute|Josiah Hawks|8015850601|Josiah.Hawks@hci.utah.edu|
21236043|NCT01790750|University of Florida|Curt DeGroff|(352) 273-7831|degroffc@peds.ufl.edu|
21246585|NCT03931408|University of Louisville|Dr. Harkema|502-582-7676|lori.clark2@louisville.edu|
21294264|NCT01250184|university of Antioquia, Research Group Rehabilitation in Health|Dr. Luz Helena Lugo, Head of Research Group Rehabilitation in Health|+57 4 2196475|luzh.lugo@gmail.com|
21294265|NCT02209545|Northwestern Medicine|Dr. Magdy Milad|3126946447|mmilad@nm.org|
21294266|NCT01205061|Galderma|Clinical Scientist|+46184749000|reception.seupp@galderma.com|
21294267|NCT01320553|SPARC|Shravanti Bhowmik, MD||shravanti.bhowmik@sparcmail.com|
21294268|NCT01988662|Novartis Pharmaceuticals|Study Director|862-778-8300||
21294269|NCT02126553|The University of Texas MD Anderson Cancer Center|Tapan Kadia MD./Professor|713-563-3534|tkadia@mdanderson.org|
21294270|NCT03831191|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21294271|NCT03748706|Cassava Sciences|Lindsay Burns, SVP of Neuroscience|512-501-2484|lburns@cassavasciences.com|
21294272|NCT01194089|Mayo Clinic|Dr. Toby N. Weingarten|507-255-1612|weingarten.toby@mayo.edu|
21294273|NCT00695955|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21294274|NCT00158249|McLean Hospital|Scott E. Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu|
21294275|NCT03655054|Valencia Technologies|Jacqueline Dister|7604294787|jdister@valenciatechnologies.com|
21294276|NCT01626118|Iroko Pharmaceuticals, LLC|Daniel Solorio|267-546-3150|dsolorio@iroko.com|
21294277|NCT03549572|Spaulding Rehabilitation Hospital|Yelena Bodien|(617) 643-3956|ybodien@mgh.harvard.edu|
21236044|NCT01992536|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21294278|NCT03931382|Senior Director|John Jacob|604-875-2393|john.jacob@cw.bc.ca|
21294279|NCT00542490|University of Oklahoma|Lisa Landrum, MD|405 271-8001|lisa-landrum@ouhsc.edu|
21294280|NCT01864148|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21294281|NCT04405999|Almazov National Medical Research Centre|Evgeny Mikhaylov|+7(812)7023764|e.mikhaylov@almazovcentre.ru|
21294282|NCT03316118|Northwestern University|Paul Fitzgerald|312 695 1064|p-fitzgerald2@northwestern.edu|
21294283|NCT01500252|UAlberta|Dr. Lauren Beaupre|780-407-3945|lauren.beaupre@albertahealthservices.ca|
21294284|NCT03490292|UW Carbone Cancer Center|Nataliya Uboha, MD, PhD|(608) 265-9966|nvuboha@medicine.wisc.edu|
21294285|NCT01106651|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise||ClinicalTrialDisclosure@its.jnj.com|
21294286|NCT03231917|White River Junction VAMC|Dr Joseph Anderson|8022959363|joseph.anderson@dartmouth.edu|
21294287|NCT01006655|Rambam medical Center|Prof Lea Bentur|xx 972 4 854 3263|l_bentur@rambam.health.gov.il|0502062400
21294288|NCT00673231|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
21294289|NCT02952313|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
21294290|NCT00945529|Nemours Cardiac Center at A. I. duPont Hospital for Children|Ellen Spurrier, MD|302-651-6600|ellen.spurrier@nemours.org|
21294291|NCT03009162|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21294292|NCT02791516|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21294293|NCT02524275|University of Nebraska Medical Center|Dr. Apar Ganti|402-559-8121|aganti@unmc.edu|
21294294|NCT04114071|University of Alabama at Birmingham|Dr. Pamela G. Bowen|12059342778|pbowen@uab.edu|
21294295|NCT02453750|SickKids|Dr Theo Moraes|416 813 2196|theo.moraes@sickkids.ca|
21294296|NCT03407053|NIDDK|Kevin Hall, PhD|301-402-8248|kevin.hall@nih.gov|
21294297|NCT00511433|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21294298|NCT02383420|Carestream Health, Inc.|Susan Pate, Senior Clinical Affairs Manager|585-627-6557|susan.pate@carestream.com|
21294299|NCT01971463|University of Pennsylvania|Michael Mullen|215-662-3339|mmullen@pennmedicine.upenn.edu|
21294300|NCT03018418|University of Cincinnati Cancer Center|Jordan Kharofa, MD|513-584 4775|kharofjr@ucmail.uc.edu|
21294301|NCT03764631|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21294302|NCT01289353|NYU Langone Health - PCC CTO|Carmen Perez, MD, PhD|212-731-5003|carmen.perez@nyulangone.org|
21294303|NCT01549886|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
21294304|NCT01505673|University of Texas Southwestern Medical Center at Dallas|Dr. Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
21294305|NCT03257202|Keck Medical Center of USC|Dr. George Hatch|323-442-5860|ghatch.md@gmail.com|
21294306|NCT00611468|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
21294307|NCT01466660|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21294308|NCT03576066|Assembly Biosciences|Linda Bahr, Sr. Director, Clinical Operations|415-521-3808|clinicaltrials@assemblybio.com|
21294309|NCT04528017|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21294310|NCT01126268|The University of Texas Health Science Center at Houston|Dr. Adelaide A Hebert|(713) 500-8339|Adelaide.A.Hebert@uth.tmc.edu|
21294311|NCT03425006|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
21236045|NCT03907501|UCSD School of Medicine|Dr. Christine Tara Peterson|7033959377|chpeterson@health.ucsd.edu|
21246586|NCT02224144|Columbia University|Thomas Nickolas MD, MS|2123053273|tln2001@cumc.columbia.edu|
21294312|NCT02972606|King's College London|Dr Whitney Scott|02071885421|whitney.scott@kcl.ac.uk|
21236046|NCT03017508|Yale University|Angeli Landeros|203-737-4809|angeli.landeros@yale.edu|
21236047|NCT03669081|University of Utah|Eryberto Martinez|801-581-2563|eddie.martinez@utah.edu|
21236048|NCT02352493|Alnylam Pharmaceuticals, Inc.|Chief Medical Officer|866.330.0326|Clinicaltrials@alnylam.com|
21236049|NCT00389324|Grifols Therapeutics, Inc.|Henry Li, PhD|800-520-2807|henry.li@grifols.com|
21236050|NCT00706121|SWOG Statistical Center|SELECT/S0000D Statistician|206-667-4623||
21236051|NCT03936244|Hospital Universitario Fuenlabrada|Dr. Hugo Otaola Arca|+56 9 4108 9452|hugotaolarca@hotmail.com|
21246587|NCT03505008|Keio University School of Medicine|Prof. Y Kaneko|+81-3-5363-3786|ykaneko@z6.keio.jp|
21294313|NCT03503591|Preceptis Medical|Steve Anderson, CEO|612-327-4795|steve@preceptismedical.com|
21246588|NCT02962076|Mercy Research|Michelle Bryant, MPH|314-251-8827|michelle.bryant@mercy.net|
21246589|NCT02780700|Boehringer Ingelheim|Boehringer IIngelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21246590|NCT03367754|Clinical Center|Kovacs, Joseph|+1 301 496 9907|jkovacs@mail.nih.gov|
21246591|NCT04538378|National Cancer Institute|Dr. Anish Thomas|240-760-7343|anish.thomas@nih.gov|
21246592|NCT04580914|Boston Scientific|Claire Dietzsch, Senior Clinical Trials Specialist|9529306745|Claire.Dietzsch@bsci.com|
21246593|NCT05205486|B. Braun Medical Inc.|Director, Scientific Affairs Operations|610-596-2512|kevin.minnich@bbraunusa.com|
21246594|NCT02998528|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21246595|NCT05210569|Image Plus Laser Eye Centre|Dr James Wiens|1-204-943-6287|jamesjwiens@gmail.com|
21246596|NCT00544414|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
21246597|NCT05035654|Lyra Therapeutics|Senior Vice President, Clinical Affairs|617-393-4600|lyraclinical@lyratx.com|
21246598|NCT04204083|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
21246599|NCT04750941|Columbia University|Jennifer E. Amengual, MD|212-326-5720|jea2149@cumc.columbia.edu|
21246600|NCT05814211|Coloplast A/S|Christian Riis Forman, Medical writer|49111756|dkcrif@coloplast.com|
21246601|NCT03812289|OHSU Knight Cancer Institute|Nima Nabavizadeh, MD|503-418-3685|nabaviza@ohsu.edu|
21246602|NCT02484430|Mayo Clinic|Aref Al-Kali, M.D.|(507) 284-2511|alkali.aref@mayo.edu|
21246603|NCT03421340|Boston Scientific|Pooja Goswamy|15086834335|pooja.goswamy@bsci.com|
21246604|NCT03624465|Levita Magnetics|Vivian Soto|+56958360507|VSoto@Levita.com|
21246605|NCT01199133|Stallergenes|Michel Roux, Medical Director|+33 (0) 1 55 59 29 70|mroux@stallergenes.com|
21246606|NCT02575950|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
21246607|NCT04181736|Stanford University|Laura Hack, MD, PhD|650-724-7478|lhack@stanford.edu|
21246608|NCT05080283|Cochlear Ltd.|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
21246609|NCT03993392|Indivior, Inc|Global Director, Clinical Development|804-379-1090|Robert.Dobbins@Indivior.com|
21246610|NCT03106740|Massachusetts General Hospital|Marco Loggia|(617) 643-7267|marco.loggia@mgh.harvard.edu|
21246611|NCT06262477|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21246612|NCT03963518|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Carine Bellera|+33556333333|c.bellera@bordeaux.unicancer.fr|
21246613|NCT05365958|University of Houston|Dr. Chakema Carmack, Ph.D., Associate Professor|713-743-6231|ccarmack@central.uh.edu|
21246614|NCT03220035|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21246615|NCT05452460|Department of Physical Education and Sport Sciences, National Taiwan Normal University|Dr. Yu-Kai Chang|+886277493223|yukaichangnew@gmail.com|
21246616|NCT04433208|Prolacta Bioscience|Dr David Rechtman VP, Medical Affairs|8887765228|drechtman@prolacta.com|
21246617|NCT02010242|Calliditas Therapeutics|Richard Philipson, MD Chief Medical Officer|+46 556659-9766|richard.philipson@calliditas.com|
21246618|NCT02424617|BerGenBio ASA|BerGenBio Clinical Team|+ 47 55961159|registry.postings@bergenbio.com|
21246619|NCT05270876|Cochlear|PRS Specialist|+61294286555|cltd-prs-admin@cochlear.com|
21246620|NCT04359654|University College London|Ms Donna Basire|+44-2031087748|d.basire@ucl.ac.uk|
21246621|NCT04024020|University of Pennsylvania|Philip Gehrman|2157463578|philip.gehrman@pennmedicine.upenn.edu|
21246622|NCT04738591|Health Research Institute of the Balearic Islands (IdISBa)|Dr. Rocío Zamanillo Campos|971175897|rocio.zamanillo@ssib.es|
21246623|NCT05269966|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21246624|NCT05575219|The University of Texas Health Science Center at Houston|Andrea Leigh Heifner, MD|407-729-2972|andrea.heifner@stjude.org|
21246625|NCT03476343|Cincinnati Children's Hospital Medical Center|Dr. Beth Kline-Fath|(513) 636-1856|beth.kline-fath@cchmc.org|
21246626|NCT05974501|University of Miami|Dr. Victor H. Hernandez|305-243-4000|vhh1@med.miami.edu|
21246627|NCT04304144|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
21246628|NCT04585815|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21246629|NCT04362085|St. Michael's Hospital|Dr. Michelle Sholzberg|4168606060|michelle.sholzberg@unityhealth.to|
21246630|NCT02497950|Rigshospitalet Copenhagen, Denmark|Prof. Finn Gustafsson|+4535459743|finn.gustafsson@regionh.dk|
21246631|NCT04660539|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21246632|NCT04249362|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21246633|NCT04862234|Emory University|Georgia Davis, MD|404-251-8957|georgia.marie.davis@emory.edu|
21246634|NCT03292484|Aimmune Therapeutics, a Nestlé Health Science Company|Jay Patel|(800) 422-2752|jay.patel@uk.nestle.com|
21246635|NCT04484428|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
21246636|NCT05290493|Nobias Therapeutics, Inc.|Patrick Dougherty|(215) 821-4698|dougherty@nobiastx.com|
21246637|NCT05524402|Massachusetts General Hospital|Dr. Jonathan Greenberg|617-643-9402|jgreenberg5@mgh.harvard.edu|
21246638|NCT05976334|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21246639|NCT03381586|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
21246640|NCT05280574|Outcomes Research Consortium, Department of Anesthesiology, Cleveland Clinic, Cleveland, Ohio|Daniel I. Sessler MD, Professor and Michael Cudahy Chair|216-870-2620|DS@OR.org|
21246641|NCT05363163|Eurofins Dermscan Pharmascan|Florence REBER|0472823656|Florence.Reber@cpt.eurofinseu.com|+33
21246642|NCT05735652|Boston Scientific|Taimin.Yue|18911590729|Taimin.yue@bsci.com|
21246643|NCT03154190|Stanford University School of Medicine|Manali Patel|650-723-4000|manalip@stanford.edu|
21246644|NCT05838027|University of Pennsylvania|Eva Fabian|760-791-2633|eva.fabian@pennmedicine.upenn.edu|
21262275|NCT02553915|Massachusetts General Hospital|Dr David Mischoulon, Director, Depression Clinical and Research Program, MGH|617-724-5198|dmischoulon@mgh.harvard.edu|
21294314|NCT01113008|H Virgen de la Victoria|Dr Manuel Jiménez Navarro|951 032 354|jimeneznavarro@secardiologia.es|0034
21294315|NCT00614445|Duchesnay, Inc.|Michael Gallo|450-433-7734|mgallo@duchesnay.com|
21294316|NCT01467037|McGill University Health Centre|Dr Caroline Quach, Pediatric Infectious Diseases Consultant & Medical Microbiologist|514-934-1934|caroline.quach@mcgill.ca|24485
21294317|NCT03070171|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21294318|NCT00323960|IRCCS Istituto Giannina Gaslini|Dr. Nicolino Ruperto|+39-010-382854|nicolaruperto@gaslini.org|
21246645|NCT05237284|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21246646|NCT04999111|Janssen R&D US|SENIOR ADVISOR CLINICAL DEVELOPMENT|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21294319|NCT03768089|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21294320|NCT00712725|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21294321|NCT01901289|Cook Research Incorporated|Manager, Biostatistics|7654637537|Alan.Saunders@CookMedical.com|321204
21294322|NCT00889603|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294323|NCT03525600|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
21246647|NCT05987072|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21246648|NCT03169972|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21246649|NCT00670241|LEO Pharma|Anders Rhod Larsen, Scientific Advisor|+4572262990|anders.larsen@leo-pharma.com|
21246650|NCT04056611|Janssen Research & Development, LLC|Senior Director Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21246651|NCT03213873|Karolinska Institutet|Erika Franzén|08-52488878|erika.franzen@ki.se|
21246652|NCT05776875|Yale University|Wei Cheng|203-737-7005|w.cheng@yale.edu|
21246653|NCT04709419|The University of Texas Health Science Center at San Antonio|Lawrence Lavery, DPM|214-399-5381|lavery@uthscsa.edu|
21246654|NCT05683340|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81363617366|CL_OPCJ_RDA_Team@otsuka.jp|
21246655|NCT02437136|Syndax Pharmaceuticals, Inc.|Kate Madigan, MD, Chief Medical Officer|858-888-3798|kmadigan@syndax.com|
21246656|NCT02056834|Synthes GmbH|Clinical Research Scientist Biomaterials|0041327204465|clinicalaffairs.emea@synthes.com|
21246657|NCT04117178|Department of Neurology, Zealand University Hospital|Michael Fischer|+4547322800|mihh@regionsjaelland.dk|
21246658|NCT04312841|The Ohio State University Comprehensive Cancer Center|Dr. John Reneau|614-293-3196|John.Reneau@osumc.edu|
21246659|NCT06193070|Fred Hutchinson Cancer Center|Dr. Megan Shen, Associate Professor|206-667-4172|mshen2@fredhutch.org|
21246660|NCT05046639|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.edu|
21246661|NCT03276676|Huntsman Cancer Institute, Center for Quantitative Cancer Imaging|Sam Mitchell|801-213-6110|sam.mitchell@hci.utah.edu|
21246662|NCT04753788|LSHTM|Professor Michael Marks|+44020 7636 8636|michael.marks@lshtm.ac.uk|
21246663|NCT05015751|Rhaeos, Inc.|Anna Somera|855-814-3569|info@rhaeos.com|
21246664|NCT05482360|University of Washington|Anjuli Wagner, PI|978 460 2331|anjuliw@uw.edu|
21246665|NCT03926130|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21246666|NCT03583333|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21246667|NCT03980925|MFAR Clinical Research|Federico Nepote|+34 93 434 44 12|investigacion@mfar.net|
21246668|NCT05723575|University of Wisconsin - Madison|Carrie Niziolek, PhD|(608) 262-7583|cniziolek@wisc.edu|
21246669|NCT06397443|IRCCS Istituto Ortopedico Rizzoli|Dr. Manila Boarini|+39 051 63666062|manila.boarini@ior.it|
21246670|NCT01569659|Northwestern University|Herbert Meltzer, MD|312-503-9096|h-meltzer@northwestern.edu|
21246671|NCT03149822|University of Colorado Hospital|Dr. Elaine Lam|7208480723|elaine.lam@cuanschutz.edu|
21246672|NCT03687762|The University of Queensland|Dr. Melissa Day, Co-Principal Investigator|+61 7 3365 6421|m.day@uq.edu.au|
21246673|NCT05130814|Emoled srl|Duccio Rossi Degl'Innocenti|+390550751960|d.rossi@emoled.com|
21246674|NCT04723147|Emory University|Dr. Jennifer Felger|404-727-3987|jfelger@emory.edu|
21246675|NCT03824366|Washington University School of Medicine|Hyun Kim, M.D.|314-362-8502|kim.hyun@wustl.edu|
21246676|NCT04587024|Johns Hopkins University|Dr. Cozumel S. Pruette|410-955-2467|csouthe1@jhmi.edu|
21246677|NCT05069896|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21246678|NCT04068831|Memorial Sloan Kettering Cancer Center|Dr. Ritesh Kotecha, MD|646-422-4791|kotechar@mskcc.org|
21246679|NCT05395871|Imperial College London|Amish Acharya|0203312 6666|aa2107@ic.ac.uk|
21246680|NCT05715528|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21246681|NCT03118518|Medtronic|Erika Pouliot|17635261270|erika.pouliot@medtronic.com|
21246682|NCT04667468|University of Pittsburgh|Dr. Jason Sperry|412-215-7025|sperryjl@upmc.edu|
21246683|NCT00696124|Helixmith Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
21246684|NCT04565990|Actelion Pharmaceuticals Ltd|Executive Medical Director CP|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21246685|NCT04797858|University of Pennsylvania|Robert Gross|2158982437|grossr@pennmedicine.upenn.edu|
21246686|NCT03426891|Moffitt Cancer Center|Dr. Peter Forsyth|813-745-3063|Peter.Forsyth@moffitt.org|
21246687|NCT01960452|University of Wisconsin|Meredith Rumble, PhD|608-232-3171|rumble@wisc.edu|
21246688|NCT04766892|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21246689|NCT02668692|LEO Pharma A/S|Clinical Trial Disclosure Manager||disclosure@leo-pharma.com|
21246690|NCT03981926|University of California, Los Angeles|April W. Armstrong, MD, MPH; Professor and Chief of Dermatology|424-365-4129|skinstudy@mednet.ucla.edu|
21246691|NCT04491617|Cleveland Clinic|Cecile Ferrando, M.D.|216-444-0642|ferranc2@ccf.org|
21246692|NCT06262347|University of Cincinnati|T. John Winhusen, PhD.|513-585-8292|winhust@ucmail.uc.edu|
21236052|NCT00504829|Life Cycle Pharma|H. Eugene Griffin, MS, DVM|646-200-8505|ggr@lcpharma.com|
21236053|NCT01854827|University of Michigan|DCC PI|734-936-3585|mageej@med.umich.edu|
21236054|NCT02667912|Tomsk National Research Medical Center of the Russian Academy of Sciences|Dr. Stanislav Pekarskiy|+73822558122|pekarski@cardio-tomsk.ru|
21236055|NCT04443218|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
21236056|NCT01131312|National Cancer Institute|Dr. Mark Schiffman|240-276-7259|schiffmm@nih.gov|
21236057|NCT01984398|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21236058|NCT03834194|University of Virginia, School of Medicine|Dr. Rebecca Krukowski|9014482426|wae4mq@virginia.edu|
21236059|NCT01751568|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 544-7040|mallen@fhi360.org|11246
21236060|NCT02660944|Resolve Therapeutics LLC|James Posada|(208)7277010|jp@resolvebio.com|
21236061|NCT02843568|University of Wisconsin Carbone Cancer Center|Cancer Connect|800-622-8922|clinicaltrials@cancer.wisc.edu|
21236062|NCT03586999|University of Colorado|Brad Haverkos, MD|7208488698|brad.haverkos@cuanschutz.edu|
21236063|NCT03447769|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
21236064|NCT01701375|Johns Hopkins University|Ivana Gojo, MD|410-502-7726|Igojo1@jhmi.edu|
21236065|NCT03526900|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
21236066|NCT03264989|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21236067|NCT02807597|UT Southwestern Medical Center|Dr. Samuel Achilefu|314-362-8599|Samuel.Achilefu@UTSouthwestern.edu|
21236068|NCT00797667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21236069|NCT01986829|Washington University School of Medicine|Brian Van Tine, M.D.|314-362-5817|bvantine@wustl.edu|
21236070|NCT02073968|Montefiore Medical Center / Albert Einstein College of Medicine|Dr. Nitin Ohri|718-920-7750|nitin.ohri@einsteinmed.edu|
21236071|NCT01645709|CaloSyn Pharma Inc.|Stephen Snowdy, PhD|404-863-8892|ssnowdy@ansleyvc.com|
21236072|NCT03054844|Columbia University|Dr. Daniel Tsze|212-305-9825|dst2141@columbia.edu|
21236073|NCT02673697|Corcym|Elisa Cerutti|+39 3459182413|elisa.cerutti@corcym.com|
21236074|NCT00437489|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21236075|NCT01286818|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21236076|NCT01525082|Stanford University|Shaheen Shagufta, Clinical Assistant Professor|650-725-6454|sshaheen@stanford.edu|
21236077|NCT03259035|Canadian Cancer Trials Group|Dr. Chris O'Callaghan|6135336430|cocallaghan@ctg.queensu.ca|
21236078|NCT01528228|A.T. Still University|Corey Luebbering|660.626.2147|coreyluebbering@atsu.edu|
21236079|NCT02209324|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
21236080|NCT01985126|Janssen Research & Development, LLC|Senior Director Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
21236081|NCT00366626|Medical University of South Carolina|Dr. Raymond F. Anton, Distinguished University Professor|843-792-1226|antonr@musc.edu|
21236082|NCT04177108|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21236083|NCT04496258|University of Denver|Kateri McRae|3038713632|Kateri.McRae@du.edu|
21236084|NCT00499889|UT MD Anderson Cancer Center|Richard E. Champlin, MD/Professor|713-792-8848|pmcadams@mdanderson.org|
21236085|NCT03176693|University of California Los Angeles|Masha Livhits, MD|310-206-0585|mlivhits@mednet.ucla.edu|
21236086|NCT05003791|University of Illinois Chicago|Dr. Madison Goodyke|6166446417|mbuurs2@uic.edu|
21236087|NCT00766376|Palomar Medical Technologies, Inc.|Director of Regulatory Affairs|781-993-2414|stimberlake@palomarmedical.com|
21236088|NCT01422070|Università degli Studi di Ferrara|Dr Maurizia Capuzzo|+393355932642|cpm@unife.it|
21236089|NCT03149328|University of Alberta|Dr. Kara Schick-Makaroff|1-780-492-9043|kara.schickmakaroff@ualberta.ca|
21236090|NCT02584309|Washington University School of Medicine|Brian A. Van Tine, M.D., Ph.D.|314-747-8475|bvantine@wustl.edu|
21236091|NCT00852397|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21236092|NCT01751022|Medtronic|Shelby Li|+17635262704|shelby.li@medtronic.com|
21236093|NCT03861000|National Institute of Mental Health|Dr Robert Innis|+1 301 693 2979|innisr@mail.nih.gov|
21236094|NCT01968434|Clalit HS|Prof. Herman Avner Cohen|00972 3-939-8203|hermanc@clalit.org.il|
21236095|NCT02199691|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext 1#|Contact-US@sanofi.com|
21236096|NCT00774995|GlaxoSmithKline|GSK Response Center|866-435-7343||
21236097|NCT03964454|RTI International|Yukiko Washio|9194852794|ywashio@rti.org|
21236098|NCT00136955|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21236099|NCT02239510|TriHealth Hatton Research Institute|Jenni Steinbrunner|513-862-4033|jenni_steinbrunner@trihealth.com|
21236100|NCT01787604|MeshalkinRI|Dmitry|+79069090505|dmhvan@mail.ru|
21236101|NCT01203189|Saint Louis Univ Hospital|Aibing Mary Guo, M.D., Assistant Professor|3142563430|aguo@slu.edu|
21236102|NCT02180646|University of Missouri|Dr Jill Kanaley|573-882-2519|kanaleyj@missouri.edu|
21236103|NCT05349617|Bavarian Nordic A/S|Medical Information|1-844-422-8274|medical.information_na@bavarian-nordic.com|
21236104|NCT00566228|Mayo Clinic|Luis F. Porrata, M.D.|507/284-2511|Porrata.Luis@mayo.edu|
21236105|NCT05706506|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21236106|NCT00987467|Johns Hopkins University, Wilmer Eye Institute|Esen Akpek, MD, Associate Professor of Ophthalmology, Wilmer Eye Institute|410-955-5214|esakpek@jhmi.edu|
21236107|NCT00262834|SKCCC|Vered Stearns|4432876489|vstearn1@jhmi.edu|
21236108|NCT03523533|University of New Mexico Health Sciences Center (HSC)|Dr. Tim Petersen|5052722610|timpetersen@salud.unm.edu|
21236109|NCT01303627|Ministry of Health Diskapi Yildirim Beyazit Training and Research Hospital 1. Anesthesiology|Derya Özkan MD|0903125962553|derya_z@yahoo.com|
21236110|NCT00111657|Duke University Medical Center|John S. Sundy, MD, PhD|919-684-2347|john.sundy@duke.edu|
21246693|NCT04267120|Washington University School of Medicine|Joel Picus, M.D.|314-362-9115|jpicus@wustl.edu|
21294324|NCT00344318|GlaxoSmithKline|GSK Response Center|866-435-7343||
21294325|NCT01014936|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21294326|NCT00118248|Washington University School of Medicine|Jeffrey F. Moley, M.D.||moleyj@wustl.edu|
21294327|NCT00700882|ECOG-ACRIN Statistical Office|Study Statistician|6176323012|eatrials@jimmy.harvard.edu|
21294328|NCT00683930|Hoffmann-La Roche|Medical Communications|800-821-8590||
21294329|NCT01153711|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21294330|NCT01606176|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
21294331|NCT01832493|Medtronic CRHF|Medtronic SOCR Clinical Trial Leader|1-800-328-2518|medtronicCRMtrials@medtronic.com|
21294332|NCT03158740|Connecting Health Innovations|Senior Scientist|8649154636|admin@chi-llc.net|
21294333|NCT01454505|Alcon Research, Ltd.|Terri Pasquine, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21294334|NCT00869791|Impax Laboratories, Inc.|Michelle Landolfi, PhD. Sr. Director, Regulatory Affairs|(510) 240-6496|Michelle.Landolfi@impaxlabs.com|
21294335|NCT00290771|Novartis Pharmaceuticals|Study Director|862 778-8300||
21294336|NCT03703817|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294337|NCT02247011|Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital,Chinese Academy of Medical Science|Dr. Weibo Xia|86-10-6915-5076|xiaweibo@medmail.com.cn|
21294338|NCT05145322|University of Minnesota School of Dentistry|Hooi Pin Chew|6126256975|chew0014@umn.edu|
21294339|NCT06359028|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
21294340|NCT00792740|Italfarmaco SpA|Tiziano Oldoni, MD|+39 0264432540|t.oldoni@italfarmaco.com|
21246694|NCT05427253|Vicore Pharma AB|Cecilia Ganslandt, MD, MSc, Global Medical Director|+46 317880560|info@vicorepharma.com|
21294341|NCT02485639|Emory University|Rafi Ahmed, PhD|404-727-3571|rahmed@emory.edu|
21294342|NCT01439971|Catalyst Biosciences|Chief Medical Officer|1-650-266-8671|hlevy@catbio.com|
21294343|NCT02628600|Insmed Inc|Kevin Mange (Senior Vice President, Clinical Development & Medical Affairs, ALIS)|908-947-2651|kevin.mange@insmed.com|
21294344|NCT03236909|MED-EL Corporation|Clinical Research Manager|888-633-3524|research.us@medel.com|
21294345|NCT04283994|University of Washington|Dr. Erin Kross|206-744-4649|ekross@uw.edu|
21294346|NCT00583752|University of Iowa, Holden Comprehensive Cancer Center|David Lubaroff, MD|3193561527|david-lubaroff@uiowa.edu|
21294347|NCT01101958|ThoraxKlinik, University of Heidelberg|Prof. Dr. F.J.F. Herth|650-216-0176|Felix.Herth@thoraxklinik-heidelberg.de|
21294348|NCT00830375|University of Minnesota|Jon E. Grant|612-273-9800|grant045@umn.edu|
21294349|NCT01700959|St. Jude Children's Research Hospital|Tara M. Brinkman, PhD|(901) 595-5683|tara.brinkman@stjude.org|
21294350|NCT03040011|Magee-Womens Hospital of UPMC|Dr. Lauren Giugale, PI|412-641-1498|giugalele@upmc.edu|
21294351|NCT02867813|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21294352|NCT02013206|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21294353|NCT01301521|MOMH|Amanda Crawford|702-653-3583|amanda.j.crawford.ctr@health.mil|
21294354|NCT01952665|CooperVision|Donald Siegel, OD Principal Investigator|(949) 597-4700|dsiegel@coopervision.com|
21294355|NCT01760473|New York State Psychiatric Institute|Dr. Sandra Comer|646 774-6146|sdc10@columbia.edu|
21294356|NCT01537081|Reckitt Benckiser LLC|Gail Solomon,MS; Director Clinical Development|973-404-2752|gail.solomon@rb.com|
21246695|NCT03711474|West Virginia University|Scott Daffner, MD|304-293-1172|sdaffner@hsc.wvu.edu|
21246696|NCT05618587|University at Buffalo|Thomas Guttuso, Jr., MD|716-932-6080|tguttuso@buffalo.edu|
21246697|NCT03442309|New York University|Richard Niederman|917-280-5920|r.niederman@nyu.edu|
21246698|NCT03314688|Yale School of Medicine|Tara Sanft, MD|(203) 200-2328|tara.sanft@yale.edu|
21246699|NCT02446236|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
21246700|NCT05176093|Helixmith Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
21246701|NCT03085719|Dana-Farber Cancer Institute|Jonathan Schoenfeld, MD, MPH|617-582-8731|Jonathan_Schoenfeld@dfci.harvard.edu|
21246702|NCT04136912|UNC Lineberger Comprehensive Cancer Center|Desma Jones|(919) 843-9463|desma_jones@med.unc.edu|
21246703|NCT00661141|Horizon Pharma USA, Inc.|Beth Robinson, Executive Director||clinicaltrials@horizonpharma.com|
21246704|NCT03804788|University of Missouri|Dr. Mary Beth Miller|573-882-1813|millmary@health.missouri.edu|
21246705|NCT03018366|Mayo Clinic|Dr. Chrisandra Shufelt|904-953-7224|shufelt.chrisandra@mayo.edu|
21246706|NCT04003246|University of Texas Southwestern Medical Center|Dr. Yuanyuan Zhang|2146458525|yuanyuan.zhang@utsouthwestern.edu|
21246707|NCT05716763|Unither-Pharmaceuticals|Non-clinical & clinical Project Manager|33 (0)1 44 63 51 78|clinicaltrials@unither-pharma.com|
21246708|NCT03703908|ChemoCentryx|Study Director|650-210-2900|clinicaltrials@chemocentryx.com|
21246709|NCT01866163|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
21246710|NCT02834390|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21246711|NCT06029452|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21246712|NCT01726257|Endologix|Tammy Stiver|5136731452|tstiver@endologix.com|
21246713|NCT04560595|Johns Hopkins University|Dr. Dustin C. Lee|410-550-4035|dlee214@jhmi.edu|
21246714|NCT05533190|The Institute of Cancer Research|Prof Ceire Costelloe|20 3437 6777|ceire.costelloe@icr.ac.uk|
21262276|NCT03662334|Halozyme Therapeutics|Dimitrios Chondros, M.D., Chief Medical Officer|858-794-8889|dchondros@halozyme.com|
21262277|NCT00477451|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
21246715|NCT05856435|Cincinnati Children's Hospital Medical Center|Katie Nause|513-803-1506|Katie.Fox@cchmc.org|
21294357|NCT01022359|Imperial College London|Neill Duncan|+44 (0 )207 594 7243|n.duncan@imperial.ac.uk|
21294358|NCT03817463|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21294359|NCT00882583|FDA|Shanthi Marur|2404026373|shanthi.marur@fda.hhs.gov|
21294360|NCT02964559|Emory University|Dr. Michael Lowe|404-778-7215|mlowe3@emory.edu|
21294361|NCT01215643|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
21294362|NCT02596958|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21294363|NCT01559259|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294364|NCT01995669|University of Texas M D Anderson Cancer Center|Dr. Loretta Nastoupil|(713) 792-2860|lnastoupil@mdanderson.org|
21294365|NCT05425732|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21294366|NCT02150551|Children's National Hospital|Catherine Bollard, MD|202-476-4776|cbollard@childrensnational.org|
21294367|NCT01120236|Department of Medicine, Division of Oncology, University of Washington|Evan Y. Yu, MD||evenyu@u.washington.edu|
21294368|NCT00327015|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
21294369|NCT04569136|National Cheng Kung University|Dr. Kuan-Yin Lin|+886-6-2353535|10802003@gs.ncku.edu.tw|6737
21294370|NCT00129701|Imperial College London|Prof Martyn R Patridge|+44 (0)20 7594 7959|m.patridge@imperial.ac.uk|
21294371|NCT04478071|The University of Texas Health Science Center at Houston|Bentley J. Bobrow, MD|713-500-7863|Bentley.J.Bobrow@uth.tmc.edu|
21294372|NCT02704702|Celerion|Dr.Laura Sterling|1-402-476-2811|laura.sterling@celerion.com|
21294373|NCT00123162|MS Hershey Medical Center|Richard S Legro MD|717-531-8478|rsl1@psu.edu|
21294374|NCT01232504|Department of Hematology, Shanghai Jiao Tong University Affiliated First People's Hospital, China|Chun Wang||wangchun2@medmail.com.cn|
21294375|NCT02591537|Northwestern University|Dr. Robert Galiano, Associate Professor of Surgery|312.695.3908||
21294376|NCT01178944|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21294377|NCT00005901|National Institute of Child Health and Human Development|Joan Marini|+1 301 594 3418|marinij@cc1.nichd.nih.gov|
21294378|NCT00244933|Barbara Ann Karmanos Cancer Institute|Amy Weise, M.D.|313-576-8599|weisea@karmanos.org|
21294379|NCT02661737|LG Chem|Study Leader|82-2-6987-4148|sodam@lgchem.com|
21294380|NCT01591954|Department of Biomedical Engineering, Johns Hopkins University|Jeffrey H. Siewerdsen, PhD / Professor of Biomedical Engineering|443-287-6269|jeff.siewerdsen@jhu.edu|
21294381|NCT05129449|OLYMPUS EUROPA SE & CO. KG|Dr. Peter Teichmann|+49 40 23773|peter.teichmann@olympus.com|7835
21294382|NCT01777217|Century Cancer Centers|Dr. Sanjay Mehta|713-631-8181||
21294383|NCT03814382|Massachusetts General Hospital|Jessica Gerber, DAc.|617-724-1992|jgerber2@mgh.harvard.edu|
21294384|NCT01818739|The Ohio State University Comprehensive Cancer Center|Floor Backes, MD|614-730-6968|Floor.Backes@osumc.edu|
21294385|NCT00656058|National Cancer Institute|Dr. Ronald E. Gress|301-496-1791|gressr@dc10a.nci.nih.gov|
21294386|NCT00642434|University of New Mexico Health Sciences Center|Dr. Kathleen Colleran|505-272-4658|KColleran@salud.unm.edu|
21294387|NCT00616018|Denver Health|Jody Green|303-389-1246|jody.green@rmpdc.org|
21294388|NCT03718884|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21294389|NCT02609841|ZS Pharma, Inc.|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21294390|NCT01818258|Organization: Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
21294391|NCT02099344|Kaiser Permanente NW|Earl Schuman, MD|503-331-6017|kathleen.ann.arnold@kpchr.org|
21294392|NCT02708849|Yale School of Medicine|Chadi Abdallah|347-987-0717|chadi.abdallah@yale.edu|
21294393|NCT00404755|New York State Psychiatric Institute|Jonathan W. Stewart, M.D.|646-774-8000|jws6@columbia.edu|
21294394|NCT02839720|UAB Heersink School of Medicine|Bruce R. Korf, MD, PhD|205-996-9487|bkorf@uabmc.edu|
21294395|NCT04700540|University of Minnesota|Dr. Jude Mikal|385-212-4185|jpmikal@umn.edu|
21294396|NCT03194568|Children's Hospital of Philadelphia|Dr. Patrick Cahill|2155901000|cahillp1@chop.edu|
21294397|NCT03927482|The Miriam Hospital|Beth Bock, PhD|4017938020|Beth_Bock@Brown.edu|
21294398|NCT03306979|Sunnybrook Health Sciences Centre|Dr. Krista Lanctôt, Senior Scientist|416-480-6100|krista.lanctot@sunnybrook.ca|62241
21294399|NCT05248997|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294400|NCT03515551|Immunocore, Ltd|Study Director|1-844-IMMUNO-1|clinicaltrials@immunocore.com|
21294401|NCT00920387|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corp.|Berra Yazar-Klosinski, PhD / Chief Scientific Officer|(831) 429-6362|trialdata@mapsbcorp.com|
21294402|NCT04470908|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21294403|NCT02835313|University of Delaware|Dr. Darcy Reisman, PT, PhD, FAPTA|302-831-0508|dreisman@udel.edu|
21294404|NCT04084366|OBI Pharma, Inc.|Dr. Wayne Saville, Chief Medical Officer|619-537-7821|waynesaville@obipharmausa.com|
21294405|NCT02602275|Biologische Heilmittel Heel GmbH|Head of Clinical Research|+49 7221 501|info@heel.com|0
21294406|NCT01258790|Cincinnati Children's Hospital Medical Center|Steve Wu, MD|513-636-4222|steve.wu@cchmc.org|
21294407|NCT02241733|Edward Hines Jr., VA Hospital|Eileen Collins RN, PhD, Research Nurse Scientist|312-413-5621|ecollins@uic.edu|
21294408|NCT01866111|SK Life Science|Chief Medical Officer|201-421-3830|mkamin@sklsi.com|
21246716|NCT05660434|West Virginia University|Dr. Marian Reven, PhD, RN, AHN-BC, CNE, RA|304-293-3399|marian.reven@hsc.wvu.edu|
21246717|NCT06324344|Baylor College of Medicine|Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
21246718|NCT03213678|Children's Oncology Group|Results Reporting Coordinator|6264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21246719|NCT04951076|Bionomics Limited|SVP Clinical Development|+61 8 8150 7400|BNC210clinicalstudies@bionomics.com.au|
21294409|NCT03829969|Shanghai Junshi Bioscience Co., Ltd.|Huimei Xie|86-021-50796193|huimei_xie@junshipharma.com|
21294410|NCT04113018|Atrium Health Levine Cancer|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
21294411|NCT03802630|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21294412|NCT00157196|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21294413|NCT05005013|NYU Langone Health|Matthew Lustberg|929-455-5090|matthew.lustberg@nyulangone.org|
21294414|NCT06099223|Hartford Hospital|Aseel Walker|860-972-1778|aseel.walker@hhchealth.org|
21294415|NCT01252186|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21294416|NCT04420598|Medica Scientia Innovation Research (Medsir)|Alicia García Sanz PhD|611261467|contact.trials@medsir.org|+34
21294417|NCT01221623|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
21294418|NCT00661726|NERI|Nancy Gee, TCRN Network Manager|617-972-3295|ngee@neriscience.com|
21294419|NCT02147197|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21294420|NCT03088930|University of Colorado Cancer Center|Dr. Tejas Patil|7208489264|tajas.patil@cuanschutz.edu|
21294421|NCT04091581|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
21294422|NCT03315793|Shionogi|Shionogi Clinical Trial Administrator|+81-6-6209-7885|shionogiclinicaltrials-admin@shionogi.co.jp|
21294423|NCT01331837|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21294424|NCT03345160|Johns Hopkins School of Medicine|Dr. Robert Wood|410-919-7617|RWood@JHMI.edu|
21294425|NCT01521871|Oslo University Hospital, Rikshospitalet|Dr. Ole Øyen|+4723070000|ooyen@ous-hf.no|
21294426|NCT03724981|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21294427|NCT03284333|Cutera|Margot Doucette|415-357-5518|mdoucette@cutera.com|
21294428|NCT00790868|BostonUCRC|Michael W. Otto, Ph.D.|(617)353-9610|mwotto@bu.edu|
21236111|NCT02416791|Neurostimulation Laboratory, Hospital das Clínicas/São Paulo University, Brazil|Professor Adriana Bastos Conforto|+55 11 2661-7955|adriana.conforto@hc.fm.usp.br|
21294429|NCT01380535|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
21236112|NCT01054820|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21236113|NCT00321919|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21236114|NCT02624804|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
21236115|NCT02590354|Institute of Tropical Medicine Antwerp|Dr. Eric Florence|+32 3 247 66 42|eflorence@itg.be|
21236116|NCT00996996|GlaxoSmithKline|GSK Response Center|866-435-7343||
21236117|NCT00760929|F. Hoffmann-La Roche AG|Study Director|+41 616878333|global.trial_information@roche.com|
21236118|NCT02019719|GlaxoSmithKline|GSK Response Center|866-435-7343||
21236119|NCT01319318|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21236120|NCT02348216|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
21236121|NCT01055639|VA San Diego Healthcare System|Dr. Julie Wetherell|858-552-8585|jwetherell@ucsd.edu|2752
21236122|NCT00765245|Vanderbilt-Ingram Cancer Center|Dr. Nishitha Reddy|800-811-8480|nishitha.reddy@vanderbilt.edu|
21236123|NCT04483479|Enterin|Dr. Richard Larson, Chief Medical Officer|5054692670|r.larson@enterininc.com|
21236124|NCT04495712|VA Portland Health Care System|Merritt Raitt MD|503-220-8262|merritt.raitt@va.gov|57571
21236125|NCT02546544|University of Oxford|Joint Research Office|+441865572245|ctrg@admin.ox.ac.uk|
21236126|NCT01921348|University of MS Medical Center|Gailen D. Marshall, Jr., MD, PhD, Director, Division of Clinical Immunology and Allergy|6018155527|gmarshall@umc.edu|
21236127|NCT02223390|Duke University (Currently at Columbia University)|Kathleen Sikkema, PhD|212-305-8236|ks3364@cumc.columbia.edu|
21236128|NCT01994486|UNIVERSITY OF FLORIDA|Giuseppe (Joseph) Morelli, MD|352-273-9467|GIUSEPPE.MORELLI@MEDICINE.UFL.EDU|
21236129|NCT02896855|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21236130|NCT02169674|Vaccine Evaluation Center|Director of Vaccine Evaluation Center|604-845-2422||
21236131|NCT02511431|NIDDK|Christopher Koh, MD|301-443-9402|christopher.koh@nih.gov|
21236132|NCT01184014|International Diabetes Center|Dr. Richard Bergenstal|952-993-3796|richard.bergenstal@parknicollet.com|
21236133|NCT00614939|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21236134|NCT00736996|University of Colorado|Robert S. Schwartz, M.D.|303-724-1919|robert.schwartz@ucdenver.edu|
21236135|NCT04040985|Smith and Nephew|Michael Howarth|07540268240|michael.howarth@smith-nephew.com|+44
21236136|NCT01343407|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21236137|NCT03370887|AstraZeneca|Global Clinical LEad|1-877-240-9479|information.center@astrazeneca.com|
21236138|NCT04079933|Altria|Jeffery Edmiston, Functional Director Clinical Research|8043352366|Jeffery.S.Edmiston@altria.com|
21236139|NCT02504866|Clinical Center|Damiano, Diane|+1 301 451 7544|damianod@cc.nih.gov|
21236140|NCT01229436|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21236141|NCT01775137|Novartis Pharmaceuticals|Study Director|862-778-8300||
21236142|NCT01343056|University of Pittsburgh|Linda Siminerio, PhD|412-864-0158|simineriol@upmc.edu|
21236143|NCT00289341|Rockefeller University|Mayu Frank|212-327-7443|frankm@rockefeller.edu|
21236144|NCT03893448|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21236145|NCT00583492|Henry Ford Health System|Benjamin Movsas|313-516-2319|bmovsas1@hfhs.org|
21236146|NCT01351740|British Columbia Centre for Excellence in HIV/AIDS|Dr Marianne Harris|1-604-806-8771|mharris@cfenet.ubc.ca|
21236147|NCT00022516|IBCSG|Rudolf Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org|
21236148|NCT01568047|BIAL - Portela & Cª S.A.|Head of Clinical Research|+351-229866100|clinical.trials@bial.com|
21236149|NCT03783923|PTC Therapeutics, Inc.|Medical Information|1-866-562-4620|medinfo@ptcbio.com|
21294430|NCT01579565|Omeros Corporation|Chief Medical Officer|(206) 676-5000|swhitaker@omeros.com|
21294431|NCT02791191|Eli Lilly and Company|Chief Medical Officer|800-545-5079|Clinicaltrials.gov@lilly.com|
21294432|NCT01448824|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21294433|NCT00678535|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merck.de|
21294434|NCT01463111|Emory University|Dr. Boadie Dunlop|404-727-8969|bdunlop@emory.edu|
21294435|NCT02578680|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21294436|NCT04140695|Vanda Pharmaceuticals Inc.|Vanda Pharmaceuticals Inc.|202-734-3400|clinicaltrials@vandapharma.com|
21294437|NCT00218634|Mass General Hospital|Steven Safren|617 724 0817|ssafren@partners.org|
21294438|NCT00734604|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21294439|NCT02589665|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21294440|NCT01461928|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21294441|NCT01159171|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21294442|NCT04086693|Beaumont Health|Amit Bahl, MD|248-551-1792|Amit.Bahl@beaumont.edu|
21294443|NCT01892436|Novartis Pharmaceuticals|Clinical Disclosure Office|+1 (862) 778-8300|novartis.email@novartis.com|
21294444|NCT02918396|Johns Hopkins University|Dr. Tarek Zghaib|410-955-5000|tzghaib1@jhmi.edu|
21294445|NCT02923830|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
21294446|NCT00837265|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21294447|NCT00583414|Massachusetts General Hospital|Matthew Eagleton, MD|617-726-8279|meagleton@mgh.harvard.edu|
21294448|NCT01751906|Abbott Vascular|Latania Chura / Project Manager|503.935.3002|latania.chura@abbott.com|
21294449|NCT00733291|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21246720|NCT02413489|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21246721|NCT04456296|Endo Pharmaceuticals|Clinical Operations|800-462-3636|clinicaltrials@endo.com|
21246722|NCT05736458|University of Pennsylvania|Dr. Desmond Oathes, Principal Investigator|215-573-9390|oathes@pennmedicine.upenn.edu|
21246723|NCT04011644|Dept of Family Medicine and Community Health, UW-Madison|Dr. Andrew Quanbeck|608-609-7308|andrew.quanbeck@fammed.wisc.edu|
21246724|NCT05493852|Boston Scientific|Dr Xiuyue Jia|+86 15104673346|xiuyue.jia@bsci.com|
21246725|NCT05100628|Noxopharm|Lorena Figueroa, Director Clinical Operations|+ 61 2 9144 2223|lorena.figueroa@noxopharm.com|
21246726|NCT03717753|Hospital for Special Surgery|Dr. Jacques YaDeau, MD PhD|212- 606-1206|yadeauj@hss.edu|
21246727|NCT04588415|University of Ottawa|Dr. James Downar|613 562 6262|jdownar@toh.ca|1502
21246728|NCT05900154|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21246729|NCT01570361|Johnson & Johnson Medical N.V., Biosense Webster|Liesbeth Vanderlinden|+32 (0) 2 746 3446|lvanderl@its.jnj.com|
21246730|NCT04129554|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21246731|NCT03309644|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
21246732|NCT05158504|IstanbulSBU|HKARTAL|05378870982|kartal_hilal@yahoo.com|
21246733|NCT03606512|Janssen Vaccines & Prevention B.V|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21246734|NCT05513937|A. Menarini Industrie Farmaceutiche Riunite SrL|Clinical Operation Director|055 5680459|pfabrizzi@menarini.it|+39
21246735|NCT02846545|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21246736|NCT05215613|Zimmer Biomet|Andrea Singer|(0)79 318 06 55|andrea.singer@zimmerbiomet.com|+41
21246737|NCT05654662|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
21246738|NCT04230681|Washington University|Dr. Greg Miller|314-454-6000|g.c.miller@wustl.edu|
21246739|NCT01064440|Helixmith, Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
21246740|NCT05507333|Gedea Biotech AB|Annette Säfholm, CEO|0046 708 91 86 81|annette.safholm@gedeabiotech.com|
21246741|NCT01880515|Instituto Nacional de Cancerología de México|Oscar Gerardo Arrieta Rodriguez|+52 1 55 56 28 04 00|ogar@unam.mx|71101
21246742|NCT05247034|Universidad Anáhuac México Norte|Dr. Carlos Alberto Cuéllar Ramos|5556270210|carlos.cuellarra@anahuac.mx|8736
21246743|NCT03489122|VA Bedford Healthcare System|Administrative Officer/R&D|781-687-2903|karen.smith9@va.gov|
21246744|NCT03505710|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo_us@daiichisankyo.com|
21246745|NCT05879991|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21246746|NCT04414722|Dept. of Family Medicine, Georgetown University Medical Center|Dan Merenstein, Director of Research Programs|202-687-1600|djm23@georgetown.edu|
21246747|NCT05464069|Theranica|Dr Dagan Harris, VP Clinical and Regulatory Affairs|+972542220121|daganh@theranica.com|
21280528|NCT00981812|University of Cincinnati Medical Center|Mary Mahoney, MD|513-584-4396|mary.mahoney@uchealth.com|
21280529|NCT02603887|UT MD Anderson Cancer Center|Dr. Elisabet Manasanch/ Assistant Professor, Lymphoma-Myeloma|713-745-8092|eemanasanch@mdanderson.org|
21280530|NCT04442464|Mayo Clinic|Cherie B. Nau, O.D.|507-284-4152|Nau.Cherie@mayo.edu|
21280531|NCT01308424|Beech Tree Labs, Inc.|Dr. John McMichael|518-872-1144||
21280532|NCT00948155|University of Pennsylvania|Andrew A. Strasser, Ph.D., Associate Professor|215 746 5788|strasse3@mail.med.upenn.edu|
21280533|NCT04620746|Johns Hopkins University School of Medicine|Jonathan Zenilman|410-550-9080|jzenilm1@jh.edu|
21280534|NCT04584502|Geisel School of Medicine|Sarah Lord, Ph.D.|6036467089|sarah.e.lord@dartmouth.edu|
21280535|NCT05767905|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21280536|NCT03897634|Northwestern University|Kendra Marks|847-467-0897|kendra.marks@northwestern.edu|
21280537|NCT03404674|PATH|Rahsan Erdem|202-540-4546|rerdem@path.org|
21246748|NCT05320406|Emory University|Dr. Sagar Patel|404-778-1900|sagar.patel@emory.edu|
21294450|NCT01018134|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914-345-9001|natalie.yantovskiy@taro.com|
21294451|NCT02759107|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21294452|NCT02390414|Dana-Farber Cancer Institute|Dr. Gregory A. Abel|6176322304|gaabel@partners.org|
21294453|NCT04051710|Aurobindo Pharma|Dr. Joseph Marialouis|9196150585|jmarialouis@aurobindousa.com|4013
21294454|NCT03086707|Philip Morris Products S.A.|Julia Hoeng, PhD|+41 (58) 242 11 11|ClinicalTrials.PMI@pmi.com|
21294455|NCT00309140|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21294456|NCT00420004|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21294457|NCT00470093|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Carol Ann Huff|410-955-8842|huffca@jhmi.edu|
21294458|NCT00664560|POZEN Inc|Sr VP Clinical Research|919-913-1030|eorlemans@pozen.com|
21294459|NCT00100230|Retina Foundation of the Southwest|Dennis Hoffman, Ph.D., Sr. Research Scientist|214-363-3911|dhoffman@retinafoundation.org|125
21294460|NCT00473668|GlaxoSmithKline|GSK Response Center|866-435-7343||
21294461|NCT02039219|Indiana University School of Medicine|Naga Chalasani, MD|(317) 278-0414|nchalasa@iu.edu|
21294462|NCT01084278|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21294463|NCT02226562|GlaxoSmithKline|GSK Response Center|866-435-7343||
21294464|NCT00006164|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|James E. Everhart, MD, MPH, Project Officer|301-594-8878|EverhartJ@extra.niddk.nih.gov|
21294465|NCT02750345|Cycle Pharmaceuticals Ltd|James Price|+44 1223 803638|james.price@cyclepharma.com|
21294466|NCT00223808|CTVHCS|Charles Burgar, MD|254/743-0085|charles.burgar1@va.gov|
21294467|NCT00635739|Tufts University|Dr. Roger Fielding|6175563083|Roger.Fielding@tufts.edu|
21294468|NCT00191724|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21294469|NCT00608023|Theratechnologies|Marilyn de Chantal, Global Senior Medical Director|1 438-315-6624|Mdechantal@theratech.com|
21294470|NCT00366028|Department of Veterans Affairs|Dr. Carol VanDeusen Lukas|857-364-5685|carol.vandeusenlukas@va.gov|
21294471|NCT01231321|Abbott|Global Medical Services|800-633-9110||
21294472|NCT00489736|sanofi-aventis|International Clinical Development, Clinical Study Director||GV-Contact-us@sanofi-aventis.com|
21294473|NCT04021524|University of Washington|Dr. Jason E. Hsu|(206) 543-3690|jehsu@uw.edu|
21294474|NCT06422364|Indiana University|Dr. Harish Rao, Assistant Professor of Clinical Pediatrics|317-948-7208|harirao@iu.edu|
21246749|NCT04615273|Ascendis Pharma, Inc.|Aimee D. Shu, MD|+1 650-461-4835|ads@ascendispharma.com|
21246750|NCT03677141|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21246751|NCT06038708|BIOTRONIK Italy|Paola Napoli, Clinical Project Manager|3357369277|paola.napoli@biotronik.com|0039
21246752|NCT04197869|UCLA Health|Dr. Alexandra Goodwin|917-969-1654|zangoodwin@gmail.com|
21246753|NCT01314105|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21246754|NCT04526886|Dartmouth Hitchcock Medical Center|Gabriel Brooks|(603) 650-4344|gabriel.a.brooks@hitchcock.org|
21246755|NCT04417998|Mayo Clinic|Bradley J. Kemp, Ph.D.|507-284-4399|Kemp.Brad@mayo.edu|
21246756|NCT02827838|Wake Forest Baptist Comprehensive Cancer Center|Mercedes Porosnicu|336-716-8664|mporosni@wakehealth.edu|
21246757|NCT04820322|INQUIS Clinical Research|Principal Scientist|4168619177|twolever@inquis.com|
21246758|NCT04209595|National Cancer Institute|Dr. Anish Thomas|240-760-7343|anish.thomas@nih.gov|
21246759|NCT03156465|University of Iowa|Camille Dunn|319-353-8776|camille-dunn@uiowa.edu|
21246760|NCT03640286|Neurovalens|Head of Clinical and Regulatory|02890991835|sinead.watson@neurovalens.com|
21246761|NCT03580356|Novartis Pharmaceuticals|Study Director|1 (862) 778-8300|novartis.email@novartis.com|
21246762|NCT04393207|Yale|Antonio Gonzalez|203.785.2802|antonio.gonzalez-fiol@yale.edu|
21246763|NCT06197360|Yangzhou University|Yueqi Zhao|13390676131|mz120221975@stu.yzu.edu.cn|
21246764|NCT03331835|LEO Pharma AS|Clinical Disclosure|(+1) 877-557-1168|disclosure@leo-pharma.com|
21246765|NCT05791435|Nemours Children Health System|Tariq Rahman|302 651 6831|trahman@nemours.org|
21246766|NCT02874001|Institut Bergonié|S Mathoulin-Pélissier, Director of Clinical Trials Unit|+33556333333|s.mathoulin@bordeaux.unicancer.fr|
21246767|NCT05848947|Sirtex Medical|Janet Bell, Director, Clinical Research Operations|978-866-1798|jbell@sirtex.com|
21246768|NCT02839265|Montefiore Medical Center|Dr. Nitin Ohri|718-920-7750|nitin.ohri@einsteinmed.edu|
21246769|NCT05552508|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21246770|NCT04227288|University of Alabama at Birmingham|Dr. Boni Elewski|205-502-9960|dermresearch@uabmc.edu|
21246771|NCT04311632|ITB-MED LLC|Jesse Scott, MPH|+46 8 410 02 887|KTX@itb-med.com|
21246772|NCT04632225|Helixmith Co, Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
21246773|NCT02323880|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21246774|NCT04934072|Fresenius Kabi SwissBioSim GmbH|Clinical Development|+41 793075735|medinfo_biosim@fresenius-kabi.com|
21246775|NCT00780494|Stanford University|Pamela Kunz|650-725-8738|pkunz@stanford.edu|
21246776|NCT05664958|Duke Unversity School of Medicine|Ashraf Haib|919-668-2024|ashraf.habib@duke.edu|
21246777|NCT00844415|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21246778|NCT03174275|University of North Carolina Lineberger Comprehensive Cancer Center|Dr. Jared Weiss|+1 919-843-7718|jared_weiss@med.unc.edu|
21246779|NCT03717935|University of Colorado|Melanie Cree-Green, PI|720-777-5743|melanie.green@childrenscolorado.org|
21246780|NCT04601480|University of Minnesota|Ezra Golberstein|612-626-2572|egolber@umn.edu|
21246781|NCT03015532|Heron Therapeutics, Inc.|Vice President, Clinical Operations|858-251-7232|svisonneau@herontx.com|
21246782|NCT02990338|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21246783|NCT00758862|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
21294475|NCT03713294|Mayo Clinic|Sikander Ailawadhi|904/953-6468|ailawadhi.sikander@mayo.edu|
21294476|NCT05260073|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
21262278|NCT00943878|Division of Infectious Diseases and Immunology, Saint Louis University Medical School|Sharon E. Frey, M.D.|314-977-5500|freyse@slu.edu|
21262279|NCT00940927|Nemours Children's Clinic|Kathryn Blake, Pharm.D.|904 858 3806|kblake@nemours.org|
21262280|NCT01478347|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21262281|NCT01645930|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21262282|NCT01748760|Brown University|Shirley Yen, Ph.D.|401-444-1915|Shirley_Yen_PhD@Brown.edu|
21262283|NCT03245814|The University of Arizona|Dr. Maggie O'Haire|520-621-6767|maggieohaire@arizona.edu|
21262284|NCT03489291|CSL Behring|Study Director|+1 610-878-4000|clinicaltrials@cslbehring.com|
21262285|NCT00946270|The University of Texas MD Anderson Cancer Center|Dr. Srdan Verstovsek, MD./Professor|713-745-3429|sverstov@mdanderson.org|
21262286|NCT02263365|Cedars Sinai Medical Center|Phillip Fleshner, MD|310-289-9224|pfleshner@aol.com|
21262287|NCT00510692|S.L.A. Pharma (UK) Ltd|Dr Chris Jordan|+44 (0)1923 681001|cjordan@slapharma.com|
21262288|NCT00945191|Daiichi Sankyo|Contact of Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21262289|NCT02116972|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
21262290|NCT00784784|Mount Sinai Hospital|Dr. Brenda Coleman|416-586-4800|bcoleman@mtsinai.on.ca|4161
21262291|NCT01765712|Nicholas Institute of Sports Medicine and Athletic Trauma|Malachy McHugh Director of Research|2124342714|mchugh@nismat.org|
21262292|NCT01879618|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21262293|NCT04337138|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21262294|NCT00392444|The Ottawa Hospital Cancer Centre|Dr. Scott Laurie|613-737-7700|slaurie@toh.on.ca|70175
21262295|NCT00387660|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
21262296|NCT00872898|Forest Research Institute|Ephraim Katz, PhD / Associate Director|201-427-8000|Ephraim.Katz@frx.com|8169
21262297|NCT01004146|University of Texas at Houston Medical School / Dept. of Anesthesiology|Dr. Davide Cattano|713-500-6235|davide.cattano@uth.tmc.edu|
21262298|NCT01183546|Human Engineering Research Laboratories|Dr. Alicia Koontz|412-822-3700|alicia.koontz@va.gov|
21262299|NCT00138125|University of California at Los Angeles|Richard J. Pietras, M.D. Ph.D|310 825 9769|rpietras@ucla.edu|
21262300|NCT02099799|VA Boston Healthcare System|Marilyn Moy, MD, MSc|857-203-6622|marilyn.moy@va.gov|
21262301|NCT00863928|Virginia Mason Medical Center|Kathryn Dahl, RN|206-341-0578|kathryn.dahl@vmmc.org|
21262302|NCT01269034|Albert Einstein College of Medicine|Roger Hicks, Administrative Director for Research - Department of Pediatrics|718-920-7386|roger.hicks@einsteinmed.org|
21262303|NCT01001494|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
21262304|NCT03863496|Ilizarov centre|Sergey Raybukh|+79226716007|rso_@mail.ru|
21262305|NCT02795156|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
21262306|NCT03320512|University of North Carolina at Chapel Hill|Lisa Hightow-Weidman|919-843-0033|lisa_hightow@med.unc.edu|
21262307|NCT00734929|Duke University Medical Center|Dr. Ashraf Habib|9196686265|habib001@mc.duke.edu|
21262308|NCT02351037|Pharmacyclics|Priyanka Mandava, Director of Clinical Operations|408-215-3776|psingh@pcyc.com|
21262309|NCT02961764|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
21262310|NCT02989727|Univeristy of Saskatchewan|Dr. Evyn Peters|13062904493|evyn.peters@usask.ca|
21262311|NCT04331730|Alkahest, Inc.|Head of Communications|(650) 801-0474|trials@alkahest.com|
21262312|NCT01903434|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21262313|NCT02211495|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
21262314|NCT04267562|MicroCube, LLC|Dinesh Mody|(510) 651-5000|m@minitouch.us|
21262315|NCT02026908|Northwestern University/Northwestern Memorial Hospital|Samdeep Mouli MD|312-926-5200|s-mouli@northwestern.edu|
21262316|NCT01842061|The University Of British Columbia|Associate Professor MC Ashe|604-675-2574|maureen.ashe@ubc.ca|
21262317|NCT00128206|University of California, San Francisco|Mary White|415-476-5213|mary.white@nursing.ucsf.edu|
21262318|NCT04220489|UPMC|Jacques E. Chelly, MD, PhD, MBA|412-623-6904|chelje@anes.upmc.edu|
21262319|NCT00912158|Chest Department, Faculty of Medicine, Assiut University- EGYPT|Dr. Maha K Ghanem, MD, FCCP|+ 2 0127694434|mahaghanem@hotmail.com|
21262320|NCT02338076|Rockefeller University|Dr. Emma Guttman|212-327-8333|skhattri@rockefeller.edu|
21280538|NCT01841593|SSAT Research, Chelsea & Westminster Hospital|Dr. Marta Boffito|+442033155601|marta.boffito@chelwest.nhs.uk|
21280539|NCT01651078|Monteris Medical|Nissa Mollema (Clinical Operations Manager)|763-253-4710|nmollema@monteris.com|
21280540|NCT03125798|Wielkoposkie Centrum Pulmonologii i Torakochirurgii|Dr Piotr Gabryel|+48616654249|piotrgabryel@gmail.com|
21280541|NCT03135015|Housey Healthcare ULC|Project Manager|2486637000|info@housey.com|
21280542|NCT01487525|University of Iowa|Dr. Neil Segal|3193358204|segal-research@uiowa.edu|
21280543|NCT03618017|University of Michigan Rogel Cancer Center|Lauren Wallner, Ph.D.|734-232-0788|lwallner@med.umich.edu|
21280544|NCT00291317|Children's Specialized Hospital|Frank Castello|732 258 7065|fcastello@childrens-specialized.org|
21280545|NCT01223378|Bausch & Lomb|H DeCory, PhD|585-338-8161|heleen.decory@bausch.com|
21280546|NCT00262028|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21280547|NCT03518008|Alcon Research|Senior Clinical Project Lead, GCRA - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21280548|NCT01515423|Janssen Research & Development, LLC|Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
21280549|NCT03490110|Veterans Affairs|Dr. Anthony Chen|925-372-2530|anthony.chen@va.gov|
21262321|NCT03459131|Alcon, A Novartis Division|Sr Clinical Project Lead, GCRA - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21294477|NCT03458910|University of Southern California|Dr. Mara Mather|(213) 821-1868|mara.mather@usc.edu|
21294478|NCT05275010|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21294479|NCT02975999|LUrie Children's Hospital|Dr. Jamie Penk, co-investigator|7735773782|jpenk@luriechildrens.org|
21294480|NCT04484649|Columbia University Irving Medical Center|Samantha Garbers-Adams, PhD|212-305-0123|svg2108@cumc.columbia.edu|
21294481|NCT01463696|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21294482|NCT02731820|Istituto Ortopedico Rizzoli|Director of Clinical Trials|+39 051.6366392|ctc@ior.it|
21294483|NCT00967694|University of Utah Department of Anesthesiology|Dr. Eric Fox|775-340-0219|ericbfox@yahoo.com|
21294484|NCT06053541|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21294485|NCT05742646|Medical University of South Carolina|Dr. Michelle Nichols|8437928515|nicholmg@musc.edu|
21294486|NCT03544476|University of Washington|Sarah Iribarren|2065435211|sjiribar@uw.edu|
21294487|NCT00152477|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21294488|NCT02301546|University of Utah|Kevin Duff|8015859983|kevin.duff@hsc.utah.edu|
21294489|NCT00729677|Beth Israel Cancer Center|Victoria Rosenwald, RN MPH|212 844-8285|vrosenwa@chpnet.org|
21294490|NCT03905265|Medicines Development for Global Health Limited|Clinical Project Manager|+61 399122400|MDGH-MOX-2001@medicinesdevelopment.com|
21294491|NCT01636063|Baystate Medical Center|David R Kattan|413-794-5256|davidrkattan@gmail.com|
21294492|NCT01801436|Janssen Pharmaceutical Taiwan|Medical Affairs Director|+886-2-23762155||
21294493|NCT01294306|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
21294494|NCT02447250|OHSU|Cindy McEvoy, MD|5034940223|mcevoyc@ohsu.edu|
21294495|NCT03632993|Endo Pharmaceuticals|Clinical Operations|800-462-3636|clinicaltrials@endo.com|
21294496|NCT03389555|Beth Israel Deaconness Medical Center Emergency Department|Michae Donnino|(617) 754-2882|mdonnino@bidmc.harvard.edu|
21294497|NCT00960011|The University of Hong Kong|Dr. Joe Fan King Man|852-22553111|drfanj@gmail.com|
21236150|NCT00723177|NYSPI/Columbia University|Sandra Comer PhD|646 774-6146|SDC10@columbia.edu|
21236151|NCT01427712|Medical affairs|Medical affairs manager|+81-3-5656-0516|takumi.kanzo@viatris.com|
21236152|NCT00661492|US Oncology|Dr. Mark T. Fleming|757-827-9400|Mark.Fleming@USONCOLOGY.COM|
21236153|NCT01143259|Intermountain Healthcare|Matthew Peters RN MS|801-442-3703|matthew.peters@imail.org|
21236154|NCT00099983|VA Connecticut HCS|John Krystal, MD|203-937-4790|john.krystal@yale.edu|
21236155|NCT02641080|West Virginia University Department of Orthopaedics|Matthew J. Dietz, MD|304-285-7445|mdietz@hsc.wvu.edu|
21236156|NCT00803634|The Medicines Company|Jason Campagna|973-290-6199|jason.campagna@themedco.com|
21236157|NCT03835533|Parker Institute for Cancer Immunotherapy|Ute Dugan|203-379-6757|udugan@parkerici.org|
21236158|NCT03115424|Mayo Clinic|Adrian Vella, M.D.|507-266-1387|vella.adrian@mayo.edu|
21236159|NCT02582905|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD PhD MBA|214-645-6950|sherwood.brown@utsouthwestern.edu|
21236160|NCT01866709|ZS Pharma, Inc|Henrik Rasmussen, MD, PhD|443-699-5230|hrasmussen@zspharma.com|
21236161|NCT04292301|SpinTech MRI|Rana El Hachem|2487126789|rana@spintechmri.com|
21236162|NCT03285477|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
21236163|NCT00560833|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21236164|NCT03283670|Washington University|Ben Palanca, MD PhD|314 273-9076|palancab@wustl.edu|
21236165|NCT01085318|EMD Serono, Inc.|Fernando Dangond, MD FAAN|781-681-2348|fernando.dangond@emdserono.com|
21236166|NCT01059617|GlaxoSmithKline|GSK Response Center|866-435-7343||
21236167|NCT01307501|Galil Medical, a wholly owned indirect subsidiary of Boston Scientific|Sr. Clinical Trial Specialist|651-287-5000|GalilClinical@bsci.com|
21236168|NCT02331992|Fisher & Paykel Healthcare|Clinical Research Scientist|+64 9 5740123|cpaptrial@fphcare.co.nz|
21236169|NCT00724347|VANCHCS|David L. Woods, Ph.D.|925-372-2571|David.Woods@va.gov|
21236170|NCT01736566|Brigham and Women's Hospital|Carrie Blout, Genetic Counselor Project Manager|617-264-5837|carrie.blout@gmail.com|
21236171|NCT01209624|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21236172|NCT03403634|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kristopher.Attwood@Roswellpark.org|
21236173|NCT03859323|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
21236174|NCT02062502|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21236175|NCT00993447|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21236176|NCT03082963|University of Miami|Dr Jeffrey Goldberger|305-243-4356|j-goldberger@miami.edu|
21236177|NCT04401579|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
21236178|NCT00489970|GlaxoSmithKline|GSK Response Center|866-435-7343||
21236179|NCT01438411|Retrophin, Inc.|Retrophin Medical Information|1-877-659|medinfo@retrophin.com|5518
21236180|NCT01863680|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21236181|NCT00618514|Image Guided Surgery Associates|Robert Worthington-Kirsch|(610) 327-7236|kirsch@igsapc.com|
21236182|NCT01093794|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21236183|NCT02740127|UT MD Anderson Cancer Center|Bobby Bellard, Assistant Professor, Anesthesiology & PeriOper Med|(713) 794-1461|bbellard@mdanderson.org|
21236184|NCT03320070|Mallinckrodt|Medical Information Call Center|1-800-844-2830|medInfo@mnk.com|
21236185|NCT02041195|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
21236186|NCT03564496|NYU Langone|Matthew Lustberg|929 455 5090|matthew.lustberg@nyulangone.org|
21236187|NCT00674986|Hoffman-LaRoche|Medical Communications|800-821-8590||
21294498|NCT04417218|Vanderbilt University Medical Center|Dr. Jane Ferguson|6158759896|jane.f.ferguson@vumc.org|
21294499|NCT00873041|Novartis Pharmaceuticals|Study Director|862-778-8300||
21294500|NCT01074463|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21294501|NCT00758264|GlaxoSmithKline|GSK Response Center|866-435-7343||
21294502|NCT01345513|Ontario Institute for Cancer Research|Janet E. Dancey|1-613-533-6430|janet.dancey@oicr.on.ca|
21294503|NCT02899650|University of Texas at Austin|Koichiro Hayashi|512-471-8594|k-hayashi@kokugakuin.ac.jp|
21294504|NCT04154605|Stryker|Robyn Schacherer, Manager Clinical Affairs|763-463-7054|robyn.schacherer@stryker.com|
21294505|NCT00675441|UT MD Anderson Cancer Center|Amin Alousi, MD / Assisstant Professor||CR_Study_Registration@mdanderson.org|
21294506|NCT01179217|Emmaus Medical, Inc|Yutaka Niihara, MD, MPH|310-214-0065|yniihara@emmausmedical.com|
21294507|NCT02493257|The University of Texas Health Science Center at Houston|Dr. Amber U. Luong, Associate Professor and Director of Research|(713) 500-5410|Amber.U.Luong@uth.tmc.edu|
21262322|NCT03032068|Cleveland Clinic|Jayson Zadzilka|216-445-8023|zadzilj@ccf.org|
21262323|NCT01597622|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21262324|NCT00408421|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21262325|NCT02772965|University of North Carolina at Chapel Hill|Michael Kappelman, MD, MPH|919-966-1343|michael_kappelman@med.unc.edu|
21262326|NCT03132805|Johns Hopkins University|Nicholas S. Ialongo, Principal Investigator|410-493-1252|nialong1@jhu.edu|
21262327|NCT03009539|University of Miami|Guillermo Prado|305-284-2002|gprado@miami.edu|
21262328|NCT03151148|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21262329|NCT00710034|University of Minnesota|Dorothy Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu|
21262330|NCT00494871|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21262331|NCT03046472|Maccabi Health services and Wingate college|Neta Vitman|0508955529|vitmanan@gmail.com|
21262332|NCT03238248|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
21262333|NCT03463265|Aadi Bioscience, Inc.|Aadi Medical Information|1-888-246-2234|MedInfo@aadibio.com|
21262334|NCT02241512|UT Southwestern|Dr. David Troendle|214456-8000|david.troendle@utsouthwestern.edu|
21262335|NCT02296346|Huntsman Cancer Institute, University of Utah|Dr. Daniel Couriel|801-213-3082|dan.couriel@hci.utah.edu|
21262336|NCT02739698|University Hospital Reina Sofia, Cordoba, Spain|Angela Casado-Adam, MD|0034957010439|angeti@hotmail.com|
21262337|NCT02385123|Emory University|Rafi Ahmed, PhD|404-727-3571|rahmed@emory.edu|
21262338|NCT04498910|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21262339|NCT03121352|University Hospitals|Joseph Baar|216-844-8683|joseph.baar@uhhospitals.org|
21262340|NCT03215264|University of Pennsylvania/ Abramson Cancer Center|Thomas Karasic, MD|2156141858|thomas.karasic@pennmedicine.upenn.edu|
21262341|NCT02145156|University of Colorado Denver|Julie A. Maertens|303-724-7319|julie.maertens@ucdenver.edu|
21262342|NCT01740440|BioMedical Research Ltd|Gary Rainsford|0035391774361|grainsford@bmr.ie|
21262343|NCT02631135|UludagU|Hale Aksu Erdost,MD,spesialist|+905323615722|haleaksu78@yahoo.com|
21262344|NCT02688842|Shanghai Microport Medical (Company) Co.,Ltd.|Haotian Zhang|+86-21-38954600|zhanght@microport.com|8552
21262345|NCT03408873|Case Western Reserve University and University Hospitals Cleveland Medical Center|Joy Yala, MPH|216-368-0783|jxy790@case.edu|
21262346|NCT01264965|University of Chicago|Theodore Karrison|773-702-9326|karr@health.bsd.uchicago.edu|
21262347|NCT02221739|Weill Cornell Medical College|Silvia Formenti, M.D.|646-962-4065|formenti@med.cornell.edu|
21262348|NCT00406315|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21294508|NCT00569309|The Ohio State University Comprehensive Cancer Center|Craig Hofmeister, MD|614-293-9869|Craig.Hofmeister@osumc.edu|
21262349|NCT02844582|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
21262350|NCT01469013|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21262351|NCT05232097|Helsinki University Hospital|Dr. Jari Punkkinen|+358 50 427 9864|jari.punkkinen@hus.fi|
21262352|NCT05748925|mansoura urology and nephrology center|Nourelsabah Mohamed Elbialy , consaltant nephrology|01065619243|nourelsabah@mans.edu.eg|
21262353|NCT01172288|Yale University- School of Medicine|Associate Professor|(203)737-4809|michael.bloch@yale.edu|
21262354|NCT01327339|GlaxoSmithKline|GSK Response Center|866-435-7343||
21262355|NCT00871858|Institut Bergonié, Medical Oncology department|Dr. Nathalie Quenel-Tueux|05.56.33.33.33|N.Quenel-Tueux@bordeaux.unicancer.fr|
21262356|NCT00700752|Vistakon|Kurt Moody OD|904-443-3088||
21262357|NCT01302769|99MDG Regional Clinical Investigation Program|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
21262358|NCT00691197|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
21262359|NCT00298610|Walter Reed Army Institute of Research|Shon A. Remich, MD|254-733-628-670|sremich@hotmail.com|
21262360|NCT01734993|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21262361|NCT01426386|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
21262362|NCT01858428|Spectranetics|Julie Wolfram Smith|763-955-1072|julie.wolframsmith@spnc.com|
21262363|NCT01797432|University of Minnesota|Maria Hordinsky, MD|612-625-6118|hordi001@umn.edu|
21262364|NCT02792777|Thomas Jefferson|Kristin L Rising, MD MS|215-503-5507|kristin.rising@jefferson.edu|
21262365|NCT00638846|Vistakon|Kurt Moody OD|904-443-3088||
21294509|NCT01740089|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28|linkova@biocad.ru|930
21262366|NCT02428140|University of Alberta|Dr. Brian Buck|78024819227|bbuck@Ualberta.ca|
21262367|NCT03534271|Rush University|Dr. Jonathan Brady Scott|3129426389|jonathan_b_scott@rush.edu|
21262368|NCT03176966|Vanderbilt University Medical Center|Michael McGill|615-322-4643|michael.g.mcgill@vumc.org|
21262369|NCT01507246|Atlanta Colon and Rectal Surgery|Stephen Cohen, MD|770-997-1975|klong@atlantacolon.com|
21262370|NCT03103750|Yale School of Medicine|Marc Potenza, PhD, MD|(203) 974-7356|marc.potenza@yale.edu|
21246784|NCT03655080|Washington University School of Medicine|Hiram A. Gay, M.D.|314-362-8516|hiramgay@wustl.edu|
21246785|NCT02641730|Janssen Pharmaceutical K.K.|Senior Director, Immunology General|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21246786|NCT05460871|University of Iowa Hospitals and Clinics|Dr. Lee Kral|(319) 384-6593|lee-kral@uiowa.edu|
21246787|NCT04984590|OnPoint Vision Inc.|Head of Clinical|949-688-0660|larcher@onpoint-vision.com|
21246788|NCT04614948|Janssen Vaccines & Prevention B.V.|VICE PRESIDENT Medical Affairs IDV|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21246789|NCT04271046|Kaiser Permanente Washington Health Research Institute|Robert Penfold|206-287-2232|robert.b.penfold@kp.org|
21246790|NCT03663205|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
21246791|NCT05962814|Bionics Institute|Prof Colette McKay|+61 408698202|cmckay@bionicsinstitute.org|
21246792|NCT06149338|Saint Andrew's General Hospital of Patras|Dr. Vasileios Boviatsis|+306982925945|billboviatsis@gmail.com|
21246793|NCT03057054|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21246794|NCT03972150|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21246795|NCT04380337|Stanford University|Dr. Erqi Pollom|650-498-0484|erqiliu@stanford.edu|
21246796|NCT03181516|Georgetown University Medical Center|Dr. Daniel Merenstein|2026872745|djm23@georgetown.edu|
21246797|NCT04444518|University of Rochester|Cynthia Rand, PI|5852759316|cynthia_rand@urmc.rochester.edu|
21246798|NCT04544007|University of Alabama at Birmingham|Coretta Thomas, Scientist & Data Manager for NF Consortium|205-975-8629|coretta@uab.edu|
21246799|NCT03485729|Chimerix, Inc.|Chief Medical Officer|919-806-1074|clinicaltrials@chimerix.com|101
21246800|NCT04880733|University California-Irvine|Jeffery Dusek|617-519-8082|jdusek@hs.uci.edu|
21246801|NCT03314740|Istituto di Ricerche Farmacologiche Mario Negri|Elena Biagioli|+39 0239014650|elena.biagioli@marionegri.it|
21246802|NCT04075318|Vaxxinity, Inc.|Executive Director, Clinical Development|254-244-5739|info@vaxxinity.com|
21246803|NCT04451772|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21246804|NCT04605159|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21246805|NCT05599334|Pierre Fabre Médicament|Medical Director (Jeanne Suissa)|+33149108269|jeanne.suissa@pierre-fabre.com|
21246806|NCT03631290|Duke University Medical Center|Rasheeda Hall, M.D.|919-660-6861|rasheeda.hall@duke.edu|
21246807|NCT04218851|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21246808|NCT01820611|Zimmer Biomet|Linda Meijer|+31 6 57933741|linda.meijer@zimmerbiomet.com|
21246809|NCT03484819|Mayo Clinic|Nora Bennani, M.D.|(507) 284-2511|bennani.nora@mayo.edu|
21246810|NCT05970861|Asfendiyarov Kazakh National Medical University|Prof. Abdugani Musayev|+77772509406|musaev.dr56@gmail.com|
21246811|NCT00971087|Hologic|Jennifer Bartoshevich, Sr Manager of Clinical Affairs|781-999-7764|jennifer.bartoshevich@hologic.com|
21246812|NCT04186819|Blue Earth Diagnostics|Head of R&D|+44 (0) 1865 784 186|matthew.miller@blueearthdx.com|
21246813|NCT06435624|Nanjing Mingzhou Rehabilitation Hospital|Jingzhi Zhang|16677137704|170787717@qq.com|86
21246814|NCT04874948|Klinikum der Universität München (LMU)|Dr. med. vet. Julia Dreisbach|+49 89 4400|julia.dreisbach@med.uni-muenchen.de|59825
21246815|NCT03988621|University of Pennsylvania|Barbara Riegel, PhD, RN, Professor|2158989927|briegel@nursing.upenn.edu|
21246816|NCT05013385|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21246817|NCT06356285|Imperial College London|Dr Kate Grailey|07912563290|k.grailey18@imperial.ac.uk|
21246818|NCT01447719|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
21280550|NCT01015534|Instituto Nacional de Cancerologia de Mexico|Carlos Gamboa Vignolle/ Radiation Oncologist|0155556280400|cswgamboa@yahoo.com|441
21246819|NCT03914469|UT Southwestern Medical Center|Dr. Makris|214 648 3133|una.makris@utsouthwestern.edu|
21246820|NCT03252288|University of South Carolina|Jan Ostermann|+1803-777-8747|jano@mailbox.sc.edu|
21246821|NCT00677365|Horizon Pharma USA, Inc.|Jeffery Nieves, PharmD, Senior Director||clinicaltrials@horizonpharma.com|
21246822|NCT02944968|Johnson and Johnson Medical NV/SA|Nathalie Macours, Clinical Research Director|+32 2 746 35 27|nmacours1@its.jnj.com|
21246823|NCT02905331|Janssen Research & Development, LLC|Senior Director, Immunology General|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21246824|NCT05408663|Extend Biosciences|Laura Hales PhD|(732) 599-8581|lhales@extendbio.com|
21246825|NCT04102111|Janssen Research & Development, LLC|Vice President|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21246826|NCT03334695|Janssen Research & Development, LLC|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21246827|NCT02542631|Johnson & Johnson Diabetes Companies|Brian Levy, MD-Chief Medical Officer|484 328-6128|BLevy1@its.jnj.com|
21246828|NCT02938923|Washington University in St. Louis School of Medicine|Dr. Ellen F. Binder, Professor of Medicine and Occupational Therapy|314-286-2707|ebinder@wustl.edu|
21246829|NCT00721149|Biosense Webster, Inc.|Diana Bordley, Director, Regulatory Affairs|800-729-9010|dbordley@its.jnj.com|8604
21246830|NCT01240122|Abbott Medical Optics|Senior Manager, Clinical Research|714.247.8723|eugenia.kao@amo.abbott.com|
21246831|NCT06468982|Atatürk University|Dr. Ümit Arslan|05418209007|kvcumit@gmail.com|
21246832|NCT05932407|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21280551|NCT00613171|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21280552|NCT03737357|Institut Straumann|Anaïs Robert, Clinical Trial Leader|+41799258750|anais.robert@straumann.com|
21280553|NCT02020278|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21280554|NCT04201197|Johns Hopkins School of Medicine|Dr. Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
21280555|NCT02577991|Northwestern University Department of Orthopaedic Surgery|Surabhi Bhatt|312-472-6024|surabhi.bhatt@nm.org|
21280556|NCT00950365|Montefiore Medical Center|Roman Perez-Soler, MD|(718) 405-8505|RPEREZSO@montefiore.org|
21246833|NCT02561611|Pennington Biomedical Research Center|Corby Martin|225-763-2585|Corby.Martin@pbrc.edu|
21246834|NCT06010836|Johns Hopkins|Associate Professor|4109552611|jsampso4@jhmi.edu|
21246835|NCT04923776|Columbia University|Brian Henick, MD|212-342-5162|bh2682@cumc.columbia.edu|
21246836|NCT04817176|Florida State University College of Medicine|Dr. Julia Sheffler|850-644-4199|julia.sheffler@med.fsu.edu|
21246837|NCT05890105|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21246838|NCT04206787|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21246839|NCT05117008|Medical College of Wisconsin|Meera Mohan MD, MS|414-805-4600|memohan@mcw.edu|
21246840|NCT04505410|University of Miami Miller School of Medicine|Associate Professor, Director of Translational Studies for the Crohn's and Colitis Center|3057733573|odamas@med.miami.edu|
21246841|NCT02361658|Toronto Western Hospital, University Health Network|Emad Al Azazi|4166035800|emad.alazazi@uhnresearch.ca|2508
21246842|NCT03875339|University of Kentucky|Dr. Matthew L. Bush, Professor and Chair of Otolaryngology- Head and Neck Surgery|(859)218-2139|matthew.bush@uky.edu|
21246843|NCT03533257|Amylyx Pharmaceuticals, Inc.|Chief Medical Officer|(877) 374-1208|medinfo@amylyx.com|
21246844|NCT06834490|Pharmasoft|Y.E. Meshcherskiy, Medical Director|+ 7 (495) 626-47- 55|meshcherskiy_y@pharmasoft.ru|140
21246845|NCT04108130|Columbia University Medical Center|Dr. Marcos F. Vidal Melo|2123424799|mv2869@cumc.columbia.edu|
21246846|NCT01130883|Abbott|Global Medical Services|1-800-633-9110||
21246847|NCT04998305|Columbia University|Hiroshi Mitsumoto, MD|212-305-1319|hm264@cumc.columbia.edu|
21246848|NCT05311176|Imugene|Study Director|+61 2 9423 0881|info@imugene.com|
21246849|NCT05512650|Tufts University|Nancy Baker, Professor|617 627 5562|nancy.baker@tufts.edu|
21246850|NCT05465239|Barron Associates, Inc.|Jason Burkholder|434-973-1215|burkholder@bainet.com|
21280557|NCT01876446|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
21280558|NCT02513212|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
21280559|NCT02473926|University of Colorado - Anschutz Medical Campus|Dr. Amy Huebschmann|3037242268|amy.huebschmann@cuanschutz.edu|
21280560|NCT00202930|UPMC Children's Hospital of Pittsburgh|Jean M. Tersak, M.D.|412-692-8570|jean.tersak@chp.edu|
21280561|NCT01244503|Virginia Commonwealth University|Arun J Sanyal|804 828 6314|asanyal@mcvh-vcu.edu|
21280562|NCT03629184|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21280563|NCT01461538|Seattle Genetics, Inc.|Chief Medical Office|855-473-2436|medinfo@seagen.com|
21280564|NCT01982955|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21280565|NCT03051672|Dana-Farber Cancer Institute|Dr. Sara Tolaney|6176323800|sara_tolaney@dfci.harvard.edu|
21280566|NCT01328184|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21280567|NCT00692692|Vanderbilt University Medical Center|Jason Wendel, MD|615-936-0160|jason.wendel@vanderbilt.edu|
21280568|NCT01611779|Siesta Medical, Inc.|Michael Kolber|408-320-9424|mkolber@siestamedical.com|
21280569|NCT03475992|MVG Industries|Luc Duchesne|0033169298156|luc.duchesne@mvg-world.com|
21280570|NCT05655546|Scripps Research|Julia Moore Vogel|8587842275|immunocare@scripps.edu|
21280571|NCT03493685|Travere Therapeutics, Inc|Travere Therapeutics Call Center|1-877-659-5518|medinfo@travere.com|
21280572|NCT04452669|Aerogen Pharma|David Durand, MD|510-928-2111|ddurand@aerogenpharma.com|
21280573|NCT02218463|University of Missouri-Kansas City School of Medicine|Dr. Tazim Dowlut-McElroy, M.D., M.S.|816-404-5150|tdowlut@cmh.edu|
21236188|NCT01787617|Pennington Biomedical Research Center|Dr. Robert Newton|225-763-3034|Robert.Newton@pbrc.edu|
21236189|NCT02244944|University of Kentucky|Gregory Graf|8592574749|Gregory.Graf@uky.edu|
21236190|NCT01747772|Division of Abdominal Imaging and Interventional Radiology, Massachusetts General Hospital|Anthony E. Samir MD||asamir@partners.org|
21236191|NCT02492100|Massachusetts General Hospital|Areej El-Jawahri|248-763-3912|ael-jawahri@partners.org|
21236192|NCT04121962|Johns Hopkins Bloomberg School of Public Health|Dr. Karin Tobin|4105025368|ktobin2@jhu.edu|
21236193|NCT01308749|Duke University Center for Autism and Brain Development|Linmarie Sikich, MD|9196810026|linmarie.sikich@duke.edu|
21236194|NCT01301963|CCCC|Hien Duong, MD|216-445-5531|duongh@ccf.org|
21236195|NCT01197950|Universty of Skovde|Professor Lena Mårtensson|+46500448000|lena.martensson@his.se|
21236196|NCT02585895|Amgen Inc.|Study Director|866-572-6436||
21236197|NCT01452269|University of Rochester|Dr. Steven Barnett||steven_barnett@urmc.rochester.edu|
21236198|NCT01243333|Huntsman Cancer Institute Research Compliance Officer|Josiah Hawks|8015850601|Josiah.Hawks@hci.utah.edu|
21236199|NCT03108924|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21236200|NCT02127164|University of Arizona|Andrew Tang, MD|520-626-5056|traumaresearch@arizona.edu|
21236201|NCT01173848|Cleveland Clinic|Dr. James Simon|216-445-4891|simonj2@ccf.org|
21236202|NCT02265705|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21236203|NCT04030416|seca gmbh & co. kg|Kristin Klückmann|+49(40)200000|kristin.klueckmann@seca.com|232
21236204|NCT00462384|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21236205|NCT04000165|The National Institutes of Health / The National Heart, Lung, and Blood Institute|Dr. Swee Lay Thein, Chief of Sickle Cell Branch|301.402.6699|sweelay.thein@nih.gov|
21236206|NCT01753193|MedImmune, LLC|Raj Tummala|+1 301-398-0548|information.center@astrazeneca.com|
21236207|NCT02682264|Cassiopea, SPA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
21236208|NCT02942160|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|ClinicalTrials@Endo.com|
21236209|NCT03879798|Memorial Sloan Kettering Cancer Center|Dr. Charles Rudin|646-888-4527|rudinc@mskcc.org|
21236210|NCT01255358|EryDel spa|Clinical Study Coordinator|+39 02 36504470|guenter.janhofer@erydel.com|
21236211|NCT06027216|Schepens Eye Research Institute, Mass Eye and Ear|Eli Peli|617-912-2597|eli_peli@meei.harvard.edu|
21294510|NCT03703310|Sol-Gel Technologies, Ltd.|VP Clinical & Regulatory Affairs|+972-73-3729453|Ofra.Levy-Hacham@sol-gel.com|
21294511|NCT00932620|University of Ioannina|Prof Moses Elisaf|+302651007509|egepi@cc.uoi.gr|
21294512|NCT03614416|Bioserenity|Eléonore CAILLET|01 57 27 40 00.|eleonore.caillet@bioserenity.com|
21294513|NCT00731653|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|mfava@partners.org|
21294514|NCT02526524|Elcelyx Therapeutics, Inc|Chief Scientific Officer|858-876-1814|info@elcelyx.com|
21294515|NCT03711929|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
21294516|NCT00591149|University of Kansas Medical Center|Chao Huang, MD|913-588-6029|chuang2@kumc.edu|
21294517|NCT00539513|Yale University School of Medicine|Christopher Pittenger, MD Ph.D|203-974-7675|christopher.pittenger@yale.edu|
21294518|NCT03002818|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21294519|NCT01328041|ViiV Healthcare|GSK Response Center|866-435-7343||
21294520|NCT00711113|DENTSPLY Implants|Manager Global Clinical Operations|+46313763500||
21294521|NCT02456636|University of Kansas Medical Center|Christie Befort, PhD|913 588-3338|cbefort@kumc.edu|
21294522|NCT00780481|Vanderbilt University Medical Center|James Muldowney|615-936-1720|james.muldowney@vanderbilt.edu|
21294523|NCT01606787|Memorial Sloan Kettering Cancer Center|Dr. Jonathan Coleman, MD|646-422-4432|colemanj@mskcc.org|
21294524|NCT02913430|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MSCR|412-647-5554|stadtermanbm@upmc.edu|
21294525|NCT00313313|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
21294526|NCT00368836|Carolinas Medical Center|Dr. Jeffrey Kline|704-355-3181|jkline@carolinas.org|
21294527|NCT01082874|Population Health Research Institute|P.J. Devereaux, MD, PhD, FRCPC|905-527-4322|philipj@mcmaster.ca|40654
21294528|NCT02084706|Brigham and Women's Hospital|Dr. Philip Blazar|617-732-5384|pblazar@partners.org|
21294529|NCT01846663|Bausch Health Americas, Inc|Study Director|7072851528|Varsha.Bhatt@bauschhealth.com|
21294530|NCT00986401|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
21294531|NCT04392141|Kermanshah University of Medical Sciences|Prof. Ali Mostafaie|+989188302044|amostafaie@kums.ac.ir|
21236212|NCT03231371|University of Michigan|Bryan Goldstein||Bryan.Goldstein@cchmc.org|
21236213|NCT02745626|University of Connecticut Health|Dr. Madhur Upadhyay, Director Orthodontic Clinic, Assistant Professor|860-679-3729|maupadhyay@uchc.edu|
21246851|NCT06106022|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-7428|medicalinformation@phathompharma.com|
21246852|NCT05405985|Galderma|Clinical Operations|08179615000|Clinical.Studies@galderma.com|1
21246853|NCT02787031|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
21246854|NCT05424380|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21246855|NCT03204825|University of Stirling|Dr Chris Seenan|+441413318151|christopher.seenan@stir.ac.uk|
21246856|NCT02473445|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224- 383-3000|clinicaltrials@horizonpharma.com|
21246857|NCT04247802|Oxford University Hospitals NHS Foundation Trust|Mrs Martha Batting|01865|martha.batting@ouh.nhs.uk|737526
21246858|NCT03165786|University of Illinois Chicago|Pamela Martyn-Nemeth, Professor|(312) 996-7903|pmartyn@uic.edu|
21246859|NCT05265065|Murdoch Children's Research Institute|Kim Mulholland|+61 3 99366656|kim.mulholland@mcri.edu.au|
21246860|NCT04778410|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21246861|NCT03235440|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
21246862|NCT04574583|National Cancer Institute|Dr. James Gulley|301-480-8870|james.gulley@nih.gov|
21246863|NCT05422885|Marcus Institute|Courtney Millar|6179715531|courtneymillar@hsl.harvard.edu|
21246864|NCT01146704|Department of Veterans Affairs, VAGLAHS|Dr. Joseph Pisegna|3104783711|Joseph.Pisegna@va.gov|41664
21246865|NCT03691298|Smith+Nephew|Laura Everson|+447718320892|laura.everson@smith-nephew.com|
21246866|NCT04072861|Renibus Therapeutics|Donald J Keyser, Chief Operating Officer|18178756991|jkeyser@renibus.com|
21246867|NCT05571267|IVERIC Bio, Inc.|Medical Director|609-474-6755|info@ivericbio.com|
21246868|NCT04214834|RTI International|Dr. Abhik Das|3017708214|adas@rti.org|
21246869|NCT04924400|Geisinger|Dr. Thomas Morland|703-593-0088|tmorland@geisinger.edu|
21246870|NCT04424316|Pfizer Inc.|PfizerClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21246871|NCT04633538|Oxford University Hospital|Dr Elizabeth Orchard|01865223084|elizabeth.orchard@ouh.nhs.uk|
21246872|NCT05070741|University of Kansas Medical Center|Paige Geiger, PhD|913-588-7408|pgeiger@kumc.edu|
21246873|NCT03245840|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21246874|NCT01116895|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
21246875|NCT03995979|University of Florida|Dr. Salvatore Scali|(352) 376-1611|salvatore.scali@surgery.ufl.edu|
21246876|NCT06609486|Hanyang University Seoul Hospital|Jongshill Lee, Ph.D.|+82-10-6209-4260|netlee@hanyang.ac.kr|
21294532|NCT02357472|Ji Ai Genetics & IVF Institute|Dr.Jing Fu|86-021-63459977|fujing_givf@163.com|
21236214|NCT00345579|GlaxoSmithKline|GSK Response Center|866-435-7343||
21236215|NCT03029208|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21236216|NCT01863017|University of Kansas Medical Center|Merlin G Butler|9135881800|mbutler4@kumc.edu|
21236217|NCT03207750|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21236218|NCT02493361|University of California, San Francisco|Dr. Katy Tsai|(415) 402-5483|katy.tsai@ucsf.edu|
21236219|NCT02785406|The University of Texas Health Science Center at Houston|Scott Lane|713-486-2535|Scott.D.Lane@uth.tmc.edu|
21236220|NCT00856583|H. Lundbeck A/S|H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
21236221|NCT01944046|Duke University|Linmarie Sikich, M.D.|919-681-0026|linmarie.sikich@duke.edu|
21294533|NCT05623475|College of Nursing, Taipei Medical University, Taiwan|Kee-Hsin Chen, R.N., Ph.D.|+886-2-27361661|keehsin@tmu.edu.tw|3613
21294534|NCT00832598|Memorial Sloan Kettering Cancer Center|Dr. Ronald Blasburg, MD|646-888-2211|blasberr@mskcc.org|
21294535|NCT00803400|Psychiatry Academic Unit at J.A.Fernandez Hospital, University of Buenos Aires Medicine School Department of Mental Health|Dr. Marcelo Rudelir|54 11 48254740|mrudelir@hotmail.com|
21294536|NCT02241655|Washington University|Dr. Michael Avidan, MBBCh|314-332-7265|avidanm@wustl.edu|
21294537|NCT03466099|KalVista Pharmaceuticals|Director Clinical|857-999-0075|clinicalinfo@kalvista.com|
21294538|NCT01671293|Universidad del Desarrollo|J. Carola Pérez Ewert|5623279875|janetperez@udd.cl|
21294539|NCT00075946|ECOG Statistical Office|Study Statistician|617-632-3012||
21294540|NCT01923363|Loma Linda University Medical Center|Dr. Steven Forland|909-558-4000|sforland@llu.edu|43980
21294541|NCT00410826|University of Washington|Renato G. Martins, MD, MPH|2062882048|rgmart@uw.edu|
21294542|NCT02901054|Washington University School of Medicine|Simon Haroutounian, PhD|3142861715|simon.haroutounian@wustl.edu|
21294543|NCT04674111|Boston Scientific Corporation|Amy Maurer, Director of Clinical Trials|800-876-9960|amy.maurer@bsci.com|
21294544|NCT05593913|Acer Medical Inc.|Regulator Manager|886-2-26960366|AcerMedicalofficial@gmail.com|
21294545|NCT01453205|MedImmune, LLC|Mohammed Dar|301-398-4095|information.center@astrazeneca.com|
21294546|NCT01666119|BDSI|Enoch Bortey|919 582 9050|ebortey@bdsi.com|
21294547|NCT04570605|University of Utah School of Medicine|Glen Lau, MD|801-213-2700|Glen.Lau@hsc.utah.edu|
21294548|NCT05549232|Hemanext Inc.|Sr. Director, Clinical Affairs|781-301-7474|jill.bagdasarian@hemanext.com|
21294549|NCT03255967|NYU Langone Health|Abraham Brody|2129927341|Abraham.Brody@nyulangone.org|
21294550|NCT02664311|Beth Israel Deaconess Medical Center|Eleanor Greene|617-667-1836|ergreene@bidmc.harvard.edu|
21294551|NCT00722722|Mayo Clinic|Mark Stegall, MD|507-266-2812|Stegall.Mark@mayo.edu|
21294552|NCT00778258|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21294553|NCT00780143|Pharma Mar, S.A.|Clinical Development Department of PharmaMar´s Oncology,Business Unit.,|+34 918466000|clinicaltrials@pharmamar.com|
21294554|NCT01098253|University of Pennsylvania, Perelman School of Medicine|Dr. Hillary R Bogner|215-746-4181|hillary.bogner@uphs.upenn.edu|
21294555|NCT02644096|University of Copenhagen|Chief researcher Britta Hørdam|+ 45 22214383|britta@hordam.dk|
21294556|NCT02461290|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21294557|NCT00322452|AstraZeneca|Gerard Lynch||AZTrial_results_posting@AstraZeneca.com|
21294558|NCT00526656|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Jorge Garcia, MD|216-444-7774|garciaj4@ccf.org|
21294559|NCT02438384|Department of Emergency Medicine, UNC School of Medicine|Tim Platts-Mills, MD|559-240-6073|tim_platts-mills@med.unc.edu|
21280574|NCT03700125|Barts Health NHS Trust|Dr Simon Finney|02073777000|simon.finney2@nhs.net|
21280575|NCT04576507|New York State Psychiatric Institute|Caroline A. Arout, Ph.D.|646-774-6167|caroline.arout@nyspi.columbia.edu|
21280576|NCT04470518|Leuven Unit Health Technology Assessment Research, KU Leuven|Tine De Burghgraeve, PhD|+3216377276|tine.deburghgraeve@kuleuven.be|
21280577|NCT03848715|UCLA|Dr. Chloe Boyle|310 794 9383|ccboyle@mednet.ucla.edu|
21280578|NCT04653454|Mayo Clinic|Adrian Dumitrascu M.D.|904-956-0081|Dumitrascu.Adrian@mayo.edu|
21280579|NCT05525520|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21280580|NCT02732730|HPTN Statistical & Data Management Center|HPTN Statistical Manager|206-667-4004|HPTN-Data-Access@scharp.org|
21280581|NCT05878093|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
21280582|NCT02721732|The University of Texas MD Anderson Cancer Center|Dr. Aung Naing|(713) 563-3885|anaing@mdanderson.org|
21280583|NCT00725283|GlaxoSmithKline|GSK Response Center|866-435-7343||
21280584|NCT00118157|Barbara Ann Karmanos Cancer Institute|Sayeh Lavasani, M.D.|(313) 576-8751|lavasans@karmanos.org|
21280585|NCT03514459|University of Washington|Dr. McKenna Eastment|5742101120|mceast@uw.edu|
21280586|NCT01557504|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21246877|NCT03582033|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
21246878|NCT05741294|Almirall S.A|Valentina Cappello/Global Medical Operations Manager|+34932913000|valentina.cappello@almirall.com|
21246879|NCT03681912|Florida State University|Sylvie Naar, PhD; Distinguished Endowed Professor|850-644-2334|sylvie.naar@med.fsu.edu|
21246880|NCT04707768|Akebia Therapeutics, Inc.|Akebia Therapeutics, Inc.|6178446128|trials@akebia.com|
21246881|NCT02518048|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
21246882|NCT03419052|Indiana University|Daniel Clark, PhD|317-274-9292|daniclar@iu.edu|
21246883|NCT05123027|Medical University of South Carolina|Dr. Ralph Ward|843-876-6110|wardrc@musc.edu|
21246884|NCT03735979|Medical University of South Carolina|Jordan J. Elm, PhD|843-876-1605|elmj@musc.edu|
21246885|NCT05958927|Usak University Medical Faculty|Suzan Doğruya|05322270732|sdogruya@hotmail.com|
21246886|NCT00319111|Actelion Pharmaceuticals Ltd|Loïc Perchenet PhD/Clinical Trial Leader|+41 61 565 6457||
21246887|NCT04330040|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21246888|NCT05525104|Erasmus Medical center|I.J. de Heer, MD|+31107040704|i.deheer@erasmusmc.nl|
21246889|NCT02039401|Helixmith, LLC|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
21246890|NCT06946888|Kaohsiung Veterans General Hospital|Li-Ying Lin|07-3422121|llylin@vghks.gov.tw|71571
21246891|NCT02585323|University of British Columbia|Dr. Linda Li|604-207-4020|lli@arthritisresearch.ca|
21246892|NCT04536012|Hospital of the University of Pennsylvania|Alexander C. Fanaroff, MD, MHS|2156157674|alexander.fanaroff@pennmedicine.upenn.edu|
21246893|NCT05850052|Cleveland Clinic Foundation|YanYan Han|216-444-2250|HANY3@ccf.org|
21246894|NCT01449513|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
21246895|NCT04466098|University of Minnesota, Masonic Cancer Center|Dr. David Ingbar|612-624-9452|ingba001@umn.edu|
21246896|NCT04200313|Jaeb Center for Health Research|Katrina Ruedy|813-975-8690|kruedy@jaeb.org|
21294560|NCT02889289|Washington DC VA Medical Center|Dr. Shane Chanpimol|202-745-8000|shane.chanpimol@va.gov|55854
21294561|NCT01795495|Nationwide Children's Hospital|David Martin, MD|6147224200|David.Martin@nationwidechildrens.org|
21294562|NCT04027049|Johns Hopkins University|Department of Neurology|410-955-2228|ezink1@jhmi.edu|
21294563|NCT02650128|Shockwave Medical, Inc.|Beaux Alexander, Vice President Clinical Affairs|510-279-4262|balexander@shockwavemedical.com|145
21294564|NCT03116828|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
21294565|NCT00983515|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clincialtrials@urlmutual.com|
21294566|NCT05243745|HALEON|Haleon Response Center|+441932 95 95 00|ww.clinical-trial-register@haleon.com|
21294567|NCT02998203|Cyprus University of Technology|Dr. Konstantinos C. Makris|00357-25-002398|konstantinos.makris@cut.ac.cy|
21294568|NCT01746511|University of Rochester|Carl D'Angio|585-273-4911|carol_dangio@urmc.rochester.edu|
21294569|NCT04187144|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21294570|NCT01044745|University of Nebraska Medical Center|R. Gregory Bociek, MD|402-559-5388|rgbociek@unmc.edu|
21294571|NCT00966849|Imperial College London|Professor Simon Gregson|+4402075943279|Sajgregson@aol.com|2075943279
21294572|NCT05312632|Eisai Korea Inc. Medical department|Serena SoYoun Kwon|+82-10-7409-5623|s-kwon@eisaikorea.com|
21294573|NCT03015649|Envision Healthcare Scientific Intelligence, Inc.|Women's Imaging Director|9549397729|clinicaltrials@shcr.com|
21294574|NCT02379221|Travis AFB OMFS Clinic|Dr. Jason May|707-423-7085|jason.may.11@us.af.mil|
21294575|NCT02019108|University of British Columbia|Dr. Michael Hunt|604-827-4721|michael.hunt@ubc.ca|
21294576|NCT02200328|Cleveland Clinic Florida|Dr.Alison Schneider|9546595646|schneia2@ccf.org|
21294577|NCT00519376|GlaxoSmithKline|GSK Response Center|866-435-7343||
21236222|NCT03023891|Vanderbilt University Medical Center|Vivian Kawai|(615) 322-3304|vivian.k.kawai@vumc.org|
21236223|NCT01761747|Dana-Farber Cancer Institute|Dr. Peter Hammerman|617-632-6335|phammerman@partners.org|
21262371|NCT01810991|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
21262372|NCT01663740|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21262373|NCT03340805|The Children's Hospital of Philadelphia|Dr. Scott L. Weiss, study co-PI|215-590-5505|WeissS@email.chop.edu|
21262374|NCT03575468|Consumer Wellness Solutions|Dr. Katrina Vickerman|469-608-4208|katrina.vickerman@optum.com|
21262375|NCT00404768|GlaxoSmithKline|GSK Response Center|866-435-7343||
21262376|NCT01522651|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21262377|NCT02658656|James J Peters VA Medical Center|Dr. Ann Spungen, Study Chairperson|7185849000|ann.spungen@va.gov|5814
21262378|NCT01118143|University of Tromsø|Professor Jan Bergdahl|+4777649122|jan.bergdahl@uit.no|
21262379|NCT02112448|Advocate Children's Hospital|Jamie Penk|7086845580|jamie.penk@advocatehealth.com|
21262380|NCT03624101|University of Alabama at Birmingham Child Health Research Unit|Heather Hathorne|2055032829|hyhathorne@uabmc.edu|
21262381|NCT03729869|Medical University of South Carolina|Lisa Nunn, Program Manager|843-792-0476|jenkinli@musc.edu|
21262382|NCT03478878|National Institutes of Health|Emily Chew, MD, Principal Investigator, NEI|3014966583|emily.chew@nih.gov|
21262383|NCT03918642|VA Greater Los Angeles Healthcare System|Brandon C. Yarns|310-478-3711|brandon.yarns@va.gov|
21262384|NCT03823937|Sultan.abdulhamid|Tugbaozsoy|+905074583382|tugbaozsoyy@gmail.com|
21262385|NCT01115569|Zogenix|Kevin Romanko|(510) 550-8323|kromanko@zogenix.com|
21262386|NCT05057988|Stanford University|Dr. Dokyoung Sophia You|650-724-9320|dsyou@stanford.edu|
21262387|NCT01070303|Abbott|Global Medical Services|800-633-9110||
21262388|NCT03881163|Zambon S.p.A|Valentina Vaja|+390266524497|Valentina.Vaja@ZambonGroup.com|
21262389|NCT00859898|Clinical Trial Transparency|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com|
21262390|NCT02191917|BioMarin Pharmacuetical Inc.|Trial Specialist|1-800-983-4587|medinfo@bmrn.com|
21262391|NCT01397071|UCLA Department of Medicine/Center for Human Nutrition|Zhaoping Li|310-206-1987|zli@mednet.ucla.edu|
21280587|NCT02892955|Abbott|Joyce Chuang|9253535817|joyce.chuang@abbott.com|
21280588|NCT01365819|UCLA, Dept of Family Medicine|Dr. Steve Shoptaw|310-794-0619|sshoptaw@mednet.ucla.edu|
21280589|NCT01582490|Pacira Pharmaceuticals, Inc.|Erol Onel, MD|858-625-2424|erol.onel@pacira.com|
21280590|NCT01962103|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
21280591|NCT03825939|NYU Langone|Dr. Jan Koenig|516-678-2232|Jan.Koenig@nyulangone.org|
21280592|NCT03456102|Johns Hopkins University School of Medicine|Petros C. Karakousis, MD|410-502-8233|petros@jhmi.edu|
21280593|NCT03077737|Northwestern University|Dr. Brian Hitsman, PhD|312-503-2074|b-hitsman@northwestern.edu|
21280594|NCT02763046|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21280595|NCT00080912|NCIC Clinical Trials Group|Dr. Bingshu Chen|613-533-6000|bechen@ctg.queensu.ca|77703
21280596|NCT00818766|Brigham & Women's Hospital|David Oxman, MD|215-503-1198|doxman2001@yahoo.com|
21280597|NCT00086684|Janssen R&D US|SENIOR DIRECTOR CLINICAL LEADER|1 609 730-4529||
21280598|NCT01103180|University of Chicago|Dr. Emil Coccaro|773-834-4083|ecoccaro@yoda.bsd.uchicago.edu|
21280599|NCT01067105|Sunovion|Respiratory Medical Director|1-866-503-6351||
21280600|NCT00853099|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21280601|NCT01917682|Corindus, Inc.|John Van Vleet, VP of Clinical and Regulatory Affairs|(260)615-8892|john.van_vleet@siemens-healthineers.com|
21280602|NCT02521415|Carolinas Medical Center|Dr. Stacy Reynolds|704-355-3181|stacy.reynolds@carolinashealthcare.org|
21280603|NCT02203357|Peking University Health Science Center|Dr. Hui Zhuang|86-10-82801617|zhuangbmu@126.com|
21294578|NCT00484393|Fraser Health|Brandi Newby|604-585-5666|brandi.newby@fraserhealth.ca|774374
21262392|NCT03350750|Johns Hopkins|Jessica Wollett|6673068141|jwollet1@jh.edu|
21280604|NCT04505969|Barau Dikko Teaching Hospital, Kaduna State University|Study Principal investigator|+2348066664042|abubakarabdulkareem8@gmail.com|
21294579|NCT01245738|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21294580|NCT02688088|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21294581|NCT02642393|Massachusetts General Hospital|Dr. Michael Schwarzschild|617-724-9611|michaels@helix.mgh.harvard.edu|
21294582|NCT01246479|Valneva Austria GmbH|Senior Scientist Clinical Research|+43120620|info@valneva.com|0
21294583|NCT03333317|Janssen Research & Development, LLC|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21294584|NCT03812185|Henry Ford Health System|Yoshihisa Morita|3059784358|moritayoshihisa2016@gmail.com|
21294585|NCT04924530|University of Bath|Professor Javier Gonzalez|01225 38|j.t.gonzalez@bath.ac.uk|5518
21294586|NCT01591837|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
21294587|NCT04022226|The University of New Mexico|Dr. Jeremy Miller|5052724490|jermiller@salud.unm.edu|
21294588|NCT03130439|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-5743|Sara_Tolaney@dfci.harvard.edu|
21294589|NCT01681069|Analyze & Realize GmBH|Dr Christof Jänicke|+49 30 40 00 83 23|cj@a-r.com|
21294590|NCT04726137|Fondazione Penta ETS|Giorgia Dalla Valle|393783022748|giorgia.dallavalle@pentafoundation.org|
21246897|NCT05524116|Boston University|Dr. Deepak Kumar|3026901455|kumard@bu.edu|
21294591|NCT03883165|University of Michigan Medical School|James T Eckner, MD, MS|734-647-5568|jeckner@med.umich.edu|
21294592|NCT00245050|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Vivian von Gruenigen, MD|216-844-5011|vev1@case.edu|
21294593|NCT00730041|Medtronic Xomed, Inc.|David Hodge|904-281-2774|david.l.hodge@medtronic.com|
21294594|NCT04838054|Stony Brook University|Srinivas Rao Myneni Venkatasatya, DDS, PhD|631-632-8739|srinivas.MyneniVenkatasatya@stonybrookmedicine.edu|
21294595|NCT05526781|Eye Consultants of Atlanta|Dr Joseph Christenbury|14043512220|jchristenbury@eyeconsultants.net|
21294596|NCT04085458|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
21294597|NCT02743949|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
21294598|NCT01921218|Emory University|Idelberto R. Badell, MD|404-712-6562|ibadell@emory.edu|
21294599|NCT01885208|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
21294600|NCT00920218|GlaxoSmithKline|GSK Response Center|866-435-7343||
21294601|NCT02130687|Yale University|Nancy J. Brown, M.D.|16153644022|nancy.j.brown@yale.edu|
21294602|NCT02449889|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
21294603|NCT01973387|Janssen Research & Development, LLC|Vice President (VP)||ClinicalTrialDisclosure@its.jnj.com|
21294604|NCT02141867|South African Surgical Outcomes Study|Prof Bruce Biccard|+27312604328|biccardb@ukzn.ac.za|
21294605|NCT02613117|Procter and Gamble|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
21294606|NCT00596154|Memorial Sloan Kettering Cancer Center|Dr. Christian Grommes, MD|212-610-0344|grommesc@mskcc.org|
21246898|NCT04389957|San Francisco Veterans Affairs Medical Center|Dr. Tonya Kaltenbach|(415) 221-4810|tonya.kaltenbach@va.gov|24406
21246899|NCT01540994|Sharp Healthcare|Dr. Geoffrey Weinstein|858-939-5010|geoffrey.weinstein@sharp.com|
21246900|NCT03489434|Georgia State University|Amanda Gilmore|404-413-2000|agilmore12@gsu.edu|
21246901|NCT05308979|UC Irvine Medical Center|Dr. Carly Crowder|7144562911|crowderc@hs.uci.edu|
21246902|NCT03318159|Seoul National University Hospital|Dr. Koh|82220727217|go01@snu.ac.kr|
21246903|NCT04084574|Duke University|Crystal Tyson, MD, MHS|919-660-6671|crystal.simpson@duke.edu|
21246904|NCT01121588|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21246905|NCT00942877|National Cancer Institute|Dr. Alice Chen|240-781-3274|chenali@nih.gov|
21246906|NCT04502186|University of Michigan School of Social Work|Dr. Addie Weaver|734-615-2122|weaverad@umich.edu|
21246907|NCT01385202|Biosense Webster, Inc.|Robert Stagg, Manager, Clinical Operations|(800) 729-9010|RStagg@its.jnj.com|8611
21246908|NCT03681262|Stanford University|Vafi Salmasi, MD. MS.|6507250246|vsalmasi@stanford.edu|
21246909|NCT02095691|Biosense Webster, EMEA|Liesbeth Vanderlinden, Manager Clinical Research|+32(0)2 7463527|lvanderl@its.JNJ.com|
21246910|NCT04583280|Janssen Research & Development LLC|Senior Director Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21246911|NCT00964392|Biosense Webster, Inc.|Robert Stagg, Clinical Franchise|(800) 729-9010|RStagg@its.jnj.com|
21246912|NCT04068792|Janssen Research & Development, LLC|Senior director medical leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21246913|NCT03969563|VA Northern California Health Care System|Dr. Jerry Nadler, Chief of Research|9168432776|Jerry.Nadler@va.gov|
21246914|NCT03652272|Northwestern University|Dr. Michael Wolf|(312) 503-5592|mswolf@northwestern.edu|
21246915|NCT02326974|Dana-Farber Cancer Institute|Project Manager|617-632-3500|ctopm@dfci.harvard.edu|
21246916|NCT02577354|Mainstay Medical|Vice President Clinical Affairs|7637727637|diane.burnside@mainstay-medical.com|
21246917|NCT05985382|University of Central Florida|Abigail Anderson|4078231026|Abigail.Wilson@ucf.edu|
21246918|NCT02938520|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21246919|NCT04265807|University of Washington|Graham Nichol|206 521 1784|nichol@uw.edu|
21246920|NCT03812614|University of Pittsburgh School of Medicine|Ann-Marie Rosland, MD, MS|412-648-5660|roslandam@pitt.edu|
21246921|NCT05652010|Coloplast A/S|Senior Scientific Manager|+4549113192|dkmbs@coloplast.com|
21246922|NCT05451693|HealthPartners Institute|Bhavani Kashyap, PhD, MBBS|651-495-6363|Bhavani.x.kashyap@healthpartners.com|
21246923|NCT04704869|The University of Texas Health Science Center at Houston|Bryan A Cotton, MD|713-500-7313|Bryan.A.Cotton@uth.tmc.edu|
21246924|NCT04763772|UH Cleveland Medical Center|Ian Neeland|216-844-5965|ian.neeland@uhhospitals.org|
21246925|NCT04490109|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
21246926|NCT03372057|Secura Bio, Inc.|Ohad Bentur, MD, MHA, MSc|1-702-254-0011|obentur@securabio.com|
21246927|NCT05953740|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21246928|NCT03880955|Stryker|Monica Fleeman|251-465-5969|monica.fleeman@stryker.com|
21246929|NCT05112900|Huntsman Cancer Institute at the University of Utah|Dr. Yelena Wu|801-213-5653|yelena.wu@utah.edu|
21246930|NCT03745716|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
21246931|NCT04761198|Mereo BioPharma|Mereo BioPharma|Please Email|enquiries@mereobiopharma.com|
21246932|NCT02994927|ChemoCentryx, Inc.|Clinical trial disclosure|650.210.2900|clinicaltrials@chemocentryx.com|
21246933|NCT04046094|University of Kansas Medical Center|Faith Rahman|913-588-2502|frahman2@kumc.edu|
21246934|NCT02865538|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21246935|NCT05505578|225.763.2500 Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
21246936|NCT04427007|Liberating Technologies, Inc.|Brianna Rozell|774-233-0876|brianna.rozell@liberatingtech.com|
21246937|NCT06237686|Medical Consultant|Principal Investigator: Søren Meisner, MD|+4520117378|sm_meisner@hotmail.com|
21246938|NCT04734197|Surface Ophthalmics, Inc.|VP, Clinical Operations|(925) 494-3660|cbaenziger@surfaceophthalmics.com|18
21246939|NCT04165213|University of Pennsylvania, School of Nursing|Emily Summerhayes, Project Manager|6099233786|esummer@nursing.upenn.edu|
21246940|NCT04464564|Otsuka Pharmaceutical Development & Commercialization, Inc.|Clinical Transparency|08446878522|smb_clinicaltranspa@otsuka-us.com|
21246941|NCT05423730|Beth Israel Deaconess Medical Center|Kenneth J Mukamal|617-754-1401|kmukamal@hsph.harvard.edu|
21246942|NCT03550170|Case Western Reserve University|Dr. Matthew Plow|216-368-8969|map208@case.edu|
21246943|NCT04276935|Memorial Sloan Kettering Cancer Center|Dr. Thomas M. Atkinson|646-888-0089|atkinsot@mskcc.org|
21262393|NCT00205504|Virginia Commonwealth University|Kai Cheang, Principal Investigator|804-828-9698|kicheang@vcu.edu|
21262394|NCT02202031|University of California, San Francisco|Alison Huang, MD|415-514-8697|alison.huang@ucsf.edu|
21262395|NCT02184143|Vanderbilt University Medical Center|Kristin Archer|(615) 322-2732|kristin.archer@Vanderbilt.Edu|
21262396|NCT00748826|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21262397|NCT00321984|Takeda Global Research & Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
21262398|NCT01596842|Dong-A University|Professor|82-51-240-2811|anws@dau.ac.kr|
21280605|NCT02687451|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|clinicaltrials@endo.com|
21280606|NCT03652051|Azura Ophthalmics|Charles Bosworth|17145598435|charles.bosworth@azuraophthalmics.com|
21280607|NCT03473925|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21280608|NCT04481035|Cincinnati Children's Hospital Medical Center|Donald L. Gilbert MD|513-636-4222|donald.gilbert@cchmc.org|
21280609|NCT05198518|Icahn School of Medicine at Mount Sinai|Alfred Marc C Iloreta Jr, MD|(212) 241-9410|alfred-marc.iloreta@mountsinai.org|
21280610|NCT00501995|Johns Hopkins University|Gwen Leatherman,R.N.,M.S.|410-550-8582|gleathe@jhmi.edu|
21280611|NCT03645863|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608 Japanese only|cti-inq-ml@ml.mt-pharma.co.jp|
21280612|NCT02396511|TRACON Pharmaceuticals|Medical Monitor|8585500780|ctheuer@traconpharma.com|
21280613|NCT02756611|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21280614|NCT00124917|National Cancer Institute|Dr. Deborah Citrin|301-496-5457|Debra_Citrin@nih.gov|
21280615|NCT01422213|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
21280616|NCT00951496|NRG Oncology|Linda Gedeon for Mark Brady, PhD|716-845-1169|lgedeon@gogstats.org|
21280617|NCT00571324|Children's Hospital of Philadelphia|Diva De Leon, MD|267-426-5529|DELEON@email.chop.edu|
21280618|NCT01555697|UC San Diego|Neal Swerdlow, M.D., Ph.D.|619-543-6270|nswerdlow@health.ucsd.edu|
21280619|NCT01169350|University of Washington|Dr. Janet F. Eary|206-598-6244|jeary@uw.edu|
21280620|NCT01875978|China Medical University Hospital|Dr. Dalong Chen|+886-227919696|my686chen@gmail.com|1205
21280621|NCT04429945|James A Haley Veterans Hospital|Dr. Christopher Fowler|619-647-4470|christopher.fowler3@va.gov|
21280622|NCT04870710|BIDMC|Dr. Paulo Lizano|617-754-1227|plizano@bidmc.harvard.edu|
21280623|NCT00476190|Dana Farber Cancer Institute|Dr. Dan DeAngelo|6175828410|Daniel_Deangelo@dfci.harvard.edu|
21280624|NCT04782076|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21280625|NCT02860546|Taiho Oncology, Inc.|Taiho|844-878-2446|medicalinformation@taihooncology.com|
21280626|NCT01042093|Towson Orthopaedic Associates|David F. Dalury, MD|410-337-7900|ddalury@gmail.com|1221
21280627|NCT07034820|Nimsai Academia|Cem Atabiner, Principal Investigator|05324593292|cem.atabiner@kecioutdoor.com.tr|
21280628|NCT04851873|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21280629|NCT02198963|Mercury Street Medical|Dr. John Pullman|(406) 723-1375|john.pullman@mecurystmed.com|
21280630|NCT00995774|Washington DC Veterans Affairs Medical Center|Peter Lum, PhD|202-319-5181|lum@cua.edu|
21280631|NCT00683657|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
21280632|NCT04135937|Durham VA Health Care System|Angela Kirby|919-286-0411|angela.kirby@va.gov|175526
21280633|NCT04796961|Johns Hopkins University School of Medicine|Gail Daumit MD, MHS|410-614-6460|gdaumit@jhmi.edu|
21280634|NCT03657797|Nicox Ophthalmics Inc.|Doug Hubatsch / Chief Scientific Officer|832-360-3022|hubatsch@nicox.com|
21280635|NCT03103087|Myovant Sciences GmbH|Clinical Trials at Myovant|+1 650 238 0250|clinicaltrials@myovant.com|
21280636|NCT00413699|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21280637|NCT02115269|Abbott|Jean-Pascal Berrou, Global Medical Director CNS/Pain|+41614870457|jean-pascal.berrou@abbott.com|
21280638|NCT01051310|Medtronic|M. Hollander|+31620534428|maarten.hollander@medtronic.com|
21280639|NCT00711243|Northwestern University|Mary Mulcahy (MD)|312.695.6182|Mary.Mulcahy@nm.org|
21246944|NCT03364127|University of Illinois Chicago|Judith M. Schlaeger, PhD, CNM, LAc, FAAN|(312) 413-4469|jschlaeg@uic.edu|
21280640|NCT05989672|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21294607|NCT03691844|Amzell B.V.|Clinical Trial Manager|+41614864000|amzell-disclosure@amzell.com|
21294608|NCT02808052|Melinta Therapeutics|Global Health Science Center|1-844-633-6568|medinfo@melinta.com|
21294609|NCT02512874|Mayo Clinic|Dr. Cassie C. Kennedy|507-266-3958|kennedy.cassie@mayo.edu|
21246945|NCT04089865|Hospital for Special Surgery|Stavros G. Memtsoudis, MD, PhD, MBA|(212) 606-1206|memtsoudiss@hss.edu|
21294610|NCT03888235|University of British Columbia Department of Family Practice|Dr. Helene Bertrand|7782277776|dr.hbertrand@gmail.com|
21236224|NCT02007577|Stanford Universtiy|Dr. Gerald Reaven|650-724-3416|greaven@stanford.edu|
21236225|NCT02626715|UPMC Children's Hospital of Pittsburgh|Dr. Randy Windreich|412-692-5055|randy.windreich@chp.edu|
21246946|NCT04214860|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
21246947|NCT04282980|Zai Lab|Medical Director|+86 4008201022|Medinfo@zailaboratory.com|
21246948|NCT05860114|Italfarmaco SpA|Maurizio Caserini, MD|+39 02 64431|m.caserini@italfarmacogroup.com|
21280641|NCT03511105|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21280642|NCT02810457|Centus Biotherapeutics Limited|Clinical Trial Information|+353 1 609 7100|Clinical-Trial@centusbio.com|
21280643|NCT02750618|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
21280644|NCT02019472|Janssen-Cilag International N.V.|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
21280645|NCT00513695|Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium|Jennifer Specht, MD|(206) 288-6889|jspecht@uw.edu|
21280646|NCT02157935|AstraZeneca|Tor Skärby||tor.skarby@astrazeneca.com|
21280647|NCT01866826|NCI|Frank Maldarelli, MD|301-846-5611|fmalli@mail.nih.gov|
21280648|NCT03073876|City University of New York - Queens College and The Graduate Center|Nancy S. Foldi, PhD; Professor|718.997.3253|nfoldi@qc.cuny.edu|
21280649|NCT02493660|Stryker Company|Colleen Roden, Director, Clinical Operations|1 931 267 2041|colleen.roden@stryker.com|
21280650|NCT02288312|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21280651|NCT04552795|UT Health San Antonio|Bess Frost, PhD|210-562-5037|bfrost@uthscsa.edu|
21280652|NCT01276041|Memorial Sloan Kettering Cancer Center|Dr. Chau Dang, MD|914-367-7181|dangc@mskcc.org|
21280653|NCT00725491|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21280654|NCT01094704|UNC-Chapel Hill|Scott Donaldson|919-966-9198|scott_donaldson@med.unc.edu|
21280655|NCT01495000|GlaxoSmithKline|GSK Response Center|866-435-7343||
21280656|NCT02070965|Promius Pharma, LLC|Director of Clinical Operations|609-282-1476|kgulbronson@promiuspharma.com|
21280657|NCT02058069|MAKO Surgical Corp.|Michael Conditt|7132408675|michael.conditt@stryker.com|
21280658|NCT02222922|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21280659|NCT01930162|Novartis Pharmaceuticals|Study Director|862-778-8300||
21280660|NCT00840749|Accuray Inc|study admin|4087164608|ccheung@accuray.com|
21280661|NCT03411863|James J. Peters VAMC|Dr. Noam Y. Harel|718-584-9000|noam.harel@va.gov|1742
21280662|NCT03164551|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21280663|NCT01805089|DFCI|Dr. Wendy Chen|617-632-3800|wychen@partners.org|
21280664|NCT04941131|King Abdulaziz University|Dr Zuhair Natto|9666943899|znatto@kau.edu.sa|
21280665|NCT00729937|Olive View-UCLA Medical Center|David A. Talan, MD|818-364-3107|dtalan@ucla.edu|
21280666|NCT03420521|Johns Hopkins University|Dr. Christine Hann|410-502-0678|chann1@jh.edu|
21280667|NCT03098082|Indiana University School of Medicine|Jeffrey J. Easler, MD|3179440980|jjeasler@iu.edu|
21280668|NCT04277962|University of Texas Medical Branch Galveston|Dr. Antonio Saad Director of Clinical Research Division|409-772-0982|afsaad@utmb.edu|
21280669|NCT02757326|Duke University Medical Center, Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy|Yubin Kang, M.D., Principal Investigator|(919) 668-2331|yubin.kang@duke.edu|
21280670|NCT03423940|Rutgers, The State University of New Jersey|Brian D. Greer, Ph.D., BCBA-D|848-800-8505|brian.greer@rutgers.edu|
21280671|NCT01998841|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21280672|NCT00972595|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21280673|NCT01263938|University of Pennsylvania School of Medicine|Dr. Ronald Collman|215-898-0193|collmanr@pennmedicine.upenn.edu|
21280674|NCT03552380|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
21280675|NCT03447743|University of Kentucky|Dr. Michele Staton|859-312-8245|mstaton@uky.edu|
21280676|NCT02461160|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21236226|NCT02504294|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1--800--718--1021|ClinicalTrials.gov_Inquiries@Pfizer.com|
21236227|NCT00864032|University of California Davis Comprehensive Cancer Center|Dr. Robert J. Canter|916-734-5907|robert.canter@ucdmc.ucdavis.edu|
21236228|NCT01059760|Intermountain Heart Institute|Benjamin D. Horne|8015074708|benjamin.horne@imail.org|
21236229|NCT02252211|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21236230|NCT03694548|Emory University|Dr. Nitya Bakshi|404-727-3149|nitya.bakshi@emory.edu|
21236231|NCT04307186|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21236232|NCT01757964|University of Washington|David Suskind MD Professor of Pediatrics|206-987-2521|Jani.Klien@seattlechildrens.org|
21236233|NCT06281548|University of North Carolina-Chapel Hill|Adams Sibley|423-227-9198|asibley@live.unc.edu|
21236234|NCT01618838|Georgetown University Hospital|Dr. Sean Collins|202-444-3062|spc9@gunet.georgetown.edu|
21236235|NCT01587651|Daiichi Sankyo Medical Affairs|Fred Lipkin|973-944-2216|flipkin@dsi.com|
21236236|NCT03191903|Anika|Carol Pekar, VP Clinical Affairs|781-457-9218|cpekar@anikatherapeutics.com|
21236237|NCT02358889|Iconic Therapeutics|Gabriela Burian, M.D.|6504371000|gburian@iconictherapeutics.com|
21294611|NCT01054560|Covidien|Director of Clinical Affairs|9498373700||
21246949|NCT01917084|New England Research Institutes|Felicia Trachtenberg|617-972-3120|FTrachtenberg@neriscience.com|
21294612|NCT00210353|International Extranodal Lymphoma Study Group (IELSG)|Prof. Emanuele Zucca MD, Scientific and Medical Director|+41 91 811 9040|ielsg@eoc.ch|
21294613|NCT02135029|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294614|NCT02210689|Teva Pharmaceuticals USA. Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
21294615|NCT00866047|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
21294616|NCT05427539|Johnson & Johnson Vision Care, Inc. (JJVC)|Ben Straker|1-800-843-2020|bstraker@its.jnj.com|
21294617|NCT00223977|Watson Laboratories, Inc|Gary Hoel, RPh, PhD|801-588-6641|gary.hoel@watson.com|
21294618|NCT02063867|University of California, Irvine|Susan Huang, Principal Investigator & Medical Director of Epidemiology and Infection Prevention|949-824-5073|sshuang@uci.edu|
21294619|NCT01335724|Novartis Consumer Health|Clinical project Leader|+41223635528||
21294620|NCT04376684|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21294621|NCT02244840|Seoul National University Hospital|Professor|82-2-2072-2901|kjparkmd@plaza.snu.ac.kr|
21294622|NCT04934800|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|6151-72-5200|service@emdgroup.com|+49
21294623|NCT05596734|BioNTech SE|BioNTech clinical trials patient information|+49 6131 90840|patients@biontech.de|
21294624|NCT01974206|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
21294625|NCT02333396|ChildrensMemorialH|Karen Rychlik, MS|(773) 755-6310|krychlik@luriechildrens.org|
21294626|NCT05413512|Baylor University|Debroah Holland|(254) 710-1438|Deborah_L_Holland@baylor.edu|
21294627|NCT02059499|AMC Statistical Center|Dr Himanshu Joshi, MBBS, MPH, PhD (Assistant Professor)|212-259-9635|himanshu.joshi@mountsinai.org|
21294628|NCT04210245|NGM Biopharmaceuticals|VP, Clinical Operations|(650) 243-5555|ngm282@ngmbio.com|
21294629|NCT00053677|University of Chicago|Dr. Jon E. Grant|773-834-1325|jongrant@uchicago.edu|
21294630|NCT03989349|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
21294631|NCT02488135|University of Alberta|Scott Murray|587-891-6240|sipmurray@gmail.com|
21294632|NCT02684058|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
21294633|NCT03219034|Texas A&M University College of Dentistry|Dr. Emet Schneiderman|2148288377|eschneiderman@tamu.edu|
21294634|NCT01802580|Wake Forest University Health Sciences|Dr. Steve Feldman, Professor of Dermatology, Public Health Scienes, and Pathology|336-716-7740|sfeldman@wakehealth.edu|
21294635|NCT00772915|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
21294636|NCT01457014|Sleep and Alertness Research Inc.|Sharon A. Chung|416-603-5275|sachung@uhnres.utoronto.ca|
21294637|NCT03319953|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21294638|NCT00789581|Sarah Cannon Development Innovations|Charles H. Davis, RAC|615 524-4341|charles.davis2@scri-innovations.com|
21294639|NCT04385238|Harvard T.H. Chan School of Public Health|Sonia Hernandez-Diaz|6174323942|shernan@hsph.harvard.edu|
21294640|NCT03440723|Elm Tree Medical Inc.|CEO|2158050862|evamartin@elmtreemedical.com|
21294641|NCT03392883|Center for Technology and Behavioral Health, Geisel School of Medicine, Dartmouth College|Lisa A. Marsch, PhD|603-646-7092|Lisa.a.marsch@dartmouth.edu|
21294642|NCT01792817|electroCore, LLC|Clinical Affairs|+1 973-355-6683|clinical@electrocorellc.com|
21294643|NCT00201448|Virginia Commonwealth University|Stuart Adler|8048281807|sadler@vcu.edu|
21294644|NCT01498575|The Children's Hospital of Philadelphia|Dennis Durbin, MD, MSCE|215-590-7331|DURBIND@EMAIL.CHOP.EDU|
21294645|NCT00396006|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21294646|NCT01345591|University of Pittsburgh|J. Peter Rubin|412-624-9703|rubipj@upmc.edu|
21294647|NCT00090142|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21294648|NCT02442310|ApoPharma Inc.|Caroline Fradette, PhD|416-401-7543|cfradett@apopharma.com|
21294649|NCT01126437|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21294650|NCT01418703|University of Virginia|Marc D Breton, Ph.D.|434-982-6484|mb6nt@virginia.edu|
21294651|NCT01220973|Rutgers Cancer Institute of New Jersey|Susan Goodin PharmD, FCCP, BCOP|732-235-6783|goodin@cinj.rutgers.edu|
21294652|NCT02163967|Weill Cornell Medical College|Margaret Altemus|646-209-6277|maltemus@med.cornell.edu|
21294653|NCT00006046|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21294654|NCT03176472|Regenacy Pharmaceuticals Inc.|Dr. David Michelson, CMO|2676639826|dmichelson@regenacy.com|
21294655|NCT03272828|University of Washington|Dr. Mats Kronstrom|425-877-7345|mk33@uw.edu|
21262399|NCT02214186|Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo|M.D. Wallace Andrino da Silva|+551126616787|wallaceandrino@yahoo.com.br|
21294656|NCT01215110|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|212-227-7540|Dan.Everitt@tballiance.org|
21294657|NCT00847665|University Hospital Virgen de las Nieves|Dr. Francisco Manzano|34958020125|fmanzano@mailpersonal.com|
21294658|NCT03582553|Pennington Biomedical Research Center|Dr. Candida Rebello|225-763-3159|Candida.Rebello@pbrc.edu|
21294659|NCT00585546|University of Michigan|Francis Pagani|734 647-2894|fpagani@med.umich.edu|
21294660|NCT02851797|Italfarmaco SpA|Dr Paolo Bettica, MD and PhD|+3902 66041503|p.bettica@italfarmacogroup.com|
21294661|NCT03077438|Sanofi Pasteur Inc.|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21294662|NCT00813865|Patient Advocacy|Amicus Therapeutics|+1-609-662-2000|Clinicaltrials@amicusrx.com|
21294663|NCT03570918|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@Macrogenics.com|
21294664|NCT04295681|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
21294665|NCT00939029|Mayo Clinic|Dr. Jon Ebbert|507-284-4736|ebbert.jon@mayo.edu|
21294666|NCT03368053|GlaxoSmithKline|GSK Response Center|877-379-3718|GSKClinicalSupportHD@gsk.com|
21294667|NCT04686084|UCLA Oral & Maxillofacial Radiology|Sanjay M Mallya|3108251689|smallya@dentistry.ucla.edu|
21262400|NCT01525849|Entellus Medical|Ellen O'Malley|763-463-1598|eomalley@entellusmedical.com|
21262401|NCT00076219|VA Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh, PA|Paul M. Palevsky MD|410-360-3932|paul.palevsky@va.gov|
21262402|NCT02560701|Harvard Pilgrim Health Care Institute|Dr. J. Frank Wharam|(617) 867-4948|jwharam@post.harvard.edu|
21262403|NCT01776268|Vanderbilt University Medical Center|James Wynn MD||james.wynn@peds.ufl.edu|
21262404|NCT01847547|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21262405|NCT04392011|Washington State University|Dr. Mary Paine|509-358-7759|mary.paine@wsu.edu|
21262406|NCT00611130|Catalyst Pharmaceutical Partners, Inc.|M Douglas Winship|305-529-2522|dwinship@catalystpharma.com|12
21262407|NCT01765647|University of Alberta|Dory Sample|780-248-5599|dory.sample@ahs.ca|
21262408|NCT03303339|Cardiff Oncology|Nancy Sherman, Head of Clinical Operations|858-952-7570|clinops@cardiffoncology.com|
21262409|NCT03694522|Amgen|Study Director|866-572-6436|medinfo@amgen.com|
21262410|NCT02760407|R-Pharm|Maria Lemak, Scientific Advisor|0074959567937|lemak@rpharm.ru|1408
21262411|NCT02522377|CLEVELAND CLINIC FOUNDATION|MURAT ALTINAY, MD|2164453359|altinam@ccf.org|
21262412|NCT01158950|University of California, San Francisco|Dr. Jennifer Mitchell|510-985-3522|jennifer.mitchell@ucsf.edu|
21262413|NCT01206595|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
21262414|NCT02137772|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21262415|NCT01844700|Zucker Hillside Hospital, Division of Psychiatry Research|Anil Malhotra, MD|718-470-8281|amalhotra@nshs.edu|
21262416|NCT03290300|Aerin Medical, Inc.|Scott Wolf, M.D.; Chief Medical Officer|650-597-0111|swolf@aerinmedical.com|
21262417|NCT00864227|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
21262418|NCT02124798|GlaxoSmithKline|GSK Response Center|866-435-7343||
21262419|NCT03531957|Asana BioSciencxes, LLC|Pablo Jimenez|9086980782|pablo.jimenez@asanabio.com|
21262420|NCT03809546|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
21262421|NCT00487279|St. Jude Medical CRMD|Heidi Hinrichs/Sr. Director, Clinical Operations|(818) 493-3297|hhinrichs@sjm.com|
21262422|NCT02746679|The First Affiliated Hospital of Sun Yat-sen University|Yuqing Chen|+86 020-87755766-8341|fangchenyq@163.com|
21262423|NCT00501852|Novartis Pharmaceuticals|Study Director|862-778-8300||
21262424|NCT02679066|Johns Hopkins Bayview|Erik Hasenboehler MD|4105504190|ehasenb1@jhmi.edu|
21262425|NCT01171521|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu|
21262426|NCT01221298|AbbVie|Global Medical Services|800-633-9110||
21262427|NCT01416610|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21262428|NCT01520922|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21262429|NCT04036136|University of North Carollina at Chapel Hill|Gabriel Dichter, PhD|919-364-4275|dichter@med.unc.edu|
21262430|NCT01696877|Johns Hopkins University|Emmanuel S. Antonarakis, M.D., principal investigator|443-287-0553|eantona1@jhmi.edu|
21262431|NCT04076072|Vanderbilt University Medical Center|Marybeth Carter|615-936-1639|Marybeth.l.carter@vumc.org|
21262432|NCT01422304|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21262433|NCT01566838|Cardiac, Vascular, and Thoracic Surgery Associates|Sandeep Khandhar, MD|703-280-5858|SKhandhar@CVTSA.com|
21262434|NCT00469014|University of Texas MD Anderson Cancer Center|Richard Champlin, MD / Professor, Chair, Stem Cell Transplantation|713-792-3618|CR_Study_Registration@mdanderson.org|
21262435|NCT02722577|State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China|Guodong Niu|+86(10)88398866|guodongniu@fuwai.com|
21280677|NCT01112059|UAB|Amit Gaggar, MD|934-5400|agaggar@uab.edu|
21280678|NCT03672227|REGENTS OF THE UNIVERSITY OF MICHIGAN|Dr. Katherine Bauer|(734)763-2546|kwbauer@umich.edu|
21280679|NCT03567980|University of Alabama at Birmingham|Dr. Boni Elewski|205-502-9960|dermresearch@uabmc.edu|
21280680|NCT04599075|University of Massachusetts Chan School of Medicine|Dr. Gianna Wilkie|7743642523|Gianna.Wilkie@umassmemorial.org|
21280681|NCT02575833|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21280682|NCT00967330|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21280683|NCT02771977|Yale University|F. Perry Wilson|203-737-1704|francis.p.wilson@yale.edu|
21280684|NCT02698163|UCLA School of Dentistry|Dr. Eric Sung|(310) 206-6407|esung@dentistry.ucla.edu|
21280685|NCT01133067|Dept. of Radiation Oncology, Tata Memorial Hospital|Dr. J.P. Agarwal|+91 22 24177000|agarwaljp@tmc.gov.in|7164
21280686|NCT00752128|Medtronic Bakken Research Center B.V.|Marianne Wanten|+3143356|marianne.wanten@medtronic.com|6815
21280687|NCT00610428|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
21280688|NCT00349973|University of Maryland, Baltimore|Dr. Elliot Hong, Prinicipal Investigator|410-402-6828|ehong@som.umaryland.edu|
21280689|NCT02548143|LFB USA|Kerry Biron, Director US Clinical Operations|508.370.5166|kerry.biron@lfb-usa.com|
21280690|NCT05493501|EQRx International|EQRx Clinical Trials|(650) 779-2300|clinicalstudies@eqrx.com|
21280691|NCT05620082|University of Southampton|Dr Samantha J Meredith|0238120|s.j.meredith@soton.ac.uk|4656
21280692|NCT04004403|University of Illinois Chicago|Krista Varady|3129967897|varady@uic.edu|
21280693|NCT00625820|University of Michigan|Rajiv Saran, MD|734-763-6611|rsaran@umich.edu|
21280694|NCT05201794|Janssen Research & Development, LLC|Senior Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21280695|NCT01490086|Reviva Pharmaceuticals, Inc.|Marc Cantillon, M.D|408-960-2209|mcantillon@revivapharma.com|
21280696|NCT06497699|Ocumension Therapeutics (Shanghai) Co., Ltd|Director of Clinical Trials|2289 3653|clinicalop@ocumension.com|3653
21280697|NCT04510090|Escient Pharmaceuticals|Kristin Taylor, Sr VP, Head of Clinical Development|(858) 617-8220|clinicaltrials@escientpharma.com|
21294668|NCT01535599|Alcon Research, Ltd.|Sally Scheib, Sr. Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21294669|NCT03397394|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
21294670|NCT03172325|CinnaGen Co.|Dr. Nassim Anjidani|00989125477964|anjidani.n@orchidpharmed.com|
21294671|NCT03848208|Achieve Life Sciences|Daniel Cain, Vice President, Clinical Research|425.686.1546|dcain@achievelifesciences.com|
21294672|NCT03520348|Laboratorios Sophia|Ricardo Alonso Llamas Velázquez (clinical safety pharmacologist)|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
21294673|NCT02292758|Dana-Farber Cancer Institute|Kimmie Ng, M.D., M.P.H.|(617) 632-4150|Kimmie_Ng@dfci.harvard.edu|
21294674|NCT00668382|UMass Medical Scool|Dr. Sheila Noone|508 856 5015|Sheil.Noone@umasmed.edu|
21294675|NCT03622112|AstraZeneca AB|Global Clinical Lead|301-398-5799|ClinicalTrialTransparency@astrazeneca.com|
21294676|NCT03826173|Brown University School of Public Health|David M Williams|4018636248|david_m_williams@brown.edu|
21294677|NCT03305419|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21294678|NCT01155466|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21294679|NCT03709277|Vanderbilt University Medical Center|Amanda Kibbons|615-875-4745|amanda.m.kibbons@vumc.org|
21294680|NCT02231892|National Institute on Drug Abuse|Dr. Elliott Stein|443-740-2650|estein@mail.nih.gov|
21294681|NCT03832322|Evergreen General Hospital, Taiwan|Dr. Chi-Liang Cheng|0919768058|chiliang.cheng@gmail.com|
21294682|NCT00799227|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21294683|NCT01191736|Maricopa Integrated Health System|David Drachman|602-344-5161|david.drachman@mihs.org|
21294684|NCT01694121|Center on Gender Equity and Health at UCSD|Dr. Anita Raj|8588220229|anitaraj@ucsd.edu|
21294685|NCT00932438|University of Louisville|Robert Martin, Md, PhD|602-629-3355|robert.martin@louisville.edu|
21294686|NCT00744978|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294687|NCT03773133|Ipsen|Ipsen Medical Director|See email|clinical.trials@ipsen.com|
21294688|NCT02928029|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21294689|NCT00515294|Boston University|Jonathan Howland, Professor|617 638 5158|jhowl@bu.edu|
21294690|NCT03119181|Tusker Medical|Laura England, PhD|(650) 223-6909|lengland@tuskermed.com|
21294691|NCT02959827|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21294692|NCT02359045|AstraZeneca AB|Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
21294693|NCT01382303|Ajou University|Kwan Woo Lee|82-31-219-4526|LKW65@ajou.ac.kr|
21294694|NCT03858335|Samsung Medical Center|Jeong-Yi Kwon|+821045911039|jeongyi.kwon@samsung.com|
21294695|NCT03354546|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
21294696|NCT02713997|University of Minnesota|Melena Bellin|612-625-4686|bell0130@umn.edu|
21294697|NCT05487040|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294698|NCT03269968|MedStar Health Reseach Institute|Rachael Overcash|202-877-6093|rachael.overcash@medstar.net|
21294699|NCT02950155|Karolinska Institutet|Prof. Fredrik Piehl|+46 736718101|fredrik.piehl@ki.se|
21294700|NCT03569748|University of Catania|Maria Signorelli|095.378.2636/794|maria.signorelli@unict.it|
21294701|NCT02979093|University of Iowa|Lane Strathearn|3193849464|lane-strathearn@uiowa.edu|
21294702|NCT06107803|Minerva Neurosciences|Joseph Reilly|617-600-7373|JReilly@minervaneurosciences.com|
21262436|NCT03418662|Indiana University|Rachel Lahr|317-948-0724|rlahr@iu.edu|
21262437|NCT03461289|Novartis Gene Therapies EU Limited|EMEA Medical Information|+353 (1) 566-2364|medinfoemea.gtx@novartis.com|
21262438|NCT00866294|GlaxoSmithKline|GSK Response Center|866-435-7343||
21262439|NCT03241173|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21262440|NCT00515463|Amgen Inc.|Study Director|866-572-6436||
21262441|NCT00916721|Massachusetts General Hospital|A. Eden Evins, MD, MPH, Director Center for Addiction Medicine|617-643-4679|a_eden_evins@hms.harvard.edu|
21262442|NCT01202110|Cedars-Sinai|Leah Silbert|310 423-3783|Leah.Silbert@cshs.org|
21262443|NCT01469052|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21262444|NCT02167204|University of Washington|Hannah Linden|206-606-2053|hmlinden@uw.edu|
21294703|NCT03099174|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
21236238|NCT00503685|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21236239|NCT02379585|CTCA|Jessica L. Coats|6232073899|jessica.coats@ctca-hope.com|
21236240|NCT01976416|Indiana University|Dr Chandy John|317-274-8940|chjohn@iu.edu|
21236241|NCT01110239|University Miami|Sebastian Koch|305 243-6733|skoch@med.miami.edu|
21236242|NCT02897141|Columbia University|Dr. Rebecca Schnall|212-342-6886|rb897@cumc.columbia.edu|
21236243|NCT00080223|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21236244|NCT02936076|The Miriam Hospital|Dr. Jessica Unick|401-793-8966|junick@lifespan.org|
21236245|NCT01127438|Eisai Call Center|Eisai Inc.|888-422-4743||
21236246|NCT03099382|Jiangsu HengRui Pharmaceuticals Co., Ltd.|Shiwei Sun; Project Manager|+86-18036618554|shiwei.sun@hengrui.com|
21236247|NCT00499369|SWOG|Study Statistician|206-667-4623||
21236248|NCT02939105|Zeltiq Aesthetics|Kerrie Jiang, Sr. Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
21236249|NCT01898195|Department of Population Health, New York University School of Medicine|Donna Shelley, MD, MPH/ Vice Chair for Research; Associate Professor of Population Health and Medici|646-501-2526|Donna.Shelley@nyumc.org|
21236250|NCT01802411|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|Pacira Pharmaceuticals, Inc.|MedInfo@pacira.com|
21262445|NCT03648996|University of Missouri, School of Medicine|Dr. Camila Manrique, MD|(573) 882-2554|manriquec@umsystem.edu|
21262446|NCT01553539|Wake Forest University Health Sciences|Dr. William J. Petty|336-716-3313|wpetty@wakehealth.edu|
21297162|NCT01279616|Nationwide Children's Hospital|Kristy Ott|614-722-6313|kristy.ott@nationwidechildrens.org|
21246950|NCT03571386|Vanderbilt University|David Vago|236-516-6530|vago.dave@gmail.com|
21246951|NCT03938246|Sagimet Biosciences Inc.|Study Director|650-561-8675|sitecontact@sagimet.com|
21246952|NCT05717400|M D Anderson Cancer Center|Harrys A. Torres, MD|(713) 792-6503|htorres@mdanderson.org|
21246953|NCT02909686|University of Alabama at Birmingham|Dr. Jarred Younger|205-975-5821|youngerlab@uab.edu|
21246954|NCT03858517|Stryker|Monica Fleeman|251-465-5969|monica.fleeman@stryker.com|
21246955|NCT04370834|National Cancer Institute|Dr. Richard Little, Principal Investigator|240-276-6093|littler@mail.nih.gov|
21246956|NCT00887198|Janssen R&D US|SENIOR DIRECTOR CLINICAL RESEARCH||ClinicalTrialDisclosure@its.jnj.com|
21246957|NCT02782676|Abbott Medical Optics, Inc.|Kendra Hileman, Ph.D., Head of Clinical Sciences|714-247-8613|kendra.hileman@abbott.com|
21246958|NCT05007080|Janssen Vaccines & Prevention B.V.|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21246959|NCT03329937|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21246960|NCT02874742|Janssen Research & Development, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21246961|NCT04442165|Insitute of Tropical Medicine|Brecht Ingelbeen|+32(0)33455787|bingelbeen@itg.be|
21246962|NCT01223352|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk||clinical-trials-disclosure@actelion.com|
21246963|NCT04332211|University of Maryland School of Medicine, Department of Emergency Medicine|Siamak Moayedi MD|4103288025|Mak.Moayedi@som.umaryland.edu|
21246964|NCT00631475|Actelion Pharmaceuticals Ltd|Isabelle Leconte, PhD/Data Science Group Leader, Director|+ 41 61 565 64 18|isabelle.leconte@actelion.com|
21246965|NCT00303459|Actelion Pharmaceuticals Ltd|Jonathan Tolson|+41 61 565 56 04|jonathon.tolson@actelion.com|
21246966|NCT05633147|Cinclus Pharma Holding AB|Kajsa Larsson, CMO|+46 706750128|kajsa.larsson@cincluspharma.com|
21246967|NCT02492711|TerSera Therapeutics LLC|VP, Scientific Communications|1-844-334-4035|tersera@medinfodept.com|
21246968|NCT01474122|Actelion Pharmaceuticals Ltd|Angelina Marr|+41 61 565 63 69|angelina.marr@actelion.com|
21246969|NCT03188692|Mitsubishi Tanabe Pharma Corporation / The Research Foundation for Microbial Diseases of Osaka University|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp, clinicaldevelopment@mail.biken.or.jp|
21246970|NCT05830799|Vicore Pharma AB|Cecilia Ganslandt, MD, MSc|+46 31788 05 60|info@vicorepharma.com|
21246971|NCT04801368|Mayo Clinic|Dr. Matthew Ziegelmann|507-266-3982|Ziegelmann.Matthew@mayo.edu|
21246972|NCT05043064|Aalborg University Hospital|Dr Gennady V Atroshchenko|97 66 46 49|g.atroshchenko@rn.dk|45
21246973|NCT04947137|Navidea Biopharmaceuticals|Senior Medical Director|6149737555|mblue@navidea.com|
21246974|NCT06097494|Pfizer Ltd|Ranjit Nagra|01304 616161|ranjit.nagra@pfizer.com|
21280698|NCT05825404|Penn State University|Ying-Ling Jao|8148655634|yuj15@psu.edu|
21280699|NCT01127256|Eisai Korea Inc.|Jihee Mun, Pharmacist, Medical Department manager|+82-2-3451-5531|jihee_mun@eisaikorea.com|
21280700|NCT01749826|Stanford University School of Medicine Department of Anesthesiology|Dr. Larry F. Chu|6507236632|lchu@stanford.edu|
21280701|NCT00679211|Genentech, Inc.|Medical Communications|800-821-8590||
21280702|NCT00931528|NRG Onoclogy|Wendy Seiferheld||seiferheldw@nrg.oncology.org|
21262447|NCT02749370|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21262448|NCT02101411|taipei city hospital|chen yueh-chung|88627093600|chenyuehchung.tw@yahoo.com.tw|3741
21262449|NCT01519427|Vanderbilt-Ingram Cancer Center|Jeff Sosman, MD|615-936-3048|jeff.sosman@vanderbilt.edu|
21262450|NCT03894904|The University of Texas Health Science Center at Houston|Nischal K. Gautam, MD|(713) 500-6200|Nischal.K.Gautam@uth.tmc.edu|
21262451|NCT03020524|University of Pennsylvania|Regulatory Lead|215.662.4484|psom-ind-ide@pobox.upenn.edu|
21262452|NCT02273323|Unilever R&D Vlaardingen|Theo Mulder|+31 10 460 8315|theo.mulder@unilever.com|
21262453|NCT00121810|Hoffmann-La Roche|Medical Communications|800-821-8590||
21262454|NCT00633139|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21262455|NCT02160977|Peking University Third Hospital|Dr. Jia-Kuo Yu|86-10-82267392|yujiakuo@126.com|
21262456|NCT02269319|MicuRx Pharmaceuticals Inc.|John M. Sall, Global Head of Regulatory|919-670-7803|jsall@micurx.com|
21262457|NCT04543955|University of Kentucky|Dr. Lowell Anthony|859-323-8043|lowell.anthony@uky.edu|
21262458|NCT01614769|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21262459|NCT02115815|MedImmune, LLC|Judith Falloon, MD|301-398-5000|falloonj@medimmune.com|
21262460|NCT01228071|Endo Pharmaceutical, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
21262461|NCT01989546|National Cancer Institute|Dr. Alice P. Chen|240-781-3274|chenali@mail.nih.gov|
21262462|NCT03960138|University of Missouri|Dr. Brett Froeliger|5738824785|froeligerb@health.missouri.edu|
21262463|NCT02819310|Braintree Laboratories, Inc.|VP, Clinical Affairs|781-843-2202|john.mcgowan@sebelapharma.com|
21262464|NCT02046265|University of Pennsylvania School of Nursing|Dr. Anne Teitelman|215-898-1910|teitelm@nursing.upenn.edu|
21262465|NCT01793051|UT MD Anderson Cancer Center|Dr. Robert Orlowski, Professor, Lymphoma-Myeloma|(713) 794-3234|rorlowski@mdanderson.org|
21262466|NCT04688346|University of Washington|Dr. Travis Nelson|206-290-2899|tmnelson@uw.edu|
21262467|NCT00059215|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21262468|NCT04439838|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21262469|NCT04985799|University of North Carolina at Chapel Hill|Jennifer Wu, MD, MPH, Professor of OBGYN|919-966-0014|jennifer_wu@med.unc.edu|
21262470|NCT01741272|Alberta Health Services|Dr. Robert Balyk|7804395858|rbalyk6@aol.com|
21262471|NCT01958671|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21262472|NCT02778867|Cincinnati Children's Hospital Medical Center|Marc E. Rothenberg, MD, PhD|513-636-7177|marc.rothenberg@cchmc.org|
21262473|NCT02948777|Helsinki University and Helsinki University Hospital|Prof. Marja-Riitta Taskinen|+358-9-47171990|marja-riitta.taskinen@helsinki.fi|
21280703|NCT01470248|Emory University|Taofeek K. Owonikoko, MD, PhD, MSCR|404-778-1900|towonik@emory.edu|
21262474|NCT01290484|Stanford University|Dr. Alfred Lane|650-721-7170|alfred.lane@stanford.edu|
21262475|NCT03242928|Novartis Pharma AG|Clinical Disclosure Office|613241111|Novartis.email@Novartis.com|
21262476|NCT00960440|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21262477|NCT03333057|Novaliq GmbH|Dr. Sonja Kroesser|+49 6221 50259|info@novaliq.com|0
21262478|NCT03504774|Stanford University School of Medicine|Sayantani B. Sindher, MD|650-521-7237|tina.sindher@stanford.edu|
21262479|NCT00625365|Lantheus Medical Imaging|Dana Washburn, M.D.|978-671-8686|dana.washburn@lantheus.com|
21262480|NCT01781429|BioMed Valley Discoveries|Brent Kreider, PhD|816-960-4644|bkreider@biomed-valley.com|
21262481|NCT05014776|SKCCC Johns Hopkins Medical Institution|Katherine Bever, MD|443-287-0966|kbever1@jhmi.edu|
21262482|NCT01703286|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21262483|NCT00931892|Beth Israel Deaconess Medical Center|Dr. Ciaran Kelly|617-667-1272|ckelly2@bidmc.harvard.edu|
21262484|NCT00964548|UMASS Medical School|Susanne Muehlschlegel, MD, MPH, Principal Investigator|508-856-4667|susanne.muehlschlegel@umassmemorial.org|
21294704|NCT04730635|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21294705|NCT03070223|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
21294706|NCT00516906|3M|J M Heilman|651-733-9897|jmheilman@mmm.com|
21294707|NCT02620878|Università di Padova-Italy|Dr. Daniela Bruttomesso|00390498212183|daniela.bruttomesso@unipd.it|
21294708|NCT01327053|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21294709|NCT03172884|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21294710|NCT05470842|UNiversity of East Anglia|Dr Katharina Mattishent|01603286286|k.mattishent@uea.ac.uk|
21246975|NCT05683158|Department of Physiotherapy, University of Valencia|PI. Jose Casaña Granell|+34 656-437-371|jose.casana@uv.es|
21246976|NCT04109066|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21246977|NCT05205161|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21246978|NCT05864040|Rob Surgical Systems|Jaume Amat, CEO|+34 93 013 08 83|jaume.amat@robsurgical.com|
21246979|NCT04369911|HealthPartners Institute|Amanda Herrmann, PhD|6514956565|amanda.a.herrmann@healthpartners.com|
21246980|NCT04325815|University College London|Professor Laurence B Lovat|020-7679-9060|l.lovat@ucl.ac.uk|
21246981|NCT04163991|Horizon Therapeutics USA, Inc.|Ilias Alevizos, PhD, DMD|866-479-6742|clinicaltrials@horizontherapeutics.com|
21246982|NCT01768013|LEO Pharma A/S|Clinical trial disclosure manager|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com|
21246983|NCT02510235|Dompé farmaceutici SpA|Clinical Development & operations|+39583831|clinical.trials@dompe.com|
21246984|NCT00450216|Horizon Pharma, Inc.|Amy Grahn, MS Senior Vice President, Clinical Development and Operations|224-383-3012|agrahn@horizonpharma.com|
21246985|NCT05008055|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21246986|NCT03003533|Spark Therapeutics|Spark Therapeutics|Please Email|clinicaltrials@sparktx.com|
21246987|NCT00640822|LeoPharma|Torsten Skov|+4520736294|torsten.skov@leo-pharma.com|
21246988|NCT03011034|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21246989|NCT04564209|University of Colorado College of Nursing|Dr. Samantha Stonbraker, Study PI|720-880-8194|Samantha.Stonbraker@CUAnschutz.edu|
21246990|NCT04099732|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21246991|NCT06229119|Carolina Eyecare Physicians, LLC|Director of Clinical Research|8438813937|hsandoval@cepmd.com|
21246992|NCT02461134|Actelion Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 61 565 6565|clinical-trials-disclosure@its.jnj.com|
21246993|NCT03165955|Athenex Inc.|Regional Project Manager|+886-978365735|lmeiying@athenex.com|
21246994|NCT00626795|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
21246995|NCT03493542|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21246996|NCT04499521|University of Virginia|Kara Romano, MD|434-982-6278|ked7c@uvahealth.org|
21246997|NCT04479514|DFCI|Jennifer Huang|6173558937|jennifer.huang@childrens.harvard.edu|
21246998|NCT04244175|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21246999|NCT03417284|The University of Texas MD Anderson Cancer Center|Qaiser Bashir, MD / Stem Cell Transplantation|713-794-4422|QBashir@mdanderson.org|
21247000|NCT03636490|Columbia University Irving Medical Center|Daichi Shimbo|‭(646) 317-0305‬|ds2231@cumc.columbia.edu|
21247001|NCT04079972|Dongguk University|Dr.NaNa Keum|+82 10-6793-6654|nak212@mail.harvard.edu|
21247002|NCT02278211|University of Edinburgh|Professor Dave Newby|0131 242 6515|D.E.Newby@ed.ac.uk|
21247003|NCT05268276|Faculty of nursing /cairo university|Asmaa Abdallah Ahmed Hussein|01006961502|asmaaabdallah.cu@cu.edu.eg|
21247004|NCT06037668|Sumitomo Pharma America|Director, Frontier Business Office|1-866-503-6351|gazeleh.vakili@us.sumitomo-pharma.com|
21247005|NCT04804540|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21247006|NCT05172232|Linköping University|Professor Magnus Falk|+46708106176|magnus.falk@liu.se|
21247007|NCT04881461|ALK-Abelló A/S|Senior Director, Clinical Data Science, Global Clinical Development|+4545747576|clinicaltrials@alk.net|
21247008|NCT02997202|Astellas Pharma Global Development, Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
21247009|NCT03778801|Aksaray University training and Research Hospital|Principal Investigator|905555289493|mlk.aykut@gmail.com|
21247010|NCT04629339|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21247011|NCT04158739|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21294711|NCT00721578|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294712|NCT04621240|Center for BrainHealth at the University of Texas at Dallas|Erin Venza|972-883-3208|erin.venza@utdallas.edu|
21294713|NCT04448392|UAB|Dr. Nicole Samies|570-271-6440|nsamies2@geisinger.edu|
21294714|NCT00211757|Montefiore Medical Center|Dr. Eric Hollander|718-920-4287|eholland@montefiore.org|
21294715|NCT01585779|Medtronic Coronary and Structural Heart|Shari Benoit|(763) 514-4000|shari.g.benoit@medtronic.com|9749
21294716|NCT02226198|AstraZeneca Plc|Robin Mukherjee|+46 31 776 1000|robin.mukherjee@astrazeneca.com|
21294717|NCT04545047|VA Cooperative Studies Program|Project Manager|2062774780|Sarah.Keithly@va.gov|
21294718|NCT03895632|Medical Physics & Clinical Engineering, Royal Liverpool Hospital|Dr. Tristan Payne|0151 7064225|tristan.payne@nhs.net|
21294719|NCT01440517|GE Healthcare|Arnold Jacobson, M.D.|1-609-514-6325|Arnold.Jacobson@ge.com|
21294720|NCT01288612|Mayo Clinic|Prasad G. Iyer|507-284-6469|iyer.prasad@mayo.edu|
21294721|NCT00871923|UT MD Anderson Cancer Center|James Welsh,MD- Associate Professor, Radiation Oncology Department|(713) 563-2447|jwelsh@mdanderson.org|
21294722|NCT02263911|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21294723|NCT01263015|GlaxoSmithKline|GSK Response Center|866-435-7343||
21294724|NCT05599451|Philip Morris Products S.A.|Christelle Haziza, Global Head Clinical Research and Operations|+41582421111|ClinicalTrials.PMI@pmi.com|
21294725|NCT02723006|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21294726|NCT00303446|National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH)|Kenneth Fischbeck, M.D.|301-435-9318|kf@ninds.nih.gov|
21262485|NCT02207530|AstraZeneca LP|Jean Fan, MD, Global Clinical Lead|1-301-398-5080|jean.fan@astrazeneca.com|
21294727|NCT03285958|University of Michigan|Dr. Mary Janevic|734 647 3194|mjanevic@umich.edu|
21294728|NCT00230802|Brigham & Women's Hospital|Erik Alexander, MD|6177325666|ekalexander@partners.org|
21294729|NCT05160168|Theseus Pharmaceuticals (a subsidiary of Concentra Biosciences)|Stew Kroll|(650) 576-9679|skroll@concentrabiosciences.com|
21294730|NCT03842969|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21294731|NCT02890303|Mynosys Cellular Devices, Inc.|Daniel Marinsik|(510) 857-6296|dmarinsik@mynosys.com|
21294732|NCT04388319|Rose Research Center|Dr. Jed E. Rose|9193282345|jed.rose@roseresearchcenter.com|
21294733|NCT02264665|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294734|NCT01468207|AbbVie|Global Medical Information|1-800-633-9110||
21294735|NCT02075047|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294736|NCT03552536|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21294737|NCT03639623|Zydus Therapeutics Inc.|Dr Deven Parmar|7324050886|dparmar@zydustherapeutics.com|
21247012|NCT03866837|Columbia University|Gary M. Brittenham, M.D.|212 305 7005|gmb31@cumc.columbia.edu|
21262486|NCT00719576|Vericel Corporation|Ann Remmers, Senior Director, Clinical Science|734-428-4526|aremmers@vcel.com|
21262487|NCT06094296|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21262488|NCT00986258|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|clinical-trials@grunenthal.com|
21262489|NCT03332667|New Advances in Neuroblastoma Therapy|NANT Medical Director|3233615687|nantops@chla.usc.edu|
21262490|NCT01035606|VA Northern California|Anthony Chen, MD|925-372-2000|anthony.chen@ucsf.edu|
21262491|NCT01809262|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21262492|NCT01505491|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21247013|NCT03967379|Massachusetts General Hospital|Areej El-Jawahri|617-724-4000|ael-jawahri@partners.org|
21247014|NCT04055012|The University of Pittsburgh|Study Coordinator|412-692-2084|kesslerl@upmc.edu|
21247015|NCT04173247|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-716-4760|jkettler@wakehealth.edu|
21247016|NCT05496140|UCSF|Lauren M. Haack|415-502-8060|lauren.haack@ucsf.edu|
21247017|NCT05386589|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21247018|NCT02785991|Medtronic Ibérica|Patricia Pascual|636183869|patricia.pascual@medtronic.com|
21247019|NCT03418740|The Children's Hospital of Philadelphia|Dr. David Lynch|215-590-2242|lynchd@pennmedicine.upenn.edu|
21247020|NCT01475786|Helixmith|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
21247021|NCT01536938|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
21247022|NCT00329836|Doylestown Hospital|Abraham Ashkenazi, M.D./ Prinicpal Investigator|215-625-2894|aashkenazi@yahoo.com|
21247023|NCT05305560|MedinCell|Head of Clinical Development|6 40 38 93 83|caroline.denot@medincell.com|0033
21247024|NCT06412965|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21247025|NCT04678856|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
21247026|NCT01828021|TerSera Therapeutics LLC|VP, Scientific Communications|1-844-334-4035|tersera@medinfodept.com|
21247027|NCT04012931|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21247028|NCT04938726|University of Alabama at Birmingham|Dr. Eric P. Plaisance|2057090980|plaisep@uab.edu|
21247029|NCT04664959|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
21247030|NCT05960032|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21247031|NCT02163694|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21247032|NCT05061017|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
21262493|NCT02404155|Maryland Psychiatric Research Center|Dr. Deanna L. Kelly, Pharm.D., BCPP|410-402-6860|dlkelly@som.umaryland.edu|
21294738|NCT01229254|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
21247033|NCT05883345|Konkuk University Medical Center|Sun-Young Lee|82-2-2030-7747|sunyoung1973.lee@gmail.com|7505
21262494|NCT04860713|Maimonides Medical Center|Research Administration Director|718-283-6896|alikourezos@maimonidesmed.org|
21262495|NCT01797783|Alcon Research, Ltd.|Stacie Cummings, O.D.|1-888-451-3937|alcon.medinfo@alcon.com|
21262496|NCT02786355|UBC Department of Anesthesia - BC Women's Hospital|James Taylor|604-875-2424|james.taylor1@phsa.ca|6076
21262497|NCT04412954|Ohio State Univeristy|Sandy Solove|6142478366|solove.3@osu.edu|
21262498|NCT00431847|Philadelphia Veterans Affairs Medical Center|Rollin M Gallagher, MD, MPH|(215) 823-5800|Rollin.Gallagher@va.gov|4907
21262499|NCT00339183|Amgen Inc.|Study Director|866-572-6436||
21262500|NCT00446446|Amgen Inc.|Study Director|866-572-6436||
21262501|NCT02142894|QIAGEN Sciences|Clinical Study Coordinator|301-944-7094|andrew.schumacher@qiagen.com|
21262502|NCT01564654|ConforMIS|Marc Quartulli, VP Clinical Affairs|781-345-9191|marc.quartulli@conformis.com|
21262503|NCT00717418|Allergan, Inc.|Vice President, GHOSR|714-246-4500|clinicaltrials@allergan.com|
21262504|NCT01024465|ReShape Medical|Director of Clinical Operations|949-429-6680|lfong@reshapemedical.com|
21262505|NCT02836990|University at Buffalo, SUNY|Dr Linda Harris|7168594207|lmharris@buffalo.edu|
21262506|NCT03078608|Kaiser Permanente Northern California|Elaine Kurtovich|510-891-3118|elaine.m.kurtovich@kp.org|
21262507|NCT00723840|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21262508|NCT01137435|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21262509|NCT00492921|JHU SKCCC|Dr. Javier Bolanos Meade|410-614-6398|Fbolano2@jhmi.edu|
21262510|NCT00652093|Translational Pain Research, University of Rochester Medical Center|Dr. John D. Markman, MD|585-276-3616|john_markman@urmc.rochester.edu|
21262511|NCT02213757|MHRI|Dr. Richter|2028776526|Lee.Ann.Richter@medstar.net|
21262512|NCT00564629|Mallinckrodt Pharmaceuticals|Lawrence Hill|(908) 238-6370|lawrence.hill@mallinckrodt.com|
21262513|NCT03415464|FACULTY OF SPORT|Vedran Hadzic|+38615207700|vedran.hadzic@fsp.uni-lj.si|728
21262514|NCT03519308|Abramson Cancer Center, University of Pennsylvania|Liudmila Mazaleuskaya/Pancreas Research Program Manager|2674559141|mazali@pennmedicine.upenn.edu|
21262515|NCT04064684|The University of Texas Health Science Center at Houston|Alvaro Jose Coronado Munoz, MD|713-500-5553|Alvaro.J.CoronadoMunoz@uth.tmc.edu|
21262516|NCT03117049|Ono Pharmaceutical Co. Ltd|Medical Information Center|---|clinical_trial@ono.co.jp|
21262517|NCT00651118|Meda Pharmaceutical|David Ginsberg,..|732 564 2364|david.ginsberg@meda.us|
21262518|NCT00839098|Human Engineering Reserach Laboratories|Clinical Coordinator|412-822-3700|annmarie.kelleher@va.gov|
21262519|NCT00365976|Duke University|Jenny Bridgers, CRC|919-684-0752|jenny.bridgers@duke.edu|
21262520|NCT02190435|William Beaumont Hospital|Denise Koueiter, MS|248-551-5166|denise.koueiter@beaumont.org|
21262521|NCT03028025|VALBHS|Dr. Arnold Seto|562-826-8000|arnold.seto@va.gov|
21262522|NCT02644525|Laboratory of Parasitic Diseases, NIAID/NIH|Elise O'Connell, MD, Principal Investigator|301-661-0172|oconnellem@mail.nih.gov|
21262523|NCT02986958|Johns Hopkins Bloomberg School of Public Health|Research Program Manager|410-614-7910|dechava1@jhu.edu|
21262524|NCT02399475|University of Pennsylvania|Dr. Anne Cappola|2155375359|acappola@pennmedicine.upenn.edu|
21262525|NCT02260193|Akebia Therapeutics, Inc.|Akebia Therapeutics, Inc.|+1 617-844-6128|trials@akebia.com|
21262526|NCT01780389|Duke University Medical Center|David Marks, MD|619 668-2859|d.marks@duke.edu|
21262527|NCT00935220|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21262528|NCT03625986|Penn State College of Medicine|Dr. Jonathan Foulds|(717) 531-3504|jfoulds@pennstatehealth.psu.edu|
21262529|NCT01850563|Dartmouth-Hitchcock Medical Center|Alan Hartford, MD, PhD, FACR, Professor of Medicine (RadOnc) Director, Radiation Oncology|603-650-6600|Alan.C.Hartford@Hitchcock.org|
21262530|NCT04359823|MUSC|Gabriella Santa Lucia|724-413-8833|santaluc@musc.edu|
21262531|NCT02078713|University of California, San Francisco|Dr. Christine Dehlendorf, Principal Investigator|415-206-8712|christine.dehlendorf.@ucsf.edu|
21262532|NCT02096861|Celltrion, Inc.|BoYoung Choi / Clinical Operation Team Leader|+82-32-850-6594|BoYoung.Choi@celltrion.com|
21262533|NCT00962065|Lexicon Pharmaceuticals, Inc.|Joel P. Freiman, MD, MPH|281-863-3000||
21262534|NCT01419275|Stanford University|Dr. Greg Zaharchuk|650-736-6172|susanmir@stanford.edu|
21262535|NCT02073435|Northwestern University|Donna Woods, MD|312-503-5550|woods@northwestern.edu|
21280704|NCT05085834|University Hospitals Cleveland Medical Center|Grace McComsey|216-368-3731|Grace.McComsey@uhhospitals.org|
21280705|NCT01741311|University of Connecticut|Michael Copenhaver|8602083632|michael.copenhaver@uconn.edu|
21280706|NCT05842967|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21280707|NCT04673149|GeneOne Life Science|Chief Medical Officer|6106576351|dkane@genels.us|
21280708|NCT01410097|Wake Forest University|Stephen B. Kritchevsky, PhD|336-713-8548|skritche@wakehealth.edu|
21280709|NCT04074941|Marcus Institute, Hebrew SeniorLife|Shivani Sahni, PhD|6179715382|shivanisahni@hsl.harvard.edu|
21280710|NCT01402570|University of Michigan|Claire Z. Kalpakjian|734-763-0153|clairez@umich.edu|
21280711|NCT03642262|Reckitt Benckiser Inc.|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
21280712|NCT01173523|Dana-Farber Cancer Institute|David M. Jackman, MD|617.632.3468||
21280713|NCT02806908|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
21280714|NCT01634048|Imperial College|Professor Gary Frost|+44 20 7594 0959|g.frost@imperial.ac.uk|
21280715|NCT01760304|Brigham and Women's Hospital|Dr. Miguel Divo|8573070311|mdivo@bwh.harvard.edu|
21280716|NCT02302833|The University of Texas MD Anderson Cancer Center|Dr. Camilo Jimenez|(713) 792-2841|cjimenez@mdanderson.org|
21280717|NCT04429503|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21280718|NCT05516108|University of Pittsburgh|Emily K Lindsay, PhD|412-601-0585|emily.lindsay@pitt.edu|
21280719|NCT02717507|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21280720|NCT05017246|Washington University School of Medicine|Dr. Premal H Thaker|314-747-3604|thakerp@wustl.edu|
21294739|NCT04463693|University of Colorado Anschutz Medical Campus|Aaron Lazorwitz|3037242019|aaron.lazorwitz@cuanschutz.edu|
21294740|NCT01114971|Cedars Sinai Medical Center|Proffesor Paul F. White|2147703775|paul.white@cshs.org|
21294741|NCT02186652|Duke Clinical Research Institute|Chad Livingston|919-668-1935|chad.livingston@duke.edu|
21294742|NCT01218958|Alkermes, Inc.|Bernard L. Silverman, VP, Clinical Development|781-609-6000|bernard.silverman@alkermes.com|
21294743|NCT03770728|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21280721|NCT00709995|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21294744|NCT00503776|Vanderbilt-Ingram Cancer Center|Barbara Murphy, MD|615-343-9444|barbara.murphy@vanderbilt.edu|
21294745|NCT02778555|Stanford University|Dr. Beth Darnall, Clinical Associate Professor, Division of Pain Medicine|(650) 721-2104|bdarnall@stanford.edu|
21294746|NCT00107315|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21294747|NCT00178919|Vanderbilt University|Italo Biaggioni|615-343-6499|italo.biaggioni@vanderbilt.edu|
21294748|NCT02509039|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21294749|NCT02089464|Nexstim Plc|Vice President, Medical Affairs||jarmo.laine@nexstim.com|
21294750|NCT03943550|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21294751|NCT01907321|University of Florida|Dr. Karen Hegland, PI|352 294-8366|kwheeler@ufl.edu|
21294752|NCT00735826|Dartmouth-Hitchcock Medical Center|Konstnatin Dragnev, MD Professor of Medicine|603-650-6344|Konstantin.H.Dragnev@Hitchcock.org|
21294753|NCT03539211|ChristianaCare|Brian Catania|302-838-4700|bcatania@christianacare.org|
21294754|NCT01024972|University of Massachusetts Medical School|Dr. Susanne Muehlschlegel|508-421-5500|susanne.muehlschlegel@umassmemorial.org|
21294755|NCT01180894|Denver Health Hospital|Dr. Fredric Pieracci|303-436-4029|fredric.pieracci@dhha.org|
21294756|NCT04659174|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21294757|NCT04077996|Instituto Mexicano del Seguro Social|Dr. Jesus Venegas-Ramírez|3143058373|nefrojesusvr@gmail.com, jesus.venegas@imss.gob.mx|
21294758|NCT03276026|Jefferson|Dr. Adam Thaler|215-901-0749|thaler.adam@gmail.com|
21294759|NCT01083979|William Beaumont Hospital|Kenneth M. Peters, MD|248-551-0387|kmpeters@beaumont.edu|
21294760|NCT03650803|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Holly Marshall|216-844-5330|Holly.Marshall@uhhospitals.org|
21294761|NCT01534260|IndianaU|Dr. Hamid Sayar|(317) 948-7576|ssayar@iu.edu|
21262536|NCT04494633|Clinical Tools, Inc.|Mary Metcalf, PhD, MPH|(919) 960-8118|metcalf@clinicaltools.com|
21262537|NCT01254604|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21280722|NCT01662778|Imperial College London|Dr Omar Usmani||o.usmani@imperial.ac.uk|
21280723|NCT02968576|"University of Colorado | Skaggs School of Pharmacy and Pharmaceutical Sciences"|Dr. Peter Anderson|3037246128|peter.anderson@ucdenver.edu|
21280724|NCT01999920|NYSPI|Franklin Schneier, MD|6464774-8041|fschneier@nyspi.columbia.edu|
21280725|NCT02002221|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21280726|NCT01998919|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21280727|NCT01068860|Novartis Pharmaceuticals|Dr. Tom Thuren/Global Brand Medical Director|862-778-1828|tom.thuren@novartis.com|
21280728|NCT01302743|Mike O'Callaghan Federal Medical Center|Jill M. Clark, MBA/HCM|702-653-3298|jill.clark.3.ctr@us.af.mil|
21280729|NCT00897715|VA Tennessee Valley Healthcare System.|Adriana Hung|615-873-7480|adriana.hung@va.gov|
21280730|NCT00513240|Baylor College of Medicine|Dr. Dean B. Andropoulos|832-826-5831|dra@bcm.edu|
21280731|NCT00860795|University of Washington|James A Taylor, MD|206-616-1206|uncjat@u.washington.edu|
21280732|NCT03103438|Biocad|Nadezhda Kravtsova|+7 (812) 380 49 33|kravtsovana@biocad.ru|
21280733|NCT00882518|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21280734|NCT03238651|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21280735|NCT03743051|Helsinn Healthcare SA|Florin Muraru|+41 91985 21 21|florin.muraru@helsinn.com|
21280736|NCT01422200|Cincinnati Children's Hospital Medical Center|Dr. Brenda Wong|5136364222|brenda.wong@cchmc.org|
21280737|NCT02137252|Dana-Farber Cancer Institute/Brigham and Women's Hospital|Fremonta Meyer, MD||flmeyer@partners.org|
21280738|NCT04460911|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21280739|NCT02550561|University of California, Irvine|Phuong Linh Huynh, CRC|7144566155|plhuynh@hs.uci.edu|
21280740|NCT03535740|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21280741|NCT05966506|The University of Texas Health Science Center at Houston|Nitha Mathew Joseph, PhD, RN, CNE, CGNC|713-500-2165|Nitha.Mathew@uth.tmc.edu|
21280742|NCT05317312|Viatris|Susanne Vogt|004906172|susanne.vogt@viatris.com|88801
21280743|NCT02857816|Medtronic Pelvic Health & Gastric Therapies|Beth Michaud / Sr. Principal Clinical Research Specialist|763.526.8102|beth.m.michaud@medtronic.com|
21280744|NCT03123068|Stanford University|Professor of Anesthesia|650-723-6412|ang@stanford.edu|
21280745|NCT00462917|Brigham and Women's Hospital and Harvard Medical School|Robert C. Green, MD, MPH|617-264-5838|rcgreen@genetics.med.harvard.edu|
21280746|NCT00822692|Wilford Hall Medical Center|Gillian Schmitz, MD|919-724-9185|gillianmd@gmail.com|
21280747|NCT02208089|Moorfields Eye Hospital NHS Foundation Trust|Mr Bruce Allan|02075662320|bruce.allan@ucl.ac.uk|
21280748|NCT02443740|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21280749|NCT00456300|Montefiore Medical College|Rubina Heptulla|832824000|rubhep@gmail.com|
21280750|NCT00194779|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
21280751|NCT02103855|Indiana University|Jeanne Chen|317-944-3570|jchen@iuhealth.org|
21294762|NCT03655301|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21262538|NCT03074162|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21280752|NCT03560128|Indiana University|Study Coordinator|317-948-0724|rlahr@iu.edu|
21247034|NCT02506673|Hospital for Special Surgey|Danya DeMeo, Research Assistant|2127742678|demeod@hss.edu|
21247035|NCT04967599|University of Southern California|Susan Luczak, PI of study|2137402203|luczak@usc.edu|
21247036|NCT03817983|Addenbrookes Hospital, Cambridge, UK|Dr Deepak Jadon|01223 805000|deepak.jadon@addenbrookes.nhs.uk|
21247037|NCT03744676|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
21247038|NCT05990335|Kansas State|Study Director|(785) 532-6850|external+studydirector@nxtech.co|
21247039|NCT05541484|Washington University School of Medicine|Janet McGill, Professor Medicine|314-273-3929|jmcgill@wustl.edu|
21247040|NCT01438853|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Office|855-797-9277|Bobby.Reddy@Immunitybio.com|
21247041|NCT02919917|Icahn School of Medicine at Mount Sinai|Dr. Jill Wecht|718-584-9000|jm.wecht@va.gov|3122
21247042|NCT04807777|Columbia University|Alexander Wei, MD|212-305-7115|aw3056@cumc.columbia.edu|
21280753|NCT03714828|University of Arizona Cancer Center|Clara Curiel-Lewandrowski, MD|(520) 626-5351|ccuriel@arizona.edu|
21280754|NCT03200717|Novartis Pharmaceuticals|Study director|+1 862-778-8300|novartis.email@novartis.com|
21280755|NCT02046603|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21280756|NCT02431364|Karyopharm Therapeutics Inc|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
21280757|NCT00061932|Montefiore Medical Center|Rutvi Patel|718-379-6861|rupatel@montefiore.org|
21280758|NCT00916383|Teikoku Pharma USA, Inc.|Director of Clinical Trials|(408) 501-1821||
21280759|NCT02899962|LEO Pharma A/S|Clinical Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
21280760|NCT00258960|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34 916 592 870|geicam@geicam.org|
21280761|NCT02139137|SDSU/UCSD Joint Doctoral Program in Clinical Psychology|Jessica Bomyea|8585528585|jbomyea@ucsd.edu|3720
21280762|NCT03367819|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21280763|NCT00550459|Otsuka Pharmaceutical Development & Commercialization, Inc.|Frank Czerwiec, MD, PhD; Sr. Director, Global Clinical Development|(240) 683-3523|frank.czerwiec@otsuka.com|
21280764|NCT02633787|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21280765|NCT02404805|University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences|Dr. Jennifer Kiser|(303) 724-6131|jennifer.kiser@ucdenver.edu|
21280766|NCT01742897|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-739-7200||5888
21280767|NCT03793608|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21280768|NCT04211831|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
21280769|NCT01243957|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21280770|NCT05373108|University of California, Los Angeles|Rushi V. Parikh, MD|(310) 825-9011|RParikh@mednet.ucla.edu|
21280771|NCT04871776|Brigham and Women's Hospital|Nancy Haff, MD, MPH|857-307-3826|nhaff@partners.org|
21280772|NCT00619723|Psychoneuroendocrine Research Group|Dr. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
21280773|NCT04665765|City of Hope Medical Center|Dr. Alex Herrera , MD|6263598111|aherrera@coh.org|
21280774|NCT00070564|SWOG Statistical Center|Breast Committee Statistician|206-667-4623|jmiao@fredhutch.org|
21280775|NCT01168232|NRG Oncology Statistics and Data Management Center - Buffalo Office|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
21280776|NCT02059512|First Pavlov State Medical University of St. Petersburg|Vladimir V Komok, Ph.D|8-904-632-19-00|vladimir_komok@mail.ru|
21280778|NCT03018288|National Cancer Institute|Dr. Kevin Camphausen|240-760-6205|camphauk@mail.nih.gov|
21280779|NCT03593473|University of North Carollina at Chapel Hill|Alison Stuebe, MD, MSc|919-966-1601|astuebe@med.unc.edu|
21280780|NCT06700512|WSAUDAS|Dr. Veronika Littmann|+4991313080|Veronika.littmann@wsa.com|
21280781|NCT01922037|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21280782|NCT01730053|Regeneron Pharmaceuticals|Clinical Trial Management||clinicaltrials@regeneron.com|
21280783|NCT02572570|University of North Carolina at Chapel Hill|Ricardo Walter, DDS, MS|9195373596|walterr@unc.edu|
21280784|NCT00867529|Fred Hutch|David G Maloney, MD PhD||dmaloney@fredhutch.org|
21280785|NCT04144413|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
21280786|NCT03070236|Dana-Farber Cancer Institute (DFCI)|Ann H. Partridge, MD, MPH|617-632-3800|Ann_Partridge@dfci.harvard.edu|
21280787|NCT00742209|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
21280788|NCT00485264|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
21280789|NCT01514461|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21280790|NCT03565900|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21280791|NCT06160609|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21280792|NCT03359850|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21280793|NCT01280643|Fox Chase Cancer Center|Dr. Crystal Denlinger|215-214-1676|crystal.denlinger@fccc.edu|
21280794|NCT02090088|Amgen Inc.|Study Director|866-572-6436||
21280795|NCT03290378|Avenue Therapeutics|VP of Clinical Operations and Program Management|781-652-4514|mryan@avenuetx.com|
21280796|NCT01629511|UT MD Anderson Cancer Center|Dr. Chitra Hosing|713-792-8750|cmhosing@mdanderson.org|
21280797|NCT03817125|Parker Institute for Cancer Immunotherapy|Ute Dugan|203-379-6757|udugan@parkerici.org|
21280798|NCT00942084|Duke Clinical Research Institute|P. Brian Smith, MD MPH MHS|919-668-8951|brian.smith@duke.edu|
21280799|NCT01087918|UZurich|Hubertus van Hedel, PhD|+41 44 762 52 91|hubertus.vanhedel@kispi.uzh.ch|
21280800|NCT01037218|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
21280801|NCT02568072|St George's, University of London|Dr Andrew D'Silva|020 7188 7188|adsilva@nhs.net|51554
21294763|NCT00405509|Allegheny General Hospital|Deborah Gentile, MD|412-359-6654|dgentile@wpahs.org|
21294764|NCT00835198|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
21294765|NCT00895752|Cincinnati Childrens Hospital|Craig Erickson MD|5136366265|craig.erickson@cchmc.org|
21294766|NCT00503581|NRG Oncology|Linda Gedeon for James Kauderer|716-845-1169|linda.gedeon@roswellpark.org|
21294767|NCT05747209|Allegheny General Hospital|Colin Champ, MD|412-734-7605|colin.champ@ahn.org|
21294768|NCT01301066|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@kowaus.com|
21294769|NCT00868140|Virginia Commonwealth University|Dr. John Nestler|(804) 828-3389|john.nestler@vcuhealth.org|
21294770|NCT02187887|RAND|Eric Pedersen|3103930411|ericp@rand.org|6078
21294771|NCT02118766|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294772|NCT03645941|Mayo Clinic|Christi A. Patten, MD|507-266-2554|patten.Christi@mayo.edu|
21294773|NCT02248649|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
21294774|NCT02438683|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21294775|NCT01926041|National Taiwan University Hospital & College of Medicine|Dr. Chien-Hsieh Chiang|+88623123456|jiansie@gmail.com|66699
21294776|NCT04319380|London School of Hygiene and Tropical Medicine|Professor Daniel Chandramohan|+447570410351|daniel.chandramohan@lshtm.ac.uk|
21294777|NCT00147017|Imperial College London|Professor Louise Donnelly|+442075947895|l.donnelly@imperial.ac.uk|
21294778|NCT01404559|University of South Florida|William S. Quillen|8139749863|wquillen@health.usf.edu|
21247043|NCT05933772|CooperVision|Jose A. Vega,OD,MSc,FAAO|925-621-3761|jvega2@coopervision.com|
21247044|NCT04743973|Mayo Clinic|Dr. Ivana T. Croghan|507-284-2511|GIMRESEARCHSTUDIES@mayo.edu|
21247045|NCT04159519|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21247046|NCT03998488|Weill Cornell Medicine|Dr. Randy Longman|646-962-6289|ral2006@med.cornell.edu|
21247047|NCT04780581|IBSAL|Project manager|+34 923 29 11 00|uicec.coordinacion@ibsal.es|55779
21247048|NCT01756300|Biosense Webster, EMEA|Liesbeth Vanderlinden, Manager Clinical Research|+32(0)2 7463527|lvanderl@its.JNJ.com|
21247049|NCT04595331|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
21247050|NCT02246127|Grupo Español de Tumores Neuroendocrinos y Endocrinos (GETNE)|GETNE Secretary|0034934344412|getne@getne.org|
21247051|NCT03635567|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21247052|NCT00739908|CeNeRx BioPharma Inc.|Mahnaz Asgharnejad, Pharm.D.; Daniel Burch, M.D.|(919) 655 1435; (919) 674 6041|masgharnejad@cenerx.com; danburch@cenerx.com|
21247053|NCT05157841|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
21247054|NCT02299349|TriHealth Hatton Research Institute|Angela N Fellner PhD CCRP|513-862-2330|Angie_Fellner@trihealth.com|
21247055|NCT03884101|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21247056|NCT04560179|Stanford University School of Medicine|Erik Jensen, MD, MSCE|267-648-2720|jensene@stanford.edu|
21247057|NCT04631016|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
21247058|NCT03076021|University of Washington|Dr. Mary Hebert|206-616-5016|mhebert@u.washington.edu|
21247059|NCT03771612|UCLA|Naomi Eisenberger|3108494330|neisenbe@ucla.edu|
21247060|NCT05334355|Montclair State University|Dr. Evan Matthews, Associate Professor|9736553948|matthewse@montclair.edu|
21247061|NCT05454514|HIDO TECHNOLOGIES, INC.|Charles Gellman, CEO|5108137224|charles@hidohealth.com|
21247062|NCT05698368|Stanford University|Dr. Melissa Boswell|(650) 725-4009|boswellm@stanford.edu|
21247063|NCT05954546|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21247064|NCT02624050|Milton S. Hershey Medical Center|Dr. Anthony Bonavia|717-531-6140|abonavia@pennstatehealth.psu.edu|
21247065|NCT04795245|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21247066|NCT03904576|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21247067|NCT04881110|University of Campania Luigi Vanvitelli|Prof. Katherine Esposito, Head of the Division of Endocrinology and Metabolic Diseases|+390815665031|katherine.esposito@unicampania.it|
21247068|NCT01897441|Albert Einstein College of Medicine|Dr. Jesus Anampa Mesias|718-405-8505|janampa@montefiore.org|
21247069|NCT03279978|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21247070|NCT01651000|OPKO Health, Inc.|Douglass Laidlaw, PhD, Vice President, Medical Affairs|305-575-4172|dlaidlaw@opko.com|
21247071|NCT02765412|VA Ann Arbor Healthcare System|Angela Larkin|734-845-3612|angela.larkin@va.gov|
21247072|NCT03990883|Croma Pharma GmbH|Clinical Development - Head of Clinical Operations|+43 2262 684680|clinical.studies@croma.at|
21247073|NCT03734029|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21247074|NCT05207033|University of Massachusetts Chan Medical School|Elise Stevens, Assistant Professor|(774) 455-6684|elise.stevens@umassmed.edu|56684
21247075|NCT04300127|Mayo Clinic Arizona|Dr. Jay Pasricha|(480)301-4279|pasricha.jay@mayo.edu|
21247076|NCT05412004|Eli Lilly and Company|Chief Medical Officer|800-459-5979|ClinicalTrials.gov@lilly.com|
21247077|NCT03781089|Duke University Medical Center|Dr. John Middleton|919-684-8111|j.p.middleton@duke.edu|
21247078|NCT04644029|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21247079|NCT05132400|NYU Langone Health|Marco Campello, PT, PhD|212-255-6690|Marco.campello@nyulangone.org|
21247080|NCT03934931|University of California Irvine|Professor Adithya Cattamanchi|415-206-5489|adithya.cattamanchi@uci.edu|
21247081|NCT03952520|University of North Carolina at Chapel Hill|Jane Chen, PhD|919-966-2537|janechen@live.unc.edu|
21247082|NCT02076009|Janssen R&D US|Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
21247083|NCT04310423|University of California, Los Angeles|Dr. Lara Ray|310-794-5383|lararay@psych.ucla.edu|
21294779|NCT02406573|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
21294780|NCT01202188|Novartis Pharmaceuticals|Study Director|862-778-8300||
21294781|NCT05032690|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294782|NCT00487942|Cephalon, Inc.|Medical Monitor|1-800-896-5855||
21294783|NCT05151445|Ohio State University College of Nursing|Tara O'Brien|614-292-8045|obrien.782@osu.edu|
21294784|NCT03111550|Johnson & Johnson Surgical Vision|Devi Priya Janakiraman,OD, FAAO|+1 714-247-8628|djanaki1@its.jnj.com|
21294785|NCT02298179|GlaxoSmithKline|GSK Response Center|866-435-7343|kt144805@gsk.com|
21294786|NCT04696276|Saint Savvas Hospital of Athens|Maria Bourazani|+302106409000|mbourazani@yahoo.com|
21294787|NCT01846299|Novartis|Study Director|862-778-8300||
21294788|NCT03559517|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
21294789|NCT00082368|National Cancer Institute|Dr. Peter Choyke|301-402-8409|peter_choyke@nih.gov|
21294790|NCT01330628|Spectranetics|Amanda Johnson, VP of Regulatory & Medical Affairs|(719) 447-2000|amanda.johnson@spnc.com|
21294791|NCT04910074|Albert Einstein College of Medicine|Timothy P. Levine, DMD|718-918-5635|timothy.levine@nychhc.org|
21294792|NCT01332188|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
21294793|NCT00413894|Hoffmannb-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21294794|NCT04225676|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21294795|NCT01942161|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Trials|+81-3-6361-7366||
21294796|NCT00866034|UMC Utrecht|Ouijdane Hamdine, MD|+31-88-7557524|O.Hamdine@umcutrecht.nl|
21294797|NCT01783574|Massachusetts General Hospital|Dr. Karen K. Miller|617-726-3870|KKMILLER@MGH.HARVARD.EDU|
21247084|NCT03786926|HUTCHMED Limited|Chao Pan|(+86)15215192478|chaop@hutch-med.com|
21247085|NCT00449748|The University of Texas M. D. Anderson Cancer Cent|Srdan Verstovsek M.D./Associate Professor|713-792-7305|eharriso@mdanderson.org|
21247086|NCT03944915|University of Chicago|Dr. Ari Rosenberg|855-702-8222|arirosenberg@bsd.uchicago.edu|
21247087|NCT01746979|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com|
21247088|NCT05988398|University of Michigan|Dr. Katie M Edwards|734-647-8812|edkatie@umich.edu|
21247089|NCT05891275|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21247090|NCT00942734|University of Texas (UT) MD Anderson Cancer Center|Vali Papadimitrakopoulou, MD||CR_Study_Registration@mdanderson.org|
21247091|NCT00319046|Actelion Pharmaceuticals Ltd|Cécile Luzy, MSc/Clinical Research Scientist|+ 41 61 565 6386||
21247092|NCT05147584|Raydiant Oximetry, Inc.|Laura Kemp|4083751465|laurakemp@raydiantoximetry.com|
21247093|NCT01950234|University of Minnesota|Sarah Hikbert|612-624-7745|hilbe010@umn.edu|
21247094|NCT02765854|Atrium Health Wake Forest Baptist Comprehensive Cancer Center|Leon Bernal-Mizrachi, MD|336-716-9253|lbernalm@wakehealth.edu|
21247095|NCT03370913|BioMarin Pharmaceutical Inc.|Tara Robinson, MD, PhD, Senior Medical Director, Clinical Sciences|415-455-7931|tara.robinson@bmrn.com|
21247096|NCT06603766|faculty of medicine Benha University|Dr. Heba Morsy Saad El Din El Ganady|+201111211367|Heba.Aljanadi21@fmed.bu.edu.eg|
21247097|NCT05757193|Duke University|Senthil Selvaraj, MD|919-660-0730|Senthil.Selvaraj@duke.edu|
21247098|NCT04496752|Linus Health|Dr. Sean Tobyne|(617) 433-1777|stobyne@linus.health|
21247099|NCT04078152|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21247100|NCT04679389|Mayo Clinic|Eva Morava-Kozicz, M.D., Ph.D.|507-266-9140|Morava-Kozicz.Eva@mayo.edu|
21247101|NCT05257603|State University of New York at Buffalo|Dr. Kathleen Parks|(716) 887-3301|kparks@buffalo.edu|
21247102|NCT04494958|APICES|Juan Luis Sanz|91 816 68 04|juanluis.sanz@apices.es|112
21247103|NCT04835363|University of Malaga|Garcia-perez, Patricia|+34 675447206|terapiaocupacional.patricia@gmail.com|
21247104|NCT04198701|Medtronic, Inc.|Clinical Research Specialist|800-328-2518|medtroniccrmtrials@medtronic.com|
21247105|NCT03522298|Kazia|Jeremy Simpson|+61 400 410 974|jeremy.simpson@kaziatherapeutics.com|
21247106|NCT01992913|Corporal Michael J Crescenz VA Medical Center|Steven L. Sayers, Ph.D.|(215) 823-5196|steven.sayers@va.gov|
21247107|NCT05718687|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21247108|NCT04177771|RxSight|Jeffrey Ha, VP Clinical Affairs|949-521-7870|jha@rxsight.com|
21247109|NCT03250676|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21247110|NCT05020353|Li Ka Shing Knowledge Institute, St. Michael's Hospital|Sean B. Rourke|(416) 878-2779|sean.rourke@utoronto.ca|
21247111|NCT00640978|UT MD Anderson Cancer Center|Milind Javle, MD/Associate Professor|713-792-2828|mjlim@mdanderson.org|
21247112|NCT03801616|Cedars-Sinai Medical Center|Dr. Alice Chung|3104239331|alice.chung@cshs.org|
21247113|NCT06024642|Imbrium Therapeutics L.P.|Clinical Leader|1-888-827-0622|Medinfo@imbriumthera.com|
21247114|NCT04633278|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21247115|NCT02611687|Bioprojet Pharma|Clinical Project Manager|+33 (0)1 47 03 66 23|a.viatte@bioprojet.com|
21247116|NCT05448014|Umeå University|Inga Dennhag, Associate Professor|+46706217414|inga.dennhag@umu.se|
21247117|NCT02047500|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com|
21247118|NCT02075554|Globus Medical Inc.|Brandon Bucklen|610-930-1800|bbucklen@globusmedical.com|2517
21247119|NCT00624442|Cytokinetics, Inc.|Medical Director|(650) 624-3011||
21247120|NCT04933474|Cedars-Sinai Medical Center|Samuel Eberlein|310-423-6721|samuel.eberlein@cshs.org|
21247121|NCT04282109|APICES|Juan Luis Sanz (MW)|+34 918166804|juanluis.sanz@apices.es|103
21247122|NCT03340428|Johns Hopkins University|Christopher Hoffmann|410-614-4257|choffmann@jhmi.edu|
21247123|NCT04757753|SEPTODONT|Dr. Farid BENABDALLAH|+33785662179|clinical-operations@septodont.com|
21247124|NCT04868656|Durham VA Medical Center|Dr. Susan N. Hastings, MD, M.H.Sc|(919) 286-6936|susan.hastings@va.gov|
21294798|NCT05289271|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21294799|NCT01257568|Stryker Orthopaedics|Shaherah Yancy, Director, Clinical Operations|901-650-6601|shaherah.yancy@stryker.com|
21294800|NCT02074345|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
21294801|NCT02994953|Merck KGaA, Darmstadt, Germany|Communication Center|6151 72 5200|service@merckgroup.com|
21294802|NCT00132691|Center for Presventive Ophthalmology and Biostatistics, Department of Ophthalmology, University of Pennsylvania|John H. Kempen, MD, PhD, MUST Trial Vice-Chairman|215-615-1500|john.kempen@uphs.upenn.edu|
21294803|NCT03356977|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294804|NCT02043197|Abbott|Tatiana V. Vladimirova|+74952584280|tatiana.vladimirova@abbott.com|
21294805|NCT01846195|Zynex Monitoring Solutions|Donald Gregg|1-800-495-6670|dgregg@zynex.com|
21294806|NCT01545232|University of Texas Health Science Center - Houston|John Holcomb, M.D.|713-500-5493|John.Holcomb@uth.tmc.edu|
21294807|NCT01247363|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21294808|NCT00908115|GlaxoSmithKline|GSK Response Center|866-435-7343||
21294809|NCT01728077|Cares|UCB|+1844599||2273
21294810|NCT00378599|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21294811|NCT00642369|Guang Dong Provinical Mental Health Institute|Zhang Bin|86-20-81888553|zhang73bin@hotmail.com|
21294812|NCT04035564|"Hospital del Niño de Saltillo Dr. Federico Gomez Santos"|Carlos Sanchez|+528441757244|sanchez.carlos8516@gmail.com|
21294813|NCT04243577|Purdue University|Georgia Malandraki|7654960206|malandraki@purdue.edu|
21294814|NCT00624585|H. Lee Moffitt Cancer Center and Research Institute|Alan F. List, Executive Vice President & President, Moffitt Medical Group|813-745-6086|alan.list@moffitt.org|
21294815|NCT02330653|Boston Children's Hospital|Dr. Stacy A. Kahn|617-355-6058|stacy.kahn@childrens.harvard.edu|
21294816|NCT02970006|The Ohio State University- Neurological Institute|Vibhor Krishna, MD|6142939274|Vibhor.Krishna@osumc.edu|
21294817|NCT02563860|Montefiore MC|Aleksandra Djukic|7189204378|adjukic@montefiore.org|
21294818|NCT04154345|University of Antwerp|Prof. Filip Struyf|32652783|filip.struyf@uantwerpen.be|0032
21294819|NCT02576041|Allergology Unit, Azienda Ospedaliero-Universitaria Policlinico di Modena|Patrizia Pepe, MD|+39. 059 4225449||
21294820|NCT00676520|Abbott Vascular|Ellen Travis|408-845-3000|Ellen.Travis@av.abbott.com|
21294821|NCT01425359|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21247125|NCT02954809|University at Buffalo|Dr. Carleara Weiss|716-829-2006|carleara@buffalo.edu|
21280802|NCT01268553|Los Angeles Biomedical research INst at Harbor-UCLA|Dr. Ronald Oudiz|310-222-3560|roudiz@labiomed.org|310
21280803|NCT00927589|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21280804|NCT02695446|BioPharmX, Inc.|AnnaMarie Daniels|310-701-2080|amdaniels@biopharmx.com|
21280805|NCT05263908|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21280806|NCT02714218|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
21280807|NCT01641640|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21280808|NCT01545648|University of California, San Francisco|Hope Rugo, MD|877-827-3222|cancertrials@ucsf.edu|
21280809|NCT01199939|Janssen Pharmaceuticals|SENIOR MEDICAL DIRECTOR|1 609 730-2931||
21280810|NCT02792517|Amgen Inc.|Study Director|866-572-6436||
21280811|NCT03875508|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21280812|NCT01113892|Getinge Group|Elizabeth Bulger|603 880 1433|Elizabeth.Bulger@getinge.com|5368
21280813|NCT01656460|Brown University Oncology Research Group (BrUOG)|Thomas DiPetrillo, MD|4018633000|kayla_rosati@brown.edu|
21280814|NCT01285362|Columbia Universty|Dr Mercedes Martinez|212-305-3438|mm2479@cumc.columbia.edu|
21280815|NCT00489866|Durham VAMC|Christine E. Marx, MD|9192860411|marx0001@mc.duke.edu|7426
21280816|NCT00789854|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21280817|NCT02766335|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
21280818|NCT00281957|SWOG Statistical Office|SWOG melanoma statistician|206-667-4408||
21280819|NCT03787134|University of Wisconsin - Madison|Brad Postle, PhD|608-262-4330|postle@wisc.edu|
21280820|NCT03281876|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21280821|NCT00978874|University of Pennsylvania|Lilie Lin, MD|215-662-6515|lin@xrt.upenn.edu|
21280822|NCT01964976|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21280823|NCT02452476|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+39 0521 2791|clinicaltrials_info@chiesi.com|
21280824|NCT03008174|Johns Hopkins University|Vinciya Pandian|4436553482|vpandia1@jhu.edu|
21280825|NCT01074944|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21280826|NCT02348112|Coloplast Corp.|Liz Driessen|1-800-258-3476|usedri@coloplast.com|
21280827|NCT03741400|Professor of Neurology and Neurological Sciences|Maarten G. Lansberg, MD PhD|(650) 723-4448|lansberg@stanford.edu|
21280828|NCT02586155|Resverlogix Corp.|Sr. Director of Clinical Operations|403.254.9252|clinicaltrials@resverlogix.com|
21247126|NCT06655818|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21247127|NCT03901534|Columbia University|Sanja Jelic, MD|212-543-8875|sj366@cumc.columbia.edu|
21247128|NCT03816397|F.I. Proctor Foundation, University of California, San Francisco|Nisha Acharya, MD, MS|(415) 476-6687|nisha.acharya@ucsf.edu|
21247129|NCT05275556|Verily|Dr. Scooter Plowman|650-861-9783|splowman@verily.com|
21247130|NCT04908930|Wake Forest University Health Sciences|Jillian Urban, PhD|336.716.0947|jurban@wakehealth.edu|
21247131|NCT03248479|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21247132|NCT02777593|W.L. Gore|Meier Hsu|928-864-3338|mhsu@wlgore.com|
21280829|NCT02085447|University Hospitals Cleveland Medical Center|Dr. Martha Sajatovic|2168442808|martha.sajatovic@uhhospitals.org|
21280830|NCT02072980|Alcon Research, Ltd.|Cecile Maissa, Global Brand Medical Affairs Lead - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21294822|NCT01528891|Children's Hospital of Pittsburgh of UPMC|Peter J. Davis, MD|4126925260|davispj@anes.upmc.edu|
21247133|NCT04024059|Johns Hopkins University School of Medicine|Kenneth Silverman, Ph.D.|4436176051|ksilverm@jhmi.edu|
21294823|NCT04452435|Vicore Pharma|Carl-Johan Dalsgaard|+46 70 975 98 63|carl-johan.dalsgaard@vicorepharma.com|
21294824|NCT04043234|Infinite Biomedical Technologies, LLC|Chief Executive Officer|(443) 451-7177|rahul@i-biomed.com|
21294825|NCT01165320|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21294826|NCT01558362|University of Ottawa Heart Institute|Dr. Terrence Ruddy, Principal Investigator|613-696-7267|truddy@ottawaheart.ca|
21294827|NCT00385944|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21294828|NCT00590824|University of Madison Carbone Cancer Center|Paul Sondel, MD, PhD|(608) 263-9069|pmsondel@humonc.wisc.edu|
21294829|NCT05898672|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294830|NCT01778049|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21294831|NCT01025076|Royal Alexandra Hospital/CAMIS|Xinzhe Shi|7807356735|xinzhe.shi@ahs.ca|
21294832|NCT02379988|Peace Health St. Joseph's cancer center|Victor Gonzalez|360-788-8222|vgonzalez1@peachehealth.org|
21294833|NCT01849575|Umea University, Sweden|Dr Margareta Norberg|+46907865544|margareta.norberg@umu.se|
21294834|NCT00945061|University Hospitals Cleveland Medical Center , Case Comprehensive Cancer Center|Dr. Janice A. Lyons, MD|+1 216-844-2536|Janice.Lyons@uhhospitals.org|
21294835|NCT03359785|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
21294836|NCT01895543|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21294837|NCT00367744|Case Western Reserve University|Dr. Grace McComsey|216 844 3607|mccomsey.grace@clevelandactu.org|
21294838|NCT00793572|Fred Hutchinson Cancer Research Center|Dr. Marco Mielcarek|(206) 667-2827|mmielcar@fhcrc.org|
21247134|NCT05785130|ChangGung Memorial Hospital|Ya-Ching, Nien|+886 913112012|yaching79@cgmh.org.tw|
21247135|NCT03547271|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext: 6#|Contact-US@sanofi.com|
21247136|NCT06065735|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21247137|NCT03982186|Janssen Sciences Ireland UC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21247138|NCT02325154|Hospital for Special Surgery, Anesthesiology|Dr. Sean Garvin|2126061036|GarvinS@hss.edu|
21247139|NCT01265537|St. Paul's Hospital|Dr. Jagbir Gill|6046822344|JAGill@providencehealth.bc.ca|64706
21247140|NCT01612351|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
21247141|NCT03512301|Psychology Software Tools, Inc.|Anthony Zuccolotto|412-449-0078|anthony.zuccolotto@pstnet.com|
21247142|NCT03697408|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
21247143|NCT02720068|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21247144|NCT03094052|University of California, San Francisco|Dr. A. Jo Chien, MD|(415) 885-7577|Jo.Chien@ucsf.edu|
21247145|NCT05002738|University of Colorado Anschutz Medical Campus|Eva Dindinger|3037242019|eva.dindinger@cuanschutz.edu|
21247146|NCT01773993|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21247147|NCT01144455|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com|
21247148|NCT04993677|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21247149|NCT06102421|Second Faculty of Medicine, Charles University|Mgr. Jakub Katolicky|+420702088258|jakubkatolicky@gmail.com|
21247150|NCT05265871|Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, The First Affiliated Hospital of Guangzhou Medical University|Kefang Lai|18928868231|klai@vip.163.com|
21247151|NCT01167010|Eurofarma Laboratórios S.A|Sandra Rodrigues (Clinical Research)|1150908600|sandra.rodrigues@eurofarma.com.br|8417
21247152|NCT04243759|Northeastern University|Robert Leeman|6173736501|r.leeman@northeastern.edu|
21247153|NCT02295891|Johns Hopkins University|Kristen Rodgers- Research Program Manager, Dept, of Thoracic Surgery|410-955-9047|kpelosk1@jhmi.edu|
21247154|NCT04408755|Otsuka Pharmaceutical Development & Commercialization, Inc.|Clinical Transparency|08446878522|smb_clinicaltranspa@otsuka-us.com|
21247155|NCT03733626|William Beaumont Hospitals|Jad Khalil, MD|(248) 663-1900|jad.khalil@corewellhealth.org|
21247156|NCT06664684|İstanbul Bilgi University|Dr. Tugce Ozlu Karahan|+90 212 311 5042|tugce.karahan@bilgi.edu.tr|
21247157|NCT00412607|Biosense Webster, Inc.|Karen Cropper, Manager, Clinical Operations|(800) 729-9010|Kcropper@its.jnj.com|8607
21247158|NCT03662022|Insitute of Tropical Medicine|Carolien Hoof|+32470102562|choof@itg.be|
21247159|NCT04323397|Prince of Songkla University|Anucha Thatrimontrichai|66 74451257|tanucha@medicine.psu.ac.th|
21247160|NCT05292222|HealthPartners Institute|Bhavani Kashyap, MBBS, PhD|651-495-6565|bhavani.x.kashyap@healthpartners.com|
21247161|NCT05966766|Tufts Medical Center|Dan Drzymalski, MD|617-913-8168‬‬‬‬‬‬‬‬‬‬‬‬‬‬|dan.drzymalski@tuftsmedicine.org|
21247162|NCT03907982|Barts and London NHS trust|Dr Malcolm Finlay, Principal Investigator|+442037658635|malcolm.finlay1@nhs.net|
21247163|NCT06017115|Universitat Internacional de Catalunya|Dr. Jordi Gargallo|+34 935 04 20 00|jgargallo@uic.es|
21247164|NCT03884439|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21247165|NCT05215054|Eurofins Dermscan Pharmascan|Florence REBER|0472823656|Florence.Reber@cpt.eurofinseu.com|+33
21247166|NCT02933489|ECOG-ACRIN|Director Clinical Research Administration|800-227-5463|dhartfeil@acr.org|4765
21247167|NCT05485935|Coloplast A/S|Malene Hornbak Landauro, Medical writer of Clinical strategies|+4549112057|dkmhla@coloplast.com|
21247168|NCT02806726|Johnson & Johnson Surgical Vision, Inc.|Priya Janakiraman|1 714 2478628|djanaki1@its.jnj.com|
21262539|NCT00589888|Emory Univ SOM|Guillermo Umpierrez, MD|4047781665|geumpie@emory.edu|
21294839|NCT04262882|University of Texas at San Antonio|Dr. Katelyn Sileo|210-458-7900|katelyn.sileo@utsa.edu|
21294840|NCT00726037|Northwestern Medicine Regional Medical Group|Margret Shoup|630-352-5450|MSHOUP@lumc.edu|
21294841|NCT00443053|GlaxoSmithKline|GSK Response Center|866-435-7343||
21294842|NCT00541866|Sunesis Pharmaceuticals, Inc.|Mike Johnston, Senior Director Regulatory Affairs|(650) 266-3727|mjohnston@sunesis.com|
21294843|NCT00522418|Cyberonics, Inc|Mark Bunker, Senior Director, Global Medical Affairs|281-228-7223|Mark.Bunker@cyberonics.com|
21294844|NCT00578877|CONRAD|Jill Schwartz, M.D.|703-276-3913|jschwartz@conrad.org|
21294845|NCT04432064|Indiana University|Prof. Joshua Brown|812 855-9282|jwmbrown@iu.edu|
21294846|NCT02256384|Cincinnati Children's Hospital Medical Center|Mario Patino|513-636-4200|mario.patino@cchmc.org|
21294847|NCT02136680|University of Maryland Baltimore, School of Medicine|Dr. Carla Alexander|410-328-7129|calexand@medicine.umaryland.edu|
21294848|NCT01632241|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21294849|NCT01638013|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
21294850|NCT02802241|BIDMC|Judy Nee|6176672193|jnee@bidmc.harvard.edu|
21294851|NCT00845039|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21247169|NCT01499368|Boryung Pharmaceuticals|Manager of Clinical Research|+82-2-708-8069|rainbowleo@boryung.co.kr|
21247170|NCT03092674|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|2066674623|amoseley@fredhutch.org|
21247171|NCT04626427|Becton Dickinson|Simon Lubek, Clinical Program Manager|+33 6 07 56 66 08|simon.lubek@bd.com|
21247172|NCT03698669|Boston University|Michael Stein, MD|617 358 1956|mdstein@bu.edu|
21247173|NCT04518943|VA Puget Sound Health Care System|Dr. Paul Hebert|(206) 277-4165|paul.hebert2@va.gov|
21247174|NCT03873805|City of Hope Medical Center|Dr. Tanya Dorff|626 218 8231|tdorff@coh.org|
21247175|NCT03705793|Washington University in St. Louis|Pawina JIramongkolchai, MD|314-362-5296|pawina@wustl.edu|
21247176|NCT04174170|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
21247177|NCT04664881|Mayo Clinic|Joerg Herrmann, M.D.|507-255-1267|Herrmann.Joerg@mayo.edu|
21247178|NCT00324415|AMC|Director, AMC Statistical Center|501-526-6712|jylee@uams.edu|
21247179|NCT05419856|4Moving Biotech|Odile Fleurot|03 20 11 80 30|odile.fleurot@4p-pharma.com|
21247180|NCT05643196|NYU Langone Health|Wei Qi|212-961-4492|wei.qi@nyulangone.org|
21247181|NCT04772534|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21247182|NCT04194450|University of British Columbia|Dr. Jonathan Little|(250) 807-9876|jonathan.little@ubc.ca|
21247183|NCT03718130|GenevaUSA.org|Elissa K. Thomas, Associate Director, Corporate Strategy|248-802-6095|ethomas@genevausa.org|
21247184|NCT05875701|Novavax Inc.|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
21247185|NCT03910218|The University of Texas Health Science Center at Houston|Diane Santa Maria, DrPH|713-500-2187|diane.m.santamaria@uth.tmc.edu|
21247186|NCT05441683|Department of Periodontology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China|Dr. Yan-Min Wu|+86-13757119560|wuyanmin@zju.edu.cn|
21247187|NCT05109871|Liverpool University Hospitals NHS Foundation Trust|Richard Norris|0151529 2534|richard.norris2@liverpoolft.nhs.uk|
21247188|NCT05769634|Icahn School of Medicine at Mount Sinai|Allison C.Waters|(212) 523-8832|allison.waters@mssm.edu|
21247189|NCT00308997|Yale University School of Medicine|Ralph Hoffman, MD|203-688-9734|Ralph.Hoffman@yale.edu|
21247190|NCT00704769|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21247191|NCT04490356|Duke University Medical Center|Kathryn Starr, Ph.D.|919-660-7571|kathryn.starr@duke.edu|
21247192|NCT05374538|VITRAC Therapeutics, LLC|Linda Paradiso, DVM, Chief Development Officer|713-898-8965|linda.paradiso@vitractherapeutics.com|
21247193|NCT04602611|Wake Forest|Danielle M Boselli|2017903385|Danielle.Boselli@AtriumHealth.org|
21247194|NCT00503971|Fundación GECP|Eva Pereira|+34 934302006|secretaria@gecp.org|
21247195|NCT04567316|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21247196|NCT04214418|Columbia University|Gulam Manji, MD, PhD|212-304-6357|gam2140@cumc.columbia.edu|
21247197|NCT02637609|Johns Hopkins Bloomberg School of Public Health|John FP Bridges|614-685-2543|john.bridges@osumc.edu|
21247198|NCT05836012|HilleVax, Inc.|Astrid Borkowski, Chief Medical Officer|+1 (617) 213-6562|aborkowski@hillevax.com|
21247199|NCT03351998|University of Kansas Medical Center|John P. Thyfault|913-588-1790|jthyfault@kumc.edu|
21247200|NCT04093869|Duke University|Stephanie K. Mabe, MS|919-668-3555|stephanie.mabe@duke.edu|
21247201|NCT05129501|University of Nebraska-Lincoln, Nebraska Center for Research on Children, Youth, Families, and Schools/Interpersonal Violence Research Laboratory|Katie M Edwards, PhD|402-472-2448|katie.edwards@unl.edu|
21247202|NCT04342260|University of North Carolina Lineberger Comprehensive Cancer Center|Amanda Gentry|(336) 655-7743|agentry@email.unc.edu|
21247203|NCT01527188|Stallergenes|Michel Roux, Medical Director|+33 (0) 1 33 55 59 29 70|mroux@stallergenes.com|
21247204|NCT04632394|St George's University of London|Dr Michael Waight|020 8672 9944|m2110065@citystgeorges.ac.uk|
21247205|NCT02988193|Optima Integrated Health|Gabriela Voskerician|6502233588|gxv4@case.edu|
21247206|NCT03363763|Aucta Pharmaceuticals, Inc.|Dr. Marie Tan|7329129575|Marie.Tan@auctapharma.com|
21247207|NCT05162586|Merck Healthcare KGaA, DarmstadtGermany, an affiliate of Merck KGaA,Darmstadt, Germany|Communication Center|6151-72-5200|service@emdgroup.com|+49
21247208|NCT02514915|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP, Clinical Research Manager|4126233272|stadtermanbm@upmc.edu|
21247209|NCT02656706|Brown University Oncology Research Group|Maria Constantinou, MD|401-863-300|BrUOG@BROWN.EDU|
21247210|NCT04819191|Johns Hopkins Bloomberg School of Public Health|Jennifer Wolff, PhD|(410) 502-0458|jwolff2@jhu.edu|
21247211|NCT04675034|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
21297163|NCT00183625|Semel Institute at UCLA|Stephen R. Marder, M.D.|310-268-3647|marder@ucla.edu|
21297164|NCT01369641|Thomas Jefferson University|David Cognetti, MD|215-955-6670|David.Cognetti@jefferson.edu|
21247212|NCT03201939|Vanderbilt University Medical Center|C. William Wester|6158750145|william.wester@vumc.org|
21247213|NCT04107116|Stanford University School of Medicine|Manali I Patel, MD MPH MS|650-723-4000|manalip@stanford.edu|
21247214|NCT02532621|Phraxis, Inc.|Cindy Setum, PhD|612-801-6730|csetum@phraxis.com|
21247215|NCT02360371|Johns Hopkins University School of Medicine|Dr. Kelly Dunn, Ph.D., MBA|410-550-2254|kdunn9@jhmi.edu|
21247216|NCT05886452|Mann Eye Institute|Dr Phillip Brunson|17135802500|Phillip.Brunson@manneye.com|
21247217|NCT04731233|University of Florida|Dr. Charles G. Widmer|352-273-5696|widmer@dental.ufl.edu|
21247218|NCT03839446|UPMC Hillman Cancer Center|Barbara M Stadterman, MPH, MSCR, CCRP|412-647-5554|stadtermanbm@upmc.edu|
21247219|NCT04281498|Icahn School of Medicine at Mount Sinai|Dr. John Mascarenhas|212-241-3417|john.mascarenhas@mssm.edu|
21247220|NCT03142009|University of New Mexico College of Population Health|Dr. Nina Wallerstein|404-272-4173|nwallerstein@salud.unm.edu|
21247221|NCT03587805|LEO Pharma A/S|Clinical Disclosure|+45 44945888|disclosure@leo-pharma.com|
21247222|NCT01553149|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21247223|NCT03008382|Virginia Commonwealth University|Dr. Thomas Chelimsky|(804) 628-4859|Thomas.Chelimsky@vcuhealth.org|
21247224|NCT05073510|BlueDop Medical, Ltd.|Dr. Patrick Kelly|+1 605 521 9831|patrick@bluedopmedical.co.uk|
21247225|NCT05267639|Liberating Technologies, Inc.|Jen Johansson|774-233-0874|jen.johansson@liberatingtech.com|
21247226|NCT04732871|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21247227|NCT05372042|University of Washington|Dr. Kristen Lindgren|206-658-8083|kpl9716@uw.edu|
21247228|NCT03109873|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Adam Luginbuhl|215-240-0748|adam.luginbuhl@jefferson.ed|
21247229|NCT00983307|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Maria Werner-Wasik|215 955-6702|maria.werner-wasik@jefferson.edu|
21247230|NCT05180539|Lehigh University|Lucy Napper|610 758 4689|lun214@lehigh.edu|
21247231|NCT03779984|UTexasSouthwestern|David Mercier|214-645-3479|David.Mercier@utsouthwestern.edu|
21247232|NCT06202560|Institute of dermatology, Thailand|Chinmanat Lekhavat|+66 95-207-2870|chinmanat@gmail.com|
21247233|NCT00968149|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21247234|NCT00447980|Neurotech USA, Inc.|Patricia Davis, Sr. Director of Clinical Operations|401.333.3880|p.davis@neurotechusa.com|
21247235|NCT02467270|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21247236|NCT06408870|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21280831|NCT00580502|NYULMC|Heekoung Youn|2122632174|younh01@nyumc.org|
21280832|NCT01757275|AstraZeneca|Huifang Chen|+86 21 60301335|ariel.chen@astrazeneca.com|
21280833|NCT04446247|Owlet Baby Care, Inc|Madison Kenley, Clinical Research Director|801-552-8383|mkenley@owletcare.com|
21280834|NCT01401452|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
21280835|NCT00584454|UAMRIID Division of Medicine|LTC Robert Rivard, MD|301-619-8244|robert.g.rivard.mil@mail.mil|
21280836|NCT00254592|University of California Irvine Medical Center|Rita S. MEHTA, MD|(714) 456-5153|rsmehta@uci.edu|
21280837|NCT01459783|University of California Los Angeles|Joshua Chodosh or Barbara Vickrey|310-206-7671|jchodosh@mednet.ucla.edu|
21280838|NCT02601014|University of Minnesota Division of Hematology, Oncology and Transplantation|Emmanuel Antonarakis, MD|612-301-2180|anton401@umn.edu|
21280839|NCT02624180|Johns Hopkins Hospital|Robert G. Weiss, MD|410-955-1703|rweiss@jhmi.edu|
21280840|NCT00445146|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@Gilead.com|
21280841|NCT02456740|Amgen Inc.|Study Director|866-572-6436||
21280842|NCT02623725|Sanofi Pasteur|Medical Director|800-633-1610|Contact-US@sanofi.com|ext 1#
21280843|NCT03918629|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21280844|NCT01615367|Massachusetts General Hospital|Dr. Louisa Sylvia|617-643-4804|lsylvia2@partners.org|
21280845|NCT01891864|Sandoz|Dr Guido Wuerth - Global Program Medical Director|+4980244762925|guido.wuerth@sandoz.com|
21280846|NCT00607321|Medtronic Cardiovascular|K Bogdanovich||rs.medtroniccardiovascularclinicaltrials@medtronic.com|
21280847|NCT04720105|Icahn School of Medicine at Mount Sinai|Hassan Hamade|212-844-8811|hassan.hamade@mountsinai.org|
21280848|NCT02892331|University of Virginia|Damon Swift|(434) 924-1436|dls3s@virgina.edu|
21280849|NCT03717155|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21280850|NCT01333592|Kissei Pharmaceutical Co., Ltd|Clinical Development Division||rinsyousiken@pharm.kissei.co.jp|
21280851|NCT05120193|Medtronic, Inc.|Clinical Research Specialist|800-328-2518|medtroniccrmtrials@medtronic.com|
21280852|NCT04692103|UWashington|Hannah Linden, MD|206-606-2053|hmlinden@uw.edu|
21280853|NCT04563754|Baylor College of Medicine|Dr. Sharmila Anandasabapathy|713-798-8105|Sharmila.Anandasabapathy@bcm.edu|
21280854|NCT04023396|Abivax|Associate Director Clinical Operations|+33630031132|laurence.desroys@abivax.com|
21280855|NCT02513160|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
21280856|NCT03220204|Massachusetts General Hospital|Dr. Christopher Celano|617-726-6485|ccelano@partners.org|
21280857|NCT02861586|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21280858|NCT00728260|Sanofi Pasteur Inc|Medical Drector||RegistryContactus@sanofipasteur.com|
21280859|NCT04514692|Stanford University|Dr. Elizabeth Kidd|(650) 723-6171|ekidd@stanford.edu|
21280860|NCT02243605|Institut Bergonie|Pr Italiano Antoine, Department of Medical Oncology|0524071947|a.italiano@bordeaux.unicancer.fr|
21280861|NCT04173507|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
21280862|NCT01823328|Hennepin Healthcare|Audrey Hendrickson|612-873-9528|Audrey.Hendrickson@hcmed.org|
21280863|NCT01417156|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21280864|NCT03192488|Indiana University|Robert Chapman|812-856-2452|rfchapma@indiana.edu|
21280865|NCT00572936|University of Nebraska Medical Center|Carol Toris, PhD|402-559-1852|ctoris@unmc.edu|
21280866|NCT06192589|U.S. Food and Drug Administration|Jeffry Florian|301-796-4847|Jeffry.Florian@fda.hhs.gov|
21280867|NCT03664232|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21280868|NCT01439802|Albert Einstein College of Medicine|Dr. Erika Levi|718-405-8260|elevi@montefiore.org|
21280869|NCT02562066|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|305-420-3200|gingenito@catalystpharma.com|
21280870|NCT02003209|NSABP Foundation|Judy Langer, Director of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
21280871|NCT00638508|Maimonides Medical Center|Kalpana Tyagaraj, M.D.|718-283-9162|Kalpana_tyagaraj@msn.com|
21280872|NCT01332487|GlaxoSmithKline|GSK Response Center|866-435-7343||
21280873|NCT03500198|Johnson & Johnson Surgical Vision|Devi Priya Janakiraman, OD, FAAO|+1 714 247- 8628|djanaki1@its.jnj.com|
21280874|NCT00654095|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21280875|NCT04650217|New York State Psychiatric Institute|Dr. Bret Rutherford|646 774 8660|brr8@cumc.columbia.edu|
21280876|NCT00595621|Texas Tech|Irene Sarosiek, MD, AGAF, FACG, CCRP|915.215.5254|Irene.sarosiek@ttuhsc.edu|
21280877|NCT00324987|SWOG Statistical Center|SWOG Statistician|206-667-4408||
21280878|NCT00268450|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
21280879|NCT01254643|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21280880|NCT01062425|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21280881|NCT02383017|Onnit Labs|Vince Kreipke|3176954359|Vkreipke@onnit.com|
21280882|NCT01234350|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21280883|NCT01960413|Vanderbilt University Medical Center|Michael DeBaun, MD MPH|(615) 875-3040|m.debaun@vumc.org|
21280884|NCT00791778|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21280885|NCT03051100|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
21247237|NCT00495677|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21247238|NCT01969916|University of Chicago|Victor Mor-Avi|773-702-7780|vmoravi@bsd.uchicago.edu|
21247239|NCT04899778|Cedars-Sinai Medical Center|Dr. Melodie Metzger|310-423-7765|Melodie.Metzger@cshs.org|
21247240|NCT02567435|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21247241|NCT05771467|AkdenizU|Dr. Aslı Cetinkaya Yaprak|+0905069228431|ysf20smt@gmail.com|
21247242|NCT03520114|Wake Forest University|Sachin Nalin Vyas, MS,PhD|336-713-4098|svyas@wakehealth.edu|
21247243|NCT01220531|Sumitomo Pharma America, Inc.|Director Clinical Operations|+1 (508) 481-6700|ravi.grewal@us.sumitomo-pharma.com|
21247244|NCT05047952|Brain and Cognition Discovery Foundation|Dr. Roger S. McIntyre|416-669-5279|roger.mcintyre@bcdf.org|
21247245|NCT01607853|Leo Pharma A/S|Clinical Trial Disclosure Manager|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com|
21247246|NCT05866926|Ferrer|Clinical Operations Head|649442389|nalbareda@ferrer.com|
21247247|NCT00709956|Actelion|Laila Rouault, M.D.|+ 41 61 565 8128|laila.rouault@actelion.com|
21247248|NCT01105091|Actelion Pharmaceuticals, US|Wade Benton, PharmD, Director of Medical Affairs|650-808-6562|wade.benton@actelion.com|
21247249|NCT04079517|Karolinska Institutet|Per Hall|+4670750 2110|per.hall@ki.se|
21247250|NCT02206828|Medtronic|Djamila Bennat|33474089000|djamila.bennat@medtronic.com|1591
21247251|NCT05672017|Bournemouth University|Dr Katherine Appleton|01202965985|k.appleton@bournemouth.ac.uk|
21247252|NCT05362474|University of Colorado Denver|Jessica Kendrick|303-724-4837|jessica.kendrick@cuanschutz.edu|
21247253|NCT04039113|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21280886|NCT03335475|Nationwide Children's Hospital|Jamie Jackson, Ph.D.|614-722-3585|jamie.jackson2@nationwidechildrens.org|
21247254|NCT00353496|Ipsen|Medical Director Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21247255|NCT00945724|International Extranodal Lymphoma Study Group (IELSG)|Scientific and Medical Director|+41 58 666|ielsg@ior.usi.ch|7321
21247256|NCT05550636|Boehringer Ingelheim, Call Centre|Boehringer Ingelheim|18002430127|clintriage.rdg@boehringer-ingelheim.com|
21247257|NCT02502266|NRG Oncology|Christopher Purdy on behalf of Austin Miller, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
21247258|NCT02719574|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21247259|NCT03027128|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
21247260|NCT00113360|UT M. D. Anderson Cancer Center|James Yao, M.D./Associate Professor|713-792-2828|CR_Study_Registration@mdanderson.org|
21247261|NCT00124735|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21280887|NCT04886596|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21280888|NCT02411656|The University of Texas MD Anderson Cancer Center|Bora Lim, MD|(713) 745-0689|blim@mdanderson.org|
21280889|NCT03305848|Regions Hospital|Benjamin A Willenbring, MD|651-254-3563|benjamin.a.willenbring@healthpartners.com|
21280890|NCT01949662|UT MD Anderson Cancer Center|David Hui, MD/ Associate Professor, Palliative Care Medicine|713-792-6258|dhui@mdanderson.org|
21280891|NCT02291237|Gilead Sciences|Clinical Trial Disclosures & Data Transparency|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21280892|NCT03207386|University of Nebraska Lincoln|Dr. Katie Edwards|6034223207|katie.edwards@unl.edu|
21280893|NCT03326193|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21280894|NCT02845700|Florida State University|Dr. Wen Li|850-645-1409|wenli@neuro.fsu.edu|
21280895|NCT01478373|Novartis Pharmaceuticals|Study Director|862-778-8300||
21280896|NCT01199380|University of Maryland|Laura MacPherson|6198578425|lauramac.phd@gmail.com|
21280897|NCT01408043|Case Comprehensive Cancer Center|Navneet Majhail|216-444-2199|majhain@ccf.org|
21280898|NCT02552121|Genmab A/S|Genmab|7020 2728|clinicaltrials@genmab.com|+45
21247262|NCT00630487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21247263|NCT01976936|Columbia University|Mitchell S.V. Elkind, MD, MS, MPhil|212-305-1710|mse13@cumc.columbia.edu|
21247264|NCT04726410|University of Pittsburgh|Jason Sperry|4128028270|sperryjl@upmc.edu|
21247265|NCT02945800|Moffitt Cancer Center|Jonathan Metts, MD|813-745-5616|Jonathan.Metts@moffitt.org|
21247266|NCT02231749|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
21247267|NCT05377411|University of Florida|Dr. Aprinda Queen|(352) 294-8990|aprinda.indahlas@phhp.ufl.edu|
21247268|NCT06139302|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21247269|NCT05394844|uwashington|Dr nicole ehrhardt|2404479566|nehrhard@uw.edu|
21247270|NCT02989662|Johns Hopkins University School of Medicine|Mary E McCaul, Ph.D.|4437225728|mmccaul1@jhmi.edu|
21247271|NCT00328783|Thomas Jefferson University|Rani Anne, MD|215-955-6045|Rani.Anne@jeffersonhospital.org|
21247272|NCT00357682|NICE|Prof Janusz A Z Jankowski|07968 479355|prof.jankowski@outlook.com|
21247273|NCT04276779|University of Alabama at Birmingham|Dr. Caitlin Clevenger|205-934-7008|cwclev@uab.edu|
21247274|NCT02823327|Statistical and Data Analysis Center, AIDS Malignancy Consortium|Deukwoo Kwon|(713) 500-7964|deukwoo.kwon@mountsinai.org|
21247275|NCT04712903|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21247276|NCT05424718|Columbia University|Rebecca Schnall, PhD, MPH, RN-BC, FAAN, FACMI|212-342-6886|rb897@columbia.edu|
21247277|NCT04046549|Horizon Therapeutics USA, Inc.|Todd Wilson, DO|866-479-6742|clinicaltrials@horizontherapeutics.com|
21247278|NCT06059443|Columbia University School of Nursing|Dr. Rebecca Schnall|212-342-6886|rb897@cumc.columbia.edu|
21247279|NCT04319887|Saluda Medical|Angela Leitner|651-208-4223|angela.leitner@saludamedical.com|
21247280|NCT04549792|Northwestern University|Principal Investigator|312-503-5944|NUderm-research@northwestern.edu|
21247281|NCT03696433|Vanderbilt University Medical Center|Cassandra Reynolds, BS, CCRC|615-875-9854|cassandra.f.reynolds@vumc.org|
21247282|NCT04479787|Abbott|Devyani Nanduri, Sr. Director, Clinical and Regulatory Affairs|+16698329450|Udoka.okaro@abbott.com|
21247283|NCT00575016|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21247284|NCT01864538|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilso2112@gmail.com|
21247285|NCT06003075|University of Kentucky|Dr. Ralph Zinner|859-562-2864|ralph.zinner@uky.edu|
21247286|NCT03983382|Memorial Sloan Kettering Cancer Center|Dr. Anthony Yu, MD|212-639-5154|yua3@mskcc.org|
21247287|NCT03694262|Medical College of Wisconsin|William Bradley, MD|414-805-6606|wbradley@mcw.edu|
21247288|NCT02348632|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-970-7145|ClinicalTrialDisclosure@JazzPharma.com|
21247289|NCT02757898|Emory University|Dr. John Roback|404-712-1774|jroback@emory.edu|
21247290|NCT03744559|Medical University of South Carolina|Dr Michael Saladin|(843) 792-5306|saladinm@musc.edu|
21247291|NCT02166463|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21247292|NCT00982644|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21247293|NCT03767335|Menarini Ricerche S.p.A.|Clinical Sciences|+39 05556809990|martine.piccart@bordet.be|
21247294|NCT03660930|University of Washington|Lee Cranmer, MD, PhD|206-606-7439|ldcranme@fredhutch.org|
21247295|NCT04098276|Johns Hopkins University|Bushra Sabri|+1 (410) 955-7105|bsabri1@jhu.edu|
21247296|NCT02726386|NeuroDerm Ltd.|Laurence Salin, MD, Senior Medical Director|+33687548073|laurence@neuroderm.com|
21247297|NCT04955431|University of Montana|Dr. John Quindry|406-243-4268|john.quindry@mso.umt.edu|
21247298|NCT06415045|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|001
21247299|NCT02112916|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21247300|NCT06995755|Pro-Change Behavior Systems, Inc.|Sara Johnson, PhD|401.360.2980|sjohnson@prochange.com|
21247301|NCT03333915|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21247302|NCT03601897|Deciphera Pharmaceuticals, LLC|Clinical Trials|785-830-2100|clinicaltrials@deciphera.com|
21247303|NCT03598998|City of Hope Medical Center|Dr. Alex Herrera|6263598111|aherrera@coh.org|
21247304|NCT02831283|Columbia University|Patrick Lao|2123421351|PJL2133@CUMC.COLUMBIA.EDU|
21247305|NCT04174560|Cincinnati Children's Hospital|Robert Frenck, Jr., MD|513-636-4463|Robert.Frenck@cchmc.org|
21247306|NCT04591080|University at Buffalo|Thikriat Al-Jewair, Program Director|17168296190|thikriat@buffalo.edu|
21247307|NCT04940624|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21247308|NCT06637774|University of Pittsburgh|James Coyle|4123836608|jcoyle@pitt.edu|
21247309|NCT05648890|Thomas Bata Hospital, Zlin, Czech Republic|Dr. Klára Nekvindová|+420 577 552 280|klara.nekvindova@bnzlin.cz|
21247310|NCT02890355|SWOG Statistical Center|SWOG Statistician|2066674623|mduong@fredhutch.org|
21247311|NCT02379351|University of Utah, Department of Obstetrics & Gynecology|Dr. Erin Clark|801-5818425|erin.clark@hsc.utah.edu|
21247312|NCT02180867|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21247313|NCT05787054|Catholic University of the Sacred Heart, Fondazione Policlinico Gemelli|Dr Alessandra Familiari|+393285887422|alessandra.familiari@policlinicogemelli.it|
21247314|NCT00994643|Thomas Jefferson University|Dr. Matthew Carabasi|215-955-8874|matthew.carabasi@jefferson.edu|
21247315|NCT03653364|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21247316|NCT05595213|BUCA School of Medicine, Endocrinology|Michael F Holick, PhD MD|(617) 358-6139|mfholick@bu.edu|
21247317|NCT02306161|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21247318|NCT00410423|Thomas Jefferson University|Joanne Filicko-O'Hara, MD|215-955-8874|Joanne.Filicko@jefferson.edu|
21247319|NCT03705390|CRCTU, University of Birmingham|D3B Trial Mangement Team Leader|+44 (0) 121 371 8027|ALS@trials.bham.ac.uk|
21262540|NCT02421120|Hartford Hospital|Dr. Joseph L. Kuti, PharmD|860-972-3612|joseph.kuti@hhchealth.org|
21262541|NCT04179968|UT Southwestern Medical Center|Kelli Key, Ph.D.|214-648-8152|Kelli.Key@UTSouthwestern.edu|
21262542|NCT00273858|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21262543|NCT02045277|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
21262544|NCT02440178|seoul national university|Pf. Youngil Koh|82-2-2072-7217|go01@snu.ac.kr|
21262545|NCT01070550|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21262546|NCT00305006|Teachers College, Columbia University|Dr. Andrew Gordon|212-678-3326|ag275@columbia.edu|
21262547|NCT04964063|HALEON|Haleon Response Center|+447880182593|ww.clinical-trial-register@haleon.com|
21262548|NCT01084499|Asan Medical Center|Principal Investigator||mdlhs@amc.seoul.kr|
21262549|NCT01849848|SymBio Pharmaceuticals|Toshihiko Nagase|+81-3-5472-1127||
21262550|NCT01702363|GlaxoSmithKline|GSK Response Center|866-435-7343||
21236251|NCT01337245|University of Arizona|Senior Regulatory Coordinator|520-621-6417|regulatory@arizona.edu|
21262551|NCT01312428|Stryker Orthopedics|Director of Clinical Research|201-831-5401|ellen.axelson@stryker.com|
21262552|NCT04929262|Temple University|Margaret Crane|‭(215) 204-7165‬|margaret.crane@temple.edu|
21262553|NCT01387295|Herlev University Hospital|Dr Dorte Nielsen|+45 38682344|dorte.nielsen.01@regionh.dk|
21262554|NCT00816907|Columbia University|Dr. Scott Stroup|212-543-5676|stroups@nyspi.columbia.edu|
21262555|NCT00793819|Watson Pharmaceuticals|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com|
21262556|NCT01351766|University of Maryland|Laura MacPherson|6198578425|lauramac.phd@gmail.com|
21262557|NCT01488318|University of Pittsburgh Cancer Institute|Barbara Stadterman, Regulatory Supervisor|414-647-5554|stadtermanbm@upmc.edu|
21262558|NCT00733356|University of California Irvine Child Development Center|Kinberley Lakes|949-824-3009|klakes@uci.edu|
21262559|NCT03036592|University of Murcia|Prof. Marta Garaulet Aza|868884030|garaulet@um.es|
21262560|NCT05100199|AbbVie|ABBVIE CALL CENTER|844-663-3742|abbvieclinicaltrials@abbvie.com|
21262561|NCT02853331|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21262562|NCT01455428|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21262563|NCT03425799|Exela Pharma Sciences|Aruna Koganti, VP Clinical Programs|828-758-5474|akoganti@exela.us|
21262564|NCT01747330|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
21262565|NCT00257192|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21262566|NCT04004507|Ophthalmic Consultants Of Long Island|Dr. Marguerite McDonald|7342501718|margueritemcdmd@aol.com|
21262567|NCT02062151|USF Pediatrics|Laura Weathers|813/844-3046|lweathers@health.usf.edu|
21262568|NCT00693719|University of Arizona Cancer Center|Dr. Robert Livingston|520/626-4175|rlivingston@azcc.arizona.edu|
21262569|NCT01161524|Eisai Inc.|Eisai Call Center|888-422-4743||
21262570|NCT04946344|Wake Forest University|Dr. Stephen Messier|336-758-3969|messier@wfu.edu|
21262571|NCT01618656|Yale University School of Medicine|Deepak Cyril D'Souza, MD|203-932-5711|deepak.dsouza@yale.edu|2594
21262572|NCT01899144|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21262573|NCT00492401|The Ohio State University Comprehensive Cancer Center|William Blum, MD|614-293-9273|William.Blum@osumc.edu|
21262574|NCT02119104|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21262575|NCT02222129|USAF|Richard Knight, MD|+44 1638 528186|richard_b_knight@yahoo.com|
21262576|NCT00081289|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
21262577|NCT03419533|The University of Adelaide|Prof. Helen Marshall|8161 8115|helen.marshall@adelaide.edu.au|
21262578|NCT01952015|Novartis Pharmaceuticals|Study Director|862-778-8300||
21262579|NCT02239094|Depression Evaluation Service (New York State Psychiatric Institute)|David J. Hellerstein|646-774-8069|david.hellerstein@nyspi.columbia.edu|
21262580|NCT01797029|PATH|Senior Clinical Research Scientist|206-285-3500|klewis@path.org|
21262581|NCT02508701|Purdue University|Stewart Chang Alexander|765-427-9860|alexan90@purdue.edu|
21262582|NCT00317941|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21262583|NCT01863563|Children's Hospital of the Kings Daughters|Craig Derkay, MD|757.668. 9327|Craig.Derkay@chkd.org|
21262584|NCT00530712|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
21262585|NCT00734409|Duke University Health System|DaiWai M Olson, PhD RN|(919) 668-3751|Olson006@mc.duke.edu|
21262586|NCT03242759|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21262587|NCT01095250|Novartis Pharmaceuticals|Study Director|862-778-8300||
21262588|NCT01000064|Vanderbilt University Medical Center|Dr. Michael G. Tramontana|615-327-7144|Michael.Tramontana@Vanderbilt.Edu|
21262589|NCT02518620|Ablynx NV|Medical Monitor|+32 (0)9 262 00 00|clinicaltrials@ablynx.com|
21262590|NCT00798967|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21262591|NCT00978445|Cleveland Clinic Foundation|Dr. Heather Gornik|216-445-3689|gornikh@ccf.org|
21262592|NCT01377467|University Hospital Zürich|Prof. Rudolf P. Wüthrich|+41 44 255 33 84|rudolf.wuethrich@usz.ch|
21262593|NCT01415440|NYSPI|Jonathan Posner, MD|6467745735|jonathan.posner@nyspi.columbia.edu|
21280899|NCT01522456|Galderma Laboratories, L.P.|Elizabeth M. Nieman, Associate Medical Information Specialist|817-961-5130|elizabeth.nieman@galderma.com|
21280900|NCT04052620|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
21280901|NCT01406574|Otsuka Pharmaceutical Co., Ltd|"Leader of Department of Small Global Clinical Development"|+81-3-6361-7366||
21280902|NCT01500473|Children's Hospital Los Angeles|Thomas Keens|3233612101|tkeens@chla.usc.edu|
21262594|NCT01593748|MUSC|Cameron Coggins|843-792-4743|cogginca@musc.edu|
21280903|NCT02201784|Jawaharlal Nehru Medical College, AMU, Aligarh, India|Dr. Manazir Athar|+918868056469|drmanazirathar@gmail.com|
21294852|NCT02825420|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|0034 91846 60 00|clinicaltrials@pharmamar.com|
21294853|NCT03020017|Northwestern University|Priya Kumthekar|312 908 5073|p-kumthekar@northwestern.edu|
21294854|NCT00496483|Veloxis A/S|Christina Sylvest, Sr VP, Global Clinical Development and Operations|+45 20553877|csy@veloxis.com|
21294855|NCT03571672|Lantheus Medical Imaging, Inc|Istvan Molnar|978-671-8686|istvan.molnar@lantheus.com|
21294856|NCT04258995|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294857|NCT04580277|Cedars Sinai Inflammatory Bowel Disease Center|Dr. Gil Y. Melmed|310-423-4100|gil.melmed@cshs.org|
21294858|NCT00450294|Department of Anesthesia|Dr. Amit Chopra|204-880-5370|amitchopra1@live.com|
21294859|NCT01962987|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
21294860|NCT01967823|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|sar@mail.nih.gov|
21294861|NCT00316693|GlaxoSmithKline|GSK Response Center|866-435-7343||
21294862|NCT01559922|Suneva Medical, Inc.|Suneva Medical,Inc.||Acne.ScarInfo@sunevamedical.com|
21294863|NCT03245736|Genmab A/S|Clinical Trial Information|70202728|clinicaltrials@genmab.com|
21294864|NCT01116024|Medtronic, Inc.|Ryan Palmer, Principal Clinical Research Specialist|763-514-9732|ryan.j.palmer@medtronic.com|49732
21294865|NCT01739933|Vanderbilt University Medical Center|Dr. Pratik Pandharipande, Vice Chair Faculty Affairs, PI|6153436268|pratik.pandharipande@vumc.org|
21294866|NCT01366612|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
21294867|NCT00416715|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
21294868|NCT03879044|The Ohio State University Wexner Medical Center|Dr. Ulysses Magalang|614-292- 4307|Ulysses.Magalang@osumc.edu|
21294869|NCT01106859|Purdue Pharma LP|Clinical Leader|800-733-1333||
21294870|NCT04028765|Thomas Jefferson University Health System|Dr. Whitney Bender|4342948416|whitney.bender@jefferson.edu|
21294871|NCT04857437|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294872|NCT03224507|University of Alabama at Birmingham|Luciano J Costa- Principal Investigator|2059349695|ljcosta@uabmc.edu|
21294873|NCT01007435|Hoffmann-La Roche|Medical Communications|800 821-8590||
21294874|NCT01032291|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21294875|NCT02576535|NYU Langone Medical Center|Paul Huang|212-263-6414|Paul.Huang@nyumc.org|
21247320|NCT03047213|Yale School of Medicine: Medical Oncology|Joseph Kim, MD, Associate Professor of Internal Medicine|(203) 200-4822|joseph.w.kim@yale.edu|
21294876|NCT00347438|University of Chicago Medical Center|Dr. Funmi Olopade|773-702-1632|folopade@medicine.bsd.uchicago.edu|
21294877|NCT02545517|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21294878|NCT01529515|Janssen Research & Development, LLC|Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
21294879|NCT01706497|University Hospitals Leuven (UZ Leuven) and KU Leuven|Prof Dr Geert Meyfroidt, Associate Professor|0032 16 344021|geert.meyfroidt@uzleuven.be|
21294880|NCT03334851|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294881|NCT03327220|Pacira CryoTech, Inc.|Kent Jones/ Sr. Director, Quality and Medical Affairs|510-933-1513|kent.jones@pacira.com|
21294882|NCT00523705|University of Pennsylvania|Ellen Freeman, Principal Investigator|215 662-3329|freemane@mail.med.upenn.edu|
21294883|NCT00693017|Eisai Inc|Antonio Laurenza, MD, Executive Director|1 201 949-4157|antonio_laurenza@eisai.com|
21294884|NCT00504504|University of Texas (UT) MD Anderson Cancer|Anas Younes, MD / Professor||CR_Study_Registration@mdanderson.org|
21294885|NCT01691885|GlaxoSmithKline|GSK Response Center|866-435-7343||
21294886|NCT00615589|University of Michigan Comprehensive Cancer Center|Dr. Attaphol Pawarode, M.D.|734-936-8785|pawarode@umich.edu|
21247321|NCT05988957|HealthPartners Institute|Holly Willis|952-993-3219|holly.willis@parknicollet.com|
21247322|NCT03725332|University of Kentucky|Wendy Hansen, MD|859-218-0765|wendy.hansen@uky.edu|
21247323|NCT04599296|University of Washington|Dr. Mia Hagen, Associate Professor|206-598-3404|smia@uw.edu|
21247324|NCT03242915|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
21247325|NCT02754596|Glaukos|Study Manager|949-481-8076|ldoan@glaukos.com|
21247326|NCT03872466|Barron Associates, Inc.|Richard Adams|4348253435|adams@bainet.com|
21247327|NCT01778686|Rigshospitalet and University of Copenhagen|Gitte Moos Knudsen|+4535456720|gmk@nru.dk|
21247328|NCT04012567|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
21247329|NCT00391443|Actelion Pharmaceuticals Ltd|Isabelle Leconte,PhD -Data Science Group Leader, Director|+41 61 565 64 18|isabelle.leconte@actelion.com|
21247330|NCT03782116|Elidah, Inc.|Director of Clinical Trials|978.435.4324|customercare@elitone.com|
21247331|NCT02586974|Città della Salute e della Scienza di Torino - Ospedale Molinette|Dr. Marco Oderda|+393479383465|marco.oderda@libero.it|
21247332|NCT05714059|Medtronic Diabetes|DZ Dai, Sr Statistician|8185764034|dz.dai@medtronic.com|
21247333|NCT04899674|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21247334|NCT04129450|Boston Medical Center|Natalia Morone, MD, MS|617-414-6652|natalia.morone@bmc.org|
21247335|NCT03485287|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
21247336|NCT05039021|Ethicon Endo-Surgery, Inc.|Senior Director Medical Affair-Endomechanical and Trx|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21247337|NCT02566889|Janssen Scientific Affairs|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21247338|NCT02377700|Xeltis|Eliane Schutte, CEO|+31 40 751 7614|clinical@xeltis.com|
21247339|NCT04974047|BeiGene|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
21247340|NCT00655499|GERCOR|Regulatory affairs|00331 40 29 85 00|Regulatory.Affairs@gercor.com.fr|
21247341|NCT03391466|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
21262595|NCT00336492|Johnson & Johnson Pharmaceutical Research and Development|Senior Director, Clinical Research|610-240-8092||
21262596|NCT01354691|Bar Ilan University|Jonathan Rabinowitz, PhD||jonathan.rabinowitz@biu.ac.il|
21262597|NCT01781026|Yale University|Harriet Kluger||Harriet.Kluger@yale.edu|
21262598|NCT03141307|University of Utah|Dr. Bob Wong|801-587-9666|bob.wong@nurs.utah.edu|
21262599|NCT03090737|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
21262600|NCT00227877|Boston Children's Hospital - Center for Adolescent Substance Use and Addiction Research|Sion Kim Harris, PhD|857-218-4304|sion.harris@childrens.harvard.edu|
21262601|NCT02517047|Boston Children's Hospital|Dr. Wanda Phipatanakul|6173556117|wanda.phipatanakul@childrens.harvard.edu|
21262602|NCT01452425|UCLouvain|Pr Patrice Forget|3227641821|forgetpatrice@yahoo.fr|
21262603|NCT03458000|George Washington University|Dr. Andrew Meltzer|202-741-2952|ameltzer@mfa.gwu.edu|
21262604|NCT03596177|MedImmune, LLC|Victoria Parker|+44 747 1357172|information.center@astrazeneca.com|
21262605|NCT01301742|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21262606|NCT02522481|Bracco Diagnostics Inc.|Melda S. Dolan, MD, FACC, FASE, Head, Medical Affairs and Cardiac Ultrasound|1-609-514-2506|Melda.Dolan@diag.bracco.com|
21262607|NCT04400318|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21262608|NCT00165646|Eisai Co.,Ltd. Eisai Product Creation Systems|Nobuyuki Sugisaki, Study Director|+81-3-3817-3908|n-sugisaki@hhc.eisai.co.jp|
21262609|NCT01790438|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21262610|NCT00950612|GlaxoSmithKline|GSK Response Center|866-435-7343||
21262611|NCT02433210|University of Missouri, Department of Medicine, Division of Nephrology|Dr. Madhukar Misra, MD|573 882-7993|misram@health.missouri.edu|
21262612|NCT04907539|Redx Pharma Limited|Craig Tilston|+44 (0)7787 983 638|c.tilston@redxpharma.com|
21262613|NCT01701583|University of Colorado|Jenny Stitt|303-724-7205|jenny.stitt@ucdenver.edu|
21262614|NCT05070429|University of North Carolina, Chapel Hill|Lisa Gravens-Mueller, Biostatistician/Supervisor|919-962-3098|lgravens@email.unc.edu|
21262615|NCT02311478|University of Utah|Dr. Dave Turok|8015818160|david.turok@hsc.utah.edu|
21262616|NCT03276936|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
21262617|NCT03041116|Retrophin, Inc.|Clinical Trial Information Desk|+1-877-659-5518|medinfo@retrophin.com|
21262618|NCT00943319|UChicago|Dr. Andrew Artz|773-834-8980|aartz@medicine.bsd.uchicago.edu|
21262619|NCT02043301|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21262620|NCT01798134|Boston Scientific Corporation|Senior Clinical Program Manager|763-494-2172|hansenj2@bsci.com|
21262621|NCT02653976|Solasia Pharma K.K.|Clinical Development Department|+81358438045|clinicaldev@solasia.co.jp|
21262622|NCT02023164|TerSera Therapeutics LLC|Executive Director, Clinical Development|888 600 8116|jnorth@tersera.com|
21262623|NCT02436577|AstraZeneca AB|Brilinta Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
21262624|NCT03703375|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|855-907-3286|Clinical.Trials@bms.com|
21262625|NCT01675011|Boston Scientific|Anastasia Becker - Director of Clinical Trials|763-494-2170|Ana.Becker@bsci.com|
21280904|NCT00946920|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21247342|NCT03140670|Abramson Cancer Center|Pancreas Research Program Manager|2672575567|mazali@pennmedicine.upenn.edu|
21247343|NCT00220805|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
21247344|NCT02325466|Icahn School of Medicine at Mount Sinai|Dr. Robert S. Rosenson|212-241-9101|robert.rosenson@mssm.edu|
21247345|NCT03699163|Imperial College London|Professor George Hanna|02033122124|g.hanna@imperial.ac.uk|
21247346|NCT01596972|Planned Parenthood League of Massachusetts|Director of Clinical Research and Training|617.616.1600|agoldberg@pplm.org|
21247347|NCT00176800|University of Michigan Comprehensive Cancer Center|Dr. Susan Urba, M.D.|734-615-4762|surba@umich.edu|
21247348|NCT01964300|Pediatric Brain Tumor Consortium|Catherine Billups|901-595-3709|catherine.billups@stjude.org|
21247349|NCT00557492|UPMC CancerCenter|Herbert Zeh, MD|4126922852|zehxhx@upmc.edu|
21247350|NCT02524769|Loyola University Chicago|Dr. Elizabeth Mueller|708-216-2180|EMUELLE@lumc.edu|
21247351|NCT04129164|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21247352|NCT05186740|ProVerum|"Vice President, Clinical Affairs |"|"+1-720-472-1504|"|diane@proverummedical.com|
21247353|NCT00195403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21247354|NCT05288348|University of Pittsburgh|Francis X Guyette|412 651 1077|guyettef@upmc.edu|
21247355|NCT03053960|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Lionel Gold|215-955-6215|Lionel.Gold@jefferson.edu|
21247356|NCT01260896|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21247357|NCT01925144|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21247358|NCT00909649|Mansoura university hospital|Elnakeeb Ayman|0106752021|elnakeebayman@yahoo.com|
21247359|NCT01318694|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
21247360|NCT03820544|Sidney Kimmel Cancer Center at Thomas Jefferson University|Thomas Kowalski, MD|215-955-9396|Thomas.Kowalski@jefferson.edu|
21247361|NCT00003222|University of Virginia|Craig L. Slingluff, MD|434-924-1730|CLS8H@hscmail.mcc.virginia.edu|
21247362|NCT05030584|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21247363|NCT01380743|Patient Advocacy|Amicus Therapeutics|+1-609-662-2000|clinicaltrials@amicusrx.com|
21247364|NCT05858905|Shockwave Medical|Josh Popp|1-510-279-4262|jpopp@shockwavemedical.com|
21247365|NCT02224729|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Joanne Filicko, O'Hara|215-955-8874|joanne.filicko@jeffersron.edu|
21247366|NCT01313559|Thomas Jefferson University|Jianqing Lin, MD|215-955-8874|Jianqing.Lin@jefferson.edu|
21247367|NCT06393127|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21294887|NCT00688324|Maryland Psychiatric Research Center|Robert W. Buchanan, M.D.|410-402-7876|rwbuchanan@som.umaryland.edu|
21247368|NCT02446600|NRG Oncology|Linda Gedeon for Austin Miller, PhD.|716-845-1169|Linda.Gedeon@roswellpark.org|
21247369|NCT03228719|University of Delaware|Daniel K. White|3028317607|dkw@udel.edu|
21247370|NCT02466971|NRG Oncology|Christopher Purdy on behalf of Wei Deng, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
21247371|NCT02101853|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21247372|NCT02752685|NYU Langone Health|Sylvia Adams, MD|212-731-5795|Sylvia.Adams@nyulangone.org|
21247373|NCT05707351|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21247374|NCT01996436|The University of Texas Health Science Center at Houston|Peng Roc Chen, MD|713-486-8016|Peng.R.Chen@uth.tmc.edu|
21247375|NCT05856266|Biovitrum|CPL|0795914760|rolf.schlosshauer@sobi.com|
21247376|NCT04261790|Johns Hopkins Universtiy|Bardia Nourbakhsh|410-614-1522|bnourba1@jhmi.edu|
21247377|NCT05934292|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21247378|NCT05545280|Cleveland Clinic Foundation|Kurt Ruetzler, MD|216 636-0561|RUETZLK@ccf.org|
21247379|NCT05517902|Mallinckrodt|Medical Information Call Center|1-800-844-2830|medinfo@mnk.com|
21247380|NCT02454283|Laguna Pharmaceuticals|Chief Medical Officer|858-405-1429|hdittrich@imager.com|
21247381|NCT01639131|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University|Nilofer Azad, MD|410-614-9169|nazad2@jhmi.edu|
21247382|NCT01637402|University of California, San Francisco|Dr. Terry Friedlander, MD|415-514-6380|Terence.Friedlander@ucsf.edu|
21247383|NCT02285270|University of Pennsylvania|Daniel Pryma|215-349-5272|daniel.pryma@uphs.upenn.edu|
21247384|NCT00439270|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21247385|NCT01268306|Arthur B. Epstein, OD|Dr. Arthur Epstein|424-226-2020|artepstein@yahoo.com|
21247386|NCT04334317|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
21247387|NCT04098575|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21247388|NCT01149759|Rockefeller University|Emma Guttman Yassky, MD|212-327-8333|skhattri@rockefeller.edu|
21247389|NCT04121546|Indiana University School of Medicine|Dr. Michael Bushey|3179637300|mabushey@iu.edu|
21247390|NCT06065501|National Cheng Kung University|Professor Miaofen Yen / Professor of Nursing department|886-6-2353535|miaofen@mail.ncku.edu.tw|5823
21247391|NCT06203990|Washington University in St. Louis|Gammon Earhart|314-286-1407|earhartg@wustl.edu|
21247392|NCT03286114|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
21247393|NCT02956642|University of California San Francisco|Dr. Jenise Wong|415-476-3316|jenise.wong@ucsf.edu|
21247394|NCT01209195|Merrimack Pharmaceuticals, Inc.|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
21247395|NCT00943917|Intarcia Therapeutics, Inc|Michelle Baron MD|510-782-7800|clinicaltrials@intarcia.com|
21247396|NCT01171976|Novartis Pharmaceuticals|Study Director|862-778-8300||
21247397|NCT03248492|Daiichi Sankyo|Contact for Clinical Trial Information|1-908-992-6400|CTRinfo_us@daiichisankyo.com|
21247398|NCT04612244|BSC|Allison Anderson|651-582-5077|allison.anderson@bsci.com|
21247399|NCT04495621|Menarini Ricerche S.p.A.|Clinical Sciences|+39 0555680|martine.piccart@bordet.be|9990
21247400|NCT03260569|University of Cincinnati|Michael Goodman|5135585661|michael.goodman@uc.edu|
21247401|NCT04227600|JCR Pharmaceuticals|Study Director|+81 797 32 8582|clinical_development@jp.jcrpharm.com|
21247402|NCT04908514|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
21247403|NCT03774472|M D Anderson Cancer Center|Debasish Tripathy|713-794-4385|dtripathy@mdanderson.org|
21247404|NCT05495945|University of Michigan|Zirui Huang|(734) 615-2875|huangzu@med.umich.edu|
21247405|NCT05155306|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21247406|NCT03150862|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21247407|NCT04158141|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21247408|NCT03850899|Indiana University School of Medicine|Samer Gawrieh|(317) 278-9326|sgawrieh@iu.edu|
21247409|NCT04121741|Medical College of WI|Principal Investigator: Jacquelyn P Kulinski|414-955-6896|jakulinski@mcw.edu|
21247410|NCT01084863|Celltrion|Head of Clinical Planning Department|82328505000|contact@celltrion.com|
21247411|NCT04056910|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
21247412|NCT04505722|Janssen R&D US|SENIOR ADVISOR CLINICAL DEVELOPMENT|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21247413|NCT03473223|CSL Behring|Study Director|+1 610-878-4000|clinicaltrials@cslbehring.com|
21247414|NCT04755595|SUNY Downstate Health Sciences University|Jared Jagdeo MD, MS|(718) 270-1229|jared.jagdeo@downstate.edu|
21247415|NCT00319696|Actelion Pharmaceuticals Ltd|Andjela Kusic-Pajic, MD/Clinical Project Team Leader|+41 61 565 64 17||
21247416|NCT01513122|The Kirby Institute|Prof Sean Emery|+61293850900|semery@kirby.unsw.edu.au|
21247417|NCT04530487|M D Anderson Cancer Center|Jeremy S Connors, MD|(713) 792-6624|jsconnors@mdanderson.org|
21247418|NCT00210106|Digestive Tumours Unit, Institut Bergonie|Pr Serge Evrard|s.evrard@brdeaux.unicancer.fr||
21247419|NCT00825344|Johns Hopkins|Dr. Steven P. Cohen|410-955-1818|scohen40@jhmi.edu|
21247420|NCT01288443|Sanofi|Trial Transparency Team||Contact --US@sanofi.com|
21247421|NCT00351299|BrighamHospital|Dr. Gerald Weinhouse|617-732-5499|gweinhouse@partners.org|
21247422|NCT04876417|University of Iowa|Thorsten Rudroff, PhD, Associate Professor|(319) 467-0363|thorsten-rudroff@uiowa.edu|
21247423|NCT02111096|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21262626|NCT00615290|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21247424|NCT01143142|University of Colorado|Amanda Dempsey|303-724-6679|amanda.dempsey@ucdenver.edu|
21247425|NCT05274321|University of California, San Francisco|Julius Oatts, MD|(415) 353-2800|Julius.Oatts@ucsf.edu|
21247426|NCT03875313|Calithera Biosciences, Inc|Study Director|650-870-1000|clinicaltrials@calithera.com|
21280905|NCT00193050|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSarah@scresearch.net|
21280906|NCT00473590|Hoffman-LaRoche|Medical Communications|800-821-8590||
21247428|NCT03213457|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21247429|NCT02951052|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21247430|NCT03875001|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21280907|NCT04778475|Medical University of South Carolina|Sinead Farrelly DPT|843-792-3069|farrelsi@musc.edu|
21280908|NCT01245283|UF&Shands Orthopaedics and Sports Medicine Institute|Kevin R. Vincent, M.D. Ph.D.|352-273-7458|vincekr@ortho.ufl.edu|
21294888|NCT00746239|Penn State Hershey Medical Center|Ravi Singareddy|717-531-0040|rsingare@gmail.com|
21247431|NCT04018495|Medical College of Wisconsin|Rose Franco, MD|414-955-7040|rfranco@mcw.edu|
21280909|NCT02153983|NICHD, National Institutes of Health|Dr. Jack Yanovski|13014960858|yanovskj@mail.nih.gov|
21247432|NCT02879318|Canadian Cancer Trials Group|Chris O'Callaghan|6135336430|cocallaghan@ctg.queensu.ca|
21247433|NCT02382003|University of Virginia Department of Psychology|Dr. Bethany Teachman|434-924-0676|bethanyteachman@gmail.com|
21280910|NCT00395161|University of Utah|Jeri Burr, MS, RN-BC, CCRC|801-587-7753|jeri.burr@hsc.utah.edu|
21280911|NCT01610492|GlaxoSmithKline|GSK Response Center|866-435-7343||
21247434|NCT04059406|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
21247435|NCT03857646|Stanford University|Cody Arnold|(650) 723-8772|codya@stanford.edu|
21247436|NCT03593356|University of California, Irvine|Greg John Duncan|(949) 824-7831|gduncan@uci.edu|
21280912|NCT03093259|Abivax|Sharon Skare|+33 (0) 1 53 83 08 41|sharon.skare@abivax.com|
21294889|NCT01562314|GW Research Ltd|Medical Enquiries||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
21294890|NCT01180036|Mayo Clinic|Dr. Fernando Fervenza|507-266-1045|fervenza.fernando@mayo.edu|
21294891|NCT01190475|Mereo BioPharma|Jacqueline Parkin|+44 333 0237300|enquiries@mereobiopharma.com|
21280913|NCT01821807|Adiyaman University Research Hospital, Department of Anesthesiology and Reanimation|Dr. Ruslan Abdullayev|+905063010833|ruslan_jnr@hotmail.com|
21280914|NCT02833337|Centro de Implantologia, Cirugia Oral y Maxilofacial|Alberto Monje|+41798836264|amonjec@umich.edu|
21280915|NCT02483676|Baltimore VA Medical Center VA Maryland Health Care System|Dr. Steven Kittner|410-706-0414|skittner@som.umaryland.edu|
21280916|NCT02490631|Vanderbilt University Medical Center|Elizabeth Card|615-875-4611|elizabeth.b.card@vumc.org|
21280917|NCT03796988|University of Miami|Hadar Lev-Tov, Assistant Professor|305-243-4472|hltevtov@med.miami.edu|
21280918|NCT03150329|City of Hope Medical Center|Dr. Alex Herrera|626-359-8111|aherrera@coh.org|
21280919|NCT04748510|Perth Hip & Knee|Dr Serene Lee, Orthopaedic Research Officer|64891720|research@hipnknee.com.au|
21280920|NCT02325973|Abbott Medical Italia|Vanoni Benedetta, Abbott Clinical Site Lead|+39340571064|benedetta.vanoni@abbott.com|
21280921|NCT01279317|Maastricht University Medical Centre|Drs. Jan-Willem van Dijk|+31(0)433881394|janwillem.vandijk@maastrichtuniversity.nl|
21280922|NCT03241862|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
21280923|NCT03874117|VA Palo Alto|Tammy Sirich|6504935000|tsirich@stanford.edu|
21280924|NCT05012098|National Cancer Institute|Dr. Charalampos Floudas|240-858-3032|charalampos.floudas@nih.gov|
21280925|NCT04815083|photonamic GmbH & Co. KG|Vice President Clinical Development & Regulatory Affairs|+49 (0)4101 78539 09|info@photonamic.de|
21280926|NCT06025721|Hennepin Healthcare Research Institute|Katherine Diaz Vickery|612-873-6852|katherine.vickery@hcmed.org|
21280927|NCT00075816|The EMMES Corporation|Adam Mendizabal|301-251-1161|amedizabal@EMMES.com|
21280928|NCT02832687|CHRISTUS St. Vincent Regional Medical Center|Dr. Michal Gajewski, DO|(505) 913-3361|Michal.Gajewski@stvin.org|
21280929|NCT04231825|University of California San Francisco|Dr. Theodore Zanto|415-502-7322|theodore.zanto@ucsf.edu|
21280930|NCT03861390|University of North Carolina at Chapel Hill|Terry Noah, MD|919-966-1055|terry_noah@med.unc.edu|
21280931|NCT00611923|Weill Cornell Medical College and Yale School of Medicine|Margaret Altemus|646-209-6277|maltemus@med.cornell.edu|
21280932|NCT03588910|Montefiore Medical Center|Dr. Kari Plewniak|718-920-5157|kplewnia@montefiore.org|
21280933|NCT00471822|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21280934|NCT03499067|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
21280935|NCT02440464|The Emmes Company|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
21294892|NCT00543803|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21247437|NCT05501548|Johns Hopkins University|Channing Paller, M.D., principal investigator|410-955-8239|cpaller1@jhmi.edu|
21247438|NCT04305327|LEO Pharma A/S|Clinical disclosure|+45 4494 5888|disclosure@leo-pharma.com|
21247439|NCT04977583|Department of Veterans Affairs|Dr. Grant Huang|(202) 443-5700|CSP@va.gov|
21247440|NCT04406272|Dana-Farber Cancer Institute|Patrick Y. Wen, MD|617-632-2166|patrick_wen@dfci.harvard.edu|
21247441|NCT00979459|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21247442|NCT01078909|The Pennsylvania State University|Dr. Penny Kris-Etherton|814-863-2923|pmk3@psu.edu|
21247443|NCT03971539|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21247444|NCT00753337|Medtronic Aortic and Peripheral Vascular|Arslan Malik - Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com|
21247445|NCT06336967|University of Pennsylvania|Dr. Heather Nuske, PI|(215) 746-6041|heather.nuske@pennmedicine.upenn.edu|
21247446|NCT00786864|University of the Witwatersrand|Gina L Fanucchi|+27 11 616 4400|gfanucs@mweb.co.za|
21247447|NCT03373916|University of Michigan|Paul Pfeiffer, MD|734-845-3645|ppfeiffe@med.umich.edu|
21247448|NCT02422615|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21247449|NCT01036724|CTI Clinical Trials and Consulting|Dr. Tina Hunter, Consulting Statistician to Biosense Webster|513-619-5541|tinah@s2stats.com|
21280936|NCT02392481|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21247450|NCT04327843|Case Western Reserve University|Kaylee Sarna|(216) 368-3577|kns17@case.edu|
21280937|NCT01299103|Chicago Center for Facial Plastic Surgery|Dr. Steven Dayan|(312) 335-2070|sdayan@drdayan.com|
21280938|NCT02961595|University of Tampere|Hanna Viskari||hanna.viskari@uta.fi|
21280939|NCT02386319|Herlev Hospital|Dr. Anders Gram-Hanssen|004526225318|anders.gram-hanssen@regionh.dk|
21247451|NCT01617369|University of North Carolina Chapel Hill|Dr. Scott Donaldson|919-966-9198|scott_donaldson@med.unc.edu|
21247452|NCT00557284|IMMUNOe International Research Centers|Dr. Isaac Melamed, principle investigator|303-773-9000|melamedi@immunoe.com|
21247453|NCT02291913|Sarah Cannon Development Innovations|Senior Director, Regulatory Science|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
21247454|NCT03709706|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21247455|NCT01105975|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21247456|NCT04868617|Coloplast A/S|Pernille Nonboe|+4549113143|dkpen@coloplast.com|
21247457|NCT02502526|Alcon, A Novartis Division|Dir Surg Instrumentation, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21247458|NCT02964741|University of Michigan|Jacqueline Dobson|734-763-8469|contacthope@umich.edu|
21247459|NCT00610558|University of California, Irvine|Dr. Lydia Su|(949) 824-4925|msu@uci.edu|
21247460|NCT01074294|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21247461|NCT00640159|Baylor College of Medicine/Houston Methodist|William G. Ondo , MD|713-363-8930|wondo@houstonmethodist.org|
21247462|NCT00112359|Gilead Sciences, Inc.|Mark Bresnik, MD, Director, Clinical Research|(650) 522-5934|mark.bresnik@gilead.com|
21247463|NCT00312208|sanofi-aventis|Medical Affairs study director||publicregistryGMA@sanofi-aventis.com|
21247464|NCT01315132|Sidney Kimmel Cancer Center at Thomas Jefferson University|Neal Flomenberg, MD|215-955-4367|Neal.Flomenberg@jefferson.edu|
21247465|NCT06199986|University of Chicago|Dr. Ted Skolarus|773 702-0881|tskolarus@bsd.uchicago.edu|
21247466|NCT00743951|University of Ottawa, Ottawa Hospital Research Institute|Dawn Stacey|613-737-8899|dstacey@uottawa.ca|73817
21247467|NCT03275285|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21247468|NCT00115934|New England Research Institutes|Lynn Sleeper, ScD|617-972-3235|lsleeper@neriscience.com|
21247469|NCT00747565|Abbott Medical Optics, Inc.|Nicholas Tarantino, O.D., Head, Global Clinical Research & Development|866-427-8477|nicholas.tarantino@amo.abbott.com|8613
21247470|NCT03777657|BeiGene|Study Director|877-828-5568|Clinicaltrials@beigene.com|
21247471|NCT06284941|Jiangyan District Hospital of traditional Chinese medicine attached to the Nanjing University of Chinese Medicine|Yang Zhang|15861013918|617405180@qq.com|
21247472|NCT06229106|Carolina Eyecare Physicians, LLC|Director of Clinical Research|8438813937|hsandoval@cepmd.com|
21247473|NCT05365997|University of Pennsylvania|Dr. Ravi Parikh|3524224285|ravi.parikh@pennmedicine.upenn.edu|
21247475|NCT00319020|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk||clinical-trials-disclosure@actelion.com|
21247476|NCT04959812|University of Texas Southwestern Medical Center|Craig Crandall|214-345-4623|CraigCrandall@texashealth.org|
21247477|NCT02549352|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
21247478|NCT04980300|University of Delaware|Daniel White|302-831-7607|dkw@udel.edu|
21247479|NCT01347255|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
21247480|NCT05709860|Northwestern University|Research Assistant Professor|312-503-0274|allison.pack@northwestern.edu|
21247481|NCT05864209|NYU Langone Health|Linda G Kahn, PhD, MPH|(917) 439-8069|linda.kahn@nyulangone.org|
21247482|NCT04207736|Aldeyra Therapeutics, Inc.|Bill Cavanagh|781-257-3063|bcavanagh@aldeyra.com|
21247483|NCT02722434|Mayo Clinic|Charles L Loprinzi MD|507/284-2511|cloprinzi@mayo.edu|
21247484|NCT04559698|Yale University School of Public Health|Dr. Zachary Soulliard|646-344-4060|zachary.soulliard@yale.edu|
21247485|NCT03437733|Biosense Webster, Inc.|Franchise Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21247486|NCT01982682|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Dolores Grosso|215-955-0182|dolores.grosso@jefferson.edu|
21247487|NCT02760654|University of Michigan School of Nursing|Robert Knoerl, Doctoral Student|734-536-9369|rjknoerl@umich.edu|
21247488|NCT00146172|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
21247489|NCT01675063|Emory University|James Blum|404-778-3482|jmblum@emory.edu|
21247490|NCT03876457|University Hospitals Cleveland Medical Center|Dr. Amrou Sarraj|(216)844-0474|Amrou.Sarraj@UHhospitals.org|
21247491|NCT02967458|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Ethan Halpern|215-955-5345|ethan.halpern@jefferson.edu|
21247492|NCT01574716|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21247493|NCT02438137|UMichigan|Tiffany Braley, M.D., M.S.|734-232-1147|tbraley@med.umich.edu|
21247494|NCT00945321|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21247495|NCT01411137|Impax Laboratories, Inc.|Michelle Landolfi, Senior Director, Regulatory Affairs|(510) 240-6496|Michelle.Landolfi@impaxlabs.com|
21247496|NCT00692913|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21247497|NCT03621735|University of Michigan|Susan Shore|734-647-2116|sushore@umich.edu|
21247498|NCT03614663|Zynerba Pharmaceuticals|Stephen O'Quinn, PharmD|919-271-1339|oquinns@Zynerba.com|
21247499|NCT00605306|Novartis Pharmaceuticals|Study Director|862-778-8300||
21247500|NCT01750684|Acorda Therapeutics, Inc.|Chief Scientific Officer|914-347-4300|acorda@acorda.com|
21247501|NCT00702884|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii-Saab|614-293-6529|Tanios.Bekaii-Saab@osumc.edu|
21247502|NCT02185794|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21247503|NCT00336505|Advanced Life Sciences|David Eiznhamer, PhD, Executive Vice President, Clinical Development|630-739-6744|deiznhamer@advancedlifesciences.com|
21262627|NCT02849990|University of Washington|Dr. Michael Schweizer|2066066252|schweize@uw.edu|
21262628|NCT01252134|Alcon Research, Ltd.|Director of Medical Affairs|888.451.3937|medinfo@alconlabs.com|
21247504|NCT01092416|Cardiovascular Systems, Inc.|Clinical Project Manager|6512591600|clinicaltrials_csi@csi360.com|
21247505|NCT00366249|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21247506|NCT00246805|Medtronic BRC - Medtronic Italia|Giorgio Corbucci - Sr Principal Scientist|+39 02 241371|giovanna.zucchi@medtronic.com|
21262629|NCT02969317|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21247507|NCT03183050|Georgetown University|Suzanne O'Neill|202-687-0869|sco4@georgetown.edu|
21262630|NCT02678741|LumaBridge|Timothy Vreeland, MD|6363465458|tvreeland@lumabridge.com|
21280940|NCT01342471|National Cancer Institute|Jeremy Steeves Ph.D.|(865)-308-3506|jeremy.steeves@nih.gov|
21280941|NCT02088177|NYSPI|Dr. Frances R. Levin||frl2@cumc.columbia.edu|
21280942|NCT00289848|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21280943|NCT04784091|Tarsus Pharmaceuticals|Mark Holdbrook, Senior Vice-President of Clinical Development|408-431-6613|mark@tarsusrx.com|
21280944|NCT00063934|UTMDACC|Francisco Esteva, MD, PHD / Professor|713-792-2817|Francisco.Esteva@nyumc.org|
21280945|NCT00395629|Novartis Pharmaceuticals|Study Director|862-778-8300||
21280946|NCT03428152|Derince Training and Research Hospital|Dr|+905336515650|handegrbz@gmail.com|
21280947|NCT01686373|University of South Carolina|Dr. Julius Fridriksson|1-803-777-5931|jfridrik@sc.edu|
21280948|NCT00754130|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21280949|NCT01836471|Novaratis Pharmaceuticals|Study Director|862-778-8300||
21280950|NCT01564693|SAPIENZA UNIVERSITY OF ROME|PROF. ALESSANDRO LAVIANO|+390649973902|alessandro.laviano@uniroma1.it|
21280951|NCT00774163|Tulane University School of Public Health and Tropical Medicine|Dr. Richard Oberhelman|504-988-2511|oberhel@tulane.edu|
21280952|NCT02570308|Immunocore, Ltd|Nicola McKelvie|484-534-5261|nicola.mckelvie@immunocore.com|
21280953|NCT03957200|University of manitoba|Dr Helen Pymar|204-787-4184|hpymar@hsc.mb.ca|
21280954|NCT01283464|Johns Hopkins Dermatology|Dr. Anna L. Chien|4105027546|ctrep@jhmi.edu|
21280955|NCT06481709|APR Applied Pharma Research s.a.|Giorgio Reiner Chief Scientific Officer|+41.91.6957020|giorgio.reiner@apr.ch|
21280956|NCT05921903|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21280957|NCT00923013|National Cancer Institute|Dr. Robert Kreitman|301-648-7375|kreitmar@mail.nih.gov|
21280958|NCT05365451|Washington State University|Dr. Mary Paine|509-358-7759|mary.paine@wsu.edu|
21280959|NCT03933904|Center for Cytokine Storm Treatment & Laboratory (CSTL), University of Pennsylvania|Dr. David Fajgenbaum|215-614-0935|davidfa@pennmedicine.upenn.edu|
21280960|NCT05366010|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
21280961|NCT02224157|AstraZeneca AB|Stefan Ivanov|000000000|information.center@astrazeneca.com|
21280962|NCT05906628|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21280963|NCT01108718|Beth Israel Medical Center|Diana Vu|212-844-6747|dvu@bethisraelny.org|
21280964|NCT00423878|Columbia University|Dr. Scott Stroup|212-543-5676|stroups@nyspi.columbia.edu|
21280965|NCT01060072|Bausch & Lomb Incorporated|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
21280966|NCT02301169|Tools4Patient|Stephanie Alvarez|+32 71 14|stephanie.alvarez@tools4patient.com|02 00
21280967|NCT03762265|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
21280968|NCT02289729|AbbVie|Global Medical Services|800-633-9110||
21280969|NCT00470470|Memorial Sloan-Kettering Cancer Center|Dr. Richard Carvajal|646-888-4161|carvajar@mskcc.org|
21280970|NCT01149863|Emory University|Dr. Harvey|404-778-4381|rdharve@emory.edu|
21280971|NCT00640315|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21280972|NCT01256879|U of Maryland|James Polli, Professor|410-706-8292|jpolli@rx.umaryland.edu|
21280973|NCT00397514|University of British Columbia|Dr. Shubhayan Sanatani|6048752345|ssanatani@cw.bc.ca|7955
21280974|NCT00725920|Federal University of Sao Paulo|Marcelo F Mello|55 11 50822860|mf-mello@uol.com.br|
21280975|NCT02286713|UT MD Anderson Cancer Center|Clinical Research Operations Team, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org|
21280976|NCT02654054|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21280977|NCT02409927|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
21280978|NCT06018129|Genmab|CLINICAL TRIAL INFORMATION|+45 7020 2728|clinicaltrials@genmab.com|
21280979|NCT03832686|Stanford University|Heather Starmer, MD|650-529-5903|hstarmer@stanford.edu|
21280980|NCT02235454|Duke University|Sanjay Asrani|919-684-8656|sanjay.asrani@duke.edu|
21280981|NCT03323398|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
21280982|NCT03641469|Green Sun Medical|James A. Arthur|720-202-3621|jarthur@greensunmedical.com|
21280983|NCT06389487|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21280984|NCT05479435|Istanbul Medipol University|Arzu Abalay|+905075891917|arzuabalay@hotmail.com|
21280985|NCT05081063|Loma Linda University Health|Kaushik Mukherjee|9096515948|kmukherjee@llu.edu|
21280986|NCT00955617|Guerbet|Emilie Huchet|+33 1 45 91 50 00|emilie.huchet@guerbet-group.com|7688
21280987|NCT06954493|SCYNEXIS, Inc|David Angulo, MD|(201) 884 - 5471|david.angulo@scynexis.com|
21280988|NCT00982657|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21262631|NCT01795898|Janssen Philippines|Medical Affairs Manager|+632-8247901||
21280989|NCT04199104|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21294893|NCT00996281|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21262632|NCT04510194|University of Minnesota|Carolyn Bramante|612-624-0468|jcharles@umn.edu|
21294894|NCT03777709|Mayo Clinic|Dr. LaPrincess Brewer|5072661376|brewer.laprincess@mayo.edu|
21294895|NCT02494518|Cleveland Clinic|Dr. Susan Linder|(216) 445-9815|linders@ccf.org|
21262633|NCT06648161|Kocaeli University|Dr. Resmiye Özdilek|+90 262 303 47 38|resmiyeozdilek@gmail.com|
21294896|NCT04011826|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0123|CPAP.trial@fphcare.co.nz|7044
21294897|NCT01639339|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21294898|NCT02649218|Novartis Pharmaceuticals|Study Lead|+1 (862) 778-8300|novartis.email@novartis.com|
21294899|NCT00499655|City of Hope|Karen L. Reckamp, M.D.|(626) 256-4673|kreckamp@coh.org|
21294900|NCT00534118|Roswell Park Cancer Institute|Theresa Hahn|716-845-2300|theresa.hahn@roswellpark.org|
21294901|NCT04003207|Icahn School of Medicine at Mount Sinai|Alexander Kolevzon, MD|(212) 659-9134|alexander.kolevzon@mssm.edu|
21294902|NCT03894969|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21262634|NCT05730829|McMaster University|Dr Lisa Carlesso|2896805640|carlesl@mcmaster.ca|
21262635|NCT02880319|DFCI/BWH|Dr. Tracy Balboni|6177327948|tbalboni@bwh.harvard.edu|
21262636|NCT00372190|Radboud University Medical Center|Dr. M.I.J.Withagen|+31 6 51262468|M.I.J.Withagen@umcutrecht.nl|
21262637|NCT00623467|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21262638|NCT02597673|University of Tennessee Health Science Center|Dr. Laura Talbot|901-448-3630|ltalbot@uthsc.edu|
21262639|NCT03691623|Enanta Pharmaceuticals, Inc.|Guy De La Rosa, MD, Senior Medical Director, Infectious Diseases|+1 857 760 0548|gdelarosa@enanta.com|
21262640|NCT02816710|Department of Ophthalmology, Ruijin Hospital Affiliated Shanghai Jiaotong University School of Medicine, 197 Ruijin Er Road, 200025, Shanghai, China.|Dr. Xi Shen|021-64370025|carl_shen2005@126.com|
21262641|NCT01532700|University Health Network|Dr. Christine Chen|416-946-2827|Christine.Chen@uhn.ca|
21262642|NCT02606045|University of Pittsburgh|Margaret V. Ragni, MD, PHD|412-209-7480|ragni@pitt.edu|
21262643|NCT03952468|VA Providence Health Care system|Dr. Jennifer Primack|(401) 273-7100|Jennifer.Primack@va.gov|16295
21262644|NCT01996319|Novartis Pharmaceuticals|Study Director|862-778-8300||
21262645|NCT02758717|Lombardi Comprehensive Cancer Center|Bruce D. Cheson, M.D.|507-266-0800|bdc4@georgetown.edu|
21262646|NCT01671085|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21262647|NCT00637273|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21262648|NCT00365716|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21262649|NCT04465370|Edwards Lifesciences|Cristina Johnson|888.713.1564|CC_Clinical_Affairs@edwards.com|
21262650|NCT03649321|UT Southwestern Medical Center|Dr. Syed Kazmi|214-648-4180|syed.kazmi@utsouthwestern.edu|
21262651|NCT00002663|Atara Biotherapeutics|Study Director|650-278-8930|clinicalstudies@atarabio.com|1
21262652|NCT00751101|University of California, San Francisco|Dr. Hope Rugo, MD|(415) 353-7618|Hope.Rugo@ucsf.edu|
21262653|NCT01905397|Duke University Medical Center|Dan Blazer III, MD|919-668-1861|trey.blazer@duke.edu|
21262654|NCT02535949|Washington University School of Medicine|Dr. Philip Spinella|314-286-0858|pspinella@wustl.edu|
21262655|NCT01921270|Emory University|Dr. Stewart Factor|404-728-4952|sfactor@emory.edu|
21294903|NCT00589056|University of Pennsylvania|Ramesh Rengan, M.D., Ph.D.|(215) 662-2428|Rengan@xrt.upenn.edu|
21262656|NCT00844428|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alxn.com|
21262657|NCT00789477|Regeneron|Clinical Trial Management|9148475385|clinicaltrials@regeneron.com|
21262658|NCT00455858|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21262659|NCT01927562|Fractyl|Sarah Hackett|617-596-9522|shackett@fractyl.com|
21262660|NCT00642616|Sanofi|Trial Transparency Team||ContactUS@sanofi.com|
21262661|NCT00399802|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21262662|NCT00542815|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21262663|NCT04172831|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 904-0355|greg.sullivan@tonixpharma.com|
21262664|NCT01041573|Valneva Austria GmbH|Senior Manager Clinical Research|+43 1 206 20|katrin.dubischar-kastner@valneva.com|1175
21262665|NCT02955186|Yale School of Medicine|Dana Cavallo, Project Coordinator|203-610-9788|dana.cavallo@yale.edu|
21262666|NCT02234115|Foresee Pharmaceuticals co., Ltd.|Dr. John Mao||john.mao@foreseepharma.com|
21262667|NCT01088815|Johns Hopkins SKCCC|Dr. Ana De Jesus Acosta|443-287-0411|adejesu1@jhmi.edu|7-0411
21262668|NCT01276847|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21262669|NCT02138578|University of Michigan Comprehensive Cancer Center|Dr. Daniel Spratt, M.D.|734-936-4300|sprattda@med.umich.edu|
21294904|NCT00468676|Dept Psychiatry, University of Washington Medical School|Dr Wayne Katon, Professor and Vice Chair|206-543-7177|wkaton@uw.edu|
21294905|NCT05129072|Bausch + Lomb Incorporated|Steffen Robert, Senior Director Clinical Affairs|15853386399|robert.steffen@bauschcloud.com|
21294906|NCT02388490|Seoul National University Hospital|Tae Min Kim|82+2-2072-3559|gabriel9@snu.ac.kr|
21294907|NCT02378298|Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg|Helena Filipsson Nyström|0046-705833398|helena.filipsson@medic.gu.se|
21294908|NCT04173260|University of Pennsylvania|Dr. Andres Deik|2158297049|adeik@upenn.edu|
21294909|NCT04762043|Altec, Inc.|Dr. Joshua Kline|5085458212|jkline@altecresearch.com|
21262670|NCT02021812|W.L. Gore & Associates|Jennifer Gorman|928-863-8483|jgorman@wlgore.com|
21262671|NCT02698423|Geneva University Hospitals|Dr Manuela Viviano|07955 32 272|manuela.viviano@hcuge.ch|
21294910|NCT02308163|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-0512|astellas.resultsdisclosure@astellas.com|
21262672|NCT01319760|Columbia Presbytarian Hospital, NY|Dr. Ajay Kirtane|212-305-7060|akirtane@columbia.edu|
21294911|NCT05235971|University of Michigan|Lara N. Coughlin, Ph.D.|734-936-3101|laraco@med.umich.edu|
21294912|NCT01394692|Johann Wolfgang Goethe University|Dr. Christian Senft|+49 69 63015939|c.senft@med.uni-frankfurt.de|
21294913|NCT02320812|jCyte, Inc|Terry O'Neal, Chief Operating Officer|949-243-0688|terry.oneal@jcyte.com|
21294914|NCT02956044|Translational Medicine Group|Program Director|617-726-4236|yhalvorsen@ccib.mgh.harvard.edu|
21297165|NCT00842543|Nemours Children's Clinic|J. Atilio Canas MD|9046973600|jcanas@nemours.org|3674
21297166|NCT03738891|Zeltiq Aesthetics|Lori Brandt, Director, Clinical Trial Management|(925) 621-7460|lori.brandt@abbvie.com|
21297167|NCT01483183|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21297168|NCT00239928|Pfizer, Inc.|Pfizer Clinical Trails.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21297169|NCT03276546|Queen's University, Belfast|Professor Margaret Cupples|07714233204|m.cupples@qub.ac.uk|
21297170|NCT04047979|Emory University|Dr. Nadine Rouphael|404-712-1435|nroupha@emory.edu|
21297171|NCT00510744|University of Pittsburgh|Stephen O'Keefe|412 648 7217|sjokeefe@pitt.edu|
21297172|NCT00077649|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21297173|NCT02479139|Allergan, Inc|Therapeutic Area Head,|1-877-277-8566|IR-CTRegistration@allergan.com|
21297174|NCT00764673|DJO Surgical|Manager of Clinical Affairs|512-832-9500|jane.jacob@djosurgical.com|6323
21297175|NCT01438177|Perlmutter Cancer Center|Amitabha Mazumder, MD|212-731-5757|amitabha.mazumder@nyumc.org|
21297176|NCT00849862|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21297177|NCT01727336|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21297178|NCT02772978|University of California at San Francisco|Andrew Kayser, MD PhD|415-502-7332|Andrew.Kayser@ucsf.edu|
21297179|NCT02953886|University of Michigan|Emily Yanca|734-763-3988|emthorpe@umich.edu|
21297180|NCT00820222|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
21297181|NCT02690714|Prometic Biotherapeutics Inc.|Senior Director, Clinical Development|301-549-9761|clinical@prometic.com|
21297182|NCT00293020|BioDelivery Sciences International|Andrew Finn, Pharm.D.|919-582-9050|AFinn@bdsi.com|
21297183|NCT01147848|GlaxoSmithKline|GSK Response Center|866-435-7343||
21297184|NCT02540265|Recro Pharma, Inc.|Randall Mack|484-395-2470|rmack@recropharma.com|2406
21297185|NCT01417455|Instituto de Medicina Molecular|João Eurico Fonseca|+351217999544|jecfonseca@gmail.com|47221
21297186|NCT00534833|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21297187|NCT01972789|Novartis Pharmaceutical|Study Director|862-778-8300|novartis.email@novartis.com|
21297188|NCT02837042|UAB|Gurudatta Naik, Scientist 3|205-996-5530|alkanand@uab.edu|
21297189|NCT00418574|Menarini Ricerche SpA|Clinical Research Director||abagovomab@menarini-ricerche.it|
21297190|NCT03596450|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21297191|NCT00498355|University of California San Francisco|Dr. Nisha Acharya|415-476-8131|nisha.acharya@ucsf.edu|
21297192|NCT04496453|Emory University|Lavanya Vasudevan, Ph.D., M.P.H., C.P.H.|404-727-3956|lavanya.vasudevan@emory.edu|
21297193|NCT02013245|Centre Hospitalier Universitaire Vaudois (CHUV)|Dr. François Spertini, Associate Professor, Division Immunology & Allergy|+41 21 31 40 799|Francois.Spertini@chuv.ch|
21297194|NCT04058886|University of North Carolina at Chapel Hill|Kim Faurot, PhD|919-966-8586|faurot@med.unc.edu|
21297195|NCT02474407|SK Bio-pharmaceuticals Co, Ltd|Lee Min Jae, Associate Manager||minj.lee@sk.com|
21297196|NCT04390841|Biotronik (Beijing) Medical Device Limited|Senior Clinical Study Project Manager|+86 10 6522 3851-863|lan.chen@biotronik.com|
21297197|NCT02999633|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21297198|NCT03262441|Fred Hutchinson Cancer Research Center|Dr. Joshua Schiffer|(206)667-7359|jschiffe@fredhutch.org|
21297199|NCT04356040|Abbott|Anne Sarver|6517563813|anne.sarver@abbott.com|
21297200|NCT00360568|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21297201|NCT03281304|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21297202|NCT01114438|GI Dynamics|Clinical Affairs Manager|781.357.3263|kwoessner@gidynamics.com|
21247508|NCT00698867|Zimmer Biomet|Kelly Francher, Clinical Affairs Manager|574-371-9783|kelly.francher@zimmerbiomet.com|
21262673|NCT01651260|Hollister Incorporated|Malford Cullum|847-918-3975|malford.cullum@Hollister.com|
21280990|NCT04075825|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21280991|NCT04581824|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21247509|NCT05441449|Spinal Cord Damage research Center, James J. Peters VA Medical Center|Dr. John Handrakis|(718) 584-9000|john.handrakis@va.gov|5439
21247510|NCT00686595|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21247511|NCT02797132|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21247512|NCT03304418|Huntsman Cancer Institute/University of Utah|Clinicaltrials.gov and CTRP Specialist|8012136215|IITDataManagement@hci.utah.edu|
21247513|NCT01342367|The University of Chicago|Dr. Stanley Liauw|7737026870|sliauw@radonc.uchicago.edu|
21247514|NCT01961609|Novartis Pharmaceuticals|Study Director|862-778-1873||
21247515|NCT02284113|Pacira Pharmaceuticals, Inc.|Medical Information||MedInfo@Pacira.com|
21247516|NCT04191824|Duke University|Hrishikesh Chakraborty, PhD|919-668-1238|hrishikesh.chakraborty@duke.edu|
21247517|NCT01357512|Oulu University Hospital and Univeristy of Oulu|Chief urologist Markku Vaarala|+3588315|markku.vaarala@oulu.fi|2840
21247518|NCT01218009|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
21247519|NCT01324310|Celgene Corporation|Senior Manager|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21247520|NCT03170882|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21247521|NCT03433794|Old Dominion University|Dr. Abby Braitman|757-683-3708|abraitma@odu.edu|
21247522|NCT01371994|Astellas Pharma Global Development, Inc.|Medical Director, Urology||clinicaltrials@us.astellas.com|
21247523|NCT00087685|The University of Texas (UT) MD Anderson Cancer Center|Karen H. Lu, MD, Chair, Gynecologic Oncology & Reproductive Medicine|713-745-8902|CR_Study_Registration@mdanderson.org|
21280992|NCT04796909|The Hong Kong Polytechnic University|Dr. Chi-Wen Chien, Associate Professor|+85227666703|will.chien@polyu.edu.hk|
21247524|NCT04529616|RxSight, Inc.|Associate Director, Clinical Trials|9494215463|dgoffredo@rxsight.com|
21247525|NCT03891758|Mitsubishi Tanabe Pharma Corporation / The Research Foundation for Microbial Diseases of Osaka University|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp, clinicaldevelopment@mail.biken.or.jp|
21247526|NCT01983683|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk|0041615656565|clinical-trials-disclosure@its.jnj.com|
21247527|NCT04528459|Columbia University|Wakenda K. Tyler, MD, MPH|2123059192|wkt2106@cumc.columbia.edu|
21247528|NCT01162096|Thomas Jefferson University|Neal Flomenberg, MD|215-955-4367|neal.flomenberg@jefferson.edu|
21247529|NCT00536120|Biogen Idec Inc.|Biogen Idec Medical Director||clinicaltrials@biogenidec.com|
21247530|NCT04989816|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21247531|NCT00712179|Ralph H Johnson VA Medical Center|Dr. Steven A Kautz|843-792-3867|kautz@musc.edu|
21247532|NCT03684590|University of Texas Southwestern|Tiffany Moon, MD|2145345456|tiffany.moon@utsouthwestern.edu|
21247533|NCT01184326|Dana-Farber Cancer Institute|Dr. Mark Pomerantz|617-632-4524|mark_pomerantz@dfci.harvard.edu|
21247534|NCT01084694|Northside Hospital|Dr. Dawn Speckhart, PhD|404-255-1930|dawn.speckhart@northside.com|
21247535|NCT02414633|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21247536|NCT01211106|Cpl Micheal J Crescenz VA Medical Center|David Oslin, MD|215-823-5894|dave.oslin@va.gov|
21247537|NCT00290537|U.T. M.D. Anderson Cancer Center|Vali Papadimitrakopoulou, MD / Associate Professor|713-792-6363||
21247538|NCT04017611|Masimo|Chelsea Frank|(949) 297-7000|studies@masimo.com|
21247539|NCT03406325|Hong Kong Sanatorium & Hospital|Prof. Tak Hong Lee|28358430|TakHong.Lee@hksh.com|
21247540|NCT00145587|St. Jude Children's Research Hospital|Kimberly Kasow, DO|901-595-3300|kimberly_kasow@med.unc.edu|
21247541|NCT00777049|Translational Research in Oncology (TRIO)|Valérie Bee-Muntenau, Director of Project Management|+33 1 58 10 09 09|Valerie.Bee@trioncology.org|
21247542|NCT00609869|H. Lee Moffitt Cancer Center and Research Institute|Javier Pinilla-Ibarz|813-745-1387|javier.pinilla@moffitt.org|
21247543|NCT03478969|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21247544|NCT03878979|Johns Hopkins University|Dr. Tanguy Seiwert|443-287-8312|tseiwert@jhmi.edu|
21247545|NCT03885232|University of Colorado at Anschutz Medical Campus|Sean O'Leary, MD, MPH - Principal Investigator|(303)724-1582|sean.oleary@cuanschutz.edu|
21247546|NCT05139992|ASH Research Collaborative|Nicole Mortier|866-828-1231|nmortier@ashrc.org|
21247547|NCT05521516|University of California San Diego|Brian Ilfeld, MD, MS|(858) 220-5714|bilfeld@health.ucsd.edu|
21247548|NCT05747599|RTIInternational|Yukiko Washio, PhD|9194852794|ywashio@rti.org|
21247549|NCT02500576|M D Anderson Cancer Center|Dr. Rodabe Amaria|(713) 792-2921|rnamaria@mdanderson.org|
21247550|NCT03399500|University of Oklahoma Health Sciences|Michael Businelle|405-271-8001|michael-businelle@ouhsc.edu|50460
21247551|NCT04032106|Ohio State University|Dr. Paul Reiter|614-292-4803|reiter.36@osu.edu|
21247552|NCT03400150|BioProtect|Dafna Carmi Yinon|+972 (9) 7731-929|dafna@bioprotect.com|
21247553|NCT04882917|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21247554|NCT00227266|University of Utah|Sandra Reyna, M.D.|801-581-3551|sreyna@genetics.utah.edu|
21247555|NCT05357989|Annovis Bio, Inc.|Matthew Peterson, PhD|484-875-3192|peterson@annovisbio.com|
21247556|NCT03959423|Medtronic Diabetes|DZ Dai, Sr Statistician|8185764034|dz.dai@medtronic.com|
21247557|NCT04926740|Lawson Health Research Institute|Kristine Van Aarsen (Research Associate)|5196858500|kristine.vanaarsen@lhsc.on.ca|76089
21247558|NCT02278185|University of Colorado School of Medicine|Dr. Elizabeth R Kessler|720-848-0402|elizabeth.kessler@cuanschutz.edu|
21247559|NCT01470144|Actelion Pharmaceuticals Ltd|Thomas Pfister, PhD||thomas.pfister@actelion.com|
21247560|NCT00593840|Washington University School of Medicine|Wade Thorstad, M.D.|314-362-8516|thorstad@radonc.wustl.edu|
21280993|NCT03879135|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21280994|NCT03428958|NuCana plc|Medical and Scientific Affairs Department|+44 131 357 1111|info@nucana.com|
21294915|NCT03505788|Ziekenhuis Oost-Limburg|Prof. dr. Wilfried Mullens|+32(0)89327140|wilfried.mullens@zol.be|
21294916|NCT03575065|BeiGene|Study Director|+1 - 877-828-5568|clinicaltrials@beigene.com|
21294917|NCT03617536|Cara Therapeutics|Director of Clinical Trials|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
21294918|NCT02323126|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21294919|NCT00396136|Biotronik, Inc.|Clinical Studies|503-451-8050|katerina.demetz@biotronik.com|
21294920|NCT01779856|Medtronic, plc|RCS Sr. Director of Medical Affairs|763-505-4566|amy.denise.roettger@medtronic.com|
21294921|NCT03960580|OptiNose|John Messina, PharmD, SVP of Clinical Research & Medical Affairs|265-521-0565|john.messina@optinose.com|
21294922|NCT03106844|Brigham and Women's Hospital|Jessica Allegretti MD MPH|617-525-7322|jallegretti@bwh.harvard.edu|
21294923|NCT00380029|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
21247561|NCT01663363|Abbott Medical Optics|Ann Murphy, Manager, Clinical Research|619-518-4158|Ann.Murphy@abbott.org|
21247562|NCT02432300|EmotEd, LLC|Dawn Neumann|716-713-5048|dneumann73@gmail.com|
21247563|NCT01128595|GlaxoSmithKline|GSK Response Center|866-435-7343||
21247564|NCT01970410|Providence Health & Services|Director of PBSI /WC Clinical Research Program|(503) 216-1012|Chiayi.Chen@providence.org|
21247565|NCT01561300|Unilever R&D Vlaardingen|Dr Theo Mulder|+31 10 460 8315|theo.mulder@unilever.com|
21247566|NCT01185600|University of Miami|Wenche Jy, PhD, Research Associate Professor, Principal Investigator|305-243-6617|wjy@med.miami.edu|
21247567|NCT01436175|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21247568|NCT05405244|University of North Carolina at Chapel Hill|Kyle Burger, PhD, RD, MPH|9198439933|Kyle_burger@unc.edu|
21247569|NCT00739934|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21247570|NCT03455985|The Ohio State University|Kathleen Dungan|6146853333|kathleen.dungan@osumc.edu|
21247571|NCT05230433|Happy Trails Nutrition|Jennifer Meijer|6036505250|jen@htnutrition.com|
21247572|NCT04497727|University of Florida|Dr. Carl J. Pepine|(352) 339-0696|carl.pepine@medicine.ufl.edu|
21247573|NCT04353492|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21247574|NCT04250194|Vanderbilt University Medical Center|Dr. Fabien Maldonado|615-322-2386|fabien.maldonado@vumc.org|
21247575|NCT00857766|GlaxoSmithKline|GSK Response Center|866-435-7343||
21247576|NCT00647400|Abbott|Global Medical Services|800-633-9110||
21247577|NCT01212744|BioMarin Pharmaceutical Inc.|Medical Director|415-475-5854|ari.gershman@bmrn.com|
21247578|NCT01262339|University of Wisconsin- Madison|Dermatology Clinical Trials Administrator|608-287-2640|dbock@dermatology.wisc.edu|
21247579|NCT02167451|Cincinnati Children's Hospital Medical Center|Pooja Khandelwal, MD|513-803-4762|Pooja.Khandelwal@cchmc.org|
21247580|NCT00571649|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21247581|NCT01218659|Amicus Therapeutics|Medical Affairs|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
21247582|NCT02555306|Santen Inc|R&D Quality Manager|+1 415 268 9199|evelyn.chikere@santen.com|
21247583|NCT00588406|North Shore Long Island Jewish Health System|Dr. Robert Silverman|718-470-7501|rsilverman@nshs.edu|
21247584|NCT03066609|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21247585|NCT03355573|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21247586|NCT01566890|Medical College of Wisconsin Department of Hematology|Joshua Field, MD|414-937-6896|JField@Versiti.org|
21247587|NCT02534285|Technical University Dresden, Dept. of Anaesthesiology|Prof. Dr. Matthias Hübler|+4945814002|matthias.huebler@uniklinikum-dresden.de|
21247588|NCT00588471|Mayo Clinic|Dr. Amir Lerman|507-255-7760|lerman.amir@mayo.edu|
21247589|NCT04124432|Johns Hopkins School of Medicine|Dr. Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
21247590|NCT00523419|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21247591|NCT00822120|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623||
21247592|NCT02999763|Syneron Medical|Director of Clinical Affairs|+972-73-2442347|shlomitm@syneron-candela.com|
21247593|NCT01437319|Johnson &Johnson Vision Care, Inc|Tawnya Wilson, OD Principal Research Optometrist|904-443-3500|TWilson@ITS.JNJ.com|1834
21247594|NCT00811941|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
21247595|NCT03496545|Weill Cornell Medicine|Judy Ch'ang, MD|(212) 746-2596|jhc9010@med.cornell.edu|
21247596|NCT01201772|University of Florida|Dominick Angiolillo|904-244-3933|dominick.angiolillo@jax.ufl.edu|
21247597|NCT03938337|O'Neal Comprehensive Cancer Center at University of Alabama at Birmingham|Eddy S. Yang|12059960780|eyang@uab.edu|
21247598|NCT00942266|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21247599|NCT04027439|Verona Pharma|Verona Pharma|+44 (0)203 283 4200|info@veronapharma.com|
21247600|NCT02397096|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21247601|NCT00918203|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21247602|NCT06456723|Imperial College London|Professor Rohini Sharma|0203 313 3720|r.sharma@imperial.ac.uk|
21247603|NCT03357952|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21247604|NCT05018143|University of Pennsylvania|Dr. José A. Bauermeister|215-898-3242|bjose@upenn.edu|
21247605|NCT01830595|Minneapolis Medical Research Foundation|Jason Baker|612-873-2705|baker@umn.edu|
21247606|NCT06688357|University of Florida - Norman Fixel Brain Institute|Dawn Bowers, Ph.D.|(352) 273-6617|dawnbowers@phhp.ufl.edu|
21247607|NCT05116774|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
21247608|NCT03280030|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21247609|NCT05601882|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21247610|NCT03834740|Ivy Brain Tumor Center|Dr. Nader Sanai|602-406-8605|research@ivybraintumorcenter.org|
21294924|NCT01794741|Meda Pharmaceuticals|Dr Nancy Ruiz, MD|732 564 2390|nancy.ruiz@meda.us|
21247611|NCT01208974|University of Miami|Cristiane Takita MD|305-243-4337|ctakita@med.miami.edu|
21247612|NCT03691493|Emory University|Dr. Mylin Torres|404-778-1900|matorre@emory.edu|
21247613|NCT04213807|Anthos Therapeutics|Debra Freedholm|609-439-8246|Deb.f@anthostherapeutics.com|
21247614|NCT03442777|Belgian Healthcare Knowledge Centre|Jillian Harrison|+32 2 287 33 89|jillian.harrison@kce.fgov.be|
21247615|NCT02866942|Imperial College London|Dr Paul Turner|+44 20 3312 7754|p.turner@imperial.ac.uk|
21247616|NCT00743574|Yale University|Dr. Lubna Pal|203-737-5619|lubna.pal@yale.edu|
21247617|NCT03418922|Eisai Co., Ltd.|Eisai Inquiry Service|none|eisai-chiken_hotline@hhc.eisai.co.jp|
21247618|NCT03577106|UPMC|Scott Ward|412-683-7105|wards7@upmc.edu|
21247619|NCT01929291|GlaxoSmithKline|GSK Response Center|866-435-7343||
21247620|NCT01119755|Hypertension Center, Third Department of Medicine, University of Athens, Greece|George S Stergiou, Associate Professor of Internal Medicine and Hypertension|+302107763117|gstergi@med.uoa.gr|
21247621|NCT00754065|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21247622|NCT03893318|University of California, San Diego|Michael Kelly, MD|508-410-9567|mpkelly@ucsd.edu|
21280995|NCT03985800|Department of Psychiatry, University of Pittsburgh|Eva Szigethy, Co-Principal Investigator, Adjunct Professor of Psychiatry, Staff Psychiatrist|412-667-0416|szigethye@upmc.edu|
21280996|NCT05258773|Sensorion|Chief Medical Officer|+33 4 67 20 77 30|contact@sensorion-pharma.com|
21280997|NCT05277922|Vicore Pharma AB|Cecilia Ganslandt|+46 705 797075|info@vicorepharma.com|
21280998|NCT01662635|Thoracic Oncology Unit. Instituto Nacional de Cancerología|Oscar Gerardo Arrieta-Rodríguez|+52 55 56280400|ogar@unam.mx|832
21280999|NCT00595920|Opexa Therapeutics, Inc.|Kenny Frazier, VP of Clinical Development and Regulatory Affairs|281-775-0660|kfrazier@opexatherapeutics.com|
21281000|NCT00351468|Novartis|Study Director|862-778-8300||
21281001|NCT04565145|University of Florida|Robyn Nelson|3522945563|r.nelson@ufl.edu|
21247623|NCT01500200|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
21247624|NCT00623194|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21247625|NCT01952366|Sykehuset Innlandet|Dr. Tom Borza|+47 91834607|tom.borza@sykehuset-innlandet.no|
21247626|NCT04860505|Emory University|Dr. Colleen Kelley|404-712-1823|colleen.kelley@emory.edu|
21247627|NCT01988402|San Antonio Military Medical Center|Jay B Higgs,|2109160797|jay.b.higgs.civ@mail.mil|
21247628|NCT03983434|Indiana University|Dr. Huiping Xu|317-278-6735|huipxu@iu.edu|
21247629|NCT01759862|Stanford University|Paul Grimm|6507237903||
21247630|NCT04060212|University of Rochester|Matthew Rand|585-275-5459|matthew_rand@urmc.rochester.edu|
21247631|NCT01499849|Tesaro|Martin Huber, M.D., Senior Vice President and Chief Medical Officer|781.257.2536|mhuber@tesarobio.com|
21247632|NCT00622700|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21247633|NCT03664011|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21247634|NCT01693822|Institute of Cancer Research, Clinical Trials and Statistics Unit (ICR-CTSU)|Professor Judith Bliss (Director of ICR-CTSU)|+44 0208 722 4297|apredict-icrctsu@icr.ac.uk|
21247635|NCT02646618|University of Connecticut|Dr. Sherry Pagoto|8604868979|Sherry.Pagoto@uconn.edu|
21247636|NCT04035447|Duke University School of Medicine|Caroline Dorfman, PhD|919-416-3473|caroline.dorfman@duke.edu|
21281002|NCT03096314|Massachusetts General Hospital|Nancy Ringwood, CCC Project Manager|617-724-9836|nringwood@mgh.harvard.edu|
21281003|NCT02547428|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
21281004|NCT03318861|Kite, A Gilead Company|Medical Information|844-454-5483(1-844-454-KITE)|medinfo@kitepharma.com|
21281005|NCT00917852|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com|
21281006|NCT02502149|Bioverativ|Bioverativ Study Medical Director|781-6631801|clinicaltrials@bioverativ.com|
21281007|NCT02548832|INSTITUTO DE TERAPÉUTICA EXPERIMENTAL Y CLÍNICA|Esperanza Martinez Abundis|3310585200|esperanzamartnezabundi@yahoo.com|34211
21281008|NCT03036657|Oregon Health & Science University|Alexandra Dimitrova, PI|503-494-0766|dimitroa@ohsu.edu|
21281009|NCT01774760|Turku University Hospital, Turku, Finland|Prof. Heikki Minn|+35823130000|heikki.minn@tyks.fi|30149
21281010|NCT03711188|Immodulon Therapeutics Ltd|Clinical Trial Information Desk,|0044 0203137 6346|info@immodulon.com|
21281011|NCT01433471|NYU Langone Medical Center|Martin Wolff|(646) 329-7259|martin.wolff@nyumc.org|
21281012|NCT01823861|London School of Hygiene and Tropical Medicine|Dr. Chris Smith|07974562199|christopher.smith@lshtm.ac.uk|
21281013|NCT00314340|UC Davis Medical Center|Barth Wilsey MD|916-843-7165|blwilsey@ucdavis.edu|
21281014|NCT02285361|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21281015|NCT02059135|LFB USA|Laura Massey, Sr. Clinical Project Manager|508-370-5157|laura.massey@lfb-usa.com|
21281016|NCT00191477|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21281017|NCT01275365|Brigham and Women's Hospital|Shalendar Bhasin, MD|617-525-9040|Sbhasin@partners.org|
21281018|NCT02182492|Department of ENT of Tongji Hospital Tongji Medical College Huazhong University of Science and Technology|Dr. Zheng Liu|86 027 83663807|zhengliuent@hotmail.com|
21281019|NCT03776357|Stanford University|Derek Amanatullah, MD, PhD|650-723-2257|dfa@stanford.edu|
21281020|NCT04973267|Brown University - SPH|Tyler Wray, PhD|4018636659|tyler_wray@brown.edu|
21281021|NCT03751098|Eyenovia, Inc.|VP, Development|714-269-8838|gclasby@eyenoviabio.com|
21281022|NCT01639157|University of Kentucky|William W. Stoops, Ph.D.|859-257-5388|william.stoops@uky.edu|
21281023|NCT00837148|Memorial Sloan Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org|
21281024|NCT01416636|SciPharm SàRL|Bianca Tan||b.tan@scipharm.eu|
21281025|NCT04535141|University of North Carolina Lineberger Comprehensive Cancer Center|Jonathan Ptachcinski PharmD, BCPS, BCOP|+1 919-966-9786|Jonathan.Ptachcinski@unchealth.unc.edu|
21281026|NCT06811155|hospital universitario virgen de la victoria|eva cabrera cesar|646905201|evacabreracesar@gmail.com|
21247637|NCT00274261|NICHD|Jason Woo, MD, MPH|301-496-1662|woojj@mail.nih.gov|
21262674|NCT00064662|New England Research Institutes|Anne M. Stoddard, ScD|617-972-3331|astoddard@neriscience.com|
21262675|NCT04436510|Healey Center for ALS at Massachusetts General Hospital|Healey Center for ALS Project Management|833-425-8257 (HALT ALS)|healeyalsplatform@mgh.harvard.edu|
21262676|NCT01963117|Samsung Medical Center|Professor|82-2-3410-2612|hee.ro.park@gmail.com|
21262677|NCT03844633|Ohio State University|Maria Gallo|6146882145|gallo.86@osu.edu|
21262678|NCT03569111|Medtronic|Julie Krzykowski|763-202-3325|Julie.Krzykowski@Medtronic.com|
21262679|NCT04083222|Ionis Pharmaceuticals, Inc|Ionis Pharmaceuticals, Inc|800-679-4747|patients@ionisph.com|
21262680|NCT00328263|Bio-K+ International Inc.|Dr. Serge Carrière|450-978-2465|scarriere@biokplus.com|
21262681|NCT00410280|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21262682|NCT03123939|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21262683|NCT01937130|Conatus Pharmaceuticals|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
21262684|NCT04191967|Univerisity of North Carolina (UNC)|Dr. Chemtai Mungo, MD, MPH|(984) 974-1000|cmungo@email.unc.edu|
21262685|NCT01431144|University of Louisville|Henry Greenwell, Principal Investigator|502-852-6928|henry.greenwell@louisville.edu|
21262686|NCT01641835|Heidelberg Engineering GmbH|Gerhard Zinser, PhD|+4962216463|Contact@HeidelbergEngineering.com|0
21262687|NCT03805932|National Cancer Institute|Dr. Robert J. Kreitman|301-480-6187|kreitmar@mail.nih.gov|
21262688|NCT05141435|Children's Hospital of Chongqing Medical University|Prof. Shi Yuan|+86 15084335697|shiyuan@hospital.cqmu.edu.cn|
21262689|NCT00953043|Mayo Clinic|Dr. Michael Camilleri, Professor of Medicine and Physiology, Gastroenterology|507-266-2305|camilleri.michael@mayo.edu|
21262690|NCT03059810|Johnson & Johnson Vision|Thomas Karkkainen- SR PRINCIPAL RESEARCH OPTOMETRIST|904 443-3402|TKarkkai@its.jnj.com|
21262691|NCT02322892|Beth Israel Deaconess Medical Center|Dr. Lars W. Andersen|6173886343|larswiuffandersen@gmail.com|
21262692|NCT00747617|UCSD School of Medicine|R. Jeffrey Chang, M.D.|858-534-8930|rjchang@ucsd.edu|
21262693|NCT03509207|Medical University of Graz|Prof. Edgar Petru|0043 31638581082|edgar.petru@medunigraz.at|
21262694|NCT02125331|GE Healthcare|Clinical Affairs Project Manager|262-443-7008|stephanie.karwedsky@ge.com|
21262695|NCT01432262|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21262696|NCT04657016|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21262697|NCT05291598|University of Miami Department of Orthopedics|Dr. Victor Hernandez|(305) 689-5195|vhh1@miami.edu|
21262698|NCT01104558|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21262699|NCT00696657|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
21294925|NCT01774097|UT-Houston School of Public Health|Lemuel Moye, MD, PhD|713-500-9518|lemmoye@msn.com|
21294926|NCT03447314|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21294927|NCT01920568|GlaxoSmithKline|GSK Response Center|866-435-7343||
21294928|NCT00350363|Stanford|Professor|650-723-6995|cta@stanford.edu|
21294929|NCT01703208|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
21294930|NCT00252694|AstraZeneca|Niklas Berglind, GPS Atacand|+46 31 7766310|ClinicalTrialTransparency@astrazeneca.com|
21294931|NCT03651856|Medical University of SC|Dr. Gonzalo Revuelta|843-792-7262|revuelta@musc.edu|
21247638|NCT03500549|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
21247639|NCT05509816|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21247640|NCT02431273|Auritec Pharmaceuticals|Sarjan Shah|909-210-9715|sshah@auritecpharma.com|
21247641|NCT01447706|Merrimack Pharmaceuticals|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
21247642|NCT00589875|Candel Therapeutics|Garrett Nichols (CMO)|617-916-5445|Gnichols@candeltx.com|
21247643|NCT00859781|Weill Cornell Medicine|Sarah Yuan|6469626040|say7008@med.cornell.edu|
21247644|NCT02016872|Memorial Sloan Kettering Cancer Center|Dr. Jacob Shin, MD|848-225-6436|shinj2@mskcc.org|
21247645|NCT03029286|Georgetown University|Suzanne O'Neill, PhD|202-687-0869|sco4@georgetown.edu|
21247646|NCT03222609|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21247647|NCT03789110|Dana-Farber Cancer Institute|Sara Tolaney|617-632-5743|Sara_Tolaney@dfci.harvard.edu|
21247648|NCT00545545|HiberCell|Michele A. Gargano, MSC/ VP Clin Ops and Prg Mngt|651.675.0300|mgargano@hibercell.com|
21247649|NCT05507970|Medicines for Malaria Venture|Project Director|+41 22 555 03 00|info@mmv.org|
21247650|NCT05827068|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
21247651|NCT00650078|Horizon Pharma|Senior Vice President, Clinical Development & Operations|224-383-3012|agrahn@horizonpharma.com|
21247652|NCT05019742|Shanghai Pharma Biotherapeutics USA Inc.|CSO|8587755354|kenneth@sphbio.com|
21247653|NCT05617300|HealthPartners Neuroscience Research|Leah Hanson, PhD|6514956352|Leah.R.Hanson@HealthPartners.com|
21262700|NCT00738543|University of Guanajuato|Alejandro Macias|52 477 7145859|aaeemmhh@yahoo.com|400
21262701|NCT03609658|Wake Forest School of Medicine|Jennifer Gabbard, M.D.|336-716-8028|jgabbard@wakehealth.edu|
21262702|NCT00523341|Amgen Inc.|Study Director|866-572-6436||
21262703|NCT05131880|Universidad Europea de Madrid|Alberto Bermejo Franco|+34912115535|alberto.bermejo@universidadeuropea.es|
21262704|NCT02601001|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21262705|NCT01356602|Novartis Pharmaceuticals|Study Director|862-778-8300||
21262706|NCT03123354|Masimo Corporation|Vikram Ramakanth|1 (949) 297-7416|clinicalresearchdept@masimo.com|
21262707|NCT01931462|University of Wisconsin|Director of Clinical Research, Department of Surgery|608-262-0540|clinicalresearch@surgery.wisc.edu|
21262708|NCT00366548|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21262709|NCT02531373|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21294932|NCT01101971|Queen's University|Dr. Robert Reid|6135332898|reidr@queensu.ca|32898
21262710|NCT01623531|Department of Anesthesia, Dalhousie University, Halifax, Canada|Dr. Myron Kwapisz|+1 902 473 4326|myron.kwapisz@nshealth.ca|
21262711|NCT01134887|Veterans Administration Health Services Research and Development|Richard M. Frankel Ph.D.|317-988-4000|Richard.Frankel@VA.Gov|
21262712|NCT02834403|Houston Methodist Cancer Center|Polly Niravath, MD|713-441-0629|ccresearch@houstonmethodist.org|
21262713|NCT04705597|BioAge Labs, Inc.|Patrick Martin, M.D.|215-260-5134|patrick@bioagelabs.com|
21262714|NCT00390780|Bioalliance Pharma|Dr Pierre Attali|+33 (0)1 45 58 76 00|pierre.attali@bioalliancepharma.com|
21262715|NCT02232516|Northwestern University, Feinberg School of Medicine|Dr. Jonathan Moreira|312-695-6180|jonathan.moreira@northwestern.edu|
21262716|NCT01585961|Biosense Webster|Ellen Harris, Project Manager, Clinical Operations|909-839-7376|eharris8@its.jnj.com|
21262717|NCT01258348|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21262718|NCT02759146|Michigan State University|Dr. Gwen Wyatt|517-353-6672|gwyatt@msu.edu|
21262719|NCT04332640|Johnson & Johnson Surgical Vision|Head of Clinical Science|7142478200|LVarga17@ITS.JNJ.com|
21262720|NCT01120093|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
21262721|NCT00385268|University of Pennsylvania|Dr. Helen Pettinati|215-222-3200|helenp@mail.med.upenn.edu|139
21262722|NCT01016106|Northwestern University|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu|
21262723|NCT00525148|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21262724|NCT00570739|Daiichi Sankyo, Inc.|John Raia, Senior Director Professional Affairs|(973) 944-2683|jraia@dsi.com|
21262725|NCT02289755|Allena Pharmaceuticals|VP of Clinical Development|617-467-4577|akausz@allenapharma.com|314
21262726|NCT02086565|University of Pennsylvania|Andrea J Apter, MD|215 349-5120|andrea.apter@uphs.upenn.edu|
21262727|NCT00739297|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21262728|NCT01400971|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21262729|NCT00325442|United Therapeutics Corporation|Kevin Laliberte, PharmD; Senior Director, Product Development|919-425-8176|klaliberte@unither.com|
21262730|NCT01729598|University of Kentucky|Dr. Gregory A. Jicha|859-323-5550|gregory.jicha@uky.edu|
21262731|NCT02092389|AbbVie|Global Medical Information|1-800-633-9110||
21262732|NCT01242020|Associate Dean for Clinical and Translational Research, College of Physicians and Surgeons|Muredach P. Reilly, MBBCh, MSCE|212-305-9453|mpr2144@cumc.columbia.edu|
21262733|NCT02680847|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21262734|NCT00787332|Canyon Pharmaceuticals|Director of Clinical Trials|888-434-7003|info@canyonpharma.com|
21262735|NCT02273310|The Children's Hospital of Philadelphia/Perleman School of Medicine of The University of Pennsylvania|Lamia Barakat, Ph.D.|267-426-8135|barakat@email.chop.edu|
21262736|NCT03958201|University of Washington|Research Coordinator|206-744-4634|ajames1@uw.edu|
21262737|NCT01595646|Wake Forest School of Medicine|Suzanne Craft, PhD|3366-713-8830|suzcraft@wakehealth.edu|
21262738|NCT02946229|GE Healthcare|Sean Lucas - Research Manager|1-248-533-5575|sean.lucas@ge.com|
21262739|NCT00339079|Brigham and Women's Hospital|Arthur J. Barsky, MD|617-732-5236|abarsky@partners.org|
21262740|NCT00751881|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21262741|NCT04770155|University of Mississippi Medical Center|Director of Clinical Trials|601-815-5000|clinicaltrials@umc.edu|
21262742|NCT01765764|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21262743|NCT00929578|Tufts Medical Center|Alice Gottlieb, MD PhD|617-636-7462|agottlieb@tuftsmedicalcenter.org|
21262744|NCT01597193|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21262745|NCT04073823|Tactile Medical|Michelle Wetherby|612.230.4576|mwetherby@tactilemedical.com|
21262746|NCT03008590|VA Boston Healthcare System|Dr Paul Monach, Chief, Rheumatology Section|857-364-5552|Paul.Monach@va.gov|
21262747|NCT01713400|H. Lee Moffitt Cancer Center and Research Institute|Dr. Joseph Pidala|813-745-2556|joseph.pidala@moffitt.org|
21262748|NCT00872833|New England Research Institutes, Inc.|Eric Gerstenberger|6179237747|egerstenberger@neriscience.com|
21262749|NCT01345786|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21262750|NCT01070784|AstraZeneca|Goran Eckerwall, MSD||ClinicalTrialTransparency@astrazeneca.com|
21262751|NCT01323673|GlaxoSmithKline|GSK Response Center|866-435-7343||
21294933|NCT05082428|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294934|NCT04699032|VectivBio AG|Reda Sheik|+41615513030|clinicaltrials@vectivbio.com|
21294935|NCT01271712|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21294936|NCT00607269|Friends Research Institute, Inc.|Jesse B. Fletcher, Ph.D., Statistician|323-463-1601|jfletcher@friendsresearch.org|
21294937|NCT00096226|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
21294938|NCT03609385|Charité-Universitätsmedizin Berlin|Dr. Christian Nolte|+4930450560676|christian.nolte@charite.de|
21294939|NCT03941964|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21294940|NCT03006458|CooperVision|Myhanh Nguyen|9257306716|MNguyen@coopervision.com|
21294941|NCT00118846|Director, Atherosclerosis Research Unit, University of Southern California|Howard N. Hodis, M.D.|323-442-1478|athero@usc.edu|
21294942|NCT01468233|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
21294943|NCT01574157|VA Salt Lake City Healthcare System|Dr. Kalani Raphael, Principal Investigator|801-582-1565|kalani.raphael@va.gov|1794
21262752|NCT03677089|Massachusetts General Hospital - Clinical Coordinating Center|Dr. Karen Kuhlthau|617-724-2842|KKUHLTHAU@PARTNERS.ORG|
21262753|NCT03403491|patientMpower Ltd|Chief Scientific Officer|+353872599131|colin@patientmpower.com|
21262754|NCT02588248|UHClevelandMC|L-Menthol Injection as a Novel Technique during Colonoscopy: The MINT-C study|216-844-1000|Richard.wong@UHhospitals.org|6172
21294944|NCT02480166|Stanford University Medical Center|Mindie H. Nguyen, MD, MAS|650-4985691|mindiehn@stanford.edu|
21247654|NCT05704725|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21247655|NCT00490139|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21247656|NCT00872729|Horizon Orphan LLC|Evelyn Olson, Director|224-383-3000|clinicaltrials@horizonpharma.com|
21247657|NCT03664804|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21247658|NCT05529992|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21247659|NCT06140290|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21247660|NCT03301467|ChemoCentryx, Inc.|Clinical trial disclosure|650.210.2900|clinicaltrials@chemocentryx.com|
21247661|NCT02798471|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21247662|NCT05747014|Medtronic|Rianna Rapson - Clinical Study Manager|763-526-2170|rianna.k.rapson@medtronic.com|
21247663|NCT02896907|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. James Posey|215-503-6442|James.Posey@jefferson.edu|
21247664|NCT04503681|Cooper University Health Care|Brian Roberts|856-342-2352|roberts-brian-w@cooperhealth.edu|
21247665|NCT01596231|McLean Hospital|Scott E. Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu|
21247666|NCT03352713|Center for Technology and Behavioral Health, Dartmouth Geisel School of Medicine|Dr. Shea Lemley|603-646-7040|behavior.change@dartmouth.edu|
21247667|NCT01812759|UT MD Anderson Cancer Center|Kumar Alagappan,Chair, Emergency Medicine|(713) 745-9911|kalagappan@mdanderson.org|
21247668|NCT03758638|Washington University in St. Louis|Rachel Tabak|3149350153|rtabak@wustl.edu|
21247669|NCT02186509|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Wenyin Shi|215-955-6702|Wenyin.Shi@jefferson.edu|
21247670|NCT00372775|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21247671|NCT00724126|Salix|David Sorscher|919-862-1827|david.sorscher@salix.com|
21247672|NCT01579318|OncoSec Medical Incorporated|Sharron E Gargosky, Chief Clinical Regulatory Officer|+1 858-255-4729|ClinicalTrialsInfo@OncoSec.com|
21247673|NCT00635700|Yale University|Scott W. Woods, M.D.|203-974-7038|scott.woods@yale.edu|
21247674|NCT03601715|Federal University of Santa Catarina|Inaihá Benincá|(+55 48) 3721-6255|inaiha.b@gmail.com|
21247675|NCT02347332|Institut de Recherche Pierre Fabre, Toulouse France|Zahida Issiakhem, Clinical Development Physician|+33 5 34 50 61 71|zahida.issiakhem@pierre-fabre.com|
21247676|NCT01478594|AVEO|Medical Director|1.617.588.1960|clinical@aveooncology.com|
21247677|NCT01313884|Stanford University Medical Center|Kristen Ganjoo, MD|650-725-6413|kganjoo@stanford.edu|
21247678|NCT01970007|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
21247679|NCT00776009|Novartis Pharmaceuticals|Study Director|862 778-8300||
21247680|NCT01640951|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21247681|NCT00582972|University of Wisconsin|Dr. Karen Hansen|608-263-3457|keh@medicine.wisc.edu|
21247682|NCT03911271|Rigshospitalet-Glostrup|Niklas Cyril Hansen MD-PhD|+45 31433244|niklas.cyril.hansen@regionh.dk|
21247683|NCT00293397|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
21247684|NCT02195232|Beth Israel Deaconess Medical Center, Harvard Medical School|Jeffrey Zwicker, Division of Thrombosis and Haemostasis, Division of Hematology and Oncology|617.667.9299|jzwicker@bidmc.harvard.edu|
21247685|NCT02139436|Spaulding Rehabilitation Hospital|Glen Picard|6177585511|gpicard@partners.org|
21247686|NCT03950817|Maimonides Medical Center|Dr. Sergey Motov (Director of Emergency Medicine Research)|718-283-8693|smotov@maimo.org|
21247687|NCT03304587|Michigan State University College of Nursing|Dr. Horng-Shiuann Wu, Associate Professor|517-884-4643|wuhorngs@msu.edu|
21247688|NCT04187573|Cerus Endovascular, part of Stryker Corporation|Vanessa Sarge|5103292048|vanessa.sarge@stryker.com|
21247689|NCT01458366|Sidney Kimmel Cancer Center at Thomas Jefferson University|Joanna Filicko-O'Hara, MD|215-503-7787|Joanna.Filicko@jefferson.edu|
21247690|NCT04647487|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21247691|NCT03840902|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21247692|NCT00174252|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21247693|NCT04144868|Affiliated Hospital of Jiujiang University|Zhiying Chen|+86 13767263459|zychenjj@jju.edu.cn|
21262755|NCT01355068|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21262756|NCT04229446|OsloUH|Primary Investigator Dr. Tone Rustøen|+47 22859229|tone.rustoen@medisin.uio.no|
21262757|NCT00705224|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21281027|NCT03440229|University of Pennsylvania|Dr. James D. Lewis|215-573-5137|james.lewis@pennmedicine.upenn.edu|
21281028|NCT00931411|Innovaderm Research|Annie Levesque|514-521-4285|alevesque@innovaderm.ca|222
21262758|NCT03283163|VA Boston Healthcare System|Erica R. Checko (Scioli), PhD|857-364-5696|ericarose.scioli@va.gov|
21262759|NCT02566525|University of Kentucky College of Medicine|Dr. Joseph Zwischenberger, MD|859-323-6013|jzwis2@uky.edu|
21262760|NCT03141086|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21262761|NCT04936724|University of Pennsylvania|Andrew Strasser Ph.D.|215-746-5788|strasse3@pennmedicine.upenn.edu|
21262762|NCT03902366|VA Portland Health Care System|Jennifer Loftis, PhD|503-220-8262|jennifer.loftis@va.gov|57155
21262763|NCT02369835|Stanford University|Beth Beadle|650-723-6194|bbeadle@stanford.edu|
21262764|NCT01441440|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inuiries@pfizer.com|
21262765|NCT01345123|Health Dialog|David R Veroff, MPP, SVP Analytic Development|617-406-5219|dveroff@healthdialog.com|
21262766|NCT03097328|Dana Farber Cancer Institute|Bradley McGregor, MD|617-632-6328|Bradley_McGregor@DFCI.harvard.edu|
21262767|NCT00883558|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|858-794-8889||
21262768|NCT03650452|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21294945|NCT04420572|SultanAbdulhamid|Adem Erbirol|+905426608788|aerbirol@hotmail.com|
21294946|NCT02305017|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21294947|NCT02302092|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21294948|NCT01944098|TeamHealth Anesthesia|Enrico Camporesi MD|813-844-7170|ecampore@health.usf.edu|
21294949|NCT04669262|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21294950|NCT00445211|William Beaumont Hospital|Dr. Justin Trivax|(248)587-2300|Justin.Trivax@beaumont.edu|
21294951|NCT03549871|Sanofi ( Genzyme, a Sanofi Company )|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
21294952|NCT00737568|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21294953|NCT01133626|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21294954|NCT00855933|The Procter & Gamble Co.|Jon Witt|513-622-2963|witt.jj.2@pg.com|
21294955|NCT00951080|KCI|VP, Global Clinical Development|12102555595|jkhart@mmm.com|
21294956|NCT05463744|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21294957|NCT01960998|Birmingham VA Medcial Center|Kathryn L. Burgio, PhD|205-999-9537|kburgio@uabmc.edu|
21294958|NCT01311115|University of California, San Francisco|Justin White|415-476-8045|Justin.White@ucsf.edu|
21294959|NCT03088748|University of Tennessee|Dr. Michael LaCour|8659742093|mlacour@utk.edu|
21294960|NCT03761394|UMass Chan Medical School|Edith Mensah Otabil|774-455-6574|edith.mensahotabil@umassmed.edu|
21294961|NCT03832114|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21294962|NCT00559468|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21294963|NCT01939002|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21247694|NCT05051982|Indiana University School of Medicine (Dept of Anesthesia)|Dr. Timothy Webb|2196893636|ttwebb@iu.edu|
21294964|NCT00750191|The Center for Clinical Research|Dr. Leonard Kapural|1-336-765-6181|LKapural@ccrpain.com|
21294965|NCT02910401|University of Virginia|Larry Borish, MD|4342436570|lb4@virginia.edu|
21294966|NCT01660672|University of Rochester Medical Center|Gretchen Birbeck|585-273-4265|Gretchen_Birbeck@URMC.Rochester.edu|
21294967|NCT01165112|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org|
21294968|NCT00098748|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21294969|NCT03955250|Butler Hospital|Brandon Gaudiano, Ph.D.|401-455-6457|BGaudiano@Butler.org|
21294970|NCT01774253|NMTRC|Giselle Sholler, MD|6162670335|genevieve.bergendahl@helendevoschildrens.org|
21294971|NCT00433160|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21294972|NCT02240368|University of Foggia|Alberto Sciusco||alberto.sciusco@gmail.com|
21294973|NCT03802344|MC2 Therapeutics|Irene Sandholdt|+45 2015 7033|isa@mc2therapeutics.com|
21294974|NCT01010568|Georgetown University Hospital|Bruce D. Cheson|202-444-1212|bdc4@georgetown.edu|
21294975|NCT02793817|Kala Pharmaceuticals, Inc.|Head, Clinical Operations|781-996-5252|Results005@kalarx.com|
21294976|NCT01097642|The Methodist Hospital Research Institute|Dr. Jenny Chang|713 441-0680|jcchang@houstonmethodist.org|
21294977|NCT03995680|Swiss Tropical and Public Health Institute|Dr. Jennifer Keiser|+41612848218|jennifer.keiser@swisstph.ch|
21294978|NCT00871117|GlaxoSmithKline|GSK Response Center|866-435-7343||
21294979|NCT03222973|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21294980|NCT02080481|Cleveland Clinic|Aplarslan Turan, MD|216-445-9857|turana@ccf.org|
21294981|NCT02439450|NightHawk Biosciences Inc.|Vice President, Clinical Development|9197948950|info@nighthawkbio.com|
21294982|NCT03998670|PEDIG Coordinating Center, Jaeb Center for Health Research|Raymond Kraker, PEDIG Coordinating Center Director|813 975 8690|rkraker@jaeb.org|
21247695|NCT00979121|ARDS Network|David A. Schoenfeld, PhD ARDSNet CCC PI|617-726-6111|dschoenfeld@mgh.harvard.edu|
21247696|NCT02107261|Icahn School of Medicine at Mount Sinai|David Simpson, M.D.|2122418748|david.simpson@mssm.edu|
21247697|NCT01913314|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21247698|NCT04337931|Pyxis Oncology, Inc.|Pyxis Oncology Clinical Operations|(339) 545 8252|clinicaltrials@pyxisoncology.com|
21247699|NCT01738438|Dana-Farber Cancer Institute|Sara Tolaney, MD|617.632.2335|Sara_Tolaney@DFCI.HARVARD.EDU|
21247700|NCT00645359|University of Michigan Comprehensive Cancer Center|Dr. Daniel Lebovic, M.D.|734-936-5310|dlebovic@umich.edu|
21247701|NCT02130557|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21247702|NCT01532999|Tuscaloosa VA Medical Center|Lori L. Davis, MD|205-554-2000|lori.davis@va.gov|
21247703|NCT02928172|Cedars Sinai Medical Center|Dr. Ofelia Loani Elvir Lazo, Research Project Advisor|310-423-1682|loani.elvir-lazo@cshs.org|
21247704|NCT02408887|National Cancer Institute|Dr. Naris Nilubol|240-760-6154|niluboln@mail.nih.gov|
21247705|NCT04474496|University of Arkansas for Medical Sciences|Dr. Pearl A. McElfish|479-713-8680|pamcelfish@uams.edu|
21247706|NCT03333109|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21247707|NCT04066075|University of California Los Angeles|Ava K. Bittner, OD, PhD|310-206-9566|researchatvrc@gmail.com|
21247708|NCT00309166|GlaxoSmithKline|GSK Response Center|866-435-7343||
21247709|NCT00701701|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21247710|NCT03224481|Queen Mary University of London|Professor Padhraig Fleming|02073777397|padhraig.fleming@qmul.ac.uk|
21247711|NCT03593226|BioLineRx Ltd|VP Clinical & Medical Affairs|+972-8-6429100|clinicaltrials@biolinerx.com|
21247712|NCT04057820|University of Arkansas for Medical Sciences|Dr. Songthip Ounpraseuth|5016867233|stounpraseuth@uams.edu|
21294983|NCT04644796|Missouri Orthopaedic Institute|Angela Atkinson|573-884-1128|avadd9@umsystem.edu|
21294984|NCT04508751|University of California Los Angeles|Dr. Kara Calkins|3108259330|kcalkins@mednet.ucla.edu|
21247713|NCT04517435|Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center|Dr. Deepa Jagadeesh|1-866-223 8100|TaussigResearch@ccf.org|
21262769|NCT00750555|Geisinger|Office of Research Compliance|570-214-9628|orc@geisinger.edu|
21262770|NCT03539458|Abbott Vascular Structural Heart|Reshma Rao, Principal Study Clinical Research Associate|651-756-2542|reshma.rao@abbott.com|
21262771|NCT02983981|Psoriasis Treatment Center of Central New Jersey|Jerry Bagel Director of Clinical Trials|6094434500|dreamacres1@aol.com|
21262772|NCT01984346|AtriCure|Medical Director of Clinical Education|513-560-5974|SGaynor@atricure.com|
21262773|NCT05936385|Nemours Children's Health|Thao-Ly Phan, Associate Professor of Pediatrics|302-331-7342|tphan@nemours.org|
21262774|NCT02042404|EarLens Corporation|Dr. Suzanne Levy, Director of Clinical Research|650 366 9000|slevy@earlenscorp.com|
21294985|NCT02436668|Pharmacyclics, An AbbVie Company|George Cole|(408) 990-7340|gcole@pcyc.com|
21262775|NCT03100942|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21294986|NCT03551665|Arizona State University|Daniel Peterson|602-543-9373|daniel.peterson1@asu.edu|
21262776|NCT01523808|Erytech Pharmaceuticals|Director of Clinical Trials|+33 4 78 74 44 38|contact@erytech.com|
21262777|NCT01876732|Staten Island University Hospital|Suzanne El-Sayegh|718-226-6158|uviola@siuh.edu|
21262778|NCT00536731|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21262779|NCT00718419|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21262780|NCT00771407|LifeCell Corporation|Chief Medical Officer|908-947-1104|mfranz@lifecell.com|
21262781|NCT01675531|Seoul ST.Mary's Hospital|Jin-Hyong Kang|82-2-2258-6043|jinkang@catholic.ac.kr|
21262782|NCT04184622|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
21262783|NCT02795988|Imugene|Study Director|+61 2 9423 0881|info@imugene.com|
21262784|NCT02341014|Memorial Sloan Kettering Cancer Center|Dr. Steve Horwitz, MD|646-608-2680|horwitzs@MSKCC.ORG|
21262785|NCT00726323|GlaxoSmithKline|GSK Response Center|866-435-7343||
21262786|NCT05058664|University of Michigan|Ewa Czyz|734 764-9466|ewac@med.umich.edu|
21262787|NCT02599766|Swiss TPH|Dr. Karin Hediger|0041795197885|karin.hediger@unibas.ch|
21294987|NCT05538312|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294988|NCT00859339|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
21294989|NCT00642174|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21294990|NCT01730339|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294991|NCT00896363|GlaxoSmithKline|GSK Response Center|866-435-7343||
21294992|NCT01065051|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21294993|NCT02068846|University of North Carolina at Chapel Hill|Jennifer Webster-Cyriaque, DDS, PhD|(919) 537-3492|jwebster@email.unc.edu|
21294994|NCT01145352|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21294995|NCT03095027|Alcon, A Novartis Division|Senior Clinical Project Lead, GCRA - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21294996|NCT02982018|Johnson & Johnson Vision|John Buch- SENIOR PRINCIPAL RESEARCH OPTOMETRIST|904 443-1707|JBUCH@its.jnj.com|
21294997|NCT03638908|UTSouthwestern medical center|Kelly Chin, MD|2146456493|kelly.chin@utsouthwestern.edu|
21294998|NCT02251717|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21294999|NCT04098367|Alcon Research, LLC|Sr. CDMA Project Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21295000|NCT00322023|Nathan Kline Institute|Dr. Daniel Javitt|845-398-6534|javitt@nki.rfmh.org|
21295001|NCT03920293|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
21295002|NCT03989427|Melaka-Manipal Medical College|Dr. Rajesh Hosadurga|+6062896662|rajesh.hosadurga@manipal.edu.my|3823
21295003|NCT01972308|University of Pennsylvania|Andrea J Apter, MD|215 349-5120|andrea.apter@uphs.upenn.edu|
21295004|NCT02002936|SymBio Pharmaceuticals|Katsuhisa Goto|+81-3-5472-1127||
21295005|NCT00369226|Dana-Farber Cancer Institute|John Koreth, MBBS, D.Phil|(617) 632-2949|jkoreth@partners.org|
21295006|NCT01685801|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21295007|NCT00113399|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org|
21295008|NCT00666588|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21295009|NCT00834990|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21295010|NCT00521599|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21295011|NCT00791479|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21295012|NCT00496197|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21295013|NCT00149994|Novartis Pharmaceuticals|Study Director|862-778-8300||
21295014|NCT01610713|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
21295015|NCT01364558|University of Minnesota|Dr. James Cloyd, Director for Center for Orphan drug research|612-624-4609|cloyd001@umn.edu|
21295016|NCT04599959|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21295017|NCT04049266|Kodiak Sciences Inc.|Pablo Velazquez-Martin, MD|1 (650) 281-0850|ClinOps@kodiak.com|
21295018|NCT02309645|Ethicon Inc.|Senior Franchise Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21295019|NCT04600076|University of Michigan|Katherine Jo Gold|734 998-2499|ktgold@med.umich.edu|
21295020|NCT03664674|Otonomy, Inc.|Otonomy Medical Information Center|1-844-686-4636|medinfo@otonomy.com|
21262788|NCT01617681|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
21295021|NCT01342965|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21295022|NCT00856206|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
21262789|NCT01883440|Umeå University|MD, PhD Krister Tano|0046705569043|krister.tano@umu.se|
21295023|NCT01175434|University of Rochester|Dr. Jill Halterman|5852755798|jill_halterman@urmc.rochester.edu|
21262790|NCT03480282|Beth Israel Deaconess Medical Center|Mara Schonberg|16177541414|mschonbe@bidmc.harvard.edu|
21262791|NCT02528500|W. L. Gore & Associates|Rimma Zakharyan|928 310 6961|rzakhary@wlgore.com|
21262792|NCT00316303|Dartmouth-Hitchcock|Stanley Rosenberg, Ph.D.|603-653-0740|Stanley.d.rosenberg@dartmouth.edu|
21262793|NCT03838367|CytoDyn|Joseph Meidling - Vice President, Clinical Operations|3609808524|jmeidling@cytodyn.com|
21262794|NCT03015610|Duke University|Jason Lang, MD|919-684-3364|jason.lang@duke.edu|
21262795|NCT01417780|Atox Bio, Ltd.|Wayne M Dankner, MD, Chief Medical Officer|1 919-219-6377|wayned@atoxbio.com|
21262796|NCT02375698|UCT|Dr. Rodney Dawson|27214066850|rodney.dawson@uct.ac.za|
21262797|NCT01632878|Mylan|Patrick Aubonnet / Medical Director||patrick.aubonnet@mylan.com|
21262798|NCT03634072|Children's Hospital of Philadelphia|Dr Mark Fogel|215-590-7566|fogel@chop.edu|
21262799|NCT02307526|James J. Peters VA Medical Center|Jill M. Wecht|7185849000|jm.wecht@va.gov|3122
21262800|NCT03595215|TheraNova|Clinical Research Associate|415-926-8616|akrajcevska@theranova.com|
21262801|NCT03184701|Albert Einstein Healthcare Netwrok|Manisha Verma|2154561026|vermam@einstein.edu|
21262802|NCT01259297|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21262803|NCT00279500|Second Sight Medical Products, Inc.|Jessy Dorn, PhD, Director, Clinical and Scientific Research|8188335089|jdorn@secondsight.com|
21262804|NCT02186795|MUSC|Sylvia Wilson, MD|843-732-2322|wilsosh@musc.edu|
21262805|NCT00504166|University of California San Francisco|Dr. Thomas M. Link|415-353-2450|Thomas.Link@ucsf.edu|
21262806|NCT01096550|Friends Research Institute|Dr. Shannon Gwin Mitchell|410-837-3977|smitchell@friendsresearch.org|238
21262807|NCT01555463|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21262808|NCT01165203|GlaxoSmithKline|GSK Response Center|866-435-7343||
21262809|NCT00797459|Medicis|Ron Staugaard|480-291-5652|rstaugaard@medicis.com|
21262810|NCT01519570|The Ohio State University College of Pharmacy|Stuart Beatty|6146888466|beatty.52@osu.edu|
21262811|NCT02815397|Northwestern University|Dr. R Karmali|312-695-6832|reem.karmali@northwestern.edu|
21262812|NCT00085540|Adult Brain Tumor Consortium (ABTC)|Howard Fine, MD|410-955-8837|jfisher@jhmi.edu|
21262813|NCT02389946|BIOTRONIK, Inc|Amy Culley, Director of Vascular Intervention Clinical Studies|503-451-8034|amy.culley@biotronik.com|
21262814|NCT01605396|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21262815|NCT04598165|Women and Infants Hospital of Rhode Island|Jennifer Unger, MD, MPH. Associate Professor, Department of Obstetrics and Gynecology|(401) 274-1122|jennifer_unger@brown.edu|48554
21262816|NCT02345642|Hospital for Special Surgery|Dr. Geoffrey Westrich|212-606-1510|ortizp@hss.edu|
21262817|NCT00426751|GlaxoSmithKline|GSK Response Center|866-435-7343||
21262818|NCT04238663|mAbxience Research SL|Susana Millan|+34917711500|susana.millan@mabxience.com|
21262819|NCT00337467|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21262820|NCT03017924|Cincinnati Childrens Hospital|Kim Foss|5136365971|kim.foss@cchmc.org|
21262821|NCT01745627|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
21262822|NCT04430582|Joslin Diabetes Center|Mary Elizabeth Patti, MD|6173091966|MaryElizabeth.Patti@Joslin.Harvard.edu|
21262823|NCT03607682|Vanderbilt University Medical Center|Teresa Melton|6159367423|teresa.melton@vumc.org|
21262824|NCT01770353|Ipsen Bioscience, Inc|Medical Director|See email|clinical.trials@ipsen.com|
21295024|NCT02638207|CRMG|Mikaela Raymond|866-337-1868|ctgov@clinicalresearchmgt.com|
21295025|NCT01170598|University Health Network|Sara O'Neill|416-597-3422|o'neill.sara@torontorehab.on.ca|7860
21295026|NCT04584346|National Institutes of Health|Dr. Debra Ehrlich|301-443-7888|debra.ehrlich@nih.gov|
21247714|NCT06191679|Children's Hospital of Philadelphia|Shannon Hammer|2678878580|bresslers@chop.edu|
21247715|NCT05464732|Carolina Eyecare Physicians, LLC|Director of Clinical Trials|8438813937|hps@cepmd.com|
21247716|NCT05501600|University of Pittsburgh|Keith Vogt|412-647-3147|vogtkm@upmc.edu|
21247717|NCT02678689|BioMarin Pharmaceutical Inc|Pascal Reisewitz, Global Medical Director, PhD|1-800-983-4587|medinfo@bmrn.com|
21247718|NCT02761187|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21247719|NCT05786612|Coloplast, Clinical strategies|Malene Hornbak Landauro, Medical writer of Clinical strategies|004549112057|dkmhla@coloplast.com|
21247720|NCT05890794|AM-Pharma|AM-Pharma Office|31 (0)30 228 92 22|office@am-pharma.com|
21247721|NCT04538352|The Cleveland Clinic Foundation|Research Administrator|(216) 445-4791|jenkink@ccf.org|
21247722|NCT05630833|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21247723|NCT03459196|Johnson and Johnson Medical NV/SA|Nathalie Macours / Clinical Research Director|+32 2 746 35 27|nmacours1@its.jnj.com|
21247724|NCT02303392|The Ohio State University Comprehensive Cancer Center|Dr. Jennifer Woyach|614-293-8165|Jennifer.Woyach@osumc.edu|
21247725|NCT00092534|Merck Sharp & Dohme Corp.|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21247726|NCT03083366|University of Utah|Karena McDonald|801-699-9740|karena.mcdonald@hsc.utah.edu|
21247727|NCT03668899|CairoU|Dr. Amira Farouk|01007192834|Amirafarouk77@gmail.com|
21247728|NCT06056310|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21247729|NCT04440228|University of Pennsylvania|Dr. Courtney Wolk|215-746-6099|courtney.wolk@pennmedicine.upenn.edu|
21247730|NCT02036970|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21262825|NCT03022032|Dana-Farber Cancer Institute|Dr. Alexi Wright|617-632-2334|alexi_wright@dfci.harvard.edu|
21262826|NCT00620321|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21262827|NCT01109004|The Emmes Corporation|Adam Mendizabal, PhD||amendizabal@emmes.com|
21262828|NCT02410902|Curemark|William E. Gannon, Jr MD, Medical Director|914-824-9716|william.gannon@curemark.com|
21262829|NCT02279524|Galmed Research and Development, Ltd.|Medical Director|+972.3.693.8448|clinicaltrial@galmedpharma.com|
21262830|NCT01746732|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21262831|NCT02817555|Eastern Health|Andrea Woodland|7097778146|andrea.woodland@easternhealth.ca|
21262832|NCT00137436|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21262833|NCT00701727|Radiant Research|Michael H Davidson, MD FACC|312-494-2220|michaeldavidson@radiantresearch.com|
21262834|NCT00912015|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
21262835|NCT01847638|Toyos Clinic|Melissa Toyos|6153274015|mtoyos@toyosclinic.com|
21262836|NCT05137041|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21262837|NCT02090114|Johns Hopkins University School of Medicine|Samuel Denmeade, M.D.|410-502-8341|denmesa@jhmi.edu|
21262838|NCT00392171|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21262839|NCT01605071|University of Colorado Denver, Anschutz Medical Campus|Kimberly Cox-York||KIMBERLY.COX-YORK@CUANSCHUTZ.EDU|
21262840|NCT02856581|Mayo Clinic|Dr. Ivana T. Croghan|507-284-7313|croghan.ivana@mayo.edu|
21262841|NCT00510224|UCSF|Charles J. Ryan, MD|415-353-9279|ryanc@medicine.ucsf.edu|
21262842|NCT00051558|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21262843|NCT04067765|University of Kansas|Dr. Michael Amlung|785-864-0334|mamlung@ku.edu|
21262844|NCT01881620|Institut Bergonié, Medical Imaging Department|Dr. Anne-Laure Cazeaux, Nuclear physician|05.56.33.78.60|A.cazeaux@bordeaux.unicancer.fr|
21262845|NCT02163993|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21262846|NCT00414310|The University of Texas (UT) MD Anderson Cancer Center|Hagop Kantarjian, MD/Chair, Leukemia Department|713-792-7026|hkantarjian@mdanderson.org|
21262847|NCT01808118|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21262848|NCT03070730|Beth Israel Deaconess Medical Center|Dr. Roy Freeman|617-632-8454|rfreeman@bidmc.harvard.edu|
21262849|NCT01993329|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21262850|NCT01815333|UT MD Anderson Cancer Center|Haesun Choi, MD/ Professor, Abdominal Imaging Department|713-745-4693|hchoi@mdanderson.org|
21262851|NCT01163162|Indiana University|Dr. Rajiv Agarwal|317 988 2241|ragarwal@iu.edu|
21262852|NCT01405313|ResMed|Director Medical Affairs|+6128841000|adamb@resmed.com.au|
21262853|NCT03685019|University of Oxford|Thomas Hamilton|01865 227374|thomas.hamilton@ndorms.ox.ac.uk|
21262854|NCT00109733|EMD Serono|Sanja Dragnic/Medical Responsible|+7816814017|sanja.dragnic@emdserono.com|
21262855|NCT00669539|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-875-8690|pedig@jaeb.org|
21262856|NCT04126603|George Washington University|Sabyasachi Sen|202-994-8560|ssen1@gwu.edu|
21262857|NCT05374408|UNMC|Margaret Emerson|4025596625|margaret.emerson@unmc.edu|
21262858|NCT00376597|The Ohio State University Comprehensive Cancer Center|Electra D. Paskett, PhD|614-293-3917|electra.paskett@osumc.edu|
21262859|NCT05100316|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21262860|NCT00879814|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21262861|NCT00630812|Pharmaxis|Brett Charlton|02 94547210|Brett.Charlton@pharmaxis.com.au|
21262862|NCT00972478|SWOG|Study Statistician|206-667-4623||
21262863|NCT02561000|Tufts Medical Center|Athan Kuliopulos, MD, PhD|617-636-8482|athan.kuliopulos@tufts.edu|
21262864|NCT01234402|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21262865|NCT03993691|University of North Carolina at Chapel Hill|Director, Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
21262866|NCT02280291|NYU Langone Health|Nirmal Tejwani|212 598 6599|Nirmal.Tejwani@nyulangone.org|
21262867|NCT05175261|Prolocor, Inc|David J Schneider, MD|8023730071|david.schneider@prolocor.com|
21262868|NCT00506077|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21262869|NCT02918266|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21262870|NCT01293032|Virginia Commonwealth University/Massey Cancer Center|Harry D Bear, MD, PhD|804-828-9325|harry.bear@vcuhealth.org|
21262871|NCT02243527|University of British Columbia|Dr. Jordan A. Guenette|604.682.2344|Jordan.guenette@hli.ubc.ca|62129
21262872|NCT01106534|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
21262873|NCT02641236|Dana-Farber Cancer Institute|Dr. Leslie Lehmann|617-632-4882|Leslie_Lehmann@DFCI.HARVARD.EDU|
21262874|NCT00148733|University of Bergen|Tor A Strand|90971086|tor.strand@cih.uib.no|
21262875|NCT01603641|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21262876|NCT00114972|Boston Scientific|Nic Van Dyck / Senior Program Manager|+ 31 43 356 8328|vandyckn@bsci.com|
21262877|NCT00358917|Abbott|Medical Information Specialist|800-633-9110||
21262878|NCT00759473|MUSC|Dr. McRae-Clark|843-792-5216|mcraeal@musc.edu|
21262879|NCT02401555|Bio-Rad Laboratories|David Bhend|425 498 1758|david_bhend@bio-rad.com|
21262880|NCT00772967|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21262881|NCT02144220|University of Rochester|Ray Dorsey, MD|585-275-0663|ray.dorsey@chet.rochester.edu|
21262882|NCT01558089|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21262883|NCT00053846|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
21262884|NCT00592501|Massachusetts General Hospital|Annie W. Chan, MD|617-726-5184|AWCHAN@PARTNERS.ORG|
21262885|NCT02229864|Abbott Vascular|Latania Chura|503-935-3002|latania.chura@abbott.com|
21262886|NCT00170157|Mayo Clinic|Eugene D. Kwon||kwon.eugene@mayo.edu|
21262887|NCT02650284|Stryker|Alissa Connelly|+61294671000|alissa.connelly@stryker.com|1075
21262888|NCT00509873|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
21262889|NCT00554294|Research Institute of Child Nutrition, Dortmund|Dr. Mathilde Kersting|0049 231 79221013|kersting@fke-do.de|
21262890|NCT05022004|Sun Pharmaceutical Industries Limited|Head-Clinical Development|2266455645|clinical.trial@sunpharma.com|5689
21262891|NCT02807454|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
21262892|NCT02275026|Icahn School of Medicine at Mount Sinai|Dr. Joshua Mincer|(917) 922-9475|joshua.mincer@mountsinai.org|
21262893|NCT01585129|WashingtonU|Dr. Anthony Shanks|3179448182|ashanks@iupui.edu|
21262894|NCT05468086|Cedars-Sinai Medical Center|Omer Liran, MD, MSHS|31042333754|omer.liran@cshs.org|
21262895|NCT00374907|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
21262896|NCT01280123|Northwestern University|Tanya Simuni, MD||TSimuni@nm.org|
21262897|NCT01618955|Antares Pharma Inc.|Jonathan Jaffe, MD; Vice President-Clinical Development|609-359-3020|jjaffe@antarespharma.com|324
21262898|NCT01200511|Alcon Research, Ltd.|Brand Lead, Surgical, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
21262899|NCT03382899|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|www.ClinicalTrials.gov@lilly.com|
21262900|NCT00540722|Adult Brain Tumor Consortium (ABTC)|John Fiveash, MD|410-955-8837|jfisher@jhmi.edu|
21262901|NCT02504892|National Cancer Institute|Dr. Ramaprasad Srinivasan|301-451-2298|srinivasanr@mail.nih.gov|
21262902|NCT00524745|PATH|Kathleen Neuzil, Principal Investigator|206-285-3500|kneuzil@path.org|4864
21295027|NCT02780856|Calcivis Ltd|Director of Clinical Research|+ 44 131 658 5152|mwillins@calcivis.com|
21295028|NCT04270682|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
21295029|NCT01790178|Duke University|Lisa Hobson-Webb|919-668-2277|lisa.hobsonwebb@dm.duke.edu|
21295030|NCT03478254|Ciudad Real University Hospital. Castilla La Mancha Health Service.|Angela M. Seco Segura RN, Endocrinology and Nutrition Department.|926278000|amsese@live.com|79510
21295031|NCT02437409|phenox GmbH|Clinical Affairs|+49 (0)234 36 919|ARTESp@phenox.info|0
21295032|NCT01352442|AcuFocus, Inc.|Eugenia Thomas, OD|949-585-9511|ethomas@acufocus.com|
21295033|NCT05131971|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21247731|NCT02702843|Cleveland Clinic Florida|Lo Menzo, M.D.,Emanuele|9546595000|lomenze@ccf.org|
21247732|NCT05802173|Technoderma Medicines|Arthur P. Bertolino MD, PhD, MBA Chief Medical Officer|+1.616.928.1145|arthur.bertolino@innovationderm.com|
21247733|NCT01779141|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
21247734|NCT03752684|University of Alabama at Birmingham|John Knight|205-996-2295|johnknight@uabmc.edu|
21247735|NCT02677766|University of Modena and Reggio Emilia|Stefania Costi|+390522522441|stefania.costi@unimore.it|
21247736|NCT00360269|Medical University of South Carolina|Aimee McRae-Clark, Pharm.D., BCPP|843-792-5215|mcraeal@musc.edu|
21247737|NCT02351791|Scientific and Regulatory affairs|Sara Gosk|+45 49113568|dksargo@coloplast.com|
21247738|NCT00048932|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21247739|NCT03987581|Duke University School of Medicine|Angela Kirby|9198247729|angela.caison.kirby@gmail.com|
21247740|NCT02568215|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
21247741|NCT00790569|Butler Hospital|Dr. Michael Stein|401-455-6646|michael_stein@brown.ed|
21247742|NCT01627561|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21247743|NCT03244800|MedImmune Limited|Victoria Parker|+44 747 1357152|information.center@astrazeneca.com|
21247744|NCT02330588|Department of Pediatrics, University of Alberta|Dr. Geoff Ball|780-248-5490|gdball@ualberta.ca|
21247745|NCT02803749|University of Rochester|Dr. Ruth Schneider|584-341-7500|ruth_schneider@urmc.rochester.edu|
21262903|NCT00576693|Medical University of South Carolina|Marc I. Chimowitz, MBChB|843-792-3020|mchimow@musc.edu|
21281029|NCT00793455|Northwestern University|Kenzie A. Cameron, PhD, MPH|312-503-3910|k-cameron@northwestern.edu|
21281030|NCT02329015|Long Island University|Marshall Hagins PhD, PT|3478048512|mhagins@liu.edu|
21281031|NCT01306305|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
21281032|NCT04030299|The University of Iowa|Dr. Yu-Hsaing Wu|(319) 335-9758|yu-hsiang-wu@uiowa.edu|
21281033|NCT00699998|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21281034|NCT03093701|Taiwan Liposome Company|Dr. Carl Brown|886-2-2655-7377|tlc_clinicaltrials@tlcbio.com|
21281035|NCT04616612|Indiana University|Dr. Rebecca Bartlett Ellis|3172740047|rjbartle@iu.edu|
21281036|NCT01451463|The Ohio State University|Sandra K Kostyk, MD, PhD|6142934969|sandra.kostyk@osumc.edu|
21281037|NCT04740918|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21281038|NCT01168427|Medtronic - CRDM|RIO Clinical Research Specialist.|1-800-328-2518|MedtronicCRMtrials@medtronic.com|63277
21281039|NCT00266279|University of Louisville, James Graham Brown Cancer Center|University of Louisville, James Graham Brown Cancer Center Clinical Trials|502-562-3429|bcccto@louisville.edu|
21281040|NCT02964247|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21281041|NCT03759392|Cytokinetics, Inc.|Cytokinetics MD|650-624-2929|medicalaffairs@cytokinetics.com|
21281042|NCT01288079|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21281043|NCT01530464|Duke University Medical Center|Dr. Thies Schroeder|919 681 4721|thies.schroeder@duke.edu|
21281044|NCT01709500|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com|
21281045|NCT00226577|Karmanos Cancer Institute|Gerold Bepler, M.D., Ph.D. via Moffitt Cancer Center|813-745-4398|beplerg@karmanos.org|
21281046|NCT02044380|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21281047|NCT04143373|Tehran UMS|Dr. Nariman Nikparto|+989124969058|n-nikparto@razi.tums.ac.ir|
21281048|NCT03888469|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21281049|NCT03539302|InCarda Therapeutics|VP Clinical Operations|510-422-5522|propst.meisa@incardatherapeutics.com|111
21281050|NCT01927120|H. Lee Moffitt Cancer Center and Research Institute|Dr. Brian Betts|813-745-5410|brian.betts@moffitt.org|
21281051|NCT02107131|California Retina Consultants|Director of Research|8059631648|gabe@californiaretina.com|
21295034|NCT02251561|Alcon Japan, Ltd.|Director, Clinical & Regulatory Affairs, Division of Medical Affairs||alcon.medinfo@alcon.com|
21262904|NCT01413178|U.T. MD Anderson Cancer Center|Dr. Muzaffar H. Qazilbash / Stem Cell Transplantation and Cellular Therapy|713-745-3219|mqazilba@mdanderson.org|
21262905|NCT00540449|Janssen Infectious Diseases BVBA|Medical Leader||ClinicalTrialDisclosure@its.jnj.com|
21262906|NCT00376688|The University of Chicago Comprehensive Cancer Center|Dr. Gini F. Fleming|773-702-6712|gfleming@medicine.bsd.uchicago.edu|
21262907|NCT05128162|University of Michigan|Kevin Boehnke, PhD|734-998-6939|kboehnke@med.umich.edu|
21262908|NCT06787781|university of messina|Dr Fiammetta Iannuzzo|327 628 4688|fiannuzzo@unime.it|
21262909|NCT01113398|Duke University Medical Center|Katherine B. Peters, MD, PhD|919-684-6173|katy.peters@duke.edu|
21262910|NCT02262039|Yale University|Dr. Sanjay Kulkarni|203-785-6501|sanjay.kulkarni@yale.edu|
21262911|NCT04174638|Akdeniz University|Dr Sefika Tugba Yangoz|+905058039716|tugbayangoz@gmail.com|
21262912|NCT01831934|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
21262913|NCT02985450|Carla Coffin|Dr.|403-220-7808|cscoffin@ucalgary.ca|
21262914|NCT00069576|GWU Biostatistics Center|Rebecca Clifton, Ph.D.|(301) 881-9260|rclifton@bsc.gwu.edu|
21262915|NCT00905307|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800-562-3924||
21262916|NCT05590793|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
21262917|NCT04060667|Massachusetts General Hospital|Adeline Boatin|617 724 61320|adeline_boatin@mgh.harvard.edu|
21262918|NCT04488822|Daiichi Sankyo, Inc.|Clinical Director|908-992-6400|CTRinfo@dsi.com|
21262919|NCT03406104|Gensight Biologics|Magali TAIEL Chief Medical Officer|0762891252|mtaiel@gensight-biologics.com|
21262920|NCT03277729|Fred Hutchinson Cancer Center|Mazyar Shadman|206-667-4216|mshadman@fredhutch.org|
21262921|NCT03347617|Oregon Health and Science University|Amy Huddleston|5034942910|huddlesa@ohsu.edu|
21262922|NCT02005601|Hospital for Special Surgery|Dr. Jacques Yadeau|212-606-1206|yadeauj@hss.edu|
21262923|NCT02890329|Dana Farber Cancer Institute|Dr. Jacqueline Garcia|617-632-1906|Jacqueline_Garcia@dfci.harvard.edu|
21262924|NCT04111276|University of Tennessee|Dr. Michael LaCour|865-974-7684|mlacour@utk.edu|
21262925|NCT01035255|Novartis Pharmaceuticals|Study Director|862-778-8300||
21262926|NCT01556633|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21295035|NCT02124018|First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens|Professor Konstantinos A. Gatzoulis|6944580369|kgatzoul@med.uoa.gr|0030
21295036|NCT00835640|Manager, Biopharmaceutics|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21295037|NCT00068250|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21295038|NCT01357161|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21295039|NCT01824823|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
21295040|NCT02345772|CTCA|Jessica L. Coats, RN|6232073899|jessica.coats@ctca-hope.com|
21281052|NCT04314037|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21281053|NCT01941615|Boehringer Ingelheim|Boehringer Ingelheim Call Center|+1 800 243 0127|clintriage.rdg@boehringer-ingelheim.com|
21281054|NCT04707573|Akebia Therapeutics|Akebia Therapeutics|617-844-6128|trials@akebia.com|
21281055|NCT00856492|SWOG Statistical Center|Breast Committee Statistician|206-667-4623||
21281056|NCT01618344|Hunstman Cancer Institute|Dr. Yelena Wu|801-213-5653|yelena.wu@utah.edu|
21281057|NCT03296813|Duke University|Robert Mentz, MD|919-668-7121|robert.mentz@duke.edu|
21281058|NCT00739882|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|Medical Responsible|+49 6151 72 5200|service@merckgroup.com|
21281059|NCT04021914|Emory University|Dr. Jeffrey N. Siegelman|4042518868|jsiegelman@emory.edu|
21281060|NCT00955409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21281061|NCT00803790|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
21281062|NCT04710576|Syndax Pharmaceuticals|Chief Medical Officer|781-419-1400|clinicaltrials@syndax.com|
21281063|NCT04162847|Washington University in St. Louis School of Medicine|Dr. Denise Wilfley|3142862079|wilfleyd@wustl.edu|
21281064|NCT05573464|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21281065|NCT05734157|Abbott|Krista Stiefel, Principal Clinical Scientist|+12246689359|krista.stiefel@abbott.com|
21281066|NCT01415518|AstraZeneca|Goran Eckerwall||ClinicalTrialTransparency@astrazeneca.com|
21281067|NCT00637312|Orthofix|Ruba Sarris|214-937-2256|rubasarris@orthofix.com|
21281068|NCT03944668|HealthPartners Neuroscience Research|Amanda Herrmann, PhD|651-495-6356|amanda.a.herrmann@healthpartners.com|
21281069|NCT02068508|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21281070|NCT00813150|Jan-Cil Germany|Therapeutic Areas Director||ClinicalTrialDisclosure@its.jnj.com|
21281071|NCT00210210|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials' Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
21281072|NCT02445248|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
21281073|NCT01217112|GW Research Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223266800|rp@gwpharm.com|
21281074|NCT03190993|Pennington Biomedical Research Center|John Apolzan|225-763-2827|john.apolzan@pbrc.edu|
21281075|NCT02596971|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21281076|NCT01401361|St. Jude Medical|Nancy Ouch|+19497695041|NOuch@sjm.com|
21281077|NCT00127231|Johns Hopkins University School of Medicine|Mary E McCaul|410-955-9526|mmccaul1@jhmi.edu|
21281078|NCT02764762|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21262927|NCT01732263|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21262928|NCT00231062|Acclarent|Laura England, Manager-Clinical Affairs|650-687-4466|lenglan1@its.jnj.com|
21281079|NCT00887575|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21295041|NCT03730961|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
21295042|NCT02071420|University of Iowa|Lucas Carr, PhD|319-353-5432|lucas-carr@uiowa.edu|
21295043|NCT00840060|Lamar University|Monica Harn|409-880-8174|monica.harn@lamar.edu|
21295044|NCT00428220|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21247746|NCT00890591|Daiichi Sankyo Pharma Development|Howard Kessler|732-590-5032|hmkessler@dsus.com|
21247747|NCT02941549|Afimmune|Study Director|+3532946380|info@afimmune.com|
21247748|NCT03234374|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
21247749|NCT01214759|The University of Texas Health Science Center at Houston|Dr. Karen Vigil|(713) 500-6703|Karen.J.Vigil@uth.tmc.edu|
21247750|NCT01664741|Johns Hopkins School of Medicine|Mary E McCaul|410-955-9526|mmccaul1@jhmi.edu|
21247751|NCT03451422|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21247752|NCT04545619|Biosense Webster, Inc.|Associate Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21247753|NCT05896267|Masimo Corporation|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
21247754|NCT01816971|University of Chicago Medical Center|Andrzej Jakubowiak, MD, PhD|773-702-4005|ajakubowiak@medicine.bsd.uchicago.edu|
21247755|NCT04384172|University of Michigan|Tim Bruns|734-647-8727|bruns@umich.edu|
21247756|NCT04949542|University of Washington (affiliate) / University of North Carolina at Chapel Hill|Dr. Benjamin Buck, Associate Professor|(919) 445-4330|buckbe@uw.edu|
21247757|NCT01567605|Simon Fraser University|Dr Victoria Claydon (Principal Investigator)|7787828513|victoria_claydon@sfu.ca|
21247758|NCT01536093|Seoul National University College of Medicine|Dr. Juyoung Lee|82-31-787-7301|lamb4122@snu.ac.kr|
21247759|NCT01211184|Södertälje Hospital|Robert Hahn|+46855024670|robert.hahn@sodertaljesjukhus.se|4670
21247760|NCT01421667|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
21247761|NCT00503906|UM/Sylvester Comprehensive Cancer CEnter|Stefan Gluck MD|305-243-4909|sgluck@med.miami.edu|
21247762|NCT03631407|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21247763|NCT01378416|Eisai Inc.|Yufang Lu, MD PhD|1-888-422-4743||
21247764|NCT03802994|Ralph H. Johnson VA Medical Center|ACOS/R, R. Amanda C. LaRue|843-789-6707|Rutha.LaRue@va.gov|
21247765|NCT00983294|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21247766|NCT00980954|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
21247767|NCT04614454|Massachusetts General Hospital|Michael Levy|6177267565|mlevy11@mgh.harvard.edu|
21247768|NCT03736564|Mayo Clinic|Dr. Stephen Broski|507-293-6155|broski.stephen@mayo.edu|
21247769|NCT02744066|Magee Womens, UPMC Hamot Hospital|Dr. Michael J. Balsan|814-877-3190|balsanmj@upmc.edu|
21247770|NCT02415127|Horizon Pharma Ireland, Ltd. Dublin, Ireland|Julie Ball, Executive Director Clinical Development & Operations||clinicaltrials@horizonpharma.com|
21247771|NCT05120856|Monash University|Dr Joshua B. B. Garfield|+61 3 8413 8711|joshuag@turningpoint.org.au|
21247772|NCT04153890|West Virginia University School of Nursing|Dr. Ubolrat Piamjariyakul, PhD, RN|3042936729|ubolrat.piamjariyakul@hsc.wvu.edu|
21247773|NCT02868970|Canadian Center for Vaccinology, Dalhousie University|Dr. Jennifer Isenor|902-494-2378|jennifer.isenor@dal.ca|
21247774|NCT03997474|Achilles Therapeutics UK Limited|Dr Matilde Saggese|0786 9814607|matildesaggese@gmail.com|
21247775|NCT05140902|University of Alabama at Birmingham|Dr. Harrison Kim|205-996-4088|hyunkikim@uabmc.edu|
21247776|NCT03277989|Stryker|Jennifer Seidman, Manager, Clinical Research|9016338616|jennifer.seidman@stryker.com|
21247777|NCT05048394|Point Designs|Becca Connolly|720-600-4753|becca@pointdesigns.com|
21247778|NCT04640974|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
21247779|NCT05037513|University of Kentucky|Dr. Hilary Surratt|8595622458|hilary.surratt@uky.edu|
21247780|NCT04257994|St George's, University of London|Dr Angeliki Asimaki|+447484764641|aasimaki@sgul.ac.uk|
21247781|NCT00984815|Horizon Pharma|Amy Y. Grahn, MS|224-383-3012|agrahn@horizonpharma.com|
21247782|NCT02986789|Masimo Corporation|Cristina Johnson|949-297-7000|clinicalresearchdept@masimo.com|
21247783|NCT02232737|University of Vermont|Stephen T. Higgins, PhD, Professor|802-735-6267|stephen.higgins@uvm.edu|
21247784|NCT03849937|University of Kansas School of Nursing|Kristine Williams, RN, PhD, FNP-BC, FGSA, FAAN, E. Jean Hill Professor|913 588 1673|kwilliams1@kumc.edu|
21247785|NCT01727167|Duke University Medical Center|John J. Freiberger, M.D.|919-684-6726|john.freiberger@duke.edu|
21247786|NCT04779177|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|6464409333|ITCIClinicalTrials@itci-inc.com|
21247787|NCT02261805|Lombardi Comprehensive Cancer Center|Giuseppe Giaccone|202-687-7072|gg496@georgetown.edu|
21247788|NCT00065182|GlaxoSmithKline|GSK Response Center|866-435-7343||
21247789|NCT03738228|NRG Oncology|Linda Gedeon for Wei Deng|716-845-1169|linda.gedeon@roswellpark.org|
21247790|NCT01641900|Massachusetts General Hospital|Dara S. Manoach, Principal Investigator|617-724-6148|dara.manoach@mgh.harvard.edu|
21247791|NCT00135200|University of Michigan Comprehensive Cancer Center|Dr. Mark Kaminski, M.D.|(734) 936-5310|mkaminsk@umich.edu|
21247792|NCT02169869|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
21247793|NCT02275611|University of North Carolina at Chapel Hill|Dr. Cort A. Pedersen|(919) 966-4447|Cort_Pedersen@med.unc.edu|
21247794|NCT02101775|University Health Network - Princess Margaret Cancer Centre|Dr. Amit Oza|416-946-4501|Amit.Oza@uhn.ca|3911
21247795|NCT03611556|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
21247796|NCT02844439|Kadmon Corporation|Miranda Ross|724-778-6170|Miranda.Ross@kadmon.com|
21247797|NCT04023175|Atrium Health|Dr. Elizabeth Braxton|8032613377|egwbraxton@gmail.com|
21247798|NCT00390884|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21247799|NCT00756574|McMaster University|Dr. Mark Loeb|905-525-9140|loebm@mcmaster.ca|26066
21262929|NCT03321929|Lumicell|Jorge Ferrer, PhD|617-571-0592|jmferrer@lumicell.com|
21262930|NCT00616239|UT Southwestern Medical Center at Dallas|Amit Pandya, M.D.|214-645-8300|amit.pandya@utsouthwestern.edu|
21262931|NCT02873715|University at Buffalo|Leonard H. Epstein, PhD, SUNY Distinguished Professor|716-829-3400|lhenet@buffalo.edu|
21262932|NCT00590681|University of Chicago|Amanda Spratt|773-834-4031|aspratt@bsd.uchicago.edu|
21262933|NCT02991820|Nationwide Children's Hospital|Joseph D. Tobias, MD|6147224200|Joseph.Tobias@nationwidechildrens.org|
21262934|NCT00933335|GlaxoSmithKline|GSK Response Center|866-435-7343||
21262935|NCT03880227|The University of Texas at Dallas|Hans Klein|8304562444|hans.klein@utdallas.edu|
21262936|NCT04590937|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21262937|NCT01929044|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21262938|NCT01461863|Dartmouth-Hitchcock|Dr. Charles Fordham von Reyn|6036505000|fvr@dartmouth.edu|8840
21262939|NCT02084134|Washington University School of Medicine|Dr. Julie Silverstein|314-747-7006|jsilverstein@wustl.edu|
21262940|NCT04333433|Santen, Inc.|Edith van Dijkman|+31683667357|edith.vandijkman@santen.com|
21262941|NCT02026271|Alaunos Therapeutics|Jaymes Holland|6502732627|jholland@alaunos.com|
21262942|NCT00878072|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21262943|NCT03288779|DukeUMC|Steven T Szabo|3524540101|steven.szabo@duke.edu|3524540101
21262944|NCT00237796|VA San Diego Healthcare System, San Diego|Eric Granholm, PhD|858-552-8585|egranholm@ucsd.edu|7768
21262945|NCT00968253|The University of Texas (UT) MD Anderson Cancer Center|Marina Konopleva, MD, PHD/Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
21262946|NCT01721408|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21262947|NCT03638947|UIOWA|Randy W. Loftus|6033066475|randy-loftus@uiowa.edu|
21262948|NCT04160468|ContraFect|Medical Director|914-207-2300|clinicalstudies@contrafect.com|
21262949|NCT01187901|University of Utah|N. Jewel Samadder|801-213-4211|jewel.samadder@hsc.utah.edu|
21262950|NCT03987620|SCYNEXIS|Dr. David Angulo|(201) 884-5471|david.angulo@scynexis.com|
21262951|NCT02149836|Icahn School of Medicine at Mount Sinai|Dr. James W. Murrough|212-241-6539|james.murrough@mssm.edu|
21262952|NCT01613014|NIAAA|Megan Ryan, Clinical Program Director|3014434225|mryan1@mail.nih.gov|
21262953|NCT05319535|Durham VA Medical Center|Courtney H Van Houtven, PhD|919-286-6936|courtney.vanhoutven@va.gov|
21262954|NCT04624932|University of British Columbia|Dr. Mariana Brussoni|604-875-3712|mbrussoni@bcchr.ubc.ca|
21262955|NCT00370149|Riley Hospital for Children|Elaine G Cox, MD|317-944-7260|elmcox@iu.edu|
21262956|NCT01027910|Massachusetts General Hospital|Dr. Edwin Choy|617-724-4000|echoy@mgh.harvard.edu|
21262957|NCT01096446|OSF Saint Francis Medical Center|Dr. Kamlesh Macwan|309-624-0611|kamlesh.s.macwan@osfhealthcare.org|
21262958|NCT01043185|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
21262959|NCT03488472|University of Alabama at Birmingham (UAB)|Drexell Hunter Boggs, MD; Principal Investigator|(205) 934-3411|dboggs@uabmc.edu|
21262960|NCT00028002|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org|
21262961|NCT04149899|Bausch & Lomb Incorporated|Clinical Development|949-416-1194|kevin.kerr@bausch.com|
21262962|NCT02750800|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21262963|NCT03848221|The University of Alabama at Birmingham|Dr. Andrew Pucker|920-579-2900|apucker@uab.edu|
21262964|NCT02251704|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21262965|NCT00681538|GW Pharma Ltd|Richard Potts, Clinical Operations Director|+44 1353 616600|rp@gwpham.com|
21262966|NCT04889144|Fred Hutchinson Cancer Center|Megan Shen, Associate Professor|206-667-4172|mshen2@fredhutch.org|
21262967|NCT03430245|Candela Corporation|Director of Clinical Marketing|+1 949.246.7983|doranr@candelamedical.com|
21262968|NCT05628181|University of Michigan|Donovan Maust|734-845-3649|maustd@med.umich.edu|
21262969|NCT00610727|Alexza Pharmaceuticals, Inc.|Dave Hasegawa, VP, Device Development|650.947.7031|dhasegawa@alexza.com|
21262970|NCT04742907|Tsumura USA, Inc.|Yu Tanaka, Ph.D., MBA|609-799-2083|Tanaka_yuu@mail.tsumura.co.jp|
21262971|NCT01428063|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21262972|NCT05761444|Organon Korea Co. Ltd|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
21262973|NCT03508622|Children's Hospital Los Angeles|Brenda Manzanarez|323/361-8245|bmanzanarez@chla.usc.edu|
21262974|NCT02534805|Virginia Commonwealth University|Dr. Jasmohan Bajaj|(804) 828-4060|jasmohan.bajaj@vcuhealth.org|
21262975|NCT03196505|University of California-San Francisco Fresno|Dr. Pearl Ma|5592614500|pma@fresno.ucsf.edu|
21262976|NCT01005719|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21262977|NCT01753076|GlaxoSmithKline|GSK Response Center|866-435-7343||
21262978|NCT02575079|Emory University|Elizabeth Stenger|404-785-1272|elizabeth.o'brien.stenger@emory.edu|
21262979|NCT01259856|Icahn School of Medicine at Mount Sinai|Dr. Ronald Hoffman|212-241-2296|ronald.hoffman@mssm.edu|
21262980|NCT01212172|UC Irvine Dermatology Research Center|Christopher B. Zachary|949 824 7103|czachary@uci.edu|
21262981|NCT00788775|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu|
21262982|NCT03450369|Naked Biome|Emma Taylor, MD CEO|626-260-1230|emma.t@nakedbiome.com|
21262983|NCT01757704|Lunds University|Dr. Bansi Koul|+4646171649|bansi.koul@skane.se|
21262984|NCT00938327|GlaxoSmithKline|GSK Response Center|866-435-7343||
21262985|NCT00584220|Vistakon|Kurt Moody, OD, FAAO|904-443-3088|kmoody1@its.jnj.com|
21262986|NCT00803244|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
21262987|NCT01253460|The University of Texas MD Anderson Cancer Center|William G Wierda, MD/Professor|713-745-0428|wwierda@mdanderson.org|
21262988|NCT00878228|Hospital for Special Surgery|Dr. David Kim|212-606-1206|KimD@hss.edu|
21262989|NCT00668525|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Carl Gommoll, MS|201-427-8000|carl.gommoll@frx.com|
21247800|NCT04622332|Sironax|Lisa Fitzgerald, Senior Director Clinical Operation|781-201-3892|Lisa.Fitzgerald@sironax.com|
21247801|NCT05966155|Duke University|Hrishikesh Chakraborty, PhD|919-668-1238|hrishikesh.chakraborty@duke.edu|
21247802|NCT04122196|University of Missouri|Eliza DeFroda|573-882-4141|elddmc@health.missouri.edu|
21247803|NCT05036278|Bayer AG|Bayer Clinical Trials Contact|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21247804|NCT06122935|Fresenius Kabi|Jason Friedmann|847-550-2365|jason.friedmann@fresenius-kabi.com|
21247805|NCT02787005|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21247806|NCT04375072|The University of Arizona|Hyochol Brian Ahn|520.626.1769|hbrian@arizona.edu|
21247807|NCT03498612|University of Washington|Ajay Gopal, MD|206-606-2037|agopal@uw.edu|
21247808|NCT05580003|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21247809|NCT03516812|University of Washington|Michael Schweizer|206-606-6252|schweize@uw.edu|
21247810|NCT04795167|Inari Medical|Ashleigh Willson|925-330-3446|ashleigh.willson@inarimedical.com|
21247811|NCT01753999|Rutgers Robert Wood Johnson Medical School|Dr. Jag Sunderram|732-235-7038|sunderja@rwjms.rutgers.edu|
21247812|NCT03890289|"Policlinico S.Orsola-Malpighi - Istituto di Ematologia Seragnoli"|Lisa Argnani|051 214 3827|lisa.argnani@unibo.it|
21247813|NCT05440344|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21247814|NCT02867059|Medicines for Malaria Venture|Andrew Slade|+41 22 555 0415|sladea@mmv.org|
21247815|NCT02392234|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21247816|NCT02313675|University of Pittsbur|John R Fowler, MD|412-605-3245|fowlerjr@upmc.edu|
21247817|NCT02029235|Penn State Health Milton S. Hershey Medical Center|Alexander Payatakes, MD|717-531-4805|apayatakes@pennstatehealth.psu.edu|
21247818|NCT01387516|University of Rhode Island|Dr. Lynda Stein, Ph.D.|401-874-5562|lynda_stein@uri.edu|
21247819|NCT03582475|UCLA / Department of Radiology|Sara Rodriguez|310-794-2877|SaraRodriguez@mednet.ucla.edu|
21247820|NCT00853606|Vivus, Inc|Wesley W Day PhD|650-934-5200||
21247821|NCT03170648|Dana-Farber Cancer Institute|Weidong Lu, MB, MPH, PhD|617-632-3322|weidong_lu@dfci.harvard.edu|
21247822|NCT02052440|Denver Veterans Administration Medical Center|Daniel Heppe MD|303 399 8020|daniel.heppe@ucdenver.edu|3940
21247823|NCT03509909|VA San Diego Healthcare System|Ariel J Lang|858-552-8585|ariel.lang@va.gov|5359
21247824|NCT01400958|H. Lee Moffitt Cancer Center and Research Institute|Peter A. Forsyth, M.D.|813-745-3063|peter.forsyth@moffitt.org|
21247825|NCT04436289|Johns Hopkins University|Christopher Hoffmann|410-614-4257|choffmann@jhmi.edu|
21247826|NCT06571058|The Ohio State University Comprehensive Cancer Center|Karen Meade|614-366-5060|Karen.Meade@osumc.edu|
21247827|NCT00258830|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21247828|NCT01939288|Imperial College London|Miss Katherine Williams|020 3311 7335|k.williams@imperial.ac.uk|
21247829|NCT04801420|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|0
21247830|NCT03598907|Department of anesthesiology and intensive care medicine, Charles University and Motol Hospital|prof. Miroslav Durila|+420224435440|miroslav.durila@fnmotol.cz|
21247831|NCT00972621|Abbott Medical Optics, Inc.|Kendra Hileman, Ph.D., Head, Clinical Research & Development|714-247-8613|kendra.hileman@abbott.com|
21247832|NCT02078648|Stemline Therapeutics, Inc.|Clinical Development & Medical Affairs - Solid Tumors|1-973-775-2845|clinicaltrials@menarinistemline.com|
21247833|NCT04088227|Andrews Research & Education Foundation|Director of Research|8509168570|jessica.truett@andrewsref.org|
21247834|NCT01675492|Abbott Medical Optics|Director, Clinical Operations|714-247-8628|lachelle.arredondo@abbott.com|
21247835|NCT03656718|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21247836|NCT03211247|DBV Technologies|Pharis Mohideen, MD, Chief Medical Officer|908-679-5200|clinicaltrials@dbv-technologies.com|
21247837|NCT01855750|Janssen Research & Development, LLC|Medical Officer|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21247838|NCT05379270|George Washington University|Allison Sylvetsky|202-994-5602|asylvets@gwu.edu|
21247839|NCT03160885|LEO Pharma A/S|Disclosure|+45 44945888|disclosure@leo-pharma.com|
21247840|NCT03610581|Janssen Vaccines & Prevention B.V|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21247841|NCT02307682|Novartis Pharmaceuticals|Study Director|1-862-778-8300|novartis.email@novartis.com|
21247842|NCT01713660|AMO|Carrie Garufis|7145663728|carrie.garufis@amo.abbott.com|
21247843|NCT03905694|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
21247844|NCT03367156|UT MD Anderson Cancer Center|Dr. David Hui- Professor, Palliative Care Medicine|(713) 792-6258|dhui@mdanderson.org|
21247845|NCT03762850|Travere Therapeutics, Inc|Travere Therapeutics Call Center|1-877-659-5518|medinfo@travere.com|
21247846|NCT04803370|Son Llàtzer University Hospital|Joan Bargay Lleonart|34871202000|khaoulahelhaji@gmail.com|
21247847|NCT02298842|Terumo BCT|Heather Pidcoke, MD, PhD|(303) 231-4805|Heather.Pidcoke@terumobct.com|
21247848|NCT02386098|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21247849|NCT03002194|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
21247850|NCT02200705|IceCure Medical|Clinical Trial Manager|+972-4-623-0333|ronitl@icecure-medical.com|
21281080|NCT00471081|GlaxoSmithKline|GSK Response Center|866-435-7343||
21281081|NCT02844933|Radius Pharmaceuticals, Inc.|Tarek El Akkad, Head of Clinical Development|6175514000|telakkad@radiuspharm.com|
21281082|NCT01479465|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21281083|NCT01892501|Institute Bergonie|Dr. Dominique Bechade, Coordinating Investigator|0556337805|d.bechade@bordeaux.unicancer.fr|
21281084|NCT00083382|UAMS Myeloma Institute|Bart Barlogie|526-6990|barlogiebart@uams.edu|2420
21281085|NCT02739789|Stony Brook University|Dr. David Hsu, Assistant Professor of Psychiatry|(631) 638-1522|david.hsu@stonybrookmedicine.edu|
21247851|NCT05250115|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21262990|NCT01254396|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21262991|NCT00443430|University of Washington and Seattle Children's Hospital|Carol Wallace, MD Principal Investigator|206-987-2057|cwallace@u.washington.edu|
21262992|NCT01635933|Alcon Research, Ltd.|Sharon Holden Thomas, O.D., Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com|
21262993|NCT04525222|Fred Hutchinson Cancer Center|Jaimee Heffner, Ph.D., Associate Professor|206.667.7314|jheffner@fredhutch.org|
21262994|NCT01544595|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21262995|NCT01108809|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21262996|NCT03395340|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|Dr. Edward W. Cowen|301-827-2328|cowene@mail.nih.gov|
21262997|NCT01293396|Medical University of Graz|Dr. Norbert Tripolt|0316385|norbert.tripolt@medunigraz.at|78038
21262998|NCT04072237|Catalyst Biosciences|Howard Levy, Chief Medical Officer|+1.650.266.6871|hlevy@catbio.com|
21262999|NCT04985773|Infraredx, A Nipro Company|Priti Shah|781-345-9646|pshah@infraredx.com|646
21263000|NCT01704781|Bionor Pharma ASA|Maja Sommerfelt|+4723010960|ms@bionorpharma.com|
21263001|NCT02379923|Asahi Intecc USA, Inc.|Robert Ricker|408.429.3749|robertr@asahi-intecc.com|
21263002|NCT03643432|Oxford University Hospitals NHS FT|Jon Room|01865737526|jonathan.room@ouh.nhs.uk|
21263003|NCT00804193|Perrigo|Jonathan Schwartz|718-960-0119|jonathan.schwartz@perrigo.com|
21263004|NCT04415489|University of North Carolina at Chapel Hill|Sarah Moustafa, MD|919-908-0000|sarah_moustafa@med.unc.edu|
21263005|NCT01193348|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|clinicaltrials@alxn.com|clinicaltrials@alxn.com|
21263006|NCT02928406|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21263007|NCT01745393|Temple University|Bradley Collins|215-204-2849|collinsb@temple.edu|
21263008|NCT00905021|Baylor College of Medicine|Dr. Mothaffar Rimawi|713-798-1311|rimawi@bcm.edu|
21263009|NCT00786838|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|Senior Medical Director|1 908 704-5779||
21263010|NCT04937816|Boehringer Ingelheim, Call Center|Boehringer Ingelheim|018002430127|clintriage.rdg@boehringer-ingelheim.com|
21263011|NCT00390364|Sidney Kimmel Comprehensive Cancer Center at JHMI|Manuel Hidalgo, MD (no longer works at Hopkins)|410-502-5328|tbrown55@jhmi.edu|
21263012|NCT02488759|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21263013|NCT03860844|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21263014|NCT01128972|GlaxoSmithKline|GSK Response Center|866-435-7343||
21263015|NCT01678807|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21295045|NCT00509093|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Anjali Advani|+1 216-445-9354|advania@ccf.org|
21263016|NCT02574312|DePuy Ortho Joint US|Kirstin Cosgrove|800-827-7003|kcosgro1@its.jnj.com|
21263017|NCT05306873|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21263018|NCT03538652|National Institute on Drug Abuse (NIDA)|Dr. David Epstein|667-312-5092|david.epstein@nih.gov|
21263019|NCT06018350|Duke University|Kai Sun, M.D.|919-681-7417|kai.sun@duke.edu|
21263020|NCT04920084|Memorial Sloan Kettering Cancer Center|Dr. Urvi Shah, MD, MS|646-608-3713|shahu@mskcc.org|
21263021|NCT00074412|Statistical Center for HIV/AIDS Research and Prevention|Statistical Research Associate|2066677524|cherron@fhcrc.org|
21263022|NCT00924352|Vector Oncology (formerly Accelerated Community Oncology Research Network, Inc.)|Vice President of Scientific Affairs|901-435-5570|mwalker@vectoroncology.com|
21263023|NCT00418834|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21263024|NCT03300752|Columbia University School of Nursing|Dr. Maureen George|2123051175|mg3656@cumc.columbia.edu|
21263025|NCT01755195|National Cancer Institute|Dr. Alice Chen|240-781-3274|chenali@mail.nih.gov|
21263026|NCT05113953|Otsuka Pharmaceutical Development & Commercialization, Inc.|Clinical Transparency|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21263027|NCT01915108|assistant professor|Dr. Sangjin Park|82-53-620-3366|apsj0718@naver.com|
21263028|NCT03499808|SWOG Statistics and Data Management Center|Adam Rosenthal|206-652-9711|adamr@crab.org|
21263029|NCT03470922|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21263030|NCT02340819|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21263031|NCT02626819|Manhattan Campus of the VA NY Harbor Healthcare System|Melanie Jay, MD MS|212-686-7500|melanie.jay@va.gov|5097
21263032|NCT02361762|Boston Children's Hospital|Dr. Susan Faja|617-919-4108|susan.faja@childrens.harvard.edu|
21263033|NCT02491437|Abbott|Erik van Leeuwen MSc, PMP|+31294479241|erik.vanleeuwen@abbott.com|
21263034|NCT00502307|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|857-400-0101|Clinical@aveooncology.com|
21263035|NCT02094872|Yale University|Manuel Avedissian, M.D.|203-737-3669|manuel.avedissian@yale.edu|
21263036|NCT00539253|Johns Hopkins Hospital|Ihab R. Kamel, M.D. PhD|410-955-4567|ikamel@jhmi.edu|
21263037|NCT04467164|Massachusetts General Hospital, Harvard Medical School|Jill M. Goldstein|617-724-3776|jill_goldstein@hms.harvard.edu|
21263038|NCT02750813|Alcon, A Novartis Division|Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21263039|NCT01998581|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
21295046|NCT01103063|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21295047|NCT05858450|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21295048|NCT04143217|Supernus Pharmaceuticals Inc.|Jonathan Rubin, MD, MBA, Senior Vice President/Chief Medical Officer|240-403-5710|jrubin@supernus.com|
21295049|NCT00395291|University of Virginia|W. Kline Bolton, MD|434-924-9692|wkb5s@Virginia.edu|
21263040|NCT00255684|Wake Forest|Gordon L. Phillips|604.875.4111|gophilli@wakehealth.edu|67806
21263041|NCT03463941|Duke School of Nursing|Cherie Conley|2166597128|cherie.conley@duke.edu|
21281086|NCT03426124|Boston Scientific|Leslie Cass|206-641-4529|Leslie.Cass@bsci.com|
21247852|NCT01083732|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
21247853|NCT02633215|University of Kentucky|Dr. Lumy Sawaki||lsawa2@uky.edu|
21247854|NCT00754325|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21247855|NCT03801148|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21247856|NCT06212752|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21247857|NCT04162210|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21247858|NCT00371345|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21247859|NCT00705406|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|919-859-1302||
21247860|NCT01779700|Indiana University|Dr. Alan Breier|317-880-8495|abreier@iupui.edu|
21247861|NCT00442104|Marinus Pharmaceuticals, Inc.|Marinus|484-801-4670|clinicaltrials@marinuspharma.com|
21247862|NCT00123409|Philadelphia VAMC|David Oslin|2158235894|dave.oslin@upenn.edu|
21247863|NCT00918333|Mayo Clinic Cancer Center|Shaji Kumar, MD|507-284-2511|Kumar.shaji@mayo.edu|
21247864|NCT04497415|New York State Psychiatric Institute|Yuval Y. Neria|646-774-8092|ny126@cumc.columbia.edu|
21247865|NCT00263757|Mayo Clinic|Dr. Sean M. Caples|507-293-1031|Caples.Sean@mayo.edu|
21247866|NCT00713596|Mayo Clinic|Dr. Oren Friedman|507-538-1392||
21247867|NCT03712371|Medical University of South Carolina, Hollings Cancer Center, Clinical Trials|Alan Brisendine, CCRP, Manager, Sponsor-Investigator Support Unit|843-792-9007|brisend@musc.edu|
21247868|NCT05579600|Butler Hospital|Sarah Arias|909-753-9444|sarias@butler.org|
21247869|NCT04732000|Stanford University|Professor of Anesthesia|650-723-6412|ang@stanford.edu|
21247870|NCT02463448|Beaumont Hospitals|Jennifer Giordano|248-551-3517|jennifer.geiordano@beaumont.org|
21247871|NCT01082575|Covidien|Fran Haury Clinical Program Manager II|303 305-2314|fran.haury@covidien.com|
21247872|NCT04053270|CLINUVEL PHARMACEUTICAL LIMITED|Dr. Dennis Wright|+ 61 3 9660 4900|mail@clinuvel.com|
21247873|NCT04941703|University of Maryland School of Medicine|Wonder Drake|410-710-1412|WDrake@som.umaryland.edu|
21247874|NCT03021993|Medical University of South Carolina|Alan Brisendine, Sponsor-Investigator Support Unit Manager|843-792-9007|brisend@musc.edu|
21247875|NCT04033315|Ascensia Diabetes Care|Jane Wallace|5748501467|jane.wallace@ascensia.com|
21247876|NCT00909324|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21247877|NCT03502447|Sight Sciences, Inc.|VP Medical & Clinical Affairs|877-266-1144|info@sightsciences.com|
21247878|NCT00482911|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-435-7507|sbpso@mail.nih.gov|
21247879|NCT04230941|University of Rochester|Allison Magnuson, (Principal Investigator), Associate Professor of Medicine|585-276-7155|allison_magnuson@urmc.rochester.edu|
21247880|NCT00317720|UT MD Anderson Cancer Center|Dr. Francisco Esteva|713-563-0742|CR_Study_Registration@mdanderson.org|
21247881|NCT03660618|University of Iowa Healthcare|Dr. Randy Kardon|319-356-8299|randy-karon@uiowa.edu|
21247882|NCT02816398|Avenu Medical - Sponsor|Gene Reu|949 276 2483|greu@avenumedical.com|102
21247883|NCT02972424|Hospital for Special Surgery|Dr. Jeri W. Nieves|2126061604|nievesje@hss.edu|
21247884|NCT01273610|City of Hope|Dr. Daneng Li|626-359-8111|danli@coh.org|
21247885|NCT02990858|CytoDyn|Vice President, Clinical Operations|36009808524|jmeidling@cytodyn.com|
21247886|NCT02499328|Astrazeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21247887|NCT03414684|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-5743|Sara_Tolaney@dfci.harvard.edu|
21247888|NCT05525572|University of Miami, Miller School of Medicine|Thomas A Masterson, III|(305) 243 - 6260|TMasterson@med.miami.edu|
21247889|NCT05251363|BIOTRONIK, Inc.|Crystal Miller|(503) 475-4984|crystal.miller@biotronik.com|
21247890|NCT03425682|Aziyo Biologics, Inc.|Associate Director, Clinical Operations|678-492-4712|srichardson@aziyo.com|
21247891|NCT04306367|Lombardi Comprehensive Cancer Center|Aiwu Ruth He, MD|202-444-2223|Aiwu.R.He@gunet.georgetown.edu|
21247892|NCT03227861|Janssen Scientific Affairs, LLC|Senior director medical leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21247893|NCT03044158|University of California Irvine|Adithya Cattamanchi|714-456-2959|Adithya.Cattamanchi@uci.edu|
21247894|NCT02157116|Duke University|Richard Riedel, MD|919-681-6932|richard.riedel@duke.edu|
21247895|NCT00975585|Vistakon|Sheila Hickson-Curran, MCOptom/ Director, Medical Affairs|904-443-1754||
21247896|NCT01953224|The University of Texas Medical Branch|Eloisa Martinez|4092669643|esmartin@utmb.edu|
21247897|NCT00683800|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21247898|NCT01359150|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21247899|NCT01619059|AstraZeneca Pharmaceuticals|Eva Johnsson, Clinical Science Lead|+46 31 7762484|Eva.Johnsson@astrazeneca.com|762484
21247900|NCT03578965|Washington University School of Medicine|Mary M. Mullen, M.D.|314-655-8750|marymullen@wustl.edu|
21247901|NCT02406092|Hoffman-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21247902|NCT03041233|Abbott|Clinical Scientist|7639541350|emily.jesser@abbott.com|
21247903|NCT05783843|Wake Forest University School of Medicine|Erin L. Sutfin, PhD|336-713-5282|esutfin@wakehealth.edu|
21247904|NCT00853593|Medtronic, Inc|4396 Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|62808
21247905|NCT03304639|University of Pittsburgh Medical Center|Dr. Jason Luke|412-647-2811|lukejj@upmc.edu|
21247906|NCT03362190|IVERIC bio, Inc|Hersh Patel, OD / Zimura Medical Director|609-474-6755|clinicaltrials@ivericbio.com|
21247907|NCT04041219|Mayo Clinic|Heather P. May, Pharm.D.|507-266-7405|May.Heather@mayo.edu|
21247908|NCT01588951|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Margaret Showel, MD|410-614-0675|mshowel1@jhmi.edu|
21263042|NCT02273050|AstraZeneca|Eva Johnsson, MD, PhD|46 31 7762484|Eva.Johnsson@astrazeneca.com|
21281087|NCT01129440|University of California, San Francisco|Dr. Stuart Gansky|415-502-8094|stuart.gansky@ucsf.edu|
21295050|NCT02210832|University of Vermont|Stephen T. Higgins|802-735-6267|stephen.higgins@uvm.edu|
21295051|NCT03824405|Botanix Pharmaceuticals|Head of Development|+1 (445) 300-3403|trials@botanixpharma.com|
21295052|NCT00445939|Abbott|Global Medical Services|800-633-9110||
21295053|NCT02154048|Duke University|Steve Melton, MD|919.668.2047|steve.melton@duke.edu|
21247909|NCT03683576|GB001, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.|Gossamer Study Director|1-866-668-4083|ClinicalTrials@gossamerbio.com|
21247910|NCT03488719|Saniona A/S|Janus Schreiber Larsen|+45 7070 5225|janus.larsen@saniona.com|
21247911|NCT04724759|Massachusetts General Hospital|Jingping Wang - Principal Investigator|617-643-2729|jwang23@mgh.harvard.edu|
21247912|NCT05807074|University of California, San Francisco|Dr. Merisa Piper, MD|(415) 353-4320|Merisa.Piper@ucsf.edu|
21247913|NCT04038580|University of Michigan|Dr. Deanna Gates|7346472698|gatesd@umich.edu|
21247914|NCT03477175|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21247915|NCT04021862|Janssen Research & Development, LLC|Director Clinical Research Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21247916|NCT03371017|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21247917|NCT05637970|UCLA|David Tehrani|8583360666|davidmtehrani@gmail.com|
21247918|NCT00489307|UT MD Anderson Cancer Center|Dr. Sriram Yennu, Professor, Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
21247919|NCT03835754|TransMedics, Inc.|Laura Damme|9785520900|ldamme@transmedics.com|
21247920|NCT04660721|Sealantium Medical Ltd.|Prof. Orgad Laub, Chief Executive Officer|+972 0544434387|orgad@sealantium-med.com|
21247921|NCT05483517|Tri-service general hospital|Lai Chia-Ying|87923311|pokerface165@gmail.com|18792
21247922|NCT02751528|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
21247923|NCT05485805|Bayer AG|Bayer Clinical Trials Contact|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21247924|NCT04218357|Brown University|Carolina Haass-Koffler, PharmD, PhD|4155191385|carolina_haass-koffler@brown.edu|
21247925|NCT05349838|Research Organisation (KC) Ltd|Clinical Project Manager|07376618244|WISARD@rokcservices.com|
21247926|NCT05075395|University of Nebraska Medical Center|Breanna Hetland|402-559-5460|breanna.hetland@unmc.edu|
21247927|NCT05071430|HB Biotech|Tomer Seifan|917-685-7351|tomer.seifan@hbbio.com|
21247928|NCT01958021|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21247929|NCT00085982|NIDDK|Rebecca Brown, MD|301-594-0609|brownrebecca@mail.nih.gov|
21247930|NCT05256797|Brigham and Women's Hospital|Shirley Wang|617-525-8376|swang1@bwh.harvard.edu|
21247931|NCT05810285|Permedicaspa|Lorenzo Banci, study coordinator - clinical affairs|0399514811|lorenzo.banci@permedica.it|
21247932|NCT04484623|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21247933|NCT05470114|Leo Pharma|Clinical Disclosure|+4544945888|disclosure@leo-pharma.com|
21247934|NCT06214052|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21247935|NCT04649047|Ohio State University College of Nursing|Dr. Mei-Wei Chang|614-247-7211|chang.1572@osu.edu|
21247936|NCT02488408|BerGenBio ASA|BerGenBio Clinical Team|+47 559 61 159|trialsites@bergenbio.com|
21247937|NCT00719888|Fred Hutchinson Cancer Center|Dr. Ann Dahlberg|206-667-1959|adahlber@fredhutch.org|
21247938|NCT05886777|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21247939|NCT03773107|Levine Cancer Institute|Jim Symanowski, PhD|9804422371|james.symanowski@atriumhealth.org|
21247940|NCT05961995|The Ohio State University Hospital|Dr. Thangam Venkatesan|614-293-6255|thangam.venkatesan@osumc.edu|
21247941|NCT07204444|University of Florida|Laura R. Shannonhouse, PhD|352-273-4332|lshannonhouse@coe.ufl.edu|
21247942|NCT05199571|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21247943|NCT05029284|University of Minnesota|Dr. Emily Kringle|(612) 624-8994|ekringle@umn.edu|
21247944|NCT02972034|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21247945|NCT03861052|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21247946|NCT03009344|Eisai Co., Ltd.|Inquiry Service||eisai-chiken_hotline@hhc.eisai.co.jp|
21247947|NCT01427517|University of Minnesota|Mary Holmay|612-812-5854|holma101@umn.edu|
21247948|NCT03284359|University of Pennsylvania|Dr. Katherine Courtright|267-978-5083|Katherine.Courtright@pennmedicine.upenn.edu|
21247949|NCT01026805|Interlace Medical, Inc.|John Vozella, V.P. Clinical & Regulatory Affairs|508-875-1343|john@interlacemedical.com|112
21247950|NCT02683174|NHS Lothian|Dr Matt Reed|+44 131 242 1448|Matthew.Reed@nhslothian.scot.nhs.uk|
21247951|NCT02522104|Addmedica|Medical director|+33 1 72 69 01 86|corinne.duguet@addmedica.com|
21247952|NCT00454194|Roswell Park Cancer Institute|Alex A. Adjei, M.D., Ph.D.|507-284-9265|alex.adjei@roswellpark.org|
21247953|NCT01556594|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21247954|NCT01703598|Oregon Health & Science University|Matthew Brodsky MD|503-494-9054|brodskym@ohsu.edu|
21247955|NCT02927249|Dana Farber Cancer Institute|Wendy Chen|617-632-3800|Wendy_chen@dfci.harvard.edu|
21247956|NCT02723929|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526158|Fregni.felipe@mgh.harvard.edu|
21247957|NCT05462912|UC Davis Orthopaedic Surgery|Eric Giza, MD|916-734-6805|egiza@ucdavis.edu|
21247958|NCT04566861|Johns Hopkins Bloomberg School of Public Health|Dr. Pamela Surkan|4105027396|psurkan@jhu.edu|
21247959|NCT00504023|Memorial Sloan Kettering Cancer Center|Dr. Dennis Chi, MD|212-639-5016|chid@mskcc.org|
21247960|NCT02639637|Vanderbilt University Medical Center|Nancy J. Brown, M.D., Principal Investigator|6153644022|nancy.j.brown@vanderbilt.edu|
21247961|NCT00229658|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21247962|NCT00205179|University of Wisconsin|Dr. Carey Gleason|608-280-7000|ceg@medicine.wisc.edu|
21247963|NCT00463229|McMaster University|Maureen Markle-Reid|905-525-9140|mreid@mcmaster.ca|22306
21247964|NCT00455650|Massachusetts General Hospital|A. Eden Evins, MD, MPH|617-643-4679|aeevins@mgh.harvard.edu|
21295054|NCT00919867|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21247965|NCT01700205|Monell Chemical Senses Center|Julia A. Mennella, PhD|267-519-4880|mennella@monell.org|
21247966|NCT03542305|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21247967|NCT01728324|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21247968|NCT01170208|International Diabetes Center|Dr. Richard Bergenstal|952-993-3796|richard.bergenstal@parknicollet.com|
21247969|NCT01351376|Rehabilitation Medicine, New York University School of Medicine|Tara Denham, MD|212 263 8240|Tara.Denham@nyumc.org|
21247970|NCT03113409|NYS Psychiatric Institute|Adam Bisaga MD|646-774-6155|adam.bisaga@nyspi.columbia.edu|
21247971|NCT00388726|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21247972|NCT03805672|Oregon Health & Science University|Samantha Underwood|503-494-8481|underwos@ohsu.edu|
21247973|NCT00641537|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21247974|NCT03229408|University of Illinois at Chicago|Frank González|(312) 413-1984|frgz12@uic.edu|
21247975|NCT02586857|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
21247976|NCT06193590|Indiana University Health|Dr. Alissa M Conklin|317.944.8231|alconkli@iu.edu|
21247977|NCT03745313|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
21247978|NCT01706159|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21247979|NCT04816955|Bournemouth University|Dr Katherine Appleton|01202965985|k.appleton@bournemouth.ac.uk|
21247980|NCT02707198|Whiteside Institute for Clinical Research/St. Luke's Hospital Duluth|Lynsie Radovich, PhD|216-726-7940|lradovic@d.umn.edu|
21247981|NCT02235298|University of Miami|Gianluca Iacobellis, MD|305-243-3636|giacobellis@miami.edu|
21247982|NCT04960813|Columbia University|Kate D. Fitzgerald|646-774-5681|kf2688@cumc.columbia.edu|
21247983|NCT01595282|PPLM|Principal Investigator|617-616-1600||
21247984|NCT02628626|Mayo Clinic|Dr. Adil Bharucha|507-284-2687|bharucha.adil@mayo.edu|
21247985|NCT01593020|UT MD Anderson Cancer Center|Dr. Valero Vicente, Professor, Breast Medical Oncology|(713) 563-0751|vvalero@mdanderson.org|
21247986|NCT02454959|Pearl Therapeutics, Inc.|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
21247987|NCT02350634|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|AVD_Clinical_Ops@lists.lilly.com|
21247988|NCT04205487|Florida International University|Adam W. Carrico, PhD|305-348-7887|acarrico@fiu.edu|
21247989|NCT04241848|James J. Peters VA Medical Center, Spinal Cord Damage Research Center|Dr. Ann Spungen|(718) 584-9000|Ann.Spungen@va.gov|5814
21247990|NCT01732120|Washington University School of Medicine|Manager of Clinical Trials|3147479781|klima@wustl.edu|
21247991|NCT03102034|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
21247992|NCT02766517|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
21247993|NCT03611075|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
21247994|NCT02063659|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD||plapuerta@lexpharma.com|
21247995|NCT02972359|Grünenthal GmbH|Clinical Trial Helpdesk|+49 241 569|clinical-trials@grunenthal.com|3223
21247996|NCT02788019|UT Southwestern Medical Center|Anthony Machi, MD, Assistant Professor|214-648-6400|Anthony.Machi@UTSouthwestern.edu|
21247997|NCT02830204|Baylor Scott and White Research Institute|Walter Cerqueira|469-814-3393|walter.cerqueira@bswhealth.org|
21247998|NCT05162261|Novoxel Ltd|Dr. Ifat Klein|+972-52-6009860|ifat@novoxel.com|
21247999|NCT02517268|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Harish Lavu|215-955-6888|Harish.Lavu@jefferson.edu|
21248000|NCT03436992|Augusta University|Dr. Ryan Harris|706-721-5483|ryharris@augusta.edu|
21248001|NCT02401815|Cogent Biosciences, Inc.|VP, Head of Clinical Development Operations|617-945-5576|clinops@cogentbio.com|
21248002|NCT05246709|Columbia University|Seon Mi Jeong|646-317-5238|smj9007@nyp.org|
21248003|NCT04837937|Northwestern University- Feinberg School of Medicine- Division of Geriatrics|Vanessa Ramirez-Zohfeld|+1 312 503 3916|vanessa-ramirez-0@northwestern.edu|
21248004|NCT03850379|Henry Ford Health|Shatha Farhan|3137133910|sfarhan1@hfhs.org|
21248005|NCT00378898|Vanderbilt University Medical Center|Dr. Michael Vaezi|615-322-3739|michael.vaezi@vanderbilt.edu|
21248006|NCT06307457|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21248007|NCT03116464|VA New York Harbor Healthcare System|Dr. Cory K. Chen|212-686-7500|cory.chen@va.gov|4002
21248008|NCT00808834|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
21248009|NCT00345046|Indiana University|Louis B. Cantor|317-278-2651|lcantor@iupui.edu|
21248010|NCT03689946|Cedars-Sinai Medical Center|Daniel Berman|310-423-4224|daniel.berman@cshs.org|
21248011|NCT03376659|Georgetown University|Benjamin Weinberg, MD|202-444-2223|benjamin.a.weinberg@gunet.georgetown.edu|
21248012|NCT01410409|Aalborg University Hospital|Dr. Søren T. Skou|+4523708640|sots@rn.dk|
21248013|NCT04608409|University of Kentucky|Dr. Frederick Ueland|859-257-1613|frederick.ueland@uky.edu|
21248014|NCT01787032|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21248015|NCT03552276|Sun Pharmaceutical Industries Limited|Head-Regulatory Affairs|2266455645|Clinical.Trial@sunpharma.com|5689
21248016|NCT00687219|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21248017|NCT02940249|King's College London|Dr Wendy Hall|020 7836 5454|wendy.hall@kcl.ac.uk|
21248018|NCT02227706|ETHICON Inc|Patricia Schleckser|9082182244|pschleck@its.jnj.com|
21248019|NCT02962102|Brigham and Women's Hospital|Dr. David Leaf|617-525-7612|deleaf@bwh.harvard.edu|
21248020|NCT02823028|University of California Irvine|Professor Cornelia Pechmann|3108920619|cpechman@uci.edu|
21248021|NCT06211530|GE HealthCare|Principal Engineer|+358 (40) 7755194|100012917@gehealthcare.com|
21248022|NCT04827732|Washington University School of Medicine|Dr. Michael Waters|314-747-7236|m.r.waters@wustl.edu|
21263043|NCT02273752|Emory University|R. Donald Harvey, PharmD|404-778-1900|donald.harvey@emory.edu|
21248023|NCT05785832|Tandem Diabetes Care|Sr. Supervisor of Clinical Operations|18583666900|clinicalaffairs@tandemdiabetes.com|
21248024|NCT04300023|University of Wisconsin - Madison|Kristen Pickett, PhD|(608) 890-2103|Kristen.pickett@wisc.edu|
21248025|NCT05116163|Brigham and Women's Hospital|Dr. Candace Feldman|617-525-1035|chfeldman@partners.org|
21248026|NCT05025384|Vanderbilt University Medical Center|Krista Vermillion|615-875-1921|krista.k.vermillion@vumc.org|
21248027|NCT04057131|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21248028|NCT03024866|Xoft Inc.|Robert Burnside|14084931533|rob.burnside@elekta.com|
21248029|NCT04686266|University of Pennsylvania|Lauren Massimo, PhD, CRNP|215-349-5863|lmassimo@upenn.edu|
21248030|NCT05579730|Bausch & Lomb|Daniel Donatello|585-338-5306|Daniel.Donatello@bausch.com|
21248031|NCT05613907|Leeds Vascular Institute|Dr Assad Khan|0113|assad.khan3@nhs.net|
21248032|NCT05080777|University of Connecticut Center on Aging|Dr. Richard Fortinsky|860-679-8069|fortinsky@uchc.edu|
21248033|NCT04705415|NeurobBo|Sr. Vice President Clinical Operations|8572991035|crinfo@neurobopharma.com|
21248034|NCT00748709|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21248035|NCT03789656|Crinetics Pharmaceuticals, Inc|Crinetics Clinical Trials|+1 858-450-6464|clinicaltrials@crinetics.com|
21248036|NCT01586104|Ann & Robert H. Lurie Children's Hospital of Chicago|Dr. David Walterhouse|3122274000|d-walterhouse@northwestern.edu|
21248037|NCT02473276|Columbia University|Richard Smiley|212 305 5006|rms7@cumc.columbia.edu|
21248038|NCT05325294|Medtronic Diabetes|Fang Niu, Sr Statistician|8185763319|fang.niu@medtronic.com|
21248039|NCT00491894|Shionogi USA|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
21248040|NCT01563185|Horizon Pharma|Julie Ball, Senior Director of Clinical Development & Operations|224-383-3059|jball@horizonpharma.com|
21248041|NCT04577651|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
21248042|NCT04202133|University of Pennsylvanai|Dr. Ariana Chao|215-746-7183|arichao@upenn.edu|
21248043|NCT05422339|MapHabit|Matt Golden|9143301776|mgolden@maphabit.com|
21248044|NCT04172675|Janssen Research & Development, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21248045|NCT03070392|Immunocore, Ltd|Study Director|1-844-IMMUNO-1|clinicaltrials@immunocore.com|
21248046|NCT02794428|Vanderbilt-Ingram Cancer Center|Douglas Morgan|615-936-7423|drmorgan@uabmc.edu|
21248047|NCT03560323|University of Texas Health -San Antonio|Yuejuan Qin, Assistant Professor|210-358-7200|qiny@uthscsa.edu|
21248048|NCT02534233|Johns Hopkins Hospital|Dr Marcia Canto, Director of Clinical Research|443-287-8083|mcanto1@jhmi.edu|
21248049|NCT00925548|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21248050|NCT01278030|St. Jude Medical|John Gill|818-493-2609|jgill@sjm.com|
21248051|NCT02949297|Endologix, LLC|Manager, Clinical Affairs|864-270-8524|nsmith@endologix.com|
21248052|NCT00458783|Cleveland Clinic|Andra Duncan, MD|216-445-2372|duncana@ccf.org|
21248053|NCT01737398|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
21248054|NCT04456413|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|Joshua.Zenreich@hmhn.org|
21248055|NCT02372799|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
21248056|NCT00089609|National Cancer Institute, National Institutes of Health|Ravi Madan, M.D.|301-480-7168|rm480i@nih.gov|
21248057|NCT03706261|Columbia University|Adam M. Brickman, PhD|212-342-1348|amb2139@cumc.columbia.edu|
21248058|NCT05815342|Insulet Corporation|Dr. Trang Ly|9786007628|Tly@insulet.com|
21248059|NCT03559205|Keele University|Jonathan Hill|01782 733900|j.hill@keele.ac.uk|
21248060|NCT03150875|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+86 13382419112|jessica.yi@innoventbio.com|
21248061|NCT01555138|Novartis Pharmaceuticals|Study Director|862-778-8300||
21248062|NCT04612868|AEYE Health Inc.|Zack Dvey-Aharon, PhD|8662627343|info@aeyehealth.com|
21248063|NCT03220724|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
21248064|NCT01613417|Executive Director, MRI|Gianpaolo Pirovano, MD|609-514-2226|gianpaolo.pirovano@diag.bracco.com|
21248065|NCT00512252|Washington University School of Medicine|Geoffrey L. Uy, M.D.|314-454-8304|guy@dom.wustl.edu|
21248066|NCT02357966|XBiotech USA, Inc.|Haritha Pallapotu|512-386-2992|hpallapotu@xbiotech.com|
21248067|NCT03819543|University of Manitoba|Dr. Marcus Ng|204-787-2684|marcus.ng@umanitoba.ca|
21248068|NCT00047385|Early Detection Research Group, NCI, NIH|Christine D. Berg, M.D.|301-496-8544|bergc@mail.nih.gov|
21248069|NCT03392194|Brigham and Women's Hospital|Dr. Susan Redline|617-732-5859|SREDLINE@BWH.HARVARD.EDU|
21248070|NCT03865732|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
21248071|NCT01379651|Unit of Pediatrics, Fatebenefratelli Hospital, Benevento, Italy|Dr. Iride Dello Iacono|+39 824 771111|iridedello@hotmail.com|
21248072|NCT00620854|Tarsa Therapeutics, Inc.|Thomas Wicks, Ph.D., Vice-President Global RA/QA|267 273 7946|twicks@tarsatherapeutics.com|
21248073|NCT03345979|Alkermes, Inc|Eva Stroynowski|7816097000|eva.stroynowski@alkermes.com|
21248074|NCT04689932|Rockwell Medical|Raymond D Pratt, MD|2489609009|rpratt@rockwellmed.com|
21248075|NCT01354145|Bioiberica|Marta Herrero - Clinical R&D Manager|+34934904908|mherrero@bioiberica.com|
21248076|NCT00734578|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21248077|NCT00999596|Philips Healthcare|Sarah Baxter or Linda Jalbert|425-487-7665 / 978-659-7434|sarah.baxter@philips.com, linda.jalbert@philips.com|
21248078|NCT02095145|University of Wisconsin Carbone Cancer Center|David Jarrard|608-262-0759|jarrard@urology.wisc.edu|
21248079|NCT01542255|Dartmouth-Hitchcock|Marc Ernstoff|603-650-5534|marc.s.ernstoff@hitchcock.org|
21248080|NCT02085941|Brigham & Women's Hospital/Dana-Farber Cancer Institute|Thomas C. Lee, MD|617-732-7260|tchlee@bwh.harvard.edu|
21248081|NCT03447912|George Washington University|Carla Berg, PhD, MBA, LP|202-994-0168|carlaberg@email.gwu.edu|
21248082|NCT01477177|Mayo Clinic|Herbert C. Wolfsen, M.D.|904-953-6319|Wolfsen.Herbert@mayo.edu|
21295055|NCT03515226|University of Washington, Department of Psychiatry & Behavioral Sciences|Dr. Patricia Arean, Director, UW ALACRITY Center|206-221-8692|parean@uw.edu|
21295056|NCT03010137|UC Davis Medical Center|Dr. Yunfeng Xue|408-603-0507|yunxue@ucdavis.edu|
21295057|NCT01952444|Elusys Therapeutics Inc.|Senior Director of Regulatory|973-808-0222|cdillon@elusys.com|
21295058|NCT01477463|Stanford University School of Medicine|Jean Y Tang MD PhD, assistant professor|650-721-7149|baileyhi@stanford.edu|
21295059|NCT03555981|London School of Hygiene & Tropical Medicine|Dr Helen Brotherton|07481474150|helen.brotherton@lshtm.ac.uk|
21295060|NCT00354107|Children's Oncology Group|Results Reporting Coordinator|3522730558|resultsreportingcoordinator@childrensoncologygroup.org|
21295061|NCT03093636|University of Virginia Center for Diabetes Technology|Marc Breton, PhD|(434) 982-6484|MB6NT@uvahealth.org|
21295062|NCT03361189|UCLA|Dr. Jeremy P. Moore|310-267-7667|RGoldstein@mednet.ucla.edu|
21295063|NCT03344549|University of Colima|Ari Cisneros Hernández|3335762299|aricisneroshernandez@gmail.com|
21295064|NCT03333252|Weill Medical College of Cornell University|Sara J. Czaja|646-962-7141|sjc7004@med.cornell.edu|
21295065|NCT01679600|Bern University of Applied Sciences|Dr. Oliver Stoller|+41344264195|oliver.stoller@bfh.ch|
21295066|NCT00108303|VA|Dr. Robert Freedman|3037244940|Robert.Freedman@ucdenver.edu|
21295067|NCT01437098|Medtronic|Hiroko Ookubo|81367760811|hiroko.ookubo@medtronic.com|
21295068|NCT03287674|National Center for Cancer Immune Therapy, Herlev Hospital|Anders Kverneland, MD|38686467|anders.kverneland@regionh.dk|
21295069|NCT00557310|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21295070|NCT00585494|University of Wisconsin Madison|Ann Marie Sheehy, M.D., M.S.|608-335-6734|asr@medicine.wisc.edu|
21295071|NCT02781792|Washington University School of Medicine|Dr. Milan Chheda|314-747-2712|mchheda@wustl.edu|
21295072|NCT03061721|Zydus Therapeutics Inc.|Dr Deven Parmar|7324050886|dparmar@zydustherapeutics.com|
21248083|NCT00093496|Mayo Clinic Cancer Center|Charles Erlichman, M.D.||erlichman.charles@mayo.edu|
21248084|NCT00586313|Indiana University Hospital|John DeWitt, MD|317-944-1113|jodewitt@iu.edu|
21248085|NCT00229970|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21248086|NCT01932970|Amgen Inc.|Study Director|866-572-6436||
21248087|NCT01979276|Weill Cornell Medical College|Jennifer Hess|646-962-9440|jmh2004@med.cornell.edu|
21248088|NCT03205566|Guy's & St. Thomas' NHS Foundation Trust|Dr Julie Fox|020 7188 7188|julie.fox@gstt.nhs.uk|
21248089|NCT03184987|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21248090|NCT00853580|The University of Alabama at Birmingham|Bruce R. Korf|205.934.9411|bkorf@uabmc.edu|
21248091|NCT01767467|GlaxoSmithKline|GSK Response Center|866-435-7343||
21248092|NCT01085513|Given Imaging|director of clinical affairs|+972-4-9097774|Hila.debby@givenimaging.com|
21248093|NCT02040870|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21248094|NCT02483468|Ralph H. Johnson VA Medical Center, Charleston, SC & Medical University of South Carolina|Jeffrey J Borckardt, PhD|843.792.3295|borckard@musc.edu|
21248095|NCT04971733|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
21248096|NCT00600353|University of Kansas Medical Center|Dr. Omar Aljitawi|913-588-6029|oaljitawi@kumc.edu|
21248097|NCT04941482|Hanoi Medical University|Dr. Thao Thi Phuong Nguyen|+84916911897|dr.nguyenthiphuongthao.hmu@gmail.com|
21248098|NCT04200664|Ear Institute, University College London|Dr N Kharytaniuk (Clinical Research Fellow)|02076792000|n.kharytaniuk@ucl.ac.uk|
21248099|NCT03292133|Massachusetts General Hospital|Zofia Piotrowska, MD|6176439707|Zofia.Piotrowska@MGH.HARVARD.EDU|
21248100|NCT00291694|University of Kansas Medical Center|Dr. Carol Fabian|913-588-3666|cfabian@kumc.edu|
21248101|NCT01367236|Imperial College London|Professor Alan Winston|+44 (0)20 3312 1603|a.winston@imperial.ac.uk|
21248102|NCT02921555|Grupo Español de Trabajo en Enfermedad de Crohn y colitis Ulcerosa|Dr. Eugeni Domènech|635899553|soporte@geteccu.org|
21248103|NCT04728711|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
21248104|NCT02842749|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
21248105|NCT05293717|University of Rochester|Anna De Benedetto, MD|(585) 275-7546|anna_debenedetto@urmc.rochester.edu|
21248106|NCT00357994|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21248107|NCT01655563|Hospital for Sick Children|Dr. Seema Mital|416-813-7418|seema.mital@sickkids.ca|207418
21248108|NCT02431741|Faculty Hospital Kralovske Czech Republic|Prof. Dr. Petr Arenberger|+420 267 16 11 11|avemedica@email.cz|
21248109|NCT00019604|National Cancer Institute, National Institutes of Health|Caryn Steakley|301-435-3685|steaklec@mail.nih.gov|
21248110|NCT01583868|Bausch Health|Study Director||robert.steffen@bausch.com|
21248111|NCT00252382|Sunesis Pharmaceuticals, Inc.|Mike Johnston, Senior Director Regulatory Affairs|(650) 266-3727|mjohnston@sunesis.com|
21248112|NCT01545583|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21248113|NCT01509183|Propeller Health|Research Team at Propeller Health|9545369563|leanne.kaye@propellerhealth.com|
21248114|NCT03783936|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 921-2050|fsharmin@hoosiercancer.org|
21248115|NCT01263132|Merck S.A. de C.V., Mexico, an affiliate of Merck KGaA, Darmstadt, Germany|Medical Responsible|+49-6151-72-5200|service@merckgroup.com|
21248116|NCT02489357|Johns Hopkins University/Sidney Kimmel Cancer Center|Emmanuel Antonarakis, MD|410-502-7528|eantona1@jhmi.edu|
21248117|NCT01218048|University of Pittsburgh Cancer Institute|Robert Ferris, MD, PhD|412-623-3205|ferrrl@upmc.edu|
21248118|NCT01335867|University of Pennsylvania Treatment Research Center|Kyle M. Kampman, M.D.|215 746 2764|kampman@pennmedicine.upenn.edu|
21248119|NCT00748982|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21248120|NCT02203799|Baylor College of Medicine|Carla M. Davis, MD|832-824-1319|carlad@bcm.edu|
21248121|NCT03335488|Horizon Therapeutics, LLC|Horizon Therapeutics, LLC|866-479-6742|clinicaltrials@horizontherapeutics.com|
21248122|NCT01953692|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21263044|NCT00903032|VA ECHCS|P. Michael Ho|720-857-5115|Michael.Ho@va.gov|
21263045|NCT01429792|Hoffman-La Roche|Medical Communications|8008218590|genentech@druginfo.com|
21263046|NCT01380106|Boston VA Research Institute, Inc.|Nikhil C. Munshi, M.D.|6176325607|nikhil.munshi@dfci.harvard.edu|
21263047|NCT04346628|Stanford University|Yvonne A. Maldonado, MD|(650) 723-5682|bonniem@stanford.edu|
21263048|NCT01763905|Amgen Inc.|Study Director|866-572-6436||
21263049|NCT02324842|University of Texas Health San Antonio|Eugenio Cersosimo, MD|210-358-7220|cersosimo@uthscsa.edu|
21263050|NCT04341675|University of Cincinnati|Nishant Gupta, MD|513-558-4861|Nishant.Gupta@uc.edu|
21263051|NCT03226223|New York State Psychiatric Institute|Dr. Jermaine Jones|6467746113|jermaine.jones@nyspi.columbia.edu|
21263052|NCT01263691|Emergent BioSolutions|Dr. Robert Hopkins|(301) 944-0136|hopkinsr@ebsi.com|
21263053|NCT01202227|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21263054|NCT00643487|Upstate Medical University|Thomas V. Smallman|315-464-8618|smallmat@me.com|
21263055|NCT01894477|Fred Hutchinson Cancer Research Center|Eileen J Sickle|206-271-7066|esickle@fredhutch.org|
21263056|NCT01706549|Tampere University Hospital|MD Satu Pokkinen|+3583311611|Satu.pokkinen@pshp.fi|
21281088|NCT02393950|Orion Corporation|Clinical Trials Information Desk|+358104261|clinicaltrials@orionpharma.com|
21281089|NCT04335123|Kansas University Medical Center|Dr Matthias Salathe|9135886000|msalathe@kumc.edu|
21281090|NCT05486091|Anxiety Disorders Center|Gretchen Diefenbach, Ph.D.|860-545-7396|gretchen.diefenbach@hhchealth.org|
21281091|NCT00370552|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21281092|NCT01607450|Indiana University|Kieren J Mather MD FRCPC|317-278-7826|kmather@iu.edu|
21281093|NCT00659711|State University of NY at Buffalo|Paresh Dandona|7165351850|dandona@buffalo.edu|
21281094|NCT03207776|Atrium Health|Dr. Jason Roberge|704-898-3855|Jason.Roberge@AtriumHealth.org|
21281095|NCT01651117|Corporal Michael J. Crescenz VA Medical Center|Judith A. Long, MD|215-898-4311|judith.long@va.gov|
21281096|NCT03871543|Johnson & Johnson Vision Care, Inc.|Ross Franklin|1 800-843-2020|RFRANKL1@its.jnj.com|
21281097|NCT01894919|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
21281098|NCT01839708|Ohio State University|Mei-Wei Chang|(614) 292-4041|chang.1572@osu.edu|
21281099|NCT00663793|University of Washington|John K Amory, MD, MPH|206-616-1727|jamory@u.washington.edu|
21281100|NCT04341363|Yale University|Brett King|(203) 785-7421|Brett.King@yale.edu|
21281101|NCT01468337|National Eye Institute|Emily Chew, MD|301-496-6583|emily.chew@nih.gov|
21281102|NCT03534687|University of Michigan|Jacob Haus|734 647-2790|jmhaus@umich.edu|
21281103|NCT02069015|Wayne State University|Julie Gleason-Comstock|313-577-6681|jgleason@med.wayne.edu|
21281104|NCT00957801|University of Texas Medical Branch|Randall J Urban, Professor and Chair, Internal Medicine|409-772-1176|rurban@utmb.edu|
21281105|NCT01778855|UCLA|David S Liebeskind, MD|310-794-6379|dliebeskind@mednet.ucla.edu|
21281106|NCT02479451|Mass General Hospital|Sagar Nigwekar|5857298636|sagarnigs@gmail.com|
21281107|NCT00806403|Sahlgren's University Hospital/S, Gothenburg|Lars Grip||lars.grip@vgregion.se|
21281108|NCT04910100|BLP Management Group LLC|Barry Butler|813-766-9539|bbutler@blpmgmt.com|
21281109|NCT03482973|Beth Israel Deaconess Medical Center|Dr. Balachundhar Subramaniam|6176320706|bsubrama@bidmc.harvard.edu|0706
21281110|NCT00524940|Sanofi Pasteur Inc|Medical Director||RegistryContactUs@sanofipasteur.com|
21281111|NCT01609790|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21281112|NCT05207865|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21281113|NCT02141438|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21281114|NCT02546986|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
21281115|NCT02844543|Stanford University|Dr. Jamshid Ghajar, MD, PhD|(650) 725-5562|acrevelt@stanford.edu|
21281116|NCT03349060|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21281117|NCT00485732|GlaxoSmithKline|GSK Response Center|866-435-7343||
21281118|NCT00437021|Saint Louis University Medical Center|Sharon E. Frey, M.D.|315-977-5500|sharon.frey@health.slu.edu|
21281119|NCT02024607|Sumitomo Dainippon Pharma Oncology|Tegan Nguyen|617-674-8745|tnguyen@bostonbiomedical.com|
21281120|NCT05423093|Johns Hopkins University|Rheanna Platt|410-550-8753|rplatt1@jhmi.edu|
21281121|NCT05364931|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21281122|NCT03593525|The Hospital for Sick Children|Dr. Lillian Sung|416 813 5287|lillian.sung@sickkids.ca|
21281123|NCT05537233|Indiana University School of Medicine|Viral N Shah, MD|317-278-6017|shahvi@iu.edu|
21281125|NCT05338489|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
21281126|NCT05857488|Massachusetts General Hospital|Guillermo Tearney, MD, PhD|617-724-2979|gtearney@mgb.org|
21281127|NCT03851406|University of North Carolina at Chapel Hill|Terry Noah, MD|919-966-1055|terry_noah@med.unc.edu|
21281128|NCT04570670|Banner Life Sciences LLC|Thomas Lategan, PhD|3368990959|thomas.lategan@bannerls.com|
21281129|NCT04067050|CooperVision, Inc|Jose A. Vega|925-640-2964|javega2@coopervision.com|
21281130|NCT02677753|University of Louisville|Dr. Sean Francis|5025617260|sean.francis@louisville.edu|
21281131|NCT00460603|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21281132|NCT01313897|University of Arkansas for Medical Sciences|Frits van Rhee|501-526-6990|vanrheefrits@uams.edu|
21281133|NCT03982511|Central Michigan University|Sarah Domoff, PhD|989-774-6461|domof1se@cmich.edu|
21281134|NCT01293695|Baylor University|Dr. Gary Elkins, Director of the Mind-Body Medicine Research Laboratory|254-296-0643|gary_elkins@baylor.edu|
21281135|NCT01967862|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
21281136|NCT00607620|University of Washington|Douglas Zatzick, MD|206-744-6701|dzatzick@uw.edu|206
21263057|NCT02424955|Stanford University|Lucas Kas Vitzthum|(650) 498-6000|ccto-website@stanford.edu|
21263058|NCT00850759|UAB|David Schwebel|205-934-8745|schwebel@uab.edu|
21263059|NCT02389816|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21263060|NCT00578864|BAYLOR|Peter Zage, MD|832-824-4615|pezage@txch.org|
21263061|NCT01253044|VA San Diego Healthcare System and UCSD|Dr. Ariel Lang|858-246-0631|ajlang@ucsd.edu|
21263062|NCT01087528|Givenimaging|Hilla Debby/Director of clinical affairs|972490977740|hila.debby@givenimaging.com|77740
21263063|NCT03116399|Weill Medical College of Cornell University|Sara J. Czaja, PhD|646-962-7141|sjc7004@med.cornell.edu|
21263064|NCT01226420|Dana-Farber Cancer Institute|Corey S. Cutler, MD, MPH, FRCP(C)|617-632-5946|cscutler@partners.org|
21263065|NCT02868216|Cardiologia (Institute of Cardiology of Rio Grande do Sul/University Foundation of Cardiology|Dra Marcia Moura Schmidt|5551 32333600|mmoura22@terra.com.br|3765
21263066|NCT00987623|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
21263067|NCT00752609|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21263068|NCT05114590|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21263069|NCT01425190|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21263070|NCT00195260|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21263071|NCT02749721|Rush University Medical Center|Dr. John Zajecka|312-942-5592|John_Zajecka@rush.edu|
21263072|NCT01379534|Novartis|Study Director|862-778-8300||
21263073|NCT02691247|Caladrius Biosciences|William Sietsema|9495352391|bsietsema@caladrius.com|
21263074|NCT01519245|University of Saskatchewan|Dr. Kelsey Brose, Primary Investigator|306-655-1483|kelsey.brose@saskcancer.ca|
21263075|NCT02582749|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317.921.2050|jsmith@hoosiercancer.org|
21263076|NCT02213198|UTHSCSA|Dr. Dawn Velligan|210-567-5508|velligand@uthscsa.edu|
21263077|NCT01518192|Department of Infectious Diseases, University Medical Center Ljubljana|Franc Strle|+386 1 522 2610|franc.strle@kclj.si|
21263078|NCT00001262|National Institute of Child Health and Human Development|Kaler, Stephen G|+1 301 451 6034|kalers@mail.nih.gov|
21263079|NCT00783705|Mayo Clinic Rochester|Paul J. Limburg, M.D., M.P.H.|507-284-2511|limburg.paul@mayo.edu|
21263080|NCT01987986|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquires@endo.com|
21263081|NCT01617434|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21263082|NCT01568905|University of Minnesota Tobacco Research Programs|Dorohty Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu|
21263083|NCT01402284|National Cancer Institute|Dr. Dickran Kazandijian|301-480-8870|kazandijiandg@mail.nih.gov|
21263084|NCT03302416|Univesity of Pittsburgh|Rajesh Narendran|412-647-5176|narendranr@upmc.edu|
21263085|NCT04038255|University of Miami|Dr. Taghrid Asfar|+1 (901)-371-7229|tasfar@miami.edu|
21263086|NCT05183867|Center for Healthy Minds|Simon Goldberg|(608) 265-8986|sbgoldberg@wisc.edu|
21263087|NCT04491877|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21263088|NCT02614287|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21263089|NCT00751530|Community Research Initiative|Project Manager|617 502 1700|pmacht@crine.org|
21263090|NCT00441441|GlaxoSmithKline|GSK Response Center|866-435-7343||
21263091|NCT02713230|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-397-2467|MedInfo@pacira.com|
21263092|NCT05619172|SOTIO Biotech a.s.|Richard Kapsa|(+420) 2241 74448|kapsa@sotio.com|
21263094|NCT03165721|National Cancer Institute|Dr. John Glod|240-760-6194|john.glod@nih.gov|
21263095|NCT02078882|University of California Davis|Christopher L Bowlus|9167348696|clbowlus@ucdavis.edu|
21263096|NCT01457118|Nektar Therapeutics|Study Director|415-482-5300|medicalaffairs@nektar.com|
21263097|NCT03298412|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21263098|NCT03456713|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21263099|NCT03656926|Zambon S.p.A.|Enrica Bucchioni, M.D., PhD, Global Clinical Development Head|+39 02 665241|clinicaltrials@zambongroup.com|
21263100|NCT00069095|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21263101|NCT05610176|BIOTRONIK SE & Co. KG|Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
21263102|NCT03909763|Peking University People's Hospital|Dr. Xiaohui Zhang, Director of Clinical Trials|86-10-88324577|zhangxh@bjmu.edu.cn|
21263103|NCT00216099|Hoosier Cancer Research Network|Jeff Smith|317-921-2050|jsmith@hoosiercancer.org|
21263104|NCT00300469|Abbott|Medical Information Specialist|800-633-9110||
21263105|NCT03796091|Green Counseling Services PLLC|Dr. Melinda Green|5154508913|drgreen@greencounselingservice.com|
21295073|NCT00794365|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21295074|NCT01509677|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21295075|NCT03538444|Medical University of South Carolina|Gregory Sahlem MD|843-792-5716|sahlem@musc.edu|
21295076|NCT03022097|AstraZeneca|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
21295077|NCT00358332|University of Maryland School of Medicine|Christopher V. Plowe|410-706-3082|cplowe@medicine.umaryland.edu|
21295078|NCT00457821|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com|
21263106|NCT01217190|Par Pharmaceutical|Medical Affairs|1-800-828-9393|DrugInfo@strativapharma.com|
21263107|NCT01594476|Oregon Health & Science University|Dr. Maureen Baldwin, MD MPH|(503) 494-9762|schaum@ohsu.edu|
21263108|NCT00436969|DePuy Mitek|Aileen Michael|508.828.3337|amichae2@its.jnj.com|
21263109|NCT00962000|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
21263110|NCT03161678|University of Maryland, School of Medicine|Joshua P. Lewis, PhD|410-706-5087|jlewis2@som.umaryland.edu|
21263111|NCT02552355|Colorado State University|Manager of Research Operations|9704912242|Laurie.Biela@colostate.edu|
21263112|NCT05309369|Medical University of South Carolina|Professor|843 367 4260|mintzerj@musc.edu|
21263113|NCT00850460|The Rockefeller University Center for Clinical and Translational|Principal Investigator|212 327-8408|trinnamaningatmd@yahoo.com|
21263114|NCT02773914|Göteborg University|Isabelle Andersson Hammar|+4631 786 5719|isabelle.a-h@neuro.gu.se|
21263115|NCT03007953|Department of Veterans Affairs|Dr. Lynn F. Reinke|206-277-4186|Lynn.Reinke1@va.gov|
21263116|NCT01052012|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
21263117|NCT02224846|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21263118|NCT00923910|National Cancer Institute|Dr. Terry Fry|301-402-0215|fryt@mail.nih.gov|
21263119|NCT00418262|University of Oklahoma Health Sciences Center|Mark Wolraich, M.D.|(405) 271-5700|mark-wolraich@ouhsc.edu|45123
21263120|NCT03196297|Novo Nordisk A/S|Clinical Transparency and Medical Writing (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21263121|NCT02538666|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21263122|NCT02615717|University of Nebraska, Lincoln|Christina Hein, M.A.|7036184722|chein9@gmail.com|
21263123|NCT04942483|Imperial College London|Professor Andrew Bush|020 7352 8121|a.bush@imperial.ac.uk|2255
21263124|NCT01943864|GlaxoSmithKline|GSK Response Center|866-435-7343||
21263125|NCT00320385|GlaxoSmithKline|GSK Response Center|866-435-7343||
21263126|NCT04370028|OOO NPF Materia Medica Holding|Mikhail Putilovskiy, MD, PhD|+74952761575|PutilovskiyMA@materiamedica.ru|302
21263127|NCT02492750|Mayo Clinic|John A Lust MD PhD|507/284-2511|lustj@mayo.edu|
21263128|NCT02965534|University of Applied Sciences Jena|Philipp Hessler|+4916097089677|philipp@hessler.de|
21263129|NCT03230175|TissueTech, Inc.|Nick McCoy, Vice President Clinical Operations|7867340023|nmccoy@tissuetechinc.com|
21263130|NCT02200458|Christie Medical Holdings, Inc.|Clinical Affairs Manager|901-721-0330|christiemedinfo@christiedigital.com|
21263131|NCT00748540|MED-EL Corporation|Allison Racey, AuD|888-633-3524|allison.racey@medel.com|
21263132|NCT04743635|Revelle Aesthetics, Inc.|Rachel Walsh, Senior Manager of Clinical Affairs|6509634498|rwalsh@revelleax.com|
21263133|NCT01043523|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21263134|NCT01954121|UCB Cares|UCB (Study Director)|+1 887 822 9493||
21263135|NCT00872170|New England Research Institutes|Nancy Gee|617-972-3295|ngee@neriscience.com|
21263136|NCT00601523|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21263137|NCT04072146|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
21263138|NCT02915367|Massachusetts General Hospital|Jessica Haberer|617-643-9195|jhaberer@partners.org|
21263139|NCT00722553|Allos Therapeutics, Inc.|Medical Monitor|303-426-6262|gweems@allos.com|
21263140|NCT00540436|GlaxoSmithKline|GSK Response Center|866-435-7343||
21263141|NCT01064648|SWOG Statistics & Data Management Center|SWOG statistician|2066674263|jmiao@fredhutch.org|
21263142|NCT05281523|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21263143|NCT05513391|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21263144|NCT02429427|Imperial College London|Prof Charles Coombes|+44 20 7594 2135|c.coombes@imperial.ac.uk|
21263145|NCT00719732|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21263146|NCT00436215|National Cancer Institute|Dr. Christina Annunziata|301-402-7189|annunzic@mail.nih.gov|
21263147|NCT02775760|Boston University Chobanian & Avedisian School of Medicine|Karin Schon, Ph.D.|(617) 358-2118|kschon@bu.edu|
21295079|NCT00842946|Department of Veterans Affairs (formerly Drexel University)|Dr. Erica England|207-239-6323|elengland02@yahoo.com|
21263148|NCT01760941|Virginia Commonwealth University/Massey Cancer Center|Drew Moghanaki, MD, MPH|804-765-5850|Drew.moghanaki@vcuhealth.org|
21263149|NCT01760993|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21263150|NCT03364335|NuSirt Biopharma|Barbara Cannon|6156567898|BCannon@nusirt.com|
21263151|NCT00492856|SWOG Statistical Center|SWOG Leukemia Committee Statistician|206-667-4408||
21263152|NCT04710862|Syracuse University|Dr. Soren Lowell|315-443-9615|slowell@syr.edu|
21263153|NCT01520324|Cosmo Pharmaceuticals NV|Dr. Richard Jones|+353 18170370|RJones@cosmopharma.com|
21263154|NCT03813719|Imperial College London|Dr Diana Marcus|07525133957|d.marcus16@imperial.ac.uk|
21263155|NCT00948818|Forest Research Institute|Paul F.C. Eng Ph.D Director, Clinical Development|201-427-8071|Paul.Eng@frx.com|
21263156|NCT00745368|University of Rochester|Robert DiCenzo|518 694 7228|rob.dicenzo@acphs.edu|
21263157|NCT02364947|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials||CL_OPCJ_RDA_Team@otsuka.jp|
21263158|NCT00853489|Saint Louis University|Dr. Lisa Kaye Cannada|3145778850|LCannada@slu.edu|7
21281137|NCT01082328|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21281138|NCT00031590|Childrens Hospital of Philadelphia|Peter Phillips|215-590-1000|phillipsp@email.chop.edu|
21281139|NCT03124368|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
21281140|NCT05506046|Georgia State University|Lyudmila Popova|404-413-9338|lpopova1@gsu.edu|
21281141|NCT01120808|Stanford Department of Emergency Medicine|Dr. Grant Lipman|415-290-9286|gslipman@stanford.edu|
21281142|NCT00381862|OHSU Knight Cancer Institute|Joseph Bubalo, PharmD, BCPS, BCOP|503-494-1080|bubaloj@ohsu.edu|
21263159|NCT02326467|Boston Children's Hospital|Celeste Chandonnet|781-216-0050|celeste.chandonnet@childrens.harvard.edu|
21263160|NCT00434512|GlaxoSmithKline|GSK Response Center|866-435-7343||
21263161|NCT02405429|University of Iowa|Edward F. Bell, MD|319-356-4006|edward-bell@uiowa.edu|
21263162|NCT04253834|Emory University|Dr. Jeffrey Miller|404-252-6104|jeffrey.miller@emory.edu|
21263163|NCT01251276|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21263164|NCT02245568|TauRx Therapeutics Ltd|Dr. Diane Downie|+44 1224440905|info@taurx.com|
21263165|NCT02658994|Human Development Research Foundation|Siham Sikander|+923330590373|sihamsikander@gmail.com|
21263166|NCT01725152|Marinus Pharmaceuticals, Inc.|Marinus|484-801-4670|clinicaltrials@marinuspharma.com|
21263167|NCT00849121|University of Wisconsin Carbone Cancer Center|Dr. Douglas McNeel|608-265-8131|dm3@medicine.wisc.edu|
21263168|NCT01111539|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21263169|NCT03007485|Northwell Health|Dr. Negin Hajizadeh|516-600-1401|Nhajizadeh@northwell.edu|
21263170|NCT01848054|PRA International|Lynn R. Webster, MD|801-892-5140|LRWebsterMD@gmail.com|
21263171|NCT03580382|NYU Langone Health - PCC CTO|Rachael Keller, Sr. Regulatory Specialist|929-455-2453|Rachael.Keller@nyulangone.org|
21263172|NCT02808312|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21263173|NCT03628417|Szeged University|Principal Investigator, Assistant Professor|+36-62-545-259|kis.erika.gabriella@med.u-szeged.hu|
21263174|NCT02420223|Medical College of Wisconsin|Dr. Jennifer Knight|866-680-0505|jknight@mcw.edu|
21263175|NCT01826422|IMSS|Dr. Maricela Rodriguez-Cruz|5256276900|maricela.rodriguez.cruz@gmail.com|. 22483
21263176|NCT04549597|Ardelyx|David Rosenbaum|6175134929|drosenbaum@ardelyx.com|
21263177|NCT00769704|Amgen, Inc.|Study Director|866-572-6436||
21263178|NCT00450372|UM/Sylvester Comprehensive Cancer Center|Lynn Feun MD|305-243-4909|lfeun@med.miami.edu|
21263179|NCT05131451|Johns Hopkins University|Dr. Risa Wolf|4109556463|rwolf@jhu.edu|
21263180|NCT00335504|Mayo Clinic|Dr. Paul Limburg|507-266-9093|limburg.paul@mayo.edu|
21263181|NCT01487668|Department of Veterans Affairs, VA Ann Arbor Healthcare System|Amy M. Kilbourne, PhD, MPH|734-845-3452|amy.kilbourne@va.gov|
21263182|NCT01856595|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21263183|NCT01835496|ApoPharma Inc.|Caroline Fradette, PhD|416-401-7543|cfradett@apopharma.com|
21263184|NCT04426825|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21263185|NCT03000309|Skin Sciences, PLLC|M. McAllister|5024519000|mmdermresearch@yahoo.com|
21263186|NCT02145299|Yale School of Medicine|Dr. Alexandra Lansky|203-737-2142|alexandra.lansky@yale.edu|
21263187|NCT00458406|CTRC, Children's Hospital of Philadelphia|Paul R. Gallagher, MA|215-590-2739|gallagherp@email.chop.edu|
21263188|NCT03161938|Rigshospitalet|Kristin steinthorsdottir|31666112|kjs@dadlnet.dk|
21263189|NCT01863849|Fluart Innovative Vaccines Ltd|Zsolt Németh|+3620|info@fluart.hu|4197020
21263190|NCT03540134|University of Virginia|Dr. Jeff Elias|(434) 924-0451|FUSbrain@virginia.edu|
21263191|NCT02902172|St. Louis University|Dr. Jennifer Goldkamp|3149772200|jen.goldkamp@health.slu.edu|
21263192|NCT01434472|Fred Hutchinson Cancer Research Center|Dr. Ajay Gopal|206-606-2037|agopal@uw.edu|
21263193|NCT00818324|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
21263194|NCT00138034|Radboud University Medical Center Nijmegen|Professor Doctor F.W.A. Verheugt|+31(0)24-3614533|f.verheugt@cardio.umcn.nl|
21263195|NCT01727713|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
21263196|NCT00532948|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21263197|NCT01773135|Ain Shams University Maternity Hospital|Mohamed Saied Eldein El-Safty, Lecturer of Obstetrics and Gynecology Faculty of Medicine - Ain Shams|01003922211|dr.mai_elshahm@yahoo.com|002
21263198|NCT01842308|Mayo Clinic|Suzanne R. Hayman, M.D|(855) 776-0015|hayman.suzanne@mayo.edu|
21263199|NCT00370695|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
21263200|NCT03885726|Vapotherm, Inc.|George C. Dungan, II|(267)347-3305|gdungan@vtherm.com|
21263201|NCT02702193|University of Miami|Victoria Mitrani|305 284-9139|vmitrani@miami.edu|
21263202|NCT01734512|University of California, San Francisco|Dr. Sabine Mueller, MD, PhD|(415) 502-7301|sabine.mueller@ucsf.edu|
21263203|NCT05692154|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21263204|NCT02154750|UC San Diego Health|Gregory Feld, MD|(858) 246-2972|gfeld@health.ucsd.edu|
21263205|NCT01912729|Northwestern University|David C. Mohr, PhD|312-503-1403|d-mohr@northwestern.edu|
21263206|NCT00904826|Mayo Clinic|Dr. Sean J. Pittock|507-284-4741|pittock.sean@mayo.edu|
21263207|NCT01429987|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020||
21263208|NCT03860311|UAB|Dr. Stephen Ruffenach|5202707665|stephenruffenach@gmail.com|
21263209|NCT05513053|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21263210|NCT05299983|UC San Diego|Andrea LaCroix|(858) 822-0627|alacroix@ucsd.edu|
21263211|NCT00683475|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21263212|NCT01953328|Amgen Inc.|Study Director|866-572-6436||
21263213|NCT05138783|Alcon Research, LLC|Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21263214|NCT02429258|AstraZeneca, PLL|Sergey Zhuplatov MD, PhD|215-542-3222|sergey.zhuplatov@astrazeneca.com|
21263215|NCT00554463|NRG Onocology|Wendy Seiferheld||wseiferheld@nrgonology.org|
21263216|NCT03987919|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21263217|NCT03725202|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21263218|NCT01247220|Retina Associates of Florida|Ivan J. Suner, MD|813-875-6373|ivansuner@gmail.com|
21263219|NCT01328249|Eisai Inc.|Eisai Medical Information|1-888-422-4743|esi_oncmedinfo@eisai.com|
21281143|NCT01286467|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21263220|NCT00748553|Huntsman Cancer Institute|Kimberlee Taylor|8012135673|Kimberlee.Taylor@hci.utah.edu|
21281144|NCT00765102|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21281145|NCT03447639|Beaumont Hospital|Director of Urology Research|248.551.0804|Deborah.Hasenau@Beaumont.org|
21263221|NCT02330549|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21263222|NCT00495495|Indiana University School of Dentistry|Domenick T. Zero, DDS MS Principal Investigator|317-274-8822|dzero@iupui.edu|
21263223|NCT01156597|University of Miami Miller School of Medicine|Armando J. Mendez, Ph.D.|305-243-5342|a.mendez@miami.edu|
21263224|NCT02536170|Emory University|Claudia Morris|404-727-5500|claudia.r.morris@emory.edu|
21263225|NCT00423085|Novartis Pharmaceuticals|Study Director|862-778-8300||
21263226|NCT02702518|University of Illinois Chicago|Dr. Sandeep Jain|312-996-4476|jains@uic.edu|
21263227|NCT03331666|Columbia University Irving Medical Center|Dr. Nan Wang|212-342-1761|nw30@cumc.columbia.edu|
21263228|NCT05525975|University of Iowa Health Care|Brendan Patterson|319 678-8451|brendan-patterson@uiowa.edu|
21263229|NCT01392989|Stanford University|Everett Meyer, Assistant Professor of Medicine (Blood and Marrow Transplantation)|650) 725-5816|evmeyer@stanford.edu|
21263230|NCT01051986|Seoul National University Hospital|Ki-Bong Kim|+82-2-2072-3482|kimkb@snu.ac.kr|
21263231|NCT00262080|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21263232|NCT02728258|NRG Oncology|Linda Gedeon on behalf of Virginia Filiaci, PhD.|716-845-1169|gedeonl@nrgoncology.org|
21263233|NCT02044159|Children's Hospital of Eastern Ontario|Katie O'Hearn, Research Coordinator|613-737-7600|kohearn@cheo.on.ca|4006
21263234|NCT01361009|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21263235|NCT04009096|University of Oxford|Dr. Angela Minassian|01865611425|angela.minassian@ndm.ox.ac.uk|
21263236|NCT04263142|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21263237|NCT00812916|Biosense Webster, EMEA|Nathalie Macours|+32 2 7463076|MNathalie@its.jnj.com|
21263238|NCT01351077|Indiana University School of Medicine|Aaron E. Carroll, MD, MS|3172789616|aaecarro@iu.edu|
21263239|NCT03010423|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21263240|NCT01597557|University at Buffalo|Dr. Anne Curtis|716-859-4828|abcurtis@buffalo.edu|
21263241|NCT00312884|Imperial College london|Professor Cowie|0207 349 7716|m.cowie@imperial.ac.uk|
21263242|NCT00115349|UCL Cancer Institute|John Porter, MD, Principal Investigator|+011 (44) 207 679 6224|j.porter@ucl.ac.uk|
21263243|NCT02012608|University of Arkansas for Medical Sciences|Beth Scanlan|501-686-8274|bscanlan@uams.edu|
21263244|NCT04402008|Assertio Holdings|Howard Franklin, MD|224 419 7106|Hfranklin@assertiotx.com|
21263245|NCT02874404|University of Nebraska Medical Center|Dr. Matthew Lunning, DO, Associate Professor|402-559-7164|mlunning@unmc.edu|
21263246|NCT01533935|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21263247|NCT05132569|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
21263248|NCT01554956|Kedrion SpA|Clinical Trial Manager|+39 05831969231|a.lotti@kedrion.com|
21263249|NCT00913978|Northwestern University|Meltem Yilmaz, MD|312-695-0061|m-yilmaz@northwestern.edu|
21263250|NCT04716933|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21263251|NCT04272216|Clinical Project Manager|Paige Gowen|908-208-3749|paige.gowen@terumomedical.com|
21263252|NCT01125176|Weill Cornell Medical College|Richard Furman, MD|646-962-2064|rrfurman@med.cornell.edu|
21263253|NCT00740779|Watson Pharmaceuticals|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com|
21263254|NCT00988559|Johns Hopkins University|Cornelia L. Trimble, MD|410-502-0512|ctrimbl@jhmi.edu|
21263255|NCT05372575|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21263256|NCT00829166|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21263257|NCT03510663|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21263258|NCT03208192|Moscow Clinical Scientific Center|Mikhail Efanov, MD, PhD,|+79161058830|m.efanov@mknc.ru|
21263259|NCT00843622|Fagerström Consulting AB|Dr Karl Fagerström||karl.fagerstrom@swipnet.se|
21263260|NCT02796924|University of Manitoba|Dr. Mandana Modirrousta|2042372303|mmodirrousta@sbgh.mb.ca|
21263261|NCT01465178|University of Wisconsin|Neil Binkley|608-265-6410|nbinkley@wisc.edu|
21263262|NCT03342469|American University|Dr. Kathleen Holton|(202) 885-3797|holton@american.edu|
21263263|NCT02932475|University of North Carolina at Chapel Hill|Kim Boggess, MD|919-966-1601|kboggess@med.unc.edu|
21263264|NCT01081223|TVAX Biomedical, Inc.|Gary Wood PhD|913-961-1327|gwood@tvaxbiomedical.com|
21295080|NCT00790647|Boston Medical Center|Vaishali Sanchorawala|617-638-8265|vaishali.sanchorawala@bmc.org|
21263265|NCT02426658|Wake Forest University Health Sciences|Study Nurse|336-716-2121|saverill@wakehealth.edu|
21295081|NCT00027378|University of Pittsburgh|Jack R. Cornelius, M.D., M.P.H.|412-246-5149|corneliusjr@upmc.edu|
21263266|NCT00088634|Sunovion|Josephine Cucchiaro, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
21263267|NCT02227329|Mayo Clinic|Dr. Ryan Hurt|507-284-4461|Hurt.Ryan@mayo.edu|
21263268|NCT01204658|GlaxoSmithKline|GSK Response Center|866-435-7343||
21263269|NCT04594239|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
21263270|NCT02100748|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
21263271|NCT00309777|Kowa Research Europe, Ltd.|Neil Hounslow|01189229004|nhounslow@kowa.co.uk|
21263272|NCT02236546|Vanderbilt-Ingram Cancer Center|Dr. Tom Yankeelov||thomas.yankeelov@utexas.edu|
21263273|NCT00520676|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21295082|NCT03296137|National Center for Cancer Immune Therapy, Herlev Hospital|Anders Kverneland, MD, PhD|+4538686467|anders.kverneland@regionh.dk|
21295083|NCT02637427|Rutgers, The State University of New Jersey|Jeffrey L Carson, MD|732-235-7122|Jeffrey.Carson@Rutgers.edu|
21295084|NCT01687088|Thomas Jefferson University|Michael J. Marmura, MD|215-955-2243|michael.marmura@jefferson.edu|
21263274|NCT03568539|Innovent Biologics (Suzhou) Co., Ltd.|YiBo|+8613382419112|jessica.yi@innoventbio.com|
21263275|NCT03484923|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
21263276|NCT03439748|UCLA|Dr. Michelle G. Craske|(310) 825-8403|mcraske@mednet.ucla.edu|
21295085|NCT02851407|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-870-9177|ClinicalTrialDisclosure@JazzPharma.com|
21295086|NCT01713283|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21295087|NCT02585830|University of Colorado Anschutz Medical Campus|Stacey L. Simon|720-777-5681|stacey.simon@childrenscolorado.org|
21295088|NCT00350272|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
21295089|NCT00235391|Novartis Pharmaceuticals|Study Director|862-778-8300||
21248123|NCT00176202|University of Illinois at Chicago|Dr Mani Pavuluri|3124130064|mpavuluri@psych.uic.edu|
21248124|NCT00731614|San Francisco VA Medical Center|John R. McQuaid, Ph.D.|415-221-4810|john.mcquaid@va.gov|4106
21248125|NCT01160354|The University of Texas (UT) MD Anderson Cancer Center|Dr. Jan Burger, Associate Professor, Leukemia|7137927734|CR_Study_Registration@mdanderson.org|
21248126|NCT01006538|King's College Hospital, London|Mr Tim Jackson|+44 2032999000|t.jackson1@nhs.net|1297
21248127|NCT03849066|University of Colorado Denver|James Feinstein, MD, MPH, Principal Investigator|303-724-4186|james.feinstein@cuanschutz.edu|
21248128|NCT01801007|MicroVention, Inc., A TERUMO Group Company|Senior Manager, Clinical Quality Compliance and Clinical Operations|714-247-8000|jennifer.jelf@microvention.com|
21248129|NCT02743819|University of Chicago|Daniel Olson, Clinical Instructor|773-834-4183|daniel.olson2@uchospitals.edu|
21248130|NCT00145470|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21248131|NCT02628106|West China Hospital of Sichuan University|Mr.Zhi-cheng Li|+86 13795581617|wangcaizi2@163.com|
21248132|NCT03160521|Laboratorios Farmacéuticos Rovi, S.A.|Director of Medical Department|91 375 62 30|departamento.medico@rovi.es|
21248133|NCT00692185|New York State Psychiatric Institute|Evelyn Attia, MD|212-543-5923|ea12@columbia.edu|
21248134|NCT00914966|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21248135|NCT01701401|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21248136|NCT03975400|northwell|Michael Birnbaum|718-470-8305|mbirnbaum@northwell.edu|
21248137|NCT04762277|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21248138|NCT05824559|MEI Pharma|Richard Ghalie, MD CMO|619 990-1153|rghalie@meipharma.com|
21248139|NCT01690624|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21248140|NCT04445831|AC Immune|Olivier Sol|+41 21 345 91 21|clinicaltrials@acimmune.com|
21248141|NCT03110575|Tonix Pharmaceuticals|Gregory Sullivan, MD|862-904-0355|greg.sullivan@tonixpharma.com|
21248142|NCT04701203|Ascendis Pharma, Inc.|Aimee D. Shu, MD|+1 650 352 8389|ADS@ascendispharma.com|
21248143|NCT01804166|Janssen Scientific Affairs, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21248144|NCT05001139|Relife Srl|Prof. Giuseppe Micali|05556809528|lfabbri@relifecompany.it|
21248145|NCT02434328|Novartis Pharmaceuticals|Study Director|1-862-778-8300|novartis.email@novartis.com|
21248146|NCT03147287|Dana-Farber Cancer Institute|Project Manager|617-632-3800|ctopm@dfci.harvard.edu|
21248147|NCT06072170|Altasciences|Senior Regulatory Affairs Associate|450 973 3155|mgalarza@altasciences.com|112084
21248148|NCT03678688|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21248149|NCT00551421|Dana-Farber Cancer Institute|Dr. Kimmie Ng|617-632-4150|kimmie_ng@dfci.harvard.edu|
21248150|NCT03136159|Loyola University Medical Center|Dr Jean Goodman|7082165459|Jrgoodman@lumc.edu|
21248151|NCT03823703|Corcept Therapeutics Incorporated|Medical Director|650-327-3270|info@corcept.com|
21248152|NCT04323800|The Johns Hopkins University School of Medicine|Shmuel Shoham|410-614-6431|sshoham1@jhmi.edu|
21248153|NCT00489554|GlaxoSmithKline|GSK Response Center|866-435-7343||
21248154|NCT01732757|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21248155|NCT00731692|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21248156|NCT00747006|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
21248157|NCT01767688|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21248158|NCT00686257|Tufts Medical Center|Nicholas Hill MD|617-636-4288|nhill@tuftsmedicalcenter.org|
21248159|NCT02132949|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21248160|NCT01354444|Johns Hopkins University|Paul Rosenberg, MD|410-550-9883|prosenb9@jhmi.edu|
21248161|NCT00982072|Imperial College NHS Trust|Dr Megan Griffith|02033137309|m.e.griffith@imperial.ac.uk|
21248162|NCT00745875|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21248163|NCT01583166|UMass Worcester|Michael Flynn, MD|508-334-9840|michael.flynn@umassmemorial.org|
21248164|NCT04652869|University of Pittsburgh|Dr. Cynthia Conklin|4125869840|conkca@upmc.edu|
21248165|NCT01372085|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21248166|NCT01833455|University of Wisconsin|Stephen Wasmund, PhD|801-587-3740|stephen.wasmund@carma.utah.edu|
21248167|NCT00562094|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
21248168|NCT01600482|Vasorum Ltd|Dr James Coleman|00 353 1 4035460|jcoleman@vasorum.ie|
21248169|NCT01429454|University of California San Diego|Dr. Kristin Cadenhead|(619) 543-6445|kcadenhead@ucsd.edu|
21248170|NCT02000752|Fundación Investigación Biomédica Príncipe de Asturas|Beatriz López Garrido (Midwife)|+34 678210013|bealopega@gmail.com|
21248171|NCT03903692|Medline Industries, LP|Julie Miller|630-418-6891|jamiller@medline.com|
21248172|NCT00790699|Texas Diabetes & Endocrinology|Thomas Blevins,MD|5812.334.3505|blevins@texasdiabetes.com|
21248173|NCT03732807|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21248174|NCT00639418|MedImmune LLC|Chris Ambrose|301-398-0000|ambrosec@medimmune.com|
21263277|NCT03696758|UT Southwestern, Dallas, Texas|Dr. Kara Goss|214-648-6868|kara.goss@utsouthwestern.edu|
21248175|NCT00599196|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
21295090|NCT03349645|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
21263278|NCT02780765|Tata Memorial Hospital, Mumbai|Dr Vijaya Patil|+91-2224177000|vijayappatil@yahoo.com|7048
21263279|NCT01028651|United Therapeutics Corp.|Kevin Laliberte, PharmD|919-425-8176|KLaliberte@unither.com|
21263280|NCT06150573|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
21263281|NCT00210158|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
21263282|NCT01327651|Fred Hutchinson Cancer Research Center|Maoji Li (Statistical Research Associate)|2066676035|mli2@fredhutch.org|
21263283|NCT03249792|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21263284|NCT01071044|Rochester Center for Behavioral Medicine|Joel L. Young, MD|248-608-8800|jyoung@rcbm.net|261
21263285|NCT02284906|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21263286|NCT00995345|ActivX Biosciences|Dr. Diane Plotkin, Sr. Director Clinical Development|858-558-5558|dianep@activx.com|
21263287|NCT02913222|Washington University School of Medicine|Marcie Harris-Hayes, PT, DPT, MSCI, Professor, Physical Therapy and Orthopaedic Surgery|314-286-1435|harrisma@wustl.edu|
21263288|NCT00809458|UNM Cancer Center|Richard Lauer, MD|505-925-0390|rlauer@salud.unm.edu|
21263289|NCT03248947|Duke University|Dr. Li-Tzy Wu|919-889-9369|litzy.wu@duke.edu|
21263290|NCT01201798|Alcon Research, Ltd.|Head, Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
21263291|NCT02509598|Cardinal Health 414, LLC|Director, Regulatory & Medical Affairs|6147570226|npsmedicalaffairs@cardinalhealth.com|
21263292|NCT01507584|ucsdmed|Eunice Williams-Steppe|8588221133|emwilliamssteppe@ucsd.edu|
21263293|NCT03521687|Icahn School of Medicine at Mount Sinai|Ingrid Sanabria-Gonzalez|212-523-3812|ingrid.sanabria@mountsinai.org|
21263294|NCT02458690|Indiana University-Purdue University Indianapolis (IUPUI)|Jesse C. Stewart, PhD., Principal Investigator|317-274-6761|jstew@iupui.edu|
21263295|NCT05174039|Theranexus|Chief Medical Officer|0688941976|marie.sebille@theranexus.com|+33
21263296|NCT01040208|Sprout Pharmaceuticals|Krista Barbour|9198820850|kbarbour@sproutpharma.com|
21248176|NCT01009645|Northwestern University|Kenzie Cameron, PhD, MPH|312-503-3910|kcameron@northwestern.edu|
21248177|NCT01079806|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email|Clinical.Trials@bms.com|
21248178|NCT02788981|University of Chicago|Dr. Nan Chen|773-702-6149|nchen@bsd.uchicago.edu|
21248179|NCT01786876|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21248180|NCT00795184|Mauna Kea Technologies|Christophe Bailleul|+ 33 1 70 08 09 74|christopheb@maunakeatech.com|
21248181|NCT03781375|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21248182|NCT02909959|University of North Carolina at Chapel Hill|Laura Politte, MD|919-350-1726|lpolitte@wakemed.org|
21248183|NCT03760913|OliPass Corporation|OliPass Call Center|82-2-6488-2200|clinicaltrials.inquiries@olipass.com|
21248184|NCT00843050|Piramal Healthcare Limited|Dr. Alan Hatfield|02230275000|alan.hatfield@piramal.com|5002
21248185|NCT03489369|Symphogen AS|Medical Director|004545265050|info@symphogen.com|
21248186|NCT02168309|Central Coast Perinatology|Kathryn Sharma|8058980258|katy.jones@gmail.com|
21248187|NCT02106884|UZ Leuven|Prof. Dr. Eric Van Cutsem|0032 16 344418|eric.vancutsem@uzleuven.be|
21248188|NCT02384382|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21248189|NCT05313412|CooperVision|Jose A. Vega, OD, MSc, FAAO|925-621-3761|JVega2@coopervision.com|
21248190|NCT01822756|Incyte Corporation|Study Director|1-855-463-3463||
21248191|NCT02091752|Novartis|Study Director|862-778-8300||
21248192|NCT01708278|University of Michigan|Fernando Martinez|(734) 763-2540|fmartine@umich.edu|
21248193|NCT00665392|GERCOR|Regulatory Affairs|+33 (0)1 40 29 85 00|regulatory.affairs@gercor.com.fr|
21248194|NCT03617835|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21248195|NCT04111510|Yale School of Medicine|Michael Hurwitz, MD, PhD|(877) 925-3637|michael.hurwitz@yale.edu|
21248196|NCT04205903|The Ohio State University Comprehensive Cancer Center|Dr. Nicole Williams|(614) 293-0066|Nicole.Williams@osumc.edu|
21248197|NCT04233567|The Ohio State University Comprehensive Cancer Center|Dr. Sameek Roychowdhury|614-685-5842|Sameek.Roychowdhury@osumc.edu|
21248198|NCT03389802|PediatricBTC|Catherine Billups|901-595-3370|catherine.billups@stjude.org|
21248199|NCT02426138|University of North Carolina at Chapel Hill|Dr. Seth A. Berkowitz|919-966-2276|seth__berkowitz@med.unc.edu|
21248200|NCT04677738|Morinaga Milk Industry Co., Ltd.|Director of Clinical Trials|+81-46-252-3067|izen-ri138@morinagamilk.co.jp|
21248201|NCT02502461|Dept. of Anesthesia, University of Saskatchewan|Dr. William P. McKay|306 655 1202|bill.mckay@usask.ca|
21248202|NCT03340415|CUHK|Dr Samuel Ling|35052010|samuel-kk-ling@alumni.cuhk.net|
21248203|NCT01683409|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21263297|NCT05122650|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
21263298|NCT02439281|U Pittsbutgh, UPMC Children's Hospital|Mihaela Visoiu|4126925260|visoium@upmc.edu|
21281146|NCT01320293|University of North Carolina|Aida Lugo-Somolinos MD|919-843-9447|alugosom@med.unc.edu|
21248204|NCT05350501|Enterome|Dr Jan Fagerberg|+33175772785|info@enterome.com|
21248205|NCT00553332|The Ohio State University Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute|Tanios Bekaii-Saab, MD|614-293-9863|Tanios.Bekaii-Saab@osumc.edu|
21281147|NCT02280200|University of Minnesota|Ryan Mays PhD, MPH, MS|612-625-0430|rjmays@umn.edu|
21281148|NCT01827111|UT MD Anderson Cancer Center|Adi Diab, MD-Associate Professor, Melanoma Medical Oncology|(713) 745-7336|adiab@mdanderson.org|
21281149|NCT01147068|Protein Sciences Corporation|Dr. Ruvim Izikson, M.D.|203-599-6064|rizikson@proteinsciences.com|163
21281150|NCT03181633|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
21281151|NCT02641093|University of Cincinnati|Trisha Wise-Draper, MD, PhD|513 558 2826|wiseth@ucmail.uc.edu|
21281152|NCT02749617|Hematology Research Program (HRP)|Director of HRP|6048754111|alee14@bccancer.bc.ca|22958
21248206|NCT04119063|Northern Arizona University|Zach Lerner, Associate Professor|928-523-1787|Zachary.Lerner@nau.edu|
21248207|NCT03637296|New York State Psychiatric Institute|Thomas Smith, MD|(646)774-8442|thomas.smith@nyspi.columbia.edu|
21248208|NCT03520036|Mitsubishi Tanabe Pharma Development America, Inc.|Clinical Trials, Information Desk|888-449-2670|information@mt-pharma-us.com|
21248209|NCT01536366|BIAL - Portela & Cª, S.A.|Head of Clinical Research|+351 22 9866100|jose.rocha@bial.com|
21248210|NCT00873782|University of North Carolina at Chapel HIll|William J. Powers, MD|919 966 8178|powersw@neurology.unc.edu|
21248211|NCT00467272|University of Texas (UT) MD Anderson Cancer Center|Issam Raad, MD / Chair, Infectious Diseases|713-792-7943|iraad@mdanderson.org|
21248212|NCT06110546|The University of Texas Health Science Center at Houston|Pascal Kingah, MD,MPH|713-500-6828|Pascal.L.Kingah@uth.tmc.edu|
21248213|NCT04745676|University of Rochester Medical Center, Wilmot Cancer Institute|Research Project Manager|585 410 5044|cait_fallone@urmc.rochester.edu|
21248214|NCT00676091|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21248215|NCT00989196|Octapharma AG|Dr. Sigurd Knaub|+41 554512141|sigurd.knaub@octapharma.com|
21248216|NCT02954432|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526158|Fregni.felipe@mgh.harvard.edu|
21248217|NCT03268421|Cincinnati Children's Hospital|Susmita Kashikar-Zuck, PhD|513-636-6337|susmita.kashikar-zuck@cchmc.org|
21248218|NCT04912856|Xenon Pharmaceuticals|Dr. Noam Butterfield|604 484 3300|nbutterfield@xenon-pharma.com|
21248219|NCT00302211|Actelion Pharmaceuticals US, Inc.|Gary Palmer SVP, US Medical Affairs|650-624-6900||
21248220|NCT02556918|Emory University|Dr. Guillermo Umpierrez|404-778-1665|GEUMPIE@emory.edu|
21248221|NCT00768716|Washington State University|Dr Michael H. Court|5093350817|michael.court@wsu.edu|
21248222|NCT06134089|University of Utah|Andy King|801-646-4274|andy.king@utah.edu|
21248223|NCT05643885|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21248224|NCT03954106|Jazz Pharmaceuticals|Director, Clinical Trial Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
21248225|NCT04511702|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21248226|NCT05349721|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
21248227|NCT06006455|Erchonia Corporation|Clinical Affairs Manager|8882420571|tsammons@erchonia.com|
21248228|NCT02271906|UT MD Anderson Cancer Center|George Simon, MD|713-792-7734|GSimon@mdanderson.org|
21248229|NCT00799409|Ortho-McNeil Janssen Scientific Affairs, LLC|VP Medical Affairs, CNS|609-730-2136||
21248230|NCT03137459|Yale School of Medicine|Dr. Terri Fried|203-932-5711|terri.fried@yale.edu|5412
21248231|NCT03377049|UW School of Medicine and Public Health|Azam Ahmed, MD, FAANS, FACS|608-263-0485|azam.ahmed@neurosurgery.wisc.edu|
21248232|NCT04921358|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
21248233|NCT02278796|Inselspital University Hospital Bern|Thomas Pabst, Prof Dr. med|+41 31 632 84 30|thomas.pabst@insel.ch|
21248234|NCT04926857|Medtronic|Nirav Patel|1 (800) 633-8766|nirav.a.patel@medtronic.com|
21248235|NCT02310581|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
21248236|NCT00887224|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21248237|NCT03883828|Montefiore Medical Center|Dr. Beth McLellan|718.862.8840|bmclella@montefiore.org|
21248238|NCT03960645|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21248239|NCT04938453|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21248240|NCT03737110|Kiniksa Pharmaceuticals (UK), Ltd. c/o Kiniksa Pharmaceuticals Corp.|Clinical Operations Study Director|1-781-431-9100|studyinfo@kiniksa.com|
21248241|NCT01890954|University of Virginia|Daniel Chernavvsky|434-243-1395|drc2v@virginia.edu|
21248242|NCT03883724|UPittsburgh|Shachi Tyagi|4126471274|sht55@pitt.edu|
21248243|NCT02124304|Sport & Spine Rehab Clinical Research Foundation|Jena Slaski|301-251-2777|jslaski@ssrehab.com|838
21248244|NCT04228952|Masonic Cancer Center|Susan Murphy, PhD|612-624-7633|murph062@umn.edu|
21248245|NCT05553366|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21248246|NCT00249769|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
21248247|NCT01505166|Gradalis, Inc.|Director of Clinical Trials|2144428124|info@gradalisinc.com|
21248248|NCT03187678|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk|0041615656565|clinical-trials-disclosure@its.jnj.com|
21248249|NCT02022657|Skaggs School of Pharmacy, University of Colorado Anschutz Medical Campus, Aurora|Dr. Peter Anderson|3037246821|peter.anderson@ucdenver.edu|
21248250|NCT03274076|University of Michigan|Dinesh Khanna|734-763-7182|khannad@med.umich.edu|
21248251|NCT01629589|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21248252|NCT01530334|SPARC CONSULTING SRL|Claudio Iannacone|+39 0243119667|info@sparcconsulting.com|
21248253|NCT00797212|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
21248254|NCT02079649|Alcon Research, Ltd.|Clinical Project Lead, Pharma, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
21248255|NCT02304757|Tenth People's Hospital of Tongji University|Chao Ma|02125078593|mc_7419@hotmail.com|86
21248256|NCT03739866|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21248257|NCT01034306|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il|
21248258|NCT00836498|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||ClinicalTrialsDisclosure@merck.com|
21248259|NCT01968967|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21248260|NCT02785159|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
21248261|NCT00701415|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21248262|NCT00109031|Swedish Orphan Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com|
21248263|NCT04029090|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608|cti-inq-ml@ml.mt-pharma.co.jp|
21263299|NCT03609359|National Cancer Center Hospital East|Dr.Kohei Shitara|(+81)-4-7133-1111|LenvaPembro_core@east.ncc.go.jp|91520
21263300|NCT01716468|VA Pittsburgh Healthcare System|Jocelyn Tan, MD|412-360-6178|Jocelyn.Tan@va.gov|
21263301|NCT04285346|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
21263302|NCT02432287|Albert Einstein College of Medicine|Erika Brutsaert|7188397961|erika.brutsaert@einstein.yu.edu|
21263303|NCT01975272|Maastricht University Medical Centre|Prof. dr. Roy Kruitwagen|0031-3874764|r.kruitwagen@mumc.nl|
21263304|NCT00610935|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
21263305|NCT03392753|Imperial College London|Mr Roshan Bootun|+442033117335|r.bootun@imperial.ac.uk|
21263306|NCT03220048|hVIVO|Tim Sharpington|02071480862|t.sharpington@hvivo.com|
21263307|NCT02399813|Advaxis, Inc.|Sumitra Sheeri|609-423-2528|sheeri@advaxis.com|
21263308|NCT03280550|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21263309|NCT02188121|McLean Hospital|Dr. Dost Ongur|617 855 3922|dongur@partners.org|
21263310|NCT03345836|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21263311|NCT00222729|UPMC Cancer Centers|Rita Johnson, Associate Director of Clinical Research Services|412-647-8571|johnsonr1@upmc.edu|
21263312|NCT01167595|CERU Queen's University|Dr.Daren Heyland|403-915-5573|dkh2@queensu.ca|
21263313|NCT01915849|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21263314|NCT02775864|Columbia University|Dr. Scott Stroup|646-774-8435|Scott.Stroup@nyspi.columbia.edu|
21263315|NCT04747808|MediPrint Ophthalmics, Inc.|Chief Operating Officer|(858) 522-0815|clinical@mediprintlens.com|
21263316|NCT00619684|Fred Hutchinson Cancer Research Ctr|Dr. William Bensinger|2066674730|wbensing@fredhutch.org|
21263317|NCT00843310|NYU Cancer Institute|Hearn J. Cho, MD|212-263-9274|hearn.jay.cho@med.nyu.edu|
21263318|NCT03552549|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21263319|NCT02761993|Noveome Biotherapeutics, Inc|David Steed, MD|4124029913|dsteed@noveome.com|
21263320|NCT01231633|Long Island Vitreoretinal Consultants|Vincent A. Deramo, MD|5164660390|vaderamo@gmail.com|222
21263321|NCT02993224|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
21263322|NCT00668434|Kaiser Permanente, Northern California|Dr. Andrew Avins|510-891-3557|andy.l.avins@kp.org|
21263323|NCT01921257|Circassia Ltd|VP Clinical Operations|+44 1864 405560||
21263324|NCT05515601|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21263325|NCT00364845|Amgen Inc.|Study Director|866-572-6436||
21263326|NCT01423617|Analyze & Realize|Dr Christof Jänicke|+49 30 40 00 83 23|cj@a-r.com|
21263327|NCT01515306|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21263328|NCT00634244|ECOG Statistical Office|Study Statistician|617-632-3012||
21263329|NCT03929588|EyeQue|VP Science and Technology|5104558168|noam.sapiens@eyeque.com|
21263330|NCT02335216|St. Jude Medical|Roni Diaz|+19723098601|rdiaz@sjm.com|
21263331|NCT01672996|GE Healthcare|Rubin Sheng, MD|609-514-6899|Rubin.Sheng@ge.com|
21263332|NCT04737031|University of Pennsylvania|Robert Schnoll, PhD|215.746.7143|schnoll@pennmedicine.upenn.edu|
21263333|NCT03453151|Duke University|Marat Fudim|(919) 681-5816|marat.fudim@duke.edu|
21263334|NCT04574297|Changhai Hospital|Dr. Zhuan Liao|86-21-31161004|liaozhuan@smmu.edu.cn|
21263335|NCT02678780|Kapadi|Start Up Unit|+34961452190|maria.rocasalbas@kapadi.com|
21263336|NCT03229759|Becton Dickinson|Erin Zook|224-358-5019|erin.zook@bd.com|
21263337|NCT01686503|Eastern Virginia Medical School|Dr. Stephanie Troy|757-446-8999|troysb@evms.edu|
21263338|NCT03050359|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21263339|NCT02020031|Mayo Clinic|Dr. Mark J. Spanghel|480-301-5685|Spangehl.Mark@mayo.edu|
21263340|NCT01136668|Hospital for Sick Children|Dr. Jason Hayes|416-813-7445|jason.hayes@sickkids.ca|
21263341|NCT00755846|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21263342|NCT01830543|Janssen Scientific Affairs, LLC|Senior Director Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
21263343|NCT03496467|Mati Therapeutics|Deepank Utkhede|6046379717|dutkhede@matitherapeutics.com|
21263344|NCT01151046|Merrimack Pharmaceuticals|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
21263345|NCT00127530|Acorda Therapeutics, Inc.|Andrew Blight, Chief Scientific Officer|914-347-4300|ablight@acorda.com|102
21263346|NCT01030458|University of Leuven|Prof. Dr. Jan A Staessen|+32 16 34 7104|jan.staessen@med.kuleuven.be|
21263347|NCT00884052|University od California San Diego|Sponsor and Principal Investigator|8588226700|rhaas@ucsd.edu|
21263348|NCT05209932|Family Transitions - PTW, LLC|Michele M Porter, PhD - Co-PI/Partner|4802037550|m.marie.porter@gmail.com|
21263349|NCT00803010|H. Lee Moffitt Cancer Center|Dr. Joseph Pidala|813-745-4673|Joseph.Pidala@moffitt.org|2556
21263350|NCT05631548|The University of Texas Health Science Center at Houston|Heather Webber, PhD|713-486-2723|Heather.E.Webber@uth.tmc.edu|
21263351|NCT01592409|Centre for Addiction and Mental Health|Dr. Robert Mann, Senior Scientist|416-535-8501|robert.mann@camh.ca|34496
21263352|NCT02935634|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21263353|NCT02869854|RegionSkane|Mr Peter Nymberg|0705759810|peter.nymberg@med.lu.se|
21263354|NCT03484533|Makerere University Infectious Diseases Institute|Andrew Mujugira|206 520 3800|mujugira@uw.edu|
21263355|NCT04056455|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21263356|NCT04365985|William Beaumont Hospitals|Matthew Sims, MD|248 551-0027|matthew.sims@beaumont.org|
21263357|NCT04891770|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21263358|NCT04026412|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21263359|NCT00830037|Indiana University School of Medicine & Richard L Roudebush VA Medical Center|Rajiv Agarwal, MD, FAHA, FASN, FASH|317-988-2241|ragarwal@iu.edu|
21263360|NCT00660504|Cancer Hospital of Chinese Academy of Medical Sciences|Dr.Sunyan|86-10-87788519|suny@csco.org.cn|
21263361|NCT01401010|Michigan State University|Gary E Stein|517-353-5126|Gary.Stein@hc.msu.edu|
21263362|NCT01952834|Medical College of Wisconsin|Dr. Michael Widlansky|414-955-6755|mwidlans@mcw.edu|
21263363|NCT02110121|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
21263364|NCT04058054|KeraNetics, Inc.|Chris Holder, PhD|336-413-3393|cholder@keranetics.com|
21263365|NCT03115801|Weill Cornell Medicine|Sharanya Chandrasekhar|6469623110|shc2043@med.cornell.edu|
21263366|NCT05091060|Erchonia Corporation|Travis Sammons|3214731251|tsammons@erchonia.com|
21263367|NCT01318083|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
21263368|NCT02028338|International Partnership for Microbicides|Dr John Steytler||jsteytler@ipmglobal.org|
21263369|NCT03403504|Mundipharma(China) Pharmaceutical. Co. Ltd|Rongna. A|86 10 65636885|rongna.a@mundipharma.com.cn|
21263370|NCT01257217|Alcon Research, Ltd.|Brand Lead, Surgical, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
21263371|NCT00256867|GlaxoSmithKline|GSK Response Center|866-435-7343||
21263372|NCT00041717|Acorda Therapeutics, Inc.|Andrew Blight, Ph.D. Chief Scientific Officer|914-347-4300|ablight@acorda.com|5102
21263373|NCT04286412|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21263374|NCT01930799|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21263375|NCT02916498|Boston Scientific|Director, Clinical Sciences and Scientific Communication|855-213-9890|BSNClinicalTrials@bsci.com|
21263376|NCT00875017|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21263377|NCT02689219|IndianaU|Dr. Nabil Adra|(317) 944-5349|nadra@iu.edu|
21263378|NCT01477892|Seoul National University Hospital|Pf. Han-suk Kim|+82-2-2072-0647|kimhans@snu.ac.kr|
21263379|NCT01515176|The Ohio State University Comprehensive Cancer Center|Jeffrey Jones, MD|614-293-3507|Jeffrey.Jones@osumc.edu|
21263380|NCT01452126|UNM Department of Anesthesiology|Dr Tim Petersen|5052722610|timpetersen@salud.unm.edu|505
21263381|NCT00363805|University of Arizona|Dr. Sherry Chow|520-626-3358|schow@azcc.arizona.edu|
21263382|NCT03255291|Washington University School of Medicine|Erika Waters, MPH, Ph.D.|314-286-2757|waterse@wustl.edu|
21263383|NCT02467387|CardioCell, LLC|Sergey Sikora, President and CEO|760-315-0861|SSIKORA@STEMCARDIOCELL.COM|
21263384|NCT03591146|Taiwan Liposome Company|Cynthia Lin|+886 2 2655 7377|cynthia_lin@tlcbio.com|
21263385|NCT02330627|University of California, San Diego|Dr. Charles Taylor|8585349446|c1taylor@ucsd.edu|
21263386|NCT04369430|Alkahest, Inc.|Clinical Development|(650) 801-0474|trials@alkahest.com|
21263387|NCT00962039|The Ohio State University|John V. Campo|614-581-5984|john.campo@hsc.wvu.edu|
21263388|NCT00142519|Memorial Sloan Kettering Cancer Center|Dr. Natalia Moryl, MD|646-888-2681|moryln@mskcc.org|
21263389|NCT01468909|NRG Oncology|Linda Gedeon on behalf of Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org|
21263390|NCT02592629|Penn State Hershey Medical Center|Robert Gallo, M.D.|7175310003|rgallo@pennstatehershey.psu.edu|289222
21263391|NCT01511419|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
21263392|NCT00937768|Mayo Clinic|Dr. R. Jeffrey Karnes|507 284-4430|Karnes.R@mayo.edu|
21263393|NCT03302793|UTHealth|Dr. Sheng Li|713-797-7125|Sheng.Li@uth.tmc.edu|
21263394|NCT05818527|Cairo university|mohamed atfy abdelmotaleb ( PhD student )|01222798922|atfy2002@yahoo.com|
21263395|NCT01687413|Washington University School of Medicine|Jason Rich, M.D.|314-747-3742|richj@wustl.edu|
21263396|NCT04973228|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
21263397|NCT03566108|University of Alabama at Birmingham|Dr. Maria Geisinger, PI, Professor, Director of Advanced Education in Periodontology|205-934-4984|miagdds@uab.edu|
21263398|NCT00091390|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
21263399|NCT00406640|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21263400|NCT04748783|University of North Carolina at Chapel Hill|Laura Jacox, DMD, PhD, MS|919-537-3424|ljacox@live.unc.edu|
21263401|NCT04047121|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21263402|NCT00810459|Philips|Jeff Jasko|412-542-3651|Jeff.Jasko@philips.com|
21263403|NCT02604810|Grifols Therapeutics LLC|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
21263404|NCT03754933|GeoVax, Inc.|Kelly T. McKee, Jr., MD, MPH|(678) 384-7220|kmckee@geovax.com|
21263405|NCT02891798|VA Pittsburgh Health System, and University of Pittsburgh|Brian A. Williams, MD, MBA|412-360-1602|brian.williams6@va.gov|
21263406|NCT02723604|Barbara Ann Karmanos Cancer Institute|Dr. Harold Kim|313-576-9543|kimh@karmanos.org|
21263407|NCT02669862|Aclaris Therapeutics, Inc.|Judy Schnyder, Senior Director of Clinical Operations|484-329-2144|jschnyder@aclaristx.com|
21263408|NCT00311181|St Jude Medical|Ashish Oza|818-493-3648|aoza@sjm.com|
21263409|NCT02294318|ResearchFMH|Dr. Efrat Aharonovich|646-774-7954|efrat.aharonovich@nyspi.columbia.edu|
21263410|NCT00734344|University of Alabama at Bimingham|Principal Investigator|996-2371|heaths@uab.edu|
21263411|NCT01313520|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
21281153|NCT02574598|Instituto Nacional de Cancerología|Dr. Oscar Arrieta|(52) 55-5628-0400|ogar@unam.mx|71101
21281154|NCT04837196|Astellas Pharma Inc|Clinical Transparency|08008887704|astellas.resultsdisclosure@astellas.com|
21281155|NCT02387840|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Deborah Runkin Gold|1-800-641-2422|CTUReferral@UHhospitals.org|
21281156|NCT01213966|Faculty of Tropical Medicine|Professor Sasithon Pukrittayakamee|(662) 354-9400-19|yon@tropmedres.ac|1435
21281157|NCT05192239|Colorado State University|Christopher Bell, Associate Professor|(970) 491-7522|christopher.bell@colostate.edu|
21281158|NCT04507464|University of Illinois at Chicago|Dr. Ulf Bronas|3123555886|bronas@uic.edu|
21281159|NCT01710787|Jean Brown Research|Adam D. Marberger, DDS|801-261-2000||
21281160|NCT02696291|Emergent Product Development Gaithersburg, Inc.|Tim Babinchak, MD|(240) 631-3585|tbabinchak@ebsi.com|
21281161|NCT00273182|Medtronic, Inc.|InSync Registry Clinical Trial Leader||medtroniccrmtrials@medtronic.com|
21263412|NCT00506948|University of Texas (UT) MD Anderson Cancer Center|Amin Alousi, MD /Professor, Stem Cell Transplantation|713-745-8613|aalousi@mdanderson.org|
21263413|NCT02395653|The Medicines Company|Global Health Science Center|1-888-977-6326|medical.information@themedco.com|
21263414|NCT01194804|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alexion.com|
21263415|NCT02670915|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21263416|NCT00818207|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21263417|NCT02616185|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21263418|NCT03621943|Sharp Healthcare|Dr. Anup Katheria|8589394170|Anup.Katheria@sharp.com|
21263419|NCT01215734|Vanderbilt University|Natasha Halasa, Associate Professor of Pediatrics|615-322-3346|natasha.halasa@vanderbilt.edu|
21263420|NCT00315705|Genzyme Corporation|Genzyme Medical Information|1-800-745-4447||
21263421|NCT01346371|Minnesota Eye Consultants, P.A.|Ahmad Fahmy, OD|612-813-3665|amfahmy@mneye.com|
21263422|NCT01393171|Kaiser Permanente|Dr John Nguyen|562-657-2642|john.n.nguyen@kp.org|
21263423|NCT02543398|UTHSCSA Periodontics|Guy Huynh-Ba|2105673569|huynhba@uthscsa.edu|
21263424|NCT02417870|Brigham and Women's Hospital|Anil Chandraker|617-732-7412|achandraker@bwh.harvard.edu|
21263425|NCT00833248|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
21263426|NCT00839423|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
21263427|NCT01071096|Clinvest|Jeanne Tarrasch|417-841-3673|jtarrasch@clinvest.com|
21263428|NCT02585999|Boston Medical Center|Dr. Antonella Lavelanet|6174143745|Katharine.White@bmc.org|
21263429|NCT01332019|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21263430|NCT00980785|University of Wisconsin School of Medicine and Public Health|Cynthia M. Carlsson, MD, MS|608-256-1901|cmc@medicine.wisc.edu|11691
21263431|NCT01369849|Mayo Clinic|Wei Ding, MBBS, PhD||ding.wei@mayo.edu|
21263432|NCT00871377|UCLA School of Medicine|Christopher M. DeGiorgio, MD|310-206-3753|cmd@mednet.ucla.edu|
21263433|NCT04281030|NYU Langone Health|Mia Minen|9294555130|Mia.Minen@nyulangone.org|
21263434|NCT03474406|Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University.|Asist. Prof. Suratsawadee Wangnamthip|6624197842|suratsawadee.wan@mahidol.ac.th|
21263435|NCT00922194|Sircar Diabetes Clinic|Dr. Amulya R Sircar|+ 91 (522) 2324747|arsircar@yahoo.com|
21263436|NCT04131517|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21263437|NCT00288860|Nationa Center for PTSD Dissemination & Training Division|Craig S. Rosen|650-493-5000|craig.rosen@va.gov|22812
21263438|NCT05142332|University of California San Francsico|Robert Rodriguez|(628) 206-5875|Robert.Rodriguez@ucsf.edu|
21263439|NCT02116660|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21263440|NCT01718509|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21263441|NCT00208494|DePuy Orthopaedics, Inc.|Jennifer Hoag, MS, Project Leader, Clinical Research|574-372-7399|JHoag2@its.jnj.com|
21263442|NCT00411788|Yale University|Abu-Khalaf, Maysa|(203) 785-4095|maysa.abu-khalaf@yale.edu|
21263443|NCT00848549|Eisai Call Center|Eisai Inc.|888-422-4743||
21263444|NCT02561299|Cardiovascular Systems Inc.|Clinical Trials Manager|651.259.2500|clintrials_csi@csi360.com|
21263445|NCT00390416|Memorial Sloan Kettering Cancer Center|Dr. David Ilson|646-888-4183|ilsond@mskcc.org|
21263446|NCT00941889|Washington University|Steven Hunt, MD|314-454-7177|hunts@wudosis.wustl.edu|
21263447|NCT01219959|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
21263448|NCT01728584|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21263449|NCT01842841|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21263450|NCT04183179|Michigan State University College of Nursing|Jiying Ling|5173538591|lingjiyi@msu.edu|
21263451|NCT03207022|Cork University Hospital|Dr Anil Ranganath||drmrak.2@gmail.com|
21263452|NCT01409031|University of Colorado, Denver|John Kinsella, MD|303-724-2853|John.Kinsella@ucdenver.edu|
21263453|NCT02336594|Study Information Center AstraZeneca|Jesse Hall, MD|+1 877-240-9479|information.center@astrazeneca.com|
21263454|NCT00471536|Karmanos Cancer Institute at Wayne State University|Ulka Vaishampayan, M.D.||vaishamu@karmanos.org|
21263455|NCT02651194|AbbVie|Global Medical Services|800-633-9110||
21263456|NCT02403830|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu|
21263457|NCT01980706|University of North Carolina at Chapel Hill|James C Garbutt, MD|984-974-2201|jc_garbutt@med.unc.edu|
21263458|NCT02546674|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
21263459|NCT01504854|Alzheimer's Disease Cooperative Study|Michael Rafii, MD, PhD|858-846-1300|mrafii@ucsd.edu|
21263460|NCT01094730|Johnson & Johnson Vision Care|John R. Buch, O.D., M.S., F.A.A.O., Principal Research Optometrist|1-904-443-1707|jbuch@its.jnj.com|
21263461|NCT04490265|US Department of Veterans Affairs|Lisa McAndrew|862-400-3317|lisa.mcandrew@va.gov|
21263462|NCT01864018|Mayo Clinic|Shaji Kumar|507-284-2511|Kumar.Shaji@mayo.edu|
21263463|NCT01750398|SKCCC at Johns Hopkins|Samuel Denmeade|410-955-8875|denmesa@jhmi.edu|
21295091|NCT01657344|Lurie Children's Hospital|Elizabeth Alpern|312-227-6080|ealpern@luriechildrens.org|
21295092|NCT01686750|Johns Hopkins University|Dr. Gregory M.Lucas|410-614-0560|glucas@jhmi.edu|
21295093|NCT02927925|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21295094|NCT01080768|Novartis Pharmaceuticals|Study Director|862-778-8300||
21263464|NCT02512068|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21263465|NCT01798706|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21263466|NCT05896761|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21295095|NCT03510468|Clinical Center|Dr. Joseph Kovacs|+1 301 496 9907|jkovacs@mail.nih.gov|
21263467|NCT02094586|Emergent BioSolutions Canada Inc.|David Cassie, Scientist, Clinical Research|204-275-4589|dcassie@ebsi.com|
21263468|NCT02739594|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21263469|NCT00527111|US Oncology Network, McKesson Specialty Health|Dr. David McCollum|214-370-1080|david.mccollum@usoncology.com|
21263470|NCT01270581|Mount Sinai School of Medicine|Dr. Andrea Weintraub|212-241-6186|andrea.weintraub@mssm.edu|
21263471|NCT00952289|Incyte Corporation|Study Director|855 463-3463||
21263472|NCT03259334|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
21263473|NCT00777491|NRG Oncology|Wendy Seiferheld, M.S.|215-574-3208|seiferheldw@nrgoncology.org|
21263474|NCT01689207|AstraZeneca|Paul Newell, Medical Science Director|+44 1625 515727|paul.newell@astrazeneca.com|
21263475|NCT01912768|Alcon Research, Ltd.|Clinical Project Lead, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
21263476|NCT00524316|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21263477|NCT01199263|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|linda.gedeon@roswellpark.org|
21263478|NCT00488033|Intermountain Heart Institute|J.Brent Muhlestein|8015074702|jbrent.muhlestein@imail.org|
21263479|NCT02963714|Shanxi Medical University|Suping Wang, PhD|#86-351-4135103|spwang88@163.com|
21263480|NCT04019093|University of Florida|Jeff Boissoneault, PhD|352-273-6147|jboissoneault@phhp.ufl.edu|
21263481|NCT00444626|Genzyme|Genzyme Medical Information (MedInfo)||medinfo@genzyme.com|
21263482|NCT00008138|SWOG Statistical Center|GYN Committee Statistician|206-667-4623||
21263483|NCT03047993|The University of Texas MD Anderson Cancer Center|Courtney DiNardo/Professor|713-794-1141|cdinardo@mdanderson.org|
21263484|NCT03492463|Duke University|Jed E. Rose, Ph.D.|919-668-5055|jed.rose@duke.edu|
21263485|NCT05345691|Biocon Biologics Limited|Sarika S Deodhar|0802808|Sarika.Deodhar@biocon.com|5301
21263486|NCT00078559|University of Wisconsin - Department of Medicine, Madison, Wisconsin|Arjang Djamali, MD, MS, FASN|608-262-7330|axd@medicine.wisc.edu|
21263487|NCT01694420|Duke University Medical Center|Mehri McKeller, MD|919-668-0242|kara.mcgee@duke.edu|
21263488|NCT00762372|Baxter Healthcare|Baxter Clinical Trial Disclosures Call Center|(224)948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
21263489|NCT02494778|Prilenia|Prilenia|+972 775558|info@prilenia.com|482
21263490|NCT01303380|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
21263491|NCT00967226|Childrens Research Institute|Nancy M. Bauman MD, Principle Investigator|2024764270|nbauman@cnmc.org|
21263492|NCT02174861|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21263493|NCT01716533|GlaxoSmithKline|GSK Response Center|866-435-7343||
21263494|NCT03309787|Dartmouth-Hitchcock|John A. Batsis, MD|603-650-5000|john.batsis@gmail.com|
21263495|NCT02320695|Johnson & Johnson Consumer and Personal Products Worldwide|Christopher Nunez, PhD|973-385-7984|cnunez1@its.jnj.com|
21263496|NCT02295735|Charité Universitätsmedizin Berlin, Department of Dermatology and Allergy|PD Dr. Jan Kottner|+4930450518218|jan.kottner@charite.de|
21263497|NCT01670656|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21281162|NCT02208362|City of Hope Medical Center|Dr. Christine Brown|626-256-4673|CBrown@coh.org|83977
21281163|NCT02290444|University at Buffalo|Curtis Wojcik, Lab Coordinator|7163230551|cmwojcik@buffalo.edu|
21281164|NCT00858273|Nemours Children's Clinic|Dominique Darmaun, MD|(904) 697 3674|ddarmaun@nemours.org|
21281165|NCT02004366|Emory University|Priyathama Vellanki|404-778-1665|priyathama.vellanki@emory.edu|
21281166|NCT00350207|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21281167|NCT02626026|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21281168|NCT01568892|GlaxoSmithKline|GSK Response Center|866-435-7343||
21281169|NCT02962492|State University of NY at Buffalo|Dr. Paresh Dandona|7165351850|dandona@buffalo.edu|
21281170|NCT01169064|Vanderbilt University Medical Ctr., Dept OB/GYN|Dr. Kelly Bennett; Director of Maternal Fetal Medicine|6153436275|kelly.a.bennett@vanderbilt.edu|
21281171|NCT02179892|Emory University|Dr. Colette Curtis|404-778-3900|ccurti3@emory.edu|
21281172|NCT01058642|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
21281173|NCT02375971|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21281174|NCT05209867|University of Florida|Dr. Simone Marini|3522948951|simone.marini@ufl.edu|
21281175|NCT02755103|Medical University of South Carolina|Therese K Killeen PhD, Principal Investigator|843-792-5232|killeent@musc.edu|
21281176|NCT01833481|University of Tennessee|Dr. Richard D. Komistek|8659742093|rkomiste@utk.edu|
21281177|NCT03437863|Department of Digital Health Research (previously Center for Shared Decision Making and Collaborative Care Research)|Head of Research and Development|+47 23 03 31 67|elin.borosund@rr-research.no|
21281178|NCT01592786|Forest Research Institute|Joel Trugman, MD|201-427-8000|Joel.Trugman@frx.com|8681
21281179|NCT01909934|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
21281180|NCT03810092|CHD VENDEE|Romain DECOURS|02 51 44 65 72|romain.decours@ght85.fr|+33
21281181|NCT01841047|Institut Bergonié|Pr Guy KANTOR||G.Kantor@bordeaux.unicancer.fr|
21295096|NCT02387801|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21295097|NCT00391469|University of Washington|Francis Kim, MD Associate Professor of Medicine|206-744-8712|fkim@u.washington.edu|
21295098|NCT02752958|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21295099|NCT01799239|Coloplast A/S|Camilla Felsvang Vibjerg, Senior Clinical manager|+45 4911 1990|dkcfv@coloplast.com|
21263498|NCT00789958|SWOG|SWOG Statistician|206-667-4408||
21263499|NCT02622724|Faron Pharmaceuticals|Chief Medical Officer|+3584005529411|medical@faron.com|
21295100|NCT01660737|PASCOE Pharamzeutische Präparate GmbH|Jennifer Lebert|0049+(0)641-7960-955|Jennifer.lebert@pascoe.de|
21263500|NCT00487084|Northwestern University|Cynthia A. Wong,M.D.|630-472-3555|c-wong2@northwestern.edu|
21263501|NCT00254293|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21281182|NCT04578535|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
21248264|NCT01065779|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21248265|NCT02157948|Amgen Inc.|Study Director|866-572-6436||
21248266|NCT03067948|Johns Hopkins University SOM (Adjunct)|Anne Monroe MD|202-994-0251|amonroe@gwu.edu|
21248267|NCT01604824|Regeneron Pharmaceuticals|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
21248268|NCT02630966|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
21248269|NCT03758742|University of Alabama at Birmingham|Dr. Courtney M. Peterson|205-934-0122|cpeterso@uab.edu|
21248270|NCT03395080|Leap Therapeutics, Inc.|Cynthia Sirard, MD, Chief Medical Officer|+1-617-714-0360|csirard@leaptx.com|
21248271|NCT03387189|HealthPartners|Kamalini Das|651-293-8233|Kamalini.X.Das@HealthPartners.Com|
21248272|NCT00003459|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
21248273|NCT04218864|Women & Infants Hospital|Dr. Caron Zlotnick|4014743332|czlotnick@butler.org|
21248274|NCT00933270|Abbott Vascular|Margo Zaugg|408-845-0576|margo.zaugg@av.abbott.com|
21248275|NCT02409680|RTI International|Elizabeth McClure|919-316-3773|mcclure@rti.org|
21248276|NCT05366751|Sage Therapeutics|Carrie Vaudreuil|+1-857-259-4766|carrie.vaudreuil@sagerx.com|
21248277|NCT05885763|CSL Vifor|Milica Enoiu|+41 58 851 82 64|milica.enoiu@viforpharma.com|
21248278|NCT03427463|Medical University of South Carolina|Katherine Hatter, M.D.|(843) 792-5454|herbertk@musc.edu|
21248279|NCT01850355|Massachusetts General Hospital|Dr. Gagan Joshi|617-724-1541|joshi.gagan@mgh.harvard.edu|
21248280|NCT04906057|Cleveland Clinic|Donayja Harris|2164454125|harrisD47@ccf.org|
21248281|NCT05395351|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21248282|NCT00108355|VA-CT Healthcare System|Guadalupe Garcia-Tsao|203-932-5711|guadalupe.garcia-tsao@yale.edu|2210
21248283|NCT03214081|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21248284|NCT02962284|Sun Pharma Global FZE|Harin Mehta|97145520096, 912266455645|clinicaltrials@sparcmail.com, harin.mehta@sparcmail.com|
21248285|NCT02637063|Oregon Center for Applied Science|Amelia J Birney (PI), Director of Research|541-342-7227|abirney@orcasinc.com|541
21248286|NCT02634307|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21248287|NCT01467934|Columbia University|Melissa Stockwell|212-342-5732|mss2112@columbia.edu|
21248288|NCT05741450|CooperVision, Inc.|José A. Vega OD, MSc, FAAO|+19256213761|jvega2@coopervision.com|
21248289|NCT01532648|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
21248290|NCT02824198|Sanofi Pasteur|Medical Director|800-633-1610|Contact-US@sanofi.com|ext 1#
21248291|NCT01256359|University of Oxford|Professor Mark Middleton|+44 (0)1865 617331|mark.middleton@oncology.ox.ac.uk|
21248292|NCT03292406|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
21248293|NCT02575365|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21248294|NCT00343083|University of Maryland Baltimore|Ritesh Kataria|410-328-8018|rkataria@umm.edu|
21248295|NCT00487240|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21248296|NCT01698918|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
21248297|NCT03176407|Ovesco Endoscopy AG|Prof. Dr. T. Gottwald|0049707196528||160
21248298|NCT01482325|GE Healthcare|Global Research Manager|414 721 2423|Jeffrey.Conner@ge.com|
21248299|NCT05197452|Research Manager|Dr. Yolanda Cartwright|224-420-0323|yolanda_cartwright@rush.edu|
21248300|NCT01428583|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21248301|NCT01817491|Cleveland Clinic|Michael Macknin, MD|216 444-5512|macknim@ccf.org|
21248302|NCT00768755|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21248303|NCT00670488|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21248304|NCT00878189|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21248305|NCT04693637|AlloVir, Inc|Michelle Matzko, MD, PhD|617-433-2605|mmatzko@allovir.com|
21248306|NCT04237792|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21248307|NCT04885998|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21248308|NCT05260437|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21248309|NCT00910962|GlaxoSmithKline|GSK Response Center|866-435-7343||
21248310|NCT00195819|Abbott|Global Medical Services|800-633-9110||
21248311|NCT00787176|Northwerstern University|Paloma Toledo|312-472-3585|p-toledo@northwestern.edu|
21248312|NCT01124045|Alcon Research, Ltd.|Pam Kaur, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
21248313|NCT00884806|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
21248314|NCT02486939|Coherus BioSciences, Inc|Barbara K. Finck, MD Chief Medical Officer|650-649-3529|Bfinck@coherus.com|
21248315|NCT03057600|Calithera Biosciences, Inc|Study Director|650-870-1000|clinicaltrials@calithera.com|
21248316|NCT04273672|University of Massachusetts Medical School|Kara Smith, MD|5083342527|kara.smith@umassmed.edu|
21248317|NCT01868230|UMass Amherst|Dr. Lisa Chasan-Taber, Principal Investigator|4135451664|lct@umass.edu|
21248318|NCT02022670|University of Colorado Boulder|Dr. Allison DeVan|303-735-6410|allison.devan@colorado.edu|
21248319|NCT02113449|GlaxoSmithKline|GSK Response Center|866-435-7343||
21248320|NCT04638816|QMedAB|Clinical Project Manager|(817) 961-500|aestheticclinicaltrials@galderma.com|
21248321|NCT00087022|Heidelberg Pharma AG (previously Wilex AG)|Head of R&D||info@hdpharma.com|
21248322|NCT01328496|St. Jude Children's Research Hospital|Amr Qudeimat, MD|901-595-8342|amr.qudeimat@stjude.org|
21248323|NCT03960957|QMedAB|Clinical Project Manager|8179615000|aestheticclinicaltrials@galderma.com|
21248324|NCT02208843|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21248325|NCT04899999|University of Rochester|Dr. Francisco Cartujano Barrera, M.D|(585) 273-1646|francisco_cartujano@urmc.rochester.edu|
21248326|NCT03822832|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21248327|NCT00243867|American Regent Inc.|Manager Medical Writing|631-772-3555|HRathfon@americanregent.com|
21248328|NCT02422524|Duke University|Julius Wilder, MD, PhD|919-668-3063|julius.wilder@duke.edu|
21248329|NCT00544115|City of Hope|Dr. Monzr Al Malki, MD|626359811|malmalki@coh.org|
21248330|NCT04248803|TamilNadu MU|Dr Geeth Deepika|9952331820|geethdeepika@gmail.com|
21248331|NCT05352230|UAB|Orlando Gutierrez|2059962736|ogutierrez@uabmc.edu|
21248332|NCT04399837|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21248333|NCT02060487|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21248334|NCT03697603|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21248335|NCT05182606|University of Pittsburgh|Dr. Jessica Merlin|(412) 383-0617|merlinjs@upmc.edu|
21248336|NCT02309294|Church & Dwight Co., Inc.|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
21248337|NCT01695291|New York State Psychiatric Institute|Kelsey Hill, Research Coordinator|646-774-5793|Kelsey.Hill@nyspi.columbia.edu|
21248338|NCT03683030|Biosense Webster, Inc.|Senior Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21248339|NCT04502472|Inova Health Systems|Anne Whitney Brown, MD|7037763067|anne.brown@inova.org|
21248340|NCT02222493|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21248341|NCT03132298|Stony Brook University|Jessica Schleider|631-632-4131|jessica.schleider@stonybrook.edu|
21248342|NCT02542943|GlaxoSmithKline|GSK Response Center|866-435-7343||
21248343|NCT02734355|Research Institute for Complex Problems of Cardiovascular Diseases, Russia|Dr. Sergey Mamchur|+73842643308|reception@kemcardio.ru|
21248344|NCT02581137|University of Arizona|Dr. Sherry Chow|5206263358|schow@azcc.arizona.edu|
21248345|NCT03476798|Stephenson Cancer Center|Dr. Kathleen Moore|405-271-8777|Kathleen-Moore@ouhsc.edu|
21248346|NCT06269003|University of Hawaii Cancer Center|Donghee Nicole Lee, Assistant Professor|8084418184|nlee@cc.hawaii.edu|
21248347|NCT06677203|Asceneuron S.A.|Asceneuron Clinical Research|+41213538245|clinicaltrials.gov@asceneuron.com|
21248348|NCT00647387|Abbott Structural Heart|Ryan Palmer, Director of Clinical Programs|+1 651-202-8362|ryan.palmer@abbott.com|
21248349|NCT00985088|GlaxoSmithKline|GSK Response Center|866-435-7343||
21248350|NCT01970878|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
21248351|NCT01550952|Hospital for Special Surgery|Dr. Jacques YaDeau|2127742224|yadeauj@hss.edu|
21248352|NCT03062488|Nemours Children's Healthcare System|Carlos A. Archilla, MD|4076507646|carlos.archilla@nemours.org|
21248353|NCT06571695|Loyola University Medical Center|Dr. Dane H. Salazar|773-562-0456|dsalazar@lumc.edu|
21248354|NCT00491400|Boston University|Joseph A. Vita, MD|617-638-8700|jvita@bu.edu|
21248355|NCT00597376|Rush University Medical Center|Raj C. Shah, MD|312-563-2902|Raj_C_Shah@rush.edu|
21248356|NCT02698475|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21248357|NCT03926026|Nicox Ophthalmics, inc.|Doug Hubatsch|832-360-3022|hubatsch@nicox.com|
21248358|NCT01214200|Temple University School of Medicine|Mark Weir, MBChB|215-707-5864|mark.weir@tuhs.temple.edu|
21248359|NCT01005615|Kennedy Krieger institute|Cristina Sadowsky|443-923-9232|sadowsky@kennedykrieger.org|
21248360|NCT05005351|Swing Therapeutics, Inc.|Clinical Project Manager|1 (415) 662-0415|research@swingtherapeutics.com|
21248361|NCT02736188|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
21248362|NCT02708498|Department of Health Sciences, Lund University|Professor Gerd Ahlström|+46702747767|gerd.ahlstrom@med.lu.se|
21248363|NCT03052517|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21248364|NCT01858688|Brigham and Women's Hospital/Dana-Farber Cancer Institute|Neil Martin, MD|(617) 632-3000|NEMARTIN@PARTNERS.ORG|
21248365|NCT05794191|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21248366|NCT03298087|West LA VAMC|Nathanael Kane|3104783711|nathanael.kane@va.gov|46735
21248367|NCT01303510|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
21248368|NCT04278755|University of North Carolina at Chapel Hill|Jessica Baker, PhD|984-974-3929|jhbaker@med.unc.edu|
21248369|NCT02108171|Guangzhou First People's Hospital, Affiliated Hospital of Guangzhou Medical College|Dr. Xiangcai Ruan|+8620-81048306|xc_ruan@hotmail.com|
21248370|NCT00822900|Emergency Neurosciences, Emergency Medicine, Emory University|David W. Wright, Associate Professor, Department of Emergency Medicine, Emory University|404-778-1709|david.wright@emory.edu|
21248371|NCT04864834|Sandoz|Clinical Disclosure Representative|+49 8024 / 908 0|sandoz.disclosure@sandoz.com|
21248372|NCT01676298|Spartan Bioscience Inc.|Dr. Chris Harder|613-228-7756|chris.harder@spartanbio.com|778
21248373|NCT00407888|Medical Oncology University of Washington|Hannah Linden MD FACP|206-288-6989|hmlinden@uw.edu|
21248374|NCT00659373|IBCSG|Rudolph Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org|
21248375|NCT01607320|Greenville Health System|Bruce Lessey|864-455-1600|blessey@ghs.org|
21248376|NCT03042767|Emory University|Dr. Miriam Vos|404-727-5383|mvos@emory.edu|
21248377|NCT03784898|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21248378|NCT05414682|University of Kansas Medical Center|Dr. Ashley Shaw|913-945-5023|ashaw10@kumc.edu|
21248379|NCT03088800|Maimonides Medical Center|Sergey Motov, MD|7182836000|smotov@maimonidesmed.org|
21248380|NCT02831816|Zurex Pharma, Inc.|Andrew Morgan|16082039090|amorgan@zurexpharma.com|
21248381|NCT02686658|IVERIC Bio, Inc.|Medical Director|609-474-6755|info@ivericbio.com|
21248382|NCT00485693|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
21248383|NCT01227421|Romark Laboratories, L.C.|Marc Ayers|813-282-8544|Marc.Ayers@romark.com|
21263502|NCT01575197|PATH|Senior Clinical Research Scientist|206-285-3500|klewis@path.org|
21263503|NCT02709083|Emory University|William Blum, MD|404-778-1900|william.g.blum@emory.edu|
21263504|NCT00111475|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21263505|NCT03303092|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21263506|NCT01062568|UCSD|Dr. R. Jeffery Chang|858-534-8930|rjchang@ucsd.edu|
21263507|NCT00050986|University of Texas, M. D. Anderson Cancer Center|W.K. Yung,MD/Clinical Professor, Neuro-Oncology|(713) 794-1285|wyung@mdanderson.org|
21263508|NCT01170117|Columbia Center for Eating Disorders|Dr. Evelyn Attia|646-774-8085|ea12@cumc.columbia.edu|
21263509|NCT01995136|Alcon Japan, Ltd.|Senior Manager, Phase IV|1-888-451-3937|alcon.medinfo@alcon.com|
21263510|NCT03222076|MD Anderson Cancer Center|Dr. Ahmed Kaseb|(713) 792-2828|akaseb@mdanderson.org|
21263511|NCT01626352|Sarah Cannon Research Institute|Charles H. Davis|615-524-4341|charles.davis2@scri-innovations.com|
21263512|NCT02681055|MediciNova, Inc.|Director, Research and Development|8583444535|makhay@medicinova.com|
21263513|NCT01206478|University of Kansas Medical Center|Ann M Davis, PI|913-588-6300|adavis6@kumc.edu|
21263514|NCT02935699|TerSera Therapeutics|Medical Affairs|844-334-4035|tersera@medinfodept.com|
21263515|NCT03446651|Yale School of Medicine|Jeffrey Testani, MD, MTR|(203) 785-7191|jeffrey.testani@yale.edu|
21263516|NCT00343291|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21263517|NCT05250830|The Ohio State University|Kara Rood|440-321-0264|Kara.Rood@osumc.edu|
21263518|NCT00401622|LifeScan Scotland|Mike Grady|(44) 01463 721889|mgrady@its.jnj.com|
21263519|NCT00882999|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21263520|NCT02082145|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
21263521|NCT01757405|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21263522|NCT00082758|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21263523|NCT00238303|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-3902|galanis.evanthia@mayo.edu|
21263524|NCT01833741|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21263525|NCT00937560|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21263526|NCT05906732|Thryv Therapeutics Inc.|VP Clinical Research|514-973-0915|admin@thryvtrx.com|
21263527|NCT01248130|Massachusetts General Hospital|Gagan Joshi, MD|617-726-4651|lkfeinberg@mgh.harvard.edu|
21263528|NCT02052778|Taiho Oncology, Inc.|Taiho|+1 844-878-2446|medicalinformation@taihooncology.com|
21263529|NCT04168593|USaoPauloGH|Andre Wan Wen Tsai|5511981456449|tsai.andre@gmail.com|
21263530|NCT00305643|UT MD Anderson Cancer Center|Scott Kopetz, MD, PHD / Assistant Professor||CR_Study_Registration@mdanderson.org|
21263531|NCT01994226|Keele University|Sponsor|01782|research.governance@keele.ac.uk|734882
21263532|NCT02190747|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
21248384|NCT00758550|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21248385|NCT01827839|GlaxoSmithKline|GSK Response Center|866-435-7343||
21248386|NCT00614614|GlaxoSmithKline|GSK Response Center|866-435-7343||
21248387|NCT05426109|Virginia Tech|Dr. Larson-Meyer|540-231-1025|enette@vt.edu|
21248388|NCT05212285|Huadong hospital,Shanghai ,China|Dr.Yinggang Zhu,Dr Ting Zhao|1374321007|robinzyg-zhu@vip.sina.com;vivianzaza@163.com|+86
21248389|NCT00684242|UT MD Anderson Cancer Center|Sriram Yennurajalingam, MD / Assistant Professor||CR_Study_Registration@mdanderson.org|
21248390|NCT01000805|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21248391|NCT04162873|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
21248392|NCT03343704|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21248393|NCT01341301|Thomas Jefferson University|Dr. Neal Flomenberg|215-955-8874|neal.flomenberg@jefferson.edu|
21248394|NCT05986617|University of Iowa|Victoria Tappa|3193846136|victoria-tappa@uiowa.edu|
21248395|NCT03715946|UPMC Hillman Cancer Center|Barbara Stadterman, MPH|4126475554|stadtermanbm@upmc.edu|
21248396|NCT05432986|Rhaeos, Inc.|Anna Somera|855-814-3569|info@rhaeos.com|
21248397|NCT00949117|SunCoast CCOP Research Base|Cristina Burroughs, Clinical Research Coordinator|(813) 396-9237|Cristina.Burroughs@epi.usf.edu|
21248398|NCT03964974|University of Michigan|Mark Ilgen|734-845-3646|marki@med.umich.edu|
21248399|NCT02014402|Grifols Therapeutics Inc|Henry Li, PhD|+1 919 316 6042|henry.li@grifols.com|
21248400|NCT02542202|UChicago|Rohan Katipally|773-702-0137|Rohan.Katipally@bsd.uchicago.edu|
21248401|NCT01364597|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21248402|NCT03774849|Candela|Dr. Konika Patel Schallen|5083580357|cie.studyinfo@candelamedical.com|
21248403|NCT03493282|Cogntion Therapeutics Inc|Chief Medical Officer, Head of R&D|914-221-6730|acaggiano@cogrx.com|
21248404|NCT01380145|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21248405|NCT02038049|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21248406|NCT01363128|The University of Texas MD Anderson Cancer Center|Elias Joseph Jabbour, MD/ Professor|7137924764|ejabbour@mdanderson.org|
21248407|NCT02660086|Massachusetts General Hospital|Dr. Anne Thorndike, Prinicipal Investigator|6177244608|athorndike@mgh.harvard.edu|
21248408|NCT01653509|GlaxoSmithKline|GSK Response Center|866-435-7343||
21248409|NCT00587171|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H.|813-975-8690|pedig@jaeb.org|
21263533|NCT04322994|Stanford University|Dr Thomas Caruso, MD, PhD|6507235728|tjcaruso@stanford.edu|
21248410|NCT01303796|Cyclacel Ltd|Mark H. Kirschbaum MD|+1 908 517 7330|mkirschbaum@cyclacel.com|
21248411|NCT02148705|MediWound|Keren David Zarbiv|972-77-9714103|kerend@mediwound.com|
21263534|NCT02345252|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21248412|NCT01737021|Imperial College London|Professor Elena Garralda|+44 (0)20 3312 6085|e.garralda@imperial.ac.uk|
21263535|NCT02864940|Rush University Medical Center|Michael Chen, MD|312-563-2817|Michael_Chen@rush.edu|
21263536|NCT02175771|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
21263537|NCT02232087|Quotient Clinical Ltd|Pui Leung|44(0)115 974 9000|Pui Leung <Pui.Leung@quotientclinical.com>|
21263538|NCT01958125|electroCore Inc.|Director Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
21263539|NCT04096326|AbbVie|Global Medical Services|1-800-633-9110|abbvieclinicaltrials@abbvie.com|
21263540|NCT04804033|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21263541|NCT01879176|Medical University of Vienna|Dr. Martin H. Bernardi|004314040041090|martin.bernardi@meduniwien.ac.at|
21263542|NCT01106625|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1 800 526 7736||
21263543|NCT02496585|Memorial Sloan Kettering Cancer Center|Dr. Zachary Moore, MD, PhD|929-687-0151|moorez@mskcc.org|
21263544|NCT01276457|Novartis Pharmaceuticals|Study director|862 778-8300||
21263545|NCT04360187|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21263546|NCT02203838|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
21263547|NCT00496873|University of Texas (UT) MD Anderson Cancer Center|Felipe Samaniego, MD/Associate Professor, Lymphoma/Myeloma||CR_Study_Registration@mdanderson.org|
21263548|NCT01842620|GlaxoSmithKline|GSK Response Center|866-435-7343||
21263549|NCT01442129|Mount Sinai|Deborah D. Ascheim, MD, Associate Professor, Clinical Director of Research, InCHOIR|212-659-9567|deborah.ascheim@mountsinai.org|
21263550|NCT02435277|NuSirt Biopharma|Barbara Cannon|615-656-7898|BCannon@nusirt.com|
21263551|NCT00462020|Children's Mercy Hospital|Shawn D. St. Peter, MD|816-983-6479|sspeter@cmh.edu|
21263552|NCT02635737|UHSM|Mr James Harvey|01612914436|james.harvey@uhsm.nhs.uk|
21263553|NCT04237207|Advanced Bionics, LLC|Ankur Kaushal, VP of Global Regulatory Affairs|661 362 1400|clinicalresearch@advancedbionics.com|
21263554|NCT00306917|DePuy Orthopaedics, Inc|Barry Sisson|574-372-7156|BSisson@its.jnj.com|
21263555|NCT00304265|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21263556|NCT00165841|Eisai Medical Research Inc.|Yufang Lu, Study Director|201-403-2500||
21263557|NCT01000727|GlaxoSmithKline|GSK Response Center|866-435-7343||
21263558|NCT01290445|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21263559|NCT01026389|Guerbet|Post M. A. Clinical Unit Manager|+33 1 45 91 50 00|corinne.dubourdieu@guerbet-group.com|
21263560|NCT01697267|Cambridge University Hospitals NHS Foundation Trust|Prof David Jayne|01223 748062|dj106@cam.ac.uk|
21263561|NCT03544268|University of North Carolina at Chapel Hill|Director, Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
21263562|NCT04410198|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG4592-097Study@fibrogen.com|
21263563|NCT02006667|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21263564|NCT02059213|University of Michigan Rogel Cancer Center|Phillip Palmbos, M.D., Ph.D.|734-936-3591|ppalmbos@umich.edu|
21263565|NCT02796391|Moffitt Cancer Center|Dr. Vani Simmons|813-745-4816|Vani.Simmons@moffitt.org|
21263566|NCT02695524|University of São Paulo|Anamaria Siriani de Oliveira|+551633154415|siriani@fmrp.usp.br|
21263567|NCT00377611|GlaxoSmithKline|GSK Response Center|866-435-7343||
21263568|NCT03913221|University of North Carolina at Chapel Hill|Wesley Jackson, MD, MPH|984-215-3449|wesley.jackson@unc.edu|
21263569|NCT05439460|Stanford University|Chandra Ramamoorthy, MD|(650) 723-5728|chandrar@stanford.edu|
21263570|NCT00798655|University of Pittsburgh|Robert Ferris, MD|412-647-4654|ferrrl@UPMC.EDU|
21295101|NCT04092907|Harbour Biomed|Nina Shen|18251811067|nina.shen@harbourbiomed.com|
21295102|NCT01300819|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
21295103|NCT01444027|University of Washington, School of Nursing|Dr. George Demiris|206-221-3866|gdemiris@uw.edu|
21295104|NCT01485380|Massachusetts General Hospital|Dr. Oluwaseun Johnson-Akeju|6177247200|oluwaseun.akeju@mgh.harvard.edu|
21295105|NCT03561701|Mycovia Pharmaceuticals Inc|Clinical Trial Administration|919-467-8539|adminops@mycovia.com|
21295106|NCT00438854|Massachusetts General Hospital|Philip C. Amrein, M.D.|617-726-8748|pamrein@partners.org|
21295107|NCT03966885|Columbia University|Jeremy Kane, PhD, MPH|7179914098|jk4397@cumc.columbia.edu|
21295108|NCT01514240|Biometrics Department, Science Affairs Division, R&D, AstraZeneca Japan|Masahiro Nii||Masahiro.Nii@astrazeneca.com|
21295109|NCT05013424|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21295110|NCT04411420|Duke University|Leo Brothers|919-668-8322|joseph.l.brothers@duke.edu|
21295111|NCT00549900|GlaxoSmithKline|GSK Response Center|866-435-7343||
21295112|NCT05693922|University of North Carolina at Chapel Hill|Erin Bondy, PhD|919-843-7694|erin_bondy@med.unc.edu|
21295113|NCT03383757|GE Healthcare|Clinical Affairs Project Manager|262-443-7008|stephanie.karwedsky@ge.com|
21295114|NCT03899064|MC2 Therapeutics|Birgitte Vestbjerg|+44 2077 2575|bve@mc2therapeutics.com|
21295115|NCT03283098|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21295116|NCT00607113|UT MD Anderson Cancer Center|Dr. James Yao|713-792-2828|mjlim@mdanderson.org|
21295117|NCT04790812|The University of Texas Health Science Center at Houston|Harry Gilbert, DDS|713-486-4315|Harry.D.Gilbert@uth.tmc.edu|
21295118|NCT00798317|ThromboGenics|Petra Kozma-Wiebe|+32 16751310|petra.kozma@thrombogenics.com|
21295119|NCT01278407|Eisai Co., Ltd.|Masaki Nakagawa|+81-3-3817-5245||5245
21295120|NCT02534935|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21295121|NCT01069861|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21295122|NCT01596335|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21295123|NCT01460719|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21295124|NCT03350256|Abbott|Filippo Agnesi|+19725264860|filippo.agnesi@abbott.com|
21295125|NCT02680041|Blue Earth Diagnostics, Ltd.|Peter Gardiner MB ChB, MRCP, FFPM|1-781-552-3403|P.Gardiner@blueearthDx.com|
21263571|NCT03712345|InflaRx GmbH|Prof. Niels C. Riedemann|+49 3641-508-180|niels.Riedemann@inflarx.de|
21263572|NCT00960934|Merck Sharp and Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
21263573|NCT01819311|Florida International University|Jeremy W. Pettit (PI)|305-348-1671|jpettit@fiu.edu|
21263574|NCT02343276|Instituto de Cardiologia de Santa Catarina|Roberto Léo da Silva|55 48 32719077|robertoleo@hotmail.com|
21263575|NCT04348656|McMaster University/Hamilton Health Sciences|Dr Donald Arnold|905 525 9140|arnold@mcmaster.ca|28603
21263576|NCT01395368|Washington University in St. Louis|Dr. Jay F. Piccirillo, Professor|314 362-8641|piccirilloj@ent.wustl.edu|
21263577|NCT00310388|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21263578|NCT00330863|Medical College of Georgia, Georgia Regents University|Peter F. Buckley, MD|706-721-2231|pbuckley@gru.edu|
21263579|NCT02179515|National Cancer Institute|Dr. James Gulley|301-480-8870|James_Gulley@nih.gov|
21263580|NCT05161351|Imperial College London Faculty of Medicine|Agnese Zicari,Quality Assurance Facilitator|+44(0)2075946615|a.zicari08@imperial.ac.uk|
21263581|NCT00782418|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21263582|NCT01434641|St. Luke's-Roosevelt Hospital|E. Gordon DePuey, M.D.|212-523-3400|edepuey@chpnet.org|
21263583|NCT04087343|The University of Texas Health Science Center at Houston|Jessica Lee, MD, MS, Assistant Professor|713-500-5457|Jessica.Lee@uth.tmc.edu|
21263584|NCT00501046|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21263585|NCT00689819|Wayne State University|Phillip Levy, MD|3139938558|plevy@med.wayne.edu|
21263586|NCT02488551|Central Arkansas Veterans Health Care System|Michael Cucciare|501-526-8179|michael.cucciare@va.gov|
21263587|NCT02239770|Penn State College of Medicine|Dr. Patricia Sue Grigson|717-531-5772|psg6@psu.edu|
21263588|NCT01188564|Pharming Technologies|Anurag Relan, Vice President Clinical Research and Medical Affairs||a.relan@pharming.com|
21263589|NCT04171037|The University of Texas MD Anderson Cancer Center|Gang Zheng, MD|(713) 563-2731|gzheng@mdanderson.org|
21263590|NCT01934894|SCRI Development Innovations|Charles Davis, RAC|615-524-4341|Charles.Davis2@scri-innovations.com|
21263591|NCT02520518|COLORADO STATE UNIVERSITY|Manager of Research Operations|970-491-2242|Laurie.Biela@colostate.edu|
21263592|NCT01954251|GlaxoSmithKline|GSK Response Center|866-435-7343||
21263593|NCT03364673|Dana-Farber Cancer Institute|Alexi Wright, MD, MPH|617-632-2334|alexi_wright@dfci.harvard.edu|
21263594|NCT02208024|University of Cincinnati Cancer Center|Jordan Kharofa, Associate Professor, Department of Radiation Oncology|(513)-584-4073|kharofjr@ucmail.uc.edu|
21263595|NCT02207556|Medical College of Wisconsin|Dr. Anita D'Souza|414-805-0637|dsouza@mcw.edu|
21263596|NCT03558555|Icahn School of Medicine at Mount Sinai|Dr. Alopi Patel|(212) 523-6357|Alopi.patel@mountsinai.org|
21263597|NCT00194025|Case Western Reserve University and Unversity Hospitals Case Medical Center|Martha Sajatovic MD|216-844-2808|martha.sajatovic@uhhospitals.org|
21263598|NCT00004418|Kennedy Krieger Institute|Gerald Raymond|443-923-2750|raymond@kennedykrieger.org|
21263599|NCT04124536|University of North Carolina at Chapel Hill|Benjamin Chi, MD, MSc|919-445-4174|bchi@med.unc.edu|
21263600|NCT02918409|National Jewish Health|Dr. Milene Saavedra|303-270-2333|saavedram@njhealth.org|
21263601|NCT03741725|University of North Carolina, Project-China|Dr. Weiming Tang|+86-15920567132|weiming_tang@med.unc.edu|
21263602|NCT00803543|University of Alabama at Birmingham|Nicholas Van Wagoner|205-934-2840|nvw@uab.edu|
21263603|NCT00511342|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21263604|NCT02432040|University of the Philippines - Philippine General Hospital Section of Dermatology|Dr. Sharlene Chua|2418118|sharlene_chua@yahoo.com|
21263605|NCT01100307|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21263606|NCT00997321|MinneapolisMRF|James Miner|612-873-3000|miner015@umn.edu|
21263607|NCT00590018|Baylor College of Medicine|Dr. Heather Dickerson|832-826-5637|had@bcm.edu|
21263608|NCT01962714|VA Puget Sound Health Care System|David Kearney, MD|206-277-1445|david.kearney@va.gov|
21263609|NCT00608530|VA San Diego Healthcare System|Joseph H. Atkinson MD, Principal Investigator|858 642 3775|joseph.atkinson@va.gov|
21263610|NCT00077610|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21263611|NCT00837512|Emory University School of Medicine|Dr. Eric Felner|404-727-7651|efelner@emory.edu|
21263612|NCT04544709|University of Utah Orthopaedics Center|Heather Littell, Regulatory Coordinator|801-587-5432|u6041929@utah.edu|
21263613|NCT03135028|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21263614|NCT02065869|Bellicum Pharmaceuticals|Rivogenlecleucel Study Team|(832) 384 1100|clinicaltrials@bellicum.com|
21263615|NCT01814800|ADMA Biologics|Jimmy Mond, M.D., Ph.D|201-478-5552|jmond@admabio.com|
21263616|NCT02402218|Johns Hopkins School of Medicine|Dr. Mark Sulkowski|443-997-1900|msulkowski@jhmi.edu|
21263617|NCT03827473|Huntsman Cancer Institute Research Compliance Office|Data Manager|8015850601|compliance@hci.utah.edu|
21263618|NCT04436822|Medtronic Diabetes|Robin Mottackel|8185764886|robin.e.mottackel@medtronic.com|
21263619|NCT03807739|Genentech, Inc|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21263620|NCT02371759|University of Belgrade, Faculty of Dental Medicine|DDS PhD Professor Dragica Stojic, DDS PhD Professor Bozidar Brkovic, DDS PhD Marija Milic|+ 381 11 2685 280|brkovic73@yahoo.com|244
21263621|NCT03375112|Henry Ford Health System|Dr. Michael Charters|1-800-436-7936|mcharte1@hfhs.org|
21263622|NCT02774226|Augusta University|Dr. Ryan Harris|706-721-5483|ryharris@augusta.edu|
21263623|NCT03599141|Indiana University|Heather K. Hardin|317.274.5966|hhardin@iu.edu|
21295126|NCT01235923|University of Utah|Robin Ohls|801-581-7052|robin.ohls@hsc.utah.edu|
21295127|NCT00457977|University of Minnesota|Sarah Harnden|612-626-9011|sharnden@ccbr.umn.edu|
21295128|NCT03405935|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21295129|NCT04979897|Universidad del Desarrollo|Ana Castro-Avila|+56223279648|anacastro@udd.cl|
21295130|NCT03397134|Minerva Neurosciences|Senior Vice President and Head of R&D|617-600-7378|rkuchibhatla@minervaneurosciences.com|
21295131|NCT04195438|University of Maryland School of Medicine|Dr. Cherif Boutros (Surgical Oncologist)|410-328-7320|cboutros@som.umaryland.edu|
21248413|NCT01673594|Massachusetts General Hospital|Research Regulatory Coordinator|617-726-4651|apulli@mgh.harvard.edu|
21248414|NCT01711294|Boston Scientific Corporation|Lina Ginnetti, Clinical Endoscopy Director|508-683-4512|lina.ginnetti@bsci.com|
21248415|NCT02605174|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21248416|NCT04250636|The Rockefeller University|Marina Caskey|2123277396|mcaskey@rockefeller.edu|
21248417|NCT02117310|The Ohio State University|Dr. Daniel Prevedello, Associate Professor|(614) 685-1965|daniel.prevedello@osumc.edu|
21248418|NCT00568087|Minneapolis VA Health Care System|Gihyun Yoon, MD|612-467-3996|Gihyun.Yoon@va.gov|
21248419|NCT03510195|Universiti Putra Malaysia|Dr. Aneesa Abdul Rashid|03-86092956|aneesa@upm.edu.my|
21248420|NCT05005247|MinervaX|CMO|004553883002|LIO@minervax.com|
21248421|NCT01271244|VA NEBRASKA WESTERN IOWA VA HEALTHCARE|SRIRAM RAMASWAMY MD|4029954712|SRIRAM.RAMASWAMY@VA.GOV|
21248422|NCT01738698|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21248423|NCT02827201|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
21248424|NCT02630186|Clovis Oncology, Inc.|Elizabeth Bradley|1-415-409-5495|ebradley@clovisoncology.com|
21248425|NCT00439218|Westat|René Gonin, PhD (Math. Stats.)|301-251-1500|renegonin@westat.com|
21248426|NCT02124044|NIH Clinical Center|Masur, Henry|+1 301 496 9320|HMasur@cc.nih.gov|
21248427|NCT02128269|Alexion|Alexion Medical Monitor|617-613-1071|Bert.Yao@alexion.com|
21248428|NCT01021748|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21248429|NCT01829711|MedImmune, LLC|Priti Patel|+1-650-264-9079|information.center@astrazeneca.com|
21248430|NCT01480258|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21248431|NCT01482091|Albert Einstein College of Medicine/Children's Hospital at Montefiore|Dr. Daniel Fein|718-920-5312|dfein@montefiore.org|
21248432|NCT01640288|Duke University School of Medicine, Department of Radiology|H. Cecil Charles, Ph.D.|919-684-7921|cecil.charles@duke.edu|
21248433|NCT00546156|Dana-Farber Cancer Institute|Dr Ian Krop|617-632-2335|ian.krop@dfci.harvard.edu|
21248434|NCT04263714|McMaster University|Dr. Stuart Phillips|9055259140|phillis@mcmaster.ca|24465
21248435|NCT01485887|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21248436|NCT02234141|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21248437|NCT00895245|University of Washington|Dr. Keith Eaton|206-288-2048|kdeaton@uw.edu|
21248438|NCT02095678|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Vikas Gulani|+1 216-844-3312|Vikas.Gulani@UHhospitals.org|
21248439|NCT03418545|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21248440|NCT04447027|National Cancer Institute|Dr. Mark J. Roschewski|240-760-6183|mark.roschewski@nih.gov|
21248441|NCT04224272|Jazz Pharmaceuticals Inc.|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
21248442|NCT02609048|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21248443|NCT04069247|Chinese University of Hong Kong|Dr. Yun Kwok Wing|+852 39197593|ykwing@cuhk.edu.hk|
21248444|NCT04104022|University of Vermont|Dr. Kelly R. Peck, Ph.D.|8026569610|Kelly.Peck@uvm.edu|
21248445|NCT04118894|Stryker|Jennifer Seidman, Manager, Clinical Research|9016338616|jennifer.seidman@stryker.com|
21248446|NCT03496766|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
21248447|NCT00604890|Berg LLC|Nathaniel DiTommaso|617-588-1002|nate.ditommaso@berghealth.com|
21248448|NCT02678455|University of Vermont|Beth Kirkpatrick MD|802-656-5822|beth.kirkpatrick@med.uvm.edu|
21248449|NCT03187223|Department of Medical Oncology, Inselspital, University Hospital and University of Bern, Bern, Switzerland|Prof Dr. Thomas Pabst|+41 31 63 2 84 30|Thomas.Pabst@insel.ch|
21248450|NCT04700904|Pennington Biomedical Research Center|Corby Martin|763-2585|corby.martin@pbrc.edu|
21248451|NCT03508700|Tonix Pharmaceuticals|Gregory Sullivan|(862) 904-0355|greg.sullivan@tonixpharma.com|
21248452|NCT02808468|University of Washington|Dr. Michele Bedard-Gilligan|206-616-4215|mab29@uw.edu|
21248453|NCT00279409|USSF|Laurence Greenhill||larrylgreenhill@gmail.com|
21248454|NCT04992273|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21248455|NCT00670449|Novartis Pharmaceuticals|Study Director|862 778-8300||
21248456|NCT02771366|University of Florida|Adam Woods, Ph.D.|352-294-5842|ajwoods@phhp.ufl.edu|
21248457|NCT01823224|Womack Army Medical Center|Anthony R Plunkett, MD|910-907-6000|anthonyrplunkett@gmail.com|
21248458|NCT02094534|Orange County Research Center|Joel M. Neutel, M.D., Study Director|714-550-9990|jmneutel@aol.com|
21248459|NCT01779050|Washington University School of Medicine|Rebecca Aft, M.D., Ph.D.|314-747-0063|aftr@wustl.edu|
21248460|NCT00022672|Hoffman-LaRoche|Medical Communications|800-821-8590||
21248461|NCT03648541|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|18002430127|clintriage.rdg@boehringer-ingelheim.com|
21248462|NCT00273052|GlaxoSmithKline|GSK Response Center|866-435-7343||
21248463|NCT01852045|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21248464|NCT03142932|Johns Hopkins University School of Medicine|Dr. Jonathan E. Golub|(443) 287-2969|jgolub@jhmi.edu|
21248465|NCT00703092|Virginia Commonwealth University|Dr. John Nestler|804-828-3389|jnestler@mcvh-vcu.edu|
21295132|NCT03136497|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
21295133|NCT00934947|UNC Department of Anesthesiology|Samuel McLean|919-966-7315|smclean@aims.unc.edu|
21248466|NCT00681109|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana|(617) 573-4331|Reza_Dana@meei.harvard.edu|
21263624|NCT03136185|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21263625|NCT00125658|VA Brain Rehabilitation Research Center|Dr. Carolynn Patten|352.376.1611|carolynn.patten@va.gov|4160
21263626|NCT02876055|Mayo Clinic|Dr. Jason K. Panchamia|507-284-9698|panchamia.jason@mayo.edu|
21263627|NCT04158908|Weill Cornell Medicine|Sophia Kakarala|(646) 962-5650|sok4004@med.cornell.edu|
21263628|NCT00303108|New York Oncology Hematology, Albany Medical Center|Dr. Rufus Collea|518-262-6696|rufus.collea@usoncology.com|
21263629|NCT00894413|Johns Hopkins University School of Medicine|Zubair Khan, MD|410-955-3157|zkhan@jhmi.edu|
21263630|NCT02349789|Kennedy Krieger Institute|Anthony Gonzalez|4439080074|gonzalezan@kennedykrieger.org|
21263631|NCT03522350|Weill Cornell Medical College|Nikica Zaninovic, PhD|212-746-5790|nizanin@med.cornell.edu|
21263632|NCT00786032|Hines Coordinating Center|Project Manager|708-202-5785|tamara.paine@va.gov|
21263633|NCT02457182|University of New Mexico|Gregg Kanter, MD|818-599-3456|greggkanter@gmail.com|
21263634|NCT03534063|University of Florida|Dr. Larisa Cavallari|(352) 273-8245|LCavallari@cop.ufl.edu|
21263635|NCT02397694|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21263636|NCT01116687|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-7257|jonathan.strosberg@moffitt.org|
21263637|NCT00424528|Sepracor Inc|Respiratory Medical Affairs Director|866-503-6351||
21263638|NCT02115113|Novartis Pharmaceuticals|Study Director|862-778-8300||
21263639|NCT01009983|Wake Forest University Health Sciences|Dr. Susan Melin|336-716-2839|smelin@wakehealth.edu|
21263640|NCT00849251|University of Washington|Dr. Pamela Becker|206-616-1589|pbecker@uw.edu|
21263641|NCT00074724|MedStar Health Research Institute|Scientific Center Administrator|301-560-7300|Research@medstar.net|
21263642|NCT00296725|New York State Psychiatric Institute|Jonathan W. Stewart, M.D., Principle Investigator|646-774-8070|jws6@cumc.columbia.edu|
21263643|NCT04863417|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21263644|NCT01648452|National Eye Institute|Paul A Sieving, MD, PhD|301-496-2234|ps261o@nih.gov|
21263645|NCT00797797|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Robert Palmer, MD|1-201-427-8218|robert.palmer@frx.com|
21263646|NCT03196193|Zimmer Biomet G.K.|Senior Manager of Clinical Affairs|+81-3-6402-6610|takahito.nakai@zimmerbiomet.com|
21263647|NCT03583372|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
21263648|NCT04831515|Coopervision|Jose A. Vega, O.D., MSc, FAAO|9256213761|JVega2@coopervision.com|
21263649|NCT00748085|CSA Medical|Ann Murphy Legg, Director of Clinical Research|781-538-4732|alegg@csamedical.com|
21263650|NCT02943265|University of Kansas Medical Center|Simon Lee|(913) 588-2689|slee21@kumc.edu|
21263651|NCT03623334|UT Southwestern Medical Center|Sarah Hardee|214-648-1836|sarah.hardee@utsouthwestern.edu|
21263652|NCT02338492|IlluminOss Medical Inc.|Gene DiPoto|401-714-0008|gdipoto@illuminoss.com|202
21263653|NCT00756886|Surgery - Cardiovascular/Thoracic|Ayesha S. Bryant, MD|(205) 996-7561|abryant@uab.edu|
21263654|NCT03377244|University of Arkansas for Medical Sciences|Dr. Pearl A. McElfish|479-713-8680|pamcelfish@uams.edu|
21263655|NCT00174785|sanofi-aventis|International Clinical Development (ICD), Clinical Study Director||GV-Contact-us@sanofi-aventis.com|
21263656|NCT00274768|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Antonio Wolff|410-614-6192|awolff@jhmi.edu|
21263657|NCT00120289|Axio Research, LLC|Ruth McBride|206-577-0212|ruthm@axioresearch.com|
21263658|NCT01590394|Mayo Clinic|Christopher J. Gostout|507-284-7647|gostout.christopher@mayo.edu|
21263659|NCT03664193|Weill Cornell Medicine|Josephine Kang|212-746-3607|jok9106@med.cornell.edu|
21263660|NCT00779324|Indiana University School of Medicine|Flora Hammond, MD|3173292106|flora.hammond@rhin.com|
21263661|NCT00543569|Astellas Pharma Global Development, Inc. (APGD)|Global Head Global Medical Sciences--Transplant and Immunology/Inflammation||Astellas.resultsdisclosure@astellas.com|
21263662|NCT00862849|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|858-794-8889||
21281183|NCT00235755|GlaxoSmithKline|GSK Response Center|866-435-7343||
21281184|NCT02816736|Duke Clinical Research Institute|Kevin J. Anstrom, Ph.D., Director of Biostatistics|919-668-8902|kevin.anstrom@duke.edu|
21281185|NCT01707290|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21281186|NCT02774941|Children's Health - Children's Medical Center, Dallas|Clinical Research Coordinator - Respiratory Care Dept|214-456-1367|gerald.moody@childrens.com|
21281187|NCT01882985|University of California, Irvine|Dr. John P. Fruehauf|714-456-5153|jfruehau@uci.edu|
21281188|NCT03197389|University Hospitals Leuven|Prof. Dr. Ann Smeets|003216340903|hanne.vos@uzleuven.be|
21281189|NCT03193853|Baylor Scott and White Health|Joyce O'Shaughnessy|214-818-8472|joyce.oshaughnessy@usoncology.com|
21281190|NCT04129125|Imperative Care|Didem Aksoy, Senior Director of Clinical Affairs|650-644-8293|daksoy@imperativecare.com|
21281191|NCT06684951|AlNahrain university|Omaima Ismail Khalaf|9647831475217|khokh7871@gmail.com|
21281192|NCT02547012|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
21281193|NCT01787292|Health Science Specialist|Dr. Keith McGregor|4043216111|keith.mcgregor2@va.gov|126792
21281194|NCT01532934|University of Rochester|Marc T. Swogger, Ph.D.|585-275-7418|marc_swogger@urmc.rochester.edu|
21281195|NCT04846400|University of Michigan|David A Zopf, MD|734-936-5730|davidzop@med.umich.edu|
21281196|NCT02962648|Pharmacosmos A/S|Clinical trial disclosure desk|+45 5948 5935|trial@pharmacosmos.com|
21281197|NCT02755285|Fujifilm Medical Systems USA, Inc.|Randy Vader|(360) 356-6821|randy.vader@fujifilm.com|
21281198|NCT01597778|The Emmes Company|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
21281199|NCT03267212|Harvard Medical School|Dr J. Andrew Taylor|6177585503|jandrew_taylor@hms.harvard.edu|
21263663|NCT00974051|UColorado|Dr. H Peter Chase|303-724-2323|peter.chase@ucdenver.edu|
21263664|NCT01362686|Regenstrief Insitute|Dr. Noll Campbell|317-274-9051|cambenl@regenstrief.org|
21295134|NCT01933230|Cleveland Clinic|Dr. Jose Javier Provencio, Faculty, Neuroinflammation Research Center|216-445-242|provenj@ccf.org|
21295135|NCT00118352|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
21248467|NCT04660799|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21248468|NCT02706483|Bausch Health|Matt Markovich|908-541-1341|Matthew.Markovich@bauschhealth.com|
21248469|NCT04248868|Eminence Clinical Research, Inc.|Christopher A. Schultz|9715067552|cschultz@ecr-inc.com|
21248470|NCT02764970|Medical University of Graz|Assoc. Prof. Dr. Dirk von Lewinski|31638580684|dirk.von-lewinski@medunigraz.at|316
21248471|NCT03131713|Tufts Medical Center|Bichchau Nguyen, Principal Investigato|617-636-1286|bnguyen2@tuftsmedicalcenter.org|
21248472|NCT01972776|Novartis|Study Director|862-778-8300||
21248473|NCT02144597|Imperial College London|Prof Gary Frost|07872850308|g.frost@imperial.ac.uk|
21248474|NCT01228734|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21248475|NCT03672032|University of Iowa Hospitals and Clinics|Dr. Henning Gerke|319-384-6582|henning-gerke@uiowa.edu|
21248476|NCT00462072|University of Rochester|Rick Barrett|585-275-1647|rick_barrett@urmc.rochester.edu|
21248477|NCT01934452|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21248478|NCT02382640|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21248479|NCT01543204|Amgen Inc.|Study Director|866-572-6436||
21248480|NCT01220999|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
21248481|NCT00603018|UCSD|Walter Kaye, MD/Director, Eating Disorders Program Professor, UCSD Department of Psychiatry|858- 534-8019|wkaye@ucsd.edu|
21248482|NCT02356198|Mayo Clinic|Dr. Dorin T. Colibaseanu, MD|904-953-2596|colibaseanu.dorin@mayo.edu|
21248483|NCT01560429|Queen's University|Dr. Vidur Shyam|(613) 548-7827|shyamv@kgh.kari.net|
21248484|NCT02449902|TherapeuticsMD|Shelli Graham, PhD|561-961-1900|Shelli.Graham@TherapeuticsMD.com|
21248485|NCT01365546|Octapharma|Director of Clinical Operations|4152609577|sylvia.werner@octapharma.com|
21248486|NCT03326856|Eirion Therapeutics|Chief Executive Officer|(781) 935-1216|info@eirionthera.com|
21248487|NCT02037568|University of Colorado Denver|Mark L. Laudenslager, PhD|303-724-9277|biel@ucdenver.edu|
21248488|NCT02684136|HenryFordHS|Timothy Roehrs PhD Study Investigator|313-916-5177|troehrs1@hfhs.org|
21248489|NCT00721734|Amgen, Inc.|Study Director|866-572-6436||
21248490|NCT03162614|GlaxoSmithKline|GSK Response Center|877-379-3718|GSKClinicalSupportHD@gsk.com|
21248491|NCT03861234|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21248492|NCT00621842|Case Western Reserve University|Christopher Bialko|216-286-4362|Christopher.Bialko@UHhospitals.org|
21248493|NCT05353296|Columbia University|Carmela Alcantara, PhD|212-851-2187|ca2543@cumc.columbia.edu|
21248494|NCT02251652|Icahn School of Medicine at Mount Sinai|Dr. Gary Goldenberg|212-241-9728|garygoldenbergmd@gmail.com|
21248495|NCT01989793|Johns Hopkins University|Dr. Jeremy D. Walston, M.D. , Raymond and Anna Lublin Professor of Geriatric Medicine|410-550-1003|jwalston@jhmi.edu|
21248496|NCT01074242|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21248497|NCT01957163|GlaxoSmithKline|GSK Response Center|866-435-7343||
21248498|NCT05169684|Bristol Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
21248499|NCT01668719|SWOG Statistics and Data Management Center|Myeloma Committee Statistician|2066674623|rachaels@crab.org|
21248500|NCT03539055|Vanderbilt Cardiovascular Research Enterprise|Terry Weyand, MS., CCRP|6153229349|terry.l.weyand@vumc.org|
21248501|NCT01321073|The University of Alabama at Birmingham|Robert Bourge, M.D., Professor of Medicine, Radiology, and Surgery|(205)934-7400|bbourge@uab.edu|
21248502|NCT01638000|Astellas Pharma Europe Ltd|Medical Director||Astellas.resultsdisclosure@astellas.com|
21248503|NCT05484661|UT Health San Antonio|Monica Serra|210-949-9759|serram@Uthscsa.edu|
21248504|NCT00875706|Department of Veterans Affairs|Dr. Carol VanDeusen Lukas|857-364-5685|carol.vandeusenlukas@va.gov|
21248505|NCT03775213|Duke University|Dr. Marc D. Ryser|(919) 684 8294|marc.ryser@duke.edu|
21248506|NCT00786188|Noven Therapeutics, LLC|Sailaja Bhaskar, Executive Director, Clinical Research|(212) 287-0798|sbhaskar@noven.com|
21248507|NCT00326183|Merck Sharp & Dohme Corp|Senior Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
21248508|NCT01742832|University of Chicago|Dr. Jon Grant|773-834-1325|jongrant@uchicago.edu|
21248509|NCT03787628|UCLA David Geffen School of Medicine|Dr. Edythe London|3106142150|elondon@mednet.ucla.edu|
21248510|NCT00570505|Apollo Endosurgery|Laura Eaton|949-468-9301|laura.eaton@apolloendo.com|
21248511|NCT05250206|Indizen Optical Technologies (Madrid), Universidad Complutense de Madrid|Director of Clinical Trials|+34 (91) 833 37 86|evachamorro@iot.es|
21248512|NCT03016871|City of Hope Medical Center|Dr. Alex Herrera|626-359-8111|aherrera@coh.org|
21248513|NCT05865392|University of Colorado|Dr. Danielle M. Ostendorf|3037249203|danielle.ostendorf@cuanschutz.edu|
21248514|NCT02159989|MD Anderson Cancer Center|Aung Naing|713-563-3885|anaing@mdanderson.org|
21248515|NCT04889989|Ethicon, Inc.|Erin Meyers|937-681-0322|eprifog1@its.jnj.com|
21248516|NCT04278833|Stanford University|Clinical Research Coordinator|(650) 723-0003|jessn16@stanford.edu|
21248517|NCT05200416|Coloplast A/S|Senior Clinical Strategy Project Manager|+4549111341|dkteaa@coloplast.com|
21248518|NCT02485925|Biosense Webster, Inc.|Kendra McInnis|949-450-7783|kmcinnis@its.jnj.com|
21248519|NCT02969356|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
21248520|NCT04924608|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21248521|NCT04493424|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21248522|NCT03769090|Avillion LLP|Chief Medical Officer|+44 (0)203 764 9530|avillion@avillionllp.com|
21248523|NCT02786966|Ottawa Hospital Research Institute|Manya Charette|613-798-5555|mancharette@ohri.ca|17758
21248524|NCT03627299|Johns Hopkins University|Christine Durand, MD|410-955-5684|ChristineDurand@jhmi.edu|
21248525|NCT01190124|Hospital de Santa Maria - Centro Hospitalar Lisboa Norte|Doroana, Maria Manuela, M.D.|351 217938043|manuela.doroana@hsm.min-saude.pt|
21248526|NCT02713594|University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|6082627563|sss@ctri.wisc.edu|
21248527|NCT00413283|Amgen Inc.|Study Director|866-572-6436||
21248528|NCT02068157|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
21248529|NCT00671853|University Hospitals Cleveland Medical Center|Dr. Kemp Gao|216-844-2865|keming.gao@UHhopsitals.org|
21248530|NCT01377844|Theracos Sub, LLC|Albert Collinson, Ph.D.|(508) 688-4221|acollinson@theracos.com|
21248531|NCT00785798|Yale University School of Medicine|Francine Foss, MD||Francine.Foss@yale.edu|
21248532|NCT01928732|Palo Alto CSPCC|Lisa Zehm|(650) 493-5000|Lisa.Zehm@va.gov|28805
21248533|NCT01185340|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21248534|NCT00667017|University of Texas Southwestern Medical Center|Larry Andeson, MD|214-648-7097||
21248535|NCT01848483|Emory University|Marcia McDonnell Holstad|404-727-1307|nurmmcd@emory.edu|
21248536|NCT01093690|Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University|Suthinee Ithimakin, MD|6624197000|aesi105@yahoo.co.th|4489
21248537|NCT00246129|imperial College Kidney & Transplant Centre|Dr Adam McLean|+44 (0) 208 383 5164|adam.mclean@imperial.nhs.uk|356164
21248538|NCT03469258|Beth Israel Deaconess Medical Center|A. James Moser, MD|(617) 632-1032|ajmoser@bidmc.harvard.edu|
21248539|NCT00326196|Roudebush VAMC|Masoor Kamalesh, MD|317-988-2401|masoor.kamalesh@va.gov|
21248540|NCT02005172|University at Buffalo|Deepika Narasimha||deepikan@buffalo.edu|
21248541|NCT00770874|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.||toiawase@taiho.co.jp|
21248542|NCT03041090|Saint Louis University|Medhat Osman, MD, PhD - Professor of Radiology, Director of Nuclear Medicine and PET/CT|314-577-8047|medhat.osman@health.slu.edu|
21248543|NCT02202317|University of Miami Miller School of Medicine|Dr Jason Salsamendi|305-585-7500|jsalsamendi@miami.edu|
21248544|NCT01353274|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21248545|NCT02701296|ST. FRANCIS HOSPITAL AND MEDICAL CENTER|Sanjay Sinha, MD||sanjaysinha@comcast.net|
21248546|NCT01682928|Mednax|Ana Braescu|480-969-5999|ana_braescu@mednax.com|
21248547|NCT01409837|University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu|Dr. Anthony Mbah, Principal investigator|2348051519065|cmd_unth@yahoo.com|
21248548|NCT04053699|Octapharma|Sigurd Knaub, Senior VP CR&D Haematology|01554512141|Sigurd.Knaub@octapharma.com|
21248549|NCT00403494|BioMarin Pharmaceutical Inc.|Joshua Lilienstein/Medical Director, Global Medical Affairs|651.523.0310|MEDINFO@bmrn.com|
21248550|NCT01335061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21248551|NCT03851094|ResMed|Clinical Research Team|800-424-0737|clinicaltrials@resmed.com.au|
21248552|NCT04658784|Ascension Saint Thomas Medical Group|Dr. Amanda Merriman|615-397-6919|amanda.yacko@gmail.com|
21248553|NCT03490032|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21248554|NCT02958553|Ottobock Healthcare|Russ Lundstrom|512-806-2606|russ.lundstrom@ottobock.com|
21248555|NCT01083706|Fred Hutchinson Cancer Research Center|Bart Scott|206-667-1990|bscott@fredhutch.org|
21248556|NCT00308308|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
21248557|NCT02125292|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21248558|NCT02392507|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
21248559|NCT03068312|Vertex Pharmaceuticals Incorporated|Medical Monitor|+1 617 341 6777|medicalinfo@vrtx.com|
21248560|NCT02551224|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
21248561|NCT01802333|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|206-667-4623|amoseley@fredhutch.org|
21248562|NCT02224755|Abbott|Joyce Chuang/Principal scientist|925-353-5817|joyce.chuang@abbott.com|
21248563|NCT01951703|Clinical Compliance Manager|Jurandir Araujo|904 443-1379|jaraujo7@jnj.com|
21248564|NCT01487954|Case Comprehensive Cancer Center AND Summa Health System|Dr. Charles A. Kunos, MD, PhD|(330) 375-3557|kunosc@summahealth.org|
21248565|NCT00240994|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21248566|NCT01759459|Allina Health|David Gurda|612-863-6566|david.gurda@allina.com|
21248567|NCT01299285|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21248568|NCT01019135|University Health Network & York University|Dr. Sherry L Grace|416.736.2100|sgrace@yorku.ca|22364
21248569|NCT05124210|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21248570|NCT00638456|Univeristy of California, San Diego|Dr. Ranjan Dohil|(858) 966-4003|rdohil@ucsd.edu|
21248571|NCT02007070|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21248572|NCT03128099|Vanderbilt University|Dr. Sohee Park, Project Director|6153223435|sohee.park@vanderbilt.edu|
21281200|NCT04132973|The University of Sheffield|Elaine Clarke|01142226533|e.n.clarke@shef.ac.uk|
21281201|NCT04383327|NYU Langone Health|Keng-Yen Huang, PhD, MPH|646-501-2879|Keng-Yen.Huang@nyulangone.org|
21281202|NCT05691712|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21281203|NCT05303194|The University of Texas Medical Branch|Rafael Samper-Ternent|8322057994|rasamper@utmb.edu|
21248573|NCT02527694|Seoul National University Hospital|So Yeon Kong|82220724412|soyeon.kong@gmail.com|
21248574|NCT02070276|Hôpitaux Universitaires de Genève|Dr. med. Samuele Ceruti|0765661181|samuele.ceruti@me.com|
21281204|NCT01210560|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
21281205|NCT01289678|Brody School of Medicine|Paul R. Walker, MD|2527441888|walkerp@ecu.edu|2527441888
21248575|NCT02362789|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
21248576|NCT00407485|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
21248577|NCT00432445|University of Texas (UT) MD Anderson Cancer Center|Dan Gombos, MD/Professor, Ophthalmology|713-792-6920|CR_Study_Registration@mdanderson.org|
21263665|NCT01204255|Virginia Commonwealth University|Thomas J. Smith, MD|804-828-9723|tsmith5@mcvh-vcu.edu|
21281206|NCT00991887|Carolinas Medical Center|Rachel Seymour, PhD|704-355-6969|Rachel.Seymour@carolinashealthcare.org|
21281207|NCT00226499|GlaxoSmithKline|GSK Response Center|866-435-7343||
21281208|NCT04306211|Indiana University|John M. DeWitt, MD|317-944-0980|jodewitt@iu.edu|
21281209|NCT02723344|Eastern Colorado Health Care System, Rocky Mountain MIRECC|Dr. Lisa A Brenner|720-723-6488|lisa.brenner@va.gov|
21281210|NCT03473184|Castle Creek Pharmaceuticals, LLC|Dr. Mary Spellman; Chief Medical Officer|862 286 0400|mspellman@castlecreekpharma.com|
21281211|NCT02524847|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-844-2830|clinicaltrials@mnk.com|5
21248578|NCT05270460|Processa Pharmaceuticals Inc.|Dr. Sian Bigora|410-693-6844|sbigora@processapharmaceuticals.com|
21248579|NCT00783952|Massachusetts General Hospital|Robert M Kacmarek PhD, RRT|617-314-2222|rkacmarek@partners.org|
21248580|NCT02170532|Duke University Medical Center|Neil MacIntyre, MD|(919) 681-2720|macin001@mc.duke.edu|
21248581|NCT00680771|University of rochester|Wilfred Pigeon|(585) 275-3374|Wilfred_pigeon@urmc.rochester.edu|
21248582|NCT03796767|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
21248583|NCT04939233|Departments of Mechanical Engineering and Electrical and Computer Engineering, Virginia Tech|Dr. Pinhas Ben-Tzvi|NA|bentzvi@vt.edu|
21248584|NCT02506283|University of Applied Sciences and Arts of Southern Switzerland (SUPSI)|Dr. Erich Hohenauer|+41813000175|erich.hohenauer@supsi.ch|
21248585|NCT03212638|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
21248586|NCT03205488|Northwestern University|Dr. Tanya Simuni|312-503-2970|Tatyana.Simuni@nm.org|
21248587|NCT03652610|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21248588|NCT01990794|Cardno|Dr. David Galbraith|415-618-3211|david.galbraith@cardno.com|
21248589|NCT04748341|Lahore school of nursing, University of lahore, Pakistan|Ms. Mishal Liaqat (Principal Investigator)|+923441481666|mishee861@gmail.com|
21248590|NCT02334215|Friends Research Institute|Robert P. Schwartz, M.D.|410-837-3977|rschwartz@friendsresearch.org|276
21248591|NCT05615363|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21248592|NCT01276509|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21248593|NCT01534052|Astellas Pharma Europe B.V. (APEB)|Clinical Trial Disclosure|800-888-7704 Ext:5473|astellas.resultsdisclosure@astellas.com|
21248594|NCT02470312|Abbott|Kristin Ruffner, Clinical Program Director|+1 651 756 6717|Kristin.Ruffner@abbott.com|
21248595|NCT03403036|Icahn School of Medicine at Mount Sinai|Dr. Mark Lebwohl|212-241-9728|mark.lebwohl@mountsinai.org|
21248596|NCT01128959|Lundbeck LCC|Lundbeck LLC|+45 36301311|LundbeckClinicalTrials@lundbeck.com|
21248597|NCT02338999|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Kaplan, Mariana|+1 301 496 0517|mariana.kaplan@nih.gov|
21281212|NCT04352101|Emory University|Andrew H. Miller, MD|404-727-8260|amill02@emory.edu|
21281213|NCT02794727|Mayo Clinic|Sanjeev Nanda, MD|507-284-2511|nanda.sanjeev@mayo.edu|
21281214|NCT01268527|Eisai Medical Research Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
21281215|NCT01008605|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21281216|NCT03170544|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21281217|NCT03223350|Henry Ford Hospital|Dr. Joseph Miller, associate research director|313-916-5419|jmiller6@hfhs.org|
21281218|NCT04564092|GE Healthcare|Yongqing Tang, MD PhD|189-1820-3986|Yongqing.Tang@ge.com|
21281219|NCT00420420|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21281220|NCT00359424|University of Cincinnati Academic Health Center|Joseph P. Broderick|513-558-5429|broderjp@ucmail.uc.edu|
21281221|NCT04762160|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
21281222|NCT02816346|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
21281223|NCT02362360|Coloplast|Head of Clinical Operations|0045 49111990|dkcfv@coloplast.com|
21281224|NCT05425927|SyntheticMR|Erik Lange|+46(0)70-331 56 78|erik.lange@syntheticmr.com|
21281225|NCT02996227|Cleveland Clinic|Fabio Rodriguez|215 444-9950|rodrigf3@ccf.org|
21281226|NCT00868530|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21281227|NCT01047527|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@mail.med.upenn.edu|
21281228|NCT03576326|University of California, San Francisco|Dr. Stuart Gansky|415-502-8094|stuart.gansky@ucsf.edu|
21281229|NCT01880554|Institut Bergonie|Derek Dinart||d.dinart@bordeaux.unicancer.fr|
21248598|NCT02746107|Carol Davila University of Medicine and Pharmacy Bucharest|Professor Cristian Baicus|+40788302355|cbaicus@gmail.com|
21248599|NCT01450007|Mayo Clinic|Dr. David M. Rosenfeld|480-301-7586|Rosenfeld.David@mayo.edu|
21248600|NCT00484198|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21248601|NCT01536704|GlaxoSmithKline|GSK Response Center|866-435-7343||
21248602|NCT01947491|Promius Pharma, LLC|Director of Clinical Operations|609-282-1476|kgulbronson@promiuspharma.com|
21248603|NCT00724009|The University of Chicago|Wendy Stock, MD|773-834-8982|wstock@medicine.bsd.uchicago.edu|
21248604|NCT02067663|Stanford University School of Medicine|Lisa Goldthwaite|541-515-1825|lgoldthw@stanford.edu|
21248605|NCT00704340|Integra LifeSciences|Director, Medical Affairs|609-275-0500||
21281230|NCT02999269|University of New Mexico|Dr. Chris Abbott, Division Chief Neuromodulaton, Department of Psychiatry|505272223|cabbott@salud.unm.edu|
21281231|NCT03976362|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21248606|NCT04220983|Weill Cornell Medicine|Sharanya Chandrasekhar|646-962-3110|shc2043@med.cornell.edu|
21248607|NCT03236779|Head of iPhysio Research Group. Editor-in-Chief Journal of Invasive Techniques in Physical Therapy|Dr. Pablo Herrero Gallego. PT, PhD.|(+34) 646168248|pherrero@usj.es|
21248608|NCT03070548|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_inquiries@pfizer.com|
21248609|NCT01260883|Seattle Children's Hospital|Anne Lynn MD|206 987-2518|anne.lynn@seattlechildrens.org|
21248610|NCT00403845|Novartis Pharmaceuticals|Study Director|862 778-8300||
21248611|NCT01836523|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21248612|NCT03775915|University of Oxford|Dr Melanie Fleming, Research Associate|+441865611461|melanie.fleming@ndcn.ox.ac.uk|
21248613|NCT00624377|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21248614|NCT04347941|National University of Ireland, Galway|Dr Bairbre McNicholas|+35391893063|bmcnicholas@nuigalway.ie|
21248615|NCT06631313|Becton, Dickinson and Company|Director of Clinical Affairs|551-225-1164|kirsten.hammitt@bd.com|
21248616|NCT00089791|Amgen Inc.|Study Director|866-572-6436||
21248617|NCT00148122|University of Michigan Comprehensive Cancer Center|Dr. Francis Worden|734-936-0453|fworden@umich.edu|
21248618|NCT02941692|Medical University of South Carolina|Dr. Julianne Flanagan|843-792-5569|Hellmuth@musc.edu|
21248619|NCT05074433|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
21248620|NCT04397263|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21248621|NCT01989689|Emory University|Arshed Ali Quyyumi MD/FACC|404-727-3655|aquyyum@emory.edu|
21248622|NCT04492475|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
21248623|NCT02066636|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21248624|NCT00391170|National Heart Lung and Blood Institute|Clara, Joseph|+1 301 402 2399|joseph.clara@nih.gov|
21248625|NCT02494336|Johns Hopkins All Children's Hospital|Nicole Chandler, MD|7277674170|nicole.chandler@jhmi.edu|
21248626|NCT02696200|Cincinnati Childrens Hospital|Kim Foss|513-636-5971|kim.foss@cchmc.org|
21248627|NCT03567616|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21248628|NCT00849485|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-3848-5525|clinicaltrialqueries@tevausa.com|
21248629|NCT01235936|Akebia Therapeutics, Inc|Akebia Therapeutics, Inc|617-844-6128|trials@akebia.com|
21248630|NCT02359916|Rush University Medical Center|Brad Appelhans, PhD (PI)|312-942-3477|brad_appelhans@rush.edu|
21248631|NCT00556478|Plethora Solutions|Chief Scientific Officer|+44 (0) 20 3077 5400|mail@plethorasolutions.co.uk|
21248632|NCT03200574|Corcym S.r.l.|Elisa Cerutti|+393459182413|elisa.cerutti@corcym.com|
21263666|NCT00305253|University of California San Francisco (UCSF)|Suellen Miller|415 597 9394|smiller@globalhealth.ucsf.edu , suellenmiller@gmail.com|
21263667|NCT01357915|GlaxoSmithKline|GSK Response Center|866-435-7343||
21263668|NCT03615469|Indiana University|Dr. Christine Haedtke|317-274-5358|chaedtke@iu.edu|
21263669|NCT01153763|GlaxoSmithKline|GSK Response Center|866-435-7343||
21263670|NCT02841787|Northwestern University|David C. Mohr, PhD|312-503-1403|d-mohr@northwestern.edu|
21263671|NCT01474746|University of California, Davis, MIND Institute|Dr. Randi Hagerman|916-703-0247|rjhagerman@ucdavis.edu|
21263672|NCT00853333|University of Alabama at Birmigham|Michael Froelich|(205)975-0145|froelich@uab.edu|
21263673|NCT01766336|Transition Therapeutics Ireland Limited|Aleksandar Pastrak, MD, PhD, Vice President Clinical Development|+1 416 263 1227|apastrak@transitiontherapeutics.com|
21263674|NCT03029650|University of Iowa|Nicole Brogden|319-335-8752|nicole-brogden@uiowa.edu|
21263675|NCT02322320|The Emmes Company|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
21263676|NCT00430625|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21263677|NCT03705962|University of Virginia|Eric McVey|434.243.5382|edm9u@hscmail.mcc.virginia.edu|
21263678|NCT03744780|McGill University|Mallory Frayn, PhD(c)|N/A|mallory.frayn@mail.mcgill.ca|
21263679|NCT05118386|Gates Medical Research Institute|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
21263680|NCT00369668|University of Florida, Motor Behavior Laboratory|James Cauraugh, Ph.D., PI|352-294-1623|jcaura@hhp.ufl.edu|
21263681|NCT03855137|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21263682|NCT03054077|Virginia Commonwealth University|Debra Shockey|804-828-3744|dpshockey@vcu.edu|
21263683|NCT02427477|Johnson & Johnson Vision Care Inc.|John R. Buch, O.D., M.S., F.A.A.O.|904-443-3500|JBUCH@its.jnj.com|1707
21263684|NCT01067508|UCLA Center for Human Nutrition|Zhaoping Li|310-206-1987|zli@mednet.ucla.edu|
21263685|NCT03213626|IndianaU|Dr. Patrick Loehrer|(317) 278-7418|ploehrer@iu.edu|
21263686|NCT00958308|Bio-K+ International. Inc.|Dr. Serge Carrière|450-978-2465|scarriere@biokplus.com|
21263687|NCT01005732|University of Washington|Loren Engrav|206-744-3209|engrav@u.washington.edu|
21263688|NCT01552928|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21263689|NCT04030104|Seno Medical Instruments, Inc.|Vice President of Clinical Operations|210-615-6501|sschaeffer@senomedical.com|
21263690|NCT00632463|ADMA Biologics|Chief Medical Officer|201-478-5552|agrossman@admabio.com|
21263691|NCT02065622|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21263692|NCT01249872|University Hospital Of Patras, Greece|Dr Anastasia Zotou|0026130603341|anzotou@hotmail.com|
21263693|NCT02366663|City of Hope National Medical Center|Dr. Amrita Krishnan|626-256-4673|AKrishnan@coh.org|82405
21263694|NCT04357379|Medical University of South Carolina|Dr. Tracy Smith|8437925164|smithtra@musc.edu|
21263695|NCT06704178|Citruslabs|Patrick Renner|+1 805-876-4484|hello@citruslabs.com|
21248633|NCT00705159|Bausch & Lomb Incorporated|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
21263696|NCT00500045|Palo Alto Medical Foundation|Renee Kaneshiro|650-853-4744|kaneshr@pamf.org|
21263697|NCT00488618|Allergan, Inc.|Therapeutic Area Head|714-246-4500||
21263698|NCT00992446|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
21263699|NCT00659724|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
21263700|NCT02389712|Mayo Clinic|Mark A. Frye, M.D.|507-255-7164|MFrye@mayo.edu|
21263701|NCT02922634|BWH|Dr. Gregory Crosby|617-732-7330|gcrosby@bwh.harvard.edu|
21263702|NCT02625324|Medtronic|Rianna Rapson - Clinical Study Manager|763-526.2170|rianna.k.rapson@medtronic.com|
21263703|NCT00352755|Washington University School of Medicine|Dr. James Fleshman|314-747-4610|James.Fleshman@BSWHealth.org|
21263704|NCT02278640|Ethicon Endo-Surgery|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
21263705|NCT00789191|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21263706|NCT02168933|University of Utah, Derpartment of Dermatology|Kristina Callis-Duffin|8015816465||
21263707|NCT03497429|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21263708|NCT02860845|Laboratorios Ordesa|Roser De Castellar|+34 902105243|Roser.DeCastellar@ordesa.es|
21263709|NCT03137121|Univ Alabama Birmingham|Rudolph M Navari|574-261-8385|rmnavari@gmail.com|
21263710|NCT02207478|Shanghai Chest hospital|Dr. Jiayuan Sun|+86 18017321598|jysun1976@163.com|
21263711|NCT02568345|Central Hospital, Irmandade da Santa Casa de Misericórdia (ISCM)|Mauro Prado da Silva|+55 11 2176 7000|comissaocientifica@fcmsantacasasp.edu.br|
21263712|NCT00280150|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
21263713|NCT03209440|University of Florida|Dr. Diana Wilkie|352-273-6401|diwilkie@ufl.edu|
21263714|NCT02939937|assistant|dr.alireza gholizade|989112550646|a.gholizade13@yahoo.com|
21248634|NCT00526994|CDC|Joanne Klevens|770-488-1386|dzk8@cdc.gov|
21248635|NCT03026166|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21248636|NCT03035942|Pontificia Catholic University of Sao Paulo|Dr. Eduardo Toshiyuki Moro|+5515997728015|edumoro85@gmail.com|
21263715|NCT02152670|Yale University|Gustavo Angarita, MD, Assistant Professor of Clinical Psychiatry|(203) 974-7536|gustavo.angarita@yale.edu|
21248637|NCT00380250|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
21248638|NCT01989104|Pennington Biomedical Research Center|Dr. William Johnson|225-763-2932|William.Johnson@pbrc.edu|
21248639|NCT02833948|The Heart Center - Rigshospitalet, Copenhagen, Denmark|Ole De Backer, MD, PhD|+45-35457086|ole.debacker@gmail.com|
21263716|NCT00568958|Yale University School of Medicine|Dr. Stephanie S. O'Malley|203-974-7590|stephanie.omalley@yale.edu|
21248640|NCT02397707|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21263717|NCT02607254|Johns Hopkins University|Dr. Mohammad Khoshnoodi|410-955-5406|mkhoshn1@jhmi.edu|
21248641|NCT02691702|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21263718|NCT03837353|NYU Langone Health|David Wise, MD, PhD|(212) 731-5405|David.Wise@nyulangone.org|
21248642|NCT05613088|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21248643|NCT04603586|Changhai Hospital|Xiaofei Zhu|86-021-31162222|zhuxiaofei_zxf@163.com|
21248644|NCT05163353|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
21263719|NCT00442013|Johns Hopkins University|Janet Holbrook|443-287-3170|ala-acrc@jhsph.edu|
21248645|NCT02790281|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21248646|NCT06086028|Tulane University|Leia Y. Saltzman Associate Professor|504-247-1452|lsaltzman@tulane.edu|
21248647|NCT00824408|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21248648|NCT00718120|GlaxoSmithKline|GSK Response Center|866-435-7343||
21248649|NCT01218594|Sun Yat-Sen University Cancer Center|Ming Chen|86-20-87343640|chenming@sysucc.org.cn|
21263720|NCT05254613|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
21248650|NCT01836445|Northwestern University|Dr. Brian Mustanski|312-503-5421|brian@northwestern.edu|
21248651|NCT04602728|Emory University|Soumitri Sil, PhD|404-727-2712|soumitri.sil@emory.edu|
21263721|NCT02387372|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21248652|NCT04181788|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21263722|NCT01902953|Maimonides|Danny Sherwinter|7182837952|dsherwinter@maimonidesmed.org|
21248653|NCT04535414|National Cancer Institute|Dr. Andrew Blakely|240-760-7647|andrew.blakely@nih.gov|
21248654|NCT04186247|Amsterdam University Medical Center|Johan Van Limbergen, MD, PhD|+31-20 566 9111|j.e.vanlimbergen@amsterdamumc.nl|
21263723|NCT01911845|AbbVie|Global Medical Information|800-633-9110||
21263724|NCT01576016|Abbott|Grant Kim, Program Director - Traditional Cardiac Rhythm Management|818-493-3147|grant.kim1@abbott.com|
21248655|NCT03662659|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
21263725|NCT01774344|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21248656|NCT04369664|NYU Langone Health|Jeffrey Berger, MD|212-263-4004|jeffrey.berger@nyulangone.org|
21295136|NCT02725879|2nd Department of Paediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, AHEPA University Hospital, 54636 Thessaloniki,|Professor Assimina Galli-Tsinopoulou|+302310994802|agalli@auth.gr|
21248657|NCT06149416|Stryker Sustainability Solutions|Senior Principal Regulatory Affairs|5602-410-0204|moira.barton@stryker.com|
21248658|NCT04173000|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
21248659|NCT01668355|VA|Alexander Young|310-794-7219|alexander.young@va.gov|
21248660|NCT00535626|Stryker Orthopedics|Director, Clinical Operations|201-831-5401|ellen.axelson@stryker.com|
21248661|NCT02830893|University of California Irvine|Dr. Steven Cramer|(949) 824-8423|SCCramer@mednet.ucla.edu|
21248662|NCT01277302|Genentech, Inc.|Medical Communications|800 821-8590||
21263726|NCT03546413|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21248663|NCT02710669|Vanderbilt University Medical Center|Benjamin Shoemaker, MD|615-322-2318|moore.b.shoemaker@vumc.org|
21263727|NCT01157416|Tulane University School of Medicine|Dr. Michael Scheeringa|5046692322|mscheer@tulane.edu|
21248664|NCT01386632|Sanford Clinical Research|Dr. Steven Powell|605-328-8000|patientquestionsSHDCA@sanfordhealth.org|
21263728|NCT04866303|University of Washington|Clinical Trial Manager|2066169195|cgregor2@uw.edu|
21248665|NCT01567852|University of NewMexico|Dr. Tony Yen|505-272-2610|tyen@salud.unm.edu|
21248666|NCT03332589|Spirita Oncology, LLC|Chief Development Officer|+1 (713) 898-8965|linda.paradiso@spiritaoncology.com|
21263729|NCT00436566|Mayo Clinic|Dr. Edith A. Perez|507-266-0800|perez.edith@mayo.edu|
21248667|NCT04633200|Environment and Health Group|Patricia Flynn Weitzman|617-455-5976|pat.weitzman@gmail.com|
21248668|NCT03690219|Rehabilitation Research Laboratory, University of Applied Sciences and Arts of Southern Switzerland (SUPSI)|Dr Ron Clijsen|0041 81 300 01 78|ron.clijsen@supsi.ch|
21248669|NCT01523392|AstraZeneca|Tomas LG Andersson, MD, PhD|1-800-236-9933|ClinicalTrialTransparency@astrazeneca.com|
21248670|NCT04809623|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21248671|NCT02002689|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
21248672|NCT02354417|Fate Therapeutics, Inc.|Chris Storgard, Chief Medical Officer|866-875-1833|chris.storgard@fatetherapeutics.com|
21248673|NCT02092285|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21263730|NCT04507867|Universidad Anáhuac México Norte|Dr. Fernando Leal Martínez|+52 5521094339|ferman5@hotmail.com|
21248674|NCT00087516|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21248675|NCT01719172|Covidien|Julie Totten|781-839-1729|Julie.Totten@Covidien.com|
21248676|NCT05062161|Columbia University Medical Center|Marwah Abdalla|212 342 1275|ma2947@cumc.columbia.edu|
21263731|NCT01515995|UT Southwestern Medical Center|Mohamed Badawy, MD|2144567106|mohamed.badawy@utsouthwestern.edu|
21248677|NCT02236611|GlaxoSmithKline|GSK Response Center|866-435-7343||
21248678|NCT01332266|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
21248679|NCT03302091|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21248680|NCT00486954|GlaxoSmithKline|GSK Response Center|866-435-7343||
21248681|NCT02822599|Nicklaus Children's Hospital|Jenny Esteves|786-624-2854|jenny.esteves@nicklaushealth.org|
21248682|NCT03316170|University of Kentucky|Dr. Jessica Burris|+1 859-257-9612|jessica.burris@uky.edu|
21248683|NCT02935673|Janssen Research & Development, LLC|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21263732|NCT01860534|University of Texas medical Branch, Galveston|Dr. Cara Geary|409-772-2815|cageary@utmb.edu|
21248684|NCT03054506|Massachusetts General Hospital|Dr. Kyle Staller|617-726-3080|kstaller@mgh.harvard.edu|
21248685|NCT01102426|Pharma Mar, S.A.|Pharma Mar, S.A.|0034918466000|clinicaltrials@pharmamar.com|
21281232|NCT04846569|Brown University|Jennifer Pellowski|4018635453|jennifer_pellowski@brown.edu|
21248686|NCT02580799|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21248687|NCT04806100|The University of Iowa|Jason M Wilken, PT, PhD|319-335-6857|jason-wilken@uiowa.edu|
21248688|NCT03150758|Cleveland Clinic|Dr. Eric Klein|1-800-223-2273|CancerCenterResearch@ccf.org|
21248689|NCT02233998|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
21248690|NCT01262456|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21248691|NCT03938272|OxThera|Chief Operating Officer|0046 86600223|elisabeth.lindner@oxthera.com|
21248692|NCT02074384|Park Nicollet Institute|Dr. Deborah Mullen|952-993-2070|deborah.mullen@parknicollet.com|
21248693|NCT03897699|University of Minnesota|Dr. Kathryn Cullen|612-273-9732|rega0026@umn.edu|
21248694|NCT02110381|University of Michigan|Dr. Elizabeth Jackson|734-998-7411|lisjacks@med.umich.edu|
21248695|NCT04821271|National Institute of Mental Health|Zarate, Carlos|+1 301 451 0861|zaratec@mail.nih.gov|
21248696|NCT03241810|Elevation oncology|VP, Clinical Operations|+1-716 371 1125|clinical@elevationoncology.com|
21248697|NCT05640167|University of Rhode Island|Dr Christine Clarkin, Principal Investigator|4018742998|chrisclarkin@uri.edu|
21248698|NCT02521493|Children's Oncology Group|Results Reporting Coordinator|6264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21248699|NCT04083781|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21248700|NCT01263496|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
21248701|NCT01450397|Hospital for Special Surgery|Scott W. Wolfe|212-606-1529|WolfeS@hss.edu|
21248702|NCT02203032|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
21248703|NCT02241785|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21248704|NCT01640340|Ohio State University Medical Center|Rachel Layman, MD|614-293-0066|Rachel.Layman@osumc.edu|
21248705|NCT03905642|Insmed Incorporated|Kevin Mange (Senior VP, Clinical Development and Medical Affairs)|908-947-2651|kevin.mange@insmed.com|
21248706|NCT06716632|Gulab Devi Hospital, Lahore|Dr. Zain Himayoun|03043862033|Zain.1080@gmail.com|
21248707|NCT05289037|The Hope Clinic of Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
21248708|NCT05995977|Karaman Provincial Health Directorate|Handan Altunkan|05367443152|handanaltunkan@gmail.com|
21248709|NCT04937504|Boston Medical Center, Psychiatry Department|Sarah Valentine, PhD|(617) 414-1989|sarah.valentine@bmc.org|
21248710|NCT04025125|Duke University|Gerald Bloomfield|919-668-8702|gerald.bloomfield@duke.edu|
21248711|NCT06922643|Nanogen Biopharmaceutical JSC|Dr. Thuy Phuong Nguyen|+84 903 754 559|phuongthuy@nanogenpharma.com|
21281233|NCT02512302|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
21281234|NCT01174823|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
21281235|NCT00683618|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21248712|NCT06943638|"General Oncology Hospital of Kifissia Agioi Anargyroi"|Christine Mavrogiannopoulou, Physiotherapist and Study coordinator|+30 6941464095|x.mavrogiannopoulou@gmail.com|
21248713|NCT04852978|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|18447346643|clinicaltrials@regeneron.com|
21248714|NCT05992350|Children's Mercy Research Institute|Priscilla Connell|8166014543|Endocrine-RisingT1deAlliance@cmh.edu|
21248715|NCT02421679|Tonix Pharmaceuticals|Gregory M. Sullivan, Chief Medical Officer|862-904-0355|greg.sullivan@tonixpharma.com|
21248716|NCT01458015|Universitätsklinikum Schleswig-Holstein, Campus Kiel; Sektion neurologische Schmerzforschung und -therapie|Prof. Ralf Baron|+4943123911|r.baron@neurologie.uni-kiel.de|
21248717|NCT00070707|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21248718|NCT01808534|IndianaU|Dr. Lawrence H. Einhorn|(317)274-3515|leinhorn@iu.edu|
21248719|NCT02494076|University Colorado School of Medicine, Chidren's Hospital Colorado|Nidhya Navanandan, MD|847-636-0817|nidhya.navanandan@childrenscolorado.org|
21248720|NCT00278395|University of Texas Health Science Center at San Antonio|Dr. John Sarantopoulos|210-450-1000|sarantopoulo@uthscsa.edu|
21248721|NCT01148017|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
21248722|NCT03740737|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
21248723|NCT01212822|Fox Chase Cancer Center|Protocol Development Coordinator|215-728-4097|ryan.romasko@fccc.edu|
21248724|NCT00569166|Mayo Clinic|Dr. Amit Sood|507-538-7623|sood.amit@mayo.edu|8-7623
21248725|NCT01686152|Teva Pharmaceuticals USA|Director, PD/CE Studies|1-888-483-8279|usmedinfo@tevapharm.com|
21248726|NCT01853384|Smith & Nephew, Inc|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
21248727|NCT00929526|GlaxoSmithKline|GSK Response Center|866-435-7343||
21248728|NCT00996164|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
21248729|NCT02169414|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21248730|NCT00321971|Duquesne University School of Nursing|Linda Garand PhD|412-396-6543|garandl@duq.edu|
21248731|NCT03374254|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
21248732|NCT04070105|University of Michigan|Dr. Deanna Gates|7346472698|gatesd@umich.edu|
21248733|NCT02395692|ABTC|Sr. Research Program Manager|410-955-8837|ABTC@jhmi.edu|
21248734|NCT00749944|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21248735|NCT02547974|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21248736|NCT00923078|VA Connecticut Healthcare System|Dr Jason K. Johannesen|2039325711|jason.johannesen@va.gov|2224
21248737|NCT01513902|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21248738|NCT01072149|GlaxoSmithKline|GSK Response Center|866-435-7343||
21248739|NCT02143713|AbbVie|Global Medical Services|800-633-9110||
21248740|NCT01768572|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21248741|NCT04264156|Windtree Therapeutics, Inc.|Executive Director of Biostatistics & Data Management|2154889300|psimmons@windtreetx.com|
21248742|NCT02245620|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
21248743|NCT01999335|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21248744|NCT04766996|Emory University|Kelly Wiltse Nicely, MD|404-727-6946|kelly.wiltse.nicely@emory.edu|
21248745|NCT00080119|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
21248746|NCT01322386|Stanford University|Kenneth L Cox, MD / Principal Investigator|650-723-5070|KCox@stanfordchildrens.org|
21248747|NCT00949234|UCLA CARE Center|Dr. Raphael Landovitz|310-557-1891|rlandovitz@mednet.ucla.edu|
21248748|NCT00950235|Kaiser Permanente Center for Health Research|Victor J. Stevens, PhD Principle Investigator|503 335 6751|victor.j.stevens@kpchr.org|
21248749|NCT00508183|Ottawa Hospital Research Institute|Dr. Peter Lapner|613-737-8899|plapner@toh.ca|74700
21248750|NCT03785756|Reckitt Benckiser (Health) Limited|Clinical Project Manager|+44 1482 326151|clinicaldatacontroller@reckitt.com|
21248751|NCT05228834|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21248752|NCT00871494|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21248753|NCT02637999|MYR GmbH|Dr. med. Alexander Alexandrov|+491777168259|alexandrov@myr-pharma.com|
21248754|NCT00889863|Novartis Pharmaceuticals|Study Director|862-778-8300||
21248755|NCT00564447|Inspire Pharmaceuticals, Inc.|Director of Clinical Research|010-941-9777|kkuhn@inspirepharm.com|
21248756|NCT04410445|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
21248757|NCT03879538|Cleveland Clinic|Alparslan Turan|2162172312|turana@ccf.org|
21248758|NCT03082313|University of Southern California|Beth Smith|13234424072|beth.smith@usc.edu|
21248759|NCT02336958|Helios Kliniken Schwerin|Dr. med. Ronald Seidel|0049 (0)385 5204251|ronald.seidel@helios-kliniken.de|
21248760|NCT03547154|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21248761|NCT02988713|Boston Scientific|Director, Clinical Sciences and Scientific Communication|855-213-9890|BSNClinicalTrials@bsci.com|
21248762|NCT03265132|Swedish Orphan Biovitrum|Kineret Clinical Program Leader|+46(8)6972000|info@sobi.com|
21248763|NCT05012462|Zynex Monitoring Solutions|ZMS Clinical|800-495-6670|clinical@zynexmonitoring.com|
21248764|NCT04884191|CTI BioPharma, Inc.|John Volpone SVP, Strategic Operations|+1 (206) 272-4652|jvolpone@ctibiopharma.com|
21248765|NCT00666705|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21248766|NCT02065609|Washington University School of Medicine in St. Louis|Dr. Farrokh Dehdashti|314-362-1474|dehdashtif@wustl.edu|
21248767|NCT03259568|Dept of Neurology, Duke University School of Medicine|Simon W Davis|9195991927|simon.davis@duke.edu|
21248768|NCT01976507|Vanderbilt University Medical Center|Christopher Ellis||christopher.ellis@Vanderbilt.Edu|
21248769|NCT00022490|OHSU Knight Cancer Institute|Dr. Brian Druker|(503) 494 5596|drukerb@ohsu.edu|
21248770|NCT01029704|Theracos, Inc.|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
21248771|NCT03845517|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21263733|NCT00301028|UT MD Anderson Cancer Center|Merrill S. Kies, MD / Professor||CR_Study_Registration@mdanderson.org|
21248772|NCT01109979|Brigham and Women's Hospital|Ellen Seely, MD|617-732-5012|eseely@partners.org|
21263734|NCT00502320|Lehigh Valley Hospital|Edward R. Norris, MD|610-402-5766|Edward.Norris@lvh.com|
21248773|NCT02161458|University of Pennsylvania|Yvette Sheline, Principal Investigator|215-746-2637|cndslab@pennmedicine.upenn.edu|
21263735|NCT04732819|Hebrew SeniorLife|Sarah Berry, MD|617-971-5355|sarahberry@hsl.harvard.edu|
21248774|NCT00201825|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii-Saab, MD|614-293-6529|Tanios.Saab@osumc.edu|
21263736|NCT02124707|UNC Lineberger Comprehensive Cancer Center|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
21248775|NCT03136861|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21263737|NCT00677690|Fondazione Salvatore Maugeri, IRCCS, Pavia, Italy|Ercole Zanotti|39 385 247|ercole.zanotti@fsm.it|324
21248776|NCT03390166|Mahidol|Punnee Pitisuttithum|6626435599|punnee.pit@mahidol.ac.th|
21248777|NCT03125148|Medical College of Wisconsin|Kulwinder Dua, MD|4149556896|kdua@mcw.edu|
21248778|NCT00274287|Oncology Specialists, S.C.|Chadi Nabhan, MD|847-268-8200|cnabhan@oncmed.net|
21263738|NCT01202721|Population Health Research Institute|Dr. Tara McCready, Program Director||tara.mccready@phri.ca|
21248779|NCT00186446|Stanford University|aimee-noelle swanson|650-736-4559|aimnoe@stanford.edu|
21248780|NCT03292692|University of Miami|Dr. Brian Doss|305-284-1101|bdoss@miami.edu|
21248781|NCT01880736|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21263739|NCT02740504|ResMed|Paul Phillips|+447789633508|paul.phillips@resmed.com|
21248782|NCT01706666|Mayo Clinic Cancer Center|Craig B Reeder, MD|4803018335|Reeder.Craig@mayo.edu|
21263740|NCT00555048|Fred Hutchinson Cancer Research Center|Ann Woolfrey, MD|206-667-4453|awoolfre@fredhutch.org|
21251361|NCT03990298|Hospital of the University of Pennsylvania, Dept of Otorhinolaryngology, Head & Neck Surgery|Erica Thaler, MD|215-662-4533|erica.thaler@pennmedicine.upenn.edu|
21251362|NCT02023905|University of California, San Francisco|Dr. Jennifer Clarke, MD MPH|(415) 353-2167|Jennifer.Clarke@ucsf.edu|
21263741|NCT02196038|Wake Forest School of Medicine|Dr. Dalane Kitzman|336-716-3274|dkitzman@wakehealth.edu|
21251363|NCT01313624|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21251364|NCT01017263|Duke UMC|Scott Kollins, PhD|9196810014|scott.kollins@dm.duke.edu|
21251365|NCT02980705|Sun Pharma Advanced Research Company Limited|Dr Mudgal Kothekar|912266455645|clinical.trials@sparcmail.com|
21251366|NCT01721746|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
21251367|NCT00263575|Strakan Pharmaceuticals Ltd|Fiona Miller|01896 66868|fiona.miller@prostrakan.com|
21251368|NCT03849768|Jiangsu Hansoh Pharmaceutical Group Co., Ltd.|Alison Li|86-21-51211850|Alison.li@hspharm.com|
21251369|NCT02447718|IWK Health Centre|Dr. Karina Top|902-470-6343|karina.top@dal.ca|
21251370|NCT00239681|AstraZeneca|Torbjorn Lundstrom||ClinicalTrialTransparency@astrazeneca.com|
21251371|NCT03121612|Arnolda Consulting|Dr Gaston Arnolda|+61 2 8068 4963|gaston.arnolda@gmail.com|
21251372|NCT02654132|Bristol Myers-Squibb|Bristol Myers-Squibb Study Director|Please email|Clinical.Trials@bms.com|
21251373|NCT03467698|UT Dallas|UT Dallas IRB DIrector|972-883-4506|amanda.boone@utdallas.edu|
21263742|NCT01580592|Charité - University of Berlin; Dpt. of Dermatology and Allergy|Professor Dr. Martin Metz|+49 30 450 518 159|martin.metz@charite.de|
21251374|NCT01305473|C.R. Bard: Davol, Inc.|Dawn Heimer/Director, Clinical Affairs|401-825-8681|dawn.heimer@crbard.com|
21251375|NCT01781832|Cincinnati Children's Hospital Medical Center|Ethan Smith, MD|513 636-4200|Ethan.Smith@cchmc.org|
21251376|NCT00358007|Thomas Jefferson University|Pramila Rani Anne, MD|215-955-6702|Pramila.Anne@jefferson.edu|
21251377|NCT03772613|Mayo Clinic|Dr. Shahyar M. Gharacholou|904-956-8400|Gharacholou.Shahyar@mayo.edu|
21251378|NCT03536702|MS Hershey Medical Center|Monika Joshi, MD, MRCP|717-531-8678|muj14@psu.edu|
21263743|NCT01151579|Genesys Regional Medical Center|Dr. Fahim Khorfan|810-606-7722|kbarber@genesys.org|
21251379|NCT01185171|University of Chicago Medicine and Biological Sciences|Dr Everett Vokes, MD|855-702-8222|evokes@medicine.bsd.uchicago.edu|
21251380|NCT01482429|Federal University of Uberlândia|Liliane Barbosa da Silva Passos|553432182150|lilibsp@yahoo.com.br|
21251381|NCT01729845|Fred Hutch Cancer Research Center|Dr. Anna Halpern|2066676233|halpern2@uw.edu|206
21251382|NCT03561597|KKWCH|Dr Chew Chu Shan Elaine|63946042|elaine.chew.c.s@singhealth.com.sg|
21251383|NCT00573651|The MetroHealth System|Nora G Singer|216-778-2138|nsinger@metrohealth.org|
21251384|NCT03506347|Mayo Clinic|Dr. Mark Spangehl|480-342-2948|Spangehl.Mark@mayo.edu|
21263744|NCT00790738|The Zucker Hillside Hospital|Raphael J. Braga, MD|718-4708060|rbraga@nshs.edu|
21251385|NCT03783546|Dana-Farber Cancer Institute|Weidong Lu, MB, MPh, PhD|617-632-3322|weidong_lu@dfci.harvard.edu|
21251386|NCT05275023|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21251387|NCT01437488|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Jean Hoffman-Censits|215 955-8874|jean.hoffman-censits@jefferson.edu|
21263745|NCT01098461|GlaxoSmithKline|GSK Response Center|866-435-7343||
21295137|NCT02868034|University of Utah|Julie Fritz|18015872237|julie.fritz@utah.edu|
21295138|NCT01451931|University of California, San Francisco|Dr. Rebecca Smith-Bindman|415-353-4946|rebecca.smith-bindman@ucsf.edu|
21295139|NCT01431014|Chang Gung Memorial Hospital|Lun-Jou Lo, MD,Hye-Young Kim, MD||lunjoulo@cgmh.org.tw|
21251388|NCT04562896|The University of Iowa|Jason M. Wilken, PT, PhD|319-335-6857|jason-wilken@uiowa.edu|
21251389|NCT06124131|Tulane University|Laura Perry|504-988-8906|lperry5@tulane.edu|
21251390|NCT03797989|University of Oxford|Dr. Angela Minassian|07973684040|angela.minassian@bioch.ox.ac.uk|
21251391|NCT04052997|ADC Therapeutics SA|Clinical Trials Information|954-903-7994|clinical.trials@adctherapeutics.com|954
21248783|NCT00747149|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21248784|NCT03840200|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21248785|NCT04995601|Recovery Force Health, University of Massachusetts Amherst|Jeff Schwegman (PI), Dr. Karen Giuliano (PI, clinical trial subaward)|317-605-4696; 224-725-0270|kschwegman@recoveryforceusa.com; kkgiuliano@umass.edu|
21248786|NCT02196259|University of Michigan|Dr. Scott Peltier|734-647-8077|spelt@umich.edu|
21248787|NCT00443820|Novartis Pharmaceuticals|Study Director|862-778-8300||
21248788|NCT02507297|University of Michigan|Leslie Swanson|734-764-2242|lmswan@umich.edu|
21248789|NCT02489799|The Johns Hopkins University School of Medicine|Rebecca Aslakson, M.D., Ph.D.|410-955-9082|raslaks1@jhmi.edu|
21248790|NCT05139615|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21248791|NCT03462966|Cedars-Sinai medical center|Mohamad Rashid|310-423-0617|mohamad.rashid@cshs.org|
21248792|NCT04669366|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21248793|NCT01304940|VA ORD|Suzanne Pineles|857-364-5906|suzanne.pineles@va.gov|
21248794|NCT02132520|University of Minnesota|Bin He|612-626-1115|binhe@umn.edu|
21248795|NCT04311983|Washington University School of Medicine|Matthew Kreuter, Ph.D.|314-935-3701|mkreuter@wustl.edu|
21281236|NCT02954601|Oramed|Chief Scientific Officer|+972-2-566-0001|miriam@oramed.com|
21248796|NCT01205126|Janssen Research & Development, LLC|Director, Established Products|+1 609 730 3387;||
21248797|NCT00578344|Baylor College of Medicine/Texas Children's Hospital|Dr. Tami D. John|832-824-4723|tdjohn@texaschildrens.org|
21248798|NCT04803734|Intech Biopharm Ltd.|Sabina Chien|+886-2-7721-8877|sabina.i198@intechbiopharm.com|631
21248799|NCT00667953|Penn|Tara C Mitchell|215-662-4000|Tara.Mitchell@pennmedicine.upenn.edu|
21248800|NCT02309515|Mayo Clinic|Tait D. Shanafelt, MD|507.284.2511|shanafelt.tait@mayo.edu|
21248801|NCT02605876|University of North Carolina at Chapel Hill|Troy Blackburn|9198432021|troyb@email.unc.edu|
21248802|NCT00239642|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|601-650-4200|mfalone@luitpold.com|
21248803|NCT04026256|Massachusetts General Hospital|Benjamin Leder|617-724-2039|bzleder@mgh.harvard.edu|
21248804|NCT00854594|Louis Stokes VA Medical Center|Jeneen Shell-Boyd|(216) 791-2300|Jeneen.shell-boyd@va.gov|5831
21248805|NCT02784834|UC San Diego|Dr. Michael Choi|(858) 534-1765|mychoi@ucsd.edu|
21248806|NCT01062165|Texas Tech UHSC|Ronald Hall|214-654-9404|ronald.hall@ttuhsc.edu|
21248807|NCT03800563|Alma Lasers|Dr Meital Grafi-Cohen|+972-523708780|meital.grafi@almalasers.co.il|
21248808|NCT01163214|Mayo Clinic|Mark J. Spangehl, M.D.|480-342-2377|spangehl.mark@mayo.edu|
21248809|NCT01090739|University of Michigan, Professor of Obstetrics and Gynecology|Dee Fenner, MD, Study Coordinating Investigator|734-647-5866|deef@med.umich.edu|
21248810|NCT00441168|Jan-Cilag Germany|EMEA Medical Affairs Director Oncology|+49 2137 955-492|rangermu@its.jnj.com|
21248811|NCT00825318|St. Luke's-Roosevelt Hospital Center|James Jones, MD|2125233530|JaJones@chpnet.org|
21248812|NCT02404441|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21281237|NCT01775813|University of Colorado School of Medicine|Dr. Megan Kelsey|720-777-0991|megan.kelsey@childrenscolorado.org|
21248813|NCT01918033|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21248814|NCT01338506|Medical University of South Carolina|Dr. Sudie Back|843-792-9383|backs@musc.edu|
21248815|NCT00529204|University of California Davis Medical Center|Christopher L. Bowlus, MD|916-734-8986|chris.bowlus@ucdmc.ucdavis.edu|
21248816|NCT01702259|Surgeon's Inc.|Dr. Robert F. Jackson|765-662-8303|rjlipodr@comteck.com|
21248817|NCT03909100|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21248818|NCT00088166|Celtic Pharma Development Services America Inc|Patrick O'Connor, MD, Managing Director Clinical Development|212-616-4050|patrick.oconnor@dev.celticpharma.com|
21248819|NCT02671266|Massachusetts General Hospital/Harvard Medical School|Dr. Angela Fang|617-643-7717|afang@mgh.harvard.edu|
21248820|NCT02538094|Johns Hopkins University SOM|Dr. Tracy Vannorsdall|4105023701|TVannor1@jhmi.edu|
21248821|NCT03803475|University of California, San Francisco|Dr. Thomas Hope, MD|(415) 221-4810|Thomas.Hope@ucsf.edu|
21248822|NCT00309751|Kowa Research Institute Inc|Bill Arana|919 433 1600|barana@kowaus.com|
21248823|NCT02807857|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21248824|NCT03530631|University of Alabama, Birmingham|Karen Cropsey|(205) 975-7809|kcropsey@uabmc.edu|
21248825|NCT00513071|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
21248826|NCT00286325|Duke University Medical Center|Dr. Russell P Hall|919-684-3110|hall0009@mc.duke.edu|
21248827|NCT00667732|Oregon Health and Science University|Dr. Matthew Riddle|503-494-0557|riddlem@ohsu.edu|
21248828|NCT01213940|University of South Alabama, Department of Surgery|William O. Richards, MD|251-471-7993|brichards@health.southalabama.edu|
21248829|NCT02106325|New York University School of Medicine|Stephen Ross, MD/ Principal Investigator|212 562 4097|Stephen.Ross@nyumc.org|
21248830|NCT02656199|Albert Einstein Healthcare Network|Roberta Costello; Research Compliance|215-456-7225|bcostell@einstein.edu|
21248831|NCT00452114|University of Massachusetts Medical School|Stephen Krinzman, Principal Investigator|508-856-1975|stephen.krinzman@umassmed.edu|
21248832|NCT04197713|University of M D Anderson Cancer Center|Dr. Timothy Yap|713) 563-1784|tyap@mdanderson.org|
21248833|NCT03242863|Laboratory for the Study of Human Ingestive Behavior, The Pennsylvania State University|Dr. Barbara J. Rolls|814-863-8481|bjr4@psu.edu|
21248834|NCT05940688|University of Alabama at Birmingham|Dr. Rachel Sinkey|(205) 934-5612|rsinkey@uabmc.edu|
21248835|NCT03365622|University of Rochester Medical Center|Joseph Dooley, MD|5852752141|joseph_dooley@urmc.rochester.edu|
21248836|NCT07016568|LLC UkrMedGroup|Yevheniia Poliakova|+380502818399|jenyapolyakova@gmail.com|
21248837|NCT05376449|HealthPartners Institute Neuroscience Research Center|Amanda Herrmann, PhD|651-495-6363|Amanda.A.Herrmann@HealthPartners.com|
21281238|NCT05251337|Indiana University Health|Alyson Keen|3173413060|akeen2@iuhealth.org|
21248838|NCT06164743|VivaVisionBio|Dr. Joanne Li|(86) 021-58598290|joanne.li@vivavisionbio.com|
21248839|NCT05338476|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21248840|NCT00210236|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Palissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
21295140|NCT04283942|Zhongshan Hospital, Fudan University|Dr. Hua Bian|+86 64041990|zhongshan_bh@126.com|
21248841|NCT02831049|National Institute on Drug Abuse (NIDA)|Dr David Epstein|1-667-312-5092|david.epstein@nih.gov|
21295141|NCT00230282|Stanford University|Steven E. Coutre, Associate Professor of Medicine|650-723-6661|coutre@stanford.edu|
21248842|NCT03786471|University of California Los Angeles|Jenny Summapund|3233660667|jsummapund@mednet.ucla.edu|
21248843|NCT03346200|KARMA project, Karolinska Institute|PI Professor MD Per Hall|+46 8 524 85000|Per.hall@ki.se|
21295142|NCT01459653|Sandoz GmBH|Andriy Krendyukov, Global Medical Director|+49 8024 4764855|andriy.krendyukov@sandoz.com|
21248844|NCT00215943|H. Lee Moffitt Cancer Center and Research Institute|Melissa Alsina, M.D.|813-745-6886|melissa.alsina@moffitt.org|
21295143|NCT01369680|Medical University of South Carolina|Dr. Amy-Lee Bredlau|843-792-2957|bredlau@musc.edu|62872
21248845|NCT04205669|CERMEL|Julian Matthewman|00241 07-98-91-91|julianmatthewman@gmail.com|
21248846|NCT03137784|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21248847|NCT00805792|Mayo Clinic|James F. Meschia, MD|904-953-2903|meschia.james@mayo.edu|
21248848|NCT00630409|University of Pittsburgh|Leonard Appleman, MD, PhD|412-648-6538|applemanlj@upmc.edu|
21248849|NCT02165202|PATH|Heather Kelly|650-392-2510|hkelly@path.org|
21248850|NCT01689740|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
21248851|NCT01773707|Yale University|Dr. Kevan Herold|203-785-6507|Kevan.Herold@Yale.edu|
21248852|NCT01420328|Division of Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo, 462 Grider St, Buffalo, NY 14215, USA|Dr. Husam Ghanim|7169574325|ghanim@buffalo.edu|
21248853|NCT00990184|SIBCR|Steven E. Kahn|206-277-5515|skahn@u.washington.edu|
21248854|NCT03835416|Durham VA Medical Center|Dr. Connie Bales, Assoc. Director, GRECC|919-286-0411|connie.bales@va.gov|6780
21248855|NCT02753075|GlaxoSmithKline|GSK Response Center|866-435-7343||
21248856|NCT02152384|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21248857|NCT00823966|Pfizer, Inc.|Pfizer ClinicalTraials.gov Call Center|1-800-718-1021|ClinicalTraials.govCallCenter@pfizer.com|
21248858|NCT04471805|University of Iowa, Department of Health and Human Physiology|Thorsten Rudroff, PhD|(319)467-0363|thorsten-rudroff@uiowa.edu|
21248859|NCT01215253|University of Rochester|Wojciech Zareba|585-275-5391|wojciech.zareba@heart.rochester.edu|
21248860|NCT01320683|City of Hope|Paul Frankel, Ph.D.|626-256-4673|pfrankel@coh.org|65265
21248861|NCT02291861|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21248862|NCT01828476|Rutgers Cancer Institute of New Jersey|Mark Stein, MD|732-235-5773|steinmn@cinj.rutgers.edu|
21248863|NCT00267956|Centocor Research & Development, Inc|Senior Director Clinical Research|1-800-457-6399||
21248864|NCT01263223|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21248865|NCT04332991|Mass General Hopsital (PETAL Network Coordinating Center)|B.Taylor Thompson, MD|617-726-8854|TTHOMPSON1@mgh.harvard.edu|
21248866|NCT02005484|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21248867|NCT02246647|Mayo Clinic|Madhusudan Grover, MBBS|507-253-5384|Grover.Madhusudan@mayo.edu|
21248868|NCT01393964|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21248869|NCT01113541|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21248870|NCT04405180|University of Pittsburgh|Dr. Daniel Forman|412-864-2507|formand@pitt.edu|
21248871|NCT04679675|Kaiser Permanente Washington Health Research Institute|Dr. Beverly Green|206-220-2997|bev.b.green@kp.org|
21248872|NCT02802111|Children's Hospital Los Angeles|Dr. Patrick Ross|323-361-7864|pross@chla.usc.edu|
21248873|NCT02424968|Stanford University|Robert Lowsky, Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)|650-723-0822|rlowsky@stanford.edu|
21248874|NCT01762982|GlaxoSmithKline|GSK Response Center|866-435-7343||
21248875|NCT01794299|Kiadis Pharma Netherlands B.V.|Andrew Sandler, MD / Chief Medical Officer|+1 206 779 9213|a.sandler@kiadis.com|
21248876|NCT03006393|Emory University|Dr. Michael Treadway|(404) 727-3166|mtreadway@emory.edu|
21248877|NCT03500406|Mayo Clinic|Dr. Landon Trost|507-284-3728|Trost.Landon@mayo.edu|
21248878|NCT00807599|Memorial Sloan Kettering Cancer Center|Dr. Hani Hassoun, MD|212-639-3228|hassounh@mskcc.org|
21248879|NCT03695185|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21248880|NCT05919732|Nemours|Dr. Gohalem Felema|904-416-5430|gohalem.felema@nemours.org|
21248881|NCT01735214|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21248882|NCT01328756|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21251392|NCT04594733|MUSC|Research Coordinator|843-792-1869|nitchie@musc.edu|
21251393|NCT02657954|VA San Diego Healthcare System|Dr Elizabeth Twamley|858-642-3848|elizabeth.twamley@va.gov|
21251394|NCT01145547|Legacy Health System|W. Kenneth Ward|503-413-5171|kenward503@msn.com|
21251395|NCT01024036|Janssen R&D US|DIRECTOR CLINICAL RESEARCH||ClinicalTrialDisclosure@its.jnj.com|
21251396|NCT03459612|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
21251397|NCT01251887|NIAAA/NIA|Ramsden, Christopher|+1 410 558 8369|ramsdence@mail.nih.gov|
21251398|NCT04811339|University of Cincinnati|Dr. Bruce Yacyshyn|513-633-8715|yacyshbr@ucmail.uc.edu|
21251399|NCT05896696|A.Stein Regulatory Affairs Consulting Ltd.|Ahava Stein|+972-9-7670002|ahava@asteinrac.com|
21251400|NCT02531867|Alexion|Medical Director|(781) 357-9900|clinicaltrials@alexion.com|
21251401|NCT01131104|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21251402|NCT04523207|Janssen Research & Development, LLC|Group Medical Director Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21248883|NCT00257309|Centro Nacional de Investigaciones Cardiovasculares|Héctor Bueno|(+34) 914 531 200|hbueno@cnic.es|4110
21248884|NCT04144088|Chung Shan Medical University Hospital|Dr. Cheng Chung Wei|+886-4-24739595|wei3228@gmail.com|34718
21281239|NCT03334435|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
21248885|NCT04183491|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.Strauss@fda.hhs.gov|
21248886|NCT03288506|Queen's University Belfast|Dr Paul Best|0289097|p.best@qub.ac.uk|3256
21248887|NCT03692871|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21248888|NCT00257894|Veterans Affairs Medical Center (VAMC), Providence|Damaris J. Rohsenow, Ph.D.|401-863-6648|damaris.rohsenow@va.gov|
21248889|NCT02852824|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21248890|NCT01316913|GlaxoSmithKline|GSK Response Center|866-435-7343||
21248891|NCT01860079|AcibademU|Prof.Dr.Şevket Görgülü|+902623174444|sevket5@yahoo.com|4123
21248892|NCT04867382|HealthPartners Institute|Stephanie Hooker, PhD, MPH, MS, Principal Investigator|(952) 967-5056|Stephanie.A.HookerShowalter@HealthPartners.com|
21248893|NCT02102724|Rush University College of Nursing|Barbara Swanson|3129428977|BARBARA_A_SWANSON@RUSH.EDU|
21248894|NCT05445557|Raziel Therapeutics|Racheli Gueta, Director of Clinical Trials|97289124670|racheli@raziel-therapy.com|
21248895|NCT02008916|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21248896|NCT01323790|AstraZeneca|Mark Sostek||ClinicalTrialTransparency@astrazeneca.com|
21248897|NCT00046475|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21248898|NCT05011292|Emory University|Dr. Jean Welsh|404-375-1165|jwelsh1@emory.edu|
21248899|NCT00266656|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21248900|NCT04063124|UT Health San Antonio|Mitzi Gonzales, PhD|210-450-9047|Gonzalesm20@uthscsa.edu|
21248901|NCT02915783|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21248902|NCT02950961|VA Greater Los Angeles Healthcare System, West Los Angeles, CA|Alison B Hamilton, PhD MPH|(310) 478-3711|alison.hamilton@va.gov|44157
21248903|NCT01971255|National Institute of Allergy and Infectious Diseases|Matthew James Memoli|+1 301 443 5971|memolim@niaid.nih.gov|
21248904|NCT01915914|GlaxoSmithKline|GSK Response Center|866-435-7343||
21248905|NCT00145145|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21248906|NCT00428714|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21248907|NCT02432274|Eisai Ltd.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21248908|NCT01736475|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21248909|NCT01479010|Virginia Commonwealth University|Benjamin Van Tassell, PharmD|8048284583|bvantassell@vcu.edu|
21248910|NCT02114515|University of Illinois at Chicago|Jerry A. Krishnan, MD, PhD|312-413-3291|partner@uic.edu|
21248911|NCT01513447|Northwestern University Feinberg School of Medicine|Cynthia A. Wong, M.D.|312-472-3585|c-wong2@northwestern.edu|
21248912|NCT02534129|ProTechSure Scientific Inc.|L. Michael Glode, MD|303-526-9031|mike.glode@ucdenver.edu|
21248913|NCT05522777|Yakult U.S.A. Inc|Hideyuki Shibata|714-434-6500|hideyuki.shibata@yakultusa.com|
21248914|NCT05489770|EKHUFT|Dr Jane Povey- Research Facilitator|01227766877|jane.povey2@nhs.net|
21248915|NCT05487300|University of Utah|Dr. Guillaume Lamotte|801-585-7575|guillaume.lamotte@hsc.utah.edu|
21248916|NCT03141177|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
21248917|NCT05006703|University Hospital Southampton|Professor Graham Roberts|02381 204335|g.c.roberts@soton.ac.uk|
21248918|NCT03565640|Atrium Wake Forest Baptist Health|Sachin Vyas|7865564412|svyas@wakehealth.edu|
21248919|NCT03854734|Penn State College of Medicine|Dr. Jennifer Kraschnewski, Professor of Medicine and Public Health Sciences|717-531-8161|jkraschnewski@pennstatehealth.psu.edu|
21248920|NCT00264576|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21248921|NCT02659059|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21248922|NCT00092456|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21248923|NCT04783389|Connect Biopharma|Dr. Malinda Longphre, PhD, Head of Clinical Operations|+1 510 520 3361|mlongphre@connectpharm.com|
21248924|NCT02121808|Laval University|Jean S. Bussières|418 656-8711|jbuss@criucpq.ulaval.ca|
21248925|NCT00647699|Avedro, Inc.|Vineeta Belanger, VP of Clinical Affairs|781-768-3459|vbelanger@avedro.com|
21248926|NCT04909593|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
21248927|NCT01018992|Emory University|Dr. Boadie Dunlop|404-727-8474|bdunlop@emory.edu|
21248928|NCT01241448|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21248929|NCT04425252|Clear Creek Bio, Inc.|Vice President Clinical Operations|(617) 765-2252|clinical@clearcreekbio.com|
21248930|NCT00307489|Gilead Sciences, Inc.|Stephen J. Rossi, PharmD|650-522-4212|stephen.rossi@gilead.com|
21248931|NCT01825785|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21248932|NCT04721600|Inmode|Maria Shusterman|9057076787|Maria.Shusterman@inmodemd.com|
21248933|NCT01458288|TaiGen Biotechnology Co., Ltd.|Chen-En Tsai, M.D., Ph.D.|+886-2-8177-7072|cetsai@taigenbiotech.com|1211
21248934|NCT00304278|Southern Illinois University|Dr. Krishna Rao|217-545-7969|krao@siumed.edu|
21248935|NCT02065895|Boston Children's Hospital|Garry M. Steil, PhD|617-355-7504|garry.steil@childrens.harvard.edu|
21248936|NCT01053897|Garnet BioTherapeutics, Inc.|Gerri Henwood, CEO|484-395-2440|ghenwood@garnetbio.com|
21248937|NCT03034863|James J Peters VAMC|Marianne Goodman, MD|718-584-9000|Marianne.Goodman@va.gov|5188
21281240|NCT03922321|Immunovant, Inc|Central Study Contact|1-800-797-0414|clinicaltrials@immunovant.com|
21248938|NCT03331978|RAND Corporation|Laura Bogart|3103930411|lbogart@rand.org|7281
21248939|NCT01381549|GlaxoSmithKline|GSK Response Center|866-435-7343||
21281241|NCT01644240|Theravance Biopharma US, Inc.|Dr. Brett Haumann, SVP, Clinical Development|650-808-6000|BHaumann@theravance.com|
21281242|NCT02342678|University of California, San Francisco|Alison Huang, MD|415-514-8697|alison.huang@ucsf.edu|
21248940|NCT02981953|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
21248941|NCT02556606|Michael E. DeBakey VA Medical Center|Marijn Lijffijt, PhD|3618274395|marijn.lijffijt@bcm.edu|
21248942|NCT04785794|FluGen|Pamuk Bilsel, CSO|608-442-6562|pbilsel@flugen.com|
21248943|NCT01655498|Pelvalon|Director of Clinical|650-276-0130||
21248944|NCT00603798|Graceway Pharmaceuticals|Sharon F Levy, MD|267-948-0400|sharon.levy@gracewaypharma.com|
21248945|NCT04540952|Atrium Health|Dr. Paul Marshburn|704-619-2537|Paul.Marshburn@atriumhealth.org|
21281243|NCT06188715|Swiss Tropical and Public Health Institute|Prof Jennifer Keiser|+41 61 284 82 18|jennifer.keiser@swisstph.ch|
21281244|NCT03808948|Charité - Universitätsmedizin Berlin|Prof. Dr. med. Kai Schmidt-Ott|+4930450614671|Kai.schmidt-ott@charite.de|
21281245|NCT03214224|Penn State College of Medicine|Andrew Geronimo|717-531-0003|geronimo@psu.edu|282576
21281246|NCT03566199|University of California, San Francisco|Dr. Sabine Mueller, MD, PhD.|(415) 502-7301|Sabine.Mueller@ucsf.edu|
21281247|NCT03802825|Kaiser Permanente Center for Health Research|Dr. Stephanie L. Fitzpatrick, Senior Investigator|502-345-1476|Stephanie.L.Fitzpatrick@kpchr.org|
21281248|NCT05266053|Indiana University|Dr. Lisa Mims - Principal Investigator|7733074863|lamims@iupui.edu|
21281249|NCT01837901|Okuvision GmbH|Dr. R. Schippert|+49 7121 15935|ruth.schippert@okuvision.de|50
21281250|NCT01051960|University of California, Los Angeles|Rajan Saggar, MD|(310) 794-9718|rsaggar@mednet.ucla.edu|
21281251|NCT00360282|University of Pittsburgh|Joseph M. Furman, MD, PhD|(412) 647-2115|furmanjm@upmc.edu|
21281252|NCT02996968|TriHealth Inc.|Abigail Shatkin-Margolis, MD|513-463-4300|Abigail_Shatkin-margolis@trihealth.com|
21281253|NCT00661557|GlaxoSmithKline|GSK Response Center|866-435-7343||
21281254|NCT04537078|Elshatby University Maternity Hospital|Dr. Aly Hussein|002-0119448000|emam_aly@me.com|
21281255|NCT03396653|University of Connecticut|Zeely Denmat|860-455-3842|zeely.denmat@uconn.edu|
21281256|NCT00444535|Novartis Pharmaceuticals|Clinical Disclosure Office|8620778-8300||
21281257|NCT05005507|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21281258|NCT01072773|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
21281259|NCT01704495|AstraZeneca|Medical Science Director Bengt Larsson||ClinicalTrialTransparency@astrazeneca.com|
21281260|NCT03328507|Braintree Laboratories, Inc.|Head of R&D, GI|7818432202|studydirector@sebelapharma.com|
21281261|NCT02531308|Northwestern University|Dr. R Karmali|312-695-0686|reem.karmali@northwestern.edu|
21281262|NCT02721277|University of Florida|Josef Neu, MD|352-273-8985|neuj@peds.ufl.edu|
21281263|NCT04177095|Massachusetts General Hospital|Hannah Gilligan, MD|617-726-2000|hgilligan@mgh.harvard.edu|
21281264|NCT01346059|Beaumont Health|Rose Callahan|248 551-5147|rose.callahan@beaumont.org|
21281265|NCT00777296|Insmed Incorporated|Dr. Kevin Mange, Sr. Vice President, Clinical Development|908-947-2651|Kevin.Mange@Insmed.com|
21281266|NCT02211209|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
21281267|NCT00749073|Vertos Medical|VP Clinical, Regulatory, Quality|9493490008|cmyers@vertosmed.com|216
21281268|NCT03876743|Northwestern University|Melissa Shauver; Research Project Manager|3124726024|melissa.shauver1@nm.org|
21281269|NCT05002790|University Hospitals Coventry &Watwickshire NHS Trust|Cyprian Mendonca|02476964000|cyprian.mendonca@uhcw.nhs.uk|25874
21281270|NCT00092118|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21281271|NCT01549587|Procter & Gamble|Clinical Trial Manager|5136225362|combs.cs@pg.com|
21281272|NCT02025725|Evoke|Chief Medical Officer|858-345-1494|mcarlson@evokepharma.com|206
21281273|NCT05697809|Oxular Ltd|Friedrich Asmus, MD, Chief Medical Officer|617 882 7179|friedrich.asmus@ocular-cc.com|
21281274|NCT02199964|Baylor College of Medicine|Stephen Pflugfelder, M.D.|713-798-6100|stevenp@bcm.edu|
21281275|NCT02172664|Indiana University School of Dentistry|Dr. Jeffrey Platt|3172747229|jplatt2@iu.edu|
21281276|NCT03839628|The University of Utah|Micah Drummond|801-213-2737|micah.drummond@hsc.utah.edu|
21281277|NCT00380874|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21295144|NCT01644695|Institute For Advanced Reconstruction|Dr. Andrew Elkwood, MD|732-741-0970|aelkwood@hotmail.com|
21281278|NCT02314026|Exalenz Bioscience|Clinical trial manager|97289737513|avrahamh@exalenz.com|
21281279|NCT01139775|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21281280|NCT00586703|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
21281281|NCT02946463|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
21281282|NCT01560975|NYEE|Dr. Robert Ritch|+1 212 477 7540|ritchmd@earthlink.net|
21281283|NCT05271175|Cyprus rTMS|Georgios Mikellides|0035799430330|george.mikellides@gmail.com|
21281284|NCT00682786|Washington University School of Medicine|Benjamin R. Tan, M.D.|314-362-3560|btan@dom.wustl.edu|
21281285|NCT01370629|Correvio International|Head of Clinical Development|+41 (0) 22 907 79 70|info@correvio.com|
21281286|NCT01831635|Queen's University Belfast|Dr Lesley Anderson|02890632315|l.anderson@qub.ac.uk|
21281287|NCT02859337|Oregon Health & Science University|Dr. A Edelman|503-418-2585|edelmana@ohsu.edu|
21295145|NCT01904149|Menarini Ricerche S.p.A.|Dr. Angela Capriati, Corporate Director of Clinical Research|+3905556809933|ACapriati@menarini-ricerche.it|
21248946|NCT00988429|Bial - portela & Cª, S.A.|Head of Clinical Research|+351 22 986 6100|clinical.trials@bial.com|
21248947|NCT02964234|University of Illinois at Chicago|Dr. Yamile Molina|312-355-2679|ymolin2@uic.edu|
21248948|NCT01799993|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21248949|NCT04361617|Wake Forest University Health Sciences|Lindsay Reynolds, PhD|336.713.1134|lireynol@wakehealth.edu|
21248950|NCT02067000|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0123|CPAPtrial@fphcare.co.nz|7044
21248951|NCT04387773|Oregon Health & Science University|Dr. Amie Hiller|503-494-7772|peterami@ohsu.edu|
21295146|NCT00812006|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com|
21295147|NCT00760461|Yale University|Anish A Sheth M.D|203-785-4576|anish.sheth@yale.edu|
21295148|NCT01044212|University of Rochester|Gunhilde Buchsbaum, Division Director Urogynecology|585-273-3233|gunhilde_buchsbaum@urmc.rochester.edu|
21248952|NCT00825734|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21248953|NCT00687297|PrECOG|Study Statistician|617-632-3633|jmanola@jimmy.harvard.edu|
21248954|NCT04534738|University of Maryland Baltimore|Amber Kleckner, PhD|410-706-5961|amber.kleckner@umaryland.edu|
21248955|NCT03195127|University of Maryland, Baltimore|Avelino C. Verceles, M.D., M.S.|4103288141|avercele@medicine.umaryland.edu|
21248956|NCT04617847|Wave Life Sciences|Medical Director|855-215-4687|clinicaltrials@wavelifesci.com|
21248957|NCT00700999|Jesse Brown VA Medical Center|Dr. K Luan Phan|312-569-7161|Kinh.Phan@va.gov|
21248958|NCT00244751|GlaxoSmithKline|GSK Response Center|866-435-7343||
21248959|NCT00695188|Department of Clinical Pharmacology, Medical University of Vienna|Eva-Luise Hobl|+43 1 40400 2981|eva-luise.hobl@meduniwien.ac.at|
21248960|NCT03031782|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
21248961|NCT02699099|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21248962|NCT01094106|Kuopio University Hospital|Matti Reinikainen|+358447176681|matti.reinikainen@kuh.fi|
21248963|NCT01240590|National Cancer Institute|Dr. James Gulley|301-480-7164|gulleyj@mail.nih.gov|
21248964|NCT02725372|Bellerophon Therapeutics Inc|Bobae Kim|(917) 675-2254|bobae.kim@bellerophon.com|
21248965|NCT00703391|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21248966|NCT05184062|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21248967|NCT04620733|CymaBay Therapeutics, Inc.|CymaBay Study Director|1-510-293-8800|medinfo@cymabay.com|
21248968|NCT03976102|Dr. Reddy's Laboratories Ltd.|Head - Clinical Development|91-40-4464-4000|RI-01-006@drreddys.com|
21248969|NCT04555694|Cleveland Eye Clinic|Dr. Thomas Chester, OD|440-526-1974|tchester@midwestvision.com|
21248970|NCT00230009|Wayne State University|Steven J. Ondersma, ,PI|313-577-6680|s.ondersma@wayne.edu|
21248971|NCT02834624|University of Missouri-Columbia|Dr. Naomi Lauriello|573-882-2272|lauriellon@health.missouri.edu|
21281288|NCT03817190|DS Biopharma|Study Director|+35312933590|info@dsbiopharma.com|
21281289|NCT04146012|Accidentals Inc. (Formally Artegraft Inc.)|Tony Calandra, President|973.540.1250|arc@mcguggan.com|
21281290|NCT01546025|Brown University|Suzanne Colby|4018636655|Suzanne_Colby@brown.edu|
21281291|NCT02729025|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21281292|NCT05142722|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
21281293|NCT05086744|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21281294|NCT03896503|National Cancer Institute|Dr. Anish Thomas|240-760-7343|anish.thomas@nih.gov|
21281295|NCT04170738|Icahn School of Medicine at Mount Sinai|Iliyan Ivanov|(212) 523-1924|iliyan.ivanov@mssm.edu|
21281296|NCT03055338|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21281297|NCT03058705|University of Rochester|Edward Messing, MD|585-275-0998|edward_messing@urmc.rochester.edu|
21281298|NCT03507608|Johns Hopkins SOM, Dept of Radiation Oncology|Dana Kaplin|443-690-7007|dkaplin1@jh.edu|
21281299|NCT03752970|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21281300|NCT04767282|Michigan State University|Amy Custack, Associate Professor|8106005656|saxeamym@msu.edu|
21281301|NCT00382200|Memorial Sloan Kettering Cancer Center|Dr. Raajit Rampal, MD, PhD|646-608-3746|rampalr@mskcc.org|
21281302|NCT01120184|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21281303|NCT03096418|University of Wisconsin Carbone Cancer Center|Cancer Connect|800-622-8922|clinicaltrials@cancer.wisc.edu|
21281304|NCT02525783|Stryker|Matt Venegoni|612-297-0939|matthew.venegoni@stryker.com|
21281305|NCT00824772|Inje University|Kye-Min Kim, Associate Professor, Dept of Anesthesiology & Pain Medicine|82-2-950-1168|kyemin@paik.ac.kr|
21281306|NCT00838903|GlaxoSmithKline|GSK Response Center|866-435-7343||
21281307|NCT03532425|University of Alberta|Dr. Stephen D. Shafran|780-407-6945|sshafran@ualberta.ca|
21281308|NCT00730483|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
21281309|NCT02767011|Charleston Area Medical Center Research Institute|Mike Broce|304-388-9923|mike.broce@camc.org|
21281310|NCT01002989|Hypertension Center, Third University Department of Medicine, Sotiria Hospital|George S. Stergiou, MD, FRCP, Associate Professor of Medicine|+30 2107763117|gstergi@med.uoa.gr|
21281311|NCT00318474|Saint Joseph's Hospital and Medical Center|Ron Hogg, M.D.|602-406-3246|ronhogg@gmail.com|
21281312|NCT05177484|Royal Wolverhampton NHS Trust|Group Research Sponsorship Manager|01902|rwh-tr.sponsorshipofresearch@nhs.net|695065
21281313|NCT02075203|SATVI|Dr. Mark Hatherill|+27214066145|mark.hatherill@uct.ac.za|
21281314|NCT00495391|Romark Laboratories, L.C.|Marc Ayers|813-282-8544|Marc.Ayers@romark.com|
21281315|NCT02712320|Foresee Pharmaceuticals Co., Ltd.|Dr. John Mao|+886 2-2655-2658|john.mao@foreseepharma.com|
21281316|NCT00568451|Mayo Clinic Cancer Center|Svetomir N. Markovic M.D., Ph.D.|507-284-2511|markovic.svetomir@mayo.edu|4-2511
21281317|NCT05344560|Johnson & Johnson Vision Care, Inc. (JJVC)|Benjamin Straker|1-800-843-2020|bstraker@its.jnj.com|
21281318|NCT01620138|Universidade Federal do Rio de Janeiro|Monica Gadelha|+552139382323|mgadelha@hucff.ufrj.br|
21281319|NCT03922308|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21281320|NCT00942578|National Cancer Institute|Dr. Ravi Madan|301-480-7168|rm480i@nih.gov|
21281321|NCT03313180|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
21281322|NCT01697748|University of South Florida|Dr Sheila Connery, Associate Professor Obstetrics and Gynecology|813-259-8542|sconnery@health.usf.edu|
21281323|NCT00553839|Stanford University|Chandra Ramamoorthy, MBBS, FRCA|650-723-5728|chandrar@stanford.edu|
21263746|NCT03491553|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21263747|NCT00400829|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
21263748|NCT00039195|Memorial Slaon Kettering|Dr. Craig Moskowitz|212-639-7992|moskowic@mskcc.org|
21263749|NCT01606761|Janssen Research & Development, LLC|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
21263750|NCT05086289|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21263751|NCT03150108|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21263752|NCT00145249|University of Alabama at Birmingham|Peter G. Pappas, MD|205-934-9951|pappas@uab.edu|
21263753|NCT00515008|tufts medical center|chenchen wang|617-636-3251|cwang2@tuftsmedicalcenter.org|
21263754|NCT03238235|Italfarmaco SpA|Maurizio Caserini, MD|+ 39 02 64431|m.caserini@italfarmacogroup.com|
21263755|NCT00540969|Mayo Clinic|Matthew Callstrom, M.D., Ph.D.|5072664532|callstrom.matthew@mayo.edu|
21263756|NCT01975935|University of Michigan|Dr. Elif Oral|7346157271|eliforal@med.umich.edu|
21263757|NCT02742077|Corindus, Inc.|Clinical Research Manager|(757) 910-4818|tina.ridgeway@corindus.com|
21263758|NCT00086957|City of Hope|Paul Frankel, Ph.D.|626-359-8111|pfrankel@coh.org|65265
21281324|NCT00832455|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21295149|NCT04274153|Johns Hopkins SOM Department of GYN/OB|Dr. Jenell Coleman|(410)614-9178|colemanj@jhmi.edu|
21295150|NCT00580034|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
21295151|NCT01182805|University of Michigan|Theodore J. Kolias, MD|(734) 615-4907|tkolias@umich.edu|
21295152|NCT00772369|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21295153|NCT03372460|Center for Neurorestoration and Neurotechnology, VA Providence Healthcare System|Dr. Noah S Philip, MD|4012737100|noah_philip@brown.edu|16200
21295154|NCT02499900|Teva Pharmaceutical Industries Ltd.|Director, Clinical Research|+01 215-591-3000|USMedInfo@tevapharm.com|
21295155|NCT00916058|Weill Cornell Medical College|Tsiporah Shore|646-962-7950|tbs2001@med.cornell.edu|
21295156|NCT03385265|Nemours Children's Health|Dr. Susana Patton|904-697-2000|susana.patton@nemours.org|
21295157|NCT03416920|Massachusetts General Hospital|Dr. Pradeep Natarajan|617-724-3526|PNATARAJAN@PARTNERS.ORG|
21295158|NCT03403231|VA Center for Clinical Management Research|Bradley Youles, Project Manager|734-845-5055|Bradley.Youles@va.gov|
21295159|NCT02538419|Brigham and Women's Hospital|Dr. Jessie Bakker|617-732-5987|jpbakker@bwh.harvard.edu|
21295160|NCT01170065|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21295161|NCT01071200|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21295162|NCT02434354|Abramson Cancer Center|Dr. Tara Mitchell|215-662-7908|tara.mitchell@pennmedicine.upenn.edu|
21295163|NCT01920893|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21295164|NCT02794844|Nemours Children's Hospital|James P. Franciosi, MD|407-567-3832|jfrancio@nemours.org|
21295165|NCT01767493|Invicro|Stephanie Pizarro|203-990-1613|spizarro@invicro.com|
21295166|NCT00101816|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21295167|NCT00724854|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21295168|NCT01819129|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
21295169|NCT01863134|First Department of Cardiac Surgery, Medical University of Silesia, Katowice, Poland|Miroslaw Wilczynski|+48 32 20 24 025|miroslaw.wilczynski@cardiosurg.pl|
21281325|NCT02215369|Angiodynamics|Ariel Bloch|7742453646|abloch@angiodynamics.com|
21281326|NCT05188261|Ironwood Pharmaceuticals, Inc|Ironwood Study Chair|617-621-7722|info@ironwoodpharma.com|
21281327|NCT02275819|VA Boston Healthcare System|Dr. Jayashri Aragam|617-323-7700|Jayashri.Aragam@va.gov|
21281328|NCT02556775|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21281329|NCT01719367|Florida Electrophysiology Associates|Matthew Kolek, MD|(561) 434-0353|info@heartrhythmexperts.com|
21281330|NCT00658723|ETHICON, Inc.|Jonathan Batiller, Director Clinical Development|908-218-2819|JBatill2@its.jnj.com|
21281331|NCT03889418|Ochsner Health|Principal Investigator|504-842-8256|eboni.pricehaywood@ochsner.org|
21281332|NCT01139125|Georgia Regents University|Peter F. Buckley, MD|706-721-2231|PBuckley@gru.edu|
21281333|NCT00739661|Genentech, Inc|Medical Communications|800-821-8590||
21281334|NCT05267236|Midwest Evaluation and Research|Midwest Evaluation and Research|620-208-6143|mer@midwestevaluation.com|
21281335|NCT05600283|Mayo Clinic|Dr. Kathy MacLaughlin|507-266-4648|maclaughlin.kathy@mayo.edu|
21281336|NCT02883062|Washington University School of Medicine|Dr. William Gillanders|314-747-0072|gillandersw@wustl.edu|
21281337|NCT06180122|Imperial College Healthcare NHS Trust|Sophie Connolly|02033117322|sophie.connolly1@nhs.net|
21281338|NCT03380429|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21281339|NCT00218023|The University of Texas Health Science Center at Houston|Joy M. Schmitz, PhD|(713) 486-2867|Joy.M.Schmitz@uth.tmc.edu|
21281340|NCT01198470|Globus Medical|Jacqueline Myer|610-930-1800|jmyer@globusmedical.com|1669
21281341|NCT02949973|Aurinia Pharmaceuticals|Rashieda Gluck|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
21281342|NCT04760626|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21281343|NCT02452944|Department of Anesthesiology, Gachon University Gil Hospital|Mi Geum Lee|82-32-460-3637|mikeum2@gilhospital.com|
21281344|NCT01924689|BioMed Valley Discoveries, Inc.|Brent Kreider|816-960-4644|bkreider@biomed-valley.com|
21281345|NCT00468819|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21281346|NCT02492867|University of Michigan Rogel Cancer Center|ClinicalTrials.gov CC Admin|734-936-9499|clinicaltrialsgov_ccadmin@med.umich.edu|
21281347|NCT03296527|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
21263759|NCT00321100|Fox Chase Cancer Center|Dr. Steven Cohen|215-214-1676|steven.cohen@fccc.edu|
21263760|NCT03201198|University of Michigan School of Nursing|Dr. Janet Larson|7346470126|janetlar@med.umich.edu|
21263761|NCT00471445|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
21263762|NCT00218036|The University of Texas Health Science Center at Houston|Joy M Schmitz, PhD|(713) 486-2867|Joy.M.Schmitz@uth.tmc.edu|
21263763|NCT04715230|InterveXion Therapeutics|Chief Operating Officer|5015542377|misty.stevens@intervexion.com|
21263764|NCT03645408|Boston Medical Center/Boston University School of Medicine|Dr. Eric Devine|617-414-1990|eric.devine@bmc.org|
21263765|NCT00654511|Children's National Medical Center|Julia Finkel, MD|202-476-4867|jfinkel@cnmc.org|4867
21263766|NCT02596711|UT MD Anderson Cancer Center|Dr. Marcel A. de Dios / Health Disparities Research|713-792-7734|CR_Study_Registration@mdanderson.org|
21263767|NCT00586924|MedImmune, LLC|Nai Shun Yao, MD|1-301-398-5936|information.center@astrazenea.com|
21263768|NCT02010216|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21263769|NCT01767194|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21263770|NCT02223455|CADRE - Iowa City VAHCS|Heather Reisinger|319-338-0581|heather.reisinger@va.gov|7715
21263771|NCT01683071|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
21263772|NCT03736629|University of Chicago|Theodore Karrison (Research Professor)|773-702-9326|tkarrison@health.bsd.uchicago.edu|
21263773|NCT00605722|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21263774|NCT02560493|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|2257632869|amanda.staiano@pbrc.edu|
21263775|NCT00356863|The Gertner Institute for Epidemiology and Health Service Research|Rachel S Dankner, MD, MPH|972-3-5305390|RachelD@gertner.health.gov.il|
21263776|NCT00836277|University of Pittsburgh Cancer Institute|Weijing Sun, MD|412-864-7764|sunw@upmc.edu|
21263777|NCT03303040|University of Florida|Dr. Barbara K. Smith|352-294-5315|bksmith@ufl.edu|
21263778|NCT02871401|Vanderbilt University Medical Center|Jonathan Kropski MD|615-322-3412|jon.kropski@vumc.org|
21263779|NCT03162055|AstraZeneca|Vice President, Inhalation and Oral Respiratory|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
21263780|NCT00509496|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
21263781|NCT01709136|Children's Hospital of Pittsburgh|Dr. Rakesh Sindhi, MD|412-692-6110|rakesh.sindhi@chp.edu|
21263782|NCT00831441|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21263783|NCT01319110|Beth Israel Deaconess Medical Center|Dr. Michael Cocchi||mcocchi@bidmc.harvard.edu|
21263784|NCT00485589|F. Hoffmann-La Roche AG|Medical Communications|41 616878333|global.trial_information@roche.com|
21263785|NCT01944969|H. Lundbeck A/S|H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@lundbeck.com|
21263786|NCT02600325|Erasmus MC|Dr. B. J. A. Rijnders|0|b.rijnders@erasmusmc.nl|
21263787|NCT01104584|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21263788|NCT02370498|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21263789|NCT04017442|Icahn School of Medicine at Mount Sinai|Dr. Daniel Katz|212-241-7475|daniel.katz@mountsinai.org|
21263790|NCT01453569|Shanghai Greenvalley Pharmaceutical Co., Ltd.|Dr. Xianliang Xin|86 21-50504988|xinxianliang@hotmail.com|1370
21263791|NCT02586233|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21263792|NCT03225716|DFCI|Steven Treon|617-632-2681|steven_treon@dfci.harvard.edu|
21263793|NCT01205451|GlaxoSmithKline|GSK Response Center|866-435-7343||
21263794|NCT01236742|The Hong Kong Polytechnic University|Prof Pauline Cho|+852 2766 6100|pauline.cho@polyu.edu.hk|
21263795|NCT02373241|University of Alabama at Birmingham|Jeffrey Lebensbugrer|2056389285|jlebensburger@uabmc.edu|
21263796|NCT03575884|Seattle Children's Research Institute|Jason Mendoza, MD, MPH|206.884.1261|Jay.Mendoza@seattlechildrens.org|
21263797|NCT03421964|Virginia Commonwealth University|Nancy Hsu, PsyD, PI|804-327-1166|nancy.hsu@vcuhealth.org|
21263798|NCT02938585|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21263799|NCT01850745|Liver Section. Hospital del Mar|Professor Ricard Sola|0034932483200|35783@parcdesalutmar.cat|
21263800|NCT03075176|University of Utah John A. Moran Eye Center|Mark Mifflin, MD|801-213-4152|Mark.Mifflin@hsc.utah.edu|
21263801|NCT02106455|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21263802|NCT00213980|University of Wisconsin Carbone Cancer Center|Dr. Daniel Mulkerin|608-265-8090|dm2@medicine.wisc.edu|
21263803|NCT03607838|Seikagaku Corporation|General Manager, Clinical Development Department|(81)3-5220-8593|reply@seikagaku.co.jp|
21263804|NCT02411201|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical Writing|+33 (0) 1 45 91 50 00|corinne.dubourdieu@guerbet-group.com|
21263805|NCT01260467|University of Rochester Medical Center|Jennifer Serventi Research Associate|585-276-3971|jennifer_serventi@urmc.rochester.edu|
21263806|NCT00798694|Wills Eye Hospital|Principal Investigator|215-928-3197|ljaykatz@gmail.com|
21263807|NCT03709810|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21263808|NCT05117229|Mayo Clinic|Rafael J. Sierra, M.D.|507-284-2226|Sierra.Rafael@mayo.edu|
21263809|NCT03364608|Pearl Therapeutics, Inc, a Member of the AstraZeneca Group|Colin Reisner, MD FCCP, FAAAAI|9739750321|Colin.Reisner@astrazeneca.com|
21263810|NCT02665364|Neovacs|Head of Regulatory Affairs|+33153109300|info@neovacs.com|
21263811|NCT03888391|University of California, Los Angeles|James McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu|
21263812|NCT02581111|Washington University in St. Louis School of Medicine|Dr. Rajat Dhar|3143622999|dharr@neuro.wustl.edu|
21263813|NCT02504268|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
21263814|NCT03025217|Massachusetts General Hospital|Dr. Michelle Dossett|617-643-6034|mdossett@mgh.harvard.edu|
21263815|NCT03654755|Libertas BioSciences|Niranjan Rao|908-872-1133|niranjan@libertasbiosciences.com|
21281348|NCT01597973|University of Michigan|Jolene Daniel|732 235-7713|jd1557@rwjms.rutgers.edu|
21281349|NCT01326845|Novartis Pharmaceuticals|Study Director|862-778-8300||
21263816|NCT02835677|VA Medical Center|Dr. Linda Nichols, Co-Director Caregiver Center|901 523-8990|linda.nichols@va.gov|5082
21263817|NCT04019275|University of Pittsburgh|Elizabeth Skidmore|412-383-6620|skidmore@pitt.edu|
21263818|NCT00617409|H. Lee Moffitt Cancer Center and Research Institute|Dr. Scott Antonia|813-745-3883|scott.antonia@moffitt.org|
21263819|NCT02344407|Division of Biostatistics, University of Minnesota|Greg Grandits|612-626-9033|grand001@umn.edu|
21263820|NCT03198754|Icahn School of Medicine at Mount Sinai|Heiðdís B. Valdimarsdottir|(212) 659-5678|heiddis.valdimarsdottir@mssm.edu|
21263821|NCT00503880|University of Nebraska Medical Center|Lori Maness-Harris, MD|402-559-3848|lmaness@unmc.edu|
21263822|NCT03247413|Johns Hopkins University School of Medicine|Akhil Chhatre|443-997-5476|achhatr1@jh.edu|
21263823|NCT00668200|Novartis Pharmaceuticals|Study Director|8627788300||
21281350|NCT02692859|jiangsuPCDCP|Kai Chu|18915999781|chukai19812007@163.com|
21263824|NCT01496430|Takeda|Medical Director; Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21263825|NCT00932152|University of Pittsburgh|Ahmad Tarhini, MD|(412) 648-6578|tarhiniaa@upmc.edu|
21263826|NCT00360243|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
21263827|NCT02569411|St. Michael's Hospital|Dr. Areti Angeliki Veroniki|416-360-4000|averonik@cc.uoi.gr|
21263828|NCT02528097|NYU Langone Medical Center|The Office of Clinical Trials|646.754.7431|clinicaltrials@nyumc.org|
21263829|NCT03806179|Nordic Nanovector|Head of Clinical Operations|+47 22 18 33 01|mail@nordicnanovector.com|
21263830|NCT02991937|NYU Langone Health|Jason Fisher, MD|212-263-7391|Jason.Fisher@nyulangone.org|
21263831|NCT02662985|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
21263832|NCT01277341|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
21263833|NCT05373706|University of Washington|Dr. Anne Fairlie|(206) 221-5896|afairlie@uw.edu|
21263834|NCT01486784|Abramson Cancer Center at the University of Pennsylvania|Dr. Noelle Frey||noelle.frey@pennmedicine.upenn.edu|
21263835|NCT03633227|Intercept Pharmaceuticals, Inc.|Medical Information|+1 844-782-4278|medinfo@interceptpharma.com|
21263836|NCT04836455|University of North Carolina at Chapel Hill|Dr. Seth M. Noar|9192607269|noar@unc.edu|
21263837|NCT03976531|Institut Bergonié|Pr S Mathoulin-Pélissier|33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
21263838|NCT01479374|Alcon Research, Ltd.|Abhijit Narvekar, MS, MBBS|1-888-451-3937|alcon.medinfo@alcon.com|
21263839|NCT03628508|The Hong Kong Polytechnic University|Dr Amy Fu|8522766 6726|amy.fu@polyu.edu.hk|
21263840|NCT01996748|Laboratorios SALVAT|Enrique Jimenez, Medical Director|+34933946470|ejimenezv@salvatbiotech.com|
21263841|NCT00243230|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21263842|NCT03011840|Tata Memorial Hospital, Mumbai|Dr. Sumitra Bakshi|+912224177058|sumitrabakshi@yahoo.com|
21263843|NCT02112994|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
21263844|NCT04211155|University of Minnesota|Bonny Donzella|6126244351|donzella@umn.edu|
21263845|NCT04031404|University of North Carolina at Chapel Hill|Rachel B. Force, PhD|9199669929|rachel_force@med.unc.edu|
21263846|NCT02581865|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
21263847|NCT01993615|Madigan Army Medical Center|Daniel Rhon|253-968-0780|daniel.i.rhon.ctr@mail.mil|
21263848|NCT03235817|Anesthesiology|T. Wesley Templeton, MD|336-716-4498|ttemplet@wakehealth.edu|
21263849|NCT02621619|Albany Medical Center|Dr. Andrew Chang|518-262-0042|changa1@amc.edu|
21263850|NCT02282982|AbbVie|Global Medical Services|800-633-9110||
21263851|NCT01354353|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21263852|NCT05674344|Masimo Corporation|Chelsea Frank|(949) 297-7000|clinicalresearchdept@masimo.com|
21263853|NCT00111917|National Jewish Health|Lisa Maier, MD|303-398-1983|maierl@njhealth.org|
21263854|NCT01640925|Houston Methodist Hospital|Dr. Joshua Swan|713-441-0165|jtswan@houstonmethodist.org|
21263855|NCT02156492|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21263856|NCT02363270|Maimonides Medical Center|Dr. Sergey Motov|718-283-8693|smotov@maimonidesmed.org|
21263857|NCT02311309|CHU de Caen|Dr Jean-Luc Hanouz|2 31 06 47 36|hanouz-jl@chu-caen.fr|33
21263858|NCT03508661|Lady Davis Institute|Dr. Brett Thombs|514-340-8222|brett.thombs@mcgill.ca|25112
21263859|NCT00131677|Centers for Disease Control and Prevention (CDC)|Taraz Samandari|404-639-1676|tts0@cdc.gov|
21263860|NCT02924688|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21263861|NCT02574858|University of Michigan|Dr. D. Kim Turgeon|734-764-6860|kturgeon@med.umich.edu|
21263862|NCT00882102|The University of Texas MD Anderson Cancer Center|Gautam Borthakur, MD/Associate Professor|713-563-1586|eharriso@mdanderson.org|
21263863|NCT03072719|GlaxoSmithKline|GSK Response Center|866-435-7343||
21263864|NCT00868959|Sunovion|Medical Director, CNS|1-866-503-6351||
21263865|NCT00838006|Central Arkansas Veterans Healthcare System|Jeff Pyne, MD|501-257-1083|jeffrey.pyne@va.gov|
21281351|NCT00908544|MUC Research GmbH|Dr. phil. Eva Wolf|+49 (0)89-558703-0|Eva.Wolf@MUCResearch.de|
21281352|NCT00204490|University of Texas Medical Branch Galveston|Dr. Lee Jane W. Lu|409-772-1730|llu@utmb.edu|
21281353|NCT00740636|Memorial Sloan Kettering Cancer Center|Dr. Maria C. Pietanza|646-888-4203|PietanzM@mskcc.org|
21281354|NCT03477006|University of Pittsburgh|Jason Sperry|4128028270|sperryjl@upmc.edu|
21281355|NCT00762710|VA Puget Sound|Dr. Tracy Simpson|(206) 277-3337|Tracy.Simpson@va.gov|
21281356|NCT02462603|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
21281357|NCT03760744|Vanderbilt Medical Center|Dr. Manus J. Donahue|615.322.8350|mj.donahue@vumc.org|
21281358|NCT05731700|Abbott|Krista Stiefel, Principal Clinical Scientist|+12246689359|krista.stiefel@abbott.com|
21263866|NCT02173392|Valeant Pharmaceuticals|Director of Clinical Trials|908|lindsey.mathew@valeant.com|
21263867|NCT00992784|GlaxoSmithKline|GSK Response Center|866-435-7343||
21263868|NCT00781599|University of Kansas Medical Center|Dr. Nikki Nollen|(913) 588-3784|NNOLLEN@kumc.edu|
21295170|NCT02836873|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
21263869|NCT01088438|University of Illinois at Chicago|Dr. Alan Schwartz|312-996-2070|alansz@uic.edu|
21263870|NCT01363713|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
21263871|NCT01199055|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21263872|NCT01094717|University of Utah, Derpartment of Dermatology|Kristina Callis-Duffin|8015816465|Kristina.Duffin@hsc.utah.edu|
21263873|NCT01940510|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21263874|NCT00913133|Canyon Pharmaceuticals|Director of Clinical Trials|888-434-7003|info@canyonpharma.com|
21263875|NCT00424294|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21263876|NCT03337152|PATH|Gonzalo Domingo|206-285-3500|gdomingo@path.org|
21263877|NCT00718666|GlaxoSmithKline|GSK Response Center|866-435-7343||
21263878|NCT00421343|Hebrew SeiorLife|Sarah Berry|617-971-5355|sarahberry@hrca.harvard.edu|
21263879|NCT03471767|Duke University|James Davis, MD|919-668-5055|james.m.davis@duke.edu|
21263880|NCT00116857|Washington University School of Medicine|Robert M. Carney, Ph.D.|314-286-1313|carneyr@bmc.wustl.edu|
21263881|NCT01952730|Massachusetts General Hospital|Cristina R. Ferrone, MD|617-643-6189|CFERRONE@PARTNERS.ORG|
21263882|NCT02076321|University of Missouri, Department of Orthopaedics|Dr. Daniel Hoernschemeyer|(573)882-1351|hoernschemeyerd@health.missouri.edu|
21263883|NCT01785810|Abramson Cancer Center|Michael Gardo|215-615-2232|michael.gardo@uphs.upenn.edu|
21263884|NCT00757484|University of Rochester Medical Center|Dr. Erin Duecy|585-275-4004|erin_duecy@urmc.rochester.edu|
21263885|NCT04895605|Regulatory Insight, Inc.|Elvira Cawthon|6154475150|elvira@reginsight.com|
21263886|NCT01019486|University of Colorado, Denver|Robert A. Quaife M.D.|720-848-6562|robert.quaife@ucdenver.edu|
21281359|NCT05400655|Centers for Disease Control and Prevention|Dr. Laura Steinhardt, PhD, MPH|1 6467641472|LSteinhardt@cdc.gov|
21281360|NCT04495946|Wake Forest University School of Medicine|Marc Kowalkowski, PhD|704-355-9902|marc.kowalkowski@advocatehealth.org|
21281361|NCT03375918|UMass Chan Medical School|Jennifer Tjia|774-455-3538|jennifer.tjia@umassmed.edu|
21281362|NCT05161481|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
21281363|NCT05022667|University of Michigan Medical Center|Dr. Paul Gauger|734-936-0231|pgauger@med.umich.edu|
21281364|NCT05468164|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21281365|NCT04632927|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|novartis.email@Novartis.com|
21281366|NCT03827291|Duke University|Amanda Kumar, MD|919-681-6437|amanda.kumar@duke.edu|
21281367|NCT04795466|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
21281368|NCT04652726|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21281369|NCT04286269|University of Minnesota|Sonya Wang|612-301-1454|sgwang@umn.edu|
21281370|NCT04526639|University of Massachusetts Lowell|Jiabin Shen|978-934-3965|jiabin_shen@uml.edu|
21281371|NCT01135381|University of California San Francisco (UCSF); University of Alabama at Birmingham (UAB)|Dr. Christine Ritchie|415-514-0605|christine.ritchie@ucsf.edu; critchie@uab.edu|
21281372|NCT01256164|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
21281373|NCT01754350|JohannWGUH|Johannes Rieger|+4969630187711|j.rieger@uni-tuebingen.de|
21281374|NCT01102257|Mount Sinai School of Medicine|Dr. Penny Asbell|(212) 241-7977|penny.asbell@mssm.edu|
21281375|NCT02979587|Medtronic|Lindsey Gustafson, Clinical Study Manager|7635262782|lindsey.m.gustafson@medtronic.com|
21281376|NCT01467713|Takeda|Medical Director, Clinical Science|1-877-825-3327|trialdisclosures@takeda.com|
21281377|NCT02974686|Washington University|Dr. R. Delos Santos|314-362-8351|delossantos@wustl.edu|
21281378|NCT01894841|Providence VAMC|Jennifer Primack|401 273-7100|jennifer.primack@va.gov|6295
21281379|NCT01100086|Purdue Pharma L.P.|Stephen Harris, M.D.|203-588-7592|Stephen.Harris@Pharma.com|
21281380|NCT01611935|University of Pennsylvania|Dr. Carrie Sims|215-588-5154|carrie.sims@uphs.upenn.edu|
21281381|NCT01735916|Medtronic|MIRACLE EF Study Manager|(763) 514-4000|medtroniccrmtrials@medtronic.com|
21281382|NCT04227197|Massachusetts General Hospital|Brian G Skotko, MD, MPP, Principal Investigator|(617) 643-3196|bskotko@mgh.harvard.edu|
21281383|NCT04547985|Weill Cornell Medicine|Dr. Holly G. Prigerson|646-962-9655|hgp2001@med.cornell.edu|
21281384|NCT02992236|Nephrology University Erlangen Germany|Prof Dr Rroland Schmieder|+49 9131 8536207|roland.schmieder@uk-erlangen.de|
21281385|NCT02549859|University of Chicago|Ms. Lani Leong, Research Coordinator|7738341688|lani@neurology.bsd.uchicago.edu|
21281386|NCT01379768|Alcon Research|Director of Alcon Clinical, Atlanta|1-800-241-7629||
21281387|NCT03446027|Imperial College London|Laura Burgess|0203 311 5208|l.burgess@imperial.ac.uk|
21281388|NCT03097341|Aronora, Inc.|Christina U. Lorentz, PhD, Senior Scientist and Project Manager|503-964-0250|christina.lorentz@aronorabio.com|
21281389|NCT01209949|Galderma Laboratories, L.P.|Norman Preston|817-961-5360|Norman.Preston@galderma.com|
21281390|NCT01067781|Valneva Austria GmbH|Head Clinical Developement|0043120620|info@valneva.com|0
21281391|NCT00729612|The Ohio State University|Gregory Otterson, MD|614-293-2887|Greg.Otterson@osumc.edu|
21281392|NCT00708552|GlaxoSmithKline|GSK Response Center|866-435-7343||
21281393|NCT01904526|Yale School of Medicine|Sherry McKee, PhD|2037373529|sherry.mckee@yale.edu|
21281394|NCT03971071|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21281395|NCT00391768|Collaborative Antiviral Study Group|Penelope Jester|877-975-7280|PJester@peds.uab.edu|
21281396|NCT00891020|Hoffman-LaRoche|Medical Communications|800-821-8590||
21281397|NCT00320710|Novartis|Study Director|862-778-8300||
21281398|NCT04578457|Sonova AG|Juliane Raether|+41 58 928 01 01|juliane.raether@sonova.com|
21263887|NCT03134313|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
21263888|NCT03442829|Bournemouth University|Prof. Katherine Appleton|01202965985|k.appleton@bournemouth.ac.uk|
21281399|NCT00717912|Biofortis|Doctor|0240205799|info@mxns.com|
21281400|NCT01051596|Georgetown University|Michael Pishvaian, MD, PhD|202-444-2223|pishvaim@georgetown.edu|
21263889|NCT02724774|University of Washington|Carol Rhodes, Director of Sponsored Programs|206 543-2139|carhodes@uw.edu|
21263890|NCT02605447|Boston Scientific Corp.|Peter Maurer, Director Clinical Trials|+1 (508) 683|Peter.Maurer@bsci.com|6678
21263891|NCT02237157|RenovoRx|Charles Li|(650) 284-4433|charles@renovorx.com|
21263892|NCT01062074|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21263893|NCT02045212|Regenera Pharma Ltd|Dr Konstantin Adamsky|+972 8 9316306|kostia@Regenerapharma.com|
21263894|NCT03992768|Hamamatsu Photonics, K.K.|MCG Manager|+81-53-435-1560|fujisaka@sys.hpk.co.jp|
21263895|NCT03126539|Johns Hopkins University|Dr. Anna Chien|410-502-7546|CTReP@jhmi.edu|
21263896|NCT00926796|University of Arkansas for Medical Sciences|Shelly Lensing|501-686-8203|sylensing@uams.edu|
21263897|NCT02410707|Einstein Healthcare Network|Joseph Herres, DO, Director of Research|215-456-6666|herresjo@einstein.edu|
21263898|NCT03185455|UPenn|Dr. Adi Hirshberg|917-553-9643|adi.hirshberg@uphs.upenn.edu|
21263899|NCT00626912|Centre de Recherches du Centre Hospitalier de l'Université de Montréal|Ruby Klink, coordinator|(514) 890 8000|ruby.klink@crchum.qc.ca|25245
21263900|NCT00946530|Stanford University|Jerome A. Yesavage, MD|650-493-5000|yesavage@stanford.edu|x64330
21263901|NCT00115804|University of Cincinnati|Dr. Lesley Arnold|513-475-8110|lesley.arnold@uc.edu|
21263902|NCT00621855|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21263903|NCT03095521|Sandoz|Study Director|+41613241111|Sandoz.email@sandoz.com|
21263904|NCT04614545|The Cleveland Clinic Foundation|Dr. Marcio Griebeler|216.444.6568|jenkink@ccf.org|
21263905|NCT00430521|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21263906|NCT05366413|Dana-Farber Cancer Institute|Andrea Enzinger, MD|617-582-7335|andrea_enzinger@dfci.harvard.edu|
21263907|NCT02198651|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21263908|NCT03713957|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
21263909|NCT00369746|New York State Psychiatric Institute|Patrick J. McGrath, M.D.|646-774-8076|mcgrath@nyspi.columbia.edu|
21263910|NCT00961662|University of Kentucky|Robert Lodder|859-955-0845|lodder@uky.edu|
21263911|NCT01042613|St. Jude Children's Research Hospital|Luis Trujillo Huaccho, MD|1-866-278-5833|info@stjude.org|
21263912|NCT00333619|VA Greater Los Angeles Healthcare System|Dr. Cathy Alessi|818 895-9311|cathy.alessi@va.gov|
21263913|NCT03379506|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21263914|NCT03006471|INSITITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
21263915|NCT05283863|Case Western Reserve University|Jennifer Sweet, MD|216-844-3192|Jennifer.Sweet@UHhospitals.org|
21263916|NCT01120379|Abbott Vascular|Robert Smith Jr, Ph.D., Sr Clinical Research Scientist|408-845-8265|robert.smithjr@av.abbott.com|
21263917|NCT00848250|Vanderbilt University Medical Center|Mias Pretorius|615-8757402|mias.pretorius@vanderbilt.edu|
21263918|NCT01122030|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
21263919|NCT00734734|Novartis Vaccines and Diagnostics S.r.l|Posting Director||RegistryContactVaccinesUS@novartis.com|
21263920|NCT04032171|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21263921|NCT00642746|OHSU Knight Cancer Institute|Charles Lopez, MD|503-494-8534|lopezc@ohsu.edu|
21263922|NCT01811355|Mayo Clinic, Jacksonville|Dr. Bjorn Oskarsson|9049536896|oskarsson.bjorn@mayo.edu|
21263923|NCT02108951|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21263924|NCT00678587|GlaxoSmithKline|GSK Response Center|866-435-7343||
21263925|NCT01514188|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
21263926|NCT02932332|UT MD Anderson Cancer Center|David Hui, MD, Associate Professor/Palliative Care Med|713-792-6258|dhui@mdanderson.org|
21263927|NCT02493426|University of Minnesota|Suma Jacob, MD, PhD|612-624-0018|sjacob@umn.edu|
21263928|NCT01069523|University of Texas Health Science Center at San Antonio|Steven R.Pliszka MD|210-567-5475|pliszka@uthscsa.edu|
21263929|NCT01875367|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
21263930|NCT00473837|Medical Research Council Unit, The Gambia|Mrs Vivat Thomas-Njie|+220-4495442/6|vthomas@mrc.gm|2204
21263931|NCT01016691|Vistakon|Brian Schwam MD|1-904-443-1482|bschwam@its.jnj.com|
21263932|NCT04533815|University of Alabama|Dr. Lynn Snow|205-201-0312|LSNOW@ua.edu|
21263933|NCT00488592|Hematology Branch, NHLBI|Minoo Battiwalla, MD|301 827 0939|battiwam@nhlbi.nih.gov|
21263934|NCT00441103|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21263935|NCT02951988|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
21263936|NCT05836818|University of California San Francisco|Robert Rodriguez|925-457-2145|robert.rodriguez@ucsf.edu|
21263937|NCT03738566|Mayo Clinic|Dr. Jeffrey A. Alexander|507-538-0474|Alexander.Jeffrey14@mayo.edu|
21263938|NCT04539249|Federal Medical Centre, Yenagoa|Dr. Olakunle I. Makinde|08032136315|olakunleife@gmail.com|
21263939|NCT01627067|UT MD Anderson Cancer Center|Dr. Vicente Valero, MD/ Professor, Breast Medical Oncology|713- 563-0751|vvalero@mdanderson.org|
21263940|NCT00516269|UT MD Anderson Cancer Center|Carmen Escalante, MD / Professor||RABaker@mdanderson.org|
21263941|NCT03483506|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21263942|NCT04570657|AstraZeneca AB|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21263943|NCT01079962|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21295171|NCT02266277|University of Massachusetts Medical School|Dr. Sarah Cutrona|508-856-3086|sarah.cutrona@umassmed.edu|
21295172|NCT00853125|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu|
21295173|NCT00182767|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
21281401|NCT03809663|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21248972|NCT01578278|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
21248973|NCT02164578|Medical Clinic III, Universitätsklinikum Carl Gustav Carus, Dresden, Germany|Dr. Frank Pistrosch|0049 351 458|frank.pistrosch@uniklinikum-dresden.de|5955
21248974|NCT00112827|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
21248975|NCT03924193|Yale University School of Medicine|Dr. Valentina Ivezaj|2037857807|valentina.ivezaj@yale.edu|
21248976|NCT01562275|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21248977|NCT01863368|Alcon Research, Ltd.|Global Brand Med Affairs Lead, Pharma, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
21248978|NCT04371471|NumaHealth international|Dr. Kamyar Hedayat|+33660404192|khedayat@numahealth.com|
21248979|NCT00515112|The University of Chicago|Dr. Walter Stadler|773-702-4400|wstadler@medicine.bsd.uchicago.edu|
21248980|NCT01366976|Vanderbilt University School of Medicine|Mias Pretorius|16153220758|mias.pretorius@vanderbilt.edu|
21248981|NCT03029585|US Biotest, Inc.|Gere S. diZerega, MD, Responsible Medical Officer|1-805-595-1300|gere.dizerega@usbiotest.com|
21248982|NCT01448447|Mercy|Dr. Robert Frazier|314-251-6844|Robert.Frazier@mercy.net|
21248983|NCT04025762|University of Cambridge|Dr Charlotte Boughton|+441223769066|cb2000@medschl.cam.ac.uk|
21248984|NCT00759798|The University of Texas MD Anderson Cancer Center|William Wierda MD/Professor|713-745-0428|wwierda@mdanderson.org|
21248985|NCT03340961|Dr. Reddy's Lab, INC|Dr. Srinivas Sidgiddi, Senior Director|908-458-5362|Srinivassidgiddi@drreddys.com|
21248986|NCT01286311|Northwestern University|Stephen D. Persell, MD MPH|312-503-6464|spersell@nmff.org|
21248987|NCT01437540|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
21248988|NCT01690000|Aarhus University|Anne Kristine Amstrup|4578467681|anne_kristine_am@hotmail.com|
21248989|NCT04351243|Kinevant Sciences, Inc. on behalf of Kinevant Sciences GmbH|Simon Lowry, MD, Chief Medical Officer|(646) 495-5368|simon.lowry@roivant.com|
21248990|NCT04328467|University of Minnesota|Radha Rajasingham, MD|612-626-8171|radha@umn.edu|
21248991|NCT01975701|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novatis.com|
21248992|NCT01301183|Massachusetts General Hospital|Madhu Misra|6177265790|mmisra@mgh.harvard.edu|
21248993|NCT02446015|Alcon, A Novartis Division|WW Medical Affairs Director, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com|
21248994|NCT01393600|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
21248995|NCT01670877|Washington University School of Medicine|Cynthia Ma, M.D., Ph.D.|314-362-9383|cynthiaxma@wustl.edu|
21248996|NCT02525744|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21248997|NCT01182285|National Cancer Institute|Dr. Naris Nilubol|301-451-2355|niluboln@nih.gov|
21248998|NCT00472082|Emory University|Kenneth A. Newell, MD, PhD|404-727-2489|kanewel@emory.edu|
21248999|NCT03449979|University of North Carolina at Chapel Hill|Justin Riddle, PhD|6617131602|justin_riddle@med.unc.edu|
21249000|NCT02069379|University of Michigan|Alison Berent-Spillson|(734) 936-4400|berent@umich.edu|
21249001|NCT01762345|Procter & Gamble Company Global Clinical Sciences|Mylissa Trowbridge||trowbridge.mm@pg.com|
21249002|NCT01525875|Icahn School of Medicine at Mount Sinai|Dr. Mark Lebwohl|212-241-9728|mark.lebwohl@mountsinai.org|
21249003|NCT02379078|St. Michael's Hospital (Unity Health Toronto)|Dr. Catherine Yu|(416) 360-4000|catherine.yu@unityhealth.to|
21249004|NCT02206607|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21249005|NCT00761267|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21249006|NCT03398798|University of North Carolina at Chapel Hill|Christian Piers, DDS, MS, MFA|(828) 433-1242|christian.piers@gmail.com|
21249007|NCT01777932|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21249008|NCT02466958|UCLA|Helen Lavretsky, MD|310-794-4619|HLavretsky@mednet.ucla.edu|
21249009|NCT04604652|HighTide Therapeutics|VP Clinical Operations|760-809-3523|cbennett@hightidetx.com|
21249010|NCT03936699|Elira Therapeutics, Inc.|Stephanie Amlung, PhD, RN, Vice President, Clinical Affairs|513.236.6799|samlung@elira.com|
21249011|NCT01414192|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21249012|NCT03989232|Novo Nordisk A/S|Clinical Transparency and Medical Writing Office (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21249013|NCT04658888|Penn State Health Milton S Hershey Medical Center|Dr. Christina Scartozzi|484-650-0885|Cscartozzi@pennstatehealth.psu.edu|
21249014|NCT03400579|University of North Carolina at Chapel Hill|Mehul Patel, PhD|919-843-7307|mehul_patel@med.unc.edu|
21249015|NCT02644122|University of California, San Diego|Ezra Cohen, MD|(858)822-5800|ecohen@ucsd.edu|
21249016|NCT01604122|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21249017|NCT01930188|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
21249018|NCT02514824|Dana-Farber Cancer Institute|Robert Haddad, MD|617.632.3090|Robert_Haddad@dfci.harvard.edu|
21249019|NCT03576118|Ajou University Hospital|Dr. Jong Yeop Kim|+82312195574|kjyeop@ajou.ac.kr|
21249020|NCT02170207|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21249021|NCT03122860|Biosplice Therapeutics, Inc.|Christopher Swearingen, PhD, VP of Biometrics|858.926.2952|chris.swearingen@biosplice.com|
21249022|NCT01138657|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21249023|NCT00869609|University of Pittsburgh|Trevor J Orchard|412-383-1032|tjo@pitt.edu|
21249024|NCT02399449|University of Maryland Baltimore|James Polli|410-465-3466|jpolli@rx.umaryland.edu|
21249025|NCT01020435|Palmer College of Chiropractic|Christine M Goertz, DC, PhD (Study Principal Investigator)|563-884-5150|christine.goertz@palmer.edu|
21281402|NCT00323453|Santa Barbara Cottage Hospital|Laura Isaacs (Research Quality Assurance & Integrity Analyst) on behalf of Dr. Kenneth Waxman (PI)|805-324-9255|lisaacs@sbch.org|
21281403|NCT03376789|Director Global Clinical Operations, General Medicine|Keri L Vaughan|+1 267.980.5015|keri.vaughan@mylan.com|
21263944|NCT01072539|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21263945|NCT01331239|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21263946|NCT01008995|Janssen R&D US|Director, Clinical Research|1 215-793-7646||
21263947|NCT04167306|Addiction BIology Unit - Clinical Trials, Inst Neuroecience and Physiology, Gotheburg University/ Dep of Addictions and Dependency, Sahlgrenska University Hostpital|Andrea de Bejczy|+46313424724|andrea.debejczy@neuro.gu.se|
21263948|NCT03689504|Wuqu' Kawoq|Peter Rohloff, Chief Medical Officer|011-502-4958-1253|peter@wuqukawoq.org|
21263949|NCT03731364|Concentric Analgesics|Nancy Wu|(415) 484-7921|nancy@concentricanalgesics.com|
21263950|NCT00665288|Ottawa Hospital Research Institute|Manya Charette|613-798-5555|mancharette@ohri.ca|17758
21263951|NCT01934192|GlaxoSmithKline|GSK Response Center|866-435-7343||
21263952|NCT01189435|Memorial Sloan Kettering Cancer Center|Dr. Gregory Riely|646-888-4199|rielyg@mskcc.org|
21263953|NCT00403559|Dermatology Specialists, PSC|Joseph F. Fowler, Jr., M.D.|502-583-7546|fowlerjoe@msn.com|184
21263954|NCT00547378|Pelvic Health & Gastric Therapies|Shenita Bolstrom|763-526-8254|shenita.bolstrom@medtronic.com|
21263955|NCT04105244|Frances Payne Bolton School of Nursing, Case Western Reserve University|Valerie Boebel Toly, PhD, RN, CPNP-PC, FAAN|216-534-5844|vab@case.edu|
21263956|NCT02768194|GlaxoSmithKline|GSK Response Center|866-435-7343||
21263957|NCT04863014|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
21263958|NCT04387136|University of Minnesota|Aaron Berg|612-625-7675|bergx831@umn.edu|
21263959|NCT01982773|National Center for Telehealth and Technology|Nigel E. Bush, PhD|253-968-4153|nigel.e.bush.civ@mail.mil|
21263960|NCT02278289|Department of Physical Medicine and Rehabilitation, Taipei Tzuchi Hospital, Buddhist Tzuchi Medical Foundation, New Taipei City, Taiwan, ROC|Dr. Yi-Shiung Horng|+886-2-66289779|d97841001@ntu.edu.tw|64515
21263961|NCT01029886|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21263962|NCT03294681|Cochlear|Nicole Neben|+4951154277220|nneben@cochlear.com|
21263963|NCT03089216|Federal University of Goias|Dr. Terezinha de Jesus Esteves Barata|+55 62 3209-6325|terezinhabarata@yahoo.com.br|
21263964|NCT00242385|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21263965|NCT00417976|The Ohio State University|Tanios Bekaii-Saab|614-293-9863|Tanios.saab@osumc.edu|
21263966|NCT04501679|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
21281404|NCT01703260|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21263967|NCT01032993|BIDMC|Catherine Buettner, MD MPH, Assistant Professor of Medicine|617-754-9600|cbuettne@bidmc.harvard.edu|
21263968|NCT02121756|University of Pittsburgh Department of Medicine|Sharon Riddler, MD|412-383-1675|riddler@pitt.edu|
21263969|NCT00751114|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi.com|
21263970|NCT02358369|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21263971|NCT05027516|Institute of Tropical Medicine Antwerp|Dr. Chris Kenyon|+32(0)32470786|ckenyon@itg.be|
21263972|NCT01536119|University of Toronto|Jennifer Abbass Dick||jennifer.abbass@mail.utoronto.ca|
21263973|NCT04191577|Cerevance|Michelle Charles, Executive Director Regulatory Affairs|(408) 220-5722|michelle.charles@cerevance.com|
21263974|NCT00448916|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21263975|NCT03655717|Massachusetts General Hospital|Dr. Jodi Gilman|617-643-7293|jgilman1@mgh.harvard.edu|
21263976|NCT01185249|Central DuPage Hospital|Dr. Alice Siehoff, Nurse Scientist|1-630-858-0260|asiehoffrn@msn.com|
21263977|NCT02365584|Ipsen SpA|Medical Director|see email|clinical.trials@ipsen.com|
21263978|NCT01973452|Memorial Sloan Kettering Cancer Center|Dr. Alessia Pedoto, MD|212-639-6840|pedotoa@mskcc.org|
21263979|NCT03521193|Centro Cardiologico Monzino, IRCCS|Clinical Trials' Office Chief|+390258002|alessandra.terragni@ccfm.it|675
21263980|NCT02193815|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21263981|NCT03675737|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21263982|NCT00369967|VCUHS|Nicole Karjane|804-828-8614|nkarjane@mcvh-vcu.edu|
21263983|NCT01708941|ECOG-ACRIN Statistical Office|Study Statistician|(617) 632-3012|eatrials@jimmy.harvard.edu|
21263984|NCT02226146|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
21263985|NCT05464836|MD Anderson Cancer Center|Miriam Garcia, DO|(713) 745-4312|mbgarcia@mdanderson.org|
21263986|NCT02883049|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
21263987|NCT00229203|PharmaMar USA Inc|Claudia Silvia Corrado M.D.|1 212 201 6770|cscorrado@pharmamar.com|
21263988|NCT03457103|NYU Langone|Dr. Anna Norweg|646-501-7777|AnnaMaria.Norweg@nyulangone.org|
21263989|NCT02351258|Johns Hopkins University|Dr. Aaron Milstone|443-287-8932|amilsto1@jhmi.edu|
21263990|NCT03004469|Polichem S.A.|Francesco Scarci|+41 091 9864 005|francesco.scarci@almirall.com|
21263991|NCT01163253|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21263992|NCT01397552|Upstate Medical University|William Lavelle|315-464-4472|lavellew@upstate.edu|
21263993|NCT00423735|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
21263994|NCT00439673|GIMEMA|Alfonso Piciocchi|+39 06.70390521|a.piciocchi@gimema.it|
21263995|NCT00654784|Santhera|Thomas Meier|+4161 906 8964|thomas.meier@santhera.com|
21263996|NCT01722487|Pharmacyclics LLC|Dr. Lori Styles, Medical Monitor|+1 (408) 215-3770|lstyles@pcyc.com|
21281405|NCT05333601|Nemours Children's Health|Dr. Kimberly Canter|3026514501|kimberly.canter@nemours.org|
21263997|NCT01089582|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21263998|NCT02394808|Johnson & Johnson Vision Care Inc.|Tawnya Wilson O.D. SR. MANAGER GLOBAL CLINICAL SALES EDU|443-1834|TWilson@ITS.JNJ.com|
21263999|NCT00289185|GlaxoSmithKline|GSK Response Center|866-435-7343||
21264000|NCT00576251|Alcon Research, Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21264001|NCT01124448|Complutense University Madrid|Dr. Juan M Rodríguez|34 91 3943837|jmrodrig@vet.ucm.es|
21264002|NCT05025787|MGH|Allison Campbell|617-595-8372|acampbell17@mgh.harvard.edu|
21264003|NCT00976950|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21264004|NCT04124042|Xalud Therapeutics, Inc.|Director of Medical Inquiries|212-301-6673|medical.information@xaludthera.com|
21264005|NCT02408796|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
21264006|NCT01025817|Novartis|Study Director|+1 (862) 778-8300||
21264007|NCT02130258|Massachusetts General Hospital|Dr. Yi Zhang|617-724-6102|yzhang20@partners.org|
21264008|NCT00807846|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21264009|NCT01081873|Abbott|Global Medical Services|800-633-9110||
21264010|NCT00441558|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
21264011|NCT01165021|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21264012|NCT02491073|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351||
21264013|NCT03977727|Texas Diabetes & Endocrinology|Thomas Blevins, MD|512-334-3505|blevins@texasdiabetes.com|1
21264014|NCT01419665|Hexal AG / Novartis Pharmaceuticals|Study Director|+41613241111|novartis.email@novartis.com|
21264015|NCT03448718|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
21264016|NCT02683525|IndianaU|Dr. Sherif Farag|(317) 278-0460|ssfarag@iu.edu|
21264017|NCT01700517|Madre Teresa´s Hospital|Dr Lucio Honorio de Carvalho Júnior|+55 31 33398000|luciohcj@gmail.com|
21264018|NCT03352414|University of California, San Diego|Raymond Diep, Clinical Research Coordinator|(858) 822-5352|rhdiep@health.ucsd.edu|
21264019|NCT01341652|University of Wisconsin Carbone Cancer Center|Douglas McNeel|608-263-4198|dm3@medicine.wisc.edu|
21295174|NCT00832130|TearScience, Inc. (formerly Kolis Scientific)|Christy Stevens, OD|919-459-4815|cstevens@tearscience.com|
21295175|NCT01646645|Memorial Sloan Kettering Cancer Center|Dr. Susan Prockop|212-639-6715|prockops@mskcc.org|
21295176|NCT00884039|Cornea Research Foundation of America|Marianne Price, PhD|317-814-2990|mprice@cornea.org|
21295177|NCT00717522|Celgene Corporation|Associate Director, Clinical Trial Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21295178|NCT04431713|UCL|Professor Foltynie|020 3448 8726|t.foltynie@ucl.ac.uk|
21295179|NCT01344538|University of Michigan|Suzanna M Zick|734-998-9553|szick@umich.edu|
21295180|NCT00297102|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21295181|NCT01655381|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21295182|NCT02324205|GE Healthcare|Sara Lam|1-262-548-2369|Sara.J.Lam@ge.com|
21295183|NCT00043108|Fox Chase Cancer Center|Dr. Mark Hallman|215-728-2581|Mark.Hallman@fccc.edu|
21295184|NCT00773786|Saint Francis Hospital and Medical Center|Richard ZuWallack, MD||rzuwalla@stfranciscare.org|
21295185|NCT00868218|University of Bergen|Professor Rebecca Jane Cox|+4755974668|rebecca.cox@uib.no|
21295186|NCT00613925|Oregon health & Science University|Alison Edelman, Associate Professor|503-418-2585|edelmana@ohsu.edu|
21295187|NCT00543296|Duke University Medical Center|Glenn J. Jaffe, MD|919-684-4458|jaffe001@mc.duke.edu|
21295188|NCT00929773|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
21295189|NCT03828422|University Medical Centre Ljubljana|dr. Aleš Blinc, MD, PhD|+38615227124|ales.blinc@kclj.si|
21295190|NCT02891681|Washington University School of Medicine|Quing Zhu, Ph.D.|314-935-7519|zhu.q@wustl.edu|
21295191|NCT01224821|GlaxoSmithKline|GSK Response Center|866-435-7343||
21295192|NCT00683917|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
21295193|NCT02174523|Phase I Clinical Research Unit , Shanghai Xuihui Central Hospital|Dr.Hu Chaoying|021-54036058|cyhu@shxh-centerlab.com|
21295194|NCT04422561|Zagazig University|Dr. Waheed Shouman|+201114812048|shouman66@gmail.com|
21295195|NCT03640052|Brigham and Women's Hospital|Luigi Taranto Montemurro, MD|6177326541|ltarantomontemurro@bwh.harvard.edu|
21295196|NCT00623545|University of Wisconsin-Madison|Dale A Schoeller|608-262-1082|dschoell@nutrisci.wisc.edu|
21295197|NCT04239222|Ottobock SE & Co. KGaA|Clinical Project Manager|+4955278483054|pawel.maciejasz@ottobock.com|
21295198|NCT05494736|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21295199|NCT02685748|CPD Dr Laza Lazarevic, Belgrade, Serbia|Pavicevic Dragana|0652207970|gagapavicevic@yahoo.com|+381
21295200|NCT05479097|University of Wisconsin School of Medicine and Public Health|Dr. Sean Duffy|608-263-3111|sean.duffy@fammed.wisc.edu|
21295201|NCT00937404|GlaxoSmithKline|GSK Response Center|866-435-7343||
21295202|NCT01638052|Ann & Robert H. Lurie Children's Hospital of Chicago|Santhanam Suresh, MD|312-227-5147|SSuresh@luriechildrens.org|
21295203|NCT04854031|Boys Town National Research Hospital|Adam Bosen|531-355-5030|adam.bosen@boystown.org|
21295204|NCT01893372|The Universtiy of Texas MD Anderson Cancer Center|Courtney DiNardo, MD/Associate Professor|713-794-1141|CDiNardo@mdanderson.org|
21295205|NCT03232645|Boston Scientific|Clinical Trial Manager|00393421994999|alberto.belligoli@bsci.com|
21295206|NCT01482169|Ochsner Clinic Foundation|Dr. Robert Bober|504-842-4135|rbober@ochsner.org|
21295207|NCT00445848|Swog Statistical Center|Lung Committee Statistican|2066674623|jmoon@fredhutch.org|
21295208|NCT02139878|University of Prince Edward Island|Kim S. Stote PhD, MPH, RD|518-587-2100|Kim.Stote@esc.edu|2873
21295209|NCT03541187|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21264020|NCT01628016|Hunan Normal University|Dr. Wenhui Yang|+86 731 8873076|yangwh110@163.com|
21264021|NCT02998554|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21264022|NCT02953782|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21295210|NCT02701777|Hines VA|Reagan Morehouse|312-238-2993|rmorehouse@sralab.org|
21295211|NCT00383643|Stanford University School of Medicine, Dept of Psychiatry|Dr. Jed Black|650 736 4559|jedblack@stanford.edu|
21295212|NCT01571284|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21295213|NCT03352557|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21295214|NCT03242772|Duke Center for Autism and Brain Development|Dr. Geraldine Dawson, PhD, PI of Duke Autism Center of Excellence|919-668-0070|geraldine.dawson@duke.edu|
21295215|NCT02023801|Minerva Surgical, Inc.|Dr. Eugene Skalnyi, VP Medical Affairs|(1) 650-284-3500|eugenes@minervasurgical.com|
21295216|NCT01648296|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
21295217|NCT03964246|Veterans Affairs San Diego Healthcare System|Barton W. Palmer|8582460765|bpalmer@ucsd.edu|
21295218|NCT01560637|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
21295219|NCT01089023|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21295220|NCT03220581|UConn Health|Kristyn Zajac, PhD|860-679-8572|zajac@uchc.edu|
21295221|NCT01527513|BIAL - Portela & Cª SA|Director R&D|+351-229866100|clinical.trials@bial.com|
21295222|NCT01185964|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21295223|NCT05894538|Duke University|Susanna Naggie, MD, MHS, FIDSA|919-684-2584|susanna.naggie@duke.edu|
21295224|NCT04465877|Akros Pharma Inc.|Kazuhiro Okamiya|609-919-6123|okamiya@akrospharma.com|
21295225|NCT02323204|University of Iowa/ University of Minnesota|Dr. Marizen R Ramirez|612-624-3143|mramirez@umn.edu|
21295226|NCT00395135|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
21295227|NCT02257177|Galecto|Professor Bertil Lindmark|+4570705210|info@galecto.com|
21295228|NCT03440918|Vanderbilt University Medical Center|Dr. Sophie Katz|615-343-6190|sophie.e.katz@vumc.org|
21295229|NCT01396265|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21295230|NCT03576755|University of California San Francisco|Principal Investigator: Dr. Monika Sarkar|415-502-2656|monika.sarkar@ucsf.edu|
21295231|NCT04962230|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21295232|NCT03444766|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21295233|NCT04346108|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21295234|NCT01598753|University of Washington|Dennis C. Turk, Ph.D.|(206)616-2626|turkdc@uw.edu|
21295235|NCT02275117|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
21295236|NCT00386477|Indiana University School of Medicine|David M. Haas, MD, MS|317-630-7837|dahaas@iupui.edu|
21295237|NCT01081301|University of Alberta|Dr. Wendy Duggleby|780-492-8660|wendy.duggleby@ualberta.ca|
21295238|NCT02014480|GlaxoSmithKline|GSK Response Center|866-435-7343||
21295239|NCT01865812|Intercept Pharmaceuticals, Inc.|Medical Information|+1 844-782-4278|medinfo@interceptpharma.com|
21295240|NCT01338610|Alcon Research, Ltd.|Christian Leisner|1-888-451-3937|alcon.medinfo@alcon.com|
21295241|NCT02046226|Halyard Health, Inc.|David T Curd|470-448-5178|david.curd@hyh.com|
21295242|NCT01095653|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
21295243|NCT00171925|Novartis Pharmaceuticals|Study Director|862-778-8300||
21295244|NCT02692040|Imperial College London|Dr Tricia Tan|020 838 38038|t.tan@imperial.ac.uk|
21295245|NCT03089879|GlaxoSmithKline|GSK Response Center|866-435-7343|ass77028@gsk.com|
21295246|NCT02470754|University of California, San Francisco|Natalie Nardone, PhD|415-514-1450|natalie.nardone@ucsf.edu|
21295247|NCT02825966|ZOLL|Director, Clinical Operations|4129683333|mosz@zoll.com|
21295248|NCT00054691|University of Texas (UT) MD Anderson Cancer Center|Bonnie Glisson, MD / Professor, Thoracic/Head & Neck Med Oncology|713-792-6363|CR_Study_Registration@mdanderson.org|
21295249|NCT02599649|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor|713-745-3428|ggarciam@mdanderson.org|
21295250|NCT02914548|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21295251|NCT03023826|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21295252|NCT03746600|University of Kentucky College of Medicine|Carolyn Lauckner, PhD|989-928-2359|carolyn.lauckner@uky.edu|
21295253|NCT01310179|University of Alabama at Birmingham|Eben Rosenthal, MD|205-934-9713|erosenthal@uabmc.edu|
21295254|NCT01371643|NYU Langone Medical Center|David Kleinberg|212 263 6772|David.Kleinberg@nyumc.org|
21295255|NCT02374814|SUNY Upstate Medical University|Dr. Timothy Endy|315-464-7692|endyt@upstate.edu|
21249026|NCT00337610|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
21249027|NCT00346398|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21249028|NCT03979040|VA Finger Lakes Health Care System|Dr. Nik Allan - Study Statistician|(850) 274-0567|Nicholas.Allan@osumc.edu|
21249029|NCT02607956|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21249030|NCT04012970|Edinburgh Napier Univerisity|Rebecca Hamilton, PhD student|0131 455|rebeccaisabel.hamilton@napier.ac.uk|2350
21249031|NCT01326455|UAlberta|Jennifer Fech||jennifer.fech@albertahealthservices.ca|
21249032|NCT02326220|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
21249033|NCT00824850|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21249034|NCT01782209|University of Alabama at Birmingham|Richard J. Whitley, MD|205.638.2530|rwhitley@peds.uab.edu|
21249035|NCT01075152|University of Minnesota|Dr. David R Boulware|6126249996|coat.trial@gmail.com|
21249036|NCT04820491|Virginia Commonwealth University|Jordan Tozer|804-828-5250|jordan.tozer@vcuhealth.org|
21249037|NCT01840722|University of Kentucky|Michele Staton, Associate Professor|859-257-2483|mstaton@uky.edu|
21295256|NCT02648022|Va San Diego Healthcare System|Dr. Samuel B. Ho|858-552-8585|Samuel.Ho2@va.gov|3280
21295257|NCT00072293|IBCSG|Rudolf Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org|
21264023|NCT01737840|Akdeniz University|Cenker Eken|00905321593948|cenkereken@akdeniz.edu.tr|
21264024|NCT03637699|Brigham and Women's Hospital|Bonnie Glanz, PhD|617-525-6574|bglanz@bwh.harvard.edu|
21264025|NCT03105700|Dartmouth Hitchcock Medical Center|Krzysztof Bujarski, MD|6036505000|krzysztof.a.bujarski@hitchcock.org|
21264026|NCT01449682|Retina Macula Institute|Ron P. Gallemore, M.D., Ph. D.|310) 944-9393|rongallemoremd@gmail.com|
21264027|NCT02720016|VHASDC|Dr. Leslie A. Morland|858-552-4324|Leslie.Morland@va.gov|
21264028|NCT04846348|Mayo Clinic|Dr. Joseph Butterfield|507-284-3783|butterfield.joseph@mayo.edu|
21264029|NCT05319080|New York State Psychiatric Institute|Michael Avissar|(646) 774-5431|MichaelAvissarMDPhD@gmail.com|
21264030|NCT00406783|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21264031|NCT00838916|GlaxoSmithKline|GSK Response Center|866-435-7343||
21264032|NCT03488251|Molecular Templates, Inc.|Study Director|512 930-0304|trials@mtem.com|
21264033|NCT03600714|NIDDK|Dr. Christopher Koh|301-443-9402|kohchris@mail.nih.gov|
21264034|NCT01935336|U of Colorado, Division of Medical Oncology. Anschutz Medical Campus|Dr. Ross Camidge|7208480300|ross.camidge@cuanschutz.edu|
21264035|NCT01810042|Pusan National University Hospital|Ji Eun Lee|+82-51-240-7957|jlee@pusan.ac.kr|
21264036|NCT03707158|Boston University|Donna Pincus|(617) 353-9610|dpincus@bu.edu|
21264037|NCT05092971|National Institute of Mental Health (NIMH)|Dr. Maryland Pao|301-435-5770|paom@mail.nih.gov|
21264038|NCT01328158|AbbVie (prior sponsor, Abbott)|AbbVie Japan PMOS Desk|+81-3-4577-1125|abvj-pmos@abbvie.com|
21264039|NCT01454401|Reapplix Blokken 45 3460 Birkerød Denmark|MD, PhD Senior Consultant Magnus Löndahl||magnus.londahl@med.lu.se|
21264040|NCT01968187|Ferring Pharmaceuticals|Global Clinical Compliance|+1 862-286-5200|Disclosure@ferring.com|
21264041|NCT05149040|Helse Bergen|Dr. G.L. Schwarz|0047-55976850|gabriele.leonie.schwarz@helse-bergen.no|
21264042|NCT04552535|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21264043|NCT05108805|Vanderbilt University Medical Center|Dr. Olalekan Oluwole|(615) 936-8422|olalekan.oluwole@vumc.org|
21264044|NCT01594294|Alcon Research, Ltd.|Renee Garofalo, OD, FAAO|1-888-451-3937|alcon.medinfo@alcon.com|
21264045|NCT03422133|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
21264046|NCT01274338|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21264047|NCT01927744|M.D. Anderson Cancer Center|Xiuning Le, MD|713-792-6363|xle1@mdanderson.org|
21264048|NCT03073213|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21264049|NCT02064205|TNO|W.J. Pasman, PhD|+31888665129|wilrike.pasman@tno.nl|
21264050|NCT05340322|Duke University|Nimmi Ramanujam, PhD|9196605307|nimmi@duke.edu|
21264051|NCT01522976|SWOG Statistical Center|Leukemia Committee Statistician|206-667-6597|amoseley@fredhutch.org|
21281406|NCT01118741|Johns Hopkins University|Michael Carducci, MD|410-614-3977|carducci@jhmi.edu|
21281407|NCT03197038|University of Illinois at Chicago|Dr. Ulf Bronas|312-355-5886|bronas@uic.edu|
21281408|NCT01464424|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
21281409|NCT03193684|UTHSCSA|Dr. Muhammad Abdul-Ghani|210 567 6691|abdulghani@uthscsa.edu|
21281410|NCT02174627|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
21281411|NCT01766076|Makarere University|Damalie Nakanjako|41407000|dnakanjako@gmail.com|249
21281412|NCT00848718|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21281413|NCT01769573|UW Madison|Gina Crisafi|608-262-5240|gmc@medicine.wisc.edu|
21281414|NCT02389829|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|718-920-6266|befriedm@montefiore.org|
21281415|NCT03757312|Nationwide Children's Hospital|Marco Corridore, MD|614-722-4200|Marco.Corridore@nationwidechildrens.org|
21281416|NCT05514873|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21281417|NCT01267019|VA Greater Los Angeles, VISN 22 MIRECC|Michael F. Green, PhD|(310) 268-3376|mgreen@ucla.edu|
21281418|NCT04955691|Yale school of Medicine|Laura Nally|203-785-5831|laura.nally@yale.edu|
21281419|NCT05795153|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
21281420|NCT03668119|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21281421|NCT03769168|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21281422|NCT05336227|University of Alabama at Birmingham|Byron Lai|205.638.9790|blai@uabmc.edu|8-9725
21281423|NCT04050462|NYU Langone Health|Nina Beri, MD|212-731-5770|nina.beri@nyulangone.org|
21281424|NCT04042467|Vanderbilt University Medical Center|Filoteia Popescu|615-875-9083|filoteia.popescu@vumc.org|
21281425|NCT05151744|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21281426|NCT05228470|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21281427|NCT04053868|University of California San Francisco|Dr. Neal Benowitz|628-206-8324|neal.benowitz@ucsf.edu|
21281428|NCT04541017|City of Hope|Paul Frankel, Ph.D.|6262185265|pfrankel@coh.org|
21281429|NCT01068678|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21281430|NCT02565628|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21281431|NCT00975611|Massachusetts General Hospital Schizophrenia Research Program|Dr. David Henderson|(617) 912-7800|dchenderson@partners.org|
21281432|NCT03123120|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21281433|NCT02632175|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21281434|NCT02088554|Medtronic|Jessica Halverson, Director of Clinical Research|(800) 633-8766|rsperigonpivotaltrial@medtronic.com|
21281435|NCT03100864|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21281436|NCT04066244|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21281437|NCT00866281|Novartis Pharmaceuticals|Study Director|862-778-8300||
21264052|NCT00579501|PharmaMar SA, Av de los Reyes 1 Mine Industrial Estate, 28770 Colmenar Viejo, Madrid, Spain|Medical Specialist, Clinical Oncology|+34 91 646-6087||
21264053|NCT00190983|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21264054|NCT02287402|Japan Development Center, Pharmaceutical Development Division, Takeda Pharmaceutical Company Limited|Hitoshi Onouchi|+81-6-6204-5116|hitoshi.onouchi@takeda.com|
21264055|NCT04069156|Abbott|Nourdine Chakouri, PhD|(925) 989-5982|nourdine.chakouri@abbott.com|
21264056|NCT04247815|Aclaris Therapeutics, Inc.|Ajay Aggarwal|484-540-6296|Clintrials@aclaristx.com|
21264057|NCT00209170|University of Miami School of Medicine|Dominique Musselman, MD|404-723-8361|dmusselman@med.miami.edu|
21264058|NCT02108600|University of California, San Francisco|Sindhu Chandran|4153538374|sindhu.chandran@ucsf.edu|
21264059|NCT01295580|Bioventus, LLC|Director, Regulatory and Clinical Affairs|1-800-396-4325||
21264060|NCT00089479|Hoffman-LaRoche|Medical Communications|800-821-8590||
21264061|NCT03943953|Oxford University Hospitals NHS Foundation Trust|Dr Matthew Hotton|01865 234714|matthew.hotton@ouh.nhs.uk|
21281438|NCT00536939|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21281439|NCT04225715|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21281440|NCT01598064|National Cheng Kung University Hospital|Dr. Po Lin Chen|886-2353535|n939492@mail.hosp.ncku.edu.tw|4733
21281441|NCT03158038|MedImmune, LLC|Raburn Mallory|+1-301-398-5799|information.center@astrazeneca.com|
21281442|NCT02275546|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21281443|NCT01220466|Abbott Medical Optics|Amelia Saliba, Sr. Manager, Clinical Research|408-273-4158|amelia.saliba@amo.abbott.com|
21281444|NCT02918565|Stanford University|Brian Suffoletto|4129016892|suffbp@stanford.edu|
21281445|NCT02955355|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21281446|NCT02612623|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21295258|NCT04209114|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
21295259|NCT02403895|AstraZeneca|Medical Science Director||clinicaltrialtransparency@astrazeneca.com|
21295260|NCT00901511|Fondazione IRCCS Policlinico San Matteo Pavia|Francesca Mariani|+39 0382 503590|fr.mariani@smatteo.pv.it|
21295261|NCT02880514|Intersect ENT, Inc.|James Stambaugh, Vice President of Clinical & Medical Affairs|650-641-2103|jstambaugh@intersectent.com|
21295262|NCT04151628|Shockwave Medical Inc|Randee Randoll, Director Clinical Affairs|1-408-577-7856|rrandoll@shockwavemedical.com|
21295263|NCT02826421|Alcon, A Novartis Division|Sr Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21295264|NCT04899440|Procter & Gamble|Clinical Trial Manager|5136225362|combs.cs@pg.com|
21295265|NCT02210221|UZA|Prof. Em. Dr Andrew Maas|0032 3 821 45 37|andrew.maas@uza.be|
21295266|NCT02230761|Topokine Therapeutics, Inc.|Chief Scientific Officer|617 203 2034|CSO@topokine.com|
21295267|NCT00405964|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21295268|NCT00167180|Masonic Cancer Center, University of Minnesota|Dr. Jeffrey Miller|612-625-7409|mille011@umn.edu|
21295269|NCT03785587|Botanix Pharmaceuticals|Anthony Robinson MS CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
21295270|NCT00937118|Oregon Health & Science University|John Mayberry, MD|503-494-5300|mayberrj@ohsu.edu|
21295271|NCT04030247|Stanford University|Rajesh Dash, MD|650-725-7087|rdash@stanford.edu|
21295272|NCT05320393|Evolus, Inc.|Rui Avelar|1-949-284-4689|rui.avelar@evolus.com|
21295273|NCT03187834|F.I. Proctor Foundation, University of Califonia, San Francisco|Dr. Thomas Lietman|415-502-2662|tom.lietman@ucsf.edu|
21295274|NCT03559699|Agios Pharmaceuticals, Inc|Medical Affairs|833-228-8474|medinfo@agios.com|
21295275|NCT00031460|Collaborative Antiviral Study Group|Penelope M. Jester|(205) 934-2424|pjester@peds.uab.edu|
21295276|NCT01401699|Massachusetts General Hospital|Gary Tearney, PI|617-724-2979|gtearney@partners.org|
21295277|NCT02968381|University of Arizona|Judith Gordon|520-626-4970|judithg@email.arizona.edu|
21264062|NCT01102218|Fresenius Medical Care North America|Christina Kahn, Senior Manager of Clinical Trials|615-345-5542|christina.meng@fmc-na.com|
21281447|NCT01739231|PATH|Richard Walker|202-822-0033|rwalker@path.org|
21281448|NCT00570141|Healthpoint, Ltd.|Herbert B. Slade, M.D., FAAAI|917-900-4000|bert.slade@healthpoint.com|
21281449|NCT02309411|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
21281450|NCT02506868|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28|linkova@biocad.ru|930
21281451|NCT04878432|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21281452|NCT00925704|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21281453|NCT03207815|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21281454|NCT03817853|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21295278|NCT01722292|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21236252|NCT03930745|University of Alabama at Birmingham School of Medicine|Jeanne Marrazzo, MD, MPH|205-975-5500|jmarrazzo@uabmc.edu|
21236253|NCT02670629|"Servicio de Ortopedia y Traumatología . Hospital Universitario José Eleuterio González"|Dr. Adriana Hernández|8112901288|adrianahl@gmail.com|
21236254|NCT04095858|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21236255|NCT01343706|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21236256|NCT02116322|Johns Hopkins Hospital|Dr. Mouen Khashab|443-287-1960|mkhasha1@jhmi.edu|
21236257|NCT01688336|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
21236258|NCT03154710|Weprom|Dr Katell LE DU|241682940|k.ledu@cjb72.org|0033
21236259|NCT00612313|UT Southwestern Medical Center|Dr. Graham Emslie and Dr. Betsy Kennard|214-456-5900|beth.kennard@utsouthwestern.edu|
21236260|NCT00428610|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21295279|NCT00471887|UCLA|Antoni Ribas, MD|310-206-3928|aribas@mednet.ucla.edu|
21295280|NCT01930890|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21295281|NCT03710876|Ferring Ventures Ltd|Lindsay Caygill Clinical Trial Manager|+44 (0) 74 213 02230|linsdsay.caygill@trizell.com|
21295282|NCT03115853|Vanderbilt University Medical Center|James Muldowney, MD|615-936-1720|james.muldowney@vanderbilt.edu|
21295283|NCT02209948|MFAR Clinical Research|Pau Doñate|0034934344412|investigacion@mfar.net|
21295284|NCT02630017|University of Arkansas for Medical Sciences|Merideth Addicott|501-526-8436|maddicott@uams.edu|
21295285|NCT01176565|University of Minnesota|Adnan I. Qureshi, MD|612-624-2431|qureshai@gmail.com|
21295286|NCT01151761|Stanford University Cancer Center|Dr. Daniel Chang|650-724-3547|dtchang@stanford.edu|
21295287|NCT03602885|DFCI|Andrea Enzinger, MD|617-582-7335|andrea_enzinger@dfci.harvard.edu|
21295288|NCT02754141|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21295289|NCT03911752|University of A Coruña|Thais Pousada García|+34 981 167 000|thais.pousada.garcia@udc.es|5870
21295290|NCT01187446|Stanford University Medical Center|Youn H Kim, MD|650-521-3545|younkim@stanford.edu|
21295291|NCT01430325|Intermountain Healthcare|Lindell K. Weaver, MD|801-408-3623|lindell.weaver@imail.org|
21295292|NCT02838901|Wake Forest School of Medicine|Dr. Cheryl Bushnell|336-716-4101|cbushnel@wakehealth.edu|
21295293|NCT01007123|Albireo|Dr Mats Ekelund|+46 31 741 14 80|info@albireopharma.com|
21295294|NCT00823212|Boston Scientific Corporation|Ruth Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com|
21295295|NCT04114604|KITE Research Institute - Toronto Rehabilitation Institute, University Health Network|Director, Swallowing Rehabilitation Research Laboratory|416 597 3422|tri-swallowinglab@uhn.ca|7802
21295296|NCT02285114|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21295297|NCT00320255|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21295298|NCT01156389|Shin Poong Pharmaceutical Co., Ltd.|Jangsik Shin|+82-2-2189-3468|jsshin@shinpoong.co.kr|
21295299|NCT02351349|MUHC|Sameena Iqbal|5146302225|sameena.iqbal@mcgill.ca|1841
21295300|NCT00350623|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21295301|NCT03660228|Dana-Farber Cancer Institute|Gregory A. Abel, MD|617-632-2304|GAABEL@PARTNERS.ORG|
21295302|NCT04685707|University of Southern Mississippi|Dr. Nuno Oliveira|6012665804|nuno.oliveira@usm.edu|
21295303|NCT04126564|Sadhguru Center for a Conscious Planet, BIDMC|Dr. Balachundar Subramaniam|(617)632-8071|bsubrama@bidmc.harvard.edu|
21249038|NCT01079949|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21249039|NCT02144285|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21249040|NCT01529632|Novartis Pharmaceuticals|Study Director|862-778-8300||
21249041|NCT02759575|University of Cincinnati|Vinita Takiar, MD, PhD, Associate Professor|(513)584-8956|Vinita.Takiar@UCHealth.com|
21249042|NCT01818063|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Edith Mitchell|215-955-8874|edith.mitchell@jefferson.edu|
21249043|NCT04445337|University of Nebraska Medical Center|Michael Lankhorst|402-559-4081|michael.lankhorst@unmc.edu|
21249044|NCT03659136|Boehringer Ingelheim, Call Centre|Boehringer Ingelheim|018002430127|clintriage.rdg@boehringer-ingelheim.com|
21249045|NCT04914897|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21249046|NCT03020914|Hospital for Special Surgery|Marla Sharp, MPH, MA|646-797-8419|sharpm@hss.edu|
21249047|NCT02713217|Central Arkansas Veterans Healthcare System|Richard R. Owen, MD|5012574802|richard.owen2@va.gov|
21249048|NCT02221934|Neuros Medical, Inc.|Nick Hargus, PhD. Vice President of Clinical and Medical Affairs|440-951-2565|nhargus@neurosmedical.com|
21249049|NCT01921166|AtriumHealth|Bradley Hurst, M.D., Director of Assisted Reproduction|704-355-3149|brad.hurst@atriumhealth.org|
21249050|NCT03624023|Transwell Biotech Co., Ltd.|Dr. Bin-Ru She|+886-3-5670399|binru.she@tw-bio.com|207
21249051|NCT00451906|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21249052|NCT01250717|BIDMC|Glenn Bubley MD, Director of GU ONC|617-735-2062|gbubley@bidmc.harvard.edu|
21249053|NCT05066230|Kodiak Sciences Inc|Chief Medical Officer|1 (650) 281-0850|ClinOps@kodiak.com|
21249054|NCT03072238|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21249055|NCT02400749|Innovaderm Research Inc.|Dr Robert Bissonnette|514-521-4285|rbissonnette@innovaderm.ca|
21249056|NCT00507429|OXiGENE, Inc.|Peter Langecker, MD, PhD|650 635 7008|plangecker@oxigene.com|
21249057|NCT02889900|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazenca.com|
21249058|NCT00813709|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21249059|NCT02958826|University of Missouri|Dr. Hope Gole|573-882-8030|golehk@health.missouri.edu|
21249060|NCT03761849|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21249061|NCT03840993|Mitsubishi Tanabe Pharma America Inc.|Clinical Trials, Information Desk|Please email|information@mt-pharma-us.com|
21249062|NCT01587703|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21249063|NCT04751929|Dana-Farber Cancer Institute|Atish Choudhury, MD PhD|6176326328|atish_choudhury@dfci.harvard.edu|
21249064|NCT01123356|Medical University of South Carolina|Clinical Trials Network Manager|843-792-1753|adraleta@musc.edu|
21249065|NCT03015961|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
21249066|NCT00376259|Novartis Pharmaceuticals|Study Director|862-778-8300||
21249067|NCT03734588|Spark Therapeutics|Tiffany Chang, MD, MAS Clinical Development Lead, Hematology|Please Email|Tiffany.chang@sparktx.com|
21249068|NCT00759681|Greenville Memorial Hospital|David Cull, MD|864-455-9825||
21249069|NCT00930644|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21249070|NCT01877720|Seoul National University College of Medicine|Dr. Han-Suk Kim|82-2-2072-1696|kimhans@snu.ac.kr|
21295304|NCT00328653|Santen Inc|R&D Quality Manager|415 268 9199|evelyn.chikere@santen.com|
21295305|NCT01752400|Massachusetts General Hospital|Alice Shaw, MD, PhD|617-724-4000|ashaw1@mgh.harvard.edu|
21295306|NCT02540330|Atossa Therapeutics, Inc.|Heather Fraser, VP Clinical, Regulatory & CMC|206-707-3088|heather.fraser@atossainc.com|
21295307|NCT00090233|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21295308|NCT04863248|G1 Therapeutics, Inc|Clinical Trial Info|919-213-9835|clinicalinfo@g1therapeutics.com|
21295309|NCT01779869|Washington University School of Medicine|Pamela K. Woodard, M.D.|314-362-7130|woodardp@wustl.edu|
21295310|NCT01035346|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21295311|NCT02536300|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21295312|NCT03760016|University of Cincinnati|Pierce Boyne|5135587499|Pierce.Boyne@uc.edu|
21295313|NCT04754230|Stanford University|Zara M. Patel, MD|650-723-5651|zmpatel@stanford.edu|
21295314|NCT01318278|Baylor College of Medicine|Dr. Danielle R. Rios|832-826-1380|drrios@texaschildrens.org|
21295315|NCT01691105|Yale School of Medicine|Dr. Steven Bernstein|203-737-3574|steven.bernstein@yale.edu|
21295316|NCT00957944|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
21295317|NCT00803517|Samsung Medical Center|Jiwon Lim|82-10-9933-5596|samnyasa@naver.com|
21295318|NCT01777542|Boston Children's Hospital|Dr. Mustafa Sahin, Director of Translational Neuroscience Center|617-919-6258|ResearchTNC@childrens.harvard.edu|
21295319|NCT02270255|McGill University Health Centre|Louis-Martin boucher|5149341934|lmboucher@yahoo.com|44454
21295320|NCT05605691|Apyx Medical|Kari Larson, Sr. Director of Clinical Affairs|8012440058|kari.larson@apyxmedical.com|
21295321|NCT02279719|Sumitomo Dainippon Pharma Oncology|Matthew Hitron, MD|617-674-6800|mhitron@bostonbiomedical.com|
21295322|NCT04706273|W. L. Gore & Associates|Eric Novak|314-440-2110|enovak@wlgore.com|
21295323|NCT05257148|A. Menarini Industrie Farmaceutiche Riunite SrL|Clinical Operation Director|+39 055 5680459|pfabrizzi@menarini.it|
21295324|NCT00869050|Columbia University|Dr. Paul Oberstein|212-305-0592|po2178@cumc.columbia.edu|
21295325|NCT00899717|University of Santiago de Compostela|Urbano Santana Penín|0034647344093|urbano.santana@usc.es|
21295326|NCT03199053|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21295327|NCT00759356|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com|
21295328|NCT02769338|Department of Veterans Affairs|Dr. Dawn M. Bravata|317-988-2676|Dawn.Bravata2@va.gov|
21295329|NCT00561002|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21295330|NCT03298984|Sumitomo Dainippon Pharma Oncology, Inc.|Susan Smith|2104147702|Susan.smith@sdponcology.com|
21295331|NCT02089113|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com|
21295332|NCT00970814|NIAAA|Megan Ryan - Clinical Trials Project Manager|301-443-4225|mryan1@mail.nih.gov|
21295333|NCT00359944|Sunovion|Medical Director, CNS|1-866-503-6351||
21295334|NCT02509052|Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA 91010|Michael Rosenzweig, MD|626-218-2405|mrosenzweig@coh.org|
21295335|NCT01323270|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21295336|NCT00075725|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21295337|NCT04677660|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21295338|NCT01070693|Helsinki University Central Hospital|Dr. Georgios Pierides|+358 9 4711|georgios.pierides@hus.fi|
21295339|NCT03410797|University of Pittsburgh|Jacqueline Gartner-Schmidt|412-232-8970|jgs@pitt.edu|
21295340|NCT03190265|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dung Le, MD|443-287-0002|dle@jhmi.edu|
21295341|NCT02170363|St. Jude Medical|Poornima Sood|+17818528334|PSood@sjm.com|
21295342|NCT02182440|AM-Pharma B.V.|JAcques Arend MD, DiMD, Chief Medical Officer|+31302598836|j.arend@am-pharma.com|
21295343|NCT03754582|Eisai Co., Ltd.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
21295344|NCT03630198|Vanderbilt Univeristy Medical center|Dr. Brian Drolet|615-322-2918|brian.c.drolet@vumc.org|
21295345|NCT01561755|Icahn School of Medicine at Mount Sinai|Dr. David Simpson|212-241-8748|david.simpson@mssm.edu|
21295346|NCT02981407|Rutgers Robert Wood Johnson Medical School|Dr. Jeffrey Carson|732-235-7122|jeffrey.carson@rutgers.edu|
21295347|NCT02466074|The University of Texas Health Science Center at Houston|John A. Lincoln, MD, PhD|713-500-7016|John.A.Lincoln@uth.tmc.edu|
21295348|NCT03058666|Ony Biotech|James Cummings, MD|7166369096|jcummings@onybiotech.com|
21249071|NCT02962609|Istanbul University|Duygu Gözen (Associate Professor)|+902124400000|dgozen@istanbul.edu.tr|27082
21295349|NCT02818036|University of Pittsburgh|Dr. Tristen Inagaki|412-624-4211|inagaki@pitt.edu|
21295350|NCT05434013|BU School of Public Health|Jennifer Ross, PhD|617 358 1905|jjross@bu.edu|
21295351|NCT01319721|State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University|Dr. Shiyou Zhou|+86-020-87331540|zhoushiy@mail.sysu.edu.cn|
21295352|NCT00468845|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21295353|NCT00585221|Huntsman Cancer Institute|Director of Clinical Trials|801-213-4241|candace.larson@hci.utah.edu|
21295354|NCT00620425|Zogenix, Inc|Edward Smith III, PhD, VP Regulatory Affairs & Product Quality/Safety|510 550 8325|esmith@zogenix.com|
21295355|NCT03263923|Case Western Reserve University|Dr. Carol M. Musil|216-368-2545|cmm4@case.edu|
21295356|NCT05357664|DePuy Synthes|Dave Whalen|574-404-9399|dwhalen@its.jnj.com|
21295357|NCT01655043|Northwestern University|Dr. James Carr|(312)926-2270|jcarr@northwestern.edu|
21295358|NCT01924442|VA Medical Center, Denver, Colorado|Frederick Grover, MD|303-724-2798|Frederic.Grover@ucdenver.edu|
21249072|NCT00473512|Janssen R & D|Senior Director, Clinical Research|(310) 943-8040||2917
21249073|NCT01129011|POZEN|Senior Vice President, Clinical Research|919-913-1030|eorlemans@pozen.com|
21249074|NCT02416973|Regenesis Biomedical Inc.|Heather Vander Ploeg|602-428-7041|Heather.VanderPloeg@regenesisbio.com|
21295359|NCT01057225|Mayo Clinic|Joseph Riad Mikhael, M.D.||Mikhael.Joseph@mayo.edu|
21264063|NCT01742078|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21264064|NCT00986310|University of California, Davis|Lisa Bateman, MD, FRCPC||lb2863@cumc.columbia.edu|
21264065|NCT05600309|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21264066|NCT05822830|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21264067|NCT03368664|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21264068|NCT05441592|University of Michigan|Edwin Wilkins|734-936-6680|ewilkins@med.umich.edu|
21264069|NCT01021852|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21264070|NCT01371981|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21264071|NCT01655823|Wex Pharmaceuticals|Mehran Kavoosi|6046767900|mehrank@wexpharma.com|
21264072|NCT00603980|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
21264073|NCT00711269|Clinical Research, Drug Development Division|Regional Function Head of CNS Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
21264074|NCT02632110|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Anna Houlihan|9147608796|anna.houlihan@sunpharma.com|
21264075|NCT00906074|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21264076|NCT02618928|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21264077|NCT03927508|Clinical Reserach Specialist|Pamela Dicamillo|719-400-7463|pdicamillo@ecr-inc.com|
21264078|NCT02118610|Maryland Psychiatric Research Center|Ann Kearns, MS|4104066854|akearns@som.umaryland.edu|
21264079|NCT02357849|Northwell Health|Dr. Christoph Correll|718-470|ccorrell@northwell.edu|7000
21264080|NCT00426517|National Institute of Allergy and Infectious Diseases|Kang, Elizabeth|+1 301 402 7567|ekang@niaid.nih.gov|
21264081|NCT01022567|Turku University Hospital|Paulina Salminen|+358 2 313 0542|paulina.salminen@tyks.fi|
21264082|NCT01317667|US Army Medical Research Institute of Infectious Diseases (USAMRIID)|Denise P Clizbe, RN, CCRC|301.619.6869|denise.p.clizbe.civ@mail.mil|
21264083|NCT03615911|University Medical Center Hamburg-Eppendorf|Prof. Marylyn M. Addo|+49 40 7410|m.addo@uke.de|51102
21264084|NCT04363437|Maimonides Medical Center|Dr. Felix Yang|7182836000|fyang@maimonidesmed.org|
21264085|NCT00064350|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
21264086|NCT01927419|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21264087|NCT00115765|Amgen Inc.|Study Director|866-572-6436||
21264088|NCT03019744|Fondazione Don Carlo Gnocchi|Dr Maurizio Ferrarin|+390240308305|mferrarin@dongnocchi.it|
21264089|NCT00995670|Zablocki VA Medical Center|Thomas J. Ebert, MD, PhD|414-384-2000|thomas.ebert@va.gov|42429
21264090|NCT00675103|Savient Pharmaceuticals, Inc.|Chief Medical Officer|732-418-9300||
21264091|NCT04597619|Maine Medical Center|David Sobel, MD|207-773-1728|david.sobel@mainehealth.org|
21264092|NCT00592553|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
21264093|NCT02006264|Albert Einstein College of Medicine|Marla Keller, MD, Principal Investigator|718-430-3240|marla.keller@einstein.yu.edu|
21264094|NCT01208038|Chelsea and Westminster NHS Trust|Dr Kate Maclaran|020 3315 3000|kate.maclaran@nhs.net|
21264095|NCT02773238|University of Washington|Dr. Jing Zeng|206-598-4110|jzeng13@uw.edu|
21264096|NCT01743963|Eastern Colorado Health Care System, VA|Liron Caplan, Primary Investigator|7208575103|liron.caplan@ucdenver.edu|
21264097|NCT01877382|Daiichi Sankyo, Inc.|Clinical Director|908-992-6400|CTRinfo@dsi.com|
21264098|NCT03829332|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21264099|NCT00479557|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21264100|NCT01511107|Children's Hospital of Pittsburgh of UPMC|Dr. Alejandro Hoberman|412-692-5249|hobermana@upmc.edu|
21264101|NCT02598661|Geron Corp.|Study Director|650-473-7700|mds3001-info@Geron.com|
21264102|NCT05195359|Resmed Germany Inc|Susanne Fischer / Sr. Manager Clinical Research|+491707854257|susanne.fischer@resmed.de|
21264103|NCT00847938|Clinique Jules Verne|Dr Florent CAPRON|0251171775|florent.capron@mla.fr|33
21264104|NCT01146951|Eisai Call Center|Eisai Inc.|888-422-4743||
21281455|NCT04268771|Dr. Reddy's Laboratories Ltd.|Head-Clinical Development|91-40-4464-4000|RI-01-007@drreddys.com|
21264105|NCT01586026|Bard Access Systems, Inc.|Christopher DiMatteo|801-522-5000|chris.dimatteo@crbard.com|
21264106|NCT04092816|University of North Carolina at Chapel Hill|Zev Nakamura, MD|984-974-3829|zev_nakamura@med.unc.edu|
21264107|NCT03342937|Duke University|Dr. Hope Uronis|919-668-1861|hope.uronis@duke.edu|
21264108|NCT01747811|University of Arizona|William Killgore|520-621-0605|killgore@psychiatry.arizona.edu|
21264109|NCT01353144|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
21264110|NCT01617655|Sanofi|Trial Transparency Team||Contact--US@sanofi.com|
21249075|NCT01012999|University of Utah|Robert Stephen, MD|801-587-7653|rlstephen@comcast.net|
21249076|NCT01369147|Emory University|Thomas Ziegler, MD|404-727-7351|tzieg01@emory.edu|
21249077|NCT02132676|VA Ann Arbor Healthcare System Center for Clinical Management & Research|Dr. Michele Heisler|734-845-3502|mheisler@umich.edu|
21249078|NCT01567150|Hollister Incorporated|Director, Global Clinical Affairs|8479183996|ginger.salvadalena@hollister.com|
21249079|NCT01494467|Galderma R&D, LLC|Clinical Science Director|609-409-7701||
21249080|NCT03711279|Jiangsu HengRui Pharmaceuticals Co., Ltd.|Project manager|+86-18036618962|qianna.zhan@hengrui.com|
21249081|NCT02410278|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
21249082|NCT02584257|Lupin Research Inc|Dr. Mark Lepore|(443) 740-9323|marklepore@lupin.com|
21249083|NCT01672242|University of Maryland School of Medicine|Carl Shanholtz, MD|410.328.8141|cshanhol@som.umaryland.edu|
21249084|NCT05376397|Rutgers School of Public Health|Dr. Devin English, Prinicipal Investigator|19739727212|devin.english@rutgers.edu|
21264111|NCT01175213|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21264112|NCT03224585|VCU Health|Antonio Abbate, MD, PhD|804-828-0513|antonio.abbate@vcuhealth.org|
21264113|NCT01921634|The Pennsylvania State University, Hershey Medical Center|Andrea Benton, MD|717-531-5394|abenton@pennstatehealth.psu.edu|
21264114|NCT03057951|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21264115|NCT02700919|Mereo BioPharma Group|Ian Hodgson, Head of Clinical Operations|+44 3330237300|enquiries@mereobiopharma.com|
21264116|NCT04393038|Abivax|Study Director|+33 1 53 83 09 63|info@abivax.com|
21264117|NCT05168813|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
21264118|NCT03624478|Mayo Clinic|Dr. Carlos Vargas|480-342-1267|Vargas.Carlos@mayo.edu|
21264119|NCT03263117|The University of Texas Health Science Center at Houston|Peng Roc Chen, MD|713-486-8016|peng.r.chen@uth.tmc.edu|
21264120|NCT02680587|Johns Hopkins University|Dr. Phuoc T. Tran|4106143880|ptran12@jhmi.edu|
21264121|NCT01010854|University of California, San Francisco|Pamela Munster, MD|877-827-3222|clinicaltrials@ucsf.edu|
21264122|NCT00259740|Amgen Inc.|Study Director|866-572-6436||
21264123|NCT02492997|Venus Concept Ltd.|Dr. Yoni Iger|888-907-0115|yoni@venusconcpet.com|
21264124|NCT05848323|University of Washington|Lindsey Knowles|2067449640|lmknow@uw.edu|
21264125|NCT01367301|Albert Einstein College of Medicine - Montefiore Medical center|Dr. Jessica Atrio, Professor, Department of Obstetrics & Gynecology and Women's Health|917-721-6155|jatrio@montefiore.org|
21264126|NCT01844830|Loma Linda University|Yiming Li, DDS|909-558-4600|kkellingsworth@llu.edu|
21264127|NCT02500602|Medical University of South Carolina|Sudie Back|843-792-9383|backs@musc.edu|
21264128|NCT03934710|University of Chicago|Dr. Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
21264129|NCT04735393|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
21264130|NCT02130427|University of Pennsylvania|Dr. Wei Zou|800-789-7366|Wei.Zou@pennmedicine.upenn.edu|
21264131|NCT00258427|Masonic Cancer Center, University of Minnesota|Margaret L. MacMillan, M.D.|612-273-2800|macmi002@umn.edu|
21264132|NCT01621672|University of Arkansas for Medical Sciences|Bart Barlogie|526-6990|barlogiebart@uams.edu|2420
21264133|NCT03150095|Mayo Clinic|Dr. Cassie Kennedy|507-266-3958|kennedy.cassie@mayo.edu|
21264134|NCT01735617|Diurnal Ltd.|CEO|+44 (0) 871 716 8848|info@diurnal.co.uk|
21264135|NCT04570332|Highlight Therapeutics Ltd.|M. Quintero, CEO|+34686219355|mquintero@highlighttherapeutics.com|
21264136|NCT02769351|Fresenius Medical Care Deutschland GmbH|Dr. Jennifer Braun|+49617260893488|jennifer.braun@fmc-ag.com|
21264137|NCT03822871|Cancer Targeted Technology|Dr. Beatrice Langton-Webster, CEO|(206) 617-0699|bealw@cancertargetedtechnology.com|
21264138|NCT04580394|Apnimed, Inc.|Clinical Trials|6175008880|clinicaltrials@apnimed.com|
21264139|NCT00564954|Novartis Pharmaceuticals|Study Director|862-778-8300||
21264140|NCT04397718|Department of Veterans Affairs GLA|Dr. Matthew Rettig|310-478-3711|matthew.rettig@va.gov|44761
21264141|NCT03589326|Director|Medical|+1-877-825-3327|trialdisclosures@takeda.com|
21264142|NCT01029002|Albert Einstein College of Medicine|Dr. Michal Melamed|718-430-2304|michal.melamed@einsteinmed.edu|
21264143|NCT04593940|Washington University in St. Louis|William G. Powderly MD|314-454-8276|wpowderly@wustl.edu|
21264144|NCT01096849|Achaogen, Inc.|Clinical Trials Posting Group||clinical-trials@achaogen.com|
21264145|NCT00127062|Imperial College London|Professor Fan Chung|+44 (0)20 7594 7954|f.chung@imperial.ac.uk|
21264146|NCT02856269|University Hospitals Cleveland Medical Center|Dr. Grace McComsey|216-8442739|Grace.McComsey@UHhospitals.org|
21264147|NCT01269372|Givenimaging|Hilla Debby/ Director of Clinical Affairs|97299077740|hila.debby@medtronic.com|77740
21264148|NCT04146467|Apyx Medical|Kari Larson, MBA, Sr. Director, Clinical Affairs|8012440058|kari.larson@apyxmedical.com|
21264149|NCT02128763|University of Pennsylvania|Maureen G. Maguire, PhD|215-615-1501|maguirem@pennmedicine.upenn.edu|
21264150|NCT01253421|McLean Hospital|Diego Pizzagalli, Ph.D.|617-855-4230|dap@mclean.harvard.edu|
21264151|NCT01525927|North Shore LIJ Cancer Institute|Jeffrey Revello Sr. Administrative Manager|516 734 7629|jrevello@nshs.edu|
21264152|NCT01608724|Astrazeneca Investment (China) Co., Ltd.|Anya Huang, Brand Physician|+86 21 6030 2032|anya.huang@astrazeneca.com|
21295360|NCT02229214|VIVUS Inc.|Craig Peterson, Sr. Director, Clinical Research|650-934-5200|ClinicalTrials@vivus.com|
21295361|NCT00246025|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21249085|NCT02721147|Fox Chase Cancer Center|Dr. Jennifer Reese, Assistant Professor|215-214-3223|Jennifer.Reese@fccc.edu|
21249086|NCT01722097|Herlev Hospital, University of Copenhagen, Department of Anaesthesiology|Dr. Matias Vested Madsen|+45 38683868|matias.vested.madsen@regionh.dk|
21249087|NCT00711022|DENTSPLY Implants|Senior Manager Global Clinical Research|+46313763500|clinicalresearchmolndal@dentsply.com|
21249088|NCT01535261|Novartis|Study Director|862-778-8300||
21249089|NCT01137682|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21249090|NCT04812977|Hayatabad Medical Complex, Peshawar|Yousaf Jamal Mahsood|091921714047|yousaf82@hotmail.com|
21249091|NCT02009332|Aadi Bioscience|Berta Grigorian|818-416-8378|bgrigorian@aadibio.com|
21249092|NCT01912599|University of North Carolina|Jean-Claude Mwanza, MD, MPH, PhD|919-843-4917|jean-claude_mwanza@med.unc.edu|
21249093|NCT02791308|Teva Pharmaceuticals Inc. USA|Senior Director, CE Studies|1-888-483-8279|USMedinfo@tevapharm.com|
21249094|NCT01280721|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366||
21249095|NCT01180400|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21249096|NCT05188248|NYU Langone|Matthew Lustberg|929-455-5090|matthew.lustberg@nyulangone.org|
21264153|NCT04633473|Oregon Research Behavioral Intervention Strategies|Jessie Marquez|541-484-2123|jessie.marquez@influentsin.com|
21264154|NCT05291949|Henry Ford Health|Director of Research, Department of Anesthesiology|313-771-7128|knowak2@hfhs.org|
21264155|NCT00099359|Westat|Margaret Camarca, Project Director|301-517-4128|margaretcamarca@westat.com|
21249097|NCT00042939|ECOG Statistical Office|Study Statistician|617-632-3012||
21249098|NCT03349476|Icahn School of Medicine at Mount Sinai|Stephanie Harcum|(212) 824-8927|stephanie.harcum@mountsinai.org|
21249099|NCT00795639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21249100|NCT00068107|Baylor Research Institute|Dr. Raphael Schiffmann|214-820-4533|raphael.schiffmann@baylorhealth.edu|
21249101|NCT01419184|Cubist Pharmaceuticals|Vice President, Clinical Research|1.781.860.8660||
21249102|NCT02773732|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
21249103|NCT02978183|Noveome Biotherapeutics, Inc|David Steed, MD|4124029913|dsteed@noveome.com|
21249104|NCT01888484|Clinical Research Management Group|Mikaela Raymond|866-337-1868|ctgov@cllinicalresearchmgt.com|
21249105|NCT01441596|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21249106|NCT03055988|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21249107|NCT01528605|Peking University|Xiaoming Lin|010-82805336|linbjmu@bjmu.edu.cn|
21249108|NCT01681511|ICET, Inc.|Dr. Shantha Sarangapani|781-769-6064|Shantha@icetinc.com|
21249109|NCT01156675|Globus Medical|Director, Clinical Affairs|610-930-1800|jmyer@globusmedical.com|1669
21249110|NCT02151994|BIAL-Portela & Ca, S.A.,|Head of Clinical Research|(+351)-22-9866100|clinical.trials@bial.com|
21249111|NCT00090519|Chromaderm|info@chroma-derm.com||info@chroma-derm.com|
21249112|NCT00116649|Graceway Pharmaceuticals LLC|Sharon Levy, MD VP Product Development|267-948-0500|sharon.levy@gracewaypharma.com|
21249113|NCT02161146|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21249114|NCT00845520|RxSight, Inc.|Maureen O'Connell Vice President, Regulator and Clinical Affairs|978-207-12415|moconnell@rxsight.com|
21249115|NCT02613403|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21249116|NCT00800176|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21249117|NCT04000399|University of Pittsburgh|Stephanie D. Stepp, PhD|4127155447|steppsd@upmc.edu|
21249118|NCT02659540|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
21249119|NCT02739100|Rockwell Medical, Inc|Clinical Project Manager|248-960-9009|sgrimberg@rockwellmed.com|
21249120|NCT01605435|University of Pennsylvania|Dr. Anne Cappola, PI|215-573-5359|acappola@mail.med.upenn.edu|
21249121|NCT01298219|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
21249122|NCT00506025|University of California Irvine Medical Center|Deborah A. Wing, MD|714-456-5967|dwing@uci.edu|
21249123|NCT00608959|Cadence Pharmaceuticals, Inc|Catherine J Hardalo, MD Vice President, Anti-Infectives Clinical Development|858 4361439|chardalo@cadencepharm.com|
21249124|NCT01416285|Chang Gung Memorial Hospital|CHAO-HUNG WANG, MD|+886-2-24313131|bearty54@gmail.com|2923
21249125|NCT01005602|University of Illinois at Chicago|Dr. Robert J. DiDomenico|(312) 413-4654|rdidom1@uic.edu|
21249126|NCT01248715|University Louisville|Dr. Paula Peyrani|502-852-3905|paula.peyrani@louisville.edu|
21249127|NCT01919489|Emory University|Dr. Francisco Pasquel|404-778-1695|fpasque@emory.edu|
21249128|NCT01131325|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21249129|NCT03884478|Loyola Marymount University|Dr. Sarah C. Boyle, Senior Research Scientist|3105686681|sarah.boyle@lmu.edu|
21249130|NCT01807234|Johns Hopkins University School of Medicine|Dr. B. Lee Peterlin|410-550-9550|hnitchi1@jhmi.edu|
21249131|NCT01540474|Walter Reed Institute of Research|Jason W. Bennett|3013199477|jason.w.bennett.mil@mail.mil|
21249132|NCT00857311|Merck Sharp & Dohme|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21249133|NCT00828139|SWOG Statistical Center|Lung Committee Statistician|2066674623|jmoon@fredhutch.org|
21249134|NCT01714947|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21249135|NCT06182631|SUNY Buffalo|Jill Fenenll|716-323-0220|jillfenn@buffalo.edu|
21249136|NCT04271254|University of North Carolina Lineberger Comprehensive Cancer Center|David Lalush|9195137671|dlalush@email.unc.edu|
21249137|NCT01345253|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21249138|NCT02662023|University of California, San Diego|Brian M. Ilfeld, MD, MS||bilfeld@ucsd.edu|
21249139|NCT01074099|Harvest Technologies|Director of Clinical Operations|508-732-7530|CLI2011communication@harvesttech.com|
21249140|NCT02137785|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Anna Houlihan|9147608796|anna.houlihan@sunpharma.com|
21249141|NCT00417885|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21249142|NCT02309892|Helix BioPharma Corp.|Brenda Lee, Director, Clinical Operations|416 642 1807|blee@helixbiopharma.com|
21249143|NCT01584648|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21249144|NCT03146845|Smith & Nephew, Inc.|Judith Horner|+44 1482 673251|judith.horner@smith-nephew.com|
21249145|NCT03403153|Department of Veterans Affairs|Dr, Suzannah Creech Ph.D|254-297-3025|suzannah.creech@va.gov|
21249146|NCT00185692|Stanford University|Robert Lowsky|650-723-0822|rlowsky@stanford.edu|
21249147|NCT02450747|Johnson & Johnson Vision Care Inc.|Tom Karkkainen O.D., M.S., F.A.A.O- Sr. Research Principal Optometrist|904-443-3500|TKarkkai@its.jnj.com|3402
21249148|NCT04184271|Advantage Silver Dental Arrest, LLC|Peter Milgrom|2062516831|drmilgrom@silverarrest.com|
21249149|NCT03029156|Tufts Medical Center|Nicholas S. Hill|617-636-0688|nhill@tuftsmedicalcenter.org|
21249150|NCT03798756|Keele University|Mrs Sarah Lawton|01782 734887|s.a.lawton@keele.ac.uk|
21249151|NCT01757288|UT Southwestern Medical Center|Dr. Yuanyuan Zhang|214-648-6764|Yuanyuan.Zhang@UTSouthwestern.edu|
21249152|NCT00722865|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu|
21249153|NCT02825550|Department of Internal Medicine, National Cheng Kung University|Dr. Xi-Zhang Lin|886-6-2353535|linxz@mail.ncku.edu.tw|3624/5603
21249154|NCT03386344|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
21249155|NCT01516710|Oslo University Hospital|Dr. Aasmund A. Fretland|004723070100|aafret@ous-hf.no|
21249156|NCT04417907|Stanford University|Kimford Meador|650-721-5552|kmeador@stanford.edu|
21249157|NCT00674765|University of Pennsylvania|Dr. Kyle Kampman|215-222-3200|kampman@mail.med.upenn.edu|109
21249158|NCT00248794|VA Connecticut Healthcare System|Gary Bryson|860-594-6348|gary.bryson@va.gov|
21249159|NCT04421456|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
21249160|NCT03209492|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21249161|NCT03481725|University of California San Diego|Brian M. Ilfeld, MD, MS|(858) 822-0776|m1medeiros@health.ucsd.edu|
21249162|NCT01125436|Case Western Reserve University|Research Compliance Officer|216-368-0134|kav6@case.edu|
21249163|NCT01694199|Regenesis Biomedical, Inc.|Dr. Rick Isenberg|877-970-4970|isenberg@regenesisbio.com|
21249164|NCT01894620|University of Manitoba|Dr Zahra Moussavi|204 474-7023|Zahra.Moussavi@umanitoba.ca|
21249165|NCT02877680|Baylor College of Medicine|Marisa Hilliard, Associate Professor of Pediatrics|832-824-7209|marisa.hilliard@bcm.edu|
21249166|NCT01133678|University of Chicago|Everett Vokes, MD|(773) 702-6227|evokes@medicine.bsd.uchicago.edu|
21249167|NCT03424187|Imperial College London|Gary Frost|+44 20 7594 0959|g.frost@imperial.ac.uk|
21249168|NCT00879710|Medical College of Wisconsin|Srividya Kidambi, MD, MS|414-955-4843|skidambi@mcw.edu|
21249169|NCT01864200|BTG|Shirley Steiner, Director of Clinical Operations|610 943 3631|shirley.steiner@btgplc.com|
21249170|NCT02077374|Conatus Pharmaceuticals Inc.|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
21249171|NCT00446095|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
21249172|NCT00424476|GlaxoSmithKline|GSK Response Center|866-435-7343||
21249173|NCT00886834|University of Utah, Department of Obstetrics and Gynecology|Dr. David Turok|801-581-7647|david.turok@hsc.utah.edu|
21249174|NCT00657709|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21249175|NCT02574286|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21249176|NCT05303324|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
21249177|NCT01029925|University of California Los Angeles Jonsson Comprehensive Cancer Center|Edward Garon, MD|310 586 2098|egaron@mednet.ucla.edu|
21249178|NCT02279732|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21249179|NCT02203513|National Cancer Institute|Dr. Jung-min Lee|240-760-6128|leej6@mail.nih.gov|
21249180|NCT04182217|Université d'État d'Haïti|Axler JEAN PAUL, Author|+50943776900|jeanpaulaxler@hotmail.com|
21249181|NCT03060525|University of Rochester|Dr. Steven Barnett|585-273-2548|steven_barnett@urmc.rochester.edu|
21249182|NCT02978716|G1 Therapeutics, Inc|Clinical Trial Info|+1 9192139835|clinicalinfo@g1therapeutics.com|
21249183|NCT00960206|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@stryker.com|
21249184|NCT00779194|STATE UNIVERSITY OF NEW YORK|Andras Perl|3154644194|perla@upstate.edu|
21249185|NCT02612285|Esanex Inc|Eric Orlemans PhD||eorlemans@esanexpharma.com|
21249186|NCT02548585|MedImmune, LLC|Philip Ambery|+44 (0) 1223 895997|information.center@astrazeneca.com|
21249187|NCT02033174|IiSGM|Dr Alvarez-Sala|+34 915868287|luisantonio.alvarezsala@salud.madrid.org|
21249188|NCT00452452|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21249189|NCT04343716|University of Alabama at Birmingham|Dr. Robert Sorge|2059348563|rsorge@uab.edu|
21249190|NCT00711555|University of Illinois|Sandra Cuellar|312-996-6985|scuell1@uic.edu|
21249191|NCT01574105|Saskatoon Health Region|Mark Rosin|306-655-2128|mark.rosin@sasktoonhealthregion.ca|
21249192|NCT02416102|University of Miami|Matthias Salathe, MD|913-588-6000|msalathe@kumc.edu|
21249193|NCT02068352|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21249194|NCT01732419|Maxima Medical Center|Dr. J. Kraal|+31612520944|j.kraal@mmc.nl|
21249195|NCT02740517|ResMed|Paul Phillips|+44 7789633508|paul.phillips@resmed.com|
21249196|NCT03557307|AstraZeneca|Maria Jison, MD Global Clinical Head, FASENRA, Late-stage R&I|+13013980340|Maria.Jison@astrazeneca.com|
21249197|NCT03745651|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21249198|NCT03456856|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21249199|NCT01190436|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21249200|NCT00113529|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21249201|NCT01077284|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21249202|NCT04626128|Clearside Biomedical, Inc.|Susan Coultas, PhD|678.270.3639|susan.coultas@clearsidebio.com|
21249203|NCT00841321|Portland VA Medical Center Multiple Sclerosis Center of Excellence|Dennis Bourdette, MD|503-220-8262|dennis.bourdette@va.gov|54594
21249204|NCT02632747|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21249205|NCT04908488|Alcon Research, LLC|Sr. Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21249206|NCT03444155|Otto Loewi Research Center, Chair of Physiological Medicine, Medical University of Graz, Austria|Dr. Willibald Wonisch|00436505299540|willibald.wonisch@medunigraz.at|
21249207|NCT01107912|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21249208|NCT02432183|KU Leuven|Dominique MA Bullens|3216341338|dominique.bullens@kuleuven.be|
21249209|NCT01124916|Loyola University|Elizabeth Mueller, M.D.|708-216-2180|emuelle@lumc.edu|
21249210|NCT00595959|Spectranetics Inc|Thomas M. Rasmussen V.P. Clinical Affairs|719-447-2471|thomas.rasmussen@spnc.com|
21249211|NCT01958346|Teamhealth Anesthesia|Devanand Mangar MD|813-844-4434|devanandmangar@teamhealth.com|
21249212|NCT00963924|Nathan Klein Institute for Psychiatric Research|Dr. Donald C Goff|646-754-4843|donald.goff@nyumc.org|
21249213|NCT03014726|Urotronic, Inc.|Ian Schorn, Vice President of Clinical Affairs|320.282.6312|schorni@urotronic.com|
21249214|NCT03875729|Sanofi|Clinical and Translational Medicine Lead|1-703-344-2992|laura.knecht@sanofi.com|
21249215|NCT00753896|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21295362|NCT03054350|Akebia Therapeutics|Akebia Therapeutics|(617) 844-6128|trials@akebia.com|
21295363|NCT02115750|Coherus BioSciences, Inc|Barbara K. Finck, MD Chief Medical Officer|650-649-3529|Bfinck@coherus.com|
21295364|NCT01643850|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21295365|NCT00931723|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21295366|NCT03305081|TulaneU|Resident of OB/GYN|858-499-2702|sjunya@tulane.edu|
21295367|NCT04600505|AstraZeneca Clinical Study Information Center|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
21295368|NCT04065074|Flexion Therapeutics, Inc.|David Golod, Vice President, Clinical Operations|(781) 305-7572|dgolod@flexiontherapeutics.com|
21295369|NCT01218100|Forest Research Institute|Manfred Stapff, MD, PhD|201-427-8000|Manfred.stapff@frx.com|
21249216|NCT01280656|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21249217|NCT00952523|Valeant Pharmaceuticals International Inc|David Lineberry, Associate Director, Clinical Operations|949-973-1153|David.Lineberry@valeant.com|
21249218|NCT05265247|HALEON|Haleon Response Center|+4407880182593|ww.clinical-trial-register@haleon.com|
21249219|NCT02841449|University of Bath|Dr Harriet Carroll|+447706548573|hac38@bath.ac.uk|
21249220|NCT02159352|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21249221|NCT00529529|Novartis Pharmaceuticals|Study Director|862 778-8300||
21249222|NCT02354144|Division of Cancer Epidemiology, Department of Oncology, McGill University|Dr. Eduardo Franco|514-398-6032|eduardo.franco@mcgill.ca|
21249223|NCT02951702|St. Luke's Hospital|Ryan Medas, Pharm.D.|314-205-6053|ryan.medas@stlukes-stl.com|
21249224|NCT04749797|University of Pennsylvania|Timothy Lucas|(215) 662-3487|Timothy.Lucas@pennmedicine.upenn.edu|
21249225|NCT03072862|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
21249226|NCT00632736|GlaxoSmithKline|GSK Response Center|866-435-7343||
21249227|NCT03347396|Bioverativ, a Sanofi company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21249228|NCT00871715|University of Southern California|Carolee Winstein, Principal Investigator|3234422903|winstein@usc.edu|
21249229|NCT01047709|University of Michigan|Devin Brown, MD|7349369075|devinb@umich.edu|
21249230|NCT01331408|Galderma Uppsala|Head of Medical Affairs|+46 (0)18 474 9000|receptionen.SEUPP@galderma.com|
21249231|NCT03015220|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21249232|NCT01673256|St. Jude Medical Inc.|Kyle Brunner|651.756.3482|kbrunner02@sjm.com|
21249233|NCT01670526|Hines CSPCC|Tom Sindowski|708-202-5858|tom.sindowski@va.gov|
21249234|NCT00392197|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
21249235|NCT01794689|Johns Hopkins University|Dr. Michael T. Smith, PhD|410-550-7000|msmith62@jhmi.edu|
21249236|NCT02312258|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21249237|NCT01970527|University of Washington Medical Center|Dr. Ramesh Rengan|206-598-4100|rengan@uw.edu|
21249238|NCT01964547|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
21249239|NCT04447287|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
21249240|NCT00613405|Medical University of South Carolina|Aimee McRae-Clark, PharmD|843-792-5126|mcraeal@musc.edu|
21249241|NCT02147093|Johnson & Johnson Vision Care INC.|Tom Karkkainen, OD, MS, FAAO|904-443-3500|TKarkkai@its.jnj.com|3402
21249242|NCT01974102|YALE UNIVERSITY SCHOOL OF MEDICINE|Dr. Rajita Sinha|2038592840|rajita.sinha@yale.edu|
21249243|NCT02302157|Lineage|Avi Ben Shabat, MD|+972-509105205|avi@cellcure.co.il|
21249244|NCT02934932|Duke University|Dr. Steven Szabo|919-681-8742|steven.szabo@duke.edu|
21249245|NCT02067819|Weill Cornell Medicine|Shannon Bennett, PhD|646-962-2820|smb9017@med.cornell.edu|
21249246|NCT01138969|KaohsiungVGH|Dr. Ping-I Hsu|886-7-3462121|pihsu@isca.vghks.gov.tw|8233
21249247|NCT01229176|Novartis Vaccines Institute for Global Health|Dr. Audino Podda|+39 0577 243496|audino.podda@novartis.com|
21249248|NCT03890484|University of Washington|Dr. Jessica Canning|206.221.4430|jrcannin@uw.edu|
21249249|NCT00518206|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21249250|NCT03075878|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
21249251|NCT02188459|University of Pennsylvania Perelman School of Medicine|Henry R. Kranzler, M.D.|215-386-6662|kranzler@pennmedicine.upenn.edu|
21249252|NCT04348357|Texas Tech University Health and Science Center El Paso|Dr Steven Radtke|2177254940|dr.radtke@gmail.com|
21249253|NCT00623714|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21249254|NCT00882050|University of Pennsylvania|Kim Lacy, RN BSN|215-893-7234|kim.lacy@uphs.upenn.edu|
21249255|NCT00805441|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21249256|NCT02399111|Northwell Health System|Dr. Kambhampaty Krishnasastry|516-233-3643|kkrishna@northwell.edu|
21249257|NCT02935894|USDA, ARS Western Human Nutrition Research Center|Dr. John W. Newman|530-752-1009|john.newman@ars.usda.gov|
21249258|NCT00853957|Novartis Pharmaceuticals|Study Director|862-778-8300||
21249259|NCT02942771|University of Kentucky|Dr. Linda Van Eldik|(859) 257-5566|linda.vaneldik@uky.edu|
21249260|NCT01186809|Asst Papa Giovanni XXIII|Prof Alessandro Rambaldi|+390352673681|arambaldi@asst-pg23.it|
21249261|NCT04895085|University of Wisconsin School of Medicine and Public Health|Dr. Ryan Coller|608-263-9408|rcoller@pediatrics.wisc.edu|
21249262|NCT01303744|Cerespir|Richard Margolin|(646) 202-2562|rmargolin@cerespir.com|
21249263|NCT04919499|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21249264|NCT00476151|EpiCept Corporation|Chief Medical Officer|914-606-3500|deverton@epicept.com|
21295370|NCT02437305|Northwestern Univeristy|Dr. Roopal Kundu|312-926-4926|rkundu@nm.org|
21249265|NCT01767376|GlaxoSmithKline|GSK Response Center|866-435-7343||
21249266|NCT04175834|Providence Health & Services|Chiayi Chen, Director of WC/PBSI Clinical Research Program|503-216-1012|Chiayi.Chen@providence.org|
21249267|NCT00946088|Stanford University School of Medicine|Deirdre Lyell, MD|(650) 384-5107|deirdre.lyell@stanford.edu|
21249268|NCT03490942|Xeris Pharmaceuticals|B J. Witkin|919-412-6483|bwitkin@xerispharma.com|
21249269|NCT04239911|Weill Cornell Medicine|Dr. Madeline Sterling|646-962-5029|mrs9012@med.cornell.edu|
21249270|NCT03823794|Guy's & St Thomas' NHS Foundation Trust|Carsten Flohr|020 7188 8884|carsten.flohr@kcl.ac.uk|
21249271|NCT03693989|Laboratorios Sophia|Dr. Ricardo Llamas (clinical safety pharmacologist)|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
21249272|NCT01052272|University of Alabama at Birmingham|Louis . J. Dell'Italia, M.D|205-934-3969|Dell'Italia@PHYSIOLOGY.UAB.EDU|
21249273|NCT00648895|Forest Laboratories|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|1-201-427-8259|John.Whalen@frx.com|
21249274|NCT02955225|Rush University Medical Center|Dr. Markus Wimmer, Director Motion Analysis Laboratory|(312) 942 2789|markus_a_wimmer@rush.edu|
21249275|NCT00096278|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600||
21249276|NCT02137603|All Children's Hospital Johns Hopkins Medicine|Dr. Nicole Chandler|727-767-4170|Nicole.Chandler@jhmi.edu|
21249277|NCT00379210|University of Pennsylvania|Amishi Jha|215-898-8011|apjha@psych.upenn.edu|
21249278|NCT01358175|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
21249279|NCT00887471|SUNY Downsate Medical Center|Nira A Goldstein, MD|718-270-1638|ngoldstein@downstate.edu|
21249280|NCT02991118|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
21249281|NCT02562521|Yale University School of Medicine|Dr. Krysten Bold|2039747603|krysten.bold@yale.edu|
21249282|NCT03400748|Spiration, Inc.|Lauri DeVore|425-636-5464|lauri.devore@olympus.com|
21249283|NCT01469585|University of Hawaii|Investigator|808-203-6500|blissk@hawaii.edu|
21249284|NCT02627794|Cedars-Sinai Medical Center|Dr. Martin L. Hopp|310-657-7704|marty@towerent.com|
21249285|NCT02764320|Mayo Clinic|Dr. Todd J. Schwedt|480-301-9443|Schwedt.Todd@mayo.edu|
21249286|NCT04085614|Philips Medical Systems Nederland B.V.|Peter Eshuis|+31628739280|peter.g.eshuis@philips.com|
21249287|NCT03529942|Flexion Therapeutics, Inc.|David Golod, Vice President, Clinical Operations|(781) 305-7572|dgolod@flexiontherapeutics.com|
21249288|NCT00476957|Medtronic Bakken Research Center|Dr. Frank van Leeuwen, Director Clinical Research Coronary and Renal Denervation|+31 43 3566622|frank.van.leeuwen@medtronic.com|
21249289|NCT00999336|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
21249290|NCT02516202|Fred Hutchinson Cancer Research Center|Dr. Katherine A. Guthrie|2066675595|kguthrie@fredhutch.org|
21249291|NCT01214109|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21249292|NCT00409747|NIH/NIMH/PDN Branch|Dr. Susan Swedo|301-496-5323|swedos@mail.nih.gov|
21249293|NCT03132571|Yale School of Medicine, Department of Psychiatry|Dr. Cenk Tek|(203) 974-7500|cenk.tek@yale.edu|
21281456|NCT01256450|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
21281457|NCT02104219|Alexion Pharmaceuticals|Senior Medical Director, Clinical Development|203-272-2596|clinicaltrials@alxn.com|
21281458|NCT02667704|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21281459|NCT03866512|University of Exeter|Dr Marlou Dirks|+44 1392 725496|m.dirks@exeter.ac.uk|
21281460|NCT04545008|Prisma Health|Dr. Julie Martin - Director, Cancer Research|864-455-3667|julie.martin@prismahealth.org|
21281461|NCT00506415|Novartis|Study Director|862 778 8300||
21281462|NCT00997373|UC Davis|Lloyd H. Smith MD, PhD|916-734-6945|lhsmith@ucdavis.edu|
21281463|NCT02841995|Sanofi ( Kadmon, a Sanofi Company )|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
21281464|NCT02042014|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
21281465|NCT02792062|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21281466|NCT02632409|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21281467|NCT03331796|Veterans Affairs Palo Alto Health Care System|Joy L Taylor, PhD|650-776-3385|joyt@stanford.edu|
21281468|NCT04426006|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
21281469|NCT01262872|GlaxoSmithKline|GSK Response Center|866-435-7343||
21281470|NCT04709562|Vapotherm Inc|Kathy Gerich|(585) 469-6753|kgerich@vtherm.com|
21281471|NCT01000155|Brigham&Women's Hospital|Maureen Okam, MD, MPH|617-732-5048|mokam@partners.org|
21281472|NCT00720213|Sleepcare Diagnostics|Shahrokh Javaheri, MD|513-459-7750|javaheri@snorenomore.com|
21281473|NCT00097448|Massachusetts Eye and Ear Infirmary|Dr. Steven Rauch|617-573-1166|steven_rauch@meei.harvard.edu|
21281474|NCT00620945|Cleveland Clinic|Muhammad A. Mumtaz, MD|216 444 9125|mumtazm@ccf.org|
21281475|NCT02092298|UT MD Anderson Cancer Center|Brian Badgwell,Professor, Surgical Oncology|713-745-3715|csentonn@mdanderson.org|
21281476|NCT00920439|GlaxoSmithKline|GSK Response Center|866-435-7343||
21281477|NCT00660517|Meda Pharmaceuticals|David Ginsberg, D.O.|7325642364|david.ginsberg@meda.us|
21281478|NCT01252095|Progen Pharmaceuticals Ltd|Director of Clinical Development|+61 7 32739133||
21281479|NCT01420068|Noden Pharma DAC|Ciara Walsh|+ 353 1 9121573|cwalsh@nodenpharma.com|
21281480|NCT00745901|North America Pharmaceutical (Ortho-McNeil Janssen Scientific Affairs, LLC)|Chief Scientific Officer|1-888-526-5060||2915
21281481|NCT00758290|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
21281482|NCT02022202|Mayo Clinic|Matthew P. Goetz MD and Judy C. Boughey MD|507-284-2511|Goetz.Matthew@mayo.edu|
21281483|NCT03957473|Penumbra, Inc.|Study Manager|+1 415-601-9561|apascua@penumbrainc.com|
21281484|NCT03831932|The Ohio State University Comprehensive Cancer Center|Dr. Dwight Owen|614-685-2039|Dwight.Owen@osumc.edu|
21281485|NCT01956773|Duke University Medical Center|Dr. Lori A. Orlando, Director Program in Precision Medicine|919-660-6606|orlan002@duke.edu|
21281486|NCT01565889|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21281487|NCT00122382|Bristol-Myers Squibb|Study Director||Clinical.Trials@bms.com|
21264156|NCT01822691|H. Lee Moffitt Cancer Center and Research Institute|Dr. Rami Komrokji|813-745-4692|rami.komrokji@moffitt.org|
21264157|NCT01003080|Montefiore Medical Center|Dr. Sun Jin Kim|718-920-2060|sukim@montefiore.org|
21264158|NCT01778127|St. Jude Children's Research Hospital|Kirsten K. Ness, PT, PhD|901-595-5157|kiri.ness@stjude.org|
21264159|NCT02104804|AstraZeneca|Eva Johnsson, MD, PhD, Global Clinical Lead||Eva.Johnsson@astrazeneca.com|
21264160|NCT01348425|Cook|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|765-463-7537|ssnyder@medinst.com|
21264161|NCT02049749|Children's Hospital of Philadelphia|Dr. Joanne Wood, PI|267-426-3107|woodjo@email.chop.edu|
21264162|NCT01968954|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21264163|NCT04511026|Stanford University|Amer Karam, MD|650-498-6004|amkaram@stanford.edu|
21264164|NCT01568424|St. Jude Medical|Poornima Sood|+1.781.852.8334|psood@sjm.com|
21264165|NCT02487901|Seoul National Unversity College of Medicine|Chun Kee Chung|+82-2-2072-2357|chungc@snu.ac.kr|
21264166|NCT03260205|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21264167|NCT03423979|Urotronic, Inc|Sr. Clinical Project Manager|612-245-6434|jmoland@laborie.com|
21264168|NCT00808249|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21264169|NCT04095286|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21249294|NCT01000649|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21264170|NCT02509494|Janssen Vaccines & Prevention B.V.|Senior Director Clinical Franchise Lead|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21249295|NCT01916109|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org|
21249296|NCT00103857|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21249297|NCT03032965|University of Michigan|Hamid Ghanbari|734-963-7141|ghhamid@med.umich.edu|
21249298|NCT00636168|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21264171|NCT05371912|Christiana Care|Mitra Assadi, MD|3026233017|mitra.assadi@christianacare.org|
21264172|NCT04752189|Wayne State University|Dr. Andria Eisman, Principal Investigator|313-649-7477|aeisman@wayne.edu|
21264173|NCT00975195|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21249299|NCT01852175|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD-Associate Professor of Medicine Director, Cardiovascular Research|+1-904-244-3005|dominick.angiolillo@jax.ufl.edu|
21249300|NCT03541369|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21264174|NCT03052842|Armata Pharmaceuticals, Inc.|Clinical Operations|3106652928|info@armatapharma.com|
21249301|NCT01856569|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21264175|NCT03003403|Duke University|Gary G. Bennett, PhD|919-808-7821|gary.bennett@duke.edu|
21281488|NCT02040805|University of California, San Francisco|Dr. Kevin L. Delucchi|415-476-4180|kevin.delucchi@ucsf.edu|
21281489|NCT02245516|Kala Pharmaceuticals Inc|VP, Clinical Development||results004@kalarx.com|
21281490|NCT01662492|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21249302|NCT02707952|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21249303|NCT01141075|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
21281491|NCT01591096|SeattleChildrens|Catherine Amlie-Lefond MD|206-987-2078|calefond@seattlechildrens.org|
21281492|NCT02716714|Korea University Ansan Hospital|Ilhwan Kim|+82314125986|kumcihk@korea.ac.kr|
21249304|NCT00696241|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21281493|NCT02045264|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21249305|NCT01287832|St. John Hospital and Medical Center|Leonard Johnson MD|3133438823|leonard.johnson@stjohn.org|
21249306|NCT01790659|Instituto Conmemorativo Gorgas de Estudios de la Salud|Nestor Sosa, MD, FACP|507-527-4950|drnsosa@gmail.com|
21249307|NCT01894503|Intersect ENT, Inc.|James Stambaugh, Vice President of Clinical & Medical Affairs|650-641-2103|jstambaugh@intersectent.com|
21249308|NCT03065400|Icahn School of Medicine at Mount Sinai|Mikaela Dougherty|212-241-8839|Mikaela.dougherty@mssm.edu|
21281494|NCT03134144|Institute of Occupational and Social Medicine and Health Services Research, University of Tübingen|Tessy Luger|004970712984364|Tessy.Luger@med.uni-tuebingen.de|
21249309|NCT02513667|UT Southwestern Medical Center|Dr. Sawsan Rashdan|214-648-4180|Sawsan.Rashdan@UTSouthwestern.edu|
21281495|NCT01167140|Myoscience|Francis Rogers Palmer III, MD|650-474-2600|thenry@myoscience.com|
21249310|NCT01297595|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21249311|NCT02291549|Intersect ENT, Inc.|James Stambaugh, Vice President of Clinical & Medical Affairs|650-641-2103|jstambaugh@intersectent.com|
21249312|NCT00537914|Sandoz|Clinical Disclosure Representative|+4980249080|sandoz.disclosure@sandoz.com|
21281496|NCT03805412|University of Washington Diabetes Institute|Dr. Nicole Ehrhardt|202-741-3422|nehrhard@uw.edu|
21281497|NCT02817763|Institute of Science and Technology of São José dos Campos (Unesp)|Dr. Mauro P. Santamaria|+55 (16) 981937777|mauro.santamaria@ict.unesp.br|
21281498|NCT00571727|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
21249313|NCT01180959|UT MD Anderson Cancer Center|Dr. Ahmed Kaseb, MD- Professor, GI Medical Oncology|(713) 792-2828|akaseb@mdanderson.org|
21281499|NCT01276860|Arkansas Children's Hospital|Clinical Research Coordinator|501-364-2018|boswelljl@archildrens.org|
21281500|NCT03525678|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21281501|NCT03771898|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
21281502|NCT03135548|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21281503|NCT04623216|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novatis.email@novartis.com|
21249314|NCT01697956|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21264176|NCT03906227|University of North Carolina at Chapel Hill|Anne Froment|919-445-2622|anne_froment@med.unc.edu|
21249315|NCT01115309|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
21264177|NCT04857593|King's College London|Professor Carmine Pariante|020 78480807|carmine.pariante@kcl.ac.uk|
21249316|NCT05700851|University of Nottingham|Prof. Maarten Taal|01332224618|m.taal@nottingham.ac.uk|
21249317|NCT03246724|Boston Medical Center|Marissa Fiorello, Clinical Research Manager|617-414-8848|Marissa.Fiorello@bmc.org|
21249318|NCT00655824|GlaxoSmithKline|GSK Response Center|866-435-7343||
21249319|NCT00589628|Duke Health Systems|Dr. C. Egla Rabinovich|919-668-0238|egla.rabinovich@duke.edu|
21249320|NCT01862159|Region Örebro län, Sweden AND Örebro University, Sweden|Dr Erik Stenberg|+46196021000|erik.stenberg@regionorebrolan.se|
21249321|NCT00507767|MD Anderson Cancer Center|Dr. Vassiliki Papadimitrakopoulou, Professor|713-792-6363|vpapadim@mdanderson.org|
21264178|NCT05076370|Yale University, Department of Psychiatry|Joao De Aquino, M.D.|203-932-5711|joao.deaquinolima@yale.edu|12916
21264179|NCT02690207|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21249322|NCT00663819|CMU College of Medicine|Dr. Anthony Senagore|989-790-1001|anthony.senagore@cmich.edu|
21249323|NCT01502813|University of Utah, Diagnostic Neuroimaging Lab|Deborah Yurgelun-Todd, Ph.D.|801-587-1538|Deborah.Yurgelun-Todd@hsc.utah.edu|
21249324|NCT00725959|Colorado School of Public Health|Dr. Sheana Bull|303-724-1238||
21249325|NCT02189759|University of Alabama at Birmingham|Manimaran Ramani|2054731425|mramani@peds.uab.edu|
21249326|NCT02470806|Smith & Nephew, Inc.|Natasha Schappell, CCRP|817-302-3949|natasha.schappell@smith-nephew.com|
21249327|NCT03032198|Seno Medical, Inc.|Shaan Schaeffer|6106983259|sschaeffer@senomedical.com|
21249328|NCT00866619|GlaxoSmithKline|GSK Response Center|866-435-7343||
21264180|NCT02862548|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21249329|NCT01147471|Virginia Commonwealth University|Ajai K Malhotra, MD|804-827-2409|akmalhot@mcvh-vcu.edu|
21249330|NCT02579915|McLean Hospital|Courtney Beard|16178553557|CBEARD@MCLEAN.HARVARD.EDU|
21249331|NCT00946998|University of Texas Southwestern Medical Center|Susan Hedayati, MD, Professor of Medicine|214-645-6106|susan.hedayati@utsouthwestern.edu|
21249332|NCT01857362|Swedish Orphan Biovitrum|Dr Erik Brouwer, Medical Director|+4686972000|erik.brouwer@sobi.com|
21264181|NCT02475850|Yale University|Erich Greene PhD|203-737-3636|erich.greene@yale.edu|
21264182|NCT03330041|University of California, Davis, Department of Dermatology|Daniel Eisen, M.D.|916-734-6479|dbeisen@ucdavis.edu|
21249333|NCT02024477|The George Washington University|Dr Saby Sen|202-994-8560|ssen1@gwu.edu|
21264183|NCT01746940|STATKING Clinical Services|Lori Christman, PhD|513-858-2989|lori@statkingclinical.com|317
21249334|NCT01020487|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21249335|NCT01272388|Washington University School of Medicine|Brian R. Lindman, MD|314-747-3617|brlindman@wustl.edu|
21249336|NCT01922102|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21249337|NCT04077437|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
21264184|NCT03434418|Duke University|Thomas Stinchcombe, MD|919-681-9509|thomas.stinchcombe@duke.edu|
21264185|NCT04241146|Children's Hospital of Nevada at UMC|Prashant Jha|702-383-2420|prashant.jha@umcsn.com|
21264186|NCT04807101|Northwestern University|Greg Cohen, MD|312-695-4452|gregcohen@northwestern.edu|
21264187|NCT02254551|Sarah Cannon Development Innovations|Charles Davis, Sr Mgr Regulatory Strategy & Operations|615-524-4341|charles.davis2@scri-innovations.com|
21264188|NCT03569449|Boston Medical Center, Boston University School of Public Health|Emily Feinberg, ScD, CPNP|617-414-1425|emfeinbe@bu.edu|
21249338|NCT00447499|Ipsen|Bert Bakker, MD, PhD.|+1 650 238 1669|bert.bakker@ipsen.com|
21264189|NCT04124692|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
21264190|NCT02325687|Hospital for Special Surgery, Anesthesiology Department|Kethy Jules-Elysee|212-606-1206|juleselyseek@hss.edu|
21264191|NCT01753830|Q-Med AB|Clinical Project Manager|+46 18 4749000|reception.seupp@galderma.com|
21264192|NCT03027388|National Cancer Institute|Dr. Eric Burton|240-760-6436|eric.burton@nih.gov|
21249339|NCT01286870|Mentor Worldwide, LLC|Laura Vellucci|(805) 879-6000|lvelucci@its.jnj.com|
21264193|NCT03746808|University of North Texas Health Sciece Center|Scott Walters|817-735-2365|scott.walters@unthsc.edu|
21264194|NCT00671723|University of Oklahoma Health Sciences Center|Dr. Houssein Youness|405-271-6173|houssein-youness@ouhsc.edu|
21264195|NCT02263014|The University of Texas (UT) MD Anderson Cancer Center|Dr. Abenaa Brewster, Professor, Clinical Cancer Prevention|713-792-7734|abrewster@mdanderson.org|
21249340|NCT01322347|Rockwell Medical|Senior Director, Clinical Research & Development|248-960-9009|rd@rockwellmed.com|
21249341|NCT01193283|NIH NHLBI|Dr. Danielle Townsley|301-402-3477|townsleydm@nhlbi.nih.gov|
21264196|NCT05279898|Beth Israel Deaconess Medical Center|Balachundhar Subramaniam|617-278-8000|bsubrama@bidmc.harvard.edu|
21264197|NCT05136170|Dompé farmaceutici S.p.A.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
21249342|NCT04883541|Üsküdar Üniversitesi|Assistant Professor Tuğba YILMAZ ESENCAN|+905057084946|tugba.yilmazesencan@uskudar.edu.tr|
21295371|NCT00904618|Centre Hospitalier Universitaire de Sherbrooke|Louis-Olivier Gagnon|1-819-437-4965|louis.olivier.gagnon@gmail.com|
21295372|NCT03883113|Vaccitech Ltd.|Tom Evans, MD|+44 01865 591 445|enquiries@vaccitech.co.uk|
21295373|NCT01672658|Rehabilitation Instititute of Chicago|Arun Jayaraman, PT, PhD|312-238-2091|a-jayaraman@northwestern.edu|
21295374|NCT02081638|National Institute of Allergy and Infectious Diseases|Dr. Irini Sereti|301-496-5533|isereti@niaid.nih.gov|
21249343|NCT01383616|Hospital for Special Surgery|Brian Rebolledo, MD|212-606-1172|rebolledob@hss.edu|
21249344|NCT02755948|Imperial College London|Professor Christopher Chiu|(0)20 8383 2301|c.chiu@imperial.ac.uk|
21249345|NCT02823574|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.gov|
21249346|NCT00590759|W. L. Gore and Associates, Inc.|Robert Makowsky|6232345784|rmakowsk@wlgore.com|
21249347|NCT01580306|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21249348|NCT02043652|CDC|Alexande Macedo de Oliveira|404 718 4751|acq7@cdc.gov|
21249349|NCT02542696|Sumitomo Pharma America, Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
21249350|NCT03345407|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21249351|NCT00065611|NIDDK, NIH|Jeffrey B Kopp, MD|3015943403|jbkopp@nih.gov|
21249352|NCT03262389|Mayo Clinic|Michael C. Roarke, M.D.|480-342-0988|Roarke.Michael@mayo.edu|
21249353|NCT00547456|North Shore LIJ Health System|Rubin Cohen, MD|516-465-5400|rocohen@nshs.edu|
21249354|NCT02256553|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21249355|NCT02865083|Saint Louis University|Jennifer Goldkamp, MD|314-977-2574|jgolka2@slu.edu|
21249356|NCT03651271|Parker Institute for Cancer Immunotherapy|Ute Dugan|203-379-6757|udugan@parkerici.org|
21249357|NCT00329771|Doylestown Hospital, Pennsylvania|Abraham A. Ashkenazi, M.D./Principal Investigator|215-625-2894|aashkenzai2001@yahoo.com|
21249358|NCT00821093|Novartis Pharmaceuticals|Study Director|862 778-8300||
21249359|NCT02010021|Dartmouth-Hitchcock Medical Center and Norris Cotton Cancer Center|Gary N. Schwartz, MD|(603) 653-6181|gary.n.schwartz@hitchcock.org|
21249360|NCT02469155|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinicalTrials@itci-inc.com|
21249361|NCT01508117|University of Cincinnati|Alison Kastl|513-584-0436|kastla@ucmail.uc.edu|
21249362|NCT03150589|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
21249363|NCT01405508|UCB Cares|UCB (Study Director)|+1 887 822 9493||
21249364|NCT02314000|Boston Scientific|Roshini Jain, Director of Clinical Sciences|6619494355|roshini.jain@bsci.com|
21249365|NCT01989156|Philip Morris Products S.A.|Christelle Haziza, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
21249366|NCT03839355|Mayo Clinic|Dr. Malini Madhavan|507-255-4152|Madhavan.Malini@mayo.edu|
21249367|NCT05866887|Dana-Farber Cancer Institute|Maimouna Oumar|617-632-3000|maimouna_sy@dfci.harvard.edu|
21249368|NCT02892019|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21249369|NCT00689351|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com|
21249370|NCT01766206|GlaxoSmithKline|GSK Response Center|866-435-7343|sss42438@gsk.com|
21249371|NCT01662505|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21249372|NCT01313663|GlaxoSmithKline|GSK Response Center|866-435-7343||
21249373|NCT04588207|University of Pittsburgh School of Medicine|Dr. Helbert Rondon Berrios, Professor of Medicine|4126473120|rondonberriosh@upmc.edu|
21249374|NCT01661972|Duke University Medical Center|John Strickler, M.D.|919-668-1861|john.strickler@duke.edu|
21249375|NCT03020498|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
21249376|NCT02138838|Amgen Inc.|Study Director|866-572-6436||
21249377|NCT00860457|Lombardi Comprehensive Cancer Center, Georgetown University Hospital|Dr. Bruce D. Cheson|202-444-7932|bdc4@georgetown.edu|
21249378|NCT01294644|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
21249379|NCT02367794|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21249380|NCT01986348|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
21249381|NCT02010684|University of California Los Angeles|Dr. Jeanne Miranda|310-794-3710|mirandaj@ucla.edu|
21249382|NCT04520321|Trefoil Therapeutics.com|Thomas M Tremblay, RN, BSN|4153053491|ttremblay@trefoiltherapeutics.com|
21249383|NCT01884571|Emory University|Jonathan Glass, MD|404-727-3507|jglas03@emory.edu|
21249384|NCT01175980|Barbara Ann Karmanos Cancer Institute|Dr. Ulka N. Vaishampayan|313-576-8718|vaishamu@karmanos.org|
21249385|NCT01695044|Progenics Pharmaceuticals, Inc.|Dr. Vincent A. DiPippo|(646) 975-2502|vdipippo@progenics.com|
21249386|NCT03444298|University of North Carolina at Chapel Hill|Carole Robinette|919-966-5638|carole_robinette@med.unc.edu|
21249387|NCT02158806|University of Auckland|Professor Andrew Jull|+64 9 923 4259|a.jull@auckland.ac.nz|
21249388|NCT02383043|University of Kentucky|Joshua A. Lile, Ph.D.|859-420-0503|jalile2@uky.edu|
21249389|NCT01898299|New York State Psychiatric Institute|Joshua Kantrowitz|6467746738|jk3380@cumc.columbia.edu|
21249390|NCT02340806|Northwestern University|Elizabeth Lange, MD|312-472-3585|elizabeth.lange@northwestern.edu|
21249391|NCT02591056|Regulatory Insight, Inc.|Elvira Cawthon, Clinical Consultant|615-712-9743|elvira@reginsight.com|
21249392|NCT01159600|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21249393|NCT00760877|Novartis|Study Director|862-778-8300||
21249394|NCT00090064|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
21249395|NCT03833934|Addario Lung Cancer Medical Institute (ALCMI)|Ericka Izzo, Clinical Project Manager|941-713-1225|eizzo@alcmi.org|
21249396|NCT02680314|Montefiore Medical Center|Peter Bernstein, MD|718-904-2767|pbernste@montefiore.org|
21249397|NCT02101554|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21249398|NCT04820023|Bridge Biotherapeutics, Inc.|Clinical Trial Lead|+82-31-8092-3280|Clinicaltrials.gov_inquiries@bridgebiorx.com|
21249399|NCT03239899|National Institutes of Health|Avindra Nath, MD|301-496-1561|avindra.nath@nih.gov|
21249400|NCT04049578|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21249401|NCT02240810|Boston Scientific|Director, Clinical Trials|508-683-6678|peter.maurer@bsci.com|
21249402|NCT02802176|University of California, San Francisco|Marcelle Cedars, MD, Director, Division of Reproductive Endocrinology|(415) 353-7475|Marcelle.Cedars@ucsf.edu|
21295375|NCT01327274|UCSF Benioff Children's Hospital|Jill Imamura-Ching, RN|415-476-3446|Jill.Imamura-Ching@ucsf.edu|
21249403|NCT01945593|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21249404|NCT00228813|Emory University|Kuang-Yueh Chiang, MD|404-785-0858|kchian2@emory.edu|
21295376|NCT02446418|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21295377|NCT03114124|UF Health- Jacksonville|Andrea Goosen|904-244-5617|andrea.ggosen@jax.ufl.edu|
21295378|NCT03421743|Savara Inc|Paymond D Pratt, Chief Medical Officer|+1 512 784 8757|ray.pratt@savarapharma.com|
21295379|NCT00435162|Novartis Pharmaceuticals|Study Director|862-778-8300||
21295380|NCT00694096|Huntsman Cancer Institute|Mark Wade, Ph.D. - Compliance Officer|801-213-5746|mark.wade@hci.utah.edu|
21295381|NCT03900923|NYU Langone Health|Francisco X Castellanos, MD|646-754-5194|Francisco.Castellanos@nyulangone.org|
21295382|NCT00711490|National Eye Institute|Catherine Meyerle, MD|301-435-7821|meyelec@nei.nih.gov|
21295383|NCT00977938|Harvard Clinical Research Institute|Priscilla Driscoll Shempp, Sr. Director Trial Design, Development and Strategy|617.307.5200|pdriscoll@hcri.harvard.edu|
21295384|NCT02142283|Stryker Neurovascular|Cheryl Fontana, Sr. Manager, Clinical Services|510-413-2948|cheryl.fontana1@stryker.com|
21295385|NCT03373890|SeattleChildrens|Kristie Bjornson, PT, PhD|206-884-2066|kristie.bjornson@seattlechildrens.org|
21295386|NCT00747344|Janssen Research & Development, LLC|Director, Clinical Research|215-793-7646||
21295387|NCT02460783|National Institute on Aging|Dimitrios Kapogiannis|+1-202-290-0433|kapogiannisd@nih.mail.gov|
21295388|NCT01484834|UNESC|Dr. Antonio Jose Grande|04834312500|grandeto@unesc.net|2571
21295389|NCT02881112|Regenesis Biomedical|Clinical Operations Manager|602-428-7041|heather.vanderploeg@regenesisbio.com|
21295390|NCT00712530|Szent Laszlo Hospital, Budapest, Hungary|Dr. Denes Banhegyi|+3614558152|immunol@mail.datanet.hu|
21295391|NCT01861925|Haag Streit AG|Dr. Lucio Robledo, Clinical Trials Biometry|+41 31 978 01 11|lucio.robledo@haag-streit.com|209
21295392|NCT00167102|University of Minnesota|Dr. Maria Hordinsky|612-624-5721|hordi001@umn.edu|
21295393|NCT01166958|University of Wisconsin Osteoporosis Clinical Research Program|Neil Binkley, MD|608-265-6410|uwosteoporosis@gmail.com|
21295394|NCT02680574|Akebia Therapeutics, Inc.|Clinical Trial Information Desk|+1 617-844-6128|trials@akebia.com|
21295395|NCT01605227|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
21295396|NCT01286987|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21295397|NCT02847858|University of California San Francisco|Dr. Kathleen Tebb|415-514-0941|Kathleen.Tebb@ucsf.edu|
21295398|NCT00624819|GlaxoSmithKline|GSK Response Center|866-435-7343||
21295399|NCT00681564|Universidad del Valle|Jorge Hernán Ramírez and Adolfo Contreras (adolfo@yahoo.com).|5723753778|jorge.h.ramirez00@gmail.com|
21295400|NCT03468816|Åby vårdcentral, County council of Östergötland|Dr. Fredrik Iredahl|010-103 00 00|fredrik.iredahl@liu.se|
21295401|NCT03093974|Zambon S.p.A.|Michela Meroni - Clinical Trial Manager|+39 02 665241|clincaltrials@zambongroup.com|
21295402|NCT02387164|Skåne University Hospital|Helena Elding Larsson|+4640337676|helena.larsson@med.lu.se|
21295403|NCT01550341|Yale University|Dr. Frederick Altice, Principal Investigator|203-737-2883|frederick.altice@yale.edu|
21295404|NCT03109262|Stanford University|Andrei Iagaru, PROFESSOR OF RADIOLOGY (NUCLEAR MEDICINE)|1650-725=4711|aiagaru@stanford.edu|
21295405|NCT02342379|University of Texas Health San Antonio|Andrew Brenner, MD, PhD|210-450-5936|brennera@uthscsa.edu|
21295406|NCT00541099|Barbara Ann Karmanos Cancer Institute|Shirish Gadgeel, M.D.|(313) 576-8753|sgadgeel@med.umich.edu|
21295407|NCT00066469|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
21295408|NCT01038713|Dartmouth-Hitchcock Medical Center|Timothy Gardner|603-650-6472|timothy.b.gardner@hitchcock.org|
21295409|NCT01853072|Alcon Research, Ltd.|Therapeutic Unit Head, Cornea and Inflammation|1-888-451-3937|alcon.medinfo@alcon.com|
21295410|NCT00930969|Medtronic Cardiac Rhythm Disease Management|ST Detect Study Team|1-800-328-2518|medtronicCRMtrials@medtronic.com|
21295411|NCT00657150|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21295412|NCT01416441|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21295413|NCT04627675|Providence Portland Medical Center|Dr. Rom Leidner|503-215-5696|rom.leidner@providence.org|
21295414|NCT02649192|St. Jude Children's Research Hospital|Nehali Patel, MD|866-278-5833|info@stjude.org|
21295415|NCT03849690|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21295416|NCT01243567|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21295417|NCT01256281|Icahn School of Medicine at Mount Sinai|Dr. Jeffrey Glassberg|(212) 824-8056|jeffrey.glassberg@mountsinai.org|
21295418|NCT02653495|Rockefeller University|Dr. Ursula Andreo|212-327-7894|uandreo@gmail.com|
21295419|NCT04883528|Duke University|Stephen J. Greene, MD|919-684-3854|stephen.greene@duke.edu|
21295420|NCT03515941|Baylor College of Medicine|Eunji Jo|713-798-4923|ejo@bcm.edu|
21295421|NCT00461305|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21295422|NCT01628614|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21295423|NCT01896271|UT Southwestern Medical Center|Dr. Raquibul Hannan|214-645-8525|Raquibul.Hannan@UTSouthwestern.edu|
21295424|NCT01294462|AstraZeneca|Judith Hsia||ClinicalTrialTransparency@astrazeneca.com|
21295425|NCT02743780|Alcon, A Novartis Division|Translational Medicine Expert II, TM-Ophthalmic|1-888-451-3937|alcon.medinfo@alcon.com|
21295426|NCT01357135|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21249405|NCT04714359|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
21249406|NCT01330953|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21249407|NCT02109172|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
21249408|NCT03605745|Boston Scientific|Kaitlyn Rainbow, Clinical Research Associate|952-930-6627|kat.rainbow@bsci.com|
21295427|NCT01540409|Sarepta Therapeutics, Inc.|Medical Director|+1-888-727-3782|clinicaltrials@sarepta.com|
21295428|NCT01460407|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21249409|NCT01279447|Northwestern|Lawrence Hsu, MD|312 9262000|larryphsu@gmail.com|
21249410|NCT00674609|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
21264198|NCT01754922|VA NJ Health Care System|Dr. Michael Falvo|973-676-1000|Michael.Falvo@va.gov|2423
21264199|NCT01207388|Amgen Inc.|Study Director|866-572-6436||
21249411|NCT02213094|UNC at Chapel Hill|Kim Boggess MD Principal Investigator|919-966-1601|kboggess@med.unc.edu|
21264200|NCT00418964|The Chinese University of Hong Kong|Pauline Lui|852 2632 3072|pauline@ort.cuhk.edu.hk|
21264201|NCT02275767|Univ of Texas Health Sci Ctr San Antonjio, Dept of Periodontics|Brian L. Mealey DDS, MS|210-567-3567|mealey@uthscsa.edu|
21249412|NCT01074229|Northwestern University|Gildasio De Oliveira, MD|312-926-8373|g-jr@northwestern.edu|
21249413|NCT02163499|ZS Pharma, Inc|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21249414|NCT02301299|Northwestern University|Erin Wymore|3125033243|erin.wymore@northwestern.edu|
21249415|NCT00555620|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21249416|NCT05203822|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21264202|NCT00571688|University of Alabama at Birmingham|Tracy Manley|205-975-3442|tlmanley@uabmc.edu|
21249417|NCT00365599|H. Lee Moffitt Cancer Center and Research Institute|Susan Minton, D.O.|813-745-3806|susan.minton@moffitt.org|
21264203|NCT01194869|Emory University|Elisavet Paplomata, MD|404-778-1900|elisavet.paplomata@emory.edu|
21264204|NCT01048853|The University of Texas MD Anderson Cancer Center|Kathleen Schmeler, MD|(713) 854-9150|kschmele@mdanderson.org|
21249418|NCT04343989|NYU Langone Health|Bonnie Lonze, MD, PhD|212-263-3865|bonnie.lonze@nyulangone.org|
21249419|NCT05361304|Johnson & Johnson Vision Care, Inc. (JJVC)|John R. Buch, OD, MS, FAAO|800-843-2020|jbuch@its.jnj.com|
21249420|NCT03320941|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
21264205|NCT03739853|University of Oxford, NDORMS|Laura Coates|+441865737838|laura.coates@ndorms.ox.ac.uk|
21249421|NCT05087849|UCSF|Ayan Kusari|4153537800|ayan.kusari@ucsf.edu|
21249422|NCT03360071|John Hopkins University School of Medicine|Jody Tversky, MD|410-550-2300|hoddin1@jhmi.edu|
21249423|NCT00830284|Boston Children's Hospital|John Kheir|6179194712|john.kheir@childrens.harvard.edu|
21249424|NCT00896389|University of Maryland, Baltimore|Dr. Yen Pei Christy Chang|410-706-6737|cchang@som.umaryland.edu|
21249425|NCT01074437|Seattle childrens research institute|Jonathan Perkins, Prinicipal Investigator|206-987-1927|jonathan.perkins@seattlechildrens.org|
21249426|NCT03184519|IVIValencia|LAURA CARACENA (STUDY COORDINATOR)|034 963050900|laura.caracena@ivirma.com|
21264206|NCT06964165|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21249427|NCT00237718|Vanderbilt University|T. Alp Ikizler, MD||alp.ikizler@vanderbilt.edu|
21249428|NCT00834483|Rush University Medical Center|Dr. Brett R. Levine|312-432-2466|brettlevine@gmail.com|
21264207|NCT02170649|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|clinical.trials@bial.com|
21264208|NCT01309867|Bausch Health|Study Director|585-338-6399|robert.steffen@bausch.com|
21264209|NCT00432094|Masonic Cancer Center, University of Minnesota|Dr. Najla El Jurdi|612-625-8942|neljurdi@umn.edu|
21249429|NCT05104242|University Hospitals of Derby & Burton NHS Foundation Trust, Royal Derby Hospital|Catherine Johnson|01332 789354|catherine.johnson16@nhs.net|
21264210|NCT03224104|UniversitaetsSpital Zurich - Neurology Clinic|Dr Emilie Le Rhun|+41 762847518|emilie.lerhun@usz.ch|
21249430|NCT05756647|Washington University, Department of Otolaryngology - Head and Neck Surgery|Jay F. Piccirillo, MD|314-362-8641|piccirj@wustl.edu|
21249431|NCT02428595|Pelvalon|Clinical Management|650-276-0130|steve@pelvalon.com|
21264211|NCT06087328|Medical University of South Carolina|Amanda M. Palmer, PhD|843-792-1413|palmeram@musc.edu|
21264212|NCT05388656|University of North Carolina at Chapel Hill|Elizabeth Andersen, PhD|(970) 420-4944|elizabeth_andersen@med.unc.edu|
21264213|NCT03201965|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21264214|NCT05612581|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
21264215|NCT00156910|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
21295429|NCT00526110|The University of Texas (UT) MD Anderson Cancer Center|Jaffer Ajani, MD/Professor, GI Medical Oncology|1-877-632-6789|CR_Study_Registration@mdanderson.org|
21295430|NCT01400243|Southern Illinois University Carbondale|David G. Gilbert|618-453-3527|dgilbert@siu.edu|
21295431|NCT00953680|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
21295432|NCT04895293|Midwest Eye Institute|Raj K. Maturi, M.D.|317-817-1423|maturi.md@midwesteye.com|
21295433|NCT01309269|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21295434|NCT03880838|Geisinger Clinic|Amir Goren|5702144395|agoren@geisinger.edu|
21295435|NCT01798641|Johns Hopkins University|Dr. Daniele Rigamonti, MD FACS|410-955-2259|hydrocephalus@jhmi.edu|
21295436|NCT03383783|Oral Health Research Institute|Domenick T Zero, DDS, MS|317-274-8822|dzero@iu.edu|
21295437|NCT00308165|Columbia University|Jeffrey N. Bruce, MD|212-305-7346|jnb2@columbia.edu|
21295438|NCT01703117|Icahn School of Medicine at Mount Sinai|Dr. Ana Pereira|212-241-6984|ana.pereira@mssm.edu|
21295439|NCT02583230|Northwestern University|David C. Mohr, PhD|312-503-1403|d-mohr@northwestern.edu|
21295440|NCT00440310|Light Sciences Oncology, Inc.|Vice President of Regulatory Affairs and Clinical Operations|425-957-8986|lisak@lsoncology.com|
21295441|NCT02119156|GlaxoSmithKline|GlaxoSmithKline|866-435-7343|GSKClinicalSupportHD@gsk.com|1
21249432|NCT00901459|Duke Center for Nicotine and Smoking Cessation Research|Jed E. Rose, Ph.D.|919-668-5055|jed.rose@mc.duke.edu|
21264216|NCT01153893|GlaxoSmithKline|GSK Response Center|866-435-7343||
21264217|NCT04799405|Hebrew SeniorLife|Dr. Pascual-Leone|6179715372|apleone@hsl.harvard.edu|
21264218|NCT00118482|University of Calgary|Dr. Robert S. Sheldon|403-2208191|sheldon@ucalgary.ca|
21295442|NCT02469415|The University of Texas MD Anderson Cancer Center|Courtney DiNardo, MD/Assistant Professor|713-794-1141|CR_Study_Registration@mdanderson.org|
21295443|NCT04081961|Kazakhstan Academy of Preventive Medicine|Baurzhan Zhussupov|87774822171|baurzhan.zhussupov@gmail.com|
21295444|NCT05740332|Medline Industries LP|Director Clinical Operations|630-418-6891|jamiller@medline.com|
21295445|NCT03837665|University of Kansas Medical Center|Hinrich Staecker, MD, PhD|913-588-6701|hstaecker@kumc.edu|
21295446|NCT03315104|Emergent BioSolutions|Dr. Christine Hall|204-275-4200|chall@ebsi.com|4248
21249433|NCT04765046|Medtronic|Ami Stuart|8017934800|ami.stuart@medtronic.com|
21249434|NCT01597856|VA Connecticut/ Yale University|Christina Lazar|203-932-5711|Christina.Lazar@Yale.edu|4833
21249435|NCT02959866|St. Michael's Hospital|Anne Rucchetto, Research Coordinator|416-864-6060|rucchettoa@smh.ca|76155
21249436|NCT00963105|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
21249438|NCT04529941|Cedars-Sinai Medical Center|Dr. Peng-Sheng Chen|310-967-2707|Peng-Sheng.Chen@cshs.org|
21249439|NCT01005914|Oregon Health & Science University|Dr. Brandon Hayes-Lattin|503-494-1551|hayeslat@ohsu.edu|
21249440|NCT01240785|Department of Obstetrics and Gynecology, Turku University Central Hospital|Dr Kristiina Tertti|+358 2 3130000|kristiina.tertti@tyks.fi|
21249441|NCT00872339|New England Research Institutes|Felicia Trachtenberg|6179723120|ftrachtenberg@neriscience.com|
21249442|NCT01107795|University of Alabama at Birmingham|Dr. Kirk Withrow|(205) 801-7874|kwithrow@uabmc.edu|
21249443|NCT00321555|National Cancer Institute|Dr. Robert Kreitman|301-648-7375|robert_kreitman@nih.gov|
21249444|NCT00762853|Colgate Palmolive Co.|William Devizio|732-878-7901|William_Devizio@colpal.com|
21249445|NCT04520256|The Miriam Hospital|Dr. J. Graham Thomas|(401) 793-8154|jthomas4@brownhealth.org|
21249446|NCT01730118|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|hoyoung.maeng@nih.gov|
21249447|NCT05480410|Fundación Universitaria María Cano|Physiotherapy professor|+573206728934|catalinaloperamuneton@fumc.edu.co|
21249448|NCT05356130|Kaiser Permanente Center for Health Research|Greg Clarke, PhD|503-335-2400|greg.clarke@kpchr.org|
21249449|NCT04851587|University of Florida|Emily Bartley|352-273-8934|EBartley@dental.ufl.edu|
21249450|NCT02232009|GE Healthcare|Yvonne Celestial|+33 130709133|MarieYvonne.CELESTIAL@ge.com|
21249451|NCT00538629|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21249452|NCT00234832|Abbott|Global Medical Services|800-633-9110||
21249453|NCT01107717|University of Texas Health Science Center at San Antonio|Muhammad Abdul-Ghani, MD|210-557-1157|abdulghani@uthscsa.edu|
21249454|NCT04454125|University of Pittsburgh|Dr. Franziska Rosser|412-692-8429|franziska.rosser2@chp.edu|
21249455|NCT01493947|Galderma R&D|Galderma CPM|00 33 4 93 95 70 70|clinicaltrials@galderma.com|
21249456|NCT01183013|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21249457|NCT00584909|UAB|J. MIchael Straughn, MD|205-934-4986|Michael.Straughn@ccc.uab.edu|
21249458|NCT02092909|Idera Pharmaceuticals|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
21249459|NCT04463004|Virginia Commonwealth University|Antonio Abbate, MD, PhD|804-628-1215|antonio.abbate@vcuhealth.org|
21249460|NCT01532830|electroCore LLC|Clinical Affairs|+1 973 355 6683|clinical@electrocore.com|
21249461|NCT02465632|Glenmark Pharmaceuticals Ltd|Cathy Tyrrell|91 2267720000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
21249462|NCT04791917|University of Florida Department of Clinical and Health Psychology|Jeff Boissoneault, PhD|352-273-6200|jboissoneault@phhp.ufl.edu|
21249463|NCT00910871|Janssen Infectious Diseases - Diagnostics BVBA|Medical Leader|1 609 730-7768||
21249464|NCT00850993|Mallinckrodt Pharmaceuticals|Medical Information Call Center|1-800-844-2830|clinicaltrials@mnk.com|5
21249465|NCT00349713|University of Bamako|Mahamadou A. Thera, MD, MPH, Professor|223-20-22-81-09|mthera@icermaili.org|
21249466|NCT03816202|Integra LifeSciences|Andrew Tummon, Director, Global Clinical Trials|609-936-5490|andrew.tummon@integralife.com|
21249467|NCT04501614|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21249468|NCT04374435|University of California, Irvine|Anand Ganesan, MD, Professor|949-824-0606|aganesan@uci.edu|
21249469|NCT02555397|Henry Ford Health System|Shyam Nyati|734-272-1751|snyati1@hfhs.org|
21249470|NCT01842360|Inmunotek S.L|Miguel Casanovas|34691490175|mcasanovas@inmunotek.com|
21249471|NCT03800602|Emory University|Olumide B. Gbolahan MBBS, MSc|404-778-0032|ogbolah@emory.edu|
21249472|NCT04206501|University of Rochester Medical Center|Spencer Z. Rosero, M.D.|5852752756|spencer_rosero@urmc.rochester.edu|
21249473|NCT00237809|Yale University|Dr. Deepak Cyril D'Souza|203-932-5711|deepak.dsouza@yale.edu|2594
21249474|NCT02006641|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
21249475|NCT01613599|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21249476|NCT01158716|Cardiovasular RS|Theodoros Zografos|+306956161001|theodoroszografos@gmail.com|
21249477|NCT02132195|Emory University|Dr. Greenbaum|404-712-6374|LGREEN6@emory.edu|
21249478|NCT04407442|University of California, San Francisco|Dr. Alfred Chung|(415) 353-2421|Alfred.Chung@ucsf.edu|
21249479|NCT02066389|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21249480|NCT02429115|Penn State College of Medicine - Penn State Health|Nasrollah Ghahramani|7175318156|nghahramani@pennstatehealth.psu.edu|
21249481|NCT02417376|GCD Indore|Dr Divya Singh Hada|+918720898289|dr_dshada@yahoo.com|
21249482|NCT01468597|Medical University of Graz|Elisabeth Mahla, MD|0043 316 385 13027|elisabeth.mahla@medunigraz.at|
21249483|NCT02684435|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
21249484|NCT02561195|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21249485|NCT03905512|Selecta Biosciences, Inc.|Study Director|617-923-1400|ptraber@selectabio.com|
21295447|NCT01309906|Bausch Health|Study Director||robert.steffen@bausch.com|
21264219|NCT01963208|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
21264220|NCT00438399|Galderma|Farzaneh SIDOU Clinical Project Manager|00 33 4 93 95 70 70|farzaneh.sidou@galderma.com|70 51
21264221|NCT00723073|Brigham and Women's Hospital|David Kubiak, Principle Investigator|617-525-8417|dwkubiak@partners.org|
21264222|NCT05522673|National Institute of Mental Health (NIMH)|Dr. Robert Innis|301-594-1368|robert.innis@nih.gov|
21264223|NCT05294211|Marani Health, Inc.|Vice President, Clinical Affairs|612-718-9699|mindy@maranihealth.com|
21264224|NCT04914377|Novatek Pharmaceuticals|Ahmed Kaseb MD|877-662-8351|akaseb@novatekpharmaceuticals.com|
21264225|NCT00012012|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
21264226|NCT02159469|Antares Pharma, Inc.|Jonathan Jaffe, MD|609-359-3020|jjaffe@antarespharma.com|
21264227|NCT02034474|NYSPI|Ragy Girgis,MD|6467745553|ragy.girgis@nyspi.columbia.edu|
21264228|NCT01391819|GlaxoSmithKline|GSK Response Center|866-435-7343||
21264229|NCT01519284|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21264230|NCT01262755|Temple University|Frank Friedenberg, MD|215-707-9900|frank.friedenberg@temple.edu|
21264231|NCT03730194|University of Nebraska Medical Center|Alyson E Hanish|402-559-6731|alyson.hanish@unmc.edu|
21264232|NCT04427917|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21264233|NCT01244191|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21264234|NCT01752842|Washington University School of Medicine|Jean E. Schaffer, MD|314-362-8717|jschaff@wustl.edu|
21264235|NCT02164513|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21264236|NCT05584202|ModernaTX, Inc.|Moderna WeCare Team|866-663-3762|WeCareClinicalTrials@modernatx.com|
21264237|NCT05301322|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21264238|NCT05084053|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21264239|NCT02180724|Acerta Pharma|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21264240|NCT00571519|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21264241|NCT05458011|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
21264242|NCT00574119|Vanderbilt University School of Medicine|Marvin W. Kronenberg,M.D.|615 936-7437|marvin.w.kronenberg@vumc.org|
21264243|NCT03292952|KemPharm|Gerald Orehostky|321-250-3699|gorehostky@kempharm.com|
21264244|NCT04656418|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
21264245|NCT03287245|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21281505|NCT02235064|Cooper University Health System|Dr. Richard L Fischer|856-342-2491|fischer-richard@cooperhealth.edu|
21264246|NCT02586077|OrthoCarolina Research Institute|Susan Odum|7049457710|susan.odum@orthocarolina.com|
21264247|NCT02701192|Carolinas Healthcare System|Rachel Seymour, PhD|704-355-2000|Rachel.Seymour@carolinas.org|
21264248|NCT00880763|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21264249|NCT02267226|Octapharma USA|Director of Clinical Operations|201 604-1149|sylvia.werner@octapharma.com|
21264250|NCT00003476|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
21264251|NCT00696436|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21264252|NCT00944216|Wright State University School of Medicine, Dept of Dermatology|Amy Chen, MD|927-224-3345|amy.chen@wright.edu|
21264253|NCT00751179|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21264254|NCT03039738|Medtronic|Anne Kinney|+1-303-876-8904|anne.r.kinney@medtronic.com|
21264255|NCT00912340|Emory University|Elisavet Paplomata, Principal Investigator|404-778-1900|elisavet.paplomata@emory.edu|
21264256|NCT00915538|Western Sky Medical Research|Lyndon Mansfield MD|915-544-2557|immunman@westernskymed.com|
21264257|NCT01517412|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21264258|NCT01253187|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21264259|NCT02527187|Inmunotek|Dr. Miguel Casanovas/ Medical Director|91 6510010|mcasanovas@inmunotek.com|
21264260|NCT05158179|University of California San Francisco|Yue Ma|415-885-7700|yue.ma@ucsf.edu|
21264261|NCT01293006|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21264262|NCT01494987|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21264263|NCT06170866|University of Connecticut|Dr. Cristina Colon-Semenza, Assistant Professor|8604860019|cristina.colon-semenza@uconn.edu|
21264264|NCT03353753|Deciphera Pharmaceuticals, LLC|INVICTUS Clinical Team|7812096400|clinicaltrials@deciphera.com|
21264265|NCT00205699|Florida Atlantic University|John W. Newcomer|(561) 297-0252|jnewcomer@health.fau.edu|
21264266|NCT01885078|Eli Lilly & Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
21264267|NCT01895452|Alkermes, Inc.|ARISTADA Medical Information|866-204-7823|usmedinfo@alkermes.com|
21264268|NCT01653158|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21264269|NCT04999969|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21264270|NCT04026178|Chiesi|Metreleptin Clinical Program Lead|+3905212791|clinicaltrials_info@chiesi.com|
21264271|NCT04321252|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21281506|NCT00529087|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21281507|NCT01135329|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Yvette Kasamon|410-955-8839|ykasamo1@jhmi.edu|
21281508|NCT00981214|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
21264272|NCT06245044|University of Michigan|Dr. Corey Lester|734-647-8849|lesterca@umich.edu|
21281509|NCT03204786|Stanford University|Antonio Hardan, MD|(650)736-1235|autismdd@stanford.edu|
21264273|NCT00611897|Yale School of Medicine, Department of Psychiatry|Handan Gunduz-Bruce, MD|(203) 785-2117|handan.gunduz-bruce@yale.edu|
21264274|NCT02823600|University of North Carolina at Chapel Hill|Seema Garg, MD, PhD|919-966-5296|sgarg@med.unc.edu, ashton.madison@alumni.duke.edu|
21264275|NCT01658579|Sanofi|Trial Transparency Team||Contact--US@sanofi.com|
21264276|NCT05590767|Tri-Service General Hospital, National Defense Medical Center|Dr. Lu Yi-Hsiung|+886933429559|luyihsiung@gmail.com|
21264277|NCT01464788|McGovern Medical School UTHealth - Houston|Dr. Andrew Barreto|713-500-7002|andrew.d.barreto@uth.tmc.edu|
21264278|NCT05127044|University of Arkansas for Medical Sciences|Rebecca P Sartini, DNP|5015261580|rpsartini@uams.edu|
21264279|NCT01577160|Janssen Research & Development|Medical Director|886 2 23762155||
21264280|NCT01551758|GlaxoSmithKline|GSK Response Center|866-435-7343||
21264281|NCT04460690|University of Wisconsin - Madison|Kristi Hall|608-890-0844|klhall1@wisc.edu|
21264282|NCT01586156|Cleveland Clinic|Dr. Serpil Erzurum|216-445-6624|erzurus@ccf.org|
21264283|NCT00363246|James A. Haley Veterans' Hospital|Andrea M. Spehar, DVM, MPH, JD|813-558-3947|Andrea.Spehar@va.gov|
21264284|NCT00264849|Novartis Pharmaceuticals|Study Director|862-778-8300||
21264285|NCT01788306|University of Washington|Dr. Caleb Banta-Green|206-543-0937|calebbg@uw.edu|
21264286|NCT00717366|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21264287|NCT01553916|Washington University School of Medicine|Clifford Robinson, M.D.|314-362-4653|clifford.robinson@wustl.edu|
21264288|NCT03497026|Auris Health|Scott Rehage|925 6832590|srehage@its.jnj.com|
21264289|NCT01423773|Alcon Research|Head, Clinical Trial Management|1-800-241-7629||
21264290|NCT00645567|James A Haley VA, Tampa|John Lloyd|813-624-8986|john.lloyd2@va.gov|
21264291|NCT00547638|Ethicon, Inc.|John Lombard, Clinical Research Manager|908 218 2877|jlombar8@its.jnj.com|
21264292|NCT03259490|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21264293|NCT00434122|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
21264294|NCT00622544|University of MN|Clifford E. Kashtan|646 692 9309|cassi044@umn.edu|
21264295|NCT00255086|VA Palo Alto Health Care System|Wes Ashford, PhD, MD|650-493-5000|wes.ashford@va.gov|
21264296|NCT01364233|Medline Industries, Inc.|Ed Drower|847-643-3874|edrower@medline.com|
21264297|NCT00379197|University of Minnesota, Dept. Medicine|Dr. Douglas Yee, MD|612-273-5700|yeexx006@umn.edu|
21264298|NCT00819585|Novartis Pharmaceuticals|Study Director|862-778-8300||
21264299|NCT00349752|UCB Clinical Trial Call Center|Study Director|+1 877 822 9493||
21264300|NCT03334396|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21264301|NCT00601796|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-2158|alberto.chiappori@moffitt.org|
21264302|NCT01842607|GlaxoSmithKline|GSK Response Center|866-435-7343||
21264303|NCT03629041|Innoture Ltd|Jemma Burridge, Clinical Project Manager|+44 (0)7799 902476|jburridge@innoture.co|
21264304|NCT03011450|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
21264305|NCT03814590|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21264306|NCT00810719|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu|
21264307|NCT04971785|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21264308|NCT01255306|"University Hospital Sestre milosrdnice"|Mia Zoric Geber, MD|+385 1 3787 354|mia.zoric-geber@zg.t-com.hr|
21264309|NCT00168324|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
21264310|NCT01677624|Eisai Co., Ltd.|Shin Maeda|+81-3-3817-5252||
21264311|NCT01299610|GlaxoSmithKline|GSK Response Center|866-435-7343||
21264312|NCT01337167|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21264313|NCT02223429|Emory University|Dr. James Rilling|404-727-3062|jrillin@emory.edu|
21264314|NCT02097485|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
21264315|NCT02126670|Promius Pharma, LLC|Director of Clinical Operations|609-282-1476|kgulbronson@promiuspharma.com|
21264316|NCT02757092|Chang Gung Memorial Hospital|Respiratory therapist Nai-Ying Kuo|+886077317123|ellen0605@gmail.com|2648
21264317|NCT03363919|Mayo Clinic|Paul E. Croarkin, D.O., M.S.|507-293-2557|Croarkin.Paul@mayo.edu|
21264318|NCT01975246|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21264319|NCT01646398|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21264320|NCT01263093|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21264321|NCT01827319|CryoLife, Inc.|Scott Capps|800-438-8285|brown.carolyn@cryolife.com|
21264322|NCT02500368|CooperVision Inc.|Sr. Manager Clinical Research|(925) 730-6754|PChamberlain@coopervision.com|
21264323|NCT00989612|GlaxoSmithKline|GSK Response Center|866-435-7343||
21249486|NCT03293238|Andrews Research & Education Foundation|Dr. Joshua Hackel|850-916-8796|jghackelmd@yahoo.com|
21249487|NCT00736502|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21249488|NCT02502019|Biom'Up|Dr. William Spotnitz, Chief Medical Officer|352-514-5009|wspotnitz@gmail.com|
21249489|NCT03987074|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21249490|NCT01307800|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21249491|NCT05062343|Brigham and Women's Hospital|Sarah Little|6174557372|selittle@bwh.harvard.edu|
21249492|NCT01517282|MorphoSys|Roman Korolkiewicz|+49 89 89927 208|roman.korolkiewicz@morphosys.com|
21249493|NCT00267774|Stanford University|William F. Fearon, MD|650 725-2621|wfearon@stanford.edu|
21264324|NCT05343585|Pennington Biomedical Research Center|Chloe Panizza Lozano|(225) 763-2500|cpanizza@hawaii.edu|
21264325|NCT02062463|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21281510|NCT00216125|Hoosier Cancer Research Network|Georgia Gould|3176385842|ggould@hoosiercancer.org|10
21281511|NCT05340764|Washington University School of Medicine GI Division|Dr. Chien-Huan Chen|3143623201|chen330@wustl.edu|
21281512|NCT01671007|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21281513|NCT03877068|Emory University|Guillermo E. Umpierrez, MD|404-778-1665|geumpie@emory.edu|
21281514|NCT00406367|Merz Pharmaceuticals GmbH|Angelika Hanschmann|++49-69-1503|angelika.hanschmann@merz.de|538
21281515|NCT00253435|Chidlren's Hospital Los Angeles|Araz Marachelian, MD, NANT Medical Director|323-3691-5687|amarachelian@chla.usc.edu|
21281516|NCT03187301|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
21281517|NCT01966120|Biofrontera Bioscience GmbH|Clinical Trial Department,|+49 2148763226|ameluz@biofrontera.com|
21281518|NCT00461630|Clinical Trial Service Unit, University of Oxford|Professor Jane Armitage|+44 (0)1865 743743|thrive@ctsu.ox.ac.uk|
21281519|NCT00375973|University of Cincinnati College of Medicine|Lesley M. Arnold, M.D.|513-558-7700|lesley.arnold@uc.edu|
21281520|NCT01339260|Helsinn Healthcare SA|Head of Clinical Development|+41 91 9852121|marco.palmas@helsinn.com|
21295448|NCT00330928|InfraReDx, Inc|Director Clinical and Regulatory|781-221-0053|pshah@infraredx.com|
21295449|NCT03028480|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21295450|NCT05074888|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
21295451|NCT01030874|VAORD|Mark Helfand, MD|5032203406|mark.helfand@va.gov|
21295452|NCT02299570|Rebiotix|Assoc. Director of Clinical Research|651-705-8778|Sarah.Mische@Ferring.com|
21295453|NCT02403635|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
21249494|NCT01045057|Atos Medical AB|Director of Clinical Affairs|+1 352 870 0872|Corina.van.As@atosmedical.com|
21295454|NCT04942665|University of Florida|Dr. Ali Zarrinpar|(352) 265-0606|ali.zarrinpar@surgery.ufl.edu|
21295455|NCT03554772|Dr Reddy's Laboratories, Inc.|Srinivas Shenoy B.|6099550249|srinivasshenoyb@drreddys.com|
21295456|NCT01690546|Duke University Medical Center|Paolo Mannelli, M.D|919-681-0613|paolo.mannelli@dm.duke.edu|
21295457|NCT03362931|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21295458|NCT01998893|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21295459|NCT03276052|AstraZeneca|Global Clinical Head|+187724094 79|information.center@astrazeneca.com|
21295460|NCT02061397|University of Pennsylvania|Dr. Vera Krymskaya|215-573-9861|krymskay@pennmedicine.upenn.edu|
21295461|NCT03404804|Medical College of Wisconsin|Dr. David Vyles, DO|414-266-2625|dvyles@mcw.edu|
21295462|NCT00711347|Alcon Research, Ltd.|Erin Rogut|813-426-4036|Erin.Rogut@alconlabs.com|
21295463|NCT05136898|UroGen Pharma|Head of Clinical Development|+1 855-987-6436|info@urogen.com|
21295464|NCT01133405|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21295465|NCT02737553|Ege University|Ali Akdemir|+905056748904|md.aliakdemir@gmail.com|
21295466|NCT03300024|Johns Hopkins University|Thomas Reifsnyder|410-955-7518|treifsn1@jhmi.edu|
21295467|NCT01238835|Edwards Lifesciences|Edwards THV Clinical Affairs|949-250-2500|THV_CT.gov@edwards.com|
21295468|NCT00554619|GlaxoSmithKline|GSK Response Center|866-435-7343||
21249495|NCT01078402|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21249496|NCT01199302|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21249497|NCT04433091|Vanderbilt University Medical Center|M.Benjamin Shoemaker,MD MSCI|615-322-2318|moore.b.shoemaker@vumc.org|
21249498|NCT03820024|UNC Lineberger|Leslie Clark|919-966-5996|leslie_Clark@med.unc.edu|
21249499|NCT03016091|Davidoff Cancer Center at Rabin Medical Center|Shlomit Yust-Katz MD|92739378002|shlomit2@clalit.org.il|
21249500|NCT05379400|NYU Langone Health|Sharine Wittkopp|646-501-7733|Sharine.Wittkopp@nyulangone.org|
21249501|NCT03523897|Virtua Health|Dr. Jeremy Reid|8008967326|jreid@reconstructiveortho.com|
21249502|NCT03409276|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
21249503|NCT01309802|Southern Illinois University School of Medicine|Research Administrator|217-545-2531|surgeryresearch@siumed.edu|
21249504|NCT01816165|University of Colorado Denver|Irene Schauer, MD|3037241111|clinicaresearchsupportcenter@ucdenver.edu|
21249505|NCT03960437|Columbia University|Thomas L.Nickolas, MD, MS|212-305-9847|tln2001@cumc.columbia.edu|
21249506|NCT02368691|Oncternal|Mary Breitmeyer|858-434-1113|MBreitmeyer@oncternal.com|
21249507|NCT01838447|Children's Hospital of Eastern Ontario|Katie O'Hearn, PICU Research Coordinator|613-737-7600|kohearn@cheo.on.ca|4006
21249508|NCT01114217|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
21249509|NCT06247488|Azurity Pharmaceuticals, Inc.|Vice President of Clinical Development|(913) 389-7961|david.sequeira@azurity.com|
21249510|NCT01189370|University of Kansas Cancer Center|Dr. Peter Van Velduizen|913-945-5059|SWILLIAM@kumc.edu|
21249511|NCT03436797|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
21249512|NCT04739306|CELLTRION, Inc.|Head of Clinical Planning|+82-32-850-4190|keumyoung.ahn@celltrion.com|
21249513|NCT00641797|Lehigh Valley Health Network|Regina Sacco, DPT, BA, BHSC|610-969-0300|Regina_R.Sacco@lvhn.org|
21249514|NCT02074709|University of Texas Southwestern Medical Center|Irina Gasanova|214-590-0064|Irina.Gasanova@UTSouthwestern.edu|
21249515|NCT01951105|Northwestern University|Apkar Vania Apkarian|312-503-0404|a-apkarian@northwestern.edu|
21249516|NCT04175392|Beaumont Hospitals|Kirsten Gage, CRM|947-521-8519|kirsten.gage@beaumont.org|
21249517|NCT02727998|Yale School of Medicine|Dr. Ilan Harpaz-Rotem|(203) 937-4760|ilan.harpaz-rotem@yale.edu|
21249518|NCT02105688|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21249519|NCT00561678|Icahn School of Medicine at Mount Sinai|Dr. Stacie Deiner|212-241-7749|stacie.deiner@mountsinai.org|
21281521|NCT03291080|Nova Laboratories|Dr Hussain Mulla|+44 (0) 116 223 0100|hussain.mulla@novalabs.co.uk|
21295469|NCT02250807|Janssen R&D BE|Trial Physician||ClinicalTrialDisclosure@its.jnj.com|
21264326|NCT01743872|Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center|Dr. Vikram S. Kashyap|216-844-1631|vikram.kashyap@uhhospitals.org|
21264327|NCT01509872|Queen's University Belfast|Dr Paul O'Callaghan|+44 7501 43 46 32|pocallaghan02@qub.ac.uk|
21264328|NCT00707655|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
21264329|NCT02858154|Cincinnati Children's Hospital Medical Center|Dr. Neepa Gurbani|513-736-1814|Neepa.Gurbani@cchmc.org|
21264330|NCT02979301|Mayo Clinic|Dr. Carrie Hruska|507-293-4719|hruska.carrie@mayo.edu|
21264331|NCT02092441|Brooke Army Medical Center|Dr. Michael D. April|210-916-6129|Michael.D.April@post.harvard.edu|
21264332|NCT00600028|Johns Hopkins University School of Medicine|Maureen R. Horton|410-955-4176|mhorton2@jhmi.edu|
21264333|NCT02716194|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21264334|NCT00363051|Novartis Pharmaceuticals|Novartis Study Director|(862 778-8300||
21264335|NCT02093234|GW Medical Faculty Associates|Richard Katz, MD|202-741-2323|RKatz@mfa.gwu.edu|
21264336|NCT01107405|Bausch & Lomb Incorporated|Tuyen Ong, MD MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
21264337|NCT01827930|Institut Bergonié|Pr Simone Mathoulin-Pelissier|05 56 33 33 33|S.Mathoulin@bordeaux.unicancer.fr|
21264338|NCT00421603|NYSPI|Daniel Brooks|212-740-3205|brooksd@nyspi.columbia.edu|
21264339|NCT00765128|Mayo Clinic|Mitchell R. Humphreys MD|480-301-8000|humphreys.mitchell@mayo.edu|
21264340|NCT01170702|Northwestern University Feinberg School of Medicine|Edward Yaghmour|312-695-0693|edward.yaghmour@nm.org|
21264341|NCT01677507|University of Michigan|Dr. Sayoko Moroi|734-763-3732|smoroi@med.umich.edu|
21264342|NCT03779334|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21264343|NCT00085917|RCHSPB|John Tierney|301-451-5136|john.tierney@nih.gov|
21264344|NCT02476357|Lausanne University Hospita! and University of Lausanne|Prof. Dr Med. Maurice MATTER|795561071|maurice.matter@chuv.ch|0041
21264345|NCT01103778|Rogosin Institute|Dr. Choli Hartono|212-746-1578|chh2001@nyp.org|
21264346|NCT05080179|University of Pennsylvania, Perelman School of Medicine|Dr. Erica Dixon|215-573-9987|erica.dixon@pennmedicine.upenn.edu|
21264347|NCT03670641|University of Pittsburgh Medical Center (UPMC)|David Rometo, MD|412-586-9700|rometoda@upmc.edu|
21264348|NCT01662297|Yale University/West Haven VAMC|Dr. Albert Arias|2039325711|albert.arias@va.gov|8155
21264349|NCT00538980|Weill Cornell Medicine|Richard T. Silver, MD|646-962-2273|rtsilve@med.cornell.edu|
21264350|NCT01981967|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21264351|NCT00125190|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
21264352|NCT00916370|Abbott Vascular|Robert Smith Jr, Ph.D., Sr Clinical Research Scientist|408-845-8265|robert.smithjr@av.abbott.com|
21264353|NCT00414960|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21264354|NCT03722784|CooperVision, Inc.|Martine Robie|9256604477|mrobie@coopervision.com|
21264355|NCT04465396|Takeda|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
21264356|NCT02902913|University of California, Davis|Roberta R Holt|530-752-4950|rrholt@ucdavis.edu|
21264357|NCT01766817|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
21264358|NCT03041909|Global Blood Therapeutics|Margaret Tonda, Sr. Director, Clinical Science|650-741-7761|mtonda@gbt.com|
21264359|NCT00383721|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21264360|NCT03519516|Laboratorios Sophia|Ricardo Alonso Llamas Velázquez (clinical safety pharmacologist)|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
21264361|NCT02300077|Department of Anesthesiology Washington University in St. Louis|Helga Komen|3148527622|komenh@anest.wustl.edu|
21264362|NCT05757427|MVG Industries SAS|Luc Duchesne|+33 (0) 6 70 33 91 20|luc.duchesne91@gmail.com|
21264363|NCT01283997|UT MD Anderson Cancer Center|Dr. Sheeba Thomas,Professor, Lymphoma-Myeloma|(713) 792-2860|sthomas@mdanderson.org|
21264364|NCT01179347|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21264365|NCT02109744|University of Rochester|Jane Liesveld|585 - 275 - 5823|Jane_Liesveld@urmc.rochester.edu|
21264366|NCT04095442|Indiana University Indianapolis|Andrew R. Coggan|3172740656|acoggan@iu.edu|
21264367|NCT03833817|Fred Hutchinson Cancer Center|Megan Shen|206-667-4172|mshen2@fredhutch.org|
21264368|NCT00884221|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
21264369|NCT04172701|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21264370|NCT00255034|Merck, Sharp & Dohme Corp.|Senior Vice Predsident, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21264371|NCT00424346|Novartis Pharmaceuticals|Study Director|862-778-8300||
21264372|NCT01109069|Pharmacyclics|James Dean|669-224-1880|jdean@pcyc.com|
21295470|NCT00908648|Gastroenterology Unit, Valduce Hospital - Como - Italy|Dr Vittorio Terruzzi, Director of Gastroenterology Unit|+39031324009|vterruzzi@valduce.it|
21295471|NCT00907803|SIGA Technologies, Inc.|Annie Frimm, Vice President, Regulatory Affairs|951-303-8797|afrimm@siga.com|
21295472|NCT00909545|Feinberg School of Medicine, Northwestern University|Tanya Simuni, MD|312-503-2970|TSimuni@nmff.org|
21295473|NCT05426031|University of Miami|Michael Fabbro II, DO|305-689-1106|mxf790@miami.edu|
21295474|NCT00529126|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
21295475|NCT00241631|Imperial College London|Ian M Adcock|+44 (0)20 7594 7840|ian.adcock@imperial.ac.uk|
21295476|NCT01118520|Imperial College London|Professor Neil Poulter|+44(0) 20 7594 3446|n.poulter@imperial.ac.uk|
21295477|NCT03958656|National Cancer Institute|Dr. James N. Kochendefer|240-760-6062|kochendj@mail.nih.gov|
21295478|NCT03158012|UCSD Dermatology|Teruaki Nakatsuji|8588227814|tnakatsuji@ucsd.edu|
21295479|NCT01852825|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21264373|NCT03947255|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
21264374|NCT02499575|Orthopedic Foot and Ankle Center|Dr. Christopher Hyer|614-895-8747|hyerofac@gmail.com|
21264375|NCT03794752|UT Southwestern Medical Center|Peter Chen|12146283837|peter.chen@utsouthwestern.edu|
21264376|NCT01206452|University of Kansas Medical Center|Donita Atkins, RN, CCRC|(913) 588-9714|datkins2@kumc.edu|
21264377|NCT01245764|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21264378|NCT02667457|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21264379|NCT03097614|Allergan Sales LLC|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
21264380|NCT00781963|VA Greater Los Angeles Healthcare System|Dr. Cathy Alessi|818 895-9311|Cathy.Alessi@va.gov|
21264381|NCT03297216|University of North Carolina at Chapel Hill|Joan Price, MD, MPH|919-962-4717|joan_price@med.unc.edu|
21264382|NCT00605696|Albert Einstein College of Medicine of Yeshiva University|Michelle Ng Gong, MD, MS|718 920 5464|mgong@montefiore.org|
21264383|NCT01842646|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jeffrey Lancet|813-745-1387|jeffrey.lancet@moffitt.org|
21264384|NCT01383109|Shin Poong Pharmaceutical Co., Ltd.|Jansik Shin|+82-2-2189-3468|jsshin@shinpoong.co.kr|
21264385|NCT00436982|Stryker EU Operations B.V. Herikerbergweg 110 1101 CM Amsterdam The Netherlands|Eric Garling, PhD, Snr. Director Medical & Scientific Affairs Europe|+31 20 219 2660|Eric.Garling@stryker.com|
21264386|NCT00953225|Ralph H. Johnson VA Medical Center|Sebastiano Gattoni-Celli, M.D.|843-876-5103|gatttonis@musc.edu|
21264387|NCT03864536|UAB|Pariya Wheeler|2052423924|plfazeli@uab.edu|
21264388|NCT04058158|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
21264389|NCT01634113|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21264390|NCT01598207|Temple University|Dr. Ron Schey|215-707-9900|Ron.schey@tuhs.temple.edu|
21264391|NCT01956240|Methodist University of Piracicaba|Ms Dayana Patricia Rosa|+55 16 3306-6696|dad_rosa@hotmail.com|
21264392|NCT00218426|University of Pennsylvania|Dr. George E Woody|215-746-7702|woodg@pennmedicine.upenn.edu|
21264393|NCT01830816|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21264394|NCT03172481|Purdue Pharma L.P.|Clinical Leader|1-800-733-1333|steven.ripa@pharma.com|
21264395|NCT05197140|University of Arkansas for Medical Sciences|Robert Wolfe|501-526-5769|rwolfe2@uams.edu|
21264396|NCT02759562|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21264397|NCT02293993|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21264398|NCT03587584|University of Minnesota|Aaron Berg|612-625-7675|bergx831@umn.edu|
21264399|NCT00830115|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
21264400|NCT02928380|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21264401|NCT00232505|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
21264402|NCT03050216|Masonic Cancer Center, University of Minnesota|Dr.Claudio G. Brunstein MD, PhD|612 625 3918|bruns072@umn.edu|
21264403|NCT01061736|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21264404|NCT03115112|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
21264405|NCT01610076|Mayo Clinic|Kianoush Kashani; Principal Investigator|5072667093|kashani.kianoush@mayo.edu|
21264406|NCT01396239|Sarepta Therapeutics, Inc.|Edward M. Kaye MD, Interim CEO, SVP & Chief Medical Officer|+1-888-727-3782|clinicaltrials@sarepta.com|
21264407|NCT00980343|Adult Brain Tumor Consortium (ABTC)|Charles J Nock, MD|410-955-8837|jfisher@jhmi.edu|
21264408|NCT03060083|University of Vermont|Elias M Klemperer|8026561641|elias.klemperer@med.uvm.edu|
21264409|NCT00284739|Kaiser Permanente|Hyo-Chun Yoon, MD,PHD|8084327342|Hyo-Chun.Yoon@nsmtp.kp.org|
21264410|NCT02899377|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|1
21264411|NCT01231607|GlaxoSmithKline|GSK Response Center|866-435-7343||
21264412|NCT01583985|Minneapolis VA Health Care System|Erin Krebs, MD|612-725-2000|erin.krebs@va.gov|
21264413|NCT01709786|University of Cincinnati|Betty Tsuei, MD|513-558-5661|Betty.Tsuei@uc.edu|
21264414|NCT06533475|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21264415|NCT00664755|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
21264416|NCT00098020|National Institutes of Diabetes, Digestive, and Kidney Disorders|Dr. Jeffery Kopp|301-594-3403|koppj@mail.nih.gov|
21264417|NCT01453998|GlaxoSmithKline|GSK Response Center|866-435-7343||
21264418|NCT01840228|Ohio State University|Dr. Heather Frey|614-688-6798|Heather.Frey@osumc.edu|
21264419|NCT00943488|Carver College of Medicine, University of Iowa|Patricia Winokur, MD|319-384-1735|patricia-winokur@uiowa.edu|
21281522|NCT02588612|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21281523|NCT01216241|University of Rochester|Dr. Robert F. Betts|585-275-5871|robert_betts@urmc.rochester.edu|
21281524|NCT03123393|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21281525|NCT05245526|Stryker Sustainability Solutions|Monique Ketcher|602-354-0917|monique.ketcher@stryker.com|
21281526|NCT00558701|USAISR|Leopoldo C. Cancio, COL, MC|210-916-3301|leopoldo.c.cancio.mil@mail.mil|
21281527|NCT00427648|NorthShore Health|Frank F. Tu|8475702521|ftu@northshore.org|
21281528|NCT02230904|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
21281529|NCT01681212|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21281530|NCT02069041|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21281531|NCT01464333|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21281532|NCT01511978|Jacobus Pharmaceutical Company, Inc.|Dr. Kathy Aleš, Medical Director|6099217447|kathy.ales@jacobus-pharmaceutical.com|231
21281533|NCT05047211|UTMB Galveston|Dr Antonio Saad Director of PRD|4097721795|antalar@me.com|
21264420|NCT03495453|NYU Langone Health|Anvar Babaev, MD, PhD|212-263-5656|Anvar.Babaev@nyulangone.org|
21264421|NCT00712933|GlaxoSmithKline|GSK Response Center|866-435-7343||
21281534|NCT00561392|Novartis Pharmaceuticals|Study Director|862 778-8300||
21281535|NCT03321968|Medicago|Medical Director|+1 418-658-9393|clinicaltrialinquiries@medicago.com|
21281536|NCT03822468|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
21281537|NCT02198664|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
21281538|NCT00529308|Yale University|Dr. Angeli Landeros-Weisenberger||angeli.landeros-weisenberger@yale.edu|
21281539|NCT01808066|CogCubed|Chief Medical Officer|612-250-9737|monika@cogcubed.com|
21281540|NCT00365794|University of Southern California|Fred Sattler, MD|323-409-4635|fsattler@usc.edu|
21281541|NCT02554682|Children's Hospital of Philadelphia|Dr. Carol Ford|267-426-3938|fordc@email.chop.edu|63938
21295480|NCT02159118|The University of Texas Health Science Center|Chatchawin Assanasen, MD|210-567-7456|assanasen@uthscsa.edu|
21249520|NCT01103141|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Affairs|765-463-7537|Scott.Snyder@CookMedical.com|
21249521|NCT05072795|Medical University of South Carolina|Dr. Andreana Benitez|843-876-8479|benitez@musc.edu|
21249522|NCT00138645|Pennington Biomedical Research Center|Corby K. Martin, Ph.D.; Assistant Professor|225-763-2585|martinck@pbrc.edu|
21249523|NCT00212888|OHRI|Dr. Jonathan B Angel|613-737-8442|JANGEL@toh.ca|
21249524|NCT00427297|University of Washington|Grace John-Stewart|206 5434278|gjohn@uw.edu|
21249525|NCT00422162|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21249526|NCT05274906|Fred Hutchinson Cancer Center|Marian L. Neuhouser, Principal Investigator|206-667-4797|mneuhous@fredhutch.org|
21249527|NCT00848198|TearLab, Inc.|Michael Berg, VP of Regulatory|858-795-6887|mberg@TearLab.com|
21249528|NCT02062827|The University of Alabama at Birmingham|James Markert, MD|(205) 934-7171|jmarkert@uabmc.edu|
21249529|NCT04930263|National Yang Ming Chiao Tung University|Mrs Cheng-Chen Chou|28267176|chou8278@gmail.com|
21249530|NCT02812706|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21249531|NCT04362176|Vanderbilt University Medical Center|Todd Rice, M.D., MSc|615-343-8010|vcc@vumc.org|
21249532|NCT06312566|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21249533|NCT02971683|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21249534|NCT01699178|Clarus Therapeutics|Theodore Danoff, MD, PhD|847-562-4300|tdanoff@clarustherapeutics.com|
21249535|NCT02907489|Cairo university|Mohamed Omaia Ahmed|00201224474609|mohamed.omaia@dentistry.cu.edu.eg|
21249536|NCT04016415|Milton S. Hershey Medical Center, Penn State Hershey College of Medicine|Dr. Nazia T Raja-Khan, M.D., M.S., Associate Prof, Dept of Medicine, Div. of Endocrin & Diabetes|717-531-8395|nrajakhan@pennstatehealth.psu.edu|
21249537|NCT00828178|Johns Hopkins University School of Medicine|Dr. Michelle Petri|410-955-9114|mpetri@jhmi.edu|
21249538|NCT00912964|Astellas Pharma Global Development, Europe|Medical Director, Global Medical Sciences||ClinicalTrials.Disclosure@us.astellas.com|
21249539|NCT02260154|Abbott|Tatiana V. Vladimirova MD, PhD|+7 495-258-4280|tatiana.vladimirova@abbott.com|
21249540|NCT01664806|University of Colorado School of Medicine|Dr. Thomas Robinson|303-724-2728|thomas.robinson@Ucdenver.edu|
21249541|NCT04990388|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
21249542|NCT03547167|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21249543|NCT00070317|NRG Oncology|Linda Gedeon for Wei Deng, PhD.|716-845-1169|lgedeon@gogstats.org|
21249544|NCT01885559|Mayo Clinic|Dr. Vicente Torres||torres.vicente@mayo.edu|
21249545|NCT00645411|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21249546|NCT03560206|University of Kentucky|Misook Chung, PhD|(859) 323-8024|misook.chung@uky.edu|
21249547|NCT03100370|Rice University|Marcia O'Malley, PhD|713-348-3545|omalleym@rice.edu|
21249548|NCT00738400|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21249549|NCT02674399|Nature Cell co., ltd|Project Manager|02-545-4137|tin50@stemcellbio.com|
21249550|NCT00508144|The University of Texas (UT) MD Anderson Cancer Center|Ralph Zinner, MD/Thoracic & Head and Neck Medicine|713-792-7734|CR_Study_Registration@mdanderson.org|
21249551|NCT00780741|Jaeb Center for Health Research|Ray Kraker, Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
21249552|NCT00442507|Washington University School of Medicine|Daniel Morgensztern, M.D.|314-362-5740|dmorgens@dom.wustl.edu|
21249553|NCT01084772|Smith & Nephew, Inc.|Stuart Pratt|+1 (901) 497-0365|stuart.pratt@smith-nephew.com|
21249554|NCT00835328|The Children's Hospital of Philadelphia|Diva D. Deleon, MD,MSCE|215-590-3420|deleon@email.chop.edu|
21249555|NCT02736175|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com|
21249556|NCT05777772|University of Washington|Dr. Elizabeth Phelan|(206) 520-5000|phelane@uw.edu|
21249557|NCT02168855|University of Arkansas|Dr. Brian Primack|479-575-3208|bprimack@uark.edu|
21249558|NCT03000829|Intermountain Health|Dr. Ithan Peltan|801-507-6556|ithan.peltan@imail.org|
21249559|NCT00091572|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21249560|NCT04097535|Imperial College London|Professor Eric Aboagye|02083833759|eric.aboagye@imperial.ac.uk|
21249561|NCT03070301|Memorial Sloan Kettering Cancer Center|Dr. Diane Reidy-Lagunes, MD|646-888-4185|reidyd@mskcc.org|
21249562|NCT01612221|Huntsman Cancer Institute|Kimberlee Taylor|801-213-5673|Kimberlee.Taylor@hci.utah.edu|
21249563|NCT04413149|Peking Union Medical College Hospital|Dr. Shi Juhong|+86-13701178492|Shijh@pumch.cn|
21249564|NCT02878590|InnoMed Healthscience|Javier Collazo|9547739656|jcollazo@innomedhs.com|
21249565|NCT00814632|William Beaumont Hospital|Kenneth M. Peters, MD|248-551-0387|kmpeters@beaumont.edu|
21249566|NCT03154827|BioLineRx Ltd|VP Clinical & Medical Affairs|+972-8-642-9100|clinicaltrials@biolinerx.com|
21249567|NCT02004132|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21249568|NCT00282828|Rush University Medical Center|Mark Pollack, M.D.|312-942-5372|mark_pollack@rush.edu|
21249569|NCT02514577|Bausch Health Americas, Inc.|Director of Clinical Operations|1-510-259-5284|aloncaric@bauschhealth.com|
21249570|NCT00489489|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi-aventis.com|
21281542|NCT00884117|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21295481|NCT02030080|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh S. Patel|215-898-3367|mpatel@upenn.edu|
21295482|NCT02214225|Seqirus|Seqirus Clinical Trial Disclosure Lead||Seqirus.ClinicalTrials@Seqirus.com|
21295483|NCT03987932|University of South Carolina|Christine Pellegrini|803-777-0911|pellegca@mailbox.sc.edu|
21295484|NCT01394614|Center for Advanced Research in Sleep Medicine|Dr. Jacques Montplaisir|514-388-2693|jy.montplaisir@umontreal.ca|
21295485|NCT01669421|University of Miami|Michael Campos|305-243-3045|mcampos1@med.miami.edu|
21295486|NCT02129478|The Hospital for Sick Children|Dr. Laura Lee Dupuis|416-813-7654|lee.dupuis@sickkids.ca|309355
21295487|NCT02961790|Mayo Clinic|Charles L. Loprinzi, M.D|507/284-4565|loprinzi.charles@mayo.edu|
21295488|NCT02078102|IndianaU|Dr. Sherif Farag|(317) 278-0460|ssfarag@iu.edu|
21295489|NCT02185014|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21295490|NCT05418153|Center For Sight|Director of Clinical Research|8438813937|hsandoval@cepmd.com|
21295491|NCT02141490|National Cancer Institute|Dr. Ismail B. Turkbey|240-760-6112|turkbeyi@nih.gov|
21295492|NCT01009346|Johns Hopkins|Ranee Mehra, MD||rmehra1@jhmi.edu|
21295493|NCT03906656|Ottobock|Russ Lundstrom|6127182025|russ.lundstrom@ottobock.com|
21295494|NCT00033540|Southwest Oncology Group (SWOG) Statistical Center|Study Statistician|206-667-4623||
21295495|NCT01036529|Boston Scientific|Valerie Lucero-Cimmarusti|661-949-4745|Valerie.Lucero-Cimmarusti@bsci.com|
21249571|NCT06091982|National Cardivascular Center Harapan Kita|Prieta Adriane MD|+62 21 5684093|prietaadriane@gmail.com|7406
21249572|NCT04206397|UC San Diego|Dr. Laura Case|858-246-4968|lcase@health.ucsd.edu|
21249573|NCT03978130|NYU Langone Health|John Dodson, MD|6465012714|john.dodson@nyulangone.org|
21249574|NCT02880293|Memorial Sloan Kettering Cancer Center|Dr. Brian Shaffer, MD|646-608-3737|shaffeb1@mskcc.org|
21249575|NCT05349123|Mayo Clinic|Roberto P Benzo|507-284-0561|benzo.roberto@mayo.edu|
21249576|NCT04198428|HealthPartners Institute|Dr. Rebecca Rossom, Co-Principal Investigator|952-883-5466|Rebecca.C.Rossom@HealthPartners.com|
21249577|NCT03473665|Columbia University|Runsheng Wang|212-305-4308|rw2646@cumc.columbia.edu|
21249578|NCT05878990|Hackensack Meridian Health|Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN|2018803443|lisa.carterbawa@hmh-cdi.org|
21249579|NCT00668746|OraPharma|Ms. Bindu Patel, Senior Scientist, Regulatory Affairs and Quality Assurance|215-420-4064|bpatel@orapharma.com|
21249580|NCT04179799|University of Florida|Emily Fox|352-273-6500|ejfox@phhp.ufl.edu|
21249581|NCT01038128|McLean Hospital|Study Coordinator|617-855-2984|eryan@mclean.harvard.edu|
21249582|NCT03512041|Washington University School of Medicine|Catherine E Lang|314-286-1945|langc@wustl.edu|
21249583|NCT02169089|University Hospitals Cleveland Medical Center|Dr. Sanjay Rajagopalan|216-844-5191|Sanjay.Rajagopalan@uhhospitals.org|
21249584|NCT04694300|University of Pennsylvania School of Dental Medicine|Elliot V Hersh DMD, MS, PhD. Professor of Oral Surgery and Pharmacology|215-898-9686|evhersh@upenn.edu|
21249585|NCT04203199|Wake Forest University Health Sciences|Colleen Hanlon, PhD|844-386-7001|DeepTMS@brainsway.com|
21249586|NCT01838499|AstraZeneca|Humphrey Gardner MD FCAP|+1 781 839 4523|Humphrey.Gardner@astrazeneca.com|
21249587|NCT03614923|AnaptysBio, Inc.|Clinical Project Leader|858-362-6295|info@anaptysbio.com|
21295496|NCT00300482|Abbott|Medical Information Specialist|800-633-9110||
21295497|NCT01001546|Durham VA Medical Center - HSRD|Dr. Patrick S. Calhoun|919-286-0411|patrick.calhoun2@va.gov|7970
21295498|NCT01253265|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21295499|NCT00921310|Washington University School of Medicine|Maria Baggstrom, M.D.|314-362-5737|mbaggstr@dom.wustl.edu|
21295500|NCT02863523|East Carolina University|Dr. Doyle Cummings|252-744-2607|FLOYDS14@ecu.edu|
21295501|NCT03271047|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21295502|NCT00711802|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
21295503|NCT01275092|Columbia University Medical Center, New York, NY, 10032|Giora Weisz, MD; Director of Clinical Resarch Center for Interven tional Vascular Therapy|212-305-7060|gweisz@crf.org|
21295504|NCT03283150|University of Wisconsin-Madison|Jeremy Sullivan|6082639976|jasullivan@wisc.edu|
21295505|NCT05291936|Johnson & Johnson Vision Care, Inc.|Benjamin Straker|1-800-843-2020|bstraker@its.jnj.com|
21295506|NCT03503292|Mayo Clinic|Yvette N. Martin McGrew, M.D., Ph.D.|507-255-7481|martin.yvette@mayo.edu|
21249588|NCT01136733|Eisai Medical Inc.|Eisai Medical Services|1-888-422-4743||
21249589|NCT00113334|University of Texas (UT) MD Anderson Cancer Center|Edward Kim, MD, BS / Assistant Professor|713-792-6363|CR_Study_Registration@mdanderson.org|
21249590|NCT01882088|Federal research Center of Nutrition and Biotechnology|Dr Sergey Morozov, Senior Reseracher, Dpt Gastroenterology and Hepatology|+74996131091|morosoffsv@mail.ru|
21249591|NCT02186015|Loyola University Chicago|Patricia Sheean|708-216-0344|psheean1@luc.edu|
21249592|NCT00125619|VA Brain Rehabilitation Research Center|Dr. Carolynn Patten|352.376.1611|patten@phhp.ufl.edu|4160
21249593|NCT02069366|Wayne State University|Dr. Christine Rabinak|(313) 577-9875|rabinak@wayne.edu|
21249594|NCT01537900|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21249595|NCT01585597|Emory University|Christopher Horn|404 387 7320|cmhorn@emory.edu|
21249596|NCT00168805|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21249597|NCT01837719|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21249598|NCT03075449|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21249599|NCT02604199|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
21264422|NCT00947752|Teva Neuroscience, Inc.|Thomas Smith, MD, VP, Medical Affairs|816-508-5000|tom.smith@tevapharm.com|
21295507|NCT02032407|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21295508|NCT02091284|Federal University of Espírito Santo|Dr. Ester Miyuki Nakamura-Palacios|+55 27 3335-7337|emnpalacios@gmail.com|
21295509|NCT01340937|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21249600|NCT02051972|Abbott Medical|Nicole Harbert|1-972-526-4841|nicole.harbert@abbott.com|
21249601|NCT02255474|The Ohio State University|Dr. Jeffrey Walline|614-247-6840|walline.1@osu.edu|
21249602|NCT02993926|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
21249603|NCT01867307|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21249604|NCT01082159|Vertos Medical|VP Clinical Research|949-349-0008|cmyers@vertosmed.com|216
21249605|NCT01542502|Virginia Commonwealth University|Antonio Abbate|804-828-0513|aabbate@vcu.edu|
21249606|NCT02009865|AstraZeneca AB|Hong Yang, Study Statistician|+46-(0)317762397|hong.yang1@astrazeneca.com|
21249607|NCT01760876|Queen Mary Hospital,University of Hong kong|Prof. Stephen Wai-luen LEE|(852) 22555409 or 28181314|prof.stephenlee@gmail.com ; kongsl@hku.hk|
21249608|NCT03584282|University of Washington|Dr. Joanne Stekler, Primary Investigator|(206) 744-8312|jstekler@uw.edu|
21249609|NCT04604899|jCyte, Inc.|Chief Strategy Officer|9492430687|media@jcyte.com|
21249610|NCT00525915|University of Texas (UT) MD Anderson Cancer Center|Jaffer Ajani, MD / Professor, GI Medical Oncology|713-792-2828|CR_Study_Registration@mdanderson.org|
21249611|NCT00732498|University of Arizona|NCTN Program Coordinator|520-626-0301|aselegue@email.arizona.edu|
21249612|NCT03394508|Karolinska Institutet|Jon Konradsen|+46704242058|jon.konradsen@ki.se|
21249613|NCT00267865|National Cancer Institute|Dr. Robert Yarchoan|240-760-6075|yarchoar@nih.gov|
21249614|NCT03458416|Radius Pharmaceuticals, Inc.|Tarek El Akkad, Head of Clinical Development|6175514000|telakkad@radiuspharm.com|
21249615|NCT00083122|Mayo Clinic Cancer Center|Keith C. Bible, M.D, Ph.D.||Bible.Keith@mayo.edu|
21249616|NCT04295499|Unicon Optical Co., Ltd.|Dr. Jimmy Chou|+88635775586|ra@uniconvision.com.tw|1307
21249617|NCT01755598|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21249618|NCT03122548|Aduro Biotech, Inc.|Medical Affairs|510.809.2452|MedicalAffairs@aduro.com|
21249619|NCT03677986|Johns Hopkins University School of Medicine|Kenneth Silverman, Professor|4105502694|ksilverm@jhmi.edu|
21249620|NCT02332889|University of Louisville|Nancy Alsip|5028522905|nancy.alsip@louisville.edu|502
21249621|NCT00308113|University of Pittsburgh|Dr. Paula R. Clemens|412-648-9762|pclemens@pitt.edu|
21249622|NCT01634165|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21249623|NCT02135445|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21249624|NCT00635609|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
21249625|NCT01044901|The University of Chicago|Dr. Amit Patel, MD|773-702-9461|apatel2@medicine.bsd.uchicago.edu|
21249626|NCT00676195|Stanford University School of Medicine|Antonio Hardan, MD|650-736-1235|hardanay@stanford.edu|
21249627|NCT03322514|Imperial College London|Prof Gary Frost|+44 (0)20 7594 0959|g.frost@imperial.ac.uk|
21249628|NCT04523571|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
21249629|NCT00627523|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21249630|NCT05030467|Brigham and Women's Hospial|Niteesh Choudhry|617-278-0930|nkchoudhry@bwh.harvard.edu|
21249631|NCT01933776|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21249632|NCT02011568|University of Ottawa Heart Institute|Dr Michel Le May|613-696-7000|mlemay@ottawaheart.ca|14646
21249633|NCT03344458|Ascendis Pharma, Inc.|Aimee D. Shu, MD|+1 650 352 8389|ads@ascendispharma.com|
21249634|NCT00984334|S.L.A. Pharma UK Ltd|Dr C Jordan, Head of Clinical Operations|44 01923 681001|cjordan@slapharma.com|
21249635|NCT00396409|Novartis Pharmaceuticals|Study Director|862-778-8300||
21249636|NCT00331799|Duke University Medical Center Dept of Psychiatry|Wei Zhang MD|919 684 5645|wei.zhang@duke.edu|
21249637|NCT02889809|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21249638|NCT03696342|Medical Affairs Operations Chief|Dr. Alejandra Sanchez-Rios|33 3001 4200|alejandra.sanchez@sophia.com.mx|1190
21249639|NCT02409732|Dartmouth-Hitchcock Medical Center|Dr. Michael Shane Chapman Section Chief of Dermatology|603-650-3106|Michael.Shane.Chapman@hitchcock.org|
21249640|NCT00553800|Hossein.Borghaei@fccc.edu|Hossein Borghaei|215-214-4297|Hossein.Borghaei@fccc.edu|
21249641|NCT00113880|MedImmune, LLC|Chris Ambrose, MD, Sr Director, Medical Affairs|301-398-0000|ambrosec@medimmune.com|
21249642|NCT02630147|University of Sherbrooke Hospital Research Center, QC, Canada|Dr Jean-Paul Praud|819-346-1110|jean-paul.praud@usherbrooke.ca|14851
21295510|NCT02233738|Ralph H. Johnson VA Medical Cneter|Dr. Elizabeth Santa Ana|843-789-7168|Elizabeth.Santaana2@va.gov|
21249643|NCT01634620|Aerocrine, Inc.|Nancy Herje, BSN, RN, MBA|919-449-8873|Nancy.Herje@aerocrine.com|
21249644|NCT03863184|Weill Cornell Medicine|Jia Ruan, MD, PhD|646-962-2064|jruan@med.cornell.edu|
21249645|NCT03314233|Childrens Hospital of Philadelphia|Dr. Elizabeth Foglia|215-590-1653|foglia@email.chop.edu|
21249646|NCT01797705|DeVilbiss Healthcare|Jim Froehlich|814-443-7692|Jim.Froehlich@devilbisshc.com|
21249647|NCT03785210|National Cancer Institute|Dr. Tim F. Greten|240-760-6114|gretentf@mail.nih.gov|
21249648|NCT04468633|Duke University|Andrew Gross, MD|919-684-8656|andrew.gross@duke.edu|
21249649|NCT00460434|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
21249650|NCT01498445|The University of Texas MD Anderson Cancer Center|Jorge Cortes MD/Professor|713-792-7734|CR_Study_Registration@mdanderson.org|
21249651|NCT02722278|Clarus Therapeutics|Theodore Danoff, MD, PhD|847-562-4300|tdanoff@clarustherapeutics.com|
21249652|NCT02465866|Charleston Laboratories, Inc|Chief Commercial Officer|561-748-2007|cliregulatory@charlestonlabs.com|
21249653|NCT02023099|AbbVie|Global Medical Services|800-633-9110||
21249654|NCT00203502|University of Arkansas for Medical Sciences|Dr. Issam Makhoul|5016868274|MakhoulIssam@uams.edu|
21249655|NCT01469819|Texas Tech University Health Sciences Center El Paso|Dr. Irene Sarosiek|(915)215-5254|irene.sarosiek@ttuhsc.edu|
21249656|NCT03082196|Advantage Silver Dental Arrest, LLC|Dr. Peter Milgrom|206-251-6831|drmilgrom@silverarrest.com|
21249657|NCT01403805|Department of Dentistry, Yubari Kibounomori, Japan|Dr. Masahiro Hatta|+81-123-52-4339|masahiro.hatta@hotmail.co.jp|
21249658|NCT01695993|University of Rochester Medical Center|Joseph A. Roscoe, PhD Associate Research Professor|585 275-9962|joseph_roscoe@urmc.rochester.edu|
21249659|NCT01601821|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21249660|NCT00147745|Daiichi Sankyo, Inc|John Raia, Senior Director, Professional Affairs|(973) 944-2683|jraia@dsi.com|
21249661|NCT01901302|Cubist Pharamceuticals|Vice President Clinical Research|1.781.860.8660||
21249662|NCT00815347|University of Connecticut Health Center|MArk Metersky, MD|860-679-3582|metersky@nso.uchc.edu|
21249663|NCT00510783|Emory|Brittney Copeland|404-616-0301|bcopel3@emory.edu|
21249664|NCT00316121|Advanced Technologies and Regenerative Medicine, LLC|Manny Lazaro, Director, Clinical Affairs|508-828-2741|mlazaro@its.jnj.com|
21249665|NCT01318356|Radboud university medical center|S.P. Keijmel, MD PhD|0031243611111|stephan.keijmel@radboudumc.nl|
21249666|NCT01979211|University of Cincinnati Cancer Center|Vinita Takiar, Associate Professor, MD|513-584-4775|vinita.takiar@uc.edu|
21249667|NCT02741297|Boston Scientific|Roshini Jain, Director of Clinical Sciences|6619494350|roshini.jain@bsci.com|
21249668|NCT03708744|Zosano Pharma Corporation|Dr. Don Kellerman, Sr. VP, Clinical Development and Medical Affairs|+1 (510) 745-4004|dkellerman@zosanopharma.com|
21249669|NCT01368874|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
21249670|NCT02342275|Sichuan University|Yi jJi|+86 02885423453|jijiyuanyuan@163.com|
21249671|NCT02100189|OHSU|John Hunter, MD|503-494-4937|hunterj@ohsu.edu|
21249672|NCT01648491|Beaumont Hospital - Royal Oak|Kenneth Peters MD|248-551-0387|Kenneth.Peters@Beaumont.org|
21249673|NCT00460577|Novartis Pharmaceuticals|Study Director|862-778-8300||
21249674|NCT02213458|University of California, San Francisco|Dr. Katherine Possin|(415) 476-1889|katherine.possin@ucsf.edu|
21249675|NCT04043806|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21249676|NCT03166215|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
21249677|NCT01357564|Center of Innovation on Disability and Rehabilitation Research, Department of Veterans Affairs; St. Catherine University, Department of Occupational Therapy|Dr. Paul Arthur|3176881499|pbarthur824@stkate.edu|
21249678|NCT02438410|Mayo Clinic|Dr. Darrell Pardi|(507) 538-1827|pardi.darrell@mayo.edu|
21249679|NCT04985604|Day One Biopharmaceuticals, Inc.|Study Director|1-650-484-0899|clinicaltrials@dayonebio.com|
21249680|NCT00658632|Eisai Inc.|Eisai Medical Services|888-422-4743||
21249681|NCT03590847|University of Florida|Dr. Stephen Anton|(352) 273-7514|santon@ufl.edu|
21249682|NCT05263492|Virginia Commonwealth University Massey Cancer Center|Massey IIT Research Operations|804-628-6430|masseyepd@vcu.edu|
21249683|NCT03680092|University of California, San Diego|Dr. Dimitrios Tzachanis|(858) 822-6600|dtzachanis@health.ucsd.edu|
21249685|NCT04551053|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21249686|NCT02091102|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
21249687|NCT00596960|VAMC|Eric Dieperink, MD|612-467-3964|eric.dieperink@va.gov|
21249688|NCT03503188|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21249689|NCT00927849|Mansoura university hospital|ayman elnakeeb|0020106752021|elnakeebayman@yahoo.com|
21249690|NCT02394912|Volcano|VP Clinical Trials|858-720-8731|jonathan.batiller@philips.com|
21249691|NCT01127737|Northwestern University|June Robinson, MD|312-695-6624|june-robinson@northwestern.edu|
21249692|NCT01892007|NIHR Nottingham Biomedical Research Centre, University of Nottingham|Dr Helen Henshaw|+44 (0)115 8232606|helen.henshaw@nottingham.ac.uk|
21249693|NCT00424502|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21249694|NCT03556891|Valencia Technologies|Jackie Dister|7604294787|jdister@valenciatechnologies.com|
21249695|NCT02661490|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21249696|NCT00961298|Allegheny General Hospital|Alicia Kaplan MD|412-330-4069|akaplan@wpahs.org|
21249697|NCT00729053|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
21249698|NCT02388932|Cleveland Clinic, Case Comprehensive Cancer Center|Shlomo Koyfman, MD|216-444-7552|koyfmas@ccf.org|
21249699|NCT04588246|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21249700|NCT05927753|Bruno Vision|Richard E Lippman|301-580-3931|richard.lippman@gmail.com|
21249701|NCT00612716|Masonic Cancer Center, University of Minnesota|Dr. Daniel J.Weisdorf, M.D|612 624-3101|weisd001@umn.edu|
21249702|NCT02136797|Memorial Sloan Kettering Cancer Center|Dr. Kevin Curran, MD|212-639-5836|currank@mskcc.org|
21249703|NCT03782545|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
21249704|NCT00409006|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21249705|NCT02123797|Baptist Cancer Center|Dr. Raymond Osarogiagbon|901-752-6131|Raymond.Osarogiagbon@bmg.md|
21249706|NCT02132598|UPMC Hillman Cancer Center|Barbara Stadterman, MPH MCCR|412-647-5554|stadtermanbm@upmc.edu|
21249707|NCT04441996|Emory University|Cheryl Maier MD, PhD|404-712-2795|cheryl.maier@emory.edu|
21249708|NCT01093976|University of Minnesota|Jon E. Grant|612-273-9800|grant045@umn.edu|
21249709|NCT00376935|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21249710|NCT00406276|Emory University|Dr.Suresh Ramalingam, MD|404-778-5378|ssramal@emory.edu|
21249711|NCT03602053|PATH|Dr Niraj Rathi, MD; Senior Medical Officer|+91 11 4064 0000|nrathi@path.org|
21249712|NCT01769352|Johns Hopkins University School of Medicine|Dr. Peter A. Campochiaro|410-955-5106|pcampo@jhmi.edu|
21249713|NCT05129592|Johns Hopkins Bloomberg School of Public Health|Caitlin Weiger|3017128357|cweiger2@jhmi.edu|
21249714|NCT04203225|Harbor-UCLA Medical Center|Kelly D. Young, MD|424-306-5431|kyoung3@dhs.lacounty.gov|
21249715|NCT03672188|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
21249716|NCT01234675|Cleveland Sleep Research Center|Mansoor Ahmed, MD|4402438044|sleepresearchcenter@yahoo.com|
21249717|NCT03997409|Vanderbilt University Medical Center|Dr. Sara Duffus|+1 (615)322-7427|sara.duffus@vumc.org|
21249718|NCT01753323|Novartis Pharmaceuticals|Study Director|862-778-8300||
21249719|NCT01870999|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Medical Affairs|800-562-3974||
21249720|NCT03416335|Sumitomo Pharma America|Reyna Bishop|617-674-6800|reyna.bishop@us.sumitomo-pharma.com|
21249721|NCT00116584|ULouisville|Dr. In Kim|502-629-7212|in.kim@louisville.edu|
21249722|NCT01745380|University of Pennsylvania School of Dental Medicine|Elliott V. Hersh, Principal Investigator|215-898-9686|evhersh@pobox.upenn.edu|
21249723|NCT02660034|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21249724|NCT02333071|AMAG Pharmaceuticals|Medical Information|1-877-411-2510|amag@druginfo.com|
21249725|NCT01533181|H. Lee Moffitt Cancer Center and Research Institute|Dr. Alberto Chiappori|813-745-2158|alberto.chiappori@moffitt.org|
21249726|NCT02030847|Abramson Cancer Center of the University of Pennsylvania|Noelle Frey, MD|215-662-6901|noelle.frey@uphs.upenn.edu|
21249727|NCT01703988|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21249728|NCT02995733|Brigham and Women's Hospital|Dr. Elliot Israel|617-732-8110|eisrael@bwh.harvard.edu|
21249729|NCT02186587|University of Missouri - Department of Orthopaedic Surgery|Sonny B. Bal, MD, PI|573-882-6762|BalB@health.missouri.edu|
21249730|NCT02720198|Duke University Medical Center|Dr. Narei Hong|984-215-8493|narei.hong@duke.edu|
21249731|NCT04879823|UPMC Children's Hospital of Pittsburgh|Dr. Amber Shaffer|4126926874|shafferad@upmc.edu|
21249732|NCT03897075|Sun Pharmaceutical Industries Limited|Head-Regulatory Affairs|2266455645|Clinical.Trial@sunpharma.com|5689
21249733|NCT02592434|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21249734|NCT00472199|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21249735|NCT01540071|Io Therapeutics, Inc.|Martin E. Sanders, M.D.|(650) 219-5973|msanders@io-therapeutics.com|
21249736|NCT01106586|Gilead Sciences, Inc|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21249737|NCT00105521|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
21249738|NCT02732899|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com|
21249739|NCT02790788|National and Kapodistrian University of Athens|Associate Professor in Intensive Care Medicine|00302132043307|sdmentzelopoulos@yahoo.com|
21249740|NCT01622088|Knopp Biosciences|Head of Regulatory|4124881776|greg@knoppbio.com|
21249741|NCT05607147|Rutgers School of Dental Medicine, Newark, New Jersey, United States|Gayathri Subramanian, PhD, DMD|7328247241|subramga@sdm.rutgers.edu|
21249742|NCT02499497|Brigham and Women's hospital|Dr. Shalender Bhasin, Principal Investigator|617 525 9150|sbhasin@bwh.harvard.edu|
21249743|NCT01721109|Gilead Sciences|Gilead Clinical Study Information Center||GileadClinicalTrials@gilead.com|
21249744|NCT03045302|Ipsen|Medical Director|Use email address below|clinical.trials@ipsen.com|
21249745|NCT00134056|University of Southern California Norris Comprehensive Cancer Center|Dr. David I Quinn|3238653956|diquinn@med.usc.edu|
21249746|NCT02035345|Massachusetts General Hospital|Dr. Aleena Banerji|6177263850|abanerji@mgh.harvard.edu|
21249747|NCT00742560|AbbVie|Global Medical Services|800-633-9110||
21249748|NCT01536795|Institut Pasteur, Tunisia|Afif Ben Salah, MD|011-216-71-792-429|afif.bensalah@pateur.rns.tn|
21249749|NCT01812837|UC Davis|Dr. Raja Sivamani|9167035145|rksivamani@ucdavis.edu|
21249750|NCT05008224|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21249751|NCT04598776|CeraRoot CLINIC|Dr. Josep Oliva-Ochoa. Director of Clinical Trials|+34 935950247|josep.oliva@cerarootclinic.com|
21249752|NCT00348283|Abbott|Medical Information Specialist|800-633-9110||
21249753|NCT04453709|University of Massachusetts Amherst|Kalpana Poudel-Tandukar, Associate Professor|413-545-5095|kalpana@umass.edu|
21249754|NCT02282761|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinicalTrials@itci-inc.com|
21249755|NCT00515281|University of Chicago|Michael D. Schreiber, MD|773-702-6205|mschreiber@bsd.uchicago.edu|
21249756|NCT02632045|Columbia University|Melissa Accordino, MD|212-342-5162|mkg2134@cumc.columbia.edu|
21249757|NCT05878522|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21249758|NCT05216835|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21249759|NCT03861078|Virginia Commonwealth University|Alison Breland|804 628 2300|abbrelan@vcu.edu|
21249760|NCT01075815|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21249761|NCT00617708|SWOG|Study Statistician|206-667-4623||
21249762|NCT02058992|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21249763|NCT02991456|Duke University|James Herndon II, Ph.D.|919-668-8145|james.herndon@duke.edu|
21249764|NCT03747575|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21249765|NCT01229527|Department of Anesthesia and Intensive Care|Dr. Massimo Agostoni|+39.02.2643.2656|agostoni.massimo@hsr.it|
21249766|NCT02916745|on behalf of Concordia Laboratories Inc./Advanz Pharma|Kim McDonald-Taylor|647-267-2942|kmcdonald-taylor@rogers.com|
21249767|NCT00936065|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21249768|NCT04617574|Holyoke Medical Center Weight Management Program|Bariatric Clinical Administrator|(413) 535 - 4759|davidson_elana@holyokehealth.com|
21249769|NCT01549951|Takeda|Medical Director|+1-866-835-2233|GlobalOncologyMedinfo@takeda.com|
21249770|NCT00990314|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director|301-608-9292||
21249771|NCT04992494|NYU Langone Health|Amanda Shallcross|646-501-3426|Amanda.Shallcross@nyulangone.org|
21249772|NCT02819141|Mayo Clinic|Dr. Linda L. Chlan, Professor of Nursing|507-255-7859|chlan.linda@mayo.edu|
21249773|NCT01613807|Sansum Diabetes Research Institute|Dr. Kristin Castorino|8056827640|kcastorino@sansum.org|256
21249774|NCT00710814|Columbia University|Judith Korner, M.D., PhD|2123053725|jk181@cumc.columbia.edu|
21281543|NCT01753310|Ipsen Biopharmaceuticals, Inc.|Medical Director||clinical.trials@ipsen.com|
21281544|NCT01580670|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21249775|NCT00705614|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21249776|NCT01178281|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21249777|NCT00088452|Cincinnati Children's Hospital Medical Center|Tracy Glauser, MD|513-636-8854|tracy.glauser@cchmc.org|
21249778|NCT01184859|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21249779|NCT02629419|Matinas BioPharma|Theresa Matkovits, PhD|862-812-1436|tmatkovits@matinasbiopharma.com|
21249780|NCT02081196|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
21249781|NCT02055053|Lahey Clinic|dmitry nepomnayshy MD|781 744 8576|dmitry.nepomnayshy@lahey.org|
21249782|NCT02515656|Laboratoire Innotech International|Director of Medical Affairs|+33 (0)1 46 15 29 00||
21249783|NCT02652390|Hässleholm Hospital, Hässleholm, Sweden|Dr. Isam Atroshi|+46443091260|Isam.Atroshi@skane.se|
21249784|NCT05335005|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21249785|NCT01862614|The Ohio State University College of Dentistry|Dr. John Nusstein, Professor|614-292-3596|nusstein.1@osu.edu|
21249786|NCT04385849|ImmunityBio|Lennie Sender, Chief Operating Officer|855-797-9277|lennie.sender@immunitybio.com|
21249787|NCT01375777|Amgen Inc.|Study Director|866-572-6436||
21249788|NCT00355784|University of Michigan, Ann Arbor, Michigan|Jeffrey F. Horowitz|734-647-1076|jeffhoro@umich.edu|
21249789|NCT03034772|Wills Eye Physicians, Mid Atlantic Retina|Jason Hsu, MD|215-928-3092|research@midatlanticretina.com|
21249790|NCT02795819|Virginia Commonwealth University Massey Cancer Center|Andrew Poklepovic, MD|877-462-7739|AskMassey@vcu.edu|
21249791|NCT01843920|Mid Atlantic Retina|Jason Hsu, MD|215-928-3092|research@midatlanticretina.com|
21249792|NCT00730925|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21249793|NCT02137239|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21249794|NCT02446912|AstraZeneca AB|Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
21249795|NCT00828542|Sao Paulo University|Dr. Milena Bastos Brito|551636022814|milenabastos@usp.br|
21249796|NCT01757171|Weill Cornell Medical College|Navjot Kaur, GI Program Manager|646-962-9350|nak2028@med.cornell.edu|
21249797|NCT00103116|UKentucky|Edward Hirschowitz|8596081981|eahirs2@uky.edu|
21249798|NCT00094497|University Hospital of Wuerzburg, Germany|Martin Fassnacht|+49-931-201-39021|fassnacht_m@ukw.de|
21249799|NCT03912298|University of Pennsylvania|Peggy Compton|2158986679|pcompton@nursing.upenn.edu|
21249800|NCT00385697|Provention Bio, Inc|Sharon Rowland|443-987-0797|SRowland@proventionbio.com|
21249801|NCT00724750|University of Chicago|Lawrence Gottlieb|(773) 702-6302|lgottlie@surgery.bsd.uchicago.edu|
21249802|NCT00442559|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21249803|NCT02305797|Cardinal Health Regulatory Sciences|Director of Regulatory Affairs and Product Development|913.451.3955|david.rhein@cardinalhealth.com|
21249804|NCT03906240|VISN 17 Center of Excellence for Research on Returning War Veterans|Dr. Adam McGuire|254-297-5173|adam.mcguire@va.gov|
21249805|NCT02267746|Teva Pharmaceuticals USA, Inc.|Director, CE Studies|1-888-483-8279|USMedinfo@tevapharm.com|
21249806|NCT03720717|University of Alabama at Birmingham|Timothy J Ness MD PhD, Professor Emeritus|2059079743|tness@uabmc.edu|
21249807|NCT05234632|Smith & Nephew, Inc.|Dr Rochelle O'Hara|+44 1923 477218|Rochelle.OHara@smith-nephew.com|
21249808|NCT03613363|Philips|Chuck Cain|412-657-1814|chuck.cain@philips.com|
21249809|NCT02849509|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21249810|NCT01292005|Mayo Clinic|Dr. Santhi Swaroop Vege|507-284-2175|vege.santhi@mayo.edu|
21249811|NCT02423447|Stanford University|Carlos Milla, MD|650-723-5193|cmilla@stanford.edu|
21249812|NCT03010878|Colorado State University|Dr. Arlene Schmid|9704917562|arlene.schmid@colostate.edu|
21249813|NCT02924051|University of Kentucky|Dr. Frances Hardin-Fanning|(859) 257-4866|fdbowe2@uky.edu|
21249814|NCT05615870|University of Arkansas for Medical Sciences|Jing Jin|501-214-2236|JJin@UAMS.edu|
21249815|NCT02130401|Scion NeuroStim|Dr. Robert Black|(919) 260-5528|bacllc@earthlink.net|
21249816|NCT03019289|Prilenia|Prilenia|+972 775558|info@prilenia.com|482
21249817|NCT03266419|Asan Medical Center|Dr. Byung-Moon Choi|82-2-3010-1704|byungmoonchoi7@gmail.com|
21249818|NCT01334606|BD Medical - Diabetes Care|Laurence J. Hirsch. Medical Director|201-847-6513|laurence_hirsch@bd.com|
21249819|NCT02312245|Mayo Clinic|S. John Weroha, M.D., Ph.D.|(507) 284-2511|weroha.saravut@mayo.edu|
21249820|NCT00410150|Cincinnati Children's Hospital Medical Center|Dr. Derek Wheeler|513-636-4239|derek.wheeler@cchmc.org|
21249821|NCT00604461|H. Lee Moffitt Cancer Center and Research Institute|Tawee Tanvetyanon, M.D.|813-745-3050|tawee.tanvetyanon@moffitt.org|
21249822|NCT03689452|Icahn School of Medicine at Mount Sinai|Dr. Danielle P. Dubin|212-731-3311|DPDubin121@gmail.com|
21249823|NCT02676778|Eisai Co., Ltd.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
21249824|NCT01430299|SeaSpine|Vice President, Orthobiologics Research & Development|760.216.5138|frank.vizesi@seaspine.com|
21249825|NCT06466655|University of Delaware|Jody Greaney, PhD|3028312193|jgreaney@udel.edu|
21249826|NCT03686176|Johns Hopkins University|Therese Canares|4109964711|tcanare1@jhmi.edu|
21249827|NCT00515879|Boston University|Dr. Stefan G. Hofmann, Ph.D., Professor of Psychology|617 353 9233|shofmann@bu.edu|
21249828|NCT01154699|University of California San Diego|Robert L. Owens|8586575258|rowens@ucsd.edu|
21249829|NCT05492786|Geisinger health|Gail Rosenbaum|570-243-1199|grosenbaum@geisinger.edu|
21249830|NCT01232569|Hoffmann-La Roche|Medical Communications|800 821-8590||
21249831|NCT04044352|University of Maryland School of Medicine|Kathleen M. Neuzil, MD, MPH|410-706-4946|kneuzil@som.umaryland.edu|
21249832|NCT00097708|Jazz Pharmaceuticals, Inc.|Grace Wang, MD Director Clinical Development & Medical Monitor|650 - 496 - 3777||
21249833|NCT01100268|Columbia University Department of Psychiatry|Dr. Carolyn Rodriguez|(646) 774-8061|cr2163@columbia.edu|
21295511|NCT00096174|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
21295512|NCT02098369|University of Illinois at Chicago|Jerry A. Krishnan, MD, PhD|312-413-0637|jakris@uic.edu|
21295513|NCT01414205|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21295514|NCT01166373|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
21295515|NCT01874275|Independent Principal Investigator|Charlotte Stelly-Seitz, MD|713-523-3463|drstellyseitzmd@gmail.com|
21295516|NCT00320749|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii-Saab, M.D.|614-293-9863|Tanios.Bekaii-Saab@osumc.edu|
21295517|NCT02740543|NYU Langone Health - Bellevue Hospital|Angeliki Kazeros, MD|212-263-6479|Angeliki.Kazeros@nyulangone.org|
21295518|NCT01007071|Stanford University|Dr. Laurence Katznelson|650-736-9551|katznels@stanford.edu|
21295519|NCT01053013|The Rogosin Institute|Betty-Jane Sloan, Clinical Research Manager|646-317-0701|bjsloan@nyp.org|
21295520|NCT02594098|Icahn School of Medicine at Mount Sinai|Dr. Emma Guttman|212-241-9728|emma.guttman@mountsinai.org|
21295521|NCT02042534|Asan Medical Center, University of Ulsan|Sun U. Kwon, MD, PhD, Prof|82-2-3010-3960|sukwon@amc.seoul.kr|
21295522|NCT00885638|Lund University|Professor Bo Ahrén|+46462220758|Bo.Ahren@med.lu.se|
21295523|NCT00402714|Yale University School of Medicine|Francine Foss MD|2037375312|francine.foss@yale.edu|
21295524|NCT02370641|UCLA Department of Medicine/Center for Human Nutrition|Zhaoping Li, Professor|310-206-1987|zli@mednet.ucla.edu|
21295525|NCT02133664|Oregon Health & Science University|Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu|
21295526|NCT02330523|The McGuire Institute|E. Todd Scheyer DDS, MS|713-783-544|etsperio@swbell.net|
21295527|NCT01688843|Boston Scientific|Gena Kantor, MPH|1-800-227-3422|gena.kantor@bsci.com|
21295528|NCT00343915|GlaxoSmithKline|GSK Response Center|866-435-7343||
21295529|NCT01719003|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
21295530|NCT00915655|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Medical Leader|+1 609 730-7548||
21295531|NCT00882908|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
21249834|NCT02956122|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21249835|NCT02176356|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21249836|NCT00392704|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21249837|NCT00958711|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
21249838|NCT03722485|3M|Sher-ree Beekman|262-409-5112|sbeekman@mmm.com|
21249839|NCT00197119|GlaxoSmithKline|GSK Response Center|866-435-7343||
21249840|NCT02151643|Shield Therapeutics|Mark Sampson|+44 (0) 207 186 8500|msampson@shieldtx.com|
21249841|NCT00515697|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21249842|NCT03087851|Dep. of Endocrinology and Internal Medicine, Aarhus University Hospital|MD Anne Sophie Sølling|78 45 54 75|annesoel@rm.dk|
21249843|NCT00644332|Gilead Sciences|Emmanuelle Bellemin, Senior Manager, Regulatory Affairs||emmanuelle.bellemin@gilead.com|
21249844|NCT03694210|Interscope, Inc.|Alexis James Global Director of Clinical Affairs|508-847-9478|alexis.james@interscopemed.com|
21249845|NCT03050372|Medical University of South Carolina|Thomas W. Uhde, M.D.|843-792-0028|uhde@musc.edu|
21249846|NCT01742949|Hopital Bichat-Claude Bernard|Dr Marie-Pia D'Ortho|+33140258080|marie-pia.dortho@bch.aphp.fr|
21249847|NCT01502787|University of Texas Southwestern Medical Center|Wanpen Vongpatanasin|2146458000|wanpen.vongpatanasin@utsouthwestern.edu|
21249848|NCT00443755|Mayo Clinic|K. Sreekumaran Nair, MD, Ph.D.|507-255-3605|nair@mayo.edu|
21249849|NCT02775214|Riley Hospital for Children at Indiana University Health|Dr Nicole Horn|3179449981|nhorn@iuhealth.org|
21249850|NCT01896921|University of Maryland|Gregg Brogden|4107061660|gbrogden@ihv.umaryland.edu|
21249851|NCT02706834|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21249852|NCT00678899|Cochlear Americas|Ginger Grant/Clinical Project Manager|410-375-0883|ggrant@cochlear.com|
21249853|NCT02543294|UT MD Anderson Cancer Center|Dr. Anecita P. Fadol,PHD/Associate Professor, Department of Nursing|713-792-8397|afadol@mdanderson.org|
21249854|NCT05065918|The University of Arkansas for Medical Sciences|Jocelyn Anderson|501-686-7712|andersonjocelyn@uams.edu|
21249855|NCT03149887|UPittsburgh|Dr. Steven L. Orebaugh|412-877-5832|orebaughsl@anes.upmc.edu|
21249856|NCT02115542|Moffitt Cancer Center|Richard Kim, MD|813-745-1432|Richard.Kim@moffitt.org|
21249857|NCT01636258|The Cleveland Clinic|Adam M. Bernstein MD|216-448-8538|bernsta2@ccf.org|
21249858|NCT01107353|Roxane Laboratories, Inc.|Anton (Tony) Amann, PhD., Executive Director, DRAMA|614-272-4785|tony.amann@boehringer-ingelheim.com|
21249859|NCT03327051|Stanford University|Aida Habtezion|650-736-5555|aidah@stanford.edu|
21249860|NCT02798861|University of Pittsburgh|Andres Duarte-Rojo|412-647-7922|duarterojoa@pitt.edu|
21249861|NCT00907517|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21249862|NCT04117711|Applied Therapeutics, Inc|Riccardo Perfetti, MD|2122209226|rperfetti@appliedtherapeutics.com|
21249863|NCT04057937|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21249864|NCT02029521|Intermountain Healthcare|Clark Bishop|385 224 7343|clark.bishop@imail.org|
21249865|NCT01072396|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21249866|NCT01268488|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|914-333-6280|carmine.greene@ascensia.com|
21249867|NCT03317288|UT Southwestern Medical Center|Dr. Yi-Ting Tzen|2146481786|Yi-Ting.Tzen@UTSouthwestern.edu|
21249868|NCT05287178|University of Oregon|Yoel Everett|541-346-7054|yeverett@uoregon.edu|
21249869|NCT01426217|Dartmouth-Hitchcock Medical Center|Randy Loftus, MD|(603) 650-6177|Randy.W.Loftus@hitchcock.org|
21295532|NCT02370095|University of North Carolina at Chapel Hill|Wayne H Anderson, PhD|919-445-0351|wayne_anderson@med.unc.edu|
21249870|NCT01648699|Janssen Philippines|Medical Affairs Manager|+632-8248935||
21295533|NCT00581828|University of Wisconsin|Dr Karen Hansen|608-263-3457|keh@medicine.wisc.edu|
21295534|NCT00700102|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21249871|NCT01920178|Cambridge Health Alliance|Paul M. Heffernan, D.P.M.|617-665-2556|pheffernan@challiance.org|
21249872|NCT03023878|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21249873|NCT00288353|Northwestern University|Dr. Herbert Meltzer|(312) 503-0309|h-meltzer@northwestern.edu|
21249874|NCT04799587|Northwestern University|Paul Fitzgerald, RN, BSN,MS|312-695-1064|p-fitzgerald2@northwestern.edu|
21249875|NCT00728884|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
21249876|NCT03867396|University of Colorado Anschutz SOM|Dr. Melinda Anderson|303-724-9316|melinda.anderson@cuanschutz.edu|
21249877|NCT00763919|University Hospitals Case Medical Center|Christopher Bialko|216-286-4362|Christopher.Bialko@UHhospitals.org|
21249878|NCT02374476|Icahn School of Medicine at Mount Sinai|Dr. Srinivas R Dukkipati|(212) 241-7114|srinivas.dukkipati@mountsinai.org|
21249879|NCT05431543|LENZ Therapeutics, Inc.|Marc Odrich, MD|(646) 249-2800|marc@lenz-tx.com|
21249880|NCT02784535|Vanderbilt University Medical center|Dr Cyndya Shibao|615-322-2318|cyndya.shibao@vumc.org|
21249881|NCT00914732|Saint Louis University Medical School|Sharon E. Frey, M.D.|314-977-5500|sharon.frey@health.slu.edu|
21249882|NCT02214017|Herning Hospital|Finn Lauszus|+45 78434614|finlau@rm.dk|
21249883|NCT03005106|Mallinckrodt|Medical Information Call Center|800-844-2830|MedInfo@mnk.com|
21249884|NCT03163472|Cork University Hospital|Dr Anil Ranganath||drmrak.2@gmail.com|
21249885|NCT00321672|NeurogesX|Trudy Vanhove, VP Clinical Development|650-393-7444|tvanhove@neurogesx.com|
21249886|NCT03953079|Graybug Vision|Executive Director, Biostatistics|650-459-4235|pdinh@graybug.vision|
21249887|NCT00939211|AstraZeneca|Gerard Lynch|+441509645895|clinicaltrialtransparency@astrazeneca.com|
21249888|NCT02389894|Icahn School of Medicine at Mount Sinai|Annetine C. Gelijns, PhD|212-659-9568|annetine.gelijns@mssm.edu|
21249889|NCT00145496|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21249890|NCT02228889|The Ohio State University Wexner Medical Center|Dr. Jeffrey Janis|(614) 297-2913|jeffrey.janis@osumc.edu|
21249891|NCT05957198|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21249892|NCT01429285|Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-7464|achang@montefiore.org|
21249893|NCT01288729|Stanford Childrens Health|Bruce Buckingham|650725-6549|buckingham@stanford.edu|
21249894|NCT03868735|Rush University|Dr. J. Brady Scott|3129426389|jonathan_b_scott@rush.edu|
21249895|NCT01557699|SERUM INSTITUTE OF INDIA LIMITED|Dr Prasad Kulkarni|+912026602384|drpsk@seruminstitute.com|
21249896|NCT01002547|Malcom Randall VA Medical Center|Dr. Kenneth Cusi|352-273-8662|Kenneth.Cusi@va.gov; Kenneth.Cusi@medicine.ufl.edu|
21249897|NCT03273283|Hospital Clínic de Barcelona|Pol Bruguera Soler|628162567|pbruguer@clinic.cat|
21249898|NCT00925288|Johns Hopkins University|Dr. Brandon Brown|949-266-4401|bbrown@jhsph.edu|
21249899|NCT00434577|GlaxoSmithKline|GSK Response Center|866-435-7343||
21249900|NCT00651937|The University of Texas (UT) MD Anderson Cancer Center|Dr. Richard E Champlin,MD/Chair, Stem Cell Transplantation|713- 203-8632|rchampli@mdanderson.org|
21249901|NCT01921114|AngioDynamics|Alicia Conway|774-249-8707|aconway@angiodynamics.com|
21249902|NCT01904019|Zimmer Biomet|Emilie Rohmer, Clinical Operations Manager|+41 58 85 48210|Emilie.Rohmer@zimmerbiomet.com|
21249903|NCT01064882|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21249904|NCT01537120|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21249905|NCT02552810|University of Valencia|Dr. Luigi Canullo|+39 347 6201976|luigicanullo@yahoo.com|
21249906|NCT04816708|Duke University|Christopher E. Cox, MD|919-681-7232|christopher.cox@duke.edu|
21249907|NCT01732627|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21249908|NCT01994538|Minneapolis VA Health Care System|Dimitri Drekonja, MD, MS|612 467 4183|dimitri.drekonja@va.gov|
21249909|NCT02475733|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21249910|NCT05216952|University of North Carolina at Chapel Hill|Jill Hagey, MD, MPH|919-966-5280|jmhagey1@ad.unc.edu|
21249911|NCT02131155|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21249912|NCT04864236|UCLA Anesthesiology|John Shin MD, Associate Clinical Professor|310-267-6629|JShin@mednet.ucla.edu|
21249913|NCT01887418|Antares Pharma Inc.|Jonathan Jaffe, MD; Vice President Clinical Development|609-329-3020|jjaffe@antarespharma.com|324
21249914|NCT02744898|NYU Langone Health|Franco Muggia, MD|212 263 2172|Franco.Muggia@nyulangone.org|
21249915|NCT01014013|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21249916|NCT05319756|Viatris|Dik WH Ng|+44 (0)1304 626895|dik.ng@viatris.com|
21249917|NCT03508830|University of California, San Francisco|Dr. Greg J. Haro|415-353-7502|greg.haro@ucsf.edu|
21249918|NCT02522299|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21249919|NCT02391714|Division of Family Planning, University of New Mexico|Sunderjeet Kaur|Email|skaur@salud.unm.edu|
21249920|NCT02097056|Eisai Korea Inc.|Youngji Pyo|+82-2-3451-5533|y-pyo@eisaikorea.com|
21249921|NCT01446042|Trimel Pharmaceuticals Corp.|Natalia Tkachenko, MD Director Clinical Affairs|9054641755|ntkachenko@trimelpharmaceuticals.com|
21249922|NCT00720629|H. Lee Moffitt Cancer Center and Research Institute|Lia Perez, M.D.|813-745-7202|lia.perez@moffitt.org|
21249923|NCT02713698|Centro Hospitalar do Porto|Ana Maria Araujo|22 2077549|amfariaaraujo@gmail.com|1280
21249924|NCT03152409|Brigham and Women's Hospital|Dr. Jessica Harder|6177326753|jaharder@bwh.harvard.edu|
21249925|NCT03575572|University of Utah|Stephanie Goldstein|801 587-7572|stephanie.goldstein@hsc.utah.edu|
21249926|NCT04908800|Kyorin Pharmaceutical Co.,Ltd|Yoji Mimaki|+81-3-3525-4788|ml-kyorin_clinicaltrials.gov@mb.kyorin-pharm.co.jp|
21249927|NCT03751280|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21295535|NCT02525939|DalCor Pharmaceuticals|Dr. Don Black, Chief Medical Officer|‭+1 (609) 613-6637‬|dblack@dalcorpharma.com|
21295536|NCT01667562|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21249928|NCT03287947|Atrium Health/Levine Cancer Institute, Department of Cancer Biostatistics|Danielle M Boselli|12017903385|Danielle.Boselli@AtriumHealth.org|
21249929|NCT00296504|ViiV Healthcare|GSK Response Center|866-435-7343||
21249930|NCT02815709|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
21249931|NCT01323309|Memorial Sloan Kettering Cancer Center|Dr. William Breitbart, MD|646-888-0020|breitbaw@MSKCC.ORG|
21249932|NCT02162771|CELLTRION, Inc.|Dr. Sung Hyun Kim|+82-32-850-5000|contact@celltrion.com|
21249933|NCT01348763|Imperial College London|Alan Winston|+442033121603|a.winston@imperial.ac.uk|21603
21249934|NCT00685659|University of Pennsylvania|James R. McKay, Ph.D.|215-746-7704|jimrache@mail.med.upenn.edu|
21249935|NCT01078571|Abbott|Global Medical Services|1-800-633-9110||
21249936|NCT04422210|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21249937|NCT03594266|BiotronikUS|Crystal Miller|503-475-4984|crystal.miller@biotronik.com|
21249938|NCT00166361|Mayo Clinic|Dr. Lance A. Mynderse|507-284-1250|mynderse.lance@mayo.edu|
21249939|NCT01047306|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21249940|NCT01132378|Heekin Institute for Orthopaedic Research|R. David Heekin MD, FACS|904-634-0640|drheekin@heekinortho.com|
21249941|NCT01878253|Zimmer Biomet Inc|Clinical Operation Director|574-371-9823|Bill.Bourdeau@zimmerbiomet.com|
21249942|NCT00472056|UT MD Anderson Cancer Center|Chitra M. Hosing, MD / Associate Professor||mvpacheco@mdanderson.org|
21249943|NCT03647709|St Elizabeth Medical Center|Dr Andrew Wickline|315-735-4496|awickline23@gmail.com|
21249944|NCT01818245|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21249945|NCT00449033|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21249946|NCT04393779|Edwards Lifesciences, LLC|Sabrina Hundt, Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Sabrina_Hundt@edwards.com|
21249947|NCT05045638|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21249948|NCT03802513|VA RR&D National Center for Rehabilitative Auditory Research|Principal Investigator|503-220-8262|sarah.theodoroff@va.gov|
21249949|NCT01591655|Bausch Health|Study Director||susan.harris@bauschhealth.com|
21249950|NCT01190228|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21249951|NCT03941769|The University of Texas MD Anderson Cancer Center|Gheath Al-Atrash, M.D. / Stem Cell Transplantation|713-792-7734|galatras@mdanderson.org|
21249952|NCT01855399|VA HSRD: CCMR Ann Arbor and University of Michigan Medical School|Dr. Michele Heisler|(734) 845-3614|mheisler@umich.edu|
21249953|NCT00512902|University of California at Los Angeles|Dr. Daniel Furst, Carl M Pearson Professor of Rheumatology|310-794-9504|defurst@mednet.ucla.edu|
21249954|NCT03214198|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21249955|NCT03247985|Mayo Clinic|Dr. David R. Farley|507-284-7565|farley.david@mayo.edu|
21249956|NCT02577315|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21249957|NCT01245699|Maricopa Integrated Health System|Bentley J Bobrow, MD|602-364-0580|bentley.bobrow@azdhs.gov|
21249958|NCT01846988|Cincinnati Children's Hospital Medical Center|Dr. Neepa Gurbani, Assistant Professor|(513) 736-1814|Neepa.Gurbani@cchmc.org|
21249959|NCT03530345|Grünenthal GmbH|Director Clinical Trials|+49 241 569|Clinical-Trials@grunenthal.com|3223
21249960|NCT03282071|The University of Hong Kong|Dr. Yuying Sun|(852)39179144|gyysun@hku.hk|
21249961|NCT03537014|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
21249962|NCT02442622|NYU Langone Health|Steve Vanlew, PhD|646-501-7707|Steve.Vanlew@nyulangone.org|
21249963|NCT04448561|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
21249964|NCT05022472|UCSD|Dr. Britt Skaathun|619-543-5011|bskaathun@health.ucsd.edu|
21249965|NCT01819233|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Nicole Simone|215-955-6702|nicole.simone@jefferson.edu|
21249966|NCT05579769|St. Jude Children's Research Hospital|Dr. Ashok Srinivasan|8662785833|referralinfo@stjude.org|
21249967|NCT02924350|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21249968|NCT00635570|Department of Obstetrics and Gynecology, The University of Chicago|Melissa Gilliam|773-834-0840|mgilliam@babies.bsd.uchicago.edu|
21249969|NCT01101464|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
21249970|NCT01816685|Duke University|Andrew Krystal|(919) 668-1212|andrew.krystal@dm.duke.edu|
21249971|NCT00381888|Masonic Cancer Center, University of Minnesota|Levi S. Downs, Jr., M.D.|612-626-6628|downs008@umn.edu|
21249972|NCT01410084|Wake Forest School of Medicine|Dr. Denise Houston|336-713-8558|dhouston@wakehealth.edu|
21249973|NCT00383630|Columbia University|Yoshifumi Naka, MD, PhD|(212) 305-0828|yn33@columbia.edu|
21249974|NCT00197106|GlaxoSmithKline|GSK Response Center|866-435-7343||
21249975|NCT00762723|Zimmer|Laura Herdrich|952-830-6224|laura.herdrich@zimmer.com|
21249976|NCT00382408|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|info.era-clinical@teva.de|
21249977|NCT00926952|Innovaderm Research Inc.|Annie Levesque|514-521-4285|alevesque@innovaderm.ca|222
21249978|NCT00694564|UC San Diego|Dr. Jeannie Huang|858-576-1700|jshuang@ucsd.edu|7322
21249979|NCT02402465|University of Chicago|Fuad Baroody, MD|773-702-4790|fbaroody@surgery.bsd.uchicago.edu|
21249980|NCT01284634|GW Research Ltd|Medical Enquires||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
21249981|NCT02236598|Duke University Health System|Ranee Chatterjee Montgomery, M.D.||ranee.chatterjee@duke.edu|
21249982|NCT01484314|Brigham and Womens Hospital/ Dana Farber Cancer Institute|Dr. Nancy Berliner|617-732-5840|nberliner@parnes.org|
21249983|NCT03643705|University of Washington|Dr. Chris Longenecker|2066161159|ctlongen@uw.edu|
21249984|NCT00605384|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21295537|NCT01028716|Fred Hutchinson Cancer Center|Rachel Salit|2066671317|rsalit@fredhutch.org|
21264423|NCT01360762|Institute of Tropical Medicine Antwerp|Johan Van Griensven|+32(0)32476426|jvangriensven@itg.be|
21264424|NCT03084718|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
21264425|NCT02806947|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
21264426|NCT00865189|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21264427|NCT02484898|Medtronic CRHF|Medtronic SEEQ Performance Clinical Trial Leader|1-800-328-2518|medtronicCRMtrials@medtronic.com|
21264428|NCT03930641|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21264429|NCT00634114|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21264430|NCT01599754|SFJ Pharmaceuticals|Stewart Hallett|19252011003|stewart.hallett@sfj-pharma.com|
21264431|NCT02038218|DEKK-TEC, Inc.|Dr. Lee Roy Morgan|504-583-6135|lrm1579@aol.com|
21264432|NCT00738374|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21264433|NCT00680953|Daiichi Sankyo Co., Ltd.|H. Takami|+81 3 5740 3445|takami.hideo.hs@daiichisankyo.co.jp|
21264434|NCT00603733|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21264435|NCT01057134|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
21264436|NCT02215616|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21264437|NCT00520299|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21264438|NCT01352845|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21264439|NCT01957709|Fred Hutchinson Cancer Research Center|Seth Pollack, MD|206-667-6629|spollack@fredhutch.org|
21264440|NCT01925612|Seattle Genetics, Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
21264441|NCT00397878|University of Texas MD Anderson Cancer Center|Cathy Eng, MD / Professor|713-792-2828|ceng@mdanderson.org|
21264442|NCT01093755|Mayo Clinic|Prasad Iyer, MD|507-284-0970|Iyer.Prasad@mayo.edu|
21264443|NCT01608490|Boston Scientific|Kristi Winterfeldt|+1 763-494-1165|Kristi.Winterfeldt@bsci.com|
21264444|NCT02310906|Sarepta Therapeutics, Inc.|Medical Director|1-800-690-2003|clinicaltrials@sarepta.com|
21264445|NCT00433446|SWOG Statistical Center|Study Statistician|206-667-4623||
21295538|NCT01129882|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21249985|NCT00428441|University of Insubria|Dr. Walter Ageno|+39 0332 278831|agewal@yahoo.com|
21249986|NCT00125853|Imperial College London|Professor Neil Poulter|+44 2075943445|n.poulter@imperial.ac.uk|
21249987|NCT01093183|University of Nebraska Medical Center|James Schwarz, MD|402-559-5166|jkschwarz@unmc.edu|
21249988|NCT02724423|Neurelis, Inc.|Sunita Misra, M.D. Medical Director|(832) 257-1975|smisra@neurelis.com|
21249989|NCT00310050|Wake Forest University Health Sciences|Dr. William Blackstock|3367136501|ablackst@wakehealth.edu|
21249990|NCT03048058|Wake Forest University Health Sciences|Irma M. RIchardson, MHA;|336-716-2903|irichard@wakehealth.edu|
21249991|NCT01257698|Mid Atlantic Retina|Jason Hsu MD|215-928-3092|jhsu@midatlanticretina.com|
21249992|NCT01395914|Helsinn Therapeutics (US), Inc.|Richard K. Bourne, Ph.D.|732-603-2852|richard.bourne@helsinn.com|
21249993|NCT00581009|University of California Irvine|Dr. Joseph Wu|7142252212|jcwu@uci.edu|
21249994|NCT02256488|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
21249995|NCT02268526|Novartis Pharmaceuticals|Study Director|8627788300||
21249996|NCT00975130|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21249997|NCT01261793|Care|UCB|+1844599|UCBCares@ucb.com|2273
21249998|NCT03219216|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21249999|NCT03305458|Medical University of South Carolina|Dr. Tatiana Davidson|8437921866|davidst@musc.edu|
21250000|NCT02332824|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21250001|NCT00498797|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21250002|NCT03562117|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21250003|NCT03928821|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
21250004|NCT02684942|Chulabhorn hospital|Saengrawee Thanthong|+662-576-6021|saengrawee81@gmail.com|
21250005|NCT04743999|Henry Ford Health System|Marissa Gilbert|313-556-8422|mgilber6@hfhs.org|
21250006|NCT01721759|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21250007|NCT01114334|Denver Health and University of Colorado Denver|Dr. Robert D. Keeley|303-602-8270|robert.keeley@dhha.org|
21250008|NCT00998517|Washington University in St. Louis|Indi Trehan|5039284634|itrehan@wustl.edu|
21250009|NCT03138499|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21250010|NCT04313985|Stanford University|Geoffrey Gurtner|(520) 626-2222|gurtner@surgery.arizona.edu|
21250011|NCT02680145|Mayo Clinic|Dr. John A. Occhino|(507) 538-5883|Occhino.John@mayo.edu|
21250012|NCT01123200|University of Michigan|Jane Huggins|734-936-7177|janeh@umich.edu|
21250013|NCT02070640|The Ohio State University Wexner Medical Center|Associate Professor|614-293-3230|raaja.narula@osumc.edu|
21250014|NCT01052714|Psychiatry Department at VA Greater Los Angeles Healthcare System|Dr. Donna Ames, Principal Investigator|310-478-3037|donna.ames@va.gov|
21250015|NCT01195584|General Hospital Amstetten|Wolfgang Senker, MD|+43 7472 6040|wolfgang.senker@aon.at|6611
21250016|NCT02168153|Palmer Center for Chiropractic Research|Dr. Cyndy Long|563-884-5157|Long_C@palmer.edu|
21250017|NCT04623996|Sumitomo Pharma Oncology|Tegan Nguyen|617-674-8745|tegan.nguyen@oncology.sumitomo-pharma.com|
21250018|NCT00924833|Istituto Auxologico Italiano|Gianfranco Parati, Professor|+3961911|gianfranco.parati@unimib.it|2949
21250019|NCT02704156|Changhai Hospital affiliated to Naval Medical University|Huojun Zhang|86-021-31162207|chyyzhj@163.com|
21250020|NCT01636778|GlaxoSmithKline|GSK Response Center|866-435-7343||
21264446|NCT01188538|Galderma|Farzaneh SIDOU|00 33 4 93 95 70 51|farzaneh.sidou@galderma.com|
21264447|NCT00654953|UAMS|Alison Oliveto, Ph.D.|501-526-8441|olivetoalison@uams.edu|
21250021|NCT00170950|Novartis Pharmaceuticals|Study Director|862 778-8300||
21295539|NCT02130986|University of Pittsburgh|David T Huang, MD, MPH, Associate Professor|412-647-6818|huangdt@upmc.edu|
21295540|NCT02305849|Astellas Pharma Inc.|Clinical Trial Disclosure|+81-3-3244-6500 Japanese only|Astellas.resultsdisclosure@astellas.com|
21295541|NCT00355342|GlaxoSmithKline|GSK Response Center|866-435-7343||
21250022|NCT00748098|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
21250023|NCT01754389|Dana Farber Cancer Institute|Dr. John Koreth|617-632-2949|John_Koreth@dfci.harvard.edu|
21250024|NCT00332488|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
21250025|NCT00792259|Topcon Medical Systems|Bob Gibson|(201) 599-5121|RGIBSON@TOPCON.COM|
21250026|NCT03721978|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
21250027|NCT05244226|Duke University|Lisa Einhorn, MD|919-681-4877|lisa.einhorn@duke.edu|
21250028|NCT01997437|Kuban State Medical University|Dr. Paolo Macchiarini|+7(928)-268-80-00|pmacchiarini@ksma.ru|
21250029|NCT00555997|Massachusetts General Hospital|Dr. George Papakostas|617-726-6697|gpapakostas@partners.org|
21250030|NCT02097849|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21250031|NCT04483791|EVP, Clinical Research|Candace Elek, M.S.|408-913-5468|celek@elixirmedical.com|
21250032|NCT04050722|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21250033|NCT00377312|University of Pittsburgh|Mara J Horwitz|412-692-2848|horwitz@pitt.edu|
21250034|NCT01654445|University of Calgary, Department of Clinical Neurosciences|Shelagh B Coutts and Michael D Hill|4039448065|michael.hill@ucalgary.ca|
21250035|NCT03451292|Instituto Grifols, S.A.|Mireia Torres|+34 93 5710500|approach_preciosa@grifols.com|
21250036|NCT02794441|Children's Hospital of Eastern Ontario Research Institute|Dr. Roger Zemek|6137377600|rzemek@cheo.on.ca|3931
21250037|NCT01572493|National Cancer Institute|Dr. Kevin C. Conlon|240-858-3570|conlonkc@mail.nih.gov|
21250038|NCT01090076|Changi General Hospital|Mr Alvin Wong|68504627|alvin_wong@cgh.com.sg|
21250039|NCT00411463|University of Pittsburgh|Holly Swartz, MD|412-246-5588|swartzha@upmc.edu|
21250040|NCT02143310|FontemVentures|Tanvir Walele|01779337589|tanvir.walele@fontemventures.com|
21250041|NCT01955720|Boehringer Ingelheim pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21250042|NCT00191984|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21250043|NCT01654289|University of Wisconsin|Bruce Barrett MD PhD|608-263-2220|bruce.barrett@fammed.wisc.edu|
21250044|NCT02103816|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
21250045|NCT04086576|University of Pennsylvania|Jessie Hemmons|215-746-8255|jhemmons@pennmedicine.upenn.edu|
21250046|NCT04748445|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21250047|NCT04736602|Ipsen Pharma|Medical Director|see email|clinical.trials@ipsen.com|
21250048|NCT00578929|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21250049|NCT04362111|University of Alabama at Birmingham|Walter Winn Chatham MD|205-612-7402|wchatham@uabmc.edu|
21250050|NCT00938041|GlaxoSmithKline|GSK Response Center|866-435-7343||
21250051|NCT03042559|Loma Linda University|Dr. Everett Lohman III|9095584632|elohman@llu.edu|83171
21250052|NCT01509040|University of Washington Harborview Center for Pre Hospital Emergency Care|Dr. Graham Nichol|206-521-1728|nichol@uw.edu|
21250053|NCT01536535|Connecticut Childrens|Dr. Jeffrey Hyams|8605459532|jhyams@connecticutchildrens.org|
21250054|NCT00404547|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21250055|NCT01485991|Janssen IDV - Janssen Dx|Trial Physician||ClinicalTrialDisclosure@its.jnj.com|
21250056|NCT01475370|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21250057|NCT02538471|Weill Cornell Medicine|Dr. Silvia Formenti|212-746-3608|formenti@med.cornell.edu|
21250058|NCT00475735|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21250059|NCT03132753|Chestnut Health's Lighthouse Institute; Chicago, Illinois|Dennis Watson|224-534-0114|dpwatson@chestnut.org|
21250060|NCT00084747|UCLA|Dr. Gary Schiller|310-206-5755|gschiller@mednet.ucla.edu|
21250061|NCT03410953|UICEC, Complejo Asistencial Universitario de Salamanca - Instituto de Investigación Biomédica de Salamanca (IBSAL), Plataforma SCReN, Salamanca, Spain|Ricardo López-Pérez, PhD. Study Coordinator and Manager of Clinical Trial|923 291100|ricardo.lopez@scren.es|55779
21250062|NCT00679549|The Ohio State Unveristy|Rami Khayat|6142477717|rami.khayat@osumc.edu|
21250063|NCT01614899|Clinical Research, Drug Development Division|Regional Function Head of CNS Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
21250064|NCT02350127|San Francisco VA|Dr. Deborah Barnes, PI|415-221-4810|deborah.barnes4@va.gov|24221
21250065|NCT00157209|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21250066|NCT04474691|New York University|Tara McAllister|212-992-9445|tkm214@nyu.edu|
21250067|NCT00538616|Duke University|Dr. Carmelo Graffagnino|919/681-3751|Carmelo.Graffagnino@duke.edu|
21250068|NCT01109602|Colorado State University, Department of Occupational Therapy|Arlene Schmid, PhD, OTR|970-491-7562|arlene.schmid@colostate.edu|
21250069|NCT00274846|Masonic Cancer Center, University of Minnesota|Jeffrey Miller, M.D.|612-625-7409|mille011@umn.edu|
21250070|NCT02032420|University of New Mexico|Dr. Nicholas Lam|505-272-2610|nlam@salud.unm.edu|
21250071|NCT03869541|Imperial College London|Huw Woodbridge|+44 (0)20 7594 3192|h.woodbridge@imperial.ac.uk|
21250072|NCT02488070|Stanford University|Andrei Iagaru, MD|650-725-4711|aiagaru@stanford.edu|
21250073|NCT00050167|UT MD Anderson Cancer Center|Aman Buzdar, M.D./Professor||agmadrig@mail.mdanderson.org|
21250074|NCT03418701|University of Florida|Dr. Lori Bilello, Project Manager|904-244-9202|Lori.bilello@jax.ufl.edu|
21250075|NCT02038803|Rush University Medical Center|Dr. Robert Balk|3129426744|Robert_Balk@rush.edu|
21250076|NCT04754594|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
21250077|NCT01247922|Astellas Pharma Global Development, Inc.|Sr. Medical Director||Astellas.resultsdisclosure@astellas.com|
21264448|NCT00469209|University of Texas M.D. Anderson Cancer Center|Muzaffar H. Qazilbash, MD/Professor, Stem Cell Transplantation|713-745-3458|mqazilba@mdanderson.org|
21264449|NCT00961441|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
21264450|NCT01082367|Novartis|Study Director|862-778-8300||
21264451|NCT02307838|Novartis Pharmaceuticals|Study Director|862-778-8300||
21264452|NCT05137730|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21264453|NCT01222572|Dana-Farber Cancer Institute/Brigham and Women's Hospital|Raymond Mak, MD|6177328651|rmak@partners.org|
21264454|NCT02022033|Brown University Oncology Research Group|Howard Safran, MD|401-863-3000|BrUOG@BROWN.EDU|
21264455|NCT01429077|Rehabilitation Institute of Chicago|Leora R. Cherney, PhD|312-238-1117|Lcherney@ric.org|
21264456|NCT00280241|University of Pittsburgh|Michael Boyiadzis, MD|412-623-0040|boyiadzism@upmc.edu|
21264457|NCT01413542|Department of Medicine Vanderbilt University Medical Center|Dr. Nancy J. Brown|615-343-8701|nancy.j.brown@vanderbilt.edu|
21264458|NCT04929613|West Virginia University|Keith Zullig, PhD|304-293-1091|kzullig@hsc.wvu.edu|
21295542|NCT00536874|Memorial Sloan-Kettering Cancer Center|Dr. Eileen O'Reilly|646-888-4182|oreillye@mskcc.org|
21264459|NCT01978509|Mayo Clinic|Dr. Francisco Ramirez|(480) 301-6990|Ramirez.Francisco@mayo.edu|
21264460|NCT00084929|ACRIN|Donna Harfeil, Director of Protocol Management|215-717-2765|dhartfeil@acr.org|
21264461|NCT03641547|OCTO, University of Oxford|Dr Ruth Harman, Trial Manager|01865 617018|octo-CHARIOT@oncology.ox.ac.uk|
21264462|NCT02767856|State University of New York College of Optometry|Dr. Jingyun Wang|212-938-5759|jwang@sunyopt.edu|
21264463|NCT00091026|University of Chicago|Hedy Kindler, MD|(773) 702-0360|hkindler@medicine.bsd.uchicago.edu|
21264464|NCT01797965|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
21264465|NCT00973921|Columbia University Medical Center|Giora Weisz MD|212-305 7060|gw2128@mail.cumc.columbia.edu|
21264466|NCT02754830|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21264467|NCT02670330|Amicus Therapeutics, Inc.|Patient Advocacy|+1-609-662-2000|clinicaltrials@amicusrx.com|
21264468|NCT04404010|Precision OS Technology|Dr. Danny P Goel|604-345-0401|danny@precisionostech.com|
21264469|NCT02120157|Johns Hopkins University|Heather Symons, MD|410-502-9961|hsymons2@jhmi.edu|
21264470|NCT04368455|Cincinnati Children's Hospital Medical Center|Dr. Francis Real|5136364200|francis.real@cchmc.org|
21264471|NCT01354431|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21264472|NCT03176277|Ono Pharmaceutical Co., Ltd.|Medical Information Center|Please see email|trials.uk-eu@ono-pharma.com|
21264473|NCT02802878|University of Kansas Medical Center|Dr. Neil Segal|913-945-8985|segal-research@kumc.edu|
21264474|NCT00702052|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21264475|NCT00101192|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-341-3408|mleventhal@gogstats.org|
21264476|NCT03691610|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21264477|NCT00242580|Novartis Pharmaceuticals|Study Director|862 778-8300||
21264478|NCT01232894|Novartis|Study Director|41 61 324 1111||
21264479|NCT00753935|Vanderbilt_University MC|John A. Oates, MD|615 4343 4847|john.oates@vanderbilt.edu|
21264480|NCT03970395|Azienda Ospedaliera Città della Salute e della scienza di Torino _ Italy|Dr Claudio G Priolo|0039 3471403064|claudiog.priolo@gmail.com|
21264481|NCT00929734|University of Oslo|Professor Torbjørn Omland|+47 40107050|torbjorn.omland@medisin.uio.no|
21264482|NCT00980980|University of California, Irvine|Dr. Susan Huang|949-824-5073|sshuang@uci.edu|
21264483|NCT03172520|Mayo Clinic|Eric J. Moore, M.D.|507-284-3853|Moore.Eric@mayo.edu|
21264484|NCT02921919|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21264485|NCT03666858|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21264486|NCT00121992|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
21264487|NCT03282357|Merz Pharmaceuticals GmbH.|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
21264488|NCT03550131|University of Washington|Dr. Karen Fredriksen-Goldsen|206-543-5722|fredrikk@uw.edu|
21264489|NCT01318512|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21264490|NCT00669916|Novartis|Study Director|862-778-8300||
21264491|NCT02756650|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
21264492|NCT01948388|Arthritis & Rheumatic Disease Specialties|Joanne Sagliani|3059324162|drnbg@rheum-care.com|
21264493|NCT00230100|McLean Hospital|Shelly F. Greenfield, MD, MPH|617-855-2241|sgreenfield@mclean.harvard.edu|
21264494|NCT03371160|ENvizion Medical (Nutriseal)|Clinical Director|+972-72-2288240|anath@envizionmed.com|
21264495|NCT04348591|Duke University|Dr. Andrada D. Neacsiu|919-684-6714|andrada.neacsiu@duke.edu|
21264496|NCT00186056|Stanford University|Brent Solvason|650-723-8331|solvason@stanford.edu|
21295543|NCT00762996|Vistakon|Kurt Moody, OD, FAAO|904-443-3088||
21295544|NCT03236168|London School of Hygiene and Tropical Medicine|Dr Michael Marks|02079272566|michael.marks@lshtm.ac.uk|
21295545|NCT00434759|Central Institute of Mental Health, Mannheim, Germany|Prof. Martin Bohus|+49 621 1703 4002|martin.bohus@zi-mannheim.de|
21295546|NCT01241344|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
21295547|NCT00997425|James A. Haley VA Hospital, Tampa, FL|Dorothy H. Moore, PhD|813 558-3931|Dorothy.Moore4@va.gov|
21295548|NCT00539617|University of California, San Francisco|W. Michael Korn, MD|415-502-2844|michael.korn@ucsf.edu|
21264497|NCT00910429|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21264498|NCT01317615|Novartis|Study Director|862-778-8300||
21295549|NCT00495521|Jacobus Pharmaceutical Company, Inc.|Dr. Kathy Aleš, Medical Director|609-921-7448|kathy.ales@jacobus-pharmaceutical.com|238
21264499|NCT01322646|University at Buffalo|Gregory A. Fabiano, Ph.D.|7166451130|fabiano@buffalo.edu|
21264500|NCT02821455|University of Edinburgh|E Alexandra Page|7938645122|s1305565@sms.ed.ac.uk|
21295550|NCT02410824|CooperVision Inc.|Sr. Manager Clinical Research|925-730-6754|pchamberlain@coopervision.com|
21295551|NCT00392808|Centro Superior de Investigacion en Salud Publica|Javier Diez-Domingo|+34961925937|diez_jav@gva.es|
21250078|NCT04372186|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genetech@druginfo.com|
21250079|NCT04736472|University of Pennsylvania|Sony Tuteja, PI|215-573-7834|Sony.Tuteja@PennMedicine.upenn.edu|
21250080|NCT00739024|Swedish Headache Center|Pat Barrodale, RN|206-215-3502|pat.barrodale@swedish.org|
21250081|NCT01911819|Loma Linda University|Prof. Joseph Kan|(909) 558-4980|jkan@llu.edu|
21250082|NCT04374253|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21250083|NCT00448344|VA Connecticut|Dr. Lori Bastian|860-667-6853|lori.bastian@va.gov|
21250084|NCT00417989|Medtronic|Scott Lee, M.D.|8185764204|scott.w.lee@medtronic.com|
21250085|NCT00990821|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21250086|NCT04150250|PATH|Gwen Ambler|206-285-3500|gambler@path.org|
21250087|NCT01436045|HealthPartners Institute for Education and Research|Michael H Rosenbloom, MD|6512547900|michael.h.rosenbloom@healthpartners.com|
21250088|NCT01945086|Janssen Research & Development, LLC.|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
21250089|NCT01391234|University of Virginia Department of Radiation Oncology|Dr. Paul Read|(434) 924-5191|PWR3U@hscmail.mcc.virginia.edu|
21250090|NCT01184755|Rutgers - Robert Wood Johnson Medical School|Lynn Clemow, PhD|732-235-6972|lynn.clemow@rutgers.edu|
21250091|NCT04212299|University of Illinois Chicago|Andrew Sawers|312-996-1427|asawers@uic.edu|
21250092|NCT02548754|University of Oklahoma Health Sciences Center|Dr. Stavros Stavrakis|4052714742|stavros-stavrakis@ouhsc.edu|
21250093|NCT00509821|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21250094|NCT02720185|University of Wisconsin Carbone Cancer Center|Kari Wisinski|(608) 262-2876|kbwisinski@medicine.wisc.edu|
21250095|NCT01157351|Janssen Research & Development|Director, Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
21250096|NCT01589523|Cincinnati Children's Hospital Medical Center|Ken Setchell, PhD|5136364548|kenneth.setchell@cchmc.org|
21250097|NCT00506922|UT MD Anderson Cancer Center|Marcos de Lima, MD / Professor|713-745-3219|bmcmullin@mdanderson.org|
21250098|NCT04397614|University of Oklahoma Health Sciences Center|Krista Kezbers|405-271-8001|krista-kezbers@ouhsc.edu|45042
21250099|NCT02507687|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21250100|NCT02675998|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
21250101|NCT00275301|University of Minnesota|S. Charles Schulz, MD|612-273-9820|scs@umn.edu|
21250102|NCT02137499|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
21250103|NCT02561078|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21250104|NCT00575367|Inspire Pharmaceuticals, Inc.|Karen Kuhn/ Director|919 941-9777|kkuhn@inspirepharm.com|
21250105|NCT00598871|ReGenTree, LLC|Won S. Yang, President & CEO|609-734-4328|wonsyang@regentreellc.com|
21250106|NCT01194271|The University of Texas (UT) MD Anderson Cancer Center|Padmanee Sharma, Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org|
21250107|NCT00349622|MGH|Merit Cudkowicz|617-724-1873|mcudkowicz@partners.org|
21250108|NCT03619889|Universidad Complutense de Madrid|Dra. Gema Serrano-Hernanz|669332986|gema.serrano.hernanz@gmail.com, gemase01@ucm.es|
21250109|NCT03296566|University of British Columbia|Dr. Marette Lee|604.875.5608|Marette.Lee@vch.ca|
21250110|NCT03065205|University of Colorado|Heather Hoch MD|720-777-4108|heather.hoch@childrenscolorado.org|
21250111|NCT00821119|Instituto Materno Infantil prof. Fernando Figueira|Jucille Meneses|55 (81) 2122-4100|jmeneses@elogica.com.br|4135
21250112|NCT01341444|Medstar Georgetown University Hospital|Dr. Matthew Cooper|202-444-0753|Matthew.Cooper@gunet.georgetown.edu|
21250113|NCT01503515|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21250114|NCT01350102|Penn State Milton S. Hershey Medical Center|Nell Blake, DPM|(717) 531-5638|nblake@pennstatehealth.psu.edu|
21250115|NCT01828593|Entera Health|Senior Director, Clinical Research|515-963-7565|audrey.shaw@enterahealth.com|
21250116|NCT02640807|Revimmune|Dr Michel Morre, DVM, Chief Scientific Officer|+33(0)603357060|m.morre@revimmune.com|
21250117|NCT00726388|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21250118|NCT00084409|University of Colorado Denver|Robert Keith, M.D.|303-399-8020|robert.keith@ucdenver.edu|3182
21250119|NCT00609245|Vanderbilt University Medical Center|Bassel Abou-Khalil, MD|615-936-0060|bassel.abou-khalil@vanderbilt.edu|
21250120|NCT01631825|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
21250121|NCT01103271|Massachusetts General Hospital|Dr. Maurizio Fava|617-724-0838|mfava@partners.org|
21250122|NCT03022045|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21250123|NCT05372913|Woebot Health|Dr. Athena Robinson|(415) 209-5642|athena@woebothealth.com|
21250124|NCT00253019|Emory University|Carrie Cwiak, MD, MPH|404-778-1696|ccwiak@emory.edu|
21250125|NCT05012397|Rain Oncology|Clinical Research|7082323791|clinicalresearch@rainoncology.com|
21250126|NCT03334747|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21250127|NCT03303521|AstraZeneca|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
21250128|NCT00005908|National Cancer Institute, National Institutes of Health|JoAnne Zujewski, M.D.|301-435-9207|zujewskij@mail.nih.gov|
21250129|NCT01379521|Novartis Pharmaceuticals|Study Director|862-778-8300||
21250130|NCT02504502|Geisinger Health System|Alanna Kulchak Rahm, PhD|570-214-5093|akrahm@geisinger.edu|
21250131|NCT01855997|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21250132|NCT02389725|Mayo Clinic|Dr. Tobias Kummer|507-255-4399|kummer.tobias@mayo.edu|
21250133|NCT03866434|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21295552|NCT02436408|University of Michigan Rogel Cancer Center|Cagri Besirli, MD, PhD|734-232-8404|cbesirli@med.umich.edu|
21264501|NCT02648724|Symphogen AS|Medical Director|0045 45265050|info@symphogen.com|
21264502|NCT00302718|VA HSR&D Center for Innovations in Quality, Effectiveness & Safety (IQuESt)|Dr. Laura A. Petersen|713-794-8623|Laura.Petersen@va.gov|
21264503|NCT00632541|Hoosier Cancer Research Network|Jeff Smith|317-634-5842|jsmith@hoosiercancer.org|41
21264504|NCT04860752|Edwards Lifesciences|Edwards THV Clinical Affairs|949-250-2500|THV_CT.gov@Edwards.com|
21264505|NCT06025396|Tempero Bio|Director, Clinical Operations|510-250-4750|TMP-301-HNV-101@Temperobio.com|
21264506|NCT01512108|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21264507|NCT06422377|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21264508|NCT02017899|GSK Vaccines Institute for Global Health S.r.l.|Dr. Audino Podda|+39 0577 243496|audino.p.podda@gsk.com|
21264509|NCT01985971|University of Pennsylvania|Lilie Lin, MD|215-662-7267|lin@xrt.upenn.edu|
21264510|NCT02420795|UT MD Anderson Cancer Center|Michael Wang, MD, Professor, Lymphoma-Myeloma|(713) 792-2860|miwang@mdanderson.org|
21264511|NCT01546285|GE Healthcare|Jeffrey Conner - Global Research Manager|414.721.2423|Jeffrey.Conner@ge.com|
21264512|NCT04019795|Revian, Inc.|John Oakley|919-321-1726|joakley@knowbiollc.com|
21264513|NCT03625141|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21264514|NCT02168803|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21264515|NCT01280266|Seoul National University|Dr. Eun Bong Lee|+82 2 2072-3944|leb7616@snu.ac.kr|
21264516|NCT01784588|Boston Scientific|Teresa Takle-Flach|952-930-6000|Teresa.Takle-Flach@bsci.com|
21264517|NCT02084069|Seyyed-al-Shohada Heart Center, Urmia University of Medical Sciences|Yousef Rezaei|+989126231864|yousefrezaei1986@gmail.com|
21264518|NCT03807245|MinervaX ApS|Dr Per Fischer|+45 20 25 20 38|pbf@minervax.com|
21264519|NCT04116073|Sidney Kimmel Comprehensive Center at Johns Hopkins|Nilo Azad|410-614-9169|nilo.azad@jhu.edu|
21264520|NCT05814471|Topmed|Edith Martin|418 683-2104|emartin@topmed.ca|1302
21264521|NCT01148563|Louisiana State Univeristy Health Care Services Division|Dr. Ron Horswell|225-763-2983|rhorsw@lsuhsc.edu|
21264522|NCT01879319|Amgen Inc.|Study Director|866-572-6436||
21264523|NCT03067129|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21264524|NCT00289744|GlaxoSmithKline|GSK Response Center|866-435-7343||
21264525|NCT01256983|University Hospital Zürich|Mrs. Hanna Burkahlter|0041 76 371 12 35|hanna.burkhalter@usz.ch|
21264526|NCT00664209|UCaliforniaLA|Jeff Bronstein MD, PhD|310 206-9799|jbronste@mednet.ucla.edu|
21264527|NCT01392053|Universidade de São Paulo|Prof Silvana Quintana|55 16 3602-2813|quintana@fmrp.usp.br|
21264528|NCT02513784|Columbia University Medical Center|Julian A Abrams, MD|2123059541|ja660@cumc.columbia.edu|
21264529|NCT00418379|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
21264530|NCT00843843|Rush University Medical Center|Dr. Helen Burgess|3125634785|Helen_J_Burgess@rush.edu|
21264531|NCT00065442|Dendreon Corporation|Kathleen Picha|206-274-6762|kpicha@dendreon.com|
21264532|NCT01594333|Brigham & Women's Hospital|Dr. Paul Ridker and Dr. Robert Glynn|617-732-4965|pridker@bwh.harvard.edu|
21264533|NCT01764256|PATH|Jorge Flores|2028220033|jeflores@path.org|
21264534|NCT00304915|Central Arkansas Veterans Healthcare System|Dr. Jeff Pyne|501-257-1083|jmpyne@uams.edu|
21264535|NCT00565058|Aptose Biosciences Inc.|Peter Murray, Director Clinical Development|647-479-9812|pmurray@aptose.com|
21264536|NCT02029638|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21264537|NCT01647464|OHSU|Jonathan Lindner|5034948750|lindnerj@ohsu.edu|
21264538|NCT05489081|Children's Hospital of Philadelphia|Dr. Gwendolyn Lawson|2674266612|lawsong@chop.edu|
21264539|NCT03329599|Northern California Institute for Research & Education|Bruce Ovbiagele|415-750-2047|bruce.ovbiagele@va.gov|
21264540|NCT03886701|Thomas Jefferson University|Dr. Walter K. Kraft|215 955-9077|walter.kraft@jefferson.edu|
21264541|NCT00712322|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21264542|NCT02242994|Children's National|Dr. Axel Krieger|2024761284|akrieger@childrensnational.org|
21264543|NCT01887587|Medical College of Wisconsin|Ehab Atallah, MD|414-805-8900|eatallah@mcw.edu|
21264544|NCT00400712|Queen's University|Brenda Brouwer|613-533-6079|brouwerb@queensu.ca|
21264545|NCT00570531|University of Michigan Comprehensive Cancer Center|Susan Urba, M.D.|734-615-4762|surba@umich.edu|
21264546|NCT02466412|Philip Morris Products S.A.|Steffen Fredersdorf|+41 (58) 242 2182|Steffen.Fredersdorf@pmi.com|
21264547|NCT02553317|Ablynx|Medical Monitor|+32 (9) 262 00 00|clinicaltrials@ablynx.com|
21264548|NCT00769808|Bausch & Lomb Incorporated|Study Director|9083009926|susan.harris@bauschhealth.com|
21264549|NCT00400439|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
21264550|NCT00536978|UT MD Anderson Cancer Center|Issa F. Khouri, MD / Professor, Stem Cell Transplantation|713-745-0049|ikhouri@mdanderson.org|
21264551|NCT00622869|Novartis Pharmaceuticals|Study Director|862 778-8300||
21264552|NCT04398199|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-713-5440|mfarris@wakehealth.edu|
21264553|NCT02927873|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21264554|NCT01518244|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
21264555|NCT00870818|Provention Bio, Inc|Sharon Rowland|443-987-0797|SRowland@proventionbio.com|
21264556|NCT00094887|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
21295553|NCT02084238|Peking University People's Hospital|Dr. Jing He|86|hejing1105@126.com|1861170734
21264557|NCT04900038|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21264558|NCT00258206|Johns Hopkins University|Dr. Carol Ann Huff|410-955-8842|chuff1@jhmi.edu|
21264559|NCT01559064|Allergan, Inc.|Medical Monitor|714-246-4500|clinicaltrials@allergan.com|
21264560|NCT04390568|Boehringer Ingelheimv|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21264561|NCT03245723|UT Southwestern Medical Center, Dallas, Texas|Dr. Kara Goss|214-648-6868|kara.goss@utsouthwestern.edu|
21281545|NCT05581641|BioNTech SE|BioNTech clinical trials patient information|61319084|patients@biontech.de|+49
21281546|NCT04390763|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21281547|NCT02170220|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
21250134|NCT01209936|University of Southern California|Dr. David Erceg|(323) 442-2900|erceg@usc.edu|
21250135|NCT00577096|University of Arkansas for Medical Sciences|Elizabeth Ann Coleman|501-661-7902|colemanelizabetha@uams.edu|
21250136|NCT00832650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21250137|NCT01370564|Medtronic|Todd Fonseca, VP Clinical|763-526-8151|todd.fonseca@medtronic.com|
21250138|NCT00440037|Kyowa Kirin Co., Ltd.|Research & Development Planning Department , Research & Development Division||clinical.info.jp@kyowakirin.com|
21250139|NCT03356145|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
21250140|NCT00702234|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21250141|NCT03740919|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
21250142|NCT04964297|Weill Cornell Medical Center|Dr. Mehraneh Jafari|+1 646 962 2270|mdj9003@med.cornell.edu|
21250143|NCT00985621|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21250144|NCT01732406|Massachusetts General Hospital|Dr. Karen Miller|617-726-3870|kkmiller@partners.org|
21250145|NCT04394624|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21250146|NCT00905255|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
21250147|NCT03479502|Vanderbilt_University MC|Rosemary Sanders, Research Coordinator|16155930171|Rosemary.a.sanders@vumc.org|
21250148|NCT00603278|GlaxoSmithKline|GSK Response Center|866-435-7343||
21250149|NCT00991185|duke|brian smith|919668951|brian.smith@duke.edu|
21250150|NCT02418819|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21250151|NCT02406859|James J. Peters VAMC|Dr. Mark Korsten|718-741-4675|mark.korsten@va.gov|6753
21250152|NCT01332318|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
21250153|NCT02040532|MGH Center for Women's Mental Health|Dr. Lee Cohen|617-724-0816|lcohen2@partners.org|
21250154|NCT01207453|Brigham and Women's Hospital|Yvonne C Lee, MD, MMSc|617-732-8736|ylee9@partners.org|
21250155|NCT02814279|Institute of Science and Technology of São José dos Campos (Unesp)|Dr. Mauro P. Santamaria|+55 (16) 981937777|mauro.santamaria@ict.unesp.br|
21250156|NCT00676663|Syndax Pharmaceuticals, Inc.|Kate Madigan, MD, Chief Medical Officer|+1-858-888-3798|kmadigan@syndax.com|
21250157|NCT04382053|Novartis Pharmaceuticals|Study Director|862 778 8300|Novartis.email@novartis.com|
21250158|NCT01399905|Oregon Health and Science University|John G. Nutt, MD|503-494-9054|nuttj@ohsu.edu|
21250159|NCT00672100|William Beaumont Hospital|Craig T. Hartrick, MD|248-964-3440|chartrick@beaumont.edu|
21250160|NCT00513292|University of Texas MD Anderson Cancer Center, Houston, TX, USA|Aman U. Buzdar, MD|713-792-2817|abuzdar@mdanderson.org|
21250161|NCT02135419|University of California, San Francisco|Dr. Joel Palefsky|(415) 476-1574|joel.palefsky@ucsf.edu|
21250162|NCT00714688|Janssen-Cilag Germany|EMEA Medical Affairs Director|+49 2137 955258||
21250163|NCT01786551|Brigham and Women's Hospital|Gail K Adler|617-732-5661|gadler@partners.org|
21250164|NCT00318591|Coloplast|Anna Karina Busch, Intl. Senior Scientific Manager|+45 49112350|dkakb@coloplast.com|
21250165|NCT04853394|University of Illinois Chicago|Mary E. Mackesy-Amiti|312-355-4892|mmamiti@uic.edu|
21250166|NCT01524887|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21250167|NCT01808144|Ardea Biosciences, Inc.|Nihar Bhakta, MD|1-858-652-6671|nbhakta@ardeabio.com|
21250168|NCT03098797|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
21250169|NCT02956278|University of California San Francisco|Kathy Giacomini, PhD|415-514-4363|kathy.giacomini@ucsf.edu|
21250170|NCT02329223|Novartis|Study Director|862-778-8300||
21250171|NCT02628964|NYU Langone Health|Donna Shelley, MD MPH|917-494-4210|donna.shelley@nyulangone.org|
21250172|NCT03443063|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
21250173|NCT00552513|Population Health Research Institute|TIMACS Project Office|19055244322|timacs@phri.ca|
21250174|NCT04357964|Vanderbilt University Medical Center|Alp Ikizler, Catherine McLaughlin Hakim Chair in Vascular Biology, Professor of Medicine|(615) 343-7592|alp.ikizler@vumc.org|
21250175|NCT00733226|Kecioren Education and Training Hospital|Cem Hasan RAZİ|090 312 3659000|cemrazi2@gmail.com|1139
21250176|NCT00848393|Nationwide Children's Hospital|Aymen Naguib, MD|6147220596|Aymen.Naguib@nationwidechildrens.org|
21250177|NCT01750086|Massachusetts General Hospital|Dr. Joy Tsai|617-726-6723|jntsai@mgh.harvard.edu|
21250178|NCT02288364|Duke University Medical Center|Jay A. Baker, MD|919-684-7645|jay.baker@duke.edu|
21250179|NCT00443898|Novartis Pharmaceuticals|Study Director|862-778-8300||
21250180|NCT00043186|Amgen Inc.|Study Director|866-572-6436||
21250181|NCT00508274|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
21250182|NCT05012280|Insitute of Tropical Medicine|Carolien Hoof|+32470102562|choof@itg.be|
21250183|NCT00550771|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21250184|NCT03681353|Duke University Medical Center|Angela Kirby, MS|919-286-0411|angela.kirby@duke.edu|175526
21250185|NCT01189617|Johnson & Johsnon Consumer and Personal Products Worldwide|Joyce Hauze, Sr. Specialist|9285-277-0715|jhauze@its.jnj.com|
21250186|NCT01530477|GE Healthcare|Yi Xia|1 (608) 221-1551|Yi.Xia@ge.com|500-3045
21250187|NCT00520403|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21250188|NCT03924947|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21250189|NCT01145417|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21250190|NCT01797562|Allerderm(dba) SmartPractice|Kathryn Shannon|602 225 0595|kshannon@smarthealth.com|
21295554|NCT00391391|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21295555|NCT02649855|National Cancer Institute|Dr. Ravi A. Madan|301-480-7168|madanr@mail.nih.gov|
21295556|NCT02782325|University of North Carolina at Chapel Hill|Hans Herfarth, MD|919-966-6806|hherf@med.unc.edu|
21250191|NCT03930238|University of Iowa|Jacob Simmering|319-384-1107|jacob-simmering@uiowa.edu|
21250192|NCT00917462|Memorial Sloan Kettering Cancer Center|Dr. David Ilson, MD, PhD|646-888-4183|ilsond@mskcc.org|
21250193|NCT03939793|Penn Center for Community Health Workers|Director of Evaluation|267-624-5465|molly.knowles@pennmedicine.upenn.edu|
21250194|NCT00702338|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21250195|NCT03341312|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
21250196|NCT00839306|Eisai Inc.|Eisai Medical Services|888-422-4743||
21250197|NCT01812707|Sanofi|Trial Transparency Team||Contact --US@sanofi.com|
21250198|NCT05376787|F2 Labs|Wendy Fuster|3013682586|wfuster@f2labs.com|
21250199|NCT05060237|Biofrontera Bioscience GmbH|Clinical Trial Department|+49 214 876 32|ameluz@biofrontera.com|66
21250200|NCT02396758|Boston Scientific|Nancy O'Connell|763-494-2706|nancy.oconnell@bsci.com|
21250201|NCT02176018|Clinvest Research|Jim Sly|4178413673|jsly@clinvest.com|
21250202|NCT01514630|The Brain Institute of the University of Utah|Perry Renshaw, MD, PhD, MBA|801-587-1216|perry.renshaw@hsc.utah.edu|
21250203|NCT00265096|Centocor Research and Development, Inc.|Director, Clinical Research|1-800-457-6399||
21250204|NCT01116440|Mereo BioPharma Group Plc.|William Moore|+44333023300|WM@mereobiopharma.com|
21250205|NCT00774306|Thomas Jefferson University|Dr. Scott Mintzer|215-955-1222|scott.mintzer@jefferson.edu|
21250206|NCT03436433|Duke Neurosugery|Claudia E. Pamanes, MPH, CCRP|9196680897|claudia.pamanes@duke.edu|
21250207|NCT03568708|CIncinnati Children's Hospital Medical Center|Dr. Halley Wasserman|513-803-3815|halley.wasserman@cchmc.org|
21250208|NCT01126879|Northwestern University|William Catalona, MD|312-695-1301|WCatalona@nm.org|
21250209|NCT00666835|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com|
21250210|NCT03861429|University of Utah|Dr. Gail Towsley|801-585-9085|gail.towsley@nurs.utah.edu|
21250211|NCT00511147|Grifols Therapeutics Inc|Henry Li, PhD|1 + 919 316 6042|henry.li@grifols.com|
21250212|NCT00899379|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21250213|NCT01443546|Weill Cornell Medical College|Ina Cholst, MD|646-962-3025|icholst@med.cornell.edu|
21250214|NCT00744796|University of Texas Southwestern Medical Center|Dr. Vinod Mootha|214-648-3837|peter.chen@utsouthwestern.edu|
21250215|NCT05135156|University of Washington|Dr. Kathleen J. Ramos|2065430393|ramoskj@uw.edu|
21250216|NCT02223871|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure desk||clinical-trials-disclosure@idorsia.com|
21250217|NCT02986659|Atrium Health Wake Forest Baptist|Jingzhong Ding, PhD|336-713-8601|jding@wakehealth.edu|
21250218|NCT02253147|Teoxane|Clinical Project Manager|+41 (0) 22 344 96 36|m.chenet@teoxane.com|
21250219|NCT00647998|Hospital of the University of Pennsylvania|Steven Messe, MD|2156623363|messe@mail.med.upenn.edu|
21250220|NCT01939405|MGH|Dr. Nicolas Oreskovic|6177260593|noreskovic@mgh.harvard.edu|
21250221|NCT01956071|Pennington Biomedical Research Center|Dr. Corby K. Martin|225-763-2585|corby.martin@pbrc.edu|
21250222|NCT01259440|VA San Diego Healthcare System|Carl J. Stepnowsky, PhD|858-642-1240|Carl.Stepnowsky@va.gov|
21250223|NCT02254681|Allina Health|Srinevas K. Reddy|612-863-8716|laura.rockwell@allina.com|
21250224|NCT02469077|Vanderbilt University Medical Center|Stephen Bruehl, Ph.D.|615-936-1821|stephen.bruehl@vumc.org|
21250225|NCT00396097|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21250226|NCT02973477|University of Michigan|Lynn Ang|734-232-8058|angly@med.umich.edu|
21250227|NCT03461211|Horizon Pharma USA, Inc.|Roxann Becco|866-479-6742|clinicaltrials@horizontherapeutics.com|
21250228|NCT03807700|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21250229|NCT01059526|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21250230|NCT01732588|MMV|Dr Fiona Macintyre|+41 22 799 4060|macintyref@mmv.org|4078
21250231|NCT02720081|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21250232|NCT03209050|mmc medical international services|Clinical Research Organization and Trial Manager|9492805700|laura22@mmc-medical.com|
21250233|NCT02005029|Virginia Commonwealth University|Dr. Leslie Cloud|804-662-5304|leslie.cloud@vcuhealth.org|
21250234|NCT02316847|SK Bio-pharmaceuticals Co, Ltd|MinJae Lee, Associate Manager||minj.lee@sk.com|
21250235|NCT02621047|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21250236|NCT01370018|Institute for Human Genetics and Biochemistry|Cynthia L. Bristow, MS, PhD|6314446238|cynthia.bristow@alpha1biologics.com|
21250237|NCT03690921|M D Anderson Cancer Center|Dr. Emma Holliday|713-563-2340|EBHolliday@mdanderson.org|
21250238|NCT02406495|Coopervision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
21250239|NCT01525641|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21250240|NCT03772041|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21250241|NCT02204319|ProHealth Care|Linda LaBorde PT|262-928-5139|linda.laborde@phci.org|
21250242|NCT00383747|Massachusetts General Hospital - Harvard Medical School|A. Eden Evins, MD, MPH. Director of the MGH-Harvard Center for Addiction Medicine|6176434679|a_eden_evins@hms.harvard.edu|
21250243|NCT00858507|Providence VA Medical Center|Thomas O'Toole, MD|4012737100|thomas.otoole@va.gov|
21295557|NCT03777917|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|Aesthetic.Trials@merz.com|
21250244|NCT03544229|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21250245|NCT01954771|Beijing Anzhen Hospital|Dr.Yingsheng Zhou|0086-010-64456185|zys626@aliyun.com|
21250246|NCT03635775|University of Wisconsin Madison|Bernadette Gillick|612-625-3645|bgillick@wisc.edu|
21295558|NCT01154283|UMichigan|Kirsten Gruis|7346041172|klgruis@gmail.com|
21295559|NCT00042432|Amgen Inc.|Study Director|866-572-6436||
21295560|NCT04063787|University of Chicago|Dr. Mary Hammes|773-702-6134|mhammes@bsd.uchicago.edu|
21295561|NCT00320372|Cyberonics, Inc|Mark Bunker, PharmD, Sr. Director, Global Medical Affairs|281-228-7223|mark.bunker@cyberonics.com|
21295562|NCT01527383|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21295563|NCT01287221|Mayo Clinic|Dr. Phillip A. Low|507-284-3375|low@mayo.edu|
21295564|NCT02966795|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21295565|NCT00432744|University of Florida|Dr. Peter W Stacpoole|352-273-9023|pws@ufl.edu|
21295566|NCT04432493|Rutgers University|Travis Baker, PhD|18622503351|travis.e.baker@rutgers.edu|
21295567|NCT02761694|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21295568|NCT03840525|Florida International University|Dr. Gladys Ibanez|305-348-4920|gibanez@fiu.edu|
21295569|NCT02652416|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21295570|NCT02395055|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
21295571|NCT00787930|Duke University Medical Center|John Beyer, MD|919-668-0209|john.beyer@dm.duke.edu|
21295572|NCT02513823|Texas Woman's University|Carolyn Moore|713-794-2377|cmoore8@twu.edu|
21295573|NCT00394901|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21295574|NCT02076399|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
21295575|NCT03002623|National Cancer Institute|Dr. Naris Nilubol|301- 451-2355|niluboln@nih.gov|
21295576|NCT00085254|Adult Brain Tumor Consortium (ABTC)|Louis Burt Nabors, MD|205-934-1432|bnabors@uab.edu|
21295577|NCT04342689|Yale School of Medicine|Sherry Mansour, MD, MS Assistant Professor|(203) 785-4184|sherry.mansour@yale.edu|
21250247|NCT01136798|The University of Chicago|Eve Van Cauter, PhD|773-834-4001|evcauter@bsd.uchicago.edu|
21295578|NCT00844805|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21295579|NCT00475865|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi.com|
21250248|NCT03840278|Massachusetts General Hospital Diabetes Research Center|Courtney A Balliro, BS, RN, CDE|617-726-1242|cballiro@partners.org|
21250249|NCT03805698|Cedars-Sinai Medical Center|David Kulber, MD, PI|3104235900|david.kulber@cshs.org|
21250250|NCT00360971|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
21250251|NCT00024102|University of North Carolina|Hyman Muss, MD||hyman.muss@gmail.com|
21250252|NCT01078376|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21250253|NCT02588027|University of California, San Francisco|Dr. Jennifer Tangtiphaiboontana|5622095440|Jennifer.Tangtiphaiboontana@ucsf.edu|
21250254|NCT02116582|Astellas Pharma Europe B.V.|Executive Medical Director|+31 (0) 71 5455 050|Astellas.resultsdisclosure@astellas.com|
21250255|NCT01876823|Columbia Psychiatry|Dr. Gregory Pelton, MD|(646) 774-8669|ghp4@columbia.edu|
21250256|NCT03067610|University of Texas Southwestern Medical Center|Dr. David Sher|214/645-7607|david.sher@utsouthwestern.edu|
21250257|NCT00961896|Novartis|Study Director|862-778-8300||
21250258|NCT01540162|National Medical University Odessa|Prof. Mykola L. Aryayev, MD & PhD|+380 48 740 5249|nataly_kononenko@ukr.net|
21250259|NCT00755716|UConn Health|Dr. Cheryl Oncken|860-679-3425|oncken@uchc.edu|
21250260|NCT03022578|UT MD Anderson Cancer Center|Dr. Barbara O'Brien, MD/Associate Professor, Neuro-Oncology|(713) 794-4380|bjobrien@mdanderson.org|
21250261|NCT00111839|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|496151725200|service@merckgroup.com|
21250262|NCT00871143|Institute of Psychiatry|Dr. David Veale|0203 228 3461|david.veale@kcl.ac.uk|
21250263|NCT03009019|BioDelivery Sciences (a subsidiary of Collegium Pharmaceutical)|Director, Scientific Communications|913-940-1789|tkunkel@collegiumpharma.com|
21250264|NCT00805285|University of Maryland, Baltimore|Raymond Cross, MD, MS|410-706-3387|rcross@medicine.umaryland.edu|
21250265|NCT01441583|Boston Scientific|Clinical Trial Manager|+18002273422|jens.goetzke@bsci.com|
21250266|NCT01066897|Stanford University|Dr. Jennifer Keller|650-724-0070|jkeller@stanford.edu|
21250267|NCT01763645|BIOCAD|Feder Krykov|+7 (812) 380 4933|kryukov@biocad.ru|8552
21250268|NCT01697592|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21250269|NCT02110225|Dompé farmaceutici s.p.a.|Flavio Mantelli, MD, PhD|+39 02 583831|clinical.trials@dompe.com|
21250270|NCT01763346|University or Southern California|Dr. Thomas Buchanan|3234794319|buchanan@usc.edu|
21250271|NCT00809783|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21250272|NCT00126555|University of Texas MD Anderson Cancer Center|Randal S. Weber, MD / Head & Neck Surgery|7137927734|rsweber@mdanderson.org|
21250273|NCT00529555|Sunstar Americas, Inc|Marie Wilson, Clinical Program Manager|773-481-3327|marie.wilson@us.sunstar.com|
21250274|NCT02133066|Children's Hospital of Philadelphia|Aaron Chen|2674260383|chena2@email.chop.edu|
21250275|NCT01797822|Baylor College of Medicine|Stephen Pflugfelder|713-798-6100|stevenp@bcm.edu|
21250276|NCT03441789|Skin Sciences, PLLC|M. McAllister|5024519000|mmdermresearch@yahoo.com|
21250277|NCT01780545|Hoosier Cancer Research Network|Clinical Data Manager|3176345842|hcrndm@hoosiercancer.org|41
21250278|NCT04318587|University of Pittsburgh|Naomi Ryssel|412-335-9688|agostinonr@upmc.edu|
21250279|NCT01212952|Mayo Clinic|Martha Q. Lacy, M.D.|(507) 284-8430|lacy.martha@mayo.edu|
21250280|NCT02581189|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21295580|NCT04316741|University of Michigan|Dr. Erin Bonar|7347647936|erinbona@med.umich.edu|
21250281|NCT03229356|Johns Hopkins University|Geetanjali Chander|443-287-2030|gchande1@jhmi.edu|
21295581|NCT02032641|Bascom Palmer Eye Institute|Dr. Sara T. Wester|3053266132|SWester2@med.miami.edu|
21295582|NCT01071356|Public Health Institute: Alcohol Research Group|Dr. Douglas Polcin|510-597-3440|dpolcin@arg.org|277
21264562|NCT01628250|Ruijin Hospital, Shanghai Jiao Tong University School of Medicine|Dr. Bo Feng|021-64458887|fengbo2022@163.com|
21264563|NCT00077376|ECOG Statistical Office|Study Statistician|617-632-3012||
21264564|NCT03784027|University of Cambridge|Prof Roman Hovorka|+44 1223 762 862|rh347@cam.ac.uk|
21264565|NCT03637842|New York State Psychiatric Institute|Christina Brezing, MD|6467748181|christina.brezing@nyspi.columbia.edu|
21264566|NCT05294341|Hershey Medical Center|Dr. Halina Yee; Primary Resident Investigator|7175313503|hyee@pennstatehealth.psu.edu|
21264567|NCT02843178|Stanford University|Mandy Murphy Carroll, Study Coordinator|(650) 509-0004|mandyiam@stanford.edu|
21264568|NCT00646113|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
21264569|NCT00591240|VA Palo Alto Health Care System|Dr. Joseph Liao|650-493-5000|joseph.liao@va.gov|65581
21264570|NCT02762799|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28|linkova@biocad.ru|930
21264571|NCT03722472|Access to Advanced Health Institute (AAHI)|Christopher Fox PhD|(206) 381-0883|Christopher.Fox@aahi.org|
21264572|NCT03927911|Pacira Pharmaceuticals|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
21264573|NCT02658968|Nordic Nanovector|Head of Clinical Operations|+47 22 18 33 01|mail@nordicnanovector.com|
21264574|NCT01362946|Penn State Hershey Medical Center|Dr. Dan Waschbusch|7175318514|dwaschbusch@hmc.psu.edu|
21264575|NCT00949910|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21264576|NCT03287869|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21264577|NCT01666145|Carolinas Healthcare System|Principal Investigator|704-446-2772|john.martinie@carolinashealthcare.org|
21264578|NCT02591238|Peking Union Medical College Hospital.|Prof. Changwei Liu. Director of vascular surgery.|+86 1069152509|aresbill@outlook.com|
21264579|NCT00640146|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
21264580|NCT02455388|Virginia Tech|Dr. Brenda Davy|540-231-6784|bdavy@vt.edu|
21264581|NCT00324740|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
21264582|NCT01052831|University of Pennsylvania|Dr. Daniel Weintraub|12153498389|Daniel.Weintraub@uphs.upenn.edu|
21264583|NCT00971425|GlaxoSmithKline|GSK Response Center|866-435-7343||
21264584|NCT02528253|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21264585|NCT00505752|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21264586|NCT01624506|Ethicon|Janet DeMarchi|612-867-8727|jdemarch@its.jnj.com|
21264587|NCT01149343|GlaxoSmithKline|GSK Response Center|866-435-7343||
21264588|NCT01016678|Premiere Research Institute|Paul Winner, DO|561-845-0500|pwinner777@aol.com|102
21264589|NCT01766219|Wake Forest University Health Sciences|Caio Max Rocha Lima|336-703-4246|crochali@wakehealth.edu|
21264590|NCT00132314|VA New England Mental Illness, Research, Education and Clinical Center|Robert Rosenheck, MD|(203) 932-5711|Robert.Rosenheck@va.gov|3723
21264591|NCT01009918|University of South Florida|Maya Guglin, MD, PhD|813-259-0600|mguglin@health.usf.edu|
21264592|NCT01271413|Johns Hopkins University School of Medicine|Dr. Miriam Mintzer|410 550-0529|mmintzer@jhmi.edu|
21264593|NCT01589263|Baylor College of Medicine|Christopher Smith|713-798-4001|cps@bcm.edu|
21264594|NCT03955055|UMass Chan Medical School|Anne Foley, Senior Clinical Research Coordinator|774-442-4098|anne.foley@umassmed.edu|
21264595|NCT00756093|Alcon Research Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21264596|NCT03250377|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21264597|NCT03444870|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21264598|NCT00698035|University of California, San Francisco|Michelle Melisko, MD|415-353-7070|mmelisko@medicine.ucsf.edu|
21264599|NCT02034552|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
21264600|NCT00074802|Temple University|Richard G. Heimberg, Ph.D.|215.204.7489|heimberg@temple.edu|
21264601|NCT03007719|University of California, San Francisco|Dr. Lawrence Fong|(415) 353-2051|Lawrence.Fong@ucsf.edu|
21264602|NCT00550277|Sarah Cannon Research Institute|John D. Hainsworth, MD|615-329-7274|jhainsworth@tnonc.com|
21264603|NCT04295356|CELLTRION, Inc.|Sung Hyun Kim, Head of Clinical Planning Department|+82 32 850 5778|SungHyun.Kim@celltrion.com|
21264604|NCT02892201|Yale School of Medicine|Barbara Burtness, MD|(203) 200-4622|arbara.burtness@yale.edu|
21264605|NCT04904614|Tufts Medical Center|Dr. Jennifer Chow|617-636-5244|jennifer.chow@tuftsmedicine.org|
21264606|NCT01668030|University of Louisville School of Nursing|Dr. Carlee Lehna, Associate Professor|502-852-3913|carlee.lehna@louisville.edu|
21264607|NCT03986190|University of Miami Miller School of Medicine|Dr. Sara St George|305-243-0726|s.stgeorge@med.miami.edu|
21264608|NCT04511819|Fulcrum Therapeutics|Call Center|617-651-8853|clinicaltrials@fulcrumtx.com|
21264609|NCT02792049|Brooke Army Medical Center|Dr. Michael D. April|(210) 916 - 0808|Michael.D.April@post.harvard.edu|
21264610|NCT00425477|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|B. Douglas Smith|410-614-5068|smithdo@jhmi.edu|
21264611|NCT01868776|The Ohio State University|Dr. Melissa Drum|6142923596|drum.13@osu.edu|
21264612|NCT02180217|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21264613|NCT00776555|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21264614|NCT01181102|Daiichi Sankyo.,LTD|Kei Ibusuki, Associate Director|81-90-2732-9505|ibusuki.kei.tx@daiichisankyo.co.jp|
21264615|NCT00239837|University of Oregon|Dr Leslie Leve|541-346-9528|leve@uoregon.edu|
21264616|NCT01838590|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21281548|NCT01383174|University of California San Francisco|Dr. Anna Maria Napoles|415-476-6290|anapoles@ucsf.edu|
21264617|NCT04685499|Weill Cornell Medicine|Meyer Cancer Center GI Program Manager|646-962-8189|cdo4001@med.cornell.edu|
21264618|NCT02055430|Cairo University|dr Mohammed Said ElSheemy|01006117755|mohammedshemy@yahoo.com|
21281549|NCT00126750|VA Bedford CHOIR|Dr. Thomas Houston II|781-687-2884|thomas.houston2@va.gov|
21281550|NCT01153815|GlaxoSmithKline|GSK Response Center|866-435-7343||
21250282|NCT03275402|Y-mAbs Therapeutics|Joris Wilms|+4570261414|clinicaltrials@ymabs.com|
21250283|NCT01514864|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21250284|NCT03371485|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
21250285|NCT03187353|Perlman School of Medicine, University of Pennsylvania|James Loughead, Ph.D.|215-205-1876|loughead@pennmedicine.upenn.edu|
21250286|NCT02567227|Albert Einstein College of Medicine|Dr. Joe Verghese|718-430-3877|joe.verghese@einsteinmed.org|
21250287|NCT00475787|Canandaigua VA Medical Center|Paul Dougherty, DC|585-463-2673|paul.dougherty@va.gov|
21250288|NCT01026103|Covidien|Noreen Fahey|203-821-4716|noreen.fahey@covidien.com|
21250289|NCT02498418|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
21250290|NCT02502487|West China Hospital, Department of Anesthesiology|Dr. Guizhi Du, Associate professor|+86 18980602213|du_guizhi@yahoo.com|
21250291|NCT01150500|Study Manager|Hiroko Ookubo|+81-3-6430-7017|hiroko.ookubo@medtronic.com|
21250292|NCT00741468|Repros Therapeutics Inc.|Jennifer Wike|281-719-3402|jwike@reprosrx.com|
21250293|NCT05021757|Shockwave Medical|Randee Randoll|408.577.7856|rrandoll@shockwavemedical.com|
21250294|NCT03799289|The Miriam Hospital|Jessica Unick, PD (Principal Investigator)|401-793-8966|junick@lifespan.org|
21250295|NCT01363297|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21250296|NCT04593641|Celltrion Inc.|JiWoong Lim|82-32-850-5806|jiwoong.lim@celltrion.com|
21250297|NCT00794573|Jewish General Hospital / McGill University|Mark Eisenberg, MD MPH|5143408222|mark.eisenberg@ladydavis.ca|
21250298|NCT04763863|Coloplast AB|Catarina Sternhufvud|+46 (0)705 56 10 97|secast@coloplast.com|
21250299|NCT01774929|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-792-7200||5888
21250300|NCT00500539|Novartis Pharmaceuticals|Study Director|862-778-8300||
21250301|NCT04890158|Montefiore Medical Center|Dr. Alecia Thompson-Branch|718-904-4105|alethomp@montefiore.org|
21250302|NCT03993054|University of Miami|Sara St. George|305-243-0726|s.stgeorge@med.miami.edu|
21250303|NCT00383500|Stanford University|Stanley G. Rockson|650-725-7571|rockson@stanford.edu|
21250304|NCT02648282|Sidney Kimmel Cancer Center at Johns Hopkins|Lei Zheng MD, PhD|410-502-6241|lzheng6@jhmi.edu|
21250305|NCT03051984|University of Vermont College of Medicine|Michael Toth|802-656-7989|michael.toth@med.uvm.edu|
21250306|NCT01123642|VISN 17 Center of Excellence for Research on Returning War Veterans|Sandra B. Morissette, Ph.D.|254-297-5170|sandra.morissette@va.gov|
21250307|NCT04853238|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21250308|NCT02025647|NCS Pearson|Dr. Paul E Williams, Sr. Research Director|952-681-4553|paul.e.williams@pearson.com|
21250309|NCT02093897|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
21250310|NCT02972242|WRNMMC Cardiology|Hampton Crimm|301-295-4500|hampton.a.crimm.mil@mail.mil|
21250311|NCT03480919|Hospital for Special Surgery|Jonathan Kirschner|6467146327|kirschnerj@hss.edu|
21250312|NCT04572997|Prof. Dr. Kristian Reich|Prof. Dr. Kristian Reich|+49 1722701941|kreich@jerucon.com|
21250313|NCT01967719|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
21250314|NCT04588519|Spark Biomedical, Inc.|Navid Khodaparast, PhD|832-280-4756|navid.khodaparast@sparkbiomedical.com|
21250315|NCT00371462|Edward Hines Jr., VA Hospital|Associate Chief of Staff for Research|708-202-5689|eileen.collins@va.gov|
21250316|NCT01983462|University of Iowa|Gary Pierce, PhD|3193359487|gary-pierce@uiowa.edu|
21250317|NCT03511378|Lupin Ltd. (Lupin Research Park), Pune, India|Dr. Chirag Shah, Director|91-20-67917368|chiragshah@lupin.com|
21250318|NCT01701271|Bio Basic Europe|Prof. Fulvio Marzatico|(39) 0382 - 506390|fulviomk@unipv.it|
21250319|NCT02229396|AstraZeneca|Global Clinical Leader|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
21250320|NCT00082641|University of Nebraska|Elizabeth Reed|402-559-5166|ereed@unmc.edu|
21250321|NCT01223963|Q-Med AB|Chief Medical Officer|+46 18 4749000|reception.seupp@galderma.com|
21250322|NCT02679079|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
21250323|NCT02312622|Stanford University|Joel W. Neal, MD PhD, Assistant Professor of Medicine (Oncology)|(650) 498-4696|jwneal@stanford.edu|
21250324|NCT03193216|Medical University of South Carolina|Dr. Puja Elias, Associate Professor, PI for study|8438764269|eliasps@musc.edu|
21250325|NCT02490878|MD Anderson Cancer Center|Caroline Chung, MD|(713) 745-5422|cchung3@mdanderson.org|
21250326|NCT01264887|Grünenthal GmbH|Director Clinical Trials|+49 241 569|clinical-trials@grunenthal.com|3223
21250327|NCT02171130|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21250328|NCT04531813|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21250329|NCT01947153|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21250330|NCT01340300|Dana-Farber Cancer Institute|Meyerhardt, Jeffrey,M.D.,M.P.H.|617-632-6855|Jeffrey_Meyerhardt@dfci.harvard.edu|
21250331|NCT01163955|Glinn and Giordano Physical Therapy|W. Brian Monroe, Doctor of Physical Therapy|661-832-9737|tandbmonroe@hotmail.com|
21250332|NCT01061775|Children's Hospitals and Clinics of Minnesota|Dr. Jennifer Abuzzahab|651-220-6867|jennifer.abuzzahab@childrensmn.org|
21250333|NCT00784277|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
21250334|NCT01093222|SWOG|Study Statistician|206-667-4623||
21250335|NCT00588341|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|(646) 888-4162|chapmanp@mskcc.org|
21250336|NCT03746483|First Wave BioPharma Inc.|Chief Medical Officer|(561) 589-7020|info@firstwavebio.com|
21281551|NCT01786993|St. Jude Medical|Director of Clinical Studies|972-309-8000|ccohorn@sjm.com|8087
21281552|NCT00450437|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@Novartis.com|
21281553|NCT01890122|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21281554|NCT00867659|Virginia Center for Reproductive Medicine|Dr Fady Sharara|7034377722|fsharara@vcrmed.com|
21281555|NCT03591874|Ocugen|Vijay Tammara, VP, Strategic Regulatory Operations|484-328-4751|Vijay.tammara@ocugen.com|
21281556|NCT01225250|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
21281557|NCT00071110|University of Pittsburgh|Benoit H. Mulsant, MD|(416) 535-8501|benoit_mulsant@camh.net|3655
21281558|NCT01759602|Johns Hopkins University|Michael Levy, MD, PhD|443-287-4412|mlevy@jhmi.edu|
21281559|NCT02166333|Johns Hopkins University|Dr. Lawrence Appel|410-955-4156|lappel@jhmi.edu|
21281560|NCT00503698|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21281561|NCT02269098|Medstar Health Research Institute|Michelle F Magee, MD|202-877-0351|michelle.f.magee@medstar.net|
21295583|NCT02278614|Laboratoires Théa|Director of Medical Operations|04 73 98 50 89|J.AUGER@laboratoires-thea.fr|
21295584|NCT02279498|Anthera Pharmaceuticals|Monica Gangal|510-856-5600|info@anthera.com|
21295585|NCT00737711|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21295586|NCT00624780|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21295587|NCT04068519|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
21295588|NCT03762616|Exact Imaging|Dr. Brian Wodlinger|6475279032|bwodlinger@exactimaging.com|
21295589|NCT03081858|LIPAC Oncology|Karl Bean|714-900-4412|karl@lipaconcology.com|
21295590|NCT00340379|Duke University|Frederick Cassidy|919-575-7801|cassi002@mc.duke.edu|
21295591|NCT05438602|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21295592|NCT00628589|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
21295593|NCT02418312|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
21295594|NCT00803413|Hospital das Clínicas - São Paulo University School of Medicine|Mario Fereira Junior|55 11 3069-7691|mariofj@uol.com.br|
21295595|NCT04524455|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21295596|NCT01688739|Amgen Inc.|Study Director|866-572-6436||
21295597|NCT02406443|Renal Physiology Laboratory|University Health Network|416-340-4800|vesta.lai@uhn.ca|8508
21250337|NCT04349124|Duke University|Brenna Hughes, M.D.|919-668-0843|brenna.hughes@duke.edu|
21250338|NCT01924806|Smith & Nephew|Henry Jaimes|01923-477-164|henry.jaimes@smith-nephew.com|
21250339|NCT02886234|The Miriam Hospital|Dr. Michael Carey|401793-8218|michael_carey@brown.edu|
21250340|NCT00935649|PathoLase|David M Harris, PhD, Research Director|510-502-3345|bmcinc@comcast.net|
21250341|NCT00957671|University of Texas Medical Branch|Randall Urban, MD|409-772-1176|rurban@utmb.edu|
21250342|NCT00762502|Johnson & Johnson Vision Care, Inc.|John Buch, OD|1-904-443-1707|RA-Visus-ClnclStds@its.jnj.com|
21250343|NCT01675050|University of Michigan|Ismaeel Hashemi, M.D. Principal Investigator|6169165566|ismaeel.hashemi@gmail.com|
21250344|NCT01961921|Alnylam Pharmaceuticals Inc|Chief Medical Officer|1-877-256-9526|Clinicaltrials@alnylam.com|
21250345|NCT03327571|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21250346|NCT00264498|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
21250347|NCT03794609|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21250348|NCT03638258|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
21250349|NCT04543942|The Ohio State University|Dr. Jessica Weafer|859-533-9878|jessica.weafer@osumc.edu|
21250350|NCT02205476|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21250351|NCT04405089|Minneapolis VA Medical Center|Dr. Shalamar Sibley, MD, MPH|612-467-1727|Shalamar.Sibley@va.gov|
21250352|NCT00179478|University of California San Diego|Revere P Kinkel MD (PI)|619-543-5295|rkinkel@ucsd.edu|
21250353|NCT00139659|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21250354|NCT00924209|National Cancer Institute, National Institutes of Health|Caryn Steakley, Deputy Clinical Director|240-858-3749|steaklec@nih.gov|
21250355|NCT02943109|Ohio State University College of Medicine|Prof. Ann Scheck McAlearney|614-293-8973|Ann.McAlearney@osumc.edu|
21250356|NCT02625922|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
21250357|NCT02359552|Cleveland Clinic Lou Ruvo Center for Brain Health|Dr. Aaron Ritter|702-483-6049|rittera@ccf.org|
21250358|NCT02382913|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21250359|NCT02520414|Boston Scientific|Meaghan Wilk Clinical Project Manager|5086834113|meaghan.wilk@bsci.com|
21250360|NCT01747629|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
21250361|NCT01313299|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21250362|NCT02506881|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
21250363|NCT01919398|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21250364|NCT03722836|ServierRussia|Medical Manager-Olga Linnik|8-495-93707-00|olga.linnik@servier.com|1316
21250365|NCT02391545|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
21250366|NCT02016690|AbbVie|Global Medical Services|800-633-9110||
21250367|NCT01222078|GlaxoSmithKline|GSK Response Center|866-435-7343||
21250368|NCT04089332|University of Wisconsin - Madison|Dr. William Schrage|608-262-7715|william.schrage@wisc.edu|
21250369|NCT05756348|Medline Industries, LP|Julie Miller|630-418-6891|jamiller@medline.com|
21250370|NCT05401149|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21250371|NCT00495612|Genentech, Inc.|Medical Communications|800 821-8590||
21250372|NCT02189122|VANDERBILT UNIVERSITY MEDICAL CENTER|Nancy J. Brown, M.D.|6153438701|nancy.j.brown@vanderbilt.edu|
21250373|NCT04281875|Vanderbilt University Medical Center|Dr. Carmen C Solorzano|615-343-2735|carmen.solorzano@vumc.org|
21250374|NCT02656745|Click Therapeutics|Director of Scientific Affairs|646-844-2158|brian@clicktherapeutics.com|
21250375|NCT03847389|Hill Dermaceuticals, Inc.|Rosario G Ramirez, MD|4073231887|nini.ramirez@hillderm.com|
21295598|NCT06276881|Dandelion Science|Chief Executive Officer (CEO)|628-777-3477|info@dandelion.science|
21295599|NCT01657760|Harbor-UCLA Department of Psychiatry|Todd Zorick|310-781-3400|tzorick@mednet.ucla.edu|
21250376|NCT01770509|The Department of Dermatology, Sheba Medical Center|Dr. Shoshana Greenberger|972-3-5302443|shoshana.greenberger@sheba.health.gov.il|
21250377|NCT02033499|University of North Carolina at Chapel Hill|Dr. Katrina Donahue|919-966-5090|Katrina_Donahue@med.unc.edu|
21250378|NCT02865135|Dana Farber Cancer Institute (DFCI)|Kartik Sehgal, MD|617-632-3090|Kartik_Sehgal@dfci.harvard.edu|
21250379|NCT02363933|Duke University Medical Center|Katherine Peters, MD, PhD|9196846173|katherine.peters@duke.edu|
21250380|NCT04387201|The University of Texas Health Science Center at Houston|Absalon D Gutierrez, MD|713-500-6641|absalon.d.gutierrez@uth.tmc.edu|
21250381|NCT04320602|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
21250382|NCT02762500|Lycera Corp.|H. Jeffrey Wilkins, MD, Chief Medical Officer|484-243-6222|wilkins@lycera.com|
21250383|NCT00730847|GlaxoSmithKline|GSK Response Center|866-435-7343||
21250384|NCT00280683|UCaliforniaDavis|Dr. Nicholas Kenyon|916-734-3564|njkenyon@ucdavis.edu|
21250385|NCT01243411|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
21250386|NCT04517877|Photozig, Inc.|Bruno Kajiyama|6506947496|info@photozig.com|
21250387|NCT03245762|University of Florida|Jennifer Miller, MD|352-265-7337|millejl@peds.ufl.edu|
21250388|NCT00637247|AmpliMed Corporation|Robert Dorr|520-626-7892|bdorr@azcc.arizona.edu|
21250389|NCT03935932|University of Pittsburgh|Tim Corcoran, Associate Professor|4126922210|corcorante@upmc.edu|
21250390|NCT00488319|Johnson & Johnson Research & Development, LLC|Director Clinical Research|1-609-730-6771||
21250391|NCT01982786|Canadian cancer trials group|Dr. Keyue Ding|1-613-533-6000|kding@ctg.queensu.ca|77705
21250392|NCT00352053|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21250393|NCT01592396|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com|
21250394|NCT01057888|University of Rochester, Deparentment of Pediatrics|Dr. Peter Szilagyi|585 275-5798|peter_szilagyi@urmc.rochester.edu|
21250395|NCT02499835|University of Wisconsin Carbone Cancer Center|Douglas McNeel, MD|608-263-4198|dm3@medicine.wisc.edu|
21250396|NCT01369706|Deutsches Herzzentrum München|Prof. Dr. Christof Kolb|+49891218|kolb@dhm.mhn.de|2020
21250397|NCT01751451|Memorial Sloan Kettering Cancer Center|Dr. Howard Scher, MD|646-888-4878|scherh@MSKCC.ORG|
21250398|NCT01906658|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
21250399|NCT03226353|CooperVision|Jose A. Vega OD MSc FAAO|(925) 621- 3761|javega@coopervision.com|
21250400|NCT03319719|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
21250401|NCT00991029|Medical University of South Carolina|Dr. Jordan Elm|843-876-1605|elmj@musc.edu|
21250402|NCT05110014|Wake Forest Baptist Health Sciences|Study Coordinator|336-713-3103|eswright@wakehealth.edu|
21250403|NCT02959177|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
21250404|NCT03389451|University of Iowa Health Care|Dr. Michael Graham|319-356-4302|michael-graham@uiowa.edu|
21250405|NCT01860807|UCLA|Keith Heinzerling MD|310-319-4700|kheinzerling@mednet.ucla.edu|
21250406|NCT00591409|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21250407|NCT02853305|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21250408|NCT00349388|Atlantic Health System|Dr. Joel Rosh|973-971-5676|joel.rosh@atlantichealth.org|
21250409|NCT02381652|Anika|Carol Pekar, VP Clinical Affairs|781.457.9218|cpekar@anikatherapeutics.com|
21250410|NCT04772313|Horizon Therapeutics USA, Inc.|Supra Verma, MD|866-479-6742|clinicaltrials@horizontherapeutics.com|
21250411|NCT01836198|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21250412|NCT02215954|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21250413|NCT02754310|iLumens|Dr David Drummond|+0033144494848|david.drummond@ilumens.org|6
21250414|NCT02222337|Lombardi Comprehensive Cancer Center, Georgetown University|Kristi Graves, PhD|202-687-1591|Kristi.Graves@georgetown.edu|
21250415|NCT00187135|St. Jude Children's Research Hospital|Doralina Anghelescu, MD|866-278-5833|referralinfo@stjude.org|
21250416|NCT00999141|Baxter Innovations, GmbH|Edith Hantak, DVM, Dir, Global Therapeutic Area, BioSurgery||edith_hantak@baxter.com|
21250417|NCT05562583|Northwestern University|Judith Tedlie Moskowitz|312-503-7712|judith.moskowitz@northwestern.edu|
21250418|NCT02046941|VANCHCS|Juliana Baldo|925-372-4649|juliana.baldo@va.gov|
21250419|NCT00745121|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
21250420|NCT03280108|Alcon Research|Expert Clinical Project Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21250421|NCT01187407|Eli Lilly and Company|Chief Medical Officer|800-545-597||
21250422|NCT02996097|Johns Hopkins School of Medicine|Dr. Ginette Okoye|9142158980|ginette.okoye@howard.edu|
21250423|NCT01820637|Boston Scientific|Lieve Cornelis, Clinical Trial Manager|+ 32 476-840-183|Lieve.Cornelis@bsci.com|
21250424|NCT02382406|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
21250425|NCT01713998|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
21250426|NCT00640042|King Pharmaceuticals, Inc.|Professional Information Services|1-800-776-3637||
21250427|NCT02391116|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21250428|NCT02694198|Ain Shams Maternity hospital|amr ahmed mahmoud riad|01005347179|amr.riad@med.asu.edu.eg|+2
21250429|NCT00607789|Lindner Center of HOPE|Susan McElroy, MD|513-536-0718|susan.mcelroy@lindnercenter.org|
21250430|NCT00006099|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21250431|NCT06016127|Albany Saratoga Centers for Pain Management|Kasandra Cliff|518-371-6772|khopkins@northwayspc.com|
21250432|NCT02264353|University of California, San Diego|Atul Malhotra, MD|(858) 657-6159|amalhotra@ucsd.edu|
21295600|NCT02124512|University of Kentucky|Philip Kern|859-323-2232|pake222@uky.edu|
21264619|NCT02938052|Massachusetts General Hospital|Dr. Christopher Celano|617-726-6485|ccelano@partners.org|
21264620|NCT03076190|Stanford University|Dr. Beth Darnall|6507365494|bdarnall@stanford.edu|
21264621|NCT00393913|NYU School o Medicine|Indu Ayappa, PhD|2125628437|indu.ayappa@nyumc.org|
21264622|NCT00594204|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21264623|NCT00567541|Bioness|Keith McBride, CTO|661-362-4866|Keith.McBride@bioness.com|
21264624|NCT01529385|Center for Lower Extremity Ambulatory Research|Ryan Crews, Clinical Scientist|847-578-8437|ryan.crews@rosalindfranklin.edu|
21264625|NCT01401465|Sunovion|Respiratory Medical Director|1-866-503-6351||
21264626|NCT01115738|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21264627|NCT00413335|Yale University School of Medicine|Dr. Sonia Caprio, Principal Investigator|203-785-5692|Sonia.Caprio@yale.edu|
21264628|NCT04009213|Advanced Medical Solutions|Tina Warburton, Senior Clinical Research Associate|07791742957|tina.warburton@admedsol.com|
21264629|NCT00772382|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21264630|NCT01709981|NYU Langone Health|Dr. Binita Shah|212-263-6631|Binita.Shah@nyulangone.org|
21264631|NCT06076148|Topmed|Edith Martin|418 683-2104|emartin@topmed.ca|1302
21264632|NCT05691829|NYU Langone Health|Fraustina Hsu|646-754-7124|Fraustina.Hsu@nyulangone.org|
21264633|NCT01297309|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21264634|NCT01804257|Zucker Hillside Hospital, Glen Oaks, NY|John M. Kane MD|(718) 470-8141|psychiatry@nshs.edu|
21264635|NCT04055467|Johns Hopkins School of Medicine|Dr. Elise Weerts, Professor|410-550-2781|eweerts@jhmi.edu|
21264636|NCT00609804|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21264637|NCT04847141|Sr Manager, Clinical Research, Scientific Innovation Office (SIO)|Mireia Torres|+34 93 5710500|mireia.torres@grifols.com|
21264638|NCT01807091|University of Washington|Elihu Estey, MD|206-606-6744|eestey@seattlecca.org|
21264639|NCT02427750|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
21264640|NCT04578015|The Ohio State University|Kartik Venkatesh, MD, PhD|614-293-2222|kartik.venkatesh@osumc.edu|
21264641|NCT03472040|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
21264642|NCT02769832|University of Iowa, Holden Comprehensive Cancer Center|Muhammad Furqan, MD|319-356-1527|muhammad-furqan@uiowa.edu|
21264643|NCT00225147|Pharming Technologies BV|Medical Affairs Department|+31715247400|medicalinfo@pharming.com|
21264644|NCT03532776|Dermax|Chauvel Virginie|+32 488 07 04 18|chauvelvirginie07@gmail.com|
21264645|NCT00193219|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net|
21295601|NCT02961946|Massachusetts General Hospital|Dr. Brian Ghoshhajra|617-726-5954|BGHOSHHAJRA@mgh.harvard.edu|
21295602|NCT05039671|Yale University|Dr. Elizabeth Connors|12038150685|elizabeth.connors@yale.edu|
21295603|NCT01987219|NYU School of Medicine|Dr. Horacio Kaufmann|212 263 7225|horacio.kaufmann@nyumc.org|
21295604|NCT02317809|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21295605|NCT00953524|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21250433|NCT04896502|Arkansas Children's Hospital|Robbie Pesek, MD|501-364-3149|rdpesek@uams.edu|
21250434|NCT03340766|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21250435|NCT00853021|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@ccf.org|
21250436|NCT02864147|Clinical Research Team Leader, Gynecologic Oncology, Yale Cancer Center|Alessandro Santin, MD|(203) 200-4176|alessandro.santin@yale.edu|
21250437|NCT02269917|Janssen Research & Development|Medical Officer|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21250438|NCT00240097|UAB|Dr. Francisco Robert|205-934-5077|pacorobertuab@cs.com|
21250439|NCT01518517|Erytech Pharma|Anne-Sophie Clermont|+33 4 78 78 15 70|anne-sophie.clermont@erytech.com|
21250440|NCT00981578|InSightec|Nadir Alikacem|214.360.2000|nadira@insightec.com|
21250441|NCT03427177|Fox Chase Cancer Center|Dr. Linda Fleisher|215-214-3757|Linda.Fleisher@fccc.edu|
21250442|NCT01294358|National Cancer Institute|Dr. Udo Rudloff|301-496-3098|udo_rudloff@nih.gov|
21250443|NCT02963922|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21250444|NCT02150109|Ascensia Diabetes Care|Jane Wallace, Deputy Director Clinical Trials|574-257-3063|jane.wallace@ascensia.com|
21250445|NCT02181400|Sydney Eye Hospital|Maria Willilams|02 9382 7309|maria.williams@sydney.edu.au|
21250446|NCT04374019|University of Kentucky|Susanne Arnold MD|8592579568|smarno0@uky.edu|
21250447|NCT01239056|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu|
21250448|NCT01180790|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
21250449|NCT00655668|Celgene|Associate Director, Clinical Trial Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21250450|NCT02335242|Stanford University|Jean Teng, MD, PhD|(650) 724-9627|jteng3@stanford.edu|
21250451|NCT03840148|Venatorx Pharmaceuticals, Inc.|Paul McGovern, MD|484-329-8615|mcgovern@venatorx.com|
21250452|NCT03615404|Duke University Medical Center|Principal Investigator|919-684-0000|pedsneuronc@duke.edu|
21250453|NCT00257556|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21250454|NCT03873038|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21250455|NCT01074034|Boston Scientific|Elke Sommerijns|+32 479 76 71 56|elke.sommerijns@bsci.com|
21250456|NCT04222088|Research Institute for Tropical Medicine|Dr. Fe Esperanza Caridad J. Espino|63288072628|fe.espino2019@gmail.com|343
21250457|NCT00595764|Yale University|Dr. David Fiellin|203-737-3347|david.fiellin@yale.edu|
21264646|NCT01114373|Emory University|Frederic Rahbari-Oskoui, Associate Professor of Medicine|404-727-3425|frahbar@emory.edu|
21264647|NCT00868166|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21295606|NCT06239441|Hôpital du Sacre Coeur de Montreal|Catherine Lemiere|514 338 2492|catherine.lemiere@umontreal.ca|
21264648|NCT00240539|GlaxoSmithKline|GSK Response Center|866-435-7343||
21264649|NCT03819218|MC2 Therapeutics|Irene Sandholdt|+45 2015 7033|isa@mc2therapeutics.com|
21264650|NCT03728504|Libertas BioSciences|Niranjan Rao|908-872-1133|niranjan@libertasbiosciences.com|
21264651|NCT02197897|Baylor College of Medicine|Dr. Guilherme Godoy|713-798-4001|godoy@bcm.edu|
21264652|NCT02501902|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21264653|NCT02267278|The University of Texas MD Anderson Cancer Center|Srdan Verstovsek, MD/Professor|713-745-3429|sverstov@mdanderson.org|
21264654|NCT02513771|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21264655|NCT00650091|Duke Clinical Research Institute|Kevin J Anstrom|919-668-8902|kevin.anstrom@duke.edu|
21264656|NCT01204697|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21264657|NCT01147406|N30 Pharmaceuticals Inc.|Janice M Troha|720-945-7714|janice.troha@n30pharma.com|
21264658|NCT04655703|Northwell Health System|Eugene S. Krauss|516-496-2637|ekrauss@northwell.edu|
21264659|NCT03939637|Baylor College of Medicine/ Texas Children's Hospital|Amanda Grimes|832-822-4217|abgrimes@texaschildrens.org|
21264660|NCT04268004|Nationwide Children's Hospital|Leena Nahata|6147224502|leena.nahata@nationwidechildrens.org|
21264661|NCT04724733|Washington State University College of Nursing|Julie Postma, Professor, Associate Dean for Research|509-324-7287|jpostma@wsu.edu|
21264662|NCT03372603|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21264663|NCT03341923|Alcon Japan, Ltd.|Group Manager, Vision Care|+81.3.6899.5061|alcon.medinfo@alcon.com|
21264664|NCT00844649|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21264665|NCT00168064|Yaupon Therapeutics|H. Jeffrey Wilkins, MD|4843247935|hjwilkins@yaupontherapeutics.com|935
21264666|NCT00082329|NHLBI NIH|Dr. Richard Childs|301-594-8008|childsr@nhlbi.nih.gov|
21264667|NCT00589979|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator|Use e-mail contact|clinicalsite.inquiries@endo.com|
21264668|NCT01153841|GlaxoSmithKline|GSK Response Center|866-435-7343||
21264669|NCT03373110|Massachusetts General Hospital|Dr. Andrew Nierenberg|617-512-2641|anierenberg@mgh.harvard.edu|
21264670|NCT00830804|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21264671|NCT00779311|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
21264672|NCT03428997|Johnson & Johnson Consumer Inc.|Heather Smith|(908) 874-1235|HSmith21@its.jnj.com|
21264673|NCT05506969|Dynavax Technologies|Ouzama Henry, MD|617-686-4796|ohenry@dynavax.com|
21264674|NCT00510068|Novartis Pharmaceuticals|Study Director|862-778-8300||
21264675|NCT01397448|Eisai Co., Ltd.|Nobuyuki Sugisaki|+81-3-3817-3908||3908
21264676|NCT03452891|University of Nebraska Medical Center|Amy C Killeen|402-479-6205|akilleen@unmc.edu|
21264677|NCT03482141|University of California, San Francisco|Mary Norton|(415) 467 4080|mary.norton@ucsf.edu|
21264678|NCT03483116|Murdoch Children's Research Institute|Professor Julie Bines|+61 3 9345 5522|julie.bines@mcri.edu.au|
21264679|NCT01315002|University Hospital Bonn, Department of Psychiatry and Psychotherapy|Prof. Dr. Michael Wagner|004922828716377|michael.wagner@uni-bonn.de|
21264680|NCT03438578|St Olavs Hospital|Erlend Johan Skraastad|0047 79829184|Erlend.Johan.Skraastad@stolav.no|
21264681|NCT01309841|AstraZeneca|Mark Sostek||ClinicalTrialTransparency@astrazeneca.com|
21264682|NCT04664855|Montana State University|Dr. Lauren Davis|8287736328|lauren.davis6@montana.edu|
21264683|NCT01441115|National Cancer Institute|Dr. Deborah E. Citrin|301-496-5457|citrind@mail.nih.gov|
21264684|NCT02235987|Strongbridge Biopharma|Fredric Cohen, MD|610-254-9200|f.cohen@strongbridgebio.com|
21264685|NCT01906866|Neurim Pharmaceuticals|Dr. Tali Nir|972-7684902|talin@neurim.com|
21264686|NCT01848899|NYU Langone Medical Center|Binita Shah|212-263-4235|binita.shah@nyumc.org|
21264687|NCT03180489|Colorado State University|Christopher Bell|9704917522|christopher.bell@colostate.edu|
21264688|NCT02475395|Sandstone Diagnostics|Cheif Science Officer|9253157246|gsommer@sandstonedx.com|925
21264689|NCT01086150|Albany Medical College|Charles E. Argoff, MD|518 262-0034|argoffc@mail.amc.edu|
21295607|NCT00294645|Medtronic CRDM|CRDM Clinical|800-328-2518|medtroniccrmtrials@medtronic.com|
21250458|NCT03849300|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
21250459|NCT04839289|Sonova USCS|Lisa Standaert|331-702-0173|lisa.standaert@phonak.com|
21250460|NCT01189136|Women & Infants Hospital of Rhode Island|Charles R. Rardin, MD|401 453-7560|crardin@wihri.org|
21250461|NCT00663923|Tabriz University of Medical Sciences|Mohammad R sedghipour,MD|+98 411 3306619|sedghipm@yahoo.com|
21250462|NCT02785900|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
21250463|NCT04341584|Hopital Hotel-Dieu (AP-HP)|Dr Raphael Porcher|:+33 (0)1.42.34.89.87|raphael.porcher@aphp.fr|
21250464|NCT00497198|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21250465|NCT01772147|GlaxoSmithKline|GSK Response Center|866-435-7343||
21250466|NCT01226485|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21250467|NCT00796614|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21250468|NCT00740597|City of Hope National Medical Center|Paul Frankel, Ph.D.|(626)359-8111|pfrankel@coh.org|65265
21250469|NCT00932659|Duke University|Patrick Pun, MD, MHS|919-660-6865|patrick.pun@duke.edu|
21250470|NCT00746785|The Mind Reseach Network|Kent Hutchison, Ph.D.|505-272-5028|khutchison@mrn.org|
21250471|NCT01231464|GlaxoSmithKline|GSK Response Center|866-435-7343||
21250472|NCT00993798|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
21264690|NCT01681576|Novartis|Study Director|862-778-8300||
21264691|NCT01770691|ConTIPI LTD.|Dr. Elan Ziv|972-4-627-6066|eziv@contipi.com|
21264692|NCT03543358|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21295608|NCT01975519|TRACON Pharmaceuticals Inc|Charles Theuer, Medical Monitor|8585500780|ctheuer@traconpharma.com|
21264693|NCT00178464|St. Christopher's Hospital for Children|Dr. Norma B. Lerner|215 427-5261|norma.lerner@drexelmed.edu|
21264694|NCT02260648|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21264695|NCT04093258|Johnson & Johnson Vision Care|Thomas R. Karkkainen, OD, MS, FAAO|1-800-843-2020|tkarkkai@its.jnj.com|
21264696|NCT01890512|Guidant Europe SA/NV A Boston Scientific Company|Giovanni Raciti|+39 02 26983213|giovanni.raciti@bsci.com|
21250473|NCT00957996|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|919-859-1302||
21264697|NCT02379390|Sanofi|Trial Transparency Team|800-633-1610|Us@sanofipasteur.com|1
21264698|NCT00575094|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21264699|NCT05128682|Beaumont Hosptials|Jennifer Giordano CRM|248-551-3517|jennifer.giordano@corewellhealth.org|
21264700|NCT02995330|Johns Hopkins University|"Dr. Samuel R. Denmeade Professor of Oncology| Director Genitourinary Oncology"|410-502-8341|DENMESA@jhmi.edu|
21264701|NCT02721251|VA|David Thompson|602-496-0242|david.thompson4@va.gov|
21264702|NCT05515952|University of Arizona|Lisbeth Haaheim|520-626-7755|lhaaheim@arizona.edu|
21264703|NCT02921763|Mylan EPD G.K.|Takumi Kanzo|+81-3-5656-0516|takumi.kanzo@viatris.com|
21264704|NCT03450915|BiondVax Pharmaceuticals ltd.|Chief Scientific Officer & Clinical Management|+97289302529|benyedidia@BiondVax.com|5103
21264705|NCT01740388|Valeant Pharmaceuticals|Johnson Varughese|908-541-2179|Johnson.Varughese@valeant.com|
21264706|NCT04142216|Demiroglu bilim University|Assistant Professor Nurten Ozen|+905334509382|ozenurten@yahoo.com.tr|
21264707|NCT01369212|University of Pittsburgh|Dr. Abdus Wahed|412-624-3053|wahed@pitt.edu|
21264708|NCT00862121|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
21264709|NCT01582971|Michigan State University|Dr. Gwen Wyatt|517-432-5511|gwyatt@msu.edu|
21264710|NCT02373371|CHU de Limoges|Project Manager|0555058616|abdeslam.bentaleb@chu-limoges.fr|+33
21264711|NCT01539811|Greenville Health System|Dr. David Cull|8644548295|dcull@ghs.org|
21264712|NCT00453180|Cincinnati Childrens Hospital|Craig Erickson|513-636-6258|craig.erickson@cchmc.org|
21264713|NCT00804843|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21264714|NCT03380026|Rochester Skin Lymphoma Medical Group|Clinical Research Coordinator|(585)364-1188|scarroll@roclymphoma.com|
21264715|NCT00547898|Valeant Pharmaceuticals|Johnson Varughese|9089271162|christine.hnatko@valeant.com|
21264716|NCT03326869|Eye Center of N Florida|Christina Menck|8507843937|eyenerdgyrl1@gmail.com|1124
21264717|NCT01874119|Saint Louis University|Dr. John Richart|314-577-8854|richartj@slu.edu|
21264718|NCT01002742|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
21264719|NCT00562640|Memorial Sloan Kettering Cancer Center|Dr. Roisin O'Cearbhaill, MD|646-888-4227|ocearbhr@mskcc.org|
21264720|NCT01357980|Ipsen|Medical Director Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
21264721|NCT01705964|University of Louisville|Dr. Kerry Caperell|502-629-7212|k0cape01@louisville.edu|
21264722|NCT00094835|Amgen Inc.|Study Director|866-572-6436||
21264723|NCT00278863|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
21264724|NCT00700063|Leo Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
21264725|NCT00092677|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21264726|NCT04624672|Geisinger Medical Center|Project Manager|570-214-2245|kcunningham1@geisinger.edu|
21264727|NCT03064568|UTHSCSA|Sally Kabro|210-567-4950|kabro@uthscsa.edu|
21264728|NCT03024255|Botanix Pharmaceuticals|Anthony Robinson, MS CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
21264729|NCT01415908|Medtronic Spinal and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
21264730|NCT04169113|Northwestern University|Melissa Shauver; Research Project Manager|3124726024|melissa.shauver1@nm.org|
21264731|NCT02685995|University of Pennsylvania|Gregory Nadolski, MD|(215) 662-7892|gregory.nadolski@pennmedicine.upenn.edu|
21264732|NCT01188096|Atrium Health|Donald L. Durden, MD, PhD|980-442-2048|donald.durden@atriumhealth.org|
21264733|NCT01797445|Gilead Sciences|Gilead Clinical Study Information Center||GileadClinicalTrials@gilead.com|
21264734|NCT00688545|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21264735|NCT01878097|University of Kentucky|Dr. Ann Coker|859-323-6758|ann.coker@uky.edu|
21264736|NCT04547998|AVITA|SVP Global Clinical Research|1-833-462-8482|ekirshner@avitamedical.com|
21264737|NCT01595438|AstraZeneca/ PPD|Gayan Makumburage|9105588682|gayan.makumburage@ppdi.com|
21250474|NCT02983877|Case Western Reserve University|Dr. Jennifer Levin|2168445057|jennifer.levin@uhhospitals.org|
21250475|NCT02503982|Schneider Children's Medical Center of Israel|Dr. Liat Ashkenazi-Hoffnung|972-3-9253681|LiatA3@clalit.org.il|
21250476|NCT00970320|Ostfold Hospital Trust|Dr Hege Hølmo Johannessen|+4799721345|hege.holmo.johannessen@so-hf.no|
21250477|NCT00381797|St. Jude Children's Research Hospital|Shengjie Wu|(901) 595-2859|shengjie.wu@stjude.org|
21250478|NCT00684203|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21250479|NCT01709123|Louisiana State University Health Science Shreveport|Sushil K. Jain, PhD|318.675.6086|sushil.jain@lsuhs.edu|
21250480|NCT01902381|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-713-5440|bpowell@wakehealth.edu|
21250481|NCT00791102|University of Chicago|Robert Naclerio, MD|773-702-0080|rnacleri@surgery.bsd.uchicago.edu|
21250482|NCT00387959|Memorial Sloan Kettering Cancer Center|Dr. Juliet Barker|212-639-3468|barkerj@mskcc.org|
21250483|NCT03897049|dfusion, Inc|Tamara Kuhn, Vice President & Research Scientist|831-222-5003|tamara.kuhn@dfusioninc.com|
21264738|NCT02236273|Columbia University|Melissa Stockwell|2123425732|mss2112@cumc.columbia.edu|
21264739|NCT02487277|University of California, San Francisco|Dr. Andrew Ko|(415) 353-7286|Andrew.Ko@ucsf.edu|
21264740|NCT03617913|Mayo Clinic|Parminder Singh, MD|5072555123|Singh.Parminder@mayo.edu|
21264741|NCT03783442|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
21295609|NCT01994863|Coloplast A/S|Director Clinical Affairs||dkdac@coloplast.com|
21295610|NCT03784846|Pacific University|Michael Christopher, Ph.D.|503-352-2498|mchristopher@pacificu.edu|
21295611|NCT00867087|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21295612|NCT00570037|Duke University Medical Center|Emmanuel Walter MD, Principal Investigator|919-620-5374|walte002@mc.duke.edu|
21295613|NCT04612842|Oregon Health & Science University|Dr. Hiroko Kiyoshi-Teo (Assistant Professor)|5034943858|kiyoshi@ohsu.edu|
21295614|NCT02419131|Massachusetts General Hospital, Harvard Medical School|Dr. Tim Houle|617-724-2111|thoule1@mgh.harvard.edu|
21295615|NCT03060512|AstraZeneca Pharmaceutical LP|Catherine J. Datto, MD, MS, Movantik Medical Head, USMA|+1 302 885 1180|Information.Center@astrazeneca.com|
21295616|NCT00089986|GlaxoSmithKline|GSK Response Center|866-435-7343||
21295617|NCT03946124|University of Pennsylvania|Dr. Lily Arya|215-662-3230|larya@pennmedicine.upenn.edu|
21295618|NCT02370004|Brigham and Women's Hospital|Dr. Elliot Israel|6177328201|eisrael@partners.org|
21250484|NCT03972137|Rutgers, The State University of New Jersey|Dr. Teresa Leyro|848-445-2090|tml124@psych.rutgers.edu|
21250485|NCT00498433|Novartis Pharmaceuticals|Study Director|862-778-8300||
21250486|NCT00922441|Boryung Pharmaceutical|Manager of Clinical Research|+82-2-708-8069|rainbowleo@boryung.co.kr|
21250487|NCT01885936|Duke University|Dwight Koeberl, M.D., Ph.D.|919-681-9919|dwight.koeberl@duke.edu|
21250488|NCT00317603|Mass General Brigham|Beth Overmoyer|617 632 3800|Beth_Overmoyer@DFCI.HARVARD.EDU|
21250489|NCT00523549|Novartis Pharmaceuticals|Study Director|862-778-8300||
21250490|NCT02487251|Michigan State University|Holly E. Brophy-Herb, PI|517-355-3397|hbrophy@msu.edu|
21250491|NCT00321321|Gentofte Hospital, University of Copenhagen|Dr. Kasper Aaboe|+4539978474|Kasper@dadlnet.dk|
21250492|NCT00439647|Novartis Pharmaceuticals|Novartis Study Director|862-778-8300||
21250493|NCT00843115|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21250494|NCT02845375|Leiden University Medical Center|Dr Albert Dahan|+31715262301|a.dahan@lumc.nl|
21250495|NCT00397020|UCSD Medical Center|Dr. David Feifel|619-543-2485|dfeifel@ucsd.edu|
21250496|NCT00735462|Graceway Pharmaceuticals|Robert Babilon, Vice President, Product Development|267-948-0400|robert.babilon@gracewaypharma.com|20428
21250497|NCT04970381|Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College|Prof. Yan Liang|+8618801287180|fwyy2803@163.com|
21250498|NCT00677092|University of Massachusetts Medical School|Jonathan Kay, MD|508-793-6936|jonathan.kay@umassmemorial.org|
21250499|NCT01656486|Carolinas Medical Center|David Iannitti, MD|704-446-2772|david.iannitti@carolinashealthcare.org|
21250500|NCT02460562|Faculty of Dentistry, Thammasat University|Dr. Kritirat Kiatsirirote|662-9869213-5|kkritirat@yahoo.com|7150
21250501|NCT04194541|University of Miami|Hadar Lev-Tov, MD|305-243-4472|hlevtov@med.miami.edu|
21250502|NCT02642159|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21250503|NCT01951261|Hospital Puerta de Hierro|Dra Patricia Mínguez Clemente|911916859|drapat3@gmail.com|
21250504|NCT01372202|SKCCC|Ronan Kelly, MD|443-287-0005|rkelly25@jhmi.edu|
21250505|NCT03927222|Duke University|Mustafa Khasraw, MD|919-684-5301|mustafa.khasraw@duke.edu|
21250506|NCT03690284|University of Texas Southwestern|Clinical Research Coordinator|3106127741|matthew.oh@utsouthwestern.edu|
21250507|NCT04098497|University of Wisconsin - Madison|Amy Cochran|(608) 262-0772|cochran4@wisc.edu|
21250508|NCT03723915|Northwestern University, Feinberg School of Medicine|Devalingam Mahalingam MD, PhD Associate Professor, Division of Hematology and Oncology|312-695-6929|mahalingam@nm.org|
21250509|NCT00297778|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21250510|NCT02201771|Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China|Dr. Yunpeng Zhu|008613816819346|zypB1014@rjh.com.cn|
21250511|NCT00583115|Indiana University|Ronald Mark Payne MD|317-278-6329|rpayne@iu.edu|
21250512|NCT03569475|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21250513|NCT00549042|Covidien|Alfredo Bozzini, MD|314-654-2000|Alfredo.Bozzini@covidien.com|
21250514|NCT03039088|Rheumatology department, Cochin Hospital, APHP|Doctor Anna MOLTO|0158412617|anna.molto@aphp.fr|
21250515|NCT01212484|NYU Medical Center|Horacio Kaufmann, MD; director of Dysautonomia Center|212 263 7225|horacio.kaufmann@nyumc.org|
21250516|NCT02383927|Kura Oncology, Inc.|Clinical Operations|+1 617-588-3755|KO-TIP-001@kuraoncology.com|
21250517|NCT00734851|DukeUMC|Andrew J. Armstrong, MD ScM FACP|(919) 668-8797|andrew.armstrong@duke.edu|
21250518|NCT01393314|Case Western Reserve University|Research Compliance Officer|216-368-0134|kav6@case.edu|
21250519|NCT03613454|University of Alabama at Birmingham|Dr. AJ Gunn|205-975-4850|agunn@uabmc.edu|
21250520|NCT00585910|Massachusetts General Hospital|Kerry Brodziak|617-503-1043|kbrodziak@partners.org|
21250521|NCT00464737|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
21250522|NCT01350388|University of Utah|Srinivasan Beddhu, M.D.|801-585-3810|srinivansan.beddhu@hsc.utah.edu|
21250523|NCT01894256|AstraZeneca|Dr Anitra Fielding|+44 1625 582828|anitra.fielding@astrazeneca.com|
21250524|NCT01780584|Pediatric Cardiac ICU National Cardiovascular Center Harapan Kita|Dr Eva M Marwali, Principal Investigator|+62215684085|evamarwali@yahoo.com|2807
21250525|NCT02825849|UCSF|Heather Huddleston|415-353-3040|heather.huddleston@ucsf.edu|
21250526|NCT00546884|University of Minnesota|John Song MD MPH MAT|612-624-8936|songx006@umn.edu|
21250527|NCT03249272|Duke Cardiovascular Magnetic Resonance Center|Han Kim, MD|9196683539|han.kim@duke.edu|
21250528|NCT01544153|Truth Initiative|Amanda L. Graham, PhD|202-454-5938|agraham@truthinitiative.org|
21250529|NCT02127892|Children's Hospital Los Angeles|Neena Kapoor, M.D.|323-361-2546|nkapoor@chla.usc.edu|
21250530|NCT00390806|GlaxoSmithKline|GSK Response Center|866-435-7343||
21250531|NCT01879735|Dept. of Nuclear Medicine & PET-center, Dept. of Hepatology and Gastroenterolgy. Aarhus University Hospital|Susanne Keiding M.D., Associate professor, D.Sc.|+45 7846 3031|susanne@pet.auh.dk|
21264742|NCT00973622|University of Arkansas for Medical Sciences|Christine Sheffer, PhD|212 650 6860|csheffer@med.cuny.edu|
21264743|NCT00171314|Novartis Pharamaceuticals|Novartis Pharmaceuticals|862-778-8300||
21264744|NCT02855450|Dompè|Flavio Mantelli, MD, PhD|+39 02583831|info@dompe.com|
21264745|NCT01996904|CM Chungmu Hospital|Sang-Hoon Lhee|+82(2)2068/4525|cmirb@naver.com|
21264746|NCT00756496|Siemens Medical Solutions USA, Inc.|Milind Dhamankar|+1 (610) 448-6467|milind.dhamankar@siemens-healthineers.com|
21264747|NCT00585923|Biomet|Jacquelyn Hughes|973-299-9300|jacquelyn.hughes@biomet.com|3075
21264748|NCT00878215|Washington University School of Medicine|William C. Chapman, M.D.|314-362-7792|chapmanw@wustl.edu|
21264749|NCT02815293|Allergan, Inc.|Therapeutic Area Head|877-277-8566|clinicaltrials@allergan.com|
21264750|NCT03001843|University of Florida|Joshua Sappenfield, MD|352-273-5259|jsappenfield@anest.ufl.edu|
21264751|NCT00321269|Iowa City VA Health Care System|Carolyn Turvey|319 338 0581|Carolyn-Turvey@uiowa.edu|7714
21264752|NCT00805545|University of Florida|Patrick Duff, M.D.|352 273 7673|duffp@ufl.edu|
21264753|NCT01583452|ITESM - Pediatrics Division|Gabriela López Jaimez|+527211476044|gabylopez7@gmail.com|
21264754|NCT00986427|Columbia University Dept of Dermatology|Julian Mackay-Wiggan, MD|212-305-6953|jc299@columbia.edu|
21264755|NCT01606735|Icon Bioscience, Inc|Wendy Murahashi, MD|6503694049|wendymurahashi@iconbioscience.com|
21264756|NCT00643604|United Therapeutics Corporation|Remodulin Program Leader|919-485-8350|clinicalrecordsmanagement@unither.com|
21264757|NCT02007954|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
21264758|NCT03095053|Antalya IVF|Kevin Coetzee|090 530 764 3135|kevincoetzee61@yahoo.co.nz|
21264759|NCT02659605|The University of Texas Health Science Center at Houston|Dr. Pamela D. Berens|(713) 500-6471|Pamela.D.Berens@uth.tmc.edu|
21264760|NCT01641991|Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center|David Bernstein, MD, MA|513-636-7625|david.bernstein@cchmc.org|
21264761|NCT01054976|Jan-Cil Korea|Business Unit Director|82 2 2094-4537||
21264762|NCT01929473|IROM CS Co., Ltd.|Tsutomu Takeda|+81-92-738-0500|tsutomu-takeda@irom-cs.co.jp|
21264763|NCT01195363|UTHSCSA|Charles L Bowden, MD|210-567-5393|BowdenC@uthscsa.edu|
21264764|NCT01589510|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21264765|NCT01763866|Amgen Inc.|Study Director|866-572-6436||
21264766|NCT05055570|Department of Anesthesiology, Beijing Anzhen Hospital, Capital Medical University|Dr. Jun Ma|13370103671|majun@mail.ccmu.edu.cn|
21264767|NCT02396342|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
21264768|NCT00895193|University of Kansas Medical Center|Julie-Ann Dutton, MS, RD|(913) 588-4064|jdutton@kumc.edu|
21264769|NCT00750165|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 9 574 0123|cpaptrial@fphcare.co.nz|7044
21264770|NCT01164865|Alcon Global Medical Affairs|Jami Kern, Ph.D.|1-888-451-3937||
21264771|NCT00475540|MedStar Health Research Institute|Allie Moses, Manager, Clinical Research Systems and Recruitment Center|301-560-7353|Allison.E.Moses@MedStar.net|
21264772|NCT00377429|Fresenius Biotech|Anne Kuan|781 699 4618|anne.kuan@fresenius-biotech.com|
21264773|NCT02618343|UT Health San Antonio|David Wampler, PhD, LP|210-414-9548|wamplerd@uthscsa.edu|
21264774|NCT02394795|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21264775|NCT05202223|University of Kentucky|Dr. Elizabeth Rhodus|859-257-5562|elizabeth.rhodus@uky.edu|
21264776|NCT01669811|Clinical Statistics & Programming Department, Clinical Science Division, R&D, AstraZeneca Japan|Masahiro Nii||Masahiro.Nii@astrazeneca.com|
21264777|NCT03288493|Poseida Therapeutics|Rajesh Belani, MD, Vice President Clinical Development|858-779-3100|rbelani@poseida.com|
21264778|NCT01871896|University of California San Francisco|Matthew Lin|415 353 2161|Matthew.Lin@ucsf.edu|
21264779|NCT02415439|ReveraGen BioPharma, Inc.|Eric P. Hoffman, PhD|301-962-1578|eric.hoffman@reveragen.com|
21264780|NCT05263921|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21264781|NCT04327518|Johnson & Johnson Surgical Vision|Director of Clinical Science, Ophthalmic Implants|7142478200|EThoma39@its.jnj.com|
21264782|NCT01966263|Sint Maartenskliniek Nijmegen|Dr Maaike Fenten|31243659111|m.fenten@maartenskliniek.nl|2941
21264783|NCT02670928|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21264784|NCT02678312|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21264785|NCT00656084|New York Oncology Hematology|Dr. Lawrence E. Garbo|(518) 489-0044|Lawrence.Garbo@usoncology.com|
21264786|NCT01184456|AIDS Healthcare Foundation - Public Health Division|Adam Sukhija-Cohen|(323) 436-8900|adam.cohen@aidshealth.org|
21264787|NCT00525785|The University of Texas (UT) MD Anderson Cancer Center|Dr. Jaffer Ajani, MD / Professor, GI Medical Oncology|713-792-2828|jajani@mdanderson.org|
21264788|NCT04507776|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21264789|NCT00393068|Sarah Cannon Research Institute|Johanna C. Bendell, MD|615-329-7274|jbendell@tnonc.com|
21264790|NCT00387348|Massachusetts General Hospital|William F Pirl, MD|617-724-9151|wpirl@partners.org|
21264791|NCT03628599|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21264792|NCT01136746|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21264793|NCT00834886|University of Bergen|Dr. Bjørn Bjorvatn|55586130|bjorn.bjorvatn@igs.uib.no|
21264794|NCT00873288|Northwestern University|Bonnie Spring|312-908-2293|bspring@northwestern.edu|
21264795|NCT03874351|MJHS Institute for Innovation in Palliative Care, New York, NY|Helena Knotkova, PhD, PhilD|646-784-2262|HKnotkov@mjhs.org|
21264796|NCT00010803|University of Virginia|Steven T. DeKosky MD|434-924-5118|SD3ZC@hscmail.mcc.virginia.edu|
21264797|NCT05905601|University of Washington / University of North Carolina at Chapel Hill|Benjamin Buck, Ph.D.|(919) 445-4330|ben.buck@med.unc.edu|
21264798|NCT01754207|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
21264799|NCT01779648|SMG-SNU Boramae Medical Center|Principal Investigator|+82-10-9988-2691|turejsreal@hanmail.net|
21295619|NCT02334683|Icahn School of Medicine at Mount Sinai|David Simpson, M.D.|(212) 241-8748|david.simpson@mssm.edu|
21295620|NCT01062841|University of Michigan|Lona Mody, MD, MSc|734-764-8942|lonamody@umich.edu|
21250532|NCT00884793|UCSF|Steven Yukl|415-221-4810|steven.yukl@ucsf.edu|3930
21250533|NCT03169530|Beth Israel Deaconess Medical Center|Kenneth Mukamal, MD, MPH|617 754-1401|kmukamal@bidmc.harvard.edu|
21250534|NCT04783519|University of Washington|Mary Larimer|(206) 543-3513|larimer@uw.edu|
21250535|NCT01032200|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
21250536|NCT00067808|The University of Texas M. D. Anderson Cancer Center|Hagop Kantarjian, MD / Professor|713-792-7026||
21250537|NCT00727259|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21250538|NCT01021683|Clinical Research Team, Medical Affairs, Medical Dept. Janssen Korea|Clinical Research Associate|+82-2-2094-4879||
21250539|NCT02273180|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21295621|NCT02046174|The Rogosin Institute|Betty-Jane Sloan, Clinical Research Manager|646-317-0701|bjsloan@nyp.org|
21250540|NCT00645099|Janssen-Cilag Germany|EMEA Therapeutic Area Leader CNS|+492137955153||
21250541|NCT01201915|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
21250542|NCT00966641|PLx Pharma|Ronald Zimmerman|1-713-842-1249|ron.zimmerman@plxpharma.com|205
21250543|NCT02316171|Viralytics|Mark Grose|+1 905 593 2891|Mark.Grose@viralytics.com|
21250544|NCT04130061|University of Utah|Vikas Sharma, MD|801-581-5311|vikas.sharma@hsc.utah.edu|
21250545|NCT02270463|Stemline Therapeutics, Inc.|Ira Gupta, MD, Senior Vice President, Clinical Development & Medical Affairs - Hematology|1-877-332-7967|clinicaltrials@menarinistemline.com|
21250546|NCT04990973|Columbia University Irving Medical Center|Dr. Marie-Pierre St-Onge|212-305-9379|ms2554@cumc.columbia.edu|
21250547|NCT03449134|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21250548|NCT02916706|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please e-mail|cti-inq-ml@ml.mt-pharma.co.jp|
21250549|NCT01093599|University of Wisconsin|James M. Davis MD, Assistant Professor, Duke University|608-217-9405|jjamesdavis@hotmail.com|
21250550|NCT01703845|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21250551|NCT00719212|Translational Research In Oncology (formerly CIRG)|Matthieu Rupin|+33 (1) 58 10 08 89|matthieu.rupin@trioncology.org|
21250552|NCT00526097|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21250553|NCT00966979|Stryker Orthopaedics|Stryker JR Clinical Research|201-831-5000|StrykerJRClinical@stryker.com|
21250554|NCT01318317|City of Hope|Dr. Lwaliw Popplewell|626-359-8111|lpopplewell@coh.org|
21250555|NCT00943618|UT MD Anderson Cancer Center|Paul M. Cinciripini, BS,MS,PHD/Chair, Behavioral Science|(713) 745-1868|pcinciri@mdanderson.org|
21250556|NCT06142578|Kylane Laboratoires|Basste Hadjab, Sponsor|0225889611|compliance@kylane.com|
21250557|NCT03713281|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
21250558|NCT05566886|Corsano Health B.V.|Clinical Research Manager|+31 61 640 7778|info@corsano.com|
21250559|NCT01990313|Stanford University|Chioma Anidi|6507236709|chioma.anidi@stanford.edu|
21250560|NCT02412111|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21250561|NCT00837096|Acelity|VP, Global Clinical Affairs|210-255-5595|jane.hart@acelity.com|
21250562|NCT00329550|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
21250563|NCT00494026|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21250564|NCT05153499|Finch Therapeutics|CEO|617-229-6499|info@finchtherapeutics.com|
21250565|NCT05786521|University of Texas Health Science Center San Antonio|TIffany M Cortes, MD|210-450-3333|cortest@uthscsa.edu|
21250566|NCT05109117|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
21250567|NCT02747121|Helsetilsynet|Dr Einar Hovlid|+4721529900|eho@helsetilsynet.no|
21250568|NCT03168425|Vanderbilt University Medical Center|Sarah Osmundson, MD|+1 (615) 343-5700|sarah.osmundson@vumc.org|
21250569|NCT01960114|McNeil Consumer Healthcare|Rajesh Mishra, MD, PhD/Vice President, Medical/Clinical Affairs, Global OTC|215-273-8569 USA EST|rmishr16@its.jnj.com|
21250570|NCT00902226|H. Lundbeck A/S|Study Director|email contact via|LundbeckClinicalTrials@lundbeck.com|Lundbeck
21250571|NCT02685007|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21250572|NCT00468858|GSK|Faina Rose, PhD|610-664-8986|faina.v.rose@gsk.com|
21250573|NCT00543101|Community Research Initiative of New England (CRINE)|Clavin Cohen MD|617 502 1700|ccohen@crine.org|
21250574|NCT03214250|Parker Institute for Cancer Immunotherapy|Ute Dugan|203-379-6757|udugan@parkerici.org|
21250575|NCT00427778|Queen's University|Dr Marie-Andree Harvey|613-548-6115|harveym@queensu.ca|
21250576|NCT00225277|Takeda Global Research and Development Center Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
21250577|NCT03432650|Hospital for Special Surgery, Anesthesiology|Dr. Stephen Haskins|212-606-1036|haskinss@hss.edu|
21250578|NCT01177137|Center for Clinical Trials and Evidence Synthesis, Johns Hopkins Bloomberg School of Public Health|Roberta W. Scherer, Director Data Coordinating Center|410 502 4636|rschere1@jhu.edu|
21250579|NCT03455218|Medical College of Wisconsin|Robert Niebler, MD|4142663360|rniebler@mcw.edu|
21250580|NCT01287416|University of Manitoba|Shay-Lee Bolton|204-787-5082|sbolton@hsc.mb.ca|
21250581|NCT02109107|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
21295622|NCT01187004|UTurin|Dr Daniela Pasero|00390116335511|daniela.pasero@unito.it|
21250582|NCT03697083|University of Pennsylvania|Katherine K. Milkman Ph.D.|215-573-9646|kmilkman@wharton.upenn.edu|
21295623|NCT00145418|Oncology Specialists, S.C.|Chadi Nabhan, MD|847-268-8200|cnabhan@oncmed.net|
21295624|NCT00413920|Novartis Pharmaceuticals|Study Director|862-778-8300||
21295625|NCT03831880|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21250583|NCT01643902|Johns Hopkins University School of Medicine|Victor C. Urrutia|410-955-2228|vurruti1@jhmi.edu|
21264800|NCT02384395|University of North Carolina at Chapel Hill|Cynthia Gay, MD, MPH|919-966-6712|cynthia_gay@med.unc.edu|
21264801|NCT00756678|Allergan, Inc|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
21264802|NCT00985738|University of Colorado Hospital|Dr. Al Baha Barqawi|303-724-2722|AL.BARQAWI@UCDENVER.EDU|
21264803|NCT02119026|Medical University Vienna, Internal Med. I, Dep. of Oncology|Werner Scheithauer, MD|+43 1 40400|werner.scheithauer@meduniwien.ac.at|54620
21264804|NCT00109005|National Cancer Institute, National Institutes of Health|Caryn Steakley|301-435-3685|steaklec@mail.nih.gov|
21264805|NCT00340834|Novartis Pharmaceuticals|Study Director|862-778-8300||
21264806|NCT00291499|IBSA Institut biochimique|Project Leader|0041 58360100|rd@ibsa.ch|
21264807|NCT02786836|UT Southwestern Medical Center at Dallas|William M. Lee, MD|(214) 645-6110|William.Lee@UTSouthwestern.edu|
21264808|NCT01143714|Healthpoint, Ltd.|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|817-302-3914|jaime.dickerson@healthpoint.com|
21264809|NCT02849184|Jichi Medical University School of Medicine|Professor Kazuomi Kario|+81-285-58-7538|kkario@jichi.ac.jp|
21264810|NCT04426890|Celltrion. Inc|Yunju Bae/Head of Clinical Planning 1 Department|+82 32 850 4160|Yunju.bae@celltrion.com|
21264811|NCT01803854|Department of Veterans Affiairs, Office of Research and Development|Dr. Christina D. Williams, Acting Director of Cooperative Studies Program Epidemiology Center Durham|919-286-0411|christina.williams4@va.gov|175464
21264812|NCT02016898|Duke University Health System|Michael Quist, MD|718-490-7657|michael.quist@duke.edu|
21264813|NCT01381718|Children's Hospital Boston/Harvard Medical School|Nicole J. Ullrich, MD, PhD|617-355-3193|Nicole.Ullrich@childrens.harvard.edu|
21264814|NCT00365768|Columbia University Medical Center|Julia Glade-Bender, MD|212-305-3379|jg589@cumc.columbia.edu|
21264815|NCT01306032|National Cancer Institute|Dr. Alice Chen|301-435-0517|chenali@mail.nih.gov|
21264816|NCT00992186|Centocor Research & Development, Inc., PA, USA|Senior Director, Early Clinical Development Global Leader|+1-908-927-3159||
21264817|NCT02451202|Department of Anesthesiology, King Chulalongkorn Memorial Hospital|Dr. Prok Laosuwan|+66 2256 4295|plaospir@yahoo.com|
21264818|NCT02666508|UIC College of Dentistry|Kimberly Fasula RDH, MS, MPH|(312) 996-5513|kfasul1@uic.edu|
21264819|NCT01804036|University of Utah|Yoshio Nakamura, PhD|801-585-7690|yn5@utah.edu|
21264820|NCT02677220|Cochlear|Director of Clinical Research|3032647180|loneill@cochlear.com|
21264821|NCT03859960|Fatih Sultan Mehmet Education and Research Hospital|MD. Arzu Atici|+905335621208|arzususinatici@gmail.com|
21264822|NCT00830960|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21264823|NCT03074149|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21264824|NCT01519063|Yale University|Dana Cavallo, Assistant Professor|203974-7607|dana.cavallo@yale.edu|
21264825|NCT01376245|GlaxoSmithKline|GSK Response Center|866-435-7343||
21264826|NCT01170221|Cubist Pharmaceuticals, Inc.|Philippe Prokocimer, MD|858-452-0370|Philippe.Prokocimer@cubist.com|241
21264827|NCT00050960|Eisai Call Center|Eisai, Inc.|888-422-4743||
21264828|NCT00764946|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21264829|NCT02219087|OhioHealth|Sara Jordan Clinical Pharmacist for Surgery Services|614-461-8174|sara.jordan@ohiohealth.com|
21264830|NCT04311177|University of Minnesota|Christopher Tignanelli|612-626-1968|ctignane@umn.edu|
21264831|NCT01632735|Azusa Pacific University|Dr. Rachel Gonzales Castaneda|6268156000|rcastaneda@apu.edu|2744
21264832|NCT01912716|Indiana University|Dr. Evan Fogel|317-944-2816|efogel@iu.edu|
21264833|NCT02176291|University of Pittsburgh|Dr. Jordan F. Karp|412-246-6048|karpjf@upmc.edu|
21264834|NCT01969799|Cardeas Pharma|Bruce Montgomery, MD|2069713756|bruce.montgomery@cardeaspharma.com|
21264835|NCT02431468|Neurotrope BioScience, Inc.|David Crockford, Vice President, Regulatory Affairs|(973)242-0005|dcrockford@neurotropebioscience.com|
21264836|NCT01056341|Pierre Fabre Dermatologie|Dr. Jean-Jacques VOISARD - General Manager -|+33 5 63 58 88 00|jean.jacques.voisard@pierre-fabre.com|
21264837|NCT01361919|St. Michael's Hospital|Dr. Paul Dorian|416-864-5104|dorianp@smh.ca|
21264838|NCT00736580|West Virginia University|Michael Stitely, MD|304-293-1566|mstitely@hsc.wvu.edu|
21264839|NCT02227108|MedImmune LLC|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazenea.com|
21264840|NCT02486952|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21264841|NCT04111107|Tulane University|Stefan Grant, MD|504-988-5800|sgrant6@tulane.edu|
21264842|NCT03589885|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21264843|NCT03956225|Alcon Research, LLC|Sr. CDMA Project Lead, Ocular Health|1-888-451-3937|alcon.medinfo@alcon.com|
21264844|NCT02157506|Bristol-Myers Squibb International Corporation|EU Study Start-Up Unit||clinical.trials@bms.com|
21264845|NCT03448224|University of Kentucky|Dr. Jerod Stapleton|859.562.2802|jerod.stapleton@uky.edu|
21264846|NCT03103906|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21264847|NCT00764478|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21264848|NCT02763072|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
21264849|NCT02702011|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21264850|NCT02029495|Valeant Pharmaceuticals|Director of Clinical Trials|908|binu.alexander@valeant.com|
21264851|NCT03498287|Pressure Profile Systems|Clinical Trials Manager|310.641.8100|research@wrist-aid.com|
21264852|NCT02939599|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
21264853|NCT01064076|Cameron Health, Inc. a subsidiary of Boston Scientific|Michael Husby, Clinical Studies Manager|312-402-1877|michael.husby@bsci.com|
21264854|NCT00800865|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21281562|NCT03523520|University of Missouri Health Care|Dr. Kara B. Goddard|5738841605|goddardk@health.missouri.edu|
21281563|NCT03807544|Theranova|Director of Clinical Trials|14159268616|clindquist@theranova.com|
21295626|NCT01891344|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
21295627|NCT00902018|Weill Cornell Medical College|Dr James Bussel|22-746-3474|jbussel@med.cornell.edu|
21295628|NCT02969590|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
21295629|NCT01765426|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
21295630|NCT02498067|University of Chicago|Soo Young Lee|6513430045|sooyoungl@uchicago.edu|
21295631|NCT02337530|Canadian Cancer Trials Group|Lesely Seymour|6135336430|lseymour@ctg.queensu.ca|
21295632|NCT03351114|Duke University|Dr. Adela R. Cardones|9196843110|adela.cardones@duke.edu|
21295633|NCT01665430|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21295634|NCT02310230|University of Vermont Medical Center|Alexander Friend, Clinical Research Coordinator|802-847-4259|alexander.friend@uvmhealth.org|4259
21295635|NCT03249935|University of Arkansas for Medical Sciences|Jeannette Lee|501-526-6712|jylee@uams.edu|
21295636|NCT00989235|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
21295637|NCT02813668|Emory University|Dr. Mary Beth Weber|404-712-1902|mbweber@emory.edu|
21295638|NCT04662073|Stanford University|Manesha Desai, PhD|(650) 725-1946|manisha.desai@stanford.edu|
21295639|NCT01135914|Novartis Pharmaceuticals|Study Director|862-778-8300||
21295640|NCT00598078|Jazz Pharmaceuticals|Grace Wang, MD Director Clinical Development and Medical Monitor|650-496-3777||
21295641|NCT01813721|Amgen Inc.|Study Director|866-572-6436||
21295642|NCT03398265|University of Washington|Dr. Caleb Banta-Green|206-543-0937|calebbg@uw.edu|
21295643|NCT02120365|Virginia Commonwealth University|Albert Arias|8046286777|albert.arias@vcuhealth.org|
21295644|NCT00900146|Novartis Pharmaceuticals|Study Director|862-778-8300||
21295645|NCT01635764|AbbVie|Global Medical Services|800-633-9110||
21295646|NCT05590000|Abbott|Devyani Nanduri, Senior Director, Clinical & Regulatory Affairs|+16698329450|devyani.nanduri@abbott.com|
21295647|NCT00693472|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21295648|NCT02575118|NORCE|Dr. Trine Lise Lundekvam Berge|+47 56 10 72 12|trbe@norceresearch.no|
21250584|NCT00818519|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21250585|NCT04167085|David Geffen School of Medicine at UCLA|Justin P. McWilliams, MD, FSIR|(310) 267-8773|jumcwilliams@mednet.ucla.edu|
21250586|NCT00789399|Prairie Education and Research Cooperative|Chief Operating Officer|217 492 9104|jchambers@prairieresearch.com|
21250587|NCT00580047|University of Nebraska Medical Center|Lynn Mack|402-559-6208|lmack@unmc.edu|
21250588|NCT02820298|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
21250589|NCT00141271|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21250590|NCT01478256|George John MD|George John|5028949757|grjohn777@yahoo.com|
21250591|NCT01374971|Nathan Wei, MD, PA dba Arthritis Treatment Center|Nathan Wei, MD|301-694-5800|nwei@arthritistreatmentcenter.com|
21250592|NCT02154516|Smith and Nephew|Clinical Study Manager|0499905851|stephanie.rufo@smith-nephew.com|+61
21250593|NCT03406507|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|1.855.752.2356|clinicaltrials@alexion.com|
21250594|NCT02319304|University of Maryland Medical Center|Caitlin Eggleston|4103287586|caitlineggleston@umm.edu|
21250595|NCT03859622|Karl Landsteiner Institute of General Medicine|Dr.med.Gustav Kamenski|+4322832226|kamenski@aon.at|
21250596|NCT01804140|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21250597|NCT00547300|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21250598|NCT01596699|University of California, San Francisco|Dr. Christopher Dvorak, MD|(415) 476-0554|Christopher.Dvorak@ucsf.edu|
21250599|NCT02965599|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21250600|NCT01431105|UC San Diego|Adriana Tremoulet|858-246-0012|atremoulet@ucsd.edu|
21250601|NCT02946788|Timber Pharmaceuticals|Alan Mendelsohn, MD|12673004249|amendelsohn@timberpharma.com|
21250602|NCT04435522|Rhode Island Hospital|Philip Chan, M.D.|401-793-4859|philip_chan@brown.edu|
21250603|NCT02799745|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
21250604|NCT00092521|Merck Sharp & Dohme Corp.|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21250605|NCT01878383|University of Alabama at Birmingham|David Kimberlin, MD|205.638.2530|DKimberlin@peds.uab.edu|
21250606|NCT03464383|Wake Forest University School of Medicine|Heidi M. Munger Clary, MD, MPH Associate Professor of Neurology|336-716-7110|hmungerc@wakehealth.edu|
21250607|NCT00560313|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21250608|NCT03475056|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
21250609|NCT02542410|BOSTON CHILDREN'S HOSPITAL|DR. AMY DIVASTA|6173556000|amy.divasta@childrens.harvard.edu|
21250610|NCT00113269|Astellas Pharma Global Development|Senior Medical Director||clinicaltrials@us.astellas.com|
21250611|NCT00835510|Taro Pharmaceuticals|Medical Director|(914) 345-9001|medical.affairs@taro.com|6427
21250612|NCT01502306|UCSD|Principal Investigator|8583001056|szhu@ucsd.edu|
21250613|NCT01960348|Alnylam Pharmaceuticals, Inc.|Chief Medical Officer|866.330.0326|medinfo@alnylam.com|
21250614|NCT01580995|VAORD|Mary Jane Burton|6013624471|mary.burton2@va.gov|
21250615|NCT01821729|Massachusetts General Hospital|Dr. Theodore Hong|617-726-6050|TSHONG1@mgh.harvard.edu|
21250616|NCT02517528|AbbVie|Global Medical Services|800-633-9110||
21250617|NCT04298099|Baylor College of Medicine|Karla Wyatt-Thompson|8328245800|karla.wyatt@bcm.edu|
21250618|NCT00665132|Bioness|Keith McBride, CTO|661-362-4866|Keith.McBride@bioness.com|
21250619|NCT01644188|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21250620|NCT03756168|Venus Concept|Director of Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
21250621|NCT01542398|Queen's University, Belfast|Dr Paul O'Callaghan|+44 7501 43 46 32|pocallaghan02@qub.ac.uk|
21264855|NCT03154294|Avera Cancer Institute|Dr. Casey Williams|605-322-3588|Casey.Williams@avera.org|
21264856|NCT00223652|Northwestern University|David C. Mohr|312- 503-1403|d-mohr@northwestern.edu|
21264857|NCT00749268|Covidien|Jessica Carlson, Clinical Project Manager|(203) 821-4734|jessica.carlson@covidien.com|
21264858|NCT00081328|TODAY Coordinating Center at George Washington University Biostatistics Center|Dr. Kathryn Hirst, Coordinating Center PI|301-881-9260|khirst@bsc.gwu.edu|8025
21264859|NCT00093470|ECOG-ACRIN Statistical Office|Study statistician|617-632-6012||
21264860|NCT02814448|Cleveland Clinic|Dr. Miriam Cremer|216-312-0618|cremerm@ccf.org|
21264861|NCT02514772|Sandoz|Global Program Medical Director|+49 8024 476|biopharma.clinicaltrials@sandoz.com|0
21264862|NCT00877006|Teva Pharmaceuticals USA|Manager|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21264863|NCT04671342|Philips|Bill Hardy|412-874-2710|bill.hardy@philips.com|
21264864|NCT03583606|Cincinnati Children's Hospital|Paul Spearman, MD|513-636-4509|paul.spearman@cchmc.org|
21264865|NCT00817206|Veloxis Pharmaceuticals A/S|Christina Sylvest|+45 20553877|csy@veloxis.com|
21264866|NCT00126581|Dana-Farber Cancer Institute|Pasi Janne, MD, PhD||pjanne@partners.org|
21264867|NCT00793182|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical Writing|33 (0) 1 45 91 50 00|corinne.dubourdieu@guerbet-group.com|
21264868|NCT03728140|Reproductive medcine of Jinan central hospatil|Dr. bin wu|+86 053185695203|wb0538@163.com|
21264869|NCT00851253|Boston Medical Center|Dr. Minh Tam Truong|617-638-7070|Minh-Tam.Truong@bmc.org|
21264870|NCT00806078|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlmutual.com|
21264871|NCT04150562|National Cancer Institute|Dr. Kevin C. Conlon|240-858-3570|conlonkc@mail.nih.gov|
21264872|NCT00707343|Huntsman Cancer Institute|Mark Wade, Ph.D. - Compliance Officer|801-213-5746|mark.wade@hci.utah.edu|
21264873|NCT00555568|CHOIR (Center for Healthcare Organization & Implementation Research|Susan V. Eisen|781-687-2858|susan.eisen@va.gov|
21264874|NCT01588353|XIA Project, Pharmaceuticals Sales Division, Asahi Kasei Pharma Corporation|Norihiro Tateishi, Manager|+81-3-3296-3641|xia_project@om.asahi-kasei.co.jp|
21264875|NCT00493467|University of Texas (UT) MD Anderson Cancer Center|Felipe Samaniego, MD/Associate Professor, Lymphoma/Myeloma|713-563-1509|fsamaniego@mdanderson.org|
21264876|NCT01409993|Vanderbilt University Medical Center|Nancy J. Brown, M.D., Principal Investigator|6153438701|nancy.j.brown@vanderbilt.edu|
21295649|NCT02075632|GlaxoSmithKline|GSK Response Center|866-435-7343||
21295650|NCT04240093|Brown University|Jaclyn White Hughto, PhD, MPH|401-863-6580|jaclyn_hughto@brown.edu|
21295651|NCT00740714|Weill Medical College of Cornell University|M. Flint Beal, MD|212-746-6575|fbeal@med.cornell.edu|
21295652|NCT01049802|The Rehabilitation Institute of Chicago|Richard L. Harvey, MD|312-238-1000|rharvey@ric.org|
21295653|NCT04070326|Takeda|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
21295654|NCT01287377|UCSD|Dr. Shu-Hong Zhu|8583001056|szhu@ucsd.edu|
21295655|NCT01367704|Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center|Dr. Elizabeth Miller|412-692-8504|elizabeth.miller@chp.edu|
21295656|NCT01216943|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21295657|NCT02193087|Takeda|Medical Director Clinical Science, Study Official|+1-877-825-3327|trialdisclosures@takeda.com|
21295658|NCT02726880|UConn Health|Kristyn Zajac, PhD|860-679-8572|zajac@uchc.edu|
21295659|NCT00787202|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21295660|NCT02953665|Cedars-Sinai|Vicki Manoukian, Neurology Clinical Research Program Manager|310-423-5067|Vicki.Manoukian@cshs.org|
21295661|NCT00969761|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21295662|NCT00474617|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21295663|NCT01800318|University of Arkansas for Medical Sciences|Richard W. Hall, professor of pediatrics, co-director of neonatal intensive care unit|501-680-7894|HallRichardw@uams.edu|
21295664|NCT00131456|Columbia University|Dr. Frances R. Levin|212-543-5896|frl2@columbia.edu|
21295665|NCT03959982|University of Iowa|Dr. Spyridon Fortis|319-356-4419|spyridon-fortis@uiowa.edu|
21295666|NCT00664326|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21295667|NCT00262847|Gynecologic Oncology Group (GOG) Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
21295668|NCT00758589|AstraZeneca|Alison Holt||ClinicalTrialTransparency@astrazeneca.com|
21295669|NCT00387647|H. Lee Moffitt Cancer Center and Research Institute|Jeffrey Lancet, M.D.|813-745-6841|jeffrey.lancet@moffitt.org|
21295670|NCT02191605|Wayne State University, Merrill Palmer Skillman Institute|Dr. Jessica Beatty|3136642518|jbeatty@wayne.edu|
21295671|NCT03809910|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21295672|NCT04787055|Sonova US Corporate Services, LLC|Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
21295673|NCT03647267|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|drcrnet@jaeb.org|
21295674|NCT05079477|University of Pennsylvania|Dr. Laura Gibson|215-898-7093|gibla@pennmedicine.upenn.edu|
21295675|NCT04948307|Orexo US, Inc.|David Capano|9085079909|david.capano@orexo.com|
21295676|NCT03131596|Fuxing Hospital, Capital Medical University, Beijing, China|Dr. Shi Xiaoyu|+86 18618496384|petershi1990@163.com|
21295677|NCT00434356|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
21264877|NCT03688685|Cadent Therapeutics (A Novartis Company)|Cadent Therapeutics (A Novartis Company)|1-888-669-6682|Novartis.email@novartis.com|
21264878|NCT05053126|Viatris|Dik WH Ng|+44 (0)1304 626895|dik.ng@viatris.com|
21264879|NCT01803711|UConn Health Center|Jayesh Kamath MD PhD|8606796727|jkamath@uchc.edu|
21295678|NCT00734071|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21295679|NCT03654885|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21295680|NCT05275582|VA Center for Integrated Healthcare|Dr. Julie Gass|716-834-9200|julie.gass@va.gov|25429
21295681|NCT02384434|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
21250622|NCT04333732|Washington University School of Medicine in Saint Louis|Professor Michael S. Avidan|+1-(314)-273-2456|avidanm@wustl.edu|
21250623|NCT01845649|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21250624|NCT01699698|Kyushu University|Dr. Taketo Matsunaga|092-642-5444|mtaketo@surg1.med.kyushu-u.ac.jp|
21250625|NCT02028247|Baylor College of Medicine|Dr. Eric Storch|7137983579|eric.storch@bcm.edu|
21250626|NCT04140266|Hans Rosling Center for Population Health|Jen Balkus|260 616 6614|jbalkus@uw.edu|
21250627|NCT00721214|Massey Cancer Center|John M. McCarty, MD|804-828-4360|jmccarty@vcu.edu|
21264880|NCT00225212|Stanford University Medical Center|Neal Birkett, MS, RAC|650-723-6456|nbirkett@stanford.edu|
21264881|NCT05159362|Q2i, LLC|Steven Jenkins, CEO Q2i|646-660-2151|sjenkins@q2i-group.com|
21264882|NCT01335698|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21264883|NCT02171819|IVAC|Dr. Le Van Be||ivaclevanbe@gmail.com|
21264884|NCT01162304|University of Rochester|Joel Kent, MD|585-273-2972|joel_kent@urmc.rochester.edu|
21264885|NCT01315847|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21264886|NCT02940626|X4 Pharmaceuticals (merged with Arsanis)|Vice President, Clinical Operations|(857) 529-8300|rnd@x4pharma.com|
21264887|NCT01324622|DePuy Synthes|Allyson Morris|610-719-5298|amorris5@its.jnj.com|
21264888|NCT00618449|University of California, San Francisco|Julius Schachter, PhD / Emeritus Professor of Laboratory Medicine|+1 (415) 824-5115|Julius.Schachter@ucsf.edu|
21264889|NCT05127421|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21264890|NCT00138424|Collaborative Antiviral Study Group|Penelope Jester, BSN,MPH,CCRC|(205) 877-975-7280|PJester@peds.uab.edu|
21264891|NCT01802554|University of California San Diego|Brent T Mausbach, PhD|858-822-7529|BMausbach@ucsd.edu|
21264892|NCT02391350|University of Utah|Dr. Julie Fritz|8015872237|julie.fritz@utah.edu|
21264893|NCT00574496|Memorial Sloan Kettering Cancer Center|Dr. Miguel-Angel Perales, MD|646-608-3757|peralesm@mskcc.org|
21264894|NCT00413062|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21264895|NCT00006604|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
21264896|NCT03454412|International Clinic of Rehabilitation|Oleh Kachmar|+380324765200|okachmar@ic.reha.lviv.ua|
21264897|NCT01167582|Rutgers University|Jeffrey Carson|732-235-7122|jeffrey.carson@rutgers.edu|
21264898|NCT01928485|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Lee Ponsky|+1 216-844-4831|lee.ponsky@uhhospitals.org|
21264899|NCT01825655|Virginia Commonwealth University|Santhosh Kumar, MD|804-628-1605|santhosh.kumar@vcuhealth.org|
21264900|NCT00946881|STEBA Biotech|Bertrand Gaillac International Project Leader|+ 33 974197905|b.gaillac@stebabiotech.com|
21264901|NCT00293423|University of California, Davis|Dr. Orin Bloch||obloch@ucdavis.edu|
21264902|NCT04428359|BP Koirala Institute of Health Sciences|Dr. Bibisha Baaniya|9841744777|cul.bibisha@gmail.com|+977
21264903|NCT01182337|DePuy Synthes Spine|Mark Lotito|508-880-8045|Mlotito@its.jnj.com|
21264904|NCT01673191|Retinal Consultants of Arizona|Dr. Pravin Dugel|602-222-2221|PDugel@gmail.com|
21264905|NCT02407041|Galectin Therapeutics|Vice President of Regulatory Affairs|678-620-3186|horton@galectintherapeutics.com|
21264906|NCT01714817|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
21264907|NCT02486211|University of Pittsburgh|Dr. Jon Rittenberger|4126479489|rittjc@upmc.edu|
21264908|NCT04169061|Mallinckrodt|Medical Information Call Center|800-844-2830|MedInfo@mnk.com|
21264909|NCT02555657|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21264910|NCT02807363|Enteris Biopharma Inc.|Paul Shields, Ph.D|9734533520|pshields@enterisbiopharma.com|
21264911|NCT01948141|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21264912|NCT02188719|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21264913|NCT03700970|Vanderbilt university medical center|Dr. Galen Perdikis|+1 (615) 936-0198|galen.perdikis@vumc.org|
21264914|NCT01578785|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21264915|NCT00192036|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
21264916|NCT03371732|Institute Bergonie|Dr. Marion Barrault Couchouron, Coordinating Investigator|0556337805|m.barrault@bordeaux.unicancer.fr|
21264917|NCT00599027|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21264918|NCT02581982|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-713-5440|mgoodman@wakehealth.edu|
21264919|NCT02372097|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21264920|NCT02608229|Washington University School of Medicine|Kian-Huat Lim, M.D., Ph.D.|314-362-6157|kian-huat.lim@wustl.edu|
21264921|NCT00476996|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21264922|NCT00904995|The University of Texas MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-745-5783|eharrison@mdanderson.org|
21264923|NCT00675558|Columbia University Medical Center|Paul D. Berk, MD|2120-305-4491|pb2158@columbia.edu|
21264924|NCT04218799|University of Maryland School of Medicine|Dr. Mary-Claire Roghmann|410 706 0062|mroghmann@som.umaryland.edu|
21264925|NCT01476748|BWH|Dr. JI Einarsson|617-525-8582|jeinarsson@partners.org|
21264926|NCT02750267|Center for Diabetes Technology|Dr. Daniel R. Chernavvsky|4342431395|drc2v@virginia.edu|
21264927|NCT02714504|Univ Fed Rio de Janeiro|Dr Marcio Nucci|552139382463|mnucci@hucff.ufrj.br|
21295682|NCT05264116|Stryker Sustainability Solutions|Monique Ketcher|602-354-0917|monique.ketcher@stryker.com|
21250628|NCT00983905|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlmutual.com|
21250629|NCT01169636|UT MD Anderson Cancer Center|Dr. Christopher Flowers, MD/ Chair, Chair, Lymphoma-Myeloma|713-745-6095|crflowers@mdanderson.org|
21264928|NCT02392494|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21264929|NCT04152642|Procter & Gamble|Clinical Trial Manager|5136225362|combs.cs@pg.com|
21264930|NCT02443571|Blue Earth Diagnostics Ltd.|Chief Medical Officer|+44 (0) 1865 784 186|contact@blueearthdx.com|
21264931|NCT01214317|Isfahan University of medical sciences|Director of clinical trial|+983136202020|etemadifar.m@gmail.com|
21264932|NCT00587769|Mayo Clinic|Jon O. Ebbert|507-284-2511|ebbert.jon@mayo.edu|
21264933|NCT00505895|University of Texas MD Anderson Cancer Center|Muzaffar Qazilbash, MD / Professor, Stem Cell Transplantation|713-745-4371|CR_Study_Registration@mdanderson.org|
21264934|NCT05351710|Florida State University|Dr. Jesse Cougle|8506458729|cougle@psy.fsu.edu|
21264935|NCT00676793|LSU Health, Shreveport|Dr. Jerry w. McLarty, Ph.D.|(318)813-1446|jmclar@lsuhsc.edu|
21264936|NCT02133742|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21264937|NCT03479216|Derince Training and Research Hospital|Dr. Hande Aytuluk|00905336515650|handegrbz@gmail.com|
21264938|NCT00798577|Alcon Labs|Alcon Clinical|1.888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21264939|NCT05406440|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21264940|NCT01412151|Massachusetts General Hospital|Steven M. Hersch, MD, PhD|617-726-1254|hersch@helix.mgh.harvard.edu|
21264941|NCT03127852|Centre for Global eHealth Innovation|Dr. Patrick Ware|1 (416) 340 4800|Patrick.Ware@uhn.ca|4765
21264942|NCT01824693|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21264943|NCT02150213|Novartis|Study Director|862-778-8300||
21264944|NCT01175590|Bausch & Lomb Inc.|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
21264945|NCT01090102|University of California, San Francisco|Dr. Ma Somsouk|415-206-6480|somsoukma@medsfgh.ucsf.edu|
21264946|NCT01019252|Massachusetts General Hospital|Susan Sprich, Ph.D.|617-726-5991|ssprich@mgh.harvard.edu|
21264947|NCT00546429|DePuy Orthopaedics, Inc.|Sam Himden|574-372-7231|SHimden@its.jnj.com|
21264948|NCT02062398|BlueWind Medical|Amit Korner, VP Clinical Research|+972.74.7218905|amit.korner@bluewindmedical.com|
21264949|NCT03154307|Miami Neuroscience Institute|Clinical Research Administrator|17865961825|starlieb@baptisthealth.net|
21264950|NCT02227849|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21264951|NCT05859971|University of Wisconsin School of Medicine and Public Health|Heather Neuman, MD, MS, FACS|(608) 262-9060|neuman@surgery.wisc.edu|
21264952|NCT00762268|McLean Hospital|Beth Murphy MD|617-855-2297|BMurphy5@partners.org|
21264953|NCT03004976|Duke University|Emily Poehlein, MB|919-668-8473|emily.poehlein@duke.edu|
21264954|NCT01106391|Cordis Corp.|Brandy Maschhaupt, Clinical Project Manager|847-887-5744|brandy.maschhaupt@cardinalhealth.com|
21264955|NCT04190186|University of Rochester|David Huang, MD|585 275 5391|david_huang@urmc.rochester.edu|
21264956|NCT02141217|GlaxoSmithKline|GSK Response Center|866-435-7343||
21264957|NCT02505542|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21264958|NCT01899677|Zeynep Kamil Maternity and Children's Education Training Hospital|Ozge Serce (Investigator, MD)|+905323270375|ozge_serce@hotmail.com|
21264959|NCT00618995|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21264960|NCT01213264|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21264961|NCT00134017|Johns Hopkins University|Leo Luznik, MD|4105027732|luznile@jhmi.edu|
21264962|NCT01504971|ChinaPLAGH|Dr. Weifeng Wang|0086-13911952018|wangwf301@hotmail.com|
21264963|NCT00050622|Florida International University|William E. Pelham, Jr.|305-348-3002|wpelham@fiu.edu|
21264964|NCT02703987|Danone Nutricia Research|Danone Nutricia Research||register.clinicalresearchnutricia@danone.com|
21264965|NCT00936117|University of Texas (UT) MD Anderson Cancer Center|Jorge Cortes, MD/Professor, Leukemia Department|713-745-2723|CR_Study_Registration@mdanderson.org|
21264966|NCT01342952|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21264967|NCT04581863|University of Pennsylvania|Mucio Delgado, MD, Principal Investigator|215-746-8256|mucio.delgado@pennmedicine.upenn.edu|
21264968|NCT04024072|Padagis LLC|Jonathan Schwartz|929-502-7291|jonathan.schwartz@padagis.com|
21264969|NCT02494440|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
21264970|NCT01357889|GlaxoSmithKline|GSK Response Center|866-435-7343||
21264971|NCT02693691|Abbott|Dr. Marie-Elena Brett|7815283613|marieelena.brett@abbott.com|
21264972|NCT00739960|UIC|Nadera J Sweiss, MD|312-996-5723|nsweiss@uic.edu|
21264973|NCT00416312|Johns Hopkins University, School of Medicine|George Sgouros, Ph.D.|410 614 0116|gsgouros@jhmi.edu|
21264974|NCT02727660|Pearl Therapeutics, a Member of the AstraZeneca Group|Paul M. Dorinsky, MD|650-305-2600|paul.dorinsky1@astrazeneca.com|
21264975|NCT01567891|Adaptimmune|Clinical Trials Management|215-825-9302|clinicaltrials@adaptimmune.com|6302
21264976|NCT04569799|Penn State Health College of Medicine|Kathryn McGillen, M.D.|717-531-0003|kmcgillen@pennstatehealth.psu.edu|
21264977|NCT01192204|The Ohio State University|Susan R, Mallery DDS, PhD|614 292-5892|mallery.1@osu.edu|
21264978|NCT03571256|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21264979|NCT00868452|Sunovion|Medical Director, CNS|1-866-503-6351||
21264980|NCT02270684|University of Southern California|Dr Christopher Powers|3234422900|powers@usc.edu|
21264981|NCT03141372|Cleveland Clinic Florida|Sara Farag, Fellow in Minimally Invasive Gynecologic Surgery|8147691904|faragsara@gmail.com|
21264982|NCT02247401|AbbVie|Global Medical Services|800-633-9110||
21264983|NCT01374217|Carolinas HealthCare System|Nilanjan Ghosh, MD|9804422000||
21264984|NCT03418051|University of North Carolina at Chapel Hill|Erik Wikstrom|9199622260|wikstrom@unc.edu|
21264985|NCT03695393|Boston Medical Center and BU School of Medicine|Karsten Lunze, MD|617-638-6933|lunze@bu.edu|
21264986|NCT04585451|PainQx|VP R&D|6179817753|bd@painqx.com|
21295683|NCT06034652|Integra LifeSciences Corporation|Andrew Tummon, Director, Global Clinical Operations|609-936-5490|andrew.tummon@integralife.com|
21295684|NCT00240110|Univeristy of Miami|Dr. Ihsan Salloum|305-243-7931|isalloum@med.miami.edu|
21295685|NCT00583791|Abbott|Maren Wagner|6517565585|maren.wagner@abbott.com|
21295686|NCT00203021|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21295687|NCT01330966|George Clinical|Lindsey Munn|901-350-8801|lmunn@georgeclinical.com|
21295688|NCT02080260|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
21295689|NCT04699812|Apple Inc.|Clinical Health Product Clinician|866-905-5303|htclinicalquestions@apple.com|
21295690|NCT03204890|Boston Medical Group|Dr. José Pablo Saffon|+573208899777|jsaffon@bostonmedical.com.co|
21295691|NCT02943915|Moss Rehabilitation Research Institute, Elkins Park, PA, USA|Dylan Edwards|215-663-6554|dylan.edwards@jefferson.edu|
21295692|NCT03769311|University of Wisconsin Carbone Cancer Center|Justine Bruce, MD|608-262-4961|jybruce@medicine.wisc.edu|
21295693|NCT02853435|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21295694|NCT04973696|Center for Health Outcomes and Interdisciplinary Research, Massachusetts General Hospital|Dr. Ana-Maria Vranceanu|617-724-4977|avranceanu@mgh.harvard.edu|
21295695|NCT03747120|University of Texas Southwestern Medical Center|Dr. Heather McArthur, Professor IM-Hem Onc|214-645-9380|heather.mcarthur@utsouthwestern.edu|
21295696|NCT03627065|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21295697|NCT04562597|Medical University of South Carolina|Dr. Sylvia Wilson|843-792-2322|wilsosh@musc.edu|
21295698|NCT01838785|Chang Gung Memorial Hospital|Dr. kun-Ju Lin|033281200|lin4857@adm.cgmh.org.tw|2632
21295699|NCT01266317|University of Pittsburgh|Dr. Michael Donahoe|412-383-2049|donahoem@upmc.edu|
21295700|NCT00490776|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21295701|NCT02937766|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
21295702|NCT00098722|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21295703|NCT02506660|Hospital of Special Surgery|Dr. Richard Kahn|212-774-7274|KahnR@HSS.EDU|
21295704|NCT04599166|Penn State College of Medicine|Dr. Benjamin Levi|717-531-8778|BHLevi@psu.edu|
21264987|NCT00966693|UT MD Anderson Cancer Center|Weber,Donna M.,M.D. / Lymphoma/Myeloma|713-792-2860|dmweber@mdanderson.org|
21295705|NCT01974752|AstraZeneca|Karin Bowen|+001 301 398 3254|karin.bowen@astrazeneca.com|
21250630|NCT02396953|Ipsen|Medical Director|Use email address below|clinical.trials@ipsen.com|
21250631|NCT03018223|Moffitt Cancer Center|Nelli Bejanyan, MD|813-745-7208|Nellie.Bejanyan@moffitt.org|
21250632|NCT02994784|Boston Medical Center and BU School of Medicine|John M Sloan, MD|617-638-7519|mark.sloan@bmc.org|
21250633|NCT02466243|Corbus Pharmaceuticals, Inc.|Head of Clinical Operations|6179630100|info@corbuspharma.com|
21250634|NCT04867707|University of Missouri|Dr. Luis Martinez|(573) 882-3244.|martinezlemusl@umsystem.edu|
21250635|NCT01649557|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21250636|NCT01011049|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21250637|NCT02435381|Baylor College of Medicine|Christopher D. Verrico Ph.D.|713-791-1414|Cverrico@bcm.edu|26020
21250638|NCT01490359|University of Pennsylvania|Dr. John B. Jemmott III|215-573-9366|jjemmott@asc.upenn.edu|
21250639|NCT04150341|Theravance Biopharma US, Inc|Nathan Pfeifer|001 (650) 808-3711|npfeifer@theravance.com|
21250640|NCT00875615|University of Miami Sylvester Comprehensive Cancer Center|Lynn Feun MD|305-243-4981|lfeun@med.miami.edu|
21250641|NCT03713073|The University of Texas Health Science Center at Houston|Chun-Teh Lee, DDS, DMSc, MS|713-486-4384|Chun-Teh.Lee@uth.tmc.edu|
21250642|NCT00405912|Mayo Clinic|Dr. Amit Sood|507-266-1944|nicotineresearch@mayo.edu|
21250643|NCT03730662|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21250644|NCT01907113|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21250645|NCT01309243|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21250646|NCT00632931|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
21250647|NCT00833898|University of Colorado Denver|Mark L. Laudenslager, PhD|303-724-9279|biel@ucdenver.edu|
21250648|NCT02176382|Massachusetts General Hospital|Dr. Joy Tsai|6177266723|jntsai@mgh.harvard.edu|
21250649|NCT01402063|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
21250650|NCT02209610|VAORD|Dr Markus Amann|801-582-1565|markus.amann@hsc.utah.edu|4358
21250651|NCT02149524|Samsung Bioepis Co., Ltd.|Director of Clinical Trials||sbregistry@samsung.com|
21250652|NCT03712449|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21250653|NCT00666198|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21250654|NCT03220776|Medical University of South Carolina|James J. Prisciandaro, Ph.D.|843-792-1433|priscian@musc.edu|
21250655|NCT04151706|Stanford University|Dr. Robert Lowsky|(650) 723-0822|rlowsky@stanford.edu|
21250656|NCT03029234|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21250657|NCT04491006|Athira Pharma|Hans Moebius, CMO|1-866-725-0930|clinicaltrials@athira.com|
21250658|NCT02166047|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21250659|NCT03192202|Columbia University Irving Medical Center (CUIMC)|Ahmed Sawas, MD|212-305-0591|as4386@cumc.columbia.edu|
21250660|NCT01176435|University of Minnesota|C. Gail Summers, MD|612-625-6469|summe001@umn.edu|
21250661|NCT02541942|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21250662|NCT00451555|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21250663|NCT04765553|Swedish Orphan Biovitrum AB|Veronica Asnaghi|+41 61 508 72 13|Veronica.Asnaghi@Sobi.com|
21295706|NCT02435680|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21264988|NCT01861054|Dompé Farmaceutici|Pier Adelchi Ruffini, MD|+39 (0)2 583831|info@dompe.it|
21264989|NCT00405821|NIAID|Steven Reynolds|256-772-220-087|sjreynolds@niaid.nih.gov|
21264990|NCT04962503|CLINUVEL PHARMACEUTICALS LIMITED|Clinical Operations Manager|Tel: +61 3 9660 4900|mail@clinuvel.com|
21264991|NCT01769469|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
21264992|NCT02790463|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Jeff Foster|205-996-6086|pjfoster@uabmc.edu|
21264993|NCT02031432|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|Clinical-Trials@grunenthal.com|
21264994|NCT02148211|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21264995|NCT01425229|University of Heidelberg|Prof. Gerd Mikus|4962215639197|gerd.mikus@med.uni-heidelberg.de|
21264996|NCT01617187|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21264997|NCT00538824|Weill Cornell Medical College|Jennifer Hess|6469629440|jmh2004@med.cornell.edu|
21264998|NCT01265420|Indiana Hand to Shoulder Center|F. Thomas D. Kaplan|317-875-9105|tdk@hand.md|
21264999|NCT03828149|Novus Therapeutics|Clinical Director|949-679-1110|study001@novustherapeutics.com|
21265000|NCT03337139|Drexel University|Dr. Meghan Butryn|215-553-7108|mlb34@drexel.edu|
21265001|NCT04430283|Faraday Pharmaceuticals, Inc.|Clinical Trial Manager|206-492-5310|info@faradaypharma.com|
21265002|NCT02554253|Mayo Clinic|Erica Wittwer|5072559814|wittwer.erica@mayo.edu|
21265003|NCT02664532|Tata Main Hospital|Dr.Deb Sanjay Nag|+91-7763807101|debsanjay@gmail.com|
21265004|NCT03558191|Jiangsu HengRui Pharmaceuticals Co., Ltd.|Project manager|0518-82342973|linan.wang@hengrui.com|
21265005|NCT01561560|Alcon Research, Ltd.|Jami Kern, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
21265006|NCT03862131|Washington University School of Medicine|Dr. Joshua Mitchell|314-362-1291|jdmitchell@wustl.edu|
21265007|NCT02024204|NYU Langone|Joan Reibman, MD|212-263-6479|joan.reibman@nyumc.org|
21265008|NCT00937794|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21265009|NCT04777214|University of Pennsylvania|Samuel Cason|215-573-4336|sacason@pennmedicine.upenn.edu|
21265010|NCT00597935|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
21265011|NCT01738737|University of Sao Paulo|Sarah Rubia Ferreira de Meneses|+55(11)470898-71|sarah.meneses@usp.br|
21265012|NCT01770145|US WorldMeds|Regulatory Associate, Clinical Operations|5028158130|rgerlach@usworldmeds.com|
21265013|NCT03488238|Masimo Corporation|Cristina Johnson|949-297-7000|clincalresearchdept@masimo.com|
21265014|NCT01316939|GlaxoSmithKline|GSK Response Center|866-435-7343||
21265015|NCT01432457|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21265016|NCT04134728|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21265017|NCT00801892|University of Pittsburgh|E. Chasens, PhD|412-624-9380|chasense@pitt.edu|
21265018|NCT01711541|Alliance for Clinical Trials in Oncology|Everett E. Vokes, M.D.|773-702-9306|evokes@medicine.bsd.uchicago.edu|
21265019|NCT00728936|Idera Pharmaceuticals, Inc|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
21265020|NCT00905268|The National Hospital, University College London|Prof. Nicholas William Wood|020 7837 3611|n.wood@ucl.ac.uk|
21265021|NCT05355818|LEO Pharma A/S|Clinical Disclosure|+45 4494 5888|disclosure@leo-pharma.com|
21265022|NCT02966353|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21265023|NCT02273037|The Hospital for Sick Children|Dr. Diego G. Bassani|+14168137654|diego.bassani@sickkids.ca|303033
21265024|NCT03351478|Lexicon Pharmaceuticals, Inc|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
21265025|NCT03657810|Charleston Laboratories, Inc.|Bernard P. Schachtel, MD, Chief Scientific Officer|561.379.8726|bschachtel@charlestonlabs.com|
21265026|NCT03911869|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21265027|NCT03554850|Stryker Neurovascular|Fei Qin|+8613524821775|fei.qin@stryker.com|
21265028|NCT01619488|Nemours Childrens Health Delaware|Kirk W Reichard, MD, MBA, Surgical Director|302-651-5999|kreichar@nemours.org|
21265029|NCT00367341|Emory University School of Medicine|Helen Mayberg, MD|404-727-6740|hmayber@emory.edu|
21265030|NCT03325556|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-|medicalinformation@acadia-pharm.com|2897
21265031|NCT01705587|University of Pittsburgh|Susan Greenspan, MD|412-692-2477|greenspn@pitt.edu|
21265032|NCT00812604|University of Hong Kong|Dr. Ricky Wing Kit Wong, Associate professor in orthodontics|852-2859 0554|fyoung@hkucc.hku.hk|
21265033|NCT00510484|Solvay Pharmaceuticals|Sven Voet - Global Communication|+32 (0)2 509 69 77|sven.voet@solvay.com|
21265034|NCT02533401|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21265035|NCT00081939|The Myeloma Institute, University of Arkansas for Medical Sciences|Director of Clinical Trials and Regulatory Affairs|501-526-6990|npetty@uams.edu|
21265036|NCT02451488|Mayo Clinic|Dr. James Jakub|507-284-3629|Jakub.James@mayo.edu|
21265037|NCT04897594|Terns, Inc.|Study Director|+1 650-525-5535|clinicaltrials@ternspharma.com|101
21265038|NCT00511108|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21265039|NCT04866823|Wake Forest School of Medicine|Morgana Mongraw-Chaffin|13367133108|mmongraw@wakehealth.edu|
21265040|NCT00150345|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21265041|NCT01998958|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21265042|NCT02373163|PREVENCION|Josefina Medina-Lezama|+5154251269|jmedinal2911@gmail.com|
21265043|NCT01532570|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21265044|NCT05034614|Mayo Clinic|Danielle J. O'Laughlin, P.A.-C., M.S.|507-284-5164|OLaughlin.Danielle@mayo.edu|
21265045|NCT01324128|Vifor Pharma|Medical Information|41 58 851 8222|medinfo@viforpharma.com|
21281564|NCT03644342|Baylor College of Medicine|Michelle S. Ludwig, MD, MPH, PhD|713-566-3662|Michelle.Ludwig@bcm.edu|
21281565|NCT02259010|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21265046|NCT03892707|Woerwag Pharma LLC|Anna Shagako, Clinical Trials Manager/ Authorized Person of Pharmacovigilance|+7 (495) 382 85 56|anna.shagako@woerwagpharma.ru|
21295707|NCT02867618|Columbia University|Ana Ignat|212-305-3612|ai2111@cumc.columbia.edu|
21295708|NCT03846531|Pulse Biosciences, Inc.|William A. Knape|(510) 906-4649|bill.knape@pulsebiosciences.com|
21295709|NCT02088073|ZS Pharma, Inc.|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21295710|NCT01310400|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
21295711|NCT01909180|GE Healthcare|RIchard Petrisko|262-548-4637|richard.petrisko@ge.com|
21295712|NCT02788201|National Cancer Institute|Dr. Andrea Apolo|301-480-0536|apoloab@nih.gov|
21295713|NCT01854632|PATH|Senior Clinical Research Scientist|206-285-3500|klewis@path.org|
21295714|NCT00186537|Stanford University|Dr. Gerald Reaven|650-724-3416|greaven@stanford.edu|
21295715|NCT01510184|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|gajanan.Bhat@sppirx.com|
21295716|NCT01143051|Amphastar Pharmaceuticals, Inc.|Stephen A. Campbell, Esq.|(909) 980-9484|stephenc@amphastar.com|2016
21295717|NCT02231762|Ipsen|Medical Director||clinical.trials@ipsen.com|
21295718|NCT01757561|FirstSunYetSen|Juan-ying Guo|8602087755766(8273)|gjunying@aliyun.com|
21265047|NCT03646760|Henry Ford Health|Steven Keteyian, PhD|313-972-1920|sketeyian1@hfhs.org|
21265048|NCT05224076|University of Kansas School of Nursing|Dr. Barbara Polivka|6142049915|bpolivka@kumc.edu|
21265049|NCT04263363|UCLA|Dr. Eilon Gabel, MD|310-267-8693|EGabel@mednet.ucla.edu|
21265050|NCT01807949|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21265051|NCT00881361|Mayo Clinic|Judy C. Boughey, MD|507-284-3629|boughey.judy@mayo.edu|
21265052|NCT01457924|GlaxoSmithKline|GSK Response Center|866-435-7343||
21265053|NCT01978600|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
21265054|NCT01665768|Johns Hopkins University|Douglas Gladstone, MD|4109558781|dgladst1@jhmi.edu|
21265055|NCT01329341|James A Haley Veterans Hospital|Stephanie McGovern|813-558-3964|stephanie.mcgovern@va.gov|
21265056|NCT00448760|UM/Sylvester Comprehensive Cancer Center|Bach Ardalan MD, Professor|305-243-4909|bardalan@med.miami.edu|
21265057|NCT01226706|Gynecology, Regina Qu'Appelle Health Region|Dr. Corrine Jabs|(306) 586-3120|corrinejabs@hotmail.com|
21265058|NCT04015440|Walter Reed Army Institute of Research|Jeffrey M Osgood, Ph.D. Associate Director of Military Psychiatry Branch|301-319-7475|jeffrey.m.osgood.mil@mail.mil|
21265059|NCT03017846|Albert Einstein College of Medicine|Anthony Guzman, MD|7189208352|anguzman@montefiore.org|
21265060|NCT01789346|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
21265061|NCT04603391|University of Florida|John S. Markowitz, Pharm.D.|(352) 273-6262|jmarkowitz@cop.ufl.edu|
21265062|NCT02759861|University of Nebraska Medical Center|Mark Mailliard|402-559-8126|mark.mailliard@unmc.edu|
21265063|NCT02151682|Grünenthal GmbH|Clinical Trial Helpdesk|+49-(0)241-569|clinical-trials@grunenthal.com|3223
21265064|NCT00290589|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|(718)920-6266|befriedm@montefiore.org|
21265065|NCT05014542|Family Medicine Practice Svijetlana Perculija Durdevic, MD, Ninska 10, Sesvete|Svijetlana Perculija Durdevic, MD, family medicine specialist, acupuncturist|00385913302507|svijetlana.perculija.durdevic@outlook.com|
21265066|NCT01438307|UAB|Francisco Robert, MD|205-934-5077|paco@uab.edu|
21265067|NCT06000501|NYU Langone Health|Lenard Adler, MD|212-263-3580|Lenard.Adler@nyulangone.org|
21265068|NCT02378883|Medtronic Neurovascular|Darren Lacour, Sr. Manager, Clinical Project Management|949-680-1274|darren.j.lacour@medtronic.com|
21265069|NCT00318565|Biosense Webster|Christine Liu|9098398608|cliu10@its.jnj.com|8608
21265070|NCT00691093|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21265071|NCT03123055|Rainier Therapeutics|Chief Medical Officer|510-878-2486|Sabella@RainierRx.com|
21265072|NCT00835003|Aarhus University Hospital, Dep. Obstetrics and Gynecology, Aarhus, Denmark|MD, PhD Julie Glavind|+4578450000|julie.glavind@dadlnet.dk|
21265073|NCT01700985|Therapeutics Inc.|Clinical Research, Therapeutics Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com|
21265074|NCT00965146|Stryker Orthopaedics®|Director of Clinical Research|201-831-5401|ellen.axelson@stryker.com|
21265075|NCT00067470|BioMarin Pharmaceutical Inc.|Medical Information Services|800-983-4587|medinfo@bmrn.com|
21265076|NCT01148693|Tehran medical university of science|Dr. Rasoul sotoudehmanesh|(+98 21) 82414000|r.sotudemanesh@gmail.com|82415000
21265077|NCT01135017|Sanofi|Trial Transparency Team||Contact_US@sanofi.com|
21265078|NCT01200160|Abbott Laboratories de México|Carlos A Gonzalez MD, PhD|(5255) 5809-|carlos.gonzalez@abbott.com|7576
21265079|NCT02146248|OHSU|Jeffrey T. Jensen|503-629-4058|jensenje@ohsu.edu|
21265080|NCT03086317|Emory University|Dr. Wissam Jaber, Assistant Professor|4046861000|wissam.jaber@emory.edu|
21265081|NCT03699631|Froedtert and the Medical College of Wisconsin|William Drobyski, MD|414-805-6700|wdrobyski@mcw.edu|
21265082|NCT00039741|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
21265083|NCT00507416|Millennium Pharmaceuticals Inc|Medical Director|1-800-778-2860|clinicaltrialregistry@tpna.com|
21265084|NCT00964158|GlaxoSmithKline|GSK Response Center|866-435-7343||
21265085|NCT03101514|the first affiliated hospital of Harbin medical university|Dr. Zhi-Ping Liu|+8613936034546|as150001@aliyun.com|
21265086|NCT01998269|University of North Carolina at Chapel Hill|Dr. Stacy Bailey|919-843-9834|scbailey@unc.edu|
21265087|NCT01736254|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21265088|NCT02559206|Ironwood Pharmaceuticals, Inc.|Nick Omniewski, MPH|(617) 621-8454|nomniewski@ironwoodpharma.com|
21265089|NCT01375647|University of Vermont|Dorothy M Dickson, MSc|802 656 9296|dorothy.dickson@med.uvm.edu|
21295719|NCT03593681|Boston Scientific|Clinical Trial Project Manager|612-209-9532|blake.hedstrom@bsci.com|
21295720|NCT01229943|Dana-Farber Cancer Institute|Matthew Kulke, MD, MMSc||matthew_kulke@dfci.harvard.edu|
21295721|NCT01149486|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
21265090|NCT01102140|University of Michigan|Dr. Jennifer Cowger|7345464911|jennifercowger@gmail.com|
21265091|NCT03788967|Senior Vice President Clinical Development|Angela Talley|857-242-1575|atalley@sperotherapeutics.com|
21265092|NCT04268303|BioXcel Therapeutics|Vice President Head of Clinical Operations|(475) 355 5177|cgommoll@bioxceltherapeutics.com|
21265093|NCT00355134|Novartis Pharmaceuticals|Study Director|862-778-8300||
21265094|NCT00741104|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21265095|NCT04306900|Trishula Therapeutics, Inc.|Executive Director|1-650-509-5732|info@trishulatx.com|
21265096|NCT03621189|Chang Gung Memorial Hospital|Dr. Hsing Chang Ni|886975365663|alanni0918@yahoo.com.tw|
21265097|NCT00233324|University of Alabama|Waldemar A. Carlo, M.D|(205) 934-4680|wcarlo@peds.uab.edu|
21265098|NCT00438464|University of Texas (UT) MD Anderson Cancer Center|Jeri Kim, MD / Associate Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org|
21265099|NCT01759160|First Affiliated Hospital of Sun Yat-sen University|Dr. Xia Feng|008613688877856|fengxiar@yahoo.cn|
21265100|NCT02911818|The University of Pennsylvania Center for Weight and Eating Disorders|Dr. Thomas Wadden|215-746-5046|wadden@pennmedicine.upenn.edu|
21265101|NCT01281189|Knopp Biosciences|Head of Regulatory|4124881776|greg@knoppbio.com|
21265102|NCT03518034|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21265103|NCT00415519|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21265104|NCT01618422|Chinese University of Hong Kong|Prof David SC Hui|2632 3134|dschui@cuhk.edu.hk|
21265105|NCT03485222|Icahn School of Medicine at Mount Sinai|Dr. Juan Badimon|(212) 241-8484|juan.badimon@mssm.edu|
21265106|NCT01527110|GlaxoSmithKline|GSK Response Center|866-435-7343||
21265107|NCT02007252|Novartis Pharmaceuticals|Study Director|862-778-8300||
21265108|NCT00608881|Massachusetts General Hospital|Dr. Merit Cudkowicz|617-726-0813|mcudkowicz@partners.org|
21265109|NCT01373918|University of California, Los Angeles|Dr. Kara L. Calkins|310 825-9330|KCalkins@mednet.ucla.edu|
21265110|NCT01590212|University of Glasgow|Prof. Phil Wilson|+44 (0)1463 255892|p.wilson@abdn.ac.uk|
21265111|NCT01387074|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21265112|NCT02147691|DermResearch, PLLC|Leon H. Kircik, M.D.|502-451-9000|wedoderm@yahoo.com|
21265113|NCT01392742|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21265114|NCT04526067|University of Texas Health Science Center in San Antonio|Dawn Velligan, PhD|210-567-5508|velligand@uthscsa.edu|
21265115|NCT03515213|University of California, Irvine|Leslie Thompson|9498243990|lmthomps@hs.uci.edu|
21265116|NCT01628393|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
21265117|NCT02988219|Warsaw Medical University|Dr. Karolina Dobronska|48 22 502 17 21|karolinapladzyk@gmail.com|
21265118|NCT02375984|Saint John's Cancer Institute (formerly John Wayne Cancer Institute)|Lisa van Kreuningen|3105827053|lisa.vankreuningen@providence.org|
21265119|NCT01522443|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
21265120|NCT03260894|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
21265121|NCT00706394|Endologix|Sharone Trifskin|949-599-8860|strifskin@endologix.com|
21265122|NCT00118911|Massachusetts General Hospital|Susan Sprich, Ph.D.|617-726-5991|ssprich@partners.org|
21265123|NCT01707368|LEO Pharma GmbH|Tobias Anger, Medical Advisor|+49 610 220 1258|TANDE@leo-pharma.com|
21265124|NCT03814005|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21265125|NCT01896856|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Nilofer Azad|410-614-9169|nazad2@jhmi.edu|
21265126|NCT04446299|Braintree Laboratories, Inc.|Head of R&D, GI|7819646710|studydirector@sebelapharma.com|
21265127|NCT02563925|Memorial Sloan Kettering Cancer Center|Dr. Shanu Modi, MD|646-888-5243|modis@MSKCC.ORG|
21265128|NCT00282867|University of Virginia|Karen C. Johnston, MD, MSc|434 924-5323|kj4v@virginia.edu|
21265129|NCT05067452|University of California San Francisco|Dr. Kartika Palar|415-502-8492|kartika.palar@ucsf.edu|
21265130|NCT00426556|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21265131|NCT02584868|Centre Hospitalier Universitaire Brugmann|Philippe Van der Linden, MD, PhD|+32 2 477 23 30|philippe.vanderlinden@chu-brugmann.be|
21265132|NCT00091962|University of Pittsburgh School of Medicine|Dr. Bruce L Rollman, Principal Investigator|(412) 692-2659|rollmanbl@upmc.edu|
21265133|NCT00432562|Adventrx Pharmaceuticals|Chief Executive Officer|858-768-6325|culley@adventrx.com|
21295722|NCT04066686|Imperial College Healthcare NHS Trust|Dr Annabelle Lee|02033121077|annabellelee@nhs.net|
21265134|NCT03970824|CELLTRION, Inc.|SungHyun Kim|+82 32 850 5778|SungHyun.Kim@celltrion.com|
21265135|NCT01488409|Massachusetts General Hospital|Steven K. Grinspoon|617-724-9109|sgrinspoon@partners.org|
21265136|NCT00425100|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21265137|NCT00979017|Duke University Medical Center, The Preston Robert Tisch Brain Tumor Center|Katherine B. Peters, MD, PhD|(919) 684-6173|katherine.peters@duke.edu|
21265138|NCT03488914|Hunter College|Dr. Tyrel Starks|212-772-5550|tstarks@hunter.cuny.edu|
21265139|NCT01767519|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21265140|NCT02682030|Cedars Sinai Medical Center - 8700|Dr. Ashraf Elsayegh|3105560335|ashraf.elsayegh@cshs.org|
21265141|NCT00493974|University of Minnesota|Sarah Lindberg|612-626-9011|slindberg@umn.edu|
21265142|NCT00862654|Galderma|Farzi Sidou, Clinical Project Manager|+33 4 93 95 70 51|farzaneh.sidou@galderma.com|
21265143|NCT03219567|Duke University|Anthony Kuo, M.D.|919-684-3799|anthony.kuo@duke.edu|
21265144|NCT03258632|Department of Veterans Affairs|Christine Timko|650-493-5000|Christine.Timko@va.gov|23336
21265145|NCT01829217|Dana-Farber Cancer Institute|Principal Investigator: Geoffrey Oxnard, MD|617-632-6049|geoffrey_oxnard@dfci.harvard.edu|
21265146|NCT03162458|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Head of department of clinical trials|+74952761571|PutilovskiyMA@materiamedica.ru|302
21265147|NCT01181778|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21295723|NCT03366103|Johns Hopkins University/SKCCC|Judy Murray|443-927-3568|jmurra33@jhmi.edu|
21295724|NCT01726673|Feinstein Institute for Medical Research at Northwell Health|Johanna Chang, Senior Research Coordinator|(516) 562-3646|jchang14@northwell.edu|
21295725|NCT01344629|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21295726|NCT00837824|Genzyme Corporation|Genzyme MedInfo|800-745-4447|medinfo@genzyme.com|
21295727|NCT02944565|The Ohio State University Comprehensive Cancer Center|Hallie Barr, PharmD BCOP|614-685-5803|Hallie.Barr@osumc.edu|
21295728|NCT02481713|VA Connecticut Healthcare System|Joanna Fiszdon, PhD|2039325711|joanna.fiszdon@va.gov|2231
21295729|NCT00746733|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21295730|NCT00849875|GlaxoSmithKline|GSK Response Center|866-435-7343||
21295731|NCT02165462|Universidad Católica San Antonio de Murcia|Rubén Cuesta-Barriuso, PhD|+34 913146508|ruben.cuestab@gmail.com|
21295732|NCT02989844|University of Minnesota, Masonic Cancer Center|Jeffrey Miller|612-625-7409|mille011@umn.edu|
21295733|NCT01312389|University of Pennsylvania|Director of Clinical Trial Operations|215-662-3324|tracey.thomas@pennmedicine.upenn.edu|
21295734|NCT01955434|Mayo Clinic|P. Leif Bergsagel, MD|480/301-8335|Bergsagel.leif@mayo.edu|
21295735|NCT04096820|Queen's University/Kingston General Health Research Institute|Heather McFarlane, Administrative Assistant|613-549-6666|heather.mcfarlane@kingstonhsc.ca|8171
21295736|NCT00996801|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clincaltrialsdisclosure@merck.com|
21295737|NCT00289198|GlaxoSmithKline|GSK Response Center|866-435-7343||
21295738|NCT04172467|Hematology Oncology Kaiserslautern|Prof. Hartmut Link|0631|praxis-link@kabelmail.de|3503709
21295739|NCT04332614|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
21295740|NCT03369431|University College London|Susan Simmons|+44 7952961881|susan.simmons.16@ucl.ac.uk|
21295741|NCT01062061|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21295742|NCT00004445|Louis Stokes Cleveland VAMC|Lisa Lombardo, MPT|216-791-3800|lisa.lombardo2@va.gov|4909
21295743|NCT00076336|Novartis Pharmaceuticals|Study Director|862-778-8300||
21295744|NCT00524589|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21295745|NCT03435562|Virginia Commonwealth University|Alison Breland|804 628 2300|abbrelan@vcu.edu|
21295746|NCT04214639|Bausch Health Americas, Inc|Study Director|7072851528|Varsha.Bhatt@bauschhealth.com|
21295747|NCT02753127|Sumitomo Dainippon Pharma Oncology|Keiichi Saito|+1 (617)674-6800|keiichi.saito@SDPOncology.com|
21295748|NCT01670565|Hospital For Special Surgery|Annel Fernandez|212 774 2123|fernandeza@hss.edu|
21295749|NCT00046930|ECOG Statistical Office|Study Statistician|617-632-3012||
21295750|NCT01694108|Rigshospitalet|Lone Graff Stensballe, Research leader, Pediatrician, PhD|+0045 35459727|lone.graff.stensballe@regionh.dk|
21295751|NCT01410812|University of Pennsylvania|Katherine L. Milkman, Ph.D.|215-573-9646|kmilkman@wharton.upenn.edu|
21295752|NCT00940485|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21295753|NCT01113580|Seqirus|Clinical Study Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
21295754|NCT03037541|Wake Forest University Health Sciences|Joseph Jorizzo, MD|336-716-3775|jjorizzo@wakehealth.edu|
21295755|NCT01519674|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21295756|NCT01610596|Therapeutics, Inc.|Clinical Research, Therapeutics Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com|
21295757|NCT00799591|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21295758|NCT06687824|Manipal University College Malaysia|Heng Sy Xuan|+601110752589|hengsyxuan@hotmail.com|
21295759|NCT03597178|Johnson & Johnson|Brian Pall OD, MS, FAAO- Director of Clinical Sciences|9044431290|BPALL@its.jnj.com|
21295760|NCT00733135|Covidien|Director of Medical Communications|763-591-3047|jean.ahlstrom@covidien.com|
21295761|NCT03523273|Mayo Clinic|Dr. Michael Camilleri|507-266-2305|camilleri.michael@mayo.edu|
21295762|NCT02590562|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21295763|NCT01457950|GlaxoSmithKline|GSK Response Center|866-435-7343||
21295764|NCT03180398|Henry Ford Health|Dr. Stephen Brown|3135858415|sbrown1@hfhs.org|
21295765|NCT00765882|Forest Research Institute|Paul F.C. Eng, PhD. Director, Clinical Development|201-427-8071|Paul.Eng@frx.com|
21295766|NCT04709484|SultanAbdulhamid|Adem Erbirol|+905426608788|aerbirol@hotmail.com|
21295767|NCT01866423|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist|323-865-0454|Victoria.Soto@med.usc.edu|
21295768|NCT01479595|Novartis|Study Director|862-778-8300||
21295769|NCT00852527|Southern AZ VA Health Care System|Dr. Judith Babcock-Parziale, PI|520-7921450|judith.babcock@va.gov|5698
21295770|NCT01811303|RSSL|Rungano Munyuki (Clinical Project Manager)|0118 9184034||
21295771|NCT00048815|Cedars Sinai Medical Center|Mark Hyman Rapaport, M.D.|310-423-2600|mark.rapaport@cshs.org|
21295772|NCT04610489|Carilion Clinic|John Epling, MD, MSEd|540-581-0123|jwepling@carilionclinic.org|
21295773|NCT01174004|ACADIA Pharmaceuticals Inc.|Roger Mills, MD|858-202-7563|rmills@acadia-pharm.com|
21295774|NCT00933244|University of Wisconsin - School of Medicine & Public Health|Dr. Karen E Hansen|608-265-8162|keh@medicine.wisc.edu|
21295775|NCT02266875|OhioHealth|Dr. Kruti Patel, DO|614-857-7735|kruti.patel@ohiohealth.com|
21295776|NCT01143896|Michael E. DeBakey VA Medical Center|Fasiha Kanwal, MD, MSHS|(713) 440-4495|Fasiha.Kanwal@va.gov|
21250664|NCT03430050|MUSC|Dr. Sherman|843-792-8174|shermanb@musc.edu|
21250665|NCT01887990|University of Cincinnati|Cheryl McCullumsmith|513-5588022|cheryl.mccullumsmith@uc.edu|
21250666|NCT01004185|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
21250667|NCT00797511|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21250668|NCT01990664|Johnson & Johnson Vision Care, Inc.|Jurandir Araujo, Clinical Compliance Manager|9044431379|jaraujo7@its.jnj.com|
21295777|NCT02312765|University of Pennsylvania|Dr Nalaka Gooneratne|215 573 2048|ngoonera@upenn.edu|
21295778|NCT00525629|Beth Israel Deaconess Medical Center|Christos Mantzoros|617-667-8630|cmantzor@bidmc.harvard.edu|
21295779|NCT01643876|Université de Montréal|Dr. Elham Emami|5143436111|elham.emami@umontreal.ca|6053
21295780|NCT01735708|Butler Hospital|Lisa Uebelacker|401-455-6381|luebelacker@butler.org|
21295781|NCT01689350|School of Pharmaceutical Sciences, Sun Yat-sen University|Lingyan CHEN, Master candidate|+8615018706960|chlingy@mail2.sysu.edu.cn|
21295782|NCT01510145|Alcon Research, Ltd|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
21295783|NCT01442064|Genentech|Genentech||ctg-post-d@gene.com|
21295784|NCT01360398|GlaxoSmithKline|GSK Response Center|866-435-7343||
21295785|NCT00846040|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Kevin Hall, PhD|3014028248|kevinh@niddk.nih.gov|
21295786|NCT02153346|GlaxoSmithKline|GSK Response Center|866-435-7343||
21295787|NCT03158272|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
21295788|NCT01822535|James J. Peters VA Medical Center|Dr. John P. Handrakis|718-584-9000|john.handrakis@va.gov|5439
21295789|NCT03582813|Center on Mental Health Services Research and Policy, University of Illinois at Chicago, Department of Psychiatry|Dr. Judith A. Cook, Director|312-355-3921|jcook@uic.edu|
21295790|NCT01048866|Reckitt Benckiser Inc.|Gail Solomon, Director, Clinical Development|973-404-2752|gail.solomon@rb.com|
21295791|NCT04765644|Imperial College London|Dr Ricky Vaja|020 7589 5111|r.vaja@imperial.ac.uk|
21295792|NCT02366767|Stanford School of Medicine|Bruce Buckingham|650-725-9549|buckingham@stanford.edu|
21295793|NCT01258153|Menarini Ricerche|Dr. Angela Capriati|+39 05556809990|acapriati@menarini-ricerche.it|
21295794|NCT02230683|Conatus Pharmaceuticals Inc.|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
21295795|NCT02410577|Memorial Sloan Kettering Cancer Center|Dr. Joseph Osborne, MD, PhD|212-639-7788|osbornej@mskcc.org|
21295796|NCT04573881|HistoSonics, Inc.|Vice President of Clinical Affairs|(877) 740-0543|clinicaltrials@histosonics.com|
21295797|NCT00528996|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21295798|NCT02936284|Children's Mercy Hospital, Kansas University|Kai Ling Kong, PhD|816-731-7239|kkong@cmh.edu|
21295799|NCT01352637|Weill Cornell Medical College|Dr. JoAnn Difede|212 746 3079|jdifede@med.cornell.edu|
21295800|NCT02118597|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21295801|NCT00273754|University of Texas Medical School/ Houston|Samia Khalil, M.D./ Professor|713-500-6242|Samia.N.Khalil@uth.tmc.edu|
21295802|NCT03684304|University Hospitals|University Hospitals|216-844-1000|info@uhhospitals.org|
21295803|NCT02677844|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21295804|NCT00545532|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21295805|NCT03630302|Abbott neuromodulation|Erika Ross|972-526-8207|erika.ross@abbott.com|
21295806|NCT00353431|Intern Medicine Solothurn, Switzerland|Robert Thomann, MD|+41326274501|endodiab.bss@bluewin.ch|
21295807|NCT00706329|Children's Hospital Boston and South Shore Hospital|Dr. Neil Feins|6173556915||
21295808|NCT05268744|UCSF|Dr. Robert Hendren|(415) 476-7500|robert.hendren@ucsf.edu|
21295809|NCT02255565|Dept. of Psychiatry, University of Washington|Dr. Mark Stein|206-987-1161|mstein42@uw.edu|
21295810|NCT02699450|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21295811|NCT00810901|University of Hawaii, School of Nursing|Cheryl Albright|8089569716|cherylal@hawaii.edu|
21295812|NCT00931801|Community Research Initiative of New England|Calvin J. Cohen MD, MSc, Director of Research|617-502-1700|ccohen@crine.org|
21295813|NCT01133275|H. Lee Moffitt Cancer Center and Research Institute|Dr. Rami Komrokji|813-745-4692|rami.komrokji@moffitt.org|
21295814|NCT02689076|James J. Peters VA Medical Center|Kimberly M. Judon|718-584-9000|Kimberly.Judon@va.gov|1174
21295815|NCT01318070|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
21295816|NCT01556061|University of Texas at Houston Medical School/ Dept. of Anesthesiology|Dr. Davide Cattano MD PhD|713-500-6235|davide.cattano@uth.tmc.edu|
21295817|NCT01816906|Staffordshire University|Professor Nachiappan Chockalingam|+44 1782 295853|n.chockalingam@staffs.ac.uk|
21295818|NCT04375397|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21295819|NCT00086502|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21250669|NCT03041298|Guerbet GmbH|Oliver Heine, MD, Radiology & Scientific Affairs Manager|+49 6196 76250|oliver.heine@guerbet-group.com|
21250670|NCT01376297|Helsinn Healthcare SA|Head of Clinical Development|+41 91 9852121|marco.palmas@helsinn.com|
21250671|NCT02569632|Children's Hospital Oakland Research Institute (CHORI)|Dan Granoff, MD (Principal Investigator)|510-428-3000|dgranoff@chori.org|7640
21250672|NCT02630706|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21250673|NCT00673127|Beth Israel Deaconess|Steven Balk|617-735-2065|sbalk@bidmc.harvard.edu|
21250674|NCT01678898|Protalix Ltd|Raul Chertkoff|+972-4-9028100|raul@protalix.com|
21250675|NCT00837590|Indiana University|Dr. Kieren Mather|317-278-2187|kmather@iupui.edu|
21250676|NCT00356993|Addictions Program|Dr. Peter Selby|416-535-8501|peter_selby@camh.net|77432
21250677|NCT00853372|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21250678|NCT00467298|VA Puget Sound Health Care System-Seattle|Cynthia M. Dougherty|206 764 2205|cynthia.dougherty@va.gov|
21250679|NCT01268098|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21250680|NCT01522703|Johns Hopkins University School of Medicine|Elizabeth Matsui, MD MHS|410-502-3858|ematsui@jhmi.edu|
21250681|NCT01355978|Clinical Research Consuting|Richard J. Morishige, MS, RRT|510-606-0374|rjmorishige@gmail.com|
21250682|NCT02624869|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21250683|NCT00510198|Medtronic CRDM Clinical Research and Reimbursement|Clinical Trial leader|7635262788|ming.duanmu@medtronic.com|
21265148|NCT02713789|Urovant Sciences GmbH|JP Nicandro, PharmD|833-219-5557|clinicaltrials@urovant.com|
21265149|NCT04491240|MC Dinasty|Tyumina Olga|+78462039808|centr123@bk.ru|201
21265150|NCT02726113|Medical University of South Carolina|Sebastiano Gattoni-Celli, M.D.; Professor of Radiation Oncology|843-876-5103|gattonis@musc.edu|
21265151|NCT03549117|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21265152|NCT01664858|University of Leeds|Professor John P Greenwood|+44 (0)113 3925481|j.greenwood@leeds.ac.uk|
21265153|NCT03148756|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21265154|NCT01376362|National Institutes of Health|Hatice Nida Sen, Principal Investigator, National Eye Institute|(301) 402-3254|senh@nei.nih.gov|
21265155|NCT00637377|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21265156|NCT00638924|Unicamp|Juliana Gomes Zabatiero||juzabatiero@yahoo.com.br|
21265157|NCT04021706|Tufts University|Bess Dawson-Hughes|6175563066|bess.dawson-hughes@tufts.edu|
21265158|NCT04884945|Indiana University School of Medicine, Pediatrics|Stacy Keller|3172786127|stasulli@iu.edu|
21265159|NCT02332798|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
21265160|NCT02688153|Edwards Lifesciences, LLC|Mary Edwards, VP Clinical and Regulatory Affairs, HVT|949-250-2500|mary_edwards@edwards.com|1536
21265161|NCT00595868|University of Vermont|John R. Hughes, MD|802-656-3195|john.hughes@uvm.edu|
21265162|NCT00107172|Boston Medical Center|Hiran C. Fernando, MD|617-638-5600|hiran.fernando@bmc.org|
21265163|NCT02354092|Oregon Health & Science University|Ob/Gyn Regulatory Specialist, Women's Health Research Unit|503-494-3666|whru@ohsu.edu|
21265164|NCT02979444|Northwestern University Feinberg School of Medicine|Darius Tandon, PhD|410-852-0399|dtandon@northwestern.edu|
21265165|NCT00859573|University of Arkansas for Medical Sciences|Michael J. Mancino, M.D.|501-526-8442|mjmancino@uams.edu|
21265166|NCT01135394|University of Maryland School of Medicine|Soren Snitker, MD, PhD|4107061511|ssnitker@som.umaryland.edu|
21265167|NCT05711862|The University of Texas Health Science Center at Houston|Heather Webber, PhD|713-486-2723|Heather.E.Webber@uth.tmc.edu|
21265168|NCT03750240|NYU Langone Health|Guillaume Madelin, PhD|(212) 263-3343|guillaume.madelin@nyulangone.org|
21265169|NCT03510910|NYU Langone Health|Thomas Youm, MD|212-348-3636|Thomas.Youm@nyulangone.org|
21265170|NCT03382262|Flexion Therapeutics|Scott Kelley MD, Chief Medical Officer|781-305-7142|skelley@flexiontherapeutics.com|
21265171|NCT04914819|University of Pennsylvania|Dr. Jennifer Lewey|215-662-7700|jennifer.lewey@pennmedicine.upenn.edu|
21265172|NCT00962754|Princess Amalia Children's Clinic, Isala Klinieken|Dr. J. Bekhof|0031-38-4245050|j.bekhof@isala.nl|
21265173|NCT03943446|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21265174|NCT02905825|Exalenz Bisocience|Avraham Hershkowitz|972-8-9737513|avrahamh@exalenz.com|
21265175|NCT00662389|Apsara Medical Corporation|Eve Conner, Ph.D. Consultant|510 566-2495|eaconner@sbcglobal.net|
21265176|NCT01601704|Orexigen Therapeutics, Inc.|Global Head of Development|858-875-8600|MedInfo@Orexigen.com|
21265177|NCT00601146|DFCI|Andrea Ng|617-732-6310|ang@lroc.harvard.edu|
21265178|NCT01709708|Clinvest Research|Jim Sly|4178413673|jsly@clinvest.com|
21265179|NCT02657434|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21265180|NCT00129740|The University of Texas MD Anderson Cancer Center|Cortes,Jorge E, MD./Professor|713-794-5783|jcortes@mdanderson.org|
21265181|NCT01858597|The first Affiliated Hospital of Sun-Yat Sen University|Director of Clinical Trials|86-020-28823388|zsyyyb@mail.sysu.edu.cn|
21295820|NCT01304329|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21295821|NCT02568449|Karmanos Cancer Instiute|Dr. Dipesh Uprety|313-576-8722|upretyd@karmanos.org|
21295822|NCT05545644|University of New Mexico|Dr. Barbara McCrady|505-925-2388|bmccrady@unm.edu|
21295823|NCT00610441|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21295824|NCT05810714|The Ohio State University Comprehensive Cancer Center|Dr. Mira Katz|614-293-6603|Mira.katz@osumc.edu|
21295825|NCT00283816|University of Rochester Medical Center|Kathleen M. Hoeger, MD, MPH|585-275-7891|Kathy_Hoeger@urmc.rochester.edu|
21295826|NCT01797380|Duke University Health Systems|Harold Goforth, M.D.|216-636-3999|goforth@ccf.org|
21295827|NCT02469714|Illinois Institute of Technology|Patrick Corrigan|(312)567-6751|corrigan@iit.edu|
21295828|NCT01945775|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21295829|NCT02876328|National Institute of Allergy and Infectious Diseases (NIAID)|John Tierney, Director of Office of the Clinical Research Policy and Regulatory Operations (OCRPRO)|301.451.5136|JTierney@niaid.nih.gov|
21295830|NCT00885768|Kidney Reasearch Center, Tehran University of Medical Sciences|Mohammad Reza Khatami MD|00982161192659|khatami@hbi.ir|
21295831|NCT03562793|Richard L. Roudebush VA Medical Center|Dr. Marianne Matthias|317-988-4514|Marianne.Matthias@va.gov|
21295832|NCT00892606|University Louisville|Nancy Alsip|502-852-2905|nlalsi01@exchange.louisville.edu|
21295833|NCT01152515|Department of Anaesthesiology and Pain Medicine and Anaesthesia and Pain Research Institute, Yonsei University College of Medicine|Dr. Shin Ok Koh|82-2-2228-2420|sokoh@yuhs.ac|
21295834|NCT00334282|GlaxoSmithKline|GSK Response Center|866-435-7343||
21295835|NCT05242354|Biruni University|Dr Mustafa YILMAZ|+90 533 7129952|myilmaz@biruni.edu.tr|
21295836|NCT01511809|Ospedale San Raffaele|Dr. Antonella Castagna|00390226437934|castagna.antonella1@hsr.it|
21295837|NCT01996592|Wake Forest School of Medicine|Jessica L. Booth, MD|336-718-8278|jbooth@wakehealth.edu|
21295838|NCT02759315|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21295839|NCT01406015|Brigham and Women's Hospital|Dr. Rajesh K. Garg||RGARG@bwh.harvard.edu|
21265182|NCT02698566|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21265183|NCT02432703|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21265184|NCT03819764|The Cleveland Clinic Foundation|Dr. Susan Linder, PT, DPT, PhD|216-445-9815|linders@ccf.org|
21265185|NCT04325906|Rush University|Jie Li, PI|3125634643|jie_li@rush.edu|
21265186|NCT01181141|Daiichi Sankyo.,LTD|Kenichi Sakakura, Manager|81-90-1885-0271|sakakura.kenichi.ef@daiichisankyo.co.jp|
21265187|NCT00561340|University of Nebraska Medical Center|Christopher Kratochvil|402-552-6005|ckratoch@unmc.edu|
21265188|NCT02186457|Indiana University School of Medicine|Dr. Michael House|3179440113|michouse@iupui.edu|
21250684|NCT01037413|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21265189|NCT02307318|HealthEast Care System|Amy Fehrer|651-232-5363|afehrer@healtheast.org|
21265190|NCT03496662|Washington University School of Medicine|Kian-Huat Lim, M.D., Ph.D.|314-362-6157|kian-huat.lim@wustl.edu|
21265191|NCT06444165|Eli Lilly and Company|Chief Medical Officer|08004595979|ClinicalTrials.gov@lilly.com|
21265192|NCT03395223|Provepharm SAS|Emilie HUYGHUES|+33 6 20 58 28 27|emilie.huyghues@provepharm.com|
21265193|NCT00810810|Bloodworks Northwest (formerly Puget Sound Blood Center)|Karen Nelson, PhD., Vice President Laboratories|206-689-6549|knelson@bloodworksnw.org|
21265194|NCT01156532|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21265195|NCT03819478|Wake Forest University Health Sciences|Ashley Weaver, PhD|336-716-0944|asweaver@wakehealth.edu|
21265196|NCT01074658|Medronic Bakken Research Center|Hanne Gonnissen|+3143356|hanne.gonnissen@medtronic.com|6734
21265197|NCT00763243|Indiana University School of Medicine|William Kronenberger, Ph.D.|317-944-8162|wkronenb@iupui.edu|
21265198|NCT03005041|GlaxoSmithKline|GSK Response Center|866-435-7343||
21265199|NCT00105560|Massachusetts General Hospital|Dr. Nancy Tarbell, Pediatric Radiation Oncologist|617-724-1836|NTARBELL@mgh.harvard.edu|
21265200|NCT01248364|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21265201|NCT04406389|Weill Cornell Medicine|Dr. Maria T. DeSancho|646-962-2065|mtd2002@med.cornell.edu|
21265202|NCT02559713|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21265203|NCT01021813|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21265204|NCT03539861|University of Michigan|Lenar Yessayan|734-763-9041|lenar@med.umich.edu|
21265205|NCT01555905|University of Florida|D. Barbara Smith|3522945315|bksmith@ufl.edu|
21265206|NCT02293096|"University of Colorado Denver | Anschutz"|Andrew Monte, MD, PhD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
21265207|NCT02781454|University of Washington|Dr. Michael D. Weiss|206-598-7688|mdweiss@uw.edu|
21265208|NCT00673894|Garvan Institute of Medical Research|Dr. Dorit Samocha-Bonet|+61292958309|d.samochabonet@garvan.org.au|
21265209|NCT00326417|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
21265210|NCT03219892|Xuanwu Hospital|Piu Chan|010-83198677|pbchan@hotmail.com|
21265211|NCT04682353|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
21265212|NCT00555906|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21265213|NCT01586806|Hospital for Special Surgery|Dr. Mary Chisholm|2126061206|chisholmm@hss.edu|
21265214|NCT01185704|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21250685|NCT00619983|Wake Forest School of Medicine|Dr. James Eisenach|336-716-4182|jimeisenach@gmail.com|
21250686|NCT00809341|Johns Hopkins Sidney Kimmel Cancer Center|Dr. Lode Swinnen|410-955-8603|lswinne1@jhmi.edu|
21250687|NCT00496626|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21250688|NCT01219777|The Ohio State University Comprehensive Cancer Center|Ritu Salani, MD, MBA|614-293-3873|Ritu.Salani@osumc.edu|
21250689|NCT02975297|The University of Texas Health Science Center at Houston|Luba Yammine, PhD, APRN, FNP-C, Associate Professor|(713) 500-2005|Luba.Yammine@uth.tmc.edu|
21250690|NCT00570921|University of Kentucky|Dr. Mara D. Chambers|866-340-4488|mdcham2@email.uky.edu|
21250691|NCT00711997|BioCancell Ltd.|Monique Ben-Am, M.Sc.|+972-2-5486533|monique.ben-am@biocancell.com|
21250692|NCT04731675|AmMax Bio, Inc.|Dorothy Nguyen, MD|(650)285-6560|clinical@ammaxbio.com|
21250693|NCT02367105|Michael E DeBakey VA Medical Center|Dennis T Villareal, MD|713-794-7156|dennis.villareal@va.gov|
21250694|NCT02560389|University of Wisconsin School of Medicine and Public Health, University of Wisconsin, Madison|Josh Cisler|608-263-6100|jcisler2@wisc.edu|
21250695|NCT02716298|CooperVision|Senior Manager Global Medical Scientific Affairs|925-621-3761|javega@coopervision.com|
21250696|NCT03247738|University of Florida College of Medicine, Jacksonville|Dominick J. Angiolillo|9042443933|dominick.angiolillo@jax.ufl.edu|
21250697|NCT03628456|International Biophysics Corporation|VP of Engineering and Quality|512-804-0046|quality@biophysicscorp.com|
21250698|NCT01723514|Amgen Inc.|Study Director|866-572-6436||
21250699|NCT01547247|Digestive Diseases Center, Vítkovice Hospital, Ostrava, Czech Republic|Přemysl Falt MD|+420602689561|faltprem@centrum.cz|
21250700|NCT01281917|University of Wisconsin Carbone Cancer Center|Lymphoma Disease Oriented Team|608-265-5542|neils@wisc.edu|
21250701|NCT00802438|UW Madison|Gina Crisafi, BS|608-265-4554|gmc@medicine.wisc.edu|
21250702|NCT00096109|Barbara Ann Karmanos Cancer Institute|Elaina Gartner, M.D.|(425) 527-4398|egartner@seagen.com|
21250703|NCT04016805|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
21250704|NCT00740870|Medtronic|Karla Mezera|612-306-4325|karla.p.mezera@medtronic.com|
21250705|NCT00819013|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21250706|NCT02831998|Zurex Pharma, Inc.|Andrew Morgan|16082039090|amorgan@zurexpharma.com|
21250707|NCT00607997|Sunesis Pharmaceuticals, Inc.|Linda Neuman, Vice President, Clinical Development|(650) 266-3760|lneuman@sunesis.com|
21250708|NCT00839332|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21250709|NCT01200485|UT MD Anderson Cancer Center|Saroj Vadhan, MD/Professor, Cytokine & Supportive Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
21250710|NCT06080438|University of Miami|Principal investigator|305-326-6434|wlee@med.miami.edu|
21265215|NCT01313208|Amgen Inc.|Study Director|866-572-6436||
21265216|NCT00187889|University of Florida|Dr. Carl J. Pepine|352-273-9082|carl.pepine@medicine.ufl.edu|
21265217|NCT04350905|NIH|Jessica Manning|+85561856557|Jessica.manning@nih.gov|
21265218|NCT01285791|Hadassah Medical Organization|Dr Ido Mizrahi|+972-2-5844550|idomiz17@gmail.com|
21265219|NCT01998880|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21265220|NCT02248857|Northwestern University|Dr. Michael Wolf|(312) 503-5592|mswolf@northwestern.edu|
21265221|NCT02671461|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
21265222|NCT01412060|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21265223|NCT00004732|Mayo Clinic|Thomas G. Brott, MD - Principal Investigator|904-953-0556|Brott.thomas@mayo.edu|
21265224|NCT00442767|Montefiore Medical Center|Dr. Rubina Heptulla|718-920-4664|rheptull@montefiore.org|
21265225|NCT01183312|Emory University School of Medicine|Dr. Lynn Marie Trotti|404-728-4752|lbecke2@emory.edu|
21265226|NCT01688635|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21265227|NCT02674685|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21265228|NCT01305213|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|lgedeon@gogstats.org|
21265229|NCT02661464|Janssen Vaccines & Prevention B.V.|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21265230|NCT01924299|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21265231|NCT02177175|Memorial Sloan Kettering Cancer Center|Dr. Anthony Yu, MD|212-639-7932|yua3@mskcc.org|
21265232|NCT01011218|Stanford University Medical Center|Oxana RG Palesh, MD, PhD; Assistant Professor of Psychiatry and Behavioral Sciences|650-725-7011|oxana.palesh@stanford.edu|
21265233|NCT03820726|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21265234|NCT00605072|University of Southern California|Dr. Ihab Hajjar|323-226-6720|ihajjar@usc.edu|
21265235|NCT01293084|Johns Hopkins Univeristy|Beth Laube Professor|410-502-5791|blaube@jhmi.edu|
21295840|NCT00787137|PanGenetics UK Limited|John Powell|+441763257869|info@pangenetics.com|
21265236|NCT04186663|University of California San Francisco|Dr. Hellene Ellenikiotis|408-313-0166|hellene.ellenikiotis@ucsf.edu|
21265237|NCT02259127|MRC CTU at UCL|Prof Diana M Gibb (Chief Investigator)|+44 (0) 207 670 4700|diana.gibb@ucl.ac.uk|
21265238|NCT00719862|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2351|WWheeler@medapharma.us|
21265239|NCT01184846|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
21265240|NCT00713284|California Pacific Medical Center|Dr. V. Ram Peddi|415-600-1000|peddir@sutterhealth.org|
21265241|NCT04432376|Hill Dermaceuticals|Dr. Rosario G Ramirez, Medical Director|4073231887|nini.ramirez@hillderm.com|
21265242|NCT00462488|Sesen Bio|Rachelle Dillon, Ph.D.|204-452-7126|rachelle.dillon@sesenbio.com|308
21265243|NCT03140722|Akebia Therapeutics|Akebia Therapeutics|(617) 844-6128|trials@akebia.com|
21265244|NCT02061748|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21265245|NCT01742091|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21265246|NCT02088541|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
21265247|NCT05742841|Wake Forest School of Medicine|Nick Ashburn|336-716-4646|n.ashburn@wakehealth.edu|
21265248|NCT00612339|Duke University Medical Center|Katherine Peters, MD, PhD|9196846173|katherine.peters@duke.edu|
21265249|NCT00439725|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21265250|NCT02848313|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
21265251|NCT01673490|GlaxoSmithKline|GSK Response Center|866-435-7343||
21265252|NCT00379236|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21265253|NCT00110591|CytoDyn, Inc.|Joe Meidling|360-980-8524|jmeidling@cytodyn.com|
21265254|NCT02715804|Halozyme Therapeutics|VP, Medical, Regulatory and Drug Safety|858-794-8889|medinfo@halozyme.com|
21265255|NCT03961295|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
21265256|NCT01625611|Yale University|Dr. Krishnan-Sarin|203.974.7595|nicholas.franco@yale.edu|
21265257|NCT00948194|University of Colorado Denver|Nick Naughton|303-724-0833|nick.naughton@cuanschutz.edu|
21265258|NCT01089751|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21265259|NCT03300258|University of Wisconsin, Madison|Peter Adamczyk|(608) 263-3231|peter.adamczyk@wisc.edu|
21265260|NCT00527072|Janssen Biotech, Inc.|Sr. Director, Clinical Research - Medical Affairs|215-325-5711||
21265261|NCT02137837|SWOG Statistics and Data Management Center|Breast Committee Statistician|2066674623|dlew@fredhutch.org|
21265262|NCT01467661|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21265263|NCT00270998|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
21265264|NCT01902004|UCLA Semel Institute for Neuroscience and Human Behavior|Dr. Helen Lavretsky|(310)794-4619|hlavretsky@mednet.ucla.edu|
21265265|NCT04075396|Janssen Research & Development, LLC|Executive Medical Director Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21265266|NCT01855945|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21265267|NCT02156804|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21265268|NCT03228394|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
21265269|NCT02157103|Emory University|William L. Read, MD, Principal Investigator|404-778-1900|william.l.read@emory.edu|
21265270|NCT01921452|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|49-6151-72-5200|service@merckgroup.com|
21265271|NCT00047853|National Institute of Mental Health|Pao, Maryland|+1 301 435 5770|paom@mail.nih.gov|
21265272|NCT04206670|University of California, Berkeley|Robert W. Levenson|510-643-8952|boblev@berkeley.edu|
21295841|NCT00985907|University of California, San Francisco|Dr. Thomas Martin, MD|(415) 353-9365|Tom.Martin@ucsf.edu|
21295842|NCT00130923|Psychopharmacology Research Group|Dr. Mary Brunette|603-271-5747|mary.f.brunette@hitchcock.org|
21265273|NCT02443805|Stallergenes Greer|Martine Le Gall, Director of Clinical Development|+33 1 55 59 25 56|martine.legall@stallergenesgreer.com|
21265274|NCT00961116|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21265275|NCT00968708|Takeda|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
21265276|NCT02708966|Institute of Experimental and Clinical Therapeutics|Dra. Esperanza Martínez Abundis|+52-33-10-58-52-00|esperanzamartnezabundi@yahoo.com|34211
21265277|NCT01515488|Maricopa Integrated Health System|Madhumita Sinha, MD, MHSM|602-344-5404|madhumita_sinha@dmgaz.org|
21265278|NCT02260388|University of Kansas Medical Center|Dr. Richard Barohn|9139459943|rbarohn@kumc.edu|
21265279|NCT00389441|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21265280|NCT01981109|Dendreon|Shabnam Vaziri|206.455.2323|svaziri@Dendreon.com|
21265281|NCT03407170|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21265282|NCT00587834|Organogenesis Inc.|Director of Clinical Operations|781-575-0775|clinical@organo.com|
21281566|NCT03655405|a. Community Pharmacy, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Switzerland|Dr Anne Niquille|+41213144845|anne.niquille@unisante.ch|
21281567|NCT01991743|Northwestern University|Dr. Robert J McCarthy|312-695-4976|r-mccarthy@northwestern.edu|
21281568|NCT04390113|AlloVir, Inc.|Senior Vice President|+1 617-433-2605|rriese@allovir.com|
21281569|NCT01682226|Memorial Sloan Kettering Cancer Center|Dr. Juliet Barker, MBBS|646-608-3756|barkerj@mskcc.org|
21281570|NCT03521154|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21281571|NCT05386680|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21281572|NCT01624740|Boston Scientific|Nitzan Mekel-Bobrov, PhD|661-949-4537|Nitzan.Mekel-Bobrov@bsci.com|
21281573|NCT04168112|SightMD|Dr. Alanna Nattis|631-957-2816|anattis@sightmd.com|
21281574|NCT00455403|Wash. Univ. School of Medicine|Janet McGill, MD|314-362-8681|jmcgill@wustl.edu|
21281575|NCT00449865|University of Rochester|Karl Kieburtz, Director of CTSI|585-275-0553|Karl.kieburtz@chet.rochester.edu|
21281576|NCT00171210|Novartis Pharmaceuticals|Study Director|862-778-8300||
21281577|NCT01808963|UC Davis Medical Center|Dr. Neal Fleming|916-734-5394|nwfleming@ucdavis.edu|
21281578|NCT03252535|Cellavita|Cristiane Valverde Wenceslau|+55 (19) 3829.0849|cristiane.valverde@cellavitabrasil.com.br|
21281579|NCT00304096|University of Virginia|Kimberly Bullock, PhD and David Brenin, MD|434-924-0180|kb9d@virginia.edu|
21281580|NCT02158585|DENT Neurosciences Research Center|Dr. Jennifer Cox|716-250-7002|jcox@dentinstitute.com|
21281581|NCT02546375|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21281582|NCT01965756|Massachusetts General Hospital|Dr. Steven E. Arnold MD|617-643-5607|SEARNOLD@mgh.harvard.edu|
21281583|NCT00442897|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21281584|NCT04381728|WOMED|Pauline Chirouze|0785225561|pauline@womedtech.com|+33
21281585|NCT04498182|Alcon Research, LLC|Scientific Advisor, Clinical Research and Development|1-888-451-3937|alcon.medinfo@alcon.com|
21281586|NCT05541003|Robert Wood Johnson|Dr. Keerthana Kesavarapu|6784690425|kk1132@rwjms.rutgers.edu|
21281587|NCT02182843|Zimmer Biomet Spine|Clinical Affairs|303-501-8571|spinemedinfo@zimmerbiomet.com|
21281588|NCT01788631|Dana-Farber Cancer Institute|Dr. David G. Nathan|61746322155|David_Nathan@dfci.harvard.edu|
21281589|NCT03137160|The Ohio State University- Dermatology|Dr. Benjamin Kaffenberger, MD|6143463399|Benjamin.Kaffenberger@osumc.edu|
21281590|NCT01932060|Stanford University School of Medicine|Dr. Alexander Butwick|(650) 736-8513|ajbut@stanford.edu|
21281591|NCT01354652|AsanMC|Dr. Han Chu Lee|82230103915|hch@amc.seoul.kr|
21281592|NCT00343044|Benaroya Research Institute at Virginia Mason|Thomas Malpass, M.D., Principal Investigator|206-223-6193|thomas.malpass@vmmc.org|
21281593|NCT02187198|Yale University School of Medicine, Department of Psychiatry|Elizabeth Ralevski, PhD|203-932-5711|elizabeth.ralevski@yale.edu|4282
21281594|NCT01532518|Menarini Ricerche|Dr. Angela Capriati|+39 05556809990|acapriati@menarini-ricerche.it|
21281595|NCT06509438|EspadPharmed|Hamidreza Kafi|+989129232594|Kafi.h@orchidpharmed.com|
21281596|NCT00952068|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
21281597|NCT00488644|UT MD Anderson Cancer Center|Victor Levin, MD, BS / Professor||kuhunter@mdanderson.org|
21281598|NCT04025879|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21281599|NCT02174510|Shanghai Xuhui Central Hospital, Drug Clinical Trial Institution|Prof.Hu Chaoying|13816319160|cyhu@shxh-centerlab.com|
21281600|NCT01845441|University Hospitals Cleveland Medical Center|Dr. Kristine Blackham|216-403-2705|kristine.blackham@gmail.com|
21281601|NCT03194542|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21281602|NCT02976129|VHsquared|Chief Medical Officer|+44 (0)1223 837650|info@vhsquared.com|
21281603|NCT02712554|Charleston Laboratories, Inc.|Chief Commercial Officer|561-748-2007|cliregulatory@charlestonlabs.com|
21281604|NCT02188147|ZOLL|Vice President Medical Affairs|412-968-3333|stevens@zoll.com|4400
21281605|NCT02503540|Cole Eye Institute Cleveland Clinic Foundation|Dr.Justis P. Ehlers|2166360183|ehlersj@ccf.org|
21281606|NCT03175536|Harvard Medical School and Harvard Pilgrim Health Care Institute|Dr. Alison Galbraith|6178674893|alison_galbraith@harvardpilgrim.org|
21281607|NCT00979654|MedImmune, LLC|Jerry Green|1-888-483-7729|rtpsafety@ppdi.com|
21281608|NCT00413582|Children's Mercy Hospital|Shawn D. St. Peter, MD|816-983-6479|sspeter@cmh.edu|
21281609|NCT03218995|Sarepta Therapeutics, Inc.|Medical Director|800-690-2003|clinicaltrials@sarepta.com|
21281610|NCT01445730|Helsinki University and Helsinki University Hospital|Prof. Marja-Riitta Taskinen|+358-9-4717 1990|marja-riitta.taskinen@helsinki.fi|
21281611|NCT03711786|University of North Carolina at Chapel Hill|Brian Pence, PhD|919-966-7430|bpence@unc.edu|
21295843|NCT00554099|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
21281612|NCT01611883|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21265283|NCT00049504|Fred Hutchinson Cancer Research Center|Rachel Salit|206-667-1317|rsalit@fredhutch.gov|
21265284|NCT00305604|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21265285|NCT00636441|Duke University Medical Center|P. Kelly Marcom, M.D.|919-684-3877|marco001@mc.duke.edu|
21265286|NCT00334204|University of Mississippi|Tibor Fulop, M.D./Associate Professor of Medicine|601 984-5670|tfulop@umc.edu|
21295844|NCT03464422|Yale University|Dr. John Pachankis|6463444060|john.pachankis@yale.edu|
21295845|NCT01370837|Maastricht University Medical Center|Kristy Pickwell|+31433877019|k.pickwell@mumc.nl|
21295846|NCT01628367|University of Michigan|Dr. Hom-Lay Wang|734-647-6175|homlay@umich.edu|
21295847|NCT02839902|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21295848|NCT04957758|Oyster Point Pharma Inc|Marian Macsai, MD|312-259-2477|mmacsai@oysterpointrx.com|
21295849|NCT03353922|Neurana Pharmaceuticals|Judy Caron, Chief Operating Officer|(617) 640-5043|jcaron@neuranapharma.com|
21295850|NCT03688555|Idorsia Pharmaceuticals Ltd|Clinical Trials Disclosure Desk|+41 588 441977|clinical-trials-disclosure@idorsia.com|
21295851|NCT05260333|Baylor College of Medicine|Dr. Leah Antoniewicz, MD-PI|832-8267458|leah.antoniewicz@bcm.edu|
21295852|NCT00686842|AMC|Susan Krown, MD, Protocol Chair|301-251-1161|amcpm@emmes.com|
21295853|NCT02818114|Minneapolis VA Health Care System|J. Irene Harris|612-467-1654|jeanette.harris2@va.gov|
21295854|NCT01335750|Erdy/Searcy Group|Dr. Gary Andrasko, MS|(614) 459-3363|gandrask@columbus.rr.com|
21295855|NCT00462735|Florida Radiation Oncology Group|Dr. Johnny Kao|813-661-6442|johnnykaomd@gmail.com|
21295856|NCT05182580|Orbis International|Dr. Nathan Congdon, Director of Research|646-674-5514|ncongdon1@gmail.com|
21295857|NCT03461406|Instituto Grifols, S.A.|Sandra Camprubi Gimenez|+34670923160|sandra.camprubi@grifols.com|
21295858|NCT01886690|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21295859|NCT01140568|UCSD - Moores Cancer Center|Lara Rose|858-822-6575|ljrose@ucsd.edu|
21295860|NCT03618628|Washington University School of Medicine|Dr. Mary Hastings|3142861433|hastingsmk@wustl.edu|
21295861|NCT00957333|WanFangH|Ruei-Ming Chen|02-27361661|rmchen@tmu.edu.tw|3222
21295862|NCT00858897|Nemours Children's Clinic|Dr. Dominique Darmaun|904-697-3863|ddarmaun@nemours.org|
21295863|NCT02248740|Virginia Commonwealth Univeristy|Dr. Malcolm Sydnor|(804) 828-0534|malcolm.sydnor@vcuhealth.org|
21295864|NCT03190694|University Medical Center Groningen|Prof.dr.H.J. Lambers-Heerspink|+31 50 361 7859|h.j.lambers.heerspink@umcg.nl|
21295865|NCT00316524|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
21295866|NCT01591863|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21295867|NCT00160654|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21265287|NCT02849626|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
21265288|NCT04176445|Hospital Moinhos de Vento|PT Douglas Neves|(51) 9.98975514|nevesfisioup@gmail.com|
21265289|NCT04046341|Children's Hospital of Philadelphia|Marsha Wallace|2155900119|wallacem@chop.edu|
21265290|NCT04377672|Johns Hopkins University|Sanjay K. Jain|4105028241|sjain5@jhmi.ed|
21265291|NCT02447458|Takeda|Takeda Study Registration Call Center|+1-877-825-3327|medicalinformation@tpna.com|
21265292|NCT03505749|VA Portland Health Care System|Dr. Vanessa Somohano, Postdoctoral Research Fellow|503-220-8262|vanessa.somohano@va.gov|
21265293|NCT00435994|Indiana University|Robert Tepper, MD, Ph.D.|317-274-9647|rtepper@iu.edu|
21265294|NCT01151540|Eisai Co., Ltd.|Customer Joy Department. EJ|8133817-3700|_ML_CLNCL@hhc.eisai.co.jp|
21265295|NCT03288324|Cincinnati Childrens Hospital Medical Center|Hermine Brunner|(513) 636-6320|hermine.brunner@cchmc.org|
21265296|NCT03846219|Immunic AG|Andreas Muehler, MD|+4917678738359|andreas.muehler@imux.com|
21265297|NCT05109702|Hanall Biopharma|Project Manager|82-222041763|parksm@hanall.co.kr|
21265298|NCT02679807|University of Virginia|Ronald Turner|434-981-9141|rbt2n@virginia.edu|
21265299|NCT01392378|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21265300|NCT02322411|University of Wisconsin - Madison|Dr. Nicole Pulia|6082561901|npulia@wisc.edu|11697
21265301|NCT02261883|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
21265302|NCT00629525|Duke University|Dr. Daniel George|919-668-4615|daniel.george@duke.edu|
21265303|NCT00976248|Dana-Farber Cancer Institute|Steven P. Treon, MD, PhD|617-632-2681|steven_treon@dfci.harvard.edu|
21265304|NCT05567393|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
21265305|NCT02540772|San Rafael University Hospital|Monica Triviño Mosquera|34958275700|monica.trivino@sjd.es|
21265306|NCT00358501|Jazz Pharmaceuticals|Head of Clinical Development|650.496.3777||
21265307|NCT04199793|Vanderbilt University Medical Center|Sandip Zalawadiya, MBBS|6159368187|sandip.k.zalawadiya@vumc.org|
21265308|NCT05064332|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21265309|NCT00888615|NRG Oncology|Christopher Purdy on behalf of James Kauderer|(716)845-1300|purdyc@nrgoncology.org|2296
21265310|NCT00141037|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21265311|NCT00861380|GlaxoSmithKline|GSK Response Center|866-435-7343||
21295868|NCT02033213|KBC Zagreb|Maja Karaman Ilić, MD PhD|00385 1 2385 122|majakilic1@gmail.com|
21295869|NCT00579995|University of Nebraska Medical Center|Scott Shurmur, M.D.|402-559-6463|sshurmur@unmc.edu|
21295870|NCT03474081|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21265312|NCT00628758|AstraZeneca|Gerard Lynch|+44 1509 645895|aztrial_results_posting@astrazeneca.com|
21265313|NCT01495923|The Johns Hopkins Hospital|Steven Cohen|410-955-1818|scohen40@jhmi.edu|
21265314|NCT03706040|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21295871|NCT01176955|Wake Forest Baptist Medical Center|Brad Yentzer|336-716-4735|byentzer@wakehealth.edu|
21295872|NCT02558400|Aerie Pharmaceuticals, Inc|Theresa GH Heah, MD, MBA|908-947-3844|theah@aeriepharma.com|
21295873|NCT01685021|MorphoSys AG|Dr. Sumeet Ambarkhane, Director, Clinical Program Leader|004989899270|sumeet.ambarkhane@morphosys.com|
21295874|NCT00456599|University of Michigan|Mark Zalupski, MD|734-615-3969|zalupski@med.umich.edu|
21295875|NCT00260065|Eisai Inc.|Eisai Call Center|888-422-4743||
21295876|NCT02198235|Hospital for Special Surgery|Dr. Jacques YaDeau|212-606-1206|yadeauj@hss.edu|
21295877|NCT02246608|Kettering Health Network|Manager, Research Operation and Regulatory Compliance|937-395-8367|innovationcenter@ketteringhealth.org|
21295878|NCT03052530|OrbusNeich|Debbie Morrell, Clinical Research Manager|954-730-0711|DMorrell@OrbusNeich.com|
21295879|NCT01999218|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21295880|NCT02382848|Penn State University College of Medicine|Dr. Fauzia Mahr|717 531-8133|fmahr@pennstatehealth.psu.edu|
21295881|NCT00546260|Portola Pharmaceuticals Inc.|Kevin Romanko, Senior Director Clinical Operations|650-246-7305|kromanko@portola.com|
21295882|NCT01307462|FHCRC|Guang-Shing Cheng MD|206-667-7074|gcheng2@fhcrc.org|
21295883|NCT03875664|Atrium Health|Dr. Sarah Evans|704-304-1660|sarah.evans@atriumhealth.org|
21295884|NCT04129411|Mayo Clinic|Dr. Marius Stan|507-284-2463|stan.marius@mayo.edu|
21295885|NCT02559414|New York University School of Medicine|Jeffrey Berger, MD|212 263 4004|Jeffrey.Berger@nyumc.org|
21295886|NCT02151331|University of Michigan|Amy Kilbourne, PhD|734-845-3452|amykilbo@umich.edu|
21295887|NCT02046070|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21295888|NCT04619004|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|9089926400|CTRinfo@dsi.com|
21295889|NCT00306475|Vanderbilt Psychiatric Hospital|Herbert Meltzer, M.D.|615-327-7049|herbert.meltzer@vanderbilt.edu|
21295890|NCT05991934|Johns Hopkins Bloomberg School of Public Health|Johannes Thrul, PhD|(443) 318-6633‬|jthrul@jhu.edu|
21295891|NCT03007745|Corporal Michael J. Crescenz VA Medical Center|Samuel T. Kuna, MD|215-823-4400|Samuel.Kuna@va.gov|
21295892|NCT04912895|Emory University|Larry Anderson, MD|404-727-1746|larry.anderson@emory.edu|
21295893|NCT03859739|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21295894|NCT01145053|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21295895|NCT00293709|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21295896|NCT02785458|Northwestern University|Dr. Michael S. Wolf, PhD MPH|312-503-5592|mswolf@northwestern.edu|
21295897|NCT01146652|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21295898|NCT00520013|Dana-Farber Cancer Institute|Susana M. Campos, MD, MPH|617-632-5269|susana_campos@dfci.harvard.edu|
21295899|NCT02981524|Sidney Kimmel Cancer Center at Johns Hopkins|Nilofer Azad, MD|410-614-9169|nazad2@jhmi.edu|
21295900|NCT03476876|Baylor College of Medicine|Prof. Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
21295901|NCT02499692|The General Hospital of ShenYang Military|Dr Hanyaling|02428851876|hanyl@medmail.com.cn|
21295902|NCT00159913|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21295903|NCT03294135|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21295904|NCT02763254|Cell Medica|Dr. Kurt Gunter (Chief Medical Officer)|832-581-4480|Kurt.Gunter@cellmedica.com|
21295905|NCT02963987|Laboratory for the Study of Human Ingestive Behavior, The Pennsylvania State University|Dr. Barbara J. Rolls|814-863-8481|bjr4@psu.edu|
21295906|NCT00824005|UT-Houston School of Public Health|Lemuel Moye, MD, PhD|713-500-9518|Lemmoye@msn.com|
21295907|NCT00431951|SIGA Technologies, Inc.|Annie Frimm, Vice President, Regulatory Affairs|951-303-8797|afrimm@siga.com|
21295908|NCT01146288|Rabin Medical Center|Dr Boris Zingerman||borisz@clalit.org.il|
21295909|NCT03458702|Texas Tech University|Dr. Jacalyn McComb|806-834-6306|jacalyn.mccomb@ttu.edu|
21295910|NCT01697462|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21295911|NCT00168103|CSL Behring|Clinical Program Director|Use email contact|clinicaltrials@cslbehring.com|
21295912|NCT03532932|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21295913|NCT02227836|Mayo Clinic|Karthik Ravi, MD|507-284-4824|Ravi.Karthik@mayo.edu|
21295914|NCT02956850|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21295915|NCT01920152|University of Colorado, Denver|Omer Mei-Dan, MD|3033159900|omer.meidan@cuanschutz.edu|
21295916|NCT03412604|Massachusetts General Hospital|Emiliano Santarnecchi|617-667-0326|esantarnecchi@mgh.harvard.edu|
21295917|NCT00993499|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21295918|NCT01287195|Brigham and Women's Hospital|Scott B. Snapper, M.D., Ph.D.|617-919-4973|ssnapper@partners.org|
21250711|NCT00655083|Menarini Group- Clinical Research|Angela Capriati, Clinical research Director|+ 39-055 56809990|acapriati@menarini-ricerche.it|
21250712|NCT03083093|LUMC|F.A. Klok, MD PhD|003171 526 9111|f.a.klok@LUMC.nl|
21250713|NCT03078751|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21250714|NCT04414397|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21250715|NCT03106337|Massachusetts General Hospital|Antonia Stephen, MD||ASTEPHEN@PARTNERS.ORG|
21250716|NCT06135675|TenNor Therapeutics (Suzhou) Limited.|TenNor|0512-86861990|info@tennorx.com|
21250717|NCT02515097|Bausch Health Americas, Inc.|Director of Clinical Operations|1-510-259-5284|aloncaric@bauschhealth.com|
21250718|NCT00702273|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21250719|NCT03030599|Jazz Pharmaceuticals|Director, Clinical Trial Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
21250720|NCT01592383|University of Chicago|Hedy Kindler|7737020360|hkindler@medicine.bsd.uchicago.edu|
21250721|NCT01064856|AbbVie|Global Medical Services|800-633-9110||
21295919|NCT01420627|Leadiant Biosciences, Inc.|Scott Rodgers, MS, CCRA, ACRP-PM / Sr Director Clinical Operations|301-670-1565|scott.rodgers@leadiant.com|
21295920|NCT00837876|Vanderbilt-Ingram Cancer Center|Jordan Berlin, MD|615-343-4128|jordan.berlin@vanderbilt.edu|
21265315|NCT00927758|Sandoz|Study Director|609-627-8889|yaping.zhu@sandoz.com|
21265316|NCT01544478|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21265317|NCT00212758|Oregon Health & Science University|Dr. Amira Al-Uzri|503-494-7327|aluzria@ohsu.edu|
21265318|NCT03062267|University of Washington|Principal Investigator|(206) 685-9655|dbenzeev@uw.edu|
21265319|NCT02940860|Pharmacosmos A/S|Clinical trial disclosure desk|+45 5948 5935|trial@pharmacosmos.com|
21265320|NCT01807611|St. Jude Children's Research Hospital|Brandon M. Triplett, MD|866-278-5833|referralinfo@stjude.org|
21265321|NCT02431793|Northwestern University|Dr. Danielle McCarthy|312-926-7532|d-mccarthy2@northwestern.edu|
21265322|NCT01818986|University of Texas Southwestern Medical Center Dallas|Dr. Raquibul Hannan|214-645-7696|raquibul.Hannan@UTSouthwestern.edu|
21265323|NCT02286726|The University of Texas MD Anderson Cancer Center|Ghayas Issa C. MD./Assistant Professor|713-745-6798|GCIssa@mdanderson.org|
21265324|NCT01563107|Vanderbilt University Medical Center|Alfredo Gamboa MD|6158751003|alfredo.gamboa@vumc.org|
21265325|NCT02707601|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21265326|NCT01769612|Institut Pasteur of Tunis|Afif Gen Salah, MD, PhD|011-216-71-792-429|noemailavailable@no.com|
21265327|NCT00063986|ECOG Statistical Office|Study Statistician|617-632-3012||
21265328|NCT00247273|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
21265329|NCT02580240|Subei People's Hospital|QQLv|18051063899|bonhomie2014@163.com|
21265330|NCT00607919|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21265331|NCT00646581|UMass Medical School|Matthew Goodnow|508-856-2494|matthew.goodnow@umassmed.edu|
21265332|NCT02911519|SAMEIN|Dr. Jenny Garcia|+57 4 219 6014|jenny.garcia@udea.edu.co|
21265333|NCT01707095|University of Colorado|Thomas Robinson|303-724-2728|thomas.robinson@ucdenver.edu|
21265334|NCT02001688|Kamada Ltd|Head of Clinical Operations|+972-72-2219172|sharonc@kamada.com|
21265335|NCT03744598|patientMpower Ltd|Chief Scientific Officer|353872599131|colin@patientmpower.com|
21265336|NCT00445341|National Cancer Institute, National Institutes of Health|Kieron Dunleavy, M.D.|301-435-1007|DunleavK@mail.nih.gov|
21265337|NCT03051217|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21265338|NCT01675141|National Cancer Institute|Dr. Dickran Kazandijian|301-451-2677|kazandijiandg@nih.gov|
21265339|NCT00109772|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21265340|NCT01498588|Emory University|Keerthi Gogineni, MD, MSHP|404-778-1801|keerthi.gogineni@emory.edu|
21265341|NCT01369225|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21265342|NCT01229891|National nutrition and food technology institute|T Neyestani|0982122376471|neytr@yahoo.com|
21265343|NCT00105183|Fresenius Biotech|Regulatory Affairs|781 699 4618|anne.kuan@fresenius-biotech.com|
21265344|NCT00792701|SWOG Statistical Center|Lung Committee Statistician|206-667-6197|jmoon@fredhutch.org|
21265345|NCT05507580|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21265346|NCT02135900|Staten Island University Hospital|Michel Chalhoub, MD|7182269000|chalhoubmichel@gmail.com|
21265347|NCT03167541|Reckitt Benckiser Healthcare (UK) Ltd|Clinical Research Director, Clinical Research|+44 (0) 1482326151|clinicalrequests@rb.com|
21265348|NCT00615914|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21265349|NCT03673956|Mayo Clinic|Dr. Garret W. Choby|507-284-2533|Choby.Garret@mayo.edu|
21265350|NCT02021071|Philips|Rami Nachabe, PhD|+1-513-926-1486|Rami.Nachabe@philips.com|
21265351|NCT01118715|Athens Orthopedic Clinic|Dr. Michael Shuler|706-549-1663|mshuler@athensorthopedicclinic.com|
21265352|NCT00983359|The Ohio State University Comprehensive Cancer Center|Mario Ammirati, MD|614-293-1970|Mario.Ammirati@osumc.edu|
21265353|NCT01117012|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com|
21265354|NCT00844285|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21265355|NCT03796182|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21265356|NCT05425719|MediBeacon, Inc.|Richard B Dorshow, PhD|314-735-0967|rbdorshow@medibeacon.com|
21265357|NCT01033487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21265358|NCT02193828|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
21265359|NCT00889681|Medtronic- AF Solutions|Dana Wigert- Sr. Clinical Research Specialist|763-526-2802|dana.wigert@medtronic.com|
21265360|NCT01957787|Galil Medical, a wholly owned indirect subsidiary of Boston Scientific|Sr. Clinical Trial Specialist|651-287-5000|GalilClinical@bsci.com|
21265361|NCT03954444|Teva Pharmaceuticals Development Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
21265362|NCT01637870|University of Iowa Hospitals and Clinics|Abbey Hardy-Fairbanks, MD|319-356-2291|abbey-hardy-fairbanks@uiowa.edu|
21265363|NCT03096444|University of Miami|Leigh Nattkemper|3055889734|Lxn202@med.miami.edu|
21265364|NCT03812588|New York State Psychiatric Institute|Dr. Bret Rutherford|646-774-8660|bret.rutherford@nyspi.columbia.edu|
21265365|NCT03094832|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21265366|NCT00180271|Boston Scientific|Jill Leigh|800 227 3422|jill.leigh@bsci.com|
21265367|NCT00788697|Bracco Diagnostics Inc.|Maria Luigia Storto, MD Executive Director X-Ray and Ultrasound Medical Affairs|(609) 514-2200|MariaLuigia.Storto@diag.bracco.com|
21265368|NCT00367432|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
21265369|NCT00903370|Icahn School of Medicine at Mount Sinai|Annetine C. Gelijns, PhD|212-659-9568|annetine.gelijns@mssm.edu|
21265370|NCT00014911|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21265371|NCT00744848|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
21281613|NCT02689154|Children's Hospital of Los Angeles|Dr. Alaina Vidmar|323-361-3385|avidmar@chla.usc.edu|
21281614|NCT00030901|SWOG Statistical Center|Study Statistician|206-667-4623||
21265372|NCT00345540|Novelos Therapeutics, Inc.|Vice President, Clinical Development|617-244-1616|hpalmin@novelos.com|
21265373|NCT04179786|VBI Vaccines|Dr. Francisco Diaz-Mitoma|1 613 297 3304|fdiazmitoma@vbivaccines.com|
21265374|NCT01938001|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21265375|NCT03310580|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director, Global Clinical Operations|(908) 947-3543|nramirez@aeriepharma.com|
21265376|NCT00089102|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
21265377|NCT01269047|Children's Hospital at Montefiore|Dr. Rubina Heptulla|718-920-7004|rheptull@montefiore.org|
21265378|NCT01576120|Given Imaging|"Ravit Peled | Clinical Trials Manager"|+972 (4) 909-7894|Ravit.peled@covidien.com|7894
21265379|NCT03205982|Columbia University|Rebecca Schnall, PhD, MPH|212-342-6886|rb897@columbia.edu|
21265380|NCT00877604|Fondazione Istituto Neurologico Carlo Besta|Alberto Albanese|+39 02 2392 4552|alberto.albanese@unicatt.it|
21265381|NCT02983799|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21265382|NCT02025829|Riley Hospital for Children|Dr. James Chmiel|317-948-7180|jfchmiel@iu.edu|
21265383|NCT02677623|Columbia University|Nisha Philip, Clinical Research Manager|212-305-4973|np2173@cumc.columbia.edu|
21265384|NCT01999348|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21265385|NCT01569087|Biocad|Roman Ivanov, Director of Clinical Trials|+7 (812) 380 49 33|ivanov@biocad.ru|950
21265386|NCT01626989|Philips|Jeremy Powers|412-542-3669|jeremy.powers@philips.com|
21265387|NCT01987349|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
21265388|NCT02293902|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21265389|NCT02947022|UNC Chapel Hill, Department of Radiology|Clinical Research Manager|919-966-4997|rad_research@med.unc.edu|
21265390|NCT03366844|Cedars-Sinai Medical Center|Stephen Shiao, MD, PhD|310-423-2836|Stephen.Shiao@cshs.org|
21265391|NCT02480998|The catholic university of Korea, Seoul ST. Marry's Hospital|Dr.Dong-suck Lim, CI|+82-2-2258-7327||
21265392|NCT03077243|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat G. Canter MD MS Clinical Trial Analyst|(919) 962-0000|Melahat_Canter@med.unc.edu|
21265393|NCT03030183|Ra Pharmaceutical, Inc|Sponsor Ra Pharmaceutical, Inc|1 617 401 4060|trials@rapharma.com|
21265394|NCT03788616|Faculty of dentistry, Ain Shams University|Dr. Marina Fakhry assistant lecturer of pediatric dentistry|01273731722|Dr.marina.fakhry@gmail.com|+02
21265395|NCT03984812|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21265396|NCT02574481|Boston Scientific|Nicole Kilburn|970-294-4082|Nicole.Kilburn@bsci.com|
21265397|NCT01105936|GlaxoSmithKline|GSK Response Center|866-435-7343||
21265398|NCT03404219|Boston University|Dr. Daniel Fulford|(617) 358-6723|dfulford@bu.edu|
21265399|NCT02971007|Matinas Biopharma|Director Clinical Development|9082953235|jjohnson@matinasbiopharma.com|
21265400|NCT02683707|JohnsHopkinsU|Dr J William McEvoy|4109555000|jmcevoy1@jhmi.edu|
21265401|NCT03537092|University Of Pittsburgh|Leslie Meyn, PhD|412-641-4233|meynla@mwri.magee.edu|
21265402|NCT03170258|Duke University|R. Alison Adcock, MD, PhD|919-681-7486|alison.adcock@duke.edu|
21265403|NCT01333098|Washington University School of Medicine|Eric Lenze, MD|314-362-5154|lenzee@wustl.edu|
21265404|NCT01488188|International Vaccine Institute|Dr. Jae Seung Yang|82-2-881-1198|jsyang@ivi.int|
21265405|NCT01783470|NIDDK / NIH|Aaron M. Cypess, MD, PhD, MMSc|301-435-9267|aaron.cypess@nih.gov|
21265406|NCT03276572|Weill Cornell Medicine|Dr. Scott Tagawa|646-962-2027|stt2007@med.cornell.edu|
21265407|NCT01660230|ZZ Biotech, LLC|Kent Pryor, PhD, MBA, Chief Operating Officer||kpryor@zzbiotech.com|
21265408|NCT02954952|Masimo Corporation|Director of Clinical Research|949-297-7416|clinicalresearchdept@masimo.com|
21265409|NCT00724815|NuPathe Inc.|Mark Pierce, MD, PhD|484-567-0130|mpierce@nupathe.com|
21265410|NCT00810043|Medtronic|John Tillman|408-548-6518|tillmj1@mspexcng.medtronic.com|
21265411|NCT01089569|International Diabetes Center|Dr. Richard M. Bergenstal|952-993-1913|richard.bergenstal@parknicollet.com|
21265412|NCT02864706|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
21265413|NCT00641706|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-3902|Galanis.evanthia@mayo.edu|
21265414|NCT01989754|Janssen Research & Development, LLC|Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21265415|NCT01359046|Mayo Clinic|Dr. John Gebhart|507-266-7711|gebhart.john@mayo.edu|
21265416|NCT03364491|George Washington University Biostatistics Center|Principal Investigator, MFMU|301-881-9260|mfmudatasets@bsc.gwu.edu|
21265417|NCT03037307|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21265418|NCT01661946|Queen's University Department of Ophthalmology|Dr. Sanjay Sharma|613-544-3400|sanjay_sharma60@hotmail.com|2227
21265419|NCT00802867|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21265420|NCT02256345|UPenn|Julio Chirinos|2158235800|julio.chirinos@uphs.upenn.edu|
21265421|NCT02052141|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21265422|NCT03000686|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21265423|NCT02920450|University of Florida Heath Cancer Center|Protocol Development Manager|352-273-8128|clh1230@ufl.edu|
21281615|NCT03126968|University of Maryland|Robert M. Reed|4103288141|rreed@som.umaryland.edu|
21281616|NCT02576847|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
21281617|NCT01806051|Children's Hospital Los Angeles|Linda Randolph, M.D.|323-361-2178|lrandolph@chla.usc.edu|
21281618|NCT02757053|Heartland Regional Medical Center dba Mosaic Life Care|Clinical Research Development Manager|816 271 7937|Linda.Schumacher@mymlc.com|
21281619|NCT02418182|University of Alabama at Birmingham|Deidre Gunn, Assistant Professor|205-934-1030|ddowns@uabmc.edu|
21265424|NCT02291445|Maastricht University (Medical Center)|Z. Weerts||z.weerts@maastrichtuniversity.nl|
21265425|NCT05097157|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
21281620|NCT00734994|Duke University, Division of Urology|Brant A. Inman, MD, MS|919 684-1322|brant.inman@duke.edu|
21265426|NCT01525667|Pluristem Ltd.|Dr.Esther Lukasiewicz Hagai|+972-972-74-710-8600|estherl@Pluristem.com|694
21265427|NCT00770224|SWOG Statistics and Data Management Center|Lymphoma Committee Statistician|206-667-4623|lymph@crab.org|
21265428|NCT04737759|Boston College|Dr. Karen Lyons|6175526379|karen.lyons@bc.edu|
21265429|NCT01484561|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21265430|NCT01112982|University of South Florida|John Carter, M.D|813-974-2473|mpatelli@health.usf.edu|
21265431|NCT03371251|Boston Pharmaceuticals, Inc.|Etienne Dumont, MD|(484) 986 8699|clinicaltrials@bostonpharmaceuticals.com|
21265432|NCT00294684|NIDDK|Ed Doo||dooe@niddk.gov|
21265433|NCT00126672|Dana-Farber Cancer Institute|Dabora Sandra L MD|(617) 732-5500|sandy.dabora@gmail.com|
21265434|NCT01001234|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21295921|NCT03558074|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
21265435|NCT00125372|Dartmouth-Hitchcock Medical Center|Konstantin Dragnev, MD|603-650-6344|Konstantin.H.Dragnev@hitchcock.org|
21265436|NCT01851863|Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Institute of Digestive Disease, Shanghai, China|Sheng-Liang Chen, MD|86-21-58752345|slchenmd@hotmail.com|
21265437|NCT00753623|MGH Center for Translational Pain Research|Dr. Jianren Mao|617-724-6102|mghpainresearch@partners.org|
21265438|NCT03332303|Prasco LLC|Senior Director, Quality Assurance|513-618-3333|b.inskeep@prasco.com|
21265439|NCT00996593|GlaxoSmithKline|GSK Response Center|866-435-7343||
21265440|NCT00871572|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21265441|NCT02026206|Pusan Natinal University Yangsan Hospital|Professor Yong-Il Shin|82-55-360-2872|rmshin01@gmail.com|
21295922|NCT00506597|The University of Texas (UT) MD Anderson Cancer Center|Robert J. Wells, MD / Professor||CR_Study_Registration@mdanderson.org|
21295923|NCT00453973|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
21295924|NCT00276094|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
21295925|NCT00707746|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
21295926|NCT00660985|Galderma|Michael Graeber, MD, Head of Global Clinical Project Management and US Development|609-860-8201|michael.graeber@galderma.com|
21295927|NCT00183963|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist, Clinical Investigations Support Office|323-226-6384|Victoria.Soto@med.usc.edu|
21295928|NCT00886119|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
21295929|NCT00357656|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21295930|NCT01656629|Johns Hopkins University|Dr. Suzanne Jan De Beur|410-550-0100|sjandebe@jhmi.edu|
21295931|NCT01219933|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21295932|NCT01902888|W.L. Gore and Associates, Inc.|Arthur Scott / Clinical Study Manager|623.208.3365|artscott@wlgore.com|
21295933|NCT02256267|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21295934|NCT01685983|Janssen R&D BE|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21295935|NCT01352741|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223||
21295936|NCT00259298|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21295937|NCT00645528|Hunter Holmes McGuire VA Medical Center|Sonja K Fredrickson, MD|804-675-5151|sonja.fredrickson@va.gov|
21295938|NCT03077698|Xenetic Biosciences Inc|Dr. Curtis Lockshin|781-778-7720|info@xeneticbio.com|
21295939|NCT05445206|Analog Devices, Inc.|Emily Wycallis|9784351644|emily.wycallis@analog.com|
21295940|NCT01969500|University of Washington|Dror Ben-Zeev|(206) 685-9655|dbenzeev@uw.edu|
21295941|NCT01893359|Avedro, Inc.|Vineeta Belanger, VP of Clinical Affairs|781-768-3459|vbelanger@avedro.com|
21295942|NCT00612508|Women's Health Research Unit|Oregon Health & Science University|503-494-3666|whru@ohsu.edu|
21295943|NCT02008357|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21295944|NCT05044104|Mayo Clinic|Dr. Vinay Chandrasekhara|207-284-2687|Chandrasekhara.Vinay@mayo.edu|
21295945|NCT01269385|Mayo Clinic|Stephen M. Ansell MD||Ansell.Stephen@mayo.edu|
21295946|NCT01842594|Shin Kong Wu Ho-Su Memorial Hospital|Kwan-Hwa Chi|+886-28332211|M006565@ms.skh.org.tw|2612
21295947|NCT03553498|Albert Einstein College of Medicine|Polly Bijur|718-430-4217|polly.bijur@einsteinmed.org|
21295948|NCT04941807|Weill Cornell Medicine|Dr. Shari Lipner|6469623376|shl9032@med.cornell.edu|
21295949|NCT02741570|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21295950|NCT01453946|Perrigo|Beatriz North|718-960-0163|beatriz.north@perrigo.com|
21295951|NCT01710527|GlaxoSmithKline|GSK Response Center|866-435-7343||
21295952|NCT01075971|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
21295953|NCT01688921|PharmaJet, Inc.|Tara Miller, Clinical Affairs Manager|888-900-4321|tara.miller@pharmajet.com|4163
21295954|NCT01213823|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21295955|NCT03697993|Vaccine Treatment Evaluation Unit (VTEU)|Nadine Rouphael, MD, MSc|(404) 822-1411|nroupha@emory.edu|
21265442|NCT00735670|University of Michigan Spinal Cord Injury System|Dr. Denise G Tate|734 763-0971|dgtate@umich.edu|
21295956|NCT04384107|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21295957|NCT02242981|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21295958|NCT02739321|The Cleveland Clinic|Dr. Thomas Frazier||fraziet2@ccf.org|
21295959|NCT00459537|Novartis Pharmaceuticals|Study Director|862 778-8300||
21265443|NCT00405652|Novartis Pharmaceuticals|Study Director|862-778-8300||
21295960|NCT03780959|Amgen Inc.|Study Director|866-572-6436||
21295961|NCT04559022|UT Southwestern|Research Coordinator|2146458907|jennifer.barillas@utsouthwestern.edu|
21295962|NCT03172130|University of Utah|Krishna Sundar|801-581-7806|krishna.sundar@hsc.utah.edu|
21295963|NCT02218593|Nemours Children's Health|Director of Clinical Trials|4076507652|kristen.gibbs@nemours.org|
21265444|NCT02629614|Cala Health|Sr. Director of Clinical Operations|6506515296|vivien@calahealth.com|
21265445|NCT00631540|Cook Incorporated|Scott Snyder, PhD|765-463-7537|ssnyder@medinst.com|
21265446|NCT00795509|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21265447|NCT00970268|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
21265448|NCT01079195|Abbott|Global Medical Services|1-800-633-9110||
21265449|NCT00201760|The Ohio State University Comprehensive Cancer Center|Kari Kendra, MD|614-293-7956|Kari.Kendra@osumc.edu|
21265450|NCT02320214|Church & Dwight Co., Inc.|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
21265451|NCT01999946|NYU Langone Health|Joshua Lee, MD MS|646-501-3552|joshua.lee@nyulangone.org|
21265452|NCT02687711|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21265453|NCT03125018|Masimo|Tala Harake||studies@masimo.com|
21265454|NCT01461824|The Research Institute at Nationwide Children's Hospital|Dr. Andrea Bonny|614-722-2450|andrea.bonny@nationwidechildrens.org|
21265455|NCT02038790|Indivior, Inc.|Global Director Clinical Development|804-379-1090||
21265456|NCT02431702|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21265457|NCT03907969|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21265458|NCT06103591|EmStop, Inc.|Phil Ebeling, CEO|763-227-9954|phil.ebeling@emstopeps.com|
21265459|NCT04209530|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|clinicaltrials@endo.com|
21265460|NCT00633893|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21265461|NCT02044822|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21265462|NCT02967172|University of Iowa|Michael Willey, MD|319-384-8452|michael-willey@uiowa.edu|
21265463|NCT02025530|University of Manchester|Professor Alexander Heazell|+441612766484|alexander.heazell@manchester.ac.uk|
21265464|NCT03551626|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
21265465|NCT00653328|Vanderbilt-Ingram Cancer Center|Marta Crispens, M.D.|800-811-8480|marta.crispens@vanderbilt.edu|
21265466|NCT02100410|Alcon Research, Ltd.|Joachim Nick, Dipl.-Ing. (FH), Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21265467|NCT01237223|Novartis Pharmaceuticals|Study Director|862-778-8300||
21265468|NCT03967847|University Hospitals Cleveland Medical Center|John Strony, MD|908-268-3663|john.strony@uhhospitals.org|
21265469|NCT01017549|iCAD, Inc. Xoft, Inc|Michael A. Patz MBA, RAC, Senior Director Clinical Affairs|603-882-5200|mpatz@icadmed.com|7308
21265470|NCT00364819|University of California Davis|Christopher L. Bowlus, MD|916-734-8986|clbowlus@ucdavis.edu|
21265471|NCT00443846|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21265472|NCT03304262|University of New Mexico|Sarah Pirio Richardson|505-272-3342|spiriorichardson@salud.unm.edu|
21265473|NCT02057276|Cincinnati Children's Hospital Medical Center|Steve Wu, MD|513-636-4222|steve.wu@cchmc.org|
21265474|NCT02516150|Massachusetts General Hospital|Courtney Balliro|617-726-1242|cballiro@partners.org|
21265475|NCT03437044|University of Florida|Dominick J. Angiolillo, MD, PhD|9042443378|dominick.angiolillo@jax.ufl.edu|
21265476|NCT00391807|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
21265477|NCT01659268|College of Nursing at Ribeirão Preto, University of Sao Paulo|Cesar Eduardo Pedersoli|55(16)3602-3421|cesinhajardel@ig.com.br|
21265478|NCT05441540|UNC School of Medicine|Benjamin Succop|8284439726|benjamin_succop@med.unc.edu|
21265479|NCT00813917|Mayo Clinic|Jon O. Ebbert, MD|507-266-1944|nicotineresearch@mayo.edu|
21265480|NCT03168841|Western University of Health Sciences|David Shofler|9097063898|dshofler@westernu.edu|
21265481|NCT03043807|Johns Hopkins University|Kenneth Pienta|4105023137|kpienta1@jh.edu|
21265482|NCT04539262|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21265483|NCT02351739|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
21265484|NCT02980692|Sun Pharma Advanced Research Company Limited|Head-Clinical Development|912266455645|clinical.trials@sparcmail.com|
21265485|NCT01788150|Svelte Medical|Betsy Lowry|19082642181|blowry@sveltemedical.com|
21265486|NCT03943888|Seoul National University Hospital|Dr. Sang-Hwan Ji|+82-2-2072-3661|taepoongshin@gmail.com|
21265487|NCT01998438|Fuwai Hospital|Dr. Hongwen Ji|+86 13701229553|jihongwen@hotmail.com|
21265488|NCT04702984|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21265489|NCT03725293|Beaumont Hospitals|Amit Bahl, MD|(248) 898-9111|ahmit.bahl@beaumont.edu|
21265490|NCT03862495|Skin Disease Hospital of Southern Medical University|Deputy Chief Physician Li Changchang|18585239166|lichch8@mail2.sysu.edu.cn|
21265491|NCT00064077|NRG Oncology|Angela Kuras on behalf of Michael Sill and Helen Huang|716-845-5702|kurasa@nrgoncology.org|
21265492|NCT01057862|Yale University|Dr. Marc N Potenza|2037373553|marc.potenza@yale.edu|
21265493|NCT03363165|Northwestern University|Mary McDermott MD|312-503-6419|mdm608@northwestern.edu|
21265494|NCT02255760|MedImmune LLC|Hasan S. Jafri, MD, Senior Director, Clinical Development|301-398-0000|jafrih@medimmune.com|
21265495|NCT00003838|National Heart Lung and Blood Institute (NHLBI)|Richard Childs, M.D. Principal Investigator, NIH, NHLBI|301.451.7128|childsr@nhlbi.nih.gov|
21265496|NCT00618813|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
21265497|NCT00268463|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600||
21265498|NCT03495817|Aclaris Therapeutics, Inc.|Aclaris Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
21265499|NCT01686958|Profound Medical|Mathieu Burtnyk|647-476-1350|mburtnyk@profoundmedical.com|408
21265500|NCT02486367|University Hospitals Cleveland Medical Center|Dr. David Zidar|216-791-3800|daz21@case.edu|
21265501|NCT03380624|The Ohio State University College of Optometry|Jennifer Fogt|614-292-2020|fogt.78@osu.edu|
21265502|NCT01078558|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21265503|NCT00411086|UT MD Anderson Cancer Center|Clinical Research Operations Team, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org|
21265504|NCT00992602|University of Washington|Maciej M. Mrugala, MD, PhD, MPH|206-543-4069|mmrugala@uw.edu|
21265505|NCT02224638|Swedish Covenant Hospital|Nancy Chaiken|847-372-3500|nchaiken@comcast.net|
21265506|NCT01406652|Geneva University Hospitals|Dr.med Ilker Uçkay|+412237123311|ilker.uckay@hcuge.ch|
21265507|NCT03644108|Reckitt Benckiser, Inc|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
21265508|NCT01875510|Dr. Sami Ulus Children's Hospital|Dr. Serdar Beken|00903123056449|serbeken@gmail.com|
21265509|NCT02281344|Medicines for Malaria Venture|Dr Cristina Donini|+41 22 555 0312|doninic@mmv.org|
21265510|NCT01360229|University of Colorado School of Medicine|Dr. Benzi Kluger|3037242194|benzi.kluger@ucdenver.edu|
21265511|NCT00587301|NYU Langone Health|Christine Ren Fielding, MD|2122633166|christine.ren-fielding@nyulangone.org|
21265512|NCT00418717|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21265513|NCT02867163|University of New Mexico|Dr. David Siegel|505-272-2610|dsiegel@salud.unm.edu|
21265514|NCT01400139|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
21265515|NCT01804114|NSUHS|Michael Ujiki, MD|8475701700|rpulido@northshore.org|
21265516|NCT00994162|Smith+Nephew|Rachael Winter|+44 1482 673475|rachael.winter@smith-nephew.com|
21265517|NCT00607126|DAvdi Geffen School of Medicine at UCLA|Barbara Giesser,MD|310-825-7313|bgiesser@mednet.ucla.edu|
21265518|NCT02762708|Mayo Clinic|Meera Shah, MB, ChB|507-284-0106|Shah.Meera@mayo.edu|
21265519|NCT01468701|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21265520|NCT00156013|Oncology Specialists|Chadi Nabhan, MD|847-268-8200|cnabhan@oncmed.net|
21265521|NCT00719953|Sourazky Tel-Aviv Medical Center|Professor N. Vaisman|972-3-6974807|vaisman@tasmc.health.gov.il|
21295964|NCT02831933|Houston Methodist Neal Cancer Center|Eric Bernicker|713.790.3333|ccresearch@houstonmethodist.org|
21265522|NCT01549223|Brigham and Women's Hospital|Lawrence Tsen, MD|617-732-8216|ltsen@partners.org|
21265523|NCT02437487|Seres Therapeutics|Dr. Michele Trucksis, Chief Medical Officer|(617) 945-9626|mtrucksis@serestherapeutics.com|
21265524|NCT03175562|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21265525|NCT03801356|Cleveland Clinic|Dr. Michael Steinmetz|216-445-5754|STEINMM@ccf.org|
21265526|NCT04532918|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21265527|NCT01230749|Janssen R&D US|Director, Translational Medicine|1 908 927-7881||
21265528|NCT03906136|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
21265529|NCT04772469|University of California San Francisco|Dr. Carol Camlin|5109679558|Carol.Camlin@ucsf.edu|
21265530|NCT00878644|University of Utah|Marianne Gildea, BSN, MS; Director of THAPCA Trials|801-608-4907|marianne.gildea@hsc.utah.edu|
21265531|NCT01389076|University of Michigan Comprehensive Cancer Center|Dr. Mark Kaminski, M.D.|734-936-5310|mkaminsk@umich.edu|
21265532|NCT00394277|Hoffmann-La Roche|Medical Communications|800-821-8590||
21265533|NCT02371980|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21265534|NCT00547729|Abbott|Clay Cohorn - Director, Clinical Research|469-929-7116|clay.cohorn@abbott.com|
21265535|NCT01280812|UC San Francisco|Yoshimi Fukuoka, PhD, RN, FAAN|415-476-8419|yoshimi.fukuoka@ucsf.edu|
21265536|NCT01060098|Imperial College London|Sonya Abraham|+44 (0)20 3313 4114|s.abraham@imperial.ac.uk|
21265537|NCT00789724|VCU Pauley Heart Center|Antonio Abbate, MD, PhD|8048280513|aabbate@mcvh-vcu.edu|
21265538|NCT00959894|UNC School of Medicine|Michelle Floris-Moore, M.D., M.S.|919-966-2537|mfloris@med.unc.edu|
21265539|NCT00922974|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21265540|NCT03682055|Cullinan Oncology|Phill Gallacher|+1 617 710 9127|pgallacher@cullinanoncology.com|
21265541|NCT00191386|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21265542|NCT01689324|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21265543|NCT01826448|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
21265544|NCT04038385|William Paterson University, Sociology Department|Jennifer Di Noia, PhD, Principal Investigator|19737203714|dinoiaj@wpunj.edu|
21265545|NCT05302804|University of Montana|Dustin Slivka|(406) 243-2389|dustin.slivka@umontana.edu|
21265546|NCT02935595|The University of Texas Health Science Center at Houston|Sudhakar Selvaraj, MD, PhD, Assistant Professor|(713) 486-2500|Sudhakar.Selvaraj@uth.tmc.edu|
21265547|NCT00402285|University of California, San Francisco|Peter Carroll, MD|415-353-7098|pcarroll@urology.ucsf.edu|
21265548|NCT00784459|Washington University|Dr Jonathan Green|314-747-3591|jgreen@wustl.edu|
21265549|NCT01391468|China Medical University|II-Kuan Wang|88975681050|ikwang@seed.net.tw|
21265550|NCT03669146|The Ohio State University College of Optometry|Ann Morrison|614-570-3416|morrison.421@osu.edu|
21265551|NCT02471586|Abbott|Kristina M Gibbens, Senior Clinical Project Manager|+1 651-756-3859|Kristina.gibbens@abbott.com|
21265552|NCT01510834|Pacific Health Research and Education Institute|Laurel King, PhD|808-564-5711|laurel.king@va.gov|
21265553|NCT00488059|Hoffmann-La Roche|Medical Communications|800-821-8590||
21265554|NCT01419015|Edwards Lifesciences|Aya Saeki||Aya_Saeki@edwards.com|
21265555|NCT04839393|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21265556|NCT01510028|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21265557|NCT02741310|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21295965|NCT03028987|Stanford University School of Medicine, Dept. of Pediatrics|Cornelia Dekker, MD|6507244437|cdekker@stanford.edu|
21265558|NCT05091918|Stryker|Kevin Barga|+12018315073|Kevin.Barga@stryker.com|
21265559|NCT00994760|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666|clinicaltrials@nycomed.com|0
21265560|NCT01766986|University Hospital Hamburg-Eppendorf|Dr. Matthias Reeh|+49015222816521|m.reeh@uke.de|
21265561|NCT01100658|Masonic Cancer Center, University of Minnesota|Alicia Kunin-Batson|612-624-6931|kunin003@umn.edu|
21265562|NCT01784211|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21265563|NCT02668952|Dept of Anesthesiology, University of New Mexico|Neal Gerstein, MD|5052722610|ngerstein@salud.unm.edu|
21265564|NCT00239356|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21265565|NCT01001572|Novartis Pharmaceuticals|Study Director|862 778-8300||
21265566|NCT01094808|Mayo Clinic|Dr. Michael Camilleri|507-266-2305|camilleri.michael@mayo.edu|
21265567|NCT00369278|Novartis Pharmaceuticals|Study Director|862-778-8300||
21265568|NCT05364437|Imperial College London|Gary Frost|07872850308|g.frost@imperial.ac.uk|
21265569|NCT01349972|University of North Carolina, Lineberger Comprehensive Cancer Center|Joshua Zeidner|(919) 962-5164|Joshua_Zeidner@med.unc.edu|
21265570|NCT02665468|VA-CHOIR|Dr. Timothy P. Hogan|781-687-3181|timothy.hogan@va.gov|
21265571|NCT02143141|Wake Forest School of Medicine|Dr. Jessica Booth|3367188278|jbooth@wakehealth.edu|
21265572|NCT04397796|ImmunityBio|Lennie Sender, Chief Operating Officer|855-797-9277|lennie.sender@immunitybio.com|
21265573|NCT01809197|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21265574|NCT00425113|National Institute of Allergy and Infectious Diseases|Ray Chen|301-443-5816|ray.chen@nih.gov|
21265575|NCT04362813|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
21265576|NCT04965116|University of California, San Diego|Dr. Sarah Averbach, MD, MAS|858-329-4464|familyplanningresearch@health.ucsd.edu|
21265577|NCT01153672|University of Washington|Hannah M. Linden, MD|206-288-6989|hmlinden@u.washington.edu|
21295966|NCT02068118|CDM e-Health|Clinical Development Physician|33 (0) 1 39 07 62 86|fralsi-ctpublication@airliquide.com|
21295967|NCT03035773|Johns Hopkins School of Public Health/SKCCC|Dr. Katherine C. Smith|443.927.3350|ksmit103@jhu.edu|
21295968|NCT00685373|Novartis Pharmaceuticals|Study Director|862-778-8300||
21295969|NCT02758301|Medtronic, PLC|Lindsay Werder, Senior Clinical Research Specialist|6123003066|lindsay.k.werder@medtronic.com|
21295970|NCT00582738|Pharmaceuticals|Novartis|41613241111||
21295971|NCT02228343|University of New Mexico Health Sciences|Hadya Khawaja|505-272-7028|hkhawaja@salud.unm.edu|
21295972|NCT03412097|Parker University|Dr. Katherine A Pohlman|972 438 6932|kpohlman@parker.edu|7148
21295973|NCT01167907|Wake Forest School of Medicine|Robert S. Weller, MD|336-716-7150|rweller@wakehealth.edu|
21295974|NCT00376805|Masonic Cancer Center, University of Minnesota|Sarah Cooley, MD|612-625-8474|cool0023@umn.edu|
21295975|NCT02916407|Inje University, Haeundae Paik hospital|Dr Ki Hwa Lee|82-51-797-0421|tedy3333@naver.com|
21295976|NCT01011933|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
21295977|NCT01439074|Changhai Hospital of Shanghai|Prof Xia, Zhaofan|+86 2181873471||
21295978|NCT00815191|Cleveland Clinic Foundation|Daniel Sessler|216-444-4900|DS@OR.org|
21295979|NCT01873729|Pediatric Psychopharmacology at Massachusetts General Hospital|Dr. Thomas Spencer|6177243883|tspencer@partners.org|
21295980|NCT01741532|ApoPharma Inc.|Caroline Fradette|416-401-7543|cfradett@apopharma.com|
21295981|NCT02463032|Oncternal|Mary Breitmeyer|858-434-1113|MBreitmeyer@oncternal.com|
21295982|NCT00613080|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.com|
21295983|NCT01066780|Advanced Bionics, LLC|Kenneth Ripley, Director of Clinical Research|1.661.362.1400|clinical.research@advancedbionics.com|
21295984|NCT02226549|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21295985|NCT04983797|Biosense Webster, Inc.|Associate Director Medical Affairs|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21295986|NCT03099148|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
21295987|NCT02312219|Mass General Hospital|Ahmed Tawakol, MD|617-726-0791|atawakol@mgh.harvard.edu|
21295988|NCT01100567|Boston Children's Hospital|Dr. Amy DiVasta, PI|6173553792|amy.divasta@childrens.harvard.edu|
21295989|NCT01005212|Houston Methodist Research Institute - Heart Center Research|Bevin Lopez, Clinical Trials Manager|7134413912|balopez@houstonmethodist.org|
21295990|NCT01498185|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
21295991|NCT00946322|Trauma Recovery Center, Cincinnati VA Medical Center|Jeremiah A. Schumm, PhD, Associate Director|859-572-6717|Jeremiah.Schumm@va.gov|
21295992|NCT02713529|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21295993|NCT03352453|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
21295994|NCT02367391|Penn State College of Medicine|Project Coordinator|7175310003|jyingst@phs.psu.edu|289511
21295995|NCT02827500|Duke Clinical Research Institute|Dr. Robert Mentz|919-668-7121|robert.mentz@duke.edu|
21295996|NCT03343080|Mayo Clinic|Dr. Troy Seelhammer|507-255-6051|seelhammer.troy@mayo.edu|
21295997|NCT01241760|Janssen Infectious Diseases BVBA|Compound Development Team Leader|32 14 64 13 70||
21295998|NCT00514020|Vanderbilt-Ingram Cancer Center|Laura Goff, MD|615-936-0059|laura.goff@vanderbilt.edu|
21295999|NCT04064346|Centessa Pharmaceuticals|Milena Kanova|+44 7780 430583|milena.kanova@centessa.com|
21296000|NCT00884910|Netherlands Cancer Institute|Prof Dr FJM Hilgers|+31 20 512 2550|f.hilgers@nki.nl|
21296001|NCT01636713|GlaxoSmithKline|GSK Response Center|866-435-7343||
21296002|NCT01667146|ANZIC - RC, Monash University|Prof Carol Hodgson|+61 (3) 99030598|carol.hodgson@monash.edu|
21296003|NCT02700165|Zeltiq Aesthetics|Kerrie Jiang, Exective Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
21296004|NCT01428336|Cleveland Clinic Foundation|Seenia Peechakara|216 4105901|peechas@ccf.org|
21296005|NCT02423122|EIP Pharma|John Alam||jalam@eippharma.com|
21296006|NCT00276614|David Geffen School of Medicine at UCLA|Matthew Rettig, M.D.|310-794-3565|mrettig@mednet.ucla.edu|
21265578|NCT01150760|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21296007|NCT01985763|Icahn School of Medicine at Mount Sinai|Dr. Sofya Pintova|212-824-8461|Sofya.Pintova@mountsinai.org|
21296008|NCT00552448|TexasTech|Dr. Adaobi Kanu|806 743 7336|adaobi.kanu@ttuhsc.edu|
21296009|NCT01522404|Emory University|Allan I. Levey, MD, PhD|404-727-7220|alevey@emory.edu|
21265579|NCT02076334|University University Chapel Hill|Abbie Smith-Ryan, PhD|919-962-2574|abbsmith@email.unc.edu|
21265580|NCT03238352|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21265581|NCT01614912|Clinical Research, Drug Development Division|Regional Function Head of CNS Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
21265582|NCT01654523|University of Michigan|Joseph Himle - Professor|7343303258|himlej@umich.edu|
21265583|NCT04294095|Colorado School of Public Health|Jenn Leiferman|303-724-4386|jenn.leiferman@cuanschutz.edu|
21265584|NCT01142193|Upsher-Smith Laboratories, Inc.|Bob Anders, Sr. Director of Clinical Operations|763-315-2000|Bob.Anders@upsher-smith.com|
21265585|NCT01062009|UCSF Benioff Childrens Hospital Oakland|Natalie Cvijanovich, MD|510-428-3784|NCvijanovich@mail.cho.org|
21265586|NCT01961089|Ziemer Ophthalmic Systems AG|Dr. Gregor Schmid|+41323327154|gregor.schmid@ziemergroup.com|
21265587|NCT04644484|Synermore Biologics Co., Ltd.|Director of Clinical Trials|+86-512-87658266|xjli@synermore.cn|8077
21265588|NCT04366713|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|1-424-248-6500|clinicaltrials@pumabiotechnology.com|
21265589|NCT00677560|Queen Mary University of London|Dr Harpal Singh Kalsi|07872492181|h.kalsi@qmul.ac.uk|
21265590|NCT03984838|ViiV Healthcare|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|1
21265591|NCT03136367|Dartmouth College|Marie-Anne Durand|603-667-8601|marie-anne.durand@dartmouth.edu|
21265592|NCT04034043|IRCSS Istituto Ortopedico Rizzoli|Federico Giardina|+390516366418|federico.giardina@ior.it|
21265593|NCT00523614|Berlin Center for Epidemiology and Health Research, Germany|Juergen Dinger, MD, PhD, Principal Investigator|+49 30 94510145|dinger@zeg-berlin.de|
21265594|NCT02146833|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
21265595|NCT03726333|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials_gov_Inquiries@pfizer.com|
21265596|NCT00189436|Allegheny Singer Research Institute, WPAHS|David Skoner, MD|412-359-4099|dskoner@hsc.wvu.edu|
21265597|NCT00442611|Stanford University|Dr. Lorinda Chung|(650)493-5000|shauwai@stanford.edu|6242
21265598|NCT00405275|VA Nebraska-Western Iowa Health Care System|James R. O'Dell, MD|402-559-7288|jrodell@unmc.edu|
21265599|NCT00088595|Novartis Pharmaceuticals|Study Director|862-778-8300||
21265600|NCT02058706|Karmanos Cancer Institute|Dr. Elisabeth Heath|313.576.8734|heathe@karmanos.org|
21265601|NCT03870893|Samsung Medical Center|Jeong-Yi Kwon|+821045911039|jeongyi.kwon@samsung.com|
21296010|NCT02525094|MedImmune, LLC|Rene van der Merwe|301-398-2532|information.center@astrazeneca.com|
21265602|NCT01308853|Akademikliniken, Stockholm, Sweden|Dr. Per Hedén|+46 8 614 54 00|per.heden@ak.se|
21265603|NCT01951326|RedHill Biopharma|Reza Fathi, Senior VP Research and Development|972-(0)3-541-3131|reza@redhillbio.com|
21265604|NCT03689699|Columbia University|Mark N. Stein, MD|212 305 5874|mns2146@cumc.columbia.edu|
21265605|NCT01376388|GlaxoSmithKline|GSK Response Center|866-435-7343||
21265606|NCT03542149|Medicines for Malaria Venture (MMV)|Dr. Helen Demarest|: +41 22 555 03 24|demaresth@mmv.org|
21265607|NCT02009930|David Grant Medical Center, Travis Air Force Base|Dr. Elijah Burton|707-423-7950|elijah.j.burton2.mil@mail.mil|
21265608|NCT02468804|University of Colorado Denver|Isabelle Buard, PhD|(303)472-5973|Isabelle.Buard@cuanschutz.edu|
21265609|NCT00666536|Novartis Pharmaceuticals|Study Director|862-778-8300||
21265610|NCT02252068|McLean Hospital|Dr. R. Kathryn McHugh|617-855-2000|kmchugh@mclean.harvard.edu|
21265611|NCT02853123|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21265612|NCT00671970|Dana Farber Cancer Institute|Dr. David Reardon|(617) 632-2166|David_Reardon@DFCI.HARVARD.EDU|
21265613|NCT03417505|Tangible Science|Dr. Kelly Mabry|650-241-1045|kelly@tangiblescience.com|108
21265614|NCT05686044|Annovis Bio, Inc.|Matthew Peterson, PhD|484-875-3192|peterson@annovisbio.com|
21265615|NCT03235726|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21265616|NCT00879437|Baylor College of Medicine|Jack Su|8328224306|jmsu@txch.org|
21265617|NCT00291187|Vanda Pharmaceuticals Inc.|Marlene Dressman, PhD.|202-734-3462|marlene.dressman@vandapharma.com|
21265618|NCT01040845|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21265619|NCT03882723|Rush University Medical Center|Dr. David Vines|3129424408|David_Vines@rush.edu|
21265620|NCT01732107|Hoosier Cancer Research Network|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
21265621|NCT02023268|Laboratoires Théa|Dr Pascale Pouliquen|04 73 98 14 36|p.pouliquen@laboratoires-thea.fr|
21265622|NCT04445688|Apnimed, Inc|Clinical Trials|617-500-8880|clinicaltrials@apnimed.com|
21265623|NCT00615459|Novartis Pharmaceuticals|Study Director|862-778-8300||
21265624|NCT00442260|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
21265625|NCT00660075|Laval University|Patrick Couture|418-654-2106|patrick.couture@crchul.ulaval.ca|
21265626|NCT02074904|UPENN|Timothy Pond, MPH|215-746-1959|timpond@pennmedicine.upenn.edu|
21265627|NCT00466661|Medical University of South Carolina|Bryan K. Tolliver, M.D., Ph.D. (Principal Investigator)|(843) 792-4869|tollive@musc.edu|
21265628|NCT01363258|UAB School of Nursing|Rita Jablonski|205-975-9019|rjablonski@uabmc.edu|
21265629|NCT00918346|Santen Oy|Auli Ropo|+358405012416|auli.ropo@santen.fi|
21265630|NCT03379376|Wake Forest University Health Sciences|Meg O'Mara - Study Coordinator|336-716-5440|megreen@wakehealth.edu|
21265631|NCT01611298|Baylor College of Medicine|Dr. Robert A. Krance|832-824-4661|rakrance@txch.org|
21265632|NCT04153929|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21265633|NCT04083794|Spaulding Rehabilitation Hospital Cambridge|Dr. Adina E. Draghici|617-758-5508|adraghici@mgh.harvard.edu|
21296011|NCT01490294|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21265634|NCT01170949|University Charité Berlin|Markus Magerl|+4930450618304|markus.magerl@charite.de|
21265635|NCT01749800|Spaulding Rehabilitation Hospital|Paolo Bonato|+1-617-952-6319|pbonato@partners.org|
21296012|NCT02789410|Mayo Clinic|Dr. Hans P. Sviggum|507-284-9697|sviggum.hans@mayo.edu|
21265636|NCT02801006|CooperVision|Jose Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com|
21265637|NCT01975675|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21265638|NCT03639987|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21265639|NCT00224003|Watson Laboratories, Inc|Gary Hoel, RPh, PhD|801-588-6641|gary.hoel@watson.com|
21265640|NCT02157168|University of Arizona|Dr. Ada Wilkinson-Lee, Co-Investigator|(520) 626-7766|adaw@email.arizona.edu|
21265641|NCT02971293|AstraZeneca|Dr Ioannis Psallidas, MD, PhD|1-877-240-9479|Information.centre@astrazeneca.com|
21265642|NCT00729326|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21265643|NCT03104985|State Scientific Center of Laser Medicine, Russia, Moscow|Sergey Moskvin|+7-905-770-1860|7652612@mail.ru|
21265644|NCT00661570|Netherlands Cancer Institute|Prof. Dr. F.J.M. Hilgers|+31-20-5122550|f.hilgers@nki.nl|
21265645|NCT01235728|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21265646|NCT01000025|NCIC Clinical Trails Group|Dr. Keyue Ding|1-613-533-6000|kding@ctg.queensu.ca|77705
21265647|NCT02738580|IVIValencia|DR. ERNESTO BOSCH|+34 963050900|Ernesto.Bosch@ivirma.com|
21265648|NCT04354155|Johns Hopkins All Children's Hospital|Anthony Alexander Sochet|17277672912|anthony.sochet@jhmi.edu|
21265649|NCT04197986|QED Therapeutics, Inc.|Acting Chief Medical Officer|1-877-280-5655|Proof302.ct@qedtx.com|
21265650|NCT00158223|Icahn School of Medicine at Mount Sinai|Dr. Joseph I. Friedman|631-761-3607|joseph.friedman@mssm.edu|
21265651|NCT01575899|Buddhist Tzu Chi General Hospital|Dr. Ming-Cheh, Chen|+886-910-521003|MingCheh_chen@tzuchi.com.tw|
21265652|NCT03097029|Children's Hospital of Philadelphia|Dr. Nina Sainath|267.426.1736|sainathn@email.chop.edu|
21265653|NCT02807844|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21265654|NCT00709124|Johns Hopkins University School of Medicine|Dr Dale Needham|(410) 955-3467|dale.needham@jhmi.edu|
21265655|NCT00373490|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21265656|NCT01669642|washington university in st louis|SRI SANKAR CHINTA PI|3144544661|schinta@wustl.edu|
21265657|NCT00753688|GlaxoSmithKline|GSK Response Center|866-435-7343||
21265658|NCT00108953|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21265659|NCT02999100|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21265660|NCT03803202|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21265661|NCT03595384|Emory University|Jennifer K Frediani PhD, RD|404-727-3766|jfredia@emory.edu|
21265662|NCT01125293|Dana-Farber Cancer Institute|Irene Ghobrial|617-632-4101|irene_ghobrial@dfci.harvard.edu|
21265663|NCT00936299|University of Colorado Denver|Paula Riggs, MD|303.724.2235|paula.riggs@ucdenver.edu|
21265664|NCT00659126|Oregon Health and Science University|Amy Huddleston|5034945626|huddlesa@ohsu.edu|
21265665|NCT02481596|Vanderbilt University Medical Center|Lindsay S. Mayberry, PhD, MS|615-875-5821|lindsay.mayberry@vumc.org|
21265666|NCT02228564|Becton Dickinson|Spark Yamanoglu|480-597-8604|Spark.yamanoglu@bd.com|
21265667|NCT01216397|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21265668|NCT01324687|University of Rochester|Manish N. Shah|585-276-6565|manish_shah@urmc.rochester.edu|
21265669|NCT02633046|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
21265670|NCT03406715|Moffitt Cancer Center|Alberto A. Chiappori, MD|813-745-4541|Alberto.Chiappori@moffitt.org|
21265671|NCT00845507|University of Cincinnati|Dr. DelBello|513-558-2989|Melissa.Delbello@uc.edu|
21265672|NCT01068717|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
21265673|NCT02679781|Hadassah School of Dental Medicine, P.O.Box 12272|Dr. Avia Fux-Noy|+97226776135|fuxavia@gmail.com|
21265674|NCT03700736|University of Connecticut|Dr. Molly Waring|860-486-1446|molly.waring@uconn.edu|
21265675|NCT00446641|Asan Medical Center, University of Ulsan College of Medicine|Professor Sun U. Kwon|82-2-3010-3960|sukwon@amc.seoul.kr|
21265676|NCT00302055|Northwestern University|Dr. Ronald T Ackermann|(312) 503-6400|r.ackermann@northwestern.edu|
21265677|NCT03180294|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21265678|NCT02650193|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21265679|NCT02108223|Sisli etfal training anf research hospital|Fatma yazıcı yılmaz|+905079234033|fatmayazc@gmail.com|
21265680|NCT02959970|Almirall LLC|Ayman Grada|610-840-7107|ayman.grada@almirall.com|
21265681|NCT03300427|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21265682|NCT02568852|Haseki-156|Dr.Turgut Donmez|00905347400967|surgeont73@hotmail.com|
21265683|NCT01473355|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
21265684|NCT04685538|Sintetica SA|Anna Guaita|+41 (0)91 640 42 50|aguaita@sintetica.com|
21265685|NCT00299416|UT-Houston Health Science Center, Department of Neurology|James C. Grotta, MD|713-500-7088|james.c.grotta@uth.tmc.edu|
21265686|NCT02017704|SKCCC @ Johns Hopkins Medicine|Amol Narang, MD|410-955-7390|anarang2@jhmi.edu|
21265687|NCT02475629|TaiMed Biologics USA Corp.|Manager - Clinical Services|(949) 331-3225|bbell@taimedbio.com|
21265688|NCT00928512|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21265689|NCT01963780|TransMedics, Inc.|VP, Clinical Affairs|978.552.0900|ldamme@transmedics.com|
21265690|NCT03383614|DNDi|Jean Yves Gillon|+41.22.906.92.32|jygillon@dndi.org|
21265691|NCT01296698|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
21296013|NCT01751776|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21296014|NCT01902459|Ethicon, Inc|Richard Kocharian, MD, PhD|+1 908-218-2013|rkochar1@its.jnj.com|
21265692|NCT01511640|University of Kentucky College of Medicine|Joshua Lile, Ph.D., Professor|8593236034|jalile2@uky.edu|
21265693|NCT03549429|Tufts Medical Center|Dr. Dan Drzymalski|‪617-913-8168|ddrzymalski@tuftsmedicalcenter.org|
21265694|NCT02754661|Medtronic GIH (Given Imaging LTD)|Liron Bar Yaakov, Senior Manager Clinical Affairs|972-526060466|liron.baryaakov@medtronic.com|
21265695|NCT04423757|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21265696|NCT01202760|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21265697|NCT02810951|Castle Creek Biosciences|Chief Medical Officer|(484) 713-6000|medinfo@castlecreekbio.com|
21265698|NCT03199638|Nemours Children's Health|Dr Dominique Darmaun, PI|904 6973674|ddarmaun@nemours.org|
21265699|NCT00293241|Medtronic Bakken|Lidwien Vainer|+31 433566752|lidwien.vainer@medtronic.com|
21265700|NCT00583661|Berlin Heart Inc.|Robert Kroslowitz, CEO|1-281-863-9700|kroslowitz@berlinheart.com|
21265701|NCT01367860|IOT/HC University of SãoPaulo|Dr. Alexandre Cristante Fogaça|+55 11 2661-6951|aacristante@uol.com.br|
21265702|NCT01270958|GlaxoSmithKline|GSK Response Center|866-435-7343||
21265703|NCT00260429|Auxilium Pharmaceuticals, Inc.|Greg Kaufman, MD; Senior Director of Clinical Development|484 321 5900|gkaufman@auxilium.com|5920
21265704|NCT03383627|Northwell Health|Lubaina Presswala, DO|516-708-2540|lpresswala@northwell.edu|
21265705|NCT02142504|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21265706|NCT01998399|Vanderbilt University|Gordon Bernard, Professor of Medicine, Associate Vice Chancellor for Research|615-343-0077|gordon.bernard@Vanderbilt.Edu|
21265707|NCT00971633|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
21265708|NCT03124901|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
21265709|NCT04114539|Emalex Biosciences, Inc.|Sr. Director of Clinical Operations|1847|dkim@emalexbiosciences.com|7150562
21265710|NCT00617591|H. Lee Moffitt Cancer Center and Research Institute|Rachid Baz, M.D.|813-745-8212|rachid.baz@moffitt.org|
21265711|NCT00376246|UCSD Medical Center|Ori Ben-Yehuda, MD|619-543-2814|obenyehuda@ucsd.edu|
21265712|NCT02766907|TissueTech|VP Medical Affairs|8882968858|hsheha@tissuetechinc.com|
21265713|NCT01711658|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21265714|NCT00166517|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21265715|NCT02918656|University of Split School of Medicine|Ivan Buljan|+385989027209|ibuljan@mefst.hr|
21265716|NCT01455415|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21265717|NCT03094611|The University of Texas MD Anderson Cancer Center|Elias Jabbour, MD./ Professor, Leukemia|713-792-4764|ejabbour@mdanderson.org|
21265718|NCT04285853|Emory University|Dr. John Xerogeanes|404-778-7202|jxeroge@emory.edu|
21265719|NCT04128527|Ambu|Signe Toräng|31267089|sito@ambu.com|
21265720|NCT02758613|Eli Lilly and Company|Chief Medical Officer|800-545-5079||
21265721|NCT01496274|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
21265722|NCT00721617|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
21265723|NCT00351819|Brigham and Women's Hospital|Dr. Shehzad Basaria|617-525-9150|sbasaria@partners.org|
21265724|NCT01877941|University of California San Francisco|Arthur Wallace, M.D., Ph.D.|415-750-2069|art.wallace@va.gov|3732
21265725|NCT00249795|sanofi-aventis|International Clinical Development, Clinical Study Director||GV-Contact-us@sanofi-aventis.com|
21265726|NCT03179410|Duke University|Andrew Armstrong, M.D.|919-668-8797|andrew.armstrong@duke.edu|
21265727|NCT00719537|William Beaumont Hospital|John Uckele|2485510610|john.uckele@beaumont.edu|
21265728|NCT02460978|AstraZeneca|Anna Maria Langkilde|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
21265729|NCT03380000|Penn State University|David N. Proctor|8145715234|dnp3@psu.edu|
21265730|NCT02562989|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21265731|NCT00588523|Memorial Sloan Kettering Cancer Center|Dr. Thomas Kaley, MD|212-639-7523|kaleyt@mskcc.org|
21265732|NCT01459068|Johns Hopkins Bloomberg School of Public Health|Courtland Robinson|4104155266|crobinso@jhsph.edu|
21265733|NCT00088972|SWOG|Study Statistician|206-667-4623||
21265734|NCT00841269|University of Utah|Dr. Douglas Kondo|(801) 587-1549|doug.kondo@hsc.utah.edu|
21265735|NCT02023112|AbbVie|Global Medical Information|800-633-9110||
21265736|NCT02910219|Georgetown University|Sandra M. Swain, MD, FACP, FASCO|202-687-4600|Sandra.Swain@georgetown.edu|
21265737|NCT01425749|University of Virginia|Craig L Slingluff Jr|434-924-1730|cls8h@virginia.edu|
21265738|NCT02096042|The University of Texas (UT) MD Anderson Cancer Center|Nitin Jain, MD/Assistant Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
21265739|NCT00701441|Ohio State University|Rami Khayat|614-247-7707|rami.khayat@osumc.edu|
21265740|NCT02690168|Pennington Biomedical Research Center|Dr. David McDougal|2257630278|DAVID.MCDOUGAL@PBRC.EDU|
21265741|NCT04209400|VBI Vaccines Inc.|Dr Francisco Diaz-Mitoma|613-297-3304|fdiazmitoma@vbivaccines.com|
21265742|NCT03404518|Loma Linda University Health System|Khanh Nguyen, MD|909-558-8558|khanguyen@llu.edu|
21265743|NCT01347632|CONRAD|Andrea Thurman|757-446-7444|thurmaar@evms.edu|
21265744|NCT00771173|Loyola University Chicago|Dr. Linda Brubaker|708-216-3960|lbrubaker@lumc.edu|
21265745|NCT00651313|Columbia Laboratories, Inc.|George W. Creasy, MD Vice President, Clinical Research|973-486-8797|gcreasy@columbialabs.com|
21265746|NCT03328624|SALSA@USC|Research Coordinator|323-442-5528|dhuyvett@usc.edu|
21265747|NCT01760187|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|8572425142|alison.long@aegerion.com|
21265748|NCT03296787|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21265749|NCT02853032|University of Texas Health -- San Antonio|Felipe S. Salinas, Ph.D.|210-567-8214|salinasf@uthscsa.edu|
21265750|NCT01962688|Icahn School of Mediine at Mount Sinai|Dr. Jagat Narula|212-241-4122|jagat.narula@mountsinai.org|
21265751|NCT02823080|Benha university|dr khalid M Salama|01225861026|dr.khalid_sleem@yahoo.com|
21265752|NCT00676208|Louis Stokes VA Medical Center|Michelle Davidson|(216) 791-2300|michelle.davidson@va.gov|2338
21265753|NCT01410799|University of Pennsylvania|Dr. Anne Cappola|215-573-5359|acappola@upenn.edu|
21265754|NCT00617656|Fundación GECP|Eva Pereira|+34 934302006|gecp@gecp.org|
21265755|NCT01696396|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21265756|NCT00983242|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlpharma.com|
21265757|NCT00323310|Bracco Diagnostics Inc|Usha Halemane/Executive Director|609-514-2578|usha.halemane@diag.bracco.com|
21265758|NCT03565991|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21265759|NCT02314598|Medtronic|Ilaria Marcotullio|+39 06 32814218|ilaria.marcotullio@medtronic.com|
21265760|NCT00937326|GlaxoSmithKline|GSK Response Center|866-435-7343||
21265761|NCT00681291|LifeCell|Donna Jacobs|908-809-7856|djacobs@lifecell.com|
21265762|NCT00790218|Can-Fite BioPharma|Sari Fishman, Director of Clincal Trials|972528998666|sari@canfite.co.il|
21265763|NCT00086385|University of California, San Francisco|Sharon M. Hall, PhD|415-476-7574|sharon.hall@ucsf.edu|
21265764|NCT00899600|Dartmouth-Hitchcock Medical Center|Dr. Randy Loftus|6036504642|randy.w.loftus@hitchcock.org|
21265765|NCT01149772|Michael E. DeBakey VA Medical Center|Dr. Jeffrey Cully|713-794-8526|Jeffrey.Cully@va.gov|
21265766|NCT00880100|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1- 800- 472- 263||
21265767|NCT02225925|Johns Hopkins University|Daniel Song|410-502-5875|dsong2@jhmi.edu|
21265768|NCT03424044|Oregon Health and Science University|Jessica Castle MD|503-494-7072|castleje@ohsu.edu|
21265769|NCT00505518|Massachusetts General Hospital|Albert Yeung|617-724-5138|ayeung@partners.org|
21265770|NCT02279160|United Therapeutics|Derek Solum, PhD|919-425-8122|dsolum@unither.com|
21265771|NCT04402385|Yale School of Medicine|Olga Grechukhina, MD: Assistant Professor of Obstetrics, Gynecology & Reproductive Sciences|(203) 785-3091|olga.grechukhina@yale.edu|
21265772|NCT00731666|Coloplast Corp|Clinical Trials Manager|612-302-4990|usdibe@coloplast.com|
21265773|NCT00693420|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
21265774|NCT00509028|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
21265775|NCT04241120|HabitAware|Sameer Kumar|2489904720|sameer@habitaware.com|
21265776|NCT03008187|Menarini Ricerche|Angela Capriati, MD|+39 055 56 80 9990|acapriati@menarini-ricerche.it|
21265777|NCT05516134|Hopeful Aging|Michael Skrajner|4404777881|mike@hopefulaging.com|
21265778|NCT01155193|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21265779|NCT03962634|Virginia Commonwealth University|Parthasarathy Madurantakam|804-828-4953|madurantakap@vcu.edu|
21265780|NCT01355497|GTx Inc.|Senior Director, Clinical Operations|1-901-261-3795|mdesordi@gtxinc.com|
21265781|NCT01502761|University of Southern California|Dr. William J Mack|323 442 7512|william.mack@med.usc.edu|
21265782|NCT01838655|National Institutes of Health|Brian Brooks, MD, PhD, Principal Investigator, NEI|301-451-2238|brian.brooks@nih.gov|
21265783|NCT05935982|University of Alabama at Birmingham (UAB)|Byron Lai, PhD|205-638-9790|byronlai@uab.edu|8-9725
21265784|NCT01831804|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21265785|NCT01819506|Ralph H Johnson VAMC|Michelle Woodbury|843-792-1671|Woodbuml@musc.edu|
21265786|NCT02420990|Center on Addiction|Dr. Aaron Hogue|212-841-5278|ahogue@centeronaddiction.org|
21265787|NCT03326583|George Washington Medical Faculty Associates|Dominic Raj|(202) 741-2296|draj@mfa.gwu.edu|
21265788|NCT00228943|Indiana University|Janet S. Carpenter|317-278-6093|carpentj@iupui.edu|
21265789|NCT00176878|Masonic Cancer Center, University of Minnesota|Paul Orchard, M.D.|612-626-2313|orcha001@umn.edu|
21265790|NCT01784614|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21265791|NCT00114218|NRG Oncology|Linda Gedeon for Austin Miller, PhD.|716-845-1169|lgedeon@gogstats.org|
21265792|NCT01505114|Fred Hutchinson cancer Research center|Chunyuan Wu|206-667-5567|cwu@scharp.org|
21265793|NCT03168555|Zealand University Hospital|Dr. Christian Borup, coordinating investigator|+4523328035|chrbo@regionsjaelland.dk|
21265794|NCT02165072|Texas Tech university Health Sciences Center, Lubbock, TX|Dr Kenneth Nugent|(806) 743-6847|Kenneth.nugent@ttuhsc.edu|
21265795|NCT01235507|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21265796|NCT01082588|Massachusetts General Hospital|Dr. David Henderson|617-912-7800|dchenderson@partners.org|
21265797|NCT01587274|Montefiore Health|Benjamin W. Friedman, MD|7189206626|befriedm@montefiore.org|
21296015|NCT00831701|Department of Urology, University Hospital Zürich, Switzerland|Räto T. Strebel|0041-44-2551111|raeto.strebel@ksgr.ch|
21296016|NCT02117349|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
21265798|NCT01421069|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21296017|NCT02535416|Arrowhead Pharmaceuticals, Inc.|James Hamilton, MD|626-696-3400|jhamilton@arrowheadpharma.com|
21296018|NCT00693654|Wake Forest University Health Sciences|Alan Fleischer, Jr., MD|336-716-7753|afleisch@wfubmc.edu|
21296019|NCT01977690|Johann Wolfgang Goethe University|Stephan Duetzmann|001491781470479|stephan.duetzmann@gmail.com|
21296020|NCT01058941|Oregon Health & Science University|Dr. Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu|
21296021|NCT02644356|Collinge and Associates, Inc.|William Collinge, PhD, MPH|541-632-3502|william@collinge.org|
21296022|NCT01557881|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Philipp Frank Graner|+1 216-844-8275|philipp.graner@uhhospitals.org|
21296023|NCT02210091|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21265799|NCT01641081|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
21265800|NCT00643097|Duke University Medical Center|Dr. John H. Sampson|919-684-9041|john.sampson@duke.edu|
21265801|NCT01095666|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
21265802|NCT01927887|Massachusetts General Hospital|Mukesh Harisinghani|6176432009|mharisinghani@partners.org|
21265803|NCT03297944|University of Kentucky|Marion Coe|859-257-6488|mcoe07@gmail.com|
21265804|NCT01250756|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21296024|NCT00737594|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
21296025|NCT01711866|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
21296026|NCT00897390|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
21296027|NCT01831817|GlaxoSmithKline|GSK Response Center|866-435-7343||
21296028|NCT03159104|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
21296029|NCT00958217|VA San Diego Healthcare System/UCSD|Susan R. Tate, Ph.D., Clinical Psychologist|619-426-9402|srtate@ucsd.edu|
21296030|NCT01742065|Kaiser Permanente Center for Health Research|Gloria D. Coronado|503 335 2427|Gloria.D.Coronado@kpchr.org|
21296031|NCT02440789|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21296032|NCT01858753|Castle Creek Biosciences|Head, Research and Development|13128471291|medinfo@castlecreekbio.com|
21265805|NCT01854593|Department of Ophthalmology, Surugadai Hospital of Nihon University|Dr. Ayumu Manabe|+81-3-3293-1711|ayumu.m76@gmail.com|429
21265806|NCT02925312|Medstar Health Research Institute|Dr Michelle Magee|2028772383|michelle.f.magee@medstar.net|
21265807|NCT00537680|Santhera Pharmaceuticals|Dr Thomas Meier|+41619068964|thomas.meier@santhera.com|
21296033|NCT05065190|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21296034|NCT04544683|University of Utah Orthopaedic Center/ Physical Medicine & Rehabilitation|Aaron Conger, MD|801-587-1493|u6007025@umail.utah.edu|
21296035|NCT00151372|Weill Cornell Medical College|George S. Alexopoulos, M.D.|914-997-5767|gsalexop@med.cornell.edu|
21296036|NCT01266590|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21296037|NCT04253587|UCSF Dept of Neurology|Peter Wais, Principal Investigator|415-502-1212|peter.wais@ucsf.edu|
21296038|NCT04732949|Synairgen|Brooke Clarke, SVP, Head of Communications|02380 512 800|info@synairgen.com|
21296039|NCT05160766|University Hospital Cologne|Prof. Dr. med. Oliver A. Cornely|0049 221 478 85523|oliver.cornely@uk-koeln.de|
21296040|NCT01282294|Synthes GmbH|Clinical Research Scientist|0041 32 720 44 65|clinicalaffairs.emea@synthes.com|
21296041|NCT00877370|University of Michigan|Bruce A. Mueller|(734) 615-4578|muellerb@umich.edu|
21296042|NCT00418977|Icahn School of Medicine at Mount Sinai|Katharine Loeb, PhD|212-659-8724|katharine.loeb@mssm.edu|
21296043|NCT00890682|Pacira Pharmaceuticals, Inc|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
21296044|NCT04979910|Icahn School of Medicine at Mount Sinai|Esther Lee|212-585-6133|esther.lee@mssm.edu|
21296045|NCT04030962|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21296046|NCT05601102|University of Stirling|Professor Anna C. Whittaker|0178646|a.c.whittaker@stir.ac.uk|7816
21296047|NCT05621239|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
21296048|NCT06504524|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21296049|NCT04424225|University of Minnesota|Jessica Nielson|714-904-7939|jnielson@umn.edu|
21296050|NCT04284813|McLean Hospital/Harvard Medical School|Julie M. McCarthy, PhD|6178553521|jmccarthy@mclean.harvard.edu|
21296051|NCT03106415|Mayo Clinic|Saranya Chumsri MD|904-953-2000|Chumsri.Saranya@mayo.edu|
21296053|NCT01804582|University of Maryland, Baltimore|Gloria M. Reeves, M.D.|410-328-3522|greeves@psych.umaryland.edu|
21296054|NCT02811913|VA Northeast Ohio Healthcare System|Dr. Svetlana Pundik|(216)791-3800|svetlana.pundik@va.gov|
21296055|NCT00385723|Institute for Behavioral Medicine Research, Ohio State University College of Medicine, OH, USA|Dr. Janice K. Kiecolt-Glaser|+1 614 293 3499|Janice.Kiecolt-Glaser@osumc.edu|
21296056|NCT01390779|UCSD|Mona Moshtaghi|858 534-6290|momoshta@ucsd.edu|
21296057|NCT03455829|G1 Therapeutics, Inc.|Clinical Trial Info.|919-213-9835|clinicalinfo@g1therapeutics.com|
21296058|NCT03446053|Institute of iNtRON Biotechnology|Jun SooYoun, Ph.D. / Executive Director/ Principal researcher|+82-31-739-5332|jsy@intron.co.kr|
21296059|NCT01789138|Department of Public Health, University of Tartu, ESTONIA|Prof. Anneli Uusküla|+372 7374195|anneli.uuskula@ut.ee|
21296060|NCT03040414|HealthPartners Institute|Amy Becker LaFrance, Sr. Manager, Research Project Management Office|952.967.5079|Amy.B.LaFrance@healthpartners.com|
21296061|NCT01305655|NOPHO|Dr Jesper Heldrup|+46705172389|jesper.heldrup@skane.se|
21296062|NCT03689712|Galera Therapeutics|Megan Holm|484-615-2036|mholm@galeratx.com|
21296063|NCT00689793|Departement of ambulatory care and community medicine, University of Lausanne, Switzerland|Dr Bernard Favrat MD|+41795566183314|Bernard.favrat@chuv.ch|
21296064|NCT01224444|White River Junction VA|Heiko Pohl|802-295-9363|heiko.pohl@dartmouth.edu|5595
21296065|NCT01342549|Michael E. DeBakey VAMC|Dr. Ricardo Jorge|713-794-7010|ricardo.jorge@va.gov|
21296066|NCT02674425|PolyPhotonix|Dr|00441740625|duncan@polyphotonix.com|557
21296067|NCT01189292|Department of General, Abdominal and Transplant Surgery, University of Heidelberg|Dr. Ignazio Tarantino||ignazio.tarantino@med.uni-heidelberg.de|
21296068|NCT02459275|University of Miami|Dr. D. Dante Yeh|305-585-1822|dxy154@med.miami.edu|
21296069|NCT00875056|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21296070|NCT00708734|Tampa VA Hospital|Tatjana Bulat|8135583932|tatjana.bulat@va.gov|
21296071|NCT02634606|UCLA Department of Medicine/Center for Human Nutrition|Zhaoping Li, Professor|310-206-1987|zli@mednet.ucla.edu|x61987
21296072|NCT01842581|Bausch Health Americas, Inc.|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
21296073|NCT01995552|India Medtronic Pvt. Ltd.|Vinay Rajan Ph.D|+91 22.3307.4700|vinay.rajan@medtronic.com|
21296074|NCT00140842|Massachusetts General Hospital|Madhu Misra, MD|617-724-5602|mmisra@partners.org|
21296075|NCT00283868|University of California, San Diego|Brett C. Meyer, MD|619-543-7760|bcmeyer@ucsd.edu|
21296076|NCT00353873|GlaxoSmithKline|GSK Response Center|866-435-7343||
21296077|NCT01968057|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21296078|NCT03743064|Helsinn Healthcare SA|Florin Muraru|+41 91985 21 21|florin.muraru@helsinn.com|
21265808|NCT01225172|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21265809|NCT02758119|iLumens|David Drummond|0033144494848|david.drummond@ilumens.org|6
21265810|NCT01822223|University of Alabama at Birmingham|Michael S. Reddy, DMD, DMSc|2059344720|mreddy@uab.edu|
21265811|NCT00360685|Moffitt Cancer Center|Janelle Perkins, PharmD|813-745-7226|Janelle.Perkins@moffit.org|
21265812|NCT03001310|MeiraGTx|Program Manager|0044 (0)20 3866 4320|CNGB3@meiragtx.com|
21265813|NCT05041062|University of Chicago|Theodore Karrison (Research Professor)|773-702-9326|tkarrison@health.bsd.uchicago.edu|
21265814|NCT04018612|Nevakar, Inc.|Eric Lang, MD|(908) 367-7400|Clinicaltrials@nevakar.com|
21265815|NCT00044655|NYSPI|Nancy H. Covell, Ph.D.|6469450227|covelln@nyspi.columbia.edu|
21265816|NCT00361218|Massachusetts General Hospital|John W. Denninger, MD, PhD|617-726-2985|jdenninger@partners.org|
21265817|NCT03693404|NYU Langone Health|Philipp Leucht, MD|646-501-0291|philipp.leucht@nyulangone.org|
21265818|NCT01176240|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
21265819|NCT05200455|Dartmouth-Hitchcock Medical Center|Dr. Barbara Jobst|6036505000|Barbara.C.Jobst@hitchcock.org|
21265820|NCT00807014|GlaxoSmithKline|GSK Response Center|866-435-7343||
21265821|NCT00892957|BAXTER INNOVATIONS GmbH|Edith Hantak, Dir, Global Therapeutic Area, BioSurgery||edith_hantak@baxter.com|
21265822|NCT03307629|Noxopharm|Lorena Figueroa, Director clinical Operations|+612 9144 2223|lorena.figueroa@noxopharm.com|
21265823|NCT04876599|Massachusetts General Hospital|Dr. Daniel Hall|‭+1 (704) 517-7273‬|dhall7@mgh.harvard.edu|
21265824|NCT04482244|Dana-Farber Cancer Institute|Dr. Manan Nayak|617-632-5096|manan_nayak@dfci.harvard.edu|
21265825|NCT00669032|Tedec-Meiji Farma, S.A.|R&D Director|918870980|m.gimeno@tedecmeiji.com|
21265826|NCT01379924|Boston Children's Hospital|Dr. Joanne Cox|6173557701|joanne.cox@childrens.harvard.edu|
21265827|NCT00642018|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21265828|NCT01607073|Gillette Children's Specialty Healthcare|Beverly Wical, MD|(651) 229-3870|BWical@gillettechildrens.com|
21265829|NCT02564029|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21265830|NCT04126031|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21265831|NCT00131664|Dr. Anatoly Langer, Chair CHRC, Canadian Heart Research Centre|Dr. Robert Josse|416-977-8010|langera@chrc.net|
21265832|NCT01946412|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21265833|NCT04374149|Prisma Health|Dr. Julie Martin, Director of Cancer Research|(864) 455-3667|julie.martin@prismahealth.org|
21265834|NCT00053014|SWOG statistical office|SWOG leukemia statistician|206-667-4408||
21296079|NCT00870194|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21296080|NCT01483209|Duke University Medical Center|Dr. Cynthia Shortell|919-681-2223|cynthia.shortell@duke.edu|
21296081|NCT02573246|Duke University Health System|Dr. Andrada D. Neacsiu|919-684-6714|andrada.neacsiu@duke.edu|
21296082|NCT03149003|Sumitomo Pharma Oncology|Sheila Dhaskali|617-674-6800|Sheila.dhaskali@oncology.sumitomo-pharma.com|
21296083|NCT01443130|University of Maryland School of Medicine|Miriam K. Laufer, MD, MPH|410-706-5333|mlaufer@medicine.umaryland.edu|
21296084|NCT00364533|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-6780||
21296085|NCT04557787|Coloplast A/S|Vice President, Medical Affairs|+454911 1111|clinical-studies@coloplast.com|
21296086|NCT00701636|LA BioMed at Harbor-UCLA Medical Center|Loren Miller MD|310-222-3813|Lgmiller@ucla.edu|
21296087|NCT02639338|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21296088|NCT00493636|ACORN Research, LLC|Study Chair|901-435-5570|lschwartzberg@acornresearch.net|
21296089|NCT03094286|Fundación GECP|Eva Pereira|+34 934302006|gecp@gecp.org|
21296090|NCT02900170|Albert Einstein Medical Center|Basma Abdulhadi|215456500|abdulhab@einstein.edu|
21296091|NCT01291836|Alere San Diego|William Arnold|858-505-2000|william.arnold@alere.com|
21296092|NCT02945553|University of Vermont College of Medicine|Michael Toth|802-656-7989|michael.toth@med.uvm.edu|
21250722|NCT02133131|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
21250723|NCT00509925|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21250724|NCT00230971|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21250725|NCT00068718|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
21250726|NCT00951171|WIHRI|Andrew S Blazar, MD Principal Investigator|401-274-1122|ablazar@WIHRI.org|8461
21250727|NCT02868788|State University of NY at Buffalo|Paresh Dandona|7165351852|dandona@buffalo.edu|
21250728|NCT03579680|University of Michigan|Ted Skolarus|Ph: (734) 845-3506|tskolarus@uchicago.edu|
21250729|NCT05294328|LENZ Therapeutics, Inc.|Marc Odrich, MD|(646) 249-2800|marc@lenz-tx.com|
21250730|NCT04267393|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21250731|NCT03864341|NYU Langone Health|Kelly Doran, MD, MHS|(212) 263-5850|Kelly.doran@nyulangone.org|
21250732|NCT01066936|Smith & Nephew|Tracey Brengola|978-319-2702|tracey.brengola@smith-nephew.com|
21250733|NCT01811498|Northwell Health|John Boockvar, MD|212-434-3900|jboockvar@northwell.edu|
21250734|NCT02416713|University of Pennsylvania|Dr. M. Kit Delgado|215-746-8256|Mucio.Delgado@uphs.upenn.edu|
21250735|NCT04156399|University of Illinois Chicago|Judith Schlaeger, PhD|3124134669|jschlaeg@uic.edu|
21250736|NCT03339271|Mayo Clinic|Dr. Joan Griffin|507-538-1490|griffin.joan@mayo.edu|
21250737|NCT01929876|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21250738|NCT03991988|Emory University|Dr. Ihab Hajjar|4047121763|ihajjar@emory.edu|
21250739|NCT00248534|North American Brain Tumor Consortium|Lauren Abrey, MD|410-955-3657|jfisher@jhmi.edu|
21250740|NCT01222533|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21250741|NCT03418493|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21265835|NCT03250624|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
21265836|NCT00106249|CUNY|Dr. Antonio Mantovani|212-650-5417|amantovani@med.cuny.edu|
21265837|NCT01810289|University of California at San Francisco|Dr. Elvin Geng|415-476-4082|elvin.geng@ucsf.edu|409
21265838|NCT01597440|Children's National Health System|Dr. Mendel Tuchman||mtuchman@childrensnational.org|
21265839|NCT00948428|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
21265840|NCT01952288|VA Puget Sound Health Care System|Rebekah J. Rein, JD|206-764-2711|rebekah.rein@va.gov|
21265841|NCT01843205|University of Kentucky|Craig R. Rush, Ph.D.|(859) 257-5388|crush2@email.uky.edu|
21265842|NCT00606177|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
21265843|NCT00136357|The Center for Mind-Body Medicine|Dr. James Gordon|202-966-7338|jgordon@cmbm.ort|
21265844|NCT01518309|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
21265845|NCT02603172|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21265846|NCT00863317|Richmond Emergency Physicians Inc|Frank Petruzella|773 447-2489|fpetruzella@gmail.com|
21265847|NCT00927576|VANCHCS|Dr. David L. Woods|925-372-2571|dlwoods@ucdavis.edu|
21265848|NCT00038142|The University of Texas (UT) MD Anderson Cancer Center|Dr. Eugenie S. Kleinerman, Professor, Pediatrics - Research|713-792-8110|ekleiner@mdanderson.org|
21265849|NCT00441727|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
21265850|NCT00762528|Colgate Palmolive Company|William DeVizio, DMD|732-878-7901|william_Devizio@colpal.com|
21265851|NCT00728728|VHA Durham|Christine E. Marx, MD|9192860411|christine.marx@va.gov|3626
21265852|NCT02133001|Janssen Research & Development, LLC|Senior Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21265853|NCT04211961|University of Galway|Dr. Alberto Alvarez-Iglesias|+35391524411|alberto.alvarez-iglesias@universityofgalway.ie|
21265854|NCT00420342|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21265855|NCT03933215|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21265856|NCT04586673|University of Oxford|Dr Paola Cicconi|01865611425|paola.cicconi@ndm.ox.ac.uk|
21265857|NCT05784129|Janssen Pharmaceuticals, Inc, US Medical Affairs|Medical Director Gastroenterology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21265858|NCT00407550|Mayo Clinic|Julian R. Molina, M.D., Ph.D.|507-284-8318|molina.julian@mayo.edu|
21265859|NCT01444898|Children's Hospital Los Angeles|Dr. Mitchell Geffner|323-361-7032|mgeffner@chla.usc.edu|
21265860|NCT02238782|AstraZeneca|Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com|
21265861|NCT02580591|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21265862|NCT01801124|Maimonides Medical Center|Mark Kronefeld, MD|(718) 283-8816||
21265863|NCT01599806|AstraZeneca/ PPD|Gayan Makumburage|9105588682|gayan.makumburage@ppdi.com|
21265864|NCT02023918|UCSF|Dr. Ethan Weiss|4155140819|ethan.weiss@ucsf.edu|
21265865|NCT00324272|John Radcliffe Hospital|Mr. Henk Giele, Consultant Plastic & Reconstructive Surgeon|01865 231 056|henk.giele@orh.nhs.uk|
21265866|NCT00990249|The University of Texas (UT) MD Anderson Cancer Center|Partow Kebriaei, MD/Professor, Stem Cell Transplantation|713-792-7734|CR_Study_Registration@mdanderson.org|
21265867|NCT00602771|SKCCC|Judith Karp, MD|410-502-7726|jkarp2@jhmi.edu|
21265868|NCT02873208|Alkermes|Director, Corporate and R&D Communications|781-609-7000|Gretchen.Murphy@alkermes.com|
21265869|NCT00415584|Montefiore Medical Center|Dr. Maria Coco|718-920-4136|mcoco@montefiore.org|
21265870|NCT01061567|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21265871|NCT00563368|Vivus, Inc.|Wesley W. Day PhD|650-934-5200|day@vivus.com|
21265872|NCT02640755|AstraZeneca|Medical Science Director||clinicaltrialtransparency@astrazeneca.com|
21265873|NCT03979872|University of Utah|Dr. Yelena Wu|801-213-5653|yelena@utah.edu|
21265874|NCT01192100|Purdue University|Dr. Heather Leidy|765-496-0184|hleidy@purdue.edu|
21265875|NCT00588380|Mayo Clinic|Adrian Vella|507-284-3754|vella.adrian@mayo.edu|
21265876|NCT00841672|Novartis Pharmaceuticals|Study Director|862-778-8300||
21265877|NCT02352103|Vattikuti Urology Institute, Henry Ford Hospital|Deepansh Dalela, MD|3139162600|ddalela1@hfhs.org|
21265878|NCT02186561|Medtronic Neurovascular, Clinical Affairs|Senior Project Manager, Clinical Project Management|949-680-1274|darren.j.lacour@medtronic.com|
21265879|NCT00842361|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21265880|NCT02573233|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21265881|NCT01072448|Novartis Pharmaceuticals|Study Director|862 778-8300||
21265882|NCT02119468|City of Hope National Medical Center|Dr. Amrita Krishnan|626-256-4673|AKrishnan@coh.org|62405
21265883|NCT05103475|Veterans Health Administration|Bella Etingen, PhD|214-857-0240|Bella.Etingen@va.gov|
21265884|NCT00196196|Codman & Shurtleff, Inc.|Jandira Ramos, MPH|508-828-3127|jramos8@its.jnj.com|
21265885|NCT00214487|Dr. Thomas Aller, Optometrist Inc.|Dr. Thomas Aller|650 871-1816|cptreyes@earthlink.net|
21265886|NCT01015820|Mayo Clinic|Dr. Michael B. Wallace|904-953-6970|wallace.michael@mayo.edu|
21265887|NCT03034057|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21265888|NCT03339401|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
21265889|NCT00718523|Translational Research In Oncology (formerly CIRG)|Matthieu Rupin|+331 58 10 08 89|matthieu.rupin@trioncology.org|
21265890|NCT01313078|National Cancer Institute, National Institutes of Health|Elise Kohn, M.D.|301-496-9336|kohne@mail.nih.gov|
21296093|NCT01703065|University of Washington|Dr. Celestia Higano, MD|206-606-1152|thigano@u.washington.edu|
21296094|NCT02124772|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21265891|NCT00910728|AstraZeneca|Dr Gregory Curt, MD|+1 301 398 0109|Gregory.Curt@astrazeneca.com|
21265892|NCT01042938|University of Rochester Medical Center|Julie L Ryan, PhD, MPH (PI)|585-276-3862|julie_ryan@urmc.rochester.edu|
21265893|NCT03136484|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21265894|NCT04399980|Cleveland Clinic|Paul C. Cremer, MD|216-444-6765|cremerp@ccf.org|
21265895|NCT01449955|UT Southwestern/VA North Texas|Dr. Alina Suris|214-857-0334|alina.suris@va.gov|
21265896|NCT01203787|UNIVERSITY OF FLORIDA|Roniel Cabrera, MD|352-273-9468|RONIEL.CABRERA@MEDICINE.UFL.EDU|
21265897|NCT00856986|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21265898|NCT01601470|Novartis Pharmaceuticals|Study Director|862-778-8300||
21265899|NCT03032510|La Jolla Pharmaceutical Company|Chief Development Officer|617-715-3600|ljpcregulatory@ljpc.com|
21265900|NCT03061812|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21265901|NCT01602549|GlaxoSmithKline|GSK Response Center|866-435-7343||
21265902|NCT01576406|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21265903|NCT02091921|University of Southern California|Leonardo Clavijo, MD|3234426130|lclavijo@usc.edu|
21265904|NCT02483078|CytoDyn|Joseph Meidling Senior Director Clinical Operations|(360) 980-8524|jmeidling@cytodyn.com|
21250742|NCT01947517|Queen's University|Dr. Stephanie Baxter|613 544 3310|baxters@baxtereyemd.com|
21250743|NCT05446714|al-azhar university|dr. mohamed shendy|01223303833|Shendy_ortho@azhar.edu.eg|
21250744|NCT02276638|Nidek|Head, Regulatory Affairs|(800) 223-9044|support@nidek.com|
21250745|NCT02742532|University of California, San Francisco|Jennifer Mitchell, PhD|510-985-3921|jennifer.mitchell@ucsf.edu|
21250746|NCT02418845|Lupin Pharmaceuticals Inc|Gregory Kaufman, MD|908.603.6062|gregorykaufman@lupin.com|
21250747|NCT00460564|GlaxoSmithKline|GSK Response Center|866-435-7343||
21250748|NCT00630552|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
21250749|NCT03226106|Eastern Colorado VA Medical Center|Cory Christiansen, PT, PhD|303-724-9101|cory.christiansen@cuanschutz.edu|
21250750|NCT04349644|Vanderbilt University Medical Center|Blythe Corbett, Ph.D.|(615) 936-0280|blythe.corbett@vumc.org|
21250751|NCT01084239|Massachusetts Genderal Hospital Biostatistics Center|Pearl Zakroysky|617 724 0309|pzakroysky@partners.org|
21250752|NCT05006417|UW School of Medicine and Public Health|Michael Suer, MD|(608) 265-3207|suer@rehab.wisc.edu|
21250753|NCT00863798|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21250754|NCT04238520|The Ohio State University|Dr. Xi Chen, Associate Professor|614-2920474|chen.13047@osu.edu|
21250755|NCT01470599|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21250756|NCT00195442|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21250757|NCT01917006|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21250758|NCT00624013|Charles Drew University of Medicine and Science|Diana Echeverry, MD, Principal Investigator|3235634800||
21250759|NCT02179853|UCSD|Dr. Adriana Tremoulet|858-246-0012|atremoulet@health.ucsd.edu|
21250760|NCT02158247|The Catholic University of Korea|Dr. Oh Saecheol|+88-42-220-9046|oscane0822@gmail.com|
21250761|NCT02041221|SPARC|Dr Shravanti Bhowmik|+91 22 66455645||
21250762|NCT02637856|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21250763|NCT02509312|Beth Israel Deaconess Medical Center|John J. Kowalczyk, MD|617-667-3112|jkowalcz@bidmc.harvard.edu|
21250764|NCT02815735|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com|
21250765|NCT00702650|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21250766|NCT00661544|U.T. M.D. Anderson Cancer Center|Muzaffar H. Qazilbash, MD / Associate Professor|713-745-3458||
21250767|NCT00943722|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21250768|NCT01772823|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
21250769|NCT03993457|UTexasSouthwestern|Maria Monastirsky|214-648-0174|maria.monastirsky@utsouthwestern.edu|
21250770|NCT01036165|EMD Serono, Inc.|Fernando Dangond, MD|781-681-2348|Fernando.dangond@emdserono.com|
21250771|NCT03082898|Vanderbilt University|Dr. Michael Goldfarb|615 343 6924|michael.goldfarb@vanderbilt.edu|
21250772|NCT01387815|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21250773|NCT02895360|Basilea Pharmaceutica International Ltd.|Thomas Kaindl, MD, Global Medical Director, Oncology|+41615671505|Thomas.Kaindl@basilea.com|
21250774|NCT00307164|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
21250775|NCT01940523|Hospital for Special Surgery|David Mayman MD|212.774.2024|maymand@hss.edu|
21250776|NCT02544113|Cleveland Clinic|Dr. Bijan Eghtesad|216 444-9898|eghtesb@ccf.org|
21250777|NCT00583050|Massachusetts General Hospital|Matthew Eagleton, M. D.|617-726-8279|MEAGLETON@mgh.harvard.edu|
21250778|NCT02847637|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21250779|NCT01271036|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, Sr. Specialist|928-277-0715|jhauze@its.jnj.com|
21250780|NCT01746108|GlaxoSmithKline|GSK Response Center|866-435-7343||
21250781|NCT03036150|AstraZeneca|AstraZeneca Clinical Study Information Center|+1-877-240-9479|Information.center@astrazeneca.com|
21250782|NCT01649505|Oregon Health and Science University|Dr. Juliana Hansen|503-494-4834|hansenju@ohsu.edu|
21250783|NCT00616577|Loma Linda University|Charles Lee, MD|909-558-9408|thamilton@llu.edu|
21250784|NCT01318538|McLean Hospital|Shelly F. Greenfield, MD, MPH|617-855-2241|sgreenfield@mclean.harvard.edu|
21250785|NCT01376050|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com|
21250786|NCT00053352|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21296095|NCT01827332|MUSC|Aimee McRae-Clark|843-792-5216|mcraeal@musc.edu|
21250787|NCT02154477|SLU|sandeep dhindsa|314-977-4911|dhindsa@slu.edu|
21265905|NCT05151367|Columbia University|Melissa Stockwell|2123425732|mss2112@cumc.columbia.edu|
21265906|NCT01731990|Novartis Pharmaceuticals|Study Director|862-778-8300||
21250788|NCT02741713|Wake Forest Baptist Health|Dr.Jon Wells Reynolds|336-715-9695|jreynold@wakehealth.edu|
21250789|NCT01388478|University of Kansas Medical Center|Jeffrey Burns, M.D., M.S.|913-588-0555|KUAMP@kumc.edu|
21250790|NCT04458181|University of Minnesota|Amy R. Krentzman|612-625-2312|akrentzm@umn.edu|
21250791|NCT00550446|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21250792|NCT02856490|Joylux|Colette Courtion|206.219.6444|sophia@joylux.com|
21250793|NCT01859611|ELECTRONIC ENGINEERING EL.EN. SPA|ALESSANDRO BIZZARRI STUDY DIRECTOR|+390558826807|A.BIZZARRI@ELEN.IT|
21250794|NCT01182103|Kaohsiung Chang Gung Memorial Hospital|Tiao-Lai Huang|886-7-7317123|a540520@adm.cgmh.org.tw|8753
21296096|NCT02725593|Study Information Center|Global Clinical Lead|+1-887-240-9479|information.center@astrazeneca.com|
21296097|NCT02698371|University Fernando Pessoa|Prof. Patricia Manarte-Monteiro; Associate Professor|+351 225 071 300|patmon@ufp.edu.pt|
21296098|NCT00167661|University of Wisconsin - Madison|Dr. Sharon Bartosh|(608) 265-6020|smbartosh@wisc.edu|
21296099|NCT03306641|CooperVision, Inc|Lee Hall, BSc, PhD, MCOptom, FBCLA|925 251 6684|lhall@coopervision.com|
21296100|NCT05714943|innovation Research & Training|Dr. Alison Parker|919-493-7700|aparker@irtinc.us|
21296101|NCT01440881|University of Florida|Dr. Thomas Beaver|352-273-5501|thomas.beaver@surgery.ufl.edu|
21296102|NCT02290938|RAND|Elizabeth D'Amico|310-393-0411|damico@rand.org|6487
21296103|NCT03295396|Chimerix, Inc.|Chief Medical Officer|919-806-1074|clinicaltrials@chimerix.com|101
21296104|NCT01825941|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|718-920-6266|befriedm@montefiore.org|
21296105|NCT00168454|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
21296106|NCT00668811|MedStar Washington Hospital Center|Dr Kenneth D. Burman|202-877-8109|kenneth.d.burman@medstar.net|
21296107|NCT03938324|Duke University|Sharron Docherty, PhD|919-668-3836|sharron.docherty@duke.edu|
21296108|NCT02769962|National Cancer Institute|Dr. Anish Thomas|240-760-7343|anish.thomas@nih.gov|
21296109|NCT05565937|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
21296110|NCT01286077|Janssen-Cilag Greece|EMEA Medical Affairs Director|+30 210 8090738||
21296111|NCT01973608|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21296112|NCT02797184|Washington University in St. Louis|Dr. Lauren Park|3143633915|l.park@wustl.edu|
21296113|NCT04243330|VA Rocky Mountain MIRECC|Nazanin Bahraini, PhD|720-723-6490|Nazanin.Bahraini@va.gov|
21296114|NCT04927663|University of California, San Francisco|Dr. Rahul Aggarwal, MD|(415) 353-7171|rahul.aggarwal@ucsf.edu|
21296115|NCT05251753|Wake Forest School of Medicine|Caleb Suggs|3367164171|csuggs@wakehealth.edu|
21296116|NCT02212678|University of Minnesota|Lisa Coles, MS, PhD|4109264788|durh0016@umn.edu|
21296117|NCT06250738|Rollins School of Public Health|Dr. Andrea Lopez-Cepero|404-727-3956|andrea.a.lopez-cepero@emory.edu|
21296118|NCT00419315|Philadelphia VA Medical Center|David Oslin|215 823 5894|dave.oslin@va.gov|
21296119|NCT05288166|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21296120|NCT01114360|Emory University|Frederic Rahbari-Oskoui, Associate Professor of Medicine|404-727-2590|frahbar@emory.edu|
21296121|NCT03344172|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR; CRS Regulatory Supervisor|412-647-5554|stadtermanbm@upmc.edu|
21296122|NCT00673881|Radiant Research|Michael H. Davidson, MD FACC|312-494-2220|michaeldavidson@radiantresearch.com|2220
21296123|NCT01299571|GlaxoSmithKline|GSK Response Center|866-435-7343||
21296124|NCT00413010|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21296125|NCT01173029|Universidade Gama Filho|Paulo Robeto Benchimol Barbosa|+55-21-95320182|ecgar@yahoo.com|
21296126|NCT05432167|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21296127|NCT01515475|Jaeb Center for Health Research|Ray Kraker M.S.P.H.|813-975-8690|rkraker@jaeb.org|
21296128|NCT01814670|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21296129|NCT00201123|NYU School of Medicine|William Rom MD|212 263-6479|William.Rom@nyumc.org|
21296130|NCT02360293|VA ORD|Laura Damschroder|734-845-3603|laura.damschroder@va.gov|
21296131|NCT00853840|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21296132|NCT02012686|Department of Anesthesiology and Pain Medicine, Gangnam Severance Hospital, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 135-720, Republic of Korea|Dr Dong Woo Han|82-2-2019-3549|HANESTH@yuhs.ac|
21296133|NCT00966719|Children's Hospital of Eastern Ontario|Dr Catherine Pound|613-737-7600|cpound@cheo.on.ca|
21296134|NCT03242018|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
21296135|NCT00624416|Pennington Biomedical Research Center|Leanne Redman|225-763-0947|Leanne.Redman@pbrc.edu|
21296136|NCT02635347|Rutgers-NJ Medical School|Baburao Koneru, MD, MPH|973-972-9599|koneruba@njms.rutgers.edu|
21296137|NCT03089944|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21296138|NCT03689244|Actelion Pharmaceuticals Ltd|Senior Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21296139|NCT04498377|Evive Biotech|Jianmin Chen|6095124566|jianmin.chen@evivebiotech.com|
21296140|NCT02308488|NYU Langone Health - Perlmutter Cancer Center|Carmen A. Perez, M.D., Ph.D.|212-731-5003|Carmen.Perez@nyulangone.org|
21296141|NCT01541917|Children's Mercy Hospital|Mark Connelly, PhD (Principal Investigator)|816-234-3000|mconnelly1@cmh.edu|3193
21296142|NCT02011490|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21296143|NCT01739803|University of Tennessee College of Pharmacy|Marie Chisholm-Burns|901-448-7141|mchisho3@uthsc.edu|
21296144|NCT00915148|Stavanger UH|Torbjørn Moe Eggebø, phd|004792699433|tme@lyse.net|
21296145|NCT01244633|Psyadon Pharmaceuticals|Dr. Richard Chipkin|3019192020|rchipkin@psyadonrx.com|
21250795|NCT04081389|Roswell Park Comprehensive Cancer Center|Kristopher Attwood|716-845-1300|Kristopher.Attwood@roswellpark.org|
21250796|NCT01537185|Comprehensive Clinical Development Northwest|Dr. Royce Morrison|206 285 3500|ckeech@path.org|
21250797|NCT04074343|Chao Family Comprehensive Cancer Center, University of California, Irvine|Chao Family Comprehensive Cancer Center, University of California, Irvine|1-877-UC-STUDY|ucstudy@uci.edu|
21250798|NCT01114672|Winthrop University Hospital|Mary Schanler, Principal Investigator|5156639028|mschanler@winthrop.org|
21250799|NCT01710800|Walter Reed National Military Medical Center|Dr. Fouad J. Moawad|(301) 400-1551|Fouad.Moawad@us.army.mil|
21250800|NCT00827775|University of Texas Southwestern Medical Center|Peter Van Buren|214-645-8293|peter.vanburen@utsouthwestern.edu|
21250801|NCT03891641|University of North Carolina at Chapel Hill|Jason R Franz, PhD|919-966-6119|jrfranz@email.unc.edu|
21250802|NCT02212301|Johnson & Johnson Vision Care Inc.|Tawnya Wilson OD|904-443-3500|TWilson@ITS.JNJ.com|1834
21250803|NCT00413634|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21250804|NCT00866918|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21250805|NCT03041701|National Cancer Institute|Dr. Christine Heske|240-760-6197|christine.heske@nih.gov|
21250806|NCT00527514|Daiichi Sankyo|John Raia|(973) 630-2683|jraia@dsus.com|
21250807|NCT00001941|National Cancer Institute, National Institues of Health|Thomas Waldmann, M.D.|301-496-6653|tawald@mail.nih.gov|
21296146|NCT03283436|Brigham and Women's Hospital|Dr. Jon Einarsson|617-525-8582|jeinarsson@partners.org|
21250808|NCT04289714|Royal Brompton Hospital|Sukeshi Makhecha|0207-3528121|s.makhecha@rbht.nhs.uk|4375
21250809|NCT04380688|AstraZeneca|Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21250810|NCT00919061|Memorial Sloan Kettering Cancer Center|Dr. Ghassan Abou-Alfa|646-888-4184|abou-alg@mskcc.org|
21250811|NCT02056873|Univeristy of Florida|Dr. Michael Okun|3522945400|okun@neurology.ufl.edu|
21250812|NCT00605566|Princess Margaret Cancer Centre|Dr. Lillian Siu||lillian.siu@uhn.ca|
21250813|NCT01904136|Samer Srour, MD / Stem Cellular Transplantation Department|UT MD Anderson Cancer Center|713-794-4354|ssrour@mdanderson.org|
21250814|NCT02668198|Mayo Clinic|Dr. Michael B. Wallace|904-953-2221|wallace.michael@mayo.edu|
21250815|NCT02202109|University of Miami|Dr. Erin Kobetz|3052436185|ekobetz@med.miami.edu|
21250816|NCT04334668|Cleveland Clinic|Dr. W. H. Wilson Tang|216-444-2121|tangw@ccf.org|
21250817|NCT03834623|Moffitt Cancer Center|Nikhil Khushalani, MD|813-745-3437|Nikhil.Khushalani@moffitt.org|
21250818|NCT03024996|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21250819|NCT00478647|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21250820|NCT01936324|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21250821|NCT06178718|TenNor Therapeutics (Suzhou) Limited.|TenNor|0512-86861990|info@tennorx.com|
21250822|NCT00487552|MED Institute, Inc.|Scott Snyder, Ph.D., Manager, Biostatistics and Data Management, Senior Statistician|765-463-7537|ssnyder@medinst.com|
21250823|NCT03119688|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21296147|NCT01565564|Tianjin Medical University|Dr. Xilin Yang|+86 22 83336727|yangxilin@tijmu.edu.cn|
21296148|NCT03759041|Seres Therapeutics|Lisa von Moltke, MD, Chief Medical Officer|617-945-9626|clinicalstudies@serestherapeutics.com|
21296149|NCT02449018|Novartis Pharmaceuticals|Study Director|8627781873||
21296150|NCT02378207|Desmond Tutu HIV Foundation, Cape Town, South Africa|Dr. Linda-Gail Bekker|+27214066959|linda-gail.bekker@hiv-research.org.za|
21250824|NCT00320398|GlaxoSmithKline|GSK Response Center|866-435-7343||
21250825|NCT02705625|Medivir|Linda Basse, Cheif Medical Officer|+46 8 546 831 00|linda.basse@medivir.com|
21250826|NCT02190552|Neuravi Limited|Mairsil Claffey|0035391394123|mclaffey@neuravi.com|
21250827|NCT04544865|Ethicon Endo-Surgery|SENIOR DIRECTOR OF CLINICAL AFFAIRS|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21250828|NCT01848067|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Jianqing Lin|(215) 955-8874|jianqing.lin@jefferson.edu|
21250829|NCT01649297|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21250830|NCT01685047|St Jude Medical|Karolien Timmermans|0032 497 51 39 21|ktimmermans@sjm.com|
21250831|NCT02601105|UC Davis Department of Dermatology|Raja Sivamani MD|916-703-5145|dermstudies@ucdavis.edu|
21250832|NCT01732926|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21250833|NCT02434523|Boston Medical Center|Dr. Jacob Pieter Noordzij|617-638-8124|Pieter.Noordzij@bmc.org|
21250834|NCT02262364|Zimmer Biomet|Jennifer Woodell-May, PhD||jennifer.woodell-may@zimmerbiomet.com|
21250835|NCT01049984|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21250836|NCT00337285|Shire Pharmaceutical Development, Inc.|Timothy Whitaker||twhitaker@shire.com|
21250837|NCT01040403|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21250838|NCT05215418|Vivus LLC|Lan Nguyen|650-934-5246|clinical@vivus.com|
21250839|NCT00931918|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21250840|NCT02840916|Kaohsiung Chang Gung Memorial Hospital|Dr. Wen-Long Hu|+886-7-731-7123|oolonghu@gmail.com|2334
21250841|NCT04191148|Medpace|Clinical Trial Manager|513-630-0130|E.Plummer@Medpace.com|
21250842|NCT02647788|University of Pennsylvania|Dr. Benjamin Gray|215-294-9650|Benjamin.Gray@uphs.upenn.edu|
21250843|NCT03245619|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21250844|NCT02832284|Boston Scientific Corporation|G Mark Grubb, RN, CCRA|412 749 1423|grubbm@bsci.com|
21250845|NCT03201900|Eisai, Inc.|Inquiry Service.|none|eisai-chiken_hotline@hhc.eisai.co.jp|
21250846|NCT04752033|Mayo Clinic|Dr. Joseph Pleticha|5073588378|Pleticha.joseph@mayo.edu|
21250847|NCT02971228|Zealand Pharma A/S|Kim Mark Knudsen|+45 5060 3780|KMKnudsen@zealandpharma.com|
21250848|NCT01233999|Emory University|Dr. Suephy Chen|404-778-3084|schen2@emory.edu|
21250849|NCT00129649|Imperial College London|Prof Martyn R Patridge|+44 (0)20 7594 7959|m.patridge@imperial.ac.uk|
21296151|NCT00525824|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
21250850|NCT00025506|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
21250851|NCT00713206|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
21250852|NCT04952701|CooperVision|Jose Vega|9256402964|JVega2@coopervision.com|
21250853|NCT01657877|GlaxoSmithKline|GSK Response Center|866-435-7343||
21250854|NCT01532635|Thomas Jefferson University|Neal Flomenberg, MD|215-955-8874|Neal.Flomenberg@jefferson.edu|
21250855|NCT03700372|FARAPULSE, Inc.|Christopher (Kit) Schneider Sr. Director of Clinical & Pre-Clinical Engineering|617-686-7661|cschneider@farapulse.com|
21250856|NCT04672798|University of Pittsburgh|Dr. Stephanie Stepp|412-715-5447|steppsd@upmc.edu|
21250857|NCT00992719|Department of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine, Duke University School of Medicine|Geeta K. Swamy, M.D.|919-681-5220|geeta.swamy@duke.edu|
21250858|NCT01670188|Mayo Clinic|Dr. Alejandro Rabinstein|507-284-4741|Rabinstein.Alejandro@mayo.edu|
21250859|NCT01262118|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21265907|NCT05569850|DIBINE, University of Bologna|Prof. Lorenzo Breschi|+393482210664|lorenzo.breschi@unibo.it|
21296152|NCT02645617|Advantage Silver Dental Arrest, LLC|Peter Milgrom|2062516831|drmilgrom@silverarrest.com|
21296153|NCT01965899|Medtronic, plc|CRHF Clinical Research|800-328-2518|MedtronicCRMtrials@medtronic.com|
21296154|NCT00054028|The Ohio State University Comprehensive Cancer Center|Maryam Lustberg, MD|614-293-0066|Maryam.Lustberg@osumc.edu|
21296155|NCT01274611|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
21296156|NCT05011513|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21296157|NCT03495102|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21296158|NCT04802187|Massachusetts General Hospital|Madeline Davies|617-726-6653|medavies@mgh.harvard.edu|
21296159|NCT01969435|Washington University School of Medicine|Amanda F. Cashen, M.D.|314-454-8304|acashen@wustl.edu|
21296160|NCT02349685|SeoulNUBH|Nayoung Kim|+ 82-31-787-7008|nayoungkim49@empas.com|
21296161|NCT01161537|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21296162|NCT00520910|University of Miami|Dr. Robert Kirsner|305-243-4472|RKirsner@med.miami.edu|
21296163|NCT00358436|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
21296164|NCT05101798|Icahn School of Medicine at Mount Sinai|Orli Weiss|9086700847|orli.weiss@icahn.ismms.edu|
21296165|NCT01597635|GlaxoSmithKline|GSK Response Center|866-435-7343||
21296166|NCT01073930|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21296167|NCT04558359|University of Kentucky|Alexander Flannery, PharmD, PhD|859-562-2766|alexander.flannery@gmail.com|
21296168|NCT02706197|Program for Clinical Oximetry and Imaging Geisel School of Medicine & Dartmouth Health; Dartmouth College|Periannan (Kupps) Kuppusamy MS, PhD|603-646-5490|Periannan.Kuppusamy@dartmouth.edu|
21296169|NCT00541346|University of Oklahoma Health Sciences Center|Thomas M. Lock, M.D.|405-271-5700|Thomas-Lock@ouhsc.edu|45167
21296170|NCT02008773|Indiana University Psychotic Disorders Program|Alan Breier, MD|317-880-8495|abreier@iupui.edu|
21296171|NCT04938037|ErciyesU|Dr. Isa Cuce|+905056263723|dr.icüce@hotmail.com|
21296172|NCT03350906|Mayo Clinic|Ian R. Lanza, Ph.D.|507-255-8147|Lanza.Ian@mayo.edu|
21296173|NCT03323736|Smith+Nephew|Laura England, PhD|(650) 223-6909|laura.england@smith-nephew.com|
21296174|NCT04872998|University of Utah|Principal Investigator Joel Trinity Associate Professor|801-582-1565|joel.trinity@utah.edu|
21296175|NCT01806064|TRACON Pharmaceuticals Inc.|Charles Theuer|(858) 550-0780|ctheuer@traconpharma.com|233
21296176|NCT01885910|DermResearch, PLLC|Dr. Leon Kircik|502-451-9000|wedoderm@yahoo.com|
21250860|NCT02427958|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21281621|NCT02021929|University of Pennsylvania|Dr. Steven Kawut|215-573-0258|kawut@upenn.edu|
21281622|NCT04031846|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21281623|NCT02431676|Johns Hopkins University|Dr. Jessica Yeh|410-614-4316|hyeh1@jhmi.edu|
21281624|NCT01622673|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21281625|NCT05009602|Imperial College London|Laura Burgess|0203 311 5208|l.burgess@imperial.ac.uk|
21281626|NCT02573597|Stanford University School of Medicine|Dr. Brendan Carvalho|(650) 861-8607|bcarvalho@stanford.edu|
21281627|NCT05966584|Memorial Sloan Kettering Cancer Center|Dr. Alina Markova, MD|646-608-2380|markovaa@mskcc.org|
21281628|NCT00570687|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
21281629|NCT05343000|Mayo Clinic|Roberto Benzo, M.D.|480-301-8244|benzo.roberto@mayo.edu|
21281630|NCT05271370|CytoDyn|Vice President, Clinical Operations|3609808524|jmeidling@cytodyn.com|
21281631|NCT03773172|Columbia University Irving Medical Center|Henry Ginsberg, MD|212-305-9562|hng1@cumc.columbia.edu|
21281632|NCT02527746|Evivebiotech|Catrina Wang / Senior Medical Director|021-61760866|catrina.wang@evivebiotech.com|
21281633|NCT00333983|VA Maryland Health Care System, Baltimore|Dr. Susan S. Conroy|(410) 605-7000|susan.conroy@va.gov|3213
21281634|NCT00833105|Oregon Health & Science University|Dr. Paul Cordo|503 418 2520|cordop@ohsu.edu|
21281635|NCT03656068|Pinnacle Clinical Research|Stephen Harrison, MD|210-982-0320|stephenharrison87@gmail.com|
21281636|NCT00154284|Novartis Pharmaceuticals|Study Director|862-778-8300||
21281637|NCT04506463|Sun Pharmaceutical Industries Limited|Head-Clinical Development|2266455645|Clinical.Trial@sunpharma.com|5689
21281638|NCT04229095|The Scripps Research Institute|Dr. Barbara J. Mason, Ph.D. Professor|(858 784-7324|mason@scripps.edu|
21281639|NCT01780038|University of Nebraska Medical Center|Julia F Houfek|402-660-4046|jhoufek@unmc.edu|
21281640|NCT03168711|Massachusetts General Hospital|Dr. Sabrina Paganoni|617-724-3914|spaganoni@mgh.harvard.edu|
21281641|NCT01202578|Acclarent, Inc.|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
21265908|NCT01183104|Japan Association for Diabetes Education and Care|Prof. Yasuo Terauchi|+81-3-3514-1721|terauchi-tky@umin.ac.jp|
21265909|NCT01594749|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21265910|NCT02748785|Seoul National University Hospital|Eun Bong Lee|+82-2-2072-4399|leb7616@snu.ac.kr|
21265911|NCT01957215|GlaxoSmithKline|GSK Response Center|866-435-7343||
21265912|NCT00698139|Columbia University|Dr. Paolo C. Colombo|212-305-2638|pcc2001@columbia.edu|
21265913|NCT03597503|Supernus|Gianpiera Ceresoli-Borroni/ Director Clinical Development|3018382521|gceresoliborroni@supernus.com|
21265914|NCT02944513|Brigham and Women's Hospital|Dr. Robert Jamison|617-732-9046|rjamison@bwh.harvard.edu|
21265915|NCT03690674|Seattle Children's Research Institute|Dr. Pooja Tandon|206-884-1130|pooja.tandon@seattlechildrens.org|
21265916|NCT02578992|Tri-Service General Hospital|Dr. Wei-Hung Chan|+886-2-87927128|whcken@gmail.com|
21265917|NCT00179998|Nationwide Children's Hospital|Dr. Robert Castile|614-355-6670|robert.castile@nationwidechildrens.org|
21265918|NCT02933372|U of Michigan|Dr. Cathie Spino, Research Professor of Biostatistics|7346155469|spino@umich.edu|
21265919|NCT01495689|Ottawa Hospital Research Institute|Smita Pakhale|613-737-8899|spakhale@ohri.ca|79428
21265920|NCT03805971|Centre hospitalier universitaire de Liège|Dr Olivier Bonhomme|003243667881|obonhomme@chuliege.be|
21265921|NCT03613818|Boise State Universtiy|Dr. Diana Doumas|2084261219|dianadoumas@boisestate.edu|
21265922|NCT03012594|Northwell health|Dr.Larry Miller|5165620334|lmiller7@northwell.edu|
21265923|NCT01480232|Massachusetts General Hospital-Center for Addiction Medicine|A. Eden Evins, MD, MPH|617-643-4679|aeevins@mgh.harvard.edu|
21265924|NCT00517413|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21265925|NCT01224106|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21265926|NCT03210220|Department of Anesthesiology and Pain Medicine, Gil Medical Center, Gachon University|Dr Junju Choi|82-32-460-3636|jjchoi2@gilhospital.com|
21265927|NCT03053401|Akron Children's Hospital|Dr. Rami Karroum|330-543-8823|rkarroum@akronchildrens.org|
21265928|NCT01973972|Duke University|William S. Yancy, Jr.|919-681-2863|yancy006@mc.duke.edu|
21265929|NCT00839436|NIAID|Dr. Virginia Sheikh|3014357939|sheikhv@niaid.nih.gov|
21265930|NCT01440972|University of Iowa|Dr. Neil Segal|3193358204|segal-research@uiowa.edu|
21265931|NCT04072575|Janssen Research & Development, LLC|Director Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21265932|NCT00810095|MindFrame, Inc .|Dr. Thomas J. McCarthy|949-204-0806|tmccarthy@mindframeinc.com|
21265933|NCT05301803|CathVision ApS|Clinical Research Manager|+4531324745|kpf@cathvision.com|
21265934|NCT03006926|Eisai Co., Ltd.|Eisai Inquiry Service|none|eisai-chiken_hotline@hhc.eisai.co.jp|
21265935|NCT01838213|Vestre Viken Hospital Trust|Arne Søraas, PhD|+4790652904|arne@meg.no|
21265936|NCT04882072|Janssen Pharmaceutical K.K.|Senior Director GI Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21265937|NCT02918318|Janssen Pharmaceutical K.K., Japan|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21265938|NCT01548417|The Scripps Research Institute|Barbara J. Mason, Ph.D.|858-784-7328|mason@scripps.edu|
21265939|NCT04583969|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
21265940|NCT00444080|University of Virginia|Peter A. Netland, MD, PhD|434-982-1086|pan9c@virginia.edu|
21265941|NCT02057068|Atlanta Department of Veterans Affairs Medical Center CVNR|Patricia C. Griffiths, PhD|6783615462|pcgriff@emory.edu|
21265942|NCT00954824|UPenn|Muredach Reilly|215-573-1214|muredach@mail.med.upenn.edu|
21265943|NCT00865046|VA Pittsburgh Healthcare System|Dr. Debra K. Weiner|412-360-2920|debra.weiner@va.gov|
21265944|NCT01592006|University of Chicago Medical Center|Dr. Helen S. Te|773-702-2395|hte@medicine.bsd.uchicago.edu|
21265945|NCT01704976|BUAS|Slavko Rogan (Study Chair)|+41 31 848 35 56|slavko.rogan@bfh.ch|
21265946|NCT01188460|OHRI|Dr. Keith Wilson||kewilson@toh.ca|
21265947|NCT01098032|Clinica Mediterranea|Dr. Carlo Briguori, Principal Investigator|+390817259|carlobriguori@clinicamediterranea.it|764
21265948|NCT02959190|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21265949|NCT01522768|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian, MD|646-888-4186|janjigiy@mskcc.org|
21265950|NCT02709109|Parion Sciences|Alison Church|919-313-1183|achurch@parion.com|
21265951|NCT01787799|Boston Scientific|Peter Maurer, MPH; Director of Clinical Trials|508-683-6678|peter.maurer@bsci.com|
21265952|NCT01928082|The University of Chicago|Murray J. Favus|(773) 702-6138|mfavus@medicine.bsd.uchicago.edu|
21265953|NCT00927264|Johns Hopkins University|Cynthia Rand, Ph.D.|410-550-0487|crand@jhmi.edu|
21265954|NCT01815580|Fred Hutchinson Cancer Center|Ann Duerr|206 667 7938|aduerr@fredhutch.org|
21265955|NCT02219997|Alcon Research, Ltd.|Global Brand Med Affairs Lead, VGR|1-888-451-3937|alcon.medinfo@alcon.com|
21265956|NCT00444964|Children's Mercy Hospital|Jaylene Weigel|816-701-1359|jweigel@cmh.edu|
21265957|NCT01814826|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
21265958|NCT02917629|UW Carbone Cancer Center|Dr. Howard Bailey|800-622-8922|clinicaltrials@cancer.wisc.edu|
21265959|NCT03271307|University of California Los Angeles|Dr. Kathryn Dovel|7143303416|KDovel@mednet.ucla.edu|
21265960|NCT03997760|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21265961|NCT00136838|New York State Psychiatric Institute|Dr. Adam Bisaga|646-774-6155|bisagaa@nyspi.columbia.edu|
21265962|NCT04454138|Prism Eye Institute|Ronaldo Santiago|905-456-3937|ronaldo.santiago@prismeye.ca|267
21265963|NCT01883804|Barbara Davis Center for Diabetes, University of Colorado School of Medicine|Dr. Aaron Michels|303-724-1923|aaron.michels@ucdenver.edu|
21265964|NCT02079519|Hoffmann-La Roche|Medical Communications|800 821-8590||
21265965|NCT01802515|Yale University|Dr. Mehmet Sofuoglu, Principal Investigator|203 937-4809|mehmet.sofuoglu@yale.edu|
21265966|NCT02566109|Wake Forest University Health Sciences|Gregory Hundley, MD|336-716-0607|ghundley@wakehealth.edu|
21265967|NCT01906476|Northwestern University|Mary Kwasny|312-503-2294|m-kwasny@northwestern.edu|
21281642|NCT01644292|University of Manitoba|Ed Giesbrecht|204-977-5630|Ed.Giesbrecht@med.umanitoba.ca|
21250861|NCT00578318|Georgetown University Medical Center|Alfiee M. Breland-Noblem Ph.D., MHSc|2026872392|ab2892@georgetown.edu|
21250862|NCT02025985|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
21250863|NCT00096681|Desmond Tutu HIV Centre|Prof LG Bekker|+2721 633 6599|Linda-Gail.Bekker@hiv-research.org.za|21
21250864|NCT00812838|Baylor College of Medicine|Mohit Khera, MD|713-798-6593|mkhera@bcm.edu|
21250865|NCT04148521|Atrium Health|Jason Roberge|7043550268|jason.roberge@atriumhealth.org|
21250866|NCT01530659|Neurotech USA, Inc.|Neurotech, Sr. Director of Clinical Operations|629-333-5804|p.davis@neurotechusa.com|
21250867|NCT00920699|Johns Hopkins University|Christopher A. Ross M.D. Ph.D.|410-614-0011|caross@jhmi.edu|
21250868|NCT00953862|NYU School of Medicine|Dr. Lenard Adler|(212) 263-3580|lenard.adler@nyumc.org|
21250869|NCT02287883|University of California, Berkeley|Patricia Ramsay, Project Drector|(510)643-8063|pramsay@berkeley.edu|
21250870|NCT03416621|Duke Cancer Institute|Dr. Kathryn I Pollak|919-681-4757|kathryn.pollak@duke.edu|
21250871|NCT04491084|Albert Einstein College of Medicine|Dr. Nitin Ohri|718-405-8550|nitin.ohri@einsteinmed.edu|
21250872|NCT02101268|Sierra Oncology, a GlaxoSmithKline company|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21250873|NCT05324007|University of Chicago|Dr. Hyesung Grace Hwang|(773) 834-9791|hyesung@uchicago.edu|
21250874|NCT00576823|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
21250875|NCT01242371|Sheppard Pratt|Dr. Faith Dickerson|410-938-4359|fdickerson@sheppardpratt.org|
21250876|NCT03360110|CooperVision|Myhanh Nguyen, OD, Manager of Clinical Research|19257306716|MNguyen@coopervision.com|
21250877|NCT00510146|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21250878|NCT02132117|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21250879|NCT01564953|Aarhus University Hospital|Dr. Sarah Hashim Ali Hussein|0045 42660308|sarsuri@hotmail.com|
21250880|NCT03589300|Zimmer Biomet|Director of Clinical Operations|800-613-6131|clinicaloperations@zimmerbiomet.com|
21250881|NCT04947436|University of Texas Health San Antonio|Dr. Donna Gardner|210-450-8479|dgardner62001@gmail.com|
21250882|NCT03719378|Colorado Joint Replacement|Rose Johnson, CCRP Research Lead|3032602940|roseannjohnson@centura.org|
21250883|NCT02551692|Duke University|Anthony DeVito, MD|919-684-1377|anthony.devito@duke.edu|
21250884|NCT01196741|University of Glasgow|Prof Iain McNeish, Professor of Gynaecological Oncology|+44 (0)141 330 3968|iain.mcneish@glasgow.ac.uk|
21250885|NCT04582864|Washington University School of Medicine|Dr. Matthew Christopher|314-273-0286|christopherm@wustl.edu|
21250886|NCT03640754|MenoGeniX|Debra Duke|303-995-7979|debra.duke@menogenix.com|
21250887|NCT05329402|Fengh Medical Co., Ltd.|Jiao Liu|13815132106|jiao.liu@fulbrightmed.com|
21250888|NCT01679613|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21250889|NCT03735147|Imperial College London|Dr Paul Turner|+44 20 3312 7754|p.turner@imperial.ac.uk|
21250890|NCT02917421|Weill Medical College|Dr.Silvia Formenti|212-746-3608|shc2043@med.cornell.edu|
21250891|NCT04396847|UNC-Chapel Hill|Christian Hendershot|(919) 962-5565|christian_hendershot@med.unc.edu|
21250892|NCT01932762|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21250893|NCT02210208|Mölnlycke Health Care|Global Clinical Research Director|+46 31 722 30 00|info@monlycke.com|
21250894|NCT00695136|Pediatrics & Developmental Neuroscience Branch, NIMH|Susan E. Swedo, MD|301-496-5323|swedos@mail.nih.gov|
21250895|NCT03469492|Yale School Of Medicine|Elizabeth Sanchez Rangel, MD|203-737-6067|elizabeth.sanchezrangel@yale.edu|
21250896|NCT01726049|University Hospital Groningen, NL|E.S. Hoendermis, MD, PHD|0031503616161|e.s.hoendermis@umcg.nl|
21250897|NCT04831047|Bascom Palmer Eye Institute|Wendy W. Lee MD|305-243-6434|wlee@med.miami.edu|
21250898|NCT01333111|Novo Nordisk A/S|Global Clinical Regstry (GCR, 1452)||clinicaltrials@novonordisk.com|
21250899|NCT02161406|University of Michigan DCC (SABER)|Dr. Cathie Spino|734-615-5469|spino@umich.edu|
21250900|NCT00664105|Vanderbilt-Ingram Cancer Center|Vicki Keedy, M.D.|(615) 322-4967||
21250901|NCT01343251|St John Hospital and Medical Center|Dr. Robert Provenzano|313-886-8787|Rprovenzano@scsp.net|
21250902|NCT00004146|Adult Brain Tumor Consortium|Stuart A Grossman|410-955-3657|jfisher@jhmi.edu|
21250903|NCT00847132|Massachusetts General Hospital|Dr. Jeff Huffman|617-724-2910|jhuffman@partners.org|
21250904|NCT01057251|Forest Research Institute|Manfred Stapff, MD, PhD|201-427-8000|manfred.stapff@frx.com|8686
21250905|NCT00784147|TaiMed Biologics, Inc.|Stanley T. Lewis, Jr., MD|949-769-6543|stlewis@taimedbiologics.com|108
21250906|NCT03596242|Wake Forest School of Medicine|Claudia L. Campos, MD|ccampos@wakehealth.edu|ccampos@wakehealth.edu|
21250907|NCT04912700|Beaumont Hospitals|Ahmit Bahl, MD|(248) 898-9111|ahmit.bahl@beaumont.edu|
21250908|NCT01508832|University of California San Francisco|Ronald D Miller, MD|415 476-9034|millerr@anesthesia.ucsf.edu|
21250909|NCT02973802|Apitope International|CEO|+44(0)1291 635511|info@apitope.com|
21250910|NCT03357471|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21250911|NCT01202409|UT MD Anderson Cancer Center|Dr. Michael J Overman/ Professor, GI Medical Oncology|713-745-4317|moverman@mdanderson.org|
21250912|NCT00997932|University of North Carolina School of Medicine|Dr. G Stuart|919-962-4880|gstuart@med.unc.edu|
21250913|NCT03206476|Universidad de Guadalajara|Dra. Gabriela Macedo Ojeda|(+52) 3310585200|gabriela.macedo@cucs.udg.mx|33900
21250914|NCT05694533|Indivior Inc.|Global Director Clinical Development|(804) 594-4488|trialdisclosure@indivior.com|
21250915|NCT00292981|CSL Behring|Clinical Program Director|Use email contact|clinicaltrials@cslbehring.com|
21250916|NCT01085812|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
21250917|NCT01983553|Sanofi Pasteur SA|Director||Contact-US@sanofi.com|
21250918|NCT00594178|Dept of PM&R; University of Arkansas for Medical Sciences|Thomas S. Kiser|501-221-1311|kiserthomass@uams.edu|
21250919|NCT01035047|Wake Forest Baptist Medical Center|Erin Harper|336-716-2059|erharper@wakehealth.edu|
21250920|NCT04582669|Montefiore Medical Center|Haley Heibel, MD|(718) 920-8352|hheibel@montefiore.org|
21296177|NCT01023672|Mayo Clinic|Dr. Bradley F. Boeve|507-266-4106|bboeve@mayo.edu|
21296178|NCT03046225|Hospital de Clínicas de Porto Alegre|Graciele Sbruzzi|55 51 9423-9420|graciele.sbruzzi@ufrgs.br|
21265968|NCT03032250|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-713-1432|cnightin@wakehealth.edu|
21265969|NCT01041404|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21265970|NCT01115517|Robert Cizik Eye Clinic|Dr. Nan Wang|713-559-5200|nwang@cizikeye.org|
21265971|NCT00318370|Morphotek, Inc.|Susan Weil, MD|610-423-6182|sweil@morphotek.com|
21265972|NCT00410904|Barbara Ann Karmanos Cancer Institute|Shirish M. Gadgeel, M.D.|313-576-8753|gadgeels@karmanos.org|
21265973|NCT02650440|Coordination of Improvement of Higher Level Personnel - CAPES|Thais A. Rodrigues, MS, PT.|55 (61) 2022-6002|faleconosco@capes.gov.br|
21265974|NCT03627494|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21265975|NCT02027272|University of Mississippi Medical Center|James N. Martin, Jr.|601-984-5358|jnmartin@umc.edu|
21265976|NCT00688623|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21265977|NCT02443155|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21265978|NCT01780324|Seattle Children's Hospital|Neil Uspal, MD|206-987-2599|neil.uspal@seattlechildrens.org|
21265979|NCT04037462|VA Ann Arbor Healthcare System|Dr. Nithya Ramnath|(734) 845-5800|Nithya.Ramnath@va.gov|
21265980|NCT00608894|Veloxis Pharmaceuticals, Inc.|Director, Regulatory Affairs|919-591-3090|bbu@veloxis.com|
21265981|NCT01894555|Johns Hopkins School of Medicine|Rehan Qayyum|410-955-7781|rqayyum@jhmi.edu|
21265982|NCT02809118|Auris Medical|RAM|0041 61 201 13|ra@aurismedical.com|50
21265983|NCT02918721|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
21265984|NCT02828644|Akili Interactive Labs|Kathryn Jenkins|7742666693|kjenkins@akiliinteractive.com|
21265985|NCT02408484|Octapharma|Sigurd Knaub|55 451 21 41|sigurd.knaub@octapharma.com|+41 (0)
21265986|NCT02436915|Institute for Aging Research, Hebrew SeniorLife|Brad Manor|617-971-5332|bradmanor@hsl.harvard.edu|
21265987|NCT04830839|Cincinnati Children's Hospital Medical Center|Professor|+15136363370|shari.wade@cchmc.org|
21265988|NCT01117181|Johns Hopkins|Anne Casper, MA|410-955-8183|ashankli@jhsph.edu|
21265989|NCT04083404|Queen Margaret University|Dr Susan Prior|44 (0)131 474 0000|sprior@qmu.ac.uk|
21265990|NCT02037204|UMC Utrecht|Prof. Daniel Saris|000000000000000000|d.saris@umcutrecht.nl|
21265991|NCT01119963|Mednax. Inc|Kimberly Maurel|714-593-9171|kimberly_maurel@mednax.com|
21265992|NCT00254163|Ocala Oncology|Dr. Craig Reynolds|(352) 732-4032|Craig.Reynolds@USOncology.com|
21265993|NCT04480749|LSHTM|Michael Marks|020 7636 8636|michael.marks@lshtm.ac.uk|
21265994|NCT02253394|Brigham and Women's Hospital|Dr. Bradley Maron|617-525-4857|bmaron@bwh.harvard.edu|
21265995|NCT00216086|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
21265996|NCT00809614|Novartis|Study Director|862-778-8300||
21265997|NCT01080625|SNUH|Chul-Woo Jung/ Assistant professor|82-2-2072-0640|spss@snuh.org|
21265998|NCT02019758|University of North Carolina at Chapel Hill|Evan S. Dellon, MD MPH|919-966-2513|edellon@med.unc.edu|
21265999|NCT00446797|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21266000|NCT01092364|Duke University Medical Center|Dr. Laura P. Svetkey|919-660-6626|laura.svetkey@dm.duke.edu|
21266001|NCT00364832|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
21266002|NCT01620658|Baptist Health South Florida|Raul Herrera, MD. Director Miami Cardiac and Vascular Institute, Research and Outcomes|786-596-3505|raulh@baptisthealth.net|
21266003|NCT04521920|Duke University|Dr. Mehri McKellar|(919) 613-6129|mehri.mckellar@duke.edu|
21296179|NCT04638127|University of Cincinnati|Principal Investigator: Ashley Weber, PhD, RN, RNC-NIC|513-5580132|ashley.weber@uc.edu|
21296180|NCT02654236|IU School of Medicine|Dr. Suthat Liangpunsakul|(317) 988-3232|sliangpu@iu.edu|
21296181|NCT02408523|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21250921|NCT01274559|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21250922|NCT00726713|Pamlab Inc.|Page Young, Clinical Project Manager|985-867-5788|pyoung@pamlab.com|
21250923|NCT01167192|Washington University School of Medicine|Rebecca Aft, M.D., Ph.D.|314-747-0063|aftr@wustl.edu|
21250924|NCT03231969|Faes Farma|Nieves Fernández, MD, PhD|+34 94 481 83 00|nfernandez@faes.es|
21250925|NCT00498615|Johns Hopkins University|Gwen Leatherman, R.N.|410-550-8582|gleathe@jhmi.edu|
21250926|NCT02314104|St. Barnabas Medical Center|Dr. Eric Liberman|917-696-1370|eliberma@montefiore.org|
21250927|NCT02482935|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21250928|NCT03503162|Motus GI|Director of Clinical Operations|954-541-8000|anniec@motusgi.com|
21250929|NCT02835092|Medifast|Linda Arterburn, VP Scientific & Clinical Affairs|443-379-5191|linda.arterburn@medifastinc.com|
21250930|NCT02246218|Horizon Therapeutics, LLC|Colleen Canavan, Director|866-479-6742|clinicaltrials@horizonpharma.com|
21250931|NCT01321723|Unigene Laboratories, Inc.|Nozer Mehta, PhD. Chief Scientific Officer|(973) 265-1100|nmehta@unigene.com|
21250932|NCT02561806|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21250933|NCT02547441|Clinical Development Dept.|Maruho Co., Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
21250934|NCT01322009|University of Pittsburgh|Robert Clark|412-692-7260|clarkrs@ccm.upmc.edu|
21250935|NCT00905034|University of Texas (UT) MD Anderson Cancer Center|Gautam Borthakur, MD/Associate Professor, Leukemia|713-563-1586|CR_Study_Registration@mdanderson.org|
21250936|NCT00394589|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21266004|NCT01263314|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21266005|NCT03960658|Minneapolis VA Health Care System|Dr. Paulo R. Shiroma|612-467-2264|paulo.shiroma@va.gov|
21296182|NCT01549873|Nationwide Children's Hospital|David Martin, MD|614-722-4200|David.Martin@nationwidechildrens.org|
21266006|NCT00748865|Alcon Research Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
21266007|NCT01929018|University of Colorado Denver, Anschutz Medical Campus|Dr. Cory Christiansen|303.724.9101|cory.christiansen@ucdenver.edu|
21296183|NCT00701805|Abbott|Global Medical Services|800-633-9110||
21296184|NCT02905006|Cares|UCB|+1877 822|UCBCares@ucb.com|9493
21296185|NCT05063539|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
21296186|NCT04256512|Mayo Clinic|Pooja P. Advani, MBBS|904-953-7291|Advani.Pooja@mayo.edu|
21296187|NCT01733771|Bnai Zion Medical Center|Dr. Samuel Attias|+972524707304|samuel.attias@b-zion.org.il|
21296188|NCT02262078|Mayo Clinic|Barry A. Borlaug, MD||Borlaug.Barry@mayo.edu|
21296189|NCT00167388|University of Pittsburgh|Dr. Toby Yanowitz|412-641-4111|yanotd@mail.magee.edu|
21296190|NCT04144959|Penumbra, Inc.|Erin Archard, Senior Director of Clinical Research, Vascular|+1 802 377 9715|earchard@penumbrainc.com|
21296191|NCT04435600|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21296192|NCT05149313|Almirall S.A|Head of Global Clinical Development|+34932913000|gco@almirall.com|
21296193|NCT04271475|Actelion Pharmaceuticals Ltd|Clinical Science Director CP|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21296194|NCT02337634|University of Chicago|Dr. Jon Grant|7738341325|jgrant4@bsd.uchicago.edu|
21296195|NCT04555837|The University of Texas MD Anderson Cancer Center|Faye Johnson, MD|(713) 792-6363|fmjohns@mdanderson.org|
21296196|NCT03298841|Toyos Clinic|Melissa Toyos|6153274015|mtoyos@toyosclinic.com|
21296197|NCT01300351|AstraZeneca China|Guofei Dai|+86 21 60301242|guofei.dai@astrazeneca.com|
21296198|NCT01221194|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
21296199|NCT03968159|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261|medicalinformation@acadia-pharm.com|2897
21296200|NCT02258529|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21296201|NCT00443781|Medtronic Spine and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
21296202|NCT00430937|Novartis Pharmaceuticals|Study Director|862-778-8300||
21296203|NCT02942654|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21296204|NCT01777945|Hoffmann-La Roche|Medical Communications|1-800-821-8590||
21296205|NCT02688868|Shanghai Microport Medicine|HT Zhang|+862138954600|zhanght@microport.com|8552
21296206|NCT02006069|Abbott|Kwangdeok Lee PhD|+19725269673|kwangdeok.lee@abbott.com|
21296207|NCT00875342|Weil Cornell Medical College|Program director|212 821 0783|jdifede@med.cornell.edu|
21296208|NCT02276547|Neovasc|Lisa Read, Clinical Study Manager|8558025180|lread@neovasc.com|323
21296209|NCT02066129|Penn State University Dept of Public Health Sciences|David Mauger, PhD|717.531.3584|dmauger@psu.edu|
21296210|NCT02642965|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21296211|NCT00180297|Boston Scientific|Elisabeth Mouton - Clinical Trial Manager|+33 1 39 30 11 90|elisabeth.mouton@bsci.com|
21296212|NCT00973102|University of Washington|Scott Emerson, PhD|206-616-6678|semerson@uw.edu|
21296213|NCT01439126|Concordia Pharmaceuticals Inc.|John AR McCleery, CPA, CA, Managing Director and CFO|1-246-256-1861|jmccleery@concordiarx.com|
21266008|NCT00282568|Astellas Pharma Global Development, Inc.|Vice President, Therapeutic Area Head, Transplantation||ClinicalTrials.Disclosure@us.astellas.com|
21281643|NCT03270657|Duke University|Dr. Dennis Turner|919-684-7777|dennis.turner@duke.edu|
21281644|NCT00162981|Lundbeck LLC|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
21281645|NCT00459862|Mayo Clinic|Julian Molina, M.D, Ph.D.||Molina.julian@mayo.edu|
21281646|NCT02535026|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21281647|NCT01343043|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21281648|NCT04029584|University of California, San Francisco|Leslie Benet, PhD|(415) 476-3853|leslie.benet@ucsf.edu|
21281649|NCT00502242|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21281650|NCT01812109|University of Texas Southwestern Medical Center|Dr. Linda Baker|214/456-2480|Linda.baker@childrens.com|
21281651|NCT01346696|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
21281652|NCT04630002|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21281653|NCT01691560|GlaxoSmithKline|GSK Response Center|866-435-7343||
21281654|NCT02348918|Allegro Ophthalmics, LLC|Director of Clinical Research|949-940-8130|info@allegroeye.com|
21281655|NCT00245128|OHSU Knight Cancer Institute|Dr. Michael Mauro|503-494-1080|maurom@ohsu.edu|
21281656|NCT04548193|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-2300|Chong.Wang@roswellpark.org|
21281657|NCT00630825|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21281658|NCT01011816|formerly Spinal Restoration, Inc|Jeff Doerzbacher||jdoerzbacher@renascentmed.com|
21281659|NCT01081769|Janssen-Cilag Germany|EMEA Medical Affairs Director Psychiatry||ClinicalTrialDisclosure@its.jnj.com|
21281660|NCT03309943|Duke University School of Medicine|Jason A. Oliver, Ph.D.|(919) 668-0093|Jason.A.Oliver@duke.edu|
21281661|NCT04557215|Cedars-Sinai Medical Center|Mohamad Rashid|310.423.7302|mastprogram@cshs.org|
21281662|NCT01069510|Oregon Health and Science Univ.|Dr. Craig Broberg|503-494-7400|brobergc@ohsu.edu|
21281663|NCT03337087|Accru|Dr. Tanios Bekaii-Saab|507/266-0800|Bekaii-Saab.Tanios@mayo.edu|
21281664|NCT02798380|Hallux, Inc.|Thomas M Tremblay, RN BSN, Vice President of Clinical Affairs|(415) 305-3491|ttremblay@halluxinc.com|
21296214|NCT00687609|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21296215|NCT00160199|Solvay Pharmaceuticals|Sven Voet - Global Communication|+32(0)2 509 69 77|sven.voet@solvay.com|
21296216|NCT00969436|GlaxoSmithKline|GSK Response Center|866-435-7343||
21296217|NCT01018095|Tulane University|Patricia Kissinger, PhD|5049887320|kissing@tulane.edu|
21296218|NCT01122108|Louisville Metabolic and Atherosclerosis Research Center (L-MARC)|Harold E. Bays, MD|502-515-5672|kschmitz@lmarc.com|
21296219|NCT02544373|University of Michigan|Tiffany J. Braley, MD, MS, Associate Professor of Neurology|734-936-6267|tbraley@med.umich.edu|
21296220|NCT01280695|Metabolic Solutions Development Company|Jerry Colca, PhD|269.343.6732|jcolca@msdrx.com|
21296221|NCT03667690|Cidara Therapeutics, Inc.|Taylor Sandison, M.D., MPH|858-888-7868|clinicaltrialinfo@cidara.com|
21296222|NCT01350115|Novartis Pharmaceuticals|Study Director|862-778-8300||
21296223|NCT04327024|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21296224|NCT00582998|University of Alabama at Birmingham|Asya Love, RN|205-996-6781|asyalove@uab.edu|
21296225|NCT00837759|NIDDK, National Institutes of Health|Dr. Rana Malek|3015945288|malekr@mail.nih.gov|
21296226|NCT01192568|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21296227|NCT02783170|Duke University|Dr. Geeta Swamy|919-681-5220|geeta.swamy@duke.edu|
21296228|NCT02804750|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
21250937|NCT03409731|Abbott medical device|Hajime Kusano|+1 408-845-1626|hajime.kusano@abbott.com|
21250938|NCT04545476|Vanderbilt University Medical Center|Karen Arnaud|615-322-6485|karen.arnaud@vumc.org|
21250939|NCT00241969|Cincinnati Children's Hospital Medical Center|Scott Powers, PhD|513-636-8106|scott.powers@cchmc.org|
21250940|NCT03175198|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21250941|NCT02906696|The University of Texas MD Anderson Cancer Center|Philip Thompson, MD/Assistant Professor|713-792-7430|PAThompson2@mdanderson.org|
21250942|NCT00634920|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21250943|NCT01193218|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21250944|NCT00363649|Johns Hopkins University|Doug Smith, MD|4102872935|smithdo@jhmi.edu|
21250945|NCT01013740|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
21250946|NCT02161185|Proximagen, LLC|David Sequeira,|952-658-7437|dsequeira@proximagen.com|
21250947|NCT03029611|UWashington (University of Washington)|Director of Clinical Operations|206-616-2305|childj@u.washington.edu|
21250948|NCT00776984|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21250949|NCT00661466|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
21250950|NCT01544309|Department of Cardiovascular Medicine, Faculty of Life Sciences, Kumamoto University|Hisao Ogawa, Ph.D; Study Chair|+ 81 963735175|ogawah@kumamoto-u.ac.jp|
21250951|NCT00953212|Maine Medical Center|Dr. Robert Kramer|207-662-2923|KRAMER@mmc.org|
21250952|NCT02341599|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21250953|NCT01125566|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21250954|NCT00988117|UCaliforniaSF|Dr. Bruce Miller|415-476-5569|bmiller@memory.ucsf.edu; kpossin@memory.ucsf.edu|
21250955|NCT04088500|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21250956|NCT01123512|Benvenue Medical, Inc.|Barbara S. Lindsay, Vice President Clinical & Regulatory Affairs|408-454-9300|blindsay@benvenuemedical.com|
21250957|NCT01091519|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21250958|NCT00621946|The University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD|214-645-6950|Sherwood.Brown@UTSouthwestern.edu|
21250959|NCT01227928|GlaxoSmithKline|GSK Response Center|866-435-7343||
21250960|NCT01204775|AstraZeneca AB, S-151 85 Södertälje, Sweden|Eva Johnsson, Clinical Science Lead, GLOBAL_MEDICINES_DEV|+46 31 7762484|Eva.Johnsson@astrazeneca.com|762 484
21250961|NCT00276016|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21250962|NCT02207322|Massachusetts General Hospital|Areej El-Jawahri|617-724-4000|ael-jawahri@partners.org|
21250963|NCT02185105|CooperVision, Inc|Sr. Manager, Clinical Research|9257306754|pchamberlain@coopervision.com|
21250964|NCT01468077|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21250965|NCT04333147|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21250966|NCT01009762|Statens Serum Institut|Professor Anders Fomsgaard|+45-32683460|afo@ssi.dk|
21250967|NCT02363998|USWM, LLC|Medical Affairs|1-888-900-8796|medinfo@usworldmeds.com|
21250968|NCT03677245|University of Mississippi Medical Center|Dr. Meredith Flowers|662-386-5926|mmflowers@umc.edu|
21250969|NCT00706914|AstraZeneca|Esther Garcia||ClinicalTrialTransparency@astrazeneca.com|
21250970|NCT02122549|ZOLL|Vice President of Medical Affairs|412-968-3333|stevens@zoll.com|14400
21250971|NCT01850823|Teva Pharmaceuticals Inc., USA|Director, PD/CE Studies|1-888-483-8279|usmedinfo@tevapharm.com|
21250972|NCT01751165|GlaxoSmithKline|GSK Response Center|866-435-7343||
21250973|NCT00988533|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com|
21250974|NCT03752242|BioMimetix|Director of Clinical Operations|303-862-7268|contact@bmxpharma.com|
21250975|NCT00913523|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Senior Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
21296229|NCT05501795|Bismarck Lasik|Dr Stephen Wexler|701-222-2020|drwexler@bismarcklasik.com|
21250976|NCT01475461|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21250977|NCT04051242|University of Pittsburgh|J. Peter Rubin, MD Principal Investigator and Endowed Chair of Plastic Surgery|412-383-8080|rubipj@UPMC.EDU|
21250978|NCT00676897|Beth Israel Deaconess Medical Center|Dr. Michael W. Donnino|6177542341|mdonnino@bidmc.harvard.edu|
21250979|NCT02512861|Children's Hospitals and Clinics of Minnesota|Mark Lo Galbo, MPH, CCRP|(612)-813-7828|mark.logalbo@childrensmn.org|
21250980|NCT00553605|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21250981|NCT02005393|FujiFilm Medical Systems USA|Robert Uzenoff: Executive Director of Clinical Science|(203) 602-3664|ruzenoff@fujifilm.com|
21266009|NCT01266070|The University of Texas (UT) MD Anderson Cancer Center|Eric Jonasch, MD/Professor, Genitourinary Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
21266010|NCT02417064|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266011|NCT03185819|Janssen-Cilag International NV|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266012|NCT02939976|Duke University Medical Center|David Kong, M.D.|919-668-8946|David.F.Kong@duke.edu|
21266013|NCT04080752|Janssen Research & Development, LLC|BE-R and D-Research Physician - Seni|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266014|NCT01585168|Yale University|Dr. Godfrey Pearlson|(860) 545-7757|Godfrey.Pearlson@hhchealth.org|
21266015|NCT01194414|Hoffman-LaRoche|Medical Communications|800-821-8590||
21266016|NCT04146038|Cancer Institute of New Jersey Rutgers|Roger K. Strair, MD, PhD|732-235-4523|strairrk@cinj.rutgers.edu|
21266017|NCT01782885|Universidad Autónoma de Nuevo León|M Sc Mario Simental-Mendía|+52 (81) 8329 4174|mario.simental@gmail.com|
21266018|NCT03447821|Cosmo Technologies Ltd.|Richard Jones|+353 18170370|RJones@cosmopharma.com|
21266019|NCT00654420|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21266020|NCT00250497|University_of_Minnesota|Dr. Dianne Neumark-Sztainer, Professor|612-624-0880|neuma011@umn.edu|
21266021|NCT02242760|Novan, Inc.|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
21266022|NCT02228824|University of Pittsburgh|Dr. Saul Shiffman|412-567-1761|shiffman@pinneyassociates.com|
21296230|NCT03133221|University of Maryland Greenebaum Comprehensive Cancer Center|Jean Yared, MD|410-328-1230|jyared@umm.edu|
21296231|NCT05970120|Biosense Webster, Inc.|Director Medical Affairs|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21296232|NCT04692077|HPTN Statistical & Data Management Center|HPTN Statistical Manager|+1 (206) 667-4004|HPTN-Data-Access@scharp.org|
21296233|NCT04831424|Columbia University|Martin Picard|6467748967|mp3484@columbia.edu|
21296234|NCT01751139|GlaxoSmithKline|GSK Response Center|435-7343|GSKClinicalSupportHD@gsk.com|866
21296235|NCT03199391|Zimmer Biomet|Madison Murphy|5745262059|madison.murphy@zimmerbiomet.com|
21296236|NCT01867086|Gradalis, Inc.|Director of Clinical Trials|2144428124|info@gradalisinc.com|
21296237|NCT03826342|University of Michigan|Golfo Tzilos Wernette|734-988-3424|gtzilos@med.umich.edu|
21296238|NCT01727011|Centre Antoine Lacassagne|Professeur JM Hannoun-Levi|04.92.03.12.60|jean-michel.hannoun-levi@nice.unicancer.fr|
21296239|NCT02733653|Boston Scientific Japan K.K.|Yoko Takizawa/Clinical Project Manager|+81-3-6853-7500|Yoko.Takizawa@bsci.com|
21296240|NCT00759525|Brigham and Women's Hospital|Mark A. Creager, MD|617-732-5267|mcreager@partners.org|
21296241|NCT03493607|Icahn School of Medicine at Mount Sinai|Christina Layton|212-241-6231|christina.layton@mssm.edu|
21296242|NCT01818284|UT MD Anderson Cancer Center|Chitra Hosing, MD/Professor, Stem Cell Transplantation|713-792-7734|cmhosing@mdanderson.org|
21296243|NCT00527319|Oxford Pharmaceutical Resources, Inc.|Dr. Richard Guarino|973-256-0600|Guarino@oxfordpharm.com|
21296244|NCT04908280|University of Rochester|Christopher T Richardson MD, PhD|585 - 275 - 7546|crichardson@urmc.rochester.edu|
21296245|NCT03119389|University of Maryland|Kerri Thom|410-706-6124|kthom@som.umaryland.edu|
21296246|NCT03779503|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
21296247|NCT00864851|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21296248|NCT02066415|Amgen Inc.|Study Director|866-572-6436||
21296249|NCT03826199|UCLA|Dvora Joseph Davey|3107011526|dvoradavey@ucla.edu|
21296250|NCT03242252|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
21296251|NCT01012921|Institut Straumann AG|Julia Dorn|0041619651111|julia.dorn@straumann.com|
21296252|NCT01267175|Medtronic Diabetes|Harold Torunsky|(818) 576 5445|harold.torunsky@medtronic.com|
21296253|NCT00895661|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu|
21296254|NCT00958932|National Jewish Health|Dr. Bruce Bender|303-398-1697|benderb@njhealth.org|
21296255|NCT02989805|Emory University|Benjamin Druss, MD, MPH|404-712-9602|bdruss@emory.edu|
21296256|NCT00286221|Johns Hopkins School of Medicine|Dr. Bradford Winters|4109559080|bwinter1@jh.edu|
21266023|NCT00431496|Amgen Inc.|Study Director|866-572-6436||
21266024|NCT02343952|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
21266025|NCT01983878|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21266026|NCT02671760|Sequential Medicine Ltd|Head of Product Development|617-818-2735|tadahl@outlook.com|
21266027|NCT02999191|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21266028|NCT01745913|Weill Cornell Medical College|Koen van Besien, MD|2127462646|kov9001@med.cornell.edu|
21266029|NCT03418064|CooperVision|Jose A. Vega, O.D., MSc., FAAO|19256213761|jvega2@coopervision.com|
21266030|NCT04821960|Northwestern University|James W. Griffith|3125035345|j-griffith@northwestern.edu|
21266031|NCT01240304|University of Arkansas for Medical Sciences|Beth Scanlan|501-686-8274|bscanlan@uams.edu|
21266032|NCT01993667|University of Utah|Dr. Scott McIntosh, MD, MPH|801-581-2730|Scott.McIntosh@hsc.utah.edu|
21266033|NCT01931150|Memorial Sloan Kettering Cancer Center|Dr. Mario Lacouture|646-888-6014|LacoutuM@mskcc.org|
21266034|NCT01248585|Canadian Cancer Trials Group|Keyue Ding, Biostatistician|613-533-6430|kding@ctg.queensu.ca|
21266035|NCT04968353|Virginia Commonwealth University School of Dentistry, Orthodontics|Steven J Lindauer|8048289326|sjlindau@vcu.edu|
21266036|NCT00845845|The University of Illinois Chicago|Scott Cotler, M.D. Professor of Medicine|708-216-3789|scotler@lumc.edu|
21266037|NCT01685203|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
21266038|NCT02896192|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
21266039|NCT03561246|Brooks Rehabilitation Clinical Research Center|Mark G. Bowden - PI|904-345-6626|mark.bowden@brooksrehab.org|
21296257|NCT02771626|Calithera Biosciences, Inc|Study Director|650-870-1000|clinicaltrials@calithera.com|
21266040|NCT01750840|Biomet|Manager of Research|973-299-9300|hallie.murray@zimmerbiomet.com|3415
21266041|NCT00479167|Rush University Medical Center|Stephanie Gregory, MD|312-942-5982|stephanie_gregory@rush.edu|
21266042|NCT01570309|Jacobi Medical Center|Dr Seth I Sokol|718-918-5735|seth.sokol@nbhn.net|
21266043|NCT03619837|University of Southern California|Norah Terrault|323-442-5100|terrault@usc.edu|
21266044|NCT04095793|Theravance Biopharma|Medical Monitor|855 633 8479|medinfo@theravance.com|+1
21266045|NCT01199198|University of Texas (UT) MD Anderson Cancer Center|Carmen Escalante,MD/Chair, General Internal Med|(713) 745-4516|cescalan@mdanderson.org|
21266046|NCT04315298|Regeneron Pharmaceuticals, Inc.|Clinical Trials Adminstrator|844-734-6643|clinicaltrials@regeneron.com|
21266047|NCT03267511|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21266048|NCT01636453|Penumbra, Inc.|Michaella Corso|(510) 748-3200||
21266049|NCT01977040|Mednax. Inc|Kimberly Maurel|714593-9171|kimberly_maurel@mednax.com|
21266050|NCT02000219|OxThera|Chief Operating Officer|0046 86600223|elisabeth.lindner@oxthera.com|
21266051|NCT02667236|Aclaris Therapeutics|Judy Schnyder, Sr. Director Clinical Operations|484-329-2144|jschnyder@aclaristx.com|
21266052|NCT01605890|Hopital Bichat-Claude Bernard, AP-HP, Paris, France|Pr Sophie Matheron|+33140257883|sophie.matheron@aphp.fr|
21266053|NCT00634751|University of Wisconsin Carbone Cancer Center|Dr. Noelle LoConte|608-265-5883|ns3@medicine.wisc.edu|
21266054|NCT01572844|GW Medical Faculty Associates|Alison Ehrlich, MD, Chair of Department of Dermatology|202-741-2625|aehrlich@mfa.gwu.edu|
21266055|NCT05724069|Alfasigma|Sara Manzoni|3473778218|sara.manzoni@alfasigma.com|
21266056|NCT02444936|Cleveland VA|Dr. David Canaday|216-368-8901|dxc44@case.edu|
21266057|NCT03552289|Cook Research Incorporated|Alan Saunders|765-463-7537|Alan.Saunders@CookMedical.com|
21266058|NCT03654560|United Health Products, Inc.|Gerard Abate, MD Chief Medical Officer|(386) 627-1598|G.Abate@unitedhealthproductsinc.com|
21266059|NCT00209092|Emory University|Dr. Amelia Zelnak|404-778-1900|amelia.zelnak@emory.edu|
21266060|NCT01235338|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21266061|NCT05283499|Rutgers University School of Dental Medicine|Cecile A. Feldman|973-972-4634|feldman@rutgers.edu|
21266062|NCT02996110|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21266063|NCT00524043|Johnson & Johnson Pharmaceutical Research & Development|Clinical Team Leader, Paliperidone|609 730-2436||
21266064|NCT03938636|Navidea Biopharmaceuticals|Chief Medical Officer|614-822-2320|mrosol@navidea.com|
21266065|NCT02579863|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21266066|NCT03135262|www.roche.com/about_roche/roche_worldwide.htm|Reference Study ID Number: BH39147|888-662-6728 (U.S. Only)|global-roche-genentech-trials@gene.com|
21266067|NCT02728206|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21266068|NCT01291511|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
21266069|NCT01366534|GlaxoSmithKline|GSK Response Center|866-435-7343||
21266070|NCT03436147|bakirkoy dr sadi konuk training and research hospital|Ismail Alay|+905462375638|dr_ismailalay@hotmail.com|
21266071|NCT03689972|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21266072|NCT00732641|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21266073|NCT00732238|Michael E DeBakey VA Medical Center-Baylor College of Medicine|Rabih Darouiche|713-841-3882|rdarouiche@aol.com|
21266074|NCT03434041|Janssen Research & Development, LLC|DIRECTOR CLINICAL LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266075|NCT03605836|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21266076|NCT02977507|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21266077|NCT01525420|Fred Hutchinson Cancer Research Center|Jonathan B. Bricker, Ph.D.||jbricker@fhcrc.org|
21266078|NCT00610207|Cook Biotech, Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@CookBiotech.com|
21266079|NCT03011775|Ukrainian Medical Stomatological Academy|Prof. Igor Kaidashev|+380505858953|kaydashevip@gmail.com|
21266080|NCT03378973|Hospital for Special Surgery|Ronald Emerson, MD|2127742742|emersonr@hss.edu|
21266081|NCT03634228|The University of Texas MD Anderson Cancer Center|Courtney DiNardo, MD/ Associate Professor|713-794-1141|CDiNardo@mdanderson.org|
21266082|NCT00744692|Duke University Medical Center|Dr. Suhag Parikh|919-668-1100|suhag.parikh@dm.duke.edu|
21266083|NCT02809846|Scripps TSRI|Lase Ajayi|785.218.1643|tajayi@scripps.edu|
21266084|NCT01594411|CardioDx, Inc.|EJ Fernandez, MD, CCRP - Sr. Manager Clinical Affairs|650-383-3350|jkuo@cardiodx.com|
21266085|NCT01577628|Innovaderm Research|Dr Robert Bissonnette|514-521-4285|rbissonnette@innovaderm.ca|
21266086|NCT00838383|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21266087|NCT01451398|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
21266088|NCT00422669|Medtronic, Inc.|Optimize RV Trial Leader|1-800-328-2518|medtroniccrmtrials@medtronic.com|
21266089|NCT01000818|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21266090|NCT00741260|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
21266091|NCT02565615|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21266092|NCT03920865|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21266093|NCT04010370|Institute of Experimental andl Clinical Therapeutics|Dr. Manuel González Ortiz|+52-33-10-58-52-00|uiec@prodigy.net.mx|34212
21296258|NCT02553538|Massachusetts General Hospital|Dr. Sanja Percac-Lima|617-643-6980|spercaclima@partners.org|
21296259|NCT02690649|Parkview Health|Julie Hughbanks|260-266-1444|julie.hughbanks@parkview.com|
21296260|NCT00530920|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21266094|NCT05563714|University of Michigan|Dr. Jacob E. Kurlander, MD, MS|734-660-4883|jkurland@umich.edu|
21266095|NCT01262599|Columbia University Medical Center|Dr. Christine Rohde|(212) 342-3707|chr2111@columbia.edu|
21266096|NCT02427100|The University of Oklahoma Health Sciences Center|Dr. Darla Kendzor, Associate Professor|(405) 271-8001|Darla-Kendzor@ouhsc.edu|50478
21266097|NCT01351064|IUSM|Aaron Carroll|3172789696|aaecarro@iu.edu|
21266098|NCT02120352|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21266099|NCT01610206|University of Virginia|Linda Duska, MD|434-982-1719|lrd5d@virginia.edu|
21266100|NCT00924729|Johns Hopkins University|Walter J. Stark, M.D./Professor of Ophthalmology|410-955-5490|wstark@jhmi.edu|
21266101|NCT01929707|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21266102|NCT00023712|Gynecologic Oncology Group(GOG) Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
21266103|NCT00437203|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21266104|NCT01332097|Mereo BioPharma|Dr. Jackie Parkin|+44 333 0237300|enquiries@mereobiopharma.com|
21266105|NCT01915095|Hines VA|Audrey Wilson|3122383637|awilson03@sralab.org|
21266106|NCT02067533|Isfahan University of Medical Sciences|Amin Nemati|00989131009918|nemati@med.mui.ac.ir|
21266107|NCT00565812|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21266108|NCT00383708|Ipsen|Medical Director, Endocrinology||clinical.trials@ipsen.com|
21266109|NCT00464711|Massachusetts General Hospital|Dr. Dan Iosifescu||diosifescu@partners.org|
21266110|NCT02448914|LobSor Pharmaceutical AB|Roger Bolsöy, CEO|+46 (0) 72 222 44 08|roger.bolsoy@lsmgroup.se|
21266111|NCT01997281|Seoul National University College of Medicine|Youn Min Cho, M.D, PhD|+82-2-2072-1965|ymchomd@snu.ac.kr|
21266112|NCT02384993|University of Wisconsin - Madison|Ozioma C. Okonkwo|(608) 265-4479|ozioma@medicine.wisc.edu|
21266113|NCT01372813|National Cancer Institute, National Institutes of Health|Marston Linehan, M.D.|301-496-6353|linehanm@mail.nih.gov|
21266114|NCT02650895|OncoImmune, Inc.|Dr. Pan Zheng|2027516823|pzheng@oncoimmune.com|
21266115|NCT01628042|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21266116|NCT02988401|Johns Hopkins University|Dr. Ellen Mowry|4106141522|Emowry1@jhmi.edu|
21266117|NCT02859558|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
21266118|NCT04507360|University of Washington|Tim Althoff|206-543-4243|althoff@cs.washington.edu|
21266119|NCT01432756|Boston Children's Hospital|Laura Bogart|857-218-4073|laura.bogart@childrens.harvard.edu|
21266120|NCT01357720|Crucell Switzerland AG|Medical Affairs Director|+41(0)319086111|info@crucell.com|
21266121|NCT01004159|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21266122|NCT02712008|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
21266123|NCT02481440|The Third Affiliated Hospital of Sun Yat-sen University|Li-Min Rong M.D., Director of Clinical Trials|862085252900|ronglimin@21cn.com, ronglm@mail.sysu.edu.cn|
21266124|NCT04483544|Miami Cancer Institute at Baptist Health, Inc.|Director, Research Concept & Protocol Development|(786) 527-9546|MCIResearchConceptAndProtocolDev@baptisthealth.net|
21266125|NCT03140488|University of Arizona|Meghan Hill|+64273095220|meghan.hill@auckland.ac.nz|
21266126|NCT01131078|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21266127|NCT00736385|Duke University Medical Center|Christopher Kigongo|919-668-6579|christopher.kigongo@duke.edu|
21266128|NCT00098865|DFCI|Mark W. Kieran, MD, PhD|617-632-4907|mark_kieran@dfci.harvard.edu|
21266129|NCT00364351|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21266130|NCT00653068|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21266131|NCT02177786|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21266132|NCT01305941|UNC Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
21266133|NCT03950440|University Hospitals Leuven|Dr. Danny Feike Hoogma|003216344270|danny.hoogma@uzleuven.be|
21266134|NCT02892734|Northwestern University|William Gradishar, MD|312 695 4541|w-gradishar@northwestern.edu|
21266135|NCT02043509|University of East Anglia|Dr Joanne Emery||joanne.emery@uea.ac.uk|
21266136|NCT02145754|University Medical center Ljubljana, Infectious Diseases Department|Daša Stupica|+386 1 522 21 10|dasa.stupica@kclj.si|
21266137|NCT04724291|George Washington University|Dr. Andrew C. Meltzer|2027412952|ameltzer@mfa.gwu.edu|
21266138|NCT03189563|Dong-A ST|Xiaofei Du|82-2-92-8457|duxiaofeicat@donga.co.kr|
21266139|NCT00608244|Veloxis Pharmaceuticals A/S|Christina Sylvest|+45 20553877|csy@veloxis.com|
21266140|NCT00430027|University of Colorado, Denver|Dr. Tracey Schefter|720-848-0100|Tracey.Schefter@ucdenver.edu|
21266141|NCT01670825|Johns Hopkins Hospital|Steven Cohen|410-955-1818|scohen40@jhmi.edu|
21266142|NCT04697888|Children's Mercy Hospital|Joel Lim, MD - Principal Investigator|(816)234-3000|jlim@cmh.edu|
21266143|NCT02613338|University of Tennessee|Adrija Sharma, Principal Investigator|8659747684|adrija.sharma@utk.edu|
21281665|NCT02169271|UT MD Anderson Cancer Center|Dr. Therese Bevers / Clinical Cancer Prevention Department|713-745-8048|tbevers@mdanderson.org|
21281666|NCT04926831|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21281667|NCT04577807|Istari Oncology|Head of Operations|919-245-7662|info@istarioncology.com|
21281668|NCT03859427|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21281669|NCT00564850|Ipsen|Medical Director, Endocrinology||clinical.trials@ipsen.com|
21281670|NCT02640664|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21266144|NCT01685060|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
21281671|NCT01804946|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Head of department of clinical trials|+74952761575|PutilovskiyMA@materiamedica.ru|302
21281672|NCT05286450|Sohag University|dr magdy mohamed amin|(093)- 4602963|portal@med.sohag.edu.eg|
21266145|NCT01193049|Merck Sharp and Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21266146|NCT04403802|Cedars-Sinai Medical Center|Dr. Arash Asher|310-423-1218|arash.asher@cshs.org|
21266147|NCT01726504|Guang An Men Hosptial of China Academy of Chinese Medical Sciences|Liu Zhishun|86 13651016313|liuzhishun@hotmail.com|
21266148|NCT00864539|National Nutrition and Food Technology Research Institute|Dr. Tirang R. Neyestani|(+9821)22376471|neytr@yahoo.com|
21266149|NCT02158728|Medtronic|Clinical Research Specialist L. Vainer|+31 43 3566752|lidwien.vainer@medtronic.com|
21266150|NCT03531762|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21266151|NCT00054756|NIDDK|Dr Joanna Klubo-Gwiezdzinska|301-496-1211|joanna.klubo-gwiezdzinska@nih.gov|
21266152|NCT01536418|GlaxoSmithKline|GSK Response Center|866-435-7343||
21266153|NCT02734849|Allakos, Inc.|Henrik Rasmussen, MD, PhD, Chief Medical Officer|1 6505975002|hrasmussen@allakos.com|
21266154|NCT04210232|Johnson & Johnson Surgical Vision|Eugenia K. Thomas|+1 657 2903260|EThoma39@its.jnj.com|
21266155|NCT02658149|Beaumont Health|Dr. James Verner|1(248)551-9722|jverner1@aol.com|
21266156|NCT00711412|Northwestern University|Dr. Mary Mulcahy|312 695 6182|Mary.Mulcahy@nm.org|
21266157|NCT04097028|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-2300|Kris.Attwood@roswellpark.org|
21266158|NCT02473289|Janssen Research & Development, LLC|ASSOCIATE DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266159|NCT02244619|Kettering Health Network|Skip Hickman, RPH|(937) 762-1339|skip.hickman@ketteringhealth.org|
21266160|NCT01156363|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21266161|NCT00383266|Washington University School of Medicine|Maria Baggstrom, M.D.|314-362-5740|mbaggstr@dom.wustl.edu|
21266162|NCT03285490|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
21266163|NCT03745989|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21266164|NCT00068822|Mayo Clinic|David F. Kallmes, M.D.|507-266-3350|kallmes.david@mayo.edu|
21266165|NCT04944758|University of British Columbia|Dr. Raymond Lam|6048227325|r.lam@ubc.ca|
21266166|NCT04989504|Mayo Clinic|Dr. Kimberly Corbin|855-776-0015|corbin.kimberly@mayo.edu|
21266167|NCT00617162|Abbott|Lyndahl Himes, Sr. Clinical Research Scientist|+1 214 998 1137|lyndahl.himes@abbott.com|
21266168|NCT00735072|University of California, San Francisco|Peter W. Hunt, MD|(415) 476-4082|phunt@php.ucsf.edu|345
21266169|NCT00911144|GlaxoSmithKline|GSK Response Center|866-435-7343||
21266170|NCT02367859|Stanford University|Dr. A. Dimitrios Colevas, Professor of Medicine (Oncology)|650-724-9707|colevas@stanford.edu|
21266171|NCT00047008|NRG Oncology|Wendy Seiferheld||SeiferheldW@nrgoncology.org|
21266172|NCT00429572|UT MD Anderson Cancer Center|Naoto Ueno, MD, PhD/Professor|713-792-8754|CR_Study_Registration@mdanderson.org|
21266173|NCT02773368|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21266174|NCT01665872|Yale University|Dr. Megan Smith|2037648655|megan.smith@yale.edu|
21266175|NCT02748525|The University of Texas Health Science Center at Houston|Isis Gayed, MD|713-704-1787|isis.w.gayed@uth.tmc.edu|
21266176|NCT01047436|Xidea Solutions Limited|Dr D Bendel||daryl@xideasolutions.com|
21266177|NCT05784103|University of Pittsburgh|Dr. Surya Gnyawali, PhD|6143712027|scg92@pitt.edu|
21266178|NCT01789255|University of Michigan Comprehensive Cancer Center|Pavan Reddy, M.D.|734-647-5954|reddypr@umich.edu|
21266179|NCT02635867|University of Illinois at Chicago|Adriana Semprum-Clavier|312-966-3535|asemprum@uic.edu|
21266180|NCT02128958|Can-Fite BioPharma|Pnina Fishman, PhD, CEO|972-3-924-1114|pnina@canfite.co.il|
21266181|NCT02565576|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21266182|NCT00939341|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|28062
21266183|NCT00424099|UT MD Anderson Cancer Center|Dr. Eduardo Bruera, MD- Chair, Palliative Care Med|(713) 792-6084|ebruera@mdanderson.org|
21266184|NCT01408732|University of Minnesota|Holly Boyer, MD|612-725-2000|boyer011@umn.edu|
21266185|NCT04904640|IRCCS Istituto Ortopedico Rizzoli|Francesco Castagnini, MD|+390516366418|francesco.castagnini@ior.it|
21266186|NCT00764322|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
21266187|NCT03097133|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266188|NCT00371540|Indiana University School of Medicine|Kara Wools-Kaloustian|317-274-7936|kwools@iu.edu|
21266189|NCT02910089|Astrazeneca Pharmaceuticals|Susan Thomas, MD|302-886-5589|Susan.Thomas2@astrazeneca.com|
21266190|NCT00633360|Brigham & Women's Hospital|Dr Hadine Joffe|617-732-4906|hjoffe@partners.org|
21266191|NCT00329784|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21266192|NCT03241589|VHA|Sara Peracca|415-750-2091|sara.peracca@va.gov|
21266193|NCT03236506|University of Dundee|Professor John Dillon|01382 383017|j.f.dillon@dundee.ac.uk|
21266194|NCT00865202|University of Colorado|Thomas Robinson MD|303-724-2728|thomas.robinson@ucdenver.edu|
21266195|NCT00638274|Wake Forest University School of Medicine|Peter H. Pan, MD|336-718-82748|ppan@wakehealth.edu|
21266196|NCT00643448|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21266197|NCT00981682|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
21266198|NCT03695471|Mayo Clinic|Jason Sluzevich|904-953-6402|Sluzevich.Jason@mayo.edu|
21296261|NCT01754194|Medtronic MITG|Maria Young - Clinical Research Manager|+353 (0)1 4381611|maria.young@medtronic.com|
21266199|NCT00400946|Dana-Farber Cancer Institute|Lewis B. Silverman, MD|617.632.6191|Lewis_Silverman@dfci.harvard.edu|
21266200|NCT00638651|University of Miami|Dr. Keyvan Nouri|305-243-3380|knouri@med.miami.edu|
21266201|NCT03050307|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21266202|NCT00439309|Integra LifeSciences|Director, Medical Affairs|609-275-0500||
21296262|NCT02392403|Cochlear|Chris James|+33 534 638 584|cjames@cochlear.com|
21266203|NCT00464620|SARC|SARC|(734) 930-7600|sarc@sarctrials.org|
21266204|NCT01998906|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21266205|NCT02204410|Massachusetts General Hospital|Dr. Timothy Wilens|(617)643-3481|twilens@mgh.harvard.edu|
21266206|NCT05241470|Stuart Therapeutics|Brian Del Buono, Executive Vice President|7034025866|brian@stuarttherapeutics.com|
21266207|NCT02334813|University Hospital Essen, Germany|Prof. Dr. Ulrich Dührsen|+49 201 723|ulrich.duehrsen@uk-essen.de|2417
21266208|NCT00911326|Navidea Biopharmaceuticals|Dr. Frederick O. Cope, Chief Scientific Officer|614-793-7500|fcope@navidea.com|140
21266209|NCT06048809|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
21266210|NCT02784496|The University of MD Anderson Cancer Center|Prithviraj Bose, MD/Professor|713-792-7747|PBose@mdnaderson.org|
21266211|NCT01250899|University of California, Los Angeles|Dr Jordan Lake|310-557-2273|jlake@mednet.ucla.edu|
21266212|NCT01847560|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21266213|NCT01525745|Beth Israel Deaconess Medical Center|Anand Mahadevan, MD|617-667-2345|amahadev@bidmc.harvard.edu|
21266214|NCT00794469|Hadassah Medical Organization|Gal Dubnov-Raz|+972+54-4570250|gal-d@bezeqint.net|
21266215|NCT04358991|University of Pittsburgh|Dr. Ryan Shields, Associate Professor of Medicine|412-864-3745|shieldsrk@upmc.edu|
21266216|NCT05129124|Bausch + Lomb Incorporated|Jill Schafer|0000000|Jill.Schafer@bausch.com|
21266217|NCT02458352|University Hospital Zurich|Dr. Ronny Buechel|0041442551059|ronny.buechel@usz.ch|
21266218|NCT02234050|EORTC|Dr. Thierry Gorlia|027741652|thierry.gorlia@eortc.org|
21266219|NCT02527564|Stanford University|Po W. Wang|650-723-2483|wangp0@stanford.edu|
21266220|NCT00257322|University of California, Irvine|Chao Family Comprehensive Cancer Center|(877) 827-8839|UCstudy@uci.edu|
21266221|NCT00628134|University of Pittsburgh|Tim Corcoran, Ph.D.|412-624-8918|corcorante@upmc.edu|
21266222|NCT01680991|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21266223|NCT06073054|University of Iowa|Linnea Polgreen|(319) 384-3024|linnea-polgreen@uiowa.edu|
21266224|NCT00796003|Janssen Pharm KK Japan|Director|+81-3-4411-5801||
21266225|NCT00564265|Hospital de La Serena|Dr. Marcelo A. Beltran|56 - 51 - 485923|beltran_01@yahoo.com|
21266226|NCT01131130|Bausch + Lomb|Dr. Robert Steffen|585-338-6399|robert.steffen@bausch.com|
21266227|NCT03345342|Janssen Research & Development, LLC|Compound Development Team Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266228|NCT01268943|Chinese Academic Medical Sciences|Dr. Jing Jin|010-87788503|tangyu.pumc@gmail.com|
21266229|NCT02437162|Johnson&Johnson|SENIOR DIRECTOR CLINICAL DEVELOPMENT|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266230|NCT03981744|Janssen Pharmaceutical K.K.|PRODUCT DEVELOPMENT PORTFOLIO LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266231|NCT04338321|Janssen-Cilag International NV|Europe, Middle East, Africa (EMEA) Medical Advisor Spravato|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266232|NCT03321526|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266233|NCT01989572|ECOG Statistical Office|Study Statistician|617-632-3012||
21266234|NCT00262639|Medical University of South Carolina|Raymond F. Anton, M.D.|843-792-1226|antonr@musc.edu|
21266235|NCT02280096|Instituto Mexicano del Seguro Social. Unidad de Investigación Médica en Enfermedades Neurológicas.|Dr. Israel Grijalva|(01152) 5555780240|igrijalvao@yahoo.com|
21266236|NCT06181708|Imperial College Healthcare NHS Trust|Emma Flint|02033117322|e.flint1@nhs.net|
21266237|NCT03733132|Mayo Clinic|K Sreekumaran Nair, M.D., Ph.D.|507-255-2415|Nair@mayo.edu|
21266238|NCT00246376|Baylor College of Medicine|Ashok Balasubramanyam, MD, Prinicipal Investigator|713-798-8654|ashokb@bcm.edu|
21266239|NCT04254796|University of California, San Francisco|Olga Tymofiyeva|415-514-4870|olga.tymofiyeva@ucsf.edu|
21266240|NCT01976975|McLean Hospital|David Crowley|6178554432|djcrowley@mclean.harvard.edu|
21266241|NCT02463227|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s3.com|
21266242|NCT01933399|MUSC|David Morrisette, PhD|843-792-2940|morrisdc@musc.edu|
21266243|NCT01849562|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
21266244|NCT00481988|Division of Experimental Therapeutics, NY State Psychiatric Organization|Peter Bulow MD, Assistant Professor of Clinical Psychiatry|(212) 543 5664|pb2182@columbia.edu|
21266245|NCT03136913|Tufts University|Dr. Yong Hur|6176366531|Yong.Hur@tufts.edu|
21266246|NCT01673425|VA National Center for Occupational Health & Infection Control|Lewis Radonovich|352-376-1611|Lewis.radonovich@va.gov|4988
21266247|NCT00926185|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21266248|NCT04599972|Orasis Pharmaceuticals, Ltd.|Head of Regulatory Affairs|+972-9-8877745|iris.meisner@orasis-pharma.com|
21266249|NCT02069704|mAbxience|Susana Millan|+34917711500|susana.millan@mabxience.com|
21266250|NCT01347073|Hyperion Therapeutics, Inc.|Craig James R.N. Associate Dir. UCD Clinical Operations|(650) 745- 7480|craig.james@hyperiontx.com|
21266251|NCT01478581|Pharmacyclics Switzerland GmbH|Dr. Bernhard Hauns, Medical Monitor|+41 52 556 0800|bhauns@pcyc.com|
21266252|NCT00621244|Novartis Pharmaceuticals|Study Director|862-778-8300||
21266253|NCT01690988|Washington University School of Medicine|Dr. Michael Avidan|314-747-4155|avidanm@wustl.edu|
21266254|NCT00312728|Hoffman-LaRoche|Medical Communications|800-821-8590||
21266255|NCT03696576|Emory University|Sandeep Shelly|404-686-4206|SSHELLY@emory.edu|
21266256|NCT01137006|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21266257|NCT00356057|BIOTRONIK, Inc.|Katerina de Metz, Director Clinical Studies|5036752169|katerina.demetz@biotronik.com|
21266258|NCT00179517|Beth Israel Deaconess Medical Center|Andrew G Herzog MD,MSc|781-431-0277|aherzog@bidmc.harvard.edu|
21266259|NCT00946023|Johns Hopkins University|Rich Ambinder, MD|4109558839|rambind1@jhmi.edu|
21266260|NCT04857892|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21266261|NCT01311895|Montefiore Medical Center|Dr. Andrew Chang|718-920-6626|achang3@yahoo.com|
21296263|NCT04904809|Abbott Vascular|Sandeep Pingle|858-222-9673|sandeep.pingle1@abbott.com|
21266262|NCT03304912|Drexel University|Alexis Roth, PhD, MPH|267.359.6123|alexisroth@drexel.edu|
21266263|NCT00880607|Children's Hospital of Colorado, University of Colorado|Mindy Cohen, MD FAAP, Assistant Professor, Department of Anesthesiology||Mindy.cohen@childrenscolorado.org|
21266264|NCT05849441|innovation Research & Training|Dr. Alison Parker|919-493-7700|aparker@irtinc.us|
21266265|NCT01627782|Janssen Research & Development, LLC|Senior Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
21266266|NCT01431521|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21266267|NCT02782104|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266268|NCT03464136|Janssen Scientific Affairs, LLC|DIRECTOR MEDICAL AFFAIRS MD|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266269|NCT02438787|Janssen Research & Development, LLC|Scientific Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266270|NCT03412565|Janssen Research & Development, LLC|GLOBAL MEDICAL HEAD|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266271|NCT03277105|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266272|NCT02968277|Rehabilitation Institute of Chicago|Arun Jayaraman, PT, PhD; Director of Max Nader Lab for Rehabilitation Technologies and Outcomes|3122386875|ajayaraman@ricres.org|
21266273|NCT02418585|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266274|NCT04159701|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21266275|NCT01775800|The Rogosin Institute|Dr. Nathaniel Berman|212-746-9766|nab2009@nyp.org|
21266276|NCT00638690|Johnson & Johnson Pharmaceutical Research & Development|Senior Director, Clinical Research|310-914-2915||
21266277|NCT00554853|UMichigan|PPAR-gamma agonist, rheumatoid arthritis and cardiovascular disease|734-936-7905|makaplan@umich.edu|
21266278|NCT02861118|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21266279|NCT01452191|University of Nottingham|Professor Denise Kendrick||denise.kendrick@nottingham.ac.uk|
21266280|NCT02348840|Emory University|Gari D. Clifford, DPhil|404-727-0229|gari.clifford@emory.edu|
21266281|NCT00373880|New York State Psychiatric Institute at Columbia University Medical Center|Margaret Haney, Ph.D.|646-774-6153|meg.haney@nyspi.columbia.edu|
21266282|NCT00626340|University of Pennsylvania|Dr. Cynthia Neill Epperson|215-573-8871|cepp@mail.med.upenn.edu|
21266283|NCT03531710|United Neuroscience|Medical Director|+1 (972) 809-0481|info@unitedneuroscience.com|
21266284|NCT02865928|Northwell Health|Louis Ballas|718-470-5827|lballas@northwell.edu|
21266285|NCT03152110|University of Pittsburgh|Alicia Koontz|412-822-3700|akoontz@pitt.edu|
21266286|NCT02705352|Massachusetts Eye and Ear|Shyana Harper|6173915982|Shyana_harper@meei.harvard.edu|
21266287|NCT01922986|University of Minnesota|James R. Carey|612-626-2746|carey007@umn.edu|
21266288|NCT00552344|UCB Cares|UCB (Study Director)|+1 887 822 9493||
21266289|NCT01634100|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21266290|NCT00471276|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21266291|NCT00338806|NYSPInstitute|Dr. Helen Verdeli|212 543 5262|verdelih@nyspi.columbia.edu|
21266292|NCT00438490|Massachusetts General Hospital|Corrine Welt, MD|617-726-8437|cwelt@partners.org|
21266293|NCT00744991|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21266294|NCT01501162|Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea|Dr. Ki Tae Suk|+82-33-240-5826|ktsuk@hallym.ac.kr|
21266295|NCT01662986|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21266296|NCT01975376|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21266297|NCT01620593|UT Health San Antonio Cancer Center|Sukeshi Arora, MD|210-450-1015|aroras@uthscsa.edu|
21266298|NCT03536923|Renovia, Inc|Chief Medical Officer, Dr. Samantha Pulliam|866-735-8424|sjpulliam@renoviainc.com|
21266299|NCT00456885|BIDMC|Jody Dushay|6177353343|jdushay@bidmc.harvard.edu|617
21266300|NCT01448707|Janssen Research & Development, LLC|EMEA Medical Affairs Program Lead||ClinicalTrialDisclosure@its.jnj.com|
21266301|NCT04266158|The Ohio University|College of Medicine Office of Research Compliance Team|6145886811|comresearchcompliance@osumc.edu|
21266302|NCT03595449|Mayo Clinic|Shari A. Ochoa, M.D.|480-301-6479|Ochoa.Shari@mayo.edu|
21266303|NCT03242590|Lipocine, INC.|Nachiappan Chidambaram, Vice President, Product Development|8018819495|nc@lipocine.com|
21266304|NCT02667392|VAORD|Dr. Dorian Rose|352-376-1611|dorian.rose@va.gov; dkrose@phhp.ufl.edu|105238
21266305|NCT02033850|'L. Sacco' Department of Biomedical and Clinical Sciences University of Milan|Prof. Leonardo Pantoni, Principal Investigator|0039-02-50319865|leonardo.pantoni@unimi.it|
21266306|NCT01308294|Department of Oncology, Division of Medical Oncology University Hospital Lausanne|Prof. Olivier Michielin, MD PhD|+41 21 314 01 85|Olivier.Michielin@chuv.ch|
21266307|NCT02820038|University of North Carolina at Chapel Hill|Susan J. Blalock, PhD|919-962-0080|s_blalock@unc.edu|
21266308|NCT03215667|Sunstar Americas, Inc.|Akane Takemura|8477944276|akane.takemura@us.sunstar.com|
21266309|NCT00560794|Amgen Inc.|Study Director|866-572-6436||
21266310|NCT00614991|Garden State Infectious Disease Associates|David Condoluci|856-566-3190|dcondoluci@gsida.org|
21266311|NCT00655811|University of Miami|Gil Yosipovitch, MD, Professor|305-243-5121|gyosipovitch@med.miami.edu|
21266312|NCT01237301|International Diabetes Center|Dr. Richard Bergenstal|952-993-3796|richard.bergenstal@parknicollet.com|
21266313|NCT00368472|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
21266314|NCT01044056|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21266315|NCT01922739|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21266316|NCT00044213|Mount Sinai Medical Center|Gervasio A. Lamas, M.D.|305-674-2162|Gervasio.Lamas@msmc.com|
21296264|NCT00084149|University of California, San Diego|Dr. Florin Vaida|619 543-8045|fvaida@ucsd.edu|
21266317|NCT00422240|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
21266318|NCT01927068|Spectranetics LLC, now part of Philips Image Guided Therapy|Associate Director, Clinical Operations|612-297-6655|nicolas.aguirre@philips.com|
21266319|NCT00118404|The University of Texas Southwestern Medical Center|Dr. Robin B. Jarrett, Professor of Psychiatry|214-648-5345|Robin.Jarrett@UTSouthwestern.edu|
21266320|NCT05104749|Sonoran University of Health Sciences|Elizabeth Rice Principal Investigator|4809700000|e.rice@sonoran.edu|
21266321|NCT03964493|TenNor Therapeutics Limited|Zhenkun Ma, PhD / CEO|+1(646) 775-1861|zhenkun.ma@tennorx.com|
21266322|NCT02963766|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21266323|NCT01947647|Ralph H. Johnson VAMC|Daniel Gros, PHD|843-789-7311|daniel.gros@va.gov|
21266324|NCT01154322|ResMed|June Mendoza|1-800-424-0737|june.mendoza@resmed.com|
21266325|NCT02224274|UMC Ljubljana|Marko Noc|+386 1 522 22 96|marko.noc@mf.uni-lj.si|
21266326|NCT00887068|UT MD Anderson Cancer Center|Dr. Richard E. Champlin, MD/ Chair, Stem Cell Transplantation|713-792-3618|rchampli@mdanderson.org|
21266327|NCT00499460|Clinical Research Division, Fred Hutchinson Cancer Research Center|Danny D. Shen, Member (Retired)|206-685-2920|ds@uw.edu|
21266328|NCT01256918|Dr. Ram Manohar Lohia Hospital|Dr. Praveen Kumar Malik|00919810405681|praveenk002@yahoo.com|
21266329|NCT03054298|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
21266330|NCT03073200|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21266331|NCT00901394|University of Chicago|Principal Investigator|7737022544||
21266332|NCT01474889|UPenn|Cornelia V. Dalton Bakes|215-746-2085|corneliv@pennmedicine.upenn.edu|
21266333|NCT02482389|Duke University Health System|Joan Cahill|(919) 668-5211|joan.cahill@duke.edu|
21266334|NCT02590640|"University of Colorado Denver | Anschutz"|Director, Research Services|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
21266335|NCT02290340|MedImmune, LLC|M. Pamela Griffin|301-398-4095|information.center@astrazeneca.com|
21266336|NCT04129086|The University of Texas Health Science Center at Houston|John Andrew Harvin, MD|713-500-7292|John.Harvin@uth.tmc.edu|
21266337|NCT04964557|AstraZeneca|AstraZeneca Clinical Study Information Center|+1-877-240-9479|information.center@astrazeneca.com|
21266338|NCT00045487|University of Texas Health Science Center San Antonio|Alain Mita, MD|210-450-5094|goodwine@uthscsa.edu|
21266339|NCT03209362|Seikagaku Corporation|Clinical Development Dept.|(81)3-5220-8948|taku.hosaka@seikagaku.co.jp|
21266340|NCT00251589|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21266341|NCT00323427|Portland VA Medical Center|Mitchel Turbin, Ph.D.|503-220-8262|bonnie.becker@va.gov|54525
21266342|NCT02493868|Janssen Research & Development, LLC|Senior Director, Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266343|NCT02407236|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266344|NCT00093756|Roswell Park Cancer Institute|Alex A. Adjei, M.D., Ph.D.|507/284- 9265|alex.adjei@roswellpark.org|
21266345|NCT02168660|UT Southwestern Medical Center|Dr Perrin C White, Professor of Pediatrics|2146486875|perrin.white@utsouthwestern.edu|
21266346|NCT02177812|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21266347|NCT04888507|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21266348|NCT00636155|Duke University Medical Center|Mark Lanasa, MD, PhD|919-286-6897|mark.lanasa@duke.edu|
21266349|NCT00766142|Institut Bergonié|Pr Simone Mathoulin-Pélissier|0556333333|s.mathoulin@bordeaux.unicancer.fr|
21266350|NCT04685408|Case Western Reserve University|Dr. Martha Sajatovic|216-844-2808|martha.sajatovic@uhhospitals.org|
21266351|NCT05643170|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21266352|NCT00142818|University of Pennsylvania|Dr. Kyle Kampman|215-222-3200|kampman@mail.med.upenn.edu|109
21266353|NCT02358863|Lombardi Comprehensive Cancer Center (LCCC)|John Marshall, MD|202-444-7064|marshalj@georgetown.edu|
21266354|NCT00438191|Massachusetts General Hospital|Taylor Pong||tpong1@partners.org|
21266355|NCT06436300|Washington State University|Clemma Muller|612-327-7237|clemma.muller@wsu.edu|
21266356|NCT03765736|Duke Cancer Institute|John Strickler, MD|(919) 668-6608|john.strickler@duke.edu|
21266357|NCT00365872|H. Lee Moffitt Cancer Center and Research Institute|Scott J. Antonia, M.D., Ph.D.|813-745-3883|scott.antonia@moffitt.org|
21266358|NCT00863434|University of Washington|Pamela Becker, MD, PhD|206-288-7273|pbecker@uw.edu|
21266359|NCT01116661|University of California San Francisco|Mitch Berger, MD; Director of Neurosurgery|415-353-7500|Mtich.Berger@ucsf.edu|
21266360|NCT02632344|Massachusetts General Hospital|Dr. Sara Pai, Principal Investigator|617-726-5251|sarapaimdphd@gmail.com|
21266361|NCT00777257|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21266362|NCT05426460|University of Pittsburgh|Dr. Cynthia Conklin|4125869840|conkca@upmc.edu|
21266363|NCT02996305|Ovid Therapeutics|Adera Matthews, MD|570 620 6290|madera@ovidrx.com|
21266364|NCT02973997|University of Colorado, School of Medicine|Bryan Haugen, M.D.|507-266-0800|bryan.haugen@ucdenver.edu|
21266365|NCT00444951|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21266366|NCT00366444|Xanodyne Pharmaceuticals, Inc.|Steve Boesing|1-877-926-6396|clinical-trials@xanodyne.com|
21266367|NCT04984876|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21266368|NCT02000622|AstraZeneca|Medical Science Director|1-877-240-9479|clinicaltrialtransparency@astrazeneca.com|
21266369|NCT01405027|Chronic Liver Disease Foundation|Dr. Fred Poordad|732-381-8887|poordad@txliver.com|
21266370|NCT05085327|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
21266371|NCT02462122|Bausch Health|Study Director||anyaloncaric@bauschhealth.com|
21266372|NCT01938391|NYU Langone Medical Center|Anvar Babaev, MD, PHD, FACC, FSCAI|212-263-5656|anvar.babaev@nyumc.org|
21266373|NCT01077193|Ethicon-Endo Surgery, Inc.|Michael L. Schwiers|513-337-1172|mschwier@its.jnj.com|
21266374|NCT04283773|Assiut Univercity|Demonstrator at pathology department|00201033986747|omar011523@med.au.edu.eg|
21266375|NCT04924114|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21266376|NCT04960202|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21266377|NCT00592176|University of Alabama at Birmingham|Dr. Tyler Hall, M.D.|205-325-8310|tandrewhall@yahoo.com|
21266378|NCT03774875|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21266379|NCT02498392|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266380|NCT02352090|Helsinki University Central Hospital|Oskari Heikinheimo|+358 50 4271533|oskari.heikinheimo@helsinki.fi|
21266381|NCT03687827|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21266382|NCT03630185|The University of Texas Health Science Center at Houston|Stuart A Harlin, MD|713-486-5131|Stuart.A.Harlin@uth.tmc.edu|
21266383|NCT02869451|Duke University Medical Center|Angela Kirby|919-286-0411|angela.kirby@duke.edu|5526
21266384|NCT00987727|Allergan, Inc|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
21266385|NCT01678313|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|Dr. Hann-Chorng Kuo|886-3-8561825|hck@tzuchi.com.tw|2113
21266386|NCT00981292|Northumbria university|Emma Wightman|+44 (0) 191 2437253|emma.l.wightman@unn.ac.uk|
21266387|NCT03377452|VA Greater Los Angeles Healthcare System|Jennifer Martin, PhD|818-891-7711|jennifer.martin@va.gov|36080
21266388|NCT05179057|AlloVir, Inc.|Senior Vice President|+1 617-433-2605|rriese@allovir.com|
21266389|NCT03375203|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266390|NCT03107793|Janssen-Cilag International N.V.|European Medicines Agency (EMEA) Advisor-Immunology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266391|NCT02808507|Johns Hopkins Bloomberg School of Public Health|Colleen Hanrahan|410-502-9289|chanrah1@jhu.edu|
21266392|NCT02219516|Study Information Center AstraZeneca|Jesse Hall, MD|+1 877-240-9479|information.center@astrazeneca.com|
21266393|NCT01872897|Reckitt Benckiser|Clinical Data Controller||clinicaldatacontroller@reckitt.com|
21266394|NCT02040857|Dana-Farber Cancer Institute|Project Manager|617-632-5313|ctopm@dfci.harvard.edu|
21266395|NCT02845440|Massachusetts General Hospital, Center for Addiction Medicine|A. Eden Evins|6177333131|aeevins@mgh.harvard.edu|
21266396|NCT03146403|Genocea|Jennifer LaVin|617-876-8191|jennifer.lavin@genocea.com|
21266397|NCT01024920|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21266398|NCT00077922|National Cancer Institute, National Institutes of Health|Robert J. Kreitman, M.D.|301-496-6947|kreitmar@mail.nih.gov|
21266399|NCT02182999|Department of Orthopedic Surgery, Medical University of Innsbruck|Dr. Matthias Braito|0043 512 504|matthias.braito@gmail.com|81214
21266400|NCT02252588|University of Minnesota|Christine Wendt, MD|612-624-0999|wendt005@umn.edu|
21266401|NCT05241288|University of North Carolina at Chapel Hill|Michael B Drummond, MD|919-966-7054|brad_drummond@med.unc.edu|
21266402|NCT00693693|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-3775|sfeldman@wfubmc.edu|
21266403|NCT02972593|Indiana University School of Medicine Department of Orthopaedic Surgery|Dr. Brian H. Mullis|317-963-1966|bmullis@iupui.edu|
21266404|NCT00285649|Palmer College of Chiropractic|Ting Xia, PhD (Principal Investigator)|563-884-5161|Ting.Xia@palmer.edu|
21266405|NCT02203916|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21266406|NCT01466062|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21266407|NCT01925014|The LOCAT Group|Kyoung Ho Lee|82317877607|kholeemail@gmail.com|
21266408|NCT03077711|Lehigh Valley Health Network|Dr. Carolyn Botros, DO|4845917480|carolyn.botros@lvhn.org|
21266409|NCT01819194|Vistakon|Daria Wicks|904-443-1391|RA-VISUS-ClnclStds@its.jnj.com|
21266410|NCT00045630|SWOG Statistical Center|Study Statistician|206-667-4623||
21266411|NCT04449276|CureVac AG|Clinical Trial Information|+49 6976805870|clinicaltrials@curevac.com|
21266412|NCT01614795|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21266413|NCT00701103|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21266414|NCT01378299|Michael E. DeBakey VA Medical Center|Reina Villareal, MD|713-794-7534|reina.villareal@va.gov|
21266415|NCT02046382|TriHealth|Clinical Research Specialist|513-862-2341|ganga_devaiah@trihealth.com|
21266416|NCT01624467|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21266417|NCT00089999|GlaxoSmithKline|GSK Response Center|866-435-7343||
21266418|NCT03039569|University of Nebraska-Lincoln|Weiwen Chai|402-472-7822|wchai2@unl.edu|
21266419|NCT01167153|Novartis Pharmaceuticals|Study Director|862-778-8300||
21266420|NCT04852666|University of North Carolina at Chapel Hill|Michael Kappelman, MD, MPH|919-843-5908|michael_kappelman@med.unc.edu|
21266421|NCT03637959|Mayo Clinic|Shigao Chen, Ph.D.|507-284-3703|Chen.Shigao@mayo.edu|
21266422|NCT04829734|Multi Radiance Medical|Douglas Johnson, ATC, EES, CLS - Chief Science Officer, Clinical and Scientific Affairs|440-542-0761|info@multiradiance.com|
21266423|NCT01462045|University of New Mexico|Sang Hwan Kim, PhD/Lead Investigator|5057954545|sanghk@gmail.com|
21266424|NCT03558828|Rush University College of Nursing|Manju Daniel|312.942.3460|manju_n_daniel@rush.edu|
21266425|NCT03671148|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21266426|NCT02855086|Stanford University Medical Center|Gordon Li, MD, Associate Professor of Neurosurgery|650-721-1020|gordonli@stanford.edu|
21266427|NCT00673816|National Eye Institute|Catherine Meyerle, MD|301-435-7821|meyerlec@nei.nih.gov|
21266428|NCT01804842|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com|
21266429|NCT00413777|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21266430|NCT00435929|Roche Trial Information Hotline|F. Hoffmann-La Roche AG|+41 61 6878333|global.trial_information@roche.com|
21266431|NCT05180721|Yale|Robin Whittemore|203-432-7000|robin.whittemore@yale.edu|
21296265|NCT03757130|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21266432|NCT04246489|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
21266433|NCT01520688|Allegheny Health Network|Deborah Gentile, MD|412-359-4099|dgentile@ahn.org|
21266434|NCT01791465|Vanderbilt University Medical Center|John Koethe MD|615-343-0533|john.r.koethe@vanderbilt.edu|
21266435|NCT04246541|University Hospitals Cleveland Medical Center|Dr. Michael Karns|216-844-7200|michael.karns@uhhospitals.org|
21266436|NCT02575300|H. Lee Moffitt Cancer and Research Center|Dr. Jonathan Strosberg, MD|813-745-7257|Jonathan.Strosberg@moffitt.org|
21266437|NCT02736929|Duke University School of Medicine|Angela Kirby|919-286-0411|angela.kirby@duke.edu|175526
21266438|NCT01744041|Washington University - School of Medicine|Dr. Shannon Lenze|3143622752|slenze@wustl.edu|
21266439|NCT02465489|ApoPharma Inc.|Caroline Fradette, PhD|416-401-7543|cfradett@apopharma.com|
21266440|NCT03003130|Q-Med AB|Head of Development|+ 46 (0) 18 474 90 00|reception.seupp@galderma.com|
21266441|NCT01236768|Agile Therapeutics|Lisa Flood, Associate Director of Clinical Operations|609-683-1880|lflood@agiletherapeutics.com|
21266442|NCT03949621|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21266443|NCT01855425|Carestream Health, Inc.|Susan Pate, RN, MS, RAC|585-627-6557|susan.pate@carestream.com|
21266444|NCT00605358|Weill Cornell Medicine|Dr. Jo Anne Sirey|9149974333|jsirey@med.cornell.edu|
21266445|NCT01957085|Lewis Katz School of Medicine|Robert L. Bettiker, MD/MGA, Principle Investigator|215.707.1982|robert.bettiker@temple.edu|
21266446|NCT02128919|Nathan Kline institute for Psycghatric Research|Robert C Smith MD|845-398-6531|rsmiith@nki.rfmh.org|
21266447|NCT02108522|AlloVir|Iain Fraser, MD|833-409-2281|ClinicalTrials@allovir.com|
21266448|NCT01987752|Allergan, Inc|Vice President GSE,|714-246-4500|clinicaltrials@allergan.com|
21266449|NCT00414973|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21266450|NCT03813199|Abivax|Vice President Clinical Operations|01 53 83 08 41|paul.gineste@abivax.com|
21266451|NCT01196091|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21266452|NCT03645811|University of Health Science|Dr. Demet İnangil|+905303021160|demet.inangil@sbu.edu.tr|
21266453|NCT01487863|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@Dendreon.com|
21266454|NCT04555811|University of Minnesota, Masonic Cancer Center|Veronika Bachanova MD, PhD|612-625-5469|bach0173@umn.edu|
21266455|NCT04247828|Altec Inc.|Dr. Paola Contessa|508-545-8236|pcontessa@altecresearch.com|
21266456|NCT02324049|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|475-230-2596|clinicaltrials@alexion.com|
21266457|NCT03198728|Marius Pharmaceuticals, LLC|Nita Nimmons|919-374-1913|Nita@mariuspharma.com|
21266458|NCT03083470|US Biotest, Inc.|Gere diZerega, MD; President & CEO|805-595-1300|gere.dizerega@usbiotest.com|
21266459|NCT01512693|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21266460|NCT02044367|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21266461|NCT00491751|Boston University School of Medicine|Naomi M. Hamburg, MD|617-638-7462|nhamburg@bu.edu|
21266462|NCT00736450|University of Nebraska Medical Center|Julie Vose|402-559-3848|jmvose@unmc.edu|
21266463|NCT02564068|Medical Faculty Associates at The George Washington University|Dr. Vivek Jain|202-741-2676|vjain@mfa.gwu.edu|
21266464|NCT00427791|UT MD Anderson Cancer Center|Dr. Partow Kebriaei, Associate Professor|713-792-2648|ytdinh@mdanderson.org|
21296266|NCT02391961|Louis Stokes VAMC|Alessandro Serra|2167913800|Alessandro.Serra@va.gov|
21296267|NCT00121641|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
21296268|NCT03263780|Cedars-Sinai Medical Center|Timothy Daskivich, M.D.|310-423-4700|timothy.daskivich@cshs.org|
21296269|NCT01014455|Mayo Clinic|David O. Warner MD|5072846277|warner.david@mayo.edu|
21296270|NCT03995355|Johnson & Johnson Vision|Meredith Bishop, OD, MS, FAAO - Sr. Principal Research Optometrist|1-800-843-2020|MBishop4@its.jnj.com|
21296271|NCT00249613|UCLA Integrated Substance Abuse Programs|Michael Prendergast|310-267-5503|mlp@ucla.edu|
21296272|NCT00094107|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21296273|NCT01184417|Alameda County Medical Center|Jonathan Rosenson MD|510-407-6743|jonrosenson@yahoo.com|
21296274|NCT03335254|TesoRx Pharma, LLC|Michael Oefelein, MD, Chief Medical Officer|909-595-0500|karl@tesorx.com|104
21296275|NCT01355796|University of Iowa|Janice Launspach|319-356-2047|janice-launspach@uiowa.edu|
21296276|NCT00806442|Brigham and Women's Hospital|Elliot Israel, MD|617-732-2801|eisrael@partners.org|
21296277|NCT00535821|Loma Linda University|H. Bryant Nguyen|909-558-4000|hbnguyen@llu.edu|44023
21296278|NCT01455220|University of South Florida|Dr.Tuan Vu/ Dr. Derrick Robertson|813-974-6378|droberts@health.usf.edu|
21296279|NCT00267150|Novartis Pharmaceuticals|Study Director|862-778-8300||
21296280|NCT02138240|Johns Hopkins University School of Medicine|Kimberly Gudzune|443-287-7238|gudzune@jhu.edu|
21296281|NCT00424190|Cerexa|Vice President, Clinical Sciences|(510) 285-9200|clinicaltrials@cerexa.com|
21296282|NCT00351273|University of South Florida|John D. Carter, M.D.|(813) 974-2681|jocarter@health.usf.edu|
21296283|NCT01672866|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21296284|NCT00424268|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21296285|NCT00619489|Millennium Pharmaceuticals Inc|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
21296286|NCT03320330|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21296287|NCT01778426|Medtronic|Neuromodulation, Clinical Study Management||medtronicneurotrials@medtronic.com|
21266465|NCT04238689|Radboudumc, Department of Medical Microbiology|Dr. Matthew B.B. McCall|+31 024 361 1111|matthew.mccall@radboudumc.nl|
21266466|NCT01395966|Laboratorios SALVAT|Enrique Jimenez, Medical Director|+34933946470|ejimenezv@salvatbiotech.com|
21266467|NCT04401904|UT Health San Antonio|Carolina Solis-Herrera, MD|210-567-4900|solisherrera@uthscsa.edu|
21296288|NCT02428205|University of Missouri|Dr David Beversdorf|5738826081|beversdorfd@health.missouri.edu|
21266468|NCT00981747|University of Iowa|Dr. Alicia Gerke|319-356-1616|alicia-gerke@uiowa.edu|
21266469|NCT00655057|University of Pennsylvania|Tyrone Quarterman|215-349-5537|tyroneq@upenn.edu|
21266470|NCT03054740|Aultman Health Foundation|Jane Sewell|330 363 0000|Jane.Sewell@aultman.com|3334
21250982|NCT01874665|Ariad Pharmaceuticals|Medical Director|+1-844-662-8532|globaloncologymedinfo@takeda.com|
21250983|NCT02090998|Rutgers/RWJMS|william grubb md|7322357827|grubbwr@rwjms.rutgers.edu|
21250984|NCT00374088|University of Michigan - Pediatric Cardiology|Ranjit Aiyagari, MD|734-647-8761|ranjita@umich.edu|
21250985|NCT00776659|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21250986|NCT01585298|Novartis Pharmaceuticals|Study Director|862-778-8300||
21250987|NCT01980524|Medical University of Vienna|Dr. Peter Wolf|004314040043110|peter.wolf@meduniwien.ac.at|
21250988|NCT01978236|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21250989|NCT03811834|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21250990|NCT01527500|Novartis Pharmaceuticals|Study Director|862-778-8300||
21250991|NCT00372255|GlaxoSmithKline|GSK Response Center|866-435-7343||
21250992|NCT03790878|Duke University|Katherine (Kibby) McMahon|917-880-1551|Kibby.McMahon@duke.edu|
21250993|NCT02573883|Medstar Health Research Institute|Dr. Cheryl Iglesia|202-877-6526|cheryl.iglesia@medstar.net|
21250994|NCT00582114|Professor of Medicine|Dr. Rajiv Agarwal|317-988-2241|ragarwal@iu.edu|
21250995|NCT00130728|Genentech, Inc.|Medical Communications Specialist|800-821-8590|genentech@druginfo.com|
21250996|NCT02301364|Memorial Sloan Kettering Cancer Center|Christian Grommes, MD|212-639-4058|grommesc@mskcc.org|
21250997|NCT03796208|University of Kentucky|Kristin Ashford, PhD, Study MPI|859-257-9333|khashf0@uky.edu|
21250998|NCT05127018|Peking University School of Stomatology|Xi Gong|15201304426|gongx31480528@163.com|
21250999|NCT01560585|University Hospitals Cleveland Medical Center - Cleveland, OH|Alan J Lerner,MD|1 216 464 6449|alan.lerner@uhhospitals.org|
21251000|NCT00519285|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
21251001|NCT01729923|University of Washington|Dr. Stacey Cohen, Principal Investigator|206-606-6658|shiovitz@uw.edu|
21251002|NCT00574171|UW Carbone Cancer Center|Dr. William Schelman|608-265-4347|wrs@medicine.wisc.edu|
21251003|NCT04206384|CAO Group|VP, Quality & Regulatory|801-256-9282|info@caogroup.com|
21251004|NCT01355471|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
21251005|NCT01078584|Abbott|Global Medical Services|800-633-9110||
21251006|NCT01208870|SUNY Buffalo|Leonard H. Epstein, Ph.D.|716-829-3400|lhenet@buffalo.edu|
21251007|NCT01121185|MassBiologics|Director Clinical Affairs|617-474-3000|MBLclinicaldirector@umassmed.edu|
21251008|NCT01260142|Eisai Call Center|Eisai Inc.|888-422-4743||
21251009|NCT03927742|University of Minnesota|Rachel Vogel|612-624-6928|isak0023@umn.edu|
21251010|NCT00618917|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS|412-647-5554|stadtermanbm@upmc.edu|
21251011|NCT00496834|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21251012|NCT01042145|Washington University School of Medicine|Dr. Jane Garbutt|314-454-8613|jgarbutt@dom.wustl.edu|
21251013|NCT00356759|McMaster University|Dr. Sam Schulman|19055270271|schulms@mcmaster.ca|44810
21251014|NCT01494298|Mercer University College of Pharmacy|Gina Ryan Clinical Professor|678.547.6222|ryan_gj@mercer.edu|
21251015|NCT04159805|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21251016|NCT02930837|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21251017|NCT01393613|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21251018|NCT01618227|Massachusetts General Hospital|Neal Chen|617-726-4700|nchen1@partners.org|
21251019|NCT04236245|Venclose, Inc.|Mai-Ly Wilcox|415-254-1930|mwilcox@venclose.com|
21251020|NCT00654615|Wake Forest University Health Sciences|Zhongyu Li, MD, PhD, Professor - Department of Orthopaedic Surgery|336-716-9520|zli@wakehealth.edu|
21251021|NCT02998918|University of South Carolina|Mark Sarzynski|8037779510|sarz@mailbox.sc.edu|
21251023|NCT01071317|Montefiore Health|Benjamin W. Friedman, MD|718-920-6626|befriedm@montefiore.org|
21251024|NCT00316589|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
21251025|NCT02592486|Department of Pulmonary Medicine, Kameda Medical Center|Kei Nakashima, Associate Chief|81-4-7092-2211|kei.7.nakashima@gmail.com|8614
21251026|NCT03594045|Massachusetts General Hospital|Dr. Rachel Rosovsky|617-724-4000|RPROSOVSKY@mgh.harvard.edu|
21251027|NCT01283971|Hoffman-LaRoche|Medical Communications|800-821-8590||
21251028|NCT02617667|Novaliq GmbH|Dr Sonja Krösser, VP Preclinical and Clinical Development|+49 6221 50259-0||
21251029|NCT03777553|Durham Veterans Affairs Medical Center|Elizabeth Van Voorhees|919-886-5542|elizabeth.vanvoorhees@va.gov|
21251030|NCT01554371|University of California, San Francisco|Dr. Hope Rugo, MD|(415) 353-7618|Hope.Rugo@ucsf.edu|
21251031|NCT00562484|Seqirus|Clinical Study Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
21251032|NCT02598934|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21251033|NCT02811302|Medtronic - MITG, RGI|Melanie Crystal, Sr. Clinical Program Manager|720-435-5737|melanie.crystal@medtronic.com|
21251034|NCT00702520|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21251035|NCT02154347|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
21251036|NCT02481934|Hospital universitario 12 de octubre|Alejandra Leivas PhD|+34917792612|alejandraleial@gmail.com|4612
21251037|NCT01879085|UPMC Hillman Cancer Center|Barbara M Stadterman, MPH, MCCR, Clinical Trials Administrator|412-647-5554|stadtermanbm@upmc.edu|
21266471|NCT01437267|Novartis Vaccines Institute for Global Health|Dr. Audino Podda|+39 0577 243496|audino.podda@novartis.com|
21296289|NCT02888743|Department of Data Science, Dana-Farber Cancer Institute|Anita Giobbie-Hurder, MS (Study biostatistician)|617-632-2193|agiohur@ds.dfci.harvard.edu|
21266472|NCT03934203|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21266473|NCT00838695|VAnderbilt University Medical Center|Dr. C. Michael Stein|615-936-3420|mike.stein@vumc.org|
21266474|NCT00333970|VA Connecticut Healthcare System|Dr. Joanna Fiszdon|203-932-5711|joanna.fiszdon@va.gov|2231
21266475|NCT00441480|The Institute for Lipid and Atherosclerosis Research and Internal Medicine C, Sheba Medical Center, Tel Hashomer|Prof. Dror Harats|972-3-5302940|dror@vbl.co.il|
21296290|NCT04495868|Emory University|Brian Bobzien, MD|404-616-4226|brian.patrick.bobzien@emory.edu|
21296291|NCT00300677|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21296292|NCT00343863|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
21296293|NCT05824936|Nemours Children's Hospital|Dr. Abigail Strang|3026516400|astrang@nemours.org|
21296294|NCT00096018|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21296295|NCT01533922|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21296296|NCT00889200|Butler Hospital|Linda Carpenter, MD|401 455 6349|Linda_Carpenter_MD@Brown.edu|
21296297|NCT00106691|GTx, Inc.|Senior Director, Clinical Operations|901-523-9700|mdesordi@gtxinc.com|
21296298|NCT00907296|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21296299|NCT03208530|Brigham and Women's Hospital|Kei Ouchi, MD, MPH|(617) 732-5640|kei_ouchi@dfci.harvard.edu|
21296300|NCT00678834|The Ohio State University Wexner Medical Center|Dr. Chandan K. Sen, PhD. Professor and Associate Dean|614-247-7658|chandan.sen@osumc.edu|
21296301|NCT02776033|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21296302|NCT01403376|Sanofi|Trial Transparency Team||Contact_US@sanofi.com|
21296303|NCT02616393|Kadmon Corporation|Miranda Ross|724-778-6170|Miranda.Ross@kadmon.com|
21296304|NCT01302054|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21296305|NCT02657564|Evergreen General Hospital|Dr. Chiliang Cheng|+886-3-4631230|chiliang.cheng@gmail.com|1510
21296306|NCT02445573|Guang'anmen hospital of China Academy of Chinese Medical Sciences|Dr. Huanfang Xu|+86 10 8800 1124|huanfang_xu@126.com|
21296307|NCT04047420|University of Pittsburgh|Sharon Riddler, MD, MPH|4123831741|riddler@pitt.edu|
21296308|NCT01639755|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21296309|NCT02365285|Vanderbilt University Medical Center|Cyndya Shibao, MD|615-322-2318|cyndya.shibao@vumc.org|
21296310|NCT03262116|Massachusetts General Hospital|Dr Steven J. Russell, MD, PhD|617.726.1848|sjrussell@mgh.harvard.edu|
21296311|NCT02968914|AstraZeneca Clinical Study Information Center|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
21296312|NCT02608450|Cassiopea SPA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
21296313|NCT03923582|University of Minnesota|Gudrun Kilian|612-624-0358|kilian@umn.edu|
21296314|NCT01727791|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21266476|NCT00899678|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
21266477|NCT02092324|OHSU|Dr. Kim-Hien Dao|503-494-5074|daok@ohsu.edu|
21266478|NCT00398138|Memorial Sloan Kettering Cancer Center|Dr. Peter Maslak, Attending|+1212-639-5518|maslakp@mskcc.org|
21266479|NCT03190967|National Cancer Institute|Dr. Stanley Lipkowitz, PhD|240-760-6129|lipkowis@navmed.nci.nih.gov|
21266480|NCT03954704|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21266481|NCT00550290|Aultman Health Foundation|Jane Sewell|330-363-6793|Jane.Sewell@aultman.com|
21266482|NCT02569398|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266483|NCT02571972|Retina Service of Wills Eye Hospital, Mid Atlantic Retina|Dr. Jason Hsu|215-928-3092|jhsu@midatlanticretina.com|
21266484|NCT00695500|National Institute on Alcohol Abuse and Alcoholism|Ramchandani, Vijay|+1 301 402 8527|vijayr@mail.nih.gov|
21266485|NCT03559192|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266486|NCT03039192|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266487|NCT00533780|Stanford University|Kathy Turner, RN, NP|650-724-6850|kathyt@stanford.edu|
21266488|NCT01994109|Solstice Neurosciences|Regulatory Affairs Associate||regulatoryaffairs@usworldmeds.com|
21266489|NCT03287830|Columbia University|Dr. Melissa Stockwell|2123425732|mss2112@cumc.columbia.edu|
21266490|NCT00608842|Kythera Biopharmaceuticals, Inc.|Clinical Trial Disclosure||clinical_trials@kythera.com|
21266491|NCT01688999|National Cancer Institute|Dr. Andrea Apolo|301-480-0536|apoloab@nih.gov|
21266492|NCT02768103|VA Palo Alto Health Care System|Dr Johanson|408-250-1982|lisa.johanson29@gmail.com|
21266493|NCT02951455|University of Illinois Urbana Champaign|Liliane Windsor|2173001782|lwindsor@illinois.edu|
21266494|NCT03039790|Takeda (Note: This product was divested to HilleVax in 2022)|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
21266495|NCT00058188|Northwestern University|Clinical Trials Office|312-695-1301||
21266496|NCT00498368|Mayo Clinic|Dr. Fernando Fervenza|507-255-3712|Fervenza.Fernando@mayo.edu|
21296315|NCT02144155|UCSD|David Feifel||dfeifel@kadimanp.com|
21296316|NCT00635089|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21296317|NCT01617447|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
21296318|NCT01304407|Baylor College of Medicine|Dr. Steven Abrams|512-495-4700|sabrams@bcm.edu|
21266497|NCT02266004|University of Miami|Corneliu Luca, MD|305-243-6732|cluca@med.miami.edu|
21266498|NCT03289052|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
21266499|NCT02283840|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21266500|NCT01025232|Retinal Consultants of Houston|David M. Brown, MD Director of Clinical Research|713-394-7534|dmbmd@houstonretina.com|
21266501|NCT03748420|HealthPartners Institute|Dr. Patrick O'Connor|952-967-5034|patrick.j.oconnor@healthpartners.com|
21266502|NCT01263444|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
21266503|NCT01764022|BIOCAD|Dr. Mariia Shustova|+7812380 49 33|shustova@biocad.ru|651
21266504|NCT01899768|GlaxoSmithKline|GSK Response Center|866-435-7343||
21266505|NCT04476108|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21266506|NCT00850135|Stanford University School of Medicine|Yasser El-Sayed, MD|(650) 723-3198|Yasser.el-sayed@stanford.edu|
21266507|NCT02253992|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21266508|NCT02159365|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21266509|NCT04051944|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21266510|NCT01526928|Clovis Oncology|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
21266511|NCT04157751|Boehringer Ingelheim, Call Centre|Boehringer Ingelheim|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21266512|NCT04731922|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21296319|NCT01283542|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21296320|NCT02636946|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21296321|NCT05059977|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21296322|NCT00576472|St. Jude Children's Research Hospital|Heather Conklin PhD|1-866-278-5833|info@stjude.org|
21296323|NCT03443427|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21296324|NCT04285489|Integra LifeSciences (Shanghai) Co., Ltd.|Dr. Hua Tang|0086 21 63179772|hua.tang@integralife.com|8029
21296325|NCT04405245|EyePoint Pharmaceuticals, Inc|David Bauer|8573410747|dbauer@eyepointpharma.com|
21296326|NCT00780273|University if Rochester Medical Center|Dr. George Romanos|585-276-4149|GeorgiosRomanos@urmc.rochester.edu|
21296327|NCT02576860|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
21296328|NCT00477269|Novartis Pharmaceuticals|Study Director|862-778-8300||
21296329|NCT01792518|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21296330|NCT04807387|Baylor College of Medicine|Dr Julie Hakim|832-826-7464|julie.hakim@bcm.edu|
21296331|NCT00047619|University of Calgary|Dr. Chester Ho|(403) 944 4620|chester.ho@albertahealthservices.ca|
21296332|NCT04468074|University of Colorado, Boulder|Marta Ceko|443-835-6587|Marta.Ceko@colorado.edu|
21296333|NCT04728594|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
21296334|NCT01497613|University of Miami Miller School of Medicine|Dr. Sara J. Czaja|305-355-9068|sczaja@med.miami.edu|
21296335|NCT00128713|New England Research Institutes|Susan Assmann, PhD|617-923-7747|sassmann@neriscience.com|548
21296336|NCT02528357|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21296337|NCT02718040|Galderma Laboratories|Jay Mashburn||jay.mashburn@galderma.com|
21296338|NCT00475215|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21296339|NCT00699218|UC Davis|Guohua Xia|916-734-3574|gxia@ucdavis.edu|
21296340|NCT01378429|Sunovion|Respiratory Medical Director|866-503-6351||
21296341|NCT02356887|Toronto western Hospital/UHN|Emad Al Azazi|416-603-5800|emad.alazazi@uhnresearch.ca|6237
21296342|NCT04208087|Seikagaku Corporation|Clinical Development Dept.|(81)3-5220-8593|722_clinical_project_team@seikagaku.co.jp|
21296343|NCT01012323|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201 604-1155|michael.eppolito@octapharma.com|
21296344|NCT02920957|CooperVision Inc|Sr.Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
21296345|NCT01789606|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21296346|NCT00428207|Joslin Diabetes Center|Howard Wolpert, MD|6173092665|howard.wolpert@joslin.harvard.edu|
21296347|NCT01563172|GlaxoSmithKline|GSK Response Center|866-435-7343||
21296348|NCT04350307|Yale University|Dr. Robin Raju|203-688-8800|robin.raju@yale.edu|
21296349|NCT01120990|Hypertension Center, Third University Department of Medicine, University of Athens|George S Stergiou, MD|+30 210 7763117|gstergi@med.uoa.gr|
21296350|NCT01638559|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21296351|NCT00712582|Memorial Sloan Kettering Cancer Center|Dr. Andrew Zelenetz, MD, PhD|646-608-3728|zeleneta@mskcc.org|
21296352|NCT01216683|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21296353|NCT01706588|The School of Dentistry, University of Birmingham|Prof. Thomas Dietrich|+44-121-46 65494|t.dietrich@bham.ac.uk|
21296354|NCT01882868|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
21296355|NCT00652951|GlaxoSmithKline|GSK Response Center|866-435-7343||
21296356|NCT02593825|Duquesne University|Regina Harbourne, Primary Investigator|4026570538|harbourner@duq.edu|
21296357|NCT01022424|Otsuka Pharmaceutical Co.,Ltd.|Director of Clinical Trials|+81-3-6361-7366||
21296358|NCT06359080|JelikaLite Corp|Katya Sverdlov, Chief Operating Officer|9175668151|katya@jelikalite.com|
21296359|NCT00511134|Yale University|Andrea H. Weinberger, Ph.D.|203-974-7598|andrea.weinberger@yale.edu|
21296360|NCT01949090|GlaxoSmithKline|GSK Response Center|866-435-7343||
21296361|NCT03459365|Cleveland Clinic|Carlos Higuera|954 659-5430|higuerc@ccf.org|
21266513|NCT03489850|University of California Los Angeles|Dr. Lara Ray|310-794-5383|lararay@psych.ucla.edu|
21296362|NCT00599755|Merck Sharp and Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21296363|NCT02198794|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21296364|NCT01306656|Columbia University|Shonni Silverberg, MD|212-305-6291|sjs7@cumc.columbia.edu|
21296365|NCT00477152|Baxter Halthcare Corporation|George Harb, MD, MPH||george_harb@baxter.com|
21296366|NCT01085435|Boston Scientific|Jens Goetzke|1-800-227-3422|jens.goetzke@bsci.com|
21296367|NCT01918332|Yonsei University Healthcare System Severance Hospital|Prof. YangSoo Jang|82-2-6924-3109|yejung@lgls.com|
21296368|NCT04736628|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21296369|NCT05138549|Prisma Health|Harley T. Davis|8032969533|pamela.davis2@prismahealth.org|
21296370|NCT00680368|Loma Linda VA Healthcare System|T. Michael Kashner, PhD, PI|909 825-7084|michael.kashner@va.gov|2853
21296371|NCT00483041|MedImmune|Joseph Parker, MD|301-398-0000|parkerj@medimmune.com|
21296372|NCT03842683|Steno Diabetes Center North Denmark|Dr. Morten Hasselstrøm Jensen|+4522226964|mhj@hst.aau.dk|
21296373|NCT03973905|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21296374|NCT02648217|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
21296375|NCT04094584|University of California, San Francisco|Ralph Wang|(415) 353-4890|ralph.wang@ucsf.edu|
21296376|NCT00316888|ECOG-ACRIN Statistical Office|ECOG-ACRIN statistician|617-632-3012||
21296377|NCT02715726|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
21296378|NCT01565941|Boston Children's Hospital|Dr. Michael Agus|617-355-5849|michael.agus@childrens.harvard.edu|
21296379|NCT03230292|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
21296380|NCT03123614|University of Utah Moran Eye Center|Mark Mifflin, MD|801-213-4152|Mark.Mifflin@hsc.utah.edu|
21296381|NCT02855944|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
21296382|NCT01581008|VA Eastern Colorado Health Care System|David Bekelman, MD, MPH|720-857-5088|david.bekelman@va.gov|
21296383|NCT03619135|University of Iowa College of Dentistry|Dr. Kyle Stein|319-384-5105|kyle-stein@uiowa.edu|
21296384|NCT02641522|Benaroya Research Institute|Sarah Robinson/ Administrative Assistant|(206) 342-6931|diabetes@benaroyaresearch.org|
21296385|NCT03629912|Western Kentucky University|Dr. Matthew Shake|270-745-3918|matthew.shake@wku.edu|
21296386|NCT01852383|New York State Psychiatric Institute|Dr. D.P. Devanand|(646) 774-8658|dpd3@columbia.edu|
21296387|NCT02478580|University Of Texas Southwestern Medical Center|Dr. Enas Kandil|214-590-8509|Enas.Kandil@UTSouthwestern.edu|
21296388|NCT03984487|Cincinnati Children's Hospital|Dr. Amie Duncan|513-803-2416|Amie.Duncan@cchmc.org|
21296389|NCT03544307|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3774|song-youngpark@unomaha.edu|
21296390|NCT01365624|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D|610-650-4200|dbregman@lpicrd.com|828
21296391|NCT01504204|Wake Forest University Health Sciences|Irma M Richardsom, MHA|336-716-2903|irichard@wakehealth.edu|
21296392|NCT00860015|Columbia University|Rober Taub, MD - Vivian and Seymour Milstein Family Prof. of Clinical Medicine||rntaubipod@gmail.com|
21296393|NCT00654004|Oregon Health & Science Univeristy|Dr. Melanie Gillingham|503-494-1682|gillingm@ohsu.edu|
21296394|NCT01571453|Study Director|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
21296395|NCT00444067|Integra LifeSciences|Director, Medical Affairs|609-275-0500||
21251038|NCT03302559|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
21251039|NCT00771238|Nebraska Medical Center|Joyce Black, PhD, RN|402-559-6573|JBlack@unmc.edu|
21251040|NCT03390933|MetroHealth System|Dr. Ashwini Sehgal|216-778-8484|axs81@case.edu|
21251041|NCT03371706|University of Chicago|Dr. Emily Rogalski|855-824-7887|emily.rogalski@bsd.uchicago.edu|
21251042|NCT04260464|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21251043|NCT01181609|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21251044|NCT00612352|Yale University|Ismene Petrakis||ismene.petrakis@yale.edu|
21251045|NCT01339299|Fertility Clinic Regional Hospital Skive|Prof, M.D. Peter Humaidan|+45 78445760|peter.humaidan@viborg.rm.dk|
21251046|NCT00263211|Department of Medicine Div. of Oncology, Washington University School of Medicine St. Louis MO|Katherine Weilbacher, M.D,|Fax: 314-454-8973|kweiblac@dom.wustl.edu|
21251047|NCT02820597|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
21251048|NCT01880697|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21251049|NCT00545571|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21251050|NCT00874497|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21251051|NCT03367910|Washington University in St. Louis School of Medicine|Kimberly Reske, Research Coordinator|3147474041|kreske@wustl.edu|
21251052|NCT00644878|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21251053|NCT04353817|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21251054|NCT00948610|UCLA|Michael R. Irwin|3108258281|mirwin1@ucla.edu|
21251055|NCT00665223|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
21251056|NCT00591591|ISS, Inc., Champaign Illinois|Antonios Michalos|217-359-8681|antonios.michalos@iss.com|
21251057|NCT01419977|Duke University Medical Center|Nirmish Shah, MD|919-684-5350|nirmish.shah@duke.edu|
21251058|NCT00979745|CLINUVEL PHARMACEUTICALS LTD|Clinical Operations Manager||mail@clinuvel.com|
21251059|NCT00338949|UCSD/VA San Diego|Jonathan Meyer MD|8589640777|jmmeyer@ucsd.edu|
21251060|NCT00878553|Somnus Therapeutics, Inc|Dr. Christine Blumhardt, Chief Regulatory Officer|617-710-0928|cblumhardt@somnusthera.com|
21251061|NCT03517111|Arizona State University|Dr. Sonia Vega-López|602-496-3350|sonia.vega.lopez@asu.edu|
21251062|NCT03188536|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21251063|NCT01930214|Cardiovascular Systems Inc.|Clinical Project Manager|6512591600|clinicaltrials_csi@csi360.com|
21251064|NCT01748045|Tufts Medical Center|Dr. Christiane Dammann|617-636-8738|cdammann@tuftsmedicalcenter.org|
21251065|NCT00025662|NHLBI|A. John Barrett|301-402-4170|barrettjj@mail.nih.gov|
21251066|NCT00859976|Zimmer Biomet|Clinical Project Lead||Maggie.Shen@zimmerbiomet.com|
21251067|NCT02062645|Novartis Pharmaceuticals|Study Director|862-778-8300||
21266514|NCT00422903|GlaxoSmithKline|GSK Response Center|866-435-7343||
21266515|NCT00801138|Cleveland Clinic Foundation|Daniel I Sessler, MD|2164458396|sesslerd@ccf.org|
21266516|NCT03446612|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21266517|NCT02901080|Electromedical Products International, Inc.|Science and Education Director|8174583295|josh@epii.com|
21266518|NCT00260195|RAND Corporation|Lisa Jaycox|703-344-8236|jaycox@rand.org|5118
21266519|NCT04319445|Wake Forest University Health Sciences|Rebecca E Wells, MD, MPH|336-716-2357|rewells@wakehealth.edu|
21266520|NCT04925947|Weill Cornell Medicine|Barbara Ma|646-962-6444|btm9003@med.cornell.edu|
21266521|NCT01810380|H. Lundbeck A/S|Email contact via||LundbeckClinicalTrials@Lundbeck.com|
21266522|NCT02829775|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21266523|NCT00033371|University of Texas (UT) MD Anderson Cancer Center|Patrick Lynch, MD/Professor, Gastroenterology/Hepatology|713-794-5073|plynch@mdanderson.org|
21266524|NCT02150460|National Eye Centre, Kaduna. Nigeria|Dr Aminatu Ali AbdulRahman|+2348037878367|aaaminatu@yahoo.com|
21266525|NCT02699125|University of California San Diego|Michael G. Ziegler, M.D.|619 543 2885|mziegler@ucsd.edu|
21266526|NCT03787095|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
21266527|NCT01390038|Tornier/Wright Medical|Josh Myers|9529217119|josh.myers@wright.com|
21266528|NCT03799627|Akebia Therapeutics, Inc|Akebia Therapeutics, Inc|617-844-6128|trials@akebia.com|
21266529|NCT01451983|Cleveland Clinic Center for Autism|Thomas W. Frazier, PhD|216-448-6440|fraziet2@ccf.org|
21266530|NCT02512276|Brigham and Women's Hospital|Niteesh K. Choudhry, MD, PhD|617-278-0930|nkchoudhry@bwh.harvard.edu|
21266531|NCT02637804|CooperVision Inc.|Director, Professional Service|+81 3 5449 6619|Taku.Muraoka@jp.coopervision.com|
21266532|NCT03150199|Massachusetts General Hospital|Dr. Jeff Huffman|617-724-2910|JHUFFMAN@mgh.harvard.edu|
21296396|NCT04039867|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
21296397|NCT03897036|Senhwa Biosciences|Jason Huang, MD / Chief Medical Officer and Acting Chief Executive Officer|(858) 552-6808|jasonhuang@senhwabio.com|112
21296398|NCT02966015|Clinical operations,Medical Affairs|Head of clinical operations|+45 49113267|dkphl@coloplast.com|
21296399|NCT02241187|Memorial Sloan Kettering Cancer Center|Dr. Kenneth Yu, MD|646-888-4188|YuK1@mskcc.org|
21296400|NCT00199888|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
21296401|NCT01198509|New York University School of Medicine|Steven B. Abramson, MD|212-263-8003|StevenB.Abramson@nyumc.org|
21296402|NCT00330668|Ipsen|Ipsen Medical Director|See email|clinical.trials@ipsen.com|
21296403|NCT02621073|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu|
21296404|NCT01994993|Duke University Medical Center|Michael Cohen-Wolkowiez, M.D|9196688812|michael.cohenwolkowiez@duke.edu|
21296405|NCT01595581|University of Southern California|Edward Schroeder|323-442-2498|eschroed@usc.edu|
21296406|NCT00408590|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-2511|galanis.evanthia@mayo.edu|
21296407|NCT01605942|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21296408|NCT01969721|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21296409|NCT03028636|Pelvalon|Clinical Management|650-276-0130|steve@pelvalon.com|
21296410|NCT00495755|Dana-Farber Cancer Institute|Corey S. Cutler, MD, MPH, FRCP(C)|617-632-5946|cscutler@partners.org|
21296411|NCT02273960|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21296412|NCT00795288|Washington University|Michael Diringer|314-362-2999|diringerm@wustl.edu|
21296413|NCT03180307|On Target Laboratories|Tommy Lee, MSHS, Vice President, Clinical Operations|765-588-4547|Tlee@ontargetlabs.com|
21296414|NCT01294163|Radboudumc, Department of Anaesthesiology|Dr. Jan HOFLAND|+31243611111|Jan.Hofland@radboudumc.nl|3658
21296415|NCT01105377|Johns Hopkins Oncology Center|Nilofer S. Azad, M.D.||nazad2@jhmi.edu|
21296416|NCT02495454|Fondazione Italiana Linfomi ONLUS|Dr. Luigi Marcheselli - FIL statistician|059 4223873|lmarcheselli@filinf.it|
21296417|NCT02014584|GlaxoSmithKline|GSK Response Center|866-435-7343||
21296418|NCT00483002|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21296419|NCT02651220|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
21296420|NCT00447122|BrUOG|Howard Safran, MD|4018633000|BrUOG@brown.edu|
21296421|NCT01447121|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3062|carmine.greene@ascensia.com|
21296422|NCT01399008|Metabolex|Mary Jean Stempien, M.D., Acting Chief Medical Officer|510-293-8800|mjstempien@metabolex.com|
21296423|NCT01439373|GlaxoSmithKline|GSK Response Center|866-435-7343||
21296424|NCT00370838|Johns Hopkins University|Dr. Harvey Singer|410-955-7212|hsinger@jhmi.edu|
21296425|NCT04046250|Tosk, Inc.|Emile Youssef, MD, PhD|312.244.0068|eyoussef@tosk.com|
21296426|NCT00709878|Northwestern University|Mario Lacouture, MD|212-610-0079|LacoutuM@mskcc.org|
21296427|NCT03834220|Debiopharm International S.A.|Head Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
21296428|NCT00574548|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21296429|NCT02593318|University of Kansas Medical Center|Russell H. Swerdlow, MD|9135885000|rswerdlow@kumc.edu|
21296430|NCT02020408|UCSD Department of Psychiatry|Walter H. Kaye, MD|858-534|wkaye@ucsd.edu|8019
21296431|NCT03684694|ADC Therapeutics SA|Clinical Trials Information|954-903-7994|clinical.trials@adctherapeutics.com|954
21296432|NCT00575965|Dana Farber Cancer Institute|Steven P. Treon MD, PhD|617 632 5880|steven_treon@dfci.harvard.edu|
21296433|NCT03268941|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21296434|NCT02069119|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
21266533|NCT03148795|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21266534|NCT00441012|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21266535|NCT04489940|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center,|+49 6151725200|service@emdgroup.com|
21266536|NCT04498468|Johns Hopkins Wilmer Eye Institute|Michael Lin, BA, Research coordinator|8653851192|mlin60@jhu.edu|
21266537|NCT02725268|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21266538|NCT01838304|University of Pennsylvania|Vice-Chair of Research|(215) 662-3766|roderic.eckenhoff@uphs.upenn.edu|
21266539|NCT03674541|Brigham and Women's Hospital|Dr. David Systrom|6175431554|dsystrom@bwh.harvard.edu|
21266540|NCT02104141|Zimmer Biomet Spine|Clinical Affairs|303-501-8571|tammy.stinson2@zimmerbiomet.com|
21266541|NCT00262314|EMD Serono, Inc.|Fernando Dangond, M.D., Medical Responsible|+1 781 681 2348||
21266542|NCT03338036|University of Western Ontario|Dr Jim Dickey, Associate Professor|519-661-2111|jdickey@uwo.ca|87834
21266543|NCT04973085|University of Vermont|Adam Sprouse Blum, MD|8028478050|Adam.Sprouse-Blum@uvmhealth.org|
21266544|NCT00997555|Hurley Medical Center|John Alfred Carr, MD|810-262-4993|heartandbones@yahoo.com|
21266545|NCT00654368|Amgen Inc.|Study Director|866-572-6436||
21266546|NCT00815776|Ascentia Health, Inc.|Lawrence G. Clayton, M.A., Study Director|(815) 484-9258|LGClayton@aol.com|
21266547|NCT00559013|Synovis|Lesa Hobright-Turner, Director of Clinical Affairs|651-796-7506|lesa.hobrightturner@synovissurgical.com|
21266548|NCT03418376|Hasselt University|Dr. Charly Keytsman|+32477611122|charly.keytsman@uhasselt.be|
21266549|NCT00814307|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21266550|NCT02253160|Terumo BCT|Raymond P. Goodrich, PhD, VP, Scientific and Clinical Affairs; Chief Science Officer - BBT|303-232-6800|Ray.Goodrich@terumobct.com|
21266551|NCT00149890|Novartis Pharmaceuticals|Study Director|862-778-8300||
21266552|NCT00460525|Department of Epidemiology of Parasitic Diseases, University of Bamako|Mahamadou A. Thera, MD, MPH|223-222-8109|mthera@mrtcbko.org|
21266553|NCT04757376|CELLTRION, Inc.|Head of Clinical Planning Department|+82 32 850 4167|jeehye.suh@celltrion.com|
21266554|NCT01307046|Merch Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21266555|NCT03898323|University of California, San Francisco/San Francisco VA Health Care System|Steven L. Batki, MD|415-221-4810|steven.batki@ucsf.edu|23671
21266556|NCT01547806|National Cancer Institute|Dr. Jennifer Kanakry|301-451-3787|kanakryja@nih.gov|
21266557|NCT02550093|Northwestern University, Feinberg School of Medicine|David Walega, MD|312-695-2500|d-walega@northwestern.edu|
21266558|NCT01186003|University of Colorado Denver|Director, Clinical Research Administration|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
21266559|NCT01990703|University of Utah, Department of OBGYN|Dr. David Turok|801-581-6170|david.turok@hsc.utah.edu|
21266560|NCT03277794|Centre for Addiction and Mental Health|Dr. Sean Kidd|416-535-8501|sean.kidd@camh.ca|36295
21266561|NCT00616772|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21266562|NCT03991468|Hamamatsu Photonics, K.K.|MCG Manager|+81-53-435-1560|fujisaka@sys.hpk.co.jp|
21266563|NCT03186261|Faculty of Dentistry, Cairo University|Ali Mostafa Shamaa|+201005276468|alishamaa@hotmail.com|
21266564|NCT05166603|US Department of Veterans Affairs|Dawn M. Bravata, MD|3179882676|dawn.bravata2@va.gov|
21266565|NCT00615420|BC Cancer|Dr. Philippa Hawley|(604) 877-6000|phawley@bccancer.bc.ca|67-2752
21266566|NCT01673373|Getinge|Sr. Clinical Trial Manager|603-864-5219|inka.vesela@getinge.com|
21266567|NCT02710422|University of Miami|Sanoj Punnen MD, MAS|305-243-6596|s.punnen@med.miami.edu|
21266568|NCT01370499|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21266569|NCT00887822|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21266570|NCT00424840|University of Massachusetts Medical School|Dr. William Walsh|508-334-5539|William.Walsh@umassmemorial.org|
21266571|NCT02045979|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21266572|NCT03979495|Massachusetts General Hospital|Dr. Jennifer Haas|617-724-1832|jhaas@mgh.harvard.edu|
21266573|NCT01145833|University of CA, San Diego Center for Healthy Eating and Activity Research|Kerri Boutelle, Principal Investigator|858-534-8037|kboutelle@ucsd.edu|
21266574|NCT04021628|St George's, University of London|Dr Shari Sapuan|02086729944|ssapuan@sgul.ac.uk|5382
21266575|NCT00354484|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
21281673|NCT00722137|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21281674|NCT03830333|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21281675|NCT01129557|Columbia University Medical Center, Division of Nephrology|Andrew Bomback, MD|212-305-5020|asb68@columbia.edu|
21281676|NCT01486446|Xenon Pharmaceuticals Inc.|Dr. Y Paul Goldberg|604 484 3300|pgoldberg@xenon-pharma.com|
21281677|NCT01938092|University of Missouri-Columibia, Dept. Ob/Gyn|Erma Z. Drobnis, Associate Director, Research Success Center|573-817-3124|drobnise@health.missouri.edu|
21281678|NCT01367886|Washington University School of Medicine|H. Henry Lai, MD|314-362-8295|laih@wudosis.wustl.edu|
21281679|NCT00574704|Cytos Biotechnology AG|Head of Clinical Develpment|+41 44 733 4|info@cytos.com|7 47
21281680|NCT00985504|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21281681|NCT03379727|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21281682|NCT00715273|University of Washington|Xue-Qiao Zhao|206-744-8305|xueqiao@uw.edu|
21281683|NCT01205776|Abbott Vascular|Rhonda Hensley, Clinical Project Manager|+1 828-559-0080|rhonda.hensley@abbott.com|
21281684|NCT03334344|Ceevra|Russ Yoshinaka|415-926-9434|ryoshinaka@ceevra.com|
21281685|NCT02747108|VA Center for Clinical Management Research|Jeffrey Kullgren, MD, MS, MPH - Principal Investigator|(734) 845-3502|jkullgre@med.umich.edu|
21281686|NCT05096403|Swedish Orphan Biovitrum AB|Luis López Lazaro|46733319155|luis.lopezlazaro@sobi.com|
21281687|NCT03208166|Medical University of South Carolina|Marc Chimowitz, MD|843-792-3020|mchimow@musc.edu|
21266576|NCT00378534|NIH NHLBI OCD DIR ORIC|Sara Hauffe, RN Protocol Liaison|301-827-2720|sara.hauffe@nih.gov|
21266577|NCT04969900|Principal Investigator|Dr. Leanne Free|303-724-8576|leanne.free@cuanschutz.edu|
21266578|NCT03537937|Pragmatic Critical Care Research Group|Chair of the Steering Committee|(615) 322-3412|matthew.w.semler@vumc.org|
21266579|NCT03261037|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21266580|NCT00425945|Stanford University School of Medicine|Dr. Randall Stafford|650-724-2400|rstafford@stanford.edu|
21266581|NCT02209259|Massachusetts General Hospital|Taylor Pong||tpong1@partners.org|
21266582|NCT03878160|Massachusetts General Hospital|Dr. Christina Luberto|617-643-9453|cluberto@mgh.harvard.edu|
21296435|NCT02720692|Baudax Bio Inc.|Development|484-395-2440|info@baudaxbio.com|
21296436|NCT03878758|Becton Dickinson|Michael Gibney|201-847-6170|michael.gibney@bd.com|
21296437|NCT01769196|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21296438|NCT00765063|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21296439|NCT03614325|Beth Israel Deaconess Medical Center|Dr. Brian P. O'Gara|6177543189|bpogara@bidmc.harvard.edu|
21296440|NCT00119366|Fred Hutchinson Cancer Research Center|Johnnie Orozco, MD, PhD|(206) 667-4102|jorozco@fredhutch.org|
21296441|NCT01206582|Mayo Clinic|Dr. Adil E. Bharucha|507-284-6439|bharucha.adil@mayo.edu|
21296442|NCT02522325|University of Kentucky|William W. Stoops|859-257-5388|william.stoops@uky.edu|
21296443|NCT02100969|University of Kansas Medical Center|Dr. Mazen Dimachkie|913-588-6970|mdimachkie@kumc.edu|
21296444|NCT01755455|Dartmouth-Hitchcock Medical Center|Alex H. Gifford, M.D.|603-650-5533|alex.h.gifford@hitchcock.org|
21296445|NCT02081599|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21296446|NCT01629953|VA North Texas Health Care System|James LePage, Ph.D. Chief Research and Development|214-857-0240|james.lepage@va.gov|
21296447|NCT00720343|Stanford University|Pamela Flood, M.D.|201-370-3933|pflood@stanford.edu|
21296448|NCT01840527|Massachusetts General Hospital Cancer Center|Ryan Sullivan|6177244000|rsullivan7@mgh.harvard.edu|
21296449|NCT00707954|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21296450|NCT01356628|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Avnish Bhatia|215-955-8874|avnish.Bhatia@jefferson.edu|
21296451|NCT04037254|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
21296452|NCT01364740|Stanford University|Clete A. Kushida, MD, PhD|650-721-7560|clete@stanford.edu|
21296453|NCT05532891|Imperial College London|Dr Emma Rose McGlone|07949565678|e.mcglone@ic.ac.uk|
21296454|NCT02504580|Heron Therapeutics, Inc.|Clinical Operations|1-800-767-0524|cquaratino-baker@herontx.com|
21296455|NCT01329848|Western University of Health Sciences|Dr. Chris Chase|909 706-3882|cchase@westernu.edu|
21296456|NCT00789672|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-875-8690|pedig@jaeb.org|
21296457|NCT04473664|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21296458|NCT02478164|Dana-Farber Cancer Institute|Eudocia Q. Lee, MD, MPH|617-632-2166|eqlee@partners.org|
21296459|NCT01116427|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21251068|NCT03352882|University of Pennsylvania|Kimberly A. Forde, MD, PhD - Principal Investigator|(215) 349-8222|kforde@pennmedicine.upenn.edu|
21251069|NCT02864342|AstraZeneca|Medical Director|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
21251070|NCT00118703|GlaxoSmithKline|GSK Response Center|866-435-7343||
21251071|NCT02261285|Ono Pharmaceutical Co., Ltd.|Medical Information Center||clinical_trial@ono-pharma.com|
21251072|NCT02344173|Abbott|Principal Clinical Research Scientist|6517564067|eric.grovender@abbott.com|
21251073|NCT01209286|Amgen Inc.|Study Director|866-572-6436||
21251074|NCT01349036|Daiichi Sankyo Inc.|Study Director|908-992-6400|CTRinfo@dsi.com|
21251075|NCT01161628|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD (Principal Investigator)|404-255-1930|ssolomon@bmtga.com|
21251076|NCT01143883|University of South Florida|Jorge E. Marcet, M.D.|813-844-4545|jmateka@health.usf.edu|
21251077|NCT01263925|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
21251078|NCT03029819|Georgia State University School of Public Health|Claire Spears|4044139335|cspears@gsu.edu|
21251079|NCT01449747|The Catholic University of Korea|Dr. Ji Hyun Kim|82-2-961-4534|kjhyun@catholic.ac.kr|
21251080|NCT00806598|The University of Texas MD Anderson Cancer Center|Tapan Kadia, MD/Assistant Professor|713-563-3534|eharriso@mdanderson.org|
21251081|NCT01215032|Mass General Hospital Cancer Center|Maria Kempner|508.533.4132|mkempner@partners.org|
21251082|NCT01149876|MGH|Dr. Molly Wanner|617-726-2914|harvardskinstudies@partners.org|
21251083|NCT01020747|Massachusetts General Hospital|Monica Tettamanti|617-643-5696|mtettamanti@ccib.mgh.harvard.edu|
21251084|NCT02970305|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261|medicalinformation@acadia-pharm.com|2897
21251085|NCT02175745|Stanford University|Erik Mittra, MD, PhD|650-736-2859|emittra@stanford.edu|
21251086|NCT00983892|Ann Arbor Veterans Administration|Maria J. Silveira MD MA MPH|734-763-4550|mariajs@med.umich.edu|
21251087|NCT00808899|St. Jude Children's Research Hospital|Wayne L. Furman|1-866-278-5833|info@stjude.org|
21251088|NCT02881047|Hospital of the University of Pennsylvania|Study Coordinator|215-662-6722|leahyd@uphs.upenn.edu|
21251089|NCT01726517|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21251090|NCT03181282|Washington University in St. Louis|Ryan Duncan|314-273-1052|duncanr@wustl.edu|
21251091|NCT02624375|University of Washington|Dr. Christine Johnston, Associate Professor|206 520 4340|cjohnsto@uw.edu|
21251092|NCT04525456|NUS|Study administrator|+65 6601 7766|lsixtc@nus.edu.sg|
21251093|NCT03765164|QURE Healthcare|Director of Clinical Trials|415-321-3388|qureadmin@qurehealthcare.com|
21251094|NCT01813305|Charsire Biotechnology Corp.|R&D associate|+886-6-702-0817|cs42@charsire.com|
21251095|NCT02736955|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
21266583|NCT04193605|School of Nursing at the University of Alabama at Birmingham|Crystal Chapman Lambert|205-934-3481|cclamber@uab.edu|
21266584|NCT02881151|Stanford University School of Medicine|Dr. Jaimie Henderson|+1 (650) 723-5574|henderj@stanford.edu|
21266585|NCT03315702|Department of Anesthesia, Xinhua hospital affiliated to Shanghai Jiaotong University School of medicine|Dr. Lai Jiang|021-25078999|jianglaimz@sina.com|
21266586|NCT00732654|Johns Hopkins University|Corinne Keet|4109555883|pediatricallergy@jhmi.edu|
21266587|NCT00589602|Cleveland Clinic|Jarek Maciejewski, MD|216-445-5962|maciejj@ccf.org|
21266588|NCT05618808|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21266589|NCT03887052|Kestra Medical Technologies, Inc.|Laura Gustavson, VP Clinical Marketing|14255264759|laura.gustavson@kestramedical.com|
21266590|NCT02365506|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21266591|NCT04428580|Stanford University|James Lock, MD, PhD|(650) 498-9111|jimlock@stanford.edu|
21266592|NCT03008889|Emory University|Dr. Lawrence Scahill|404-785-9336|lawrence.scahill@emory.edu|
21266593|NCT02155712|Stryker Orthopaedics|Stryker JR Clinical Research|201-831-5000|StrykerJRClinical@stryker.com|
21266594|NCT04288089|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21266595|NCT00976963|University of Washington|Ann Stapleton|‪(206) 880-3464‬|stapl@uw.edu|
21266596|NCT01328769|University of Utah|Paul Hopkins|801-585-8139|paul.hopkins@utah.edu|
21266597|NCT00537771|AstraZeneca|James J. Armbrust|+44 1625 518062|ClinicalTrialTransparency@astrazeneca.com|
21266598|NCT02148952|Ariadne Labs|Dr. Katherine Semrau|617-384-6555|betterbirth@ariadnelabs.org|
21266599|NCT01600105|Icahn School of Medicine at Mount Sinai|Dr. Bachir Taouli|212-824-8475|bachir.taouli@mountsinai.org|
21266600|NCT04007367|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21266601|NCT04043416|The University of Ottawa|Katherine Reilly|613-562-5800|kreilly@uottawa.ca|8238
21266602|NCT04098016|Duke University|Dr. Melissa Kay|7812493062|melissa.kay@duke.edu|
21266603|NCT01215786|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
21266604|NCT02515851|University Louisville|Nancy Alsip|502-852-2610|nlalsi01@exchange.louisville.edu|
21266605|NCT03441594|Pennington Biomedical Research Center|Candice A. Myers|12257632849|candice.myers@pbrc.edu|
21266606|NCT00623766|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21266607|NCT00893763|University of South Florida|Cindy L. Munro, APRN, PhD|813-974-7597|cmunro2@health.usf.edu|
21266608|NCT00796549|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21266609|NCT00285246|Edith Nourse Rogers Memorial VA Hospital|Karen S. Quigley, Ph.D., Research Physiologist|781-687-2273|karen.quigley@va.gov|
21266610|NCT03523715|University of Southern California|Begum Ozel, MD|562-657-2961|ozel@usc.edu|
21266611|NCT00606229|Otsuka Pharmaceutical CO., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
21266612|NCT02139280|Dartmouth-Hitchcock Medical Center|Kenneth Meehan, MD|603.650.4628|Kenneth.R.Meehan@hitchcock.org|
21266613|NCT01425853|Bioiberica|Clinical R&D Manager|+34934904908|mherrero@bioiberica.com|
21266614|NCT01302691|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21266615|NCT02939651|Fox Chase Cancer Center|Namrata Vijayvergia|+1 215-214-4283|Namrata.Vijayvergia@fccc.edu|
21266616|NCT00570362|St.Mary's Hospital, College of Medicine, The Catholic University of Korea|Jung-Il Moon|82-2-3779-2114|jimoon@catholic.ac.kr|1243
21266617|NCT02996994|TriHealth Inc.|Dr. Rachel Pauls|513-463-4300|Rachel_Pauls@trihealth.com|
21266618|NCT00390429|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
21266619|NCT01039428|KDL|Study Director|818058844243|toiawase@advance-cro.co.jp|
21266620|NCT01313039|University of Miami Sylvester Comprehensive Cancer Center|Judith Hurley MD|305-243-6462|JHurley@med.miami.edu|
21266621|NCT00117572|UC San Diego Moores Cancer Center|Dr. Ezra E.W. Cohen||ecohen@ucsd.edu|
21266622|NCT00090766|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
21266623|NCT00804986|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21266624|NCT02774291|Albert Einstein College of Medicine/Montefiore medical center|Braunschweig, Ira|718-798-7474|ibraunsc@montefiore.org|
21266625|NCT01387594|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21266626|NCT01611311|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21266627|NCT03017040|Massachusetts General Hospital|Dr. Neal Chen|617-726-4700|nchen1@mgh.harvard.edu|
21266628|NCT00397891|Wyeth|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21266629|NCT00412113|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21266630|NCT00796224|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21266631|NCT03227224|Janssen Research & Development, LLC|SENIOR DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266632|NCT04195750|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21266633|NCT02406027|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21266634|NCT06535932|Philips|Sarah Bass|240-278-0838|sarah.bass@philips.com|
21266635|NCT02254304|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21266636|NCT03649815|Centre for Addiction and Mental Health|Dr. Sean Kidd|416-535-8501|sean.kidd@camh.ca|36295
21281688|NCT04432831|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21281689|NCT03782792|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21281690|NCT04704050|Tulane University|Nassir Marrouche|504-988-2025|nmarrouche@tulane.edu|
21281691|NCT00617890|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21296460|NCT03675516|Momentum Data|Dr Andrew McGovern|+447531221970|andy.mcgovern@momentumdata.co.uk|
21296461|NCT00791557|University Hospitals of Cleveland|Dr. Amanda Suggs, MD|216-844-7546|Amanda.suggs@uhhospitals.org|
21296462|NCT01079936|University of Texas (UT) MD Anderson Cancer Center|Muzaffar H. Qazilbash, Professor, Stem Cell Transplantation||CR_Study_Registration@mdanderson.org|
21296463|NCT02322190|National Cancer Institute|Dr. Ronald Gress|240-760-6167|rg26g@nih.gov|
21296464|NCT03344640|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
21296465|NCT01264614|UNION COLLEGE|Cay Anderson-Hanley, PhD|518-388-6355|andersoc@union.edu|
21296466|NCT00110461|Otsuka Pharmaceutical Development & Commercialization, Inc.|Andy Forbes||andy.forbes@otsuka-us.com|
21296467|NCT00657371|UT MD Anderson Cancer Center|Robert S. Bresalier, MD / Professor||CR_Study_Registration@mdanderson.org|
21296468|NCT00537407|Debiopharm International S.A.|Jean-Maurice Dumont, Vice President Medical Affairs|4121 321 01 11|jean-maurice.dumont@debiopharm.com|
21296469|NCT00652899|University of Minnesota, Dept. Ob/Gyn|Melissa Geller, M.D.|612-626-3111|gelle005@umn.edu|
21296470|NCT02713867|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
21296471|NCT00857948|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com|
21296472|NCT04135859|Nationwide Children's Hospital|Jamie Jackson, Ph.D.|614-722-3585|jamie.jackson2@nationwidechildrens.org|
21296473|NCT01600053|University of California, San Diego|Thomas Kipps, MD|(858) 534-5400|tkipps@ucsd.edu|
21296474|NCT00996346|University of New Mexico Cancer Center|Monte Shaheen, MD / Study Principal Investigator|505-925-0404|MoShaheen@salud.unm.edu|
21296475|NCT02282904|NIAID|Elizabeth Kang|3014027567|ekang@niaid.nih.gov|
21296476|NCT01848847|namik kemal university|cem celik|905324205365|cemcel@yahoo.com|
21296477|NCT03833713|Stanford University|Brian Suffoletto|4129016892|suffbp@stanford.edu|
21296478|NCT02049138|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21296479|NCT05086510|AinShamsU|Dr. Mohammad Gamal|2001114115331|mdgamal92@gmail.com|
21296480|NCT04881747|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21296481|NCT00521222|Columbia University Irving Medical Center|Marjorie Slankard, MD|212-326-8410|ms53@columbia.edu|
21296482|NCT01175395|University of Illinois at Chicago|Jennifer I Lim MD|312-413-0704|jennylim@uic.edu|
21296483|NCT00721539|Stanford|Edward Damrose, MD, associate professor|650-725-6500|edamrose@stanford.edu|
21296484|NCT04054999|Mayo Clinic|Sher-Lu Pai, M.D.|904-956-3327|Pai.SherLu@mayo.edu|
21296485|NCT00225784|Dartmouth-Hitchcock|J. Marc Pipas, MD|603-650-9474|J.Marc.Pipas@hitchcock.org|
21296486|NCT03869333|PATH|Rahsan Erdem|+1 202 540 4546|rerdem@path.org|
21296487|NCT01927055|H. Lundbeck A/S|Study director||LundbeckClinicalTrials@Lundbeck.com|
21296488|NCT02598128|Alcresta Therapeutics, Inc.|Russell G. Clayton, D.O., Chief Medical Officer|215.813.5100|rclayton@alcresta.com|
21296489|NCT00499408|Comprehensive Cancer Center of Wake Forest University|K.C. Balaji, MD|336-716-5690|kbalaji@wakehealth.edu|
21296490|NCT03002454|Winnipeg Regional Health Authority|Dr. Sandor Demeter|1 (204) 787-3375|sdemeter@hsc.mb.ca|
21296491|NCT01064687|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21296492|NCT02030288|VA Boston Healthcare System|Nicholas Livingston|857-364-6360|nicholas.livingston@va.gov|
21296493|NCT01020903|Staten Island University Hospital|Michael Silverberg/Principal Investigator|718-226-6629|msilverberg@siuh.edu|
21296494|NCT05219669|Opiant Pharmaceuticals|Clinical Director|18043791090|PatientSafetyNA@Indivior.com|
21296495|NCT05216627|University of Pennsylvania|Daniel Blumenthal|215-746-7155|daniel.blumenthal@pennmedicine.upenn.edu|
21296496|NCT03134183|Virginia Commonwealth University|Frances Casey, MD|804-828-5076|frances.casey@vcuhealth.org|
21296497|NCT02504931|UT Health San Antonio|Dr. John Roache|210-562-5406|roache@uthscsa.edu|
21296498|NCT02177838|Rutgers Cancer Institute of New Jersey|Sung Kim, MD|732-235-3986|sk1375@cinj.rutgers.edu|
21296499|NCT03274804|Universitätsklinikum Heidelberg, NCT|Dr. Georg Martin Haag|+49 (0) 6221 56|GeorgMartin.Haag@med.uni-heidelberg.de|4801
21296500|NCT02404649|Harvard School of Dental Medicine|Dr. Kevin Guze|6177210707|kevin_guze@hsdm.harvard.edu|
21296501|NCT04075409|Cares|UCB|+1844599|UCBCares@ucb.com|2273
21296502|NCT00162266|Bristol-Myers Squibb|BMS Study Director||clinical.trials@bms.com|
21296503|NCT02299076|VAL HEALTH, LLC|Daniel Astrachan|2033769388|dastrachan@valhealth.com|
21296504|NCT01839656|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
21296505|NCT00499746|Johns Hopkins University School of Medicine|Eric C. Strain, M.D.|410-550-1191|ecsgss@aol.com|
21251096|NCT00770588|AstraZeneca|Gerard Lynch|52564555|aztrial_results_posting@astrazeneca.com|86 21
21296506|NCT00790478|University of Tennessee|Paul Terry|(865) 305-9341|pterry@utmck.edu|
21296507|NCT00558272|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21296508|NCT04311463|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21296509|NCT03449433|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
21296510|NCT01291277|Yale School of Medicine|Dr. Loren Laine|203-937-3462|loren.laine@yale.edu|
21251097|NCT01424189|Alcon Research, Ltd.|Expert Clinical Project Lead, GCRA, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21251098|NCT03120949|R-Pharm|Sergey Grishin, Head of Scientific Affairs Department|0074959567937|sa.grishin@rpharm.ru|1506
21251099|NCT01705145|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21251100|NCT01203956|Sleep Medicine Associates of Texas|Leon Rosenthal, MD|214-750-7776|LRosenthal@sleepmed.com|
21251101|NCT00513461|University of California, Irvine|Dr. Timothy R. Morgan|562-826-5756|timothy.morgan@va.gov|
21251102|NCT02230306|University of Pittsburgh Cancer Institute|Melissa Burgess, MD|412-623-7277|burgessma@upmc.edu|
21296511|NCT02963701|Boehringer Ingelheim|Boehringer Ingelheim Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21296512|NCT03480009|University of Pittsburgh|Principal Investigator, MD MPH|412-641-5496|fpr@upmc.edu|
21296513|NCT00637572|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
21281692|NCT05088460|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
21281693|NCT06045325|Berkeley Eye Center|Tetiana Huff|713-620-7640|tetiana.huff@berkeleyeye.com|
21281694|NCT04659863|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21281695|NCT02283268|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21281696|NCT02898597|University of Massachusetts Boston|Dr. Sun Kim|617-287-6831|sun.kim@umb.edu|
21251103|NCT00312845|Johnson & Johnson Pharmaceutical Research & Development|Yusri A. Elsayed, M.D., M.H.Sc., Ph.D.||YElsaye1@ITS.JNJ.COM|
21251104|NCT02212197|Camurus AB|Clinical Trial Manager||info@camurus.com|
21251105|NCT01688895|Icahn School of Medicine at Mount Sinai|Dr. Hetanshi Naik|212-241-7699|hetanshi.naik@mssm.edu|
21251106|NCT01077622|GlaxoSmithKline|GSK Response Center|866-435-7343||
21251107|NCT00424177|GlaxoSmithKline|GSK Response Center|866-435-7343||
21251108|NCT01503164|Johns Hopkins University|Naresh Punjabi|410-550-6384|npunjabi@jhmi.edu|
21251109|NCT04088136|Georgia Institute of Technology|Dr. Christopher Hertzog|404-894-6774|ch18@gatech.edu|
21251110|NCT02473913|University of Chicago|Stephanie Valle|773-834-3778|svalle@yoda.bsd.uchicago.edu|
21251111|NCT05041439|Massachusetts General Hospital|Dr. Julie H Levison|(617) 724-4698|jlevison@mgb.org|
21251112|NCT04013932|University of North Carolina at Chapel Hill|Joy Noel Baumgartner|919.923.8534|joy.baumgartner@unc.edu|
21251113|NCT02979613|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21251114|NCT05399082|Mayo Clinic|Ryan M. Kern, M.D.|507-266-3958|Kern.Ryan@mayo.edu|
21251115|NCT00960505|University of Illinois Chicago|Krista Varady, PhD, Associate Professor|3129967897|varady@uic.edu|
21251116|NCT02250183|Allegheny Health Network-West Penn Hospital Burn Center|Ariel M. Aballay, MD|412-578-1836|Ariel.Aballay@AHN.org|
21251117|NCT03282799|University of Pittsburgh|Dr. Catherine Chappell|412-641-1403|chappelca@upmc.edu|
21251118|NCT03749616|UMissouri|Vicki L Jones|573-882-7583|jonesvicki@health.missouri.edu|
21251119|NCT03614676|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21251120|NCT02388347|MedImmune LLC|Rene van der Merwe||information.center@astrazeneca.com|
21251121|NCT00497874|Pro-Change Behavior Systems, Inc.|Deborah A. Levesque, Ph.D.|(401) 360-2975|dlevesque@prochange.com|
21251122|NCT02080403|Dexcel Pharma|Clinical Trial Department Manager|972-4-6364000|sigalit.melcer@dexcel.com|467
21251123|NCT01999972|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21251124|NCT01171183|University of Arkansas for Medical Sciences|Alison Oliveto, PhD|501-526-8441|olivetoalison@uams.edu|
21251125|NCT01101334|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21251126|NCT01004029|Covis Pharma|Clinical Trial Interest|1-877-374-4177|CTInterest@covispharma.com|
21251127|NCT02826798|VBI|Bebi Yassin-Rajkumar|613-749-4200|byassin-rajkumar@vbivaccines.com|151
21251128|NCT02806505|Hoffmann-La Roche|Medical Communications|800-821-8590|global.trial_information@roche.com|
21251129|NCT00803777|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
21251130|NCT03440047|Mayo Clinic|Dr. Nayantara Coelho-Prabhu|(507)284-2407|CoelhoPrabhu.Nayantara@mayo.edu|
21251131|NCT03379545|NYU Langone Health|Joseph Zuckerman, MD|212-598-6674|Joseph.Zuckerman@nyulangone.org|
21251132|NCT00384865|Penn|Steven Kawut|215-573-0258|kawut@upenn.edu|
21251133|NCT03006185|Bispebjerg Hospital|Emily Wenande|+4540505590|emilycathrinew@hotmail.com|
21251134|NCT03984513|Cincinnati Children's Hospital|Dr. Amie Duncan|513-803-2416|Amie.Duncan@cchmc.org|
21251135|NCT04843579|Weill Cornell Medicine|Multiple Myeloma Program Manager|646-962-9376|hyk4001@med.cornell.edu|
21251136|NCT04009629|University of Kansas Medical Center|Dr. Eric Vidoni|913-588-0555|kuamp@kumc.edu|
21251137|NCT01083199|American Medical Systems|Laura Olson, Clinical Project Manager|952-930-6428|laura.olson2@bsci.com|
21251138|NCT00848510|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21251139|NCT04702893|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21251140|NCT04606199|University of California San Francisco|Dr. Stefanie Mayer|7345450698|Stefanie.mayer@ucsf.edu|
21251141|NCT00408928|Thomas Jefferson University|John Wagner, MD|215-955-8874|John.Wagner@jefferson.edu|
21251142|NCT02948569|University of Missouri|Dr. Elizabeth Parks|15738825864|parksej@missouri.edu|
21251143|NCT05145439|Vibrato Medical|Vice President of Clinical Affairs|2139215088|bisrat@vibratomedical.com|
21251144|NCT01114139|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
21251145|NCT01951378|Seton Family of Hospital|Director Pediatric Fellowship|512-324-9999|a.a@abc.com|
21251146|NCT03376555|Penn State University|Professor Lacy Alexander|8148671781|lma191@psu.edu|
21251147|NCT00477464|GlaxoSmithKline|GSK Response Center|866-435-7343||
21251148|NCT03568812|Tropical and Infectious Disease Division, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia-Cipto Mangunkusumo Hospital, Indonesia|Dr dr. Erni Juwita Nelwan, Ph.D, Sp.PD-KPTI|+62811961229|ejnelwan@yahoo.com|
21251149|NCT00429143|Thomas Jefferson University|Neal Flomenberg, MD|215-955-4367|neal.flomenberg@jefferson.edu|
21251150|NCT05252845|Mahidol-Oxford Tropical Medicine Research Unit (MORU)|Professor Lorenz von Seidlein|+66-(0)2-3549170|Lorenz@tropmedres.ac|
21251151|NCT00639769|Vanderbilt-Ingram Cancer Center|Barbara Murphy, M.D.||barbara.murphy@vanderbilt.edu|
21251152|NCT00634842|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21251153|NCT03468179|Vanderbilt University|Sean S. Davies|6153225049|sean.davies@vanderbilt.edu|
21251154|NCT01774019|Boston Scientific|Andrea Burbage|15086834387|Andrea.Burbage@bsci.com|
21251155|NCT02447432|GlaxoSmithKline|GSK Response Center|866-435-7343||
21251156|NCT03470545|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21251157|NCT00156923|Alkermes, Inc.|Bernard L. Silverman / VP, Clinical Development|781-609-6000|bernard.silverman@alkermes.com|
21281697|NCT00326716|Bristol-Myers Squibb|BMS Study Director||clinical.trials@bms.com|
21281698|NCT00684411|Dana-Farber Cancer Institute|Eric Jacobsen, MD|617.632.6633|EDJACOBSEN@PARTNERS.ORG|
21281699|NCT05253573|University of Oklahoma Stephenson Cancer Center|Thanh Cong Bui, MD, DrPH|1-405-271-8001|thanh-c-bui@ouhsc.edu|50559
21281700|NCT01344824|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
21281701|NCT03417557|CooperVision|Myhanh Nguyen, Sr. Optometrist|19257306716|MNguyen@coopervision.com|
21251158|NCT04035577|Northwestern University|Dr. Emily Lattie|3125033741|emily.lattie@northwestern.edu|
21281702|NCT01295671|Boston Children's Hospital|Dr. David Ludwig|617-355-4878|david.ludwig@childrens.harvard.edu|
21281703|NCT01944878|Hallym University College of Medicine, Chuncheon Sacred Heart Hospital|Dr. Chang Seok Bang|+82-33-240-5000|cloudslove@naver.com|
21281704|NCT01436370|Department of Internal Medicine, University of Iowa|Jack Stapleton, MD|319-356-3168|jack-stapleton@uiowa.edu|
21281705|NCT02395848|McMaster University|Christine Lee|2505191898|clee@mcmaster.ca|
21281706|NCT01754129|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
21281707|NCT02276560|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
21281708|NCT00616343|Loma Linda University|Dr. David Swope|909-558-4908|Thamilton@llu.edu|
21281709|NCT02126579|University of Virginia|Craig Slingluff, MD; Professor, Department of Surgery; Program Director, UVA Cancer Center|4349249311|cls8h@virginia.edu|
21281710|NCT01085630|HealthPartners Cancer Care Center|Arkadiusz Z. Dudek M.D., Ph.D.|651 254-3321|Arkadiusz.Z.Dudek@HealthPartners.Com|
21281711|NCT02366637|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21281712|NCT03691207|Ayala Pharmaceuticals|Chief Medical Officer|+1-857-444-0553|info@ayalapharma.com|
21281713|NCT01317095|Thomas Jefferson University|Hitoshi Hirose, Professor of Surgery|2159556925|Hitoshi.Hirose@jefferson.edu|
21281714|NCT01609010|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21281715|NCT01134107|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21281716|NCT02314260|kasr EL alini|Dr Ahmed Kamel|0201120022332|dr.ahmed.m.kamel@gmail.com|
21281717|NCT02027545|VA Ann Arbor Healthcare System|Sameer D. Saini, MD, MS|734-845-5865|sameer.saini@va.gov; sdsaini@med.umich.edu|
21281718|NCT00695292|Sarah Cannon Research Institute|Dr. David Spigel|615-329-7274|askSARAH@scresearch.net|
21281719|NCT01543178|Salix|David Sorscher|919-862-1827|david.sorscher@salix.com|
21281720|NCT04541589|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
21281721|NCT02770170|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21281722|NCT04376346|Centers for American Indian and Alaska Native Health, University of Colorado Anschutz Medical Campus|Carol Kaufman|303-880-7795|carol.kaufman@cuanschutz.edu|
21281723|NCT03581123|University of Washington|Eric Meier, Study Biostatistician|206-450-0020|emeier11@uw.edu|
21281724|NCT04195685|VA Pacific Islands Healthcare System|Dr. Judy Carlson|808-433-6677|judy.carlson@va.gov|
21281725|NCT01323517|Memorial Sloan Kettering Cancer Center|Dr. Charlotte Ariyan, MD|212-639-6280|ariyanc@mskcc.org|
21281726|NCT00300235|Rho Federal Systems Division|Karen Kesler, PhD|919-408-8000|karen_kesler@rhoworld.com|244
21281727|NCT04509076|San Diego State University|D. Keith Horvath, Professor of Psychology|619-594-3346|khorvath@sdsu.edu|
21281728|NCT03351608|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21281729|NCT02877004|Mayo Clinic|Dr. Ivana Croghan|507-266-1944|nicotineresearch@mayo.edu|
21281730|NCT02727478|Karolinska Instituet|Dr Breiffni Leavy|+46852488814|breiffni.leavy@ki.se|
21281731|NCT02356588|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
21281732|NCT01418378|DePuy Synthes|Dave Whalen|574-372-7028|dwhalen@its.jnj.com|
21281733|NCT01987089|Crescenz VA Medical Center|Subhajit Chakravorty|(215)-823-5800|Subhajit.Chakravorty@va.gov|
21281734|NCT01051791|University of Pittsburgh Cancer Institute|Barbara Stadterman, Regulatory Supervisor|412-647-5554|stadtermanbm@upmc.edu|
21281735|NCT00288626|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
21281736|NCT03097757|Montefiore Medical Center|Roger Hicks|718-862-1751|roger.hicks@einsteinmed.org|
21281737|NCT01372618|NYU Langone|David Kleinberg|646 501 7504|david.kleinberg@nyumc.org|
21281738|NCT03448419|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21281739|NCT04610346|Jefferson Moss Rehabilitation Research Institute|Sharon Antonucci, Ph.D CCC-SLP, C-AAIS|215-663-6561|sharon.antonucci@jefferson.edu|
21281740|NCT02019264|Eisai Ltd|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
21251159|NCT02591862|Akari Therapeutics plc|Chief Scientific Officer|02080040261|miles.nunn@akaritx.com|
21251160|NCT00505414|Grünenthal GmbH|Director of Clinical Trials|+49 (0)241 569 3223|Clinical-Trials@grunenthal.com|
21251161|NCT00846768|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21251162|NCT00002597|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
21251163|NCT02143063|UConn Health|Sheila Alessi, PhD|860-679-1849|salessi@uchc.edu|
21251164|NCT03245463|Hospital for Special Surgery|Dr. James Wyss|2126061731|wyssj@hss.edu|
21251165|NCT00912223|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
21251166|NCT02601209|Memorial Sloan-Kettering Cancer Center|William D. Tap, MD|646-888-4156|tapw@mskcc.org|
21251167|NCT00927901|Novartis Pharmaceuticals|Study Director|862 778-8300||
21251168|NCT00984698|University of Arizona|Dr. Patricia Haynes, Assistant Professor|5206261855|thaynes@email.arizona.edu|
21251169|NCT00746356|St. Jude Medical|Ashish Oza, Clinical Studies Director|818 362 6822|aoza@sjm.com|3648
21251170|NCT02196168|London Health Sciences centre|Dr.Eric Winquist|519-685-8500|Winquist@lhsc.on.ca|
21281741|NCT05028790|University of Houston|David A Berntsen, OD PhD|713-743-5836|dberntsen@uh.edu|
21281742|NCT01155180|Beth Israel Deaconess Medical Center|Dr. Christos Manztoros|617-667-8630|cmantzor@bidmc.harvard.edu|
21251171|NCT03605368|Children's Hospital of Philadelphia|Julia Parish-Morris|267-426-7540|parishmorrisj@chop.edu|
21251172|NCT00702546|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21251173|NCT03028012|University of Utah Physical Medicine and Rehabilitation Orthopedics|Dr. Daniel Cushman|8015852373|heidi.hansen@hsc.utah.edu|
21251174|NCT00569010|The University of MD Anderson Cancer Center|Jean-Pierre Issa, M.D./Professor|713-745-2260|eharriso@mdanderson.org|
21251175|NCT02484547|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
21251176|NCT03448536|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
21251177|NCT01665599|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
21251178|NCT04688086|NIRAMAI Health Analytix Private Limited|Dr Sathiakar Collison|+919810823838|sathiakar.collison@niramai.com|
21251179|NCT02920021|AnaptysBio, Inc.|Clinical Project Leader|858-362-6295|info@anaptysbio.com|
21251180|NCT05400226|Vergent Bio|Maggie Neptune|+1-510-410-9124|mneptune@vergentbio.com|
21251181|NCT03015181|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD|301-451-8715|martin.gaudinski@nih.gov|
21251182|NCT03822377|Cardiology Clinic, Sassari University Hospital, Sassari, Italy|Prof. Guido Parodi|0039|parodiguido@gmail.com|792830626
21251183|NCT01831726|Novartis Pharmaceuticals|Study Director|862-778-8300||
21251184|NCT03821064|Medical University of South Carolina|Evan Graboyes (PI)|843-792-0719|graboyes@musc.edu|
21251185|NCT00474383|Clinical Research, Janssen R&D, 10990 Wilshire Blvd, Suite 1200, Los Angeles, CA 90024.|Senior Director|310-943-8040||2917
21251186|NCT01314014|James P. Wilmot Cancer Center, University of Rochester|Paul M. Barr, MD|585-273-3258|Paul_Barr@urmc.rochester.edu|
21251187|NCT01482819|Johnson & Johnson Vision Care|Daria Wicks, Senior Clinical Research Manager|904-443-1391|RA-ClnclStds@its.jnj.com|
21251188|NCT02364609|UC Davis Comprehensive Cancer Center|Leslie Garcia, Data Research Supervisor|916-734-0156|lesgarcia@ucdavis.edu|
21251189|NCT03110692|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh S. Patel|215-898-3367|mpatel@pennmedicine.upenn.edu|
21251190|NCT01502371|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21251191|NCT02672514|Herzzentrum Coswig|Dr. Jessica Vogler|+491749740710|j_vo@web.de|
21251192|NCT01669720|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
21251193|NCT00514813|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21251194|NCT00749671|Baystate|James R. Cook MD|413-794-4492|james.cook@bhs.org|
21251195|NCT01138098|GlaxoSmithKline|GSK Response Center|866-435-7343||
21251196|NCT01075100|US Oncology Research, McKesson Specialty Health|Dr. Cynthia Osborne|214-370-1057|Cynthia.Osborne@usoncology.com|
21251197|NCT04944784|Cytokinetics|Cytokinetics MD|6506242929|medicalaffairs@cytokinetics.com|
21251198|NCT04510948|Department of Medicine, Yale School of Medicine|Mary Tinetti, MD|203-688-5238|MARY.TINETTI@yale.edu|
21251199|NCT04398368|Mayo Clinic|Stephen A. Boorjian, M.D.|507 422-5516|Boorjian.Stephen@mayo.edu|
21251200|NCT03602586|NRG Oncology|Christopher Purdy on behalf of Danielle Enserro, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
21251201|NCT02263040|Mount Sinai Hospital, Toronto|Dr. Allison McGeer|416-586-3118|allison.mcgeer@sinaihealthsystem.ca|
21251202|NCT01479270|MetroHealth Medical Center|Robert Pollard|216-778-4444|rpollard@metrohealth.org|
21251203|NCT00511836|Alkermes, Inc.|Bernard L. Silverman|781-609-6000|bernard.silverman@alkermes.com|
21251204|NCT00030823|Memorial Sloan Kettering Cancer Center|Dr. Teresa Gilewski|646-888-4557|gilewskt@mskcc.org|
21251205|NCT01755546|BIODELIVERY|Vice President, Operations|919-582-0294|twarneke@bdsi.com|
21251206|NCT00891046|Novartis Pharmaceuticals|Study Director|862--778--8300||
21251207|NCT00362375|SisterLove, Inc.|Dazon Dixon-Diallo, Executive Director|404-505-7777|ddiallo@sisterlove.org|
21251208|NCT02106195|Kadmon Corporation, LLC|Associate VP, Clinical Operations|833-900-5366|karin.herrera@kadmon.com|
21251209|NCT04984239|University of Pittsburgh|William Evans|412-383-6943|will.evans@pitt.edu|
21251210|NCT03294941|HepQuant, LLC|Elyse Handley|303-923-2109|elyse.handley@hepquant.com|
21251403|NCT02641587|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|christelle.haziza@pmi.com|
21251404|NCT03124693|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
21251405|NCT01663506|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21251406|NCT02431052|Eli Lilly and Company.|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21251407|NCT02094898|Mayo Clinic|William V. Bobo, M.D.|507-538-9041|Bobo.William@mayo.edu|
21251408|NCT03520075|Taiho Oncology, Inc|Taiho|609-250-7336|clinicaltrialinfo@taihooncology.com|
21251409|NCT01439854|University of Texas Health San Antonio|Muhammad Abdul-Ghani|210-557-1157|abdulghani@uthscsa.edu|
21251410|NCT00328562|Thomas Jefferson University|Maria Werner-Wasik, MD|215-955-6702|Maria.Werner-Wasik@jeffersonhospital.org|
21251411|NCT03305809|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21251412|NCT00816556|Mayo Clinic|Maire Brid MacBride MB BCh|507-538-2271|MacBride.Maire@mayo.edu|
21251413|NCT05146206|Community and Patient Preference Research (CaPPRe)|Dr Lili Toh|+61 452551409|lili.toh@cappre.com.au|
21251414|NCT04014790|REGiMMUNE|Chief Executive Officer|+81-80-7022-7536|kenzo@regimmune.com|
21251415|NCT03546816|Menlo Therapeutics Inc.|Iain Stuart, PhD|1- 800-775-7936|Iain.Stuart@foamix.com|
21251416|NCT00810342|University of Hawaii, School of Nursing|Cheryl Albright|8089569716|cherylal@hawaii.edu|
21251417|NCT01852032|UC Davis|John Brock Staff Research Associate|916-734-3101|jmbrock@ucdavis.edu|
21251418|NCT03065933|McLean Hospital|Elizabeth S. Liebson, M.D.|617-855-2284|eliebson@partners.org|
21251419|NCT04504630|UT Southwestern Medical Center|Christian LoBue, PhD|2146484658|Christian.LoBue@utsw.edu|
21251420|NCT01010204|Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center|K.N. Roy Chengappa, Md|412-246-5006|chengappakn@upmc.edu|
21251421|NCT01513330|Coloplast A/S|Director of Clinical Trials|+45 4911 3595|dkbir@coloplast.com|
21281743|NCT01575834|Amgen Inc.|Study Director|866-572-6436||
21281744|NCT02155283|Radiancy Ltd|Dr. Daniele Perl-Treves, Clinical Director|972-97757556|daniele@radiancy.com|
21281745|NCT00470717|UHClevelandMC|Dr. Lydia Furman|216-844-8260|Lydia.Furman@uhhospitals.org|
21281746|NCT02282813|OPKO Health, Inc.|Douglass Laidlaw, PhD, Vice President, Medical Affairs|305-575-4172|dlaidlaw@opko.com|
21281747|NCT05209464|Spaulding Rehabilitation Hospital|Paolo Bonato, PhD|617-952-6319|pbonato@mgh.harvard.edu|
21281748|NCT01514292|Dexcom, Inc|Andy Balo, SVP, Regulatory, Clinical and Biometrics|8582000200|abalo@dexcom.com|
21281749|NCT00426166|University of Toledo|Dr. Martin Skie|419-383-3515|martin.skie@utoledo.edu|
21281750|NCT05000164|Johnson & Johnson Vision Care (JJVC)|Ross Franklin, BAppSc-Optom|1-800-843-2020|RFRANKL1@its.jnj.com|
21281751|NCT02422446|Brigham and Women's Hospital|Dr. Luc Djousse|617-525-7591|Ldjousse@rics.bwh.harvard.edu|
21281752|NCT04278417|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21281753|NCT01391858|UTexas Southwestern Medical Center|Babatunde Ogunnaike|(214) 590|Babatunde.Ogunnaike@UTSouthwestern.edu|8536
21281754|NCT03146806|Emory University|Vinita Singh, MD|404-686-2410|vinita.singh@emory.edu|
21281755|NCT04830969|University at Buffalo|Lu Li|7168296284|lli59@buffalo.edu|
21281756|NCT00996125|GlaxoSmithKline|GSK Response Center|866-435-7343||
21281757|NCT02147834|North Florida South Georigai Veteran Health System|Anthony A Bavry, M.D.|352-548-6000|anthony.bavry@va.gov|104726
21281758|NCT01796392|Pulmonx Corporation|Narinder Shargill|650-216-0108|nshargill@pulmonx.com|
21281759|NCT04681066|CalciMedica|Sudarshan Hebbar (Chief Medical Officer)|(816) 838-7105|sudarshan@calcimedica.com|
21281760|NCT04495829|Woolfson Eye Institute|R. Doyle Stulting, MD, PhD|(770) 255-3330|dstulting@icloud.com|
21281761|NCT03111940|Oxford Heart Centre, John Radcliffe Hospital|Prof Adrian Banning|01865 228934|Adrian.Banning@ouh.nhs.uk|
21281762|NCT02003404|Loyola University of Chicago|Dr James Swan, MD|708-485-1271|jswan@lumc.edu|
21281763|NCT01205269|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21281764|NCT00987337|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21281765|NCT05682729|University of Dayton|Mary Wagner|9372292775|mwagner8@udayton.edu|
21281766|NCT05678959|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21281767|NCT06360588|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
21281768|NCT04010240|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Pr Antoine Italiano|0556333333|a.italiano@bordeaux.unicancer.fr|
21281769|NCT03263936|Therapeutic Advanced in Childhood Leukemia and Lymphoma|Ellynore Florendo|323-361-3022|eflorendo@chla.usc.edu|
21281770|NCT01540487|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21281771|NCT03503370|Baltimore VA Medical Center|Dr. Mary-Claire Roghmann|(410) 706-0062|Mary-Claire.Roghmann@va.gov|
21281772|NCT04545489|Durham VA Health Care System|Dr. Hayden Bosworth, PhD|919-286-0411|Hayden.Bosworth@va.gov|177101
21281773|NCT00457002|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21281774|NCT01623310|OptiNose|Vice President Global Clinical Operations & Outsourcing|267-364-3508|jennifer.carothers@optinose.com|
21281775|NCT00454246|Hoffman-LaRoche|Medical Communications|800-821-8590||
21281776|NCT01234870|Northwestern University|Dr. James Carr|(312)695-4218|jcarr@northwestern.edu|
21281777|NCT02058537|Temple University Hospital|Ron Schey|215-540-0120|Ron.schey@tuhs.temple.edu|
21281778|NCT01237041|NICHD, National Institutes of Health|Dr. Jack Yanovski|13014960858|yanovskj@mail.nih.gov|
21281779|NCT01033032|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21281780|NCT00651261|Dana Farber Cancer Institute|Richard Stone, MD||rstone@partners.org|
21281781|NCT02633293|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
21281782|NCT00808210|F. Hoffmann-La Roche Ltd|Medical Communications|+41 616878333|global.trial_information@roche.com|
21281783|NCT02044302|Yale Center for Clinical Investigations|Katisha Brown CPC|(203) 737-7495|katisha.brown@yale.edu|
21296514|NCT00896649|Boston Medical Center|Gustavo Mercier, House Radiologist|617-638-6610|gustavo.mercier@bmc.org|
21296515|NCT03652675|Columbia University / New York State Psychiatric Institute|Jennifer C Elliott, PhD|646 774 7953|jce2130@cumc.columbia.edu|
21296516|NCT02539511|New York State Psychiatric Institute|Elias Dakwar, MD|6467748728|elias.dakwar@nyspi.columbia.edu|
21296517|NCT03442296|Johns Hopkins University School of Medicine|Dr. Carrie Nieman|410-502-6965|cnieman1@jhmi.edu|
21296518|NCT02885246|GlaxoSmithKline|GSK Response Center|866-435-7343|gskclinicalhd@gsk.com|
21296519|NCT01237613|Orthopedic Foot and Ankle Center|Terrence M. Philbin, DO|614-895-8747|ofacresearch@orthofootankle.com|111
21296520|NCT01673620|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21296521|NCT00528801|Children's Hospital of Oakland and Research Institute|Elliott Vichinsky, MD|510-428-3651|evichinsky@mail.cho.org|
21296522|NCT00344500|Psychiatry Department at VA Greater Los Angeles Healthcare System|Dr. Donna Ames, Principal Investigator|310-478-3037|donna.ames@va.gov|
21296523|NCT02252965|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21296524|NCT00680797|VA Greater Los Angeles|Dr. Cathy Lee|310-478-3711|cathy.lee2@va.gov|42627
21296525|NCT01387464|InSite Vision|Senior Manager, Clinical Sciences||manjiri.desai@sparcmail.com|
21296526|NCT02429791|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21296527|NCT02615691|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21296528|NCT04201093|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21296529|NCT00881504|Georgetown University Medical Center|Dr. John L Marshall|202-444-7064|marshalj@georgetown.edu|
21281784|NCT01953302|Varazdin General Hospital|Alen Pajtak|+38542393053|alen.pajtak@obv.hr|
21281785|NCT01790984|University of Surrey|Professor Bruce A.Griffin|+44 0483 689724|b.griffin@surrey.ac.uk|
21281786|NCT04742400|National Institutes of Health|Daniel Reich, MD|301-496-1801|reichds@ninds.nih.gov|
21281787|NCT00558467|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21281788|NCT00507455|Astellas Pharma Global Development, Inc.|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
21281789|NCT00931255|UMaryland|Abdolreza Haririan, MD|410-328-5720|ahariria@medicine.umaryland.edu|
21281790|NCT02344238|Medical University of South Carolina|Dr. Aimee McRae-Clark||mcraeal@musc.edu|
21281791|NCT00746889|UCSD|Jeannie Chao|858-657-7040|j5chao@ucsd.edu|
21281792|NCT03038867|Weill Cornell Medical College|Research coordinator|212-746-5385|mac4015@med.cornell.edu|
21281793|NCT02414243|Laboratorios Ordesa|Roser De Castellar|+34 902105243|Roser.DeCastellar@ordesa.es|
21281794|NCT01609296|Medtronic|Kristel Wittebols Clinical Research Director|+31433566580|kristel.wittebols@medtronic.com|
21281795|NCT03782012|William Jewell College|Dr. Amy Elizabeth Barth|816-415-7622|bartha@william.jewell.edu|
21281796|NCT00546377|Memorial Sloan Kettering Cancer Center|Dr. Renier Brentjens, Associate Attending|+1212-639-7053|brentjer@mskcc.org|
21281797|NCT01684423|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
21281798|NCT00232739|Cordis|Sidney Cohen, MD PhD, Vice President|650 614-2726|scohen7@its.jnj.com|
21281799|NCT01741688|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21281800|NCT01548040|Theragen Inc.|Richard Pearce|901 634 0544|richard.pearce@theragen.com|
21281801|NCT01342770|Mayo Clinic|Dennis Wigle, M.D., Ph.D.|507-284-2511|wigle.dennis@mayo.edu|
21296530|NCT01276223|Alcon Research|Director of Alcon Clinical|1-888-451-3937||
21251211|NCT04629443|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33 1 55 72 60 00|scientificinformation@servier.com|
21251212|NCT03954223|Children's Hospital Los Angeles|Alaina Vidmar, MD|323-361-3385|avidmar@chla.usc.edu|
21251213|NCT02431455|Lahey Hospital and Medical Center|Haddon Pantel|3013566674|Haddon.Pantel@Lahey.org|
21251214|NCT00916305|London School of Hygiene & Tropical Medicine|Clare Gilbert|+44 207 958 8332|clare.gilbert@lshtm.ac.uk|
21251215|NCT04067843|University Hospital Zurich|Dr. Yvonne Achermann|+41442553402|yvonne.achermann@usz.ch|
21251216|NCT04184349|The University of Texas Health Science Center at Houston|Olga Pewelek, MD|713-500-6227|Olga.I.Lyuksyutova@uth.tmc.edu|
21251217|NCT00858247|Mayo Clinic|Seema Kumar, MD|507-284-3300|kumar.seema@mayo.edu|
21251218|NCT04731142|Imperial College London|Dr Jack Halligan|+447742161980|j.halligan@imperial.ac.uk|
21251219|NCT01664923|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21251220|NCT01336205|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21251221|NCT02767609|Loma Linda University medical Center|Brenda Bartnik Olson|909-558-4000|bbartnik@llu.edu|85216
21251222|NCT01086384|GlaxoSmithKline|GSK Response Center|866-435-7343||
21251223|NCT03854019|The University of Texas Health Science Center at Houston|Erin Furr Stimming, MD|713-500-7033|Erin.E.Furr@uth.tmc.edu|
21251224|NCT02586415|Stanford University/School of Medicine|Dr. Gregory Albers|650-723-4448|albers@stanford.edu|
21251225|NCT03974100|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
21251226|NCT03318783|Oregon Health and Science University|Ross Martini|4013386803|martinir@ohsu.edu|
21251227|NCT03398421|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21251228|NCT01009138|Research Institute of the Diabetes Academy Mergentheim|Dr. Bernhard Kulzer|+49 7931|kulzer@diabetes-zentrum.de|594151
21251229|NCT01690923|ResMed Ltd|Xueling Zhu, Clinical Consultant|61288842265|xueling.zhu@resmed.com.au|
21251230|NCT04358068|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
21251231|NCT01426113|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
21251232|NCT01494545|Alcon Research, Ltd|Jami Kern, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
21251233|NCT03579433|Alcon Research, LLC|Sr. CDMA Project Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
21251234|NCT02719743|GlaxoSmithKline|GSK Response Center|866-435-7343|ct427449@gsk.com|
21251235|NCT01438840|Eisai Call Center|Eisai Inc.|888-422-4743||
21251236|NCT00193596|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
21251237|NCT00461123|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
21251238|NCT02024750|University of Wisconsin School of Medicine and Public Health|Elizabeth Cox|608-263-9104|ecox@wisc.edu|
21251239|NCT01612767|BIOTRONIK|Amy Culley, Director of Vascular Intervention|503-451-8034|amy.culley@biotronik.com|
21251240|NCT01891890|Emory University|David Loring, PhD|404-778-5943|dloring@emory.edu|
21251241|NCT02383407|George Washington University|Dr. Mohamad Koubeissi|202-741-2533|mkoubeissi@mfa.gwu.edu|
21251242|NCT02725008|New York Presbyterian - Brooklyn Methodist Hospital|Christopher P Kelly|718.780.5040|chk9064@nyp.org|
21251243|NCT05288504|Avalo Therapeutics, Inc.|Garry Neil, MD|610.254.4201|gneil@avalotx.com|
21251244|NCT01329419|GlaxoSmithKline|GSK Response Center|866-435-7343||
21251245|NCT00361842|Jazz Pharmaceuticals|Director, Clinical Trial Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
21251246|NCT03512288|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21251247|NCT02356484|Lausanne University Hospital|Pr. Nicolas Demartines|0041213142424|demartines@chuv.ch|
21251248|NCT01817712|VA Cooperative Studies Program|Tassos C. Kyriakides, Ph.D, Biostatistician|203-932-5711|tassos.kyriakides@va.gov|3771
21251249|NCT00097669|VITATOPS|Clinical Trial Coordinator|+61892247004|julia.o'dea@health.wa.gov.au|
21251250|NCT05250960|TriHealth|Rachel Baker|513-569-6191|Rachel_Baker2@trihealth.com|
21251251|NCT01177228|Millennium Pharmaceuticals Inc|Medical Director|1-800-778-2860|clinicaltrialregistry@tpna.com|
21251252|NCT03325608|NYU Langone Health|Joshua Chodosh, MD, MSHS, FACP|212-263-6768|Joshua.Chodosh@nyumc.org|
21251253|NCT00942188|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21281802|NCT00463047|Cephalon, Inc.|Medical Monitor|1-800-896-5855||
21281803|NCT03674112|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21281804|NCT03283787|Integra LifeSciences|Allison Matthews|443-766-3869|allison.matthews@integralife.com|
21281805|NCT02220764|Zahnärztliche Prothetik|Dr. Konstantinidis Ioannis|+49 351 458 4231|ioannis.konstantinidis@uniklinikum-dresden.de|
21281806|NCT03020992|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21281807|NCT01006122|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21281808|NCT03493854|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21281809|NCT00410813|SWOG Statistical Center|SWOG Breast Committee Statistician|206-667-4623||
21281810|NCT02818946|Duke University|Sujata Ghate, MD|919-684-2711|sujata.ghate@duke.edu|
21281811|NCT04123496|Medical University of South Carolina|Donna Robers, MD|843-792-9343|Robertdr@musc.edu|
21281812|NCT02905981|Rockwell Medical|Ray Pratt, MD|248 960-9009|rpratt@rockwellmed.com|405
21281813|NCT03365635|Penn Presbyterian Medical Center|Michael R. Rudnick, MD|215-662-8738|rudnickm@uphs.upenn.edu|
21281814|NCT02268916|VA Ann Arbor|Pearl Lee, MD|734-845-3182|Pearl.Lee2@va.gov|
21281815|NCT03926117|Novo Nordisk A/S|Clinical Reporting Office (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21281816|NCT04205643|CELLTRION, Inc.|Head of Clinical Planning|+82-32-850-4160|YunJu.Bae@celltrion.com|
21281817|NCT04526288|Fred Hutchinson Cancer Center|Dr. Filippo Milano, Director of FHCC Cord Blood Transplant Program|206.667.5925|fmilano@fredhutch.org|
21281818|NCT01699373|Changi General Hospital|Dr Lim Yean Chin|+65 68503831|yean_chin_lim@cgh.com.sg|
21281819|NCT00594165|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
21281820|NCT05236764|Baylor College of Medicine|Dr. Erin Morales|832-826-0860|erin.moralesubico@bcm.edu|
21281821|NCT03527589|Merit Medical|Casey Holland|6178420251|casey.holland@merit.com|
21281822|NCT02203721|Abbott Medical Optics|Kendra Hileman, Ph.D., Director of Clinical Research and Development|714-247-8613|kendra.hileman@abbott.com|
21281823|NCT00703157|Medtronic Bakken Research Center, Coronary and Structural Heart Disease Management|Ber Kleijnen|+31 (0) 43 356 6566|ber.kleijnen@medtronic.com|
21281824|NCT00347009|GlaxoSmithKline|GSK Response Center|866-435-7343||
21281825|NCT03308097|Rhode Island Hospital|Larry K. Brown, MD|(401) 793 - 8808|lkbrown@lifespan.org|
21281826|NCT02907177|Actelion Pharmaceuticals Ltd (a Janssen Pharmaceutical Company of Johnson & Johnson)|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21281827|NCT03482635|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21281828|NCT04639219|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
21281829|NCT00673439|James Graham Brown Cancer Center|Goetz H Kloecker, MD, MSPH|502/562-4358|ghkloe01@exchange.edu|
21281830|NCT02571673|Memorial Sloan Kettering Cancer Center|Dr. Talya Salz, PhD|646-227-3646|salzt@mskcc.org|
21281831|NCT01465412|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21281832|NCT00669669|Fred Hutch Cancer Research Center|Hans-Peter Kiem, M.D., Ph.D.|206.667.4425|hkiem@fredhutch.org|
21281833|NCT07091916|Medtronic Japan Co., Ltd.|Takuto Yamamoto|+818046716498|takuto.yamamoto@medtronic.com|
21281834|NCT03103152|Queen Mary University, London.|Professor Jack Cuzick, Director of The Wolfson Institute|+44 (0)207 882 3504|j.cuzick@qmul.ac.uk|
21281835|NCT03474965|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21281836|NCT03100903|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21281837|NCT04659993|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|3367135440|Katie.Duckworth@advocatehealth.org|
21281838|NCT04850989|National University of Singapore|Nur Hani Zainal|+65 6516 3749|hanizainal@nus.edu.sg|
21281839|NCT00754234|United States Department of Agriculture (USDA) Grand Forks Human Nutrition Research Center|Brenda Ling|701-795-8300|brenda.ling@ars.usda.gov|
21281840|NCT03483961|Emergent BioSolutions|Sharmila Rajendran|650-486-0244|rajendras@ebsi.com|
21281841|NCT04003636|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
21281842|NCT03048747|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21281843|NCT00298272|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
21281844|NCT00915018|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
21281845|NCT05326529|University Hospital of Derby and Burton|Charlotte Smith|01283 593150|charlotte.smith79@nhs.net|3150
21281846|NCT00734162|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21281847|NCT00566020|GlaxoSmithKline|GSK Response Center|866-435-7343||
21281848|NCT02609607|University of Pittsburgh Medical Center|Dr. David Levinthal|14123030525|levinthald@upmc.edu|
21281849|NCT00687271|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21281850|NCT00693498|University of Rochester|Jill M. Cholette MD, Principle Investigator|585-275-8138|Jill_Cholette@urmc.rochester.edu|
21281851|NCT01593670|Masonic Cancer Center, University of Minnesota|Dr. Erica Warlick|612-625-5467|ewarlick@umn.edu|
21281852|NCT02017210|Garvan Institute of Medical Research|Dr. Dorit Samocha-Bonet|+61292958309|d.samochabonet@garvan.org.au|
21281853|NCT00778817|The University of Chicago|Walter M. Stadler, MD|(773) 702-6149|wstadler@medicine.bsd.uchicago.edu|
21281854|NCT03150719|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21281855|NCT03892642|OU Health Stephenson Cancer Center|Associate Professor|405-271-6900|kelly-stratton@ouhsc.edu|
21281856|NCT04005404|Helios Center for Research and Innovation|Director Prof. Dr. Petra Thürmann|0049 (0)202 896-1851|petra.thuermann@helios-gesundheit.de|
21281857|NCT01372995|Emory University|Jenny Han, MD|404-616-0821|jehan2@emory.edu|
21281858|NCT02914613|OcuTerra Therapeutics, Inc.|Chief Medical Officer|(617) 701-7382|info@ocuterratx.com|
21281859|NCT02403479|St. Joseph's Healthcare London|Dr. Leigh Sowerby|519-646-6143|leigh.sowerby@sjhc.london.on.ca|
21251254|NCT02188784|Duke Clinical Research Institute|Dr. Adrian Hernandez|919-668-7515|adrian.hernandez@duke.edu|
21251255|NCT01568021|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
21251256|NCT00731588|University of Iowa|John A. Widness, M.D.|319-356-8102|john-widness@uiowa.edu|
21251257|NCT00420147|University of Delaware|Todd Royer|302-831-4351|royer@udel.edu|
21251258|NCT01568112|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
21251259|NCT01722045|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator||clinicaltrials@regeneron.com|
21251260|NCT02034162|Janssen R&D US|DIRECTOR CLINICAL LEAD||ClinicalTrialDisclosure@its.jnj.com|
21251261|NCT00760513|University Hospital Southampton|Professor CD Byrne|02381205006|c.d.byrne@soton.ac.uk|
21251262|NCT01053247|Fougera Pharmaceuticals Inc|Angela C. Kaplan|631-659-2256|angela.kaplan@sandoz.com|
21281860|NCT01964222|Washington University's School of Medicine|Mary C. Politi, PhD|314-747-1968|politim@wudosis.wustl.edu|
21281861|NCT01831076|University of Colorado|Anthony Elias|720-848-0347|anthony.elias@ucdenver.edu|
21281862|NCT04994691|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
21281863|NCT04244084|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
21281864|NCT02249728|Prana Biotechnology|Dr Dianne Angus|+61 393494906|info@pranabio.com|
21281865|NCT02744430|Baylor College of Medicine|Perla Ramirez|713-798-8514|Perla.Ramirez@bcm.edu|
21281866|NCT03850496|Imperial College London|Dr Tristan Lane, Clinical Lecturer|02033117317|tristan.lane@imperial.ac.uk|
21281867|NCT03090958|UNC-Chapel Hill|Lisa Hightow Weidman, MD|919 966 2536|lisa_hightow@med.unc.edu|
21281868|NCT01417741|OHSU department of APOM|Dr. Christine Martin, assistant professor|503 494 7641|martich@ohsu.edu|
21281869|NCT00676364|Lehigh Valley Health Network|Jenny Boucher|610-402-8844|jenny.boucher@LVH.com|
21281870|NCT03821259|University of Edinburgh/NHS Tayside|Klaudia Suchorab|+44 1738 621151|klaudia.suchorab@nhs.net|
21281871|NCT00869999|Massachusetts General Hospital Cancer Center|Jeffrey Barnes, MD|617-724-4000|jabarnes@partners.org|
21281872|NCT03858998|Weill Cornell Medicine|Dr. Robert Peck|(646) 962-8140|rnp2002@med.cornell.edu|
21281873|NCT03363776|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email:|Clinical.Trials@bms.com|
21281874|NCT04157348|AstraZeneca|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
21281875|NCT02527434|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
21281876|NCT02861807|University of New Mexico|Katie Witkiewitz|505-277-4121|katiew@unm.edu|
21281877|NCT02094352|HSS|Dr. Richman|212.517.4481|RichmanD@HSS.EDU|
21281878|NCT00568061|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
21281879|NCT05027451|InterveXion Therapeutics, LLC|Chief Operating Officer|501-554-2377|misty.stevens@intervexion.com|
21281880|NCT04316104|University of Kansas Alzheimer's Disease Research Center|Jaime Perales Puchalt|913-588-3716|jperales@kumc.edu|
21281881|NCT02693002|University of Kentucky|Dr. Gretchen Wells, PI||gretchen.wells@uky.edu|
21251263|NCT03458728|Bayer AG|Therapeutic Area Head|30 300139003|clinical-trials-contact@bayer.com|
21251264|NCT01572298|UTHSCSA Periodontics|Dr. Brian Mealey|210-567-3589|mealey@uthscsa.edu|
21251265|NCT03898700|Thomas Jefferson University|Dr. MJ Mulcahey|215-503-2888|maryjane.mulcahey@jefferson.edu|
21251266|NCT01788475|Lahey Medical Center|Christine Gould PAC, MS|9785384412|christine.gould@lahey.org|
21251267|NCT00701909|University of California, San Francisco|Dr. Kathleen Puntillo, RN, PhD|415 819 2655|kathleen.puntillo@ucsf.edu|
21251268|NCT00908349|Supernus Pharmaceuticals, Inc|Janet K. Johnson, PhD|301-838-2623|jjohnson@supernus.com|
21251269|NCT01789840|Merit Medical|Casey Holland|1 (617) 842-0251|casey.holland@merit.com|
21251270|NCT00971997|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21251271|NCT01937195|Evangelical Community Hospital|Norman R. Anderson|570-222-2000|nanderson@evanhospital.com|
21251272|NCT00761956|Zimmer, Inc|Kacy Arnold, Associate Director, Clinical Affairs|574-371-8336|kacy.arnold@zimmer.com|
21251273|NCT01928693|Cornea Consultants of Nashville|Ira Shivitz MD|615-320-7200|jhatley@corneaconsultants.net|
21251274|NCT02022111|Emory University|Mohammed Kumail Ali, MD|404-727-9776|mkali@emory.edu|
21251275|NCT02808975|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21251276|NCT01288209|Janssen Pharmaceutical K.K., Japan|Manager|81 3 44115639||
21251277|NCT01379703|Abbott|Global Medical Services|1-800-633-9110||
21251278|NCT03463577|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21251279|NCT00236184|Eisai Medical Research Inc.|Yufang Lu, MD, PhD, Study Director|201-403-2500||
21251280|NCT01172639|University Hospitals Leuven|Prof. Dr. Patrick Verschueren|+32 16 34 25 41|patrick.verschueren@uzleuven.be|
21251281|NCT02172950|CSL Behring|Clinical Trial Disclosure Manager|use email contact|clinicaltrials@cslbehring.com|
21281882|NCT02266797|NYU Langone Medical Center|Michael Gerling|(718) 630-8600|Michael.Gerling@nyumc.org|
21281883|NCT00694473|Massachusetts General Hospital|Steven J Russell, M.D. PhD|617-726-8722|sjrussell@mgh.harvard.edu|
21281884|NCT01422889|Boston Scientific|Peter Maurer, MPH; Director, Clinical Trials|508-683-6678|Peter.Maurer@bsci.com|
21281885|NCT00086138|JHU|Paul Rosenberg|410-550-9883|prosenb9@jhmi.edu|
21281886|NCT02359955|Shanghai No. 9 People's Hospital|Dr. Haixin Qian|13501961651|drqian8167@126.com|
21281887|NCT02748356|MedStar Health Research Institute|Inger Ljungberg|202-877-1694|inger.h.ljungberg@medstar.net|
21281888|NCT01732458|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21281889|NCT03546491|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
21281890|NCT05107492|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21281891|NCT04331067|Washington University School of Medicine|Andrew Davis, M.D.|314-273-3581|aadavis@wustl.edu|
21281892|NCT02522884|Intact Vascular, Inc.|Joseph C. Griffin, III|4842531048|JGriffin@intactvascular.com|1043
21296531|NCT02017522|University of Michigan|Venkatesh Murthy, MD||vlmurthy@umich.edu|
21296532|NCT02596230|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21296533|NCT00771615|GlaxoSmithKline|GSK Response Center|866-435-7343||
21296534|NCT01854268|University of Florida|Alexandra E. Brandimore, M.A. CCC/SLP|352-273-3711|aessman@ufl.edu|
21251282|NCT01743521|Kirby Institute|A/Prof Gail Matthews|+61 (0)2 9385 0900|gmatthews@kirby.unsw.edu.au|
21296535|NCT04279613|Yale University|Dr. Kevan Herold|203-785-6507|kevan.herold@yale.edu|
21296536|NCT02704689|Stryker|Jennifer Warnke|(201) 749-8000|jennifer.warnke@stryker.com|
21296537|NCT00802893|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
21296538|NCT00320424|GlaxoSmithKline|GSK Response Center|866-435-7343||
21296539|NCT03123328|Masimo Corporation|Director, Clinical Research|949-297-7416|clinicalresearchdept@masimo.com|
21296540|NCT03270891|University of Michigan|Laurie Buis|734-998-5694|buisl@med.umich.edu|
21296541|NCT02540668|Eli Lilly and Company|Chief Medical Officer|800-545-5079||
21296542|NCT04051827|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21296543|NCT05779007|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
21296544|NCT01424566|GW Pharmaceuticals Ltd.|Medical Enquiries||medinfo.USA@gwpharm.com|
21296545|NCT00849108|Lantheus Medical Imaging|Cesare Orlandi, MD, Chief Medical Officer|978-671-8686|cesare.orlandi@lantheus.com|
21296546|NCT04909229|Yale University|Joseph Ross, MD, MHS|203-785-2987|joseph.ross@yale.edu|
21296547|NCT02484950|Rush University Medical Center|Brian Cole|(312) 432-2818|Brian.cole@rushortho.com|
21296548|NCT05147662|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
21296549|NCT00450073|Emory University|Vin Tangpricha|4047277254|vin.tangpricha@emory.edu|
21296550|NCT01100528|Cleveland Clinic, Case Comprehensive Cancer Center|Yogen Saunthararajah, MD|866-223-8100|CancerCenterResearch@ccf.org|
21296551|NCT02211313|Washington University School of Medicine|Alana Desai, M.D.|(314) 362-7581|desaia@wustl.edu|
21296552|NCT00551291|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21296553|NCT01943552|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21296554|NCT01177969|University of South Florida|Dr. Eric Storch|727-767-8230|estorch@health.usf.edu|
21296555|NCT01722435|Centre for Interdisciplinary Addiction research of Hamburg University ZIS|Prof. Dr. Jens reimer|+4940741057900|reimer@uke.de|
21296556|NCT01475162|Medical College of Wisconsin|William R. Drobyski|414-456-4941|wdrobysk@mcw.edu|
21296557|NCT00025155|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
21296558|NCT00552760|Lehigh Valley Hospital|Edward R. Norris, MD|(610) 402-5766|Edward.Norris@lvh.com|
21296559|NCT04079881|Wash Univ School of Medicine|Janet McGill, MD|(314) 362-8681|jmcgill@wustl.edu|
21296560|NCT03426631|Brigham and Women's Hospital|Luigi Taranto Montemurro, MD|6177326541|ltarantomontemurro@bwh.harvard.edu|
21296561|NCT00906958|ResMed Ltd|Alison Wimms|+44 7901332675|alison.wimms@resmed.com|
21296562|NCT04971941|Harvard School of Dental Medicine|Dr. Jeffry R Shaefer|(781) 718-6793|jeffry_shaefer@hms.harvard.edu|
21296563|NCT00710385|Substance Abuse|Sandra D. Comer|646-774-6146|sdc10@columbia.edu|
21296564|NCT01264770|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
21296565|NCT00129961|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21296566|NCT01325714|Houston Center for Innovations in Quality, Effectiveness, and Safety|Mark Kunik, MD, MPH|713-794-8639|kunik.marke@va.gov|
21296567|NCT01985360|NYU Langone Health|Sripal Bangalore|(212) 263 3540|Sripal.Bangalore@nyulangone.org|
21296568|NCT03691779|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21296569|NCT01102894|University of Minnesota|Dr. Joanne Slavin|612-624-7234|jslavin@umn.edu|
21296570|NCT00737633|Vivus, Inc|Wesley W Day, PhD|650-934-5200|day@vivus.com|
21296571|NCT02745535|Institute of Human Virology, University of Maryland|Dr. Eleanor Wilson|1(410)706-1710|eleanor.wilson@ihv.umaryland.edu|
21296572|NCT00440830|Columbia University|Pamela Flood, MD|212-305-2008|pdf3@columbia.edu|
21296573|NCT00377364|UT Southwetern Medical Center at Dallas|E.Sherwood Brown, M.D., Ph.D.|214-645-6950|Sherwood.Brown@utsouthwestern.edu|
21251283|NCT00704171|Covidien|Jennifer L. Doyle, Global Director of Clinical Affairs|781-839-1770|jennifer.doyle@covidien.com|
21251284|NCT00078728|The Johns Hopkins University School of Medicine|Golda Ginsburg, PhD,Professor|410-955-1544|gginnsbu@jhmi.edu|
21251285|NCT00913068|Capital District Health Authority|Dr. Ricardo A. Rendon|9024736604|rrendon@dal.ca|
21251286|NCT00813098|Lexicon Pharmaceuticals, Inc.|Clinical Project Manager|281-863-3000||
21251287|NCT04269434|Instituut van Tropische Geneeskunde Antwerpen|Dr. Chris Kenyon|+3232470786|ckenyon@itg.be|
21251288|NCT01777490|HSR&D/COIN, Durham VAHCS|Courtney Van Houtven|(919)286-6936|Courtney.VanHoutven@va.gov|
21251289|NCT01772563|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21251290|NCT00832000|University of Kansas Medical Center|Richard J. Barohn, MD|913-588-6095|rbarohn@kumc.edu|
21251291|NCT03045809|University of Liverpool|Prof. Janneke van de Wijgert, Chief Investigator|+447557195108|j.vandewijgert@liverpool.ac.uk|
21251292|NCT01898442|University of Florida - Jacksonville|Dominick J. Angiolillo, MD, PhD|9042443933|dominick.angiolillo@jax.ufl.edu|
21251293|NCT00255944|University of Colorado|Dr. Sheana Bull|3037241238|sheana.bull@ucdenver.edu|303
21251294|NCT03124550|Brandeis University|Dr. Margie E. Lachman|7817363255|lachman@brandeis.edu|
21251295|NCT01121913|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
21251296|NCT00690378|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
21251297|NCT03671239|University of Pennsylvania|Jose A. Bauermeister, PhD|215-898-9993|bjose@nursing.upenn.edu|
21251298|NCT00014222|Canadian Cancer Trials Group|Bingshu Chen|613-533-6000|bechen@ctg.queensu.ca|77703
21251299|NCT02019641|Clinical Center|Leighton Chan|+1 301 496 4733|chanle@mail.nih.gov|
21296574|NCT00716742|Allergan, Inc.|Vice President, Global Health Outcomes Strategy and Research|714-246-4500|clinicaltrials@allergan.com|
21296575|NCT02145351|Mayo Clinic|Barry A. Borlaug, M.D.|507-255-4152|Borlaug.Barry@mayo.edu|
21296576|NCT01548742|Minneapolis VA Medical Center|Kelvin O. Lim, MD (Principal Investigator)|612-467-3323|kolim@umn.edu|
21296577|NCT01345682|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21296578|NCT01075984|Merck Sharp & Dohme Corp.|Senior Vice President, Global Cllinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21296579|NCT03101085|University of Kansas Medical Center|Dr. Russell Swerdlow|913-588-0970|rswerdlow@kumc.edu|
21296580|NCT01154751|Abbott Vascular|Margo Zaugg|408-845-0576|margo.zaugg@av.abbott.com|
21296581|NCT02986854|GlaxoSmithKline|GSK Response Center|866-435-7343|mb116236@gsk.com|
21296582|NCT00491374|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
21296583|NCT01181674|McMaster University|Dr. Natalia McInnes (nee Yakubovich)|905-521-2100|natalia.mcinnes@mcmaster.ca|
21296584|NCT02409342|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21296585|NCT00279812|Institute of Food Research|Dr Charlotte Armah|01603 255 000|charlotte.armah@ifr.ac.uk|5360
21296586|NCT01274429|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director of the UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
21296587|NCT03907033|Mayo Clinic|Dr. Johnny Yi|480-342-0612|Yi.Johnny@mayo.edu|
21296588|NCT00007644|Minneapolis VA Medical Center|Timothy Wilt, MD|612-467-2158|timothy.wilt@va.gov|
21296589|NCT04576897|Indiana University|Samer Gawrieh|317-278-9326|sgawrieh@iu.edu|
21296590|NCT00527332|Deptartment of Obstetrics and Gynecology, University Hospital, Linköping, Sweden|Dr Preben Kjolhede|+46101030000|Preben.Kjolhede@lio.se|3187
21296591|NCT05498467|Department of Dermatology and Allergy - Herlev-Gentofte Hospital|Kelvin Yeung|38673243|kelvin.yeung@sund.ku.dk|0045
21296592|NCT02100475|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
21296593|NCT03109184|NORTHEASTERN UNIVERSITY|DR. CHRISTIE RIZZO|(617) 373-2486|C.RIZZO@NORTHEASTERN.EDU|
21296594|NCT02503501|HealthPartners Neuroscience Research|Clinical Research Manager|651-495-6363|aleta.l.svitak@healthpartners.com|
21296595|NCT01740401|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu|
21296596|NCT02806960|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21296597|NCT00321464|Amgen Inc.|Study Director|866-572-6436||
21296598|NCT01209078|GlaxoSmithKline|GSK Response Center|866-435-7343||
21296599|NCT02146001|University of Pittsburgh|Dr. Bethany Barone Gibbs|412-383-4002|bbarone@pitt.edu|
21296600|NCT02207491|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
21296601|NCT00126776|Minneapolis VAMC|Kathryn Rice MD|612 725 2000|kathryn.rice@va.gov|4400
21296602|NCT03603106|Guerbet|Jing Hao, MD|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
21296603|NCT00372697|Novartis Pharmaceuticals|Study Director|862 778-8300||
21296604|NCT03221842|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
21296605|NCT00448747|Aeterna Zentaris|Nicola Ammer|+496942602|nammer@aezsinc.com|3472
21296606|NCT00387725|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21296607|NCT00568126|Depression Clinical and Research Program, Massachusetts General Hospital|Dr. David Mischoulon, Director|617-724-5198|dmischoulon@partners.org|
21296608|NCT02692755|Georgetown University|Nicole Swanson|2026879194|ns1209@georgetown.edu|
21296609|NCT00527982|UT MD Anderson Cancer Center|Waun K. Hong, MD/Professor||CR_Study_Registration@mdanderson.org|
21296610|NCT01939366|Grünenthal GmbH|Study Director|+49 241 569 3223|Clinical-Trials@grunenthal.com|
21296611|NCT04724967|University of Miami|Robert Kirsner|305-689-2646|rkirsner@med.miami.edu|
21296612|NCT00007020|Retrophin, Inc.|Retrophin Medical Information|+1 8776595|medinfo@retrophin.com|518
21296613|NCT00548717|Dana Farber Cancer Institute|Dr. Corey Cutler|617-632-3470|Corey_Cutler@dfci.harvard.edu|
21296614|NCT02712424|Geisel School of Medicine|Dr C Fordham von Reyn|6036505000|fvr@dartmouth.edu|
21296615|NCT01395277|University of Texas at Austin|Dr. R. Matthew Brothers|512-232-6016|r.m.brothers@austin.utexas.edu|
21296616|NCT05375214|Johns Hopkins University|Kevin Li|443-475-0671|kevinli@jhmi.edu|
21296617|NCT02809053|Archigen Biotech Ltd|Medical Director|+44 (0)20 3749 5000|info@archigenbio.com|
21296618|NCT02411929|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21296619|NCT00628147|SF VA Medical Center|Dr. Tonya Kaltenbach|415-221-4810|tonya.kaltenbach@va.gov|24103
21296620|NCT02636712|Zhongshan Hospital|Dr Yangang Su|+86 13788905096|suyangang111@163.com|
21296621|NCT00908037|GlaxoSmithKline|GSK Response Center|866-435-7343||
21296622|NCT02565810|Samsung Bioepis Co., Ltd.|Director of Clinical Trials||sbregistry@samsung.com|
21296623|NCT02358044|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21296624|NCT02768753|General Hospital of Jinan Military Area|Dr.Qing Qing He，Dr.Gao Feng Ni|15653853675|m15653853675@163.com|
21296625|NCT02723175|Medical University of South Carolina|Jeffrey Borckardt|843-792-3295|borckard@musc.edu|
21296626|NCT04596085|Natural Supplements LLC|Dr. Mahir Abduldaim|+966557880299|maherdaim@yahoo.com|
21296627|NCT00491608|ZymoGenetics, a Bristol-Myers Squibb company|John Pribble, Vice President, Medical Affairs; Scot Maxon, Scientific Information|(206) 428-2756; (206) 434-3365|John.Pribble@bms.com; Scot.Maxon@bms.com|
21296628|NCT04897607|Christiana Care Health System|Dr. Scott Siegel|302-623-4500|ssiegel@christianacare.org|
21296629|NCT03781791|Enterin|Richard Larson, MD Chief Medical Officer|505-469-2670|r.larson@enterininc.com|
21296630|NCT03022981|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21296631|NCT01944345|Wenzel Spine, Inc.|Director, Quality & Regulatory Affairs|5123148271|bnowatzke@wenzelspine.com|
21296632|NCT03615066|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21296633|NCT00924404|University of Iowa|Lakshmi Durairaj|319-353-7968|lakshmi-durairaj@uiowa.edu|
21281893|NCT04495751|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-713-5440|hklepin@advocatehealth.org|
21281894|NCT03289754|restor3d, Inc.|Director of Clinical Affairs|(984) 888-0593|clinicalresearch@restor3d.com|
21281895|NCT04873934|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21281896|NCT01934582|United Therapeutics Corp.|Global Medical Information|919-425-8350|clinicaltrials@unither.com|
21281897|NCT02438423|Georgia Tech|Mark Prausnitz, PhD|404-894-5135|prausnitz@gatech.edu|
21281898|NCT00314327|NSLIJ|Delbert Robinson, M.D.|718-470-8195|Drobinson@nshs.edu|
21281899|NCT02134015|Daiichi Sankyo, Inc.|Global Clinical Leader|9089926400|DataSharing@dsi.com|
21281900|NCT04722315|Kennedy Krieger Institute|Dr. Jacqueline Harris|6672054295|harrisjac@kennedykrieger.org|
21281901|NCT03868930|VA Boston Healthcare System|Dr. Catherine B. Fortier|857-364-4361|Catherine.Fortier@va.gov|
21281902|NCT06047366|Indiana University School of Dentistry|Dr. Ken Spolnik|317-274-7280|kspolnik@iu.edu|
21281903|NCT02151851|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
21281904|NCT02640950|Sheppard Pratt Health System|Director of Clinical Research|4109383125|saaronson@sheppardpratt.org|
21281905|NCT00652626|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
21281906|NCT05336630|Dartmouth-Hitchcock Medical Center|Dr. Timothy B. Gardner|603-653-9033|timothy.b.gardner@hitchcock.org|
21281907|NCT00356603|GlaxoSmithKline|GSK Response Center|866-435-7343||
21281908|NCT00932373|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
21281909|NCT02273063|Neuromodulation Research Clinic|Director|401-455-6200|Linda_Carpenter_MD@Brown.edu|
21281910|NCT05125848|Zynex Monitoring Solutions|ZMS Clinical|(800) 495-6670|clinical@zynexmonitoring.com|
21281911|NCT04134767|Rollins School of Public Health at Emory University|Dr. Hannah LF Cooper|404-727-0261|hcoope3@emory.edu|
21281912|NCT02582242|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21281913|NCT00638404|Wake Forest School of Medicine-Anesthesiology|Peter H. Pan MD, MSEE|336-718-8278|ppan@wakehealth.edu|
21281914|NCT00603902|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
21281915|NCT02101736|The University of Alabama at Birmingham|Karen Cole-Plourde, Program Director -NFCTC|(205) 514-1317|kplourde@uab.edu|
21281916|NCT02282631|Institute of Health and Society, Newcastle University|Dr Samuel Ginja|+44191208|samuel.ginja@newcastle.ac.uk|4565
21281917|NCT00459290|Gynecologic Oncology Group Statistical and Data Center|Jessalyn Reboy|716-845-7738|ReboyJ@nrgoncology.org|
21281918|NCT01841762|Actelion Pharmaceuticals US, Inc.|Scott Tsurutani / Associate Director, Clinical Operations|6508086586|scott.tsurutani@actelion.com|
21281919|NCT05483686|ISA Associates, Inc.|Dr. Samantha Leaf|703-739-0880|sleaf@isagroup.com|4
21281920|NCT05780983|Wake Forest University Health Sciences|Jaime M Hughes, PhD, MPH, MSW|336-716 -0835|jane.hughes@wfusm.edu|
21281921|NCT01017874|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21281922|NCT02509507|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21281923|NCT01954056|University of New Mexico|Dr. Kristi Watterberg|505-272-8609|KWatterberg@salud.unm.edu|
21281924|NCT02110758|National Committee for Quality Assurance|Sarah Hudson Scholle|202-955-1726|scholle@ncqa.org|
21281925|NCT02074358|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
21281926|NCT03337113|Kent State University|William Lechner|814-450-1093|wlechner@kent.edu|
21281927|NCT00725153|Alcon Research, Ltd.|Jessie Lemp, MS|817-615-2739|Jessie.Lemp@alconlabs.com|
21281928|NCT03070600|University of Washington|Grace John-Stewart|206-543-4278|gjohn@uw.edu|
21281929|NCT01483963|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
21281930|NCT06110494|University of Pennsylvania|Dr. Bekir Karabucak Chair of the Department of Endodontics|215-898-4927|bekirk@upenn.edu|
21281931|NCT00105079|Hoffman-LaRoche|Medical Communications|800-821-8590||
21281932|NCT02182115|University of Minnesota|Dr. Susan Kline|612-626-3662|kline003@umn.edu|
21281933|NCT01464593|Celsion Corporation|Chief Medical Officer|609-896-9100|nborys@celsion.com|
21281934|NCT01297517|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
21281935|NCT00775229|University of Chicago|Dr. Jon Grant|773-834-1325|jongrant@uchicago.edu|
21281936|NCT00386360|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
21281937|NCT01163851|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21281938|NCT00789373|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21281939|NCT02461966|Tanta university|Sherief Abd-Elsalam|00201095159522|sherif_tropical@yahoo.com|
21281940|NCT04938180|AmMax Bio., Inc.|Dorothy Nguyen, MD|(650)285-6560|clinical@ammaxbio.com|
21281941|NCT04332081|NYU Langone|David Lee|212-263-3293|David.lee@nyulanogne.org|
21281942|NCT05343364|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-7428|medicalinformation@phathompharma.com|
21281943|NCT01753570|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
21281944|NCT01791894|Stanford University School of Medicine, Department of Dermatology|Jean Y Tang MD PhD|650-721-7149|baileyhi@stanford.edu|
21281945|NCT05870371|Musculoskeletal Research Laboratory (MRL) of Physiotherapy Department University of West Attica, Athens, Greece|Dr. George Georgoudis|+30-210-5387487|physiolab@uniwa.gr|
21281946|NCT05630287|Eli Lilly and Company|Chief Medical Officer|8005955979|ClinicalTrials.gov@lilly.com|
21281947|NCT04873869|Neurocrine Biosciences|Neurocrine Medical Information|+1 877-641-3461|medinfo@neurocrine.com|
21281948|NCT01873846|Bausch Health Americas, Inc|Robert Steffen||Robert.Steffen@bausch.com|
21281949|NCT02555228|MOHH Holdings|Dr Song Mingjun|86337635|mingjun.song0950c@gmail.com|
21281950|NCT02062450|TORNIER SAS|Nathalie TRETOUT|+33 4 76 71 35 00|nathalie.tretout@tornier.com|
21296634|NCT02437084|Stanford University School of Medicine|Dr Joshua W. Knowles, MD, PhD; Assistant Professor, Cardiovascular Medicine|650-723-1431|knowlej@stanford.edu|
21296635|NCT00587847|North Shore-Long Island Jewish Health System|Kanti Rai, MD|(718) 470-4050|krai@nshs.edu|
21296636|NCT00343382|Mayo Clinic|Dr. Charles L. Loprinzi|507-284-1623|cloprinzi@mayo.edu|
21296637|NCT04032080|Baylor Scott & White Health|Joyce O'Shaughnessy, MD|214-818-8472|joyce.oshaughnessy@usoncology.com|
21296638|NCT03945019|CELLTRION, Inc.|Head of Clinical Planning|+82-32-850-4160|YunJu.Bae@celltrion.com|
21296639|NCT01462877|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
21296640|NCT02337725|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
21296641|NCT00721175|Khon Kaen University|Assist. Prof. Apichat Sangchan|66850004651|apichaz@yahoo.com|
21296642|NCT03294629|Sleep Center, Taoyuan Chang Gung Memorial Hospital|Ning-Hung, Chen|+886-3-3281200|ninghung@yahoo.com.tw|2281
21296643|NCT04040621|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
21296644|NCT00845065|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21296645|NCT00181610|Massachusetts General Hospital|Corrine Welt, MD|617-726-8437|cwelt@partners.org|
21296646|NCT02228096|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21296647|NCT02265796|Malcom Randall VA Medical Center|Dr. Anthony Bavry|352-376-1611|anthony.bavry@va.gov|6325
21296648|NCT02208349|St Vincent Hospital|Jestin Carlson|8144525000|jcarlson@svhs.org|
21296649|NCT00952614|Duke University Medical Center|Glenn J. Jaffe, MD|919-684-4458|jaffe001@mc.duke.edu|
21296650|NCT01599741|Philips|Thijs Grunhagen|+31 6 11645166|thijs.grunhagen@philips.com|
21296651|NCT00569868|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|5015266990|pettynathanm@uams.edu|2461
21296652|NCT02530996|Salt Lake VAMC and University of Utah|Dr. Tracy Frech|801 213 2312|tracy.frech@hsc.utah.edu|
21296653|NCT01624090|National Cancer Institute|Dr. David S. Schrump|240-858-7000|schrumpd@nih.gov|
21296654|NCT01403116|Clarus Therapeutics|Theodore Danoff, MD, PhD|847-562-4300|tdanoff@clarustherapeutics.com|
21296655|NCT01895309|Samsung Bioepis|Director, Clinical Development|+82 31 8061 4534||
21296656|NCT00042666|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21296657|NCT02454153|Johns Hopkins University|Naresh M. Punjabi|410-550-6487|npunjabi@jhmi.edu|
21296658|NCT01555125|Novartis Pharmaceutical|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
21296659|NCT04268745|New York University|Dr. Anat Lubetzky|2129989195|anat@nyu.edu|
21296660|NCT01086852|Bio Products Laboratory|Miranda Norton|020 8 957 2661|miranda.norton@bpl.co.uk|
21296661|NCT00896441|Stanford University|Mike Greicius|650-723-8331|greicius@stanford.edu|
21296662|NCT05327361|University of Miami|Enzo Berardesca|3052434472|exb743@med.miami.edu|
21296663|NCT00626405|Mayo Clinic|Svetomir Markovic, M.D., Ph.D.|5072840527|markovic.svetomir@mayo.edu|
21296664|NCT01174173|Northwestern University|Sanjiv J. Shah, MD|3129262926|sanjiv.shah@northwestern.edu|
21296665|NCT02107157|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
21296666|NCT05856227|Basilea Pharmaceutica International Ltd, Allschwil|Marc Engelhardt, MD, Study Director|+41 79 701 0551|marc.engelhardt@basilea.com|
21296667|NCT05011058|Viracta Therapeutics|Dr. Darrel Cohen|858-400-8470|ClinicalTrials@Viracta.com|
21296668|NCT01272869|Coloplast A/S|Director Medical Affairs|4549111111|dkbir@coloplast.com|
21296669|NCT01571232|Retina Macula Institute|Ron P. Gallemore M.D., Ph.D.|310-944-9393|rongallemoremd@gmail.com|
21296670|NCT02455076|Emory University|Guillermo Umpierrez|(404)778-1665|geumpie@emory.edu|
21296671|NCT03908476|Abbott|Marie Fahey|+15122864398|Marie.fahey@abbott.com|
21296672|NCT05194267|UCSD|Jean-Phillipe Miron|514-890-8000|jmiron@health.ucsd.edu|26489
21296673|NCT02868229|Novo Nordisk A/S|Clinical Transparency and Medical Writing Office|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21296674|NCT06151288|Vaxcyte, Inc.|Study Director: Clinical Development|650-585-0029|clinicaltrialsgov@vaxcyte.com|
21296675|NCT00759408|Brigham and Women's Hospital|Anju Nohria, MD|617-525-6852|ANOHRIA@PARTNERS.ORG|
21296676|NCT00687102|Wake Forest University Health Sciences|Sally A. Shumaker, PhD|336-71696934|sshumake@wakehealth.edu|
21296677|NCT02251938|Santen Inc|R&D Quality Manager|+1 415 268 9199|evelyn.chikere@santen.com|
21296678|NCT06225466|University of Texas Southwestern Medical Center|Dr. Proshad Efune|2144566393|proshad.efune@utsouthwestern.edu|
21296679|NCT06328660|CooperVision Inc.|José A. Vega|+1 (925) 621-3761|JVega2@coopervision.com|
21296680|NCT03194438|State University of New York at Buffalo School of Nursing|Tania Von Visger, APRN, PhD, PCCN|7168292201|Taniavon@buffalo.edu|
21296681|NCT04394715|Yale University|Nihar Desai|203-767-6399|nihar.desai@yale.edu|
21296682|NCT02708485|USherbrooke|Stephen Cunnane|1-819-780-2220|Stephen.Cunnane@USherbrooke.ca|45670
21296683|NCT00231413|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21296684|NCT01646203|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21296685|NCT01659255|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
21296686|NCT01423916|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
21296687|NCT03316950|UT Southwestern|Research Coordinator|214-645-8907|jennifer.barillas@utsouthwestern.edu|
21296688|NCT02717130|Thriving Mind South Florida|John W. Newcomer, M.D., President & CEO|305-860-0653|jnewcomer@thrivingmind.org|
21296689|NCT02435706|Columbia University College of Dental Medicine|Elena Sanz Miralles, DDS, PhD|212-342-3008|ecs2181@cumc.columbia.edu|
21296690|NCT02294734|GlaxoSmithKline|GSK Response Center|866-435-7343||
21296691|NCT02335424|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21296692|NCT03847909|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
21296693|NCT01147900|GlaxoSmithKline|GSK Response Center|866-435-7343||
21296694|NCT00903331|Actelion Pharmaceuticals Ltd|Parisa Danaietash||parisa.danaietash@actelion.com|
21296695|NCT03249103|Aptinyx|Aptinyx Clinical Development|847-871-0377|clinicalstudies@aptinyx.com|1
21296696|NCT04109976|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
21296697|NCT00257660|Ipsen|Senior Director, Medical Development, Neurology||clinical.trials@ipsen.com|
21296698|NCT01407523|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
21296699|NCT01600092|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21296700|NCT02976103|Dana-Farber Cancer Institute|Donna Berry, PhD, RN|617-632-1909|donna_berry@dfci.harvard.edu|
21296701|NCT02914561|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
21296702|NCT00084487|Case Comprehensive Cancer Center|Afshin Dowlati MD|216-844-1228|afshin.dowlati@uhhospitals.org|
21296703|NCT03074682|Yale University|Dr. Marc Auerbach|203-688-3333|marc.auerbach@yale.edu|
21296704|NCT00412074|Medical University of South Carolina|Carol Wagner|18437922112|wagnercl@musc.edu|
21296705|NCT01561963|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21296706|NCT04598269|Aclaris Therapeutics, Inc.|Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
21296707|NCT01848366|William Beaumont Hospital|Dr. Kenneth Peters|248-551-0387|Kenneth.Peters@Beaumont.org|
21296708|NCT04018313|Celltrion. Inc|Keumyoung Ahn/Head of Clinical Planning 2 Department|+82 32 850 4190|Keumyoung.ahn@celltrion.com|
21296709|NCT00509171|London Health Sciences Centre|Emil H. Schemitsch, MD, FRCS|5196633349|emil.schemistch@lhsc.on.ca|
21296710|NCT03040986|National Cancer Institute|Dr. Udo Rudloff|240-760-6238|udo.rudloff@nih.gov|
21296711|NCT02383433|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Davendra Sohal|+1 216-444-8258|sohald@ccf.org|
21296712|NCT02477553|Indiana University|Peter H. Schwartz, M.D., Ph.D.|317-278-4037|phschwar@iu.edu|
21296713|NCT00803062|NRG Oncology Statistics and Data Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
21296714|NCT04023682|University of Iowa Hospitals and Clinics|Sundara Reddy, MBBS|(319) 356-2108|sundarareddy-durgempuditripura@uiowa.edu|
21296715|NCT04042727|Stony Brook University|Andreas KAlogeropoulos|4045124463|Andreas.Kalogeropoulos@stonybrookmedicine.edu|
21296716|NCT01181258|Masonic Cancer Center, University of Minnesota|Dr. Veronika Bachanova|612-625-5469|bach0173@umn.edu|
21296717|NCT03385330|Children's Hospital of Philadelphia|Dr. Sara DeMauro|445-225-6400|demauro@chop.edu|
21296718|NCT00695864|Stanford University|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@pain.stanford.edu|
21296719|NCT00375167|Queens University|Dr. Terry Krupa|613-533-6236|terry.krupa@queensu.ca|
21296720|NCT04484207|New York State Psychiatric Institute|Yuval Y. Neria|646-774-8092|ny126@cumc.columbia.edu|
21296721|NCT00772109|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21296722|NCT00752726|GlaxoSmithKline|GSK Response Center|866-435-7343||
21296723|NCT04232215|Mayo Clinic|Yvonne S. Butler Tobah, M.D.|507-284-0210|ButlerTobah.Yvonne@mayo.edu|
21296724|NCT00410605|Univerisity of Wisconsin Carbone Cancer Center|Dr. Natalie Callander|608-265-8690|nsc@medicine.wisc.edu|
21296725|NCT04836247|University of Delaware|Valerie Earnshaw|302-831-4772|earnshaw@udel.edu|
21296726|NCT01887353|Intermountain Healthcare|T. Jared Bunch|8015074701|jared.bunch@imail.org|
21296727|NCT02039856|VA Greater Los Angeles Healthcare System|Elizabeth M. Yano, PhD, MSPH|(818) 891-7711|elizabeth.yano@va.gov|36031
21296728|NCT00602420|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
21296729|NCT01735981|The Ohio State University|Anne Kloos|614-688-5942|kloos.4@osu.edu|
21296730|NCT00592124|Johns Hopkins University|Craig W. Hendrix, MD|1 410 955-9707|chendrix@jhmi.edu|
21296731|NCT00649428|CBR International Corp.|Kevin Hennegan|720-746-1190|khennegan@cbrintl.com|
21296732|NCT02315560|University of Pittsburgh|Dr. Heidi Stephany|412-692-7932|heidi.stephany@chp.edu|
21296733|NCT02008227|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
21296734|NCT04599465|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21296735|NCT00742417|Instituto Grifols S.A.|Mireia Torres|+34935710500|mireia.torres@grifols.com|12273
21296736|NCT00627367|Department of Emergency Medicine, Albert Einstein College of Medicine|Andrew Chang, MD, MS|718-920-7464|achang@montefiore.org|
21296737|NCT00258817|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
21296738|NCT00965575|Cincinnti Childrens|Sejal Jain|513-636-4222|sejal.jain@cchmc.org|
21296739|NCT00757822|Central Arkansas Veterans Healthcare System|Dr. Muhammad Jaffar|501-688-9310|Muhammad.Jaffar@va.gov|
21296740|NCT01041287|Emory University|Dr. Arshed Quyyumi|404-727-3655|aquyyum@emory.edu|
21296741|NCT01557959|Wake Forest Baptist Health|Dr. William J. Petty|336-716-3313|wpetty@wakehealth.edu|
21296742|NCT03157583|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21296743|NCT01141478|Loma Linda University Medical Center|Diane Scavone, research coordinator|909 558-3636|dscavone@llu.edu|33670
21296744|NCT03096873|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
21296745|NCT05236712|Univcersity of Washington|Oleg Zaslavsky|2068493301|ozasl@uw.edu|
21296746|NCT00290498|U.T. MD Anderson Cancer Center|Dr. Luis E. Fayad / Lymphoma/Myeloma|7137922860|lefayad@mdanderson.org|
21296747|NCT04122170|SFJ Pharmaceuticals, Inc.|Michele LaRussa SVP, Chief Regulatory Officer|925-223-6233|Bentracimab.General@SFJ-Pharma.com|
21296748|NCT00490022|University of Washington|Dr. Stephanie Page, PhD, MD|206.616.0483|page@u.washington.edu|
21296749|NCT04268173|University of Wisconsin-Madison|Dr. Ryan Westergaard|(608) 265-7927|rpw@medicine.wisc.edu|
21296750|NCT00869401|Mayo Clinic|Nadia Laack M.D.|5072844561|laack.nadia@mayo.edu|
21296751|NCT00545103|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
21296752|NCT01953913|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21296753|NCT05026853|University of Michigan|Dr. Dinesh Khanna|734-763-7182|khannad@med.umich.edu|
21296754|NCT01732913|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21296755|NCT01353911|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21296756|NCT03233438|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
21296757|NCT02219503|AbbVie|Global Medical Services|800-633-9110||
21296758|NCT02925741|Cleveland Clinic|Mary Montague|216-444-1878|montagm@ccf.org|
21296759|NCT02025439|Edward Hines VA Hospital|Theresa Bender-Pape|708-202-4953|Theresa.BenderPape@va.gov|
21296760|NCT00413374|Brigham and Women's Hospital|Research Coordinator|617-732-6984|arao2@partners.org|
21296761|NCT03286283|Apyx Medical (formerly Bovie Medical Corporation)|Shawn Roman/Vice President of Research and Development|1-727-384-2323|shawn.roman@apyxmedical.com|
21296762|NCT01786252|Michigan State University|Dr. Asgerally Fazleabas|(517) 884-6031|asgi@hc.msu.edu|
21296763|NCT02345330|OncoSec Medical Incorporated|Sharron E Gargosky, Chief Clinical Regulatory Officer|+1 858-255-4729|ClinicalTrialsInfo@OncoSec.com|
21296764|NCT00494507|University of Rochester|Robert Griggs, MD|585-275-3707|robert_griggs@urmc.rochester.edu|
21296765|NCT04882787|Sonova|Jinyu Qian, Director Innovation Centre Toronto|905-677-1167|jinyu.qian@sonova.com|5873
21296766|NCT03831945|National Institute of Allergy and Infectious Diseases|Sneller, Michael|+1 301 496 0491|MSNELLER@niaid.nih.gov|
21296767|NCT00295932|Memorial Sloan Kettering Cancer Center|Dr. Carol Portlock|212-639-8109|portlocc@mskcc.org|
21296768|NCT00454181|Amarillo Biosciences, Inc.|Martin J. Cummins|806-376-1741|mcummins@amarbio.com|14
21296769|NCT02613169|University of Washington|Dr. Sylvia M. LaCourse|206-616-5978|sylvial2@uw.edu|
21296770|NCT03729245|Nektar Therapeutics|Study Director|4154825300|StudyInquiry@nektar.com|
21296771|NCT00884832|Mayo Clinic|Dr. Adil E. Bharucha|507-266-9156|bharucha.adil@mayo.edu|
21296772|NCT02096263|GlaxoSmithKline|GSK Response Center|866-435-7343||
21296773|NCT03098745|CooperVision Inc.|Dr.Jose A.Vega O.D., MSc., FAAO|9256213761|javega@coopervision.com|
21296774|NCT00141115|New York State Psychiatric Institute|John J. Mariani|2125435987|jm2330@columbia.edu|
21296775|NCT00500760|Amgen Inc.|Study Director|866-572-6436||
21296776|NCT03178669|InDex Pharmaceuticals|Karin Arnesson, Clinical Trial Manager|+46 8 122 038 57|karin.arnesson@indexpharma.com|
21296777|NCT00614484|Professor of Radiation Medicine, Loma Linda University Medical Center|David Bush MD|909-558-4280|dbush@llu.edu|
21296778|NCT00079677|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
21296779|NCT01300455|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21296780|NCT03332160|Tactile Medical|Heather Smith|612.800.5539|HSmith@tactilemedical.com|
21296781|NCT01008969|University of California, San Francisco|Youngho Seo, PhD|415-353-9464|youngho.seo@ucsf.edu|
21296782|NCT01008462|Fred Hutchinson Cancer Research Center|Dr. Mohamed L. Sorror|(206) 667-6298|msorror@fredhutch.org|
21296783|NCT01459913|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
21296784|NCT01915823|Meda Pharmaceuticals|Dr.Nancy Ruiz,MD|7325642390|nancy.ruiz@meda.us|
21296785|NCT00454649|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21296786|NCT02925728|Centre Hospitalier Départemental Vendée|Sylvie VERBRUGGHE|0251446161|sylvie.verbrugghe@ght85.fr|
21296787|NCT00971295|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
21296788|NCT00086411|University of Pennsylvania|Peter Gariti, Ph.D.|215-222-3200|gar1iti@mail.med.upenn.edu|0
21296789|NCT00718770|University of Colorado School of Medicine|Joshua Klopper, MD|303-724-3921|joshua.klopper@ucdenver.edu|
21296790|NCT00988364|Baylor College of Medicine|Dr. Chu-Huang Chen|832-355-9026|chu-huang.chen@bcm.edu|
21296791|NCT00609739|Masonic Cancer Center, University of Minnesota|Margaret MacMillan, M.D.|612-626-2778|macmi002@umn.edu|
21281951|NCT01014169|Boston University School of Medicine/Boston Medical Center|Dr Caroline Kistin|617-414-3642|caroline.kistin@bmc.org|
21281952|NCT02589639|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21281953|NCT00708461|University of Minnesota|Jennifer A. Linde, Ph.D.|612-624-0065|linde074@umn.edu|
21281954|NCT03584854|University of Chicago|Dr. Naida Cole|773-702-6700|nmcole@bsd.uchicago.edu|
21281955|NCT02968173|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21281956|NCT01099618|Emory University SOM|Dawn Smiley|4047781665|dsmiley@emory.edu|
21281957|NCT00953654|The University of Georgia|Matthew P. Herring, PhD|706-542-4381|mph8@uga.edu|
21281958|NCT00153179|Brigham and Women's Hospital|Mark A. Creager|603-650-8283|Mark.A.Creager@hitchcock.org|
21281959|NCT01408303|AstraZeneca Pharmaceuticals|Torbjörn Lundström||ClinicalTrialTransparency@astrazeneca.com|
21281960|NCT01207687|Johns Hopkins Comprehensive Neurofibromatosis Center|Dr. Jaishri Blakeley|410-614-3853|jblakel3@jhmi.edu|
21281961|NCT01801865|Cincinnati Children's Hospital Medical Center|Dr. Beth Kline-Fath|(513) 636-1856|beth.kline-fath@cchmc.org|
21281962|NCT01022307|VANCHCS|David L. Woods, Chief Clinical Neurophysiology|925-372-2571|David.Woods@va.gob|
21281963|NCT03867201|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21281964|NCT04138498|Cingulate Therapeutics|VP of Clinical Operations and Regulatory Affairs|913-942-2304|hmitzel@cingulatetherapeutics.com|
21281965|NCT05763875|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
21296792|NCT02540291|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
21296793|NCT01304589|University of Tennessee Health Science Center|Dr. Candace Brown|901-412-4341|csbrown@uthsc.edu|
21296794|NCT01441466|Princess Amlia Children's Clinic, Isala|Jolita Bekhof|+31384245050|j.bekhof@isala.nl|
21296795|NCT02048371|SARC|SARC|734-930-7600|sarc@sarctrials.org|
21296796|NCT02423980|Xeris Pharmaceuticals, Inc.|Martin Cummins, VP Drug Development|512-498-2675|mcummins@xerispharma.com|
21296797|NCT01879072|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
21296798|NCT02108691|Hanyang University|Dr. Yongsoon Park|82-2-2220-1205|yongsoon@hanyang.ac.kr|
21296799|NCT01776723|H Lee Moffitt Cancer Center & Research Institute|Eric Padron, MD|813-745-3907|Eric.Padron@Moffitt.org|
21296800|NCT02933502|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
21296801|NCT04667104|Janssen Research & Development, LLC|Clinical Registry Group|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21296802|NCT02666105|University of Minnesota|Manish Patel, DO|612-625-2654|patel069@umn.edu|
21296803|NCT01078168|Clinic of Psychiatry and Psychotherapy, University Medical Center JGU Mainz|Prof. Dr. Andreas Fellgiebel|+49-6131-17-7363|Andreas.Fellgiebel@unimedizin-mainz.de|
21296804|NCT02147769|Stanford University|Valerie Chock, MD|650-723-5711|vchock@stanford.edu|
21296805|NCT01264419|Silk Road Medical, Inc.|Richard Ruedy, Exec VP Clinical Affairs|408-828-7281|ric@silkroadmed.com|
21296806|NCT01962870|Stanford University|Antonio Hardan, MD|(650) 736-1235|hardanay@stanford.edu|
21296807|NCT01178268|Abbott Vascular|Dana Haudek|928-925-4054|dana.haudek@av.abbott.com|
21296808|NCT01593592|Tropical Medicine Departement, Faculty of Medicine, Zagazig University, Egypt|Dr Mohamed Emara|+2 0100 272 4482|emara_20007@yahoo.com|
21296809|NCT02814175|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21296810|NCT03335774|Nivagen Pharmaceuticals|Dr Vishal S Narang|+919820020278|vnarang@nivagen.com|
21296811|NCT05126836|University of Minnesota|Dr. Markus Meyer|612.625-9538|meye3249@umn.edu|
21296812|NCT01971008|Innsbruck Medical University|Prof. Dr. Klaus Seppi|004351250481498|klaus.seppi@tirol-kliniken.at|
21296813|NCT00924508|UCSF|John Koo, MD|415-476-6281|john.koo@ucsfmedctr.org|
21296814|NCT03775512|Biosense Webster, Inc.|Franchise Medical Manager|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
21296815|NCT03679624|Weill Cornell Medicine|Dr. John Allan, Associate Professor of Medicine|2127463481|joa9069@med.cornell.edu|
21296816|NCT01610336|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21296817|NCT02629822|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21296818|NCT01912339|Boston Scientific Corporation|Kevin Hagelin, Clinical Program Manager|(800) 328-3881|kevin.hagelin@bsci.com|
21296819|NCT00741013|Washington University School of Medicine|Delphine L. Chen|314-362-7029|chend@mir.wustl.edu|
21296820|NCT00856726|University of Alabama at Birmingham|Orlando Gutierrez|205-996-2736|ogutierrez@uabmc.edu|
21296821|NCT00082407|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21296822|NCT03464019|Milestone Pharmaceuticals Inc.|Cameron Szakacs_PhD_VP Drug Development|1 704-594-4102|cszakacs@milestonepharma.com|
21296823|NCT01754493|New York State Psychiatric Institute|Roberto Lewis-Fernandez|646-774-8102|rlewis@nyspi.columbia.edu|
21251300|NCT00937521|Novartis Vaccines|Novartis Vaccines||RegistryContactVaccinesUS@novartis.com|
21296824|NCT00767806|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21296825|NCT02489942|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0217|clintriage.rdg@boehringer-ingelheim.com|
21296826|NCT00858208|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21296827|NCT01272635|Penn State University|David Mauger|717-531-7178|dtm5@psu.edu|
21296828|NCT04996251|Northwell Health (previously) now at Advocate Aurora Health|Dr. Vini Chopra Konowitz|859-905-8782|vinichopra924@gmail.com|
21296829|NCT01543776|University of Chicago|Theodore Karrison|773-702-9326|tkarrison@health.bsd.uchicago.edu|
21296830|NCT00306527|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
21296831|NCT02702180|Savara Inc|Raymond D. Pratt, MD, PACP - Chief Medical Officer|+1 512 784 8757|ray.pratt@savarapharma.com|
21296832|NCT00785980|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
21296833|NCT00417963|C.R. Bard Inc.|Director of Clinical Affairs|480-303-2644|john.reviere@crbard.com|2644
21296834|NCT01815840|Hoffmann-La Roche|Medical Communications|800 821-8590||
21296835|NCT00704288|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
21296836|NCT01055314|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
21296837|NCT02241343|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
21296838|NCT04680975|Sanofi (Kadmon, a Sanofi Company)|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21296839|NCT03927144|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21296840|NCT03909152|Memorial Sloan Kettering Cancer Center|Dr. Rachel Grisham, MD|646-888-4653|grishamr@mskcc.org|
21296841|NCT05346653|University of Chicago|Sr. Compliance Specialist|773-702-6505|czwieg@bsd.uchicago.edu|
21296842|NCT03858530|Children's Mercy Kansas City|Dr. Sherwin Chan|816-234-3273|sschan@cmh.edu|
21296843|NCT01463072|City of Hope|Dr. Mina Sedrak|626-359-8111|msedrak@coh.org|
21296844|NCT02702414|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21296845|NCT02917733|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21296846|NCT04099511|University of Missouri|Dr. Gregory Petroski|(573) 884-2119|petroskig@health.missouri.edu|
21296847|NCT04369950|The University of Texas Health Science Center at Houston|Linden Lee, MD, Assistant Professor|(713) 500-6200|Linden.O.Lee@uth.tmc.edu|
21296848|NCT02473367|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21296849|NCT04816721|Enanta Pharmaceuticals, Inc.|Medical Monitor|+1 6176070800|enquiries@enanta.com|
21296850|NCT02466009|University of Rochester|Aram Hezel|585-275-5823|Aram_Hezel@urmc.rochester.edu|
21296851|NCT02176161|NYU Langone Health|Aaron Katz, MD|516-535-1900|Aaron.Katz@nyulangone.org|
21296852|NCT01286740|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21296853|NCT04676867|DalCor Pharmaceuticals|David Kallend|+1 514-508-5099|dkallend@dalcorpharma.com|
21296854|NCT02387294|Fluart Innovative Vaccines Ltd|Zsolt Németh|+3620|info@fluart.hu|4197020
21296855|NCT00997620|Westernsky|Lyndon E Mansfield, MD|915-544-2557|immunman@westernskymed.com|
21296856|NCT01554514|Washington University|Dr. Elaine Majerus|314-362-8866|emajerus@wustl.edu|
21251301|NCT00468130|Rutgers University|Sherie Novotny, MD|7322354119|novotnsl@ubhc.rutgers.edu|
21296857|NCT02903394|Duke University|Kengyeh Chu|919-681-2093|ken.chu@duke.edu|
21296858|NCT00549770|Novartis Pharmaceuticals|Study Director|862-778-8300||
21296859|NCT00847015|Memorial Sloan Kettering Cancer Center|Dr. M. Catherine Pietanza|646-888-4203|pietanzm@mskcc.org|
21296860|NCT03222414|Vanderbilt University Medical Center|Laura Sorabella||laura.sorabella@vumc.org|
21296861|NCT03957876|Cleveland Clinic Foundation, Case Comprehensive Cancer Center|Sudipto Mukherjee, MD, PhD, MPH|216-444-0506|mukhers2@ccf.org|
21296862|NCT02981966|UTexas_SanAntonio|Ralph DeFronzo, MD|210-567-6691|defronzo@uthscsa.edu|
21296863|NCT00565136|Boston Urogynecology Associates|Peter Rosenblatt, MD; Director of Urogynecology|(617) 354-5452|prosenbl@mah.harvard.edu|
21296864|NCT01218399|Astra Zeneca|Elena Pizzi|+1 302 885 2677|Elena.Pizzi@astrazeneca.com|
21296865|NCT01399268|HSS|Dr. Jules|212.606.1206|JulesK@hss.edu|
21296866|NCT00694304|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
21296867|NCT00576576|Emory|Dr. Habib Samady|4047781237|hsamady@emory.edu|
21296868|NCT03445390|Stanford University|Dr. Mark Burbridge|(650) 353-8484|markburb@stanford.edu|
21296869|NCT02102399|Federal University of Bahia|Lilian Paternostro|+55 (71) 8191-9730|lilian_fono@hotmail.com|
21296870|NCT00955513|Novartis Consumer Health|Clinical Project Leader Pain category|+41223635528||
21296871|NCT04566601|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21296872|NCT03828331|VA Eastern Colorado Healthcare System|Dr. Alena Grabowski|303-492-5208|alena.grabowski@va.gov|
21296873|NCT00746863|UNC Hospitals|Gena Dunivan, MD|919-966-4717|gdunivan@med.unc.edu|
21296874|NCT00495625|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-7257|jonathan.strosberg@moffitt.org|
21296875|NCT00567359|Massachusetts General Hospital|Lecia Van Dam Sequist, M.D.|617-724-4000|LVSEQUIST@PARTNERS.ORG|
21296876|NCT02397057|American Regent, Inc|Mark A. Falone, MD MPH|6317723544|mfalone@americanregent.com|61844
21296877|NCT02352753|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
21296878|NCT00539305|University of Washington|Monique Cherrier PhD.|206-277-3594|cherrier@u.washington.edu|
21296879|NCT02870101|UCLA David Geffen School of Medicine and Fielding School of Public Health|Jeffrey D. Klausner, MD, MPH|310-557-2273|JDKlausner@mednet.ucla.edu|
21296880|NCT03267888|Emory University|Mohammad K Khan|404-778-3473|m.k.khan@emory.edu|
21296881|NCT02893917|Yale School of Medicine: Medical Oncology|Joseph Kim, MD|(203) 200-4822|joseph.w.kim@yale.edu|
21296882|NCT00679172|Emergent Product Development Gaithersburg|Dr. Tim Babinchak|(240) 631-3585||
21296883|NCT00793169|Northwestern University|Murad Alam, MD|312-695-6785|m-alam@northwestern.edu|
21296884|NCT00901199|Children's Hospital & Research Center at Oakland|Ashutosh Lal, MD|510-428-3172|ashutosh.lal@ucsf.edu|
21296885|NCT04395690|Aula Dental Avanzada|G. Esteve-Pardo|965215755|guillem@clinicaesteve.com|
21296886|NCT00434642|Hoffman-LaRoche|Medical Communications|800-821-8590||
21296887|NCT04120363|Pennington Biomedical Research Center|Jennifer C Rood, PhD|225-763-2524|jennifer.rood@pbrc.edu|
21296888|NCT03392649|Univerisity of Chicago Medicine|Dr. Gaurav Upadhyay|773-702-9461|gupadhyay@medicine.bsd.uchicago.edu|
21296889|NCT00753454|UCB Clinical Trial Call Center|UCB (Study Director)|1-887-822-9493||
21296890|NCT05249569|UT Southwestern Medical Center|Dr. David Hsieh|214/648-4180|david.hsieh@utsouthwestern.edu|
21296891|NCT04541628|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
21296892|NCT02781480|MeiraGTx|Chief Medical Officer|+1 973 609-2156|robert.zeldin@meiragtx.com|
21296893|NCT02271945|MedImmune, LLC|Mohammed Dar|301-398-4095|information.center@astrazeneca.com|
21296894|NCT01192412|St. George's, University of London|Dr. Laura A. Magee|+442086729944|LMagee@sgul.ac.uk|52621
21296895|NCT00859937|University of Chicago Comprehensive Cancer Center|Dr. Stuart Wong|773-702-9311|swong@mcw.edu|
21296896|NCT00383942|Loyola University|Scott Graziano, M.D.|708-216-6288|sgrazia@lumc.edu|
21296897|NCT00308074|University of Massachusetts Medical School|Dr. Jean A. Frazier|508-856-5896|ChildResearch@umassmed.edu|
21296898|NCT00687674|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
21296899|NCT01240200|Emory University School of Medicine|Christopher Newton, MD|404-355-4393|cnewton@atlantadiabetes.com|
21296900|NCT00765570|Summa Health System|Tracy Mondello, MS|330-375-6131|mondellot@summahealth.org|
21296901|NCT01529034|Proximagen, LLC|David Sequeira|952-658-7438|dsequeira@proximagen.com|
21296902|NCT02911142|National Cancer Institute|Dr. Ramya Ramaswami|240-506-1088|ramya.ramaswami@nih.gov|
21296903|NCT01178099|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21296904|NCT03266172|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21296905|NCT05222555|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
21296906|NCT00300365|University of Pennsylvania|Dr. Richard L. Dunbar|(215) 315-3378|richard.dunbar@uphs.upenn.edu|
21296907|NCT01274520|Columbia University College of Physicians and Surgeons - Center for Liver Disease and Transplantation|James V. Guarrera, MD, FACS|(212)305.3839|jjg46@cumc.columbia.edu|
21296908|NCT00524017|SKCCC|Dr. Zubair Khan|4109553157|zkhan@jhmi.edu|
21296909|NCT01422824|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
21296910|NCT00902174|Novartis Pharmaceuticals|Study Director|862-778-8300||
21296911|NCT01641822|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
21296912|NCT00454584|Centocor Research & Development, Inc.|Senior Director, Compound Development Team Leader|1 215-793-7612||
21296913|NCT02760810|Johnson & Johnson Vision Care Inc.|Andrea Le, OD, MBA - Manager, Global Medical Affairs|904 4431866|ale3@ITS.JNJ.com|
21296914|NCT02421601|Seikagaku Corporation|Clinical Development Department|(81)3-5220-8948|kyoichi.osano@seikagaku.co.jp|
21296915|NCT01581619|Massachusetts General Hospital|Alphonse Taghian, MD, PhD|617-726-7559|ATAGHIAN@mgh.harvard.edu|
21296916|NCT02250664|University of Vermont|Stephen T. Higgins, PhD, Professor|802-735-6267|stephen.higgins@uvm.edu|
21296917|NCT01716104|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Director of Clinical Research and Medical Information|+74952761571|PutilovskiyMA@materiamedica.ru|302
21296918|NCT00117793|Dept. of Veterans Affairs, Rehabilitation Research & Development Service|Glenn K. Klute, PhD|206-277-6724|Glenn.Klute@va.gov|
21296919|NCT02522442|Sleep Therapy & Research Center|Eric Powell, Ph.D.|(210) 614-6000|powell.eric@sleeptrc.com|
21296920|NCT00975143|Cipher Pharmaceuticals Inc.|Julia Chan, RAC|905-602-5840|jchan@cipherpharma.com|326
21296921|NCT01753401|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
21296922|NCT00581360|Clinical Research Services, UPCI|Rita Johnson, Associate Director of Clinical Research Services|412-647-8571|johnsonr1@upmc.edu|
21296923|NCT03129360|NYU Langone Health|Donald Goff, MD|646.485.4843|Donald.Goff@nyulangone.org|
21296924|NCT00599638|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21296925|NCT01463202|Center for Family Planning Research|Principal Investigator|412-641-5496|fpr@upmc.edu|
21296926|NCT02825212|Icahn School of Medicine at Mount Sinai|Dr. Peter D. Gorevic|212-241-0968|peter.gorevic@mountsinai.org|
21296927|NCT03006887|Eisai, Inc.|Inquiry Service||eisai-chiken_hotline@hhc.eisai.co.jp|
21296928|NCT03836677|AstraZeneca AB|AstraZeneca AB|1-877-240-9479|information.center@astrazeneca.com|
21296929|NCT02895945|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
21296930|NCT00462748|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
21296931|NCT01818492|Sobi AB|Carl Johan Treutiger|46 76 00 11 815|CarlJohan.Treutiger@sobi.com|
21296932|NCT00082381|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
21296933|NCT01729208|CooperVision Inc.|Paul Chamberlain|925 730-6754|PChamberlain@coopervision.com|
21296934|NCT02428413|Teleflex|Thomas Philbeck, PhD, MBA, Senior Director of Global Research and Scientific Services|210-581-7778|thomas.philbeck@teleflex.com|
21296935|NCT00109577|University of Calgary|Dr. Bonnie Kaplan|403-955-7363|kaplan@ucalgary.ca|
21296936|NCT04891107|Boston University Department of Physical Therapy & Athletic Training|Terry Ellis PT, PhD, FAPTA|617-353-7571|tellis@bu.edu|
21296937|NCT02964585|George Washington University Medical Faculty Associates|Dr. Sabyasachi Sen|202-741-2233|ssen1@email.gwu.edu|
21296938|NCT02879578|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
21296939|NCT03040115|University of Cincinnati|Elizabeth Kopras, Senior Research Associate|513-558-7205|koprasej@uc.edu|
21296940|NCT03517566|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
21296941|NCT04566692|Grifols Therapeutics LLC|Rhonda Griffin|+1 919 757 1744|rhonda.griffin@grifols.com|
21296942|NCT00671437|Washington University School of Medicine|Dr. Douglas R. Adkins|314-362-5654|dadkins@dom.wustl.edu|
21296943|NCT00590577|Johnson & Johnson Pharmaceutical Research & Development|Compound Development Team Leader, Paliperidone|609-730-4530||
21296944|NCT00303511|Emory University|Dr. Wendy Book|404-778-5545|wbook@emory.edu|
21296945|NCT00123604|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
21296946|NCT04512976|University of Texas Southwestern Medical Center|Craig Crandall|214-345-4623|craigcrandall@texashealth.org|
21296947|NCT00414518|University of Colorado Denver|Michelle A. Barron|303-724-4939|michelle.barron@ucdenver.edu|
21296948|NCT03950492|WVU Rockefeller Neuroscience Institute|James Mahoney, PhD|304-293-5323|james.mahoney@hsc.wvu.edu|
21296949|NCT00597493|Duke University Health System|David Reardon, MD|617-632-2166|David_Reardon@DFCI.harvard.edu|
21296950|NCT00615030|Novartis Pharmaceuticals|Study Director|862-778-8300||
21296951|NCT00151476|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
21296952|NCT03446456|University of Maryland School of Nursing|Rachel Massalee|4107068244|rmassalee@umaryland.edu|
21296953|NCT03433417|Cutera, Inc.|Margot Doucette|(415) 657-5518|mdoucette@cutera.com|
21296954|NCT04532931|Shin Poong Pharm. Co., Ltd.|Shin Poong Pharm. Co., Ltd.|82-2-2189-3478|bwon@shinpoong.co.kr|
21296955|NCT03781505|Aga Khan University|Dr. Muhammad Saad Yousuf|+92213486|saad.yousuf@aku.edu|4253
21296956|NCT00065806|Duke University Medical Center|Laura Schanberg, MD|919-684-6575|laura.schanberg@duke.edu|
21296957|NCT00581867|University of Kansas Medical Center|Dr. Jeffrey Burns|(913) 588-0555|jburns2@kumc.edu|
21296958|NCT03002311|WASHINGTON UNIVERSITY MEDICAL SCHOOL|Brian F. Gage, MD|3144548697|bgage@wustl.edu|
21296959|NCT02092311|OMID FERTILITY CENTER|Dr.Navid Pooyan|00989124474032|navidpooyan@yahoo.com|
21296960|NCT00652080|Berg LLC|Nathaniel DiTommaso|617-588-1002|nate.ditommaso@berghealth.com|
21296961|NCT01329939|North Shore - Long Island Jewish Health System; Hofstra North Shore-LIJ School of Medicine|Dr. Sherry Farzan, Attending Physician, Assistant Professor of Medicine and Pediatrics|5166225070|sfarzan@nshs.edu|
21296962|NCT03722524|AO Servier|Natalya LOGUNOVA|+7 495 9370700|Natalya.LOGUNOVA@servier.com|
21296963|NCT00989963|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director||info@lungbiotechnology.com|
21296964|NCT02408263|HSS|Dr. Gungor|212.606.1206|GungorS@hss.edu|
21296965|NCT00612560|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
21296966|NCT04588389|UMass Chan Medical School|Dr Alexander Chan for Eman Nada, MD|7743030338|alexander.chan@umassmemorial.org|
21296967|NCT02227394|Zambon S.p.A.|Luca Raiteri, MD|+39 02 6652461|luca.raiteri@zambongroup.com|
21296968|NCT00663403|University of Michigan College of Pharmacy|Bruce A. Mueller|7347636629|muellerb@umich.edu|
21296969|NCT00719680|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
21296970|NCT00658814|SWOG|Study Statistician|206-667-4623||
21296971|NCT04071158|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21296972|NCT02703480|Tufts University School of Dental Medicine|Associate Professor|6176366659|yumi.ogata@tufts.edu|
21296973|NCT03445559|VA New York Harbor Healthcare System|Dr. Danil V. Makarov|212-686-7500|Danil.Makarov@Va.gov|
21296974|NCT02678923|The Medicines Company|Global Health Science Center|1-888-977-6326|medical.information@themedco.com|
21296975|NCT00455143|Icahn School of Medicine at Mount Sinai|Department of Anesthesiology|212-241-7473||
21296976|NCT04921332|University of Pittsburgh|Erica Osborn DNP, CRNP|814-282-9793|elo25@pitt.edu|
21296977|NCT01966445|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
21296978|NCT01374178|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
21296979|NCT04856904|Galderma R&D, Inc.|Clinical Scientist|+46184749000|reception.seupp@galderma.com|
21296980|NCT01375608|NIH, NHLBI, MCHB|Dr Matthew Hsieh|301-402-7687|matthewhs@nhlbi.nih.gov|
21296981|NCT03429543|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
21296982|NCT03077204|Ascension Texas Spine and Scoliosis|Devender Singh, Research Scientist|512 324 3580|dpsingh@ascension.org|15916
21296983|NCT03322423|Johnson & Johnson Vision Care Inc.|Thomas Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|1-904-443-3402|TKarkkai@its.jnj.com|
21251302|NCT02485899|BioMarin Pharmaceutical, Inc.|Trial Specialist|1-800-983-4587|medinfo@bmrn.com|
21251303|NCT00436956|National Cancer Institute|William L. Dahut, M.D.|301-435-8183|dahutw@mail.nih.gov|
21251304|NCT05674292|Erchonia Corporation|Clinical Affairs Manager|8882420571|tsammons@erchonia.com|501
21251305|NCT01841112|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21251306|NCT00623363|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
21251307|NCT03713320|Viridian Therapeutics (formerly miRagen Therapeutics)|Regulatory Affairs|720-722-5917|clinicaltrials@viridiantherapeutics.com|
21251308|NCT01880437|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21251309|NCT00909532|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com|
21251310|NCT01209598|Memorial Sloan Kettering Cancer Center|Mark Dickson, MD|646-888-4164|dicksonm@mskcc.org|
21251311|NCT01062269|Louisville Metabolic and Atherosclerosis Research Center (L-MARC)|Harold E. Bays, MD|502-515-5672|HBaysMD@aol.com|
21251312|NCT00085566|Memorial Sloan Kettering Cancer Center|Dr. Howard Scher|646-422-4323|scherh@mskcc.org|
21251313|NCT02111863|National Cancer Institute|Dr. Steven A. Rosenberg|301-496-4164|steven-rosenberg@nih.gov|
21251314|NCT02604342|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
21251315|NCT01702519|GlaxoSmithKline|GSK Response Center|866-435-7343||
21251316|NCT03559829|Associate Professor of Neurology and Neurological Sciences|Maarten G. Lansberg, MD PhD|(650) 723-4448|lansberg@stanford.edu|
21251317|NCT01837797|Study Director|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
21251318|NCT01664897|The University of Texas MD Anderson Cancer Center|Jorge Cortes MD./Professor|713-794-5783|jcortes@mdanderson.org|
21251319|NCT04522778|UPMC|Ryan St. Pierre-Hetz|3154369898|stpierrehetzre@upmc.edu|
21251320|NCT00069277|Eisai Inc|Eisai Call Center|888-422-4743||
21251321|NCT00953199|Penn State Hershey Medical center|Abraham Mathew MD|717 531 3834|amathew@hmc.psu.edu|
21251322|NCT01225159|Department of Anesthesiology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand|Dr.Panthila Rujirojindakul, Staff|+66 74 45 1651|rpanthi@medicine.psu.ac.th|
21251323|NCT01770314|Inflexxion|Emil Chiauzzi|617-614-0429|echiauzzi@inflexxion.com|
21251324|NCT02083679|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
21251325|NCT01220856|Dompé SpA|Luisa Daffonchio, PhD|+39 583831|daffonchio@dompe.it|
21251326|NCT04814992|University of Pennsylvania|Dr. Peggy Compton|2158988283|pcompton@nursing.upenn.edu|
21251327|NCT00557349|University of Missouri|Archana Ramaswamy, MD|573-884-4003|ramaswamya@health.missouri.edu|
21251328|NCT00934700|Imperial College London|Research Integrity Officer|+44 020 7594 1872|jrco@imperial.ac.uk|
21251329|NCT00143598|Centre for Clinical Epidemiology, Jewish General Hospital|Dr. Susan R Kahn|514-340-8222|susan.kahn@mcgill.ca|7587
21251330|NCT03900715|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
21251331|NCT01329185|University of Minnesota|Dr. Priya Verghese, Director of Pediatric Kidney Transplantation|6126262922|pverghes@umn.edu|0
21251332|NCT02034019|Ocular Therapeutix, Inc.|Director, Clinical Affairs|781-357-4000|dmulani@ocutx.com|
21251333|NCT03113383|Vanderbilt University Medical Center|Thomas C Naslund, MD|5-322-2343|thomas.naslund@vumc.org|
21251334|NCT02122172|University of Chicago|Dr. Peter O'Donnell|(773) 702-7564|podonnel@bsd.uchicago.edu|
21251335|NCT03062449|Dartmouth Health|Aleksandra C. Stark|(603) 650-5104|Aleksandra.C.Stark@hitchcock.org|
21251336|NCT03765398|University of Illinois at Chicago|Tanvi Bhatt|3123554443|tbhatt6@uic.edu|
21251337|NCT01296763|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Thomas Brown|410-502-5328|tbrown55@jhmi.edu|
21251338|NCT03194867|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
21296984|NCT01141491|MabVax Therapeutics, Inc.|Dave Hansen|858.259.9405|dhansen@mabvax.com|301
21296985|NCT02453555|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
21296986|NCT03045341|Yale University|Dr Carlos Grilo|203 785 7210|carlos.grilo@yale.edu|
21296987|NCT02409719|Universidad Autonoma de Nuevo Leon|FELIX VILCHEZ CAVAZOS|8183476698|vilchez.doctor@gmail.com|
21296988|NCT01054625|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
21296989|NCT03689855|Washington University School of Medicine|Daniel Morgensztern, M.D.|314-747-7948|danielmorgensztern@wustl.edu|
21296990|NCT00619099|Eisai Inc.|Erhan Berrack, M.D.|888-422-4743||
21296991|NCT00885482|Catholic University of S. Heart|Andrea De Luca|+390630155366|deluca.andrea@fastwebnet.it|
21296992|NCT00989781|UCSD|R. Jeffrey Chang, M.D.|858-534-8930|rjchang@ucsd.edu|
21296993|NCT01532869|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
21296994|NCT02438813|Allergan, Inc|Medical Director/ Epidemiologist|714-246-4500|clinicaltrials@allergan.com|
21251461|NCT03432390|Anesthesiology Unit, Teaching Hospital of the Federal University of Pernambuco, Recife, Pernambuco, Brazil|Dr. Jayme Marques dos Santos Neto|5581996212977|jaymemed@yahoo.com.br|
21251462|NCT05702541|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
21251463|NCT01774305|Yonsei Univ. Health System, Gangnam Severance Hospital|Dr. Jeongsoo Lee|+82-2-2019-6092|ration99@yuhs.ac|
21251464|NCT03738397|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21251465|NCT00691678|Columbia University|Dawn L. Hershman, MD|212-305-1945|dlh23@cumc.columbia.edu|
21251466|NCT03049306|Johns Hopkins University School of Medicine|Jonathan Jun|410-550-0115|jjun2@jhmi.edu|
21251467|NCT03972397|The University of Texas Health Science Center at Houston|Anthony L Estrera, MD|713-486-5100|anthony.l.estrera@uth.tmc.edu|
21296995|NCT00778895|GlaxoSmithKline|GSK Response Center|866-435-7343||
21296996|NCT05096312|East Avenue Medical Center|Dr. Monqiue Lianne Lim-Ang|0287100957|moniquelianne.lim@gmail.com|
21296997|NCT03135210|University of Minnesota|Amanda Sharp|(612) 626-4691|sharp@umn.edu|
21296998|NCT00552409|University of Washington|Dr. Ian de Boer|206-616-5403|deboer@u.washington.edu|
21296999|NCT02647346|Podimetrics Inc|Brian Petersen|860-558-9204|brian@podimetrics.com|
21297000|NCT01805037|Northwestern University, Feinberg School of Medicine|Barbara Pro, MD|312-695-6180|barbara.pro@northwestern.edu|
21297001|NCT01270256|University of Chicago|Dr. Robert M Naclerio|773-702-0080|rnackeri@surgery.bsd.uchicago.edu|
21297002|NCT01229449|Reckitt Benckiser Healthcare International|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
21297003|NCT03203291|Columbia University Irving Medical Center|Sunil Agrawal, PhD|(212) 854-2841|sunil.agrawal@columbia.edu|
21297004|NCT00439374|Northwestern University Medical School|William Grobman, MD|312-472-4661|w-grobman@northwestern.edu|
21297005|NCT05098509|Radius Pharmaceuticals, Inc.|Ellie Ratigan|617-444-1800|scout015@radiuspharm.com|
21297006|NCT02533726|Stanford University School of Medicine|Dr David Pickham|650 701 6830|dpickham@stanford.edu|
21297007|NCT03157037|Linköping University|Professor Mårten Segelmark|+46 70 287 19 44|marten.segelmark@liu.se|
21297008|NCT01919216|New York State Psychiatric Institute|Bret Rutherford|6467748660|brr8@cumc.columbia.edu|
21297009|NCT04349033|Wayne State University|Dr. Mark A. Lumley, Professor|3135772247|mlumley@wayne.edu|
21297010|NCT00324233|Coloplast A/S|Kristine Gjødsbøl, PhD|+4549113557|dkkg@coloplast.com|
21297011|NCT01707381|Bausch + Lomb|Heleen DeCory, Ph.D.|(585) 338-8161|Heleen.DeCory@bausch.com|
21297012|NCT01704456|UBC|Dr Lori Brotto|604-875-4111|lori.brotto@vch.ca|68898
21297013|NCT04583956|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
21297014|NCT04016077|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21297015|NCT00915551|LEO Pharma|Dr. Torsten Skov|+4520736294|torsten.skov@leo-pharma.com|
21297016|NCT03908970|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
21297017|NCT01729494|University of Cincinnati|Rita R. Alloway, Pharm.D., Director of Clinical Trials|513-558-1568|rita.alloway@uc.edu|
21297018|NCT04943432|University of North Carolina at Chapel Hill|Catherine Paquette, MA, MPS|919-962-5082|cpaq@live.unc.edu|
21297019|NCT01123707|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
21297020|NCT02986802|Kaiser Permanente Division of Research|De-Kun Li, MD, PhD|510.891.3755|De-Kun.Li@kp.org|
21297021|NCT00488826|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
21297022|NCT02725866|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
21297023|NCT01549977|Takeda|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
21297024|NCT01705106|University of Chicago|Manish R. Sharma, MD|773-834-0312|msharma@bsd.uchicago.edu|
21297025|NCT00006400|New England Research Institutes, Inc|Julie Miller|617-972-3197|JMiller@healthcore.com|
21297026|NCT00671606|UT MD Anderson Cancer Center|Dr. Michael Frumovitz, ND/Assistant Professor||tjohnsto@mdanderson.org|
21297027|NCT00605345|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21297028|NCT02577016|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
21297029|NCT02126839|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
21297030|NCT00411632|UT MD Anderson Cancer Center|Dr. John V Heymach, PHD/ Chair, Thoracic-Head & Neck Med Onc|713-792-6363|jheymach@mdanderson.org|
21297031|NCT01108523|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
21297032|NCT00761527|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
21297033|NCT03210961|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
21297034|NCT00680459|Baystate Medical Center|Dr. Christine McKiernan|413-794-5370|Christine.McKiernan@bhs.org|
21297035|NCT02625844|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
21297036|NCT02376179|Nationwide Children's Hospital|Kris Jatana, MD|614-722-6032|Kris.Jatana@nationwidechildrens.org|
21297037|NCT01248741|British Columbia Cancer Agency|Dr Juanita Crook|2507123958|jcrook@bccancer.bc.ca|
21297038|NCT02454478|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
21297039|NCT02227667|Memorial Sloan Kettering Cancer Center|Dr. Neil Segal, MD, PhD|646-888-4187|segaln@mskcc.org|
21297040|NCT01732770|Amgen Inc.|Study Director|866-572-6436||
21297041|NCT00389493|New York State Psychiatric Institute|Dr. Helen Blair Simpson|646-774-7000|kimeldo@nyspi.columbia.edu|
21297042|NCT00791089|University of Michigan|Hakan Oral|734 936-6868|oralh@med.umich.edu|
21297043|NCT01959841|Maruho Co.,Ltd. Kyoto R&D Center|linical Development Dept.|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
21297044|NCT00860171|Fred Hutchinson Cancer Research Center|Ajay K. Gopal, MD|206-288-2037|agopal@u.washington.edu|
21297045|NCT00780416|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
